id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
156407542|NCT02906683|564587306|FG000|Overall Study|Adverse Event|0|||
156407543|NCT02906683|564587307|FG001|Overall Study|Adverse Event|1|||
156407544|NCT02906683|564587308|FG002|Overall Study|Adverse Event|0|||
156407545|NCT02906683|564587306|FG000|Overall Study|Physician Decision|0|||
156407546|NCT02906683|564587307|FG001|Overall Study|Physician Decision|1|||
156407547|NCT02906683|564587308|FG002|Overall Study|Physician Decision|1|||
156407548|NCT02906683|564587306|FG000|Overall Study|Withdrawal by Subject|0|||
156407549|NCT02906683|564587307|FG001|Overall Study|Withdrawal by Subject|2|||
156407550|NCT02906683|564587308|FG002|Overall Study|Withdrawal by Subject|1|||
156407551|NCT02906683|564587306|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
156407552|NCT02906683|564587307|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
156407553|NCT02906683|564587308|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
156407554|NCT02906683|564587306|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
156407555|NCT02906683|564587307|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
156407556|NCT02906683|564587308|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
156407557|NCT01167179|564587311|FG000|Overall Study|disease recurrence|4|||
156407558|NCT01167179|564587312|FG001|Overall Study|disease recurrence|4|||
156407559|NCT01167179|564587311|FG000|Overall Study|Death|4|||
156407560|NCT01167179|564587312|FG001|Overall Study|Death|10|||
156407561|NCT01167179|564587311|FG000|Overall Study|Withdrawal by Subject|1|||
156407562|NCT01167179|564587312|FG001|Overall Study|Withdrawal by Subject|2|||
156407563|NCT01167179|564587311|FG000|Overall Study|diverse|6|||
156407564|NCT01167179|564587312|FG001|Overall Study|diverse|5|||
156407565|NCT00663117|564587313|FG000|Overall Study|Lack of Efficacy|1|||
156407566|NCT00663117|564587314|FG001|Overall Study|Lack of Efficacy|0|||
156407567|NCT01158378|564587315|FG000|Overall Study|Death|4|||
156407568|NCT01158378|564587316|FG001|Overall Study|Death|5|||
156407569|NCT01158378|564587315|FG000|Overall Study|Lost to Follow-up|2|||
156407570|NCT01158378|564587316|FG001|Overall Study|Lost to Follow-up|4|||
156407571|NCT01158378|564587315|FG000|Overall Study|Withdrawal by Subject|4|||
156407572|NCT01158378|564587316|FG001|Overall Study|Withdrawal by Subject|0|||
156407573|NCT02769065|564587317|FG000|Overall Study|Voluntary Withdrawal|1|||
156407574|NCT02769065|564587318|FG001|Overall Study|Voluntary Withdrawal|0|||
156407575|NCT02769065|564587319|FG002|Overall Study|Voluntary Withdrawal|0|||
156407576|NCT02769065|564587320|FG003|Overall Study|Voluntary Withdrawal|0|||
156407577|NCT02769065|564587321|FG004|Overall Study|Voluntary Withdrawal|0|||
156407578|NCT02769065|564587322|FG005|Overall Study|Voluntary Withdrawal|0|||
156407579|NCT02769065|564587323|FG006|Overall Study|Voluntary Withdrawal|0|||
156407580|NCT02769065|564587324|FG007|Overall Study|Voluntary Withdrawal|0|||
156407581|NCT02769065|564587325|FG008|Overall Study|Voluntary Withdrawal|0|||
156407582|NCT02769065|564587326|FG009|Overall Study|Voluntary Withdrawal|0|||
156407583|NCT02769065|564587327|FG010|Overall Study|Voluntary Withdrawal|0|||
156407584|NCT02769065|564587328|FG011|Overall Study|Voluntary Withdrawal|0|||
156407585|NCT02769065|564587329|FG012|Overall Study|Voluntary Withdrawal|0|||
156407586|NCT02769065|564587330|FG013|Overall Study|Voluntary Withdrawal|0|||
156407587|NCT02769065|564587331|FG014|Overall Study|Voluntary Withdrawal|0|||
156407588|NCT02769065|564587332|FG015|Overall Study|Voluntary Withdrawal|0|||
156407589|NCT02769065|564587333|FG016|Overall Study|Voluntary Withdrawal|0|||
156407590|NCT02769065|564587334|FG017|Overall Study|Voluntary Withdrawal|0|||
156407591|NCT02769065|564587335|FG018|Overall Study|Voluntary Withdrawal|0|||
156407592|NCT02769065|564587336|FG019|Overall Study|Voluntary Withdrawal|0|||
156407593|NCT02769065|564587337|FG020|Overall Study|Voluntary Withdrawal|0|||
156407594|NCT02769065|564587338|FG021|Overall Study|Voluntary Withdrawal|0|||
156407595|NCT02769065|564587339|FG022|Overall Study|Voluntary Withdrawal|0|||
156407596|NCT02769065|564587340|FG023|Overall Study|Voluntary Withdrawal|0|||
156407597|NCT02769065|564587341|FG024|Overall Study|Voluntary Withdrawal|0|||
156407598|NCT02769065|564587342|FG025|Overall Study|Voluntary Withdrawal|0|||
156407599|NCT02769065|564587343|FG026|Overall Study|Voluntary Withdrawal|0|||
156407600|NCT02769065|564587344|FG027|Overall Study|Voluntary Withdrawal|0|||
156407601|NCT02769065|564587345|FG028|Overall Study|Voluntary Withdrawal|0|||
156407602|NCT02769065|564587346|FG029|Overall Study|Voluntary Withdrawal|0|||
156407603|NCT02769065|564587317|FG000|Overall Study|Reason Not Specified|0|||
156407604|NCT02769065|564587318|FG001|Overall Study|Reason Not Specified|0|||
156407605|NCT02769065|564587319|FG002|Overall Study|Reason Not Specified|0|||
156407606|NCT02769065|564587320|FG003|Overall Study|Reason Not Specified|0|||
156407607|NCT02769065|564587321|FG004|Overall Study|Reason Not Specified|0|||
156407608|NCT02769065|564587322|FG005|Overall Study|Reason Not Specified|0|||
156407609|NCT02769065|564587323|FG006|Overall Study|Reason Not Specified|1|||
156407610|NCT02769065|564587324|FG007|Overall Study|Reason Not Specified|0|||
156407611|NCT02769065|564587325|FG008|Overall Study|Reason Not Specified|0|||
156407612|NCT02769065|564587326|FG009|Overall Study|Reason Not Specified|0|||
156407613|NCT02769065|564587327|FG010|Overall Study|Reason Not Specified|0|||
156407614|NCT02769065|564587328|FG011|Overall Study|Reason Not Specified|0|||
156407615|NCT02769065|564587329|FG012|Overall Study|Reason Not Specified|0|||
156635644|NCT03255226|565412138|FG000|Overall Study|Adverse Event|2|||
156407616|NCT02769065|564587330|FG013|Overall Study|Reason Not Specified|0|||
156407617|NCT02769065|564587331|FG014|Overall Study|Reason Not Specified|0|||
156407618|NCT02769065|564587332|FG015|Overall Study|Reason Not Specified|0|||
156407619|NCT02769065|564587333|FG016|Overall Study|Reason Not Specified|0|||
156407620|NCT02769065|564587334|FG017|Overall Study|Reason Not Specified|0|||
156407621|NCT02769065|564587335|FG018|Overall Study|Reason Not Specified|0|||
156407622|NCT02769065|564587336|FG019|Overall Study|Reason Not Specified|0|||
156407623|NCT02769065|564587337|FG020|Overall Study|Reason Not Specified|0|||
156407624|NCT02769065|564587338|FG021|Overall Study|Reason Not Specified|0|||
156407625|NCT02769065|564587339|FG022|Overall Study|Reason Not Specified|0|||
156407626|NCT02769065|564587340|FG023|Overall Study|Reason Not Specified|0|||
156407627|NCT02769065|564587341|FG024|Overall Study|Reason Not Specified|0|||
156407628|NCT02769065|564587342|FG025|Overall Study|Reason Not Specified|0|||
156407629|NCT02769065|564587343|FG026|Overall Study|Reason Not Specified|0|||
156407630|NCT02769065|564587344|FG027|Overall Study|Reason Not Specified|0|||
156407631|NCT02769065|564587345|FG028|Overall Study|Reason Not Specified|0|||
156407632|NCT02769065|564587346|FG029|Overall Study|Reason Not Specified|0|||
156407633|NCT02769065|564587317|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407634|NCT02769065|564587318|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407635|NCT02769065|564587319|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407636|NCT02769065|564587320|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407637|NCT02769065|564587321|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407638|NCT02769065|564587322|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407639|NCT02769065|564587323|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407640|NCT02769065|564587324|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407641|NCT02769065|564587325|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407642|NCT02769065|564587326|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407643|NCT02769065|564587327|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
156407644|NCT02769065|564587328|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407645|NCT02769065|564587329|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407646|NCT02769065|564587330|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407647|NCT02769065|564587331|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407648|NCT02769065|564587332|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407649|NCT02769065|564587333|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407650|NCT02769065|564587334|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407651|NCT02769065|564587335|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407652|NCT02769065|564587336|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407653|NCT02769065|564587337|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407654|NCT02769065|564587338|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407655|NCT02769065|564587339|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407656|NCT02769065|564587340|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407657|NCT02769065|564587341|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407658|NCT02769065|564587342|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407659|NCT02769065|564587343|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
156863836|NCT00303069|566260781|FG000|Overall Study|Lost to Follow-up|1|||
156863837|NCT00303069|566260782|FG001|Overall Study|Lost to Follow-up|0|||
156863838|NCT00303069|566260783|FG002|Overall Study|Lost to Follow-up|0|||
156863839|NCT00303069|566260784|FG003|Overall Study|Lost to Follow-up|2|||
156863840|NCT00303069|566260781|FG000|Overall Study|subject moved|1|||
156863841|NCT00303069|566260782|FG001|Overall Study|subject moved|0|||
156863842|NCT00303069|566260783|FG002|Overall Study|subject moved|0|||
156407660|NCT02769065|564587344|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407661|NCT02769065|564587345|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407662|NCT02769065|564587346|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
156407663|NCT02531295|564587347|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
156407664|NCT02531295|564587348|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
156407665|NCT02531295|564587349|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
156407666|NCT02531295|564587350|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
156407667|NCT02531295|564587351|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
156635645|NCT03255226|565412138|FG000|Overall Study|Physician Decision|3|||
156635646|NCT03255226|565412138|FG000|Overall Study|Withdrawal by Subject|1|||
156635647|NCT03255226|565412138|FG000|Overall Study|Serum or blood sodium increased|4|||
156635648|NCT03255226|565412138|FG000|Overall Study|Serum or blood potassium increased|4|||
156407668|NCT02531295|564587352|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
156407669|NCT01923896|564587354|FG000|Overall Study|Adverse Event|1|||
156407670|NCT01923896|564587355|FG001|Overall Study|Adverse Event|0|||
156635649|NCT01035229|565412139|FG000|Overall Study|Adverse Event|61|||
156863843|NCT00303069|566260784|FG003|Overall Study|subject moved|0|||
156863844|NCT00303069|566260781|FG000|Overall Study|Recruitment into Army Reserves|0|||
156863845|NCT00303069|566260782|FG001|Overall Study|Recruitment into Army Reserves|0|||
156863846|NCT00303069|566260783|FG002|Overall Study|Recruitment into Army Reserves|1|||
156863847|NCT00303069|566260784|FG003|Overall Study|Recruitment into Army Reserves|0|||
156407671|NCT03545113|564587358|FG000|Overall Study|Surgery Cancelled|1|||
156407672|NCT03545113|564587359|FG001|Overall Study|Surgery Cancelled|0|||
156407673|NCT03545113|564587358|FG000|Overall Study|Death|1|||
156407674|NCT03545113|564587359|FG001|Overall Study|Death|0|||
156407675|NCT03545113|564587358|FG000|Overall Study|Adverse Event|2|||
156407676|NCT03545113|564587359|FG001|Overall Study|Adverse Event|0|||
156407677|NCT03545113|564587358|FG000|Overall Study|Received different surgery|1|||
156407678|NCT03545113|564587359|FG001|Overall Study|Received different surgery|0|||
156863848|NCT00092417|566260785|FG000|Overall Study|Lost to Follow-up|2|||
156863849|NCT00092417|566260786|FG001|Overall Study|Lost to Follow-up|0|||
156863850|NCT00092417|566260785|FG000|Overall Study|Withdrawal by Subject|2|||
156863851|NCT00092417|566260786|FG001|Overall Study|Withdrawal by Subject|1|||
156863852|NCT00092417|566260785|FG000|Overall Study|Other|1|||
156863853|NCT00092417|566260786|FG001|Overall Study|Other|0|||
156863854|NCT01520506|566260787|FG000|Overall Study|Missed Visit|4|||
156863855|NCT01520506|566260787|FG000|Overall Study|Lost to Follow-up|1|||
156863856|NCT01520506|566260787|FG000|Overall Study|Withdrawal by Subject|1|||
156863857|NCT00425269|566260788|FG000|Overall Study|Pregnancy|5|||
156863858|NCT00425269|566260789|FG001|Overall Study|Pregnancy|7|||
156863859|NCT00425269|566260788|FG000|Overall Study|Lost to Follow-up|9|||
156863860|NCT00425269|566260789|FG001|Overall Study|Lost to Follow-up|9|||
156863861|NCT00425269|566260788|FG000|Overall Study|moved or medical reason|5|||
156863862|NCT00425269|566260789|FG001|Overall Study|moved or medical reason|4|||
156863863|NCT01084655|566260794|FG000|Overall Study|Radiographic disease progression|3|||
156863864|NCT01084655|566260795|FG001|Overall Study|Radiographic disease progression|2|||
156863865|NCT01084655|566260796|FG002|Overall Study|Radiographic disease progression|8|||
156863866|NCT01084655|566260794|FG000|Overall Study|Withdrawal by Subject|1|||
156863867|NCT01084655|566260795|FG001|Overall Study|Withdrawal by Subject|0|||
156863868|NCT01084655|566260796|FG002|Overall Study|Withdrawal by Subject|4|||
156863869|NCT01084655|566260794|FG000|Overall Study|Adverse Event|2|||
156863870|NCT01084655|566260795|FG001|Overall Study|Adverse Event|1|||
156863871|NCT01084655|566260796|FG002|Overall Study|Adverse Event|2|||
156863872|NCT01084655|566260794|FG000|Overall Study|Other|0|||
156863873|NCT01084655|566260795|FG001|Overall Study|Other|3|||
156863874|NCT01084655|566260796|FG002|Overall Study|Other|2|||
156863875|NCT01084655|566260794|FG000|Overall Study|Symptomatic deterioration|0|||
156863876|NCT01084655|566260795|FG001|Overall Study|Symptomatic deterioration|0|||
156863877|NCT01084655|566260796|FG002|Overall Study|Symptomatic deterioration|2|||
156863878|NCT01084655|566260794|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
156863879|NCT01084655|566260795|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
156863880|NCT01084655|566260796|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
156863881|NCT01256788|566260797|FG000|Overall Study|Lost to Follow-up|5|||
156863882|NCT01256788|566260798|FG001|Overall Study|Lost to Follow-up|8|||
156863883|NCT01256788|566260799|FG002|Overall Study|Lost to Follow-up|3|||
156863884|NCT01972217|566260800|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
156863885|NCT01972217|566260801|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
156863886|NCT01972217|566260802|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
156863887|NCT01972217|566260803|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
156863888|NCT01972217|566260800|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
156863889|NCT01972217|566260801|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
156863890|NCT01972217|566260802|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
156863891|NCT01972217|566260803|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
156863892|NCT01972217|566260800|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
156863893|NCT01972217|566260801|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
156863894|NCT01972217|566260802|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
156863895|NCT01972217|566260803|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
156863896|NCT01972217|566260800|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
156863897|NCT01972217|566260801|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
156863898|NCT01972217|566260802|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
156863899|NCT01972217|566260803|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
156863900|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Death|0|||
156863901|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Death|0|||
156407679|NCT00474929|564587363|FG000|Overall Study|Withdrawal by Subject|0|||
156407680|NCT00474929|564587364|FG001|Overall Study|Withdrawal by Subject|1|||
156407681|NCT00474929|564587365|FG002|Overall Study|Withdrawal by Subject|0|||
156863902|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Death|43|||
156863903|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Death|44|||
156863904|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
156863905|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
156863906|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
156407682|NCT00474929|564587366|FG003|Overall Study|Withdrawal by Subject|0|||
156407683|NCT00474929|564587367|FG004|Overall Study|Withdrawal by Subject|0|||
156407684|NCT00474929|564587363|FG000|Overall Study|Unrelated medical condition|0|||
156863907|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
156863908|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
156407685|NCT00474929|564587364|FG001|Overall Study|Unrelated medical condition|0|||
156407686|NCT00474929|564587365|FG002|Overall Study|Unrelated medical condition|1|||
156863909|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
156863910|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
156863911|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
156863912|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
156863913|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
156863914|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
156863915|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
156863916|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
156863917|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
156863918|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
156863919|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
156863920|NCT00906204|566260804|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
156863921|NCT00906204|566260805|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
156863922|NCT00906204|566260804|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
156863923|NCT00906204|566260805|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
156863924|NCT00906204|566260804|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
156863925|NCT00906204|566260805|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
156863926|NCT00906204|566260804|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
156863927|NCT00906204|566260805|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
156863928|NCT00906204|566260804|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
156863929|NCT00906204|566260805|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
156863930|NCT00696072|566260806|FG000|Overall Study|continuing active treatment|10|||
156863931|NCT00696072|566260807|FG001|Overall Study|continuing active treatment|13|||
156863932|NCT00696072|566260806|FG000|Overall Study|Adverse Event|10|||
156863933|NCT00696072|566260807|FG001|Overall Study|Adverse Event|6|||
156863934|NCT00696072|566260806|FG000|Overall Study|Patient Request|3|||
156863935|NCT00696072|566260807|FG001|Overall Study|Patient Request|7|||
156863936|NCT00696072|566260806|FG000|Overall Study|Investigator Request|1|||
156863937|NCT00696072|566260807|FG001|Overall Study|Investigator Request|4|||
156863938|NCT00696072|566260806|FG000|Overall Study|Sponsor Request|0|||
156863939|NCT00696072|566260807|FG001|Overall Study|Sponsor Request|1|||
156863940|NCT00696072|566260806|FG000|Overall Study|Disease Progression|32|||
156863941|NCT00696072|566260807|FG001|Overall Study|Disease Progression|30|||
156863942|NCT00696072|566260806|FG000|Overall Study|Non-specified|1|||
156863943|NCT00696072|566260807|FG001|Overall Study|Non-specified|2|||
156863944|NCT01597596|566260808|FG000|Overall Study|Study terminated by sponsor|1|||
156863945|NCT01597596|566260809|FG001|Overall Study|Study terminated by sponsor|0|||
156863946|NCT01597596|566260808|FG000|Overall Study|Physician Decision|0|||
156407687|NCT00474929|564587366|FG003|Overall Study|Unrelated medical condition|0|||
156407688|NCT00474929|564587367|FG004|Overall Study|Unrelated medical condition|0|||
156407689|NCT00474929|564587363|FG000|Overall Study|Physician Decision|0|||
156407690|NCT00474929|564587364|FG001|Overall Study|Physician Decision|0|||
156407691|NCT00474929|564587365|FG002|Overall Study|Physician Decision|1|||
156407692|NCT00474929|564587366|FG003|Overall Study|Physician Decision|2|||
156407693|NCT00474929|564587367|FG004|Overall Study|Physician Decision|0|||
156407694|NCT03661996|564587370|FG000|Overall Study|Adverse Event|0|||
156407695|NCT03661996|564587371|FG001|Overall Study|Adverse Event|0|||
156407696|NCT03661996|564587372|FG002|Overall Study|Adverse Event|1|||
156407697|NCT03661996|564587373|FG003|Overall Study|Adverse Event|1|||
156407698|NCT03661996|564587374|FG004|Overall Study|Adverse Event|0|||
156407699|NCT03661996|564587370|FG000|Overall Study|Lost to Follow-up|5|||
156407700|NCT03661996|564587371|FG001|Overall Study|Lost to Follow-up|1|||
156407701|NCT03661996|564587372|FG002|Overall Study|Lost to Follow-up|2|||
156407702|NCT03661996|564587373|FG003|Overall Study|Lost to Follow-up|2|||
156407703|NCT03661996|564587374|FG004|Overall Study|Lost to Follow-up|6|||
156749958|NCT00385827|565836900|FG000|Part 1|Adverse Event|1|||
156749959|NCT00385827|565836901|FG001|Part 1|Adverse Event|0|||
156749960|NCT00385827|565836902|FG002|Part 1|Adverse Event|0|||
156749961|NCT00385827|565836900|FG000|Part 1|Death|2|||
156749962|NCT00385827|565836901|FG001|Part 1|Death|0|||
156749963|NCT00385827|565836902|FG002|Part 1|Death|0|||
156749964|NCT00385827|565836900|FG000|Part 1|Lack of Efficacy|5|||
156863947|NCT01597596|566260809|FG001|Overall Study|Physician Decision|1|||
156863948|NCT00992108|566260816|FG000|Overall Study|Lost to Follow-up|0|||
156863949|NCT00992108|566260817|FG001|Overall Study|Lost to Follow-up|1|||
156863950|NCT04639245|566260818|FG000|Overall Study|Death|1|||
156863951|NCT02419001|566260821|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
156407704|NCT03661996|564587370|FG000|Overall Study|Physician Decision|1|||
156407705|NCT03661996|564587371|FG001|Overall Study|Physician Decision|1|||
156749965|NCT00385827|565836901|FG001|Part 1|Lack of Efficacy|0|||
156863952|NCT02419001|566260822|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
156863953|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
156863954|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
156863955|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
156863956|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
156863957|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
156863958|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
156863959|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
156863960|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156863961|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156863962|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
156863963|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
156863964|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
156863965|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156863966|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156863967|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156863968|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156863969|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
156863970|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
156863971|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156863972|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156863973|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156863974|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
156863975|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
156863976|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
156863977|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
156863978|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
156863979|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
156863980|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
156863981|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863982|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863983|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
156863984|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863985|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
156863986|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863987|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863988|NCT03175367|566260826|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863989|NCT03175367|566260827|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863990|NCT03175367|566260828|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863991|NCT03175367|566260829|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863992|NCT03175367|566260830|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863993|NCT03175367|566260831|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863994|NCT03175367|566260832|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
156863995|NCT03175367|566260826|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863996|NCT03175367|566260827|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863997|NCT03175367|566260828|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863998|NCT03175367|566260829|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156407706|NCT03661996|564587372|FG002|Overall Study|Physician Decision|1|||
156749966|NCT00385827|565836902|FG002|Part 1|Lack of Efficacy|0|||
156407707|NCT03661996|564587373|FG003|Overall Study|Physician Decision|2|||
156407708|NCT03661996|564587374|FG004|Overall Study|Physician Decision|0|||
156407709|NCT03661996|564587370|FG000|Overall Study|Protocol Violation|0|||
156407710|NCT03661996|564587371|FG001|Overall Study|Protocol Violation|0|||
156407711|NCT03661996|564587372|FG002|Overall Study|Protocol Violation|0|||
156407712|NCT03661996|564587373|FG003|Overall Study|Protocol Violation|0|||
156407713|NCT03661996|564587374|FG004|Overall Study|Protocol Violation|1|||
156407714|NCT03661996|564587370|FG000|Overall Study|Withdrawal by Subject|3|||
156407715|NCT03661996|564587371|FG001|Overall Study|Withdrawal by Subject|5|||
156407716|NCT03661996|564587372|FG002|Overall Study|Withdrawal by Subject|1|||
156407717|NCT03661996|564587373|FG003|Overall Study|Withdrawal by Subject|7|||
156407718|NCT03661996|564587374|FG004|Overall Study|Withdrawal by Subject|7|||
156407719|NCT03661996|564587370|FG000|Overall Study|Sponsors Decision|2|||
156407720|NCT03661996|564587371|FG001|Overall Study|Sponsors Decision|0|||
156407721|NCT03661996|564587372|FG002|Overall Study|Sponsors Decision|0|||
156749967|NCT00385827|565836900|FG000|Part 1|Other|1|||
156749968|NCT00385827|565836901|FG001|Part 1|Other|0|||
156407722|NCT03661996|564587373|FG003|Overall Study|Sponsors Decision|0|||
156407723|NCT03661996|564587374|FG004|Overall Study|Sponsors Decision|0|||
156407724|NCT03661996|564587370|FG000|Overall Study|Other|1|||
156863999|NCT03175367|566260830|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156864000|NCT03175367|566260831|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
156864001|NCT03175367|566260832|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
156864002|NCT02851615|566260833|FG000|Overall Study|Cognitive Issue|1|||
156864003|NCT02851615|566260834|FG001|Overall Study|Cognitive Issue|0|||
156864004|NCT02851615|566260833|FG000|Overall Study|Lost to Follow-up|0|||
156864005|NCT02851615|566260834|FG001|Overall Study|Lost to Follow-up|4|||
156864006|NCT00371150|566260836|FG000|Overall Study|Lost to Follow-up|3|||
156864007|NCT00371150|566260837|FG001|Overall Study|Lost to Follow-up|2|||
156864008|NCT02151058|566260839|FG000|Overall Study|Withdrawal by Subject|1|||
156407725|NCT03661996|564587371|FG001|Overall Study|Other|1|||
156407726|NCT03661996|564587372|FG002|Overall Study|Other|1|||
156407727|NCT03661996|564587373|FG003|Overall Study|Other|1|||
156407728|NCT03661996|564587374|FG004|Overall Study|Other|0|||
156407729|NCT03321513|564587375|FG000|Overall Study|Death|11|||
156407730|NCT03321513|564587376|FG001|Overall Study|Death|5|||
156407731|NCT03321513|564587375|FG000|Overall Study|Withdrawal by Subject|5|||
156407732|NCT03321513|564587376|FG001|Overall Study|Withdrawal by Subject|10|||
156407733|NCT03321513|564587375|FG000|Overall Study|Lost to Follow-up|10|||
156407734|NCT03321513|564587376|FG001|Overall Study|Lost to Follow-up|11|||
156407735|NCT03029247|564587377|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
156407736|NCT03029247|564587378|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
156407737|NCT03029247|564587377|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
156407738|NCT03029247|564587378|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
156407739|NCT03029247|564587377|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
156407740|NCT03029247|564587378|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
156407741|NCT03029247|564587377|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
156864009|NCT02151058|566260840|FG001|Overall Study|Withdrawal by Subject|1|||
156864010|NCT02151058|566260841|FG002|Overall Study|Withdrawal by Subject|3|||
156864011|NCT02151058|566260839|FG000|Overall Study|Lost to Follow-up|1|||
156864012|NCT02151058|566260840|FG001|Overall Study|Lost to Follow-up|0|||
156864013|NCT02151058|566260841|FG002|Overall Study|Lost to Follow-up|2|||
156864014|NCT03337477|566260842|FG000|Overall Study|not categorized into the listed ones|11|||
156864015|NCT03337477|566260843|FG001|Overall Study|not categorized into the listed ones|9|||
156864016|NCT03337477|566260842|FG000|Overall Study|Withdrawal by Subject|0|||
156864017|NCT03337477|566260843|FG001|Overall Study|Withdrawal by Subject|1|||
156864018|NCT03337477|566260842|FG000|Overall Study|Death|0|||
156864019|NCT03337477|566260843|FG001|Overall Study|Death|1|||
156864020|NCT03337477|566260842|FG000|Overall Study|Lost to Follow-up|0|||
156864021|NCT03337477|566260843|FG001|Overall Study|Lost to Follow-up|2|||
156864022|NCT03304626|566260844|FG000|Overall Study|Adverse Event|1|||
156407742|NCT03029247|564587378|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
156864023|NCT03304626|566260845|FG001|Overall Study|Adverse Event|0|||
156864024|NCT03304626|566260844|FG000|Overall Study|Lack of Efficacy|1|||
156864025|NCT03304626|566260845|FG001|Overall Study|Lack of Efficacy|1|||
156864026|NCT00744497|566260846|FG000|Overall Study|Withdrawal by Subject|21|||
156864027|NCT00744497|566260847|FG001|Overall Study|Withdrawal by Subject|18|||
156864028|NCT00744497|566260846|FG000|Overall Study|Death|11|||
156864029|NCT00744497|566260847|FG001|Overall Study|Death|9|||
156864030|NCT00744497|566260846|FG000|Overall Study|Lost to Follow-up|4|||
156864031|NCT00744497|566260847|FG001|Overall Study|Lost to Follow-up|2|||
156864032|NCT00744497|566260846|FG000|Overall Study|Poor compliance/noncompliance|9|||
156864033|NCT00744497|566260847|FG001|Overall Study|Poor compliance/noncompliance|5|||
156864034|NCT00744497|566260846|FG000|Overall Study|No longer meets study criteria|7|||
156864035|NCT00744497|566260847|FG001|Overall Study|No longer meets study criteria|3|||
156864036|NCT00744497|566260846|FG000|Overall Study|Administrative Reason By Sponsor|25|||
156864037|NCT00744497|566260847|FG001|Overall Study|Administrative Reason By Sponsor|8|||
156864038|NCT00744497|566260846|FG000|Overall Study|Disease progression|312|||
156864039|NCT00744497|566260847|FG001|Overall Study|Disease progression|219|||
156864040|NCT00744497|566260846|FG000|Overall Study|Study drug toxicity|68|||
156864041|NCT00744497|566260847|FG001|Overall Study|Study drug toxicity|141|||
156864042|NCT00744497|566260846|FG000|Overall Study|Adverse event unrelated to study drug|78|||
156864043|NCT00744497|566260847|FG001|Overall Study|Adverse event unrelated to study drug|122|||
156864044|NCT00744497|566260846|FG000|Overall Study|Patient requested to stop study drug|65|||
156407743|NCT02593305|564587379|FG000|Post 1|Comparison only group. No intervention.|0|||
156407744|NCT02593305|564587380|FG001|Post 1|Comparison only group. No intervention.|0|||
156407745|NCT02593305|564587381|FG002|Post 1|Comparison only group. No intervention.|10|||
156407746|NCT01993017|564587382|FG000|Overall Study|Death|23|||
156864045|NCT00744497|566260847|FG001|Overall Study|Patient requested to stop study drug|80|||
156864046|NCT00744497|566260846|FG000|Overall Study|Maximum clinical benefit|141|||
156864047|NCT00744497|566260847|FG001|Overall Study|Maximum clinical benefit|142|||
156864048|NCT00744497|566260846|FG000|Overall Study|Not defined|19|||
156864049|NCT00744497|566260847|FG001|Overall Study|Not defined|13|||
156864050|NCT03182374|566260850|FG000|Overall Study|Lost to Follow-up|3|||
156864051|NCT03182374|566260851|FG001|Overall Study|Lost to Follow-up|2|||
156864052|NCT03182374|566260850|FG000|Overall Study|Lack of Efficacy|8|||
156864053|NCT03182374|566260851|FG001|Overall Study|Lack of Efficacy|14|||
156864054|NCT03182374|566260850|FG000|Overall Study|Withdrawal by Subject|1|||
156864055|NCT03182374|566260851|FG001|Overall Study|Withdrawal by Subject|1|||
156864056|NCT03182374|566260850|FG000|Overall Study|exit for non-compliance|1|||
156864057|NCT03182374|566260851|FG001|Overall Study|exit for non-compliance|1|||
156864058|NCT03182374|566260850|FG000|Overall Study|one subject was randomized but not treated|1|||
156864059|NCT03182374|566260851|FG001|Overall Study|one subject was randomized but not treated|0|||
156864060|NCT03182374|566260850|FG000|Overall Study|Other reasons|0|||
156864061|NCT03182374|566260851|FG001|Overall Study|Other reasons|3|||
156864062|NCT06271993|566260856|FG000|Overall Study|Not reactive to histamine|5|||
156864063|NCT06271993|566260857|FG001|Overall Study|Not reactive to histamine|5|||
156864064|NCT06271993|566260858|FG002|Overall Study|Not reactive to histamine|5|||
156864065|NCT04613362|566260859|FG000|3 Month Follow-up|Lost to Follow-up|1|||
156864066|NCT04613362|566260860|FG001|3 Month Follow-up|Lost to Follow-up|2|||
156864067|NCT04613362|566260859|FG000|6 Month Follow-up|Lost to Follow-up|0|||
156864068|NCT04613362|566260860|FG001|6 Month Follow-up|Lost to Follow-up|1|||
156864069|NCT03331315|566260862|FG000|Overall Study|Physician Decision|18|||
156864070|NCT03331315|566260863|FG001|Overall Study|Physician Decision|14|||
156864071|NCT00481832|566260864|FG000|Enrollment|Physician Decision|8|||
156864072|NCT00481832|566260864|FG000|Enrollment|Unable to collect enough stem cells|2|||
156864073|NCT00481832|566260864|FG000|Inter-transplant Period|Adverse Event|4|||
156864074|NCT00481832|566260864|FG000|Inter-transplant Period|Death|3|||
156864075|NCT00481832|566260864|FG000|Inter-transplant Period|Physician Decision|4|||
156864076|NCT00481832|566260864|FG000|Inter-transplant Period|Disease relapse|11|||
156864077|NCT00481832|566260864|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
156864078|NCT00581308|566260865|FG000|Pre Discharge|Lost to Follow-up|1|||
156864079|NCT00581308|566260865|FG000|Pre Discharge|Device Removed|1|||
156864080|NCT00581308|566260865|FG000|Month 1|Lost to Follow-up|3|||
156864081|NCT00581308|566260865|FG000|Month 1|Withdrawal by Subject|2|||
156864082|NCT00581308|566260865|FG000|Month 1|Device Removed|2|||
156864083|NCT00581308|566260865|FG000|Month 1|Uknown|1|||
156864084|NCT00581308|566260865|FG000|Month 6|Lost to Follow-up|1|||
156864085|NCT00581308|566260865|FG000|Month 6|Withdrawal by Subject|2|||
156864086|NCT00581308|566260865|FG000|Month 12|Death|1|||
156864087|NCT00581308|566260865|FG000|Month 12|Lost to Follow-up|14|||
156864088|NCT00581308|566260865|FG000|Month 12|Withdrawal by Subject|3|||
156864089|NCT00581308|566260865|FG000|Month 12|Device Removed|1|||
156864090|NCT00581308|566260865|FG000|Month 12|Other|1|||
156864091|NCT00456846|566260866|FG000|Overall Study|Adverse Event|2|||
156864092|NCT00456846|566260867|FG001|Overall Study|Adverse Event|15|||
156864093|NCT00456846|566260866|FG000|Overall Study|Physician Decision|11|||
156864094|NCT00456846|566260867|FG001|Overall Study|Physician Decision|6|||
156864095|NCT00456846|566260866|FG000|Overall Study|Protocol Deviation|2|||
156864096|NCT00456846|566260867|FG001|Overall Study|Protocol Deviation|0|||
156864097|NCT00456846|566260866|FG000|Overall Study|Participant Discretion|1|||
156864098|NCT00456846|566260867|FG001|Overall Study|Participant Discretion|5|||
156864099|NCT00456846|566260866|FG000|Overall Study|Other|0|||
156864100|NCT00456846|566260867|FG001|Overall Study|Other|2|||
156864101|NCT03253796|566260870|FG000|Period 1: Run-In|Adverse Event|4|||
156864102|NCT03253796|566260871|FG001|Period 1: Run-In|Adverse Event|0|||
156864103|NCT03253796|566260872|FG002|Period 1: Run-In|Adverse Event|0|||
156864104|NCT03253796|566260873|FG003|Period 1: Run-In|Adverse Event|0|||
156864105|NCT03253796|566260874|FG004|Period 1: Run-In|Adverse Event|0|||
156864106|NCT03253796|566260870|FG000|Period 1: Run-In|Lack of Efficacy|1|||
156864107|NCT03253796|566260871|FG001|Period 1: Run-In|Lack of Efficacy|0|||
156864108|NCT03253796|566260872|FG002|Period 1: Run-In|Lack of Efficacy|0|||
156864109|NCT03253796|566260873|FG003|Period 1: Run-In|Lack of Efficacy|0|||
156864110|NCT03253796|566260874|FG004|Period 1: Run-In|Lack of Efficacy|0|||
156864111|NCT03253796|566260870|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
156864112|NCT03253796|566260871|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
156864113|NCT03253796|566260872|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
156864114|NCT03253796|566260873|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
156864115|NCT03253796|566260874|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
156864116|NCT03253796|566260870|FG000|Period 1: Run-In|Protocol Violation|5|||
156864117|NCT03253796|566260871|FG001|Period 1: Run-In|Protocol Violation|0|||
156864118|NCT03253796|566260872|FG002|Period 1: Run-In|Protocol Violation|0|||
156864119|NCT03253796|566260873|FG003|Period 1: Run-In|Protocol Violation|0|||
156864120|NCT03253796|566260874|FG004|Period 1: Run-In|Protocol Violation|0|||
156864121|NCT03253796|566260870|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
156864122|NCT03253796|566260871|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
156864123|NCT03253796|566260872|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
156864124|NCT03253796|566260873|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
156864125|NCT03253796|566260874|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
156864126|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
156864127|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
156864128|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
156864129|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
156864130|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
156864131|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
156864132|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
156864133|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
156864134|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
156864135|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
156864136|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
156407747|NCT01993017|564587383|FG001|Overall Study|Death|26|||
156407748|NCT01993017|564587384|FG002|Overall Study|Death|18|||
156407749|NCT01993017|564587382|FG000|Overall Study|Could not be contacted|43|||
156407750|NCT01993017|564587383|FG001|Overall Study|Could not be contacted|42|||
156407751|NCT01993017|564587384|FG002|Overall Study|Could not be contacted|38|||
156407752|NCT01993017|564587382|FG000|Overall Study|Dropped out|19|||
156407753|NCT01993017|564587383|FG001|Overall Study|Dropped out|6|||
156407754|NCT01993017|564587384|FG002|Overall Study|Dropped out|11|||
156407755|NCT01993017|564587382|FG000|Overall Study|Other reasons|17|||
156407756|NCT01993017|564587383|FG001|Overall Study|Other reasons|11|||
156407757|NCT01993017|564587384|FG002|Overall Study|Other reasons|7|||
156407758|NCT01993017|564587382|FG000|Overall Study|Ineligible after randomization|4|||
156407759|NCT01993017|564587383|FG001|Overall Study|Ineligible after randomization|5|||
156407760|NCT01993017|564587384|FG002|Overall Study|Ineligible after randomization|5|||
156407761|NCT00068380|564587385|FG000|Overall Study|Withdrawal by Subject|3|||
156407762|NCT00068380|564587385|FG000|Overall Study|Adverse Event|2|||
156407763|NCT01976364|564587386|FG000|Main Study (36 Months)|Adverse Event|63|||
156407764|NCT01976364|564587387|FG001|Main Study (36 Months)|Adverse Event|0|||
156407765|NCT01976364|564587388|FG002|Main Study (36 Months)|Adverse Event|0|||
156407766|NCT01976364|564587386|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
156407767|NCT01976364|564587387|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
156407768|NCT01976364|564587388|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
156407769|NCT01976364|564587386|FG000|Main Study (36 Months)|Other|13|||
156407770|NCT01976364|564587387|FG001|Main Study (36 Months)|Other|0|||
156407771|NCT01976364|564587388|FG002|Main Study (36 Months)|Other|0|||
156407772|NCT01976364|564587386|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
156407773|NCT01976364|564587387|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
156407774|NCT01976364|564587388|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
156407775|NCT01976364|564587386|FG000|Main Study (36 Months)|Medication error|1|||
156407776|NCT01976364|564587387|FG001|Main Study (36 Months)|Medication error|0|||
156407777|NCT01976364|564587388|FG002|Main Study (36 Months)|Medication error|0|||
156407778|NCT01976364|564587386|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
156407779|NCT01976364|564587387|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
156407780|NCT01976364|564587388|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
156407781|NCT01976364|564587386|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
156407782|NCT01976364|564587387|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
156407783|NCT01976364|564587388|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
156407784|NCT01976364|564587386|FG000|Main Study (36 Months)|Protocol Violation|13|||
156407785|NCT01976364|564587387|FG001|Main Study (36 Months)|Protocol Violation|0|||
156407786|NCT01976364|564587388|FG002|Main Study (36 Months)|Protocol Violation|0|||
156407787|NCT01976364|564587386|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
156407788|NCT01976364|564587387|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
156407789|NCT01976364|564587388|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
156407790|NCT01976364|564587386|FG000|Main Study (36 Months)|Death|5|||
156521261|NCT00729378|565003051|FG000|Baseline|Did not complete study measurements|72|||
156521262|NCT00729378|565003052|FG001|Baseline|Did not complete study measurements|33|||
156521263|NCT00729378|565003051|FG000|Baseline|Withdrawal by Subject|66|||
156521264|NCT00729378|565003052|FG001|Baseline|Withdrawal by Subject|59|||
156521265|NCT00729378|565003051|FG000|12-months|Lost to Follow-up|100|||
156521266|NCT00729378|565003052|FG001|12-months|Lost to Follow-up|65|||
156521267|NCT00729378|565003051|FG000|24-months|Lost to Follow-up|72|||
156521268|NCT00729378|565003052|FG001|24-months|Lost to Follow-up|51|||
156521269|NCT00729378|565003051|FG000|36-months|Lost to Follow-up|15|||
156521270|NCT00729378|565003052|FG001|36-months|Lost to Follow-up|6|||
156521271|NCT00690443|565003053|FG000|Overall Study|Adverse Event|1|||
156521272|NCT00690443|565003054|FG001|Overall Study|Adverse Event|2|||
156521273|NCT02874924|565003055|FG000|Overall Study|Adverse Event|2|||
156521274|NCT02874924|565003056|FG001|Overall Study|Adverse Event|0|||
156521275|NCT02874924|565003057|FG002|Overall Study|Adverse Event|0|||
156521276|NCT02874924|565003055|FG000|Overall Study|Withdrawal by Subject|1|||
156521277|NCT02874924|565003056|FG001|Overall Study|Withdrawal by Subject|0|||
156521278|NCT02874924|565003057|FG002|Overall Study|Withdrawal by Subject|0|||
156521279|NCT02808143|565003058|FG000|Maintenance Phase|Disease recurrence|1|||
156407791|NCT01976364|564587387|FG001|Main Study (36 Months)|Death|0|||
156407792|NCT01976364|564587388|FG002|Main Study (36 Months)|Death|0|||
156407793|NCT01976364|564587386|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
156521280|NCT02808143|565003059|FG001|Maintenance Phase|Disease recurrence|3|||
156521281|NCT02808143|565003058|FG000|Maintenance Phase|Disease progression|1|||
156521282|NCT02808143|565003059|FG001|Maintenance Phase|Disease progression|2|||
156521283|NCT02808143|565003058|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
156521284|NCT02808143|565003059|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
156521285|NCT02808143|565003058|FG000|Survival Follow-Up|Disease recurrence|0|||
156521286|NCT02808143|565003059|FG001|Survival Follow-Up|Disease recurrence|2|||
156521287|NCT02808143|565003058|FG000|Survival Follow-Up|Adverse Event|0|||
156521288|NCT02808143|565003059|FG001|Survival Follow-Up|Adverse Event|1|||
156521289|NCT02808143|565003058|FG000|Survival Follow-Up|Death|1|||
156521290|NCT02808143|565003059|FG001|Survival Follow-Up|Death|0|||
156521291|NCT01689337|565003060|FG000|Overall Study|Study Discontinuation|1|||
156521292|NCT01874431|565003061|FG000|Overall Study|Physician Decision|0|||
156521293|NCT01874431|565003062|FG001|Overall Study|Physician Decision|0|||
156521294|NCT01874431|565003063|FG002|Overall Study|Physician Decision|1|||
156521295|NCT01874431|565003064|FG003|Overall Study|Physician Decision|0|||
156521296|NCT01874431|565003065|FG004|Overall Study|Physician Decision|0|||
156521297|NCT01874431|565003066|FG005|Overall Study|Physician Decision|0|||
156521298|NCT01874431|565003067|FG006|Overall Study|Physician Decision|0|||
156521299|NCT01874431|565003068|FG007|Overall Study|Physician Decision|0|||
156521300|NCT01874431|565003061|FG000|Overall Study|Adverse Event|5|||
156521301|NCT01874431|565003062|FG001|Overall Study|Adverse Event|4|||
156521302|NCT01874431|565003063|FG002|Overall Study|Adverse Event|6|||
156521303|NCT01874431|565003064|FG003|Overall Study|Adverse Event|5|||
156521304|NCT01874431|565003065|FG004|Overall Study|Adverse Event|2|||
156521305|NCT01874431|565003066|FG005|Overall Study|Adverse Event|8|||
156521306|NCT01874431|565003067|FG006|Overall Study|Adverse Event|2|||
156521307|NCT01874431|565003068|FG007|Overall Study|Adverse Event|3|||
156521308|NCT01874431|565003061|FG000|Overall Study|Protocol Violation|1|||
156521309|NCT01874431|565003062|FG001|Overall Study|Protocol Violation|1|||
156521310|NCT01874431|565003063|FG002|Overall Study|Protocol Violation|1|||
156407794|NCT01976364|564587387|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
156407795|NCT01976364|564587388|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
156407796|NCT01976364|564587386|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
156407797|NCT01976364|564587387|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
156407798|NCT01976364|564587388|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
156407799|NCT01976364|564587386|FG000|Sub-study (12 Months)|Protocol Violation|0|||
156407800|NCT01976364|564587387|FG001|Sub-study (12 Months)|Protocol Violation|1|||
156407801|NCT01976364|564587388|FG002|Sub-study (12 Months)|Protocol Violation|1|||
156407802|NCT01976364|564587386|FG000|Sub-study (12 Months)|Adverse Event|0|||
156407803|NCT01976364|564587387|FG001|Sub-study (12 Months)|Adverse Event|4|||
156407804|NCT01976364|564587388|FG002|Sub-study (12 Months)|Adverse Event|3|||
156407805|NCT02757521|564587389|FG000|Overall Study|Adverse Event|1|||
156407806|NCT02757521|564587390|FG001|Overall Study|Adverse Event|0|||
156407807|NCT01190215|564587391|FG000|Up to Month 6|Lost to Follow-up|2|||
156407808|NCT01190215|564587392|FG001|Up to Month 6|Lost to Follow-up|0|||
156407809|NCT01161472|564587393|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
156407810|NCT01161472|564587394|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
156407811|NCT01161472|564587395|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
156407812|NCT01161472|564587396|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
156407813|NCT00003511|564587397|FG000|Overall Study|Not evaluable|4|||
156407814|NCT02914184|564587398|FG000|Overall Study|Lost to Follow-up|7|||
156407815|NCT02914184|564587399|FG001|Overall Study|Lost to Follow-up|10|||
156407816|NCT02914184|564587400|FG002|Overall Study|Lost to Follow-up|8|||
156407817|NCT02914184|564587401|FG003|Overall Study|Lost to Follow-up|7|||
156407818|NCT02914184|564587398|FG000|Overall Study|Withdrawal by Subject|4|||
156407819|NCT02914184|564587399|FG001|Overall Study|Withdrawal by Subject|2|||
156407820|NCT02914184|564587400|FG002|Overall Study|Withdrawal by Subject|7|||
156407821|NCT02914184|564587401|FG003|Overall Study|Withdrawal by Subject|3|||
156407822|NCT02914184|564587398|FG000|Overall Study|Other|1|||
156407823|NCT02914184|564587399|FG001|Overall Study|Other|0|||
156407824|NCT02914184|564587400|FG002|Overall Study|Other|0|||
156407825|NCT02914184|564587401|FG003|Overall Study|Other|0|||
156407826|NCT02914184|564587398|FG000|Overall Study|Migrated/moved from the study area|2|||
156407827|NCT02914184|564587399|FG001|Overall Study|Migrated/moved from the study area|1|||
156407828|NCT02914184|564587400|FG002|Overall Study|Migrated/moved from the study area|2|||
156407829|NCT02914184|564587401|FG003|Overall Study|Migrated/moved from the study area|1|||
156407830|NCT00798174|564587407|FG000|Overall Study|inability to implant azygos coil|3|||
156407831|NCT00798174|564587408|FG001|Overall Study|inability to implant azygos coil|3|||
156407832|NCT00798174|564587407|FG000|Overall Study|Inability to sedate for DFT testing|1|||
156407833|NCT00798174|564587408|FG001|Overall Study|Inability to sedate for DFT testing|0|||
156407834|NCT01683994|564587427|FG000|Overall Study|Withdrawal by Subject|1|||
156407835|NCT01683994|564587428|FG001|Overall Study|Withdrawal by Subject|0|||
156407836|NCT01683994|564587429|FG002|Overall Study|Withdrawal by Subject|0|||
156407837|NCT01683994|564587430|FG003|Overall Study|Withdrawal by Subject|1|||
156521311|NCT01874431|565003064|FG003|Overall Study|Protocol Violation|0|||
156521312|NCT01874431|565003065|FG004|Overall Study|Protocol Violation|3|||
156521313|NCT01874431|565003066|FG005|Overall Study|Protocol Violation|2|||
156521314|NCT01874431|565003067|FG006|Overall Study|Protocol Violation|1|||
156407838|NCT01683994|564587431|FG004|Overall Study|Withdrawal by Subject|0|||
156407839|NCT01683994|564587427|FG000|Overall Study|Intercurrent illness|0|||
156407840|NCT01683994|564587428|FG001|Overall Study|Intercurrent illness|0|||
156407841|NCT01683994|564587429|FG002|Overall Study|Intercurrent illness|0|||
156407842|NCT01683994|564587430|FG003|Overall Study|Intercurrent illness|2|||
156407843|NCT01683994|564587431|FG004|Overall Study|Intercurrent illness|1|||
156407844|NCT00999661|564587432|FG000|Overall Study|Lost to Follow-up|59|||
156407845|NCT00999661|564587432|FG000|Overall Study|Adverse Event|1|||
156407846|NCT00999661|564587432|FG000|Overall Study|Withdrawal by Subject|1|||
156407847|NCT00999661|564587432|FG000|Overall Study|Not meeting eligibility criteria|9|||
156407848|NCT02960763|564587433|FG000|Step 1|Withdrawal by Subject|10|||
156407849|NCT02960763|564587434|FG001|Step 1|Withdrawal by Subject|8|||
156407850|NCT02960763|564587435|FG002|Step 1|Withdrawal by Subject|13|||
156407851|NCT02960763|564587436|FG003|Step 1|Withdrawal by Subject|0|||
156407852|NCT02960763|564587437|FG004|Step 1|Withdrawal by Subject|0|||
156407853|NCT02960763|564587433|FG000|Step 1|Lost to Follow-up|7|||
156407854|NCT02960763|564587434|FG001|Step 1|Lost to Follow-up|9|||
156407855|NCT02960763|564587435|FG002|Step 1|Lost to Follow-up|12|||
156407856|NCT02960763|564587436|FG003|Step 1|Lost to Follow-up|0|||
156407857|NCT02960763|564587437|FG004|Step 1|Lost to Follow-up|0|||
156407858|NCT02960763|564587433|FG000|Step 1|Death|1|||
156407859|NCT02960763|564587434|FG001|Step 1|Death|1|||
156407860|NCT02960763|564587435|FG002|Step 1|Death|1|||
156407861|NCT02960763|564587436|FG003|Step 1|Death|0|||
156407862|NCT02960763|564587437|FG004|Step 1|Death|0|||
156407863|NCT02960763|564587433|FG000|Step 1|Investigator discretion|1|||
156407864|NCT02960763|564587434|FG001|Step 1|Investigator discretion|0|||
156407865|NCT02960763|564587435|FG002|Step 1|Investigator discretion|1|||
156407866|NCT02960763|564587436|FG003|Step 1|Investigator discretion|0|||
156407867|NCT02960763|564587437|FG004|Step 1|Investigator discretion|0|||
156407868|NCT02960763|564587433|FG000|Step 1|Other|0|||
156407869|NCT02960763|564587434|FG001|Step 1|Other|0|||
156407870|NCT02960763|564587435|FG002|Step 1|Other|1|||
156407871|NCT02960763|564587436|FG003|Step 1|Other|0|||
156407872|NCT02960763|564587437|FG004|Step 1|Other|0|||
156407873|NCT02960763|564587433|FG000|Step 2|Withdrawal by Subject|0|||
156407874|NCT02960763|564587434|FG001|Step 2|Withdrawal by Subject|0|||
156407875|NCT02960763|564587435|FG002|Step 2|Withdrawal by Subject|0|||
156407876|NCT02960763|564587436|FG003|Step 2|Withdrawal by Subject|7|||
156407877|NCT02960763|564587437|FG004|Step 2|Withdrawal by Subject|3|||
156407878|NCT02960763|564587433|FG000|Step 2|Lost to Follow-up|0|||
156407879|NCT02960763|564587434|FG001|Step 2|Lost to Follow-up|0|||
156407880|NCT02960763|564587435|FG002|Step 2|Lost to Follow-up|0|||
156407881|NCT02960763|564587436|FG003|Step 2|Lost to Follow-up|4|||
156407882|NCT02960763|564587437|FG004|Step 2|Lost to Follow-up|1|||
156407883|NCT02960763|564587433|FG000|Step 2|Investigator discretion|0|||
156407884|NCT02960763|564587434|FG001|Step 2|Investigator discretion|0|||
156407885|NCT02960763|564587435|FG002|Step 2|Investigator discretion|0|||
156407886|NCT02960763|564587436|FG003|Step 2|Investigator discretion|0|||
156407887|NCT02960763|564587437|FG004|Step 2|Investigator discretion|1|||
156407888|NCT00312858|564587441|FG000|Overall Study|Adverse Event|0|||
156407889|NCT00312858|564587442|FG001|Overall Study|Adverse Event|1|||
156407890|NCT00312858|564587441|FG000|Overall Study|Lost to Follow-up|25|||
156407891|NCT00312858|564587442|FG001|Overall Study|Lost to Follow-up|42|||
156407892|NCT00312858|564587441|FG000|Overall Study|Protocol Violation|3|||
156407893|NCT00312858|564587442|FG001|Overall Study|Protocol Violation|8|||
156407894|NCT00312858|564587441|FG000|Overall Study|Withdraw by Participant|20|||
156407895|NCT00312858|564587442|FG001|Overall Study|Withdraw by Participant|20|||
156407896|NCT00312858|564587441|FG000|Overall Study|Participant Moved|11|||
156407897|NCT00312858|564587442|FG001|Overall Study|Participant Moved|10|||
156407898|NCT00312858|564587441|FG000|Overall Study|Other|9|||
156407899|NCT00312858|564587442|FG001|Overall Study|Other|12|||
156407900|NCT03638635|564587443|FG000|Initial Hospitalization|Study terminated prematurely|0|||
156407901|NCT03638635|564587444|FG001|Initial Hospitalization|Study terminated prematurely|1|||
156407902|NCT03638635|564587443|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
156407903|NCT03638635|564587444|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
156407904|NCT03638635|564587443|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
156407905|NCT03638635|564587444|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
156407906|NCT01336634|564587459|FG000|Overall Study|Study closed/terminated|5|||
156407907|NCT01336634|564587460|FG001|Overall Study|Study closed/terminated|6|||
156407908|NCT01336634|564587461|FG002|Overall Study|Study closed/terminated|6|||
156407909|NCT01336634|564587459|FG000|Overall Study|Lost to Follow-up|2|||
156407910|NCT01336634|564587460|FG001|Overall Study|Lost to Follow-up|1|||
156407911|NCT01336634|564587461|FG002|Overall Study|Lost to Follow-up|1|||
156407912|NCT01336634|564587459|FG000|Overall Study|Physician Decision|1|||
156407913|NCT01336634|564587460|FG001|Overall Study|Physician Decision|1|||
156407914|NCT01336634|564587461|FG002|Overall Study|Physician Decision|0|||
156407915|NCT01336634|564587459|FG000|Overall Study|Withdrawal by Subject|6|||
156407916|NCT01336634|564587460|FG001|Overall Study|Withdrawal by Subject|0|||
156407917|NCT01336634|564587461|FG002|Overall Study|Withdrawal by Subject|2|||
156407918|NCT01863043|564587462|FG000|Overall Study|Death|6|||
156407919|NCT01863043|564587463|FG001|Overall Study|Death|1|||
156407920|NCT01863043|564587462|FG000|Overall Study|Withdrawal by Subject|0|||
156407921|NCT01863043|564587463|FG001|Overall Study|Withdrawal by Subject|2|||
156407922|NCT01863043|564587462|FG000|Overall Study|Adverse Event|7|||
156407923|NCT01863043|564587463|FG001|Overall Study|Adverse Event|8|||
156407924|NCT01863043|564587462|FG000|Overall Study|exclusion criteria found after enrollment|0|||
156407925|NCT01863043|564587463|FG001|Overall Study|exclusion criteria found after enrollment|1|||
156407926|NCT01987596|564587464|FG000|Overall Study|Physician Decision|1|||
156407927|NCT01987596|564587465|FG001|Overall Study|Physician Decision|0|||
156407928|NCT01987596|564587464|FG000|Overall Study|Progressive Disease; missing all period|0|||
156407929|NCT01987596|564587465|FG001|Overall Study|Progressive Disease; missing all period|1|||
156407930|NCT00854295|564587468|FG000|Overall Study|Death|7|||
156407931|NCT00854295|564587469|FG001|Overall Study|Death|0|||
156407932|NCT00854295|564587470|FG002|Overall Study|Death|1|||
156407933|NCT00854295|564587471|FG003|Overall Study|Death|1|||
156407934|NCT00854295|564587468|FG000|Overall Study|Adverse Event|6|||
156407935|NCT00854295|564587469|FG001|Overall Study|Adverse Event|1|||
156407936|NCT00854295|564587470|FG002|Overall Study|Adverse Event|1|||
156407937|NCT00854295|564587471|FG003|Overall Study|Adverse Event|3|||
156407938|NCT00854295|564587468|FG000|Overall Study|Lost to Follow-up|18|||
156407939|NCT00854295|564587469|FG001|Overall Study|Lost to Follow-up|5|||
156407940|NCT00854295|564587470|FG002|Overall Study|Lost to Follow-up|21|||
156407941|NCT00854295|564587471|FG003|Overall Study|Lost to Follow-up|21|||
156407942|NCT00854295|564587468|FG000|Overall Study|Physician Decision|10|||
156407943|NCT00854295|564587469|FG001|Overall Study|Physician Decision|0|||
156407944|NCT00854295|564587470|FG002|Overall Study|Physician Decision|0|||
156407945|NCT00854295|564587471|FG003|Overall Study|Physician Decision|0|||
156407946|NCT02440594|564587475|FG000|Overall Study|Lost to Follow-up|34|||
156407947|NCT02440594|564587476|FG001|Overall Study|Lost to Follow-up|33|||
156407948|NCT02440594|564587477|FG002|Overall Study|Lost to Follow-up|54|||
156407949|NCT02440594|564587478|FG003|Overall Study|Lost to Follow-up|47|||
156407950|NCT02440594|564587479|FG004|Overall Study|Lost to Follow-up|5|||
156407951|NCT02440594|564587480|FG005|Overall Study|Lost to Follow-up|4|||
156407952|NCT02440594|564587481|FG006|Overall Study|Lost to Follow-up|28|||
156407953|NCT02440594|564587482|FG007|Overall Study|Lost to Follow-up|48|||
156407954|NCT02440594|564587475|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
156407955|NCT02440594|564587476|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
156407956|NCT02440594|564587477|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
156407957|NCT02440594|564587478|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
156407958|NCT02440594|564587479|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
156407959|NCT02440594|564587480|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
156407960|NCT02440594|564587481|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
156407961|NCT02440594|564587482|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
156407962|NCT02440594|564587475|FG000|Overall Study|Withdrawal by Subject|81|||
156407963|NCT02440594|564587476|FG001|Overall Study|Withdrawal by Subject|67|||
156407964|NCT02440594|564587477|FG002|Overall Study|Withdrawal by Subject|59|||
156407965|NCT02440594|564587478|FG003|Overall Study|Withdrawal by Subject|38|||
156407966|NCT02440594|564587479|FG004|Overall Study|Withdrawal by Subject|2|||
156407967|NCT02440594|564587480|FG005|Overall Study|Withdrawal by Subject|2|||
156407968|NCT02440594|564587481|FG006|Overall Study|Withdrawal by Subject|7|||
156407969|NCT02440594|564587482|FG007|Overall Study|Withdrawal by Subject|7|||
156407970|NCT02440594|564587475|FG000|Overall Study|Administratively w/drawn|3|||
156407971|NCT02440594|564587476|FG001|Overall Study|Administratively w/drawn|2|||
156407972|NCT02440594|564587477|FG002|Overall Study|Administratively w/drawn|0|||
156407973|NCT02440594|564587478|FG003|Overall Study|Administratively w/drawn|0|||
156407974|NCT02440594|564587479|FG004|Overall Study|Administratively w/drawn|0|||
156407975|NCT02440594|564587480|FG005|Overall Study|Administratively w/drawn|0|||
156407976|NCT02440594|564587481|FG006|Overall Study|Administratively w/drawn|2|||
156407977|NCT02440594|564587482|FG007|Overall Study|Administratively w/drawn|1|||
156407978|NCT04250337|564587483|FG000|Overall Study|Adverse Event|0|||
156407979|NCT04250337|564587484|FG001|Overall Study|Adverse Event|3|||
156407980|NCT04250337|564587483|FG000|Overall Study|Lack of Efficacy|1|||
156407981|NCT04250337|564587484|FG001|Overall Study|Lack of Efficacy|3|||
156407982|NCT04250337|564587483|FG000|Overall Study|Physician Decision|1|||
156407983|NCT04250337|564587484|FG001|Overall Study|Physician Decision|0|||
156407984|NCT04250337|564587483|FG000|Overall Study|Protocol Deviation|2|||
156407985|NCT04250337|564587484|FG001|Overall Study|Protocol Deviation|2|||
156407986|NCT04250337|564587483|FG000|Overall Study|Withdrawal by Subject|4|||
156407987|NCT04250337|564587484|FG001|Overall Study|Withdrawal by Subject|3|||
156407988|NCT00152763|564587485|FG000|Overall Study|Death|4|||
156407989|NCT00152763|564587486|FG001|Overall Study|Death|1|||
156407990|NCT00152763|564587487|FG002|Overall Study|Death|2|||
156407991|NCT00152763|564587488|FG003|Overall Study|Death|1|||
156407992|NCT00152763|564587485|FG000|Overall Study|Lost to Follow-up|6|||
156407993|NCT00152763|564587486|FG001|Overall Study|Lost to Follow-up|4|||
156407994|NCT00152763|564587487|FG002|Overall Study|Lost to Follow-up|2|||
156407995|NCT00152763|564587488|FG003|Overall Study|Lost to Follow-up|13|||
156407996|NCT00422799|564587493|FG000|Overall Study|Withdrawal by Subject|6|||
156407997|NCT00422799|564587493|FG000|Overall Study|Adverse Event|7|||
156407998|NCT01965158|564587494|FG000|Overall Study|Adverse Event|14|||
156407999|NCT01965158|564587495|FG001|Overall Study|Adverse Event|5|||
156408000|NCT01965158|564587494|FG000|Overall Study|Withdrawal by Subject|16|||
156408001|NCT01965158|564587495|FG001|Overall Study|Withdrawal by Subject|24|||
156408002|NCT01965158|564587494|FG000|Overall Study|Lost to Follow-up|7|||
156408003|NCT01965158|564587495|FG001|Overall Study|Lost to Follow-up|5|||
156408004|NCT01965158|564587494|FG000|Overall Study|Protocol Violation|1|||
156408005|NCT01965158|564587495|FG001|Overall Study|Protocol Violation|1|||
156408006|NCT01965158|564587494|FG000|Overall Study|Other - Miscellaneous|3|||
156408007|NCT01965158|564587495|FG001|Overall Study|Other - Miscellaneous|0|||
156408008|NCT01617005|564587498|FG000|Overall Study|Pregnancy|1|||
156408009|NCT01617005|564587498|FG000|Overall Study|Lack of motivation for treatment|1|||
156408010|NCT02307513|564587499|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
156408011|NCT02307513|564587500|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
156408012|NCT02307513|564587499|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
156408013|NCT02307513|564587500|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
156408014|NCT02307513|564587499|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
156408015|NCT02307513|564587500|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
156408016|NCT02307513|564587499|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
156408017|NCT02307513|564587500|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
156408018|NCT02307513|564587499|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
156408019|NCT02307513|564587500|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
156408020|NCT02307513|564587499|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
156408021|NCT02307513|564587500|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
156408022|NCT02307513|564587499|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
156408023|NCT02307513|564587500|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
156408024|NCT02307513|564587499|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
156408025|NCT02307513|564587500|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
156408026|NCT02307513|564587499|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
156408027|NCT02307513|564587500|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
156408028|NCT02307513|564587499|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
156408029|NCT02307513|564587500|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
156408030|NCT02307513|564587499|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
156408031|NCT02307513|564587500|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
156408032|NCT02307513|564587499|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
156408033|NCT02307513|564587500|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
156408034|NCT02307513|564587499|FG000|Long-term Extension|Physician Decision|1|||
156408035|NCT02307513|564587500|FG001|Long-term Extension|Physician Decision|0|||
156408036|NCT01913639|564587503|FG000|Overall Study|Not Eligible|3|||
156408037|NCT02759185|564587504|FG000|Stage 1|Adverse Event|0|||
156408038|NCT02759185|564587505|FG001|Stage 1|Adverse Event|1|||
156408039|NCT02759185|564587506|FG002|Stage 1|Adverse Event|3|||
156408040|NCT02759185|564587507|FG003|Stage 1|Adverse Event|0|||
156408041|NCT02759185|564587508|FG004|Stage 1|Adverse Event|0|||
156408042|NCT02759185|564587509|FG005|Stage 1|Adverse Event|0|||
156408043|NCT02759185|564587510|FG006|Stage 1|Adverse Event|0|||
156408044|NCT02759185|564587504|FG000|Stage 1|Withdrawal by Subject|1|||
156408045|NCT02759185|564587505|FG001|Stage 1|Withdrawal by Subject|0|||
156408046|NCT02759185|564587506|FG002|Stage 1|Withdrawal by Subject|0|||
156408047|NCT02759185|564587507|FG003|Stage 1|Withdrawal by Subject|0|||
156408048|NCT02759185|564587508|FG004|Stage 1|Withdrawal by Subject|0|||
156408049|NCT02759185|564587509|FG005|Stage 1|Withdrawal by Subject|0|||
156408050|NCT02759185|564587510|FG006|Stage 1|Withdrawal by Subject|0|||
156408051|NCT02759185|564587504|FG000|Stage 2|Adverse Event|0|||
156408052|NCT02759185|564587505|FG001|Stage 2|Adverse Event|0|||
156408053|NCT02759185|564587506|FG002|Stage 2|Adverse Event|0|||
156408054|NCT02759185|564587507|FG003|Stage 2|Adverse Event|0|||
156408055|NCT02759185|564587508|FG004|Stage 2|Adverse Event|1|||
156408056|NCT02759185|564587509|FG005|Stage 2|Adverse Event|2|||
156635650|NCT01035229|565412140|FG001|Overall Study|Adverse Event|14|||
156408057|NCT02759185|564587510|FG006|Stage 2|Adverse Event|0|||
156408058|NCT02759185|564587504|FG000|Stage 2|Withdrawal by Subject|0|||
156408059|NCT02759185|564587505|FG001|Stage 2|Withdrawal by Subject|0|||
156408060|NCT02759185|564587506|FG002|Stage 2|Withdrawal by Subject|0|||
156408061|NCT02759185|564587507|FG003|Stage 2|Withdrawal by Subject|0|||
156408062|NCT02759185|564587508|FG004|Stage 2|Withdrawal by Subject|1|||
156408063|NCT02759185|564587509|FG005|Stage 2|Withdrawal by Subject|1|||
156408064|NCT02759185|564587510|FG006|Stage 2|Withdrawal by Subject|1|||
156408065|NCT04395183|564587511|FG000|Overall Study|Withdrawal by Subject|1|||
156408066|NCT04395183|564587512|FG001|Overall Study|Withdrawal by Subject|0|||
156408067|NCT04395183|564587513|FG002|Overall Study|Withdrawal by Subject|2|||
156408068|NCT04395183|564587514|FG003|Overall Study|Withdrawal by Subject|2|||
156408069|NCT00962247|564587517|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
156408070|NCT00962247|564587517|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
156408071|NCT00886639|564587522|FG000|Overall Study|acute exacerbation|14|||
156408072|NCT00886639|564587522|FG000|Overall Study|non-compliance|2|||
156408073|NCT00118898|564587523|FG000|Overall Study|Death|6|||
156408074|NCT00118898|564587524|FG001|Overall Study|Death|11|||
156408075|NCT00118898|564587525|FG002|Overall Study|Death|6|||
156408076|NCT00118898|564587526|FG003|Overall Study|Death|8|||
156408077|NCT00118898|564587523|FG000|Overall Study|Lost to Follow-up|26|||
156408078|NCT00118898|564587524|FG001|Overall Study|Lost to Follow-up|34|||
156408079|NCT00118898|564587525|FG002|Overall Study|Lost to Follow-up|33|||
156408080|NCT00118898|564587526|FG003|Overall Study|Lost to Follow-up|33|||
156408081|NCT00118898|564587523|FG000|Overall Study|Withdrawal by Subject|10|||
156408082|NCT00118898|564587524|FG001|Overall Study|Withdrawal by Subject|5|||
156408083|NCT00118898|564587525|FG002|Overall Study|Withdrawal by Subject|8|||
156408084|NCT00118898|564587526|FG003|Overall Study|Withdrawal by Subject|8|||
156408085|NCT00118898|564587523|FG000|Overall Study|Site Closure|33|||
156408086|NCT00118898|564587524|FG001|Overall Study|Site Closure|31|||
156408087|NCT00118898|564587525|FG002|Overall Study|Site Closure|28|||
156408088|NCT00118898|564587526|FG003|Overall Study|Site Closure|37|||
156408089|NCT00118898|564587523|FG000|Overall Study|Severe debilitation|1|||
156408090|NCT00118898|564587524|FG001|Overall Study|Severe debilitation|4|||
156408091|NCT00118898|564587525|FG002|Overall Study|Severe debilitation|6|||
156408092|NCT00118898|564587526|FG003|Overall Study|Severe debilitation|4|||
156408093|NCT00118898|564587523|FG000|Overall Study|Not compliant with requirements|11|||
156408094|NCT00118898|564587524|FG001|Overall Study|Not compliant with requirements|13|||
156408095|NCT00118898|564587525|FG002|Overall Study|Not compliant with requirements|11|||
156408096|NCT00118898|564587526|FG003|Overall Study|Not compliant with requirements|11|||
156408097|NCT00118898|564587523|FG000|Overall Study|Not able to get to clinic|34|||
156408098|NCT00118898|564587524|FG001|Overall Study|Not able to get to clinic|43|||
156408099|NCT00118898|564587525|FG002|Overall Study|Not able to get to clinic|31|||
156408100|NCT00118898|564587526|FG003|Overall Study|Not able to get to clinic|40|||
156408101|NCT01338012|564587529|FG000|Overall Study|Death|4|||
156408102|NCT01338012|564587529|FG000|Overall Study|Study terminated|4|||
156408103|NCT02714205|564587530|FG000|Overall Study|Cannot tolerate medication|1|||
156408104|NCT02714205|564587531|FG001|Overall Study|Cannot tolerate medication|0|||
156408105|NCT02714205|564587530|FG000|Overall Study|Adverse Event|2|||
156408106|NCT02714205|564587531|FG001|Overall Study|Adverse Event|0|||
156408107|NCT02714205|564587530|FG000|Overall Study|Too busy|1|||
156408108|NCT02714205|564587531|FG001|Overall Study|Too busy|0|||
156408109|NCT02714205|564587530|FG000|Overall Study|Incomplete outcome data|0|||
156408110|NCT02714205|564587531|FG001|Overall Study|Incomplete outcome data|1|||
156408111|NCT02089230|564587532|FG000|Overall Study|Death|0|||
156408112|NCT02089230|564587533|FG001|Overall Study|Death|0|||
156408113|NCT02089230|564587534|FG002|Overall Study|Death|2|||
156408114|NCT02089230|564587532|FG000|Overall Study|Seeking Alternative Therapy|0|||
156408115|NCT02089230|564587533|FG001|Overall Study|Seeking Alternative Therapy|0|||
156408116|NCT02089230|564587534|FG002|Overall Study|Seeking Alternative Therapy|4|||
156408117|NCT03813147|564587535|FG000|Overall Study|Lack of Efficacy|4|||
156408118|NCT03813147|564587536|FG001|Overall Study|Lack of Efficacy|4|||
156408119|NCT03813147|564587535|FG000|Overall Study|Physician Decision|2|||
156408120|NCT03813147|564587536|FG001|Overall Study|Physician Decision|1|||
156408121|NCT02248961|564589202|FG000|Overall Study|Adverse Event|1|||
156408122|NCT02248961|564589203|FG001|Overall Study|Adverse Event|0|||
156408123|NCT02248961|564589202|FG000|Overall Study|Withdrawal by Subject|1|||
156408124|NCT02248961|564589203|FG001|Overall Study|Withdrawal by Subject|2|||
156408125|NCT02248961|564589202|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
156408126|NCT02248961|564589203|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
156408127|NCT02802319|564589205|FG000|Overall Study|Physician Decision|2|||
156408128|NCT02802319|564589206|FG001|Overall Study|Physician Decision|1|||
156408129|NCT02802319|564589205|FG000|Overall Study|Lost to Follow-up|0|||
156408130|NCT02802319|564589206|FG001|Overall Study|Lost to Follow-up|4|||
156408131|NCT00235443|564589211|FG000|Overall Study|Adverse Event|4|||
156408132|NCT00235443|564589212|FG001|Overall Study|Adverse Event|12|||
156408133|NCT00235443|564589213|FG002|Overall Study|Adverse Event|17|||
156408134|NCT00235443|564589214|FG003|Overall Study|Adverse Event|44|||
156408135|NCT00235443|564589215|FG004|Overall Study|Adverse Event|10|||
156408136|NCT00235443|564589216|FG005|Overall Study|Adverse Event|15|||
156408137|NCT00235443|564589211|FG000|Overall Study|Lack of Efficacy|0|||
156408138|NCT00235443|564589212|FG001|Overall Study|Lack of Efficacy|1|||
156408139|NCT00235443|564589213|FG002|Overall Study|Lack of Efficacy|5|||
156408140|NCT00235443|564589214|FG003|Overall Study|Lack of Efficacy|12|||
156408141|NCT00235443|564589215|FG004|Overall Study|Lack of Efficacy|2|||
156408142|NCT00235443|564589216|FG005|Overall Study|Lack of Efficacy|9|||
156408143|NCT00235443|564589211|FG000|Overall Study|Withdrawal by Subject|3|||
156408144|NCT00235443|564589212|FG001|Overall Study|Withdrawal by Subject|9|||
156408145|NCT00235443|564589213|FG002|Overall Study|Withdrawal by Subject|25|||
156408146|NCT00235443|564589214|FG003|Overall Study|Withdrawal by Subject|24|||
156408147|NCT00235443|564589215|FG004|Overall Study|Withdrawal by Subject|10|||
156408148|NCT00235443|564589216|FG005|Overall Study|Withdrawal by Subject|12|||
156408149|NCT00235443|564589211|FG000|Overall Study|Lost to Follow-up|0|||
156408150|NCT00235443|564589212|FG001|Overall Study|Lost to Follow-up|8|||
156408151|NCT00235443|564589213|FG002|Overall Study|Lost to Follow-up|6|||
156408152|NCT00235443|564589214|FG003|Overall Study|Lost to Follow-up|6|||
156408153|NCT00235443|564589215|FG004|Overall Study|Lost to Follow-up|4|||
156408154|NCT00235443|564589216|FG005|Overall Study|Lost to Follow-up|3|||
156408155|NCT00235443|564589211|FG000|Overall Study|Unsatisfactory compliance|0|||
156408156|NCT00235443|564589212|FG001|Overall Study|Unsatisfactory compliance|2|||
156408157|NCT00235443|564589213|FG002|Overall Study|Unsatisfactory compliance|3|||
156408158|NCT00235443|564589214|FG003|Overall Study|Unsatisfactory compliance|4|||
156408159|NCT00235443|564589215|FG004|Overall Study|Unsatisfactory compliance|1|||
156408160|NCT00235443|564589216|FG005|Overall Study|Unsatisfactory compliance|0|||
156408161|NCT00235443|564589211|FG000|Overall Study|Other reasons for premature termination|1|||
156408162|NCT00235443|564589212|FG001|Overall Study|Other reasons for premature termination|6|||
156408163|NCT00235443|564589213|FG002|Overall Study|Other reasons for premature termination|6|||
156408164|NCT00235443|564589214|FG003|Overall Study|Other reasons for premature termination|7|||
156408165|NCT00235443|564589215|FG004|Overall Study|Other reasons for premature termination|3|||
156408166|NCT00235443|564589216|FG005|Overall Study|Other reasons for premature termination|6|||
156408167|NCT02318719|564589217|FG000|Double-blind Phase|Adverse Event|7|||
156408168|NCT02318719|564589218|FG001|Double-blind Phase|Adverse Event|6|||
156408169|NCT02318719|564589219|FG002|Double-blind Phase|Adverse Event|12|||
156408170|NCT02318719|564589220|FG003|Double-blind Phase|Adverse Event|4|||
156408171|NCT02318719|564589221|FG004|Double-blind Phase|Adverse Event|0|||
156408172|NCT02318719|564589217|FG000|Double-blind Phase|Lack of Efficacy|5|||
156408173|NCT02318719|564589218|FG001|Double-blind Phase|Lack of Efficacy|0|||
156408174|NCT02318719|564589219|FG002|Double-blind Phase|Lack of Efficacy|1|||
156408175|NCT02318719|564589220|FG003|Double-blind Phase|Lack of Efficacy|1|||
156408176|NCT02318719|564589221|FG004|Double-blind Phase|Lack of Efficacy|0|||
156408177|NCT02318719|564589217|FG000|Double-blind Phase|Protocol Violation|0|||
156408178|NCT02318719|564589218|FG001|Double-blind Phase|Protocol Violation|1|||
156408179|NCT02318719|564589219|FG002|Double-blind Phase|Protocol Violation|3|||
156408180|NCT02318719|564589220|FG003|Double-blind Phase|Protocol Violation|0|||
156408181|NCT02318719|564589221|FG004|Double-blind Phase|Protocol Violation|0|||
156408182|NCT02318719|564589217|FG000|Double-blind Phase|Withdrawal by Subject|25|||
156408183|NCT02318719|564589218|FG001|Double-blind Phase|Withdrawal by Subject|7|||
156408184|NCT02318719|564589219|FG002|Double-blind Phase|Withdrawal by Subject|9|||
156521315|NCT01874431|565003068|FG007|Overall Study|Protocol Violation|1|||
156521316|NCT01874431|565003061|FG000|Overall Study|Non-compliance|0|||
156408185|NCT02318719|564589220|FG003|Double-blind Phase|Withdrawal by Subject|10|||
156408186|NCT02318719|564589221|FG004|Double-blind Phase|Withdrawal by Subject|0|||
156521317|NCT01874431|565003062|FG001|Overall Study|Non-compliance|0|||
156521318|NCT01874431|565003063|FG002|Overall Study|Non-compliance|0|||
156521319|NCT01874431|565003064|FG003|Overall Study|Non-compliance|0|||
156521320|NCT01874431|565003065|FG004|Overall Study|Non-compliance|1|||
156408187|NCT02318719|564589217|FG000|Double-blind Phase|Other|1|||
156408188|NCT02318719|564589218|FG001|Double-blind Phase|Other|2|||
156408189|NCT02318719|564589219|FG002|Double-blind Phase|Other|0|||
156408190|NCT02318719|564589220|FG003|Double-blind Phase|Other|0|||
156408191|NCT02318719|564589221|FG004|Double-blind Phase|Other|0|||
156408192|NCT02318719|564589217|FG000|Open-label Extension Phase|Adverse Event|0|||
156408193|NCT02318719|564589218|FG001|Open-label Extension Phase|Adverse Event|0|||
156408194|NCT02318719|564589219|FG002|Open-label Extension Phase|Adverse Event|0|||
156408195|NCT02318719|564589220|FG003|Open-label Extension Phase|Adverse Event|0|||
156408196|NCT02318719|564589221|FG004|Open-label Extension Phase|Adverse Event|15|||
156408197|NCT02318719|564589217|FG000|Open-label Extension Phase|Death|0|||
156408198|NCT02318719|564589218|FG001|Open-label Extension Phase|Death|0|||
156408199|NCT02318719|564589219|FG002|Open-label Extension Phase|Death|0|||
156408200|NCT02318719|564589220|FG003|Open-label Extension Phase|Death|0|||
156408201|NCT02318719|564589221|FG004|Open-label Extension Phase|Death|1|||
156408202|NCT02318719|564589217|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
156408203|NCT02318719|564589218|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
156408204|NCT02318719|564589219|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
156408205|NCT02318719|564589220|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
156408206|NCT02318719|564589221|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
156408207|NCT02318719|564589217|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
156408208|NCT02318719|564589218|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
156408209|NCT02318719|564589219|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
156408210|NCT02318719|564589220|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
156408211|NCT02318719|564589221|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
156408212|NCT02318719|564589217|FG000|Open-label Extension Phase|Other|0|||
156408213|NCT02318719|564589218|FG001|Open-label Extension Phase|Other|0|||
156408214|NCT02318719|564589219|FG002|Open-label Extension Phase|Other|0|||
156749969|NCT00385827|565836902|FG002|Part 1|Other|0|||
156749970|NCT00385827|565836900|FG000|Part 2|Adverse Event|0|||
156408215|NCT02318719|564589220|FG003|Open-label Extension Phase|Other|0|||
156408216|NCT02318719|564589221|FG004|Open-label Extension Phase|Other|7|||
156408217|NCT03093428|564589222|FG000|Overall Study|Not eligible for treatment|2|||
156408218|NCT03093428|564589223|FG001|Overall Study|Not eligible for treatment|1|||
156408219|NCT03093428|564589222|FG000|Overall Study|Progression|14|||
156521321|NCT01874431|565003066|FG005|Overall Study|Non-compliance|0|||
156521322|NCT01874431|565003067|FG006|Overall Study|Non-compliance|1|||
156521323|NCT01874431|565003068|FG007|Overall Study|Non-compliance|0|||
156521324|NCT01874431|565003061|FG000|Overall Study|Logistical difficulties|0|||
156521325|NCT01874431|565003062|FG001|Overall Study|Logistical difficulties|0|||
156521326|NCT01874431|565003063|FG002|Overall Study|Logistical difficulties|0|||
156521327|NCT01874431|565003064|FG003|Overall Study|Logistical difficulties|0|||
156521328|NCT01874431|565003065|FG004|Overall Study|Logistical difficulties|0|||
156521329|NCT01874431|565003066|FG005|Overall Study|Logistical difficulties|0|||
156521330|NCT01874431|565003067|FG006|Overall Study|Logistical difficulties|1|||
156521331|NCT01874431|565003068|FG007|Overall Study|Logistical difficulties|0|||
156521332|NCT01874431|565003061|FG000|Overall Study|Withdrawal by Subject|0|||
156521333|NCT01874431|565003062|FG001|Overall Study|Withdrawal by Subject|0|||
156521334|NCT01874431|565003063|FG002|Overall Study|Withdrawal by Subject|1|||
156521335|NCT01874431|565003064|FG003|Overall Study|Withdrawal by Subject|2|||
156521336|NCT01874431|565003065|FG004|Overall Study|Withdrawal by Subject|1|||
156521337|NCT01874431|565003066|FG005|Overall Study|Withdrawal by Subject|1|||
156521338|NCT01874431|565003067|FG006|Overall Study|Withdrawal by Subject|3|||
156521339|NCT01874431|565003068|FG007|Overall Study|Withdrawal by Subject|0|||
156521340|NCT01874431|565003061|FG000|Overall Study|Sponsor decision|0|||
156521341|NCT01874431|565003062|FG001|Overall Study|Sponsor decision|0|||
156521342|NCT01874431|565003063|FG002|Overall Study|Sponsor decision|0|||
156521343|NCT01874431|565003064|FG003|Overall Study|Sponsor decision|0|||
156521344|NCT01874431|565003065|FG004|Overall Study|Sponsor decision|1|||
156521345|NCT01874431|565003066|FG005|Overall Study|Sponsor decision|0|||
156521346|NCT01874431|565003067|FG006|Overall Study|Sponsor decision|0|||
156521347|NCT01874431|565003068|FG007|Overall Study|Sponsor decision|0|||
156521348|NCT01874431|565003061|FG000|Overall Study|Lost to Follow-up|0|||
156521349|NCT01874431|565003062|FG001|Overall Study|Lost to Follow-up|0|||
156635651|NCT01035229|565412139|FG000|Overall Study|Withdrawal by Subject|20|||
156635652|NCT01035229|565412140|FG001|Overall Study|Withdrawal by Subject|7|||
156635653|NCT01035229|565412139|FG000|Overall Study|Lost to Follow-up|1|||
156635654|NCT01035229|565412140|FG001|Overall Study|Lost to Follow-up|0|||
156635655|NCT01035229|565412139|FG000|Overall Study|Administrative problems|1|||
156635656|NCT01035229|565412140|FG001|Overall Study|Administrative problems|1|||
156635657|NCT01035229|565412139|FG000|Overall Study|Death|13|||
156635658|NCT01035229|565412140|FG001|Overall Study|Death|5|||
156635659|NCT01035229|565412139|FG000|Overall Study|New cancer therapy|2|||
156635660|NCT01035229|565412140|FG001|Overall Study|New cancer therapy|0|||
156635661|NCT01035229|565412139|FG000|Overall Study|Protocol Violation|0|||
156635662|NCT01035229|565412140|FG001|Overall Study|Protocol Violation|2|||
156635663|NCT01035229|565412139|FG000|Overall Study|Sponsor's decision to end study|3|||
156635664|NCT01035229|565412140|FG001|Overall Study|Sponsor's decision to end study|3|||
156635665|NCT01035229|565412139|FG000|Overall Study|Disease Progression|261|||
156635666|NCT01035229|565412140|FG001|Overall Study|Disease Progression|152|||
156635667|NCT00564486|565412145|FG000|Overall Study|Adverse Event|0|||
156635668|NCT00564486|565412146|FG001|Overall Study|Adverse Event|1|||
156635669|NCT00564486|565412147|FG002|Overall Study|Adverse Event|0|||
156635670|NCT00564486|565412148|FG003|Overall Study|Adverse Event|0|||
156635671|NCT00564486|565412145|FG000|Overall Study|Withdrawal by Subject|4|||
156635672|NCT00564486|565412146|FG001|Overall Study|Withdrawal by Subject|0|||
156635673|NCT00564486|565412147|FG002|Overall Study|Withdrawal by Subject|0|||
156635674|NCT00564486|565412148|FG003|Overall Study|Withdrawal by Subject|5|||
156635675|NCT00564486|565412145|FG000|Overall Study|Subject refused to have blood drawn|0|||
156635676|NCT00564486|565412146|FG001|Overall Study|Subject refused to have blood drawn|0|||
156635677|NCT00564486|565412147|FG002|Overall Study|Subject refused to have blood drawn|1|||
156635678|NCT00564486|565412148|FG003|Overall Study|Subject refused to have blood drawn|0|||
156635679|NCT00564486|565412145|FG000|Overall Study|Lost to Follow-up|3|||
156635680|NCT00564486|565412146|FG001|Overall Study|Lost to Follow-up|0|||
156635681|NCT00564486|565412147|FG002|Overall Study|Lost to Follow-up|2|||
156635682|NCT00564486|565412148|FG003|Overall Study|Lost to Follow-up|2|||
156635683|NCT03387423|565412149|FG000|Overall Study|Lost to Follow-up|16|||
156635684|NCT03387423|565412150|FG001|Overall Study|Lost to Follow-up|12|||
156635685|NCT03387423|565412151|FG002|Overall Study|Lost to Follow-up|1|||
156635686|NCT03387423|565412152|FG003|Overall Study|Lost to Follow-up|0|||
156635687|NCT03387423|565412149|FG000|Overall Study|Other|0|||
156749971|NCT00385827|565836901|FG001|Part 2|Adverse Event|6|||
156749972|NCT00385827|565836902|FG002|Part 2|Adverse Event|10|||
156749973|NCT00385827|565836900|FG000|Part 2|Death|0|||
156749974|NCT00385827|565836901|FG001|Part 2|Death|0|||
156521350|NCT01874431|565003063|FG002|Overall Study|Lost to Follow-up|1|||
156635688|NCT03387423|565412150|FG001|Overall Study|Other|3|||
156521351|NCT01874431|565003064|FG003|Overall Study|Lost to Follow-up|0|||
156635689|NCT03387423|565412151|FG002|Overall Study|Other|0|||
156635690|NCT03387423|565412152|FG003|Overall Study|Other|0|||
156635691|NCT03387423|565412149|FG000|Overall Study|Administrative Reason|166|||
156749975|NCT00385827|565836902|FG002|Part 2|Death|2|||
156635692|NCT03387423|565412150|FG001|Overall Study|Administrative Reason|89|||
156635693|NCT03387423|565412151|FG002|Overall Study|Administrative Reason|17|||
156521352|NCT01874431|565003065|FG004|Overall Study|Lost to Follow-up|0|||
156521353|NCT01874431|565003066|FG005|Overall Study|Lost to Follow-up|0|||
156521354|NCT01874431|565003067|FG006|Overall Study|Lost to Follow-up|0|||
156521355|NCT01874431|565003068|FG007|Overall Study|Lost to Follow-up|0|||
156521356|NCT00642772|565003070|FG000|Overall Study|Lost to Follow-up|3|||
156521357|NCT00642772|565003070|FG000|Overall Study|Withdrawal by Subject|7|||
156521358|NCT05398237|565003079|FG000|Overall Study|Withdrawal by Subject|1|||
156521359|NCT01312857|565003081|FG000|Overall Study|Adverse Event|1|||
156635694|NCT03387423|565412152|FG003|Overall Study|Administrative Reason|19|||
156635695|NCT03387423|565412149|FG000|Overall Study|Revocation Consent|76|||
156635696|NCT03387423|565412150|FG001|Overall Study|Revocation Consent|32|||
156635697|NCT03387423|565412151|FG002|Overall Study|Revocation Consent|3|||
156635698|NCT03387423|565412152|FG003|Overall Study|Revocation Consent|5|||
156635699|NCT00798707|565412161|FG000|Overall Study|Adverse Event|6|||
156635700|NCT00798707|565412162|FG001|Overall Study|Adverse Event|8|||
156635701|NCT00798707|565412163|FG002|Overall Study|Adverse Event|8|||
156635702|NCT00798707|565412161|FG000|Overall Study|Failed to return|2|||
156635703|NCT00798707|565412162|FG001|Overall Study|Failed to return|2|||
156635704|NCT00798707|565412163|FG002|Overall Study|Failed to return|0|||
156635705|NCT00798707|565412161|FG000|Overall Study|Investigator|0|||
156635706|NCT00798707|565412162|FG001|Overall Study|Investigator|1|||
156635707|NCT00798707|565412163|FG002|Overall Study|Investigator|2|||
156635708|NCT00798707|565412161|FG000|Overall Study|Lack of Efficacy|2|||
156635709|NCT00798707|565412162|FG001|Overall Study|Lack of Efficacy|2|||
156635710|NCT00798707|565412163|FG002|Overall Study|Lack of Efficacy|1|||
156635711|NCT00798707|565412161|FG000|Overall Study|Lost to Follow-up|5|||
156635712|NCT00798707|565412162|FG001|Overall Study|Lost to Follow-up|6|||
156635713|NCT00798707|565412163|FG002|Overall Study|Lost to Follow-up|6|||
156521360|NCT01312857|565003082|FG001|Overall Study|Adverse Event|1|||
156521361|NCT01312857|565003081|FG000|Overall Study|Lost to Follow-up|2|||
156521362|NCT01312857|565003082|FG001|Overall Study|Lost to Follow-up|0|||
156521363|NCT01312857|565003081|FG000|Overall Study|Physician Decision|3|||
156521364|NCT01312857|565003082|FG001|Overall Study|Physician Decision|0|||
156521365|NCT01312857|565003081|FG000|Overall Study|Withdrawal by Subject|2|||
156521366|NCT01312857|565003082|FG001|Overall Study|Withdrawal by Subject|0|||
156521367|NCT04275089|565003088|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
156521368|NCT01382706|565003089|FG000|Overall Study|Adverse Event|1|||
156521369|NCT01382706|565003089|FG000|Overall Study|Withdrawal by Subject|1|||
156521370|NCT03256851|565003090|FG000|Overall Study|Withdrawal by Subject|1|||
156521371|NCT03256851|565003091|FG001|Overall Study|Withdrawal by Subject|0|||
156521372|NCT03545503|565003094|FG000|Overall Study|Protocol Violation|14|||
156521373|NCT03545503|565003095|FG001|Overall Study|Protocol Violation|16|||
156521374|NCT00825916|565003099|FG000|Overall Study|Lost to Follow-up|4|||
156521375|NCT00825916|565003100|FG001|Overall Study|Lost to Follow-up|2|||
156521376|NCT00825916|565003101|FG002|Overall Study|Lost to Follow-up|1|||
156408220|NCT03093428|564589223|FG001|Overall Study|Progression|4|||
156408221|NCT03093428|564589222|FG000|Overall Study|Death|1|||
156408222|NCT03093428|564589223|FG001|Overall Study|Death|0|||
156408223|NCT03093428|564589222|FG000|Overall Study|Adverse Event|1|||
156408224|NCT03093428|564589223|FG001|Overall Study|Adverse Event|0|||
156408225|NCT03093428|564589222|FG000|Overall Study|Withdrawal by Subject|1|||
156408226|NCT03093428|564589223|FG001|Overall Study|Withdrawal by Subject|1|||
156408227|NCT05340751|564589225|FG000|Overall Study|Physician Decision|3|||
156408228|NCT01014975|564589226|FG000|Overall Study|Withdrawal by Subject|1|||
156408229|NCT01014975|564589227|FG001|Overall Study|Withdrawal by Subject|0|||
156635714|NCT00798707|565412161|FG000|Overall Study|Other|0|||
156635715|NCT00798707|565412162|FG001|Overall Study|Other|1|||
156635716|NCT00798707|565412163|FG002|Overall Study|Other|0|||
156635717|NCT00798707|565412161|FG000|Overall Study|Protocol Violation|4|||
156749976|NCT00385827|565836900|FG000|Part 2|Lack of Efficacy|0|||
156408230|NCT01014975|564589228|FG002|Overall Study|Withdrawal by Subject|1|||
156408231|NCT01014975|564589226|FG000|Overall Study|Death|3|||
156408232|NCT01014975|564589227|FG001|Overall Study|Death|3|||
156408233|NCT01014975|564589228|FG002|Overall Study|Death|4|||
156408234|NCT01014975|564589226|FG000|Overall Study|Lost to Follow-up|0|||
156521377|NCT01098097|565003102|FG000|Overall Study|Adverse Event|17|||
156521378|NCT01098097|565003102|FG000|Overall Study|Lost to Follow-up|18|||
156635718|NCT00798707|565412162|FG001|Overall Study|Protocol Violation|0|||
156635719|NCT00798707|565412163|FG002|Overall Study|Protocol Violation|2|||
156635720|NCT00798707|565412161|FG000|Overall Study|Withdrawal by Subject|3|||
156635721|NCT00798707|565412162|FG001|Overall Study|Withdrawal by Subject|8|||
156635722|NCT00798707|565412163|FG002|Overall Study|Withdrawal by Subject|2|||
156635723|NCT00798707|565412161|FG000|Overall Study|Randomized not treated|4|||
156635724|NCT00798707|565412162|FG001|Overall Study|Randomized not treated|5|||
156408235|NCT01014975|564589227|FG001|Overall Study|Lost to Follow-up|0|||
156408236|NCT01014975|564589228|FG002|Overall Study|Lost to Follow-up|1|||
156635725|NCT00798707|565412163|FG002|Overall Study|Randomized not treated|1|||
156635726|NCT01473589|565412164|FG000|Overall Study|Adverse Event|1|||
156635727|NCT01473589|565412165|FG001|Overall Study|Adverse Event|1|||
156408237|NCT01973491|564589231|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
156408238|NCT01973491|564589231|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
156408239|NCT01973491|564589231|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
156635728|NCT01473589|565412164|FG000|Overall Study|Death|2|||
156635729|NCT01473589|565412165|FG001|Overall Study|Death|0|||
156635730|NCT01473589|565412164|FG000|Overall Study|Lost to Follow-up|2|||
156635731|NCT01473589|565412165|FG001|Overall Study|Lost to Follow-up|2|||
156635732|NCT01473589|565412164|FG000|Overall Study|Protocol Violation|1|||
156635733|NCT01473589|565412165|FG001|Overall Study|Protocol Violation|0|||
156408240|NCT02632786|564589232|FG000|Overall Study|Adverse Event|2|||
156635734|NCT01473589|565412164|FG000|Overall Study|Withdrawal by Subject|5|||
156635735|NCT01473589|565412165|FG001|Overall Study|Withdrawal by Subject|11|||
156635736|NCT01473589|565412164|FG000|Overall Study|Physician Decision|0|||
156635737|NCT01473589|565412165|FG001|Overall Study|Physician Decision|1|||
156635738|NCT01473589|565412164|FG000|Overall Study|Entry criteria not met|0|||
156635739|NCT01473589|565412165|FG001|Overall Study|Entry criteria not met|1|||
156635740|NCT03457727|565412167|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
156635741|NCT03457727|565412168|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
156635742|NCT03457727|565412169|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
156635743|NCT03457727|565412170|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
156635744|NCT01299272|565412173|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
156635745|NCT01299272|565412174|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
156635746|NCT01299272|565412175|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
156635747|NCT01299272|565412176|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
156635748|NCT01299272|565412173|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
156635749|NCT01299272|565412174|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
156635750|NCT01299272|565412175|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
156635751|NCT01299272|565412176|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
156635752|NCT01299272|565412173|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
156635753|NCT01299272|565412174|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
156635754|NCT01299272|565412175|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
156635755|NCT01299272|565412176|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
156635756|NCT01299272|565412173|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
156635757|NCT01299272|565412174|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
156635758|NCT01299272|565412175|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
156635759|NCT01299272|565412176|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
156635760|NCT01299272|565412173|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
156635761|NCT01299272|565412174|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
156635762|NCT01299272|565412175|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
156635763|NCT01299272|565412176|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
156635764|NCT01299272|565412173|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
156635765|NCT01299272|565412174|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
156635766|NCT01299272|565412175|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
156635767|NCT01299272|565412176|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
156635768|NCT01299272|565412173|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
156635769|NCT01299272|565412174|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
156635770|NCT01299272|565412175|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
156635771|NCT01299272|565412176|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
156635772|NCT01299272|565412173|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
156635773|NCT01299272|565412174|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
156635774|NCT01299272|565412175|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
156635775|NCT01299272|565412176|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
156635776|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
156749977|NCT00385827|565836901|FG001|Part 2|Lack of Efficacy|14|||
156864137|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
156408241|NCT02632786|564589233|FG001|Overall Study|Adverse Event|1|||
156408242|NCT02632786|564589232|FG000|Overall Study|Death|3|||
156408243|NCT02632786|564589233|FG001|Overall Study|Death|2|||
156408244|NCT02632786|564589232|FG000|Overall Study|Physician Decision|5|||
156408245|NCT02632786|564589233|FG001|Overall Study|Physician Decision|4|||
156408246|NCT02632786|564589232|FG000|Overall Study|Withdrawal by Subject|1|||
156408247|NCT02632786|564589233|FG001|Overall Study|Withdrawal by Subject|0|||
156635777|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
156635778|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
156635779|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
156635780|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
156635781|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
156635782|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
156635783|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
156635784|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
156749978|NCT00385827|565836902|FG002|Part 2|Lack of Efficacy|13|||
156749979|NCT00385827|565836900|FG000|Part 2|Randomized but not treated|0|||
156749980|NCT00385827|565836901|FG001|Part 2|Randomized but not treated|2|||
156749981|NCT00385827|565836902|FG002|Part 2|Randomized but not treated|2|||
156749982|NCT00385827|565836900|FG000|Part 2|Other|0|||
156749983|NCT00385827|565836901|FG001|Part 2|Other|11|||
156749984|NCT00385827|565836902|FG002|Part 2|Other|21|||
156749985|NCT01421147|565836903|FG000|Treatment Period|Adverse Event|2|||
156749986|NCT01421147|565836904|FG001|Treatment Period|Adverse Event|3|||
156749987|NCT01421147|565836903|FG000|Treatment Period|Lost to Follow-up|2|||
156749988|NCT01421147|565836904|FG001|Treatment Period|Lost to Follow-up|1|||
156749989|NCT01421147|565836903|FG000|Treatment Period|Physician Decision|2|||
156749990|NCT01421147|565836904|FG001|Treatment Period|Physician Decision|2|||
156749991|NCT01421147|565836903|FG000|Treatment Period|Withdrawal by Subject|10|||
156749992|NCT01421147|565836904|FG001|Treatment Period|Withdrawal by Subject|5|||
156749993|NCT01421147|565836903|FG000|Extension Period|Adverse Event|0|||
156749994|NCT01421147|565836904|FG001|Extension Period|Adverse Event|2|||
156749995|NCT01421147|565836903|FG000|Extension Period|Death|0|||
156749996|NCT01421147|565836904|FG001|Extension Period|Death|1|||
156749997|NCT01421147|565836903|FG000|Extension Period|Lost to Follow-up|2|||
156749998|NCT01421147|565836904|FG001|Extension Period|Lost to Follow-up|5|||
156749999|NCT01421147|565836903|FG000|Extension Period|Physician Decision|1|||
156750000|NCT01421147|565836904|FG001|Extension Period|Physician Decision|0|||
156750001|NCT01421147|565836903|FG000|Extension Period|Withdrawal by Subject|5|||
156750002|NCT01421147|565836904|FG001|Extension Period|Withdrawal by Subject|3|||
156750003|NCT01212159|565836905|FG000|Overall Study|Withdrawal by Subject|12|||
156750004|NCT01212159|565836906|FG001|Overall Study|Withdrawal by Subject|12|||
156750005|NCT00582426|565836917|FG000|Overall Study|Lost to Follow-up|0|||
156750006|NCT00582426|565836918|FG001|Overall Study|Lost to Follow-up|2|||
156750007|NCT00582426|565836917|FG000|Overall Study|Adverse Event|4|||
156750008|NCT00582426|565836918|FG001|Overall Study|Adverse Event|2|||
156750009|NCT00582426|565836917|FG000|Overall Study|Protocol Violation|6|||
156750010|NCT00582426|565836918|FG001|Overall Study|Protocol Violation|2|||
156635785|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
156635786|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
156750011|NCT00582426|565836917|FG000|Overall Study|Death|4|||
156635787|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
156635788|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
156635789|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
156635790|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
156635791|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
156635792|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
156635793|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
156635794|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
156635795|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
156635796|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
156635797|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
156635798|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
156635799|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
156635800|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
156635801|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
156635802|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
156635803|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
156635804|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
156635805|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
156635806|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
156635807|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
156635808|NCT01299272|565412173|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
156635809|NCT01299272|565412174|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
156635810|NCT01299272|565412175|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
156635811|NCT01299272|565412176|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
156750012|NCT00582426|565836918|FG001|Overall Study|Death|3|||
156750013|NCT00582426|565836917|FG000|Overall Study|Withdrawal by Subject|3|||
156635812|NCT01299272|565412173|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
156635813|NCT01299272|565412174|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
156635814|NCT01299272|565412175|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
156635815|NCT01299272|565412176|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
156635816|NCT01299272|565412173|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
156635817|NCT01299272|565412174|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
156635818|NCT01299272|565412175|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
156750014|NCT00582426|565836918|FG001|Overall Study|Withdrawal by Subject|2|||
156635819|NCT01299272|565412176|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
156635820|NCT01299272|565412173|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
156635821|NCT01299272|565412174|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
156635822|NCT01299272|565412175|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
156635823|NCT01299272|565412176|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
156635824|NCT01299272|565412173|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
156635825|NCT01299272|565412174|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
156635826|NCT01299272|565412175|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
156635827|NCT01299272|565412176|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
156635828|NCT01299272|565412173|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
156635829|NCT01299272|565412174|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
156635830|NCT01299272|565412175|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
156635831|NCT01299272|565412176|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
156635832|NCT01299272|565412173|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
156635833|NCT01299272|565412174|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
156635834|NCT01299272|565412175|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
156635835|NCT01299272|565412176|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
156635836|NCT01299272|565412173|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
156635837|NCT01299272|565412174|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
156635838|NCT01299272|565412175|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
156635839|NCT01299272|565412176|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
156635840|NCT01299272|565412173|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
156635841|NCT01299272|565412174|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
156635842|NCT01299272|565412175|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
156635843|NCT01299272|565412176|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
156635844|NCT00464308|565412177|FG000|Overall Study|Adverse Event|22|||
156635845|NCT00464308|565412178|FG001|Overall Study|Adverse Event|27|||
156635846|NCT00464308|565412179|FG002|Overall Study|Adverse Event|16|||
156635847|NCT00464308|565412177|FG000|Overall Study|Lost to Follow-up|29|||
156635848|NCT00464308|565412178|FG001|Overall Study|Lost to Follow-up|19|||
156635849|NCT00464308|565412179|FG002|Overall Study|Lost to Follow-up|20|||
156635850|NCT00464308|565412177|FG000|Overall Study|Patient discontinued and other reasons|17|||
156635851|NCT00464308|565412178|FG001|Overall Study|Patient discontinued and other reasons|17|||
156635852|NCT00464308|565412179|FG002|Overall Study|Patient discontinued and other reasons|23|||
156635853|NCT00464308|565412177|FG000|Overall Study|Physician Decision|1|||
156635854|NCT00464308|565412178|FG001|Overall Study|Physician Decision|0|||
156635855|NCT00464308|565412179|FG002|Overall Study|Physician Decision|0|||
156635856|NCT01721200|565412180|FG000|Overall Study|Lost to Follow-up|3|||
156635857|NCT01721200|565412181|FG001|Overall Study|Lost to Follow-up|5|||
156635858|NCT01513759|565412182|FG000|Overall Study|Protocol Violation|4|||
156635859|NCT01513759|565412182|FG000|Overall Study|Death during catheter placement|1|||
156635860|NCT03926728|565412183|FG000|Overall Study|Withdrawal by Subject|0|||
156635861|NCT03926728|565412184|FG001|Overall Study|Withdrawal by Subject|1|||
156635862|NCT03926728|565412185|FG002|Overall Study|Withdrawal by Subject|1|||
156635863|NCT03926728|565412186|FG003|Overall Study|Withdrawal by Subject|0|||
156635864|NCT03926728|565412187|FG004|Overall Study|Withdrawal by Subject|0|||
156635865|NCT03926728|565412188|FG005|Overall Study|Withdrawal by Subject|1|||
156635866|NCT03926728|565412189|FG006|Overall Study|Withdrawal by Subject|1|||
156635867|NCT03926728|565412190|FG007|Overall Study|Withdrawal by Subject|0|||
156750015|NCT00582426|565836917|FG000|Overall Study|Disease Progression|2|||
156750016|NCT00582426|565836918|FG001|Overall Study|Disease Progression|2|||
156635868|NCT03926728|565412191|FG008|Overall Study|Withdrawal by Subject|0|||
156635869|NCT03926728|565412192|FG009|Overall Study|Withdrawal by Subject|1|||
156635870|NCT03926728|565412193|FG010|Overall Study|Withdrawal by Subject|0|||
156635871|NCT03926728|565412194|FG011|Overall Study|Withdrawal by Subject|0|||
156750017|NCT00582426|565836917|FG000|Overall Study|Use of illicit drugs|1|||
156750018|NCT00582426|565836918|FG001|Overall Study|Use of illicit drugs|0|||
156635872|NCT03669640|565412195|FG000|Overall Study|Study Terminated by Sponsor|0|||
156635873|NCT03669640|565412196|FG001|Overall Study|Study Terminated by Sponsor|0|||
156635874|NCT03669640|565412197|FG002|Overall Study|Study Terminated by Sponsor|0|||
156635875|NCT03669640|565412198|FG003|Overall Study|Study Terminated by Sponsor|0|||
156635876|NCT03669640|565412199|FG004|Overall Study|Study Terminated by Sponsor|1|||
156635877|NCT03669640|565412200|FG005|Overall Study|Study Terminated by Sponsor|0|||
156635878|NCT03669640|565412195|FG000|Overall Study|Lost to Follow-up|0|||
156635879|NCT03669640|565412196|FG001|Overall Study|Lost to Follow-up|0|||
156635880|NCT03669640|565412197|FG002|Overall Study|Lost to Follow-up|2|||
156635881|NCT03669640|565412198|FG003|Overall Study|Lost to Follow-up|0|||
156635882|NCT03669640|565412199|FG004|Overall Study|Lost to Follow-up|0|||
156635883|NCT03669640|565412200|FG005|Overall Study|Lost to Follow-up|0|||
156635884|NCT03669640|565412195|FG000|Overall Study|Death|0|||
156635885|NCT03669640|565412196|FG001|Overall Study|Death|0|||
156750019|NCT00199849|565836919|FG000|Overall Study|Unrelated illness or complication|0|||
156635886|NCT03669640|565412197|FG002|Overall Study|Death|1|||
156635887|NCT03669640|565412198|FG003|Overall Study|Death|0|||
156635888|NCT03669640|565412199|FG004|Overall Study|Death|0|||
156635889|NCT03669640|565412200|FG005|Overall Study|Death|0|||
156635890|NCT03669640|565412195|FG000|Overall Study|Withdrawal by Subject|1|||
156635891|NCT03669640|565412196|FG001|Overall Study|Withdrawal by Subject|2|||
156635892|NCT03669640|565412197|FG002|Overall Study|Withdrawal by Subject|1|||
156635893|NCT03669640|565412198|FG003|Overall Study|Withdrawal by Subject|0|||
156635894|NCT03669640|565412199|FG004|Overall Study|Withdrawal by Subject|1|||
156635895|NCT03669640|565412200|FG005|Overall Study|Withdrawal by Subject|3|||
156635896|NCT03669640|565412195|FG000|Overall Study|Protocol Violation|1|||
156635897|NCT03669640|565412196|FG001|Overall Study|Protocol Violation|0|||
156635898|NCT03669640|565412197|FG002|Overall Study|Protocol Violation|0|||
156635899|NCT03669640|565412198|FG003|Overall Study|Protocol Violation|0|||
156635900|NCT03669640|565412199|FG004|Overall Study|Protocol Violation|0|||
156635901|NCT03669640|565412200|FG005|Overall Study|Protocol Violation|0|||
156635902|NCT03669640|565412195|FG000|Overall Study|Physician Decision|0|||
156635903|NCT03669640|565412196|FG001|Overall Study|Physician Decision|2|||
156635904|NCT03669640|565412197|FG002|Overall Study|Physician Decision|0|||
156635905|NCT03669640|565412198|FG003|Overall Study|Physician Decision|0|||
156635906|NCT03669640|565412199|FG004|Overall Study|Physician Decision|0|||
156635907|NCT03669640|565412200|FG005|Overall Study|Physician Decision|0|||
156635908|NCT03669640|565412195|FG000|Overall Study|Disease Relapse|1|||
156635909|NCT03669640|565412196|FG001|Overall Study|Disease Relapse|0|||
156635910|NCT03669640|565412197|FG002|Overall Study|Disease Relapse|0|||
156635911|NCT03669640|565412198|FG003|Overall Study|Disease Relapse|0|||
156635912|NCT03669640|565412199|FG004|Overall Study|Disease Relapse|0|||
156635913|NCT03669640|565412200|FG005|Overall Study|Disease Relapse|0|||
156635914|NCT03669640|565412195|FG000|Overall Study|Adverse Event|2|||
156635915|NCT03669640|565412196|FG001|Overall Study|Adverse Event|1|||
156635916|NCT03669640|565412197|FG002|Overall Study|Adverse Event|0|||
156635917|NCT03669640|565412198|FG003|Overall Study|Adverse Event|0|||
156635918|NCT03669640|565412199|FG004|Overall Study|Adverse Event|1|||
156635919|NCT03669640|565412200|FG005|Overall Study|Adverse Event|0|||
156635920|NCT03722849|565412203|FG000|Overall Study|Withdrawal by Subject|1|||
156635921|NCT03722849|565412204|FG001|Overall Study|Withdrawal by Subject|1|||
156635922|NCT03993288|565412205|FG000|Overall Study|Lost to Follow-up|2|||
156635923|NCT03993288|565412206|FG001|Overall Study|Lost to Follow-up|1|||
156635924|NCT03993288|565412205|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
156635925|NCT03993288|565412206|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
156635926|NCT03993288|565412205|FG000|Overall Study|wrong randomization|0|||
156635927|NCT03993288|565412206|FG001|Overall Study|wrong randomization|1|||
156635928|NCT03993288|565412205|FG000|Overall Study|improper enrollment|0|||
156635929|NCT03993288|565412206|FG001|Overall Study|improper enrollment|1|||
156635930|NCT03993288|565412205|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
156635931|NCT03993288|565412206|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
156635932|NCT03993288|565412205|FG000|Overall Study|developed SAE|2|||
156635933|NCT03993288|565412206|FG001|Overall Study|developed SAE|0|||
156635934|NCT03993288|565412205|FG000|Overall Study|consent withdrawal|1|||
156635935|NCT03993288|565412206|FG001|Overall Study|consent withdrawal|0|||
156635936|NCT03993288|565412205|FG000|Overall Study|did not follow the treatment schedule|1|||
156635937|NCT03993288|565412206|FG001|Overall Study|did not follow the treatment schedule|0|||
156635938|NCT03993288|565412205|FG000|Overall Study|did not follow the treatment regimen|1|||
156635939|NCT03993288|565412206|FG001|Overall Study|did not follow the treatment regimen|0|||
156635940|NCT03993288|565412205|FG000|Overall Study|Adverse Event|1|||
156635941|NCT03993288|565412206|FG001|Overall Study|Adverse Event|0|||
156635942|NCT03993288|565412205|FG000|Overall Study|Withdrawal by Subject|1|||
156635943|NCT03993288|565412206|FG001|Overall Study|Withdrawal by Subject|1|||
156635944|NCT02729545|565412207|FG000|Overall Study|Pregnancy|1|||
156635945|NCT02729545|565412208|FG001|Overall Study|Pregnancy|1|||
156635946|NCT02729545|565412207|FG000|Overall Study|Lost to Follow-up|0|||
156635947|NCT02729545|565412208|FG001|Overall Study|Lost to Follow-up|1|||
156635948|NCT02729545|565412207|FG000|Overall Study|Withdrawal by Subject|2|||
156864138|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
156635949|NCT02729545|565412208|FG001|Overall Study|Withdrawal by Subject|3|||
156635950|NCT03533608|565412209|FG000|Overall Study|Withdrawal by Subject|3|||
156635951|NCT03533608|565412209|FG000|Overall Study|Physician Decision|2|||
156635952|NCT00915473|565412210|FG000|Screening|Withdrawal by Subject|1|||
156635953|NCT00915473|565412211|FG001|Screening|Withdrawal by Subject|0|||
156635954|NCT00915473|565412210|FG000|4-week Follow Up|Lost to Follow-up|1|||
156635955|NCT00915473|565412211|FG001|4-week Follow Up|Lost to Follow-up|5|||
156635956|NCT01389024|565412212|FG000|Overall Study|Withdrawal by Subject|0|||
156635957|NCT01389024|565412213|FG001|Overall Study|Withdrawal by Subject|1|||
156635958|NCT01389024|565412212|FG000|Overall Study|Lost to Follow-up|1|||
156635959|NCT01389024|565412213|FG001|Overall Study|Lost to Follow-up|0|||
156635960|NCT03514121|565412217|FG000|Overall Study|Withdrawal by Subject|0|||
156635961|NCT03514121|565412218|FG001|Overall Study|Withdrawal by Subject|0|||
156635962|NCT03514121|565412219|FG002|Overall Study|Withdrawal by Subject|0|||
156635963|NCT03514121|565412220|FG003|Overall Study|Withdrawal by Subject|0|||
156635964|NCT03514121|565412221|FG004|Overall Study|Withdrawal by Subject|1|||
156635965|NCT03514121|565412222|FG005|Overall Study|Withdrawal by Subject|2|||
156635966|NCT03514121|565412223|FG006|Overall Study|Withdrawal by Subject|1|||
156635967|NCT03514121|565412224|FG007|Overall Study|Withdrawal by Subject|1|||
156635968|NCT03514121|565412225|FG008|Overall Study|Withdrawal by Subject|7|||
156635969|NCT03514121|565412226|FG009|Overall Study|Withdrawal by Subject|2|||
156635970|NCT03514121|565412217|FG000|Overall Study|Death|0|||
156635971|NCT03514121|565412218|FG001|Overall Study|Death|0|||
156635972|NCT03514121|565412219|FG002|Overall Study|Death|0|||
156635973|NCT03514121|565412220|FG003|Overall Study|Death|0|||
156635974|NCT03514121|565412221|FG004|Overall Study|Death|0|||
156635975|NCT03514121|565412222|FG005|Overall Study|Death|3|||
156635976|NCT03514121|565412223|FG006|Overall Study|Death|2|||
156635977|NCT03514121|565412224|FG007|Overall Study|Death|1|||
156635978|NCT03514121|565412225|FG008|Overall Study|Death|26|||
156635979|NCT03514121|565412226|FG009|Overall Study|Death|3|||
156635980|NCT03514121|565412217|FG000|Overall Study|Lost to Follow-up|0|||
156635981|NCT03514121|565412218|FG001|Overall Study|Lost to Follow-up|0|||
156635982|NCT03514121|565412219|FG002|Overall Study|Lost to Follow-up|1|||
156635983|NCT03514121|565412220|FG003|Overall Study|Lost to Follow-up|0|||
156635984|NCT03514121|565412221|FG004|Overall Study|Lost to Follow-up|0|||
156635985|NCT03514121|565412222|FG005|Overall Study|Lost to Follow-up|0|||
156635986|NCT03514121|565412223|FG006|Overall Study|Lost to Follow-up|0|||
156635987|NCT03514121|565412224|FG007|Overall Study|Lost to Follow-up|0|||
156635988|NCT03514121|565412225|FG008|Overall Study|Lost to Follow-up|1|||
156635989|NCT03514121|565412226|FG009|Overall Study|Lost to Follow-up|0|||
156635990|NCT03514121|565412217|FG000|Overall Study|Adverse Event|0|||
156635991|NCT03514121|565412218|FG001|Overall Study|Adverse Event|0|||
156635992|NCT03514121|565412219|FG002|Overall Study|Adverse Event|0|||
156635993|NCT03514121|565412220|FG003|Overall Study|Adverse Event|0|||
156635994|NCT03514121|565412221|FG004|Overall Study|Adverse Event|0|||
156635995|NCT03514121|565412222|FG005|Overall Study|Adverse Event|0|||
156635996|NCT03514121|565412223|FG006|Overall Study|Adverse Event|1|||
156635997|NCT03514121|565412224|FG007|Overall Study|Adverse Event|0|||
156635998|NCT03514121|565412225|FG008|Overall Study|Adverse Event|0|||
156635999|NCT03514121|565412226|FG009|Overall Study|Adverse Event|0|||
156636000|NCT03514121|565412217|FG000|Overall Study|Other|0|||
156636001|NCT03514121|565412218|FG001|Overall Study|Other|1|||
156636002|NCT03514121|565412219|FG002|Overall Study|Other|1|||
156636003|NCT03514121|565412220|FG003|Overall Study|Other|0|||
156636004|NCT03514121|565412221|FG004|Overall Study|Other|1|||
156636005|NCT03514121|565412222|FG005|Overall Study|Other|2|||
156636006|NCT03514121|565412223|FG006|Overall Study|Other|3|||
156636007|NCT03514121|565412224|FG007|Overall Study|Other|2|||
156636008|NCT03514121|565412225|FG008|Overall Study|Other|7|||
156636009|NCT03514121|565412226|FG009|Overall Study|Other|3|||
156636010|NCT03514121|565412217|FG000|Overall Study|Study termination by Sponsor|0|||
156636011|NCT03514121|565412218|FG001|Overall Study|Study termination by Sponsor|0|||
156636012|NCT03514121|565412219|FG002|Overall Study|Study termination by Sponsor|0|||
156636013|NCT03514121|565412220|FG003|Overall Study|Study termination by Sponsor|0|||
156636014|NCT03514121|565412221|FG004|Overall Study|Study termination by Sponsor|0|||
156636015|NCT03514121|565412222|FG005|Overall Study|Study termination by Sponsor|0|||
156636016|NCT03514121|565412223|FG006|Overall Study|Study termination by Sponsor|0|||
156636017|NCT03514121|565412224|FG007|Overall Study|Study termination by Sponsor|0|||
156636018|NCT03514121|565412225|FG008|Overall Study|Study termination by Sponsor|11|||
156636019|NCT03514121|565412226|FG009|Overall Study|Study termination by Sponsor|3|||
156636020|NCT03514121|565412217|FG000|Overall Study|Investigator decision|0|||
156636021|NCT03514121|565412218|FG001|Overall Study|Investigator decision|0|||
156636022|NCT03514121|565412219|FG002|Overall Study|Investigator decision|0|||
156636023|NCT03514121|565412220|FG003|Overall Study|Investigator decision|0|||
156636024|NCT03514121|565412221|FG004|Overall Study|Investigator decision|0|||
156636025|NCT03514121|565412222|FG005|Overall Study|Investigator decision|0|||
156636026|NCT03514121|565412223|FG006|Overall Study|Investigator decision|0|||
156750020|NCT00199849|565836920|FG001|Overall Study|Unrelated illness or complication|1|||
156636027|NCT03514121|565412224|FG007|Overall Study|Investigator decision|0|||
156636028|NCT03514121|565412225|FG008|Overall Study|Investigator decision|1|||
156636029|NCT03514121|565412226|FG009|Overall Study|Investigator decision|0|||
156636030|NCT03443973|565412227|FG000|Double-blind Treatment Period|Adverse Event|5|||
156636031|NCT03443973|565412228|FG001|Double-blind Treatment Period|Adverse Event|19|||
156636032|NCT03443973|565412229|FG002|Double-blind Treatment Period|Adverse Event|0|||
156636033|NCT03443973|565412230|FG003|Double-blind Treatment Period|Adverse Event|0|||
156636034|NCT03443973|565412227|FG000|Double-blind Treatment Period|Death|5|||
156636035|NCT03443973|565412228|FG001|Double-blind Treatment Period|Death|7|||
156636036|NCT03443973|565412229|FG002|Double-blind Treatment Period|Death|0|||
156636037|NCT03443973|565412230|FG003|Double-blind Treatment Period|Death|0|||
156636038|NCT03443973|565412227|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
156636039|NCT03443973|565412228|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
156636040|NCT03443973|565412229|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
156636041|NCT03443973|565412230|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
156636042|NCT03443973|565412227|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156636043|NCT03443973|565412228|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
156636044|NCT03443973|565412229|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
156636045|NCT03443973|565412230|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
156636046|NCT03443973|565412227|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
156636047|NCT03443973|565412228|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
156636048|NCT03443973|565412229|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
156636049|NCT03443973|565412230|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
156636050|NCT03443973|565412227|FG000|Double-blind Treatment Period|Physician Decision|5|||
156636051|NCT03443973|565412228|FG001|Double-blind Treatment Period|Physician Decision|6|||
156636052|NCT03443973|565412229|FG002|Double-blind Treatment Period|Physician Decision|0|||
156636053|NCT03443973|565412230|FG003|Double-blind Treatment Period|Physician Decision|0|||
156636054|NCT03443973|565412227|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
156636055|NCT03443973|565412228|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
156636056|NCT03443973|565412229|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
156750021|NCT00199849|565836921|FG002|Overall Study|Unrelated illness or complication|0|||
156750022|NCT00199849|565836919|FG000|Overall Study|Progressive disease requiring intervention|0|||
156750023|NCT00199849|565836920|FG001|Overall Study|Progressive disease requiring intervention|0|||
156750024|NCT00199849|565836921|FG002|Overall Study|Progressive disease requiring intervention|1|||
156750025|NCT00199849|565836919|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
156750026|NCT00199849|565836920|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
156750027|NCT00199849|565836921|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
156636057|NCT03443973|565412230|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
156636058|NCT03443973|565412227|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
156636059|NCT03443973|565412228|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
156636060|NCT03443973|565412229|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156636061|NCT03443973|565412230|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
156636062|NCT03443973|565412227|FG000|Open-label Extension Period|Reason Not Specified|0|||
156636063|NCT03443973|565412228|FG001|Open-label Extension Period|Reason Not Specified|0|||
156636064|NCT03443973|565412229|FG002|Open-label Extension Period|Reason Not Specified|3|||
156636065|NCT03443973|565412230|FG003|Open-label Extension Period|Reason Not Specified|0|||
156636066|NCT03443973|565412227|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
156636067|NCT03443973|565412228|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
156636068|NCT03443973|565412229|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
156636069|NCT03443973|565412230|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
156636070|NCT01956123|565412231|FG000|COS Cycle 2|Protocol Violation|8|||
156636071|NCT01956123|565412232|FG001|COS Cycle 2|Protocol Violation|3|||
156636072|NCT01956123|565412233|FG002|COS Cycle 2|Protocol Violation|0|||
156636073|NCT01956123|565412234|FG003|COS Cycle 2|Protocol Violation|0|||
156636074|NCT01956123|565412231|FG000|COS Cycle 2|Adverse Event|3|||
156636075|NCT01956123|565412232|FG001|COS Cycle 2|Adverse Event|4|||
156636076|NCT01956123|565412233|FG002|COS Cycle 2|Adverse Event|0|||
156636077|NCT01956123|565412234|FG003|COS Cycle 2|Adverse Event|0|||
156636078|NCT01956123|565412231|FG000|COS Cycle 2|Personal Reasons|2|||
156636079|NCT01956123|565412232|FG001|COS Cycle 2|Personal Reasons|0|||
156750028|NCT02164318|565836922|FG000|Overall Study|Withdrawal by Subject|0|||
156750029|NCT02164318|565836923|FG001|Overall Study|Withdrawal by Subject|1|||
156750030|NCT02164318|565836924|FG002|Overall Study|Withdrawal by Subject|0|||
156750031|NCT02164318|565836925|FG003|Overall Study|Withdrawal by Subject|1|||
156750032|NCT00662311|565836926|FG000|Overall Study|Respiratory Infection|1|||
156750033|NCT00662311|565836927|FG001|Overall Study|Respiratory Infection|0|||
156750034|NCT00662311|565836928|FG002|Overall Study|Respiratory Infection|0|||
156750035|NCT04727528|565836929|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
156636080|NCT01956123|565412233|FG002|COS Cycle 2|Personal Reasons|0|||
156636081|NCT01956123|565412234|FG003|COS Cycle 2|Personal Reasons|0|||
156750036|NCT04727528|565836930|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
156750037|NCT04727528|565836929|FG000|Open-label Period|Randomized who did not receive treatment|1|||
156750038|NCT04727528|565836930|FG001|Open-label Period|Randomized who did not receive treatment|0|||
156636082|NCT01956123|565412231|FG000|COS Cycle 2|Withdrawal by Subject|1|||
156636083|NCT01956123|565412232|FG001|COS Cycle 2|Withdrawal by Subject|0|||
156750039|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156636084|NCT01956123|565412233|FG002|COS Cycle 2|Withdrawal by Subject|0|||
156636085|NCT01956123|565412234|FG003|COS Cycle 2|Withdrawal by Subject|0|||
156636086|NCT01956123|565412231|FG000|COS Cycle 3|Protocol Violation|0|||
156636087|NCT01956123|565412232|FG001|COS Cycle 3|Protocol Violation|0|||
156636088|NCT01956123|565412233|FG002|COS Cycle 3|Protocol Violation|2|||
156636089|NCT01956123|565412234|FG003|COS Cycle 3|Protocol Violation|1|||
156636090|NCT01956123|565412231|FG000|COS Cycle 3|Adverse Event|0|||
156636091|NCT01956123|565412232|FG001|COS Cycle 3|Adverse Event|0|||
156636092|NCT01956123|565412233|FG002|COS Cycle 3|Adverse Event|3|||
156636093|NCT01956123|565412234|FG003|COS Cycle 3|Adverse Event|0|||
156750040|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Adverse Event|1|||
156750041|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Death|0|||
156750042|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Death|1|||
156750043|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
156750044|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
156750045|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
156750046|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
156750047|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Physician Decision|0|||
156750048|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Physician Decision|1|||
156750049|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
156750050|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156750051|NCT01467271|565836934|FG000|Overall Study|Death|84|||
156750052|NCT01467271|565836934|FG000|Overall Study|Lost to Follow-up|83|||
156750053|NCT01467271|565836934|FG000|Overall Study|Retraction of patient's consent|21|||
156750054|NCT01467271|565836934|FG000|Overall Study|Other reason|14|||
156750055|NCT01964989|565836936|FG000|Overall Study|Protocol Violation|3|||
156750056|NCT01964989|565836937|FG001|Overall Study|Protocol Violation|4|||
156750057|NCT01964989|565836936|FG000|Overall Study|Administrative Reason|103|||
156750058|NCT01964989|565836937|FG001|Overall Study|Administrative Reason|95|||
156750059|NCT01964989|565836936|FG000|Overall Study|Adverse Event|0|||
156750060|NCT01964989|565836937|FG001|Overall Study|Adverse Event|1|||
156750061|NCT01964989|565836936|FG000|Overall Study|Death|1|||
156750062|NCT01964989|565836937|FG001|Overall Study|Death|3|||
156750063|NCT01964989|565836936|FG000|Overall Study|Withdrawal by Subject|156|||
156750064|NCT01964989|565836937|FG001|Overall Study|Withdrawal by Subject|160|||
156750065|NCT01964989|565836936|FG000|Overall Study|Lost to Follow-up|254|||
156750066|NCT01964989|565836937|FG001|Overall Study|Lost to Follow-up|232|||
156750067|NCT01964989|565836936|FG000|Overall Study|Other|267|||
156750068|NCT01964989|565836937|FG001|Overall Study|Other|252|||
156750069|NCT02815267|565836938|FG000|Double-Blind Phase|Adverse Event|0|||
156750070|NCT02815267|565836939|FG001|Double-Blind Phase|Adverse Event|3|||
156750071|NCT02815267|565836938|FG000|Double-Blind Phase|Lost to Follow-up|17|||
156750072|NCT02815267|565836939|FG001|Double-Blind Phase|Lost to Follow-up|9|||
156750073|NCT02815267|565836938|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
156750074|NCT02815267|565836939|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
156750075|NCT02815267|565836938|FG000|Double-Blind Phase|Protocol Violation|3|||
156750076|NCT02815267|565836939|FG001|Double-Blind Phase|Protocol Violation|2|||
156750077|NCT02815267|565836938|FG000|Double-Blind Phase|Site withdrawal|1|||
156750078|NCT02815267|565836939|FG001|Double-Blind Phase|Site withdrawal|6|||
156750079|NCT02815267|565836938|FG000|Double-Blind Phase|Received a disallowed medication|1|||
156750080|NCT02815267|565836939|FG001|Double-Blind Phase|Received a disallowed medication|1|||
156750081|NCT02815267|565836938|FG000|Open-Label Phase|Adverse Event|1|||
156750082|NCT02815267|565836939|FG001|Open-Label Phase|Adverse Event|1|||
156750083|NCT02815267|565836938|FG000|Open-Label Phase|Lost to Follow-up|23|||
156750084|NCT02815267|565836939|FG001|Open-Label Phase|Lost to Follow-up|9|||
156750085|NCT02815267|565836938|FG000|Open-Label Phase|Withdrawal by Subject|24|||
156750086|NCT02815267|565836939|FG001|Open-Label Phase|Withdrawal by Subject|13|||
156750087|NCT02815267|565836938|FG000|Open-Label Phase|Protocol Violation|0|||
156750088|NCT02815267|565836939|FG001|Open-Label Phase|Protocol Violation|1|||
156750089|NCT02815267|565836938|FG000|Open-Label Phase|Administrative|21|||
156750090|NCT02815267|565836939|FG001|Open-Label Phase|Administrative|12|||
156750091|NCT02815267|565836938|FG000|Open-Label Phase|Other|2|||
156750092|NCT02815267|565836939|FG001|Open-Label Phase|Other|5|||
156750093|NCT02769312|565836940|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
156750094|NCT02769312|565836941|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
156750095|NCT02769312|565836940|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
156750096|NCT02769312|565836941|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
156750097|NCT02769312|565836940|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
156750098|NCT02769312|565836941|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
156750099|NCT02769312|565836940|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
156750100|NCT02769312|565836941|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
156750101|NCT02769312|565836940|FG000|Follow-up|Lost to Follow-up|1|||
156750102|NCT02769312|565836941|FG001|Follow-up|Lost to Follow-up|1|||
156750103|NCT04126317|565836942|FG000|Overall Study|Adverse Event|0|||
156750104|NCT04126317|565836943|FG001|Overall Study|Adverse Event|1|||
156750105|NCT04126317|565836942|FG000|Overall Study|Withdrawal by Subject|4|||
156750106|NCT04126317|565836943|FG001|Overall Study|Withdrawal by Subject|1|||
156750107|NCT00948922|565836946|FG000|Overall Study|Did not start study treatment|2|||
156750108|NCT00948922|565836947|FG001|Overall Study|Did not start study treatment|5|||
156521379|NCT01098097|565003102|FG000|Overall Study|Status unknown|16|||
156636094|NCT01956123|565412231|FG000|COS Cycle 3|Personal Reasons|0|||
156750109|NCT00948922|565836948|FG002|Overall Study|Did not start study treatment|0|||
156750110|NCT00948922|565836946|FG000|Overall Study|Withdrawal by Subject|0|||
156750111|NCT00948922|565836947|FG001|Overall Study|Withdrawal by Subject|2|||
156750112|NCT00948922|565836948|FG002|Overall Study|Withdrawal by Subject|1|||
156750113|NCT00948922|565836946|FG000|Overall Study|Death|3|||
156750114|NCT00948922|565836947|FG001|Overall Study|Death|0|||
156750115|NCT00948922|565836948|FG002|Overall Study|Death|0|||
156750116|NCT00948922|565836946|FG000|Overall Study|Disease progression|0|||
156750117|NCT00948922|565836947|FG001|Overall Study|Disease progression|1|||
156750118|NCT00948922|565836948|FG002|Overall Study|Disease progression|0|||
156750119|NCT00948922|565836946|FG000|Overall Study|Insurance issues|1|||
156750120|NCT00948922|565836947|FG001|Overall Study|Insurance issues|0|||
156750121|NCT00948922|565836948|FG002|Overall Study|Insurance issues|0|||
156750122|NCT00948922|565836946|FG000|Overall Study|Transplant eligibility issues|2|||
156750123|NCT00948922|565836947|FG001|Overall Study|Transplant eligibility issues|3|||
156750124|NCT00948922|565836948|FG002|Overall Study|Transplant eligibility issues|0|||
156750125|NCT00948922|565836946|FG000|Overall Study|Not evaluable at time of analysis|0|||
156750126|NCT00948922|565836947|FG001|Overall Study|Not evaluable at time of analysis|3|||
156750127|NCT00948922|565836948|FG002|Overall Study|Not evaluable at time of analysis|0|||
156750128|NCT04854057|565836949|FG000|Overall Study|Adverse Event|0|||
156750129|NCT04854057|565836950|FG001|Overall Study|Adverse Event|1|||
156750130|NCT02131233|565836951|FG000|Overall Study|Not Treated|2|||
156750131|NCT02131233|565836952|FG001|Overall Study|Not Treated|3|||
156750132|NCT02131233|565836951|FG000|Overall Study|Adverse Event|7|||
156750133|NCT02131233|565836952|FG001|Overall Study|Adverse Event|6|||
156750134|NCT02131233|565836951|FG000|Overall Study|Death|0|||
156750135|NCT02131233|565836952|FG001|Overall Study|Death|1|||
156750136|NCT02131233|565836951|FG000|Overall Study|Lack of Efficacy|6|||
156750137|NCT02131233|565836952|FG001|Overall Study|Lack of Efficacy|3|||
156750138|NCT02131233|565836951|FG000|Overall Study|Lost to Follow-up|14|||
156750139|NCT02131233|565836952|FG001|Overall Study|Lost to Follow-up|13|||
156750140|NCT02131233|565836951|FG000|Overall Study|Non-Compliance With Study Drug|8|||
156750141|NCT02131233|565836952|FG001|Overall Study|Non-Compliance With Study Drug|5|||
156750142|NCT02131233|565836951|FG000|Overall Study|Physician Decision|7|||
156750143|NCT02131233|565836952|FG001|Overall Study|Physician Decision|0|||
156750144|NCT02131233|565836951|FG000|Overall Study|Pregnancy|4|||
156750145|NCT02131233|565836952|FG001|Overall Study|Pregnancy|0|||
156750146|NCT02131233|565836951|FG000|Overall Study|Withdrawal by Subject|18|||
156750147|NCT02131233|565836952|FG001|Overall Study|Withdrawal by Subject|11|||
156750148|NCT05114564|565836954|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
156750149|NCT05114564|565836955|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
156750150|NCT05114564|565836954|FG000|First Intervention|Adverse Event|0|||
156750151|NCT05114564|565836955|FG001|First Intervention|Adverse Event|1|||
156750152|NCT00339833|565836964|FG000|Overall Study|Withdrawal by Subject|1|||
156750153|NCT00339833|565836965|FG001|Overall Study|Withdrawal by Subject|2|||
156750154|NCT00339833|565836964|FG000|Overall Study|toothache|0|||
156750155|NCT00339833|565836965|FG001|Overall Study|toothache|1|||
156750156|NCT00339833|565836964|FG000|Overall Study|indigestion|0|||
156750157|NCT00339833|565836965|FG001|Overall Study|indigestion|1|||
156750158|NCT00339833|565836964|FG000|Overall Study|Chest pain|0|||
156750159|NCT00339833|565836965|FG001|Overall Study|Chest pain|1|||
156750160|NCT00339833|565836964|FG000|Overall Study|minor infection|0|||
156750161|NCT00339833|565836965|FG001|Overall Study|minor infection|1|||
156750162|NCT00339833|565836964|FG000|Overall Study|Poor venous access|2|||
156750163|NCT00339833|565836965|FG001|Overall Study|Poor venous access|2|||
156750164|NCT00339833|565836964|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
156750165|NCT00339833|565836965|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
156750166|NCT00339833|565836964|FG000|Overall Study|Error in data records|1|||
156750167|NCT00339833|565836965|FG001|Overall Study|Error in data records|0|||
156750168|NCT00217581|565836966|FG000|Overall Study|Withdrawal by Subject|1|||
156750169|NCT02829047|565836967|FG000|Overall Study|Withdrawal by Subject|1|||
156750170|NCT01597492|565836987|FG000|Overall Study|Withdrawal by Subject|1|||
156750171|NCT01597492|565836988|FG001|Overall Study|Withdrawal by Subject|2|||
156750172|NCT01597492|565836987|FG000|Overall Study|Adverse Event|3|||
156750173|NCT01597492|565836988|FG001|Overall Study|Adverse Event|0|||
156750174|NCT01597492|565836987|FG000|Overall Study|Lost to Follow-up|0|||
156408248|NCT00709592|564589234|FG000|Overall Study|Unable to proceed to transplant|0|||
156750175|NCT01597492|565836988|FG001|Overall Study|Lost to Follow-up|2|||
156750176|NCT01597492|565836987|FG000|Overall Study|Other Reason|2|||
156750177|NCT01597492|565836988|FG001|Overall Study|Other Reason|0|||
156750178|NCT02570750|565836989|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
156408249|NCT00709592|564589235|FG001|Overall Study|Unable to proceed to transplant|1|||
156408250|NCT01129336|564589236|FG000|Overall Study|Protocol Violation|1|||
156750179|NCT02570750|565836990|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
156750180|NCT02570750|565836989|FG000|Overall Study|Protocol deviation|4|||
156750181|NCT02570750|565836990|FG001|Overall Study|Protocol deviation|2|||
156750182|NCT02570750|565836989|FG000|Overall Study|Withdrawal by Subject|5|||
156750183|NCT02570750|565836990|FG001|Overall Study|Withdrawal by Subject|0|||
156750184|NCT02570750|565836989|FG000|Overall Study|Lost to Follow-up|2|||
156750185|NCT02570750|565836990|FG001|Overall Study|Lost to Follow-up|2|||
156750186|NCT02570750|565836989|FG000|Overall Study|Adverse Event|2|||
156750187|NCT02570750|565836990|FG001|Overall Study|Adverse Event|1|||
156750188|NCT01410240|565836991|FG000|Overall Study|Physician Decision|0|||
156636095|NCT01956123|565412232|FG001|COS Cycle 3|Personal Reasons|0|||
156636096|NCT01956123|565412233|FG002|COS Cycle 3|Personal Reasons|1|||
156750189|NCT01410240|565836992|FG001|Overall Study|Physician Decision|0|||
156750190|NCT01410240|565836993|FG002|Overall Study|Physician Decision|1|||
156750191|NCT01410240|565836991|FG000|Overall Study|Missed week 6 assessments|1|||
156750192|NCT01410240|565836992|FG001|Overall Study|Missed week 6 assessments|1|||
156750193|NCT01410240|565836993|FG002|Overall Study|Missed week 6 assessments|1|||
156750194|NCT00496587|565836994|FG000|Overall Study|Adverse Event|2|||
156750195|NCT00496587|565836994|FG000|Overall Study|Progressive Disease|24|||
156750196|NCT00496587|565836994|FG000|Overall Study|Withdrawal by Subject|2|||
156750197|NCT00496587|565836994|FG000|Overall Study|Death|1|||
156750198|NCT00496587|565836994|FG000|Overall Study|Complications unrelated|2|||
156750199|NCT00482170|565836995|FG000|Overall Study|Adverse Event|5|||
156750200|NCT00482170|565836996|FG001|Overall Study|Adverse Event|14|||
156750201|NCT00482170|565836995|FG000|Overall Study|Withdrawal by Subject|6|||
156750202|NCT00482170|565836996|FG001|Overall Study|Withdrawal by Subject|1|||
156750203|NCT00482170|565836995|FG000|Overall Study|Protocol Violation|2|||
156750204|NCT00482170|565836996|FG001|Overall Study|Protocol Violation|3|||
156750205|NCT00482170|565836995|FG000|Overall Study|Lost to Follow-up|2|||
156750206|NCT00482170|565836996|FG001|Overall Study|Lost to Follow-up|0|||
156750207|NCT00482170|565836995|FG000|Overall Study|Unspecified reason|0|||
156750208|NCT00482170|565836996|FG001|Overall Study|Unspecified reason|2|||
156750209|NCT01134263|565836997|FG000|Overall Study|Serious adverse event|2|||
156750210|NCT01134263|565836998|FG001|Overall Study|Serious adverse event|1|||
156750211|NCT01134263|565836999|FG002|Overall Study|Serious adverse event|1|||
156750212|NCT01134263|565837000|FG003|Overall Study|Serious adverse event|1|||
156750213|NCT01134263|565837001|FG004|Overall Study|Serious adverse event|1|||
156750214|NCT01134263|565836997|FG000|Overall Study|Other adverse event|1|||
156750215|NCT01134263|565836998|FG001|Overall Study|Other adverse event|2|||
156750216|NCT01134263|565836999|FG002|Overall Study|Other adverse event|5|||
156750217|NCT01134263|565837000|FG003|Overall Study|Other adverse event|3|||
156750218|NCT01134263|565837001|FG004|Overall Study|Other adverse event|0|||
156750219|NCT01134263|565836997|FG000|Overall Study|Protocol Violation|8|||
156750220|NCT01134263|565836998|FG001|Overall Study|Protocol Violation|7|||
156750221|NCT01134263|565836999|FG002|Overall Study|Protocol Violation|2|||
156750222|NCT01134263|565837000|FG003|Overall Study|Protocol Violation|4|||
156750223|NCT01134263|565837001|FG004|Overall Study|Protocol Violation|2|||
156750224|NCT01134263|565836997|FG000|Overall Study|Lost to Follow-up|4|||
156750225|NCT01134263|565836998|FG001|Overall Study|Lost to Follow-up|3|||
156750226|NCT01134263|565836999|FG002|Overall Study|Lost to Follow-up|5|||
156750227|NCT01134263|565837000|FG003|Overall Study|Lost to Follow-up|3|||
156750228|NCT01134263|565837001|FG004|Overall Study|Lost to Follow-up|1|||
156750229|NCT01134263|565836997|FG000|Overall Study|Withdrawal by Subject|8|||
156750230|NCT01134263|565836998|FG001|Overall Study|Withdrawal by Subject|6|||
156750231|NCT01134263|565836999|FG002|Overall Study|Withdrawal by Subject|16|||
156750232|NCT01134263|565837000|FG003|Overall Study|Withdrawal by Subject|7|||
156750233|NCT01134263|565837001|FG004|Overall Study|Withdrawal by Subject|5|||
156750234|NCT01134263|565836997|FG000|Overall Study|Enrolled, but not treated|1|||
156750235|NCT01134263|565836998|FG001|Overall Study|Enrolled, but not treated|1|||
156750236|NCT01134263|565836999|FG002|Overall Study|Enrolled, but not treated|0|||
156750237|NCT01134263|565837000|FG003|Overall Study|Enrolled, but not treated|1|||
156750238|NCT01134263|565837001|FG004|Overall Study|Enrolled, but not treated|0|||
156750239|NCT01557517|565837002|FG000|Overall Study|Death|1|||
156750240|NCT01557517|565837003|FG001|Overall Study|Death|0|||
156750241|NCT01557517|565837002|FG000|Overall Study|Refused further treatment|0|||
156750242|NCT01557517|565837003|FG001|Overall Study|Refused further treatment|2|||
156750243|NCT01557517|565837002|FG000|Overall Study|Adverse Event|0|||
156750244|NCT01557517|565837003|FG001|Overall Study|Adverse Event|2|||
156750245|NCT01557517|565837002|FG000|Overall Study|Pt declined before treatment started|1|||
156750246|NCT01557517|565837003|FG001|Overall Study|Pt declined before treatment started|0|||
156750247|NCT00162097|565837004|FG000|Overall Study|Participant no longer met study criteria|0|||
156750248|NCT00162097|565837005|FG001|Overall Study|Participant no longer met study criteria|0|||
156750249|NCT00162097|565837006|FG002|Overall Study|Participant no longer met study criteria|0|||
156750250|NCT00162097|565837007|FG003|Overall Study|Participant no longer met study criteria|1|||
156750251|NCT01204918|565837008|FG000|Overall Study|Withdrawal by Subject|4|||
156864139|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
156636097|NCT01956123|565412234|FG003|COS Cycle 3|Personal Reasons|0|||
156750252|NCT01204918|565837009|FG001|Overall Study|Withdrawal by Subject|10|||
156750253|NCT01204918|565837010|FG002|Overall Study|Withdrawal by Subject|5|||
156750254|NCT03585712|565837013|FG000|Treatment Period 1|Protocol Violation|1|||
156750255|NCT03585712|565837014|FG001|Treatment Period 1|Protocol Violation|0|||
156750256|NCT03585712|565837015|FG002|Treatment Period 1|Protocol Violation|0|||
156750257|NCT03585712|565837013|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
156750258|NCT03585712|565837014|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
156750259|NCT03585712|565837015|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
156750260|NCT03585712|565837013|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
156750261|NCT03585712|565837014|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
156750262|NCT03585712|565837015|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
156750263|NCT03585712|565837013|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
156750264|NCT03585712|565837014|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
156750265|NCT03585712|565837015|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
156750266|NCT03517449|565837018|FG000|Overall Study|Death|184|||
156750267|NCT03517449|565837019|FG001|Overall Study|Death|236|||
156750268|NCT03517449|565837018|FG000|Overall Study|Lost to Follow-up|0|||
156750269|NCT03517449|565837019|FG001|Overall Study|Lost to Follow-up|2|||
156750270|NCT03517449|565837018|FG000|Overall Study|Withdrawal by Subject|7|||
156750271|NCT03517449|565837019|FG001|Overall Study|Withdrawal by Subject|26|||
156750272|NCT03517449|565837018|FG000|Overall Study|Participants Ongoing|220|||
156750273|NCT03517449|565837019|FG001|Overall Study|Participants Ongoing|152|||
156750274|NCT01280682|565837028|FG000|Overall Study|Lost to Follow-up|0|||
156750275|NCT01280682|565837029|FG001|Overall Study|Lost to Follow-up|6|||
156750276|NCT01280682|565837028|FG000|Overall Study|Withdrawal by Subject|0|||
156750277|NCT01280682|565837029|FG001|Overall Study|Withdrawal by Subject|7|||
156750278|NCT00269477|565837035|FG000|Overall Study|Protocol Violation|5|||
156750279|NCT00269477|565837036|FG001|Overall Study|Protocol Violation|5|||
156750280|NCT00269477|565837037|FG002|Overall Study|Protocol Violation|1|||
156750281|NCT00269477|565837038|FG003|Overall Study|Protocol Violation|0|||
156750282|NCT00269477|565837035|FG000|Overall Study|Missed post-vaccination blood draw|0|||
156750283|NCT00269477|565837036|FG001|Overall Study|Missed post-vaccination blood draw|1|||
156750284|NCT00269477|565837037|FG002|Overall Study|Missed post-vaccination blood draw|0|||
156750285|NCT00269477|565837038|FG003|Overall Study|Missed post-vaccination blood draw|0|||
156750286|NCT00431067|565837039|FG000|Overall Study|Other Adverse Event|9|||
156750287|NCT00431067|565837039|FG000|Overall Study|Progressive disease|30|||
156750288|NCT00431067|565837039|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
156750289|NCT00548249|565837040|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
156750290|NCT00548249|565837041|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
156750291|NCT00548249|565837042|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
156750292|NCT00548249|565837043|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
156750293|NCT00548249|565837044|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
156750294|NCT00548249|565837040|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
156750295|NCT00548249|565837041|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
156750296|NCT00548249|565837042|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
156750297|NCT00548249|565837043|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
156750298|NCT00548249|565837044|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
156750299|NCT00548249|565837040|FG000|Overall Study|Protocol Violation|1|||
156750300|NCT00548249|565837041|FG001|Overall Study|Protocol Violation|1|||
156750301|NCT00548249|565837042|FG002|Overall Study|Protocol Violation|4|||
156750302|NCT00548249|565837043|FG003|Overall Study|Protocol Violation|0|||
156750303|NCT00548249|565837044|FG004|Overall Study|Protocol Violation|3|||
156750304|NCT00548249|565837040|FG000|Overall Study|Miscellaneous|2|||
156750305|NCT00548249|565837041|FG001|Overall Study|Miscellaneous|3|||
156750306|NCT00548249|565837042|FG002|Overall Study|Miscellaneous|2|||
156750307|NCT00548249|565837043|FG003|Overall Study|Miscellaneous|0|||
156750308|NCT00548249|565837044|FG004|Overall Study|Miscellaneous|2|||
156750309|NCT00548249|565837040|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
156750310|NCT00548249|565837041|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
156750311|NCT00548249|565837042|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
156750312|NCT00548249|565837043|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
156750313|NCT00548249|565837044|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
156750314|NCT00548249|565837040|FG000|Overall Study|Adverse Event|2|||
156750315|NCT00548249|565837041|FG001|Overall Study|Adverse Event|2|||
156750316|NCT00548249|565837042|FG002|Overall Study|Adverse Event|0|||
156750317|NCT00548249|565837043|FG003|Overall Study|Adverse Event|1|||
156750318|NCT00548249|565837044|FG004|Overall Study|Adverse Event|1|||
156750319|NCT00548249|565837040|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
156750320|NCT00548249|565837041|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
156750321|NCT00548249|565837042|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
156750322|NCT00548249|565837043|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
156750323|NCT00548249|565837044|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
156864140|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
156864141|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
156864142|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
156864143|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
156864144|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
156864145|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
156864146|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
156750324|NCT00548249|565837040|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
156750325|NCT00548249|565837041|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
156750326|NCT00548249|565837042|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
156750327|NCT00548249|565837043|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
156750328|NCT00548249|565837044|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
156750329|NCT00548249|565837040|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
156750330|NCT00548249|565837041|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
156750331|NCT00548249|565837042|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
156864147|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
156864148|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
156864149|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
156864150|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
156864151|NCT03253796|566260870|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
156864152|NCT03253796|566260871|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
156864153|NCT03253796|566260872|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
156864154|NCT03253796|566260873|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
156864155|NCT03253796|566260874|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
156864156|NCT00231816|566260875|FG000|Overall Study|Adverse Event|1|||
156864157|NCT00231816|566260876|FG001|Overall Study|Adverse Event|0|||
156864158|NCT00231816|566260875|FG000|Overall Study|Lost to Follow-up|8|||
156864159|NCT00231816|566260876|FG001|Overall Study|Lost to Follow-up|5|||
156864160|NCT00231816|566260875|FG000|Overall Study|Protocol Violation|2|||
156864161|NCT00231816|566260876|FG001|Overall Study|Protocol Violation|3|||
156864162|NCT00231816|566260875|FG000|Overall Study|Withdrawal by Subject|3|||
156864163|NCT00231816|566260876|FG001|Overall Study|Withdrawal by Subject|3|||
156864164|NCT00231816|566260875|FG000|Overall Study|Other|2|||
156864165|NCT00231816|566260876|FG001|Overall Study|Other|1|||
156864166|NCT01075243|566260877|FG000|Overall Study|Lost to Follow-up|5|||
156864167|NCT01075243|566260878|FG001|Overall Study|Lost to Follow-up|2|||
156864168|NCT01075243|566260879|FG002|Overall Study|Lost to Follow-up|0|||
156864169|NCT01075243|566260877|FG000|Overall Study|Withdrawal by Subject|1|||
156864170|NCT01075243|566260878|FG001|Overall Study|Withdrawal by Subject|1|||
156864171|NCT01075243|566260879|FG002|Overall Study|Withdrawal by Subject|0|||
156864172|NCT00551642|566260880|FG000|Treatment Period|Protocol Deviation|6|||
156864173|NCT00551642|566260881|FG001|Treatment Period|Protocol Deviation|11|||
156864174|NCT00551642|566260880|FG000|Treatment Period|Delivery device failure|1|||
156864175|NCT00551642|566260881|FG001|Treatment Period|Delivery device failure|3|||
156864176|NCT00551642|566260880|FG000|Treatment Period|Physician Decision|0|||
156864177|NCT00551642|566260881|FG001|Treatment Period|Physician Decision|1|||
156864178|NCT00551642|566260880|FG000|Treatment Period|Death|33|||
156864179|NCT00551642|566260881|FG001|Treatment Period|Death|31|||
156408251|NCT01129336|564589237|FG001|Overall Study|Protocol Violation|0|||
156864180|NCT00551642|566260880|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
156864181|NCT00551642|566260881|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
156864182|NCT00551642|566260880|FG000|Treatment Period|Adverse Event|15|||
156864183|NCT00551642|566260881|FG001|Treatment Period|Adverse Event|12|||
156864184|NCT00551642|566260880|FG000|Treatment Period|Withdrawal by Subject|2|||
156864185|NCT00551642|566260881|FG001|Treatment Period|Withdrawal by Subject|1|||
156864186|NCT03337308|566260882|FG000|Overall Study|Adverse Event|2|||
156864187|NCT03337308|566260883|FG001|Overall Study|Adverse Event|3|||
156864188|NCT03337308|566260884|FG002|Overall Study|Adverse Event|3|||
156864189|NCT03337308|566260885|FG003|Overall Study|Adverse Event|1|||
156864190|NCT03337308|566260882|FG000|Overall Study|Lost to Follow-up|1|||
156864191|NCT03337308|566260883|FG001|Overall Study|Lost to Follow-up|2|||
156864192|NCT03337308|566260884|FG002|Overall Study|Lost to Follow-up|0|||
156864193|NCT03337308|566260885|FG003|Overall Study|Lost to Follow-up|0|||
156864194|NCT03337308|566260882|FG000|Overall Study|Withdrawal by Subject|2|||
156864195|NCT03337308|566260883|FG001|Overall Study|Withdrawal by Subject|1|||
156864196|NCT03337308|566260884|FG002|Overall Study|Withdrawal by Subject|2|||
156864197|NCT03337308|566260885|FG003|Overall Study|Withdrawal by Subject|1|||
156864198|NCT03337308|566260882|FG000|Overall Study|Protocol Violation|0|||
156864199|NCT03337308|566260883|FG001|Overall Study|Protocol Violation|1|||
156864200|NCT03337308|566260884|FG002|Overall Study|Protocol Violation|0|||
156864201|NCT03337308|566260885|FG003|Overall Study|Protocol Violation|0|||
156864202|NCT03558737|566260886|FG000|Overall Study|Death|1|||
156864203|NCT03558737|566260887|FG001|Overall Study|Death|1|||
156864204|NCT00005780|566260890|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
156864205|NCT04973449|566260891|FG000|Overall Study|Withdrawal by Subject|3|||
156864206|NCT04973449|566260892|FG001|Overall Study|Withdrawal by Subject|3|||
156864207|NCT04973449|566260893|FG002|Overall Study|Withdrawal by Subject|2|||
156864208|NCT04973449|566260894|FG003|Overall Study|Withdrawal by Subject|5|||
156408252|NCT01129336|564589236|FG000|Overall Study|Disease Progression|1|||
156864209|NCT04973449|566260895|FG004|Overall Study|Withdrawal by Subject|5|||
156864210|NCT04973449|566260896|FG005|Overall Study|Withdrawal by Subject|4|||
156864211|NCT04973449|566260897|FG006|Overall Study|Withdrawal by Subject|7|||
156864212|NCT04973449|566260898|FG007|Overall Study|Withdrawal by Subject|5|||
156864213|NCT04973449|566260891|FG000|Overall Study|Lost to Follow-up|15|||
156864214|NCT04973449|566260892|FG001|Overall Study|Lost to Follow-up|16|||
156864215|NCT04973449|566260893|FG002|Overall Study|Lost to Follow-up|16|||
156864216|NCT04973449|566260894|FG003|Overall Study|Lost to Follow-up|13|||
156864217|NCT04973449|566260895|FG004|Overall Study|Lost to Follow-up|5|||
156864218|NCT04973449|566260896|FG005|Overall Study|Lost to Follow-up|6|||
156864219|NCT04973449|566260897|FG006|Overall Study|Lost to Follow-up|10|||
156864220|NCT04973449|566260898|FG007|Overall Study|Lost to Follow-up|6|||
156864221|NCT04973449|566260891|FG000|Overall Study|Death|1|||
156864222|NCT04973449|566260892|FG001|Overall Study|Death|0|||
156864223|NCT04973449|566260893|FG002|Overall Study|Death|0|||
156864224|NCT04973449|566260894|FG003|Overall Study|Death|0|||
156864225|NCT04973449|566260895|FG004|Overall Study|Death|0|||
156864226|NCT04973449|566260896|FG005|Overall Study|Death|1|||
156864227|NCT04973449|566260897|FG006|Overall Study|Death|0|||
156864228|NCT04973449|566260898|FG007|Overall Study|Death|0|||
156864229|NCT04973449|566260891|FG000|Overall Study|Other|1|||
156864230|NCT04973449|566260892|FG001|Overall Study|Other|1|||
156338104|NCT01847274|564336531|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
156338105|NCT01847274|564336532|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
156338106|NCT01847274|564336522|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338107|NCT01847274|564336523|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338108|NCT01847274|564336524|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338109|NCT01847274|564336525|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338110|NCT01847274|564336526|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338111|NCT01847274|564336527|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338112|NCT01847274|564336528|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338113|NCT01847274|564336529|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
156338114|NCT01847274|564336530|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338115|NCT01847274|564336531|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
156750332|NCT00548249|565837043|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
156750333|NCT00548249|565837044|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
156750334|NCT00548249|565837040|FG000|Overall Study|Prolonged hospitalization|0|||
156750335|NCT00548249|565837041|FG001|Overall Study|Prolonged hospitalization|0|||
156750336|NCT00548249|565837042|FG002|Overall Study|Prolonged hospitalization|2|||
156750337|NCT00548249|565837043|FG003|Overall Study|Prolonged hospitalization|1|||
156750338|NCT00548249|565837044|FG004|Overall Study|Prolonged hospitalization|0|||
156750339|NCT00548249|565837040|FG000|Overall Study|Withdrawal by Subject|2|||
156750340|NCT00548249|565837041|FG001|Overall Study|Withdrawal by Subject|0|||
156750341|NCT00548249|565837042|FG002|Overall Study|Withdrawal by Subject|0|||
156750342|NCT00548249|565837043|FG003|Overall Study|Withdrawal by Subject|0|||
156750343|NCT00548249|565837044|FG004|Overall Study|Withdrawal by Subject|0|||
156750344|NCT00548249|565837040|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
156750345|NCT00548249|565837041|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
156750346|NCT00548249|565837042|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
156750347|NCT00548249|565837043|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
156750348|NCT00548249|565837044|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
156750349|NCT00548249|565837040|FG000|Overall Study|Sponsor's request|0|||
156750350|NCT00548249|565837041|FG001|Overall Study|Sponsor's request|0|||
156750351|NCT00548249|565837042|FG002|Overall Study|Sponsor's request|0|||
156750352|NCT00548249|565837043|FG003|Overall Study|Sponsor's request|1|||
156750353|NCT00548249|565837044|FG004|Overall Study|Sponsor's request|0|||
156750354|NCT03760458|565837046|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
156750355|NCT03760458|565837047|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
156750356|NCT03760458|565837048|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
156750357|NCT03760458|565837049|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
156750358|NCT03760458|565837050|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
156750359|NCT00750919|565837051|FG000|Overall Study|Adverse Event|9|||
156750360|NCT00750919|565837051|FG000|Overall Study|Withdrawal by Subject|1|||
156750361|NCT00750919|565837051|FG000|Overall Study|Lack of Efficacy|8|||
156750362|NCT00750919|565837051|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
156750363|NCT00750919|565837051|FG000|Overall Study|Other|36|||
156750364|NCT02886884|565837066|FG000|Follow-up|Withdrawal by Subject|0|||
156750365|NCT02886884|565837067|FG001|Follow-up|Withdrawal by Subject|0|||
156750366|NCT02886884|565837068|FG002|Follow-up|Withdrawal by Subject|0|||
156750367|NCT02886884|565837069|FG003|Follow-up|Withdrawal by Subject|1|||
156750368|NCT01573754|565837070|FG000|Overall Study|Noncompliance or remission not achieved|3|||
156750369|NCT01573754|565837071|FG001|Overall Study|Noncompliance or remission not achieved|15|||
156808566|NCT01070979|566052715|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
156864231|NCT04973449|566260893|FG002|Overall Study|Other|2|||
156750370|NCT04227405|565838802|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
156750371|NCT04227405|565838803|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
156750372|NCT04227405|565838802|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
156750373|NCT04227405|565838803|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
156750374|NCT04227405|565838802|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
156750375|NCT04227405|565838803|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
156750376|NCT03396822|565838806|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
156750377|NCT03396822|565838806|FG000|Overall Study|Physician Decision|1|||
156750378|NCT04985942|565838807|FG000|Overall Study|Adverse Event|14|||
156750379|NCT04985942|565838808|FG001|Overall Study|Adverse Event|2|||
156750380|NCT04985942|565838807|FG000|Overall Study|Lack of Efficacy|0|||
156750381|NCT04985942|565838808|FG001|Overall Study|Lack of Efficacy|3|||
156750382|NCT04985942|565838807|FG000|Overall Study|Lost to Follow-up|1|||
156750383|NCT04985942|565838808|FG001|Overall Study|Lost to Follow-up|1|||
156864232|NCT04973449|566260894|FG003|Overall Study|Other|1|||
156864233|NCT04973449|566260895|FG004|Overall Study|Other|4|||
156864234|NCT04973449|566260896|FG005|Overall Study|Other|0|||
156864235|NCT04973449|566260897|FG006|Overall Study|Other|2|||
156864236|NCT04973449|566260898|FG007|Overall Study|Other|2|||
156864237|NCT01488890|566260899|FG000|Overall Study|Serious adverse event|2|||
156864238|NCT01488890|566260900|FG001|Overall Study|Serious adverse event|0|||
156864239|NCT01488890|566260901|FG002|Overall Study|Serious adverse event|0|||
156750384|NCT04985942|565838807|FG000|Overall Study|Protocol Violation|1|||
156750385|NCT04985942|565838808|FG001|Overall Study|Protocol Violation|1|||
156750386|NCT04985942|565838807|FG000|Overall Study|Withdrawal by Subject|5|||
156750387|NCT04985942|565838808|FG001|Overall Study|Withdrawal by Subject|4|||
156750388|NCT00171158|565838809|FG000|Core Study|Death|27|||
156750389|NCT00171158|565838809|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
156750390|NCT00171158|565838809|FG000|Core Study|Protocol Violation|4|||
156750391|NCT00171158|565838809|FG000|Core Study|Administrative problems|1|||
156750392|NCT00171158|565838809|FG000|Core Study|Adverse event, non-fatal|21|||
156750393|NCT00171158|565838809|FG000|Core Study|Consent withdrawn by subject|6|||
156864240|NCT01488890|566260902|FG003|Overall Study|Serious adverse event|0|||
156864241|NCT01488890|566260899|FG000|Overall Study|Protocol Violation|3|||
156864242|NCT01488890|566260900|FG001|Overall Study|Protocol Violation|0|||
156864243|NCT01488890|566260901|FG002|Overall Study|Protocol Violation|4|||
156864244|NCT01488890|566260902|FG003|Overall Study|Protocol Violation|0|||
156864245|NCT01488890|566260899|FG000|Overall Study|Lost to Follow-up|13|||
156864246|NCT01488890|566260900|FG001|Overall Study|Lost to Follow-up|10|||
156864247|NCT01488890|566260901|FG002|Overall Study|Lost to Follow-up|20|||
156864248|NCT01488890|566260902|FG003|Overall Study|Lost to Follow-up|3|||
156864249|NCT01488890|566260899|FG000|Overall Study|Withdrawal by Subject|14|||
156864250|NCT01488890|566260900|FG001|Overall Study|Withdrawal by Subject|10|||
156864251|NCT01488890|566260901|FG002|Overall Study|Withdrawal by Subject|11|||
156864252|NCT01488890|566260902|FG003|Overall Study|Withdrawal by Subject|2|||
156864253|NCT05712460|566260903|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864254|NCT05712460|566260904|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864255|NCT05712460|566260905|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864256|NCT05712460|566260906|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864257|NCT05712460|566260907|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864258|NCT05712460|566260908|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864259|NCT05712460|566260909|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864260|NCT05712460|566260910|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
156864261|NCT05712460|566260911|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864262|NCT05712460|566260912|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864263|NCT05712460|566260913|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864264|NCT05712460|566260914|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864265|NCT05135767|566260918|FG000|Baseline|Lost to Follow-up|1|||
156864266|NCT05135767|566260919|FG001|Baseline|Lost to Follow-up|1|||
156864267|NCT05135767|566260918|FG000|Baseline|Withdrawal by Subject|0|||
156750394|NCT00171158|565838809|FG000|Core Study|No longer required drug (BMT)|14|||
156750395|NCT00171158|565838809|FG000|Core Study|Abnormal Laboratory Values|2|||
156750396|NCT00171158|565838809|FG000|Core Study|Lost to Follow-up|1|||
156750397|NCT00171158|565838809|FG000|E2 Extension|Other|7|||
156750398|NCT03630705|565838814|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
156750399|NCT03630705|565838815|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
156750400|NCT03630705|565838816|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156750401|NCT03630705|565838817|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156750402|NCT03630705|565838814|FG000|Overall Study|Lost to Follow-up|1|||
156750403|NCT03630705|565838815|FG001|Overall Study|Lost to Follow-up|2|||
156750404|NCT03630705|565838816|FG002|Overall Study|Lost to Follow-up|0|||
156750405|NCT03630705|565838817|FG003|Overall Study|Lost to Follow-up|0|||
156750406|NCT02757352|565838818|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
156750407|NCT02757352|565838819|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750408|NCT02757352|565838820|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
156750409|NCT02757352|565838821|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750410|NCT02757352|565838822|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156864268|NCT05135767|566260919|FG001|Baseline|Withdrawal by Subject|2|||
156864269|NCT05135767|566260918|FG000|Active Study Phase|Lost to Follow-up|2|||
156864270|NCT05135767|566260919|FG001|Active Study Phase|Lost to Follow-up|0|||
156864271|NCT02694185|566260920|FG000|Overall Study|Withdrawal by Subject|45|||
156864272|NCT02694185|566260921|FG001|Overall Study|Withdrawal by Subject|0|||
156864273|NCT05082857|566260922|FG000|Overall Study|participants relocated and could not continue|2|||
156864274|NCT05082857|566260923|FG001|Overall Study|participants relocated and could not continue|1|||
156864275|NCT05082857|566260922|FG000|Overall Study|Lost to Follow-up|1|||
156864276|NCT05082857|566260923|FG001|Overall Study|Lost to Follow-up|3|||
156864277|NCT04363320|566260924|FG000|Overall Study|Lost to Follow-up|43|||
156864278|NCT04363320|566260925|FG001|Overall Study|Lost to Follow-up|42|||
156864279|NCT04363320|566260926|FG002|Overall Study|Lost to Follow-up|24|||
156864280|NCT04363320|566260927|FG003|Overall Study|Lost to Follow-up|29|||
156864281|NCT04363320|566260924|FG000|Overall Study|Death|0|||
156864282|NCT04363320|566260925|FG001|Overall Study|Death|0|||
156864283|NCT04363320|566260926|FG002|Overall Study|Death|1|||
156864284|NCT04363320|566260927|FG003|Overall Study|Death|0|||
156864285|NCT00604565|566260931|FG000|Overall Study|Study terminated|0|||
156864286|NCT00604565|566260932|FG001|Overall Study|Study terminated|3|||
156864287|NCT02260934|566260940|FG000|Overall Study|Lost to Follow-up|2|||
156864288|NCT02260934|566260941|FG001|Overall Study|Lost to Follow-up|1|||
156864289|NCT02260934|566260940|FG000|Overall Study|Withdrawal by Subject|0|||
156864290|NCT02260934|566260941|FG001|Overall Study|Withdrawal by Subject|2|||
156864291|NCT02260934|566260940|FG000|Overall Study|Participant Relocated|1|||
156864292|NCT02260934|566260941|FG001|Overall Study|Participant Relocated|0|||
156864293|NCT02260934|566260940|FG000|Overall Study|Site error|0|||
156864294|NCT02260934|566260941|FG001|Overall Study|Site error|1|||
156864295|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
156864296|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
156864297|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
156864298|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
156864299|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
156864300|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
156864301|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
156864302|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
156864303|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
156864304|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
156864305|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
156864306|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
156864307|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
156864308|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
156864309|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
156864310|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
156864311|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
156864312|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
156864313|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
156864314|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
156864315|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
156864316|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
156864317|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Other|6|||
156864318|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Other|8|||
156864319|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
156864320|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
156864321|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
156864322|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
156864323|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
156864324|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
156864325|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
156864326|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
156864327|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
156864328|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
156864329|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
156864330|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
156864331|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Death|0|||
156864332|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Death|2|||
156864333|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
156864334|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
156864335|NCT05632211|566260946|FG000|Overall Study|Withdrawal by Subject|2|||
156864336|NCT05632211|566260947|FG001|Overall Study|Withdrawal by Subject|0|||
156864337|NCT05632211|566260948|FG002|Overall Study|Withdrawal by Subject|2|||
156864338|NCT05632211|566260946|FG000|Overall Study|Other reasons|1|||
156864339|NCT05632211|566260947|FG001|Overall Study|Other reasons|1|||
156864340|NCT05632211|566260948|FG002|Overall Study|Other reasons|1|||
156636098|NCT01956123|565412231|FG000|COS Cycle 3|Withdrawal by Subject|0|||
156750411|NCT02757352|565838823|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750412|NCT02757352|565838824|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750413|NCT02757352|565838825|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750414|NCT02757352|565838826|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750415|NCT02757352|565838827|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750416|NCT02757352|565838818|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750417|NCT02757352|565838819|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750418|NCT02757352|565838820|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
156750419|NCT02757352|565838821|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750420|NCT02757352|565838822|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750421|NCT02757352|565838823|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750422|NCT02757352|565838824|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750423|NCT02757352|565838825|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750424|NCT02757352|565838826|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750425|NCT02757352|565838827|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750426|NCT02757352|565838818|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
156750427|NCT02757352|565838819|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
156750428|NCT02757352|565838820|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
156750429|NCT02757352|565838821|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750430|NCT02757352|565838822|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750431|NCT02757352|565838823|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750432|NCT02757352|565838824|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750433|NCT02757352|565838825|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750434|NCT02757352|565838826|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750435|NCT02757352|565838827|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750436|NCT02757352|565838818|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750437|NCT02757352|565838819|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
156750438|NCT02757352|565838820|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750439|NCT02757352|565838821|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750440|NCT02757352|565838822|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750441|NCT02757352|565838823|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750442|NCT02757352|565838824|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750443|NCT02757352|565838825|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750444|NCT02757352|565838826|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750445|NCT02757352|565838827|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750446|NCT02757352|565838818|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750447|NCT02757352|565838819|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
156750448|NCT02757352|565838820|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750449|NCT02757352|565838821|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750450|NCT02757352|565838822|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750451|NCT02757352|565838823|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750452|NCT02757352|565838824|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750453|NCT02757352|565838825|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750454|NCT02757352|565838826|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750455|NCT02757352|565838827|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750456|NCT02757352|565838818|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
156750457|NCT02757352|565838819|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
156750458|NCT02757352|565838820|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
156750459|NCT02757352|565838821|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750460|NCT02757352|565838822|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750461|NCT02757352|565838823|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750462|NCT02757352|565838824|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750463|NCT02757352|565838825|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750464|NCT02757352|565838826|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750465|NCT02757352|565838827|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750466|NCT02757352|565838818|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
156750467|NCT02757352|565838819|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
156750468|NCT02757352|565838820|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
156864341|NCT02532517|566260949|FG000|Overall Study|Did not complete 24-Month visit|4|||
156864342|NCT02532517|566260949|FG000|Overall Study|Failed Angiographic eligibility|1|||
156864343|NCT02532517|566260949|FG000|Overall Study|Lost to Follow-up|4|||
156864344|NCT02532517|566260949|FG000|Overall Study|Withdrawal by Subject|4|||
156864345|NCT02532517|566260949|FG000|Overall Study|Death|4|||
156864346|NCT03312231|566260950|FG000|Overall Study|Lost to Follow-up|2|||
156864347|NCT03312231|566260951|FG001|Overall Study|Lost to Follow-up|6|||
156864348|NCT03312231|566260952|FG002|Overall Study|Lost to Follow-up|1|||
156864349|NCT03312231|566260953|FG003|Overall Study|Lost to Follow-up|3|||
156864350|NCT03312231|566260954|FG004|Overall Study|Lost to Follow-up|1|||
156864351|NCT03312231|566260950|FG000|Overall Study|Withdrawal by Subject|0|||
156864352|NCT03312231|566260951|FG001|Overall Study|Withdrawal by Subject|3|||
156864353|NCT03312231|566260952|FG002|Overall Study|Withdrawal by Subject|1|||
156864354|NCT03312231|566260953|FG003|Overall Study|Withdrawal by Subject|0|||
156864355|NCT03312231|566260954|FG004|Overall Study|Withdrawal by Subject|0|||
156864356|NCT03312231|566260950|FG000|Overall Study|Death|0|||
156864357|NCT03312231|566260951|FG001|Overall Study|Death|1|||
156864358|NCT03312231|566260952|FG002|Overall Study|Death|1|||
156864359|NCT03312231|566260953|FG003|Overall Study|Death|0|||
156864360|NCT03312231|566260954|FG004|Overall Study|Death|0|||
156864361|NCT03312231|566260950|FG000|Overall Study|Study Vaccination not Received|1|||
156864362|NCT03312231|566260951|FG001|Overall Study|Study Vaccination not Received|1|||
156864363|NCT03312231|566260952|FG002|Overall Study|Study Vaccination not Received|1|||
156864364|NCT03312231|566260953|FG003|Overall Study|Study Vaccination not Received|0|||
156864365|NCT03312231|566260954|FG004|Overall Study|Study Vaccination not Received|0|||
156864366|NCT03157830|566260955|FG000|Overall Study|Lost to Follow-up|1|||
156864367|NCT03157830|566260955|FG000|Overall Study|Withdrawal by Subject|1|||
156864368|NCT03472885|566260956|FG000|24-Week Treatment Period|Adverse Event|1|||
156408253|NCT01129336|564589237|FG001|Overall Study|Disease Progression|4|||
156408254|NCT01129336|564589236|FG000|Overall Study|Lost to Follow-up|1|||
156408255|NCT01129336|564589237|FG001|Overall Study|Lost to Follow-up|0|||
156408256|NCT01129336|564589236|FG000|Overall Study|Withdrawal by Subject|7|||
156408257|NCT01129336|564589237|FG001|Overall Study|Withdrawal by Subject|4|||
156408258|NCT01129336|564589236|FG000|Overall Study|Adverse Event|0|||
156408259|NCT01129336|564589237|FG001|Overall Study|Adverse Event|1|||
156408260|NCT01129336|564589236|FG000|Overall Study|Missing Study Completion Status|2|||
156408261|NCT01129336|564589237|FG001|Overall Study|Missing Study Completion Status|3|||
156864369|NCT01083771|566263098|FG000|Overall Study|non-compliant|2|||
156864370|NCT01083771|566263098|FG000|Overall Study|Withdrawal by Subject|3|||
156864371|NCT01462370|566263103|FG000|Overall Study|Lack of Qualifying Event|1|||
156864372|NCT01462370|566263104|FG001|Overall Study|Lack of Qualifying Event|1|||
156864373|NCT01462370|566263103|FG000|Overall Study|Physician Decision|0|||
156864374|NCT01462370|566263104|FG001|Overall Study|Physician Decision|1|||
156864375|NCT01462370|566263103|FG000|Overall Study|Withdrawal by Subject|0|||
156864376|NCT01462370|566263104|FG001|Overall Study|Withdrawal by Subject|3|||
156864377|NCT01747876|566263105|FG000|Overall Study|Adverse Event|1|||
156864378|NCT01747876|566263106|FG001|Overall Study|Adverse Event|0|||
156864379|NCT01747876|566263107|FG002|Overall Study|Adverse Event|2|||
156864380|NCT01747876|566263105|FG000|Overall Study|Withdrawal by Subject|0|||
156864381|NCT01747876|566263106|FG001|Overall Study|Withdrawal by Subject|1|||
156864382|NCT01747876|566263107|FG002|Overall Study|Withdrawal by Subject|1|||
156864383|NCT01747876|566263105|FG000|Overall Study|Disease progression|4|||
156864384|NCT01747876|566263106|FG001|Overall Study|Disease progression|13|||
156864385|NCT01747876|566263107|FG002|Overall Study|Disease progression|8|||
156864386|NCT01747876|566263105|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
156864387|NCT01747876|566263106|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
156864388|NCT01747876|566263107|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
156864389|NCT03198715|566263110|FG000|Overall Study|Death|0|||
156864390|NCT03198715|566263111|FG001|Overall Study|Death|0|||
156864391|NCT03198715|566263112|FG002|Overall Study|Death|1|||
156864392|NCT03198715|566263113|FG003|Overall Study|Death|0|||
156864393|NCT03198715|566263114|FG004|Overall Study|Death|2|||
156864394|NCT03198715|566263110|FG000|Overall Study|Other|0|||
156864395|NCT03198715|566263111|FG001|Overall Study|Other|1|||
156864396|NCT03198715|566263112|FG002|Overall Study|Other|1|||
156864397|NCT03198715|566263113|FG003|Overall Study|Other|0|||
156864398|NCT03198715|566263114|FG004|Overall Study|Other|0|||
156864399|NCT00853307|566263115|FG000|Overall Study|Adverse Event|1|||
156864400|NCT00853307|566263116|FG001|Overall Study|Adverse Event|2|||
156864401|NCT00853307|566263115|FG000|Overall Study|Withdrawal by Subject|1|||
156864402|NCT00853307|566263116|FG001|Overall Study|Withdrawal by Subject|2|||
156408262|NCT01129336|564589236|FG000|Overall Study|Death|0|||
156864403|NCT00853307|566263115|FG000|Overall Study|Reason Not Specified|0|||
156864404|NCT00853307|566263116|FG001|Overall Study|Reason Not Specified|1|||
156864405|NCT00473564|566263117|FG000|Overall Study|robot surgery aborted in OR|23|||
156864406|NCT00914316|566263120|FG000|Phase 1|Physician Decision|4|||
156864407|NCT00914316|566263121|FG001|Phase 1|Physician Decision|0|||
156864408|NCT00914316|566263122|FG002|Phase 1|Physician Decision|1|||
156864409|NCT00914316|566263123|FG003|Phase 1|Physician Decision|2|||
156864410|NCT00914316|566263120|FG000|Phase 1|Withdrawal by Subject|0|||
156864411|NCT00914316|566263121|FG001|Phase 1|Withdrawal by Subject|2|||
156864412|NCT00914316|566263122|FG002|Phase 1|Withdrawal by Subject|4|||
156864413|NCT00914316|566263123|FG003|Phase 1|Withdrawal by Subject|0|||
156864414|NCT00914316|566263120|FG000|Phase 1|Adverse Event|1|||
156864415|NCT00914316|566263121|FG001|Phase 1|Adverse Event|0|||
156864416|NCT00914316|566263122|FG002|Phase 1|Adverse Event|0|||
156864417|NCT00914316|566263123|FG003|Phase 1|Adverse Event|0|||
156864418|NCT00914316|566263120|FG000|Phase 2|Withdrawal by Subject|1|||
156864419|NCT00914316|566263121|FG001|Phase 2|Withdrawal by Subject|0|||
156864420|NCT00914316|566263122|FG002|Phase 2|Withdrawal by Subject|1|||
156864421|NCT00914316|566263123|FG003|Phase 2|Withdrawal by Subject|0|||
156864422|NCT03131219|566263124|FG000|Initial Evaluation Period|Adverse Event|2|||
156864423|NCT03131219|566263125|FG001|Initial Evaluation Period|Adverse Event|0|||
156864424|NCT03131219|566263124|FG000|Initial Evaluation Period|Protocol Violation|1|||
156864425|NCT03131219|566263125|FG001|Initial Evaluation Period|Protocol Violation|0|||
156864426|NCT03131219|566263124|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
156864427|NCT03131219|566263125|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
156864428|NCT03131219|566263124|FG000|Initial Evaluation Period|Physician Decision|1|||
156864429|NCT03131219|566263125|FG001|Initial Evaluation Period|Physician Decision|0|||
156864430|NCT03131219|566263124|FG000|Extension Period|Physician Decision|1|||
156864431|NCT03131219|566263125|FG001|Extension Period|Physician Decision|0|||
156864432|NCT00616759|566263127|FG000|Overall Study|Physician Decision|2|||
156864433|NCT00616759|566263128|FG001|Overall Study|Physician Decision|0|||
156864434|NCT00616759|566263127|FG000|Overall Study|Withdrawal by Subject|1|||
156864435|NCT00616759|566263128|FG001|Overall Study|Withdrawal by Subject|2|||
156864436|NCT02399163|566263131|FG000|Overall Study|Adverse Event|2|||
156864437|NCT02399163|566263131|FG000|Overall Study|Protocol Deviation|2|||
156408263|NCT01129336|564589237|FG001|Overall Study|Death|4|||
156408264|NCT04668989|564589240|FG000|First Intervention|Covid-19 related self-isolation|0|||
156636099|NCT01956123|565412232|FG001|COS Cycle 3|Withdrawal by Subject|0|||
156636100|NCT01956123|565412233|FG002|COS Cycle 3|Withdrawal by Subject|0|||
156864438|NCT02399163|566263131|FG000|Overall Study|Withdrawal by Participant|5|||
156864439|NCT01391546|566263137|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
156864440|NCT01391546|566263138|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
156864441|NCT04225897|566263139|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864442|NCT04225897|566263140|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
156864443|NCT04225897|566263141|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864444|NCT04225897|566263142|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864445|NCT04225897|566263143|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864446|NCT04225897|566263144|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864447|NCT04225897|566263145|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864448|NCT04225897|566263146|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864449|NCT04225897|566263147|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864450|NCT04225897|566263148|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864451|NCT04225897|566263149|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864452|NCT04225897|566263150|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864453|NCT04225897|566263139|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864454|NCT04225897|566263140|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864455|NCT04225897|566263141|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
156864456|NCT04225897|566263142|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864457|NCT04225897|566263143|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864458|NCT04225897|566263144|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864459|NCT04225897|566263145|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864460|NCT04225897|566263146|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864461|NCT04225897|566263147|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864462|NCT04225897|566263148|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864463|NCT04225897|566263149|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864464|NCT04225897|566263150|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864465|NCT04225897|566263139|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864466|NCT04225897|566263140|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864467|NCT04225897|566263141|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
156864468|NCT04225897|566263142|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864469|NCT04225897|566263143|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864470|NCT04225897|566263144|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864471|NCT04225897|566263145|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864472|NCT04225897|566263146|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864473|NCT04225897|566263147|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864474|NCT04225897|566263148|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864475|NCT04225897|566263149|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864476|NCT04225897|566263150|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864477|NCT04225897|566263139|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864478|NCT04225897|566263140|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864479|NCT04225897|566263141|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864480|NCT04225897|566263142|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864481|NCT04225897|566263143|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864482|NCT04225897|566263144|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864483|NCT04225897|566263145|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864484|NCT04225897|566263146|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
156864485|NCT04225897|566263147|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864486|NCT04225897|566263148|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864487|NCT04225897|566263149|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864488|NCT04225897|566263150|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864489|NCT00074711|566263151|FG000|Overall Study|Withdrawal by Subject|1|||
156864490|NCT00074711|566263152|FG001|Overall Study|Withdrawal by Subject|1|||
156864491|NCT00074711|566263151|FG000|Overall Study|Lost to Follow-up|10|||
156864492|NCT00074711|566263152|FG001|Overall Study|Lost to Follow-up|8|||
156864493|NCT00074711|566263151|FG000|Overall Study|Participant stopped study drug|4|||
156864494|NCT00074711|566263152|FG001|Overall Study|Participant stopped study drug|6|||
156864495|NCT03466658|566263153|FG000|Overall Study|Withdrawal by Subject|3|||
156864496|NCT00360230|566263158|FG000|Overall Study|Withdrawal by Subject|1|||
156864497|NCT00360230|566263159|FG001|Overall Study|Withdrawal by Subject|1|||
156864498|NCT00360230|566263160|FG002|Overall Study|Withdrawal by Subject|0|||
156864499|NCT00360230|566263161|FG003|Overall Study|Withdrawal by Subject|1|||
156864500|NCT00360230|566263162|FG004|Overall Study|Withdrawal by Subject|1|||
156864501|NCT00360230|566263163|FG005|Overall Study|Withdrawal by Subject|1|||
156864502|NCT00360230|566263164|FG006|Overall Study|Withdrawal by Subject|0|||
156864503|NCT00360230|566263158|FG000|Overall Study|Migrated|4|||
156864504|NCT00360230|566263159|FG001|Overall Study|Migrated|1|||
156864505|NCT00360230|566263160|FG002|Overall Study|Migrated|3|||
156864506|NCT00360230|566263161|FG003|Overall Study|Migrated|1|||
156864507|NCT00360230|566263162|FG004|Overall Study|Migrated|4|||
156864508|NCT00360230|566263163|FG005|Overall Study|Migrated|1|||
156864509|NCT00360230|566263164|FG006|Overall Study|Migrated|1|||
156864510|NCT00360230|566263158|FG000|Overall Study|Other|1|||
156864511|NCT00360230|566263159|FG001|Overall Study|Other|0|||
156864512|NCT00360230|566263160|FG002|Overall Study|Other|0|||
156864513|NCT00360230|566263161|FG003|Overall Study|Other|0|||
156864514|NCT00360230|566263162|FG004|Overall Study|Other|0|||
156864515|NCT00360230|566263163|FG005|Overall Study|Other|0|||
156864516|NCT00360230|566263164|FG006|Overall Study|Other|0|||
156864517|NCT00360230|566263158|FG000|Overall Study|Protocol Violation|0|||
156864518|NCT00360230|566263159|FG001|Overall Study|Protocol Violation|0|||
156864519|NCT00360230|566263160|FG002|Overall Study|Protocol Violation|0|||
156864520|NCT00360230|566263161|FG003|Overall Study|Protocol Violation|0|||
156864521|NCT00360230|566263162|FG004|Overall Study|Protocol Violation|0|||
156864522|NCT00360230|566263163|FG005|Overall Study|Protocol Violation|1|||
156864523|NCT00360230|566263164|FG006|Overall Study|Protocol Violation|0|||
156864524|NCT00360230|566263158|FG000|Overall Study|Death|0|||
156864525|NCT00360230|566263159|FG001|Overall Study|Death|1|||
156864526|NCT00360230|566263160|FG002|Overall Study|Death|0|||
156864527|NCT00360230|566263161|FG003|Overall Study|Death|0|||
156864528|NCT00360230|566263162|FG004|Overall Study|Death|0|||
156864529|NCT00360230|566263163|FG005|Overall Study|Death|1|||
156864530|NCT00360230|566263164|FG006|Overall Study|Death|1|||
156864531|NCT02703597|566263165|FG000|Assignment to Baseline|Lost to Follow-up|17|||
156864532|NCT02703597|566263166|FG001|Assignment to Baseline|Lost to Follow-up|16|||
156864533|NCT02703597|566263165|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
156864534|NCT02703597|566263166|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
156864535|NCT02703597|566263165|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
156864536|NCT02703597|566263166|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
156864537|NCT02703597|566263165|FG000|First Post-test to First Follow-up|Site drop out|0|||
156864538|NCT02703597|566263166|FG001|First Post-test to First Follow-up|Site drop out|58|||
156864539|NCT02703597|566263165|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
156864540|NCT02703597|566263166|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
156864541|NCT02703597|566263165|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
156864542|NCT02703597|566263166|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
156864543|NCT02703597|566263165|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
156864544|NCT02703597|566263166|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
156864545|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
156864546|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
156864547|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
156864548|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
156864549|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
156864550|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
156864551|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
156864552|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
156864553|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
156864554|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
156864555|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
156864556|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
156864557|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
156864558|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
156864559|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
156864560|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Other|1|||
156864561|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Other|5|||
156864562|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Other|0|||
156864563|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Other|2|||
156864564|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Other|3|||
156864565|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
156864566|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
156864567|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
156864568|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
156864569|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
156864570|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
156864571|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
156408265|NCT04668989|564589241|FG001|First Intervention|Covid-19 related self-isolation|1|||
156864572|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
156864573|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
156864574|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
156864575|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
156864576|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
156864577|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
156864578|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
156864579|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
156864580|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
156864581|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
156864582|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
156864583|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
156864584|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
156864585|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
156864586|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
156864587|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
156864588|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
156864589|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
156408266|NCT04668989|564589240|FG000|Second Intervention|Adverse Event|0|||
156408267|NCT04668989|564589241|FG001|Second Intervention|Adverse Event|1|||
156864590|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Other|0|||
156864591|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Other|1|||
156864592|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Other|0|||
156864593|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Other|1|||
156864594|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Other|0|||
156864595|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Not treated|0|||
156864596|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Not treated|0|||
156864597|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Not treated|2|||
156864598|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Not treated|0|||
156864599|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Not treated|0|||
156864600|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
156864601|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
156864602|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
156864603|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
156864604|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
156864605|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
156864606|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
156864607|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
156864608|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
156864609|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
156864610|NCT00886379|566263172|FG000|Overall Study|Transferred Schools|0|||
156864611|NCT00886379|566263173|FG001|Overall Study|Transferred Schools|0|||
156864612|NCT00886379|566263174|FG002|Overall Study|Transferred Schools|2|||
156864613|NCT00886379|566263175|FG003|Overall Study|Transferred Schools|1|||
156864614|NCT00886379|566263176|FG004|Overall Study|Transferred Schools|1|||
156864615|NCT00886379|566263172|FG000|Overall Study|Final blood draw not obtained|3|||
156864616|NCT00886379|566263173|FG001|Overall Study|Final blood draw not obtained|3|||
156864617|NCT00886379|566263174|FG002|Overall Study|Final blood draw not obtained|4|||
156864618|NCT00886379|566263175|FG003|Overall Study|Final blood draw not obtained|2|||
156864619|NCT00886379|566263176|FG004|Overall Study|Final blood draw not obtained|2|||
156864620|NCT03219723|566263177|FG000|Overall Study|Case Report Forms Uncollected|6|||
156864621|NCT03219723|566263177|FG000|Overall Study|Protocol Deviation|4|||
156864622|NCT00459316|566263182|FG000|Steps 1 & 2|Other eligibility failure|1|||
156864623|NCT00459316|566263183|FG001|Steps 1 & 2|Other eligibility failure|1|||
156864624|NCT00459316|566263184|FG002|Steps 1 & 2|Other eligibility failure|0|||
156864625|NCT00459316|566263182|FG000|Steps 1 & 2|Death|1|||
156864626|NCT00459316|566263183|FG001|Steps 1 & 2|Death|1|||
156864627|NCT00459316|566263184|FG002|Steps 1 & 2|Death|0|||
156864628|NCT00459316|566263182|FG000|Steps 1 & 2|Not able to get to clinic|7|||
156864629|NCT00459316|566263183|FG001|Steps 1 & 2|Not able to get to clinic|4|||
156864630|NCT00459316|566263184|FG002|Steps 1 & 2|Not able to get to clinic|0|||
156864631|NCT00459316|566263182|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
156864632|NCT00459316|566263183|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
156864633|NCT00459316|566263184|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
156864634|NCT00459316|566263182|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
156864635|NCT00459316|566263183|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
156864636|NCT00459316|566263184|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
156864637|NCT00459316|566263182|FG000|Steps 1 & 2|Lost to Follow-up|5|||
156864638|NCT00459316|566263183|FG001|Steps 1 & 2|Lost to Follow-up|0|||
156864639|NCT00459316|566263184|FG002|Steps 1 & 2|Lost to Follow-up|2|||
156864640|NCT00459316|566263182|FG000|Step 3|Withdrawal by Subject|3|||
156864641|NCT00459316|566263183|FG001|Step 3|Withdrawal by Subject|0|||
156864642|NCT00459316|566263184|FG002|Step 3|Withdrawal by Subject|1|||
156864643|NCT01614886|566263185|FG000|Overall Study|Adverse Event|15|||
156408268|NCT01993823|564589242|FG000|Overall Study|Requested by the patient|6|||
156408269|NCT01993823|564589243|FG001|Overall Study|Requested by the patient|11|||
156636101|NCT01956123|565412234|FG003|COS Cycle 3|Withdrawal by Subject|1|||
156864644|NCT01614886|566263186|FG001|Overall Study|Adverse Event|20|||
156864645|NCT01614886|566263185|FG000|Overall Study|Withdrawal by Subject|4|||
156864646|NCT01614886|566263186|FG001|Overall Study|Withdrawal by Subject|4|||
156864647|NCT01614886|566263185|FG000|Overall Study|Death|1|||
156864648|NCT01614886|566263186|FG001|Overall Study|Death|0|||
156864649|NCT01614886|566263185|FG000|Overall Study|Protocol deviation|0|||
156864650|NCT01614886|566263186|FG001|Overall Study|Protocol deviation|2|||
156864651|NCT01207414|566263187|FG000|Overall Study|Adverse Event|25|||
156864652|NCT01207414|566263188|FG001|Overall Study|Adverse Event|39|||
156864653|NCT01207414|566263187|FG000|Overall Study|Abnormal test procedure results|0|||
156864654|NCT01207414|566263188|FG001|Overall Study|Abnormal test procedure results|1|||
156864655|NCT01207414|566263187|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
156864656|NCT01207414|566263188|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156864657|NCT01207414|566263187|FG000|Overall Study|Patient withdrew consent|14|||
156864658|NCT01207414|566263188|FG001|Overall Study|Patient withdrew consent|11|||
156864659|NCT01207414|566263187|FG000|Overall Study|Lost to Follow-up|15|||
156864660|NCT01207414|566263188|FG001|Overall Study|Lost to Follow-up|17|||
156864661|NCT01207414|566263187|FG000|Overall Study|Administrative problems|1|||
156864662|NCT01207414|566263188|FG001|Overall Study|Administrative problems|1|||
156864663|NCT01207414|566263187|FG000|Overall Study|Protocol deviation|12|||
156864664|NCT01207414|566263188|FG001|Overall Study|Protocol deviation|9|||
156864665|NCT01207414|566263187|FG000|Overall Study|Randomized in error|1|||
156864666|NCT01207414|566263188|FG001|Overall Study|Randomized in error|0|||
156864667|NCT01435382|566263191|FG000|Overall Study|Lost to Follow-up|1|||
156864668|NCT01435382|566263192|FG001|Overall Study|Lost to Follow-up|0|||
156864669|NCT01435382|566263193|FG002|Overall Study|Lost to Follow-up|1|||
156864670|NCT01435382|566263194|FG003|Overall Study|Lost to Follow-up|0|||
156864671|NCT01435382|566263191|FG000|Overall Study|Withdrawal by Subject|0|||
156864672|NCT01435382|566263192|FG001|Overall Study|Withdrawal by Subject|2|||
156864673|NCT01435382|566263193|FG002|Overall Study|Withdrawal by Subject|0|||
156864674|NCT01435382|566263194|FG003|Overall Study|Withdrawal by Subject|1|||
156864675|NCT00910650|566263195|FG000|Overall Study|Death|2|||
156864676|NCT00423579|566263196|FG000|Overall Study|Lost to Follow-up|3|||
156864677|NCT00423579|566263197|FG001|Overall Study|Lost to Follow-up|0|||
156864678|NCT00423579|566263196|FG000|Overall Study|Protocol Violation|1|||
156864679|NCT00423579|566263197|FG001|Overall Study|Protocol Violation|3|||
156864680|NCT00423579|566263196|FG000|Overall Study|Diagnosis of diabetes|0|||
156864681|NCT00423579|566263197|FG001|Overall Study|Diagnosis of diabetes|1|||
156864682|NCT04004988|566263199|FG000|Period 1|Physician Decision|2|||
156864683|NCT04004988|566263200|FG001|Period 1|Physician Decision|0|||
156864684|NCT04004988|566263199|FG000|Period 1|Withdrawal by Subject|0|||
156864685|NCT04004988|566263200|FG001|Period 1|Withdrawal by Subject|1|||
156864686|NCT04004988|566263199|FG000|Period 1|Adverse Event|1|||
156864687|NCT04004988|566263200|FG001|Period 1|Adverse Event|2|||
156864688|NCT03873116|566263201|FG000|Part 1|Study drug discontinuation due to rash|0|||
156864689|NCT03873116|566263202|FG001|Part 1|Study drug discontinuation due to rash|0|||
156864690|NCT03873116|566263203|FG002|Part 1|Study drug discontinuation due to rash|0|||
156864691|NCT03873116|566263204|FG003|Part 1|Study drug discontinuation due to rash|0|||
156864692|NCT03873116|566263205|FG004|Part 1|Study drug discontinuation due to rash|0|||
156864693|NCT03873116|566263206|FG005|Part 1|Study drug discontinuation due to rash|1|||
156864694|NCT03873116|566263201|FG000|Part 2|Withdrawal by Subject|0|||
156864695|NCT03873116|566263202|FG001|Part 2|Withdrawal by Subject|0|||
156864696|NCT03873116|566263203|FG002|Part 2|Withdrawal by Subject|1|||
156864697|NCT03873116|566263204|FG003|Part 2|Withdrawal by Subject|0|||
156864698|NCT03873116|566263205|FG004|Part 2|Withdrawal by Subject|0|||
156864699|NCT03873116|566263206|FG005|Part 2|Withdrawal by Subject|0|||
156864700|NCT03873116|566263201|FG000|Part 2|Lab abnormality or AE|0|||
156864701|NCT03873116|566263202|FG001|Part 2|Lab abnormality or AE|0|||
156864702|NCT03873116|566263203|FG002|Part 2|Lab abnormality or AE|0|||
156864703|NCT03873116|566263204|FG003|Part 2|Lab abnormality or AE|0|||
156864704|NCT03873116|566263205|FG004|Part 2|Lab abnormality or AE|1|||
156864705|NCT03873116|566263206|FG005|Part 2|Lab abnormality or AE|0|||
156864706|NCT03873116|566263201|FG000|Part 3|Withdrawal by Subject|0|||
156864707|NCT03873116|566263202|FG001|Part 3|Withdrawal by Subject|0|||
156864708|NCT03873116|566263203|FG002|Part 3|Withdrawal by Subject|0|||
156864709|NCT03873116|566263204|FG003|Part 3|Withdrawal by Subject|0|||
156864710|NCT03873116|566263205|FG004|Part 3|Withdrawal by Subject|1|||
156864711|NCT03873116|566263206|FG005|Part 3|Withdrawal by Subject|0|||
156864712|NCT04682366|566263207|FG000|Overall Study|Lost to Follow-up|1|||
156864713|NCT04682366|566263208|FG001|Overall Study|Lost to Follow-up|1|||
156864714|NCT02461758|566263210|FG000|Overall Study|Lost to Follow-up|0|||
156864715|NCT02461758|566263211|FG001|Overall Study|Lost to Follow-up|1|||
156864716|NCT02461758|566263212|FG002|Overall Study|Lost to Follow-up|1|||
156864717|NCT02461758|566263213|FG003|Overall Study|Lost to Follow-up|0|||
156864718|NCT00929695|566263214|FG000|Overall Study|Death|2|||
156864719|NCT00929695|566263215|FG001|Overall Study|Death|1|||
156864720|NCT00929695|566263214|FG000|Overall Study|Withdrawal by Subject|0|||
156864721|NCT00929695|566263215|FG001|Overall Study|Withdrawal by Subject|2|||
156864722|NCT00929695|566263214|FG000|Overall Study|discharge home|4|||
156864723|NCT00929695|566263215|FG001|Overall Study|discharge home|3|||
156864724|NCT00929695|566263214|FG000|Overall Study|incorrect stratification|2|||
156864725|NCT00929695|566263215|FG001|Overall Study|incorrect stratification|0|||
156864726|NCT04030143|566263216|FG000|Overall Study|Adverse Event|5|||
156864727|NCT04030143|566263217|FG001|Overall Study|Adverse Event|10|||
156864728|NCT04030143|566263216|FG000|Overall Study|Lost to Follow-up|3|||
156864729|NCT04030143|566263217|FG001|Overall Study|Lost to Follow-up|7|||
156864730|NCT04030143|566263216|FG000|Overall Study|Protocol Deviation|2|||
156864731|NCT04030143|566263217|FG001|Overall Study|Protocol Deviation|2|||
156864732|NCT04030143|566263216|FG000|Overall Study|Withdrawal by Subject|16|||
156864733|NCT04030143|566263217|FG001|Overall Study|Withdrawal by Subject|18|||
156750469|NCT02757352|565838821|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750470|NCT02757352|565838822|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750471|NCT02757352|565838823|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750472|NCT02757352|565838824|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750473|NCT02757352|565838825|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750474|NCT02757352|565838826|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750475|NCT02757352|565838827|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750476|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750477|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750478|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750479|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
156750480|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750481|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
156750482|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750483|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750484|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750485|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750486|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750487|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750488|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750489|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
156750490|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
156750491|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
156750492|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750493|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750494|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750495|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750496|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750497|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750498|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750499|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750500|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
156750501|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750502|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750503|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750504|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750505|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750506|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750507|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750508|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750509|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750510|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750511|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
156750512|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750513|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750514|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750515|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750516|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750517|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750518|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750519|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
156750520|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
156750521|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
156750522|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750523|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750524|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750525|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750526|NCT02757352|565838818|FG000|Follow-Up Period|Adverse Event|0|||
156750527|NCT02757352|565838819|FG001|Follow-Up Period|Adverse Event|0|||
156750528|NCT02757352|565838820|FG002|Follow-Up Period|Adverse Event|0|||
156750529|NCT02757352|565838821|FG003|Follow-Up Period|Adverse Event|0|||
156750530|NCT02757352|565838822|FG004|Follow-Up Period|Adverse Event|0|||
156750531|NCT02757352|565838823|FG005|Follow-Up Period|Adverse Event|0|||
156750532|NCT02757352|565838824|FG006|Follow-Up Period|Adverse Event|1|||
156864734|NCT04030143|566263216|FG000|Overall Study|Physician Decision|1|||
156864735|NCT04030143|566263217|FG001|Overall Study|Physician Decision|1|||
156864736|NCT04030143|566263216|FG000|Overall Study|Due to Covid-19|2|||
156864737|NCT04030143|566263217|FG001|Overall Study|Due to Covid-19|3|||
156864738|NCT04030143|566263216|FG000|Overall Study|Not Due to Covid-19|1|||
156864739|NCT04030143|566263217|FG001|Overall Study|Not Due to Covid-19|1|||
156864740|NCT01352715|566263218|FG000|Overall Study|Death|3|||
156864741|NCT01352715|566263219|FG001|Overall Study|Death|3|||
156864742|NCT01352715|566263218|FG000|Overall Study|Lost to Follow-up|5|||
156864743|NCT01352715|566263219|FG001|Overall Study|Lost to Follow-up|7|||
156864744|NCT01352715|566263218|FG000|Overall Study|Withdrawal by Subject|4|||
156864745|NCT01352715|566263219|FG001|Overall Study|Withdrawal by Subject|8|||
156864746|NCT01352715|566263218|FG000|Overall Study|site closure|16|||
156864747|NCT01352715|566263219|FG001|Overall Study|site closure|15|||
156864748|NCT01352715|566263218|FG000|Overall Study|no final visit in closeout period|15|||
156864749|NCT01352715|566263219|FG001|Overall Study|no final visit in closeout period|12|||
156864750|NCT01352715|566263218|FG000|Overall Study|major ineligibility|2|||
156864751|NCT01352715|566263219|FG001|Overall Study|major ineligibility|1|||
156864752|NCT02000440|566263221|FG000|Overall Study|Adverse Event|3|||
156864753|NCT02000440|566263221|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
156864754|NCT02383576|566263222|FG000|Overall Study|Death|53|||
156864755|NCT02383576|566263223|FG001|Overall Study|Death|33|||
156864756|NCT02383576|566263222|FG000|Overall Study|Lost to Follow-up|7|||
156864757|NCT02383576|566263223|FG001|Overall Study|Lost to Follow-up|1|||
156864758|NCT02383576|566263222|FG000|Overall Study|Withdrew Consent|1|||
156864759|NCT02383576|566263223|FG001|Overall Study|Withdrew Consent|6|||
156864760|NCT02383576|566263222|FG000|Overall Study|Investigator's Decision|0|||
156864761|NCT02383576|566263223|FG001|Overall Study|Investigator's Decision|1|||
156864762|NCT02383576|566263222|FG000|Overall Study|Administrative/Other|2|||
156864763|NCT02383576|566263223|FG001|Overall Study|Administrative/Other|4|||
156864764|NCT00528112|566263224|FG000|Treatment up to 3 Years|Adverse Event|313|||
156864765|NCT00528112|566263225|FG001|Treatment up to 3 Years|Adverse Event|278|||
156864766|NCT00528112|566263224|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
156864767|NCT00528112|566263225|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
156864768|NCT00528112|566263224|FG000|Treatment up to 3 Years|Protocol Violation|16|||
156864769|NCT00528112|566263225|FG001|Treatment up to 3 Years|Protocol Violation|16|||
156408270|NCT01993823|564589242|FG000|Overall Study|Protocol Violation|0|||
156408271|NCT01993823|564589243|FG001|Overall Study|Protocol Violation|1|||
156408272|NCT01993823|564589242|FG000|Overall Study|Lost to Follow-up|1|||
156408273|NCT01993823|564589243|FG001|Overall Study|Lost to Follow-up|4|||
156408274|NCT01622348|564589244|FG000|Overall Study|Withdrawal by Subject|1|||
156408275|NCT01622348|564589245|FG001|Overall Study|Withdrawal by Subject|0|||
156408276|NCT01622348|564589246|FG002|Overall Study|Withdrawal by Subject|1|||
156408277|NCT00791921|564589247|FG000|Overall Study|Protocol planed|24|||
156408278|NCT00791921|564589248|FG001|Overall Study|Protocol planed|88|||
156408279|NCT00791921|564589247|FG000|Overall Study|Withdrawal by Subject|1|||
156408280|NCT00791921|564589248|FG001|Overall Study|Withdrawal by Subject|2|||
156408281|NCT00791921|564589247|FG000|Overall Study|Adverse Event|8|||
156408282|NCT00791921|564589248|FG001|Overall Study|Adverse Event|2|||
156408283|NCT00791921|564589247|FG000|Overall Study|Lack of Efficacy|0|||
156408284|NCT00791921|564589248|FG001|Overall Study|Lack of Efficacy|2|||
156408285|NCT00791921|564589247|FG000|Overall Study|Lack of study drug administration|1|||
156408286|NCT00791921|564589248|FG001|Overall Study|Lack of study drug administration|1|||
156408287|NCT00791921|564589247|FG000|Overall Study|Reason other than those above|0|||
156408288|NCT00791921|564589248|FG001|Overall Study|Reason other than those above|1|||
156408289|NCT00474175|564589251|FG000|Overall Study|Lack of Efficacy|0|||
156408290|NCT00474175|564589252|FG001|Overall Study|Lack of Efficacy|0|||
156408291|NCT00474175|564589253|FG002|Overall Study|Lack of Efficacy|1|||
156408292|NCT00474175|564589251|FG000|Overall Study|Withdrawal by Subject|0|||
156408293|NCT00474175|564589252|FG001|Overall Study|Withdrawal by Subject|1|||
156408294|NCT00474175|564589253|FG002|Overall Study|Withdrawal by Subject|1|||
156408295|NCT00474175|564589251|FG000|Overall Study|Ineligible|1|||
156408296|NCT00474175|564589252|FG001|Overall Study|Ineligible|3|||
156408297|NCT00474175|564589253|FG002|Overall Study|Ineligible|1|||
156408298|NCT00474175|564589251|FG000|Overall Study|Protocol Violation|0|||
156408299|NCT00474175|564589252|FG001|Overall Study|Protocol Violation|2|||
156408300|NCT00474175|564589253|FG002|Overall Study|Protocol Violation|1|||
156408301|NCT00474175|564589251|FG000|Overall Study|Administrative|0|||
156408302|NCT00474175|564589252|FG001|Overall Study|Administrative|1|||
156864770|NCT00528112|566263224|FG000|Treatment up to 3 Years|Death|0|||
156408303|NCT00474175|564589253|FG002|Overall Study|Administrative|0|||
156408304|NCT00467142|564589254|FG000|Overall Study|Withdrawal by Subject|1|||
156408305|NCT00467142|564589254|FG000|Overall Study|Adverse Event|1|||
156408306|NCT00467142|564589254|FG000|Overall Study|Protocol Violation|1|||
156408307|NCT01619787|564589255|FG000|Overall Study|Lost to Follow-up|5|||
156864771|NCT00528112|566263225|FG001|Treatment up to 3 Years|Death|1|||
156864772|NCT00528112|566263224|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
156864773|NCT00528112|566263225|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
156408308|NCT04537897|564589256|FG000|Overall Study|Other than listed|0|||
156408309|NCT04537897|564589257|FG001|Overall Study|Other than listed|0|||
156408310|NCT04537897|564589258|FG002|Overall Study|Other than listed|0|||
156408311|NCT04537897|564589259|FG003|Overall Study|Other than listed|0|||
156408312|NCT04537897|564589260|FG004|Overall Study|Other than listed|0|||
156521380|NCT01098097|565003102|FG000|Overall Study|No reason reported|31|||
156521381|NCT00394082|565003105|FG000|Overall Study|Unacceptable toxicity|15|||
156521382|NCT00394082|565003105|FG000|Overall Study|Adverse Event|4|||
156521383|NCT00394082|565003105|FG000|Overall Study|Physician Decision|4|||
156521384|NCT00394082|565003105|FG000|Overall Study|Withdrawal by Subject|2|||
156521385|NCT00394082|565003105|FG000|Overall Study|Other|1|||
156521386|NCT02344004|565003109|FG000|Overall Study|Adverse Event|11|||
156521387|NCT02344004|565003110|FG001|Overall Study|Adverse Event|1|||
156521388|NCT02344004|565003109|FG000|Overall Study|Death|9|||
156521389|NCT02344004|565003110|FG001|Overall Study|Death|7|||
156521390|NCT02344004|565003109|FG000|Overall Study|Physician Decision|4|||
156521391|NCT02344004|565003110|FG001|Overall Study|Physician Decision|1|||
156521392|NCT02344004|565003109|FG000|Overall Study|Withdrawal by Subject|22|||
156521393|NCT02344004|565003110|FG001|Overall Study|Withdrawal by Subject|5|||
156521394|NCT02344004|565003109|FG000|Overall Study|Rescue Medication|2|||
156521395|NCT02344004|565003110|FG001|Overall Study|Rescue Medication|0|||
156521396|NCT02344004|565003109|FG000|Overall Study|Other Not Specified|12|||
156521397|NCT02344004|565003110|FG001|Overall Study|Other Not Specified|0|||
156521398|NCT02344004|565003109|FG000|Overall Study|Protocol Violation|1|||
156521399|NCT02344004|565003110|FG001|Overall Study|Protocol Violation|0|||
156521400|NCT01768117|565003111|FG000|Overall Study|Lost to Follow-up|1|||
156521401|NCT01768117|565003111|FG000|Overall Study|Withdrawal by Subject|2|||
156521402|NCT01768117|565003111|FG000|Overall Study|Protocol Violation|3|||
156521403|NCT01945060|565003112|FG000|Overall Study|Lost to follow up|1|||
156521404|NCT01945060|565003113|FG001|Overall Study|Lost to follow up|0|||
156521405|NCT01945060|565003112|FG000|Overall Study|Distress related to IV access|0|||
156521406|NCT01945060|565003113|FG001|Overall Study|Distress related to IV access|1|||
156521407|NCT01000636|565003116|FG000|Overall Study|Withdrawal by Subject|1|||
156521408|NCT01000636|565003116|FG000|Overall Study|Adverse Event|1|||
156521409|NCT00138671|565003117|FG000|Overall Study|Death|0|||
156521410|NCT00138671|565003118|FG001|Overall Study|Death|3|||
156521411|NCT00138671|565003117|FG000|Overall Study|Adverse Event|6|||
156521412|NCT00138671|565003118|FG001|Overall Study|Adverse Event|3|||
156521413|NCT00138671|565003117|FG000|Overall Study|Lost to Follow-up|1|||
156521414|NCT00138671|565003118|FG001|Overall Study|Lost to Follow-up|2|||
156521415|NCT00138671|565003117|FG000|Overall Study|Withdrawal by Subject|3|||
156521416|NCT00138671|565003118|FG001|Overall Study|Withdrawal by Subject|5|||
156521417|NCT00138671|565003117|FG000|Overall Study|Other|3|||
156521418|NCT00138671|565003118|FG001|Overall Study|Other|3|||
156521419|NCT00906945|565003120|FG000|Overall Study|Found to be not eligible|0|||
156521420|NCT00906945|565003121|FG001|Overall Study|Found to be not eligible|0|||
156521421|NCT00906945|565003122|FG002|Overall Study|Found to be not eligible|0|||
156521422|NCT00906945|565003123|FG003|Overall Study|Found to be not eligible|1|||
156521423|NCT00906945|565003124|FG004|Overall Study|Found to be not eligible|1|||
156521424|NCT00906945|565003125|FG005|Overall Study|Found to be not eligible|1|||
156521425|NCT00906945|565003120|FG000|Overall Study|Physician Decision|0|||
156521426|NCT00906945|565003121|FG001|Overall Study|Physician Decision|0|||
156521427|NCT00906945|565003122|FG002|Overall Study|Physician Decision|0|||
156521428|NCT00906945|565003123|FG003|Overall Study|Physician Decision|0|||
156864774|NCT00528112|566263224|FG000|Treatment up to 3 Years|Pregnancy|9|||
156864775|NCT00528112|566263225|FG001|Treatment up to 3 Years|Pregnancy|10|||
156864776|NCT00528112|566263224|FG000|Treatment up to 3 Years|Other reasons|186|||
156864777|NCT00528112|566263225|FG001|Treatment up to 3 Years|Other reasons|186|||
156864778|NCT00528112|566263224|FG000|Extension Phase|Withdrawal by Subject|0|||
156864779|NCT00528112|566263225|FG001|Extension Phase|Withdrawal by Subject|3|||
156864780|NCT00528112|566263224|FG000|Extension Phase|Other reasons|0|||
156864781|NCT00528112|566263225|FG001|Extension Phase|Other reasons|100|||
156864782|NCT00528112|566263224|FG000|Extension Phase|Pregnancy|0|||
156864783|NCT00528112|566263225|FG001|Extension Phase|Pregnancy|3|||
156864784|NCT00528112|566263224|FG000|Extension Phase|Lost to Follow-up|0|||
156864785|NCT00528112|566263225|FG001|Extension Phase|Lost to Follow-up|12|||
156864786|NCT00528112|566263224|FG000|Extension Phase|Death|0|||
156408313|NCT04537897|564589261|FG005|Overall Study|Other than listed|0|||
156521429|NCT00906945|565003124|FG004|Overall Study|Physician Decision|0|||
156521430|NCT00906945|565003125|FG005|Overall Study|Physician Decision|1|||
156521431|NCT01853644|565003126|FG000|Registration and Treatment Start|Did not start treatment|1|||
156521432|NCT01853644|565003126|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
156521433|NCT01853644|565003126|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
156521434|NCT01853644|565003126|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
156521435|NCT01853644|565003126|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
156750533|NCT02757352|565838825|FG007|Follow-Up Period|Adverse Event|0|||
156864787|NCT00528112|566263225|FG001|Extension Phase|Death|1|||
156864788|NCT00528112|566263224|FG000|Extension Phase|Adverse Event|0|||
156864789|NCT00528112|566263225|FG001|Extension Phase|Adverse Event|36|||
156864790|NCT00528112|566263224|FG000|Extension Phase|Protocol Violation|0|||
156864791|NCT00528112|566263225|FG001|Extension Phase|Protocol Violation|2|||
156864792|NCT02559622|566263227|FG000|Overall Study|Progressive disease|0|||
156864793|NCT02559622|566263228|FG001|Overall Study|Progressive disease|1|||
156864794|NCT02559622|566263229|FG002|Overall Study|Progressive disease|0|||
156864795|NCT02559622|566263230|FG003|Overall Study|Progressive disease|0|||
156864796|NCT02559622|566263227|FG000|Overall Study|Adverse Event|0|||
156864797|NCT02559622|566263228|FG001|Overall Study|Adverse Event|2|||
156864798|NCT02559622|566263229|FG002|Overall Study|Adverse Event|2|||
156864799|NCT02559622|566263230|FG003|Overall Study|Adverse Event|2|||
156864800|NCT02559622|566263227|FG000|Overall Study|Patient/guardian decision|1|||
156864801|NCT02559622|566263228|FG001|Overall Study|Patient/guardian decision|2|||
156864802|NCT02559622|566263229|FG002|Overall Study|Patient/guardian decision|0|||
156864803|NCT02559622|566263230|FG003|Overall Study|Patient/guardian decision|1|||
156864804|NCT00894803|566263231|FG000|Overall Study|Death|20|||
156864805|NCT00894803|566263232|FG001|Overall Study|Death|4|||
156864806|NCT00894803|566263231|FG000|Overall Study|Lost to Follow-up|0|||
156864807|NCT00894803|566263232|FG001|Overall Study|Lost to Follow-up|1|||
156864808|NCT00449696|566263233|FG000|Overall Study|Other Treatment Required|6|||
156864809|NCT00449696|566263234|FG001|Overall Study|Other Treatment Required|1|||
156864810|NCT00449696|566263233|FG000|Overall Study|Withdrawal by Subject|5|||
156864811|NCT00449696|566263234|FG001|Overall Study|Withdrawal by Subject|5|||
156864812|NCT00449696|566263233|FG000|Overall Study|Lost to Follow-up|2|||
156864813|NCT00449696|566263234|FG001|Overall Study|Lost to Follow-up|3|||
156864814|NCT00449696|566263233|FG000|Overall Study|Others|7|||
156864815|NCT00449696|566263234|FG001|Overall Study|Others|0|||
156864816|NCT01033019|566263237|FG000|Overall Study|Withdrawal by Subject|1|||
156864817|NCT01033019|566263238|FG001|Overall Study|Withdrawal by Subject|0|||
156864818|NCT01052493|566263241|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
156864819|NCT01052493|566263242|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
156864820|NCT01052493|566263243|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
156864821|NCT00307801|566263246|FG000|Overall Study|Adverse Event|12|||
156864822|NCT00307801|566263247|FG001|Overall Study|Adverse Event|4|||
156864823|NCT00307801|566263246|FG000|Overall Study|Withdrawal by Subject|9|||
156864824|NCT00307801|566263247|FG001|Overall Study|Withdrawal by Subject|4|||
156864825|NCT00307801|566263246|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
156864826|NCT00307801|566263247|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
156864827|NCT00307801|566263246|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
156864828|NCT00307801|566263247|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
156864829|NCT00307801|566263246|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
156864830|NCT00307801|566263247|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
156864831|NCT00307801|566263246|FG000|Overall Study|Wrong Randomization|1|||
156864832|NCT00307801|566263247|FG001|Overall Study|Wrong Randomization|0|||
156864833|NCT00307801|566263246|FG000|Overall Study|Lack of Efficacy|0|||
156864834|NCT00307801|566263247|FG001|Overall Study|Lack of Efficacy|2|||
156864835|NCT00307801|566263246|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
156864836|NCT00307801|566263247|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
156864837|NCT00307801|566263246|FG000|Overall Study|Frustration with e-diary|1|||
156864838|NCT00307801|566263247|FG001|Overall Study|Frustration with e-diary|0|||
156864839|NCT00307801|566263246|FG000|Overall Study|Protocol Violation|3|||
156864840|NCT00307801|566263247|FG001|Overall Study|Protocol Violation|2|||
156864841|NCT00307801|566263246|FG000|Overall Study|No reason specified|2|||
156864842|NCT00307801|566263247|FG001|Overall Study|No reason specified|0|||
156864843|NCT00307801|566263246|FG000|Overall Study|Pregnancy|0|||
156864844|NCT00307801|566263247|FG001|Overall Study|Pregnancy|1|||
156864845|NCT03944577|566263251|FG000|Overall Study|Adverse Event|3|||
156864846|NCT03011099|566263252|FG000|Overall Study|Withdrawal by Subject|0|||
156864847|NCT03011099|566263253|FG001|Overall Study|Withdrawal by Subject|2|||
156864848|NCT00283296|566263258|FG000|Overall Study|in-home trial not completed|5|||
156864849|NCT05417438|566263261|FG000|Overall Study|Withdrawal by Subject|3|||
156864850|NCT02681523|566263266|FG000|Overall Study|Adverse Event|1|||
156864851|NCT02681523|566263266|FG000|Overall Study|Patient Non-compliance|1|||
156864852|NCT03253393|566263270|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
156864853|NCT03253393|566263271|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
156864854|NCT03253393|566263272|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
156864855|NCT01350999|566263274|FG000|Overall Study|Adverse Event|4|||
156864856|NCT01350999|566263275|FG001|Overall Study|Adverse Event|9|||
156864857|NCT01350999|566263276|FG002|Overall Study|Adverse Event|10|||
156864858|NCT01350999|566263274|FG000|Overall Study|Voluntary withdrawal|3|||
156864859|NCT01350999|566263275|FG001|Overall Study|Voluntary withdrawal|4|||
156864860|NCT01350999|566263276|FG002|Overall Study|Voluntary withdrawal|6|||
156864861|NCT01350999|566263274|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
156864862|NCT01350999|566263275|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
156864863|NCT01350999|566263276|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
156864864|NCT00124943|566265356|FG000|Phase II|Adverse Event|0|||
156864865|NCT00124943|566265357|FG001|Phase II|Adverse Event|2|||
156864866|NCT00124943|566265358|FG002|Phase II|Adverse Event|0|||
156864867|NCT00124943|566265359|FG003|Phase II|Adverse Event|1|||
156864868|NCT00124943|566265356|FG000|Phase II|Protocol Violation|0|||
156864869|NCT00124943|566265357|FG001|Phase II|Protocol Violation|0|||
156864870|NCT00124943|566265358|FG002|Phase II|Protocol Violation|0|||
156864871|NCT00124943|566265359|FG003|Phase II|Protocol Violation|1|||
156750534|NCT02757352|565838826|FG008|Follow-Up Period|Adverse Event|2|||
156864872|NCT00124943|566265356|FG000|Phase II|Lost to Follow-up|0|||
156864873|NCT00124943|566265357|FG001|Phase II|Lost to Follow-up|0|||
156864874|NCT00124943|566265358|FG002|Phase II|Lost to Follow-up|0|||
156864875|NCT00124943|566265359|FG003|Phase II|Lost to Follow-up|1|||
156864876|NCT00124943|566265356|FG000|Phase II|Withdrawal by Subject|0|||
156864877|NCT00124943|566265357|FG001|Phase II|Withdrawal by Subject|0|||
156864878|NCT00124943|566265358|FG002|Phase II|Withdrawal by Subject|0|||
156864879|NCT00124943|566265359|FG003|Phase II|Withdrawal by Subject|2|||
156864880|NCT00321620|566265360|FG000|Overall Study|Death|269|||
156864881|NCT00321620|566265361|FG001|Overall Study|Death|294|||
156864882|NCT00321620|566265360|FG000|Overall Study|Withdrawal by Subject|164|||
156864883|NCT00321620|566265361|FG001|Overall Study|Withdrawal by Subject|147|||
156864884|NCT00321620|566265360|FG000|Overall Study|Disease progression|113|||
156864885|NCT00321620|566265361|FG001|Overall Study|Disease progression|117|||
156864886|NCT00321620|566265360|FG000|Overall Study|Adverse Event|43|||
156864887|NCT00321620|566265361|FG001|Overall Study|Adverse Event|56|||
156864888|NCT00321620|566265360|FG000|Overall Study|Lost to Follow-up|13|||
156864889|NCT00321620|566265361|FG001|Overall Study|Lost to Follow-up|9|||
156864890|NCT00321620|566265360|FG000|Overall Study|Physician Decision|4|||
156864891|NCT00321620|566265361|FG001|Overall Study|Physician Decision|1|||
156864892|NCT00321620|566265360|FG000|Overall Study|Noncompliance|14|||
156864893|NCT00321620|566265361|FG001|Overall Study|Noncompliance|7|||
156864894|NCT00321620|566265360|FG000|Overall Study|Protocol deviation|4|||
156864895|NCT00321620|566265361|FG001|Overall Study|Protocol deviation|3|||
156864896|NCT00321620|566265360|FG000|Overall Study|Ineligibility determined|2|||
156864897|NCT00321620|566265361|FG001|Overall Study|Ineligibility determined|3|||
156864898|NCT00321620|566265360|FG000|Overall Study|Participant request|75|||
156864899|NCT00321620|566265361|FG001|Overall Study|Participant request|52|||
156864900|NCT00321620|566265360|FG000|Overall Study|Other|42|||
156864901|NCT00321620|566265361|FG001|Overall Study|Other|33|||
156864902|NCT03181932|566265362|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
156864903|NCT03181932|566265363|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
156864904|NCT03181932|566265362|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
156864905|NCT03181932|566265363|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
156864906|NCT03181932|566265362|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
156864907|NCT03181932|566265363|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
156864908|NCT03181932|566265362|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
156864909|NCT03181932|566265363|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
156864910|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
156864911|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
156864912|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
156864913|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
156864914|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
156864915|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
156864916|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
156864917|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
156864918|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Reason missing|2|||
156864919|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Reason missing|0|||
156864920|NCT00408317|566265368|FG000|First Intervention Period|Adverse Event|0|||
156864921|NCT00408317|566265369|FG001|First Intervention Period|Adverse Event|1|||
156864922|NCT00408317|566265368|FG000|Second Intervention Period|Adverse Event|2|||
156864923|NCT00408317|566265369|FG001|Second Intervention Period|Adverse Event|0|||
156864924|NCT00408317|566265368|FG000|Second Intervention Period|Protocol Violation|0|||
156864925|NCT00408317|566265369|FG001|Second Intervention Period|Protocol Violation|1|||
156864926|NCT00408317|566265368|FG000|Second Intervention Period|Withdrawal of consent|0|||
156864927|NCT00408317|566265369|FG001|Second Intervention Period|Withdrawal of consent|1|||
156864928|NCT02177123|566265370|FG000|Overall Study|Lost to Follow-up|6|||
156864929|NCT02177123|566265370|FG000|Overall Study|Withdrawal by Subject|4|||
156864930|NCT02177123|566265370|FG000|Overall Study|Adverse Event|4|||
156864931|NCT02177123|566265370|FG000|Overall Study|Physician Decision|3|||
156864932|NCT02177123|566265370|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
156864933|NCT02177123|566265370|FG000|Overall Study|Excluded for medical reasons|2|||
156864934|NCT02177123|566265370|FG000|Overall Study|Death|1|||
156864935|NCT02177123|566265370|FG000|Overall Study|Other|1|||
156864936|NCT02177123|566265370|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
156864937|NCT01921205|566265376|FG000|Overall Study|Adverse Event|12|||
156864938|NCT01921205|566265377|FG001|Overall Study|Adverse Event|7|||
156864939|NCT01921205|566265376|FG000|Overall Study|Lack of Efficacy|1|||
156864940|NCT01921205|566265377|FG001|Overall Study|Lack of Efficacy|0|||
156864941|NCT01921205|566265376|FG000|Overall Study|Protocol Violation|1|||
156864942|NCT01921205|566265377|FG001|Overall Study|Protocol Violation|3|||
156864943|NCT01921205|566265376|FG000|Overall Study|Lost to Follow-up|1|||
156864944|NCT01921205|566265377|FG001|Overall Study|Lost to Follow-up|1|||
156864945|NCT01921205|566265376|FG000|Overall Study|Withdrawal by Subject|6|||
156864946|NCT01921205|566265377|FG001|Overall Study|Withdrawal by Subject|5|||
156864947|NCT01921205|566265376|FG000|Overall Study|Use Of Prohibited Medication|0|||
156864948|NCT01921205|566265377|FG001|Overall Study|Use Of Prohibited Medication|1|||
156864949|NCT01921205|566265376|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
156864950|NCT01921205|566265377|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
156864951|NCT01921205|566265376|FG000|Overall Study|Non Compliance Of The Parent|0|||
156864952|NCT01921205|566265377|FG001|Overall Study|Non Compliance Of The Parent|1|||
156864953|NCT01921205|566265376|FG000|Overall Study|Non Compliance Of Child|0|||
156864954|NCT01921205|566265377|FG001|Overall Study|Non Compliance Of Child|1|||
156864955|NCT05966142|566265384|FG000|Overall Study|Death|3|||
156864956|NCT05966142|566265385|FG001|Overall Study|Death|3|||
156864957|NCT05966142|566265384|FG000|Overall Study|Lost to Follow-up|55|||
156521436|NCT01853644|565003126|FG000|Continued Treatment After First Response|Adverse Event|2|||
156521437|NCT01853644|565003126|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
156521438|NCT01588496|565003129|FG000|Overall Study|Withdrawal by Subject|0|||
156521439|NCT01588496|565003130|FG001|Overall Study|Withdrawal by Subject|1|||
156521440|NCT01588496|565003131|FG002|Overall Study|Withdrawal by Subject|0|||
156521441|NCT03143166|565003132|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
156521442|NCT00705523|565003133|FG000|Overall Study|Lost to Follow-up|2|||
156521443|NCT00705523|565003134|FG001|Overall Study|Lost to Follow-up|3|||
156521444|NCT05924945|565003135|FG000|Overall Study|Withdrawal by Subject|3|||
156521445|NCT05924945|565003136|FG001|Overall Study|Withdrawal by Subject|4|||
156521446|NCT02673515|565003140|FG000|Overall Study|Lack of motivation|2|||
156521447|NCT02673515|565003141|FG001|Overall Study|Lack of motivation|1|||
156521448|NCT00994682|565003142|FG000|Double Bilnd|Withdrawal by Subject|5|||
156521449|NCT00994682|565003143|FG001|Double Bilnd|Withdrawal by Subject|6|||
156521450|NCT00994682|565003142|FG000|Double Bilnd|Lost to Follow-up|3|||
156521451|NCT00994682|565003143|FG001|Double Bilnd|Lost to Follow-up|3|||
156521452|NCT00994682|565003142|FG000|Double Bilnd|Adverse Event|1|||
156521453|NCT00994682|565003143|FG001|Double Bilnd|Adverse Event|0|||
156521454|NCT00994682|565003142|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
156521455|NCT00994682|565003143|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
156521456|NCT00994682|565003142|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
156521457|NCT00994682|565003143|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
156521458|NCT00994682|565003142|FG000|Pioglitazone Open Label|Physician Decision|6|||
156521459|NCT00994682|565003143|FG001|Pioglitazone Open Label|Physician Decision|1|||
156521460|NCT01323972|565003144|FG000|Overall Study|Withdrawal by Subject|1|||
156521461|NCT01323972|565003145|FG001|Overall Study|Withdrawal by Subject|0|||
156521462|NCT01323972|565003146|FG002|Overall Study|Withdrawal by Subject|1|||
156521463|NCT01323972|565003147|FG003|Overall Study|Withdrawal by Subject|0|||
156521464|NCT01323972|565003144|FG000|Overall Study|Migrated/moved from study area|1|||
156521465|NCT01323972|565003145|FG001|Overall Study|Migrated/moved from study area|2|||
156521466|NCT01323972|565003146|FG002|Overall Study|Migrated/moved from study area|0|||
156521467|NCT01323972|565003147|FG003|Overall Study|Migrated/moved from study area|0|||
156521468|NCT01323972|565003144|FG000|Overall Study|Lost to Follow-up|0|||
156521469|NCT01323972|565003145|FG001|Overall Study|Lost to Follow-up|1|||
156521470|NCT01323972|565003146|FG002|Overall Study|Lost to Follow-up|1|||
156521471|NCT01323972|565003147|FG003|Overall Study|Lost to Follow-up|1|||
156521472|NCT01049217|565003150|FG000|Overall Study|Adverse Event|2|||
156521473|NCT01049217|565003151|FG001|Overall Study|Adverse Event|1|||
156521474|NCT01049217|565003150|FG000|Overall Study|Lack of Efficacy|1|||
156521475|NCT01049217|565003151|FG001|Overall Study|Lack of Efficacy|1|||
156521476|NCT01049217|565003150|FG000|Overall Study|Lost to Follow-up|3|||
156521477|NCT01049217|565003151|FG001|Overall Study|Lost to Follow-up|8|||
156521478|NCT01049217|565003150|FG000|Overall Study|Withdrawal by Subject|4|||
156521479|NCT01049217|565003151|FG001|Overall Study|Withdrawal by Subject|3|||
156521480|NCT01049217|565003150|FG000|Overall Study|Protocol Violation|1|||
156521481|NCT01049217|565003151|FG001|Overall Study|Protocol Violation|3|||
156521482|NCT01049217|565003150|FG000|Overall Study|Pregnancy|1|||
156521483|NCT01049217|565003151|FG001|Overall Study|Pregnancy|0|||
156521484|NCT01049217|565003150|FG000|Overall Study|Study Terminated by Sponsor|43|||
156521485|NCT01049217|565003151|FG001|Overall Study|Study Terminated by Sponsor|43|||
156521486|NCT01049217|565003150|FG000|Overall Study|Other|1|||
156521487|NCT01049217|565003151|FG001|Overall Study|Other|2|||
156521488|NCT01049217|565003150|FG000|Overall Study|Randomized but not Treated|0|||
156521489|NCT01049217|565003151|FG001|Overall Study|Randomized but not Treated|2|||
156864958|NCT05966142|566265385|FG001|Overall Study|Lost to Follow-up|52|||
156864959|NCT05966142|566265384|FG000|Overall Study|Physician Decision|1|||
156864960|NCT05966142|566265385|FG001|Overall Study|Physician Decision|0|||
156864961|NCT05966142|566265384|FG000|Overall Study|Withdrawal by Subject|9|||
156521490|NCT01946438|565003152|FG000|Overall Study|Adverse Event|0|||
156521491|NCT01946438|565003153|FG001|Overall Study|Adverse Event|0|||
156521492|NCT01946438|565003154|FG002|Overall Study|Adverse Event|0|||
156521493|NCT01946438|565003155|FG003|Overall Study|Adverse Event|1|||
156521494|NCT01946438|565003152|FG000|Overall Study|Serious Adverse event|1|||
156521495|NCT01946438|565003153|FG001|Overall Study|Serious Adverse event|0|||
156521496|NCT01946438|565003154|FG002|Overall Study|Serious Adverse event|0|||
156521497|NCT01946438|565003155|FG003|Overall Study|Serious Adverse event|0|||
156521498|NCT01946438|565003152|FG000|Overall Study|Protocol Violation|0|||
156521499|NCT01946438|565003153|FG001|Overall Study|Protocol Violation|0|||
156521500|NCT01946438|565003154|FG002|Overall Study|Protocol Violation|1|||
156521501|NCT01946438|565003155|FG003|Overall Study|Protocol Violation|0|||
156521502|NCT01946438|565003152|FG000|Overall Study|Withdrawal by Subject|1|||
156521503|NCT01946438|565003153|FG001|Overall Study|Withdrawal by Subject|0|||
156521504|NCT01946438|565003154|FG002|Overall Study|Withdrawal by Subject|0|||
156521505|NCT01946438|565003155|FG003|Overall Study|Withdrawal by Subject|0|||
156521506|NCT00589121|565003156|FG000|Overall Study|Protocol Violation|2|||
156521507|NCT00589121|565003157|FG001|Overall Study|Protocol Violation|6|||
156521508|NCT00589121|565003156|FG000|Overall Study|No protocol treatment received|0|||
156521509|NCT00589121|565003157|FG001|Overall Study|No protocol treatment received|1|||
156521510|NCT02412371|565003158|FG000|Overall Study|Withdrawal by Subject|0|||
156521511|NCT02412371|565003159|FG001|Overall Study|Withdrawal by Subject|2|||
156521512|NCT02412371|565003160|FG002|Overall Study|Withdrawal by Subject|0|||
156521513|NCT02412371|565003161|FG003|Overall Study|Withdrawal by Subject|1|||
156521514|NCT02412371|565003162|FG004|Overall Study|Withdrawal by Subject|1|||
156521515|NCT02412371|565003163|FG005|Overall Study|Withdrawal by Subject|0|||
156521516|NCT02412371|565003158|FG000|Overall Study|Sponsor Discontinued Study|1|||
156521517|NCT02412371|565003159|FG001|Overall Study|Sponsor Discontinued Study|4|||
156521518|NCT02412371|565003160|FG002|Overall Study|Sponsor Discontinued Study|6|||
156521519|NCT02412371|565003161|FG003|Overall Study|Sponsor Discontinued Study|4|||
156521520|NCT02412371|565003162|FG004|Overall Study|Sponsor Discontinued Study|5|||
156521521|NCT02412371|565003163|FG005|Overall Study|Sponsor Discontinued Study|0|||
156521522|NCT02412371|565003158|FG000|Overall Study|Death|4|||
156521523|NCT02412371|565003159|FG001|Overall Study|Death|2|||
156521524|NCT02412371|565003160|FG002|Overall Study|Death|1|||
156521525|NCT02412371|565003161|FG003|Overall Study|Death|3|||
156521526|NCT02412371|565003162|FG004|Overall Study|Death|5|||
156521527|NCT02412371|565003163|FG005|Overall Study|Death|2|||
156521528|NCT02412371|565003158|FG000|Overall Study|Other|2|||
156521529|NCT02412371|565003159|FG001|Overall Study|Other|1|||
156521530|NCT02412371|565003160|FG002|Overall Study|Other|0|||
156521531|NCT02412371|565003161|FG003|Overall Study|Other|0|||
156521532|NCT02412371|565003162|FG004|Overall Study|Other|1|||
156521533|NCT02412371|565003163|FG005|Overall Study|Other|3|||
156521534|NCT00847808|565003164|FG000|Overall Study|Adverse Event|7|||
156521535|NCT00847808|565003164|FG000|Overall Study|Protocol Violation|1|||
156521536|NCT00847808|565003164|FG000|Overall Study|Lost to Follow-up|1|||
156521537|NCT00847808|565003164|FG000|Overall Study|Withdrawal by Subject|4|||
156521538|NCT00847808|565003164|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
156521539|NCT00847808|565003164|FG000|Overall Study|Participant Took Excluded Medication|1|||
156521540|NCT05000931|565003173|FG000|Overall Study|Lost to Follow-up|1|||
156521541|NCT00925132|565003174|FG000|Overall Study|Withdrawal by Subject|2|||
156521542|NCT00925132|565003175|FG001|Overall Study|Withdrawal by Subject|0|||
156521543|NCT00925132|565003176|FG002|Overall Study|Withdrawal by Subject|0|||
156521544|NCT00925132|565003177|FG003|Overall Study|Withdrawal by Subject|0|||
156521545|NCT00925132|565003178|FG004|Overall Study|Withdrawal by Subject|1|||
156521546|NCT00925132|565003174|FG000|Overall Study|Removed due to disease progression|0|||
156521547|NCT00925132|565003175|FG001|Overall Study|Removed due to disease progression|0|||
156521548|NCT00925132|565003176|FG002|Overall Study|Removed due to disease progression|0|||
156521549|NCT00925132|565003177|FG003|Overall Study|Removed due to disease progression|0|||
156521550|NCT00925132|565003178|FG004|Overall Study|Removed due to disease progression|4|||
156521551|NCT02545933|565003179|FG000|Overall Study|Adverse Event|3|||
156521552|NCT02545933|565003180|FG001|Overall Study|Adverse Event|0|||
156521553|NCT02545933|565003181|FG002|Overall Study|Adverse Event|0|||
156521554|NCT02545933|565003179|FG000|Overall Study|Withdrawal by Subject|2|||
156521555|NCT02545933|565003180|FG001|Overall Study|Withdrawal by Subject|3|||
156521556|NCT02545933|565003181|FG002|Overall Study|Withdrawal by Subject|3|||
156521557|NCT02545933|565003179|FG000|Overall Study|Protocol Violation|1|||
156521558|NCT02545933|565003180|FG001|Overall Study|Protocol Violation|0|||
156521559|NCT02545933|565003181|FG002|Overall Study|Protocol Violation|1|||
156521560|NCT03149549|565003182|FG000|Study Discontinuation--Treatment Period|Death|0|||
156521561|NCT03149549|565003183|FG001|Study Discontinuation--Treatment Period|Death|0|||
156521562|NCT03149549|565003184|FG002|Study Discontinuation--Treatment Period|Death|0|||
156521563|NCT03149549|565003185|FG003|Study Discontinuation--Treatment Period|Death|1|||
156521564|NCT03149549|565003186|FG004|Study Discontinuation--Treatment Period|Death|2|||
156521565|NCT03149549|565003187|FG005|Study Discontinuation--Treatment Period|Death|1|||
156636102|NCT01432600|565412235|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
156521566|NCT03149549|565003188|FG006|Study Discontinuation--Treatment Period|Death|1|||
156521567|NCT03149549|565003189|FG007|Study Discontinuation--Treatment Period|Death|2|||
156521568|NCT03149549|565003190|FG008|Study Discontinuation--Treatment Period|Death|4|||
156521569|NCT03149549|565003191|FG009|Study Discontinuation--Treatment Period|Death|1|||
156521570|NCT03149549|565003192|FG010|Study Discontinuation--Treatment Period|Death|0|||
156521571|NCT03149549|565003193|FG011|Study Discontinuation--Treatment Period|Death|0|||
156521572|NCT03149549|565003194|FG012|Study Discontinuation--Treatment Period|Death|1|||
156521573|NCT03149549|565003182|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521574|NCT03149549|565003183|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521575|NCT03149549|565003184|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521576|NCT03149549|565003185|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521577|NCT03149549|565003186|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521578|NCT03149549|565003187|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521579|NCT03149549|565003188|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521580|NCT03149549|565003189|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
156521581|NCT03149549|565003190|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521582|NCT03149549|565003191|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521583|NCT03149549|565003192|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521584|NCT03149549|565003193|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
156521585|NCT03149549|565003194|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
156521586|NCT03149549|565003182|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
156521587|NCT03149549|565003183|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
156521588|NCT03149549|565003184|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
156521589|NCT03149549|565003185|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
156521590|NCT03149549|565003186|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
156521591|NCT03149549|565003187|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
156521592|NCT03149549|565003188|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
156521593|NCT03149549|565003189|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
156521594|NCT03149549|565003190|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
156521595|NCT03149549|565003191|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
156521596|NCT03149549|565003192|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
156521597|NCT03149549|565003193|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
156521598|NCT03149549|565003194|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
156521599|NCT03149549|565003182|FG000|Study Discontinuation--Treatment Period|Other|0|||
156521600|NCT03149549|565003183|FG001|Study Discontinuation--Treatment Period|Other|0|||
156521601|NCT03149549|565003184|FG002|Study Discontinuation--Treatment Period|Other|0|||
156521602|NCT03149549|565003185|FG003|Study Discontinuation--Treatment Period|Other|0|||
156521603|NCT03149549|565003186|FG004|Study Discontinuation--Treatment Period|Other|0|||
156521604|NCT03149549|565003187|FG005|Study Discontinuation--Treatment Period|Other|0|||
156521605|NCT03149549|565003188|FG006|Study Discontinuation--Treatment Period|Other|0|||
156521606|NCT03149549|565003189|FG007|Study Discontinuation--Treatment Period|Other|1|||
156521607|NCT03149549|565003190|FG008|Study Discontinuation--Treatment Period|Other|0|||
156521608|NCT03149549|565003191|FG009|Study Discontinuation--Treatment Period|Other|1|||
156521609|NCT03149549|565003192|FG010|Study Discontinuation--Treatment Period|Other|0|||
156521610|NCT03149549|565003193|FG011|Study Discontinuation--Treatment Period|Other|0|||
156521611|NCT03149549|565003194|FG012|Study Discontinuation--Treatment Period|Other|0|||
156521612|NCT03149549|565003182|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521613|NCT03149549|565003183|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521614|NCT03149549|565003184|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521615|NCT03149549|565003185|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521616|NCT03149549|565003186|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521617|NCT03149549|565003187|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
156521618|NCT03149549|565003188|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
156521619|NCT03149549|565003189|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521620|NCT03149549|565003190|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
156521621|NCT03149549|565003191|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521622|NCT03149549|565003192|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521623|NCT03149549|565003193|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521624|NCT03149549|565003194|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
156521625|NCT03149549|565003182|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
156521626|NCT03149549|565003183|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
156521627|NCT03149549|565003184|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
156521628|NCT03149549|565003185|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
156521629|NCT03149549|565003186|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
156636103|NCT01432600|565412236|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
156521630|NCT03149549|565003187|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
156521631|NCT03149549|565003188|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
156521632|NCT03149549|565003189|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
156521633|NCT03149549|565003190|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
156521634|NCT03149549|565003191|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
156521635|NCT03149549|565003192|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
156521636|NCT03149549|565003193|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
156521637|NCT03149549|565003194|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
156521638|NCT03149549|565003182|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
156521639|NCT03149549|565003183|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
156521640|NCT03149549|565003184|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
156521641|NCT03149549|565003185|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
156521642|NCT03149549|565003186|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
156521643|NCT03149549|565003187|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
156521644|NCT03149549|565003188|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
156521645|NCT03149549|565003189|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
156521646|NCT03149549|565003190|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
156521647|NCT03149549|565003191|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
156521648|NCT03149549|565003192|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
156521649|NCT03149549|565003193|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
156521650|NCT03149549|565003194|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
156521651|NCT03149549|565003182|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
156521652|NCT03149549|565003183|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
156521653|NCT03149549|565003184|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
156521654|NCT03149549|565003185|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
156521655|NCT03149549|565003186|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
156521656|NCT03149549|565003187|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
156521657|NCT03149549|565003188|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
156521658|NCT03149549|565003189|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
156521659|NCT03149549|565003190|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
156521660|NCT03149549|565003191|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
156521661|NCT03149549|565003192|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
156521662|NCT03149549|565003193|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
156521663|NCT03149549|565003194|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
156521664|NCT03149549|565003182|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
156521665|NCT03149549|565003183|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
156521666|NCT03149549|565003184|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
156521667|NCT03149549|565003185|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
156521668|NCT03149549|565003186|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
156521669|NCT03149549|565003187|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
156521670|NCT03149549|565003188|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
156521671|NCT03149549|565003189|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
156521672|NCT03149549|565003190|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
156521673|NCT03149549|565003191|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
156521674|NCT03149549|565003192|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
156521675|NCT03149549|565003193|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
156521676|NCT03149549|565003194|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
156521677|NCT01892540|565003195|FG000|Overall Study|Did not complete PET/MRI|0|||
156521678|NCT01892540|565003196|FG001|Overall Study|Did not complete PET/MRI|0|||
156521679|NCT01892540|565003197|FG002|Overall Study|Did not complete PET/MRI|2|||
156521680|NCT01892540|565003195|FG000|Overall Study|Did not fit in scanner|0|||
156521681|NCT01892540|565003196|FG001|Overall Study|Did not fit in scanner|0|||
156521682|NCT01892540|565003197|FG002|Overall Study|Did not fit in scanner|1|||
156521683|NCT01370590|565003198|FG000|Period 1|Adverse Event|8|||
156521684|NCT01370590|565003199|FG001|Period 1|Adverse Event|4|||
156521685|NCT01370590|565003198|FG000|Period 1|Lost to Follow-up|2|||
156521686|NCT01370590|565003199|FG001|Period 1|Lost to Follow-up|2|||
156521687|NCT01370590|565003198|FG000|Period 1|Protocol Violation|2|||
156521688|NCT01370590|565003199|FG001|Period 1|Protocol Violation|2|||
156521689|NCT01370590|565003198|FG000|Period 1|Withdrawal by Subject|4|||
156521690|NCT01370590|565003199|FG001|Period 1|Withdrawal by Subject|2|||
156521691|NCT01370590|565003198|FG000|Period 1|Could not access randomization system|0|||
156521692|NCT01370590|565003199|FG001|Period 1|Could not access randomization system|1|||
156521693|NCT01370590|565003198|FG000|Crossover Washout Period|Adverse Event|1|||
156521694|NCT01370590|565003199|FG001|Crossover Washout Period|Adverse Event|4|||
156521695|NCT01370590|565003198|FG000|Crossover Washout Period|Lost to Follow-up|2|||
156521696|NCT01370590|565003199|FG001|Crossover Washout Period|Lost to Follow-up|0|||
156521697|NCT01370590|565003198|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
156521698|NCT01370590|565003199|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
156521699|NCT01370590|565003198|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
156521700|NCT01370590|565003199|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
156521701|NCT01370590|565003198|FG000|Period 2|Adverse Event|0|||
156521702|NCT01370590|565003199|FG001|Period 2|Adverse Event|1|||
156521703|NCT01370590|565003198|FG000|Period 2|Withdrawal by Subject|1|||
156521704|NCT01370590|565003199|FG001|Period 2|Withdrawal by Subject|1|||
156521705|NCT04617275|565003203|FG000|Treatment Period|Adverse Event|1|||
156521706|NCT04617275|565003204|FG001|Treatment Period|Adverse Event|6|||
156521707|NCT04617275|565003205|FG002|Treatment Period|Adverse Event|4|||
156521708|NCT04617275|565003206|FG003|Treatment Period|Adverse Event|6|||
156521709|NCT04617275|565003207|FG004|Treatment Period|Adverse Event|7|||
156521710|NCT04617275|565003208|FG005|Treatment Period|Adverse Event|8|||
156521711|NCT04617275|565003209|FG006|Treatment Period|Adverse Event|0|||
156521712|NCT04617275|565003210|FG007|Treatment Period|Adverse Event|12|||
156521713|NCT04617275|565003203|FG000|Treatment Period|Lost to Follow-up|0|||
156521714|NCT04617275|565003204|FG001|Treatment Period|Lost to Follow-up|0|||
156521715|NCT04617275|565003205|FG002|Treatment Period|Lost to Follow-up|2|||
156521716|NCT04617275|565003206|FG003|Treatment Period|Lost to Follow-up|0|||
156521717|NCT04617275|565003207|FG004|Treatment Period|Lost to Follow-up|0|||
156521718|NCT04617275|565003208|FG005|Treatment Period|Lost to Follow-up|3|||
156521719|NCT04617275|565003209|FG006|Treatment Period|Lost to Follow-up|0|||
156521720|NCT04617275|565003210|FG007|Treatment Period|Lost to Follow-up|2|||
156521721|NCT04617275|565003203|FG000|Treatment Period|No longer meets eligibility criteria|0|||
156521722|NCT04617275|565003204|FG001|Treatment Period|No longer meets eligibility criteria|0|||
156521723|NCT04617275|565003205|FG002|Treatment Period|No longer meets eligibility criteria|0|||
156521724|NCT04617275|565003206|FG003|Treatment Period|No longer meets eligibility criteria|1|||
156521725|NCT04617275|565003207|FG004|Treatment Period|No longer meets eligibility criteria|0|||
156521726|NCT04617275|565003208|FG005|Treatment Period|No longer meets eligibility criteria|0|||
156521727|NCT04617275|565003209|FG006|Treatment Period|No longer meets eligibility criteria|0|||
156521728|NCT04617275|565003210|FG007|Treatment Period|No longer meets eligibility criteria|0|||
156521729|NCT04617275|565003203|FG000|Treatment Period|Other|0|||
156521730|NCT04617275|565003204|FG001|Treatment Period|Other|1|||
156521731|NCT04617275|565003205|FG002|Treatment Period|Other|0|||
156521732|NCT04617275|565003206|FG003|Treatment Period|Other|0|||
156521733|NCT04617275|565003207|FG004|Treatment Period|Other|0|||
156521734|NCT04617275|565003208|FG005|Treatment Period|Other|0|||
156521735|NCT04617275|565003209|FG006|Treatment Period|Other|0|||
156521736|NCT04617275|565003210|FG007|Treatment Period|Other|0|||
156521737|NCT04617275|565003203|FG000|Treatment Period|Withdrawal by Subject|2|||
156521738|NCT04617275|565003204|FG001|Treatment Period|Withdrawal by Subject|0|||
156521739|NCT04617275|565003205|FG002|Treatment Period|Withdrawal by Subject|0|||
156521740|NCT04617275|565003206|FG003|Treatment Period|Withdrawal by Subject|2|||
156521741|NCT04617275|565003207|FG004|Treatment Period|Withdrawal by Subject|2|||
156521742|NCT04617275|565003208|FG005|Treatment Period|Withdrawal by Subject|0|||
156521743|NCT04617275|565003209|FG006|Treatment Period|Withdrawal by Subject|1|||
156521744|NCT04617275|565003210|FG007|Treatment Period|Withdrawal by Subject|2|||
156521745|NCT04617275|565003203|FG000|Follow-up Period|Adverse Event|1|||
156521746|NCT04617275|565003204|FG001|Follow-up Period|Adverse Event|1|||
156521747|NCT04617275|565003205|FG002|Follow-up Period|Adverse Event|2|||
156521748|NCT04617275|565003206|FG003|Follow-up Period|Adverse Event|3|||
156521749|NCT04617275|565003207|FG004|Follow-up Period|Adverse Event|4|||
156521750|NCT04617275|565003208|FG005|Follow-up Period|Adverse Event|3|||
156521751|NCT04617275|565003209|FG006|Follow-up Period|Adverse Event|0|||
156521752|NCT04617275|565003210|FG007|Follow-up Period|Adverse Event|3|||
156521753|NCT04617275|565003203|FG000|Follow-up Period|Lost to Follow-up|0|||
156636104|NCT01432600|565412237|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
156636105|NCT00398632|565412238|FG000|Overall Study|Withdrawal by Subject|1|||
156636106|NCT00398632|565412238|FG000|Overall Study|Lack of Efficacy|1|||
156636107|NCT00640614|565412242|FG000|Overall Study|Lost to Follow-up|1|||
156636108|NCT00640614|565412243|FG001|Overall Study|Lost to Follow-up|0|||
156636109|NCT00529802|565412244|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
156636110|NCT00529802|565412244|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
156636111|NCT00529802|565412244|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
156636112|NCT00529802|565412244|FG000|Evaluable for Primary Endpoint|Death|1|||
156636113|NCT00529802|565412244|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
156636114|NCT00529802|565412244|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
156636115|NCT00529802|565412244|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
156636116|NCT00366678|565412250|FG000|Infant Series|Withdrawal by Subject|8|||
156636117|NCT00366678|565412251|FG001|Infant Series|Withdrawal by Subject|6|||
156636118|NCT00366678|565412252|FG002|Infant Series|Withdrawal by Subject|0|||
156636119|NCT00366678|565412250|FG000|Infant Series|Protocol Violation|4|||
156636120|NCT00366678|565412251|FG001|Infant Series|Protocol Violation|3|||
156636121|NCT00366678|565412252|FG002|Infant Series|Protocol Violation|0|||
156636122|NCT00366678|565412250|FG000|Infant Series|Failed to return|1|||
156521754|NCT04617275|565003204|FG001|Follow-up Period|Lost to Follow-up|1|||
156521755|NCT04617275|565003205|FG002|Follow-up Period|Lost to Follow-up|2|||
156521756|NCT04617275|565003206|FG003|Follow-up Period|Lost to Follow-up|0|||
156521757|NCT04617275|565003207|FG004|Follow-up Period|Lost to Follow-up|0|||
156521758|NCT04617275|565003208|FG005|Follow-up Period|Lost to Follow-up|4|||
156521759|NCT04617275|565003209|FG006|Follow-up Period|Lost to Follow-up|0|||
156521760|NCT04617275|565003210|FG007|Follow-up Period|Lost to Follow-up|3|||
156521761|NCT04617275|565003203|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
156521762|NCT04617275|565003204|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
156521763|NCT04617275|565003205|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
156521764|NCT04617275|565003206|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
156521765|NCT04617275|565003207|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
156521766|NCT04617275|565003208|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
156521767|NCT04617275|565003209|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
156521768|NCT04617275|565003210|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
156521769|NCT04617275|565003203|FG000|Follow-up Period|Other|0|||
156521770|NCT04617275|565003204|FG001|Follow-up Period|Other|1|||
156521771|NCT04617275|565003205|FG002|Follow-up Period|Other|0|||
156521772|NCT04617275|565003206|FG003|Follow-up Period|Other|0|||
156521773|NCT04617275|565003207|FG004|Follow-up Period|Other|0|||
156521774|NCT04617275|565003208|FG005|Follow-up Period|Other|0|||
156521775|NCT04617275|565003209|FG006|Follow-up Period|Other|0|||
156521776|NCT04617275|565003210|FG007|Follow-up Period|Other|0|||
156521777|NCT04617275|565003203|FG000|Follow-up Period|Withdrawal by Subject|2|||
156521778|NCT04617275|565003204|FG001|Follow-up Period|Withdrawal by Subject|0|||
156521779|NCT04617275|565003205|FG002|Follow-up Period|Withdrawal by Subject|0|||
156521780|NCT04617275|565003206|FG003|Follow-up Period|Withdrawal by Subject|2|||
156521781|NCT04617275|565003207|FG004|Follow-up Period|Withdrawal by Subject|2|||
156521782|NCT04617275|565003208|FG005|Follow-up Period|Withdrawal by Subject|0|||
156521783|NCT04617275|565003209|FG006|Follow-up Period|Withdrawal by Subject|1|||
156521784|NCT04617275|565003210|FG007|Follow-up Period|Withdrawal by Subject|2|||
156521785|NCT05195489|565005257|FG000|Overall Study|Lost to Follow-up|1|||
156521786|NCT05195489|565005258|FG001|Overall Study|Lost to Follow-up|0|||
156521787|NCT05195489|565005257|FG000|Overall Study|Protocol Violation|0|||
156521788|NCT05195489|565005258|FG001|Overall Study|Protocol Violation|2|||
156521789|NCT05195489|565005257|FG000|Overall Study|Withdrawal by Subject|1|||
156521790|NCT05195489|565005258|FG001|Overall Study|Withdrawal by Subject|1|||
156521791|NCT05195489|565005257|FG000|Overall Study|Removed|0|||
156521792|NCT05195489|565005258|FG001|Overall Study|Removed|1|||
156521793|NCT01328717|565005267|FG000|Overall Study|Adverse Event|1|||
156521794|NCT00346268|565005268|FG000|Overall Study|Adverse Event|1|||
156521795|NCT00346268|565005269|FG001|Overall Study|Adverse Event|0|||
156521796|NCT00346268|565005268|FG000|Overall Study|Protocol Violation|1|||
156521797|NCT00346268|565005269|FG001|Overall Study|Protocol Violation|0|||
156521798|NCT00346268|565005268|FG000|Overall Study|Participant refused|0|||
156521799|NCT00346268|565005269|FG001|Overall Study|Participant refused|3|||
156521800|NCT00031551|565005270|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
156636123|NCT00366678|565412251|FG001|Infant Series|Failed to return|1|||
156636124|NCT00366678|565412252|FG002|Infant Series|Failed to return|0|||
156636125|NCT00366678|565412250|FG000|Infant Series|Adverse Event|1|||
156636126|NCT00366678|565412251|FG001|Infant Series|Adverse Event|0|||
156636127|NCT00366678|565412252|FG002|Infant Series|Adverse Event|0|||
156636128|NCT00366678|565412250|FG000|After Infant|Withdrawal by Subject|8|||
156636129|NCT00366678|565412251|FG001|After Infant|Withdrawal by Subject|4|||
156636130|NCT00366678|565412252|FG002|After Infant|Withdrawal by Subject|0|||
156636131|NCT00366678|565412250|FG000|After Infant|Lost to Follow-up|2|||
156636132|NCT00366678|565412251|FG001|After Infant|Lost to Follow-up|1|||
156636133|NCT00366678|565412252|FG002|After Infant|Lost to Follow-up|0|||
156636134|NCT00366678|565412250|FG000|After Infant|Failed to return|5|||
156636135|NCT00366678|565412251|FG001|After Infant|Failed to return|5|||
156636136|NCT00366678|565412252|FG002|After Infant|Failed to return|0|||
156636137|NCT00366678|565412250|FG000|After Infant|Adverse Event|1|||
156636138|NCT00366678|565412251|FG001|After Infant|Adverse Event|0|||
156636139|NCT00366678|565412252|FG002|After Infant|Adverse Event|0|||
156636140|NCT00366678|565412250|FG000|After Infant|Protocol Violation|1|||
156636141|NCT00366678|565412251|FG001|After Infant|Protocol Violation|0|||
156636142|NCT00366678|565412252|FG002|After Infant|Protocol Violation|0|||
156636143|NCT00366678|565412250|FG000|Toddler Dose|Protocol Violation|2|||
156636144|NCT00366678|565412251|FG001|Toddler Dose|Protocol Violation|1|||
156636145|NCT00366678|565412252|FG002|Toddler Dose|Protocol Violation|0|||
156636146|NCT00366678|565412250|FG000|Toddler Dose|Failed to return|1|||
156636147|NCT00366678|565412251|FG001|Toddler Dose|Failed to return|0|||
156636148|NCT00366678|565412252|FG002|Toddler Dose|Failed to return|0|||
156636149|NCT00366678|565412250|FG000|Toddler Dose|Withdrawal by Subject|1|||
156636150|NCT00366678|565412251|FG001|Toddler Dose|Withdrawal by Subject|0|||
156636151|NCT00366678|565412252|FG002|Toddler Dose|Withdrawal by Subject|0|||
156636152|NCT00366678|565412250|FG000|Toddler Dose|protocol deviation|1|||
156636153|NCT00366678|565412251|FG001|Toddler Dose|protocol deviation|0|||
156636154|NCT00366678|565412252|FG002|Toddler Dose|protocol deviation|0|||
156636155|NCT04465916|565412262|FG000|Overall Study|Withdrawal by Subject|0|||
156521801|NCT00031551|565005271|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
156521802|NCT02164383|565005272|FG000|Overall Study|Lost to Follow-up|1|||
156521803|NCT02164383|565005273|FG001|Overall Study|Lost to Follow-up|0|||
156521804|NCT01036763|565005274|FG000|Overall Study|Adverse Event|25|||
156521805|NCT01036763|565005274|FG000|Overall Study|Lost to Follow-up|28|||
156521806|NCT01036763|565005274|FG000|Overall Study|Other reason (not specified)|40|||
156521807|NCT00743275|565005275|FG000|Overall Study|Protocol Violation|0|||
156521808|NCT00743275|565005276|FG001|Overall Study|Protocol Violation|1|||
156521809|NCT01672723|565005277|FG000|First Intervention|Adverse Event|3|||
156521810|NCT01672723|565005278|FG001|First Intervention|Adverse Event|0|||
156521811|NCT00484289|565005289|FG000|Long Term Phase|Adverse Event|1|||
156521812|NCT00484289|565005290|FG001|Long Term Phase|Adverse Event|17|||
156521813|NCT00484289|565005291|FG002|Long Term Phase|Adverse Event|5|||
156521814|NCT00484289|565005289|FG000|Long Term Phase|Withdrawal by Subject|0|||
156521815|NCT00484289|565005290|FG001|Long Term Phase|Withdrawal by Subject|7|||
156521816|NCT00484289|565005291|FG002|Long Term Phase|Withdrawal by Subject|6|||
156521817|NCT00484289|565005289|FG000|Long Term Phase|Inadequate response|2|||
156521818|NCT00484289|565005290|FG001|Long Term Phase|Inadequate response|7|||
156521819|NCT00484289|565005291|FG002|Long Term Phase|Inadequate response|4|||
156521820|NCT00484289|565005289|FG000|Long Term Phase|Other Reason|0|||
156521821|NCT00484289|565005290|FG001|Long Term Phase|Other Reason|5|||
156521822|NCT00484289|565005291|FG002|Long Term Phase|Other Reason|1|||
156521823|NCT00484289|565005289|FG000|Post Marketing Phase|Adverse Event|0|||
156521824|NCT00484289|565005290|FG001|Post Marketing Phase|Adverse Event|1|||
156521825|NCT00484289|565005291|FG002|Post Marketing Phase|Adverse Event|0|||
156521826|NCT00262951|565005292|FG000|Overall Study|Progressive disease/relapse|3|||
156521827|NCT00262951|565005292|FG000|Overall Study|Adverse Event|7|||
156521828|NCT00262951|565005292|FG000|Overall Study|Death|1|||
156521829|NCT00262951|565005292|FG000|Overall Study|Withdrawal by Subject|1|||
156521830|NCT00262951|565005292|FG000|Overall Study|Alternative treatment|3|||
156521831|NCT00262951|565005292|FG000|Overall Study|Off treatment for other disease|1|||
156521832|NCT01778023|565005293|FG000|Overall Study|Withdrawal by Subject|0|||
156521833|NCT01778023|565005294|FG001|Overall Study|Withdrawal by Subject|3|||
156521834|NCT01602562|565005295|FG000|Overall Study|Adverse Event|3|||
156521835|NCT01602562|565005296|FG001|Overall Study|Adverse Event|1|||
156521836|NCT01602562|565005295|FG000|Overall Study|Physician Decision|1|||
156521837|NCT01602562|565005296|FG001|Overall Study|Physician Decision|1|||
156521838|NCT01602562|565005295|FG000|Overall Study|Withdrawal by Subject|1|||
156521839|NCT01602562|565005296|FG001|Overall Study|Withdrawal by Subject|1|||
156521840|NCT00577577|565005299|FG000|Overall Study|Adverse Event|3|||
156521841|NCT00577577|565005300|FG001|Overall Study|Adverse Event|2|||
156521842|NCT00577577|565005299|FG000|Overall Study|Lost to Follow-up|1|||
156521843|NCT00577577|565005300|FG001|Overall Study|Lost to Follow-up|0|||
156521844|NCT00577577|565005299|FG000|Overall Study|Protocol Violation|0|||
156521845|NCT00577577|565005300|FG001|Overall Study|Protocol Violation|3|||
156521846|NCT00577577|565005299|FG000|Overall Study|Transportation|1|||
156521847|NCT00577577|565005300|FG001|Overall Study|Transportation|0|||
156521848|NCT00232544|565005301|FG000|Overall Study|Lost to Follow-up|20|||
156521849|NCT00232544|565005302|FG001|Overall Study|Lost to Follow-up|15|||
156521850|NCT00116753|565005303|FG000|Overall Study|Adverse Event|16|||
156521851|NCT00116753|565005304|FG001|Overall Study|Adverse Event|10|||
156521852|NCT00116753|565005305|FG002|Overall Study|Adverse Event|7|||
156521853|NCT00116753|565005303|FG000|Overall Study|Withdrawal by Subject|11|||
156521854|NCT00116753|565005304|FG001|Overall Study|Withdrawal by Subject|12|||
156521855|NCT00116753|565005305|FG002|Overall Study|Withdrawal by Subject|8|||
156521856|NCT00116753|565005303|FG000|Overall Study|Lost to Follow-up|0|||
156521857|NCT00116753|565005304|FG001|Overall Study|Lost to Follow-up|2|||
156521858|NCT00116753|565005305|FG002|Overall Study|Lost to Follow-up|1|||
156521859|NCT00116753|565005303|FG000|Overall Study|Protocol Violation|0|||
156521860|NCT00116753|565005304|FG001|Overall Study|Protocol Violation|0|||
156521861|NCT00116753|565005305|FG002|Overall Study|Protocol Violation|1|||
156521862|NCT00116753|565005303|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
156521863|NCT00116753|565005304|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
156521864|NCT00116753|565005305|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
156521865|NCT00116753|565005303|FG000|Overall Study|Disease Progression|3|||
156521866|NCT00116753|565005304|FG001|Overall Study|Disease Progression|4|||
156521867|NCT00116753|565005305|FG002|Overall Study|Disease Progression|3|||
156521868|NCT00116753|565005303|FG000|Overall Study|Abnormal Echocardiogram|0|||
156521869|NCT00116753|565005304|FG001|Overall Study|Abnormal Echocardiogram|0|||
156521870|NCT00116753|565005305|FG002|Overall Study|Abnormal Echocardiogram|1|||
156636156|NCT04465916|565412263|FG001|Overall Study|Withdrawal by Subject|1|||
156636157|NCT00826176|565412270|FG000|Overall Study|Lost to Follow-up|1|||
156636158|NCT00826176|565412271|FG001|Overall Study|Lost to Follow-up|0|||
156521871|NCT00116753|565005303|FG000|Overall Study|Progressive Parkinson's Disease|1|||
156521872|NCT00116753|565005304|FG001|Overall Study|Progressive Parkinson's Disease|0|||
156521873|NCT00116753|565005305|FG002|Overall Study|Progressive Parkinson's Disease|0|||
156521874|NCT00116753|565005303|FG000|Overall Study|Dosing Error|0|||
156521875|NCT00116753|565005304|FG001|Overall Study|Dosing Error|1|||
156521876|NCT00116753|565005305|FG002|Overall Study|Dosing Error|0|||
156521877|NCT01200589|565005306|FG000|Overall Study|Withdrawal by Subject|13|||
156521878|NCT01200589|565005307|FG001|Overall Study|Withdrawal by Subject|11|||
156521879|NCT01200589|565005306|FG000|Overall Study|Physician Decision|2|||
156521880|NCT01200589|565005307|FG001|Overall Study|Physician Decision|2|||
156521881|NCT01200589|565005306|FG000|Overall Study|Lost to Follow-up|5|||
156521882|NCT01200589|565005307|FG001|Overall Study|Lost to Follow-up|4|||
156521883|NCT01200589|565005306|FG000|Overall Study|Study terminated|170|||
156521884|NCT01200589|565005307|FG001|Overall Study|Study terminated|172|||
156521885|NCT00986973|565005308|FG000|Overall Study|Withdrawn by study team|1|||
156521886|NCT00598273|565005309|FG000|Overall Study|Adverse Event|4|||
156521887|NCT00598273|565005310|FG001|Overall Study|Adverse Event|5|||
156521888|NCT00598273|565005311|FG002|Overall Study|Adverse Event|2|||
156521889|NCT00598273|565005309|FG000|Overall Study|Death|6|||
156521890|NCT00598273|565005310|FG001|Overall Study|Death|12|||
156521891|NCT00598273|565005311|FG002|Overall Study|Death|8|||
156521892|NCT00598273|565005309|FG000|Overall Study|Lost to Follow-up|8|||
156521893|NCT00598273|565005310|FG001|Overall Study|Lost to Follow-up|3|||
156521894|NCT00598273|565005311|FG002|Overall Study|Lost to Follow-up|5|||
156521895|NCT00598273|565005309|FG000|Overall Study|Physician Decision|0|||
156521896|NCT00598273|565005310|FG001|Overall Study|Physician Decision|0|||
156521897|NCT00598273|565005311|FG002|Overall Study|Physician Decision|1|||
156521898|NCT00598273|565005309|FG000|Overall Study|Withdrawal by Subject|12|||
156521899|NCT00598273|565005310|FG001|Overall Study|Withdrawal by Subject|10|||
156521900|NCT00598273|565005311|FG002|Overall Study|Withdrawal by Subject|10|||
156521901|NCT00598273|565005309|FG000|Overall Study|Noncompliance|3|||
156521902|NCT00598273|565005310|FG001|Overall Study|Noncompliance|2|||
156521903|NCT00598273|565005311|FG002|Overall Study|Noncompliance|3|||
156521904|NCT00598273|565005309|FG000|Overall Study|Relocation|0|||
156521905|NCT00598273|565005310|FG001|Overall Study|Relocation|2|||
156521906|NCT00598273|565005311|FG002|Overall Study|Relocation|4|||
156521907|NCT00598273|565005309|FG000|Overall Study|Renal transplant|1|||
156521908|NCT00598273|565005310|FG001|Overall Study|Renal transplant|0|||
156521909|NCT00598273|565005311|FG002|Overall Study|Renal transplant|1|||
156521910|NCT00598273|565005309|FG000|Overall Study|Site elected to close|1|||
156521911|NCT00598273|565005310|FG001|Overall Study|Site elected to close|0|||
156521912|NCT00598273|565005311|FG002|Overall Study|Site elected to close|0|||
156521913|NCT00598273|565005309|FG000|Overall Study|Started dialysis|6|||
156521914|NCT00598273|565005310|FG001|Overall Study|Started dialysis|4|||
156521915|NCT00598273|565005311|FG002|Overall Study|Started dialysis|5|||
156521916|NCT01590082|565005312|FG000|Overall Study|Withdrawal by Subject|1|||
156521917|NCT01590082|565005313|FG001|Overall Study|Withdrawal by Subject|0|||
156521918|NCT01590082|565005312|FG000|Overall Study|Ineligible|1|||
156521919|NCT01590082|565005313|FG001|Overall Study|Ineligible|0|||
156521920|NCT01210664|565005315|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
156521921|NCT01210664|565005316|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
156521922|NCT01210664|565005317|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
156521923|NCT01210664|565005318|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
156521924|NCT01210664|565005315|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
156521925|NCT01210664|565005316|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
156521926|NCT01210664|565005317|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
156521927|NCT01210664|565005318|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
156521928|NCT01210664|565005315|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
156521929|NCT01210664|565005316|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
156521930|NCT01210664|565005317|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
156521931|NCT01210664|565005318|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
156521932|NCT02891408|565005319|FG000|Overall Study|Lost to Follow-up|0|||
156521933|NCT02891408|565005320|FG001|Overall Study|Lost to Follow-up|0|||
156521934|NCT02891408|565005321|FG002|Overall Study|Lost to Follow-up|1|||
156521935|NCT02891408|565005322|FG003|Overall Study|Lost to Follow-up|0|||
156521936|NCT02891408|565005323|FG004|Overall Study|Lost to Follow-up|0|||
156521937|NCT02891408|565005324|FG005|Overall Study|Lost to Follow-up|0|||
156521938|NCT02891408|565005325|FG006|Overall Study|Lost to Follow-up|0|||
156521939|NCT02549196|565005326|FG000|Overall Study|Protocol Violation|0|||
156521940|NCT02549196|565005327|FG001|Overall Study|Protocol Violation|0|||
156521941|NCT02549196|565005328|FG002|Overall Study|Protocol Violation|0|||
156521942|NCT02549196|565005329|FG003|Overall Study|Protocol Violation|1|||
156521943|NCT02549196|565005326|FG000|Overall Study|Withdrawal by Subject|1|||
156521944|NCT02549196|565005327|FG001|Overall Study|Withdrawal by Subject|0|||
156521945|NCT02549196|565005328|FG002|Overall Study|Withdrawal by Subject|1|||
156521946|NCT02549196|565005329|FG003|Overall Study|Withdrawal by Subject|0|||
156521947|NCT01442779|565005330|FG000|Overall Study|Withdrawal by Subject|3|||
156521948|NCT01442779|565005330|FG000|Overall Study|Death|3|||
156521949|NCT01442779|565005330|FG000|Overall Study|Non-compliance|1|||
156521950|NCT05249829|565005331|FG000|Overall Study|Participant Relocation|0|||
156521951|NCT05249829|565005332|FG001|Overall Study|Participant Relocation|1|||
156521952|NCT05249829|565005333|FG002|Overall Study|Participant Relocation|2|||
156521953|NCT05249829|565005334|FG003|Overall Study|Participant Relocation|2|||
156521954|NCT05249829|565005331|FG000|Overall Study|Withdrawal by Subject|9|||
156521955|NCT05249829|565005332|FG001|Overall Study|Withdrawal by Subject|17|||
156521956|NCT05249829|565005333|FG002|Overall Study|Withdrawal by Subject|40|||
156521957|NCT05249829|565005334|FG003|Overall Study|Withdrawal by Subject|35|||
156521958|NCT05249829|565005331|FG000|Overall Study|Physician Decision|1|||
156521959|NCT05249829|565005332|FG001|Overall Study|Physician Decision|0|||
156521960|NCT05249829|565005333|FG002|Overall Study|Physician Decision|0|||
156521961|NCT05249829|565005334|FG003|Overall Study|Physician Decision|0|||
156521962|NCT05249829|565005331|FG000|Overall Study|Lost to Follow-up|16|||
156521963|NCT05249829|565005332|FG001|Overall Study|Lost to Follow-up|16|||
156521964|NCT05249829|565005333|FG002|Overall Study|Lost to Follow-up|57|||
156521965|NCT05249829|565005334|FG003|Overall Study|Lost to Follow-up|60|||
156521966|NCT05249829|565005331|FG000|Overall Study|Adverse Event|2|||
156521967|NCT05249829|565005332|FG001|Overall Study|Adverse Event|2|||
156521968|NCT05249829|565005333|FG002|Overall Study|Adverse Event|2|||
156521969|NCT05249829|565005334|FG003|Overall Study|Adverse Event|2|||
156521970|NCT05249829|565005331|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
156521971|NCT05249829|565005332|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
156521972|NCT05249829|565005333|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
156521973|NCT05249829|565005334|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
156521974|NCT05249829|565005331|FG000|Overall Study|Protocol Violation|2|||
156521975|NCT05249829|565005332|FG001|Overall Study|Protocol Violation|0|||
156521976|NCT05249829|565005333|FG002|Overall Study|Protocol Violation|5|||
156521977|NCT05249829|565005334|FG003|Overall Study|Protocol Violation|3|||
156521978|NCT05249829|565005331|FG000|Overall Study|Death|0|||
156521979|NCT05249829|565005332|FG001|Overall Study|Death|1|||
156521980|NCT05249829|565005333|FG002|Overall Study|Death|2|||
156521981|NCT05249829|565005334|FG003|Overall Study|Death|4|||
156521982|NCT00196976|565005336|FG000|Primary Study|Migrated from study area|0|||
156521983|NCT00196976|565005337|FG001|Primary Study|Migrated from study area|0|||
156521984|NCT00196976|565005338|FG002|Primary Study|Migrated from study area|0|||
156521985|NCT00196976|565005339|FG003|Primary Study|Migrated from study area|0|||
156521986|NCT00196976|565005340|FG004|Primary Study|Migrated from study area|0|||
156521987|NCT00196976|565005341|FG005|Primary Study|Migrated from study area|0|||
156521988|NCT00196976|565005342|FG006|Primary Study|Migrated from study area|0|||
156521989|NCT00196976|565005343|FG007|Primary Study|Migrated from study area|1|||
156521990|NCT00196976|565005344|FG008|Primary Study|Migrated from study area|0|||
156521991|NCT00196976|565005345|FG009|Primary Study|Migrated from study area|0|||
156521992|NCT00196976|565005346|FG010|Primary Study|Migrated from study area|0|||
156521993|NCT00196976|565005347|FG011|Primary Study|Migrated from study area|0|||
156521994|NCT00196976|565005348|FG012|Primary Study|Migrated from study area|0|||
156521995|NCT00196976|565005349|FG013|Primary Study|Migrated from study area|0|||
156521996|NCT00196976|565005336|FG000|Primary Study|Protocol Violation|0|||
156521997|NCT00196976|565005337|FG001|Primary Study|Protocol Violation|1|||
156521998|NCT00196976|565005338|FG002|Primary Study|Protocol Violation|1|||
156521999|NCT00196976|565005339|FG003|Primary Study|Protocol Violation|0|||
156522000|NCT00196976|565005340|FG004|Primary Study|Protocol Violation|0|||
156522001|NCT00196976|565005341|FG005|Primary Study|Protocol Violation|0|||
156522002|NCT00196976|565005342|FG006|Primary Study|Protocol Violation|0|||
156522003|NCT00196976|565005343|FG007|Primary Study|Protocol Violation|0|||
156522004|NCT00196976|565005344|FG008|Primary Study|Protocol Violation|0|||
156522005|NCT00196976|565005345|FG009|Primary Study|Protocol Violation|0|||
156522006|NCT00196976|565005346|FG010|Primary Study|Protocol Violation|0|||
156522007|NCT00196976|565005347|FG011|Primary Study|Protocol Violation|0|||
156522008|NCT00196976|565005348|FG012|Primary Study|Protocol Violation|0|||
156522009|NCT00196976|565005349|FG013|Primary Study|Protocol Violation|0|||
156522010|NCT00196976|565005336|FG000|Primary Study|Withdrawal by Subject|1|||
156522011|NCT00196976|565005337|FG001|Primary Study|Withdrawal by Subject|0|||
156522012|NCT00196976|565005338|FG002|Primary Study|Withdrawal by Subject|1|||
156522013|NCT00196976|565005339|FG003|Primary Study|Withdrawal by Subject|1|||
156522014|NCT00196976|565005340|FG004|Primary Study|Withdrawal by Subject|2|||
156522015|NCT00196976|565005341|FG005|Primary Study|Withdrawal by Subject|1|||
156522016|NCT00196976|565005342|FG006|Primary Study|Withdrawal by Subject|0|||
156522017|NCT00196976|565005343|FG007|Primary Study|Withdrawal by Subject|0|||
156522018|NCT00196976|565005344|FG008|Primary Study|Withdrawal by Subject|0|||
156522019|NCT00196976|565005345|FG009|Primary Study|Withdrawal by Subject|1|||
156522020|NCT00196976|565005346|FG010|Primary Study|Withdrawal by Subject|0|||
156522021|NCT00196976|565005347|FG011|Primary Study|Withdrawal by Subject|0|||
156522022|NCT00196976|565005348|FG012|Primary Study|Withdrawal by Subject|0|||
156522023|NCT00196976|565005349|FG013|Primary Study|Withdrawal by Subject|0|||
156522024|NCT00196976|565005336|FG000|Primary Study|Lost to Follow-up|0|||
156522025|NCT00196976|565005337|FG001|Primary Study|Lost to Follow-up|0|||
156522026|NCT00196976|565005338|FG002|Primary Study|Lost to Follow-up|0|||
156522027|NCT00196976|565005339|FG003|Primary Study|Lost to Follow-up|0|||
156522028|NCT00196976|565005340|FG004|Primary Study|Lost to Follow-up|1|||
156522029|NCT00196976|565005341|FG005|Primary Study|Lost to Follow-up|1|||
156522030|NCT00196976|565005342|FG006|Primary Study|Lost to Follow-up|0|||
156522031|NCT00196976|565005343|FG007|Primary Study|Lost to Follow-up|2|||
156522032|NCT00196976|565005344|FG008|Primary Study|Lost to Follow-up|0|||
156522033|NCT00196976|565005345|FG009|Primary Study|Lost to Follow-up|0|||
156522034|NCT00196976|565005346|FG010|Primary Study|Lost to Follow-up|0|||
156522035|NCT00196976|565005347|FG011|Primary Study|Lost to Follow-up|0|||
156522036|NCT00196976|565005348|FG012|Primary Study|Lost to Follow-up|0|||
156522037|NCT00196976|565005349|FG013|Primary Study|Lost to Follow-up|0|||
156522038|NCT00196976|565005336|FG000|Primary Study|Other|0|||
156522039|NCT00196976|565005337|FG001|Primary Study|Other|0|||
156522040|NCT00196976|565005338|FG002|Primary Study|Other|2|||
156522041|NCT00196976|565005339|FG003|Primary Study|Other|0|||
156522042|NCT00196976|565005340|FG004|Primary Study|Other|0|||
156522043|NCT00196976|565005341|FG005|Primary Study|Other|0|||
156522044|NCT00196976|565005342|FG006|Primary Study|Other|0|||
156522045|NCT00196976|565005343|FG007|Primary Study|Other|0|||
156522046|NCT00196976|565005344|FG008|Primary Study|Other|0|||
156522047|NCT00196976|565005345|FG009|Primary Study|Other|0|||
156522048|NCT00196976|565005346|FG010|Primary Study|Other|0|||
156522049|NCT00196976|565005347|FG011|Primary Study|Other|0|||
156522050|NCT00196976|565005348|FG012|Primary Study|Other|0|||
156522051|NCT00196976|565005349|FG013|Primary Study|Other|0|||
156522052|NCT00196976|565005336|FG000|Booster Study|Withdrawal by Subject|0|||
156522053|NCT00196976|565005337|FG001|Booster Study|Withdrawal by Subject|0|||
156522054|NCT00196976|565005338|FG002|Booster Study|Withdrawal by Subject|0|||
156522055|NCT00196976|565005339|FG003|Booster Study|Withdrawal by Subject|0|||
156522056|NCT00196976|565005340|FG004|Booster Study|Withdrawal by Subject|0|||
156522057|NCT00196976|565005341|FG005|Booster Study|Withdrawal by Subject|0|||
156522058|NCT00196976|565005342|FG006|Booster Study|Withdrawal by Subject|0|||
156522059|NCT00196976|565005343|FG007|Booster Study|Withdrawal by Subject|0|||
156522060|NCT00196976|565005344|FG008|Booster Study|Withdrawal by Subject|0|||
156522061|NCT00196976|565005345|FG009|Booster Study|Withdrawal by Subject|0|||
156522062|NCT00196976|565005346|FG010|Booster Study|Withdrawal by Subject|1|||
156522063|NCT00196976|565005347|FG011|Booster Study|Withdrawal by Subject|0|||
156522064|NCT00196976|565005348|FG012|Booster Study|Withdrawal by Subject|0|||
156522065|NCT00196976|565005349|FG013|Booster Study|Withdrawal by Subject|0|||
156522066|NCT00196976|565005336|FG000|Booster Study|Lost to Follow-up|0|||
156522067|NCT00196976|565005337|FG001|Booster Study|Lost to Follow-up|0|||
156522068|NCT00196976|565005338|FG002|Booster Study|Lost to Follow-up|0|||
156522069|NCT00196976|565005339|FG003|Booster Study|Lost to Follow-up|0|||
156522070|NCT00196976|565005340|FG004|Booster Study|Lost to Follow-up|0|||
156522071|NCT00196976|565005341|FG005|Booster Study|Lost to Follow-up|0|||
156522072|NCT00196976|565005342|FG006|Booster Study|Lost to Follow-up|0|||
156522073|NCT00196976|565005343|FG007|Booster Study|Lost to Follow-up|0|||
156522074|NCT00196976|565005344|FG008|Booster Study|Lost to Follow-up|0|||
156522075|NCT00196976|565005345|FG009|Booster Study|Lost to Follow-up|0|||
156522076|NCT00196976|565005346|FG010|Booster Study|Lost to Follow-up|1|||
156522077|NCT00196976|565005347|FG011|Booster Study|Lost to Follow-up|2|||
156522078|NCT00196976|565005348|FG012|Booster Study|Lost to Follow-up|0|||
156522079|NCT00196976|565005349|FG013|Booster Study|Lost to Follow-up|0|||
156522080|NCT01535560|565005350|FG000|Overall Study|Adverse Event|12|||
156522081|NCT01535560|565005351|FG001|Overall Study|Adverse Event|7|||
156522082|NCT01535560|565005350|FG000|Overall Study|Lost to Follow-up|1|||
156522083|NCT01535560|565005351|FG001|Overall Study|Lost to Follow-up|3|||
156522084|NCT01535560|565005350|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
156522085|NCT01535560|565005351|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
156522086|NCT01535560|565005350|FG000|Overall Study|Treatment Failure|21|||
156522087|NCT01535560|565005351|FG001|Overall Study|Treatment Failure|83|||
156522088|NCT01535560|565005350|FG000|Overall Study|Other|0|||
156522089|NCT01535560|565005351|FG001|Overall Study|Other|1|||
156522090|NCT01535560|565005350|FG000|Overall Study|Randomized in Error|0|||
156522091|NCT01535560|565005351|FG001|Overall Study|Randomized in Error|1|||
156522092|NCT02009761|565005352|FG000|Overall Study|Adverse Event|4|||
156522093|NCT02842827|565005353|FG000|Overall Study|Adverse Event|0|||
156522094|NCT02842827|565005354|FG001|Overall Study|Adverse Event|1|||
156522095|NCT02842827|565005355|FG002|Overall Study|Adverse Event|0|||
156522096|NCT02842827|565005356|FG003|Overall Study|Adverse Event|1|||
156522097|NCT02842827|565005357|FG004|Overall Study|Adverse Event|0|||
156522098|NCT02842827|565005358|FG005|Overall Study|Adverse Event|1|||
156522099|NCT02842827|565005359|FG006|Overall Study|Adverse Event|0|||
156522100|NCT02842827|565005360|FG007|Overall Study|Adverse Event|0|||
156522101|NCT02842827|565005353|FG000|Overall Study|Death|1|||
156522102|NCT02842827|565005354|FG001|Overall Study|Death|0|||
156522103|NCT02842827|565005355|FG002|Overall Study|Death|2|||
156522104|NCT02842827|565005356|FG003|Overall Study|Death|3|||
156522105|NCT02842827|565005357|FG004|Overall Study|Death|2|||
156522106|NCT02842827|565005358|FG005|Overall Study|Death|1|||
156522107|NCT02842827|565005359|FG006|Overall Study|Death|0|||
156522108|NCT02842827|565005360|FG007|Overall Study|Death|4|||
156522109|NCT02842827|565005353|FG000|Overall Study|Physician Decision|1|||
156522110|NCT02842827|565005354|FG001|Overall Study|Physician Decision|3|||
156522111|NCT02842827|565005355|FG002|Overall Study|Physician Decision|0|||
156522112|NCT02842827|565005356|FG003|Overall Study|Physician Decision|0|||
156522113|NCT02842827|565005357|FG004|Overall Study|Physician Decision|1|||
156522114|NCT02842827|565005358|FG005|Overall Study|Physician Decision|4|||
156522115|NCT02842827|565005359|FG006|Overall Study|Physician Decision|2|||
156522116|NCT02842827|565005360|FG007|Overall Study|Physician Decision|1|||
156522117|NCT02842827|565005353|FG000|Overall Study|Protocol Defined Disease Progression|0|||
156522118|NCT02842827|565005354|FG001|Overall Study|Protocol Defined Disease Progression|0|||
156522119|NCT02842827|565005355|FG002|Overall Study|Protocol Defined Disease Progression|0|||
156522120|NCT02842827|565005356|FG003|Overall Study|Protocol Defined Disease Progression|0|||
156522121|NCT02842827|565005357|FG004|Overall Study|Protocol Defined Disease Progression|0|||
156522122|NCT02842827|565005358|FG005|Overall Study|Protocol Defined Disease Progression|1|||
156522123|NCT02842827|565005359|FG006|Overall Study|Protocol Defined Disease Progression|0|||
156522124|NCT02842827|565005360|FG007|Overall Study|Protocol Defined Disease Progression|0|||
156522125|NCT02842827|565005353|FG000|Overall Study|Participant Withdrawal of Consent|1|||
156522126|NCT02842827|565005354|FG001|Overall Study|Participant Withdrawal of Consent|2|||
156522127|NCT02842827|565005355|FG002|Overall Study|Participant Withdrawal of Consent|2|||
156522128|NCT02842827|565005356|FG003|Overall Study|Participant Withdrawal of Consent|2|||
156522129|NCT02842827|565005357|FG004|Overall Study|Participant Withdrawal of Consent|2|||
156522130|NCT02842827|565005358|FG005|Overall Study|Participant Withdrawal of Consent|1|||
156522131|NCT02842827|565005359|FG006|Overall Study|Participant Withdrawal of Consent|2|||
156522132|NCT02842827|565005360|FG007|Overall Study|Participant Withdrawal of Consent|1|||
156522133|NCT01815138|565005361|FG000|Overall Study|Withdrawal by Subject|0|||
156522134|NCT01815138|565005362|FG001|Overall Study|Withdrawal by Subject|1|||
156522135|NCT01815138|565005361|FG000|Overall Study|Physician Decision|8|||
156522136|NCT01815138|565005362|FG001|Overall Study|Physician Decision|5|||
156522137|NCT00825825|565005363|FG000|First Medication Period (14 Days)|Adverse Event|1|||
156522138|NCT00825825|565005364|FG001|First Medication Period (14 Days)|Adverse Event|0|||
156522139|NCT00825825|565005365|FG002|First Medication Period (14 Days)|Adverse Event|0|||
156522140|NCT00825825|565005366|FG003|First Medication Period (14 Days)|Adverse Event|0|||
156522141|NCT00825825|565005367|FG004|First Medication Period (14 Days)|Adverse Event|0|||
156522142|NCT00825825|565005368|FG005|First Medication Period (14 Days)|Adverse Event|1|||
156522143|NCT00825825|565005363|FG000|First Medication Period (14 Days)|Physician Decision|2|||
156522144|NCT00825825|565005364|FG001|First Medication Period (14 Days)|Physician Decision|0|||
156522145|NCT00825825|565005365|FG002|First Medication Period (14 Days)|Physician Decision|1|||
156522146|NCT00825825|565005366|FG003|First Medication Period (14 Days)|Physician Decision|0|||
156522147|NCT00825825|565005367|FG004|First Medication Period (14 Days)|Physician Decision|0|||
156522148|NCT00825825|565005368|FG005|First Medication Period (14 Days)|Physician Decision|1|||
156522149|NCT00825825|565005363|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
156522150|NCT00825825|565005364|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
156522151|NCT00825825|565005365|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
156522152|NCT00825825|565005366|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
156522153|NCT00825825|565005367|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
156522154|NCT00825825|565005368|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
156522155|NCT00825825|565005363|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
156522156|NCT00825825|565005364|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
156522157|NCT00825825|565005365|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
156522158|NCT00825825|565005366|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
156522159|NCT00825825|565005367|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
156522160|NCT00825825|565005368|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
156522161|NCT00825825|565005363|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
156522162|NCT00825825|565005364|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
156522163|NCT00825825|565005365|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
156522164|NCT00825825|565005366|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
156522165|NCT00825825|565005367|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
156522166|NCT00825825|565005368|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
156522167|NCT00825825|565005363|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
156522168|NCT00825825|565005364|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
156522169|NCT00825825|565005365|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
156522170|NCT00825825|565005366|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
156522171|NCT00825825|565005367|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
156522172|NCT00825825|565005368|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
156522173|NCT00825825|565005363|FG000|Third Medication Period (14 Days)|poor data quality|0|||
156522174|NCT00825825|565005364|FG001|Third Medication Period (14 Days)|poor data quality|1|||
156522175|NCT00825825|565005365|FG002|Third Medication Period (14 Days)|poor data quality|0|||
156522176|NCT00825825|565005366|FG003|Third Medication Period (14 Days)|poor data quality|0|||
156522177|NCT00825825|565005367|FG004|Third Medication Period (14 Days)|poor data quality|0|||
156522178|NCT00825825|565005368|FG005|Third Medication Period (14 Days)|poor data quality|0|||
156522179|NCT02649946|565005374|FG000|Overall Study|Withdrawal by Subject|1|||
156522180|NCT02649946|565005375|FG001|Overall Study|Withdrawal by Subject|1|||
156522181|NCT02649946|565005374|FG000|Overall Study|Death|7|||
156522182|NCT02649946|565005375|FG001|Overall Study|Death|9|||
156522183|NCT02649946|565005374|FG000|Overall Study|Physician Decision|1|||
156522184|NCT02649946|565005375|FG001|Overall Study|Physician Decision|0|||
156522185|NCT02649946|565005374|FG000|Overall Study|Lost to Follow-up|2|||
156522186|NCT02649946|565005375|FG001|Overall Study|Lost to Follow-up|1|||
156522187|NCT02649946|565005374|FG000|Overall Study|Erroneously enrolled|1|||
156522188|NCT02649946|565005375|FG001|Overall Study|Erroneously enrolled|0|||
156522189|NCT02649946|565005374|FG000|Overall Study|Missed 6-month follow-up visit|0|||
156522190|NCT02649946|565005375|FG001|Overall Study|Missed 6-month follow-up visit|4|||
156522191|NCT00950950|565005376|FG000|Overall Study|Adverse Event|1|||
156522192|NCT00950950|565005377|FG001|Overall Study|Adverse Event|0|||
156522193|NCT00950950|565005376|FG000|Overall Study|Withdrawal by Subject|0|||
156522194|NCT00950950|565005377|FG001|Overall Study|Withdrawal by Subject|1|||
156522195|NCT01047293|565005380|FG000|Overall Study|DLT criteria not fulfilled|1|||
156522196|NCT01047293|565005381|FG001|Overall Study|DLT criteria not fulfilled|1|||
156522197|NCT01047293|565005382|FG002|Overall Study|DLT criteria not fulfilled|0|||
156522198|NCT01047293|565005383|FG003|Overall Study|DLT criteria not fulfilled|0|||
156522199|NCT01920854|565005387|FG000|Overall Study|Withdrawal by Subject|1|||
156522200|NCT01920854|565005388|FG001|Overall Study|Withdrawal by Subject|0|||
156522201|NCT01920854|565005389|FG002|Overall Study|Withdrawal by Subject|0|||
156522202|NCT01920854|565005390|FG003|Overall Study|Withdrawal by Subject|0|||
156522203|NCT01920854|565005391|FG004|Overall Study|Withdrawal by Subject|1|||
156522204|NCT01920854|565005392|FG005|Overall Study|Withdrawal by Subject|0|||
156522205|NCT01920854|565005393|FG006|Overall Study|Withdrawal by Subject|1|||
156522206|NCT00757783|565005394|FG000|Overall Study|Adverse Event|0|||
156522207|NCT00757783|565005395|FG001|Overall Study|Adverse Event|2|||
156522208|NCT00757783|565005394|FG000|Overall Study|Lost to Follow-up|1|||
156522209|NCT00757783|565005395|FG001|Overall Study|Lost to Follow-up|1|||
156522210|NCT00757783|565005394|FG000|Overall Study|Protocol Violation|1|||
156522211|NCT00757783|565005395|FG001|Overall Study|Protocol Violation|0|||
156522212|NCT00757783|565005394|FG000|Overall Study|Withdrawal by Subject|2|||
156522213|NCT00757783|565005395|FG001|Overall Study|Withdrawal by Subject|1|||
156522214|NCT00757783|565005394|FG000|Overall Study|Other|1|||
156522215|NCT00757783|565005395|FG001|Overall Study|Other|2|||
156522216|NCT02372136|565005396|FG000|Overall Study|Death|3|||
156522217|NCT02372136|565005397|FG001|Overall Study|Death|1|||
156522218|NCT03265938|565005398|FG000|Overall Study|Withdrawal by Subject|1|||
156522219|NCT03265938|565005398|FG000|Overall Study|Physician Decision|1|||
156522220|NCT03265938|565005398|FG000|Overall Study|friable mass|6|||
156522221|NCT02471833|565005399|FG000|Overall Study|Lost to Follow-up|1|||
156522222|NCT02471833|565005400|FG001|Overall Study|Lost to Follow-up|0|||
156522223|NCT02471833|565005401|FG002|Overall Study|Lost to Follow-up|0|||
156522224|NCT02471833|565005399|FG000|Overall Study|Withdrawal by Subject|2|||
156522225|NCT02471833|565005400|FG001|Overall Study|Withdrawal by Subject|1|||
156522226|NCT02471833|565005401|FG002|Overall Study|Withdrawal by Subject|5|||
156522227|NCT03683823|565005419|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
156522228|NCT03683823|565005420|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
156522229|NCT03683823|565005419|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
156522230|NCT03683823|565005420|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
156522231|NCT03683823|565005419|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
156522232|NCT03683823|565005420|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
156522233|NCT02523599|565005421|FG000|Overall Study|Adverse Event|1|||
156522234|NCT02523599|565005422|FG001|Overall Study|Adverse Event|0|||
156522235|NCT02523599|565005421|FG000|Overall Study|Physician Decision|1|||
156522236|NCT02523599|565005422|FG001|Overall Study|Physician Decision|0|||
156522237|NCT02523599|565005421|FG000|Overall Study|Lost to Follow-up|4|||
156522238|NCT02523599|565005422|FG001|Overall Study|Lost to Follow-up|1|||
156522239|NCT02523599|565005421|FG000|Overall Study|Did not return for Day 30 visit|2|||
156522240|NCT02523599|565005422|FG001|Overall Study|Did not return for Day 30 visit|0|||
156522241|NCT03519971|565005423|FG000|Overall Study|Death|142|||
156522242|NCT03519971|565005424|FG001|Overall Study|Death|69|||
156522243|NCT03519971|565005423|FG000|Overall Study|Lost to Follow-up|0|||
156522244|NCT03519971|565005424|FG001|Overall Study|Lost to Follow-up|1|||
156522245|NCT03519971|565005423|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
156522246|NCT03519971|565005424|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
156522247|NCT03519971|565005423|FG000|Overall Study|Withdrawal by Subject|3|||
156522248|NCT03519971|565005424|FG001|Overall Study|Withdrawal by Subject|2|||
156522249|NCT03519971|565005423|FG000|Overall Study|Other|1|||
156522250|NCT03519971|565005424|FG001|Overall Study|Other|0|||
156522251|NCT03141905|565005425|FG000|Overall Study|Death|3|||
156522252|NCT03141905|565005426|FG001|Overall Study|Death|2|||
156522253|NCT03141905|565005425|FG000|Overall Study|Withdrawal by Subject|1|||
156522254|NCT03141905|565005426|FG001|Overall Study|Withdrawal by Subject|0|||
156522255|NCT03141905|565005425|FG000|Overall Study|Lost to Follow-up|3|||
156522256|NCT03141905|565005426|FG001|Overall Study|Lost to Follow-up|7|||
156522257|NCT03141905|565005425|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
156537816|NCT02490475|565062857|FG001|Period 2: Extension Phase|Refused Treatment|0|||
156522258|NCT03141905|565005426|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
156522259|NCT05180500|565005427|FG000|Overall Study|Adverse Event|1|||
156522260|NCT05180500|565005428|FG001|Overall Study|Adverse Event|0|||
156522261|NCT05180500|565005427|FG000|Overall Study|Withdrawal by Subject|2|||
156522262|NCT05180500|565005428|FG001|Overall Study|Withdrawal by Subject|0|||
156522263|NCT04927884|565005429|FG000|Overall Study|Progressive Disease|2|||
156522264|NCT01775124|565005430|FG000|Core Period|Disease Progression|0|||
156522265|NCT01775124|565005431|FG001|Core Period|Disease Progression|1|||
156522266|NCT01775124|565005430|FG000|Core Period|Physician Decision|1|||
156522267|NCT01775124|565005431|FG001|Core Period|Physician Decision|1|||
156522268|NCT01775124|565005430|FG000|Core Period|Death|0|||
156522269|NCT01775124|565005431|FG001|Core Period|Death|1|||
156522270|NCT01775124|565005430|FG000|Core Period|Administrative problems|1|||
156522271|NCT01775124|565005431|FG001|Core Period|Administrative problems|0|||
156522272|NCT01775124|565005430|FG000|Core Period|Withdrawal by Subject|4|||
156522273|NCT01775124|565005431|FG001|Core Period|Withdrawal by Subject|2|||
156522274|NCT01775124|565005430|FG000|Core Period|Adverse Event|5|||
156522275|NCT01775124|565005431|FG001|Core Period|Adverse Event|5|||
156522276|NCT01775124|565005430|FG000|Extension Period|Adverse Event|3|||
156522277|NCT01775124|565005431|FG001|Extension Period|Adverse Event|2|||
156522278|NCT01775124|565005430|FG000|Extension Period|Physician Decision|0|||
156522279|NCT01775124|565005431|FG001|Extension Period|Physician Decision|2|||
156522280|NCT01775124|565005430|FG000|Extension Period|Administrative problems|0|||
156522281|NCT01775124|565005431|FG001|Extension Period|Administrative problems|1|||
156522282|NCT01775124|565005430|FG000|Extension Period|Lost to Follow-up|0|||
156522283|NCT01775124|565005431|FG001|Extension Period|Lost to Follow-up|1|||
156522284|NCT01775124|565005430|FG000|Extension Period|Withdrawal by Subject|9|||
156522285|NCT01775124|565005431|FG001|Extension Period|Withdrawal by Subject|12|||
156522286|NCT00727311|565005432|FG000|Overall Study|Did not receive drug|316|||
156522287|NCT00727311|565005432|FG000|Overall Study|Missing end of therapy data|205|||
156522288|NCT00727311|565005432|FG000|Overall Study|Adverse Event|58|||
156522289|NCT00727311|565005432|FG000|Overall Study|Lack of Efficacy|242|||
156522290|NCT00727311|565005432|FG000|Overall Study|Lost to Follow-up|73|||
156522291|NCT00727311|565005432|FG000|Overall Study|Withdrawal by Subject|77|||
156522292|NCT00727311|565005432|FG000|Overall Study|Other|97|||
156636159|NCT00826176|565412270|FG000|Overall Study|Subject Withdrew Consent|3|||
156636160|NCT00826176|565412271|FG001|Overall Study|Subject Withdrew Consent|0|||
156636161|NCT00826176|565412270|FG000|Overall Study|Administrative|9|||
156636162|NCT00826176|565412271|FG001|Overall Study|Administrative|0|||
156636163|NCT00740480|565412272|FG000|Overall Study|Adverse Event|1|||
156636164|NCT00740480|565412272|FG000|Overall Study|Physician Decision|1|||
156750535|NCT02757352|565838827|FG009|Follow-Up Period|Adverse Event|0|||
156522293|NCT00727311|565005432|FG000|Overall Study|Multiple reasons|39|||
156522294|NCT03992846|565005433|FG000|Overall Study|Adverse Event|8|||
156522295|NCT03992846|565005434|FG001|Overall Study|Adverse Event|6|||
156522296|NCT03992846|565005435|FG002|Overall Study|Adverse Event|3|||
156522297|NCT03992846|565005433|FG000|Overall Study|Lost to Follow-up|0|||
156522298|NCT03992846|565005434|FG001|Overall Study|Lost to Follow-up|1|||
156522299|NCT03992846|565005435|FG002|Overall Study|Lost to Follow-up|1|||
156522300|NCT03992846|565005433|FG000|Overall Study|Pregnancy|2|||
156522301|NCT03992846|565005434|FG001|Overall Study|Pregnancy|0|||
156522302|NCT03992846|565005435|FG002|Overall Study|Pregnancy|1|||
156522303|NCT03992846|565005433|FG000|Overall Study|Protocol Violation|1|||
156522304|NCT03992846|565005434|FG001|Overall Study|Protocol Violation|2|||
156522305|NCT03992846|565005435|FG002|Overall Study|Protocol Violation|0|||
156522306|NCT03992846|565005433|FG000|Overall Study|Withdrawal by Subject|8|||
156522307|NCT03992846|565005434|FG001|Overall Study|Withdrawal by Subject|10|||
156522308|NCT03992846|565005435|FG002|Overall Study|Withdrawal by Subject|20|||
156522309|NCT03992846|565005433|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
156522310|NCT03992846|565005434|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
156522311|NCT03992846|565005435|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
156537817|NCT02490475|565062858|FG002|Period 2: Extension Phase|Refused Treatment|0|||
156537818|NCT02490475|565062859|FG003|Period 2: Extension Phase|Refused Treatment|1|||
156636165|NCT00568776|565412274|FG000|Overall Study|Adverse Event|8|||
156636166|NCT00568776|565412275|FG001|Overall Study|Adverse Event|8|||
156636167|NCT00568776|565412276|FG002|Overall Study|Adverse Event|10|||
156537819|NCT02490475|565062856|FG000|Period 2: Extension Phase|Adverse Event|0|||
156537820|NCT02490475|565062857|FG001|Period 2: Extension Phase|Adverse Event|0|||
156537821|NCT02490475|565062858|FG002|Period 2: Extension Phase|Adverse Event|1|||
156537822|NCT02490475|565062859|FG003|Period 2: Extension Phase|Adverse Event|0|||
156537823|NCT01195090|565062865|FG000|Overall Study|Adverse Event|1|||
156537824|NCT01195090|565062866|FG001|Overall Study|Adverse Event|2|||
156537825|NCT01195090|565062865|FG000|Overall Study|Lost to Follow-up|2|||
156537826|NCT01195090|565062866|FG001|Overall Study|Lost to Follow-up|2|||
156537827|NCT01195090|565062865|FG000|Overall Study|Protocol Violation|3|||
156537828|NCT01195090|565062866|FG001|Overall Study|Protocol Violation|4|||
156537829|NCT05111041|565062869|FG000|Overall Study|Lost to Follow-up|6|||
156537830|NCT05111041|565062870|FG001|Overall Study|Lost to Follow-up|7|||
156522312|NCT01177722|565007683|FG000|Overall Study|Serious Adverse Event|0|||
156522313|NCT01177722|565007684|FG001|Overall Study|Serious Adverse Event|0|||
156522314|NCT01177722|565007685|FG002|Overall Study|Serious Adverse Event|1|||
156522315|NCT01177722|565007686|FG003|Overall Study|Serious Adverse Event|0|||
156522316|NCT01177722|565007683|FG000|Overall Study|Protocol Violation|0|||
156522317|NCT01177722|565007684|FG001|Overall Study|Protocol Violation|0|||
156522318|NCT01177722|565007685|FG002|Overall Study|Protocol Violation|1|||
156522319|NCT01177722|565007686|FG003|Overall Study|Protocol Violation|0|||
156522320|NCT01177722|565007683|FG000|Overall Study|Lost to Follow-up|3|||
156522321|NCT01177722|565007684|FG001|Overall Study|Lost to Follow-up|4|||
156522322|NCT01177722|565007685|FG002|Overall Study|Lost to Follow-up|3|||
156522323|NCT01177722|565007686|FG003|Overall Study|Lost to Follow-up|1|||
156522324|NCT01177722|565007683|FG000|Overall Study|Withdrawal by Subject|10|||
156522325|NCT01177722|565007684|FG001|Overall Study|Withdrawal by Subject|6|||
156522326|NCT01177722|565007685|FG002|Overall Study|Withdrawal by Subject|4|||
156522327|NCT01177722|565007686|FG003|Overall Study|Withdrawal by Subject|6|||
156522328|NCT02831387|565007687|FG000|Overall Study|Withdrawal by Subject|1|||
156522329|NCT02831387|565007688|FG001|Overall Study|Withdrawal by Subject|1|||
156522330|NCT02831387|565007687|FG000|Overall Study|Discontinued due to stock recovery|0|||
156522331|NCT02831387|565007688|FG001|Overall Study|Discontinued due to stock recovery|1|||
156522332|NCT00192647|565007689|FG000|Overall Study|Death|1|||
156522333|NCT00192647|565007690|FG001|Overall Study|Death|1|||
156522334|NCT00192647|565007689|FG000|Overall Study|Adverse Event|35|||
156522335|NCT00192647|565007690|FG001|Overall Study|Adverse Event|29|||
156522336|NCT00192647|565007689|FG000|Overall Study|Laboratory Test Abnormality|4|||
156522337|NCT00192647|565007690|FG001|Overall Study|Laboratory Test Abnormality|2|||
156522338|NCT00192647|565007689|FG000|Overall Study|Insufficient Therapeutic Response|53|||
156522339|NCT00192647|565007690|FG001|Overall Study|Insufficient Therapeutic Response|83|||
156522340|NCT00192647|565007689|FG000|Overall Study|Entry Criteria Violation|6|||
156522341|NCT00192647|565007690|FG001|Overall Study|Entry Criteria Violation|6|||
156522342|NCT00192647|565007689|FG000|Overall Study|Protocol Violation|3|||
156522343|NCT00192647|565007690|FG001|Overall Study|Protocol Violation|1|||
156522344|NCT00192647|565007689|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
156522345|NCT00192647|565007690|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
156522346|NCT00192647|565007689|FG000|Overall Study|Failure to Return|11|||
156522347|NCT00192647|565007690|FG001|Overall Study|Failure to Return|13|||
156522348|NCT00192647|565007689|FG000|Overall Study|Other/Administrative|5|||
156522349|NCT00192647|565007690|FG001|Overall Study|Other/Administrative|3|||
156522350|NCT01828073|565007691|FG000|Overall Study|Lost to Follow-up|1|||
156522351|NCT01828073|565007692|FG001|Overall Study|Lost to Follow-up|2|||
156522352|NCT03057977|565007700|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
156522353|NCT03057977|565007701|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
156522354|NCT03057977|565007700|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
156522355|NCT03057977|565007701|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
156522356|NCT03057977|565007700|FG000|Discontinuation From Treatment|Protocol Violation|6|||
156522357|NCT03057977|565007701|FG001|Discontinuation From Treatment|Protocol Violation|5|||
156522358|NCT03057977|565007700|FG000|Discontinuation From Treatment|Not treated|4|||
156522359|NCT03057977|565007701|FG001|Discontinuation From Treatment|Not treated|0|||
156522360|NCT03057977|565007700|FG000|Discontinuation From Treatment|Adverse Event|343|||
156522361|NCT03057977|565007701|FG001|Discontinuation From Treatment|Adverse Event|337|||
156522362|NCT03057977|565007700|FG000|Discontinuation From Treatment|Reason Unknown|0|||
156522363|NCT03057977|565007701|FG001|Discontinuation From Treatment|Reason Unknown|1|||
156522364|NCT03057977|565007700|FG000|Discontinuation From Treatment|Personal Reasons|1|||
156522365|NCT03057977|565007701|FG001|Discontinuation From Treatment|Personal Reasons|1|||
156522366|NCT03057977|565007700|FG000|Discontinuation From Treatment|Unblinded medication|1|||
156522367|NCT03057977|565007701|FG001|Discontinuation From Treatment|Unblinded medication|0|||
156522368|NCT03057977|565007700|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
156522369|NCT03057977|565007701|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
156522370|NCT03057977|565007700|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
156522371|NCT03057977|565007701|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
156522372|NCT03057977|565007700|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
156522373|NCT03057977|565007701|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
156522374|NCT03057977|565007700|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
156522375|NCT03057977|565007701|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
156522376|NCT03057977|565007700|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
156522377|NCT03057977|565007701|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
156522378|NCT03057977|565007700|FG000|Discontinuation From Treatment|Not attending study visit|3|||
156522379|NCT03057977|565007701|FG001|Discontinuation From Treatment|Not attending study visit|10|||
156522380|NCT03057977|565007700|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
156522381|NCT03057977|565007701|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
156636168|NCT00568776|565412277|FG003|Overall Study|Adverse Event|8|||
156408314|NCT04537897|564589262|FG006|Overall Study|Other than listed|1|||
156522382|NCT03057977|565007700|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
156522383|NCT03057977|565007701|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
156522384|NCT03057977|565007700|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
156522385|NCT03057977|565007701|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
156522386|NCT03057977|565007700|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
156522387|NCT03057977|565007701|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
156522388|NCT03057977|565007700|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
156522389|NCT03057977|565007701|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
156522390|NCT01201317|565007702|FG000|Overall Study|Withdrawal by Subject|5|||
156522391|NCT01201317|565007703|FG001|Overall Study|Withdrawal by Subject|0|||
156636169|NCT00568776|565412274|FG000|Overall Study|Death|0|||
156636170|NCT00568776|565412275|FG001|Overall Study|Death|1|||
156636171|NCT00568776|565412276|FG002|Overall Study|Death|4|||
156636172|NCT00568776|565412277|FG003|Overall Study|Death|3|||
156636173|NCT00568776|565412274|FG000|Overall Study|Physician Decision|0|||
156636174|NCT00568776|565412275|FG001|Overall Study|Physician Decision|2|||
156636175|NCT00568776|565412276|FG002|Overall Study|Physician Decision|0|||
156636176|NCT00568776|565412277|FG003|Overall Study|Physician Decision|0|||
156636177|NCT00568776|565412274|FG000|Overall Study|Lack of Efficacy|2|||
156636178|NCT00568776|565412275|FG001|Overall Study|Lack of Efficacy|2|||
156636179|NCT00568776|565412276|FG002|Overall Study|Lack of Efficacy|2|||
156636180|NCT00568776|565412277|FG003|Overall Study|Lack of Efficacy|4|||
156636181|NCT00568776|565412274|FG000|Overall Study|Lost to Follow-up|1|||
156636182|NCT00568776|565412275|FG001|Overall Study|Lost to Follow-up|1|||
156636183|NCT00568776|565412276|FG002|Overall Study|Lost to Follow-up|1|||
156636184|NCT00568776|565412277|FG003|Overall Study|Lost to Follow-up|1|||
156636185|NCT00568776|565412274|FG000|Overall Study|Protocol Violation|1|||
156636186|NCT00568776|565412275|FG001|Overall Study|Protocol Violation|0|||
156636187|NCT00568776|565412276|FG002|Overall Study|Protocol Violation|1|||
156636188|NCT00568776|565412277|FG003|Overall Study|Protocol Violation|1|||
156636189|NCT00568776|565412274|FG000|Overall Study|Withdrawal by Subject|13|||
156636190|NCT00568776|565412275|FG001|Overall Study|Withdrawal by Subject|15|||
156636191|NCT00568776|565412276|FG002|Overall Study|Withdrawal by Subject|13|||
156636192|NCT00568776|565412277|FG003|Overall Study|Withdrawal by Subject|7|||
156636193|NCT00568776|565412274|FG000|Overall Study|Loss of Caregiver|0|||
156636194|NCT00568776|565412275|FG001|Overall Study|Loss of Caregiver|2|||
156750536|NCT02757352|565838818|FG000|Follow-Up Period|Lost to Follow-up|0|||
156750537|NCT02757352|565838819|FG001|Follow-Up Period|Lost to Follow-up|0|||
156750538|NCT02757352|565838820|FG002|Follow-Up Period|Lost to Follow-up|0|||
156750539|NCT02757352|565838821|FG003|Follow-Up Period|Lost to Follow-up|0|||
156750540|NCT02757352|565838822|FG004|Follow-Up Period|Lost to Follow-up|0|||
156750541|NCT02757352|565838823|FG005|Follow-Up Period|Lost to Follow-up|0|||
156750542|NCT02757352|565838824|FG006|Follow-Up Period|Lost to Follow-up|0|||
156750543|NCT02757352|565838825|FG007|Follow-Up Period|Lost to Follow-up|0|||
156750544|NCT02757352|565838826|FG008|Follow-Up Period|Lost to Follow-up|1|||
156750545|NCT02757352|565838827|FG009|Follow-Up Period|Lost to Follow-up|0|||
156750546|NCT02757352|565838818|FG000|Follow-Up Period|Lack of Efficacy|0|||
156750547|NCT02757352|565838819|FG001|Follow-Up Period|Lack of Efficacy|0|||
156750548|NCT02757352|565838820|FG002|Follow-Up Period|Lack of Efficacy|0|||
156750549|NCT02757352|565838821|FG003|Follow-Up Period|Lack of Efficacy|0|||
156750550|NCT02757352|565838822|FG004|Follow-Up Period|Lack of Efficacy|0|||
156750551|NCT02757352|565838823|FG005|Follow-Up Period|Lack of Efficacy|0|||
156522392|NCT01201317|565007704|FG002|Overall Study|Withdrawal by Subject|3|||
156522393|NCT01201317|565007702|FG000|Overall Study|Adverse Event|2|||
156522394|NCT01201317|565007703|FG001|Overall Study|Adverse Event|2|||
156522395|NCT01201317|565007704|FG002|Overall Study|Adverse Event|2|||
156522396|NCT01201317|565007702|FG000|Overall Study|Screen failure|1|||
156522397|NCT01201317|565007703|FG001|Overall Study|Screen failure|1|||
156522398|NCT01201317|565007704|FG002|Overall Study|Screen failure|0|||
156522399|NCT01201317|565007702|FG000|Overall Study|Protocol Violation|0|||
156522400|NCT01201317|565007703|FG001|Overall Study|Protocol Violation|1|||
156522401|NCT01201317|565007704|FG002|Overall Study|Protocol Violation|1|||
156522402|NCT01201317|565007702|FG000|Overall Study|Death|0|||
156522403|NCT01201317|565007703|FG001|Overall Study|Death|1|||
156636195|NCT00568776|565412276|FG002|Overall Study|Loss of Caregiver|1|||
156750552|NCT02757352|565838824|FG006|Follow-Up Period|Lack of Efficacy|0|||
156750553|NCT02757352|565838825|FG007|Follow-Up Period|Lack of Efficacy|0|||
156750554|NCT02757352|565838826|FG008|Follow-Up Period|Lack of Efficacy|1|||
156750555|NCT02757352|565838827|FG009|Follow-Up Period|Lack of Efficacy|1|||
156750556|NCT02757352|565838818|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156750557|NCT02757352|565838819|FG001|Follow-Up Period|Withdrawal by Subject|0|||
156636196|NCT00568776|565412277|FG003|Overall Study|Loss of Caregiver|2|||
156750558|NCT02757352|565838820|FG002|Follow-Up Period|Withdrawal by Subject|0|||
156636197|NCT00568776|565412274|FG000|Overall Study|Sponsor Decision|2|||
156636198|NCT00568776|565412275|FG001|Overall Study|Sponsor Decision|2|||
156636199|NCT00568776|565412276|FG002|Overall Study|Sponsor Decision|41|||
156636200|NCT00568776|565412277|FG003|Overall Study|Sponsor Decision|42|||
156636201|NCT00568776|565412274|FG000|Overall Study|Miscellaeneous|3|||
156522404|NCT01201317|565007704|FG002|Overall Study|Death|0|||
156522405|NCT01201317|565007702|FG000|Overall Study|Study-specific withdrawal criteria|0|||
156522406|NCT01201317|565007703|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156522407|NCT01201317|565007704|FG002|Overall Study|Study-specific withdrawal criteria|1|||
156522408|NCT01201317|565007702|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
156522409|NCT01201317|565007703|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
156522410|NCT01201317|565007704|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
156522411|NCT01201317|565007702|FG000|Overall Study|Decrease in renal function|0|||
156522412|NCT01201317|565007703|FG001|Overall Study|Decrease in renal function|1|||
156522413|NCT01201317|565007704|FG002|Overall Study|Decrease in renal function|0|||
156522414|NCT01201317|565007702|FG000|Overall Study|Lack of Efficacy|1|||
156522415|NCT01201317|565007703|FG001|Overall Study|Lack of Efficacy|0|||
156522416|NCT01201317|565007704|FG002|Overall Study|Lack of Efficacy|0|||
156522417|NCT01201317|565007702|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
156522418|NCT01201317|565007703|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
156522419|NCT01201317|565007704|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
156522420|NCT01350336|565007705|FG000|Overall Study|Lost to Follow-up|31|||
156522421|NCT01350336|565007705|FG000|Overall Study|Withdrawal by Subject|14|||
156522422|NCT01350336|565007705|FG000|Overall Study|Physician Decision|8|||
156522423|NCT01350336|565007705|FG000|Overall Study|Death|4|||
156522424|NCT00876928|565007707|FG000|Overall Study|Lost to Follow-up|2|||
156522425|NCT00876928|565007708|FG001|Overall Study|Lost to Follow-up|5|||
156522426|NCT00876928|565007707|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
156522427|NCT00876928|565007708|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
156522428|NCT02795429|565007709|FG000|Overall Study|Adverse Event|1|||
156522429|NCT02795429|565007710|FG001|Overall Study|Adverse Event|2|||
156522430|NCT02795429|565007711|FG002|Overall Study|Adverse Event|1|||
156522431|NCT02795429|565007712|FG003|Overall Study|Adverse Event|2|||
156522432|NCT02795429|565007713|FG004|Overall Study|Adverse Event|1|||
156522433|NCT02795429|565007709|FG000|Overall Study|Death|1|||
156522434|NCT02795429|565007710|FG001|Overall Study|Death|0|||
156522435|NCT02795429|565007711|FG002|Overall Study|Death|1|||
156522436|NCT02795429|565007712|FG003|Overall Study|Death|2|||
156522437|NCT02795429|565007713|FG004|Overall Study|Death|1|||
156750559|NCT02757352|565838821|FG003|Follow-Up Period|Withdrawal by Subject|0|||
156750560|NCT02757352|565838822|FG004|Follow-Up Period|Withdrawal by Subject|0|||
156522438|NCT02795429|565007709|FG000|Overall Study|Physician Decision|0|||
156522439|NCT02795429|565007710|FG001|Overall Study|Physician Decision|0|||
156522440|NCT02795429|565007711|FG002|Overall Study|Physician Decision|2|||
156522441|NCT02795429|565007712|FG003|Overall Study|Physician Decision|1|||
156522442|NCT02795429|565007713|FG004|Overall Study|Physician Decision|5|||
156522443|NCT02795429|565007709|FG000|Overall Study|Progressive disease|3|||
156522444|NCT02795429|565007710|FG001|Overall Study|Progressive disease|7|||
156522445|NCT02795429|565007711|FG002|Overall Study|Progressive disease|6|||
156522446|NCT02795429|565007712|FG003|Overall Study|Progressive disease|26|||
156522447|NCT02795429|565007713|FG004|Overall Study|Progressive disease|20|||
156522448|NCT02795429|565007709|FG000|Overall Study|Subject/guardian decision|1|||
156522449|NCT02795429|565007710|FG001|Overall Study|Subject/guardian decision|1|||
156522450|NCT02795429|565007711|FG002|Overall Study|Subject/guardian decision|1|||
156522451|NCT02795429|565007712|FG003|Overall Study|Subject/guardian decision|1|||
156522452|NCT02795429|565007713|FG004|Overall Study|Subject/guardian decision|3|||
156522453|NCT05220254|565007714|FG000|Overall Study|Withdrawal by Subject|4|||
156522454|NCT05220254|565007714|FG000|Overall Study|Removed due to ineligibility|1|||
156522455|NCT05220254|565007714|FG000|Overall Study|Lost to Follow-up|7|||
156522456|NCT01016977|565007722|FG000|Overall Study|Lost to Follow-up|1|||
156522457|NCT01016977|565007723|FG001|Overall Study|Lost to Follow-up|0|||
156522458|NCT01016977|565007722|FG000|Overall Study|Withdrawal by Subject|2|||
156522459|NCT01016977|565007723|FG001|Overall Study|Withdrawal by Subject|2|||
156522460|NCT02080221|565007724|FG000|Overall Study|Withdrawal by Subject|1|||
156522461|NCT02080221|565007724|FG000|Overall Study|Clinical Progression of Disease|1|||
156522462|NCT03184870|565007730|FG000|Initial Treatment|Death|6|||
156522463|NCT03184870|565007731|FG001|Initial Treatment|Death|6|||
156522464|NCT03184870|565007732|FG002|Initial Treatment|Death|8|||
156522465|NCT03184870|565007733|FG003|Initial Treatment|Death|8|||
156522466|NCT03184870|565007734|FG004|Initial Treatment|Death|6|||
156522467|NCT03184870|565007735|FG005|Initial Treatment|Death|6|||
156522468|NCT03184870|565007736|FG006|Initial Treatment|Death|6|||
156522469|NCT03184870|565007737|FG007|Initial Treatment|Death|7|||
156522470|NCT03184870|565007738|FG008|Initial Treatment|Death|1|||
156522471|NCT03184870|565007739|FG009|Initial Treatment|Death|2|||
156522472|NCT03184870|565007740|FG010|Initial Treatment|Death|26|||
156750561|NCT02757352|565838823|FG005|Follow-Up Period|Withdrawal by Subject|0|||
156522473|NCT03184870|565007741|FG011|Initial Treatment|Death|28|||
156522474|NCT03184870|565007742|FG012|Initial Treatment|Death|10|||
156522475|NCT03184870|565007743|FG013|Initial Treatment|Death|33|||
156522476|NCT03184870|565007744|FG014|Initial Treatment|Death|34|||
156522477|NCT03184870|565007745|FG015|Initial Treatment|Death|26|||
156522478|NCT03184870|565007746|FG016|Initial Treatment|Death|20|||
156522479|NCT03184870|565007747|FG017|Initial Treatment|Death|18|||
156522480|NCT03184870|565007730|FG000|Initial Treatment|Other Reasons|2|||
156750562|NCT02757352|565838824|FG006|Follow-Up Period|Withdrawal by Subject|0|||
156750563|NCT02757352|565838825|FG007|Follow-Up Period|Withdrawal by Subject|1|||
156750564|NCT02757352|565838826|FG008|Follow-Up Period|Withdrawal by Subject|6|||
156750565|NCT02757352|565838827|FG009|Follow-Up Period|Withdrawal by Subject|2|||
156750566|NCT03536663|565838828|FG000|Endexo|Protocol Violation|1|||
156750567|NCT01128400|565838829|FG000|Overall Study|Lost to Follow-up|1|||
156750568|NCT01128400|565838830|FG001|Overall Study|Lost to Follow-up|0|||
156750569|NCT01128400|565838831|FG002|Overall Study|Lost to Follow-up|1|||
156522481|NCT03184870|565007731|FG001|Initial Treatment|Other Reasons|2|||
156522482|NCT03184870|565007732|FG002|Initial Treatment|Other Reasons|0|||
156522483|NCT03184870|565007733|FG003|Initial Treatment|Other Reasons|1|||
156522484|NCT03184870|565007734|FG004|Initial Treatment|Other Reasons|0|||
156522485|NCT03184870|565007735|FG005|Initial Treatment|Other Reasons|0|||
156522486|NCT03184870|565007736|FG006|Initial Treatment|Other Reasons|0|||
156522487|NCT03184870|565007737|FG007|Initial Treatment|Other Reasons|2|||
156522488|NCT03184870|565007738|FG008|Initial Treatment|Other Reasons|0|||
156522489|NCT03184870|565007739|FG009|Initial Treatment|Other Reasons|0|||
156522490|NCT03184870|565007740|FG010|Initial Treatment|Other Reasons|4|||
156522491|NCT03184870|565007741|FG011|Initial Treatment|Other Reasons|2|||
156522492|NCT03184870|565007742|FG012|Initial Treatment|Other Reasons|2|||
156522493|NCT03184870|565007743|FG013|Initial Treatment|Other Reasons|0|||
156522494|NCT03184870|565007744|FG014|Initial Treatment|Other Reasons|0|||
156522495|NCT03184870|565007745|FG015|Initial Treatment|Other Reasons|1|||
156522496|NCT03184870|565007746|FG016|Initial Treatment|Other Reasons|0|||
156522497|NCT03184870|565007747|FG017|Initial Treatment|Other Reasons|2|||
156522498|NCT03184870|565007730|FG000|Initial Treatment|Lost to Follow-up|2|||
156750570|NCT01128400|565838829|FG000|Overall Study|Screening failure|1|||
156750571|NCT01128400|565838830|FG001|Overall Study|Screening failure|0|||
156750572|NCT01128400|565838831|FG002|Overall Study|Screening failure|0|||
156750573|NCT01128400|565838829|FG000|Overall Study|were not invited to participate on taste|0|||
156750574|NCT01128400|565838830|FG001|Overall Study|were not invited to participate on taste|0|||
156750575|NCT01128400|565838831|FG002|Overall Study|were not invited to participate on taste|15|||
156750576|NCT01128400|565838829|FG000|Overall Study|Excluded due to sinus problems|0|||
156750577|NCT01128400|565838830|FG001|Overall Study|Excluded due to sinus problems|1|||
156750578|NCT01128400|565838831|FG002|Overall Study|Excluded due to sinus problems|0|||
156750579|NCT04750278|565838832|FG000|Overall Study|Death|9|||
156750580|NCT04750278|565838833|FG001|Overall Study|Death|10|||
156750581|NCT04750278|565838834|FG002|Overall Study|Death|10|||
156750582|NCT04750278|565838832|FG000|Overall Study|Withdrawal by Subject|4|||
156750583|NCT04750278|565838833|FG001|Overall Study|Withdrawal by Subject|1|||
156750584|NCT04750278|565838834|FG002|Overall Study|Withdrawal by Subject|2|||
156750585|NCT04750278|565838832|FG000|Overall Study|Lost to Follow-up|1|||
156750586|NCT04750278|565838833|FG001|Overall Study|Lost to Follow-up|1|||
156522499|NCT03184870|565007731|FG001|Initial Treatment|Lost to Follow-up|0|||
156750587|NCT04750278|565838834|FG002|Overall Study|Lost to Follow-up|1|||
156750588|NCT04750278|565838832|FG000|Overall Study|Pregnancy|1|||
156750589|NCT04750278|565838833|FG001|Overall Study|Pregnancy|0|||
156750590|NCT04750278|565838834|FG002|Overall Study|Pregnancy|0|||
156750591|NCT04750278|565838832|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
156750592|NCT04750278|565838833|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
156750593|NCT04750278|565838834|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
156750594|NCT04750278|565838832|FG000|Overall Study|Non-compliance|0|||
156750595|NCT04750278|565838833|FG001|Overall Study|Non-compliance|0|||
156750596|NCT04750278|565838834|FG002|Overall Study|Non-compliance|1|||
156750597|NCT04750278|565838832|FG000|Overall Study|Transfer to Outside Facility|0|||
156750598|NCT04750278|565838833|FG001|Overall Study|Transfer to Outside Facility|2|||
156750599|NCT04750278|565838834|FG002|Overall Study|Transfer to Outside Facility|1|||
156522500|NCT03184870|565007732|FG002|Initial Treatment|Lost to Follow-up|0|||
156522501|NCT03184870|565007733|FG003|Initial Treatment|Lost to Follow-up|1|||
156522502|NCT03184870|565007734|FG004|Initial Treatment|Lost to Follow-up|1|||
156522503|NCT03184870|565007735|FG005|Initial Treatment|Lost to Follow-up|1|||
156522504|NCT03184870|565007736|FG006|Initial Treatment|Lost to Follow-up|0|||
156522505|NCT03184870|565007737|FG007|Initial Treatment|Lost to Follow-up|2|||
156522506|NCT03184870|565007738|FG008|Initial Treatment|Lost to Follow-up|0|||
156522507|NCT03184870|565007739|FG009|Initial Treatment|Lost to Follow-up|0|||
156522508|NCT03184870|565007740|FG010|Initial Treatment|Lost to Follow-up|2|||
156522509|NCT03184870|565007741|FG011|Initial Treatment|Lost to Follow-up|0|||
156522510|NCT03184870|565007742|FG012|Initial Treatment|Lost to Follow-up|2|||
156522511|NCT03184870|565007743|FG013|Initial Treatment|Lost to Follow-up|2|||
156522512|NCT03184870|565007744|FG014|Initial Treatment|Lost to Follow-up|0|||
156522513|NCT03184870|565007745|FG015|Initial Treatment|Lost to Follow-up|0|||
156522514|NCT03184870|565007746|FG016|Initial Treatment|Lost to Follow-up|2|||
156522515|NCT03184870|565007747|FG017|Initial Treatment|Lost to Follow-up|2|||
156750600|NCT04750278|565838832|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
156522516|NCT03184870|565007730|FG000|Initial Treatment|Withdrawal by Subject|0|||
156522517|NCT03184870|565007731|FG001|Initial Treatment|Withdrawal by Subject|0|||
156522518|NCT03184870|565007732|FG002|Initial Treatment|Withdrawal by Subject|2|||
156522519|NCT03184870|565007733|FG003|Initial Treatment|Withdrawal by Subject|1|||
156522520|NCT03184870|565007734|FG004|Initial Treatment|Withdrawal by Subject|1|||
156522521|NCT03184870|565007735|FG005|Initial Treatment|Withdrawal by Subject|0|||
156522522|NCT03184870|565007736|FG006|Initial Treatment|Withdrawal by Subject|1|||
156522523|NCT03184870|565007737|FG007|Initial Treatment|Withdrawal by Subject|0|||
156522524|NCT03184870|565007738|FG008|Initial Treatment|Withdrawal by Subject|0|||
156522525|NCT03184870|565007739|FG009|Initial Treatment|Withdrawal by Subject|0|||
156522526|NCT03184870|565007740|FG010|Initial Treatment|Withdrawal by Subject|0|||
156522527|NCT03184870|565007741|FG011|Initial Treatment|Withdrawal by Subject|2|||
156522528|NCT03184870|565007742|FG012|Initial Treatment|Withdrawal by Subject|3|||
156636202|NCT00568776|565412275|FG001|Overall Study|Miscellaeneous|3|||
156636203|NCT00568776|565412276|FG002|Overall Study|Miscellaeneous|1|||
156636204|NCT00568776|565412277|FG003|Overall Study|Miscellaeneous|4|||
156636205|NCT01005680|565412278|FG000|Overall Study|Lost to Follow-up|4|||
156636206|NCT01005680|565412279|FG001|Overall Study|Lost to Follow-up|6|||
156636207|NCT01005680|565412278|FG000|Overall Study|Withdrawal by Subject|1|||
156636208|NCT01005680|565412279|FG001|Overall Study|Withdrawal by Subject|4|||
156636209|NCT01005680|565412278|FG000|Overall Study|Physician Decision|1|||
156636210|NCT01005680|565412279|FG001|Overall Study|Physician Decision|1|||
156636211|NCT03576131|565412280|FG000|Overall Study|Investigator decision|0|||
156636212|NCT03576131|565412281|FG001|Overall Study|Investigator decision|0|||
156636213|NCT03576131|565412282|FG002|Overall Study|Investigator decision|0|||
156636214|NCT03576131|565412283|FG003|Overall Study|Investigator decision|1|||
156636215|NCT03576131|565412284|FG004|Overall Study|Investigator decision|0|||
156636216|NCT03576131|565412285|FG005|Overall Study|Investigator decision|1|||
156636217|NCT03576131|565412286|FG006|Overall Study|Investigator decision|0|||
156636218|NCT03576131|565412287|FG007|Overall Study|Investigator decision|0|||
156636219|NCT03576131|565412280|FG000|Overall Study|Withdrawal by Subject|1|||
156636220|NCT03576131|565412281|FG001|Overall Study|Withdrawal by Subject|1|||
156636221|NCT03576131|565412282|FG002|Overall Study|Withdrawal by Subject|0|||
156636222|NCT03576131|565412283|FG003|Overall Study|Withdrawal by Subject|1|||
156636223|NCT03576131|565412284|FG004|Overall Study|Withdrawal by Subject|2|||
156636224|NCT03576131|565412285|FG005|Overall Study|Withdrawal by Subject|3|||
156636225|NCT03576131|565412286|FG006|Overall Study|Withdrawal by Subject|1|||
156636226|NCT03576131|565412287|FG007|Overall Study|Withdrawal by Subject|0|||
156636227|NCT03576131|565412280|FG000|Overall Study|Death|3|||
156636228|NCT03576131|565412281|FG001|Overall Study|Death|3|||
156636229|NCT03576131|565412282|FG002|Overall Study|Death|1|||
156636230|NCT03576131|565412283|FG003|Overall Study|Death|5|||
156636231|NCT03576131|565412284|FG004|Overall Study|Death|4|||
156636232|NCT03576131|565412285|FG005|Overall Study|Death|1|||
156636233|NCT03576131|565412286|FG006|Overall Study|Death|0|||
156636234|NCT03576131|565412287|FG007|Overall Study|Death|1|||
156636235|NCT03576131|565412280|FG000|Overall Study|New anti-cancer treatment|5|||
156636236|NCT03576131|565412281|FG001|Overall Study|New anti-cancer treatment|1|||
156636237|NCT03576131|565412282|FG002|Overall Study|New anti-cancer treatment|2|||
156636238|NCT03576131|565412283|FG003|Overall Study|New anti-cancer treatment|3|||
156636239|NCT03576131|565412284|FG004|Overall Study|New anti-cancer treatment|0|||
156636240|NCT03576131|565412285|FG005|Overall Study|New anti-cancer treatment|0|||
156636241|NCT03576131|565412286|FG006|Overall Study|New anti-cancer treatment|0|||
156636242|NCT03576131|565412287|FG007|Overall Study|New anti-cancer treatment|0|||
156636243|NCT03576131|565412280|FG000|Overall Study|Unspecified reason|0|||
156636244|NCT03576131|565412281|FG001|Overall Study|Unspecified reason|0|||
156636245|NCT03576131|565412282|FG002|Overall Study|Unspecified reason|1|||
156636246|NCT03576131|565412283|FG003|Overall Study|Unspecified reason|1|||
156636247|NCT03576131|565412284|FG004|Overall Study|Unspecified reason|1|||
156636248|NCT03576131|565412285|FG005|Overall Study|Unspecified reason|1|||
156636249|NCT03576131|565412286|FG006|Overall Study|Unspecified reason|0|||
156636250|NCT03576131|565412287|FG007|Overall Study|Unspecified reason|0|||
156636251|NCT03576131|565412280|FG000|Overall Study|Subject non-compliance|0|||
156750601|NCT04750278|565838833|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
156408315|NCT04537897|564589263|FG007|Overall Study|Other than listed|0|||
156636252|NCT03576131|565412281|FG001|Overall Study|Subject non-compliance|0|||
156636253|NCT03576131|565412282|FG002|Overall Study|Subject non-compliance|0|||
156636254|NCT03576131|565412283|FG003|Overall Study|Subject non-compliance|0|||
156636255|NCT03576131|565412284|FG004|Overall Study|Subject non-compliance|0|||
156636256|NCT03576131|565412285|FG005|Overall Study|Subject non-compliance|1|||
156636257|NCT03576131|565412286|FG006|Overall Study|Subject non-compliance|0|||
156636258|NCT03576131|565412287|FG007|Overall Study|Subject non-compliance|0|||
156636259|NCT04484805|565412292|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
156636260|NCT04484805|565412293|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
156636261|NCT04484805|565412292|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
156750602|NCT04750278|565838834|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
156636262|NCT04484805|565412293|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
156636263|NCT00539006|565412295|FG000|Pre-treatment|Other|0|||
156636264|NCT00539006|565412296|FG001|Pre-treatment|Other|1|||
156636265|NCT00539006|565412297|FG002|Pre-treatment|Other|0|||
156636266|NCT00539006|565412298|FG003|Pre-treatment|Other|0|||
156636267|NCT00539006|565412295|FG000|Treatment Period 1|Lost to Follow-up|0|||
156636268|NCT00539006|565412296|FG001|Treatment Period 1|Lost to Follow-up|0|||
156636269|NCT00539006|565412297|FG002|Treatment Period 1|Lost to Follow-up|1|||
156636270|NCT00539006|565412298|FG003|Treatment Period 1|Lost to Follow-up|0|||
156636271|NCT00539006|565412295|FG000|Treatment Period 1|Protocol Violation|0|||
156636272|NCT00539006|565412296|FG001|Treatment Period 1|Protocol Violation|0|||
156636273|NCT00539006|565412297|FG002|Treatment Period 1|Protocol Violation|1|||
156636274|NCT00539006|565412298|FG003|Treatment Period 1|Protocol Violation|0|||
156636275|NCT00539006|565412295|FG000|Treatment Period 1|Lack of Efficacy|0|||
156636276|NCT00539006|565412296|FG001|Treatment Period 1|Lack of Efficacy|0|||
156636277|NCT00539006|565412297|FG002|Treatment Period 1|Lack of Efficacy|0|||
156636278|NCT00539006|565412298|FG003|Treatment Period 1|Lack of Efficacy|1|||
156750603|NCT04750278|565838832|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
156750604|NCT04750278|565838833|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
156750605|NCT04750278|565838834|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
156750606|NCT01616758|565838838|FG000|Overall Study|Adverse Event|1|||
156750607|NCT01616758|565838838|FG000|Overall Study|Withdrawal by Subject|2|||
156750608|NCT01616758|565838838|FG000|Overall Study|Disease progression|18|||
156750609|NCT01616758|565838838|FG000|Overall Study|Study termination by Sponsor|1|||
156750610|NCT01054222|565838843|FG000|Overall Study|Lack of Efficacy|1|||
156750611|NCT01054222|565838843|FG000|Overall Study|Lost to Follow-up|4|||
156750612|NCT01054222|565838843|FG000|Overall Study|Withdrawal by Subject|6|||
156750613|NCT03782571|565838844|FG000|Period 1|Withdrawal by Subject|1|||
156750614|NCT03782571|565838845|FG001|Period 1|Withdrawal by Subject|0|||
156750615|NCT03782571|565838846|FG002|Period 1|Withdrawal by Subject|0|||
156750616|NCT03782571|565838847|FG003|Period 1|Withdrawal by Subject|0|||
156750617|NCT03782571|565838844|FG000|Period 3|Subject Unable to Attend V5|1|||
156750618|NCT03782571|565838845|FG001|Period 3|Subject Unable to Attend V5|0|||
156750619|NCT03782571|565838846|FG002|Period 3|Subject Unable to Attend V5|0|||
156750620|NCT03782571|565838847|FG003|Period 3|Subject Unable to Attend V5|0|||
156750621|NCT03782571|565838844|FG000|Period 3|Adverse Event|1|||
156750622|NCT03782571|565838845|FG001|Period 3|Adverse Event|0|||
156750623|NCT03782571|565838846|FG002|Period 3|Adverse Event|0|||
156750624|NCT03782571|565838847|FG003|Period 3|Adverse Event|0|||
156750625|NCT03504189|565838848|FG000|Overall Study|Withdrawal by Subject|1|||
156750626|NCT03504189|565838848|FG000|Overall Study|Screening Failure|1|||
156750627|NCT03504189|565838848|FG000|Overall Study|Device Failure|2|||
156750628|NCT03488563|565838849|FG000|Overall Study|Lost to Follow-up|7|||
156750629|NCT03488563|565838850|FG001|Overall Study|Lost to Follow-up|6|||
156750630|NCT03488563|565838851|FG002|Overall Study|Lost to Follow-up|7|||
156750631|NCT03488563|565838849|FG000|Overall Study|Withdrawal by Subject|8|||
156750632|NCT03488563|565838850|FG001|Overall Study|Withdrawal by Subject|7|||
156750633|NCT03488563|565838851|FG002|Overall Study|Withdrawal by Subject|7|||
156750634|NCT03488563|565838849|FG000|Overall Study|Physician Decision|0|||
156750635|NCT03488563|565838850|FG001|Overall Study|Physician Decision|0|||
156750636|NCT03488563|565838851|FG002|Overall Study|Physician Decision|1|||
156750637|NCT03488563|565838849|FG000|Overall Study|Protocol Violation|3|||
156750638|NCT03488563|565838850|FG001|Overall Study|Protocol Violation|2|||
156750639|NCT03488563|565838851|FG002|Overall Study|Protocol Violation|6|||
156750640|NCT03488563|565838849|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
156750641|NCT03488563|565838850|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
156750642|NCT03488563|565838851|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
156750643|NCT03488563|565838849|FG000|Overall Study|Use of prohibited medication|2|||
156750644|NCT03488563|565838850|FG001|Overall Study|Use of prohibited medication|0|||
156750645|NCT03488563|565838851|FG002|Overall Study|Use of prohibited medication|0|||
156750646|NCT03488563|565838849|FG000|Overall Study|Adverse Event|1|||
156750647|NCT03488563|565838850|FG001|Overall Study|Adverse Event|0|||
156750648|NCT03488563|565838851|FG002|Overall Study|Adverse Event|1|||
156750649|NCT03488563|565838849|FG000|Overall Study|Subject returned for ET visit|0|||
156750650|NCT03488563|565838850|FG001|Overall Study|Subject returned for ET visit|1|||
156636279|NCT00539006|565412295|FG000|Washout|Adverse Event|2|||
156636280|NCT00539006|565412296|FG001|Washout|Adverse Event|1|||
156636281|NCT00539006|565412297|FG002|Washout|Adverse Event|0|||
156338252|NCT05248867|564336594|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156636282|NCT00539006|565412298|FG003|Washout|Adverse Event|0|||
156636283|NCT00539006|565412295|FG000|Washout|Protocol Violation|1|||
156636284|NCT00539006|565412296|FG001|Washout|Protocol Violation|1|||
156636285|NCT00539006|565412297|FG002|Washout|Protocol Violation|0|||
156636286|NCT00539006|565412298|FG003|Washout|Protocol Violation|0|||
156636287|NCT00539006|565412295|FG000|Washout|Withdrawal by Subject|0|||
156636288|NCT00539006|565412296|FG001|Washout|Withdrawal by Subject|2|||
156636289|NCT00539006|565412297|FG002|Washout|Withdrawal by Subject|0|||
156636290|NCT00539006|565412298|FG003|Washout|Withdrawal by Subject|0|||
156636291|NCT00539006|565412295|FG000|Washout|Failed to meet continuation criteria|16|||
156636292|NCT00539006|565412296|FG001|Washout|Failed to meet continuation criteria|5|||
156636293|NCT00539006|565412297|FG002|Washout|Failed to meet continuation criteria|14|||
156636294|NCT00539006|565412298|FG003|Washout|Failed to meet continuation criteria|6|||
156636295|NCT00539006|565412295|FG000|Washout|Other|1|||
156636296|NCT00539006|565412296|FG001|Washout|Other|1|||
156636297|NCT00539006|565412297|FG002|Washout|Other|2|||
156636298|NCT00539006|565412298|FG003|Washout|Other|3|||
156750651|NCT03488563|565838851|FG002|Overall Study|Subject returned for ET visit|0|||
156750652|NCT03488563|565838849|FG000|Overall Study|Sponsor's decision|0|||
156636299|NCT00539006|565412295|FG000|Treatment Period 2|Protocol Violation|1|||
156636300|NCT00539006|565412296|FG001|Treatment Period 2|Protocol Violation|0|||
156750653|NCT03488563|565838850|FG001|Overall Study|Sponsor's decision|0|||
156750654|NCT03488563|565838851|FG002|Overall Study|Sponsor's decision|1|||
156750655|NCT02007278|565838870|FG000|Overall Study|Failure to comply with an eligibility|0|||
156750656|NCT02007278|565838871|FG001|Overall Study|Failure to comply with an eligibility|1|||
156750657|NCT02007278|565838870|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
156750658|NCT02007278|565838871|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
156750659|NCT02007278|565838870|FG000|Overall Study|Incorrect medication administration|1|||
156750660|NCT02007278|565838871|FG001|Overall Study|Incorrect medication administration|0|||
156750661|NCT02007278|565838870|FG000|Overall Study|Mis-randomization|1|||
156750662|NCT02007278|565838871|FG001|Overall Study|Mis-randomization|1|||
156750663|NCT01429441|565838875|FG000|Overall Study|Adverse Event|5|||
156750664|NCT01429441|565838876|FG001|Overall Study|Adverse Event|1|||
156750665|NCT01429441|565838875|FG000|Overall Study|Death|0|||
156750666|NCT01429441|565838876|FG001|Overall Study|Death|2|||
156750667|NCT01429441|565838875|FG000|Overall Study|Lost to Follow-up|5|||
156750668|NCT01429441|565838876|FG001|Overall Study|Lost to Follow-up|2|||
156750669|NCT01429441|565838875|FG000|Overall Study|Physician Decision|1|||
156750670|NCT01429441|565838876|FG001|Overall Study|Physician Decision|0|||
156750671|NCT01429441|565838875|FG000|Overall Study|Withdrawal by Subject|27|||
156750672|NCT01429441|565838876|FG001|Overall Study|Withdrawal by Subject|18|||
156750673|NCT02670382|565838880|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
156750674|NCT02670382|565838881|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
156750675|NCT03244618|565838882|FG000|Overall Study|Lost to Follow-up|3|||
156750676|NCT03244618|565838883|FG001|Overall Study|Lost to Follow-up|4|||
156750677|NCT03244618|565838882|FG000|Overall Study|Protocol Violation|4|||
156750678|NCT03244618|565838883|FG001|Overall Study|Protocol Violation|3|||
156750679|NCT03244618|565838882|FG000|Overall Study|Withdrawal by Subject|0|||
156750680|NCT03244618|565838883|FG001|Overall Study|Withdrawal by Subject|2|||
156750681|NCT03469999|565838886|FG000|Overall Study|Lost to Follow-up|2|||
156750682|NCT03383692|565838889|FG000|Overall Study|Progressive disease as per RECIST|3|||
156750683|NCT03383692|565838890|FG001|Overall Study|Progressive disease as per RECIST|3|||
156750684|NCT03383692|565838889|FG000|Overall Study|Clinical progression|0|||
156750685|NCT03383692|565838890|FG001|Overall Study|Clinical progression|1|||
156750686|NCT03383692|565838889|FG000|Overall Study|Adverse Event|3|||
156750687|NCT03383692|565838890|FG001|Overall Study|Adverse Event|0|||
156750688|NCT03816007|565838891|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
156750689|NCT03816007|565838892|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
156750690|NCT03816007|565838891|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
156750691|NCT03816007|565838892|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
156750692|NCT03816007|565838891|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
156750693|NCT03816007|565838892|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
156750694|NCT02179749|565838893|FG000|Overall Study|Adverse Event|0|||
156750695|NCT02179749|565838894|FG001|Overall Study|Adverse Event|0|||
156750696|NCT02179749|565838895|FG002|Overall Study|Adverse Event|1|||
156750697|NCT02179749|565838893|FG000|Overall Study|Withdrawal by Subject|0|||
156750698|NCT02179749|565838894|FG001|Overall Study|Withdrawal by Subject|0|||
156750699|NCT02179749|565838895|FG002|Overall Study|Withdrawal by Subject|1|||
156750700|NCT01810783|565838897|FG000|Overall Study|Adverse Event|32|||
156750701|NCT01810783|565838897|FG000|Overall Study|Withdrawal by Subject|22|||
156750702|NCT01810783|565838897|FG000|Overall Study|Lack of Efficacy|12|||
156750703|NCT01810783|565838897|FG000|Overall Study|Lost to Follow-up|10|||
156750704|NCT01810783|565838897|FG000|Overall Study|Protocol Violation|5|||
156750705|NCT01810783|565838897|FG000|Overall Study|Non-compliance with IMP|4|||
156750706|NCT01810783|565838897|FG000|Overall Study|Adminstrative or other reason(s)|23|||
156750707|NCT01810783|565838897|FG000|Overall Study|Enrolled, not treated|1|||
156750708|NCT00793546|565838898|FG000|Overall Study|Death|3|||
156750709|NCT00793546|565838899|FG001|Overall Study|Death|0|||
156750710|NCT00793546|565838898|FG000|Overall Study|Lost to Follow-up|1|||
156750711|NCT00793546|565838899|FG001|Overall Study|Lost to Follow-up|0|||
156750712|NCT00793546|565838898|FG000|Overall Study|Withdrawal by Subject|1|||
156750713|NCT00793546|565838899|FG001|Overall Study|Withdrawal by Subject|1|||
156750714|NCT00793546|565838898|FG000|Overall Study|Study Terminated by Sponsor|8|||
156750715|NCT00793546|565838899|FG001|Overall Study|Study Terminated by Sponsor|27|||
156750716|NCT00793546|565838898|FG000|Overall Study|Other|1|||
156750717|NCT00793546|565838899|FG001|Overall Study|Other|0|||
156750718|NCT02620384|565838900|FG000|Overall Study|Adverse Event|2|||
156750719|NCT02620384|565838901|FG001|Overall Study|Adverse Event|1|||
156750720|NCT02620384|565838900|FG000|Overall Study|Discharged prior to 2nd dose|2|||
156750721|NCT02620384|565838901|FG001|Overall Study|Discharged prior to 2nd dose|5|||
156750722|NCT02620384|565838900|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
156750723|NCT02620384|565838901|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
156750724|NCT00094536|565838902|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
156750725|NCT00094536|565838902|FG000|Treatment and Follow-up|Adverse Event|4|||
156750726|NCT00094536|565838902|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
156750727|NCT00094536|565838902|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
156750728|NCT00094536|565838902|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
156750729|NCT00094536|565838902|FG000|Treatment and Follow-up|Subject non-compliance|9|||
156750730|NCT00094536|565838902|FG000|Treatment and Follow-up|Unable to attend visits|1|||
156750731|NCT02071082|565838903|FG000|Overall Study|Enrolled and Never Treated|1|||
156750732|NCT02071082|565838904|FG001|Overall Study|Enrolled and Never Treated|1|||
156750733|NCT02071082|565838903|FG000|Overall Study|Adverse Event|0|||
156750734|NCT02071082|565838904|FG001|Overall Study|Adverse Event|1|||
156750735|NCT02071082|565838903|FG000|Overall Study|Withdrew Consent|0|||
156750736|NCT02071082|565838904|FG001|Overall Study|Withdrew Consent|4|||
156750737|NCT02071082|565838903|FG000|Overall Study|Lost to Follow-up|1|||
156750738|NCT02071082|565838904|FG001|Overall Study|Lost to Follow-up|1|||
156750739|NCT02101359|565838905|FG000|Overall Study|Not included|23|||
156750740|NCT02101359|565838906|FG001|Overall Study|Not included|13|||
156750741|NCT02101359|565838905|FG000|Overall Study|Withdrawal by Subject|5|||
156750742|NCT02101359|565838906|FG001|Overall Study|Withdrawal by Subject|4|||
156750743|NCT02101359|565838905|FG000|Overall Study|Lost to Follow-up|1|||
156750744|NCT02101359|565838906|FG001|Overall Study|Lost to Follow-up|0|||
156750745|NCT02101359|565838905|FG000|Overall Study|Protocol Violation|0|||
156750746|NCT02101359|565838906|FG001|Overall Study|Protocol Violation|2|||
156750747|NCT00494221|565838907|FG000|Overall Study|Death|15|||
156750748|NCT00494221|565838908|FG001|Overall Study|Death|9|||
156750749|NCT00494221|565838909|FG002|Overall Study|Death|14|||
156750750|NCT00494221|565838907|FG000|Overall Study|Withdrawal by Subject|1|||
156750751|NCT00494221|565838908|FG001|Overall Study|Withdrawal by Subject|2|||
156750752|NCT00494221|565838909|FG002|Overall Study|Withdrawal by Subject|0|||
156750753|NCT01900431|565838914|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
156750754|NCT01900431|565838915|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
156750755|NCT01900431|565838916|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
156750756|NCT01900431|565838914|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
156750757|NCT01900431|565838915|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
156750758|NCT01900431|565838916|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
156750759|NCT01900431|565838914|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
156750760|NCT01900431|565838915|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
156750761|NCT01900431|565838916|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
156750762|NCT01900431|565838914|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
156750763|NCT01900431|565838915|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
156750764|NCT01900431|565838916|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
156750765|NCT01900431|565838914|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
156750766|NCT01900431|565838915|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
156750767|NCT01900431|565838916|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
156750768|NCT01900431|565838914|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
156750769|NCT01900431|565838915|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
156750770|NCT01900431|565838916|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
156750771|NCT01900431|565838914|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
156750772|NCT01900431|565838915|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
156750773|NCT01900431|565838916|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
156750774|NCT01900431|565838914|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
156750775|NCT01900431|565838915|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
156636301|NCT00539006|565412297|FG002|Treatment Period 2|Protocol Violation|0|||
156636302|NCT00539006|565412298|FG003|Treatment Period 2|Protocol Violation|0|||
156636303|NCT00539006|565412295|FG000|Treatment Period 2|Other|0|||
156636304|NCT00539006|565412296|FG001|Treatment Period 2|Other|1|||
156636305|NCT00539006|565412297|FG002|Treatment Period 2|Other|0|||
156636306|NCT00539006|565412298|FG003|Treatment Period 2|Other|0|||
156636307|NCT00577031|565412299|FG000|Overall Study|Adverse Event|52|||
156636308|NCT00577031|565412299|FG000|Overall Study|Progression of disease|93|||
156636309|NCT00577031|565412299|FG000|Overall Study|Protocol Violation|5|||
156636310|NCT00577031|565412299|FG000|Overall Study|Participant withdrew consent|13|||
156636311|NCT00577031|565412299|FG000|Overall Study|Participant non-compliance|5|||
156636312|NCT00577031|565412299|FG000|Overall Study|Need for surgery|17|||
156636313|NCT00577031|565412299|FG000|Overall Study|Medical decision|14|||
156636314|NCT00577031|565412299|FG000|Overall Study|Death|6|||
156636315|NCT02050373|565412300|FG000|Overall Study|Adverse Event|4|||
156636316|NCT02050373|565412301|FG001|Overall Study|Adverse Event|7|||
156750776|NCT01900431|565838916|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
156750777|NCT01900431|565838914|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
156750778|NCT01900431|565838915|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
156750779|NCT01900431|565838916|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
156750780|NCT01841567|565838917|FG000|Overall Study|Adverse Event|3|||
156750781|NCT00630747|565838918|FG000|Overall Study|Death|1|||
156750782|NCT00630747|565838918|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
156750783|NCT00630747|565838918|FG000|Overall Study|Returned to country of origin|1|||
156750784|NCT02732327|565838921|FG000|Overall Study|Protocol Violation|0|||
156750785|NCT02732327|565838922|FG001|Overall Study|Protocol Violation|1|||
156750786|NCT00435019|565838923|FG000|Overall Study|Adverse Event|1|||
156750787|NCT00435019|565838924|FG001|Overall Study|Adverse Event|0|||
156750788|NCT00435019|565838923|FG000|Overall Study|Lack of Efficacy|1|||
156750789|NCT00435019|565838924|FG001|Overall Study|Lack of Efficacy|2|||
156750790|NCT00435019|565838923|FG000|Overall Study|Protocol Violation|3|||
156750791|NCT00435019|565838924|FG001|Overall Study|Protocol Violation|1|||
156750792|NCT00435019|565838923|FG000|Overall Study|Personal reasons for withdrawal|8|||
156750793|NCT00435019|565838924|FG001|Overall Study|Personal reasons for withdrawal|7|||
156750794|NCT04503668|565838925|FG000|Overall Study|Incomplete data|4|||
156750795|NCT04503668|565838926|FG001|Overall Study|Incomplete data|3|||
156750796|NCT04503668|565838925|FG000|Overall Study|Withdrawal by Subject|1|||
156750797|NCT04503668|565838926|FG001|Overall Study|Withdrawal by Subject|1|||
156750798|NCT04503668|565838925|FG000|Overall Study|Adverse Event|2|||
156750799|NCT04503668|565838926|FG001|Overall Study|Adverse Event|0|||
156750800|NCT02306694|565838927|FG000|Overall Study|Withdrawal by Subject|3|||
156750801|NCT02306694|565838927|FG000|Overall Study|Lost to Follow-up|1|||
156750802|NCT00603382|565838928|FG000|Overall Study|Adverse Event|0|||
156750803|NCT00603382|565838929|FG001|Overall Study|Adverse Event|1|||
156750804|NCT00603382|565838930|FG002|Overall Study|Adverse Event|1|||
156750805|NCT00603382|565838931|FG003|Overall Study|Adverse Event|2|||
156750806|NCT00603382|565838932|FG004|Overall Study|Adverse Event|1|||
156750807|NCT00603382|565838933|FG005|Overall Study|Adverse Event|2|||
156750808|NCT00603382|565838928|FG000|Overall Study|Lack of Efficacy|14|||
156750809|NCT00603382|565838929|FG001|Overall Study|Lack of Efficacy|9|||
156750810|NCT00603382|565838930|FG002|Overall Study|Lack of Efficacy|3|||
156750811|NCT00603382|565838931|FG003|Overall Study|Lack of Efficacy|6|||
156750812|NCT00603382|565838932|FG004|Overall Study|Lack of Efficacy|6|||
156750813|NCT00603382|565838933|FG005|Overall Study|Lack of Efficacy|11|||
156750814|NCT00603382|565838928|FG000|Overall Study|Protocol Violation|1|||
156750815|NCT00603382|565838929|FG001|Overall Study|Protocol Violation|0|||
156750816|NCT00603382|565838930|FG002|Overall Study|Protocol Violation|1|||
156750817|NCT00603382|565838931|FG003|Overall Study|Protocol Violation|2|||
156750818|NCT00603382|565838932|FG004|Overall Study|Protocol Violation|1|||
156750819|NCT00603382|565838933|FG005|Overall Study|Protocol Violation|0|||
156750820|NCT00603382|565838928|FG000|Overall Study|Lost to Follow-up|0|||
156750821|NCT00603382|565838929|FG001|Overall Study|Lost to Follow-up|1|||
156750822|NCT00603382|565838930|FG002|Overall Study|Lost to Follow-up|1|||
156750823|NCT00603382|565838931|FG003|Overall Study|Lost to Follow-up|1|||
156750824|NCT00603382|565838932|FG004|Overall Study|Lost to Follow-up|0|||
156636317|NCT02050373|565412300|FG000|Overall Study|Death|3|||
156636318|NCT02050373|565412301|FG001|Overall Study|Death|3|||
156636319|NCT04764669|565412303|FG000|Overall Study|Adverse Event|1|||
156636320|NCT04764669|565412304|FG001|Overall Study|Adverse Event|0|||
156636321|NCT04764669|565412305|FG002|Overall Study|Adverse Event|1|||
156636322|NCT04764669|565412306|FG003|Overall Study|Adverse Event|0|||
156636323|NCT04764669|565412303|FG000|Overall Study|Subject Choice|0|||
156636324|NCT04764669|565412304|FG001|Overall Study|Subject Choice|0|||
156636325|NCT04764669|565412305|FG002|Overall Study|Subject Choice|1|||
156636326|NCT04764669|565412306|FG003|Overall Study|Subject Choice|0|||
156636327|NCT04764669|565412303|FG000|Overall Study|Withdrawal by Subject|2|||
156636328|NCT04764669|565412304|FG001|Overall Study|Withdrawal by Subject|0|||
156636329|NCT04764669|565412305|FG002|Overall Study|Withdrawal by Subject|0|||
156636330|NCT04764669|565412306|FG003|Overall Study|Withdrawal by Subject|0|||
156636331|NCT00572910|565412307|FG000|Overall Study|Adverse Event|1|||
156636332|NCT00572910|565412308|FG001|Overall Study|Adverse Event|2|||
156636333|NCT00572910|565412309|FG002|Overall Study|Adverse Event|0|||
156750825|NCT00603382|565838933|FG005|Overall Study|Lost to Follow-up|1|||
156750826|NCT00603382|565838928|FG000|Overall Study|Physician Decision|0|||
156750827|NCT00603382|565838929|FG001|Overall Study|Physician Decision|0|||
156750828|NCT00603382|565838930|FG002|Overall Study|Physician Decision|2|||
156750829|NCT00603382|565838931|FG003|Overall Study|Physician Decision|0|||
156750830|NCT00603382|565838932|FG004|Overall Study|Physician Decision|1|||
156636334|NCT00572910|565412310|FG003|Overall Study|Adverse Event|2|||
156636335|NCT00572910|565412311|FG004|Overall Study|Adverse Event|0|||
156636336|NCT00572910|565412312|FG005|Overall Study|Adverse Event|0|||
156636337|NCT00572910|565412313|FG006|Overall Study|Adverse Event|4|||
156636338|NCT00572910|565412314|FG007|Overall Study|Adverse Event|2|||
156636339|NCT00572910|565412315|FG008|Overall Study|Adverse Event|1|||
156636340|NCT00572910|565412316|FG009|Overall Study|Adverse Event|3|||
156636341|NCT00572910|565412317|FG010|Overall Study|Adverse Event|2|||
156636342|NCT00572910|565412307|FG000|Overall Study|Lost to Follow-up|0|||
156636343|NCT00572910|565412308|FG001|Overall Study|Lost to Follow-up|1|||
156636344|NCT00572910|565412309|FG002|Overall Study|Lost to Follow-up|1|||
156636345|NCT00572910|565412310|FG003|Overall Study|Lost to Follow-up|2|||
156636346|NCT00572910|565412311|FG004|Overall Study|Lost to Follow-up|1|||
156636347|NCT00572910|565412312|FG005|Overall Study|Lost to Follow-up|0|||
156636348|NCT00572910|565412313|FG006|Overall Study|Lost to Follow-up|0|||
156636349|NCT00572910|565412314|FG007|Overall Study|Lost to Follow-up|0|||
156636350|NCT00572910|565412315|FG008|Overall Study|Lost to Follow-up|0|||
156636351|NCT00572910|565412316|FG009|Overall Study|Lost to Follow-up|1|||
156636352|NCT00572910|565412317|FG010|Overall Study|Lost to Follow-up|0|||
156750831|NCT00603382|565838933|FG005|Overall Study|Physician Decision|3|||
156750832|NCT00603382|565838928|FG000|Overall Study|Withdrawal by Subject|3|||
156750833|NCT00603382|565838929|FG001|Overall Study|Withdrawal by Subject|3|||
156750834|NCT00603382|565838930|FG002|Overall Study|Withdrawal by Subject|1|||
156750835|NCT00603382|565838931|FG003|Overall Study|Withdrawal by Subject|1|||
156750836|NCT00603382|565838932|FG004|Overall Study|Withdrawal by Subject|0|||
156750837|NCT00603382|565838933|FG005|Overall Study|Withdrawal by Subject|1|||
156750838|NCT00395642|565838934|FG000|Overall Study|Death|4|||
156750839|NCT00395642|565838934|FG000|Overall Study|Lost to Follow-up|1|||
156750840|NCT00395642|565838934|FG000|Overall Study|Physician Decision|7|||
156750841|NCT00395642|565838934|FG000|Overall Study|Withdrawal by Subject|1|||
156750842|NCT01078298|565838942|FG000|Overall Study|Lost to Follow-up|12|||
156750843|NCT01078298|565838943|FG001|Overall Study|Lost to Follow-up|13|||
156750844|NCT01078298|565838942|FG000|Overall Study|Withdrawal by Subject|31|||
156750845|NCT01078298|565838943|FG001|Overall Study|Withdrawal by Subject|33|||
156750846|NCT01078298|565838942|FG000|Overall Study|Protocol Violation|6|||
156750847|NCT01078298|565838943|FG001|Overall Study|Protocol Violation|6|||
156750848|NCT01078298|565838942|FG000|Overall Study|Adverse Event|6|||
156750849|NCT01078298|565838943|FG001|Overall Study|Adverse Event|5|||
156750850|NCT01078298|565838942|FG000|Overall Study|Death|2|||
156750851|NCT01078298|565838943|FG001|Overall Study|Death|0|||
156750852|NCT01078298|565838942|FG000|Overall Study|Did not meet entrance criteria|0|||
156750853|NCT01078298|565838943|FG001|Overall Study|Did not meet entrance criteria|1|||
156750854|NCT01078298|565838942|FG000|Overall Study|Other|24|||
156750855|NCT01078298|565838943|FG001|Overall Study|Other|32|||
156750856|NCT00659776|565838947|FG000|Overall Study|Withdrawal by Subject|12|||
156750857|NCT00659776|565838948|FG001|Overall Study|Withdrawal by Subject|2|||
156750858|NCT00659776|565838949|FG002|Overall Study|Withdrawal by Subject|0|||
156750859|NCT00742027|565838950|FG000|Overall Study|Disease Progression|76|||
156750860|NCT00742027|565838950|FG000|Overall Study|New Cancer Therapy|19|||
156750861|NCT00742027|565838950|FG000|Overall Study|Withdrawal by Subject|18|||
156750862|NCT00742027|565838950|FG000|Overall Study|Death|7|||
156750863|NCT00742027|565838950|FG000|Overall Study|Lost to Follow-up|4|||
156750864|NCT00742027|565838950|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
156750865|NCT00742027|565838950|FG000|Overall Study|Missing|2|||
156750866|NCT00742027|565838950|FG000|Overall Study|Administrative Problems|1|||
156750867|NCT01180049|565838951|FG000|Overall Study|Other|9|||
156750868|NCT01180049|565838952|FG001|Overall Study|Other|7|||
156750869|NCT01180049|565838951|FG000|Overall Study|Lost to Follow-up|8|||
156750870|NCT01180049|565838952|FG001|Overall Study|Lost to Follow-up|6|||
156750871|NCT01180049|565838951|FG000|Overall Study|Death|36|||
156750872|NCT01180049|565838952|FG001|Overall Study|Death|35|||
156750873|NCT00628927|565838953|FG000|Overall Study|Problems performing blood draw|6|||
156750874|NCT00628927|565838954|FG001|Overall Study|Problems performing blood draw|0|||
156750875|NCT00628927|565838953|FG000|Overall Study|Lost to Follow-up|1|||
156750876|NCT00628927|565838954|FG001|Overall Study|Lost to Follow-up|0|||
156750877|NCT00628927|565838953|FG000|Overall Study|Equipment failure|1|||
156750878|NCT00628927|565838954|FG001|Overall Study|Equipment failure|0|||
156750879|NCT01298141|565838958|FG000|Overall Study|Adverse Event|3|||
156750880|NCT01298141|565838958|FG000|Overall Study|Refusal of Required Study Procedures|1|||
156636353|NCT00572910|565412307|FG000|Overall Study|Withdrawal by Subject|3|||
156636354|NCT00572910|565412308|FG001|Overall Study|Withdrawal by Subject|0|||
156636355|NCT00572910|565412309|FG002|Overall Study|Withdrawal by Subject|1|||
156636356|NCT00572910|565412310|FG003|Overall Study|Withdrawal by Subject|0|||
156750881|NCT01298141|565838958|FG000|Overall Study|Withdrawal by Subject|6|||
156750882|NCT01298141|565838958|FG000|Overall Study|Termination of Study by the Investigator|5|||
156750883|NCT01298141|565838958|FG000|Overall Study|Other|5|||
156750884|NCT01298141|565838958|FG000|Overall Study|Lost to Follow-up|1|||
156750885|NCT01298141|565838958|FG000|Overall Study|Death|6|||
156750886|NCT01298141|565838958|FG000|Overall Study|Not treated|4|||
156750887|NCT02552888|565838959|FG000|Overall Study|Lost to Follow-up|1|||
156636357|NCT00572910|565412311|FG004|Overall Study|Withdrawal by Subject|1|||
156750888|NCT02552888|565838960|FG001|Overall Study|Lost to Follow-up|1|||
156636358|NCT00572910|565412312|FG005|Overall Study|Withdrawal by Subject|3|||
156636359|NCT00572910|565412313|FG006|Overall Study|Withdrawal by Subject|0|||
156636360|NCT00572910|565412314|FG007|Overall Study|Withdrawal by Subject|2|||
156636361|NCT00572910|565412315|FG008|Overall Study|Withdrawal by Subject|2|||
156636362|NCT00572910|565412316|FG009|Overall Study|Withdrawal by Subject|2|||
156636363|NCT00572910|565412317|FG010|Overall Study|Withdrawal by Subject|1|||
156636364|NCT01803464|565412319|FG000|Overall Study|Incomplete data|0|||
156636365|NCT01803464|565412320|FG001|Overall Study|Incomplete data|0|||
156636366|NCT01803464|565412321|FG002|Overall Study|Incomplete data|4|||
156636367|NCT01803464|565412322|FG003|Overall Study|Incomplete data|0|||
156636368|NCT01803464|565412319|FG000|Overall Study|Withdrawal by Subject|1|||
156636369|NCT01803464|565412320|FG001|Overall Study|Withdrawal by Subject|0|||
156636370|NCT01803464|565412321|FG002|Overall Study|Withdrawal by Subject|0|||
156636371|NCT01803464|565412322|FG003|Overall Study|Withdrawal by Subject|0|||
156636372|NCT02851069|565412323|FG000|Overall Study|Failure to Return|3|||
156636373|NCT02851069|565412323|FG000|Overall Study|Other|3|||
156636374|NCT00388674|565413947|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
156636375|NCT00388674|565413948|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
156636376|NCT00388674|565413947|FG000|Initial Treatment|Adverse Event|22|||
156636377|NCT00388674|565413948|FG001|Initial Treatment|Adverse Event|87|||
156636378|NCT00388674|565413947|FG000|Initial Treatment|Death|215|||
156636379|NCT00388674|565413948|FG001|Initial Treatment|Death|216|||
156636380|NCT00388674|565413947|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
156636381|NCT00388674|565413948|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
156636382|NCT00388674|565413947|FG000|Initial Treatment|HCC|12|||
156636383|NCT00388674|565413948|FG001|Initial Treatment|HCC|20|||
156636384|NCT00388674|565413947|FG000|Initial Treatment|Lost to Follow-up|526|||
156636385|NCT00388674|565413948|FG001|Initial Treatment|Lost to Follow-up|624|||
156636386|NCT00388674|565413947|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
156636387|NCT00388674|565413948|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
156636388|NCT00388674|565413947|FG000|Initial Treatment|Never Treated with Study Medication|1|||
156636389|NCT00388674|565413948|FG001|Initial Treatment|Never Treated with Study Medication|7|||
156636390|NCT00388674|565413947|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
156636391|NCT00388674|565413948|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
156636392|NCT00388674|565413947|FG000|Initial Treatment|Not Defined|125|||
156636393|NCT00388674|565413948|FG001|Initial Treatment|Not Defined|172|||
156636394|NCT00388674|565413947|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
156636395|NCT00388674|565413948|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
156636396|NCT00388674|565413947|FG000|Initial Treatment|Pregnancy|26|||
156636397|NCT00388674|565413948|FG001|Initial Treatment|Pregnancy|16|||
156636398|NCT00388674|565413947|FG000|Initial Treatment|Study Drug Toxicity|5|||
156636399|NCT00388674|565413948|FG001|Initial Treatment|Study Drug Toxicity|92|||
156636400|NCT00388674|565413947|FG000|Initial Treatment|Participant Request|501|||
156636401|NCT00388674|565413948|FG001|Initial Treatment|Participant Request|673|||
156636402|NCT00388674|565413947|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
156636403|NCT00388674|565413948|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
156636404|NCT00388674|565413947|FG000|Initial Treatment|Not Reported|10|||
156636405|NCT00388674|565413948|FG001|Initial Treatment|Not Reported|12|||
156636406|NCT00388674|565413947|FG000|End of Study|Administrative Reason By Sponsor|299|||
156636407|NCT00388674|565413948|FG001|End of Study|Administrative Reason By Sponsor|253|||
156636408|NCT00388674|565413947|FG000|End of Study|Death|239|||
156636409|NCT00388674|565413948|FG001|End of Study|Death|262|||
156636410|NCT00388674|565413947|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
156636411|NCT00388674|565413948|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
156636412|NCT00388674|565413947|FG000|End of Study|HCC|8|||
156636413|NCT00388674|565413948|FG001|End of Study|HCC|7|||
156636414|NCT00388674|565413947|FG000|End of Study|Lost to Follow-up|587|||
156636415|NCT00388674|565413948|FG001|End of Study|Lost to Follow-up|715|||
156636416|NCT00388674|565413947|FG000|End of Study|Malignancy (Non-HCC)|1|||
156636417|NCT00388674|565413948|FG001|End of Study|Malignancy (Non-HCC)|1|||
156636418|NCT00388674|565413947|FG000|End of Study|Non-Study Related Comorbidities|3|||
156636419|NCT00388674|565413948|FG001|End of Study|Non-Study Related Comorbidities|4|||
156636420|NCT00388674|565413947|FG000|End of Study|Not Defined|135|||
156636421|NCT00388674|565413948|FG001|End of Study|Not Defined|214|||
156636422|NCT00388674|565413947|FG000|End of Study|Participant Withdrew Consent|437|||
156636423|NCT00388674|565413948|FG001|End of Study|Participant Withdrew Consent|673|||
156636424|NCT00388674|565413947|FG000|End of Study|No Off-Treatment Status Data|22|||
156636425|NCT00388674|565413948|FG001|End of Study|No Off-Treatment Status Data|30|||
156636426|NCT00388674|565413947|FG000|End of Study|Not Reported|0|||
156636427|NCT00388674|565413948|FG001|End of Study|Not Reported|1|||
156636428|NCT02118896|565413951|FG000|Overall Study|Death|4|||
156636429|NCT02118896|565413952|FG001|Overall Study|Death|0|||
156636430|NCT02118896|565413953|FG002|Overall Study|Death|4|||
156636431|NCT02118896|565413954|FG003|Overall Study|Death|6|||
156636432|NCT02118896|565413955|FG004|Overall Study|Death|3|||
156636433|NCT02118896|565413956|FG005|Overall Study|Death|1|||
156636434|NCT02118896|565413957|FG006|Overall Study|Death|0|||
156636435|NCT02118896|565413958|FG007|Overall Study|Death|0|||
156636436|NCT02118896|565413959|FG008|Overall Study|Death|0|||
156636437|NCT02118896|565413960|FG009|Overall Study|Death|0|||
156636438|NCT02118896|565413951|FG000|Overall Study|Adverse Event|5|||
156636439|NCT02118896|565413952|FG001|Overall Study|Adverse Event|4|||
156636440|NCT02118896|565413953|FG002|Overall Study|Adverse Event|4|||
156636441|NCT02118896|565413954|FG003|Overall Study|Adverse Event|5|||
156636442|NCT02118896|565413955|FG004|Overall Study|Adverse Event|5|||
156636443|NCT02118896|565413956|FG005|Overall Study|Adverse Event|9|||
156636444|NCT02118896|565413957|FG006|Overall Study|Adverse Event|1|||
156636445|NCT02118896|565413958|FG007|Overall Study|Adverse Event|1|||
156636446|NCT02118896|565413959|FG008|Overall Study|Adverse Event|4|||
156636447|NCT02118896|565413960|FG009|Overall Study|Adverse Event|0|||
156636448|NCT02118896|565413951|FG000|Overall Study|Consent withdrawn|2|||
156636449|NCT02118896|565413952|FG001|Overall Study|Consent withdrawn|0|||
156636450|NCT02118896|565413953|FG002|Overall Study|Consent withdrawn|3|||
156636451|NCT02118896|565413954|FG003|Overall Study|Consent withdrawn|4|||
156636452|NCT02118896|565413955|FG004|Overall Study|Consent withdrawn|1|||
156636453|NCT02118896|565413956|FG005|Overall Study|Consent withdrawn|4|||
156636454|NCT02118896|565413957|FG006|Overall Study|Consent withdrawn|0|||
156636455|NCT02118896|565413958|FG007|Overall Study|Consent withdrawn|0|||
156636456|NCT02118896|565413959|FG008|Overall Study|Consent withdrawn|0|||
156636457|NCT02118896|565413960|FG009|Overall Study|Consent withdrawn|0|||
156636458|NCT02118896|565413951|FG000|Overall Study|Non-compliance|2|||
156636459|NCT02118896|565413952|FG001|Overall Study|Non-compliance|1|||
156636460|NCT02118896|565413953|FG002|Overall Study|Non-compliance|1|||
156636461|NCT02118896|565413954|FG003|Overall Study|Non-compliance|5|||
156636462|NCT02118896|565413955|FG004|Overall Study|Non-compliance|0|||
156636463|NCT02118896|565413956|FG005|Overall Study|Non-compliance|1|||
156636464|NCT02118896|565413957|FG006|Overall Study|Non-compliance|0|||
156636465|NCT02118896|565413958|FG007|Overall Study|Non-compliance|1|||
156636466|NCT02118896|565413959|FG008|Overall Study|Non-compliance|0|||
156636467|NCT02118896|565413960|FG009|Overall Study|Non-compliance|0|||
156636468|NCT02118896|565413951|FG000|Overall Study|Pregnancy|1|||
156636469|NCT02118896|565413952|FG001|Overall Study|Pregnancy|1|||
156636470|NCT02118896|565413953|FG002|Overall Study|Pregnancy|0|||
156636471|NCT02118896|565413954|FG003|Overall Study|Pregnancy|0|||
156636472|NCT02118896|565413955|FG004|Overall Study|Pregnancy|1|||
156636473|NCT02118896|565413956|FG005|Overall Study|Pregnancy|3|||
156636474|NCT02118896|565413957|FG006|Overall Study|Pregnancy|1|||
156636475|NCT02118896|565413958|FG007|Overall Study|Pregnancy|0|||
156636476|NCT02118896|565413959|FG008|Overall Study|Pregnancy|0|||
156636477|NCT02118896|565413960|FG009|Overall Study|Pregnancy|0|||
156636478|NCT02118896|565413951|FG000|Overall Study|Lost to Follow-up|1|||
156636479|NCT02118896|565413952|FG001|Overall Study|Lost to Follow-up|2|||
156636480|NCT02118896|565413953|FG002|Overall Study|Lost to Follow-up|1|||
156636481|NCT02118896|565413954|FG003|Overall Study|Lost to Follow-up|0|||
156636482|NCT02118896|565413955|FG004|Overall Study|Lost to Follow-up|2|||
156636483|NCT02118896|565413956|FG005|Overall Study|Lost to Follow-up|1|||
156636484|NCT02118896|565413957|FG006|Overall Study|Lost to Follow-up|0|||
156636485|NCT02118896|565413958|FG007|Overall Study|Lost to Follow-up|0|||
156636486|NCT02118896|565413959|FG008|Overall Study|Lost to Follow-up|0|||
156636487|NCT02118896|565413960|FG009|Overall Study|Lost to Follow-up|0|||
156636488|NCT02118896|565413951|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
156636489|NCT02118896|565413952|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
156636490|NCT02118896|565413953|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
156636491|NCT02118896|565413954|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
156636492|NCT02118896|565413955|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
156636493|NCT02118896|565413956|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
156636494|NCT02118896|565413957|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
156636495|NCT02118896|565413958|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
156636496|NCT02118896|565413959|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
156636497|NCT02118896|565413960|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
156636498|NCT02118896|565413951|FG000|Overall Study|Prohibited medication|0|||
156636499|NCT02118896|565413952|FG001|Overall Study|Prohibited medication|0|||
156636500|NCT02118896|565413953|FG002|Overall Study|Prohibited medication|0|||
156636501|NCT02118896|565413954|FG003|Overall Study|Prohibited medication|0|||
156636502|NCT02118896|565413955|FG004|Overall Study|Prohibited medication|1|||
156636503|NCT02118896|565413956|FG005|Overall Study|Prohibited medication|3|||
156636504|NCT02118896|565413957|FG006|Overall Study|Prohibited medication|0|||
156636505|NCT02118896|565413958|FG007|Overall Study|Prohibited medication|0|||
156636506|NCT02118896|565413959|FG008|Overall Study|Prohibited medication|0|||
156636507|NCT02118896|565413960|FG009|Overall Study|Prohibited medication|0|||
156636508|NCT02118896|565413951|FG000|Overall Study|Miscellaneous|1|||
156636509|NCT02118896|565413952|FG001|Overall Study|Miscellaneous|2|||
156636510|NCT02118896|565413953|FG002|Overall Study|Miscellaneous|0|||
156636511|NCT02118896|565413954|FG003|Overall Study|Miscellaneous|2|||
156636512|NCT02118896|565413955|FG004|Overall Study|Miscellaneous|0|||
156636513|NCT02118896|565413956|FG005|Overall Study|Miscellaneous|4|||
156636514|NCT02118896|565413957|FG006|Overall Study|Miscellaneous|0|||
156636515|NCT02118896|565413958|FG007|Overall Study|Miscellaneous|0|||
156636516|NCT02118896|565413959|FG008|Overall Study|Miscellaneous|0|||
156636517|NCT02118896|565413960|FG009|Overall Study|Miscellaneous|0|||
156636518|NCT00566631|565413961|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
156636519|NCT00566631|565413961|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
156636520|NCT00566631|565413961|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
156636521|NCT00566631|565413961|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
156636522|NCT00566631|565413961|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
156636523|NCT00566631|565413961|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
156636524|NCT00566631|565413961|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
156636525|NCT00566631|565413961|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
156636526|NCT00566631|565413961|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
156636527|NCT00566631|565413961|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
156636528|NCT00566631|565413961|FG000|Part 2: Extension Phase|Adverse Event|11|||
156636529|NCT00566631|565413961|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
156636530|NCT00566631|565413961|FG000|Part 2: Extension Phase|Death|1|||
156636531|NCT00566631|565413961|FG000|Part 2: Extension Phase|Other|5|||
156636532|NCT00877799|565413962|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
156636533|NCT00877799|565413963|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
156636534|NCT00877799|565413964|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
156636535|NCT00877799|565413965|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
156636536|NCT00877799|565413966|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
156636537|NCT00877799|565413962|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
156636538|NCT00877799|565413963|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
156636539|NCT00877799|565413964|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
156636540|NCT00877799|565413965|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
156636541|NCT00877799|565413966|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
156636542|NCT00877799|565413962|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
156636543|NCT00877799|565413963|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
156636544|NCT00877799|565413964|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
156636545|NCT00877799|565413965|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
156636546|NCT00877799|565413966|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
156636547|NCT00877799|565413962|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
156636548|NCT00877799|565413963|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
156636549|NCT00877799|565413964|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
156636550|NCT00877799|565413965|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
156636551|NCT00877799|565413966|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
156636552|NCT00877799|565413962|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
156636553|NCT00877799|565413963|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
156636554|NCT00877799|565413964|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
156636555|NCT00877799|565413965|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
156636556|NCT00877799|565413966|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
156636557|NCT04054011|565413967|FG000|Overall Study|COVID|3|||
156636558|NCT00592007|565413968|FG000|Overall Study|Withdrawal by Subject|1|||
156636559|NCT00592007|565413968|FG000|Overall Study|patient ineligible (out of lab range)|1|||
156636560|NCT00595127|565413969|FG000|Overall Study|Death|6|||
156636561|NCT00595127|565413969|FG000|Overall Study|Relapsed|3|||
156636562|NCT00595127|565413969|FG000|Overall Study|joined another trial|1|||
156636563|NCT00557830|565413971|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
156636564|NCT00557830|565413972|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
156636565|NCT00557830|565413973|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
156636566|NCT00557830|565413971|FG000|Screening Treatment Phase|Adverse Event|2|||
156636567|NCT00557830|565413972|FG001|Screening Treatment Phase|Adverse Event|0|||
156636568|NCT00557830|565413973|FG002|Screening Treatment Phase|Adverse Event|0|||
156636569|NCT00557830|565413971|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
156636570|NCT00557830|565413972|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
156636571|NCT00557830|565413973|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
156636572|NCT00538473|565413974|FG000|Overall Study|Adverse Event|1|||
156636573|NCT00538473|565413975|FG001|Overall Study|Adverse Event|0|||
156636574|NCT01569074|565413976|FG000|Overall Study|Study stopped|6|||
156636575|NCT01569074|565413977|FG001|Overall Study|Study stopped|6|||
156636576|NCT01569074|565413978|FG002|Overall Study|Study stopped|8|||
156636577|NCT01569074|565413979|FG003|Overall Study|Study stopped|7|||
156636578|NCT01569074|565413980|FG004|Overall Study|Study stopped|7|||
156636579|NCT01569074|565413976|FG000|Overall Study|Study-specific discontinuation criteria|0|||
156636580|NCT01569074|565413977|FG001|Overall Study|Study-specific discontinuation criteria|1|||
156636581|NCT01569074|565413978|FG002|Overall Study|Study-specific discontinuation criteria|0|||
156636582|NCT01569074|565413979|FG003|Overall Study|Study-specific discontinuation criteria|0|||
156636583|NCT01569074|565413980|FG004|Overall Study|Study-specific discontinuation criteria|0|||
156408316|NCT04537897|564589264|FG008|Overall Study|Other than listed|0|||
156750889|NCT01299896|565840470|FG000|Overall Study|Withdrawal by Subject|1|||
156750890|NCT01299896|565840471|FG001|Overall Study|Withdrawal by Subject|7|||
156750891|NCT01299896|565840470|FG000|Overall Study|Lost to Follow-up|0|||
156750892|NCT01299896|565840471|FG001|Overall Study|Lost to Follow-up|11|||
156750893|NCT01502956|565840474|FG000|Overall Study|Death|0|||
156750894|NCT01502956|565840475|FG001|Overall Study|Death|2|||
156750895|NCT01502956|565840474|FG000|Overall Study|Lost to Follow-up|14|||
156750896|NCT01502956|565840475|FG001|Overall Study|Lost to Follow-up|11|||
156750897|NCT01502956|565840474|FG000|Overall Study|Physician Decision|2|||
156750898|NCT01502956|565840475|FG001|Overall Study|Physician Decision|3|||
156750899|NCT01502956|565840474|FG000|Overall Study|Withdrawal by Subject|8|||
156750900|NCT01502956|565840475|FG001|Overall Study|Withdrawal by Subject|10|||
156750901|NCT04076319|565840476|FG000|Overall Study|Withdrawal by Subject|2|||
156750902|NCT04076319|565840477|FG001|Overall Study|Withdrawal by Subject|0|||
156750903|NCT04076319|565840476|FG000|Overall Study|Death|1|||
156750904|NCT04076319|565840477|FG001|Overall Study|Death|0|||
156750905|NCT02626000|565840478|FG000|Overall Study|Decision by Sponsor|1|||
156750906|NCT02626000|565840478|FG000|Overall Study|Death|29|||
156750907|NCT01411319|565840483|FG000|Overall Study|Lost to Follow-up|1|||
156750908|NCT01796301|565840502|FG000|Overall Study|Withdrawal by Subject|15|||
156750909|NCT01796301|565840503|FG001|Overall Study|Withdrawal by Subject|15|||
156750910|NCT01796301|565840502|FG000|Overall Study|Lost to Follow-up|3|||
156750911|NCT01796301|565840503|FG001|Overall Study|Lost to Follow-up|3|||
156750912|NCT01796301|565840502|FG000|Overall Study|Death|0|||
156750913|NCT01796301|565840503|FG001|Overall Study|Death|1|||
156750914|NCT01796301|565840502|FG000|Overall Study|Decision by Sponsor|0|||
156750915|NCT01796301|565840503|FG001|Overall Study|Decision by Sponsor|1|||
156750916|NCT02187029|565840504|FG000|Overall Study|Adverse Event|0|||
156750917|NCT02187029|565840505|FG001|Overall Study|Adverse Event|1|||
156750918|NCT02187029|565840506|FG002|Overall Study|Adverse Event|1|||
156750919|NCT02187029|565840507|FG003|Overall Study|Adverse Event|0|||
156750920|NCT02187029|565840504|FG000|Overall Study|Study Terminated by Sponsor|0|||
156750921|NCT02187029|565840505|FG001|Overall Study|Study Terminated by Sponsor|0|||
156750922|NCT02187029|565840506|FG002|Overall Study|Study Terminated by Sponsor|10|||
156750923|NCT02187029|565840507|FG003|Overall Study|Study Terminated by Sponsor|3|||
156750924|NCT02187029|565840504|FG000|Overall Study|Withdrawal by Subject|1|||
156750925|NCT02187029|565840505|FG001|Overall Study|Withdrawal by Subject|0|||
156750926|NCT02187029|565840506|FG002|Overall Study|Withdrawal by Subject|0|||
156750927|NCT02187029|565840507|FG003|Overall Study|Withdrawal by Subject|0|||
156750928|NCT04105842|565840508|FG000|Overall Study|Withdrawal by Subject|2|||
156750929|NCT04399889|565840510|FG000|Overall Study|Death|5|||
156750930|NCT04399889|565840511|FG001|Overall Study|Death|1|||
156750931|NCT04399889|565840512|FG002|Overall Study|Death|1|||
156750932|NCT00707980|565840513|FG000|Overall Study|Adverse Event|49|||
156750933|NCT00707980|565840513|FG000|Overall Study|Lack of Efficacy|35|||
156750934|NCT00707980|565840513|FG000|Overall Study|Non-Compliance with Study Drug|28|||
156750935|NCT00707980|565840513|FG000|Overall Study|Protocol Deviations|19|||
156750936|NCT00707980|565840513|FG000|Overall Study|Withdrawal of Consent|81|||
156750937|NCT00707980|565840513|FG000|Overall Study|Lost to Follow-up|59|||
156750938|NCT00707980|565840513|FG000|Overall Study|Other|39|||
156750939|NCT01152996|565840517|FG000|Overall Study|Withdrawal by Subject|142|||
156750940|NCT01152996|565840517|FG000|Overall Study|Adverse Event|115|||
156750941|NCT01152996|565840517|FG000|Overall Study|Lost to Follow-up|112|||
156750942|NCT01152996|565840517|FG000|Overall Study|Lack of Efficacy|68|||
156750943|NCT01152996|565840517|FG000|Overall Study|Noncompliance|41|||
156750944|NCT01152996|565840517|FG000|Overall Study|Other|36|||
156750945|NCT01152996|565840517|FG000|Overall Study|Protocol Violation|22|||
156750946|NCT01152996|565840517|FG000|Overall Study|Elevated liver enzymes|1|||
156750947|NCT00460239|565840519|FG000|Overall Study|Physician Decision|0|||
156750948|NCT00460239|565840520|FG001|Overall Study|Physician Decision|1|||
156750949|NCT00460239|565840521|FG002|Overall Study|Physician Decision|0|||
156750950|NCT00460239|565840522|FG003|Overall Study|Physician Decision|0|||
156750951|NCT00460239|565840523|FG004|Overall Study|Physician Decision|0|||
156750952|NCT00460239|565840524|FG005|Overall Study|Physician Decision|2|||
156750953|NCT00460239|565840525|FG006|Overall Study|Physician Decision|0|||
156750954|NCT00460239|565840526|FG007|Overall Study|Physician Decision|0|||
156750955|NCT00460239|565840527|FG008|Overall Study|Physician Decision|0|||
156750956|NCT00460239|565840519|FG000|Overall Study|Withdrawal by Subject|0|||
156750957|NCT00460239|565840520|FG001|Overall Study|Withdrawal by Subject|0|||
156750958|NCT00460239|565840521|FG002|Overall Study|Withdrawal by Subject|0|||
156750959|NCT00460239|565840522|FG003|Overall Study|Withdrawal by Subject|0|||
156750960|NCT00460239|565840523|FG004|Overall Study|Withdrawal by Subject|0|||
156750961|NCT00460239|565840524|FG005|Overall Study|Withdrawal by Subject|1|||
156750962|NCT00460239|565840525|FG006|Overall Study|Withdrawal by Subject|0|||
156750963|NCT00460239|565840526|FG007|Overall Study|Withdrawal by Subject|0|||
156750964|NCT00460239|565840527|FG008|Overall Study|Withdrawal by Subject|0|||
156750965|NCT01535443|565840529|FG000|Overall Study|Physician Decision|3|||
156750966|NCT00760487|565840531|FG000|Overall Study|Unilateral implantation|3|||
156750967|NCT02260817|565840534|FG000|Overall Study|Lost to Follow-up|0|||
156750968|NCT02260817|565840535|FG001|Overall Study|Lost to Follow-up|14|||
156750969|NCT02260817|565840534|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
156750970|NCT02260817|565840535|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
156750971|NCT02260817|565840534|FG000|Overall Study|Observation, no biopsy|0|||
156750972|NCT02260817|565840535|FG001|Overall Study|Observation, no biopsy|1|||
156750973|NCT02260817|565840534|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
156750974|NCT02260817|565840535|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
156750975|NCT02260817|565840534|FG000|Overall Study|Protocol Violation|0|||
156750976|NCT02260817|565840535|FG001|Overall Study|Protocol Violation|14|||
156750977|NCT00592592|565840540|FG000|Overall Study|Patient found ineligible upon chart review|1|||
156750978|NCT03230838|565840545|FG000|Overall Study|Withdrawal by Subject|3|||
156750979|NCT03230838|565840546|FG001|Overall Study|Withdrawal by Subject|0|||
156750980|NCT03230838|565840545|FG000|Overall Study|Temperature excursion|1|||
156750981|NCT03230838|565840546|FG001|Overall Study|Temperature excursion|0|||
156750982|NCT00435188|565840547|FG000|Overall Study|Death|1|||
156750983|NCT00435188|565840548|FG001|Overall Study|Death|6|||
156750984|NCT00435188|565840547|FG000|Overall Study|Withdrawal by Subject|16|||
156750985|NCT00435188|565840548|FG001|Overall Study|Withdrawal by Subject|11|||
156750986|NCT00435188|565840547|FG000|Overall Study|Lost to Follow-up|5|||
156750987|NCT00435188|565840548|FG001|Overall Study|Lost to Follow-up|6|||
156750988|NCT01915771|565840549|FG000|Day 1|Withdrawal by Subject|1|||
156750989|NCT01915771|565840549|FG000|Day 15|Withdrawal by Subject|1|||
156750990|NCT00575510|565840552|FG000|Overall Study|Lost to Follow-up|4|||
156750991|NCT00575510|565840553|FG001|Overall Study|Lost to Follow-up|6|||
156636584|NCT01569074|565413976|FG000|Overall Study|Severe non-compliance to protocol|0|||
156636585|NCT01569074|565413977|FG001|Overall Study|Severe non-compliance to protocol|0|||
156636586|NCT01569074|565413978|FG002|Overall Study|Severe non-compliance to protocol|1|||
156636587|NCT01569074|565413979|FG003|Overall Study|Severe non-compliance to protocol|0|||
156636588|NCT01569074|565413980|FG004|Overall Study|Severe non-compliance to protocol|0|||
156636589|NCT01569074|565413976|FG000|Overall Study|eg change in circumstances|0|||
156636590|NCT01569074|565413977|FG001|Overall Study|eg change in circumstances|2|||
156636591|NCT01569074|565413978|FG002|Overall Study|eg change in circumstances|0|||
156636592|NCT01569074|565413979|FG003|Overall Study|eg change in circumstances|1|||
156636593|NCT01569074|565413980|FG004|Overall Study|eg change in circumstances|1|||
156636594|NCT01569074|565413976|FG000|Overall Study|Adverse Event|1|||
156636595|NCT01569074|565413977|FG001|Overall Study|Adverse Event|0|||
156636596|NCT01569074|565413978|FG002|Overall Study|Adverse Event|3|||
156636597|NCT01569074|565413979|FG003|Overall Study|Adverse Event|0|||
156636598|NCT01569074|565413980|FG004|Overall Study|Adverse Event|0|||
156636599|NCT02860039|565413986|FG000|Overall Study|Death|4|||
156636600|NCT02860039|565413987|FG001|Overall Study|Death|0|||
156636601|NCT02860039|565413986|FG000|Overall Study|Lost to Follow-up|2|||
156636602|NCT02860039|565413987|FG001|Overall Study|Lost to Follow-up|2|||
156636603|NCT02860039|565413986|FG000|Overall Study|Protocol Violation|3|||
156636604|NCT02860039|565413987|FG001|Overall Study|Protocol Violation|1|||
156636605|NCT02860039|565413986|FG000|Overall Study|Withdrawal by Subject|1|||
156636606|NCT02860039|565413987|FG001|Overall Study|Withdrawal by Subject|0|||
156636607|NCT02860039|565413986|FG000|Overall Study|Not otherwise eligible|1|||
156636608|NCT02860039|565413987|FG001|Overall Study|Not otherwise eligible|1|||
156636609|NCT02723786|565413990|FG000|Overall Study|Lost to Follow-up|1|||
156636610|NCT03170271|565413994|FG000|Overall Study|Adverse Event|7|||
156636611|NCT03170271|565413995|FG001|Overall Study|Adverse Event|2|||
156636612|NCT03170271|565413994|FG000|Overall Study|Lost to Follow-up|0|||
156636613|NCT03170271|565413995|FG001|Overall Study|Lost to Follow-up|1|||
156636614|NCT03170271|565413994|FG000|Overall Study|Physician Decision|1|||
156636615|NCT03170271|565413995|FG001|Overall Study|Physician Decision|0|||
156636616|NCT03170271|565413994|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
156636617|NCT03170271|565413995|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
156636618|NCT03170271|565413994|FG000|Overall Study|Withdrawal by Subject|17|||
156750992|NCT00575510|565840554|FG002|Overall Study|Lost to Follow-up|9|||
156750993|NCT00575510|565840552|FG000|Overall Study|Withdrawal by Subject|1|||
156750994|NCT00575510|565840553|FG001|Overall Study|Withdrawal by Subject|0|||
156750995|NCT00575510|565840554|FG002|Overall Study|Withdrawal by Subject|0|||
156750996|NCT00575510|565840552|FG000|Overall Study|Clinic Called Patient|7|||
156750997|NCT00575510|565840553|FG001|Overall Study|Clinic Called Patient|7|||
156750998|NCT00575510|565840554|FG002|Overall Study|Clinic Called Patient|7|||
156750999|NCT00575510|565840552|FG000|Overall Study|Pregnancy|0|||
156751000|NCT00575510|565840553|FG001|Overall Study|Pregnancy|0|||
156751001|NCT00575510|565840554|FG002|Overall Study|Pregnancy|1|||
156751002|NCT02697734|565840555|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
156636619|NCT03170271|565413995|FG001|Overall Study|Withdrawal by Subject|5|||
156636620|NCT03170271|565413994|FG000|Overall Study|Other|2|||
156636621|NCT03170271|565413995|FG001|Overall Study|Other|2|||
156636622|NCT03170271|565413994|FG000|Overall Study|Randomized in error|4|||
156636623|NCT03170271|565413995|FG001|Overall Study|Randomized in error|0|||
156636624|NCT01036594|565413999|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
156636625|NCT01036594|565414000|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
156751003|NCT02697734|565840556|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
156751004|NCT02697734|565840555|FG000|Core Phase - up to Week 48|Adverse Event|1|||
156751005|NCT02697734|565840556|FG001|Core Phase - up to Week 48|Adverse Event|2|||
156751006|NCT02697734|565840555|FG000|Core Phase - up to Week 48|Physician Decision|1|||
156751007|NCT02697734|565840556|FG001|Core Phase - up to Week 48|Physician Decision|0|||
156751008|NCT02697734|565840555|FG000|Optional Extension Phase|Adverse Event|5|||
156751009|NCT02697734|565840556|FG001|Optional Extension Phase|Adverse Event|1|||
156751010|NCT02697734|565840555|FG000|Optional Extension Phase|Physician Decision|0|||
156751011|NCT02697734|565840556|FG001|Optional Extension Phase|Physician Decision|1|||
156751012|NCT03970200|565840557|FG000|Overall Study|Death|2|||
156751013|NCT03970200|565840558|FG001|Overall Study|Death|2|||
156751014|NCT03970200|565840559|FG002|Overall Study|Death|1|||
156751015|NCT03970200|565840557|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
156751016|NCT03970200|565840558|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
156751017|NCT03970200|565840559|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
156751018|NCT01607346|565840560|FG000|Overall Study|Adverse Event|3|||
156751019|NCT01098162|565840561|FG000|Overall Study|Adverse Event|37|||
156751020|NCT01098162|565840561|FG000|Overall Study|Lack of Efficacy|4|||
156751021|NCT01098162|565840561|FG000|Overall Study|Wish of Patient|7|||
156751022|NCT01098162|565840561|FG000|Overall Study|Lost to Follow-up|9|||
156751023|NCT01098162|565840561|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
156751024|NCT01098162|565840561|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
156751025|NCT01098162|565840561|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
156751026|NCT01098162|565840561|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
156751027|NCT01098162|565840561|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
156751028|NCT01098162|565840561|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
156751029|NCT01098162|565840561|FG000|Overall Study|Other Reason|1|||
156751030|NCT01098162|565840561|FG000|Overall Study|Reason Unknown|26|||
156751031|NCT01605825|565840562|FG000|Overall Study|Adverse Event|4|||
156751032|NCT01605825|565840563|FG001|Overall Study|Adverse Event|2|||
156751033|NCT01605825|565840562|FG000|Overall Study|Withdrawal by Subject|0|||
156751034|NCT01605825|565840563|FG001|Overall Study|Withdrawal by Subject|1|||
156751035|NCT01605825|565840562|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
156751036|NCT01605825|565840563|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
156751037|NCT01605825|565840562|FG000|Overall Study|Non-Compliance with Protocol|3|||
156751038|NCT01605825|565840563|FG001|Overall Study|Non-Compliance with Protocol|0|||
156751039|NCT02279745|565840564|FG000|Overall Study|Adverse Event|7|||
156751040|NCT02279745|565840564|FG000|Overall Study|Death|6|||
156751041|NCT02279745|565840564|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
156751042|NCT02279745|565840564|FG000|Overall Study|Withdrawal by Subject|2|||
156751043|NCT02279745|565840564|FG000|Overall Study|Pregnancy|1|||
156751044|NCT02279745|565840564|FG000|Overall Study|Study Non-compliance|1|||
156751045|NCT02279745|565840564|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
156751046|NCT00380718|565840565|FG000|Overall Study|Adverse Event|1|||
156751047|NCT00380718|565840565|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
156751048|NCT01706575|565840567|FG000|Overall Study|Participant Withdrew Consent|4|||
156751049|NCT01706575|565840567|FG000|Overall Study|Lost to Follow-up|2|||
156751050|NCT01706575|565840567|FG000|Overall Study|Started but not Treated|6|||
156751051|NCT02155322|565840576|FG000|Overall Study|Adverse Event|1|||
156751052|NCT02155322|565840576|FG000|Overall Study|Physician Decision|1|||
156751053|NCT02155322|565840576|FG000|Overall Study|Relapse/Recurrence|8|||
156751054|NCT02155322|565840576|FG000|Overall Study|Withdrawal by Subject|4|||
156751055|NCT00840034|565840582|FG000|Acute Treatment Phase|Adverse Event|6|||
156751056|NCT00840034|565840583|FG001|Acute Treatment Phase|Adverse Event|8|||
156751057|NCT00840034|565840582|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
156751058|NCT00840034|565840583|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
156751059|NCT00840034|565840582|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
156751060|NCT00840034|565840583|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
156751061|NCT00840034|565840582|FG000|Acute Treatment Phase|Physician Decision|0|||
156751062|NCT00840034|565840583|FG001|Acute Treatment Phase|Physician Decision|1|||
156751063|NCT00840034|565840582|FG000|Acute Treatment Phase|Protocol Violation|2|||
156751064|NCT00840034|565840583|FG001|Acute Treatment Phase|Protocol Violation|4|||
156751065|NCT00840034|565840582|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
156751066|NCT00840034|565840583|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
156751067|NCT00840034|565840582|FG000|Taper Phase|Adverse Event|1|||
156751068|NCT00840034|565840583|FG001|Taper Phase|Adverse Event|0|||
156751069|NCT00840034|565840582|FG000|Taper Phase|Lost to Follow-up|1|||
156751070|NCT00840034|565840583|FG001|Taper Phase|Lost to Follow-up|1|||
156751071|NCT00840034|565840582|FG000|Taper Phase|Withdrawal by Subject|1|||
156751072|NCT00840034|565840583|FG001|Taper Phase|Withdrawal by Subject|1|||
156751073|NCT01215435|565840584|FG000|Overall Study|Adverse Event|1|||
156751074|NCT01215435|565840585|FG001|Overall Study|Adverse Event|0|||
156751075|NCT01215435|565840584|FG000|Overall Study|Protocol Violation|2|||
156751076|NCT01215435|565840585|FG001|Overall Study|Protocol Violation|0|||
156751077|NCT01215435|565840584|FG000|Overall Study|Withdrawal Criteria|8|||
156864962|NCT05966142|566265385|FG001|Overall Study|Withdrawal by Subject|8|||
156751078|NCT01215435|565840585|FG001|Overall Study|Withdrawal Criteria|11|||
156751079|NCT01215435|565840584|FG000|Overall Study|Lost to Follow-up|3|||
156751080|NCT01215435|565840585|FG001|Overall Study|Lost to Follow-up|0|||
156751081|NCT01215435|565840584|FG000|Overall Study|Unclassified|5|||
156751082|NCT01215435|565840585|FG001|Overall Study|Unclassified|5|||
156751083|NCT02839876|565840590|FG000|Overall Study|Protocol Violation|10|||
156751084|NCT02839876|565840591|FG001|Overall Study|Protocol Violation|11|||
156751085|NCT01428115|565840594|FG000|Overall Study|Lack of Efficacy|3|||
156751086|NCT01428115|565840594|FG000|Overall Study|Lost to Follow-up|10|||
156751087|NCT01428115|565840594|FG000|Overall Study|Pregnancy|1|||
156751088|NCT01428115|565840594|FG000|Overall Study|Protocol Violation|3|||
156751089|NCT01428115|565840594|FG000|Overall Study|Withdrawal by Subject|4|||
156751090|NCT01738191|565840595|FG000|Overall Study|Withdrawal by Subject|4|||
156751091|NCT01738191|565840596|FG001|Overall Study|Withdrawal by Subject|1|||
156751092|NCT02483572|565840597|FG000|Overall Study|Withdrawal by Subject|1|||
156751093|NCT02483572|565840598|FG001|Overall Study|Withdrawal by Subject|0|||
156751094|NCT02483572|565840597|FG000|Overall Study|Lost to Follow-up|1|||
156751095|NCT02483572|565840598|FG001|Overall Study|Lost to Follow-up|0|||
156751096|NCT02483572|565840597|FG000|Overall Study|Physician Decision|0|||
156751097|NCT02483572|565840598|FG001|Overall Study|Physician Decision|1|||
156751098|NCT00350779|565840599|FG000|Overall Study|Adverse Event|4|||
156751099|NCT00350779|565840600|FG001|Overall Study|Adverse Event|2|||
156751100|NCT00350779|565840599|FG000|Overall Study|Lack of Efficacy|0|||
156751101|NCT00350779|565840600|FG001|Overall Study|Lack of Efficacy|4|||
156751102|NCT00350779|565840599|FG000|Overall Study|Lost to Follow-up|2|||
156751103|NCT00350779|565840600|FG001|Overall Study|Lost to Follow-up|0|||
156751104|NCT00350779|565840599|FG000|Overall Study|Physician Decision|2|||
156751105|NCT00350779|565840600|FG001|Overall Study|Physician Decision|4|||
156751106|NCT00350779|565840599|FG000|Overall Study|Protocol Violation|3|||
156751107|NCT00350779|565840600|FG001|Overall Study|Protocol Violation|1|||
156751108|NCT00350779|565840599|FG000|Overall Study|Withdrawal by Subject|9|||
156751109|NCT00350779|565840600|FG001|Overall Study|Withdrawal by Subject|8|||
156751110|NCT00350779|565840599|FG000|Overall Study|Patient Moved|2|||
156751111|NCT00350779|565840600|FG001|Overall Study|Patient Moved|1|||
156751112|NCT00350779|565840599|FG000|Overall Study|Non-compliance with study procedures|0|||
156751113|NCT00350779|565840600|FG001|Overall Study|Non-compliance with study procedures|1|||
156751114|NCT00262002|565840603|FG000|Overall Study|Adverse Event|2|||
156751115|NCT00262002|565840604|FG001|Overall Study|Adverse Event|1|||
156751116|NCT00262002|565840605|FG002|Overall Study|Adverse Event|0|||
156751117|NCT00262002|565840606|FG003|Overall Study|Adverse Event|0|||
156751118|NCT00262002|565840607|FG004|Overall Study|Adverse Event|0|||
156751119|NCT00262002|565840608|FG005|Overall Study|Adverse Event|1|||
156751120|NCT00262002|565840609|FG006|Overall Study|Adverse Event|0|||
156751121|NCT00262002|565840603|FG000|Overall Study|Withdrawal by Subject|4|||
156751122|NCT00262002|565840604|FG001|Overall Study|Withdrawal by Subject|2|||
156751123|NCT00262002|565840605|FG002|Overall Study|Withdrawal by Subject|0|||
156751124|NCT00262002|565840606|FG003|Overall Study|Withdrawal by Subject|1|||
156751125|NCT00262002|565840607|FG004|Overall Study|Withdrawal by Subject|2|||
156751126|NCT00262002|565840608|FG005|Overall Study|Withdrawal by Subject|2|||
156751127|NCT00262002|565840609|FG006|Overall Study|Withdrawal by Subject|2|||
156751128|NCT00262002|565840603|FG000|Overall Study|Lost to Follow-up|2|||
156751129|NCT00262002|565840604|FG001|Overall Study|Lost to Follow-up|0|||
156751130|NCT00262002|565840605|FG002|Overall Study|Lost to Follow-up|0|||
156751131|NCT00262002|565840606|FG003|Overall Study|Lost to Follow-up|2|||
156751132|NCT00262002|565840607|FG004|Overall Study|Lost to Follow-up|0|||
156751133|NCT00262002|565840608|FG005|Overall Study|Lost to Follow-up|1|||
156751134|NCT00262002|565840609|FG006|Overall Study|Lost to Follow-up|0|||
156751135|NCT00262002|565840603|FG000|Overall Study|Inapropriate enrollment|0|||
156751136|NCT00262002|565840604|FG001|Overall Study|Inapropriate enrollment|1|||
156751137|NCT00262002|565840605|FG002|Overall Study|Inapropriate enrollment|0|||
156751138|NCT00262002|565840606|FG003|Overall Study|Inapropriate enrollment|0|||
156751139|NCT00262002|565840607|FG004|Overall Study|Inapropriate enrollment|0|||
156751140|NCT00262002|565840608|FG005|Overall Study|Inapropriate enrollment|0|||
156751141|NCT00262002|565840609|FG006|Overall Study|Inapropriate enrollment|0|||
156751142|NCT00262002|565840603|FG000|Overall Study|Protocol Violation|3|||
156751143|NCT00262002|565840604|FG001|Overall Study|Protocol Violation|2|||
156751144|NCT00262002|565840605|FG002|Overall Study|Protocol Violation|0|||
156751145|NCT00262002|565840606|FG003|Overall Study|Protocol Violation|2|||
156751146|NCT00262002|565840607|FG004|Overall Study|Protocol Violation|5|||
156751147|NCT00262002|565840608|FG005|Overall Study|Protocol Violation|3|||
156751148|NCT00262002|565840609|FG006|Overall Study|Protocol Violation|2|||
156751149|NCT00262002|565840603|FG000|Overall Study|Unable to classify|0|||
156751150|NCT00262002|565840604|FG001|Overall Study|Unable to classify|0|||
156751151|NCT00262002|565840605|FG002|Overall Study|Unable to classify|0|||
156751152|NCT00262002|565840606|FG003|Overall Study|Unable to classify|0|||
156751153|NCT00262002|565840607|FG004|Overall Study|Unable to classify|0|||
156751154|NCT00262002|565840608|FG005|Overall Study|Unable to classify|0|||
156751155|NCT00262002|565840609|FG006|Overall Study|Unable to classify|2|||
156751156|NCT03951753|565840610|FG000|Overall Study|Adverse Event|1|||
156751157|NCT03951753|565840611|FG001|Overall Study|Adverse Event|0|||
156751158|NCT03951753|565840612|FG002|Overall Study|Adverse Event|3|||
156751159|NCT03951753|565840610|FG000|Overall Study|Withdrawal by Subject|3|||
156751160|NCT03951753|565840611|FG001|Overall Study|Withdrawal by Subject|1|||
156751161|NCT03951753|565840612|FG002|Overall Study|Withdrawal by Subject|0|||
156751162|NCT03951753|565840610|FG000|Overall Study|Lost to Follow-up|0|||
156751163|NCT03951753|565840611|FG001|Overall Study|Lost to Follow-up|0|||
156751164|NCT03951753|565840612|FG002|Overall Study|Lost to Follow-up|1|||
156751165|NCT01905592|565840615|FG000|Overall Study|Disease Progression|51|||
156751166|NCT01905592|565840616|FG001|Overall Study|Disease Progression|110|||
156751167|NCT01905592|565840615|FG000|Overall Study|Toxicity|1|||
156751168|NCT01905592|565840616|FG001|Overall Study|Toxicity|16|||
156751169|NCT01905592|565840615|FG000|Overall Study|Physician Decision|0|||
156751170|NCT01905592|565840616|FG001|Overall Study|Physician Decision|2|||
156751171|NCT01905592|565840615|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
156751172|NCT01905592|565840616|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
156751173|NCT01905592|565840615|FG000|Overall Study|Protocol Violation|0|||
156751174|NCT01905592|565840616|FG001|Overall Study|Protocol Violation|1|||
156751175|NCT01905592|565840615|FG000|Overall Study|Sponsor's decision|1|||
156751176|NCT01905592|565840616|FG001|Overall Study|Sponsor's decision|1|||
156751177|NCT01905592|565840615|FG000|Overall Study|Not treated|7|||
156751178|NCT01905592|565840616|FG001|Overall Study|Not treated|3|||
156636626|NCT01036594|565413999|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
156636627|NCT01036594|565414000|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
156636628|NCT01036594|565413999|FG000|Week 12 Evaluation|Adverse Event|5|||
156636629|NCT01036594|565414000|FG001|Week 12 Evaluation|Adverse Event|0|||
156636630|NCT01036594|565413999|FG000|Week 12 Evaluation|Physician Decision|1|||
156636631|NCT01036594|565414000|FG001|Week 12 Evaluation|Physician Decision|0|||
156636632|NCT01036594|565413999|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
156636633|NCT01036594|565414000|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
156636634|NCT01036594|565413999|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
156636635|NCT01036594|565414000|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
156636636|NCT01036594|565413999|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
156636637|NCT01036594|565414000|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
156636638|NCT01036594|565413999|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
156636639|NCT01036594|565414000|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
156636640|NCT01036594|565413999|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
156636641|NCT01036594|565414000|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
156636642|NCT03466060|565414003|FG000|Period 1|Test Lens Damage|0|||
156636643|NCT03466060|565414004|FG001|Period 1|Test Lens Damage|2|||
156636644|NCT03466060|565414005|FG002|Period 1|Test Lens Damage|0|||
156636645|NCT03466060|565414006|FG003|Period 1|Test Lens Damage|0|||
156636646|NCT03466060|565414007|FG004|Period 1|Test Lens Damage|0|||
156636647|NCT03466060|565414008|FG005|Period 1|Test Lens Damage|0|||
156636648|NCT03466060|565414003|FG000|Period 1|Withdrawal by Subject|0|||
156636649|NCT03466060|565414004|FG001|Period 1|Withdrawal by Subject|0|||
156636650|NCT03466060|565414005|FG002|Period 1|Withdrawal by Subject|2|||
156636651|NCT03466060|565414006|FG003|Period 1|Withdrawal by Subject|0|||
156636652|NCT03466060|565414007|FG004|Period 1|Withdrawal by Subject|0|||
156636653|NCT03466060|565414008|FG005|Period 1|Withdrawal by Subject|0|||
156636654|NCT03466060|565414003|FG000|Period 1|Lost to Follow-up|0|||
156636655|NCT03466060|565414004|FG001|Period 1|Lost to Follow-up|0|||
156636656|NCT03466060|565414005|FG002|Period 1|Lost to Follow-up|0|||
156636657|NCT03466060|565414006|FG003|Period 1|Lost to Follow-up|1|||
156636658|NCT03466060|565414007|FG004|Period 1|Lost to Follow-up|0|||
156636659|NCT03466060|565414008|FG005|Period 1|Lost to Follow-up|0|||
156636660|NCT03466060|565414003|FG000|Period 1|Grade 2 Conjunctivitis|0|||
156636661|NCT03466060|565414004|FG001|Period 1|Grade 2 Conjunctivitis|0|||
156636662|NCT03466060|565414005|FG002|Period 1|Grade 2 Conjunctivitis|1|||
156636663|NCT03466060|565414006|FG003|Period 1|Grade 2 Conjunctivitis|0|||
156636664|NCT03466060|565414007|FG004|Period 1|Grade 2 Conjunctivitis|0|||
156636665|NCT03466060|565414008|FG005|Period 1|Grade 2 Conjunctivitis|0|||
156636666|NCT03466060|565414003|FG000|Period 2|Lens Handling Difficulties|0|||
156751179|NCT01905592|565840615|FG000|Overall Study|Withdrawal by Subject|10|||
156751180|NCT01905592|565840616|FG001|Overall Study|Withdrawal by Subject|2|||
156751181|NCT02109445|565840617|FG000|Overall Study|Symptomatic deterioration|2|||
156751182|NCT02109445|565840617|FG000|Overall Study|Adverse Event|1|||
156751183|NCT00966355|565840622|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
156751184|NCT00966355|565840623|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
156751185|NCT00966355|565840624|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
156636667|NCT03466060|565414004|FG001|Period 2|Lens Handling Difficulties|0|||
156636668|NCT03466060|565414005|FG002|Period 2|Lens Handling Difficulties|1|||
156636669|NCT03466060|565414006|FG003|Period 2|Lens Handling Difficulties|0|||
156636670|NCT03466060|565414007|FG004|Period 2|Lens Handling Difficulties|0|||
156636671|NCT03466060|565414008|FG005|Period 2|Lens Handling Difficulties|0|||
156636672|NCT00244881|565414011|FG000|Overall Study|Withdrawal by Subject|3|||
156751186|NCT00966355|565840622|FG000|Overall Study|newly diagnosed advanced HCC|11|||
156751187|NCT00966355|565840623|FG001|Overall Study|newly diagnosed advanced HCC|12|||
156751188|NCT00966355|565840624|FG002|Overall Study|newly diagnosed advanced HCC|10|||
156751189|NCT00966355|565840622|FG000|Overall Study|Lost to Follow-up|5|||
156751190|NCT00966355|565840623|FG001|Overall Study|Lost to Follow-up|4|||
156751191|NCT00966355|565840624|FG002|Overall Study|Lost to Follow-up|3|||
156751192|NCT00958412|565840625|FG000|Overall Study|Study prematurely terminated|18|||
156751193|NCT02526160|565841941|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
156751194|NCT02526160|565841942|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
156751195|NCT02526160|565841941|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
156751196|NCT02526160|565841942|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
156751197|NCT02526160|565841941|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
156751198|NCT02526160|565841942|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
156751199|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period I|Death|0|||
156751200|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period I|Death|1|||
156751201|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
156751202|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
156751203|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
156751204|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
156751205|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
156751206|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
156751207|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
156751208|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
156751209|NCT00398216|565841943|FG000|Overall Study|Adverse Event|4|||
156636673|NCT03345485|565414012|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
156636674|NCT03345485|565414013|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
156636675|NCT03345485|565414014|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
156636676|NCT03345485|565414015|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
156636677|NCT03345485|565414016|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
156636678|NCT03345485|565414017|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
156636679|NCT03345485|565414018|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
156636680|NCT03345485|565414019|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
156636681|NCT03345485|565414020|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
156636682|NCT03345485|565414021|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
156636683|NCT03345485|565414022|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
156636684|NCT03345485|565414023|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
156636685|NCT03345485|565414024|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
156636686|NCT01610284|565414025|FG000|Randomization Phase|Adverse Event|1|||
156636687|NCT01610284|565414026|FG001|Randomization Phase|Adverse Event|0|||
156636688|NCT01610284|565414025|FG000|Randomization Phase|Physician Decision|1|||
156636689|NCT01610284|565414026|FG001|Randomization Phase|Physician Decision|1|||
156636690|NCT01610284|565414025|FG000|Randomization Phase|Death|0|||
156636691|NCT01610284|565414026|FG001|Randomization Phase|Death|1|||
156636692|NCT01610284|565414025|FG000|Treatment Phase|Adverse Event|80|||
156636693|NCT01610284|565414026|FG001|Treatment Phase|Adverse Event|12|||
156636694|NCT01610284|565414025|FG000|Treatment Phase|Lost to Follow-up|1|||
156636695|NCT01610284|565414026|FG001|Treatment Phase|Lost to Follow-up|0|||
156636696|NCT01610284|565414025|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
156636697|NCT01610284|565414026|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
156636698|NCT01610284|565414025|FG000|Treatment Phase|Physician Decision|27|||
156636699|NCT01610284|565414026|FG001|Treatment Phase|Physician Decision|24|||
156636700|NCT01610284|565414025|FG000|Treatment Phase|Progressive Disease|377|||
156636701|NCT01610284|565414026|FG001|Treatment Phase|Progressive Disease|486|||
156636702|NCT01610284|565414025|FG000|Treatment Phase|Protocol Deviation|2|||
156636703|NCT01610284|565414026|FG001|Treatment Phase|Protocol Deviation|3|||
156636704|NCT01610284|565414025|FG000|Treatment Phase|Study terminated by Sponsor|18|||
156636705|NCT01610284|565414026|FG001|Treatment Phase|Study terminated by Sponsor|15|||
156636706|NCT01610284|565414025|FG000|Treatment Phase|Subject/Guardian Decision|55|||
156636707|NCT01610284|565414026|FG001|Treatment Phase|Subject/Guardian Decision|23|||
156636708|NCT01610284|565414025|FG000|Treatment Phase|Death|6|||
156636709|NCT01610284|565414026|FG001|Treatment Phase|Death|5|||
156636710|NCT01610284|565414025|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
156636711|NCT01610284|565414026|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156636712|NCT01610284|565414025|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
156636713|NCT01610284|565414026|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
156636714|NCT01610284|565414025|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
156636715|NCT01610284|565414026|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
156636716|NCT01610284|565414025|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
156751210|NCT00398216|565841944|FG001|Overall Study|Adverse Event|2|||
156751211|NCT00398216|565841945|FG002|Overall Study|Adverse Event|5|||
156751212|NCT00398216|565841946|FG003|Overall Study|Adverse Event|7|||
156751213|NCT00398216|565841947|FG004|Overall Study|Adverse Event|2|||
156636717|NCT01610284|565414026|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
156636718|NCT01610284|565414025|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
156636719|NCT01610284|565414026|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
156636720|NCT01610284|565414025|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
156636721|NCT01610284|565414026|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
156636722|NCT03020966|565414027|FG000|Overall Study|Withdrawal by Subject|2|||
156636723|NCT03020966|565414028|FG001|Overall Study|Withdrawal by Subject|0|||
156636724|NCT01856257|565414029|FG000|Overall Study|Death|2|||
156636725|NCT01856257|565414030|FG001|Overall Study|Death|0|||
156636726|NCT01856257|565414031|FG002|Overall Study|Death|0|||
156751214|NCT00398216|565841943|FG000|Overall Study|Protocol Violation|2|||
156751215|NCT00398216|565841944|FG001|Overall Study|Protocol Violation|4|||
156751216|NCT00398216|565841945|FG002|Overall Study|Protocol Violation|5|||
156751217|NCT00398216|565841946|FG003|Overall Study|Protocol Violation|7|||
156751218|NCT00398216|565841947|FG004|Overall Study|Protocol Violation|5|||
156751219|NCT00398216|565841943|FG000|Overall Study|Lost to Follow-up|1|||
156751220|NCT00398216|565841944|FG001|Overall Study|Lost to Follow-up|6|||
156751221|NCT00398216|565841945|FG002|Overall Study|Lost to Follow-up|4|||
156751222|NCT00398216|565841946|FG003|Overall Study|Lost to Follow-up|4|||
156751223|NCT00398216|565841947|FG004|Overall Study|Lost to Follow-up|1|||
156751224|NCT00398216|565841943|FG000|Overall Study|Death|0|||
156751225|NCT00398216|565841944|FG001|Overall Study|Death|3|||
156751226|NCT00398216|565841945|FG002|Overall Study|Death|0|||
156751227|NCT00398216|565841946|FG003|Overall Study|Death|0|||
156751228|NCT00398216|565841947|FG004|Overall Study|Death|0|||
156751229|NCT00398216|565841943|FG000|Overall Study|Withdrawal by Subject|1|||
156751230|NCT00398216|565841944|FG001|Overall Study|Withdrawal by Subject|0|||
156751231|NCT00398216|565841945|FG002|Overall Study|Withdrawal by Subject|3|||
156636727|NCT01856257|565414032|FG003|Overall Study|Death|0|||
156636728|NCT01856257|565414029|FG000|Overall Study|Physician Decision|0|||
156636729|NCT01856257|565414030|FG001|Overall Study|Physician Decision|0|||
156636730|NCT01856257|565414031|FG002|Overall Study|Physician Decision|0|||
156636731|NCT01856257|565414032|FG003|Overall Study|Physician Decision|1|||
156636732|NCT01856257|565414029|FG000|Overall Study|Withdrawal by Subject|1|||
156636733|NCT01856257|565414030|FG001|Overall Study|Withdrawal by Subject|1|||
156636734|NCT01856257|565414031|FG002|Overall Study|Withdrawal by Subject|0|||
156636735|NCT01856257|565414032|FG003|Overall Study|Withdrawal by Subject|0|||
156636736|NCT01856257|565414029|FG000|Overall Study|Donor complication|0|||
156636737|NCT01856257|565414030|FG001|Overall Study|Donor complication|0|||
156636738|NCT01856257|565414031|FG002|Overall Study|Donor complication|0|||
156751232|NCT00398216|565841946|FG003|Overall Study|Withdrawal by Subject|1|||
156751233|NCT00398216|565841947|FG004|Overall Study|Withdrawal by Subject|2|||
156751234|NCT00398216|565841943|FG000|Overall Study|administrative reasons|3|||
156751235|NCT00398216|565841944|FG001|Overall Study|administrative reasons|4|||
156751236|NCT00398216|565841945|FG002|Overall Study|administrative reasons|4|||
156636739|NCT01856257|565414032|FG003|Overall Study|Donor complication|1|||
156636740|NCT01125358|565414036|FG000|Overall Study|Adverse Event|3|||
156636741|NCT01125358|565414037|FG001|Overall Study|Adverse Event|0|||
156636742|NCT01125358|565414038|FG002|Overall Study|Adverse Event|0|||
156636743|NCT01125358|565414039|FG003|Overall Study|Adverse Event|2|||
156636744|NCT01125358|565414036|FG000|Overall Study|Perceived Lack of Efficacy|6|||
156636745|NCT01125358|565414037|FG001|Overall Study|Perceived Lack of Efficacy|3|||
156636746|NCT01125358|565414038|FG002|Overall Study|Perceived Lack of Efficacy|7|||
156636747|NCT01125358|565414039|FG003|Overall Study|Perceived Lack of Efficacy|4|||
156636748|NCT01125358|565414036|FG000|Overall Study|Protocol Violation|1|||
156636749|NCT01125358|565414037|FG001|Overall Study|Protocol Violation|0|||
156636750|NCT01125358|565414038|FG002|Overall Study|Protocol Violation|0|||
156636751|NCT01125358|565414039|FG003|Overall Study|Protocol Violation|0|||
156636752|NCT01125358|565414036|FG000|Overall Study|Sponsor Decision|0|||
156636753|NCT01125358|565414037|FG001|Overall Study|Sponsor Decision|0|||
156636754|NCT01125358|565414038|FG002|Overall Study|Sponsor Decision|1|||
156636755|NCT01125358|565414039|FG003|Overall Study|Sponsor Decision|1|||
156636756|NCT01125358|565414036|FG000|Overall Study|Withdrawal by Subject|2|||
156636757|NCT01125358|565414037|FG001|Overall Study|Withdrawal by Subject|1|||
156636758|NCT01125358|565414038|FG002|Overall Study|Withdrawal by Subject|1|||
156636759|NCT01125358|565414039|FG003|Overall Study|Withdrawal by Subject|1|||
156636760|NCT05168657|565414042|FG000|Overall Study|Adverse Event|0|||
156636761|NCT05168657|565414043|FG001|Overall Study|Adverse Event|0|||
156636762|NCT05168657|565414044|FG002|Overall Study|Adverse Event|1|||
156636763|NCT05168657|565414045|FG003|Overall Study|Adverse Event|0|||
156751237|NCT00398216|565841946|FG003|Overall Study|administrative reasons|3|||
156751238|NCT00398216|565841947|FG004|Overall Study|administrative reasons|3|||
156751239|NCT00398216|565841943|FG000|Overall Study|entrance criteria|0|||
156751240|NCT00398216|565841944|FG001|Overall Study|entrance criteria|0|||
156751241|NCT00398216|565841945|FG002|Overall Study|entrance criteria|0|||
156751242|NCT00398216|565841946|FG003|Overall Study|entrance criteria|0|||
156751243|NCT00398216|565841947|FG004|Overall Study|entrance criteria|2|||
156751244|NCT02985021|565841948|FG000|Overall Study|Inability to comply with study procedures|1|||
156751245|NCT03299101|565841953|FG000|Overall Study|Lost to Follow-up|1|||
156751246|NCT03299101|565841953|FG000|Overall Study|Withdrawal by Subject|5|||
156751247|NCT03299101|565841953|FG000|Overall Study|Surgery was changed|3|||
156751248|NCT03299101|565841953|FG000|Overall Study|Not enough time to complete prehab|1|||
156751249|NCT01884545|565841956|FG000|Overall Study|Lost to Follow-up|6|||
156751250|NCT01884545|565841957|FG001|Overall Study|Lost to Follow-up|4|||
156751251|NCT01884545|565841958|FG002|Overall Study|Lost to Follow-up|9|||
156751252|NCT01884545|565841959|FG003|Overall Study|Lost to Follow-up|4|||
156751253|NCT01884545|565841956|FG000|Overall Study|Patient withdrawn|7|||
156751254|NCT01884545|565841957|FG001|Overall Study|Patient withdrawn|12|||
156751255|NCT01884545|565841958|FG002|Overall Study|Patient withdrawn|5|||
156751256|NCT01884545|565841959|FG003|Overall Study|Patient withdrawn|5|||
156751257|NCT01884545|565841956|FG000|Overall Study|Non-adherence|0|||
156751258|NCT01884545|565841957|FG001|Overall Study|Non-adherence|2|||
156751259|NCT01884545|565841958|FG002|Overall Study|Non-adherence|0|||
156751260|NCT01884545|565841959|FG003|Overall Study|Non-adherence|0|||
156751261|NCT01424241|565841960|FG000|Overall Study|Withdrawal by Subject|1|||
156751262|NCT01424241|565841960|FG000|Overall Study|Time constraints|2|||
156751263|NCT00551525|565841961|FG000|Overall Study|Protocol Violation|5|||
156751264|NCT05259917|565841963|FG000|Overall Study|Protocol Violation|0|||
156751265|NCT05259917|565841964|FG001|Overall Study|Protocol Violation|0|||
156751266|NCT05259917|565841965|FG002|Overall Study|Protocol Violation|1|||
156751267|NCT05259917|565841966|FG003|Overall Study|Protocol Violation|0|||
156751268|NCT05259917|565841967|FG004|Overall Study|Protocol Violation|0|||
156751269|NCT05259917|565841968|FG005|Overall Study|Protocol Violation|0|||
156751270|NCT05259917|565841963|FG000|Overall Study|Lost to Follow-up|0|||
156751271|NCT05259917|565841964|FG001|Overall Study|Lost to Follow-up|0|||
156751272|NCT05259917|565841965|FG002|Overall Study|Lost to Follow-up|1|||
156751273|NCT05259917|565841966|FG003|Overall Study|Lost to Follow-up|0|||
156751274|NCT05259917|565841967|FG004|Overall Study|Lost to Follow-up|0|||
156751275|NCT05259917|565841968|FG005|Overall Study|Lost to Follow-up|1|||
156751276|NCT05259917|565841963|FG000|Overall Study|Physician Decision|0|||
156636764|NCT05168657|565414046|FG004|Overall Study|Adverse Event|0|||
156636765|NCT05168657|565414047|FG005|Overall Study|Adverse Event|0|||
156636766|NCT05168657|565414048|FG006|Overall Study|Adverse Event|0|||
156636767|NCT05168657|565414049|FG007|Overall Study|Adverse Event|0|||
156636768|NCT04935931|565414050|FG000|Overall Study|Withdrawal by Subject|1|||
156636769|NCT00962013|565414051|FG000|Overall Study|Did not have surgery|1|||
156636770|NCT00962013|565414051|FG000|Overall Study|Death|8|||
156636771|NCT00962013|565414051|FG000|Overall Study|Lost to Follow-up|12|||
156636772|NCT00962013|565414051|FG000|Overall Study|Unable/Unwilling to return|6|||
156636773|NCT00962013|565414051|FG000|Overall Study|Withdrawal by Subject|8|||
156636774|NCT00962013|565414051|FG000|Overall Study|Removal of study device|3|||
156636775|NCT00962013|565414051|FG000|Overall Study|Site Termination|24|||
156636776|NCT00962013|565414051|FG000|Overall Study|No 5 year evaluation|6|||
156636777|NCT00077766|565414061|FG000|Overall Study|Adverse Event|1|||
156636778|NCT00077766|565414062|FG001|Overall Study|Adverse Event|1|||
156636779|NCT00077766|565414061|FG000|Overall Study|Withdrawal by Subject|4|||
156636780|NCT00077766|565414062|FG001|Overall Study|Withdrawal by Subject|3|||
156636781|NCT00077766|565414061|FG000|Overall Study|Death|12|||
156636782|NCT00077766|565414062|FG001|Overall Study|Death|10|||
156636783|NCT00077766|565414061|FG000|Overall Study|Lost to Follow-up|2|||
156636784|NCT00077766|565414062|FG001|Overall Study|Lost to Follow-up|0|||
156636785|NCT00077766|565414061|FG000|Overall Study|Protocol Violation|1|||
156636786|NCT00077766|565414062|FG001|Overall Study|Protocol Violation|0|||
156636787|NCT00077766|565414061|FG000|Overall Study|Kidney Transplantation|9|||
156636788|NCT00077766|565414062|FG001|Overall Study|Kidney Transplantation|5|||
156636789|NCT00077766|565414061|FG000|Overall Study|Transplantation|5|||
156636790|NCT00077766|565414062|FG001|Overall Study|Transplantation|1|||
156636791|NCT00077766|565414061|FG000|Overall Study|Investigators Discretion|1|||
156636792|NCT00077766|565414062|FG001|Overall Study|Investigators Discretion|0|||
156636793|NCT00077766|565414061|FG000|Overall Study|Participant's decision|1|||
156636794|NCT00077766|565414062|FG001|Overall Study|Participant's decision|0|||
156636795|NCT00077766|565414061|FG000|Overall Study|Dialysis Discontinued|1|||
156636796|NCT00077766|565414062|FG001|Overall Study|Dialysis Discontinued|0|||
156636797|NCT00077766|565414061|FG000|Overall Study|Dialysis|0|||
156636798|NCT00077766|565414062|FG001|Overall Study|Dialysis|1|||
156636799|NCT00077766|565414061|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
156636800|NCT00077766|565414062|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
156636801|NCT00077766|565414061|FG000|Overall Study|Started Nocturnal Dialysis|0|||
156636802|NCT00077766|565414062|FG001|Overall Study|Started Nocturnal Dialysis|1|||
156636803|NCT00077766|565414061|FG000|Overall Study|Stop Dialysis|0|||
156636804|NCT00077766|565414062|FG001|Overall Study|Stop Dialysis|1|||
156636805|NCT00077766|565414061|FG000|Overall Study|Participants Vacation|2|||
156636806|NCT00077766|565414062|FG001|Overall Study|Participants Vacation|1|||
156636807|NCT02057549|565414064|FG000|Overall Study|Lost to Follow-up|1|||
156636808|NCT02057549|565414065|FG001|Overall Study|Lost to Follow-up|0|||
156636809|NCT02057549|565414064|FG000|Overall Study|Physician Decision|1|||
156636810|NCT02057549|565414065|FG001|Overall Study|Physician Decision|0|||
156636811|NCT02057549|565414064|FG000|Overall Study|Withdrawal by Subject|1|||
156636812|NCT02057549|565414065|FG001|Overall Study|Withdrawal by Subject|0|||
156636813|NCT01418365|565414066|FG000|First Intervention|Withdrawal by Subject|0|||
156636814|NCT01418365|565414067|FG001|First Intervention|Withdrawal by Subject|1|||
156636815|NCT01418365|565414066|FG000|First Intervention|Non-compliance|1|||
156636816|NCT01418365|565414067|FG001|First Intervention|Non-compliance|0|||
156636817|NCT01418365|565414066|FG000|Second Intervention|Withdrawal by Subject|0|||
156636818|NCT01418365|565414067|FG001|Second Intervention|Withdrawal by Subject|1|||
156636819|NCT03319368|565414072|FG000|Overall Study|Discharge swabs not collected from resident|57|||
156636820|NCT03319368|565414073|FG001|Overall Study|Discharge swabs not collected from resident|46|||
156636821|NCT00824993|565414080|FG000|Overall Study|Withdrawal by Subject|1|||
156636822|NCT00824993|565414081|FG001|Overall Study|Withdrawal by Subject|1|||
156636823|NCT00824993|565414080|FG000|Overall Study|Malignancy Relapse|9|||
156636824|NCT00824993|565414081|FG001|Overall Study|Malignancy Relapse|10|||
156636825|NCT00824993|565414080|FG000|Overall Study|Rapid Bone Loss|0|||
156636826|NCT00824993|565414081|FG001|Overall Study|Rapid Bone Loss|1|||
156636827|NCT00824993|565414080|FG000|Overall Study|Non-Compliant|2|||
156636828|NCT00824993|565414081|FG001|Overall Study|Non-Compliant|1|||
156636829|NCT00824993|565414080|FG000|Overall Study|Insurance Issue|2|||
156636830|NCT00824993|565414081|FG001|Overall Study|Insurance Issue|1|||
156636831|NCT00824993|565414080|FG000|Overall Study|Death|0|||
156636832|NCT00824993|565414081|FG001|Overall Study|Death|3|||
156636833|NCT02380248|565414084|FG000|Overall Study|Lost to Follow-up|11|||
156636834|NCT02380248|565414084|FG000|Overall Study|Withdrawal by Subject|3|||
156636835|NCT01275170|565414087|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
156636836|NCT01275170|565414088|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
156636837|NCT01275170|565414089|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
156636838|NCT01275170|565414090|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
156636839|NCT01275170|565414091|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
156636840|NCT01275170|565414092|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
156636841|NCT01275170|565414093|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
156636842|NCT01275170|565414094|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
156636843|NCT02864953|565414095|FG000|Overall Study|Adverse Event|22|||
156636844|NCT02864953|565414096|FG001|Overall Study|Adverse Event|19|||
156636845|NCT02864953|565414095|FG000|Overall Study|Withdrawal by Subject|1|||
156636846|NCT02864953|565414096|FG001|Overall Study|Withdrawal by Subject|0|||
156636847|NCT02864953|565414095|FG000|Overall Study|Physician Decision|4|||
156636848|NCT02864953|565414096|FG001|Overall Study|Physician Decision|2|||
156636849|NCT02864953|565414095|FG000|Overall Study|Death|3|||
156636850|NCT02864953|565414096|FG001|Overall Study|Death|13|||
156636851|NCT02864953|565414095|FG000|Overall Study|Reason not specified|14|||
156636852|NCT02864953|565414096|FG001|Overall Study|Reason not specified|12|||
156636853|NCT02864953|565414095|FG000|Overall Study|Withdrew Prior to Dosing|9|||
156636854|NCT02864953|565414096|FG001|Overall Study|Withdrew Prior to Dosing|8|||
156636855|NCT04636437|565414100|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
156636856|NCT04636437|565414101|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
156636857|NCT04636437|565414102|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
156636858|NCT04636437|565414100|FG000|Overall Study|Started weight loss drug/program|2|||
156636859|NCT04636437|565414101|FG001|Overall Study|Started weight loss drug/program|1|||
156636860|NCT04636437|565414102|FG002|Overall Study|Started weight loss drug/program|1|||
156636861|NCT04636437|565414100|FG000|Overall Study|Lost to Follow-up|3|||
156636862|NCT04636437|565414101|FG001|Overall Study|Lost to Follow-up|1|||
156636863|NCT04636437|565414102|FG002|Overall Study|Lost to Follow-up|4|||
156636864|NCT04636437|565414100|FG000|Overall Study|Participant or physician decision|3|||
156636865|NCT04636437|565414101|FG001|Overall Study|Participant or physician decision|1|||
156636866|NCT04636437|565414102|FG002|Overall Study|Participant or physician decision|1|||
156636867|NCT00816166|565414103|FG000|Overall Study|Lost to Follow-up|6|||
156636868|NCT00816166|565414104|FG001|Overall Study|Lost to Follow-up|10|||
156636869|NCT00816166|565414103|FG000|Overall Study|Death|4|||
156636870|NCT00816166|565414104|FG001|Overall Study|Death|2|||
156636871|NCT01071278|565414105|FG000|Overall Study|Premature Discontinuation|254|||
156636872|NCT01071278|565414105|FG000|Overall Study|Completion Status Unknown|459|||
156636873|NCT00352664|565414106|FG000|Overall Study|Withdrawal by Subject|7|||
156636874|NCT00352664|565414107|FG001|Overall Study|Withdrawal by Subject|0|||
156636875|NCT03539952|565414108|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
156636876|NCT03539952|565414109|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
156636877|NCT03539952|565414108|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
156636878|NCT03539952|565414109|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
156636879|NCT03539952|565414108|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
156636880|NCT03539952|565414109|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
156636881|NCT03539952|565414108|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
156636882|NCT03539952|565414109|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
156636883|NCT03539952|565414108|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
156751277|NCT05259917|565841964|FG001|Overall Study|Physician Decision|1|||
156751278|NCT05259917|565841965|FG002|Overall Study|Physician Decision|0|||
156751279|NCT05259917|565841966|FG003|Overall Study|Physician Decision|0|||
156751280|NCT05259917|565841967|FG004|Overall Study|Physician Decision|0|||
156751281|NCT05259917|565841968|FG005|Overall Study|Physician Decision|0|||
156751282|NCT05259917|565841963|FG000|Overall Study|Withdrawal by Subject|0|||
156751283|NCT05259917|565841964|FG001|Overall Study|Withdrawal by Subject|1|||
156751284|NCT05259917|565841965|FG002|Overall Study|Withdrawal by Subject|0|||
156751285|NCT05259917|565841966|FG003|Overall Study|Withdrawal by Subject|0|||
156751286|NCT05259917|565841967|FG004|Overall Study|Withdrawal by Subject|1|||
156751287|NCT05259917|565841968|FG005|Overall Study|Withdrawal by Subject|1|||
156751288|NCT05259917|565841963|FG000|Overall Study|Trial Termination by Sponsor|7|||
156751289|NCT05259917|565841964|FG001|Overall Study|Trial Termination by Sponsor|2|||
156751290|NCT05259917|565841965|FG002|Overall Study|Trial Termination by Sponsor|3|||
156751291|NCT05259917|565841966|FG003|Overall Study|Trial Termination by Sponsor|5|||
156751292|NCT05259917|565841967|FG004|Overall Study|Trial Termination by Sponsor|11|||
156751293|NCT05259917|565841968|FG005|Overall Study|Trial Termination by Sponsor|4|||
156751294|NCT05259917|565841963|FG000|Overall Study|Other|1|||
156751295|NCT05259917|565841964|FG001|Overall Study|Other|0|||
156751296|NCT05259917|565841965|FG002|Overall Study|Other|2|||
156751297|NCT05259917|565841966|FG003|Overall Study|Other|0|||
156751298|NCT05259917|565841967|FG004|Overall Study|Other|0|||
156751299|NCT05259917|565841968|FG005|Overall Study|Other|0|||
156751300|NCT00303472|565841973|FG000|Treatment Period|Adverse Event|0|||
156751301|NCT00303472|565841974|FG001|Treatment Period|Adverse Event|0|||
156751302|NCT00303472|565841975|FG002|Treatment Period|Adverse Event|0|||
156751303|NCT00303472|565841976|FG003|Treatment Period|Adverse Event|0|||
156751304|NCT00303472|565841977|FG004|Treatment Period|Adverse Event|1|||
156751305|NCT00303472|565841978|FG005|Treatment Period|Adverse Event|0|||
156751306|NCT00303472|565841979|FG006|Treatment Period|Adverse Event|0|||
156751307|NCT00303472|565841973|FG000|Treatment Period|Death|0|||
156751308|NCT00303472|565841974|FG001|Treatment Period|Death|0|||
156751309|NCT00303472|565841975|FG002|Treatment Period|Death|0|||
156751310|NCT00303472|565841976|FG003|Treatment Period|Death|1|||
156751311|NCT00303472|565841977|FG004|Treatment Period|Death|0|||
156751312|NCT00303472|565841978|FG005|Treatment Period|Death|0|||
156751313|NCT00303472|565841979|FG006|Treatment Period|Death|1|||
156751314|NCT00303472|565841973|FG000|Treatment Period|Withdrawal by Subject|0|||
156751315|NCT00303472|565841974|FG001|Treatment Period|Withdrawal by Subject|0|||
156751316|NCT00303472|565841975|FG002|Treatment Period|Withdrawal by Subject|0|||
156751317|NCT00303472|565841976|FG003|Treatment Period|Withdrawal by Subject|1|||
156751318|NCT00303472|565841977|FG004|Treatment Period|Withdrawal by Subject|0|||
156751319|NCT00303472|565841978|FG005|Treatment Period|Withdrawal by Subject|1|||
156751320|NCT00303472|565841979|FG006|Treatment Period|Withdrawal by Subject|0|||
156751321|NCT00303472|565841973|FG000|Treatment Period|Other|0|||
156751322|NCT00303472|565841974|FG001|Treatment Period|Other|0|||
156751323|NCT00303472|565841975|FG002|Treatment Period|Other|0|||
156751324|NCT00303472|565841976|FG003|Treatment Period|Other|0|||
156751325|NCT00303472|565841977|FG004|Treatment Period|Other|1|||
156751326|NCT00303472|565841978|FG005|Treatment Period|Other|0|||
156751327|NCT00303472|565841979|FG006|Treatment Period|Other|1|||
156751328|NCT00303472|565841973|FG000|Treatment Period|Disease Progression (to AML)|0|||
156751329|NCT00303472|565841974|FG001|Treatment Period|Disease Progression (to AML)|0|||
156751330|NCT00303472|565841975|FG002|Treatment Period|Disease Progression (to AML)|0|||
156751331|NCT00303472|565841976|FG003|Treatment Period|Disease Progression (to AML)|0|||
156751332|NCT00303472|565841977|FG004|Treatment Period|Disease Progression (to AML)|1|||
156751333|NCT00303472|565841978|FG005|Treatment Period|Disease Progression (to AML)|0|||
156751334|NCT00303472|565841979|FG006|Treatment Period|Disease Progression (to AML)|0|||
156751335|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Adverse Event|1|||
156751336|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Adverse Event|0|||
156751337|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Adverse Event|1|||
156751338|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Adverse Event|0|||
156751339|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Adverse Event|0|||
156751340|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Adverse Event|0|||
156751341|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Adverse Event|0|||
156751342|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Death|2|||
156751343|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Death|0|||
156751344|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Death|1|||
156751345|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Death|0|||
156751346|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Death|0|||
156751347|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Death|0|||
156751348|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Death|0|||
156751349|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751350|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751351|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751352|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
156751353|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751354|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751355|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751356|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Physician Decision|0|||
156751357|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Physician Decision|4|||
156751358|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Physician Decision|2|||
156751359|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Physician Decision|3|||
156751360|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Physician Decision|2|||
156751361|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Physician Decision|0|||
156751362|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Physician Decision|0|||
156751363|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
156751364|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
156751365|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
156751366|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
156751367|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
156751368|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
156751369|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
156751370|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Other|0|||
156751371|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Other|2|||
156751372|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Other|4|||
156751373|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Other|2|||
156751374|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Other|1|||
156751375|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Other|0|||
156751376|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Other|0|||
156751377|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
156751378|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751379|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751380|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751381|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751382|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
156751383|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751384|NCT02937636|565841988|FG000|Overall Study|Other (Not specified)|3|||
156751385|NCT02937636|565841989|FG001|Overall Study|Other (Not specified)|2|||
156751386|NCT00770913|565841990|FG000|Overall Study|Adverse Event|1|||
156751387|NCT00770913|565841991|FG001|Overall Study|Adverse Event|3|||
156751388|NCT00770913|565841992|FG002|Overall Study|Adverse Event|6|||
156751389|NCT00770913|565841990|FG000|Overall Study|Refusal to continue participation|6|||
156751390|NCT00770913|565841991|FG001|Overall Study|Refusal to continue participation|4|||
156751391|NCT00770913|565841992|FG002|Overall Study|Refusal to continue participation|5|||
156751392|NCT00770913|565841990|FG000|Overall Study|Physician Decision|0|||
156751393|NCT00770913|565841991|FG001|Overall Study|Physician Decision|1|||
156751394|NCT00770913|565841992|FG002|Overall Study|Physician Decision|1|||
156751395|NCT00770913|565841990|FG000|Overall Study|Protocol Violation|3|||
156751396|NCT00770913|565841991|FG001|Overall Study|Protocol Violation|0|||
156751397|NCT00770913|565841992|FG002|Overall Study|Protocol Violation|1|||
156751398|NCT00770913|565841990|FG000|Overall Study|Incorrect drug was allocated|1|||
156751399|NCT00770913|565841991|FG001|Overall Study|Incorrect drug was allocated|0|||
156751400|NCT00770913|565841992|FG002|Overall Study|Incorrect drug was allocated|0|||
156751401|NCT02347072|565841996|FG000|Overall Study|Adverse Event|2|||
156751402|NCT02347072|565841996|FG000|Overall Study|Withdrawal by Subject|6|||
156751403|NCT02347072|565841996|FG000|Overall Study|Physician Decision|1|||
156751404|NCT02347072|565841996|FG000|Overall Study|Lost to Follow-up|2|||
156751405|NCT02347072|565841996|FG000|Overall Study|Protocol Violation|1|||
156751406|NCT02347072|565841996|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
156751407|NCT01134393|565842001|FG000|Overall Study|Adverse Event|18|||
156751408|NCT01134393|565842001|FG000|Overall Study|Lack of Efficacy|2|||
156751409|NCT01134393|565842001|FG000|Overall Study|Protocol Violation|12|||
156751410|NCT01134393|565842001|FG000|Overall Study|Lost to Follow-up|3|||
156751411|NCT01134393|565842001|FG000|Overall Study|Withdrawal by Subject|11|||
156751412|NCT01134393|565842001|FG000|Overall Study|Other|6|||
156751413|NCT01808222|565842004|FG000|Overall Study|mpMR scan was not performed|1|||
156751414|NCT02324699|565842007|FG000|Overall Study|study terminated|1|||
156751415|NCT02912455|565842010|FG000|Overall Study|Withdrawal by Subject|0|||
156751416|NCT02912455|565842011|FG001|Overall Study|Withdrawal by Subject|1|||
156751417|NCT02912455|565842010|FG000|Overall Study|Lack of Efficacy|0|||
156751418|NCT02912455|565842011|FG001|Overall Study|Lack of Efficacy|1|||
156751419|NCT02912455|565842010|FG000|Overall Study|Lost to Follow-up|2|||
156751420|NCT02912455|565842011|FG001|Overall Study|Lost to Follow-up|1|||
156751421|NCT00621517|565842012|FG000|Overall Study|Lost to Follow-up|3|||
156751422|NCT00621517|565842013|FG001|Overall Study|Lost to Follow-up|3|||
156636884|NCT03539952|565414109|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
156751423|NCT00621517|565842012|FG000|Overall Study|Withdrawal by Subject|3|||
156751424|NCT00621517|565842013|FG001|Overall Study|Withdrawal by Subject|4|||
156751425|NCT00621517|565842012|FG000|Overall Study|Adverse Event|1|||
156636885|NCT03539952|565414108|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
156636886|NCT03539952|565414109|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
156636887|NCT03539952|565414108|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
156636888|NCT03539952|565414109|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
156636889|NCT02184988|565414110|FG000|Overall Study|Pregnancy|2|||
156636890|NCT02184988|565414110|FG000|Overall Study|Adverse Event|2|||
156636891|NCT02184988|565414110|FG000|Overall Study|moving away/travelling/unable to complet|6|||
156636892|NCT02184988|565414110|FG000|Overall Study|work scheduling issues|4|||
156636893|NCT02184988|565414110|FG000|Overall Study|various other reasons|9|||
156636894|NCT02184988|565414110|FG000|Overall Study|Lost to Follow-up|32|||
156636895|NCT03075215|565414111|FG000|12-Month Primary Endpoint|Death|152|||
156636896|NCT03075215|565414111|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
156636897|NCT03075215|565414111|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
156636898|NCT03075215|565414111|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
156636899|NCT01821391|565414112|FG000|Overall Study|Adverse Event|1|||
156636900|NCT01821391|565414113|FG001|Overall Study|Adverse Event|0|||
156636901|NCT02146365|565414114|FG000|Overall Study|Lost to Follow-up|2|||
156636902|NCT02146365|565414115|FG001|Overall Study|Lost to Follow-up|1|||
156636903|NCT02146365|565414116|FG002|Overall Study|Lost to Follow-up|3|||
156636904|NCT02146365|565414117|FG003|Overall Study|Lost to Follow-up|3|||
156636905|NCT02146365|565414118|FG004|Overall Study|Lost to Follow-up|1|||
156636906|NCT02146365|565414119|FG005|Overall Study|Lost to Follow-up|1|||
156636907|NCT02146365|565414120|FG006|Overall Study|Lost to Follow-up|0|||
156636908|NCT02146365|565414121|FG007|Overall Study|Lost to Follow-up|1|||
156636909|NCT02146365|565414114|FG000|Overall Study|Withdrawal by Subject|1|||
156751426|NCT00621517|565842013|FG001|Overall Study|Adverse Event|0|||
156751427|NCT00073008|565842015|FG000|Overall Study|Missing|6|||
156751428|NCT00073008|565842016|FG001|Overall Study|Missing|6|||
156751429|NCT00073008|565842015|FG000|Overall Study|Withdrawal by Subject|2|||
156751430|NCT00073008|565842016|FG001|Overall Study|Withdrawal by Subject|2|||
156751431|NCT00073008|565842015|FG000|Overall Study|Lost to Follow-up|1|||
156751432|NCT00073008|565842016|FG001|Overall Study|Lost to Follow-up|3|||
156751433|NCT00073008|565842015|FG000|Overall Study|Death|46|||
156751434|NCT00073008|565842016|FG001|Overall Study|Death|47|||
156751435|NCT00073008|565842015|FG000|Overall Study|"Other selected on Case Report Form"|7|||
156751436|NCT00073008|565842016|FG001|Overall Study|"Other selected on Case Report Form"|5|||
156751437|NCT01778751|565842026|FG000|Overall Study|Lost to Follow-up|1|||
156751438|NCT01778751|565842027|FG001|Overall Study|Lost to Follow-up|0|||
156751439|NCT01778751|565842026|FG000|Overall Study|Withdrawal by Subject|0|||
156751440|NCT01778751|565842027|FG001|Overall Study|Withdrawal by Subject|2|||
156751441|NCT01778751|565842026|FG000|Overall Study|Transfered care|1|||
156751442|NCT01778751|565842027|FG001|Overall Study|Transfered care|0|||
156751443|NCT02669667|565842028|FG000|Overall Study|Lost to Follow-up|0|||
156751444|NCT02669667|565842029|FG001|Overall Study|Lost to Follow-up|0|||
156751445|NCT02669667|565842030|FG002|Overall Study|Lost to Follow-up|0|||
156751446|NCT02669667|565842031|FG003|Overall Study|Lost to Follow-up|0|||
156751447|NCT02669667|565842032|FG004|Overall Study|Lost to Follow-up|0|||
156751448|NCT02669667|565842033|FG005|Overall Study|Lost to Follow-up|1|||
156751449|NCT02669667|565842034|FG006|Overall Study|Lost to Follow-up|0|||
156751450|NCT00636961|565842046|FG000|Period 1|Administrative problems|1|||
156751451|NCT00636961|565842047|FG001|Period 1|Administrative problems|1|||
156751452|NCT00636961|565842046|FG000|Period 2|Adverse Event|1|||
156751453|NCT00636961|565842047|FG001|Period 2|Adverse Event|0|||
156751454|NCT01156051|565842051|FG000|Overall Study|Lost to Follow-up|1|||
156751455|NCT01156051|565842052|FG001|Overall Study|Lost to Follow-up|0|||
156751456|NCT01156051|565842051|FG000|Overall Study|patient not compliant with protocol|0|||
156751457|NCT01156051|565842052|FG001|Overall Study|patient not compliant with protocol|1|||
156751458|NCT03628716|565842053|FG000|Overall Study|Adverse Event|1|||
156751459|NCT03628716|565842054|FG001|Overall Study|Adverse Event|1|||
156751460|NCT03628716|565842053|FG000|Overall Study|Death|1|||
156751461|NCT03628716|565842054|FG001|Overall Study|Death|0|||
156751462|NCT03628716|565842053|FG000|Overall Study|Lack of Efficacy|15|||
156751463|NCT03628716|565842054|FG001|Overall Study|Lack of Efficacy|20|||
156751464|NCT03628716|565842053|FG000|Overall Study|Withdrawal by Subject|1|||
156751465|NCT03628716|565842054|FG001|Overall Study|Withdrawal by Subject|2|||
156751466|NCT03628716|565842053|FG000|Overall Study|Study Terminated by Sponsor|1|||
156751467|NCT03628716|565842054|FG001|Overall Study|Study Terminated by Sponsor|0|||
156751468|NCT00856843|565842055|FG000|Overall Study|Withdrawal by Subject|1|||
156751469|NCT00856843|565842056|FG001|Overall Study|Withdrawal by Subject|5|||
156751470|NCT00856843|565842055|FG000|Overall Study|Lack of Efficacy|1|||
156751471|NCT00856843|565842056|FG001|Overall Study|Lack of Efficacy|0|||
156751472|NCT03172364|565842057|FG000|Overall Study|Adverse Event|1|||
156751473|NCT03172364|565842058|FG001|Overall Study|Adverse Event|1|||
156751474|NCT03172364|565842057|FG000|Overall Study|Protocol Violation|1|||
156636910|NCT02146365|565414115|FG001|Overall Study|Withdrawal by Subject|2|||
156751475|NCT03172364|565842058|FG001|Overall Study|Protocol Violation|0|||
156751476|NCT03755518|565842059|FG000|Overall Study|Lack of Efficacy|10|||
156751477|NCT03755518|565842059|FG000|Overall Study|Adverse Event|7|||
156751478|NCT03755518|565842059|FG000|Overall Study|Study Terminated by Sponsor|5|||
156751479|NCT03755518|565842059|FG000|Overall Study|Death|1|||
156751480|NCT03755518|565842059|FG000|Overall Study|Withdrawal by Subject|3|||
156751481|NCT03755518|565842059|FG000|Overall Study|Progressive Disease|4|||
156751482|NCT03755518|565842059|FG000|Overall Study|Bone Marrow Transplant|4|||
156751483|NCT03755518|565842059|FG000|Overall Study|Physicians Decision|1|||
156751484|NCT03755518|565842059|FG000|Overall Study|Relapse|1|||
156751485|NCT03755518|565842059|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
156751486|NCT03755518|565842059|FG000|Overall Study|Withdrawal by PI|1|||
156751487|NCT01714609|565842060|FG000|Overall Study|Protocol Violation|1|||
156751488|NCT01714609|565842061|FG001|Overall Study|Protocol Violation|0|||
156751489|NCT00583102|565842062|FG000|Overall Study|Adverse Event|3|||
156751490|NCT03403621|565842063|FG000|Overall Study|Withdrawal by Subject|2|||
156751491|NCT03403621|565842064|FG001|Overall Study|Withdrawal by Subject|2|||
156751492|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
156751493|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751494|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751495|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751496|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751497|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751498|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156864963|NCT05966142|566265384|FG000|Overall Study|Duplicate Enrollment|1|||
156864964|NCT05966142|566265385|FG001|Overall Study|Duplicate Enrollment|0|||
156864965|NCT05966142|566265384|FG000|Overall Study|Study Logistical Reason|1|||
156864966|NCT05966142|566265385|FG001|Overall Study|Study Logistical Reason|0|||
156864967|NCT05966142|566265384|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
156864968|NCT05966142|566265385|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
156864969|NCT04849364|566265386|FG000|Overall Study|Eligibility criteria not meet|0|||
156864970|NCT04849364|566265387|FG001|Overall Study|Eligibility criteria not meet|1|||
156864971|NCT04849364|566265388|FG002|Overall Study|Eligibility criteria not meet|0|||
156864972|NCT01643668|566265389|FG000|Overall Study|Death|1|||
156864973|NCT01294553|566265392|FG000|Overall Study|Duplicated Participants|1|||
156864974|NCT01294553|566265392|FG000|Overall Study|Protocol Violation|268|||
156864975|NCT01217229|566265393|FG000|Overall Study|Adverse Event|1|||
156864976|NCT01217229|566265393|FG000|Overall Study|Disease progression, deterioration|2|||
156864977|NCT01217229|566265393|FG000|Overall Study|Disease progression, Cheson criteria|14|||
156864978|NCT01217229|566265393|FG000|Overall Study|Protocol Violation|1|||
156864979|NCT01217229|566265393|FG000|Overall Study|Disease progression not confirmed|2|||
156864980|NCT00453206|566265395|FG000|Overall Study|Death|1|||
156864981|NCT03058146|566265396|FG000|Overall Study|Withdrawal by Subject|4|||
156864982|NCT03058146|566265397|FG001|Overall Study|Withdrawal by Subject|1|||
156864983|NCT03058146|566265396|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
156864984|NCT03058146|566265397|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
156864985|NCT00632229|566265398|FG000|Overall Study|Adverse Event|6|||
156864986|NCT00632229|566265399|FG001|Overall Study|Adverse Event|0|||
156864987|NCT00632229|566265398|FG000|Overall Study|Lost to Follow-up|0|||
156864988|NCT00632229|566265399|FG001|Overall Study|Lost to Follow-up|3|||
156864989|NCT00632229|566265398|FG000|Overall Study|Lack of Efficacy|0|||
156864990|NCT00632229|566265399|FG001|Overall Study|Lack of Efficacy|2|||
156864991|NCT00632229|566265398|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
156864992|NCT00632229|566265399|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
156864993|NCT00577889|566265402|FG000|Overall Study|Withdrawal by Subject|1|||
156864994|NCT00577889|566265403|FG001|Overall Study|Withdrawal by Subject|0|||
156864995|NCT00577889|566265404|FG002|Overall Study|Withdrawal by Subject|0|||
156864996|NCT03041181|566265406|FG000|Overall Study|Disease Progression|1|||
156864997|NCT03041181|566265407|FG001|Overall Study|Disease Progression|2|||
156864998|NCT03224819|566265408|FG000|Overall Study|Withdrawal by Subject|0|||
156864999|NCT03224819|566265409|FG001|Overall Study|Withdrawal by Subject|0|||
156865000|NCT03224819|566265410|FG002|Overall Study|Withdrawal by Subject|0|||
156865001|NCT03224819|566265411|FG003|Overall Study|Withdrawal by Subject|0|||
156865002|NCT03224819|566265412|FG004|Overall Study|Withdrawal by Subject|0|||
156865003|NCT03224819|566265413|FG005|Overall Study|Withdrawal by Subject|0|||
156751499|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751500|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751501|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
156865004|NCT03224819|566265414|FG006|Overall Study|Withdrawal by Subject|0|||
156865005|NCT03224819|566265415|FG007|Overall Study|Withdrawal by Subject|0|||
156865006|NCT03224819|566265416|FG008|Overall Study|Withdrawal by Subject|0|||
156865007|NCT03224819|566265417|FG009|Overall Study|Withdrawal by Subject|0|||
156865008|NCT03224819|566265418|FG010|Overall Study|Withdrawal by Subject|0|||
156865009|NCT03224819|566265419|FG011|Overall Study|Withdrawal by Subject|0|||
156865010|NCT03224819|566265420|FG012|Overall Study|Withdrawal by Subject|1|||
156865011|NCT03224819|566265421|FG013|Overall Study|Withdrawal by Subject|0|||
156865012|NCT03224819|566265408|FG000|Overall Study|Sponsor Decision|0|||
156751502|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
156751503|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
156751504|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
156751505|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
156751506|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
156751507|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
156751508|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
156751509|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
156751510|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
156751511|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
156751512|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
156751513|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
156751514|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
156751515|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
156751516|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
156751517|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
156751518|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
156751519|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
156751520|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
156751521|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
156751522|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
156751523|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
156751524|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
156751525|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
156751526|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
156751527|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
156751528|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751529|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751530|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751531|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
156751532|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751533|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
156751534|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751535|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751536|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156865013|NCT03224819|566265409|FG001|Overall Study|Sponsor Decision|0|||
156865014|NCT03224819|566265410|FG002|Overall Study|Sponsor Decision|0|||
156865015|NCT03224819|566265411|FG003|Overall Study|Sponsor Decision|1|||
156865016|NCT03224819|566265412|FG004|Overall Study|Sponsor Decision|1|||
156865017|NCT03224819|566265413|FG005|Overall Study|Sponsor Decision|2|||
156865018|NCT03224819|566265414|FG006|Overall Study|Sponsor Decision|1|||
156865019|NCT03224819|566265415|FG007|Overall Study|Sponsor Decision|1|||
156865020|NCT03224819|566265416|FG008|Overall Study|Sponsor Decision|1|||
156865021|NCT03224819|566265417|FG009|Overall Study|Sponsor Decision|2|||
156865022|NCT03224819|566265418|FG010|Overall Study|Sponsor Decision|1|||
156865023|NCT03224819|566265419|FG011|Overall Study|Sponsor Decision|1|||
156865024|NCT03224819|566265420|FG012|Overall Study|Sponsor Decision|1|||
156865025|NCT03224819|566265421|FG013|Overall Study|Sponsor Decision|0|||
156865026|NCT03224819|566265408|FG000|Overall Study|Lost to Follow-up|0|||
156865027|NCT03224819|566265409|FG001|Overall Study|Lost to Follow-up|0|||
156865028|NCT03224819|566265410|FG002|Overall Study|Lost to Follow-up|0|||
156865029|NCT03224819|566265411|FG003|Overall Study|Lost to Follow-up|0|||
156865030|NCT03224819|566265412|FG004|Overall Study|Lost to Follow-up|0|||
156865031|NCT03224819|566265413|FG005|Overall Study|Lost to Follow-up|0|||
156865032|NCT03224819|566265414|FG006|Overall Study|Lost to Follow-up|0|||
156865033|NCT03224819|566265415|FG007|Overall Study|Lost to Follow-up|0|||
156865034|NCT03224819|566265416|FG008|Overall Study|Lost to Follow-up|1|||
156865035|NCT03224819|566265417|FG009|Overall Study|Lost to Follow-up|0|||
156865036|NCT03224819|566265418|FG010|Overall Study|Lost to Follow-up|0|||
156865037|NCT03224819|566265419|FG011|Overall Study|Lost to Follow-up|0|||
156865038|NCT03224819|566265420|FG012|Overall Study|Lost to Follow-up|0|||
156865039|NCT03224819|566265421|FG013|Overall Study|Lost to Follow-up|0|||
156865040|NCT03224819|566265408|FG000|Overall Study|Death|0|||
156865041|NCT03224819|566265409|FG001|Overall Study|Death|1|||
156865042|NCT03224819|566265410|FG002|Overall Study|Death|0|||
156865043|NCT03224819|566265411|FG003|Overall Study|Death|0|||
156865044|NCT03224819|566265412|FG004|Overall Study|Death|0|||
156865045|NCT03224819|566265413|FG005|Overall Study|Death|0|||
156865046|NCT03224819|566265414|FG006|Overall Study|Death|0|||
156865047|NCT03224819|566265415|FG007|Overall Study|Death|1|||
156865048|NCT03224819|566265416|FG008|Overall Study|Death|0|||
156865049|NCT03224819|566265417|FG009|Overall Study|Death|0|||
156865050|NCT03224819|566265418|FG010|Overall Study|Death|0|||
156865051|NCT03224819|566265419|FG011|Overall Study|Death|1|||
156865052|NCT03224819|566265420|FG012|Overall Study|Death|0|||
156865053|NCT03224819|566265421|FG013|Overall Study|Death|0|||
156865054|NCT01903460|566265424|FG000|Overall Study|Adverse Event|0|||
156865055|NCT01903460|566265425|FG001|Overall Study|Adverse Event|0|||
156865056|NCT01903460|566265426|FG002|Overall Study|Adverse Event|0|||
156865057|NCT01903460|566265427|FG003|Overall Study|Adverse Event|1|||
156865058|NCT03104868|566265428|FG000|6 Week Follow up|Lost to Follow-up|5|||
156865059|NCT03104868|566265429|FG001|6 Week Follow up|Lost to Follow-up|8|||
156865060|NCT03104868|566265428|FG000|6 Week Follow up|Death|1|||
156865061|NCT03104868|566265429|FG001|6 Week Follow up|Death|1|||
156865062|NCT03104868|566265428|FG000|6 Week Follow up|Withdrawal by Subject|7|||
156865063|NCT03104868|566265429|FG001|6 Week Follow up|Withdrawal by Subject|6|||
156865064|NCT03104868|566265428|FG000|6 Week Follow up|Completed Later Timepoint|24|||
156865065|NCT03104868|566265429|FG001|6 Week Follow up|Completed Later Timepoint|22|||
156865066|NCT03104868|566265428|FG000|6 Month Follow up|Lost to Follow-up|2|||
156865067|NCT03104868|566265429|FG001|6 Month Follow up|Lost to Follow-up|2|||
156865068|NCT03104868|566265428|FG000|6 Month Follow up|Death|0|||
156865069|NCT03104868|566265429|FG001|6 Month Follow up|Death|1|||
156865070|NCT03104868|566265428|FG000|6 Month Follow up|Completed Later Timepoint|22|||
156865071|NCT03104868|566265429|FG001|6 Month Follow up|Completed Later Timepoint|32|||
156865072|NCT03104868|566265428|FG000|12 Month Follow up|Lost to Follow-up|1|||
156865073|NCT03104868|566265429|FG001|12 Month Follow up|Lost to Follow-up|2|||
156865074|NCT03104868|566265428|FG000|12 Month Follow up|Death|0|||
156865075|NCT03104868|566265429|FG001|12 Month Follow up|Death|1|||
156865076|NCT03104868|566265428|FG000|12 Month Follow up|Withdrawal by Subject|0|||
156865077|NCT03104868|566265429|FG001|12 Month Follow up|Withdrawal by Subject|3|||
156865078|NCT03104868|566265428|FG000|12 Month Follow up|Completed Later Timepoint|32|||
156865079|NCT03104868|566265429|FG001|12 Month Follow up|Completed Later Timepoint|29|||
156865080|NCT03104868|566265428|FG000|18 Month Follow up|Lost to Follow-up|7|||
156865081|NCT03104868|566265429|FG001|18 Month Follow up|Lost to Follow-up|11|||
156865082|NCT03104868|566265428|FG000|18 Month Follow up|Death|2|||
156865083|NCT03104868|566265429|FG001|18 Month Follow up|Death|1|||
156865084|NCT03104868|566265428|FG000|18 Month Follow up|Withdrawal by Subject|1|||
156865085|NCT03104868|566265429|FG001|18 Month Follow up|Withdrawal by Subject|2|||
156865086|NCT03104868|566265428|FG000|18 Month Follow up|Graft Loss|1|||
156865087|NCT03104868|566265429|FG001|18 Month Follow up|Graft Loss|1|||
156865088|NCT03104868|566265428|FG000|18 Month Follow up|Completed Later Timepoint|19|||
156865089|NCT03104868|566265429|FG001|18 Month Follow up|Completed Later Timepoint|20|||
156865090|NCT03104868|566265428|FG000|24 Month Follow up|Lost to Follow-up|15|||
156865091|NCT03104868|566265429|FG001|24 Month Follow up|Lost to Follow-up|16|||
156865092|NCT03104868|566265428|FG000|24 Month Follow up|Death|3|||
156865093|NCT03104868|566265429|FG001|24 Month Follow up|Death|2|||
156865094|NCT03104868|566265428|FG000|24 Month Follow up|Withdrawal by Subject|1|||
156865095|NCT03104868|566265429|FG001|24 Month Follow up|Withdrawal by Subject|0|||
156865096|NCT03104868|566265428|FG000|24 Month Follow up|Graft Loss|2|||
156865097|NCT03104868|566265429|FG001|24 Month Follow up|Graft Loss|0|||
156865098|NCT00521079|566265430|FG000|Overall Study|Adverse Event|7|||
156865099|NCT00521079|566265431|FG001|Overall Study|Adverse Event|1|||
156865100|NCT00521079|566265430|FG000|Overall Study|Lost to Follow-up|2|||
156865101|NCT00521079|566265431|FG001|Overall Study|Lost to Follow-up|1|||
156865102|NCT00521079|566265430|FG000|Overall Study|Withdrawal by Subject|5|||
156865103|NCT00521079|566265431|FG001|Overall Study|Withdrawal by Subject|3|||
156865104|NCT02059278|566265432|FG000|Overall Study|Adverse Event|1|||
156865105|NCT02059278|566265433|FG001|Overall Study|Adverse Event|1|||
156865106|NCT02059278|566265432|FG000|Overall Study|Lost to Follow-up|1|||
156865107|NCT02059278|566265433|FG001|Overall Study|Lost to Follow-up|0|||
156865108|NCT02059278|566265432|FG000|Overall Study|Withdrawal by Subject|0|||
156865109|NCT02059278|566265433|FG001|Overall Study|Withdrawal by Subject|3|||
156865110|NCT02059278|566265432|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
156865111|NCT02059278|566265433|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
156865112|NCT00888173|566265434|FG000|Overall Study|Wrong Primary|1|||
156865113|NCT00888173|566265434|FG000|Overall Study|Ineligible: required test not done|1|||
156865114|NCT00737672|566265441|FG000|Overall Study|Graft Abandonment|48|||
156865115|NCT00737672|566265442|FG001|Overall Study|Graft Abandonment|56|||
156865116|NCT00737672|566265441|FG000|Overall Study|Death|23|||
156865117|NCT00737672|566265442|FG001|Overall Study|Death|22|||
156865118|NCT00737672|566265441|FG000|Overall Study|Withdrawal by Subject|1|||
156865119|NCT00737672|566265442|FG001|Overall Study|Withdrawal by Subject|2|||
156865120|NCT00737672|566265441|FG000|Overall Study|Lost to Follow-up|1|||
156865121|NCT00737672|566265442|FG001|Overall Study|Lost to Follow-up|0|||
156865122|NCT00737672|566265441|FG000|Overall Study|Miscellaneous|7|||
156865123|NCT00737672|566265442|FG001|Overall Study|Miscellaneous|1|||
156865124|NCT00737672|566265441|FG000|Overall Study|Physician Decision|0|||
156865125|NCT00737672|566265442|FG001|Overall Study|Physician Decision|2|||
156865126|NCT00829426|566265447|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
156408317|NCT04537897|564589256|FG000|Overall Study|Adverse Event|0|||
156865127|NCT00829426|566265448|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
156865128|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
156865129|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
156865130|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
156865131|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
156865132|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Adverse Event|2|||
156865133|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Adverse Event|5|||
156865134|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Adverse Event|1|||
156865135|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Adverse Event|2|||
156865136|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Death|13|||
156865137|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Death|17|||
156865138|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Death|1|||
156865139|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Death|0|||
156865140|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
156865141|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
156865142|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
156865143|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
156865144|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Disease Progression|2|||
156865145|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Disease Progression|0|||
156865146|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Disease Progression|0|||
156865147|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Disease Progression|0|||
156865148|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
156865149|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
156865150|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
156865151|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
156865152|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
156865153|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
156865154|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
156865155|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
156865156|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
156865157|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
156865158|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
156865159|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
156865160|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Participant Decision|9|||
156865161|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Participant Decision|12|||
156865162|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Participant Decision|1|||
156865163|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Participant Decision|1|||
156865164|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
156865165|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
156865166|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
156865167|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
156865168|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
156865169|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
156865170|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
156865171|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
156865172|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
156865173|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
156865174|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
156865175|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
156865176|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
156865177|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
156865178|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
156865179|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
156865180|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
156865181|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
156865182|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
156865183|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
156865184|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
156865185|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
156865186|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
156865187|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
156865188|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
156865189|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
156865190|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
156865191|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
156865192|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
156865193|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
156865194|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
156865195|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
156865196|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
156865197|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
156865198|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
156865199|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
156865200|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
156865201|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
156865202|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
156865203|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
156865204|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
156865205|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
156865206|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
156865207|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
156865208|NCT04408989|566265453|FG000|Overall Study|Lost to Follow-up|0|||
156865209|NCT04408989|566265454|FG001|Overall Study|Lost to Follow-up|0|||
156865210|NCT04408989|566265455|FG002|Overall Study|Lost to Follow-up|1|||
156865211|NCT04408989|566265453|FG000|Overall Study|Withdrawal by Subject|0|||
156865212|NCT04408989|566265454|FG001|Overall Study|Withdrawal by Subject|0|||
156865213|NCT04408989|566265455|FG002|Overall Study|Withdrawal by Subject|2|||
156865214|NCT02002598|566265460|FG000|Dose Level 1|Withdrawal by Subject|1|||
156865215|NCT02002598|566265461|FG001|Dose Level 1|Withdrawal by Subject|0|||
156865216|NCT02002598|566265462|FG002|Dose Level 1|Withdrawal by Subject|0|||
156865217|NCT02002598|566265463|FG003|Dose Level 1|Withdrawal by Subject|0|||
156865218|NCT02002598|566265464|FG004|Dose Level 1|Withdrawal by Subject|0|||
156865219|NCT02628873|566265465|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
156865220|NCT02628873|566265466|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
156865221|NCT02628873|566265465|FG000|Second Test (1 Hour)|Physician Decision|1|||
156865222|NCT02628873|566265466|FG001|Second Test (1 Hour)|Physician Decision|0|||
156865223|NCT04672239|566265467|FG000|Week 2 Survey|Failed survey check items|1|||
156865224|NCT04672239|566265468|FG001|Week 2 Survey|Failed survey check items|2|||
156865225|NCT04672239|566265469|FG002|Week 2 Survey|Failed survey check items|3|||
156865226|NCT04672239|566265467|FG000|Week 2 Survey|Partially completed survey|7|||
156865227|NCT04672239|566265468|FG001|Week 2 Survey|Partially completed survey|1|||
156865228|NCT04672239|566265469|FG002|Week 2 Survey|Partially completed survey|4|||
156865229|NCT04672239|566265467|FG000|Week 2 Survey|Withdrawal by Subject|0|||
156865230|NCT04672239|566265468|FG001|Week 2 Survey|Withdrawal by Subject|1|||
156865231|NCT04672239|566265469|FG002|Week 2 Survey|Withdrawal by Subject|0|||
156865232|NCT04672239|566265467|FG000|Week 2 Survey|Lost to Follow-up|3|||
156865233|NCT04672239|566265468|FG001|Week 2 Survey|Lost to Follow-up|2|||
156865234|NCT04672239|566265469|FG002|Week 2 Survey|Lost to Follow-up|5|||
156865235|NCT04672239|566265467|FG000|Week 6 Survey|Failed survey check items|2|||
156865236|NCT04672239|566265468|FG001|Week 6 Survey|Failed survey check items|2|||
156865237|NCT04672239|566265469|FG002|Week 6 Survey|Failed survey check items|2|||
156865238|NCT04672239|566265467|FG000|Week 6 Survey|Partially completed survey|3|||
156865239|NCT04672239|566265468|FG001|Week 6 Survey|Partially completed survey|3|||
156865240|NCT04672239|566265469|FG002|Week 6 Survey|Partially completed survey|2|||
156865241|NCT04672239|566265467|FG000|Week 6 Survey|Withdrawal by Subject|1|||
156865242|NCT04672239|566265468|FG001|Week 6 Survey|Withdrawal by Subject|1|||
156865243|NCT04672239|566265469|FG002|Week 6 Survey|Withdrawal by Subject|1|||
156865244|NCT04672239|566265467|FG000|Week 6 Survey|Withdrawn by PI|0|||
156865245|NCT04672239|566265468|FG001|Week 6 Survey|Withdrawn by PI|1|||
156865246|NCT04672239|566265469|FG002|Week 6 Survey|Withdrawn by PI|0|||
156865247|NCT04672239|566265467|FG000|Week 6 Survey|Lost to Follow-up|12|||
156865248|NCT04672239|566265468|FG001|Week 6 Survey|Lost to Follow-up|2|||
156865249|NCT04672239|566265469|FG002|Week 6 Survey|Lost to Follow-up|5|||
156865250|NCT04672239|566265467|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
156865251|NCT04672239|566265468|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
156865252|NCT04672239|566265469|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
156865253|NCT04672239|566265467|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
156865254|NCT04672239|566265468|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
156865255|NCT04672239|566265469|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
156865256|NCT04672239|566265467|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
156865257|NCT04672239|566265468|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
156865258|NCT04672239|566265469|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
156865259|NCT04672239|566265467|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
156865260|NCT04672239|566265468|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
156865261|NCT04672239|566265469|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
156865262|NCT04672239|566265467|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
156865263|NCT04672239|566265468|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
156865264|NCT04672239|566265469|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
156865265|NCT04672239|566265467|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
156865266|NCT04672239|566265468|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
156865267|NCT04672239|566265469|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
156865268|NCT04672239|566265467|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
156865269|NCT04672239|566265468|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
156865270|NCT04672239|566265469|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
156865271|NCT03597347|566265473|FG000|Overall Study|Withdrawal by Subject|1|||
156865272|NCT03597347|566265474|FG001|Overall Study|Withdrawal by Subject|1|||
156865273|NCT03597347|566265475|FG002|Overall Study|Withdrawal by Subject|0|||
156865274|NCT03597347|566265473|FG000|Overall Study|Withdrawal due to Covid-19|3|||
156865275|NCT03597347|566265474|FG001|Overall Study|Withdrawal due to Covid-19|0|||
156865276|NCT03597347|566265475|FG002|Overall Study|Withdrawal due to Covid-19|0|||
156865277|NCT03597347|566265473|FG000|Overall Study|Sponsor decision to terminate study|3|||
156865278|NCT03597347|566265474|FG001|Overall Study|Sponsor decision to terminate study|2|||
156865279|NCT03597347|566265475|FG002|Overall Study|Sponsor decision to terminate study|4|||
156865280|NCT04606134|566265476|FG000|Overall Study|Adverse Event|0|||
156865281|NCT04606134|566265477|FG001|Overall Study|Adverse Event|1|||
156865282|NCT00107653|566265478|FG000|Overall Study|Adverse Event|24|||
156865283|NCT00107653|566265479|FG001|Overall Study|Adverse Event|43|||
156865284|NCT00107653|566265478|FG000|Overall Study|Insufficient Therapeutic Response|25|||
156865285|NCT00107653|566265479|FG001|Overall Study|Insufficient Therapeutic Response|11|||
156865286|NCT00107653|566265478|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
156865287|NCT00107653|566265479|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156865288|NCT00107653|566265478|FG000|Overall Study|Protocol Violation|1|||
156865289|NCT00107653|566265479|FG001|Overall Study|Protocol Violation|0|||
156865290|NCT00107653|566265478|FG000|Overall Study|Withdrawal by Subject|12|||
156865291|NCT00107653|566265479|FG001|Overall Study|Withdrawal by Subject|13|||
156865292|NCT00107653|566265478|FG000|Overall Study|Lost to Follow-up|13|||
156865293|NCT00107653|566265479|FG001|Overall Study|Lost to Follow-up|5|||
156865294|NCT00107653|566265478|FG000|Overall Study|Administrative Reasons|3|||
156865295|NCT00107653|566265479|FG001|Overall Study|Administrative Reasons|3|||
156865296|NCT00541658|566265481|FG000|Overall Study|Adverse Event|28|||
156865297|NCT00541658|566265482|FG001|Overall Study|Adverse Event|37|||
156865298|NCT00541658|566265483|FG002|Overall Study|Adverse Event|25|||
156865299|NCT00541658|566265481|FG000|Overall Study|Physician Decision|0|||
156865300|NCT00541658|566265482|FG001|Overall Study|Physician Decision|0|||
156865301|NCT00541658|566265483|FG002|Overall Study|Physician Decision|4|||
156865302|NCT00541658|566265481|FG000|Overall Study|Lost to Follow-up|3|||
156865303|NCT00541658|566265482|FG001|Overall Study|Lost to Follow-up|3|||
156865304|NCT00541658|566265483|FG002|Overall Study|Lost to Follow-up|6|||
156865305|NCT00541658|566265481|FG000|Overall Study|Protocol Violation|0|||
156865306|NCT00541658|566265482|FG001|Overall Study|Protocol Violation|1|||
156865307|NCT00541658|566265483|FG002|Overall Study|Protocol Violation|1|||
156865308|NCT00541658|566265481|FG000|Overall Study|Withdrawal by Subject|28|||
156865309|NCT00541658|566265482|FG001|Overall Study|Withdrawal by Subject|32|||
156865310|NCT00541658|566265483|FG002|Overall Study|Withdrawal by Subject|32|||
156865311|NCT00541658|566265481|FG000|Overall Study|Took No Study Drug|1|||
156865312|NCT00541658|566265482|FG001|Overall Study|Took No Study Drug|0|||
156865313|NCT00541658|566265483|FG002|Overall Study|Took No Study Drug|0|||
156865314|NCT01099267|566265484|FG000|MDS-003 Study|Adverse Event|37|||
156865315|NCT01099267|566265484|FG000|MDS-003 Study|Lack of Efficacy|52|||
156865316|NCT01099267|566265484|FG000|MDS-003 Study|Withdrawal by Subject|8|||
156865317|NCT01099267|566265484|FG000|MDS-003 Study|Lost to Follow-up|1|||
156865318|NCT01099267|566265484|FG000|MDS-003 Study|Death|11|||
156865319|NCT01099267|566265484|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
156865320|NCT01099267|566265484|FG000|MDS-003 Study|Disease Progression|7|||
156865321|NCT01099267|566265484|FG000|MDS-003 Study|Investigator Decision|2|||
156865322|NCT01099267|566265484|FG000|MDS-003 Study|Non-Compliance|2|||
156865323|NCT01099267|566265484|FG000|MDS-003 Study|Loss of Response|1|||
156865324|NCT01099267|566265484|FG000|MDS-003 Study|Secondary Malign Disease|1|||
156865325|NCT04986904|566265485|FG000|Overall Study|Lost to Follow-up|11|||
156865326|NCT04986904|566265485|FG000|Overall Study|Withdrawal by Subject|1|||
156865327|NCT04123470|566265492|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
156865328|NCT04123470|566265493|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
156865329|NCT04123470|566265492|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
156865330|NCT04123470|566265493|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
156865331|NCT04123470|566265492|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
156865332|NCT04123470|566265493|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
156636911|NCT02146365|565414116|FG002|Overall Study|Withdrawal by Subject|1|||
156865333|NCT04123470|566265492|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
156865334|NCT04123470|566265493|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
156865335|NCT02018562|566265494|FG000|Overall Study|Withdrawal by Subject|2|||
156865336|NCT02018562|566265495|FG001|Overall Study|Withdrawal by Subject|0|||
156865337|NCT02018562|566265494|FG000|Overall Study|Discharged prior to study completion|1|||
156865338|NCT02018562|566265495|FG001|Overall Study|Discharged prior to study completion|0|||
156865339|NCT05408429|566265500|FG000|Overall Study|Lost to Follow-up|1|||
156865340|NCT05408429|566265501|FG001|Overall Study|Lost to Follow-up|1|||
156865341|NCT05408429|566265502|FG002|Overall Study|Lost to Follow-up|0|||
156865342|NCT05408429|566265500|FG000|Overall Study|Withdrawal by Subject|5|||
156865343|NCT05408429|566265501|FG001|Overall Study|Withdrawal by Subject|0|||
156865344|NCT05408429|566265502|FG002|Overall Study|Withdrawal by Subject|1|||
156865345|NCT03435211|566265503|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
156865346|NCT01253291|566265505|FG000|Overall Study|Withdrawal by Subject|1|||
156865347|NCT01253291|566265506|FG001|Overall Study|Withdrawal by Subject|1|||
156865348|NCT01253291|566265507|FG002|Overall Study|Withdrawal by Subject|0|||
156865349|NCT01253291|566265508|FG003|Overall Study|Withdrawal by Subject|0|||
156865350|NCT01253291|566265509|FG004|Overall Study|Withdrawal by Subject|0|||
156865351|NCT01253291|566265505|FG000|Overall Study|Adverse Event|0|||
156865352|NCT01253291|566265506|FG001|Overall Study|Adverse Event|1|||
156865353|NCT01253291|566265507|FG002|Overall Study|Adverse Event|0|||
156865354|NCT01253291|566265508|FG003|Overall Study|Adverse Event|0|||
156865355|NCT01253291|566265509|FG004|Overall Study|Adverse Event|0|||
156865356|NCT01253291|566265505|FG000|Overall Study|Lack of Efficacy|1|||
156865357|NCT01253291|566265506|FG001|Overall Study|Lack of Efficacy|0|||
156865358|NCT01253291|566265507|FG002|Overall Study|Lack of Efficacy|0|||
156865359|NCT01253291|566265508|FG003|Overall Study|Lack of Efficacy|0|||
156865360|NCT01253291|566265509|FG004|Overall Study|Lack of Efficacy|0|||
156865361|NCT01253291|566265505|FG000|Overall Study|Physician Decision|2|||
156865362|NCT01253291|566265506|FG001|Overall Study|Physician Decision|0|||
156865363|NCT01253291|566265507|FG002|Overall Study|Physician Decision|0|||
156865364|NCT01253291|566265508|FG003|Overall Study|Physician Decision|0|||
156865365|NCT01253291|566265509|FG004|Overall Study|Physician Decision|2|||
156865366|NCT01838395|566265513|FG000|Overall Study|Withdrawal by Subject|0|||
156865367|NCT01838395|566265514|FG001|Overall Study|Withdrawal by Subject|0|||
156865368|NCT01838395|566265515|FG002|Overall Study|Withdrawal by Subject|0|||
156865369|NCT01838395|566265516|FG003|Overall Study|Withdrawal by Subject|0|||
156865370|NCT01838395|566265517|FG004|Overall Study|Withdrawal by Subject|1|||
156865371|NCT01838395|566265518|FG005|Overall Study|Withdrawal by Subject|0|||
156865372|NCT01838395|566265513|FG000|Overall Study|Death|0|||
156865373|NCT01838395|566265514|FG001|Overall Study|Death|0|||
156865374|NCT01838395|566265515|FG002|Overall Study|Death|1|||
156865375|NCT01838395|566265516|FG003|Overall Study|Death|0|||
156865376|NCT01838395|566265517|FG004|Overall Study|Death|0|||
156865377|NCT01838395|566265518|FG005|Overall Study|Death|0|||
156865378|NCT01838395|566265513|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865379|NCT01838395|566265514|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
156865380|NCT01838395|566265515|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865381|NCT01838395|566265516|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865382|NCT01838395|566265517|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865383|NCT01838395|566265518|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865384|NCT05972993|566265519|FG000|Overall Study|Lost to Follow-up|2|||
156865385|NCT05972993|566265520|FG001|Overall Study|Lost to Follow-up|0|||
156865386|NCT05972993|566265521|FG002|Overall Study|Lost to Follow-up|1|||
156865387|NCT05972993|566265522|FG003|Overall Study|Lost to Follow-up|0|||
156865388|NCT05972993|566265523|FG004|Overall Study|Lost to Follow-up|0|||
156865389|NCT05972993|566265524|FG005|Overall Study|Lost to Follow-up|0|||
156865390|NCT05972993|566265525|FG006|Overall Study|Lost to Follow-up|0|||
156865391|NCT05972993|566265526|FG007|Overall Study|Lost to Follow-up|2|||
156865392|NCT05972993|566265527|FG008|Overall Study|Lost to Follow-up|0|||
156865393|NCT03866577|566265528|FG000|Overall Study|Protocol Violation|0|||
156865394|NCT03866577|566265529|FG001|Overall Study|Protocol Violation|0|||
156865395|NCT03866577|566265530|FG002|Overall Study|Protocol Violation|0|||
156865396|NCT03866577|566265531|FG003|Overall Study|Protocol Violation|0|||
156865397|NCT03866577|566265532|FG004|Overall Study|Protocol Violation|0|||
156865398|NCT03866577|566265533|FG005|Overall Study|Protocol Violation|0|||
156865399|NCT03866577|566265534|FG006|Overall Study|Protocol Violation|0|||
156865400|NCT03866577|566265535|FG007|Overall Study|Protocol Violation|0|||
156865401|NCT03866577|566265536|FG008|Overall Study|Protocol Violation|0|||
156865402|NCT03866577|566265537|FG009|Overall Study|Protocol Violation|0|||
156865403|NCT03866577|566265538|FG010|Overall Study|Protocol Violation|0|||
156865404|NCT03866577|566265539|FG011|Overall Study|Protocol Violation|1|||
156865405|NCT03866577|566265540|FG012|Overall Study|Protocol Violation|0|||
156865406|NCT03866577|566265528|FG000|Overall Study|Withdrawal by Subject|0|||
156865407|NCT03866577|566265529|FG001|Overall Study|Withdrawal by Subject|0|||
156408318|NCT04537897|564589257|FG001|Overall Study|Adverse Event|0|||
156865408|NCT03866577|566265530|FG002|Overall Study|Withdrawal by Subject|0|||
156865409|NCT03866577|566265531|FG003|Overall Study|Withdrawal by Subject|0|||
156865410|NCT03866577|566265532|FG004|Overall Study|Withdrawal by Subject|0|||
156865411|NCT03866577|566265533|FG005|Overall Study|Withdrawal by Subject|0|||
156865412|NCT03866577|566265534|FG006|Overall Study|Withdrawal by Subject|0|||
156865413|NCT03866577|566265535|FG007|Overall Study|Withdrawal by Subject|0|||
156865414|NCT03866577|566265536|FG008|Overall Study|Withdrawal by Subject|1|||
156865415|NCT03866577|566265537|FG009|Overall Study|Withdrawal by Subject|1|||
156865416|NCT03866577|566265538|FG010|Overall Study|Withdrawal by Subject|0|||
156865417|NCT03866577|566265539|FG011|Overall Study|Withdrawal by Subject|0|||
156865418|NCT03866577|566265540|FG012|Overall Study|Withdrawal by Subject|0|||
156636912|NCT02146365|565414117|FG003|Overall Study|Withdrawal by Subject|5|||
156636913|NCT02146365|565414118|FG004|Overall Study|Withdrawal by Subject|1|||
156636914|NCT02146365|565414119|FG005|Overall Study|Withdrawal by Subject|0|||
156636915|NCT02146365|565414120|FG006|Overall Study|Withdrawal by Subject|0|||
156636916|NCT02146365|565414121|FG007|Overall Study|Withdrawal by Subject|0|||
156636917|NCT02146365|565414114|FG000|Overall Study|Unable to Comply with Protocol|0|||
156636918|NCT02146365|565414115|FG001|Overall Study|Unable to Comply with Protocol|1|||
156636919|NCT02146365|565414116|FG002|Overall Study|Unable to Comply with Protocol|1|||
156751537|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
156636920|NCT02146365|565414117|FG003|Overall Study|Unable to Comply with Protocol|0|||
156636921|NCT02146365|565414118|FG004|Overall Study|Unable to Comply with Protocol|0|||
156636922|NCT02146365|565414119|FG005|Overall Study|Unable to Comply with Protocol|0|||
156636923|NCT02146365|565414120|FG006|Overall Study|Unable to Comply with Protocol|0|||
156636924|NCT02146365|565414121|FG007|Overall Study|Unable to Comply with Protocol|0|||
156636925|NCT02146365|565414114|FG000|Overall Study|Other|1|||
156636926|NCT02146365|565414115|FG001|Overall Study|Other|0|||
156636927|NCT02146365|565414116|FG002|Overall Study|Other|2|||
156636928|NCT02146365|565414117|FG003|Overall Study|Other|1|||
156636929|NCT02146365|565414118|FG004|Overall Study|Other|0|||
156636930|NCT02146365|565414119|FG005|Overall Study|Other|0|||
156751538|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751539|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
156751540|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751541|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751542|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
156751543|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751544|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751545|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751546|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
156751547|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751548|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751549|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
156751550|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751551|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751552|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751553|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
156751554|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751555|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
156751556|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
156751557|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
156751558|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
156751559|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
156751560|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
156751561|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
156751562|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
156751563|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
156751564|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
156751565|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
156751566|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
156751567|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
156751568|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
156751569|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
156751570|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
156751571|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
156751572|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
156751573|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
156751574|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
156751575|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
156751576|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
156751577|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
156751578|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
156751579|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
156751580|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
156751581|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
156751582|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
156751583|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
156636931|NCT02146365|565414120|FG006|Overall Study|Other|0|||
156865419|NCT03866577|566265528|FG000|Overall Study|Not qualified for IVIg infusion|0|||
156865420|NCT03866577|566265529|FG001|Overall Study|Not qualified for IVIg infusion|0|||
156865421|NCT03866577|566265530|FG002|Overall Study|Not qualified for IVIg infusion|0|||
156865422|NCT03866577|566265531|FG003|Overall Study|Not qualified for IVIg infusion|0|||
156865423|NCT03866577|566265532|FG004|Overall Study|Not qualified for IVIg infusion|0|||
156865424|NCT03866577|566265533|FG005|Overall Study|Not qualified for IVIg infusion|0|||
156865425|NCT03866577|566265534|FG006|Overall Study|Not qualified for IVIg infusion|0|||
156865426|NCT03866577|566265535|FG007|Overall Study|Not qualified for IVIg infusion|0|||
156865427|NCT03866577|566265536|FG008|Overall Study|Not qualified for IVIg infusion|0|||
156865428|NCT03866577|566265537|FG009|Overall Study|Not qualified for IVIg infusion|1|||
156865429|NCT03866577|566265538|FG010|Overall Study|Not qualified for IVIg infusion|0|||
156865430|NCT03866577|566265539|FG011|Overall Study|Not qualified for IVIg infusion|0|||
156865431|NCT03866577|566265540|FG012|Overall Study|Not qualified for IVIg infusion|0|||
156865432|NCT04825678|566265543|FG000|Overall Study|Decision by Sponsor|2|||
156865433|NCT04825678|566265544|FG001|Overall Study|Decision by Sponsor|3|||
156865434|NCT04825678|566265543|FG000|Overall Study|Withdrawal of Consent From Study|7|||
156865435|NCT04825678|566265544|FG001|Overall Study|Withdrawal of Consent From Study|9|||
156865436|NCT04825678|566265543|FG000|Overall Study|Lost to Follow-up|3|||
156865437|NCT04825678|566265544|FG001|Overall Study|Lost to Follow-up|4|||
156865438|NCT04825678|566265543|FG000|Overall Study|Never Received Investigational Product|1|||
156865439|NCT04825678|566265544|FG001|Overall Study|Never Received Investigational Product|1|||
156865440|NCT02195518|566265545|FG000|Overall Study|Adverse Event|1|||
156865441|NCT02195518|566265545|FG000|Overall Study|Protocol Violation|4|||
156865442|NCT02195518|566265545|FG000|Overall Study|Pregnancy|2|||
156865443|NCT02195518|566265545|FG000|Overall Study|Withdrawal by Subject|1|||
156865444|NCT02195518|566265545|FG000|Overall Study|Lost to Follow-up|1|||
156865445|NCT03818256|566265546|FG000|Overall Study|Withdrawal by Subject|2|||
156865446|NCT03818256|566265547|FG001|Overall Study|Withdrawal by Subject|2|||
156865447|NCT03818256|566265546|FG000|Overall Study|Adverse Event|3|||
156865448|NCT03818256|566265547|FG001|Overall Study|Adverse Event|1|||
156865449|NCT03818256|566265546|FG000|Overall Study|Lost to Follow-up|0|||
156865450|NCT03818256|566265547|FG001|Overall Study|Lost to Follow-up|5|||
156865451|NCT03818256|566265546|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
156865452|NCT03818256|566265547|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
156865453|NCT03818256|566265546|FG000|Overall Study|Not reporting for scheduled visits|1|||
156865454|NCT03818256|566265547|FG001|Overall Study|Not reporting for scheduled visits|0|||
156865455|NCT03818256|566265546|FG000|Overall Study|Non-compliant with investigational product|1|||
156865456|NCT03818256|566265547|FG001|Overall Study|Non-compliant with investigational product|0|||
156865457|NCT00400179|566265554|FG000|Overall Study|Adverse Event|2|||
156865458|NCT00400179|566265555|FG001|Overall Study|Adverse Event|2|||
156865459|NCT00400179|566265554|FG000|Overall Study|Death|1|||
156865460|NCT00400179|566265555|FG001|Overall Study|Death|2|||
156865461|NCT00400179|566265554|FG000|Overall Study|Withdrew Consent|1|||
156865462|NCT00400179|566265555|FG001|Overall Study|Withdrew Consent|5|||
156865463|NCT00400179|566265554|FG000|Overall Study|Disease progression|1|||
156865464|NCT00400179|566265555|FG001|Overall Study|Disease progression|1|||
156865465|NCT00400179|566265554|FG000|Overall Study|Intercurrent illness|0|||
156865466|NCT00400179|566265555|FG001|Overall Study|Intercurrent illness|1|||
156865467|NCT00400179|566265554|FG000|Overall Study|Investigator judgment|0|||
156865468|NCT00400179|566265555|FG001|Overall Study|Investigator judgment|1|||
156865469|NCT00400179|566265554|FG000|Overall Study|Randomization error/patient ineligible|1|||
156865470|NCT00400179|566265555|FG001|Overall Study|Randomization error/patient ineligible|6|||
156865471|NCT04780061|566265556|FG000|Overall Study|Withdrawal by Subject|5|||
156865472|NCT04780061|566265557|FG001|Overall Study|Withdrawal by Subject|8|||
156865473|NCT04780061|566265556|FG000|Overall Study|Adverse Event|2|||
156865474|NCT04780061|566265557|FG001|Overall Study|Adverse Event|2|||
156865475|NCT04780061|566265556|FG000|Overall Study|Lost to Follow-up|1|||
156865476|NCT04780061|566265557|FG001|Overall Study|Lost to Follow-up|5|||
156865477|NCT02023086|566265560|FG000|Overall Study|Withdrawal by Subject|2|||
156865478|NCT02023086|566265561|FG001|Overall Study|Withdrawal by Subject|0|||
156865479|NCT03589859|566265564|FG000|Overall Study|Withdrawal by Subject|0|||
156865480|NCT03589859|566265565|FG001|Overall Study|Withdrawal by Subject|6|||
156865481|NCT05530252|566265567|FG000|Overall Study|Lost to Follow-up|1|||
156865482|NCT05530252|566265568|FG001|Overall Study|Lost to Follow-up|1|||
156865483|NCT05530252|566265569|FG002|Overall Study|Lost to Follow-up|1|||
156865484|NCT03125395|566267261|FG000|Overall Study|Adverse Event|2|||
156865485|NCT03125395|566267261|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156865486|NCT03125395|566267261|FG000|Overall Study|Physician Decision|2|||
156865487|NCT03125395|566267261|FG000|Overall Study|Commercial drug is available|5|||
156865488|NCT02531802|566267262|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
156865489|NCT02531802|566267263|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
156865490|NCT02531802|566267264|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
156865491|NCT02531802|566267265|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
156865492|NCT02531802|566267266|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
156865493|NCT02531802|566267267|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
156865494|NCT02531802|566267268|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
156865495|NCT02531802|566267269|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
156865496|NCT02531802|566267270|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
156865497|NCT02531802|566267271|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
156865498|NCT02531802|566267272|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
156865499|NCT02531802|566267273|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
156865500|NCT02531802|566267274|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
156865501|NCT02531802|566267275|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
156865502|NCT02531802|566267276|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
156865503|NCT02531802|566267277|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
156865504|NCT02531802|566267278|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
156865505|NCT02531802|566267279|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
156865506|NCT02531802|566267280|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
156865507|NCT02531802|566267281|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
156865508|NCT02531802|566267282|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
156865509|NCT02531802|566267262|FG000|Received Vaccination 2|Physician Decision|0|||
156865510|NCT02531802|566267263|FG001|Received Vaccination 2|Physician Decision|0|||
156865511|NCT02531802|566267264|FG002|Received Vaccination 2|Physician Decision|0|||
156865512|NCT02531802|566267265|FG003|Received Vaccination 2|Physician Decision|0|||
156865513|NCT02531802|566267266|FG004|Received Vaccination 2|Physician Decision|0|||
156865514|NCT02531802|566267267|FG005|Received Vaccination 2|Physician Decision|1|||
156865515|NCT02531802|566267268|FG006|Received Vaccination 2|Physician Decision|0|||
156865516|NCT02531802|566267269|FG007|Received Vaccination 2|Physician Decision|0|||
156865517|NCT02531802|566267270|FG008|Received Vaccination 2|Physician Decision|0|||
156865518|NCT02531802|566267271|FG009|Received Vaccination 2|Physician Decision|2|||
156865519|NCT02531802|566267272|FG010|Received Vaccination 2|Physician Decision|0|||
156865520|NCT02531802|566267273|FG011|Received Vaccination 2|Physician Decision|0|||
156865521|NCT02531802|566267274|FG012|Received Vaccination 2|Physician Decision|0|||
156865522|NCT02531802|566267275|FG013|Received Vaccination 2|Physician Decision|1|||
156865523|NCT02531802|566267276|FG014|Received Vaccination 2|Physician Decision|0|||
156865524|NCT02531802|566267277|FG015|Received Vaccination 2|Physician Decision|0|||
156865525|NCT02531802|566267278|FG016|Received Vaccination 2|Physician Decision|0|||
156865526|NCT02531802|566267279|FG017|Received Vaccination 2|Physician Decision|1|||
156865527|NCT02531802|566267280|FG018|Received Vaccination 2|Physician Decision|0|||
156865528|NCT02531802|566267281|FG019|Received Vaccination 2|Physician Decision|0|||
156865529|NCT02531802|566267282|FG020|Received Vaccination 2|Physician Decision|0|||
156865530|NCT02531802|566267262|FG000|Received Vaccination 2|Adverse Event|0|||
156865531|NCT02531802|566267263|FG001|Received Vaccination 2|Adverse Event|0|||
156865532|NCT02531802|566267264|FG002|Received Vaccination 2|Adverse Event|0|||
156865533|NCT02531802|566267265|FG003|Received Vaccination 2|Adverse Event|0|||
156865534|NCT02531802|566267266|FG004|Received Vaccination 2|Adverse Event|0|||
156865535|NCT02531802|566267267|FG005|Received Vaccination 2|Adverse Event|2|||
156865536|NCT02531802|566267268|FG006|Received Vaccination 2|Adverse Event|0|||
156865537|NCT02531802|566267269|FG007|Received Vaccination 2|Adverse Event|0|||
156865538|NCT02531802|566267270|FG008|Received Vaccination 2|Adverse Event|0|||
156865539|NCT02531802|566267271|FG009|Received Vaccination 2|Adverse Event|0|||
156865540|NCT02531802|566267272|FG010|Received Vaccination 2|Adverse Event|0|||
156865541|NCT02531802|566267273|FG011|Received Vaccination 2|Adverse Event|0|||
156865542|NCT02531802|566267274|FG012|Received Vaccination 2|Adverse Event|0|||
156865543|NCT02531802|566267275|FG013|Received Vaccination 2|Adverse Event|0|||
156865544|NCT02531802|566267276|FG014|Received Vaccination 2|Adverse Event|0|||
156865545|NCT02531802|566267277|FG015|Received Vaccination 2|Adverse Event|0|||
156865546|NCT02531802|566267278|FG016|Received Vaccination 2|Adverse Event|0|||
156865547|NCT02531802|566267279|FG017|Received Vaccination 2|Adverse Event|2|||
156865548|NCT02531802|566267280|FG018|Received Vaccination 2|Adverse Event|1|||
156865549|NCT02531802|566267281|FG019|Received Vaccination 2|Adverse Event|0|||
156865550|NCT02531802|566267282|FG020|Received Vaccination 2|Adverse Event|1|||
156865551|NCT02531802|566267262|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
156865552|NCT02531802|566267263|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
156865553|NCT02531802|566267264|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
156865554|NCT02531802|566267265|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
156865555|NCT02531802|566267266|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
156408319|NCT04537897|564589258|FG002|Overall Study|Adverse Event|0|||
156865556|NCT02531802|566267267|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
156865557|NCT02531802|566267268|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
156865558|NCT02531802|566267269|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
156865559|NCT02531802|566267270|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
156865560|NCT02531802|566267271|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
156865561|NCT02531802|566267272|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
156865562|NCT02531802|566267273|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
156865563|NCT02531802|566267274|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
156865564|NCT02531802|566267275|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
156865565|NCT02531802|566267276|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
156865566|NCT02531802|566267277|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
156865567|NCT02531802|566267278|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
156865568|NCT02531802|566267279|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
156865569|NCT02531802|566267280|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
156865570|NCT02531802|566267281|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
156865571|NCT02531802|566267282|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
156865572|NCT00482053|566267283|FG000|Inter-treatment Period|Disease progression|1|||
156865573|NCT02224560|566267286|FG000|Overall Study|Protocol Deviation|1|||
156865574|NCT02224560|566267287|FG001|Overall Study|Protocol Deviation|0|||
156865575|NCT02224560|566267288|FG002|Overall Study|Protocol Deviation|0|||
156865576|NCT02224560|566267286|FG000|Overall Study|Withdrawal by Subject|2|||
156865577|NCT02224560|566267287|FG001|Overall Study|Withdrawal by Subject|0|||
156865578|NCT02224560|566267288|FG002|Overall Study|Withdrawal by Subject|1|||
156865579|NCT02224560|566267286|FG000|Overall Study|Met Withdrawal Criteria|1|||
156865580|NCT02224560|566267287|FG001|Overall Study|Met Withdrawal Criteria|0|||
156865581|NCT02224560|566267288|FG002|Overall Study|Met Withdrawal Criteria|0|||
156865582|NCT02224560|566267286|FG000|Overall Study|Adverse Event|4|||
156865583|NCT02224560|566267287|FG001|Overall Study|Adverse Event|1|||
156865584|NCT02224560|566267288|FG002|Overall Study|Adverse Event|1|||
156865585|NCT02224560|566267286|FG000|Overall Study|Withdrawn by Investigator|1|||
156865586|NCT02224560|566267287|FG001|Overall Study|Withdrawn by Investigator|1|||
156865587|NCT02224560|566267288|FG002|Overall Study|Withdrawn by Investigator|0|||
156865588|NCT00728689|566267289|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
156865589|NCT00728689|566267290|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
156865590|NCT01523366|566267291|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156865591|NCT01523366|566267292|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156865592|NCT01523366|566267291|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
156865593|NCT01523366|566267292|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
156865594|NCT04543279|566267294|FG000|Overall Study|Withdrawal by Subject|1|||
156865595|NCT04543279|566267295|FG001|Overall Study|Withdrawal by Subject|0|||
156865596|NCT04543279|566267294|FG000|Overall Study|Adverse Event|1|||
156865597|NCT04543279|566267295|FG001|Overall Study|Adverse Event|0|||
156865598|NCT04543279|566267294|FG000|Overall Study|Physician Decision|1|||
156865599|NCT04543279|566267295|FG001|Overall Study|Physician Decision|0|||
156865600|NCT03216226|566267298|FG000|Overall Study|Adverse Event|3|||
156865601|NCT03216226|566267299|FG001|Overall Study|Adverse Event|0|||
156865602|NCT03216226|566267298|FG000|Overall Study|Protocol Violation|1|||
156865603|NCT03216226|566267299|FG001|Overall Study|Protocol Violation|3|||
156865604|NCT03216226|566267298|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
156865605|NCT03216226|566267299|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
156865606|NCT03216226|566267298|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
156865607|NCT03216226|566267299|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
156865608|NCT03216226|566267298|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
156865609|NCT03216226|566267299|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
156865610|NCT00871975|566267301|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
156865611|NCT00871975|566267301|FG000|Overall Study|Catheters could not be inserted|1|||
156865612|NCT00871975|566267301|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
156865613|NCT00871975|566267301|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
156865614|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
156865615|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
156865616|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
156865617|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
156865618|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
156865619|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
156865620|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
156865621|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156865622|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156865623|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
156865624|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156865625|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156865626|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
156865627|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
156865628|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
156865629|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Other|119|||
156408320|NCT04537897|564589259|FG003|Overall Study|Adverse Event|1|||
156865630|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Other|0|||
156865631|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Other|0|||
156865632|NCT01436149|566267305|FG000|Randomized Phase|Adverse Event|9|||
156865633|NCT01436149|566267306|FG001|Randomized Phase|Adverse Event|10|||
156865634|NCT01436149|566267307|FG002|Randomized Phase|Adverse Event|11|||
156865635|NCT01436149|566267305|FG000|Randomized Phase|Protocol Violation|4|||
156865636|NCT01436149|566267306|FG001|Randomized Phase|Protocol Violation|5|||
156865637|NCT01436149|566267307|FG002|Randomized Phase|Protocol Violation|0|||
156865638|NCT01436149|566267305|FG000|Randomized Phase|Withdrawal by Subject|16|||
156865639|NCT01436149|566267306|FG001|Randomized Phase|Withdrawal by Subject|10|||
156865640|NCT01436149|566267307|FG002|Randomized Phase|Withdrawal by Subject|10|||
156865641|NCT01436149|566267305|FG000|Randomized Phase|Lost to Follow-up|34|||
156865642|NCT01436149|566267306|FG001|Randomized Phase|Lost to Follow-up|5|||
156865643|NCT01436149|566267307|FG002|Randomized Phase|Lost to Follow-up|6|||
156865644|NCT01436149|566267305|FG000|Randomized Phase|Lack of Efficacy|0|||
156865645|NCT01436149|566267306|FG001|Randomized Phase|Lack of Efficacy|0|||
156865646|NCT01436149|566267307|FG002|Randomized Phase|Lack of Efficacy|1|||
156865647|NCT01436149|566267305|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
156865648|NCT01436149|566267306|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
156865649|NCT01436149|566267307|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
156865650|NCT01436149|566267305|FG000|Randomized Phase|Other|12|||
156865651|NCT01436149|566267306|FG001|Randomized Phase|Other|5|||
156865652|NCT01436149|566267307|FG002|Randomized Phase|Other|11|||
156865653|NCT01690143|566267308|FG000|Overall Study|Withdrawal by Subject|1|||
156865654|NCT01710345|566267324|FG000|Overall Study|Adverse Event|0|||
156865655|NCT01710345|566267325|FG001|Overall Study|Adverse Event|2|||
156865656|NCT01710345|566267326|FG002|Overall Study|Adverse Event|0|||
156865657|NCT01710345|566267324|FG000|Overall Study|Lack of Efficacy|2|||
156865658|NCT01710345|566267325|FG001|Overall Study|Lack of Efficacy|3|||
156865659|NCT01710345|566267326|FG002|Overall Study|Lack of Efficacy|1|||
156865660|NCT01710345|566267324|FG000|Overall Study|Drug Dosing Error|1|||
156865661|NCT01710345|566267325|FG001|Overall Study|Drug Dosing Error|0|||
156865662|NCT01710345|566267326|FG002|Overall Study|Drug Dosing Error|0|||
156865663|NCT01502293|566267328|FG000|Overall Study|Progressive Disease|20|||
156865664|NCT01502293|566267329|FG001|Overall Study|Progressive Disease|12|||
156865665|NCT01502293|566267330|FG002|Overall Study|Progressive Disease|2|||
156865666|NCT01502293|566267328|FG000|Overall Study|Withdrawal by Subject|3|||
156865667|NCT01502293|566267329|FG001|Overall Study|Withdrawal by Subject|3|||
156865668|NCT01502293|566267330|FG002|Overall Study|Withdrawal by Subject|1|||
156865669|NCT01502293|566267328|FG000|Overall Study|Adverse Event|0|||
156865670|NCT01502293|566267329|FG001|Overall Study|Adverse Event|2|||
156865671|NCT01502293|566267330|FG002|Overall Study|Adverse Event|0|||
156865672|NCT01502293|566267328|FG000|Overall Study|Reason Not Specified|2|||
156865673|NCT01502293|566267329|FG001|Overall Study|Reason Not Specified|0|||
156865674|NCT01502293|566267330|FG002|Overall Study|Reason Not Specified|0|||
156865675|NCT01502293|566267328|FG000|Overall Study|Physician Decision|0|||
156865676|NCT01502293|566267329|FG001|Overall Study|Physician Decision|0|||
156865677|NCT01502293|566267330|FG002|Overall Study|Physician Decision|1|||
156865678|NCT00391586|566267332|FG000|Overall Study|Progressive disease|13|||
156865679|NCT00391586|566267332|FG000|Overall Study|Adverse Event|5|||
156865680|NCT00391586|566267332|FG000|Overall Study|Physician Decision|2|||
156865681|NCT00391586|566267332|FG000|Overall Study|Death|4|||
156865682|NCT00198822|566267333|FG000|Overall Study|Lost to Follow-up|14|||
156865683|NCT00198822|566267334|FG001|Overall Study|Lost to Follow-up|20|||
156865684|NCT00198822|566267335|FG002|Overall Study|Lost to Follow-up|21|||
156865685|NCT01409707|566267336|FG000|Overall Study|Withdrawal by Subject|5|||
156865686|NCT01409707|566267337|FG001|Overall Study|Withdrawal by Subject|17|||
156865687|NCT01409707|566267338|FG002|Overall Study|Withdrawal by Subject|16|||
156865688|NCT01716234|566267339|FG000|Overall Study|Protocol Violation|0|||
156865689|NCT01716234|566267340|FG001|Overall Study|Protocol Violation|0|||
156865690|NCT01716234|566267341|FG002|Overall Study|Protocol Violation|0|||
156865691|NCT01716234|566267342|FG003|Overall Study|Protocol Violation|1|||
156865692|NCT01716234|566267343|FG004|Overall Study|Protocol Violation|1|||
156865693|NCT01716234|566267344|FG005|Overall Study|Protocol Violation|1|||
156865694|NCT01716234|566267345|FG006|Overall Study|Protocol Violation|0|||
156865695|NCT01716234|566267339|FG000|Overall Study|Lack of Efficacy|0|||
156865696|NCT01716234|566267340|FG001|Overall Study|Lack of Efficacy|0|||
156865697|NCT01716234|566267341|FG002|Overall Study|Lack of Efficacy|0|||
156865698|NCT01716234|566267342|FG003|Overall Study|Lack of Efficacy|1|||
156865699|NCT01716234|566267343|FG004|Overall Study|Lack of Efficacy|0|||
156865700|NCT01716234|566267344|FG005|Overall Study|Lack of Efficacy|0|||
156865701|NCT01716234|566267345|FG006|Overall Study|Lack of Efficacy|0|||
156865702|NCT01716234|566267339|FG000|Overall Study|Did not meet protocol eligibility|0|||
156865703|NCT01716234|566267340|FG001|Overall Study|Did not meet protocol eligibility|0|||
156865704|NCT01716234|566267341|FG002|Overall Study|Did not meet protocol eligibility|1|||
156865705|NCT01716234|566267342|FG003|Overall Study|Did not meet protocol eligibility|0|||
156865706|NCT01716234|566267343|FG004|Overall Study|Did not meet protocol eligibility|0|||
156865707|NCT01716234|566267344|FG005|Overall Study|Did not meet protocol eligibility|4|||
156865708|NCT01716234|566267345|FG006|Overall Study|Did not meet protocol eligibility|0|||
156865709|NCT01716234|566267339|FG000|Overall Study|Adverse Event|7|||
156865710|NCT01716234|566267340|FG001|Overall Study|Adverse Event|10|||
156865711|NCT01716234|566267341|FG002|Overall Study|Adverse Event|2|||
156865712|NCT01716234|566267342|FG003|Overall Study|Adverse Event|8|||
156865713|NCT01716234|566267343|FG004|Overall Study|Adverse Event|3|||
156865714|NCT01716234|566267344|FG005|Overall Study|Adverse Event|6|||
156865715|NCT01716234|566267345|FG006|Overall Study|Adverse Event|0|||
156865716|NCT01716234|566267339|FG000|Overall Study|Withdrawal by Subject|3|||
156865717|NCT01716234|566267340|FG001|Overall Study|Withdrawal by Subject|0|||
156865718|NCT01716234|566267341|FG002|Overall Study|Withdrawal by Subject|2|||
156865719|NCT01716234|566267342|FG003|Overall Study|Withdrawal by Subject|2|||
156865720|NCT01716234|566267343|FG004|Overall Study|Withdrawal by Subject|1|||
156865721|NCT01716234|566267344|FG005|Overall Study|Withdrawal by Subject|3|||
156865722|NCT01716234|566267345|FG006|Overall Study|Withdrawal by Subject|0|||
156865723|NCT02667119|566267346|FG000|Overall Study|Lost to Follow-up|3|||
156865724|NCT02667119|566267347|FG001|Overall Study|Lost to Follow-up|0|||
156865725|NCT01523756|566267348|FG000|Baseline Period|Adverse Event|0|||
156865726|NCT01523756|566267349|FG001|Baseline Period|Adverse Event|1|||
156865727|NCT01523756|566267348|FG000|Test Period 1|Adverse Event|1|||
156865728|NCT01523756|566267349|FG001|Test Period 1|Adverse Event|0|||
156865729|NCT01523756|566267348|FG000|Test Period 2|Withdrawal by Subject|0|||
156865730|NCT01523756|566267349|FG001|Test Period 2|Withdrawal by Subject|1|||
156865731|NCT03783078|566267352|FG000|Overall Study|Death|31|||
156865732|NCT03783078|566267352|FG000|Overall Study|Sponsor Decision|23|||
156865733|NCT03783078|566267352|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156865734|NCT01467960|566267354|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
156865735|NCT01467960|566267355|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
156865736|NCT01467960|566267356|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
156865737|NCT01467960|566267357|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
156865738|NCT01467960|566267358|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
156865739|NCT01467960|566267359|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
156865740|NCT00474812|566267362|FG000|Overall Study|Withdrawal by Subject|5|||
156865741|NCT00474812|566267362|FG000|Overall Study|No Initiation of treatment|2|||
156865742|NCT00651742|566267375|FG000|Overall Study|Objective Disease Progression|22|||
156865743|NCT00651742|566267375|FG000|Overall Study|Toxicity|3|||
156865744|NCT00651742|566267375|FG000|Overall Study|Investigator Judgment|1|||
156865745|NCT00651742|566267375|FG000|Overall Study|Withdrawal of Consent|1|||
156865746|NCT00651742|566267375|FG000|Overall Study|Enrolled but not treated|1|||
156865747|NCT05720897|566267378|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
156865748|NCT05720897|566267379|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
156865749|NCT04050553|566267381|FG000|Period 1|Physician Decision|2|||
156865750|NCT04050553|566267382|FG001|Period 1|Physician Decision|2|||
156865751|NCT04050553|566267381|FG000|Period 1|Adverse Event|1|||
156865752|NCT04050553|566267382|FG001|Period 1|Adverse Event|1|||
156865753|NCT04050553|566267381|FG000|Period 1|Withdrawal by Subject|0|||
156865754|NCT04050553|566267382|FG001|Period 1|Withdrawal by Subject|1|||
156865755|NCT04050553|566267381|FG000|Wash-out|Adverse Event|0|||
156865756|NCT04050553|566267382|FG001|Wash-out|Adverse Event|1|||
156865757|NCT04050553|566267381|FG000|Wash-out|Withdrawal by Subject|0|||
156865758|NCT04050553|566267382|FG001|Wash-out|Withdrawal by Subject|1|||
156865759|NCT01535040|566267383|FG000|Overall Study|Physician Decision|0|||
156865760|NCT01535040|566267384|FG001|Overall Study|Physician Decision|1|||
156865761|NCT01535040|566267383|FG000|Overall Study|Withdrawal by Subject|13|||
156865762|NCT01535040|566267384|FG001|Overall Study|Withdrawal by Subject|10|||
156865763|NCT01535040|566267383|FG000|Overall Study|Never Started|9|||
156865764|NCT01535040|566267384|FG001|Overall Study|Never Started|4|||
156865765|NCT01535040|566267383|FG000|Overall Study|Toxicity|7|||
156865766|NCT01535040|566267384|FG001|Overall Study|Toxicity|5|||
156865767|NCT01535040|566267383|FG000|Overall Study|Multiple Reasons|1|||
156865768|NCT01535040|566267384|FG001|Overall Study|Multiple Reasons|1|||
156865769|NCT01074970|566267385|FG000|Overall Study|Never Treated|0|||
156865770|NCT01074970|566267386|FG001|Overall Study|Never Treated|0|||
156865771|NCT01074970|566267387|FG002|Overall Study|Never Treated|8|||
156865772|NCT01074970|566267388|FG003|Overall Study|Never Treated|1|||
156865773|NCT01074970|566267385|FG000|Overall Study|Adverse Event|1|||
156865774|NCT01074970|566267386|FG001|Overall Study|Adverse Event|0|||
156865775|NCT01074970|566267387|FG002|Overall Study|Adverse Event|4|||
156865776|NCT01074970|566267388|FG003|Overall Study|Adverse Event|3|||
156865777|NCT01074970|566267385|FG000|Overall Study|Disease progression during treatment|3|||
156865778|NCT01074970|566267386|FG001|Overall Study|Disease progression during treatment|1|||
156865779|NCT01074970|566267387|FG002|Overall Study|Disease progression during treatment|2|||
156865780|NCT01074970|566267388|FG003|Overall Study|Disease progression during treatment|9|||
156865781|NCT01074970|566267385|FG000|Overall Study|Lost to Follow-up|0|||
156865782|NCT01074970|566267386|FG001|Overall Study|Lost to Follow-up|0|||
156865783|NCT01074970|566267387|FG002|Overall Study|Lost to Follow-up|1|||
156865784|NCT01074970|566267388|FG003|Overall Study|Lost to Follow-up|0|||
156865785|NCT01074970|566267385|FG000|Overall Study|Withdrawal by Subject|0|||
156865786|NCT01074970|566267386|FG001|Overall Study|Withdrawal by Subject|0|||
156865787|NCT01074970|566267387|FG002|Overall Study|Withdrawal by Subject|6|||
156865788|NCT01074970|566267388|FG003|Overall Study|Withdrawal by Subject|4|||
156865789|NCT00734149|566267390|FG000|Overall Study|Withdrawal by Subject|1|||
156865790|NCT05430854|566267391|FG000|Overall Study|Trial terminated by Sponsor|39|||
156865791|NCT05430854|566267392|FG001|Overall Study|Trial terminated by Sponsor|50|||
156865792|NCT05430854|566267393|FG002|Overall Study|Trial terminated by Sponsor|46|||
156865793|NCT05430854|566267391|FG000|Overall Study|Withdrawal by Subject|0|||
156865794|NCT05430854|566267392|FG001|Overall Study|Withdrawal by Subject|3|||
156865795|NCT05430854|566267393|FG002|Overall Study|Withdrawal by Subject|0|||
156865796|NCT04314284|566267394|FG000|Overall Study|Withdrawal by Subject|4|||
156636932|NCT02146365|565414121|FG007|Overall Study|Other|0|||
156636933|NCT01608321|565414122|FG000|Overall Study|Withdrawal by Subject|1|||
156636934|NCT01608321|565414123|FG001|Overall Study|Withdrawal by Subject|0|||
156636935|NCT03222856|565414126|FG000|Overall Study|Adverse Event|6|||
156636936|NCT03222856|565414126|FG000|Overall Study|Death|1|||
156751584|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
156751585|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
156751586|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
156751587|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
156751588|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
156751589|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
156751590|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
156751591|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751592|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
156751593|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
156751594|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
156751595|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751596|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751597|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
156751598|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751599|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751600|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751601|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751602|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751603|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751604|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
156751605|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
156751606|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751607|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751608|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751609|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751610|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
156751611|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751612|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751613|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751614|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751615|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
156865797|NCT04314284|566267395|FG001|Overall Study|Withdrawal by Subject|7|||
156865798|NCT04314284|566267394|FG000|Overall Study|Consented but did not complete survey|0|||
156865799|NCT04314284|566267395|FG001|Overall Study|Consented but did not complete survey|6|||
156865800|NCT01652235|566267399|FG000|Overall Study|Death|9|||
156865801|NCT01652235|566267399|FG000|Overall Study|Lost to Follow-up|5|||
156865802|NCT01652235|566267399|FG000|Overall Study|Withdrawal by Subject|2|||
156865803|NCT03043794|566267404|FG000|Overall Study|Lost to Follow-up|1|||
156751616|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751617|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
156751618|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
156751619|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
156751620|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
156751621|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
156751622|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
156751623|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
156751624|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
156865804|NCT00626106|566267405|FG000|Overall Study|Withdrawal by Subject|2|||
156865805|NCT00626106|566267406|FG001|Overall Study|Withdrawal by Subject|1|||
156865806|NCT00626106|566267405|FG000|Overall Study|Lost to Follow-up|1|||
156865807|NCT00626106|566267406|FG001|Overall Study|Lost to Follow-up|4|||
156865808|NCT00626106|566267405|FG000|Overall Study|Death|64|||
156865809|NCT00626106|566267406|FG001|Overall Study|Death|19|||
156865810|NCT02201953|566267407|FG000|Overall Study|Randomized but Never Treated|1|||
156865811|NCT02201953|566267408|FG001|Overall Study|Randomized but Never Treated|5|||
156865812|NCT02201953|566267407|FG000|Overall Study|Lack of Efficacy|9|||
156865813|NCT02201953|566267408|FG001|Overall Study|Lack of Efficacy|30|||
156865814|NCT02201953|566267407|FG000|Overall Study|Lost to Follow-up|8|||
156865815|NCT02201953|566267408|FG001|Overall Study|Lost to Follow-up|8|||
156865816|NCT02201953|566267407|FG000|Overall Study|Withdrew Consent|2|||
156865817|NCT02201953|566267408|FG001|Overall Study|Withdrew Consent|5|||
156865818|NCT02201953|566267407|FG000|Overall Study|Adverse Event|0|||
156865819|NCT02201953|566267408|FG001|Overall Study|Adverse Event|5|||
156865820|NCT02201953|566267407|FG000|Overall Study|Death|0|||
156865821|NCT02201953|566267408|FG001|Overall Study|Death|3|||
156865822|NCT00911170|566267409|FG000|Treatment Period|Randomized in error|1|||
156865823|NCT00911170|566267410|FG001|Treatment Period|Randomized in error|1|||
156865824|NCT00911170|566267409|FG000|Treatment Period|Ineligibility determined|1|||
156865825|NCT00911170|566267410|FG001|Treatment Period|Ineligibility determined|3|||
156865826|NCT00911170|566267409|FG000|Treatment Period|Protocol deviation|1|||
156865827|NCT00911170|566267410|FG001|Treatment Period|Protocol deviation|2|||
156865828|NCT00911170|566267409|FG000|Treatment Period|Adverse Event|9|||
156865829|NCT00911170|566267410|FG001|Treatment Period|Adverse Event|10|||
156865830|NCT00911170|566267409|FG000|Treatment Period|Withdrawal by Subject|4|||
156865831|NCT00911170|566267410|FG001|Treatment Period|Withdrawal by Subject|4|||
156865832|NCT00911170|566267409|FG000|Treatment Period|Disease progression|0|||
156865833|NCT00911170|566267410|FG001|Treatment Period|Disease progression|2|||
156865834|NCT00911170|566267409|FG000|Treatment Period|Physician Decision|5|||
156865835|NCT00911170|566267410|FG001|Treatment Period|Physician Decision|5|||
156865836|NCT00911170|566267409|FG000|Treatment Period|Lost to Follow-up|0|||
156865837|NCT00911170|566267410|FG001|Treatment Period|Lost to Follow-up|1|||
156865838|NCT00911170|566267409|FG000|Treatment Period|Death|6|||
156865839|NCT00911170|566267410|FG001|Treatment Period|Death|9|||
156865840|NCT00911170|566267409|FG000|Long Term Follow-Up|Continuing in study|274|||
156865841|NCT00911170|566267410|FG001|Long Term Follow-Up|Continuing in study|269|||
156865842|NCT00911170|566267409|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
156865843|NCT00911170|566267410|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
156865844|NCT00911170|566267409|FG000|Long Term Follow-Up|Physician Decision|5|||
156865845|NCT00911170|566267410|FG001|Long Term Follow-Up|Physician Decision|4|||
156865846|NCT00911170|566267409|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
156865847|NCT00911170|566267410|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
156865848|NCT00911170|566267409|FG000|Long Term Follow-Up|Death|116|||
156865849|NCT00911170|566267410|FG001|Long Term Follow-Up|Death|121|||
156865850|NCT02079246|566269053|FG000|OLEX|Withdrawal before treatment|1|||
156865851|NCT02079246|566269054|FG001|OLEX|Withdrawal before treatment|0|||
156865852|NCT02079246|566269053|FG000|OLEX|Death|11|||
156865853|NCT02079246|566269054|FG001|OLEX|Death|0|||
156865854|NCT02079246|566269053|FG000|OLEX|Adverse Event|66|||
156865855|NCT02079246|566269054|FG001|OLEX|Adverse Event|0|||
156865856|NCT02079246|566269053|FG000|OLEX|Withdrawal by Subject|60|||
156865857|NCT02079246|566269054|FG001|OLEX|Withdrawal by Subject|0|||
156865858|NCT02079246|566269053|FG000|OLEX|Lost to Follow-up|6|||
156865859|NCT02079246|566269054|FG001|OLEX|Lost to Follow-up|0|||
156865860|NCT02079246|566269053|FG000|OLEX|Protocol Violation|6|||
156865861|NCT02079246|566269054|FG001|OLEX|Protocol Violation|0|||
156865862|NCT02079246|566269053|FG000|OLEX|Lack of Efficacy|3|||
156865863|NCT02079246|566269054|FG001|OLEX|Lack of Efficacy|0|||
156865864|NCT02079246|566269053|FG000|OLEX|Results of the lead-in studies|58|||
156865865|NCT02079246|566269054|FG001|OLEX|Results of the lead-in studies|0|||
156865866|NCT02079246|566269053|FG000|OLEX|Other: Disallowed medication|8|||
156865867|NCT02079246|566269054|FG001|OLEX|Other: Disallowed medication|0|||
156865868|NCT02079246|566269053|FG000|OLEX|Other: Insufficient compliance|2|||
156865869|NCT02079246|566269054|FG001|OLEX|Other: Insufficient compliance|0|||
156865870|NCT02079246|566269053|FG000|OLEX|Other: Caregiver unavailable|3|||
156865871|NCT02079246|566269054|FG001|OLEX|Other: Caregiver unavailable|0|||
156865872|NCT02079246|566269053|FG000|OLEX|Other: Coordinator decision|1|||
156865873|NCT02079246|566269054|FG001|OLEX|Other: Coordinator decision|0|||
156865874|NCT02079246|566269053|FG000|OLEX|Other: Worsening of condition|1|||
156865875|NCT02079246|566269054|FG001|OLEX|Other: Worsening of condition|0|||
156865876|NCT02079246|566269053|FG000|OLEX|Other: Moved to nursing home|1|||
156865877|NCT02079246|566269054|FG001|OLEX|Other: Moved to nursing home|0|||
156865878|NCT02079246|566269053|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
156865879|NCT02079246|566269054|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
156865880|NCT02079246|566269053|FG000|OLEX-MEM|Adverse Event|0|||
156865881|NCT02079246|566269054|FG001|OLEX-MEM|Adverse Event|6|||
156865882|NCT02079246|566269053|FG000|OLEX-MEM|Withdrawal by Subject|0|||
156865883|NCT02079246|566269054|FG001|OLEX-MEM|Withdrawal by Subject|7|||
156865884|NCT02079246|566269053|FG000|OLEX-MEM|Protocol Violation|0|||
156865885|NCT02079246|566269054|FG001|OLEX-MEM|Protocol Violation|2|||
156865886|NCT02079246|566269053|FG000|OLEX-MEM|Lost to Follow-up|0|||
156865887|NCT02079246|566269054|FG001|OLEX-MEM|Lost to Follow-up|1|||
156865888|NCT02079246|566269053|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
156865889|NCT02079246|566269054|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
156865890|NCT03591406|566269059|FG000|Overall Study|Adverse Event|5|||
156865891|NCT03591406|566269060|FG001|Overall Study|Adverse Event|3|||
156865892|NCT03591406|566269059|FG000|Overall Study|Protocol Violation|2|||
156865893|NCT03591406|566269060|FG001|Overall Study|Protocol Violation|1|||
156865894|NCT03591406|566269059|FG000|Overall Study|Withdrawal by Subject|0|||
156865895|NCT03591406|566269060|FG001|Overall Study|Withdrawal by Subject|5|||
156865896|NCT02144610|566269061|FG000|Overall Study|Physician Decision|1|||
156865897|NCT02144610|566269062|FG001|Overall Study|Physician Decision|0|||
156865898|NCT02144610|566269061|FG000|Overall Study|Withdrawal by Subject|1|||
156865899|NCT02144610|566269062|FG001|Overall Study|Withdrawal by Subject|5|||
156865900|NCT02144610|566269061|FG000|Overall Study|Death|2|||
156865901|NCT02144610|566269062|FG001|Overall Study|Death|2|||
156865902|NCT02144610|566269061|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
156865903|NCT02144610|566269062|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
156865904|NCT02144610|566269061|FG000|Overall Study|Other|0|||
156865905|NCT02144610|566269062|FG001|Overall Study|Other|1|||
156865906|NCT02796170|566269069|FG000|Overall Study|Lost to Follow-up|3|||
156865907|NCT02796170|566269070|FG001|Overall Study|Lost to Follow-up|0|||
156865908|NCT01527370|566269073|FG000|Overall Study|Withdrawal by Subject|4|||
156865909|NCT01527370|566269073|FG000|Overall Study|Physician Decision|1|||
156865910|NCT01527370|566269073|FG000|Overall Study|Death|1|||
156865911|NCT00907335|566269078|FG000|Overall Study|Withdrawal by Subject|2|||
156865912|NCT00907335|566269079|FG001|Overall Study|Withdrawal by Subject|0|||
156865913|NCT00907335|566269078|FG000|Overall Study|Adverse Event|4|||
156865914|NCT00907335|566269079|FG001|Overall Study|Adverse Event|1|||
156865915|NCT00907335|566269078|FG000|Overall Study|Lost to Follow-up|2|||
156865916|NCT00907335|566269079|FG001|Overall Study|Lost to Follow-up|0|||
156865917|NCT03879772|566269080|FG000|Overall Study|Adverse Event|2|||
156865918|NCT03879772|566269081|FG001|Overall Study|Adverse Event|2|||
156865919|NCT03879772|566269082|FG002|Overall Study|Adverse Event|3|||
156865920|NCT03879772|566269083|FG003|Overall Study|Adverse Event|4|||
156865921|NCT03879772|566269084|FG004|Overall Study|Adverse Event|3|||
156865922|NCT03879772|566269080|FG000|Overall Study|Treatment Failure|1|||
156865923|NCT03879772|566269081|FG001|Overall Study|Treatment Failure|0|||
156865924|NCT03879772|566269082|FG002|Overall Study|Treatment Failure|0|||
156865925|NCT03879772|566269083|FG003|Overall Study|Treatment Failure|2|||
156865926|NCT03879772|566269084|FG004|Overall Study|Treatment Failure|1|||
156865927|NCT03879772|566269080|FG000|Overall Study|Lost to Follow-up|0|||
156865928|NCT03879772|566269081|FG001|Overall Study|Lost to Follow-up|0|||
156865929|NCT03879772|566269082|FG002|Overall Study|Lost to Follow-up|0|||
156865930|NCT03879772|566269083|FG003|Overall Study|Lost to Follow-up|0|||
156865931|NCT03879772|566269084|FG004|Overall Study|Lost to Follow-up|1|||
156865932|NCT03879772|566269080|FG000|Overall Study|Withdrawal by Subject|0|||
156865933|NCT03879772|566269081|FG001|Overall Study|Withdrawal by Subject|1|||
156865934|NCT03879772|566269082|FG002|Overall Study|Withdrawal by Subject|3|||
156865935|NCT03879772|566269083|FG003|Overall Study|Withdrawal by Subject|1|||
156865936|NCT03879772|566269084|FG004|Overall Study|Withdrawal by Subject|1|||
156865937|NCT03879772|566269080|FG000|Overall Study|Protocol Violation|0|||
156865938|NCT03879772|566269081|FG001|Overall Study|Protocol Violation|0|||
156865939|NCT03879772|566269082|FG002|Overall Study|Protocol Violation|3|||
156865940|NCT03879772|566269083|FG003|Overall Study|Protocol Violation|1|||
156865941|NCT03879772|566269084|FG004|Overall Study|Protocol Violation|2|||
156865942|NCT03879772|566269080|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
156865943|NCT03879772|566269081|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
156865944|NCT03879772|566269082|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
156865945|NCT03879772|566269083|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
156865946|NCT03879772|566269084|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
156865947|NCT00887809|566269092|FG000|Overall Study|Patient Not Treated|3|||
156865948|NCT00887809|566269093|FG001|Overall Study|Patient Not Treated|0|||
156865949|NCT00887809|566269092|FG000|Overall Study|Death|1|||
156865950|NCT00887809|566269093|FG001|Overall Study|Death|0|||
156865951|NCT03131570|566269094|FG000|Overall Study|Adverse Event|1|||
156865952|NCT03131570|566269095|FG001|Overall Study|Adverse Event|0|||
156865953|NCT04596267|566269096|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
156865954|NCT04596267|566269097|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
156865955|NCT04596267|566269096|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
156865956|NCT04596267|566269097|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
156865957|NCT00071058|566269098|FG000|Overall Study|brain tumor-removed from study|1|||
156865958|NCT01210313|566269106|FG000|Overall Study|Withdrawal by Subject|3|||
156865959|NCT01210313|566269106|FG000|Overall Study|Adverse Event|2|||
156865960|NCT01210313|566269106|FG000|Overall Study|Distant recurrence|4|||
156865961|NCT01210313|566269106|FG000|Overall Study|Non-compliance|7|||
156865962|NCT03113487|566269111|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
156865963|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
156865964|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
156865965|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
156865966|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
156865967|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
156865968|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
156865969|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
156865970|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
156865971|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
156865972|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
156865973|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
156865974|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
156865975|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
156865976|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
156865977|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
156865978|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
156865979|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
156865980|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
156865981|NCT03773978|566269112|FG000|DBW Period|Adverse Event|2|||
156865982|NCT03773978|566269113|FG001|DBW Period|Adverse Event|2|||
156865983|NCT03773978|566269112|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
156408321|NCT04537897|564589260|FG004|Overall Study|Adverse Event|0|||
156636937|NCT02545868|565415540|FG000|Overall Study|Lack of Efficacy|1|||
156865984|NCT03773978|566269113|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
156865985|NCT03773978|566269112|FG000|DBW Period|Withdrawal by Subject|2|||
156865986|NCT03773978|566269113|FG001|DBW Period|Withdrawal by Subject|1|||
156865987|NCT03773978|566269112|FG000|DBW Period|Due to epidemic or pandemic|5|||
156865988|NCT03773978|566269113|FG001|DBW Period|Due to epidemic or pandemic|6|||
156865989|NCT03773978|566269112|FG000|DBW Period|Study team decision|1|||
156865990|NCT03773978|566269113|FG001|DBW Period|Study team decision|0|||
156865991|NCT03777982|566269114|FG000|Overall Study|Physician Decision|0|||
156865992|NCT03777982|566269115|FG001|Overall Study|Physician Decision|1|||
156865993|NCT04189952|566269118|FG000|Follow-up Period|Death|1|||
156865994|NCT04189952|566269118|FG000|Follow-up Period|Withdrawal by Subject|1|||
156865995|NCT00870740|566269119|FG000|Overall Study|Adverse Event|2|||
156865996|NCT00870740|566269120|FG001|Overall Study|Adverse Event|1|||
156865997|NCT00870740|566269121|FG002|Overall Study|Adverse Event|3|||
156865998|NCT00870740|566269122|FG003|Overall Study|Adverse Event|2|||
156865999|NCT00870740|566269123|FG004|Overall Study|Adverse Event|1|||
156866000|NCT00870740|566269124|FG005|Overall Study|Adverse Event|6|||
156866001|NCT00870740|566269119|FG000|Overall Study|Consent Withdrawn|6|||
156866002|NCT00870740|566269120|FG001|Overall Study|Consent Withdrawn|3|||
156866003|NCT00870740|566269121|FG002|Overall Study|Consent Withdrawn|4|||
156866004|NCT00870740|566269122|FG003|Overall Study|Consent Withdrawn|6|||
156866005|NCT00870740|566269123|FG004|Overall Study|Consent Withdrawn|6|||
156866006|NCT00870740|566269124|FG005|Overall Study|Consent Withdrawn|5|||
156866007|NCT00870740|566269119|FG000|Overall Study|Investigator Decision|2|||
156866008|NCT00870740|566269120|FG001|Overall Study|Investigator Decision|0|||
156866009|NCT00870740|566269121|FG002|Overall Study|Investigator Decision|1|||
156866010|NCT00870740|566269122|FG003|Overall Study|Investigator Decision|0|||
156866011|NCT00870740|566269123|FG004|Overall Study|Investigator Decision|0|||
156866012|NCT00870740|566269124|FG005|Overall Study|Investigator Decision|0|||
156866013|NCT00870740|566269119|FG000|Overall Study|Subject Non-compliance|0|||
156866014|NCT00870740|566269120|FG001|Overall Study|Subject Non-compliance|0|||
156866015|NCT00870740|566269121|FG002|Overall Study|Subject Non-compliance|0|||
156866016|NCT00870740|566269122|FG003|Overall Study|Subject Non-compliance|0|||
156866017|NCT00870740|566269123|FG004|Overall Study|Subject Non-compliance|0|||
156866018|NCT00870740|566269124|FG005|Overall Study|Subject Non-compliance|1|||
156866019|NCT00870740|566269119|FG000|Overall Study|Death|0|||
156866020|NCT00870740|566269120|FG001|Overall Study|Death|0|||
156866021|NCT00870740|566269121|FG002|Overall Study|Death|0|||
156866022|NCT00870740|566269122|FG003|Overall Study|Death|0|||
156866023|NCT00870740|566269123|FG004|Overall Study|Death|1|||
156866024|NCT00870740|566269124|FG005|Overall Study|Death|0|||
156866025|NCT00870740|566269119|FG000|Overall Study|Other|2|||
156866026|NCT00870740|566269120|FG001|Overall Study|Other|5|||
156866027|NCT00870740|566269121|FG002|Overall Study|Other|2|||
156866028|NCT00870740|566269122|FG003|Overall Study|Other|4|||
156866029|NCT00870740|566269123|FG004|Overall Study|Other|3|||
156866030|NCT00870740|566269124|FG005|Overall Study|Other|5|||
156866031|NCT03995368|566269132|FG000|Overall Study|Lost to Follow-up|1|||
156866032|NCT03995368|566269133|FG001|Overall Study|Lost to Follow-up|4|||
156866033|NCT03995368|566269134|FG002|Overall Study|Lost to Follow-up|1|||
156866034|NCT03995368|566269132|FG000|Overall Study|Did not meet inclusion criteria|1|||
156866035|NCT03995368|566269133|FG001|Overall Study|Did not meet inclusion criteria|6|||
156866036|NCT03995368|566269134|FG002|Overall Study|Did not meet inclusion criteria|3|||
156866037|NCT03995368|566269132|FG000|Overall Study|Withdrawal by Subject|0|||
156866038|NCT03995368|566269133|FG001|Overall Study|Withdrawal by Subject|1|||
156866039|NCT03995368|566269134|FG002|Overall Study|Withdrawal by Subject|1|||
156866040|NCT03592186|566269135|FG000|Overall Study|Withdrawal by Subject|1|||
156866041|NCT03592186|566269136|FG001|Overall Study|Withdrawal by Subject|0|||
156866042|NCT03592186|566269135|FG000|Overall Study|Lost to Follow-up|16|||
156866043|NCT03592186|566269136|FG001|Overall Study|Lost to Follow-up|11|||
156866044|NCT03755934|566269137|FG000|Overall Study|Adverse Event|4|||
156866045|NCT03755934|566269138|FG001|Overall Study|Adverse Event|1|||
156866046|NCT03755934|566269139|FG002|Overall Study|Adverse Event|1|||
156866047|NCT03755934|566269140|FG003|Overall Study|Adverse Event|3|||
156866048|NCT03755934|566269137|FG000|Overall Study|Physician Decision|2|||
156866049|NCT03755934|566269138|FG001|Overall Study|Physician Decision|0|||
156866050|NCT03755934|566269139|FG002|Overall Study|Physician Decision|0|||
156866051|NCT03755934|566269140|FG003|Overall Study|Physician Decision|1|||
156866052|NCT03755934|566269137|FG000|Overall Study|Withdrawal by Subject|5|||
156866053|NCT03755934|566269138|FG001|Overall Study|Withdrawal by Subject|0|||
156866054|NCT03755934|566269139|FG002|Overall Study|Withdrawal by Subject|0|||
156866055|NCT03755934|566269140|FG003|Overall Study|Withdrawal by Subject|1|||
156866056|NCT03755934|566269137|FG000|Overall Study|Other|3|||
156866057|NCT03755934|566269138|FG001|Overall Study|Other|1|||
156866058|NCT03755934|566269139|FG002|Overall Study|Other|3|||
156866059|NCT03755934|566269140|FG003|Overall Study|Other|1|||
156866060|NCT01498068|566269141|FG000|Overall Study|Withdrawal by Subject|1|||
156866061|NCT01498068|566269142|FG001|Overall Study|Withdrawal by Subject|1|||
156866062|NCT00361296|566269145|FG000|Overall Study|Physician Decision|1|||
156866063|NCT00361296|566269145|FG000|Overall Study|Lack of Efficacy|2|||
156866064|NCT01353898|566269148|FG000|Overall Study|Study site terminated|0|||
156866065|NCT01353898|566269149|FG001|Overall Study|Study site terminated|0|||
156866066|NCT01353898|566269150|FG002|Overall Study|Study site terminated|0|||
156866067|NCT01353898|566269151|FG003|Overall Study|Study site terminated|0|||
156866068|NCT01353898|566269152|FG004|Overall Study|Study site terminated|0|||
156866069|NCT01353898|566269153|FG005|Overall Study|Study site terminated|1|||
156866070|NCT02072668|566269154|FG000|Second Intervention|Lost to Follow-up|1|||
156866071|NCT02072668|566269155|FG001|Second Intervention|Lost to Follow-up|0|||
156866072|NCT02668653|566269156|FG000|Overall Study|Refractory disease|41|||
156866073|NCT02668653|566269157|FG001|Overall Study|Refractory disease|70|||
156866074|NCT02668653|566269156|FG000|Overall Study|Relapse|44|||
156866075|NCT02668653|566269157|FG001|Overall Study|Relapse|65|||
156866076|NCT02668653|566269156|FG000|Overall Study|Adverse Event|58|||
156866077|NCT02668653|566269157|FG001|Overall Study|Adverse Event|23|||
156866078|NCT02668653|566269156|FG000|Overall Study|Subject decision to stop study drug|25|||
156866079|NCT02668653|566269157|FG001|Overall Study|Subject decision to stop study drug|23|||
156866080|NCT02668653|566269156|FG000|Overall Study|Other reasons not specified|16|||
156866081|NCT02668653|566269157|FG001|Overall Study|Other reasons not specified|11|||
156866082|NCT02668653|566269156|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
156866083|NCT02668653|566269157|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
156866084|NCT02668653|566269156|FG000|Overall Study|Investigator decision|10|||
156866085|NCT02668653|566269157|FG001|Overall Study|Investigator decision|7|||
156866086|NCT02668653|566269156|FG000|Overall Study|Failure to meet continuation criteria|5|||
156866087|NCT02668653|566269157|FG001|Overall Study|Failure to meet continuation criteria|12|||
156866088|NCT02668653|566269156|FG000|Overall Study|Lost to Follow-up|1|||
156866089|NCT02668653|566269157|FG001|Overall Study|Lost to Follow-up|0|||
156866090|NCT02668653|566269156|FG000|Overall Study|Pregnancy|0|||
156866091|NCT02668653|566269157|FG001|Overall Study|Pregnancy|1|||
156866092|NCT02668653|566269156|FG000|Overall Study|Death|0|||
156866093|NCT02668653|566269157|FG001|Overall Study|Death|1|||
156866094|NCT01352793|566269163|FG000|Overall Study|Lost to Follow-up|289|||
156866095|NCT01352793|566269164|FG001|Overall Study|Lost to Follow-up|125|||
156866096|NCT01352793|566269163|FG000|Overall Study|Withdrawal by Subject|120|||
156866097|NCT01352793|566269164|FG001|Overall Study|Withdrawal by Subject|55|||
156866098|NCT01352793|566269163|FG000|Overall Study|Protocol Violation|44|||
156866099|NCT01352793|566269164|FG001|Overall Study|Protocol Violation|23|||
156866100|NCT01352793|566269163|FG000|Overall Study|Adverse Event|44|||
156866101|NCT01352793|566269164|FG001|Overall Study|Adverse Event|10|||
156866102|NCT01352793|566269163|FG000|Overall Study|Physician Decision|1|||
156866103|NCT01352793|566269164|FG001|Overall Study|Physician Decision|0|||
156866104|NCT01352793|566269163|FG000|Overall Study|Pregnancy|26|||
156866105|NCT01352793|566269164|FG001|Overall Study|Pregnancy|8|||
156866106|NCT01352793|566269163|FG000|Overall Study|Other|25|||
156866107|NCT01352793|566269164|FG001|Overall Study|Other|7|||
156866108|NCT01352793|566269163|FG000|Overall Study|Medication error|2|||
156866109|NCT01352793|566269164|FG001|Overall Study|Medication error|2|||
156866110|NCT01352793|566269163|FG000|Overall Study|Death|1|||
156866111|NCT01352793|566269164|FG001|Overall Study|Death|0|||
156866112|NCT01352793|566269163|FG000|Overall Study|Randomized but not vaccinated|8|||
156866113|NCT01352793|566269164|FG001|Overall Study|Randomized but not vaccinated|0|||
156866114|NCT01352793|566269163|FG000|Overall Study|No longer meets eligibility criteria|25|||
156866115|NCT01352793|566269164|FG001|Overall Study|No longer meets eligibility criteria|15|||
156866116|NCT04322526|566269167|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
156866117|NCT04322526|566269168|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
156866118|NCT04322526|566269167|FG000|Washout (1 Week)|Lost to Follow-up|1|||
156866119|NCT04322526|566269168|FG001|Washout (1 Week)|Lost to Follow-up|2|||
156866120|NCT00993967|566269172|FG000|Overall Study|Adverse Event|8|||
156866121|NCT00993967|566269172|FG000|Overall Study|Death|1|||
156866122|NCT00993967|566269172|FG000|Overall Study|Lost to Follow-up|14|||
156866123|NCT00993967|566269172|FG000|Overall Study|Withdrawal by Subject|36|||
156866124|NCT00993967|566269172|FG000|Overall Study|Protocol Violation|2|||
156866125|NCT01342211|566269175|FG000|Overall Study|Lost to Follow-up|0|||
156866126|NCT01342211|566269176|FG001|Overall Study|Lost to Follow-up|0|||
156866127|NCT01342211|566269177|FG002|Overall Study|Lost to Follow-up|0|||
156866128|NCT01342211|566269178|FG003|Overall Study|Lost to Follow-up|1|||
156866129|NCT01342211|566269179|FG004|Overall Study|Lost to Follow-up|0|||
156866130|NCT01342211|566269175|FG000|Overall Study|Adverse Event|0|||
156866131|NCT01342211|566269176|FG001|Overall Study|Adverse Event|0|||
156866132|NCT01342211|566269177|FG002|Overall Study|Adverse Event|0|||
156866133|NCT01342211|566269178|FG003|Overall Study|Adverse Event|0|||
156866134|NCT01342211|566269179|FG004|Overall Study|Adverse Event|1|||
156866135|NCT01342211|566269175|FG000|Overall Study|Withdrawal by Subject|0|||
156866136|NCT01342211|566269176|FG001|Overall Study|Withdrawal by Subject|0|||
156408322|NCT04537897|564589261|FG005|Overall Study|Adverse Event|0|||
156636938|NCT02545868|565415541|FG001|Overall Study|Lack of Efficacy|1|||
156408323|NCT04537897|564589262|FG006|Overall Study|Adverse Event|0|||
156408324|NCT04537897|564589263|FG007|Overall Study|Adverse Event|0|||
156408325|NCT04537897|564589264|FG008|Overall Study|Adverse Event|0|||
156408326|NCT04537897|564589256|FG000|Overall Study|Withdrawal by Subject|0|||
156408327|NCT04537897|564589257|FG001|Overall Study|Withdrawal by Subject|1|||
156408328|NCT04537897|564589258|FG002|Overall Study|Withdrawal by Subject|0|||
156408329|NCT04537897|564589259|FG003|Overall Study|Withdrawal by Subject|0|||
156408330|NCT04537897|564589260|FG004|Overall Study|Withdrawal by Subject|0|||
156408331|NCT04537897|564589261|FG005|Overall Study|Withdrawal by Subject|0|||
156408332|NCT04537897|564589262|FG006|Overall Study|Withdrawal by Subject|0|||
156408333|NCT04537897|564589263|FG007|Overall Study|Withdrawal by Subject|0|||
156408334|NCT04537897|564589264|FG008|Overall Study|Withdrawal by Subject|0|||
156408335|NCT00197028|564589271|FG000|Overall Study|Adverse Event|2|||
156408336|NCT00197028|564589272|FG001|Overall Study|Adverse Event|2|||
156408337|NCT00197028|564589271|FG000|Overall Study|Protocol Violation|2|||
156408338|NCT00197028|564589272|FG001|Overall Study|Protocol Violation|1|||
156408339|NCT00197028|564589271|FG000|Overall Study|Withdrawal by Subject|8|||
156408340|NCT00197028|564589272|FG001|Overall Study|Withdrawal by Subject|12|||
156408341|NCT00197028|564589271|FG000|Overall Study|Lost to Follow-up|1|||
156408342|NCT00197028|564589272|FG001|Overall Study|Lost to Follow-up|0|||
156408343|NCT00197028|564589271|FG000|Overall Study|Other|3|||
156408344|NCT00197028|564589272|FG001|Overall Study|Other|6|||
156408345|NCT00178256|564589273|FG000|Overall Study|Adverse Event|2|||
156408346|NCT00178256|564589274|FG001|Overall Study|Adverse Event|0|||
156408347|NCT00178256|564589275|FG002|Overall Study|Adverse Event|0|||
156408348|NCT00178256|564589276|FG003|Overall Study|Adverse Event|0|||
156408349|NCT00178256|564589273|FG000|Overall Study|Death|0|||
156408350|NCT00178256|564589274|FG001|Overall Study|Death|1|||
156408351|NCT00178256|564589275|FG002|Overall Study|Death|0|||
156408352|NCT00178256|564589276|FG003|Overall Study|Death|1|||
156408353|NCT00178256|564589273|FG000|Overall Study|Cancer progression|2|||
156408354|NCT00178256|564589274|FG001|Overall Study|Cancer progression|0|||
156408355|NCT00178256|564589275|FG002|Overall Study|Cancer progression|0|||
156408356|NCT00178256|564589276|FG003|Overall Study|Cancer progression|1|||
156408357|NCT01763788|564589277|FG000|Overall Study|Lost to Follow-up|0|||
156408358|NCT01763788|564589278|FG001|Overall Study|Lost to Follow-up|0|||
156408359|NCT01763788|564589279|FG002|Overall Study|Lost to Follow-up|1|||
156408360|NCT01763788|564589280|FG003|Overall Study|Lost to Follow-up|0|||
156408361|NCT03303469|564589281|FG000|Overall Study|Lost to Follow-up|2|||
156408362|NCT01460160|564589282|FG000|Treatment Phase|Lack of Efficacy|3|||
156408363|NCT01460160|564589282|FG000|Treatment Phase|Study Drug Toxicity|2|||
156408364|NCT01460160|564589282|FG000|Treatment Phase|Adverse Event|8|||
156408365|NCT01460160|564589282|FG000|Treatment Phase|Withdrawal by Subject|4|||
156408366|NCT01460160|564589282|FG000|Treatment Phase|Death|2|||
156408367|NCT01460160|564589282|FG000|Treatment Phase|Other reasons|9|||
156408368|NCT01460160|564589282|FG000|Follow-up Phase|Withdrawal by Subject|4|||
156408369|NCT01460160|564589282|FG000|Follow-up Phase|Death|14|||
156408370|NCT01460160|564589282|FG000|Follow-up Phase|Lost to Follow-up|7|||
156408371|NCT01460160|564589282|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
156408372|NCT01460160|564589282|FG000|Follow-up Phase|Other and not reported reasons|5|||
156408373|NCT03893825|564589283|FG000|Overall Study|Death|2|||
156408374|NCT03893825|564589284|FG001|Overall Study|Death|1|||
156408375|NCT03893825|564589283|FG000|Overall Study|Adverse Event|0|||
156408376|NCT03893825|564589284|FG001|Overall Study|Adverse Event|2|||
156408377|NCT03893825|564589283|FG000|Overall Study|Withdrawal by Subject|19|||
156408378|NCT03893825|564589284|FG001|Overall Study|Withdrawal by Subject|21|||
156408379|NCT03893825|564589283|FG000|Overall Study|Protocol deviation|1|||
156408380|NCT03893825|564589284|FG001|Overall Study|Protocol deviation|0|||
156408381|NCT03893825|564589283|FG000|Overall Study|Lost to Follow-up|10|||
156408382|NCT03893825|564589284|FG001|Overall Study|Lost to Follow-up|10|||
156408383|NCT03893825|564589283|FG000|Overall Study|Other than specified|7|||
156408384|NCT03893825|564589284|FG001|Overall Study|Other than specified|6|||
156408385|NCT02006121|564589285|FG000|Double Blind Phase|Adverse Event|6|||
156408386|NCT02006121|564589286|FG001|Double Blind Phase|Adverse Event|0|||
156408387|NCT02006121|564589285|FG000|Double Blind Phase|Lack of Efficacy|1|||
156408388|NCT02006121|564589286|FG001|Double Blind Phase|Lack of Efficacy|16|||
156408389|NCT02006121|564589285|FG000|Double Blind Phase|Withdrawal by Subject|3|||
156408390|NCT02006121|564589286|FG001|Double Blind Phase|Withdrawal by Subject|4|||
156408391|NCT02006121|564589285|FG000|Double Blind Phase|Non-compliance with study drug|1|||
156408392|NCT02006121|564589286|FG001|Double Blind Phase|Non-compliance with study drug|3|||
156408393|NCT02006121|564589285|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
156408394|NCT02006121|564589286|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
156408395|NCT02006121|564589285|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
156408396|NCT02006121|564589286|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
156408397|NCT02006121|564589285|FG000|Open Label Phase|Adverse Event|15|||
156408398|NCT02006121|564589286|FG001|Open Label Phase|Adverse Event|0|||
156408399|NCT02006121|564589285|FG000|Open Label Phase|Lack of Efficacy|2|||
156408400|NCT02006121|564589286|FG001|Open Label Phase|Lack of Efficacy|0|||
156408401|NCT02006121|564589285|FG000|Open Label Phase|Protocol Violation|2|||
156408402|NCT02006121|564589286|FG001|Open Label Phase|Protocol Violation|0|||
156408403|NCT02006121|564589285|FG000|Open Label Phase|Withdrawal by Subject|3|||
156408404|NCT02006121|564589286|FG001|Open Label Phase|Withdrawal by Subject|0|||
156408405|NCT02006121|564589285|FG000|Open Label Phase|Non-compliance with study drug|3|||
156408406|NCT02006121|564589286|FG001|Open Label Phase|Non-compliance with study drug|0|||
156408407|NCT03101241|564589289|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
156636939|NCT02545868|565415542|FG002|Overall Study|Lack of Efficacy|0|||
156408408|NCT03101241|564589290|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
156408409|NCT03101241|564589289|FG000|Overall Study|Participant withdrew consent|3|||
156408410|NCT03101241|564589290|FG001|Overall Study|Participant withdrew consent|1|||
156408411|NCT03101241|564589289|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
156408412|NCT03101241|564589290|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
156408413|NCT03101241|564589289|FG000|Overall Study|Lost to Follow-up|2|||
156408414|NCT03101241|564589290|FG001|Overall Study|Lost to Follow-up|0|||
156408415|NCT03101241|564589289|FG000|Overall Study|Lack of Efficacy|0|||
156408416|NCT03101241|564589290|FG001|Overall Study|Lack of Efficacy|1|||
156408417|NCT03101241|564589289|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
156408418|NCT03101241|564589290|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
156408419|NCT00669903|564589291|FG000|Overall Study|Adverse Event|0|||
156408420|NCT00669903|564589292|FG001|Overall Study|Adverse Event|1|||
156408421|NCT00669903|564589293|FG002|Overall Study|Adverse Event|3|||
156408422|NCT00669903|564589294|FG003|Overall Study|Adverse Event|1|||
156408423|NCT00669903|564589291|FG000|Overall Study|Withdrawal by Subject|0|||
156408424|NCT00669903|564589292|FG001|Overall Study|Withdrawal by Subject|2|||
156408425|NCT00669903|564589293|FG002|Overall Study|Withdrawal by Subject|2|||
156408426|NCT00669903|564589294|FG003|Overall Study|Withdrawal by Subject|2|||
156408427|NCT00669903|564589291|FG000|Overall Study|Lost to Follow-up|1|||
156408428|NCT00669903|564589292|FG001|Overall Study|Lost to Follow-up|1|||
156408429|NCT00669903|564589293|FG002|Overall Study|Lost to Follow-up|0|||
156408430|NCT00669903|564589294|FG003|Overall Study|Lost to Follow-up|1|||
156408431|NCT00669903|564589291|FG000|Overall Study|Protocol Violation|0|||
156408432|NCT00669903|564589292|FG001|Overall Study|Protocol Violation|1|||
156408433|NCT00669903|564589293|FG002|Overall Study|Protocol Violation|0|||
156408434|NCT00669903|564589294|FG003|Overall Study|Protocol Violation|0|||
156408435|NCT04488003|564589300|FG000|Assessed for Eligibility|Screen Failure|24|||
156408436|NCT04488003|564589301|FG001|Assessed for Eligibility|Screen Failure|0|||
156408437|NCT04488003|564589302|FG002|Assessed for Eligibility|Screen Failure|0|||
156408438|NCT04488003|564589300|FG000|Assessed for Eligibility|Adverse Event|1|||
156408439|NCT04488003|564589301|FG001|Assessed for Eligibility|Adverse Event|0|||
156408440|NCT04488003|564589302|FG002|Assessed for Eligibility|Adverse Event|0|||
156408441|NCT04488003|564589300|FG000|Assessed for Eligibility|Death|1|||
156408442|NCT04488003|564589301|FG001|Assessed for Eligibility|Death|0|||
156408443|NCT04488003|564589302|FG002|Assessed for Eligibility|Death|0|||
156408444|NCT04488003|564589300|FG000|Assessed for Eligibility|Physician Decision|1|||
156408445|NCT04488003|564589301|FG001|Assessed for Eligibility|Physician Decision|0|||
156408446|NCT04488003|564589302|FG002|Assessed for Eligibility|Physician Decision|0|||
156408447|NCT04488003|564589300|FG000|Allocated to Treatment|Progressive Disease|51|||
156408448|NCT04488003|564589301|FG001|Allocated to Treatment|Progressive Disease|0|||
156408449|NCT04488003|564589302|FG002|Allocated to Treatment|Progressive Disease|0|||
156408450|NCT04488003|564589300|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
156408451|NCT04488003|564589301|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
156408452|NCT04488003|564589302|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
156408453|NCT04488003|564589300|FG000|Allocated to Treatment|Adverse Event|6|||
156408454|NCT04488003|564589301|FG001|Allocated to Treatment|Adverse Event|0|||
156408455|NCT04488003|564589302|FG002|Allocated to Treatment|Adverse Event|0|||
156408456|NCT04488003|564589300|FG000|Allocated to Treatment|Other|5|||
156408457|NCT04488003|564589301|FG001|Allocated to Treatment|Other|0|||
156408458|NCT04488003|564589302|FG002|Allocated to Treatment|Other|0|||
156408459|NCT04488003|564589300|FG000|Allocated to Treatment|Physician Decision|4|||
156408460|NCT04488003|564589301|FG001|Allocated to Treatment|Physician Decision|0|||
156408461|NCT04488003|564589302|FG002|Allocated to Treatment|Physician Decision|0|||
156408462|NCT04488003|564589300|FG000|Allocated to Treatment|Death|4|||
156408463|NCT04488003|564589301|FG001|Allocated to Treatment|Death|0|||
156408464|NCT04488003|564589302|FG002|Allocated to Treatment|Death|0|||
156408465|NCT01737996|564589303|FG000|Overall Study|Adverse Event|0|||
156408466|NCT01737996|564589304|FG001|Overall Study|Adverse Event|1|||
156408467|NCT01737996|564589305|FG002|Overall Study|Adverse Event|1|||
156408468|NCT01737996|564589303|FG000|Overall Study|Withdrawal by Subject|0|||
156408469|NCT01737996|564589304|FG001|Overall Study|Withdrawal by Subject|0|||
156408470|NCT01737996|564589305|FG002|Overall Study|Withdrawal by Subject|1|||
156408471|NCT01248962|564589308|FG000|Overall Study|Withdrawal by Subject|1|||
156408472|NCT01248962|564589309|FG001|Overall Study|Withdrawal by Subject|1|||
156408473|NCT01248962|564589308|FG000|Overall Study|Adverse Event|2|||
156408474|NCT01248962|564589309|FG001|Overall Study|Adverse Event|1|||
156408475|NCT01248962|564589308|FG000|Overall Study|Complete Response after 4 Cycles|1|||
156408476|NCT01248962|564589309|FG001|Overall Study|Complete Response after 4 Cycles|0|||
156408477|NCT01248962|564589308|FG000|Overall Study|Complete Response after 3 Cycles|0|||
156408478|NCT01248962|564589309|FG001|Overall Study|Complete Response after 3 Cycles|1|||
156408479|NCT01248962|564589308|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
156408480|NCT01248962|564589309|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
156408481|NCT00245856|564589311|FG000|Period Two|Withdrawal by Subject|0|||
156408482|NCT00245856|564589312|FG001|Period Two|Withdrawal by Subject|1|||
156408483|NCT01003184|564589313|FG000|Overall Study|Adverse Event|12|||
156408484|NCT01003184|564589314|FG001|Overall Study|Adverse Event|5|||
156408485|NCT01003184|564589313|FG000|Overall Study|Lost to Follow-up|1|||
156408486|NCT01003184|564589314|FG001|Overall Study|Lost to Follow-up|0|||
156408487|NCT01003184|564589313|FG000|Overall Study|Loss of glucose control|1|||
156408488|NCT01003184|564589314|FG001|Overall Study|Loss of glucose control|1|||
156408489|NCT01003184|564589313|FG000|Overall Study|Protocol Violation|3|||
156408490|NCT01003184|564589314|FG001|Overall Study|Protocol Violation|0|||
156408491|NCT01003184|564589313|FG000|Overall Study|Withdrawal by Subject|1|||
156408492|NCT01003184|564589314|FG001|Overall Study|Withdrawal by Subject|6|||
156408493|NCT01003184|564589313|FG000|Overall Study|Physician Decision|1|||
156408494|NCT01003184|564589314|FG001|Overall Study|Physician Decision|0|||
156408495|NCT00557622|564589315|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
156408496|NCT00557622|564589316|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
156408497|NCT00557622|564589315|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
156408498|NCT00557622|564589316|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
156408499|NCT00557622|564589315|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
156408500|NCT00557622|564589316|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
156408501|NCT01468922|564589317|FG000|Overall Study|Screening failure|0|||
156408502|NCT01468922|564589318|FG001|Overall Study|Screening failure|0|||
156408503|NCT01468922|564589319|FG002|Overall Study|Screening failure|0|||
156408504|NCT01468922|564589320|FG003|Overall Study|Screening failure|0|||
156408505|NCT01468922|564589321|FG004|Overall Study|Screening failure|0|||
156408506|NCT01468922|564589322|FG005|Overall Study|Screening failure|0|||
156408507|NCT01468922|564589323|FG006|Overall Study|Screening failure|0|||
156408508|NCT01468922|564589324|FG007|Overall Study|Screening failure|0|||
156408509|NCT01468922|564589325|FG008|Overall Study|Screening failure|1|||
156408510|NCT01468922|564589317|FG000|Overall Study|Per patient choice|1|||
156408511|NCT01468922|564589318|FG001|Overall Study|Per patient choice|0|||
156408512|NCT01468922|564589319|FG002|Overall Study|Per patient choice|0|||
156408513|NCT01468922|564589320|FG003|Overall Study|Per patient choice|0|||
156408514|NCT01468922|564589321|FG004|Overall Study|Per patient choice|0|||
156408515|NCT01468922|564589322|FG005|Overall Study|Per patient choice|0|||
156408516|NCT01468922|564589323|FG006|Overall Study|Per patient choice|0|||
156408517|NCT01468922|564589324|FG007|Overall Study|Per patient choice|0|||
156408518|NCT01468922|564589325|FG008|Overall Study|Per patient choice|0|||
156408519|NCT01468922|564589317|FG000|Overall Study|Switched to alternative treatment|1|||
156408520|NCT01468922|564589318|FG001|Overall Study|Switched to alternative treatment|0|||
156408521|NCT01468922|564589319|FG002|Overall Study|Switched to alternative treatment|0|||
156408522|NCT01468922|564589320|FG003|Overall Study|Switched to alternative treatment|0|||
156408523|NCT01468922|564589321|FG004|Overall Study|Switched to alternative treatment|1|||
156408524|NCT01468922|564589322|FG005|Overall Study|Switched to alternative treatment|0|||
156408525|NCT01468922|564589323|FG006|Overall Study|Switched to alternative treatment|0|||
156408526|NCT01468922|564589324|FG007|Overall Study|Switched to alternative treatment|0|||
156408527|NCT01468922|564589325|FG008|Overall Study|Switched to alternative treatment|0|||
156408528|NCT01468922|564589317|FG000|Overall Study|Enrolled on new protocol|0|||
156408529|NCT01468922|564589318|FG001|Overall Study|Enrolled on new protocol|0|||
156408530|NCT01468922|564589319|FG002|Overall Study|Enrolled on new protocol|0|||
156408531|NCT01468922|564589320|FG003|Overall Study|Enrolled on new protocol|0|||
156408532|NCT01468922|564589321|FG004|Overall Study|Enrolled on new protocol|1|||
156408533|NCT01468922|564589322|FG005|Overall Study|Enrolled on new protocol|0|||
156408534|NCT01468922|564589323|FG006|Overall Study|Enrolled on new protocol|0|||
156408535|NCT01468922|564589324|FG007|Overall Study|Enrolled on new protocol|0|||
156408536|NCT01468922|564589325|FG008|Overall Study|Enrolled on new protocol|0|||
156408537|NCT01468922|564589317|FG000|Overall Study|Adverse Event|0|||
156408538|NCT01468922|564589318|FG001|Overall Study|Adverse Event|0|||
156408539|NCT01468922|564589319|FG002|Overall Study|Adverse Event|0|||
156408540|NCT01468922|564589320|FG003|Overall Study|Adverse Event|0|||
156408541|NCT01468922|564589321|FG004|Overall Study|Adverse Event|0|||
156408542|NCT01468922|564589322|FG005|Overall Study|Adverse Event|0|||
156408543|NCT01468922|564589323|FG006|Overall Study|Adverse Event|0|||
156408544|NCT01468922|564589324|FG007|Overall Study|Adverse Event|1|||
156408545|NCT01468922|564589325|FG008|Overall Study|Adverse Event|0|||
156408546|NCT01468922|564589317|FG000|Overall Study|Infection of blood|0|||
156408547|NCT01468922|564589318|FG001|Overall Study|Infection of blood|0|||
156408548|NCT01468922|564589319|FG002|Overall Study|Infection of blood|0|||
156408549|NCT01468922|564589320|FG003|Overall Study|Infection of blood|0|||
156408550|NCT01468922|564589321|FG004|Overall Study|Infection of blood|0|||
156408551|NCT01468922|564589322|FG005|Overall Study|Infection of blood|0|||
156408552|NCT01468922|564589323|FG006|Overall Study|Infection of blood|0|||
156408553|NCT01468922|564589324|FG007|Overall Study|Infection of blood|1|||
156408554|NCT01468922|564589325|FG008|Overall Study|Infection of blood|0|||
156408555|NCT01468922|564589317|FG000|Overall Study|Patient choice - surgery|0|||
156408556|NCT01468922|564589318|FG001|Overall Study|Patient choice - surgery|0|||
156408557|NCT01468922|564589319|FG002|Overall Study|Patient choice - surgery|0|||
156408558|NCT01468922|564589320|FG003|Overall Study|Patient choice - surgery|0|||
156408559|NCT01468922|564589321|FG004|Overall Study|Patient choice - surgery|0|||
156408560|NCT01468922|564589322|FG005|Overall Study|Patient choice - surgery|0|||
156408561|NCT01468922|564589323|FG006|Overall Study|Patient choice - surgery|0|||
156408562|NCT01468922|564589324|FG007|Overall Study|Patient choice - surgery|1|||
156408563|NCT01468922|564589325|FG008|Overall Study|Patient choice - surgery|0|||
156408564|NCT01468922|564589317|FG000|Overall Study|Refused further treatment|0|||
156408565|NCT01468922|564589318|FG001|Overall Study|Refused further treatment|0|||
156408566|NCT01468922|564589319|FG002|Overall Study|Refused further treatment|0|||
156408567|NCT01468922|564589320|FG003|Overall Study|Refused further treatment|0|||
156408568|NCT01468922|564589321|FG004|Overall Study|Refused further treatment|0|||
156408569|NCT01468922|564589322|FG005|Overall Study|Refused further treatment|0|||
156408570|NCT01468922|564589323|FG006|Overall Study|Refused further treatment|0|||
156408571|NCT01468922|564589324|FG007|Overall Study|Refused further treatment|1|||
156408572|NCT01468922|564589325|FG008|Overall Study|Refused further treatment|0|||
156408573|NCT01923389|564589326|FG000|Overall Study|Protocol Violation|1|||
156408574|NCT01923389|564589327|FG001|Overall Study|Protocol Violation|0|||
156408575|NCT04848662|564589328|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
156408576|NCT04848662|564589329|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
156408577|NCT03237013|564589337|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
156408578|NCT03237013|564589338|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
156408579|NCT03237013|564589339|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
156408580|NCT00007475|564589342|FG000|Overall Study|Withdrawal by Subject|1|||
156408581|NCT00007475|564589343|FG001|Overall Study|Withdrawal by Subject|0|||
156408582|NCT00007475|564589344|FG002|Overall Study|Withdrawal by Subject|0|||
156408583|NCT00007475|564589345|FG003|Overall Study|Withdrawal by Subject|0|||
156408584|NCT00007475|564589342|FG000|Overall Study|Adverse Event|3|||
156408585|NCT00007475|564589343|FG001|Overall Study|Adverse Event|0|||
156408586|NCT00007475|564589344|FG002|Overall Study|Adverse Event|0|||
156408587|NCT00007475|564589345|FG003|Overall Study|Adverse Event|0|||
156408588|NCT01719224|564589346|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
156408589|NCT01719224|564589347|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
156408590|NCT00258440|564589348|FG000|Overall Study|Withdrawal by Subject|0|||
156408591|NCT00258440|564589349|FG001|Overall Study|Withdrawal by Subject|0|||
156408592|NCT00258440|564589350|FG002|Overall Study|Withdrawal by Subject|1|||
156408593|NCT00737061|564589351|FG000|Waiting Period|Lost to Follow-up|6|||
156408594|NCT00737061|564589351|FG000|Waiting Period|Withdrawal by Subject|1|||
156408595|NCT00737061|564589351|FG000|Waiting Period|Bilateral placement failure|34|||
156636940|NCT02545868|565415540|FG000|Overall Study|Lost to Follow-up|1|||
156636941|NCT02545868|565415541|FG001|Overall Study|Lost to Follow-up|5|||
156636942|NCT02545868|565415542|FG002|Overall Study|Lost to Follow-up|1|||
156408596|NCT00737061|564589351|FG000|Waiting Period|Deemed patent following HSG|26|||
156408597|NCT00737061|564589351|FG000|Waiting Period|Alternative contraception failure|3|||
156408598|NCT00737061|564589351|FG000|Waiting Period|Elected surgical tubal ligation|5|||
156408599|NCT00737061|564589351|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
156408600|NCT00737061|564589351|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
156408601|NCT00737061|564589351|FG000|1 Year Wearing Period|Discontinued reilance|3|||
156408602|NCT00737061|564589351|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
156408603|NCT05266963|564589352|FG000|Drug Period A|Withdrawal by Subject|0|||
156408604|NCT05266963|564589353|FG001|Drug Period A|Withdrawal by Subject|1|||
156408605|NCT04091360|564589354|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156408606|NCT04091360|564589355|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156408607|NCT04091360|564589356|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156408608|NCT04091360|564589357|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156408609|NCT04091360|564589358|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156408610|NCT04091360|564589359|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156408611|NCT04091360|564589360|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156408612|NCT04091360|564589361|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156408613|NCT04091360|564589362|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
156408614|NCT04091360|564589363|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
156408615|NCT04091360|564589354|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156408616|NCT04091360|564589355|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156408617|NCT04091360|564589356|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156408618|NCT04091360|564589357|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156408619|NCT04091360|564589358|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156408620|NCT04091360|564589359|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156408621|NCT04091360|564589360|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
156408622|NCT04091360|564589361|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
156408623|NCT04091360|564589362|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156408624|NCT04091360|564589363|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156408625|NCT04091360|564589354|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156408626|NCT04091360|564589355|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156408627|NCT04091360|564589356|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156408628|NCT04091360|564589357|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156408629|NCT04091360|564589358|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156408630|NCT04091360|564589359|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156408631|NCT04091360|564589360|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
156408632|NCT04091360|564589361|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156408633|NCT04091360|564589362|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156408634|NCT04091360|564589363|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
156408635|NCT00692406|564589364|FG000|Overall Study|PI dropped, bad data|57|||
156408636|NCT02597933|564589365|FG000|Overall Study|Withdrawal by Subject|7|||
156408637|NCT02597933|564589366|FG001|Overall Study|Withdrawal by Subject|5|||
156408638|NCT02597933|564589365|FG000|Overall Study|Protocol Violation|2|||
156408639|NCT02597933|564589366|FG001|Overall Study|Protocol Violation|2|||
156408640|NCT02597933|564589365|FG000|Overall Study|Adverse Event|20|||
156408641|NCT02597933|564589366|FG001|Overall Study|Adverse Event|28|||
156408642|NCT02597933|564589365|FG000|Overall Study|Not treated|2|||
156408643|NCT02597933|564589366|FG001|Overall Study|Not treated|2|||
156408644|NCT02597933|564589365|FG000|Overall Study|Other than stated above|7|||
156408645|NCT02597933|564589366|FG001|Overall Study|Other than stated above|14|||
156408646|NCT01320735|564589370|FG000|Overall Study|Adverse Event|3|||
156408647|NCT01320735|564589370|FG000|Overall Study|Withdrawal by Subject|3|||
156408648|NCT01320735|564589370|FG000|Overall Study|Lost to Follow-up|13|||
156408649|NCT01320735|564589370|FG000|Overall Study|Administrative Reason|6|||
156408650|NCT01320735|564589370|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
156408651|NCT01320735|564589370|FG000|Overall Study|Protocol Violation|1|||
156408652|NCT01320735|564589370|FG000|Overall Study|Other|1|||
156408653|NCT01320735|564589370|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
156408654|NCT01320735|564589370|FG000|Overall Study|Investigator Unable to be Contacted|17|||
156408655|NCT04599101|564589371|FG000|Overall Study|Lost to Follow-up|5|||
156408656|NCT04599101|564589372|FG001|Overall Study|Lost to Follow-up|5|||
156408657|NCT05952297|564589373|FG000|Overall Study|Withdrawal by Subject|1|||
156408658|NCT05952297|564589374|FG001|Overall Study|Withdrawal by Subject|0|||
156408659|NCT00284089|564589377|FG000|Multiple Dose Phase|Adverse Event|1|||
156408660|NCT00284089|564589378|FG001|Multiple Dose Phase|Adverse Event|0|||
156408661|NCT00284089|564589379|FG002|Multiple Dose Phase|Adverse Event|1|||
156408662|NCT00284089|564589380|FG003|Multiple Dose Phase|Adverse Event|1|||
156408663|NCT00284089|564589377|FG000|Multiple Dose Phase|Protocol Violation|0|||
156408664|NCT00284089|564589378|FG001|Multiple Dose Phase|Protocol Violation|0|||
156408665|NCT00284089|564589379|FG002|Multiple Dose Phase|Protocol Violation|1|||
156408666|NCT00284089|564589380|FG003|Multiple Dose Phase|Protocol Violation|0|||
156408667|NCT00284089|564589377|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
156408668|NCT00284089|564589378|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
156408669|NCT00284089|564589379|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
156408670|NCT00284089|564589380|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
156408671|NCT00284089|564589377|FG000|Multiple Dose Phase|Death|0|||
156408672|NCT00284089|564589378|FG001|Multiple Dose Phase|Death|0|||
156408673|NCT00284089|564589379|FG002|Multiple Dose Phase|Death|1|||
156408674|NCT00284089|564589380|FG003|Multiple Dose Phase|Death|1|||
156408675|NCT00284089|564589377|FG000|Extension Phase|Adverse Event|0|||
156408676|NCT00284089|564589378|FG001|Extension Phase|Adverse Event|0|||
156408677|NCT00284089|564589379|FG002|Extension Phase|Adverse Event|2|||
156408678|NCT00284089|564589380|FG003|Extension Phase|Adverse Event|2|||
156408679|NCT00284089|564589377|FG000|Extension Phase|condition no longer requires study drug|2|||
156408680|NCT00284089|564589378|FG001|Extension Phase|condition no longer requires study drug|0|||
156408681|NCT00284089|564589379|FG002|Extension Phase|condition no longer requires study drug|2|||
156408682|NCT00284089|564589380|FG003|Extension Phase|condition no longer requires study drug|7|||
156408683|NCT00284089|564589377|FG000|Extension Phase|Protocol Violation|0|||
156408684|NCT00284089|564589378|FG001|Extension Phase|Protocol Violation|0|||
156408685|NCT00284089|564589379|FG002|Extension Phase|Protocol Violation|1|||
156408686|NCT00284089|564589380|FG003|Extension Phase|Protocol Violation|0|||
156408687|NCT00284089|564589377|FG000|Extension Phase|Withdrawal by Subject|0|||
156408688|NCT00284089|564589378|FG001|Extension Phase|Withdrawal by Subject|0|||
156408689|NCT00284089|564589379|FG002|Extension Phase|Withdrawal by Subject|1|||
156408690|NCT00284089|564589380|FG003|Extension Phase|Withdrawal by Subject|3|||
156408691|NCT02234063|564589384|FG000|Overall Study|Lost to Follow-up|235|||
156408692|NCT02234063|564589385|FG001|Overall Study|Lost to Follow-up|42|||
156408693|NCT02234063|564589384|FG000|Overall Study|Withdrawal by Subject|20|||
156408694|NCT02234063|564589385|FG001|Overall Study|Withdrawal by Subject|1|||
156408695|NCT01871558|564589386|FG000|Overall Study|Other reason|0|||
156408696|NCT01871558|564589387|FG001|Overall Study|Other reason|1|||
156408697|NCT01871558|564589386|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
156408698|NCT01871558|564589387|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
156408699|NCT01871558|564589386|FG000|Overall Study|Withdrawal by Subject|2|||
156408700|NCT01871558|564589387|FG001|Overall Study|Withdrawal by Subject|0|||
156408701|NCT02781506|564590996|FG000|Overall Study|Adverse Event|5|||
156408702|NCT00437125|564590997|FG000|Overall Study|Adverse Event|12|||
156408703|NCT00437125|564590997|FG000|Overall Study|Death|1|||
156408704|NCT00437125|564590997|FG000|Overall Study|Clinical Relapse|1|||
156408705|NCT00437125|564590997|FG000|Overall Study|Lack of Efficacy|1|||
156408706|NCT00437125|564590997|FG000|Overall Study|Lost to Follow-up|1|||
156408707|NCT00437125|564590997|FG000|Overall Study|Withdrawal by Subject|13|||
156408708|NCT00437125|564590997|FG000|Overall Study|Withdrawal by Caregiver|2|||
156408709|NCT00437125|564590997|FG000|Overall Study|Physician Decision|1|||
156408710|NCT04651114|564591002|FG000|Overall Study|Withdrawal by Subject|8|||
156408711|NCT00806624|564591005|FG000|Overall Study|Adverse Event|2|||
156408712|NCT00806624|564591006|FG001|Overall Study|Adverse Event|8|||
156408713|NCT00806624|564591007|FG002|Overall Study|Adverse Event|0|||
156408714|NCT00806624|564591005|FG000|Overall Study|Death|0|||
156408715|NCT00806624|564591006|FG001|Overall Study|Death|1|||
156408716|NCT00806624|564591007|FG002|Overall Study|Death|1|||
156408717|NCT00806624|564591005|FG000|Overall Study|Lost to Follow-up|1|||
156408718|NCT00806624|564591006|FG001|Overall Study|Lost to Follow-up|0|||
156408719|NCT00806624|564591007|FG002|Overall Study|Lost to Follow-up|1|||
156408720|NCT00806624|564591005|FG000|Overall Study|Withdrawal by Subject|6|||
156408721|NCT00806624|564591006|FG001|Overall Study|Withdrawal by Subject|3|||
156408722|NCT00806624|564591007|FG002|Overall Study|Withdrawal by Subject|3|||
156408723|NCT00806624|564591005|FG000|Overall Study|discontinued before start of treatment|0|||
156408724|NCT00806624|564591006|FG001|Overall Study|discontinued before start of treatment|0|||
156408725|NCT00806624|564591007|FG002|Overall Study|discontinued before start of treatment|1|||
156408726|NCT00603265|564591008|FG000|Overall Study|Adverse Event|2|||
156408727|NCT00603265|564591009|FG001|Overall Study|Adverse Event|11|||
156408728|NCT00603265|564591010|FG002|Overall Study|Adverse Event|1|||
156408729|NCT00603265|564591008|FG000|Overall Study|Withdrawal by Subject|1|||
156408730|NCT00603265|564591009|FG001|Overall Study|Withdrawal by Subject|2|||
156408731|NCT00603265|564591010|FG002|Overall Study|Withdrawal by Subject|1|||
156408732|NCT00603265|564591008|FG000|Overall Study|Lack of Efficacy|3|||
156408733|NCT00603265|564591009|FG001|Overall Study|Lack of Efficacy|0|||
156408734|NCT00603265|564591010|FG002|Overall Study|Lack of Efficacy|3|||
156408735|NCT00603265|564591008|FG000|Overall Study|Lost to Follow-up|0|||
156408736|NCT00603265|564591009|FG001|Overall Study|Lost to Follow-up|1|||
156636943|NCT02545868|565415540|FG000|Overall Study|Non-compliance|1|||
156636944|NCT02545868|565415541|FG001|Overall Study|Non-compliance|1|||
156636945|NCT02545868|565415542|FG002|Overall Study|Non-compliance|1|||
156636946|NCT02545868|565415540|FG000|Overall Study|Treatment change|21|||
156408737|NCT00603265|564591010|FG002|Overall Study|Lost to Follow-up|0|||
156408738|NCT00603265|564591008|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
156408739|NCT00603265|564591009|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
156408740|NCT00603265|564591010|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
156408741|NCT00603265|564591008|FG000|Overall Study|Participant Left Country, No Responses|0|||
156408742|NCT00603265|564591009|FG001|Overall Study|Participant Left Country, No Responses|1|||
156408743|NCT00603265|564591010|FG002|Overall Study|Participant Left Country, No Responses|0|||
156408744|NCT00603265|564591008|FG000|Overall Study|Protocol Violation|1|||
156408745|NCT00603265|564591009|FG001|Overall Study|Protocol Violation|0|||
156408746|NCT00603265|564591010|FG002|Overall Study|Protocol Violation|0|||
156408747|NCT00569803|564591011|FG000|Overall Study|Lost to Follow-up|1|||
156408748|NCT00569803|564591012|FG001|Overall Study|Lost to Follow-up|0|||
156408749|NCT00569803|564591013|FG002|Overall Study|Lost to Follow-up|0|||
156408750|NCT00569803|564591014|FG003|Overall Study|Lost to Follow-up|0|||
156408751|NCT00569803|564591015|FG004|Overall Study|Lost to Follow-up|0|||
156408752|NCT00569803|564591016|FG005|Overall Study|Lost to Follow-up|0|||
156408753|NCT00569803|564591017|FG006|Overall Study|Lost to Follow-up|0|||
156408754|NCT00569803|564591018|FG007|Overall Study|Lost to Follow-up|0|||
156408755|NCT00569803|564591011|FG000|Overall Study|injection syringe leaked during dosing|0|||
156408756|NCT00569803|564591012|FG001|Overall Study|injection syringe leaked during dosing|0|||
156408757|NCT00569803|564591013|FG002|Overall Study|injection syringe leaked during dosing|0|||
156408758|NCT00569803|564591014|FG003|Overall Study|injection syringe leaked during dosing|1|||
156408759|NCT00569803|564591015|FG004|Overall Study|injection syringe leaked during dosing|0|||
156408760|NCT00569803|564591016|FG005|Overall Study|injection syringe leaked during dosing|0|||
156408761|NCT00569803|564591017|FG006|Overall Study|injection syringe leaked during dosing|0|||
156408762|NCT00569803|564591018|FG007|Overall Study|injection syringe leaked during dosing|0|||
156408763|NCT00569803|564591011|FG000|Overall Study|Withdrawal by Subject|0|||
156408764|NCT00569803|564591012|FG001|Overall Study|Withdrawal by Subject|0|||
156408765|NCT00569803|564591013|FG002|Overall Study|Withdrawal by Subject|0|||
156408766|NCT00569803|564591014|FG003|Overall Study|Withdrawal by Subject|0|||
156408767|NCT00569803|564591015|FG004|Overall Study|Withdrawal by Subject|0|||
156408768|NCT00569803|564591016|FG005|Overall Study|Withdrawal by Subject|0|||
156408769|NCT00569803|564591017|FG006|Overall Study|Withdrawal by Subject|0|||
156408770|NCT00569803|564591018|FG007|Overall Study|Withdrawal by Subject|1|||
156408771|NCT03029780|564591021|FG000|Overall Study|Disease Progression|20|||
156408772|NCT03029780|564591022|FG001|Overall Study|Disease Progression|22|||
156408773|NCT03029780|564591021|FG000|Overall Study|Study Drug Toxicity|15|||
156408774|NCT03029780|564591022|FG001|Overall Study|Study Drug Toxicity|11|||
156408775|NCT03029780|564591021|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
156408776|NCT03029780|564591022|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
156408777|NCT03029780|564591021|FG000|Overall Study|Participant request to discontinue study treatment|4|||
156408778|NCT03029780|564591022|FG001|Overall Study|Participant request to discontinue study treatment|1|||
156408779|NCT03029780|564591021|FG000|Overall Study|Maximum clinical benefit|1|||
156408780|NCT03029780|564591022|FG001|Overall Study|Maximum clinical benefit|0|||
156408781|NCT03029780|564591021|FG000|Overall Study|Participant no longer meets study criteria|0|||
156408782|NCT03029780|564591022|FG001|Overall Study|Participant no longer meets study criteria|1|||
156408783|NCT03029780|564591021|FG000|Overall Study|Other reasons|6|||
156408784|NCT03029780|564591022|FG001|Overall Study|Other reasons|6|||
156408785|NCT03029780|564591021|FG000|Overall Study|Not reported|1|||
156408786|NCT03029780|564591022|FG001|Overall Study|Not reported|1|||
156408787|NCT03029780|564591021|FG000|Overall Study|Death|2|||
156408788|NCT03029780|564591022|FG001|Overall Study|Death|6|||
156408789|NCT03066622|564591023|FG000|Overall Study|Lost to Follow-up|24|||
156408790|NCT03066622|564591024|FG001|Overall Study|Lost to Follow-up|25|||
156408791|NCT03066622|564591023|FG000|Overall Study|Withdrawal by Subject|2|||
156408792|NCT03066622|564591024|FG001|Overall Study|Withdrawal by Subject|1|||
156408793|NCT03321006|564591025|FG000|Overall Study|Death|1|||
156408794|NCT03321006|564591026|FG001|Overall Study|Death|0|||
156408795|NCT03321006|564591025|FG000|Overall Study|Lack of Efficacy|1|||
156408796|NCT03321006|564591026|FG001|Overall Study|Lack of Efficacy|0|||
156408797|NCT04741802|564591029|FG000|Overall Study|Death|1|||
156408798|NCT04741802|564591029|FG000|Overall Study|Lost to Follow-up|11|||
156408799|NCT03560258|564591030|FG000|Overall Study|Lost to Follow-up|3|||
156408800|NCT03560258|564591031|FG001|Overall Study|Lost to Follow-up|0|||
156408801|NCT03560258|564591032|FG002|Overall Study|Lost to Follow-up|0|||
156408802|NCT03560258|564591030|FG000|Overall Study|Protocol Violation|0|||
156408803|NCT03560258|564591031|FG001|Overall Study|Protocol Violation|1|||
156408804|NCT03560258|564591032|FG002|Overall Study|Protocol Violation|0|||
156408805|NCT03560258|564591030|FG000|Overall Study|Withdrawal by Subject|0|||
156408806|NCT03560258|564591031|FG001|Overall Study|Withdrawal by Subject|0|||
156408807|NCT03560258|564591032|FG002|Overall Study|Withdrawal by Subject|1|||
156408808|NCT04498247|564591037|FG000|Overall Study|Lost to Follow-up|0|||
156408809|NCT04498247|564591038|FG001|Overall Study|Lost to Follow-up|0|||
156408810|NCT04498247|564591039|FG002|Overall Study|Lost to Follow-up|0|||
156408811|NCT04498247|564591040|FG003|Overall Study|Lost to Follow-up|1|||
156408812|NCT04498247|564591041|FG004|Overall Study|Lost to Follow-up|0|||
156408813|NCT04498247|564591042|FG005|Overall Study|Lost to Follow-up|0|||
156408814|NCT04498247|564591043|FG006|Overall Study|Lost to Follow-up|0|||
156408815|NCT04498247|564591044|FG007|Overall Study|Lost to Follow-up|0|||
156408816|NCT04498247|564591037|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
156408817|NCT04498247|564591038|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
156408818|NCT04498247|564591039|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
156408819|NCT04498247|564591040|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
156408820|NCT04498247|564591041|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
156408821|NCT04498247|564591042|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
156408822|NCT04498247|564591043|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
156408823|NCT04498247|564591044|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
156408824|NCT04498247|564591037|FG000|Overall Study|Withdrawal by Subject|0|||
156408825|NCT04498247|564591038|FG001|Overall Study|Withdrawal by Subject|8|||
156408826|NCT04498247|564591039|FG002|Overall Study|Withdrawal by Subject|0|||
156408827|NCT04498247|564591040|FG003|Overall Study|Withdrawal by Subject|7|||
156408828|NCT04498247|564591041|FG004|Overall Study|Withdrawal by Subject|0|||
156408829|NCT04498247|564591042|FG005|Overall Study|Withdrawal by Subject|0|||
156408830|NCT04498247|564591043|FG006|Overall Study|Withdrawal by Subject|1|||
156408831|NCT04498247|564591044|FG007|Overall Study|Withdrawal by Subject|0|||
156408832|NCT04498247|564591037|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156408833|NCT04498247|564591038|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
156408834|NCT04498247|564591039|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156408835|NCT04498247|564591040|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
156408836|NCT04498247|564591041|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156408837|NCT04498247|564591042|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156408838|NCT04498247|564591043|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
156408839|NCT04498247|564591044|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156408840|NCT02765490|564591045|FG000|Overall Study|Lost to Follow-up|1|||
156408841|NCT02765490|564591046|FG001|Overall Study|Lost to Follow-up|1|||
156408842|NCT02765490|564591045|FG000|Overall Study|Other|0|||
156408843|NCT02765490|564591046|FG001|Overall Study|Other|1|||
156408844|NCT02765490|564591045|FG000|Overall Study|Death|0|||
156408845|NCT02765490|564591046|FG001|Overall Study|Death|1|||
156408846|NCT03000673|564591047|FG000|Overall Study|Withdrawal by Subject|1|||
156408847|NCT03000673|564591048|FG001|Overall Study|Withdrawal by Subject|0|||
156408848|NCT03000673|564591049|FG002|Overall Study|Withdrawal by Subject|0|||
156408849|NCT03000673|564591050|FG003|Overall Study|Withdrawal by Subject|0|||
156408850|NCT01512745|564591052|FG000|Overall Study|Adverse Event|22|||
156408851|NCT01512745|564591053|FG001|Overall Study|Adverse Event|3|||
156408852|NCT01512745|564591052|FG000|Overall Study|Death|9|||
156408853|NCT01512745|564591053|FG001|Overall Study|Death|13|||
156408854|NCT01512745|564591052|FG000|Overall Study|Withdrawal by Subject|2|||
156408855|NCT01512745|564591053|FG001|Overall Study|Withdrawal by Subject|2|||
156408856|NCT01512745|564591052|FG000|Overall Study|Lost to Follow-up|4|||
156408857|NCT01512745|564591053|FG001|Overall Study|Lost to Follow-up|0|||
156408858|NCT01512745|564591052|FG000|Overall Study|Lack of Efficacy|2|||
156408859|NCT01512745|564591053|FG001|Overall Study|Lack of Efficacy|2|||
156408860|NCT01512745|564591052|FG000|Overall Study|Protocol Violation|1|||
156408861|NCT01512745|564591053|FG001|Overall Study|Protocol Violation|0|||
156408862|NCT02357810|564591054|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
156408863|NCT02357810|564591054|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
156408864|NCT02357810|564591054|FG000|Reached 12 Weeks Response|Adverse Event|5|||
156408865|NCT02357810|564591054|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
156408866|NCT02357810|564591054|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
156408867|NCT02357810|564591054|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
156408868|NCT02357810|564591054|FG000|Reached 12 Weeks Response|Death|1|||
156408869|NCT02357810|564591054|FG000|Reached 12 Weeks Response|Physician Decision|1|||
156408870|NCT02357810|564591054|FG000|Reached 12 Weeks Response|Other|1|||
156408871|NCT02357810|564591054|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
156408872|NCT02357810|564591054|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
156408873|NCT02357810|564591054|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
156408874|NCT02357810|564591054|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
156408875|NCT02357810|564591054|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
156408876|NCT02357810|564591054|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
156408877|NCT00562978|564591055|FG000|Overall Study|Patient had imaging dose only|1|||
156408878|NCT00562978|564591056|FG001|Overall Study|Patient had imaging dose only|11|||
156408879|NCT00152971|564591058|FG000|Overall Study|Adverse Event|12|||
156408880|NCT00152971|564591059|FG001|Overall Study|Adverse Event|10|||
156408881|NCT00152971|564591060|FG002|Overall Study|Adverse Event|9|||
156408882|NCT00152971|564591058|FG000|Overall Study|Protocol Violation|10|||
156408883|NCT00152971|564591059|FG001|Overall Study|Protocol Violation|11|||
156408884|NCT00152971|564591060|FG002|Overall Study|Protocol Violation|8|||
156408885|NCT00152971|564591058|FG000|Overall Study|Lost to Follow-up|17|||
156408886|NCT00152971|564591059|FG001|Overall Study|Lost to Follow-up|14|||
156408887|NCT00152971|564591060|FG002|Overall Study|Lost to Follow-up|13|||
156408888|NCT00152971|564591058|FG000|Overall Study|Withdrawal by Subject|9|||
156408889|NCT00152971|564591059|FG001|Overall Study|Withdrawal by Subject|8|||
156408890|NCT00152971|564591060|FG002|Overall Study|Withdrawal by Subject|14|||
156408891|NCT00152971|564591058|FG000|Overall Study|Other|3|||
156408892|NCT00152971|564591059|FG001|Overall Study|Other|5|||
156408893|NCT00152971|564591060|FG002|Overall Study|Other|5|||
156408894|NCT00152971|564591058|FG000|Treatment|Adverse Event|49|||
156408895|NCT00152971|564591059|FG001|Treatment|Adverse Event|40|||
156408896|NCT00152971|564591060|FG002|Treatment|Adverse Event|54|||
156408897|NCT00152971|564591058|FG000|Treatment|Protocol Violation|8|||
156408898|NCT00152971|564591059|FG001|Treatment|Protocol Violation|6|||
156408899|NCT00152971|564591060|FG002|Treatment|Protocol Violation|10|||
156408900|NCT00152971|564591058|FG000|Treatment|Lost to Follow-up|1|||
156408901|NCT00152971|564591059|FG001|Treatment|Lost to Follow-up|2|||
156408902|NCT00152971|564591060|FG002|Treatment|Lost to Follow-up|1|||
156408903|NCT00152971|564591058|FG000|Treatment|Withdrawal by Subject|4|||
156408904|NCT00152971|564591059|FG001|Treatment|Withdrawal by Subject|4|||
156408905|NCT00152971|564591060|FG002|Treatment|Withdrawal by Subject|5|||
156408906|NCT00152971|564591058|FG000|Treatment|Other|9|||
156408907|NCT00152971|564591059|FG001|Treatment|Other|11|||
156408908|NCT00152971|564591060|FG002|Treatment|Other|10|||
156408909|NCT00675506|564591061|FG000|Overall Study|Lost to Follow-up|1|||
156408910|NCT00675506|564591062|FG001|Overall Study|Lost to Follow-up|5|||
156408911|NCT00675506|564591061|FG000|Overall Study|Lost interest|3|||
156408912|NCT00675506|564591062|FG001|Overall Study|Lost interest|5|||
156408913|NCT00675506|564591061|FG000|Overall Study|Elevated fasting glucose|2|||
156408914|NCT00675506|564591062|FG001|Overall Study|Elevated fasting glucose|1|||
156408915|NCT00675506|564591061|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
156408916|NCT00675506|564591062|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
156408917|NCT00675506|564591061|FG000|Overall Study|Elevated IGF-1|2|||
156408918|NCT00675506|564591062|FG001|Overall Study|Elevated IGF-1|0|||
156408919|NCT00675506|564591061|FG000|Overall Study|Hypersensitivity Reaction|1|||
156408920|NCT00675506|564591062|FG001|Overall Study|Hypersensitivity Reaction|0|||
156408921|NCT00675506|564591061|FG000|Overall Study|Disclosed history of cancer|1|||
156408922|NCT00675506|564591062|FG001|Overall Study|Disclosed history of cancer|0|||
156408923|NCT00675506|564591061|FG000|Overall Study|Declined participation|1|||
156408924|NCT00675506|564591062|FG001|Overall Study|Declined participation|0|||
156408925|NCT00675506|564591061|FG000|Overall Study|Schedule conflict|0|||
156408926|NCT00675506|564591062|FG001|Overall Study|Schedule conflict|1|||
156408927|NCT00936221|564591063|FG000|Overall Study|Withdrawal by Subject|1|||
156408928|NCT00936221|564591064|FG001|Overall Study|Withdrawal by Subject|1|||
156408929|NCT06173570|564591065|FG000|Overall Study|Adverse Event|1|||
156408930|NCT06173570|564591066|FG001|Overall Study|Adverse Event|0|||
156408931|NCT06173570|564591067|FG002|Overall Study|Adverse Event|0|||
156408932|NCT06173570|564591068|FG003|Overall Study|Adverse Event|2|||
156408933|NCT06173570|564591069|FG004|Overall Study|Adverse Event|0|||
156408934|NCT06173570|564591065|FG000|Overall Study|Lost to Follow-up|1|||
156408935|NCT06173570|564591066|FG001|Overall Study|Lost to Follow-up|0|||
156408936|NCT06173570|564591067|FG002|Overall Study|Lost to Follow-up|0|||
156408937|NCT06173570|564591068|FG003|Overall Study|Lost to Follow-up|0|||
156408938|NCT06173570|564591069|FG004|Overall Study|Lost to Follow-up|2|||
156408939|NCT06173570|564591065|FG000|Overall Study|Protocol Violation|0|||
156408940|NCT06173570|564591066|FG001|Overall Study|Protocol Violation|2|||
156408941|NCT06173570|564591067|FG002|Overall Study|Protocol Violation|0|||
156408942|NCT06173570|564591068|FG003|Overall Study|Protocol Violation|0|||
156408943|NCT06173570|564591069|FG004|Overall Study|Protocol Violation|1|||
156408944|NCT06173570|564591065|FG000|Overall Study|Withdrawal by Subject|0|||
156408945|NCT06173570|564591066|FG001|Overall Study|Withdrawal by Subject|1|||
156408946|NCT06173570|564591067|FG002|Overall Study|Withdrawal by Subject|1|||
156408947|NCT06173570|564591068|FG003|Overall Study|Withdrawal by Subject|1|||
156408948|NCT06173570|564591069|FG004|Overall Study|Withdrawal by Subject|1|||
156408949|NCT06173570|564591065|FG000|Overall Study|Non-compliance with Study Drug|1|||
156408950|NCT06173570|564591066|FG001|Overall Study|Non-compliance with Study Drug|0|||
156408951|NCT06173570|564591067|FG002|Overall Study|Non-compliance with Study Drug|0|||
156408952|NCT06173570|564591068|FG003|Overall Study|Non-compliance with Study Drug|0|||
156408953|NCT06173570|564591069|FG004|Overall Study|Non-compliance with Study Drug|0|||
156408954|NCT06173570|564591065|FG000|Overall Study|Screen Failure|0|||
156408955|NCT06173570|564591066|FG001|Overall Study|Screen Failure|0|||
156408956|NCT06173570|564591067|FG002|Overall Study|Screen Failure|0|||
156408957|NCT06173570|564591068|FG003|Overall Study|Screen Failure|0|||
156408958|NCT06173570|564591069|FG004|Overall Study|Screen Failure|1|||
156408959|NCT06173570|564591065|FG000|Overall Study|Other|2|||
156408960|NCT06173570|564591066|FG001|Overall Study|Other|1|||
156408961|NCT06173570|564591067|FG002|Overall Study|Other|0|||
156408962|NCT06173570|564591068|FG003|Overall Study|Other|2|||
156408963|NCT06173570|564591069|FG004|Overall Study|Other|0|||
156408964|NCT03820323|564591070|FG000|Overall Study|Lost to Follow-up|2|||
156408965|NCT03820323|564591071|FG001|Overall Study|Lost to Follow-up|1|||
156408966|NCT03820323|564591070|FG000|Overall Study|Missed 12-month visit|22|||
156408967|NCT03820323|564591071|FG001|Overall Study|Missed 12-month visit|14|||
156408968|NCT03820323|564591070|FG000|Overall Study|Death|2|||
156408969|NCT03820323|564591071|FG001|Overall Study|Death|1|||
156408970|NCT03820323|564591070|FG000|Overall Study|Transferred out|13|||
156408971|NCT03820323|564591071|FG001|Overall Study|Transferred out|11|||
156408972|NCT03820323|564591070|FG000|Overall Study|Terminated|0|||
156408973|NCT03820323|564591071|FG001|Overall Study|Terminated|3|||
156408974|NCT03820323|564591070|FG000|Overall Study|Withdrawal by Subject|1|||
156408975|NCT03820323|564591071|FG001|Overall Study|Withdrawal by Subject|6|||
156408976|NCT03151395|564591072|FG000|Overall Study|Adverse Event|2|||
156408977|NCT03151395|564591072|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
156408978|NCT03151395|564591072|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
156408979|NCT03151395|564591072|FG000|Overall Study|Unspecified reason|4|||
156408980|NCT00366301|564591073|FG000|Overall Study|Lost to Follow-up|4|||
156408981|NCT00366301|564591074|FG001|Overall Study|Lost to Follow-up|4|||
156408982|NCT00366301|564591075|FG002|Overall Study|Lost to Follow-up|3|||
156408983|NCT00366301|564591076|FG003|Overall Study|Lost to Follow-up|7|||
156408984|NCT00366301|564591073|FG000|Overall Study|Withdrawal by Subject|4|||
156408985|NCT00366301|564591074|FG001|Overall Study|Withdrawal by Subject|2|||
156408986|NCT00366301|564591075|FG002|Overall Study|Withdrawal by Subject|1|||
156408987|NCT00366301|564591076|FG003|Overall Study|Withdrawal by Subject|1|||
156408988|NCT01348776|564591080|FG000|Overall Study|Lost to Follow-up|3|||
156408989|NCT01372605|564591081|FG000|Overall Study|Death|1|||
156408990|NCT01372605|564591082|FG001|Overall Study|Death|2|||
156408991|NCT01372605|564591081|FG000|Overall Study|Lost to Follow-up|2|||
156408992|NCT01372605|564591082|FG001|Overall Study|Lost to Follow-up|1|||
156408993|NCT01372605|564591081|FG000|Overall Study|Withdrawal by Subject|4|||
156408994|NCT01372605|564591082|FG001|Overall Study|Withdrawal by Subject|7|||
156408995|NCT01372605|564591081|FG000|Overall Study|Moved|3|||
156408996|NCT01372605|564591082|FG001|Overall Study|Moved|0|||
156408997|NCT01372605|564591081|FG000|Overall Study|Changed medical home|2|||
156408998|NCT01372605|564591082|FG001|Overall Study|Changed medical home|0|||
156408999|NCT01108510|564591083|FG000|Overall Study|Randomized but Not Treated|5|||
156409000|NCT01108510|564591084|FG001|Overall Study|Randomized but Not Treated|1|||
156409001|NCT01108510|564591083|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
156409002|NCT01108510|564591084|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
156409003|NCT01108510|564591083|FG000|Overall Study|Adverse Event|26|||
156409004|NCT01108510|564591084|FG001|Overall Study|Adverse Event|19|||
156409005|NCT01108510|564591083|FG000|Overall Study|Lost to Follow-up|20|||
156409006|NCT01108510|564591084|FG001|Overall Study|Lost to Follow-up|17|||
156409007|NCT01108510|564591083|FG000|Overall Study|Withdrew Consent|21|||
156409008|NCT01108510|564591084|FG001|Overall Study|Withdrew Consent|15|||
156409009|NCT01108510|564591083|FG000|Overall Study|Investigator's Discretion|12|||
156409010|NCT01108510|564591084|FG001|Overall Study|Investigator's Discretion|10|||
156409011|NCT01108510|564591083|FG000|Overall Study|Participant Noncompliance|5|||
156409012|NCT01108510|564591084|FG001|Overall Study|Participant Noncompliance|7|||
156409013|NCT01108510|564591083|FG000|Overall Study|Lack of Efficacy|3|||
156409014|NCT01108510|564591084|FG001|Overall Study|Lack of Efficacy|0|||
156409015|NCT01108510|564591083|FG000|Overall Study|Pregnancy|0|||
156409016|NCT01108510|564591084|FG001|Overall Study|Pregnancy|3|||
156409017|NCT01108510|564591083|FG000|Overall Study|Death|1|||
156409018|NCT01108510|564591084|FG001|Overall Study|Death|1|||
156409019|NCT00210119|564591085|FG000|Overall Study|Protocol Violation|1|||
156409020|NCT00210119|564591085|FG000|Overall Study|Withdrawal by Subject|1|||
156409021|NCT00951509|564591086|FG000|Overall Study|Withdrawal by Subject|2|||
156409022|NCT03125941|564591090|FG000|Overall Study|did not receive intervention|1|||
156409023|NCT03125941|564591091|FG001|Overall Study|did not receive intervention|2|||
156409024|NCT00089895|564591092|FG000|Overall Study|Consent Withdrawn|11|||
156409025|NCT00089895|564591093|FG001|Overall Study|Consent Withdrawn|14|||
156409026|NCT00089895|564591092|FG000|Overall Study|Technical reason|7|||
156409027|NCT00089895|564591093|FG001|Overall Study|Technical reason|2|||
156409028|NCT00089895|564591092|FG000|Overall Study|Surgery|0|||
156409029|NCT00089895|564591093|FG001|Overall Study|Surgery|1|||
156409030|NCT00089895|564591092|FG000|Overall Study|Bleeding|0|||
156409031|NCT00089895|564591093|FG001|Overall Study|Bleeding|2|||
156409032|NCT00089895|564591092|FG000|Overall Study|Physician Decision|3|||
156409033|NCT00089895|564591093|FG001|Overall Study|Physician Decision|7|||
156409034|NCT00089895|564591092|FG000|Overall Study|Exclusion criteria met|6|||
156409035|NCT00089895|564591093|FG001|Overall Study|Exclusion criteria met|6|||
156409036|NCT00089895|564591092|FG000|Overall Study|Not otherwise specified|4|||
156409037|NCT00089895|564591093|FG001|Overall Study|Not otherwise specified|8|||
156409038|NCT00089895|564591092|FG000|Overall Study|Missing|4|||
156409039|NCT00089895|564591093|FG001|Overall Study|Missing|2|||
156409040|NCT03679767|564591094|FG000|Overall Study|Death|16|||
156409041|NCT03679767|564591095|FG001|Overall Study|Death|11|||
156409042|NCT03679767|564591096|FG002|Overall Study|Death|17|||
156409043|NCT03679767|564591097|FG003|Overall Study|Death|10|||
156409044|NCT03679767|564591094|FG000|Overall Study|Lost to Follow-up|1|||
156409045|NCT03679767|564591095|FG001|Overall Study|Lost to Follow-up|1|||
156409046|NCT03679767|564591096|FG002|Overall Study|Lost to Follow-up|1|||
156409047|NCT03679767|564591097|FG003|Overall Study|Lost to Follow-up|1|||
156409048|NCT03679767|564591094|FG000|Overall Study|Withdrawal by Subject|0|||
156409049|NCT03679767|564591095|FG001|Overall Study|Withdrawal by Subject|0|||
156409050|NCT03679767|564591096|FG002|Overall Study|Withdrawal by Subject|0|||
156409051|NCT03679767|564591097|FG003|Overall Study|Withdrawal by Subject|1|||
156409052|NCT03679767|564591094|FG000|Overall Study|Follow-up Completed|18|||
156409053|NCT03679767|564591095|FG001|Overall Study|Follow-up Completed|11|||
156409054|NCT03679767|564591096|FG002|Overall Study|Follow-up Completed|11|||
156409055|NCT03679767|564591097|FG003|Overall Study|Follow-up Completed|20|||
156409056|NCT03679767|564591094|FG000|Overall Study|Entered Hospice Care|0|||
156409057|NCT03679767|564591095|FG001|Overall Study|Entered Hospice Care|0|||
156409058|NCT03679767|564591096|FG002|Overall Study|Entered Hospice Care|0|||
156409059|NCT03679767|564591097|FG003|Overall Study|Entered Hospice Care|1|||
156409060|NCT03679767|564591094|FG000|Overall Study|Progressive Disease|0|||
156409061|NCT03679767|564591095|FG001|Overall Study|Progressive Disease|0|||
156409062|NCT03679767|564591096|FG002|Overall Study|Progressive Disease|0|||
156409063|NCT03679767|564591097|FG003|Overall Study|Progressive Disease|1|||
156409064|NCT03915951|564591098|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
156409065|NCT03915951|564591099|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
156409066|NCT03915951|564591098|FG000|Overall Study|Adverse Event|12|||
156409067|NCT03915951|564591099|FG001|Overall Study|Adverse Event|6|||
156409068|NCT03915951|564591098|FG000|Overall Study|Disease progression (radiological)|17|||
156409069|NCT03915951|564591099|FG001|Overall Study|Disease progression (radiological)|15|||
156409070|NCT03915951|564591098|FG000|Overall Study|Disease progression (clinical)|4|||
156409071|NCT03915951|564591099|FG001|Overall Study|Disease progression (clinical)|1|||
156409072|NCT03915951|564591098|FG000|Overall Study|Patient decision|0|||
156409073|NCT03915951|564591099|FG001|Overall Study|Patient decision|4|||
156409074|NCT03915951|564591098|FG000|Overall Study|Investigator decision|0|||
156409075|NCT03915951|564591099|FG001|Overall Study|Investigator decision|1|||
156409076|NCT03915951|564591098|FG000|Overall Study|Consent withdrawn|1|||
156409077|NCT03915951|564591099|FG001|Overall Study|Consent withdrawn|1|||
156409078|NCT03915951|564591098|FG000|Overall Study|Death|0|||
156409079|NCT03915951|564591099|FG001|Overall Study|Death|3|||
156409080|NCT05408468|564591100|FG000|Overall Study|Lost to Follow-up|3|||
156409081|NCT05408468|564591101|FG001|Overall Study|Lost to Follow-up|1|||
156409082|NCT05408468|564591100|FG000|Overall Study|Physician Decision|1|||
156409083|NCT05408468|564591101|FG001|Overall Study|Physician Decision|0|||
156409084|NCT05408468|564591100|FG000|Overall Study|Overwhelmed by clinical situation|3|||
156409085|NCT05408468|564591101|FG001|Overall Study|Overwhelmed by clinical situation|0|||
156409086|NCT05408468|564591100|FG000|Overall Study|Personal illness precluding participation|1|||
156409087|NCT05408468|564591101|FG001|Overall Study|Personal illness precluding participation|0|||
156409088|NCT05408468|564591100|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
156409089|NCT05408468|564591101|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
156409090|NCT02204579|564591106|FG000|Overall Study|Screen failures|2|||
156409091|NCT01396395|564591107|FG000|Overall Study|Withdrawal by Subject|10|||
156409092|NCT01396395|564591108|FG001|Overall Study|Withdrawal by Subject|12|||
156409093|NCT01396395|564591107|FG000|Overall Study|Protocol Violation|3|||
156409094|NCT01396395|564591108|FG001|Overall Study|Protocol Violation|1|||
156409095|NCT01396395|564591107|FG000|Overall Study|Adverse Event|10|||
156409096|NCT01396395|564591108|FG001|Overall Study|Adverse Event|2|||
156409097|NCT01396395|564591107|FG000|Overall Study|Lost to Follow-up|17|||
156409098|NCT01396395|564591108|FG001|Overall Study|Lost to Follow-up|11|||
156409099|NCT01396395|564591107|FG000|Overall Study|Other|0|||
156409100|NCT01396395|564591108|FG001|Overall Study|Other|1|||
156409101|NCT03691948|564591109|FG000|Overall Study|Lost to Follow-up|1|||
156409102|NCT03691948|564591110|FG001|Overall Study|Lost to Follow-up|3|||
156409103|NCT01370005|564591111|FG000|Overall Study|Not treated|1|||
156409104|NCT01370005|564591112|FG001|Overall Study|Not treated|0|||
156409105|NCT01370005|564591113|FG002|Overall Study|Not treated|0|||
156409106|NCT01370005|564591111|FG000|Overall Study|Adverse Event|5|||
156409107|NCT01370005|564591112|FG001|Overall Study|Adverse Event|5|||
156409108|NCT01370005|564591113|FG002|Overall Study|Adverse Event|6|||
156409109|NCT01370005|564591111|FG000|Overall Study|Lack of Efficacy|1|||
156409110|NCT01370005|564591112|FG001|Overall Study|Lack of Efficacy|0|||
156409111|NCT01370005|564591113|FG002|Overall Study|Lack of Efficacy|0|||
156409112|NCT01370005|564591111|FG000|Overall Study|Non compliant with protocol|0|||
156409113|NCT01370005|564591112|FG001|Overall Study|Non compliant with protocol|1|||
156409114|NCT01370005|564591113|FG002|Overall Study|Non compliant with protocol|2|||
156409115|NCT01370005|564591111|FG000|Overall Study|Lost to Follow-up|1|||
156409116|NCT01370005|564591112|FG001|Overall Study|Lost to Follow-up|1|||
156409117|NCT01370005|564591113|FG002|Overall Study|Lost to Follow-up|1|||
156409118|NCT01370005|564591111|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
156409119|NCT01370005|564591112|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
156409120|NCT01370005|564591113|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
156409121|NCT01370005|564591111|FG000|Overall Study|Other reason not defined above|3|||
156409122|NCT01370005|564591112|FG001|Overall Study|Other reason not defined above|0|||
156409123|NCT01370005|564591113|FG002|Overall Study|Other reason not defined above|2|||
156409124|NCT03916744|564591115|FG000|Overall Study|Withdrawal by Subject|0|||
156409125|NCT03916744|564591116|FG001|Overall Study|Withdrawal by Subject|1|||
156409126|NCT03916744|564591117|FG002|Overall Study|Withdrawal by Subject|2|||
156409127|NCT03556358|564591122|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
156409128|NCT03556358|564591123|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
156409129|NCT03556358|564591122|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
156409130|NCT03556358|564591123|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
156636947|NCT02545868|565415541|FG001|Overall Study|Treatment change|19|||
156636948|NCT02545868|565415542|FG002|Overall Study|Treatment change|22|||
156636949|NCT02545868|565415540|FG000|Overall Study|Physician Decision|1|||
156636950|NCT02545868|565415541|FG001|Overall Study|Physician Decision|1|||
156636951|NCT02545868|565415542|FG002|Overall Study|Physician Decision|1|||
156636952|NCT02545868|565415540|FG000|Overall Study|Withdrawal by Subject|6|||
156636953|NCT02545868|565415541|FG001|Overall Study|Withdrawal by Subject|7|||
156636954|NCT02545868|565415542|FG002|Overall Study|Withdrawal by Subject|9|||
156409131|NCT03556358|564591122|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
156409132|NCT03556358|564591123|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
156409133|NCT03556358|564591122|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
156409134|NCT03556358|564591123|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
156409135|NCT03556358|564591122|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
156409136|NCT03556358|564591123|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
156409137|NCT03556358|564591122|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
156409138|NCT03556358|564591123|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
156409139|NCT03556358|564591122|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
156409140|NCT03556358|564591123|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
156409141|NCT05067933|564591133|FG000|Overall Study|Withdrawal by Subject|2|||
156409142|NCT05067933|564591134|FG001|Overall Study|Withdrawal by Subject|0|||
156409143|NCT05067933|564591135|FG002|Overall Study|Withdrawal by Subject|0|||
156409144|NCT05067933|564591136|FG003|Overall Study|Withdrawal by Subject|0|||
156409145|NCT05067933|564591137|FG004|Overall Study|Withdrawal by Subject|0|||
156409146|NCT05067933|564591138|FG005|Overall Study|Withdrawal by Subject|0|||
156409147|NCT05067933|564591133|FG000|Overall Study|Lost to Follow-up|1|||
156409148|NCT05067933|564591134|FG001|Overall Study|Lost to Follow-up|1|||
156409149|NCT05067933|564591135|FG002|Overall Study|Lost to Follow-up|1|||
156409150|NCT05067933|564591136|FG003|Overall Study|Lost to Follow-up|2|||
156409151|NCT05067933|564591137|FG004|Overall Study|Lost to Follow-up|1|||
156409152|NCT05067933|564591138|FG005|Overall Study|Lost to Follow-up|0|||
156409153|NCT05067933|564591133|FG000|Overall Study|Miscellaneous|1|||
156409154|NCT05067933|564591134|FG001|Overall Study|Miscellaneous|0|||
156409155|NCT05067933|564591135|FG002|Overall Study|Miscellaneous|0|||
156409156|NCT05067933|564591136|FG003|Overall Study|Miscellaneous|0|||
156409157|NCT05067933|564591137|FG004|Overall Study|Miscellaneous|0|||
156409158|NCT05067933|564591138|FG005|Overall Study|Miscellaneous|0|||
156409159|NCT05067933|564591133|FG000|Overall Study|Death|0|||
156409160|NCT05067933|564591134|FG001|Overall Study|Death|0|||
156409161|NCT05067933|564591135|FG002|Overall Study|Death|0|||
156409162|NCT05067933|564591136|FG003|Overall Study|Death|1|||
156409163|NCT05067933|564591137|FG004|Overall Study|Death|0|||
156409164|NCT05067933|564591138|FG005|Overall Study|Death|0|||
156409165|NCT01103960|564591139|FG000|Overall Study|Adverse Event|2|||
156409166|NCT01103960|564591140|FG001|Overall Study|Adverse Event|1|||
156409167|NCT01103960|564591139|FG000|Overall Study|Withdrawal by Subject|2|||
156409168|NCT01103960|564591140|FG001|Overall Study|Withdrawal by Subject|1|||
156409169|NCT01103960|564591139|FG000|Overall Study|Other|1|||
156409170|NCT01103960|564591140|FG001|Overall Study|Other|0|||
156409171|NCT02875834|564591141|FG000|Open-label Phase|Withdrawal by Subject|3|||
156409172|NCT02875834|564591142|FG001|Open-label Phase|Withdrawal by Subject|0|||
156409173|NCT02875834|564591143|FG002|Open-label Phase|Withdrawal by Subject|0|||
156409174|NCT02875834|564591144|FG003|Open-label Phase|Withdrawal by Subject|0|||
156409175|NCT02875834|564591141|FG000|Open-label Phase|(Not collected)|4|||
156409176|NCT02875834|564591142|FG001|Open-label Phase|(Not collected)|0|||
156409177|NCT02875834|564591143|FG002|Open-label Phase|(Not collected)|0|||
156409178|NCT02875834|564591144|FG003|Open-label Phase|(Not collected)|0|||
156409179|NCT02875834|564591141|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
156409180|NCT02875834|564591142|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
156409181|NCT02875834|564591143|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
156409182|NCT02875834|564591144|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
156409183|NCT02875834|564591141|FG000|Randomized Treatment Phase|Protocol Violation|0|||
156409184|NCT02875834|564591142|FG001|Randomized Treatment Phase|Protocol Violation|2|||
156409185|NCT02875834|564591143|FG002|Randomized Treatment Phase|Protocol Violation|0|||
156409186|NCT02875834|564591144|FG003|Randomized Treatment Phase|Protocol Violation|0|||
156409187|NCT02875834|564591141|FG000|Randomized Treatment Phase|(Not collected)|0|||
156409188|NCT02875834|564591142|FG001|Randomized Treatment Phase|(Not collected)|9|||
156409189|NCT02875834|564591143|FG002|Randomized Treatment Phase|(Not collected)|10|||
156409190|NCT02875834|564591144|FG003|Randomized Treatment Phase|(Not collected)|9|||
156409191|NCT01340482|564592477|FG000|Overall Study|Adverse Event|2|||
156409192|NCT01340482|564592478|FG001|Overall Study|Adverse Event|0|||
156409193|NCT01340482|564592479|FG002|Overall Study|Adverse Event|0|||
156409194|NCT02593539|564592480|FG000|Overall Study|Adverse Event|1|||
156409195|NCT01282476|564592481|FG000|Overall Study|Death|11|||
156409196|NCT01811563|564592488|FG000|Overall Study|Lost to Follow-up|5|||
156409197|NCT01811563|564592489|FG001|Overall Study|Lost to Follow-up|2|||
156409198|NCT01811563|564592488|FG000|Overall Study|Incorrect Randomization procedure|0|||
156409199|NCT01811563|564592489|FG001|Overall Study|Incorrect Randomization procedure|1|||
156409200|NCT04424290|564592491|FG000|Overall Study|Not treated|0|||
156409201|NCT04424290|564592492|FG001|Overall Study|Not treated|0|||
156409202|NCT04424290|564592493|FG002|Overall Study|Not treated|1|||
156409203|NCT04424290|564592494|FG003|Overall Study|Not treated|0|||
156409204|NCT04424290|564592495|FG004|Overall Study|Not treated|1|||
156409205|NCT04424290|564592491|FG000|Overall Study|Adverse Event|0|||
156409206|NCT04424290|564592492|FG001|Overall Study|Adverse Event|0|||
156409207|NCT04424290|564592493|FG002|Overall Study|Adverse Event|0|||
156409208|NCT04424290|564592494|FG003|Overall Study|Adverse Event|2|||
156409209|NCT04424290|564592495|FG004|Overall Study|Adverse Event|0|||
156409210|NCT04424290|564592491|FG000|Overall Study|Withdrawal by Subject|0|||
156409211|NCT04424290|564592492|FG001|Overall Study|Withdrawal by Subject|0|||
156409212|NCT04424290|564592493|FG002|Overall Study|Withdrawal by Subject|0|||
156409213|NCT04424290|564592494|FG003|Overall Study|Withdrawal by Subject|0|||
156409214|NCT04424290|564592495|FG004|Overall Study|Withdrawal by Subject|1|||
156409215|NCT04424290|564592491|FG000|Overall Study|Other than listed|0|||
156409216|NCT04424290|564592492|FG001|Overall Study|Other than listed|0|||
156409217|NCT04424290|564592493|FG002|Overall Study|Other than listed|0|||
156409218|NCT04424290|564592494|FG003|Overall Study|Other than listed|1|||
156409219|NCT04424290|564592495|FG004|Overall Study|Other than listed|0|||
156409220|NCT02936037|564592496|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
156409221|NCT02936037|564592497|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
156409222|NCT02936037|564592496|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
156409223|NCT02936037|564592497|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
156409224|NCT02936037|564592496|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
156409225|NCT02936037|564592497|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
156409226|NCT02936037|564592496|FG000|Double-Blind Treatment Period|Death|0|||
156409227|NCT02936037|564592497|FG001|Double-Blind Treatment Period|Death|1|||
156409228|NCT02936037|564592496|FG000|Double-Blind Treatment Period|Adverse Event|11|||
156409229|NCT02936037|564592497|FG001|Double-Blind Treatment Period|Adverse Event|11|||
156409230|NCT02936037|564592496|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
156409231|NCT02936037|564592497|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
156409232|NCT02936037|564592496|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156409233|NCT02936037|564592497|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
156409234|NCT02936037|564592496|FG000|Open Label Extension|Adverse Event|0|||
156409235|NCT02936037|564592497|FG001|Open Label Extension|Adverse Event|3|||
156409236|NCT02936037|564592496|FG000|Open Label Extension|Other|0|||
156409237|NCT02936037|564592497|FG001|Open Label Extension|Other|3|||
156409238|NCT02936037|564592496|FG000|Open Label Extension|Withdrawal by Subject|0|||
156409239|NCT02936037|564592497|FG001|Open Label Extension|Withdrawal by Subject|4|||
156409240|NCT01267825|564592498|FG000|Overall Study|study terminated. no data collected.|1|||
156409241|NCT01267825|564592499|FG001|Overall Study|study terminated. no data collected.|0|||
156409242|NCT04249336|564592500|FG000|Overall Study|Lost to Follow-up|3|||
156409243|NCT04249336|564592501|FG001|Overall Study|Lost to Follow-up|3|||
156409244|NCT04249336|564592502|FG002|Overall Study|Lost to Follow-up|3|||
156409245|NCT04249336|564592503|FG003|Overall Study|Lost to Follow-up|3|||
156409246|NCT01242176|564592504|FG000|Washout Period of 7 Days|Adverse Event|0|||
156409247|NCT01242176|564592505|FG001|Washout Period of 7 Days|Adverse Event|2|||
156409248|NCT01242176|564592504|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
156409249|NCT01242176|564592505|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
156409250|NCT00871351|564592506|FG000|Overall Study|Withdrawal by Subject|1|||
156409251|NCT00871351|564592507|FG001|Overall Study|Withdrawal by Subject|0|||
156409252|NCT00871351|564592508|FG002|Overall Study|Withdrawal by Subject|0|||
156409253|NCT00871351|564592506|FG000|Overall Study|Adverse Event|3|||
156409254|NCT00871351|564592507|FG001|Overall Study|Adverse Event|1|||
156409255|NCT00871351|564592508|FG002|Overall Study|Adverse Event|0|||
156409256|NCT02791490|564592509|FG000|Overall Study|Lost to Follow-up|1|||
156409257|NCT02791490|564592510|FG001|Overall Study|Lost to Follow-up|2|||
156409258|NCT02791490|564592509|FG000|Overall Study|Withdrawal by Subject|2|||
156409259|NCT02791490|564592510|FG001|Overall Study|Withdrawal by Subject|6|||
156409260|NCT01189890|564592511|FG000|Overall Study|Adverse Event|3|||
156409261|NCT01189890|564592512|FG001|Overall Study|Adverse Event|4|||
156409262|NCT01189890|564592511|FG000|Overall Study|Lack of Efficacy|7|||
156409263|NCT01189890|564592512|FG001|Overall Study|Lack of Efficacy|2|||
156409264|NCT01189890|564592511|FG000|Overall Study|Lost to Follow-up|1|||
156409265|NCT01189890|564592512|FG001|Overall Study|Lost to Follow-up|7|||
156409266|NCT01189890|564592511|FG000|Overall Study|Protocol Violation|1|||
156409267|NCT01189890|564592512|FG001|Overall Study|Protocol Violation|5|||
156409268|NCT01189890|564592511|FG000|Overall Study|Withdrawal by Subject|15|||
156409269|NCT01189890|564592512|FG001|Overall Study|Withdrawal by Subject|11|||
156409270|NCT01189890|564592511|FG000|Overall Study|Non Compliance|0|||
156409271|NCT01189890|564592512|FG001|Overall Study|Non Compliance|1|||
156409272|NCT01189890|564592511|FG000|Overall Study|Physician Decision|5|||
156409273|NCT01189890|564592512|FG001|Overall Study|Physician Decision|4|||
156409274|NCT01189890|564592511|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
156409275|NCT01189890|564592512|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
156409276|NCT00077636|564592513|FG000|Overall Study|Refused Treatment|9|||
156636955|NCT01777191|565415543|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
156636956|NCT01777191|565415544|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
156636957|NCT01777191|565415543|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
156636958|NCT01777191|565415544|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
156636959|NCT01777191|565415543|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
156636960|NCT01777191|565415544|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
156636961|NCT01777191|565415543|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
156636962|NCT01777191|565415544|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
156636963|NCT01777191|565415543|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
156636964|NCT01777191|565415544|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
156636965|NCT01777191|565415543|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
156636966|NCT01777191|565415544|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
156636967|NCT01777191|565415543|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
156636968|NCT01777191|565415544|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
156636969|NCT01777191|565415543|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
156636970|NCT01777191|565415544|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
156636971|NCT01777191|565415543|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
156636972|NCT01777191|565415544|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
156636973|NCT01777191|565415543|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
156636974|NCT01777191|565415544|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
156636975|NCT01777191|565415543|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
156636976|NCT01777191|565415544|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
156636977|NCT03286400|565415549|FG000|Overall Study|Death|10|||
156636978|NCT03286400|565415549|FG000|Overall Study|Lost to Follow-up|10|||
156636979|NCT03286400|565415549|FG000|Overall Study|Physician Decision|1|||
156636980|NCT03286400|565415549|FG000|Overall Study|Scheduling difficulty|4|||
156636981|NCT01856686|565415550|FG000|Overall Study|Lost to Follow-up|5|||
156636982|NCT01856686|565415551|FG001|Overall Study|Lost to Follow-up|11|||
156636983|NCT01461369|565415552|FG000|Overall Study|Lack of Efficacy|2|||
156636984|NCT01461369|565415553|FG001|Overall Study|Lack of Efficacy|0|||
156636985|NCT01461369|565415554|FG002|Overall Study|Lack of Efficacy|6|||
156636986|NCT01461369|565415552|FG000|Overall Study|Lost to Follow-up|0|||
156636987|NCT01461369|565415553|FG001|Overall Study|Lost to Follow-up|0|||
156636988|NCT01461369|565415554|FG002|Overall Study|Lost to Follow-up|3|||
156636989|NCT01461369|565415552|FG000|Overall Study|Adverse Event|9|||
156636990|NCT01461369|565415553|FG001|Overall Study|Adverse Event|12|||
156636991|NCT01461369|565415554|FG002|Overall Study|Adverse Event|4|||
156636992|NCT01461369|565415552|FG000|Overall Study|Protocol Violation|1|||
156636993|NCT01461369|565415553|FG001|Overall Study|Protocol Violation|2|||
156409277|NCT00077636|564592514|FG001|Overall Study|Refused Treatment|31|||
156409278|NCT00077636|564592513|FG000|Overall Study|Admin|3|||
156636994|NCT01461369|565415554|FG002|Overall Study|Protocol Violation|2|||
156636995|NCT01461369|565415552|FG000|Overall Study|Withdrawal by Subject|1|||
156636996|NCT01461369|565415553|FG001|Overall Study|Withdrawal by Subject|3|||
156409279|NCT00077636|564592514|FG001|Overall Study|Admin|3|||
156409280|NCT00077636|564592513|FG000|Overall Study|Withdrawal by Subject|2|||
156409281|NCT00077636|564592514|FG001|Overall Study|Withdrawal by Subject|2|||
156409282|NCT00077636|564592513|FG000|Overall Study|Adverse Event|17|||
156409283|NCT00077636|564592514|FG001|Overall Study|Adverse Event|34|||
156409284|NCT00077636|564592513|FG000|Overall Study|Protocol Violation|0|||
156409285|NCT00077636|564592514|FG001|Overall Study|Protocol Violation|2|||
156409286|NCT00077636|564592513|FG000|Overall Study|Lost to Follow-up|10|||
156409287|NCT00077636|564592514|FG001|Overall Study|Lost to Follow-up|18|||
156409288|NCT00077636|564592513|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
156409289|NCT00077636|564592514|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
156409290|NCT01087723|564592515|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
156409291|NCT01087723|564592516|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
156409292|NCT01087723|564592515|FG000|Overall Study|Withdrawal by Subject|10|||
156409293|NCT01087723|564592516|FG001|Overall Study|Withdrawal by Subject|13|||
156409294|NCT01087723|564592515|FG000|Overall Study|Physician Decision|2|||
156409295|NCT01087723|564592516|FG001|Overall Study|Physician Decision|0|||
156409296|NCT01087723|564592515|FG000|Overall Study|Lost to Follow-up|1|||
156409297|NCT01087723|564592516|FG001|Overall Study|Lost to Follow-up|4|||
156409298|NCT01087723|564592515|FG000|Overall Study|Reason Not Specified|1|||
156409299|NCT01087723|564592516|FG001|Overall Study|Reason Not Specified|2|||
156409300|NCT04399551|564592517|FG000|Overall Study|Adverse Event|15|||
156409301|NCT04399551|564592517|FG000|Overall Study|Withdrawal by Subject|6|||
156409302|NCT04399551|564592517|FG000|Overall Study|Physician Decision|3|||
156409303|NCT04399551|564592517|FG000|Overall Study|Lost to Follow-up|2|||
156409304|NCT04399551|564592517|FG000|Overall Study|Protocol Deviation|2|||
156409305|NCT01642602|564592521|FG000|Overall Study|Adverse Event|2|||
156409306|NCT02961881|564592522|FG000|Overall Study|Adverse Event|1|||
156409307|NCT02961881|564592523|FG001|Overall Study|Adverse Event|2|||
156409308|NCT02961881|564592524|FG002|Overall Study|Adverse Event|2|||
156409309|NCT02961881|564592525|FG003|Overall Study|Adverse Event|0|||
156409310|NCT02961881|564592526|FG004|Overall Study|Adverse Event|1|||
156409311|NCT02961881|564592522|FG000|Overall Study|Participant request|0|||
156409312|NCT02961881|564592523|FG001|Overall Study|Participant request|2|||
156409313|NCT02961881|564592524|FG002|Overall Study|Participant request|0|||
156409314|NCT02961881|564592525|FG003|Overall Study|Participant request|0|||
156409315|NCT02961881|564592526|FG004|Overall Study|Participant request|0|||
156409316|NCT02961881|564592522|FG000|Overall Study|Disease progression|1|||
156409317|NCT02961881|564592523|FG001|Overall Study|Disease progression|0|||
156409318|NCT02961881|564592524|FG002|Overall Study|Disease progression|1|||
156409319|NCT02961881|564592525|FG003|Overall Study|Disease progression|0|||
156409320|NCT02961881|564592526|FG004|Overall Study|Disease progression|0|||
156409321|NCT00451217|564592531|FG000|Overall Study|Lost to Follow-up|0|||
156409322|NCT00451217|564592532|FG001|Overall Study|Lost to Follow-up|1|||
156409323|NCT00451217|564592533|FG002|Overall Study|Lost to Follow-up|1|||
156409324|NCT00451217|564592534|FG003|Overall Study|Lost to Follow-up|1|||
156409325|NCT00451217|564592531|FG000|Overall Study|Withdrawal by Subject|1|||
156409326|NCT00451217|564592532|FG001|Overall Study|Withdrawal by Subject|0|||
156409327|NCT00451217|564592533|FG002|Overall Study|Withdrawal by Subject|0|||
156409328|NCT00451217|564592534|FG003|Overall Study|Withdrawal by Subject|0|||
156409329|NCT00451217|564592531|FG000|Overall Study|Not Treated|1|||
156409330|NCT00451217|564592532|FG001|Overall Study|Not Treated|1|||
156409331|NCT00451217|564592533|FG002|Overall Study|Not Treated|3|||
156409332|NCT00451217|564592534|FG003|Overall Study|Not Treated|4|||
156409333|NCT03154359|564592535|FG000|Overall Study|Adverse Event|1|||
156409334|NCT03154359|564592535|FG000|Overall Study|Lack of Efficacy|2|||
156409335|NCT03154359|564592535|FG000|Overall Study|Lost to Follow-up|3|||
156409336|NCT03154359|564592535|FG000|Overall Study|Physician Decision|3|||
156409337|NCT03154359|564592535|FG000|Overall Study|Protocol Violation|4|||
156409338|NCT03154359|564592535|FG000|Overall Study|Withdrawal by Subject|5|||
156409339|NCT03154359|564592535|FG000|Overall Study|Disruption of study due to COVID-19|4|||
156409340|NCT01592695|564592541|FG000|Overall Study|Lost to Follow-up|8|||
156409341|NCT01592695|564592542|FG001|Overall Study|Lost to Follow-up|4|||
156409342|NCT00641719|564592543|FG000|Overall Study|Lack of Efficacy|1|||
156409343|NCT00641719|564592544|FG001|Overall Study|Lack of Efficacy|2|||
156409344|NCT00641719|564592543|FG000|Overall Study|Adverse Event|24|||
156409345|NCT00641719|564592544|FG001|Overall Study|Adverse Event|29|||
156409346|NCT00641719|564592543|FG000|Overall Study|Withdrawal by Subject|4|||
156409347|NCT00641719|564592544|FG001|Overall Study|Withdrawal by Subject|4|||
156409348|NCT00641719|564592543|FG000|Overall Study|Reason Not Specified|1|||
156409349|NCT00641719|564592544|FG001|Overall Study|Reason Not Specified|2|||
156409350|NCT00885352|564592545|FG000|Overall Study|Adverse Event|2|||
156636997|NCT01461369|565415554|FG002|Overall Study|Withdrawal by Subject|2|||
156636998|NCT01563029|565415561|FG000|Overall Study|Adverse Event|1|||
156409351|NCT00885352|564592546|FG001|Overall Study|Adverse Event|3|||
156409352|NCT00885352|564592545|FG000|Overall Study|Lost to Follow-up|2|||
156409353|NCT00885352|564592546|FG001|Overall Study|Lost to Follow-up|2|||
156409354|NCT00885352|564592545|FG000|Overall Study|Physician Decision|0|||
156409355|NCT00885352|564592546|FG001|Overall Study|Physician Decision|3|||
156409356|NCT00885352|564592545|FG000|Overall Study|Protocol Violation|0|||
156409357|NCT00885352|564592546|FG001|Overall Study|Protocol Violation|2|||
156409358|NCT00885352|564592545|FG000|Overall Study|Withdrawal by Subject|1|||
156409359|NCT00885352|564592546|FG001|Overall Study|Withdrawal by Subject|5|||
156409360|NCT00885352|564592545|FG000|Overall Study|Contradiction to study medication|0|||
156409361|NCT00885352|564592546|FG001|Overall Study|Contradiction to study medication|2|||
156409362|NCT00885352|564592545|FG000|Overall Study|Excluded medication|2|||
156409363|NCT00885352|564592546|FG001|Overall Study|Excluded medication|2|||
156409364|NCT00885352|564592545|FG000|Overall Study|Lab abnormalities|1|||
156409365|NCT00885352|564592546|FG001|Overall Study|Lab abnormalities|1|||
156409366|NCT03662997|564592547|FG000|Overall Study|Adverse Event|0|||
156409367|NCT03662997|564592548|FG001|Overall Study|Adverse Event|2|||
156409368|NCT03662997|564592549|FG002|Overall Study|Adverse Event|0|||
156409369|NCT03662997|564592550|FG003|Overall Study|Adverse Event|0|||
156409370|NCT00734214|564592552|FG000|Overall Study|Withdrawal by Subject|3|||
156409371|NCT00734214|564592553|FG001|Overall Study|Withdrawal by Subject|4|||
156409372|NCT00734214|564592552|FG000|Overall Study|MD withdrawal|1|||
156409373|NCT00734214|564592553|FG001|Overall Study|MD withdrawal|0|||
156409374|NCT04362137|564592554|FG000|Overall Study|Death|9|||
156409375|NCT04362137|564592555|FG001|Overall Study|Death|3|||
156409376|NCT04362137|564592554|FG000|Overall Study|Patient decision|6|||
156409377|NCT04362137|564592555|FG001|Overall Study|Patient decision|3|||
156409378|NCT04362137|564592554|FG000|Overall Study|Adverse Event|1|||
156409379|NCT04362137|564592555|FG001|Overall Study|Adverse Event|0|||
156409380|NCT04362137|564592554|FG000|Overall Study|Lost to Follow-up|1|||
156409381|NCT04362137|564592555|FG001|Overall Study|Lost to Follow-up|0|||
156409382|NCT04362137|564592554|FG000|Overall Study|Protocol deviation|1|||
156409383|NCT04362137|564592555|FG001|Overall Study|Protocol deviation|0|||
156409384|NCT02494206|564592559|FG000|Overall Study|Adverse Event|1|||
156409385|NCT02494206|564592559|FG000|Overall Study|Disease Progression|1|||
156409386|NCT01121484|564592561|FG000|Overall Study|Adverse Event|12|||
156409387|NCT01121484|564592562|FG001|Overall Study|Adverse Event|5|||
156409388|NCT01121484|564592561|FG000|Overall Study|Lack of Efficacy|3|||
156409389|NCT01121484|564592562|FG001|Overall Study|Lack of Efficacy|11|||
156409390|NCT01121484|564592561|FG000|Overall Study|Lost to Follow-up|5|||
156409391|NCT01121484|564592562|FG001|Overall Study|Lost to Follow-up|9|||
156409392|NCT01121484|564592561|FG000|Overall Study|Physician Decision|0|||
156409393|NCT01121484|564592562|FG001|Overall Study|Physician Decision|3|||
156409394|NCT01121484|564592561|FG000|Overall Study|Protocol Violation|1|||
156409395|NCT01121484|564592562|FG001|Overall Study|Protocol Violation|0|||
156409396|NCT01121484|564592561|FG000|Overall Study|Withdrawal by Subject|8|||
156409397|NCT01121484|564592562|FG001|Overall Study|Withdrawal by Subject|7|||
156409398|NCT01121484|564592561|FG000|Overall Study|Discontinuation of study by sponsor|0|||
156409399|NCT01121484|564592562|FG001|Overall Study|Discontinuation of study by sponsor|1|||
156409400|NCT01121484|564592561|FG000|Overall Study|Other|3|||
156409401|NCT01121484|564592562|FG001|Overall Study|Other|3|||
156409402|NCT01121484|564592561|FG000|Overall Study|Randomized, not treated|1|||
156409403|NCT01121484|564592562|FG001|Overall Study|Randomized, not treated|4|||
156409404|NCT00180713|564592564|FG000|Overall Study|Withdrawal by Subject|2|||
156409405|NCT00180713|564592565|FG001|Overall Study|Withdrawal by Subject|0|||
156409406|NCT00180713|564592564|FG000|Overall Study|Adverse Event|3|||
156409407|NCT00180713|564592565|FG001|Overall Study|Adverse Event|3|||
156409408|NCT05295732|564592566|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
156409409|NCT05295732|564592567|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
156409410|NCT05295732|564592568|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
156409411|NCT05295732|564592569|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
156409412|NCT05295732|564592570|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
156409413|NCT05295732|564592566|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
156409414|NCT05295732|564592567|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
156409415|NCT05295732|564592568|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
156409416|NCT05295732|564592569|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
156409417|NCT05295732|564592570|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
156409418|NCT01065350|564592572|FG000|Overall Study|Received incorrect drug allocation|0|||
156409419|NCT01065350|564592573|FG001|Overall Study|Received incorrect drug allocation|1|||
156409420|NCT02716038|564592580|FG000|Overall Study|Not evaluable|1|||
156409421|NCT02716038|564592580|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
156409422|NCT02716038|564592580|FG000|Overall Study|Unresectable|3|||
156409423|NCT00550550|564592581|FG000|Overall Study|Adverse Event|13|||
156409424|NCT00550550|564592582|FG001|Overall Study|Adverse Event|5|||
156409425|NCT00550550|564592581|FG000|Overall Study|Treatment Failure|0|||
156409426|NCT00550550|564592582|FG001|Overall Study|Treatment Failure|1|||
156409427|NCT00550550|564592581|FG000|Overall Study|Lost to Follow-up|4|||
156409428|NCT00550550|564592582|FG001|Overall Study|Lost to Follow-up|0|||
156409429|NCT00550550|564592581|FG000|Overall Study|Withdrawal by Subject|10|||
156409430|NCT00550550|564592582|FG001|Overall Study|Withdrawal by Subject|8|||
156409431|NCT00550550|564592581|FG000|Overall Study|Protocol Violation|5|||
156409432|NCT00550550|564592582|FG001|Overall Study|Protocol Violation|14|||
156409433|NCT00550550|564592581|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
156409434|NCT00550550|564592582|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
156409435|NCT00550550|564592581|FG000|Overall Study|Randomized But Not Treated|1|||
156409436|NCT00550550|564592582|FG001|Overall Study|Randomized But Not Treated|0|||
156409437|NCT00118092|564592583|FG000|Overall Study|Withdrawal by Subject|1|||
156409438|NCT00118092|564592583|FG000|Overall Study|Protocol Violation|1|||
156409439|NCT00591864|564592584|FG000|Overall Study|Incomplete Imaging|5|||
156409440|NCT02459093|564592585|FG000|Overall Study|Protocol Violation|6|||
156409441|NCT02459093|564592586|FG001|Overall Study|Protocol Violation|11|||
156409442|NCT02459093|564592585|FG000|Overall Study|Lost to Follow-up|6|||
156409443|NCT02459093|564592586|FG001|Overall Study|Lost to Follow-up|7|||
156409444|NCT03311230|564592597|FG000|Overall Study|Withdrawal by Subject|1|||
156409445|NCT03311230|564592598|FG001|Overall Study|Withdrawal by Subject|4|||
156409446|NCT03311230|564592599|FG002|Overall Study|Withdrawal by Subject|2|||
156409447|NCT03311230|564592600|FG003|Overall Study|Withdrawal by Subject|7|||
156409448|NCT03311230|564592597|FG000|Overall Study|Unrelated injury|0|||
156409449|NCT03311230|564592598|FG001|Overall Study|Unrelated injury|1|||
156409450|NCT03311230|564592599|FG002|Overall Study|Unrelated injury|0|||
156409451|NCT03311230|564592600|FG003|Overall Study|Unrelated injury|0|||
156409452|NCT03342053|564592601|FG000|Overall Study|Adverse Event|2|||
156409453|NCT03342053|564592602|FG001|Overall Study|Adverse Event|0|||
156409454|NCT03342053|564592601|FG000|Overall Study|Withdrawal by Subject|0|||
156409455|NCT03342053|564592602|FG001|Overall Study|Withdrawal by Subject|1|||
156409456|NCT01302938|564592603|FG000|Overall Study|Withdrawal by Subject|1|||
156409457|NCT01302938|564592604|FG001|Overall Study|Withdrawal by Subject|0|||
156409458|NCT01302938|564592603|FG000|Overall Study|Adverse Event|1|||
156409459|NCT01302938|564592604|FG001|Overall Study|Adverse Event|0|||
156409460|NCT02294474|564592605|FG000|Overall Study|Adverse Event|7|||
156409461|NCT02294474|564592606|FG001|Overall Study|Adverse Event|7|||
156409462|NCT02294474|564592605|FG000|Overall Study|Lack of Efficacy|2|||
156409463|NCT02294474|564592606|FG001|Overall Study|Lack of Efficacy|1|||
156409464|NCT02294474|564592605|FG000|Overall Study|Protocol Violation|4|||
156409465|NCT02294474|564592606|FG001|Overall Study|Protocol Violation|2|||
156409466|NCT02294474|564592605|FG000|Overall Study|Other than specified above|12|||
156409467|NCT02294474|564592606|FG001|Overall Study|Other than specified above|12|||
156409468|NCT05200936|564592610|FG000|Overall Study|Withdrawal by Subject|2|||
156409469|NCT05200936|564592611|FG001|Overall Study|Withdrawal by Subject|2|||
156409470|NCT05200936|564592610|FG000|Overall Study|Lost to Follow-up|2|||
156409471|NCT05200936|564592611|FG001|Overall Study|Lost to Follow-up|0|||
156409472|NCT05200936|564592610|FG000|Overall Study|Pregnancy|0|||
156409473|NCT05200936|564592611|FG001|Overall Study|Pregnancy|1|||
156409474|NCT00539279|564592613|FG000|Treatment|Withdrawal by Subject|10|||
156409475|NCT00539279|564592614|FG001|Treatment|Withdrawal by Subject|8|||
156409476|NCT00539279|564592613|FG000|Treatment|Death|1|||
156409477|NCT00539279|564592614|FG001|Treatment|Death|0|||
156409478|NCT00539279|564592613|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
156409479|NCT00539279|564592614|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
156409480|NCT00539279|564592613|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
156409481|NCT00539279|564592614|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
156409482|NCT04921969|564592620|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156409483|NCT04921969|564592621|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
156409484|NCT04921969|564592622|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
156409485|NCT04921969|564592623|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156409486|NCT04921969|564592624|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156409487|NCT04921969|564592625|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156409488|NCT04921969|564592626|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156409489|NCT04921969|564592620|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
156409490|NCT04921969|564592621|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156409491|NCT04921969|564592622|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156409492|NCT04921969|564592623|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156409493|NCT04921969|564592624|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156409494|NCT04921969|564592625|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156636999|NCT01563029|565415562|FG001|Overall Study|Adverse Event|0|||
156637000|NCT01563029|565415563|FG002|Overall Study|Adverse Event|1|||
156637001|NCT01563029|565415564|FG003|Overall Study|Adverse Event|2|||
156637002|NCT01563029|565415565|FG004|Overall Study|Adverse Event|1|||
156637003|NCT01563029|565415561|FG000|Overall Study|Lack of Efficacy|42|||
156637004|NCT01563029|565415562|FG001|Overall Study|Lack of Efficacy|16|||
156637005|NCT01563029|565415563|FG002|Overall Study|Lack of Efficacy|23|||
156637006|NCT01563029|565415564|FG003|Overall Study|Lack of Efficacy|21|||
156637007|NCT01563029|565415565|FG004|Overall Study|Lack of Efficacy|19|||
156637008|NCT01563029|565415561|FG000|Overall Study|Protocol Violation|1|||
156637009|NCT01563029|565415562|FG001|Overall Study|Protocol Violation|2|||
156637010|NCT01563029|565415563|FG002|Overall Study|Protocol Violation|3|||
156637011|NCT01563029|565415564|FG003|Overall Study|Protocol Violation|1|||
156637012|NCT01563029|565415565|FG004|Overall Study|Protocol Violation|3|||
156637013|NCT01563029|565415561|FG000|Overall Study|Protocol defined stopping criteria|1|||
156637014|NCT01563029|565415562|FG001|Overall Study|Protocol defined stopping criteria|0|||
156637015|NCT01563029|565415563|FG002|Overall Study|Protocol defined stopping criteria|0|||
156637016|NCT01563029|565415564|FG003|Overall Study|Protocol defined stopping criteria|0|||
156637017|NCT01563029|565415565|FG004|Overall Study|Protocol defined stopping criteria|0|||
156637018|NCT01563029|565415561|FG000|Overall Study|Lost to Follow-up|1|||
156637019|NCT01563029|565415562|FG001|Overall Study|Lost to Follow-up|0|||
156637020|NCT01563029|565415563|FG002|Overall Study|Lost to Follow-up|1|||
156637021|NCT01563029|565415564|FG003|Overall Study|Lost to Follow-up|1|||
156637022|NCT01563029|565415565|FG004|Overall Study|Lost to Follow-up|1|||
156637023|NCT01563029|565415561|FG000|Overall Study|Physician Decision|3|||
156637024|NCT01563029|565415562|FG001|Overall Study|Physician Decision|5|||
156637025|NCT01563029|565415563|FG002|Overall Study|Physician Decision|2|||
156637026|NCT01563029|565415564|FG003|Overall Study|Physician Decision|4|||
156637027|NCT01563029|565415565|FG004|Overall Study|Physician Decision|2|||
156637028|NCT01563029|565415561|FG000|Overall Study|Withdrawal by Subject|4|||
156637029|NCT01563029|565415562|FG001|Overall Study|Withdrawal by Subject|1|||
156637030|NCT01563029|565415563|FG002|Overall Study|Withdrawal by Subject|3|||
156637031|NCT01563029|565415564|FG003|Overall Study|Withdrawal by Subject|4|||
156637032|NCT01563029|565415565|FG004|Overall Study|Withdrawal by Subject|3|||
156637033|NCT01569594|565415566|FG000|Overall Study|Physician Decision|4|||
156637034|NCT01569594|565415566|FG000|Overall Study|Death|13|||
156637035|NCT01569594|565415566|FG000|Overall Study|Lost to Follow-up|22|||
156637036|NCT01569594|565415566|FG000|Overall Study|Adverse Event|2|||
156637037|NCT01569594|565415566|FG000|Overall Study|Withdrawal by Subject|13|||
156637038|NCT01569594|565415566|FG000|Overall Study|Other|4|||
156637039|NCT01569594|565415566|FG000|Overall Study|No ECM used|9|||
156637040|NCT03069365|565415567|FG000|Overall Study|Adverse Event|1|||
156637041|NCT02861534|565415568|FG000|Overall Study|Death|541|||
156637042|NCT02861534|565415569|FG001|Overall Study|Death|552|||
156409495|NCT04921969|564592626|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156637043|NCT02861534|565415568|FG000|Overall Study|Lost to Follow-up|14|||
156637044|NCT02861534|565415569|FG001|Overall Study|Lost to Follow-up|14|||
156409496|NCT04921969|564592620|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
156409497|NCT04921969|564592621|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
156409498|NCT04921969|564592622|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
156637045|NCT02861534|565415568|FG000|Overall Study|Site Terminated by Sponsor|4|||
156637046|NCT02861534|565415569|FG001|Overall Study|Site Terminated by Sponsor|3|||
156637047|NCT02861534|565415568|FG000|Overall Study|Withdrawal by Subject|15|||
156637048|NCT02861534|565415569|FG001|Overall Study|Withdrawal by Subject|18|||
156637049|NCT02886494|565415570|FG000|Overall Study|Adverse Event|1|||
156637050|NCT02886494|565415571|FG001|Overall Study|Adverse Event|0|||
156409499|NCT04921969|564592623|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156409500|NCT04921969|564592624|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156409501|NCT04921969|564592625|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156409502|NCT04921969|564592626|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156409503|NCT04921969|564592620|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156409504|NCT04921969|564592621|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
156409505|NCT04921969|564592622|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
156409506|NCT04921969|564592623|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156409507|NCT04921969|564592624|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156409508|NCT04921969|564592625|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156409509|NCT04921969|564592626|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156409510|NCT04921969|564592620|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156409511|NCT04921969|564592621|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156409512|NCT04921969|564592622|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
156409513|NCT04921969|564592623|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156409514|NCT04921969|564592624|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156409515|NCT04921969|564592625|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156409516|NCT04921969|564592626|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156409517|NCT04921969|564592620|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
156409518|NCT04921969|564592621|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
156409519|NCT04921969|564592622|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
156409520|NCT04921969|564592623|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156409521|NCT04921969|564592624|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156409522|NCT04921969|564592625|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156409523|NCT04921969|564592626|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156409524|NCT04921969|564592620|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
156409525|NCT04921969|564592621|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
156409526|NCT04921969|564592622|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156409527|NCT04921969|564592623|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156409528|NCT04921969|564592624|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156409529|NCT04921969|564592625|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156409530|NCT04921969|564592626|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156409531|NCT04921969|564592620|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156409532|NCT04921969|564592621|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156409533|NCT04921969|564592622|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156409534|NCT04921969|564592623|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156409535|NCT04921969|564592624|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156409536|NCT04921969|564592625|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156409537|NCT04921969|564592626|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
156409538|NCT04921969|564592620|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156409539|NCT04921969|564592621|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156409540|NCT04921969|564592622|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156409541|NCT04921969|564592623|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
156409542|NCT04921969|564592624|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156409543|NCT04921969|564592625|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
156409544|NCT04921969|564592626|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
156409545|NCT04921969|564592620|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156409546|NCT04921969|564592621|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156409547|NCT04921969|564592622|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156409548|NCT04921969|564592623|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
156409549|NCT04921969|564592624|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
156409550|NCT04921969|564592625|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
156409551|NCT04921969|564592626|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
156409552|NCT04921969|564592620|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
156409553|NCT04921969|564592621|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
156409554|NCT04921969|564592622|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
156409555|NCT04921969|564592623|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
156409556|NCT04921969|564592624|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
156409557|NCT04921969|564592625|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
156409558|NCT04921969|564592626|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
156409559|NCT04921969|564592620|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156409560|NCT04921969|564592621|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156409561|NCT04921969|564592622|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156409562|NCT04921969|564592623|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
156409563|NCT04921969|564592624|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
156409564|NCT04921969|564592625|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
156409565|NCT04921969|564592626|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
156409566|NCT04921969|564592620|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
156409567|NCT04921969|564592621|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
156409568|NCT04921969|564592622|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
156409569|NCT04921969|564592623|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
156409570|NCT04921969|564592624|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
156409571|NCT04921969|564592625|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
156409572|NCT04921969|564592626|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
156409573|NCT04921969|564592620|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156409574|NCT04921969|564592621|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156409575|NCT04921969|564592622|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156409576|NCT04921969|564592623|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
156409577|NCT04921969|564592624|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156409578|NCT04921969|564592625|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156409579|NCT04921969|564592626|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
156409580|NCT04921969|564592620|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
156409581|NCT04921969|564592621|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
156409582|NCT04921969|564592622|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
156409583|NCT04921969|564592623|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
156409584|NCT04921969|564592624|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
156409585|NCT04921969|564592625|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
156409586|NCT04921969|564592626|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
156409587|NCT04287868|564592627|FG000|Overall Study|Screening fail|1|||
156409588|NCT04287868|564592628|FG001|Overall Study|Screening fail|0|||
156409589|NCT00592319|564594219|FG000|Overall Study|Lost to Follow-up|0|||
156409590|NCT00592319|564594220|FG001|Overall Study|Lost to Follow-up|3|||
156409591|NCT02032173|564594223|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
156409592|NCT01017120|564594226|FG000|Overall Study|Adverse Event|9|||
156409593|NCT01017120|564594227|FG001|Overall Study|Adverse Event|0|||
156409594|NCT01017120|564594226|FG000|Overall Study|Lost to Follow-up|13|||
156409595|NCT01017120|564594227|FG001|Overall Study|Lost to Follow-up|11|||
156409596|NCT01017120|564594226|FG000|Overall Study|Lack of Efficacy|1|||
156409597|NCT01017120|564594227|FG001|Overall Study|Lack of Efficacy|0|||
156409598|NCT01017120|564594226|FG000|Overall Study|Withdrawal by Subject|39|||
156409599|NCT01017120|564594227|FG001|Overall Study|Withdrawal by Subject|21|||
156409600|NCT01017120|564594226|FG000|Overall Study|Pregnancy|1|||
156409601|NCT01017120|564594227|FG001|Overall Study|Pregnancy|1|||
156637051|NCT02886494|565415570|FG000|Overall Study|Withdrawal by Subject|12|||
156409602|NCT01017120|564594226|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
156637052|NCT02886494|565415571|FG001|Overall Study|Withdrawal by Subject|3|||
156637053|NCT02886494|565415570|FG000|Overall Study|Protocol Violation|4|||
156409603|NCT01017120|564594227|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
156409604|NCT01017120|564594226|FG000|Overall Study|Relocated Out of Town|0|||
156409605|NCT01017120|564594227|FG001|Overall Study|Relocated Out of Town|2|||
156409606|NCT01017120|564594226|FG000|Overall Study|Protocol Violation|1|||
156409607|NCT01017120|564594227|FG001|Overall Study|Protocol Violation|0|||
156409608|NCT01017120|564594226|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
156409609|NCT01017120|564594227|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
156409610|NCT01912222|564594228|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
156409611|NCT01912222|564594229|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
156409612|NCT01912222|564594230|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
156409613|NCT01912222|564594228|FG000|Part B: Treatment Period|Progressive disease|10|||
156409614|NCT01912222|564594229|FG001|Part B: Treatment Period|Progressive disease|12|||
156409615|NCT01912222|564594230|FG002|Part B: Treatment Period|Progressive disease|15|||
156409616|NCT01912222|564594228|FG000|Part B: Treatment Period|Adverse Event|1|||
156409617|NCT01912222|564594229|FG001|Part B: Treatment Period|Adverse Event|2|||
156409618|NCT01912222|564594230|FG002|Part B: Treatment Period|Adverse Event|3|||
156409619|NCT01912222|564594228|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
156409620|NCT01912222|564594229|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
156409621|NCT01912222|564594230|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
156409622|NCT01112514|564594231|FG000|Overall Study|Lost to Follow-up|1|||
156409623|NCT01118455|564594232|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
156409624|NCT01118455|564594233|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
156409625|NCT00636792|564594238|FG000|Overall Study|Adverse Event|16|||
156409626|NCT00636792|564594238|FG000|Overall Study|Physician Decision|7|||
156409627|NCT00636792|564594238|FG000|Overall Study|Progressive Disease|4|||
156409628|NCT00636792|564594238|FG000|Overall Study|Withdrawal by Subject|3|||
156409629|NCT00636792|564594238|FG000|Overall Study|Other|3|||
156409630|NCT03377790|564594239|FG000|Overall Study|Withdrawal by Subject|1|||
156409631|NCT03377790|564594240|FG001|Overall Study|Withdrawal by Subject|0|||
156409632|NCT03377790|564594239|FG000|Overall Study|Adverse Event|1|||
156409633|NCT03377790|564594240|FG001|Overall Study|Adverse Event|0|||
156409634|NCT03377790|564594239|FG000|Overall Study|Lost to Follow-up|0|||
156409635|NCT03377790|564594240|FG001|Overall Study|Lost to Follow-up|2|||
156409636|NCT03377790|564594239|FG000|Overall Study|Randomized but not treated|1|||
156409637|NCT03377790|564594240|FG001|Overall Study|Randomized but not treated|0|||
156409638|NCT03377790|564594239|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
156409639|NCT03377790|564594240|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
156409640|NCT01928225|564594241|FG000|Overall Study|Pregnancy|1|||
156409641|NCT01928225|564594242|FG001|Overall Study|Pregnancy|0|||
156409642|NCT01928225|564594241|FG000|Overall Study|basaloid cervical cancer|1|||
156409643|NCT01928225|564594242|FG001|Overall Study|basaloid cervical cancer|0|||
156409644|NCT01928225|564594241|FG000|Overall Study|Lost to Follow-up|1|||
156409645|NCT01928225|564594242|FG001|Overall Study|Lost to Follow-up|3|||
156409646|NCT01235975|564594244|FG000|Overall Study|Serious Adverse Event|0|||
156409647|NCT01235975|564594245|FG001|Overall Study|Serious Adverse Event|1|||
156409648|NCT01235975|564594244|FG000|Overall Study|Withdrawal by Subject|8|||
156409649|NCT01235975|564594245|FG001|Overall Study|Withdrawal by Subject|2|||
156409650|NCT01235975|564594244|FG000|Overall Study|Migrated/moved from study area|2|||
156409651|NCT01235975|564594245|FG001|Overall Study|Migrated/moved from study area|1|||
156409652|NCT01235975|564594244|FG000|Overall Study|Lost to Follow-up|7|||
156409653|NCT01235975|564594245|FG001|Overall Study|Lost to Follow-up|3|||
156409654|NCT05033743|564594246|FG000|Overall Study|Lost to Follow-up|1|||
156409655|NCT05033743|564594246|FG000|Overall Study|Protocol Violation|2|||
156409656|NCT05033743|564594246|FG000|Overall Study|Withdrawal by Subject|1|||
156409657|NCT00919893|564594250|FG000|Overall Study|Protocol Violation|19|||
156409658|NCT00919893|564594251|FG001|Overall Study|Protocol Violation|9|||
156409659|NCT00365378|564594261|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
156409660|NCT00365378|564594262|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
156409661|NCT00365378|564594263|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
156409662|NCT00365378|564594261|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
156409663|NCT00365378|564594262|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
156409664|NCT00365378|564594263|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
156409665|NCT00365378|564594261|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
156409666|NCT00365378|564594262|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
156409667|NCT00365378|564594263|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
156409668|NCT00365378|564594261|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
156409669|NCT00365378|564594262|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
156409670|NCT00365378|564594263|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
156409671|NCT00365378|564594261|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
156409672|NCT00365378|564594262|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
156409673|NCT00365378|564594263|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
156409674|NCT00365378|564594261|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
156409675|NCT00365378|564594262|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
156409676|NCT00365378|564594263|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
156409677|NCT00365378|564594261|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
156409678|NCT00365378|564594262|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
156409679|NCT00365378|564594263|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
156409680|NCT00365378|564594261|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
156409681|NCT00365378|564594262|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
156409682|NCT00365378|564594263|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
156409683|NCT00365378|564594261|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
156409684|NCT00365378|564594262|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
156409685|NCT00365378|564594263|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
156409686|NCT00365378|564594261|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
156409687|NCT00365378|564594262|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
156409688|NCT00365378|564594263|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
156409689|NCT00365378|564594261|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
156409690|NCT00365378|564594262|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
156409691|NCT00365378|564594263|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
156409692|NCT00365378|564594261|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
156409693|NCT00365378|564594262|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
156409694|NCT00365378|564594263|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
156409695|NCT00365378|564594261|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
156409696|NCT00365378|564594262|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
156409697|NCT00365378|564594263|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
156409698|NCT00365378|564594261|FG000|Extension|Adverse Event|0|||
156409699|NCT00365378|564594262|FG001|Extension|Adverse Event|0|||
156409700|NCT00365378|564594263|FG002|Extension|Adverse Event|1|||
156409701|NCT00365378|564594261|FG000|Extension|Moved|0|||
156409702|NCT00365378|564594262|FG001|Extension|Moved|0|||
156409703|NCT00365378|564594263|FG002|Extension|Moved|8|||
156409704|NCT00365378|564594261|FG000|Extension|Lost to Follow-up|0|||
156409705|NCT00365378|564594262|FG001|Extension|Lost to Follow-up|0|||
156409706|NCT00365378|564594263|FG002|Extension|Lost to Follow-up|57|||
156409707|NCT00365378|564594261|FG000|Extension|Protocol Violation|0|||
156409708|NCT00365378|564594262|FG001|Extension|Protocol Violation|0|||
156409709|NCT00365378|564594263|FG002|Extension|Protocol Violation|2|||
156409710|NCT00365378|564594261|FG000|Extension|Withdrawal by Subject|0|||
156409711|NCT00365378|564594262|FG001|Extension|Withdrawal by Subject|0|||
156409712|NCT00365378|564594263|FG002|Extension|Withdrawal by Subject|98|||
156409713|NCT00365378|564594261|FG000|Extension|Other|0|||
156409714|NCT00365378|564594262|FG001|Extension|Other|0|||
156409715|NCT00365378|564594263|FG002|Extension|Other|31|||
156409716|NCT00251927|564594277|FG000|Overall Study|Adverse Event|3|||
156409717|NCT00251927|564594278|FG001|Overall Study|Adverse Event|15|||
156409718|NCT00251927|564594277|FG000|Overall Study|Lack of Efficacy|22|||
156409719|NCT00251927|564594278|FG001|Overall Study|Lack of Efficacy|16|||
156409720|NCT00251927|564594277|FG000|Overall Study|Lost to Follow-up|22|||
156409721|NCT00251927|564594278|FG001|Overall Study|Lost to Follow-up|8|||
156409722|NCT00251927|564594277|FG000|Overall Study|Protocol Violation|1|||
156409723|NCT00251927|564594278|FG001|Overall Study|Protocol Violation|2|||
156409724|NCT00251927|564594277|FG000|Overall Study|Pregnancy|2|||
156409725|NCT00251927|564594278|FG001|Overall Study|Pregnancy|0|||
156409726|NCT00251927|564594277|FG000|Overall Study|Withdrawal by Subject|40|||
156409727|NCT00251927|564594278|FG001|Overall Study|Withdrawal by Subject|25|||
156409728|NCT00251927|564594277|FG000|Overall Study|Study-specific discont. achieved|13|||
156409729|NCT00251927|564594278|FG001|Overall Study|Study-specific discont. achieved|2|||
156409730|NCT00251927|564594277|FG000|Overall Study|Study procedure non-compliance|5|||
156409731|NCT00251927|564594278|FG001|Overall Study|Study procedure non-compliance|6|||
156409732|NCT01678820|564594279|FG000|Overall Study|Study Terminated by Sponsor|45|||
156409733|NCT01678820|564594280|FG001|Overall Study|Study Terminated by Sponsor|43|||
156409734|NCT01678820|564594281|FG002|Overall Study|Study Terminated by Sponsor|43|||
156409735|NCT01678820|564594279|FG000|Overall Study|Withdrawal by Subject|2|||
156409736|NCT01678820|564594280|FG001|Overall Study|Withdrawal by Subject|5|||
156409737|NCT01678820|564594281|FG002|Overall Study|Withdrawal by Subject|2|||
156409738|NCT01678820|564594279|FG000|Overall Study|Protocol Specified Criteria|2|||
156409739|NCT01678820|564594280|FG001|Overall Study|Protocol Specified Criteria|3|||
156409740|NCT01678820|564594281|FG002|Overall Study|Protocol Specified Criteria|1|||
156409741|NCT01678820|564594279|FG000|Overall Study|Adverse Event|2|||
156409742|NCT01678820|564594280|FG001|Overall Study|Adverse Event|2|||
156409743|NCT01678820|564594281|FG002|Overall Study|Adverse Event|2|||
156409744|NCT01678820|564594279|FG000|Overall Study|Lost to Follow-up|7|||
156409745|NCT01678820|564594280|FG001|Overall Study|Lost to Follow-up|2|||
156409746|NCT01678820|564594281|FG002|Overall Study|Lost to Follow-up|2|||
156409747|NCT01678820|564594279|FG000|Overall Study|Non-compliance with study drug|0|||
156409748|NCT01678820|564594280|FG001|Overall Study|Non-compliance with study drug|1|||
156409749|NCT01678820|564594281|FG002|Overall Study|Non-compliance with study drug|0|||
156409750|NCT01678820|564594279|FG000|Overall Study|Physician Decision|0|||
156409751|NCT01678820|564594280|FG001|Overall Study|Physician Decision|0|||
156409752|NCT01678820|564594281|FG002|Overall Study|Physician Decision|1|||
156409753|NCT01678820|564594279|FG000|Overall Study|Protocol Violation|4|||
156409754|NCT01678820|564594280|FG001|Overall Study|Protocol Violation|5|||
156409755|NCT01678820|564594281|FG002|Overall Study|Protocol Violation|4|||
156409756|NCT01678820|564594279|FG000|Overall Study|Not treated with double-blind study drug|0|||
156409757|NCT01678820|564594280|FG001|Overall Study|Not treated with double-blind study drug|2|||
156409758|NCT01678820|564594281|FG002|Overall Study|Not treated with double-blind study drug|2|||
156409759|NCT01381874|564594283|FG000|Overall Study|Lost to Follow-up|1|||
156409760|NCT01381874|564594284|FG001|Overall Study|Lost to Follow-up|1|||
156409761|NCT01381874|564594285|FG002|Overall Study|Lost to Follow-up|0|||
156409762|NCT01381874|564594283|FG000|Overall Study|Withdrawal by Subject|9|||
156409763|NCT01381874|564594284|FG001|Overall Study|Withdrawal by Subject|10|||
156409764|NCT01381874|564594285|FG002|Overall Study|Withdrawal by Subject|9|||
156409765|NCT01381874|564594283|FG000|Overall Study|Other|67|||
156409766|NCT01381874|564594284|FG001|Overall Study|Other|52|||
156409767|NCT01381874|564594285|FG002|Overall Study|Other|67|||
156409768|NCT00452413|564594288|FG000|Overall Study|Progressive Disease|4|||
156409769|NCT00452413|564594289|FG001|Overall Study|Progressive Disease|11|||
156409770|NCT00452413|564594290|FG002|Overall Study|Progressive Disease|30|||
156409771|NCT00452413|564594288|FG000|Overall Study|Withdrawal by Subject|0|||
156409772|NCT00452413|564594289|FG001|Overall Study|Withdrawal by Subject|1|||
156409773|NCT00452413|564594290|FG002|Overall Study|Withdrawal by Subject|4|||
156409774|NCT00452413|564594288|FG000|Overall Study|Adverse Event|0|||
156409775|NCT00452413|564594289|FG001|Overall Study|Adverse Event|0|||
156409776|NCT00452413|564594290|FG002|Overall Study|Adverse Event|5|||
156637054|NCT02886494|565415571|FG001|Overall Study|Protocol Violation|1|||
156751625|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
156409777|NCT00452413|564594288|FG000|Overall Study|Physician Decision|0|||
156409778|NCT00452413|564594289|FG001|Overall Study|Physician Decision|0|||
156409779|NCT00452413|564594290|FG002|Overall Study|Physician Decision|4|||
156409780|NCT00452413|564594288|FG000|Overall Study|Death due to study disease|0|||
156409781|NCT00452413|564594289|FG001|Overall Study|Death due to study disease|0|||
156409782|NCT00452413|564594290|FG002|Overall Study|Death due to study disease|2|||
156409783|NCT00452413|564594288|FG000|Overall Study|Death due to adverse event (AE)|0|||
156409784|NCT00452413|564594289|FG001|Overall Study|Death due to adverse event (AE)|0|||
156409785|NCT00452413|564594290|FG002|Overall Study|Death due to adverse event (AE)|1|||
156409786|NCT00452413|564594288|FG000|Overall Study|On treatment|0|||
156409787|NCT00452413|564594289|FG001|Overall Study|On treatment|0|||
156409788|NCT00452413|564594290|FG002|Overall Study|On treatment|3|||
156409789|NCT03119610|564594292|FG000|Overall Study|Adverse Event|1|||
156409790|NCT03119610|564594293|FG001|Overall Study|Adverse Event|0|||
156409791|NCT03119610|564594292|FG000|Overall Study|Lost to Follow-up|0|||
156409792|NCT03119610|564594293|FG001|Overall Study|Lost to Follow-up|1|||
156409793|NCT00114634|564594318|FG000|Overall Study|failure to return forms|3|||
156409794|NCT03283696|564594319|FG000|Overall Study|Physician Decision|5|||
156409795|NCT03283696|564594320|FG001|Overall Study|Physician Decision|6|||
156409796|NCT03283696|564594319|FG000|Overall Study|Withdrawal by Subject|2|||
156409797|NCT03283696|564594320|FG001|Overall Study|Withdrawal by Subject|0|||
156409798|NCT00684762|564594323|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
156409799|NCT00684762|564594324|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
156409800|NCT01539863|564594338|FG000|Overall Study|Lost to Follow-up|5|||
156409801|NCT01539863|564594339|FG001|Overall Study|Lost to Follow-up|4|||
156409802|NCT02693834|564594340|FG000|Baseline Measurement|Withdrawal by Subject|1|||
156409803|NCT02693834|564594341|FG001|Baseline Measurement|Withdrawal by Subject|0|||
156409804|NCT02693834|564594340|FG000|Baseline Measurement|Adverse Event|1|||
156409805|NCT02693834|564594341|FG001|Baseline Measurement|Adverse Event|0|||
156409806|NCT02693834|564594340|FG000|Week 2 Practice|Adverse Event|0|||
156409807|NCT02693834|564594341|FG001|Week 2 Practice|Adverse Event|1|||
156409808|NCT02111213|564594344|FG000|Overall Study|Withdrawal by Subject|3|||
156409809|NCT02111213|564594345|FG001|Overall Study|Withdrawal by Subject|2|||
156409810|NCT02111213|564594344|FG000|Overall Study|Lost to Follow-up|3|||
156409811|NCT02111213|564594345|FG001|Overall Study|Lost to Follow-up|4|||
156409812|NCT02761629|564594350|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
156409813|NCT02761629|564594351|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
156409814|NCT02761629|564594350|FG000|Overall Study|Insufficient Therapeutic Response|2|||
156409815|NCT02761629|564594351|FG001|Overall Study|Insufficient Therapeutic Response|7|||
156409816|NCT02761629|564594350|FG000|Overall Study|Failure to Return|2|||
156409817|NCT02761629|564594351|FG001|Overall Study|Failure to Return|4|||
156409818|NCT02761629|564594350|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
156409819|NCT02761629|564594351|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
156409820|NCT02761629|564594350|FG000|Overall Study|Protocol Violation|2|||
156409821|NCT02761629|564594351|FG001|Overall Study|Protocol Violation|2|||
156409822|NCT02761629|564594350|FG000|Overall Study|Withdrawal by Subject|0|||
156409823|NCT02761629|564594351|FG001|Overall Study|Withdrawal by Subject|3|||
156409824|NCT02761629|564594350|FG000|Overall Study|Other|0|||
156409825|NCT02761629|564594351|FG001|Overall Study|Other|2|||
156409826|NCT02761629|564594350|FG000|Overall Study|Lost to Follow-up|4|||
156409827|NCT02761629|564594351|FG001|Overall Study|Lost to Follow-up|1|||
156409828|NCT02761629|564594350|FG000|Overall Study|Randomized But Not Treated|8|||
156409829|NCT02761629|564594351|FG001|Overall Study|Randomized But Not Treated|4|||
156409830|NCT01844115|564594352|FG000|Overall Study|Adverse Event|4|||
156409831|NCT01844115|564594353|FG001|Overall Study|Adverse Event|22|||
156409832|NCT01844115|564594352|FG000|Overall Study|Lack of Efficacy|1|||
156409833|NCT01844115|564594353|FG001|Overall Study|Lack of Efficacy|4|||
156409834|NCT01844115|564594352|FG000|Overall Study|Protocol Violation|12|||
156409835|NCT01844115|564594353|FG001|Overall Study|Protocol Violation|10|||
156409836|NCT01844115|564594352|FG000|Overall Study|Withdrawal by Subject|11|||
156409837|NCT01844115|564594353|FG001|Overall Study|Withdrawal by Subject|11|||
156409838|NCT01844115|564594352|FG000|Overall Study|Lost to Follow-up|11|||
156409839|NCT01844115|564594353|FG001|Overall Study|Lost to Follow-up|10|||
156409840|NCT01844115|564594352|FG000|Overall Study|Pregnancy|0|||
156409841|NCT01844115|564594353|FG001|Overall Study|Pregnancy|1|||
156409842|NCT01830881|564594354|FG000|Overall Study|Changed decision to have an abortion|0|||
156409843|NCT01830881|564594355|FG001|Overall Study|Changed decision to have an abortion|1|||
156409844|NCT01425632|564594356|FG000|Overall Study|Adverse Event|0|||
156409845|NCT01425632|564594357|FG001|Overall Study|Adverse Event|1|||
156409846|NCT01425632|564594358|FG002|Overall Study|Adverse Event|1|||
156409847|NCT01425632|564594356|FG000|Overall Study|Physician Decision|1|||
156409848|NCT01425632|564594357|FG001|Overall Study|Physician Decision|0|||
156637055|NCT02780115|565415572|FG000|Overall Study|Withdrawal by Subject|0|||
156637056|NCT02780115|565415573|FG001|Overall Study|Withdrawal by Subject|1|||
156637057|NCT02780115|565415574|FG002|Overall Study|Withdrawal by Subject|1|||
156637058|NCT02780115|565415575|FG003|Overall Study|Withdrawal by Subject|0|||
156409849|NCT01425632|564594358|FG002|Overall Study|Physician Decision|0|||
156409850|NCT01425632|564594356|FG000|Overall Study|Protocol Violation|0|||
156409851|NCT01425632|564594357|FG001|Overall Study|Protocol Violation|0|||
156409852|NCT01425632|564594358|FG002|Overall Study|Protocol Violation|2|||
156409853|NCT01425632|564594356|FG000|Overall Study|Withdrawal by Subject|0|||
156409854|NCT01425632|564594357|FG001|Overall Study|Withdrawal by Subject|0|||
156409855|NCT01425632|564594358|FG002|Overall Study|Withdrawal by Subject|1|||
156637059|NCT02780115|565415576|FG004|Overall Study|Withdrawal by Subject|0|||
156409856|NCT00406419|564594365|FG000|Overall Study|Death|3|||
156409857|NCT00406419|564594366|FG001|Overall Study|Death|1|||
156409858|NCT00406419|564594367|FG002|Overall Study|Death|4|||
156409859|NCT00406419|564594365|FG000|Overall Study|Protocol Violation|6|||
156409860|NCT00406419|564594366|FG001|Overall Study|Protocol Violation|2|||
156409861|NCT00406419|564594367|FG002|Overall Study|Protocol Violation|5|||
156409862|NCT00406419|564594365|FG000|Overall Study|Study Terminated by Sponsor|260|||
156409863|NCT00406419|564594366|FG001|Overall Study|Study Terminated by Sponsor|288|||
156409864|NCT00406419|564594367|FG002|Overall Study|Study Terminated by Sponsor|282|||
156409865|NCT00406419|564594365|FG000|Overall Study|Withdrawal by Subject|17|||
156409866|NCT00406419|564594366|FG001|Overall Study|Withdrawal by Subject|24|||
156409867|NCT00406419|564594367|FG002|Overall Study|Withdrawal by Subject|26|||
156409868|NCT00406419|564594365|FG000|Overall Study|Lack of Efficacy|12|||
156409869|NCT00406419|564594366|FG001|Overall Study|Lack of Efficacy|1|||
156409870|NCT00406419|564594367|FG002|Overall Study|Lack of Efficacy|6|||
156409871|NCT00406419|564594365|FG000|Overall Study|Non-Compliance with Study Drug|5|||
156409872|NCT00406419|564594366|FG001|Overall Study|Non-Compliance with Study Drug|6|||
156409873|NCT00406419|564594367|FG002|Overall Study|Non-Compliance with Study Drug|3|||
156409874|NCT00406419|564594365|FG000|Overall Study|Adverse Event|10|||
156409875|NCT00406419|564594366|FG001|Overall Study|Adverse Event|12|||
156409876|NCT00406419|564594367|FG002|Overall Study|Adverse Event|16|||
156409877|NCT00406419|564594365|FG000|Overall Study|Lost to Follow-up|11|||
156409878|NCT00406419|564594366|FG001|Overall Study|Lost to Follow-up|10|||
156409879|NCT00406419|564594367|FG002|Overall Study|Lost to Follow-up|5|||
156409880|NCT01115491|564594370|FG000|Overall Study|Death|22|||
156409881|NCT01115491|564594370|FG000|Overall Study|Adverse Event|3|||
156409882|NCT01115491|564594370|FG000|Overall Study|Lost to Follow-up|3|||
156409883|NCT01115491|564594370|FG000|Overall Study|Withdrawal by Subject|1|||
156409884|NCT01115491|564594370|FG000|Overall Study|Physician Decision|1|||
156409885|NCT02340520|564594373|FG000|Overall Study|Lost to Follow-up|1|||
156409886|NCT02340520|564594373|FG000|Overall Study|Patient did not take drug as specified|1|||
156409887|NCT02340520|564594373|FG000|Overall Study|Withdrawal by Subject|1|||
156409888|NCT03306043|564594377|FG000|Overall Study|Adverse Event|1|||
156409889|NCT03306043|564594377|FG000|Overall Study|Lost to Follow-up|1|||
156637060|NCT02780115|565415572|FG000|Overall Study|Adverse Event|0|||
156637061|NCT02780115|565415573|FG001|Overall Study|Adverse Event|0|||
156637062|NCT02780115|565415574|FG002|Overall Study|Adverse Event|0|||
156637063|NCT02780115|565415575|FG003|Overall Study|Adverse Event|1|||
156637064|NCT02780115|565415576|FG004|Overall Study|Adverse Event|1|||
156637065|NCT00916617|565415582|FG000|Overall Study|Adverse Event|3|||
156637066|NCT00916617|565415583|FG001|Overall Study|Adverse Event|2|||
156637067|NCT00916617|565415584|FG002|Overall Study|Adverse Event|6|||
156637068|NCT00916617|565415585|FG003|Overall Study|Adverse Event|3|||
156637069|NCT00916617|565415582|FG000|Overall Study|Withdrawal by Subject|3|||
156637070|NCT00916617|565415583|FG001|Overall Study|Withdrawal by Subject|2|||
156637071|NCT00916617|565415584|FG002|Overall Study|Withdrawal by Subject|0|||
156637072|NCT00916617|565415585|FG003|Overall Study|Withdrawal by Subject|1|||
156637073|NCT00916617|565415582|FG000|Overall Study|Caregiver Request|3|||
156637074|NCT00916617|565415583|FG001|Overall Study|Caregiver Request|2|||
156637075|NCT00916617|565415584|FG002|Overall Study|Caregiver Request|1|||
156637076|NCT00916617|565415585|FG003|Overall Study|Caregiver Request|0|||
156637077|NCT00916617|565415582|FG000|Overall Study|Physician Decision|1|||
156637078|NCT00916617|565415583|FG001|Overall Study|Physician Decision|1|||
156637079|NCT00916617|565415584|FG002|Overall Study|Physician Decision|0|||
156637080|NCT00916617|565415585|FG003|Overall Study|Physician Decision|0|||
156637081|NCT00916617|565415582|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
156637082|NCT00916617|565415583|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
156637083|NCT00916617|565415584|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
156637084|NCT00916617|565415585|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
156637085|NCT00916617|565415582|FG000|Overall Study|Lost to Follow-up|2|||
156637086|NCT00916617|565415583|FG001|Overall Study|Lost to Follow-up|1|||
156637087|NCT00916617|565415584|FG002|Overall Study|Lost to Follow-up|0|||
156637088|NCT00916617|565415585|FG003|Overall Study|Lost to Follow-up|0|||
156637089|NCT00916617|565415582|FG000|Overall Study|Lack of Efficacy|1|||
156637090|NCT00916617|565415583|FG001|Overall Study|Lack of Efficacy|0|||
156637091|NCT00916617|565415584|FG002|Overall Study|Lack of Efficacy|0|||
156637092|NCT00916617|565415585|FG003|Overall Study|Lack of Efficacy|0|||
156637093|NCT00916617|565415582|FG000|Overall Study|Other|2|||
156637094|NCT00916617|565415583|FG001|Overall Study|Other|0|||
156637095|NCT00916617|565415584|FG002|Overall Study|Other|0|||
156637096|NCT00916617|565415585|FG003|Overall Study|Other|2|||
156409890|NCT03306043|564594377|FG000|Overall Study|Withdrawal by Subject|2|||
156409891|NCT01544491|564594378|FG000|Overall Study|Withdrawal by Subject|3|||
156409892|NCT01544491|564594379|FG001|Overall Study|Withdrawal by Subject|2|||
156409893|NCT01544491|564594378|FG000|Overall Study|Lost to Follow-up|0|||
156637097|NCT00769132|565415588|FG000|Period 1|Adverse Event|1|||
156637098|NCT00769132|565415589|FG001|Period 1|Adverse Event|0|||
156637099|NCT00769132|565415590|FG002|Period 1|Adverse Event|0|||
156637100|NCT00769132|565415591|FG003|Period 1|Adverse Event|1|||
156637101|NCT00769132|565415588|FG000|Period 2|Withdrawal by Subject|0|||
156637102|NCT00769132|565415589|FG001|Period 2|Withdrawal by Subject|0|||
156637103|NCT00769132|565415590|FG002|Period 2|Withdrawal by Subject|0|||
156637104|NCT00769132|565415591|FG003|Period 2|Withdrawal by Subject|1|||
156637105|NCT00769132|565415588|FG000|Period 3|Withdrawal by Subject|1|||
156637106|NCT00769132|565415589|FG001|Period 3|Withdrawal by Subject|0|||
156637107|NCT00769132|565415590|FG002|Period 3|Withdrawal by Subject|0|||
156409894|NCT01544491|564594379|FG001|Overall Study|Lost to Follow-up|1|||
156409895|NCT01544491|564594378|FG000|Overall Study|administrative problems|2|||
156409896|NCT01544491|564594379|FG001|Overall Study|administrative problems|0|||
156409897|NCT01013792|564594393|FG000|Overall Study|Study suspended|2|||
156409898|NCT01013792|564594394|FG001|Overall Study|Study suspended|1|||
156409899|NCT01013792|564594393|FG000|Overall Study|Adverse Event|0|||
156409900|NCT01013792|564594394|FG001|Overall Study|Adverse Event|3|||
156409901|NCT01013792|564594393|FG000|Overall Study|Lost to Follow-up|0|||
156409902|NCT01013792|564594394|FG001|Overall Study|Lost to Follow-up|1|||
156409903|NCT00896454|564594395|FG000|Overall Study|Death|10|||
156409904|NCT00896454|564594395|FG000|Overall Study|Adverse Event|8|||
156409905|NCT00896454|564594395|FG000|Overall Study|Disease Progression|5|||
156409906|NCT00896454|564594395|FG000|Overall Study|Other|4|||
156409907|NCT00896454|564594395|FG000|Overall Study|Requirement for alternative therapy|3|||
156409908|NCT00896454|564594395|FG000|Overall Study|Ongoing in study|2|||
156409909|NCT00896454|564594395|FG000|Overall Study|Withdrawal by Subject|1|||
156409910|NCT01461993|564594396|FG000|Overall Study|Withdrawal by Subject|60|||
156409911|NCT01461993|564594397|FG001|Overall Study|Withdrawal by Subject|53|||
156409912|NCT01461993|564594398|FG002|Overall Study|Withdrawal by Subject|16|||
156409913|NCT01461993|564594396|FG000|Overall Study|Lost to Follow-up|44|||
156409914|NCT01461993|564594397|FG001|Overall Study|Lost to Follow-up|48|||
156409915|NCT01461993|564594398|FG002|Overall Study|Lost to Follow-up|22|||
156409916|NCT01461993|564594396|FG000|Overall Study|Protocol Violation|10|||
156409917|NCT01461993|564594397|FG001|Overall Study|Protocol Violation|9|||
156409918|NCT01461993|564594398|FG002|Overall Study|Protocol Violation|7|||
156409919|NCT01461993|564594396|FG000|Overall Study|Adverse Event|9|||
156409920|NCT01461993|564594397|FG001|Overall Study|Adverse Event|11|||
156409921|NCT01461993|564594398|FG002|Overall Study|Adverse Event|3|||
156409922|NCT01461993|564594396|FG000|Overall Study|No longer met eligibility criteria|13|||
156409923|NCT01461993|564594397|FG001|Overall Study|No longer met eligibility criteria|18|||
156409924|NCT01461993|564594398|FG002|Overall Study|No longer met eligibility criteria|10|||
156409925|NCT01461993|564594396|FG000|Overall Study|Did not meet entrance criteria|2|||
156409926|NCT01461993|564594397|FG001|Overall Study|Did not meet entrance criteria|3|||
156409927|NCT01461993|564594398|FG002|Overall Study|Did not meet entrance criteria|0|||
156409928|NCT01461993|564594396|FG000|Overall Study|Other|13|||
156409929|NCT01461993|564594397|FG001|Overall Study|Other|15|||
156409930|NCT01461993|564594398|FG002|Overall Study|Other|6|||
156409931|NCT05229653|564594400|FG000|Overall Study|Lost to Follow-up|1|||
156409932|NCT05229653|564594401|FG001|Overall Study|Lost to Follow-up|0|||
156409933|NCT01018563|564594403|FG000|Overall Study|Termination of the study by Sponsor|2|||
156409934|NCT01018563|564594404|FG001|Overall Study|Termination of the study by Sponsor|1|||
156409935|NCT03176238|564594405|FG000|Overall Study|Unacceptable AEs|15|||
156409936|NCT03176238|564594406|FG001|Overall Study|Unacceptable AEs|8|||
156409937|NCT03176238|564594405|FG000|Overall Study|Abnormal lab value(s)|2|||
156409938|NCT03176238|564594406|FG001|Overall Study|Abnormal lab value(s)|0|||
156409939|NCT03176238|564594405|FG000|Overall Study|Inter-current illness|0|||
156409940|NCT03176238|564594406|FG001|Overall Study|Inter-current illness|1|||
156409941|NCT03176238|564594405|FG000|Overall Study|Consent withdrawal|14|||
156409942|NCT03176238|564594406|FG001|Overall Study|Consent withdrawal|2|||
156409943|NCT03176238|564594405|FG000|Overall Study|Lost to Follow-up|3|||
156409944|NCT03176238|564594406|FG001|Overall Study|Lost to Follow-up|0|||
156409945|NCT03176238|564594405|FG000|Overall Study|Administrative problems|1|||
156409946|NCT03176238|564594406|FG001|Overall Study|Administrative problems|0|||
156409947|NCT03176238|564594405|FG000|Overall Study|Death|3|||
156409948|NCT03176238|564594406|FG001|Overall Study|Death|0|||
156409949|NCT03176238|564594405|FG000|Overall Study|Disease Progression|133|||
156409950|NCT03176238|564594406|FG001|Overall Study|Disease Progression|22|||
156409951|NCT03176238|564594405|FG000|Overall Study|Tx duration completed per EAP|0|||
156409952|NCT03176238|564594406|FG001|Overall Study|Tx duration completed per EAP|1|||
156409953|NCT03176238|564594405|FG000|Overall Study|Patient is switched to commercial drug|16|||
156409954|NCT03176238|564594406|FG001|Overall Study|Patient is switched to commercial drug|1|||
156409955|NCT03176238|564594405|FG000|Overall Study|Protocol Violation|1|||
156409956|NCT03176238|564594406|FG001|Overall Study|Protocol Violation|0|||
156409957|NCT03176238|564594405|FG000|Overall Study|Changes in the patient's condition|2|||
156409958|NCT03176238|564594406|FG001|Overall Study|Changes in the patient's condition|1|||
156409959|NCT03176238|564594405|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
156409960|NCT03176238|564594406|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
156409961|NCT02291289|564595803|FG000|Induction Treatment|Withdrawal by Subject|0|||
156637108|NCT00769132|565415591|FG003|Period 3|Withdrawal by Subject|0|||
156409962|NCT02291289|564595804|FG001|Induction Treatment|Withdrawal by Subject|0|||
156409963|NCT02291289|564595805|FG002|Induction Treatment|Withdrawal by Subject|0|||
156409964|NCT02291289|564595806|FG003|Induction Treatment|Withdrawal by Subject|24|||
156409965|NCT02291289|564595807|FG004|Induction Treatment|Withdrawal by Subject|0|||
156409966|NCT02291289|564595808|FG005|Induction Treatment|Withdrawal by Subject|0|||
156409967|NCT02291289|564595809|FG006|Induction Treatment|Withdrawal by Subject|0|||
156409968|NCT02291289|564595810|FG007|Induction Treatment|Withdrawal by Subject|0|||
156409969|NCT02291289|564595811|FG008|Induction Treatment|Withdrawal by Subject|0|||
156409970|NCT02291289|564595812|FG009|Induction Treatment|Withdrawal by Subject|18|||
156409971|NCT02291289|564595813|FG010|Induction Treatment|Withdrawal by Subject|0|||
156409972|NCT02291289|564595814|FG011|Induction Treatment|Withdrawal by Subject|0|||
156409973|NCT02291289|564595815|FG012|Induction Treatment|Withdrawal by Subject|0|||
156409974|NCT02291289|564595803|FG000|Induction Treatment|Adverse Event|0|||
156409975|NCT02291289|564595804|FG001|Induction Treatment|Adverse Event|0|||
156409976|NCT02291289|564595805|FG002|Induction Treatment|Adverse Event|0|||
156409977|NCT02291289|564595806|FG003|Induction Treatment|Adverse Event|3|||
156409978|NCT02291289|564595807|FG004|Induction Treatment|Adverse Event|0|||
156409979|NCT02291289|564595808|FG005|Induction Treatment|Adverse Event|0|||
156409980|NCT02291289|564595809|FG006|Induction Treatment|Adverse Event|0|||
156409981|NCT02291289|564595810|FG007|Induction Treatment|Adverse Event|0|||
156409982|NCT02291289|564595811|FG008|Induction Treatment|Adverse Event|0|||
156409983|NCT02291289|564595812|FG009|Induction Treatment|Adverse Event|1|||
156409984|NCT02291289|564595813|FG010|Induction Treatment|Adverse Event|0|||
156409985|NCT02291289|564595814|FG011|Induction Treatment|Adverse Event|0|||
156409986|NCT02291289|564595815|FG012|Induction Treatment|Adverse Event|0|||
156409987|NCT02291289|564595803|FG000|Induction Treatment|Death|25|||
156409988|NCT02291289|564595804|FG001|Induction Treatment|Death|0|||
156409989|NCT02291289|564595805|FG002|Induction Treatment|Death|0|||
156409990|NCT02291289|564595806|FG003|Induction Treatment|Death|111|||
156409991|NCT02291289|564595807|FG004|Induction Treatment|Death|0|||
156409992|NCT02291289|564595808|FG005|Induction Treatment|Death|0|||
156409993|NCT02291289|564595809|FG006|Induction Treatment|Death|1|||
156409994|NCT02291289|564595810|FG007|Induction Treatment|Death|0|||
156409995|NCT02291289|564595811|FG008|Induction Treatment|Death|0|||
156409996|NCT02291289|564595812|FG009|Induction Treatment|Death|82|||
156409997|NCT02291289|564595813|FG010|Induction Treatment|Death|0|||
156409998|NCT02291289|564595814|FG011|Induction Treatment|Death|0|||
156409999|NCT02291289|564595815|FG012|Induction Treatment|Death|0|||
156410000|NCT02291289|564595803|FG000|Induction Treatment|Lost to Follow-up|1|||
156410001|NCT02291289|564595804|FG001|Induction Treatment|Lost to Follow-up|0|||
156410002|NCT02291289|564595805|FG002|Induction Treatment|Lost to Follow-up|0|||
156410003|NCT02291289|564595806|FG003|Induction Treatment|Lost to Follow-up|12|||
156410004|NCT02291289|564595807|FG004|Induction Treatment|Lost to Follow-up|0|||
156410005|NCT02291289|564595808|FG005|Induction Treatment|Lost to Follow-up|0|||
156410006|NCT02291289|564595809|FG006|Induction Treatment|Lost to Follow-up|0|||
156410007|NCT02291289|564595810|FG007|Induction Treatment|Lost to Follow-up|0|||
156410008|NCT02291289|564595811|FG008|Induction Treatment|Lost to Follow-up|0|||
156410009|NCT02291289|564595812|FG009|Induction Treatment|Lost to Follow-up|9|||
156410010|NCT02291289|564595813|FG010|Induction Treatment|Lost to Follow-up|0|||
156410011|NCT02291289|564595814|FG011|Induction Treatment|Lost to Follow-up|0|||
156410012|NCT02291289|564595815|FG012|Induction Treatment|Lost to Follow-up|0|||
156410013|NCT02291289|564595803|FG000|Induction Treatment|Non-Compliance|0|||
156410014|NCT02291289|564595804|FG001|Induction Treatment|Non-Compliance|0|||
156410015|NCT02291289|564595805|FG002|Induction Treatment|Non-Compliance|0|||
156410016|NCT02291289|564595806|FG003|Induction Treatment|Non-Compliance|1|||
156410017|NCT02291289|564595807|FG004|Induction Treatment|Non-Compliance|0|||
156410018|NCT02291289|564595808|FG005|Induction Treatment|Non-Compliance|0|||
156410019|NCT02291289|564595809|FG006|Induction Treatment|Non-Compliance|0|||
156410020|NCT02291289|564595810|FG007|Induction Treatment|Non-Compliance|0|||
156410021|NCT02291289|564595811|FG008|Induction Treatment|Non-Compliance|0|||
156410022|NCT02291289|564595812|FG009|Induction Treatment|Non-Compliance|1|||
156410023|NCT02291289|564595813|FG010|Induction Treatment|Non-Compliance|0|||
156410024|NCT02291289|564595814|FG011|Induction Treatment|Non-Compliance|0|||
156410025|NCT02291289|564595815|FG012|Induction Treatment|Non-Compliance|0|||
156410026|NCT02291289|564595803|FG000|Induction Treatment|Reason Not Specified|0|||
156410027|NCT02291289|564595804|FG001|Induction Treatment|Reason Not Specified|0|||
156410028|NCT02291289|564595805|FG002|Induction Treatment|Reason Not Specified|0|||
156410029|NCT02291289|564595806|FG003|Induction Treatment|Reason Not Specified|4|||
156410030|NCT02291289|564595807|FG004|Induction Treatment|Reason Not Specified|0|||
156410031|NCT02291289|564595808|FG005|Induction Treatment|Reason Not Specified|0|||
156410032|NCT02291289|564595809|FG006|Induction Treatment|Reason Not Specified|0|||
156410033|NCT02291289|564595810|FG007|Induction Treatment|Reason Not Specified|0|||
156410034|NCT02291289|564595811|FG008|Induction Treatment|Reason Not Specified|0|||
156410035|NCT02291289|564595812|FG009|Induction Treatment|Reason Not Specified|7|||
156410036|NCT02291289|564595813|FG010|Induction Treatment|Reason Not Specified|0|||
156410037|NCT02291289|564595814|FG011|Induction Treatment|Reason Not Specified|0|||
156410038|NCT02291289|564595815|FG012|Induction Treatment|Reason Not Specified|0|||
156410039|NCT02291289|564595803|FG000|Induction Treatment|Physician Decision|0|||
156410040|NCT02291289|564595804|FG001|Induction Treatment|Physician Decision|0|||
156410041|NCT02291289|564595805|FG002|Induction Treatment|Physician Decision|0|||
156410042|NCT02291289|564595806|FG003|Induction Treatment|Physician Decision|3|||
156410043|NCT02291289|564595807|FG004|Induction Treatment|Physician Decision|0|||
156410044|NCT02291289|564595808|FG005|Induction Treatment|Physician Decision|0|||
156410045|NCT02291289|564595809|FG006|Induction Treatment|Physician Decision|0|||
156410046|NCT02291289|564595810|FG007|Induction Treatment|Physician Decision|0|||
156410047|NCT02291289|564595811|FG008|Induction Treatment|Physician Decision|0|||
156410048|NCT02291289|564595812|FG009|Induction Treatment|Physician Decision|1|||
156410049|NCT02291289|564595813|FG010|Induction Treatment|Physician Decision|0|||
156410050|NCT02291289|564595814|FG011|Induction Treatment|Physician Decision|0|||
156410051|NCT02291289|564595815|FG012|Induction Treatment|Physician Decision|0|||
156410052|NCT02291289|564595803|FG000|Induction Treatment|Protocol Violation|0|||
156410053|NCT02291289|564595804|FG001|Induction Treatment|Protocol Violation|0|||
156410054|NCT02291289|564595805|FG002|Induction Treatment|Protocol Violation|0|||
156410055|NCT02291289|564595806|FG003|Induction Treatment|Protocol Violation|3|||
156410056|NCT02291289|564595807|FG004|Induction Treatment|Protocol Violation|0|||
156410057|NCT02291289|564595808|FG005|Induction Treatment|Protocol Violation|0|||
156410058|NCT02291289|564595809|FG006|Induction Treatment|Protocol Violation|0|||
156410059|NCT02291289|564595810|FG007|Induction Treatment|Protocol Violation|0|||
156410060|NCT02291289|564595811|FG008|Induction Treatment|Protocol Violation|0|||
156410061|NCT02291289|564595812|FG009|Induction Treatment|Protocol Violation|2|||
156410062|NCT02291289|564595813|FG010|Induction Treatment|Protocol Violation|0|||
156410063|NCT02291289|564595814|FG011|Induction Treatment|Protocol Violation|0|||
156410064|NCT02291289|564595815|FG012|Induction Treatment|Protocol Violation|0|||
156410065|NCT02291289|564595803|FG000|Induction Treatment|Missing|4|||
156410066|NCT02291289|564595804|FG001|Induction Treatment|Missing|0|||
156410067|NCT02291289|564595805|FG002|Induction Treatment|Missing|0|||
156410068|NCT02291289|564595806|FG003|Induction Treatment|Missing|14|||
156410069|NCT02291289|564595807|FG004|Induction Treatment|Missing|0|||
156410070|NCT02291289|564595808|FG005|Induction Treatment|Missing|0|||
156410071|NCT02291289|564595809|FG006|Induction Treatment|Missing|0|||
156410072|NCT02291289|564595810|FG007|Induction Treatment|Missing|0|||
156410073|NCT02291289|564595811|FG008|Induction Treatment|Missing|0|||
156410074|NCT02291289|564595812|FG009|Induction Treatment|Missing|54|||
156410075|NCT02291289|564595813|FG010|Induction Treatment|Missing|0|||
156410076|NCT02291289|564595814|FG011|Induction Treatment|Missing|0|||
156410077|NCT02291289|564595815|FG012|Induction Treatment|Missing|0|||
156410078|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410079|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410080|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410081|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410082|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
156410083|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
156410084|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410085|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410086|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410087|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410088|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
156410089|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
156410090|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156410091|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Death|0|||
156410092|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Death|29|||
156410093|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Death|16|||
156410094|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Death|0|||
156410095|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Death|188|||
156410096|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Death|107|||
156410097|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Death|0|||
156410098|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Death|1|||
156410099|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Death|1|||
156410100|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Death|0|||
156410101|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Death|46|||
156410102|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Death|19|||
156410103|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Death|0|||
156410104|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Adverse Event|0|||
156410105|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Adverse Event|0|||
156410106|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Adverse Event|0|||
156410107|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Adverse Event|0|||
156410108|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Adverse Event|1|||
156410109|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Adverse Event|1|||
156410110|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Adverse Event|0|||
156410111|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Adverse Event|0|||
156410112|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Adverse Event|0|||
156410113|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Adverse Event|0|||
156410114|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Adverse Event|0|||
156410115|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Adverse Event|0|||
156410116|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Adverse Event|0|||
156410117|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
156410118|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
156410119|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
156410120|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
156410121|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
156410122|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
156410123|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
156410124|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
156410125|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
156410126|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
156410127|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
156410128|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
156410129|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
156410130|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
156410131|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
156410132|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
156410133|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
156410134|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
156410135|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
156410136|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
156410137|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
156410138|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
156410139|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
156410140|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
156410141|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
156410142|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
156410143|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Physician Decision|0|||
156410144|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Physician Decision|2|||
156410145|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Physician Decision|0|||
156410146|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Physician Decision|0|||
156410147|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Physician Decision|3|||
156410148|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Physician Decision|0|||
156410149|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Physician Decision|0|||
156410150|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Physician Decision|0|||
156410151|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Physician Decision|0|||
156410152|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Physician Decision|0|||
156410153|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Physician Decision|1|||
156410154|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Physician Decision|3|||
156410155|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Physician Decision|0|||
156410156|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Not Treated|0|||
156410157|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Not Treated|0|||
156410158|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Not Treated|2|||
156410159|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Not Treated|0|||
156410160|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Not Treated|0|||
156410161|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Not Treated|0|||
156410162|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Not Treated|0|||
156410163|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Not Treated|0|||
156410164|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Not Treated|0|||
156410165|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Not Treated|0|||
156410166|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Not Treated|0|||
156410167|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Not Treated|0|||
156410168|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Not Treated|0|||
156410169|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410170|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
156410171|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410172|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410173|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410174|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410175|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410176|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410177|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410178|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410179|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410180|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410181|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156410182|NCT02291289|564595803|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
156410183|NCT02291289|564595804|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
156410184|NCT02291289|564595805|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
156410185|NCT02291289|564595806|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
156410186|NCT02291289|564595807|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
156410187|NCT02291289|564595808|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
156410188|NCT02291289|564595809|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
156410189|NCT02291289|564595810|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
156410190|NCT02291289|564595811|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
156410191|NCT02291289|564595812|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
156410192|NCT02291289|564595813|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
156410193|NCT02291289|564595814|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
156410194|NCT02291289|564595815|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
156410195|NCT02291289|564595803|FG000|Early Disease Progression|Death|0|||
156410196|NCT02291289|564595804|FG001|Early Disease Progression|Death|0|||
156410197|NCT02291289|564595805|FG002|Early Disease Progression|Death|0|||
156410198|NCT02291289|564595806|FG003|Early Disease Progression|Death|0|||
156410199|NCT02291289|564595807|FG004|Early Disease Progression|Death|0|||
156410200|NCT02291289|564595808|FG005|Early Disease Progression|Death|0|||
156410201|NCT02291289|564595809|FG006|Early Disease Progression|Death|0|||
156410202|NCT02291289|564595810|FG007|Early Disease Progression|Death|0|||
156410203|NCT02291289|564595811|FG008|Early Disease Progression|Death|0|||
156410204|NCT02291289|564595812|FG009|Early Disease Progression|Death|0|||
156410205|NCT02291289|564595813|FG010|Early Disease Progression|Death|0|||
156410206|NCT02291289|564595814|FG011|Early Disease Progression|Death|0|||
156410207|NCT02291289|564595815|FG012|Early Disease Progression|Death|10|||
156410208|NCT02291289|564595803|FG000|Early Disease Progression|Lost to Follow-up|0|||
156410209|NCT02291289|564595804|FG001|Early Disease Progression|Lost to Follow-up|0|||
156410210|NCT02291289|564595805|FG002|Early Disease Progression|Lost to Follow-up|0|||
156410211|NCT02291289|564595806|FG003|Early Disease Progression|Lost to Follow-up|0|||
156410212|NCT02291289|564595807|FG004|Early Disease Progression|Lost to Follow-up|0|||
156410213|NCT02291289|564595808|FG005|Early Disease Progression|Lost to Follow-up|0|||
156410214|NCT02291289|564595809|FG006|Early Disease Progression|Lost to Follow-up|0|||
156410215|NCT02291289|564595810|FG007|Early Disease Progression|Lost to Follow-up|0|||
156410216|NCT02291289|564595811|FG008|Early Disease Progression|Lost to Follow-up|0|||
156410217|NCT02291289|564595812|FG009|Early Disease Progression|Lost to Follow-up|0|||
156410218|NCT02291289|564595813|FG010|Early Disease Progression|Lost to Follow-up|0|||
156410219|NCT02291289|564595814|FG011|Early Disease Progression|Lost to Follow-up|0|||
156410220|NCT02291289|564595815|FG012|Early Disease Progression|Lost to Follow-up|1|||
156410221|NCT01868035|564595820|FG000|Overall Study|Lost to Follow-up|3|||
156410222|NCT01868035|564595820|FG000|Overall Study|Withdrawal by Subject|1|||
156410223|NCT01868035|564595820|FG000|Overall Study|Progressive Disease|2|||
156410224|NCT01868035|564595820|FG000|Overall Study|Non-compliance|1|||
156410225|NCT00154063|564595827|FG000|Overall Study|Adverse Event|4|||
156410226|NCT00154063|564595828|FG001|Overall Study|Adverse Event|8|||
156410227|NCT00154063|564595827|FG000|Overall Study|Protocol Violation|1|||
156410228|NCT00154063|564595828|FG001|Overall Study|Protocol Violation|1|||
156410229|NCT00154063|564595827|FG000|Overall Study|Investigator or Sponsor Request|0|||
156410230|NCT00154063|564595828|FG001|Overall Study|Investigator or Sponsor Request|1|||
156410231|NCT00154063|564595827|FG000|Overall Study|Withdrawal by Subject|4|||
156410232|NCT00154063|564595828|FG001|Overall Study|Withdrawal by Subject|9|||
156410233|NCT00154063|564595827|FG000|Overall Study|Other|3|||
156410234|NCT00154063|564595828|FG001|Overall Study|Other|3|||
156410235|NCT01804673|564595829|FG000|Overall Study|Adverse Event|4|||
156410236|NCT01804673|564595829|FG000|Overall Study|Withdrawal by Subject|1|||
156410237|NCT01804673|564595829|FG000|Overall Study|Lack of Efficacy|9|||
156410238|NCT01804673|564595829|FG000|Overall Study|Change to Oral Therapy|37|||
156410239|NCT01804673|564595829|FG000|Overall Study|No Further Therapy Required|84|||
156410240|NCT01804673|564595829|FG000|Overall Study|Use of Prohibited Medication|1|||
156410241|NCT01804673|564595829|FG000|Overall Study|Other|4|||
156410242|NCT01857934|564595837|FG000|Overall Study|Relapse or progression|2|||
156410243|NCT01857934|564595837|FG000|Overall Study|Unacceptable toxicity|3|||
156410244|NCT01857934|564595837|FG000|Overall Study|Unwillingness or inability to comply|2|||
156410245|NCT01857934|564595837|FG000|Overall Study|Physician Decision|3|||
156410246|NCT01024959|564595838|FG000|Overall Study|ineligible|12|||
156637109|NCT00769132|565415588|FG000|Period 4|Withdrawal by Subject|0|||
156410247|NCT01024959|564595838|FG000|Overall Study|results not evaluable|12|||
156410248|NCT01024959|564595838|FG000|Overall Study|missing results required for analysis|17|||
156410249|NCT00313911|564595842|FG000|Overall Study|Serious adverse event|6|||
156410250|NCT00313911|564595843|FG001|Overall Study|Serious adverse event|1|||
156410251|NCT00313911|564595842|FG000|Overall Study|Adverse Event|2|||
156410252|NCT00313911|564595843|FG001|Overall Study|Adverse Event|3|||
156410253|NCT00313911|564595842|FG000|Overall Study|Protocol Violation|19|||
156410254|NCT00313911|564595843|FG001|Overall Study|Protocol Violation|10|||
156637110|NCT00769132|565415589|FG001|Period 4|Withdrawal by Subject|1|||
156637111|NCT00769132|565415590|FG002|Period 4|Withdrawal by Subject|0|||
156410255|NCT00313911|564595842|FG000|Overall Study|Lost to Follow-up|27|||
156410256|NCT00313911|564595843|FG001|Overall Study|Lost to Follow-up|14|||
156410257|NCT00313911|564595842|FG000|Overall Study|Withdrawal by Subject|39|||
156410258|NCT00313911|564595843|FG001|Overall Study|Withdrawal by Subject|12|||
156410259|NCT00313911|564595842|FG000|Overall Study|Did not meet age criteria|1|||
156410260|NCT00313911|564595843|FG001|Overall Study|Did not meet age criteria|1|||
156410261|NCT01912781|564595846|FG000|Overall Study|Withdrawal by Subject|2|||
156410262|NCT01912781|564595847|FG001|Overall Study|Withdrawal by Subject|0|||
156410263|NCT04161807|564595848|FG000|Overall Study|Withdrawal by Subject|2|||
156410264|NCT04161807|564595848|FG000|Overall Study|Performed only 1 treatment|2|||
156410265|NCT00708305|564595853|FG000|Period 1|Protocol Violation|1|||
156410266|NCT00708305|564595854|FG001|Period 1|Protocol Violation|0|||
156410267|NCT00708305|564595855|FG002|Period 1|Protocol Violation|1|||
156410268|NCT00708305|564595856|FG003|Period 1|Protocol Violation|0|||
156410269|NCT00708305|564595853|FG000|Period 1|Other Reason|0|||
156410270|NCT00708305|564595854|FG001|Period 1|Other Reason|0|||
156410271|NCT00708305|564595855|FG002|Period 1|Other Reason|0|||
156410272|NCT00708305|564595856|FG003|Period 1|Other Reason|2|||
156410273|NCT00708305|564595853|FG000|Period 2|Lost to Follow-up|0|||
156410274|NCT00708305|564595854|FG001|Period 2|Lost to Follow-up|1|||
156410275|NCT00708305|564595855|FG002|Period 2|Lost to Follow-up|0|||
156410276|NCT00708305|564595856|FG003|Period 2|Lost to Follow-up|0|||
156410277|NCT00708305|564595853|FG000|Period 2|Protocol Violation|0|||
156410278|NCT00708305|564595854|FG001|Period 2|Protocol Violation|1|||
156410279|NCT00708305|564595855|FG002|Period 2|Protocol Violation|0|||
156410280|NCT00708305|564595856|FG003|Period 2|Protocol Violation|0|||
156410281|NCT00708305|564595853|FG000|Period 2|Other Reason|1|||
156410282|NCT00708305|564595854|FG001|Period 2|Other Reason|0|||
156410283|NCT00708305|564595855|FG002|Period 2|Other Reason|0|||
156410284|NCT00708305|564595856|FG003|Period 2|Other Reason|1|||
156410285|NCT00708305|564595853|FG000|Period 3|Protocol Violation|0|||
156410286|NCT00708305|564595854|FG001|Period 3|Protocol Violation|2|||
156410287|NCT00708305|564595855|FG002|Period 3|Protocol Violation|0|||
156410288|NCT00708305|564595856|FG003|Period 3|Protocol Violation|0|||
156410289|NCT00708305|564595853|FG000|Period 3|Other Reason|1|||
156410290|NCT00708305|564595854|FG001|Period 3|Other Reason|0|||
156410291|NCT00708305|564595855|FG002|Period 3|Other Reason|0|||
156410292|NCT00708305|564595856|FG003|Period 3|Other Reason|0|||
156410293|NCT00192023|564595859|FG000|Period III - Double-Blind|Adverse Event|3|||
156410294|NCT00192023|564595860|FG001|Period III - Double-Blind|Adverse Event|0|||
156410295|NCT00192023|564595859|FG000|Period III - Double-Blind|Physician Decision|2|||
156410296|NCT00192023|564595860|FG001|Period III - Double-Blind|Physician Decision|0|||
156410297|NCT00192023|564595859|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
156410298|NCT00192023|564595860|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
156410299|NCT00192023|564595859|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
156410300|NCT00192023|564595860|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
156410301|NCT00192023|564595859|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
156410302|NCT00192023|564595860|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
156410303|NCT00192023|564595859|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
156410304|NCT00192023|564595860|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
156410305|NCT00192023|564595859|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
156410306|NCT00192023|564595860|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
156410307|NCT00192023|564595859|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
156410308|NCT00192023|564595860|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
156410309|NCT00192023|564595859|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
156410310|NCT00192023|564595860|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
156410311|NCT00192023|564595859|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
156410312|NCT00192023|564595860|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
156410313|NCT02572817|564595861|FG000|Overall Study|Death|6|||
156410314|NCT02572817|564595862|FG001|Overall Study|Death|3|||
156410315|NCT02572817|564595861|FG000|Overall Study|Lost to Follow-up|3|||
156410316|NCT02572817|564595862|FG001|Overall Study|Lost to Follow-up|3|||
156410317|NCT02153359|564595876|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
156410318|NCT02153359|564595877|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
156410319|NCT01258660|564595878|FG000|Overall Study|Adverse Event|2|||
156410320|NCT01258660|564595879|FG001|Overall Study|Adverse Event|4|||
156410321|NCT01258660|564595878|FG000|Overall Study|Withdrawal by Subject|3|||
156410322|NCT01258660|564595879|FG001|Overall Study|Withdrawal by Subject|0|||
156410323|NCT01258660|564595878|FG000|Overall Study|due to relocation|2|||
156410324|NCT01258660|564595879|FG001|Overall Study|due to relocation|0|||
156410325|NCT01258660|564595878|FG000|Overall Study|Protocol Violation|0|||
156410326|NCT01258660|564595879|FG001|Overall Study|Protocol Violation|1|||
156410327|NCT01258660|564595878|FG000|Overall Study|Invalid for primary analysis data set|4|||
156410328|NCT01258660|564595879|FG001|Overall Study|Invalid for primary analysis data set|6|||
156410329|NCT01775930|564595884|FG000|Overall Study|Futility stopping boundary met|1|||
156410330|NCT01208415|564595885|FG000|Overall Study|Death|1|||
156410331|NCT01208415|564595885|FG000|Overall Study|Lost to Follow-up|2|||
156410332|NCT01208415|564595885|FG000|Overall Study|Withdrawal by Subject|3|||
156410333|NCT01208415|564595885|FG000|Overall Study|Device not placed|1|||
156410334|NCT01208415|564595885|FG000|Overall Study|Still be eligible for follow-up|33|||
156410335|NCT03856996|564595886|FG000|Overall Study|Withdrawal by Subject|1|||
156410336|NCT03856996|564595887|FG001|Overall Study|Withdrawal by Subject|0|||
156410337|NCT03856996|564595886|FG000|Overall Study|Lost to Follow-up|0|||
156410338|NCT03856996|564595887|FG001|Overall Study|Lost to Follow-up|1|||
156410339|NCT03856996|564595886|FG000|Overall Study|Adverse Event|1|||
156410340|NCT03856996|564595887|FG001|Overall Study|Adverse Event|1|||
156410341|NCT03856996|564595886|FG000|Overall Study|Other|1|||
156410342|NCT03856996|564595887|FG001|Overall Study|Other|0|||
156410343|NCT01586338|564595888|FG000|Overall Study|Adverse Event|3|||
156410344|NCT01586338|564595888|FG000|Overall Study|Lost to Follow-up|1|||
156410345|NCT01586338|564595888|FG000|Overall Study|Withdrawal by participant|3|||
156410346|NCT01586338|564595888|FG000|Overall Study|Other|1|||
156410347|NCT01868074|564595891|FG000|Overall Study|Lost to Follow-up|3|||
156410348|NCT01868074|564595892|FG001|Overall Study|Lost to Follow-up|2|||
156410349|NCT01868074|564595891|FG000|Overall Study|Withdrawal by Subject|4|||
156410350|NCT01868074|564595892|FG001|Overall Study|Withdrawal by Subject|2|||
156410351|NCT01234649|564595893|FG000|Overall Study|Withdrawal by Subject|32|||
156410352|NCT01234649|564595894|FG001|Overall Study|Withdrawal by Subject|26|||
156410353|NCT01234649|564595893|FG000|Overall Study|Pregnancy|6|||
156410354|NCT01234649|564595894|FG001|Overall Study|Pregnancy|6|||
156410355|NCT01234649|564595893|FG000|Overall Study|intolerant to side effects|4|||
156410356|NCT01234649|564595894|FG001|Overall Study|intolerant to side effects|3|||
156410357|NCT01234649|564595893|FG000|Overall Study|Allergic reaction|1|||
156410358|NCT01234649|564595894|FG001|Overall Study|Allergic reaction|0|||
156410359|NCT01234649|564595893|FG000|Overall Study|Lack of Efficacy|0|||
156410360|NCT01234649|564595894|FG001|Overall Study|Lack of Efficacy|3|||
156410361|NCT00680056|564595897|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
156410362|NCT00680056|564595898|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
156410363|NCT00680056|564595897|FG000|Second Intervention|Protocol Violation|3|||
156410364|NCT00680056|564595898|FG001|Second Intervention|Protocol Violation|1|||
156410365|NCT01821898|564595904|FG000|Overall Study|Withdrawal by Subject|2|||
156410366|NCT01821898|564595905|FG001|Overall Study|Withdrawal by Subject|1|||
156410367|NCT04175912|564595908|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
156410368|NCT04175912|564595909|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
156410369|NCT04175912|564595908|FG000|Overall Study|Adverse Event|0|||
156410370|NCT04175912|564595909|FG001|Overall Study|Adverse Event|3|||
156410371|NCT04175912|564595908|FG000|Overall Study|Never started treatment|3|||
156410372|NCT04175912|564595909|FG001|Overall Study|Never started treatment|3|||
156410373|NCT04175912|564595908|FG000|Overall Study|Death|0|||
156410374|NCT04175912|564595909|FG001|Overall Study|Death|1|||
156410375|NCT04654468|564595910|FG000|Overall Study|Death|1|||
156410376|NCT04654468|564595910|FG000|Overall Study|Ongoing in the Study|50|||
156410377|NCT06390826|564595911|FG000|Overall Study|Never Start Protocol Therapy|1|||
156410378|NCT06390826|564595911|FG000|Overall Study|Adverse Event|1|||
156410379|NCT06390826|564595911|FG000|Overall Study|Disease Progression|8|||
156410380|NCT05064735|564595912|FG000|Overall Study|Withdrawal by Subject|7|||
156410381|NCT05064735|564595913|FG001|Overall Study|Withdrawal by Subject|8|||
156410382|NCT05064735|564595912|FG000|Overall Study|Lost to Follow-up|7|||
156410383|NCT05064735|564595913|FG001|Overall Study|Lost to Follow-up|2|||
156410384|NCT05064735|564595912|FG000|Overall Study|Physician Decision|2|||
156410385|NCT05064735|564595913|FG001|Overall Study|Physician Decision|1|||
156410386|NCT05064735|564595912|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
156410387|NCT05064735|564595913|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
156410388|NCT05064735|564595912|FG000|Overall Study|Site Closure|7|||
156410389|NCT05064735|564595913|FG001|Overall Study|Site Closure|2|||
156410390|NCT02009696|564595914|FG000|Overall Study|Withdrawal by Subject|2|||
156410391|NCT02344537|564595915|FG000|Overall Study|Protocol Violation|1|||
156410392|NCT02344537|564595916|FG001|Overall Study|Protocol Violation|1|||
156410393|NCT02344537|564595915|FG000|Overall Study|Subject started another treatment after wk 6|1|||
156410394|NCT02344537|564595916|FG001|Overall Study|Subject started another treatment after wk 6|0|||
156410395|NCT02344537|564595915|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
156410396|NCT02344537|564595916|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
156410397|NCT04844970|564595919|FG000|Overall Study|Adverse Event|0|||
156410398|NCT04844970|564595920|FG001|Overall Study|Adverse Event|1|||
156410399|NCT04844970|564595919|FG000|Overall Study|Withdrawal by Subject|2|||
156410400|NCT04844970|564595920|FG001|Overall Study|Withdrawal by Subject|0|||
156410401|NCT05490329|564595921|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
156410402|NCT05490329|564595922|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
156410403|NCT05490329|564595921|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
156410404|NCT05490329|564595922|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
156410405|NCT05490329|564595921|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
156410406|NCT05490329|564595922|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
156410407|NCT00447954|564595923|FG000|Overall Study|Adverse Event|0|||
156410408|NCT00447954|564595924|FG001|Overall Study|Adverse Event|2|||
156410409|NCT00447954|564595925|FG002|Overall Study|Adverse Event|0|||
156410410|NCT00447954|564595923|FG000|Overall Study|Withdrawal by Subject|0|||
156410411|NCT00447954|564595924|FG001|Overall Study|Withdrawal by Subject|1|||
156410412|NCT00447954|564595925|FG002|Overall Study|Withdrawal by Subject|1|||
156410413|NCT00447954|564595923|FG000|Overall Study|Lost to Follow-up|0|||
156410414|NCT00447954|564595924|FG001|Overall Study|Lost to Follow-up|1|||
156410415|NCT00447954|564595925|FG002|Overall Study|Lost to Follow-up|0|||
156410416|NCT00447954|564595923|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
156410417|NCT00447954|564595924|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
156410418|NCT00447954|564595925|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
156410419|NCT00856661|564595926|FG000|Overall Study|Death|15|||
156410420|NCT00856661|564595927|FG001|Overall Study|Death|18|||
156410421|NCT00856661|564595926|FG000|Overall Study|Protocol Violation|2|||
156410422|NCT00856661|564595927|FG001|Overall Study|Protocol Violation|1|||
156410423|NCT00856661|564595926|FG000|Overall Study|Withdrawal by Subject|1|||
156410424|NCT00856661|564595927|FG001|Overall Study|Withdrawal by Subject|2|||
156410425|NCT00856661|564595926|FG000|Overall Study|Lost to Follow-up|1|||
156410426|NCT00856661|564595927|FG001|Overall Study|Lost to Follow-up|3|||
156410427|NCT00856661|564595926|FG000|Overall Study|Physician Judgement|8|||
156410428|NCT00856661|564595927|FG001|Overall Study|Physician Judgement|5|||
156410429|NCT02120664|564595928|FG000|Overall Study|Withdrawal by Subject|0|||
156410430|NCT02120664|564595929|FG001|Overall Study|Withdrawal by Subject|0|||
156410431|NCT02120664|564595930|FG002|Overall Study|Withdrawal by Subject|0|||
156410432|NCT02120664|564595931|FG003|Overall Study|Withdrawal by Subject|1|||
156410433|NCT02120664|564595932|FG004|Overall Study|Withdrawal by Subject|0|||
156410434|NCT02460263|564595933|FG000|Transition Period|Withdrawal by Subject|1|||
156410435|NCT02460263|564595933|FG000|Transition Period|Death|1|||
156410436|NCT04524598|564595934|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
156410437|NCT04524598|564595935|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
156410438|NCT04524598|564595936|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
156410439|NCT04524598|564595937|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
156410440|NCT04524598|564595938|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
156410441|NCT04524598|564595934|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
156410442|NCT04524598|564595935|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
156410443|NCT04524598|564595936|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
156637112|NCT00769132|565415591|FG003|Period 4|Withdrawal by Subject|0|||
156410444|NCT04524598|564595937|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410445|NCT04524598|564595938|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410446|NCT04524598|564595934|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
156410447|NCT04524598|564595935|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
156410448|NCT04524598|564595936|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
156410449|NCT04524598|564595937|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
156410450|NCT04524598|564595938|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
156410451|NCT04524598|564595934|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
156410452|NCT04524598|564595935|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
156410453|NCT04524598|564595936|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
156410454|NCT04524598|564595937|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
156410455|NCT04524598|564595938|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
156410456|NCT04524598|564595934|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410457|NCT04524598|564595935|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410458|NCT04524598|564595936|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
156410459|NCT04524598|564595937|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
156410460|NCT04524598|564595938|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410461|NCT04524598|564595934|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
156410462|NCT04524598|564595935|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
156410463|NCT04524598|564595936|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
156410464|NCT04524598|564595937|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
156410465|NCT04524598|564595938|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
156410466|NCT04524598|564595934|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410467|NCT04524598|564595935|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410468|NCT04524598|564595936|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410469|NCT04524598|564595937|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
156410470|NCT04524598|564595938|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
156410471|NCT02306122|564595939|FG000|Initial Physician Randomization|Physician Decision|0|||
156410472|NCT02306122|564595940|FG001|Initial Physician Randomization|Physician Decision|0|||
156410473|NCT02306122|564595941|FG002|Initial Physician Randomization|Physician Decision|0|||
156410474|NCT02306122|564595942|FG003|Initial Physician Randomization|Physician Decision|0|||
156410475|NCT02306122|564595943|FG004|Initial Physician Randomization|Physician Decision|0|||
156410476|NCT02306122|564595944|FG005|Initial Physician Randomization|Physician Decision|0|||
156410477|NCT02306122|564595945|FG006|Initial Physician Randomization|Physician Decision|0|||
156410478|NCT02306122|564595946|FG007|Initial Physician Randomization|Physician Decision|0|||
156410479|NCT02306122|564595947|FG008|Initial Physician Randomization|Physician Decision|1|||
156410480|NCT02306122|564595948|FG009|Initial Physician Randomization|Physician Decision|0|||
156410481|NCT02306122|564595949|FG010|Initial Physician Randomization|Physician Decision|0|||
156410482|NCT01351025|564595951|FG000|Week 0 - 20|Lost to Follow-up|2|||
156410483|NCT01351025|564595952|FG001|Week 0 - 20|Lost to Follow-up|1|||
156410484|NCT01351025|564595951|FG000|Week 0 - 20|Withdrawal by Subject|1|||
156410485|NCT01351025|564595952|FG001|Week 0 - 20|Withdrawal by Subject|0|||
156410486|NCT01351025|564595951|FG000|Week 24 - 44|Lost to Follow-up|0|||
156410487|NCT01351025|564595952|FG001|Week 24 - 44|Lost to Follow-up|2|||
156410488|NCT01351025|564595951|FG000|Week 24 - 44|Site closed|0|||
156410489|NCT01351025|564595952|FG001|Week 24 - 44|Site closed|1|||
156410490|NCT01351025|564595951|FG000|Week 24 - 44|unable to get to clinic|1|||
156410491|NCT01351025|564595952|FG001|Week 24 - 44|unable to get to clinic|1|||
156410492|NCT02736968|564595955|FG000|Overall Study|Lost to Follow-up|0|||
156410493|NCT02736968|564595956|FG001|Overall Study|Lost to Follow-up|0|||
156410494|NCT02736968|564595957|FG002|Overall Study|Lost to Follow-up|0|||
156410495|NCT02736968|564595958|FG003|Overall Study|Lost to Follow-up|0|||
156410496|NCT02736968|564595959|FG004|Overall Study|Lost to Follow-up|0|||
156410497|NCT02736968|564595960|FG005|Overall Study|Lost to Follow-up|0|||
156410498|NCT02736968|564595961|FG006|Overall Study|Lost to Follow-up|5|||
156410499|NCT02736968|564595962|FG007|Overall Study|Lost to Follow-up|2|||
156410500|NCT02736968|564595955|FG000|Overall Study|COVID-19 Pandemic|0|||
156410501|NCT02736968|564595956|FG001|Overall Study|COVID-19 Pandemic|0|||
156410502|NCT02736968|564595957|FG002|Overall Study|COVID-19 Pandemic|0|||
156410503|NCT02736968|564595958|FG003|Overall Study|COVID-19 Pandemic|0|||
156410504|NCT02736968|564595959|FG004|Overall Study|COVID-19 Pandemic|0|||
156410505|NCT02736968|564595960|FG005|Overall Study|COVID-19 Pandemic|0|||
156410506|NCT02736968|564595961|FG006|Overall Study|COVID-19 Pandemic|2|||
156410507|NCT02736968|564595962|FG007|Overall Study|COVID-19 Pandemic|0|||
156410508|NCT02736968|564595955|FG000|Overall Study|Withdrawal by Subject|0|||
156410509|NCT02736968|564595956|FG001|Overall Study|Withdrawal by Subject|0|||
156410510|NCT02736968|564595957|FG002|Overall Study|Withdrawal by Subject|0|||
156410511|NCT02736968|564595958|FG003|Overall Study|Withdrawal by Subject|0|||
156410512|NCT02736968|564595959|FG004|Overall Study|Withdrawal by Subject|0|||
156410513|NCT02736968|564595960|FG005|Overall Study|Withdrawal by Subject|0|||
156410514|NCT02736968|564595961|FG006|Overall Study|Withdrawal by Subject|1|||
156410515|NCT02736968|564595962|FG007|Overall Study|Withdrawal by Subject|0|||
156410516|NCT03864926|564598144|FG000|Overall Study|Death|0|||
156410517|NCT03864926|564598145|FG001|Overall Study|Death|2|||
156410518|NCT01091428|564598146|FG000|Phase 1|Progressive Disease|24|||
156410519|NCT01091428|564598147|FG001|Phase 1|Progressive Disease|8|||
156410520|NCT01091428|564598148|FG002|Phase 1|Progressive Disease|0|||
156410521|NCT01091428|564598149|FG003|Phase 1|Progressive Disease|0|||
156410522|NCT01091428|564598146|FG000|Phase 1|Symptomatic Deterioration|3|||
156410523|NCT01091428|564598147|FG001|Phase 1|Symptomatic Deterioration|2|||
156410524|NCT01091428|564598148|FG002|Phase 1|Symptomatic Deterioration|0|||
156637113|NCT00499252|565415592|FG000|Overall Study|Adverse Event|3|||
156637114|NCT00499252|565415592|FG000|Overall Study|Refused further treatment|2|||
156637115|NCT00499252|565415592|FG000|Overall Study|Ineligible|4|||
156637116|NCT00499252|565415592|FG000|Overall Study|<no further label>|3|||
156637117|NCT02230332|565415593|FG000|Overall Study|Adverse Event|2|||
156637118|NCT02230332|565415594|FG001|Overall Study|Adverse Event|1|||
156637119|NCT02230332|565415593|FG000|Overall Study|Lost to Follow-up|1|||
156637120|NCT02230332|565415594|FG001|Overall Study|Lost to Follow-up|0|||
156637121|NCT02230332|565415593|FG000|Overall Study|Protocol Violation|1|||
156637122|NCT02230332|565415594|FG001|Overall Study|Protocol Violation|0|||
156637123|NCT01260194|565415596|FG000|Overall Study|Withdrawal of Consent|1|||
156637124|NCT01785472|565415598|FG000|Overall Study|Adverse Event|5|||
156637125|NCT01785472|565415599|FG001|Overall Study|Adverse Event|4|||
156637126|NCT01785472|565415600|FG002|Overall Study|Adverse Event|6|||
156410525|NCT01091428|564598149|FG003|Phase 1|Symptomatic Deterioration|0|||
156410526|NCT01091428|564598146|FG000|Phase 1|Adverse Event|2|||
156410527|NCT01091428|564598147|FG001|Phase 1|Adverse Event|0|||
156410528|NCT01091428|564598148|FG002|Phase 1|Adverse Event|0|||
156410529|NCT01091428|564598149|FG003|Phase 1|Adverse Event|0|||
156410530|NCT01091428|564598146|FG000|Phase 1|Withdrawal by Subject|7|||
156637127|NCT01785472|565415598|FG000|Overall Study|Lack of Efficacy|2|||
156637128|NCT01785472|565415599|FG001|Overall Study|Lack of Efficacy|0|||
156637129|NCT01785472|565415600|FG002|Overall Study|Lack of Efficacy|1|||
156410531|NCT01091428|564598147|FG001|Phase 1|Withdrawal by Subject|0|||
156410532|NCT01091428|564598148|FG002|Phase 1|Withdrawal by Subject|0|||
156410533|NCT01091428|564598149|FG003|Phase 1|Withdrawal by Subject|0|||
156410534|NCT01091428|564598146|FG000|Phase 1|Reason not specified|0|||
156410535|NCT01091428|564598147|FG001|Phase 1|Reason not specified|1|||
156410536|NCT01091428|564598148|FG002|Phase 1|Reason not specified|0|||
156410537|NCT01091428|564598149|FG003|Phase 1|Reason not specified|0|||
156410538|NCT01091428|564598146|FG000|Phase 1|Single-Patient IND|2|||
156410539|NCT01091428|564598147|FG001|Phase 1|Single-Patient IND|0|||
156410540|NCT01091428|564598148|FG002|Phase 1|Single-Patient IND|0|||
156410541|NCT01091428|564598149|FG003|Phase 1|Single-Patient IND|0|||
156410542|NCT01091428|564598146|FG000|Phase 2|Progressive Disease|0|||
156410543|NCT01091428|564598147|FG001|Phase 2|Progressive Disease|0|||
156410544|NCT01091428|564598148|FG002|Phase 2|Progressive Disease|44|||
156410545|NCT01091428|564598149|FG003|Phase 2|Progressive Disease|46|||
156410546|NCT01091428|564598146|FG000|Phase 2|Symptomatic Deterioration|0|||
156410547|NCT01091428|564598147|FG001|Phase 2|Symptomatic Deterioration|0|||
156410548|NCT01091428|564598148|FG002|Phase 2|Symptomatic Deterioration|1|||
156410549|NCT01091428|564598149|FG003|Phase 2|Symptomatic Deterioration|6|||
156410550|NCT01091428|564598146|FG000|Phase 2|Adverse Event|0|||
156410551|NCT01091428|564598147|FG001|Phase 2|Adverse Event|0|||
156410552|NCT01091428|564598148|FG002|Phase 2|Adverse Event|12|||
156410553|NCT01091428|564598149|FG003|Phase 2|Adverse Event|5|||
156410554|NCT01091428|564598146|FG000|Phase 2|Withdrawal by Subject|0|||
156410555|NCT01091428|564598147|FG001|Phase 2|Withdrawal by Subject|0|||
156410556|NCT01091428|564598148|FG002|Phase 2|Withdrawal by Subject|9|||
156410557|NCT01091428|564598149|FG003|Phase 2|Withdrawal by Subject|8|||
156410558|NCT01091428|564598146|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
156410559|NCT01091428|564598147|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
156410560|NCT01091428|564598148|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
156410561|NCT01091428|564598149|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
156410562|NCT01091428|564598146|FG000|Phase 2|Reason not specified|0|||
156410563|NCT01091428|564598147|FG001|Phase 2|Reason not specified|0|||
156410564|NCT01091428|564598148|FG002|Phase 2|Reason not specified|4|||
156410565|NCT01091428|564598149|FG003|Phase 2|Reason not specified|3|||
156410566|NCT01091428|564598146|FG000|Phase 2|Physician Decision|0|||
156410567|NCT01091428|564598147|FG001|Phase 2|Physician Decision|0|||
156410568|NCT01091428|564598148|FG002|Phase 2|Physician Decision|2|||
156410569|NCT01091428|564598149|FG003|Phase 2|Physician Decision|0|||
156410570|NCT00358215|564598156|FG000|Overall Study|Ineligibility determined|4|||
156410571|NCT00358215|564598157|FG001|Overall Study|Ineligibility determined|3|||
156410572|NCT00358215|564598156|FG000|Overall Study|Adverse Event|83|||
156410573|NCT00358215|564598157|FG001|Overall Study|Adverse Event|65|||
156410574|NCT00358215|564598156|FG000|Overall Study|Withdrawal by Subject|111|||
156410575|NCT00358215|564598157|FG001|Overall Study|Withdrawal by Subject|102|||
156410576|NCT00358215|564598156|FG000|Overall Study|Participant request|65|||
156410577|NCT00358215|564598157|FG001|Overall Study|Participant request|64|||
156410578|NCT00358215|564598156|FG000|Overall Study|Physician Decision|47|||
156410579|NCT00358215|564598157|FG001|Overall Study|Physician Decision|39|||
156410580|NCT00358215|564598156|FG000|Overall Study|Lost to Follow-up|16|||
156410581|NCT00358215|564598157|FG001|Overall Study|Lost to Follow-up|22|||
156410582|NCT00358215|564598156|FG000|Overall Study|Death|265|||
156410583|NCT00358215|564598157|FG001|Overall Study|Death|281|||
156410584|NCT00358215|564598156|FG000|Overall Study|Protocol Violation|64|||
156410585|NCT00358215|564598157|FG001|Overall Study|Protocol Violation|59|||
156410586|NCT00358215|564598156|FG000|Overall Study|Pregnancy|1|||
156410587|NCT00358215|564598157|FG001|Overall Study|Pregnancy|0|||
156410588|NCT00358215|564598156|FG000|Overall Study|Other|21|||
156410589|NCT00358215|564598157|FG001|Overall Study|Other|14|||
156410590|NCT00358215|564598156|FG000|Overall Study|Did not receive investigational product|2|||
156410591|NCT00358215|564598157|FG001|Overall Study|Did not receive investigational product|3|||
156410592|NCT00744237|564598158|FG000|Overall Study|Lack of Efficacy|1|||
156410593|NCT00744237|564598159|FG001|Overall Study|Lack of Efficacy|1|||
156410594|NCT00744237|564598160|FG002|Overall Study|Lack of Efficacy|0|||
156410595|NCT00744237|564598158|FG000|Overall Study|Withdrawal by Subject|9|||
156410596|NCT00744237|564598159|FG001|Overall Study|Withdrawal by Subject|5|||
156410597|NCT00744237|564598160|FG002|Overall Study|Withdrawal by Subject|3|||
156410598|NCT00744237|564598158|FG000|Overall Study|Lost to Follow-up|1|||
156410599|NCT00744237|564598159|FG001|Overall Study|Lost to Follow-up|1|||
156410600|NCT00744237|564598160|FG002|Overall Study|Lost to Follow-up|1|||
156410601|NCT00744237|564598158|FG000|Overall Study|Protocol Violation|3|||
156410602|NCT00744237|564598159|FG001|Overall Study|Protocol Violation|4|||
156410603|NCT00744237|564598160|FG002|Overall Study|Protocol Violation|3|||
156410604|NCT00744237|564598158|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
156410605|NCT00744237|564598159|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
156410606|NCT00744237|564598160|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
156410607|NCT00744237|564598158|FG000|Overall Study|Dosing Error|1|||
156410608|NCT00744237|564598159|FG001|Overall Study|Dosing Error|0|||
156410609|NCT00744237|564598160|FG002|Overall Study|Dosing Error|1|||
156410610|NCT00744237|564598158|FG000|Overall Study|Study Drug Error|1|||
156410611|NCT00744237|564598159|FG001|Overall Study|Study Drug Error|0|||
156410612|NCT00744237|564598160|FG002|Overall Study|Study Drug Error|0|||
156637130|NCT01785472|565415598|FG000|Overall Study|Lost to Follow-up|1|||
156410613|NCT00744237|564598158|FG000|Overall Study|Prohibited Concomitant Medication|0|||
156410614|NCT00744237|564598159|FG001|Overall Study|Prohibited Concomitant Medication|0|||
156410615|NCT00744237|564598160|FG002|Overall Study|Prohibited Concomitant Medication|1|||
156410616|NCT00744237|564598158|FG000|Overall Study|Poor Compliance|0|||
156410617|NCT00744237|564598159|FG001|Overall Study|Poor Compliance|2|||
156410618|NCT00744237|564598160|FG002|Overall Study|Poor Compliance|0|||
156410619|NCT00744237|564598158|FG000|Overall Study|Administrative. Site Closed|1|||
156410620|NCT00744237|564598159|FG001|Overall Study|Administrative. Site Closed|1|||
156410621|NCT00744237|564598160|FG002|Overall Study|Administrative. Site Closed|1|||
156410622|NCT00744237|564598158|FG000|Overall Study|Adverse Event|9|||
156410623|NCT00744237|564598159|FG001|Overall Study|Adverse Event|13|||
156410624|NCT00744237|564598160|FG002|Overall Study|Adverse Event|5|||
156410625|NCT01757665|564598161|FG000|Overall Study|Still on Study - Visit Completed|240|||
156410626|NCT01757665|564598162|FG001|Overall Study|Still on Study - Visit Completed|30|||
156410627|NCT01757665|564598161|FG000|Overall Study|Still on Study - Visit Pending|398|||
156410628|NCT01757665|564598162|FG001|Overall Study|Still on Study - Visit Pending|40|||
156410629|NCT01757665|564598161|FG000|Overall Study|Still on Study - Missed Visit|14|||
156410630|NCT01757665|564598162|FG001|Overall Study|Still on Study - Missed Visit|1|||
156410631|NCT01757665|564598161|FG000|Overall Study|Death|25|||
156410632|NCT01757665|564598162|FG001|Overall Study|Death|8|||
156410633|NCT01757665|564598161|FG000|Overall Study|Explant|1|||
156410634|NCT01757665|564598162|FG001|Overall Study|Explant|2|||
156410635|NCT01757665|564598161|FG000|Overall Study|Withdrawal by Subject|10|||
156410636|NCT01757665|564598162|FG001|Overall Study|Withdrawal by Subject|0|||
156410637|NCT01757665|564598161|FG000|Overall Study|Lost to Follow-up|1|||
156410638|NCT01757665|564598162|FG001|Overall Study|Lost to Follow-up|1|||
156410639|NCT01757665|564598161|FG000|Overall Study|Not Implanted with Device|5|||
156410640|NCT01757665|564598162|FG001|Overall Study|Not Implanted with Device|1|||
156410641|NCT01533714|564598163|FG000|Overall Study|Adverse Event|0|||
156410642|NCT01533714|564598164|FG001|Overall Study|Adverse Event|1|||
156410643|NCT01533714|564598165|FG002|Overall Study|Adverse Event|2|||
156410644|NCT01533714|564598166|FG003|Overall Study|Adverse Event|2|||
156410645|NCT01533714|564598167|FG004|Overall Study|Adverse Event|2|||
156410646|NCT01533714|564598168|FG005|Overall Study|Adverse Event|1|||
156410647|NCT01533714|564598163|FG000|Overall Study|Lack of Efficacy|0|||
156410648|NCT01533714|564598164|FG001|Overall Study|Lack of Efficacy|0|||
156410649|NCT01533714|564598165|FG002|Overall Study|Lack of Efficacy|0|||
156410650|NCT01533714|564598166|FG003|Overall Study|Lack of Efficacy|0|||
156410651|NCT01533714|564598167|FG004|Overall Study|Lack of Efficacy|0|||
156410652|NCT01533714|564598168|FG005|Overall Study|Lack of Efficacy|1|||
156410653|NCT01533714|564598163|FG000|Overall Study|Withdrawal by Subject|0|||
156410654|NCT01533714|564598164|FG001|Overall Study|Withdrawal by Subject|1|||
156410655|NCT01533714|564598165|FG002|Overall Study|Withdrawal by Subject|0|||
156410656|NCT01533714|564598166|FG003|Overall Study|Withdrawal by Subject|1|||
156410657|NCT01533714|564598167|FG004|Overall Study|Withdrawal by Subject|1|||
156410658|NCT01533714|564598168|FG005|Overall Study|Withdrawal by Subject|0|||
156410659|NCT01533714|564598163|FG000|Overall Study|Exclusion criteria|0|||
156410660|NCT01533714|564598164|FG001|Overall Study|Exclusion criteria|1|||
156410661|NCT01533714|564598165|FG002|Overall Study|Exclusion criteria|0|||
156410662|NCT01533714|564598166|FG003|Overall Study|Exclusion criteria|0|||
156410663|NCT01533714|564598167|FG004|Overall Study|Exclusion criteria|0|||
156410664|NCT01533714|564598168|FG005|Overall Study|Exclusion criteria|0|||
156410665|NCT01533714|564598163|FG000|Overall Study|Positive for purified protein derivative|0|||
156410666|NCT01533714|564598164|FG001|Overall Study|Positive for purified protein derivative|0|||
156410667|NCT01533714|564598165|FG002|Overall Study|Positive for purified protein derivative|1|||
156410668|NCT01533714|564598166|FG003|Overall Study|Positive for purified protein derivative|0|||
156410669|NCT01533714|564598167|FG004|Overall Study|Positive for purified protein derivative|1|||
156637131|NCT01785472|565415599|FG001|Overall Study|Lost to Follow-up|2|||
156410670|NCT01533714|564598168|FG005|Overall Study|Positive for purified protein derivative|0|||
156410671|NCT01533714|564598163|FG000|Overall Study|Withdrawal criteria|0|||
156410672|NCT01533714|564598164|FG001|Overall Study|Withdrawal criteria|0|||
156410673|NCT01533714|564598165|FG002|Overall Study|Withdrawal criteria|1|||
156410674|NCT01533714|564598166|FG003|Overall Study|Withdrawal criteria|0|||
156410675|NCT01533714|564598167|FG004|Overall Study|Withdrawal criteria|3|||
156410676|NCT01533714|564598168|FG005|Overall Study|Withdrawal criteria|1|||
156410677|NCT01533714|564598163|FG000|Overall Study|Ineligibility reason|0|||
156410678|NCT01533714|564598164|FG001|Overall Study|Ineligibility reason|0|||
156410679|NCT01533714|564598165|FG002|Overall Study|Ineligibility reason|0|||
156410680|NCT01533714|564598166|FG003|Overall Study|Ineligibility reason|1|||
156410681|NCT01533714|564598167|FG004|Overall Study|Ineligibility reason|0|||
156410682|NCT01533714|564598168|FG005|Overall Study|Ineligibility reason|0|||
156410683|NCT02564055|564598169|FG000|Overall Study|Adverse Event|1|||
156410684|NCT02564055|564598170|FG001|Overall Study|Adverse Event|0|||
156410685|NCT02564055|564598171|FG002|Overall Study|Adverse Event|4|||
156410686|NCT02564055|564598172|FG003|Overall Study|Adverse Event|1|||
156410687|NCT02564055|564598173|FG004|Overall Study|Adverse Event|4|||
156410688|NCT02564055|564598174|FG005|Overall Study|Adverse Event|1|||
156410689|NCT02564055|564598169|FG000|Overall Study|Protocol Violation|1|||
156410690|NCT02564055|564598170|FG001|Overall Study|Protocol Violation|0|||
156410691|NCT02564055|564598171|FG002|Overall Study|Protocol Violation|0|||
156410692|NCT02564055|564598172|FG003|Overall Study|Protocol Violation|0|||
156410693|NCT02564055|564598173|FG004|Overall Study|Protocol Violation|0|||
156410694|NCT02564055|564598174|FG005|Overall Study|Protocol Violation|0|||
156410695|NCT02564055|564598169|FG000|Overall Study|Reached stopping criteria|0|||
156410696|NCT02564055|564598170|FG001|Overall Study|Reached stopping criteria|0|||
156410697|NCT02564055|564598171|FG002|Overall Study|Reached stopping criteria|0|||
156410698|NCT02564055|564598172|FG003|Overall Study|Reached stopping criteria|0|||
156410699|NCT02564055|564598173|FG004|Overall Study|Reached stopping criteria|0|||
156410700|NCT02564055|564598174|FG005|Overall Study|Reached stopping criteria|1|||
156410701|NCT02564055|564598169|FG000|Overall Study|Lost to Follow-up|0|||
156410702|NCT02564055|564598170|FG001|Overall Study|Lost to Follow-up|1|||
156410703|NCT02564055|564598171|FG002|Overall Study|Lost to Follow-up|4|||
156410704|NCT02564055|564598172|FG003|Overall Study|Lost to Follow-up|2|||
156410705|NCT02564055|564598173|FG004|Overall Study|Lost to Follow-up|1|||
156410706|NCT02564055|564598174|FG005|Overall Study|Lost to Follow-up|0|||
156410707|NCT02564055|564598169|FG000|Overall Study|Physician Decision|0|||
156410708|NCT02564055|564598170|FG001|Overall Study|Physician Decision|0|||
156410709|NCT02564055|564598171|FG002|Overall Study|Physician Decision|1|||
156410710|NCT02564055|564598172|FG003|Overall Study|Physician Decision|0|||
156410711|NCT02564055|564598173|FG004|Overall Study|Physician Decision|0|||
156410712|NCT02564055|564598174|FG005|Overall Study|Physician Decision|0|||
156410713|NCT02564055|564598169|FG000|Overall Study|Withdrawal by Subject|4|||
156410714|NCT02564055|564598170|FG001|Overall Study|Withdrawal by Subject|4|||
156410715|NCT02564055|564598171|FG002|Overall Study|Withdrawal by Subject|3|||
156410716|NCT02564055|564598172|FG003|Overall Study|Withdrawal by Subject|3|||
156410717|NCT02564055|564598173|FG004|Overall Study|Withdrawal by Subject|10|||
156410718|NCT02564055|564598174|FG005|Overall Study|Withdrawal by Subject|10|||
156410719|NCT04012814|564598176|FG000|Overall Study|Lost to Follow-up|4|||
156410720|NCT04012814|564598176|FG000|Overall Study|Withdrawal by Subject|2|||
156410721|NCT04012814|564598176|FG000|Overall Study|Protocol Violation|1|||
156410722|NCT04012814|564598176|FG000|Overall Study|Adverse Event|1|||
156410723|NCT02310126|564598178|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
156410724|NCT02310126|564598179|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
156410725|NCT02310126|564598178|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
156410726|NCT02310126|564598179|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
156410727|NCT02441946|564598180|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
156410728|NCT02441946|564598181|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
156410729|NCT02441946|564598182|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
156410730|NCT02441946|564598180|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
156410731|NCT02441946|564598181|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
156410732|NCT02441946|564598182|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
156410733|NCT02441946|564598180|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156410734|NCT02441946|564598181|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
156410735|NCT02441946|564598182|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156410736|NCT02441946|564598180|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
156410737|NCT02441946|564598181|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
156410738|NCT02441946|564598182|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
156410739|NCT02441946|564598180|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
156410740|NCT02441946|564598181|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
156410741|NCT02441946|564598182|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
156410742|NCT02441946|564598180|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
156410743|NCT02441946|564598181|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
156410744|NCT02441946|564598182|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
156410745|NCT02441946|564598180|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
156410746|NCT02441946|564598181|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
156410747|NCT02441946|564598182|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
156410748|NCT02441946|564598180|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
156410749|NCT02441946|564598181|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
156410750|NCT02441946|564598182|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
156410751|NCT02441946|564598180|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
156410752|NCT02441946|564598181|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
156410753|NCT02441946|564598182|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
156410754|NCT02441946|564598180|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
156410755|NCT02441946|564598181|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
156410756|NCT02441946|564598182|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
156410757|NCT02441946|564598180|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
156410758|NCT02441946|564598181|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156410759|NCT02441946|564598182|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156410760|NCT02226172|564598183|FG000|Overall Study|Participant refused further follow-up|4|||
156410761|NCT02226172|564598183|FG000|Overall Study|Other|5|||
156410762|NCT02226172|564598183|FG000|Overall Study|Death|1|||
156410763|NCT02226172|564598183|FG000|Overall Study|Study terminated by sponsor|1|||
156410764|NCT02226172|564598183|FG000|Overall Study|Adverse Event|6|||
156410765|NCT00439179|564598184|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
156410766|NCT00439179|564598185|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
156410767|NCT00439179|564598186|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
156410768|NCT00439179|564598187|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
156410769|NCT00758160|564598191|FG000|Overall Study|No Longer Requires Study Medication|4|||
156410770|NCT00758160|564598191|FG000|Overall Study|Administration Problems|3|||
156410771|NCT00758160|564598191|FG000|Overall Study|Adverse Event|15|||
156410772|NCT00758160|564598191|FG000|Overall Study|Lack of Efficacy|10|||
156410773|NCT00758160|564598191|FG000|Overall Study|Lost to Follow-up|14|||
156410774|NCT00758160|564598191|FG000|Overall Study|Protocol Violation|12|||
156410775|NCT00758160|564598191|FG000|Overall Study|Withdrawal by Subject|8|||
156410776|NCT00545363|564598192|FG000|Overall Study|Adverse Event|6|||
156410777|NCT00545363|564598193|FG001|Overall Study|Adverse Event|7|||
156410778|NCT00545363|564598192|FG000|Overall Study|Withdrawal by Subject|6|||
156410779|NCT00545363|564598193|FG001|Overall Study|Withdrawal by Subject|5|||
156410780|NCT00545363|564598192|FG000|Overall Study|Non-compliance|3|||
156410781|NCT00545363|564598193|FG001|Overall Study|Non-compliance|1|||
156410782|NCT00545363|564598192|FG000|Overall Study|Did not meet entry criteria|1|||
156410783|NCT00545363|564598193|FG001|Overall Study|Did not meet entry criteria|1|||
156637132|NCT01785472|565415600|FG002|Overall Study|Lost to Follow-up|0|||
156410784|NCT00545363|564598192|FG000|Overall Study|Lost to Follow-up|2|||
156410785|NCT00545363|564598193|FG001|Overall Study|Lost to Follow-up|0|||
156410786|NCT00545363|564598192|FG000|Overall Study|Other|1|||
156410787|NCT00545363|564598193|FG001|Overall Study|Other|1|||
156410788|NCT00582491|564598194|FG000|Overall Study|Withdrawal by Subject|1|||
156410789|NCT00582491|564598195|FG001|Overall Study|Withdrawal by Subject|0|||
156410790|NCT04192630|564598196|FG000|Overall Study|Discontinued before surgery|2|||
156410791|NCT04192630|564598197|FG001|Overall Study|Discontinued before surgery|0|||
156410792|NCT04192630|564598196|FG000|Overall Study|Discontinued after surgery|5|||
156410793|NCT04192630|564598197|FG001|Overall Study|Discontinued after surgery|3|||
156410794|NCT01193582|564598198|FG000|Vaccination Series|Withdrawal by Subject|11|||
156410795|NCT01193582|564598199|FG001|Vaccination Series|Withdrawal by Subject|13|||
156410796|NCT01193582|564598200|FG002|Vaccination Series|Withdrawal by Subject|8|||
156410797|NCT01193582|564598201|FG003|Vaccination Series|Withdrawal by Subject|3|||
156410798|NCT01193582|564598198|FG000|12 Month Follow-up|Death|0|||
156410799|NCT01193582|564598199|FG001|12 Month Follow-up|Death|0|||
156410800|NCT01193582|564598200|FG002|12 Month Follow-up|Death|1|||
156410801|NCT01193582|564598201|FG003|12 Month Follow-up|Death|0|||
156410802|NCT01193582|564598198|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
156410803|NCT01193582|564598199|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
156410804|NCT01193582|564598200|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
156410805|NCT01193582|564598201|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
156410806|NCT00779584|564598202|FG000|Overall Study|Protocol Violation|0|||
156410807|NCT00779584|564598203|FG001|Overall Study|Protocol Violation|0|||
156410808|NCT00779584|564598204|FG002|Overall Study|Protocol Violation|0|||
156410809|NCT00779584|564598205|FG003|Overall Study|Protocol Violation|0|||
156410810|NCT00779584|564598206|FG004|Overall Study|Protocol Violation|0|||
156410811|NCT00779584|564598207|FG005|Overall Study|Protocol Violation|1|||
156410812|NCT00779584|564598208|FG006|Overall Study|Protocol Violation|0|||
156410813|NCT00779584|564598209|FG007|Overall Study|Protocol Violation|0|||
156410814|NCT00779584|564598210|FG008|Overall Study|Protocol Violation|0|||
156410815|NCT00779584|564598202|FG000|Overall Study|Withdrawal by Subject|1|||
156410816|NCT00779584|564598203|FG001|Overall Study|Withdrawal by Subject|1|||
156410817|NCT00779584|564598204|FG002|Overall Study|Withdrawal by Subject|2|||
156410818|NCT00779584|564598205|FG003|Overall Study|Withdrawal by Subject|0|||
156410819|NCT00779584|564598206|FG004|Overall Study|Withdrawal by Subject|0|||
156410820|NCT00779584|564598207|FG005|Overall Study|Withdrawal by Subject|2|||
156410821|NCT00779584|564598208|FG006|Overall Study|Withdrawal by Subject|1|||
156410822|NCT00779584|564598209|FG007|Overall Study|Withdrawal by Subject|0|||
156410823|NCT00779584|564598210|FG008|Overall Study|Withdrawal by Subject|0|||
156410824|NCT00779584|564598202|FG000|Overall Study|Lost to Follow-up|0|||
156410825|NCT00779584|564598203|FG001|Overall Study|Lost to Follow-up|0|||
156410826|NCT00779584|564598204|FG002|Overall Study|Lost to Follow-up|0|||
156410827|NCT00779584|564598205|FG003|Overall Study|Lost to Follow-up|0|||
156410828|NCT00779584|564598206|FG004|Overall Study|Lost to Follow-up|1|||
156410829|NCT00779584|564598207|FG005|Overall Study|Lost to Follow-up|0|||
156410830|NCT00779584|564598208|FG006|Overall Study|Lost to Follow-up|0|||
156410831|NCT00779584|564598209|FG007|Overall Study|Lost to Follow-up|0|||
156410832|NCT00779584|564598210|FG008|Overall Study|Lost to Follow-up|0|||
156410833|NCT00779584|564598202|FG000|Overall Study|Progression of Disease|0|||
156410834|NCT00779584|564598203|FG001|Overall Study|Progression of Disease|1|||
156410835|NCT00779584|564598204|FG002|Overall Study|Progression of Disease|2|||
156410836|NCT00779584|564598205|FG003|Overall Study|Progression of Disease|6|||
156410837|NCT00779584|564598206|FG004|Overall Study|Progression of Disease|5|||
156410838|NCT00779584|564598207|FG005|Overall Study|Progression of Disease|1|||
156410839|NCT00779584|564598208|FG006|Overall Study|Progression of Disease|4|||
156410840|NCT00779584|564598209|FG007|Overall Study|Progression of Disease|2|||
156410841|NCT00779584|564598210|FG008|Overall Study|Progression of Disease|1|||
156410842|NCT00779584|564598202|FG000|Overall Study|Adverse Event|1|||
156410843|NCT00779584|564598203|FG001|Overall Study|Adverse Event|0|||
156410844|NCT00779584|564598204|FG002|Overall Study|Adverse Event|2|||
156410845|NCT00779584|564598205|FG003|Overall Study|Adverse Event|0|||
156410846|NCT00779584|564598206|FG004|Overall Study|Adverse Event|0|||
156410847|NCT00779584|564598207|FG005|Overall Study|Adverse Event|0|||
156410848|NCT00779584|564598208|FG006|Overall Study|Adverse Event|2|||
156410849|NCT00779584|564598209|FG007|Overall Study|Adverse Event|1|||
156410850|NCT00779584|564598210|FG008|Overall Study|Adverse Event|1|||
156410851|NCT00779584|564598202|FG000|Overall Study|Symptomatic Deterioration|1|||
156410852|NCT00779584|564598203|FG001|Overall Study|Symptomatic Deterioration|1|||
156410853|NCT00779584|564598204|FG002|Overall Study|Symptomatic Deterioration|1|||
156637133|NCT01785472|565415598|FG000|Overall Study|Physician Decision|1|||
156410854|NCT00779584|564598205|FG003|Overall Study|Symptomatic Deterioration|0|||
156410855|NCT00779584|564598206|FG004|Overall Study|Symptomatic Deterioration|0|||
156410856|NCT00779584|564598207|FG005|Overall Study|Symptomatic Deterioration|1|||
156410857|NCT00779584|564598208|FG006|Overall Study|Symptomatic Deterioration|1|||
156410858|NCT00779584|564598209|FG007|Overall Study|Symptomatic Deterioration|0|||
156410859|NCT00779584|564598210|FG008|Overall Study|Symptomatic Deterioration|0|||
156410860|NCT00779584|564598202|FG000|Overall Study|Ongoing in Study|0|||
156410861|NCT00779584|564598203|FG001|Overall Study|Ongoing in Study|0|||
156410862|NCT00779584|564598204|FG002|Overall Study|Ongoing in Study|0|||
156410863|NCT00779584|564598205|FG003|Overall Study|Ongoing in Study|0|||
156410864|NCT00779584|564598206|FG004|Overall Study|Ongoing in Study|1|||
156410865|NCT00779584|564598207|FG005|Overall Study|Ongoing in Study|1|||
156410866|NCT00779584|564598208|FG006|Overall Study|Ongoing in Study|0|||
156410867|NCT00779584|564598209|FG007|Overall Study|Ongoing in Study|0|||
156410868|NCT00779584|564598210|FG008|Overall Study|Ongoing in Study|0|||
156410869|NCT03632434|564598212|FG000|Overall Study|Withdrawal by Subject|2|||
156410870|NCT02733042|564598220|FG000|Overall Study|Adverse Event|1|||
156410871|NCT02733042|564598221|FG001|Overall Study|Adverse Event|0|||
156410872|NCT02733042|564598222|FG002|Overall Study|Adverse Event|1|||
156410873|NCT02733042|564598223|FG003|Overall Study|Adverse Event|1|||
156410874|NCT02733042|564598224|FG004|Overall Study|Adverse Event|0|||
156410875|NCT02733042|564598225|FG005|Overall Study|Adverse Event|0|||
156410876|NCT02733042|564598226|FG006|Overall Study|Adverse Event|0|||
156410877|NCT02733042|564598227|FG007|Overall Study|Adverse Event|0|||
156410878|NCT02733042|564598228|FG008|Overall Study|Adverse Event|0|||
156410879|NCT02733042|564598229|FG009|Overall Study|Adverse Event|0|||
156410880|NCT02733042|564598230|FG010|Overall Study|Adverse Event|2|||
156410881|NCT02733042|564598231|FG011|Overall Study|Adverse Event|2|||
156410882|NCT02733042|564598232|FG012|Overall Study|Adverse Event|0|||
156410883|NCT02733042|564598233|FG013|Overall Study|Adverse Event|2|||
156410884|NCT02733042|564598234|FG014|Overall Study|Adverse Event|0|||
156410885|NCT02733042|564598235|FG015|Overall Study|Adverse Event|0|||
156410886|NCT02733042|564598236|FG016|Overall Study|Adverse Event|0|||
156410887|NCT02733042|564598237|FG017|Overall Study|Adverse Event|1|||
156410888|NCT02733042|564598238|FG018|Overall Study|Adverse Event|0|||
156410889|NCT02733042|564598220|FG000|Overall Study|Progressive Disease|2|||
156410890|NCT02733042|564598221|FG001|Overall Study|Progressive Disease|1|||
156410891|NCT02733042|564598222|FG002|Overall Study|Progressive Disease|3|||
156410892|NCT02733042|564598223|FG003|Overall Study|Progressive Disease|1|||
156410893|NCT02733042|564598224|FG004|Overall Study|Progressive Disease|2|||
156410894|NCT02733042|564598225|FG005|Overall Study|Progressive Disease|3|||
156410895|NCT02733042|564598226|FG006|Overall Study|Progressive Disease|0|||
156410896|NCT02733042|564598227|FG007|Overall Study|Progressive Disease|3|||
156410897|NCT02733042|564598228|FG008|Overall Study|Progressive Disease|3|||
156410898|NCT02733042|564598229|FG009|Overall Study|Progressive Disease|2|||
156410899|NCT02733042|564598230|FG010|Overall Study|Progressive Disease|2|||
156410900|NCT02733042|564598231|FG011|Overall Study|Progressive Disease|2|||
156410901|NCT02733042|564598232|FG012|Overall Study|Progressive Disease|8|||
156410902|NCT02733042|564598233|FG013|Overall Study|Progressive Disease|1|||
156410903|NCT02733042|564598234|FG014|Overall Study|Progressive Disease|4|||
156410904|NCT02733042|564598235|FG015|Overall Study|Progressive Disease|7|||
156410905|NCT02733042|564598236|FG016|Overall Study|Progressive Disease|2|||
156410906|NCT02733042|564598237|FG017|Overall Study|Progressive Disease|3|||
156410907|NCT02733042|564598238|FG018|Overall Study|Progressive Disease|4|||
156410908|NCT02733042|564598220|FG000|Overall Study|Withdrawal by Subject|0|||
156410909|NCT02733042|564598221|FG001|Overall Study|Withdrawal by Subject|1|||
156410910|NCT02733042|564598222|FG002|Overall Study|Withdrawal by Subject|2|||
156410911|NCT02733042|564598223|FG003|Overall Study|Withdrawal by Subject|1|||
156410912|NCT02733042|564598224|FG004|Overall Study|Withdrawal by Subject|1|||
156410913|NCT02733042|564598225|FG005|Overall Study|Withdrawal by Subject|0|||
156410914|NCT02733042|564598226|FG006|Overall Study|Withdrawal by Subject|0|||
156410915|NCT02733042|564598227|FG007|Overall Study|Withdrawal by Subject|0|||
156410916|NCT02733042|564598228|FG008|Overall Study|Withdrawal by Subject|1|||
156410917|NCT02733042|564598229|FG009|Overall Study|Withdrawal by Subject|1|||
156410918|NCT02733042|564598230|FG010|Overall Study|Withdrawal by Subject|0|||
156410919|NCT02733042|564598231|FG011|Overall Study|Withdrawal by Subject|2|||
156410920|NCT02733042|564598232|FG012|Overall Study|Withdrawal by Subject|1|||
156410921|NCT02733042|564598233|FG013|Overall Study|Withdrawal by Subject|1|||
156410922|NCT02733042|564598234|FG014|Overall Study|Withdrawal by Subject|0|||
156410923|NCT02733042|564598235|FG015|Overall Study|Withdrawal by Subject|0|||
156410924|NCT02733042|564598236|FG016|Overall Study|Withdrawal by Subject|0|||
156410925|NCT02733042|564598237|FG017|Overall Study|Withdrawal by Subject|0|||
156637134|NCT01785472|565415599|FG001|Overall Study|Physician Decision|1|||
156410926|NCT02733042|564598238|FG018|Overall Study|Withdrawal by Subject|0|||
156410927|NCT02733042|564598220|FG000|Overall Study|Other Reasons|0|||
156410928|NCT02733042|564598221|FG001|Overall Study|Other Reasons|0|||
156410929|NCT02733042|564598222|FG002|Overall Study|Other Reasons|1|||
156410930|NCT02733042|564598223|FG003|Overall Study|Other Reasons|0|||
156410931|NCT02733042|564598224|FG004|Overall Study|Other Reasons|0|||
156410932|NCT02733042|564598225|FG005|Overall Study|Other Reasons|0|||
156410933|NCT02733042|564598226|FG006|Overall Study|Other Reasons|0|||
156410934|NCT02733042|564598227|FG007|Overall Study|Other Reasons|0|||
156410935|NCT02733042|564598228|FG008|Overall Study|Other Reasons|0|||
156410936|NCT02733042|564598229|FG009|Overall Study|Other Reasons|1|||
156410937|NCT02733042|564598230|FG010|Overall Study|Other Reasons|1|||
156410938|NCT02733042|564598231|FG011|Overall Study|Other Reasons|0|||
156410939|NCT02733042|564598232|FG012|Overall Study|Other Reasons|0|||
156410940|NCT02733042|564598233|FG013|Overall Study|Other Reasons|0|||
156410941|NCT02733042|564598234|FG014|Overall Study|Other Reasons|0|||
156410942|NCT02733042|564598235|FG015|Overall Study|Other Reasons|1|||
156410943|NCT02733042|564598236|FG016|Overall Study|Other Reasons|0|||
156410944|NCT02733042|564598237|FG017|Overall Study|Other Reasons|1|||
156410945|NCT02733042|564598238|FG018|Overall Study|Other Reasons|0|||
156410946|NCT02733042|564598220|FG000|Overall Study|Death|0|||
156410947|NCT02733042|564598221|FG001|Overall Study|Death|0|||
156410948|NCT02733042|564598222|FG002|Overall Study|Death|0|||
156410949|NCT02733042|564598223|FG003|Overall Study|Death|0|||
156410950|NCT02733042|564598224|FG004|Overall Study|Death|0|||
156410951|NCT02733042|564598225|FG005|Overall Study|Death|0|||
156410952|NCT02733042|564598226|FG006|Overall Study|Death|1|||
156410953|NCT02733042|564598227|FG007|Overall Study|Death|0|||
156410954|NCT02733042|564598228|FG008|Overall Study|Death|1|||
156410955|NCT02733042|564598229|FG009|Overall Study|Death|0|||
156410956|NCT02733042|564598230|FG010|Overall Study|Death|1|||
156637135|NCT01785472|565415600|FG002|Overall Study|Physician Decision|1|||
156637136|NCT01785472|565415598|FG000|Overall Study|Protocol deviation|0|||
156637137|NCT01785472|565415599|FG001|Overall Study|Protocol deviation|2|||
156637138|NCT01785472|565415600|FG002|Overall Study|Protocol deviation|2|||
156637139|NCT01785472|565415598|FG000|Overall Study|Subject/guardian decision|15|||
156637140|NCT01785472|565415599|FG001|Overall Study|Subject/guardian decision|10|||
156637141|NCT01785472|565415600|FG002|Overall Study|Subject/guardian decision|11|||
156637142|NCT01785472|565415598|FG000|Overall Study|Technical problems|0|||
156637143|NCT01785472|565415599|FG001|Overall Study|Technical problems|0|||
156637144|NCT01785472|565415600|FG002|Overall Study|Technical problems|1|||
156637145|NCT00127192|565415602|FG000|Overall Study|Adverse Event|0|||
156637146|NCT00127192|565415603|FG001|Overall Study|Adverse Event|1|||
156637147|NCT00127192|565415604|FG002|Overall Study|Adverse Event|1|||
156637148|NCT00127192|565415605|FG003|Overall Study|Adverse Event|1|||
156637149|NCT00127192|565415606|FG004|Overall Study|Adverse Event|0|||
156637150|NCT00127192|565415602|FG000|Overall Study|Lack of Efficacy|2|||
156637151|NCT00127192|565415603|FG001|Overall Study|Lack of Efficacy|0|||
156637152|NCT00127192|565415604|FG002|Overall Study|Lack of Efficacy|0|||
156410957|NCT02733042|564598231|FG011|Overall Study|Death|0|||
156410958|NCT02733042|564598232|FG012|Overall Study|Death|0|||
156410959|NCT02733042|564598233|FG013|Overall Study|Death|0|||
156410960|NCT02733042|564598234|FG014|Overall Study|Death|1|||
156410961|NCT02733042|564598235|FG015|Overall Study|Death|2|||
156410962|NCT02733042|564598236|FG016|Overall Study|Death|0|||
156410963|NCT02733042|564598237|FG017|Overall Study|Death|0|||
156410964|NCT02733042|564598238|FG018|Overall Study|Death|0|||
156410965|NCT03688711|564598239|FG000|Overall Study|Withdrawal by Subject|0|||
156410966|NCT03688711|564598240|FG001|Overall Study|Withdrawal by Subject|1|||
156410967|NCT01088529|564598241|FG000|Overall Study|Did not receive study treatment|0|||
156410968|NCT01088529|564598242|FG001|Overall Study|Did not receive study treatment|1|||
156410969|NCT02838628|564598243|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
156410970|NCT02838628|564598244|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
156410971|NCT02838628|564598243|FG000|Recurrence Follow-up Period|Adverse Event|1|||
156410972|NCT02838628|564598244|FG001|Recurrence Follow-up Period|Adverse Event|0|||
156410973|NCT02838628|564598243|FG000|Recurrence Follow-up Period|Non-compliance|0|||
156410974|NCT02838628|564598244|FG001|Recurrence Follow-up Period|Non-compliance|1|||
156410975|NCT02838628|564598243|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
156410976|NCT02838628|564598244|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
156410977|NCT02838628|564598243|FG000|Recurrence Follow-up Period|Other un-specified|1|||
156410978|NCT02838628|564598244|FG001|Recurrence Follow-up Period|Other un-specified|1|||
156410979|NCT01155661|564598247|FG000|Overall Study|Adverse Event|101|||
156410980|NCT01155661|564598247|FG000|Overall Study|Death|1|||
156410981|NCT01155661|564598247|FG000|Overall Study|Lack of Efficacy|32|||
156410982|NCT01155661|564598247|FG000|Overall Study|Lost to Follow-up|22|||
156410983|NCT01155661|564598247|FG000|Overall Study|Physician Decision|3|||
156410984|NCT01155661|564598247|FG000|Overall Study|Protocol Violation|35|||
156410985|NCT01155661|564598247|FG000|Overall Study|Withdrawal by Subject|73|||
156410986|NCT01155661|564598247|FG000|Overall Study|Sponsor Decision|13|||
156410987|NCT03169881|564598253|FG000|Overall Study|Incomplete Follow-up|10|||
156410988|NCT03169881|564598254|FG001|Overall Study|Incomplete Follow-up|15|||
156410989|NCT03169881|564598253|FG000|Overall Study|Lost to Follow-up|18|||
156410990|NCT03169881|564598254|FG001|Overall Study|Lost to Follow-up|20|||
156410991|NCT03169881|564598253|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
156410992|NCT03169881|564598254|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
156410993|NCT03936777|564598255|FG000|Overall Study|Adverse Event|3|||
156410994|NCT03936777|564598255|FG000|Overall Study|Death|3|||
156410995|NCT03936777|564598255|FG000|Overall Study|Lack of Efficacy|24|||
156410996|NCT03936777|564598255|FG000|Overall Study|Lost to Follow-up|3|||
156410997|NCT03936777|564598255|FG000|Overall Study|Physician Decision|1|||
156410998|NCT03936777|564598255|FG000|Overall Study|Withdrawal by Subject|11|||
156410999|NCT03936777|564598255|FG000|Overall Study|Subjected Weaned of ZX008|1|||
156411000|NCT03936777|564598255|FG000|Overall Study|Missing|6|||
156411001|NCT02301156|564598256|FG000|Overall Study|Adverse Event|13|||
156411002|NCT02301156|564598257|FG001|Overall Study|Adverse Event|14|||
156411003|NCT02301156|564598256|FG000|Overall Study|Death|1|||
156411004|NCT02301156|564598257|FG001|Overall Study|Death|5|||
156411005|NCT02301156|564598256|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
156411006|NCT02301156|564598257|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
156411007|NCT02301156|564598256|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
156411008|NCT02301156|564598257|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
156411009|NCT02301156|564598256|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
156411010|NCT02301156|564598257|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
156411011|NCT02301156|564598256|FG000|Overall Study|Reason not Specified|6|||
156411012|NCT02301156|564598257|FG001|Overall Study|Reason not Specified|3|||
156411013|NCT02638623|564598258|FG000|Overall Study|Surgery timing|5|||
156411014|NCT02638623|564598259|FG001|Overall Study|Surgery timing|6|||
156411015|NCT02638623|564598258|FG000|Overall Study|Not given intervention|2|||
156411016|NCT02638623|564598259|FG001|Overall Study|Not given intervention|0|||
156411017|NCT03797326|564598263|FG000|Overall Study|Lost to Follow-up|1|||
156637153|NCT00127192|565415605|FG003|Overall Study|Lack of Efficacy|0|||
156637154|NCT00127192|565415606|FG004|Overall Study|Lack of Efficacy|2|||
156637155|NCT00127192|565415602|FG000|Overall Study|Withdrawal by Subject|0|||
156637156|NCT00127192|565415603|FG001|Overall Study|Withdrawal by Subject|0|||
156637157|NCT00127192|565415604|FG002|Overall Study|Withdrawal by Subject|1|||
156637158|NCT00127192|565415605|FG003|Overall Study|Withdrawal by Subject|0|||
156637159|NCT00127192|565415606|FG004|Overall Study|Withdrawal by Subject|3|||
156637160|NCT00127192|565415602|FG000|Overall Study|Adverse event in pre-treatment period|1|||
156637161|NCT00127192|565415603|FG001|Overall Study|Adverse event in pre-treatment period|0|||
156637162|NCT00127192|565415604|FG002|Overall Study|Adverse event in pre-treatment period|0|||
156637163|NCT00127192|565415605|FG003|Overall Study|Adverse event in pre-treatment period|0|||
156637164|NCT00127192|565415606|FG004|Overall Study|Adverse event in pre-treatment period|0|||
156637165|NCT01612780|565415620|FG000|Overall Study|Treatment not completed|1|||
156637166|NCT01612780|565415620|FG000|Overall Study|Withdrawal by Subject|5|||
156637167|NCT02628418|565415624|FG000|Overall Study|Lost to Follow-up|1|||
156637168|NCT02628418|565415625|FG001|Overall Study|Lost to Follow-up|2|||
156637169|NCT00424632|565415626|FG000|Overall Study|Death|0|||
156637170|NCT00424632|565415627|FG001|Overall Study|Death|0|||
156637171|NCT00424632|565415628|FG002|Overall Study|Death|0|||
156637172|NCT00424632|565415629|FG003|Overall Study|Death|0|||
156637173|NCT00424632|565415630|FG004|Overall Study|Death|0|||
156637174|NCT00424632|565415631|FG005|Overall Study|Death|2|||
156637175|NCT00424632|565415632|FG006|Overall Study|Death|0|||
156637176|NCT00424632|565415633|FG007|Overall Study|Death|0|||
156637177|NCT00424632|565415634|FG008|Overall Study|Death|0|||
156637178|NCT00424632|565415635|FG009|Overall Study|Death|0|||
156637179|NCT00424632|565415626|FG000|Overall Study|Adverse Event|0|||
156637180|NCT00424632|565415627|FG001|Overall Study|Adverse Event|0|||
156637181|NCT00424632|565415628|FG002|Overall Study|Adverse Event|0|||
156637182|NCT00424632|565415629|FG003|Overall Study|Adverse Event|0|||
156411018|NCT03797326|564598264|FG001|Overall Study|Lost to Follow-up|0|||
156411019|NCT03797326|564598265|FG002|Overall Study|Lost to Follow-up|0|||
156411020|NCT03797326|564598266|FG003|Overall Study|Lost to Follow-up|1|||
156411021|NCT03797326|564598267|FG004|Overall Study|Lost to Follow-up|0|||
156411022|NCT03797326|564598268|FG005|Overall Study|Lost to Follow-up|0|||
156411023|NCT03797326|564598269|FG006|Overall Study|Lost to Follow-up|0|||
156411024|NCT03797326|564598270|FG007|Overall Study|Lost to Follow-up|0|||
156411025|NCT03797326|564598263|FG000|Overall Study|Withdrawal by Subject|0|||
156411026|NCT03797326|564598264|FG001|Overall Study|Withdrawal by Subject|0|||
156411027|NCT03797326|564598265|FG002|Overall Study|Withdrawal by Subject|1|||
156637183|NCT00424632|565415630|FG004|Overall Study|Adverse Event|0|||
156637184|NCT00424632|565415631|FG005|Overall Study|Adverse Event|0|||
156637185|NCT00424632|565415632|FG006|Overall Study|Adverse Event|0|||
156637186|NCT00424632|565415633|FG007|Overall Study|Adverse Event|0|||
156637187|NCT00424632|565415634|FG008|Overall Study|Adverse Event|3|||
156637188|NCT00424632|565415635|FG009|Overall Study|Adverse Event|2|||
156637189|NCT00424632|565415626|FG000|Overall Study|Global deterioration of health status|0|||
156637190|NCT00424632|565415627|FG001|Overall Study|Global deterioration of health status|0|||
156637191|NCT00424632|565415628|FG002|Overall Study|Global deterioration of health status|0|||
156637192|NCT00424632|565415629|FG003|Overall Study|Global deterioration of health status|1|||
156411028|NCT03797326|564598266|FG003|Overall Study|Withdrawal by Subject|3|||
156411029|NCT03797326|564598267|FG004|Overall Study|Withdrawal by Subject|0|||
156411030|NCT03797326|564598268|FG005|Overall Study|Withdrawal by Subject|2|||
156411031|NCT03797326|564598269|FG006|Overall Study|Withdrawal by Subject|2|||
156411032|NCT03797326|564598270|FG007|Overall Study|Withdrawal by Subject|3|||
156411033|NCT03797326|564598263|FG000|Overall Study|Sponsor Decision|3|||
156411034|NCT03797326|564598264|FG001|Overall Study|Sponsor Decision|3|||
156411035|NCT03797326|564598265|FG002|Overall Study|Sponsor Decision|3|||
156411036|NCT03797326|564598266|FG003|Overall Study|Sponsor Decision|6|||
156411037|NCT03797326|564598267|FG004|Overall Study|Sponsor Decision|0|||
156411038|NCT03797326|564598268|FG005|Overall Study|Sponsor Decision|3|||
156411039|NCT03797326|564598269|FG006|Overall Study|Sponsor Decision|3|||
156411040|NCT03797326|564598270|FG007|Overall Study|Sponsor Decision|2|||
156411041|NCT03797326|564598263|FG000|Overall Study|Death|27|||
156411042|NCT03797326|564598264|FG001|Overall Study|Death|28|||
156411043|NCT03797326|564598265|FG002|Overall Study|Death|95|||
156411044|NCT03797326|564598266|FG003|Overall Study|Death|95|||
156411045|NCT03797326|564598267|FG004|Overall Study|Death|30|||
156411046|NCT03797326|564598268|FG005|Overall Study|Death|96|||
156411047|NCT03797326|564598269|FG006|Overall Study|Death|97|||
156411048|NCT03797326|564598270|FG007|Overall Study|Death|98|||
156411049|NCT03797326|564598263|FG000|Overall Study|Enrolled in error|0|||
156411050|NCT03797326|564598264|FG001|Overall Study|Enrolled in error|0|||
156411051|NCT03797326|564598265|FG002|Overall Study|Enrolled in error|3|||
156411052|NCT03797326|564598266|FG003|Overall Study|Enrolled in error|2|||
156411053|NCT03797326|564598267|FG004|Overall Study|Enrolled in error|2|||
156411054|NCT03797326|564598268|FG005|Overall Study|Enrolled in error|1|||
156411055|NCT03797326|564598269|FG006|Overall Study|Enrolled in error|1|||
156411056|NCT03797326|564598270|FG007|Overall Study|Enrolled in error|0|||
156411057|NCT04152343|564598271|FG000|Overall Study|Transplanted|5|||
156411058|NCT04152343|564598271|FG000|Overall Study|Death|20|||
156411059|NCT04152343|564598271|FG000|Overall Study|Lost to Follow-up|3|||
156411060|NCT01965938|564598272|FG000|Overall Study|Withdrawal by Subject|1|||
156411061|NCT01965938|564598273|FG001|Overall Study|Withdrawal by Subject|0|||
156411062|NCT02090634|564598274|FG000|Overall Study|Lost to Follow-up|0|||
156411063|NCT02090634|564598275|FG001|Overall Study|Lost to Follow-up|1|||
156411064|NCT02090634|564598274|FG000|Overall Study|Death|0|||
156411065|NCT02090634|564598275|FG001|Overall Study|Death|1|||
156411066|NCT02090634|564598274|FG000|Overall Study|Protocol Violation|3|||
156411067|NCT02090634|564598275|FG001|Overall Study|Protocol Violation|1|||
156411068|NCT02090634|564598274|FG000|Overall Study|Adverse Event|2|||
156411069|NCT02090634|564598275|FG001|Overall Study|Adverse Event|0|||
156411070|NCT03757234|564598280|FG000|Overall Study|Adverse Event|0|||
156411071|NCT03757234|564598281|FG001|Overall Study|Adverse Event|0|||
156411072|NCT03757234|564598282|FG002|Overall Study|Adverse Event|0|||
156411073|NCT03757234|564598283|FG003|Overall Study|Adverse Event|0|||
156411074|NCT03757234|564598284|FG004|Overall Study|Adverse Event|1|||
156411075|NCT03757234|564598280|FG000|Overall Study|Lost to Follow-up|1|||
156411076|NCT03757234|564598281|FG001|Overall Study|Lost to Follow-up|0|||
156411077|NCT03757234|564598282|FG002|Overall Study|Lost to Follow-up|0|||
156411078|NCT03757234|564598283|FG003|Overall Study|Lost to Follow-up|0|||
156411079|NCT03757234|564598284|FG004|Overall Study|Lost to Follow-up|1|||
156411080|NCT03757234|564598280|FG000|Overall Study|Withdrawal by Subject|1|||
156411081|NCT03757234|564598281|FG001|Overall Study|Withdrawal by Subject|1|||
156411082|NCT03757234|564598282|FG002|Overall Study|Withdrawal by Subject|0|||
156411083|NCT03757234|564598283|FG003|Overall Study|Withdrawal by Subject|1|||
156411084|NCT03757234|564598284|FG004|Overall Study|Withdrawal by Subject|2|||
156411085|NCT03757234|564598280|FG000|Overall Study|Other|1|||
156411086|NCT03757234|564598281|FG001|Overall Study|Other|1|||
156411087|NCT03757234|564598282|FG002|Overall Study|Other|0|||
156411088|NCT03757234|564598283|FG003|Overall Study|Other|0|||
156411089|NCT03757234|564598284|FG004|Overall Study|Other|0|||
156411090|NCT02401308|564598291|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
156411091|NCT02401308|564598292|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
156411092|NCT00147225|564598295|FG000|Overall Study|Withdrawal by Subject|1|||
156411093|NCT00147225|564598296|FG001|Overall Study|Withdrawal by Subject|0|||
156411094|NCT00147225|564598297|FG002|Overall Study|Withdrawal by Subject|1|||
156411095|NCT00147225|564598298|FG003|Overall Study|Withdrawal by Subject|0|||
156411096|NCT00147225|564598299|FG004|Overall Study|Withdrawal by Subject|0|||
156411097|NCT00147225|564598300|FG005|Overall Study|Withdrawal by Subject|1|||
156411098|NCT00147225|564598295|FG000|Overall Study|Adverse Event|0|||
156411099|NCT00147225|564598296|FG001|Overall Study|Adverse Event|0|||
156411100|NCT00147225|564598297|FG002|Overall Study|Adverse Event|1|||
156411101|NCT00147225|564598298|FG003|Overall Study|Adverse Event|1|||
156411102|NCT00147225|564598299|FG004|Overall Study|Adverse Event|0|||
156411103|NCT00147225|564598300|FG005|Overall Study|Adverse Event|0|||
156411104|NCT00147225|564598295|FG000|Overall Study|Screen Failure|0|||
156411105|NCT00147225|564598296|FG001|Overall Study|Screen Failure|0|||
156411106|NCT00147225|564598297|FG002|Overall Study|Screen Failure|0|||
156411107|NCT00147225|564598298|FG003|Overall Study|Screen Failure|0|||
156411108|NCT00147225|564598299|FG004|Overall Study|Screen Failure|1|||
156411109|NCT00147225|564598300|FG005|Overall Study|Screen Failure|0|||
156411110|NCT00147225|564598295|FG000|Overall Study|Chemotherapy Changed|0|||
156411111|NCT00147225|564598296|FG001|Overall Study|Chemotherapy Changed|0|||
156411112|NCT00147225|564598297|FG002|Overall Study|Chemotherapy Changed|0|||
156411113|NCT00147225|564598298|FG003|Overall Study|Chemotherapy Changed|0|||
156411114|NCT00147225|564598299|FG004|Overall Study|Chemotherapy Changed|0|||
156411115|NCT00147225|564598300|FG005|Overall Study|Chemotherapy Changed|1|||
156411116|NCT01032044|564598301|FG000|Overall Study|Protocol Violation|14|||
156411117|NCT01032044|564598302|FG001|Overall Study|Protocol Violation|8|||
156411118|NCT01032044|564598301|FG000|Overall Study|Adverse Event|0|||
156411119|NCT01032044|564598302|FG001|Overall Study|Adverse Event|1|||
156411120|NCT01032044|564598301|FG000|Overall Study|Lost to Follow-up|11|||
156411121|NCT01032044|564598302|FG001|Overall Study|Lost to Follow-up|11|||
156411122|NCT02998021|564598303|FG000|Overall Study|Withdrawal by Subject|3|||
156411123|NCT02998021|564598304|FG001|Overall Study|Withdrawal by Subject|1|||
156411124|NCT02998021|564598303|FG000|Overall Study|unsafe home|0|||
156411125|NCT02998021|564598304|FG001|Overall Study|unsafe home|1|||
156411126|NCT02961374|564598305|FG000|Overall Study|Adverse Event|4|||
156411127|NCT00171873|564598306|FG000|Overall Study|Withdrawal by Subject|4|||
156411128|NCT00171873|564598307|FG001|Overall Study|Withdrawal by Subject|2|||
156411129|NCT00171873|564598306|FG000|Overall Study|Adverse Event|5|||
156411130|NCT00171873|564598307|FG001|Overall Study|Adverse Event|0|||
156411131|NCT00171873|564598306|FG000|Overall Study|Switched to Octreotide|0|||
156411132|NCT00171873|564598307|FG001|Overall Study|Switched to Octreotide|1|||
156411133|NCT02041923|564598308|FG000|Overall Study|Lost to Follow-up|26|||
156411134|NCT02041923|564598309|FG001|Overall Study|Lost to Follow-up|30|||
156411135|NCT00309608|564598314|FG000|Overall Study|Adverse Event|1|||
156411136|NCT00309608|564598315|FG001|Overall Study|Adverse Event|5|||
156411137|NCT00309608|564598316|FG002|Overall Study|Adverse Event|3|||
156411138|NCT00309608|564598317|FG003|Overall Study|Adverse Event|2|||
156411139|NCT00309608|564598318|FG004|Overall Study|Adverse Event|3|||
156411140|NCT00309608|564598314|FG000|Overall Study|Protocol Violation|2|||
156411141|NCT00309608|564598315|FG001|Overall Study|Protocol Violation|0|||
156411142|NCT00309608|564598316|FG002|Overall Study|Protocol Violation|0|||
156411143|NCT00309608|564598317|FG003|Overall Study|Protocol Violation|0|||
156411144|NCT00309608|564598318|FG004|Overall Study|Protocol Violation|0|||
156411145|NCT00309608|564598314|FG000|Overall Study|Lost to Follow-up|0|||
156411146|NCT00309608|564598315|FG001|Overall Study|Lost to Follow-up|0|||
156411147|NCT00309608|564598316|FG002|Overall Study|Lost to Follow-up|2|||
156411148|NCT00309608|564598317|FG003|Overall Study|Lost to Follow-up|0|||
156411149|NCT00309608|564598318|FG004|Overall Study|Lost to Follow-up|1|||
156411150|NCT00309608|564598314|FG000|Overall Study|Withdrawal by Subject|1|||
156411151|NCT00309608|564598315|FG001|Overall Study|Withdrawal by Subject|4|||
156411152|NCT00309608|564598316|FG002|Overall Study|Withdrawal by Subject|2|||
156411153|NCT00309608|564598317|FG003|Overall Study|Withdrawal by Subject|0|||
156411154|NCT00309608|564598318|FG004|Overall Study|Withdrawal by Subject|0|||
156411155|NCT00309608|564598314|FG000|Overall Study|Other incl. Lack of efficacy|10|||
156411156|NCT00309608|564598315|FG001|Overall Study|Other incl. Lack of efficacy|4|||
156411157|NCT00309608|564598316|FG002|Overall Study|Other incl. Lack of efficacy|3|||
156411158|NCT00309608|564598317|FG003|Overall Study|Other incl. Lack of efficacy|4|||
156411159|NCT00309608|564598318|FG004|Overall Study|Other incl. Lack of efficacy|0|||
156411160|NCT00621296|564598325|FG000|Overall Study|Adverse Event|2|||
156411161|NCT00621296|564598325|FG000|Overall Study|Lack of Efficacy|1|||
156411162|NCT00621296|564598325|FG000|Overall Study|Physician Decision|7|||
156411163|NCT00621296|564598325|FG000|Overall Study|Unmatch Criteria|1|||
156411164|NCT00621296|564598325|FG000|Overall Study|Stopping Criteria|3|||
156411165|NCT00127413|564598328|FG000|Overall Study|Lost to Follow-up|6|||
156411166|NCT00127413|564598329|FG001|Overall Study|Lost to Follow-up|4|||
156411167|NCT00127413|564598330|FG002|Overall Study|Lost to Follow-up|8|||
156411168|NCT00127413|564598331|FG003|Overall Study|Lost to Follow-up|2|||
156411169|NCT01051063|564598334|FG000|Overall Study|Death|2|||
156411170|NCT01051063|564598335|FG001|Overall Study|Death|2|||
156411171|NCT01051063|564598334|FG000|Overall Study|Withdrawal by Subject|1|||
156411172|NCT01051063|564598335|FG001|Overall Study|Withdrawal by Subject|1|||
156411173|NCT01051063|564598334|FG000|Overall Study|Termination of the study|5|||
156411174|NCT01051063|564598335|FG001|Overall Study|Termination of the study|0|||
156411175|NCT01051063|564598334|FG000|Overall Study|Moved from the study site area|1|||
156411176|NCT01051063|564598335|FG001|Overall Study|Moved from the study site area|0|||
156411177|NCT01051063|564598334|FG000|Overall Study|Other|1|||
156411178|NCT01051063|564598335|FG001|Overall Study|Other|0|||
156411179|NCT01051063|564598334|FG000|Overall Study|Lost to Follow-up|0|||
156411180|NCT01051063|564598335|FG001|Overall Study|Lost to Follow-up|1|||
156411181|NCT02023879|564598337|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
156411182|NCT02023879|564598338|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
156411183|NCT02023879|564598339|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
156411184|NCT02023879|564598337|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
156411185|NCT02023879|564598338|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
156411186|NCT02023879|564598339|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
156411187|NCT02023879|564598337|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
156411188|NCT02023879|564598338|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
156411189|NCT02023879|564598339|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
156411190|NCT02023879|564598337|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
156411191|NCT02023879|564598338|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
156411192|NCT02023879|564598339|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
156411193|NCT02023879|564598337|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
156411194|NCT02023879|564598338|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
156411195|NCT02023879|564598339|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
156411196|NCT02023879|564598337|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
156411197|NCT02023879|564598338|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
156411198|NCT02023879|564598339|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
156411199|NCT02023879|564598337|FG000|Extension Open Label Treatment|Adverse Event|1|||
156411200|NCT02023879|564598338|FG001|Extension Open Label Treatment|Adverse Event|7|||
156411201|NCT02023879|564598339|FG002|Extension Open Label Treatment|Adverse Event|3|||
156411202|NCT02023879|564598337|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
156411203|NCT02023879|564598338|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
156411204|NCT02023879|564598339|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
156411205|NCT02023879|564598337|FG000|Extension Open Label Treatment|Participant moved|1|||
156411206|NCT02023879|564598338|FG001|Extension Open Label Treatment|Participant moved|2|||
156411207|NCT02023879|564598339|FG002|Extension Open Label Treatment|Participant moved|0|||
156411208|NCT02023879|564598337|FG000|Extension Open Label Treatment|Other than specified above|2|||
156411209|NCT02023879|564598338|FG001|Extension Open Label Treatment|Other than specified above|7|||
156411210|NCT02023879|564598339|FG002|Extension Open Label Treatment|Other than specified above|2|||
156411211|NCT00874432|564598340|FG000|Overall Study|Withdrawal by Subject|1|||
156411212|NCT00874432|564598341|FG001|Overall Study|Withdrawal by Subject|0|||
156411213|NCT00874432|564598342|FG002|Overall Study|Withdrawal by Subject|0|||
156411214|NCT00874432|564598343|FG003|Overall Study|Withdrawal by Subject|0|||
156411215|NCT00874432|564598340|FG000|Overall Study|Physician Decision|1|||
156411216|NCT00874432|564598341|FG001|Overall Study|Physician Decision|0|||
156411217|NCT00874432|564598342|FG002|Overall Study|Physician Decision|0|||
156411218|NCT00874432|564598343|FG003|Overall Study|Physician Decision|0|||
156411219|NCT00874432|564598340|FG000|Overall Study|Other|1|||
156411220|NCT00874432|564598341|FG001|Overall Study|Other|2|||
156411221|NCT00874432|564598342|FG002|Overall Study|Other|8|||
156411222|NCT00874432|564598343|FG003|Overall Study|Other|3|||
156637193|NCT00424632|565415630|FG004|Overall Study|Global deterioration of health status|1|||
156411223|NCT03713021|564598344|FG000|Overall Study|Did not have CT sim scan available|6|||
156411224|NCT03713021|564598344|FG000|Overall Study|Not eligible|4|||
156411225|NCT03713021|564598344|FG000|Overall Study|Issues with TraceIT markers|5|||
156411226|NCT00384059|564598345|FG000|Infant Series|Not consented|2|||
156411227|NCT00384059|564598346|FG001|Infant Series|Not consented|6|||
156411228|NCT00384059|564598345|FG000|Infant Series|Withdrawal by Subject|2|||
156411229|NCT00384059|564598346|FG001|Infant Series|Withdrawal by Subject|2|||
156411230|NCT00384059|564598345|FG000|Infant Series|Adverse Event|1|||
156411231|NCT00384059|564598346|FG001|Infant Series|Adverse Event|2|||
156411232|NCT00384059|564598345|FG000|Infant Series|Protocol Violation|1|||
156411233|NCT00384059|564598346|FG001|Infant Series|Protocol Violation|2|||
156411234|NCT00384059|564598345|FG000|Infant Series|Lost to Follow-up|0|||
156411235|NCT00384059|564598346|FG001|Infant Series|Lost to Follow-up|1|||
156411236|NCT00384059|564598345|FG000|After Infant Series|Protocol Violation|2|||
156411237|NCT00384059|564598346|FG001|After Infant Series|Protocol Violation|3|||
156411238|NCT00384059|564598345|FG000|After Infant Series|Withdrawal by Subject|2|||
156411239|NCT00384059|564598346|FG001|After Infant Series|Withdrawal by Subject|2|||
156411240|NCT00384059|564598345|FG000|After Infant Series|Failed to Return|0|||
156411241|NCT00384059|564598346|FG001|After Infant Series|Failed to Return|2|||
156411242|NCT00384059|564598345|FG000|After Infant Series|Adverse Event|0|||
156411243|NCT00384059|564598346|FG001|After Infant Series|Adverse Event|1|||
156411244|NCT00384059|564598345|FG000|After Infant Series|Physician Decision|0|||
156411245|NCT00384059|564598346|FG001|After Infant Series|Physician Decision|1|||
156411246|NCT00384059|564598345|FG000|After Infant Series|Lost to Follow-up|0|||
156411247|NCT00384059|564598346|FG001|After Infant Series|Lost to Follow-up|1|||
156411248|NCT00384059|564598345|FG000|Toddler Dose|Lost to Follow-up|1|||
156411249|NCT00384059|564598346|FG001|Toddler Dose|Lost to Follow-up|1|||
156411250|NCT00384059|564598345|FG000|Toddler Dose|Failed to return|0|||
156411251|NCT00384059|564598346|FG001|Toddler Dose|Failed to return|1|||
156411252|NCT00445601|564599741|FG000|Overall Study|Withdrawal by Subject|11|||
156411253|NCT00445601|564599742|FG001|Overall Study|Withdrawal by Subject|11|||
156411254|NCT00445601|564599741|FG000|Overall Study|TURBT Complication|12|||
156411255|NCT00445601|564599742|FG001|Overall Study|TURBT Complication|8|||
156411256|NCT00445601|564599741|FG000|Overall Study|Incorrect Disease Status|6|||
156411257|NCT00445601|564599742|FG001|Overall Study|Incorrect Disease Status|6|||
156411258|NCT00445601|564599741|FG000|Overall Study|Drug Delivery Issue|2|||
156411259|NCT00445601|564599742|FG001|Overall Study|Drug Delivery Issue|2|||
156411260|NCT00445601|564599741|FG000|Overall Study|Adverse Event|2|||
156411261|NCT00445601|564599742|FG001|Overall Study|Adverse Event|0|||
156411262|NCT00445601|564599741|FG000|Overall Study|Death prior to TURBT|0|||
156411263|NCT00445601|564599742|FG001|Overall Study|Death prior to TURBT|1|||
156411264|NCT03918239|564599743|FG000|Overall Study|Lost to Follow-up|3|||
156411265|NCT03918239|564599744|FG001|Overall Study|Lost to Follow-up|1|||
156411266|NCT03918239|564599743|FG000|Overall Study|Pregnancy|0|||
156411267|NCT03918239|564599744|FG001|Overall Study|Pregnancy|2|||
156411268|NCT03918239|564599743|FG000|Overall Study|Withdrawal by Subject|3|||
156411269|NCT03918239|564599744|FG001|Overall Study|Withdrawal by Subject|3|||
156411270|NCT03918239|564599743|FG000|Overall Study|positive urine drug screening results|4|||
156411271|NCT03918239|564599744|FG001|Overall Study|positive urine drug screening results|1|||
156411272|NCT01984424|564599747|FG000|Overall Study|Withdrawal by Subject|3|||
156411273|NCT01984424|564599748|FG001|Overall Study|Withdrawal by Subject|5|||
156411274|NCT01984424|564599747|FG000|Overall Study|Sponsor Decision|0|||
156411275|NCT01984424|564599748|FG001|Overall Study|Sponsor Decision|1|||
156411276|NCT01984424|564599747|FG000|Overall Study|Lost to Follow-up|0|||
156411277|NCT01984424|564599748|FG001|Overall Study|Lost to Follow-up|1|||
156411278|NCT06017999|564599749|FG000|Overall Study|Withdrawal by Subject|0|||
156411279|NCT06017999|564599750|FG001|Overall Study|Withdrawal by Subject|4|||
156411280|NCT06017999|564599751|FG002|Overall Study|Withdrawal by Subject|3|||
156411281|NCT06017999|564599749|FG000|Overall Study|Adverse Event|2|||
156411282|NCT06017999|564599750|FG001|Overall Study|Adverse Event|1|||
156411283|NCT06017999|564599751|FG002|Overall Study|Adverse Event|1|||
156411284|NCT06017999|564599749|FG000|Overall Study|Lost to Follow-up|0|||
156411285|NCT06017999|564599750|FG001|Overall Study|Lost to Follow-up|0|||
156411286|NCT06017999|564599751|FG002|Overall Study|Lost to Follow-up|1|||
156411287|NCT06017999|564599749|FG000|Overall Study|Physician Decision|1|||
156411288|NCT06017999|564599750|FG001|Overall Study|Physician Decision|1|||
156411289|NCT06017999|564599751|FG002|Overall Study|Physician Decision|0|||
156411290|NCT06017999|564599749|FG000|Overall Study|Non-Compliance|0|||
156411291|NCT06017999|564599750|FG001|Overall Study|Non-Compliance|0|||
156411292|NCT06017999|564599751|FG002|Overall Study|Non-Compliance|1|||
156411293|NCT06017999|564599749|FG000|Overall Study|Lack of Efficacy|1|||
156411294|NCT06017999|564599750|FG001|Overall Study|Lack of Efficacy|0|||
156411295|NCT06017999|564599751|FG002|Overall Study|Lack of Efficacy|7|||
156411296|NCT06017999|564599749|FG000|Overall Study|COVID Positive|0|||
156411297|NCT06017999|564599750|FG001|Overall Study|COVID Positive|1|||
156411298|NCT06017999|564599751|FG002|Overall Study|COVID Positive|0|||
156411299|NCT06017999|564599749|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
156411300|NCT06017999|564599750|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
156411301|NCT06017999|564599751|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
156411302|NCT00373295|564599752|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156411303|NCT00373295|564599753|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
156411304|NCT00373295|564599754|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156411305|NCT00373295|564599755|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156411306|NCT00373295|564599756|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
156411307|NCT00373295|564599757|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156411308|NCT01702428|564599765|FG000|Overall Study|Adverse Event|2|||
156411309|NCT01702428|564599766|FG001|Overall Study|Adverse Event|0|||
156411310|NCT01702428|564599767|FG002|Overall Study|Adverse Event|0|||
156411311|NCT01702428|564599768|FG003|Overall Study|Adverse Event|0|||
156411312|NCT01702428|564599765|FG000|Overall Study|Lost to Follow-up|33|||
156411313|NCT01702428|564599766|FG001|Overall Study|Lost to Follow-up|41|||
156411314|NCT01702428|564599767|FG002|Overall Study|Lost to Follow-up|37|||
156411315|NCT01702428|564599768|FG003|Overall Study|Lost to Follow-up|44|||
156411316|NCT01702428|564599765|FG000|Overall Study|Parents cannot assist to site|1|||
156411317|NCT01702428|564599766|FG001|Overall Study|Parents cannot assist to site|0|||
156411318|NCT01702428|564599767|FG002|Overall Study|Parents cannot assist to site|1|||
156411319|NCT01702428|564599768|FG003|Overall Study|Parents cannot assist to site|0|||
156411320|NCT01702428|564599765|FG000|Overall Study|Lost Coverage|0|||
156411321|NCT01702428|564599766|FG001|Overall Study|Lost Coverage|0|||
156411322|NCT01702428|564599767|FG002|Overall Study|Lost Coverage|0|||
156411323|NCT01702428|564599768|FG003|Overall Study|Lost Coverage|1|||
156411324|NCT01702428|564599765|FG000|Overall Study|Lost Health Plan|3|||
156411325|NCT01702428|564599766|FG001|Overall Study|Lost Health Plan|5|||
156411326|NCT01702428|564599767|FG002|Overall Study|Lost Health Plan|0|||
156411327|NCT01702428|564599768|FG003|Overall Study|Lost Health Plan|2|||
156411328|NCT01702428|564599765|FG000|Overall Study|Mother transferred care|0|||
156411329|NCT01702428|564599766|FG001|Overall Study|Mother transferred care|1|||
156411330|NCT01702428|564599767|FG002|Overall Study|Mother transferred care|0|||
156411331|NCT01702428|564599768|FG003|Overall Study|Mother transferred care|0|||
156411332|NCT01702428|564599765|FG000|Overall Study|Parents too busy|1|||
156411333|NCT01702428|564599766|FG001|Overall Study|Parents too busy|0|||
156411334|NCT01702428|564599767|FG002|Overall Study|Parents too busy|0|||
156411335|NCT01702428|564599768|FG003|Overall Study|Parents too busy|0|||
156411336|NCT01702428|564599765|FG000|Overall Study|Protocol Violation|3|||
156411337|NCT01702428|564599766|FG001|Overall Study|Protocol Violation|0|||
156411338|NCT01702428|564599767|FG002|Overall Study|Protocol Violation|1|||
156411339|NCT01702428|564599768|FG003|Overall Study|Protocol Violation|0|||
156411340|NCT01702428|564599765|FG000|Overall Study|Withdrawal by Subject|21|||
156411341|NCT01702428|564599766|FG001|Overall Study|Withdrawal by Subject|23|||
156411342|NCT01702428|564599767|FG002|Overall Study|Withdrawal by Subject|14|||
156411343|NCT01702428|564599768|FG003|Overall Study|Withdrawal by Subject|10|||
156411344|NCT02091869|564599769|FG000|Overall Study|Withdrawal by Subject|0|||
156411345|NCT02091869|564599770|FG001|Overall Study|Withdrawal by Subject|3|||
156411346|NCT01375959|564599772|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
156411347|NCT01375959|564599773|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
156411348|NCT01375959|564599772|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
156411349|NCT01375959|564599773|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
156411350|NCT01375959|564599772|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
156411351|NCT01375959|564599773|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
156411352|NCT04789577|564599776|FG000|Overall Study|Withdrawal by Subject|1|||
156411353|NCT04789577|564599777|FG001|Overall Study|Withdrawal by Subject|1|||
156411354|NCT04789577|564599778|FG002|Overall Study|Withdrawal by Subject|1|||
156411355|NCT04789577|564599779|FG003|Overall Study|Withdrawal by Subject|3|||
156411356|NCT04789577|564599780|FG004|Overall Study|Withdrawal by Subject|1|||
156411357|NCT04789577|564599781|FG005|Overall Study|Withdrawal by Subject|7|||
156411358|NCT04789577|564599782|FG006|Overall Study|Withdrawal by Subject|1|||
156411359|NCT04789577|564599776|FG000|Overall Study|Lost to Follow-up|7|||
156411360|NCT04789577|564599777|FG001|Overall Study|Lost to Follow-up|12|||
156411361|NCT04789577|564599778|FG002|Overall Study|Lost to Follow-up|7|||
156411362|NCT04789577|564599779|FG003|Overall Study|Lost to Follow-up|10|||
156411363|NCT04789577|564599780|FG004|Overall Study|Lost to Follow-up|8|||
156411364|NCT04789577|564599781|FG005|Overall Study|Lost to Follow-up|6|||
156411365|NCT04789577|564599782|FG006|Overall Study|Lost to Follow-up|10|||
156411366|NCT04789577|564599776|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
156411367|NCT04789577|564599777|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
156411368|NCT04789577|564599778|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
156411369|NCT04789577|564599779|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
156411370|NCT04789577|564599780|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
156411371|NCT04789577|564599781|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
156411372|NCT04789577|564599782|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
156411373|NCT04789577|564599776|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
156411374|NCT04789577|564599777|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
156411375|NCT04789577|564599778|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
156411376|NCT04789577|564599779|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
156411377|NCT04789577|564599780|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
156411378|NCT04789577|564599781|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
156411379|NCT04789577|564599782|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
156411380|NCT01027364|564599783|FG000|Overall Study|Adverse Event|1|||
156411381|NCT01027364|564599784|FG001|Overall Study|Adverse Event|0|||
156411382|NCT01027364|564599785|FG002|Overall Study|Adverse Event|1|||
156411383|NCT01027364|564599786|FG003|Overall Study|Adverse Event|0|||
156411384|NCT01027364|564599783|FG000|Overall Study|Lost to Follow-up|1|||
156411385|NCT01027364|564599784|FG001|Overall Study|Lost to Follow-up|0|||
156411386|NCT01027364|564599785|FG002|Overall Study|Lost to Follow-up|0|||
156411387|NCT01027364|564599786|FG003|Overall Study|Lost to Follow-up|0|||
156411388|NCT01027364|564599783|FG000|Overall Study|Protocol Violation|1|||
156411389|NCT01027364|564599784|FG001|Overall Study|Protocol Violation|0|||
156411390|NCT01027364|564599785|FG002|Overall Study|Protocol Violation|0|||
156411391|NCT01027364|564599786|FG003|Overall Study|Protocol Violation|1|||
156411392|NCT01027364|564599783|FG000|Overall Study|Withdrawal by Subject|1|||
156411393|NCT01027364|564599784|FG001|Overall Study|Withdrawal by Subject|2|||
156411394|NCT01027364|564599785|FG002|Overall Study|Withdrawal by Subject|0|||
156411395|NCT01027364|564599786|FG003|Overall Study|Withdrawal by Subject|0|||
156411396|NCT01394250|564599787|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
156411397|NCT01394250|564599788|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
156411398|NCT01394250|564599787|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
156411399|NCT01394250|564599788|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
156411400|NCT04297241|564599793|FG000|Overall Study|Withdrawal by Subject|1|||
156411401|NCT04297241|564599793|FG000|Overall Study|Adverse Event|1|||
156411402|NCT04297241|564599793|FG000|Overall Study|Physician Decision|3|||
156411403|NCT00786474|564599798|FG000|Overall Study|Death|5|||
156411404|NCT00786474|564599799|FG001|Overall Study|Death|4|||
156411405|NCT00786474|564599798|FG000|Overall Study|Withdrawal by Subject|23|||
156411406|NCT00786474|564599799|FG001|Overall Study|Withdrawal by Subject|31|||
156411407|NCT00786474|564599798|FG000|Overall Study|Lost to Follow-up|3|||
156411408|NCT00786474|564599799|FG001|Overall Study|Lost to Follow-up|3|||
156411409|NCT00786474|564599798|FG000|Overall Study|Physician Decision|2|||
156411410|NCT00786474|564599799|FG001|Overall Study|Physician Decision|1|||
156411411|NCT00786474|564599798|FG000|Overall Study|Other|4|||
156411412|NCT00786474|564599799|FG001|Overall Study|Other|4|||
156411413|NCT05407311|564599804|FG000|Overall Study|Withdrawal by Subject|5|||
156411414|NCT05407311|564599804|FG000|Overall Study|Protocol Violation|3|||
156411415|NCT05407311|564599804|FG000|Overall Study|Physician Decision|1|||
156411416|NCT05407311|564599804|FG000|Overall Study|Non-compliance|1|||
156411417|NCT01265823|564599805|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
156411418|NCT01265823|564599805|FG000|Overall Study|Failure to Return|4|||
156411419|NCT01265823|564599805|FG000|Overall Study|Protocol Violation|1|||
156411420|NCT01265823|564599805|FG000|Overall Study|Participant Request|1|||
156411421|NCT01263106|564599806|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
156411422|NCT01263106|564599807|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
156411423|NCT03734991|564599816|FG000|Overall Study|Adverse Event|4|||
156411424|NCT03734991|564599817|FG001|Overall Study|Adverse Event|0|||
156411425|NCT03734991|564599816|FG000|Overall Study|Lost to Follow-up|4|||
156411426|NCT03734991|564599817|FG001|Overall Study|Lost to Follow-up|0|||
156411427|NCT03734991|564599816|FG000|Overall Study|Physician Decision|0|||
156411428|NCT03734991|564599817|FG001|Overall Study|Physician Decision|1|||
156411429|NCT03734991|564599816|FG000|Overall Study|Pregnancy|1|||
156411430|NCT03734991|564599817|FG001|Overall Study|Pregnancy|0|||
156411431|NCT03734991|564599816|FG000|Overall Study|Withdrawal by Subject|6|||
156411432|NCT03734991|564599817|FG001|Overall Study|Withdrawal by Subject|3|||
156411433|NCT03734991|564599816|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
156411434|NCT03734991|564599817|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
156411435|NCT03734991|564599816|FG000|Overall Study|Other|2|||
156411436|NCT03734991|564599817|FG001|Overall Study|Other|2|||
156411437|NCT02322814|564599820|FG000|Overall Study|Death|7|||
156411438|NCT02322814|564599821|FG001|Overall Study|Death|29|||
156411439|NCT02322814|564599822|FG002|Overall Study|Death|32|||
156411440|NCT02322814|564599823|FG003|Overall Study|Death|23|||
156411441|NCT02322814|564599824|FG004|Overall Study|Death|14|||
156411442|NCT02322814|564599820|FG000|Overall Study|Lost to Follow-up|1|||
156411443|NCT02322814|564599821|FG001|Overall Study|Lost to Follow-up|3|||
156411444|NCT02322814|564599822|FG002|Overall Study|Lost to Follow-up|3|||
156411445|NCT02322814|564599823|FG003|Overall Study|Lost to Follow-up|1|||
156411446|NCT02322814|564599824|FG004|Overall Study|Lost to Follow-up|0|||
156411447|NCT02322814|564599820|FG000|Overall Study|Various Reasons|2|||
156411448|NCT02322814|564599821|FG001|Overall Study|Various Reasons|0|||
156411449|NCT02322814|564599822|FG002|Overall Study|Various Reasons|1|||
156411450|NCT02322814|564599823|FG003|Overall Study|Various Reasons|1|||
156411451|NCT02322814|564599824|FG004|Overall Study|Various Reasons|0|||
156411452|NCT02322814|564599820|FG000|Overall Study|Progressive Disease|0|||
156411453|NCT02322814|564599821|FG001|Overall Study|Progressive Disease|0|||
156411454|NCT02322814|564599822|FG002|Overall Study|Progressive Disease|0|||
156411455|NCT02322814|564599823|FG003|Overall Study|Progressive Disease|1|||
156411456|NCT02322814|564599824|FG004|Overall Study|Progressive Disease|1|||
156411457|NCT02322814|564599820|FG000|Overall Study|Protocol Violation|1|||
156411458|NCT02322814|564599821|FG001|Overall Study|Protocol Violation|0|||
156637194|NCT00424632|565415631|FG005|Overall Study|Global deterioration of health status|0|||
156637195|NCT00424632|565415632|FG006|Overall Study|Global deterioration of health status|0|||
156637196|NCT00424632|565415633|FG007|Overall Study|Global deterioration of health status|0|||
156411459|NCT02322814|564599822|FG002|Overall Study|Protocol Violation|0|||
156411460|NCT02322814|564599823|FG003|Overall Study|Protocol Violation|0|||
156411461|NCT02322814|564599824|FG004|Overall Study|Protocol Violation|0|||
156411462|NCT02322814|564599820|FG000|Overall Study|Study Terminated by Sponsor|0|||
156411463|NCT02322814|564599821|FG001|Overall Study|Study Terminated by Sponsor|7|||
156637197|NCT00424632|565415634|FG008|Overall Study|Global deterioration of health status|0|||
156751626|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
156751627|NCT02432144|565842076|FG000|Overall Study|Participant Non-Compliance|1|||
156751628|NCT01483599|565842077|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
156751629|NCT01483599|565842078|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751630|NCT01483599|565842079|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751631|NCT01483599|565842080|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
156751632|NCT01483599|565842081|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
156751633|NCT01483599|565842082|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
156751634|NCT01483599|565842083|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
156751635|NCT01483599|565842084|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751636|NCT01483599|565842085|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751637|NCT01483599|565842086|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751638|NCT01483599|565842087|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751639|NCT01483599|565842088|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751640|NCT01483599|565842089|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751641|NCT01483599|565842090|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751642|NCT01483599|565842077|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751643|NCT01483599|565842078|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
156751644|NCT01483599|565842079|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751645|NCT01483599|565842080|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
156751646|NCT01483599|565842081|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751647|NCT01483599|565842082|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751648|NCT01483599|565842083|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
156751649|NCT01483599|565842084|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751650|NCT01483599|565842085|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751651|NCT01483599|565842086|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751652|NCT01483599|565842087|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751653|NCT01483599|565842088|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751654|NCT01483599|565842089|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751655|NCT01483599|565842090|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751656|NCT01483599|565842077|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
156751657|NCT01483599|565842078|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751658|NCT01483599|565842079|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751659|NCT01483599|565842080|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751660|NCT01483599|565842081|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751661|NCT01483599|565842082|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751662|NCT01483599|565842083|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751663|NCT01483599|565842084|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751664|NCT01483599|565842085|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751665|NCT01483599|565842086|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751666|NCT01483599|565842087|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751667|NCT01483599|565842088|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751668|NCT01483599|565842089|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751669|NCT01483599|565842090|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751670|NCT01483599|565842077|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
156751671|NCT01483599|565842078|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
156751672|NCT01483599|565842079|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
156751673|NCT01483599|565842080|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
156751674|NCT01483599|565842081|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
156751675|NCT01483599|565842082|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
156751676|NCT01483599|565842083|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
156751677|NCT01483599|565842084|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
156751678|NCT01483599|565842085|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
156751679|NCT01483599|565842086|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
156751680|NCT01483599|565842087|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
156751681|NCT01483599|565842088|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
156751682|NCT01483599|565842089|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
156751683|NCT01483599|565842090|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
156751684|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
156751685|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
156751686|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
156751687|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
156751688|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
156751689|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
156751690|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
156751691|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
156751692|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
156411464|NCT02322814|564599822|FG002|Overall Study|Study Terminated by Sponsor|9|||
156411465|NCT02322814|564599823|FG003|Overall Study|Study Terminated by Sponsor|5|||
156411466|NCT02322814|564599824|FG004|Overall Study|Study Terminated by Sponsor|13|||
156411467|NCT02322814|564599820|FG000|Overall Study|Withdrawal by Subject|5|||
156637198|NCT00424632|565415635|FG009|Overall Study|Global deterioration of health status|0|||
156637199|NCT00424632|565415626|FG000|Overall Study|Objective progression or relapse|1|||
156411468|NCT02322814|564599821|FG001|Overall Study|Withdrawal by Subject|4|||
156411469|NCT02322814|564599822|FG002|Overall Study|Withdrawal by Subject|2|||
156411470|NCT02322814|564599823|FG003|Overall Study|Withdrawal by Subject|1|||
156411471|NCT02322814|564599824|FG004|Overall Study|Withdrawal by Subject|3|||
156411472|NCT03012061|564599825|FG000|Overall Study|Withdrawal by Subject|1|||
156411473|NCT03012061|564599826|FG001|Overall Study|Withdrawal by Subject|5|||
156411474|NCT03012061|564599827|FG002|Overall Study|Withdrawal by Subject|4|||
156411475|NCT03012061|564599825|FG000|Overall Study|Investigator Site Closed|1|||
156411476|NCT03012061|564599826|FG001|Overall Study|Investigator Site Closed|2|||
156411477|NCT03012061|564599827|FG002|Overall Study|Investigator Site Closed|0|||
156411478|NCT03012061|564599825|FG000|Overall Study|Lost to Follow-up|2|||
156411479|NCT03012061|564599826|FG001|Overall Study|Lost to Follow-up|1|||
156411480|NCT03012061|564599827|FG002|Overall Study|Lost to Follow-up|0|||
156411481|NCT03012061|564599825|FG000|Overall Study|Study closed/ Terminated|0|||
156411482|NCT03012061|564599826|FG001|Overall Study|Study closed/ Terminated|0|||
156411483|NCT03012061|564599827|FG002|Overall Study|Study closed/ Terminated|1|||
156411484|NCT03012061|564599825|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
156411485|NCT03012061|564599826|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
156411486|NCT03012061|564599827|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
156411487|NCT03012061|564599825|FG000|Overall Study|Protocol Violation|0|||
156637200|NCT00424632|565415627|FG001|Overall Study|Objective progression or relapse|1|||
156637201|NCT00424632|565415628|FG002|Overall Study|Objective progression or relapse|1|||
156637202|NCT00424632|565415629|FG003|Overall Study|Objective progression or relapse|2|||
156637203|NCT00424632|565415630|FG004|Overall Study|Objective progression or relapse|2|||
156637204|NCT00424632|565415631|FG005|Overall Study|Objective progression or relapse|13|||
156637205|NCT00424632|565415632|FG006|Overall Study|Objective progression or relapse|7|||
156637206|NCT00424632|565415633|FG007|Overall Study|Objective progression or relapse|3|||
156637207|NCT00424632|565415634|FG008|Overall Study|Objective progression or relapse|12|||
156637208|NCT00424632|565415635|FG009|Overall Study|Objective progression or relapse|4|||
156637209|NCT00424632|565415626|FG000|Overall Study|Other|0|||
156637210|NCT00424632|565415627|FG001|Overall Study|Other|0|||
156637211|NCT00424632|565415628|FG002|Overall Study|Other|0|||
156637212|NCT00424632|565415629|FG003|Overall Study|Other|1|||
156637213|NCT00424632|565415630|FG004|Overall Study|Other|0|||
156637214|NCT00424632|565415631|FG005|Overall Study|Other|0|||
156637215|NCT00424632|565415632|FG006|Overall Study|Other|0|||
156637216|NCT00424632|565415633|FG007|Overall Study|Other|0|||
156637217|NCT00424632|565415634|FG008|Overall Study|Other|1|||
156637218|NCT00424632|565415635|FG009|Overall Study|Other|0|||
156637219|NCT03159611|565415636|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
156637220|NCT03159611|565415637|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
156637221|NCT03159611|565415636|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
156637222|NCT03159611|565415637|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
156637223|NCT03159611|565415636|FG000|Overall Study|Protocol Violation|7|||
156637224|NCT03159611|565415637|FG001|Overall Study|Protocol Violation|4|||
156637225|NCT03159611|565415636|FG000|Overall Study|Adverse Event|1|||
156637226|NCT03159611|565415637|FG001|Overall Study|Adverse Event|0|||
156637227|NCT03159611|565415636|FG000|Overall Study|Withdrawal by Subject|1|||
156637228|NCT03159611|565415637|FG001|Overall Study|Withdrawal by Subject|1|||
156637229|NCT03159611|565415636|FG000|Overall Study|Non-compliance with protocol requirement|3|||
156637230|NCT03159611|565415637|FG001|Overall Study|Non-compliance with protocol requirement|2|||
156637231|NCT03159611|565415636|FG000|Overall Study|Inability to perform procedures|1|||
156637232|NCT03159611|565415637|FG001|Overall Study|Inability to perform procedures|0|||
156637233|NCT01984229|565415638|FG000|Safety Follow-up Period|Adverse Event|1|||
156637234|NCT01984229|565415639|FG001|Safety Follow-up Period|Adverse Event|1|||
156637235|NCT01984229|565415638|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
156637236|NCT01984229|565415639|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
156637237|NCT05674721|565415641|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
156637238|NCT05674721|565415642|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
156637239|NCT05674721|565415641|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
156637240|NCT05674721|565415642|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
156637241|NCT03506425|565415652|FG000|Overall Study|Adverse Event|1|||
156637242|NCT03506425|565415653|FG001|Overall Study|Adverse Event|3|||
156637243|NCT03506425|565415654|FG002|Overall Study|Adverse Event|0|||
156637244|NCT03506425|565415652|FG000|Overall Study|Death|1|||
156637245|NCT03506425|565415653|FG001|Overall Study|Death|0|||
156637246|NCT03506425|565415654|FG002|Overall Study|Death|0|||
156637247|NCT03506425|565415652|FG000|Overall Study|Withdrawal by Subject|0|||
156637248|NCT03506425|565415653|FG001|Overall Study|Withdrawal by Subject|0|||
156637249|NCT03506425|565415654|FG002|Overall Study|Withdrawal by Subject|1|||
156637250|NCT04150107|565415657|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
156637251|NCT04150107|565415658|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
156637252|NCT04150107|565415657|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
156411488|NCT03012061|564599826|FG001|Overall Study|Protocol Violation|0|||
156637253|NCT04150107|565415658|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
156637254|NCT03409328|565415659|FG000|Overall Study|Lost to Follow-up|6|||
156637255|NCT03409328|565415660|FG001|Overall Study|Lost to Follow-up|3|||
156637256|NCT02998645|565415661|FG000|Treatment Period 1|Adverse Event|6|||
156637257|NCT02998645|565415661|FG000|Treatment Period 1|Death|5|||
156637258|NCT02998645|565415661|FG000|Treatment Period 1|Technical Problems|4|||
156637259|NCT02998645|565415661|FG000|Treatment Period 1|Lack of Efficacy|2|||
156637260|NCT02998645|565415661|FG000|Treatment Period 1|Progressive disease|1|||
156637261|NCT02998645|565415661|FG000|Treatment Period 1|Subject/guardian decision|1|||
156637262|NCT02998645|565415661|FG000|Treatment Period 2|Lack of Efficacy|5|||
156637263|NCT02998645|565415661|FG000|Treatment Period 2|Adverse Event|2|||
156637264|NCT02998645|565415661|FG000|Treatment Period 2|Progressive disease|2|||
156637265|NCT02998645|565415661|FG000|Treatment Period 2|Physician Decision|1|||
156637266|NCT00478673|565415662|FG000|30-Days Post-Procedure|Death|2|||
156637267|NCT00478673|565415662|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
156637268|NCT00478673|565415662|FG000|30-Days Post-Procedure|Missed Visit|7|||
156411489|NCT03012061|564599827|FG002|Overall Study|Protocol Violation|2|||
156411490|NCT03012061|564599825|FG000|Overall Study|Lack of Efficacy|0|||
156411491|NCT03012061|564599826|FG001|Overall Study|Lack of Efficacy|1|||
156411492|NCT03012061|564599827|FG002|Overall Study|Lack of Efficacy|0|||
156411493|NCT03012061|564599825|FG000|Overall Study|Adverse Event|2|||
156411494|NCT03012061|564599826|FG001|Overall Study|Adverse Event|0|||
156411495|NCT03012061|564599827|FG002|Overall Study|Adverse Event|0|||
156411496|NCT01164228|564599828|FG000|Overall Study|Progression|24|||
156411497|NCT01164228|564599829|FG001|Overall Study|Progression|25|||
156411498|NCT01164228|564599828|FG000|Overall Study|Adverse Event|13|||
156411499|NCT01164228|564599829|FG001|Overall Study|Adverse Event|7|||
156411500|NCT01164228|564599828|FG000|Overall Study|Death|1|||
156411501|NCT01164228|564599829|FG001|Overall Study|Death|1|||
156411502|NCT01164228|564599828|FG000|Overall Study|Withdrawal by Subject|2|||
156411503|NCT01164228|564599829|FG001|Overall Study|Withdrawal by Subject|0|||
156411504|NCT01164228|564599828|FG000|Overall Study|Physician Decision|1|||
156411505|NCT01164228|564599829|FG001|Overall Study|Physician Decision|2|||
156411506|NCT01164228|564599828|FG000|Overall Study|Symptomatic deterioration|1|||
156411507|NCT01164228|564599829|FG001|Overall Study|Symptomatic deterioration|0|||
156411508|NCT01164228|564599828|FG000|Overall Study|Never started treatment|1|||
156411509|NCT01164228|564599829|FG001|Overall Study|Never started treatment|3|||
156411510|NCT01164228|564599828|FG000|Overall Study|Ineligible|1|||
156751693|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
156751694|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
156751695|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
156751696|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
156751697|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
156751698|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751699|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751700|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751701|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751702|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751703|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751704|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751705|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
156751706|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
156751707|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751708|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156411511|NCT01164228|564599829|FG001|Overall Study|Ineligible|0|||
156411512|NCT04908449|564599830|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
156411513|NCT04908449|564599831|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
156411514|NCT04908449|564599830|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
156411515|NCT04908449|564599831|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
156411516|NCT01567865|564599834|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
156411517|NCT01567865|564599835|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
156411518|NCT01567865|564599836|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
156411519|NCT01567865|564599837|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
156411520|NCT01567865|564599834|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
156411521|NCT01567865|564599835|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
156411522|NCT01567865|564599836|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
156411523|NCT01567865|564599837|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
156411524|NCT05256381|564599838|FG000|Overall Study|Withdrawal by Subject|4|||
156411525|NCT05256381|564599839|FG001|Overall Study|Withdrawal by Subject|0|||
156411526|NCT05256381|564599840|FG002|Overall Study|Withdrawal by Subject|2|||
156411527|NCT05256381|564599841|FG003|Overall Study|Withdrawal by Subject|2|||
156411528|NCT05256381|564599842|FG004|Overall Study|Withdrawal by Subject|8|||
156411529|NCT05256381|564599843|FG005|Overall Study|Withdrawal by Subject|6|||
156411530|NCT05256381|564599838|FG000|Overall Study|Physician Decision|0|||
156411531|NCT05256381|564599839|FG001|Overall Study|Physician Decision|0|||
156411532|NCT05256381|564599840|FG002|Overall Study|Physician Decision|1|||
156411533|NCT05256381|564599841|FG003|Overall Study|Physician Decision|0|||
156411534|NCT05256381|564599842|FG004|Overall Study|Physician Decision|2|||
156411535|NCT05256381|564599843|FG005|Overall Study|Physician Decision|0|||
156411536|NCT05256381|564599838|FG000|Overall Study|Death|17|||
156411537|NCT05256381|564599839|FG001|Overall Study|Death|3|||
156411538|NCT05256381|564599840|FG002|Overall Study|Death|4|||
156411539|NCT05256381|564599841|FG003|Overall Study|Death|5|||
156411540|NCT05256381|564599842|FG004|Overall Study|Death|24|||
156411541|NCT05256381|564599843|FG005|Overall Study|Death|21|||
156411542|NCT05256381|564599838|FG000|Overall Study|Other, not specified|0|||
156411543|NCT05256381|564599839|FG001|Overall Study|Other, not specified|0|||
156411544|NCT05256381|564599840|FG002|Overall Study|Other, not specified|0|||
156411545|NCT05256381|564599841|FG003|Overall Study|Other, not specified|0|||
156411546|NCT05256381|564599842|FG004|Overall Study|Other, not specified|2|||
156411547|NCT05256381|564599843|FG005|Overall Study|Other, not specified|1|||
156411548|NCT05256381|564599838|FG000|Overall Study|Study terminated by sponsor|18|||
156411549|NCT05256381|564599839|FG001|Overall Study|Study terminated by sponsor|5|||
156411550|NCT05256381|564599840|FG002|Overall Study|Study terminated by sponsor|5|||
156411551|NCT05256381|564599841|FG003|Overall Study|Study terminated by sponsor|5|||
156411552|NCT05256381|564599842|FG004|Overall Study|Study terminated by sponsor|18|||
156411553|NCT05256381|564599843|FG005|Overall Study|Study terminated by sponsor|11|||
156411554|NCT05256381|564599838|FG000|Overall Study|Lost to Follow-up|1|||
156411555|NCT05256381|564599839|FG001|Overall Study|Lost to Follow-up|0|||
156411556|NCT05256381|564599840|FG002|Overall Study|Lost to Follow-up|0|||
156411557|NCT05256381|564599841|FG003|Overall Study|Lost to Follow-up|0|||
156411558|NCT05256381|564599842|FG004|Overall Study|Lost to Follow-up|1|||
156411559|NCT05256381|564599843|FG005|Overall Study|Lost to Follow-up|0|||
156411560|NCT05569954|564599846|FG000|Overall Study|Lost to Follow-up|3|||
156411561|NCT05569954|564599847|FG001|Overall Study|Lost to Follow-up|4|||
156411562|NCT05569954|564599846|FG000|Overall Study|Protocol Violation|1|||
156411563|NCT05569954|564599847|FG001|Overall Study|Protocol Violation|2|||
156411564|NCT05569954|564599846|FG000|Overall Study|Withdrawal by Subject|4|||
156411565|NCT05569954|564599847|FG001|Overall Study|Withdrawal by Subject|2|||
156411566|NCT01518946|564599857|FG000|Open-label Phase|Other|4|||
156411567|NCT01518946|564599858|FG001|Open-label Phase|Other|0|||
156411568|NCT01518946|564599859|FG002|Open-label Phase|Other|0|||
156411569|NCT01518946|564599857|FG000|Randomized Phase (First Intervention)|Other|0|||
156411570|NCT01518946|564599858|FG001|Randomized Phase (First Intervention)|Other|1|||
156411571|NCT01518946|564599859|FG002|Randomized Phase (First Intervention)|Other|0|||
156411572|NCT03857841|564599860|FG000|Overall Study|Death|1|||
156411573|NCT03857841|564599861|FG001|Overall Study|Death|0|||
156411574|NCT03857841|564599862|FG002|Overall Study|Death|0|||
156411575|NCT03857841|564599863|FG003|Overall Study|Death|0|||
156411576|NCT03857841|564599860|FG000|Overall Study|Study Terminated by Sponsor|1|||
156411577|NCT03857841|564599861|FG001|Overall Study|Study Terminated by Sponsor|0|||
156411578|NCT03857841|564599862|FG002|Overall Study|Study Terminated by Sponsor|0|||
156411579|NCT03857841|564599863|FG003|Overall Study|Study Terminated by Sponsor|0|||
156411580|NCT00381641|564599866|FG000|Overall Study|Withdrawal by Subject|0|||
156411581|NCT00381641|564599867|FG001|Overall Study|Withdrawal by Subject|2|||
156411582|NCT04213989|564601368|FG000|Overall Study|Withdrawal by Subject|3|||
156411583|NCT04213989|564601369|FG001|Overall Study|Withdrawal by Subject|2|||
156411584|NCT04213989|564601368|FG000|Overall Study|Physician Decision|1|||
156411585|NCT04213989|564601369|FG001|Overall Study|Physician Decision|0|||
156411586|NCT04213989|564601368|FG000|Overall Study|Lost to Follow-up|0|||
156411587|NCT04213989|564601369|FG001|Overall Study|Lost to Follow-up|4|||
156411588|NCT03390036|564601372|FG000|Overall Study|Lost to Follow-up|1|||
156411589|NCT03390036|564601373|FG001|Overall Study|Lost to Follow-up|0|||
156411590|NCT03390036|564601374|FG002|Overall Study|Lost to Follow-up|0|||
156411591|NCT03390036|564601372|FG000|Overall Study|Lack of Efficacy|1|||
156411592|NCT03390036|564601373|FG001|Overall Study|Lack of Efficacy|0|||
156411593|NCT03390036|564601374|FG002|Overall Study|Lack of Efficacy|0|||
156411594|NCT01807221|564601375|FG000|Overall Study|Progressive disease|1|||
156411595|NCT01807221|564601376|FG001|Overall Study|Progressive disease|0|||
156411596|NCT01807221|564601377|FG002|Overall Study|Progressive disease|1|||
156411597|NCT01807221|564601378|FG003|Overall Study|Progressive disease|0|||
156411598|NCT01807221|564601379|FG004|Overall Study|Progressive disease|0|||
156411599|NCT01807221|564601380|FG005|Overall Study|Progressive disease|0|||
156411600|NCT01807221|564601375|FG000|Overall Study|Death|7|||
156411601|NCT01807221|564601376|FG001|Overall Study|Death|9|||
156411602|NCT01807221|564601377|FG002|Overall Study|Death|4|||
156411603|NCT01807221|564601378|FG003|Overall Study|Death|2|||
156411604|NCT01807221|564601379|FG004|Overall Study|Death|1|||
156411605|NCT01807221|564601380|FG005|Overall Study|Death|6|||
156411606|NCT01807221|564601375|FG000|Overall Study|Physician Decision|2|||
156411607|NCT01807221|564601376|FG001|Overall Study|Physician Decision|1|||
156411608|NCT01807221|564601377|FG002|Overall Study|Physician Decision|0|||
156411609|NCT01807221|564601378|FG003|Overall Study|Physician Decision|0|||
156411610|NCT01807221|564601379|FG004|Overall Study|Physician Decision|0|||
156411611|NCT01807221|564601380|FG005|Overall Study|Physician Decision|0|||
156411612|NCT01807221|564601375|FG000|Overall Study|Adverse Event|33|||
156411613|NCT01807221|564601376|FG001|Overall Study|Adverse Event|22|||
156637269|NCT00478673|565415662|FG000|12-Months Post-Procedure|Death|23|||
156637270|NCT00478673|565415662|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
156637271|NCT00478673|565415662|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
156637272|NCT00478673|565415662|FG000|12-Months Post-Procedure|Missed Visit|25|||
156411614|NCT01807221|564601377|FG002|Overall Study|Adverse Event|26|||
156411615|NCT01807221|564601378|FG003|Overall Study|Adverse Event|25|||
156411616|NCT01807221|564601379|FG004|Overall Study|Adverse Event|18|||
156411617|NCT01807221|564601380|FG005|Overall Study|Adverse Event|21|||
156411618|NCT01807221|564601375|FG000|Overall Study|Protocol Violation|0|||
156411619|NCT01807221|564601376|FG001|Overall Study|Protocol Violation|2|||
156411620|NCT01807221|564601377|FG002|Overall Study|Protocol Violation|1|||
156411621|NCT01807221|564601378|FG003|Overall Study|Protocol Violation|2|||
156411622|NCT01807221|564601379|FG004|Overall Study|Protocol Violation|0|||
156411623|NCT01807221|564601380|FG005|Overall Study|Protocol Violation|1|||
156411624|NCT01807221|564601375|FG000|Overall Study|Non-compliance|1|||
156411625|NCT01807221|564601376|FG001|Overall Study|Non-compliance|2|||
156411626|NCT01807221|564601377|FG002|Overall Study|Non-compliance|0|||
156411627|NCT01807221|564601378|FG003|Overall Study|Non-compliance|1|||
156411628|NCT01807221|564601379|FG004|Overall Study|Non-compliance|0|||
156411629|NCT01807221|564601380|FG005|Overall Study|Non-compliance|0|||
156411630|NCT01807221|564601375|FG000|Overall Study|Logistical difficulties|0|||
156411631|NCT01807221|564601376|FG001|Overall Study|Logistical difficulties|1|||
156411632|NCT01807221|564601377|FG002|Overall Study|Logistical difficulties|0|||
156411633|NCT01807221|564601378|FG003|Overall Study|Logistical difficulties|0|||
156411634|NCT01807221|564601379|FG004|Overall Study|Logistical difficulties|1|||
156411635|NCT01807221|564601380|FG005|Overall Study|Logistical difficulties|0|||
156411636|NCT01807221|564601375|FG000|Overall Study|Withdrawal by Subject|33|||
156411637|NCT01807221|564601376|FG001|Overall Study|Withdrawal by Subject|15|||
156411638|NCT01807221|564601377|FG002|Overall Study|Withdrawal by Subject|8|||
156411639|NCT01807221|564601378|FG003|Overall Study|Withdrawal by Subject|14|||
156411640|NCT01807221|564601379|FG004|Overall Study|Withdrawal by Subject|16|||
156411641|NCT01807221|564601380|FG005|Overall Study|Withdrawal by Subject|13|||
156411642|NCT01807221|564601375|FG000|Overall Study|Sponsor decision|2|||
156411643|NCT01807221|564601376|FG001|Overall Study|Sponsor decision|0|||
156411644|NCT01807221|564601377|FG002|Overall Study|Sponsor decision|1|||
156411645|NCT01807221|564601378|FG003|Overall Study|Sponsor decision|1|||
156411646|NCT01807221|564601379|FG004|Overall Study|Sponsor decision|0|||
156411647|NCT01807221|564601380|FG005|Overall Study|Sponsor decision|0|||
156411648|NCT01807221|564601375|FG000|Overall Study|Lost to Follow-up|1|||
156411649|NCT01807221|564601376|FG001|Overall Study|Lost to Follow-up|0|||
156411650|NCT01807221|564601377|FG002|Overall Study|Lost to Follow-up|2|||
156411651|NCT01807221|564601378|FG003|Overall Study|Lost to Follow-up|1|||
156411652|NCT01807221|564601379|FG004|Overall Study|Lost to Follow-up|0|||
156411653|NCT01807221|564601380|FG005|Overall Study|Lost to Follow-up|0|||
156411654|NCT01089556|564601381|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
156411655|NCT01089556|564601382|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
156411656|NCT01089556|564601383|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
156411657|NCT01089556|564601384|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
156411658|NCT01089556|564601385|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
156411659|NCT01089556|564601386|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
156411660|NCT01089556|564601381|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
156411661|NCT01089556|564601382|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
156411662|NCT01089556|564601383|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
156411663|NCT01089556|564601384|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
156411664|NCT01089556|564601385|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
156411665|NCT01089556|564601386|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
156411666|NCT01089556|564601381|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
156411667|NCT01089556|564601382|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
156411668|NCT01089556|564601383|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
156411669|NCT01089556|564601384|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
156411670|NCT01089556|564601385|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
156411671|NCT01089556|564601386|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
156411672|NCT01089556|564601381|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156411673|NCT01089556|564601382|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
156411674|NCT01089556|564601383|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156411675|NCT01089556|564601384|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156411676|NCT01089556|564601385|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156411677|NCT01089556|564601386|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156411678|NCT01089556|564601381|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
156411679|NCT01089556|564601382|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
156411680|NCT01089556|564601383|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
156411681|NCT01089556|564601384|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
156411682|NCT01089556|564601385|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
156411683|NCT01089556|564601386|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
156411684|NCT01089556|564601381|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
156411685|NCT01089556|564601382|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
156411686|NCT01089556|564601383|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
156411687|NCT01089556|564601384|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
156637273|NCT00478673|565415662|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
156637274|NCT03701516|565415663|FG000|Period 1|Lost to Follow-up|0|||
156411688|NCT01089556|564601385|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
156411689|NCT01089556|564601386|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
156411690|NCT01089556|564601381|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
156411691|NCT01089556|564601382|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
156411692|NCT01089556|564601383|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
156411693|NCT01089556|564601384|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
156411694|NCT01089556|564601385|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
156411695|NCT01089556|564601386|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
156411696|NCT01089556|564601381|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
156637275|NCT03701516|565415664|FG001|Period 1|Lost to Follow-up|1|||
156637276|NCT03701516|565415663|FG000|Period 1|Adverse Event|0|||
156637277|NCT03701516|565415664|FG001|Period 1|Adverse Event|2|||
156637278|NCT03701516|565415663|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
156637279|NCT03701516|565415664|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
156637280|NCT03701516|565415663|FG000|Period 1|Non Compliance to Protocol|2|||
156637281|NCT03701516|565415664|FG001|Period 1|Non Compliance to Protocol|1|||
156637282|NCT03701516|565415663|FG000|Period 1|Withdrawal by Subject|0|||
156637283|NCT03701516|565415664|FG001|Period 1|Withdrawal by Subject|1|||
156637284|NCT03701516|565415663|FG000|Period 2|failed to meet all eligibility creiteria|1|||
156637285|NCT03701516|565415664|FG001|Period 2|failed to meet all eligibility creiteria|0|||
156637286|NCT03701516|565415663|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
156637287|NCT03701516|565415664|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
156637288|NCT03930615|565415665|FG000|Overall Study|Death|9|||
156637289|NCT03930615|565415666|FG001|Overall Study|Death|3|||
156637290|NCT03930615|565415665|FG000|Overall Study|Lost to Follow-up|1|||
156637291|NCT03930615|565415666|FG001|Overall Study|Lost to Follow-up|2|||
156637292|NCT03930615|565415665|FG000|Overall Study|Physician Decision|3|||
156637293|NCT03930615|565415666|FG001|Overall Study|Physician Decision|4|||
156637294|NCT03930615|565415665|FG000|Overall Study|Withdrawal by Subject|13|||
156637295|NCT03930615|565415666|FG001|Overall Study|Withdrawal by Subject|2|||
156637296|NCT03930615|565415665|FG000|Overall Study|Not treated|1|||
156637297|NCT03930615|565415666|FG001|Overall Study|Not treated|1|||
156637298|NCT03644927|565415671|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
156637299|NCT03644927|565415672|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
156637300|NCT00956813|565415673|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
156637301|NCT00956813|565415674|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
156637302|NCT00956813|565415673|FG000|Flaxseed and Placebo|Ineligible|3|||
156637303|NCT00956813|565415674|FG001|Flaxseed and Placebo|Ineligible|1|||
156637304|NCT00358670|565415675|FG000|Overall Study|Adverse Event|26|||
156637305|NCT00358670|565415676|FG001|Overall Study|Adverse Event|29|||
156637306|NCT00358670|565415675|FG000|Overall Study|Lack of Efficacy|20|||
156637307|NCT00358670|565415676|FG001|Overall Study|Lack of Efficacy|23|||
156637308|NCT00358670|565415675|FG000|Overall Study|Protocol Violation|6|||
156637309|NCT00358670|565415676|FG001|Overall Study|Protocol Violation|9|||
156637310|NCT00358670|565415675|FG000|Overall Study|Lost to Follow-up|4|||
156637311|NCT00358670|565415676|FG001|Overall Study|Lost to Follow-up|5|||
156637312|NCT00358670|565415675|FG000|Overall Study|Withdrawal by Subject|13|||
156637313|NCT00358670|565415676|FG001|Overall Study|Withdrawal by Subject|24|||
156411697|NCT01089556|564601382|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
156411698|NCT01089556|564601383|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
156411699|NCT01089556|564601384|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
156411700|NCT01089556|564601385|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
156411701|NCT01089556|564601386|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
156411702|NCT01089556|564601381|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
156411703|NCT01089556|564601382|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
156411704|NCT01089556|564601383|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
156411705|NCT01089556|564601384|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
156411706|NCT01089556|564601385|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
156411707|NCT01089556|564601386|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
156411708|NCT01089556|564601381|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
156411709|NCT01089556|564601382|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
156411710|NCT01089556|564601383|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
156411711|NCT01089556|564601384|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
156411712|NCT01089556|564601385|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
156411713|NCT01089556|564601386|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
156411714|NCT01089556|564601381|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
156411715|NCT01089556|564601382|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
156411716|NCT01089556|564601383|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
156411717|NCT01089556|564601384|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
156411718|NCT01089556|564601385|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
156411719|NCT01089556|564601386|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
156411720|NCT01089556|564601381|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156411721|NCT01089556|564601382|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156411722|NCT01089556|564601383|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
156411723|NCT01089556|564601384|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156411724|NCT01089556|564601385|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156411725|NCT01089556|564601386|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156411726|NCT01089556|564601381|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
156411727|NCT01089556|564601382|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
156411728|NCT01089556|564601383|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
156411729|NCT01089556|564601384|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
156637314|NCT00358670|565415675|FG000|Overall Study|Protocol Defined Clinical Event|0|||
156637315|NCT00358670|565415676|FG001|Overall Study|Protocol Defined Clinical Event|1|||
156637316|NCT00358670|565415675|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
156637317|NCT00358670|565415676|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
156637318|NCT00358670|565415675|FG000|Overall Study|Administrative|153|||
156637319|NCT00358670|565415676|FG001|Overall Study|Administrative|125|||
156637320|NCT00981019|565415677|FG000|Overall Study|Did not respond|65|||
156637321|NCT00981019|565415677|FG000|Overall Study|Did not match target population|94|||
156637322|NCT00981019|565415677|FG000|Overall Study|Inadvertent exclusion|239|||
156637323|NCT00981019|565415677|FG000|Overall Study|Hit the survey after closure|79|||
156637324|NCT00865306|565415678|FG000|Controlled Trial|Lost to Follow-up|1|||
156637325|NCT00865306|565415679|FG001|Controlled Trial|Lost to Follow-up|1|||
156637326|NCT00865306|565415678|FG000|Controlled Trial|Difficulty commuting|2|||
156637327|NCT00865306|565415679|FG001|Controlled Trial|Difficulty commuting|0|||
156637328|NCT00865306|565415678|FG000|Controlled Trial|Improved btw baseline and first session|1|||
156637329|NCT00865306|565415679|FG001|Controlled Trial|Improved btw baseline and first session|0|||
156637330|NCT00865306|565415678|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
156637331|NCT00865306|565415679|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
156637332|NCT00865306|565415678|FG000|Controlled Trial|Withdrawal by Subject|0|||
156637333|NCT00865306|565415679|FG001|Controlled Trial|Withdrawal by Subject|1|||
156637334|NCT05083559|565415680|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
156637335|NCT05083559|565415681|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
156637336|NCT05083559|565415680|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
156637337|NCT05083559|565415681|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
156637338|NCT05083559|565415680|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
156637339|NCT05083559|565415681|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
156637340|NCT02704130|565415683|FG000|Overall Study|Physician Decision|5|||
156637341|NCT02704130|565415684|FG001|Overall Study|Physician Decision|3|||
156637342|NCT01819467|565417057|FG000|Overall Study|Physician Decision|20|||
156637343|NCT01819467|565417058|FG001|Overall Study|Physician Decision|9|||
156637344|NCT00734617|565417063|FG000|Overall Study|Adverse Event|4|||
156637345|NCT00734617|565417064|FG001|Overall Study|Adverse Event|7|||
156637346|NCT00734617|565417063|FG000|Overall Study|Withdrawal by Subject|103|||
156637347|NCT00734617|565417064|FG001|Overall Study|Withdrawal by Subject|95|||
156637348|NCT03692078|565417067|FG000|Overall Study|Adverse Event|0|||
156637349|NCT03692078|565417068|FG001|Overall Study|Adverse Event|0|||
156637350|NCT03692078|565417069|FG002|Overall Study|Adverse Event|0|||
156637351|NCT03692078|565417070|FG003|Overall Study|Adverse Event|0|||
156637352|NCT03692078|565417071|FG004|Overall Study|Adverse Event|0|||
156637353|NCT03692078|565417072|FG005|Overall Study|Adverse Event|1|||
156637354|NCT03692078|565417073|FG006|Overall Study|Adverse Event|0|||
156637355|NCT03692078|565417067|FG000|Overall Study|Enrollment Closed|5|||
156637356|NCT03692078|565417068|FG001|Overall Study|Enrollment Closed|0|||
156637357|NCT03692078|565417069|FG002|Overall Study|Enrollment Closed|0|||
156637358|NCT03692078|565417070|FG003|Overall Study|Enrollment Closed|0|||
156637359|NCT03692078|565417071|FG004|Overall Study|Enrollment Closed|0|||
156637360|NCT03692078|565417072|FG005|Overall Study|Enrollment Closed|0|||
156637361|NCT03692078|565417073|FG006|Overall Study|Enrollment Closed|0|||
156637362|NCT03692078|565417067|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
156637363|NCT03692078|565417068|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
156637364|NCT03692078|565417069|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
156637365|NCT03692078|565417070|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
156637366|NCT03692078|565417071|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
156637367|NCT03692078|565417072|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
156637368|NCT03692078|565417073|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
156637369|NCT03692078|565417067|FG000|Overall Study|Withdrawal by Subject|0|||
156637370|NCT03692078|565417068|FG001|Overall Study|Withdrawal by Subject|2|||
156637371|NCT03692078|565417069|FG002|Overall Study|Withdrawal by Subject|0|||
156637372|NCT03692078|565417070|FG003|Overall Study|Withdrawal by Subject|1|||
156637373|NCT03692078|565417071|FG004|Overall Study|Withdrawal by Subject|5|||
156637374|NCT03692078|565417072|FG005|Overall Study|Withdrawal by Subject|3|||
156637375|NCT03692078|565417073|FG006|Overall Study|Withdrawal by Subject|3|||
156637376|NCT00996632|565417076|FG000|Overall Study|Physician Decision|0|||
156637377|NCT00996632|565417077|FG001|Overall Study|Physician Decision|0|||
156637378|NCT02086968|565417078|FG000|Overall Study|Adverse Event|1|||
156637379|NCT02086968|565417079|FG001|Overall Study|Adverse Event|5|||
156637380|NCT02086968|565417078|FG000|Overall Study|Lost to Follow-up|2|||
156637381|NCT02086968|565417079|FG001|Overall Study|Lost to Follow-up|3|||
156637382|NCT02086968|565417078|FG000|Overall Study|Study drug received outside protocol|0|||
156637383|NCT02086968|565417079|FG001|Overall Study|Study drug received outside protocol|1|||
156637384|NCT02086968|565417078|FG000|Overall Study|Physician Decision|4|||
156637385|NCT02086968|565417079|FG001|Overall Study|Physician Decision|0|||
156637386|NCT02086968|565417078|FG000|Overall Study|Withdrawal by Subject|1|||
156637387|NCT02086968|565417079|FG001|Overall Study|Withdrawal by Subject|4|||
156637388|NCT00537056|565417083|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
156637389|NCT01257737|565417084|FG000|Overall Study|Lost to Follow-up|1|||
156637390|NCT01257737|565417085|FG001|Overall Study|Lost to Follow-up|2|||
156637391|NCT01257737|565417084|FG000|Overall Study|Liver transplant|1|||
156637392|NCT01257737|565417085|FG001|Overall Study|Liver transplant|0|||
156411730|NCT01089556|564601385|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
156637393|NCT01257737|565417084|FG000|Overall Study|Relocation out of the country|0|||
156637394|NCT01257737|565417085|FG001|Overall Study|Relocation out of the country|1|||
156637395|NCT01257737|565417084|FG000|Overall Study|Withdrew from study|0|||
156637396|NCT01257737|565417085|FG001|Overall Study|Withdrew from study|1|||
156637397|NCT00203892|565417092|FG000|Overall Study|Physician Decision|1|||
156637398|NCT00203892|565417093|FG001|Overall Study|Physician Decision|2|||
156637399|NCT00203892|565417094|FG002|Overall Study|Physician Decision|0|||
156637400|NCT00203892|565417092|FG000|Overall Study|Death|1|||
156637401|NCT00203892|565417093|FG001|Overall Study|Death|0|||
156637402|NCT00203892|565417094|FG002|Overall Study|Death|0|||
156637403|NCT00556166|565417095|FG000|Overall Study|Withdrawal by Subject|1|||
156637404|NCT02985515|565417096|FG000|Olfaction Testing|Lost to Follow-up|0|||
156637405|NCT02985515|565417097|FG001|Olfaction Testing|Lost to Follow-up|5|||
156637406|NCT02985515|565417096|FG000|Olfaction Testing|Protocol Violation|0|||
156637407|NCT02985515|565417097|FG001|Olfaction Testing|Protocol Violation|3|||
156637408|NCT01060007|565417100|FG000|Overall Study|Withdrawal by Subject|1|||
156637409|NCT01060007|565417100|FG000|Overall Study|Inevaluable for response at surgery|3|||
156637410|NCT00445458|565417101|FG000|Overall Study|Disease Progression|3|||
156637411|NCT00445458|565417102|FG001|Overall Study|Disease Progression|4|||
156637412|NCT00445458|565417103|FG002|Overall Study|Disease Progression|54|||
156637413|NCT00445458|565417104|FG003|Overall Study|Disease Progression|27|||
156637414|NCT00445458|565417101|FG000|Overall Study|Withdrawal by Subject|0|||
156637415|NCT00445458|565417102|FG001|Overall Study|Withdrawal by Subject|0|||
156637416|NCT00445458|565417103|FG002|Overall Study|Withdrawal by Subject|7|||
156637417|NCT00445458|565417104|FG003|Overall Study|Withdrawal by Subject|0|||
156637418|NCT00445458|565417101|FG000|Overall Study|Adverse Event|0|||
156637419|NCT00445458|565417102|FG001|Overall Study|Adverse Event|0|||
156637420|NCT00445458|565417103|FG002|Overall Study|Adverse Event|3|||
156637421|NCT00445458|565417104|FG003|Overall Study|Adverse Event|0|||
156637422|NCT00445458|565417101|FG000|Overall Study|Death|0|||
156637423|NCT00445458|565417102|FG001|Overall Study|Death|1|||
156637424|NCT00445458|565417103|FG002|Overall Study|Death|2|||
156637425|NCT00445458|565417104|FG003|Overall Study|Death|0|||
156637426|NCT00445458|565417101|FG000|Overall Study|Physician Decision|0|||
156637427|NCT00445458|565417102|FG001|Overall Study|Physician Decision|0|||
156637428|NCT00445458|565417103|FG002|Overall Study|Physician Decision|1|||
156637429|NCT00445458|565417104|FG003|Overall Study|Physician Decision|1|||
156637430|NCT00445458|565417101|FG000|Overall Study|Surgery|0|||
156637431|NCT00445458|565417102|FG001|Overall Study|Surgery|0|||
156637432|NCT00445458|565417103|FG002|Overall Study|Surgery|1|||
156637433|NCT00445458|565417104|FG003|Overall Study|Surgery|0|||
156637434|NCT02072174|565417108|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
156637435|NCT02072174|565417109|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
156637436|NCT02072174|565417108|FG000|Overall Study|Protocol Violation|16|||
156637437|NCT02072174|565417109|FG001|Overall Study|Protocol Violation|23|||
156637438|NCT02072174|565417108|FG000|Overall Study|Physician Decision|0|||
156637439|NCT02072174|565417109|FG001|Overall Study|Physician Decision|1|||
156637440|NCT02072174|565417108|FG000|Overall Study|Non-compliance with protocol requirement|2|||
156637441|NCT02072174|565417109|FG001|Overall Study|Non-compliance with protocol requirement|0|||
156637442|NCT00440193|565417110|FG000|Treatment Period|Adverse Event|74|||
156637443|NCT00440193|565417111|FG001|Treatment Period|Adverse Event|67|||
156637444|NCT00440193|565417110|FG000|Treatment Period|Death|19|||
156637445|NCT00440193|565417111|FG001|Treatment Period|Death|22|||
156637446|NCT00440193|565417110|FG000|Treatment Period|Lack of Efficacy|0|||
156637447|NCT00440193|565417111|FG001|Treatment Period|Lack of Efficacy|1|||
156637448|NCT00440193|565417110|FG000|Treatment Period|Lost to Follow-up|12|||
156637449|NCT00440193|565417111|FG001|Treatment Period|Lost to Follow-up|18|||
156637450|NCT00440193|565417110|FG000|Treatment Period|Physician Decision|3|||
156637451|NCT00440193|565417111|FG001|Treatment Period|Physician Decision|6|||
156637452|NCT00440193|565417110|FG000|Treatment Period|Protocol Violation|16|||
156637453|NCT00440193|565417111|FG001|Treatment Period|Protocol Violation|19|||
156637454|NCT00440193|565417110|FG000|Treatment Period|Withdrawal by Subject|36|||
156637455|NCT00440193|565417111|FG001|Treatment Period|Withdrawal by Subject|77|||
156637456|NCT00440193|565417110|FG000|Treatment Period|Clinical endpoint reached|28|||
156637457|NCT00440193|565417111|FG001|Treatment Period|Clinical endpoint reached|25|||
156637458|NCT00440193|565417110|FG000|Treatment Period|Study terminated by sponsor|102|||
156637459|NCT00440193|565417111|FG001|Treatment Period|Study terminated by sponsor|94|||
156637460|NCT00440193|565417110|FG000|Treatment Period|Protocol driven decision point|2|||
156637461|NCT00440193|565417111|FG001|Treatment Period|Protocol driven decision point|2|||
156637462|NCT00440193|565417110|FG000|Treatment Period|Switch to commercial drug|0|||
156637463|NCT00440193|565417111|FG001|Treatment Period|Switch to commercial drug|2|||
156637464|NCT00440193|565417110|FG000|Treatment Period|Technical problems|1|||
156637465|NCT00440193|565417111|FG001|Treatment Period|Technical problems|1|||
156637466|NCT00440193|565417110|FG000|Treatment Period|Participant convenience|5|||
156637467|NCT00440193|565417111|FG001|Treatment Period|Participant convenience|2|||
156637468|NCT00440193|565417110|FG000|Treatment Period|Participant did not receive treatment|7|||
156637469|NCT00440193|565417111|FG001|Treatment Period|Participant did not receive treatment|13|||
156637470|NCT00440193|565417110|FG000|Treatment Period|Site closed by investigator|0|||
156637471|NCT00440193|565417111|FG001|Treatment Period|Site closed by investigator|2|||
156637472|NCT00440193|565417110|FG000|Observational Period|Adverse Event|2|||
156637473|NCT00440193|565417111|FG001|Observational Period|Adverse Event|2|||
156637474|NCT00440193|565417110|FG000|Observational Period|Death|15|||
156637475|NCT00440193|565417111|FG001|Observational Period|Death|20|||
156637476|NCT00440193|565417110|FG000|Observational Period|Lost to Follow-up|12|||
156637477|NCT00440193|565417111|FG001|Observational Period|Lost to Follow-up|8|||
156637478|NCT00440193|565417110|FG000|Observational Period|Protocol Violation|1|||
156637479|NCT00440193|565417111|FG001|Observational Period|Protocol Violation|0|||
156637480|NCT00440193|565417110|FG000|Observational Period|Withdrawal by Subject|11|||
156637481|NCT00440193|565417111|FG001|Observational Period|Withdrawal by Subject|8|||
156637482|NCT00440193|565417110|FG000|Observational Period|Physician Decision|1|||
156637483|NCT00440193|565417111|FG001|Observational Period|Physician Decision|0|||
156637484|NCT00440193|565417110|FG000|Observational Period|Clinical endpoint reached|1|||
156637485|NCT00440193|565417111|FG001|Observational Period|Clinical endpoint reached|0|||
156637486|NCT00440193|565417110|FG000|Observational Period|Participant convenience|2|||
156637487|NCT00440193|565417111|FG001|Observational Period|Participant convenience|0|||
156637488|NCT00834366|565417112|FG000|Treatment Period 1|Adverse Event|1|||
156637489|NCT00834366|565417113|FG001|Treatment Period 1|Adverse Event|1|||
156637490|NCT03014570|565417114|FG000|Overall Study|COVID-19 Restrictions|38|||
156637491|NCT03014570|565417115|FG001|Overall Study|COVID-19 Restrictions|24|||
156637492|NCT03014570|565417114|FG000|Overall Study|Death|70|||
156637493|NCT03014570|565417115|FG001|Overall Study|Death|79|||
156637494|NCT03014570|565417114|FG000|Overall Study|Transfer from facility|11|||
156637495|NCT03014570|565417115|FG001|Overall Study|Transfer from facility|14|||
156637496|NCT03014570|565417114|FG000|Overall Study|Hospitalized|5|||
156637497|NCT03014570|565417115|FG001|Overall Study|Hospitalized|3|||
156637498|NCT03014570|565417114|FG000|Overall Study|Transfer within facility|1|||
156637499|NCT03014570|565417115|FG001|Overall Study|Transfer within facility|0|||
156637500|NCT03014570|565417114|FG000|Overall Study|Site refusal|0|||
156637501|NCT03014570|565417115|FG001|Overall Study|Site refusal|11|||
156637502|NCT01154673|565417121|FG000|Overall Study|Lost to Follow-up|1|||
156637503|NCT01154673|565417122|FG001|Overall Study|Lost to Follow-up|0|||
156637504|NCT01154673|565417121|FG000|Overall Study|moved out of province|1|||
156637505|NCT01154673|565417122|FG001|Overall Study|moved out of province|0|||
156637506|NCT01216319|565417123|FG000|Overall Study|Lost to Follow-up|2|||
156637507|NCT01216319|565417123|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
156637508|NCT02666768|565417124|FG000|Overall Study|Withdrawal by Subject|4|||
156637509|NCT01023022|565417127|FG000|Overall Study|Death|5|||
156637510|NCT01023022|565417127|FG000|Overall Study|Lost to Follow-up|7|||
156637511|NCT01023022|565417127|FG000|Overall Study|due to technical issues|2|||
156637512|NCT03728257|565417128|FG000|Overall Study|Death|3|||
156637513|NCT03728257|565417129|FG001|Overall Study|Death|0|||
156637514|NCT00905437|565417131|FG000|Overall Study|Adverse Event|3|||
156637515|NCT00905437|565417132|FG001|Overall Study|Adverse Event|2|||
156637516|NCT00905437|565417131|FG000|Overall Study|Lost to Follow-up|0|||
156637517|NCT00905437|565417132|FG001|Overall Study|Lost to Follow-up|1|||
156637518|NCT00905437|565417131|FG000|Overall Study|Withdrawal by Subject|0|||
156637519|NCT00905437|565417132|FG001|Overall Study|Withdrawal by Subject|1|||
156637520|NCT00905437|565417131|FG000|Overall Study|Other|5|||
156637521|NCT00905437|565417132|FG001|Overall Study|Other|6|||
156637522|NCT01306968|565417133|FG000|Overall Study|Lost to Follow-up|1|||
156637523|NCT01306968|565417134|FG001|Overall Study|Lost to Follow-up|1|||
156637524|NCT01306968|565417135|FG002|Overall Study|Lost to Follow-up|0|||
156637525|NCT01306968|565417136|FG003|Overall Study|Lost to Follow-up|0|||
156637526|NCT01306968|565417133|FG000|Overall Study|Physician Decision|0|||
156637527|NCT01306968|565417134|FG001|Overall Study|Physician Decision|1|||
156637528|NCT01306968|565417135|FG002|Overall Study|Physician Decision|0|||
156637529|NCT01306968|565417136|FG003|Overall Study|Physician Decision|0|||
156637530|NCT01306968|565417133|FG000|Overall Study|Relocated and left active duty|0|||
156637531|NCT01306968|565417134|FG001|Overall Study|Relocated and left active duty|1|||
156637532|NCT01306968|565417135|FG002|Overall Study|Relocated and left active duty|1|||
156637533|NCT01306968|565417136|FG003|Overall Study|Relocated and left active duty|1|||
156637534|NCT01306968|565417133|FG000|Overall Study|Withdrew - time commitment|0|||
156637535|NCT01306968|565417134|FG001|Overall Study|Withdrew - time commitment|0|||
156751709|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156637536|NCT01306968|565417135|FG002|Overall Study|Withdrew - time commitment|0|||
156637537|NCT01306968|565417136|FG003|Overall Study|Withdrew - time commitment|2|||
156637538|NCT01306968|565417133|FG000|Overall Study|Withdrew over privacy concerns|0|||
156637539|NCT01306968|565417134|FG001|Overall Study|Withdrew over privacy concerns|0|||
156637540|NCT01306968|565417135|FG002|Overall Study|Withdrew over privacy concerns|0|||
156637541|NCT01306968|565417136|FG003|Overall Study|Withdrew over privacy concerns|1|||
156637542|NCT03128931|565417139|FG000|Overall Study|Physician Decision|1|||
156637543|NCT03128931|565417139|FG000|Overall Study|Equipment Issues|3|||
156637544|NCT03252015|565417140|FG000|Overall Study|Withdrawal by Subject|0|||
156637545|NCT03252015|565417141|FG001|Overall Study|Withdrawal by Subject|1|||
156637546|NCT03252015|565417142|FG002|Overall Study|Withdrawal by Subject|1|||
156637547|NCT03252015|565417143|FG003|Overall Study|Withdrawal by Subject|0|||
156637548|NCT03252015|565417140|FG000|Overall Study|Adverse Event|1|||
156637549|NCT03252015|565417141|FG001|Overall Study|Adverse Event|0|||
156637550|NCT03252015|565417142|FG002|Overall Study|Adverse Event|0|||
156637551|NCT03252015|565417143|FG003|Overall Study|Adverse Event|1|||
156637552|NCT04993339|565417144|FG000|Overall Study|Lost to Follow-up|0|||
156637553|NCT04993339|565417145|FG001|Overall Study|Lost to Follow-up|1|||
156637554|NCT04993339|565417144|FG000|Overall Study|no MRI scan|3|||
156637555|NCT04993339|565417145|FG001|Overall Study|no MRI scan|1|||
156637556|NCT03151226|565417146|FG000|Overall Study|Withdrawal by Subject|2|||
156637557|NCT03151226|565417146|FG000|Overall Study|not wear device correctly|1|||
156637558|NCT01381068|565417147|FG000|Overall Study|Death|1|||
156637559|NCT01381068|565417148|FG001|Overall Study|Death|0|||
156637560|NCT00903409|565417149|FG000|Overall Study|Adverse Event|11|||
156637561|NCT00903409|565417150|FG001|Overall Study|Adverse Event|9|||
156637562|NCT00903409|565417149|FG000|Overall Study|Non-compliance with Protocol|1|||
156637563|NCT00903409|565417150|FG001|Overall Study|Non-compliance with Protocol|1|||
156637564|NCT00903409|565417149|FG000|Overall Study|Laboratory Abnormality|2|||
156637565|NCT00903409|565417150|FG001|Overall Study|Laboratory Abnormality|0|||
156637566|NCT00903409|565417149|FG000|Overall Study|Withdrawal by Subject|8|||
156637567|NCT00903409|565417150|FG001|Overall Study|Withdrawal by Subject|8|||
156637568|NCT00903409|565417149|FG000|Overall Study|Other|2|||
156637569|NCT00903409|565417150|FG001|Overall Study|Other|3|||
156637570|NCT00903409|565417149|FG000|Overall Study|Lost to Follow-up|2|||
156637571|NCT00903409|565417150|FG001|Overall Study|Lost to Follow-up|6|||
156637572|NCT00797316|565417151|FG000|Overall Study|Administrative problems|1|||
156637573|NCT00797316|565417152|FG001|Overall Study|Administrative problems|0|||
156637574|NCT00797316|565417151|FG000|Overall Study|Adverse Event|5|||
156637575|NCT00797316|565417152|FG001|Overall Study|Adverse Event|3|||
156637576|NCT00797316|565417151|FG000|Overall Study|Lost to Follow-up|4|||
156637577|NCT00797316|565417152|FG001|Overall Study|Lost to Follow-up|8|||
156637578|NCT00797316|565417151|FG000|Overall Study|Protocol Deviation|1|||
156637579|NCT00797316|565417152|FG001|Overall Study|Protocol Deviation|2|||
156637580|NCT00797316|565417151|FG000|Overall Study|Patient withdrew consent|12|||
156637581|NCT00797316|565417152|FG001|Overall Study|Patient withdrew consent|6|||
156637582|NCT00797316|565417151|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156637583|NCT00797316|565417152|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
156637584|NCT00402779|565417155|FG000|Overall Study|Screen Failure|77|||
156637585|NCT00402779|565417156|FG001|Overall Study|Screen Failure|76|||
156637586|NCT03239340|565417157|FG000|Overall Study|Other|26|||
156637587|NCT03239340|565417157|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
156637588|NCT03239340|565417157|FG000|Overall Study|Death|40|||
156637589|NCT03239340|565417157|FG000|Overall Study|Lost to Follow-up|2|||
156637590|NCT03239340|565417157|FG000|Overall Study|Physician Decision|16|||
156637591|NCT03239340|565417157|FG000|Overall Study|Withdrawal by Subject|27|||
156637592|NCT02332655|565417161|FG000|Overall Study|Lack of Efficacy|1|||
156637593|NCT01843660|565417162|FG000|Overall Study|Other|30|||
156637594|NCT01977482|565417163|FG000|Overall Study|Adverse Event|0|||
156637595|NCT01977482|565417164|FG001|Overall Study|Adverse Event|1|||
156637596|NCT01977482|565417165|FG002|Overall Study|Adverse Event|1|||
156637597|NCT01977482|565417166|FG003|Overall Study|Adverse Event|0|||
156637598|NCT01977482|565417167|FG004|Overall Study|Adverse Event|2|||
156637599|NCT01977482|565417168|FG005|Overall Study|Adverse Event|0|||
156637600|NCT01977482|565417163|FG000|Overall Study|Lost to Follow-up|1|||
156637601|NCT01977482|565417164|FG001|Overall Study|Lost to Follow-up|0|||
156637602|NCT01977482|565417165|FG002|Overall Study|Lost to Follow-up|0|||
156637603|NCT01977482|565417166|FG003|Overall Study|Lost to Follow-up|0|||
156637604|NCT01977482|565417167|FG004|Overall Study|Lost to Follow-up|0|||
156637605|NCT01977482|565417168|FG005|Overall Study|Lost to Follow-up|0|||
156637606|NCT01977482|565417163|FG000|Overall Study|Physician Decision|0|||
156637607|NCT01977482|565417164|FG001|Overall Study|Physician Decision|1|||
156637608|NCT01977482|565417165|FG002|Overall Study|Physician Decision|0|||
156637609|NCT01977482|565417166|FG003|Overall Study|Physician Decision|0|||
156637610|NCT01977482|565417167|FG004|Overall Study|Physician Decision|0|||
156637611|NCT01977482|565417168|FG005|Overall Study|Physician Decision|0|||
156637612|NCT01977482|565417163|FG000|Overall Study|Protocol Violation|0|||
156637613|NCT01977482|565417164|FG001|Overall Study|Protocol Violation|0|||
156637614|NCT01977482|565417165|FG002|Overall Study|Protocol Violation|1|||
156637615|NCT01977482|565417166|FG003|Overall Study|Protocol Violation|0|||
156637616|NCT01977482|565417167|FG004|Overall Study|Protocol Violation|0|||
156637617|NCT01977482|565417168|FG005|Overall Study|Protocol Violation|0|||
156637618|NCT01977482|565417163|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
156637619|NCT01977482|565417164|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
156637620|NCT01977482|565417165|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
156637621|NCT01977482|565417166|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
156637622|NCT01977482|565417167|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
156637623|NCT01977482|565417168|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
156637624|NCT01977482|565417163|FG000|Overall Study|Withdrawal by Subject|2|||
156637625|NCT01977482|565417164|FG001|Overall Study|Withdrawal by Subject|4|||
156637626|NCT01977482|565417165|FG002|Overall Study|Withdrawal by Subject|1|||
156637627|NCT01977482|565417166|FG003|Overall Study|Withdrawal by Subject|3|||
156637628|NCT01977482|565417167|FG004|Overall Study|Withdrawal by Subject|1|||
156637629|NCT01977482|565417168|FG005|Overall Study|Withdrawal by Subject|5|||
156637630|NCT00209560|565417169|FG000|Overall Study|Lack of Efficacy|1|||
156637631|NCT00209560|565417170|FG001|Overall Study|Lack of Efficacy|0|||
156637632|NCT01525407|565417177|FG000|Overall Study|Change in recipient treatment plan|2|||
156637633|NCT01525407|565417178|FG001|Overall Study|Change in recipient treatment plan|2|||
156637634|NCT01525407|565417177|FG000|Overall Study|Withdrawal by Subject|0|||
156637635|NCT01525407|565417178|FG001|Overall Study|Withdrawal by Subject|1|||
156637636|NCT01525407|565417177|FG000|Overall Study|Transplant was delayed|0|||
156637637|NCT01525407|565417178|FG001|Overall Study|Transplant was delayed|1|||
156637638|NCT01525407|565417177|FG000|Overall Study|Delay in Transplant|1|||
156637639|NCT01525407|565417178|FG001|Overall Study|Delay in Transplant|0|||
156637640|NCT01721369|565417179|FG000|Overall Study|Not initial etiological diagnosis|12|||
156637641|NCT00359073|565418536|FG000|Overall Study|Withdrawal by Subject|1|||
156637642|NCT00359073|565418537|FG001|Overall Study|Withdrawal by Subject|1|||
156637643|NCT00359073|565418536|FG000|Overall Study|Eligibility criteria no longer met|3|||
156637644|NCT00359073|565418537|FG001|Overall Study|Eligibility criteria no longer met|0|||
156637645|NCT00359073|565418536|FG000|Overall Study|developed RV16 antibody|0|||
156637646|NCT00359073|565418537|FG001|Overall Study|developed RV16 antibody|1|||
156637647|NCT01371006|565418538|FG000|Overall Study|Adverse Event|1|||
156637648|NCT01371006|565418539|FG001|Overall Study|Adverse Event|0|||
156637649|NCT00684645|565418540|FG000|Overall Study|Death|2|||
156637650|NCT00684645|565418540|FG000|Overall Study|Progressive disease|67|||
156637651|NCT00684645|565418540|FG000|Overall Study|Adverse Event|27|||
156637652|NCT00684645|565418540|FG000|Overall Study|Lost to Follow-up|3|||
156637653|NCT00684645|565418540|FG000|Overall Study|Other|15|||
156637654|NCT03256526|565418541|FG000|Overall Study|Adverse Event|1|||
156637655|NCT03256526|565418542|FG001|Overall Study|Adverse Event|0|||
156637656|NCT03256526|565418543|FG002|Overall Study|Adverse Event|1|||
156637657|NCT03256526|565418541|FG000|Overall Study|Lost to Follow-up|1|||
156637658|NCT03256526|565418542|FG001|Overall Study|Lost to Follow-up|0|||
156637659|NCT03256526|565418543|FG002|Overall Study|Lost to Follow-up|2|||
156637660|NCT03515837|565418547|FG000|Overall Study|Death|219|||
156637661|NCT03515837|565418548|FG001|Overall Study|Death|227|||
156637662|NCT03515837|565418547|FG000|Overall Study|Lost to Follow-up|0|||
156637663|NCT03515837|565418548|FG001|Overall Study|Lost to Follow-up|1|||
156637664|NCT03515837|565418547|FG000|Overall Study|Withdrawal by Subject|0|||
156637665|NCT03515837|565418548|FG001|Overall Study|Withdrawal by Subject|4|||
156637666|NCT03515837|565418547|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
156637667|NCT03515837|565418548|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
156637668|NCT01964898|565418549|FG000|Overall Study|ineligible post-randomization|1|||
156637669|NCT01964898|565418550|FG001|Overall Study|ineligible post-randomization|1|||
156637670|NCT01964898|565418549|FG000|Overall Study|did not receive the allocated interventi|2|||
156637671|NCT01964898|565418550|FG001|Overall Study|did not receive the allocated interventi|1|||
156637672|NCT01964898|565418549|FG000|Overall Study|Lost to Follow-up|3|||
156637673|NCT01964898|565418550|FG001|Overall Study|Lost to Follow-up|5|||
156637674|NCT01964898|565418549|FG000|Overall Study|Withdrawal by Subject|1|||
156637675|NCT01964898|565418550|FG001|Overall Study|Withdrawal by Subject|0|||
156637676|NCT02325401|565418551|FG000|Overall Study|Withdrawal by Subject|0|||
156637677|NCT02325401|565418552|FG001|Overall Study|Withdrawal by Subject|1|||
156637678|NCT02325401|565418553|FG002|Overall Study|Withdrawal by Subject|1|||
156637679|NCT00391092|565418554|FG000|Overall Study|Death|78|||
156637680|NCT00391092|565418555|FG001|Overall Study|Death|81|||
156637681|NCT00391092|565418554|FG000|Overall Study|Lost to Follow-up|13|||
156637682|NCT00391092|565418555|FG001|Overall Study|Lost to Follow-up|18|||
156637683|NCT00391092|565418554|FG000|Overall Study|Alive on treatment|29|||
156637684|NCT00391092|565418555|FG001|Overall Study|Alive on treatment|33|||
156637685|NCT00391092|565418554|FG000|Overall Study|Alive in follow-up|88|||
156637686|NCT00391092|565418555|FG001|Overall Study|Alive in follow-up|84|||
156637687|NCT00602979|565418558|FG000|Overall Study|Lost to Follow-up|3|||
156637688|NCT00602979|565418559|FG001|Overall Study|Lost to Follow-up|2|||
156637689|NCT00602979|565418560|FG002|Overall Study|Lost to Follow-up|3|||
156637690|NCT00602979|565418561|FG003|Overall Study|Lost to Follow-up|2|||
156637691|NCT00602979|565418562|FG004|Overall Study|Lost to Follow-up|3|||
156637692|NCT00602979|565418558|FG000|Overall Study|Failed Intubation|0|||
156637693|NCT00602979|565418559|FG001|Overall Study|Failed Intubation|1|||
156637694|NCT00602979|565418560|FG002|Overall Study|Failed Intubation|0|||
156637695|NCT00602979|565418561|FG003|Overall Study|Failed Intubation|1|||
156637696|NCT00602979|565418562|FG004|Overall Study|Failed Intubation|0|||
156637697|NCT02367729|565418565|FG000|Overall Study|Organic disorder diagnosed|2|||
156637698|NCT02367729|565418566|FG001|Overall Study|Organic disorder diagnosed|1|||
156637699|NCT02367729|565418565|FG000|Overall Study|Adverse Event|1|||
156637700|NCT02367729|565418566|FG001|Overall Study|Adverse Event|2|||
156637701|NCT02367729|565418565|FG000|Overall Study|Withdrawal by Subject|0|||
156637702|NCT02367729|565418566|FG001|Overall Study|Withdrawal by Subject|5|||
156637703|NCT03359473|565418575|FG000|Overall Study|Adverse Event|0|||
156637704|NCT03359473|565418576|FG001|Overall Study|Adverse Event|2|||
156637705|NCT03359473|565418577|FG002|Overall Study|Adverse Event|5|||
156637706|NCT03359473|565418578|FG003|Overall Study|Adverse Event|3|||
156637707|NCT03359473|565418575|FG000|Overall Study|Lost to Follow-up|0|||
156637708|NCT03359473|565418576|FG001|Overall Study|Lost to Follow-up|1|||
156637709|NCT03359473|565418577|FG002|Overall Study|Lost to Follow-up|0|||
156637710|NCT03359473|565418578|FG003|Overall Study|Lost to Follow-up|0|||
156637711|NCT03359473|565418575|FG000|Overall Study|Physician Decision|0|||
156637712|NCT03359473|565418576|FG001|Overall Study|Physician Decision|1|||
156637713|NCT03359473|565418577|FG002|Overall Study|Physician Decision|0|||
156637714|NCT03359473|565418578|FG003|Overall Study|Physician Decision|1|||
156637715|NCT03359473|565418575|FG000|Overall Study|Withdrawal by Subject|1|||
156637716|NCT03359473|565418576|FG001|Overall Study|Withdrawal by Subject|2|||
156637717|NCT03359473|565418577|FG002|Overall Study|Withdrawal by Subject|1|||
156637718|NCT03359473|565418578|FG003|Overall Study|Withdrawal by Subject|0|||
156637719|NCT03359473|565418575|FG000|Overall Study|Protocol-defined stopping criteria|1|||
156637720|NCT03359473|565418576|FG001|Overall Study|Protocol-defined stopping criteria|0|||
156637721|NCT03359473|565418577|FG002|Overall Study|Protocol-defined stopping criteria|0|||
156637722|NCT03359473|565418578|FG003|Overall Study|Protocol-defined stopping criteria|1|||
156637723|NCT04101721|565418580|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
156637724|NCT04101721|565418581|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
156637725|NCT04101721|565418580|FG000|Overall Study|Death|0|||
156637726|NCT04101721|565418581|FG001|Overall Study|Death|1|||
156637727|NCT04101721|565418580|FG000|Overall Study|Lost to Follow-up|0|||
156637728|NCT04101721|565418581|FG001|Overall Study|Lost to Follow-up|3|||
156637729|NCT01215955|565418582|FG000|Overall Study|Adverse Event|1|||
156637730|NCT01215955|565418583|FG001|Overall Study|Adverse Event|4|||
156637731|NCT01215955|565418584|FG002|Overall Study|Adverse Event|2|||
156637732|NCT01215955|565418585|FG003|Overall Study|Adverse Event|3|||
156637733|NCT01215955|565418582|FG000|Overall Study|Death|2|||
156637734|NCT01215955|565418583|FG001|Overall Study|Death|0|||
156637735|NCT01215955|565418584|FG002|Overall Study|Death|1|||
156637736|NCT01215955|565418585|FG003|Overall Study|Death|3|||
156637737|NCT01215955|565418582|FG000|Overall Study|Entry Criteria Not Met|1|||
156637738|NCT01215955|565418583|FG001|Overall Study|Entry Criteria Not Met|3|||
156637739|NCT01215955|565418584|FG002|Overall Study|Entry Criteria Not Met|4|||
156637740|NCT01215955|565418585|FG003|Overall Study|Entry Criteria Not Met|7|||
156637741|NCT01215955|565418582|FG000|Overall Study|Lack of Efficacy|1|||
156637742|NCT01215955|565418583|FG001|Overall Study|Lack of Efficacy|2|||
156637743|NCT01215955|565418584|FG002|Overall Study|Lack of Efficacy|1|||
156637744|NCT01215955|565418585|FG003|Overall Study|Lack of Efficacy|0|||
156637745|NCT01215955|565418582|FG000|Overall Study|Lost to Follow-up|4|||
156637746|NCT01215955|565418583|FG001|Overall Study|Lost to Follow-up|4|||
156637747|NCT01215955|565418584|FG002|Overall Study|Lost to Follow-up|8|||
156637748|NCT01215955|565418585|FG003|Overall Study|Lost to Follow-up|9|||
156637749|NCT01215955|565418582|FG000|Overall Study|Physician Decision|4|||
156637750|NCT01215955|565418583|FG001|Overall Study|Physician Decision|10|||
156637751|NCT01215955|565418584|FG002|Overall Study|Physician Decision|8|||
156637752|NCT01215955|565418585|FG003|Overall Study|Physician Decision|11|||
156637753|NCT01215955|565418582|FG000|Overall Study|Protocol Violation|17|||
156637754|NCT01215955|565418583|FG001|Overall Study|Protocol Violation|13|||
156637755|NCT01215955|565418584|FG002|Overall Study|Protocol Violation|8|||
156637756|NCT01215955|565418585|FG003|Overall Study|Protocol Violation|8|||
156637757|NCT01215955|565418582|FG000|Overall Study|Sponsor Decision|1|||
156637758|NCT01215955|565418583|FG001|Overall Study|Sponsor Decision|2|||
156637759|NCT01215955|565418584|FG002|Overall Study|Sponsor Decision|0|||
156637760|NCT01215955|565418585|FG003|Overall Study|Sponsor Decision|1|||
156637761|NCT01215955|565418582|FG000|Overall Study|Withdrawal by Subject|14|||
156637762|NCT01215955|565418583|FG001|Overall Study|Withdrawal by Subject|15|||
156637763|NCT01215955|565418584|FG002|Overall Study|Withdrawal by Subject|13|||
156637764|NCT01215955|565418585|FG003|Overall Study|Withdrawal by Subject|9|||
156637765|NCT01215955|565418582|FG000|Overall Study|Quality Issues|0|||
156637766|NCT01215955|565418583|FG001|Overall Study|Quality Issues|0|||
156637767|NCT01215955|565418584|FG002|Overall Study|Quality Issues|3|||
156637768|NCT01215955|565418585|FG003|Overall Study|Quality Issues|2|||
156637769|NCT05013749|565418589|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
156637770|NCT05013749|565418590|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
156637771|NCT05013749|565418589|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
156637772|NCT05013749|565418590|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
156637773|NCT01393626|565418591|FG000|Overall Study|Adverse Event|2|||
156637774|NCT01393626|565418592|FG001|Overall Study|Adverse Event|1|||
156637775|NCT01393626|565418593|FG002|Overall Study|Adverse Event|5|||
156637776|NCT01393626|565418594|FG003|Overall Study|Adverse Event|0|||
156637777|NCT01393626|565418591|FG000|Overall Study|Did not meet entrance criteria|1|||
156637778|NCT01393626|565418592|FG001|Overall Study|Did not meet entrance criteria|0|||
156637779|NCT01393626|565418593|FG002|Overall Study|Did not meet entrance criteria|0|||
156637780|NCT01393626|565418594|FG003|Overall Study|Did not meet entrance criteria|0|||
156637781|NCT01393626|565418591|FG000|Overall Study|Lack of Efficacy|6|||
156637782|NCT01393626|565418592|FG001|Overall Study|Lack of Efficacy|6|||
156637783|NCT01393626|565418593|FG002|Overall Study|Lack of Efficacy|4|||
156637784|NCT01393626|565418594|FG003|Overall Study|Lack of Efficacy|1|||
156637785|NCT01393626|565418591|FG000|Overall Study|Lost to Follow-up|1|||
156637786|NCT01393626|565418592|FG001|Overall Study|Lost to Follow-up|1|||
156637787|NCT01393626|565418593|FG002|Overall Study|Lost to Follow-up|1|||
156637788|NCT01393626|565418594|FG003|Overall Study|Lost to Follow-up|0|||
156637789|NCT01393626|565418591|FG000|Overall Study|Withdrawal by Subject|6|||
156637790|NCT01393626|565418592|FG001|Overall Study|Withdrawal by Subject|4|||
156637791|NCT01393626|565418593|FG002|Overall Study|Withdrawal by Subject|0|||
156637792|NCT01393626|565418594|FG003|Overall Study|Withdrawal by Subject|0|||
156637793|NCT01393626|565418591|FG000|Overall Study|Other|1|||
156637794|NCT01393626|565418592|FG001|Overall Study|Other|0|||
156637795|NCT01393626|565418593|FG002|Overall Study|Other|0|||
156637796|NCT01393626|565418594|FG003|Overall Study|Other|0|||
156637797|NCT01393626|565418591|FG000|Overall Study|Protocol Violation|1|||
156637798|NCT01393626|565418592|FG001|Overall Study|Protocol Violation|0|||
156637799|NCT01393626|565418593|FG002|Overall Study|Protocol Violation|2|||
156637800|NCT01393626|565418594|FG003|Overall Study|Protocol Violation|0|||
156637801|NCT02426125|565418595|FG000|Overall Study|Lost to Follow-up|14|||
156637802|NCT02426125|565418596|FG001|Overall Study|Lost to Follow-up|12|||
156637803|NCT02426125|565418595|FG000|Overall Study|Withdrawal by Subject|13|||
156637804|NCT02426125|565418596|FG001|Overall Study|Withdrawal by Subject|14|||
156637805|NCT02426125|565418595|FG000|Overall Study|Death|185|||
156637806|NCT02426125|565418596|FG001|Overall Study|Death|200|||
156637807|NCT02426125|565418595|FG000|Overall Study|Randomized, But Never Treated|5|||
156637808|NCT02426125|565418596|FG001|Overall Study|Randomized, But Never Treated|2|||
156637809|NCT02858076|565418597|FG000|Overall Study|Death|6|||
156637810|NCT02858076|565418598|FG001|Overall Study|Death|3|||
156637811|NCT02858076|565418597|FG000|Overall Study|Withdrawal by Subject|1|||
156637812|NCT02858076|565418598|FG001|Overall Study|Withdrawal by Subject|5|||
156637813|NCT02858076|565418597|FG000|Overall Study|Lost to Follow-up|2|||
156637814|NCT02858076|565418598|FG001|Overall Study|Lost to Follow-up|7|||
156637815|NCT02858076|565418597|FG000|Overall Study|Completed Out of Window|1|||
156637816|NCT02858076|565418598|FG001|Overall Study|Completed Out of Window|3|||
156637817|NCT00938015|565418607|FG000|Overall Study|Death|2|||
156637818|NCT00938015|565418607|FG000|Overall Study|Lost to Follow-up|32|||
156637819|NCT00938015|565418607|FG000|Overall Study|Adverse Event|32|||
156637820|NCT00938015|565418607|FG000|Overall Study|Non-responder|52|||
156637821|NCT00938015|565418607|FG000|Overall Study|Reason not related to Etanercept|29|||
156637822|NCT02341482|565418608|FG000|Overall Study|Adverse Event|1|||
156637823|NCT03186794|565418609|FG000|Overall Study|Physician Decision|2|||
156637824|NCT03186794|565418609|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
156637825|NCT00664066|565418611|FG000|Overall Study|Study terminated|3|||
156637826|NCT02575807|565418613|FG000|Overall Study|Death|8|||
156637827|NCT02575807|565418614|FG001|Overall Study|Death|3|||
156637828|NCT02575807|565418615|FG002|Overall Study|Death|7|||
156637829|NCT02575807|565418616|FG003|Overall Study|Death|0|||
156637830|NCT02575807|565418617|FG004|Overall Study|Death|1|||
156637831|NCT02575807|565418613|FG000|Overall Study|Study terminated by Sponsor|0|||
156637832|NCT02575807|565418614|FG001|Overall Study|Study terminated by Sponsor|1|||
156637833|NCT02575807|565418615|FG002|Overall Study|Study terminated by Sponsor|7|||
156637834|NCT02575807|565418616|FG003|Overall Study|Study terminated by Sponsor|0|||
156637835|NCT02575807|565418617|FG004|Overall Study|Study terminated by Sponsor|1|||
156637836|NCT02575807|565418613|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
156637837|NCT02575807|565418614|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
156637838|NCT02575807|565418615|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
156637839|NCT02575807|565418616|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
156637840|NCT02575807|565418617|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
156637841|NCT02575807|565418613|FG000|Overall Study|Terminated due to physician decision|0|||
156411731|NCT01089556|564601386|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
156637842|NCT02575807|565418614|FG001|Overall Study|Terminated due to physician decision|0|||
156637843|NCT02575807|565418615|FG002|Overall Study|Terminated due to physician decision|1|||
156637844|NCT02575807|565418616|FG003|Overall Study|Terminated due to physician decision|0|||
156637845|NCT02575807|565418617|FG004|Overall Study|Terminated due to physician decision|0|||
156637846|NCT02575807|565418613|FG000|Overall Study|Subject ineligible - medical implant|0|||
156637847|NCT02575807|565418614|FG001|Overall Study|Subject ineligible - medical implant|0|||
156637848|NCT02575807|565418615|FG002|Overall Study|Subject ineligible - medical implant|0|||
156637849|NCT02575807|565418616|FG003|Overall Study|Subject ineligible - medical implant|1|||
156637850|NCT02575807|565418617|FG004|Overall Study|Subject ineligible - medical implant|0|||
156637851|NCT02575807|565418613|FG000|Overall Study|Withdrawal by Subject|0|||
156637852|NCT02575807|565418614|FG001|Overall Study|Withdrawal by Subject|0|||
156637853|NCT02575807|565418615|FG002|Overall Study|Withdrawal by Subject|1|||
156637854|NCT02575807|565418616|FG003|Overall Study|Withdrawal by Subject|1|||
156637855|NCT02575807|565418617|FG004|Overall Study|Withdrawal by Subject|2|||
156637856|NCT03000075|565418618|FG000|Part A|Adverse Event|4|||
156637857|NCT03000075|565418619|FG001|Part A|Adverse Event|0|||
156637858|NCT03000075|565418620|FG002|Part A|Adverse Event|0|||
156637859|NCT03000075|565418621|FG003|Part A|Adverse Event|0|||
156637860|NCT03000075|565418622|FG004|Part A|Adverse Event|0|||
156637861|NCT03000075|565418623|FG005|Part A|Adverse Event|0|||
156637862|NCT03000075|565418624|FG006|Part A|Adverse Event|0|||
156637863|NCT03000075|565418618|FG000|Part B|Not dosed due to AE|0|||
156637864|NCT03000075|565418619|FG001|Part B|Not dosed due to AE|0|||
156637865|NCT03000075|565418620|FG002|Part B|Not dosed due to AE|0|||
156637866|NCT03000075|565418621|FG003|Part B|Not dosed due to AE|0|||
156637867|NCT03000075|565418622|FG004|Part B|Not dosed due to AE|0|||
156637868|NCT03000075|565418623|FG005|Part B|Not dosed due to AE|2|||
156637869|NCT03000075|565418624|FG006|Part B|Not dosed due to AE|1|||
156637870|NCT03000075|565418618|FG000|Part B|Adverse Event|0|||
156637871|NCT03000075|565418619|FG001|Part B|Adverse Event|0|||
156637872|NCT03000075|565418620|FG002|Part B|Adverse Event|0|||
156637873|NCT03000075|565418621|FG003|Part B|Adverse Event|0|||
156637874|NCT03000075|565418622|FG004|Part B|Adverse Event|1|||
156637875|NCT03000075|565418623|FG005|Part B|Adverse Event|0|||
156637876|NCT03000075|565418624|FG006|Part B|Adverse Event|0|||
156637877|NCT02180659|565418625|FG000|Overall Study|Adverse Event|1|||
156637878|NCT02180659|565418626|FG001|Overall Study|Adverse Event|0|||
156637879|NCT02180659|565418625|FG000|Overall Study|Lost to Follow-up|4|||
156637880|NCT02180659|565418626|FG001|Overall Study|Lost to Follow-up|2|||
156637881|NCT02180659|565418625|FG000|Overall Study|Subject incarcerated during conduct|1|||
156637882|NCT02180659|565418626|FG001|Overall Study|Subject incarcerated during conduct|0|||
156637883|NCT02180659|565418625|FG000|Overall Study|Withdrawal by Subject|0|||
156637884|NCT02180659|565418626|FG001|Overall Study|Withdrawal by Subject|2|||
156637885|NCT02180659|565418625|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
156637886|NCT02180659|565418626|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
156637887|NCT00518011|565418627|FG000|Overall Study|Death|1|||
156637888|NCT00518011|565418628|FG001|Overall Study|Death|1|||
156637889|NCT00518011|565418627|FG000|Overall Study|Adverse Event|2|||
156637890|NCT00518011|565418628|FG001|Overall Study|Adverse Event|3|||
156637891|NCT00518011|565418627|FG000|Overall Study|Disease Progression|2|||
156637892|NCT00518011|565418628|FG001|Overall Study|Disease Progression|2|||
156637893|NCT00518011|565418627|FG000|Overall Study|Other Reasons|3|||
156637894|NCT00518011|565418628|FG001|Overall Study|Other Reasons|2|||
156637895|NCT00518011|565418627|FG000|Overall Study|Withdrawal by Subject|1|||
156637896|NCT00518011|565418628|FG001|Overall Study|Withdrawal by Subject|0|||
156637897|NCT00090259|565418629|FG000|Overall Study|Lost to Follow-up|30|||
156637898|NCT00090259|565418630|FG001|Overall Study|Lost to Follow-up|26|||
156637899|NCT00090259|565418629|FG000|Overall Study|Withdrawal by Subject|21|||
156637900|NCT00090259|565418630|FG001|Overall Study|Withdrawal by Subject|15|||
156637901|NCT00090259|565418629|FG000|Overall Study|Investigator site closed|11|||
156637902|NCT00090259|565418630|FG001|Overall Study|Investigator site closed|7|||
156637903|NCT04797637|565418632|FG000|Overall Study|Lost to Follow-up|23|||
156637904|NCT04797637|565418633|FG001|Overall Study|Lost to Follow-up|32|||
156637905|NCT04797637|565418632|FG000|Overall Study|Withdrawal by Subject|0|||
156637906|NCT04797637|565418633|FG001|Overall Study|Withdrawal by Subject|1|||
156637907|NCT03083639|565418634|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
156637908|NCT03083639|565418635|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
156637909|NCT03083639|565418634|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
156637910|NCT03083639|565418635|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
156637911|NCT00960687|565418639|FG000|Washout Period of 7 Days|Adverse Event|3|||
156637912|NCT00960687|565418640|FG001|Washout Period of 7 Days|Adverse Event|2|||
156637913|NCT00960687|565418639|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
156637914|NCT00960687|565418640|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156637915|NCT05378269|565420361|FG000|Overall Study|Protocol Violation|1|||
156637916|NCT05378269|565420362|FG001|Overall Study|Protocol Violation|0|||
156637917|NCT05378269|565420363|FG002|Overall Study|Protocol Violation|2|||
156637918|NCT05378269|565420364|FG003|Overall Study|Protocol Violation|0|||
156637919|NCT05378269|565420365|FG004|Overall Study|Protocol Violation|0|||
156637920|NCT01607398|565420366|FG000|Overall Study|Adverse Event|0|||
156637921|NCT01607398|565420367|FG001|Overall Study|Adverse Event|2|||
156637922|NCT01607398|565420366|FG000|Overall Study|Severe COPD|2|||
156637923|NCT01607398|565420367|FG001|Overall Study|Severe COPD|0|||
156637924|NCT00891527|565420368|FG000|Overall Study|Withdrawal by Subject|2|||
156637925|NCT01186744|565420369|FG000|Overall Study|Lack of Efficacy|156|||
156637926|NCT01186744|565420370|FG001|Overall Study|Lack of Efficacy|99|||
156637927|NCT01186744|565420371|FG002|Overall Study|Lack of Efficacy|0|||
156637928|NCT01186744|565420372|FG003|Overall Study|Lack of Efficacy|2|||
156637929|NCT01186744|565420373|FG004|Overall Study|Lack of Efficacy|2|||
156637930|NCT01186744|565420374|FG005|Overall Study|Lack of Efficacy|5|||
156637931|NCT01186744|565420369|FG000|Overall Study|Protocol Violation|1|||
156637932|NCT01186744|565420370|FG001|Overall Study|Protocol Violation|2|||
156637933|NCT01186744|565420371|FG002|Overall Study|Protocol Violation|0|||
156637934|NCT01186744|565420372|FG003|Overall Study|Protocol Violation|1|||
156637935|NCT01186744|565420373|FG004|Overall Study|Protocol Violation|1|||
156637936|NCT01186744|565420374|FG005|Overall Study|Protocol Violation|2|||
156637937|NCT01186744|565420369|FG000|Overall Study|Lost to Follow-up|15|||
156637938|NCT01186744|565420370|FG001|Overall Study|Lost to Follow-up|16|||
156637939|NCT01186744|565420371|FG002|Overall Study|Lost to Follow-up|2|||
156637940|NCT01186744|565420372|FG003|Overall Study|Lost to Follow-up|1|||
156637941|NCT01186744|565420373|FG004|Overall Study|Lost to Follow-up|1|||
156637942|NCT01186744|565420374|FG005|Overall Study|Lost to Follow-up|4|||
156637943|NCT01186744|565420369|FG000|Overall Study|Screen failure|1|||
156637944|NCT01186744|565420370|FG001|Overall Study|Screen failure|1|||
156637945|NCT01186744|565420371|FG002|Overall Study|Screen failure|0|||
156637946|NCT01186744|565420372|FG003|Overall Study|Screen failure|1|||
156637947|NCT01186744|565420373|FG004|Overall Study|Screen failure|0|||
156637948|NCT01186744|565420374|FG005|Overall Study|Screen failure|0|||
156637949|NCT01186744|565420369|FG000|Overall Study|Withdrawal by Subject|14|||
156637950|NCT01186744|565420370|FG001|Overall Study|Withdrawal by Subject|10|||
156637951|NCT01186744|565420371|FG002|Overall Study|Withdrawal by Subject|2|||
156637952|NCT01186744|565420372|FG003|Overall Study|Withdrawal by Subject|5|||
156637953|NCT01186744|565420373|FG004|Overall Study|Withdrawal by Subject|0|||
156637954|NCT01186744|565420374|FG005|Overall Study|Withdrawal by Subject|6|||
156637955|NCT01186744|565420369|FG000|Overall Study|Study terminated by Sponsor|1|||
156637956|NCT01186744|565420370|FG001|Overall Study|Study terminated by Sponsor|0|||
156637957|NCT01186744|565420371|FG002|Overall Study|Study terminated by Sponsor|0|||
156637958|NCT01186744|565420372|FG003|Overall Study|Study terminated by Sponsor|0|||
156637959|NCT01186744|565420373|FG004|Overall Study|Study terminated by Sponsor|0|||
156637960|NCT01186744|565420374|FG005|Overall Study|Study terminated by Sponsor|0|||
156637961|NCT01186744|565420369|FG000|Overall Study|Other|9|||
156637962|NCT01186744|565420370|FG001|Overall Study|Other|10|||
156637963|NCT01186744|565420371|FG002|Overall Study|Other|1|||
156637964|NCT01186744|565420372|FG003|Overall Study|Other|2|||
156637965|NCT01186744|565420373|FG004|Overall Study|Other|1|||
156637966|NCT01186744|565420374|FG005|Overall Study|Other|5|||
156637967|NCT01186744|565420369|FG000|Overall Study|Adverse Event|10|||
156637968|NCT01186744|565420370|FG001|Overall Study|Adverse Event|14|||
156637969|NCT01186744|565420371|FG002|Overall Study|Adverse Event|1|||
156637970|NCT01186744|565420372|FG003|Overall Study|Adverse Event|0|||
156637971|NCT01186744|565420373|FG004|Overall Study|Adverse Event|1|||
156637972|NCT01186744|565420374|FG005|Overall Study|Adverse Event|4|||
156637973|NCT01186744|565420369|FG000|Overall Study|Death|1|||
156637974|NCT01186744|565420370|FG001|Overall Study|Death|0|||
156637975|NCT01186744|565420371|FG002|Overall Study|Death|0|||
156637976|NCT01186744|565420372|FG003|Overall Study|Death|0|||
156637977|NCT01186744|565420373|FG004|Overall Study|Death|0|||
156637978|NCT01186744|565420374|FG005|Overall Study|Death|0|||
156637979|NCT02428231|565420379|FG000|Overall Study|Other|10|||
156637980|NCT02428231|565420380|FG001|Overall Study|Other|16|||
156637981|NCT02428231|565420379|FG000|Overall Study|Required Symptomatic Therapy|0|||
156637982|NCT02428231|565420380|FG001|Overall Study|Required Symptomatic Therapy|1|||
156637983|NCT02428231|565420379|FG000|Overall Study|Adverse Event|3|||
156637984|NCT02428231|565420380|FG001|Overall Study|Adverse Event|0|||
156637985|NCT03976076|565420383|FG000|Overall Study|Withdrawal by Subject|2|||
156637986|NCT02406742|565420384|FG000|Overall Study|Progression of Disease|5|||
156637987|NCT02406742|565420385|FG001|Overall Study|Progression of Disease|1|||
156637988|NCT02406742|565420386|FG002|Overall Study|Progression of Disease|6|||
156637989|NCT02406742|565420384|FG000|Overall Study|Adverse Event|3|||
156637990|NCT02406742|565420385|FG001|Overall Study|Adverse Event|0|||
156637991|NCT02406742|565420386|FG002|Overall Study|Adverse Event|2|||
156637992|NCT02406742|565420384|FG000|Overall Study|Death|1|||
156637993|NCT02406742|565420385|FG001|Overall Study|Death|0|||
156637994|NCT02406742|565420386|FG002|Overall Study|Death|0|||
156637995|NCT02406742|565420384|FG000|Overall Study|Lack of Efficacy|0|||
156637996|NCT02406742|565420385|FG001|Overall Study|Lack of Efficacy|0|||
156637997|NCT02406742|565420386|FG002|Overall Study|Lack of Efficacy|1|||
156637998|NCT02406742|565420384|FG000|Overall Study|Withdrawal by Participant|1|||
156637999|NCT02406742|565420385|FG001|Overall Study|Withdrawal by Participant|2|||
156638000|NCT02406742|565420386|FG002|Overall Study|Withdrawal by Participant|0|||
156638001|NCT02406742|565420384|FG000|Overall Study|Physician Decision|1|||
156638002|NCT02406742|565420385|FG001|Overall Study|Physician Decision|2|||
156638003|NCT02406742|565420386|FG002|Overall Study|Physician Decision|1|||
156638004|NCT02406742|565420384|FG000|Overall Study|Transition to other treatment|2|||
156638005|NCT02406742|565420385|FG001|Overall Study|Transition to other treatment|0|||
156638006|NCT02406742|565420386|FG002|Overall Study|Transition to other treatment|1|||
156638007|NCT02406742|565420384|FG000|Overall Study|Other Reasons|1|||
156638008|NCT02406742|565420385|FG001|Overall Study|Other Reasons|11|||
156638009|NCT02406742|565420386|FG002|Overall Study|Other Reasons|5|||
156638010|NCT00765999|565420387|FG000|Overall Study|Adverse Event|203|||
156638011|NCT00765999|565420387|FG000|Overall Study|Insufficient Therapeutic Response|100|||
156638012|NCT00765999|565420387|FG000|Overall Study|Protocol Violation|95|||
156638013|NCT00765999|565420387|FG000|Overall Study|Consent Withdrawn|202|||
156638014|NCT00765999|565420387|FG000|Overall Study|Lost to Follow-up|131|||
156638015|NCT00765999|565420387|FG000|Overall Study|Study Terminated by Sponsor|2|||
156638016|NCT00765999|565420387|FG000|Overall Study|Other Miscellaneous Reasons|51|||
156638017|NCT00759174|565420392|FG000|Overall Study|Other|0|||
156638018|NCT00759174|565420393|FG001|Overall Study|Other|2|||
156638019|NCT01890109|565420394|FG000|Overall Study|Withdrawal by Subject|0|||
156638020|NCT01890109|565420395|FG001|Overall Study|Withdrawal by Subject|3|||
156638021|NCT01890109|565420394|FG000|Overall Study|Lost to Follow-up|1|||
156638022|NCT01890109|565420395|FG001|Overall Study|Lost to Follow-up|2|||
156638023|NCT01643928|565420396|FG000|Overall Study|Lost to Follow-up|1|||
156638024|NCT01643928|565420397|FG001|Overall Study|Lost to Follow-up|0|||
156638025|NCT01643928|565420398|FG002|Overall Study|Lost to Follow-up|2|||
156638026|NCT01643928|565420399|FG003|Overall Study|Lost to Follow-up|0|||
156638027|NCT01643928|565420400|FG004|Overall Study|Lost to Follow-up|0|||
156638028|NCT01643928|565420396|FG000|Overall Study|Withdrawal by Subject|2|||
156638029|NCT01643928|565420397|FG001|Overall Study|Withdrawal by Subject|0|||
156638030|NCT01643928|565420398|FG002|Overall Study|Withdrawal by Subject|0|||
156638031|NCT01643928|565420399|FG003|Overall Study|Withdrawal by Subject|1|||
156638032|NCT01643928|565420400|FG004|Overall Study|Withdrawal by Subject|0|||
156638033|NCT01643928|565420396|FG000|Overall Study|Pregnancy|0|||
156638034|NCT01643928|565420397|FG001|Overall Study|Pregnancy|0|||
156638035|NCT01643928|565420398|FG002|Overall Study|Pregnancy|0|||
156638036|NCT01643928|565420399|FG003|Overall Study|Pregnancy|1|||
156638037|NCT01643928|565420400|FG004|Overall Study|Pregnancy|0|||
156638038|NCT01643928|565420396|FG000|Overall Study|Other|5|||
156638039|NCT01643928|565420397|FG001|Overall Study|Other|1|||
156638040|NCT01643928|565420398|FG002|Overall Study|Other|1|||
156638041|NCT01643928|565420399|FG003|Overall Study|Other|0|||
156638042|NCT01643928|565420400|FG004|Overall Study|Other|0|||
156638043|NCT01643928|565420396|FG000|Overall Study|Adverse Event|2|||
156638044|NCT01643928|565420397|FG001|Overall Study|Adverse Event|1|||
156638045|NCT01643928|565420398|FG002|Overall Study|Adverse Event|0|||
156638046|NCT01643928|565420399|FG003|Overall Study|Adverse Event|1|||
156638047|NCT01643928|565420400|FG004|Overall Study|Adverse Event|2|||
156638048|NCT01615822|565420403|FG000|Period 1|Withdrawal by Subject|0|||
156638049|NCT01615822|565420404|FG001|Period 1|Withdrawal by Subject|1|||
156638050|NCT01615822|565420405|FG002|Period 1|Withdrawal by Subject|0|||
156638051|NCT01615822|565420403|FG000|Period 1|Adverse Event|1|||
156638052|NCT01615822|565420404|FG001|Period 1|Adverse Event|1|||
156638053|NCT01615822|565420405|FG002|Period 1|Adverse Event|0|||
156638054|NCT01615822|565420403|FG000|Period 2|Lost to Follow-up|0|||
156638055|NCT01615822|565420404|FG001|Period 2|Lost to Follow-up|1|||
156638056|NCT01615822|565420405|FG002|Period 2|Lost to Follow-up|2|||
156638057|NCT01988337|565420406|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
156638058|NCT02742818|565420407|FG000|Overall Study|Adverse Event|0|||
156638059|NCT02742818|565420408|FG001|Overall Study|Adverse Event|1|||
156638060|NCT02742818|565420407|FG000|Overall Study|Protocol Violation|0|||
156638061|NCT02742818|565420408|FG001|Overall Study|Protocol Violation|1|||
156638062|NCT04701658|565420409|FG000|Overall Study|Lost to Follow-up|6|||
156638063|NCT00457418|565420410|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
156638064|NCT00457418|565420410|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
156638065|NCT00457418|565420410|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
156638066|NCT00457418|565420410|FG000|Post PK Maintenance|Adverse Event|10|||
156638067|NCT00457418|565420410|FG000|Post PK Maintenance|Progression of Disease|6|||
156638068|NCT00457418|565420410|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
156638069|NCT00457418|565420410|FG000|Post PK Maintenance|Lost to Follow-up|1|||
156638070|NCT00756652|565420417|FG000|Original Phase|Withdrawal by Subject|864|||
156638071|NCT00756652|565420418|FG001|Original Phase|Withdrawal by Subject|23|||
156638072|NCT00756652|565420417|FG000|Original Phase|Lost to Follow-up|601|||
156638073|NCT00756652|565420418|FG001|Original Phase|Lost to Follow-up|0|||
156638074|NCT00756652|565420417|FG000|Original Phase|Other Discontinuation|797|||
156638075|NCT00756652|565420418|FG001|Original Phase|Other Discontinuation|5|||
156638076|NCT00756652|565420417|FG000|Original Phase|Participant Noncompliance|18622|||
156638077|NCT00756652|565420418|FG001|Original Phase|Participant Noncompliance|424|||
156638078|NCT00756652|565420417|FG000|Original Phase|Unknown Discontinuation Reason|2|||
156638079|NCT00756652|565420418|FG001|Original Phase|Unknown Discontinuation Reason|0|||
156638080|NCT00756652|565420417|FG000|Original Phase|Participants without data|3259|||
156638081|NCT00756652|565420418|FG001|Original Phase|Participants without data|466|||
156638082|NCT00756652|565420417|FG000|Original Phase|Death|168|||
156638083|NCT00756652|565420418|FG001|Original Phase|Death|1|||
156638084|NCT00756652|565420417|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
156638085|NCT00756652|565420418|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
156638086|NCT00756652|565420417|FG000|Re-Op Phase|Withdrawal by Subject|62|||
156638087|NCT00756652|565420418|FG001|Re-Op Phase|Withdrawal by Subject|0|||
156638088|NCT00756652|565420417|FG000|Re-Op Phase|Death|6|||
156638089|NCT00756652|565420418|FG001|Re-Op Phase|Death|0|||
156638090|NCT00756652|565420417|FG000|Re-Op Phase|Lost to Follow-up|340|||
156638091|NCT00756652|565420418|FG001|Re-Op Phase|Lost to Follow-up|0|||
156638092|NCT00756652|565420417|FG000|Re-Op Phase|Site Closed|2454|||
156638093|NCT00756652|565420418|FG001|Re-Op Phase|Site Closed|0|||
156638094|NCT00756652|565420417|FG000|Re-Op Phase|Withdrawn after explant|14|||
156638095|NCT00756652|565420418|FG001|Re-Op Phase|Withdrawn after explant|0|||
156638096|NCT02564952|565420419|FG000|Overall Study|Adverse Event|6|||
156638097|NCT02564952|565420419|FG000|Overall Study|Lost to Follow-up|1|||
156638098|NCT02564952|565420419|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
156638099|NCT02564952|565420419|FG000|Overall Study|Withdrawal by Subject|1|||
156638100|NCT02564952|565420419|FG000|Overall Study|Low Efficacy|1|||
156638101|NCT02564952|565420419|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
156638102|NCT00728988|565420429|FG000|Overall Study|Not Treated|2|||
156638103|NCT00728988|565420430|FG001|Overall Study|Not Treated|2|||
156638104|NCT00728988|565420429|FG000|Overall Study|Death|1|||
156638105|NCT00728988|565420430|FG001|Overall Study|Death|1|||
156638106|NCT00728988|565420429|FG000|Overall Study|Adverse Event|3|||
156638107|NCT00728988|565420430|FG001|Overall Study|Adverse Event|2|||
156638108|NCT00728988|565420429|FG000|Overall Study|Other|85|||
156638109|NCT00728988|565420430|FG001|Overall Study|Other|77|||
156638110|NCT00728988|565420429|FG000|Overall Study|Withdrawal by Subject|2|||
156638111|NCT00728988|565420430|FG001|Overall Study|Withdrawal by Subject|6|||
156638112|NCT02643394|565420431|FG000|Overall Study|Protocol Violation|4|||
156638113|NCT02643394|565420432|FG001|Overall Study|Protocol Violation|5|||
156638114|NCT00943384|565420433|FG000|Overall Study|Dispositioned prior to treatment|23|||
156638115|NCT00943384|565420433|FG000|Overall Study|Treated off protocol-protocol violation|5|||
156638116|NCT00943384|565420433|FG000|Overall Study|Lost to Follow-up|16|||
156638117|NCT00943384|565420433|FG000|Overall Study|Withdrawal by Subject|5|||
156638118|NCT00096200|565420434|FG000|Overall Study|Adverse Event|0|||
156638119|NCT00096200|565420435|FG001|Overall Study|Adverse Event|4|||
156638120|NCT00096200|565420436|FG002|Overall Study|Adverse Event|0|||
156638121|NCT00096200|565420434|FG000|Overall Study|Withdrawal by Subject|1|||
156638122|NCT00096200|565420435|FG001|Overall Study|Withdrawal by Subject|2|||
156638123|NCT00096200|565420436|FG002|Overall Study|Withdrawal by Subject|0|||
156638124|NCT00096200|565420434|FG000|Overall Study|Ineligible pathology|0|||
156638125|NCT00096200|565420435|FG001|Overall Study|Ineligible pathology|1|||
156638126|NCT00096200|565420436|FG002|Overall Study|Ineligible pathology|0|||
156638127|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
156638128|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
156638129|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Death|5|||
156638130|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Death|2|||
156638131|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
156638132|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
156638133|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
156638134|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
156638135|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
156638136|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
156638137|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Relapse|1|||
156638138|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Relapse|0|||
156638139|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
156638140|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
156638141|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
156638142|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
156638143|NCT00111007|565420439|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
156638144|NCT00111007|565420440|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
156638145|NCT00111007|565420439|FG000|Active Follow-up|Adverse Event|1|||
156638146|NCT00111007|565420440|FG001|Active Follow-up|Adverse Event|0|||
156638147|NCT00111007|565420439|FG000|Active Follow-up|Death|2|||
156638148|NCT00111007|565420440|FG001|Active Follow-up|Death|0|||
156638149|NCT00111007|565420439|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
156638150|NCT00111007|565420440|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
156638151|NCT00111007|565420439|FG000|Long Term Follow-up|Death|34|||
156638152|NCT00111007|565420440|FG001|Long Term Follow-up|Death|39|||
156638153|NCT00111007|565420439|FG000|Long Term Follow-up|Lost to Follow-up|1|||
156638154|NCT00111007|565420440|FG001|Long Term Follow-up|Lost to Follow-up|1|||
156638155|NCT00111007|565420439|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
156638156|NCT00111007|565420440|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
156638157|NCT00111007|565420439|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
156638158|NCT00111007|565420440|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
156638159|NCT00111007|565420439|FG000|Long Term Follow-up|Missing|10|||
156638160|NCT00111007|565420440|FG001|Long Term Follow-up|Missing|3|||
156638161|NCT01495793|565420441|FG000|Overall Study|Lost to Follow-up|1|||
156638162|NCT01495793|565420441|FG000|Overall Study|Violation of inclusion criteria|1|||
156638163|NCT02362646|565420445|FG000|Overall Study|Death|15|||
156638164|NCT02362646|565420446|FG001|Overall Study|Death|8|||
156638165|NCT02362646|565420445|FG000|Overall Study|Withdrawal by Subject|2|||
156638166|NCT02362646|565420446|FG001|Overall Study|Withdrawal by Subject|2|||
156638167|NCT02362646|565420445|FG000|Overall Study|received transplant|21|||
156638168|NCT02362646|565420446|FG001|Overall Study|received transplant|14|||
156638169|NCT03611751|565420450|FG000|Pre-treatment|Randomized but not treated|1|||
156638170|NCT03611751|565420451|FG001|Pre-treatment|Randomized but not treated|1|||
156638171|NCT03611751|565420452|FG002|Pre-treatment|Randomized but not treated|0|||
156638172|NCT03611751|565420450|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
156638173|NCT03611751|565420451|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
156638174|NCT03611751|565420452|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
156638175|NCT03611751|565420450|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
156638176|NCT03611751|565420451|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
156638177|NCT03611751|565420452|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
156638178|NCT03611751|565420450|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
156638179|NCT03611751|565420451|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
156638180|NCT03611751|565420452|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
156638181|NCT03611751|565420450|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
156638182|NCT03611751|565420451|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
156638183|NCT03611751|565420452|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
156638184|NCT03611751|565420450|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
156638185|NCT03611751|565420451|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
156638186|NCT03611751|565420452|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
156638187|NCT03611751|565420450|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
156638188|NCT03611751|565420451|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
156638189|NCT03611751|565420452|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
156638190|NCT03611751|565420450|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
156638191|NCT03611751|565420451|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
156638192|NCT03611751|565420452|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
156638193|NCT03611751|565420450|FG000|Treatment Week 0 - Week 16|Death|0|||
156638194|NCT03611751|565420451|FG001|Treatment Week 0 - Week 16|Death|0|||
156638195|NCT03611751|565420452|FG002|Treatment Week 0 - Week 16|Death|1|||
156638196|NCT03611751|565420450|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
156638197|NCT03611751|565420451|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
156638198|NCT03611751|565420452|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
156638199|NCT03611751|565420450|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
156638200|NCT03611751|565420451|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
156638201|NCT03611751|565420452|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
156638202|NCT03611751|565420450|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
156638203|NCT03611751|565420451|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
156638204|NCT03611751|565420452|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
156638205|NCT03611751|565420450|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
156638206|NCT03611751|565420451|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
156638207|NCT03611751|565420452|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
156638208|NCT03611751|565420450|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
156638209|NCT03611751|565420451|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
156638210|NCT03611751|565420452|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
156638211|NCT03611751|565420450|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
156638212|NCT03611751|565420451|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
156638213|NCT03611751|565420452|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
156638214|NCT03611751|565420450|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
156638215|NCT03611751|565420451|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
156638216|NCT03611751|565420452|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
156638217|NCT03611751|565420450|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
156638218|NCT03611751|565420451|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
156638219|NCT03611751|565420452|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
156638220|NCT03611751|565420450|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
156638221|NCT03611751|565420451|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
156638222|NCT03611751|565420452|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
156638223|NCT03611751|565420450|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
156638224|NCT03611751|565420451|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
156638225|NCT03611751|565420452|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
156638226|NCT03611751|565420450|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
156638227|NCT03611751|565420451|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
156638228|NCT03611751|565420452|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
156638229|NCT03611751|565420450|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
156638230|NCT03611751|565420451|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
156638231|NCT03611751|565420452|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
156638232|NCT03611751|565420450|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
156638233|NCT03611751|565420451|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
156638234|NCT03611751|565420452|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
156638235|NCT03611751|565420450|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
156638236|NCT03611751|565420451|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
156638237|NCT03611751|565420452|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
156638238|NCT00929864|565420453|FG000|Overall Study|Death|1|||
156638239|NCT00929864|565420454|FG001|Overall Study|Death|1|||
156638240|NCT00929864|565420453|FG000|Overall Study|Adverse Event|11|||
156638241|NCT00929864|565420454|FG001|Overall Study|Adverse Event|30|||
156638242|NCT00929864|565420453|FG000|Overall Study|Lack of Efficacy|19|||
156638243|NCT00929864|565420454|FG001|Overall Study|Lack of Efficacy|16|||
156638244|NCT00929864|565420453|FG000|Overall Study|Lost to Follow-up|7|||
156638245|NCT00929864|565420454|FG001|Overall Study|Lost to Follow-up|12|||
156638246|NCT00929864|565420453|FG000|Overall Study|Withdrawal by Subject|20|||
156638247|NCT00929864|565420454|FG001|Overall Study|Withdrawal by Subject|9|||
156638248|NCT00929864|565420453|FG000|Overall Study|No longer met criteria|2|||
156638249|NCT00929864|565420454|FG001|Overall Study|No longer met criteria|1|||
156638250|NCT00929864|565420453|FG000|Overall Study|Poor or non-compliance|3|||
156638251|NCT00929864|565420454|FG001|Overall Study|Poor or non-compliance|3|||
156638252|NCT00929864|565420453|FG000|Overall Study|Pregnancy|0|||
156638253|NCT00929864|565420454|FG001|Overall Study|Pregnancy|3|||
156638254|NCT00929864|565420453|FG000|Overall Study|Administrative reason by Sponsor|1|||
156638255|NCT00929864|565420454|FG001|Overall Study|Administrative reason by Sponsor|1|||
156638256|NCT00929864|565420453|FG000|Overall Study|Non-specified|2|||
156638257|NCT00929864|565420454|FG001|Overall Study|Non-specified|7|||
156638258|NCT03940742|565420457|FG000|Overall Study|Lost to Follow-up|0|||
156638259|NCT03940742|565420458|FG001|Overall Study|Lost to Follow-up|0|||
156638260|NCT03940742|565420459|FG002|Overall Study|Lost to Follow-up|0|||
156638261|NCT03940742|565420460|FG003|Overall Study|Lost to Follow-up|1|||
156638262|NCT03428217|565420462|FG000|Overall Study|Death|89|||
156638263|NCT03428217|565420463|FG001|Overall Study|Death|93|||
156638264|NCT03428217|565420462|FG000|Overall Study|Withdrawal by Subject|8|||
156638265|NCT03428217|565420463|FG001|Overall Study|Withdrawal by Subject|7|||
156638266|NCT03428217|565420462|FG000|Overall Study|Lost to Follow-up|1|||
156638267|NCT03428217|565420463|FG001|Overall Study|Lost to Follow-up|3|||
156638268|NCT03428217|565420462|FG000|Overall Study|Study terminated by sponsor|124|||
156638269|NCT03428217|565420463|FG001|Overall Study|Study terminated by sponsor|118|||
156638270|NCT03428217|565420462|FG000|Overall Study|Other, Not Specified|1|||
156638271|NCT03428217|565420463|FG001|Overall Study|Other, Not Specified|0|||
156638272|NCT00621309|565420464|FG000|Overall Study|Withdrawal by Subject|2|||
156638273|NCT00621309|565420465|FG001|Overall Study|Withdrawal by Subject|0|||
156638274|NCT00621309|565420466|FG002|Overall Study|Withdrawal by Subject|1|||
156638275|NCT00621309|565420467|FG003|Overall Study|Withdrawal by Subject|1|||
156638276|NCT00621309|565420468|FG004|Overall Study|Withdrawal by Subject|1|||
156638277|NCT00621309|565420469|FG005|Overall Study|Withdrawal by Subject|1|||
156638278|NCT05246111|565420470|FG000|Period 01|NOT ELIGIBLE IC5|1|||
156638279|NCT05246111|565420471|FG001|Period 01|NOT ELIGIBLE IC5|0|||
156638280|NCT01329562|565420472|FG000|Overall Study|Protocol Violation|5|||
156638281|NCT01329562|565420473|FG001|Overall Study|Protocol Violation|3|||
156638282|NCT01329562|565420472|FG000|Overall Study|Lost to Follow-up|1|||
156638283|NCT01329562|565420473|FG001|Overall Study|Lost to Follow-up|1|||
156638284|NCT01329562|565420472|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
156638285|NCT01329562|565420473|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
156638286|NCT01329562|565420472|FG000|Overall Study|Physician Decision|0|||
156638287|NCT01329562|565420473|FG001|Overall Study|Physician Decision|1|||
156638288|NCT00061568|565420474|FG000|Overall Study|Lost to Follow-up|12|||
156638289|NCT00061568|565420475|FG001|Overall Study|Lost to Follow-up|0|||
156638290|NCT00061568|565420474|FG000|Overall Study|Death|6|||
156638291|NCT00061568|565420475|FG001|Overall Study|Death|0|||
156638292|NCT00061568|565420474|FG000|Overall Study|Withdrawal by Subject|1|||
156638293|NCT00061568|565420475|FG001|Overall Study|Withdrawal by Subject|0|||
156638294|NCT00690573|565420482|FG000|Overall Study|Lack of Efficacy|8|||
156638295|NCT00690573|565420482|FG000|Overall Study|Withdrawal by Subject|1|||
156638296|NCT00777920|565420483|FG000|Overall Study|Adverse Event|39|||
156411732|NCT01089556|564601381|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
156638297|NCT00777920|565420483|FG000|Overall Study|Withdrawal of Consent|4|||
156638298|NCT00777920|565420483|FG000|Overall Study|Lost to Follow-up|1|||
156638299|NCT00777920|565420483|FG000|Overall Study|Investigator's discretion|1|||
156638300|NCT00777920|565420483|FG000|Overall Study|Clinical status did not improve|1|||
156751710|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
156638301|NCT00777920|565420483|FG000|Overall Study|Other, not specified|4|||
156638302|NCT02392377|565420484|FG000|Overall Study|Withdrawal by Subject|0|||
156638303|NCT02392377|565420485|FG001|Overall Study|Withdrawal by Subject|1|||
156638304|NCT01126359|565420488|FG000|First Intervention (20-minutes)|Physician Decision|0|||
156638305|NCT01126359|565420489|FG001|First Intervention (20-minutes)|Physician Decision|1|||
156638306|NCT00902486|565420490|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
156638307|NCT00902486|565420491|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
156638308|NCT00902486|565420492|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
156638309|NCT00902486|565420493|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
156638310|NCT00902486|565420494|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
156638311|NCT00902486|565420495|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
156638312|NCT00902486|565420490|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
156638313|NCT00902486|565420491|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
156638314|NCT00902486|565420492|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
156638315|NCT00902486|565420493|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
156638316|NCT00902486|565420494|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
156638317|NCT00902486|565420495|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
156638318|NCT00902486|565420490|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
156638319|NCT00902486|565420491|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
156638320|NCT00902486|565420492|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
156638321|NCT00902486|565420493|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
156638322|NCT00902486|565420494|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
156638323|NCT00902486|565420495|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
156638324|NCT00902486|565420490|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
156638325|NCT00902486|565420491|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
156638326|NCT00902486|565420492|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
156638327|NCT00902486|565420493|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
156638328|NCT00902486|565420494|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
156638329|NCT00902486|565420495|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
156638330|NCT00902486|565420490|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
156638331|NCT00902486|565420491|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
156638332|NCT00902486|565420492|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
156638333|NCT00902486|565420493|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
156638334|NCT00902486|565420494|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
156638335|NCT00902486|565420495|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
156638336|NCT00902486|565420490|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
156638337|NCT00902486|565420491|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
156638338|NCT00902486|565420492|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
156638339|NCT00902486|565420493|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
156638340|NCT00902486|565420494|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
156638341|NCT00902486|565420495|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
156638342|NCT00902486|565420490|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
156638343|NCT00902486|565420491|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
156638344|NCT00902486|565420492|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
156638345|NCT00902486|565420493|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
156638346|NCT00902486|565420494|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
156638347|NCT00902486|565420495|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
156638348|NCT00902486|565420490|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
156638349|NCT00902486|565420491|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
156638350|NCT00902486|565420492|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
156638351|NCT00902486|565420493|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
156638352|NCT00902486|565420494|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
156638353|NCT00902486|565420495|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
156638354|NCT00902486|565420490|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
156638355|NCT00902486|565420491|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
156638356|NCT00902486|565420492|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
156638357|NCT00902486|565420493|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
156638358|NCT00902486|565420494|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
156638359|NCT00902486|565420495|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
156638360|NCT00902486|565420490|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
156638361|NCT00902486|565420491|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
156638362|NCT00902486|565420492|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
156638363|NCT00902486|565420493|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
156638364|NCT00902486|565420494|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
156638365|NCT00902486|565420495|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
156638366|NCT00902486|565420490|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
156638367|NCT00902486|565420491|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
156638368|NCT00902486|565420492|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
156638369|NCT00902486|565420493|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
156638370|NCT00902486|565420494|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
156638371|NCT00902486|565420495|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
156638372|NCT00858234|565422103|FG000|Overall Study|Adverse Event|6|||
156638373|NCT00858234|565422103|FG000|Overall Study|Progressive disease|2|||
156638374|NCT00858234|565422103|FG000|Overall Study|Status unknown|1|||
156638375|NCT02957682|565422104|FG000|Overall Study|Adverse Event|64|||
156638376|NCT02957682|565422105|FG001|Overall Study|Adverse Event|67|||
156638377|NCT02957682|565422104|FG000|Overall Study|Poor Compliance to Protocol|30|||
156638378|NCT02957682|565422105|FG001|Overall Study|Poor Compliance to Protocol|26|||
156638379|NCT02957682|565422104|FG000|Overall Study|Physician Decision|4|||
156638380|NCT02957682|565422105|FG001|Overall Study|Physician Decision|4|||
156638381|NCT02957682|565422104|FG000|Overall Study|Study Terminated by Sponsor|4|||
156638382|NCT02957682|565422105|FG001|Overall Study|Study Terminated by Sponsor|3|||
156638383|NCT02957682|565422104|FG000|Overall Study|Subject Moved|10|||
156638384|NCT02957682|565422105|FG001|Overall Study|Subject Moved|16|||
156638385|NCT02957682|565422104|FG000|Overall Study|Withdrawal by Subject|64|||
156638386|NCT02957682|565422105|FG001|Overall Study|Withdrawal by Subject|33|||
156638387|NCT02957682|565422104|FG000|Overall Study|Related to IMP Administration|3|||
156638388|NCT02957682|565422105|FG001|Overall Study|Related to IMP Administration|6|||
156638389|NCT02957682|565422104|FG000|Overall Study|Non-disclosed|16|||
156638390|NCT02957682|565422105|FG001|Overall Study|Non-disclosed|12|||
156638391|NCT02957682|565422104|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
156638392|NCT02957682|565422105|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
156638393|NCT02953262|565422113|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
156638394|NCT02953262|565422114|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
156638395|NCT02953262|565422115|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
156638396|NCT02953262|565422116|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
156638397|NCT01652573|565422117|FG000|Overall Study|Adverse Event|0|||
156638398|NCT01652573|565422118|FG001|Overall Study|Adverse Event|1|||
156638399|NCT00934622|565422119|FG000|Overall Study|Lost to Follow-up|7|||
156638400|NCT00934622|565422119|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
156638401|NCT03284424|565422120|FG000|Overall Study|Death|70|||
156638402|NCT03284424|565422121|FG001|Overall Study|Death|24|||
156638403|NCT03284424|565422120|FG000|Overall Study|Lost to Follow-up|3|||
156638404|NCT03284424|565422121|FG001|Overall Study|Lost to Follow-up|1|||
156638405|NCT03284424|565422120|FG000|Overall Study|Physician Decision|1|||
156638406|NCT03284424|565422121|FG001|Overall Study|Physician Decision|2|||
156638407|NCT03284424|565422120|FG000|Overall Study|Withdrawal by Subject|4|||
156638408|NCT03284424|565422121|FG001|Overall Study|Withdrawal by Subject|5|||
156638409|NCT03284424|565422120|FG000|Overall Study|Sponsor's decision|27|||
156638410|NCT03284424|565422121|FG001|Overall Study|Sponsor's decision|22|||
156638411|NCT00468312|565422122|FG000|Overall Study|Adverse Event|2|||
156638412|NCT00468312|565422123|FG001|Overall Study|Adverse Event|1|||
156638413|NCT00468312|565422122|FG000|Overall Study|Lack of Efficacy|0|||
156638414|NCT00468312|565422123|FG001|Overall Study|Lack of Efficacy|1|||
156638415|NCT00468312|565422122|FG000|Overall Study|Withdrawal by Subject|0|||
156638416|NCT00468312|565422123|FG001|Overall Study|Withdrawal by Subject|1|||
156638417|NCT00468312|565422122|FG000|Overall Study|Protocol Violation|2|||
156638418|NCT00468312|565422123|FG001|Overall Study|Protocol Violation|1|||
156638419|NCT00468312|565422122|FG000|Overall Study|Did not meet protocol eligibility|0|||
156638420|NCT00468312|565422123|FG001|Overall Study|Did not meet protocol eligibility|1|||
156638421|NCT01052038|565422124|FG000|Overall Study|Lost to Follow-up|2|||
156638422|NCT01052038|565422125|FG001|Overall Study|Lost to Follow-up|3|||
156638423|NCT01052038|565422126|FG002|Overall Study|Lost to Follow-up|1|||
156638424|NCT01052038|565422124|FG000|Overall Study|Protocol Violation|2|||
156638425|NCT01052038|565422125|FG001|Overall Study|Protocol Violation|3|||
156638426|NCT01052038|565422126|FG002|Overall Study|Protocol Violation|3|||
156638427|NCT03349437|565422127|FG000|Screening|Screen Fail|4|||
156638428|NCT03349437|565422128|FG001|Screening|Screen Fail|0|||
156638429|NCT03349437|565422129|FG002|Screening|Screen Fail|0|||
156638430|NCT03349437|565422127|FG000|Screening|Withdrawn|1|||
156638431|NCT03349437|565422128|FG001|Screening|Withdrawn|0|||
156638432|NCT03349437|565422129|FG002|Screening|Withdrawn|0|||
156638433|NCT05723835|565422135|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
156638434|NCT05723835|565422136|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
156638435|NCT05723835|565422137|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
156638436|NCT05723835|565422138|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
156638437|NCT05723835|565422139|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
156638438|NCT05723835|565422140|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
156638439|NCT05723835|565422141|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
156638440|NCT05723835|565422142|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
156638441|NCT05226286|565422143|FG000|Overall Study|Screen failures prior to implant|62|||
156411733|NCT01089556|564601382|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
156638442|NCT05226286|565422143|FG000|Overall Study|Withdrawal by Subject|13|||
156638443|NCT05226286|565422143|FG000|Overall Study|Lost to Follow-up|3|||
156638444|NCT05226286|565422143|FG000|Overall Study|Physician Decision|1|||
156638445|NCT05226286|565422143|FG000|Overall Study|Adverse Event|1|||
156638446|NCT05226286|565422143|FG000|Overall Study|Death|1|||
156638447|NCT05226286|565422143|FG000|Overall Study|Device explant with no planned replacement|1|||
156638448|NCT05226286|565422143|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
156638449|NCT05226286|565422143|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
156638450|NCT00602641|565422144|FG000|Overall Study|Never started protocol therapy|6|||
156638451|NCT00602641|565422145|FG001|Overall Study|Never started protocol therapy|2|||
156638452|NCT00602641|565422144|FG000|Overall Study|Still on treatment at time of analysis|8|||
156638453|NCT00602641|565422145|FG001|Overall Study|Still on treatment at time of analysis|15|||
156638454|NCT00602641|565422144|FG000|Overall Study|Adverse Event|62|||
156638455|NCT00602641|565422145|FG001|Overall Study|Adverse Event|53|||
156638456|NCT00602641|565422144|FG000|Overall Study|Disease progression|38|||
156638457|NCT00602641|565422145|FG001|Overall Study|Disease progression|55|||
156638458|NCT00602641|565422144|FG000|Overall Study|Death|6|||
156638459|NCT00602641|565422145|FG001|Overall Study|Death|5|||
156638460|NCT00602641|565422144|FG000|Overall Study|Withdrawal by Subject|15|||
156638461|NCT00602641|565422145|FG001|Overall Study|Withdrawal by Subject|12|||
156638462|NCT00602641|565422144|FG000|Overall Study|Alternative therapy|5|||
156638463|NCT00602641|565422145|FG001|Overall Study|Alternative therapy|2|||
156638464|NCT00602641|565422144|FG000|Overall Study|Other Complicating Disease|5|||
156638465|NCT00602641|565422145|FG001|Overall Study|Other Complicating Disease|2|||
156638466|NCT00602641|565422144|FG000|Overall Study|Physician Decision|5|||
156638467|NCT00602641|565422145|FG001|Overall Study|Physician Decision|4|||
156638468|NCT00602641|565422144|FG000|Overall Study|Administrative Closure|1|||
156638469|NCT00602641|565422145|FG001|Overall Study|Administrative Closure|1|||
156638470|NCT00602641|565422144|FG000|Overall Study|Other|3|||
156638471|NCT00602641|565422145|FG001|Overall Study|Other|1|||
156638472|NCT01826201|565422148|FG000|Overall Study|Non compliance with protocol|4|||
156638473|NCT03387735|565422149|FG000|Overall Study|Lost to Follow-up|4|||
156638474|NCT03387735|565422150|FG001|Overall Study|Lost to Follow-up|8|||
156638475|NCT03387735|565422149|FG000|Overall Study|Death|4|||
156638476|NCT03387735|565422150|FG001|Overall Study|Death|8|||
156638477|NCT03099161|565422153|FG000|Overall Study|Adverse Event|0|||
156638478|NCT03099161|565422154|FG001|Overall Study|Adverse Event|0|||
156638479|NCT03099161|565422155|FG002|Overall Study|Adverse Event|2|||
156638480|NCT03099161|565422153|FG000|Overall Study|Physician Decision|2|||
156638481|NCT03099161|565422154|FG001|Overall Study|Physician Decision|0|||
156638482|NCT03099161|565422155|FG002|Overall Study|Physician Decision|0|||
156638483|NCT03099161|565422153|FG000|Overall Study|Progressive Disease|1|||
156638484|NCT03099161|565422154|FG001|Overall Study|Progressive Disease|4|||
156638485|NCT03099161|565422155|FG002|Overall Study|Progressive Disease|1|||
156638486|NCT00110084|565422156|FG000|Overall Study|Adverse Event|9|||
156638487|NCT00110084|565422156|FG000|Overall Study|Death|1|||
156638488|NCT00110084|565422156|FG000|Overall Study|Patient Refusal|10|||
156638489|NCT00110084|565422156|FG000|Overall Study|Alternate Therapy|5|||
156638490|NCT00110084|565422156|FG000|Overall Study|Intercurrent Illness|1|||
156638491|NCT00110084|565422156|FG000|Overall Study|Other|2|||
156638492|NCT04854707|565422157|FG000|Overall Study|Lack of Efficacy|78|||
156638493|NCT04854707|565422158|FG001|Overall Study|Lack of Efficacy|59|||
156638494|NCT04854707|565422159|FG002|Overall Study|Lack of Efficacy|30|||
156638495|NCT05302414|565422161|FG000|Pretest to Posttest|Lost to Follow-up|12|||
156638496|NCT05302414|565422162|FG001|Pretest to Posttest|Lost to Follow-up|8|||
156638497|NCT05302414|565422163|FG002|Pretest to Posttest|Lost to Follow-up|8|||
156638498|NCT05302414|565422161|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
156638499|NCT05302414|565422162|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
156638500|NCT05302414|565422163|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
156638501|NCT00742859|565422164|FG000|Overall Study|Adverse Event|5|||
156638502|NCT00742859|565422165|FG001|Overall Study|Adverse Event|6|||
156638503|NCT00742859|565422166|FG002|Overall Study|Adverse Event|3|||
156638504|NCT00742859|565422167|FG003|Overall Study|Adverse Event|1|||
156638505|NCT00742859|565422164|FG000|Overall Study|Death|1|||
156638506|NCT00742859|565422165|FG001|Overall Study|Death|0|||
156638507|NCT00742859|565422166|FG002|Overall Study|Death|0|||
156638508|NCT00742859|565422167|FG003|Overall Study|Death|1|||
156638509|NCT00742859|565422164|FG000|Overall Study|Physician Decision|1|||
156638510|NCT00742859|565422165|FG001|Overall Study|Physician Decision|2|||
156638511|NCT00742859|565422166|FG002|Overall Study|Physician Decision|0|||
156638512|NCT00742859|565422167|FG003|Overall Study|Physician Decision|0|||
156638513|NCT00742859|565422164|FG000|Overall Study|Withdrawal by Subject|4|||
156638514|NCT00742859|565422165|FG001|Overall Study|Withdrawal by Subject|2|||
156638515|NCT00742859|565422166|FG002|Overall Study|Withdrawal by Subject|4|||
156638516|NCT00742859|565422167|FG003|Overall Study|Withdrawal by Subject|1|||
156638517|NCT00742859|565422164|FG000|Overall Study|Endpoint|0|||
156638518|NCT00742859|565422165|FG001|Overall Study|Endpoint|1|||
156638519|NCT00742859|565422166|FG002|Overall Study|Endpoint|1|||
156638520|NCT00742859|565422167|FG003|Overall Study|Endpoint|2|||
156638521|NCT00742859|565422164|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
156638522|NCT00742859|565422165|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
156638523|NCT00742859|565422166|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
156638524|NCT00742859|565422167|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
156638525|NCT00742859|565422164|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
156638526|NCT00742859|565422165|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
156638527|NCT00742859|565422166|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
156638528|NCT00742859|565422167|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
156638529|NCT00742859|565422164|FG000|Overall Study|Sponsor request patient out of town|0|||
156638530|NCT00742859|565422165|FG001|Overall Study|Sponsor request patient out of town|0|||
156638531|NCT00742859|565422166|FG002|Overall Study|Sponsor request patient out of town|1|||
156638532|NCT00742859|565422167|FG003|Overall Study|Sponsor request patient out of town|1|||
156638533|NCT00742859|565422164|FG000|Overall Study|Site error|0|||
156638534|NCT00742859|565422165|FG001|Overall Study|Site error|0|||
156638535|NCT00742859|565422166|FG002|Overall Study|Site error|1|||
156638536|NCT00742859|565422167|FG003|Overall Study|Site error|1|||
156638537|NCT01346501|565422168|FG000|Overall Study|Initiated Other Biological Agents|3|||
156638538|NCT01346501|565422169|FG001|Overall Study|Initiated Other Biological Agents|1|||
156638539|NCT01346501|565422168|FG000|Overall Study|Other|8|||
156638540|NCT01346501|565422169|FG001|Overall Study|Other|12|||
156638541|NCT03972709|565422175|FG000|Overall Study|Withdrawal by Subject|18|||
156638542|NCT03972709|565422176|FG001|Overall Study|Withdrawal by Subject|7|||
156638543|NCT03972709|565422177|FG002|Overall Study|Withdrawal by Subject|14|||
156638544|NCT03972709|565422175|FG000|Overall Study|Study Terminated by Sponsor|48|||
156638545|NCT03972709|565422176|FG001|Overall Study|Study Terminated by Sponsor|25|||
156638546|NCT03972709|565422177|FG002|Overall Study|Study Terminated by Sponsor|50|||
156638547|NCT03972709|565422175|FG000|Overall Study|Physician Decision|1|||
156638548|NCT03972709|565422176|FG001|Overall Study|Physician Decision|0|||
156638549|NCT03972709|565422177|FG002|Overall Study|Physician Decision|0|||
156638550|NCT03972709|565422175|FG000|Overall Study|COVID-19|0|||
156638551|NCT03972709|565422176|FG001|Overall Study|COVID-19|1|||
156638552|NCT03972709|565422177|FG002|Overall Study|COVID-19|1|||
156638553|NCT03972709|565422175|FG000|Overall Study|Lost to Follow-up|6|||
156638554|NCT03972709|565422176|FG001|Overall Study|Lost to Follow-up|1|||
156638555|NCT03972709|565422177|FG002|Overall Study|Lost to Follow-up|2|||
156638556|NCT03972709|565422175|FG000|Overall Study|Death|5|||
156638557|NCT03972709|565422176|FG001|Overall Study|Death|1|||
156638558|NCT03972709|565422177|FG002|Overall Study|Death|4|||
156638559|NCT03972709|565422175|FG000|Overall Study|Adverse Event|3|||
156638560|NCT03972709|565422176|FG001|Overall Study|Adverse Event|1|||
156638561|NCT03972709|565422177|FG002|Overall Study|Adverse Event|4|||
156638562|NCT03972709|565422175|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
156638563|NCT03972709|565422176|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
156638564|NCT03972709|565422177|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
156638565|NCT03972709|565422175|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
156638566|NCT03972709|565422176|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
156638567|NCT03972709|565422177|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
156638568|NCT03972709|565422175|FG000|Overall Study|Subject Unable to be Contacted|0|||
156638569|NCT03972709|565422176|FG001|Overall Study|Subject Unable to be Contacted|1|||
156638570|NCT03972709|565422177|FG002|Overall Study|Subject Unable to be Contacted|0|||
156638571|NCT03972709|565422175|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
156638572|NCT03972709|565422176|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
156638573|NCT03972709|565422177|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
156638574|NCT03972709|565422175|FG000|Overall Study|Subject Moved|0|||
156638575|NCT03972709|565422176|FG001|Overall Study|Subject Moved|1|||
156638576|NCT03972709|565422177|FG002|Overall Study|Subject Moved|0|||
156638577|NCT03972709|565422175|FG000|Overall Study|Missed Study Visits|1|||
156638578|NCT03972709|565422176|FG001|Overall Study|Missed Study Visits|0|||
156638579|NCT03972709|565422177|FG002|Overall Study|Missed Study Visits|0|||
156638580|NCT01523301|565422178|FG000|Overall Study|Adverse Event|25|||
156638581|NCT01523301|565422179|FG001|Overall Study|Adverse Event|16|||
156638582|NCT01523301|565422178|FG000|Overall Study|Lack of Efficacy|0|||
156638583|NCT01523301|565422179|FG001|Overall Study|Lack of Efficacy|2|||
156638584|NCT01523301|565422178|FG000|Overall Study|Protocol Violation|3|||
156638585|NCT01523301|565422179|FG001|Overall Study|Protocol Violation|4|||
156638586|NCT01523301|565422178|FG000|Overall Study|Lost to Follow-up|1|||
156638587|NCT01523301|565422179|FG001|Overall Study|Lost to Follow-up|0|||
156638588|NCT01523301|565422178|FG000|Overall Study|Withdrawal by Subject|6|||
156638589|NCT01523301|565422179|FG001|Overall Study|Withdrawal by Subject|8|||
156638590|NCT01523301|565422178|FG000|Overall Study|Other Reason|0|||
156638591|NCT01523301|565422179|FG001|Overall Study|Other Reason|2|||
156638592|NCT03889197|565422180|FG000|Overall Study|Withdrawal by Subject|1|||
156638593|NCT03889197|565422181|FG001|Overall Study|Withdrawal by Subject|0|||
156638594|NCT03889197|565422180|FG000|Overall Study|Physician Decision|0|||
156638595|NCT03889197|565422181|FG001|Overall Study|Physician Decision|1|||
156638596|NCT03889197|565422180|FG000|Overall Study|met exclusion criteria|0|||
156638597|NCT03889197|565422181|FG001|Overall Study|met exclusion criteria|1|||
156638598|NCT03889197|565422180|FG000|Overall Study|Protocol Violation|1|||
156638599|NCT03889197|565422181|FG001|Overall Study|Protocol Violation|0|||
156638600|NCT05004181|565422184|FG000|Overall Study|Withdrawal of consent|0|||
156638601|NCT05004181|565422185|FG001|Overall Study|Withdrawal of consent|0|||
156638602|NCT05004181|565422186|FG002|Overall Study|Withdrawal of consent|1|||
156638603|NCT05004181|565422187|FG003|Overall Study|Withdrawal of consent|3|||
156638604|NCT05004181|565422188|FG004|Overall Study|Withdrawal of consent|3|||
156638605|NCT05004181|565422189|FG005|Overall Study|Withdrawal of consent|0|||
156638606|NCT05004181|565422190|FG006|Overall Study|Withdrawal of consent|30|||
156638607|NCT05004181|565422191|FG007|Overall Study|Withdrawal of consent|9|||
156638608|NCT05004181|565422192|FG008|Overall Study|Withdrawal of consent|3|||
156638609|NCT05004181|565422193|FG009|Overall Study|Withdrawal of consent|2|||
156638610|NCT05004181|565422194|FG010|Overall Study|Withdrawal of consent|5|||
156638611|NCT05004181|565422195|FG011|Overall Study|Withdrawal of consent|1|||
156638612|NCT05004181|565422184|FG000|Overall Study|Lost to Follow-up|2|||
156638613|NCT05004181|565422185|FG001|Overall Study|Lost to Follow-up|4|||
156638614|NCT05004181|565422186|FG002|Overall Study|Lost to Follow-up|2|||
156638615|NCT05004181|565422187|FG003|Overall Study|Lost to Follow-up|3|||
156638616|NCT05004181|565422188|FG004|Overall Study|Lost to Follow-up|5|||
156638617|NCT05004181|565422189|FG005|Overall Study|Lost to Follow-up|2|||
156638618|NCT05004181|565422190|FG006|Overall Study|Lost to Follow-up|15|||
156638619|NCT05004181|565422191|FG007|Overall Study|Lost to Follow-up|12|||
156638620|NCT05004181|565422192|FG008|Overall Study|Lost to Follow-up|38|||
156638621|NCT05004181|565422193|FG009|Overall Study|Lost to Follow-up|6|||
156638622|NCT05004181|565422194|FG010|Overall Study|Lost to Follow-up|6|||
156638623|NCT05004181|565422195|FG011|Overall Study|Lost to Follow-up|0|||
156638624|NCT05004181|565422184|FG000|Overall Study|Death|0|||
156638625|NCT05004181|565422185|FG001|Overall Study|Death|0|||
156638626|NCT05004181|565422186|FG002|Overall Study|Death|0|||
156638627|NCT05004181|565422187|FG003|Overall Study|Death|0|||
156638628|NCT05004181|565422188|FG004|Overall Study|Death|0|||
156638629|NCT05004181|565422189|FG005|Overall Study|Death|0|||
156638630|NCT05004181|565422190|FG006|Overall Study|Death|1|||
156638631|NCT05004181|565422191|FG007|Overall Study|Death|0|||
156638632|NCT05004181|565422192|FG008|Overall Study|Death|2|||
156638633|NCT05004181|565422193|FG009|Overall Study|Death|0|||
156638634|NCT05004181|565422194|FG010|Overall Study|Death|0|||
156638635|NCT05004181|565422195|FG011|Overall Study|Death|0|||
156638636|NCT05004181|565422184|FG000|Overall Study|Physician Decision|0|||
156638637|NCT05004181|565422185|FG001|Overall Study|Physician Decision|0|||
156638638|NCT05004181|565422186|FG002|Overall Study|Physician Decision|0|||
156638639|NCT05004181|565422187|FG003|Overall Study|Physician Decision|0|||
156638640|NCT05004181|565422188|FG004|Overall Study|Physician Decision|0|||
156638641|NCT05004181|565422189|FG005|Overall Study|Physician Decision|0|||
156638642|NCT05004181|565422190|FG006|Overall Study|Physician Decision|2|||
156638643|NCT05004181|565422191|FG007|Overall Study|Physician Decision|0|||
156638644|NCT05004181|565422192|FG008|Overall Study|Physician Decision|7|||
156638645|NCT05004181|565422193|FG009|Overall Study|Physician Decision|0|||
156638646|NCT05004181|565422194|FG010|Overall Study|Physician Decision|0|||
156638647|NCT05004181|565422195|FG011|Overall Study|Physician Decision|0|||
156638648|NCT05004181|565422184|FG000|Overall Study|Withdrawal by Subject|2|||
156638649|NCT05004181|565422185|FG001|Overall Study|Withdrawal by Subject|3|||
156638650|NCT05004181|565422186|FG002|Overall Study|Withdrawal by Subject|2|||
156638651|NCT05004181|565422187|FG003|Overall Study|Withdrawal by Subject|2|||
156638652|NCT05004181|565422188|FG004|Overall Study|Withdrawal by Subject|4|||
156638653|NCT05004181|565422189|FG005|Overall Study|Withdrawal by Subject|2|||
156638654|NCT05004181|565422190|FG006|Overall Study|Withdrawal by Subject|4|||
156638655|NCT05004181|565422191|FG007|Overall Study|Withdrawal by Subject|22|||
156638656|NCT05004181|565422192|FG008|Overall Study|Withdrawal by Subject|8|||
156638657|NCT05004181|565422193|FG009|Overall Study|Withdrawal by Subject|1|||
156638658|NCT05004181|565422194|FG010|Overall Study|Withdrawal by Subject|3|||
156638659|NCT05004181|565422195|FG011|Overall Study|Withdrawal by Subject|2|||
156638660|NCT05004181|565422184|FG000|Overall Study|Protocol Violation|2|||
156638661|NCT05004181|565422185|FG001|Overall Study|Protocol Violation|3|||
156638662|NCT05004181|565422186|FG002|Overall Study|Protocol Violation|0|||
156638663|NCT05004181|565422187|FG003|Overall Study|Protocol Violation|0|||
156638664|NCT05004181|565422188|FG004|Overall Study|Protocol Violation|1|||
156638665|NCT05004181|565422189|FG005|Overall Study|Protocol Violation|0|||
156638666|NCT05004181|565422190|FG006|Overall Study|Protocol Violation|16|||
156638667|NCT05004181|565422191|FG007|Overall Study|Protocol Violation|18|||
156638668|NCT05004181|565422192|FG008|Overall Study|Protocol Violation|2|||
156638669|NCT05004181|565422193|FG009|Overall Study|Protocol Violation|2|||
156638670|NCT05004181|565422194|FG010|Overall Study|Protocol Violation|2|||
156638671|NCT05004181|565422195|FG011|Overall Study|Protocol Violation|1|||
156638672|NCT05004181|565422184|FG000|Overall Study|Not further specified|1|||
156638673|NCT05004181|565422185|FG001|Overall Study|Not further specified|0|||
156638674|NCT05004181|565422186|FG002|Overall Study|Not further specified|0|||
156638675|NCT05004181|565422187|FG003|Overall Study|Not further specified|0|||
156638676|NCT05004181|565422188|FG004|Overall Study|Not further specified|0|||
156638677|NCT05004181|565422189|FG005|Overall Study|Not further specified|0|||
156638678|NCT05004181|565422190|FG006|Overall Study|Not further specified|1|||
156638679|NCT05004181|565422191|FG007|Overall Study|Not further specified|0|||
156638680|NCT05004181|565422192|FG008|Overall Study|Not further specified|2|||
156638681|NCT05004181|565422193|FG009|Overall Study|Not further specified|1|||
156638682|NCT05004181|565422194|FG010|Overall Study|Not further specified|0|||
156638683|NCT05004181|565422195|FG011|Overall Study|Not further specified|1|||
156638684|NCT03353415|565422204|FG000|Masked CGM Wear|Lost to Follow-up|2|||
156638685|NCT03353415|565422204|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
156638686|NCT00975000|565422205|FG000|Overall Study|Other|1|||
156638687|NCT00975000|565422206|FG001|Overall Study|Other|0|||
156638688|NCT00975000|565422205|FG000|Overall Study|Adverse Event|1|||
156638689|NCT00975000|565422206|FG001|Overall Study|Adverse Event|1|||
156638690|NCT00975000|565422205|FG000|Overall Study|Withdrawal by Subject|2|||
156638691|NCT00975000|565422206|FG001|Overall Study|Withdrawal by Subject|2|||
156638692|NCT00975000|565422205|FG000|Overall Study|Lost to Follow-up|0|||
156638693|NCT00975000|565422206|FG001|Overall Study|Lost to Follow-up|1|||
156638694|NCT00975000|565422205|FG000|Overall Study|Protocol-specified Criteria|1|||
156638695|NCT00975000|565422206|FG001|Overall Study|Protocol-specified Criteria|0|||
156638696|NCT00975000|565422205|FG000|Overall Study|Non-compliance|0|||
156638697|NCT00975000|565422206|FG001|Overall Study|Non-compliance|1|||
156638698|NCT03205163|565422207|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
156638699|NCT03205163|565422208|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
156638700|NCT00005879|565422209|FG000|Overall Study|Withdrawal by Subject|8|||
156638701|NCT00005879|565422210|FG001|Overall Study|Withdrawal by Subject|10|||
156638702|NCT01238172|565422211|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
156638703|NCT01238172|565422212|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
156638704|NCT01238172|565422211|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
156638705|NCT01238172|565422212|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
156638706|NCT05022121|565422213|FG000|Overall Study|Lack of Efficacy|1|||
156638707|NCT05022121|565422214|FG001|Overall Study|Lack of Efficacy|0|||
156638708|NCT05022121|565422213|FG000|Overall Study|Lost to Follow-up|0|||
156638709|NCT05022121|565422214|FG001|Overall Study|Lost to Follow-up|2|||
156638710|NCT04439110|565422215|FG000|Overall Study|Ineligible|2|||
156638711|NCT04439110|565422215|FG000|Overall Study|Adverse Event|4|||
156638712|NCT04439110|565422215|FG000|Overall Study|Death|2|||
156638713|NCT04439110|565422215|FG000|Overall Study|Disease proression|25|||
156638714|NCT04439110|565422215|FG000|Overall Study|Withdrawal by Subject|1|||
156638715|NCT04439110|565422215|FG000|Overall Study|Alternative therapy|1|||
156638716|NCT04439110|565422215|FG000|Overall Study|Other complicating disease|1|||
156638717|NCT04439110|565422215|FG000|Overall Study|Personal reasons|1|||
156638718|NCT04439110|565422215|FG000|Overall Study|Still on treatment|1|||
156638719|NCT00131937|565422216|FG000|Overall Study|Adverse Event|3|||
156638720|NCT00131937|565422216|FG000|Overall Study|Withdrawal by Subject|2|||
156638721|NCT00131937|565422216|FG000|Overall Study|Physician Decision|1|||
156638722|NCT00131937|565422216|FG000|Overall Study|Disease Progression|7|||
156638723|NCT00131937|565422216|FG000|Overall Study|Alternative therapy|1|||
156638724|NCT01298661|565422217|FG000|Overall Study|Withdrawal by Subject|2|||
156638725|NCT01298661|565422218|FG001|Overall Study|Withdrawal by Subject|0|||
156638726|NCT01298661|565422219|FG002|Overall Study|Withdrawal by Subject|2|||
156638727|NCT00526227|565422222|FG000|Overall Study|Device not implanted|1|||
156638728|NCT00526227|565422222|FG000|Overall Study|Death|1|||
156638729|NCT01678924|565423905|FG000|Overall Study|Adverse Event|1|||
156638730|NCT01678924|565423906|FG001|Overall Study|Adverse Event|1|||
156638731|NCT01678924|565423907|FG002|Overall Study|Adverse Event|0|||
156638732|NCT01678924|565423908|FG003|Overall Study|Adverse Event|1|||
156638733|NCT01678924|565423905|FG000|Overall Study|Lack of Efficacy|7|||
156638734|NCT01678924|565423906|FG001|Overall Study|Lack of Efficacy|2|||
156638735|NCT01678924|565423907|FG002|Overall Study|Lack of Efficacy|0|||
156638736|NCT01678924|565423908|FG003|Overall Study|Lack of Efficacy|5|||
156638737|NCT01678924|565423905|FG000|Overall Study|Lost to Follow-up|0|||
156638738|NCT01678924|565423906|FG001|Overall Study|Lost to Follow-up|4|||
156638739|NCT01678924|565423907|FG002|Overall Study|Lost to Follow-up|0|||
156638740|NCT01678924|565423908|FG003|Overall Study|Lost to Follow-up|2|||
156638741|NCT01678924|565423905|FG000|Overall Study|Personal Reasons|2|||
156638742|NCT01678924|565423906|FG001|Overall Study|Personal Reasons|2|||
156638743|NCT01678924|565423907|FG002|Overall Study|Personal Reasons|2|||
156638744|NCT01678924|565423908|FG003|Overall Study|Personal Reasons|7|||
156638745|NCT01678924|565423905|FG000|Overall Study|Withdrawal by Subject|0|||
156638746|NCT01678924|565423906|FG001|Overall Study|Withdrawal by Subject|3|||
156638747|NCT01678924|565423907|FG002|Overall Study|Withdrawal by Subject|0|||
156638748|NCT01678924|565423908|FG003|Overall Study|Withdrawal by Subject|2|||
156638749|NCT01678924|565423905|FG000|Overall Study|Unable to attend scheduled visits|0|||
156638750|NCT01678924|565423906|FG001|Overall Study|Unable to attend scheduled visits|0|||
156638751|NCT01678924|565423907|FG002|Overall Study|Unable to attend scheduled visits|0|||
156638752|NCT01678924|565423908|FG003|Overall Study|Unable to attend scheduled visits|1|||
156638753|NCT02576054|565423909|FG000|Overall Study|Withdrawal by Subject|1|||
156638754|NCT00981409|565423916|FG000|Overall Study|Adverse Event|4|||
156638755|NCT00981409|565423917|FG001|Overall Study|Adverse Event|0|||
156638756|NCT00981409|565423916|FG000|Overall Study|Protocol Violation|0|||
156638757|NCT00981409|565423917|FG001|Overall Study|Protocol Violation|1|||
156638758|NCT00981409|565423916|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
156638759|NCT00981409|565423917|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
156638760|NCT03901339|565423920|FG000|Overall Study|Death|220|||
156638761|NCT03901339|565423921|FG001|Overall Study|Death|192|||
156638762|NCT03901339|565423920|FG000|Overall Study|Informed consent withdrawn|13|||
156638763|NCT03901339|565423921|FG001|Overall Study|Informed consent withdrawn|40|||
156638764|NCT03901339|565423920|FG000|Overall Study|Sponsor request|30|||
156638765|NCT03901339|565423921|FG001|Overall Study|Sponsor request|23|||
156638766|NCT03901339|565423920|FG000|Overall Study|Reason not specified|5|||
156638767|NCT03901339|565423921|FG001|Overall Study|Reason not specified|7|||
156638768|NCT03901339|565423920|FG000|Overall Study|Lost to Follow-up|4|||
156638769|NCT03901339|565423921|FG001|Overall Study|Lost to Follow-up|7|||
156638770|NCT03901339|565423920|FG000|Overall Study|Covid19|0|||
156638771|NCT03901339|565423921|FG001|Overall Study|Covid19|2|||
156638772|NCT01071083|565423928|FG000|Overall Study|Adverse Event|1|||
156638773|NCT01071083|565423929|FG001|Overall Study|Adverse Event|0|||
156638774|NCT01071083|565423930|FG002|Overall Study|Adverse Event|1|||
156638775|NCT01071083|565423931|FG003|Overall Study|Adverse Event|0|||
156638776|NCT01071083|565423932|FG004|Overall Study|Adverse Event|1|||
156638777|NCT01071083|565423928|FG000|Overall Study|Withdrawal by Subject|3|||
156638778|NCT01071083|565423929|FG001|Overall Study|Withdrawal by Subject|0|||
156638779|NCT01071083|565423930|FG002|Overall Study|Withdrawal by Subject|2|||
156638780|NCT01071083|565423931|FG003|Overall Study|Withdrawal by Subject|0|||
156638781|NCT01071083|565423932|FG004|Overall Study|Withdrawal by Subject|3|||
156638782|NCT01071083|565423928|FG000|Overall Study|Physician Decision|1|||
156411734|NCT01089556|564601383|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
156638783|NCT01071083|565423929|FG001|Overall Study|Physician Decision|0|||
156411735|NCT01089556|564601384|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
156638784|NCT01071083|565423930|FG002|Overall Study|Physician Decision|0|||
156638785|NCT01071083|565423931|FG003|Overall Study|Physician Decision|1|||
156638786|NCT01071083|565423932|FG004|Overall Study|Physician Decision|1|||
156638787|NCT01071083|565423928|FG000|Overall Study|Early Rescue|1|||
156638788|NCT01071083|565423929|FG001|Overall Study|Early Rescue|0|||
156638789|NCT01071083|565423930|FG002|Overall Study|Early Rescue|0|||
156638790|NCT01071083|565423931|FG003|Overall Study|Early Rescue|0|||
156638791|NCT01071083|565423932|FG004|Overall Study|Early Rescue|1|||
156638792|NCT01071083|565423928|FG000|Overall Study|Subject Moved|0|||
156638793|NCT01071083|565423929|FG001|Overall Study|Subject Moved|1|||
156638794|NCT01071083|565423930|FG002|Overall Study|Subject Moved|0|||
156638795|NCT01071083|565423931|FG003|Overall Study|Subject Moved|0|||
156638796|NCT01071083|565423932|FG004|Overall Study|Subject Moved|0|||
156638797|NCT01071083|565423928|FG000|Overall Study|Images Not Usable (Motion)|0|||
156638798|NCT01071083|565423929|FG001|Overall Study|Images Not Usable (Motion)|1|||
156638799|NCT01071083|565423930|FG002|Overall Study|Images Not Usable (Motion)|0|||
156638800|NCT01071083|565423931|FG003|Overall Study|Images Not Usable (Motion)|0|||
156638801|NCT01071083|565423932|FG004|Overall Study|Images Not Usable (Motion)|0|||
156638802|NCT01071083|565423928|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156638803|NCT01071083|565423929|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
156638804|NCT01071083|565423930|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
156638805|NCT01071083|565423931|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
156638806|NCT01071083|565423932|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
156638807|NCT01071083|565423928|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
156638808|NCT01071083|565423929|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
156638809|NCT01071083|565423930|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
156638810|NCT01071083|565423931|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
156638811|NCT01071083|565423932|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
156638812|NCT01071083|565423928|FG000|Overall Study|Subject Refused to Continue|1|||
156638813|NCT01071083|565423929|FG001|Overall Study|Subject Refused to Continue|0|||
156638814|NCT01071083|565423930|FG002|Overall Study|Subject Refused to Continue|0|||
156638815|NCT01071083|565423931|FG003|Overall Study|Subject Refused to Continue|0|||
156638816|NCT01071083|565423932|FG004|Overall Study|Subject Refused to Continue|0|||
156638817|NCT00038467|565423933|FG000|Overall Study|Adverse Event|170|||
156638818|NCT00038467|565423934|FG001|Overall Study|Adverse Event|145|||
156638819|NCT00038467|565423933|FG000|Overall Study|Withdrawal by Subject|150|||
156638820|NCT00038467|565423934|FG001|Overall Study|Withdrawal by Subject|107|||
156638821|NCT00038467|565423933|FG000|Overall Study|Protocol Violation|19|||
156638822|NCT00038467|565423934|FG001|Overall Study|Protocol Violation|22|||
156638823|NCT00038467|565423933|FG000|Overall Study|Death|22|||
156638824|NCT00038467|565423934|FG001|Overall Study|Death|16|||
156638825|NCT00038467|565423933|FG000|Overall Study|Lost to Follow-up|15|||
156638826|NCT00038467|565423934|FG001|Overall Study|Lost to Follow-up|10|||
156638827|NCT00038467|565423933|FG000|Overall Study|Recurrence|109|||
156638828|NCT00038467|565423934|FG001|Overall Study|Recurrence|179|||
156638829|NCT00038467|565423933|FG000|Overall Study|Randomized, but not treated|31|||
156638830|NCT00038467|565423934|FG001|Overall Study|Randomized, but not treated|35|||
156638831|NCT00038467|565423933|FG000|Overall Study|Other|26|||
156638832|NCT00038467|565423934|FG001|Overall Study|Other|28|||
156638833|NCT04732728|565423935|FG000|Overall Study|Death|12|||
156638834|NCT04732728|565423935|FG000|Overall Study|Withdrawn|136|||
156638835|NCT01339000|565423936|FG000|Overall Study|study closed due to lack of drug supply|1|||
156638836|NCT01339000|565423937|FG001|Overall Study|study closed due to lack of drug supply|0|||
156638837|NCT02017535|565423938|FG000|Overall Study|Withdrawal by Subject|1|||
156638838|NCT02017535|565423939|FG001|Overall Study|Withdrawal by Subject|0|||
156638839|NCT02017535|565423940|FG002|Overall Study|Withdrawal by Subject|0|||
156638840|NCT02017535|565423941|FG003|Overall Study|Withdrawal by Subject|0|||
156638841|NCT05511428|565423942|FG000|Overall Study|Withdrawal by Subject|1|||
156638842|NCT05511428|565423942|FG000|Overall Study|Adverse Event|1|||
156638843|NCT04088734|565423943|FG000|Overall Study|Other, Not Specified|5|||
156638844|NCT03829462|565423944|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
156638845|NCT03829462|565423945|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
156638846|NCT03829462|565423944|FG000|Overall Study|No treatment due to progression disease|0|||
156638847|NCT03829462|565423945|FG001|Overall Study|No treatment due to progression disease|1|||
156638848|NCT00481871|565423950|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
156638849|NCT00481871|565423951|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
156638850|NCT00481871|565423952|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
156638851|NCT00481871|565423953|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
156638852|NCT00481871|565423954|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
156638853|NCT03332212|565423955|FG000|Overall Study|Not treated|0|||
156638854|NCT03332212|565423956|FG001|Overall Study|Not treated|1|||
156638855|NCT03332212|565423957|FG002|Overall Study|Not treated|0|||
156638856|NCT03332212|565423958|FG003|Overall Study|Not treated|0|||
156638857|NCT03332212|565423955|FG000|Overall Study|Adverse Event|0|||
156638858|NCT03332212|565423956|FG001|Overall Study|Adverse Event|0|||
156638859|NCT03332212|565423957|FG002|Overall Study|Adverse Event|0|||
156638860|NCT03332212|565423958|FG003|Overall Study|Adverse Event|1|||
156638861|NCT03332212|565423955|FG000|Overall Study|worsening of disease under study|1|||
156638862|NCT03332212|565423956|FG001|Overall Study|worsening of disease under study|1|||
156638863|NCT03332212|565423957|FG002|Overall Study|worsening of disease under study|0|||
156638864|NCT03332212|565423958|FG003|Overall Study|worsening of disease under study|0|||
156638865|NCT05824273|565423969|FG000|Overall Study|Lost to Follow-up|16|||
156638866|NCT05824273|565423970|FG001|Overall Study|Lost to Follow-up|13|||
156638867|NCT02736695|565423971|FG000|Overall Study|Ineligible|6|||
156638868|NCT02736695|565423972|FG001|Overall Study|Ineligible|0|||
156638869|NCT04223193|565423975|FG000|Overall Study|Adverse Event|6|||
156638870|NCT04223193|565423976|FG001|Overall Study|Adverse Event|36|||
156638871|NCT04223193|565423975|FG000|Overall Study|Lack of Efficacy|2|||
156638872|NCT04223193|565423976|FG001|Overall Study|Lack of Efficacy|2|||
156638873|NCT04223193|565423975|FG000|Overall Study|Lost to Follow-up|1|||
156638874|NCT04223193|565423976|FG001|Overall Study|Lost to Follow-up|1|||
156638875|NCT04223193|565423975|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
156638876|NCT04223193|565423976|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
156638877|NCT04223193|565423975|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
156638878|NCT04223193|565423976|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
156638879|NCT04223193|565423975|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156638880|NCT04223193|565423976|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156638881|NCT04223193|565423975|FG000|Overall Study|Physician Decision|0|||
156638882|NCT04223193|565423976|FG001|Overall Study|Physician Decision|1|||
156638883|NCT04223193|565423975|FG000|Overall Study|Protocol Violation|1|||
156638884|NCT04223193|565423976|FG001|Overall Study|Protocol Violation|1|||
156638885|NCT04223193|565423975|FG000|Overall Study|Site Terminated by Sponsor|1|||
156638886|NCT04223193|565423976|FG001|Overall Study|Site Terminated by Sponsor|3|||
156638887|NCT04223193|565423975|FG000|Overall Study|Withdrawal by Subject|5|||
156638888|NCT04223193|565423976|FG001|Overall Study|Withdrawal by Subject|6|||
156638889|NCT04223193|565423975|FG000|Overall Study|Other|3|||
156638890|NCT04223193|565423976|FG001|Overall Study|Other|6|||
156638891|NCT03193190|565423982|FG000|Stage 1|Arm Terminated by Sponsor|0|||
156638892|NCT03193190|565423983|FG001|Stage 1|Arm Terminated by Sponsor|0|||
156638893|NCT03193190|565423984|FG002|Stage 1|Arm Terminated by Sponsor|0|||
156638894|NCT03193190|565423985|FG003|Stage 1|Arm Terminated by Sponsor|1|||
156638895|NCT03193190|565423986|FG004|Stage 1|Arm Terminated by Sponsor|0|||
156638896|NCT03193190|565423987|FG005|Stage 1|Arm Terminated by Sponsor|2|||
156638897|NCT03193190|565423988|FG006|Stage 1|Arm Terminated by Sponsor|0|||
156638898|NCT03193190|565423989|FG007|Stage 1|Arm Terminated by Sponsor|0|||
156638899|NCT03193190|565423990|FG008|Stage 1|Arm Terminated by Sponsor|0|||
156638900|NCT03193190|565423991|FG009|Stage 1|Arm Terminated by Sponsor|0|||
156638901|NCT03193190|565423992|FG010|Stage 1|Arm Terminated by Sponsor|0|||
156638902|NCT03193190|565423993|FG011|Stage 1|Arm Terminated by Sponsor|0|||
156638903|NCT03193190|565423994|FG012|Stage 1|Arm Terminated by Sponsor|0|||
156638904|NCT03193190|565423995|FG013|Stage 1|Arm Terminated by Sponsor|0|||
156638905|NCT03193190|565423996|FG014|Stage 1|Arm Terminated by Sponsor|0|||
156638906|NCT03193190|565423997|FG015|Stage 1|Arm Terminated by Sponsor|0|||
156638907|NCT03193190|565423982|FG000|Stage 1|Death|22|||
156638908|NCT03193190|565423983|FG001|Stage 1|Death|8|||
156638909|NCT03193190|565423984|FG002|Stage 1|Death|23|||
156638910|NCT03193190|565423985|FG003|Stage 1|Death|14|||
156638911|NCT03193190|565423986|FG004|Stage 1|Death|34|||
156638912|NCT03193190|565423987|FG005|Stage 1|Death|28|||
156638913|NCT03193190|565423988|FG006|Stage 1|Death|19|||
156638914|NCT03193190|565423989|FG007|Stage 1|Death|21|||
156638915|NCT03193190|565423990|FG008|Stage 1|Death|14|||
156638916|NCT03193190|565423991|FG009|Stage 1|Death|10|||
156638917|NCT03193190|565423992|FG010|Stage 1|Death|59|||
156638918|NCT03193190|565423993|FG011|Stage 1|Death|14|||
156638919|NCT03193190|565423994|FG012|Stage 1|Death|14|||
156638920|NCT03193190|565423995|FG013|Stage 1|Death|0|||
156638921|NCT03193190|565423996|FG014|Stage 1|Death|0|||
156638922|NCT03193190|565423997|FG015|Stage 1|Death|0|||
156638923|NCT03193190|565423982|FG000|Stage 1|Lost to Follow-up|2|||
156638924|NCT03193190|565423983|FG001|Stage 1|Lost to Follow-up|1|||
156638925|NCT03193190|565423984|FG002|Stage 1|Lost to Follow-up|1|||
156638926|NCT03193190|565423985|FG003|Stage 1|Lost to Follow-up|0|||
156638927|NCT03193190|565423986|FG004|Stage 1|Lost to Follow-up|0|||
156638928|NCT03193190|565423987|FG005|Stage 1|Lost to Follow-up|0|||
156638929|NCT03193190|565423988|FG006|Stage 1|Lost to Follow-up|1|||
156638930|NCT03193190|565423989|FG007|Stage 1|Lost to Follow-up|0|||
156638931|NCT03193190|565423990|FG008|Stage 1|Lost to Follow-up|0|||
156638932|NCT03193190|565423991|FG009|Stage 1|Lost to Follow-up|0|||
156638933|NCT03193190|565423992|FG010|Stage 1|Lost to Follow-up|0|||
156638934|NCT03193190|565423993|FG011|Stage 1|Lost to Follow-up|0|||
156638935|NCT03193190|565423994|FG012|Stage 1|Lost to Follow-up|0|||
156638936|NCT03193190|565423995|FG013|Stage 1|Lost to Follow-up|0|||
156638937|NCT03193190|565423996|FG014|Stage 1|Lost to Follow-up|0|||
156638938|NCT03193190|565423997|FG015|Stage 1|Lost to Follow-up|0|||
156638939|NCT03193190|565423982|FG000|Stage 1|Reason not Specified|1|||
156638940|NCT03193190|565423983|FG001|Stage 1|Reason not Specified|0|||
156638941|NCT03193190|565423984|FG002|Stage 1|Reason not Specified|0|||
156638942|NCT03193190|565423985|FG003|Stage 1|Reason not Specified|1|||
156638943|NCT03193190|565423986|FG004|Stage 1|Reason not Specified|0|||
156638944|NCT03193190|565423987|FG005|Stage 1|Reason not Specified|1|||
156638945|NCT03193190|565423988|FG006|Stage 1|Reason not Specified|2|||
156638946|NCT03193190|565423989|FG007|Stage 1|Reason not Specified|2|||
156638947|NCT03193190|565423990|FG008|Stage 1|Reason not Specified|0|||
156638948|NCT03193190|565423991|FG009|Stage 1|Reason not Specified|1|||
156638949|NCT03193190|565423992|FG010|Stage 1|Reason not Specified|3|||
156638950|NCT03193190|565423993|FG011|Stage 1|Reason not Specified|0|||
156638951|NCT03193190|565423994|FG012|Stage 1|Reason not Specified|1|||
156638952|NCT03193190|565423995|FG013|Stage 1|Reason not Specified|0|||
156638953|NCT03193190|565423996|FG014|Stage 1|Reason not Specified|0|||
156638954|NCT03193190|565423997|FG015|Stage 1|Reason not Specified|0|||
156638955|NCT03193190|565423982|FG000|Stage 1|Physician Decision|0|||
156638956|NCT03193190|565423983|FG001|Stage 1|Physician Decision|0|||
156638957|NCT03193190|565423984|FG002|Stage 1|Physician Decision|0|||
156638958|NCT03193190|565423985|FG003|Stage 1|Physician Decision|0|||
156638959|NCT03193190|565423986|FG004|Stage 1|Physician Decision|0|||
156638960|NCT03193190|565423987|FG005|Stage 1|Physician Decision|0|||
156638961|NCT03193190|565423988|FG006|Stage 1|Physician Decision|0|||
156638962|NCT03193190|565423989|FG007|Stage 1|Physician Decision|0|||
156638963|NCT03193190|565423990|FG008|Stage 1|Physician Decision|0|||
156638964|NCT03193190|565423991|FG009|Stage 1|Physician Decision|0|||
156638965|NCT03193190|565423992|FG010|Stage 1|Physician Decision|0|||
156638966|NCT03193190|565423993|FG011|Stage 1|Physician Decision|1|||
156638967|NCT03193190|565423994|FG012|Stage 1|Physician Decision|0|||
156638968|NCT03193190|565423995|FG013|Stage 1|Physician Decision|0|||
156638969|NCT03193190|565423996|FG014|Stage 1|Physician Decision|0|||
156638970|NCT03193190|565423997|FG015|Stage 1|Physician Decision|0|||
156638971|NCT03193190|565423982|FG000|Stage 1|Progressive Disease|1|||
156638972|NCT03193190|565423983|FG001|Stage 1|Progressive Disease|0|||
156638973|NCT03193190|565423984|FG002|Stage 1|Progressive Disease|0|||
156638974|NCT03193190|565423985|FG003|Stage 1|Progressive Disease|0|||
156638975|NCT03193190|565423986|FG004|Stage 1|Progressive Disease|0|||
156638976|NCT03193190|565423987|FG005|Stage 1|Progressive Disease|0|||
156638977|NCT03193190|565423988|FG006|Stage 1|Progressive Disease|0|||
156638978|NCT03193190|565423989|FG007|Stage 1|Progressive Disease|0|||
156638979|NCT03193190|565423990|FG008|Stage 1|Progressive Disease|0|||
156638980|NCT03193190|565423991|FG009|Stage 1|Progressive Disease|0|||
156638981|NCT03193190|565423992|FG010|Stage 1|Progressive Disease|0|||
156638982|NCT03193190|565423993|FG011|Stage 1|Progressive Disease|0|||
156638983|NCT03193190|565423994|FG012|Stage 1|Progressive Disease|0|||
156638984|NCT03193190|565423995|FG013|Stage 1|Progressive Disease|0|||
156638985|NCT03193190|565423996|FG014|Stage 1|Progressive Disease|0|||
156638986|NCT03193190|565423997|FG015|Stage 1|Progressive Disease|0|||
156638987|NCT03193190|565423982|FG000|Stage 1|Study Terminated By Sponsor|3|||
156638988|NCT03193190|565423983|FG001|Stage 1|Study Terminated By Sponsor|0|||
156638989|NCT03193190|565423984|FG002|Stage 1|Study Terminated By Sponsor|0|||
156638990|NCT03193190|565423985|FG003|Stage 1|Study Terminated By Sponsor|0|||
156638991|NCT03193190|565423986|FG004|Stage 1|Study Terminated By Sponsor|6|||
156638992|NCT03193190|565423987|FG005|Stage 1|Study Terminated By Sponsor|0|||
156638993|NCT03193190|565423988|FG006|Stage 1|Study Terminated By Sponsor|0|||
156638994|NCT03193190|565423989|FG007|Stage 1|Study Terminated By Sponsor|0|||
156638995|NCT03193190|565423990|FG008|Stage 1|Study Terminated By Sponsor|0|||
156638996|NCT03193190|565423991|FG009|Stage 1|Study Terminated By Sponsor|0|||
156638997|NCT03193190|565423992|FG010|Stage 1|Study Terminated By Sponsor|0|||
156638998|NCT03193190|565423993|FG011|Stage 1|Study Terminated By Sponsor|0|||
156638999|NCT03193190|565423994|FG012|Stage 1|Study Terminated By Sponsor|0|||
156639000|NCT03193190|565423995|FG013|Stage 1|Study Terminated By Sponsor|0|||
156639001|NCT03193190|565423996|FG014|Stage 1|Study Terminated By Sponsor|0|||
156639002|NCT03193190|565423997|FG015|Stage 1|Study Terminated By Sponsor|0|||
156639003|NCT03193190|565423982|FG000|Stage 1|Withdrawal by Subject|6|||
156639004|NCT03193190|565423983|FG001|Stage 1|Withdrawal by Subject|0|||
156639005|NCT03193190|565423984|FG002|Stage 1|Withdrawal by Subject|1|||
156639006|NCT03193190|565423985|FG003|Stage 1|Withdrawal by Subject|0|||
156639007|NCT03193190|565423986|FG004|Stage 1|Withdrawal by Subject|2|||
156639008|NCT03193190|565423987|FG005|Stage 1|Withdrawal by Subject|0|||
156639009|NCT03193190|565423988|FG006|Stage 1|Withdrawal by Subject|3|||
156639010|NCT03193190|565423989|FG007|Stage 1|Withdrawal by Subject|2|||
156639011|NCT03193190|565423990|FG008|Stage 1|Withdrawal by Subject|2|||
156639012|NCT03193190|565423991|FG009|Stage 1|Withdrawal by Subject|4|||
156639013|NCT03193190|565423992|FG010|Stage 1|Withdrawal by Subject|9|||
156639014|NCT03193190|565423993|FG011|Stage 1|Withdrawal by Subject|1|||
156639015|NCT03193190|565423994|FG012|Stage 1|Withdrawal by Subject|0|||
156639016|NCT03193190|565423995|FG013|Stage 1|Withdrawal by Subject|0|||
156639017|NCT03193190|565423996|FG014|Stage 1|Withdrawal by Subject|0|||
156639018|NCT03193190|565423997|FG015|Stage 1|Withdrawal by Subject|0|||
156639019|NCT03193190|565423982|FG000|Stage 2|Death|0|||
156639020|NCT03193190|565423983|FG001|Stage 2|Death|0|||
156639021|NCT03193190|565423984|FG002|Stage 2|Death|0|||
156639022|NCT03193190|565423985|FG003|Stage 2|Death|0|||
156639023|NCT03193190|565423986|FG004|Stage 2|Death|0|||
156639024|NCT03193190|565423987|FG005|Stage 2|Death|0|||
156639025|NCT03193190|565423988|FG006|Stage 2|Death|0|||
156639026|NCT03193190|565423989|FG007|Stage 2|Death|0|||
156639027|NCT03193190|565423990|FG008|Stage 2|Death|0|||
156639028|NCT03193190|565423991|FG009|Stage 2|Death|0|||
156639029|NCT03193190|565423992|FG010|Stage 2|Death|0|||
156639030|NCT03193190|565423993|FG011|Stage 2|Death|0|||
156639031|NCT03193190|565423994|FG012|Stage 2|Death|0|||
156639032|NCT03193190|565423995|FG013|Stage 2|Death|14|||
156639033|NCT03193190|565423996|FG014|Stage 2|Death|4|||
156639034|NCT03193190|565423997|FG015|Stage 2|Death|1|||
156639035|NCT03193190|565423982|FG000|Stage 2|Lost to Follow-up|0|||
156639036|NCT03193190|565423983|FG001|Stage 2|Lost to Follow-up|0|||
156639037|NCT03193190|565423984|FG002|Stage 2|Lost to Follow-up|0|||
156639038|NCT03193190|565423985|FG003|Stage 2|Lost to Follow-up|0|||
156639039|NCT03193190|565423986|FG004|Stage 2|Lost to Follow-up|0|||
156639040|NCT03193190|565423987|FG005|Stage 2|Lost to Follow-up|0|||
156639041|NCT03193190|565423988|FG006|Stage 2|Lost to Follow-up|0|||
156639042|NCT03193190|565423989|FG007|Stage 2|Lost to Follow-up|0|||
156639043|NCT03193190|565423990|FG008|Stage 2|Lost to Follow-up|0|||
156639044|NCT03193190|565423991|FG009|Stage 2|Lost to Follow-up|0|||
156639045|NCT03193190|565423992|FG010|Stage 2|Lost to Follow-up|0|||
156639046|NCT03193190|565423993|FG011|Stage 2|Lost to Follow-up|0|||
156639047|NCT03193190|565423994|FG012|Stage 2|Lost to Follow-up|0|||
156639048|NCT03193190|565423995|FG013|Stage 2|Lost to Follow-up|0|||
156639049|NCT03193190|565423996|FG014|Stage 2|Lost to Follow-up|1|||
156639050|NCT03193190|565423997|FG015|Stage 2|Lost to Follow-up|0|||
156639051|NCT03193190|565423982|FG000|Stage 2|Withdrawal by Subject|0|||
156639052|NCT03193190|565423983|FG001|Stage 2|Withdrawal by Subject|0|||
156639053|NCT03193190|565423984|FG002|Stage 2|Withdrawal by Subject|0|||
156639054|NCT03193190|565423985|FG003|Stage 2|Withdrawal by Subject|0|||
156639055|NCT03193190|565423986|FG004|Stage 2|Withdrawal by Subject|0|||
156639056|NCT03193190|565423987|FG005|Stage 2|Withdrawal by Subject|0|||
156639057|NCT03193190|565423988|FG006|Stage 2|Withdrawal by Subject|0|||
156639058|NCT03193190|565423989|FG007|Stage 2|Withdrawal by Subject|0|||
156639059|NCT03193190|565423990|FG008|Stage 2|Withdrawal by Subject|0|||
156639060|NCT03193190|565423991|FG009|Stage 2|Withdrawal by Subject|0|||
156639061|NCT03193190|565423992|FG010|Stage 2|Withdrawal by Subject|0|||
156639062|NCT03193190|565423993|FG011|Stage 2|Withdrawal by Subject|0|||
156639063|NCT03193190|565423994|FG012|Stage 2|Withdrawal by Subject|0|||
156639064|NCT03193190|565423995|FG013|Stage 2|Withdrawal by Subject|1|||
156639065|NCT03193190|565423996|FG014|Stage 2|Withdrawal by Subject|1|||
156639066|NCT03193190|565423997|FG015|Stage 2|Withdrawal by Subject|0|||
156639067|NCT03532295|565423998|FG000|Overall Study|Did not start treatment|0|||
156639068|NCT03532295|565423999|FG001|Overall Study|Did not start treatment|2|||
156639069|NCT01907516|565424000|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
156639070|NCT01907516|565424001|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
156639071|NCT01907516|565424000|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
156639072|NCT01907516|565424001|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
156639073|NCT01907516|565424000|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
156639074|NCT01907516|565424001|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
156639075|NCT01907516|565424000|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
156639076|NCT01907516|565424001|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
156639077|NCT04644237|565424005|FG000|Overall Study|Death|4|||
156639078|NCT04644237|565424006|FG001|Overall Study|Death|2|||
156639079|NCT04644237|565424005|FG000|Overall Study|Adverse Event|18|||
156639080|NCT04644237|565424006|FG001|Overall Study|Adverse Event|19|||
156639081|NCT04644237|565424005|FG000|Overall Study|Progressive Disease|61|||
156639082|NCT04644237|565424006|FG001|Overall Study|Progressive Disease|23|||
156639083|NCT04644237|565424005|FG000|Overall Study|Clinical Progression|4|||
156639084|NCT04644237|565424006|FG001|Overall Study|Clinical Progression|1|||
156639085|NCT04644237|565424005|FG000|Overall Study|Withdrawal by Subject|4|||
156639086|NCT04644237|565424006|FG001|Overall Study|Withdrawal by Subject|2|||
156639087|NCT04644237|565424005|FG000|Overall Study|Physician Decision|4|||
156639088|NCT04644237|565424006|FG001|Overall Study|Physician Decision|0|||
156639089|NCT04644237|565424005|FG000|Overall Study|Other|6|||
156639090|NCT04644237|565424006|FG001|Overall Study|Other|3|||
156639091|NCT04644237|565424005|FG000|Overall Study|Randomized but not Treated|1|||
156639092|NCT04644237|565424006|FG001|Overall Study|Randomized but not Treated|0|||
156639093|NCT03131817|565424007|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
156639094|NCT03868059|565424009|FG000|Overall Study|Adverse Event|3|||
156639095|NCT03868059|565424009|FG000|Overall Study|Lost to Follow-up|3|||
156639096|NCT03868059|565424009|FG000|Overall Study|Withdrawal by Subject|6|||
156639097|NCT02061293|565424010|FG000|Overall Study|Elevated Blood Pressure|1|||
156639098|NCT02061293|565424011|FG001|Overall Study|Elevated Blood Pressure|1|||
156639099|NCT04066894|565424013|FG000|Overall Study|Lack of Efficacy|1|||
156639100|NCT04066894|565424013|FG000|Overall Study|Screen Failure|1|||
156639101|NCT02949219|565424020|FG000|Overall Study|Withdrawal by Subject|1|||
156639102|NCT04278872|565424021|FG000|Overall Study|Adverse Event|1|||
156639103|NCT04278872|565424022|FG001|Overall Study|Adverse Event|0|||
156639104|NCT04278872|565424021|FG000|Overall Study|Protocol Violation|0|||
156639105|NCT04278872|565424022|FG001|Overall Study|Protocol Violation|1|||
156639106|NCT04278872|565424021|FG000|Overall Study|Study Termination|2|||
156639107|NCT04278872|565424022|FG001|Overall Study|Study Termination|0|||
156639108|NCT05838755|565424028|FG000|Overall Study|Adverse Event|1|||
156639109|NCT05838755|565424029|FG001|Overall Study|Adverse Event|0|||
156639110|NCT05838755|565424030|FG002|Overall Study|Adverse Event|0|||
156639111|NCT05838755|565424028|FG000|Overall Study|Lack of Efficacy|1|||
156639112|NCT05838755|565424029|FG001|Overall Study|Lack of Efficacy|0|||
156639113|NCT05838755|565424030|FG002|Overall Study|Lack of Efficacy|1|||
156639114|NCT05838755|565424028|FG000|Overall Study|Lost to Follow-up|0|||
156639115|NCT05838755|565424029|FG001|Overall Study|Lost to Follow-up|1|||
156639116|NCT05838755|565424030|FG002|Overall Study|Lost to Follow-up|4|||
156639117|NCT05838755|565424028|FG000|Overall Study|Withdrawal by Subject|0|||
156639118|NCT05838755|565424029|FG001|Overall Study|Withdrawal by Subject|2|||
156639119|NCT05838755|565424030|FG002|Overall Study|Withdrawal by Subject|0|||
156639120|NCT05838755|565424028|FG000|Overall Study|Study terminated by sponsor|26|||
156639121|NCT05838755|565424029|FG001|Overall Study|Study terminated by sponsor|27|||
156639122|NCT05838755|565424030|FG002|Overall Study|Study terminated by sponsor|26|||
156639123|NCT05838755|565424028|FG000|Overall Study|Randomized, not treated|2|||
156639124|NCT05838755|565424029|FG001|Overall Study|Randomized, not treated|0|||
156639125|NCT05838755|565424030|FG002|Overall Study|Randomized, not treated|1|||
156639126|NCT05838755|565424028|FG000|Overall Study|Pregnancy|0|||
156639127|NCT05838755|565424029|FG001|Overall Study|Pregnancy|1|||
156639128|NCT05838755|565424030|FG002|Overall Study|Pregnancy|0|||
156639129|NCT00096031|565424031|FG000|Overall Study|Adverse Event|3|||
156639130|NCT00096031|565424031|FG000|Overall Study|Lack of Efficacy|42|||
156639131|NCT00096031|565424031|FG000|Overall Study|Death|4|||
156639132|NCT00096031|565424031|FG000|Overall Study|Withdrawal by Subject|1|||
156639133|NCT00096031|565424031|FG000|Overall Study|Ineligible|8|||
156639134|NCT00096031|565424031|FG000|Overall Study|Not protocol specified|5|||
156639135|NCT01283282|565424032|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
156639136|NCT01283282|565424033|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
156639137|NCT01283282|565424032|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
156639138|NCT01283282|565424033|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
156639139|NCT01283282|565424032|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
156639140|NCT01283282|565424033|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
156639141|NCT00483717|565424034|FG000|Overall Study|Protocol Violation|5|||
156639142|NCT00483717|565424035|FG001|Overall Study|Protocol Violation|7|||
156639143|NCT00483717|565424034|FG000|Overall Study|Time of dosing missing|1|||
156639144|NCT00483717|565424035|FG001|Overall Study|Time of dosing missing|1|||
156639145|NCT00483717|565424034|FG000|Overall Study|No treatment for migraine|16|||
156639146|NCT00483717|565424035|FG001|Overall Study|No treatment for migraine|13|||
156639147|NCT00483717|565424034|FG000|Overall Study|Lost to Follow-up|1|||
156639148|NCT00483717|565424035|FG001|Overall Study|Lost to Follow-up|0|||
156639149|NCT00483717|565424034|FG000|Overall Study|Withdrawal by Subject|1|||
156639150|NCT00483717|565424035|FG001|Overall Study|Withdrawal by Subject|0|||
156639151|NCT00083226|565424036|FG000|Overall Study|Lack of Efficacy|19|||
156639152|NCT00083226|565424036|FG000|Overall Study|Adverse Event|9|||
156639153|NCT00083226|565424036|FG000|Overall Study|Death|4|||
156639154|NCT00083226|565424036|FG000|Overall Study|Withdrawal by Subject|4|||
156639155|NCT00083226|565424036|FG000|Overall Study|Other|2|||
156639156|NCT00083226|565424036|FG000|Overall Study|ineligible or not receiving treatment|4|||
156639157|NCT00909857|565424037|FG000|Overall Study|Withdrawal by Subject|6|||
156639158|NCT00909857|565424038|FG001|Overall Study|Withdrawal by Subject|10|||
156639159|NCT00909857|565424037|FG000|Overall Study|Adverse Event|5|||
156639160|NCT00909857|565424038|FG001|Overall Study|Adverse Event|5|||
156639161|NCT00909857|565424037|FG000|Overall Study|Lost to Follow-up|2|||
156639162|NCT00909857|565424038|FG001|Overall Study|Lost to Follow-up|5|||
156639163|NCT00909857|565424037|FG000|Overall Study|Protocol Violation|2|||
156639164|NCT00909857|565424038|FG001|Overall Study|Protocol Violation|1|||
156639165|NCT00909857|565424037|FG000|Overall Study|Pregnancy|1|||
156639166|NCT00909857|565424038|FG001|Overall Study|Pregnancy|0|||
156639167|NCT00909857|565424037|FG000|Overall Study|Other|1|||
156639168|NCT00909857|565424038|FG001|Overall Study|Other|0|||
156639169|NCT00909857|565424037|FG000|Overall Study|Did not receive study medication|19|||
156639170|NCT00909857|565424038|FG001|Overall Study|Did not receive study medication|24|||
156639171|NCT03878108|565424039|FG000|Overall Study|Adverse Event|1|||
156639172|NCT03878108|565424040|FG001|Overall Study|Adverse Event|0|||
156639173|NCT00604175|565424047|FG000|Entry Through Week 28|Death|2|||
156639174|NCT00604175|565424048|FG001|Entry Through Week 28|Death|0|||
156639175|NCT00604175|565424049|FG002|Entry Through Week 28|Death|0|||
156639176|NCT00604175|565424047|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
156639177|NCT00604175|565424048|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
156639178|NCT00604175|565424049|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
156751711|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
156639179|NCT00604175|565424047|FG000|Entry Through Week 28|Lost to Follow-up|4|||
156639180|NCT00604175|565424048|FG001|Entry Through Week 28|Lost to Follow-up|3|||
156639181|NCT00604175|565424049|FG002|Entry Through Week 28|Lost to Follow-up|0|||
156639182|NCT00604175|565424047|FG000|Entry Through Week 28|Ineligible|1|||
156639183|NCT00604175|565424048|FG001|Entry Through Week 28|Ineligible|0|||
156639184|NCT00604175|565424049|FG002|Entry Through Week 28|Ineligible|0|||
156639185|NCT00604175|565424047|FG000|Entry Through Week 28|Did not start intervention|2|||
156639186|NCT00604175|565424048|FG001|Entry Through Week 28|Did not start intervention|0|||
156639187|NCT00604175|565424049|FG002|Entry Through Week 28|Did not start intervention|1|||
156639188|NCT00604175|565424047|FG000|Week 29 Through Week 72|Death|0|||
156639189|NCT00604175|565424048|FG001|Week 29 Through Week 72|Death|0|||
156639190|NCT00604175|565424049|FG002|Week 29 Through Week 72|Death|1|||
156639191|NCT00604175|565424047|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
156639192|NCT00604175|565424048|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
156639193|NCT00604175|565424049|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
156639194|NCT00604175|565424047|FG000|Week 29 Through Week 72|Site closure|0|||
156639195|NCT00604175|565424048|FG001|Week 29 Through Week 72|Site closure|1|||
156639196|NCT00604175|565424049|FG002|Week 29 Through Week 72|Site closure|0|||
156639197|NCT00604175|565424047|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
156639198|NCT00604175|565424048|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
156639199|NCT00604175|565424049|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
156639200|NCT01682681|565424050|FG000|Overall Study|Lack of Efficacy|62|||
156639201|NCT01682681|565424050|FG000|Overall Study|Withdrawal by Subject|1|||
156639202|NCT01682681|565424050|FG000|Overall Study|Moved to other hospital|10|||
156639203|NCT01682681|565424050|FG000|Overall Study|Lost to Follow-up|174|||
156639204|NCT01682681|565424050|FG000|Overall Study|Adverse Event|46|||
156639205|NCT01682681|565424050|FG000|Overall Study|tapering of topiramate|5|||
156639206|NCT01682681|565424050|FG000|Overall Study|Other|21|||
156639207|NCT01682681|565424050|FG000|Overall Study|Low compliance|13|||
156639208|NCT02044094|565424053|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
156639209|NCT02044094|565424053|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
156639210|NCT02044094|565424053|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
156639211|NCT02044094|565424053|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
156639212|NCT02044094|565424053|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
156639213|NCT02044094|565424053|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
156639214|NCT02044094|565424053|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
156639215|NCT02044094|565424053|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
156639216|NCT04647253|565424060|FG000|Overall Study|Death ≤ 365 Days|16|||
156639217|NCT04647253|565424061|FG001|Overall Study|Death ≤ 365 Days|7|||
156639218|NCT04647253|565424060|FG000|Overall Study|Physician Decision|0|||
156639219|NCT04647253|565424061|FG001|Overall Study|Physician Decision|1|||
156639220|NCT04647253|565424060|FG000|Overall Study|Withdrawal by Subject|7|||
156639221|NCT04647253|565424061|FG001|Overall Study|Withdrawal by Subject|2|||
156639222|NCT04647253|565424060|FG000|Overall Study|Missed 12-Month Visit|9|||
156639223|NCT04647253|565424061|FG001|Overall Study|Missed 12-Month Visit|7|||
156639224|NCT04647253|565424060|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
156639225|NCT04647253|565424061|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
156639226|NCT05257109|565424064|FG000|Overall Study|Withdrawal by Subject|1|||
156639227|NCT05257109|565424065|FG001|Overall Study|Withdrawal by Subject|0|||
156639228|NCT05257109|565424066|FG002|Overall Study|Withdrawal by Subject|0|||
156639229|NCT05257109|565424067|FG003|Overall Study|Withdrawal by Subject|0|||
156639230|NCT02239692|565425297|FG000|Overall Study|Incomplete colonoscopy|1|||
156639231|NCT02239692|565425298|FG001|Overall Study|Incomplete colonoscopy|2|||
156639232|NCT02239692|565425297|FG000|Overall Study|Adverse Event|0|||
156639233|NCT02239692|565425298|FG001|Overall Study|Adverse Event|1|||
156639234|NCT02239692|565425297|FG000|Overall Study|Physician Decision|0|||
156639235|NCT02239692|565425298|FG001|Overall Study|Physician Decision|1|||
156639236|NCT02239692|565425297|FG000|Overall Study|Lost to Follow-up|1|||
156639237|NCT02239692|565425298|FG001|Overall Study|Lost to Follow-up|4|||
156639238|NCT02239692|565425297|FG000|Overall Study|Withdrawal by Subject|3|||
156639239|NCT02239692|565425298|FG001|Overall Study|Withdrawal by Subject|5|||
156639240|NCT02239692|565425297|FG000|Overall Study|Other reason|1|||
156639241|NCT02239692|565425298|FG001|Overall Study|Other reason|0|||
156639242|NCT04318535|565425299|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
156639243|NCT04318535|565425300|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
156639244|NCT04318535|565425301|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
156639245|NCT02156466|565425308|FG000|Overall Study|Adverse Event|0|||
156639246|NCT02156466|565425309|FG001|Overall Study|Adverse Event|0|||
156639247|NCT02156466|565425310|FG002|Overall Study|Adverse Event|1|||
156639248|NCT02156466|565425311|FG003|Overall Study|Adverse Event|1|||
156639249|NCT02156466|565425312|FG004|Overall Study|Adverse Event|0|||
156639250|NCT02156466|565425308|FG000|Overall Study|Quantiferon Positivity|0|||
156639251|NCT02156466|565425309|FG001|Overall Study|Quantiferon Positivity|0|||
156639252|NCT02156466|565425310|FG002|Overall Study|Quantiferon Positivity|0|||
156639253|NCT02156466|565425311|FG003|Overall Study|Quantiferon Positivity|1|||
156639254|NCT02156466|565425312|FG004|Overall Study|Quantiferon Positivity|0|||
156639255|NCT01784419|565425313|FG000|Overall Study|Adverse Event|3|||
156639256|NCT00080288|565425314|FG000|Overall Study|Adverse Event|7|||
156639257|NCT00080288|565425315|FG001|Overall Study|Adverse Event|4|||
156639258|NCT00080288|565425314|FG000|Overall Study|Lost to Follow-up|3|||
156639259|NCT00080288|565425315|FG001|Overall Study|Lost to Follow-up|5|||
156639260|NCT00080288|565425314|FG000|Overall Study|Physician Decision|6|||
156639261|NCT00080288|565425315|FG001|Overall Study|Physician Decision|2|||
156639262|NCT00080288|565425314|FG000|Overall Study|Withdrawal by Subject|3|||
156639263|NCT00080288|565425315|FG001|Overall Study|Withdrawal by Subject|16|||
156639264|NCT00080288|565425314|FG000|Overall Study|Miscellaneous|11|||
156639265|NCT00080288|565425315|FG001|Overall Study|Miscellaneous|11|||
156639266|NCT02253654|565425316|FG000|Overall Study|Withdrawal by Subject|12|||
156639267|NCT02253654|565425317|FG001|Overall Study|Withdrawal by Subject|4|||
156639268|NCT02253654|565425316|FG000|Overall Study|Decision by Sponsor|1|||
156639269|NCT02253654|565425317|FG001|Overall Study|Decision by Sponsor|1|||
156639270|NCT02253654|565425316|FG000|Overall Study|Lost to Follow-up|2|||
156639271|NCT02253654|565425317|FG001|Overall Study|Lost to Follow-up|5|||
156639272|NCT02253654|565425316|FG000|Overall Study|Death|4|||
156639273|NCT02253654|565425317|FG001|Overall Study|Death|7|||
156639274|NCT02253654|565425316|FG000|Overall Study|Did Not Receive Study Treatment|4|||
156639275|NCT02253654|565425317|FG001|Overall Study|Did Not Receive Study Treatment|1|||
156639276|NCT03044431|565425320|FG000|Overall Study|Lost to Follow-up|59|||
156639277|NCT00569231|565425321|FG000|Overall Study|Study unrelated surgery|1|||
156639278|NCT00569231|565425321|FG000|Overall Study|Airfare expense|2|||
156639279|NCT00569231|565425321|FG000|Overall Study|Withdrawal by Subject|1|||
156639280|NCT00569231|565425321|FG000|Overall Study|Car accident injury|1|||
156639281|NCT00569231|565425321|FG000|Overall Study|Non-compliance|2|||
156639282|NCT03456726|565425322|FG000|Overall Study|Disease Progression|6|||
156639283|NCT03456726|565425323|FG001|Overall Study|Disease Progression|1|||
156639284|NCT03456726|565425322|FG000|Overall Study|Adverse Event|4|||
156639285|NCT03456726|565425323|FG001|Overall Study|Adverse Event|2|||
156639286|NCT03456726|565425322|FG000|Overall Study|Withdrawal by Subject|1|||
156639287|NCT03456726|565425323|FG001|Overall Study|Withdrawal by Subject|0|||
156639288|NCT03456726|565425322|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
156639289|NCT03456726|565425323|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
156639290|NCT01614925|565425324|FG000|Overall Study|Withdrawal by Subject|1|||
156639291|NCT01614925|565425325|FG001|Overall Study|Withdrawal by Subject|0|||
156639292|NCT01614925|565425324|FG000|Overall Study|Protocol Violation|3|||
156639293|NCT01614925|565425325|FG001|Overall Study|Protocol Violation|2|||
156639294|NCT04470622|565425326|FG000|Overall Study|Withdrawal by Subject|0|||
156639295|NCT04470622|565425327|FG001|Overall Study|Withdrawal by Subject|1|||
156639296|NCT04470622|565425326|FG000|Overall Study|Screen Failure|0|||
156639297|NCT04470622|565425327|FG001|Overall Study|Screen Failure|1|||
156639298|NCT04470622|565425326|FG000|Overall Study|Death|0|||
156639299|NCT04470622|565425327|FG001|Overall Study|Death|1|||
156639300|NCT00399490|565425330|FG000|Overall Study|Adverse Event|19|||
156639301|NCT00399490|565425330|FG000|Overall Study|Lack of Efficacy|31|||
156639302|NCT00399490|565425330|FG000|Overall Study|Lost to Follow-up|5|||
156639303|NCT00399490|565425330|FG000|Overall Study|Withdrawal by Subject|18|||
156639304|NCT00399490|565425330|FG000|Overall Study|Other|25|||
156639305|NCT00791154|565425335|FG000|Overall Study|Noncompliance|0|||
156639306|NCT00791154|565425336|FG001|Overall Study|Noncompliance|1|||
156639307|NCT00791154|565425337|FG002|Overall Study|Noncompliance|0|||
156639308|NCT00791154|565425338|FG003|Overall Study|Noncompliance|0|||
156639309|NCT00791154|565425339|FG004|Overall Study|Noncompliance|1|||
156639310|NCT00791154|565425340|FG005|Overall Study|Noncompliance|1|||
156639311|NCT00791154|565425341|FG006|Overall Study|Noncompliance|1|||
156639312|NCT00791154|565425335|FG000|Overall Study|Adverse Event|0|||
156639313|NCT00791154|565425336|FG001|Overall Study|Adverse Event|0|||
156639314|NCT00791154|565425337|FG002|Overall Study|Adverse Event|0|||
156639315|NCT00791154|565425338|FG003|Overall Study|Adverse Event|0|||
156639316|NCT00791154|565425339|FG004|Overall Study|Adverse Event|2|||
156639317|NCT00791154|565425340|FG005|Overall Study|Adverse Event|0|||
156639318|NCT00791154|565425341|FG006|Overall Study|Adverse Event|1|||
156639319|NCT00791154|565425335|FG000|Overall Study|Full Consent withdrawn|1|||
156639320|NCT00791154|565425336|FG001|Overall Study|Full Consent withdrawn|3|||
156639321|NCT00791154|565425337|FG002|Overall Study|Full Consent withdrawn|0|||
156639322|NCT00791154|565425338|FG003|Overall Study|Full Consent withdrawn|0|||
156639323|NCT00791154|565425339|FG004|Overall Study|Full Consent withdrawn|1|||
156639324|NCT00791154|565425340|FG005|Overall Study|Full Consent withdrawn|3|||
156639325|NCT00791154|565425341|FG006|Overall Study|Full Consent withdrawn|1|||
156639326|NCT00791154|565425335|FG000|Overall Study|Lost to Follow-up|0|||
156639327|NCT00791154|565425336|FG001|Overall Study|Lost to Follow-up|0|||
156639328|NCT00791154|565425337|FG002|Overall Study|Lost to Follow-up|0|||
156639329|NCT00791154|565425338|FG003|Overall Study|Lost to Follow-up|1|||
156639330|NCT00791154|565425339|FG004|Overall Study|Lost to Follow-up|2|||
156639331|NCT00791154|565425340|FG005|Overall Study|Lost to Follow-up|0|||
156639332|NCT00791154|565425341|FG006|Overall Study|Lost to Follow-up|4|||
156639333|NCT00791154|565425335|FG000|Overall Study|Death|5|||
156639334|NCT00791154|565425336|FG001|Overall Study|Death|4|||
156639335|NCT00791154|565425337|FG002|Overall Study|Death|4|||
156639336|NCT00791154|565425338|FG003|Overall Study|Death|7|||
156639337|NCT00791154|565425339|FG004|Overall Study|Death|54|||
156639338|NCT00791154|565425340|FG005|Overall Study|Death|54|||
156639339|NCT00791154|565425341|FG006|Overall Study|Death|52|||
156639340|NCT00791154|565425335|FG000|Overall Study|Other event|0|||
156639341|NCT00791154|565425336|FG001|Overall Study|Other event|0|||
156639342|NCT00791154|565425337|FG002|Overall Study|Other event|2|||
156639343|NCT00791154|565425338|FG003|Overall Study|Other event|0|||
156639344|NCT00791154|565425339|FG004|Overall Study|Other event|2|||
156639345|NCT00791154|565425340|FG005|Overall Study|Other event|4|||
156639346|NCT00791154|565425341|FG006|Overall Study|Other event|2|||
156639347|NCT00953927|565425342|FG000|Overall Study|Lost to Follow-up|61|||
156639348|NCT00953927|565425343|FG001|Overall Study|Lost to Follow-up|65|||
156639349|NCT00953927|565425342|FG000|Overall Study|Withdrawal by Subject|36|||
156639350|NCT00953927|565425343|FG001|Overall Study|Withdrawal by Subject|25|||
156639351|NCT00953927|565425342|FG000|Overall Study|Death|7|||
156639352|NCT00953927|565425343|FG001|Overall Study|Death|4|||
156639353|NCT00953927|565425342|FG000|Overall Study|Other study discontinuation|1|||
156639354|NCT00953927|565425343|FG001|Overall Study|Other study discontinuation|1|||
156639355|NCT01396161|565425345|FG000|Overall Study|Withdrawal by Subject|0|||
156639356|NCT01396161|565425346|FG001|Overall Study|Withdrawal by Subject|0|||
156639357|NCT01396161|565425347|FG002|Overall Study|Withdrawal by Subject|0|||
156639358|NCT01396161|565425348|FG003|Overall Study|Withdrawal by Subject|0|||
156639359|NCT01396161|565425349|FG004|Overall Study|Withdrawal by Subject|1|||
156639360|NCT01396161|565425350|FG005|Overall Study|Withdrawal by Subject|0|||
156639361|NCT01396161|565425351|FG006|Overall Study|Withdrawal by Subject|0|||
156639362|NCT01396161|565425345|FG000|Overall Study|Other|0|||
156639363|NCT01396161|565425346|FG001|Overall Study|Other|0|||
156639364|NCT01396161|565425347|FG002|Overall Study|Other|0|||
156639365|NCT01396161|565425348|FG003|Overall Study|Other|0|||
156639366|NCT01396161|565425349|FG004|Overall Study|Other|0|||
156639367|NCT01396161|565425350|FG005|Overall Study|Other|0|||
156639368|NCT01396161|565425351|FG006|Overall Study|Other|1|||
156639369|NCT00450177|565425352|FG000|Overall Study|Adverse Event|7|||
156639370|NCT00450177|565425353|FG001|Overall Study|Adverse Event|4|||
156639371|NCT00450177|565425352|FG000|Overall Study|Withdrawal by Subject|1|||
156639372|NCT00450177|565425353|FG001|Overall Study|Withdrawal by Subject|6|||
156639373|NCT00450177|565425352|FG000|Overall Study|Withdrawal by Primary Team|1|||
156639374|NCT00450177|565425353|FG001|Overall Study|Withdrawal by Primary Team|1|||
156639375|NCT03869684|565425356|FG000|Overall Study|Adverse Event|0|||
156639376|NCT03869684|565425357|FG001|Overall Study|Adverse Event|3|||
156639377|NCT03869684|565425358|FG002|Overall Study|Adverse Event|1|||
156639378|NCT03869684|565425356|FG000|Overall Study|Withdrawal by Subject|1|||
156639379|NCT03869684|565425357|FG001|Overall Study|Withdrawal by Subject|0|||
156639380|NCT03869684|565425358|FG002|Overall Study|Withdrawal by Subject|0|||
156639381|NCT03869684|565425356|FG000|Overall Study|Lost to Follow-up|1|||
156639382|NCT03869684|565425357|FG001|Overall Study|Lost to Follow-up|0|||
156639383|NCT03869684|565425358|FG002|Overall Study|Lost to Follow-up|0|||
156639384|NCT03869684|565425356|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
156639385|NCT03869684|565425357|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
156639386|NCT03869684|565425358|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
156639387|NCT04056299|565425359|FG000|Overall Study|Sponsor discontinued study|3|||
156639388|NCT04056299|565425360|FG001|Overall Study|Sponsor discontinued study|3|||
156639389|NCT01227954|565425365|FG000|Overall Study|Protocol Violation|6|||
156639390|NCT01227954|565425365|FG000|Overall Study|No protocol treatment|7|||
156639391|NCT00078312|565425368|FG000|Overall Study|Adverse Event|43|||
156639392|NCT00078312|565425368|FG000|Overall Study|Lack of Efficacy|15|||
156639393|NCT00078312|565425368|FG000|Overall Study|Lost to Follow-up|41|||
156639394|NCT00078312|565425368|FG000|Overall Study|Physician Decision|9|||
156639395|NCT00078312|565425368|FG000|Overall Study|Protocol Violation|3|||
156639396|NCT00078312|565425368|FG000|Overall Study|Withdrawal by Subject|33|||
156639397|NCT00078312|565425368|FG000|Overall Study|Miscellaneous|33|||
156639398|NCT01296152|565425369|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
156639399|NCT03901352|565425370|FG000|Double-blind Phase|Adverse Event|6|||
156639400|NCT03901352|565425371|FG001|Double-blind Phase|Adverse Event|4|||
156639401|NCT03901352|565425370|FG000|Double-blind Phase|Death|1|||
156639402|NCT03901352|565425371|FG001|Double-blind Phase|Death|0|||
156639403|NCT03901352|565425370|FG000|Double-blind Phase|Lack of Efficacy|0|||
156639404|NCT03901352|565425371|FG001|Double-blind Phase|Lack of Efficacy|1|||
156639405|NCT03901352|565425370|FG000|Double-blind Phase|Protocol Violation|0|||
156639406|NCT03901352|565425371|FG001|Double-blind Phase|Protocol Violation|1|||
156639407|NCT03901352|565425370|FG000|Double-blind Phase|Withdrawal by Subject|10|||
156639408|NCT03901352|565425371|FG001|Double-blind Phase|Withdrawal by Subject|8|||
156639409|NCT03901352|565425370|FG000|Open-label Extension Phase|Adverse Event|24|||
156639410|NCT03901352|565425371|FG001|Open-label Extension Phase|Adverse Event|0|||
156639411|NCT03901352|565425370|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
156639412|NCT03901352|565425371|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
156639413|NCT03901352|565425370|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
156639414|NCT03901352|565425371|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
156639415|NCT03901352|565425370|FG000|Open-label Extension Phase|Other|1|||
156639416|NCT03901352|565425371|FG001|Open-label Extension Phase|Other|0|||
156639417|NCT03981614|565425372|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
156639418|NCT03981614|565425373|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
156639419|NCT03981614|565425374|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
156639420|NCT05349188|565425375|FG000|Overall Study|Withdrawal by Subject|1|||
156639421|NCT05349188|565425376|FG001|Overall Study|Withdrawal by Subject|0|||
156639422|NCT04971226|565425377|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
156639423|NCT04971226|565425378|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156639424|NCT04971226|565425379|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
156639425|NCT04971226|565425380|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
156639426|NCT04971226|565425377|FG000|Overall Study|Adverse Event|6|||
156639427|NCT04971226|565425378|FG001|Overall Study|Adverse Event|5|||
156639428|NCT04971226|565425379|FG002|Overall Study|Adverse Event|11|||
156639429|NCT04971226|565425380|FG003|Overall Study|Adverse Event|10|||
156639430|NCT04971226|565425377|FG000|Overall Study|Progressive disease|2|||
156639431|NCT04971226|565425378|FG001|Overall Study|Progressive disease|0|||
156639432|NCT04971226|565425379|FG002|Overall Study|Progressive disease|3|||
156639433|NCT04971226|565425380|FG003|Overall Study|Progressive disease|1|||
156639434|NCT04971226|565425377|FG000|Overall Study|Protocol Deviation|1|||
156639435|NCT04971226|565425378|FG001|Overall Study|Protocol Deviation|0|||
156639436|NCT04971226|565425379|FG002|Overall Study|Protocol Deviation|1|||
156639437|NCT04971226|565425380|FG003|Overall Study|Protocol Deviation|1|||
156639438|NCT04971226|565425377|FG000|Overall Study|Subject Decision|0|||
156639439|NCT04971226|565425378|FG001|Overall Study|Subject Decision|1|||
156639440|NCT04971226|565425379|FG002|Overall Study|Subject Decision|1|||
156639441|NCT04971226|565425380|FG003|Overall Study|Subject Decision|1|||
156639442|NCT04971226|565425377|FG000|Overall Study|Pregnancy|0|||
156639443|NCT04971226|565425378|FG001|Overall Study|Pregnancy|0|||
156639444|NCT04971226|565425379|FG002|Overall Study|Pregnancy|0|||
156639445|NCT04971226|565425380|FG003|Overall Study|Pregnancy|1|||
156639446|NCT04971226|565425377|FG000|Overall Study|Participants not treated|1|||
156639447|NCT04971226|565425378|FG001|Overall Study|Participants not treated|0|||
156639448|NCT04971226|565425379|FG002|Overall Study|Participants not treated|2|||
156639449|NCT04971226|565425380|FG003|Overall Study|Participants not treated|1|||
156639450|NCT04439149|565425381|FG000|Overall Study|Ineligible|1|||
156639451|NCT04439149|565425381|FG000|Overall Study|Never start protocol therapy|1|||
156639452|NCT04439149|565425381|FG000|Overall Study|Adverse Event|4|||
156639453|NCT04439149|565425381|FG000|Overall Study|Disease Progression|14|||
156639454|NCT04439149|565425381|FG000|Overall Study|Complicating disease|1|||
156639455|NCT04439149|565425381|FG000|Overall Study|Withdrawal by Subject|3|||
156639456|NCT05264506|565425384|FG000|Overall Study|Adverse Event|59|||
156639457|NCT05264506|565425384|FG000|Overall Study|Lost to Follow-up|204|||
156639458|NCT05264506|565425384|FG000|Overall Study|Protocol Violation|185|||
156639459|NCT05264506|565425384|FG000|Overall Study|Pregnancy|60|||
156639460|NCT05264506|565425384|FG000|Overall Study|Physician Decision|6|||
156639461|NCT05264506|565425384|FG000|Overall Study|Non-compliance with Study Drug|29|||
156639462|NCT05264506|565425384|FG000|Overall Study|Study termination|677|||
156639463|NCT05264506|565425384|FG000|Overall Study|Withdrawal by Subject|208|||
156639464|NCT05264506|565425384|FG000|Overall Study|Discontinued prior treatment|89|||
156639465|NCT02032823|565425385|FG000|Overall Study|Death|75|||
156639466|NCT02032823|565425386|FG001|Overall Study|Death|109|||
156639467|NCT02032823|565425385|FG000|Overall Study|Lost to Follow-up|18|||
156639468|NCT02032823|565425386|FG001|Overall Study|Lost to Follow-up|17|||
156639469|NCT02032823|565425385|FG000|Overall Study|Withdrawal by Subject|70|||
156639470|NCT02032823|565425386|FG001|Overall Study|Withdrawal by Subject|53|||
156639471|NCT02032823|565425385|FG000|Overall Study|Ongoing study at data cut-off|755|||
156411736|NCT01089556|564601385|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
156639472|NCT02032823|565425386|FG001|Overall Study|Ongoing study at data cut-off|731|||
156639473|NCT02032823|565425385|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
156639474|NCT02032823|565425386|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
156639475|NCT04521608|565425387|FG000|Overall Study|Death|8|||
156639476|NCT04521608|565425388|FG001|Overall Study|Death|9|||
156639477|NCT04521608|565425387|FG000|Overall Study|Withdrawal by Subject|25|||
156639478|NCT04521608|565425388|FG001|Overall Study|Withdrawal by Subject|18|||
156639479|NCT04521608|565425387|FG000|Overall Study|Disease Progression|3|||
156639480|NCT04521608|565425388|FG001|Overall Study|Disease Progression|10|||
156639481|NCT04521608|565425387|FG000|Overall Study|Complicating Disease|6|||
156639482|NCT04521608|565425388|FG001|Overall Study|Complicating Disease|3|||
156639483|NCT04521608|565425387|FG000|Overall Study|Lost Contact|25|||
156639484|NCT04521608|565425388|FG001|Overall Study|Lost Contact|27|||
156639485|NCT04521608|565425387|FG000|Overall Study|Ineligible|1|||
156639486|NCT04521608|565425388|FG001|Overall Study|Ineligible|0|||
156639487|NCT04521608|565425387|FG000|Overall Study|Refused Further Study Participation|13|||
156639488|NCT04521608|565425388|FG001|Overall Study|Refused Further Study Participation|7|||
156639489|NCT04083378|565425389|FG000|Overall Study|Death|18|||
156639490|NCT04083378|565425390|FG001|Overall Study|Death|4|||
156639491|NCT04083378|565425389|FG000|Overall Study|Lost to Follow-up|4|||
156639492|NCT04083378|565425390|FG001|Overall Study|Lost to Follow-up|0|||
156639493|NCT00644228|565425391|FG000|Randomization & Eligibility|Ineligible|31|||
156639494|NCT00644228|565425392|FG001|Randomization & Eligibility|Ineligible|21|||
156639495|NCT00644228|565425391|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
156639496|NCT00644228|565425392|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
156639497|NCT00644228|565425391|FG000|Randomization & Eligibility|Invalid Consent|0|||
156639498|NCT00644228|565425392|FG001|Randomization & Eligibility|Invalid Consent|1|||
156639499|NCT00644228|565425391|FG000|Induction Therapy|Adverse Event|22|||
156639500|NCT00644228|565425392|FG001|Induction Therapy|Adverse Event|55|||
156639501|NCT00644228|565425391|FG000|Induction Therapy|Withdrawal by Subject|10|||
156639502|NCT00644228|565425392|FG001|Induction Therapy|Withdrawal by Subject|3|||
156639503|NCT00644228|565425391|FG000|Induction Therapy|Progression/Relapse|24|||
156639504|NCT00644228|565425392|FG001|Induction Therapy|Progression/Relapse|12|||
156639505|NCT00644228|565425391|FG000|Induction Therapy|Death|3|||
156639506|NCT00644228|565425392|FG001|Induction Therapy|Death|7|||
156639507|NCT00644228|565425391|FG000|Induction Therapy|Not Protocol-Specified|24|||
156639508|NCT00644228|565425392|FG001|Induction Therapy|Not Protocol-Specified|28|||
156639509|NCT00644228|565425391|FG000|Maintenance|Adverse Event|27|||
156639510|NCT00644228|565425392|FG001|Maintenance|Adverse Event|31|||
156639511|NCT00644228|565425391|FG000|Maintenance|Withdrawal by Subject|6|||
156639512|NCT00644228|565425392|FG001|Maintenance|Withdrawal by Subject|4|||
156639513|NCT00644228|565425391|FG000|Maintenance|Progression/Relapse|67|||
156639514|NCT00644228|565425392|FG001|Maintenance|Progression/Relapse|42|||
156639515|NCT00644228|565425391|FG000|Maintenance|Death|3|||
156639516|NCT00644228|565425392|FG001|Maintenance|Death|3|||
156639517|NCT00644228|565425391|FG000|Maintenance|Not Protocol-Specified|14|||
156639518|NCT00644228|565425392|FG001|Maintenance|Not Protocol-Specified|15|||
156639519|NCT00644228|565425391|FG000|Maintenance|On Treatment|26|||
156639520|NCT00644228|565425392|FG001|Maintenance|On Treatment|40|||
156639521|NCT06078124|565425393|FG000|Overall Study|Lost to Follow-up|14|||
156639522|NCT06078124|565425394|FG001|Overall Study|Lost to Follow-up|14|||
156639523|NCT00285012|565425395|FG000|Assigned to Study Treatment (Tx)|Other|2|||
156639524|NCT00285012|565425396|FG001|Assigned to Study Treatment (Tx)|Other|3|||
156639525|NCT00285012|565425395|FG000|Received Study Tx|Death|2|||
156639526|NCT00285012|565425396|FG001|Received Study Tx|Death|1|||
156639527|NCT00285012|565425395|FG000|Received Study Tx|Adverse Event|5|||
156639528|NCT00285012|565425396|FG001|Received Study Tx|Adverse Event|11|||
156639529|NCT00285012|565425395|FG000|Received Study Tx|Lack of Efficacy|0|||
156639530|NCT00285012|565425396|FG001|Received Study Tx|Lack of Efficacy|3|||
156639531|NCT00285012|565425395|FG000|Received Study Tx|Lost to Follow-up|29|||
156639532|NCT00285012|565425396|FG001|Received Study Tx|Lost to Follow-up|31|||
156639533|NCT00285012|565425395|FG000|Received Study Tx|Withdrawal by Subject|31|||
156639534|NCT00285012|565425396|FG001|Received Study Tx|Withdrawal by Subject|43|||
156639535|NCT00285012|565425395|FG000|Received Study Tx|Other|5|||
156639536|NCT00285012|565425396|FG001|Received Study Tx|Other|5|||
156639537|NCT04050293|565425398|FG000|Overall Study|Lost to Follow-up|1|||
156639538|NCT04050293|565425399|FG001|Overall Study|Lost to Follow-up|2|||
156639539|NCT04050293|565425398|FG000|Overall Study|Withdrawal by Subject|2|||
156639540|NCT04050293|565425399|FG001|Overall Study|Withdrawal by Subject|0|||
156639541|NCT04502862|565425407|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
156639542|NCT04502862|565425408|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
156639543|NCT04502862|565425407|FG000|Overall Study|Withdrawal by Subject|1|||
156639544|NCT04502862|565425408|FG001|Overall Study|Withdrawal by Subject|0|||
156639545|NCT04502862|565425407|FG000|Overall Study|Adverse Event|1|||
156639546|NCT04502862|565425408|FG001|Overall Study|Adverse Event|1|||
156639547|NCT01211613|565426843|FG000|Overall Study|Lost to Follow-up|2|||
156639548|NCT01211613|565426844|FG001|Overall Study|Lost to Follow-up|2|||
156639549|NCT01211613|565426845|FG002|Overall Study|Lost to Follow-up|2|||
156639550|NCT01211613|565426843|FG000|Overall Study|Withdrawal by Subject|1|||
156639551|NCT01211613|565426844|FG001|Overall Study|Withdrawal by Subject|0|||
156639552|NCT01211613|565426845|FG002|Overall Study|Withdrawal by Subject|0|||
156639553|NCT01020773|565426846|FG000|Overall Study|Withdrawal by Subject|4|||
156639554|NCT01020773|565426847|FG001|Overall Study|Withdrawal by Subject|3|||
156639555|NCT03853213|565426848|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
156639556|NCT03853213|565426849|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
156639557|NCT03853213|565426848|FG000|Overall Study|Other (e.g., too busy)|0|||
156639558|NCT03853213|565426849|FG001|Overall Study|Other (e.g., too busy)|2|||
156639559|NCT03302299|565426850|FG000|Overall Study|Protocol Violation|1|||
156639560|NCT01458132|565426851|FG000|Overall Study|Other|15|||
156639561|NCT01458132|565426852|FG001|Overall Study|Other|3|||
156639562|NCT02038959|565426857|FG000|Overall Study|Withdrawal by Subject|6|||
156639563|NCT02038959|565426858|FG001|Overall Study|Withdrawal by Subject|8|||
156639564|NCT00819091|565426864|FG000|Overall Study|Adverse Event|3|||
156639565|NCT00819091|565426865|FG001|Overall Study|Adverse Event|5|||
156639566|NCT00819091|565426864|FG000|Overall Study|Protocol Violation|0|||
156639567|NCT00819091|565426865|FG001|Overall Study|Protocol Violation|1|||
156639568|NCT00819091|565426864|FG000|Overall Study|Lost to Follow-up|2|||
156639569|NCT00819091|565426865|FG001|Overall Study|Lost to Follow-up|0|||
156639570|NCT00819091|565426864|FG000|Overall Study|Withdrawal by Subject|1|||
156639571|NCT00819091|565426865|FG001|Overall Study|Withdrawal by Subject|2|||
156639572|NCT00819091|565426864|FG000|Overall Study|Other|1|||
156639573|NCT00819091|565426865|FG001|Overall Study|Other|2|||
156639574|NCT01788163|565426867|FG000|Overall Study|Other|53|||
156639575|NCT01788163|565426868|FG001|Overall Study|Other|0|||
156639576|NCT01788163|565426869|FG002|Overall Study|Other|0|||
156639577|NCT01788163|565426870|FG003|Overall Study|Other|0|||
156639578|NCT01788163|565426871|FG004|Overall Study|Other|0|||
156639579|NCT01788163|565426872|FG005|Overall Study|Other|7|||
156639580|NCT01788163|565426873|FG006|Overall Study|Other|1|||
156639581|NCT01788163|565426874|FG007|Overall Study|Other|48|||
156639582|NCT01788163|565426875|FG008|Overall Study|Other|15|||
156639583|NCT01788163|565426867|FG000|Overall Study|Withdrawal by Subject|2|||
156639584|NCT01788163|565426868|FG001|Overall Study|Withdrawal by Subject|0|||
156639585|NCT01788163|565426869|FG002|Overall Study|Withdrawal by Subject|0|||
156639586|NCT01788163|565426870|FG003|Overall Study|Withdrawal by Subject|0|||
156639587|NCT01788163|565426871|FG004|Overall Study|Withdrawal by Subject|0|||
156639588|NCT01788163|565426872|FG005|Overall Study|Withdrawal by Subject|0|||
156639589|NCT01788163|565426873|FG006|Overall Study|Withdrawal by Subject|0|||
156639590|NCT01788163|565426874|FG007|Overall Study|Withdrawal by Subject|0|||
156639591|NCT01788163|565426875|FG008|Overall Study|Withdrawal by Subject|1|||
156639592|NCT00545441|565426876|FG000|Overall Study|Fistula draining at 6 months|2|||
156639593|NCT00545441|565426877|FG001|Overall Study|Fistula draining at 6 months|4|||
156639594|NCT00545441|565426876|FG000|Overall Study|Lost to Follow-up|9|||
156639595|NCT00545441|565426877|FG001|Overall Study|Lost to Follow-up|5|||
156639596|NCT00545441|565426876|FG000|Overall Study|Technical failure|0|||
156639597|NCT00545441|565426877|FG001|Overall Study|Technical failure|1|||
156639598|NCT00545441|565426876|FG000|Overall Study|Withdrawal by Subject|1|||
156639599|NCT00545441|565426877|FG001|Overall Study|Withdrawal by Subject|1|||
156639600|NCT00545441|565426876|FG000|Overall Study|Persistence or recurrence of fistula|5|||
156639601|NCT00545441|565426877|FG001|Overall Study|Persistence or recurrence of fistula|2|||
156639602|NCT00545441|565426876|FG000|Overall Study|Patients were not treated|1|||
156639603|NCT00545441|565426877|FG001|Overall Study|Patients were not treated|3|||
156639604|NCT03911960|565426878|FG000|Overall Study|Lost to Follow-up|5|||
156639605|NCT03911960|565426879|FG001|Overall Study|Lost to Follow-up|3|||
156639606|NCT00265239|565426880|FG000|Overall Study|Adverse Event|2|||
156639607|NCT00265239|565426881|FG001|Overall Study|Adverse Event|1|||
156639608|NCT02803138|565426884|FG000|Overall Study|Failure to return|38|||
156639609|NCT02803138|565426884|FG000|Overall Study|Insufficient virological response|2|||
156639610|NCT02803138|565426884|FG000|Overall Study|Withdrawn consent|1|||
156639611|NCT02803138|565426884|FG000|Overall Study|Death|1|||
156639612|NCT02803138|565426884|FG000|Overall Study|Other, not specified|28|||
156639613|NCT00424515|565426885|FG000|Overall Study|Progressive Disease|10|||
156639614|NCT00424515|565426886|FG001|Overall Study|Progressive Disease|11|||
156639615|NCT00424515|565426885|FG000|Overall Study|Adverse Event|0|||
156639616|NCT00424515|565426886|FG001|Overall Study|Adverse Event|1|||
156639617|NCT00424515|565426885|FG000|Overall Study|Intercurrent Illness|0|||
156639618|NCT00424515|565426886|FG001|Overall Study|Intercurrent Illness|1|||
156639619|NCT00424515|565426885|FG000|Overall Study|Withdrawal by Subject|1|||
156639620|NCT00424515|565426886|FG001|Overall Study|Withdrawal by Subject|0|||
156639621|NCT04071366|565426887|FG000|Part 1: Open-label (29 Days)|Death|4|||
156639622|NCT04071366|565426888|FG001|Part 1: Open-label (29 Days)|Death|2|||
156639623|NCT04071366|565426889|FG002|Part 1: Open-label (29 Days)|Death|8|||
156639624|NCT04071366|565426890|FG003|Part 1: Open-label (29 Days)|Death|0|||
156639625|NCT04071366|565426891|FG004|Part 1: Open-label (29 Days)|Death|0|||
156639626|NCT04071366|565426887|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
156639627|NCT04071366|565426888|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
156639628|NCT04071366|565426889|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
156639629|NCT04071366|565426890|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
156639630|NCT04071366|565426891|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
156639631|NCT04071366|565426887|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
156639632|NCT04071366|565426888|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
156639633|NCT04071366|565426889|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
156639634|NCT04071366|565426890|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
156639635|NCT04071366|565426891|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
156639636|NCT04071366|565426887|FG000|Part 2: Randomized (29 Days)|Death|0|||
156639637|NCT04071366|565426888|FG001|Part 2: Randomized (29 Days)|Death|0|||
156639638|NCT04071366|565426889|FG002|Part 2: Randomized (29 Days)|Death|0|||
156639639|NCT04071366|565426890|FG003|Part 2: Randomized (29 Days)|Death|2|||
156639640|NCT04071366|565426891|FG004|Part 2: Randomized (29 Days)|Death|2|||
156639641|NCT04071366|565426887|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
156639642|NCT04071366|565426888|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
156639643|NCT04071366|565426889|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
156639644|NCT04071366|565426890|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
156639645|NCT04071366|565426891|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
156639646|NCT04071366|565426887|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
156639647|NCT04071366|565426888|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
156639648|NCT04071366|565426889|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
156639649|NCT04071366|565426890|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
156639650|NCT04071366|565426891|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
156639651|NCT04071366|565426887|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
156639652|NCT04071366|565426888|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
156639653|NCT04071366|565426889|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
156639654|NCT04071366|565426890|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
156639655|NCT04071366|565426891|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
156639656|NCT04071366|565426887|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
156639657|NCT04071366|565426888|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
156639658|NCT04071366|565426889|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
156639659|NCT04071366|565426890|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
156639660|NCT04071366|565426891|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
156639661|NCT04071366|565426887|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
156639662|NCT04071366|565426888|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
156639663|NCT04071366|565426889|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
156639664|NCT04071366|565426890|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
156639665|NCT04071366|565426891|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
156639666|NCT04071366|565426887|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
156639667|NCT04071366|565426888|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
156639668|NCT04071366|565426889|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
156639669|NCT04071366|565426890|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
156639670|NCT04071366|565426891|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
156639671|NCT00021229|565426892|FG000|Overall Study|Adverse Event|10|||
156639672|NCT00021229|565426893|FG001|Overall Study|Adverse Event|5|||
156639673|NCT00021229|565426894|FG002|Overall Study|Adverse Event|2|||
156639674|NCT00021229|565426892|FG000|Overall Study|Death|0|||
156639675|NCT00021229|565426893|FG001|Overall Study|Death|1|||
156639676|NCT00021229|565426894|FG002|Overall Study|Death|0|||
156639677|NCT00021229|565426892|FG000|Overall Study|Withdrawal by Subject|7|||
156639678|NCT00021229|565426893|FG001|Overall Study|Withdrawal by Subject|7|||
156639679|NCT00021229|565426894|FG002|Overall Study|Withdrawal by Subject|1|||
156639680|NCT00021229|565426892|FG000|Overall Study|Progressive Disease|15|||
156639681|NCT00021229|565426893|FG001|Overall Study|Progressive Disease|19|||
156639682|NCT00021229|565426894|FG002|Overall Study|Progressive Disease|12|||
156639683|NCT00021229|565426892|FG000|Overall Study|Protocol Violation|1|||
156639684|NCT00021229|565426893|FG001|Overall Study|Protocol Violation|1|||
156639685|NCT00021229|565426894|FG002|Overall Study|Protocol Violation|0|||
156639686|NCT00021229|565426892|FG000|Overall Study|Physician Decision|0|||
156639687|NCT00021229|565426893|FG001|Overall Study|Physician Decision|0|||
156639688|NCT00021229|565426894|FG002|Overall Study|Physician Decision|1|||
156751712|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156639689|NCT00021229|565426892|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
156639690|NCT00021229|565426893|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
156639691|NCT00021229|565426894|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
156639692|NCT01901146|565426895|FG000|Neoadjuvant Phase|Death|1|||
156639693|NCT01901146|565426896|FG001|Neoadjuvant Phase|Death|2|||
156639694|NCT01901146|565426897|FG002|Neoadjuvant Phase|Death|0|||
156639695|NCT01901146|565426898|FG003|Neoadjuvant Phase|Death|0|||
156639696|NCT01901146|565426899|FG004|Neoadjuvant Phase|Death|0|||
156639697|NCT01901146|565426895|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
156639698|NCT01901146|565426896|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
156639699|NCT01901146|565426897|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
156639700|NCT01901146|565426898|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
156639701|NCT01901146|565426899|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
156639702|NCT01901146|565426895|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
156639703|NCT01901146|565426896|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
156639704|NCT01901146|565426897|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
156639705|NCT01901146|565426898|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
156639706|NCT01901146|565426899|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
156639707|NCT01901146|565426895|FG000|Neoadjuvant Phase|Physician Decision|1|||
156639708|NCT01901146|565426896|FG001|Neoadjuvant Phase|Physician Decision|2|||
156639709|NCT01901146|565426897|FG002|Neoadjuvant Phase|Physician Decision|0|||
156639710|NCT01901146|565426898|FG003|Neoadjuvant Phase|Physician Decision|0|||
156639711|NCT01901146|565426899|FG004|Neoadjuvant Phase|Physician Decision|0|||
156639712|NCT01901146|565426895|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
156639713|NCT01901146|565426896|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
156639714|NCT01901146|565426897|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
156639715|NCT01901146|565426898|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
156639716|NCT01901146|565426899|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
156639717|NCT01901146|565426895|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
156639718|NCT01901146|565426896|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
156639719|NCT01901146|565426897|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
156639720|NCT01901146|565426898|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
156639721|NCT01901146|565426899|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
156639722|NCT01901146|565426895|FG000|Adjuvant Phase|Other|0|||
156639723|NCT01901146|565426896|FG001|Adjuvant Phase|Other|0|||
156639724|NCT01901146|565426897|FG002|Adjuvant Phase|Other|1|||
156639725|NCT01901146|565426898|FG003|Adjuvant Phase|Other|0|||
156639726|NCT01901146|565426899|FG004|Adjuvant Phase|Other|0|||
156639727|NCT01901146|565426895|FG000|Adjuvant Phase|Death|0|||
156639728|NCT01901146|565426896|FG001|Adjuvant Phase|Death|0|||
156639729|NCT01901146|565426897|FG002|Adjuvant Phase|Death|0|||
156639730|NCT01901146|565426898|FG003|Adjuvant Phase|Death|0|||
156639731|NCT01901146|565426899|FG004|Adjuvant Phase|Death|3|||
156639732|NCT01901146|565426895|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
156639733|NCT01901146|565426896|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
156639734|NCT01901146|565426897|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
156639735|NCT01901146|565426898|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
156639736|NCT01901146|565426899|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
156639737|NCT01901146|565426895|FG000|Adjuvant Phase|Physician Decision|0|||
156639738|NCT01901146|565426896|FG001|Adjuvant Phase|Physician Decision|0|||
156639739|NCT01901146|565426897|FG002|Adjuvant Phase|Physician Decision|9|||
156639740|NCT01901146|565426898|FG003|Adjuvant Phase|Physician Decision|2|||
156639741|NCT01901146|565426899|FG004|Adjuvant Phase|Physician Decision|4|||
156639742|NCT01901146|565426895|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
156639743|NCT01901146|565426896|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
156639744|NCT01901146|565426897|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
156639745|NCT01901146|565426898|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
156639746|NCT01901146|565426899|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
156639747|NCT00297492|565426900|FG000|Set Quit Date|Lost to Follow-up|7|||
156639748|NCT00297492|565426901|FG001|Set Quit Date|Lost to Follow-up|13|||
156639749|NCT00297492|565426902|FG002|Set Quit Date|Lost to Follow-up|5|||
156639750|NCT00297492|565426900|FG000|6 Month Follow-up|Lost to Follow-up|63|||
156639751|NCT00297492|565426901|FG001|6 Month Follow-up|Lost to Follow-up|49|||
156639752|NCT00297492|565426902|FG002|6 Month Follow-up|Lost to Follow-up|27|||
156639753|NCT02675426|565426903|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
156639754|NCT02675426|565426904|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
156639755|NCT02675426|565426905|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
156639756|NCT02675426|565426906|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
156639757|NCT02675426|565426903|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
156639758|NCT02675426|565426904|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
156639759|NCT02675426|565426905|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
156639760|NCT02675426|565426906|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
156639761|NCT02675426|565426903|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
156639762|NCT02675426|565426904|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
156639763|NCT02675426|565426905|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
156639764|NCT02675426|565426906|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
156639765|NCT02675426|565426903|FG000|Period 1: Week 1 to Week 12|Other|2|||
156639766|NCT02675426|565426904|FG001|Period 1: Week 1 to Week 12|Other|1|||
156639767|NCT02675426|565426905|FG002|Period 1: Week 1 to Week 12|Other|0|||
156639768|NCT02675426|565426906|FG003|Period 1: Week 1 to Week 12|Other|2|||
156639769|NCT02675426|565426903|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
156639770|NCT02675426|565426904|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
156639771|NCT02675426|565426905|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
156639772|NCT02675426|565426906|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
156639773|NCT02675426|565426903|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
156639774|NCT02675426|565426904|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
156639775|NCT02675426|565426905|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
156639776|NCT02675426|565426906|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
156639777|NCT02675426|565426903|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
156639778|NCT02675426|565426904|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
156639779|NCT02675426|565426905|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
156639780|NCT02675426|565426906|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
156639781|NCT02675426|565426903|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
156639782|NCT02675426|565426904|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
156639783|NCT02675426|565426905|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
156639784|NCT02675426|565426906|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
156639785|NCT02675426|565426903|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
156639786|NCT02675426|565426904|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
156639787|NCT02675426|565426905|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
156639788|NCT02675426|565426906|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
156639789|NCT02675426|565426903|FG000|Period 2: Week 12 to Week 260|Other|8|||
156639790|NCT02675426|565426904|FG001|Period 2: Week 12 to Week 260|Other|12|||
156639791|NCT02675426|565426905|FG002|Period 2: Week 12 to Week 260|Other|23|||
156639792|NCT02675426|565426906|FG003|Period 2: Week 12 to Week 260|Other|15|||
156639793|NCT02237118|565426907|FG000|Overall Study|Protocol Violation|0|||
156639794|NCT02237118|565426908|FG001|Overall Study|Protocol Violation|1|||
156639795|NCT02237118|565426907|FG000|Overall Study|consent withdrawn|1|||
156639796|NCT02237118|565426908|FG001|Overall Study|consent withdrawn|0|||
156639797|NCT03978117|565426909|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
156639798|NCT03978117|565426910|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
156639799|NCT03978117|565426909|FG000|Overall Study|Lost to Follow-up|4|||
156639800|NCT03978117|565426910|FG001|Overall Study|Lost to Follow-up|4|||
156639801|NCT04723173|565426911|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
156639802|NCT02962739|565426916|FG000|Overall Study|Withdrawal by Subject|0|||
156639803|NCT02962739|565426917|FG001|Overall Study|Withdrawal by Subject|1|||
156639804|NCT02962739|565426918|FG002|Overall Study|Withdrawal by Subject|0|||
156639805|NCT02962739|565426919|FG003|Overall Study|Withdrawal by Subject|0|||
156639806|NCT02962739|565426920|FG004|Overall Study|Withdrawal by Subject|0|||
156639807|NCT02962739|565426921|FG005|Overall Study|Withdrawal by Subject|0|||
156639808|NCT02962739|565426916|FG000|Overall Study|Protocol Violation|0|||
156639809|NCT02962739|565426917|FG001|Overall Study|Protocol Violation|0|||
156639810|NCT02962739|565426918|FG002|Overall Study|Protocol Violation|1|||
156639811|NCT02962739|565426919|FG003|Overall Study|Protocol Violation|0|||
156639812|NCT02962739|565426920|FG004|Overall Study|Protocol Violation|1|||
156639813|NCT02962739|565426921|FG005|Overall Study|Protocol Violation|0|||
156639814|NCT00414011|565426922|FG000|Overall Study|Physician Decision|3|||
156639815|NCT00414011|565426922|FG000|Overall Study|Withdrawal by Subject|2|||
156639816|NCT00306852|565426923|FG000|Overall Study|Death|14|||
156639817|NCT00306852|565426924|FG001|Overall Study|Death|14|||
156639818|NCT00306852|565426923|FG000|Overall Study|Lost to Follow-up|15|||
156639819|NCT00306852|565426924|FG001|Overall Study|Lost to Follow-up|24|||
156639820|NCT00817778|565426926|FG000|Overall Study|Adverse Event|1|||
156639821|NCT00817778|565426927|FG001|Overall Study|Adverse Event|0|||
156639822|NCT00817778|565426926|FG000|Overall Study|Withdrawal by Subject|1|||
156639823|NCT00817778|565426927|FG001|Overall Study|Withdrawal by Subject|1|||
156639824|NCT00817778|565426926|FG000|Overall Study|Protocol Violation|0|||
156639825|NCT00817778|565426927|FG001|Overall Study|Protocol Violation|1|||
156639826|NCT00817778|565426926|FG000|Overall Study|Study-specific discontinuation criteria|0|||
156639827|NCT00817778|565426927|FG001|Overall Study|Study-specific discontinuation criteria|1|||
156639828|NCT00817778|565426926|FG000|Overall Study|Poor venous access|1|||
156639829|NCT00817778|565426927|FG001|Overall Study|Poor venous access|0|||
156639830|NCT03343054|565426928|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
156639831|NCT03343054|565426929|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
156639832|NCT03343054|565426930|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
156639833|NCT03343054|565426928|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
156639834|NCT03343054|565426929|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
156639835|NCT03343054|565426930|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
156639836|NCT03343054|565426928|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
156639837|NCT03343054|565426929|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
156639838|NCT03343054|565426930|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
156639839|NCT03343054|565426928|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
156639840|NCT03343054|565426929|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
156639841|NCT03343054|565426930|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
156639842|NCT01537549|565426931|FG000|Overall Study|Lost to Follow-up|1|||
156639843|NCT01537549|565426931|FG000|Overall Study|Withdrawal by Subject|2|||
156639844|NCT00883740|565426932|FG000|First Intervention|Lost to Follow-up|1|||
156639845|NCT00883740|565426933|FG001|First Intervention|Lost to Follow-up|0|||
156639846|NCT00883740|565426932|FG000|First Intervention|No longer willing to participate|2|||
156639847|NCT00883740|565426933|FG001|First Intervention|No longer willing to participate|0|||
156639848|NCT00883740|565426932|FG000|First Intervention|Protocol Violation|3|||
156639849|NCT00883740|565426933|FG001|First Intervention|Protocol Violation|6|||
156639850|NCT00883740|565426932|FG000|First Intervention|Adverse Event|1|||
156639851|NCT00883740|565426933|FG001|First Intervention|Adverse Event|2|||
156639852|NCT00883740|565426932|FG000|Second Intervention|Protocol Violation|1|||
156639853|NCT00883740|565426933|FG001|Second Intervention|Protocol Violation|0|||
156639854|NCT00883740|565426932|FG000|Second Intervention|No longer willing to participate|0|||
156639855|NCT00883740|565426933|FG001|Second Intervention|No longer willing to participate|1|||
156639856|NCT01286207|565426934|FG000|Overall Study|Adverse Event|27|||
156639857|NCT01286207|565426935|FG001|Overall Study|Adverse Event|41|||
156639858|NCT01286207|565426936|FG002|Overall Study|Adverse Event|8|||
156639859|NCT01286207|565426934|FG000|Overall Study|Lost to Follow-up|49|||
156639860|NCT01286207|565426935|FG001|Overall Study|Lost to Follow-up|43|||
156639861|NCT01286207|565426936|FG002|Overall Study|Lost to Follow-up|20|||
156639862|NCT01286207|565426934|FG000|Overall Study|Withdrawal by Subject|93|||
156639863|NCT01286207|565426935|FG001|Overall Study|Withdrawal by Subject|79|||
156639864|NCT01286207|565426936|FG002|Overall Study|Withdrawal by Subject|41|||
156639865|NCT01286207|565426934|FG000|Overall Study|Lack of Response|92|||
156639866|NCT01286207|565426935|FG001|Overall Study|Lack of Response|38|||
156639867|NCT01286207|565426936|FG002|Overall Study|Lack of Response|8|||
156639868|NCT01286207|565426934|FG000|Overall Study|Other|37|||
156639869|NCT01286207|565426935|FG001|Overall Study|Other|47|||
156639870|NCT01286207|565426936|FG002|Overall Study|Other|13|||
156639871|NCT02923115|565426937|FG000|Overall Study|Lost to Follow-up|0|||
156639872|NCT02923115|565426938|FG001|Overall Study|Lost to Follow-up|0|||
156639873|NCT02923115|565426939|FG002|Overall Study|Lost to Follow-up|0|||
156639874|NCT02923115|565426940|FG003|Overall Study|Lost to Follow-up|1|||
156639875|NCT02923115|565426941|FG004|Overall Study|Lost to Follow-up|0|||
156639876|NCT02923115|565426942|FG005|Overall Study|Lost to Follow-up|0|||
156639877|NCT02923115|565426937|FG000|Overall Study|Withdrawal by Subject|0|||
156639878|NCT02923115|565426938|FG001|Overall Study|Withdrawal by Subject|1|||
156639879|NCT02923115|565426939|FG002|Overall Study|Withdrawal by Subject|0|||
156639880|NCT02923115|565426940|FG003|Overall Study|Withdrawal by Subject|0|||
156639881|NCT02923115|565426941|FG004|Overall Study|Withdrawal by Subject|0|||
156639882|NCT02923115|565426942|FG005|Overall Study|Withdrawal by Subject|0|||
156639883|NCT02923115|565426937|FG000|Overall Study|Randomized, but not dosed|0|||
156639884|NCT02923115|565426938|FG001|Overall Study|Randomized, but not dosed|0|||
156639885|NCT02923115|565426939|FG002|Overall Study|Randomized, but not dosed|3|||
156639886|NCT02923115|565426940|FG003|Overall Study|Randomized, but not dosed|1|||
156639887|NCT02923115|565426941|FG004|Overall Study|Randomized, but not dosed|5|||
156639888|NCT02923115|565426942|FG005|Overall Study|Randomized, but not dosed|0|||
156639889|NCT01875991|565426947|FG000|Overall Study|Withdrawal by Subject|6|||
156639890|NCT01875991|565426948|FG001|Overall Study|Withdrawal by Subject|6|||
156639891|NCT01875991|565426947|FG000|Overall Study|Sponsor Decision|1|||
156639892|NCT01875991|565426948|FG001|Overall Study|Sponsor Decision|0|||
156639893|NCT04840901|565426949|FG000|Overall Study|Lost to Follow-up|3|||
156639894|NCT04840901|565426950|FG001|Overall Study|Lost to Follow-up|1|||
156639895|NCT04840901|565426949|FG000|Overall Study|Moved|1|||
156639896|NCT04840901|565426950|FG001|Overall Study|Moved|0|||
156639897|NCT04840901|565426949|FG000|Overall Study|Unable to comply with study schedule|0|||
156639898|NCT04840901|565426950|FG001|Overall Study|Unable to comply with study schedule|1|||
156639899|NCT04840901|565426949|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
156639900|NCT04840901|565426950|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
156639901|NCT01268683|565426951|FG000|Overall Study|Lost to Follow-up|1|||
156639902|NCT01268683|565426951|FG000|Overall Study|Death|1|||
156639903|NCT00103259|565426952|FG000|Overall Study|Death|3|||
156639904|NCT00103259|565426953|FG001|Overall Study|Death|2|||
156639905|NCT00103259|565426952|FG000|Overall Study|Withdrawal by Subject|2|||
156639906|NCT00103259|565426953|FG001|Overall Study|Withdrawal by Subject|3|||
156639907|NCT00103259|565426952|FG000|Overall Study|alternative therapy|1|||
156639908|NCT00103259|565426953|FG001|Overall Study|alternative therapy|0|||
156639909|NCT00103259|565426952|FG000|Overall Study|other (reasons were not specified)|2|||
156639910|NCT00103259|565426953|FG001|Overall Study|other (reasons were not specified)|1|||
156639911|NCT00103259|565426952|FG000|Overall Study|ineligible/no protocol therapy|4|||
156639912|NCT00103259|565426953|FG001|Overall Study|ineligible/no protocol therapy|6|||
156639913|NCT03224234|565426954|FG000|Main Study|Lost to Follow-up|5|||
156639914|NCT03224234|565426955|FG001|Main Study|Lost to Follow-up|5|||
156639915|NCT02610842|565426956|FG000|Overall Study|Lost to Follow-up|5|||
156639916|NCT00835068|565426957|FG000|Overall Study|Death|1|||
156639917|NCT00835068|565426958|FG001|Overall Study|Death|0|||
156639918|NCT00835068|565426957|FG000|Overall Study|Adverse Event|0|||
156639919|NCT00835068|565426958|FG001|Overall Study|Adverse Event|1|||
156639920|NCT00835068|565426957|FG000|Overall Study|Other|8|||
156639921|NCT00835068|565426958|FG001|Overall Study|Other|0|||
156639922|NCT00835068|565426957|FG000|Overall Study|Withdrawal by Subject|1|||
156639923|NCT00835068|565426958|FG001|Overall Study|Withdrawal by Subject|0|||
156639924|NCT05631093|565426963|FG000|Overall Study|Death|0|||
156639925|NCT05631093|565426964|FG001|Overall Study|Death|1|||
156639926|NCT05631093|565426963|FG000|Overall Study|Lost to Follow-up|1|||
156639927|NCT05631093|565426964|FG001|Overall Study|Lost to Follow-up|2|||
156639928|NCT05631093|565426963|FG000|Overall Study|Physician Decision|1|||
156639929|NCT05631093|565426964|FG001|Overall Study|Physician Decision|0|||
156639930|NCT05631093|565426963|FG000|Overall Study|Withdrawal by Subject|4|||
156639931|NCT05631093|565426964|FG001|Overall Study|Withdrawal by Subject|1|||
156639932|NCT05631093|565426963|FG000|Overall Study|Ongoing|353|||
156639933|NCT05631093|565426964|FG001|Overall Study|Ongoing|177|||
156639934|NCT05631093|565426963|FG000|Overall Study|Adverse Event|0|||
156639935|NCT05631093|565426964|FG001|Overall Study|Adverse Event|1|||
156639936|NCT03252756|565426965|FG000|Overall Study|Protocol Violation|2|||
156639937|NCT03252756|565426966|FG001|Overall Study|Protocol Violation|4|||
156639938|NCT03252756|565426965|FG000|Overall Study|COVID-19 Pandemic|1|||
156639939|NCT03252756|565426966|FG001|Overall Study|COVID-19 Pandemic|1|||
156639940|NCT03252756|565426965|FG000|Overall Study|Study Drug Expiration|0|||
156639941|NCT03252756|565426966|FG001|Overall Study|Study Drug Expiration|1|||
156639942|NCT03594175|565426967|FG000|Overall Study|Not treated|8|||
156639943|NCT03594175|565426968|FG001|Overall Study|Not treated|1|||
156639944|NCT03594175|565426969|FG002|Overall Study|Not treated|5|||
156639945|NCT03594175|565426967|FG000|Overall Study|Adverse Event|3|||
156639946|NCT03594175|565426968|FG001|Overall Study|Adverse Event|0|||
156639947|NCT03594175|565426969|FG002|Overall Study|Adverse Event|0|||
156639948|NCT03594175|565426967|FG000|Overall Study|Withdrawal by Subject|3|||
156639949|NCT03594175|565426968|FG001|Overall Study|Withdrawal by Subject|0|||
156639950|NCT03594175|565426969|FG002|Overall Study|Withdrawal by Subject|0|||
156639951|NCT03594175|565426967|FG000|Overall Study|Protocol Violation|2|||
156639952|NCT03594175|565426968|FG001|Overall Study|Protocol Violation|2|||
156639953|NCT03594175|565426969|FG002|Overall Study|Protocol Violation|2|||
156639954|NCT03732677|565426970|FG000|Overall Study|Terminated the study|154|||
156639955|NCT03732677|565426971|FG001|Overall Study|Terminated the study|197|||
156639956|NCT03732677|565426970|FG000|Overall Study|Continuing study off treatment|379|||
156639957|NCT03732677|565426971|FG001|Overall Study|Continuing study off treatment|333|||
156639958|NCT03494816|565426972|FG000|Overall Study|Protocol Violation|2|||
156639959|NCT03494816|565426972|FG000|Overall Study|Physician Decision|2|||
156639960|NCT03494816|565426972|FG000|Overall Study|Did not start trial treatment|1|||
156639961|NCT03494816|565426972|FG000|Overall Study|Adverse Event|1|||
156639962|NCT01500434|565426973|FG000|Overall Study|Death|1|||
156639963|NCT01500434|565426973|FG000|Overall Study|Withdrawal by Subject|1|||
156639964|NCT01500434|565426973|FG000|Overall Study|Missed 12-month follow-up|5|||
156639965|NCT00633217|565426974|FG000|Overall Study|Adverse Event|5|||
156639966|NCT00633217|565426975|FG001|Overall Study|Adverse Event|9|||
156639967|NCT00633217|565426974|FG000|Overall Study|Lack of Efficacy|0|||
156639968|NCT00633217|565426975|FG001|Overall Study|Lack of Efficacy|2|||
156639969|NCT00633217|565426974|FG000|Overall Study|Protocol Violation|3|||
156639970|NCT00633217|565426975|FG001|Overall Study|Protocol Violation|7|||
156639971|NCT00633217|565426974|FG000|Overall Study|Lost to Follow-up|2|||
156639972|NCT00633217|565426975|FG001|Overall Study|Lost to Follow-up|2|||
156639973|NCT00633217|565426974|FG000|Overall Study|Investigator Discretion|2|||
156639974|NCT00633217|565426975|FG001|Overall Study|Investigator Discretion|0|||
156639975|NCT00633217|565426974|FG000|Overall Study|Withdrew Consent|3|||
156639976|NCT00633217|565426975|FG001|Overall Study|Withdrew Consent|3|||
156639977|NCT04822701|565426976|FG000|Overall Study|Not treated|2|||
156639978|NCT04822701|565426977|FG001|Overall Study|Not treated|0|||
156639979|NCT04822701|565426976|FG000|Overall Study|Lost to Follow-up|1|||
156411737|NCT01089556|564601386|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
156639980|NCT04822701|565426977|FG001|Overall Study|Lost to Follow-up|0|||
156639981|NCT04822701|565426976|FG000|Overall Study|Withdrawal by Subject|1|||
156639982|NCT04822701|565426977|FG001|Overall Study|Withdrawal by Subject|0|||
156639983|NCT02706353|565426978|FG000|Dose Level 1|Disease Progression|1|||
156639984|NCT02706353|565426979|FG001|Dose Level 1|Disease Progression|0|||
156639985|NCT02706353|565426980|FG002|Dose Level 1|Disease Progression|0|||
156639986|NCT02706353|565426981|FG003|Dose Level 1|Disease Progression|0|||
156639987|NCT02706353|565426982|FG004|Dose Level 1|Disease Progression|0|||
156639988|NCT02706353|565426983|FG005|Dose Level 1|Disease Progression|0|||
156639989|NCT02706353|565426978|FG000|Dose Level 3|Disease Progression|0|||
156639990|NCT02706353|565426979|FG001|Dose Level 3|Disease Progression|0|||
156639991|NCT02706353|565426980|FG002|Dose Level 3|Disease Progression|2|||
156639992|NCT02706353|565426981|FG003|Dose Level 3|Disease Progression|0|||
156639993|NCT02706353|565426982|FG004|Dose Level 3|Disease Progression|0|||
156639994|NCT02706353|565426983|FG005|Dose Level 3|Disease Progression|0|||
156639995|NCT02706353|565426978|FG000|Dose Level 4|Disease Progression|0|||
156639996|NCT02706353|565426979|FG001|Dose Level 4|Disease Progression|0|||
156639997|NCT02706353|565426980|FG002|Dose Level 4|Disease Progression|0|||
156639998|NCT02706353|565426981|FG003|Dose Level 4|Disease Progression|1|||
156639999|NCT02706353|565426982|FG004|Dose Level 4|Disease Progression|0|||
156640000|NCT02706353|565426983|FG005|Dose Level 4|Disease Progression|0|||
156640001|NCT02706353|565426978|FG000|Dose Level 4|Toxicity|0|||
156640002|NCT02706353|565426979|FG001|Dose Level 4|Toxicity|0|||
156640003|NCT02706353|565426980|FG002|Dose Level 4|Toxicity|0|||
156640004|NCT02706353|565426981|FG003|Dose Level 4|Toxicity|1|||
156640005|NCT02706353|565426982|FG004|Dose Level 4|Toxicity|0|||
156640006|NCT02706353|565426983|FG005|Dose Level 4|Toxicity|0|||
156640007|NCT02706353|565426978|FG000|Dose Level 4|Death|0|||
156640008|NCT02706353|565426979|FG001|Dose Level 4|Death|0|||
156640009|NCT02706353|565426980|FG002|Dose Level 4|Death|0|||
156640010|NCT02706353|565426981|FG003|Dose Level 4|Death|1|||
156640011|NCT02706353|565426982|FG004|Dose Level 4|Death|0|||
156640012|NCT02706353|565426983|FG005|Dose Level 4|Death|0|||
156640013|NCT02706353|565426978|FG000|Dose Level 5|Toxicity|0|||
156640014|NCT02706353|565426979|FG001|Dose Level 5|Toxicity|0|||
156640015|NCT02706353|565426980|FG002|Dose Level 5|Toxicity|0|||
156640016|NCT02706353|565426981|FG003|Dose Level 5|Toxicity|0|||
156640017|NCT02706353|565426982|FG004|Dose Level 5|Toxicity|1|||
156640018|NCT02706353|565426983|FG005|Dose Level 5|Toxicity|0|||
156640019|NCT02706353|565426978|FG000|Dose Level 5|Disease Progression|0|||
156640020|NCT02706353|565426979|FG001|Dose Level 5|Disease Progression|0|||
156640021|NCT02706353|565426980|FG002|Dose Level 5|Disease Progression|0|||
156640022|NCT02706353|565426981|FG003|Dose Level 5|Disease Progression|0|||
156640023|NCT02706353|565426982|FG004|Dose Level 5|Disease Progression|3|||
156640024|NCT02706353|565426983|FG005|Dose Level 5|Disease Progression|2|||
156640025|NCT02706353|565426978|FG000|Dose Level 5|Death|0|||
156640026|NCT02706353|565426979|FG001|Dose Level 5|Death|0|||
156640027|NCT02706353|565426980|FG002|Dose Level 5|Death|0|||
156640028|NCT02706353|565426981|FG003|Dose Level 5|Death|0|||
156640029|NCT02706353|565426982|FG004|Dose Level 5|Death|1|||
156640030|NCT02706353|565426983|FG005|Dose Level 5|Death|6|||
156640031|NCT02706353|565426978|FG000|Dose Level 5|Withdrawal by Subject|0|||
156640032|NCT02706353|565426979|FG001|Dose Level 5|Withdrawal by Subject|0|||
156640033|NCT02706353|565426980|FG002|Dose Level 5|Withdrawal by Subject|0|||
156640034|NCT02706353|565426981|FG003|Dose Level 5|Withdrawal by Subject|0|||
156640035|NCT02706353|565426982|FG004|Dose Level 5|Withdrawal by Subject|0|||
156640036|NCT02706353|565426983|FG005|Dose Level 5|Withdrawal by Subject|2|||
156640037|NCT03724968|565428104|FG000|Overall Study|Insurance issues|0|||
156640038|NCT03724968|565428105|FG001|Overall Study|Insurance issues|1|||
156640039|NCT03724968|565428104|FG000|Overall Study|Study closed|0|||
156640040|NCT03724968|565428105|FG001|Overall Study|Study closed|1|||
156640041|NCT01858558|565428106|FG000|Overall Study|Death|1|||
156640042|NCT01858558|565428107|FG001|Overall Study|Death|1|||
156640043|NCT01858558|565428106|FG000|Overall Study|Lost to Follow-up|1|||
156640044|NCT01858558|565428107|FG001|Overall Study|Lost to Follow-up|0|||
156640045|NCT01858558|565428106|FG000|Overall Study|Disease progression|3|||
156640046|NCT01858558|565428107|FG001|Overall Study|Disease progression|1|||
156640047|NCT01858558|565428106|FG000|Overall Study|Product contamination|2|||
156640048|NCT01858558|565428107|FG001|Overall Study|Product contamination|0|||
156640049|NCT01858558|565428106|FG000|Overall Study|Failed expansion of cell product|2|||
156640050|NCT01858558|565428107|FG001|Overall Study|Failed expansion of cell product|0|||
156640051|NCT01336608|565428108|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
156640052|NCT01336608|565428109|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156640053|NCT01336608|565428110|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156640054|NCT01336608|565428111|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156640055|NCT01336608|565428108|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
156640056|NCT01336608|565428109|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156640057|NCT01336608|565428110|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156640058|NCT01336608|565428111|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156640059|NCT01336608|565428108|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
156640060|NCT01336608|565428109|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
156640061|NCT01336608|565428110|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
156640062|NCT01336608|565428111|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
156640063|NCT01336608|565428108|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
156640064|NCT01336608|565428109|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
156640065|NCT01336608|565428110|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
156640066|NCT01336608|565428111|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
156640067|NCT01336608|565428108|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
156640068|NCT01336608|565428109|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156640069|NCT01336608|565428110|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156640070|NCT01336608|565428111|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156640071|NCT01336608|565428108|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
156640072|NCT01336608|565428109|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
156640073|NCT01336608|565428110|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
156640074|NCT01336608|565428111|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
156640075|NCT01336608|565428108|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156640076|NCT01336608|565428109|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
156640077|NCT01336608|565428110|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156640078|NCT01336608|565428111|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156640079|NCT01336608|565428108|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
156640080|NCT01336608|565428109|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
156640081|NCT01336608|565428110|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
156640082|NCT01336608|565428111|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
156640083|NCT01336608|565428108|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
156640084|NCT01336608|565428109|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
156640085|NCT01336608|565428110|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
156640086|NCT01336608|565428111|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
156640087|NCT01336608|565428108|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
156640088|NCT01336608|565428109|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
156640089|NCT01336608|565428110|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
156640090|NCT01336608|565428111|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
156640091|NCT01336608|565428108|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156640092|NCT01336608|565428109|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
156411738|NCT01089556|564601381|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
156411739|NCT01089556|564601382|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
156640093|NCT01336608|565428110|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156640094|NCT01336608|565428111|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156640095|NCT01336608|565428108|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
156640096|NCT01336608|565428109|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
156640097|NCT01336608|565428110|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
156640098|NCT01336608|565428111|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
156640099|NCT01336608|565428108|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156640100|NCT01336608|565428109|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
156640101|NCT01336608|565428110|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
156640102|NCT01336608|565428111|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
156640103|NCT02328547|565428118|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
156640104|NCT02328547|565428119|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
156640105|NCT02328547|565428118|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
156640106|NCT02328547|565428119|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
156640107|NCT00344305|565428120|FG000|Overall Study|Lost to Follow-up|2|||
156640108|NCT00344305|565428121|FG001|Overall Study|Lost to Follow-up|0|||
156640109|NCT00344305|565428120|FG000|Overall Study|Participant was not contacted in window|0|||
156640110|NCT00344305|565428121|FG001|Overall Study|Participant was not contacted in window|1|||
156640111|NCT02996448|565428122|FG000|Overall Study|Study terminated due to adverse effects|3|||
156640112|NCT03578276|565428126|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
156640113|NCT03578276|565428127|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
156640114|NCT02360397|565428128|FG000|Overall Study|Incomplete screening|3|||
156640115|NCT02360397|565428128|FG000|Overall Study|Adverse Event|1|||
156640116|NCT00589693|565428129|FG000|Overall Study|randomized in error|12|||
156640117|NCT00589693|565428130|FG001|Overall Study|randomized in error|6|||
156640118|NCT00589693|565428129|FG000|Overall Study|Adverse Event|4|||
156640119|NCT00589693|565428130|FG001|Overall Study|Adverse Event|4|||
156640120|NCT00589693|565428129|FG000|Overall Study|Death|26|||
156640121|NCT00589693|565428130|FG001|Overall Study|Death|16|||
156640122|NCT00589693|565428129|FG000|Overall Study|Lack of Efficacy|0|||
156640123|NCT00589693|565428130|FG001|Overall Study|Lack of Efficacy|1|||
156640124|NCT00589693|565428129|FG000|Overall Study|Lost to Follow-up|1|||
156640125|NCT00589693|565428130|FG001|Overall Study|Lost to Follow-up|0|||
156640126|NCT00589693|565428129|FG000|Overall Study|Physician Decision|0|||
156640127|NCT00589693|565428130|FG001|Overall Study|Physician Decision|1|||
156640128|NCT00589693|565428129|FG000|Overall Study|Protocol Violation|1|||
156640129|NCT00589693|565428130|FG001|Overall Study|Protocol Violation|1|||
156640130|NCT04256759|565428131|FG000|Overall Study|Physician Decision|1|||
156640131|NCT04256759|565428131|FG000|Overall Study|Lack of Efficacy|1|||
156640132|NCT01783483|565428143|FG000|Overall Study|Death|3|||
156640133|NCT01783483|565428144|FG001|Overall Study|Death|3|||
156640134|NCT01783483|565428143|FG000|Overall Study|Lost to Follow-up|14|||
156640135|NCT01783483|565428144|FG001|Overall Study|Lost to Follow-up|10|||
156640136|NCT01783483|565428143|FG000|Overall Study|Withdrawal by Subject|2|||
156640137|NCT01783483|565428144|FG001|Overall Study|Withdrawal by Subject|1|||
156640138|NCT01783483|565428143|FG000|Overall Study|Physician Decision|1|||
156640139|NCT01783483|565428144|FG001|Overall Study|Physician Decision|1|||
156640140|NCT02268045|565428145|FG000|Overall Study|Death|4|||
156640141|NCT02268045|565428146|FG001|Overall Study|Death|4|||
156640142|NCT02268045|565428145|FG000|Overall Study|Disease Progression|2|||
156640143|NCT02268045|565428146|FG001|Overall Study|Disease Progression|1|||
156640144|NCT02268045|565428145|FG000|Overall Study|Adverse Event|7|||
156640145|NCT02268045|565428146|FG001|Overall Study|Adverse Event|7|||
156640146|NCT02268045|565428145|FG000|Overall Study|Withdrawal by Subject|2|||
156640147|NCT02268045|565428146|FG001|Overall Study|Withdrawal by Subject|6|||
156640148|NCT02268045|565428145|FG000|Overall Study|Physician Decision|0|||
156640149|NCT02268045|565428146|FG001|Overall Study|Physician Decision|1|||
156640150|NCT02268045|565428145|FG000|Overall Study|Protocol Violation|1|||
156640151|NCT02268045|565428146|FG001|Overall Study|Protocol Violation|1|||
156640152|NCT03151707|565428149|FG000|Overall Study|Lost to Follow-up|6|||
156640153|NCT02125734|565428151|FG000|Period 2|Adverse Event|0|||
156640154|NCT02125734|565428152|FG001|Period 2|Adverse Event|1|||
156640155|NCT01308762|565428153|FG000|Overall Study|Protocol Violation|0|||
156640156|NCT01308762|565428154|FG001|Overall Study|Protocol Violation|1|||
156640157|NCT01308762|565428155|FG002|Overall Study|Protocol Violation|0|||
156640158|NCT02617446|565428156|FG000|Overall Study|Withdrawal by Subject|0|||
156640159|NCT02617446|565428157|FG001|Overall Study|Withdrawal by Subject|2|||
156640160|NCT02617446|565428158|FG002|Overall Study|Withdrawal by Subject|0|||
156640161|NCT02617446|565428156|FG000|Overall Study|Adverse Event|1|||
156640162|NCT02617446|565428157|FG001|Overall Study|Adverse Event|0|||
156640163|NCT02617446|565428158|FG002|Overall Study|Adverse Event|5|||
156640164|NCT02617446|565428156|FG000|Overall Study|Lost to Follow-up|3|||
156640165|NCT02617446|565428157|FG001|Overall Study|Lost to Follow-up|0|||
156640166|NCT02617446|565428158|FG002|Overall Study|Lost to Follow-up|0|||
156640167|NCT02617446|565428156|FG000|Overall Study|Death|0|||
156640168|NCT02617446|565428157|FG001|Overall Study|Death|0|||
156640169|NCT02617446|565428158|FG002|Overall Study|Death|2|||
156640170|NCT01556490|565428167|FG000|Randomized Patients Summary|Protocol Violation|22|||
156640171|NCT01556490|565428168|FG001|Randomized Patients Summary|Protocol Violation|23|||
156640172|NCT01556490|565428167|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
156640173|NCT01556490|565428168|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
156640174|NCT01652872|565428169|FG000|Overall Study|Death|36|||
156640175|NCT01652872|565428170|FG001|Overall Study|Death|39|||
156640176|NCT01652872|565428169|FG000|Overall Study|Lost to Follow-up|28|||
156640177|NCT01652872|565428170|FG001|Overall Study|Lost to Follow-up|23|||
156640178|NCT01652872|565428169|FG000|Overall Study|Decision by sponsor|5|||
156640179|NCT01652872|565428170|FG001|Overall Study|Decision by sponsor|7|||
156640180|NCT01652872|565428169|FG000|Overall Study|Withdrawal by Subject|76|||
156640181|NCT01652872|565428170|FG001|Overall Study|Withdrawal by Subject|84|||
156640182|NCT03985293|565428172|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
156640183|NCT03985293|565428173|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
156640184|NCT03985293|565428174|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
156640185|NCT03985293|565428175|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
156640186|NCT03985293|565428176|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
156640187|NCT03985293|565428177|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
156640188|NCT03985293|565428172|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
156640189|NCT03985293|565428173|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
156640190|NCT03985293|565428174|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
156640191|NCT03985293|565428175|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
156640192|NCT03985293|565428176|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
156640193|NCT03985293|565428177|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
156640194|NCT03985293|565428172|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
156640195|NCT03985293|565428173|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
156640196|NCT03985293|565428174|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
156640197|NCT03985293|565428175|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
156640198|NCT03985293|565428176|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
156640199|NCT03985293|565428177|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
156640200|NCT03985293|565428172|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
156640201|NCT03985293|565428173|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
156640202|NCT03985293|565428174|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
156640203|NCT03985293|565428175|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
156640204|NCT03985293|565428176|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
156640205|NCT03985293|565428177|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
156640206|NCT03985293|565428172|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
156640207|NCT03985293|565428173|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
156640208|NCT03985293|565428174|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
156640209|NCT03985293|565428175|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
156640210|NCT03985293|565428176|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
156640211|NCT03985293|565428177|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
156640212|NCT03985293|565428172|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
156640213|NCT03985293|565428173|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
156640214|NCT03985293|565428174|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
156640215|NCT03985293|565428175|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
156640216|NCT03985293|565428176|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
156640217|NCT03985293|565428177|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
156640218|NCT03985293|565428172|FG000|FOLLOW-UP|Lost to Follow-up|0|||
156640219|NCT03985293|565428173|FG001|FOLLOW-UP|Lost to Follow-up|0|||
156640220|NCT03985293|565428174|FG002|FOLLOW-UP|Lost to Follow-up|1|||
156640221|NCT03985293|565428175|FG003|FOLLOW-UP|Lost to Follow-up|0|||
156640222|NCT03985293|565428176|FG004|FOLLOW-UP|Lost to Follow-up|0|||
156640223|NCT03985293|565428177|FG005|FOLLOW-UP|Lost to Follow-up|0|||
156640224|NCT06065176|565428178|FG000|Overall Study|Lost to Follow-up|11|||
156640225|NCT06065176|565428179|FG001|Overall Study|Lost to Follow-up|11|||
156640226|NCT06065176|565428180|FG002|Overall Study|Lost to Follow-up|10|||
156640227|NCT06065176|565428178|FG000|Overall Study|Withdrawal by Subject|1|||
156640228|NCT06065176|565428179|FG001|Overall Study|Withdrawal by Subject|1|||
156640229|NCT06065176|565428180|FG002|Overall Study|Withdrawal by Subject|2|||
156640230|NCT06065176|565428178|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
156640231|NCT06065176|565428179|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
156640232|NCT06065176|565428180|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
156640233|NCT02588651|565428181|FG000|Overall Study|Adverse Event|1|||
156640234|NCT02588651|565428181|FG000|Overall Study|Withdrawal by Subject|2|||
156640235|NCT02588651|565428181|FG000|Overall Study|Death|1|||
156640236|NCT02588651|565428181|FG000|Overall Study|Lack of Efficacy|13|||
156640237|NCT02588651|565428181|FG000|Overall Study|Lost to Follow-up|1|||
156640238|NCT02588651|565428181|FG000|Overall Study|Physician Decision|1|||
156640239|NCT02588651|565428181|FG000|Overall Study|Disease progression|2|||
156640240|NCT03078192|565428189|FG000|Overall Study|Withdrawal by Subject|2|||
156640241|NCT03078192|565428190|FG001|Overall Study|Withdrawal by Subject|1|||
156640242|NCT03078192|565428189|FG000|Overall Study|screen failure|0|||
156640243|NCT03078192|565428190|FG001|Overall Study|screen failure|3|||
156640244|NCT02873195|565428191|FG000|Overall Study|Ineligible|5|||
156640245|NCT02873195|565428192|FG001|Overall Study|Ineligible|0|||
156640246|NCT03107715|565428194|FG000|Overall Study|did not deliver at the home hospital|4|||
156640247|NCT03107715|565428195|FG001|Overall Study|did not deliver at the home hospital|6|||
156640248|NCT03107715|565428194|FG000|Overall Study|infant stillborn|0|||
156640249|NCT03107715|565428195|FG001|Overall Study|infant stillborn|1|||
156640250|NCT03560466|565428197|FG000|Overall Study|Adverse Event|1|||
156640251|NCT03560466|565428198|FG001|Overall Study|Adverse Event|2|||
156640252|NCT03560466|565428199|FG002|Overall Study|Adverse Event|0|||
156640253|NCT03560466|565428197|FG000|Overall Study|Poor Compliance to Protocol|0|||
156640254|NCT03560466|565428198|FG001|Overall Study|Poor Compliance to Protocol|2|||
156640255|NCT03560466|565428199|FG002|Overall Study|Poor Compliance to Protocol|0|||
156640256|NCT03560466|565428197|FG000|Overall Study|Other|6|||
156640257|NCT03560466|565428198|FG001|Overall Study|Other|8|||
156640258|NCT03560466|565428199|FG002|Overall Study|Other|1|||
156640259|NCT02437890|565430021|FG000|Overall Study|Non-compliance to study drug|0|||
156640260|NCT02437890|565430022|FG001|Overall Study|Non-compliance to study drug|1|||
156640261|NCT02437890|565430023|FG002|Overall Study|Non-compliance to study drug|0|||
156640262|NCT02437890|565430024|FG003|Overall Study|Non-compliance to study drug|0|||
156640263|NCT02437890|565430025|FG004|Overall Study|Non-compliance to study drug|1|||
156640264|NCT02437890|565430021|FG000|Overall Study|Sponsor's decision|1|||
156640265|NCT02437890|565430022|FG001|Overall Study|Sponsor's decision|1|||
156640266|NCT02437890|565430023|FG002|Overall Study|Sponsor's decision|4|||
156640267|NCT02437890|565430024|FG003|Overall Study|Sponsor's decision|0|||
156640268|NCT02437890|565430025|FG004|Overall Study|Sponsor's decision|2|||
156640269|NCT02437890|565430021|FG000|Overall Study|Physician Decision|0|||
156640270|NCT02437890|565430022|FG001|Overall Study|Physician Decision|0|||
156640271|NCT02437890|565430023|FG002|Overall Study|Physician Decision|0|||
156640272|NCT02437890|565430024|FG003|Overall Study|Physician Decision|1|||
156640273|NCT02437890|565430025|FG004|Overall Study|Physician Decision|0|||
156640274|NCT02437890|565430021|FG000|Overall Study|Unable to attend visit(s)|1|||
156640275|NCT02437890|565430022|FG001|Overall Study|Unable to attend visit(s)|0|||
156640276|NCT02437890|565430023|FG002|Overall Study|Unable to attend visit(s)|0|||
156640277|NCT02437890|565430024|FG003|Overall Study|Unable to attend visit(s)|0|||
156640278|NCT02437890|565430025|FG004|Overall Study|Unable to attend visit(s)|0|||
156640279|NCT02437890|565430021|FG000|Overall Study|Lack of Efficacy|1|||
156640280|NCT02437890|565430022|FG001|Overall Study|Lack of Efficacy|3|||
156640281|NCT02437890|565430023|FG002|Overall Study|Lack of Efficacy|0|||
156640282|NCT02437890|565430024|FG003|Overall Study|Lack of Efficacy|3|||
156640283|NCT02437890|565430025|FG004|Overall Study|Lack of Efficacy|1|||
156640284|NCT02437890|565430021|FG000|Overall Study|Adverse Event|4|||
156640285|NCT02437890|565430022|FG001|Overall Study|Adverse Event|9|||
156640286|NCT02437890|565430023|FG002|Overall Study|Adverse Event|5|||
156640287|NCT02437890|565430024|FG003|Overall Study|Adverse Event|11|||
156640288|NCT02437890|565430025|FG004|Overall Study|Adverse Event|7|||
156640289|NCT02437890|565430021|FG000|Overall Study|Withdrawal by Subject|1|||
156640290|NCT02437890|565430022|FG001|Overall Study|Withdrawal by Subject|2|||
156640291|NCT02437890|565430023|FG002|Overall Study|Withdrawal by Subject|6|||
156640292|NCT02437890|565430024|FG003|Overall Study|Withdrawal by Subject|5|||
156640293|NCT02437890|565430025|FG004|Overall Study|Withdrawal by Subject|5|||
156640294|NCT02437890|565430021|FG000|Overall Study|Death|0|||
156640295|NCT02437890|565430022|FG001|Overall Study|Death|0|||
156640296|NCT02437890|565430023|FG002|Overall Study|Death|0|||
156640297|NCT02437890|565430024|FG003|Overall Study|Death|2|||
156640298|NCT02437890|565430025|FG004|Overall Study|Death|0|||
156640299|NCT01190098|565430026|FG000|Overall Study|Adverse Event|2|||
156640300|NCT01190098|565430027|FG001|Overall Study|Adverse Event|0|||
156640301|NCT01190098|565430026|FG000|Overall Study|Patient coomorbidity|0|||
156640302|NCT01190098|565430027|FG001|Overall Study|Patient coomorbidity|1|||
156640303|NCT01190098|565430026|FG000|Overall Study|Lack of transportation|1|||
156640304|NCT01190098|565430027|FG001|Overall Study|Lack of transportation|0|||
156640305|NCT01190098|565430026|FG000|Overall Study|Other|0|||
156640306|NCT01190098|565430027|FG001|Overall Study|Other|1|||
156640307|NCT01586624|565430036|FG000|Overall Study|Adverse Event|3|||
156640308|NCT01586624|565430037|FG001|Overall Study|Adverse Event|0|||
156640309|NCT01586624|565430038|FG002|Overall Study|Adverse Event|2|||
156640310|NCT01586624|565430039|FG003|Overall Study|Adverse Event|1|||
156640311|NCT01586624|565430040|FG004|Overall Study|Adverse Event|3|||
156640312|NCT01586624|565430041|FG005|Overall Study|Adverse Event|3|||
156640313|NCT01586624|565430042|FG006|Overall Study|Adverse Event|2|||
156640314|NCT01586624|565430043|FG007|Overall Study|Adverse Event|3|||
156640315|NCT01586624|565430036|FG000|Overall Study|Physician Decision|0|||
156640316|NCT01586624|565430037|FG001|Overall Study|Physician Decision|1|||
156640317|NCT01586624|565430038|FG002|Overall Study|Physician Decision|1|||
156640318|NCT01586624|565430039|FG003|Overall Study|Physician Decision|0|||
156640319|NCT01586624|565430040|FG004|Overall Study|Physician Decision|2|||
156640320|NCT01586624|565430041|FG005|Overall Study|Physician Decision|0|||
156640321|NCT01586624|565430042|FG006|Overall Study|Physician Decision|1|||
156640322|NCT01586624|565430043|FG007|Overall Study|Physician Decision|1|||
156640323|NCT01586624|565430036|FG000|Overall Study|Withdrawal by Subject|0|||
156640324|NCT01586624|565430037|FG001|Overall Study|Withdrawal by Subject|0|||
156640325|NCT01586624|565430038|FG002|Overall Study|Withdrawal by Subject|0|||
156640326|NCT01586624|565430039|FG003|Overall Study|Withdrawal by Subject|1|||
156640327|NCT01586624|565430040|FG004|Overall Study|Withdrawal by Subject|0|||
156640328|NCT01586624|565430041|FG005|Overall Study|Withdrawal by Subject|0|||
156640329|NCT01586624|565430042|FG006|Overall Study|Withdrawal by Subject|0|||
156640330|NCT01586624|565430043|FG007|Overall Study|Withdrawal by Subject|0|||
156640331|NCT01586624|565430036|FG000|Overall Study|Evidence of disease progression|1|||
156640332|NCT01586624|565430037|FG001|Overall Study|Evidence of disease progression|3|||
156640333|NCT01586624|565430038|FG002|Overall Study|Evidence of disease progression|2|||
156640334|NCT01586624|565430039|FG003|Overall Study|Evidence of disease progression|5|||
156640335|NCT01586624|565430040|FG004|Overall Study|Evidence of disease progression|3|||
156640336|NCT01586624|565430041|FG005|Overall Study|Evidence of disease progression|5|||
156640337|NCT01586624|565430042|FG006|Overall Study|Evidence of disease progression|4|||
156640338|NCT01586624|565430043|FG007|Overall Study|Evidence of disease progression|6|||
156640339|NCT01586624|565430036|FG000|Overall Study|Screen failure (no treatment received)|0|||
156640340|NCT01586624|565430037|FG001|Overall Study|Screen failure (no treatment received)|0|||
156640341|NCT01586624|565430038|FG002|Overall Study|Screen failure (no treatment received)|0|||
156640342|NCT01586624|565430039|FG003|Overall Study|Screen failure (no treatment received)|0|||
156640343|NCT01586624|565430040|FG004|Overall Study|Screen failure (no treatment received)|0|||
156640344|NCT01586624|565430041|FG005|Overall Study|Screen failure (no treatment received)|0|||
156640345|NCT01586624|565430042|FG006|Overall Study|Screen failure (no treatment received)|1|||
156640346|NCT01586624|565430043|FG007|Overall Study|Screen failure (no treatment received)|0|||
156640347|NCT01160198|565430048|FG000|Overall Study|Withdrawal by Subject|2|||
156640348|NCT01160198|565430049|FG001|Overall Study|Withdrawal by Subject|1|||
156640349|NCT01160198|565430050|FG002|Overall Study|Withdrawal by Subject|0|||
156640350|NCT01160198|565430048|FG000|Overall Study|Adverse Event|0|||
156640351|NCT01160198|565430049|FG001|Overall Study|Adverse Event|1|||
156640352|NCT01160198|565430050|FG002|Overall Study|Adverse Event|0|||
156640353|NCT01160198|565430048|FG000|Overall Study|Lost to Follow-up|0|||
156640354|NCT01160198|565430049|FG001|Overall Study|Lost to Follow-up|1|||
156640355|NCT01160198|565430050|FG002|Overall Study|Lost to Follow-up|0|||
156640356|NCT01160198|565430048|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
156640357|NCT01160198|565430049|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
156640358|NCT01160198|565430050|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
156640359|NCT01796860|565430051|FG000|Overall Study|Withdrawal by Subject|3|||
156640360|NCT01408576|565430052|FG000|Overall Study|Lack of Efficacy|17|||
156640361|NCT01408576|565430053|FG001|Overall Study|Lack of Efficacy|30|||
156640362|NCT01408576|565430054|FG002|Overall Study|Lack of Efficacy|48|||
156640363|NCT01408576|565430052|FG000|Overall Study|Protocol Violation|1|||
156640364|NCT01408576|565430053|FG001|Overall Study|Protocol Violation|2|||
156640365|NCT01408576|565430054|FG002|Overall Study|Protocol Violation|2|||
156640366|NCT01408576|565430052|FG000|Overall Study|Lost to Follow-up|10|||
156640367|NCT01408576|565430053|FG001|Overall Study|Lost to Follow-up|9|||
156640368|NCT01408576|565430054|FG002|Overall Study|Lost to Follow-up|17|||
156640369|NCT01408576|565430052|FG000|Overall Study|Withdrawal by Subject|34|||
156640370|NCT01408576|565430053|FG001|Overall Study|Withdrawal by Subject|60|||
156640371|NCT01408576|565430054|FG002|Overall Study|Withdrawal by Subject|66|||
156640372|NCT01408576|565430052|FG000|Overall Study|Sponsor terminated study|89|||
156640373|NCT01408576|565430053|FG001|Overall Study|Sponsor terminated study|333|||
156640374|NCT01408576|565430054|FG002|Overall Study|Sponsor terminated study|330|||
156640375|NCT01408576|565430052|FG000|Overall Study|AE, serious fatal|4|||
156640376|NCT01408576|565430053|FG001|Overall Study|AE, serious fatal|4|||
156640377|NCT01408576|565430054|FG002|Overall Study|AE, serious fatal|1|||
156640378|NCT01408576|565430052|FG000|Overall Study|SAE, non-fatal|11|||
156640379|NCT01408576|565430053|FG001|Overall Study|SAE, non-fatal|23|||
156640380|NCT01408576|565430054|FG002|Overall Study|SAE, non-fatal|14|||
156640381|NCT01408576|565430052|FG000|Overall Study|AE, non-serious non-fatal|12|||
156640382|NCT01408576|565430053|FG001|Overall Study|AE, non-serious non-fatal|19|||
156640383|NCT01408576|565430054|FG002|Overall Study|AE, non-serious non-fatal|11|||
156640384|NCT01408576|565430052|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156640385|NCT01408576|565430053|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156640386|NCT01408576|565430054|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156640387|NCT01408576|565430052|FG000|Overall Study|AE, unknown type|0|||
156640388|NCT01408576|565430053|FG001|Overall Study|AE, unknown type|1|||
156640389|NCT01408576|565430054|FG002|Overall Study|AE, unknown type|0|||
156640390|NCT01408576|565430052|FG000|Overall Study|Other|10|||
156640391|NCT01408576|565430053|FG001|Overall Study|Other|16|||
156640392|NCT01408576|565430054|FG002|Overall Study|Other|18|||
156640393|NCT00802529|565430055|FG000|Overall Study|Lost to Follow-up|0|||
156640394|NCT00802529|565430056|FG001|Overall Study|Lost to Follow-up|1|||
156640395|NCT02476851|565430057|FG000|Overall Study|Protocol Violation|1|||
156640396|NCT02476851|565430058|FG001|Overall Study|Protocol Violation|1|||
156640397|NCT00337129|565430059|FG000|Overall Study|Adverse Event|4|||
156640398|NCT00337129|565430059|FG000|Overall Study|Withdrawal by Subject|1|||
156640399|NCT00337129|565430059|FG000|Overall Study|Lack of Efficacy|32|||
156640400|NCT00337129|565430059|FG000|Overall Study|Death|2|||
156640401|NCT00337129|565430059|FG000|Overall Study|not protocol specified|1|||
156640402|NCT00647426|565430060|FG000|Overall Study|Withdrawal by Subject|2|||
156640403|NCT01508325|565430066|FG000|Overall Study|Withdrawal by Subject|8|||
156640404|NCT01508325|565430067|FG001|Overall Study|Withdrawal by Subject|9|||
156640405|NCT01508325|565430066|FG000|Overall Study|Protocol Violation|0|||
156640406|NCT01508325|565430067|FG001|Overall Study|Protocol Violation|3|||
156640407|NCT01508325|565430066|FG000|Overall Study|Physician Decision|2|||
156640408|NCT01508325|565430067|FG001|Overall Study|Physician Decision|1|||
156640409|NCT01508325|565430066|FG000|Overall Study|Adverse Event|1|||
156640410|NCT01508325|565430067|FG001|Overall Study|Adverse Event|0|||
156640411|NCT01508325|565430066|FG000|Overall Study|Lost to Follow-up|5|||
156640412|NCT01508325|565430067|FG001|Overall Study|Lost to Follow-up|6|||
156640413|NCT01508325|565430066|FG000|Overall Study|Other|2|||
156640414|NCT01508325|565430067|FG001|Overall Study|Other|2|||
156640415|NCT03543046|565430073|FG000|Overall Study|Adverse Event|1|||
156640416|NCT03543046|565430074|FG001|Overall Study|Adverse Event|1|||
156640417|NCT03543046|565430073|FG000|Overall Study|Physician Decision|1|||
156640418|NCT03543046|565430074|FG001|Overall Study|Physician Decision|1|||
156640419|NCT03543046|565430073|FG000|Overall Study|Protocol Violation|1|||
156640420|NCT03543046|565430074|FG001|Overall Study|Protocol Violation|0|||
156640421|NCT00520494|565430080|FG000|Overall Study|Withdrawal by Subject|1|||
156640422|NCT02748616|565430083|FG000|Overall Study|Lost to Follow-up|1|||
156640423|NCT02748616|565430083|FG000|Overall Study|Withdrawal by Subject|2|||
156640424|NCT02748616|565430083|FG000|Overall Study|Physician Decision|2|||
156640425|NCT02748616|565430083|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
156640426|NCT02018042|565430084|FG000|Overall Study|Withdrawal by Subject|1|||
156640427|NCT02419469|565430085|FG000|Overall Study|Withdrawal by Subject|1|||
156640428|NCT01414062|565430086|FG000|Overall Study|Lost to Follow-up|3|||
156640429|NCT01414062|565430087|FG001|Overall Study|Lost to Follow-up|2|||
156640430|NCT01414062|565430086|FG000|Overall Study|Left Country|1|||
156640431|NCT01414062|565430087|FG001|Overall Study|Left Country|1|||
156640432|NCT01414062|565430086|FG000|Overall Study|Family Disapproval|1|||
156640433|NCT01414062|565430087|FG001|Overall Study|Family Disapproval|0|||
156640434|NCT01414062|565430086|FG000|Overall Study|Withdrawal by Subject|0|||
156640435|NCT01414062|565430087|FG001|Overall Study|Withdrawal by Subject|1|||
156640436|NCT04075292|565430088|FG000|Overall Study|Withdrawal by Subject|1|||
156640437|NCT04075292|565430089|FG001|Overall Study|Withdrawal by Subject|9|||
156640438|NCT04075292|565430088|FG000|Overall Study|Death|2|||
156640439|NCT04075292|565430089|FG001|Overall Study|Death|5|||
156640440|NCT04075292|565430088|FG000|Overall Study|Remained on study at time of DCO|74|||
156640441|NCT04075292|565430089|FG001|Overall Study|Remained on study at time of DCO|64|||
156640442|NCT04285983|565430090|FG000|Overall Study|Protocol Violation|6|||
156640443|NCT00902265|565430093|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
156640444|NCT00902265|565430093|FG000|Overall Study|Adverse Event|2|||
156640445|NCT00902265|565430093|FG000|Overall Study|Lack of Efficacy|2|||
156640446|NCT00902265|565430093|FG000|Overall Study|Protocol Violation|1|||
156640447|NCT02866695|565430094|FG000|Overall Study|Adverse Event|1|||
156640448|NCT02866695|565430094|FG000|Overall Study|Lost to Follow-up|1|||
156640449|NCT05016765|565430095|FG000|Overall Study|Lost to Follow-up|4|||
156640450|NCT01447628|565430098|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
156640451|NCT01447628|565430099|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
156640452|NCT01447628|565430100|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
156640453|NCT01447628|565430101|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
156640454|NCT00185731|565430102|FG000|Overall Study|Withdrawal by Subject|1|||
156640455|NCT00185731|565430102|FG000|Overall Study|Not Eligible|1|||
156640456|NCT02494583|565430105|FG000|Overall Study|Death|224|||
156640457|NCT02494583|565430106|FG001|Overall Study|Death|214|||
156640458|NCT02494583|565430107|FG002|Overall Study|Death|225|||
156640459|NCT02494583|565430105|FG000|Overall Study|Lost to Follow-up|1|||
156640460|NCT02494583|565430106|FG001|Overall Study|Lost to Follow-up|0|||
156640461|NCT02494583|565430107|FG002|Overall Study|Lost to Follow-up|0|||
156640462|NCT02494583|565430105|FG000|Overall Study|Protocol Violation|1|||
156640463|NCT02494583|565430106|FG001|Overall Study|Protocol Violation|2|||
156640464|NCT02494583|565430107|FG002|Overall Study|Protocol Violation|0|||
156640465|NCT02494583|565430105|FG000|Overall Study|Screen Failure|0|||
156640466|NCT02494583|565430106|FG001|Overall Study|Screen Failure|1|||
156640467|NCT02494583|565430107|FG002|Overall Study|Screen Failure|0|||
156640468|NCT02494583|565430105|FG000|Overall Study|Transferred to Extension Study|15|||
156640469|NCT02494583|565430106|FG001|Overall Study|Transferred to Extension Study|15|||
156640470|NCT02494583|565430107|FG002|Overall Study|Transferred to Extension Study|6|||
156640471|NCT02494583|565430105|FG000|Overall Study|Did Not Continue on Extension Study|8|||
156640472|NCT02494583|565430106|FG001|Overall Study|Did Not Continue on Extension Study|10|||
156640473|NCT02494583|565430107|FG002|Overall Study|Did Not Continue on Extension Study|4|||
156640474|NCT02494583|565430105|FG000|Overall Study|Withdrawal by Subject|7|||
156640475|NCT02494583|565430106|FG001|Overall Study|Withdrawal by Subject|15|||
156640476|NCT02494583|565430107|FG002|Overall Study|Withdrawal by Subject|15|||
156640477|NCT05144477|565430108|FG000|Overall Study|Withdrawal by Subject|1|||
156640478|NCT05144477|565430109|FG001|Overall Study|Withdrawal by Subject|1|||
156640479|NCT00627458|565430112|FG000|Overall Study|Migrated from study area|1|||
156640480|NCT00627458|565430113|FG001|Overall Study|Migrated from study area|0|||
156640481|NCT00627458|565430114|FG002|Overall Study|Migrated from study area|1|||
156640482|NCT00627458|565430112|FG000|Overall Study|Withdrawal by Subject|2|||
156640483|NCT00627458|565430113|FG001|Overall Study|Withdrawal by Subject|6|||
156640484|NCT00627458|565430114|FG002|Overall Study|Withdrawal by Subject|5|||
156640485|NCT00627458|565430112|FG000|Overall Study|Lost to Follow-up|1|||
156640486|NCT00627458|565430113|FG001|Overall Study|Lost to Follow-up|1|||
156640487|NCT00627458|565430114|FG002|Overall Study|Lost to Follow-up|0|||
156640488|NCT03891875|565430115|FG000|Overall Study|Withdrawal by Subject|20|||
156640489|NCT03891875|565430116|FG001|Overall Study|Withdrawal by Subject|3|||
156640490|NCT03891875|565430115|FG000|Overall Study|Adverse Event|10|||
156640491|NCT03891875|565430116|FG001|Overall Study|Adverse Event|4|||
156640492|NCT03891875|565430115|FG000|Overall Study|Physician Decision|1|||
156640493|NCT03891875|565430116|FG001|Overall Study|Physician Decision|1|||
156640494|NCT03891875|565430115|FG000|Overall Study|Protocol Violation|1|||
156640495|NCT03891875|565430116|FG001|Overall Study|Protocol Violation|0|||
156640496|NCT03891875|565430115|FG000|Overall Study|Lost to Follow-up|1|||
156640497|NCT03891875|565430116|FG001|Overall Study|Lost to Follow-up|0|||
156640498|NCT03891875|565430115|FG000|Overall Study|COVID-19 infection|1|||
156640499|NCT03891875|565430116|FG001|Overall Study|COVID-19 infection|0|||
156640500|NCT01787188|565430117|FG000|Overall Study|Adverse Event|2|||
156640501|NCT01787188|565430118|FG001|Overall Study|Adverse Event|4|||
156640502|NCT01787188|565430119|FG002|Overall Study|Adverse Event|6|||
156640503|NCT01787188|565430117|FG000|Overall Study|Lack of Efficacy|7|||
156640504|NCT01787188|565430118|FG001|Overall Study|Lack of Efficacy|3|||
156640505|NCT01787188|565430119|FG002|Overall Study|Lack of Efficacy|5|||
156640506|NCT01787188|565430117|FG000|Overall Study|Non-compliance with Study Drug|0|||
156640507|NCT01787188|565430118|FG001|Overall Study|Non-compliance with Study Drug|1|||
156640508|NCT01787188|565430119|FG002|Overall Study|Non-compliance with Study Drug|0|||
156640509|NCT01787188|565430117|FG000|Overall Study|Withdrawal by Subject|4|||
156640510|NCT01787188|565430118|FG001|Overall Study|Withdrawal by Subject|3|||
156640511|NCT01787188|565430119|FG002|Overall Study|Withdrawal by Subject|2|||
156640512|NCT01787188|565430117|FG000|Overall Study|Protocol Violation|3|||
156640513|NCT01787188|565430118|FG001|Overall Study|Protocol Violation|2|||
156640514|NCT01787188|565430119|FG002|Overall Study|Protocol Violation|3|||
156640515|NCT01787188|565430117|FG000|Overall Study|Lost to Follow-up|1|||
156640516|NCT01787188|565430118|FG001|Overall Study|Lost to Follow-up|2|||
156640517|NCT01787188|565430119|FG002|Overall Study|Lost to Follow-up|2|||
156640518|NCT01787188|565430117|FG000|Overall Study|Other, including patient moved|0|||
156640519|NCT01787188|565430118|FG001|Overall Study|Other, including patient moved|3|||
156640520|NCT01787188|565430119|FG002|Overall Study|Other, including patient moved|0|||
156640521|NCT00854607|565430120|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
156640522|NCT00965263|565430128|FG000|Overall Study|Physician Decision|2|||
156640523|NCT00965263|565430129|FG001|Overall Study|Physician Decision|0|||
156640524|NCT00965263|565430128|FG000|Overall Study|Family emergency|0|||
156640525|NCT00965263|565430129|FG001|Overall Study|Family emergency|1|||
156640526|NCT00965263|565430128|FG000|Overall Study|Protocol Violation|0|||
156640527|NCT00965263|565430129|FG001|Overall Study|Protocol Violation|2|||
156640528|NCT02756078|565430130|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
156640529|NCT02756078|565430131|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
156640530|NCT02756078|565430130|FG000|Period 1|Lost to Follow-up|0|||
156640531|NCT02756078|565430131|FG001|Period 1|Lost to Follow-up|2|||
156640532|NCT02756078|565430130|FG000|Period 1|Protocol Violation|0|||
156640533|NCT02756078|565430131|FG001|Period 1|Protocol Violation|1|||
156640534|NCT02756078|565430130|FG000|Period 1|Adverse Event|1|||
156640535|NCT02756078|565430131|FG001|Period 1|Adverse Event|10|||
156640536|NCT02756078|565430130|FG000|Period 1|Withdrawal by Subject|6|||
156640537|NCT02756078|565430131|FG001|Period 1|Withdrawal by Subject|6|||
156640538|NCT02756078|565430130|FG000|Period 1|Lens Discomfort|2|||
156640539|NCT02756078|565430131|FG001|Period 1|Lens Discomfort|2|||
156640540|NCT02756078|565430130|FG000|Period 2|Adverse Event|3|||
156640541|NCT02756078|565430131|FG001|Period 2|Adverse Event|5|||
156640542|NCT02756078|565430130|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
156640543|NCT02756078|565430131|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
156640544|NCT02756078|565430130|FG000|Period 2|Withdrawal by Subject|3|||
156640545|NCT02756078|565430131|FG001|Period 2|Withdrawal by Subject|1|||
156640546|NCT01591499|565430132|FG000|Baseline Visit|Withdrawal by Subject|0|||
156640547|NCT01591499|565430133|FG001|Baseline Visit|Withdrawal by Subject|2|||
156640548|NCT01591499|565430134|FG002|Baseline Visit|Withdrawal by Subject|0|||
156640549|NCT01591499|565430135|FG003|Baseline Visit|Withdrawal by Subject|2|||
156640550|NCT01591499|565430132|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
156640551|NCT01591499|565430133|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
156640552|NCT01591499|565430134|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
156640553|NCT01591499|565430135|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
156640554|NCT01591499|565430132|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
156640555|NCT01591499|565430133|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
156640556|NCT01591499|565430134|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
156640557|NCT01591499|565430135|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
156640558|NCT00646282|565430136|FG000|Overall Study|Protocol terminated|4|||
156640559|NCT00646282|565430137|FG001|Overall Study|Protocol terminated|4|||
156640560|NCT00530088|565430138|FG000|Overall Study|Disease Progression|4|||
156640561|NCT00530088|565430138|FG000|Overall Study|Physician Decision|4|||
156640562|NCT00530088|565430138|FG000|Overall Study|Other Not Specified|2|||
156640563|NCT02058368|565430142|FG000|Overall Study|Adverse Event|15|||
156640564|NCT02058368|565430143|FG001|Overall Study|Adverse Event|20|||
156640565|NCT02058368|565430142|FG000|Overall Study|Lack of Efficacy|0|||
156640566|NCT02058368|565430143|FG001|Overall Study|Lack of Efficacy|1|||
156640567|NCT02058368|565430142|FG000|Overall Study|Protocol Violation|0|||
156640568|NCT02058368|565430143|FG001|Overall Study|Protocol Violation|4|||
156640569|NCT02058368|565430142|FG000|Overall Study|Lost to Follow-up|2|||
156640570|NCT02058368|565430143|FG001|Overall Study|Lost to Follow-up|0|||
156640571|NCT02058368|565430142|FG000|Overall Study|Physician Decision|2|||
156640572|NCT02058368|565430143|FG001|Overall Study|Physician Decision|3|||
156640573|NCT02058368|565430142|FG000|Overall Study|Withdrawal by Subject|22|||
156640574|NCT02058368|565430143|FG001|Overall Study|Withdrawal by Subject|26|||
156640575|NCT02181842|565430145|FG000|Overall Study|Case Report Forms Uncollected|2|||
156640576|NCT00758706|565430146|FG000|Overall Study|Adverse Event|4|||
156640577|NCT00758706|565430147|FG001|Overall Study|Adverse Event|4|||
156640578|NCT05899218|565430161|FG000|Overall Study|Lost to Follow-up|2|||
156640579|NCT05899218|565430162|FG001|Overall Study|Lost to Follow-up|2|||
156640580|NCT05899218|565430161|FG000|Overall Study|deemed ineligible out of country|1|||
156640581|NCT05899218|565430162|FG001|Overall Study|deemed ineligible out of country|0|||
156640582|NCT02587325|565430163|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
156640583|NCT02587325|565430164|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
156640584|NCT02587325|565430165|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
156640585|NCT02587325|565430166|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
156640586|NCT02587325|565430167|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
156640587|NCT02587325|565430163|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
156640588|NCT02587325|565430164|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
156640589|NCT02587325|565430165|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
156640590|NCT02587325|565430166|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
156640591|NCT02587325|565430167|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
156640592|NCT02587325|565430163|FG000|32-Week Optional Extension Part|Adverse Event|0|||
156640593|NCT02587325|565430164|FG001|32-Week Optional Extension Part|Adverse Event|0|||
156640594|NCT02587325|565430165|FG002|32-Week Optional Extension Part|Adverse Event|1|||
156640595|NCT02587325|565430166|FG003|32-Week Optional Extension Part|Adverse Event|0|||
156640596|NCT02587325|565430167|FG004|32-Week Optional Extension Part|Adverse Event|0|||
156640597|NCT02587325|565430163|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
156640598|NCT02587325|565430164|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
156640599|NCT02587325|565430165|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
156640600|NCT02587325|565430166|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
156640601|NCT02587325|565430167|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
156640602|NCT00390572|565430168|FG000|Overall Study|Lost to Follow-up|8|||
156640603|NCT00390572|565430169|FG001|Overall Study|Lost to Follow-up|4|||
156640604|NCT00390572|565430168|FG000|Overall Study|health condition|0|||
156640605|NCT00390572|565430169|FG001|Overall Study|health condition|1|||
156640606|NCT00314262|565430201|FG000|Overall Study|Adverse Event|2|||
156640607|NCT00314262|565430201|FG000|Overall Study|Withdrawal by Subject|2|||
156640608|NCT00314262|565430201|FG000|Overall Study|Physician Decision|1|||
156640609|NCT02787746|565430202|FG000|Overall Study|Adverse Event|42|||
156640610|NCT02787746|565430202|FG000|Overall Study|Withdrawal by Subject|65|||
156640611|NCT02787746|565430202|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
156640612|NCT01142466|565432762|FG000|Overall Study|Adverse Event|2|||
156640613|NCT01142466|565432763|FG001|Overall Study|Adverse Event|1|||
156640614|NCT01142466|565432762|FG000|Overall Study|Withdrawal by Subject|1|||
156640615|NCT01142466|565432763|FG001|Overall Study|Withdrawal by Subject|1|||
156640616|NCT00700310|565432768|FG000|Overall Study|Adverse Event|6|||
156640617|NCT00700310|565432769|FG001|Overall Study|Adverse Event|10|||
156640618|NCT00700310|565432770|FG002|Overall Study|Adverse Event|5|||
156640619|NCT00700310|565432771|FG003|Overall Study|Adverse Event|11|||
156640620|NCT00700310|565432768|FG000|Overall Study|Lost to Follow-up|4|||
156640621|NCT00700310|565432769|FG001|Overall Study|Lost to Follow-up|1|||
156640622|NCT00700310|565432770|FG002|Overall Study|Lost to Follow-up|0|||
156640623|NCT00700310|565432771|FG003|Overall Study|Lost to Follow-up|1|||
156640624|NCT00700310|565432768|FG000|Overall Study|Withdrawal by Subject|8|||
156640625|NCT00700310|565432769|FG001|Overall Study|Withdrawal by Subject|9|||
156640626|NCT00700310|565432770|FG002|Overall Study|Withdrawal by Subject|8|||
156640627|NCT00700310|565432771|FG003|Overall Study|Withdrawal by Subject|8|||
156640628|NCT00700310|565432768|FG000|Overall Study|Lack of Efficacy|0|||
156640629|NCT00700310|565432769|FG001|Overall Study|Lack of Efficacy|3|||
156411740|NCT01089556|564601383|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
156640630|NCT00700310|565432770|FG002|Overall Study|Lack of Efficacy|0|||
156640631|NCT00700310|565432771|FG003|Overall Study|Lack of Efficacy|1|||
156640632|NCT00700310|565432768|FG000|Overall Study|Administrative/Other|1|||
156640633|NCT00700310|565432769|FG001|Overall Study|Administrative/Other|3|||
156640634|NCT00700310|565432770|FG002|Overall Study|Administrative/Other|1|||
156640635|NCT00700310|565432771|FG003|Overall Study|Administrative/Other|3|||
156640636|NCT00700310|565432768|FG000|Overall Study|Randomized, Not Treated|2|||
156640637|NCT00700310|565432769|FG001|Overall Study|Randomized, Not Treated|0|||
156411741|NCT01089556|564601384|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
156640638|NCT00700310|565432770|FG002|Overall Study|Randomized, Not Treated|2|||
156640639|NCT00700310|565432771|FG003|Overall Study|Randomized, Not Treated|2|||
156640640|NCT02414854|565432772|FG000|Overall Study|Adverse Event|9|||
156640641|NCT02414854|565432773|FG001|Overall Study|Adverse Event|7|||
156640642|NCT02414854|565432774|FG002|Overall Study|Adverse Event|1|||
156640643|NCT02414854|565432775|FG003|Overall Study|Adverse Event|12|||
156640644|NCT02414854|565432772|FG000|Overall Study|Poor compliance to protocol|1|||
156640645|NCT02414854|565432773|FG001|Overall Study|Poor compliance to protocol|1|||
156640646|NCT02414854|565432774|FG002|Overall Study|Poor compliance to protocol|2|||
156640647|NCT02414854|565432775|FG003|Overall Study|Poor compliance to protocol|2|||
156640648|NCT02414854|565432772|FG000|Overall Study|Other than specified above|12|||
156640649|NCT02414854|565432773|FG001|Overall Study|Other than specified above|37|||
156640650|NCT02414854|565432774|FG002|Overall Study|Other than specified above|17|||
156640651|NCT02414854|565432775|FG003|Overall Study|Other than specified above|37|||
156640652|NCT01422720|565432776|FG000|Overall Study|Adverse Event|16|||
156640653|NCT01422720|565432776|FG000|Overall Study|Lack of Efficacy|1|||
156640654|NCT01422720|565432776|FG000|Overall Study|Withdrawal by Subject|4|||
156640655|NCT01422720|565432776|FG000|Overall Study|Ineligibility|1|||
156640656|NCT00606801|565432777|FG000|Intervention|Protocol Violation|3|||
156640657|NCT00606801|565432778|FG001|Intervention|Protocol Violation|3|||
156640658|NCT02082262|565432779|FG000|Overall Study|Withdrawal by Subject|3|||
156640659|NCT02082262|565432779|FG000|Overall Study|Adverse Event|48|||
156640660|NCT01726335|565432780|FG000|Overall Study|Lost to Follow-up|2|||
156640661|NCT01726335|565432780|FG000|Overall Study|Withdrawal by Subject|15|||
156640662|NCT01726335|565432780|FG000|Overall Study|Adverse Event|4|||
156640663|NCT01726335|565432780|FG000|Overall Study|Lost to Follow-up|2|||
156640664|NCT01726335|565432780|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
156640665|NCT01074307|565432784|FG000|Overall Study|No primary endpoint evaluation|14|||
156640666|NCT01074307|565432785|FG001|Overall Study|No primary endpoint evaluation|6|||
156640667|NCT01074307|565432784|FG000|Overall Study|Exclusion criterion|0|||
156640668|NCT01074307|565432785|FG001|Overall Study|Exclusion criterion|1|||
156640669|NCT01074307|565432784|FG000|Overall Study|Protocol Violation|8|||
156640670|NCT01074307|565432785|FG001|Overall Study|Protocol Violation|5|||
156640671|NCT02162511|565432790|FG000|Overall Study|Lack of Efficacy|0|||
156640672|NCT02162511|565432791|FG001|Overall Study|Lack of Efficacy|0|||
156640673|NCT02162511|565432792|FG002|Overall Study|Lack of Efficacy|2|||
156640674|NCT02016755|565432797|FG000|Overall Study|Major amputation of index limb|2|||
156640675|NCT02016755|565432797|FG000|Overall Study|Adverse Event|2|||
156640676|NCT02016755|565432797|FG000|Overall Study|Physician Decision|1|||
156640677|NCT02016755|565432797|FG000|Overall Study|Death|2|||
156640678|NCT00552617|565432798|FG000|Overall Study|Not Treated|0|||
156640679|NCT00552617|565432799|FG001|Overall Study|Not Treated|0|||
156640680|NCT00552617|565432800|FG002|Overall Study|Not Treated|1|||
156640681|NCT00552617|565432801|FG003|Overall Study|Not Treated|0|||
156640682|NCT00552617|565432802|FG004|Overall Study|Not Treated|0|||
156640683|NCT00552617|565432803|FG005|Overall Study|Not Treated|0|||
156640684|NCT00552617|565432804|FG006|Overall Study|Not Treated|0|||
156640685|NCT00552617|565432805|FG007|Overall Study|Not Treated|0|||
156640686|NCT00552617|565432806|FG008|Overall Study|Not Treated|0|||
156640687|NCT00552617|565432807|FG009|Overall Study|Not Treated|1|||
156640688|NCT00552617|565432798|FG000|Overall Study|Lost to Follow-up|0|||
156640689|NCT00552617|565432799|FG001|Overall Study|Lost to Follow-up|0|||
156640690|NCT00552617|565432800|FG002|Overall Study|Lost to Follow-up|0|||
156640691|NCT00552617|565432801|FG003|Overall Study|Lost to Follow-up|1|||
156640692|NCT00552617|565432802|FG004|Overall Study|Lost to Follow-up|0|||
156640693|NCT00552617|565432803|FG005|Overall Study|Lost to Follow-up|2|||
156640694|NCT00552617|565432804|FG006|Overall Study|Lost to Follow-up|0|||
156640695|NCT00552617|565432805|FG007|Overall Study|Lost to Follow-up|0|||
156640696|NCT00552617|565432806|FG008|Overall Study|Lost to Follow-up|2|||
156640697|NCT00552617|565432807|FG009|Overall Study|Lost to Follow-up|0|||
156640698|NCT04651218|565432808|FG000|Overall Study|Withdrawal by Subject|0|||
156640699|NCT04651218|565432809|FG001|Overall Study|Withdrawal by Subject|2|||
156640700|NCT01084603|565432819|FG000|Baseline|Withdrawal by Subject|2|||
156640701|NCT01084603|565432819|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
156640702|NCT01084603|565432819|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
156640703|NCT01084603|565432819|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
156640704|NCT01084603|565432819|FG000|Washout Period 4|Adverse Event|1|||
156640705|NCT01392170|565432821|FG000|Overall Study|Withdrawal by Subject|1|||
156640706|NCT01392170|565432821|FG000|Overall Study|Ineligible|1|||
156640707|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
156640708|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
156640709|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
156640710|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
156640711|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
156640712|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
156640713|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
156640714|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
156640715|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
156640716|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
156640717|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
156640718|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
156640719|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
156640720|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
156640721|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
156640722|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
156640723|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
156640724|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
156640725|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
156640726|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
156640727|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
156640728|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
156640729|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
156640730|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
156640731|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
156640732|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
156640733|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
156640734|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
156640735|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
156640736|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
156640737|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
156640738|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
156640739|NCT03747939|565432828|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
156640740|NCT03747939|565432829|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
156640741|NCT03747939|565432830|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
156640742|NCT03747939|565432831|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
156640743|NCT03747939|565432828|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
156640744|NCT03747939|565432829|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
156640745|NCT03747939|565432830|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
156640746|NCT03747939|565432831|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
156640747|NCT03747939|565432828|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
156640748|NCT03747939|565432829|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
156640749|NCT03747939|565432830|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
156640750|NCT03747939|565432831|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
156640751|NCT03747939|565432828|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
156640752|NCT03747939|565432829|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
156640753|NCT03747939|565432830|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
156640754|NCT03747939|565432831|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
156640755|NCT03747939|565432828|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
156640756|NCT03747939|565432829|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
156640757|NCT03747939|565432830|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
156640758|NCT03747939|565432831|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
156640759|NCT03747939|565432828|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
156640760|NCT03747939|565432829|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
156640761|NCT03747939|565432830|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
156640762|NCT03747939|565432831|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
156640763|NCT03087773|565432832|FG000|Overall Study|Withdrawal by Subject|8|||
156640764|NCT03087773|565432833|FG001|Overall Study|Withdrawal by Subject|4|||
156640765|NCT03087773|565432832|FG000|Overall Study|Lost to Follow-up|12|||
156640766|NCT03087773|565432833|FG001|Overall Study|Lost to Follow-up|8|||
156640767|NCT03959137|565432836|FG000|Overall Study|Protocol Violation|6|||
156640768|NCT00810615|565432837|FG000|Overall Study|Withdrawal by Subject|1|||
156640769|NCT00810615|565432838|FG001|Overall Study|Withdrawal by Subject|1|||
156640770|NCT01766310|565432840|FG000|Overall Study|Lost to Follow-up|1|||
156640771|NCT01766310|565432841|FG001|Overall Study|Lost to Follow-up|3|||
156640772|NCT01289990|565432844|FG000|Overall Study|Death|0|||
156640773|NCT01289990|565432845|FG001|Overall Study|Death|0|||
156640774|NCT01289990|565432846|FG002|Overall Study|Death|0|||
156640775|NCT01289990|565432847|FG003|Overall Study|Death|1|||
156640776|NCT01289990|565432848|FG004|Overall Study|Death|2|||
156640777|NCT01289990|565432849|FG005|Overall Study|Death|1|||
156640778|NCT01289990|565432850|FG006|Overall Study|Death|0|||
156640779|NCT01289990|565432851|FG007|Overall Study|Death|0|||
156640780|NCT01289990|565432852|FG008|Overall Study|Death|0|||
156640781|NCT01289990|565432853|FG009|Overall Study|Death|0|||
156640782|NCT01289990|565432854|FG010|Overall Study|Death|0|||
156640783|NCT01289990|565432855|FG011|Overall Study|Death|1|||
156640784|NCT01289990|565432856|FG012|Overall Study|Death|0|||
156640785|NCT01289990|565432844|FG000|Overall Study|Lost to Follow-up|3|||
156640786|NCT01289990|565432845|FG001|Overall Study|Lost to Follow-up|2|||
156640787|NCT01289990|565432846|FG002|Overall Study|Lost to Follow-up|5|||
156640788|NCT01289990|565432847|FG003|Overall Study|Lost to Follow-up|5|||
156640789|NCT01289990|565432848|FG004|Overall Study|Lost to Follow-up|3|||
156640790|NCT01289990|565432849|FG005|Overall Study|Lost to Follow-up|4|||
156640791|NCT01289990|565432850|FG006|Overall Study|Lost to Follow-up|2|||
156640792|NCT01289990|565432851|FG007|Overall Study|Lost to Follow-up|2|||
156640793|NCT01289990|565432852|FG008|Overall Study|Lost to Follow-up|1|||
156640794|NCT01289990|565432853|FG009|Overall Study|Lost to Follow-up|4|||
156640795|NCT01289990|565432854|FG010|Overall Study|Lost to Follow-up|2|||
156640796|NCT01289990|565432855|FG011|Overall Study|Lost to Follow-up|1|||
156640797|NCT01289990|565432856|FG012|Overall Study|Lost to Follow-up|2|||
156640798|NCT01289990|565432844|FG000|Overall Study|Withdrawal by Subject|15|||
156640799|NCT01289990|565432845|FG001|Overall Study|Withdrawal by Subject|14|||
156640800|NCT01289990|565432846|FG002|Overall Study|Withdrawal by Subject|12|||
156640801|NCT01289990|565432847|FG003|Overall Study|Withdrawal by Subject|13|||
156640802|NCT01289990|565432848|FG004|Overall Study|Withdrawal by Subject|8|||
156640803|NCT01289990|565432849|FG005|Overall Study|Withdrawal by Subject|7|||
156640804|NCT01289990|565432850|FG006|Overall Study|Withdrawal by Subject|13|||
156640805|NCT01289990|565432851|FG007|Overall Study|Withdrawal by Subject|9|||
156640806|NCT01289990|565432852|FG008|Overall Study|Withdrawal by Subject|12|||
156640807|NCT01289990|565432853|FG009|Overall Study|Withdrawal by Subject|13|||
156640808|NCT01289990|565432854|FG010|Overall Study|Withdrawal by Subject|11|||
156640809|NCT01289990|565432855|FG011|Overall Study|Withdrawal by Subject|13|||
156640810|NCT01289990|565432856|FG012|Overall Study|Withdrawal by Subject|16|||
156640811|NCT01289990|565432844|FG000|Overall Study|discontinued in preceding trial|18|||
156640812|NCT01289990|565432845|FG001|Overall Study|discontinued in preceding trial|20|||
156640813|NCT01289990|565432846|FG002|Overall Study|discontinued in preceding trial|41|||
156640814|NCT01289990|565432847|FG003|Overall Study|discontinued in preceding trial|17|||
156640815|NCT01289990|565432848|FG004|Overall Study|discontinued in preceding trial|11|||
156640816|NCT01289990|565432849|FG005|Overall Study|discontinued in preceding trial|12|||
156640817|NCT01289990|565432850|FG006|Overall Study|discontinued in preceding trial|18|||
156640818|NCT01289990|565432851|FG007|Overall Study|discontinued in preceding trial|8|||
156640819|NCT01289990|565432852|FG008|Overall Study|discontinued in preceding trial|17|||
156640820|NCT01289990|565432853|FG009|Overall Study|discontinued in preceding trial|21|||
156640821|NCT01289990|565432854|FG010|Overall Study|discontinued in preceding trial|17|||
156640822|NCT01289990|565432855|FG011|Overall Study|discontinued in preceding trial|17|||
156640823|NCT01289990|565432856|FG012|Overall Study|discontinued in preceding trial|24|||
156640824|NCT01289990|565432844|FG000|Overall Study|did not continue in extension|41|||
156640825|NCT01289990|565432845|FG001|Overall Study|did not continue in extension|45|||
156640826|NCT01289990|565432846|FG002|Overall Study|did not continue in extension|51|||
156640827|NCT01289990|565432847|FG003|Overall Study|did not continue in extension|51|||
156640828|NCT01289990|565432848|FG004|Overall Study|did not continue in extension|48|||
156640829|NCT01289990|565432849|FG005|Overall Study|did not continue in extension|50|||
156640830|NCT01289990|565432850|FG006|Overall Study|did not continue in extension|54|||
156640831|NCT01289990|565432851|FG007|Overall Study|did not continue in extension|36|||
156640832|NCT01289990|565432852|FG008|Overall Study|did not continue in extension|44|||
156640833|NCT01289990|565432853|FG009|Overall Study|did not continue in extension|48|||
156640834|NCT01289990|565432854|FG010|Overall Study|did not continue in extension|45|||
156640835|NCT01289990|565432855|FG011|Overall Study|did not continue in extension|34|||
156640836|NCT01289990|565432856|FG012|Overall Study|did not continue in extension|56|||
156640837|NCT01289990|565432844|FG000|Overall Study|Not treated|0|||
156640838|NCT01289990|565432845|FG001|Overall Study|Not treated|0|||
156640839|NCT01289990|565432846|FG002|Overall Study|Not treated|0|||
156640840|NCT01289990|565432847|FG003|Overall Study|Not treated|0|||
156640841|NCT01289990|565432848|FG004|Overall Study|Not treated|0|||
156640842|NCT01289990|565432849|FG005|Overall Study|Not treated|0|||
156640843|NCT01289990|565432850|FG006|Overall Study|Not treated|1|||
156640844|NCT01289990|565432851|FG007|Overall Study|Not treated|0|||
156640845|NCT01289990|565432852|FG008|Overall Study|Not treated|1|||
156640846|NCT01289990|565432853|FG009|Overall Study|Not treated|0|||
156640847|NCT01289990|565432854|FG010|Overall Study|Not treated|1|||
156640848|NCT01289990|565432855|FG011|Overall Study|Not treated|2|||
156640849|NCT01289990|565432856|FG012|Overall Study|Not treated|0|||
156640850|NCT02441179|565432858|FG000|Overall Study|Withdrawal by Subject|1|||
156640851|NCT02441179|565432859|FG001|Overall Study|Withdrawal by Subject|1|||
156640852|NCT03454672|565432860|FG000|Overall Study|Adverse Event|1|||
156640853|NCT03454672|565432861|FG001|Overall Study|Adverse Event|1|||
156640854|NCT03454672|565432860|FG000|Overall Study|Lost to Follow-up|1|||
156640855|NCT03454672|565432861|FG001|Overall Study|Lost to Follow-up|3|||
156640856|NCT03454672|565432860|FG000|Overall Study|painful|1|||
156640857|NCT03454672|565432861|FG001|Overall Study|painful|2|||
156640858|NCT03454672|565432860|FG000|Overall Study|Non-compliance|2|||
156640859|NCT03454672|565432861|FG001|Overall Study|Non-compliance|4|||
156640860|NCT03454672|565432860|FG000|Overall Study|personal reasons|3|||
156640861|NCT03454672|565432861|FG001|Overall Study|personal reasons|2|||
156640862|NCT03454672|565432860|FG000|Overall Study|Withdrawal by Subject|1|||
156640863|NCT03454672|565432861|FG001|Overall Study|Withdrawal by Subject|0|||
156640864|NCT02139306|565432862|FG000|Overall Study|Withdrawal by Subject|4|||
156640865|NCT02139306|565432863|FG001|Overall Study|Withdrawal by Subject|6|||
156640866|NCT02139306|565432862|FG000|Overall Study|Adverse Event|3|||
156640867|NCT02139306|565432863|FG001|Overall Study|Adverse Event|4|||
156640868|NCT02139306|565432862|FG000|Overall Study|Physician Decision|0|||
156640869|NCT02139306|565432863|FG001|Overall Study|Physician Decision|1|||
156640870|NCT02139306|565432862|FG000|Overall Study|Other Unspecified|2|||
156640871|NCT02139306|565432863|FG001|Overall Study|Other Unspecified|3|||
156640872|NCT02139306|565432862|FG000|Overall Study|Protocol Violation|4|||
156640873|NCT02139306|565432863|FG001|Overall Study|Protocol Violation|0|||
156640874|NCT01220128|565432864|FG000|Overall Study|Progressive disease|0|||
156640875|NCT01220128|565432865|FG001|Overall Study|Progressive disease|0|||
156640876|NCT01220128|565432866|FG002|Overall Study|Progressive disease|2|||
156640877|NCT01220128|565432867|FG003|Overall Study|Progressive disease|0|||
156640878|NCT01220128|565432868|FG004|Overall Study|Progressive disease|0|||
156640879|NCT01220128|565432869|FG005|Overall Study|Progressive disease|0|||
156640880|NCT01220128|565432870|FG006|Overall Study|Progressive disease|0|||
156640881|NCT01220128|565432864|FG000|Overall Study|Sponsor study termination|0|||
156640882|NCT01220128|565432865|FG001|Overall Study|Sponsor study termination|1|||
156640883|NCT01220128|565432866|FG002|Overall Study|Sponsor study termination|0|||
156640884|NCT01220128|565432867|FG003|Overall Study|Sponsor study termination|0|||
156640885|NCT01220128|565432868|FG004|Overall Study|Sponsor study termination|0|||
156640886|NCT01220128|565432869|FG005|Overall Study|Sponsor study termination|0|||
156640887|NCT01220128|565432870|FG006|Overall Study|Sponsor study termination|1|||
156640888|NCT01220128|565432864|FG000|Overall Study|Adverse event, serious fatal|2|||
156640889|NCT01220128|565432865|FG001|Overall Study|Adverse event, serious fatal|0|||
156640890|NCT01220128|565432866|FG002|Overall Study|Adverse event, serious fatal|0|||
156640891|NCT01220128|565432867|FG003|Overall Study|Adverse event, serious fatal|0|||
156640892|NCT01220128|565432868|FG004|Overall Study|Adverse event, serious fatal|0|||
156640893|NCT01220128|565432869|FG005|Overall Study|Adverse event, serious fatal|0|||
156640894|NCT01220128|565432870|FG006|Overall Study|Adverse event, serious fatal|1|||
156640895|NCT01220128|565432864|FG000|Overall Study|Adverse event, non-fatal|1|||
156640896|NCT01220128|565432865|FG001|Overall Study|Adverse event, non-fatal|0|||
156640897|NCT01220128|565432866|FG002|Overall Study|Adverse event, non-fatal|0|||
156640898|NCT01220128|565432867|FG003|Overall Study|Adverse event, non-fatal|0|||
156640899|NCT01220128|565432868|FG004|Overall Study|Adverse event, non-fatal|0|||
156640900|NCT01220128|565432869|FG005|Overall Study|Adverse event, non-fatal|0|||
156640901|NCT01220128|565432870|FG006|Overall Study|Adverse event, non-fatal|3|||
156640902|NCT01220128|565432864|FG000|Overall Study|Other|0|||
156640903|NCT01220128|565432865|FG001|Overall Study|Other|0|||
156640904|NCT01220128|565432866|FG002|Overall Study|Other|1|||
156640905|NCT01220128|565432867|FG003|Overall Study|Other|0|||
156640906|NCT01220128|565432868|FG004|Overall Study|Other|0|||
156640907|NCT01220128|565432869|FG005|Overall Study|Other|0|||
156640908|NCT01220128|565432870|FG006|Overall Study|Other|0|||
156640909|NCT01220128|565432864|FG000|Overall Study|Consent withdrawn by subject|1|||
156640910|NCT01220128|565432865|FG001|Overall Study|Consent withdrawn by subject|0|||
156640911|NCT01220128|565432866|FG002|Overall Study|Consent withdrawn by subject|0|||
156640912|NCT01220128|565432867|FG003|Overall Study|Consent withdrawn by subject|0|||
156640913|NCT01220128|565432868|FG004|Overall Study|Consent withdrawn by subject|0|||
156640914|NCT01220128|565432869|FG005|Overall Study|Consent withdrawn by subject|0|||
156640915|NCT01220128|565432870|FG006|Overall Study|Consent withdrawn by subject|0|||
156640916|NCT02913261|565432871|FG000|Overall Study|Technical problems|0|||
156640917|NCT02913261|565432872|FG001|Overall Study|Technical problems|1|||
156640918|NCT02913261|565432871|FG000|Overall Study|Lack of Efficacy|32|||
156640919|NCT02913261|565432872|FG001|Overall Study|Lack of Efficacy|69|||
156411742|NCT01089556|564601385|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
156411743|NCT01089556|564601386|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
156640920|NCT02913261|565432871|FG000|Overall Study|Adverse Event|27|||
156411744|NCT00594906|564601387|FG000|Overall Study|Physician Decision|1|||
156640921|NCT02913261|565432872|FG001|Overall Study|Adverse Event|5|||
156640922|NCT02913261|565432871|FG000|Overall Study|Death|25|||
156411745|NCT00594906|564601388|FG001|Overall Study|Physician Decision|0|||
156640923|NCT02913261|565432872|FG001|Overall Study|Death|22|||
156640924|NCT02913261|565432871|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
156640925|NCT02913261|565432872|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
156640926|NCT02913261|565432871|FG000|Overall Study|Disease relapse|8|||
156640927|NCT02913261|565432872|FG001|Overall Study|Disease relapse|13|||
156640928|NCT02913261|565432871|FG000|Overall Study|Physician Decision|8|||
156640929|NCT02913261|565432872|FG001|Overall Study|Physician Decision|9|||
156640930|NCT02913261|565432871|FG000|Overall Study|Subject/guardian decision|4|||
156640931|NCT02913261|565432872|FG001|Overall Study|Subject/guardian decision|6|||
156640932|NCT02913261|565432871|FG000|Overall Study|Graft loss|2|||
156640933|NCT02913261|565432872|FG001|Overall Study|Graft loss|0|||
156640934|NCT02304302|565432873|FG000|Overall Study|Adverse Event|2|||
156640935|NCT02304302|565432874|FG001|Overall Study|Adverse Event|3|||
156640936|NCT02304302|565432873|FG000|Overall Study|Lost to Follow-up|1|||
156640937|NCT02304302|565432874|FG001|Overall Study|Lost to Follow-up|4|||
156640938|NCT02304302|565432873|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
156640939|NCT02304302|565432874|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
156640940|NCT00391118|565432875|FG000|Overall Study|Adverse Event|3|||
156640941|NCT00391118|565432876|FG001|Overall Study|Adverse Event|10|||
156640942|NCT00391118|565432877|FG002|Overall Study|Adverse Event|7|||
156640943|NCT00391118|565432875|FG000|Overall Study|Lost to Follow-up|0|||
156640944|NCT00391118|565432876|FG001|Overall Study|Lost to Follow-up|2|||
156640945|NCT00391118|565432877|FG002|Overall Study|Lost to Follow-up|3|||
156640946|NCT00391118|565432875|FG000|Overall Study|Withdrawal by Subject|0|||
156640947|NCT00391118|565432876|FG001|Overall Study|Withdrawal by Subject|9|||
156640948|NCT00391118|565432877|FG002|Overall Study|Withdrawal by Subject|1|||
156640949|NCT00391118|565432875|FG000|Overall Study|Death|0|||
156640950|NCT00391118|565432876|FG001|Overall Study|Death|1|||
156640951|NCT00391118|565432877|FG002|Overall Study|Death|0|||
156640952|NCT00391118|565432875|FG000|Overall Study|Physician Decision|0|||
156640953|NCT00391118|565432876|FG001|Overall Study|Physician Decision|3|||
156640954|NCT00391118|565432877|FG002|Overall Study|Physician Decision|0|||
156640955|NCT00391118|565432875|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
156640956|NCT00391118|565432876|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
156640957|NCT00391118|565432877|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
156640958|NCT00391118|565432875|FG000|Overall Study|Progressive Disease|7|||
156640959|NCT00391118|565432876|FG001|Overall Study|Progressive Disease|26|||
156640960|NCT00391118|565432877|FG002|Overall Study|Progressive Disease|43|||
156640961|NCT00391118|565432875|FG000|Overall Study|Sponsor Decision|0|||
156640962|NCT00391118|565432876|FG001|Overall Study|Sponsor Decision|1|||
156640963|NCT00391118|565432877|FG002|Overall Study|Sponsor Decision|3|||
156640964|NCT00391118|565432875|FG000|Overall Study|Protocol Violation|1|||
156640965|NCT00391118|565432876|FG001|Overall Study|Protocol Violation|0|||
156640966|NCT00391118|565432877|FG002|Overall Study|Protocol Violation|0|||
156640967|NCT01892020|565432879|FG000|Period 1|Adverse Event|1|||
156640968|NCT01892020|565432880|FG001|Period 1|Adverse Event|1|||
156640969|NCT01892020|565432879|FG000|Period 1|Protocol Violation|2|||
156640970|NCT01892020|565432880|FG001|Period 1|Protocol Violation|4|||
156640971|NCT01892020|565432879|FG000|Period 1|Unclassified|0|||
156640972|NCT01892020|565432880|FG001|Period 1|Unclassified|1|||
156640973|NCT01892020|565432879|FG000|Period 2|Protocol Violation|1|||
156640974|NCT01892020|565432880|FG001|Period 2|Protocol Violation|0|||
156640975|NCT01311505|565432882|FG000|First Intervention Period|Protocol Violation|0|||
156640976|NCT01311505|565432883|FG001|First Intervention Period|Protocol Violation|1|||
156640977|NCT00567996|565432890|FG000|Overall Study|Adverse Event|18|||
156640978|NCT00567996|565432891|FG001|Overall Study|Adverse Event|16|||
156640979|NCT00567996|565432892|FG002|Overall Study|Adverse Event|13|||
156640980|NCT00567996|565432890|FG000|Overall Study|Protocol Deviation|9|||
156640981|NCT00567996|565432891|FG001|Overall Study|Protocol Deviation|11|||
156640982|NCT00567996|565432892|FG002|Overall Study|Protocol Deviation|13|||
156640983|NCT00567996|565432890|FG000|Overall Study|Withdrawal by Subject|8|||
156640984|NCT00567996|565432891|FG001|Overall Study|Withdrawal by Subject|12|||
156640985|NCT00567996|565432892|FG002|Overall Study|Withdrawal by Subject|22|||
156640986|NCT00567996|565432890|FG000|Overall Study|Abnormal Lab value(s)|2|||
156640987|NCT00567996|565432891|FG001|Overall Study|Abnormal Lab value(s)|1|||
156640988|NCT00567996|565432892|FG002|Overall Study|Abnormal Lab value(s)|2|||
156640989|NCT00567996|565432890|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156640990|NCT00567996|565432891|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156640991|NCT00567996|565432892|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156640992|NCT00567996|565432890|FG000|Overall Study|Lost to Follow-up|2|||
156640993|NCT00567996|565432891|FG001|Overall Study|Lost to Follow-up|5|||
156640994|NCT00567996|565432892|FG002|Overall Study|Lost to Follow-up|2|||
156640995|NCT00567996|565432890|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156640996|NCT00567996|565432891|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156640997|NCT00567996|565432892|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
156640998|NCT00567996|565432890|FG000|Overall Study|Administrative problems|1|||
156640999|NCT00567996|565432891|FG001|Overall Study|Administrative problems|1|||
156641000|NCT00567996|565432892|FG002|Overall Study|Administrative problems|0|||
156641001|NCT00567996|565432890|FG000|Overall Study|Death|1|||
156641002|NCT00567996|565432891|FG001|Overall Study|Death|0|||
156641003|NCT00567996|565432892|FG002|Overall Study|Death|2|||
156641004|NCT00567996|565432890|FG000|Overall Study|Patient's inability to use the device|0|||
156641005|NCT00567996|565432891|FG001|Overall Study|Patient's inability to use the device|1|||
156641006|NCT00567996|565432892|FG002|Overall Study|Patient's inability to use the device|0|||
156641007|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641008|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641009|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641010|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
156641011|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
156641012|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641013|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641014|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641015|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641016|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
156641017|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641018|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641019|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
156641020|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
156641021|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
156641022|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
156641023|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
156641024|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
156641025|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
156641026|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641027|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641028|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641029|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641030|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641031|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
156641032|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641033|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641034|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641035|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
156641036|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641037|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641038|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641039|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
156641040|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
156641041|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
156641042|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
156641043|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
156641044|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156641045|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
156641046|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641047|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641048|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641049|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641050|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
156641051|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641052|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641053|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641054|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641055|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641056|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641057|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641058|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641059|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
156641060|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641061|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641062|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
156641063|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
156641064|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641065|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641066|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641067|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641068|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641069|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641070|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641071|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641072|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641073|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641074|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
156641075|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641076|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641077|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
156641078|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641079|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641080|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
156641081|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
156641082|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
156641083|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
156641084|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
156641085|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
156641086|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
156641087|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
156641088|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
156641089|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
156641090|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
156641091|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
156641092|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
156641093|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
156641094|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
156641095|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
156641096|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
156641097|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
156641098|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
156641099|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
156641100|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
156641101|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
156641102|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641103|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
156641104|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
156641105|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641106|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641107|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641108|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641109|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
156641110|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
156641111|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
156641112|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641113|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
156641114|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641115|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
156641116|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641117|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
156641118|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
156641119|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
156641120|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
156641121|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641122|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641123|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641124|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641125|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
156641126|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641127|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641128|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641129|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641130|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
156641131|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641132|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641133|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641134|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641135|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641136|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641137|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641138|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641139|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
156641140|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
156641141|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
156641142|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
156641143|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
156641144|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
156641145|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
156641146|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
156641147|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
156641148|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
156641149|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
156641150|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
156641151|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
156641152|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
156641153|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
156641154|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
156641155|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
156641156|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
156641157|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
156641158|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
156641159|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641160|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641161|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641162|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641163|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641164|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641165|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641166|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641167|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641168|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641169|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
156641170|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641171|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641172|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641173|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641174|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641175|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641176|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641177|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
156641178|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
156641179|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
156641180|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
156641181|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
156641182|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
156641183|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
156641184|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
156641185|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
156641186|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
156641187|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
156641188|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
156641189|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
156641190|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
156641191|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
156641192|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
156641193|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
156641194|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
156641195|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
156641196|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
156641197|NCT01915498|565432894|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
156641198|NCT01915498|565432895|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
156641199|NCT01915498|565432896|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
156641200|NCT01915498|565432897|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
156641201|NCT01915498|565432898|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
156641202|NCT01915498|565432899|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
156641203|NCT01915498|565432900|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
156641204|NCT01915498|565432901|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
156641205|NCT01915498|565432902|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
156641206|NCT01915498|565432903|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
156641207|NCT01915498|565432904|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
156641208|NCT01915498|565432905|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
156641209|NCT01915498|565432906|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
156641210|NCT01915498|565432907|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
156641211|NCT01915498|565432908|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
156641212|NCT01915498|565432909|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
156641213|NCT01915498|565432910|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
156641214|NCT01915498|565432911|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
156641215|NCT01915498|565432912|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
156641216|NCT01915498|565432894|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641217|NCT01915498|565432895|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641218|NCT01915498|565432896|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641219|NCT01915498|565432897|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641220|NCT01915498|565432898|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641221|NCT01915498|565432899|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641222|NCT01915498|565432900|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641223|NCT01915498|565432901|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641224|NCT01915498|565432902|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641225|NCT01915498|565432903|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641226|NCT01915498|565432904|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641227|NCT01915498|565432905|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641228|NCT01915498|565432906|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641229|NCT01915498|565432907|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641230|NCT01915498|565432908|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641231|NCT01915498|565432909|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641232|NCT01915498|565432910|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641233|NCT01915498|565432911|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
156641234|NCT01915498|565432912|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
156641235|NCT01915498|565432894|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641236|NCT01915498|565432895|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641237|NCT01915498|565432896|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641238|NCT01915498|565432897|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641239|NCT01915498|565432898|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641240|NCT01915498|565432899|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641241|NCT01915498|565432900|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641242|NCT01915498|565432901|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641243|NCT01915498|565432902|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641244|NCT01915498|565432903|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641245|NCT01915498|565432904|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641246|NCT01915498|565432905|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641247|NCT01915498|565432906|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641248|NCT01915498|565432907|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641249|NCT01915498|565432908|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641250|NCT01915498|565432909|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641251|NCT01915498|565432910|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641252|NCT01915498|565432911|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
156641253|NCT01915498|565432912|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
156641254|NCT01915498|565432894|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641255|NCT01915498|565432895|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641256|NCT01915498|565432896|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641257|NCT01915498|565432897|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641258|NCT01915498|565432898|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641259|NCT01915498|565432899|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641260|NCT01915498|565432900|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641261|NCT01915498|565432901|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641262|NCT01915498|565432902|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641263|NCT01915498|565432903|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641264|NCT01915498|565432904|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641265|NCT01915498|565432905|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641266|NCT01915498|565432906|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641267|NCT01915498|565432907|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641268|NCT01915498|565432908|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641269|NCT01915498|565432909|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641270|NCT01915498|565432910|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641271|NCT01915498|565432911|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
156641272|NCT01915498|565432912|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
156641273|NCT00883129|565432916|FG000|Overall Study|Adverse Event|7|||
156641274|NCT00883129|565432917|FG001|Overall Study|Adverse Event|15|||
156641275|NCT00883129|565432916|FG000|Overall Study|Withdrawal by Subject|8|||
156641276|NCT00883129|565432917|FG001|Overall Study|Withdrawal by Subject|9|||
156641277|NCT00883129|565432916|FG000|Overall Study|Non-compliance|3|||
156641278|NCT00883129|565432917|FG001|Overall Study|Non-compliance|6|||
156641279|NCT00883129|565432916|FG000|Overall Study|Lost to Follow-up|1|||
156641280|NCT00883129|565432917|FG001|Overall Study|Lost to Follow-up|2|||
156641281|NCT00883129|565432916|FG000|Overall Study|Death|1|||
156641282|NCT00883129|565432917|FG001|Overall Study|Death|2|||
156641283|NCT00883129|565432916|FG000|Overall Study|Defined Treatment Failure|0|||
156641284|NCT00883129|565432917|FG001|Overall Study|Defined Treatment Failure|2|||
156641285|NCT01966107|565432919|FG000|Overall Study|excluded from FAS|21|||
156641286|NCT01966107|565432920|FG001|Overall Study|excluded from FAS|20|||
156641287|NCT01966107|565432919|FG000|Overall Study|discontinued treatment|345|||
156641288|NCT01966107|565432920|FG001|Overall Study|discontinued treatment|372|||
156641289|NCT01966107|565432919|FG000|Overall Study|due to study closure|164|||
156641290|NCT01966107|565432920|FG001|Overall Study|due to study closure|186|||
156641291|NCT01966107|565432919|FG000|Overall Study|withdrew from the study|272|||
156641292|NCT01966107|565432920|FG001|Overall Study|withdrew from the study|303|||
156641293|NCT01185639|565432921|FG000|Overall Study|Progressed and didn't receive therapy|2|||
156641294|NCT02200614|565432922|FG000|Double Blind Treatment|Adverse Event|86|||
156641295|NCT02200614|565432923|FG001|Double Blind Treatment|Adverse Event|48|||
156641296|NCT02200614|565432922|FG000|Double Blind Treatment|Confirmed metastasis|120|||
156641297|NCT02200614|565432923|FG001|Double Blind Treatment|Confirmed metastasis|140|||
156641298|NCT02200614|565432922|FG000|Double Blind Treatment|Judgment of the investigator|59|||
156641299|NCT02200614|565432923|FG001|Double Blind Treatment|Judgment of the investigator|99|||
156641300|NCT02200614|565432922|FG000|Double Blind Treatment|Metastasis by local reading|1|||
156641301|NCT02200614|565432923|FG001|Double Blind Treatment|Metastasis by local reading|3|||
156641302|NCT02200614|565432922|FG000|Double Blind Treatment|Other reason|6|||
156641303|NCT02200614|565432923|FG001|Double Blind Treatment|Other reason|2|||
156641304|NCT02200614|565432922|FG000|Double Blind Treatment|Personal reason|77|||
156641305|NCT02200614|565432923|FG001|Double Blind Treatment|Personal reason|85|||
156641306|NCT02200614|565432922|FG000|Double Blind Treatment|Protocol deviation|14|||
156641307|NCT02200614|565432923|FG001|Double Blind Treatment|Protocol deviation|7|||
156641308|NCT02200614|565432922|FG000|Double Blind Treatment|Not treated|1|||
156641309|NCT02200614|565432923|FG001|Double Blind Treatment|Not treated|0|||
156641310|NCT02200614|565432922|FG000|Open Label|Adverse Event|41|||
156641311|NCT02200614|565432923|FG001|Open Label|Adverse Event|11|||
156641312|NCT02200614|565432922|FG000|Open Label|Confirmed metastasis|1|||
156641313|NCT02200614|565432923|FG001|Open Label|Confirmed metastasis|0|||
156641314|NCT02200614|565432922|FG000|Open Label|Judgment of the investigator|29|||
156641315|NCT02200614|565432923|FG001|Open Label|Judgment of the investigator|2|||
156641316|NCT02200614|565432922|FG000|Open Label|Metastasis by local reading|138|||
156641317|NCT02200614|565432923|FG001|Open Label|Metastasis by local reading|27|||
156641318|NCT02200614|565432922|FG000|Open Label|Other reason|22|||
156641319|NCT02200614|565432923|FG001|Open Label|Other reason|4|||
156641320|NCT02200614|565432922|FG000|Open Label|Personal reason|60|||
156641321|NCT02200614|565432923|FG001|Open Label|Personal reason|8|||
156641322|NCT02200614|565432922|FG000|Open Label|Protocol deviation|3|||
156641323|NCT02200614|565432923|FG001|Open Label|Protocol deviation|2|||
156641324|NCT02200614|565432922|FG000|Open Label|Missing|2|||
156641325|NCT02200614|565432923|FG001|Open Label|Missing|2|||
156641326|NCT00532779|565432924|FG000|Overall Study|Adverse Event|122|||
156641327|NCT00532779|565432925|FG001|Overall Study|Adverse Event|112|||
156641328|NCT00532779|565432926|FG002|Overall Study|Adverse Event|56|||
156641329|NCT00532779|565432924|FG000|Overall Study|Lost to Follow-up|76|||
156641330|NCT00532779|565432925|FG001|Overall Study|Lost to Follow-up|65|||
156641331|NCT00532779|565432926|FG002|Overall Study|Lost to Follow-up|66|||
156641332|NCT00532779|565432924|FG000|Overall Study|Withdrawal by Subject|63|||
156641333|NCT00532779|565432925|FG001|Overall Study|Withdrawal by Subject|60|||
156641334|NCT00532779|565432926|FG002|Overall Study|Withdrawal by Subject|90|||
156641335|NCT00532779|565432924|FG000|Overall Study|Lack of Efficacy|12|||
156641336|NCT00532779|565432925|FG001|Overall Study|Lack of Efficacy|12|||
156641337|NCT00532779|565432926|FG002|Overall Study|Lack of Efficacy|40|||
156641338|NCT00532779|565432924|FG000|Overall Study|Protocol Violation|5|||
156641339|NCT00532779|565432925|FG001|Overall Study|Protocol Violation|9|||
156641340|NCT00532779|565432926|FG002|Overall Study|Protocol Violation|7|||
156641341|NCT00532779|565432924|FG000|Overall Study|Pregnancy|2|||
156641342|NCT00532779|565432925|FG001|Overall Study|Pregnancy|5|||
156641343|NCT00532779|565432926|FG002|Overall Study|Pregnancy|3|||
156641344|NCT00532779|565432924|FG000|Overall Study|Death|0|||
156641345|NCT00532779|565432925|FG001|Overall Study|Death|1|||
156641346|NCT00532779|565432926|FG002|Overall Study|Death|0|||
156641347|NCT00532779|565432924|FG000|Overall Study|Drug noncompliance, moved, other|14|||
156641348|NCT00532779|565432925|FG001|Overall Study|Drug noncompliance, moved, other|23|||
156641349|NCT00532779|565432926|FG002|Overall Study|Drug noncompliance, moved, other|29|||
156641350|NCT02662556|565432927|FG000|Overall Study|Adverse Event|4|||
156641351|NCT02662556|565432927|FG000|Overall Study|Lack of Efficacy|4|||
156641352|NCT00828516|565432936|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
156641353|NCT00689273|565432937|FG000|Overall Study|Adverse Event|3|||
156641354|NCT00689273|565432938|FG001|Overall Study|Adverse Event|1|||
156641355|NCT00689273|565432937|FG000|Overall Study|Lack of Efficacy|3|||
156641356|NCT00689273|565432938|FG001|Overall Study|Lack of Efficacy|0|||
156641357|NCT00689273|565432937|FG000|Overall Study|Lost to Follow-up|0|||
156641358|NCT00689273|565432938|FG001|Overall Study|Lost to Follow-up|2|||
156641359|NCT00689273|565432937|FG000|Overall Study|Other|6|||
156641360|NCT00689273|565432938|FG001|Overall Study|Other|2|||
156641361|NCT00689273|565432937|FG000|Overall Study|Randomized but not Treated|1|||
156641362|NCT00689273|565432938|FG001|Overall Study|Randomized but not Treated|0|||
156641363|NCT03703297|565432945|FG000|Overall Study|Death|115|||
156641364|NCT03703297|565432946|FG001|Overall Study|Death|0|||
156641365|NCT03703297|565432947|FG002|Overall Study|Death|144|||
156641366|NCT03703297|565432945|FG000|Overall Study|Withdrawal by Subject|9|||
156641367|NCT03703297|565432946|FG001|Overall Study|Withdrawal by Subject|0|||
156641368|NCT03703297|565432947|FG002|Overall Study|Withdrawal by Subject|11|||
156641369|NCT03703297|565432945|FG000|Overall Study|Ongoing at the time of DCO|140|||
156641370|NCT03703297|565432946|FG001|Overall Study|Ongoing at the time of DCO|200|||
156641371|NCT03703297|565432947|FG002|Overall Study|Ongoing at the time of DCO|111|||
156641372|NCT01355523|565434821|FG000|Overall Study|Withdrawal by Subject|1|||
156641373|NCT01355523|565434822|FG001|Overall Study|Withdrawal by Subject|4|||
156641374|NCT01355523|565434821|FG000|Overall Study|Lost to Follow-up|0|||
156641375|NCT01355523|565434822|FG001|Overall Study|Lost to Follow-up|2|||
156641376|NCT01355523|565434821|FG000|Overall Study|Protocol Violation|0|||
156641377|NCT01355523|565434822|FG001|Overall Study|Protocol Violation|2|||
156641378|NCT01355523|565434821|FG000|Overall Study|Adverse Event|0|||
156641379|NCT01355523|565434822|FG001|Overall Study|Adverse Event|2|||
156641380|NCT00303316|565434823|FG000|Overall Study|Protocol Violation|1|||
156641381|NCT00303316|565434824|FG001|Overall Study|Protocol Violation|0|||
156641382|NCT00303316|565434823|FG000|Overall Study|Lost to Follow-up|0|||
156641383|NCT00303316|565434824|FG001|Overall Study|Lost to Follow-up|1|||
156641384|NCT00303316|565434823|FG000|Overall Study|Withdrawal by Subject|1|||
156641385|NCT00303316|565434824|FG001|Overall Study|Withdrawal by Subject|2|||
156641386|NCT02703454|565434826|FG000|Overall Study|Not treated|1|||
156641387|NCT02703454|565434827|FG001|Overall Study|Not treated|3|||
156641388|NCT02703454|565434826|FG000|Overall Study|Withdrawal by Subject|4|||
156641389|NCT02703454|565434827|FG001|Overall Study|Withdrawal by Subject|3|||
156641390|NCT02703454|565434826|FG000|Overall Study|Lost to Follow-up|1|||
156641391|NCT02703454|565434827|FG001|Overall Study|Lost to Follow-up|2|||
156641392|NCT02703454|565434826|FG000|Overall Study|Study discontinuation|5|||
156641393|NCT02703454|565434827|FG001|Overall Study|Study discontinuation|8|||
156641394|NCT02284373|565434828|FG000|Overall Study|Withdrawal by Subject|0|||
156641395|NCT02284373|565434829|FG001|Overall Study|Withdrawal by Subject|1|||
156641396|NCT02284373|565434830|FG002|Overall Study|Withdrawal by Subject|0|||
156641397|NCT02284373|565434828|FG000|Overall Study|Other|0|||
156641398|NCT02284373|565434829|FG001|Overall Study|Other|1|||
156641399|NCT02284373|565434830|FG002|Overall Study|Other|0|||
156641400|NCT02284373|565434828|FG000|Overall Study|Lost to Follow-up|0|||
156641401|NCT02284373|565434829|FG001|Overall Study|Lost to Follow-up|1|||
156641402|NCT02284373|565434830|FG002|Overall Study|Lost to Follow-up|0|||
156641403|NCT03174925|565434833|FG000|Overall Study|Elastographic images not retrievable|2|||
156641404|NCT03174925|565434833|FG000|Overall Study|Elastography image not interpretable|1|||
156641405|NCT04247594|565434836|FG000|Overall Study|Withdrawal by Subject|4|||
156641406|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
156641407|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
156641408|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
156641409|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
156641410|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
156641411|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
156641412|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
156641413|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
156641414|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
156641415|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
156641416|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
156641417|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
156641418|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
156641419|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
156641420|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
156641421|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
156641422|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
156641423|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
156641424|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
156641425|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
156641426|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
156641427|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
156641428|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
156641429|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
156641430|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
156641431|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
156641432|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
156641433|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
156641434|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
156641435|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
156641436|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
156641437|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
156641438|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
156641439|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
156641440|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
156641441|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
156641442|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
156641443|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
156641444|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
156641445|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
156641446|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
156641447|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
156641448|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
156641449|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
156641450|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
156641451|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
156641452|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
156641453|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
156641454|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
156641455|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
156641456|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
156641457|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
156641458|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
156641459|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
156641460|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
156641461|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
156641462|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
156641463|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
156641464|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
156641465|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
156641466|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
156641467|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
156641468|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
156641469|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
156641470|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
156641471|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
156641472|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
156641473|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
156641474|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
156641475|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
156641476|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
156641477|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
156641478|NCT04440163|565434838|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
156641479|NCT04440163|565434839|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
156641480|NCT04440163|565434840|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
156641481|NCT04440163|565434841|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
156641482|NCT04440163|565434842|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
156641483|NCT04440163|565434843|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
156641484|NCT04440163|565434844|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
156641485|NCT04440163|565434845|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
156641486|NCT04440163|565434838|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
156641487|NCT04440163|565434839|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
156641488|NCT04440163|565434840|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
156641489|NCT04440163|565434841|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
156641490|NCT04440163|565434842|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
156641491|NCT04440163|565434843|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
156641492|NCT04440163|565434844|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
156641493|NCT04440163|565434845|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
156641494|NCT04440163|565434838|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
156641495|NCT04440163|565434839|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
156641496|NCT04440163|565434840|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
156641497|NCT04440163|565434841|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
156641498|NCT04440163|565434842|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
156641499|NCT04440163|565434843|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
156641500|NCT04440163|565434844|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
156641501|NCT04440163|565434845|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
156641502|NCT00068406|565434848|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
156641503|NCT00068406|565434848|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
156641504|NCT03231709|565434852|FG000|Treatment Period 1|Reason not Specified|0|||
156641505|NCT03231709|565434853|FG001|Treatment Period 1|Reason not Specified|1|||
156641506|NCT03231709|565434852|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
156641507|NCT03231709|565434853|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
156641508|NCT02609178|565434854|FG000|First Crown|Withdrawal by Subject|0|||
156641509|NCT02609178|565434855|FG001|First Crown|Withdrawal by Subject|0|||
156641510|NCT02609178|565434856|FG002|First Crown|Withdrawal by Subject|1|||
156641511|NCT02609178|565434857|FG003|First Crown|Withdrawal by Subject|1|||
156641512|NCT02609178|565434858|FG004|First Crown|Withdrawal by Subject|0|||
156641513|NCT02609178|565434859|FG005|First Crown|Withdrawal by Subject|0|||
156641514|NCT01128153|565434860|FG000|Overall Study|Adverse Event|1|||
156641515|NCT01128153|565434861|FG001|Overall Study|Adverse Event|3|||
156641516|NCT01128153|565434860|FG000|Overall Study|Condition under investigation worsened|8|||
156641517|NCT01128153|565434861|FG001|Overall Study|Condition under investigation worsened|7|||
156641518|NCT01128153|565434860|FG000|Overall Study|Withdrawal by Subject|2|||
156641519|NCT01128153|565434861|FG001|Overall Study|Withdrawal by Subject|3|||
156641520|NCT01128153|565434860|FG000|Overall Study|Incorrect enrolment to study|2|||
156641521|NCT01128153|565434861|FG001|Overall Study|Incorrect enrolment to study|1|||
156641522|NCT01128153|565434860|FG000|Overall Study|Protocol Violation|2|||
156641523|NCT01128153|565434861|FG001|Overall Study|Protocol Violation|0|||
156641524|NCT01128153|565434860|FG000|Overall Study|Developed discontinuation criteria|1|||
156641525|NCT01128153|565434861|FG001|Overall Study|Developed discontinuation criteria|1|||
156641526|NCT01954082|565434862|FG000|Overall Study|Study Suspension|42|||
156641527|NCT01954082|565434863|FG001|Overall Study|Study Suspension|36|||
156641528|NCT01954082|565434862|FG000|Overall Study|Adverse Event|10|||
156641529|NCT01954082|565434863|FG001|Overall Study|Adverse Event|4|||
156641530|NCT01954082|565434862|FG000|Overall Study|Intolerance|0|||
156641531|NCT01954082|565434863|FG001|Overall Study|Intolerance|1|||
156641532|NCT01954082|565434862|FG000|Overall Study|Non-compliance|6|||
156641533|NCT01954082|565434863|FG001|Overall Study|Non-compliance|4|||
156641534|NCT01954082|565434862|FG000|Overall Study|Physician Decision|2|||
156641535|NCT01954082|565434863|FG001|Overall Study|Physician Decision|0|||
156641536|NCT01954082|565434862|FG000|Overall Study|Parent Decision|1|||
156641537|NCT01954082|565434863|FG001|Overall Study|Parent Decision|0|||
156641538|NCT01954082|565434862|FG000|Overall Study|Withdrawal by Subject|0|||
156641539|NCT01954082|565434863|FG001|Overall Study|Withdrawal by Subject|1|||
156641540|NCT01954082|565434862|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
156641541|NCT01954082|565434863|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
156641542|NCT01954082|565434862|FG000|Overall Study|Redirection of Care|0|||
156641543|NCT01954082|565434863|FG001|Overall Study|Redirection of Care|2|||
156641544|NCT01954082|565434862|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
156641545|NCT01954082|565434863|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
156641546|NCT01954082|565434862|FG000|Overall Study|Comfort Care|0|||
156641547|NCT01954082|565434863|FG001|Overall Study|Comfort Care|1|||
156641548|NCT01954082|565434862|FG000|Overall Study|Infant Moved|0|||
156641549|NCT01954082|565434863|FG001|Overall Study|Infant Moved|1|||
156641550|NCT01954082|565434862|FG000|Overall Study|Randomized not Treated|4|||
156641551|NCT01954082|565434863|FG001|Overall Study|Randomized not Treated|2|||
156641552|NCT01682512|565434864|FG000|Overall Study|Adverse Event|6|||
156641553|NCT01682512|565434865|FG001|Overall Study|Adverse Event|5|||
156641554|NCT01682512|565434866|FG002|Overall Study|Adverse Event|2|||
156641555|NCT01682512|565434864|FG000|Overall Study|Withdrawal by Subject|2|||
156641556|NCT01682512|565434865|FG001|Overall Study|Withdrawal by Subject|6|||
156641557|NCT01682512|565434866|FG002|Overall Study|Withdrawal by Subject|3|||
156641558|NCT01682512|565434864|FG000|Overall Study|Physician Decision|0|||
156641559|NCT01682512|565434865|FG001|Overall Study|Physician Decision|2|||
156641560|NCT01682512|565434866|FG002|Overall Study|Physician Decision|0|||
156641561|NCT01682512|565434864|FG000|Overall Study|Study terminated by sponsor|46|||
156641562|NCT01682512|565434865|FG001|Overall Study|Study terminated by sponsor|43|||
156641563|NCT01682512|565434866|FG002|Overall Study|Study terminated by sponsor|0|||
156641564|NCT01682512|565434864|FG000|Overall Study|Lost to Follow-up|3|||
156641565|NCT01682512|565434865|FG001|Overall Study|Lost to Follow-up|0|||
156641566|NCT01682512|565434866|FG002|Overall Study|Lost to Follow-up|2|||
156641567|NCT01682512|565434864|FG000|Overall Study|Protocol Violation|2|||
156641568|NCT01682512|565434865|FG001|Overall Study|Protocol Violation|3|||
156641569|NCT01682512|565434866|FG002|Overall Study|Protocol Violation|2|||
156641570|NCT01682512|565434864|FG000|Overall Study|Primary lack of efficacy|10|||
156641571|NCT01682512|565434865|FG001|Overall Study|Primary lack of efficacy|7|||
156641572|NCT01682512|565434866|FG002|Overall Study|Primary lack of efficacy|7|||
156641573|NCT01682512|565434864|FG000|Overall Study|Secondary lack of efficacy|1|||
156641574|NCT01682512|565434865|FG001|Overall Study|Secondary lack of efficacy|1|||
156641575|NCT01682512|565434866|FG002|Overall Study|Secondary lack of efficacy|0|||
156641576|NCT01682512|565434864|FG000|Overall Study|Other than stated above|2|||
156641577|NCT01682512|565434865|FG001|Overall Study|Other than stated above|4|||
156641578|NCT01682512|565434866|FG002|Overall Study|Other than stated above|2|||
156641579|NCT01377233|565434867|FG000|Open-label|Adverse Event|1|||
156641580|NCT01377233|565434868|FG001|Open-label|Adverse Event|0|||
156641581|NCT01377233|565434869|FG002|Open-label|Adverse Event|0|||
156641582|NCT01377233|565434870|FG003|Open-label|Adverse Event|0|||
156641583|NCT01377233|565434871|FG004|Open-label|Adverse Event|0|||
156641584|NCT01377233|565434867|FG000|Open-label|Withdrawal by Subject|3|||
156641585|NCT01377233|565434868|FG001|Open-label|Withdrawal by Subject|0|||
156641586|NCT01377233|565434869|FG002|Open-label|Withdrawal by Subject|0|||
156641587|NCT01377233|565434870|FG003|Open-label|Withdrawal by Subject|0|||
156641588|NCT01377233|565434871|FG004|Open-label|Withdrawal by Subject|0|||
156641589|NCT01377233|565434867|FG000|Double-blind|Adverse Event|0|||
156641590|NCT01377233|565434868|FG001|Double-blind|Adverse Event|1|||
156641591|NCT01377233|565434869|FG002|Double-blind|Adverse Event|2|||
156641592|NCT01377233|565434870|FG003|Double-blind|Adverse Event|2|||
156641593|NCT01377233|565434871|FG004|Double-blind|Adverse Event|0|||
156641594|NCT01377233|565434867|FG000|Double-blind|Protocol Violation|0|||
156641595|NCT01377233|565434868|FG001|Double-blind|Protocol Violation|0|||
156641596|NCT01377233|565434869|FG002|Double-blind|Protocol Violation|0|||
156641597|NCT01377233|565434870|FG003|Double-blind|Protocol Violation|0|||
156641598|NCT01377233|565434871|FG004|Double-blind|Protocol Violation|1|||
156641599|NCT01377233|565434867|FG000|Double-blind|Withdrawal by Subject|0|||
156641600|NCT01377233|565434868|FG001|Double-blind|Withdrawal by Subject|0|||
156641601|NCT01377233|565434869|FG002|Double-blind|Withdrawal by Subject|0|||
156641602|NCT01377233|565434870|FG003|Double-blind|Withdrawal by Subject|1|||
156641603|NCT01377233|565434871|FG004|Double-blind|Withdrawal by Subject|0|||
156641604|NCT01377233|565434867|FG000|Double-blind|Administrative or other|0|||
156641605|NCT01377233|565434868|FG001|Double-blind|Administrative or other|0|||
156641606|NCT01377233|565434869|FG002|Double-blind|Administrative or other|0|||
156641607|NCT01377233|565434870|FG003|Double-blind|Administrative or other|1|||
156641608|NCT01377233|565434871|FG004|Double-blind|Administrative or other|1|||
156641609|NCT01785875|565434872|FG000|Overall Study|Withdrawal by Subject|41|||
156641610|NCT01785875|565434873|FG001|Overall Study|Withdrawal by Subject|34|||
156641611|NCT01785875|565434874|FG002|Overall Study|Withdrawal by Subject|36|||
156641612|NCT01785875|565434872|FG000|Overall Study|Lost to Follow-up|19|||
156641613|NCT01785875|565434873|FG001|Overall Study|Lost to Follow-up|22|||
156641614|NCT01785875|565434874|FG002|Overall Study|Lost to Follow-up|6|||
156641615|NCT01785875|565434872|FG000|Overall Study|Death|27|||
156641616|NCT01785875|565434873|FG001|Overall Study|Death|16|||
156641617|NCT01785875|565434874|FG002|Overall Study|Death|7|||
156641618|NCT01785875|565434872|FG000|Overall Study|Sponsor Decision|0|||
156641619|NCT01785875|565434873|FG001|Overall Study|Sponsor Decision|2|||
156641620|NCT01785875|565434874|FG002|Overall Study|Sponsor Decision|0|||
156641621|NCT01785875|565434872|FG000|Overall Study|Protocol Specified Criteria|207|||
156641622|NCT01785875|565434873|FG001|Overall Study|Protocol Specified Criteria|214|||
156641623|NCT01785875|565434874|FG002|Overall Study|Protocol Specified Criteria|55|||
156641624|NCT01785875|565434872|FG000|Overall Study|Missing|0|||
156641625|NCT01785875|565434873|FG001|Overall Study|Missing|1|||
156641626|NCT01785875|565434874|FG002|Overall Study|Missing|3|||
156641627|NCT00417027|565434877|FG000|Overall Study|Protocol Violation|0|||
156641628|NCT00417027|565434878|FG001|Overall Study|Protocol Violation|5|||
156641629|NCT00417027|565434879|FG002|Overall Study|Protocol Violation|5|||
156641630|NCT03137082|565434880|FG000|Overall Study|Withdrawal by Subject|1|||
156641631|NCT03137082|565434881|FG001|Overall Study|Withdrawal by Subject|1|||
156641632|NCT03137082|565434880|FG000|Overall Study|Lost to Follow-up|1|||
156641633|NCT03137082|565434881|FG001|Overall Study|Lost to Follow-up|0|||
156641634|NCT01988493|565434882|FG000|Overall Study|Randomized but not treated|0|||
156641635|NCT01988493|565434883|FG001|Overall Study|Randomized but not treated|0|||
156641636|NCT01988493|565434884|FG002|Overall Study|Randomized but not treated|0|||
156641637|NCT01988493|565434885|FG003|Overall Study|Randomized but not treated|0|||
156641638|NCT01988493|565434886|FG004|Overall Study|Randomized but not treated|1|||
156641639|NCT03496207|565434891|FG000|Base Study|Adverse Event|0|||
156641640|NCT03496207|565434892|FG001|Base Study|Adverse Event|0|||
156641641|NCT03496207|565434893|FG002|Base Study|Adverse Event|1|||
156641642|NCT03496207|565434894|FG003|Base Study|Adverse Event|1|||
156641643|NCT03496207|565434895|FG004|Base Study|Adverse Event|4|||
156641644|NCT03496207|565434891|FG000|Base Study|Death|0|||
156641645|NCT03496207|565434892|FG001|Base Study|Death|0|||
156641646|NCT03496207|565434893|FG002|Base Study|Death|0|||
156641647|NCT03496207|565434894|FG003|Base Study|Death|0|||
156641648|NCT03496207|565434895|FG004|Base Study|Death|1|||
156641649|NCT03496207|565434891|FG000|Base Study|Withdrawal by Subject|0|||
156641650|NCT03496207|565434892|FG001|Base Study|Withdrawal by Subject|0|||
156641651|NCT03496207|565434893|FG002|Base Study|Withdrawal by Subject|1|||
156641652|NCT03496207|565434894|FG003|Base Study|Withdrawal by Subject|0|||
156641653|NCT03496207|565434895|FG004|Base Study|Withdrawal by Subject|1|||
156641654|NCT03496207|565434891|FG000|Extension Period|Adverse Event|0|||
156641655|NCT03496207|565434892|FG001|Extension Period|Adverse Event|0|||
156641656|NCT03496207|565434893|FG002|Extension Period|Adverse Event|0|||
156641657|NCT03496207|565434894|FG003|Extension Period|Adverse Event|1|||
156641658|NCT03496207|565434895|FG004|Extension Period|Adverse Event|1|||
156641659|NCT03496207|565434891|FG000|Extension Period|Death|1|||
156641660|NCT03496207|565434892|FG001|Extension Period|Death|0|||
156641661|NCT03496207|565434893|FG002|Extension Period|Death|0|||
156641662|NCT03496207|565434894|FG003|Extension Period|Death|1|||
156641663|NCT03496207|565434895|FG004|Extension Period|Death|2|||
156641664|NCT03496207|565434891|FG000|Extension Period|Withdrawal by Subject|1|||
156641665|NCT03496207|565434892|FG001|Extension Period|Withdrawal by Subject|0|||
156641666|NCT03496207|565434893|FG002|Extension Period|Withdrawal by Subject|0|||
156641667|NCT03496207|565434894|FG003|Extension Period|Withdrawal by Subject|1|||
156641668|NCT03496207|565434895|FG004|Extension Period|Withdrawal by Subject|1|||
156641669|NCT03496207|565434891|FG000|Extension Period|Elevated hemoglobin levels|0|||
156641670|NCT03496207|565434892|FG001|Extension Period|Elevated hemoglobin levels|0|||
156641671|NCT03496207|565434893|FG002|Extension Period|Elevated hemoglobin levels|0|||
156641672|NCT03496207|565434894|FG003|Extension Period|Elevated hemoglobin levels|0|||
156641673|NCT03496207|565434895|FG004|Extension Period|Elevated hemoglobin levels|1|||
156641674|NCT00902278|565434896|FG000|Overall Study|Physician Decision|1|||
156641675|NCT00902278|565434897|FG001|Overall Study|Physician Decision|0|||
156641676|NCT00902278|565434898|FG002|Overall Study|Physician Decision|2|||
156641677|NCT00902278|565434899|FG003|Overall Study|Physician Decision|0|||
156641678|NCT00902278|565434900|FG004|Overall Study|Physician Decision|1|||
156641679|NCT00902278|565434896|FG000|Overall Study|Lost to Follow-up|3|||
156641680|NCT00902278|565434897|FG001|Overall Study|Lost to Follow-up|2|||
156641681|NCT00902278|565434898|FG002|Overall Study|Lost to Follow-up|3|||
156641682|NCT00902278|565434899|FG003|Overall Study|Lost to Follow-up|0|||
156641683|NCT00902278|565434900|FG004|Overall Study|Lost to Follow-up|1|||
156641684|NCT01488071|565434901|FG000|Overall Study|Adverse Event|15|||
156641685|NCT01488071|565434902|FG001|Overall Study|Adverse Event|23|||
156641686|NCT01488071|565434901|FG000|Overall Study|Lack of Efficacy|11|||
156641687|NCT01488071|565434902|FG001|Overall Study|Lack of Efficacy|17|||
156641688|NCT01488071|565434901|FG000|Overall Study|Non-compliance with study drug|2|||
156641689|NCT01488071|565434902|FG001|Overall Study|Non-compliance with study drug|0|||
156641690|NCT01488071|565434901|FG000|Overall Study|Protocol Violation|5|||
156641691|NCT01488071|565434902|FG001|Overall Study|Protocol Violation|7|||
156641692|NCT01488071|565434901|FG000|Overall Study|Withdrawal of Consent|14|||
156641693|NCT01488071|565434902|FG001|Overall Study|Withdrawal of Consent|12|||
156641694|NCT01488071|565434901|FG000|Overall Study|Lost to Follow-up|1|||
156641695|NCT01488071|565434902|FG001|Overall Study|Lost to Follow-up|0|||
156641696|NCT01488071|565434901|FG000|Overall Study|Administrative or Other Reason(s)|5|||
156641697|NCT01488071|565434902|FG001|Overall Study|Administrative or Other Reason(s)|4|||
156641698|NCT04449354|565434903|FG000|Overall Study|Withdrawal by Subject|1|||
156641699|NCT05473247|565434906|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
156641700|NCT01831596|565434907|FG000|Overall Study|Other|8|||
156641701|NCT02508649|565434908|FG000|Overall Study|Withdrawal by Subject|4|||
156641702|NCT02508649|565434909|FG001|Overall Study|Withdrawal by Subject|6|||
156641703|NCT02508649|565434910|FG002|Overall Study|Withdrawal by Subject|5|||
156641704|NCT02508649|565434911|FG003|Overall Study|Withdrawal by Subject|6|||
156641705|NCT02508649|565434908|FG000|Overall Study|Investigator withdrew the subject|1|||
156641706|NCT02508649|565434909|FG001|Overall Study|Investigator withdrew the subject|2|||
156641707|NCT02508649|565434910|FG002|Overall Study|Investigator withdrew the subject|1|||
156641708|NCT02508649|565434911|FG003|Overall Study|Investigator withdrew the subject|0|||
156641709|NCT02508649|565434908|FG000|Overall Study|Post randomization screening failure|12|||
156641710|NCT02508649|565434909|FG001|Overall Study|Post randomization screening failure|4|||
156641711|NCT02508649|565434910|FG002|Overall Study|Post randomization screening failure|9|||
156641712|NCT02508649|565434911|FG003|Overall Study|Post randomization screening failure|3|||
156641713|NCT02508649|565434908|FG000|Overall Study|Lost to Follow-up|1|||
156641714|NCT02508649|565434909|FG001|Overall Study|Lost to Follow-up|1|||
156641715|NCT02508649|565434910|FG002|Overall Study|Lost to Follow-up|0|||
156641716|NCT02508649|565434911|FG003|Overall Study|Lost to Follow-up|1|||
156641717|NCT02149199|565434912|FG000|Overall Study|Study specific withdrawal criteria|4|||
156641718|NCT02149199|565434913|FG001|Overall Study|Study specific withdrawal criteria|21|||
156641719|NCT02149199|565434914|FG002|Overall Study|Study specific withdrawal criteria|6|||
156641720|NCT02149199|565434912|FG000|Overall Study|Other|20|||
156641721|NCT02149199|565434913|FG001|Overall Study|Other|25|||
156641722|NCT02149199|565434914|FG002|Overall Study|Other|20|||
156641723|NCT02149199|565434912|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
156641724|NCT02149199|565434913|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
156641725|NCT02149199|565434914|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
156641726|NCT02149199|565434912|FG000|Overall Study|Withdrawal by Subject|75|||
156641727|NCT02149199|565434913|FG001|Overall Study|Withdrawal by Subject|93|||
156641728|NCT02149199|565434914|FG002|Overall Study|Withdrawal by Subject|77|||
156641729|NCT02149199|565434912|FG000|Overall Study|Protocol Violation|16|||
156641730|NCT02149199|565434913|FG001|Overall Study|Protocol Violation|13|||
156641731|NCT02149199|565434914|FG002|Overall Study|Protocol Violation|15|||
156641732|NCT02149199|565434912|FG000|Overall Study|Lost to Follow-up|3|||
156641733|NCT02149199|565434913|FG001|Overall Study|Lost to Follow-up|12|||
156641734|NCT02149199|565434914|FG002|Overall Study|Lost to Follow-up|11|||
156641735|NCT02149199|565434912|FG000|Overall Study|Death|0|||
156641736|NCT02149199|565434913|FG001|Overall Study|Death|0|||
156641737|NCT02149199|565434914|FG002|Overall Study|Death|1|||
156641738|NCT02149199|565434912|FG000|Overall Study|Adverse Event|6|||
156641739|NCT02149199|565434913|FG001|Overall Study|Adverse Event|15|||
156641740|NCT02149199|565434914|FG002|Overall Study|Adverse Event|9|||
156641741|NCT02956005|565434915|FG000|Overall Study|Not eligible|1|||
156641742|NCT02956005|565434915|FG000|Overall Study|Withdrawal by Subject|3|||
156641743|NCT02956005|565434915|FG000|Overall Study|Physician Decision|12|||
156641744|NCT03125629|565434916|FG000|Overall Study|Withdrawal by Subject|2|||
156641745|NCT03125629|565434916|FG000|Overall Study|Equipment malfunction|1|||
156641746|NCT00743119|565434917|FG000|Overall Study|unreliable|3|||
156641747|NCT00743119|565434917|FG000|Overall Study|Withdrawal by Subject|1|||
156641748|NCT02524665|565434922|FG000|Overall Study|Lost to Follow-up|1|||
156641749|NCT02989610|565434923|FG000|Overall Study|Withdrawal by Subject|20|||
156641750|NCT02989610|565434923|FG000|Overall Study|Departure of PI from Site|8|||
156641751|NCT02989610|565434923|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
156641752|NCT02989610|565434923|FG000|Overall Study|Lost to Follow-up|3|||
156641753|NCT02989610|565434923|FG000|Overall Study|Death|3|||
156641754|NCT02989610|565434923|FG000|Overall Study|System Explant|3|||
156641755|NCT02989610|565434923|FG000|Overall Study|Subject Non-Compliance|2|||
156641756|NCT02989610|565434923|FG000|Overall Study|System Revision|2|||
156641757|NCT02989610|565434923|FG000|Overall Study|PI Left, Study Closing|1|||
156641758|NCT02989610|565434923|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
156641759|NCT02989610|565434923|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
156641760|NCT02602080|565434926|FG000|Overall Study|Protocol Violation|6|||
156641761|NCT02602080|565434927|FG001|Overall Study|Protocol Violation|1|||
156641762|NCT02602080|565434928|FG002|Overall Study|Protocol Violation|3|||
156641763|NCT04508621|565434934|FG000|Overall Study|Adverse Event|39|||
156641764|NCT04508621|565434935|FG001|Overall Study|Adverse Event|16|||
156641765|NCT04508621|565434934|FG000|Overall Study|Lack of Efficacy|2|||
156641766|NCT04508621|565434935|FG001|Overall Study|Lack of Efficacy|8|||
156641767|NCT04508621|565434934|FG000|Overall Study|Physician Decision|0|||
156641768|NCT04508621|565434935|FG001|Overall Study|Physician Decision|1|||
156641769|NCT04508621|565434934|FG000|Overall Study|Withdrawal by Subject|10|||
156641770|NCT04508621|565434935|FG001|Overall Study|Withdrawal by Subject|14|||
156641771|NCT04508621|565434934|FG000|Overall Study|Lost to Follow-up|12|||
156641772|NCT04508621|565434935|FG001|Overall Study|Lost to Follow-up|9|||
156641773|NCT04508621|565434934|FG000|Overall Study|COVID-19 related crisis|3|||
156641774|NCT04508621|565434935|FG001|Overall Study|COVID-19 related crisis|0|||
156641775|NCT04508621|565434934|FG000|Overall Study|Subject non-compliance|1|||
156641776|NCT04508621|565434935|FG001|Overall Study|Subject non-compliance|0|||
156641777|NCT01066039|565434936|FG000|Overall Study|Adverse Event|6|||
156641778|NCT01066039|565434936|FG000|Overall Study|Withdrawal by Subject|17|||
156641779|NCT01066039|565434936|FG000|Overall Study|Protocol Violation|2|||
156641780|NCT01066039|565434936|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
156641781|NCT01066039|565434936|FG000|Overall Study|Investigator's Request|1|||
156641782|NCT01066039|565434936|FG000|Overall Study|Dropout due to Insulin Administration|1|||
156641783|NCT01066039|565434936|FG000|Overall Study|Additional Antihypertensive Required|4|||
156641784|NCT01066039|565434936|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
156641785|NCT01066039|565434936|FG000|Overall Study|Failure to Control Blood Pressure|1|||
156641786|NCT01066039|565434936|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
156641787|NCT02574260|565434937|FG000|Overall Study|Disease Progression|1|||
156641788|NCT00752895|565434938|FG000|Overall Study|Withdrawal by Subject|8|||
156641789|NCT00752895|565434939|FG001|Overall Study|Withdrawal by Subject|3|||
156641790|NCT03022799|565434940|FG000|Overall Study|Adverse Event|0|||
156641791|NCT03022799|565434941|FG001|Overall Study|Adverse Event|0|||
156641792|NCT03022799|565434942|FG002|Overall Study|Adverse Event|0|||
156641793|NCT03022799|565434943|FG003|Overall Study|Adverse Event|0|||
156641794|NCT03022799|565434944|FG004|Overall Study|Adverse Event|0|||
156641795|NCT03022799|565434945|FG005|Overall Study|Adverse Event|0|||
156641796|NCT03022799|565434946|FG006|Overall Study|Adverse Event|0|||
156641797|NCT03022799|565434947|FG007|Overall Study|Adverse Event|0|||
156641798|NCT03022799|565434948|FG008|Overall Study|Adverse Event|0|||
156641799|NCT03022799|565434949|FG009|Overall Study|Adverse Event|1|||
156641800|NCT03022799|565434950|FG010|Overall Study|Adverse Event|1|||
156641801|NCT03022799|565434951|FG011|Overall Study|Adverse Event|0|||
156641802|NCT03022799|565434952|FG012|Overall Study|Adverse Event|0|||
156641803|NCT04881448|565434955|FG000|Overall Study|Study cancelled by sponsor|220|||
156641804|NCT04881448|565434955|FG000|Overall Study|Withdrawal by Subject|2|||
156641805|NCT04881448|565434955|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
156641806|NCT03273257|565434957|FG000|Overall Study|Death|0|||
156641807|NCT03273257|565434958|FG001|Overall Study|Death|1|||
156641808|NCT03273257|565434957|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
156751713|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156641809|NCT03273257|565434958|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
156641810|NCT03273257|565434957|FG000|Overall Study|Study terminated|3|||
156641811|NCT03273257|565434958|FG001|Overall Study|Study terminated|2|||
156641812|NCT01898884|565434959|FG000|Multiple Dose Period|Adverse Event|0|||
156641813|NCT01898884|565434960|FG001|Multiple Dose Period|Adverse Event|0|||
156641814|NCT01898884|565434961|FG002|Multiple Dose Period|Adverse Event|0|||
156641815|NCT01898884|565434962|FG003|Multiple Dose Period|Adverse Event|0|||
156641816|NCT01898884|565434963|FG004|Multiple Dose Period|Adverse Event|0|||
156641817|NCT01898884|565434964|FG005|Multiple Dose Period|Adverse Event|0|||
156641818|NCT01898884|565434965|FG006|Multiple Dose Period|Adverse Event|1|||
156641819|NCT01898884|565434966|FG007|Multiple Dose Period|Adverse Event|0|||
156641820|NCT01898884|565434967|FG008|Multiple Dose Period|Adverse Event|0|||
156641821|NCT01898884|565434959|FG000|Multiple Dose Period|Randomized Not Treated|0|||
156641822|NCT01898884|565434960|FG001|Multiple Dose Period|Randomized Not Treated|0|||
156641823|NCT01898884|565434961|FG002|Multiple Dose Period|Randomized Not Treated|0|||
156641824|NCT01898884|565434962|FG003|Multiple Dose Period|Randomized Not Treated|0|||
156641825|NCT01898884|565434963|FG004|Multiple Dose Period|Randomized Not Treated|0|||
156641826|NCT01898884|565434964|FG005|Multiple Dose Period|Randomized Not Treated|0|||
156641827|NCT01898884|565434965|FG006|Multiple Dose Period|Randomized Not Treated|0|||
156641828|NCT01898884|565434966|FG007|Multiple Dose Period|Randomized Not Treated|0|||
156641829|NCT01898884|565434967|FG008|Multiple Dose Period|Randomized Not Treated|1|||
156641830|NCT00759759|565434968|FG000|Overall Study|didn't return for period 2|1|||
156641831|NCT00759759|565434969|FG001|Overall Study|didn't return for period 2|0|||
156641832|NCT00759759|565434968|FG000|Overall Study|Didn't receive drug in period 2|1|||
156641833|NCT00759759|565434969|FG001|Overall Study|Didn't receive drug in period 2|0|||
156641834|NCT00759759|565434968|FG000|Overall Study|Withdrawal by Subject|2|||
156641835|NCT00759759|565434969|FG001|Overall Study|Withdrawal by Subject|1|||
156641836|NCT00434148|565434970|FG000|Overall Study|Adverse Event|18|||
156641837|NCT00434148|565434971|FG001|Overall Study|Adverse Event|18|||
156641838|NCT00434148|565434970|FG000|Overall Study|Lack of Efficacy|25|||
156641839|NCT00434148|565434971|FG001|Overall Study|Lack of Efficacy|28|||
156641840|NCT00434148|565434970|FG000|Overall Study|Withdrawal by Subject|15|||
156641841|NCT00434148|565434971|FG001|Overall Study|Withdrawal by Subject|15|||
156641842|NCT00434148|565434970|FG000|Overall Study|Protocol Violation|4|||
156641843|NCT00434148|565434971|FG001|Overall Study|Protocol Violation|0|||
156641844|NCT00434148|565434970|FG000|Overall Study|Administrative problems|6|||
156641845|NCT00434148|565434971|FG001|Overall Study|Administrative problems|10|||
156641846|NCT00434148|565434970|FG000|Overall Study|Lost to Follow-up|0|||
156641847|NCT00434148|565434971|FG001|Overall Study|Lost to Follow-up|1|||
156641848|NCT00434148|565434970|FG000|Overall Study|Condition no longer requires study drug|1|||
156641849|NCT00434148|565434971|FG001|Overall Study|Condition no longer requires study drug|0|||
156641850|NCT00434148|565434970|FG000|Overall Study|Abnormal test procedure result|0|||
156641851|NCT00434148|565434971|FG001|Overall Study|Abnormal test procedure result|1|||
156641852|NCT01640964|565434978|FG000|Overall Study|Lost to Follow-up|0|||
156641853|NCT01640964|565434979|FG001|Overall Study|Lost to Follow-up|0|||
156641854|NCT01640964|565434980|FG002|Overall Study|Lost to Follow-up|1|||
156641855|NCT01640964|565434978|FG000|Overall Study|Protocol Deviation|1|||
156641856|NCT01640964|565434979|FG001|Overall Study|Protocol Deviation|1|||
156641857|NCT01640964|565434980|FG002|Overall Study|Protocol Deviation|2|||
156641858|NCT01399125|565437377|FG000|Overall Study|Adverse Event|32|||
156641859|NCT01399125|565437378|FG001|Overall Study|Adverse Event|30|||
156641860|NCT01399125|565437377|FG000|Overall Study|Abnormal Lab values|0|||
156641861|NCT01399125|565437378|FG001|Overall Study|Abnormal Lab values|1|||
156641862|NCT01399125|565437377|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156641863|NCT01399125|565437378|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
156641864|NCT01399125|565437377|FG000|Overall Study|Withdrawal by Subject|5|||
156641865|NCT01399125|565437378|FG001|Overall Study|Withdrawal by Subject|8|||
156641866|NCT01399125|565437377|FG000|Overall Study|Lost to Follow-up|2|||
156641867|NCT01399125|565437378|FG001|Overall Study|Lost to Follow-up|3|||
156641868|NCT01399125|565437377|FG000|Overall Study|Administrative Problems|7|||
156641869|NCT01399125|565437378|FG001|Overall Study|Administrative Problems|11|||
156641870|NCT01399125|565437377|FG000|Overall Study|Death|0|||
156641871|NCT01399125|565437378|FG001|Overall Study|Death|1|||
156641872|NCT01399125|565437377|FG000|Overall Study|Protocol Deviation|5|||
156641873|NCT01399125|565437378|FG001|Overall Study|Protocol Deviation|2|||
156641874|NCT01902134|565437379|FG000|Overall Study|Adverse Event|3|||
156641875|NCT01902134|565437380|FG001|Overall Study|Adverse Event|1|||
156641876|NCT01902134|565437381|FG002|Overall Study|Adverse Event|2|||
156641877|NCT01902134|565437382|FG003|Overall Study|Adverse Event|1|||
156641878|NCT01902134|565437383|FG004|Overall Study|Adverse Event|1|||
156641879|NCT01902134|565437384|FG005|Overall Study|Adverse Event|3|||
156641880|NCT01902134|565437379|FG000|Overall Study|Lack of Efficacy|0|||
156641881|NCT01902134|565437380|FG001|Overall Study|Lack of Efficacy|0|||
156641882|NCT01902134|565437381|FG002|Overall Study|Lack of Efficacy|2|||
156641883|NCT01902134|565437382|FG003|Overall Study|Lack of Efficacy|0|||
156641884|NCT01902134|565437383|FG004|Overall Study|Lack of Efficacy|0|||
156641885|NCT01902134|565437384|FG005|Overall Study|Lack of Efficacy|1|||
156641886|NCT01902134|565437379|FG000|Overall Study|Physician Decision|0|||
156641887|NCT01902134|565437380|FG001|Overall Study|Physician Decision|1|||
156641888|NCT01902134|565437381|FG002|Overall Study|Physician Decision|0|||
156641889|NCT01902134|565437382|FG003|Overall Study|Physician Decision|0|||
156641890|NCT01902134|565437383|FG004|Overall Study|Physician Decision|0|||
156641891|NCT01902134|565437384|FG005|Overall Study|Physician Decision|0|||
156641892|NCT01902134|565437379|FG000|Overall Study|Protocol Violation|0|||
156641893|NCT01902134|565437380|FG001|Overall Study|Protocol Violation|0|||
156641894|NCT01902134|565437381|FG002|Overall Study|Protocol Violation|0|||
156641895|NCT01902134|565437382|FG003|Overall Study|Protocol Violation|0|||
156641896|NCT01902134|565437383|FG004|Overall Study|Protocol Violation|0|||
156641897|NCT01902134|565437384|FG005|Overall Study|Protocol Violation|1|||
156641898|NCT01902134|565437379|FG000|Overall Study|Withdrawal by Subject|4|||
156641899|NCT01902134|565437380|FG001|Overall Study|Withdrawal by Subject|8|||
156641900|NCT01902134|565437381|FG002|Overall Study|Withdrawal by Subject|9|||
156641901|NCT01902134|565437382|FG003|Overall Study|Withdrawal by Subject|1|||
156641902|NCT01902134|565437383|FG004|Overall Study|Withdrawal by Subject|5|||
156641903|NCT01902134|565437384|FG005|Overall Study|Withdrawal by Subject|4|||
156641904|NCT01902134|565437379|FG000|Overall Study|no compliance|1|||
156641905|NCT01902134|565437380|FG001|Overall Study|no compliance|0|||
156641906|NCT01902134|565437381|FG002|Overall Study|no compliance|0|||
156641907|NCT01902134|565437382|FG003|Overall Study|no compliance|0|||
156641908|NCT01902134|565437383|FG004|Overall Study|no compliance|0|||
156641909|NCT01902134|565437384|FG005|Overall Study|no compliance|0|||
156641910|NCT01902134|565437379|FG000|Overall Study|Other|0|||
156411746|NCT00594906|564601387|FG000|Overall Study|Physician Decision|0|||
156641911|NCT01902134|565437380|FG001|Overall Study|Other|1|||
156641912|NCT01902134|565437381|FG002|Overall Study|Other|2|||
156641913|NCT01902134|565437382|FG003|Overall Study|Other|0|||
156641914|NCT01902134|565437383|FG004|Overall Study|Other|1|||
156641915|NCT01902134|565437384|FG005|Overall Study|Other|0|||
156641916|NCT00305110|565437385|FG000|Overall Study|Missing data|29|||
156641917|NCT00563524|565437388|FG000|Overall Study|Adverse Event|0|||
156641918|NCT00563524|565437389|FG001|Overall Study|Adverse Event|1|||
156641919|NCT00563524|565437390|FG002|Overall Study|Adverse Event|0|||
156641920|NCT00563524|565437391|FG003|Overall Study|Adverse Event|0|||
156641921|NCT00563524|565437392|FG004|Overall Study|Adverse Event|2|||
156641922|NCT00563524|565437393|FG005|Overall Study|Adverse Event|0|||
156641923|NCT00563524|565437388|FG000|Overall Study|Lost to Follow-up|1|||
156641924|NCT00563524|565437389|FG001|Overall Study|Lost to Follow-up|0|||
156641925|NCT00563524|565437390|FG002|Overall Study|Lost to Follow-up|0|||
156641926|NCT00563524|565437391|FG003|Overall Study|Lost to Follow-up|0|||
156641927|NCT00563524|565437392|FG004|Overall Study|Lost to Follow-up|0|||
156641928|NCT00563524|565437393|FG005|Overall Study|Lost to Follow-up|0|||
156641929|NCT00563524|565437388|FG000|Overall Study|Protocol Violation|0|||
156641930|NCT00563524|565437389|FG001|Overall Study|Protocol Violation|1|||
156641931|NCT00563524|565437390|FG002|Overall Study|Protocol Violation|0|||
156641932|NCT00563524|565437391|FG003|Overall Study|Protocol Violation|0|||
156641933|NCT00563524|565437392|FG004|Overall Study|Protocol Violation|0|||
156641934|NCT00563524|565437393|FG005|Overall Study|Protocol Violation|0|||
156641935|NCT00563524|565437388|FG000|Overall Study|Withdrawal by Subject|1|||
156641936|NCT00563524|565437389|FG001|Overall Study|Withdrawal by Subject|1|||
156641937|NCT00563524|565437390|FG002|Overall Study|Withdrawal by Subject|3|||
156641938|NCT00563524|565437391|FG003|Overall Study|Withdrawal by Subject|0|||
156641939|NCT00563524|565437392|FG004|Overall Study|Withdrawal by Subject|0|||
156641940|NCT00563524|565437393|FG005|Overall Study|Withdrawal by Subject|1|||
156641941|NCT01467570|565437395|FG000|Overall Study|Lost to Follow-up|8|||
156641942|NCT01467570|565437396|FG001|Overall Study|Lost to Follow-up|9|||
156641943|NCT01272193|565437399|FG000|Overall Study|Adverse Event|1|||
156641944|NCT01272193|565437400|FG001|Overall Study|Adverse Event|1|||
156641945|NCT01272193|565437399|FG000|Overall Study|Lack of Efficacy|0|||
156641946|NCT01272193|565437400|FG001|Overall Study|Lack of Efficacy|3|||
156641947|NCT01272193|565437399|FG000|Overall Study|Withdrawal Criteria|1|||
156641948|NCT01272193|565437400|FG001|Overall Study|Withdrawal Criteria|1|||
156641949|NCT01272193|565437399|FG000|Overall Study|Unclassified|8|||
156641950|NCT01272193|565437400|FG001|Overall Study|Unclassified|7|||
156641951|NCT02626182|565437407|FG000|Overall Study|Adverse Event|2|||
156641952|NCT02626182|565437408|FG001|Overall Study|Adverse Event|0|||
156641953|NCT02766088|565437420|FG000|Overall Study|Sponsor study termination|498|||
156641954|NCT02766088|565437420|FG000|Overall Study|Migrated/moved from the study area|1|||
156641955|NCT02766088|565437420|FG000|Overall Study|Lost to Follow-up|5|||
156641956|NCT02766088|565437420|FG000|Overall Study|Other|1|||
156641957|NCT02766088|565437420|FG000|Overall Study|Death|1|||
156641958|NCT01222715|565437421|FG000|Overall Study|Adverse Event|0|||
156641959|NCT01222715|565437422|FG001|Overall Study|Adverse Event|4|||
156641960|NCT01222715|565437421|FG000|Overall Study|Death|0|||
156641961|NCT01222715|565437422|FG001|Overall Study|Death|1|||
156641962|NCT01222715|565437421|FG000|Overall Study|Lack of Efficacy|22|||
156641963|NCT01222715|565437422|FG001|Overall Study|Lack of Efficacy|14|||
156641964|NCT01222715|565437421|FG000|Overall Study|Physician Decision|12|||
156641965|NCT01222715|565437422|FG001|Overall Study|Physician Decision|2|||
156641966|NCT01222715|565437421|FG000|Overall Study|Refusal of further protocol therapy|0|||
156641967|NCT01222715|565437422|FG001|Overall Study|Refusal of further protocol therapy|4|||
156641968|NCT01222715|565437421|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
156641969|NCT01222715|565437422|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
156641970|NCT01222715|565437421|FG000|Overall Study|Ineligible|0|||
156641971|NCT01222715|565437422|FG001|Overall Study|Ineligible|1|||
156641972|NCT01222715|565437421|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
156641973|NCT01222715|565437422|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
156641974|NCT03836729|565437423|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
156641975|NCT00948025|565437424|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
156641976|NCT00948025|565437425|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
156641977|NCT00948025|565437424|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
156641978|NCT00948025|565437425|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
156641979|NCT00948025|565437424|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
156641980|NCT00948025|565437425|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
156641981|NCT02239601|565437428|FG000|Overall Study|Withdrawal by Subject|3|||
156641982|NCT02239601|565437429|FG001|Overall Study|Withdrawal by Subject|4|||
156641983|NCT02239601|565437428|FG000|Overall Study|Protocol Violation|4|||
156641984|NCT02239601|565437429|FG001|Overall Study|Protocol Violation|2|||
156641985|NCT01383954|565437430|FG000|Overall Study|Lack of Efficacy|2|||
156641986|NCT01383954|565437430|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
156641987|NCT01383954|565437430|FG000|Overall Study|Adverse Event|1|||
156641988|NCT01383954|565437430|FG000|Overall Study|Reason Not Specified|9|||
156641989|NCT01791127|565437434|FG000|Overall Study|Death|356|||
156641990|NCT01791127|565437434|FG000|Overall Study|Patient has withdrawn from study|293|||
156641991|NCT01791127|565437434|FG000|Overall Study|Lost to Follow-up|42|||
156641992|NCT01791127|565437434|FG000|Overall Study|All Siello leads are explanted|31|||
156641993|NCT01791127|565437434|FG000|Overall Study|Completion of 30 day safety registry|1|||
156641994|NCT01791127|565437434|FG000|Overall Study|Study terminated for EP Passion|749|||
156641995|NCT01017029|565437438|FG000|Overall Study|Lost to Follow-up|1|||
156641996|NCT01017029|565437439|FG001|Overall Study|Lost to Follow-up|0|||
156641997|NCT01017029|565437438|FG000|Overall Study|Administrative problem|0|||
156641998|NCT01017029|565437439|FG001|Overall Study|Administrative problem|1|||
156641999|NCT01017029|565437438|FG000|Overall Study|Death|3|||
156642000|NCT01017029|565437439|FG001|Overall Study|Death|1|||
156411747|NCT00594906|564601388|FG001|Overall Study|Physician Decision|1|||
156642001|NCT02216214|565437440|FG000|Overall Study|Randomized Never Received Study Drug|1|||
156642002|NCT02216214|565437441|FG001|Overall Study|Randomized Never Received Study Drug|0|||
156642003|NCT02216214|565437440|FG000|Overall Study|Adverse Event|10|||
156642004|NCT02216214|565437441|FG001|Overall Study|Adverse Event|8|||
156642005|NCT02216214|565437440|FG000|Overall Study|Lack of Efficacy|2|||
156642006|NCT02216214|565437441|FG001|Overall Study|Lack of Efficacy|2|||
156642007|NCT02216214|565437440|FG000|Overall Study|Lost to Follow-up|3|||
156642008|NCT02216214|565437441|FG001|Overall Study|Lost to Follow-up|2|||
156642009|NCT02216214|565437440|FG000|Overall Study|Protocol Violation|4|||
156642010|NCT02216214|565437441|FG001|Overall Study|Protocol Violation|2|||
156642011|NCT02216214|565437440|FG000|Overall Study|Withdrawal by Subject|22|||
156642012|NCT02216214|565437441|FG001|Overall Study|Withdrawal by Subject|20|||
156642013|NCT02216214|565437440|FG000|Overall Study|Study Terminated By Sponsor|0|||
156642014|NCT02216214|565437441|FG001|Overall Study|Study Terminated By Sponsor|1|||
156642015|NCT02216214|565437440|FG000|Overall Study|Miscellaneous|1|||
156642016|NCT02216214|565437441|FG001|Overall Study|Miscellaneous|1|||
156642017|NCT05354206|565437442|FG000|Overall Study|Withdrawal by Subject|1|||
156642018|NCT05354206|565437443|FG001|Overall Study|Withdrawal by Subject|0|||
156642019|NCT00422058|565437444|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
156642020|NCT00422058|565437445|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
156642021|NCT00422058|565437446|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
156642022|NCT00422058|565437447|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
156642023|NCT00422058|565437448|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
156642024|NCT00422058|565437449|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
156642025|NCT00422058|565437444|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
156642026|NCT00422058|565437445|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
156642027|NCT00422058|565437446|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
156642028|NCT00422058|565437447|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
156642029|NCT00422058|565437448|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
156642030|NCT00422058|565437449|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
156642031|NCT00422058|565437444|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
156642032|NCT00422058|565437445|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
156642033|NCT00422058|565437446|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
156642034|NCT00422058|565437447|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
156642035|NCT00422058|565437448|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
156642036|NCT00422058|565437449|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
156642037|NCT00422058|565437444|FG000|Double-Blind, Week 0-20|Other|11|||
156642038|NCT00422058|565437445|FG001|Double-Blind, Week 0-20|Other|3|||
156642039|NCT00422058|565437446|FG002|Double-Blind, Week 0-20|Other|8|||
156642040|NCT00422058|565437447|FG003|Double-Blind, Week 0-20|Other|8|||
156642041|NCT00422058|565437448|FG004|Double-Blind, Week 0-20|Other|4|||
156642042|NCT00422058|565437449|FG005|Double-Blind, Week 0-20|Other|10|||
156642043|NCT00422058|565437444|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
156642044|NCT00422058|565437445|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
156642045|NCT00422058|565437446|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
156642046|NCT00422058|565437447|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
156642047|NCT00422058|565437448|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
156642048|NCT00422058|565437449|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
156411748|NCT00594906|564601387|FG000|Overall Study|Death|0|||
156411749|NCT00594906|564601388|FG001|Overall Study|Death|1|||
156411750|NCT02771210|564601393|FG000|Period 1|Adverse Event|5|||
156642049|NCT00422058|565437444|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
156642050|NCT00422058|565437445|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
156642051|NCT00422058|565437446|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
156642052|NCT00422058|565437447|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
156642053|NCT00422058|565437448|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
156642054|NCT00422058|565437449|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
156642055|NCT00422058|565437444|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
156642056|NCT00422058|565437445|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
156642057|NCT00422058|565437446|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
156642058|NCT00422058|565437447|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
156642059|NCT00422058|565437448|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
156642060|NCT00422058|565437449|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
156642061|NCT00422058|565437444|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
156642062|NCT00422058|565437445|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
156642063|NCT00422058|565437446|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
156642064|NCT00422058|565437447|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
156642065|NCT00422058|565437448|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
156642066|NCT00422058|565437449|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
156642067|NCT00422058|565437444|FG000|Open-Label Extension, Week 20-104|Other|13|||
156642068|NCT00422058|565437445|FG001|Open-Label Extension, Week 20-104|Other|14|||
156642069|NCT00422058|565437446|FG002|Open-Label Extension, Week 20-104|Other|6|||
156642070|NCT00422058|565437447|FG003|Open-Label Extension, Week 20-104|Other|13|||
156642071|NCT00422058|565437448|FG004|Open-Label Extension, Week 20-104|Other|16|||
156642072|NCT00422058|565437449|FG005|Open-Label Extension, Week 20-104|Other|18|||
156642073|NCT00713830|565437450|FG000|Overall Study|Adverse Event|23|||
156642074|NCT00713830|565437451|FG001|Overall Study|Adverse Event|71|||
156642075|NCT00713830|565437450|FG000|Overall Study|Lack of Efficacy|24|||
156642076|NCT00713830|565437451|FG001|Overall Study|Lack of Efficacy|16|||
156642077|NCT00713830|565437450|FG000|Overall Study|Lost to Follow-up|2|||
156642078|NCT00713830|565437451|FG001|Overall Study|Lost to Follow-up|9|||
156642079|NCT00713830|565437450|FG000|Overall Study|Withdrawal by Subject|13|||
156642080|NCT00713830|565437451|FG001|Overall Study|Withdrawal by Subject|23|||
156642081|NCT00713830|565437450|FG000|Overall Study|Poor Compliance to Protocol|7|||
156642082|NCT00713830|565437451|FG001|Overall Study|Poor Compliance to Protocol|14|||
156642083|NCT00713830|565437450|FG000|Overall Study|Familial and Personal Reasons|9|||
156642084|NCT00713830|565437451|FG001|Overall Study|Familial and Personal Reasons|34|||
156642085|NCT00713830|565437450|FG000|Overall Study|Sponsor Decision|4|||
156642086|NCT00713830|565437451|FG001|Overall Study|Sponsor Decision|10|||
156642087|NCT01850108|565437455|FG000|Overall Study|Lost to Follow-up|4|||
156642088|NCT01850108|565437455|FG000|Overall Study|Not eligible|1|||
156642089|NCT01850108|565437455|FG000|Overall Study|Failed engraftment|2|||
156642090|NCT01850108|565437455|FG000|Overall Study|Physician Decision|1|||
156642091|NCT03273712|565437464|FG000|Overall Study|Death|5|||
156642092|NCT03273712|565437464|FG000|Overall Study|Adverse Event|1|||
156642093|NCT03273712|565437464|FG000|Overall Study|Disease Progression|1|||
156642094|NCT04333199|565437465|FG000|Evaluated Patients|Lost to Follow-up|0|||
156411751|NCT02771210|564601394|FG001|Period 1|Adverse Event|3|||
156411752|NCT02771210|564601393|FG000|Period 1|Lack of Efficacy|3|||
156411753|NCT02771210|564601394|FG001|Period 1|Lack of Efficacy|6|||
156411754|NCT02771210|564601393|FG000|Period 1|Lost to Follow-up|2|||
156411755|NCT02771210|564601394|FG001|Period 1|Lost to Follow-up|0|||
156411756|NCT02771210|564601393|FG000|Period 1|Physician Decision|0|||
156411757|NCT02771210|564601394|FG001|Period 1|Physician Decision|1|||
156411758|NCT02771210|564601393|FG000|Period 1|Withdrawal by Subject|0|||
156411759|NCT02771210|564601394|FG001|Period 1|Withdrawal by Subject|3|||
156411760|NCT02771210|564601393|FG000|Period 1|Withdrawal of informed consent|1|||
156411761|NCT02771210|564601394|FG001|Period 1|Withdrawal of informed consent|5|||
156411762|NCT02771210|564601393|FG000|Period 2|Adverse Event|1|||
156411763|NCT02771210|564601394|FG001|Period 2|Adverse Event|0|||
156411764|NCT02771210|564601393|FG000|Period 2|Lack of Efficacy|0|||
156411765|NCT02771210|564601394|FG001|Period 2|Lack of Efficacy|1|||
156411766|NCT02771210|564601393|FG000|Period 2|Withdrawal by Subject|1|||
156411767|NCT02771210|564601394|FG001|Period 2|Withdrawal by Subject|0|||
156411768|NCT02771210|564601393|FG000|Period 2|Withdrawal of informed consent|0|||
156411769|NCT02771210|564601394|FG001|Period 2|Withdrawal of informed consent|2|||
156411770|NCT04397523|564601396|FG000|Overall Study|Lost to Follow-up|3|||
156411771|NCT04397523|564601396|FG000|Overall Study|Transfer from/to other hospital|8|||
156411772|NCT01275196|564601397|FG000|Overall Study|Adverse Event|3|||
156411773|NCT01275196|564601398|FG001|Overall Study|Adverse Event|5|||
156411774|NCT01275196|564601397|FG000|Overall Study|Withdrawal by Subject|4|||
156411775|NCT01275196|564601398|FG001|Overall Study|Withdrawal by Subject|5|||
156411776|NCT01275196|564601397|FG000|Overall Study|Lost to Follow-up|1|||
156411777|NCT01275196|564601398|FG001|Overall Study|Lost to Follow-up|0|||
156411778|NCT01275196|564601397|FG000|Overall Study|Disease Progression|6|||
156411779|NCT01275196|564601398|FG001|Overall Study|Disease Progression|5|||
156411780|NCT01275196|564601397|FG000|Overall Study|Protocol Violation|1|||
156411781|NCT01275196|564601398|FG001|Overall Study|Protocol Violation|0|||
156411782|NCT01275196|564601397|FG000|Overall Study|Suboptimal response/treatment failure|5|||
156411783|NCT01275196|564601398|FG001|Overall Study|Suboptimal response/treatment failure|6|||
156411784|NCT02222896|564601402|FG000|Abdomen|Did not qualify|34|||
156411785|NCT02222896|564601403|FG001|Abdomen|Did not qualify|10|||
156411786|NCT02222896|564601404|FG002|Abdomen|Did not qualify|32|||
156411787|NCT02222896|564601402|FG000|Groin|Did not qualify|43|||
156411788|NCT02222896|564601403|FG001|Groin|Did not qualify|9|||
156411789|NCT02222896|564601404|FG002|Groin|Did not qualify|40|||
156411790|NCT01744496|564601405|FG000|Titration Period|Adverse Event|2|||
156411791|NCT01744496|564601406|FG001|Titration Period|Adverse Event|1|||
156411792|NCT01744496|564601405|FG000|Titration Period|Personal reasons|0|||
156411793|NCT01744496|564601406|FG001|Titration Period|Personal reasons|1|||
156411794|NCT01744496|564601405|FG000|Maintenance Period|Adverse Event|1|||
156411795|NCT01744496|564601406|FG001|Maintenance Period|Adverse Event|3|||
156411796|NCT01744496|564601405|FG000|Maintenance Period|Protocol Violation|1|||
156411797|NCT01744496|564601406|FG001|Maintenance Period|Protocol Violation|0|||
156411798|NCT01744496|564601405|FG000|Maintenance Period|Withdrawal by Subject|1|||
156411799|NCT01744496|564601406|FG001|Maintenance Period|Withdrawal by Subject|1|||
156411800|NCT01744496|564601405|FG000|Maintenance Period|Subject left town|1|||
156411801|NCT01744496|564601406|FG001|Maintenance Period|Subject left town|0|||
156411802|NCT01865617|564601409|FG000|Overall Study|Death|27|||
156411803|NCT01865617|564601410|FG001|Overall Study|Death|3|||
156411804|NCT01865617|564601411|FG002|Overall Study|Death|1|||
156411805|NCT01865617|564601412|FG003|Overall Study|Death|1|||
156411806|NCT01865617|564601413|FG004|Overall Study|Death|5|||
156411807|NCT01865617|564601414|FG005|Overall Study|Death|1|||
156411808|NCT01865617|564601415|FG006|Overall Study|Death|11|||
156411809|NCT01865617|564601416|FG007|Overall Study|Death|1|||
156411810|NCT01865617|564601417|FG008|Overall Study|Death|11|||
156411811|NCT01865617|564601418|FG009|Overall Study|Death|3|||
156411812|NCT01865617|564601419|FG010|Overall Study|Death|32|||
156411813|NCT01865617|564601420|FG011|Overall Study|Death|6|||
156411814|NCT01865617|564601421|FG012|Overall Study|Death|13|||
156411815|NCT01865617|564601409|FG000|Overall Study|Lost to Follow-up|2|||
156411816|NCT01865617|564601410|FG001|Overall Study|Lost to Follow-up|0|||
156411817|NCT01865617|564601411|FG002|Overall Study|Lost to Follow-up|0|||
156411818|NCT01865617|564601412|FG003|Overall Study|Lost to Follow-up|0|||
156411819|NCT01865617|564601413|FG004|Overall Study|Lost to Follow-up|0|||
156411820|NCT01865617|564601414|FG005|Overall Study|Lost to Follow-up|0|||
156411821|NCT01865617|564601415|FG006|Overall Study|Lost to Follow-up|0|||
156642095|NCT04333199|565437466|FG001|Evaluated Patients|Lost to Follow-up|1|||
156642096|NCT04333199|565437467|FG002|Evaluated Patients|Lost to Follow-up|2|||
156642097|NCT02981602|565437470|FG000|Overall Study|Adverse Event|0|||
156642098|NCT02981602|565437471|FG001|Overall Study|Adverse Event|0|||
156642099|NCT02981602|565437472|FG002|Overall Study|Adverse Event|0|||
156642100|NCT02981602|565437473|FG003|Overall Study|Adverse Event|1|||
156642101|NCT02981602|565437474|FG004|Overall Study|Adverse Event|0|||
156642102|NCT00666718|565437475|FG000|Overall Study|Adverse Event|0|||
156642103|NCT00666718|565437476|FG001|Overall Study|Adverse Event|1|||
156642104|NCT00666718|565437475|FG000|Overall Study|Death|1|||
156642105|NCT00666718|565437476|FG001|Overall Study|Death|0|||
156642106|NCT00666718|565437475|FG000|Overall Study|Lost to Follow-up|1|||
156642107|NCT00666718|565437476|FG001|Overall Study|Lost to Follow-up|0|||
156642108|NCT00666718|565437475|FG000|Overall Study|Entry Criteria Not Met|2|||
156642109|NCT00666718|565437476|FG001|Overall Study|Entry Criteria Not Met|0|||
156642110|NCT00666718|565437475|FG000|Overall Study|Protocol Violation|1|||
156642111|NCT00666718|565437476|FG001|Overall Study|Protocol Violation|3|||
156642112|NCT00666718|565437475|FG000|Overall Study|Withdrawal by Subject|7|||
156642113|NCT00666718|565437476|FG001|Overall Study|Withdrawal by Subject|12|||
156642114|NCT00666718|565437475|FG000|Overall Study|Physician Decision|0|||
156642115|NCT00666718|565437476|FG001|Overall Study|Physician Decision|2|||
156642116|NCT00190684|565437483|FG000|Overall Study|Adverse Event|86|||
156642117|NCT00190684|565437483|FG000|Overall Study|Satisfactory response|80|||
156642118|NCT00190684|565437483|FG000|Overall Study|Lack of efficacy|204|||
156642119|NCT00190684|565437483|FG000|Overall Study|Lost to Follow-up|232|||
156642120|NCT00190684|565437483|FG000|Overall Study|Patient moved|60|||
156642121|NCT00190684|565437483|FG000|Overall Study|Patient Decision|432|||
156642122|NCT00190684|565437483|FG000|Overall Study|Clinical relapse|67|||
156642123|NCT00190684|565437483|FG000|Overall Study|Sponsor's decision|17|||
156642124|NCT00190684|565437483|FG000|Overall Study|Physician Decision|84|||
156642125|NCT00190684|565437483|FG000|Overall Study|Protocol Violation|123|||
156642126|NCT00190684|565437483|FG000|Overall Study|Study Period III Completed|103|||
156642127|NCT00190684|565437483|FG000|Overall Study|Study Period V Completed|1|||
156642128|NCT02567266|565437489|FG000|Overall Study|Withdrawal by Subject|10|||
156642129|NCT02567266|565437490|FG001|Overall Study|Withdrawal by Subject|7|||
156642130|NCT02567266|565437491|FG002|Overall Study|Withdrawal by Subject|6|||
156642131|NCT02567266|565437489|FG000|Overall Study|Lost to Follow-up|13|||
156642132|NCT02567266|565437490|FG001|Overall Study|Lost to Follow-up|8|||
156642133|NCT02567266|565437491|FG002|Overall Study|Lost to Follow-up|10|||
156642134|NCT03070431|565437492|FG000|Overall Study|Withdrawal by Subject|2|||
156642135|NCT03070431|565437492|FG000|Overall Study|Lost to Follow-up|2|||
156642136|NCT01542736|565437493|FG000|Overall Study|Death|1|||
156642137|NCT03674827|565437494|FG000|Treatment Phase|Adverse Event|0|||
156642138|NCT03674827|565437495|FG001|Treatment Phase|Adverse Event|0|||
156642139|NCT03674827|565437496|FG002|Treatment Phase|Adverse Event|0|||
156642140|NCT03674827|565437497|FG003|Treatment Phase|Adverse Event|0|||
156642141|NCT03674827|565437498|FG004|Treatment Phase|Adverse Event|0|||
156411822|NCT01865617|564601416|FG007|Overall Study|Lost to Follow-up|0|||
156642142|NCT03674827|565437499|FG005|Treatment Phase|Adverse Event|2|||
156642143|NCT03674827|565437494|FG000|Treatment Phase|Death|2|||
156642144|NCT03674827|565437495|FG001|Treatment Phase|Death|0|||
156642145|NCT03674827|565437496|FG002|Treatment Phase|Death|0|||
156642146|NCT03674827|565437497|FG003|Treatment Phase|Death|0|||
156642147|NCT03674827|565437498|FG004|Treatment Phase|Death|1|||
156642148|NCT03674827|565437499|FG005|Treatment Phase|Death|0|||
156642149|NCT03674827|565437494|FG000|Treatment Phase|Progressive Disease|0|||
156642150|NCT03674827|565437495|FG001|Treatment Phase|Progressive Disease|4|||
156642151|NCT03674827|565437496|FG002|Treatment Phase|Progressive Disease|3|||
156411823|NCT01865617|564601417|FG008|Overall Study|Lost to Follow-up|0|||
156642152|NCT03674827|565437497|FG003|Treatment Phase|Progressive Disease|4|||
156642153|NCT03674827|565437498|FG004|Treatment Phase|Progressive Disease|4|||
156642154|NCT03674827|565437499|FG005|Treatment Phase|Progressive Disease|9|||
156642155|NCT03674827|565437494|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
156642156|NCT03674827|565437495|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
156642157|NCT03674827|565437496|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
156642158|NCT03674827|565437497|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
156642159|NCT03674827|565437498|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
156642160|NCT03674827|565437499|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
156642161|NCT03674827|565437494|FG000|Treatment Phase|Withdrawal by Subject|0|||
156642162|NCT03674827|565437495|FG001|Treatment Phase|Withdrawal by Subject|0|||
156642163|NCT03674827|565437496|FG002|Treatment Phase|Withdrawal by Subject|0|||
156642164|NCT03674827|565437497|FG003|Treatment Phase|Withdrawal by Subject|0|||
156642165|NCT03674827|565437498|FG004|Treatment Phase|Withdrawal by Subject|0|||
156642166|NCT03674827|565437499|FG005|Treatment Phase|Withdrawal by Subject|1|||
156642167|NCT03674827|565437494|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
156642168|NCT03674827|565437495|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
156642169|NCT03674827|565437496|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
156642170|NCT03674827|565437497|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
156642171|NCT03674827|565437498|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
156642172|NCT03674827|565437499|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
156642173|NCT03674827|565437494|FG000|Treatment Phase|Other|0|||
156642174|NCT03674827|565437495|FG001|Treatment Phase|Other|1|||
156642175|NCT03674827|565437496|FG002|Treatment Phase|Other|0|||
156642176|NCT03674827|565437497|FG003|Treatment Phase|Other|0|||
156642177|NCT03674827|565437498|FG004|Treatment Phase|Other|0|||
156642178|NCT03674827|565437499|FG005|Treatment Phase|Other|1|||
156642179|NCT03674827|565437494|FG000|Long-Term Follow-up Phase|Death|2|||
156642180|NCT03674827|565437495|FG001|Long-Term Follow-up Phase|Death|4|||
156642181|NCT03674827|565437496|FG002|Long-Term Follow-up Phase|Death|2|||
156642182|NCT03674827|565437497|FG003|Long-Term Follow-up Phase|Death|3|||
156642183|NCT03674827|565437498|FG004|Long-Term Follow-up Phase|Death|2|||
156642184|NCT03674827|565437499|FG005|Long-Term Follow-up Phase|Death|6|||
156642185|NCT03674827|565437494|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
156642186|NCT03674827|565437495|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
156642187|NCT03674827|565437496|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
156642188|NCT03674827|565437497|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
156642189|NCT03674827|565437498|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
156642190|NCT03674827|565437499|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
156642191|NCT03674827|565437494|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
156642192|NCT03674827|565437495|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
156642193|NCT03674827|565437496|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
156642194|NCT03674827|565437497|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
156642195|NCT03674827|565437498|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
156642196|NCT03674827|565437499|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
156642197|NCT04529096|565437505|FG000|Overall Study|Adverse Event|6|||
156642198|NCT04529096|565437506|FG001|Overall Study|Adverse Event|1|||
156642199|NCT04529096|565437505|FG000|Overall Study|Lack of Efficacy|1|||
156642200|NCT04529096|565437506|FG001|Overall Study|Lack of Efficacy|0|||
156642201|NCT04529096|565437505|FG000|Overall Study|Lost to Follow-up|1|||
156642202|NCT04529096|565437506|FG001|Overall Study|Lost to Follow-up|1|||
156642203|NCT04529096|565437505|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156642204|NCT04529096|565437506|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156642205|NCT04529096|565437505|FG000|Overall Study|Physician Decision|1|||
156642206|NCT04529096|565437506|FG001|Overall Study|Physician Decision|3|||
156642207|NCT04529096|565437505|FG000|Overall Study|Withdrawal by Subject|5|||
156642208|NCT04529096|565437506|FG001|Overall Study|Withdrawal by Subject|0|||
156642209|NCT04529499|565437507|FG000|Overall Study|Withdrawal by Subject|9|||
156642210|NCT04529499|565437508|FG001|Overall Study|Withdrawal by Subject|11|||
156642211|NCT04529499|565437507|FG000|Overall Study|Physician Decision|1|||
156642212|NCT04529499|565437508|FG001|Overall Study|Physician Decision|2|||
156642213|NCT04529499|565437507|FG000|Overall Study|Adverse Event|4|||
156642214|NCT04529499|565437508|FG001|Overall Study|Adverse Event|4|||
156642215|NCT04529499|565437507|FG000|Overall Study|Death|14|||
156642216|NCT04529499|565437508|FG001|Overall Study|Death|11|||
156642217|NCT04529499|565437507|FG000|Overall Study|Lost to Follow-up|1|||
156642218|NCT04529499|565437508|FG001|Overall Study|Lost to Follow-up|1|||
156642219|NCT04529499|565437507|FG000|Overall Study|Others|7|||
156642220|NCT04529499|565437508|FG001|Overall Study|Others|11|||
156642221|NCT00683904|565437509|FG000|Dose Level 1|Disease progression|2|||
156642222|NCT00683904|565437510|FG001|Dose Level 1|Disease progression|0|||
156642223|NCT00683904|565437509|FG000|Dose Level 1|Adverse Event|1|||
156642224|NCT00683904|565437510|FG001|Dose Level 1|Adverse Event|0|||
156642225|NCT00683904|565437509|FG000|Dose Level 2|Adverse Event|0|||
156411824|NCT01865617|564601418|FG009|Overall Study|Lost to Follow-up|0|||
156642226|NCT00683904|565437510|FG001|Dose Level 2|Adverse Event|2|||
156642227|NCT02702271|565437511|FG000|Overall Study|Death|36|||
156642228|NCT02702271|565437512|FG001|Overall Study|Death|7|||
156642229|NCT02702271|565437511|FG000|Overall Study|Lost to Follow-up|12|||
156642230|NCT02702271|565437512|FG001|Overall Study|Lost to Follow-up|0|||
156642231|NCT02702271|565437511|FG000|Overall Study|Withdrawal by Subject|8|||
156642232|NCT02702271|565437512|FG001|Overall Study|Withdrawal by Subject|1|||
156642233|NCT02702271|565437511|FG000|Overall Study|Physician Decision|2|||
156642234|NCT02702271|565437512|FG001|Overall Study|Physician Decision|0|||
156642235|NCT02702271|565437511|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
156642236|NCT02702271|565437512|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
156642237|NCT01494649|565437513|FG000|Overall Study|Lost to Follow-up|0|||
156642238|NCT01494649|565437514|FG001|Overall Study|Lost to Follow-up|1|||
156642239|NCT03091400|565437515|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
156642240|NCT03091400|565437516|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
156642241|NCT03467971|565437517|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156642242|NCT03467971|565437518|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156642243|NCT00975884|565437519|FG000|Overall Study|Adverse Event|1|||
156642244|NCT00975884|565437520|FG001|Overall Study|Adverse Event|0|||
156642245|NCT00975884|565437519|FG000|Overall Study|Lost to Follow-up|5|||
156642246|NCT00975884|565437520|FG001|Overall Study|Lost to Follow-up|3|||
156642247|NCT00975884|565437519|FG000|Overall Study|Withdrawal by Subject|9|||
156642248|NCT00975884|565437520|FG001|Overall Study|Withdrawal by Subject|9|||
156642249|NCT00975884|565437519|FG000|Overall Study|Other|1|||
156642250|NCT00975884|565437520|FG001|Overall Study|Other|3|||
156642251|NCT00363129|565437523|FG000|Overall Study|Withdrawal by Subject|11|||
156642252|NCT00363129|565437524|FG001|Overall Study|Withdrawal by Subject|18|||
156642253|NCT00363129|565437523|FG000|Overall Study|Adverse Event|8|||
156642254|NCT00363129|565437524|FG001|Overall Study|Adverse Event|3|||
156642255|NCT00363129|565437523|FG000|Overall Study|Alternate Treatment|2|||
156642256|NCT00363129|565437524|FG001|Overall Study|Alternate Treatment|4|||
156642257|NCT00363129|565437523|FG000|Overall Study|Other Medical Problems|2|||
156642258|NCT00363129|565437524|FG001|Overall Study|Other Medical Problems|4|||
156642259|NCT00363129|565437523|FG000|Overall Study|Death|0|||
156642260|NCT00363129|565437524|FG001|Overall Study|Death|1|||
156642261|NCT00363129|565437523|FG000|Overall Study|Other Reasons|6|||
156642262|NCT00363129|565437524|FG001|Overall Study|Other Reasons|3|||
156642263|NCT05166512|565437525|FG000|Randomized|Lost to Follow-up|2|||
156642264|NCT05166512|565437526|FG001|Randomized|Lost to Follow-up|0|||
156642265|NCT05166512|565437525|FG000|Randomized|Withdrawal by Subject|1|||
156642266|NCT05166512|565437526|FG001|Randomized|Withdrawal by Subject|0|||
156642267|NCT05166512|565437525|FG000|Baseline Data Collection|Lost to Follow-up|0|||
156642268|NCT05166512|565437526|FG001|Baseline Data Collection|Lost to Follow-up|3|||
156642269|NCT05166512|565437525|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
156642270|NCT05166512|565437526|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
156642271|NCT05166512|565437525|FG000|Baseline Data Collection|Protocol Violation|2|||
156642272|NCT05166512|565437526|FG001|Baseline Data Collection|Protocol Violation|0|||
156642273|NCT05166512|565437525|FG000|4 Month Data Collection|Lost to Follow-up|1|||
156642274|NCT05166512|565437526|FG001|4 Month Data Collection|Lost to Follow-up|0|||
156642275|NCT05166512|565437525|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
156642276|NCT05166512|565437526|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
156642277|NCT05166512|565437525|FG000|12 Month Data Collection|Lost to Follow-up|3|||
156642278|NCT05166512|565437526|FG001|12 Month Data Collection|Lost to Follow-up|1|||
156642279|NCT05166512|565437525|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
156642280|NCT05166512|565437526|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
156642281|NCT00420849|565437527|FG000|Overall Study|Lack of Efficacy|154|||
156642282|NCT00420849|565437527|FG000|Overall Study|Adverse Event|107|||
156642283|NCT00420849|565437527|FG000|Overall Study|Withdrawal by Subject|28|||
156642284|NCT00420849|565437527|FG000|Overall Study|Death|18|||
156642285|NCT00420849|565437527|FG000|Overall Study|Other|14|||
156642286|NCT00420849|565437527|FG000|Overall Study|Transplant|8|||
156642287|NCT00420849|565437527|FG000|Overall Study|Protocol Violation|1|||
156642288|NCT00420849|565437527|FG000|Overall Study|Lost to Follow-up|1|||
156642289|NCT05789420|565437528|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
156642290|NCT05789420|565437528|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
156642291|NCT02278952|565437529|FG000|Overall Study|Insufficient Sample|6|||
156642292|NCT00659581|565437530|FG000|Overall Study|Adverse Event|1006|||
156642293|NCT00659581|565437530|FG000|Overall Study|Lack of Efficacy|1183|||
156642294|NCT00659581|565437530|FG000|Overall Study|Other|6393|||
156642295|NCT00446134|565437531|FG000|Overall Study|Adverse Event|7|||
156642296|NCT00446134|565437532|FG001|Overall Study|Adverse Event|17|||
156642297|NCT00446134|565437533|FG002|Overall Study|Adverse Event|13|||
156642298|NCT00446134|565437534|FG003|Overall Study|Adverse Event|18|||
156642299|NCT00446134|565437531|FG000|Overall Study|Lack of Efficacy|19|||
156642300|NCT00446134|565437532|FG001|Overall Study|Lack of Efficacy|19|||
156642301|NCT00446134|565437533|FG002|Overall Study|Lack of Efficacy|24|||
156642302|NCT00446134|565437534|FG003|Overall Study|Lack of Efficacy|19|||
156642303|NCT00446134|565437531|FG000|Overall Study|Protocol Violation|0|||
156642304|NCT00446134|565437532|FG001|Overall Study|Protocol Violation|2|||
156642305|NCT00446134|565437533|FG002|Overall Study|Protocol Violation|1|||
156642306|NCT00446134|565437534|FG003|Overall Study|Protocol Violation|0|||
156642307|NCT00446134|565437531|FG000|Overall Study|Lost to Follow-up|1|||
156642308|NCT00446134|565437532|FG001|Overall Study|Lost to Follow-up|3|||
156642309|NCT00446134|565437533|FG002|Overall Study|Lost to Follow-up|1|||
156642310|NCT00446134|565437534|FG003|Overall Study|Lost to Follow-up|1|||
156642311|NCT00446134|565437531|FG000|Overall Study|Withdrawal by Subject|3|||
156642312|NCT00446134|565437532|FG001|Overall Study|Withdrawal by Subject|3|||
156642313|NCT00446134|565437533|FG002|Overall Study|Withdrawal by Subject|1|||
156642314|NCT00446134|565437534|FG003|Overall Study|Withdrawal by Subject|3|||
156642315|NCT00446134|565437531|FG000|Overall Study|Physician Decision|0|||
156642316|NCT00446134|565437532|FG001|Overall Study|Physician Decision|0|||
156642317|NCT00446134|565437533|FG002|Overall Study|Physician Decision|0|||
156642318|NCT00446134|565437534|FG003|Overall Study|Physician Decision|2|||
156642319|NCT00446134|565437531|FG000|Overall Study|Adverse Event-Diarrhea|1|||
156642320|NCT00446134|565437532|FG001|Overall Study|Adverse Event-Diarrhea|1|||
156642321|NCT00446134|565437533|FG002|Overall Study|Adverse Event-Diarrhea|2|||
156642322|NCT00446134|565437534|FG003|Overall Study|Adverse Event-Diarrhea|0|||
156642323|NCT00446134|565437531|FG000|Overall Study|Reason Not Completed|3|||
156642324|NCT00446134|565437532|FG001|Overall Study|Reason Not Completed|0|||
156642325|NCT00446134|565437533|FG002|Overall Study|Reason Not Completed|1|||
156642326|NCT00446134|565437534|FG003|Overall Study|Reason Not Completed|2|||
156642327|NCT01556165|565437535|FG000|Overall Study|Adverse Event|5|||
156642328|NCT01556165|565437536|FG001|Overall Study|Adverse Event|3|||
156642329|NCT01556165|565437535|FG000|Overall Study|Protocol Violation|0|||
156642330|NCT01556165|565437536|FG001|Overall Study|Protocol Violation|3|||
156642331|NCT01556165|565437535|FG000|Overall Study|Withdrawal of Consent|7|||
156642332|NCT01556165|565437536|FG001|Overall Study|Withdrawal of Consent|1|||
156642333|NCT02531698|565437539|FG000|Overall Study|Adverse Event|2|||
156642334|NCT02531698|565437540|FG001|Overall Study|Adverse Event|1|||
156642335|NCT02531698|565437539|FG000|Overall Study|Withdrawal by Subject|6|||
156642336|NCT02531698|565437540|FG001|Overall Study|Withdrawal by Subject|1|||
156642337|NCT02531698|565437539|FG000|Overall Study|Protocol Violation|2|||
156642338|NCT02531698|565437540|FG001|Overall Study|Protocol Violation|0|||
156642339|NCT02531698|565437539|FG000|Overall Study|Lost to Follow-up|1|||
156642340|NCT02531698|565437540|FG001|Overall Study|Lost to Follow-up|0|||
156642341|NCT01861717|565437541|FG000|Overall Study|Lost to Follow-up|1|||
156642342|NCT01861717|565437541|FG000|Overall Study|Withdrawal by Subject|1|||
156642343|NCT02395536|565437542|FG000|Overall Study|Lost to Follow-up|4|||
156642344|NCT02395536|565437543|FG001|Overall Study|Lost to Follow-up|4|||
156642345|NCT02395536|565437542|FG000|Overall Study|Death|2|||
156642346|NCT02395536|565437543|FG001|Overall Study|Death|0|||
156642347|NCT02395536|565437542|FG000|Overall Study|Physician Decision|4|||
156642348|NCT02395536|565437543|FG001|Overall Study|Physician Decision|6|||
156642349|NCT02395536|565437542|FG000|Overall Study|Withdrawal by Subject|9|||
156642350|NCT02395536|565437543|FG001|Overall Study|Withdrawal by Subject|17|||
156642351|NCT02395536|565437542|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
156642352|NCT02395536|565437543|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
156642353|NCT02395536|565437542|FG000|Overall Study|Insurance issue|0|||
156642354|NCT02395536|565437543|FG001|Overall Study|Insurance issue|1|||
156642355|NCT00701558|565437544|FG000|Overall Study|Death|7|||
156642356|NCT00701558|565437544|FG000|Overall Study|Lost to Follow-up|8|||
156642357|NCT02464059|565439159|FG000|Overall Study|Lost to Follow-up|6|||
156642358|NCT02499406|565439162|FG000|Overall Study|missed 3 treatment sessions|4|||
156642359|NCT03591107|565439166|FG000|Overall Study|Same patient in both arms|1|||
156642360|NCT03591107|565439167|FG001|Overall Study|Same patient in both arms|1|||
156642361|NCT03591107|565439166|FG000|Overall Study|Sought care at other clinics|0|||
156642362|NCT03591107|565439167|FG001|Overall Study|Sought care at other clinics|2|||
156642363|NCT03591107|565439166|FG000|Overall Study|Discharged from clinic|0|||
156642364|NCT03591107|565439167|FG001|Overall Study|Discharged from clinic|1|||
156642365|NCT03591107|565439166|FG000|Overall Study|Withdrawal by Subject|0|||
156642366|NCT03591107|565439167|FG001|Overall Study|Withdrawal by Subject|1|||
156642367|NCT00350519|565439170|FG000|Overall Study|Death|0|||
156642368|NCT00350519|565439171|FG001|Overall Study|Death|1|||
156642369|NCT00350519|565439170|FG000|Overall Study|Physician Decision|0|||
156642370|NCT00350519|565439171|FG001|Overall Study|Physician Decision|1|||
156642371|NCT00350519|565439170|FG000|Overall Study|Protocol Violation|1|||
156642372|NCT00350519|565439171|FG001|Overall Study|Protocol Violation|2|||
156642373|NCT00350519|565439170|FG000|Overall Study|Withdrawal by Subject|3|||
156642374|NCT00350519|565439171|FG001|Overall Study|Withdrawal by Subject|2|||
156642375|NCT00736099|565439173|FG000|Overall Study|Adverse Event|61|||
156642376|NCT00736099|565439174|FG001|Overall Study|Adverse Event|18|||
156642377|NCT00736099|565439173|FG000|Overall Study|Protocol Violation|10|||
156642378|NCT00736099|565439174|FG001|Overall Study|Protocol Violation|4|||
156642379|NCT00736099|565439173|FG000|Overall Study|Lost to Follow-up|12|||
156642380|NCT00736099|565439174|FG001|Overall Study|Lost to Follow-up|5|||
156642381|NCT00736099|565439173|FG000|Overall Study|Withdrawal by Subject|42|||
156642382|NCT00736099|565439174|FG001|Overall Study|Withdrawal by Subject|13|||
156642383|NCT00736099|565439173|FG000|Overall Study|Lack of Efficacy|15|||
156642384|NCT00736099|565439174|FG001|Overall Study|Lack of Efficacy|8|||
156642385|NCT00736099|565439173|FG000|Overall Study|Other reason|43|||
156642386|NCT00736099|565439174|FG001|Overall Study|Other reason|10|||
156642387|NCT04006847|565439179|FG000|Overall Study|Product issue|1|||
156642388|NCT03555890|565439187|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156642389|NCT03555890|565439188|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156642390|NCT03555890|565439189|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156642391|NCT03555890|565439190|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
156642392|NCT03372369|565439191|FG000|Qualification Period|Withdrawal by Subject|16|||
156642393|NCT03372369|565439192|FG001|Qualification Period|Withdrawal by Subject|13|||
156642394|NCT03372369|565439191|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
156642395|NCT03372369|565439192|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
156642396|NCT03372369|565439191|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
156642397|NCT03372369|565439192|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
156642398|NCT00763269|565439193|FG000|Overall Study|Lost to Follow-up|12|||
156642399|NCT00763269|565439194|FG001|Overall Study|Lost to Follow-up|13|||
156642400|NCT03333382|565439196|FG000|Overall Study|Lost to Follow-up|1|||
156642401|NCT03333382|565439197|FG001|Overall Study|Lost to Follow-up|0|||
156642402|NCT00707174|565439207|FG000|Overall Study|Adverse Event|1|||
156642403|NCT00707174|565439208|FG001|Overall Study|Adverse Event|6|||
156642404|NCT00707174|565439207|FG000|Overall Study|Withdrawal by Subject|4|||
156642405|NCT00707174|565439208|FG001|Overall Study|Withdrawal by Subject|1|||
156642406|NCT00544557|565439209|FG000|Overall Study|Adverse Event|140|||
156642407|NCT00544557|565439209|FG000|Overall Study|Lack of Efficacy|196|||
156642408|NCT00544557|565439209|FG000|Overall Study|Other|98|||
156642409|NCT01020305|565439212|FG000|Overall Study|Adverse Event|2|||
156642410|NCT00467818|565439213|FG000|Overall Study|Adverse Event|1|||
156642411|NCT00467818|565439214|FG001|Overall Study|Adverse Event|0|||
156642412|NCT00467818|565439213|FG000|Overall Study|Lost to Follow-up|2|||
156642413|NCT00467818|565439214|FG001|Overall Study|Lost to Follow-up|2|||
156642414|NCT01830920|565439219|FG000|Overall Study|Adverse Event|1|||
156642415|NCT01830920|565439220|FG001|Overall Study|Adverse Event|0|||
156642416|NCT01830920|565439221|FG002|Overall Study|Adverse Event|1|||
156642417|NCT01830920|565439222|FG003|Overall Study|Adverse Event|0|||
156642418|NCT01830920|565439223|FG004|Overall Study|Adverse Event|0|||
156642419|NCT01830920|565439219|FG000|Overall Study|Withdrawal by Subject|2|||
156642420|NCT01830920|565439220|FG001|Overall Study|Withdrawal by Subject|2|||
156642421|NCT01830920|565439221|FG002|Overall Study|Withdrawal by Subject|1|||
156642422|NCT01830920|565439222|FG003|Overall Study|Withdrawal by Subject|7|||
156642423|NCT01830920|565439223|FG004|Overall Study|Withdrawal by Subject|1|||
156642424|NCT01830920|565439219|FG000|Overall Study|Death|3|||
156642425|NCT01830920|565439220|FG001|Overall Study|Death|3|||
156642426|NCT01830920|565439221|FG002|Overall Study|Death|5|||
156642427|NCT01830920|565439222|FG003|Overall Study|Death|4|||
156642428|NCT01830920|565439223|FG004|Overall Study|Death|4|||
156642429|NCT01830920|565439219|FG000|Overall Study|Other|15|||
156642430|NCT01830920|565439220|FG001|Overall Study|Other|1|||
156642431|NCT01830920|565439221|FG002|Overall Study|Other|1|||
156642432|NCT01830920|565439222|FG003|Overall Study|Other|5|||
156642433|NCT01830920|565439223|FG004|Overall Study|Other|3|||
156642434|NCT01313728|565439224|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
156642435|NCT04936334|565439226|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
156642436|NCT04057118|565439229|FG000|Overall Study|Adverse Event|1|||
156642437|NCT04057118|565439230|FG001|Overall Study|Adverse Event|0|||
156642438|NCT04057118|565439231|FG002|Overall Study|Adverse Event|1|||
156642439|NCT04057118|565439232|FG003|Overall Study|Adverse Event|1|||
156642440|NCT04057118|565439229|FG000|Overall Study|Physician Decision|0|||
156642441|NCT04057118|565439230|FG001|Overall Study|Physician Decision|0|||
156642442|NCT04057118|565439231|FG002|Overall Study|Physician Decision|1|||
156642443|NCT04057118|565439232|FG003|Overall Study|Physician Decision|1|||
156642444|NCT04057118|565439229|FG000|Overall Study|Withdrawal by Subject|2|||
156642445|NCT04057118|565439230|FG001|Overall Study|Withdrawal by Subject|2|||
156642446|NCT04057118|565439231|FG002|Overall Study|Withdrawal by Subject|0|||
156642447|NCT04057118|565439232|FG003|Overall Study|Withdrawal by Subject|2|||
156642448|NCT04057118|565439229|FG000|Overall Study|Not Specific|0|||
156642449|NCT04057118|565439230|FG001|Overall Study|Not Specific|0|||
156642450|NCT04057118|565439231|FG002|Overall Study|Not Specific|1|||
156642451|NCT04057118|565439232|FG003|Overall Study|Not Specific|1|||
156642452|NCT02787785|565439233|FG000|Overall Study|Death|3|||
156642453|NCT02787785|565439234|FG001|Overall Study|Death|4|||
156642454|NCT02787785|565439233|FG000|Overall Study|Lost to Follow-up|1|||
156642455|NCT02787785|565439234|FG001|Overall Study|Lost to Follow-up|1|||
156642456|NCT02787785|565439233|FG000|Overall Study|Withdrawal by Subject|0|||
156642457|NCT02787785|565439234|FG001|Overall Study|Withdrawal by Subject|5|||
156642458|NCT00572156|565439244|FG000|Overall Study|Adverse Event|3|||
156642459|NCT00572156|565439245|FG001|Overall Study|Adverse Event|1|||
156642460|NCT00572156|565439246|FG002|Overall Study|Adverse Event|5|||
156642461|NCT00572156|565439247|FG003|Overall Study|Adverse Event|1|||
156642462|NCT00572156|565439244|FG000|Overall Study|Lost to Follow-up|1|||
156642463|NCT00572156|565439245|FG001|Overall Study|Lost to Follow-up|1|||
156642464|NCT00572156|565439246|FG002|Overall Study|Lost to Follow-up|1|||
156642465|NCT00572156|565439247|FG003|Overall Study|Lost to Follow-up|0|||
156642466|NCT00572156|565439244|FG000|Overall Study|Protocol Violation|1|||
156642467|NCT00572156|565439245|FG001|Overall Study|Protocol Violation|2|||
156642468|NCT00572156|565439246|FG002|Overall Study|Protocol Violation|0|||
156642469|NCT00572156|565439247|FG003|Overall Study|Protocol Violation|2|||
156642470|NCT00572156|565439244|FG000|Overall Study|Patient/Parent Decision|1|||
156642471|NCT00572156|565439245|FG001|Overall Study|Patient/Parent Decision|6|||
156642472|NCT00572156|565439246|FG002|Overall Study|Patient/Parent Decision|4|||
156642473|NCT00572156|565439247|FG003|Overall Study|Patient/Parent Decision|3|||
156642474|NCT00572156|565439244|FG000|Overall Study|Sponsor Decision|20|||
156642475|NCT00572156|565439245|FG001|Overall Study|Sponsor Decision|16|||
156642476|NCT00572156|565439246|FG002|Overall Study|Sponsor Decision|17|||
156642477|NCT00572156|565439247|FG003|Overall Study|Sponsor Decision|19|||
156642478|NCT02030834|565439248|FG000|Overall Study|Death|4|||
156642479|NCT02030834|565439249|FG001|Overall Study|Death|0|||
156642480|NCT02030834|565439250|FG002|Overall Study|Death|0|||
156642481|NCT02030834|565439248|FG000|Overall Study|Manufacturing failure|2|||
156642482|NCT02030834|565439249|FG001|Overall Study|Manufacturing failure|0|||
156642483|NCT02030834|565439250|FG002|Overall Study|Manufacturing failure|1|||
156642484|NCT02030834|565439248|FG000|Overall Study|Disease progression|2|||
156642485|NCT02030834|565439249|FG001|Overall Study|Disease progression|0|||
156642486|NCT02030834|565439250|FG002|Overall Study|Disease progression|2|||
156642487|NCT02030834|565439248|FG000|Overall Study|Lost to Follow-up|1|||
156642488|NCT02030834|565439249|FG001|Overall Study|Lost to Follow-up|0|||
156642489|NCT02030834|565439250|FG002|Overall Study|Lost to Follow-up|0|||
156642490|NCT02030834|565439248|FG000|Overall Study|Withdrawal by Subject|1|||
156642491|NCT02030834|565439249|FG001|Overall Study|Withdrawal by Subject|0|||
156642492|NCT02030834|565439250|FG002|Overall Study|Withdrawal by Subject|0|||
156642493|NCT02030834|565439248|FG000|Overall Study|Lack of funding|1|||
156642494|NCT02030834|565439249|FG001|Overall Study|Lack of funding|0|||
156642495|NCT02030834|565439250|FG002|Overall Study|Lack of funding|0|||
156642496|NCT01440595|565439251|FG000|Overall Study|Lost to Follow-up|0|||
156642497|NCT01440595|565439252|FG001|Overall Study|Lost to Follow-up|1|||
156642498|NCT01440595|565439253|FG002|Overall Study|Lost to Follow-up|0|||
156642499|NCT01440595|565439251|FG000|Overall Study|Study terminated by sponsor.|1|||
156642500|NCT01440595|565439252|FG001|Overall Study|Study terminated by sponsor.|2|||
156642501|NCT01440595|565439253|FG002|Overall Study|Study terminated by sponsor.|1|||
156642502|NCT01347879|565439254|FG000|Overall Study|Adverse Event|0|||
156642503|NCT01347879|565439255|FG001|Overall Study|Adverse Event|12|||
156642504|NCT01347879|565439254|FG000|Overall Study|Lost to Follow-up|2|||
156642505|NCT01347879|565439255|FG001|Overall Study|Lost to Follow-up|0|||
156642506|NCT01347879|565439254|FG000|Overall Study|Withdrawal by Subject|3|||
156642507|NCT01347879|565439255|FG001|Overall Study|Withdrawal by Subject|2|||
156642508|NCT01347879|565439254|FG000|Overall Study|Other|2|||
156642509|NCT01347879|565439255|FG001|Overall Study|Other|3|||
156642510|NCT03216954|565439258|FG000|Overall Study|Adverse Event|0|||
156642511|NCT03216954|565439259|FG001|Overall Study|Adverse Event|0|||
156642512|NCT03216954|565439260|FG002|Overall Study|Adverse Event|1|||
156642513|NCT03216954|565439261|FG003|Overall Study|Adverse Event|0|||
156642514|NCT03216954|565439262|FG004|Overall Study|Adverse Event|1|||
156642515|NCT03216954|565439258|FG000|Overall Study|Withdrawal by Subject|2|||
156642516|NCT03216954|565439259|FG001|Overall Study|Withdrawal by Subject|0|||
156642517|NCT03216954|565439260|FG002|Overall Study|Withdrawal by Subject|0|||
156642518|NCT03216954|565439261|FG003|Overall Study|Withdrawal by Subject|0|||
156642519|NCT03216954|565439262|FG004|Overall Study|Withdrawal by Subject|0|||
156642520|NCT03216954|565439258|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
156642521|NCT03216954|565439259|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
156642522|NCT03216954|565439260|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
156642523|NCT03216954|565439261|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
156642524|NCT03216954|565439262|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
156642525|NCT00720304|565439265|FG000|Overall Study|Withdrawal by Subject|14|||
156642526|NCT00720304|565439266|FG001|Overall Study|Withdrawal by Subject|1|||
156642527|NCT00720304|565439265|FG000|Overall Study|Death|1|||
156642528|NCT00720304|565439266|FG001|Overall Study|Death|0|||
156642529|NCT00720304|565439265|FG000|Overall Study|Physician Decision|5|||
156642530|NCT00720304|565439266|FG001|Overall Study|Physician Decision|2|||
156642531|NCT00720304|565439265|FG000|Overall Study|Adverse Event|3|||
156642532|NCT00720304|565439266|FG001|Overall Study|Adverse Event|1|||
156642533|NCT00720304|565439265|FG000|Overall Study|Disease progression|6|||
156642534|NCT00720304|565439266|FG001|Overall Study|Disease progression|1|||
156642535|NCT04330482|565439269|FG000|Overall Study|Lost to Follow-up|2|||
156642536|NCT04330482|565439270|FG001|Overall Study|Lost to Follow-up|1|||
156642537|NCT04330482|565439269|FG000|Overall Study|Withdrawal by Subject|0|||
156642538|NCT04330482|565439270|FG001|Overall Study|Withdrawal by Subject|3|||
156642539|NCT00963599|565439271|FG000|Overall Study|Adverse Event|2|||
156642540|NCT00963599|565439272|FG001|Overall Study|Adverse Event|0|||
156642541|NCT00963599|565439273|FG002|Overall Study|Adverse Event|1|||
156642542|NCT00963599|565439274|FG003|Overall Study|Adverse Event|2|||
156642543|NCT00963599|565439271|FG000|Overall Study|Lack of Efficacy|0|||
156642544|NCT00963599|565439272|FG001|Overall Study|Lack of Efficacy|2|||
156642545|NCT00963599|565439273|FG002|Overall Study|Lack of Efficacy|1|||
156642546|NCT00963599|565439274|FG003|Overall Study|Lack of Efficacy|4|||
156642547|NCT00963599|565439271|FG000|Overall Study|Lost to Follow-up|0|||
156642548|NCT00963599|565439272|FG001|Overall Study|Lost to Follow-up|1|||
156642549|NCT00963599|565439273|FG002|Overall Study|Lost to Follow-up|1|||
156642550|NCT00963599|565439274|FG003|Overall Study|Lost to Follow-up|1|||
156642551|NCT00963599|565439271|FG000|Overall Study|Protocol Violation|2|||
156642552|NCT00963599|565439272|FG001|Overall Study|Protocol Violation|2|||
156642553|NCT00963599|565439273|FG002|Overall Study|Protocol Violation|3|||
156642554|NCT00963599|565439274|FG003|Overall Study|Protocol Violation|4|||
156642555|NCT00963599|565439271|FG000|Overall Study|Withdrawal by Subject|2|||
156642556|NCT00963599|565439272|FG001|Overall Study|Withdrawal by Subject|1|||
156642557|NCT00963599|565439273|FG002|Overall Study|Withdrawal by Subject|3|||
156642558|NCT00963599|565439274|FG003|Overall Study|Withdrawal by Subject|3|||
156642559|NCT02354976|565439276|FG000|Overall Study|Other - reason not specified|1|||
156642560|NCT02354976|565439277|FG001|Overall Study|Other - reason not specified|0|||
156642561|NCT02354976|565439278|FG002|Overall Study|Other - reason not specified|1|||
156642562|NCT02354976|565439276|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
156642563|NCT02354976|565439277|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
156642564|NCT02354976|565439278|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
156642565|NCT02354976|565439276|FG000|Overall Study|Adverse Event|1|||
156642566|NCT02354976|565439277|FG001|Overall Study|Adverse Event|0|||
156642567|NCT02354976|565439278|FG002|Overall Study|Adverse Event|2|||
156411825|NCT01865617|564601419|FG010|Overall Study|Lost to Follow-up|0|||
156411826|NCT01865617|564601420|FG011|Overall Study|Lost to Follow-up|0|||
156642568|NCT01706770|565439279|FG000|Overall Study|Lost to Follow-up|1|||
156642569|NCT01706770|565439280|FG001|Overall Study|Lost to Follow-up|0|||
156642570|NCT01706770|565439279|FG000|Overall Study|Physician Decision|1|||
156642571|NCT01706770|565439280|FG001|Overall Study|Physician Decision|0|||
156642572|NCT00423488|565439281|FG000|Overall Study|No evidence of study drug intake|2|||
156642573|NCT00423488|565439282|FG001|Overall Study|No evidence of study drug intake|1|||
156642574|NCT00423488|565439281|FG000|Overall Study|No post baseline data|3|||
156642575|NCT00423488|565439282|FG001|Overall Study|No post baseline data|0|||
156642576|NCT03835975|565439283|FG000|Overall Study|Lost to Follow-up|1|||
156642577|NCT03835975|565439284|FG001|Overall Study|Lost to Follow-up|1|||
156642578|NCT03835975|565439285|FG002|Overall Study|Lost to Follow-up|0|||
156642579|NCT03835975|565439286|FG003|Overall Study|Lost to Follow-up|0|||
156642580|NCT03835975|565439287|FG004|Overall Study|Lost to Follow-up|0|||
156642581|NCT03835975|565439283|FG000|Overall Study|No longer met eligibility criteria|0|||
156642582|NCT03835975|565439284|FG001|Overall Study|No longer met eligibility criteria|1|||
156642583|NCT03835975|565439285|FG002|Overall Study|No longer met eligibility criteria|0|||
156642584|NCT03835975|565439286|FG003|Overall Study|No longer met eligibility criteria|0|||
156642585|NCT03835975|565439287|FG004|Overall Study|No longer met eligibility criteria|0|||
156642586|NCT03835975|565439283|FG000|Overall Study|Protocol Violation|1|||
156642587|NCT03835975|565439284|FG001|Overall Study|Protocol Violation|1|||
156642588|NCT03835975|565439285|FG002|Overall Study|Protocol Violation|2|||
156642589|NCT03835975|565439286|FG003|Overall Study|Protocol Violation|0|||
156642590|NCT03835975|565439287|FG004|Overall Study|Protocol Violation|0|||
156642591|NCT03835975|565439283|FG000|Overall Study|Withdrawal by Subject|1|||
156642592|NCT03835975|565439284|FG001|Overall Study|Withdrawal by Subject|0|||
156642593|NCT03835975|565439285|FG002|Overall Study|Withdrawal by Subject|1|||
156642594|NCT03835975|565439286|FG003|Overall Study|Withdrawal by Subject|1|||
156642595|NCT03835975|565439287|FG004|Overall Study|Withdrawal by Subject|0|||
156642596|NCT01612702|565439290|FG000|Overall Study|Protocol Violation|11|||
156642597|NCT01612702|565439291|FG001|Overall Study|Protocol Violation|11|||
156642598|NCT00527397|565439294|FG000|Overall Study|Adverse Event|3|||
156642599|NCT00527397|565439294|FG000|Overall Study|Lack of Efficacy|1|||
156642600|NCT00527397|565439294|FG000|Overall Study|Protocol Violation|1|||
156642601|NCT00527397|565439294|FG000|Overall Study|Withdrawal by Subject|6|||
156642602|NCT00527397|565439294|FG000|Overall Study|Study terminated by sponsor|13|||
156642603|NCT00370396|565439300|FG000|Overall Study|Withdrawal by Subject|0|||
156642604|NCT00370396|565439301|FG001|Overall Study|Withdrawal by Subject|0|||
156642605|NCT00370396|565439302|FG002|Overall Study|Withdrawal by Subject|1|||
156642606|NCT00370396|565439300|FG000|Overall Study|Lost to Follow-up|11|||
156642607|NCT00370396|565439301|FG001|Overall Study|Lost to Follow-up|1|||
156642608|NCT00370396|565439302|FG002|Overall Study|Lost to Follow-up|0|||
156642609|NCT02065791|565439303|FG000|Overall Study|Closed Site|1|||
156642610|NCT02065791|565439304|FG001|Overall Study|Closed Site|1|||
156642611|NCT02065791|565439303|FG000|Overall Study|Withdrawal by Subject|11|||
156642612|NCT02065791|565439304|FG001|Overall Study|Withdrawal by Subject|5|||
156642613|NCT02065791|565439303|FG000|Overall Study|Lost to Follow-up|13|||
156642614|NCT02065791|565439304|FG001|Overall Study|Lost to Follow-up|9|||
156642615|NCT03707522|565439305|FG000|Overall Study|Lost to Follow-up|24|||
156642616|NCT03707522|565439306|FG001|Overall Study|Lost to Follow-up|27|||
156642617|NCT03707522|565439307|FG002|Overall Study|Lost to Follow-up|41|||
156642618|NCT03707522|565439308|FG003|Overall Study|Lost to Follow-up|36|||
156642619|NCT00383019|565439309|FG000|Overall Study|Adverse Event|5|||
156642620|NCT00383019|565439310|FG001|Overall Study|Adverse Event|1|||
156642621|NCT00383019|565439309|FG000|Overall Study|Withdrawal by Subject|0|||
156642622|NCT00383019|565439310|FG001|Overall Study|Withdrawal by Subject|1|||
156411827|NCT01865617|564601421|FG012|Overall Study|Lost to Follow-up|0|||
156642623|NCT01619085|565439314|FG000|Overall Study|Adverse Event|231|||
156642624|NCT01619085|565439314|FG000|Overall Study|Protocol Violation|4|||
156642625|NCT01619085|565439314|FG000|Overall Study|Lost to Follow-up|3|||
156642626|NCT01619085|565439314|FG000|Overall Study|Withdrawal by Subject|45|||
156642627|NCT01619085|565439314|FG000|Overall Study|Other than specified|96|||
156642628|NCT01619085|565439314|FG000|Overall Study|Not treated|1|||
156642629|NCT01619085|565439314|FG000|Overall Study|Death|145|||
156642630|NCT01345058|565439315|FG000|Overall Study|Withdrawal by Subject|1|||
156642631|NCT01345058|565439316|FG001|Overall Study|Withdrawal by Subject|0|||
156642632|NCT01345058|565439315|FG000|Overall Study|Participant Reported Increase in Events|1|||
156642633|NCT01345058|565439316|FG001|Overall Study|Participant Reported Increase in Events|0|||
156642634|NCT01345058|565439315|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
156642635|NCT01345058|565439316|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
156642636|NCT01345058|565439315|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
156642637|NCT01345058|565439316|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
156642638|NCT01345058|565439315|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
156642639|NCT01345058|565439316|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
156642640|NCT00000135|565439317|FG000|Overall Study|Death|27|||
156642641|NCT00000135|565439318|FG001|Overall Study|Death|14|||
156642642|NCT00833976|565440780|FG000|Overall Study|Withdrawal by Subject|5|||
156642643|NCT00833976|565440780|FG000|Overall Study|Lost to Follow-up|4|||
156642644|NCT00833976|565440780|FG000|Overall Study|Did not meet eligibility criteria|41|||
156642645|NCT00833976|565440780|FG000|Overall Study|Physician Decision|1|||
156642646|NCT01637961|565440781|FG000|Overall Study|Ineligible: wrong primary|1|||
156642647|NCT01637961|565440781|FG000|Overall Study|Ineligible: inadequate pathology|1|||
156642648|NCT03101293|565440782|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
156642649|NCT03101293|565440783|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
156642650|NCT04682639|565440787|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
156642651|NCT04682639|565440788|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
156642652|NCT04682639|565440789|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
156642653|NCT04682639|565440790|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
156642654|NCT04682639|565440791|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
156642655|NCT04682639|565440787|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
156642656|NCT04682639|565440788|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
156642657|NCT04682639|565440789|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
156642658|NCT04682639|565440790|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156642659|NCT04682639|565440791|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156642660|NCT04682639|565440787|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
156642661|NCT04682639|565440788|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156642662|NCT04682639|565440789|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156642663|NCT04682639|565440790|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156642664|NCT04682639|565440791|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156642665|NCT04682639|565440787|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
156642666|NCT04682639|565440788|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
156642667|NCT04682639|565440789|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
156642668|NCT04682639|565440790|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
156642669|NCT04682639|565440791|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
156642670|NCT04682639|565440787|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
156642671|NCT04682639|565440788|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
156642672|NCT04682639|565440789|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
156642673|NCT04682639|565440790|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
156642674|NCT04682639|565440791|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
156642675|NCT04682639|565440787|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
156642676|NCT04682639|565440788|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
156642677|NCT04682639|565440789|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
156642678|NCT04682639|565440790|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
156642679|NCT04682639|565440791|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
156642680|NCT04682639|565440787|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
156642681|NCT04682639|565440788|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
156642682|NCT04682639|565440789|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
156642683|NCT04682639|565440790|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
156642684|NCT04682639|565440791|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
156642685|NCT04682639|565440787|FG000|OLE Period (28 Weeks)|Other|1|||
156642686|NCT04682639|565440788|FG001|OLE Period (28 Weeks)|Other|2|||
156642687|NCT04682639|565440789|FG002|OLE Period (28 Weeks)|Other|0|||
156642688|NCT04682639|565440790|FG003|OLE Period (28 Weeks)|Other|0|||
156411828|NCT01865617|564601409|FG000|Overall Study|Withdrawal by Subject|1|||
156411829|NCT01865617|564601410|FG001|Overall Study|Withdrawal by Subject|0|||
156411830|NCT01865617|564601411|FG002|Overall Study|Withdrawal by Subject|0|||
156411831|NCT01865617|564601412|FG003|Overall Study|Withdrawal by Subject|0|||
156411832|NCT01865617|564601413|FG004|Overall Study|Withdrawal by Subject|0|||
156411833|NCT01865617|564601414|FG005|Overall Study|Withdrawal by Subject|0|||
156411834|NCT01865617|564601415|FG006|Overall Study|Withdrawal by Subject|0|||
156411835|NCT01865617|564601416|FG007|Overall Study|Withdrawal by Subject|0|||
156411836|NCT01865617|564601417|FG008|Overall Study|Withdrawal by Subject|0|||
156411837|NCT01865617|564601418|FG009|Overall Study|Withdrawal by Subject|0|||
156411838|NCT01865617|564601419|FG010|Overall Study|Withdrawal by Subject|0|||
156411839|NCT01865617|564601420|FG011|Overall Study|Withdrawal by Subject|0|||
156411840|NCT01865617|564601421|FG012|Overall Study|Withdrawal by Subject|0|||
156411841|NCT01865617|564601409|FG000|Overall Study|Patient proceeded to new therapy|0|||
156411842|NCT01865617|564601410|FG001|Overall Study|Patient proceeded to new therapy|0|||
156411843|NCT01865617|564601411|FG002|Overall Study|Patient proceeded to new therapy|0|||
156411844|NCT01865617|564601412|FG003|Overall Study|Patient proceeded to new therapy|0|||
156411845|NCT01865617|564601413|FG004|Overall Study|Patient proceeded to new therapy|2|||
156411846|NCT01865617|564601414|FG005|Overall Study|Patient proceeded to new therapy|0|||
156411847|NCT01865617|564601415|FG006|Overall Study|Patient proceeded to new therapy|0|||
156411848|NCT01865617|564601416|FG007|Overall Study|Patient proceeded to new therapy|0|||
156411849|NCT01865617|564601417|FG008|Overall Study|Patient proceeded to new therapy|0|||
156411850|NCT01865617|564601418|FG009|Overall Study|Patient proceeded to new therapy|0|||
156411851|NCT01865617|564601419|FG010|Overall Study|Patient proceeded to new therapy|0|||
156411852|NCT01865617|564601420|FG011|Overall Study|Patient proceeded to new therapy|0|||
156411853|NCT01865617|564601421|FG012|Overall Study|Patient proceeded to new therapy|0|||
156411854|NCT01865617|564601409|FG000|Overall Study|Other|0|||
156411855|NCT01865617|564601410|FG001|Overall Study|Other|0|||
156411856|NCT01865617|564601411|FG002|Overall Study|Other|0|||
156411857|NCT01865617|564601412|FG003|Overall Study|Other|0|||
156411858|NCT01865617|564601413|FG004|Overall Study|Other|0|||
156411859|NCT01865617|564601414|FG005|Overall Study|Other|0|||
156411860|NCT01865617|564601415|FG006|Overall Study|Other|1|||
156411861|NCT01865617|564601416|FG007|Overall Study|Other|0|||
156411862|NCT01865617|564601417|FG008|Overall Study|Other|0|||
156411863|NCT01865617|564601418|FG009|Overall Study|Other|0|||
156411864|NCT01865617|564601419|FG010|Overall Study|Other|0|||
156411865|NCT01865617|564601420|FG011|Overall Study|Other|0|||
156411866|NCT01865617|564601421|FG012|Overall Study|Other|0|||
156411867|NCT02500979|564601426|FG000|Period 1|Hyperglycemia|1|||
156411868|NCT02500979|564601427|FG001|Period 1|Hyperglycemia|0|||
156411869|NCT02500979|564601426|FG000|Period 1|Severe non-compliance to protocol|0|||
156411870|NCT02500979|564601427|FG001|Period 1|Severe non-compliance to protocol|1|||
156411871|NCT02500979|564601426|FG000|Period 1|Adverse Event|1|||
156411872|NCT02500979|564601427|FG001|Period 1|Adverse Event|0|||
156411873|NCT02500979|564601426|FG000|Period 1|Subject decision|2|||
156411874|NCT02500979|564601427|FG001|Period 1|Subject decision|0|||
156411875|NCT02500979|564601426|FG000|Period 2|Change in risk|1|||
156411876|NCT02500979|564601427|FG001|Period 2|Change in risk|0|||
156411877|NCT03772314|564601428|FG000|Overall Study|Adverse Event|7|||
156411878|NCT03772314|564601429|FG001|Overall Study|Adverse Event|2|||
156411879|NCT01613027|564601430|FG000|Overall Study|Lost to Follow-up|5|||
156411880|NCT01613027|564601430|FG000|Overall Study|Switched Physician|1|||
156411881|NCT01613027|564601430|FG000|Overall Study|Lack of Efficacy|1|||
156411882|NCT01613027|564601430|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
156411883|NCT04267614|564601433|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
156411884|NCT04267614|564601433|FG000|Overall Study|Lost to Follow-up|115|||
156411885|NCT00119262|564601438|FG000|Overall Study|Lack of Efficacy|0|||
156411886|NCT00119262|564601439|FG001|Overall Study|Lack of Efficacy|3|||
156411887|NCT00119262|564601438|FG000|Overall Study|Withdrawal by Subject|12|||
156411888|NCT00119262|564601439|FG001|Overall Study|Withdrawal by Subject|11|||
156411889|NCT00119262|564601438|FG000|Overall Study|Adverse Event|33|||
156411890|NCT00119262|564601439|FG001|Overall Study|Adverse Event|35|||
156411891|NCT00119262|564601438|FG000|Overall Study|other disease|0|||
156411892|NCT00119262|564601439|FG001|Overall Study|other disease|2|||
156411893|NCT00119262|564601438|FG000|Overall Study|ineligble|1|||
156411894|NCT00119262|564601439|FG001|Overall Study|ineligble|2|||
156411895|NCT00119262|564601438|FG000|Overall Study|others|0|||
156411896|NCT00119262|564601439|FG001|Overall Study|others|5|||
156411897|NCT00988351|564601440|FG000|Overall Study|Withdrawal by Subject|8|||
156411898|NCT00988351|564601441|FG001|Overall Study|Withdrawal by Subject|0|||
156411899|NCT00988351|564601440|FG000|Overall Study|Lost to Follow-up|6|||
156411900|NCT00988351|564601441|FG001|Overall Study|Lost to Follow-up|9|||
156411901|NCT00988351|564601440|FG000|Overall Study|not using CPAP|5|||
156411902|NCT00988351|564601441|FG001|Overall Study|not using CPAP|3|||
156411903|NCT01799720|564601442|FG000|Overall Study|Withdrawal by Subject|3|||
156411904|NCT01799720|564601443|FG001|Overall Study|Withdrawal by Subject|0|||
156411905|NCT01799720|564601444|FG002|Overall Study|Withdrawal by Subject|0|||
156411906|NCT01799720|564601442|FG000|Overall Study|Protocol Violation|0|||
156642689|NCT04682639|565440791|FG004|OLE Period (28 Weeks)|Other|1|||
156642690|NCT04682639|565440787|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
156642691|NCT04682639|565440788|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
156642692|NCT04682639|565440789|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
156642693|NCT04682639|565440790|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
156642694|NCT04682639|565440791|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
156642695|NCT04682639|565440787|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
156642696|NCT04682639|565440788|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
156642697|NCT04682639|565440789|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156642698|NCT04682639|565440790|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156642699|NCT04682639|565440791|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156642700|NCT04682639|565440787|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
156642701|NCT04682639|565440788|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
156642702|NCT04682639|565440789|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156642703|NCT04682639|565440790|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156642704|NCT04682639|565440791|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156642705|NCT04682639|565440787|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
156642706|NCT04682639|565440788|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
156642707|NCT04682639|565440789|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
156642708|NCT04682639|565440790|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
156642709|NCT04682639|565440791|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
156642710|NCT04388527|565440792|FG000|Overall Study|Death|14|||
156642711|NCT04388527|565440792|FG000|Overall Study|Withdrawal by Subject|2|||
156642712|NCT04388527|565440792|FG000|Overall Study|Lost to Follow-up|1|||
156642713|NCT03471182|565440793|FG000|Overall Study|Withdrawal by Subject|1|||
156642714|NCT03471182|565440794|FG001|Overall Study|Withdrawal by Subject|1|||
156642715|NCT03471182|565440795|FG002|Overall Study|Withdrawal by Subject|0|||
156642716|NCT03471182|565440793|FG000|Overall Study|Technical failure|2|||
156642717|NCT03471182|565440794|FG001|Overall Study|Technical failure|0|||
156642718|NCT03471182|565440795|FG002|Overall Study|Technical failure|0|||
156642719|NCT03451331|565440799|FG000|Overall Study|Withdrawal by Subject|1|||
156642720|NCT03451331|565440800|FG001|Overall Study|Withdrawal by Subject|0|||
156642721|NCT03451331|565440799|FG000|Overall Study|Unable to start treatment.|1|||
156642722|NCT03451331|565440800|FG001|Overall Study|Unable to start treatment.|1|||
156642723|NCT02773446|565440801|FG000|First Admission|Withdrawal by Subject|0|||
156642724|NCT02773446|565440802|FG001|First Admission|Withdrawal by Subject|0|||
156642725|NCT02773446|565440803|FG002|First Admission|Withdrawal by Subject|0|||
156642726|NCT02773446|565440804|FG003|First Admission|Withdrawal by Subject|1|||
156642727|NCT02773446|565440805|FG004|First Admission|Withdrawal by Subject|0|||
156642728|NCT02773446|565440806|FG005|First Admission|Withdrawal by Subject|0|||
156642729|NCT02773446|565440801|FG000|First Admission|Lost to Follow-up|1|||
156642730|NCT02773446|565440802|FG001|First Admission|Lost to Follow-up|0|||
156642731|NCT02773446|565440803|FG002|First Admission|Lost to Follow-up|0|||
156642732|NCT02773446|565440804|FG003|First Admission|Lost to Follow-up|0|||
156642733|NCT02773446|565440805|FG004|First Admission|Lost to Follow-up|0|||
156642734|NCT02773446|565440806|FG005|First Admission|Lost to Follow-up|0|||
156642735|NCT00289731|565440807|FG000|Overall Study|Adverse Event|1|||
156642736|NCT00289731|565440808|FG001|Overall Study|Adverse Event|2|||
156642737|NCT00289731|565440809|FG002|Overall Study|Adverse Event|2|||
156642738|NCT00289731|565440807|FG000|Overall Study|Other|1|||
156642739|NCT00289731|565440808|FG001|Overall Study|Other|0|||
156642740|NCT00289731|565440809|FG002|Overall Study|Other|0|||
156642741|NCT04023994|565440810|FG000|Overall Study|Lost to Follow-up|0|||
156411907|NCT01799720|564601443|FG001|Overall Study|Protocol Violation|1|||
156642742|NCT04023994|565440811|FG001|Overall Study|Lost to Follow-up|1|||
156642743|NCT04023994|565440812|FG002|Overall Study|Lost to Follow-up|2|||
156642744|NCT04023994|565440813|FG003|Overall Study|Lost to Follow-up|0|||
156411908|NCT01799720|564601444|FG002|Overall Study|Protocol Violation|0|||
156411909|NCT01799720|564601442|FG000|Overall Study|Pregnancy|0|||
156411910|NCT01799720|564601443|FG001|Overall Study|Pregnancy|0|||
156411911|NCT01799720|564601444|FG002|Overall Study|Pregnancy|1|||
156411912|NCT05832437|564601460|FG000|Overall Study|time off work|1|||
156411913|NCT05832437|564601461|FG001|Overall Study|time off work|0|||
156411914|NCT05832437|564601462|FG002|Overall Study|time off work|0|||
156411915|NCT05832437|564601463|FG003|Overall Study|time off work|0|||
156411916|NCT05376371|564601464|FG000|Overall Study|change in release date|10|||
156411917|NCT00337662|564601465|FG000|Study Period II|Lost to Follow-up|0|||
156411918|NCT00337662|564601466|FG001|Study Period II|Lost to Follow-up|0|||
156411919|NCT00337662|564601467|FG002|Study Period II|Lost to Follow-up|0|||
156411920|NCT00337662|564601468|FG003|Study Period II|Lost to Follow-up|35|||
156411921|NCT00337662|564601465|FG000|Study Period II|Withdrawal by Subject|0|||
156411922|NCT00337662|564601466|FG001|Study Period II|Withdrawal by Subject|0|||
156411923|NCT00337662|564601467|FG002|Study Period II|Withdrawal by Subject|0|||
156411924|NCT00337662|564601468|FG003|Study Period II|Withdrawal by Subject|20|||
156411925|NCT00337662|564601465|FG000|Study Period II|Adverse Event|0|||
156411926|NCT00337662|564601466|FG001|Study Period II|Adverse Event|0|||
156411927|NCT00337662|564601467|FG002|Study Period II|Adverse Event|0|||
156411928|NCT00337662|564601468|FG003|Study Period II|Adverse Event|16|||
156411929|NCT00337662|564601465|FG000|Study Period II|Physician Decision|0|||
156411930|NCT00337662|564601466|FG001|Study Period II|Physician Decision|0|||
156411931|NCT00337662|564601467|FG002|Study Period II|Physician Decision|0|||
156411932|NCT00337662|564601468|FG003|Study Period II|Physician Decision|13|||
156411933|NCT00337662|564601465|FG000|Study Period II|Entry Criteria Not Met|0|||
156411934|NCT00337662|564601466|FG001|Study Period II|Entry Criteria Not Met|0|||
156411935|NCT00337662|564601467|FG002|Study Period II|Entry Criteria Not Met|0|||
156411936|NCT00337662|564601468|FG003|Study Period II|Entry Criteria Not Met|6|||
156411937|NCT00337662|564601465|FG000|Study Period II|Protocol Violation|0|||
156411938|NCT00337662|564601466|FG001|Study Period II|Protocol Violation|0|||
156411939|NCT00337662|564601467|FG002|Study Period II|Protocol Violation|0|||
156411940|NCT00337662|564601468|FG003|Study Period II|Protocol Violation|6|||
156411941|NCT00337662|564601465|FG000|Study Period II|Lack of Efficacy|0|||
156411942|NCT00337662|564601466|FG001|Study Period II|Lack of Efficacy|0|||
156411943|NCT00337662|564601467|FG002|Study Period II|Lack of Efficacy|0|||
156411944|NCT00337662|564601468|FG003|Study Period II|Lack of Efficacy|7|||
156411945|NCT00337662|564601465|FG000|Study Period II|Sponsor Decision|0|||
156411946|NCT00337662|564601466|FG001|Study Period II|Sponsor Decision|0|||
156411947|NCT00337662|564601467|FG002|Study Period II|Sponsor Decision|0|||
156411948|NCT00337662|564601468|FG003|Study Period II|Sponsor Decision|2|||
156411949|NCT00337662|564601465|FG000|Study Period II|Parent/Caregiver Decision|0|||
156411950|NCT00337662|564601466|FG001|Study Period II|Parent/Caregiver Decision|0|||
156411951|NCT00337662|564601467|FG002|Study Period II|Parent/Caregiver Decision|0|||
156411952|NCT00337662|564601468|FG003|Study Period II|Parent/Caregiver Decision|1|||
156411953|NCT00337662|564601465|FG000|Study Period III|Lost to Follow-up|14|||
156411954|NCT00337662|564601466|FG001|Study Period III|Lost to Follow-up|16|||
156411955|NCT00337662|564601467|FG002|Study Period III|Lost to Follow-up|14|||
156411956|NCT00337662|564601468|FG003|Study Period III|Lost to Follow-up|0|||
156411957|NCT00337662|564601465|FG000|Study Period III|Withdrawal by Subject|18|||
156411958|NCT00337662|564601466|FG001|Study Period III|Withdrawal by Subject|14|||
156411959|NCT00337662|564601467|FG002|Study Period III|Withdrawal by Subject|12|||
156411960|NCT00337662|564601468|FG003|Study Period III|Withdrawal by Subject|0|||
156411961|NCT00337662|564601465|FG000|Study Period III|Adverse Event|9|||
156411962|NCT00337662|564601466|FG001|Study Period III|Adverse Event|10|||
156411963|NCT00337662|564601467|FG002|Study Period III|Adverse Event|8|||
156411964|NCT00337662|564601468|FG003|Study Period III|Adverse Event|0|||
156411965|NCT00337662|564601465|FG000|Study Period III|Protocol Violation|3|||
156411966|NCT00337662|564601466|FG001|Study Period III|Protocol Violation|8|||
156411967|NCT00337662|564601467|FG002|Study Period III|Protocol Violation|2|||
156411968|NCT00337662|564601468|FG003|Study Period III|Protocol Violation|0|||
156411969|NCT00337662|564601465|FG000|Study Period III|Physician Decision|6|||
156411970|NCT00337662|564601466|FG001|Study Period III|Physician Decision|5|||
156411971|NCT00337662|564601467|FG002|Study Period III|Physician Decision|0|||
156411972|NCT00337662|564601468|FG003|Study Period III|Physician Decision|0|||
156411973|NCT00337662|564601465|FG000|Study Period III|Entry Criteria Not Met|4|||
156411974|NCT00337662|564601466|FG001|Study Period III|Entry Criteria Not Met|1|||
156411975|NCT00337662|564601467|FG002|Study Period III|Entry Criteria Not Met|3|||
156411976|NCT00337662|564601468|FG003|Study Period III|Entry Criteria Not Met|0|||
156411977|NCT00337662|564601465|FG000|Study Period III|Lack of Efficacy|4|||
156411978|NCT00337662|564601466|FG001|Study Period III|Lack of Efficacy|4|||
156411979|NCT00337662|564601467|FG002|Study Period III|Lack of Efficacy|2|||
156411980|NCT00337662|564601468|FG003|Study Period III|Lack of Efficacy|0|||
156411981|NCT00337662|564601465|FG000|Study Period III|Parent/Caregiver Decision|0|||
156411982|NCT00337662|564601466|FG001|Study Period III|Parent/Caregiver Decision|0|||
156411983|NCT00337662|564601467|FG002|Study Period III|Parent/Caregiver Decision|2|||
156411984|NCT00337662|564601468|FG003|Study Period III|Parent/Caregiver Decision|0|||
156411985|NCT00337662|564601465|FG000|Study Period III|Sponsor Decision|1|||
156642745|NCT04023994|565440814|FG004|Overall Study|Lost to Follow-up|0|||
156642746|NCT04023994|565440815|FG005|Overall Study|Lost to Follow-up|0|||
156642747|NCT04023994|565440810|FG000|Overall Study|Withdrawal by Subject|0|||
156642748|NCT04023994|565440811|FG001|Overall Study|Withdrawal by Subject|0|||
156642749|NCT04023994|565440812|FG002|Overall Study|Withdrawal by Subject|0|||
156642750|NCT04023994|565440813|FG003|Overall Study|Withdrawal by Subject|1|||
156642751|NCT04023994|565440814|FG004|Overall Study|Withdrawal by Subject|0|||
156642752|NCT04023994|565440815|FG005|Overall Study|Withdrawal by Subject|0|||
156642753|NCT01613131|565440816|FG000|Overall Study|Withdrawal by Subject|3|||
156642754|NCT01613131|565440817|FG001|Overall Study|Withdrawal by Subject|5|||
156642755|NCT02454972|565440818|FG000|Overall Study|Progressive disease|17|||
156642756|NCT02454972|565440819|FG001|Overall Study|Progressive disease|16|||
156642757|NCT02454972|565440820|FG002|Overall Study|Progressive disease|59|||
156642758|NCT02454972|565440821|FG003|Overall Study|Progressive disease|23|||
156642759|NCT02454972|565440822|FG004|Overall Study|Progressive disease|16|||
156642760|NCT02454972|565440823|FG005|Overall Study|Progressive disease|12|||
156642761|NCT02454972|565440824|FG006|Overall Study|Progressive disease|19|||
156642762|NCT02454972|565440825|FG007|Overall Study|Progressive disease|27|||
156642763|NCT02454972|565440826|FG008|Overall Study|Progressive disease|0|||
156642764|NCT02454972|565440818|FG000|Overall Study|Death|0|||
156642765|NCT02454972|565440819|FG001|Overall Study|Death|0|||
156642766|NCT02454972|565440820|FG002|Overall Study|Death|5|||
156642767|NCT02454972|565440821|FG003|Overall Study|Death|1|||
156642768|NCT02454972|565440822|FG004|Overall Study|Death|0|||
156642769|NCT02454972|565440823|FG005|Overall Study|Death|0|||
156642770|NCT02454972|565440824|FG006|Overall Study|Death|0|||
156642771|NCT02454972|565440825|FG007|Overall Study|Death|0|||
156642772|NCT02454972|565440826|FG008|Overall Study|Death|95|||
156642773|NCT02454972|565440818|FG000|Overall Study|Physician Decision|0|||
156642774|NCT02454972|565440819|FG001|Overall Study|Physician Decision|1|||
156642775|NCT02454972|565440820|FG002|Overall Study|Physician Decision|2|||
156642776|NCT02454972|565440821|FG003|Overall Study|Physician Decision|1|||
156642777|NCT02454972|565440822|FG004|Overall Study|Physician Decision|2|||
156642778|NCT02454972|565440823|FG005|Overall Study|Physician Decision|0|||
156642779|NCT02454972|565440824|FG006|Overall Study|Physician Decision|0|||
156642780|NCT02454972|565440825|FG007|Overall Study|Physician Decision|1|||
156642781|NCT02454972|565440826|FG008|Overall Study|Physician Decision|0|||
156642782|NCT02454972|565440818|FG000|Overall Study|Non treatment-related adverse event|2|||
156411986|NCT00337662|564601466|FG001|Study Period III|Sponsor Decision|0|||
156642783|NCT02454972|565440819|FG001|Overall Study|Non treatment-related adverse event|0|||
156642784|NCT02454972|565440820|FG002|Overall Study|Non treatment-related adverse event|1|||
156642785|NCT02454972|565440821|FG003|Overall Study|Non treatment-related adverse event|0|||
156642786|NCT02454972|565440822|FG004|Overall Study|Non treatment-related adverse event|0|||
156642787|NCT02454972|565440823|FG005|Overall Study|Non treatment-related adverse event|1|||
156642788|NCT02454972|565440824|FG006|Overall Study|Non treatment-related adverse event|0|||
156642789|NCT02454972|565440825|FG007|Overall Study|Non treatment-related adverse event|1|||
156411987|NCT00337662|564601467|FG002|Study Period III|Sponsor Decision|1|||
156642790|NCT02454972|565440826|FG008|Overall Study|Non treatment-related adverse event|0|||
156642791|NCT02454972|565440818|FG000|Overall Study|Treatment-related adverse events|0|||
156642792|NCT02454972|565440819|FG001|Overall Study|Treatment-related adverse events|1|||
156642793|NCT02454972|565440820|FG002|Overall Study|Treatment-related adverse events|1|||
156642794|NCT02454972|565440821|FG003|Overall Study|Treatment-related adverse events|0|||
156642795|NCT02454972|565440822|FG004|Overall Study|Treatment-related adverse events|2|||
156642796|NCT02454972|565440823|FG005|Overall Study|Treatment-related adverse events|0|||
156642797|NCT02454972|565440824|FG006|Overall Study|Treatment-related adverse events|0|||
156642798|NCT02454972|565440825|FG007|Overall Study|Treatment-related adverse events|2|||
156642799|NCT02454972|565440826|FG008|Overall Study|Treatment-related adverse events|0|||
156642800|NCT02454972|565440818|FG000|Overall Study|Patient moves to compassionate use|0|||
156642801|NCT02454972|565440819|FG001|Overall Study|Patient moves to compassionate use|0|||
156642802|NCT02454972|565440820|FG002|Overall Study|Patient moves to compassionate use|0|||
156642803|NCT02454972|565440821|FG003|Overall Study|Patient moves to compassionate use|0|||
156642804|NCT02454972|565440822|FG004|Overall Study|Patient moves to compassionate use|0|||
156642805|NCT02454972|565440823|FG005|Overall Study|Patient moves to compassionate use|0|||
156642806|NCT02454972|565440824|FG006|Overall Study|Patient moves to compassionate use|2|||
156642807|NCT02454972|565440825|FG007|Overall Study|Patient moves to compassionate use|0|||
156642808|NCT02454972|565440826|FG008|Overall Study|Patient moves to compassionate use|0|||
156642809|NCT02454972|565440818|FG000|Overall Study|Withdrawal by Subject|0|||
156642810|NCT02454972|565440819|FG001|Overall Study|Withdrawal by Subject|1|||
156642811|NCT02454972|565440820|FG002|Overall Study|Withdrawal by Subject|5|||
156642812|NCT02454972|565440821|FG003|Overall Study|Withdrawal by Subject|2|||
156642813|NCT02454972|565440822|FG004|Overall Study|Withdrawal by Subject|3|||
156642814|NCT02454972|565440823|FG005|Overall Study|Withdrawal by Subject|2|||
156642815|NCT02454972|565440824|FG006|Overall Study|Withdrawal by Subject|0|||
156642816|NCT02454972|565440825|FG007|Overall Study|Withdrawal by Subject|1|||
156642817|NCT02454972|565440826|FG008|Overall Study|Withdrawal by Subject|2|||
156642818|NCT02454972|565440818|FG000|Overall Study|Multiple delay/holds on treatment|0|||
156642819|NCT02454972|565440819|FG001|Overall Study|Multiple delay/holds on treatment|0|||
156642820|NCT02454972|565440820|FG002|Overall Study|Multiple delay/holds on treatment|0|||
156642821|NCT02454972|565440821|FG003|Overall Study|Multiple delay/holds on treatment|1|||
156642822|NCT02454972|565440822|FG004|Overall Study|Multiple delay/holds on treatment|0|||
156411988|NCT00337662|564601468|FG003|Study Period III|Sponsor Decision|0|||
156642823|NCT02454972|565440823|FG005|Overall Study|Multiple delay/holds on treatment|0|||
156642824|NCT02454972|565440824|FG006|Overall Study|Multiple delay/holds on treatment|0|||
156642825|NCT02454972|565440825|FG007|Overall Study|Multiple delay/holds on treatment|0|||
156642826|NCT02454972|565440826|FG008|Overall Study|Multiple delay/holds on treatment|0|||
156642827|NCT02454972|565440818|FG000|Overall Study|Never treated|0|||
156642828|NCT02454972|565440819|FG001|Overall Study|Never treated|0|||
156642829|NCT02454972|565440820|FG002|Overall Study|Never treated|3|||
156642830|NCT02454972|565440821|FG003|Overall Study|Never treated|1|||
156642831|NCT02454972|565440822|FG004|Overall Study|Never treated|1|||
156642832|NCT02454972|565440823|FG005|Overall Study|Never treated|0|||
156642833|NCT02454972|565440824|FG006|Overall Study|Never treated|0|||
156642834|NCT02454972|565440825|FG007|Overall Study|Never treated|0|||
156642835|NCT02454972|565440826|FG008|Overall Study|Never treated|5|||
156642836|NCT02454972|565440818|FG000|Overall Study|Lost to Follow-up|0|||
156642837|NCT02454972|565440819|FG001|Overall Study|Lost to Follow-up|0|||
156642838|NCT02454972|565440820|FG002|Overall Study|Lost to Follow-up|0|||
156642839|NCT02454972|565440821|FG003|Overall Study|Lost to Follow-up|0|||
156642840|NCT02454972|565440822|FG004|Overall Study|Lost to Follow-up|0|||
156642841|NCT02454972|565440823|FG005|Overall Study|Lost to Follow-up|0|||
156642842|NCT02454972|565440824|FG006|Overall Study|Lost to Follow-up|0|||
156642843|NCT02454972|565440825|FG007|Overall Study|Lost to Follow-up|0|||
156642844|NCT02454972|565440826|FG008|Overall Study|Lost to Follow-up|2|||
156642845|NCT02454972|565440818|FG000|Overall Study|Study termination|0|||
156642846|NCT02454972|565440819|FG001|Overall Study|Study termination|0|||
156642847|NCT02454972|565440820|FG002|Overall Study|Study termination|0|||
156642848|NCT02454972|565440821|FG003|Overall Study|Study termination|0|||
156642849|NCT02454972|565440822|FG004|Overall Study|Study termination|0|||
156642850|NCT02454972|565440823|FG005|Overall Study|Study termination|0|||
156642851|NCT02454972|565440824|FG006|Overall Study|Study termination|0|||
156642852|NCT02454972|565440825|FG007|Overall Study|Study termination|0|||
156642853|NCT02454972|565440826|FG008|Overall Study|Study termination|6|||
156642854|NCT01070966|565440833|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
156642855|NCT01070966|565440833|FG000|Participants for Safety Evaluation|Off-label use|9|||
156642856|NCT01070966|565440833|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
156642857|NCT01070966|565440833|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
156642858|NCT01070966|565440833|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
156642859|NCT01070966|565440833|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
156642860|NCT01070966|565440833|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
156642861|NCT01070966|565440833|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
156642862|NCT02770716|565440835|FG000|Overall Study|Death|101|||
156642863|NCT02770716|565440836|FG001|Overall Study|Death|45|||
156642864|NCT02770716|565440835|FG000|Overall Study|Withdrawal by Subject|4|||
156642865|NCT02770716|565440836|FG001|Overall Study|Withdrawal by Subject|2|||
156642866|NCT02770716|565440835|FG000|Overall Study|Lost to Follow-up|1|||
156642867|NCT02770716|565440836|FG001|Overall Study|Lost to Follow-up|0|||
156642868|NCT02770716|565440835|FG000|Overall Study|Various reasons|6|||
156642869|NCT02770716|565440836|FG001|Overall Study|Various reasons|2|||
156642870|NCT01725113|565440837|FG000|Overall Study|Kidney Transplant|1|||
156642871|NCT01725113|565440838|FG001|Overall Study|Kidney Transplant|1|||
156642872|NCT01725113|565440837|FG000|Overall Study|Withdrawal by Subject|0|||
156642873|NCT01725113|565440838|FG001|Overall Study|Withdrawal by Subject|1|||
156642874|NCT02753400|565440839|FG000|Overall Study|Adverse Event|3|||
156642875|NCT02753400|565440840|FG001|Overall Study|Adverse Event|0|||
156642876|NCT02753400|565440839|FG000|Overall Study|Withdrawal by Subject|2|||
156642877|NCT02753400|565440840|FG001|Overall Study|Withdrawal by Subject|1|||
156642878|NCT03989115|565440841|FG000|Overall Study|Withdrawal by Subject|2|||
156642879|NCT03989115|565440842|FG001|Overall Study|Withdrawal by Subject|1|||
156642880|NCT03989115|565440843|FG002|Overall Study|Withdrawal by Subject|3|||
156642881|NCT03989115|565440844|FG003|Overall Study|Withdrawal by Subject|0|||
156642882|NCT03989115|565440845|FG004|Overall Study|Withdrawal by Subject|17|||
156642883|NCT03989115|565440846|FG005|Overall Study|Withdrawal by Subject|1|||
156642884|NCT03989115|565440847|FG006|Overall Study|Withdrawal by Subject|0|||
156642885|NCT03989115|565440848|FG007|Overall Study|Withdrawal by Subject|0|||
156642886|NCT03989115|565440841|FG000|Overall Study|Sponsor decision to terminate the study|1|||
156642887|NCT03989115|565440842|FG001|Overall Study|Sponsor decision to terminate the study|1|||
156642888|NCT03989115|565440843|FG002|Overall Study|Sponsor decision to terminate the study|0|||
156642889|NCT03989115|565440844|FG003|Overall Study|Sponsor decision to terminate the study|1|||
156642890|NCT03989115|565440845|FG004|Overall Study|Sponsor decision to terminate the study|11|||
156642891|NCT03989115|565440846|FG005|Overall Study|Sponsor decision to terminate the study|0|||
156642892|NCT03989115|565440847|FG006|Overall Study|Sponsor decision to terminate the study|2|||
156642893|NCT03989115|565440848|FG007|Overall Study|Sponsor decision to terminate the study|1|||
156642894|NCT03989115|565440841|FG000|Overall Study|Lost to Follow-up|2|||
156642895|NCT03989115|565440842|FG001|Overall Study|Lost to Follow-up|0|||
156642896|NCT03989115|565440843|FG002|Overall Study|Lost to Follow-up|0|||
156642897|NCT03989115|565440844|FG003|Overall Study|Lost to Follow-up|0|||
156642898|NCT03989115|565440845|FG004|Overall Study|Lost to Follow-up|1|||
156642899|NCT03989115|565440846|FG005|Overall Study|Lost to Follow-up|0|||
156642900|NCT03989115|565440847|FG006|Overall Study|Lost to Follow-up|0|||
156642901|NCT03989115|565440848|FG007|Overall Study|Lost to Follow-up|0|||
156642902|NCT03989115|565440841|FG000|Overall Study|Death|2|||
156642903|NCT03989115|565440842|FG001|Overall Study|Death|2|||
156642904|NCT03989115|565440843|FG002|Overall Study|Death|9|||
156642905|NCT03989115|565440844|FG003|Overall Study|Death|6|||
156642906|NCT03989115|565440845|FG004|Overall Study|Death|31|||
156642907|NCT03989115|565440846|FG005|Overall Study|Death|6|||
156642908|NCT03989115|565440847|FG006|Overall Study|Death|2|||
156642909|NCT03989115|565440848|FG007|Overall Study|Death|3|||
156642910|NCT03989115|565440841|FG000|Overall Study|Other|1|||
156642911|NCT03989115|565440842|FG001|Overall Study|Other|2|||
156642912|NCT03989115|565440843|FG002|Overall Study|Other|0|||
156411989|NCT00337662|564601465|FG000|Study Period III|Clinical Relapse|1|||
156411990|NCT00337662|564601466|FG001|Study Period III|Clinical Relapse|0|||
156411991|NCT00337662|564601467|FG002|Study Period III|Clinical Relapse|0|||
156411992|NCT00337662|564601468|FG003|Study Period III|Clinical Relapse|0|||
156411993|NCT00882921|564601472|FG000|Overall Study|Death|2|||
156411994|NCT00882921|564601472|FG000|Overall Study|Other|3|||
156411995|NCT00882921|564601472|FG000|Overall Study|Lost to Follow-up|2|||
156411996|NCT00882921|564601472|FG000|Overall Study|Termination By Investigator|3|||
156411997|NCT00882921|564601472|FG000|Overall Study|Withdrawal Of Consent|1|||
156411998|NCT05027074|564601485|FG000|Overall Study|Death|47|||
156411999|NCT05027074|564601486|FG001|Overall Study|Death|42|||
156412000|NCT05027074|564601487|FG002|Overall Study|Death|39|||
156412001|NCT05027074|564601485|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156412002|NCT05027074|564601486|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156412003|NCT05027074|564601487|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156412004|NCT05027074|564601485|FG000|Overall Study|Site Terminated By Sponsor|3|||
156412005|NCT05027074|564601486|FG001|Overall Study|Site Terminated By Sponsor|0|||
156412006|NCT05027074|564601487|FG002|Overall Study|Site Terminated By Sponsor|2|||
156412007|NCT05027074|564601485|FG000|Overall Study|Withdrawal by Subject|13|||
156412008|NCT05027074|564601486|FG001|Overall Study|Withdrawal by Subject|8|||
156412009|NCT05027074|564601487|FG002|Overall Study|Withdrawal by Subject|10|||
156412010|NCT05027074|564601485|FG000|Overall Study|Lost to Follow-up|2|||
156412011|NCT05027074|564601486|FG001|Overall Study|Lost to Follow-up|4|||
156412012|NCT05027074|564601487|FG002|Overall Study|Lost to Follow-up|3|||
156412013|NCT05027074|564601485|FG000|Overall Study|Status Not Recorded|0|||
156412014|NCT05027074|564601486|FG001|Overall Study|Status Not Recorded|0|||
156412015|NCT05027074|564601487|FG002|Overall Study|Status Not Recorded|1|||
156412016|NCT02058290|564601492|FG000|Overall Study|Protocol Violation|2|||
156412017|NCT02058290|564601493|FG001|Overall Study|Protocol Violation|1|||
156412018|NCT02058290|564601492|FG000|Overall Study|Physician Decision|1|||
156412019|NCT02058290|564601493|FG001|Overall Study|Physician Decision|0|||
156412020|NCT02058290|564601492|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
156412021|NCT02058290|564601493|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
156412022|NCT02058290|564601492|FG000|Overall Study|Withdrawal by Subject|0|||
156412023|NCT02058290|564601493|FG001|Overall Study|Withdrawal by Subject|1|||
156412024|NCT04150029|564601501|FG000|Overall Study|Disease Relapse|0|||
156412025|NCT04150029|564601502|FG001|Overall Study|Disease Relapse|18|||
156412026|NCT04150029|564601501|FG000|Overall Study|Progressive Disease|2|||
156412027|NCT04150029|564601502|FG001|Overall Study|Progressive Disease|16|||
156412028|NCT04150029|564601501|FG000|Overall Study|Adverse Event|1|||
156412029|NCT04150029|564601502|FG001|Overall Study|Adverse Event|11|||
156412030|NCT04150029|564601501|FG000|Overall Study|Physician Decision|0|||
156412031|NCT04150029|564601502|FG001|Overall Study|Physician Decision|10|||
156412032|NCT04150029|564601501|FG000|Overall Study|Study Terminated by Sponsor|1|||
156412033|NCT04150029|564601502|FG001|Overall Study|Study Terminated by Sponsor|10|||
156412034|NCT04150029|564601501|FG000|Overall Study|Death|0|||
156412035|NCT04150029|564601502|FG001|Overall Study|Death|8|||
156412036|NCT04150029|564601501|FG000|Overall Study|Participant Decision|0|||
156412037|NCT04150029|564601502|FG001|Overall Study|Participant Decision|7|||
156412038|NCT04150029|564601501|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
156412039|NCT04150029|564601502|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
156412040|NCT01625910|564602768|FG000|Overall Study|Lost to Follow-up|3|||
156412041|NCT01625910|564602769|FG001|Overall Study|Lost to Follow-up|4|||
156412042|NCT02959138|564602770|FG000|Overall Study|Enrolled but Never Treated|0|||
156642913|NCT03989115|565440844|FG003|Overall Study|Other|0|||
156642914|NCT03989115|565440845|FG004|Overall Study|Other|5|||
156412043|NCT02959138|564602771|FG001|Overall Study|Enrolled but Never Treated|1|||
156412044|NCT02959138|564602772|FG002|Overall Study|Enrolled but Never Treated|0|||
156412045|NCT01681368|564602775|FG000|Overall Study|Refused further treatment|1|||
156412046|NCT01681368|564602775|FG000|Overall Study|Refused further follow up|1|||
156412047|NCT00900627|564602778|FG000|Overall Study|Condition under investigation worsened|4|||
156642915|NCT03989115|565440846|FG005|Overall Study|Other|0|||
156642916|NCT03989115|565440847|FG006|Overall Study|Other|0|||
156642917|NCT03989115|565440848|FG007|Overall Study|Other|0|||
156412048|NCT00900627|564602779|FG001|Overall Study|Condition under investigation worsened|0|||
156642918|NCT01415921|565440849|FG000|Overall Study|Adverse Event|0|||
156642919|NCT01415921|565440850|FG001|Overall Study|Adverse Event|1|||
156642920|NCT01415921|565440849|FG000|Overall Study|Physician Decision|1|||
156642921|NCT01415921|565440850|FG001|Overall Study|Physician Decision|1|||
156642922|NCT01415921|565440849|FG000|Overall Study|Withdrawal by Subject|0|||
156642923|NCT01415921|565440850|FG001|Overall Study|Withdrawal by Subject|1|||
156642924|NCT01415921|565440849|FG000|Overall Study|Other|2|||
156642925|NCT01415921|565440850|FG001|Overall Study|Other|0|||
156642926|NCT02143947|565440851|FG000|Overall Study|Lost to Follow-up|4|||
156642927|NCT02143947|565440852|FG001|Overall Study|Lost to Follow-up|2|||
156642928|NCT01244815|565440855|FG000|Overall Study|Not Treated|0|||
156642929|NCT01244815|565440856|FG001|Overall Study|Not Treated|1|||
156642930|NCT01244815|565440857|FG002|Overall Study|Not Treated|0|||
156642931|NCT01244815|565440858|FG003|Overall Study|Not Treated|0|||
156642932|NCT01244815|565440855|FG000|Overall Study|Adverse Event|4|||
156642933|NCT01244815|565440856|FG001|Overall Study|Adverse Event|7|||
156642934|NCT01244815|565440857|FG002|Overall Study|Adverse Event|5|||
156642935|NCT01244815|565440858|FG003|Overall Study|Adverse Event|5|||
156642936|NCT01244815|565440855|FG000|Overall Study|Treatment Failure|0|||
156642937|NCT01244815|565440856|FG001|Overall Study|Treatment Failure|0|||
156642938|NCT01244815|565440857|FG002|Overall Study|Treatment Failure|0|||
156642939|NCT01244815|565440858|FG003|Overall Study|Treatment Failure|1|||
156642940|NCT01244815|565440855|FG000|Overall Study|Lost to Follow-up|3|||
156642941|NCT01244815|565440856|FG001|Overall Study|Lost to Follow-up|2|||
156642942|NCT01244815|565440857|FG002|Overall Study|Lost to Follow-up|3|||
156642943|NCT01244815|565440858|FG003|Overall Study|Lost to Follow-up|2|||
156642944|NCT01244815|565440855|FG000|Overall Study|Withdrawal by Subject|0|||
156642945|NCT01244815|565440856|FG001|Overall Study|Withdrawal by Subject|2|||
156642946|NCT01244815|565440857|FG002|Overall Study|Withdrawal by Subject|0|||
156642947|NCT01244815|565440858|FG003|Overall Study|Withdrawal by Subject|3|||
156642948|NCT01244815|565440855|FG000|Overall Study|Protocol Violation|7|||
156642949|NCT01244815|565440856|FG001|Overall Study|Protocol Violation|4|||
156642950|NCT01244815|565440857|FG002|Overall Study|Protocol Violation|3|||
156642951|NCT01244815|565440858|FG003|Overall Study|Protocol Violation|1|||
156642952|NCT01244815|565440855|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
156642953|NCT01244815|565440856|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
156642954|NCT01244815|565440857|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
156642955|NCT01244815|565440858|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
156642956|NCT00697112|565440859|FG000|Overall Study|Adverse Event|8|||
156642957|NCT00697112|565440859|FG000|Overall Study|Lost to Follow-up|1|||
156642958|NCT00697112|565440859|FG000|Overall Study|Did not meet inclusion criteria|1|||
156642959|NCT03402126|565440864|FG000|Overall Study|Lost to Follow-up|6|||
156642960|NCT03402126|565440864|FG000|Overall Study|Protocol Violation|10|||
156642961|NCT03402126|565440864|FG000|Overall Study|Sponsor request/Study termination|29|||
156642962|NCT03402126|565440864|FG000|Overall Study|Study product no longer in use|1|||
156642963|NCT03402126|565440864|FG000|Overall Study|Technical problems|1|||
156642964|NCT03402126|565440864|FG000|Overall Study|Withdrawal by Subject|6|||
156642965|NCT03402126|565440864|FG000|Overall Study|Physician Decision|2|||
156642966|NCT03402126|565440864|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
156642967|NCT03402126|565440864|FG000|Overall Study|Death|4|||
156642968|NCT02261974|565440865|FG000|Overall Study|Withdrawal by Subject|3|||
156642969|NCT02261974|565440866|FG001|Overall Study|Withdrawal by Subject|2|||
156642970|NCT02261974|565440865|FG000|Overall Study|Pregnancy|0|||
156642971|NCT02261974|565440866|FG001|Overall Study|Pregnancy|1|||
156642972|NCT02261974|565440865|FG000|Overall Study|Missed treatment cut-off date|6|||
156642973|NCT02261974|565440866|FG001|Overall Study|Missed treatment cut-off date|3|||
156642974|NCT02261974|565440865|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
156642975|NCT02261974|565440866|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
156642976|NCT02261974|565440865|FG000|Overall Study|Lost to Follow-up|2|||
156642977|NCT02261974|565440866|FG001|Overall Study|Lost to Follow-up|0|||
156642978|NCT02261974|565440865|FG000|Overall Study|Adverse Event|1|||
156642979|NCT02261974|565440866|FG001|Overall Study|Adverse Event|0|||
156642980|NCT00996918|565440867|FG000|Overall Study|Lack of Efficacy|1|||
156642981|NCT00996918|565440868|FG001|Overall Study|Lack of Efficacy|1|||
156642982|NCT00996918|565440869|FG002|Overall Study|Lack of Efficacy|2|||
156642983|NCT00996918|565440870|FG003|Overall Study|Lack of Efficacy|2|||
156642984|NCT00996918|565440871|FG004|Overall Study|Lack of Efficacy|0|||
156642985|NCT00996918|565440867|FG000|Overall Study|Adverse Event|2|||
156642986|NCT00996918|565440868|FG001|Overall Study|Adverse Event|5|||
156642987|NCT00996918|565440869|FG002|Overall Study|Adverse Event|2|||
156642988|NCT00996918|565440870|FG003|Overall Study|Adverse Event|6|||
156642989|NCT00996918|565440871|FG004|Overall Study|Adverse Event|0|||
156642990|NCT00996918|565440867|FG000|Overall Study|Withdrawal by Subject|1|||
156642991|NCT00996918|565440868|FG001|Overall Study|Withdrawal by Subject|4|||
156642992|NCT00996918|565440869|FG002|Overall Study|Withdrawal by Subject|3|||
156642993|NCT00996918|565440870|FG003|Overall Study|Withdrawal by Subject|3|||
156642994|NCT00996918|565440871|FG004|Overall Study|Withdrawal by Subject|2|||
156642995|NCT00996918|565440867|FG000|Overall Study|Physician Decision|1|||
156642996|NCT00996918|565440868|FG001|Overall Study|Physician Decision|0|||
156642997|NCT00996918|565440869|FG002|Overall Study|Physician Decision|0|||
156642998|NCT00996918|565440870|FG003|Overall Study|Physician Decision|0|||
156412049|NCT00900627|564602780|FG002|Overall Study|Condition under investigation worsened|5|||
156412050|NCT00900627|564602781|FG003|Overall Study|Condition under investigation worsened|3|||
156412051|NCT00900627|564602782|FG004|Overall Study|Condition under investigation worsened|0|||
156412052|NCT00900627|564602783|FG005|Overall Study|Condition under investigation worsened|0|||
156412053|NCT00900627|564602778|FG000|Overall Study|Withdrawal by Subject|1|||
156642999|NCT00996918|565440871|FG004|Overall Study|Physician Decision|0|||
156643000|NCT00996918|565440867|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
156643001|NCT00996918|565440868|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
156643002|NCT00996918|565440869|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
156643003|NCT00996918|565440870|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
156643004|NCT00996918|565440871|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
156643005|NCT00996918|565440867|FG000|Overall Study|Loss of Caregiver|0|||
156643006|NCT00996918|565440868|FG001|Overall Study|Loss of Caregiver|1|||
156338253|NCT05248867|564336595|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
156643007|NCT00996918|565440869|FG002|Overall Study|Loss of Caregiver|0|||
156643008|NCT00996918|565440870|FG003|Overall Study|Loss of Caregiver|0|||
156643009|NCT00996918|565440871|FG004|Overall Study|Loss of Caregiver|0|||
156643010|NCT00996918|565440867|FG000|Overall Study|Other|3|||
156643011|NCT00996918|565440868|FG001|Overall Study|Other|1|||
156643012|NCT00996918|565440869|FG002|Overall Study|Other|0|||
156643013|NCT00996918|565440870|FG003|Overall Study|Other|0|||
156643014|NCT00996918|565440871|FG004|Overall Study|Other|0|||
156643015|NCT01466673|565440874|FG000|Overall Study|Non-compliance with study treatment|2|||
156643016|NCT01466673|565440875|FG001|Overall Study|Non-compliance with study treatment|0|||
156643017|NCT01466673|565440874|FG000|Overall Study|Lost to Follow-up|3|||
156643018|NCT01466673|565440875|FG001|Overall Study|Lost to Follow-up|5|||
156643019|NCT01466673|565440874|FG000|Overall Study|Adverse Event|2|||
156643020|NCT01466673|565440875|FG001|Overall Study|Adverse Event|1|||
156643021|NCT02725671|565440876|FG000|Overall Study|Lost to Follow-up|1|||
156643022|NCT02983227|565440883|FG000|Overall Study|Adverse Event|21|||
156643023|NCT02983227|565440884|FG001|Overall Study|Adverse Event|3|||
156643024|NCT02983227|565440883|FG000|Overall Study|Death|3|||
156643025|NCT02983227|565440884|FG001|Overall Study|Death|0|||
156643026|NCT02983227|565440883|FG000|Overall Study|Lack of Efficacy|8|||
156643027|NCT02983227|565440884|FG001|Overall Study|Lack of Efficacy|1|||
156643028|NCT02983227|565440883|FG000|Overall Study|Lost to Follow-up|3|||
156643029|NCT02983227|565440884|FG001|Overall Study|Lost to Follow-up|0|||
156643030|NCT02983227|565440883|FG000|Overall Study|Multiple Reasons|2|||
156643031|NCT02983227|565440884|FG001|Overall Study|Multiple Reasons|1|||
156643032|NCT02983227|565440883|FG000|Overall Study|Physician Decision|3|||
156643033|NCT02983227|565440884|FG001|Overall Study|Physician Decision|1|||
156643034|NCT02983227|565440883|FG000|Overall Study|Withdrawal by Subject|19|||
156643035|NCT02983227|565440884|FG001|Overall Study|Withdrawal by Subject|8|||
156643036|NCT00068445|565440887|FG000|Randomization|Cancel|1|||
156643037|NCT00068445|565440888|FG001|Randomization|Cancel|3|||
156643038|NCT00068445|565440887|FG000|Randomization|Ineligible|1|||
156643039|NCT00068445|565440888|FG001|Randomization|Ineligible|1|||
156643040|NCT00068445|565440887|FG000|Treatment|Refused Further Treatment|13|||
156643041|NCT00068445|565440888|FG001|Treatment|Refused Further Treatment|10|||
156643042|NCT00068445|565440887|FG000|Treatment|Adverse Event|7|||
156643043|NCT00068445|565440888|FG001|Treatment|Adverse Event|1|||
156643044|NCT00068445|565440887|FG000|Treatment|Other (Specifics not available)|9|||
156643045|NCT00068445|565440888|FG001|Treatment|Other (Specifics not available)|5|||
156643046|NCT01155284|565440889|FG000|Overall Study|Withdrawal by Subject|4|||
156643047|NCT01155284|565440890|FG001|Overall Study|Withdrawal by Subject|3|||
156643048|NCT01155284|565440889|FG000|Overall Study|Lost to Follow-up|1|||
156643049|NCT01155284|565440890|FG001|Overall Study|Lost to Follow-up|2|||
156643050|NCT01155284|565440889|FG000|Overall Study|Physician Decision|1|||
156643051|NCT01155284|565440890|FG001|Overall Study|Physician Decision|0|||
156643052|NCT01155284|565440889|FG000|Overall Study|Adverse Event|1|||
156643053|NCT01155284|565440890|FG001|Overall Study|Adverse Event|0|||
156643054|NCT01896700|565440891|FG000|Overall Study|Adverse Event|4|||
156643055|NCT01896700|565440892|FG001|Overall Study|Adverse Event|5|||
156643056|NCT01896700|565440891|FG000|Overall Study|Withdrawal by Subject|0|||
156643057|NCT01896700|565440892|FG001|Overall Study|Withdrawal by Subject|1|||
156643058|NCT00123487|565440893|FG000|Randomized|Death prior to starting treatment|0|||
156643059|NCT00123487|565440894|FG001|Randomized|Death prior to starting treatment|1|||
156643060|NCT00123487|565440893|FG000|Randomized|SAE prior to starting treatment|1|||
156643061|NCT00123487|565440894|FG001|Randomized|SAE prior to starting treatment|0|||
156643062|NCT00123487|565440893|FG000|Treated With Study Drug|Adverse Event|23|||
156643063|NCT00123487|565440894|FG001|Treated With Study Drug|Adverse Event|22|||
156643064|NCT00123487|565440893|FG000|Treated With Study Drug|Disease Progression|141|||
156643065|NCT00123487|565440894|FG001|Treated With Study Drug|Disease Progression|122|||
156643066|NCT00123487|565440893|FG000|Treated With Study Drug|Physician Decision|8|||
156643067|NCT00123487|565440894|FG001|Treated With Study Drug|Physician Decision|9|||
156643068|NCT00123487|565440893|FG000|Treated With Study Drug|Other|59|||
156643069|NCT00123487|565440894|FG001|Treated With Study Drug|Other|58|||
156643070|NCT00123487|565440893|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
156643071|NCT00123487|565440894|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
156643072|NCT00123487|565440893|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
156643073|NCT00123487|565440894|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
156643074|NCT00123487|565440893|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
156643075|NCT00123487|565440894|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
156643076|NCT03118765|565440895|FG000|Overall Study|Withdrawal by Subject|0|||
156643077|NCT03118765|565440896|FG001|Overall Study|Withdrawal by Subject|0|||
156643078|NCT03118765|565440897|FG002|Overall Study|Withdrawal by Subject|1|||
156412054|NCT00900627|564602779|FG001|Overall Study|Withdrawal by Subject|0|||
156412055|NCT00900627|564602780|FG002|Overall Study|Withdrawal by Subject|1|||
156412056|NCT00900627|564602781|FG003|Overall Study|Withdrawal by Subject|0|||
156412057|NCT00900627|564602782|FG004|Overall Study|Withdrawal by Subject|1|||
156412058|NCT00900627|564602783|FG005|Overall Study|Withdrawal by Subject|2|||
156412059|NCT00900627|564602778|FG000|Overall Study|Adverse Event|1|||
156412060|NCT00900627|564602779|FG001|Overall Study|Adverse Event|2|||
156412061|NCT00900627|564602780|FG002|Overall Study|Adverse Event|0|||
156412062|NCT00900627|564602781|FG003|Overall Study|Adverse Event|3|||
156412063|NCT00900627|564602782|FG004|Overall Study|Adverse Event|0|||
156412064|NCT00900627|564602783|FG005|Overall Study|Adverse Event|0|||
156412065|NCT00900627|564602778|FG000|Overall Study|Death|0|||
156643079|NCT03118765|565440898|FG003|Overall Study|Withdrawal by Subject|0|||
156643080|NCT03118765|565440899|FG004|Overall Study|Withdrawal by Subject|0|||
156643081|NCT03118765|565440895|FG000|Overall Study|Adverse Event|1|||
156643082|NCT03118765|565440896|FG001|Overall Study|Adverse Event|1|||
156643083|NCT03118765|565440897|FG002|Overall Study|Adverse Event|1|||
156643084|NCT03118765|565440898|FG003|Overall Study|Adverse Event|1|||
156643085|NCT03118765|565440899|FG004|Overall Study|Adverse Event|1|||
156643086|NCT03118765|565440895|FG000|Overall Study|Non compliance with Study Procedures|0|||
156643087|NCT03118765|565440896|FG001|Overall Study|Non compliance with Study Procedures|0|||
156643088|NCT03118765|565440897|FG002|Overall Study|Non compliance with Study Procedures|0|||
156643089|NCT03118765|565440898|FG003|Overall Study|Non compliance with Study Procedures|1|||
156643090|NCT03118765|565440899|FG004|Overall Study|Non compliance with Study Procedures|0|||
156643091|NCT03118765|565440895|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
156643092|NCT03118765|565440896|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
156643093|NCT03118765|565440897|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
156643094|NCT03118765|565440898|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
156643095|NCT03118765|565440899|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
156643096|NCT03118765|565440895|FG000|Overall Study|COPD Exacerbation|1|||
156643097|NCT03118765|565440896|FG001|Overall Study|COPD Exacerbation|0|||
156643098|NCT03118765|565440897|FG002|Overall Study|COPD Exacerbation|0|||
156643099|NCT03118765|565440898|FG003|Overall Study|COPD Exacerbation|1|||
156412066|NCT00900627|564602779|FG001|Overall Study|Death|0|||
156412067|NCT00900627|564602780|FG002|Overall Study|Death|0|||
156412068|NCT00900627|564602781|FG003|Overall Study|Death|0|||
156412069|NCT00900627|564602782|FG004|Overall Study|Death|28|||
156412070|NCT00900627|564602783|FG005|Overall Study|Death|24|||
156412071|NCT03685708|564602789|FG000|Overall Study|Withdrawal by Subject|0|||
156412072|NCT03685708|564602790|FG001|Overall Study|Withdrawal by Subject|0|||
156412073|NCT03685708|564602791|FG002|Overall Study|Withdrawal by Subject|1|||
156412074|NCT03685708|564602789|FG000|Overall Study|Screen Fail|0|||
156412075|NCT03685708|564602790|FG001|Overall Study|Screen Fail|1|||
156412076|NCT03685708|564602791|FG002|Overall Study|Screen Fail|1|||
156412077|NCT03685708|564602789|FG000|Overall Study|COVID 19 Pandemic|1|||
156412078|NCT03685708|564602790|FG001|Overall Study|COVID 19 Pandemic|1|||
156412079|NCT03685708|564602791|FG002|Overall Study|COVID 19 Pandemic|6|||
156412080|NCT03685708|564602789|FG000|Overall Study|Disease Progression|0|||
156412081|NCT03685708|564602790|FG001|Overall Study|Disease Progression|0|||
156412082|NCT03685708|564602791|FG002|Overall Study|Disease Progression|1|||
156412083|NCT00579982|564602795|FG000|Overall Study|Adverse Event|4|||
156412084|NCT00579982|564602795|FG000|Overall Study|Protocol Violation|4|||
156643100|NCT03118765|565440899|FG004|Overall Study|COPD Exacerbation|0|||
156643101|NCT03118765|565440895|FG000|Overall Study|Lost to Follow-up|1|||
156643102|NCT03118765|565440896|FG001|Overall Study|Lost to Follow-up|0|||
156643103|NCT03118765|565440897|FG002|Overall Study|Lost to Follow-up|1|||
156643104|NCT03118765|565440898|FG003|Overall Study|Lost to Follow-up|0|||
156643105|NCT03118765|565440899|FG004|Overall Study|Lost to Follow-up|0|||
156643106|NCT03118765|565440895|FG000|Overall Study|Sponsor Decision|1|||
156643107|NCT03118765|565440896|FG001|Overall Study|Sponsor Decision|0|||
156643108|NCT03118765|565440897|FG002|Overall Study|Sponsor Decision|1|||
156643109|NCT03118765|565440898|FG003|Overall Study|Sponsor Decision|0|||
156643110|NCT03118765|565440899|FG004|Overall Study|Sponsor Decision|1|||
156643111|NCT02164539|565440902|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
156643112|NCT02164539|565440903|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
156643113|NCT02164539|565440904|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
156643114|NCT02164539|565440905|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
156643115|NCT02164539|565440906|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
156643116|NCT02164539|565440907|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
156643117|NCT02164539|565440908|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
156643118|NCT02164539|565440902|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
156643119|NCT02164539|565440903|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
156643120|NCT02164539|565440904|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
156643121|NCT02164539|565440905|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
156643122|NCT02164539|565440906|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
156643123|NCT02164539|565440907|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
156643124|NCT02164539|565440908|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
156643125|NCT02164539|565440902|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
156643126|NCT02164539|565440903|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
156643127|NCT02164539|565440904|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
156643128|NCT02164539|565440905|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
156643129|NCT02164539|565440906|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
156643130|NCT02164539|565440907|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
156643131|NCT02164539|565440908|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
156643132|NCT02164539|565440902|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
156643133|NCT02164539|565440903|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
156643134|NCT02164539|565440904|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
156643135|NCT02164539|565440905|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
156643136|NCT02164539|565440906|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
156643137|NCT02164539|565440907|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
156643138|NCT02164539|565440908|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
156643139|NCT02164539|565440902|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
156643140|NCT02164539|565440903|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
156643141|NCT02164539|565440904|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
156643142|NCT02164539|565440905|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
156643143|NCT02164539|565440906|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
156643144|NCT02164539|565440907|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
156643145|NCT02164539|565440908|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
156643146|NCT02164539|565440902|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
156643147|NCT02164539|565440903|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
156643148|NCT02164539|565440904|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
156643149|NCT02164539|565440905|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
156643150|NCT02164539|565440906|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
156643151|NCT02164539|565440907|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
156643152|NCT02164539|565440908|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
156643153|NCT01255722|565440909|FG000|Overall Study|Adverse Event|0|||
156643154|NCT01255722|565440910|FG001|Overall Study|Adverse Event|1|||
156643155|NCT01255722|565440911|FG002|Overall Study|Adverse Event|1|||
156643156|NCT01255722|565440909|FG000|Overall Study|asymptomatic patient|1|||
156643157|NCT01255722|565440910|FG001|Overall Study|asymptomatic patient|0|||
156643158|NCT01255722|565440911|FG002|Overall Study|asymptomatic patient|0|||
156643159|NCT01255722|565440909|FG000|Overall Study|beta-blocker contraindicated|2|||
156643160|NCT01255722|565440910|FG001|Overall Study|beta-blocker contraindicated|0|||
156643161|NCT01255722|565440911|FG002|Overall Study|beta-blocker contraindicated|0|||
156643162|NCT02643966|565440912|FG000|First Screening Round|ineligible|1|||
156643163|NCT02643966|565440912|FG000|First Screening Round|excluded from analysis|2|||
156643164|NCT02643966|565440912|FG000|First Screening Round|Lost to Follow-up|56|||
156643165|NCT02643966|565440912|FG000|First Screening Round|Withdrawal by Subject|28|||
156643166|NCT02643966|565440912|FG000|First Screening Round|Death|1|||
156643167|NCT02643966|565440912|FG000|Between First and Second Screening|Lost to Follow-up|65|||
156643168|NCT02643966|565440912|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
156643169|NCT02643966|565440912|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
156643170|NCT02643966|565440912|FG000|Second Screening Round|Withdrawal by Subject|20|||
156643171|NCT02643966|565440912|FG000|Second Screening Round|Lost to Follow-up|57|||
156643172|NCT02643966|565440912|FG000|Second Screening Round|Physician Decision|2|||
156643173|NCT02643966|565440912|FG000|Second Screening Round|Death|4|||
156643174|NCT02643966|565440912|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
156643175|NCT02643966|565440912|FG000|Between Second and Third Screening|Death|1|||
156643176|NCT02643966|565440912|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
156643177|NCT02643966|565440912|FG000|Third Screening Round|PI excluded|2|||
156643178|NCT02643966|565440912|FG000|Third Screening Round|Lost to Follow-up|241|||
156643179|NCT01493531|565440913|FG000|Overall Study|Adverse Event|4|||
156643180|NCT01493531|565440914|FG001|Overall Study|Adverse Event|12|||
156643181|NCT01493531|565440915|FG002|Overall Study|Adverse Event|9|||
156643182|NCT01493531|565440913|FG000|Overall Study|Gout flare|3|||
156643183|NCT01493531|565440914|FG001|Overall Study|Gout flare|0|||
156643184|NCT01493531|565440915|FG002|Overall Study|Gout flare|2|||
156643185|NCT01493531|565440913|FG000|Overall Study|Protocol Violation|8|||
156643186|NCT01493531|565440914|FG001|Overall Study|Protocol Violation|15|||
156643187|NCT01493531|565440915|FG002|Overall Study|Protocol Violation|12|||
156643188|NCT01493531|565440913|FG000|Overall Study|Sponsor terminated study|5|||
156643189|NCT01493531|565440914|FG001|Overall Study|Sponsor terminated study|2|||
156643190|NCT01493531|565440915|FG002|Overall Study|Sponsor terminated study|3|||
156643191|NCT01493531|565440913|FG000|Overall Study|Lost to Follow-up|5|||
156643192|NCT01493531|565440914|FG001|Overall Study|Lost to Follow-up|7|||
156643193|NCT01493531|565440915|FG002|Overall Study|Lost to Follow-up|11|||
156643194|NCT01493531|565440913|FG000|Overall Study|Withdrawal by Subject|16|||
156643195|NCT01493531|565440914|FG001|Overall Study|Withdrawal by Subject|13|||
156643196|NCT01493531|565440915|FG002|Overall Study|Withdrawal by Subject|11|||
156643197|NCT01493531|565440913|FG000|Overall Study|Death|0|||
156643198|NCT01493531|565440914|FG001|Overall Study|Death|1|||
156643199|NCT01493531|565440915|FG002|Overall Study|Death|0|||
156643200|NCT03031431|565440918|FG000|Overall Study|Infant removed by maternal request|1|||
156643201|NCT00995930|565440919|FG000|Overall Study|Protocol deviation|2|||
156643202|NCT00995930|565440920|FG001|Overall Study|Protocol deviation|5|||
156643203|NCT00995930|565440919|FG000|Overall Study|Death|0|||
156643204|NCT00995930|565440920|FG001|Overall Study|Death|1|||
156643205|NCT00995930|565440919|FG000|Overall Study|Administrative problems|4|||
156643206|NCT00995930|565440920|FG001|Overall Study|Administrative problems|2|||
156643207|NCT00995930|565440919|FG000|Overall Study|Lost to Follow-up|1|||
156643208|NCT00995930|565440920|FG001|Overall Study|Lost to Follow-up|2|||
156643209|NCT00995930|565440919|FG000|Overall Study|Withdrawal by Subject|3|||
156643210|NCT00995930|565440920|FG001|Overall Study|Withdrawal by Subject|4|||
156643211|NCT00995930|565440919|FG000|Overall Study|Adverse Event|11|||
156412085|NCT01551303|564602811|FG000|Overall Study|failed awareness check on vision test|4|||
156643212|NCT00995930|565440920|FG001|Overall Study|Adverse Event|14|||
156643213|NCT01246973|565441870|FG000|Overall Study|Other|38|||
156643214|NCT01246973|565441871|FG001|Overall Study|Other|25|||
156412086|NCT01551303|564602812|FG001|Overall Study|failed awareness check on vision test|7|||
156643215|NCT01246973|565441870|FG000|Overall Study|Adverse Event|16|||
156643216|NCT01246973|565441871|FG001|Overall Study|Adverse Event|9|||
156643217|NCT01246973|565441870|FG000|Overall Study|Withdrawal by Subject|7|||
156643218|NCT01246973|565441871|FG001|Overall Study|Withdrawal by Subject|13|||
156643219|NCT02598622|565441873|FG000|Overall Study|Withdrawal by Subject|3|||
156643220|NCT02598622|565441874|FG001|Overall Study|Withdrawal by Subject|0|||
156643221|NCT02598622|565441873|FG000|Overall Study|Physician Decision|3|||
156643222|NCT02598622|565441874|FG001|Overall Study|Physician Decision|0|||
156643223|NCT00681824|565441878|FG000|Overall Study|withdrawn by investigator|0|||
156643224|NCT00681824|565441879|FG001|Overall Study|withdrawn by investigator|0|||
156643225|NCT00681824|565441880|FG002|Overall Study|withdrawn by investigator|1|||
156643226|NCT00681824|565441878|FG000|Overall Study|scheduling conflict|1|||
156643227|NCT00681824|565441879|FG001|Overall Study|scheduling conflict|0|||
156643228|NCT00681824|565441880|FG002|Overall Study|scheduling conflict|0|||
156643229|NCT00681824|565441878|FG000|Overall Study|Death|0|||
156643230|NCT00681824|565441879|FG001|Overall Study|Death|1|||
156643231|NCT00681824|565441880|FG002|Overall Study|Death|0|||
156643232|NCT04575038|565441881|FG000|Overall Study|Withdrawal by Subject|1|||
156643233|NCT04575038|565441882|FG001|Overall Study|Withdrawal by Subject|1|||
156643234|NCT01416142|565441887|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
156643235|NCT01416142|565441888|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
156643236|NCT01416142|565441889|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
156643237|NCT00678379|565441890|FG000|Overall Study|Injection performed after tonsillectomy|2|||
156643238|NCT00678379|565441891|FG001|Overall Study|Injection performed after tonsillectomy|0|||
156643239|NCT00678379|565441892|FG002|Overall Study|Injection performed after tonsillectomy|1|||
156643240|NCT00678379|565441890|FG000|Overall Study|Incomplete Data|4|||
156643241|NCT00678379|565441891|FG001|Overall Study|Incomplete Data|3|||
156643242|NCT00678379|565441892|FG002|Overall Study|Incomplete Data|3|||
156643243|NCT01835470|565441893|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
156643244|NCT01835470|565441893|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
156643245|NCT01011907|565441894|FG000|Overall Study|Withdrawal by Subject|13|||
156643246|NCT01011907|565441895|FG001|Overall Study|Withdrawal by Subject|11|||
156643247|NCT01011907|565441894|FG000|Overall Study|Adverse Event|1|||
156643248|NCT01011907|565441895|FG001|Overall Study|Adverse Event|4|||
156643249|NCT00304954|565441898|FG000|Overall Study|Withdrawal by Subject|0|||
156643250|NCT00304954|565441899|FG001|Overall Study|Withdrawal by Subject|0|||
156643251|NCT00304954|565441900|FG002|Overall Study|Withdrawal by Subject|1|||
156643252|NCT00304954|565441901|FG003|Overall Study|Withdrawal by Subject|0|||
156643253|NCT00304954|565441898|FG000|Overall Study|Adverse Event|1|||
156643254|NCT00304954|565441899|FG001|Overall Study|Adverse Event|0|||
156412087|NCT02141659|564602816|FG000|Overall Study|Major Protocol Deviation|0|||
156412088|NCT02141659|564602817|FG001|Overall Study|Major Protocol Deviation|1|||
156412089|NCT02141659|564602818|FG002|Overall Study|Major Protocol Deviation|0|||
156412090|NCT02141659|564602819|FG003|Overall Study|Major Protocol Deviation|0|||
156412091|NCT02141659|564602820|FG004|Overall Study|Major Protocol Deviation|0|||
156412092|NCT02141659|564602821|FG005|Overall Study|Major Protocol Deviation|0|||
156643255|NCT00304954|565441900|FG002|Overall Study|Adverse Event|0|||
156643256|NCT00304954|565441901|FG003|Overall Study|Adverse Event|0|||
156643257|NCT04736576|565441904|FG000|Overall Study|Progressive disease|3|||
156643258|NCT04736576|565441905|FG001|Overall Study|Progressive disease|1|||
156643259|NCT04736576|565441904|FG000|Overall Study|Death|1|||
156643260|NCT04736576|565441905|FG001|Overall Study|Death|0|||
156643261|NCT05180630|565441909|FG000|First Intervention|Physician Decision|0|||
156643262|NCT05180630|565441910|FG001|First Intervention|Physician Decision|0|||
156643263|NCT05180630|565441911|FG002|First Intervention|Physician Decision|3|||
156643264|NCT00709735|565441914|FG000|Overall Study|Lost to Follow-up|1|||
156643265|NCT00709735|565441915|FG001|Overall Study|Lost to Follow-up|1|||
156643266|NCT00709735|565441914|FG000|Overall Study|Relapse into Opioid Abuse|0|||
156412093|NCT02141659|564602816|FG000|Overall Study|Lack of Efficacy|0|||
156412094|NCT02141659|564602817|FG001|Overall Study|Lack of Efficacy|0|||
156643267|NCT00709735|565441915|FG001|Overall Study|Relapse into Opioid Abuse|1|||
156643268|NCT00709735|565441914|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
156643269|NCT00709735|565441915|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
156412095|NCT02141659|564602818|FG002|Overall Study|Lack of Efficacy|0|||
156643270|NCT01333475|565441916|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
156643271|NCT01333475|565441917|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
156643272|NCT01333475|565441916|FG000|Overall Study|Toxicity|1|||
156643273|NCT01333475|565441917|FG001|Overall Study|Toxicity|3|||
156643274|NCT04440007|565441918|FG000|Overall Study|Adverse Event|0|||
156643275|NCT04440007|565441919|FG001|Overall Study|Adverse Event|1|||
156643276|NCT04440007|565441918|FG000|Overall Study|Lost to Follow-up|1|||
156643277|NCT04440007|565441919|FG001|Overall Study|Lost to Follow-up|3|||
156643278|NCT04440007|565441918|FG000|Overall Study|Death|7|||
156643279|NCT04440007|565441919|FG001|Overall Study|Death|2|||
156643280|NCT04440007|565441918|FG000|Overall Study|Physician Decision|1|||
156643281|NCT04440007|565441919|FG001|Overall Study|Physician Decision|1|||
156643282|NCT04440007|565441918|FG000|Overall Study|Withdrawal by Subject|2|||
156643283|NCT04440007|565441919|FG001|Overall Study|Withdrawal by Subject|1|||
156643284|NCT04440007|565441918|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
156643285|NCT04440007|565441919|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
156412096|NCT02141659|564602819|FG003|Overall Study|Lack of Efficacy|0|||
156643286|NCT04440007|565441918|FG000|Overall Study|Discontinued prior to dosing|0|||
156643287|NCT04440007|565441919|FG001|Overall Study|Discontinued prior to dosing|2|||
156412097|NCT02141659|564602820|FG004|Overall Study|Lack of Efficacy|0|||
156643288|NCT01946282|565441922|FG000|Year 1|Did not return FIT kit|4186|||
156643289|NCT01946282|565441923|FG001|Year 1|Did not return FIT kit|608|||
156412098|NCT02141659|564602821|FG005|Overall Study|Lack of Efficacy|1|||
156643290|NCT01946282|565441924|FG002|Year 1|Did not return FIT kit|654|||
156643291|NCT01946282|565441922|FG000|Year 2|Did not return FIT kit|803|||
156643292|NCT01946282|565441923|FG001|Year 2|Did not return FIT kit|131|||
156643293|NCT01946282|565441924|FG002|Year 2|Did not return FIT kit|115|||
156643294|NCT01946282|565441922|FG000|Year 3|Did not return FIT kit|288|||
156643295|NCT01946282|565441923|FG001|Year 3|Did not return FIT kit|43|||
156643296|NCT01946282|565441924|FG002|Year 3|Did not return FIT kit|30|||
156643297|NCT01462695|565441925|FG000|Overall Study|Adverse Event|1|||
156643298|NCT01462695|565441926|FG001|Overall Study|Adverse Event|1|||
156643299|NCT01462695|565441925|FG000|Overall Study|Death|2|||
156643300|NCT01462695|565441926|FG001|Overall Study|Death|0|||
156643301|NCT01462695|565441925|FG000|Overall Study|Lack of Efficacy|6|||
156643302|NCT01462695|565441926|FG001|Overall Study|Lack of Efficacy|12|||
156643303|NCT01462695|565441925|FG000|Overall Study|Physician Decision|5|||
156643304|NCT01462695|565441926|FG001|Overall Study|Physician Decision|0|||
156643305|NCT01462695|565441925|FG000|Overall Study|Withdrawal by Subject|2|||
156643306|NCT01462695|565441926|FG001|Overall Study|Withdrawal by Subject|0|||
156643307|NCT01462695|565441925|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
156643308|NCT01462695|565441926|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
156643309|NCT00995488|565441929|FG000|Overall Study|Withdrawal by Subject|1|||
156643310|NCT01656967|565441930|FG000|Overall Study|faulty monitor|1|||
156643311|NCT01656967|565441931|FG001|Overall Study|faulty monitor|0|||
156643312|NCT01656967|565441930|FG000|Overall Study|unsuccessful ETT insertion|3|||
156643313|NCT01656967|565441931|FG001|Overall Study|unsuccessful ETT insertion|2|||
156643314|NCT00051636|565441932|FG000|Period 1 - Core|Adverse Event|2|||
156643315|NCT00051636|565441933|FG001|Period 1 - Core|Adverse Event|2|||
156643316|NCT00051636|565441932|FG000|Period 1 - Core|Protocol Violation|1|||
156643317|NCT00051636|565441933|FG001|Period 1 - Core|Protocol Violation|0|||
156643318|NCT00051636|565441932|FG000|Period 1 - Core|Withdrawal by Subject|1|||
156643319|NCT00051636|565441933|FG001|Period 1 - Core|Withdrawal by Subject|2|||
156643320|NCT00051636|565441932|FG000|Period 1 - Core|Lost to Follow-up|0|||
156643321|NCT00051636|565441933|FG001|Period 1 - Core|Lost to Follow-up|2|||
156643322|NCT00051636|565441932|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
156643323|NCT00051636|565441933|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
156643324|NCT00051636|565441932|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
156643325|NCT00051636|565441933|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
156643326|NCT00051636|565441932|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
156643327|NCT00051636|565441933|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
156643328|NCT00051636|565441932|FG000|Period 2- Extended Observation Period|Death|4|||
156643329|NCT00051636|565441933|FG001|Period 2- Extended Observation Period|Death|5|||
156643330|NCT00051636|565441932|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
156643331|NCT00051636|565441933|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
156643332|NCT01174368|565441934|FG000|Overall Study|Withdrawal by Subject|1|||
156643333|NCT00479765|565441935|FG000|Overall Study|study terminated|4|||
156643334|NCT01021137|565441941|FG000|Overall Study|Lost to Follow-up|9|||
156643335|NCT01021137|565441942|FG001|Overall Study|Lost to Follow-up|4|||
156643336|NCT01021137|565441943|FG002|Overall Study|Lost to Follow-up|2|||
156643337|NCT01021137|565441944|FG003|Overall Study|Lost to Follow-up|6|||
156643338|NCT01021137|565441941|FG000|Overall Study|Withdrawal by Subject|1|||
156643339|NCT01021137|565441942|FG001|Overall Study|Withdrawal by Subject|0|||
156643340|NCT01021137|565441943|FG002|Overall Study|Withdrawal by Subject|0|||
156643341|NCT01021137|565441944|FG003|Overall Study|Withdrawal by Subject|3|||
156643342|NCT00725725|565441948|FG000|Overall Study|Adverse Event|1|||
156643343|NCT00725725|565441949|FG001|Overall Study|Adverse Event|3|||
156643344|NCT00725725|565441950|FG002|Overall Study|Adverse Event|2|||
156643345|NCT00725725|565441948|FG000|Overall Study|Lost to Follow-up|2|||
156643346|NCT00725725|565441949|FG001|Overall Study|Lost to Follow-up|0|||
156643347|NCT00725725|565441950|FG002|Overall Study|Lost to Follow-up|2|||
156643348|NCT00725725|565441948|FG000|Overall Study|Withdrawal by Subject|1|||
156643349|NCT00725725|565441949|FG001|Overall Study|Withdrawal by Subject|0|||
156643350|NCT00725725|565441950|FG002|Overall Study|Withdrawal by Subject|1|||
156643351|NCT00725725|565441948|FG000|Overall Study|Protocol Violation|0|||
156643352|NCT00725725|565441949|FG001|Overall Study|Protocol Violation|1|||
156643353|NCT00725725|565441950|FG002|Overall Study|Protocol Violation|0|||
156643354|NCT02392559|565441951|FG000|Overall Study|Withdrawal by Subject|0|||
156643355|NCT02392559|565441952|FG001|Overall Study|Withdrawal by Subject|1|||
156643356|NCT02340078|565441958|FG000|Overall Study|Protocol Violation|1|||
156643357|NCT00944125|565441961|FG000|3 to 6 Months|Withdrawal by Subject|0|||
156643358|NCT00944125|565441962|FG001|3 to 6 Months|Withdrawal by Subject|2|||
156643359|NCT00944125|565441961|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
156643360|NCT00944125|565441962|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
156643361|NCT04816877|565441965|FG000|Overall Study|Withdrawal by Subject|1|||
156643362|NCT04816877|565441966|FG001|Overall Study|Withdrawal by Subject|0|||
156643363|NCT05788237|565441970|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
156643364|NCT05788237|565441971|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
156643365|NCT05788237|565441972|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
156643366|NCT05788237|565441973|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
156643367|NCT05788237|565441970|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
156643368|NCT05788237|565441971|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
156643369|NCT05788237|565441972|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
156643370|NCT05788237|565441973|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
156643371|NCT05788237|565441970|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
156643372|NCT05788237|565441971|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
156643373|NCT05788237|565441972|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
156643374|NCT05788237|565441973|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
156643375|NCT05788237|565441970|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
156643376|NCT05788237|565441971|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
156643377|NCT05788237|565441972|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
156643378|NCT05788237|565441973|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
156643379|NCT05788237|565441970|FG000|SSA (Approximately 2 Months)|Death|0|||
156643380|NCT05788237|565441971|FG001|SSA (Approximately 2 Months)|Death|1|||
156643381|NCT05788237|565441972|FG002|SSA (Approximately 2 Months)|Death|0|||
156643382|NCT05788237|565441973|FG003|SSA (Approximately 2 Months)|Death|0|||
156643383|NCT05788237|565441970|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
156643384|NCT05788237|565441971|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
156643385|NCT05788237|565441972|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
156643386|NCT05788237|565441973|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
156643387|NCT05788237|565441970|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
156643388|NCT05788237|565441971|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
156643389|NCT05788237|565441972|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
156643390|NCT05788237|565441973|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
156643391|NCT05788237|565441970|FG000|SSB (Approximately 1 Month)|Other|0|||
156643392|NCT05788237|565441971|FG001|SSB (Approximately 1 Month)|Other|0|||
156643393|NCT05788237|565441972|FG002|SSB (Approximately 1 Month)|Other|0|||
156643394|NCT05788237|565441973|FG003|SSB (Approximately 1 Month)|Other|1|||
156643395|NCT03724916|565443506|FG000|Overall Study|Withdrawal by Subject|0|||
156643396|NCT03724916|565443507|FG001|Overall Study|Withdrawal by Subject|1|||
156643397|NCT03724916|565443508|FG002|Overall Study|Withdrawal by Subject|1|||
156643398|NCT03724916|565443509|FG003|Overall Study|Withdrawal by Subject|2|||
156643399|NCT03724916|565443506|FG000|Overall Study|Randomized but not Treated|1|||
156643400|NCT03724916|565443507|FG001|Overall Study|Randomized but not Treated|0|||
156643401|NCT03724916|565443508|FG002|Overall Study|Randomized but not Treated|0|||
156643402|NCT03724916|565443509|FG003|Overall Study|Randomized but not Treated|0|||
156643403|NCT04335110|565443512|FG000|Overall Study|Withdrawal by Subject|1|||
156643404|NCT04335110|565443513|FG001|Overall Study|Withdrawal by Subject|1|||
156643405|NCT04335110|565443512|FG000|Overall Study|Death|0|||
156643406|NCT04335110|565443513|FG001|Overall Study|Death|1|||
156412099|NCT02141659|564602816|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
156412100|NCT02141659|564602817|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
156412101|NCT02141659|564602818|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
156643407|NCT02513459|565443515|FG000|Overall Study|Adverse Event|7|||
156412102|NCT02141659|564602819|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
156643408|NCT02513459|565443515|FG000|Overall Study|Withdrew consent|5|||
156643409|NCT02513459|565443515|FG000|Overall Study|Loss of efficacy|2|||
156643410|NCT02513459|565443515|FG000|Overall Study|Pregnancy|2|||
156643411|NCT02513459|565443515|FG000|Overall Study|Subject decision|2|||
156643412|NCT02513459|565443515|FG000|Overall Study|Lack of response|1|||
156643413|NCT02513459|565443515|FG000|Overall Study|Reproductive plans|1|||
156643414|NCT02513459|565443515|FG000|Overall Study|Surgery planned-- not done|1|||
156643415|NCT00923195|565443516|FG000|Overall Study|Death|0|||
156643416|NCT00923195|565443517|FG001|Overall Study|Death|1|||
156643417|NCT00525031|565443518|FG000|Overall Study|Disease Progression|1|||
156643418|NCT00525031|565443519|FG001|Overall Study|Disease Progression|1|||
156643419|NCT00787566|565443524|FG000|Overall Study|AE related to chemotherapy|0|||
156643420|NCT00787566|565443525|FG001|Overall Study|AE related to chemotherapy|1|||
156643421|NCT00787566|565443526|FG002|Overall Study|AE related to chemotherapy|0|||
156643422|NCT02140164|565443527|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
156643423|NCT00775983|565443528|FG000|Overall Study|Protocol Violation|1|||
156643424|NCT00775983|565443529|FG001|Overall Study|Protocol Violation|2|||
156643425|NCT00660790|565443538|FG000|Baseline to 3 Months|Death|1|||
156643426|NCT00660790|565443538|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
156643427|NCT00660790|565443538|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
156643428|NCT00686374|565443544|FG000|Overall Study|Lack of Efficacy|10|||
156643429|NCT00686374|565443544|FG000|Overall Study|Adverse Event|8|||
156643430|NCT00686374|565443544|FG000|Overall Study|Withdrew consent|5|||
156643431|NCT00686374|565443544|FG000|Overall Study|Lost to Follow-up|1|||
156643432|NCT00686374|565443544|FG000|Overall Study|Missing reason|33|||
156643433|NCT00686374|565443544|FG000|Overall Study|Other, not specified|4|||
156643434|NCT00618774|565443545|FG000|Overall Study|Adverse Event|5|||
156643435|NCT00618774|565443546|FG001|Overall Study|Adverse Event|3|||
156643436|NCT00618774|565443545|FG000|Overall Study|Withdrawal by Subject|1|||
156643437|NCT00618774|565443546|FG001|Overall Study|Withdrawal by Subject|0|||
156643438|NCT02424565|565443547|FG000|Period 1 (D0)|Protocol Violation|0|||
156643439|NCT02424565|565443548|FG001|Period 1 (D0)|Protocol Violation|1|||
156643440|NCT01427920|565443556|FG000|Overall Study|Adverse Event|1|||
156643441|NCT01427920|565443557|FG001|Overall Study|Adverse Event|2|||
156643442|NCT01427920|565443556|FG000|Overall Study|Lack of Efficacy|1|||
156643443|NCT01427920|565443557|FG001|Overall Study|Lack of Efficacy|0|||
156643444|NCT01427920|565443556|FG000|Overall Study|Protocol Violation|1|||
156643445|NCT01427920|565443557|FG001|Overall Study|Protocol Violation|3|||
156643446|NCT01427920|565443556|FG000|Overall Study|Withdrawal Criteria|4|||
156643447|NCT01427920|565443557|FG001|Overall Study|Withdrawal Criteria|4|||
156643448|NCT01427920|565443556|FG000|Overall Study|Unclassified|2|||
156643449|NCT01427920|565443557|FG001|Overall Study|Unclassified|8|||
156643450|NCT04228302|565443558|FG000|Overall Study|Adverse Event|0|||
156643451|NCT04228302|565443559|FG001|Overall Study|Adverse Event|0|||
156643452|NCT04228302|565443560|FG002|Overall Study|Adverse Event|0|||
156643453|NCT04228302|565443561|FG003|Overall Study|Adverse Event|0|||
156643454|NCT04228302|565443562|FG004|Overall Study|Adverse Event|1|||
156643455|NCT04228302|565443563|FG005|Overall Study|Adverse Event|0|||
156643456|NCT03066440|565443566|FG000|Overall Study|Physician Decision|1|||
156643457|NCT03066440|565443567|FG001|Overall Study|Physician Decision|1|||
156643458|NCT03066440|565443566|FG000|Overall Study|Protocol Violation|0|||
156643459|NCT03066440|565443567|FG001|Overall Study|Protocol Violation|2|||
156643460|NCT00736333|565443568|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
156643461|NCT00736333|565443568|FG000|Overall Study|Data Missing|2|||
156643462|NCT00736333|565443568|FG000|Overall Study|Tumor Progression|75|||
156643463|NCT00736333|565443568|FG000|Overall Study|Toxicity|6|||
156643464|NCT00736333|565443568|FG000|Overall Study|Withdrawal by Subject|10|||
156643465|NCT00736333|565443568|FG000|Overall Study|Death|7|||
156643466|NCT00736333|565443568|FG000|Overall Study|Other|4|||
156643467|NCT04991311|565443570|FG000|Overall Study|Adverse Event|1|||
156643468|NCT00054275|565443572|FG000|Overall Study|Withdrawal by Subject|4|||
156643469|NCT00054275|565443572|FG000|Overall Study|Adverse Event|5|||
156643470|NCT00054275|565443572|FG000|Overall Study|Progressive disease in cycle 1|1|||
156643471|NCT00054275|565443572|FG000|Overall Study|Physician Decision|1|||
156643472|NCT00755937|565443573|FG000|Recruitment|Unknown if infliximab received|164|||
156643473|NCT00755937|565443573|FG000|Observational Follow-up|Lost to Follow-up|148|||
156643474|NCT03876873|565443574|FG000|Overall Study|Physician Decision|0|||
156643475|NCT03876873|565443575|FG001|Overall Study|Physician Decision|1|||
156643476|NCT01106352|565443576|FG000|Overall Study|Subjects untreated|0|||
156643477|NCT01106352|565443577|FG001|Overall Study|Subjects untreated|0|||
156643478|NCT01106352|565443578|FG002|Overall Study|Subjects untreated|0|||
156643479|NCT01106352|565443579|FG003|Overall Study|Subjects untreated|3|||
156643480|NCT01106352|565443580|FG004|Overall Study|Subjects untreated|4|||
156412103|NCT02141659|564602820|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
156412104|NCT02141659|564602821|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
156412105|NCT02471404|564602824|FG000|Overall Study|Adverse Event|7|||
156412106|NCT02471404|564602825|FG001|Overall Study|Adverse Event|1|||
156412107|NCT02471404|564602826|FG002|Overall Study|Adverse Event|2|||
156412108|NCT02471404|564602824|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
156412109|NCT02471404|564602825|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
156412110|NCT02471404|564602826|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
156412111|NCT02471404|564602824|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
156412112|NCT02471404|564602825|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
156412113|NCT02471404|564602826|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
156412114|NCT02471404|564602824|FG000|Overall Study|Lost to Follow-up|1|||
156412115|NCT02471404|564602825|FG001|Overall Study|Lost to Follow-up|1|||
156412116|NCT02471404|564602826|FG002|Overall Study|Lost to Follow-up|3|||
156412117|NCT02471404|564602824|FG000|Overall Study|Protocol Violation|1|||
156412118|NCT02471404|564602825|FG001|Overall Study|Protocol Violation|0|||
156412119|NCT02471404|564602826|FG002|Overall Study|Protocol Violation|0|||
156412120|NCT02471404|564602824|FG000|Overall Study|Withdrawal by Subject|8|||
156412121|NCT02471404|564602825|FG001|Overall Study|Withdrawal by Subject|4|||
156412122|NCT02471404|564602826|FG002|Overall Study|Withdrawal by Subject|5|||
156412123|NCT02471404|564602824|FG000|Overall Study|Other reasons not specified|10|||
156412124|NCT02471404|564602825|FG001|Overall Study|Other reasons not specified|7|||
156412125|NCT02471404|564602826|FG002|Overall Study|Other reasons not specified|12|||
156412126|NCT01927731|564602827|FG000|Overall Study|Graft Failure|1|||
156412127|NCT01927731|564602828|FG001|Overall Study|Graft Failure|2|||
156412128|NCT01927731|564602827|FG000|Overall Study|Physician Decision|2|||
156412129|NCT01927731|564602828|FG001|Overall Study|Physician Decision|3|||
156412130|NCT01927731|564602827|FG000|Overall Study|Withdrawal by Subject|0|||
156412131|NCT01927731|564602828|FG001|Overall Study|Withdrawal by Subject|2|||
156412132|NCT01927731|564602827|FG000|Overall Study|Death|0|||
156412133|NCT01927731|564602828|FG001|Overall Study|Death|3|||
156412134|NCT00305864|564602833|FG000|Overall Study|Ineligible / No protocol treatment|0|||
156412135|NCT00305864|564602834|FG001|Overall Study|Ineligible / No protocol treatment|1|||
156412136|NCT00305864|564602835|FG002|Overall Study|Ineligible / No protocol treatment|1|||
156412137|NCT00305864|564602836|FG003|Overall Study|Ineligible / No protocol treatment|13|||
156412138|NCT02836613|564602839|FG000|Overall Study|Accidental drowning|1|||
156412139|NCT02836613|564602840|FG001|Overall Study|Accidental drowning|0|||
156412140|NCT02836613|564602839|FG000|Overall Study|Lost to Follow-up|0|||
156412141|NCT02836613|564602840|FG001|Overall Study|Lost to Follow-up|1|||
156412142|NCT02836613|564602839|FG000|Overall Study|Withdrawal by Subject|0|||
156412143|NCT02836613|564602840|FG001|Overall Study|Withdrawal by Subject|2|||
156412144|NCT01464255|564602841|FG000|Overall Study|unresolve corneal staining|0|||
156412145|NCT01464255|564602842|FG001|Overall Study|unresolve corneal staining|1|||
156412146|NCT03881059|564602843|FG000|Treatment Period - Part A|Adverse Event|1|||
156412147|NCT03881059|564602844|FG001|Treatment Period - Part A|Adverse Event|3|||
156412148|NCT03881059|564602845|FG002|Treatment Period - Part A|Adverse Event|4|||
156412149|NCT03881059|564602843|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
156412150|NCT03881059|564602844|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
156412151|NCT03881059|564602845|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
156412152|NCT03881059|564602843|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
156412153|NCT03881059|564602844|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
156412154|NCT03881059|564602845|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
156412155|NCT03881059|564602843|FG000|Treatment Period - Part A|Other reasons|2|||
156412156|NCT03881059|564602844|FG001|Treatment Period - Part A|Other reasons|1|||
156412157|NCT03881059|564602845|FG002|Treatment Period - Part A|Other reasons|0|||
156412158|NCT03881059|564602843|FG000|Treatment Period - Part B|Adverse Event|0|||
156412159|NCT03881059|564602844|FG001|Treatment Period - Part B|Adverse Event|0|||
156412160|NCT03881059|564602845|FG002|Treatment Period - Part B|Adverse Event|3|||
156412161|NCT03881059|564602843|FG000|Treatment Period - Part B|Death|0|||
156412162|NCT03881059|564602844|FG001|Treatment Period - Part B|Death|1|||
156412163|NCT03881059|564602845|FG002|Treatment Period - Part B|Death|1|||
156412164|NCT03881059|564602843|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
156412165|NCT03881059|564602844|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
156412166|NCT03881059|564602845|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
156412167|NCT03881059|564602843|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
156412168|NCT03881059|564602844|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
156412169|NCT03881059|564602845|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
156412170|NCT03881059|564602843|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
156412171|NCT03881059|564602844|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
156412172|NCT03881059|564602845|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
156412173|NCT03881059|564602843|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
156412174|NCT03881059|564602844|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
156412175|NCT03881059|564602845|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
156412176|NCT03881059|564602843|FG000|Treatment Period - Part B|Other reasons|4|||
156643481|NCT01106352|565443576|FG000|Overall Study|Sponsor Decision|1|||
156643482|NCT01106352|565443577|FG001|Overall Study|Sponsor Decision|0|||
156643483|NCT01106352|565443578|FG002|Overall Study|Sponsor Decision|0|||
156643484|NCT01106352|565443579|FG003|Overall Study|Sponsor Decision|0|||
156643485|NCT01106352|565443580|FG004|Overall Study|Sponsor Decision|0|||
156643486|NCT01106352|565443576|FG000|Overall Study|Too ill to come in for the visit|0|||
156643487|NCT01106352|565443577|FG001|Overall Study|Too ill to come in for the visit|0|||
156643488|NCT01106352|565443578|FG002|Overall Study|Too ill to come in for the visit|1|||
156643489|NCT01106352|565443579|FG003|Overall Study|Too ill to come in for the visit|0|||
156643490|NCT01106352|565443580|FG004|Overall Study|Too ill to come in for the visit|0|||
156643491|NCT01106352|565443576|FG000|Overall Study|Lost to Follow-up|0|||
156643492|NCT01106352|565443577|FG001|Overall Study|Lost to Follow-up|0|||
156643493|NCT01106352|565443578|FG002|Overall Study|Lost to Follow-up|0|||
156643494|NCT01106352|565443579|FG003|Overall Study|Lost to Follow-up|0|||
156643495|NCT01106352|565443580|FG004|Overall Study|Lost to Follow-up|1|||
156643496|NCT01106352|565443576|FG000|Overall Study|Death|0|||
156643497|NCT01106352|565443577|FG001|Overall Study|Death|0|||
156643498|NCT01106352|565443578|FG002|Overall Study|Death|1|||
156643499|NCT01106352|565443579|FG003|Overall Study|Death|3|||
156643500|NCT01106352|565443580|FG004|Overall Study|Death|1|||
156643501|NCT01106352|565443576|FG000|Overall Study|Disease progression|0|||
156643502|NCT01106352|565443577|FG001|Overall Study|Disease progression|0|||
156643503|NCT01106352|565443578|FG002|Overall Study|Disease progression|0|||
156643504|NCT01106352|565443579|FG003|Overall Study|Disease progression|1|||
156643505|NCT01106352|565443580|FG004|Overall Study|Disease progression|0|||
156643506|NCT01106352|565443576|FG000|Overall Study|Withdrawal by Subject|0|||
156643507|NCT01106352|565443577|FG001|Overall Study|Withdrawal by Subject|0|||
156643508|NCT01106352|565443578|FG002|Overall Study|Withdrawal by Subject|0|||
156643509|NCT01106352|565443579|FG003|Overall Study|Withdrawal by Subject|3|||
156643510|NCT01106352|565443580|FG004|Overall Study|Withdrawal by Subject|2|||
156643511|NCT01106352|565443576|FG000|Overall Study|Went on hospice|0|||
156643512|NCT01106352|565443577|FG001|Overall Study|Went on hospice|0|||
156643513|NCT01106352|565443578|FG002|Overall Study|Went on hospice|0|||
156643514|NCT01106352|565443579|FG003|Overall Study|Went on hospice|1|||
156643515|NCT01106352|565443580|FG004|Overall Study|Went on hospice|0|||
156643516|NCT01106352|565443576|FG000|Overall Study|Subject entered hospice|0|||
156643517|NCT01106352|565443577|FG001|Overall Study|Subject entered hospice|0|||
156643518|NCT01106352|565443578|FG002|Overall Study|Subject entered hospice|0|||
156643519|NCT01106352|565443579|FG003|Overall Study|Subject entered hospice|1|||
156643520|NCT01106352|565443580|FG004|Overall Study|Subject entered hospice|0|||
156643521|NCT01106352|565443576|FG000|Overall Study|Home hospice since July 2013|0|||
156643522|NCT01106352|565443577|FG001|Overall Study|Home hospice since July 2013|0|||
156643523|NCT01106352|565443578|FG002|Overall Study|Home hospice since July 2013|0|||
156643524|NCT01106352|565443579|FG003|Overall Study|Home hospice since July 2013|1|||
156643525|NCT01106352|565443580|FG004|Overall Study|Home hospice since July 2013|0|||
156643526|NCT03547531|565443581|FG000|Overall Study|not coming in data collection : sick|2|||
156643527|NCT03547531|565443582|FG001|Overall Study|not coming in data collection : sick|2|||
156643528|NCT03547531|565443581|FG000|Overall Study|having family occasion|0|||
156643529|NCT03547531|565443582|FG001|Overall Study|having family occasion|2|||
156643530|NCT03944707|565443590|FG000|Overall Study|Adverse Event|0|||
156643531|NCT03944707|565443591|FG001|Overall Study|Adverse Event|2|||
156643532|NCT03944707|565443590|FG000|Overall Study|Study terminated by sponsor|12|||
156643533|NCT03944707|565443591|FG001|Overall Study|Study terminated by sponsor|7|||
156643534|NCT03944707|565443590|FG000|Overall Study|Subject decision|0|||
156643535|NCT03944707|565443591|FG001|Overall Study|Subject decision|1|||
156643536|NCT02117479|565443593|FG000|Overall Study|Death|13|||
156643537|NCT02117479|565443594|FG001|Overall Study|Death|8|||
156643538|NCT02117479|565443593|FG000|Overall Study|Adverse Event|8|||
156643539|NCT02117479|565443594|FG001|Overall Study|Adverse Event|16|||
156643540|NCT02117479|565443593|FG000|Overall Study|Subject decision|8|||
156643541|NCT02117479|565443594|FG001|Overall Study|Subject decision|9|||
156643542|NCT02117479|565443593|FG000|Overall Study|Disease progression|104|||
156643543|NCT02117479|565443594|FG001|Overall Study|Disease progression|108|||
156643544|NCT02117479|565443593|FG000|Overall Study|Noncompliance with study treatment|1|||
156643545|NCT02117479|565443594|FG001|Overall Study|Noncompliance with study treatment|0|||
156643546|NCT02117479|565443593|FG000|Overall Study|Study terminated by the sponsor|4|||
156643547|NCT02117479|565443594|FG001|Overall Study|Study terminated by the sponsor|6|||
156643548|NCT02117479|565443593|FG000|Overall Study|Physician Decision|7|||
156643549|NCT02117479|565443594|FG001|Overall Study|Physician Decision|2|||
156643550|NCT02117479|565443593|FG000|Overall Study|Other unspecified|11|||
156643551|NCT02117479|565443594|FG001|Overall Study|Other unspecified|7|||
156643552|NCT02444182|565443595|FG000|Overall Study|non-compliance|2|||
156643553|NCT02444182|565443596|FG001|Overall Study|non-compliance|1|||
156643554|NCT02444182|565443595|FG000|Overall Study|Lost to Follow-up|0|||
156643555|NCT02444182|565443596|FG001|Overall Study|Lost to Follow-up|4|||
156643556|NCT01959230|565443597|FG000|Overall Study|Failure to follow study procedures|0|||
156643557|NCT01959230|565443598|FG001|Overall Study|Failure to follow study procedures|1|||
156643558|NCT01959230|565443597|FG000|Overall Study|Administrative reasons|2|||
156643559|NCT01959230|565443598|FG001|Overall Study|Administrative reasons|0|||
156643560|NCT01959230|565443597|FG000|Overall Study|Withdrawal by Subject|2|||
156643561|NCT01959230|565443598|FG001|Overall Study|Withdrawal by Subject|0|||
156643562|NCT01453374|565443599|FG000|Overall Study|Adverse Event|7|||
156643563|NCT01453374|565443599|FG000|Overall Study|Lack of Efficacy|1|||
156643564|NCT01453374|565443599|FG000|Overall Study|Lost to Follow-up|3|||
156643565|NCT01453374|565443599|FG000|Overall Study|Withdrawal by Subject|5|||
156643566|NCT01453374|565443599|FG000|Overall Study|Incarcerated|2|||
156643567|NCT00447694|565443600|FG000|Overall Study|Adverse Event|2|||
156643568|NCT00447694|565443600|FG000|Overall Study|Abnormal laboratory value|1|||
156643569|NCT00447694|565443600|FG000|Overall Study|Abnormal test procedure result|1|||
156643570|NCT00447694|565443600|FG000|Overall Study|Withdrawal by Subject|2|||
156643571|NCT01965535|565443601|FG000|Overall Study|Lack of Efficacy|2|||
156643572|NCT01965535|565443602|FG001|Overall Study|Lack of Efficacy|1|||
156643573|NCT01169987|565443603|FG000|Overall Study|Withdrawal by Subject|3|||
156643574|NCT01169987|565443603|FG000|Overall Study|Lost to Follow-up|24|||
156643575|NCT01169987|565443603|FG000|Overall Study|Other|4|||
156643576|NCT00829439|565443604|FG000|Overall Study|Adverse Event|0|||
156643577|NCT00829439|565443605|FG001|Overall Study|Adverse Event|0|||
156643578|NCT00829439|565443606|FG002|Overall Study|Adverse Event|1|||
156643579|NCT00829439|565443607|FG003|Overall Study|Adverse Event|0|||
156643580|NCT00386100|565443608|FG000|Overall Study|Did not receive study medication|6|||
156643581|NCT00386100|565443609|FG001|Overall Study|Did not receive study medication|4|||
156643582|NCT00386100|565443608|FG000|Overall Study|Adverse Event|15|||
156643583|NCT00386100|565443609|FG001|Overall Study|Adverse Event|25|||
156643584|NCT00386100|565443608|FG000|Overall Study|Death|0|||
156643585|NCT00386100|565443609|FG001|Overall Study|Death|1|||
156643586|NCT00386100|565443608|FG000|Overall Study|Insufficient therapeutic effect|30|||
156643587|NCT00386100|565443609|FG001|Overall Study|Insufficient therapeutic effect|6|||
156643588|NCT00386100|565443608|FG000|Overall Study|Lost to Follow-up|29|||
156643589|NCT00386100|565443609|FG001|Overall Study|Lost to Follow-up|29|||
156643590|NCT00386100|565443608|FG000|Overall Study|Non-compliance|18|||
156643591|NCT00386100|565443609|FG001|Overall Study|Non-compliance|19|||
156643592|NCT00386100|565443608|FG000|Overall Study|Protocol Violation|5|||
156643593|NCT00386100|565443609|FG001|Overall Study|Protocol Violation|3|||
156643594|NCT00386100|565443608|FG000|Overall Study|Withdrawal by Subject|32|||
156643595|NCT00386100|565443609|FG001|Overall Study|Withdrawal by Subject|31|||
156643596|NCT00386100|565443608|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
156643597|NCT00386100|565443609|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
156643598|NCT00386100|565443608|FG000|Overall Study|BMD <2.5|1|||
156643599|NCT00386100|565443609|FG001|Overall Study|BMD <2.5|0|||
156643600|NCT00386100|565443608|FG000|Overall Study|Consecutive elevated Hba1C|1|||
156643601|NCT00386100|565443609|FG001|Overall Study|Consecutive elevated Hba1C|0|||
156643602|NCT00386100|565443608|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
156643603|NCT00386100|565443609|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
156643604|NCT00386100|565443608|FG000|Overall Study|Laboratory findings|1|||
156643605|NCT00386100|565443609|FG001|Overall Study|Laboratory findings|0|||
156643606|NCT00386100|565443608|FG000|Overall Study|Participant's concern due to CPK levels|1|||
156643607|NCT00386100|565443609|FG001|Overall Study|Participant's concern due to CPK levels|0|||
156643608|NCT00386100|565443608|FG000|Overall Study|Participant moving out of state|2|||
156643609|NCT00386100|565443609|FG001|Overall Study|Participant moving out of state|0|||
156643610|NCT00386100|565443608|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
156643611|NCT00386100|565443609|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
156643612|NCT00386100|565443608|FG000|Overall Study|Didn't meet entry criteria|1|||
156643613|NCT00386100|565443609|FG001|Overall Study|Didn't meet entry criteria|1|||
156643614|NCT00386100|565443608|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
156643615|NCT00386100|565443609|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
156643616|NCT00386100|565443608|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
156643617|NCT00386100|565443609|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
156643618|NCT00386100|565443608|FG000|Overall Study|Bad metabolic control & patient security|1|||
156643619|NCT00386100|565443609|FG001|Overall Study|Bad metabolic control & patient security|0|||
156643620|NCT00386100|565443608|FG000|Overall Study|Bone loss by DXA bone scan|1|||
156643621|NCT00386100|565443609|FG001|Overall Study|Bone loss by DXA bone scan|0|||
156643622|NCT00386100|565443608|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
156643623|NCT00386100|565443609|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
156643624|NCT00386100|565443608|FG000|Overall Study|7.6% bone loss|1|||
156643625|NCT00386100|565443609|FG001|Overall Study|7.6% bone loss|0|||
156643626|NCT00386100|565443608|FG000|Overall Study|Osteoporosis|0|||
156643627|NCT00386100|565443609|FG001|Overall Study|Osteoporosis|1|||
156643628|NCT00386100|565443608|FG000|Overall Study|Positive pregnancy test|1|||
156643629|NCT00386100|565443609|FG001|Overall Study|Positive pregnancy test|3|||
156643630|NCT00386100|565443608|FG000|Overall Study|Out of country for 5 months|1|||
156643631|NCT00386100|565443609|FG001|Overall Study|Out of country for 5 months|0|||
156643632|NCT00386100|565443608|FG000|Overall Study|Hb1Ac >8%|0|||
156643633|NCT00386100|565443609|FG001|Overall Study|Hb1Ac >8%|1|||
156643634|NCT00386100|565443608|FG000|Overall Study|Participant randomized in error|1|||
156643635|NCT00386100|565443609|FG001|Overall Study|Participant randomized in error|0|||
156643636|NCT02525562|565443610|FG000|Overall Study|Death|9|||
156643637|NCT02525562|565443611|FG001|Overall Study|Death|0|||
156643638|NCT02525562|565443612|FG002|Overall Study|Death|0|||
156643639|NCT02525562|565443610|FG000|Overall Study|Lost to Follow-up|19|||
156643640|NCT02525562|565443611|FG001|Overall Study|Lost to Follow-up|0|||
156643641|NCT02525562|565443612|FG002|Overall Study|Lost to Follow-up|0|||
156643642|NCT02525562|565443610|FG000|Overall Study|Withdrawal by Subject|37|||
156643643|NCT02525562|565443611|FG001|Overall Study|Withdrawal by Subject|0|||
156643644|NCT02525562|565443612|FG002|Overall Study|Withdrawal by Subject|0|||
156643645|NCT02525562|565443610|FG000|Overall Study|Revision/Removal of Study Device|4|||
156643646|NCT02525562|565443611|FG001|Overall Study|Revision/Removal of Study Device|0|||
156643647|NCT02525562|565443612|FG002|Overall Study|Revision/Removal of Study Device|0|||
156643648|NCT02525562|565443610|FG000|Overall Study|Study Closed by Sponsor|154|||
156643649|NCT02525562|565443611|FG001|Overall Study|Study Closed by Sponsor|0|||
156643650|NCT02525562|565443612|FG002|Overall Study|Study Closed by Sponsor|0|||
156643651|NCT00886782|565443615|FG000|Overall Study|Disease progression|3|||
156643652|NCT00886782|565443616|FG001|Overall Study|Disease progression|3|||
156643653|NCT00886782|565443617|FG002|Overall Study|Disease progression|3|||
156643654|NCT00886782|565443615|FG000|Overall Study|Study drug toxicity|0|||
156643655|NCT00886782|565443616|FG001|Overall Study|Study drug toxicity|0|||
156643656|NCT00886782|565443617|FG002|Overall Study|Study drug toxicity|1|||
156643657|NCT00886782|565443615|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
156643658|NCT00886782|565443616|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
156643659|NCT00886782|565443617|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
156643660|NCT00849524|565443618|FG000|Overall Study|Lack of Efficacy|3|||
156643661|NCT00078819|565443619|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
156643662|NCT00078819|565443620|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
156643663|NCT00078819|565443621|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
156643664|NCT00078819|565443622|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
156643665|NCT00078819|565443619|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
156643666|NCT00078819|565443620|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
156643667|NCT00078819|565443621|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
156643668|NCT00078819|565443622|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
156643669|NCT00078819|565443619|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
156643670|NCT00078819|565443620|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
156643671|NCT00078819|565443621|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
156643672|NCT00078819|565443622|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
156643673|NCT00078819|565443619|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
156643674|NCT00078819|565443620|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
156643675|NCT00078819|565443621|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
156643676|NCT00078819|565443622|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
156643677|NCT00078819|565443619|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
156643678|NCT00078819|565443620|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
156643679|NCT00078819|565443621|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
156643680|NCT00078819|565443622|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
156643681|NCT00078819|565443619|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
156643682|NCT00078819|565443620|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
156643683|NCT00078819|565443621|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
156643684|NCT00078819|565443622|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
156643685|NCT00078819|565443619|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
156643686|NCT00078819|565443620|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
156643687|NCT00078819|565443621|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
156643688|NCT00078819|565443622|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
156643689|NCT00078819|565443619|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
156643690|NCT00078819|565443620|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
156643691|NCT00078819|565443621|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
156643692|NCT00078819|565443622|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
156643693|NCT02555618|565443623|FG000|Overall Study|Sponsor's Circumstances|1|||
156643694|NCT02555618|565443624|FG001|Overall Study|Sponsor's Circumstances|0|||
156643695|NCT02217345|565443625|FG000|Overall Study|Lost to Follow-up|2|||
156643696|NCT02217345|565443626|FG001|Overall Study|Lost to Follow-up|1|||
156643697|NCT02217345|565443625|FG000|Overall Study|Withdrawal by Subject|3|||
156643698|NCT02217345|565443626|FG001|Overall Study|Withdrawal by Subject|2|||
156643699|NCT02217345|565443625|FG000|Overall Study|Adverse Event|2|||
156643700|NCT02217345|565443626|FG001|Overall Study|Adverse Event|1|||
156643701|NCT02217345|565443625|FG000|Overall Study|Physician Decision|0|||
156643702|NCT02217345|565443626|FG001|Overall Study|Physician Decision|1|||
156643703|NCT00971204|565443627|FG000|Overall Study|Did not meet all criteria-not treated|14|||
156643704|NCT00971204|565443627|FG000|Overall Study|Lost to Follow-up|10|||
156643705|NCT04130919|565443628|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
156643706|NCT04130919|565443629|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
156643707|NCT04130919|565443630|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
156643708|NCT04130919|565443631|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
156643709|NCT04130919|565443632|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
156643710|NCT04130919|565443633|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
156643711|NCT04130919|565443628|FG000|Blinded Treatment Phase|Adverse Event|0|||
156643712|NCT04130919|565443629|FG001|Blinded Treatment Phase|Adverse Event|0|||
156643713|NCT04130919|565443630|FG002|Blinded Treatment Phase|Adverse Event|1|||
156643714|NCT04130919|565443631|FG003|Blinded Treatment Phase|Adverse Event|0|||
156643715|NCT04130919|565443632|FG004|Blinded Treatment Phase|Adverse Event|0|||
156643716|NCT04130919|565443633|FG005|Blinded Treatment Phase|Adverse Event|0|||
156643717|NCT04130919|565443628|FG000|Blinded Treatment Phase|Disease worsening|0|||
156643718|NCT04130919|565443629|FG001|Blinded Treatment Phase|Disease worsening|0|||
156643719|NCT04130919|565443630|FG002|Blinded Treatment Phase|Disease worsening|1|||
156643720|NCT04130919|565443631|FG003|Blinded Treatment Phase|Disease worsening|0|||
156643721|NCT04130919|565443632|FG004|Blinded Treatment Phase|Disease worsening|0|||
156643722|NCT04130919|565443633|FG005|Blinded Treatment Phase|Disease worsening|0|||
156643723|NCT04130919|565443628|FG000|Blinded Treatment Phase|Investigator's decision|0|||
156643724|NCT04130919|565443629|FG001|Blinded Treatment Phase|Investigator's decision|1|||
156643725|NCT04130919|565443630|FG002|Blinded Treatment Phase|Investigator's decision|0|||
156643726|NCT04130919|565443631|FG003|Blinded Treatment Phase|Investigator's decision|0|||
156643727|NCT04130919|565443632|FG004|Blinded Treatment Phase|Investigator's decision|0|||
156643728|NCT04130919|565443633|FG005|Blinded Treatment Phase|Investigator's decision|0|||
156643729|NCT04130919|565443628|FG000|Blinded Treatment Phase|Withdrew consent|1|||
156643730|NCT04130919|565443629|FG001|Blinded Treatment Phase|Withdrew consent|0|||
156643731|NCT04130919|565443630|FG002|Blinded Treatment Phase|Withdrew consent|0|||
156643732|NCT04130919|565443631|FG003|Blinded Treatment Phase|Withdrew consent|0|||
156643733|NCT04130919|565443632|FG004|Blinded Treatment Phase|Withdrew consent|0|||
156643734|NCT04130919|565443633|FG005|Blinded Treatment Phase|Withdrew consent|0|||
156643735|NCT04130919|565443628|FG000|Open-label Treatment Phase|Withdrew consent|0|||
156643736|NCT04130919|565443629|FG001|Open-label Treatment Phase|Withdrew consent|0|||
156643737|NCT04130919|565443630|FG002|Open-label Treatment Phase|Withdrew consent|0|||
156643738|NCT04130919|565443631|FG003|Open-label Treatment Phase|Withdrew consent|1|||
156643739|NCT04130919|565443632|FG004|Open-label Treatment Phase|Withdrew consent|1|||
156643740|NCT04130919|565443633|FG005|Open-label Treatment Phase|Withdrew consent|1|||
156643741|NCT04130919|565443628|FG000|Open-label Treatment Phase|Disease worsening|0|||
156643742|NCT04130919|565443629|FG001|Open-label Treatment Phase|Disease worsening|0|||
156643743|NCT04130919|565443630|FG002|Open-label Treatment Phase|Disease worsening|0|||
156643744|NCT04130919|565443631|FG003|Open-label Treatment Phase|Disease worsening|1|||
156643745|NCT04130919|565443632|FG004|Open-label Treatment Phase|Disease worsening|0|||
156643746|NCT04130919|565443633|FG005|Open-label Treatment Phase|Disease worsening|1|||
156643747|NCT04130919|565443628|FG000|Open-label Treatment Phase|Investigator's decision|0|||
156643748|NCT04130919|565443629|FG001|Open-label Treatment Phase|Investigator's decision|0|||
156643749|NCT04130919|565443630|FG002|Open-label Treatment Phase|Investigator's decision|0|||
156643750|NCT04130919|565443631|FG003|Open-label Treatment Phase|Investigator's decision|1|||
156643751|NCT04130919|565443632|FG004|Open-label Treatment Phase|Investigator's decision|0|||
156643752|NCT04130919|565443633|FG005|Open-label Treatment Phase|Investigator's decision|0|||
156643753|NCT04130919|565443628|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
156643754|NCT04130919|565443629|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
156643755|NCT04130919|565443630|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
156643756|NCT04130919|565443631|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
156643757|NCT04130919|565443632|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
156643758|NCT04130919|565443633|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
156643759|NCT04130919|565443628|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
156643760|NCT04130919|565443629|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
156643761|NCT04130919|565443630|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
156643762|NCT04130919|565443631|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
156643763|NCT04130919|565443632|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
156643764|NCT04130919|565443633|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
156643765|NCT02624518|565443634|FG000|Overall Study|Physician Decision|1|||
156643766|NCT02729194|565443635|FG000|Overall Study|Withdrawal by Subject|3|||
156643767|NCT00845026|565443636|FG000|Study Period III|Adverse Event|23|||
156643768|NCT00845026|565443637|FG001|Study Period III|Adverse Event|19|||
156643769|NCT00845026|565443636|FG000|Study Period III|Perceived lack of efficacy|27|||
156643770|NCT00845026|565443637|FG001|Study Period III|Perceived lack of efficacy|15|||
156643771|NCT00845026|565443636|FG000|Study Period III|Withdrawal by Subject|19|||
156643772|NCT00845026|565443637|FG001|Study Period III|Withdrawal by Subject|15|||
156643773|NCT00845026|565443636|FG000|Study Period III|Entry Criteria not met|8|||
156643774|NCT00845026|565443637|FG001|Study Period III|Entry Criteria not met|11|||
156643775|NCT00845026|565443636|FG000|Study Period III|Lost to Follow-up|4|||
156643776|NCT00845026|565443637|FG001|Study Period III|Lost to Follow-up|5|||
156643777|NCT00845026|565443636|FG000|Study Period III|Protocol Violation|8|||
156643778|NCT00845026|565443637|FG001|Study Period III|Protocol Violation|1|||
156643779|NCT00845026|565443636|FG000|Study Period III|Scheduled conflict|3|||
156643780|NCT00845026|565443637|FG001|Study Period III|Scheduled conflict|1|||
156643781|NCT00845026|565443636|FG000|Study Period III|Subject is moving or has moved|2|||
156643782|NCT00845026|565443637|FG001|Study Period III|Subject is moving or has moved|4|||
156643783|NCT00845026|565443636|FG000|Study Period III|Transportation issues|1|||
156643784|NCT00845026|565443637|FG001|Study Period III|Transportation issues|1|||
156643785|NCT00845026|565443636|FG000|Study Period IV|Adverse Event|4|||
156643786|NCT00845026|565443637|FG001|Study Period IV|Adverse Event|0|||
156643787|NCT00845026|565443636|FG000|Study Period IV|Perceived lack of efficacy|2|||
156643788|NCT00845026|565443637|FG001|Study Period IV|Perceived lack of efficacy|1|||
156643789|NCT00845026|565443636|FG000|Study Period IV|Protocol Violation|3|||
156643790|NCT00845026|565443637|FG001|Study Period IV|Protocol Violation|1|||
156643791|NCT00845026|565443636|FG000|Study Period IV|Lost to Follow-up|1|||
156643792|NCT00845026|565443637|FG001|Study Period IV|Lost to Follow-up|0|||
156643793|NCT00845026|565443636|FG000|Study Period IV|Withdrawal by Subject|4|||
156643794|NCT00845026|565443637|FG001|Study Period IV|Withdrawal by Subject|1|||
156643795|NCT00845026|565443636|FG000|Study Period IV|Entry Criteria Not Met|1|||
156643796|NCT00845026|565443637|FG001|Study Period IV|Entry Criteria Not Met|0|||
156643797|NCT00845026|565443636|FG000|Study Period IV|Subject is moving or has moved|0|||
156643798|NCT00845026|565443637|FG001|Study Period IV|Subject is moving or has moved|1|||
156643799|NCT00845026|565443636|FG000|Study Period IV|Scheduling conflict|1|||
156643800|NCT00845026|565443637|FG001|Study Period IV|Scheduling conflict|0|||
156643801|NCT01325532|565443638|FG000|Overall Study|Withdrawal by Subject|2|||
156643802|NCT01325532|565443639|FG001|Overall Study|Withdrawal by Subject|0|||
156643803|NCT03012815|565443640|FG000|Overall Study|Lost to Follow-up|1|||
156643804|NCT03012815|565443641|FG001|Overall Study|Lost to Follow-up|0|||
156643805|NCT03012815|565443640|FG000|Overall Study|Physician Decision|3|||
156643806|NCT03012815|565443641|FG001|Overall Study|Physician Decision|2|||
156643807|NCT03012815|565443640|FG000|Overall Study|Adverse Event|1|||
156643808|NCT03012815|565443641|FG001|Overall Study|Adverse Event|0|||
156643809|NCT00272961|565443642|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
156643810|NCT00272961|565443643|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
156643811|NCT00272961|565443644|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
156643812|NCT00272961|565443645|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
156643813|NCT00272961|565443646|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
156412177|NCT03881059|564602844|FG001|Treatment Period - Part B|Other reasons|3|||
156412178|NCT03881059|564602845|FG002|Treatment Period - Part B|Other reasons|3|||
156643814|NCT00272961|565443642|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
156643815|NCT00272961|565443643|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
156412179|NCT02065570|564602846|FG000|Induction Study|Adverse Event|5|||
156643816|NCT00272961|565443644|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
156643817|NCT00272961|565443645|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
156643818|NCT00272961|565443646|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
156643819|NCT00272961|565443642|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
156643820|NCT00272961|565443643|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
156643821|NCT00272961|565443644|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
156643822|NCT00272961|565443645|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
156643823|NCT00272961|565443646|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
156643824|NCT00272961|565443642|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
156643825|NCT00272961|565443643|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
156643826|NCT00272961|565443644|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
156643827|NCT00272961|565443645|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
156643828|NCT00272961|565443646|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
156643829|NCT00272961|565443642|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
156643830|NCT00272961|565443643|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
156643831|NCT00272961|565443644|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
156643832|NCT00272961|565443645|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
156643833|NCT00272961|565443646|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
156643834|NCT00272961|565443642|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
156643835|NCT00272961|565443643|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
156643836|NCT00272961|565443644|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
156643837|NCT00272961|565443645|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
156643838|NCT00272961|565443646|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
156643839|NCT00272961|565443642|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
156643840|NCT00272961|565443643|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
156643841|NCT00272961|565443644|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
156643842|NCT00272961|565443645|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
156643843|NCT00272961|565443646|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
156643844|NCT00272961|565443642|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
156643845|NCT00272961|565443643|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
156643846|NCT00272961|565443644|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
156643847|NCT00272961|565443645|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
156643848|NCT00272961|565443646|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
156643849|NCT02400905|565443648|FG000|Overall Study|Death|24|||
156643850|NCT02400905|565443648|FG000|Overall Study|Lost to Follow-up|18|||
156643851|NCT02400905|565443648|FG000|Overall Study|Withdrawal by Subject|16|||
156643852|NCT02400905|565443648|FG000|Overall Study|Physician Decision|4|||
156643853|NCT02400905|565443648|FG000|Overall Study|Other|1|||
156643854|NCT03196791|565443651|FG000|Overall Study|Protocol Violation|7|||
156643855|NCT03196791|565443652|FG001|Overall Study|Protocol Violation|3|||
156643856|NCT03196791|565443651|FG000|Overall Study|Withdrawal by Subject|3|||
156643857|NCT03196791|565443652|FG001|Overall Study|Withdrawal by Subject|2|||
156643858|NCT02176642|565443655|FG000|Overall Study|Withdrawal by Subject|0|||
156643859|NCT02176642|565443656|FG001|Overall Study|Withdrawal by Subject|1|||
156643860|NCT03338673|565443658|FG000|Overall Study|Lost to Follow-up|1|||
156643861|NCT03338673|565443659|FG001|Overall Study|Lost to Follow-up|1|||
156643862|NCT04556838|565443668|FG000|Overall Study|Withdrawal by Subject|3|||
156643863|NCT04556838|565443669|FG001|Overall Study|Withdrawal by Subject|1|||
156643864|NCT04556838|565443670|FG002|Overall Study|Withdrawal by Subject|2|||
156643865|NCT04556838|565443668|FG000|Overall Study|Adverse Event|0|||
156643866|NCT04556838|565443669|FG001|Overall Study|Adverse Event|1|||
156643867|NCT04556838|565443670|FG002|Overall Study|Adverse Event|1|||
156643868|NCT04556838|565443668|FG000|Overall Study|Lost to Follow-up|0|||
156643869|NCT04556838|565443669|FG001|Overall Study|Lost to Follow-up|0|||
156643870|NCT04556838|565443670|FG002|Overall Study|Lost to Follow-up|2|||
156643871|NCT04556838|565443668|FG000|Overall Study|Subject travel|0|||
156643872|NCT04556838|565443669|FG001|Overall Study|Subject travel|1|||
156643873|NCT04556838|565443670|FG002|Overall Study|Subject travel|0|||
156643874|NCT04556838|565443668|FG000|Overall Study|Physician Decision|1|||
156643875|NCT04556838|565443669|FG001|Overall Study|Physician Decision|0|||
156643876|NCT04556838|565443670|FG002|Overall Study|Physician Decision|0|||
156643877|NCT04523831|565443671|FG000|Overall Study|Lost to Follow-up|15|||
156643878|NCT04523831|565443672|FG001|Overall Study|Lost to Follow-up|17|||
156643879|NCT04523831|565443671|FG000|Overall Study|Death|0|||
156643880|NCT04523831|565443672|FG001|Overall Study|Death|3|||
156643881|NCT04523831|565443671|FG000|Overall Study|Adverse Event|2|||
156643882|NCT04523831|565443672|FG001|Overall Study|Adverse Event|0|||
156643883|NCT03033069|565443673|FG000|Overall Study|Adverse Event|6|||
156643884|NCT03033069|565443674|FG001|Overall Study|Adverse Event|7|||
156643885|NCT03033069|565443675|FG002|Overall Study|Adverse Event|4|||
156643886|NCT03033069|565443676|FG003|Overall Study|Adverse Event|6|||
156643887|NCT03033069|565443673|FG000|Overall Study|Lack of Efficacy|0|||
156643888|NCT03033069|565443674|FG001|Overall Study|Lack of Efficacy|0|||
156643889|NCT03033069|565443675|FG002|Overall Study|Lack of Efficacy|1|||
156643890|NCT03033069|565443676|FG003|Overall Study|Lack of Efficacy|0|||
156643891|NCT03033069|565443673|FG000|Overall Study|Lost to Follow-up|6|||
156643892|NCT03033069|565443674|FG001|Overall Study|Lost to Follow-up|5|||
156643893|NCT03033069|565443675|FG002|Overall Study|Lost to Follow-up|5|||
156643894|NCT03033069|565443676|FG003|Overall Study|Lost to Follow-up|6|||
156643895|NCT03033069|565443673|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156643896|NCT03033069|565443674|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156643897|NCT03033069|565443675|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156643898|NCT03033069|565443676|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156643899|NCT03033069|565443673|FG000|Overall Study|Protocol Deviation|0|||
156643900|NCT03033069|565443674|FG001|Overall Study|Protocol Deviation|1|||
156643901|NCT03033069|565443675|FG002|Overall Study|Protocol Deviation|0|||
156643902|NCT03033069|565443676|FG003|Overall Study|Protocol Deviation|0|||
156643903|NCT03033069|565443673|FG000|Overall Study|Withdrawal by Subject|10|||
156643904|NCT03033069|565443674|FG001|Overall Study|Withdrawal by Subject|10|||
156643905|NCT03033069|565443675|FG002|Overall Study|Withdrawal by Subject|11|||
156643906|NCT03033069|565443676|FG003|Overall Study|Withdrawal by Subject|6|||
156643907|NCT03033069|565443673|FG000|Overall Study|Withdrawal By Caregiver|1|||
156643908|NCT03033069|565443674|FG001|Overall Study|Withdrawal By Caregiver|0|||
156643909|NCT03033069|565443675|FG002|Overall Study|Withdrawal By Caregiver|0|||
156643910|NCT03033069|565443676|FG003|Overall Study|Withdrawal By Caregiver|0|||
156643911|NCT03033069|565443673|FG000|Overall Study|Reason not Specified|0|||
156643912|NCT03033069|565443674|FG001|Overall Study|Reason not Specified|1|||
156643913|NCT03033069|565443675|FG002|Overall Study|Reason not Specified|0|||
156643914|NCT03033069|565443676|FG003|Overall Study|Reason not Specified|1|||
156643915|NCT00550420|565445354|FG000|Overall Study|Adverse Event|28|||
156643916|NCT00550420|565445354|FG000|Overall Study|Lost to Follow-up|8|||
156643917|NCT00550420|565445354|FG000|Overall Study|Protocol Violation|11|||
156643918|NCT00550420|565445354|FG000|Overall Study|Withdrawal by Subject|30|||
156643919|NCT00550420|565445354|FG000|Overall Study|Still in study at termination|206|||
156643920|NCT00550420|565445354|FG000|Overall Study|Missing|2|||
156643921|NCT00550420|565445354|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
156643922|NCT00550420|565445354|FG000|Overall Study|Investigators opinion|1|||
156643923|NCT00550420|565445354|FG000|Overall Study|Lack of curative effect|1|||
156643924|NCT00550420|565445354|FG000|Overall Study|Unethical stop of enrollment|2|||
156643925|NCT00550420|565445354|FG000|Overall Study|Caregiver's decision to withdraw|1|||
156643926|NCT00550420|565445354|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
156643927|NCT00550420|565445354|FG000|Overall Study|Exclusion criteria|1|||
156643928|NCT00550420|565445354|FG000|Overall Study|Prohibited medicine|1|||
156643929|NCT00331773|565445355|FG000|Overall Study|Withdrawal by Subject|6|||
156643930|NCT00331773|565445356|FG001|Overall Study|Withdrawal by Subject|4|||
156643931|NCT00331773|565445355|FG000|Overall Study|Protocol Violation|10|||
156643932|NCT00331773|565445356|FG001|Overall Study|Protocol Violation|3|||
156643933|NCT01677910|565445357|FG000|Double-Blind Treatment Period|Adverse Event|6|||
156643934|NCT01677910|565445358|FG001|Double-Blind Treatment Period|Adverse Event|2|||
156643935|NCT01677910|565445359|FG002|Double-Blind Treatment Period|Adverse Event|3|||
156643936|NCT01677910|565445360|FG003|Double-Blind Treatment Period|Adverse Event|0|||
156643937|NCT01677910|565445357|FG000|Double-Blind Treatment Period|Physician Decision|0|||
156643938|NCT01677910|565445358|FG001|Double-Blind Treatment Period|Physician Decision|0|||
156643939|NCT01677910|565445359|FG002|Double-Blind Treatment Period|Physician Decision|1|||
156643940|NCT01677910|565445360|FG003|Double-Blind Treatment Period|Physician Decision|0|||
156643941|NCT01677910|565445357|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
156643942|NCT01677910|565445358|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
156643943|NCT01677910|565445359|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
156643944|NCT01677910|565445360|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
156643945|NCT01677910|565445357|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
156643946|NCT01677910|565445358|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
156643947|NCT01677910|565445359|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
156643948|NCT01677910|565445360|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
156643949|NCT01677910|565445357|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
156643950|NCT01677910|565445358|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
156643951|NCT01677910|565445359|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
156643952|NCT01677910|565445360|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
156643953|NCT01677910|565445357|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
156643954|NCT01677910|565445358|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
156643955|NCT01677910|565445359|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
156643956|NCT01677910|565445360|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
156643957|NCT01677910|565445357|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
156643958|NCT01677910|565445358|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
156643959|NCT01677910|565445359|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
156643960|NCT01677910|565445360|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
156643961|NCT01677910|565445357|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
156643962|NCT01677910|565445358|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
156643963|NCT01677910|565445359|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
156643964|NCT01677910|565445360|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
156643965|NCT01677910|565445357|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
156643966|NCT01677910|565445358|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
156643967|NCT01677910|565445359|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
156643968|NCT01677910|565445360|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
156412180|NCT02065570|564602847|FG001|Induction Study|Adverse Event|12|||
156412181|NCT02065570|564602848|FG002|Induction Study|Adverse Event|0|||
156643969|NCT01677910|565445357|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
156643970|NCT01677910|565445358|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
156643971|NCT01677910|565445359|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
156643972|NCT01677910|565445360|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
156643973|NCT01808209|565445363|FG000|Overall Study|Lost to Follow-up|0|||
156643974|NCT01808209|565445364|FG001|Overall Study|Lost to Follow-up|1|||
156643975|NCT01703741|565445365|FG000|Overall Study|Withdrawal by Subject|6|||
156643976|NCT01703741|565445365|FG000|Overall Study|Adverse Event|2|||
156643977|NCT01703741|565445365|FG000|Overall Study|Physician Decision|2|||
156643978|NCT01703741|565445365|FG000|Overall Study|Protocol Violation|1|||
156643979|NCT01703741|565445365|FG000|Overall Study|Lost to Follow-up|3|||
156643980|NCT01703741|565445365|FG000|Overall Study|Subject did not want to continue|2|||
156643981|NCT01703741|565445365|FG000|Overall Study|Subject cannot comply with study visits|1|||
156643982|NCT01703741|565445365|FG000|Overall Study|Subject started testosterone injections|1|||
156643983|NCT00368537|565445366|FG000|Randomization|No study drug dosed|13|||
156643984|NCT00368537|565445367|FG001|Randomization|No study drug dosed|6|||
156643985|NCT00368537|565445366|FG000|Baseline Participants|Lost to Follow-up|16|||
156643986|NCT00368537|565445367|FG001|Baseline Participants|Lost to Follow-up|17|||
156643987|NCT00368537|565445366|FG000|Baseline Participants|Withdrawal by Subject|6|||
156643988|NCT00368537|565445367|FG001|Baseline Participants|Withdrawal by Subject|4|||
156643989|NCT00368537|565445366|FG000|Baseline Participants|Death|1|||
156643990|NCT00368537|565445367|FG001|Baseline Participants|Death|2|||
156643991|NCT00368537|565445366|FG000|Baseline Participants|No susceptibility|1|||
156643992|NCT00368537|565445367|FG001|Baseline Participants|No susceptibility|0|||
156643993|NCT00368537|565445366|FG000|Baseline Participants|Patient uncompliant|0|||
156643994|NCT00368537|565445367|FG001|Baseline Participants|Patient uncompliant|1|||
156643995|NCT00685919|565445369|FG000|Overall Study|Withdrawal by Subject|0|||
156643996|NCT00685919|565445370|FG001|Overall Study|Withdrawal by Subject|0|||
156643997|NCT00685919|565445371|FG002|Overall Study|Withdrawal by Subject|1|||
156643998|NCT00685919|565445372|FG003|Overall Study|Withdrawal by Subject|0|||
156643999|NCT00685919|565445369|FG000|Overall Study|Physician Decision|1|||
156644000|NCT00685919|565445370|FG001|Overall Study|Physician Decision|0|||
156644001|NCT00685919|565445371|FG002|Overall Study|Physician Decision|0|||
156644002|NCT00685919|565445372|FG003|Overall Study|Physician Decision|0|||
156644003|NCT01717456|565445377|FG000|End of Treatment|Physician Decision|0|||
156644004|NCT01717456|565445378|FG001|End of Treatment|Physician Decision|1|||
156644005|NCT01717456|565445377|FG000|End of Treatment|Lost to Follow-up|0|||
156644006|NCT01717456|565445378|FG001|End of Treatment|Lost to Follow-up|1|||
156644007|NCT01717456|565445377|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
156644008|NCT01717456|565445378|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
156644009|NCT02732561|565445380|FG000|Overall Study|Lost to Follow-up|1|||
156644010|NCT02732561|565445381|FG001|Overall Study|Lost to Follow-up|1|||
156644011|NCT02732561|565445380|FG000|Overall Study|Withdrawal by Subject|1|||
156644012|NCT02732561|565445381|FG001|Overall Study|Withdrawal by Subject|0|||
156644013|NCT00751998|565445390|FG000|Overall Study|Lost to Follow-up|7|||
156644014|NCT00751998|565445390|FG000|Overall Study|Death|11|||
156644015|NCT00751998|565445390|FG000|Overall Study|Withdrawal by Subject|2|||
156644016|NCT01223196|565445392|FG000|Overall Study|Lost to Follow-up|2|||
156644017|NCT01223196|565445393|FG001|Overall Study|Lost to Follow-up|0|||
156644018|NCT01223196|565445392|FG000|Overall Study|Physician Decision|1|||
156644019|NCT01223196|565445393|FG001|Overall Study|Physician Decision|0|||
156644020|NCT01223196|565445392|FG000|Overall Study|Withdrawal by Subject|1|||
156644021|NCT01223196|565445393|FG001|Overall Study|Withdrawal by Subject|0|||
156644022|NCT02629133|565445394|FG000|Overall Study|Lost to Follow-up|3|||
156644023|NCT02629133|565445395|FG001|Overall Study|Lost to Follow-up|1|||
156644024|NCT02629133|565445394|FG000|Overall Study|Withdrawal by Subject|1|||
156644025|NCT02629133|565445395|FG001|Overall Study|Withdrawal by Subject|1|||
156644026|NCT01238822|565445396|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
156644027|NCT02598193|565445397|FG000|Overall Study|Adverse Event|13|||
156644028|NCT02598193|565445397|FG000|Overall Study|Withdrawal by Subject|1|||
156644029|NCT02598193|565445397|FG000|Overall Study|Listed in active lung transplant list|1|||
156644030|NCT02598193|565445397|FG000|Overall Study|Does not want to take Nintedanib|1|||
156644031|NCT02487979|565445398|FG000|Overall Study|Physician Decision|2|||
156644032|NCT02487979|565445398|FG000|Overall Study|Withdrawal by Subject|2|||
156644033|NCT02487979|565445398|FG000|Overall Study|Progressive Disease|17|||
156644034|NCT02410837|565445399|FG000|Overall Study|Death|387|||
156644035|NCT02410837|565445399|FG000|Overall Study|Lost to Follow-up|50|||
156644036|NCT02410837|565445399|FG000|Overall Study|Withdrawal by Subject|44|||
156644037|NCT02410837|565445399|FG000|Overall Study|Physician Decision|6|||
156644038|NCT02410837|565445399|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
156644039|NCT00837577|565445400|FG000|Double-blind Period|Clinical Adverse Event|1|||
156644040|NCT00837577|565445401|FG001|Double-blind Period|Clinical Adverse Event|0|||
156644041|NCT00837577|565445400|FG000|Double-blind Period|Withdrawal by Subject|1|||
156644042|NCT00837577|565445401|FG001|Double-blind Period|Withdrawal by Subject|0|||
156644043|NCT00837577|565445400|FG000|Open-label Period|Clinical Adverse Event|2|||
156644044|NCT00837577|565445401|FG001|Open-label Period|Clinical Adverse Event|2|||
156644045|NCT00837577|565445400|FG000|Open-label Period|Laboratory Adverse Event|0|||
156644046|NCT00837577|565445401|FG001|Open-label Period|Laboratory Adverse Event|1|||
156644047|NCT00837577|565445400|FG000|Open-label Period|Lack of Efficacy|4|||
156644048|NCT00837577|565445401|FG001|Open-label Period|Lack of Efficacy|3|||
156644049|NCT00837577|565445400|FG000|Open-label Period|Withdrawal by Subject|1|||
156644050|NCT00837577|565445401|FG001|Open-label Period|Withdrawal by Subject|2|||
156644051|NCT00837577|565445400|FG000|Open-label Period|Other Reason|1|||
156644052|NCT00837577|565445401|FG001|Open-label Period|Other Reason|1|||
156644053|NCT01825876|565445405|FG000|Period 2|Withdrawal by Subject|0|||
156644054|NCT01825876|565445406|FG001|Period 2|Withdrawal by Subject|1|||
156644055|NCT00879970|565445407|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
156644056|NCT00879970|565445408|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
156644057|NCT00879970|565445409|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
156644058|NCT00879970|565445410|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
156644059|NCT00879970|565445411|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
156644060|NCT00879970|565445407|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
156644061|NCT00879970|565445408|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
156644062|NCT00879970|565445409|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
156644063|NCT00879970|565445410|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
156644064|NCT00879970|565445411|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
156644065|NCT00879970|565445407|FG000|Period 1 TZD Randomization|Death|2|||
156644066|NCT00879970|565445408|FG001|Period 1 TZD Randomization|Death|1|||
156644067|NCT00879970|565445409|FG002|Period 1 TZD Randomization|Death|0|||
156644068|NCT00879970|565445410|FG003|Period 1 TZD Randomization|Death|0|||
156644069|NCT00879970|565445411|FG004|Period 1 TZD Randomization|Death|0|||
156644070|NCT00879970|565445407|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
156644071|NCT00879970|565445408|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
156644072|NCT00879970|565445409|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
156644073|NCT00879970|565445410|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
156644074|NCT00879970|565445411|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
156644075|NCT00879970|565445407|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
156644076|NCT00879970|565445408|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
156644077|NCT00879970|565445409|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
156644078|NCT00879970|565445410|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
156644079|NCT00879970|565445411|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
156644080|NCT00879970|565445407|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
156644081|NCT00879970|565445408|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
156644082|NCT00879970|565445409|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
156644083|NCT00879970|565445410|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
156644084|NCT00879970|565445411|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
156644085|NCT00879970|565445407|FG000|Period 2 Vitamin D Randomization|Death|0|||
156644086|NCT00879970|565445408|FG001|Period 2 Vitamin D Randomization|Death|0|||
156644087|NCT00879970|565445409|FG002|Period 2 Vitamin D Randomization|Death|0|||
156644088|NCT00879970|565445410|FG003|Period 2 Vitamin D Randomization|Death|2|||
156644089|NCT00879970|565445411|FG004|Period 2 Vitamin D Randomization|Death|0|||
156644090|NCT01749033|565445419|FG000|Overall Study|Did not receive allocated intervention|3|||
156644091|NCT01749033|565445420|FG001|Overall Study|Did not receive allocated intervention|3|||
156644092|NCT01749033|565445421|FG002|Overall Study|Did not receive allocated intervention|0|||
156644093|NCT01749033|565445419|FG000|Overall Study|Lost to Follow-up|0|||
156644094|NCT01749033|565445420|FG001|Overall Study|Lost to Follow-up|2|||
156644095|NCT01749033|565445421|FG002|Overall Study|Lost to Follow-up|1|||
156644096|NCT01256398|565445422|FG000|Overall Study|Withdrawal by Subject|1|||
156644097|NCT00061945|565445423|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
156644098|NCT00061945|565445424|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
156644099|NCT00061945|565445423|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
156644100|NCT00061945|565445424|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
156644101|NCT00061945|565445423|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
156644102|NCT00061945|565445424|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
156644103|NCT00061945|565445423|FG000|Course IV: Alemtuzumab|Early exits|6|||
156644104|NCT00061945|565445424|FG001|Course IV: Alemtuzumab|Early exits|15|||
156644105|NCT01039584|565445425|FG000|Overall Study|Withdrawal by Subject|4|||
156644106|NCT01039584|565445426|FG001|Overall Study|Withdrawal by Subject|2|||
156644107|NCT01039584|565445427|FG002|Overall Study|Withdrawal by Subject|1|||
156644108|NCT01039584|565445425|FG000|Overall Study|Protocol Violation|10|||
156644109|NCT01039584|565445426|FG001|Overall Study|Protocol Violation|4|||
156644110|NCT01039584|565445427|FG002|Overall Study|Protocol Violation|6|||
156644111|NCT01039584|565445425|FG000|Overall Study|Lost to Follow-up|5|||
156644112|NCT01039584|565445426|FG001|Overall Study|Lost to Follow-up|3|||
156644113|NCT01039584|565445427|FG002|Overall Study|Lost to Follow-up|4|||
156644114|NCT01039584|565445425|FG000|Overall Study|Negative Baseline culture for Candida|59|||
156644115|NCT01039584|565445426|FG001|Overall Study|Negative Baseline culture for Candida|59|||
156644116|NCT01039584|565445427|FG002|Overall Study|Negative Baseline culture for Candida|24|||
156644117|NCT01039584|565445425|FG000|Overall Study|Lack of Efficacy|7|||
156644118|NCT01039584|565445426|FG001|Overall Study|Lack of Efficacy|6|||
156644119|NCT01039584|565445427|FG002|Overall Study|Lack of Efficacy|10|||
156644120|NCT01039584|565445425|FG000|Overall Study|other|1|||
156644121|NCT01039584|565445426|FG001|Overall Study|other|3|||
156644122|NCT01039584|565445427|FG002|Overall Study|other|1|||
156644123|NCT01039584|565445425|FG000|Overall Study|Pap smear with significant pathology|10|||
156644124|NCT01039584|565445426|FG001|Overall Study|Pap smear with significant pathology|10|||
156644125|NCT01039584|565445427|FG002|Overall Study|Pap smear with significant pathology|3|||
156644126|NCT01039584|565445425|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
156644127|NCT01039584|565445426|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
156644128|NCT01039584|565445427|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
156644129|NCT03672396|565445430|FG000|Overall Study|Withdrawal by Subject|4|||
156644130|NCT03672396|565445430|FG000|Overall Study|Physician Decision|1|||
156644131|NCT03672396|565445430|FG000|Overall Study|Adverse Event|1|||
156644132|NCT04380701|565445433|FG000|Overall Study|Pregnancy|0|||
156644133|NCT04380701|565445434|FG001|Overall Study|Pregnancy|0|||
156644134|NCT04380701|565445435|FG002|Overall Study|Pregnancy|0|||
156644135|NCT04380701|565445436|FG003|Overall Study|Pregnancy|0|||
156644136|NCT04380701|565445437|FG004|Overall Study|Pregnancy|0|||
156644137|NCT04380701|565445438|FG005|Overall Study|Pregnancy|0|||
156644138|NCT04380701|565445439|FG006|Overall Study|Pregnancy|0|||
156644139|NCT04380701|565445440|FG007|Overall Study|Pregnancy|0|||
156644140|NCT04380701|565445441|FG008|Overall Study|Pregnancy|0|||
156644141|NCT04380701|565445442|FG009|Overall Study|Pregnancy|0|||
156644142|NCT04380701|565445443|FG010|Overall Study|Pregnancy|0|||
156644143|NCT04380701|565445444|FG011|Overall Study|Pregnancy|0|||
156644144|NCT04380701|565445445|FG012|Overall Study|Pregnancy|0|||
156644145|NCT04380701|565445446|FG013|Overall Study|Pregnancy|0|||
156644146|NCT04380701|565445447|FG014|Overall Study|Pregnancy|0|||
156644147|NCT04380701|565445448|FG015|Overall Study|Pregnancy|0|||
156644148|NCT04380701|565445449|FG016|Overall Study|Pregnancy|0|||
156644149|NCT04380701|565445450|FG017|Overall Study|Pregnancy|0|||
156644150|NCT04380701|565445451|FG018|Overall Study|Pregnancy|0|||
156644151|NCT04380701|565445452|FG019|Overall Study|Pregnancy|0|||
156644152|NCT04380701|565445453|FG020|Overall Study|Pregnancy|0|||
156644153|NCT04380701|565445454|FG021|Overall Study|Pregnancy|0|||
156644154|NCT04380701|565445455|FG022|Overall Study|Pregnancy|0|||
156644155|NCT04380701|565445456|FG023|Overall Study|Pregnancy|0|||
156644156|NCT04380701|565445457|FG024|Overall Study|Pregnancy|0|||
156644157|NCT04380701|565445458|FG025|Overall Study|Pregnancy|0|||
156644158|NCT04380701|565445459|FG026|Overall Study|Pregnancy|0|||
156644159|NCT04380701|565445460|FG027|Overall Study|Pregnancy|0|||
156644160|NCT04380701|565445461|FG028|Overall Study|Pregnancy|0|||
156644161|NCT04380701|565445462|FG029|Overall Study|Pregnancy|0|||
156644162|NCT04380701|565445463|FG030|Overall Study|Pregnancy|0|||
156644163|NCT04380701|565445464|FG031|Overall Study|Pregnancy|0|||
156644164|NCT04380701|565445465|FG032|Overall Study|Pregnancy|1|||
156644165|NCT04380701|565445466|FG033|Overall Study|Pregnancy|0|||
156644166|NCT04380701|565445433|FG000|Overall Study|Lost to Follow-up|0|||
156644167|NCT04380701|565445434|FG001|Overall Study|Lost to Follow-up|0|||
156644168|NCT04380701|565445435|FG002|Overall Study|Lost to Follow-up|0|||
156644169|NCT04380701|565445436|FG003|Overall Study|Lost to Follow-up|0|||
156644170|NCT04380701|565445437|FG004|Overall Study|Lost to Follow-up|0|||
156644171|NCT04380701|565445438|FG005|Overall Study|Lost to Follow-up|0|||
156644172|NCT04380701|565445439|FG006|Overall Study|Lost to Follow-up|0|||
156644173|NCT04380701|565445440|FG007|Overall Study|Lost to Follow-up|0|||
156644174|NCT04380701|565445441|FG008|Overall Study|Lost to Follow-up|0|||
156644175|NCT04380701|565445442|FG009|Overall Study|Lost to Follow-up|0|||
156644176|NCT04380701|565445443|FG010|Overall Study|Lost to Follow-up|0|||
156644177|NCT04380701|565445444|FG011|Overall Study|Lost to Follow-up|0|||
156644178|NCT04380701|565445445|FG012|Overall Study|Lost to Follow-up|0|||
156644179|NCT04380701|565445446|FG013|Overall Study|Lost to Follow-up|0|||
156644180|NCT04380701|565445447|FG014|Overall Study|Lost to Follow-up|0|||
156644181|NCT04380701|565445448|FG015|Overall Study|Lost to Follow-up|0|||
156644182|NCT04380701|565445449|FG016|Overall Study|Lost to Follow-up|0|||
156644183|NCT04380701|565445450|FG017|Overall Study|Lost to Follow-up|0|||
156644184|NCT04380701|565445451|FG018|Overall Study|Lost to Follow-up|0|||
156644185|NCT04380701|565445452|FG019|Overall Study|Lost to Follow-up|0|||
156644186|NCT04380701|565445453|FG020|Overall Study|Lost to Follow-up|1|||
156644187|NCT04380701|565445454|FG021|Overall Study|Lost to Follow-up|0|||
156644188|NCT04380701|565445455|FG022|Overall Study|Lost to Follow-up|0|||
156644189|NCT04380701|565445456|FG023|Overall Study|Lost to Follow-up|1|||
156644190|NCT04380701|565445457|FG024|Overall Study|Lost to Follow-up|0|||
156644191|NCT04380701|565445458|FG025|Overall Study|Lost to Follow-up|0|||
156644192|NCT04380701|565445459|FG026|Overall Study|Lost to Follow-up|0|||
156644193|NCT04380701|565445460|FG027|Overall Study|Lost to Follow-up|0|||
156644194|NCT04380701|565445461|FG028|Overall Study|Lost to Follow-up|0|||
156644195|NCT04380701|565445462|FG029|Overall Study|Lost to Follow-up|1|||
156644196|NCT04380701|565445463|FG030|Overall Study|Lost to Follow-up|0|||
156644197|NCT04380701|565445464|FG031|Overall Study|Lost to Follow-up|0|||
156644198|NCT04380701|565445465|FG032|Overall Study|Lost to Follow-up|0|||
156644199|NCT04380701|565445466|FG033|Overall Study|Lost to Follow-up|1|||
156644200|NCT04380701|565445433|FG000|Overall Study|Private reason(s)|0|||
156644201|NCT04380701|565445434|FG001|Overall Study|Private reason(s)|0|||
156644202|NCT04380701|565445435|FG002|Overall Study|Private reason(s)|0|||
156644203|NCT04380701|565445436|FG003|Overall Study|Private reason(s)|0|||
156644204|NCT04380701|565445437|FG004|Overall Study|Private reason(s)|0|||
156644205|NCT04380701|565445438|FG005|Overall Study|Private reason(s)|0|||
156644206|NCT04380701|565445439|FG006|Overall Study|Private reason(s)|1|||
156644207|NCT04380701|565445440|FG007|Overall Study|Private reason(s)|0|||
156644208|NCT04380701|565445441|FG008|Overall Study|Private reason(s)|1|||
156644209|NCT04380701|565445442|FG009|Overall Study|Private reason(s)|1|||
156644210|NCT04380701|565445443|FG010|Overall Study|Private reason(s)|0|||
156644211|NCT04380701|565445444|FG011|Overall Study|Private reason(s)|0|||
156644212|NCT04380701|565445445|FG012|Overall Study|Private reason(s)|0|||
156644213|NCT04380701|565445446|FG013|Overall Study|Private reason(s)|0|||
156644214|NCT04380701|565445447|FG014|Overall Study|Private reason(s)|0|||
156644215|NCT04380701|565445448|FG015|Overall Study|Private reason(s)|0|||
156644216|NCT04380701|565445449|FG016|Overall Study|Private reason(s)|0|||
156644217|NCT04380701|565445450|FG017|Overall Study|Private reason(s)|0|||
156644218|NCT04380701|565445451|FG018|Overall Study|Private reason(s)|0|||
156644219|NCT04380701|565445452|FG019|Overall Study|Private reason(s)|0|||
156644220|NCT04380701|565445453|FG020|Overall Study|Private reason(s)|0|||
156644221|NCT04380701|565445454|FG021|Overall Study|Private reason(s)|0|||
156644222|NCT04380701|565445455|FG022|Overall Study|Private reason(s)|0|||
156644223|NCT04380701|565445456|FG023|Overall Study|Private reason(s)|1|||
156644224|NCT04380701|565445457|FG024|Overall Study|Private reason(s)|0|||
156644225|NCT04380701|565445458|FG025|Overall Study|Private reason(s)|0|||
156644226|NCT04380701|565445459|FG026|Overall Study|Private reason(s)|0|||
156644227|NCT04380701|565445460|FG027|Overall Study|Private reason(s)|0|||
156644228|NCT04380701|565445461|FG028|Overall Study|Private reason(s)|0|||
156644229|NCT04380701|565445462|FG029|Overall Study|Private reason(s)|1|||
156644230|NCT04380701|565445463|FG030|Overall Study|Private reason(s)|0|||
156644231|NCT04380701|565445464|FG031|Overall Study|Private reason(s)|0|||
156644232|NCT04380701|565445465|FG032|Overall Study|Private reason(s)|0|||
156644233|NCT04380701|565445466|FG033|Overall Study|Private reason(s)|0|||
156644234|NCT04380701|565445433|FG000|Overall Study|Withdrawal by Subject|0|||
156644235|NCT04380701|565445434|FG001|Overall Study|Withdrawal by Subject|0|||
156644236|NCT04380701|565445435|FG002|Overall Study|Withdrawal by Subject|0|||
156644237|NCT04380701|565445436|FG003|Overall Study|Withdrawal by Subject|0|||
156644238|NCT04380701|565445437|FG004|Overall Study|Withdrawal by Subject|0|||
156644239|NCT04380701|565445438|FG005|Overall Study|Withdrawal by Subject|0|||
156644240|NCT04380701|565445439|FG006|Overall Study|Withdrawal by Subject|1|||
156644241|NCT04380701|565445440|FG007|Overall Study|Withdrawal by Subject|1|||
156644242|NCT04380701|565445441|FG008|Overall Study|Withdrawal by Subject|0|||
156644243|NCT04380701|565445442|FG009|Overall Study|Withdrawal by Subject|0|||
156644244|NCT04380701|565445443|FG010|Overall Study|Withdrawal by Subject|0|||
156644245|NCT04380701|565445444|FG011|Overall Study|Withdrawal by Subject|1|||
156644246|NCT04380701|565445445|FG012|Overall Study|Withdrawal by Subject|0|||
156644247|NCT04380701|565445446|FG013|Overall Study|Withdrawal by Subject|1|||
156644248|NCT04380701|565445447|FG014|Overall Study|Withdrawal by Subject|0|||
156644249|NCT04380701|565445448|FG015|Overall Study|Withdrawal by Subject|0|||
156644250|NCT04380701|565445449|FG016|Overall Study|Withdrawal by Subject|1|||
156644251|NCT04380701|565445450|FG017|Overall Study|Withdrawal by Subject|0|||
156644252|NCT04380701|565445451|FG018|Overall Study|Withdrawal by Subject|0|||
156644253|NCT04380701|565445452|FG019|Overall Study|Withdrawal by Subject|0|||
156644254|NCT04380701|565445453|FG020|Overall Study|Withdrawal by Subject|0|||
156644255|NCT04380701|565445454|FG021|Overall Study|Withdrawal by Subject|0|||
156644256|NCT04380701|565445455|FG022|Overall Study|Withdrawal by Subject|2|||
156644257|NCT04380701|565445456|FG023|Overall Study|Withdrawal by Subject|2|||
156644258|NCT04380701|565445457|FG024|Overall Study|Withdrawal by Subject|1|||
156644259|NCT04380701|565445458|FG025|Overall Study|Withdrawal by Subject|1|||
156644260|NCT04380701|565445459|FG026|Overall Study|Withdrawal by Subject|0|||
156644261|NCT04380701|565445460|FG027|Overall Study|Withdrawal by Subject|0|||
156644262|NCT04380701|565445461|FG028|Overall Study|Withdrawal by Subject|0|||
156644263|NCT04380701|565445462|FG029|Overall Study|Withdrawal by Subject|0|||
156644264|NCT04380701|565445463|FG030|Overall Study|Withdrawal by Subject|0|||
156644265|NCT04380701|565445464|FG031|Overall Study|Withdrawal by Subject|0|||
156644266|NCT04380701|565445465|FG032|Overall Study|Withdrawal by Subject|0|||
156644267|NCT04380701|565445466|FG033|Overall Study|Withdrawal by Subject|0|||
156644268|NCT04380701|565445433|FG000|Overall Study|Adverse Event|0|||
156644269|NCT04380701|565445434|FG001|Overall Study|Adverse Event|0|||
156644270|NCT04380701|565445435|FG002|Overall Study|Adverse Event|0|||
156644271|NCT04380701|565445436|FG003|Overall Study|Adverse Event|0|||
156644272|NCT04380701|565445437|FG004|Overall Study|Adverse Event|0|||
156644273|NCT04380701|565445438|FG005|Overall Study|Adverse Event|1|||
156644274|NCT04380701|565445439|FG006|Overall Study|Adverse Event|0|||
156644275|NCT04380701|565445440|FG007|Overall Study|Adverse Event|0|||
156644276|NCT04380701|565445441|FG008|Overall Study|Adverse Event|0|||
156644277|NCT04380701|565445442|FG009|Overall Study|Adverse Event|0|||
156644278|NCT04380701|565445443|FG010|Overall Study|Adverse Event|0|||
156644279|NCT04380701|565445444|FG011|Overall Study|Adverse Event|0|||
156644280|NCT04380701|565445445|FG012|Overall Study|Adverse Event|0|||
156644281|NCT04380701|565445446|FG013|Overall Study|Adverse Event|0|||
156644282|NCT04380701|565445447|FG014|Overall Study|Adverse Event|0|||
156644283|NCT04380701|565445448|FG015|Overall Study|Adverse Event|1|||
156644284|NCT04380701|565445449|FG016|Overall Study|Adverse Event|0|||
156644285|NCT04380701|565445450|FG017|Overall Study|Adverse Event|0|||
156644286|NCT04380701|565445451|FG018|Overall Study|Adverse Event|0|||
156644287|NCT04380701|565445452|FG019|Overall Study|Adverse Event|1|||
156644288|NCT04380701|565445453|FG020|Overall Study|Adverse Event|0|||
156644289|NCT04380701|565445454|FG021|Overall Study|Adverse Event|0|||
156644290|NCT04380701|565445455|FG022|Overall Study|Adverse Event|0|||
156644291|NCT04380701|565445456|FG023|Overall Study|Adverse Event|0|||
156644292|NCT04380701|565445457|FG024|Overall Study|Adverse Event|0|||
156644293|NCT04380701|565445458|FG025|Overall Study|Adverse Event|0|||
156644294|NCT04380701|565445459|FG026|Overall Study|Adverse Event|0|||
156644295|NCT04380701|565445460|FG027|Overall Study|Adverse Event|0|||
156644296|NCT04380701|565445461|FG028|Overall Study|Adverse Event|0|||
156644297|NCT04380701|565445462|FG029|Overall Study|Adverse Event|0|||
156644298|NCT04380701|565445463|FG030|Overall Study|Adverse Event|0|||
156644299|NCT04380701|565445464|FG031|Overall Study|Adverse Event|0|||
156644300|NCT04380701|565445465|FG032|Overall Study|Adverse Event|0|||
156644301|NCT04380701|565445466|FG033|Overall Study|Adverse Event|0|||
156644302|NCT04380701|565445433|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
156644303|NCT04380701|565445434|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
156644304|NCT04380701|565445435|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
156644305|NCT04380701|565445436|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
156644306|NCT04380701|565445437|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
156644307|NCT04380701|565445438|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
156644308|NCT04380701|565445439|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
156644309|NCT04380701|565445440|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
156644310|NCT04380701|565445441|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
156644311|NCT04380701|565445442|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
156644312|NCT04380701|565445443|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
156644313|NCT04380701|565445444|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
156644314|NCT04380701|565445445|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
156644315|NCT04380701|565445446|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
156644316|NCT04380701|565445447|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
156644317|NCT04380701|565445448|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
156644318|NCT04380701|565445449|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
156644319|NCT04380701|565445450|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
156644320|NCT04380701|565445451|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
156644321|NCT04380701|565445452|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
156644322|NCT04380701|565445453|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
156644323|NCT04380701|565445454|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
156644324|NCT04380701|565445455|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
156644325|NCT04380701|565445456|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
156644326|NCT04380701|565445457|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
156644327|NCT04380701|565445458|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
156644328|NCT04380701|565445459|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
156644329|NCT04380701|565445460|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
156644330|NCT04380701|565445461|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
156644331|NCT04380701|565445462|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
156644332|NCT04380701|565445463|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
156644333|NCT04380701|565445464|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
156644334|NCT04380701|565445465|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
156644335|NCT04380701|565445466|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
156644336|NCT04380701|565445433|FG000|Overall Study|Physician Decision|0|||
156644337|NCT04380701|565445434|FG001|Overall Study|Physician Decision|0|||
156644338|NCT04380701|565445435|FG002|Overall Study|Physician Decision|0|||
156644339|NCT04380701|565445436|FG003|Overall Study|Physician Decision|0|||
156644340|NCT04380701|565445437|FG004|Overall Study|Physician Decision|0|||
156644341|NCT04380701|565445438|FG005|Overall Study|Physician Decision|0|||
156644342|NCT04380701|565445439|FG006|Overall Study|Physician Decision|0|||
156644343|NCT04380701|565445440|FG007|Overall Study|Physician Decision|0|||
156644344|NCT04380701|565445441|FG008|Overall Study|Physician Decision|0|||
156644345|NCT04380701|565445442|FG009|Overall Study|Physician Decision|0|||
156644346|NCT04380701|565445443|FG010|Overall Study|Physician Decision|0|||
156644347|NCT04380701|565445444|FG011|Overall Study|Physician Decision|0|||
156644348|NCT04380701|565445445|FG012|Overall Study|Physician Decision|0|||
156644349|NCT04380701|565445446|FG013|Overall Study|Physician Decision|0|||
156644350|NCT04380701|565445447|FG014|Overall Study|Physician Decision|0|||
156644351|NCT04380701|565445448|FG015|Overall Study|Physician Decision|0|||
156644352|NCT04380701|565445449|FG016|Overall Study|Physician Decision|0|||
156644353|NCT04380701|565445450|FG017|Overall Study|Physician Decision|0|||
156644354|NCT04380701|565445451|FG018|Overall Study|Physician Decision|0|||
156644355|NCT04380701|565445452|FG019|Overall Study|Physician Decision|0|||
156644356|NCT04380701|565445453|FG020|Overall Study|Physician Decision|0|||
156644357|NCT04380701|565445454|FG021|Overall Study|Physician Decision|0|||
156644358|NCT04380701|565445455|FG022|Overall Study|Physician Decision|0|||
156644359|NCT04380701|565445456|FG023|Overall Study|Physician Decision|0|||
156644360|NCT04380701|565445457|FG024|Overall Study|Physician Decision|2|||
156644361|NCT04380701|565445458|FG025|Overall Study|Physician Decision|0|||
156644362|NCT04380701|565445459|FG026|Overall Study|Physician Decision|0|||
156644363|NCT04380701|565445460|FG027|Overall Study|Physician Decision|0|||
156644364|NCT04380701|565445461|FG028|Overall Study|Physician Decision|0|||
156644365|NCT04380701|565445462|FG029|Overall Study|Physician Decision|0|||
156644366|NCT04380701|565445463|FG030|Overall Study|Physician Decision|0|||
156644367|NCT04380701|565445464|FG031|Overall Study|Physician Decision|0|||
156644368|NCT04380701|565445465|FG032|Overall Study|Physician Decision|0|||
156644369|NCT04380701|565445466|FG033|Overall Study|Physician Decision|0|||
156644370|NCT04380701|565445433|FG000|Overall Study|Death|0|||
156644371|NCT04380701|565445434|FG001|Overall Study|Death|0|||
156644372|NCT04380701|565445435|FG002|Overall Study|Death|0|||
156644373|NCT04380701|565445436|FG003|Overall Study|Death|0|||
156644374|NCT04380701|565445437|FG004|Overall Study|Death|0|||
156644375|NCT04380701|565445438|FG005|Overall Study|Death|0|||
156644376|NCT04380701|565445439|FG006|Overall Study|Death|0|||
156644377|NCT04380701|565445440|FG007|Overall Study|Death|0|||
156644378|NCT04380701|565445441|FG008|Overall Study|Death|0|||
156644379|NCT04380701|565445442|FG009|Overall Study|Death|0|||
156644380|NCT04380701|565445443|FG010|Overall Study|Death|0|||
156644381|NCT04380701|565445444|FG011|Overall Study|Death|0|||
156644382|NCT04380701|565445445|FG012|Overall Study|Death|0|||
156644383|NCT04380701|565445446|FG013|Overall Study|Death|0|||
156644384|NCT04380701|565445447|FG014|Overall Study|Death|0|||
156644385|NCT04380701|565445448|FG015|Overall Study|Death|0|||
156644386|NCT04380701|565445449|FG016|Overall Study|Death|0|||
156644387|NCT04380701|565445450|FG017|Overall Study|Death|0|||
156644388|NCT04380701|565445451|FG018|Overall Study|Death|0|||
156644389|NCT04380701|565445452|FG019|Overall Study|Death|0|||
156644390|NCT04380701|565445453|FG020|Overall Study|Death|0|||
156644391|NCT04380701|565445454|FG021|Overall Study|Death|0|||
156644392|NCT04380701|565445455|FG022|Overall Study|Death|0|||
156644393|NCT04380701|565445456|FG023|Overall Study|Death|0|||
156644394|NCT04380701|565445457|FG024|Overall Study|Death|1|||
156644395|NCT04380701|565445458|FG025|Overall Study|Death|0|||
156644396|NCT04380701|565445459|FG026|Overall Study|Death|0|||
156644397|NCT04380701|565445460|FG027|Overall Study|Death|0|||
156644398|NCT04380701|565445461|FG028|Overall Study|Death|0|||
156644399|NCT04380701|565445462|FG029|Overall Study|Death|0|||
156644400|NCT04380701|565445463|FG030|Overall Study|Death|0|||
156644401|NCT04380701|565445464|FG031|Overall Study|Death|0|||
156644402|NCT04380701|565445465|FG032|Overall Study|Death|0|||
156644403|NCT04380701|565445466|FG033|Overall Study|Death|0|||
156644404|NCT04380701|565445433|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644405|NCT04380701|565445434|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644406|NCT04380701|565445435|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644407|NCT04380701|565445436|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644408|NCT04380701|565445437|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644409|NCT04380701|565445438|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644410|NCT04380701|565445439|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644411|NCT04380701|565445440|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644412|NCT04380701|565445441|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644413|NCT04380701|565445442|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644414|NCT04380701|565445443|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644415|NCT04380701|565445444|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644416|NCT04380701|565445445|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644417|NCT04380701|565445446|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644418|NCT04380701|565445447|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644419|NCT04380701|565445448|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644420|NCT04380701|565445449|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644421|NCT04380701|565445450|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644422|NCT04380701|565445451|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644423|NCT04380701|565445452|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644424|NCT04380701|565445453|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644425|NCT04380701|565445454|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
156644426|NCT04380701|565445455|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
156644427|NCT04380701|565445456|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
156644428|NCT04380701|565445457|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
156644429|NCT04380701|565445458|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644430|NCT04380701|565445459|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644431|NCT04380701|565445460|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644432|NCT04380701|565445461|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644433|NCT04380701|565445462|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644434|NCT04380701|565445463|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644435|NCT04380701|565445464|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644436|NCT04380701|565445465|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644437|NCT04380701|565445466|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
156644438|NCT03550794|565445467|FG000|Overall Study|No longer met inclusion criteria|1|||
156644439|NCT03550794|565445468|FG001|Overall Study|No longer met inclusion criteria|2|||
156644440|NCT03550794|565445467|FG000|Overall Study|Goals of care changed|1|||
156644441|NCT03550794|565445468|FG001|Overall Study|Goals of care changed|0|||
156644442|NCT03550794|565445467|FG000|Overall Study|Withdrawal by Subject|2|||
156644443|NCT03550794|565445468|FG001|Overall Study|Withdrawal by Subject|0|||
156644444|NCT03550794|565445467|FG000|Overall Study|Death|0|||
156644445|NCT03550794|565445468|FG001|Overall Study|Death|1|||
156644446|NCT01864525|565445469|FG000|Overall Study|Adverse Event|1|||
156644447|NCT01864525|565445470|FG001|Overall Study|Adverse Event|0|||
156644448|NCT01890785|565445471|FG000|Third Intervention|Withdrawal by Subject|0|||
156644449|NCT01890785|565445472|FG001|Third Intervention|Withdrawal by Subject|1|||
156644450|NCT01890785|565445473|FG002|Third Intervention|Withdrawal by Subject|0|||
156644451|NCT01890785|565445474|FG003|Third Intervention|Withdrawal by Subject|0|||
156644452|NCT01890785|565445475|FG004|Third Intervention|Withdrawal by Subject|0|||
156644453|NCT01890785|565445476|FG005|Third Intervention|Withdrawal by Subject|0|||
156644454|NCT03296553|565445477|FG000|Overall Study|Withdrawal by Subject|1|||
156644455|NCT03296553|565445478|FG001|Overall Study|Withdrawal by Subject|1|||
156644456|NCT03296553|565445477|FG000|Overall Study|Death|1|||
156644457|NCT03296553|565445478|FG001|Overall Study|Death|0|||
156644458|NCT00558519|565445479|FG000|Overall Study|Ph+|20|||
156644459|NCT00558519|565445479|FG000|Overall Study|Ineligible|1|||
156644460|NCT00558519|565445479|FG000|Overall Study|Insufficient data|1|||
156644461|NCT00558519|565445479|FG000|Overall Study|Never received treatment|1|||
156644462|NCT03001011|565445480|FG000|Overall Study|Adverse Event|9|||
156644463|NCT03001011|565445481|FG001|Overall Study|Adverse Event|3|||
156644464|NCT03001011|565445480|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
156644465|NCT03001011|565445481|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
156644466|NCT03001011|565445480|FG000|Overall Study|Other than specified above|3|||
156644467|NCT03001011|565445481|FG001|Overall Study|Other than specified above|8|||
156644468|NCT00065065|565445482|FG000|Overall Study|Adverse Event|3|||
156644469|NCT00065065|565445483|FG001|Overall Study|Adverse Event|2|||
156644470|NCT00065065|565445482|FG000|Overall Study|Withdrawal by Subject|1|||
156644471|NCT00065065|565445483|FG001|Overall Study|Withdrawal by Subject|5|||
156644472|NCT00065065|565445482|FG000|Overall Study|Lack of Efficacy|4|||
156644473|NCT00065065|565445483|FG001|Overall Study|Lack of Efficacy|11|||
156644474|NCT00065065|565445482|FG000|Overall Study|Other|2|||
156644475|NCT00065065|565445483|FG001|Overall Study|Other|2|||
156644476|NCT04363736|565445484|FG000|Overall Study|Withdrawal by Subject|1|||
156644477|NCT04363736|565445485|FG001|Overall Study|Withdrawal by Subject|0|||
156644478|NCT04363736|565445484|FG000|Overall Study|Lost to Follow-up|10|||
156644479|NCT04363736|565445485|FG001|Overall Study|Lost to Follow-up|7|||
156644480|NCT04363736|565445484|FG000|Overall Study|Death|8|||
156644481|NCT04363736|565445485|FG001|Overall Study|Death|6|||
156644482|NCT01050673|565445486|FG000|Overall Study|Physician Decision|4|||
156644483|NCT01050673|565445487|FG001|Overall Study|Physician Decision|5|||
156644484|NCT01254045|565445488|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
156644485|NCT01254045|565445489|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
156644486|NCT01254045|565445490|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
156644487|NCT01254045|565445491|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
156644488|NCT01254045|565445492|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
156644489|NCT01254045|565445493|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
156644490|NCT00597207|565445494|FG000|Overall Study|Lost to Follow-up|5|||
156644491|NCT00597207|565445495|FG001|Overall Study|Lost to Follow-up|7|||
156644492|NCT00520351|565445496|FG000|First Intervention|Withdrawal by Subject|1|||
156644493|NCT00520351|565445497|FG001|First Intervention|Withdrawal by Subject|1|||
156644494|NCT03797222|565445499|FG000|Overall Study|Withdrawal by Subject|1|||
156644495|NCT03077828|565445501|FG000|Treatment Cycles|Death|1|||
156644496|NCT03077828|565445501|FG000|Treatment Cycles|Withdrawal by Subject|1|||
156644497|NCT03077828|565445501|FG000|Treatment Cycles|Screen Fail|2|||
156644498|NCT03077828|565445501|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
156644499|NCT03077828|565445501|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
156644500|NCT03077828|565445501|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
156644501|NCT03077828|565445501|FG000|Follow-up|Patients still in follow-up|15|||
156412182|NCT02065570|564602849|FG003|Induction Study|Adverse Event|0|||
156644502|NCT04288115|565445504|FG000|Overall Study|Withdrawal by Subject|0|||
156644503|NCT04288115|565445505|FG001|Overall Study|Withdrawal by Subject|1|||
156644504|NCT04288115|565445504|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
156644505|NCT04288115|565445505|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
156644506|NCT00729365|565445507|FG000|Overall Study|Physician Decision|33|||
156644507|NCT00729365|565445508|FG001|Overall Study|Physician Decision|6|||
156644508|NCT00729365|565445509|FG002|Overall Study|Physician Decision|7|||
156644509|NCT02766400|565445510|FG000|Overall Study|Death|1|||
156644510|NCT02766400|565445511|FG001|Overall Study|Death|2|||
156644511|NCT02766400|565445510|FG000|Overall Study|Withdrawal by Subject|1|||
156644512|NCT02766400|565445511|FG001|Overall Study|Withdrawal by Subject|0|||
156644513|NCT03125915|565445516|FG000|1 Month Follow up|Lost to Follow-up|3|||
156644514|NCT03125915|565445517|FG001|1 Month Follow up|Lost to Follow-up|3|||
156644515|NCT03125915|565445518|FG002|1 Month Follow up|Lost to Follow-up|2|||
156644516|NCT03125915|565445519|FG003|1 Month Follow up|Lost to Follow-up|3|||
156644517|NCT03125915|565445516|FG000|3 Month Follow-up|Lost to Follow-up|6|||
156644518|NCT03125915|565445517|FG001|3 Month Follow-up|Lost to Follow-up|4|||
156644519|NCT03125915|565445518|FG002|3 Month Follow-up|Lost to Follow-up|4|||
156644520|NCT03125915|565445519|FG003|3 Month Follow-up|Lost to Follow-up|2|||
156644521|NCT03125915|565445516|FG000|6 Month Follow-up|Lost to Follow-up|7|||
156644522|NCT03125915|565445517|FG001|6 Month Follow-up|Lost to Follow-up|3|||
156644523|NCT03125915|565445518|FG002|6 Month Follow-up|Lost to Follow-up|6|||
156644524|NCT03125915|565445519|FG003|6 Month Follow-up|Lost to Follow-up|3|||
156644525|NCT01309828|565445520|FG000|Overall Study|Adverse Event|10|||
156644526|NCT01309828|565445521|FG001|Overall Study|Adverse Event|11|||
156644527|NCT01309828|565445520|FG000|Overall Study|Voluntary Withdrawal|5|||
156644528|NCT01309828|565445521|FG001|Overall Study|Voluntary Withdrawal|4|||
156644529|NCT01309828|565445520|FG000|Overall Study|Major Protocol Deviation|0|||
156644530|NCT01309828|565445521|FG001|Overall Study|Major Protocol Deviation|1|||
156644531|NCT01309828|565445520|FG000|Overall Study|Other|1|||
156644532|NCT01309828|565445521|FG001|Overall Study|Other|0|||
156644533|NCT00295620|565445522|FG000|Overall Study|Lost to Follow-up|9|||
156644534|NCT00295620|565445523|FG001|Overall Study|Lost to Follow-up|5|||
156644535|NCT00295620|565445522|FG000|Overall Study|Withdrawal by Subject|37|||
156644536|NCT00295620|565445523|FG001|Overall Study|Withdrawal by Subject|50|||
156644537|NCT00295620|565445522|FG000|Overall Study|Death|206|||
156644538|NCT00295620|565445523|FG001|Overall Study|Death|207|||
156644539|NCT00295620|565445522|FG000|Overall Study|Other reasons|10|||
156644540|NCT00295620|565445523|FG001|Overall Study|Other reasons|9|||
156644541|NCT00295620|565445522|FG000|Overall Study|Discontinuation by sponsor|580|||
156644542|NCT00295620|565445523|FG001|Overall Study|Discontinuation by sponsor|593|||
156644543|NCT00295620|565445522|FG000|Overall Study|Protocol Violation|30|||
156644544|NCT00295620|565445523|FG001|Overall Study|Protocol Violation|32|||
156644545|NCT00217971|565445524|FG000|Overall Study|Adverse Event|1|||
156644546|NCT00217971|565445525|FG001|Overall Study|Adverse Event|1|||
156644547|NCT00217971|565445524|FG000|Overall Study|Lost to Follow-up|15|||
156644548|NCT00217971|565445525|FG001|Overall Study|Lost to Follow-up|19|||
156644549|NCT00217971|565445524|FG000|Overall Study|Physician Decision|0|||
156644550|NCT00217971|565445525|FG001|Overall Study|Physician Decision|1|||
156644551|NCT00217971|565445524|FG000|Overall Study|Withdrawal by Subject|7|||
156644552|NCT00217971|565445525|FG001|Overall Study|Withdrawal by Subject|12|||
156644553|NCT00217971|565445524|FG000|Overall Study|non compliant|1|||
156644554|NCT00217971|565445525|FG001|Overall Study|non compliant|0|||
156644555|NCT02556632|565445526|FG000|Overall Study|Lost to Follow-up|1|||
156644556|NCT02556632|565445527|FG001|Overall Study|Lost to Follow-up|0|||
156644557|NCT02556632|565445528|FG002|Overall Study|Lost to Follow-up|0|||
156644558|NCT02556632|565445526|FG000|Overall Study|Disliked Intervention|1|||
156644559|NCT02556632|565445527|FG001|Overall Study|Disliked Intervention|1|||
156644560|NCT02556632|565445528|FG002|Overall Study|Disliked Intervention|1|||
156644561|NCT02556632|565445526|FG000|Overall Study|No Reason|1|||
156644562|NCT02556632|565445527|FG001|Overall Study|No Reason|0|||
156644563|NCT02556632|565445528|FG002|Overall Study|No Reason|1|||
156644564|NCT02556632|565445526|FG000|Overall Study|Personal Issues|0|||
156644565|NCT02556632|565445527|FG001|Overall Study|Personal Issues|1|||
156644566|NCT02556632|565445528|FG002|Overall Study|Personal Issues|1|||
156644567|NCT02556632|565445526|FG000|Overall Study|Changed Mind|0|||
156412183|NCT02065570|564602846|FG000|Induction Study|Withdrawal by Subject|2|||
156412184|NCT02065570|564602847|FG001|Induction Study|Withdrawal by Subject|3|||
156644568|NCT02556632|565445527|FG001|Overall Study|Changed Mind|1|||
156644569|NCT02556632|565445528|FG002|Overall Study|Changed Mind|0|||
156644570|NCT02556632|565445526|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
156412185|NCT02065570|564602848|FG002|Induction Study|Withdrawal by Subject|0|||
156412186|NCT02065570|564602849|FG003|Induction Study|Withdrawal by Subject|0|||
156412187|NCT02065570|564602846|FG000|Induction Study|Lost to Follow-up|1|||
156644571|NCT02556632|565445527|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
156644572|NCT02556632|565445528|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
156644573|NCT02556632|565445526|FG000|Overall Study|Unrelated Adverse Event|1|||
156644574|NCT02556632|565445527|FG001|Overall Study|Unrelated Adverse Event|0|||
156644575|NCT02556632|565445528|FG002|Overall Study|Unrelated Adverse Event|3|||
156644576|NCT02556632|565445526|FG000|Overall Study|Related Adverse Event|0|||
156644577|NCT02556632|565445527|FG001|Overall Study|Related Adverse Event|1|||
156644578|NCT02556632|565445528|FG002|Overall Study|Related Adverse Event|0|||
156644579|NCT02556632|565445526|FG000|Overall Study|Possibly Related Adverse Event|0|||
156644580|NCT02556632|565445527|FG001|Overall Study|Possibly Related Adverse Event|0|||
156644581|NCT02556632|565445528|FG002|Overall Study|Possibly Related Adverse Event|1|||
156644582|NCT02556632|565445526|FG000|Overall Study|Did Not Start RT|0|||
156644583|NCT02556632|565445527|FG001|Overall Study|Did Not Start RT|1|||
156644584|NCT02556632|565445528|FG002|Overall Study|Did Not Start RT|0|||
156644585|NCT02556632|565445526|FG000|Overall Study|Ineligible|0|||
156644586|NCT02556632|565445527|FG001|Overall Study|Ineligible|1|||
156644587|NCT02556632|565445528|FG002|Overall Study|Ineligible|0|||
156644588|NCT02556632|565445526|FG000|Overall Study|Disliked Study Procedures|0|||
156644589|NCT02556632|565445527|FG001|Overall Study|Disliked Study Procedures|0|||
156644590|NCT02556632|565445528|FG002|Overall Study|Disliked Study Procedures|1|||
156644591|NCT02556632|565445526|FG000|Overall Study|Treatment or Change Delay|0|||
156644592|NCT02556632|565445527|FG001|Overall Study|Treatment or Change Delay|0|||
156644593|NCT02556632|565445528|FG002|Overall Study|Treatment or Change Delay|1|||
156644594|NCT00808015|565445531|FG000|Overall Study|Death|1|||
156644595|NCT00808015|565445531|FG000|Overall Study|Lack of Efficacy|58|||
156644596|NCT00808015|565445531|FG000|Overall Study|Lost to Follow-up|76|||
156644597|NCT00808015|565445531|FG000|Overall Study|Participants not willing to participate|158|||
156644598|NCT00808015|565445531|FG000|Overall Study|Adverse Event|22|||
156644599|NCT00808015|565445531|FG000|Overall Study|Other|25|||
156644600|NCT00808015|565445531|FG000|Overall Study|Enrolled but not treated|4|||
156644601|NCT00084617|565445541|FG000|Overall Study|Withdrawal by Subject|7|||
156644602|NCT00084617|565445541|FG000|Overall Study|Lack of Efficacy|1|||
156644603|NCT00084617|565445541|FG000|Overall Study|Protocol Violation|1|||
156644604|NCT01625286|565445542|FG000|Overall Study|Adverse Event|0|||
156644605|NCT01625286|565445543|FG001|Overall Study|Adverse Event|0|||
156644606|NCT01625286|565445544|FG002|Overall Study|Adverse Event|0|||
156644607|NCT01625286|565445545|FG003|Overall Study|Adverse Event|0|||
156644608|NCT01625286|565445546|FG004|Overall Study|Adverse Event|1|||
156644609|NCT01625286|565445547|FG005|Overall Study|Adverse Event|2|||
156644610|NCT01625286|565445548|FG006|Overall Study|Adverse Event|1|||
156644611|NCT01625286|565445542|FG000|Overall Study|Death|0|||
156644612|NCT01625286|565445543|FG001|Overall Study|Death|0|||
156644613|NCT01625286|565445544|FG002|Overall Study|Death|1|||
156644614|NCT01625286|565445545|FG003|Overall Study|Death|1|||
156644615|NCT01625286|565445546|FG004|Overall Study|Death|0|||
156644616|NCT01625286|565445547|FG005|Overall Study|Death|11|||
156644617|NCT01625286|565445548|FG006|Overall Study|Death|16|||
156644618|NCT01625286|565445542|FG000|Overall Study|Withdrawal by Subject|0|||
156644619|NCT01625286|565445543|FG001|Overall Study|Withdrawal by Subject|1|||
156644620|NCT01625286|565445544|FG002|Overall Study|Withdrawal by Subject|0|||
156644621|NCT01625286|565445545|FG003|Overall Study|Withdrawal by Subject|1|||
156644622|NCT01625286|565445546|FG004|Overall Study|Withdrawal by Subject|0|||
156644623|NCT01625286|565445547|FG005|Overall Study|Withdrawal by Subject|0|||
156644624|NCT01625286|565445548|FG006|Overall Study|Withdrawal by Subject|1|||
156644625|NCT01625286|565445542|FG000|Overall Study|Any reason not specifically recorded|0|||
156644626|NCT01625286|565445543|FG001|Overall Study|Any reason not specifically recorded|0|||
156644627|NCT01625286|565445544|FG002|Overall Study|Any reason not specifically recorded|0|||
156644628|NCT01625286|565445545|FG003|Overall Study|Any reason not specifically recorded|0|||
156644629|NCT01625286|565445546|FG004|Overall Study|Any reason not specifically recorded|0|||
156644630|NCT01625286|565445547|FG005|Overall Study|Any reason not specifically recorded|1|||
156644631|NCT01625286|565445548|FG006|Overall Study|Any reason not specifically recorded|0|||
156644632|NCT01625286|565445542|FG000|Overall Study|Progressive disease|6|||
156644633|NCT01625286|565445543|FG001|Overall Study|Progressive disease|3|||
156644634|NCT01625286|565445544|FG002|Overall Study|Progressive disease|4|||
156644635|NCT01625286|565445545|FG003|Overall Study|Progressive disease|5|||
156644636|NCT01625286|565445546|FG004|Overall Study|Progressive disease|5|||
156644637|NCT01625286|565445547|FG005|Overall Study|Progressive disease|0|||
156644638|NCT01625286|565445548|FG006|Overall Study|Progressive disease|0|||
156644639|NCT01625286|565445542|FG000|Overall Study|Lost to Follow-up|0|||
156644640|NCT01625286|565445543|FG001|Overall Study|Lost to Follow-up|0|||
156644641|NCT01625286|565445544|FG002|Overall Study|Lost to Follow-up|0|||
156644642|NCT01625286|565445545|FG003|Overall Study|Lost to Follow-up|0|||
156644643|NCT01625286|565445546|FG004|Overall Study|Lost to Follow-up|0|||
156644644|NCT01625286|565445547|FG005|Overall Study|Lost to Follow-up|0|||
156644645|NCT01625286|565445548|FG006|Overall Study|Lost to Follow-up|1|||
156644646|NCT00928135|565445549|FG000|Overall Study|Withdrawal by Subject|1|||
156644647|NCT00928135|565445550|FG001|Overall Study|Withdrawal by Subject|0|||
156644648|NCT04355767|565445551|FG000|Overall Study|Withdrawal by Subject|2|||
156644649|NCT04355767|565445552|FG001|Overall Study|Withdrawal by Subject|2|||
156644650|NCT04355767|565445551|FG000|Overall Study|Death|5|||
156644651|NCT04355767|565445552|FG001|Overall Study|Death|1|||
156644652|NCT01999322|565445553|FG000|Overall Study|Adverse Event|1|||
156644653|NCT01999322|565445554|FG001|Overall Study|Adverse Event|0|||
156644654|NCT01458119|565445559|FG000|Overall Study|Physician Decision|4|||
156644655|NCT01458119|565445559|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
156644656|NCT01458119|565445559|FG000|Overall Study|Pregnancy|1|||
156644657|NCT01458119|565445559|FG000|Overall Study|Death|2|||
156644658|NCT01458119|565445559|FG000|Overall Study|Adverse Event|1|||
156644659|NCT01458119|565445559|FG000|Overall Study|Consent Withdrawn by Participant|8|||
156644660|NCT01458119|565445559|FG000|Overall Study|Non-compliance With Study Drug|3|||
156644661|NCT03053622|565447688|FG000|Overall Study|Lost to Follow-up|0|||
156644662|NCT03053622|565447689|FG001|Overall Study|Lost to Follow-up|0|||
156644663|NCT03053622|565447690|FG002|Overall Study|Lost to Follow-up|0|||
156644664|NCT03053622|565447691|FG003|Overall Study|Lost to Follow-up|1|||
156644665|NCT01246986|565447692|FG000|Overall Study|Lost to Follow-up|0|||
156644666|NCT01246986|565447693|FG001|Overall Study|Lost to Follow-up|1|||
156644667|NCT01246986|565447694|FG002|Overall Study|Lost to Follow-up|3|||
156644668|NCT01246986|565447695|FG003|Overall Study|Lost to Follow-up|0|||
156644669|NCT01246986|565447696|FG004|Overall Study|Lost to Follow-up|0|||
156644670|NCT01246986|565447697|FG005|Overall Study|Lost to Follow-up|1|||
156644671|NCT01246986|565447698|FG006|Overall Study|Lost to Follow-up|0|||
156644672|NCT01246986|565447692|FG000|Overall Study|Withdrawal by Subject|3|||
156644673|NCT01246986|565447693|FG001|Overall Study|Withdrawal by Subject|4|||
156644674|NCT01246986|565447694|FG002|Overall Study|Withdrawal by Subject|3|||
156644675|NCT01246986|565447695|FG003|Overall Study|Withdrawal by Subject|0|||
156644676|NCT01246986|565447696|FG004|Overall Study|Withdrawal by Subject|4|||
156644677|NCT01246986|565447697|FG005|Overall Study|Withdrawal by Subject|0|||
156644678|NCT01246986|565447698|FG006|Overall Study|Withdrawal by Subject|0|||
156644679|NCT01440647|565447703|FG000|Overall Study|Death|2|||
156644680|NCT01440647|565447704|FG001|Overall Study|Death|3|||
156644681|NCT01406873|565447718|FG000|Overall Study|Withdrawal by Subject|1|||
156644682|NCT01406873|565447719|FG001|Overall Study|Withdrawal by Subject|1|||
156644683|NCT03990389|565447720|FG000|Overall Study|Lost to Follow-up|3|||
156644684|NCT03990389|565447721|FG001|Overall Study|Lost to Follow-up|0|||
156644685|NCT00207714|565447722|FG000|Overall Study|Adverse Event|6|||
156644686|NCT00207714|565447723|FG001|Overall Study|Adverse Event|2|||
156644687|NCT00207714|565447724|FG002|Overall Study|Adverse Event|4|||
156644688|NCT00207714|565447725|FG003|Overall Study|Adverse Event|3|||
156644689|NCT00207714|565447726|FG004|Overall Study|Adverse Event|1|||
156644690|NCT00207714|565447722|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
156644691|NCT00207714|565447723|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156644692|NCT00207714|565447724|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
156644693|NCT00207714|565447725|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
156644694|NCT00207714|565447726|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
156644695|NCT00207714|565447722|FG000|Overall Study|Other|3|||
156644696|NCT00207714|565447723|FG001|Overall Study|Other|2|||
156644697|NCT00207714|565447724|FG002|Overall Study|Other|5|||
156644698|NCT00207714|565447725|FG003|Overall Study|Other|1|||
156644699|NCT00207714|565447726|FG004|Overall Study|Other|0|||
156644700|NCT03627195|565447727|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
156644701|NCT03627195|565447728|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
156644702|NCT03627195|565447729|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
156644703|NCT03627195|565447730|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
156644704|NCT03627195|565447731|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
156644705|NCT03627195|565447732|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
156644706|NCT03770000|565447736|FG000|Overall Study|Premature discontinuation due to PD|0|||
156644707|NCT03770000|565447737|FG001|Overall Study|Premature discontinuation due to PD|0|||
156644708|NCT03770000|565447738|FG002|Overall Study|Premature discontinuation due to PD|1|||
156644709|NCT03770000|565447739|FG003|Overall Study|Premature discontinuation due to PD|3|||
156644710|NCT03770000|565447740|FG004|Overall Study|Premature discontinuation due to PD|2|||
156644711|NCT02290028|565447741|FG000|Overall Study|Death|217|||
156644712|NCT02290028|565447741|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
156644713|NCT02290028|565447741|FG000|Overall Study|No longer under care of study physician|76|||
156644714|NCT02290028|565447741|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
156644715|NCT02290028|565447741|FG000|Overall Study|Withdrawal by Subject|52|||
156644716|NCT02290028|565447741|FG000|Overall Study|Study site closure|44|||
156644717|NCT02290028|565447741|FG000|Overall Study|Lost to Follow-up|34|||
156644718|NCT02290028|565447741|FG000|Overall Study|Miscellaneous|10|||
156644719|NCT02290028|565447741|FG000|Overall Study|Transition to EP PASSION|1295|||
156412188|NCT02065570|564602847|FG001|Induction Study|Lost to Follow-up|1|||
156644720|NCT02290028|565447741|FG000|Overall Study|Planned study completion at 12 months|257|||
156644721|NCT00833547|565447742|FG000|Overall Study|Withdrawal by Subject|2|||
156644722|NCT00833547|565447743|FG001|Overall Study|Withdrawal by Subject|2|||
156644723|NCT00686790|565447746|FG000|Overall Study|Adverse Event|2|||
156644724|NCT00686790|565447746|FG000|Overall Study|Withdrawal by Subject|1|||
156644725|NCT00686790|565447746|FG000|Overall Study|Death|1|||
156644726|NCT00686790|565447746|FG000|Overall Study|Lost to Follow-up|12|||
156644727|NCT00096382|565447747|FG000|Overall Study|Not treated|1|||
156644728|NCT00096382|565447748|FG001|Overall Study|Not treated|0|||
156644729|NCT00096382|565447747|FG000|Overall Study|Death during treatment|1|||
156644730|NCT00096382|565447748|FG001|Overall Study|Death during treatment|0|||
156644731|NCT03862625|565447752|FG000|Overall Study|Lost to Follow-up|0|||
156644732|NCT03862625|565447753|FG001|Overall Study|Lost to Follow-up|1|||
156644733|NCT01326702|565447754|FG000|Overall Study|Other|1|||
156644734|NCT01326702|565447755|FG001|Overall Study|Other|0|||
156644735|NCT01326702|565447756|FG002|Overall Study|Other|0|||
156644736|NCT01326702|565447757|FG003|Overall Study|Other|0|||
156644737|NCT01326702|565447758|FG004|Overall Study|Other|0|||
156644738|NCT01326702|565447759|FG005|Overall Study|Other|1|||
156644739|NCT01326702|565447760|FG006|Overall Study|Other|0|||
156644740|NCT01326702|565447754|FG000|Overall Study|progressive disease|1|||
156644741|NCT01326702|565447755|FG001|Overall Study|progressive disease|1|||
156644742|NCT01326702|565447756|FG002|Overall Study|progressive disease|3|||
156644743|NCT01326702|565447757|FG003|Overall Study|progressive disease|1|||
156644744|NCT01326702|565447758|FG004|Overall Study|progressive disease|3|||
156644745|NCT01326702|565447759|FG005|Overall Study|progressive disease|2|||
156644746|NCT01326702|565447760|FG006|Overall Study|progressive disease|3|||
156644747|NCT01326702|565447754|FG000|Overall Study|Death|0|||
156644748|NCT01326702|565447755|FG001|Overall Study|Death|1|||
156644749|NCT01326702|565447756|FG002|Overall Study|Death|0|||
156644750|NCT01326702|565447757|FG003|Overall Study|Death|0|||
156644751|NCT01326702|565447758|FG004|Overall Study|Death|0|||
156644752|NCT01326702|565447759|FG005|Overall Study|Death|0|||
156644753|NCT01326702|565447760|FG006|Overall Study|Death|0|||
156644754|NCT01326702|565447754|FG000|Overall Study|Adverse Event|0|||
156644755|NCT01326702|565447755|FG001|Overall Study|Adverse Event|0|||
156644756|NCT01326702|565447756|FG002|Overall Study|Adverse Event|1|||
156644757|NCT01326702|565447757|FG003|Overall Study|Adverse Event|1|||
156644758|NCT01326702|565447758|FG004|Overall Study|Adverse Event|0|||
156644759|NCT01326702|565447759|FG005|Overall Study|Adverse Event|3|||
156644760|NCT01326702|565447760|FG006|Overall Study|Adverse Event|1|||
156644761|NCT01326702|565447754|FG000|Overall Study|Withdrawal by Subject|0|||
156644762|NCT01326702|565447755|FG001|Overall Study|Withdrawal by Subject|0|||
156644763|NCT01326702|565447756|FG002|Overall Study|Withdrawal by Subject|1|||
156644764|NCT01326702|565447757|FG003|Overall Study|Withdrawal by Subject|0|||
156644765|NCT01326702|565447758|FG004|Overall Study|Withdrawal by Subject|1|||
156644766|NCT01326702|565447759|FG005|Overall Study|Withdrawal by Subject|1|||
156644767|NCT01326702|565447760|FG006|Overall Study|Withdrawal by Subject|3|||
156644768|NCT01326702|565447754|FG000|Overall Study|Not Treated|0|||
156644769|NCT01326702|565447755|FG001|Overall Study|Not Treated|0|||
156644770|NCT01326702|565447756|FG002|Overall Study|Not Treated|0|||
156644771|NCT01326702|565447757|FG003|Overall Study|Not Treated|1|||
156644772|NCT01326702|565447758|FG004|Overall Study|Not Treated|0|||
156644773|NCT01326702|565447759|FG005|Overall Study|Not Treated|1|||
156644774|NCT01326702|565447760|FG006|Overall Study|Not Treated|0|||
156644775|NCT02082912|565447761|FG000|Overall Study|Physician Decision|0|||
156644776|NCT02082912|565447762|FG001|Overall Study|Physician Decision|1|||
156644777|NCT02614703|565447764|FG000|Overall Study|Withdrawal by Subject|7|||
156644778|NCT02614703|565447765|FG001|Overall Study|Withdrawal by Subject|1|||
156644779|NCT02402933|565447766|FG000|Overall Study|Withdrawal by Subject|4|||
156644780|NCT02402933|565447766|FG000|Overall Study|Discontinued; Site Termination|10|||
156644781|NCT01835132|565447780|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
156644782|NCT00856778|565447781|FG000|Overall Study|Adverse Event|7|||
156644783|NCT00856778|565447781|FG000|Overall Study|Withdrawal by Subject|10|||
156644784|NCT00856778|565447781|FG000|Overall Study|Study deviation|2|||
156644785|NCT00856778|565447781|FG000|Overall Study|Lost to Follow-up|5|||
156644786|NCT01681771|565447782|FG000|Overall Study|Lost to Follow-up|4|||
156644787|NCT01681771|565447783|FG001|Overall Study|Lost to Follow-up|2|||
156644788|NCT00265083|565447784|FG000|Overall Study|Adverse Event|5|||
156644789|NCT00265083|565447785|FG001|Overall Study|Adverse Event|13|||
156644790|NCT00265083|565447786|FG002|Overall Study|Adverse Event|15|||
156644791|NCT00265083|565447784|FG000|Overall Study|Lost to Follow-up|3|||
156644792|NCT00265083|565447785|FG001|Overall Study|Lost to Follow-up|4|||
156644793|NCT00265083|565447786|FG002|Overall Study|Lost to Follow-up|4|||
156644794|NCT00265083|565447784|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
156644795|NCT00265083|565447785|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
156644796|NCT00265083|565447786|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
156644797|NCT00265083|565447784|FG000|Overall Study|Other|1|||
156644798|NCT00265083|565447785|FG001|Overall Study|Other|12|||
156644799|NCT00265083|565447786|FG002|Overall Study|Other|9|||
156644800|NCT03208933|565447787|FG000|Overall Study|Death|3|||
156644801|NCT03208933|565447787|FG000|Overall Study|Withdrawal by Subject|3|||
156644802|NCT03208933|565447787|FG000|Overall Study|Adverse Event|1|||
156644803|NCT03208933|565447787|FG000|Overall Study|Lost to Follow-up|2|||
156644804|NCT03208933|565447787|FG000|Overall Study|Physician Decision|3|||
156644805|NCT03208933|565447787|FG000|Overall Study|Protocol Violation|1|||
156644806|NCT04242186|565447797|FG000|Overall Study|Death|5|||
156644807|NCT00782275|565447800|FG000|Overall Study|Adverse Event|11|||
156644808|NCT00782275|565447800|FG000|Overall Study|Withdrawal by Subject|1|||
156644809|NCT00782275|565447800|FG000|Overall Study|Progressive Disease|21|||
156644810|NCT00782275|565447800|FG000|Overall Study|Physician Decision|4|||
156644811|NCT00782275|565447800|FG000|Overall Study|Not started treatment|1|||
156644812|NCT00782275|565447800|FG000|Overall Study|Other|3|||
156644813|NCT04378010|565447801|FG000|Overall Study|Adverse Event|8|||
156644814|NCT04378010|565447802|FG001|Overall Study|Adverse Event|14|||
156644815|NCT04378010|565447803|FG002|Overall Study|Adverse Event|4|||
156644816|NCT04378010|565447801|FG000|Overall Study|Withdrawal by Subject|0|||
156644817|NCT04378010|565447802|FG001|Overall Study|Withdrawal by Subject|2|||
156644818|NCT04378010|565447803|FG002|Overall Study|Withdrawal by Subject|1|||
156644819|NCT04378010|565447801|FG000|Overall Study|Protocol Violation|2|||
156644820|NCT04378010|565447802|FG001|Overall Study|Protocol Violation|1|||
156644821|NCT04378010|565447803|FG002|Overall Study|Protocol Violation|4|||
156644822|NCT04378010|565447801|FG000|Overall Study|Study terminated by Sponsor|22|||
156644823|NCT04378010|565447802|FG001|Overall Study|Study terminated by Sponsor|16|||
156644824|NCT04378010|565447803|FG002|Overall Study|Study terminated by Sponsor|22|||
156644825|NCT04378010|565447801|FG000|Overall Study|Subject inability to complete study visit|0|||
156644826|NCT04378010|565447802|FG001|Overall Study|Subject inability to complete study visit|0|||
156644827|NCT04378010|565447803|FG002|Overall Study|Subject inability to complete study visit|1|||
156644828|NCT04378010|565447801|FG000|Overall Study|Subject never dosed|0|||
156644829|NCT04378010|565447802|FG001|Overall Study|Subject never dosed|1|||
156644830|NCT04378010|565447803|FG002|Overall Study|Subject never dosed|0|||
156644831|NCT01792284|565447804|FG000|Lead-in Period|Adverse Event|15|||
156644832|NCT01792284|565447805|FG001|Lead-in Period|Adverse Event|0|||
156644833|NCT01792284|565447806|FG002|Lead-in Period|Adverse Event|0|||
156644834|NCT01792284|565447804|FG000|Lead-in Period|Lost to Follow-up|2|||
156644835|NCT01792284|565447805|FG001|Lead-in Period|Lost to Follow-up|0|||
156644836|NCT01792284|565447806|FG002|Lead-in Period|Lost to Follow-up|0|||
156644837|NCT01792284|565447804|FG000|Lead-in Period|Protocol Violation|1|||
156644838|NCT01792284|565447805|FG001|Lead-in Period|Protocol Violation|0|||
156644839|NCT01792284|565447806|FG002|Lead-in Period|Protocol Violation|0|||
156644840|NCT01792284|565447804|FG000|Lead-in Period|Withdrawal by Subject|10|||
156644841|NCT01792284|565447805|FG001|Lead-in Period|Withdrawal by Subject|0|||
156644842|NCT01792284|565447806|FG002|Lead-in Period|Withdrawal by Subject|0|||
156644843|NCT01792284|565447804|FG000|Lead-in Period|Physician Decision|1|||
156644844|NCT01792284|565447805|FG001|Lead-in Period|Physician Decision|0|||
156644845|NCT01792284|565447806|FG002|Lead-in Period|Physician Decision|0|||
156644846|NCT01792284|565447804|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
156644847|NCT01792284|565447805|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
156644848|NCT01792284|565447806|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
156644849|NCT01792284|565447804|FG000|Randomization Period 1|Withdrawal by Subject|0|||
156644850|NCT01792284|565447805|FG001|Randomization Period 1|Withdrawal by Subject|1|||
156644851|NCT01792284|565447806|FG002|Randomization Period 1|Withdrawal by Subject|1|||
156644852|NCT01792284|565447804|FG000|Randomization Period 1|Physician Decision|0|||
156644853|NCT01792284|565447805|FG001|Randomization Period 1|Physician Decision|1|||
156644854|NCT01792284|565447806|FG002|Randomization Period 1|Physician Decision|1|||
156644855|NCT01792284|565447804|FG000|Randomization Period 1|Adverse Event|0|||
156644856|NCT01792284|565447805|FG001|Randomization Period 1|Adverse Event|0|||
156644857|NCT01792284|565447806|FG002|Randomization Period 1|Adverse Event|2|||
156644858|NCT01792284|565447804|FG000|Randomization Period 1|Lost to Follow-up|0|||
156644859|NCT01792284|565447805|FG001|Randomization Period 1|Lost to Follow-up|0|||
156644860|NCT01792284|565447806|FG002|Randomization Period 1|Lost to Follow-up|1|||
156644861|NCT01792284|565447804|FG000|Randomization Period 2|Protocol Violation|0|||
156644862|NCT01792284|565447805|FG001|Randomization Period 2|Protocol Violation|1|||
156644863|NCT01792284|565447806|FG002|Randomization Period 2|Protocol Violation|0|||
156644864|NCT01792284|565447804|FG000|Randomization Period 2|Withdrawal by Subject|0|||
156412189|NCT02065570|564602848|FG002|Induction Study|Lost to Follow-up|0|||
156412190|NCT02065570|564602849|FG003|Induction Study|Lost to Follow-up|0|||
156412191|NCT02065570|564602846|FG000|Induction Study|Other, Not Specified|6|||
156412192|NCT02065570|564602847|FG001|Induction Study|Other, Not Specified|5|||
156412193|NCT02065570|564602848|FG002|Induction Study|Other, Not Specified|0|||
156644865|NCT01792284|565447805|FG001|Randomization Period 2|Withdrawal by Subject|2|||
156644866|NCT01792284|565447806|FG002|Randomization Period 2|Withdrawal by Subject|0|||
156644867|NCT02019979|565447807|FG000|Overall Study|study terminated|14|||
156644868|NCT00379587|565447813|FG000|Overall Study|Lost to Follow-up|2|||
156644869|NCT03237611|565447814|FG000|Overall Study|Withdrawal by Subject|1|||
156644870|NCT03237611|565447814|FG000|Overall Study|Ineligible|1|||
156644871|NCT00534092|565447818|FG000|Overall Study|Lost to Follow-up|1|||
156412194|NCT02065570|564602849|FG003|Induction Study|Other, Not Specified|0|||
156412195|NCT02065570|564602846|FG000|Maintenance Study|Adverse Event|0|||
156412196|NCT02065570|564602847|FG001|Maintenance Study|Adverse Event|0|||
156644872|NCT00534092|565447819|FG001|Overall Study|Lost to Follow-up|0|||
156644873|NCT00534092|565447818|FG000|Overall Study|personal reasons/family concerns|1|||
156644874|NCT00534092|565447819|FG001|Overall Study|personal reasons/family concerns|0|||
156644875|NCT01169649|565447820|FG000|Overall Study|Patient Not Treated|3|||
156644876|NCT02919475|565447821|FG000|Overall Study|Adverse Event|3|||
156644877|NCT02919475|565447822|FG001|Overall Study|Adverse Event|3|||
156644878|NCT02919475|565447823|FG002|Overall Study|Adverse Event|3|||
156644879|NCT02919475|565447824|FG003|Overall Study|Adverse Event|9|||
156644880|NCT02919475|565447825|FG004|Overall Study|Adverse Event|2|||
156644881|NCT02919475|565447821|FG000|Overall Study|Death|0|||
156644882|NCT02919475|565447822|FG001|Overall Study|Death|1|||
156644883|NCT02919475|565447823|FG002|Overall Study|Death|0|||
156644884|NCT02919475|565447824|FG003|Overall Study|Death|0|||
156644885|NCT02919475|565447825|FG004|Overall Study|Death|0|||
156644886|NCT02919475|565447821|FG000|Overall Study|Lost to Follow-up|0|||
156644887|NCT02919475|565447822|FG001|Overall Study|Lost to Follow-up|0|||
156644888|NCT02919475|565447823|FG002|Overall Study|Lost to Follow-up|0|||
156644889|NCT02919475|565447824|FG003|Overall Study|Lost to Follow-up|1|||
156644890|NCT02919475|565447825|FG004|Overall Study|Lost to Follow-up|0|||
156644891|NCT02919475|565447821|FG000|Overall Study|Withdrawal by Subject|2|||
156644892|NCT02919475|565447822|FG001|Overall Study|Withdrawal by Subject|3|||
156644893|NCT02919475|565447823|FG002|Overall Study|Withdrawal by Subject|1|||
156644894|NCT02919475|565447824|FG003|Overall Study|Withdrawal by Subject|2|||
156644895|NCT02919475|565447825|FG004|Overall Study|Withdrawal by Subject|2|||
156644896|NCT02919475|565447821|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156644897|NCT02919475|565447822|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156644898|NCT02919475|565447823|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156644899|NCT02919475|565447824|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156644900|NCT02919475|565447825|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156644901|NCT02323295|565447830|FG000|Overall Study|Adverse Event|0|||
156644902|NCT02323295|565447831|FG001|Overall Study|Adverse Event|1|||
156644903|NCT02323295|565447830|FG000|Overall Study|Withdrawal by Subject|0|||
156644904|NCT02323295|565447831|FG001|Overall Study|Withdrawal by Subject|1|||
156644905|NCT02323295|565447830|FG000|Overall Study|Patient did not have surgery as planned.|0|||
156644906|NCT02323295|565447831|FG001|Overall Study|Patient did not have surgery as planned.|1|||
156644907|NCT00830063|565447832|FG000|Overall Study|Adverse Event|7|||
156644908|NCT00830063|565447833|FG001|Overall Study|Adverse Event|13|||
156644909|NCT00830063|565447834|FG002|Overall Study|Adverse Event|16|||
156644910|NCT00830063|565447835|FG003|Overall Study|Adverse Event|13|||
156644911|NCT00830063|565447832|FG000|Overall Study|Death|1|||
156644912|NCT00830063|565447833|FG001|Overall Study|Death|0|||
156644913|NCT00830063|565447834|FG002|Overall Study|Death|0|||
156644914|NCT00830063|565447835|FG003|Overall Study|Death|0|||
156644915|NCT00830063|565447832|FG000|Overall Study|Lost to Follow-up|0|||
156644916|NCT00830063|565447833|FG001|Overall Study|Lost to Follow-up|0|||
156644917|NCT00830063|565447834|FG002|Overall Study|Lost to Follow-up|3|||
156644918|NCT00830063|565447835|FG003|Overall Study|Lost to Follow-up|1|||
156644919|NCT00830063|565447832|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
156644920|NCT00830063|565447833|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
156644921|NCT00830063|565447834|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
156644922|NCT00830063|565447835|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
156644923|NCT00830063|565447832|FG000|Overall Study|Lack of Efficacy|51|||
156644924|NCT00830063|565447833|FG001|Overall Study|Lack of Efficacy|23|||
156644925|NCT00830063|565447834|FG002|Overall Study|Lack of Efficacy|25|||
156644926|NCT00830063|565447835|FG003|Overall Study|Lack of Efficacy|32|||
156644927|NCT00830063|565447832|FG000|Overall Study|Other|5|||
156644928|NCT00830063|565447833|FG001|Overall Study|Other|5|||
156644929|NCT00830063|565447834|FG002|Overall Study|Other|8|||
156644930|NCT00830063|565447835|FG003|Overall Study|Other|6|||
156644931|NCT00830063|565447832|FG000|Overall Study|Withdrawal by Subject|16|||
156644932|NCT00830063|565447833|FG001|Overall Study|Withdrawal by Subject|10|||
156644933|NCT00830063|565447834|FG002|Overall Study|Withdrawal by Subject|16|||
156644934|NCT00830063|565447835|FG003|Overall Study|Withdrawal by Subject|13|||
156644935|NCT00830063|565447832|FG000|Overall Study|Protocol Violation|1|||
156644936|NCT00830063|565447833|FG001|Overall Study|Protocol Violation|0|||
156644937|NCT00830063|565447834|FG002|Overall Study|Protocol Violation|3|||
156644938|NCT00830063|565447835|FG003|Overall Study|Protocol Violation|2|||
156644939|NCT00830063|565447832|FG000|Overall Study|Randomized But Not Treated|0|||
156644940|NCT00830063|565447833|FG001|Overall Study|Randomized But Not Treated|2|||
156644941|NCT00830063|565447834|FG002|Overall Study|Randomized But Not Treated|0|||
156644942|NCT00830063|565447835|FG003|Overall Study|Randomized But Not Treated|2|||
156644943|NCT02370784|565447836|FG000|Overall Study|Patient started prohibited medication|0|||
156644944|NCT02370784|565447837|FG001|Overall Study|Patient started prohibited medication|1|||
156644945|NCT01814761|565447839|FG000|Overall Study|Other Reasons|1|||
156644946|NCT01814761|565447840|FG001|Overall Study|Other Reasons|10|||
156644947|NCT01814761|565447839|FG000|Overall Study|Ocular Adverse Event|6|||
156644948|NCT01814761|565447840|FG001|Overall Study|Ocular Adverse Event|15|||
156644949|NCT01814761|565447839|FG000|Overall Study|Lost to Follow-up|1|||
156644950|NCT01814761|565447840|FG001|Overall Study|Lost to Follow-up|5|||
156644951|NCT01059071|565447841|FG000|Overall Study|Lack of Efficacy|1|||
156644952|NCT01059071|565447842|FG001|Overall Study|Lack of Efficacy|4|||
156644953|NCT01059071|565447843|FG002|Overall Study|Lack of Efficacy|2|||
156644954|NCT01059071|565447844|FG003|Overall Study|Lack of Efficacy|3|||
156644955|NCT01059071|565447841|FG000|Overall Study|Withdrawal by Subject|1|||
156644956|NCT01059071|565447842|FG001|Overall Study|Withdrawal by Subject|0|||
156644957|NCT01059071|565447843|FG002|Overall Study|Withdrawal by Subject|0|||
156644958|NCT01059071|565447844|FG003|Overall Study|Withdrawal by Subject|2|||
156644959|NCT01059071|565447841|FG000|Overall Study|Physician Decision|0|||
156644960|NCT01059071|565447842|FG001|Overall Study|Physician Decision|0|||
156644961|NCT01059071|565447843|FG002|Overall Study|Physician Decision|0|||
156644962|NCT01059071|565447844|FG003|Overall Study|Physician Decision|1|||
156644963|NCT02962882|565447845|FG000|Overall Study|Adverse Event|2|||
156644964|NCT02962882|565447845|FG000|Overall Study|Withdrawal by Subject|2|||
156644965|NCT02962882|565447845|FG000|Overall Study|Transfer from ICU|32|||
156644966|NCT03763331|565447848|FG000|Overall Study|Lost to Follow-up|1|||
156644967|NCT03763331|565447849|FG001|Overall Study|Lost to Follow-up|0|||
156644968|NCT03763331|565447848|FG000|Overall Study|Withdrawal by Subject|1|||
156644969|NCT03763331|565447849|FG001|Overall Study|Withdrawal by Subject|0|||
156644970|NCT03763331|565447848|FG000|Overall Study|Non-compliance|0|||
156644971|NCT03763331|565447849|FG001|Overall Study|Non-compliance|3|||
156644972|NCT01155063|565447850|FG000|Overall Study|Adverse Event|1|||
156644973|NCT01155063|565447850|FG000|Overall Study|Withdrawal by Subject|1|||
156644974|NCT01155063|565447850|FG000|Overall Study|Study terminated by sponsor|87|||
156644975|NCT00936884|565447851|FG000|Double-blind|Withdrawal by Subject|6|||
156644976|NCT00936884|565447852|FG001|Double-blind|Withdrawal by Subject|4|||
156644977|NCT00936884|565447853|FG002|Double-blind|Withdrawal by Subject|0|||
156644978|NCT00936884|565447851|FG000|Double-blind|Death|2|||
156644979|NCT00936884|565447852|FG001|Double-blind|Death|1|||
156644980|NCT00936884|565447853|FG002|Double-blind|Death|0|||
156644981|NCT00936884|565447851|FG000|Double-blind|Lack of Efficacy|1|||
156644982|NCT00936884|565447852|FG001|Double-blind|Lack of Efficacy|1|||
156644983|NCT00936884|565447853|FG002|Double-blind|Lack of Efficacy|0|||
156644984|NCT00936884|565447851|FG000|Double-blind|Adverse Event|1|||
156644985|NCT00936884|565447852|FG001|Double-blind|Adverse Event|0|||
156644986|NCT00936884|565447853|FG002|Double-blind|Adverse Event|0|||
156644987|NCT00936884|565447851|FG000|Double-blind|Physician Decision|1|||
156644988|NCT00936884|565447852|FG001|Double-blind|Physician Decision|0|||
156644989|NCT00936884|565447853|FG002|Double-blind|Physician Decision|0|||
156644990|NCT00936884|565447851|FG000|Double-blind|No post baseline diary entry|1|||
156644991|NCT00936884|565447852|FG001|Double-blind|No post baseline diary entry|0|||
156644992|NCT00936884|565447853|FG002|Double-blind|No post baseline diary entry|0|||
156644993|NCT00936884|565447851|FG000|Double-blind|Did not receive study drug|0|||
156644994|NCT00936884|565447852|FG001|Double-blind|Did not receive study drug|1|||
156644995|NCT00936884|565447853|FG002|Double-blind|Did not receive study drug|0|||
156644996|NCT04741503|565447854|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
156644997|NCT04741503|565447855|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
156644998|NCT04741503|565447856|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
156644999|NCT04741503|565447854|FG000|Initial Enrollment|Overquotas removed|0|||
156645000|NCT04741503|565447855|FG001|Initial Enrollment|Overquotas removed|0|||
156645001|NCT04741503|565447856|FG002|Initial Enrollment|Overquotas removed|186|||
156645002|NCT04741503|565447854|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
156645003|NCT04741503|565447855|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
156645004|NCT04741503|565447856|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
156645005|NCT01663714|565447857|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
156645006|NCT01663714|565447857|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
156645007|NCT01663714|565447857|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
156645008|NCT01663714|565447857|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
156645009|NCT01663714|565447857|FG000|Long-Term Follow-Up|Death|4|||
156645010|NCT01663714|565447857|FG000|Long-Term Follow-Up|Non-compliance|1|||
156645011|NCT00597584|565447858|FG000|Overall Study|Adverse Event|4|||
156645012|NCT00597584|565447859|FG001|Overall Study|Adverse Event|2|||
156645013|NCT00597584|565447858|FG000|Overall Study|Death|53|||
156645014|NCT00597584|565447859|FG001|Overall Study|Death|30|||
156645015|NCT00597584|565447858|FG000|Overall Study|Lack of Efficacy|1|||
156645016|NCT00597584|565447859|FG001|Overall Study|Lack of Efficacy|0|||
156645017|NCT00597584|565447858|FG000|Overall Study|Lost to Follow-up|2|||
156645018|NCT00597584|565447859|FG001|Overall Study|Lost to Follow-up|4|||
156645019|NCT00597584|565447858|FG000|Overall Study|Physician Decision|3|||
156645020|NCT00597584|565447859|FG001|Overall Study|Physician Decision|0|||
156645021|NCT00597584|565447858|FG000|Overall Study|Pregnancy|2|||
156645022|NCT00597584|565447859|FG001|Overall Study|Pregnancy|0|||
156645023|NCT00597584|565447858|FG000|Overall Study|Withdrawal by Subject|44|||
156645024|NCT00597584|565447859|FG001|Overall Study|Withdrawal by Subject|12|||
156645025|NCT00597584|565447858|FG000|Overall Study|Discontinued Dialysis|0|||
156645026|NCT00597584|565447859|FG001|Overall Study|Discontinued Dialysis|1|||
156645027|NCT00597584|565447858|FG000|Overall Study|Lost ability to consent|1|||
156645028|NCT00597584|565447859|FG001|Overall Study|Lost ability to consent|1|||
156645029|NCT00597584|565447858|FG000|Overall Study|Never dosed|1|||
156645030|NCT00597584|565447859|FG001|Overall Study|Never dosed|0|||
156645031|NCT00597584|565447858|FG000|Overall Study|Relocation|8|||
156645032|NCT00597584|565447859|FG001|Overall Study|Relocation|6|||
156645033|NCT00597584|565447858|FG000|Overall Study|Renal transplant|9|||
156645034|NCT00597584|565447859|FG001|Overall Study|Renal transplant|7|||
156645035|NCT02280421|565447860|FG000|Washout (2 Weeks)|Adverse Event|0|||
156645036|NCT02280421|565447861|FG001|Washout (2 Weeks)|Adverse Event|1|||
156645037|NCT02280421|565447860|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
156645038|NCT02280421|565447861|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
156645039|NCT01872689|565447876|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
156645040|NCT01872689|565447877|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
156645041|NCT01872689|565447878|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
156645042|NCT01872689|565447879|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
156645043|NCT01872689|565447876|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
156645044|NCT01872689|565447877|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
156645045|NCT01872689|565447878|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
156645046|NCT01872689|565447879|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
156645047|NCT01872689|565447876|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
156645048|NCT01872689|565447877|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
156645049|NCT01872689|565447878|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
156645050|NCT01872689|565447879|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
156645051|NCT01872689|565447876|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
156645052|NCT01872689|565447877|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
156645053|NCT01872689|565447878|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
156645054|NCT01872689|565447879|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
156645055|NCT01872689|565447876|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
156645056|NCT01872689|565447877|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
156645057|NCT01872689|565447878|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
156645058|NCT01872689|565447879|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
156645059|NCT01872689|565447876|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
156645060|NCT01872689|565447877|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
156645061|NCT01872689|565447878|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
156645062|NCT01872689|565447879|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
156645063|NCT01872689|565447876|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
156645064|NCT01872689|565447877|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
156645065|NCT01872689|565447878|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
156645066|NCT01872689|565447879|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
156645067|NCT01872689|565447876|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
156645068|NCT01872689|565447877|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
156645069|NCT01872689|565447878|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
156645070|NCT01872689|565447879|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
156645071|NCT01872689|565447876|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
156645072|NCT01872689|565447877|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
156645073|NCT01872689|565447878|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
156645074|NCT01872689|565447879|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
156645075|NCT01872689|565447876|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
156645076|NCT01872689|565447877|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
156645077|NCT01872689|565447878|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
156645078|NCT01872689|565447879|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
156645079|NCT01872689|565447876|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
156645080|NCT01872689|565447877|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
156645081|NCT01872689|565447878|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
156645082|NCT01872689|565447879|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
156645083|NCT01872689|565447876|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
156645084|NCT01872689|565447877|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
156645085|NCT01872689|565447878|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
156645086|NCT01872689|565447879|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
156645087|NCT01872689|565447876|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
156645088|NCT01872689|565447877|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
156645089|NCT01872689|565447878|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
156645090|NCT01872689|565447879|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
156645091|NCT01872689|565447876|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
156645092|NCT01872689|565447877|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
156645093|NCT01872689|565447878|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
156645094|NCT01872689|565447879|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
156645095|NCT02791659|565447880|FG000|Overall Study|Protocol Violation|0|||
156645096|NCT02791659|565447881|FG001|Overall Study|Protocol Violation|1|||
156645097|NCT01456052|565447882|FG000|Overall Study|Adverse Event|1|||
156645098|NCT01456052|565447883|FG001|Overall Study|Adverse Event|1|||
156645099|NCT01456052|565447884|FG002|Overall Study|Adverse Event|2|||
156645100|NCT01456052|565447882|FG000|Overall Study|Consent withdrawn|0|||
156645101|NCT01456052|565447883|FG001|Overall Study|Consent withdrawn|2|||
156645102|NCT01456052|565447884|FG002|Overall Study|Consent withdrawn|1|||
156645103|NCT01456052|565447882|FG000|Overall Study|Protocol Violation|0|||
156645104|NCT01456052|565447883|FG001|Overall Study|Protocol Violation|1|||
156645105|NCT01456052|565447884|FG002|Overall Study|Protocol Violation|0|||
156645106|NCT01456052|565447882|FG000|Overall Study|Physician Decision|1|||
156645107|NCT01456052|565447883|FG001|Overall Study|Physician Decision|0|||
156645108|NCT01456052|565447884|FG002|Overall Study|Physician Decision|1|||
156645109|NCT01456052|565447882|FG000|Overall Study|Treatment Failure|0|||
156645110|NCT01456052|565447883|FG001|Overall Study|Treatment Failure|1|||
156645111|NCT01456052|565447884|FG002|Overall Study|Treatment Failure|1|||
156645112|NCT02853929|565447887|FG000|Overall Study|Lost to Follow-up|3|||
156645113|NCT02853929|565447888|FG001|Overall Study|Lost to Follow-up|0|||
156645114|NCT02853929|565447887|FG000|Overall Study|Withdrawal by Subject|1|||
156645115|NCT02853929|565447888|FG001|Overall Study|Withdrawal by Subject|0|||
156645116|NCT02853929|565447887|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
156645117|NCT02853929|565447888|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
156645118|NCT02762565|565447889|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
156645119|NCT01113710|565447890|FG000|Overall Study|Adverse Event|64|||
156645120|NCT01113710|565447890|FG000|Overall Study|Lack of Efficacy|41|||
156645121|NCT01113710|565447890|FG000|Overall Study|No Information Available|40|||
156645122|NCT01113710|565447890|FG000|Overall Study|Withdrawal by Subject|28|||
156645123|NCT01113710|565447890|FG000|Overall Study|Lost to Follow-up|20|||
156645124|NCT01113710|565447890|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
156645125|NCT01113710|565447890|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
156645126|NCT01113710|565447890|FG000|Overall Study|Lack of Patient's Compliance|8|||
156645127|NCT01113710|565447890|FG000|Overall Study|Other|7|||
156645128|NCT01113710|565447890|FG000|Overall Study|Adverse Event/Other|5|||
156645129|NCT01113710|565447890|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
156645130|NCT01113710|565447890|FG000|Overall Study|Lack of Efficacy/Other|4|||
156645131|NCT01113710|565447890|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
156645132|NCT01113710|565447890|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
156645133|NCT01113710|565447890|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
156645134|NCT01113710|565447890|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
156645135|NCT01113710|565447890|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
156645136|NCT01113710|565447890|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
156645137|NCT01113710|565447890|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
156645138|NCT01113710|565447890|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
156645139|NCT01113710|565447890|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
156645140|NCT01113710|565447890|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
156645141|NCT01113710|565447890|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
156645142|NCT01113710|565447890|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
156645143|NCT01113710|565447890|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
156645144|NCT01042977|565447892|FG000|Overall Study|Adverse Event|4|||
156645145|NCT01042977|565447893|FG001|Overall Study|Adverse Event|12|||
156645146|NCT01042977|565447892|FG000|Overall Study|Death|2|||
156645147|NCT01042977|565447893|FG001|Overall Study|Death|1|||
156645148|NCT01042977|565447892|FG000|Overall Study|Withdrawal by Subject|8|||
156645149|NCT01042977|565447893|FG001|Overall Study|Withdrawal by Subject|16|||
156645150|NCT01042977|565447892|FG000|Overall Study|Lost to Follow-up|0|||
156645151|NCT01042977|565447893|FG001|Overall Study|Lost to Follow-up|2|||
156645152|NCT01042977|565447892|FG000|Overall Study|Poor/non-compliance|3|||
156645153|NCT01042977|565447893|FG001|Overall Study|Poor/non-compliance|4|||
156645154|NCT01042977|565447892|FG000|Overall Study|Subject no longer meets study criteria|15|||
156645155|NCT01042977|565447893|FG001|Overall Study|Subject no longer meets study criteria|13|||
156645156|NCT01042977|565447892|FG000|Overall Study|Incorrect enrollment|6|||
156645157|NCT01042977|565447893|FG001|Overall Study|Incorrect enrollment|4|||
156645158|NCT01042977|565447892|FG000|Overall Study|Safety|0|||
156645159|NCT01042977|565447893|FG001|Overall Study|Safety|2|||
156645160|NCT01042977|565447892|FG000|Overall Study|Administrative reason by sponsor|0|||
156645161|NCT01042977|565447893|FG001|Overall Study|Administrative reason by sponsor|1|||
156645162|NCT01042977|565447892|FG000|Overall Study|Various|3|||
156645163|NCT01042977|565447893|FG001|Overall Study|Various|0|||
156645164|NCT02499354|565447894|FG000|Overall Study|Withdrawal by Subject|1|||
156645165|NCT02499354|565447895|FG001|Overall Study|Withdrawal by Subject|0|||
156645166|NCT01027884|565447911|FG000|Overall Study|Adverse Event|2|||
156645167|NCT01027884|565447912|FG001|Overall Study|Adverse Event|1|||
156645168|NCT01027884|565447911|FG000|Overall Study|Protocol Violation|1|||
156645169|NCT01027884|565447912|FG001|Overall Study|Protocol Violation|0|||
156645170|NCT01027884|565447911|FG000|Overall Study|Non-compliance|1|||
156645171|NCT01027884|565447912|FG001|Overall Study|Non-compliance|1|||
156645172|NCT01027884|565447911|FG000|Overall Study|Withdrawal by Subject|0|||
156645173|NCT01027884|565447912|FG001|Overall Study|Withdrawal by Subject|1|||
156645174|NCT01027884|565447911|FG000|Overall Study|Lost to Follow-up|0|||
156645175|NCT01027884|565447912|FG001|Overall Study|Lost to Follow-up|1|||
156645176|NCT01027884|565447911|FG000|Overall Study|Spinal fixation surgery|0|||
156645177|NCT01027884|565447912|FG001|Overall Study|Spinal fixation surgery|3|||
156645178|NCT03636542|565447914|FG000|Overall Study|Lost to Follow-up|1|||
156645179|NCT03636542|565447915|FG001|Overall Study|Lost to Follow-up|1|||
156645180|NCT03636542|565447914|FG000|Overall Study|Physician Decision|0|||
156645181|NCT03636542|565447915|FG001|Overall Study|Physician Decision|1|||
156645182|NCT03636542|565447914|FG000|Overall Study|Withdrawal by Subject|1|||
156645183|NCT03636542|565447915|FG001|Overall Study|Withdrawal by Subject|0|||
156645184|NCT03670537|565447918|FG000|Overall Study|Protocol Violation|1|||
156645185|NCT02059187|565447919|FG000|Overall Study|Adverse Event|0|||
156645186|NCT02059187|565447920|FG001|Overall Study|Adverse Event|3|||
156645187|NCT02059187|565447919|FG000|Overall Study|Death|1|||
156645188|NCT02059187|565447920|FG001|Overall Study|Death|1|||
156645189|NCT02059187|565447919|FG000|Overall Study|Lost to Follow-up|9|||
156645190|NCT02059187|565447920|FG001|Overall Study|Lost to Follow-up|8|||
156645191|NCT02059187|565447919|FG000|Overall Study|Non-compliance with study drug|1|||
156645192|NCT02059187|565447920|FG001|Overall Study|Non-compliance with study drug|0|||
156645193|NCT02059187|565447919|FG000|Overall Study|Physician Decision|1|||
156645194|NCT02059187|565447920|FG001|Overall Study|Physician Decision|2|||
156645195|NCT02059187|565447919|FG000|Overall Study|Protocol Violation|1|||
156645196|NCT02059187|565447920|FG001|Overall Study|Protocol Violation|0|||
156645197|NCT02059187|565447919|FG000|Overall Study|Withdrawal by Subject|12|||
156645198|NCT02059187|565447920|FG001|Overall Study|Withdrawal by Subject|8|||
156645199|NCT03751020|565447921|FG000|Overall Study|Withdrawal by Subject|2|||
156645200|NCT03751020|565447922|FG001|Overall Study|Withdrawal by Subject|0|||
156645201|NCT03751020|565447923|FG002|Overall Study|Withdrawal by Subject|0|||
156645202|NCT03751020|565447921|FG000|Overall Study|Lost to Follow-up|7|||
156645203|NCT03751020|565447922|FG001|Overall Study|Lost to Follow-up|4|||
156645204|NCT03751020|565447923|FG002|Overall Study|Lost to Follow-up|10|||
156645205|NCT01889862|565447924|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
156645206|NCT01889862|565447925|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
156645207|NCT01889862|565447926|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
156645208|NCT01889862|565447927|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
156645209|NCT01889862|565447928|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
156645210|NCT01889862|565447924|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
156645211|NCT01889862|565447925|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
156645212|NCT01889862|565447926|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
156645213|NCT01889862|565447927|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
156645214|NCT01889862|565447928|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
156645215|NCT01889862|565447924|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
156645216|NCT01889862|565447925|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
156645217|NCT01889862|565447926|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
156645218|NCT01889862|565447927|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
156645219|NCT01889862|565447928|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
156645220|NCT01889862|565447924|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
156645221|NCT01889862|565447925|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
156645222|NCT01889862|565447926|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
156645223|NCT01889862|565447927|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
156645224|NCT01889862|565447928|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
156645225|NCT01889862|565447924|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
156645226|NCT01889862|565447925|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
156645227|NCT01889862|565447926|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
156645228|NCT01889862|565447927|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
156645229|NCT01889862|565447928|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
156645230|NCT01889862|565447924|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
156645231|NCT01889862|565447925|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
156645232|NCT01889862|565447926|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
156645233|NCT01889862|565447927|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
156645234|NCT01889862|565447928|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
156645235|NCT01889862|565447924|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
156645236|NCT01889862|565447925|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
156645237|NCT01889862|565447926|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
156645238|NCT01889862|565447927|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
156645239|NCT01889862|565447928|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
156645240|NCT01889862|565447924|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
156645241|NCT01889862|565447925|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
156645242|NCT01889862|565447926|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
156645243|NCT01889862|565447927|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
156645244|NCT01889862|565447928|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
156645245|NCT01889862|565447924|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
156645246|NCT01889862|565447925|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
156645247|NCT01889862|565447926|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
156645248|NCT01889862|565447927|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
156645249|NCT01889862|565447928|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
156645250|NCT01889862|565447924|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
156645251|NCT01889862|565447925|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
156645252|NCT01889862|565447926|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
156645253|NCT01889862|565447927|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
156645254|NCT01889862|565447928|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
156645255|NCT00033631|565447929|FG000|Overall Study|Protocol Violation|14|||
156645256|NCT00033631|565447930|FG001|Overall Study|Protocol Violation|11|||
156645257|NCT00033631|565447929|FG000|Overall Study|Withdrawal by Subject|4|||
156645258|NCT00033631|565447930|FG001|Overall Study|Withdrawal by Subject|4|||
156645259|NCT02595528|565449579|FG000|Overall Study|Withdrawal by Subject|1|||
156645260|NCT02595528|565449580|FG001|Overall Study|Withdrawal by Subject|2|||
156645261|NCT02595528|565449581|FG002|Overall Study|Withdrawal by Subject|1|||
156645262|NCT02595528|565449582|FG003|Overall Study|Withdrawal by Subject|3|||
156645263|NCT02595528|565449579|FG000|Overall Study|Lost to Follow-up|1|||
156645264|NCT02595528|565449580|FG001|Overall Study|Lost to Follow-up|1|||
156645265|NCT02595528|565449581|FG002|Overall Study|Lost to Follow-up|0|||
156645266|NCT02595528|565449582|FG003|Overall Study|Lost to Follow-up|1|||
156645267|NCT03202511|565449583|FG000|Overall Study|Withdrawal by Subject|1|||
156645268|NCT03202511|565449584|FG001|Overall Study|Withdrawal by Subject|0|||
156645269|NCT00382291|565449588|FG000|Overall Study|Adverse Event|1|||
156645270|NCT00382291|565449589|FG001|Overall Study|Adverse Event|2|||
156645271|NCT00382291|565449590|FG002|Overall Study|Adverse Event|2|||
156645272|NCT00382291|565449588|FG000|Overall Study|Protocol Violation|1|||
156645273|NCT00382291|565449589|FG001|Overall Study|Protocol Violation|0|||
156645274|NCT00382291|565449590|FG002|Overall Study|Protocol Violation|0|||
156645275|NCT00382291|565449588|FG000|Overall Study|Temporary study suspension|2|||
156645276|NCT00382291|565449589|FG001|Overall Study|Temporary study suspension|2|||
156645277|NCT00382291|565449590|FG002|Overall Study|Temporary study suspension|5|||
156645278|NCT00382291|565449588|FG000|Overall Study|Withdrawal by Subject|0|||
156645279|NCT00382291|565449589|FG001|Overall Study|Withdrawal by Subject|2|||
156645280|NCT00382291|565449590|FG002|Overall Study|Withdrawal by Subject|0|||
156645281|NCT00382291|565449588|FG000|Overall Study|Physician Decision|0|||
156645282|NCT00382291|565449589|FG001|Overall Study|Physician Decision|1|||
156645283|NCT00382291|565449590|FG002|Overall Study|Physician Decision|0|||
156645284|NCT00382291|565449588|FG000|Overall Study|Lack of Efficacy|0|||
156645285|NCT00382291|565449589|FG001|Overall Study|Lack of Efficacy|0|||
156645286|NCT00382291|565449590|FG002|Overall Study|Lack of Efficacy|1|||
156645287|NCT01375010|565449591|FG000|Overall Study|Lost to Follow-up|8|||
156645288|NCT01375010|565449592|FG001|Overall Study|Lost to Follow-up|2|||
156645289|NCT01375010|565449591|FG000|Overall Study|Withdrawal by Subject|4|||
156645290|NCT01375010|565449592|FG001|Overall Study|Withdrawal by Subject|2|||
156645291|NCT02266706|565449593|FG000|Overall Study|Withdrawal by Subject|0|||
156645292|NCT02266706|565449594|FG001|Overall Study|Withdrawal by Subject|1|||
156645293|NCT02266706|565449595|FG002|Overall Study|Withdrawal by Subject|1|||
156645294|NCT02266706|565449596|FG003|Overall Study|Withdrawal by Subject|0|||
156645295|NCT02266706|565449597|FG004|Overall Study|Withdrawal by Subject|0|||
156645296|NCT02266706|565449598|FG005|Overall Study|Withdrawal by Subject|1|||
156645297|NCT02266706|565449599|FG006|Overall Study|Withdrawal by Subject|0|||
156645298|NCT02266706|565449600|FG007|Overall Study|Withdrawal by Subject|0|||
156645299|NCT02266706|565449601|FG008|Overall Study|Withdrawal by Subject|0|||
156645300|NCT02266706|565449593|FG000|Overall Study|Screen failure|0|||
156645301|NCT02266706|565449594|FG001|Overall Study|Screen failure|0|||
156645302|NCT02266706|565449595|FG002|Overall Study|Screen failure|0|||
156645303|NCT02266706|565449596|FG003|Overall Study|Screen failure|0|||
156645304|NCT02266706|565449597|FG004|Overall Study|Screen failure|0|||
156645305|NCT02266706|565449598|FG005|Overall Study|Screen failure|1|||
156645306|NCT02266706|565449599|FG006|Overall Study|Screen failure|1|||
156645307|NCT02266706|565449600|FG007|Overall Study|Screen failure|0|||
156645308|NCT02266706|565449601|FG008|Overall Study|Screen failure|0|||
156645309|NCT02266706|565449593|FG000|Overall Study|Enrollment in another study|0|||
156645310|NCT02266706|565449594|FG001|Overall Study|Enrollment in another study|0|||
156645311|NCT02266706|565449595|FG002|Overall Study|Enrollment in another study|0|||
156645312|NCT02266706|565449596|FG003|Overall Study|Enrollment in another study|1|||
156645313|NCT02266706|565449597|FG004|Overall Study|Enrollment in another study|0|||
156645314|NCT02266706|565449598|FG005|Overall Study|Enrollment in another study|0|||
156645315|NCT02266706|565449599|FG006|Overall Study|Enrollment in another study|0|||
156645316|NCT02266706|565449600|FG007|Overall Study|Enrollment in another study|0|||
156645317|NCT02266706|565449601|FG008|Overall Study|Enrollment in another study|0|||
156645318|NCT01977352|565449602|FG000|Overall Study|Lost to Follow-up|1|||
156645319|NCT01977352|565449603|FG001|Overall Study|Lost to Follow-up|2|||
156645320|NCT00409188|565449604|FG000|Overall Study|Ongoing at data cut-off|383|||
156645321|NCT00409188|565449605|FG001|Overall Study|Ongoing at data cut-off|175|||
156645322|NCT02270983|565449606|FG000|Overall Study|Adverse Event|3|||
156645323|NCT02270983|565449607|FG001|Overall Study|Adverse Event|2|||
156645324|NCT02270983|565449608|FG002|Overall Study|Adverse Event|6|||
156645325|NCT02270983|565449606|FG000|Overall Study|Lack of Efficacy|2|||
156645326|NCT02270983|565449607|FG001|Overall Study|Lack of Efficacy|1|||
156645327|NCT02270983|565449608|FG002|Overall Study|Lack of Efficacy|1|||
156645328|NCT02270983|565449606|FG000|Overall Study|Withdrawal by Subject|1|||
156645329|NCT02270983|565449607|FG001|Overall Study|Withdrawal by Subject|0|||
156645330|NCT02270983|565449608|FG002|Overall Study|Withdrawal by Subject|2|||
156645331|NCT02270983|565449606|FG000|Overall Study|Lost to Follow-up|1|||
156645332|NCT02270983|565449607|FG001|Overall Study|Lost to Follow-up|1|||
156645333|NCT02270983|565449608|FG002|Overall Study|Lost to Follow-up|2|||
156645334|NCT02270983|565449606|FG000|Overall Study|Protocol Violation|1|||
156645335|NCT02270983|565449607|FG001|Overall Study|Protocol Violation|1|||
156645336|NCT02270983|565449608|FG002|Overall Study|Protocol Violation|1|||
156645337|NCT02270983|565449606|FG000|Overall Study|family emergency|0|||
156645338|NCT02270983|565449607|FG001|Overall Study|family emergency|1|||
156645339|NCT02270983|565449608|FG002|Overall Study|family emergency|0|||
156645340|NCT02270983|565449606|FG000|Overall Study|study procedure non-compliance|1|||
156645341|NCT02270983|565449607|FG001|Overall Study|study procedure non-compliance|0|||
156645342|NCT02270983|565449608|FG002|Overall Study|study procedure non-compliance|0|||
156645343|NCT02270983|565449606|FG000|Overall Study|moved away from study site|0|||
156645344|NCT02270983|565449607|FG001|Overall Study|moved away from study site|1|||
156645345|NCT02270983|565449608|FG002|Overall Study|moved away from study site|0|||
156645346|NCT00854620|565449612|FG000|Overall Study|Adverse Event|1|||
156645347|NCT00275028|565449617|FG000|Overall Study|Withdrew consent before treatment began|1|||
156645348|NCT00275028|565449617|FG000|Overall Study|Withdrawal by Subject|5|||
156645349|NCT00275028|565449617|FG000|Overall Study|Adverse Event|9|||
156645350|NCT00275028|565449617|FG000|Overall Study|Progressive Disease|30|||
156645351|NCT00275028|565449617|FG000|Overall Study|Physician Decision|2|||
156645352|NCT01847313|565449621|FG000|Overall Study|Death|0|||
156645353|NCT01847313|565449622|FG001|Overall Study|Death|1|||
156645354|NCT01847313|565449621|FG000|Overall Study|Withdrawal by Subject|0|||
156645355|NCT01847313|565449622|FG001|Overall Study|Withdrawal by Subject|1|||
156645356|NCT00598559|565449623|FG000|Overall Study|Adverse Event|11|||
156645357|NCT00598559|565449624|FG001|Overall Study|Adverse Event|7|||
156645358|NCT00598559|565449625|FG002|Overall Study|Adverse Event|0|||
156645359|NCT00598559|565449623|FG000|Overall Study|Withdrawal by Subject|2|||
156645360|NCT00598559|565449624|FG001|Overall Study|Withdrawal by Subject|2|||
156645361|NCT00598559|565449625|FG002|Overall Study|Withdrawal by Subject|0|||
156645362|NCT00598559|565449623|FG000|Overall Study|Protocol Non-compliance|1|||
156645363|NCT00598559|565449624|FG001|Overall Study|Protocol Non-compliance|0|||
156645364|NCT00598559|565449625|FG002|Overall Study|Protocol Non-compliance|0|||
156645365|NCT00598559|565449623|FG000|Overall Study|Early discharge from hospital|9|||
156645366|NCT00598559|565449624|FG001|Overall Study|Early discharge from hospital|12|||
156645367|NCT00598559|565449625|FG002|Overall Study|Early discharge from hospital|3|||
156645368|NCT00598559|565449623|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
156645369|NCT00598559|565449624|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
156645370|NCT00598559|565449625|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
156645371|NCT00515073|565449630|FG000|Overall Study|Withdrawal by Subject|1|||
156645372|NCT00515073|565449630|FG000|Overall Study|Physician Decision|1|||
156645373|NCT02764489|565449631|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
156645374|NCT02764489|565449632|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
156645375|NCT02764489|565449631|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
156645376|NCT02764489|565449632|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
156645377|NCT02764489|565449631|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
156645378|NCT02764489|565449632|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
156645379|NCT02764489|565449631|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
156645380|NCT02764489|565449632|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
156645381|NCT00881959|565449633|FG000|Overall Study|Lost to Follow-up|2|||
156645382|NCT00881959|565449634|FG001|Overall Study|Lost to Follow-up|4|||
156645383|NCT03840811|565449635|FG000|Overall Study|Lost to Follow-up|0|||
156645384|NCT03840811|565449636|FG001|Overall Study|Lost to Follow-up|0|||
156645385|NCT03840811|565449637|FG002|Overall Study|Lost to Follow-up|1|||
156645386|NCT01904383|565449638|FG000|Overall Study|CRF not collected|117|||
156645387|NCT01904383|565449638|FG000|Overall Study|Reason not listed|147|||
156645388|NCT01904383|565449638|FG000|Overall Study|Lost to Follow-up|674|||
156645389|NCT01904383|565449638|FG000|Overall Study|Lack of Efficacy|370|||
156645390|NCT01904383|565449638|FG000|Overall Study|Improvement|141|||
156645391|NCT01904383|565449638|FG000|Overall Study|Adverse Event|271|||
156645392|NCT01904383|565449638|FG000|Overall Study|No patient visit after entry|54|||
156645393|NCT01625845|565449639|FG000|Overall Study|Adverse Event|1|||
156645394|NCT01625845|565449640|FG001|Overall Study|Adverse Event|2|||
156645395|NCT01625845|565449639|FG000|Overall Study|Lost to Follow-up|2|||
156645396|NCT01625845|565449640|FG001|Overall Study|Lost to Follow-up|1|||
156645397|NCT01625845|565449639|FG000|Overall Study|Withdrawal by Subject|2|||
156645398|NCT01625845|565449640|FG001|Overall Study|Withdrawal by Subject|0|||
156645399|NCT01294592|565449641|FG000|Overall Study|Adverse Event|28|||
156645400|NCT01294592|565449642|FG001|Overall Study|Adverse Event|13|||
156645401|NCT01294592|565449641|FG000|Overall Study|Lack of Efficacy|7|||
156645402|NCT01294592|565449642|FG001|Overall Study|Lack of Efficacy|5|||
156645403|NCT01294592|565449641|FG000|Overall Study|Protocol Violation|1|||
156645404|NCT01294592|565449642|FG001|Overall Study|Protocol Violation|7|||
156645405|NCT01294592|565449641|FG000|Overall Study|Lost to Follow-up|7|||
156645406|NCT01294592|565449642|FG001|Overall Study|Lost to Follow-up|9|||
156645407|NCT01294592|565449641|FG000|Overall Study|Physician Decision|6|||
156645408|NCT01294592|565449642|FG001|Overall Study|Physician Decision|11|||
156645409|NCT01294592|565449641|FG000|Overall Study|Withdrawal by Subject|28|||
156645410|NCT01294592|565449642|FG001|Overall Study|Withdrawal by Subject|28|||
156645411|NCT04313283|565449643|FG000|Overall Study|did not complete intervention|4|||
156645412|NCT04356573|565449644|FG000|Overall Study|Didn't Qualify|1|||
156645413|NCT04356573|565449645|FG001|Overall Study|Didn't Qualify|0|||
156645414|NCT03650400|565449646|FG000|Overall Study|Study terminated by sponsor|0|||
156645415|NCT03650400|565449647|FG001|Overall Study|Study terminated by sponsor|5|||
156645416|NCT01170364|565449649|FG000|Overall Study|Protocol Violation|4|||
156645417|NCT01170364|565449650|FG001|Overall Study|Protocol Violation|1|||
156645418|NCT04132232|565449651|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
156645419|NCT04132232|565449652|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
156645420|NCT04132232|565449651|FG000|Overall Study|Lost to Follow-up|6|||
156645421|NCT04132232|565449652|FG001|Overall Study|Lost to Follow-up|7|||
156645422|NCT01368276|565449654|FG000|Overall Study|Death|1|||
156645423|NCT01368276|565449655|FG001|Overall Study|Death|10|||
156645424|NCT02041494|565449658|FG000|Overall Study|Death|1|||
156645425|NCT02041494|565449659|FG001|Overall Study|Death|3|||
156645426|NCT02041494|565449658|FG000|Overall Study|Lost to Follow-up|2|||
156645427|NCT02041494|565449659|FG001|Overall Study|Lost to Follow-up|6|||
156645428|NCT02041494|565449658|FG000|Overall Study|study terminated|16|||
156645429|NCT02041494|565449659|FG001|Overall Study|study terminated|11|||
156645430|NCT03341273|565449660|FG000|Overall Study|Lost to Follow-up|7|||
156645431|NCT03341273|565449661|FG001|Overall Study|Lost to Follow-up|7|||
156645432|NCT03341273|565449660|FG000|Overall Study|Withdrawal by Subject|4|||
156645433|NCT03341273|565449661|FG001|Overall Study|Withdrawal by Subject|2|||
156645434|NCT03341273|565449660|FG000|Overall Study|Physician Decision|1|||
156645435|NCT03341273|565449661|FG001|Overall Study|Physician Decision|0|||
156645436|NCT03341273|565449660|FG000|Overall Study|Protocol Violation|0|||
156645437|NCT03341273|565449661|FG001|Overall Study|Protocol Violation|1|||
156645438|NCT03341273|565449660|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
156645439|NCT03341273|565449661|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
156645440|NCT03341273|565449660|FG000|Overall Study|Became ineligible after enrollment|1|||
156645441|NCT03341273|565449661|FG001|Overall Study|Became ineligible after enrollment|0|||
156645442|NCT03341273|565449660|FG000|Overall Study|Not Eligible at Enrollment|0|||
156645443|NCT03341273|565449661|FG001|Overall Study|Not Eligible at Enrollment|1|||
156645444|NCT03341273|565449660|FG000|Overall Study|Participant incarcerated|1|||
156645445|NCT03341273|565449661|FG001|Overall Study|Participant incarcerated|0|||
156645446|NCT04126733|565449662|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
156645447|NCT04126733|565449662|FG000|Treatment Period|Adverse Event|8|||
156645448|NCT04126733|565449662|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
156645449|NCT04126733|565449662|FG000|Treatment Period|Physician Decision|5|||
156645450|NCT04126733|565449662|FG000|Treatment Period|Death|1|||
156645451|NCT04126733|565449662|FG000|Treatment Period|Other Reasons|2|||
156645452|NCT04126733|565449662|FG000|Active Follow-up Period|Death|13|||
156645453|NCT04126733|565449662|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
156645454|NCT04126733|565449662|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
156645455|NCT04126733|565449662|FG000|Active Follow-up Period|Other Reasons|1|||
156645456|NCT04126733|565449662|FG000|Long-term Follow-up Period|Death|22|||
156645457|NCT04126733|565449662|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
156645458|NCT04126733|565449662|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
156645459|NCT00528879|565449667|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
156645460|NCT00528879|565449668|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
156645461|NCT00528879|565449669|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
156645462|NCT00528879|565449670|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
156645463|NCT00528879|565449667|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
156645464|NCT00528879|565449668|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
156645465|NCT00528879|565449669|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
156645466|NCT00528879|565449670|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
156645467|NCT00528879|565449667|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
156645468|NCT00528879|565449668|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
156645469|NCT00528879|565449669|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
156645470|NCT00528879|565449670|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
156645471|NCT00528879|565449667|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
156645472|NCT00528879|565449668|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
156645473|NCT00528879|565449669|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
156645474|NCT00528879|565449670|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
156645475|NCT00528879|565449667|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
156645476|NCT00528879|565449668|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
156645477|NCT00528879|565449669|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
156645478|NCT00528879|565449670|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
156645479|NCT00528879|565449667|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
156645480|NCT00528879|565449668|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
156645481|NCT00528879|565449669|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
156645482|NCT00528879|565449670|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
156645483|NCT00528879|565449667|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
156645484|NCT00528879|565449668|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
156645485|NCT00528879|565449669|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
156645486|NCT00528879|565449670|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
156645487|NCT00528879|565449667|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
156645488|NCT00528879|565449668|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
156645489|NCT00528879|565449669|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
156645490|NCT00528879|565449670|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
156645491|NCT00528879|565449667|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
156645492|NCT00528879|565449668|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
156645493|NCT00528879|565449669|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
156645494|NCT00528879|565449670|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
156645495|NCT00528879|565449667|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
156645496|NCT00528879|565449668|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
156645497|NCT00528879|565449669|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
156645498|NCT00528879|565449670|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
156645499|NCT00528879|565449667|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
156645500|NCT00528879|565449668|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
156645501|NCT00528879|565449669|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
156645502|NCT00528879|565449670|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
156645503|NCT00528879|565449667|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
156645504|NCT00528879|565449668|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
156645505|NCT00528879|565449669|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
156645506|NCT00528879|565449670|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
156645507|NCT00528879|565449667|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
156645508|NCT00528879|565449668|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
156645509|NCT00528879|565449669|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
156645510|NCT00528879|565449670|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
156645511|NCT00528879|565449667|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
156645512|NCT00528879|565449668|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
156645513|NCT00528879|565449669|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
156645514|NCT00528879|565449670|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
156645515|NCT00528879|565449667|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
156645516|NCT00528879|565449668|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
156645517|NCT00528879|565449669|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
156645518|NCT00528879|565449670|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
156645519|NCT00528879|565449667|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
156645520|NCT00528879|565449668|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
156645521|NCT00528879|565449669|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
156645522|NCT00528879|565449670|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
156645523|NCT01159769|565449673|FG000|Overall Study|Adverse Event|1|||
156645524|NCT01361607|565449674|FG000|Overall Study|Adverse Event|38|||
156645525|NCT01361607|565449675|FG001|Overall Study|Adverse Event|29|||
156645526|NCT01361607|565449674|FG000|Overall Study|Withdrawal by Subject|19|||
156645527|NCT01361607|565449675|FG001|Overall Study|Withdrawal by Subject|8|||
156645528|NCT01361607|565449674|FG000|Overall Study|Withdrawal by Investigator|5|||
156645529|NCT01361607|565449675|FG001|Overall Study|Withdrawal by Investigator|3|||
156645530|NCT01361607|565449674|FG000|Overall Study|Lost to Follow-up|1|||
156645531|NCT01361607|565449675|FG001|Overall Study|Lost to Follow-up|0|||
156645532|NCT01361607|565449674|FG000|Overall Study|Met Withdrawal Criteria|1|||
156645533|NCT01361607|565449675|FG001|Overall Study|Met Withdrawal Criteria|1|||
156645534|NCT01507831|565449676|FG000|Overall Study|Randomized but not treated|0|||
156645535|NCT01507831|565449677|FG001|Overall Study|Randomized but not treated|3|||
156645536|NCT01507831|565449676|FG000|Overall Study|Adverse Event|48|||
156645537|NCT01507831|565449677|FG001|Overall Study|Adverse Event|113|||
156645538|NCT01507831|565449676|FG000|Overall Study|Death|6|||
156645539|NCT01507831|565449677|FG001|Overall Study|Death|2|||
156645540|NCT01507831|565449676|FG000|Overall Study|Poor compliance to protocol|38|||
156645541|NCT01507831|565449677|FG001|Overall Study|Poor compliance to protocol|60|||
156645542|NCT01507831|565449676|FG000|Overall Study|Physician Decision|0|||
156645543|NCT01507831|565449677|FG001|Overall Study|Physician Decision|4|||
156645544|NCT01507831|565449676|FG000|Overall Study|Participant moved|5|||
156645545|NCT01507831|565449677|FG001|Overall Study|Participant moved|19|||
156645546|NCT01507831|565449676|FG000|Overall Study|Consent withdrawn by participant|34|||
156645547|NCT01507831|565449677|FG001|Overall Study|Consent withdrawn by participant|72|||
156645548|NCT01507831|565449676|FG000|Overall Study|Related to study drug administration|5|||
156645549|NCT01507831|565449677|FG001|Overall Study|Related to study drug administration|14|||
156645550|NCT01507831|565449676|FG000|Overall Study|Last visit outside protocol visit window|51|||
156645551|NCT01507831|565449677|FG001|Overall Study|Last visit outside protocol visit window|143|||
156645552|NCT01507831|565449676|FG000|Overall Study|Selection criteria finally not met|0|||
156645553|NCT01507831|565449677|FG001|Overall Study|Selection criteria finally not met|1|||
156645554|NCT01507831|565449676|FG000|Overall Study|Site closure|0|||
156645555|NCT01507831|565449677|FG001|Overall Study|Site closure|3|||
156645556|NCT01507831|565449676|FG000|Overall Study|Potential lost to follow-up|3|||
156645557|NCT01507831|565449677|FG001|Overall Study|Potential lost to follow-up|0|||
156645558|NCT01507831|565449676|FG000|Overall Study|Other|3|||
156645559|NCT01507831|565449677|FG001|Overall Study|Other|6|||
156645560|NCT01280981|565449680|FG000|Overall Study|Withdrawal by Subject|11|||
156645561|NCT01280981|565449680|FG000|Overall Study|Protocol Violation|2|||
156645562|NCT01280981|565449680|FG000|Overall Study|Lack of Efficacy|13|||
156645563|NCT01280981|565449680|FG000|Overall Study|Lost to Follow-up|3|||
156645564|NCT01280981|565449680|FG000|Overall Study|Adverse Event|6|||
156645565|NCT01280981|565449680|FG000|Overall Study|Irregular or discontinued menses|3|||
156645566|NCT01280981|565449680|FG000|Overall Study|Failed to return|45|||
156645567|NCT01280981|565449680|FG000|Overall Study|Non-compliance with protocol|3|||
156645568|NCT01280981|565449680|FG000|Overall Study|Withdrawal of consent|3|||
156645569|NCT01280981|565449680|FG000|Overall Study|Elective surgery|2|||
156645570|NCT01280981|565449680|FG000|Overall Study|Study site closure|1|||
156645571|NCT03056001|565449681|FG000|Overall Study|Death|24|||
156645572|NCT01374906|565449685|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156645573|NCT01374906|565449686|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156645574|NCT01374906|565449685|FG000|Overall Study|Administrative problems|2|||
156645575|NCT01374906|565449686|FG001|Overall Study|Administrative problems|2|||
156645576|NCT01374906|565449685|FG000|Overall Study|Adverse Event|10|||
156645577|NCT01374906|565449686|FG001|Overall Study|Adverse Event|11|||
156645578|NCT01374906|565449685|FG000|Overall Study|Death|0|||
156645579|NCT01374906|565449686|FG001|Overall Study|Death|2|||
156645580|NCT01374906|565449685|FG000|Overall Study|Protocol Violation|2|||
156645581|NCT01374906|565449686|FG001|Overall Study|Protocol Violation|2|||
156645582|NCT01374906|565449685|FG000|Overall Study|Withdrawal by Subject|15|||
156645583|NCT01374906|565449686|FG001|Overall Study|Withdrawal by Subject|9|||
156645584|NCT01374906|565449685|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
156645585|NCT01374906|565449686|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
156645586|NCT00435825|565449689|FG000|Overall Study|Abnormality of Laboratory Test|0|||
156645587|NCT00435825|565449690|FG001|Overall Study|Abnormality of Laboratory Test|1|||
156645588|NCT00435825|565449691|FG002|Overall Study|Abnormality of Laboratory Test|0|||
156645589|NCT00435825|565449692|FG003|Overall Study|Abnormality of Laboratory Test|0|||
156645590|NCT00435825|565449689|FG000|Overall Study|Insufficient Therapeutic Response|3|||
156645591|NCT00435825|565449690|FG001|Overall Study|Insufficient Therapeutic Response|1|||
156645592|NCT00435825|565449691|FG002|Overall Study|Insufficient Therapeutic Response|0|||
156645593|NCT00435825|565449692|FG003|Overall Study|Insufficient Therapeutic Response|3|||
156645594|NCT00435825|565449689|FG000|Overall Study|Other Protocol Violation|1|||
156645595|NCT00435825|565449690|FG001|Overall Study|Other Protocol Violation|0|||
156645596|NCT00435825|565449691|FG002|Overall Study|Other Protocol Violation|0|||
156645597|NCT00435825|565449692|FG003|Overall Study|Other Protocol Violation|0|||
156645598|NCT00435825|565449689|FG000|Overall Study|Refused treatment|2|||
156645599|NCT00435825|565449690|FG001|Overall Study|Refused treatment|0|||
156645600|NCT00435825|565449691|FG002|Overall Study|Refused treatment|0|||
156645601|NCT00435825|565449692|FG003|Overall Study|Refused treatment|5|||
156645602|NCT00435825|565449689|FG000|Overall Study|Failure to return|5|||
156645603|NCT00435825|565449690|FG001|Overall Study|Failure to return|0|||
156645604|NCT00435825|565449691|FG002|Overall Study|Failure to return|4|||
156645605|NCT00435825|565449692|FG003|Overall Study|Failure to return|0|||
156645606|NCT00435825|565449689|FG000|Overall Study|Did not receive study drug|1|||
156645607|NCT00435825|565449690|FG001|Overall Study|Did not receive study drug|0|||
156645608|NCT00435825|565449691|FG002|Overall Study|Did not receive study drug|2|||
156645609|NCT00435825|565449692|FG003|Overall Study|Did not receive study drug|0|||
156645610|NCT00435825|565449689|FG000|Overall Study|Did not enter follow-up|0|||
156645611|NCT00435825|565449690|FG001|Overall Study|Did not enter follow-up|4|||
156338254|NCT05248867|564336596|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156645612|NCT00435825|565449691|FG002|Overall Study|Did not enter follow-up|1|||
156645613|NCT00435825|565449692|FG003|Overall Study|Did not enter follow-up|3|||
156645614|NCT00435825|565449689|FG000|Overall Study|Did not complete full follow-up period|6|||
156645615|NCT00435825|565449690|FG001|Overall Study|Did not complete full follow-up period|6|||
156645616|NCT00435825|565449691|FG002|Overall Study|Did not complete full follow-up period|4|||
156645617|NCT00435825|565449692|FG003|Overall Study|Did not complete full follow-up period|5|||
156645618|NCT02367781|565449695|FG000|Overall Study|Withdrawal by Subject|20|||
156645619|NCT02367781|565449696|FG001|Overall Study|Withdrawal by Subject|13|||
156645620|NCT02367781|565449695|FG000|Overall Study|Protocol Violation|0|||
156645621|NCT02367781|565449696|FG001|Overall Study|Protocol Violation|1|||
156645622|NCT02367781|565449695|FG000|Overall Study|Physician Decision|7|||
156645623|NCT02367781|565449696|FG001|Overall Study|Physician Decision|0|||
156645624|NCT02367781|565449695|FG000|Overall Study|Randomized in Error|5|||
156645625|NCT02367781|565449696|FG001|Overall Study|Randomized in Error|4|||
156645626|NCT02367781|565449695|FG000|Overall Study|Non-Compliance|1|||
156645627|NCT02367781|565449696|FG001|Overall Study|Non-Compliance|0|||
156645628|NCT02367781|565449695|FG000|Overall Study|Lost to Follow-up|1|||
156645629|NCT02367781|565449696|FG001|Overall Study|Lost to Follow-up|2|||
156645630|NCT02367781|565449695|FG000|Overall Study|Death|330|||
156645631|NCT02367781|565449696|FG001|Overall Study|Death|176|||
156645632|NCT02367781|565449695|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
156645633|NCT02367781|565449696|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
156645634|NCT02367781|565449695|FG000|Overall Study|Prolonged Hospitalization|1|||
156645635|NCT02367781|565449696|FG001|Overall Study|Prolonged Hospitalization|0|||
156645636|NCT02367781|565449695|FG000|Overall Study|Death Prior First Dose|1|||
156645637|NCT02367781|565449696|FG001|Overall Study|Death Prior First Dose|0|||
156645638|NCT02367781|565449695|FG000|Overall Study|Administrative-Change Facility|1|||
156645639|NCT02367781|565449696|FG001|Overall Study|Administrative-Change Facility|0|||
156645640|NCT02367781|565449695|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
156645641|NCT02367781|565449696|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
156645642|NCT02367781|565449695|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
156645643|NCT02367781|565449696|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
156645644|NCT02367781|565449695|FG000|Overall Study|Study Terminated by Sponsor|3|||
156645645|NCT02367781|565449696|FG001|Overall Study|Study Terminated by Sponsor|1|||
156645646|NCT02367781|565449695|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
156645647|NCT02367781|565449696|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
156645648|NCT02367781|565449695|FG000|Overall Study|Sponsor Decision|2|||
156645649|NCT02367781|565449696|FG001|Overall Study|Sponsor Decision|0|||
156645650|NCT02367781|565449695|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
156645651|NCT02367781|565449696|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
156645652|NCT00789828|565449697|FG000|Core Period (48 Weeks)|Administrative problems|0|||
156645653|NCT00789828|565449698|FG001|Core Period (48 Weeks)|Administrative problems|1|||
156645654|NCT00789828|565449697|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
156645655|NCT00789828|565449698|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
156645656|NCT00789828|565449697|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
156645657|NCT00789828|565449698|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
156645658|NCT00789828|565449697|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
156645659|NCT00789828|565449698|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
156645660|NCT00789828|565449697|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
156645661|NCT00789828|565449698|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
156645662|NCT00789828|565449697|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
156645663|NCT00789828|565449698|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
156645664|NCT00789828|565449697|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
156645665|NCT00789828|565449698|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
156645666|NCT00789828|565449697|FG000|Open-label Extension Period (4 Years)|Death|1|||
156645667|NCT00789828|565449698|FG001|Open-label Extension Period (4 Years)|Death|0|||
156645668|NCT00789828|565449697|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
156645669|NCT00789828|565449698|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
156645670|NCT00789828|565449697|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
156645671|NCT00789828|565449698|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
156645672|NCT02623426|565449699|FG000|Overall Study|Lost to Follow-up|0|||
156645673|NCT02623426|565449700|FG001|Overall Study|Lost to Follow-up|0|||
156645674|NCT02623426|565449701|FG002|Overall Study|Lost to Follow-up|1|||
156645675|NCT02623426|565449699|FG000|Overall Study|Withdrawal by Subject|1|||
156645676|NCT02623426|565449700|FG001|Overall Study|Withdrawal by Subject|2|||
156645677|NCT02623426|565449701|FG002|Overall Study|Withdrawal by Subject|2|||
156645678|NCT03751124|565449702|FG000|Overall Study|Adverse Event|4|||
156645679|NCT03751124|565449703|FG001|Overall Study|Adverse Event|3|||
156645680|NCT03751124|565449702|FG000|Overall Study|Protocol Deviation|0|||
156645681|NCT03751124|565449703|FG001|Overall Study|Protocol Deviation|1|||
156412197|NCT02065570|564602848|FG002|Maintenance Study|Adverse Event|8|||
156645682|NCT03751124|565449702|FG000|Overall Study|Lost to Follow-up|6|||
156645683|NCT03751124|565449703|FG001|Overall Study|Lost to Follow-up|4|||
156645684|NCT03751124|565449702|FG000|Overall Study|Withdrawal by Subject|6|||
156645685|NCT03751124|565449703|FG001|Overall Study|Withdrawal by Subject|8|||
156645686|NCT03751124|565449702|FG000|Overall Study|Lack of Efficacy|1|||
156645687|NCT03751124|565449703|FG001|Overall Study|Lack of Efficacy|1|||
156645688|NCT03751124|565449702|FG000|Overall Study|Pregnancy|0|||
156645689|NCT03751124|565449703|FG001|Overall Study|Pregnancy|1|||
156645690|NCT03751124|565449702|FG000|Overall Study|Other|9|||
156645691|NCT03751124|565449703|FG001|Overall Study|Other|9|||
156645692|NCT03751124|565449702|FG000|Overall Study|Participants who did not receive any study drug|0|||
156645693|NCT03751124|565449703|FG001|Overall Study|Participants who did not receive any study drug|1|||
156645694|NCT05458895|565449706|FG000|Overall Study|Withdrawal by Subject|8|||
156645695|NCT05458895|565449706|FG000|Overall Study|Lost to Follow-up|17|||
156645696|NCT05458895|565449706|FG000|Overall Study|Pregnancy|2|||
156645697|NCT05458895|565449706|FG000|Overall Study|Withdrawal by Study Team|1|||
156645698|NCT05166421|565449709|FG000|Overall Study|Other|3|||
156645699|NCT05166421|565449710|FG001|Overall Study|Other|1|||
156645700|NCT05166421|565449711|FG002|Overall Study|Other|1|||
156645701|NCT05166421|565449709|FG000|Overall Study|Withdrawal by Subject|5|||
156645702|NCT05166421|565449710|FG001|Overall Study|Withdrawal by Subject|3|||
156645703|NCT05166421|565449711|FG002|Overall Study|Withdrawal by Subject|6|||
156645704|NCT05166421|565449709|FG000|Overall Study|Lost to Follow-up|4|||
156645705|NCT05166421|565449710|FG001|Overall Study|Lost to Follow-up|1|||
156645706|NCT05166421|565449711|FG002|Overall Study|Lost to Follow-up|7|||
156645707|NCT02236754|565451630|FG000|Overall Study|Withdrawal by Subject|1|||
156645708|NCT02236754|565451631|FG001|Overall Study|Withdrawal by Subject|0|||
156645709|NCT00623623|565451632|FG000|Overall Study|Previous enrolment into this study|1|||
156645710|NCT00623623|565451633|FG001|Overall Study|Previous enrolment into this study|1|||
156645711|NCT00693784|565451635|FG000|Overall Study|Lost to Follow-up|2|||
156645712|NCT00693784|565451635|FG000|Overall Study|Withdrawal by Subject|2|||
156645713|NCT02265952|565451636|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
156645714|NCT02265952|565451637|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
156645715|NCT02265952|565451636|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
156645716|NCT02265952|565451637|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
156645717|NCT00326885|565451641|FG000|Overall Study|Adverse Event|1|||
156645718|NCT00326885|565451641|FG000|Overall Study|Withdrawal by Subject|3|||
156645719|NCT00326885|565451641|FG000|Overall Study|Physician Decision|1|||
156645720|NCT00326885|565451641|FG000|Overall Study|Hospice withdrew consent|2|||
156645721|NCT03870997|565451654|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
156645722|NCT03870997|565451655|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
156645723|NCT03870997|565451656|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
156645724|NCT03870997|565451657|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
156645725|NCT03870997|565451658|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
156645726|NCT03870997|565451659|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
156645727|NCT03726437|565451660|FG000|Overall Study|Lost to Follow-up|85|||
156645728|NCT03726437|565451661|FG001|Overall Study|Lost to Follow-up|76|||
156645729|NCT00267007|565451662|FG000|Overall Study|Withdrawal by Subject|6|||
156645730|NCT00267007|565451663|FG001|Overall Study|Withdrawal by Subject|0|||
156645731|NCT00267007|565451662|FG000|Overall Study|Lost to Follow-up|1|||
156645732|NCT00267007|565451663|FG001|Overall Study|Lost to Follow-up|0|||
156645733|NCT00267007|565451662|FG000|Overall Study|Non-compliance|0|||
156645734|NCT00267007|565451663|FG001|Overall Study|Non-compliance|1|||
156645735|NCT00267007|565451662|FG000|Overall Study|Adverse Event|1|||
156645736|NCT00267007|565451663|FG001|Overall Study|Adverse Event|0|||
156645737|NCT04133519|565451669|FG000|Overall Study|Withdrawal by Subject|5|||
156645738|NCT04133519|565451670|FG001|Overall Study|Withdrawal by Subject|4|||
156645739|NCT04133519|565451669|FG000|Overall Study|Protocol Violation|0|||
156645740|NCT04133519|565451670|FG001|Overall Study|Protocol Violation|1|||
156645741|NCT04133519|565451669|FG000|Overall Study|Never started treatment|1|||
156645742|NCT04133519|565451670|FG001|Overall Study|Never started treatment|1|||
156645743|NCT00950599|565451671|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645744|NCT00950599|565451672|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645745|NCT00950599|565451673|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645746|NCT00950599|565451674|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
156645747|NCT00950599|565451675|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645748|NCT00950599|565451676|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645749|NCT00950599|565451677|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645750|NCT00950599|565451678|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645751|NCT00950599|565451679|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645752|NCT00950599|565451680|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
156645753|NCT00950599|565451671|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156645754|NCT00950599|565451672|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156645755|NCT00950599|565451673|FG002|Double-Blind Treatment Period|Adverse Event|1|||
156645756|NCT00950599|565451674|FG003|Double-Blind Treatment Period|Adverse Event|1|||
156645757|NCT00950599|565451675|FG004|Double-Blind Treatment Period|Adverse Event|1|||
156645758|NCT00950599|565451676|FG005|Double-Blind Treatment Period|Adverse Event|1|||
156645759|NCT00950599|565451677|FG006|Double-Blind Treatment Period|Adverse Event|0|||
156645760|NCT00950599|565451678|FG007|Double-Blind Treatment Period|Adverse Event|0|||
156645761|NCT00950599|565451679|FG008|Double-Blind Treatment Period|Adverse Event|0|||
156645762|NCT00950599|565451680|FG009|Double-Blind Treatment Period|Adverse Event|0|||
156645763|NCT00950599|565451671|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
156645764|NCT00950599|565451672|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
156645765|NCT00950599|565451673|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
156645766|NCT00950599|565451674|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
156645767|NCT00950599|565451675|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
156645768|NCT00950599|565451676|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
156645769|NCT00950599|565451677|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
156645770|NCT00950599|565451678|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
156645771|NCT00950599|565451679|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
156645772|NCT00950599|565451680|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
156645773|NCT00950599|565451671|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156645774|NCT00950599|565451672|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
156645775|NCT00950599|565451673|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
156645776|NCT00950599|565451674|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
156645777|NCT00950599|565451675|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
156645778|NCT00950599|565451676|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
156645779|NCT00950599|565451677|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
156645780|NCT00950599|565451678|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
156645781|NCT00950599|565451679|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
156645782|NCT00950599|565451680|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
156645783|NCT00950599|565451671|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
156645784|NCT00950599|565451672|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
156645785|NCT00950599|565451673|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
156645786|NCT00950599|565451674|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
156645787|NCT00950599|565451675|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
156645788|NCT00950599|565451676|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
156645789|NCT00950599|565451677|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
156645790|NCT00950599|565451678|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
156645791|NCT00950599|565451679|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
156645792|NCT00950599|565451680|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
156645793|NCT00950599|565451671|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
156645794|NCT00950599|565451672|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
156645795|NCT00950599|565451673|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
156645796|NCT00950599|565451674|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
156645797|NCT00950599|565451675|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
156645798|NCT00950599|565451676|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
156645799|NCT00950599|565451677|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
156645800|NCT00950599|565451678|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
156645801|NCT00950599|565451679|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
156645802|NCT00950599|565451680|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
156645803|NCT00950599|565451671|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
156645804|NCT00950599|565451672|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
156645805|NCT00950599|565451673|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
156645806|NCT00950599|565451674|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
156645807|NCT00950599|565451675|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
156645808|NCT00950599|565451676|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
156645809|NCT00950599|565451677|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
156645810|NCT00950599|565451678|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
156645811|NCT00950599|565451679|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
156645812|NCT00950599|565451680|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
156645813|NCT00950599|565451671|FG000|Follow-Up Period|Adverse Event|0|||
156645814|NCT00950599|565451672|FG001|Follow-Up Period|Adverse Event|0|||
156645815|NCT00950599|565451673|FG002|Follow-Up Period|Adverse Event|0|||
156645816|NCT00950599|565451674|FG003|Follow-Up Period|Adverse Event|0|||
156645817|NCT00950599|565451675|FG004|Follow-Up Period|Adverse Event|0|||
156645818|NCT00950599|565451676|FG005|Follow-Up Period|Adverse Event|0|||
156645819|NCT00950599|565451677|FG006|Follow-Up Period|Adverse Event|0|||
156645820|NCT00950599|565451678|FG007|Follow-Up Period|Adverse Event|0|||
156645821|NCT00950599|565451679|FG008|Follow-Up Period|Adverse Event|1|||
156645822|NCT00950599|565451680|FG009|Follow-Up Period|Adverse Event|0|||
156645823|NCT00950599|565451671|FG000|Follow-Up Period|Lack of Efficacy|0|||
156645824|NCT00950599|565451672|FG001|Follow-Up Period|Lack of Efficacy|0|||
156645825|NCT00950599|565451673|FG002|Follow-Up Period|Lack of Efficacy|0|||
156645826|NCT00950599|565451674|FG003|Follow-Up Period|Lack of Efficacy|0|||
156645827|NCT00950599|565451675|FG004|Follow-Up Period|Lack of Efficacy|0|||
156645828|NCT00950599|565451676|FG005|Follow-Up Period|Lack of Efficacy|0|||
156645829|NCT00950599|565451677|FG006|Follow-Up Period|Lack of Efficacy|0|||
156645830|NCT00950599|565451678|FG007|Follow-Up Period|Lack of Efficacy|0|||
156645831|NCT00950599|565451679|FG008|Follow-Up Period|Lack of Efficacy|3|||
156645832|NCT00950599|565451680|FG009|Follow-Up Period|Lack of Efficacy|0|||
156645833|NCT00950599|565451671|FG000|Follow-Up Period|Lost to Follow-up|0|||
156645834|NCT00950599|565451672|FG001|Follow-Up Period|Lost to Follow-up|0|||
156645835|NCT00950599|565451673|FG002|Follow-Up Period|Lost to Follow-up|0|||
156645836|NCT00950599|565451674|FG003|Follow-Up Period|Lost to Follow-up|0|||
156645837|NCT00950599|565451675|FG004|Follow-Up Period|Lost to Follow-up|0|||
156645838|NCT00950599|565451676|FG005|Follow-Up Period|Lost to Follow-up|0|||
156645839|NCT00950599|565451677|FG006|Follow-Up Period|Lost to Follow-up|0|||
156645840|NCT00950599|565451678|FG007|Follow-Up Period|Lost to Follow-up|0|||
156645841|NCT00950599|565451679|FG008|Follow-Up Period|Lost to Follow-up|5|||
156645842|NCT00950599|565451680|FG009|Follow-Up Period|Lost to Follow-up|1|||
156645843|NCT00950599|565451671|FG000|Follow-Up Period|Physician Decision|0|||
156645844|NCT00950599|565451672|FG001|Follow-Up Period|Physician Decision|0|||
156645845|NCT00950599|565451673|FG002|Follow-Up Period|Physician Decision|0|||
156645846|NCT00950599|565451674|FG003|Follow-Up Period|Physician Decision|0|||
156645847|NCT00950599|565451675|FG004|Follow-Up Period|Physician Decision|0|||
156645848|NCT00950599|565451676|FG005|Follow-Up Period|Physician Decision|0|||
156645849|NCT00950599|565451677|FG006|Follow-Up Period|Physician Decision|0|||
156645850|NCT00950599|565451678|FG007|Follow-Up Period|Physician Decision|0|||
156645851|NCT00950599|565451679|FG008|Follow-Up Period|Physician Decision|1|||
156645852|NCT00950599|565451680|FG009|Follow-Up Period|Physician Decision|0|||
156645853|NCT00950599|565451671|FG000|Follow-Up Period|Poor/Noncompliance|0|||
156645854|NCT00950599|565451672|FG001|Follow-Up Period|Poor/Noncompliance|0|||
156645855|NCT00950599|565451673|FG002|Follow-Up Period|Poor/Noncompliance|0|||
156645856|NCT00950599|565451674|FG003|Follow-Up Period|Poor/Noncompliance|0|||
156645857|NCT00950599|565451675|FG004|Follow-Up Period|Poor/Noncompliance|0|||
156645858|NCT00950599|565451676|FG005|Follow-Up Period|Poor/Noncompliance|0|||
156645859|NCT00950599|565451677|FG006|Follow-Up Period|Poor/Noncompliance|0|||
156645860|NCT00950599|565451678|FG007|Follow-Up Period|Poor/Noncompliance|0|||
156645861|NCT00950599|565451679|FG008|Follow-Up Period|Poor/Noncompliance|1|||
156645862|NCT00950599|565451680|FG009|Follow-Up Period|Poor/Noncompliance|0|||
156645863|NCT00950599|565451671|FG000|Follow-Up Period|Subject withdrew Consent|0|||
156645864|NCT00950599|565451672|FG001|Follow-Up Period|Subject withdrew Consent|0|||
156645865|NCT00950599|565451673|FG002|Follow-Up Period|Subject withdrew Consent|0|||
156645866|NCT00950599|565451674|FG003|Follow-Up Period|Subject withdrew Consent|0|||
156645867|NCT00950599|565451675|FG004|Follow-Up Period|Subject withdrew Consent|0|||
156645868|NCT00950599|565451676|FG005|Follow-Up Period|Subject withdrew Consent|0|||
156645869|NCT00950599|565451677|FG006|Follow-Up Period|Subject withdrew Consent|0|||
156645870|NCT00950599|565451678|FG007|Follow-Up Period|Subject withdrew Consent|0|||
156645871|NCT00950599|565451679|FG008|Follow-Up Period|Subject withdrew Consent|2|||
156645872|NCT00950599|565451680|FG009|Follow-Up Period|Subject withdrew Consent|1|||
156645873|NCT02570165|565451686|FG000|Overall Study|Adverse Event|1|||
156645874|NCT02570165|565451687|FG001|Overall Study|Adverse Event|0|||
156645875|NCT02570165|565451688|FG002|Overall Study|Adverse Event|2|||
156645876|NCT02570165|565451689|FG003|Overall Study|Adverse Event|0|||
156645877|NCT02570165|565451690|FG004|Overall Study|Adverse Event|0|||
156645878|NCT02570165|565451691|FG005|Overall Study|Adverse Event|0|||
156645879|NCT02570165|565451692|FG006|Overall Study|Adverse Event|0|||
156645880|NCT02570165|565451686|FG000|Overall Study|Lack of Efficacy|0|||
156645881|NCT02570165|565451687|FG001|Overall Study|Lack of Efficacy|1|||
156645882|NCT02570165|565451688|FG002|Overall Study|Lack of Efficacy|0|||
156645883|NCT02570165|565451689|FG003|Overall Study|Lack of Efficacy|0|||
156645884|NCT02570165|565451690|FG004|Overall Study|Lack of Efficacy|4|||
156645885|NCT02570165|565451691|FG005|Overall Study|Lack of Efficacy|0|||
156645886|NCT02570165|565451692|FG006|Overall Study|Lack of Efficacy|0|||
156645887|NCT02570165|565451686|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
156645888|NCT02570165|565451687|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
156645889|NCT02570165|565451688|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
156645890|NCT02570165|565451689|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
156645891|NCT02570165|565451690|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
156645892|NCT02570165|565451691|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
156645893|NCT02570165|565451692|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
156645894|NCT02570165|565451686|FG000|Overall Study|Lost to Follow-up|0|||
156645895|NCT02570165|565451687|FG001|Overall Study|Lost to Follow-up|0|||
156645896|NCT02570165|565451688|FG002|Overall Study|Lost to Follow-up|1|||
156645897|NCT02570165|565451689|FG003|Overall Study|Lost to Follow-up|1|||
156645898|NCT02570165|565451690|FG004|Overall Study|Lost to Follow-up|0|||
156645899|NCT02570165|565451691|FG005|Overall Study|Lost to Follow-up|0|||
156645900|NCT02570165|565451692|FG006|Overall Study|Lost to Follow-up|0|||
156645901|NCT02570165|565451686|FG000|Overall Study|Physician Decision|0|||
156645902|NCT02570165|565451687|FG001|Overall Study|Physician Decision|1|||
156645903|NCT02570165|565451688|FG002|Overall Study|Physician Decision|0|||
156645904|NCT02570165|565451689|FG003|Overall Study|Physician Decision|0|||
156645905|NCT02570165|565451690|FG004|Overall Study|Physician Decision|0|||
156645906|NCT02570165|565451691|FG005|Overall Study|Physician Decision|0|||
156645907|NCT02570165|565451692|FG006|Overall Study|Physician Decision|0|||
156645908|NCT02570165|565451686|FG000|Overall Study|Withdrawal by Subject|0|||
156645909|NCT02570165|565451687|FG001|Overall Study|Withdrawal by Subject|0|||
156645910|NCT02570165|565451688|FG002|Overall Study|Withdrawal by Subject|0|||
156645911|NCT02570165|565451689|FG003|Overall Study|Withdrawal by Subject|2|||
156645912|NCT02570165|565451690|FG004|Overall Study|Withdrawal by Subject|1|||
156645913|NCT02570165|565451691|FG005|Overall Study|Withdrawal by Subject|0|||
156645914|NCT02570165|565451692|FG006|Overall Study|Withdrawal by Subject|0|||
156645915|NCT02570165|565451686|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
156645916|NCT02570165|565451687|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
156645917|NCT02570165|565451688|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
156645918|NCT02570165|565451689|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
156645919|NCT02570165|565451690|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
156645920|NCT02570165|565451691|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
156645921|NCT02570165|565451692|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
156645922|NCT02570165|565451686|FG000|Overall Study|Withdrawal Request by GSK|0|||
156645923|NCT02570165|565451687|FG001|Overall Study|Withdrawal Request by GSK|0|||
156645924|NCT02570165|565451688|FG002|Overall Study|Withdrawal Request by GSK|2|||
156645925|NCT02570165|565451689|FG003|Overall Study|Withdrawal Request by GSK|0|||
156645926|NCT02570165|565451690|FG004|Overall Study|Withdrawal Request by GSK|0|||
156645927|NCT02570165|565451691|FG005|Overall Study|Withdrawal Request by GSK|0|||
156645928|NCT02570165|565451692|FG006|Overall Study|Withdrawal Request by GSK|0|||
156645929|NCT01252238|565451697|FG000|Overall Study|Sponsor terminated study|4|||
156645930|NCT01252238|565451698|FG001|Overall Study|Sponsor terminated study|4|||
156645931|NCT01252238|565451699|FG002|Overall Study|Sponsor terminated study|4|||
156645932|NCT01610167|565451700|FG000|Overall Study|Scheduling conflict.|0|||
156645933|NCT01610167|565451701|FG001|Overall Study|Scheduling conflict.|0|||
156645934|NCT01610167|565451702|FG002|Overall Study|Scheduling conflict.|2|||
156645935|NCT03276962|565451708|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
156645936|NCT03276962|565451709|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
156645937|NCT03276962|565451710|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
156645938|NCT03276962|565451711|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
156645939|NCT03276962|565451712|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
156645940|NCT03276962|565451708|FG000|Overall Study|Protocol Deviation|2|||
156645941|NCT03276962|565451709|FG001|Overall Study|Protocol Deviation|0|||
156645942|NCT03276962|565451710|FG002|Overall Study|Protocol Deviation|1|||
156645943|NCT03276962|565451711|FG003|Overall Study|Protocol Deviation|2|||
156645944|NCT03276962|565451712|FG004|Overall Study|Protocol Deviation|1|||
156645945|NCT03276962|565451708|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
156645946|NCT03276962|565451709|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
156645947|NCT03276962|565451710|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
156645948|NCT03276962|565451711|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
156645949|NCT03276962|565451712|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
156645950|NCT03276962|565451708|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
156645951|NCT03276962|565451709|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
156645952|NCT03276962|565451710|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
156645953|NCT03276962|565451711|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
156645954|NCT03276962|565451712|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
156645955|NCT03276962|565451708|FG000|Overall Study|Lost to Follow-up|10|||
156645956|NCT03276962|565451709|FG001|Overall Study|Lost to Follow-up|10|||
156645957|NCT03276962|565451710|FG002|Overall Study|Lost to Follow-up|4|||
156645958|NCT03276962|565451711|FG003|Overall Study|Lost to Follow-up|6|||
156645959|NCT03276962|565451712|FG004|Overall Study|Lost to Follow-up|10|||
156645960|NCT03276962|565451708|FG000|Overall Study|Other|0|||
156645961|NCT03276962|565451709|FG001|Overall Study|Other|2|||
156645962|NCT03276962|565451710|FG002|Overall Study|Other|0|||
156645963|NCT03276962|565451711|FG003|Overall Study|Other|2|||
156645964|NCT03276962|565451712|FG004|Overall Study|Other|1|||
156645965|NCT00411762|565451713|FG000|Overall Study|Withdrawal by Subject|5|||
156645966|NCT04428502|565451714|FG000|Overall Study|Did not meet entrance criteria|14|||
156645967|NCT01358708|565451715|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
156645968|NCT01358708|565451716|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156645969|NCT01358708|565451715|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
156645970|NCT01358708|565451716|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
156645971|NCT01364298|565451720|FG000|Overall Study|Adverse Event|3|||
156645972|NCT01364298|565451721|FG001|Overall Study|Adverse Event|4|||
156645973|NCT01364298|565451720|FG000|Overall Study|Lack of adherence to treatment|1|||
156645974|NCT01364298|565451721|FG001|Overall Study|Lack of adherence to treatment|3|||
156645975|NCT01364298|565451720|FG000|Overall Study|Lack of Efficacy|1|||
156645976|NCT01364298|565451721|FG001|Overall Study|Lack of Efficacy|0|||
156645977|NCT01364298|565451720|FG000|Overall Study|Lost to Follow-up|5|||
156645978|NCT01364298|565451721|FG001|Overall Study|Lost to Follow-up|10|||
156645979|NCT01364298|565451720|FG000|Overall Study|Withdrawal by Subject|3|||
156645980|NCT01364298|565451721|FG001|Overall Study|Withdrawal by Subject|3|||
156645981|NCT01364298|565451720|FG000|Overall Study|Other|1|||
156645982|NCT01364298|565451721|FG001|Overall Study|Other|3|||
156645983|NCT00869089|565451731|FG000|Overall Study|Lost to Follow-up|1|||
156645984|NCT00869089|565451731|FG000|Overall Study|Withdrawal by Subject|1|||
156645985|NCT00869089|565451731|FG000|Overall Study|Screen Fail|1|||
156645986|NCT05037409|565451734|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
156645987|NCT05037409|565451735|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
156645988|NCT05037409|565451736|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
156645989|NCT03499249|565451737|FG000|Overall Study|Physician Decision|1|||
156645990|NCT02475980|565451742|FG000|Overall Study|Lost to Follow-up|4|||
156645991|NCT02475980|565451742|FG000|Overall Study|Withdrawal by Subject|1|||
156645992|NCT05003167|565451750|FG000|Overall Study|Withdrawal by Subject|1|||
156645993|NCT00430638|565451751|FG000|Overall Study|Adverse Event|15|||
156645994|NCT00430638|565451752|FG001|Overall Study|Adverse Event|15|||
156645995|NCT00430638|565451751|FG000|Overall Study|Uncontrolled blood pressure|48|||
156645996|NCT00430638|565451752|FG001|Overall Study|Uncontrolled blood pressure|13|||
156645997|NCT00430638|565451751|FG000|Overall Study|Lost to Follow-up|1|||
156645998|NCT00430638|565451752|FG001|Overall Study|Lost to Follow-up|7|||
156645999|NCT00430638|565451751|FG000|Overall Study|Protocol Violation|6|||
156646000|NCT00430638|565451752|FG001|Overall Study|Protocol Violation|4|||
156646001|NCT00430638|565451751|FG000|Overall Study|Withdrawal by Subject|4|||
156646002|NCT00430638|565451752|FG001|Overall Study|Withdrawal by Subject|6|||
156646003|NCT00430638|565451751|FG000|Overall Study|Non-compliant|2|||
156646004|NCT00430638|565451752|FG001|Overall Study|Non-compliant|1|||
156646005|NCT00430638|565451751|FG000|Overall Study|Other|2|||
156646006|NCT00430638|565451752|FG001|Overall Study|Other|2|||
156646007|NCT01529749|565451753|FG000|Overall Study|Lost to Follow-up|0|||
156646008|NCT01529749|565451754|FG001|Overall Study|Lost to Follow-up|1|||
156646009|NCT01529749|565451755|FG002|Overall Study|Lost to Follow-up|1|||
156646010|NCT01529749|565451756|FG003|Overall Study|Lost to Follow-up|0|||
156646011|NCT01529749|565451753|FG000|Overall Study|Physician Decision|0|||
156646012|NCT01529749|565451754|FG001|Overall Study|Physician Decision|0|||
156646013|NCT01529749|565451755|FG002|Overall Study|Physician Decision|0|||
156646014|NCT01529749|565451756|FG003|Overall Study|Physician Decision|1|||
156646015|NCT01529749|565451753|FG000|Overall Study|Withdrawal by Subject|0|||
156646016|NCT01529749|565451754|FG001|Overall Study|Withdrawal by Subject|1|||
156646017|NCT01529749|565451755|FG002|Overall Study|Withdrawal by Subject|1|||
156646018|NCT01529749|565451756|FG003|Overall Study|Withdrawal by Subject|0|||
156646019|NCT01529749|565451753|FG000|Overall Study|Protocol Violation|0|||
156646020|NCT01529749|565451754|FG001|Overall Study|Protocol Violation|0|||
156646021|NCT01529749|565451755|FG002|Overall Study|Protocol Violation|0|||
156646022|NCT01529749|565451756|FG003|Overall Study|Protocol Violation|1|||
156646023|NCT02094937|565451757|FG000|8 Weeks in Period 1|Adverse Event|9|||
156646024|NCT02094937|565451758|FG001|8 Weeks in Period 1|Adverse Event|0|||
156646025|NCT02094937|565451759|FG002|8 Weeks in Period 1|Adverse Event|0|||
156646026|NCT02094937|565451760|FG003|8 Weeks in Period 1|Adverse Event|0|||
156646027|NCT02094937|565451757|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
156646028|NCT02094937|565451758|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
156646029|NCT02094937|565451759|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
156646030|NCT02094937|565451760|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
156646031|NCT02094937|565451757|FG000|8 Weeks in Period 1|Protocol Violation|2|||
156646032|NCT02094937|565451758|FG001|8 Weeks in Period 1|Protocol Violation|0|||
156646033|NCT02094937|565451759|FG002|8 Weeks in Period 1|Protocol Violation|0|||
156646034|NCT02094937|565451760|FG003|8 Weeks in Period 1|Protocol Violation|0|||
156646035|NCT02094937|565451757|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
156646036|NCT02094937|565451758|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
156646037|NCT02094937|565451759|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
156646038|NCT02094937|565451760|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
156646039|NCT02094937|565451757|FG000|8 Weeks in Period 1|Physician Decision|1|||
156646040|NCT02094937|565451758|FG001|8 Weeks in Period 1|Physician Decision|0|||
156646041|NCT02094937|565451759|FG002|8 Weeks in Period 1|Physician Decision|0|||
156646042|NCT02094937|565451760|FG003|8 Weeks in Period 1|Physician Decision|0|||
156646043|NCT02094937|565451757|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
156646044|NCT02094937|565451758|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
156646045|NCT02094937|565451759|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
156646046|NCT02094937|565451760|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
156412198|NCT02065570|564602849|FG003|Maintenance Study|Adverse Event|8|||
156646047|NCT02094937|565451757|FG000|12 Weeks in Period 2|Adverse Event|0|||
156646048|NCT02094937|565451758|FG001|12 Weeks in Period 2|Adverse Event|2|||
156646049|NCT02094937|565451759|FG002|12 Weeks in Period 2|Adverse Event|4|||
156646050|NCT02094937|565451760|FG003|12 Weeks in Period 2|Adverse Event|1|||
156646051|NCT02094937|565451757|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
156646052|NCT02094937|565451758|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
156646053|NCT02094937|565451759|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
156646054|NCT02094937|565451760|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
156646055|NCT02094937|565451757|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
156646056|NCT02094937|565451758|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
156646057|NCT02094937|565451759|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
156646058|NCT02094937|565451760|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
156646059|NCT02094937|565451757|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
156646060|NCT02094937|565451758|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
156646061|NCT02094937|565451759|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
156646062|NCT02094937|565451760|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
156646063|NCT02094937|565451757|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
156646064|NCT02094937|565451758|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
156646065|NCT02094937|565451759|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
156646066|NCT02094937|565451760|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
156646067|NCT01133392|565451761|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
156646068|NCT01133392|565451762|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
156646069|NCT01133392|565451761|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
156646070|NCT01133392|565451762|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
156646071|NCT00378482|565451763|FG000|Overall Study|Lost to Follow-up|1|||
156646072|NCT00378482|565451763|FG000|Overall Study|Lack of Efficacy|8|||
156646073|NCT00378482|565451763|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
156646074|NCT00378482|565451763|FG000|Overall Study|Withdrawal by Subject|4|||
156646075|NCT00378482|565451763|FG000|Overall Study|Adverse Event|9|||
156646076|NCT00555399|565451769|FG000|Overall Study|Withdrawal by Subject|0|||
156646077|NCT00555399|565451770|FG001|Overall Study|Withdrawal by Subject|0|||
156646078|NCT00555399|565451771|FG002|Overall Study|Withdrawal by Subject|1|||
156646079|NCT00555399|565451772|FG003|Overall Study|Withdrawal by Subject|0|||
156646080|NCT00555399|565451773|FG004|Overall Study|Withdrawal by Subject|0|||
156646081|NCT00555399|565451774|FG005|Overall Study|Withdrawal by Subject|0|||
156646082|NCT00555399|565451775|FG006|Overall Study|Withdrawal by Subject|0|||
156646083|NCT00555399|565451776|FG007|Overall Study|Withdrawal by Subject|0|||
156646084|NCT00555399|565451777|FG008|Overall Study|Withdrawal by Subject|0|||
156646085|NCT00555399|565451778|FG009|Overall Study|Withdrawal by Subject|0|||
156646086|NCT00555399|565451779|FG010|Overall Study|Withdrawal by Subject|0|||
156646087|NCT00555399|565451780|FG011|Overall Study|Withdrawal by Subject|1|||
156646088|NCT00555399|565451769|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
156646089|NCT00555399|565451770|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
156646090|NCT00555399|565451771|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
156646091|NCT00555399|565451772|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
156646092|NCT00555399|565451773|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
156646093|NCT00555399|565451774|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
156646094|NCT00555399|565451775|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
156646095|NCT00555399|565451776|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
156646096|NCT00555399|565451777|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
156646097|NCT00555399|565451778|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
156646098|NCT00555399|565451779|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
156646099|NCT00555399|565451780|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
156646100|NCT04639310|565451781|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
156646101|NCT04639310|565451782|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
156646102|NCT00343642|565453186|FG000|Overall Study|Lost to Follow-up|0|||
156646103|NCT00343642|565453187|FG001|Overall Study|Lost to Follow-up|1|||
156646104|NCT00343642|565453188|FG002|Overall Study|Lost to Follow-up|0|||
156646105|NCT00343642|565453186|FG000|Overall Study|Pregnancy|1|||
156646106|NCT00343642|565453187|FG001|Overall Study|Pregnancy|0|||
156646107|NCT00343642|565453188|FG002|Overall Study|Pregnancy|2|||
156646108|NCT00343642|565453186|FG000|Overall Study|Withdrawal by Subject|2|||
156646109|NCT00343642|565453187|FG001|Overall Study|Withdrawal by Subject|3|||
156646110|NCT00343642|565453188|FG002|Overall Study|Withdrawal by Subject|4|||
156646111|NCT00343642|565453186|FG000|Overall Study|Adverse Event|0|||
156646112|NCT00343642|565453187|FG001|Overall Study|Adverse Event|0|||
156646113|NCT00343642|565453188|FG002|Overall Study|Adverse Event|1|||
156646114|NCT00343642|565453186|FG000|Overall Study|Flare up|6|||
156412199|NCT02065570|564602846|FG000|Maintenance Study|Withdrawal by Subject|0|||
156646115|NCT00343642|565453187|FG001|Overall Study|Flare up|4|||
156646116|NCT00343642|565453188|FG002|Overall Study|Flare up|0|||
156646117|NCT01963676|565453189|FG000|Overall Study|Withdrawal by Subject|1|||
156646118|NCT01963676|565453190|FG001|Overall Study|Withdrawal by Subject|0|||
156646119|NCT00766506|565453191|FG000|Overall Study|Use rescue medication after 3 hours|3|||
156646120|NCT00766506|565453192|FG001|Overall Study|Use rescue medication after 3 hours|0|||
156646121|NCT00766506|565453191|FG000|Overall Study|Other|2|||
156646122|NCT00766506|565453192|FG001|Overall Study|Other|2|||
156646123|NCT03262233|565453193|FG000|Overall Study|Withdrawal by Subject|12|||
156646124|NCT03262233|565453194|FG001|Overall Study|Withdrawal by Subject|8|||
156646125|NCT03262233|565453195|FG002|Overall Study|Withdrawal by Subject|21|||
156646126|NCT03262233|565453196|FG003|Overall Study|Withdrawal by Subject|13|||
156646127|NCT03262233|565453193|FG000|Overall Study|Declined due to shock|1|||
156646128|NCT03262233|565453194|FG001|Overall Study|Declined due to shock|2|||
156646129|NCT03262233|565453195|FG002|Overall Study|Declined due to shock|2|||
156646130|NCT03262233|565453196|FG003|Overall Study|Declined due to shock|3|||
156646131|NCT03262233|565453193|FG000|Overall Study|Protocol Violation|5|||
156646132|NCT03262233|565453194|FG001|Overall Study|Protocol Violation|10|||
156646133|NCT03262233|565453195|FG002|Overall Study|Protocol Violation|2|||
156646134|NCT03262233|565453196|FG003|Overall Study|Protocol Violation|13|||
156646135|NCT03262233|565453193|FG000|Overall Study|data collection artifact|0|||
156646136|NCT03262233|565453194|FG001|Overall Study|data collection artifact|1|||
156646137|NCT03262233|565453195|FG002|Overall Study|data collection artifact|0|||
156646138|NCT03262233|565453196|FG003|Overall Study|data collection artifact|0|||
156646139|NCT01165242|565453199|FG000|Overall Study|Unreachable Subjects|1|||
156646140|NCT01165242|565453200|FG001|Overall Study|Unreachable Subjects|0|||
156646141|NCT01165242|565453201|FG002|Overall Study|Unreachable Subjects|0|||
156646142|NCT01165242|565453199|FG000|Overall Study|Incarcerated Subjects|0|||
156646143|NCT01165242|565453200|FG001|Overall Study|Incarcerated Subjects|1|||
156646144|NCT01165242|565453201|FG002|Overall Study|Incarcerated Subjects|0|||
156646145|NCT01165242|565453199|FG000|Overall Study|Visit 2 Declined by Subject|0|||
156646146|NCT01165242|565453200|FG001|Overall Study|Visit 2 Declined by Subject|0|||
156646147|NCT01165242|565453201|FG002|Overall Study|Visit 2 Declined by Subject|1|||
156646148|NCT01165242|565453199|FG000|Overall Study|Withdrawal by Subject|0|||
156646149|NCT01165242|565453200|FG001|Overall Study|Withdrawal by Subject|2|||
156646150|NCT01165242|565453201|FG002|Overall Study|Withdrawal by Subject|2|||
156646151|NCT01165242|565453199|FG000|Overall Study|Extended Holiday|0|||
156646152|NCT01165242|565453200|FG001|Overall Study|Extended Holiday|0|||
156646153|NCT01165242|565453201|FG002|Overall Study|Extended Holiday|1|||
156646154|NCT01165242|565453199|FG000|Overall Study|Lost to Follow-up|9|||
156646155|NCT01165242|565453200|FG001|Overall Study|Lost to Follow-up|7|||
156646156|NCT01165242|565453201|FG002|Overall Study|Lost to Follow-up|10|||
156646157|NCT03877237|565453202|FG000|Overall Study|Adverse Event|1|||
156646158|NCT03877237|565453203|FG001|Overall Study|Adverse Event|2|||
156646159|NCT03877237|565453202|FG000|Overall Study|Death|3|||
156646160|NCT03877237|565453203|FG001|Overall Study|Death|2|||
156646161|NCT03877237|565453202|FG000|Overall Study|Physician Decision|1|||
156646162|NCT03877237|565453203|FG001|Overall Study|Physician Decision|0|||
156646163|NCT03877237|565453202|FG000|Overall Study|Withdrawal by Subject|0|||
156646164|NCT03877237|565453203|FG001|Overall Study|Withdrawal by Subject|2|||
156646165|NCT03372083|565453205|FG000|Overall Study|Adverse Event|3|||
156646166|NCT03372083|565453205|FG000|Overall Study|Physician Decision|1|||
156646167|NCT03372083|565453205|FG000|Overall Study|Withdrawal by Subject|1|||
156646168|NCT00566098|565453206|FG000|Collection of MILs|Withdrawal by Subject|1|||
156646169|NCT00566098|565453206|FG000|Collection of MILs|Relapsed|1|||
156646170|NCT00566098|565453206|FG000|Generation of MILs Product|Relapsed|1|||
156646171|NCT00566098|565453206|FG000|Administration of ASCT+MILs|Death|10|||
156646172|NCT00566098|565453206|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
156646173|NCT01690520|565453207|FG000|Overall Study|Death|25|||
156646174|NCT01690520|565453208|FG001|Overall Study|Death|21|||
156646175|NCT01690520|565453207|FG000|Overall Study|Lost to Follow-up|2|||
156646176|NCT01690520|565453208|FG001|Overall Study|Lost to Follow-up|3|||
156646177|NCT01690520|565453207|FG000|Overall Study|Withdrawal by Subject|2|||
156646178|NCT01690520|565453208|FG001|Overall Study|Withdrawal by Subject|0|||
156646179|NCT01690520|565453207|FG000|Overall Study|Relapse|0|||
156646180|NCT01690520|565453208|FG001|Overall Study|Relapse|1|||
156646181|NCT01690520|565453207|FG000|Overall Study|Other|0|||
156646182|NCT01690520|565453208|FG001|Overall Study|Other|1|||
156646183|NCT01690520|565453207|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
156646184|NCT01690520|565453208|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
156646185|NCT01270841|565453209|FG000|Overall Study|Adverse Event|0|||
156646186|NCT01270841|565453210|FG001|Overall Study|Adverse Event|1|||
156646187|NCT01270841|565453211|FG002|Overall Study|Adverse Event|0|||
156646188|NCT01270841|565453212|FG003|Overall Study|Adverse Event|3|||
156646189|NCT01270841|565453209|FG000|Overall Study|Withdrawal by Subject|3|||
156646190|NCT01270841|565453210|FG001|Overall Study|Withdrawal by Subject|2|||
156646191|NCT01270841|565453211|FG002|Overall Study|Withdrawal by Subject|3|||
156646192|NCT01270841|565453212|FG003|Overall Study|Withdrawal by Subject|3|||
156646193|NCT01270841|565453209|FG000|Overall Study|Lost to Follow-up|3|||
156646194|NCT01270841|565453210|FG001|Overall Study|Lost to Follow-up|1|||
156646195|NCT01270841|565453211|FG002|Overall Study|Lost to Follow-up|4|||
156646196|NCT01270841|565453212|FG003|Overall Study|Lost to Follow-up|2|||
156646197|NCT01270841|565453209|FG000|Overall Study|Physician Decision|0|||
156646198|NCT01270841|565453210|FG001|Overall Study|Physician Decision|1|||
156646199|NCT01270841|565453211|FG002|Overall Study|Physician Decision|0|||
156646200|NCT01270841|565453212|FG003|Overall Study|Physician Decision|0|||
156646201|NCT01270841|565453209|FG000|Overall Study|Did not qualify|6|||
156646202|NCT01270841|565453210|FG001|Overall Study|Did not qualify|3|||
156646203|NCT01270841|565453211|FG002|Overall Study|Did not qualify|4|||
156646204|NCT01270841|565453212|FG003|Overall Study|Did not qualify|5|||
156646205|NCT01270841|565453209|FG000|Overall Study|Protocol Violation|1|||
156646206|NCT01270841|565453210|FG001|Overall Study|Protocol Violation|5|||
156646207|NCT01270841|565453211|FG002|Overall Study|Protocol Violation|0|||
156646208|NCT01270841|565453212|FG003|Overall Study|Protocol Violation|0|||
156646209|NCT01270841|565453209|FG000|Overall Study|Enrolled in error|0|||
156646210|NCT01270841|565453210|FG001|Overall Study|Enrolled in error|1|||
156646211|NCT01270841|565453211|FG002|Overall Study|Enrolled in error|0|||
156646212|NCT01270841|565453212|FG003|Overall Study|Enrolled in error|0|||
156646213|NCT02092961|565453213|FG000|Overall Study|Not reported|1|||
156646214|NCT02092961|565453214|FG001|Overall Study|Not reported|0|||
156646215|NCT02092961|565453215|FG002|Overall Study|Not reported|1|||
156646216|NCT02092961|565453213|FG000|Overall Study|Study stopped|13|||
156646217|NCT02092961|565453214|FG001|Overall Study|Study stopped|9|||
156646218|NCT02092961|565453215|FG002|Overall Study|Study stopped|12|||
156646219|NCT02092961|565453213|FG000|Overall Study|Lack of therapeutic response|2|||
156646220|NCT02092961|565453214|FG001|Overall Study|Lack of therapeutic response|1|||
156646221|NCT02092961|565453215|FG002|Overall Study|Lack of therapeutic response|3|||
156646222|NCT02092961|565453213|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
156646223|NCT02092961|565453214|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
156646224|NCT02092961|565453215|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
156646225|NCT02092961|565453213|FG000|Overall Study|Adverse Event|2|||
156646226|NCT02092961|565453214|FG001|Overall Study|Adverse Event|4|||
156646227|NCT02092961|565453215|FG002|Overall Study|Adverse Event|0|||
156646228|NCT01623830|565453218|FG000|Overall Study|Withdrawal by Subject|6|||
156646229|NCT01623830|565453219|FG001|Overall Study|Withdrawal by Subject|7|||
156646230|NCT01623830|565453218|FG000|Overall Study|Exclusion from Study|1|||
156646231|NCT01623830|565453219|FG001|Overall Study|Exclusion from Study|2|||
156646232|NCT01859390|565453220|FG000|Overall Study|Insufficient Sputum Collected|1|||
156646233|NCT01859390|565453221|FG001|Overall Study|Insufficient Sputum Collected|3|||
156646234|NCT01859390|565453220|FG000|Overall Study|Sample Missing Collection Date|0|||
156646235|NCT01859390|565453221|FG001|Overall Study|Sample Missing Collection Date|1|||
156646236|NCT01859390|565453220|FG000|Overall Study|Tube Cracked|0|||
156646237|NCT01859390|565453221|FG001|Overall Study|Tube Cracked|2|||
156646238|NCT01859390|565453220|FG000|Overall Study|Shipment Error|0|||
156646239|NCT01859390|565453221|FG001|Overall Study|Shipment Error|1|||
156646240|NCT00472446|565453232|FG000|Overall Study|Protocol Violation|0|||
156646241|NCT00472446|565453233|FG001|Overall Study|Protocol Violation|0|||
156646242|NCT00472446|565453234|FG002|Overall Study|Protocol Violation|0|||
156646243|NCT00472446|565453235|FG003|Overall Study|Protocol Violation|1|||
156646244|NCT00472446|565453232|FG000|Overall Study|Reintervention|0|||
156646245|NCT00472446|565453233|FG001|Overall Study|Reintervention|0|||
156646246|NCT00472446|565453234|FG002|Overall Study|Reintervention|1|||
156646247|NCT00472446|565453235|FG003|Overall Study|Reintervention|1|||
156646248|NCT00472446|565453232|FG000|Overall Study|Questionnaires not returned|5|||
156646249|NCT00472446|565453233|FG001|Overall Study|Questionnaires not returned|6|||
156646250|NCT00472446|565453234|FG002|Overall Study|Questionnaires not returned|6|||
156646251|NCT00472446|565453235|FG003|Overall Study|Questionnaires not returned|4|||
156646252|NCT00295854|565453237|FG000|Overall Study|Adverse Event|7|||
156646253|NCT00295854|565453238|FG001|Overall Study|Adverse Event|7|||
156646254|NCT00295854|565453239|FG002|Overall Study|Adverse Event|6|||
156646255|NCT00295854|565453237|FG000|Overall Study|Protocol Violation|1|||
156646256|NCT00295854|565453238|FG001|Overall Study|Protocol Violation|1|||
156646257|NCT00295854|565453239|FG002|Overall Study|Protocol Violation|1|||
156646258|NCT00295854|565453237|FG000|Overall Study|Lost to Follow-up|2|||
156646259|NCT00295854|565453238|FG001|Overall Study|Lost to Follow-up|0|||
156646260|NCT00295854|565453239|FG002|Overall Study|Lost to Follow-up|1|||
156646261|NCT00295854|565453237|FG000|Overall Study|Withdrawal by Subject|3|||
156646262|NCT00295854|565453238|FG001|Overall Study|Withdrawal by Subject|7|||
156646263|NCT00295854|565453239|FG002|Overall Study|Withdrawal by Subject|4|||
156646264|NCT00295854|565453237|FG000|Overall Study|did not continue to meet criteria|1|||
156646265|NCT00295854|565453238|FG001|Overall Study|did not continue to meet criteria|1|||
156646266|NCT00295854|565453239|FG002|Overall Study|did not continue to meet criteria|2|||
156646267|NCT00295854|565453237|FG000|Overall Study|required a prohibited medication|1|||
156646268|NCT00295854|565453238|FG001|Overall Study|required a prohibited medication|0|||
156646269|NCT00295854|565453239|FG002|Overall Study|required a prohibited medication|0|||
156646270|NCT00295854|565453237|FG000|Overall Study|Other|3|||
156646271|NCT00295854|565453238|FG001|Overall Study|Other|5|||
156646272|NCT00295854|565453239|FG002|Overall Study|Other|1|||
156646273|NCT03211156|565453240|FG000|Overall Study|Withdrawal by Subject|0|||
156646274|NCT03211156|565453241|FG001|Overall Study|Withdrawal by Subject|2|||
156646275|NCT03211156|565453240|FG000|Overall Study|Lost to Follow-up|1|||
156646276|NCT03211156|565453241|FG001|Overall Study|Lost to Follow-up|1|||
156646277|NCT03211156|565453240|FG000|Overall Study|Adverse Event|1|||
156646278|NCT03211156|565453241|FG001|Overall Study|Adverse Event|0|||
156646279|NCT00738673|565453243|FG000|Overall Study|Adverse Event|1|||
156646280|NCT00738673|565453244|FG001|Overall Study|Adverse Event|0|||
156646281|NCT00738673|565453243|FG000|Overall Study|Lack of Efficacy|19|||
156646282|NCT00738673|565453244|FG001|Overall Study|Lack of Efficacy|8|||
156646283|NCT00738673|565453243|FG000|Overall Study|Protocol Violation|1|||
156646284|NCT00738673|565453244|FG001|Overall Study|Protocol Violation|2|||
156646285|NCT00738673|565453243|FG000|Overall Study|Withdrawal by Subject|3|||
156646286|NCT00738673|565453244|FG001|Overall Study|Withdrawal by Subject|1|||
156646287|NCT02736227|565453245|FG000|Overall Study|Withdrawal by Subject|0|||
156646288|NCT02736227|565453246|FG001|Overall Study|Withdrawal by Subject|0|||
156646289|NCT02736227|565453247|FG002|Overall Study|Withdrawal by Subject|1|||
156646290|NCT02736227|565453245|FG000|Overall Study|Physician Decision|0|||
156646291|NCT02736227|565453246|FG001|Overall Study|Physician Decision|0|||
156646292|NCT02736227|565453247|FG002|Overall Study|Physician Decision|5|||
156646293|NCT02736227|565453245|FG000|Overall Study|Non Compliant|0|||
156646294|NCT02736227|565453246|FG001|Overall Study|Non Compliant|0|||
156646295|NCT02736227|565453247|FG002|Overall Study|Non Compliant|2|||
156646296|NCT04120194|565453248|FG000|Overall Study|Lost to Follow-up|11|||
156646297|NCT04120194|565453249|FG001|Overall Study|Lost to Follow-up|8|||
156646298|NCT04120194|565453248|FG000|Overall Study|Adverse Event|4|||
156646299|NCT04120194|565453249|FG001|Overall Study|Adverse Event|5|||
156646300|NCT04120194|565453248|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
156646301|NCT04120194|565453249|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
156646302|NCT04120194|565453248|FG000|Overall Study|Miscellaneous|4|||
156646303|NCT04120194|565453249|FG001|Overall Study|Miscellaneous|5|||
156646304|NCT02622074|565453251|FG000|Overall Study|Death|4|||
156646305|NCT02622074|565453252|FG001|Overall Study|Death|0|||
156646306|NCT02622074|565453253|FG002|Overall Study|Death|0|||
156646307|NCT02622074|565453254|FG003|Overall Study|Death|1|||
156646308|NCT02622074|565453255|FG004|Overall Study|Death|1|||
156646309|NCT02622074|565453256|FG005|Overall Study|Death|0|||
156646310|NCT02622074|565453251|FG000|Overall Study|Withdrawal by Subject|0|||
156646311|NCT02622074|565453252|FG001|Overall Study|Withdrawal by Subject|1|||
156646312|NCT02622074|565453253|FG002|Overall Study|Withdrawal by Subject|0|||
156646313|NCT02622074|565453254|FG003|Overall Study|Withdrawal by Subject|0|||
156646314|NCT02622074|565453255|FG004|Overall Study|Withdrawal by Subject|0|||
156646315|NCT02622074|565453256|FG005|Overall Study|Withdrawal by Subject|0|||
156646316|NCT02114931|565453257|FG000|Overall Study|Withdrawal by Subject|15|||
156646317|NCT02114931|565453258|FG001|Overall Study|Withdrawal by Subject|18|||
156646318|NCT02114931|565453257|FG000|Overall Study|Adverse Event|4|||
156646319|NCT02114931|565453258|FG001|Overall Study|Adverse Event|6|||
156646320|NCT02114931|565453257|FG000|Overall Study|Lost to Follow-up|3|||
156646321|NCT02114931|565453258|FG001|Overall Study|Lost to Follow-up|3|||
156646322|NCT02114931|565453257|FG000|Overall Study|Physician Decision|1|||
156646323|NCT02114931|565453258|FG001|Overall Study|Physician Decision|2|||
156646324|NCT02114931|565453257|FG000|Overall Study|Other|2|||
156646325|NCT02114931|565453258|FG001|Overall Study|Other|1|||
156646326|NCT03565211|565453262|FG000|Overall Study|Withdrawal by Subject|2|||
156646327|NCT03565211|565453262|FG000|Overall Study|Lost to Follow-up|1|||
156646328|NCT03565211|565453262|FG000|Overall Study|Adverse Event|44|||
156646329|NCT03565211|565453262|FG000|Overall Study|Personal issues|1|||
156646330|NCT00986154|565453263|FG000|Overall Study|Death|136|||
156646331|NCT00986154|565453264|FG001|Overall Study|Death|127|||
156646332|NCT00986154|565453263|FG000|Overall Study|Lost to Follow-up|7|||
156646333|NCT00986154|565453264|FG001|Overall Study|Lost to Follow-up|4|||
156646334|NCT00986154|565453263|FG000|Overall Study|Withdrawal by Subject|32|||
156646335|NCT00986154|565453264|FG001|Overall Study|Withdrawal by Subject|33|||
156646336|NCT00986154|565453263|FG000|Overall Study|investigator/subject decide not continue|6|||
156646337|NCT00986154|565453264|FG001|Overall Study|investigator/subject decide not continue|3|||
156646338|NCT00986154|565453263|FG000|Overall Study|never received study drug|25|||
156646339|NCT00986154|565453264|FG001|Overall Study|never received study drug|27|||
156646340|NCT01205529|565453267|FG000|Overall Study|Procedure Cancelled|4|||
156646341|NCT01205529|565453267|FG000|Overall Study|Withdrawal by Subject|2|||
156646342|NCT01205529|565453267|FG000|Overall Study|Physician Decision|4|||
156646343|NCT01205529|565453267|FG000|Overall Study|Unstable post op|15|||
156646344|NCT01205529|565453267|FG000|Overall Study|No longer met criteria|30|||
156646345|NCT00667719|565453268|FG000|Overall Study|Adverse Event|39|||
156646346|NCT00667719|565453268|FG000|Overall Study|Abnormal Test Procedure|1|||
156646347|NCT00667719|565453268|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156646348|NCT00667719|565453268|FG000|Overall Study|Protocol Violation|3|||
156646349|NCT00667719|565453268|FG000|Overall Study|Withdrawal by Subject|17|||
156646350|NCT00667719|565453268|FG000|Overall Study|Lost to Follow-up|8|||
156646351|NCT03840135|565453269|FG000|Overall Study|Protocol Violation|6|||
156646352|NCT03840135|565453270|FG001|Overall Study|Protocol Violation|1|||
156646353|NCT03840135|565453269|FG000|Overall Study|Withdrawal by Subject|1|||
156646354|NCT03840135|565453270|FG001|Overall Study|Withdrawal by Subject|0|||
156646355|NCT00323609|565453271|FG000|Overall Study|Death|16|||
156646356|NCT00323609|565453272|FG001|Overall Study|Death|21|||
156646357|NCT00323609|565453273|FG002|Overall Study|Death|0|||
156646358|NCT00323609|565453274|FG003|Overall Study|Death|0|||
156646359|NCT00323609|565453271|FG000|Overall Study|Lost to Follow-up|9|||
156646360|NCT00323609|565453272|FG001|Overall Study|Lost to Follow-up|10|||
156646361|NCT00323609|565453273|FG002|Overall Study|Lost to Follow-up|0|||
156646362|NCT00323609|565453274|FG003|Overall Study|Lost to Follow-up|0|||
156646363|NCT00323609|565453271|FG000|Overall Study|Physician Decision|2|||
156646364|NCT00323609|565453272|FG001|Overall Study|Physician Decision|0|||
156646365|NCT00323609|565453273|FG002|Overall Study|Physician Decision|0|||
156646366|NCT00323609|565453274|FG003|Overall Study|Physician Decision|1|||
156646367|NCT00323609|565453271|FG000|Overall Study|Withdrawal by Subject|11|||
156646368|NCT00323609|565453272|FG001|Overall Study|Withdrawal by Subject|23|||
156646369|NCT00323609|565453273|FG002|Overall Study|Withdrawal by Subject|4|||
156646370|NCT00323609|565453274|FG003|Overall Study|Withdrawal by Subject|4|||
156646371|NCT00323609|565453271|FG000|Overall Study|Other non-VCF-related medical condition|3|||
156646372|NCT00323609|565453272|FG001|Overall Study|Other non-VCF-related medical condition|2|||
156646373|NCT00323609|565453273|FG002|Overall Study|Other non-VCF-related medical condition|0|||
156646374|NCT00323609|565453274|FG003|Overall Study|Other non-VCF-related medical condition|0|||
156646375|NCT00323609|565453271|FG000|Overall Study|Sponsor discontinued trial|29|||
156646376|NCT00323609|565453272|FG001|Overall Study|Sponsor discontinued trial|29|||
156646377|NCT00323609|565453273|FG002|Overall Study|Sponsor discontinued trial|0|||
156646378|NCT00323609|565453274|FG003|Overall Study|Sponsor discontinued trial|0|||
156646379|NCT00323609|565453271|FG000|Overall Study|Unrelenting or severe back pain|1|||
156646380|NCT00323609|565453272|FG001|Overall Study|Unrelenting or severe back pain|1|||
156646381|NCT00323609|565453273|FG002|Overall Study|Unrelenting or severe back pain|0|||
156646382|NCT00323609|565453274|FG003|Overall Study|Unrelenting or severe back pain|0|||
156646383|NCT00323609|565453271|FG000|Overall Study|Logistical withdrawal|9|||
156646384|NCT00323609|565453272|FG001|Overall Study|Logistical withdrawal|5|||
156646385|NCT00323609|565453273|FG002|Overall Study|Logistical withdrawal|0|||
156646386|NCT00323609|565453274|FG003|Overall Study|Logistical withdrawal|1|||
156646387|NCT00323609|565453271|FG000|Overall Study|Other reason|11|||
156646388|NCT00323609|565453272|FG001|Overall Study|Other reason|8|||
156646389|NCT00323609|565453273|FG002|Overall Study|Other reason|4|||
156646390|NCT00323609|565453274|FG003|Overall Study|Other reason|9|||
156646391|NCT01827371|565453275|FG000|Overall Study|Adverse Event|0|||
156646392|NCT01827371|565453276|FG001|Overall Study|Adverse Event|0|||
156646393|NCT01827371|565453277|FG002|Overall Study|Adverse Event|4|||
156646394|NCT01827371|565453278|FG003|Overall Study|Adverse Event|2|||
156646395|NCT01827371|565453275|FG000|Overall Study|Lost to Follow-up|0|||
156646396|NCT01827371|565453276|FG001|Overall Study|Lost to Follow-up|2|||
156646397|NCT01827371|565453277|FG002|Overall Study|Lost to Follow-up|0|||
156646398|NCT01827371|565453278|FG003|Overall Study|Lost to Follow-up|4|||
156646399|NCT01827371|565453275|FG000|Overall Study|Protocol Violation|1|||
156646400|NCT01827371|565453276|FG001|Overall Study|Protocol Violation|0|||
156646401|NCT01827371|565453277|FG002|Overall Study|Protocol Violation|0|||
156646402|NCT01827371|565453278|FG003|Overall Study|Protocol Violation|0|||
156646403|NCT01827371|565453275|FG000|Overall Study|Withdrawal by Subject|1|||
156646404|NCT01827371|565453276|FG001|Overall Study|Withdrawal by Subject|2|||
156646405|NCT01827371|565453277|FG002|Overall Study|Withdrawal by Subject|2|||
156646406|NCT01827371|565453278|FG003|Overall Study|Withdrawal by Subject|3|||
156646407|NCT01827371|565453275|FG000|Overall Study|Physician Decision|0|||
156646408|NCT01827371|565453276|FG001|Overall Study|Physician Decision|1|||
156646409|NCT01827371|565453277|FG002|Overall Study|Physician Decision|0|||
156646410|NCT01827371|565453278|FG003|Overall Study|Physician Decision|1|||
156646411|NCT01827371|565453275|FG000|Overall Study|Temporary study halt to vaccinations|11|||
156646412|NCT01827371|565453276|FG001|Overall Study|Temporary study halt to vaccinations|2|||
156646413|NCT01827371|565453277|FG002|Overall Study|Temporary study halt to vaccinations|5|||
156646414|NCT01827371|565453278|FG003|Overall Study|Temporary study halt to vaccinations|13|||
156646415|NCT03063632|565453284|FG000|Overall Study|Death|4|||
156646416|NCT03063632|565453285|FG001|Overall Study|Death|6|||
156646417|NCT03063632|565453284|FG000|Overall Study|Lost to Follow-up|0|||
156646418|NCT03063632|565453285|FG001|Overall Study|Lost to Follow-up|1|||
156646419|NCT03063632|565453284|FG000|Overall Study|Withdrawal by Subject|0|||
156646420|NCT03063632|565453285|FG001|Overall Study|Withdrawal by Subject|2|||
156646421|NCT03063632|565453284|FG000|Overall Study|Physician Decision|2|||
156646422|NCT03063632|565453285|FG001|Overall Study|Physician Decision|0|||
156646423|NCT03063632|565453284|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
156646424|NCT03063632|565453285|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
156646425|NCT02741271|565453290|FG000|Overall Study|Lost to Follow-up|2|||
156646426|NCT02741271|565453291|FG001|Overall Study|Lost to Follow-up|0|||
156646427|NCT02741271|565453290|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156646428|NCT02741271|565453291|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156646429|NCT03652961|565453292|FG000|Overall Study|Lost to Follow-up|3|||
156646430|NCT03652961|565453292|FG000|Overall Study|Screen Failure|1|||
156646431|NCT01612156|565453293|FG000|Overall Study|Protocol Violation|2|||
156646432|NCT01612156|565453294|FG001|Overall Study|Protocol Violation|0|||
156646433|NCT00373685|565453295|FG000|Overall Study|Death|2|||
156646434|NCT00373685|565453296|FG001|Overall Study|Death|1|||
156646435|NCT00373685|565453295|FG000|Overall Study|Adverse Event|278|||
156646436|NCT00373685|565453296|FG001|Overall Study|Adverse Event|253|||
156646437|NCT00373685|565453295|FG000|Overall Study|Insufficient clinical response|169|||
156646438|NCT00373685|565453296|FG001|Overall Study|Insufficient clinical response|119|||
156646439|NCT00373685|565453295|FG000|Overall Study|Did not meet entrance criteria|167|||
156646440|NCT00373685|565453296|FG001|Overall Study|Did not meet entrance criteria|184|||
156646441|NCT00373685|565453295|FG000|Overall Study|Lost to follow up|83|||
156646442|NCT00373685|565453296|FG001|Overall Study|Lost to follow up|103|||
156646443|NCT00373685|565453295|FG000|Overall Study|No longer willing to participate|337|||
156646444|NCT00373685|565453296|FG001|Overall Study|No longer willing to participate|352|||
156646445|NCT00373685|565453295|FG000|Overall Study|Other|149|||
156646446|NCT00373685|565453296|FG001|Overall Study|Other|146|||
156646447|NCT00373685|565453295|FG000|Overall Study|Protocol Violation|191|||
156646448|NCT00373685|565453296|FG001|Overall Study|Protocol Violation|182|||
156646449|NCT00373685|565453295|FG000|Overall Study|Final Status Unknown|12|||
156646450|NCT00373685|565453296|FG001|Overall Study|Final Status Unknown|4|||
156646451|NCT00373685|565453295|FG000|Overall Study|Randomized, not treated|51|||
156646452|NCT00373685|565453296|FG001|Overall Study|Randomized, not treated|77|||
156646453|NCT00410410|565453297|FG000|Induction Period (IP)|Death|1|||
156646454|NCT00410410|565453298|FG001|Induction Period (IP)|Death|0|||
156646455|NCT00410410|565453299|FG002|Induction Period (IP)|Death|0|||
156646456|NCT00410410|565453300|FG003|Induction Period (IP)|Death|0|||
156646457|NCT00410410|565453301|FG004|Induction Period (IP)|Death|0|||
156646458|NCT00410410|565453302|FG005|Induction Period (IP)|Death|0|||
156646459|NCT00410410|565453303|FG006|Induction Period (IP)|Death|0|||
156646460|NCT00410410|565453304|FG007|Induction Period (IP)|Death|0|||
156646461|NCT00410410|565453305|FG008|Induction Period (IP)|Death|0|||
156646462|NCT00410410|565453297|FG000|Induction Period (IP)|Adverse Event|3|||
156646463|NCT00410410|565453298|FG001|Induction Period (IP)|Adverse Event|4|||
156646464|NCT00410410|565453299|FG002|Induction Period (IP)|Adverse Event|2|||
156646465|NCT00410410|565453300|FG003|Induction Period (IP)|Adverse Event|4|||
156646466|NCT00410410|565453301|FG004|Induction Period (IP)|Adverse Event|1|||
156646467|NCT00410410|565453302|FG005|Induction Period (IP)|Adverse Event|0|||
156646468|NCT00410410|565453303|FG006|Induction Period (IP)|Adverse Event|0|||
156646469|NCT00410410|565453304|FG007|Induction Period (IP)|Adverse Event|0|||
156646470|NCT00410410|565453305|FG008|Induction Period (IP)|Adverse Event|0|||
156646471|NCT00410410|565453297|FG000|Induction Period (IP)|Lack of Efficacy|26|||
156646472|NCT00410410|565453298|FG001|Induction Period (IP)|Lack of Efficacy|24|||
156646473|NCT00410410|565453299|FG002|Induction Period (IP)|Lack of Efficacy|8|||
156646474|NCT00410410|565453300|FG003|Induction Period (IP)|Lack of Efficacy|8|||
156646475|NCT00410410|565453301|FG004|Induction Period (IP)|Lack of Efficacy|7|||
156646476|NCT00410410|565453302|FG005|Induction Period (IP)|Lack of Efficacy|7|||
156646477|NCT00410410|565453303|FG006|Induction Period (IP)|Lack of Efficacy|0|||
156646478|NCT00410410|565453304|FG007|Induction Period (IP)|Lack of Efficacy|0|||
156646479|NCT00410410|565453305|FG008|Induction Period (IP)|Lack of Efficacy|0|||
156646480|NCT00410410|565453297|FG000|Induction Period (IP)|Lost to Follow-up|2|||
156646481|NCT00410410|565453298|FG001|Induction Period (IP)|Lost to Follow-up|2|||
156646482|NCT00410410|565453299|FG002|Induction Period (IP)|Lost to Follow-up|2|||
156646483|NCT00410410|565453300|FG003|Induction Period (IP)|Lost to Follow-up|3|||
156646484|NCT00410410|565453301|FG004|Induction Period (IP)|Lost to Follow-up|0|||
156646485|NCT00410410|565453302|FG005|Induction Period (IP)|Lost to Follow-up|1|||
156646486|NCT00410410|565453303|FG006|Induction Period (IP)|Lost to Follow-up|0|||
156646487|NCT00410410|565453304|FG007|Induction Period (IP)|Lost to Follow-up|0|||
156646488|NCT00410410|565453305|FG008|Induction Period (IP)|Lost to Follow-up|0|||
156646489|NCT00410410|565453297|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
156646490|NCT00410410|565453298|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
156646491|NCT00410410|565453299|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
156646492|NCT00410410|565453300|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
156646493|NCT00410410|565453301|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
156646494|NCT00410410|565453302|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
156646495|NCT00410410|565453303|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
156646496|NCT00410410|565453304|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
156646497|NCT00410410|565453305|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
156646498|NCT00410410|565453297|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
156646499|NCT00410410|565453298|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
156646500|NCT00410410|565453299|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
156646501|NCT00410410|565453300|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
156646502|NCT00410410|565453301|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
156646503|NCT00410410|565453302|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
156646504|NCT00410410|565453303|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
156646505|NCT00410410|565453304|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
156646506|NCT00410410|565453305|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
156646507|NCT00410410|565453297|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
156646508|NCT00410410|565453298|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
156646509|NCT00410410|565453299|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
156646510|NCT00410410|565453300|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
156646511|NCT00410410|565453301|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
156646512|NCT00410410|565453302|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
156646513|NCT00410410|565453303|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
156646514|NCT00410410|565453304|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
156646515|NCT00410410|565453305|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
156646516|NCT00410410|565453297|FG000|Induction Period (IP)|Other|0|||
156646517|NCT00410410|565453298|FG001|Induction Period (IP)|Other|0|||
156646518|NCT00410410|565453299|FG002|Induction Period (IP)|Other|1|||
156646519|NCT00410410|565453300|FG003|Induction Period (IP)|Other|0|||
156646520|NCT00410410|565453301|FG004|Induction Period (IP)|Other|0|||
156646521|NCT00410410|565453302|FG005|Induction Period (IP)|Other|0|||
156646522|NCT00410410|565453303|FG006|Induction Period (IP)|Other|0|||
156646523|NCT00410410|565453304|FG007|Induction Period (IP)|Other|0|||
156646524|NCT00410410|565453305|FG008|Induction Period (IP)|Other|0|||
156646525|NCT00410410|565453297|FG000|Maintenance Period (MP)|Death|0|||
156646526|NCT00410410|565453298|FG001|Maintenance Period (MP)|Death|0|||
156646527|NCT00410410|565453299|FG002|Maintenance Period (MP)|Death|0|||
156646528|NCT00410410|565453300|FG003|Maintenance Period (MP)|Death|0|||
156646529|NCT00410410|565453301|FG004|Maintenance Period (MP)|Death|0|||
156646530|NCT00410410|565453302|FG005|Maintenance Period (MP)|Death|0|||
156646531|NCT00410410|565453303|FG006|Maintenance Period (MP)|Death|1|||
156646532|NCT00410410|565453304|FG007|Maintenance Period (MP)|Death|0|||
156646533|NCT00410410|565453305|FG008|Maintenance Period (MP)|Death|0|||
156646534|NCT00410410|565453297|FG000|Maintenance Period (MP)|Adverse Event|0|||
156646535|NCT00410410|565453298|FG001|Maintenance Period (MP)|Adverse Event|0|||
156646536|NCT00410410|565453299|FG002|Maintenance Period (MP)|Adverse Event|0|||
156646537|NCT00410410|565453300|FG003|Maintenance Period (MP)|Adverse Event|0|||
156646538|NCT00410410|565453301|FG004|Maintenance Period (MP)|Adverse Event|0|||
156646539|NCT00410410|565453302|FG005|Maintenance Period (MP)|Adverse Event|0|||
156646540|NCT00410410|565453303|FG006|Maintenance Period (MP)|Adverse Event|1|||
156646541|NCT00410410|565453304|FG007|Maintenance Period (MP)|Adverse Event|3|||
156646542|NCT00410410|565453305|FG008|Maintenance Period (MP)|Adverse Event|0|||
156646543|NCT00410410|565453297|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
156646544|NCT00410410|565453298|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
156646545|NCT00410410|565453299|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
156646546|NCT00410410|565453300|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
156646547|NCT00410410|565453301|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
156646548|NCT00410410|565453302|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
156646549|NCT00410410|565453303|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
156646550|NCT00410410|565453304|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
156646551|NCT00410410|565453305|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
156646552|NCT00410410|565453297|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
156646553|NCT00410410|565453298|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
156646554|NCT00410410|565453299|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
156646555|NCT00410410|565453300|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
156646556|NCT00410410|565453301|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
156646557|NCT00410410|565453302|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
156646558|NCT00410410|565453303|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
156646559|NCT00410410|565453304|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
156646560|NCT00410410|565453305|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
156646561|NCT00410410|565453297|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
156646562|NCT00410410|565453298|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
156646563|NCT00410410|565453299|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
156646564|NCT00410410|565453300|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
156646565|NCT00410410|565453301|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
156646566|NCT00410410|565453302|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
156646567|NCT00410410|565453303|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
156646568|NCT00410410|565453304|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
156646569|NCT00410410|565453305|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
156646570|NCT00410410|565453297|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
156646571|NCT00410410|565453298|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
156646572|NCT00410410|565453299|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
156646573|NCT00410410|565453300|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
156646574|NCT00410410|565453301|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
156646575|NCT00410410|565453302|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
156646576|NCT00410410|565453303|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
156646577|NCT00410410|565453304|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
156646578|NCT00410410|565453305|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
156646579|NCT00410410|565453297|FG000|Open-Label Period (OL)|Death|0|||
156646580|NCT00410410|565453298|FG001|Open-Label Period (OL)|Death|0|||
156646581|NCT00410410|565453299|FG002|Open-Label Period (OL)|Death|0|||
156646582|NCT00410410|565453300|FG003|Open-Label Period (OL)|Death|0|||
156646583|NCT00410410|565453301|FG004|Open-Label Period (OL)|Death|0|||
156646584|NCT00410410|565453302|FG005|Open-Label Period (OL)|Death|0|||
156646585|NCT00410410|565453303|FG006|Open-Label Period (OL)|Death|0|||
156646586|NCT00410410|565453304|FG007|Open-Label Period (OL)|Death|0|||
156646587|NCT00410410|565453305|FG008|Open-Label Period (OL)|Death|1|||
156646588|NCT00410410|565453297|FG000|Open-Label Period (OL)|Adverse Event|0|||
156646589|NCT00410410|565453298|FG001|Open-Label Period (OL)|Adverse Event|0|||
156646590|NCT00410410|565453299|FG002|Open-Label Period (OL)|Adverse Event|0|||
156646591|NCT00410410|565453300|FG003|Open-Label Period (OL)|Adverse Event|0|||
156646592|NCT00410410|565453301|FG004|Open-Label Period (OL)|Adverse Event|0|||
156646593|NCT00410410|565453302|FG005|Open-Label Period (OL)|Adverse Event|0|||
156646594|NCT00410410|565453303|FG006|Open-Label Period (OL)|Adverse Event|0|||
156646595|NCT00410410|565453304|FG007|Open-Label Period (OL)|Adverse Event|0|||
156646596|NCT00410410|565453305|FG008|Open-Label Period (OL)|Adverse Event|10|||
156646597|NCT00410410|565453297|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
156646598|NCT00410410|565453298|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
156646599|NCT00410410|565453299|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
156646600|NCT00410410|565453300|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
156646601|NCT00410410|565453301|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
156646602|NCT00410410|565453302|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
156646603|NCT00410410|565453303|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
156646604|NCT00410410|565453304|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
156646605|NCT00410410|565453305|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
156646606|NCT00410410|565453297|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
156646607|NCT00410410|565453298|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
156646608|NCT00410410|565453299|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
156646609|NCT00410410|565453300|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
156646610|NCT00410410|565453301|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
156646611|NCT00410410|565453302|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
156646612|NCT00410410|565453303|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
156646613|NCT00410410|565453304|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
156646614|NCT00410410|565453305|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
156646615|NCT00410410|565453297|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
156646616|NCT00410410|565453298|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
156646617|NCT00410410|565453299|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
156646618|NCT00410410|565453300|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
156646619|NCT00410410|565453301|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
156646620|NCT00410410|565453302|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
156646621|NCT00410410|565453303|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
156646622|NCT00410410|565453304|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
156646623|NCT00410410|565453305|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
156646624|NCT00410410|565453297|FG000|Open-Label Period (OL)|Pregnancy|0|||
156646625|NCT00410410|565453298|FG001|Open-Label Period (OL)|Pregnancy|0|||
156646626|NCT00410410|565453299|FG002|Open-Label Period (OL)|Pregnancy|0|||
156646627|NCT00410410|565453300|FG003|Open-Label Period (OL)|Pregnancy|0|||
156646628|NCT00410410|565453301|FG004|Open-Label Period (OL)|Pregnancy|0|||
156646629|NCT00410410|565453302|FG005|Open-Label Period (OL)|Pregnancy|0|||
156646630|NCT00410410|565453303|FG006|Open-Label Period (OL)|Pregnancy|0|||
156646631|NCT00410410|565453304|FG007|Open-Label Period (OL)|Pregnancy|0|||
156646632|NCT00410410|565453305|FG008|Open-Label Period (OL)|Pregnancy|1|||
156646633|NCT00410410|565453297|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
156646634|NCT00410410|565453298|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
156646635|NCT00410410|565453299|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
156646636|NCT00410410|565453300|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
156646637|NCT00410410|565453301|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
156646638|NCT00410410|565453302|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
156646639|NCT00410410|565453303|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
156646640|NCT00410410|565453304|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
156646641|NCT00410410|565453305|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
156646642|NCT00410410|565453297|FG000|Open-Label Period (OL)|Other|0|||
156646643|NCT00410410|565453298|FG001|Open-Label Period (OL)|Other|0|||
156646644|NCT00410410|565453299|FG002|Open-Label Period (OL)|Other|0|||
156646645|NCT00410410|565453300|FG003|Open-Label Period (OL)|Other|0|||
156646646|NCT00410410|565453301|FG004|Open-Label Period (OL)|Other|0|||
156646647|NCT00410410|565453302|FG005|Open-Label Period (OL)|Other|0|||
156646648|NCT00410410|565453303|FG006|Open-Label Period (OL)|Other|0|||
156646649|NCT00410410|565453304|FG007|Open-Label Period (OL)|Other|0|||
156646650|NCT00410410|565453305|FG008|Open-Label Period (OL)|Other|7|||
156646651|NCT01783496|565453306|FG000|Overall Study|Lost to Follow-up|0|||
156646652|NCT01783496|565453307|FG001|Overall Study|Lost to Follow-up|0|||
156646653|NCT01783496|565453308|FG002|Overall Study|Lost to Follow-up|0|||
156646654|NCT01783496|565453309|FG003|Overall Study|Lost to Follow-up|2|||
156646655|NCT01783496|565453310|FG004|Overall Study|Lost to Follow-up|0|||
156646656|NCT01783496|565453311|FG005|Overall Study|Lost to Follow-up|1|||
156646657|NCT01783496|565453306|FG000|Overall Study|Withdrawal by Subject|1|||
156646658|NCT01783496|565453307|FG001|Overall Study|Withdrawal by Subject|0|||
156646659|NCT01783496|565453308|FG002|Overall Study|Withdrawal by Subject|0|||
156646660|NCT01783496|565453309|FG003|Overall Study|Withdrawal by Subject|0|||
156646661|NCT01783496|565453310|FG004|Overall Study|Withdrawal by Subject|0|||
156646662|NCT01783496|565453311|FG005|Overall Study|Withdrawal by Subject|0|||
156646663|NCT01953783|565453312|FG000|Overall Study|Progressive disease|2|||
156646664|NCT01789281|565453313|FG000|Overall Study|Disease progression|15|||
156646665|NCT01789281|565453314|FG001|Overall Study|Disease progression|4|||
156646666|NCT01789281|565453313|FG000|Overall Study|Adverse Event|5|||
156646667|NCT01789281|565453314|FG001|Overall Study|Adverse Event|5|||
156646668|NCT01789281|565453313|FG000|Overall Study|Withdrawal by Subject|1|||
156646669|NCT01789281|565453314|FG001|Overall Study|Withdrawal by Subject|0|||
156646670|NCT01789281|565453313|FG000|Overall Study|Lost to Follow-up|1|||
156646671|NCT01789281|565453314|FG001|Overall Study|Lost to Follow-up|0|||
156646672|NCT01789281|565453313|FG000|Overall Study|Administrative problems|0|||
156646673|NCT01789281|565453314|FG001|Overall Study|Administrative problems|1|||
156646674|NCT03712228|565453315|FG000|Treatment Period 1|Lack of Efficacy|0|||
156646675|NCT03712228|565453316|FG001|Treatment Period 1|Lack of Efficacy|0|||
156646676|NCT03712228|565453317|FG002|Treatment Period 1|Lack of Efficacy|0|||
156646677|NCT03712228|565453318|FG003|Treatment Period 1|Lack of Efficacy|0|||
156646678|NCT03712228|565453319|FG004|Treatment Period 1|Lack of Efficacy|0|||
156646679|NCT03712228|565453320|FG005|Treatment Period 1|Lack of Efficacy|1|||
156646680|NCT03712228|565453315|FG000|Treatment Period 2|Pregnancy|0|||
156646681|NCT03712228|565453316|FG001|Treatment Period 2|Pregnancy|0|||
156646682|NCT03712228|565453317|FG002|Treatment Period 2|Pregnancy|0|||
156646683|NCT03712228|565453318|FG003|Treatment Period 2|Pregnancy|1|||
156646684|NCT03712228|565453319|FG004|Treatment Period 2|Pregnancy|0|||
156646685|NCT03712228|565453320|FG005|Treatment Period 2|Pregnancy|0|||
156646686|NCT03712228|565453315|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156646687|NCT03712228|565453316|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156646688|NCT03712228|565453317|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156646689|NCT03712228|565453318|FG003|Treatment Period 2|Withdrawal by Subject|1|||
156646690|NCT03712228|565453319|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156646691|NCT03712228|565453320|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156646692|NCT01964105|565453321|FG000|Overall Study|Lost to Follow-up|2|||
156646693|NCT01964105|565453322|FG001|Overall Study|Lost to Follow-up|13|||
156646694|NCT01964105|565453323|FG002|Overall Study|Lost to Follow-up|0|||
156646695|NCT02295280|565453325|FG000|Overall Study|Adverse Event|0|||
156646696|NCT02295280|565453326|FG001|Overall Study|Adverse Event|1|||
156646697|NCT02875067|565453327|FG000|Overall Study|Withdrawal by Subject|1|||
156646698|NCT02875067|565453327|FG000|Overall Study|Withdrawal by Termination of Study|5|||
156646699|NCT01430104|565453328|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
156646700|NCT02713243|565453330|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
156646701|NCT02713243|565453331|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
156646702|NCT02713243|565453330|FG000|Overall Study|Administrative problems|0|||
156646703|NCT02713243|565453331|FG001|Overall Study|Administrative problems|1|||
156646704|NCT02713243|565453330|FG000|Overall Study|Protocol deviation|0|||
156646705|NCT02713243|565453331|FG001|Overall Study|Protocol deviation|1|||
156646706|NCT03056352|565453332|FG000|Overall Study|Lost to Follow-up|1|||
156646707|NCT02971605|565453335|FG000|Overall Study|Withdrawal by Subject|1|||
156646708|NCT03439293|565453336|FG000|Overall Study|Death|22|||
156646709|NCT03439293|565453336|FG000|Overall Study|Withdrawal by Subject|8|||
156646710|NCT03439293|565453336|FG000|Overall Study|Lost to Follow-up|2|||
156646711|NCT03439293|565453336|FG000|Overall Study|Reason Not Specified|28|||
156646712|NCT03439293|565453336|FG000|Overall Study|Missing|1|||
156646713|NCT03185949|565453339|FG000|ITT Analysis|Withdrawal by Subject|4|||
156646714|NCT03185949|565453340|FG001|ITT Analysis|Withdrawal by Subject|3|||
156646715|NCT03185949|565453339|FG000|PP Analysis|Protocol Violation|2|||
156646716|NCT03185949|565453340|FG001|PP Analysis|Protocol Violation|2|||
156646717|NCT03185949|565453339|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
156646718|NCT03185949|565453340|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
156646719|NCT00860574|565455156|FG000|Overall Study|Death|2|||
156646720|NCT00860574|565455156|FG000|Overall Study|Relapse|1|||
156646721|NCT02496221|565455158|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
156646722|NCT02496221|565455159|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
156646723|NCT02496221|565455158|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
156646724|NCT02496221|565455159|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
156646725|NCT02496221|565455158|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
156646726|NCT02496221|565455159|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
156646727|NCT01335399|565455160|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
156646728|NCT01335399|565455161|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
156646729|NCT01335399|565455160|FG000|Pre-treatment Period|Participant request to discontinue|0|||
156646730|NCT01335399|565455161|FG001|Pre-treatment Period|Participant request to discontinue|1|||
156646731|NCT01335399|565455160|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
156646732|NCT01335399|565455161|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
156646733|NCT01335399|565455160|FG000|Pre-treatment Period|Consent withdrawal|3|||
156646734|NCT01335399|565455161|FG001|Pre-treatment Period|Consent withdrawal|0|||
156646735|NCT01335399|565455160|FG000|Treatment Period|Disease progression|117|||
156646736|NCT01335399|565455161|FG001|Treatment Period|Disease progression|145|||
156646737|NCT01335399|565455160|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
156646738|NCT01335399|565455161|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
156646739|NCT01335399|565455160|FG000|Treatment Period|Study drug toxicity|52|||
156646740|NCT01335399|565455161|FG001|Treatment Period|Study drug toxicity|64|||
156646741|NCT01335399|565455160|FG000|Treatment Period|Participant request to discontinue|30|||
156646742|NCT01335399|565455161|FG001|Treatment Period|Participant request to discontinue|22|||
156646743|NCT01335399|565455160|FG000|Treatment Period|Other reasons|30|||
156646744|NCT01335399|565455161|FG001|Treatment Period|Other reasons|30|||
156646745|NCT01335399|565455160|FG000|Treatment Period|Consent withdrawal|10|||
156646746|NCT01335399|565455161|FG001|Treatment Period|Consent withdrawal|7|||
156646747|NCT01335399|565455160|FG000|Treatment Period|Death|7|||
156646748|NCT01335399|565455161|FG001|Treatment Period|Death|6|||
156646749|NCT01335399|565455160|FG000|Treatment Period|Poor/Non-compliance|3|||
156646750|NCT01335399|565455161|FG001|Treatment Period|Poor/Non-compliance|4|||
156646751|NCT01335399|565455160|FG000|Treatment Period|Lost to Follow-up|2|||
156646752|NCT01335399|565455161|FG001|Treatment Period|Lost to Follow-up|2|||
156646753|NCT01335399|565455160|FG000|Treatment Period|Maximum clinical benefit|1|||
156646754|NCT01335399|565455161|FG001|Treatment Period|Maximum clinical benefit|1|||
156646755|NCT01335399|565455160|FG000|Treatment Period|No longer meet study criteria|1|||
156646756|NCT01335399|565455161|FG001|Treatment Period|No longer meet study criteria|1|||
156646757|NCT01335399|565455160|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
156646758|NCT01335399|565455161|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
156646759|NCT01120600|565455164|FG000|Overall Study|Adverse Event|7|||
156646760|NCT01120600|565455165|FG001|Overall Study|Adverse Event|7|||
156646761|NCT01120600|565455164|FG000|Overall Study|Excessive Bone Loss|0|||
156646762|NCT01120600|565455165|FG001|Overall Study|Excessive Bone Loss|4|||
156646763|NCT01120600|565455164|FG000|Overall Study|Lost to Follow-up|1|||
156646764|NCT01120600|565455165|FG001|Overall Study|Lost to Follow-up|3|||
156646765|NCT01120600|565455164|FG000|Overall Study|Physician Decision|1|||
156646766|NCT01120600|565455165|FG001|Overall Study|Physician Decision|3|||
156646767|NCT01120600|565455164|FG000|Overall Study|Protocol Violation|0|||
156646768|NCT01120600|565455165|FG001|Overall Study|Protocol Violation|4|||
156646769|NCT01120600|565455164|FG000|Overall Study|Withdrawal by Subject|10|||
156646770|NCT01120600|565455165|FG001|Overall Study|Withdrawal by Subject|11|||
156646771|NCT02544633|565455168|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
156646772|NCT02544633|565455169|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
156646773|NCT02544633|565455170|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
156646774|NCT02544633|565455171|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
156646775|NCT02544633|565455168|FG000|Treatment Period|Adverse Event|7|||
156646776|NCT02544633|565455169|FG001|Treatment Period|Adverse Event|4|||
156646777|NCT02544633|565455170|FG002|Treatment Period|Adverse Event|0|||
156646778|NCT02544633|565455171|FG003|Treatment Period|Adverse Event|5|||
156646779|NCT02544633|565455168|FG000|Treatment Period|Lack of Efficacy|17|||
156646780|NCT02544633|565455169|FG001|Treatment Period|Lack of Efficacy|11|||
156646781|NCT02544633|565455170|FG002|Treatment Period|Lack of Efficacy|5|||
156646782|NCT02544633|565455171|FG003|Treatment Period|Lack of Efficacy|5|||
156646783|NCT02544633|565455168|FG000|Treatment Period|Global Deterioration of Health|3|||
156646784|NCT02544633|565455169|FG001|Treatment Period|Global Deterioration of Health|3|||
156646785|NCT02544633|565455170|FG002|Treatment Period|Global Deterioration of Health|0|||
156646786|NCT02544633|565455171|FG003|Treatment Period|Global Deterioration of Health|1|||
156646787|NCT02544633|565455168|FG000|Treatment Period|Withdrawal by Subject|1|||
156646788|NCT02544633|565455169|FG001|Treatment Period|Withdrawal by Subject|0|||
156646789|NCT02544633|565455170|FG002|Treatment Period|Withdrawal by Subject|0|||
156646790|NCT02544633|565455171|FG003|Treatment Period|Withdrawal by Subject|0|||
156646791|NCT02544633|565455168|FG000|Treatment Period|Lost to Follow-up|0|||
156646792|NCT02544633|565455169|FG001|Treatment Period|Lost to Follow-up|1|||
156646793|NCT02544633|565455170|FG002|Treatment Period|Lost to Follow-up|0|||
156646794|NCT02544633|565455171|FG003|Treatment Period|Lost to Follow-up|0|||
156646795|NCT02544633|565455168|FG000|Treatment Period|Death|0|||
156646796|NCT02544633|565455169|FG001|Treatment Period|Death|0|||
156646797|NCT02544633|565455170|FG002|Treatment Period|Death|1|||
156646798|NCT02544633|565455171|FG003|Treatment Period|Death|0|||
156646799|NCT02544633|565455168|FG000|Treatment Period|Non-compliance|0|||
156646800|NCT02544633|565455169|FG001|Treatment Period|Non-compliance|0|||
156646801|NCT02544633|565455170|FG002|Treatment Period|Non-compliance|1|||
156646802|NCT02544633|565455171|FG003|Treatment Period|Non-compliance|0|||
156646803|NCT02544633|565455168|FG000|Treatment Period|Clinical Disease Progression|0|||
156646804|NCT02544633|565455169|FG001|Treatment Period|Clinical Disease Progression|0|||
156646805|NCT02544633|565455170|FG002|Treatment Period|Clinical Disease Progression|0|||
156646806|NCT02544633|565455171|FG003|Treatment Period|Clinical Disease Progression|1|||
156646807|NCT02544633|565455168|FG000|Survival Follow-up Period|Death|12|||
156646808|NCT02544633|565455169|FG001|Survival Follow-up Period|Death|14|||
156646809|NCT02544633|565455170|FG002|Survival Follow-up Period|Death|3|||
156646810|NCT02544633|565455171|FG003|Survival Follow-up Period|Death|9|||
156646811|NCT02544633|565455168|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
156646812|NCT02544633|565455169|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
156646813|NCT02544633|565455170|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
156646814|NCT02544633|565455171|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
156646815|NCT02544633|565455168|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
156646816|NCT02544633|565455169|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
156646817|NCT02544633|565455170|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
156646818|NCT02544633|565455171|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
156646819|NCT02544633|565455168|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
156646820|NCT02544633|565455169|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
156646821|NCT02544633|565455170|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
156646822|NCT02544633|565455171|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
156646823|NCT01605461|565455172|FG000|Overall Study|Lost to Follow-up|3|||
156646824|NCT01605461|565455172|FG000|Overall Study|Withdrawal by Subject|1|||
156646825|NCT01312779|565455175|FG000|Overall Study|Withdrawal by Subject|2|||
156646826|NCT01312779|565455175|FG000|Overall Study|Death|3|||
156646827|NCT01312779|565455175|FG000|Overall Study|Not Implanted with Device|27|||
156646828|NCT00506753|565455176|FG000|Overall Study|Lost to Follow-up|21|||
156646829|NCT00506753|565455177|FG001|Overall Study|Lost to Follow-up|15|||
156646830|NCT02451670|565455178|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
156646831|NCT02451670|565455179|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
156646832|NCT03549130|565455185|FG000|Overall Study|Adverse Event|0|||
156646833|NCT03549130|565455186|FG001|Overall Study|Adverse Event|1|||
156646834|NCT03549130|565455185|FG000|Overall Study|Lost to Follow-up|0|||
156646835|NCT03549130|565455186|FG001|Overall Study|Lost to Follow-up|1|||
156646836|NCT01078623|565455187|FG000|Treatment Period 1|Adverse Event|1|||
156646837|NCT01078623|565455188|FG001|Treatment Period 1|Adverse Event|1|||
156646838|NCT01078623|565455189|FG002|Treatment Period 1|Adverse Event|1|||
156646839|NCT01078623|565455190|FG003|Treatment Period 1|Adverse Event|0|||
156646840|NCT01078623|565455191|FG004|Treatment Period 1|Adverse Event|0|||
156646841|NCT01078623|565455192|FG005|Treatment Period 1|Adverse Event|0|||
156646842|NCT01078623|565455193|FG006|Treatment Period 1|Adverse Event|1|||
156646843|NCT01078623|565455194|FG007|Treatment Period 1|Adverse Event|0|||
156646844|NCT01078623|565455195|FG008|Treatment Period 1|Adverse Event|1|||
156646845|NCT01078623|565455196|FG009|Treatment Period 1|Adverse Event|1|||
156646846|NCT01078623|565455197|FG010|Treatment Period 1|Adverse Event|0|||
156646847|NCT01078623|565455198|FG011|Treatment Period 1|Adverse Event|0|||
156646848|NCT01078623|565455199|FG012|Treatment Period 1|Adverse Event|0|||
156646849|NCT01078623|565455200|FG013|Treatment Period 1|Adverse Event|0|||
156646850|NCT01078623|565455201|FG014|Treatment Period 1|Adverse Event|0|||
156646851|NCT01078623|565455202|FG015|Treatment Period 1|Adverse Event|0|||
156646852|NCT01078623|565455203|FG016|Treatment Period 1|Adverse Event|0|||
156646853|NCT01078623|565455204|FG017|Treatment Period 1|Adverse Event|0|||
156646854|NCT01078623|565455205|FG018|Treatment Period 1|Adverse Event|0|||
156646855|NCT01078623|565455206|FG019|Treatment Period 1|Adverse Event|0|||
156646856|NCT01078623|565455187|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156646857|NCT01078623|565455188|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156646858|NCT01078623|565455189|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156646859|NCT01078623|565455190|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156646860|NCT01078623|565455191|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156646861|NCT01078623|565455192|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156646862|NCT01078623|565455193|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156646863|NCT01078623|565455194|FG007|Treatment Period 1|Withdrawal by Subject|1|||
156646864|NCT01078623|565455195|FG008|Treatment Period 1|Withdrawal by Subject|0|||
156646865|NCT01078623|565455196|FG009|Treatment Period 1|Withdrawal by Subject|0|||
156646866|NCT01078623|565455197|FG010|Treatment Period 1|Withdrawal by Subject|1|||
156646867|NCT01078623|565455198|FG011|Treatment Period 1|Withdrawal by Subject|0|||
156646868|NCT01078623|565455199|FG012|Treatment Period 1|Withdrawal by Subject|0|||
156646869|NCT01078623|565455200|FG013|Treatment Period 1|Withdrawal by Subject|0|||
156646870|NCT01078623|565455201|FG014|Treatment Period 1|Withdrawal by Subject|0|||
156646871|NCT01078623|565455202|FG015|Treatment Period 1|Withdrawal by Subject|0|||
156646872|NCT01078623|565455203|FG016|Treatment Period 1|Withdrawal by Subject|0|||
156646873|NCT01078623|565455204|FG017|Treatment Period 1|Withdrawal by Subject|0|||
156646874|NCT01078623|565455205|FG018|Treatment Period 1|Withdrawal by Subject|0|||
156646875|NCT01078623|565455206|FG019|Treatment Period 1|Withdrawal by Subject|0|||
156646876|NCT01078623|565455187|FG000|Treatment Period 1|Protocol Violation|0|||
156646877|NCT01078623|565455188|FG001|Treatment Period 1|Protocol Violation|0|||
156646878|NCT01078623|565455189|FG002|Treatment Period 1|Protocol Violation|0|||
156646879|NCT01078623|565455190|FG003|Treatment Period 1|Protocol Violation|0|||
156646880|NCT01078623|565455191|FG004|Treatment Period 1|Protocol Violation|0|||
156646881|NCT01078623|565455192|FG005|Treatment Period 1|Protocol Violation|1|||
156646882|NCT01078623|565455193|FG006|Treatment Period 1|Protocol Violation|0|||
156646883|NCT01078623|565455194|FG007|Treatment Period 1|Protocol Violation|0|||
156646884|NCT01078623|565455195|FG008|Treatment Period 1|Protocol Violation|0|||
156646885|NCT01078623|565455196|FG009|Treatment Period 1|Protocol Violation|0|||
156646886|NCT01078623|565455197|FG010|Treatment Period 1|Protocol Violation|0|||
156646887|NCT01078623|565455198|FG011|Treatment Period 1|Protocol Violation|0|||
156646888|NCT01078623|565455199|FG012|Treatment Period 1|Protocol Violation|0|||
156646889|NCT01078623|565455200|FG013|Treatment Period 1|Protocol Violation|0|||
156646890|NCT01078623|565455201|FG014|Treatment Period 1|Protocol Violation|0|||
156646891|NCT01078623|565455202|FG015|Treatment Period 1|Protocol Violation|0|||
156646892|NCT01078623|565455203|FG016|Treatment Period 1|Protocol Violation|0|||
156646893|NCT01078623|565455204|FG017|Treatment Period 1|Protocol Violation|0|||
156646894|NCT01078623|565455205|FG018|Treatment Period 1|Protocol Violation|0|||
156646895|NCT01078623|565455206|FG019|Treatment Period 1|Protocol Violation|0|||
156646896|NCT01078623|565455187|FG000|Treatment Period 2|Adverse Event|0|||
156646897|NCT01078623|565455188|FG001|Treatment Period 2|Adverse Event|0|||
156646898|NCT01078623|565455189|FG002|Treatment Period 2|Adverse Event|0|||
156646899|NCT01078623|565455190|FG003|Treatment Period 2|Adverse Event|0|||
156646900|NCT01078623|565455191|FG004|Treatment Period 2|Adverse Event|0|||
156646901|NCT01078623|565455192|FG005|Treatment Period 2|Adverse Event|0|||
156646902|NCT01078623|565455193|FG006|Treatment Period 2|Adverse Event|1|||
156646903|NCT01078623|565455194|FG007|Treatment Period 2|Adverse Event|0|||
156646904|NCT01078623|565455195|FG008|Treatment Period 2|Adverse Event|0|||
156646905|NCT01078623|565455196|FG009|Treatment Period 2|Adverse Event|0|||
156646906|NCT01078623|565455197|FG010|Treatment Period 2|Adverse Event|0|||
156646907|NCT01078623|565455198|FG011|Treatment Period 2|Adverse Event|0|||
156646908|NCT01078623|565455199|FG012|Treatment Period 2|Adverse Event|0|||
156646909|NCT01078623|565455200|FG013|Treatment Period 2|Adverse Event|0|||
156646910|NCT01078623|565455201|FG014|Treatment Period 2|Adverse Event|0|||
156646911|NCT01078623|565455202|FG015|Treatment Period 2|Adverse Event|0|||
156646912|NCT01078623|565455203|FG016|Treatment Period 2|Adverse Event|0|||
156646913|NCT01078623|565455204|FG017|Treatment Period 2|Adverse Event|0|||
156646914|NCT01078623|565455205|FG018|Treatment Period 2|Adverse Event|1|||
156646915|NCT01078623|565455206|FG019|Treatment Period 2|Adverse Event|0|||
156646916|NCT01078623|565455187|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156646917|NCT01078623|565455188|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156646918|NCT01078623|565455189|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156646919|NCT01078623|565455190|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156646920|NCT01078623|565455191|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156646921|NCT01078623|565455192|FG005|Treatment Period 2|Withdrawal by Subject|1|||
156646922|NCT01078623|565455193|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156646923|NCT01078623|565455194|FG007|Treatment Period 2|Withdrawal by Subject|0|||
156646924|NCT01078623|565455195|FG008|Treatment Period 2|Withdrawal by Subject|0|||
156646925|NCT01078623|565455196|FG009|Treatment Period 2|Withdrawal by Subject|0|||
156646926|NCT01078623|565455197|FG010|Treatment Period 2|Withdrawal by Subject|0|||
156646927|NCT01078623|565455198|FG011|Treatment Period 2|Withdrawal by Subject|0|||
156646928|NCT01078623|565455199|FG012|Treatment Period 2|Withdrawal by Subject|0|||
156646929|NCT01078623|565455200|FG013|Treatment Period 2|Withdrawal by Subject|0|||
156646930|NCT01078623|565455201|FG014|Treatment Period 2|Withdrawal by Subject|0|||
156646931|NCT01078623|565455202|FG015|Treatment Period 2|Withdrawal by Subject|0|||
156646932|NCT01078623|565455203|FG016|Treatment Period 2|Withdrawal by Subject|0|||
156646933|NCT01078623|565455204|FG017|Treatment Period 2|Withdrawal by Subject|0|||
156646934|NCT01078623|565455205|FG018|Treatment Period 2|Withdrawal by Subject|0|||
156646935|NCT01078623|565455206|FG019|Treatment Period 2|Withdrawal by Subject|0|||
156646936|NCT01078623|565455187|FG000|Treatment Period 3|Adverse Event|0|||
156646937|NCT01078623|565455188|FG001|Treatment Period 3|Adverse Event|0|||
156646938|NCT01078623|565455189|FG002|Treatment Period 3|Adverse Event|0|||
156646939|NCT01078623|565455190|FG003|Treatment Period 3|Adverse Event|0|||
156646940|NCT01078623|565455191|FG004|Treatment Period 3|Adverse Event|1|||
156646941|NCT01078623|565455192|FG005|Treatment Period 3|Adverse Event|0|||
156646942|NCT01078623|565455193|FG006|Treatment Period 3|Adverse Event|0|||
156646943|NCT01078623|565455194|FG007|Treatment Period 3|Adverse Event|0|||
156646944|NCT01078623|565455195|FG008|Treatment Period 3|Adverse Event|0|||
156646945|NCT01078623|565455196|FG009|Treatment Period 3|Adverse Event|0|||
156646946|NCT01078623|565455197|FG010|Treatment Period 3|Adverse Event|0|||
156646947|NCT01078623|565455198|FG011|Treatment Period 3|Adverse Event|0|||
156646948|NCT01078623|565455199|FG012|Treatment Period 3|Adverse Event|0|||
156646949|NCT01078623|565455200|FG013|Treatment Period 3|Adverse Event|1|||
156646950|NCT01078623|565455201|FG014|Treatment Period 3|Adverse Event|0|||
156646951|NCT01078623|565455202|FG015|Treatment Period 3|Adverse Event|0|||
156646952|NCT01078623|565455203|FG016|Treatment Period 3|Adverse Event|0|||
156646953|NCT01078623|565455204|FG017|Treatment Period 3|Adverse Event|0|||
156646954|NCT01078623|565455205|FG018|Treatment Period 3|Adverse Event|0|||
156646955|NCT01078623|565455206|FG019|Treatment Period 3|Adverse Event|0|||
156646956|NCT01078623|565455187|FG000|Treatment Period 4|Adverse Event|0|||
156646957|NCT01078623|565455188|FG001|Treatment Period 4|Adverse Event|0|||
156646958|NCT01078623|565455189|FG002|Treatment Period 4|Adverse Event|1|||
156646959|NCT01078623|565455190|FG003|Treatment Period 4|Adverse Event|0|||
156646960|NCT01078623|565455191|FG004|Treatment Period 4|Adverse Event|0|||
156646961|NCT01078623|565455192|FG005|Treatment Period 4|Adverse Event|0|||
156646962|NCT01078623|565455193|FG006|Treatment Period 4|Adverse Event|0|||
156646963|NCT01078623|565455194|FG007|Treatment Period 4|Adverse Event|0|||
156646964|NCT01078623|565455195|FG008|Treatment Period 4|Adverse Event|0|||
156646965|NCT01078623|565455196|FG009|Treatment Period 4|Adverse Event|0|||
156646966|NCT01078623|565455197|FG010|Treatment Period 4|Adverse Event|0|||
156646967|NCT01078623|565455198|FG011|Treatment Period 4|Adverse Event|0|||
156646968|NCT01078623|565455199|FG012|Treatment Period 4|Adverse Event|0|||
156646969|NCT01078623|565455200|FG013|Treatment Period 4|Adverse Event|0|||
156646970|NCT01078623|565455201|FG014|Treatment Period 4|Adverse Event|0|||
156646971|NCT01078623|565455202|FG015|Treatment Period 4|Adverse Event|0|||
156646972|NCT01078623|565455203|FG016|Treatment Period 4|Adverse Event|0|||
156646973|NCT01078623|565455204|FG017|Treatment Period 4|Adverse Event|0|||
156646974|NCT01078623|565455205|FG018|Treatment Period 4|Adverse Event|0|||
156646975|NCT01078623|565455206|FG019|Treatment Period 4|Adverse Event|0|||
156646976|NCT01078623|565455187|FG000|Treatment Period 4|Withdrawal by Subject|0|||
156646977|NCT01078623|565455188|FG001|Treatment Period 4|Withdrawal by Subject|0|||
156646978|NCT01078623|565455189|FG002|Treatment Period 4|Withdrawal by Subject|0|||
156646979|NCT01078623|565455190|FG003|Treatment Period 4|Withdrawal by Subject|0|||
156646980|NCT01078623|565455191|FG004|Treatment Period 4|Withdrawal by Subject|0|||
156646981|NCT01078623|565455192|FG005|Treatment Period 4|Withdrawal by Subject|0|||
156646982|NCT01078623|565455193|FG006|Treatment Period 4|Withdrawal by Subject|0|||
156646983|NCT01078623|565455194|FG007|Treatment Period 4|Withdrawal by Subject|0|||
156646984|NCT01078623|565455195|FG008|Treatment Period 4|Withdrawal by Subject|0|||
156646985|NCT01078623|565455196|FG009|Treatment Period 4|Withdrawal by Subject|0|||
156646986|NCT01078623|565455197|FG010|Treatment Period 4|Withdrawal by Subject|0|||
156646987|NCT01078623|565455198|FG011|Treatment Period 4|Withdrawal by Subject|0|||
156646988|NCT01078623|565455199|FG012|Treatment Period 4|Withdrawal by Subject|0|||
156646989|NCT01078623|565455200|FG013|Treatment Period 4|Withdrawal by Subject|0|||
156646990|NCT01078623|565455201|FG014|Treatment Period 4|Withdrawal by Subject|0|||
156646991|NCT01078623|565455202|FG015|Treatment Period 4|Withdrawal by Subject|1|||
156646992|NCT01078623|565455203|FG016|Treatment Period 4|Withdrawal by Subject|0|||
156646993|NCT01078623|565455204|FG017|Treatment Period 4|Withdrawal by Subject|0|||
156646994|NCT01078623|565455205|FG018|Treatment Period 4|Withdrawal by Subject|0|||
156646995|NCT01078623|565455206|FG019|Treatment Period 4|Withdrawal by Subject|0|||
156646996|NCT00463866|565455207|FG000|Overall Study|Adverse Event|70|||
156646997|NCT00463866|565455208|FG001|Overall Study|Adverse Event|93|||
156646998|NCT00463866|565455207|FG000|Overall Study|Withdrawal by Subject|81|||
156646999|NCT00463866|565455208|FG001|Overall Study|Withdrawal by Subject|79|||
156647000|NCT00463866|565455207|FG000|Overall Study|Lost to Follow-up|46|||
156647001|NCT00463866|565455208|FG001|Overall Study|Lost to Follow-up|55|||
156647002|NCT00463866|565455207|FG000|Overall Study|Incorrect Enrolment|64|||
156647003|NCT00463866|565455208|FG001|Overall Study|Incorrect Enrolment|66|||
156647004|NCT00463866|565455207|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
156647005|NCT00463866|565455208|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
156647006|NCT00463866|565455207|FG000|Overall Study|Safety Reason|1|||
156647007|NCT00463866|565455208|FG001|Overall Study|Safety Reason|3|||
156647008|NCT00463866|565455207|FG000|Overall Study|Mis-Randomization of subject|0|||
156647009|NCT00463866|565455208|FG001|Overall Study|Mis-Randomization of subject|1|||
156647010|NCT00463866|565455207|FG000|Overall Study|Other|22|||
156647011|NCT00463866|565455208|FG001|Overall Study|Other|22|||
156647012|NCT01706198|565455209|FG000|Overall Study|Adverse Event|12|||
156647013|NCT01706198|565455210|FG001|Overall Study|Adverse Event|15|||
156647014|NCT01706198|565455209|FG000|Overall Study|Protocol Violation|7|||
156647015|NCT01706198|565455210|FG001|Overall Study|Protocol Violation|5|||
156647016|NCT01706198|565455209|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
156647017|NCT01706198|565455210|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
156647018|NCT01706198|565455209|FG000|Overall Study|Lost to Follow-up|97|||
156647019|NCT01706198|565455210|FG001|Overall Study|Lost to Follow-up|93|||
156647020|NCT01706198|565455209|FG000|Overall Study|Physician Decision|23|||
156647021|NCT01706198|565455210|FG001|Overall Study|Physician Decision|37|||
156647022|NCT01706198|565455209|FG000|Overall Study|Withdrawal by Subject|23|||
156647023|NCT01706198|565455210|FG001|Overall Study|Withdrawal by Subject|31|||
156647024|NCT02480010|565455216|FG000|Overall Study|Adverse Event|3|||
156647025|NCT02480010|565455217|FG001|Overall Study|Adverse Event|1|||
156647026|NCT02480010|565455216|FG000|Overall Study|Death|1|||
156647027|NCT02480010|565455217|FG001|Overall Study|Death|0|||
156647028|NCT02480010|565455216|FG000|Overall Study|Insufficient therapeutic response|31|||
156647029|NCT02480010|565455217|FG001|Overall Study|Insufficient therapeutic response|29|||
156647030|NCT02480010|565455216|FG000|Overall Study|Refused Treatment|0|||
156647031|NCT02480010|565455217|FG001|Overall Study|Refused Treatment|3|||
156647032|NCT00606684|565455218|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
156647033|NCT00606684|565455219|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
156647034|NCT00606684|565455220|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
156647035|NCT00606684|565455221|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
156647036|NCT00606684|565455222|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
156647037|NCT00606684|565455223|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
156647038|NCT00606684|565455224|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
156647039|NCT00606684|565455218|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
156647040|NCT00606684|565455219|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
156647041|NCT00606684|565455220|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
156647042|NCT00606684|565455221|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
156647043|NCT00606684|565455222|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
156647044|NCT00606684|565455223|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
156647045|NCT00606684|565455224|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
156647046|NCT00606684|565455218|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
156647047|NCT00606684|565455219|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
156647048|NCT00606684|565455220|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
156647049|NCT00606684|565455221|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
156647050|NCT00606684|565455222|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
156647051|NCT00606684|565455223|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
156647052|NCT00606684|565455224|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
156647053|NCT00606684|565455218|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
156647054|NCT00606684|565455219|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
156647055|NCT00606684|565455220|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
156647056|NCT00606684|565455221|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
156647057|NCT00606684|565455222|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
156647058|NCT00606684|565455223|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
156647059|NCT00606684|565455224|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
156647060|NCT00606684|565455218|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
156647061|NCT00606684|565455219|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
156647062|NCT00606684|565455220|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
156647063|NCT00606684|565455221|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
156647064|NCT00606684|565455222|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
156647065|NCT00606684|565455223|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
156647066|NCT00606684|565455224|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
156647067|NCT00606684|565455218|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
156647068|NCT00606684|565455219|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
156647069|NCT00606684|565455220|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
156647070|NCT00606684|565455221|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
156647071|NCT00606684|565455222|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
156647072|NCT00606684|565455223|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
156647073|NCT00606684|565455224|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
156647074|NCT00606684|565455218|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
156647075|NCT00606684|565455219|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
156647076|NCT00606684|565455220|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
156647077|NCT00606684|565455221|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
156647078|NCT00606684|565455222|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
156647079|NCT00606684|565455223|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
156647080|NCT00606684|565455224|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
156647081|NCT00606684|565455218|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156647082|NCT00606684|565455219|FG001|Double-Blind Treatment Period|Adverse Event|3|||
156647083|NCT00606684|565455220|FG002|Double-Blind Treatment Period|Adverse Event|2|||
156647084|NCT00606684|565455221|FG003|Double-Blind Treatment Period|Adverse Event|4|||
156647085|NCT00606684|565455222|FG004|Double-Blind Treatment Period|Adverse Event|2|||
156647086|NCT00606684|565455223|FG005|Double-Blind Treatment Period|Adverse Event|0|||
156647087|NCT00606684|565455224|FG006|Double-Blind Treatment Period|Adverse Event|1|||
156647088|NCT00606684|565455218|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156647089|NCT00606684|565455219|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
156647090|NCT00606684|565455220|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
156647091|NCT00606684|565455221|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
156647092|NCT00606684|565455222|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
156647093|NCT00606684|565455223|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
156647094|NCT00606684|565455224|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
156647095|NCT00606684|565455218|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156647096|NCT00606684|565455219|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
156647097|NCT00606684|565455220|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
156647098|NCT00606684|565455221|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
156647099|NCT00606684|565455222|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
156647100|NCT00606684|565455223|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
156647101|NCT00606684|565455224|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
156647102|NCT00606684|565455218|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
156647103|NCT00606684|565455219|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
156647104|NCT00606684|565455220|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
156647105|NCT00606684|565455221|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
156647106|NCT00606684|565455222|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
156647107|NCT00606684|565455223|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
156647108|NCT00606684|565455224|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
156647109|NCT00606684|565455218|FG000|Double-Blind Treatment Period|Physician Decision|0|||
156647110|NCT00606684|565455219|FG001|Double-Blind Treatment Period|Physician Decision|5|||
156647111|NCT00606684|565455220|FG002|Double-Blind Treatment Period|Physician Decision|1|||
156647112|NCT00606684|565455221|FG003|Double-Blind Treatment Period|Physician Decision|0|||
156647113|NCT00606684|565455222|FG004|Double-Blind Treatment Period|Physician Decision|3|||
156647114|NCT00606684|565455223|FG005|Double-Blind Treatment Period|Physician Decision|1|||
156647115|NCT00606684|565455224|FG006|Double-Blind Treatment Period|Physician Decision|2|||
156647116|NCT00606684|565455218|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156647117|NCT00606684|565455219|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156647118|NCT00606684|565455220|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156647119|NCT00606684|565455221|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156647120|NCT00606684|565455222|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156647121|NCT00606684|565455223|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156647122|NCT00606684|565455224|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156647123|NCT01759381|565455231|FG000|Overall Study|Death|1|||
156647124|NCT01759381|565455232|FG001|Overall Study|Death|0|||
156647125|NCT03377556|565455233|FG000|Overall Study|Adverse Event|5|||
156647126|NCT03377556|565455233|FG000|Overall Study|Refusal unrelated to adverse events|1|||
156647127|NCT03377556|565455233|FG000|Overall Study|Progression/relapse|38|||
156647128|NCT03377556|565455233|FG000|Overall Study|Death|3|||
156647129|NCT00827827|565455234|FG000|Overall Study|Lost to Follow-up|3|||
156647130|NCT00827827|565455235|FG001|Overall Study|Lost to Follow-up|0|||
156647131|NCT00827827|565455234|FG000|Overall Study|Fall at home- hospitalization|1|||
156647132|NCT00827827|565455235|FG001|Overall Study|Fall at home- hospitalization|0|||
156647133|NCT00827827|565455234|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
156647134|NCT00827827|565455235|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
156647135|NCT00827827|565455234|FG000|Overall Study|Gout|1|||
156647136|NCT00827827|565455235|FG001|Overall Study|Gout|0|||
156647137|NCT00827827|565455234|FG000|Overall Study|Transportation issues|1|||
156647138|NCT00827827|565455235|FG001|Overall Study|Transportation issues|0|||
156647139|NCT00827827|565455234|FG000|Overall Study|Burned with water at home|1|||
156647140|NCT00827827|565455235|FG001|Overall Study|Burned with water at home|0|||
156647141|NCT00447603|565455240|FG000|Screening|Withdrawal by Subject|1|||
156412200|NCT02065570|564602847|FG001|Maintenance Study|Withdrawal by Subject|0|||
156412201|NCT02065570|564602848|FG002|Maintenance Study|Withdrawal by Subject|1|||
156412202|NCT02065570|564602849|FG003|Maintenance Study|Withdrawal by Subject|4|||
156647142|NCT00447603|565455241|FG001|Screening|Withdrawal by Subject|0|||
156647143|NCT00447603|565455242|FG002|Screening|Withdrawal by Subject|0|||
156647144|NCT00447603|565455240|FG000|Screening|Protocol Violation|1|||
156647145|NCT00447603|565455241|FG001|Screening|Protocol Violation|0|||
156647146|NCT00447603|565455242|FG002|Screening|Protocol Violation|0|||
156647147|NCT00447603|565455240|FG000|Screening|Screen Failure|4|||
156647148|NCT00447603|565455241|FG001|Screening|Screen Failure|0|||
156647149|NCT00447603|565455242|FG002|Screening|Screen Failure|0|||
156647150|NCT00447603|565455240|FG000|Screening|Study Terminated by Sponsor|15|||
156647151|NCT00447603|565455241|FG001|Screening|Study Terminated by Sponsor|0|||
156647152|NCT00447603|565455242|FG002|Screening|Study Terminated by Sponsor|0|||
156647153|NCT00447603|565455240|FG000|Filter Period|Adverse Event|0|||
156647154|NCT00447603|565455241|FG001|Filter Period|Adverse Event|0|||
156647155|NCT00447603|565455242|FG002|Filter Period|Adverse Event|1|||
156647156|NCT00447603|565455240|FG000|Filter Period|Screen Failure|0|||
156647157|NCT00447603|565455241|FG001|Filter Period|Screen Failure|3|||
156647158|NCT00447603|565455242|FG002|Filter Period|Screen Failure|4|||
156647159|NCT00447603|565455240|FG000|Filter Period|Study terminated by Sponsor|0|||
156647160|NCT00447603|565455241|FG001|Filter Period|Study terminated by Sponsor|1|||
156647161|NCT00447603|565455242|FG002|Filter Period|Study terminated by Sponsor|10|||
156647162|NCT01886300|565455251|FG000|Overall Study|Trial terminated by sponsor|16|||
156647163|NCT00672620|565455252|FG000|Overall Study|Adverse Event|7|||
156647164|NCT00672620|565455253|FG001|Overall Study|Adverse Event|7|||
156647165|NCT00672620|565455254|FG002|Overall Study|Adverse Event|12|||
156647166|NCT00672620|565455255|FG003|Overall Study|Adverse Event|17|||
156647167|NCT00672620|565455252|FG000|Overall Study|Lack of Efficacy|1|||
156647168|NCT00672620|565455253|FG001|Overall Study|Lack of Efficacy|2|||
156647169|NCT00672620|565455254|FG002|Overall Study|Lack of Efficacy|2|||
156647170|NCT00672620|565455255|FG003|Overall Study|Lack of Efficacy|0|||
156647171|NCT00672620|565455252|FG000|Overall Study|Noncompliance with Study Drug|3|||
156647172|NCT00672620|565455253|FG001|Overall Study|Noncompliance with Study Drug|4|||
156647173|NCT00672620|565455254|FG002|Overall Study|Noncompliance with Study Drug|0|||
156647174|NCT00672620|565455255|FG003|Overall Study|Noncompliance with Study Drug|2|||
156647175|NCT00672620|565455252|FG000|Overall Study|Protocol Deviations|5|||
156647176|NCT00672620|565455253|FG001|Overall Study|Protocol Deviations|7|||
156647177|NCT00672620|565455254|FG002|Overall Study|Protocol Deviations|2|||
156647178|NCT00672620|565455255|FG003|Overall Study|Protocol Deviations|5|||
156647179|NCT00672620|565455252|FG000|Overall Study|Withdrawal of Consent|6|||
156647180|NCT00672620|565455253|FG001|Overall Study|Withdrawal of Consent|12|||
156647181|NCT00672620|565455254|FG002|Overall Study|Withdrawal of Consent|5|||
156647182|NCT00672620|565455255|FG003|Overall Study|Withdrawal of Consent|6|||
156647183|NCT00672620|565455252|FG000|Overall Study|Lost to Follow-up|8|||
156647184|NCT00672620|565455253|FG001|Overall Study|Lost to Follow-up|19|||
156647185|NCT00672620|565455254|FG002|Overall Study|Lost to Follow-up|8|||
156647186|NCT00672620|565455255|FG003|Overall Study|Lost to Follow-up|11|||
156647187|NCT00672620|565455252|FG000|Overall Study|Reason not Specified|3|||
156647188|NCT00672620|565455253|FG001|Overall Study|Reason not Specified|3|||
156647189|NCT00672620|565455254|FG002|Overall Study|Reason not Specified|2|||
156647190|NCT00672620|565455255|FG003|Overall Study|Reason not Specified|1|||
156647191|NCT00219557|565455261|FG000|Phase 1|Lack of Efficacy|3|||
156647192|NCT00219557|565455262|FG001|Phase 1|Lack of Efficacy|0|||
156647193|NCT00219557|565455263|FG002|Phase 1|Lack of Efficacy|0|||
156647194|NCT00219557|565455261|FG000|Phase 1|Adverse Event|2|||
156412203|NCT02065570|564602846|FG000|Maintenance Study|Lost to Follow-up|0|||
156412204|NCT02065570|564602847|FG001|Maintenance Study|Lost to Follow-up|0|||
156647195|NCT00219557|565455262|FG001|Phase 1|Adverse Event|0|||
156647196|NCT00219557|565455263|FG002|Phase 1|Adverse Event|0|||
156647197|NCT00219557|565455261|FG000|Phase 1|Withdrawal by Subject|1|||
156647198|NCT00219557|565455262|FG001|Phase 1|Withdrawal by Subject|0|||
156647199|NCT00219557|565455263|FG002|Phase 1|Withdrawal by Subject|0|||
156647200|NCT00219557|565455261|FG000|Phase 1|Started chemotherapy at other institute|1|||
156647201|NCT00219557|565455262|FG001|Phase 1|Started chemotherapy at other institute|0|||
156647202|NCT00219557|565455263|FG002|Phase 1|Started chemotherapy at other institute|0|||
156647203|NCT00219557|565455261|FG000|Phase 2|Lack of Efficacy|0|||
156647204|NCT00219557|565455262|FG001|Phase 2|Lack of Efficacy|21|||
156647205|NCT00219557|565455263|FG002|Phase 2|Lack of Efficacy|15|||
156647206|NCT00219557|565455261|FG000|Phase 2|Adverse Event|0|||
156647207|NCT00219557|565455262|FG001|Phase 2|Adverse Event|22|||
156647208|NCT00219557|565455263|FG002|Phase 2|Adverse Event|2|||
156647209|NCT00219557|565455261|FG000|Phase 2|Death|0|||
156647210|NCT00219557|565455262|FG001|Phase 2|Death|8|||
156647211|NCT00219557|565455263|FG002|Phase 2|Death|2|||
156647212|NCT00219557|565455261|FG000|Phase 2|Other|0|||
156647213|NCT00219557|565455262|FG001|Phase 2|Other|8|||
156647214|NCT00219557|565455263|FG002|Phase 2|Other|6|||
156647215|NCT00219557|565455261|FG000|Phase 2|Withdrawal by Subject|0|||
156647216|NCT00219557|565455262|FG001|Phase 2|Withdrawal by Subject|9|||
156647217|NCT00219557|565455263|FG002|Phase 2|Withdrawal by Subject|5|||
156647218|NCT00219557|565455261|FG000|Phase 2|Treatment not received|0|||
156647219|NCT00219557|565455262|FG001|Phase 2|Treatment not received|1|||
156647220|NCT00219557|565455263|FG002|Phase 2|Treatment not received|3|||
156647221|NCT01023269|565455264|FG000|Overall Study|early termination of the study|2|||
156647222|NCT01023269|565455265|FG001|Overall Study|early termination of the study|0|||
156647223|NCT00106028|565455266|FG000|Overall Study|Adverse Event|3|||
156647224|NCT00106028|565455267|FG001|Overall Study|Adverse Event|2|||
156647225|NCT00106028|565455266|FG000|Overall Study|Protocol Violation|1|||
156647226|NCT00106028|565455267|FG001|Overall Study|Protocol Violation|1|||
156647227|NCT00106028|565455266|FG000|Overall Study|Withdrawal by Subject|2|||
156647228|NCT00106028|565455267|FG001|Overall Study|Withdrawal by Subject|8|||
156647229|NCT00106028|565455266|FG000|Overall Study|Lost to Follow-up|0|||
156647230|NCT00106028|565455267|FG001|Overall Study|Lost to Follow-up|1|||
156647231|NCT00947011|565455268|FG000|Overall Study|Study was terminated,PI left institution|12|||
156647232|NCT05266456|565455269|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
156647233|NCT05266456|565455270|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
156647234|NCT05266456|565455271|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
156647235|NCT05266456|565455272|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
156647236|NCT05266456|565455269|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
156647237|NCT05266456|565455270|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
156647238|NCT05266456|565455271|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
156647239|NCT05266456|565455272|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
156647240|NCT05266456|565455269|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
156647241|NCT05266456|565455270|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
156647242|NCT05266456|565455271|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
156647243|NCT05266456|565455272|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
156647244|NCT05266456|565455269|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
156647245|NCT05266456|565455270|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
156647246|NCT05266456|565455271|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
156647247|NCT05266456|565455272|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
156647248|NCT05266456|565455269|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
156647249|NCT05266456|565455270|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
156647250|NCT05266456|565455271|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
156647251|NCT05266456|565455272|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
156647252|NCT00068237|565455273|FG000|Overall Study|Ineligible|3|||
156647253|NCT00068237|565455273|FG000|Overall Study|No protocol treatment received|2|||
156647254|NCT01504867|565455277|FG000|Overall Study|Inclusion criteria not met|2|||
156647255|NCT01504867|565455278|FG001|Overall Study|Inclusion criteria not met|2|||
156647256|NCT01504867|565455277|FG000|Overall Study|Consent revoked|5|||
156647257|NCT01504867|565455278|FG001|Overall Study|Consent revoked|1|||
156647258|NCT00571922|565455284|FG000|Overall Study|Completion unknown|36|||
156647259|NCT00571922|565455285|FG001|Overall Study|Completion unknown|36|||
156647260|NCT03124381|565455286|FG000|Overall Study|Lost to Follow-up|1|||
156647261|NCT03124381|565455287|FG001|Overall Study|Lost to Follow-up|1|||
156647262|NCT03124381|565455286|FG000|Overall Study|Withdrawal by Subject|6|||
156647263|NCT03124381|565455287|FG001|Overall Study|Withdrawal by Subject|3|||
156647264|NCT03124381|565455286|FG000|Overall Study|Protocol Violation|0|||
156647265|NCT03124381|565455287|FG001|Overall Study|Protocol Violation|1|||
156647266|NCT03124381|565455286|FG000|Overall Study|Adverse Event|1|||
156647267|NCT03124381|565455287|FG001|Overall Study|Adverse Event|1|||
156647268|NCT03124381|565455286|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
156647269|NCT03124381|565455287|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
156647270|NCT02533999|565455293|FG000|Overall Study|Lost to Follow-up|3|||
156647271|NCT02533999|565455294|FG001|Overall Study|Lost to Follow-up|5|||
156647272|NCT02533999|565455293|FG000|Overall Study|Protocol Violation|3|||
156647273|NCT02533999|565455294|FG001|Overall Study|Protocol Violation|0|||
156647274|NCT02533999|565455293|FG000|Overall Study|Adverse Event|0|||
156647275|NCT02533999|565455294|FG001|Overall Study|Adverse Event|1|||
156647276|NCT02533999|565455293|FG000|Overall Study|Randomized but intervention not received|0|||
156647277|NCT02533999|565455294|FG001|Overall Study|Randomized but intervention not received|1|||
156647278|NCT05017493|565455297|FG000|Overall Study|Withdrawal by Subject|26|||
156647279|NCT05017493|565455298|FG001|Overall Study|Withdrawal by Subject|0|||
156647280|NCT05017493|565455297|FG000|Overall Study|Physician Decision|15|||
156647281|NCT05017493|565455298|FG001|Overall Study|Physician Decision|0|||
156647282|NCT05017493|565455297|FG000|Overall Study|Protocol Violation|81|||
156647283|NCT05017493|565455298|FG001|Overall Study|Protocol Violation|0|||
156412205|NCT02065570|564602848|FG002|Maintenance Study|Lost to Follow-up|2|||
156412206|NCT02065570|564602849|FG003|Maintenance Study|Lost to Follow-up|2|||
156647284|NCT01154153|565455299|FG000|Overall Study|Poor compliance to protocol|2|||
156647285|NCT01154153|565455300|FG001|Overall Study|Poor compliance to protocol|0|||
156647286|NCT01154153|565455299|FG000|Overall Study|Unable to use labs|2|||
156647287|NCT01154153|565455300|FG001|Overall Study|Unable to use labs|3|||
156647288|NCT01154153|565455299|FG000|Overall Study|Withdrew consent|1|||
156647289|NCT01154153|565455300|FG001|Overall Study|Withdrew consent|0|||
156647290|NCT02473510|565455301|FG000|Overall Study|Lost to Follow-up|1|||
156647291|NCT02473510|565455302|FG001|Overall Study|Lost to Follow-up|2|||
156647292|NCT03940586|565455306|FG000|Overall Study|Death|3|||
156647293|NCT03940586|565455307|FG001|Overall Study|Death|2|||
156647294|NCT03940586|565455308|FG002|Overall Study|Death|0|||
156647295|NCT03940586|565455306|FG000|Overall Study|Physician Decision|1|||
156647296|NCT03940586|565455307|FG001|Overall Study|Physician Decision|0|||
156647297|NCT03940586|565455308|FG002|Overall Study|Physician Decision|1|||
156647298|NCT03940586|565455306|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
156647299|NCT03940586|565455307|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
156647300|NCT03940586|565455308|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
156647301|NCT03940586|565455306|FG000|Overall Study|Not Treated|0|||
156647302|NCT03940586|565455307|FG001|Overall Study|Not Treated|2|||
156647303|NCT03940586|565455308|FG002|Overall Study|Not Treated|0|||
156647304|NCT00964223|565455309|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
156647305|NCT02006147|565455310|FG000|Overall Study|Protocol Violation|1|||
156647306|NCT02006147|565455311|FG001|Overall Study|Protocol Violation|1|||
156647307|NCT02006147|565455312|FG002|Overall Study|Protocol Violation|0|||
156647308|NCT02006147|565455313|FG003|Overall Study|Protocol Violation|0|||
156647309|NCT02006147|565455310|FG000|Overall Study|Withdrawal by Subject|0|||
156647310|NCT02006147|565455311|FG001|Overall Study|Withdrawal by Subject|1|||
156647311|NCT02006147|565455312|FG002|Overall Study|Withdrawal by Subject|0|||
156647312|NCT02006147|565455313|FG003|Overall Study|Withdrawal by Subject|0|||
156647313|NCT02006147|565455310|FG000|Overall Study|Withdrawal by Sponsor|1|||
156647314|NCT02006147|565455311|FG001|Overall Study|Withdrawal by Sponsor|0|||
156647315|NCT02006147|565455312|FG002|Overall Study|Withdrawal by Sponsor|0|||
156647316|NCT02006147|565455313|FG003|Overall Study|Withdrawal by Sponsor|0|||
156647317|NCT03404206|565455314|FG000|Overall Study|Withdrawal by Subject|1|||
156647318|NCT03404206|565455315|FG001|Overall Study|Withdrawal by Subject|1|||
156647319|NCT03404206|565455316|FG002|Overall Study|Withdrawal by Subject|0|||
156647320|NCT03404206|565455314|FG000|Overall Study|Lost to Follow-up|3|||
156647321|NCT03404206|565455315|FG001|Overall Study|Lost to Follow-up|1|||
156647322|NCT03404206|565455316|FG002|Overall Study|Lost to Follow-up|0|||
156647323|NCT05478603|565455317|FG000|Overall Study|Withdrawal by Subject|0|||
156647324|NCT05478603|565455318|FG001|Overall Study|Withdrawal by Subject|1|||
156647325|NCT05478603|565455319|FG002|Overall Study|Withdrawal by Subject|0|||
156647326|NCT05478603|565455320|FG003|Overall Study|Withdrawal by Subject|0|||
156647327|NCT00990093|565455323|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
156647328|NCT00990093|565455324|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
156647329|NCT00990093|565455323|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
156647330|NCT00990093|565455324|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
156647331|NCT00990093|565455323|FG000|Test Period 1 (1-14 Days)|Other|1|||
156647332|NCT00990093|565455324|FG001|Test Period 1 (1-14 Days)|Other|0|||
156647333|NCT00990093|565455323|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
156647334|NCT00990093|565455324|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
156647335|NCT00990093|565455323|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
156647336|NCT00990093|565455324|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
156647337|NCT00990093|565455323|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
156647338|NCT00990093|565455324|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
156647339|NCT00990093|565455323|FG000|Test Period 2 (15-28 Days)|Other|0|||
156647340|NCT00990093|565455324|FG001|Test Period 2 (15-28 Days)|Other|1|||
156647341|NCT04147611|565455326|FG000|Overall Study|Physician Decision|0|||
156647342|NCT04147611|565455327|FG001|Overall Study|Physician Decision|1|||
156647343|NCT01010230|565455328|FG000|Overall Study|Withdrawal by Subject|6|||
156647344|NCT01010230|565455329|FG001|Overall Study|Withdrawal by Subject|5|||
156647345|NCT01010230|565455328|FG000|Overall Study|Lost to Follow-up|4|||
156647346|NCT01010230|565455329|FG001|Overall Study|Lost to Follow-up|2|||
156647347|NCT00530439|565455330|FG000|Overall Study|GDM|9|||
156647348|NCT00530439|565455331|FG001|Overall Study|GDM|3|||
156647349|NCT00530439|565455330|FG000|Overall Study|Withdraw|18|||
156647350|NCT00530439|565455331|FG001|Overall Study|Withdraw|14|||
156647351|NCT00530439|565455330|FG000|Overall Study|Missed abortion|1|||
156647352|NCT00530439|565455331|FG001|Overall Study|Missed abortion|4|||
156647353|NCT00530439|565455330|FG000|Overall Study|Misclassification|2|||
156647354|NCT00530439|565455331|FG001|Overall Study|Misclassification|0|||
156647355|NCT00530439|565455330|FG000|Overall Study|Twin pregnancy|0|||
156647356|NCT00530439|565455331|FG001|Overall Study|Twin pregnancy|2|||
156647357|NCT00530439|565455330|FG000|Overall Study|Severe malformation/abortion|0|||
156647358|NCT00530439|565455331|FG001|Overall Study|Severe malformation/abortion|3|||
156647359|NCT01585831|565455338|FG000|Overall Study|Physician Decision|0|||
156647360|NCT01585831|565455339|FG001|Overall Study|Physician Decision|1|||
156647361|NCT01585831|565455338|FG000|Overall Study|Withdrawal by Subject|2|||
156647362|NCT01585831|565455339|FG001|Overall Study|Withdrawal by Subject|1|||
156647363|NCT01123980|565455340|FG000|Overall Study|Adverse Event|1|||
156647364|NCT01123980|565455341|FG001|Overall Study|Adverse Event|1|||
156647365|NCT01123980|565455340|FG000|Overall Study|Lack of Efficacy|1|||
156412207|NCT02065570|564602846|FG000|Maintenance Study|Other, Not Specified|0|||
156412208|NCT02065570|564602847|FG001|Maintenance Study|Other, Not Specified|0|||
156412209|NCT02065570|564602848|FG002|Maintenance Study|Other, Not Specified|11|||
156412210|NCT02065570|564602849|FG003|Maintenance Study|Other, Not Specified|5|||
156647366|NCT01123980|565455341|FG001|Overall Study|Lack of Efficacy|0|||
156647367|NCT01123980|565455340|FG000|Overall Study|Physician Decision|0|||
156647368|NCT01123980|565455341|FG001|Overall Study|Physician Decision|1|||
156647369|NCT01123980|565455340|FG000|Overall Study|Lost to Follow-up|0|||
156647370|NCT01123980|565455341|FG001|Overall Study|Lost to Follow-up|6|||
156647371|NCT01123980|565455340|FG000|Overall Study|Protocol Violation|6|||
156647372|NCT01123980|565455341|FG001|Overall Study|Protocol Violation|6|||
156647373|NCT01123980|565455340|FG000|Overall Study|Withdrawal by Subject|5|||
156647374|NCT01123980|565455341|FG001|Overall Study|Withdrawal by Subject|3|||
156647375|NCT01123980|565455340|FG000|Overall Study|Unclassified|6|||
156647376|NCT01123980|565455341|FG001|Overall Study|Unclassified|7|||
156647377|NCT04385199|565455342|FG000|Overall Study|Withdrawal by Subject|1|||
156647378|NCT04385199|565455343|FG001|Overall Study|Withdrawal by Subject|0|||
156647379|NCT01225991|565455344|FG000|Overall Study|Withdrawal by Subject|6|||
156647380|NCT04444752|565455345|FG000|Overall Study|Adverse Event|1|||
156647381|NCT04444752|565455346|FG001|Overall Study|Adverse Event|0|||
156647382|NCT04444752|565455347|FG002|Overall Study|Adverse Event|0|||
156647383|NCT04444752|565455348|FG003|Overall Study|Adverse Event|2|||
156647384|NCT04444752|565455345|FG000|Overall Study|Lost to Follow-up|2|||
156647385|NCT04444752|565455346|FG001|Overall Study|Lost to Follow-up|6|||
156647386|NCT04444752|565455347|FG002|Overall Study|Lost to Follow-up|2|||
156647387|NCT04444752|565455348|FG003|Overall Study|Lost to Follow-up|5|||
156647388|NCT04444752|565455345|FG000|Overall Study|Physician Decision|0|||
156647389|NCT04444752|565455346|FG001|Overall Study|Physician Decision|0|||
156647390|NCT04444752|565455347|FG002|Overall Study|Physician Decision|0|||
156647391|NCT04444752|565455348|FG003|Overall Study|Physician Decision|2|||
156647392|NCT04444752|565455345|FG000|Overall Study|Pregnancy|0|||
156647393|NCT04444752|565455346|FG001|Overall Study|Pregnancy|0|||
156647394|NCT04444752|565455347|FG002|Overall Study|Pregnancy|0|||
156647395|NCT04444752|565455348|FG003|Overall Study|Pregnancy|1|||
156647396|NCT04444752|565455345|FG000|Overall Study|Withdrawal by Subject|6|||
156647397|NCT04444752|565455346|FG001|Overall Study|Withdrawal by Subject|5|||
156647398|NCT04444752|565455347|FG002|Overall Study|Withdrawal by Subject|3|||
156647399|NCT04444752|565455348|FG003|Overall Study|Withdrawal by Subject|4|||
156647400|NCT04444752|565455345|FG000|Overall Study|Protocol Violation|1|||
156647401|NCT04444752|565455346|FG001|Overall Study|Protocol Violation|1|||
156647402|NCT04444752|565455347|FG002|Overall Study|Protocol Violation|0|||
156647403|NCT04444752|565455348|FG003|Overall Study|Protocol Violation|0|||
156647404|NCT04444752|565455345|FG000|Overall Study|Patient moving out of town|1|||
156647405|NCT04444752|565455346|FG001|Overall Study|Patient moving out of town|0|||
156647406|NCT04444752|565455347|FG002|Overall Study|Patient moving out of town|0|||
156647407|NCT04444752|565455348|FG003|Overall Study|Patient moving out of town|1|||
156647408|NCT04444752|565455345|FG000|Overall Study|Lack of Efficacy|0|||
156412211|NCT02743793|564602850|FG000|Overall Study|Death|1|||
156647409|NCT04444752|565455346|FG001|Overall Study|Lack of Efficacy|0|||
156647410|NCT04444752|565455347|FG002|Overall Study|Lack of Efficacy|0|||
156647411|NCT04444752|565455348|FG003|Overall Study|Lack of Efficacy|1|||
156647412|NCT04444752|565455345|FG000|Overall Study|Death|0|||
156412212|NCT02743793|564602851|FG001|Overall Study|Death|1|||
156647413|NCT04444752|565455346|FG001|Overall Study|Death|0|||
156647414|NCT04444752|565455347|FG002|Overall Study|Death|1|||
156647415|NCT04444752|565455348|FG003|Overall Study|Death|0|||
156647416|NCT00579254|565455349|FG000|Overall Study|Lost to Follow-up|39|||
156647417|NCT00579254|565455349|FG000|Overall Study|Discontinued when study terminated|73|||
156647418|NCT02557672|565455350|FG000|Overall Study|Withdrawal by Subject|4|||
156647419|NCT02557672|565455351|FG001|Overall Study|Withdrawal by Subject|2|||
156647420|NCT03705169|565455352|FG000|Overall Study|Lost to Follow-up|0|||
156647421|NCT03705169|565455353|FG001|Overall Study|Lost to Follow-up|0|||
156647422|NCT03705169|565455354|FG002|Overall Study|Lost to Follow-up|0|||
156647423|NCT03705169|565455355|FG003|Overall Study|Lost to Follow-up|2|||
156647424|NCT03705169|565455356|FG004|Overall Study|Lost to Follow-up|0|||
156647425|NCT03705169|565455357|FG005|Overall Study|Lost to Follow-up|2|||
156647426|NCT03705169|565455358|FG006|Overall Study|Lost to Follow-up|1|||
156647427|NCT03705169|565455359|FG007|Overall Study|Lost to Follow-up|0|||
156647428|NCT03705169|565455360|FG008|Overall Study|Lost to Follow-up|0|||
156647429|NCT03705169|565455361|FG009|Overall Study|Lost to Follow-up|1|||
156412213|NCT02743793|564602850|FG000|Overall Study|Withdrawal by Subject|0|||
156412214|NCT02743793|564602851|FG001|Overall Study|Withdrawal by Subject|1|||
156412215|NCT02743793|564602850|FG000|Overall Study|Screen Failure|4|||
156647430|NCT03705169|565455352|FG000|Overall Study|Adverse Event|0|||
156647431|NCT03705169|565455353|FG001|Overall Study|Adverse Event|0|||
156647432|NCT03705169|565455354|FG002|Overall Study|Adverse Event|0|||
156647433|NCT03705169|565455355|FG003|Overall Study|Adverse Event|1|||
156647434|NCT03705169|565455356|FG004|Overall Study|Adverse Event|0|||
156647435|NCT03705169|565455357|FG005|Overall Study|Adverse Event|0|||
156647436|NCT03705169|565455358|FG006|Overall Study|Adverse Event|0|||
156647437|NCT03705169|565455359|FG007|Overall Study|Adverse Event|0|||
156647438|NCT03705169|565455360|FG008|Overall Study|Adverse Event|0|||
156647439|NCT03705169|565455361|FG009|Overall Study|Adverse Event|0|||
156647440|NCT03705169|565455352|FG000|Overall Study|Site Closure|0|||
156647441|NCT03705169|565455353|FG001|Overall Study|Site Closure|0|||
156647442|NCT03705169|565455354|FG002|Overall Study|Site Closure|0|||
156647443|NCT03705169|565455355|FG003|Overall Study|Site Closure|1|||
156647444|NCT03705169|565455356|FG004|Overall Study|Site Closure|0|||
156647445|NCT03705169|565455357|FG005|Overall Study|Site Closure|0|||
156647446|NCT03705169|565455358|FG006|Overall Study|Site Closure|0|||
156647447|NCT03705169|565455359|FG007|Overall Study|Site Closure|0|||
156647448|NCT03705169|565455360|FG008|Overall Study|Site Closure|0|||
156647449|NCT03705169|565455361|FG009|Overall Study|Site Closure|0|||
156647450|NCT03705169|565455352|FG000|Overall Study|Did not receive study treatment|0|||
156647451|NCT03705169|565455353|FG001|Overall Study|Did not receive study treatment|0|||
156647452|NCT03705169|565455354|FG002|Overall Study|Did not receive study treatment|0|||
156647453|NCT03705169|565455355|FG003|Overall Study|Did not receive study treatment|1|||
156647454|NCT03705169|565455356|FG004|Overall Study|Did not receive study treatment|0|||
156647455|NCT03705169|565455357|FG005|Overall Study|Did not receive study treatment|0|||
156647456|NCT03705169|565455358|FG006|Overall Study|Did not receive study treatment|0|||
156647457|NCT03705169|565455359|FG007|Overall Study|Did not receive study treatment|0|||
156647458|NCT03705169|565455360|FG008|Overall Study|Did not receive study treatment|0|||
156647459|NCT03705169|565455361|FG009|Overall Study|Did not receive study treatment|0|||
156647460|NCT03705169|565455352|FG000|Overall Study|Concerns about study visit compliance|0|||
156647461|NCT03705169|565455353|FG001|Overall Study|Concerns about study visit compliance|0|||
156647462|NCT03705169|565455354|FG002|Overall Study|Concerns about study visit compliance|0|||
156647463|NCT03705169|565455355|FG003|Overall Study|Concerns about study visit compliance|1|||
156647464|NCT03705169|565455356|FG004|Overall Study|Concerns about study visit compliance|0|||
156647465|NCT03705169|565455357|FG005|Overall Study|Concerns about study visit compliance|0|||
156647466|NCT03705169|565455358|FG006|Overall Study|Concerns about study visit compliance|0|||
156647467|NCT03705169|565455359|FG007|Overall Study|Concerns about study visit compliance|0|||
156647468|NCT03705169|565455360|FG008|Overall Study|Concerns about study visit compliance|0|||
156647469|NCT03705169|565455361|FG009|Overall Study|Concerns about study visit compliance|0|||
156647470|NCT00928252|565456804|FG000|Overall Study|Physician Decision|3|||
156647471|NCT02257632|565456805|FG000|Overall Study|Withdrawal by Subject|0|||
156647472|NCT02257632|565456806|FG001|Overall Study|Withdrawal by Subject|1|||
156647473|NCT02257632|565456805|FG000|Overall Study|Adverse Event|1|||
156647474|NCT02257632|565456806|FG001|Overall Study|Adverse Event|2|||
156647475|NCT02468557|565456807|FG000|Overall Study|Adverse Event|1|||
156647476|NCT02468557|565456807|FG000|Overall Study|Death|1|||
156647477|NCT02468557|565456807|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
156647478|NCT02468557|565456807|FG000|Overall Study|All Enrolled but Never Dosed|4|||
156647479|NCT02024698|565456811|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
156647480|NCT02024698|565456812|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
156647481|NCT03322462|565456813|FG000|Overall Study|Technical difficulties|2|||
156647482|NCT03322462|565456813|FG000|Overall Study|Other|1|||
156647483|NCT01393990|565456814|FG000|Overall Study|Adverse Event|0|||
156647484|NCT01393990|565456815|FG001|Overall Study|Adverse Event|0|||
156647485|NCT01393990|565456816|FG002|Overall Study|Adverse Event|0|||
156647486|NCT01393990|565456817|FG003|Overall Study|Adverse Event|0|||
156647487|NCT01393990|565456818|FG004|Overall Study|Adverse Event|0|||
156647488|NCT01393990|565456819|FG005|Overall Study|Adverse Event|0|||
156647489|NCT01393990|565456820|FG006|Overall Study|Adverse Event|0|||
156647490|NCT01393990|565456821|FG007|Overall Study|Adverse Event|0|||
156647491|NCT01393990|565456822|FG008|Overall Study|Adverse Event|0|||
156647492|NCT01393990|565456823|FG009|Overall Study|Adverse Event|0|||
156647493|NCT01393990|565456824|FG010|Overall Study|Adverse Event|0|||
156647494|NCT01393990|565456825|FG011|Overall Study|Adverse Event|0|||
156647495|NCT01393990|565456826|FG012|Overall Study|Adverse Event|0|||
156647496|NCT01393990|565456827|FG013|Overall Study|Adverse Event|0|||
156647497|NCT01393990|565456828|FG014|Overall Study|Adverse Event|1|||
156647498|NCT01393990|565456829|FG015|Overall Study|Adverse Event|1|||
156647499|NCT01393990|565456830|FG016|Overall Study|Adverse Event|0|||
156647500|NCT01393990|565456831|FG017|Overall Study|Adverse Event|0|||
156647501|NCT01393990|565456814|FG000|Overall Study|Progressive Disease|1|||
156647502|NCT01393990|565456815|FG001|Overall Study|Progressive Disease|0|||
156647503|NCT01393990|565456816|FG002|Overall Study|Progressive Disease|0|||
156647504|NCT01393990|565456817|FG003|Overall Study|Progressive Disease|1|||
156647505|NCT01393990|565456818|FG004|Overall Study|Progressive Disease|1|||
156647506|NCT01393990|565456819|FG005|Overall Study|Progressive Disease|1|||
156647507|NCT01393990|565456820|FG006|Overall Study|Progressive Disease|1|||
156647508|NCT01393990|565456821|FG007|Overall Study|Progressive Disease|1|||
156647509|NCT01393990|565456822|FG008|Overall Study|Progressive Disease|3|||
156647510|NCT01393990|565456823|FG009|Overall Study|Progressive Disease|1|||
156647511|NCT01393990|565456824|FG010|Overall Study|Progressive Disease|0|||
156647512|NCT01393990|565456825|FG011|Overall Study|Progressive Disease|0|||
156647513|NCT01393990|565456826|FG012|Overall Study|Progressive Disease|0|||
156647514|NCT01393990|565456827|FG013|Overall Study|Progressive Disease|1|||
156647515|NCT01393990|565456828|FG014|Overall Study|Progressive Disease|6|||
156647516|NCT01393990|565456829|FG015|Overall Study|Progressive Disease|1|||
156647517|NCT01393990|565456830|FG016|Overall Study|Progressive Disease|0|||
156647518|NCT01393990|565456831|FG017|Overall Study|Progressive Disease|0|||
156647519|NCT01393990|565456814|FG000|Overall Study|Death|0|||
156647520|NCT01393990|565456815|FG001|Overall Study|Death|0|||
156647521|NCT01393990|565456816|FG002|Overall Study|Death|0|||
156647522|NCT01393990|565456817|FG003|Overall Study|Death|0|||
156647523|NCT01393990|565456818|FG004|Overall Study|Death|1|||
156647524|NCT01393990|565456819|FG005|Overall Study|Death|0|||
156647525|NCT01393990|565456820|FG006|Overall Study|Death|0|||
156647526|NCT01393990|565456821|FG007|Overall Study|Death|0|||
156647527|NCT01393990|565456822|FG008|Overall Study|Death|0|||
156647528|NCT01393990|565456823|FG009|Overall Study|Death|0|||
156647529|NCT01393990|565456824|FG010|Overall Study|Death|0|||
156647530|NCT01393990|565456825|FG011|Overall Study|Death|0|||
156647531|NCT01393990|565456826|FG012|Overall Study|Death|0|||
156647532|NCT01393990|565456827|FG013|Overall Study|Death|1|||
156647533|NCT01393990|565456828|FG014|Overall Study|Death|1|||
156647534|NCT01393990|565456829|FG015|Overall Study|Death|0|||
156647535|NCT01393990|565456830|FG016|Overall Study|Death|0|||
156647536|NCT01393990|565456831|FG017|Overall Study|Death|0|||
156647537|NCT01393990|565456814|FG000|Overall Study|Withdrawal by Subject|0|||
156647538|NCT01393990|565456815|FG001|Overall Study|Withdrawal by Subject|0|||
156647539|NCT01393990|565456816|FG002|Overall Study|Withdrawal by Subject|0|||
156647540|NCT01393990|565456817|FG003|Overall Study|Withdrawal by Subject|0|||
156647541|NCT01393990|565456818|FG004|Overall Study|Withdrawal by Subject|0|||
156647542|NCT01393990|565456819|FG005|Overall Study|Withdrawal by Subject|0|||
156647543|NCT01393990|565456820|FG006|Overall Study|Withdrawal by Subject|0|||
156647544|NCT01393990|565456821|FG007|Overall Study|Withdrawal by Subject|0|||
156647545|NCT01393990|565456822|FG008|Overall Study|Withdrawal by Subject|0|||
156647546|NCT01393990|565456823|FG009|Overall Study|Withdrawal by Subject|0|||
156647547|NCT01393990|565456824|FG010|Overall Study|Withdrawal by Subject|0|||
156647548|NCT01393990|565456825|FG011|Overall Study|Withdrawal by Subject|0|||
156647549|NCT01393990|565456826|FG012|Overall Study|Withdrawal by Subject|0|||
156647550|NCT01393990|565456827|FG013|Overall Study|Withdrawal by Subject|0|||
156647551|NCT01393990|565456828|FG014|Overall Study|Withdrawal by Subject|1|||
156647552|NCT01393990|565456829|FG015|Overall Study|Withdrawal by Subject|1|||
156647553|NCT01393990|565456830|FG016|Overall Study|Withdrawal by Subject|0|||
156647554|NCT01393990|565456831|FG017|Overall Study|Withdrawal by Subject|0|||
156647555|NCT00720798|565456837|FG000|Overall Study|Adverse Event|304|||
156647556|NCT00720798|565456837|FG000|Overall Study|Death|39|||
156647557|NCT00720798|565456837|FG000|Overall Study|Insufficient Therapeutic Response|129|||
156647558|NCT00720798|565456837|FG000|Overall Study|Protocol Violation|4|||
156647559|NCT00720798|565456837|FG000|Overall Study|Refused Treatment|151|||
156647560|NCT00720798|565456837|FG000|Overall Study|Failure to Return|46|||
156647561|NCT00720798|565456837|FG000|Overall Study|Reason not Specified|83|||
156647562|NCT02806232|565456841|FG000|Overall Study|Lost to Follow-up|1|||
156647563|NCT02806232|565456842|FG001|Overall Study|Lost to Follow-up|2|||
156647564|NCT02806232|565456843|FG002|Overall Study|Lost to Follow-up|1|||
156647565|NCT02806232|565456844|FG003|Overall Study|Lost to Follow-up|0|||
156647566|NCT02806232|565456845|FG004|Overall Study|Lost to Follow-up|0|||
156647567|NCT02806232|565456846|FG005|Overall Study|Lost to Follow-up|1|||
156647568|NCT02806232|565456847|FG006|Overall Study|Lost to Follow-up|0|||
156647569|NCT02806232|565456848|FG007|Overall Study|Lost to Follow-up|0|||
156647570|NCT02806232|565456849|FG008|Overall Study|Lost to Follow-up|0|||
156647571|NCT02806232|565456841|FG000|Overall Study|Withdrawal by Subject|0|||
156647572|NCT02806232|565456842|FG001|Overall Study|Withdrawal by Subject|2|||
156647573|NCT02806232|565456843|FG002|Overall Study|Withdrawal by Subject|0|||
156647574|NCT02806232|565456844|FG003|Overall Study|Withdrawal by Subject|0|||
156647575|NCT02806232|565456845|FG004|Overall Study|Withdrawal by Subject|2|||
156647576|NCT02806232|565456846|FG005|Overall Study|Withdrawal by Subject|1|||
156647577|NCT02806232|565456847|FG006|Overall Study|Withdrawal by Subject|0|||
156647578|NCT02806232|565456848|FG007|Overall Study|Withdrawal by Subject|0|||
156647579|NCT02806232|565456849|FG008|Overall Study|Withdrawal by Subject|0|||
156412216|NCT02743793|564602851|FG001|Overall Study|Screen Failure|0|||
156412217|NCT02743793|564602850|FG000|Overall Study|No Primary Care Physician|0|||
156647580|NCT00434161|565456852|FG000|Overall Study|Adverse Event|5|||
156647581|NCT00434161|565456853|FG001|Overall Study|Adverse Event|1|||
156647582|NCT00434161|565456854|FG002|Overall Study|Adverse Event|4|||
156647583|NCT00434161|565456852|FG000|Overall Study|Lost to Follow-up|0|||
156647584|NCT00434161|565456853|FG001|Overall Study|Lost to Follow-up|1|||
156647585|NCT00434161|565456854|FG002|Overall Study|Lost to Follow-up|0|||
156647586|NCT00434161|565456852|FG000|Overall Study|Death|1|||
156307570|NCT02891070|564225749|FG000|Overall Study|Adverse Event|1|||
156307571|NCT02891070|564225750|FG001|Overall Study|Adverse Event|0|||
156307572|NCT02891070|564225749|FG000|Overall Study|Physician Decision|0|||
156307573|NCT02891070|564225750|FG001|Overall Study|Physician Decision|1|||
156307574|NCT02891070|564225749|FG000|Overall Study|Lost to Follow-up|4|||
156307575|NCT02891070|564225750|FG001|Overall Study|Lost to Follow-up|4|||
156307576|NCT02891070|564225749|FG000|Overall Study|Other|1|||
156307577|NCT02891070|564225750|FG001|Overall Study|Other|0|||
156307578|NCT02891070|564225749|FG000|Overall Study|Protocol Violation|0|||
156307579|NCT02891070|564225750|FG001|Overall Study|Protocol Violation|1|||
156307580|NCT02891070|564225749|FG000|Overall Study|Withdrawal by Subject|1|||
156307581|NCT02891070|564225750|FG001|Overall Study|Withdrawal by Subject|2|||
156307582|NCT02891070|564225749|FG000|Overall Study|Death|3|||
156307583|NCT02891070|564225750|FG001|Overall Study|Death|0|||
156307589|NCT01716052|564225756|FG000|Overall Study|Withdrawal of funding|1|||
156307590|NCT01716052|564225757|FG001|Overall Study|Withdrawal of funding|1|||
156307591|NCT02527200|564225763|FG000|Overall Study|Withdrawal by Subject|3|||
156307592|NCT02527200|564225764|FG001|Overall Study|Withdrawal by Subject|2|||
156307593|NCT02527200|564225765|FG002|Overall Study|Withdrawal by Subject|1|||
156307594|NCT02527200|564225766|FG003|Overall Study|Withdrawal by Subject|0|||
156307595|NCT02527200|564225763|FG000|Overall Study|Unclassified|0|||
156307596|NCT02527200|564225764|FG001|Overall Study|Unclassified|1|||
156307597|NCT02527200|564225765|FG002|Overall Study|Unclassified|0|||
156307598|NCT02527200|564225766|FG003|Overall Study|Unclassified|0|||
156307599|NCT02527200|564225763|FG000|Overall Study|Lost to Follow-up|0|||
156307600|NCT02527200|564225764|FG001|Overall Study|Lost to Follow-up|0|||
156307601|NCT02527200|564225765|FG002|Overall Study|Lost to Follow-up|1|||
156307602|NCT02527200|564225766|FG003|Overall Study|Lost to Follow-up|0|||
156307603|NCT02597478|564225768|FG000|Overall Study|Withdrawal by Subject|2|||
156307604|NCT02597478|564225769|FG001|Overall Study|Withdrawal by Subject|0|||
156307605|NCT02597478|564225768|FG000|Overall Study|Change of opioid dose|1|||
156307606|NCT02597478|564225769|FG001|Overall Study|Change of opioid dose|0|||
156307607|NCT02597478|564225768|FG000|Overall Study|Insufficient exertional dyspnea|0|||
156307608|NCT02597478|564225769|FG001|Overall Study|Insufficient exertional dyspnea|1|||
156307609|NCT01305577|564225771|FG000|Overall Study|Adverse Event|2|||
156307610|NCT01305577|564225772|FG001|Overall Study|Adverse Event|2|||
156307611|NCT01305577|564225773|FG002|Overall Study|Adverse Event|1|||
156307612|NCT01305577|564225771|FG000|Overall Study|Withdrawal by Subject|7|||
156307613|NCT01305577|564225772|FG001|Overall Study|Withdrawal by Subject|5|||
156307614|NCT01305577|564225773|FG002|Overall Study|Withdrawal by Subject|6|||
156307615|NCT01305577|564225771|FG000|Overall Study|Lost to Follow-up|4|||
156307616|NCT01305577|564225772|FG001|Overall Study|Lost to Follow-up|3|||
156307617|NCT01305577|564225773|FG002|Overall Study|Lost to Follow-up|2|||
156307618|NCT01305577|564225771|FG000|Overall Study|Protocol Deviation|0|||
156307619|NCT01305577|564225772|FG001|Overall Study|Protocol Deviation|1|||
156307620|NCT01305577|564225773|FG002|Overall Study|Protocol Deviation|1|||
156307621|NCT00796978|564225774|FG000|Overall Study|Cardiac adverse event|5|||
156307622|NCT00796978|564225774|FG000|Overall Study|Adverse Event|4|||
156307623|NCT00796978|564225774|FG000|Overall Study|Withdrawal by Subject|3|||
156307624|NCT01256190|564225775|FG000|Overall Study|Lost to Follow-up|2|||
156307625|NCT01256190|564225776|FG001|Overall Study|Lost to Follow-up|0|||
156307626|NCT02834793|564225777|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
156307627|NCT02834793|564225778|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
156307628|NCT02834793|564225779|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
156307629|NCT02834793|564225780|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
156307630|NCT02834793|564225777|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
156307631|NCT02834793|564225778|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
156307632|NCT02834793|564225779|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
156307633|NCT02834793|564225780|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
156307634|NCT02834793|564225777|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
156307635|NCT02834793|564225778|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
156307636|NCT02834793|564225779|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
156307637|NCT02834793|564225780|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
156307638|NCT02834793|564225777|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
156307639|NCT02834793|564225778|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
156307640|NCT02834793|564225779|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
156307641|NCT02834793|564225780|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
156307642|NCT02834793|564225777|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
156307643|NCT02834793|564225778|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
156307644|NCT02834793|564225779|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
156307645|NCT02834793|564225780|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
156307646|NCT02834793|564225777|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
156307647|NCT02834793|564225778|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
156307648|NCT02834793|564225779|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
156307649|NCT02834793|564225780|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
156307650|NCT02834793|564225777|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
156307651|NCT02834793|564225778|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
156307652|NCT02834793|564225779|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
156307653|NCT02834793|564225780|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
156307654|NCT02834793|564225777|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
156307655|NCT02834793|564225778|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
156307656|NCT02834793|564225779|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
156307657|NCT02834793|564225780|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
156307658|NCT02834793|564225777|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
156307659|NCT02834793|564225778|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
156307660|NCT02834793|564225779|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
156307661|NCT02834793|564225780|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
156307662|NCT02834793|564225777|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
156307663|NCT02834793|564225778|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
156307664|NCT02834793|564225779|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
156307665|NCT02834793|564225780|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
156307666|NCT02834793|564225777|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
156307667|NCT02834793|564225778|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
156307668|NCT02834793|564225779|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
156307669|NCT02834793|564225780|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
156307670|NCT02834793|564225777|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
156307671|NCT02834793|564225778|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
156307672|NCT02834793|564225779|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
156307673|NCT02834793|564225780|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
156307674|NCT02834793|564225777|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
156307675|NCT02834793|564225778|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
156307676|NCT02834793|564225779|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
156307677|NCT02834793|564225780|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
156307678|NCT02834793|564225777|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
156307679|NCT02834793|564225778|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
156307680|NCT02834793|564225779|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
156307681|NCT02834793|564225780|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
156307682|NCT02834793|564225777|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
156307683|NCT02834793|564225778|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
156307684|NCT02834793|564225779|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
156307685|NCT02834793|564225780|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
156307686|NCT02364336|564225781|FG000|Overall Study|Adverse Event|0|||
156307687|NCT02364336|564225782|FG001|Overall Study|Adverse Event|1|||
156307688|NCT01731938|564225783|FG000|Preliminary Part I|Withdrawal by Subject|2|||
156307689|NCT01731938|564225784|FG001|Preliminary Part I|Withdrawal by Subject|2|||
156412218|NCT02743793|564602851|FG001|Overall Study|No Primary Care Physician|1|||
156412219|NCT02743793|564602850|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
156307690|NCT01731938|564225783|FG000|Preliminary Part I|Physician Decision|1|||
156307691|NCT01731938|564225784|FG001|Preliminary Part I|Physician Decision|0|||
156307692|NCT01731938|564225783|FG000|Preliminary Part I|Lost to Follow-up|0|||
156307693|NCT01731938|564225784|FG001|Preliminary Part I|Lost to Follow-up|3|||
156307694|NCT01731938|564225783|FG000|Preliminary Part I|Missed Week 6 visit|0|||
156647587|NCT00434161|565456853|FG001|Overall Study|Death|0|||
156647588|NCT00434161|565456854|FG002|Overall Study|Death|1|||
156307695|NCT01731938|564225784|FG001|Preliminary Part I|Missed Week 6 visit|3|||
156307696|NCT01731938|564225783|FG000|Primary Part II|Withdrawal by Subject|5|||
156307697|NCT01731938|564225784|FG001|Primary Part II|Withdrawal by Subject|4|||
156307698|NCT01731938|564225783|FG000|Primary Part II|Lost to Follow-up|4|||
156307699|NCT01731938|564225784|FG001|Primary Part II|Lost to Follow-up|5|||
156307700|NCT01731938|564225783|FG000|Primary Part II|Death|2|||
156307701|NCT01731938|564225784|FG001|Primary Part II|Death|1|||
156307702|NCT01731938|564225783|FG000|Primary Part II|Missed Week 6 visit|2|||
156307703|NCT01731938|564225784|FG001|Primary Part II|Missed Week 6 visit|3|||
156307704|NCT04931888|564225785|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
156307705|NCT04931888|564225786|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
156307706|NCT04931888|564225787|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
156307707|NCT04931888|564225788|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
156307708|NCT03179202|564225789|FG000|Overall Study|Screen Failure|67|||
156307709|NCT03179202|564225789|FG000|Overall Study|Subject Lost to Follow Up|12|||
156307710|NCT03179202|564225789|FG000|Overall Study|Withdrawal by Subject|7|||
156307711|NCT03179202|564225789|FG000|Overall Study|Adverse Event|3|||
156307712|NCT03179202|564225789|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
156307713|NCT03179202|564225789|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
156307714|NCT02969408|564225790|FG000|Overall Study|Adverse Event|2|||
156307715|NCT02969408|564225790|FG000|Overall Study|Withdrawal by Subject|8|||
156307716|NCT02969408|564225790|FG000|Overall Study|Lost to Follow-up|4|||
156307717|NCT02969408|564225790|FG000|Overall Study|Protocol Violation|1|||
156307718|NCT02969408|564225790|FG000|Overall Study|Other than specified|1|||
156307719|NCT02350478|564225791|FG000|Overall Study|Lost to Follow-up|5|||
156307720|NCT02350478|564225792|FG001|Overall Study|Lost to Follow-up|1|||
156307721|NCT02779556|564225793|FG000|Baseline|Partial baseline interview completed|1|||
156307722|NCT02779556|564225794|FG001|Baseline|Partial baseline interview completed|0|||
156307723|NCT02779556|564225793|FG000|3 Months|Lost to Follow-up|40|||
156307724|NCT02779556|564225794|FG001|3 Months|Lost to Follow-up|29|||
156307725|NCT02779556|564225793|FG000|3 Months|Missed 3 month clinic visit|27|||
156307726|NCT02779556|564225794|FG001|3 Months|Missed 3 month clinic visit|19|||
156307727|NCT02779556|564225793|FG000|6 Month|Lost to Follow-up|33|||
156307728|NCT02779556|564225794|FG001|6 Month|Lost to Follow-up|39|||
156307729|NCT02779556|564225793|FG000|6 Month HbA1c|No value collected during window|69|||
156307730|NCT02779556|564225794|FG001|6 Month HbA1c|No value collected during window|50|||
156307731|NCT02779556|564225793|FG000|12 Month HbA1c|No value collected during window|138|||
156307732|NCT02779556|564225794|FG001|12 Month HbA1c|No value collected during window|102|||
156307828|NCT01297491|564225839|FG000|Overall Study|Adverse Event|11|||
156307829|NCT01297491|564225840|FG001|Overall Study|Adverse Event|6|||
156307830|NCT01297491|564225839|FG000|Overall Study|Physician Decision|3|||
156307831|NCT01297491|564225840|FG001|Overall Study|Physician Decision|2|||
156307832|NCT01297491|564225839|FG000|Overall Study|Progressive disease|11|||
156307833|NCT01297491|564225840|FG001|Overall Study|Progressive disease|20|||
156307834|NCT01297491|564225839|FG000|Overall Study|Patient/Guardian decision|3|||
156307835|NCT01297491|564225840|FG001|Overall Study|Patient/Guardian decision|4|||
156307836|NCT01297491|564225839|FG000|Overall Study|Death|2|||
156307837|NCT01297491|564225840|FG001|Overall Study|Death|1|||
156307838|NCT00324961|564225847|FG000|Overall Study|Adverse Event|5|||
156307839|NCT00324961|564225847|FG000|Overall Study|Consent Withdrawn|11|||
156307840|NCT00324961|564225847|FG000|Overall Study|Lost to Follow-up|22|||
156307841|NCT00324961|564225847|FG000|Overall Study|Protocol Violation|3|||
156307842|NCT00324961|564225847|FG000|Overall Study|Other|2|||
156307843|NCT00344487|564225848|FG000|Overall Study|immunologic failure|1|||
156307844|NCT01703754|564225849|FG000|Overall Study|Clinically significant disease progression|2|||
156307845|NCT01703754|564225850|FG001|Overall Study|Clinically significant disease progression|2|||
156307846|NCT01703754|564225851|FG002|Overall Study|Clinically significant disease progression|1|||
156307847|NCT01703754|564225849|FG000|Overall Study|Adverse Event|1|||
156307848|NCT01703754|564225850|FG001|Overall Study|Adverse Event|1|||
156307849|NCT01703754|564225851|FG002|Overall Study|Adverse Event|0|||
156307850|NCT01703754|564225849|FG000|Overall Study|Withdrawal by Subject|2|||
156307851|NCT01703754|564225850|FG001|Overall Study|Withdrawal by Subject|0|||
156307852|NCT01703754|564225851|FG002|Overall Study|Withdrawal by Subject|0|||
156307853|NCT01459497|564225855|FG000|Overall Study|Inability to meet trial constraints.|1|||
156412220|NCT02743793|564602851|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
156412221|NCT02743793|564602850|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
156412222|NCT02743793|564602851|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
156412223|NCT04276090|564602854|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
156412224|NCT04276090|564602855|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
156412225|NCT04642469|564602856|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
156412226|NCT04642469|564602857|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
156412227|NCT04642469|564602856|FG000|Overall Study|Death|1|||
156412228|NCT04642469|564602857|FG001|Overall Study|Death|2|||
156412229|NCT04642469|564602856|FG000|Overall Study|Study/site closed following amendment 1|11|||
156412230|NCT04642469|564602857|FG001|Overall Study|Study/site closed following amendment 1|11|||
156412231|NCT04642469|564602856|FG000|Overall Study|Other|1|||
156412232|NCT04642469|564602857|FG001|Overall Study|Other|1|||
156412233|NCT04642469|564602856|FG000|Overall Study|Withdrawal by Subject|1|||
156412234|NCT04642469|564602857|FG001|Overall Study|Withdrawal by Subject|0|||
156412235|NCT02066532|564602862|FG000|Phase II|Withdrawal by Subject|1|||
156412236|NCT02066532|564602863|FG001|Phase II|Withdrawal by Subject|0|||
156412237|NCT02066532|564602864|FG002|Phase II|Withdrawal by Subject|0|||
156412238|NCT02066532|564602865|FG003|Phase II|Withdrawal by Subject|0|||
156412239|NCT02303626|564602866|FG000|Overall Study|Lack of Efficacy|1|||
156412240|NCT02303626|564602867|FG001|Overall Study|Lack of Efficacy|0|||
156412241|NCT02303626|564602868|FG002|Overall Study|Lack of Efficacy|1|||
156412242|NCT02303626|564602866|FG000|Overall Study|Adverse Event|0|||
156412243|NCT02303626|564602867|FG001|Overall Study|Adverse Event|2|||
156412244|NCT02303626|564602868|FG002|Overall Study|Adverse Event|0|||
156412245|NCT02303626|564602866|FG000|Overall Study|Protocol Violation|0|||
156412246|NCT02303626|564602867|FG001|Overall Study|Protocol Violation|1|||
156412247|NCT02303626|564602868|FG002|Overall Study|Protocol Violation|0|||
156412248|NCT02303626|564602866|FG000|Overall Study|Pregnancy|0|||
156412249|NCT02303626|564602867|FG001|Overall Study|Pregnancy|0|||
156412250|NCT02303626|564602868|FG002|Overall Study|Pregnancy|1|||
156412251|NCT02303626|564602866|FG000|Overall Study|Subject Non-Compliance|0|||
156412252|NCT02303626|564602867|FG001|Overall Study|Subject Non-Compliance|0|||
156412253|NCT02303626|564602868|FG002|Overall Study|Subject Non-Compliance|1|||
156412254|NCT04159415|564602869|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156412255|NCT04159415|564602870|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156412256|NCT04159415|564602871|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156412257|NCT04159415|564602872|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156412258|NCT04159415|564602873|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156412259|NCT04159415|564602874|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156412260|NCT04159415|564602875|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
156412261|NCT04159415|564602876|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
156412262|NCT04159415|564602877|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156412263|NCT04159415|564602878|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156412264|NCT04159415|564602869|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412265|NCT04159415|564602870|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412266|NCT04159415|564602871|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412267|NCT04159415|564602872|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412268|NCT04159415|564602873|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412269|NCT04159415|564602874|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412270|NCT04159415|564602875|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412271|NCT04159415|564602876|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
156412272|NCT04159415|564602877|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412273|NCT04159415|564602878|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156412274|NCT04159415|564602869|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156460560|NCT04625725|564781646|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
156307854|NCT01459497|564225856|FG001|Overall Study|Inability to meet trial constraints.|0|||
156307855|NCT01459497|564225855|FG000|Overall Study|Physician Decision|1|||
156307856|NCT01459497|564225856|FG001|Overall Study|Physician Decision|1|||
156307857|NCT01459497|564225855|FG000|Overall Study|Hospitalization.|0|||
156307858|NCT01459497|564225856|FG001|Overall Study|Hospitalization.|3|||
156307859|NCT01459497|564225855|FG000|Overall Study|Disease progression.|0|||
156307860|NCT01459497|564225856|FG001|Overall Study|Disease progression.|1|||
156307861|NCT03530124|564225857|FG000|Overall Study|Withdrawal by Subject|0|||
156307862|NCT03530124|564225858|FG001|Overall Study|Withdrawal by Subject|1|||
156307863|NCT03530124|564225857|FG000|Overall Study|Protocol Violation|1|||
156307864|NCT03530124|564225858|FG001|Overall Study|Protocol Violation|0|||
156307865|NCT03530124|564225857|FG000|Overall Study|Discharged prior to study completion|1|||
156307866|NCT03530124|564225858|FG001|Overall Study|Discharged prior to study completion|0|||
156307867|NCT05188053|564225859|FG000|Overall Study|Lost to Follow-up|23|||
156307868|NCT05188053|564225860|FG001|Overall Study|Lost to Follow-up|30|||
156307869|NCT05188053|564225859|FG000|Overall Study|Protocol Violation|16|||
156307870|NCT05188053|564225860|FG001|Overall Study|Protocol Violation|16|||
156307871|NCT05188053|564225859|FG000|Overall Study|Physician Decision|3|||
156307872|NCT05188053|564225860|FG001|Overall Study|Physician Decision|0|||
156307873|NCT05188053|564225859|FG000|Overall Study|Withdrawal by Subject|0|||
156307874|NCT05188053|564225860|FG001|Overall Study|Withdrawal by Subject|1|||
156307875|NCT01561313|564225872|FG000|Overall Study|Withdrawal by Subject|1|||
156307876|NCT01561313|564225873|FG001|Overall Study|Withdrawal by Subject|0|||
156307877|NCT01561313|564225872|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
156307878|NCT01561313|564225873|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
156307879|NCT04535453|564225874|FG000|Overall Study|Death|0|||
156307880|NCT04535453|564225875|FG001|Overall Study|Death|1|||
156307881|NCT04535453|564225876|FG002|Overall Study|Death|0|||
156307882|NCT04535453|564225877|FG003|Overall Study|Death|0|||
156307883|NCT04535453|564225878|FG004|Overall Study|Death|0|||
156307884|NCT04535453|564225879|FG005|Overall Study|Death|0|||
156307885|NCT04535453|564225880|FG006|Overall Study|Death|0|||
156307886|NCT04535453|564225881|FG007|Overall Study|Death|0|||
156307887|NCT04535453|564225882|FG008|Overall Study|Death|0|||
156307888|NCT04535453|564225883|FG009|Overall Study|Death|0|||
156307889|NCT04535453|564225884|FG010|Overall Study|Death|0|||
156307890|NCT04535453|564225885|FG011|Overall Study|Death|0|||
156307891|NCT04535453|564225874|FG000|Overall Study|Lost to Follow-up|1|||
156307892|NCT04535453|564225875|FG001|Overall Study|Lost to Follow-up|1|||
156307893|NCT04535453|564225876|FG002|Overall Study|Lost to Follow-up|1|||
156307894|NCT04535453|564225877|FG003|Overall Study|Lost to Follow-up|0|||
156307895|NCT04535453|564225878|FG004|Overall Study|Lost to Follow-up|3|||
156307896|NCT04535453|564225879|FG005|Overall Study|Lost to Follow-up|1|||
156307897|NCT04535453|564225880|FG006|Overall Study|Lost to Follow-up|0|||
156307898|NCT04535453|564225881|FG007|Overall Study|Lost to Follow-up|0|||
156307899|NCT04535453|564225882|FG008|Overall Study|Lost to Follow-up|1|||
156307900|NCT04535453|564225883|FG009|Overall Study|Lost to Follow-up|1|||
156307901|NCT04535453|564225884|FG010|Overall Study|Lost to Follow-up|0|||
156307902|NCT04535453|564225885|FG011|Overall Study|Lost to Follow-up|0|||
156307903|NCT04535453|564225874|FG000|Overall Study|Physician Decision|0|||
156307904|NCT04535453|564225875|FG001|Overall Study|Physician Decision|0|||
156307905|NCT04535453|564225876|FG002|Overall Study|Physician Decision|0|||
156307906|NCT04535453|564225877|FG003|Overall Study|Physician Decision|1|||
156307907|NCT04535453|564225878|FG004|Overall Study|Physician Decision|0|||
156307908|NCT04535453|564225879|FG005|Overall Study|Physician Decision|0|||
156307909|NCT04535453|564225880|FG006|Overall Study|Physician Decision|0|||
156307910|NCT04535453|564225881|FG007|Overall Study|Physician Decision|0|||
156307911|NCT04535453|564225882|FG008|Overall Study|Physician Decision|0|||
156307912|NCT04535453|564225883|FG009|Overall Study|Physician Decision|0|||
156307913|NCT04535453|564225884|FG010|Overall Study|Physician Decision|0|||
156307914|NCT04535453|564225885|FG011|Overall Study|Physician Decision|0|||
156307915|NCT04535453|564225874|FG000|Overall Study|Withdrawal by Subject|3|||
156307916|NCT04535453|564225875|FG001|Overall Study|Withdrawal by Subject|6|||
156307917|NCT04535453|564225876|FG002|Overall Study|Withdrawal by Subject|3|||
156307918|NCT04535453|564225877|FG003|Overall Study|Withdrawal by Subject|3|||
156307919|NCT04535453|564225878|FG004|Overall Study|Withdrawal by Subject|2|||
156307920|NCT04535453|564225879|FG005|Overall Study|Withdrawal by Subject|1|||
156307921|NCT04535453|564225880|FG006|Overall Study|Withdrawal by Subject|1|||
156307922|NCT04535453|564225881|FG007|Overall Study|Withdrawal by Subject|1|||
156307923|NCT04535453|564225882|FG008|Overall Study|Withdrawal by Subject|1|||
156307924|NCT04535453|564225883|FG009|Overall Study|Withdrawal by Subject|1|||
156307925|NCT04535453|564225884|FG010|Overall Study|Withdrawal by Subject|0|||
156307926|NCT04535453|564225885|FG011|Overall Study|Withdrawal by Subject|1|||
156307927|NCT04535453|564225874|FG000|Overall Study|Other|0|||
156307928|NCT04535453|564225875|FG001|Overall Study|Other|0|||
156307929|NCT04535453|564225876|FG002|Overall Study|Other|1|||
156647589|NCT00434161|565456852|FG000|Overall Study|Non-Compliance|1|||
156307930|NCT04535453|564225877|FG003|Overall Study|Other|0|||
156307931|NCT04535453|564225878|FG004|Overall Study|Other|1|||
156307932|NCT04535453|564225879|FG005|Overall Study|Other|0|||
156307933|NCT04535453|564225880|FG006|Overall Study|Other|1|||
156307934|NCT04535453|564225881|FG007|Overall Study|Other|1|||
156307935|NCT04535453|564225882|FG008|Overall Study|Other|1|||
156307936|NCT04535453|564225883|FG009|Overall Study|Other|0|||
156307937|NCT04535453|564225884|FG010|Overall Study|Other|0|||
156307938|NCT04535453|564225885|FG011|Overall Study|Other|0|||
156307939|NCT02878798|564225886|FG000|Overall Study|Withdrawal by Subject|5|||
156307940|NCT02878798|564225887|FG001|Overall Study|Withdrawal by Subject|4|||
156307941|NCT02878798|564225886|FG000|Overall Study|Lost to Follow-up|2|||
156307942|NCT02878798|564225887|FG001|Overall Study|Lost to Follow-up|2|||
156307943|NCT02878798|564225886|FG000|Overall Study|Protocol Violation|0|||
156307944|NCT02878798|564225887|FG001|Overall Study|Protocol Violation|1|||
156307945|NCT01309282|564225888|FG000|Overall Study|Lost to Follow-up|1|||
156307946|NCT02087423|564225889|FG000|Overall Study|Withdrawal by Subject|20|||
156307947|NCT02087423|564225890|FG001|Overall Study|Withdrawal by Subject|20|||
156307948|NCT02087423|564225891|FG002|Overall Study|Withdrawal by Subject|3|||
156307949|NCT02087423|564225889|FG000|Overall Study|Death|68|||
156307950|NCT02087423|564225890|FG001|Overall Study|Death|207|||
156307951|NCT02087423|564225891|FG002|Overall Study|Death|40|||
156307952|NCT02087423|564225889|FG000|Overall Study|Lost to Follow-up|0|||
156307953|NCT02087423|564225890|FG001|Overall Study|Lost to Follow-up|2|||
156307954|NCT02087423|564225891|FG002|Overall Study|Lost to Follow-up|0|||
156307955|NCT02087423|564225889|FG000|Overall Study|Terminated from study at final DCO|23|||
156307956|NCT02087423|564225890|FG001|Overall Study|Terminated from study at final DCO|36|||
156307957|NCT02087423|564225891|FG002|Overall Study|Terminated from study at final DCO|25|||
156307958|NCT01387542|564225892|FG000|Overall Study|Adverse Event|3|||
156307959|NCT01387542|564225892|FG000|Overall Study|Withdrawal by Subject|1|||
156307960|NCT01387542|564225892|FG000|Overall Study|Changed diagnosis|1|||
156307961|NCT01387542|564225892|FG000|Overall Study|Insufficient response|1|||
156307962|NCT01387542|564225892|FG000|Overall Study|Non-compliant|1|||
156307963|NCT01387542|564225892|FG000|Overall Study|Lost to Follow-up|1|||
156307964|NCT01761240|564225895|FG000|Overall Study|Progressive disease:radiology assessment|3|||
156307965|NCT01761240|564225896|FG001|Overall Study|Progressive disease:radiology assessment|3|||
156307966|NCT01761240|564225897|FG002|Overall Study|Progressive disease:radiology assessment|0|||
156412275|NCT04159415|564602870|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156412276|NCT04159415|564602871|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156412277|NCT04159415|564602872|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156412278|NCT04159415|564602873|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156412279|NCT04159415|564602874|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156412280|NCT04159415|564602875|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156412281|NCT04159415|564602876|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
156412282|NCT04159415|564602877|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156412283|NCT04159415|564602878|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156412284|NCT04159415|564602869|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412285|NCT04159415|564602870|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412286|NCT04159415|564602871|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412287|NCT04159415|564602872|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412288|NCT04159415|564602873|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412289|NCT04159415|564602874|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412290|NCT04159415|564602875|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412291|NCT04159415|564602876|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412292|NCT04159415|564602877|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156412293|NCT04159415|564602878|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
156412294|NCT02138747|564602880|FG000|Treatment Period 1|Adverse Event|10|||
156412295|NCT02138747|564602881|FG001|Treatment Period 1|Adverse Event|14|||
156412296|NCT02138747|564602882|FG002|Treatment Period 1|Adverse Event|2|||
156412297|NCT02138747|564602883|FG003|Treatment Period 1|Adverse Event|1|||
156412298|NCT02138747|564602880|FG000|Treatment Period 1|Lost to Follow-up|0|||
156412299|NCT02138747|564602881|FG001|Treatment Period 1|Lost to Follow-up|1|||
156412300|NCT02138747|564602882|FG002|Treatment Period 1|Lost to Follow-up|1|||
156412301|NCT02138747|564602883|FG003|Treatment Period 1|Lost to Follow-up|0|||
156412302|NCT02138747|564602880|FG000|Treatment Period 1|Protocol Violation|0|||
156307967|NCT01761240|564225898|FG003|Overall Study|Progressive disease:radiology assessment|0|||
156307968|NCT01761240|564225899|FG004|Overall Study|Progressive disease:radiology assessment|0|||
156307969|NCT01761240|564225895|FG000|Overall Study|Progressive disease:clinical assessment|0|||
156307970|NCT01761240|564225896|FG001|Overall Study|Progressive disease:clinical assessment|0|||
156307971|NCT01761240|564225897|FG002|Overall Study|Progressive disease:clinical assessment|3|||
156307972|NCT01761240|564225898|FG003|Overall Study|Progressive disease:clinical assessment|1|||
156307973|NCT01761240|564225899|FG004|Overall Study|Progressive disease:clinical assessment|0|||
156307974|NCT01761240|564225895|FG000|Overall Study|Withdrawal by Subject|0|||
156307975|NCT01761240|564225896|FG001|Overall Study|Withdrawal by Subject|0|||
156307976|NCT01761240|564225897|FG002|Overall Study|Withdrawal by Subject|0|||
156307977|NCT01761240|564225898|FG003|Overall Study|Withdrawal by Subject|3|||
156307978|NCT01761240|564225899|FG004|Overall Study|Withdrawal by Subject|1|||
156307979|NCT01761240|564225895|FG000|Overall Study|Adverse Event|0|||
156307980|NCT01761240|564225896|FG001|Overall Study|Adverse Event|0|||
156307981|NCT01761240|564225897|FG002|Overall Study|Adverse Event|0|||
156307982|NCT01761240|564225898|FG003|Overall Study|Adverse Event|1|||
156307983|NCT01761240|564225899|FG004|Overall Study|Adverse Event|6|||
156307984|NCT01761240|564225895|FG000|Overall Study|Death|0|||
156307985|NCT01761240|564225896|FG001|Overall Study|Death|1|||
156307986|NCT01761240|564225897|FG002|Overall Study|Death|1|||
156307987|NCT01761240|564225898|FG003|Overall Study|Death|2|||
156307988|NCT01761240|564225899|FG004|Overall Study|Death|1|||
156307989|NCT01761240|564225895|FG000|Overall Study|Non-compliance|0|||
156307990|NCT01761240|564225896|FG001|Overall Study|Non-compliance|0|||
156307991|NCT01761240|564225897|FG002|Overall Study|Non-compliance|1|||
156307992|NCT01761240|564225898|FG003|Overall Study|Non-compliance|0|||
156307993|NCT01761240|564225899|FG004|Overall Study|Non-compliance|0|||
156307994|NCT01233232|564225900|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
156307995|NCT01233232|564225901|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
156307996|NCT01233232|564225902|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
156307999|NCT00813943|564228109|FG000|Overall Study|Ongoing at cut-off date|5|||
156308000|NCT00813943|564228110|FG001|Overall Study|Ongoing at cut-off date|5|||
156308001|NCT00813943|564228111|FG002|Overall Study|Ongoing at cut-off date|3|||
156308002|NCT02704143|564228116|FG000|Overall Study|disease progression|10|||
156308003|NCT01235598|564228117|FG000|Overall Study|Adverse Event|0|||
156308004|NCT01235598|564228118|FG001|Overall Study|Adverse Event|3|||
156308005|NCT01235598|564228117|FG000|Overall Study|Lack of Efficacy|0|||
156308006|NCT01235598|564228118|FG001|Overall Study|Lack of Efficacy|1|||
156308007|NCT01235598|564228117|FG000|Overall Study|Withdrawal by Subject|1|||
156308008|NCT01235598|564228118|FG001|Overall Study|Withdrawal by Subject|0|||
156308009|NCT02551991|564228119|FG000|Overall Study|Death|5|||
156308010|NCT02551991|564228120|FG001|Overall Study|Death|7|||
156308011|NCT02551991|564228121|FG002|Overall Study|Death|8|||
156308012|NCT02551991|564228122|FG003|Overall Study|Death|7|||
156308013|NCT02551991|564228123|FG004|Overall Study|Death|17|||
156308014|NCT02551991|564228119|FG000|Overall Study|Withdrawal by Subject|1|||
156308015|NCT02551991|564228120|FG001|Overall Study|Withdrawal by Subject|0|||
156308016|NCT02551991|564228121|FG002|Overall Study|Withdrawal by Subject|0|||
156308017|NCT02551991|564228122|FG003|Overall Study|Withdrawal by Subject|0|||
156308018|NCT02551991|564228123|FG004|Overall Study|Withdrawal by Subject|2|||
156308019|NCT02551991|564228119|FG000|Overall Study|Lost to Follow-up|0|||
156308020|NCT02551991|564228120|FG001|Overall Study|Lost to Follow-up|0|||
156308021|NCT02551991|564228121|FG002|Overall Study|Lost to Follow-up|1|||
156308022|NCT02551991|564228122|FG003|Overall Study|Lost to Follow-up|0|||
156308023|NCT02551991|564228123|FG004|Overall Study|Lost to Follow-up|0|||
156308024|NCT02551991|564228119|FG000|Overall Study|Sponsor Decision|1|||
156308025|NCT02551991|564228120|FG001|Overall Study|Sponsor Decision|0|||
156308026|NCT02551991|564228121|FG002|Overall Study|Sponsor Decision|1|||
156308027|NCT02551991|564228122|FG003|Overall Study|Sponsor Decision|0|||
156308028|NCT02551991|564228123|FG004|Overall Study|Sponsor Decision|5|||
156308029|NCT02551991|564228119|FG000|Overall Study|Other|0|||
156308030|NCT02551991|564228120|FG001|Overall Study|Other|0|||
156308031|NCT02551991|564228121|FG002|Overall Study|Other|0|||
156308032|NCT02551991|564228122|FG003|Overall Study|Other|0|||
156308033|NCT02551991|564228123|FG004|Overall Study|Other|1|||
156308034|NCT00395343|564228124|FG000|Overall Study|Adverse Event|13|||
156308035|NCT00395343|564228125|FG001|Overall Study|Adverse Event|5|||
156308036|NCT00395343|564228124|FG000|Overall Study|Lack of Efficacy|0|||
156308037|NCT00395343|564228125|FG001|Overall Study|Lack of Efficacy|1|||
156412303|NCT02138747|564602881|FG001|Treatment Period 1|Protocol Violation|2|||
156412304|NCT02138747|564602882|FG002|Treatment Period 1|Protocol Violation|0|||
156308038|NCT00395343|564228124|FG000|Overall Study|Lost to Follow-up|4|||
156308039|NCT00395343|564228125|FG001|Overall Study|Lost to Follow-up|4|||
156308040|NCT00395343|564228124|FG000|Overall Study|Physician Decision|2|||
156308041|NCT00395343|564228125|FG001|Overall Study|Physician Decision|4|||
156308042|NCT00395343|564228124|FG000|Overall Study|Protocol Violation|6|||
156308043|NCT00395343|564228125|FG001|Overall Study|Protocol Violation|8|||
156647590|NCT00434161|565456853|FG001|Overall Study|Non-Compliance|1|||
156308044|NCT00395343|564228124|FG000|Overall Study|Withdrawal by Subject|11|||
156308045|NCT00395343|564228125|FG001|Overall Study|Withdrawal by Subject|12|||
156308046|NCT00395343|564228124|FG000|Overall Study|Other|5|||
156308047|NCT00395343|564228125|FG001|Overall Study|Other|2|||
156308048|NCT00942994|564228129|FG000|Overall Study|Adverse Event|7|||
156308049|NCT00942994|564228130|FG001|Overall Study|Adverse Event|4|||
156308050|NCT00942994|564228129|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156308051|NCT00942994|564228130|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156308052|NCT00942994|564228129|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156308053|NCT00942994|564228130|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156308054|NCT00942994|564228129|FG000|Overall Study|Patient withdrew consent|5|||
156308055|NCT00942994|564228130|FG001|Overall Study|Patient withdrew consent|8|||
156308056|NCT00942994|564228129|FG000|Overall Study|Lost to Follow-up|1|||
156308057|NCT00942994|564228130|FG001|Overall Study|Lost to Follow-up|4|||
156308058|NCT00942994|564228129|FG000|Overall Study|Protocol deviation|1|||
156308059|NCT00942994|564228130|FG001|Overall Study|Protocol deviation|2|||
156308060|NCT00387790|564228131|FG000|Overall Study|Adverse Event|5|||
156308061|NCT00387790|564228131|FG000|Overall Study|Lack of Efficacy|2|||
156308062|NCT00387790|564228131|FG000|Overall Study|Physician Decision|2|||
156308063|NCT00387790|564228131|FG000|Overall Study|Withdrawal by Subject|3|||
156308064|NCT00387790|564228131|FG000|Overall Study|Ineligible for study|2|||
156308065|NCT03598114|564228138|FG000|Overall Study|Staff turnover/left the program|3|||
156308066|NCT03598114|564228139|FG001|Overall Study|Staff turnover/left the program|39|||
156308067|NCT04540198|564228140|FG000|Overall Study|Lost to Follow-up|25|||
156308068|NCT04540198|564228141|FG001|Overall Study|Lost to Follow-up|23|||
156308069|NCT04540198|564228140|FG000|Overall Study|Withdrawal by Subject|15|||
156308070|NCT04540198|564228141|FG001|Overall Study|Withdrawal by Subject|9|||
156308071|NCT04540198|564228140|FG000|Overall Study|Discontinued|1|||
156308072|NCT04540198|564228141|FG001|Overall Study|Discontinued|0|||
156308073|NCT03110770|564228142|FG000|Overall Study|Death|1|||
156308074|NCT03110770|564228143|FG001|Overall Study|Death|0|||
156308075|NCT03110770|564228144|FG002|Overall Study|Death|0|||
156308076|NCT03110770|564228145|FG003|Overall Study|Death|1|||
156308077|NCT03110770|564228146|FG004|Overall Study|Death|0|||
156308078|NCT03110770|564228142|FG000|Overall Study|Enrolled but did not receive product|0|||
156308079|NCT03110770|564228143|FG001|Overall Study|Enrolled but did not receive product|0|||
156308080|NCT03110770|564228144|FG002|Overall Study|Enrolled but did not receive product|0|||
156308081|NCT03110770|564228145|FG003|Overall Study|Enrolled but did not receive product|8|||
156308082|NCT03110770|564228146|FG004|Overall Study|Enrolled but did not receive product|7|||
156308083|NCT03110770|564228142|FG000|Overall Study|Lost to Follow-up|0|||
156308084|NCT03110770|564228143|FG001|Overall Study|Lost to Follow-up|0|||
156308085|NCT03110770|564228144|FG002|Overall Study|Lost to Follow-up|0|||
156308086|NCT03110770|564228145|FG003|Overall Study|Lost to Follow-up|53|||
156308087|NCT03110770|564228146|FG004|Overall Study|Lost to Follow-up|45|||
156308088|NCT03110770|564228142|FG000|Overall Study|Investigator Decision|0|||
156308089|NCT03110770|564228143|FG001|Overall Study|Investigator Decision|0|||
156308090|NCT03110770|564228144|FG002|Overall Study|Investigator Decision|0|||
156308091|NCT03110770|564228145|FG003|Overall Study|Investigator Decision|5|||
156308092|NCT03110770|564228146|FG004|Overall Study|Investigator Decision|3|||
156308093|NCT03110770|564228142|FG000|Overall Study|Withdrawal by Subject|0|||
156308094|NCT03110770|564228143|FG001|Overall Study|Withdrawal by Subject|0|||
156308095|NCT03110770|564228144|FG002|Overall Study|Withdrawal by Subject|0|||
156308096|NCT03110770|564228145|FG003|Overall Study|Withdrawal by Subject|24|||
156308097|NCT03110770|564228146|FG004|Overall Study|Withdrawal by Subject|24|||
156308098|NCT03110770|564228142|FG000|Overall Study|Moved from area|5|||
156308099|NCT03110770|564228143|FG001|Overall Study|Moved from area|0|||
156308100|NCT03110770|564228144|FG002|Overall Study|Moved from area|2|||
156308101|NCT03110770|564228145|FG003|Overall Study|Moved from area|42|||
156308102|NCT03110770|564228146|FG004|Overall Study|Moved from area|43|||
156308103|NCT03110770|564228142|FG000|Overall Study|Illness/Injury unrelated to product|0|||
156308104|NCT03110770|564228143|FG001|Overall Study|Illness/Injury unrelated to product|0|||
156308105|NCT03110770|564228144|FG002|Overall Study|Illness/Injury unrelated to product|0|||
156308106|NCT03110770|564228145|FG003|Overall Study|Illness/Injury unrelated to product|0|||
156308107|NCT03110770|564228146|FG004|Overall Study|Illness/Injury unrelated to product|1|||
156308108|NCT02082340|564228154|FG000|Overall Study|Lost to Follow-up|1|||
156308109|NCT02082340|564228155|FG001|Overall Study|Lost to Follow-up|1|||
156308110|NCT01625260|564228156|FG000|Overall Study|Adverse Event|3|||
156308111|NCT01625260|564228157|FG001|Overall Study|Adverse Event|0|||
156308112|NCT01625260|564228156|FG000|Overall Study|Study Terminated by Investigator|2|||
156308113|NCT01625260|564228157|FG001|Overall Study|Study Terminated by Investigator|0|||
156308114|NCT01625260|564228156|FG000|Overall Study|Disease Progression|2|||
156308115|NCT01625260|564228157|FG001|Overall Study|Disease Progression|0|||
156308116|NCT01625260|564228156|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
156308117|NCT01625260|564228157|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
156308118|NCT03899805|564228158|FG000|Overall Study|Physician Decision|3|||
156308119|NCT03899805|564228159|FG001|Overall Study|Physician Decision|0|||
156308120|NCT03899805|564228160|FG002|Overall Study|Physician Decision|2|||
156308121|NCT03899805|564228158|FG000|Overall Study|Withdrawal by Subject|1|||
156308122|NCT03899805|564228159|FG001|Overall Study|Withdrawal by Subject|0|||
156308123|NCT03899805|564228160|FG002|Overall Study|Withdrawal by Subject|2|||
156308124|NCT03899805|564228158|FG000|Overall Study|Progressive Disease|10|||
156308125|NCT03899805|564228159|FG001|Overall Study|Progressive Disease|18|||
156308126|NCT03899805|564228160|FG002|Overall Study|Progressive Disease|12|||
156308127|NCT03899805|564228158|FG000|Overall Study|Adverse Event|3|||
156308128|NCT03899805|564228159|FG001|Overall Study|Adverse Event|1|||
156308129|NCT03899805|564228160|FG002|Overall Study|Adverse Event|0|||
156308130|NCT03899805|564228158|FG000|Overall Study|Death|2|||
156308131|NCT03899805|564228159|FG001|Overall Study|Death|0|||
156308132|NCT03899805|564228160|FG002|Overall Study|Death|0|||
156308133|NCT03899805|564228158|FG000|Overall Study|Came off for surgery|0|||
156308134|NCT03899805|564228159|FG001|Overall Study|Came off for surgery|0|||
156308135|NCT03899805|564228160|FG002|Overall Study|Came off for surgery|1|||
156308136|NCT03646123|564228161|FG000|Overall Study|Withdrawal by Subject|2|||
156308137|NCT03646123|564228162|FG001|Overall Study|Withdrawal by Subject|2|||
156308138|NCT03646123|564228163|FG002|Overall Study|Withdrawal by Subject|3|||
156308139|NCT03646123|564228161|FG000|Overall Study|Study termination by sponsor|0|||
156308140|NCT03646123|564228162|FG001|Overall Study|Study termination by sponsor|45|||
156308141|NCT03646123|564228163|FG002|Overall Study|Study termination by sponsor|139|||
156308142|NCT03646123|564228161|FG000|Overall Study|Lost to Follow-up|4|||
156308143|NCT03646123|564228162|FG001|Overall Study|Lost to Follow-up|10|||
156308144|NCT03646123|564228163|FG002|Overall Study|Lost to Follow-up|10|||
156308145|NCT03646123|564228161|FG000|Overall Study|Death|2|||
156308146|NCT03646123|564228162|FG001|Overall Study|Death|1|||
156308147|NCT03646123|564228163|FG002|Overall Study|Death|1|||
156308148|NCT03646123|564228161|FG000|Overall Study|Other|2|||
156308149|NCT03646123|564228162|FG001|Overall Study|Other|0|||
156308150|NCT03646123|564228163|FG002|Overall Study|Other|2|||
156308151|NCT04195893|564228164|FG000|Second Intervention|Withdrawal by Subject|1|||
156308152|NCT04195893|564228165|FG001|Second Intervention|Withdrawal by Subject|0|||
156308153|NCT01802073|564228168|FG000|Overall Study|Lost to Follow-up|0|||
156308154|NCT01802073|564228169|FG001|Overall Study|Lost to Follow-up|1|||
156308155|NCT01802073|564228168|FG000|Overall Study|Non-compliant|4|||
156308156|NCT01802073|564228169|FG001|Overall Study|Non-compliant|2|||
156308157|NCT01802073|564228168|FG000|Overall Study|Withdrawal by Subject|1|||
156308158|NCT01802073|564228169|FG001|Overall Study|Withdrawal by Subject|1|||
156308159|NCT01802073|564228168|FG000|Overall Study|Physician Decision|0|||
156308160|NCT01802073|564228169|FG001|Overall Study|Physician Decision|7|||
156308161|NCT04075734|564228170|FG000|Overall Study|Lost to Follow-up|1|||
156308162|NCT04075734|564228171|FG001|Overall Study|Lost to Follow-up|1|||
156308163|NCT04075734|564228172|FG002|Overall Study|Lost to Follow-up|0|||
156308164|NCT04075734|564228170|FG000|Overall Study|Withdrawal by Subject|3|||
156308165|NCT04075734|564228171|FG001|Overall Study|Withdrawal by Subject|0|||
156308166|NCT04075734|564228172|FG002|Overall Study|Withdrawal by Subject|0|||
156308167|NCT01776307|564228177|FG000|Overall Study|Not dosed|0|||
156308168|NCT01776307|564228178|FG001|Overall Study|Not dosed|0|||
156308169|NCT01776307|564228179|FG002|Overall Study|Not dosed|1|||
156308170|NCT02745145|564228185|FG000|Overall Study|Adverse Event|1|||
156308171|NCT02745145|564228186|FG001|Overall Study|Adverse Event|0|||
156308172|NCT02745145|564228187|FG002|Overall Study|Adverse Event|0|||
156308173|NCT02745145|564228185|FG000|Overall Study|Death|0|||
156308174|NCT02745145|564228186|FG001|Overall Study|Death|1|||
156308175|NCT02745145|564228187|FG002|Overall Study|Death|0|||
156308176|NCT02745145|564228185|FG000|Overall Study|Progressive disease|0|||
156308177|NCT02745145|564228186|FG001|Overall Study|Progressive disease|0|||
156308178|NCT02745145|564228187|FG002|Overall Study|Progressive disease|1|||
156308179|NCT02745145|564228185|FG000|Overall Study|Withdrew consent|1|||
156308180|NCT02745145|564228186|FG001|Overall Study|Withdrew consent|1|||
156308181|NCT02745145|564228187|FG002|Overall Study|Withdrew consent|1|||
156308182|NCT02745145|564228185|FG000|Overall Study|Study Termination|8|||
156308183|NCT02745145|564228186|FG001|Overall Study|Study Termination|3|||
156308184|NCT02745145|564228187|FG002|Overall Study|Study Termination|7|||
156308185|NCT04413617|564228188|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
156308186|NCT04413617|564228189|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
156308187|NCT04413617|564228190|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
156308188|NCT04413617|564228191|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
156308189|NCT04413617|564228192|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
156308190|NCT04413617|564228188|FG000|Overall Study|Protocol Violation|0|||
156308191|NCT04413617|564228189|FG001|Overall Study|Protocol Violation|1|||
156308192|NCT04413617|564228190|FG002|Overall Study|Protocol Violation|0|||
156308193|NCT04413617|564228191|FG003|Overall Study|Protocol Violation|0|||
156308194|NCT04413617|564228192|FG004|Overall Study|Protocol Violation|1|||
156308195|NCT04413617|564228188|FG000|Overall Study|Lack of Efficacy|2|||
156308196|NCT04413617|564228189|FG001|Overall Study|Lack of Efficacy|0|||
156308197|NCT04413617|564228190|FG002|Overall Study|Lack of Efficacy|2|||
156308198|NCT04413617|564228191|FG003|Overall Study|Lack of Efficacy|1|||
156308199|NCT04413617|564228192|FG004|Overall Study|Lack of Efficacy|0|||
156308200|NCT04413617|564228188|FG000|Overall Study|Withdrawal by Subject|3|||
156308201|NCT04413617|564228189|FG001|Overall Study|Withdrawal by Subject|4|||
156308202|NCT04413617|564228190|FG002|Overall Study|Withdrawal by Subject|2|||
156308203|NCT04413617|564228191|FG003|Overall Study|Withdrawal by Subject|5|||
156647591|NCT00434161|565456854|FG002|Overall Study|Non-Compliance|0|||
156308204|NCT04413617|564228192|FG004|Overall Study|Withdrawal by Subject|3|||
156308205|NCT04413617|564228188|FG000|Overall Study|Death|1|||
156308206|NCT04413617|564228189|FG001|Overall Study|Death|0|||
156308207|NCT04413617|564228190|FG002|Overall Study|Death|0|||
156308208|NCT04413617|564228191|FG003|Overall Study|Death|0|||
156308209|NCT04413617|564228192|FG004|Overall Study|Death|0|||
156308210|NCT04413617|564228188|FG000|Overall Study|Adverse Event|1|||
156308211|NCT04413617|564228189|FG001|Overall Study|Adverse Event|0|||
156308212|NCT04413617|564228190|FG002|Overall Study|Adverse Event|0|||
156308213|NCT04413617|564228191|FG003|Overall Study|Adverse Event|1|||
156308214|NCT04413617|564228192|FG004|Overall Study|Adverse Event|1|||
156308215|NCT04413617|564228188|FG000|Overall Study|COVID-19|0|||
156308216|NCT04413617|564228189|FG001|Overall Study|COVID-19|1|||
156308217|NCT04413617|564228190|FG002|Overall Study|COVID-19|0|||
156308218|NCT04413617|564228191|FG003|Overall Study|COVID-19|0|||
156308219|NCT04413617|564228192|FG004|Overall Study|COVID-19|0|||
156308220|NCT00775593|564228193|FG000|Overall Study|Unmet eligibility criteria|6|||
156308221|NCT00775593|564228193|FG000|Overall Study|Death|1|||
156308222|NCT02511106|564228196|FG000|Overall Study|Lost to Follow-up|6|||
156308223|NCT02511106|564228197|FG001|Overall Study|Lost to Follow-up|4|||
156308224|NCT02511106|564228196|FG000|Overall Study|Withdrawal by Subject|24|||
156308225|NCT02511106|564228197|FG001|Overall Study|Withdrawal by Subject|21|||
156308226|NCT02511106|564228196|FG000|Overall Study|Death|42|||
156308227|NCT02511106|564228197|FG001|Overall Study|Death|82|||
156308228|NCT02511106|564228196|FG000|Overall Study|Ongoing study at data cut-off|3|||
156308229|NCT02511106|564228197|FG001|Overall Study|Ongoing study at data cut-off|2|||
156308230|NCT02511106|564228196|FG000|Overall Study|Without specified reason|3|||
156308231|NCT02511106|564228197|FG001|Overall Study|Without specified reason|0|||
156308232|NCT01015638|564228198|FG000|Overall Study|Withdrawal by Subject|1|||
156308233|NCT01015638|564228199|FG001|Overall Study|Withdrawal by Subject|0|||
156308234|NCT00984620|564228200|FG000|Overall Study|Adverse Event|5|||
156308235|NCT00984620|564228201|FG001|Overall Study|Adverse Event|5|||
156308236|NCT00984620|564228200|FG000|Overall Study|Lost to Follow-up|1|||
156308237|NCT00984620|564228201|FG001|Overall Study|Lost to Follow-up|1|||
156308238|NCT00984620|564228200|FG000|Overall Study|Withdrawal by Subject|0|||
156308239|NCT00984620|564228201|FG001|Overall Study|Withdrawal by Subject|2|||
156308240|NCT00984620|564228200|FG000|Overall Study|reason other than listed above|0|||
156308241|NCT00984620|564228201|FG001|Overall Study|reason other than listed above|4|||
156308242|NCT00947882|564228206|FG000|Overall Study|Adverse Event|0|||
156308243|NCT00947882|564228207|FG001|Overall Study|Adverse Event|1|||
156308244|NCT00947882|564228208|FG002|Overall Study|Adverse Event|4|||
156308245|NCT00947882|564228209|FG003|Overall Study|Adverse Event|4|||
156308246|NCT00947882|564228206|FG000|Overall Study|Withdrawal by Subject|2|||
156308247|NCT00947882|564228207|FG001|Overall Study|Withdrawal by Subject|0|||
156308248|NCT00947882|564228208|FG002|Overall Study|Withdrawal by Subject|8|||
156308249|NCT00947882|564228209|FG003|Overall Study|Withdrawal by Subject|2|||
156308250|NCT00947882|564228206|FG000|Overall Study|Protocol Violation|0|||
156308251|NCT00947882|564228207|FG001|Overall Study|Protocol Violation|0|||
156308252|NCT00947882|564228208|FG002|Overall Study|Protocol Violation|1|||
156308253|NCT00947882|564228209|FG003|Overall Study|Protocol Violation|0|||
156308254|NCT00947882|564228206|FG000|Overall Study|Lost to Follow-up|0|||
156308255|NCT00947882|564228207|FG001|Overall Study|Lost to Follow-up|2|||
156308256|NCT00947882|564228208|FG002|Overall Study|Lost to Follow-up|1|||
156308257|NCT00947882|564228209|FG003|Overall Study|Lost to Follow-up|0|||
156308258|NCT00947882|564228206|FG000|Overall Study|Other/Unknown|10|||
156308259|NCT00947882|564228207|FG001|Overall Study|Other/Unknown|13|||
156308260|NCT00947882|564228208|FG002|Overall Study|Other/Unknown|3|||
156308261|NCT00947882|564228209|FG003|Overall Study|Other/Unknown|6|||
156308262|NCT00947882|564228206|FG000|Overall Study|Trial Terminated by Sponsor|62|||
156308263|NCT00947882|564228207|FG001|Overall Study|Trial Terminated by Sponsor|61|||
156308264|NCT00947882|564228208|FG002|Overall Study|Trial Terminated by Sponsor|62|||
156308265|NCT00947882|564228209|FG003|Overall Study|Trial Terminated by Sponsor|70|||
156308266|NCT02379637|564228210|FG000|Overall Study|Protocol Violation|0|||
156308267|NCT02379637|564228211|FG001|Overall Study|Protocol Violation|1|||
156308268|NCT02379637|564228210|FG000|Overall Study|Adverse Event|1|||
156308269|NCT02379637|564228211|FG001|Overall Study|Adverse Event|0|||
156308270|NCT02379637|564228210|FG000|Overall Study|Withdrawal by Subject|1|||
156308271|NCT02379637|564228211|FG001|Overall Study|Withdrawal by Subject|0|||
156308272|NCT02447302|564228212|FG000|Overall Study|Physician Decision|1|||
156308273|NCT02447302|564228213|FG001|Overall Study|Physician Decision|0|||
156308274|NCT02447302|564228214|FG002|Overall Study|Physician Decision|0|||
156308275|NCT02447302|564228212|FG000|Overall Study|Adverse Event|4|||
156308276|NCT02447302|564228213|FG001|Overall Study|Adverse Event|3|||
156308277|NCT02447302|564228214|FG002|Overall Study|Adverse Event|0|||
156308278|NCT02447302|564228212|FG000|Overall Study|Withdrawal by Subject|0|||
156308279|NCT02447302|564228213|FG001|Overall Study|Withdrawal by Subject|1|||
156308280|NCT02447302|564228214|FG002|Overall Study|Withdrawal by Subject|5|||
156308281|NCT02447302|564228212|FG000|Overall Study|Sponsor Decision|0|||
156308282|NCT02447302|564228213|FG001|Overall Study|Sponsor Decision|0|||
156308283|NCT02447302|564228214|FG002|Overall Study|Sponsor Decision|1|||
156308284|NCT02791763|564228215|FG000|Overall Study|Protocol Violation|0|||
156647592|NCT00434161|565456852|FG000|Overall Study|Withdrawal by Subject|2|||
156647593|NCT00434161|565456853|FG001|Overall Study|Withdrawal by Subject|0|||
156647594|NCT00434161|565456854|FG002|Overall Study|Withdrawal by Subject|3|||
156647595|NCT00434161|565456852|FG000|Overall Study|Logistical error study assessments|1|||
156647596|NCT00434161|565456853|FG001|Overall Study|Logistical error study assessments|0|||
156647597|NCT00434161|565456854|FG002|Overall Study|Logistical error study assessments|3|||
156647598|NCT01084005|565456855|FG000|Overall Study|Adverse Event|1|||
156647599|NCT01084005|565456856|FG001|Overall Study|Adverse Event|8|||
156647600|NCT01084005|565456855|FG000|Overall Study|Protocol Violation|3|||
156647601|NCT01084005|565456856|FG001|Overall Study|Protocol Violation|7|||
156647602|NCT01084005|565456855|FG000|Overall Study|Withdrawal by Subject|1|||
156647603|NCT01084005|565456856|FG001|Overall Study|Withdrawal by Subject|1|||
156647604|NCT03568500|565456857|FG000|Overall Study|Lost to Follow-up|1|||
156647605|NCT03568500|565456858|FG001|Overall Study|Lost to Follow-up|1|||
156647606|NCT03568500|565456859|FG002|Overall Study|Lost to Follow-up|2|||
156647607|NCT03568500|565456857|FG000|Overall Study|Adverse Event|1|||
156647608|NCT03568500|565456858|FG001|Overall Study|Adverse Event|1|||
156647609|NCT03568500|565456859|FG002|Overall Study|Adverse Event|2|||
156647610|NCT03568500|565456857|FG000|Overall Study|Physician Decision|1|||
156647611|NCT03568500|565456858|FG001|Overall Study|Physician Decision|0|||
156647612|NCT03568500|565456859|FG002|Overall Study|Physician Decision|0|||
156647613|NCT03568500|565456857|FG000|Overall Study|Withdrawal by Subject|4|||
156647614|NCT03568500|565456858|FG001|Overall Study|Withdrawal by Subject|2|||
156647615|NCT03568500|565456859|FG002|Overall Study|Withdrawal by Subject|0|||
156647616|NCT03568500|565456857|FG000|Overall Study|Technical Problems|2|||
156647617|NCT03568500|565456858|FG001|Overall Study|Technical Problems|1|||
156647618|NCT03568500|565456859|FG002|Overall Study|Technical Problems|0|||
156647619|NCT03568500|565456857|FG000|Overall Study|Participant Noncompliance|1|||
156647620|NCT03568500|565456858|FG001|Overall Study|Participant Noncompliance|1|||
156647621|NCT03568500|565456859|FG002|Overall Study|Participant Noncompliance|0|||
156647622|NCT00910858|565456861|FG000|Pharmacokinetic Phase|Adverse Event|1|||
156647623|NCT00910858|565456862|FG001|Pharmacokinetic Phase|Adverse Event|0|||
156647624|NCT00910858|565456863|FG002|Pharmacokinetic Phase|Adverse Event|0|||
156647625|NCT00910858|565456861|FG000|Monotherapy Phase|Adverse Event|3|||
156647626|NCT00910858|565456862|FG001|Monotherapy Phase|Adverse Event|2|||
156647627|NCT00910858|565456863|FG002|Monotherapy Phase|Adverse Event|0|||
156647628|NCT00910858|565456861|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
156647629|NCT00910858|565456862|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
156647630|NCT00910858|565456863|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
156647631|NCT00910858|565456861|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
156647632|NCT00910858|565456862|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
156647633|NCT00910858|565456863|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
156647634|NCT00910858|565456861|FG000|Monotherapy Phase|Protocol Violation|1|||
156647635|NCT00910858|565456862|FG001|Monotherapy Phase|Protocol Violation|0|||
156647636|NCT00910858|565456863|FG002|Monotherapy Phase|Protocol Violation|0|||
156647637|NCT00910858|565456861|FG000|Monotherapy Phase|Other|3|||
156647638|NCT00910858|565456862|FG001|Monotherapy Phase|Other|4|||
156647639|NCT00910858|565456863|FG002|Monotherapy Phase|Other|2|||
156647640|NCT00910858|565456861|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
156647641|NCT00910858|565456862|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
156647642|NCT00910858|565456863|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
156647643|NCT00910858|565456861|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
156647644|NCT00910858|565456862|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
156647645|NCT00910858|565456863|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
156647646|NCT00910858|565456861|FG000|Combined Treatment Phase|Protocol Violation|1|||
156647647|NCT00910858|565456862|FG001|Combined Treatment Phase|Protocol Violation|0|||
156647648|NCT00910858|565456863|FG002|Combined Treatment Phase|Protocol Violation|0|||
156647649|NCT00910858|565456861|FG000|Combined Treatment Phase|Other|0|||
156647650|NCT00910858|565456862|FG001|Combined Treatment Phase|Other|2|||
156647651|NCT00910858|565456863|FG002|Combined Treatment Phase|Other|1|||
156647652|NCT01907737|565456866|FG000|Overall Study|Withdrawal by Subject|1|||
156647653|NCT01165684|565456867|FG000|Overall Study|Adverse Event|1|||
156647654|NCT01165684|565456868|FG001|Overall Study|Adverse Event|1|||
156647655|NCT01165684|565456867|FG000|Overall Study|Lack of Efficacy|2|||
156647656|NCT01165684|565456868|FG001|Overall Study|Lack of Efficacy|1|||
156647657|NCT01165684|565456867|FG000|Overall Study|Protocol Violation|7|||
156308285|NCT02791763|564228216|FG001|Overall Study|Protocol Violation|0|||
156647658|NCT01165684|565456868|FG001|Overall Study|Protocol Violation|15|||
156647659|NCT01165684|565456867|FG000|Overall Study|Withdrawal Criteria|2|||
156647660|NCT01165684|565456868|FG001|Overall Study|Withdrawal Criteria|13|||
156647661|NCT01165684|565456867|FG000|Overall Study|Unclassified|16|||
156647662|NCT01165684|565456868|FG001|Overall Study|Unclassified|22|||
156647663|NCT00608205|565456873|FG000|Overall Study|Adverse Event|3|||
156647664|NCT00608205|565456874|FG001|Overall Study|Adverse Event|2|||
156647665|NCT00608205|565456873|FG000|Overall Study|Patient non-compliant|0|||
156308286|NCT02791763|564228217|FG002|Overall Study|Protocol Violation|1|||
156308287|NCT02791763|564228215|FG000|Overall Study|Withdrawal by Subject|5|||
156308288|NCT02791763|564228216|FG001|Overall Study|Withdrawal by Subject|1|||
156308289|NCT02791763|564228217|FG002|Overall Study|Withdrawal by Subject|0|||
156308290|NCT02791763|564228215|FG000|Overall Study|Physician Decision|0|||
156308291|NCT02791763|564228216|FG001|Overall Study|Physician Decision|1|||
156308292|NCT02791763|564228217|FG002|Overall Study|Physician Decision|0|||
156308293|NCT02791763|564228215|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
156308294|NCT02791763|564228216|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
156308295|NCT02791763|564228217|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
156308296|NCT02791763|564228215|FG000|Overall Study|Cancer event|1|||
156308297|NCT02791763|564228216|FG001|Overall Study|Cancer event|3|||
156308298|NCT02791763|564228217|FG002|Overall Study|Cancer event|0|||
156308299|NCT02791763|564228215|FG000|Overall Study|Participant had renal transplant|3|||
156308300|NCT02791763|564228216|FG001|Overall Study|Participant had renal transplant|0|||
156308301|NCT02791763|564228217|FG002|Overall Study|Participant had renal transplant|0|||
156647666|NCT00608205|565456874|FG001|Overall Study|Patient non-compliant|1|||
156647667|NCT02008721|565456875|FG000|Overall Study|Withdrawal by Subject|5|||
156647668|NCT02008721|565456876|FG001|Overall Study|Withdrawal by Subject|1|||
156647669|NCT02008721|565456875|FG000|Overall Study|Death|4|||
156647670|NCT02008721|565456876|FG001|Overall Study|Death|2|||
156647671|NCT02008721|565456875|FG000|Overall Study|Adverse Event|3|||
156647672|NCT02008721|565456876|FG001|Overall Study|Adverse Event|5|||
156647673|NCT02008721|565456875|FG000|Overall Study|Protocol Violation|3|||
156647674|NCT02008721|565456876|FG001|Overall Study|Protocol Violation|2|||
156647675|NCT01797120|565456879|FG000|Overall Study|Disesae progression|37|||
156647676|NCT01797120|565456880|FG001|Overall Study|Disesae progression|49|||
156647677|NCT01797120|565456879|FG000|Overall Study|Adverse Event|13|||
156647678|NCT01797120|565456880|FG001|Overall Study|Adverse Event|5|||
156647679|NCT01797120|565456879|FG000|Overall Study|Withdrawal by Subject|6|||
156647680|NCT01797120|565456880|FG001|Overall Study|Withdrawal by Subject|6|||
156647681|NCT01797120|565456879|FG000|Overall Study|Symptomatic progression|2|||
156647682|NCT01797120|565456880|FG001|Overall Study|Symptomatic progression|1|||
156647683|NCT01797120|565456879|FG000|Overall Study|Non-compliance|1|||
156647684|NCT01797120|565456880|FG001|Overall Study|Non-compliance|0|||
156647685|NCT01797120|565456879|FG000|Overall Study|Physician Decision|3|||
156647686|NCT01797120|565456880|FG001|Overall Study|Physician Decision|0|||
156647687|NCT01797120|565456879|FG000|Overall Study|still on treatment|2|||
156647688|NCT01797120|565456880|FG001|Overall Study|still on treatment|4|||
156647689|NCT01797120|565456879|FG000|Overall Study|never start protocol therapy|2|||
156647690|NCT01797120|565456880|FG001|Overall Study|never start protocol therapy|0|||
156647691|NCT01684722|565456881|FG000|Overall Study|Lost to Follow-up|78|||
156647692|NCT01684722|565456882|FG001|Overall Study|Lost to Follow-up|56|||
156647693|NCT01684722|565456883|FG002|Overall Study|Lost to Follow-up|75|||
156647694|NCT01684722|565456884|FG003|Overall Study|Lost to Follow-up|89|||
156647695|NCT01684722|565456881|FG000|Overall Study|Death|19|||
156647696|NCT01684722|565456882|FG001|Overall Study|Death|21|||
156647697|NCT01684722|565456883|FG002|Overall Study|Death|19|||
156647698|NCT01684722|565456884|FG003|Overall Study|Death|21|||
156647699|NCT01664494|565456885|FG000|Overall Study|Withdrawal by Subject|27|||
156647700|NCT01664494|565456885|FG000|Overall Study|Death|18|||
156647701|NCT01664494|565456885|FG000|Overall Study|Other|49|||
156647702|NCT01664494|565456885|FG000|Overall Study|Lost to Follow-up|99|||
156647703|NCT00814658|565456891|FG000|Overall Study|Lost to Follow-up|0|||
156647704|NCT00814658|565456892|FG001|Overall Study|Lost to Follow-up|1|||
156647705|NCT00814658|565456891|FG000|Overall Study|Physician Decision|1|||
156647706|NCT00814658|565456892|FG001|Overall Study|Physician Decision|0|||
156647707|NCT00814658|565456891|FG000|Overall Study|Adverse Event|3|||
156647708|NCT00814658|565456892|FG001|Overall Study|Adverse Event|3|||
156647709|NCT01141283|565456894|FG000|Overall Study|Adverse Event|56|||
156647710|NCT01141283|565456894|FG000|Overall Study|Lost to Follow-up|4|||
156647711|NCT01141283|565456894|FG000|Overall Study|Withdrawal by Subject|14|||
156647712|NCT01141283|565456894|FG000|Overall Study|Administrative|4|||
156308302|NCT02791763|564228215|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
156308303|NCT02791763|564228216|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
156308304|NCT02791763|564228217|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
156647713|NCT01141283|565456894|FG000|Overall Study|Lack of Efficacy|10|||
156647714|NCT00545233|565456898|FG000|Overall Study|Adverse Event|10|||
156647715|NCT00545233|565456899|FG001|Overall Study|Adverse Event|5|||
156647716|NCT00545233|565456898|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
156647717|NCT00545233|565456899|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156647718|NCT00545233|565456898|FG000|Overall Study|Protocol Violation|2|||
156308305|NCT02791763|564228215|FG000|Overall Study|Adverse Event|12|||
156647719|NCT00545233|565456899|FG001|Overall Study|Protocol Violation|0|||
156647720|NCT00545233|565456898|FG000|Overall Study|Refused Treatment|9|||
156308306|NCT02791763|564228216|FG001|Overall Study|Adverse Event|13|||
156308307|NCT02791763|564228217|FG002|Overall Study|Adverse Event|7|||
156647721|NCT00545233|565456899|FG001|Overall Study|Refused Treatment|7|||
156647722|NCT00545233|565456898|FG000|Overall Study|Failure to Return|4|||
156308308|NCT05334212|564228218|FG000|Overall Study|Study terminated prematurely|7|||
156308309|NCT01456897|564228219|FG000|Overall Study|Adverse Event|19|||
156308310|NCT01456897|564228220|FG001|Overall Study|Adverse Event|22|||
156308311|NCT01456897|564228219|FG000|Overall Study|Protocol Violation|3|||
156308312|NCT01456897|564228220|FG001|Overall Study|Protocol Violation|4|||
156308313|NCT01456897|564228219|FG000|Overall Study|Physician Decision|5|||
156308314|NCT01456897|564228220|FG001|Overall Study|Physician Decision|3|||
156308315|NCT01456897|564228219|FG000|Overall Study|Withdrawal by Subject|44|||
156308316|NCT01456897|564228220|FG001|Overall Study|Withdrawal by Subject|17|||
156308317|NCT01456897|564228219|FG000|Overall Study|Lack of Efficacy|4|||
156308318|NCT01456897|564228220|FG001|Overall Study|Lack of Efficacy|11|||
156308319|NCT02695420|564228221|FG000|Overall Study|Death|0|||
156308320|NCT02695420|564228222|FG001|Overall Study|Death|1|||
156308321|NCT02695420|564228223|FG002|Overall Study|Death|0|||
156308322|NCT02695420|564228224|FG003|Overall Study|Death|0|||
156308323|NCT00916929|564228227|FG000|Overall Study|Lost to Follow-up|1|||
156308324|NCT00916929|564228228|FG001|Overall Study|Lost to Follow-up|3|||
156308325|NCT00916929|564228227|FG000|Overall Study|Death|5|||
156308326|NCT00916929|564228228|FG001|Overall Study|Death|10|||
156308327|NCT00916929|564228227|FG000|Overall Study|Withdrawal by Subject|1|||
156308328|NCT00916929|564228228|FG001|Overall Study|Withdrawal by Subject|5|||
156308329|NCT00916929|564228227|FG000|Overall Study|Left ventricular epicardial lead|1|||
156308330|NCT00916929|564228228|FG001|Overall Study|Left ventricular epicardial lead|2|||
156308331|NCT00916929|564228227|FG000|Overall Study|Transferred to hospice care|1|||
156308332|NCT00916929|564228228|FG001|Overall Study|Transferred to hospice care|1|||
156308333|NCT00916929|564228227|FG000|Overall Study|System explant|1|||
156308334|NCT00916929|564228228|FG001|Overall Study|System explant|0|||
156308335|NCT00916929|564228227|FG000|Overall Study|Moved to another state|0|||
156308336|NCT00916929|564228228|FG001|Overall Study|Moved to another state|1|||
156308337|NCT00916929|564228227|FG000|Overall Study|Device unable to process impedance data|0|||
156308338|NCT00916929|564228228|FG001|Overall Study|Device unable to process impedance data|7|||
156308339|NCT02929407|564228229|FG000|Overall Study|Adverse Event|1|||
156308340|NCT01742286|564228230|FG000|Escalation Phase|Administrative problems|1|||
156308341|NCT01742286|564228231|FG001|Escalation Phase|Administrative problems|1|||
156308342|NCT01742286|564228232|FG002|Escalation Phase|Administrative problems|0|||
156308343|NCT01742286|564228233|FG003|Escalation Phase|Administrative problems|0|||
156308344|NCT01742286|564228234|FG004|Escalation Phase|Administrative problems|0|||
156308345|NCT01742286|564228235|FG005|Escalation Phase|Administrative problems|0|||
156308346|NCT01742286|564228236|FG006|Escalation Phase|Administrative problems|2|||
156308347|NCT01742286|564228230|FG000|Escalation Phase|Adverse Event|0|||
156308348|NCT01742286|564228231|FG001|Escalation Phase|Adverse Event|1|||
156308349|NCT01742286|564228232|FG002|Escalation Phase|Adverse Event|2|||
156308350|NCT01742286|564228233|FG003|Escalation Phase|Adverse Event|0|||
156308351|NCT01742286|564228234|FG004|Escalation Phase|Adverse Event|0|||
156308352|NCT01742286|564228235|FG005|Escalation Phase|Adverse Event|1|||
156308353|NCT01742286|564228236|FG006|Escalation Phase|Adverse Event|0|||
156308354|NCT01742286|564228230|FG000|Escalation Phase|Disease progression|3|||
156308355|NCT01742286|564228231|FG001|Escalation Phase|Disease progression|7|||
156308356|NCT01742286|564228232|FG002|Escalation Phase|Disease progression|4|||
156308357|NCT01742286|564228233|FG003|Escalation Phase|Disease progression|1|||
156308358|NCT01742286|564228234|FG004|Escalation Phase|Disease progression|4|||
156647723|NCT00545233|565456899|FG001|Overall Study|Failure to Return|6|||
156647724|NCT00545233|565456898|FG000|Overall Study|Insufficient response|14|||
156308359|NCT01742286|564228235|FG005|Escalation Phase|Disease progression|3|||
156308360|NCT01742286|564228236|FG006|Escalation Phase|Disease progression|2|||
156308361|NCT01742286|564228230|FG000|Escalation Phase|Death|0|||
156308362|NCT01742286|564228231|FG001|Escalation Phase|Death|0|||
156308363|NCT01742286|564228232|FG002|Escalation Phase|Death|0|||
156308364|NCT01742286|564228233|FG003|Escalation Phase|Death|0|||
156308365|NCT01742286|564228234|FG004|Escalation Phase|Death|0|||
156647725|NCT00545233|565456899|FG001|Overall Study|Insufficient response|15|||
156647726|NCT00545233|565456898|FG000|Overall Study|Physician Decision|2|||
156308366|NCT01742286|564228235|FG005|Escalation Phase|Death|1|||
156647727|NCT00545233|565456899|FG001|Overall Study|Physician Decision|1|||
156647728|NCT06371079|565456900|FG000|Overall Study|Missing data|88|||
156647729|NCT06371079|565456901|FG001|Overall Study|Missing data|247|||
156647730|NCT01238211|565456902|FG000|Overall Study|Continues active treatment|31|||
156308367|NCT01742286|564228236|FG006|Escalation Phase|Death|0|||
156308368|NCT01742286|564228230|FG000|Escalation Phase|Physician Decision|0|||
156308369|NCT01742286|564228231|FG001|Escalation Phase|Physician Decision|3|||
156308370|NCT01742286|564228232|FG002|Escalation Phase|Physician Decision|0|||
156412305|NCT02138747|564602883|FG003|Treatment Period 1|Protocol Violation|0|||
156308371|NCT01742286|564228233|FG003|Escalation Phase|Physician Decision|1|||
156308372|NCT01742286|564228234|FG004|Escalation Phase|Physician Decision|0|||
156308373|NCT01742286|564228235|FG005|Escalation Phase|Physician Decision|0|||
156308374|NCT01742286|564228236|FG006|Escalation Phase|Physician Decision|2|||
156308375|NCT01742286|564228230|FG000|Escalation Phase|Subject/guardian decision|1|||
156412306|NCT02138747|564602880|FG000|Treatment Period 1|Withdrawal by Subject|8|||
156647731|NCT01238211|565456902|FG000|Overall Study|Adverse Event|7|||
156647732|NCT01238211|565456902|FG000|Overall Study|Death|4|||
156647733|NCT01238211|565456902|FG000|Overall Study|Relapse/Progression|2|||
156647734|NCT01238211|565456902|FG000|Overall Study|Withdrawal by Subject|7|||
156647735|NCT01238211|565456902|FG000|Overall Study|Non-protocol treatment|4|||
156647736|NCT01238211|565456902|FG000|Overall Study|Investigator/Patient Decision|3|||
156647737|NCT00449930|565456903|FG000|Overall Study|Adverse Event|9|||
156647738|NCT00449930|565456904|FG001|Overall Study|Adverse Event|19|||
156647739|NCT00449930|565456903|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
156647740|NCT00449930|565456904|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
156647741|NCT00449930|565456903|FG000|Overall Study|Lack of Efficacy|10|||
156647742|NCT00449930|565456904|FG001|Overall Study|Lack of Efficacy|1|||
156647743|NCT00449930|565456903|FG000|Overall Study|Lost to Follow-up|9|||
156647744|NCT00449930|565456904|FG001|Overall Study|Lost to Follow-up|14|||
156647745|NCT00449930|565456903|FG000|Overall Study|Physician Decision|1|||
156647746|NCT00449930|565456904|FG001|Overall Study|Physician Decision|2|||
156647747|NCT00449930|565456903|FG000|Overall Study|Protocol Violation|14|||
156647748|NCT00449930|565456904|FG001|Overall Study|Protocol Violation|15|||
156647749|NCT00449930|565456903|FG000|Overall Study|Withdrawal by Subject|16|||
156647750|NCT00449930|565456904|FG001|Overall Study|Withdrawal by Subject|23|||
156647751|NCT00449930|565456903|FG000|Overall Study|Glycemic discontinuation criteria|1|||
156647752|NCT00449930|565456904|FG001|Overall Study|Glycemic discontinuation criteria|1|||
156647753|NCT02746705|565456907|FG000|Overall Study|Physician Decision|1|||
156647754|NCT02746705|565456908|FG001|Overall Study|Physician Decision|1|||
156647755|NCT02746705|565456907|FG000|Overall Study|Lost to Follow-up|1|||
156647756|NCT02746705|565456908|FG001|Overall Study|Lost to Follow-up|0|||
156647757|NCT02746705|565456907|FG000|Overall Study|outlier scores deemed not valid|0|||
156647758|NCT02746705|565456908|FG001|Overall Study|outlier scores deemed not valid|1|||
156647759|NCT00479401|565456909|FG000|Overall Study|Adverse Event|24|||
156647760|NCT00479401|565456910|FG001|Overall Study|Adverse Event|20|||
156647761|NCT00479401|565456911|FG002|Overall Study|Adverse Event|4|||
156647762|NCT00479401|565456909|FG000|Overall Study|Lack of Efficacy|2|||
156647763|NCT00479401|565456910|FG001|Overall Study|Lack of Efficacy|2|||
156647764|NCT00479401|565456911|FG002|Overall Study|Lack of Efficacy|4|||
156647765|NCT00479401|565456909|FG000|Overall Study|Protocol Violation|2|||
156647766|NCT00479401|565456910|FG001|Overall Study|Protocol Violation|1|||
156647767|NCT00479401|565456911|FG002|Overall Study|Protocol Violation|1|||
156647768|NCT00479401|565456909|FG000|Overall Study|Lost to Follow-up|1|||
156647769|NCT00479401|565456910|FG001|Overall Study|Lost to Follow-up|1|||
156647770|NCT00479401|565456911|FG002|Overall Study|Lost to Follow-up|1|||
156308376|NCT01742286|564228231|FG001|Escalation Phase|Subject/guardian decision|0|||
156308377|NCT01742286|564228232|FG002|Escalation Phase|Subject/guardian decision|0|||
156308378|NCT01742286|564228233|FG003|Escalation Phase|Subject/guardian decision|0|||
156308379|NCT01742286|564228234|FG004|Escalation Phase|Subject/guardian decision|0|||
156308380|NCT01742286|564228235|FG005|Escalation Phase|Subject/guardian decision|0|||
156308381|NCT01742286|564228236|FG006|Escalation Phase|Subject/guardian decision|0|||
156308382|NCT01742286|564228230|FG000|Expansion Phase|Administrative problems|0|||
156308383|NCT01742286|564228231|FG001|Expansion Phase|Administrative problems|0|||
156308384|NCT01742286|564228232|FG002|Expansion Phase|Administrative problems|0|||
156308385|NCT01742286|564228233|FG003|Expansion Phase|Administrative problems|0|||
156308386|NCT01742286|564228234|FG004|Expansion Phase|Administrative problems|0|||
156308387|NCT01742286|564228235|FG005|Expansion Phase|Administrative problems|0|||
156308388|NCT01742286|564228236|FG006|Expansion Phase|Administrative problems|5|||
156308389|NCT01742286|564228230|FG000|Expansion Phase|Physician Decision|0|||
156308390|NCT01742286|564228231|FG001|Expansion Phase|Physician Decision|0|||
156308391|NCT01742286|564228232|FG002|Expansion Phase|Physician Decision|4|||
156308392|NCT01742286|564228233|FG003|Expansion Phase|Physician Decision|0|||
156308393|NCT01742286|564228234|FG004|Expansion Phase|Physician Decision|0|||
156308394|NCT01742286|564228235|FG005|Expansion Phase|Physician Decision|0|||
156308395|NCT01742286|564228236|FG006|Expansion Phase|Physician Decision|9|||
156308396|NCT01742286|564228230|FG000|Expansion Phase|Adverse Event|0|||
156647771|NCT00479401|565456909|FG000|Overall Study|Withdrawal by Subject|16|||
156647772|NCT00479401|565456910|FG001|Overall Study|Withdrawal by Subject|10|||
156647773|NCT00479401|565456911|FG002|Overall Study|Withdrawal by Subject|2|||
156647774|NCT00479401|565456909|FG000|Overall Study|Exclusion criteria, relocation|4|||
156647775|NCT00479401|565456910|FG001|Overall Study|Exclusion criteria, relocation|3|||
156647776|NCT00479401|565456911|FG002|Overall Study|Exclusion criteria, relocation|0|||
156647777|NCT02124746|565456912|FG000|Overall Study|Adverse Event|2|||
156647778|NCT02124746|565456913|FG001|Overall Study|Adverse Event|1|||
156647779|NCT02124746|565456914|FG002|Overall Study|Adverse Event|2|||
156647780|NCT02124746|565456912|FG000|Overall Study|Death|2|||
156647781|NCT02124746|565456913|FG001|Overall Study|Death|1|||
156308397|NCT01742286|564228231|FG001|Expansion Phase|Adverse Event|0|||
156308398|NCT01742286|564228232|FG002|Expansion Phase|Adverse Event|0|||
156308399|NCT01742286|564228233|FG003|Expansion Phase|Adverse Event|0|||
156647782|NCT02124746|565456914|FG002|Overall Study|Death|3|||
156647783|NCT02124746|565456912|FG000|Overall Study|Lack of Efficacy|3|||
156308400|NCT01742286|564228234|FG004|Expansion Phase|Adverse Event|0|||
156308401|NCT01742286|564228235|FG005|Expansion Phase|Adverse Event|0|||
156308402|NCT01742286|564228236|FG006|Expansion Phase|Adverse Event|6|||
156308403|NCT01742286|564228230|FG000|Expansion Phase|Disease progression|0|||
156308404|NCT01742286|564228231|FG001|Expansion Phase|Disease progression|0|||
156308405|NCT01742286|564228232|FG002|Expansion Phase|Disease progression|3|||
156308406|NCT01742286|564228233|FG003|Expansion Phase|Disease progression|0|||
156308407|NCT01742286|564228234|FG004|Expansion Phase|Disease progression|0|||
156308408|NCT01742286|564228235|FG005|Expansion Phase|Disease progression|0|||
156308409|NCT01742286|564228236|FG006|Expansion Phase|Disease progression|15|||
156412307|NCT02138747|564602881|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156412308|NCT02138747|564602882|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156412309|NCT02138747|564602883|FG003|Treatment Period 1|Withdrawal by Subject|3|||
156412310|NCT02138747|564602880|FG000|Treatment Period 1|Other - Miscellaneous|2|||
156412311|NCT02138747|564602881|FG001|Treatment Period 1|Other - Miscellaneous|4|||
156308410|NCT01742286|564228230|FG000|Expansion Phase|Withdrawal by Subject|0|||
156308411|NCT01742286|564228231|FG001|Expansion Phase|Withdrawal by Subject|0|||
156308412|NCT01742286|564228232|FG002|Expansion Phase|Withdrawal by Subject|0|||
156308413|NCT01742286|564228233|FG003|Expansion Phase|Withdrawal by Subject|0|||
156308414|NCT01742286|564228234|FG004|Expansion Phase|Withdrawal by Subject|0|||
156308415|NCT01742286|564228235|FG005|Expansion Phase|Withdrawal by Subject|0|||
156308416|NCT01742286|564228236|FG006|Expansion Phase|Withdrawal by Subject|1|||
156308417|NCT02762370|564228237|FG000|Overall Study|Protocol Violation|1|||
156308418|NCT02762370|564228238|FG001|Overall Study|Protocol Violation|0|||
156308419|NCT01708902|564228245|FG000|Overall Study|Adverse Event|3|||
156308420|NCT01708902|564228246|FG001|Overall Study|Adverse Event|4|||
156308421|NCT01708902|564228247|FG002|Overall Study|Adverse Event|9|||
156308422|NCT01708902|564228248|FG003|Overall Study|Adverse Event|2|||
156308423|NCT01708902|564228249|FG004|Overall Study|Adverse Event|7|||
156308424|NCT01708902|564228250|FG005|Overall Study|Adverse Event|3|||
156308425|NCT01708902|564228251|FG006|Overall Study|Adverse Event|5|||
156308426|NCT01708902|564228245|FG000|Overall Study|Lack of Efficacy|3|||
156308427|NCT01708902|564228246|FG001|Overall Study|Lack of Efficacy|1|||
156308428|NCT01708902|564228247|FG002|Overall Study|Lack of Efficacy|0|||
156308429|NCT01708902|564228248|FG003|Overall Study|Lack of Efficacy|0|||
156308430|NCT01708902|564228249|FG004|Overall Study|Lack of Efficacy|0|||
156308431|NCT01708902|564228250|FG005|Overall Study|Lack of Efficacy|1|||
156308432|NCT01708902|564228251|FG006|Overall Study|Lack of Efficacy|0|||
156308433|NCT01708902|564228245|FG000|Overall Study|Non compliance with protocol|0|||
156308434|NCT01708902|564228246|FG001|Overall Study|Non compliance with protocol|2|||
156308435|NCT01708902|564228247|FG002|Overall Study|Non compliance with protocol|1|||
156308436|NCT01708902|564228248|FG003|Overall Study|Non compliance with protocol|3|||
156308437|NCT01708902|564228249|FG004|Overall Study|Non compliance with protocol|0|||
156308438|NCT01708902|564228250|FG005|Overall Study|Non compliance with protocol|0|||
156308439|NCT01708902|564228251|FG006|Overall Study|Non compliance with protocol|0|||
156308440|NCT01708902|564228245|FG000|Overall Study|Lost to Follow-up|2|||
156308441|NCT01708902|564228246|FG001|Overall Study|Lost to Follow-up|1|||
156308442|NCT01708902|564228247|FG002|Overall Study|Lost to Follow-up|2|||
156308443|NCT01708902|564228248|FG003|Overall Study|Lost to Follow-up|2|||
156308444|NCT01708902|564228249|FG004|Overall Study|Lost to Follow-up|0|||
156308445|NCT01708902|564228250|FG005|Overall Study|Lost to Follow-up|0|||
156308446|NCT01708902|564228251|FG006|Overall Study|Lost to Follow-up|1|||
156308447|NCT01708902|564228245|FG000|Overall Study|Refused to continue trial medication|8|||
156308448|NCT01708902|564228246|FG001|Overall Study|Refused to continue trial medication|0|||
156308449|NCT01708902|564228247|FG002|Overall Study|Refused to continue trial medication|4|||
156308450|NCT01708902|564228248|FG003|Overall Study|Refused to continue trial medication|2|||
156308451|NCT01708902|564228249|FG004|Overall Study|Refused to continue trial medication|8|||
156308452|NCT01708902|564228250|FG005|Overall Study|Refused to continue trial medication|1|||
156308453|NCT01708902|564228251|FG006|Overall Study|Refused to continue trial medication|1|||
156308454|NCT01708902|564228245|FG000|Overall Study|Other Reason|1|||
156308455|NCT01708902|564228246|FG001|Overall Study|Other Reason|0|||
156308456|NCT01708902|564228247|FG002|Overall Study|Other Reason|1|||
156308457|NCT01708902|564228248|FG003|Overall Study|Other Reason|1|||
156308458|NCT01708902|564228249|FG004|Overall Study|Other Reason|1|||
156308459|NCT01708902|564228250|FG005|Overall Study|Other Reason|2|||
156308460|NCT01708902|564228251|FG006|Overall Study|Other Reason|0|||
156308461|NCT02633020|564228254|FG000|Overall Study|Adverse Event|1|||
156308462|NCT02633020|564228255|FG001|Overall Study|Adverse Event|0|||
156308463|NCT00934440|564228256|FG000|Overall Study|Lost to Follow-up|1|||
156308464|NCT05661851|564228257|FG000|Overall Study|Protocol Violation|1|||
156308465|NCT05661851|564228258|FG001|Overall Study|Protocol Violation|1|||
156308466|NCT05661851|564228257|FG000|Overall Study|Covid-19 Related|3|||
156308467|NCT05661851|564228258|FG001|Overall Study|Covid-19 Related|4|||
156308468|NCT05661851|564228257|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
156308469|NCT05661851|564228258|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
156412312|NCT02138747|564602882|FG002|Treatment Period 1|Other - Miscellaneous|0|||
156308470|NCT05661851|564228257|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
156308471|NCT05661851|564228258|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
156308472|NCT00530816|564228259|FG000|Overall Study|Progressive Disease|16|||
156308473|NCT00530816|564228260|FG001|Overall Study|Progressive Disease|24|||
156308474|NCT00530816|564228261|FG002|Overall Study|Progressive Disease|24|||
156308475|NCT00530816|564228259|FG000|Overall Study|Adverse Event|6|||
156308476|NCT00530816|564228260|FG001|Overall Study|Adverse Event|13|||
156308477|NCT00530816|564228261|FG002|Overall Study|Adverse Event|7|||
156308478|NCT00530816|564228259|FG000|Overall Study|Other|3|||
156308479|NCT00530816|564228260|FG001|Overall Study|Other|3|||
156308480|NCT00530816|564228261|FG002|Overall Study|Other|4|||
156308481|NCT00530816|564228259|FG000|Overall Study|Withdrawal by Subject|1|||
156308482|NCT00530816|564228260|FG001|Overall Study|Withdrawal by Subject|2|||
156308483|NCT00530816|564228261|FG002|Overall Study|Withdrawal by Subject|6|||
156308484|NCT02152956|564228262|FG000|Overall Study|Adverse Event|0|||
156308485|NCT02152956|564228263|FG001|Overall Study|Adverse Event|0|||
156308486|NCT02152956|564228264|FG002|Overall Study|Adverse Event|0|||
156308487|NCT02152956|564228265|FG003|Overall Study|Adverse Event|0|||
156308488|NCT02152956|564228266|FG004|Overall Study|Adverse Event|0|||
156308489|NCT02152956|564228267|FG005|Overall Study|Adverse Event|0|||
156308490|NCT02152956|564228268|FG006|Overall Study|Adverse Event|0|||
156308491|NCT02152956|564228269|FG007|Overall Study|Adverse Event|0|||
156308492|NCT02152956|564228270|FG008|Overall Study|Adverse Event|0|||
156308493|NCT02152956|564228271|FG009|Overall Study|Adverse Event|0|||
156308494|NCT02152956|564228272|FG010|Overall Study|Adverse Event|0|||
156308495|NCT02152956|564228273|FG011|Overall Study|Adverse Event|4|||
156308496|NCT02152956|564228274|FG012|Overall Study|Adverse Event|0|||
156308497|NCT02152956|564228262|FG000|Overall Study|Death|0|||
156308498|NCT02152956|564228263|FG001|Overall Study|Death|3|||
156308499|NCT02152956|564228264|FG002|Overall Study|Death|3|||
156308500|NCT02152956|564228265|FG003|Overall Study|Death|4|||
156308501|NCT02152956|564228266|FG004|Overall Study|Death|1|||
156308502|NCT02152956|564228267|FG005|Overall Study|Death|2|||
156308503|NCT02152956|564228268|FG006|Overall Study|Death|6|||
156308504|NCT02152956|564228269|FG007|Overall Study|Death|6|||
156308505|NCT02152956|564228270|FG008|Overall Study|Death|4|||
156308506|NCT02152956|564228271|FG009|Overall Study|Death|5|||
156308507|NCT02152956|564228272|FG010|Overall Study|Death|3|||
156308508|NCT02152956|564228273|FG011|Overall Study|Death|143|||
156308509|NCT02152956|564228274|FG012|Overall Study|Death|12|||
156308510|NCT02152956|564228262|FG000|Overall Study|Lost to Follow-up|0|||
156308511|NCT02152956|564228263|FG001|Overall Study|Lost to Follow-up|1|||
156308512|NCT02152956|564228264|FG002|Overall Study|Lost to Follow-up|0|||
156308513|NCT02152956|564228265|FG003|Overall Study|Lost to Follow-up|0|||
156308514|NCT02152956|564228266|FG004|Overall Study|Lost to Follow-up|0|||
156308515|NCT02152956|564228267|FG005|Overall Study|Lost to Follow-up|0|||
156308516|NCT02152956|564228268|FG006|Overall Study|Lost to Follow-up|0|||
156308517|NCT02152956|564228269|FG007|Overall Study|Lost to Follow-up|0|||
156308518|NCT02152956|564228270|FG008|Overall Study|Lost to Follow-up|0|||
156308519|NCT02152956|564228271|FG009|Overall Study|Lost to Follow-up|0|||
156308520|NCT02152956|564228272|FG010|Overall Study|Lost to Follow-up|0|||
156308521|NCT02152956|564228273|FG011|Overall Study|Lost to Follow-up|3|||
156308522|NCT02152956|564228274|FG012|Overall Study|Lost to Follow-up|0|||
156308523|NCT02152956|564228262|FG000|Overall Study|Withdrawal by Subject|1|||
156308524|NCT02152956|564228263|FG001|Overall Study|Withdrawal by Subject|0|||
156308525|NCT02152956|564228264|FG002|Overall Study|Withdrawal by Subject|1|||
156308526|NCT02152956|564228265|FG003|Overall Study|Withdrawal by Subject|0|||
156308527|NCT02152956|564228266|FG004|Overall Study|Withdrawal by Subject|2|||
156308528|NCT02152956|564228267|FG005|Overall Study|Withdrawal by Subject|2|||
156308529|NCT02152956|564228268|FG006|Overall Study|Withdrawal by Subject|0|||
156308530|NCT02152956|564228269|FG007|Overall Study|Withdrawal by Subject|0|||
156308531|NCT02152956|564228270|FG008|Overall Study|Withdrawal by Subject|1|||
156308532|NCT02152956|564228271|FG009|Overall Study|Withdrawal by Subject|0|||
156308533|NCT02152956|564228272|FG010|Overall Study|Withdrawal by Subject|0|||
156308534|NCT02152956|564228273|FG011|Overall Study|Withdrawal by Subject|4|||
156308535|NCT02152956|564228274|FG012|Overall Study|Withdrawal by Subject|0|||
156412313|NCT02138747|564602883|FG003|Treatment Period 1|Other - Miscellaneous|0|||
156308536|NCT02152956|564228262|FG000|Overall Study|Physician Decision|0|||
156308537|NCT02152956|564228263|FG001|Overall Study|Physician Decision|0|||
156308538|NCT02152956|564228264|FG002|Overall Study|Physician Decision|0|||
156308539|NCT02152956|564228265|FG003|Overall Study|Physician Decision|0|||
156308540|NCT02152956|564228266|FG004|Overall Study|Physician Decision|0|||
156308541|NCT02152956|564228267|FG005|Overall Study|Physician Decision|0|||
156308542|NCT02152956|564228268|FG006|Overall Study|Physician Decision|0|||
156308543|NCT02152956|564228269|FG007|Overall Study|Physician Decision|0|||
156308544|NCT02152956|564228270|FG008|Overall Study|Physician Decision|0|||
156308545|NCT02152956|564228271|FG009|Overall Study|Physician Decision|0|||
156308546|NCT02152956|564228272|FG010|Overall Study|Physician Decision|0|||
156308547|NCT02152956|564228273|FG011|Overall Study|Physician Decision|1|||
156308548|NCT02152956|564228274|FG012|Overall Study|Physician Decision|0|||
156308549|NCT02152956|564228262|FG000|Overall Study|Study terminated by sponsor|0|||
156308550|NCT02152956|564228263|FG001|Overall Study|Study terminated by sponsor|0|||
156308551|NCT02152956|564228264|FG002|Overall Study|Study terminated by sponsor|0|||
156308552|NCT02152956|564228265|FG003|Overall Study|Study terminated by sponsor|0|||
156308553|NCT02152956|564228266|FG004|Overall Study|Study terminated by sponsor|0|||
156308554|NCT02152956|564228267|FG005|Overall Study|Study terminated by sponsor|0|||
156308555|NCT02152956|564228268|FG006|Overall Study|Study terminated by sponsor|0|||
156308556|NCT02152956|564228269|FG007|Overall Study|Study terminated by sponsor|0|||
156308557|NCT02152956|564228270|FG008|Overall Study|Study terminated by sponsor|0|||
156308558|NCT02152956|564228271|FG009|Overall Study|Study terminated by sponsor|0|||
156308559|NCT02152956|564228272|FG010|Overall Study|Study terminated by sponsor|0|||
156308560|NCT02152956|564228273|FG011|Overall Study|Study terminated by sponsor|29|||
156308561|NCT02152956|564228274|FG012|Overall Study|Study terminated by sponsor|0|||
156308562|NCT02152956|564228262|FG000|Overall Study|progressive disease|0|||
156308563|NCT02152956|564228263|FG001|Overall Study|progressive disease|0|||
156308564|NCT02152956|564228264|FG002|Overall Study|progressive disease|0|||
156308565|NCT02152956|564228265|FG003|Overall Study|progressive disease|0|||
156308566|NCT02152956|564228266|FG004|Overall Study|progressive disease|0|||
156308567|NCT02152956|564228267|FG005|Overall Study|progressive disease|0|||
156308568|NCT02152956|564228268|FG006|Overall Study|progressive disease|0|||
156308569|NCT02152956|564228269|FG007|Overall Study|progressive disease|0|||
156308570|NCT02152956|564228270|FG008|Overall Study|progressive disease|1|||
156308571|NCT02152956|564228271|FG009|Overall Study|progressive disease|0|||
156308572|NCT02152956|564228272|FG010|Overall Study|progressive disease|0|||
156308573|NCT02152956|564228273|FG011|Overall Study|progressive disease|1|||
156308574|NCT02152956|564228274|FG012|Overall Study|progressive disease|0|||
156308575|NCT01014910|564228275|FG000|Overall Study|Withdrawal by Subject|0|||
156308576|NCT01014910|564228276|FG001|Overall Study|Withdrawal by Subject|2|||
156308577|NCT02445794|564228277|FG000|Overall Study|Adverse Event|0|||
156308578|NCT02445794|564228278|FG001|Overall Study|Adverse Event|0|||
156308579|NCT02445794|564228279|FG002|Overall Study|Adverse Event|2|||
156308580|NCT02445794|564228280|FG003|Overall Study|Adverse Event|0|||
156308581|NCT01136785|564228281|FG000|Overall Study|Protocol Violation|2|||
156308582|NCT01136785|564228282|FG001|Overall Study|Protocol Violation|1|||
156308583|NCT01388985|564228283|FG000|Overall Study|Death|0|||
156308584|NCT01388985|564228284|FG001|Overall Study|Death|1|||
156308585|NCT01388985|564228283|FG000|Overall Study|Lost to Follow-up|30|||
156308586|NCT01388985|564228284|FG001|Overall Study|Lost to Follow-up|30|||
156308587|NCT01388985|564228283|FG000|Overall Study|Withdrawal by Subject|13|||
156308588|NCT01388985|564228284|FG001|Overall Study|Withdrawal by Subject|4|||
156308589|NCT01388985|564228283|FG000|Overall Study|Subject unavailable|1|||
156308590|NCT01388985|564228284|FG001|Overall Study|Subject unavailable|1|||
156308591|NCT01388985|564228283|FG000|Overall Study|Other (no reason)|0|||
156308592|NCT01388985|564228284|FG001|Overall Study|Other (no reason)|1|||
156308593|NCT01388985|564228283|FG000|Overall Study|Error of nurse|5|||
156308594|NCT01388985|564228284|FG001|Overall Study|Error of nurse|1|||
156308595|NCT01519167|564228287|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
156308596|NCT01519167|564228288|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
156308597|NCT01519167|564228287|FG000|Overall Study|Adverse Event|0|||
156308598|NCT01519167|564228288|FG001|Overall Study|Adverse Event|1|||
156308599|NCT01519167|564228287|FG000|Overall Study|Lack of Efficacy|0|||
156308600|NCT01519167|564228288|FG001|Overall Study|Lack of Efficacy|1|||
156308601|NCT01519167|564228287|FG000|Overall Study|Medical condition changes&deep sedation|0|||
156308602|NCT01519167|564228288|FG001|Overall Study|Medical condition changes&deep sedation|2|||
156308603|NCT01519167|564228287|FG000|Overall Study|Physician Decision|0|||
156308604|NCT01519167|564228288|FG001|Overall Study|Physician Decision|1|||
156308605|NCT02055118|564228291|FG000|Overall Study|Withdrawal by Subject|0|||
156308606|NCT02055118|564228292|FG001|Overall Study|Withdrawal by Subject|2|||
156308607|NCT02055118|564228293|FG002|Overall Study|Withdrawal by Subject|0|||
156308608|NCT01516034|564228295|FG000|Overall Study|Physician Decision|1|||
156308609|NCT01516034|564228295|FG000|Overall Study|Lack of Efficacy|7|||
156308610|NCT00870584|564228301|FG000|Overall Study|Adverse Event|3|||
156308611|NCT00870584|564228302|FG001|Overall Study|Adverse Event|3|||
156308612|NCT00870584|564228301|FG000|Overall Study|Withdrawal by Subject|6|||
156308613|NCT00870584|564228302|FG001|Overall Study|Withdrawal by Subject|7|||
156308614|NCT00870584|564228301|FG000|Overall Study|Lost to Follow-up|5|||
156308615|NCT00870584|564228302|FG001|Overall Study|Lost to Follow-up|1|||
156308616|NCT00870584|564228301|FG000|Overall Study|Protocol Deviation|2|||
156308617|NCT00870584|564228302|FG001|Overall Study|Protocol Deviation|2|||
156308618|NCT01497366|564228303|FG000|Overall Study|Virologic failure|2|||
156308619|NCT01497366|564228304|FG001|Overall Study|Virologic failure|50|||
156308620|NCT01497366|564228303|FG000|Overall Study|Lost to Follow-up|11|||
156308621|NCT01497366|564228304|FG001|Overall Study|Lost to Follow-up|10|||
156308622|NCT01497366|564228303|FG000|Overall Study|Withdrawal by Subject|6|||
156308623|NCT01497366|564228304|FG001|Overall Study|Withdrawal by Subject|6|||
156308624|NCT01497366|564228303|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
156308625|NCT01497366|564228304|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
156308626|NCT01497366|564228303|FG000|Overall Study|Other|5|||
156308627|NCT01497366|564228304|FG001|Overall Study|Other|0|||
156308628|NCT01497366|564228303|FG000|Overall Study|Death|1|||
156308629|NCT01497366|564228304|FG001|Overall Study|Death|1|||
156308630|NCT01497366|564228303|FG000|Overall Study|Randomized but not treated|7|||
156308631|NCT01497366|564228304|FG001|Overall Study|Randomized but not treated|21|||
156308632|NCT02703337|564228307|FG000|Period One (Part A)|Withdrawal by Subject|0|||
156308633|NCT02703337|564228308|FG001|Period One (Part A)|Withdrawal by Subject|0|||
156308634|NCT02703337|564228309|FG002|Period One (Part A)|Withdrawal by Subject|0|||
156308635|NCT02703337|564228310|FG003|Period One (Part A)|Withdrawal by Subject|0|||
156308636|NCT02703337|564228311|FG004|Period One (Part A)|Withdrawal by Subject|1|||
156308637|NCT02703337|564228312|FG005|Period One (Part A)|Withdrawal by Subject|0|||
156308638|NCT02703337|564228313|FG006|Period One (Part A)|Withdrawal by Subject|0|||
156308639|NCT02703337|564228314|FG007|Period One (Part A)|Withdrawal by Subject|0|||
156308640|NCT01031836|564230114|FG000|Stage I|Adverse Event|1|||
156647784|NCT02124746|565456913|FG001|Overall Study|Lack of Efficacy|2|||
156308641|NCT01031836|564230115|FG001|Stage I|Adverse Event|1|||
156308642|NCT01031836|564230116|FG002|Stage I|Adverse Event|0|||
156308643|NCT01031836|564230117|FG003|Stage I|Adverse Event|0|||
156308644|NCT01031836|564230118|FG004|Stage I|Adverse Event|0|||
156308645|NCT01031836|564230119|FG005|Stage I|Adverse Event|0|||
156308646|NCT01031836|564230114|FG000|Stage I|Other|0|||
156308647|NCT01031836|564230115|FG001|Stage I|Other|1|||
156308648|NCT01031836|564230116|FG002|Stage I|Other|0|||
156308649|NCT01031836|564230117|FG003|Stage I|Other|0|||
156308650|NCT01031836|564230118|FG004|Stage I|Other|0|||
156308651|NCT01031836|564230119|FG005|Stage I|Other|1|||
156308652|NCT01031836|564230114|FG000|Stage II|Adverse Event|0|||
156308653|NCT01031836|564230115|FG001|Stage II|Adverse Event|0|||
156308654|NCT01031836|564230116|FG002|Stage II|Adverse Event|2|||
156308655|NCT01031836|564230117|FG003|Stage II|Adverse Event|2|||
156308656|NCT01031836|564230118|FG004|Stage II|Adverse Event|1|||
156308657|NCT01031836|564230119|FG005|Stage II|Adverse Event|1|||
156308658|NCT01031836|564230114|FG000|Stage II|Other|2|||
156308659|NCT01031836|564230115|FG001|Stage II|Other|0|||
156308660|NCT01031836|564230116|FG002|Stage II|Other|0|||
156308661|NCT01031836|564230117|FG003|Stage II|Other|1|||
156308662|NCT01031836|564230118|FG004|Stage II|Other|1|||
156308663|NCT01031836|564230119|FG005|Stage II|Other|0|||
156308664|NCT01888432|564230124|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
156308665|NCT01888432|564230125|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
156308666|NCT01888432|564230124|FG000|12-month Analysis (FAS)|Physician Decision|1|||
156308667|NCT01888432|564230125|FG001|12-month Analysis (FAS)|Physician Decision|1|||
156308668|NCT01888432|564230124|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
156308669|NCT01888432|564230125|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
156308670|NCT01888432|564230124|FG000|12-month Analysis (FAS)|Death|4|||
156308671|NCT01888432|564230125|FG001|12-month Analysis (FAS)|Death|3|||
156308672|NCT01888432|564230124|FG000|24-month Analysis (FAS)|Graft loss|0|||
156308673|NCT01888432|564230125|FG001|24-month Analysis (FAS)|Graft loss|1|||
156308674|NCT01888432|564230124|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
156308675|NCT01888432|564230125|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
156308676|NCT01888432|564230124|FG000|24-month Analysis (FAS)|Physician Decision|2|||
156308677|NCT01888432|564230125|FG001|24-month Analysis (FAS)|Physician Decision|4|||
156308678|NCT01888432|564230124|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
156308679|NCT01888432|564230125|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
156308680|NCT01888432|564230124|FG000|24-month Analysis (FAS)|Death|8|||
156308681|NCT01888432|564230125|FG001|24-month Analysis (FAS)|Death|4|||
156308682|NCT01888432|564230124|FG000|36-month Analysis (Extension)|Death|1|||
156308683|NCT01888432|564230125|FG001|36-month Analysis (Extension)|Death|0|||
156308684|NCT03844945|564230128|FG000|Overall Study|Adverse Event|1|||
156308685|NCT03844945|564230129|FG001|Overall Study|Adverse Event|1|||
156308686|NCT03844945|564230130|FG002|Overall Study|Adverse Event|4|||
156308687|NCT03844945|564230131|FG003|Overall Study|Adverse Event|0|||
156308688|NCT03844945|564230128|FG000|Overall Study|Withdrawal by Subject|0|||
156308689|NCT03844945|564230129|FG001|Overall Study|Withdrawal by Subject|0|||
156308690|NCT03844945|564230130|FG002|Overall Study|Withdrawal by Subject|1|||
156308691|NCT03844945|564230131|FG003|Overall Study|Withdrawal by Subject|0|||
156308692|NCT03844945|564230128|FG000|Overall Study|Lack of Efficacy|0|||
156308693|NCT03844945|564230129|FG001|Overall Study|Lack of Efficacy|0|||
156308694|NCT03844945|564230130|FG002|Overall Study|Lack of Efficacy|0|||
156308695|NCT03844945|564230131|FG003|Overall Study|Lack of Efficacy|1|||
156308696|NCT01696929|564230132|FG000|Overall Study|Physician Decision|1|||
156308697|NCT01794338|564230145|FG000|Overall Study|Death|2|||
156308698|NCT01794338|564230146|FG001|Overall Study|Death|0|||
156308699|NCT01794338|564230145|FG000|Overall Study|Lost to Follow-up|6|||
156308700|NCT01794338|564230146|FG001|Overall Study|Lost to Follow-up|9|||
156308701|NCT01754402|564230147|FG000|Overall Study|Death|0|||
156308702|NCT01754402|564230148|FG001|Overall Study|Death|0|||
156308703|NCT01754402|564230149|FG002|Overall Study|Death|1|||
156308704|NCT01754402|564230147|FG000|Overall Study|Adverse Event|2|||
156308705|NCT01754402|564230148|FG001|Overall Study|Adverse Event|2|||
156308706|NCT01754402|564230149|FG002|Overall Study|Adverse Event|1|||
156308707|NCT01754402|564230147|FG000|Overall Study|Withdrawal by Subject|0|||
156308708|NCT01754402|564230148|FG001|Overall Study|Withdrawal by Subject|0|||
156308709|NCT01754402|564230149|FG002|Overall Study|Withdrawal by Subject|1|||
156308710|NCT01754402|564230147|FG000|Overall Study|Lack of Efficacy|0|||
156308711|NCT01754402|564230148|FG001|Overall Study|Lack of Efficacy|0|||
156308712|NCT01754402|564230149|FG002|Overall Study|Lack of Efficacy|1|||
156308713|NCT01282463|564230150|FG000|Overall Study|Lost to Follow-up|1|||
156308714|NCT01282463|564230151|FG001|Overall Study|Lost to Follow-up|0|||
156308715|NCT01282463|564230152|FG002|Overall Study|Lost to Follow-up|0|||
156308716|NCT01282463|564230150|FG000|Overall Study|Withdrawal by Subject|6|||
156308717|NCT01282463|564230151|FG001|Overall Study|Withdrawal by Subject|2|||
156308718|NCT01282463|564230152|FG002|Overall Study|Withdrawal by Subject|3|||
156308719|NCT01282463|564230150|FG000|Overall Study|"Never Treated Death"|0|||
156308720|NCT01282463|564230151|FG001|Overall Study|"Never Treated Death"|1|||
156308721|NCT01282463|564230152|FG002|Overall Study|"Never Treated Death"|0|||
156308722|NCT01282463|564230150|FG000|Overall Study|"Never Treated PD"|0|||
156308723|NCT01282463|564230151|FG001|Overall Study|"Never Treated PD"|1|||
156308724|NCT01282463|564230152|FG002|Overall Study|"Never Treated PD"|0|||
156308725|NCT01282463|564230150|FG000|Overall Study|Protocol Violation|0|||
156308726|NCT01282463|564230151|FG001|Overall Study|Protocol Violation|0|||
156308727|NCT01282463|564230152|FG002|Overall Study|Protocol Violation|1|||
156308728|NCT01282463|564230150|FG000|Overall Study|Physician Decision|1|||
156308729|NCT01282463|564230151|FG001|Overall Study|Physician Decision|0|||
156308730|NCT01282463|564230152|FG002|Overall Study|Physician Decision|0|||
156308731|NCT02051933|564230153|FG000|Overall Study|Physician Decision|0|||
156308732|NCT02051933|564230154|FG001|Overall Study|Physician Decision|1|||
156308733|NCT01954927|564230155|FG000|Overall Study|Withdrawal by Subject|3|||
156308734|NCT01954927|564230156|FG001|Overall Study|Withdrawal by Subject|1|||
156308735|NCT02156271|564230157|FG000|Overall Study|Physician Decision|4|||
156308736|NCT02156271|564230158|FG001|Overall Study|Physician Decision|3|||
156308737|NCT03320824|564230159|FG000|Overall Study|Withdrawal by Subject|8|||
156308738|NCT03320824|564230160|FG001|Overall Study|Withdrawal by Subject|1|||
156308739|NCT03320824|564230159|FG000|Overall Study|Lost to Follow-up|10|||
156308740|NCT03320824|564230160|FG001|Overall Study|Lost to Follow-up|1|||
156308741|NCT03320824|564230159|FG000|Overall Study|moved out of state|0|||
156308742|NCT03320824|564230160|FG001|Overall Study|moved out of state|1|||
156308743|NCT03320824|564230159|FG000|Overall Study|could not complete final visit|0|||
156308744|NCT03320824|564230160|FG001|Overall Study|could not complete final visit|1|||
156308745|NCT00955305|564230161|FG000|Overall Study|Disease progression|39|||
156308746|NCT00955305|564230162|FG001|Overall Study|Disease progression|41|||
156308747|NCT00955305|564230161|FG000|Overall Study|Adverse Event|22|||
156308748|NCT00955305|564230162|FG001|Overall Study|Adverse Event|22|||
156308749|NCT00955305|564230161|FG000|Overall Study|Death|2|||
156308750|NCT00955305|564230162|FG001|Overall Study|Death|1|||
156308751|NCT00955305|564230161|FG000|Overall Study|Withdrawal by Subject|5|||
156308752|NCT00955305|564230162|FG001|Overall Study|Withdrawal by Subject|4|||
156308753|NCT00955305|564230161|FG000|Overall Study|Alternative therapy|4|||
156308754|NCT00955305|564230162|FG001|Overall Study|Alternative therapy|0|||
156308755|NCT00955305|564230161|FG000|Overall Study|Other complicating disease|2|||
156308756|NCT00955305|564230162|FG001|Overall Study|Other complicating disease|4|||
156308757|NCT00955305|564230161|FG000|Overall Study|Physician Decision|1|||
156308758|NCT00955305|564230162|FG001|Overall Study|Physician Decision|0|||
156308759|NCT00955305|564230161|FG000|Overall Study|Continued presence of residual disease|0|||
156308760|NCT00955305|564230162|FG001|Overall Study|Continued presence of residual disease|1|||
156308761|NCT00955305|564230161|FG000|Overall Study|Functional decline|2|||
156308762|NCT00955305|564230162|FG001|Overall Study|Functional decline|0|||
156308763|NCT00955305|564230161|FG000|Overall Study|Maximum response achieved|0|||
156308764|NCT00955305|564230162|FG001|Overall Study|Maximum response achieved|1|||
156308765|NCT00955305|564230161|FG000|Overall Study|Lost to Follow-up|0|||
156308766|NCT00955305|564230162|FG001|Overall Study|Lost to Follow-up|1|||
156308767|NCT00955305|564230161|FG000|Overall Study|No off-treatment reason submitted|1|||
156308768|NCT00955305|564230162|FG001|Overall Study|No off-treatment reason submitted|0|||
156308769|NCT00955305|564230161|FG000|Overall Study|Never started protocol treatment|5|||
156308770|NCT00955305|564230162|FG001|Overall Study|Never started protocol treatment|5|||
156308771|NCT00955305|564230161|FG000|Overall Study|Ineligible|5|||
156308772|NCT00955305|564230162|FG001|Overall Study|Ineligible|7|||
156308773|NCT00109590|564230163|FG000|Overall Study|Lost to Follow-up|1|||
156308774|NCT00109590|564230164|FG001|Overall Study|Lost to Follow-up|0|||
156308775|NCT00109590|564230165|FG002|Overall Study|Lost to Follow-up|1|||
156308776|NCT00109590|564230163|FG000|Overall Study|Never Started Treatment|1|||
156308777|NCT00109590|564230164|FG001|Overall Study|Never Started Treatment|2|||
156308778|NCT00109590|564230165|FG002|Overall Study|Never Started Treatment|3|||
156308779|NCT02123251|564230166|FG000|Overall Study|Death|1|||
156308780|NCT02123251|564230167|FG001|Overall Study|Death|1|||
156308781|NCT02123251|564230166|FG000|Overall Study|Withdrawal by Subject|0|||
156308782|NCT02123251|564230167|FG001|Overall Study|Withdrawal by Subject|3|||
156308783|NCT02123251|564230166|FG000|Overall Study|Lost Medicaid eligibility|29|||
156308784|NCT02123251|564230167|FG001|Overall Study|Lost Medicaid eligibility|22|||
156308785|NCT02123251|564230166|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
156308786|NCT02123251|564230167|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
156308787|NCT01221285|564230168|FG000|Overall Study|Withdrawal by Subject|1|||
156308788|NCT00588861|564230175|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
156308789|NCT00588861|564230176|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
156308790|NCT00588861|564230175|FG000|6 Months|Patients did not return for follow-up|98|||
156308791|NCT00588861|564230176|FG001|6 Months|Patients did not return for follow-up|73|||
156308792|NCT00588861|564230175|FG000|1 Year|Patients did not return for follow-up|89|||
156308793|NCT00588861|564230176|FG001|1 Year|Patients did not return for follow-up|82|||
156308794|NCT00588861|564230175|FG000|2 Years|Patients did not return for follow-up|92|||
156308795|NCT00588861|564230176|FG001|2 Years|Patients did not return for follow-up|87|||
156308796|NCT00588861|564230175|FG000|4 Years|Patients did not return for follow-up|91|||
156308797|NCT00588861|564230176|FG001|4 Years|Patients did not return for follow-up|103|||
156308798|NCT00588861|564230175|FG000|6 Years|Patients did not return for follow-up|104|||
156308799|NCT00588861|564230176|FG001|6 Years|Patients did not return for follow-up|109|||
156308800|NCT00588861|564230175|FG000|8 Years|Patients did not return for follow-up|105|||
156308801|NCT00588861|564230176|FG001|8 Years|Patients did not return for follow-up|114|||
156308802|NCT00588861|564230175|FG000|10 Years|Incomplete due to study termination|107|||
156308803|NCT00588861|564230176|FG001|10 Years|Incomplete due to study termination|114|||
156308804|NCT00375609|564230177|FG000|Overall Study|Did not receive treatment|1|||
156308805|NCT00375609|564230178|FG001|Overall Study|Did not receive treatment|0|||
156308806|NCT00375609|564230179|FG002|Overall Study|Did not receive treatment|0|||
156308807|NCT00375609|564230177|FG000|Overall Study|Adverse Event|0|||
156308808|NCT00375609|564230178|FG001|Overall Study|Adverse Event|3|||
156308809|NCT00375609|564230179|FG002|Overall Study|Adverse Event|0|||
156308810|NCT00375609|564230177|FG000|Overall Study|Lost to Follow-up|1|||
156308811|NCT00375609|564230178|FG001|Overall Study|Lost to Follow-up|0|||
156308812|NCT00375609|564230179|FG002|Overall Study|Lost to Follow-up|0|||
156308813|NCT00375609|564230177|FG000|Overall Study|Physician Decision|0|||
156308814|NCT00375609|564230178|FG001|Overall Study|Physician Decision|0|||
156308815|NCT00375609|564230179|FG002|Overall Study|Physician Decision|1|||
156308816|NCT00375609|564230177|FG000|Overall Study|Withdrawal by Subject|1|||
156308817|NCT00375609|564230178|FG001|Overall Study|Withdrawal by Subject|4|||
156308818|NCT00375609|564230179|FG002|Overall Study|Withdrawal by Subject|0|||
156308819|NCT00375609|564230177|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
156308820|NCT00375609|564230178|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
156308821|NCT00375609|564230179|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
156308822|NCT03254459|564230185|FG000|Overall Study|Adverse Event|7|||
156308823|NCT03254459|564230186|FG001|Overall Study|Adverse Event|20|||
156308824|NCT03254459|564230185|FG000|Overall Study|Withdrawal by Subject Consent|3|||
156308825|NCT03254459|564230186|FG001|Overall Study|Withdrawal by Subject Consent|1|||
156308826|NCT03254459|564230185|FG000|Overall Study|Lost to Follow-up|0|||
156308827|NCT03254459|564230186|FG001|Overall Study|Lost to Follow-up|1|||
156308828|NCT03254459|564230185|FG000|Overall Study|Miscellaneous|0|||
156308829|NCT03254459|564230186|FG001|Overall Study|Miscellaneous|1|||
156308830|NCT01129583|564230187|FG000|Overall Study|Death|1|||
156308831|NCT01129583|564230188|FG001|Overall Study|Death|0|||
156308832|NCT01129583|564230187|FG000|Overall Study|Lost to Follow-up|1|||
156308833|NCT01129583|564230188|FG001|Overall Study|Lost to Follow-up|1|||
156308834|NCT01129583|564230187|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
156308835|NCT01129583|564230188|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
156308836|NCT02338882|564230189|FG000|Overall Study|Death|1|||
156308837|NCT02338882|564230190|FG001|Overall Study|Death|0|||
156308838|NCT02338882|564230189|FG000|Overall Study|Lost to Follow-up|6|||
156308839|NCT02338882|564230190|FG001|Overall Study|Lost to Follow-up|3|||
156308840|NCT02617485|564230203|FG000|Treatment and Observation Period|Adverse Event|9|||
156308841|NCT02617485|564230204|FG001|Treatment and Observation Period|Adverse Event|1|||
156308842|NCT02617485|564230203|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
156308843|NCT02617485|564230204|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
156308844|NCT02617485|564230203|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
156308845|NCT02617485|564230204|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
156308846|NCT02617485|564230203|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
156308847|NCT02617485|564230204|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
156308848|NCT02617485|564230203|FG000|Treatment and Observation Period|Physician Decision|0|||
156647785|NCT02124746|565456914|FG002|Overall Study|Lack of Efficacy|2|||
156308849|NCT02617485|564230204|FG001|Treatment and Observation Period|Physician Decision|1|||
156308850|NCT02617485|564230203|FG000|Follow-up Period|Adverse Event|1|||
156308851|NCT02617485|564230204|FG001|Follow-up Period|Adverse Event|0|||
156308852|NCT02617485|564230203|FG000|Follow-up Period|Withdrawal by Subject|1|||
156308853|NCT02617485|564230204|FG001|Follow-up Period|Withdrawal by Subject|0|||
156308854|NCT02617485|564230203|FG000|Follow-up Period|Disease progression|2|||
156308855|NCT02617485|564230204|FG001|Follow-up Period|Disease progression|1|||
156308856|NCT02617485|564230203|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
156308857|NCT02617485|564230204|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
156308858|NCT02617485|564230203|FG000|Follow-up Period|Patient needed radiotherapy|9|||
156308859|NCT02617485|564230204|FG001|Follow-up Period|Patient needed radiotherapy|5|||
156308860|NCT02617485|564230203|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
156308861|NCT02617485|564230204|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
156308862|NCT00220779|564230205|FG000|Overall Study|Adverse Event|1|||
156308863|NCT00220779|564230206|FG001|Overall Study|Adverse Event|0|||
156308864|NCT00220779|564230207|FG002|Overall Study|Adverse Event|0|||
156308865|NCT00220779|564230205|FG000|Overall Study|Withdrawal by Subject|1|||
156308866|NCT00220779|564230206|FG001|Overall Study|Withdrawal by Subject|4|||
156308867|NCT00220779|564230207|FG002|Overall Study|Withdrawal by Subject|1|||
156308868|NCT00220779|564230205|FG000|Overall Study|Non-compliance|1|||
156308869|NCT00220779|564230206|FG001|Overall Study|Non-compliance|0|||
156308870|NCT00220779|564230207|FG002|Overall Study|Non-compliance|0|||
156308871|NCT00220779|564230205|FG000|Overall Study|Too time consuming|1|||
156308872|NCT00220779|564230206|FG001|Overall Study|Too time consuming|0|||
156308873|NCT00220779|564230207|FG002|Overall Study|Too time consuming|0|||
156308874|NCT00220779|564230205|FG000|Overall Study|Pregnancy|0|||
156308875|NCT00220779|564230206|FG001|Overall Study|Pregnancy|0|||
156308876|NCT00220779|564230207|FG002|Overall Study|Pregnancy|2|||
156308877|NCT00220779|564230205|FG000|Overall Study|Lack of Efficacy|3|||
156308878|NCT00220779|564230206|FG001|Overall Study|Lack of Efficacy|0|||
156308879|NCT00220779|564230207|FG002|Overall Study|Lack of Efficacy|1|||
156308880|NCT00791076|564230208|FG000|Overall Study|Study was terminated,PI left institution|8|||
156308881|NCT01511055|564230209|FG000|Overall Study|Withdrawal by Subject|6|||
156308882|NCT00669409|564230215|FG000|Part 2|Withdrawal by Subject|0|||
156308883|NCT00669409|564230216|FG001|Part 2|Withdrawal by Subject|0|||
156308884|NCT00669409|564230217|FG002|Part 2|Withdrawal by Subject|0|||
156308885|NCT00669409|564230218|FG003|Part 2|Withdrawal by Subject|0|||
156308886|NCT00669409|564230219|FG004|Part 2|Withdrawal by Subject|0|||
156308887|NCT00669409|564230220|FG005|Part 2|Withdrawal by Subject|0|||
156308888|NCT00669409|564230221|FG006|Part 2|Withdrawal by Subject|0|||
156308889|NCT00669409|564230222|FG007|Part 2|Withdrawal by Subject|0|||
156308890|NCT00669409|564230223|FG008|Part 2|Withdrawal by Subject|0|||
156308891|NCT00669409|564230224|FG009|Part 2|Withdrawal by Subject|1|||
156308892|NCT00669409|564230225|FG010|Part 2|Withdrawal by Subject|0|||
156308893|NCT04491604|564230226|FG000|Overall Study|Withdrawal by Subject|3|||
156308894|NCT01874340|564230227|FG000|Overall Study|Study terminated by Sponsor|6|||
156308895|NCT01874340|564230228|FG001|Overall Study|Study terminated by Sponsor|8|||
156308896|NCT01874340|564230229|FG002|Overall Study|Study terminated by Sponsor|8|||
156308897|NCT01874340|564230230|FG003|Overall Study|Study terminated by Sponsor|4|||
156308898|NCT01874340|564230227|FG000|Overall Study|Withdrawal by Subject|0|||
156308899|NCT01874340|564230228|FG001|Overall Study|Withdrawal by Subject|0|||
156308900|NCT01874340|564230229|FG002|Overall Study|Withdrawal by Subject|0|||
156308901|NCT01874340|564230230|FG003|Overall Study|Withdrawal by Subject|1|||
156308902|NCT03263702|564230231|FG000|Overall Study|Lost to Follow-up|2|||
156308903|NCT03263702|564230232|FG001|Overall Study|Lost to Follow-up|2|||
156308904|NCT03263702|564230231|FG000|Overall Study|Withdrawal by Subject|1|||
156308905|NCT03263702|564230232|FG001|Overall Study|Withdrawal by Subject|2|||
156308906|NCT02888119|564230234|FG000|Overall Study|Lost to Follow-up|5|||
156308907|NCT02888119|564230235|FG001|Overall Study|Lost to Follow-up|4|||
156308908|NCT02888119|564230236|FG002|Overall Study|Lost to Follow-up|0|||
156308909|NCT03330002|564230237|FG000|Overall Study|Lost to Follow-up|15|||
156308910|NCT03330002|564230237|FG000|Overall Study|Death|7|||
156308911|NCT05573386|564230238|FG000|Overall Study|Withdrawal by Subject|3|||
156308912|NCT05573386|564230239|FG001|Overall Study|Withdrawal by Subject|2|||
156308913|NCT05246514|564230240|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
156308914|NCT05246514|564230240|FG000|Overall Study|Withdrawal by Subject|1|||
156308915|NCT05246514|564230240|FG000|Overall Study|Death|13|||
156412314|NCT02138747|564602880|FG000|Treatment Period 2|Adverse Event|6|||
156412315|NCT02138747|564602881|FG001|Treatment Period 2|Adverse Event|3|||
156412316|NCT02138747|564602882|FG002|Treatment Period 2|Adverse Event|1|||
156412317|NCT02138747|564602883|FG003|Treatment Period 2|Adverse Event|1|||
156412318|NCT02138747|564602880|FG000|Treatment Period 2|Lost to Follow-up|2|||
156412319|NCT02138747|564602881|FG001|Treatment Period 2|Lost to Follow-up|0|||
156412320|NCT02138747|564602882|FG002|Treatment Period 2|Lost to Follow-up|0|||
156412321|NCT02138747|564602883|FG003|Treatment Period 2|Lost to Follow-up|0|||
156308916|NCT01327482|564230241|FG000|Overall Study|Adverse Event|1|||
156308917|NCT00312195|564230242|FG000|Overall Study|Adverse Event|4|||
156308918|NCT00312195|564230243|FG001|Overall Study|Adverse Event|6|||
156308919|NCT00312195|564230242|FG000|Overall Study|Lost to Follow-up|1|||
156308920|NCT00312195|564230243|FG001|Overall Study|Lost to Follow-up|0|||
156308921|NCT00312195|564230242|FG000|Overall Study|Protocol Violation|1|||
156308922|NCT00312195|564230243|FG001|Overall Study|Protocol Violation|0|||
156412322|NCT02138747|564602880|FG000|Treatment Period 2|Protocol Violation|1|||
156412323|NCT02138747|564602881|FG001|Treatment Period 2|Protocol Violation|0|||
156308923|NCT01018810|564230244|FG000|Overall Study|Withdrawal by Subject|0|||
156308924|NCT01018810|564230245|FG001|Overall Study|Withdrawal by Subject|1|||
156308925|NCT01018810|564230246|FG002|Overall Study|Withdrawal by Subject|0|||
156308926|NCT01018810|564230247|FG003|Overall Study|Withdrawal by Subject|0|||
156308927|NCT01018810|564230248|FG004|Overall Study|Withdrawal by Subject|0|||
156308928|NCT01018810|564230244|FG000|Overall Study|Sponsor Decision|2|||
156308929|NCT01018810|564230245|FG001|Overall Study|Sponsor Decision|0|||
156308930|NCT01018810|564230246|FG002|Overall Study|Sponsor Decision|1|||
156308931|NCT01018810|564230247|FG003|Overall Study|Sponsor Decision|1|||
156308932|NCT01018810|564230248|FG004|Overall Study|Sponsor Decision|1|||
156308933|NCT02872935|564230253|FG000|Overall Study|Other|0|||
156308934|NCT02872935|564230254|FG001|Overall Study|Other|1|||
156308935|NCT03179319|564230257|FG000|Overall Study|Lost to Follow-up|6|||
156308936|NCT03179319|564230258|FG001|Overall Study|Lost to Follow-up|0|||
156308937|NCT01120717|564230259|FG000|Overall Study|Withdrawal by Subject|11|||
156308938|NCT01120717|564230260|FG001|Overall Study|Withdrawal by Subject|6|||
156308939|NCT01120717|564230259|FG000|Overall Study|Adverse Event|10|||
156308940|NCT01120717|564230260|FG001|Overall Study|Adverse Event|6|||
156308941|NCT01120717|564230259|FG000|Overall Study|Protocol Deviation|2|||
156308942|NCT01120717|564230260|FG001|Overall Study|Protocol Deviation|5|||
156308943|NCT01120717|564230259|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156308944|NCT01120717|564230260|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156308945|NCT01120717|564230259|FG000|Overall Study|Lost to Follow-up|2|||
156308946|NCT01120717|564230260|FG001|Overall Study|Lost to Follow-up|3|||
156308947|NCT01120717|564230259|FG000|Overall Study|Death|3|||
156308948|NCT01120717|564230260|FG001|Overall Study|Death|1|||
156308949|NCT01120717|564230259|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
156308950|NCT01120717|564230260|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156308951|NCT00329797|564230265|FG000|Overall Study|Protocol Violation|1|||
156308952|NCT00329797|564230266|FG001|Overall Study|Protocol Violation|0|||
156308953|NCT00329797|564230265|FG000|Overall Study|Withdrawal by Subject|6|||
156308954|NCT00329797|564230266|FG001|Overall Study|Withdrawal by Subject|6|||
156308955|NCT00910299|564230276|FG000|Overall Study|Withdrawal by Subject|16|||
156308956|NCT00910299|564230277|FG001|Overall Study|Withdrawal by Subject|13|||
156308957|NCT00910299|564230276|FG000|Overall Study|Sponsor Decision|58|||
156308958|NCT00910299|564230277|FG001|Overall Study|Sponsor Decision|60|||
156308959|NCT00910299|564230276|FG000|Overall Study|Didn't receive any study drug|2|||
156308960|NCT00910299|564230277|FG001|Overall Study|Didn't receive any study drug|1|||
156308961|NCT04530136|564230278|FG000|Overall Study|Lost to Follow-up|2|||
156308962|NCT04530136|564230279|FG001|Overall Study|Lost to Follow-up|3|||
156308963|NCT04530136|564230278|FG000|Overall Study|Withdrawal by Subject|1|||
156308964|NCT04530136|564230279|FG001|Overall Study|Withdrawal by Subject|0|||
156308965|NCT04530136|564230278|FG000|Overall Study|Death|0|||
156308966|NCT04530136|564230279|FG001|Overall Study|Death|1|||
156308967|NCT01057589|564230282|FG000|Overall Study|Disease Progression|35|||
156308968|NCT01057589|564230282|FG000|Overall Study|Adverse Event|10|||
156308969|NCT01057589|564230282|FG000|Overall Study|Physician Decision|8|||
156308970|NCT01057589|564230282|FG000|Overall Study|Withdrawal by Subject|3|||
156308971|NCT01057589|564230282|FG000|Overall Study|Sponsor Decision|1|||
156308972|NCT01057589|564230282|FG000|Overall Study|Death|8|||
156308973|NCT01057589|564230282|FG000|Overall Study|Lost to Follow-up|1|||
156308974|NCT02281383|564230283|FG000|Overall Study|Progressive Disease|1|||
156308975|NCT02281383|564230283|FG000|Overall Study|Withdrawal by Subject|6|||
156308976|NCT02281383|564230283|FG000|Overall Study|Protocol Violation|2|||
156308977|NCT02281383|564230283|FG000|Overall Study|Death|1|||
156308978|NCT02281383|564230283|FG000|Overall Study|Adverse Event|2|||
156308979|NCT00472030|564230295|FG000|Overall Study|Physician Decision|1|||
156308980|NCT00472030|564230296|FG001|Overall Study|Physician Decision|0|||
156308981|NCT00829504|564230297|FG000|First Intervention|Adverse Event|1|||
156308982|NCT00829504|564230298|FG001|First Intervention|Adverse Event|0|||
156308983|NCT00829504|564230297|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156308984|NCT00829504|564230298|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156308985|NCT00829504|564230297|FG000|Second Intervention|Physician Decision|1|||
156308986|NCT00829504|564230298|FG001|Second Intervention|Physician Decision|0|||
156308987|NCT00490529|564231930|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
156308988|NCT00490529|564231930|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
156308989|NCT00490529|564231930|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
156412324|NCT02138747|564602882|FG002|Treatment Period 2|Protocol Violation|0|||
156308990|NCT00490529|564231930|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
156308991|NCT00490529|564231930|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
156308992|NCT00490529|564231930|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
156308993|NCT02248675|564231938|FG000|Overall Study|Lost to Follow-up|3|||
156308994|NCT02248675|564231939|FG001|Overall Study|Lost to Follow-up|1|||
156308995|NCT00830869|564231940|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
156308996|NCT00830869|564231941|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
156308997|NCT00830869|564231942|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
156308998|NCT00830869|564231943|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
156308999|NCT00830869|564231944|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
156309000|NCT00830869|564231945|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
156309001|NCT00830869|564231946|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
156309002|NCT00830869|564231947|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
156309003|NCT00830869|564231948|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
156309004|NCT00830869|564231949|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
156309005|NCT00830869|564231950|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
156309006|NCT00830869|564231951|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
156309007|NCT00830869|564231940|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
156309008|NCT00830869|564231941|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
156309009|NCT00830869|564231942|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
156309010|NCT00830869|564231943|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
156309011|NCT00830869|564231944|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
156309012|NCT00830869|564231945|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
156309013|NCT00830869|564231946|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
156309014|NCT00830869|564231947|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
156309015|NCT00830869|564231948|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
156309016|NCT00830869|564231949|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
156309017|NCT00830869|564231950|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
156309018|NCT00830869|564231951|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
156309019|NCT00830869|564231940|FG000|Period 1: Part 1|Adverse Event|0|||
156309020|NCT00830869|564231941|FG001|Period 1: Part 1|Adverse Event|0|||
156309021|NCT00830869|564231942|FG002|Period 1: Part 1|Adverse Event|0|||
156309022|NCT00830869|564231943|FG003|Period 1: Part 1|Adverse Event|0|||
156309023|NCT00830869|564231944|FG004|Period 1: Part 1|Adverse Event|0|||
156309024|NCT00830869|564231945|FG005|Period 1: Part 1|Adverse Event|1|||
156309025|NCT00830869|564231946|FG006|Period 1: Part 1|Adverse Event|1|||
156309026|NCT00830869|564231947|FG007|Period 1: Part 1|Adverse Event|0|||
156309027|NCT00830869|564231948|FG008|Period 1: Part 1|Adverse Event|0|||
156309028|NCT00830869|564231949|FG009|Period 1: Part 1|Adverse Event|0|||
156309029|NCT00830869|564231950|FG010|Period 1: Part 1|Adverse Event|0|||
156309030|NCT00830869|564231951|FG011|Period 1: Part 1|Adverse Event|0|||
156309031|NCT00830869|564231940|FG000|Period 1: Part 1|Progressive disease|1|||
156309032|NCT00830869|564231941|FG001|Period 1: Part 1|Progressive disease|0|||
156309033|NCT00830869|564231942|FG002|Period 1: Part 1|Progressive disease|1|||
156309034|NCT00830869|564231943|FG003|Period 1: Part 1|Progressive disease|6|||
156309035|NCT00830869|564231944|FG004|Period 1: Part 1|Progressive disease|4|||
156309036|NCT00830869|564231945|FG005|Period 1: Part 1|Progressive disease|4|||
156309037|NCT00830869|564231946|FG006|Period 1: Part 1|Progressive disease|1|||
156309038|NCT00830869|564231947|FG007|Period 1: Part 1|Progressive disease|0|||
156309039|NCT00830869|564231948|FG008|Period 1: Part 1|Progressive disease|0|||
156309040|NCT00830869|564231949|FG009|Period 1: Part 1|Progressive disease|0|||
156309041|NCT00830869|564231950|FG010|Period 1: Part 1|Progressive disease|0|||
156309042|NCT00830869|564231951|FG011|Period 1: Part 1|Progressive disease|0|||
156309043|NCT00830869|564231940|FG000|Period 2: Part 2|Protocol Violation|0|||
156309044|NCT00830869|564231941|FG001|Period 2: Part 2|Protocol Violation|0|||
156309045|NCT00830869|564231942|FG002|Period 2: Part 2|Protocol Violation|0|||
156309046|NCT00830869|564231943|FG003|Period 2: Part 2|Protocol Violation|0|||
156309047|NCT00830869|564231944|FG004|Period 2: Part 2|Protocol Violation|0|||
156309048|NCT00830869|564231945|FG005|Period 2: Part 2|Protocol Violation|0|||
156309049|NCT00830869|564231946|FG006|Period 2: Part 2|Protocol Violation|0|||
156309050|NCT00830869|564231947|FG007|Period 2: Part 2|Protocol Violation|1|||
156309051|NCT00830869|564231948|FG008|Period 2: Part 2|Protocol Violation|0|||
156309052|NCT00830869|564231949|FG009|Period 2: Part 2|Protocol Violation|1|||
156309053|NCT00830869|564231950|FG010|Period 2: Part 2|Protocol Violation|0|||
156309054|NCT00830869|564231951|FG011|Period 2: Part 2|Protocol Violation|0|||
156309055|NCT00830869|564231940|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
156309056|NCT00830869|564231941|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
156412325|NCT02138747|564602883|FG003|Treatment Period 2|Protocol Violation|0|||
156309057|NCT00830869|564231942|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
156309058|NCT00830869|564231943|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
156309059|NCT00830869|564231944|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
156309060|NCT00830869|564231945|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
156309061|NCT00830869|564231946|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
156309062|NCT00830869|564231947|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
156309063|NCT00830869|564231948|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
156309064|NCT00830869|564231949|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
156309065|NCT00830869|564231950|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
156309066|NCT00830869|564231951|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
156309067|NCT00830869|564231940|FG000|Period 2: Part 2|Adverse Event|0|||
156309068|NCT00830869|564231941|FG001|Period 2: Part 2|Adverse Event|0|||
156309069|NCT00830869|564231942|FG002|Period 2: Part 2|Adverse Event|0|||
156309070|NCT00830869|564231943|FG003|Period 2: Part 2|Adverse Event|0|||
156309071|NCT00830869|564231944|FG004|Period 2: Part 2|Adverse Event|0|||
156309072|NCT00830869|564231945|FG005|Period 2: Part 2|Adverse Event|0|||
156309073|NCT00830869|564231946|FG006|Period 2: Part 2|Adverse Event|0|||
156309074|NCT00830869|564231947|FG007|Period 2: Part 2|Adverse Event|4|||
156309075|NCT00830869|564231948|FG008|Period 2: Part 2|Adverse Event|3|||
156309076|NCT00830869|564231949|FG009|Period 2: Part 2|Adverse Event|2|||
156309077|NCT00830869|564231950|FG010|Period 2: Part 2|Adverse Event|2|||
156309078|NCT00830869|564231951|FG011|Period 2: Part 2|Adverse Event|0|||
156309079|NCT00830869|564231940|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
156309080|NCT00830869|564231941|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
156309081|NCT00830869|564231942|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
156309082|NCT00830869|564231943|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
156309083|NCT00830869|564231944|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
156309084|NCT00830869|564231945|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
156309085|NCT00830869|564231946|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
156309086|NCT00830869|564231947|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
156309087|NCT00830869|564231948|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
156309088|NCT00830869|564231949|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
156309089|NCT00830869|564231950|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
156309090|NCT00830869|564231951|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
156309091|NCT00830869|564231940|FG000|Period 2: Part 2|Progressive disease|0|||
156309092|NCT00830869|564231941|FG001|Period 2: Part 2|Progressive disease|0|||
156309093|NCT00830869|564231942|FG002|Period 2: Part 2|Progressive disease|0|||
156309094|NCT00830869|564231943|FG003|Period 2: Part 2|Progressive disease|0|||
156309095|NCT00830869|564231944|FG004|Period 2: Part 2|Progressive disease|0|||
156309096|NCT00830869|564231945|FG005|Period 2: Part 2|Progressive disease|0|||
156309097|NCT00830869|564231946|FG006|Period 2: Part 2|Progressive disease|0|||
156309098|NCT00830869|564231947|FG007|Period 2: Part 2|Progressive disease|14|||
156309099|NCT00830869|564231948|FG008|Period 2: Part 2|Progressive disease|11|||
156309100|NCT00830869|564231949|FG009|Period 2: Part 2|Progressive disease|12|||
156309101|NCT00830869|564231950|FG010|Period 2: Part 2|Progressive disease|8|||
156309102|NCT00830869|564231951|FG011|Period 2: Part 2|Progressive disease|15|||
156309103|NCT00830869|564231940|FG000|Period 2: Part 2|Other|0|||
156309104|NCT00830869|564231941|FG001|Period 2: Part 2|Other|0|||
156309105|NCT00830869|564231942|FG002|Period 2: Part 2|Other|0|||
156309106|NCT00830869|564231943|FG003|Period 2: Part 2|Other|0|||
156309107|NCT00830869|564231944|FG004|Period 2: Part 2|Other|0|||
156309108|NCT00830869|564231945|FG005|Period 2: Part 2|Other|0|||
156309109|NCT00830869|564231946|FG006|Period 2: Part 2|Other|0|||
156309110|NCT00830869|564231947|FG007|Period 2: Part 2|Other|0|||
156309111|NCT00830869|564231948|FG008|Period 2: Part 2|Other|0|||
156309112|NCT00830869|564231949|FG009|Period 2: Part 2|Other|1|||
156309113|NCT00830869|564231950|FG010|Period 2: Part 2|Other|0|||
156309114|NCT00830869|564231951|FG011|Period 2: Part 2|Other|0|||
156309115|NCT00617669|564231952|FG000|Overall Study|Withdrawal by Subject|71|||
156309116|NCT00617669|564231953|FG001|Overall Study|Withdrawal by Subject|77|||
156309117|NCT00617669|564231952|FG000|Overall Study|Lost to Follow-up|3|||
156309118|NCT00617669|564231953|FG001|Overall Study|Lost to Follow-up|2|||
156309119|NCT00617669|564231952|FG000|Overall Study|Adverse Event|87|||
156309120|NCT00617669|564231953|FG001|Overall Study|Adverse Event|76|||
156309121|NCT00617669|564231952|FG000|Overall Study|Protocol Violation|2|||
156309122|NCT00617669|564231953|FG001|Overall Study|Protocol Violation|3|||
156309123|NCT00617669|564231952|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
156309124|NCT00617669|564231953|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
156309125|NCT00617669|564231952|FG000|Overall Study|Patients randomized but not treated|2|||
156309126|NCT00617669|564231953|FG001|Overall Study|Patients randomized but not treated|3|||
156309127|NCT03745820|564231956|FG000|Overall Study|Adverse Event|0|||
156309128|NCT03745820|564231957|FG001|Overall Study|Adverse Event|3|||
156309129|NCT03745820|564231958|FG002|Overall Study|Adverse Event|2|||
156309130|NCT03745820|564231956|FG000|Overall Study|Non-Compliance with Study Drug|4|||
156309131|NCT03745820|564231957|FG001|Overall Study|Non-Compliance with Study Drug|3|||
156309132|NCT03745820|564231958|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156309133|NCT03745820|564231956|FG000|Overall Study|Withdrawal by Subject|4|||
156309134|NCT03745820|564231957|FG001|Overall Study|Withdrawal by Subject|4|||
156309135|NCT03745820|564231958|FG002|Overall Study|Withdrawal by Subject|4|||
156309136|NCT03745820|564231956|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
156309137|NCT03745820|564231957|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
156309138|NCT03745820|564231958|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
156309139|NCT03745820|564231956|FG000|Overall Study|Lost to Follow-up|2|||
156309140|NCT03745820|564231957|FG001|Overall Study|Lost to Follow-up|0|||
156309141|NCT03745820|564231958|FG002|Overall Study|Lost to Follow-up|3|||
156309142|NCT03745820|564231956|FG000|Overall Study|Reason not Specified|2|||
156412326|NCT02138747|564602880|FG000|Treatment Period 2|Withdrawal by Subject|5|||
156309143|NCT03745820|564231957|FG001|Overall Study|Reason not Specified|4|||
156309144|NCT03745820|564231958|FG002|Overall Study|Reason not Specified|1|||
156309145|NCT00281658|564231959|FG000|Randomized Phase|Adverse Event|0|||
156309146|NCT00281658|564231960|FG001|Randomized Phase|Adverse Event|2|||
156309147|NCT00281658|564231961|FG002|Randomized Phase|Adverse Event|0|||
156412327|NCT02138747|564602881|FG001|Treatment Period 2|Withdrawal by Subject|4|||
156309148|NCT00281658|564231962|FG003|Randomized Phase|Adverse Event|0|||
156309149|NCT00281658|564231959|FG000|Randomized Phase|Lost to Follow-up|34|||
156309150|NCT00281658|564231960|FG001|Randomized Phase|Lost to Follow-up|27|||
156309151|NCT00281658|564231961|FG002|Randomized Phase|Lost to Follow-up|0|||
156309152|NCT00281658|564231962|FG003|Randomized Phase|Lost to Follow-up|0|||
156309153|NCT00281658|564231959|FG000|Randomized Phase|Withdrawal by Subject|8|||
156309154|NCT00281658|564231960|FG001|Randomized Phase|Withdrawal by Subject|7|||
156309155|NCT00281658|564231961|FG002|Randomized Phase|Withdrawal by Subject|0|||
156309156|NCT00281658|564231962|FG003|Randomized Phase|Withdrawal by Subject|0|||
156309157|NCT00281658|564231959|FG000|Randomized Phase|Study closed/terminated|1|||
156309158|NCT00281658|564231960|FG001|Randomized Phase|Study closed/terminated|1|||
156309159|NCT00281658|564231961|FG002|Randomized Phase|Study closed/terminated|0|||
156309160|NCT00281658|564231962|FG003|Randomized Phase|Study closed/terminated|0|||
156309161|NCT00281658|564231959|FG000|Randomized Phase|Disease progression|36|||
156309162|NCT00281658|564231960|FG001|Randomized Phase|Disease progression|27|||
156309163|NCT00281658|564231961|FG002|Randomized Phase|Disease progression|0|||
156309164|NCT00281658|564231962|FG003|Randomized Phase|Disease progression|0|||
156309165|NCT00281658|564231959|FG000|Randomized Phase|Physician Decision|1|||
156309166|NCT00281658|564231960|FG001|Randomized Phase|Physician Decision|1|||
156309167|NCT00281658|564231961|FG002|Randomized Phase|Physician Decision|0|||
156309168|NCT00281658|564231962|FG003|Randomized Phase|Physician Decision|0|||
156309169|NCT00281658|564231959|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
156309170|NCT00281658|564231960|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
156309171|NCT00281658|564231961|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
156309172|NCT00281658|564231962|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
156309173|NCT00281658|564231959|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
156309174|NCT00281658|564231960|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
156309175|NCT00281658|564231961|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
156309176|NCT00281658|564231962|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
156309177|NCT00281658|564231959|FG000|Randomized Phase|Treatment ongoing|1|||
156309178|NCT00281658|564231960|FG001|Randomized Phase|Treatment ongoing|0|||
156309179|NCT00281658|564231961|FG002|Randomized Phase|Treatment ongoing|0|||
156309180|NCT00281658|564231962|FG003|Randomized Phase|Treatment ongoing|0|||
156309181|NCT00281658|564231959|FG000|Open Label Phase|Adverse Event|0|||
156309182|NCT00281658|564231960|FG001|Open Label Phase|Adverse Event|0|||
156309183|NCT00281658|564231961|FG002|Open Label Phase|Adverse Event|1|||
156309184|NCT00281658|564231962|FG003|Open Label Phase|Adverse Event|0|||
156309185|NCT00281658|564231959|FG000|Open Label Phase|Lost to Follow-up|0|||
156309186|NCT00281658|564231960|FG001|Open Label Phase|Lost to Follow-up|0|||
156309187|NCT00281658|564231961|FG002|Open Label Phase|Lost to Follow-up|16|||
156309188|NCT00281658|564231962|FG003|Open Label Phase|Lost to Follow-up|2|||
156309189|NCT00281658|564231959|FG000|Open Label Phase|Withdrawal by Subject|0|||
156309190|NCT00281658|564231960|FG001|Open Label Phase|Withdrawal by Subject|0|||
156309191|NCT00281658|564231961|FG002|Open Label Phase|Withdrawal by Subject|3|||
156309192|NCT00281658|564231962|FG003|Open Label Phase|Withdrawal by Subject|2|||
156309193|NCT00281658|564231959|FG000|Open Label Phase|Disease progression|0|||
156309194|NCT00281658|564231960|FG001|Open Label Phase|Disease progression|0|||
156309195|NCT00281658|564231961|FG002|Open Label Phase|Disease progression|18|||
156309196|NCT00281658|564231962|FG003|Open Label Phase|Disease progression|0|||
156309197|NCT00281658|564231959|FG000|Open Label Phase|Physician Decision|0|||
156309198|NCT00281658|564231960|FG001|Open Label Phase|Physician Decision|0|||
156309199|NCT00281658|564231961|FG002|Open Label Phase|Physician Decision|1|||
156309200|NCT00281658|564231962|FG003|Open Label Phase|Physician Decision|0|||
156309201|NCT00281658|564231959|FG000|Open Label Phase|Relocation of patient|0|||
156309202|NCT00281658|564231960|FG001|Open Label Phase|Relocation of patient|0|||
156309203|NCT00281658|564231961|FG002|Open Label Phase|Relocation of patient|1|||
156309204|NCT00281658|564231962|FG003|Open Label Phase|Relocation of patient|0|||
156309205|NCT00281658|564231959|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
156309206|NCT00281658|564231960|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
156309207|NCT00281658|564231961|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
156309208|NCT00281658|564231962|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
156309209|NCT00507728|564231963|FG000|Randomization to Month 3|Lost to Follow-up|15|||
156309210|NCT00507728|564231964|FG001|Randomization to Month 3|Lost to Follow-up|14|||
156309211|NCT00507728|564231965|FG002|Randomization to Month 3|Lost to Follow-up|20|||
156309212|NCT00507728|564231963|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
156309213|NCT00507728|564231964|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
156309214|NCT00507728|564231965|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
156309215|NCT02151773|564231966|FG000|Overall Study|Protocol Deviation|64|||
156309216|NCT00095940|564231970|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
156309217|NCT00095940|564231971|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
156309218|NCT00095940|564231972|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
156309219|NCT00095940|564231973|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
156309220|NCT00095940|564231974|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
156309221|NCT00095940|564231975|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
156309222|NCT00095940|564231976|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
156309223|NCT00095940|564231977|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
156309224|NCT00095940|564231978|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
156309225|NCT00095940|564231970|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
156309226|NCT00095940|564231971|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
156309227|NCT00095940|564231972|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
156309228|NCT00095940|564231973|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156309229|NCT00095940|564231974|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156309230|NCT00095940|564231975|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156309231|NCT00095940|564231976|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156309232|NCT00095940|564231977|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156309233|NCT00095940|564231978|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
156309234|NCT00095940|564231970|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
156309235|NCT00095940|564231971|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
156309236|NCT00095940|564231972|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
156309237|NCT00095940|564231973|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
156309238|NCT00095940|564231974|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
156309239|NCT00095940|564231975|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
156309240|NCT00095940|564231976|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
156309241|NCT00095940|564231977|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
156309242|NCT00095940|564231978|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
156309243|NCT02864862|564231981|FG000|Overall Study|Lost to Follow-up|1|||
156309244|NCT02864862|564231982|FG001|Overall Study|Lost to Follow-up|0|||
156309245|NCT02864862|564231983|FG002|Overall Study|Lost to Follow-up|1|||
156309246|NCT02864862|564231981|FG000|Overall Study|Protocol Violation|0|||
156309247|NCT02864862|564231982|FG001|Overall Study|Protocol Violation|0|||
156309248|NCT02864862|564231983|FG002|Overall Study|Protocol Violation|1|||
156309249|NCT01523275|564231984|FG000|Overall Study|Lost to Follow-up|1|||
156309250|NCT01523275|564231985|FG001|Overall Study|Lost to Follow-up|2|||
156309251|NCT01523275|564231984|FG000|Overall Study|Withdrawal by Subject|1|||
156309252|NCT01523275|564231985|FG001|Overall Study|Withdrawal by Subject|0|||
156309253|NCT00966875|564231987|FG000|Part A|Adverse Event|2|||
156309254|NCT00966875|564231988|FG001|Part A|Adverse Event|1|||
156412328|NCT02138747|564602882|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156412329|NCT02138747|564602883|FG003|Treatment Period 2|Withdrawal by Subject|2|||
156412330|NCT02138747|564602880|FG000|Treatment Period 2|Other - Miscellaneous|3|||
156412331|NCT02138747|564602881|FG001|Treatment Period 2|Other - Miscellaneous|0|||
156412332|NCT02138747|564602882|FG002|Treatment Period 2|Other - Miscellaneous|0|||
156412333|NCT02138747|564602883|FG003|Treatment Period 2|Other - Miscellaneous|0|||
156412334|NCT02302066|564602884|FG000|Overall Study|Adverse Event|1|||
156412335|NCT02302066|564602885|FG001|Overall Study|Adverse Event|1|||
156412336|NCT02302066|564602886|FG002|Overall Study|Adverse Event|3|||
156412337|NCT02302066|564602887|FG003|Overall Study|Adverse Event|0|||
156412338|NCT02302066|564602884|FG000|Overall Study|Lost to Follow-up|4|||
156412339|NCT02302066|564602885|FG001|Overall Study|Lost to Follow-up|5|||
156412340|NCT02302066|564602886|FG002|Overall Study|Lost to Follow-up|24|||
156412341|NCT02302066|564602887|FG003|Overall Study|Lost to Follow-up|7|||
156412342|NCT02302066|564602884|FG000|Overall Study|Withdrawal by Subject|25|||
156412343|NCT02302066|564602885|FG001|Overall Study|Withdrawal by Subject|58|||
156412344|NCT02302066|564602886|FG002|Overall Study|Withdrawal by Subject|124|||
156412345|NCT02302066|564602887|FG003|Overall Study|Withdrawal by Subject|33|||
156412346|NCT02302066|564602884|FG000|Overall Study|Pregnancy|2|||
156412347|NCT02302066|564602885|FG001|Overall Study|Pregnancy|10|||
156412348|NCT02302066|564602886|FG002|Overall Study|Pregnancy|12|||
156412349|NCT02302066|564602887|FG003|Overall Study|Pregnancy|0|||
156412350|NCT02302066|564602884|FG000|Overall Study|Reason Not Specified|1|||
156412351|NCT02302066|564602885|FG001|Overall Study|Reason Not Specified|1|||
156412352|NCT02302066|564602886|FG002|Overall Study|Reason Not Specified|9|||
156412353|NCT02302066|564602887|FG003|Overall Study|Reason Not Specified|1|||
156412354|NCT00960752|564602892|FG000|Overall Study|Adverse Event|0|||
156309255|NCT00966875|564231989|FG002|Part A|Adverse Event|0|||
156309256|NCT00966875|564231990|FG003|Part A|Adverse Event|1|||
156309257|NCT00966875|564231991|FG004|Part A|Adverse Event|0|||
156309258|NCT00966875|564231992|FG005|Part A|Adverse Event|1|||
156309259|NCT00966875|564231993|FG006|Part A|Adverse Event|0|||
156309260|NCT00966875|564231994|FG007|Part A|Adverse Event|3|||
156309261|NCT00966875|564231995|FG008|Part A|Adverse Event|3|||
156309262|NCT00966875|564231987|FG000|Part A|Entry Criteria|0|||
156309263|NCT00966875|564231988|FG001|Part A|Entry Criteria|0|||
156412355|NCT00960752|564602893|FG001|Overall Study|Adverse Event|0|||
156412356|NCT00960752|564602894|FG002|Overall Study|Adverse Event|1|||
156412357|NCT00960752|564602892|FG000|Overall Study|Progression|0|||
156412358|NCT00960752|564602893|FG001|Overall Study|Progression|0|||
156412359|NCT00960752|564602894|FG002|Overall Study|Progression|1|||
156412360|NCT02180438|564602899|FG000|Overall Study|Lost to Follow-up|1|||
156412361|NCT00785707|564602900|FG000|Overall Study|Lost to Follow-up|7|||
156309264|NCT00966875|564231989|FG002|Part A|Entry Criteria|0|||
156309265|NCT00966875|564231990|FG003|Part A|Entry Criteria|0|||
156309266|NCT00966875|564231991|FG004|Part A|Entry Criteria|0|||
156309267|NCT00966875|564231992|FG005|Part A|Entry Criteria|2|||
156309268|NCT00966875|564231993|FG006|Part A|Entry Criteria|0|||
156309269|NCT00966875|564231994|FG007|Part A|Entry Criteria|0|||
156309270|NCT00966875|564231995|FG008|Part A|Entry Criteria|0|||
156309271|NCT00966875|564231987|FG000|Part A|Lack of Efficacy|0|||
156309272|NCT00966875|564231988|FG001|Part A|Lack of Efficacy|1|||
156309273|NCT00966875|564231989|FG002|Part A|Lack of Efficacy|0|||
156309274|NCT00966875|564231990|FG003|Part A|Lack of Efficacy|0|||
156309275|NCT00966875|564231991|FG004|Part A|Lack of Efficacy|0|||
156309276|NCT00966875|564231992|FG005|Part A|Lack of Efficacy|0|||
156309277|NCT00966875|564231993|FG006|Part A|Lack of Efficacy|4|||
156309278|NCT00966875|564231994|FG007|Part A|Lack of Efficacy|0|||
156309279|NCT00966875|564231995|FG008|Part A|Lack of Efficacy|0|||
156309280|NCT00966875|564231987|FG000|Part A|Lost to Follow-up|2|||
156309281|NCT00966875|564231988|FG001|Part A|Lost to Follow-up|0|||
156309282|NCT00966875|564231989|FG002|Part A|Lost to Follow-up|0|||
156309283|NCT00966875|564231990|FG003|Part A|Lost to Follow-up|0|||
156309284|NCT00966875|564231991|FG004|Part A|Lost to Follow-up|0|||
156309285|NCT00966875|564231992|FG005|Part A|Lost to Follow-up|1|||
156309286|NCT00966875|564231993|FG006|Part A|Lost to Follow-up|0|||
156309287|NCT00966875|564231994|FG007|Part A|Lost to Follow-up|0|||
156309288|NCT00966875|564231995|FG008|Part A|Lost to Follow-up|0|||
156309289|NCT00966875|564231987|FG000|Part A|Parent/Caregiver Decision|0|||
156309290|NCT00966875|564231988|FG001|Part A|Parent/Caregiver Decision|0|||
156309291|NCT00966875|564231989|FG002|Part A|Parent/Caregiver Decision|0|||
156309292|NCT00966875|564231990|FG003|Part A|Parent/Caregiver Decision|1|||
156309293|NCT00966875|564231991|FG004|Part A|Parent/Caregiver Decision|0|||
156309294|NCT00966875|564231992|FG005|Part A|Parent/Caregiver Decision|0|||
156309295|NCT00966875|564231993|FG006|Part A|Parent/Caregiver Decision|0|||
156309296|NCT00966875|564231994|FG007|Part A|Parent/Caregiver Decision|0|||
156309297|NCT00966875|564231995|FG008|Part A|Parent/Caregiver Decision|0|||
156309298|NCT00966875|564231987|FG000|Part A|Physician Decision|0|||
156309299|NCT00966875|564231988|FG001|Part A|Physician Decision|0|||
156309300|NCT00966875|564231989|FG002|Part A|Physician Decision|0|||
156309301|NCT00966875|564231990|FG003|Part A|Physician Decision|0|||
156309302|NCT00966875|564231991|FG004|Part A|Physician Decision|1|||
156309303|NCT00966875|564231992|FG005|Part A|Physician Decision|0|||
156309304|NCT00966875|564231993|FG006|Part A|Physician Decision|1|||
156309305|NCT00966875|564231994|FG007|Part A|Physician Decision|0|||
156309306|NCT00966875|564231995|FG008|Part A|Physician Decision|2|||
156309307|NCT00966875|564231987|FG000|Part A|Sponsor Decision|0|||
156309308|NCT00966875|564231988|FG001|Part A|Sponsor Decision|0|||
156309309|NCT00966875|564231989|FG002|Part A|Sponsor Decision|1|||
156309310|NCT00966875|564231990|FG003|Part A|Sponsor Decision|0|||
156309311|NCT00966875|564231991|FG004|Part A|Sponsor Decision|1|||
156309312|NCT00966875|564231992|FG005|Part A|Sponsor Decision|0|||
156309313|NCT00966875|564231993|FG006|Part A|Sponsor Decision|0|||
156309314|NCT00966875|564231994|FG007|Part A|Sponsor Decision|2|||
156309315|NCT00966875|564231995|FG008|Part A|Sponsor Decision|1|||
156309316|NCT00966875|564231987|FG000|Part A|Withdrawal by Subject|2|||
156309317|NCT00966875|564231988|FG001|Part A|Withdrawal by Subject|2|||
156309318|NCT00966875|564231989|FG002|Part A|Withdrawal by Subject|1|||
156309319|NCT00966875|564231990|FG003|Part A|Withdrawal by Subject|1|||
156309320|NCT00966875|564231991|FG004|Part A|Withdrawal by Subject|3|||
156309321|NCT00966875|564231992|FG005|Part A|Withdrawal by Subject|0|||
156309322|NCT00966875|564231993|FG006|Part A|Withdrawal by Subject|5|||
156309323|NCT00966875|564231994|FG007|Part A|Withdrawal by Subject|1|||
156309324|NCT00966875|564231995|FG008|Part A|Withdrawal by Subject|1|||
156309325|NCT00966875|564231987|FG000|Part A|Protocol Violation|0|||
156309326|NCT00966875|564231988|FG001|Part A|Protocol Violation|0|||
156309327|NCT00966875|564231989|FG002|Part A|Protocol Violation|0|||
156309328|NCT00966875|564231990|FG003|Part A|Protocol Violation|0|||
156309329|NCT00966875|564231991|FG004|Part A|Protocol Violation|0|||
156309330|NCT00966875|564231992|FG005|Part A|Protocol Violation|0|||
156309331|NCT00966875|564231993|FG006|Part A|Protocol Violation|2|||
156309332|NCT00966875|564231994|FG007|Part A|Protocol Violation|1|||
156309333|NCT00966875|564231995|FG008|Part A|Protocol Violation|1|||
156309334|NCT00966875|564231987|FG000|Part B|Adverse Event|0|||
156309335|NCT00966875|564231988|FG001|Part B|Adverse Event|1|||
156309336|NCT00966875|564231989|FG002|Part B|Adverse Event|1|||
156309337|NCT00966875|564231990|FG003|Part B|Adverse Event|0|||
156309338|NCT00966875|564231991|FG004|Part B|Adverse Event|1|||
156309339|NCT00966875|564231992|FG005|Part B|Adverse Event|0|||
156309340|NCT00966875|564231993|FG006|Part B|Adverse Event|5|||
156309341|NCT00966875|564231994|FG007|Part B|Adverse Event|2|||
156309342|NCT00966875|564231995|FG008|Part B|Adverse Event|2|||
156309343|NCT00966875|564231987|FG000|Part B|Death|0|||
156309344|NCT00966875|564231988|FG001|Part B|Death|0|||
156309345|NCT00966875|564231989|FG002|Part B|Death|1|||
156309346|NCT00966875|564231990|FG003|Part B|Death|0|||
156309347|NCT00966875|564231991|FG004|Part B|Death|0|||
156309348|NCT00966875|564231992|FG005|Part B|Death|0|||
156309349|NCT00966875|564231993|FG006|Part B|Death|0|||
156309350|NCT00966875|564231994|FG007|Part B|Death|1|||
156309351|NCT00966875|564231995|FG008|Part B|Death|0|||
156309352|NCT00966875|564231987|FG000|Part B|Lack of Efficacy|2|||
156309353|NCT00966875|564231988|FG001|Part B|Lack of Efficacy|1|||
156309354|NCT00966875|564231989|FG002|Part B|Lack of Efficacy|1|||
156309355|NCT00966875|564231990|FG003|Part B|Lack of Efficacy|1|||
156309356|NCT00966875|564231991|FG004|Part B|Lack of Efficacy|2|||
156309357|NCT00966875|564231992|FG005|Part B|Lack of Efficacy|3|||
156309358|NCT00966875|564231993|FG006|Part B|Lack of Efficacy|12|||
156309359|NCT00966875|564231994|FG007|Part B|Lack of Efficacy|9|||
156309360|NCT00966875|564231995|FG008|Part B|Lack of Efficacy|6|||
156309361|NCT00966875|564231987|FG000|Part B|Lost to Follow-up|0|||
156309362|NCT00966875|564231988|FG001|Part B|Lost to Follow-up|0|||
156309363|NCT00966875|564231989|FG002|Part B|Lost to Follow-up|0|||
156309364|NCT00966875|564231990|FG003|Part B|Lost to Follow-up|1|||
156309365|NCT00966875|564231991|FG004|Part B|Lost to Follow-up|0|||
156309366|NCT00966875|564231992|FG005|Part B|Lost to Follow-up|0|||
156309367|NCT00966875|564231993|FG006|Part B|Lost to Follow-up|0|||
156309368|NCT00966875|564231994|FG007|Part B|Lost to Follow-up|0|||
156309369|NCT00966875|564231995|FG008|Part B|Lost to Follow-up|1|||
156309370|NCT00966875|564231987|FG000|Part B|Physician Decision|0|||
156309371|NCT00966875|564231988|FG001|Part B|Physician Decision|0|||
156309372|NCT00966875|564231989|FG002|Part B|Physician Decision|1|||
156309373|NCT00966875|564231990|FG003|Part B|Physician Decision|0|||
156309374|NCT00966875|564231991|FG004|Part B|Physician Decision|2|||
156309375|NCT00966875|564231992|FG005|Part B|Physician Decision|1|||
156309376|NCT00966875|564231993|FG006|Part B|Physician Decision|0|||
156309377|NCT00966875|564231994|FG007|Part B|Physician Decision|0|||
156309378|NCT00966875|564231995|FG008|Part B|Physician Decision|2|||
156309379|NCT00966875|564231987|FG000|Part B|Sponsor Decision|1|||
156309380|NCT00966875|564231988|FG001|Part B|Sponsor Decision|0|||
156309381|NCT00966875|564231989|FG002|Part B|Sponsor Decision|0|||
156309382|NCT00966875|564231990|FG003|Part B|Sponsor Decision|0|||
156309383|NCT00966875|564231991|FG004|Part B|Sponsor Decision|0|||
156309384|NCT00966875|564231992|FG005|Part B|Sponsor Decision|1|||
156309385|NCT00966875|564231993|FG006|Part B|Sponsor Decision|0|||
156309386|NCT00966875|564231994|FG007|Part B|Sponsor Decision|2|||
156309387|NCT00966875|564231995|FG008|Part B|Sponsor Decision|1|||
156309388|NCT00966875|564231987|FG000|Part B|Withdrawal by Subject|2|||
156309389|NCT00966875|564231988|FG001|Part B|Withdrawal by Subject|1|||
156309390|NCT00966875|564231989|FG002|Part B|Withdrawal by Subject|2|||
156309391|NCT00966875|564231990|FG003|Part B|Withdrawal by Subject|1|||
156309392|NCT00966875|564231991|FG004|Part B|Withdrawal by Subject|2|||
156309393|NCT00966875|564231992|FG005|Part B|Withdrawal by Subject|1|||
156309394|NCT00966875|564231993|FG006|Part B|Withdrawal by Subject|4|||
156309395|NCT00966875|564231994|FG007|Part B|Withdrawal by Subject|5|||
156309396|NCT00966875|564231995|FG008|Part B|Withdrawal by Subject|5|||
156309397|NCT00966875|564231987|FG000|Part B|Entry Criteria|0|||
156309398|NCT00966875|564231988|FG001|Part B|Entry Criteria|0|||
156309399|NCT00966875|564231989|FG002|Part B|Entry Criteria|0|||
156309400|NCT00966875|564231990|FG003|Part B|Entry Criteria|0|||
156309401|NCT00966875|564231991|FG004|Part B|Entry Criteria|0|||
156309402|NCT00966875|564231992|FG005|Part B|Entry Criteria|0|||
156309403|NCT00966875|564231993|FG006|Part B|Entry Criteria|1|||
156309404|NCT00966875|564231994|FG007|Part B|Entry Criteria|0|||
156309405|NCT00966875|564231995|FG008|Part B|Entry Criteria|1|||
156309406|NCT00689117|564231996|FG000|Overall Study|Adverse Event|6|||
156309407|NCT00689117|564231997|FG001|Overall Study|Adverse Event|0|||
156309408|NCT00689117|564231998|FG002|Overall Study|Adverse Event|5|||
156309409|NCT00689117|564231999|FG003|Overall Study|Adverse Event|0|||
156309410|NCT00689117|564231996|FG000|Overall Study|Lost to Follow-up|26|||
156309411|NCT00689117|564231997|FG001|Overall Study|Lost to Follow-up|19|||
156309412|NCT00689117|564231998|FG002|Overall Study|Lost to Follow-up|17|||
156309413|NCT00689117|564231999|FG003|Overall Study|Lost to Follow-up|11|||
156309414|NCT00689117|564231996|FG000|Overall Study|Lack of Efficacy|1|||
156309415|NCT00689117|564231997|FG001|Overall Study|Lack of Efficacy|2|||
156309416|NCT00689117|564231998|FG002|Overall Study|Lack of Efficacy|2|||
156309417|NCT00689117|564231999|FG003|Overall Study|Lack of Efficacy|2|||
156309418|NCT00689117|564231996|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
156309419|NCT00689117|564231997|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
156309420|NCT00689117|564231998|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
156309421|NCT00689117|564231999|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
156309422|NCT00689117|564231996|FG000|Overall Study|Withdrawal by Subject|19|||
156309423|NCT00689117|564231997|FG001|Overall Study|Withdrawal by Subject|18|||
156309424|NCT00689117|564231998|FG002|Overall Study|Withdrawal by Subject|26|||
156309425|NCT00689117|564231999|FG003|Overall Study|Withdrawal by Subject|13|||
156309426|NCT00689117|564231996|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
156309427|NCT00689117|564231997|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
156309428|NCT00689117|564231998|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
156309429|NCT00689117|564231999|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
156309430|NCT00689117|564231996|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156309431|NCT00689117|564231997|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
156309432|NCT00689117|564231998|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156309433|NCT00689117|564231999|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156309434|NCT00689117|564231996|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
156309435|NCT00689117|564231997|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
156309436|NCT00689117|564231998|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
156309437|NCT00689117|564231999|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
156309438|NCT00689117|564231996|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
156309439|NCT00689117|564231997|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
156309440|NCT00689117|564231998|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
156309441|NCT00689117|564231999|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
156309442|NCT00689117|564231996|FG000|Overall Study|Use of Prohibitive Medication|2|||
156309443|NCT00689117|564231997|FG001|Overall Study|Use of Prohibitive Medication|1|||
156309444|NCT00689117|564231998|FG002|Overall Study|Use of Prohibitive Medication|3|||
156309445|NCT00689117|564231999|FG003|Overall Study|Use of Prohibitive Medication|0|||
156309446|NCT00689117|564231996|FG000|Overall Study|Pregnancy|0|||
156309447|NCT00689117|564231997|FG001|Overall Study|Pregnancy|2|||
156309448|NCT00689117|564231998|FG002|Overall Study|Pregnancy|0|||
156309449|NCT00689117|564231999|FG003|Overall Study|Pregnancy|2|||
156309450|NCT00689117|564231996|FG000|Overall Study|Incarceration|2|||
156309451|NCT00689117|564231997|FG001|Overall Study|Incarceration|0|||
156309452|NCT00689117|564231998|FG002|Overall Study|Incarceration|0|||
156309453|NCT00689117|564231999|FG003|Overall Study|Incarceration|0|||
156309454|NCT00689117|564231996|FG000|Overall Study|Fear of Birth Defects|0|||
156309455|NCT00689117|564231997|FG001|Overall Study|Fear of Birth Defects|0|||
156309456|NCT00689117|564231998|FG002|Overall Study|Fear of Birth Defects|1|||
156309457|NCT00689117|564231999|FG003|Overall Study|Fear of Birth Defects|0|||
156309458|NCT00689117|564231996|FG000|Overall Study|Transportation|1|||
156309459|NCT00689117|564231997|FG001|Overall Study|Transportation|0|||
156309460|NCT00689117|564231998|FG002|Overall Study|Transportation|0|||
156309461|NCT00689117|564231999|FG003|Overall Study|Transportation|0|||
156309462|NCT00689117|564231996|FG000|Overall Study|Patient Withdrew from Study|0|||
156309463|NCT00689117|564231997|FG001|Overall Study|Patient Withdrew from Study|0|||
156309464|NCT00689117|564231998|FG002|Overall Study|Patient Withdrew from Study|0|||
156309465|NCT00689117|564231999|FG003|Overall Study|Patient Withdrew from Study|1|||
156309466|NCT00689117|564231996|FG000|Overall Study|Personal Reason|0|||
156309467|NCT00689117|564231997|FG001|Overall Study|Personal Reason|1|||
156309468|NCT00689117|564231998|FG002|Overall Study|Personal Reason|0|||
156309469|NCT00689117|564231999|FG003|Overall Study|Personal Reason|0|||
156309470|NCT00689117|564231996|FG000|Overall Study|Dispensing Error|0|||
156309471|NCT00689117|564231997|FG001|Overall Study|Dispensing Error|1|||
156309472|NCT00689117|564231998|FG002|Overall Study|Dispensing Error|0|||
156309473|NCT00689117|564231999|FG003|Overall Study|Dispensing Error|0|||
156309474|NCT01206322|564232000|FG000|Overall Study|Adverse Event|0|||
156309475|NCT01206322|564232001|FG001|Overall Study|Adverse Event|0|||
156309476|NCT01206322|564232002|FG002|Overall Study|Adverse Event|0|||
156309477|NCT01206322|564232003|FG003|Overall Study|Adverse Event|1|||
156309478|NCT00444678|564232004|FG000|Overall Study|Toxicity|11|||
156309479|NCT00444678|564232004|FG000|Overall Study|Disease Progression|12|||
156309480|NCT00444678|564232004|FG000|Overall Study|Death|3|||
156647786|NCT02124746|565456912|FG000|Overall Study|Physician Decision|6|||
156647787|NCT02124746|565456913|FG001|Overall Study|Physician Decision|4|||
156309481|NCT00444678|564232004|FG000|Overall Study|Physician Decision|3|||
156309482|NCT00444678|564232004|FG000|Overall Study|Withdrawal by Subject|2|||
156309483|NCT01589653|564232010|FG000|Overall Study|Protocol Violation|3|||
156309484|NCT01589653|564232011|FG001|Overall Study|Protocol Violation|1|||
156309485|NCT01589653|564232010|FG000|Overall Study|Withdrawal criteria|4|||
156309486|NCT01589653|564232011|FG001|Overall Study|Withdrawal criteria|7|||
156309487|NCT01589653|564232010|FG000|Overall Study|Unclassified|0|||
156309488|NCT01589653|564232011|FG001|Overall Study|Unclassified|3|||
156309489|NCT01536067|564232012|FG000|Overall Study|Disease Progression|1|||
156309490|NCT02386189|564232015|FG000|Overall Study|Lost to Follow-up|2|||
156309491|NCT02386189|564232016|FG001|Overall Study|Lost to Follow-up|3|||
156309492|NCT02386189|564232015|FG000|Overall Study|Withdrawal by Subject|1|||
156309493|NCT02386189|564232016|FG001|Overall Study|Withdrawal by Subject|0|||
156309494|NCT02386189|564232015|FG000|Overall Study|Death|1|||
156309495|NCT02386189|564232016|FG001|Overall Study|Death|0|||
156309496|NCT04657666|564232017|FG000|Period 1|Withdrawal of participant consent|2|||
156309497|NCT04657666|564232018|FG001|Period 1|Withdrawal of participant consent|1|||
156309498|NCT04657666|564232017|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
156647788|NCT02124746|565456914|FG002|Overall Study|Physician Decision|5|||
156647789|NCT02124746|565456912|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156647790|NCT02124746|565456913|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156309499|NCT04657666|564232018|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
156309500|NCT04657666|564232017|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
156309501|NCT04657666|564232018|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
156309502|NCT04657666|564232017|FG000|Period 2|Other|2|||
156309503|NCT04657666|564232018|FG001|Period 2|Other|0|||
156647791|NCT02124746|565456914|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156309504|NCT04657666|564232017|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
156309505|NCT04657666|564232018|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
156309506|NCT00606905|564232019|FG000|Overall Study|No Pregnancy|9|||
156309507|NCT00606905|564232020|FG001|Overall Study|No Pregnancy|6|||
156309508|NCT00606905|564232019|FG000|Overall Study|Non-Index Pregnancy|1|||
156309509|NCT00606905|564232020|FG001|Overall Study|Non-Index Pregnancy|4|||
156309510|NCT00606905|564232019|FG000|Overall Study|Withdrew|5|||
156309511|NCT00606905|564232020|FG001|Overall Study|Withdrew|5|||
156309512|NCT03120351|564232021|FG000|Overall Study|Physician Decision|1|||
156309513|NCT03120351|564232022|FG001|Overall Study|Physician Decision|1|||
156309514|NCT04250077|564232031|FG000|Overall Study|Withdrawal by Subject|0|||
156309515|NCT04250077|564232032|FG001|Overall Study|Withdrawal by Subject|1|||
156309516|NCT04250077|564232033|FG002|Overall Study|Withdrawal by Subject|0|||
156309517|NCT04250077|564232031|FG000|Overall Study|Lost to Follow-up|2|||
156309518|NCT04250077|564232032|FG001|Overall Study|Lost to Follow-up|3|||
156309519|NCT04250077|564232033|FG002|Overall Study|Lost to Follow-up|0|||
156309520|NCT01022398|564232034|FG000|Overall Study|Study terminated|2|||
156309521|NCT01022398|564232035|FG001|Overall Study|Study terminated|2|||
156309522|NCT03319745|564232037|FG000|Overall Study|Death|1|||
156309523|NCT03319745|564232037|FG000|Overall Study|Toxicity Precluding Surgery|1|||
156309524|NCT00870103|564232038|FG000|Overall Study|Physician Decision|2|||
156309525|NCT00870103|564232038|FG000|Overall Study|Lost to Follow-up|2|||
156309526|NCT01317550|564232039|FG000|Overall Study|Withdrawal by Subject|1|||
156309527|NCT01317550|564232040|FG001|Overall Study|Withdrawal by Subject|0|||
156309528|NCT01317550|564232041|FG002|Overall Study|Withdrawal by Subject|0|||
156309529|NCT01317550|564232042|FG003|Overall Study|Withdrawal by Subject|0|||
156309530|NCT01317550|564232039|FG000|Overall Study|Lack of compliance study med|1|||
156309531|NCT01317550|564232040|FG001|Overall Study|Lack of compliance study med|0|||
156309532|NCT01317550|564232041|FG002|Overall Study|Lack of compliance study med|0|||
156309533|NCT01317550|564232042|FG003|Overall Study|Lack of compliance study med|0|||
156309534|NCT03255629|564232043|FG000|Overall Study|Adverse Event|1|||
156309535|NCT03255629|564232044|FG001|Overall Study|Adverse Event|0|||
156309536|NCT03255629|564232043|FG000|Overall Study|did not experience hypoglycemia|2|||
156309537|NCT03255629|564232044|FG001|Overall Study|did not experience hypoglycemia|1|||
156309538|NCT01086358|564232045|FG000|First Intervention|Lost to Follow-up|9|||
156309539|NCT01086358|564232046|FG001|First Intervention|Lost to Follow-up|4|||
156309540|NCT01086358|564232045|FG000|First Intervention|Withdrawal by Subject|0|||
156309541|NCT01086358|564232046|FG001|First Intervention|Withdrawal by Subject|1|||
156309542|NCT01086358|564232045|FG000|Second Intervention|Lost to Follow-up|4|||
156309543|NCT01086358|564232046|FG001|Second Intervention|Lost to Follow-up|4|||
156309544|NCT01767142|564232047|FG000|Overall Study|Lost to Follow-up|3|||
156309545|NCT00926029|564232048|FG000|Overall Study|Lost to Follow-up|2|||
156309546|NCT00926029|564232049|FG001|Overall Study|Lost to Follow-up|1|||
156309547|NCT00926029|564232050|FG002|Overall Study|Lost to Follow-up|1|||
156309548|NCT03206788|564232051|FG000|Overall Study|Withdrawal by Subject|0|||
156309549|NCT03206788|564232052|FG001|Overall Study|Withdrawal by Subject|1|||
156309550|NCT03206788|564232051|FG000|Overall Study|Adverse Event|0|||
156309551|NCT03206788|564232052|FG001|Overall Study|Adverse Event|1|||
156309552|NCT03206788|564232051|FG000|Overall Study|Physician Decision|0|||
156309553|NCT03206788|564232052|FG001|Overall Study|Physician Decision|1|||
156309554|NCT02471612|564232053|FG000|Overall Study|Lost to Follow-up|2|||
156309555|NCT00833417|564232054|FG000|Overall Study|Adverse Event|5|||
156309556|NCT00833417|564232055|FG001|Overall Study|Adverse Event|16|||
156309557|NCT00833417|564232054|FG000|Overall Study|Death|1|||
156309558|NCT00833417|564232055|FG001|Overall Study|Death|3|||
156309559|NCT00833417|564232054|FG000|Overall Study|Lost to Follow-up|1|||
156309560|NCT00833417|564232055|FG001|Overall Study|Lost to Follow-up|2|||
156309561|NCT00833417|564232054|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
156309562|NCT00833417|564232055|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
156309563|NCT00833417|564232054|FG000|Overall Study|Patient Decision to Withdraw|4|||
156309564|NCT00833417|564232055|FG001|Overall Study|Patient Decision to Withdraw|23|||
156309565|NCT00833417|564232054|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
156309566|NCT00833417|564232055|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
156309567|NCT00833417|564232054|FG000|Overall Study|Disease Progression|18|||
156309568|NCT00833417|564232055|FG001|Overall Study|Disease Progression|17|||
156309569|NCT00833417|564232054|FG000|Overall Study|Reason Not Specified|0|||
156309570|NCT00833417|564232055|FG001|Overall Study|Reason Not Specified|1|||
156309571|NCT00862082|564232058|FG000|Overall Study|Sponsor decision to terminate the study|5|||
156309572|NCT00862082|564232059|FG001|Overall Study|Sponsor decision to terminate the study|0|||
156309573|NCT00862082|564232058|FG000|Overall Study|Withdrawal by Subject|0|||
156309574|NCT00862082|564232059|FG001|Overall Study|Withdrawal by Subject|1|||
156309575|NCT01396070|564232062|FG000|Overall Study|Withdrawal by Subject|2|||
156412362|NCT00105586|564602901|FG000|Overall Study|Adverse Event|4|||
156309576|NCT01396070|564232062|FG000|Overall Study|Death|2|||
156309577|NCT01396070|564232062|FG000|Overall Study|Adverse Event|8|||
156309578|NCT01396070|564232062|FG000|Overall Study|Physician Decision|3|||
156309579|NCT01396070|564232062|FG000|Overall Study|Lack of Efficacy|4|||
156309580|NCT04254913|564232064|FG000|Overall Study|Adverse Event|1|||
156309581|NCT01396057|564232065|FG000|Overall Study|Adverse Event|2|||
156309582|NCT01396057|564232066|FG001|Overall Study|Adverse Event|6|||
156309583|NCT01396057|564232065|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156309584|NCT01396057|564232066|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156309585|NCT01396057|564232065|FG000|Overall Study|Protocol deviation|4|||
156309586|NCT01396057|564232066|FG001|Overall Study|Protocol deviation|4|||
156309587|NCT01396057|564232065|FG000|Overall Study|Consent withdrawn|3|||
156309588|NCT01396057|564232066|FG001|Overall Study|Consent withdrawn|2|||
156309589|NCT01324401|564232069|FG000|Overall Study|Withdrawn before any treatment|0|||
156309590|NCT01324401|564232070|FG001|Overall Study|Withdrawn before any treatment|3|||
156309591|NCT01324401|564232069|FG000|Overall Study|Adverse Event|1|||
156309592|NCT01324401|564232070|FG001|Overall Study|Adverse Event|3|||
156309593|NCT02873429|564232073|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
156309594|NCT02873429|564232074|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
156309595|NCT02873429|564232073|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
156309596|NCT02873429|564232074|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
156309597|NCT02873429|564232073|FG000|16 Weeks|Lost to Follow-up|3|||
156309598|NCT02873429|564232074|FG001|16 Weeks|Lost to Follow-up|0|||
156309599|NCT00744042|564232075|FG000|Overall Study|Withdrawal by Subject|1|||
156309600|NCT00853567|564232076|FG000|Overall Study|Study prematurely terminated|71|||
156309601|NCT02252939|564232080|FG000|Overall Study|Lost to Follow-up|3|||
156309602|NCT01033448|564232081|FG000|Overall Study|Withdrawal by Subject|4|||
156309603|NCT01033448|564232081|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
156309604|NCT01033448|564232081|FG000|Overall Study|Lost to Follow-up|3|||
156309605|NCT01033448|564232081|FG000|Overall Study|Withdrew due to other reasons|3|||
156309606|NCT01033448|564232081|FG000|Overall Study|Unknown disposition|1|||
156309607|NCT02560025|564232082|FG000|Overall Study|Ineligible after consent/ registration|3|||
156309608|NCT02745080|564232087|FG000|Overall Study|Adverse Event|13|||
156309609|NCT02745080|564232088|FG001|Overall Study|Adverse Event|21|||
156309610|NCT02745080|564232087|FG000|Overall Study|Lack of Efficacy|11|||
156309611|NCT02745080|564232088|FG001|Overall Study|Lack of Efficacy|23|||
156309612|NCT02745080|564232087|FG000|Overall Study|Lost to Follow-up|3|||
156309613|NCT02745080|564232088|FG001|Overall Study|Lost to Follow-up|3|||
156309614|NCT02745080|564232087|FG000|Overall Study|Physician Decision|3|||
156309615|NCT02745080|564232088|FG001|Overall Study|Physician Decision|0|||
156309616|NCT02745080|564232087|FG000|Overall Study|Protocol Violation|3|||
156309617|NCT02745080|564232088|FG001|Overall Study|Protocol Violation|1|||
156309618|NCT02745080|564232087|FG000|Overall Study|Withdrawal by Subject|22|||
156309619|NCT02745080|564232088|FG001|Overall Study|Withdrawal by Subject|41|||
156309620|NCT04237116|564232090|FG000|Overall Study|Adverse Event|0|||
156309621|NCT04237116|564232091|FG001|Overall Study|Adverse Event|1|||
156309622|NCT04237116|564232090|FG000|Overall Study|Study terminated by Sponsor|4|||
156309623|NCT04237116|564232091|FG001|Overall Study|Study terminated by Sponsor|1|||
156309624|NCT01821560|564232092|FG000|Overall Study|Lost to Follow-up|5|||
156309625|NCT01821560|564232093|FG001|Overall Study|Lost to Follow-up|5|||
156309626|NCT01821560|564232092|FG000|Overall Study|Withdrawal by Subject|1|||
156309627|NCT01821560|564232093|FG001|Overall Study|Withdrawal by Subject|1|||
156309628|NCT01821560|564232092|FG000|Overall Study|Protocol Violation|0|||
156309629|NCT01821560|564232093|FG001|Overall Study|Protocol Violation|1|||
156309630|NCT04189224|564232095|FG000|Period 2|Adverse Event|0|||
156309631|NCT04189224|564232096|FG001|Period 2|Adverse Event|1|||
156309632|NCT03317405|564233562|FG000|Overall Study|Withdrawal by Subject|1|||
156309633|NCT03317405|564233563|FG001|Overall Study|Withdrawal by Subject|0|||
156309634|NCT03317405|564233564|FG002|Overall Study|Withdrawal by Subject|0|||
156309635|NCT03317405|564233562|FG000|Overall Study|Physician Decision|0|||
156309636|NCT03317405|564233563|FG001|Overall Study|Physician Decision|0|||
156309637|NCT03317405|564233564|FG002|Overall Study|Physician Decision|1|||
156309638|NCT03317405|564233562|FG000|Overall Study|Surgery Rescheduled|0|||
156309639|NCT03317405|564233563|FG001|Overall Study|Surgery Rescheduled|1|||
156309640|NCT03317405|564233564|FG002|Overall Study|Surgery Rescheduled|0|||
156309641|NCT01137604|564233567|FG000|Overall Study|Adverse Event|3|||
156309642|NCT01137604|564233568|FG001|Overall Study|Adverse Event|6|||
156309643|NCT01137604|564233569|FG002|Overall Study|Adverse Event|9|||
156309644|NCT01137604|564233570|FG003|Overall Study|Adverse Event|9|||
156309645|NCT01137604|564233567|FG000|Overall Study|Participant Choice|0|||
156309646|NCT01137604|564233568|FG001|Overall Study|Participant Choice|2|||
156309647|NCT01137604|564233569|FG002|Overall Study|Participant Choice|2|||
156309648|NCT01137604|564233570|FG003|Overall Study|Participant Choice|0|||
156309649|NCT01137604|564233567|FG000|Overall Study|Withdrawal of consent|0|||
156309650|NCT01137604|564233568|FG001|Overall Study|Withdrawal of consent|0|||
156412363|NCT00105586|564602902|FG001|Overall Study|Adverse Event|3|||
156309651|NCT01137604|564233569|FG002|Overall Study|Withdrawal of consent|0|||
156309652|NCT01137604|564233570|FG003|Overall Study|Withdrawal of consent|2|||
156309653|NCT01137604|564233567|FG000|Overall Study|Clinical progression/deterioration|1|||
156309654|NCT01137604|564233568|FG001|Overall Study|Clinical progression/deterioration|2|||
156309655|NCT01137604|564233569|FG002|Overall Study|Clinical progression/deterioration|2|||
156309656|NCT01137604|564233570|FG003|Overall Study|Clinical progression/deterioration|0|||
156309657|NCT00591318|564233571|FG000|Overall Study|Lack of Efficacy|2|||
156647792|NCT02124746|565456912|FG000|Overall Study|Withdrawal by Subject|3|||
156647793|NCT02124746|565456913|FG001|Overall Study|Withdrawal by Subject|3|||
156647794|NCT02124746|565456914|FG002|Overall Study|Withdrawal by Subject|0|||
156647795|NCT02124746|565456912|FG000|Overall Study|Study Terminated by Sponsor|0|||
156647796|NCT02124746|565456913|FG001|Overall Study|Study Terminated by Sponsor|0|||
156647797|NCT02124746|565456914|FG002|Overall Study|Study Terminated by Sponsor|6|||
156647798|NCT02124746|565456912|FG000|Overall Study|Disease Progression|3|||
156647799|NCT02124746|565456913|FG001|Overall Study|Disease Progression|6|||
156647800|NCT02124746|565456914|FG002|Overall Study|Disease Progression|4|||
156647801|NCT05288673|565456915|FG000|Overall Study|Consent withdrawn by subject|0|||
156647802|NCT05288673|565456916|FG001|Overall Study|Consent withdrawn by subject|0|||
156647803|NCT05288673|565456917|FG002|Overall Study|Consent withdrawn by subject|1|||
156647804|NCT03210259|565456920|FG000|12-Week Run-in Period|Adverse Event|1|||
156647805|NCT03210259|565456921|FG001|12-Week Run-in Period|Adverse Event|0|||
156647806|NCT03210259|565456922|FG002|12-Week Run-in Period|Adverse Event|0|||
156647807|NCT03210259|565456920|FG000|12-Week Run-in Period|Death|1|||
156647808|NCT03210259|565456921|FG001|12-Week Run-in Period|Death|0|||
156647809|NCT03210259|565456922|FG002|12-Week Run-in Period|Death|0|||
156647810|NCT03210259|565456920|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
156647811|NCT03210259|565456921|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
156647812|NCT03210259|565456922|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
156647813|NCT03210259|565456920|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
156647814|NCT03210259|565456921|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
156647815|NCT03210259|565456922|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
156647816|NCT03210259|565456920|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
156647817|NCT03210259|565456921|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
156647818|NCT03210259|565456922|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
156647819|NCT03210259|565456920|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
156647820|NCT03210259|565456921|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
156647821|NCT03210259|565456922|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
156647822|NCT03210259|565456920|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
156647823|NCT03210259|565456921|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
156647824|NCT03210259|565456922|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
156647825|NCT03210259|565456920|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
156647826|NCT03210259|565456921|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
156647827|NCT03210259|565456922|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
156647828|NCT03210259|565456920|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
156647829|NCT03210259|565456921|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
156647830|NCT03210259|565456922|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
156647831|NCT03210259|565456920|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
156647832|NCT03210259|565456921|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
156647833|NCT03210259|565456922|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
156647834|NCT03210259|565456920|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
156647835|NCT03210259|565456921|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
156647836|NCT03210259|565456922|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
156647837|NCT00345683|565456923|FG000|Overall Study|Lost to Follow-up|19|||
156647838|NCT00345683|565456924|FG001|Overall Study|Lost to Follow-up|7|||
156647839|NCT00345683|565456923|FG000|Overall Study|Other|6|||
156647840|NCT00345683|565456924|FG001|Overall Study|Other|2|||
156647841|NCT03634488|565456925|FG000|Overall Study|Death|1|||
156647842|NCT03634488|565456926|FG001|Overall Study|Death|0|||
156647843|NCT03634488|565456927|FG002|Overall Study|Death|0|||
156647844|NCT03634488|565456925|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
156647845|NCT03634488|565456926|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
156647846|NCT03634488|565456927|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
156647847|NCT03182686|565456928|FG000|Overall Study|Lost to Follow-up|2|||
156647848|NCT03182686|565456929|FG001|Overall Study|Lost to Follow-up|0|||
156647849|NCT03182686|565456928|FG000|Overall Study|Adverse Event|2|||
156647850|NCT03182686|565456929|FG001|Overall Study|Adverse Event|0|||
156647851|NCT03182686|565456928|FG000|Overall Study|Withdrawal by Subject|3|||
156647852|NCT03182686|565456929|FG001|Overall Study|Withdrawal by Subject|0|||
156647853|NCT01154127|565456930|FG000|Period 1 (21 Days)|Adverse Event|3|||
156647854|NCT01154127|565456931|FG001|Period 1 (21 Days)|Adverse Event|4|||
156647855|NCT01154127|565456930|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
156647856|NCT01154127|565456931|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
156647857|NCT01154127|565456930|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
156647858|NCT01154127|565456931|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
156309658|NCT00591318|564233572|FG001|Overall Study|Lack of Efficacy|0|||
156309659|NCT00591318|564233571|FG000|Overall Study|Adverse Event|2|||
156309660|NCT00591318|564233572|FG001|Overall Study|Adverse Event|0|||
156309661|NCT01024309|564233573|FG000|Overall Study|Physician Decision|4|||
156647859|NCT01154127|565456930|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
156647860|NCT01154127|565456931|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
156309662|NCT01024309|564233574|FG001|Overall Study|Physician Decision|0|||
156309663|NCT01024309|564233573|FG000|Overall Study|Withdrawal by Subject|4|||
156309664|NCT01024309|564233574|FG001|Overall Study|Withdrawal by Subject|4|||
156309665|NCT00435045|564233575|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
156309666|NCT00435045|564233576|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
156309667|NCT00435045|564233575|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
156309668|NCT00435045|564233576|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
156309669|NCT00435045|564233575|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
156309670|NCT00435045|564233576|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
156309671|NCT00435045|564233575|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
156309672|NCT00435045|564233576|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
156309673|NCT00435045|564233575|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
156309674|NCT00435045|564233576|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
156309675|NCT00435045|564233575|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
156309676|NCT00435045|564233576|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
156309677|NCT00435045|564233575|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
156309678|NCT00435045|564233576|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
156309679|NCT00435045|564233575|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
156309680|NCT00435045|564233576|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
156309681|NCT00435045|564233575|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
156309682|NCT00435045|564233576|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
156309683|NCT00435045|564233575|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
156309684|NCT00435045|564233576|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
156309685|NCT00435045|564233575|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
156309686|NCT00435045|564233576|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
156309687|NCT00567255|564233577|FG000|Overall Study|Adverse Event|241|||
156309688|NCT00567255|564233578|FG001|Overall Study|Adverse Event|68|||
156309689|NCT00567255|564233577|FG000|Overall Study|Lost to Follow-up|77|||
156309690|NCT00567255|564233578|FG001|Overall Study|Lost to Follow-up|48|||
156309691|NCT00567255|564233577|FG000|Overall Study|Withdrawal by Subject|75|||
156309692|NCT00567255|564233578|FG001|Overall Study|Withdrawal by Subject|56|||
156309693|NCT00567255|564233577|FG000|Overall Study|Lack of Efficacy|19|||
156309694|NCT00567255|564233578|FG001|Overall Study|Lack of Efficacy|33|||
156309695|NCT00567255|564233577|FG000|Overall Study|Protocol Violation|20|||
156309696|NCT00567255|564233578|FG001|Overall Study|Protocol Violation|8|||
156309697|NCT00567255|564233577|FG000|Overall Study|Pregnancy|6|||
156309698|NCT00567255|564233578|FG001|Overall Study|Pregnancy|0|||
156309699|NCT00567255|564233577|FG000|Overall Study|Drug noncompliance,moved,other|25|||
156309700|NCT00567255|564233578|FG001|Overall Study|Drug noncompliance,moved,other|15|||
156309701|NCT01743001|564233581|FG000|Overall Study|Physician Decision|1|||
156309702|NCT01743001|564233582|FG001|Overall Study|Physician Decision|0|||
156309703|NCT01743001|564233581|FG000|Overall Study|Pregnancy|1|||
156309704|NCT01743001|564233582|FG001|Overall Study|Pregnancy|0|||
156309705|NCT01743001|564233581|FG000|Overall Study|Death|1|||
156309706|NCT01743001|564233582|FG001|Overall Study|Death|0|||
156309707|NCT03052426|564233585|FG000|Overall Study|Withdrawal by Subject|0|||
156309708|NCT03052426|564233586|FG001|Overall Study|Withdrawal by Subject|1|||
156309709|NCT03052426|564233587|FG002|Overall Study|Withdrawal by Subject|0|||
156309710|NCT03052426|564233585|FG000|Overall Study|Lost to Follow-up|2|||
156309711|NCT03052426|564233586|FG001|Overall Study|Lost to Follow-up|0|||
156309712|NCT03052426|564233587|FG002|Overall Study|Lost to Follow-up|1|||
156309713|NCT03083990|564233590|FG000|Overall Study|Adverse Event|1|||
156309714|NCT03083990|564233591|FG001|Overall Study|Adverse Event|0|||
156309715|NCT04145219|564233592|FG000|Overall Study|Adverse Event|18|||
156309716|NCT04145219|564233593|FG001|Overall Study|Adverse Event|6|||
156309717|NCT04145219|564233592|FG000|Overall Study|Lost to Follow-up|2|||
156309718|NCT04145219|564233593|FG001|Overall Study|Lost to Follow-up|3|||
156309719|NCT04145219|564233592|FG000|Overall Study|Physician Decision|0|||
156309720|NCT04145219|564233593|FG001|Overall Study|Physician Decision|2|||
156309721|NCT04145219|564233592|FG000|Overall Study|Withdrawal by Subject|12|||
156309722|NCT04145219|564233593|FG001|Overall Study|Withdrawal by Subject|8|||
156309723|NCT04145219|564233592|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
156309724|NCT04145219|564233593|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
156309725|NCT01640314|564233594|FG000|Overall Study|Protocol Violation|0|||
156309726|NCT01640314|564233595|FG001|Overall Study|Protocol Violation|1|||
156309727|NCT03672097|564233596|FG000|Period 1|Withdrawal by Subject|2|||
156309728|NCT03672097|564233596|FG000|Period 1|Adverse Event|1|||
156309729|NCT03672097|564233596|FG000|Period 1|Did not receive treatment|1|||
156309730|NCT03672097|564233596|FG000|Period 2|Withdrawal by Subject|3|||
156309731|NCT03672097|564233596|FG000|Period 2|Other|1|||
156309732|NCT02657408|564233597|FG000|Overall Study|Adverse Event|3|||
156309733|NCT02657408|564233598|FG001|Overall Study|Adverse Event|7|||
156309734|NCT02160041|564233600|FG000|Overall Study|Adverse Event|11|||
156309735|NCT02160041|564233600|FG000|Overall Study|Death|2|||
156309736|NCT02160041|564233600|FG000|Overall Study|disease progression|57|||
156309737|NCT02160041|564233600|FG000|Overall Study|Protocol Violation|1|||
156309738|NCT02160041|564233600|FG000|Overall Study|non-compliance with study|1|||
156309739|NCT02160041|564233600|FG000|Overall Study|Physician Decision|3|||
156309740|NCT02160041|564233600|FG000|Overall Study|Withdrawal by Subject|8|||
156309741|NCT02160041|564233600|FG000|Overall Study|study terminated by by sponsor|1|||
156309742|NCT01403948|564233601|FG000|Overall Study|Progressive disease|0|||
156647861|NCT01154127|565456930|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
156647862|NCT01154127|565456931|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
156647863|NCT01697449|565456938|FG000|Overall Study|Disease progression|47|||
156647864|NCT01697449|565456938|FG000|Overall Study|Adverse Event|7|||
156647865|NCT01697449|565456938|FG000|Overall Study|Lost to Follow-up|5|||
156647866|NCT01697449|565456938|FG000|Overall Study|Withdrawal by Subject|2|||
156647867|NCT01697449|565456938|FG000|Overall Study|Physician Decision|1|||
156647868|NCT01697449|565456938|FG000|Overall Study|Death|2|||
156647869|NCT01697449|565456938|FG000|Overall Study|Other|1|||
156647870|NCT01697449|565456938|FG000|Overall Study|Missing|25|||
156647871|NCT01169844|565456939|FG000|Overall Study|Adverse Event|0|||
156647872|NCT01169844|565456940|FG001|Overall Study|Adverse Event|1|||
156647873|NCT01169844|565456939|FG000|Overall Study|Patient withdrew consent|4|||
156647874|NCT01169844|565456940|FG001|Overall Study|Patient withdrew consent|0|||
156647875|NCT01169844|565456939|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156647876|NCT01169844|565456940|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156647877|NCT00529568|565456942|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
156647878|NCT00529568|565456943|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
156647879|NCT00529568|565456944|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
156647880|NCT00529568|565456942|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
156647881|NCT00529568|565456943|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
156647882|NCT00529568|565456944|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
156647883|NCT00529568|565456942|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
156647884|NCT00529568|565456943|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
156647885|NCT00529568|565456944|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
156647886|NCT00529568|565456942|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
156647887|NCT00529568|565456943|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
156647888|NCT00529568|565456944|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
156647889|NCT00529568|565456942|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
156647890|NCT00529568|565456943|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
156647891|NCT00529568|565456944|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
156647892|NCT00529568|565456942|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
156647893|NCT00529568|565456943|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
156647894|NCT00529568|565456944|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
156647895|NCT00529568|565456942|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
156647896|NCT00529568|565456943|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
156647897|NCT00529568|565456944|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
156647898|NCT00529568|565456942|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
156647899|NCT00529568|565456943|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
156647900|NCT00529568|565456944|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
156647901|NCT00529568|565456942|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
156647902|NCT00529568|565456943|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
156647903|NCT00529568|565456944|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
156647904|NCT00529568|565456942|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
156647905|NCT00529568|565456943|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
156647906|NCT00529568|565456944|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
156647907|NCT00529568|565456942|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
156647908|NCT00529568|565456943|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
156647909|NCT00529568|565456944|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
156647910|NCT04049552|565456945|FG000|Overall Study|Lost to Follow-up|1|||
156647911|NCT00738920|565456947|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
156647912|NCT00738920|565456948|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
156647913|NCT00738920|565456949|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
156647914|NCT00738920|565456947|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
156647915|NCT00738920|565456948|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
156647916|NCT00738920|565456949|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
156647917|NCT00738920|565456947|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
156647918|NCT00738920|565456948|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
156647919|NCT00738920|565456949|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
156309743|NCT01403948|564233602|FG001|Overall Study|Progressive disease|2|||
156309744|NCT01403948|564233603|FG002|Overall Study|Progressive disease|2|||
156309745|NCT01403948|564233604|FG003|Overall Study|Progressive disease|4|||
156309746|NCT01403948|564233605|FG004|Overall Study|Progressive disease|2|||
156309747|NCT01403948|564233606|FG005|Overall Study|Progressive disease|6|||
156309748|NCT01403948|564233607|FG006|Overall Study|Progressive disease|2|||
156309749|NCT01403948|564233608|FG007|Overall Study|Progressive disease|4|||
156309750|NCT01403948|564233609|FG008|Overall Study|Progressive disease|5|||
156309751|NCT01403948|564233610|FG009|Overall Study|Progressive disease|5|||
156309752|NCT01403948|564233601|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
156309753|NCT01403948|564233602|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
156309754|NCT01403948|564233603|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
156309755|NCT01403948|564233604|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
156309756|NCT01403948|564233605|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
156309757|NCT01403948|564233606|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
156309758|NCT01403948|564233607|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
156309759|NCT01403948|564233608|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
156309760|NCT01403948|564233609|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
156309761|NCT01403948|564233610|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
156309762|NCT01403948|564233601|FG000|Overall Study|Lost to Follow-up|0|||
156309763|NCT01403948|564233602|FG001|Overall Study|Lost to Follow-up|0|||
156309764|NCT01403948|564233603|FG002|Overall Study|Lost to Follow-up|0|||
156309765|NCT01403948|564233604|FG003|Overall Study|Lost to Follow-up|0|||
156309766|NCT01403948|564233605|FG004|Overall Study|Lost to Follow-up|0|||
156309767|NCT01403948|564233606|FG005|Overall Study|Lost to Follow-up|0|||
156309768|NCT01403948|564233607|FG006|Overall Study|Lost to Follow-up|0|||
156309769|NCT01403948|564233608|FG007|Overall Study|Lost to Follow-up|0|||
156309770|NCT01403948|564233609|FG008|Overall Study|Lost to Follow-up|0|||
156309771|NCT01403948|564233610|FG009|Overall Study|Lost to Follow-up|1|||
156309772|NCT01403948|564233601|FG000|Overall Study|Refused cont. medication|0|||
156309773|NCT01403948|564233602|FG001|Overall Study|Refused cont. medication|0|||
156309774|NCT01403948|564233603|FG002|Overall Study|Refused cont. medication|0|||
156309775|NCT01403948|564233604|FG003|Overall Study|Refused cont. medication|0|||
156309776|NCT01403948|564233605|FG004|Overall Study|Refused cont. medication|1|||
156309777|NCT01403948|564233606|FG005|Overall Study|Refused cont. medication|0|||
156309778|NCT01403948|564233607|FG006|Overall Study|Refused cont. medication|0|||
156309779|NCT01403948|564233608|FG007|Overall Study|Refused cont. medication|0|||
156309780|NCT01403948|564233609|FG008|Overall Study|Refused cont. medication|0|||
156309781|NCT01403948|564233610|FG009|Overall Study|Refused cont. medication|1|||
156309782|NCT01403948|564233601|FG000|Overall Study|other than above|1|||
156309783|NCT01403948|564233602|FG001|Overall Study|other than above|2|||
156309784|NCT01403948|564233603|FG002|Overall Study|other than above|1|||
156309785|NCT01403948|564233604|FG003|Overall Study|other than above|0|||
156309786|NCT01403948|564233605|FG004|Overall Study|other than above|1|||
156309787|NCT01403948|564233606|FG005|Overall Study|other than above|1|||
156309788|NCT01403948|564233607|FG006|Overall Study|other than above|2|||
156309789|NCT01403948|564233608|FG007|Overall Study|other than above|0|||
156309790|NCT01403948|564233609|FG008|Overall Study|other than above|0|||
156309791|NCT01403948|564233610|FG009|Overall Study|other than above|0|||
156309792|NCT01090323|564233611|FG000|Overall Study|Adverse Event|12|||
156309793|NCT01090323|564233612|FG001|Overall Study|Adverse Event|2|||
156309794|NCT01090323|564233611|FG000|Overall Study|Abnormal Lab Values|3|||
156309795|NCT01090323|564233612|FG001|Overall Study|Abnormal Lab Values|1|||
156309796|NCT01090323|564233611|FG000|Overall Study|Abnormal Test Procedure Results|2|||
156309797|NCT01090323|564233612|FG001|Overall Study|Abnormal Test Procedure Results|0|||
156309798|NCT01090323|564233611|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156309799|NCT01090323|564233612|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156309800|NCT01090323|564233611|FG000|Overall Study|Condition no longer requires drug|5|||
156309801|NCT01090323|564233612|FG001|Overall Study|Condition no longer requires drug|4|||
156309802|NCT01090323|564233611|FG000|Overall Study|Protocol Violation|2|||
156309803|NCT01090323|564233612|FG001|Overall Study|Protocol Violation|1|||
156309804|NCT01090323|564233611|FG000|Overall Study|Withdrew consent|33|||
156309805|NCT01090323|564233612|FG001|Overall Study|Withdrew consent|11|||
156309806|NCT01090323|564233611|FG000|Overall Study|Lost to Follow-up|11|||
156309807|NCT01090323|564233612|FG001|Overall Study|Lost to Follow-up|6|||
156309808|NCT01090323|564233611|FG000|Overall Study|Administrative problems|6|||
156309809|NCT01090323|564233612|FG001|Overall Study|Administrative problems|4|||
156309810|NCT01090323|564233611|FG000|Overall Study|Death|1|||
156309811|NCT01090323|564233612|FG001|Overall Study|Death|2|||
156309812|NCT01090323|564233611|FG000|Overall Study|Stopped end of core|7|||
156309813|NCT01090323|564233612|FG001|Overall Study|Stopped end of core|0|||
156309814|NCT01090323|564233611|FG000|Overall Study|Stopped end of extension 1#|3|||
156309815|NCT01090323|564233612|FG001|Overall Study|Stopped end of extension 1#|1|||
156309816|NCT05498701|564233613|FG000|Period 3|Adverse Event|1|||
156309817|NCT05498701|564233614|FG001|Period 3|Adverse Event|0|||
156309818|NCT02424578|564233615|FG000|Overall Study|Withdrawal by Subject|0|||
156309819|NCT02424578|564233616|FG001|Overall Study|Withdrawal by Subject|1|||
156309820|NCT03091348|564233625|FG000|Overall Study|Lost to Follow-up|2|||
156309821|NCT03091348|564233626|FG001|Overall Study|Lost to Follow-up|1|||
156309822|NCT04534686|564233627|FG000|Baseline Measurement|Lost to Follow-up|4|||
156412364|NCT00105586|564602901|FG000|Overall Study|Physician Decision|13|||
156309823|NCT04534686|564233628|FG001|Baseline Measurement|Lost to Follow-up|6|||
156309824|NCT04534686|564233627|FG000|Baseline Measurement|Withdrawal by Subject|3|||
156309825|NCT04534686|564233628|FG001|Baseline Measurement|Withdrawal by Subject|1|||
156309826|NCT04534686|564233627|FG000|Intervention|Withdrawal by Subject|2|||
156309827|NCT04534686|564233628|FG001|Intervention|Withdrawal by Subject|2|||
156309828|NCT03179605|564233629|FG000|Overall Study|Withdrawal by Subject|1|||
156309829|NCT00635999|564233630|FG000|Overall Study|Withdrawal by Subject|4|||
156309830|NCT00635999|564233631|FG001|Overall Study|Withdrawal by Subject|2|||
156309831|NCT00635999|564233632|FG002|Overall Study|Withdrawal by Subject|1|||
156309832|NCT00711477|564233633|FG000|Overall Study|Adverse Event|3|||
156309833|NCT00711477|564233634|FG001|Overall Study|Adverse Event|1|||
156309834|NCT00711477|564233633|FG000|Overall Study|Lost to Follow-up|0|||
156309835|NCT00711477|564233634|FG001|Overall Study|Lost to Follow-up|1|||
156309836|NCT00711477|564233633|FG000|Overall Study|Noncompliance|0|||
156309837|NCT00711477|564233634|FG001|Overall Study|Noncompliance|1|||
156309838|NCT02636361|564233635|FG000|Period 4|Physician Decision|0|||
156309839|NCT02636361|564233636|FG001|Period 4|Physician Decision|0|||
156647920|NCT00738920|565456947|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
156647921|NCT00738920|565456948|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
156647922|NCT00738920|565456949|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
156647923|NCT00738920|565456947|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
156647924|NCT00738920|565456948|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
156647925|NCT00738920|565456949|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
156647926|NCT00738920|565456947|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
156647927|NCT00738920|565456948|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
156647928|NCT00738920|565456949|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
156647929|NCT00738920|565456947|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
156647930|NCT00738920|565456948|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
156309840|NCT02636361|564233637|FG002|Period 4|Physician Decision|0|||
156309841|NCT02636361|564233638|FG003|Period 4|Physician Decision|1|||
156309842|NCT02636361|564233639|FG004|Period 4|Physician Decision|0|||
156309843|NCT03037580|564233646|FG000|Overall Study|Withdrawal by Subject|3|||
156309844|NCT03037580|564233647|FG001|Overall Study|Withdrawal by Subject|0|||
156309845|NCT03037580|564233646|FG000|Overall Study|Adverse Event|1|||
156309846|NCT03037580|564233647|FG001|Overall Study|Adverse Event|0|||
156309847|NCT03037580|564233646|FG000|Overall Study|Study Terminated by Sponsor|12|||
156309848|NCT03037580|564233647|FG001|Overall Study|Study Terminated by Sponsor|15|||
156309849|NCT03037580|564233646|FG000|Overall Study|Death|0|||
156309850|NCT03037580|564233647|FG001|Overall Study|Death|1|||
156309851|NCT02036853|564233648|FG000|Overall Study|Adverse Event|0|||
156309852|NCT02036853|564233649|FG001|Overall Study|Adverse Event|2|||
156309853|NCT02036853|564233648|FG000|Overall Study|Lack of Efficacy|0|||
156309854|NCT02036853|564233649|FG001|Overall Study|Lack of Efficacy|2|||
156309855|NCT02036853|564233648|FG000|Overall Study|Physician Decision|0|||
156309856|NCT02036853|564233649|FG001|Overall Study|Physician Decision|1|||
156309857|NCT02036853|564233648|FG000|Overall Study|Withdrawal by Subject|0|||
156309858|NCT02036853|564233649|FG001|Overall Study|Withdrawal by Subject|1|||
156309859|NCT00228553|564233650|FG000|Overall Study|Adverse Event|112|||
156309860|NCT00228553|564233650|FG000|Overall Study|Lack of Efficacy|34|||
156309861|NCT00228553|564233650|FG000|Overall Study|Lost to Follow-up|67|||
156309862|NCT00228553|564233650|FG000|Overall Study|Physician Decision|48|||
156309863|NCT00228553|564233650|FG000|Overall Study|Protocol Violation|6|||
156309864|NCT00228553|564233650|FG000|Overall Study|Withdrawal by Subject|115|||
156309865|NCT00228553|564233650|FG000|Overall Study|Pregnancy|2|||
156309866|NCT00228553|564233650|FG000|Overall Study|Miscellaneous|46|||
156309867|NCT03500224|564233654|FG000|Overall Study|Withdrawal by Subject|2|||
156309868|NCT00335764|564233655|FG000|Overall Study|wrong histology|1|||
156309869|NCT00335764|564233656|FG001|Overall Study|wrong histology|0|||
156309870|NCT00335764|564233657|FG002|Overall Study|wrong histology|0|||
156309871|NCT00335764|564233658|FG003|Overall Study|wrong histology|0|||
156647931|NCT00738920|565456949|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
156309872|NCT00335764|564233659|FG004|Overall Study|wrong histology|1|||
156309873|NCT00499590|564233660|FG000|Overall Study|Study Terminated|112|||
156309874|NCT00499590|564233661|FG001|Overall Study|Study Terminated|112|||
156309875|NCT00499590|564233662|FG002|Overall Study|Study Terminated|112|||
156309876|NCT00499590|564233660|FG000|Overall Study|Not treated|1|||
156309877|NCT00499590|564233661|FG001|Overall Study|Not treated|0|||
156309878|NCT00499590|564233662|FG002|Overall Study|Not treated|1|||
156309879|NCT00612807|564233664|FG000|Overall Study|Withdrawal by Subject|2|||
156309880|NCT00612807|564233665|FG001|Overall Study|Withdrawal by Subject|0|||
156309881|NCT00782834|564233674|FG000|Treatment Phase|fibrous tumor not GIST|1|||
156309882|NCT01215097|564233676|FG000|Overall Study|Adverse Event|1|||
156309883|NCT01215097|564233677|FG001|Overall Study|Adverse Event|3|||
156309884|NCT01215097|564233676|FG000|Overall Study|Protocol Violation|0|||
156309885|NCT01215097|564233677|FG001|Overall Study|Protocol Violation|2|||
156309886|NCT01215097|564233676|FG000|Overall Study|Lost to Follow-up|2|||
156309887|NCT01215097|564233677|FG001|Overall Study|Lost to Follow-up|0|||
156309888|NCT01215097|564233676|FG000|Overall Study|Withdrawal by Subject|6|||
156309889|NCT01215097|564233677|FG001|Overall Study|Withdrawal by Subject|3|||
156309890|NCT01215097|564233676|FG000|Overall Study|Lack of Efficacy|0|||
156309891|NCT01215097|564233677|FG001|Overall Study|Lack of Efficacy|3|||
156309892|NCT01215097|564233676|FG000|Overall Study|patient's refusal to come|2|||
156309893|NCT01215097|564233677|FG001|Overall Study|patient's refusal to come|2|||
156309894|NCT01215097|564233676|FG000|Overall Study|patient's private reason|1|||
156309895|NCT01215097|564233677|FG001|Overall Study|patient's private reason|1|||
156309896|NCT02259088|564233678|FG000|Overall Study|Adverse Event|6|||
156309897|NCT02259088|564233679|FG001|Overall Study|Adverse Event|4|||
156309898|NCT02259088|564233678|FG000|Overall Study|Lost to Follow-up|2|||
156309899|NCT02259088|564233679|FG001|Overall Study|Lost to Follow-up|0|||
156309900|NCT02259088|564233678|FG000|Overall Study|Death|2|||
156309901|NCT02259088|564233679|FG001|Overall Study|Death|0|||
156309902|NCT02259088|564233678|FG000|Overall Study|Physician Decision|5|||
156309903|NCT02259088|564233679|FG001|Overall Study|Physician Decision|2|||
156309904|NCT02259088|564233678|FG000|Overall Study|Protocol deviation|5|||
156309905|NCT02259088|564233679|FG001|Overall Study|Protocol deviation|0|||
156309906|NCT02259088|564233678|FG000|Overall Study|Subject/guardian decision|8|||
156309907|NCT02259088|564233679|FG001|Overall Study|Subject/guardian decision|8|||
156309908|NCT01818752|564233681|FG000|Overall Study|Adverse Event|64|||
156309909|NCT01818752|564233682|FG001|Overall Study|Adverse Event|74|||
156309910|NCT01818752|564233681|FG000|Overall Study|Death|14|||
156309911|NCT01818752|564233682|FG001|Overall Study|Death|18|||
156309912|NCT01818752|564233681|FG000|Overall Study|Non-compliance|16|||
156309913|NCT01818752|564233682|FG001|Overall Study|Non-compliance|20|||
156309914|NCT01818752|564233681|FG000|Overall Study|Withdrawal by Subject|15|||
156309915|NCT01818752|564233682|FG001|Overall Study|Withdrawal by Subject|14|||
156309916|NCT01818752|564233681|FG000|Overall Study|Physician Decision|9|||
156309917|NCT01818752|564233682|FG001|Overall Study|Physician Decision|8|||
156309918|NCT01818752|564233681|FG000|Overall Study|Disease Progression|54|||
156309919|NCT01818752|564233682|FG001|Overall Study|Disease Progression|48|||
156309920|NCT01818752|564233681|FG000|Overall Study|Other|7|||
156309921|NCT01818752|564233682|FG001|Overall Study|Other|8|||
156309922|NCT01818752|564233681|FG000|Overall Study|Continuing Treatment|1|||
156309923|NCT01818752|564233682|FG001|Overall Study|Continuing Treatment|4|||
156309924|NCT01818752|564233681|FG000|Overall Study|Randomized but not Dosed|7|||
156309925|NCT01818752|564233682|FG001|Overall Study|Randomized but not Dosed|4|||
156309926|NCT04270370|564233683|FG000|Overall Study|Lost to Follow-up|1|||
156309927|NCT04270370|564233684|FG001|Overall Study|Lost to Follow-up|0|||
156309928|NCT04270370|564233685|FG002|Overall Study|Lost to Follow-up|0|||
156309929|NCT04270370|564233686|FG003|Overall Study|Lost to Follow-up|0|||
156309930|NCT04270370|564233687|FG004|Overall Study|Lost to Follow-up|0|||
156309931|NCT04270370|564233688|FG005|Overall Study|Lost to Follow-up|0|||
156309932|NCT04270370|564233689|FG006|Overall Study|Lost to Follow-up|0|||
156309933|NCT04270370|564233690|FG007|Overall Study|Lost to Follow-up|0|||
156309934|NCT04270370|564233691|FG008|Overall Study|Lost to Follow-up|1|||
156309935|NCT04270370|564233692|FG009|Overall Study|Lost to Follow-up|0|||
156309936|NCT04270370|564233693|FG010|Overall Study|Lost to Follow-up|0|||
156309937|NCT04270370|564233694|FG011|Overall Study|Lost to Follow-up|0|||
156647932|NCT00738920|565456947|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
156647933|NCT00738920|565456948|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
156647934|NCT00738920|565456949|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
156647935|NCT00738920|565456947|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
156647936|NCT00738920|565456948|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
156647937|NCT00738920|565456949|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
156647938|NCT00738920|565456947|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
156647939|NCT00738920|565456948|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
156647940|NCT00738920|565456949|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
156647941|NCT02133352|565456951|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
156647942|NCT00331630|565459077|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
156647943|NCT00331630|565459077|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
156647944|NCT00331630|565459077|FG000|Follow up for 5 Years|Death|5|||
156647945|NCT00331630|565459077|FG000|Follow up for 5 Years|Data collection was stopped|24|||
156647946|NCT00433381|565459078|FG000|Overall Study|Ineligible / no protocol treatment|3|||
156309938|NCT01324141|564233695|FG000|Overall Study|Declined to participate before treatment started|1|||
156309939|NCT01324141|564233695|FG000|Overall Study|Disease progression on study|1|||
156309940|NCT01001325|564233696|FG000|Overall Study|Lost to Follow-up|16|||
156309941|NCT01001325|564233697|FG001|Overall Study|Lost to Follow-up|10|||
156309942|NCT01001325|564233696|FG000|Overall Study|Protocol Violation|2|||
156309943|NCT01001325|564233697|FG001|Overall Study|Protocol Violation|0|||
156309944|NCT03212144|564233700|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
156309945|NCT03212144|564233701|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
156309946|NCT03212144|564233700|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
156309947|NCT03212144|564233701|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
156309948|NCT00899431|564233702|FG000|Overall Study|Physician Decision|1|||
156647947|NCT00433381|565459079|FG001|Overall Study|Ineligible / no protocol treatment|3|||
156309949|NCT00899431|564233703|FG001|Overall Study|Physician Decision|0|||
156309950|NCT00899431|564233704|FG002|Overall Study|Physician Decision|0|||
156309951|NCT00661427|564233705|FG000|Overall Study|Adverse Event|5|||
156309952|NCT00661427|564233706|FG001|Overall Study|Adverse Event|5|||
156309953|NCT00661427|564233705|FG000|Overall Study|Patient not treated|0|||
156309954|NCT00661427|564233706|FG001|Overall Study|Patient not treated|2|||
156309955|NCT00599339|564233707|FG000|Overall Study|Adverse Event|79|||
156309956|NCT00599339|564233707|FG000|Overall Study|Withdrawal by Subject|137|||
156309957|NCT00599339|564233707|FG000|Overall Study|Other Reason|179|||
156309958|NCT00599339|564233707|FG000|Overall Study|Lost to Follow-up|221|||
156309959|NCT00599339|564233707|FG000|Overall Study|No valid data consent|36|||
156309960|NCT00599339|564233707|FG000|Overall Study|Study Termination Status Unknown|12|||
156309961|NCT05564052|564233708|FG000|Overall Study|Withdrawal by Subject|0|||
156309962|NCT05564052|564233709|FG001|Overall Study|Withdrawal by Subject|0|||
156309963|NCT05564052|564233710|FG002|Overall Study|Withdrawal by Subject|0|||
156309964|NCT05564052|564233711|FG003|Overall Study|Withdrawal by Subject|1|||
156309965|NCT05688670|564233712|FG000|Overall Study|Change in surgery plan|1|||
156309966|NCT05688670|564233713|FG001|Overall Study|Change in surgery plan|4|||
156309967|NCT05688670|564233712|FG000|Overall Study|Inability to extubate|1|||
156309968|NCT05688670|564233713|FG001|Overall Study|Inability to extubate|2|||
156309969|NCT05688670|564233712|FG000|Overall Study|Day of surgery cancellation|0|||
156309970|NCT05688670|564233713|FG001|Overall Study|Day of surgery cancellation|1|||
156309971|NCT05688670|564233712|FG000|Overall Study|Reintubated on PCICU arrival|0|||
156309972|NCT05688670|564233713|FG001|Overall Study|Reintubated on PCICU arrival|1|||
156309973|NCT00488683|564233714|FG000|Overall Study|Withdrawal by Subject|1|||
156309974|NCT00488683|564233715|FG001|Overall Study|Withdrawal by Subject|2|||
156309975|NCT00488683|564233716|FG002|Overall Study|Withdrawal by Subject|2|||
156309976|NCT00488683|564233714|FG000|Overall Study|Lost to Follow-up|5|||
156309977|NCT00488683|564233715|FG001|Overall Study|Lost to Follow-up|3|||
156309978|NCT00488683|564233716|FG002|Overall Study|Lost to Follow-up|0|||
156309979|NCT00488683|564233714|FG000|Overall Study|Protocol Violation|5|||
156309980|NCT00488683|564233715|FG001|Overall Study|Protocol Violation|1|||
156309981|NCT00488683|564233716|FG002|Overall Study|Protocol Violation|0|||
156309982|NCT00488683|564233714|FG000|Overall Study|Unable to Classify|1|||
156309983|NCT00488683|564233715|FG001|Overall Study|Unable to Classify|0|||
156309984|NCT00488683|564233716|FG002|Overall Study|Unable to Classify|0|||
156309985|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
156309986|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
156309987|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
156309988|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
156309989|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
156309990|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
156309991|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
156309992|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
156309993|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
156309994|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
156309995|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
156309996|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
156309997|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
156309998|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
156309999|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
156310000|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
156310001|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
156310002|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
156310003|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
156310004|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
156310005|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
156310006|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
156310007|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
156310008|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
156310009|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
156310010|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
156412365|NCT00105586|564602902|FG001|Overall Study|Physician Decision|13|||
156412366|NCT02262260|564602903|FG000|Overall Study|Adverse Event|4|||
156412367|NCT02262260|564602904|FG001|Overall Study|Adverse Event|1|||
156310011|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
156310012|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
156310013|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
156310014|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
156310015|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
156412368|NCT02262260|564602903|FG000|Overall Study|Withdrawal of consent|4|||
156412369|NCT02262260|564602904|FG001|Overall Study|Withdrawal of consent|2|||
156647948|NCT01133821|565459080|FG000|Overall Study|Lost to Follow-up|8|||
156647949|NCT01133821|565459081|FG001|Overall Study|Lost to Follow-up|11|||
156647950|NCT01133821|565459080|FG000|Overall Study|Withdrawal by Subject|8|||
156647951|NCT01133821|565459081|FG001|Overall Study|Withdrawal by Subject|3|||
156647952|NCT01133821|565459080|FG000|Overall Study|preferred other treatment|1|||
156647953|NCT01133821|565459081|FG001|Overall Study|preferred other treatment|1|||
156647954|NCT01133821|565459080|FG000|Overall Study|Protocol Violation|0|||
156647955|NCT01133821|565459081|FG001|Overall Study|Protocol Violation|1|||
156647956|NCT01133821|565459080|FG000|Overall Study|Refused participation|1|||
156647957|NCT01133821|565459081|FG001|Overall Study|Refused participation|3|||
156647958|NCT03342898|565459082|FG000|Overall Study|Adverse Event|3|||
156647959|NCT03342898|565459083|FG001|Overall Study|Adverse Event|1|||
156310016|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
156310017|NCT03818035|564233717|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
156310018|NCT03818035|564233718|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
156310019|NCT03818035|564233719|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
156310020|NCT03818035|564233720|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
156310021|NCT03818035|564233717|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
156412370|NCT02262260|564602903|FG000|Overall Study|Lost to Follow-up|1|||
156412371|NCT02262260|564602904|FG001|Overall Study|Lost to Follow-up|2|||
156412372|NCT02262260|564602903|FG000|Overall Study|Protocol deviation|2|||
156412373|NCT02262260|564602904|FG001|Overall Study|Protocol deviation|5|||
156412374|NCT01794117|564602905|FG000|Overall Study|Adverse Event|1|||
156412375|NCT01794117|564602906|FG001|Overall Study|Adverse Event|0|||
156412376|NCT01794117|564602907|FG002|Overall Study|Adverse Event|0|||
156412377|NCT01794117|564602908|FG003|Overall Study|Adverse Event|0|||
156412378|NCT01794117|564602905|FG000|Overall Study|Participant noncompliance|0|||
156412379|NCT01794117|564602906|FG001|Overall Study|Participant noncompliance|1|||
156412380|NCT01794117|564602907|FG002|Overall Study|Participant noncompliance|0|||
156412381|NCT01794117|564602908|FG003|Overall Study|Participant noncompliance|0|||
156412382|NCT01794117|564602905|FG000|Overall Study|Refused further treatment|0|||
156412383|NCT01794117|564602906|FG001|Overall Study|Refused further treatment|2|||
156412384|NCT01794117|564602907|FG002|Overall Study|Refused further treatment|0|||
156412385|NCT01794117|564602908|FG003|Overall Study|Refused further treatment|0|||
156412386|NCT02696902|564602909|FG000|Overall Study|Lost to Follow-up|0|||
156412387|NCT02696902|564602910|FG001|Overall Study|Lost to Follow-up|1|||
156412388|NCT02696902|564602911|FG002|Overall Study|Lost to Follow-up|1|||
156412389|NCT02696902|564602909|FG000|Overall Study|Withdrawal by Subject|0|||
156412390|NCT02696902|564602910|FG001|Overall Study|Withdrawal by Subject|0|||
156412391|NCT02696902|564602911|FG002|Overall Study|Withdrawal by Subject|1|||
156412392|NCT02696902|564602909|FG000|Overall Study|Death|19|||
156412393|NCT02696902|564602910|FG001|Overall Study|Death|3|||
156412394|NCT02696902|564602911|FG002|Overall Study|Death|24|||
156412395|NCT02696902|564602909|FG000|Overall Study|Participant not fit post-randomization|0|||
156412396|NCT02696902|564602910|FG001|Overall Study|Participant not fit post-randomization|0|||
156412397|NCT02696902|564602911|FG002|Overall Study|Participant not fit post-randomization|1|||
156412398|NCT02696902|564602909|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
156412399|NCT02696902|564602910|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
156412400|NCT02696902|564602911|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
156412401|NCT02696902|564602909|FG000|Overall Study|Principal investigator's decision|1|||
156412402|NCT02696902|564602910|FG001|Overall Study|Principal investigator's decision|0|||
156412403|NCT02696902|564602911|FG002|Overall Study|Principal investigator's decision|0|||
156412404|NCT02696902|564602909|FG000|Overall Study|Sponsor's decision|1|||
156412405|NCT02696902|564602910|FG001|Overall Study|Sponsor's decision|0|||
156412406|NCT02696902|564602911|FG002|Overall Study|Sponsor's decision|0|||
156412407|NCT02696902|564602909|FG000|Overall Study|Transferred to other hospital|1|||
156412408|NCT02696902|564602910|FG001|Overall Study|Transferred to other hospital|0|||
156412409|NCT02696902|564602911|FG002|Overall Study|Transferred to other hospital|0|||
156412410|NCT01233609|564602913|FG000|Overall Study|Death|1|||
156412411|NCT01233609|564602914|FG001|Overall Study|Death|0|||
156412412|NCT01233609|564602913|FG000|Overall Study|Lost to Follow-up|3|||
156647960|NCT03342898|565459084|FG002|Overall Study|Adverse Event|0|||
156310022|NCT03818035|564233718|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
156310023|NCT03818035|564233719|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
156310024|NCT03818035|564233720|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
156310025|NCT03818035|564233717|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
156310026|NCT03818035|564233718|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
156310027|NCT03818035|564233719|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
156310028|NCT03818035|564233720|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
156310029|NCT03818035|564233717|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
156310030|NCT03818035|564233718|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
156310031|NCT03818035|564233719|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
156310032|NCT03818035|564233720|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
156310033|NCT03818035|564233717|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
156310034|NCT03818035|564233718|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
156412413|NCT01233609|564602914|FG001|Overall Study|Lost to Follow-up|1|||
156310035|NCT03818035|564233719|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
156310036|NCT03818035|564233720|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
156310037|NCT03818035|564233717|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
156338255|NCT05248867|564336597|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156647961|NCT03342898|565459082|FG000|Overall Study|Lost to Follow-up|44|||
156647962|NCT03342898|565459083|FG001|Overall Study|Lost to Follow-up|40|||
156647963|NCT03342898|565459084|FG002|Overall Study|Lost to Follow-up|42|||
156647964|NCT03342898|565459082|FG000|Overall Study|Withdrawal of Consent|5|||
156647965|NCT03342898|565459083|FG001|Overall Study|Withdrawal of Consent|9|||
156647966|NCT03342898|565459084|FG002|Overall Study|Withdrawal of Consent|11|||
156647967|NCT03342898|565459082|FG000|Overall Study|Death|0|||
156647968|NCT03342898|565459083|FG001|Overall Study|Death|1|||
156647969|NCT03342898|565459084|FG002|Overall Study|Death|1|||
156647970|NCT03342898|565459082|FG000|Overall Study|Reason not Specified|2|||
156647971|NCT03342898|565459083|FG001|Overall Study|Reason not Specified|2|||
156647972|NCT03342898|565459084|FG002|Overall Study|Reason not Specified|0|||
156647973|NCT01387282|565459085|FG000|Overall Study|Death|47|||
156647974|NCT01387282|565459086|FG001|Overall Study|Death|16|||
156647975|NCT01387282|565459085|FG000|Overall Study|Other|5|||
156647976|NCT01387282|565459086|FG001|Overall Study|Other|1|||
156647977|NCT01387282|565459085|FG000|Overall Study|Unrelated AE|6|||
156647978|NCT01387282|565459086|FG001|Overall Study|Unrelated AE|4|||
156647979|NCT01387282|565459085|FG000|Overall Study|Withdrawal by patient|33|||
156647980|NCT01387282|565459086|FG001|Overall Study|Withdrawal by patient|23|||
156647981|NCT01387282|565459085|FG000|Overall Study|Study drug-related AE|2|||
156647982|NCT01387282|565459086|FG001|Overall Study|Study drug-related AE|2|||
156647983|NCT01387282|565459085|FG000|Overall Study|Lost to Follow-up|4|||
156647984|NCT01387282|565459086|FG001|Overall Study|Lost to Follow-up|1|||
156647985|NCT03997448|565459089|FG000|Study Treatment|Disease Progression|1|||
156647986|NCT03997448|565459089|FG000|Study Treatment|Symptomatic Deterioration|1|||
156647987|NCT03997448|565459089|FG000|Follow up|Death|2|||
156647988|NCT03997448|565459089|FG000|Follow up|study terminated|1|||
156647989|NCT01621490|565459090|FG000|Overall Study|Subject no longer meets study criteria|0|||
156647990|NCT01621490|565459091|FG001|Overall Study|Subject no longer meets study criteria|0|||
156647991|NCT01621490|565459092|FG002|Overall Study|Subject no longer meets study criteria|0|||
156647992|NCT01621490|565459093|FG003|Overall Study|Subject no longer meets study criteria|0|||
156647993|NCT01621490|565459094|FG004|Overall Study|Subject no longer meets study criteria|1|||
156647994|NCT01621490|565459095|FG005|Overall Study|Subject no longer meets study criteria|0|||
156647995|NCT01621490|565459096|FG006|Overall Study|Subject no longer meets study criteria|0|||
156647996|NCT01621490|565459097|FG007|Overall Study|Subject no longer meets study criteria|0|||
156647997|NCT01621490|565459098|FG008|Overall Study|Subject no longer meets study criteria|0|||
156647998|NCT01621490|565459099|FG009|Overall Study|Subject no longer meets study criteria|0|||
156647999|NCT01621490|565459100|FG010|Overall Study|Subject no longer meets study criteria|0|||
156648000|NCT01621490|565459090|FG000|Overall Study|Maximum clinical benefit|3|||
156648001|NCT01621490|565459091|FG001|Overall Study|Maximum clinical benefit|2|||
156648002|NCT01621490|565459092|FG002|Overall Study|Maximum clinical benefit|0|||
156648003|NCT01621490|565459093|FG003|Overall Study|Maximum clinical benefit|0|||
156648004|NCT01621490|565459094|FG004|Overall Study|Maximum clinical benefit|0|||
156648005|NCT01621490|565459095|FG005|Overall Study|Maximum clinical benefit|0|||
156648006|NCT01621490|565459096|FG006|Overall Study|Maximum clinical benefit|1|||
156648007|NCT01621490|565459097|FG007|Overall Study|Maximum clinical benefit|2|||
156648008|NCT01621490|565459098|FG008|Overall Study|Maximum clinical benefit|2|||
156648009|NCT01621490|565459099|FG009|Overall Study|Maximum clinical benefit|0|||
156648010|NCT01621490|565459100|FG010|Overall Study|Maximum clinical benefit|0|||
156648011|NCT01621490|565459090|FG000|Overall Study|Withdrawal by Subject|1|||
156648012|NCT01621490|565459091|FG001|Overall Study|Withdrawal by Subject|0|||
156648013|NCT01621490|565459092|FG002|Overall Study|Withdrawal by Subject|0|||
156648014|NCT01621490|565459093|FG003|Overall Study|Withdrawal by Subject|0|||
156648015|NCT01621490|565459094|FG004|Overall Study|Withdrawal by Subject|0|||
156648016|NCT01621490|565459095|FG005|Overall Study|Withdrawal by Subject|1|||
156648017|NCT01621490|565459096|FG006|Overall Study|Withdrawal by Subject|0|||
156648018|NCT01621490|565459097|FG007|Overall Study|Withdrawal by Subject|0|||
156648019|NCT01621490|565459098|FG008|Overall Study|Withdrawal by Subject|0|||
156648020|NCT01621490|565459099|FG009|Overall Study|Withdrawal by Subject|0|||
156648021|NCT01621490|565459100|FG010|Overall Study|Withdrawal by Subject|0|||
156648022|NCT01621490|565459090|FG000|Overall Study|Subject request to discontinue study|1|||
156648023|NCT01621490|565459091|FG001|Overall Study|Subject request to discontinue study|3|||
156648024|NCT01621490|565459092|FG002|Overall Study|Subject request to discontinue study|1|||
156648025|NCT01621490|565459093|FG003|Overall Study|Subject request to discontinue study|1|||
156648026|NCT01621490|565459094|FG004|Overall Study|Subject request to discontinue study|0|||
156648027|NCT01621490|565459095|FG005|Overall Study|Subject request to discontinue study|2|||
156648028|NCT01621490|565459096|FG006|Overall Study|Subject request to discontinue study|1|||
156648029|NCT01621490|565459097|FG007|Overall Study|Subject request to discontinue study|0|||
156648030|NCT01621490|565459098|FG008|Overall Study|Subject request to discontinue study|1|||
156648031|NCT01621490|565459099|FG009|Overall Study|Subject request to discontinue study|0|||
156648032|NCT01621490|565459100|FG010|Overall Study|Subject request to discontinue study|0|||
156648033|NCT01621490|565459090|FG000|Overall Study|Adverse event unrelated to study drug|1|||
156648034|NCT01621490|565459091|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156648035|NCT01621490|565459092|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156648036|NCT01621490|565459093|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156648037|NCT01621490|565459094|FG004|Overall Study|Adverse event unrelated to study drug|0|||
156648038|NCT01621490|565459095|FG005|Overall Study|Adverse event unrelated to study drug|0|||
156648039|NCT01621490|565459096|FG006|Overall Study|Adverse event unrelated to study drug|0|||
156648040|NCT01621490|565459097|FG007|Overall Study|Adverse event unrelated to study drug|2|||
156648041|NCT01621490|565459098|FG008|Overall Study|Adverse event unrelated to study drug|0|||
156648042|NCT01621490|565459099|FG009|Overall Study|Adverse event unrelated to study drug|0|||
156648043|NCT01621490|565459100|FG010|Overall Study|Adverse event unrelated to study drug|0|||
156648044|NCT01621490|565459090|FG000|Overall Study|Disease progression|27|||
156648045|NCT01621490|565459091|FG001|Overall Study|Disease progression|28|||
156648046|NCT01621490|565459092|FG002|Overall Study|Disease progression|1|||
156648047|NCT01621490|565459093|FG003|Overall Study|Disease progression|5|||
156648048|NCT01621490|565459094|FG004|Overall Study|Disease progression|3|||
156648049|NCT01621490|565459095|FG005|Overall Study|Disease progression|8|||
156648050|NCT01621490|565459096|FG006|Overall Study|Disease progression|7|||
156648051|NCT01621490|565459097|FG007|Overall Study|Disease progression|1|||
156648052|NCT01621490|565459098|FG008|Overall Study|Disease progression|4|||
156648053|NCT01621490|565459099|FG009|Overall Study|Disease progression|1|||
156648054|NCT01621490|565459100|FG010|Overall Study|Disease progression|1|||
156648055|NCT01621490|565459090|FG000|Overall Study|Study drug toxicity|1|||
156648056|NCT01621490|565459091|FG001|Overall Study|Study drug toxicity|4|||
156648057|NCT01621490|565459092|FG002|Overall Study|Study drug toxicity|5|||
156648058|NCT01621490|565459093|FG003|Overall Study|Study drug toxicity|3|||
156648059|NCT01621490|565459094|FG004|Overall Study|Study drug toxicity|1|||
156648060|NCT01621490|565459095|FG005|Overall Study|Study drug toxicity|10|||
156648061|NCT01621490|565459096|FG006|Overall Study|Study drug toxicity|1|||
156648062|NCT01621490|565459097|FG007|Overall Study|Study drug toxicity|4|||
156648063|NCT01621490|565459098|FG008|Overall Study|Study drug toxicity|1|||
156648064|NCT01621490|565459099|FG009|Overall Study|Study drug toxicity|0|||
156648065|NCT01621490|565459100|FG010|Overall Study|Study drug toxicity|0|||
156648066|NCT01621490|565459090|FG000|Overall Study|Death|0|||
156648067|NCT01621490|565459091|FG001|Overall Study|Death|0|||
156648068|NCT01621490|565459092|FG002|Overall Study|Death|0|||
156648069|NCT01621490|565459093|FG003|Overall Study|Death|0|||
156648070|NCT01621490|565459094|FG004|Overall Study|Death|0|||
156648071|NCT01621490|565459095|FG005|Overall Study|Death|0|||
156648072|NCT01621490|565459096|FG006|Overall Study|Death|0|||
156648073|NCT01621490|565459097|FG007|Overall Study|Death|0|||
156648074|NCT01621490|565459098|FG008|Overall Study|Death|1|||
156648075|NCT01621490|565459099|FG009|Overall Study|Death|0|||
156648076|NCT01621490|565459100|FG010|Overall Study|Death|0|||
156648077|NCT01621490|565459090|FG000|Overall Study|Other reasons|7|||
156648078|NCT01621490|565459091|FG001|Overall Study|Other reasons|6|||
156648079|NCT01621490|565459092|FG002|Overall Study|Other reasons|4|||
156648080|NCT01621490|565459093|FG003|Overall Study|Other reasons|1|||
156648081|NCT01621490|565459094|FG004|Overall Study|Other reasons|1|||
156648082|NCT01621490|565459095|FG005|Overall Study|Other reasons|3|||
156648083|NCT01621490|565459096|FG006|Overall Study|Other reasons|1|||
156648084|NCT01621490|565459097|FG007|Overall Study|Other reasons|1|||
156648085|NCT01621490|565459098|FG008|Overall Study|Other reasons|1|||
156648086|NCT01621490|565459099|FG009|Overall Study|Other reasons|0|||
156648087|NCT01621490|565459100|FG010|Overall Study|Other reasons|0|||
156648088|NCT00461500|565459101|FG000|Overall Study|Adverse Event|1|||
156648089|NCT00461500|565459102|FG001|Overall Study|Adverse Event|0|||
156648090|NCT00461500|565459101|FG000|Overall Study|Lack of Efficacy|0|||
156648091|NCT00461500|565459102|FG001|Overall Study|Lack of Efficacy|1|||
156648092|NCT00461500|565459101|FG000|Overall Study|Expired Drug Treatment|1|||
156648093|NCT00461500|565459102|FG001|Overall Study|Expired Drug Treatment|1|||
156648094|NCT00461500|565459101|FG000|Overall Study|Study Stopped|1|||
156648095|NCT00461500|565459102|FG001|Overall Study|Study Stopped|2|||
156648096|NCT00461500|565459101|FG000|Overall Study|Drug Treatment Misuse|1|||
156648097|NCT00461500|565459102|FG001|Overall Study|Drug Treatment Misuse|0|||
156648098|NCT00461500|565459101|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
156648099|NCT00461500|565459102|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
156648100|NCT00461500|565459101|FG000|Overall Study|Lost to Follow-up|2|||
156648101|NCT00461500|565459102|FG001|Overall Study|Lost to Follow-up|2|||
156648102|NCT01513551|565459103|FG000|Overall Study|Death|0|||
156648103|NCT01513551|565459104|FG001|Overall Study|Death|1|||
156648104|NCT01513551|565459105|FG002|Overall Study|Death|0|||
156648105|NCT01513551|565459103|FG000|Overall Study|Lost to Follow-up|3|||
156648106|NCT01513551|565459104|FG001|Overall Study|Lost to Follow-up|5|||
156648107|NCT01513551|565459105|FG002|Overall Study|Lost to Follow-up|2|||
156648108|NCT01513551|565459103|FG000|Overall Study|Withdrawal by Subject|1|||
156648109|NCT01513551|565459104|FG001|Overall Study|Withdrawal by Subject|0|||
156648110|NCT01513551|565459105|FG002|Overall Study|Withdrawal by Subject|2|||
156648111|NCT01513551|565459103|FG000|Overall Study|Randomized but not vaccinated|0|||
156648112|NCT01513551|565459104|FG001|Overall Study|Randomized but not vaccinated|0|||
156648113|NCT01513551|565459105|FG002|Overall Study|Randomized but not vaccinated|1|||
156648114|NCT02482805|565459109|FG000|Overall Study|Lost to Follow-up|4|||
156648115|NCT02482805|565459110|FG001|Overall Study|Lost to Follow-up|4|||
156648116|NCT02482805|565459111|FG002|Overall Study|Lost to Follow-up|0|||
156648117|NCT01806597|565459112|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
156648118|NCT01806597|565459113|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
156648119|NCT01806597|565459114|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
156648120|NCT01806597|565459115|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
156648121|NCT01806597|565459116|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
156648122|NCT01806597|565459117|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
156648123|NCT01806597|565459112|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
156648124|NCT01806597|565459113|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
156648125|NCT01806597|565459114|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
156648126|NCT01806597|565459115|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
156648127|NCT01806597|565459116|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
156648128|NCT01806597|565459117|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
156648129|NCT01806597|565459112|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
156648130|NCT01806597|565459113|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
156648131|NCT01806597|565459114|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
156648132|NCT01806597|565459115|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
156648133|NCT01806597|565459116|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
156648134|NCT01806597|565459117|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
156648135|NCT01806597|565459112|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
156648136|NCT01806597|565459113|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
156648137|NCT01806597|565459114|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
156648138|NCT01806597|565459115|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
156648139|NCT01806597|565459116|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
156648140|NCT01806597|565459117|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
156648141|NCT01806597|565459112|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
156648142|NCT01806597|565459113|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
156648143|NCT01806597|565459114|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
156648144|NCT01806597|565459115|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
156648145|NCT01806597|565459116|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
156310038|NCT03818035|564233718|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
156310039|NCT03818035|564233719|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
156310040|NCT03818035|564233720|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
156310041|NCT03818035|564233717|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
156310042|NCT03818035|564233718|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
156310043|NCT03818035|564233719|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
156310044|NCT03818035|564233720|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
156310045|NCT03338959|564234972|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
156310046|NCT03338959|564234972|FG000|Overall Study|Physician Decision|1|||
156310047|NCT02184455|564234975|FG000|Overall Study|Lost to Follow-up|1|||
156310048|NCT02894502|564234984|FG000|Baseline|Withdrawal by Subject|24|||
156310049|NCT02894502|564234985|FG001|Baseline|Withdrawal by Subject|31|||
156310050|NCT02894502|564234986|FG002|Baseline|Withdrawal by Subject|36|||
156310051|NCT02894502|564234984|FG000|Baseline|Death|3|||
156310052|NCT02894502|564234985|FG001|Baseline|Death|1|||
156310053|NCT02894502|564234986|FG002|Baseline|Death|9|||
156310054|NCT02894502|564234984|FG000|First Follow up|Withdrawal by Subject|32|||
156310055|NCT02894502|564234985|FG001|First Follow up|Withdrawal by Subject|29|||
156310056|NCT02894502|564234986|FG002|First Follow up|Withdrawal by Subject|37|||
156310057|NCT02894502|564234984|FG000|First Follow up|Death|2|||
156310058|NCT02894502|564234985|FG001|First Follow up|Death|2|||
156310059|NCT02894502|564234986|FG002|First Follow up|Death|3|||
156310060|NCT02894502|564234984|FG000|Second Follow up|Withdrawal by Subject|13|||
156310061|NCT02894502|564234985|FG001|Second Follow up|Withdrawal by Subject|15|||
156310062|NCT02894502|564234986|FG002|Second Follow up|Withdrawal by Subject|13|||
156310063|NCT02894502|564234984|FG000|Second Follow up|Death|2|||
156310064|NCT02894502|564234985|FG001|Second Follow up|Death|3|||
156310065|NCT02894502|564234986|FG002|Second Follow up|Death|1|||
156310066|NCT02894502|564234984|FG000|Third Follow up|Withdrawal by Subject|5|||
156648146|NCT01806597|565459117|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
156648147|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
156648148|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
156412414|NCT01233609|564602913|FG000|Overall Study|Adverse Event|2|||
156310067|NCT02894502|564234985|FG001|Third Follow up|Withdrawal by Subject|6|||
156412415|NCT01233609|564602914|FG001|Overall Study|Adverse Event|1|||
156648149|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
156648150|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
156648151|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
156648152|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
156648153|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
156648154|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
156648155|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
156648156|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
156648157|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
156648158|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
156648159|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
156648160|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
156648161|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
156648162|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
156648163|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
156648164|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
156648165|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
156648166|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
156648167|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
156648168|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
156648169|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
156648170|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
156648171|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
156310068|NCT02894502|564234986|FG002|Third Follow up|Withdrawal by Subject|3|||
156310069|NCT02894502|564234984|FG000|Third Follow up|Death|1|||
156310070|NCT02894502|564234985|FG001|Third Follow up|Death|1|||
156310071|NCT02894502|564234986|FG002|Third Follow up|Death|0|||
156310072|NCT01410357|564234987|FG000|Overall Study|Death|2|||
156310073|NCT01410357|564234988|FG001|Overall Study|Death|1|||
156310074|NCT01410357|564234987|FG000|Overall Study|Withdrawal by Subject|1|||
156310075|NCT01410357|564234988|FG001|Overall Study|Withdrawal by Subject|2|||
156310076|NCT01410357|564234987|FG000|Overall Study|Lost to Follow-up|23|||
156310077|NCT01410357|564234988|FG001|Overall Study|Lost to Follow-up|21|||
156310078|NCT00615901|564234989|FG000|Overall Study|Withdrawal by Subject|2|||
156310079|NCT00615901|564234989|FG000|Overall Study|Adverse Event|7|||
156412416|NCT01233609|564602913|FG000|Overall Study|Withdrawal by Subject|3|||
156648172|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
156648173|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
156648174|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
156648175|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
156648176|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
156648177|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
156648178|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
156648179|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
156648180|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
156648181|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
156648182|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
156648183|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
156648184|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
156648185|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
156648186|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
156648187|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
156648188|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
156648189|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
156648190|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
156648191|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
156648192|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
156648193|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
156648194|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
156648195|NCT01806597|565459112|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
156412417|NCT01233609|564602914|FG001|Overall Study|Withdrawal by Subject|0|||
156310080|NCT00668733|564234996|FG000|Overall Study|Lost to Follow-up|2|||
156310081|NCT00668733|564234997|FG001|Overall Study|Lost to Follow-up|3|||
156310082|NCT00668733|564234996|FG000|Overall Study|Withdrawal by Subject|0|||
156310083|NCT00668733|564234997|FG001|Overall Study|Withdrawal by Subject|4|||
156310084|NCT03467152|564234998|FG000|Overall Study|Adverse Event|4|||
156310085|NCT03467152|564234999|FG001|Overall Study|Adverse Event|5|||
156310086|NCT03467152|564235000|FG002|Overall Study|Adverse Event|0|||
156310087|NCT03467152|564234998|FG000|Overall Study|Subject Choice|1|||
156310088|NCT03467152|564234999|FG001|Overall Study|Subject Choice|3|||
156310089|NCT03467152|564235000|FG002|Overall Study|Subject Choice|0|||
156310090|NCT03467152|564234998|FG000|Overall Study|Lost to Follow-up|1|||
156310091|NCT03467152|564234999|FG001|Overall Study|Lost to Follow-up|0|||
156310092|NCT03467152|564235000|FG002|Overall Study|Lost to Follow-up|0|||
156310093|NCT03467152|564234998|FG000|Overall Study|Withdrawal by Subject|4|||
156412418|NCT00735644|564602915|FG000|Overall Study|Did not receive study vaccine|0|||
156648196|NCT01806597|565459113|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
156648197|NCT01806597|565459114|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
156648198|NCT01806597|565459115|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
156648199|NCT01806597|565459116|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
156648200|NCT01806597|565459117|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
156648201|NCT01806597|565459112|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
156648202|NCT01806597|565459113|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
156648203|NCT01806597|565459114|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
156648204|NCT01806597|565459115|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
156648205|NCT01806597|565459116|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
156648206|NCT01806597|565459117|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
156648207|NCT01806597|565459112|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
156648208|NCT01806597|565459113|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
156648209|NCT01806597|565459114|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
156648210|NCT01806597|565459115|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
156648211|NCT01806597|565459116|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
156648212|NCT01806597|565459117|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
156648213|NCT01806597|565459112|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
156648214|NCT01806597|565459113|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
156648215|NCT01806597|565459114|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
156648216|NCT01806597|565459115|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
156648217|NCT01806597|565459116|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
156648218|NCT01806597|565459117|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
156648219|NCT01806597|565459112|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
156648220|NCT01806597|565459113|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
156648221|NCT01806597|565459114|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
156648222|NCT01806597|565459115|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
156648223|NCT01806597|565459116|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
156648224|NCT01806597|565459117|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
156648225|NCT01806597|565459112|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
156648226|NCT01806597|565459113|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
156648227|NCT01806597|565459114|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
156648228|NCT01806597|565459115|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
156648229|NCT01806597|565459116|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
156648230|NCT01806597|565459117|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
156648231|NCT01144663|565459120|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
156648232|NCT01144663|565459121|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
156648233|NCT01144663|565459122|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
156648234|NCT01144663|565459123|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
156648235|NCT01144663|565459120|FG000|Primary Vaccination Phase|Adverse Event|1|||
156648236|NCT01144663|565459121|FG001|Primary Vaccination Phase|Adverse Event|0|||
156648237|NCT01144663|565459122|FG002|Primary Vaccination Phase|Adverse Event|0|||
156648238|NCT01144663|565459123|FG003|Primary Vaccination Phase|Adverse Event|1|||
156648239|NCT01144663|565459120|FG000|Primary Vaccination Phase|Protocol Violation|2|||
156648240|NCT01144663|565459121|FG001|Primary Vaccination Phase|Protocol Violation|0|||
156648241|NCT01144663|565459122|FG002|Primary Vaccination Phase|Protocol Violation|1|||
156648242|NCT01144663|565459123|FG003|Primary Vaccination Phase|Protocol Violation|0|||
156648243|NCT01144663|565459120|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
156648244|NCT01144663|565459121|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
156648245|NCT01144663|565459122|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
156648246|NCT01144663|565459123|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
156648247|NCT01144663|565459120|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
156310094|NCT03467152|564234999|FG001|Overall Study|Withdrawal by Subject|2|||
156310095|NCT03467152|564235000|FG002|Overall Study|Withdrawal by Subject|0|||
156310096|NCT03467152|564234998|FG000|Overall Study|Others|3|||
156412419|NCT00735644|564602916|FG001|Overall Study|Did not receive study vaccine|1|||
156412420|NCT00735644|564602917|FG002|Overall Study|Did not receive study vaccine|0|||
156648248|NCT01144663|565459121|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
156648249|NCT01144663|565459122|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
156648250|NCT01144663|565459123|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
156648251|NCT01144663|565459120|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
156648252|NCT01144663|565459121|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
156648253|NCT01144663|565459122|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
156648254|NCT01144663|565459123|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
156648255|NCT01144663|565459120|FG000|Primary Vaccination Phase|Other|0|||
156648256|NCT01144663|565459121|FG001|Primary Vaccination Phase|Other|1|||
156648257|NCT01144663|565459122|FG002|Primary Vaccination Phase|Other|0|||
156648258|NCT01144663|565459123|FG003|Primary Vaccination Phase|Other|2|||
156648259|NCT01144663|565459120|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
156648260|NCT01144663|565459121|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
156648261|NCT01144663|565459122|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
156648262|NCT01144663|565459123|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
156648263|NCT01144663|565459120|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
156648264|NCT01144663|565459121|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
156648265|NCT01144663|565459122|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
156648266|NCT01144663|565459123|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
156648267|NCT01144663|565459120|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
156648268|NCT01144663|565459121|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
156648269|NCT01144663|565459122|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
156648270|NCT01144663|565459123|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
156648271|NCT01144663|565459120|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
156648272|NCT01144663|565459121|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
156310097|NCT03467152|564234999|FG001|Overall Study|Others|0|||
156310098|NCT03467152|564235000|FG002|Overall Study|Others|0|||
156310099|NCT03467152|564234998|FG000|Overall Study|Not treated|3|||
156310100|NCT03467152|564234999|FG001|Overall Study|Not treated|1|||
156310101|NCT03467152|564235000|FG002|Overall Study|Not treated|6|||
156310102|NCT00945906|564235002|FG000|Overall Study|Withdrawal by Subject|1|||
156310103|NCT00945906|564235002|FG000|Overall Study|Did not want to return for last visit|2|||
156310104|NCT00945906|564235002|FG000|Overall Study|Unable to return for last visit|2|||
156310105|NCT00945906|564235002|FG000|Overall Study|Moved to another country|2|||
156310106|NCT03700684|564235003|FG000|Overall Study|COVID-19|0|||
156310107|NCT03700684|564235004|FG001|Overall Study|COVID-19|0|||
156310108|NCT03700684|564235005|FG002|Overall Study|COVID-19|2|||
156310109|NCT01120782|564235006|FG000|Overall Study|Test article shipping error|11|||
156310110|NCT04140227|564235007|FG000|Overall Study|Withdrawal by Subject|26|||
156310111|NCT04140227|564235007|FG000|Overall Study|Lost to Follow-up|8|||
156310112|NCT04140227|564235007|FG000|Overall Study|Adverse Event|8|||
156310113|NCT04140227|564235007|FG000|Overall Study|Death|1|||
156310114|NCT04140227|564235007|FG000|Overall Study|Other|3|||
156310115|NCT04140227|564235007|FG000|Overall Study|Protocol Violation|2|||
156310116|NCT00361634|564235012|FG000|Overall Study|Lost to Follow-up|1|||
156310117|NCT00361634|564235012|FG000|Overall Study|Withdrawal by Subject|1|||
156310118|NCT00635219|564235013|FG000|Overall Study|Adverse Event|12|||
156310119|NCT00635219|564235014|FG001|Overall Study|Adverse Event|10|||
156310120|NCT00635219|564235015|FG002|Overall Study|Adverse Event|18|||
156310121|NCT00635219|564235016|FG003|Overall Study|Adverse Event|15|||
156310122|NCT00635219|564235017|FG004|Overall Study|Adverse Event|19|||
156310123|NCT00635219|564235013|FG000|Overall Study|Lack of Efficacy|5|||
156310124|NCT00635219|564235014|FG001|Overall Study|Lack of Efficacy|6|||
156310125|NCT00635219|564235015|FG002|Overall Study|Lack of Efficacy|3|||
156310126|NCT00635219|564235016|FG003|Overall Study|Lack of Efficacy|4|||
156310127|NCT00635219|564235017|FG004|Overall Study|Lack of Efficacy|6|||
156310128|NCT00635219|564235013|FG000|Overall Study|Non-compliance With Study Product|0|||
156310129|NCT00635219|564235014|FG001|Overall Study|Non-compliance With Study Product|0|||
156310130|NCT00635219|564235015|FG002|Overall Study|Non-compliance With Study Product|0|||
156310131|NCT00635219|564235016|FG003|Overall Study|Non-compliance With Study Product|2|||
156310132|NCT00635219|564235017|FG004|Overall Study|Non-compliance With Study Product|1|||
156310133|NCT00635219|564235013|FG000|Overall Study|Protocol Violation|0|||
156310134|NCT00635219|564235014|FG001|Overall Study|Protocol Violation|2|||
156310135|NCT00635219|564235015|FG002|Overall Study|Protocol Violation|3|||
156310136|NCT00635219|564235016|FG003|Overall Study|Protocol Violation|2|||
156310137|NCT00635219|564235017|FG004|Overall Study|Protocol Violation|4|||
156310138|NCT00635219|564235013|FG000|Overall Study|Withdrawal of Consent|8|||
156412421|NCT00735644|564602918|FG003|Overall Study|Did not receive study vaccine|0|||
156648273|NCT01144663|565459122|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
156310139|NCT00635219|564235014|FG001|Overall Study|Withdrawal of Consent|6|||
156310140|NCT00635219|564235015|FG002|Overall Study|Withdrawal of Consent|8|||
156310141|NCT00635219|564235016|FG003|Overall Study|Withdrawal of Consent|11|||
156310142|NCT00635219|564235017|FG004|Overall Study|Withdrawal of Consent|8|||
156310143|NCT00635219|564235013|FG000|Overall Study|Lost to Follow-up|0|||
156310144|NCT00635219|564235014|FG001|Overall Study|Lost to Follow-up|0|||
156310145|NCT00635219|564235015|FG002|Overall Study|Lost to Follow-up|2|||
156648274|NCT01144663|565459123|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
156648275|NCT01144663|565459120|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
156648276|NCT01144663|565459121|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
156648277|NCT01144663|565459122|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
156648278|NCT01144663|565459123|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
156648279|NCT01144663|565459120|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
156648280|NCT01144663|565459121|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
156648281|NCT01144663|565459122|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
156648282|NCT01144663|565459123|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
156648283|NCT01267266|565459126|FG000|Enrollment Phase|Withdrawal by Subject|2|||
156648284|NCT01267266|565459127|FG001|Enrollment Phase|Withdrawal by Subject|0|||
156648285|NCT01267266|565459126|FG000|Lead-in Phase|Lack of Efficacy|20|||
156648286|NCT01267266|565459127|FG001|Lead-in Phase|Lack of Efficacy|0|||
156648287|NCT01267266|565459126|FG000|Lead-in Phase|Adverse Event|2|||
156648288|NCT01267266|565459127|FG001|Lead-in Phase|Adverse Event|0|||
156648289|NCT01267266|565459126|FG000|Lead-in Phase|Withdrawal by Subject|1|||
156648290|NCT01267266|565459127|FG001|Lead-in Phase|Withdrawal by Subject|0|||
156648291|NCT01335477|565459129|FG000|Overall Study|Adverse Event|30|||
156648292|NCT01335477|565459130|FG001|Overall Study|Adverse Event|42|||
156648293|NCT01335477|565459129|FG000|Overall Study|Non compliant with protocol|0|||
156648294|NCT01335477|565459130|FG001|Overall Study|Non compliant with protocol|2|||
156648295|NCT01335477|565459129|FG000|Overall Study|Lost to Follow-up|1|||
156648296|NCT01335477|565459130|FG001|Overall Study|Lost to Follow-up|2|||
156648297|NCT01335477|565459129|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
156648298|NCT01335477|565459130|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
156648299|NCT01335477|565459129|FG000|Overall Study|Not treated|1|||
156648300|NCT01335477|565459130|FG001|Overall Study|Not treated|2|||
156648301|NCT01335477|565459129|FG000|Overall Study|Reason other than those stated above|2|||
156648302|NCT01335477|565459130|FG001|Overall Study|Reason other than those stated above|2|||
156648303|NCT02038634|565459132|FG000|Overall Study|Lost to Follow-up|0|||
156648304|NCT02038634|565459133|FG001|Overall Study|Lost to Follow-up|1|||
156648305|NCT00549198|565459135|FG000|Overall Study|Adverse Event|28|||
156648306|NCT00549198|565459136|FG001|Overall Study|Adverse Event|26|||
156648307|NCT00549198|565459135|FG000|Overall Study|Insufficient Viral Load Response|4|||
156648308|NCT00549198|565459136|FG001|Overall Study|Insufficient Viral Load Response|2|||
156648309|NCT00549198|565459135|FG000|Overall Study|Protocol-defined Virological Failure|7|||
156648310|NCT00549198|565459136|FG001|Overall Study|Protocol-defined Virological Failure|0|||
156648311|NCT00549198|565459135|FG000|Overall Study|Non-compliance|2|||
156648312|NCT00549198|565459136|FG001|Overall Study|Non-compliance|4|||
156648313|NCT00549198|565459135|FG000|Overall Study|Lost to Follow-up|7|||
156310146|NCT00635219|564235016|FG003|Overall Study|Lost to Follow-up|0|||
156310147|NCT00635219|564235017|FG004|Overall Study|Lost to Follow-up|3|||
156310148|NCT00635219|564235013|FG000|Overall Study|Administrative or Other Reasons|0|||
156310149|NCT00635219|564235014|FG001|Overall Study|Administrative or Other Reasons|1|||
156310150|NCT00635219|564235015|FG002|Overall Study|Administrative or Other Reasons|1|||
156310151|NCT00635219|564235016|FG003|Overall Study|Administrative or Other Reasons|0|||
156310152|NCT00635219|564235017|FG004|Overall Study|Administrative or Other Reasons|1|||
156310153|NCT01290796|564235020|FG000|Overall Study|Lost to Follow-up|21|||
156310154|NCT01290796|564235020|FG000|Overall Study|Withdrawal by Subject|4|||
156310155|NCT01290796|564235020|FG000|Overall Study|Physician Decision|2|||
156310156|NCT01290796|564235020|FG000|Overall Study|Secondary Surgical Intervention|2|||
156310157|NCT01290796|564235020|FG000|Overall Study|Withdrawal by Sponsor|1|||
156310158|NCT02709538|564235022|FG000|Overall Study|Adverse Event|13|||
156310159|NCT02709538|564235023|FG001|Overall Study|Adverse Event|2|||
156310160|NCT02709538|564235024|FG002|Overall Study|Adverse Event|3|||
156310161|NCT02709538|564235022|FG000|Overall Study|Lack of Efficacy|1|||
156310162|NCT02709538|564235023|FG001|Overall Study|Lack of Efficacy|0|||
156310163|NCT02709538|564235024|FG002|Overall Study|Lack of Efficacy|0|||
156310164|NCT02709538|564235022|FG000|Overall Study|Lost to Follow-up|24|||
156310165|NCT02709538|564235023|FG001|Overall Study|Lost to Follow-up|8|||
156648314|NCT00549198|565459136|FG001|Overall Study|Lost to Follow-up|8|||
156648315|NCT00549198|565459135|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
156310166|NCT02709538|564235024|FG002|Overall Study|Lost to Follow-up|4|||
156310167|NCT02709538|564235022|FG000|Overall Study|Physician Decision|1|||
156412422|NCT00735644|564602919|FG004|Overall Study|Did not receive study vaccine|0|||
156648316|NCT00549198|565459136|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156648317|NCT00549198|565459135|FG000|Overall Study|Protocol Violation|7|||
156310168|NCT02709538|564235023|FG001|Overall Study|Physician Decision|0|||
156310169|NCT02709538|564235024|FG002|Overall Study|Physician Decision|0|||
156310170|NCT02709538|564235022|FG000|Overall Study|Withdrawal by Subject|40|||
156648318|NCT00549198|565459136|FG001|Overall Study|Protocol Violation|2|||
156648319|NCT00549198|565459135|FG000|Overall Study|Investigator Decision|4|||
156648320|NCT00549198|565459136|FG001|Overall Study|Investigator Decision|3|||
156648321|NCT00549198|565459135|FG000|Overall Study|Withdrawal by Subject|7|||
156648322|NCT00549198|565459136|FG001|Overall Study|Withdrawal by Subject|7|||
156648323|NCT00549198|565459135|FG000|Overall Study|Disease Progression|1|||
156648324|NCT00549198|565459136|FG001|Overall Study|Disease Progression|0|||
156648325|NCT00549198|565459135|FG000|Overall Study|Participant Moved|2|||
156648326|NCT00549198|565459136|FG001|Overall Study|Participant Moved|0|||
156310171|NCT02709538|564235023|FG001|Overall Study|Withdrawal by Subject|7|||
156310172|NCT02709538|564235024|FG002|Overall Study|Withdrawal by Subject|4|||
156310173|NCT02709538|564235022|FG000|Overall Study|Non-compliance with study procedures|5|||
156310174|NCT02709538|564235023|FG001|Overall Study|Non-compliance with study procedures|0|||
156310175|NCT02709538|564235024|FG002|Overall Study|Non-compliance with study procedures|0|||
156310176|NCT02709538|564235022|FG000|Overall Study|Non-compliance with study drug|2|||
156310177|NCT02709538|564235023|FG001|Overall Study|Non-compliance with study drug|0|||
156310178|NCT02709538|564235024|FG002|Overall Study|Non-compliance with study drug|0|||
156310179|NCT02709538|564235022|FG000|Overall Study|Protocol deviation|10|||
156310180|NCT02709538|564235023|FG001|Overall Study|Protocol deviation|4|||
156310181|NCT02709538|564235024|FG002|Overall Study|Protocol deviation|4|||
156310182|NCT02709538|564235022|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
156310183|NCT02709538|564235023|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
156310184|NCT02709538|564235024|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
156310185|NCT02709538|564235022|FG000|Overall Study|Other|16|||
156310186|NCT02709538|564235023|FG001|Overall Study|Other|7|||
156310187|NCT02709538|564235024|FG002|Overall Study|Other|5|||
156310188|NCT00835211|564235026|FG000|First Intervention|Withdrawal by Subject|0|||
156310189|NCT00835211|564235027|FG001|First Intervention|Withdrawal by Subject|1|||
156310190|NCT00835211|564235026|FG000|Washout: 7 Days|Adverse Event|2|||
156310191|NCT00835211|564235027|FG001|Washout: 7 Days|Adverse Event|1|||
156310192|NCT00835211|564235026|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
156310193|NCT00835211|564235027|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
156310194|NCT03087617|564235028|FG000|Overall Study|Lost to Follow-up|32|||
156310195|NCT03087617|564235029|FG001|Overall Study|Lost to Follow-up|30|||
156310196|NCT03087617|564235030|FG002|Overall Study|Lost to Follow-up|30|||
156310197|NCT03087617|564235031|FG003|Overall Study|Lost to Follow-up|39|||
156310198|NCT02343549|564235032|FG000|Overall Study|Death|11|||
156310199|NCT02343549|564235032|FG000|Overall Study|Withdrawal by Subject|2|||
156310200|NCT04450381|564235034|FG000|Overall Study|Protocol Violation|4|||
156310201|NCT04450381|564235034|FG000|Overall Study|Wrong device setting|2|||
156310202|NCT01864005|564235035|FG000|Overall Study|Protocol Violation|0|||
156310203|NCT01864005|564235036|FG001|Overall Study|Protocol Violation|1|||
156310204|NCT01864005|564235035|FG000|Overall Study|Withdrawal by Subject|0|||
156310205|NCT01864005|564235036|FG001|Overall Study|Withdrawal by Subject|1|||
156310206|NCT01864005|564235035|FG000|Overall Study|Incorrect enrolment|1|||
156310207|NCT01864005|564235036|FG001|Overall Study|Incorrect enrolment|0|||
156310208|NCT01864005|564235035|FG000|Overall Study|Disease need|1|||
156310209|NCT01864005|564235036|FG001|Overall Study|Disease need|1|||
156310210|NCT01864005|564235035|FG000|Overall Study|Need GP IIb/IIIa|1|||
156310211|NCT01864005|564235036|FG001|Overall Study|Need GP IIb/IIIa|3|||
156310212|NCT00763698|564235042|FG000|Overall Study|Unsuccessful Implant|5|||
156310213|NCT00763698|564235042|FG000|Overall Study|Death|4|||
156310214|NCT00763698|564235042|FG000|Overall Study|Withdrawal by Subject|1|||
156310215|NCT02184572|564235045|FG000|Overall Study|Lost to Follow-up|29|||
156310216|NCT02184572|564235046|FG001|Overall Study|Lost to Follow-up|21|||
156310217|NCT02184572|564235045|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
156310218|NCT02184572|564235046|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
156310219|NCT02184572|564235045|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
156310220|NCT02184572|564235046|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
156310221|NCT02184572|564235045|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
156310222|NCT02184572|564235046|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
156310223|NCT02184572|564235045|FG000|Overall Study|Traveling Outside The Country|1|||
156310224|NCT02184572|564235046|FG001|Overall Study|Traveling Outside The Country|0|||
156310225|NCT02184572|564235045|FG000|Overall Study|Withdrawal by Subject|14|||
156310226|NCT02184572|564235046|FG001|Overall Study|Withdrawal by Subject|9|||
156310227|NCT00006409|564235050|FG000|Baseline|Protocol Violation|48|||
156310228|NCT00006409|564235051|FG001|Baseline|Protocol Violation|70|||
156310229|NCT00006409|564235052|FG002|Baseline|Protocol Violation|0|||
156648327|NCT00549198|565459135|FG000|Overall Study|Participant not able to perform Week 96|1|||
156310230|NCT00006409|564235053|FG003|Baseline|Protocol Violation|0|||
156310231|NCT00006409|564235054|FG004|Baseline|Protocol Violation|0|||
156310232|NCT00006409|564235055|FG005|Baseline|Protocol Violation|0|||
156310233|NCT00006409|564235050|FG000|Post-2 Year Intervention|Protocol Violation|0|||
156310234|NCT00006409|564235051|FG001|Post-2 Year Intervention|Protocol Violation|0|||
156310235|NCT00006409|564235052|FG002|Post-2 Year Intervention|Protocol Violation|251|||
156310236|NCT00006409|564235053|FG003|Post-2 Year Intervention|Protocol Violation|168|||
156310237|NCT00006409|564235054|FG004|Post-2 Year Intervention|Protocol Violation|0|||
156310238|NCT00006409|564235055|FG005|Post-2 Year Intervention|Protocol Violation|0|||
156648328|NCT00549198|565459136|FG001|Overall Study|Participant not able to perform Week 96|0|||
156310239|NCT00006409|564235050|FG000|Post-3 Year Intervention|Protocol Violation|0|||
156648329|NCT00549198|565459135|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
156648330|NCT00549198|565459136|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
156648331|NCT00549198|565459135|FG000|Overall Study|Prohibited Medication|1|||
156648332|NCT00549198|565459136|FG001|Overall Study|Prohibited Medication|2|||
156648333|NCT00549198|565459135|FG000|Overall Study|Participant planning pregnancy|1|||
156648334|NCT00549198|565459136|FG001|Overall Study|Participant planning pregnancy|0|||
156648335|NCT00549198|565459135|FG000|Overall Study|Participant overweight, no scan possible|1|||
156648336|NCT00549198|565459136|FG001|Overall Study|Participant overweight, no scan possible|0|||
156648337|NCT00549198|565459135|FG000|Overall Study|No scan facilities|0|||
156648338|NCT00549198|565459136|FG001|Overall Study|No scan facilities|2|||
156648339|NCT00549198|565459135|FG000|Overall Study|Pregnancy|0|||
156310240|NCT00006409|564235051|FG001|Post-3 Year Intervention|Protocol Violation|0|||
156310241|NCT00006409|564235052|FG002|Post-3 Year Intervention|Protocol Violation|0|||
156310242|NCT00006409|564235053|FG003|Post-3 Year Intervention|Protocol Violation|0|||
156310243|NCT00006409|564235054|FG004|Post-3 Year Intervention|Protocol Violation|62|||
156310244|NCT00006409|564235055|FG005|Post-3 Year Intervention|Protocol Violation|62|||
156310245|NCT03679754|564235057|FG000|Overall Study|Investigator request|1|||
156648340|NCT00549198|565459136|FG001|Overall Study|Pregnancy|3|||
156648341|NCT00549198|565459135|FG000|Overall Study|Not Exposed to Study Drug|3|||
156648342|NCT00549198|565459136|FG001|Overall Study|Not Exposed to Study Drug|4|||
156648343|NCT01473758|565459138|FG000|Cycle 1|Adverse Event|10|||
156648344|NCT01473758|565459139|FG001|Cycle 1|Adverse Event|2|||
156648345|NCT01473758|565459140|FG002|Cycle 1|Adverse Event|0|||
156648346|NCT01473758|565459141|FG003|Cycle 1|Adverse Event|0|||
156648347|NCT01473758|565459138|FG000|Cycle 1|Withdrawal by Subject|1|||
156648348|NCT01473758|565459139|FG001|Cycle 1|Withdrawal by Subject|1|||
156648349|NCT01473758|565459140|FG002|Cycle 1|Withdrawal by Subject|0|||
156648350|NCT01473758|565459141|FG003|Cycle 1|Withdrawal by Subject|0|||
156648351|NCT01473758|565459138|FG000|Cycle 2|Adverse Event|0|||
156648352|NCT01473758|565459139|FG001|Cycle 2|Adverse Event|0|||
156648353|NCT01473758|565459140|FG002|Cycle 2|Adverse Event|5|||
156648354|NCT01473758|565459141|FG003|Cycle 2|Adverse Event|0|||
156648355|NCT02763579|565459151|FG000|Global Period|Death|167|||
156648356|NCT02763579|565459152|FG001|Global Period|Death|151|||
156648357|NCT02763579|565459153|FG002|Global Period|Death|0|||
156648358|NCT02763579|565459154|FG003|Global Period|Death|0|||
156648359|NCT02763579|565459151|FG000|Global Period|Lost to Follow-up|2|||
156648360|NCT02763579|565459152|FG001|Global Period|Lost to Follow-up|4|||
156648361|NCT02763579|565459153|FG002|Global Period|Lost to Follow-up|0|||
156648362|NCT02763579|565459154|FG003|Global Period|Lost to Follow-up|0|||
156648363|NCT02763579|565459151|FG000|Global Period|Physician Decision|0|||
156648364|NCT02763579|565459152|FG001|Global Period|Physician Decision|2|||
156648365|NCT02763579|565459153|FG002|Global Period|Physician Decision|0|||
156648366|NCT02763579|565459154|FG003|Global Period|Physician Decision|0|||
156648367|NCT02763579|565459151|FG000|Global Period|Study Terminated By Sponsor|21|||
156648368|NCT02763579|565459152|FG001|Global Period|Study Terminated By Sponsor|26|||
156648369|NCT02763579|565459153|FG002|Global Period|Study Terminated By Sponsor|0|||
156648370|NCT02763579|565459154|FG003|Global Period|Study Terminated By Sponsor|0|||
156648371|NCT02763579|565459151|FG000|Global Period|Withdrawal by Subject|12|||
156648372|NCT02763579|565459152|FG001|Global Period|Withdrawal by Subject|18|||
156648373|NCT02763579|565459153|FG002|Global Period|Withdrawal by Subject|0|||
156648374|NCT02763579|565459154|FG003|Global Period|Withdrawal by Subject|0|||
156648375|NCT02763579|565459151|FG000|China Period|Death|0|||
156648376|NCT02763579|565459152|FG001|China Period|Death|0|||
156648377|NCT02763579|565459153|FG002|China Period|Death|46|||
156310246|NCT00964171|564235058|FG000|Overall Study|Death|5|||
156310247|NCT00080899|564235059|FG000|Overall Study|Adverse Event|1|||
156310248|NCT05343624|564235061|FG000|Overall Study|Chart review not completed|1|||
156310249|NCT02640508|564235062|FG000|Overall Study|Death|19|||
156310250|NCT02640508|564235062|FG000|Overall Study|Withdrawal by Subject|8|||
156310251|NCT02640508|564235062|FG000|Overall Study|Physician Decision|1|||
156310252|NCT02640508|564235062|FG000|Overall Study|Lost to Follow-up|1|||
156310253|NCT05405257|564235063|FG000|Overall Study|Withdrawal by Subject|1|||
156310254|NCT00776919|564235064|FG000|Overall Study|Withdrawal by Subject|16|||
156648378|NCT02763579|565459154|FG003|China Period|Death|48|||
156648379|NCT02763579|565459151|FG000|China Period|Lost to Follow-up|0|||
156310255|NCT00776919|564235065|FG001|Overall Study|Withdrawal by Subject|14|||
156412423|NCT00735644|564602915|FG000|Overall Study|Withdrawal by Subject|0|||
156648380|NCT02763579|565459152|FG001|China Period|Lost to Follow-up|0|||
156648381|NCT02763579|565459153|FG002|China Period|Lost to Follow-up|1|||
156648382|NCT02763579|565459154|FG003|China Period|Lost to Follow-up|1|||
156648383|NCT02763579|565459151|FG000|China Period|Physician Decision|0|||
156648384|NCT02763579|565459152|FG001|China Period|Physician Decision|0|||
156648385|NCT02763579|565459153|FG002|China Period|Physician Decision|0|||
156648386|NCT02763579|565459154|FG003|China Period|Physician Decision|1|||
156648387|NCT02763579|565459151|FG000|China Period|Study Terminated By Sponsor|0|||
156648388|NCT02763579|565459152|FG001|China Period|Study Terminated By Sponsor|0|||
156648389|NCT02763579|565459153|FG002|China Period|Study Terminated By Sponsor|3|||
156648390|NCT02763579|565459154|FG003|China Period|Study Terminated By Sponsor|4|||
156310256|NCT00776919|564235066|FG002|Overall Study|Withdrawal by Subject|15|||
156310257|NCT00776919|564235067|FG003|Overall Study|Withdrawal by Subject|26|||
156310258|NCT00776919|564235064|FG000|Overall Study|Lost to Follow-up|8|||
156310259|NCT00776919|564235065|FG001|Overall Study|Lost to Follow-up|12|||
156310260|NCT00776919|564235066|FG002|Overall Study|Lost to Follow-up|11|||
156310261|NCT00776919|564235067|FG003|Overall Study|Lost to Follow-up|8|||
156310262|NCT00776919|564235064|FG000|Overall Study|Adverse Event|1|||
156310263|NCT00776919|564235065|FG001|Overall Study|Adverse Event|0|||
156310264|NCT00776919|564235066|FG002|Overall Study|Adverse Event|2|||
156310265|NCT00776919|564235067|FG003|Overall Study|Adverse Event|2|||
156310266|NCT00776919|564235064|FG000|Overall Study|Protocol Violation|1|||
156310267|NCT00776919|564235065|FG001|Overall Study|Protocol Violation|2|||
156310268|NCT00776919|564235066|FG002|Overall Study|Protocol Violation|0|||
156310269|NCT00776919|564235067|FG003|Overall Study|Protocol Violation|1|||
156310270|NCT00776919|564235064|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
156310271|NCT00776919|564235065|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
156310272|NCT00776919|564235066|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
156310273|NCT00776919|564235067|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
156310274|NCT03753789|564235068|FG000|Overall Study|Withdrawal by Subject|2|||
156648391|NCT02763579|565459151|FG000|China Period|Withdrawal by Subject|0|||
156648392|NCT02763579|565459152|FG001|China Period|Withdrawal by Subject|0|||
156648393|NCT02763579|565459153|FG002|China Period|Withdrawal by Subject|3|||
156648394|NCT02763579|565459154|FG003|China Period|Withdrawal by Subject|3|||
156648395|NCT01034137|565459158|FG000|Overall Study|Adverse Event|9|||
156648396|NCT01034137|565459159|FG001|Overall Study|Adverse Event|10|||
156648397|NCT01034137|565459160|FG002|Overall Study|Adverse Event|8|||
156310275|NCT01578850|564235070|FG000|Period 1|Insufficient Clinical Response|1|||
156310276|NCT01578850|564235071|FG001|Period 1|Insufficient Clinical Response|0|||
156648398|NCT01034137|565459158|FG000|Overall Study|Withdrawal by Subject|4|||
156310277|NCT01578850|564235072|FG002|Period 1|Insufficient Clinical Response|0|||
156310278|NCT01578850|564235070|FG000|Period 1|Adverse Event|11|||
156310279|NCT01578850|564235071|FG001|Period 1|Adverse Event|0|||
156310280|NCT01578850|564235072|FG002|Period 1|Adverse Event|0|||
156648399|NCT01034137|565459159|FG001|Overall Study|Withdrawal by Subject|3|||
156648400|NCT01034137|565459160|FG002|Overall Study|Withdrawal by Subject|3|||
156310281|NCT01578850|564235070|FG000|Period 1|Death|1|||
156310282|NCT01578850|564235071|FG001|Period 1|Death|0|||
156310283|NCT01578850|564235072|FG002|Period 1|Death|0|||
156310284|NCT01578850|564235070|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
156310285|NCT01578850|564235071|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
156310286|NCT01578850|564235072|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
156310287|NCT01578850|564235070|FG000|Period 1|Withdrawal by Subject|9|||
156310288|NCT01578850|564235071|FG001|Period 1|Withdrawal by Subject|0|||
156648401|NCT01034137|565459158|FG000|Overall Study|Lack of Efficacy|9|||
156648402|NCT01034137|565459159|FG001|Overall Study|Lack of Efficacy|4|||
156648403|NCT01034137|565459160|FG002|Overall Study|Lack of Efficacy|13|||
156648404|NCT01034137|565459158|FG000|Overall Study|Protocol Violation|2|||
156648405|NCT01034137|565459159|FG001|Overall Study|Protocol Violation|2|||
156648406|NCT01034137|565459160|FG002|Overall Study|Protocol Violation|1|||
156648407|NCT01034137|565459158|FG000|Overall Study|Refused treatment or did not cooperate|2|||
156648408|NCT01034137|565459159|FG001|Overall Study|Refused treatment or did not cooperate|0|||
156648409|NCT01034137|565459160|FG002|Overall Study|Refused treatment or did not cooperate|1|||
156648410|NCT01034137|565459158|FG000|Overall Study|Administrative or other|2|||
156648411|NCT01034137|565459159|FG001|Overall Study|Administrative or other|3|||
156648412|NCT01034137|565459160|FG002|Overall Study|Administrative or other|4|||
156648413|NCT03572933|565459161|FG000|Overall Study|Adverse Event|4|||
156648414|NCT03572933|565459162|FG001|Overall Study|Adverse Event|1|||
156648415|NCT03572933|565459161|FG000|Overall Study|Withdrawal by Subject|0|||
156310289|NCT01578850|564235072|FG002|Period 1|Withdrawal by Subject|0|||
156310290|NCT01578850|564235070|FG000|Period 1|Study Terminated by Sponsor|3|||
156310291|NCT01578850|564235071|FG001|Period 1|Study Terminated by Sponsor|0|||
156310292|NCT01578850|564235072|FG002|Period 1|Study Terminated by Sponsor|0|||
156310293|NCT01578850|564235070|FG000|Period 2|Insufficient Clinical Response|0|||
156310294|NCT01578850|564235071|FG001|Period 2|Insufficient Clinical Response|1|||
156310295|NCT01578850|564235072|FG002|Period 2|Insufficient Clinical Response|0|||
156412424|NCT00735644|564602916|FG001|Overall Study|Withdrawal by Subject|1|||
156310296|NCT01578850|564235070|FG000|Period 2|Adverse Event|0|||
156310297|NCT01578850|564235071|FG001|Period 2|Adverse Event|3|||
156310298|NCT01578850|564235072|FG002|Period 2|Adverse Event|6|||
156310299|NCT01578850|564235070|FG000|Period 2|Lost to Follow-up|0|||
156310300|NCT01578850|564235071|FG001|Period 2|Lost to Follow-up|1|||
156310301|NCT01578850|564235072|FG002|Period 2|Lost to Follow-up|2|||
156310302|NCT01578850|564235070|FG000|Period 2|Withdrawal by Subject|0|||
156648416|NCT03572933|565459162|FG001|Overall Study|Withdrawal by Subject|1|||
156648417|NCT01764854|565459166|FG000|Overall Study|Adverse Event|0|||
156648418|NCT01764854|565459167|FG001|Overall Study|Adverse Event|0|||
156648419|NCT01764854|565459168|FG002|Overall Study|Adverse Event|2|||
156648420|NCT01764854|565459169|FG003|Overall Study|Adverse Event|0|||
156648421|NCT01764854|565459166|FG000|Overall Study|Withdrawal by Subject|0|||
156648422|NCT01764854|565459167|FG001|Overall Study|Withdrawal by Subject|0|||
156648423|NCT01764854|565459168|FG002|Overall Study|Withdrawal by Subject|1|||
156648424|NCT01764854|565459169|FG003|Overall Study|Withdrawal by Subject|0|||
156648425|NCT01764854|565459166|FG000|Overall Study|relocation|0|||
156648426|NCT01764854|565459167|FG001|Overall Study|relocation|0|||
156648427|NCT01764854|565459168|FG002|Overall Study|relocation|2|||
156648428|NCT01764854|565459169|FG003|Overall Study|relocation|0|||
156648429|NCT01764854|565459166|FG000|Overall Study|Protocol Violation|0|||
156648430|NCT01764854|565459167|FG001|Overall Study|Protocol Violation|0|||
156648431|NCT01764854|565459168|FG002|Overall Study|Protocol Violation|1|||
156648432|NCT01764854|565459169|FG003|Overall Study|Protocol Violation|2|||
156648433|NCT00901628|565459200|FG000|Overall Study|disconnection of catheter|4|||
156648434|NCT00901628|565459201|FG001|Overall Study|disconnection of catheter|8|||
156648435|NCT00901628|565459200|FG000|Overall Study|disconnection of drain|0|||
156648436|NCT00901628|565459201|FG001|Overall Study|disconnection of drain|1|||
156648437|NCT00901628|565459200|FG000|Overall Study|peroneal nerve palsy|0|||
156648438|NCT00901628|565459201|FG001|Overall Study|peroneal nerve palsy|1|||
156648439|NCT01003886|565459204|FG000|Overall Study|Lack of Efficacy|5|||
156648440|NCT01003886|565459204|FG000|Overall Study|Lost to Follow-up|169|||
156648441|NCT01003886|565459204|FG000|Overall Study|Withdrawal by Subject|39|||
156648442|NCT01003886|565459204|FG000|Overall Study|Other|14|||
156648443|NCT01003886|565459204|FG000|Overall Study|Adverse Event|3|||
156648444|NCT00909727|565459222|FG000|Overall Study|Adverse Event|1|||
156648445|NCT00909727|565459223|FG001|Overall Study|Adverse Event|0|||
156648446|NCT00909727|565459222|FG000|Overall Study|Wrong Genotype|1|||
156648447|NCT00909727|565459223|FG001|Overall Study|Wrong Genotype|0|||
156648448|NCT00909727|565459222|FG000|Overall Study|Withdrawal of Consent|1|||
156648449|NCT00909727|565459223|FG001|Overall Study|Withdrawal of Consent|0|||
156648450|NCT00909727|565459222|FG000|Overall Study|Prohibited Medication|1|||
156648451|NCT00909727|565459223|FG001|Overall Study|Prohibited Medication|0|||
156648452|NCT05751629|565459224|FG000|Overall Study|Withdrawal by Subject|6|||
156648453|NCT05751629|565459224|FG000|Overall Study|Death|25|||
156648454|NCT05751629|565459224|FG000|Overall Study|Study Site Closed|9|||
156648455|NCT05751629|565459224|FG000|Overall Study|Physician Decision|1|||
156648456|NCT01909466|565459226|FG000|Overall Study|Lost to Follow-up|5|||
156648457|NCT01909466|565459227|FG001|Overall Study|Lost to Follow-up|7|||
156648458|NCT01909466|565459226|FG000|Overall Study|Adverse Event|3|||
156648459|NCT01909466|565459227|FG001|Overall Study|Adverse Event|4|||
156648460|NCT01909466|565459226|FG000|Overall Study|Met Withdrawal Criteria|0|||
156648461|NCT01909466|565459227|FG001|Overall Study|Met Withdrawal Criteria|3|||
156412425|NCT00735644|564602917|FG002|Overall Study|Withdrawal by Subject|1|||
156412426|NCT00735644|564602918|FG003|Overall Study|Withdrawal by Subject|1|||
156412427|NCT00735644|564602919|FG004|Overall Study|Withdrawal by Subject|0|||
156412428|NCT06385483|564602920|FG000|Overall Study|Withdrawal by Subject|2|||
156412429|NCT06385483|564602920|FG000|Overall Study|Never start protocol therapy|2|||
156412430|NCT06385483|564602920|FG000|Overall Study|Disease progression|15|||
156412431|NCT00654940|564604833|FG000|Period 1|Adverse Event|0|||
156412432|NCT00654940|564604834|FG001|Period 1|Adverse Event|1|||
156412433|NCT00654940|564604833|FG000|Period 1|Intolerable Pain Level|1|||
156412434|NCT00654940|564604834|FG001|Period 1|Intolerable Pain Level|0|||
156412435|NCT00802737|564604835|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
156648462|NCT01909466|565459226|FG000|Overall Study|Physician Decision|2|||
156648463|NCT01909466|565459227|FG001|Overall Study|Physician Decision|0|||
156310303|NCT01578850|564235071|FG001|Period 2|Withdrawal by Subject|2|||
156310304|NCT01578850|564235072|FG002|Period 2|Withdrawal by Subject|2|||
156310305|NCT01578850|564235070|FG000|Period 2|Study Terminated by Sponsor|0|||
156310306|NCT01578850|564235071|FG001|Period 2|Study Terminated by Sponsor|5|||
156310307|NCT01578850|564235072|FG002|Period 2|Study Terminated by Sponsor|4|||
156310308|NCT01578850|564235070|FG000|Period 2|Unspecified Reasons|0|||
156310309|NCT01578850|564235071|FG001|Period 2|Unspecified Reasons|1|||
156310310|NCT01578850|564235072|FG002|Period 2|Unspecified Reasons|0|||
156310311|NCT04629066|564235081|FG000|Overall Study|Lost to Follow-up|3|||
156310312|NCT04629066|564235082|FG001|Overall Study|Lost to Follow-up|2|||
156310313|NCT00282308|564235083|FG000|Treatment Period|Lost to Follow-up|1|||
156648464|NCT01909466|565459226|FG000|Overall Study|Withdrawal by Subject|11|||
156310314|NCT00282308|564235084|FG001|Treatment Period|Lost to Follow-up|0|||
156648465|NCT01909466|565459227|FG001|Overall Study|Withdrawal by Subject|9|||
156648466|NCT01909466|565459226|FG000|Overall Study|Lack of Efficacy|1|||
156648467|NCT01909466|565459227|FG001|Overall Study|Lack of Efficacy|0|||
156648468|NCT00772577|565459233|FG000|Overall Study|Adverse Event|6|||
156648469|NCT00772577|565459234|FG001|Overall Study|Adverse Event|3|||
156648470|NCT00772577|565459233|FG000|Overall Study|Abnormal laboratory values|0|||
156310315|NCT00282308|564235085|FG002|Treatment Period|Lost to Follow-up|0|||
156648471|NCT00772577|565459234|FG001|Overall Study|Abnormal laboratory values|1|||
156648472|NCT00772577|565459233|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156648473|NCT00772577|565459234|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
156648474|NCT00772577|565459233|FG000|Overall Study|Patient withdrew consent|8|||
156310316|NCT00282308|564235083|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
156310317|NCT00282308|564235084|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
156310318|NCT00282308|564235085|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
156310319|NCT00282308|564235083|FG000|Treatment Period|Adverse Event|0|||
156310320|NCT00282308|564235084|FG001|Treatment Period|Adverse Event|2|||
156310321|NCT00282308|564235085|FG002|Treatment Period|Adverse Event|0|||
156310322|NCT00282308|564235083|FG000|Treatment Period|Not Treated with Study Drug|1|||
156310323|NCT00282308|564235084|FG001|Treatment Period|Not Treated with Study Drug|0|||
156310324|NCT00282308|564235085|FG002|Treatment Period|Not Treated with Study Drug|0|||
156310325|NCT00282308|564235083|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
156310326|NCT00282308|564235084|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
156310327|NCT00282308|564235085|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
156310328|NCT00282308|564235083|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
156310329|NCT00282308|564235084|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
156310330|NCT00282308|564235085|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
156310331|NCT00282308|564235083|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
156310332|NCT00282308|564235084|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
156310333|NCT00282308|564235085|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
156310334|NCT00282308|564235083|FG000|Safety Follow-up Period|Adverse Event|0|||
156310335|NCT00282308|564235084|FG001|Safety Follow-up Period|Adverse Event|0|||
156310336|NCT00282308|564235085|FG002|Safety Follow-up Period|Adverse Event|1|||
156310337|NCT00282308|564235083|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
156310338|NCT00282308|564235084|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
156310339|NCT00282308|564235085|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
156648475|NCT00772577|565459234|FG001|Overall Study|Patient withdrew consent|5|||
156648476|NCT00772577|565459233|FG000|Overall Study|Lost to Follow-up|4|||
156648477|NCT00772577|565459234|FG001|Overall Study|Lost to Follow-up|3|||
156648478|NCT00772577|565459233|FG000|Overall Study|Administrative problems|2|||
156648479|NCT00772577|565459234|FG001|Overall Study|Administrative problems|1|||
156648480|NCT00772577|565459233|FG000|Overall Study|Protocol Deviation|3|||
156648481|NCT00772577|565459234|FG001|Overall Study|Protocol Deviation|2|||
156310340|NCT00282308|564235083|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
156310341|NCT00282308|564235084|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
156310342|NCT00282308|564235085|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
156310343|NCT00282308|564235083|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
156310344|NCT00282308|564235084|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
156310345|NCT00282308|564235085|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
156310346|NCT01584440|564235086|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
156310347|NCT01584440|564235087|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
156310348|NCT01584440|564235088|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
156310349|NCT01584440|564235089|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
156310350|NCT01584440|564235090|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
156310351|NCT01584440|564235086|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
156310352|NCT01584440|564235087|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
156310353|NCT01584440|564235088|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
156648482|NCT02965820|565459235|FG000|Period 2, Second 30 Days|Adverse Event|1|||
156648483|NCT02965820|565459236|FG001|Period 2, Second 30 Days|Adverse Event|1|||
156310354|NCT01584440|564235089|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
156310355|NCT01584440|564235090|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
156648484|NCT01567306|565459237|FG000|Overall Study|Protocol Violation|2|||
156648485|NCT01567306|565459238|FG001|Overall Study|Protocol Violation|2|||
156648486|NCT01567306|565459239|FG002|Overall Study|Protocol Violation|0|||
156648487|NCT01567306|565459240|FG003|Overall Study|Protocol Violation|3|||
156310356|NCT01584440|564235086|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
156310357|NCT01584440|564235087|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
156310358|NCT01584440|564235088|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
156310359|NCT01584440|564235089|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
156310360|NCT01584440|564235090|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
156310361|NCT01584440|564235086|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
156310362|NCT01584440|564235087|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
156310363|NCT01584440|564235088|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
156310364|NCT01584440|564235089|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
156310365|NCT01584440|564235090|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
156310366|NCT01584440|564235086|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
156310367|NCT01584440|564235087|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
156310368|NCT01584440|564235088|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
156310369|NCT01584440|564235089|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
156310370|NCT01584440|564235090|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
156310371|NCT01584440|564235086|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
156648488|NCT01567306|565459241|FG004|Overall Study|Protocol Violation|1|||
156648489|NCT01567306|565459242|FG005|Overall Study|Protocol Violation|1|||
156648490|NCT01567306|565459237|FG000|Overall Study|Change site living|1|||
156310372|NCT01584440|564235087|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
156310373|NCT01584440|564235088|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
156310374|NCT01584440|564235089|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
156310375|NCT01584440|564235090|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
156310376|NCT01584440|564235086|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
156310377|NCT01584440|564235087|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
156310378|NCT01584440|564235088|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
156412436|NCT00802737|564604836|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
156412437|NCT00802737|564604837|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
156412438|NCT00802737|564604835|FG000|Overall Study|Death|6|||
156412439|NCT00802737|564604836|FG001|Overall Study|Death|5|||
156412440|NCT00802737|564604837|FG002|Overall Study|Death|1|||
156412441|NCT00802737|564604835|FG000|Overall Study|Adverse Event|1|||
156412442|NCT00802737|564604836|FG001|Overall Study|Adverse Event|0|||
156412443|NCT00802737|564604837|FG002|Overall Study|Adverse Event|0|||
156412444|NCT00802737|564604835|FG000|Overall Study|Received Prohibited Therapy|1|||
156310379|NCT01584440|564235089|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
156310380|NCT01584440|564235090|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
156310381|NCT01584440|564235086|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
156310382|NCT01584440|564235087|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
156310383|NCT01584440|564235088|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
156310384|NCT01584440|564235089|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
156310385|NCT01584440|564235090|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
156310386|NCT01584440|564235086|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
156310387|NCT01584440|564235087|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
156310388|NCT01584440|564235088|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
156310389|NCT01584440|564235089|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
156310390|NCT01584440|564235090|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
156310391|NCT01338298|564235094|FG000|Overall Study|Withdrawal by Subject|1|||
156310392|NCT01338298|564235095|FG001|Overall Study|Withdrawal by Subject|1|||
156310393|NCT01338298|564235094|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
156310394|NCT01338298|564235095|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
156310395|NCT01338298|564235094|FG000|Overall Study|Administrative error|0|||
156310396|NCT01338298|564235095|FG001|Overall Study|Administrative error|1|||
156310397|NCT01338298|564235094|FG000|Overall Study|Positive symptom worsening|1|||
156310398|NCT01338298|564235095|FG001|Overall Study|Positive symptom worsening|0|||
156310399|NCT01338298|564235094|FG000|Overall Study|Depressive symptoms and nausea|1|||
156310400|NCT01338298|564235095|FG001|Overall Study|Depressive symptoms and nausea|0|||
156310401|NCT01338298|564235094|FG000|Overall Study|Non-adherence|1|||
156310402|NCT01338298|564235095|FG001|Overall Study|Non-adherence|0|||
156310403|NCT02872285|564235096|FG000|Overall Study|Withdrawal by Subject|2|||
156310404|NCT02872285|564235097|FG001|Overall Study|Withdrawal by Subject|0|||
156310405|NCT02872285|564235096|FG000|Overall Study|Lost to Follow-up|2|||
156310406|NCT02872285|564235097|FG001|Overall Study|Lost to Follow-up|2|||
156310407|NCT02872285|564235096|FG000|Overall Study|Discontinued due to back surgery|1|||
156310408|NCT02872285|564235097|FG001|Overall Study|Discontinued due to back surgery|0|||
156310409|NCT00531427|564235098|FG000|Overall Study|Withdrawal by Subject|7|||
156310410|NCT00531427|564235099|FG001|Overall Study|Withdrawal by Subject|13|||
156310411|NCT00531427|564235098|FG000|Overall Study|Adverse Event|44|||
156310412|NCT00531427|564235099|FG001|Overall Study|Adverse Event|30|||
156310413|NCT00531427|564235098|FG000|Overall Study|Lost to Follow-up|4|||
156412445|NCT00802737|564604836|FG001|Overall Study|Received Prohibited Therapy|0|||
156412446|NCT00802737|564604837|FG002|Overall Study|Received Prohibited Therapy|0|||
156412447|NCT00802737|564604835|FG000|Overall Study|Ongoing CLL-Treatment|0|||
156412448|NCT00802737|564604836|FG001|Overall Study|Ongoing CLL-Treatment|1|||
156412449|NCT00802737|564604837|FG002|Overall Study|Ongoing CLL-Treatment|0|||
156412450|NCT00802737|564604835|FG000|Overall Study|Participant too Unwell|0|||
156412451|NCT00802737|564604836|FG001|Overall Study|Participant too Unwell|2|||
156412452|NCT00802737|564604837|FG002|Overall Study|Participant too Unwell|0|||
156412453|NCT00619476|564604843|FG000|Overall Study|Adverse Event|12|||
156412454|NCT00619476|564604844|FG001|Overall Study|Adverse Event|6|||
156412455|NCT00619476|564604845|FG002|Overall Study|Adverse Event|12|||
156412456|NCT00619476|564604846|FG003|Overall Study|Adverse Event|16|||
156412457|NCT00619476|564604843|FG000|Overall Study|Lack of Efficacy|6|||
156412458|NCT00619476|564604844|FG001|Overall Study|Lack of Efficacy|1|||
156412459|NCT00619476|564604845|FG002|Overall Study|Lack of Efficacy|1|||
156412460|NCT00619476|564604846|FG003|Overall Study|Lack of Efficacy|4|||
156310414|NCT00531427|564235099|FG001|Overall Study|Lost to Follow-up|3|||
156310415|NCT00531427|564235098|FG000|Overall Study|Lack of Efficacy|14|||
156310416|NCT00531427|564235099|FG001|Overall Study|Lack of Efficacy|39|||
156310417|NCT00531427|564235098|FG000|Overall Study|Administrative|4|||
156310418|NCT00531427|564235099|FG001|Overall Study|Administrative|9|||
156310419|NCT05477108|564235100|FG000|Overall Study|Participants randomized, not treated|1|||
156310420|NCT05477108|564235101|FG001|Overall Study|Participants randomized, not treated|1|||
156412461|NCT00619476|564604843|FG000|Overall Study|Protocol Violation|5|||
156412462|NCT00619476|564604844|FG001|Overall Study|Protocol Violation|4|||
156412463|NCT00619476|564604845|FG002|Overall Study|Protocol Violation|4|||
156412464|NCT00619476|564604846|FG003|Overall Study|Protocol Violation|9|||
156412465|NCT00619476|564604843|FG000|Overall Study|Lost to Follow-up|1|||
156412466|NCT00619476|564604844|FG001|Overall Study|Lost to Follow-up|2|||
156412467|NCT00619476|564604845|FG002|Overall Study|Lost to Follow-up|0|||
156412468|NCT00619476|564604846|FG003|Overall Study|Lost to Follow-up|1|||
156412469|NCT00619476|564604843|FG000|Overall Study|Investigator Discretion|2|||
156412470|NCT00619476|564604844|FG001|Overall Study|Investigator Discretion|2|||
156412471|NCT00619476|564604845|FG002|Overall Study|Investigator Discretion|2|||
156412472|NCT00619476|564604846|FG003|Overall Study|Investigator Discretion|0|||
156412473|NCT00619476|564604843|FG000|Overall Study|Withdrawal by Subject|5|||
156412474|NCT00619476|564604844|FG001|Overall Study|Withdrawal by Subject|7|||
156412475|NCT00619476|564604845|FG002|Overall Study|Withdrawal by Subject|5|||
156412476|NCT00619476|564604846|FG003|Overall Study|Withdrawal by Subject|4|||
156412477|NCT02391038|564604847|FG000|Overall Study|Progressive disease|3|||
156648491|NCT01567306|565459238|FG001|Overall Study|Change site living|0|||
156648492|NCT01567306|565459239|FG002|Overall Study|Change site living|0|||
156648493|NCT01567306|565459240|FG003|Overall Study|Change site living|0|||
156310421|NCT05477108|564235102|FG002|Overall Study|Participants randomized, not treated|1|||
156310422|NCT05477108|564235100|FG000|Overall Study|Physician Decision|0|||
156310423|NCT05477108|564235101|FG001|Overall Study|Physician Decision|0|||
156310424|NCT05477108|564235102|FG002|Overall Study|Physician Decision|1|||
156310425|NCT05477108|564235100|FG000|Overall Study|withdrawn from study|0|||
156310426|NCT05477108|564235101|FG001|Overall Study|withdrawn from study|0|||
156310427|NCT05477108|564235102|FG002|Overall Study|withdrawn from study|1|||
156310428|NCT01253577|564235105|FG000|Overall Study|Lost to Follow-up|3|||
156310429|NCT00721968|564235106|FG000|Overall Study|Lost to Follow-up|2|||
156310430|NCT00721968|564235107|FG001|Overall Study|Lost to Follow-up|0|||
156310431|NCT01948193|564237382|FG000|Overall Study|Serious event|2|||
156310432|NCT01948193|564237382|FG000|Overall Study|Lost to Follow-up|7|||
156310433|NCT00843778|564237383|FG000|Overall Study|Adverse Event|15|||
156310434|NCT00843778|564237383|FG000|Overall Study|Lack of Efficacy|14|||
156310435|NCT00843778|564237383|FG000|Overall Study|Loss of efficacy|2|||
156310436|NCT00843778|564237383|FG000|Overall Study|Withdrawal by Subject|4|||
156310437|NCT00409331|564237384|FG000|Overall Study|Physician Decision|1|||
156310438|NCT00730028|564237386|FG000|Overall Study|Adverse Event|23|||
156310439|NCT00730028|564237387|FG001|Overall Study|Adverse Event|26|||
156310440|NCT00730028|564237388|FG002|Overall Study|Adverse Event|16|||
156310441|NCT00730028|564237389|FG003|Overall Study|Adverse Event|20|||
156310442|NCT00730028|564237390|FG004|Overall Study|Adverse Event|43|||
156310443|NCT00730028|564237386|FG000|Overall Study|Lost to Follow-up|13|||
156310444|NCT00730028|564237387|FG001|Overall Study|Lost to Follow-up|26|||
156310445|NCT00730028|564237388|FG002|Overall Study|Lost to Follow-up|22|||
156310446|NCT00730028|564237389|FG003|Overall Study|Lost to Follow-up|26|||
156310447|NCT00730028|564237390|FG004|Overall Study|Lost to Follow-up|25|||
156310448|NCT00730028|564237386|FG000|Overall Study|Protocol Violation|6|||
156310449|NCT00730028|564237387|FG001|Overall Study|Protocol Violation|1|||
156310450|NCT00730028|564237388|FG002|Overall Study|Protocol Violation|1|||
156310451|NCT00730028|564237389|FG003|Overall Study|Protocol Violation|2|||
156310452|NCT00730028|564237390|FG004|Overall Study|Protocol Violation|0|||
156310453|NCT00730028|564237386|FG000|Overall Study|Withdrawal by Subject|9|||
156310454|NCT00730028|564237387|FG001|Overall Study|Withdrawal by Subject|5|||
156310455|NCT00730028|564237388|FG002|Overall Study|Withdrawal by Subject|4|||
156310456|NCT00730028|564237389|FG003|Overall Study|Withdrawal by Subject|5|||
156310457|NCT00730028|564237390|FG004|Overall Study|Withdrawal by Subject|9|||
156310458|NCT00730028|564237386|FG000|Overall Study|Physician Decision|3|||
156310459|NCT00730028|564237387|FG001|Overall Study|Physician Decision|3|||
156310460|NCT00730028|564237388|FG002|Overall Study|Physician Decision|2|||
156310461|NCT00730028|564237389|FG003|Overall Study|Physician Decision|3|||
156310462|NCT00730028|564237390|FG004|Overall Study|Physician Decision|2|||
156310463|NCT00730028|564237386|FG000|Overall Study|Treatment Failure|5|||
156310464|NCT00730028|564237387|FG001|Overall Study|Treatment Failure|5|||
156310465|NCT00730028|564237388|FG002|Overall Study|Treatment Failure|0|||
156310466|NCT00730028|564237389|FG003|Overall Study|Treatment Failure|0|||
156310467|NCT00730028|564237390|FG004|Overall Study|Treatment Failure|1|||
156310468|NCT00730028|564237386|FG000|Overall Study|Randomization Error|1|||
156310469|NCT00730028|564237387|FG001|Overall Study|Randomization Error|0|||
156310470|NCT00730028|564237388|FG002|Overall Study|Randomization Error|0|||
156412478|NCT02391038|564604848|FG001|Overall Study|Progressive disease|3|||
156412479|NCT02391038|564604849|FG002|Overall Study|Progressive disease|6|||
156412480|NCT01327547|564604855|FG000|Overall Study|Adverse Event|4|||
156648494|NCT01567306|565459241|FG004|Overall Study|Change site living|0|||
156310471|NCT00730028|564237389|FG003|Overall Study|Randomization Error|0|||
156310472|NCT00730028|564237390|FG004|Overall Study|Randomization Error|2|||
156310473|NCT03680742|564237391|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
156310474|NCT01250496|564237394|FG000|Overall Study|Study terminated|124|||
156310475|NCT01250496|564237395|FG001|Overall Study|Study terminated|124|||
156648495|NCT01567306|565459242|FG005|Overall Study|Change site living|0|||
156310476|NCT00003590|564237396|FG000|Overall Study|Ineligible Patient|1|||
156310477|NCT00003590|564237396|FG000|Overall Study|Adverse Event|7|||
156310478|NCT00003590|564237396|FG000|Overall Study|Withdrawal by Subject|1|||
156310479|NCT00003590|564237396|FG000|Overall Study|Lack of Efficacy|11|||
156310480|NCT00003590|564237396|FG000|Overall Study|Death|1|||
156310481|NCT00003590|564237396|FG000|Overall Study|Physician Decision|1|||
156310482|NCT01425463|564237402|FG000|Overall Study|Adverse Event|5|||
156310483|NCT01425463|564237403|FG001|Overall Study|Adverse Event|7|||
156310484|NCT01425463|564237402|FG000|Overall Study|Lack of Efficacy|1|||
156310485|NCT01425463|564237403|FG001|Overall Study|Lack of Efficacy|1|||
156310486|NCT01425463|564237402|FG000|Overall Study|Protocol Violation|2|||
156648496|NCT01567306|565459237|FG000|Overall Study|Adverse Event|0|||
156648497|NCT01567306|565459238|FG001|Overall Study|Adverse Event|0|||
156648498|NCT01567306|565459239|FG002|Overall Study|Adverse Event|0|||
156648499|NCT01567306|565459240|FG003|Overall Study|Adverse Event|2|||
156648500|NCT01567306|565459241|FG004|Overall Study|Adverse Event|4|||
156648501|NCT01567306|565459242|FG005|Overall Study|Adverse Event|1|||
156648502|NCT01567306|565459237|FG000|Overall Study|Lost to Follow-up|0|||
156648503|NCT01567306|565459238|FG001|Overall Study|Lost to Follow-up|0|||
156648504|NCT01567306|565459239|FG002|Overall Study|Lost to Follow-up|0|||
156648505|NCT01567306|565459240|FG003|Overall Study|Lost to Follow-up|0|||
156648506|NCT01567306|565459241|FG004|Overall Study|Lost to Follow-up|2|||
156648507|NCT01567306|565459242|FG005|Overall Study|Lost to Follow-up|0|||
156648508|NCT01567306|565459237|FG000|Overall Study|Withdrawal by Subject|0|||
156648509|NCT01567306|565459238|FG001|Overall Study|Withdrawal by Subject|0|||
156648510|NCT01567306|565459239|FG002|Overall Study|Withdrawal by Subject|0|||
156648511|NCT01567306|565459240|FG003|Overall Study|Withdrawal by Subject|0|||
156648512|NCT01567306|565459241|FG004|Overall Study|Withdrawal by Subject|0|||
156648513|NCT01567306|565459242|FG005|Overall Study|Withdrawal by Subject|1|||
156648514|NCT04272775|565459250|FG000|Overall Study|Study Terminated by Sponsor|1|||
156648515|NCT04272775|565459251|FG001|Overall Study|Study Terminated by Sponsor|0|||
156648516|NCT04272775|565459250|FG000|Overall Study|Protocol Violation|0|||
156648517|NCT04272775|565459251|FG001|Overall Study|Protocol Violation|1|||
156648518|NCT04272775|565459250|FG000|Overall Study|Symptomatic Deterioration|1|||
156648519|NCT04272775|565459251|FG001|Overall Study|Symptomatic Deterioration|1|||
156648520|NCT04272775|565459250|FG000|Overall Study|Withdrawal by Subject|1|||
156648521|NCT04272775|565459251|FG001|Overall Study|Withdrawal by Subject|2|||
156648522|NCT04272775|565459250|FG000|Overall Study|Adverse Event|1|||
156648523|NCT04272775|565459251|FG001|Overall Study|Adverse Event|2|||
156648524|NCT04272775|565459250|FG000|Overall Study|Progressive Disease|3|||
156648525|NCT04272775|565459251|FG001|Overall Study|Progressive Disease|1|||
156648526|NCT00475852|565459261|FG000|Overall Study|Death|444|||
156648527|NCT00475852|565459262|FG001|Overall Study|Death|456|||
156648528|NCT00475852|565459261|FG000|Overall Study|Withdrawal by Subject|19|||
156648529|NCT00475852|565459262|FG001|Overall Study|Withdrawal by Subject|24|||
156648530|NCT00475852|565459261|FG000|Overall Study|Lost to Follow-up|54|||
156648531|NCT00475852|565459262|FG001|Overall Study|Lost to Follow-up|68|||
156648532|NCT02063698|565459263|FG000|Overall Study|did not complete booklet for days 2-8|1|||
156648533|NCT02063698|565459264|FG001|Overall Study|did not complete booklet for days 2-8|2|||
156648534|NCT02974114|565459265|FG000|Overall Study|Other (Not specified)|0|||
156648535|NCT02974114|565459266|FG001|Overall Study|Other (Not specified)|1|||
156648536|NCT02974114|565459267|FG002|Overall Study|Other (Not specified)|2|||
156648537|NCT00185211|565459271|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
156648538|NCT00185211|565459272|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
156648539|NCT00185211|565459271|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
156648540|NCT00185211|565459272|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
156648541|NCT00185211|565459271|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
156310487|NCT01425463|564237403|FG001|Overall Study|Protocol Violation|2|||
156412481|NCT01327547|564604856|FG001|Overall Study|Adverse Event|1|||
156412482|NCT01327547|564604855|FG000|Overall Study|Death|1|||
156310488|NCT01425463|564237402|FG000|Overall Study|Lost to Follow-up|5|||
156310489|NCT01425463|564237403|FG001|Overall Study|Lost to Follow-up|2|||
156310490|NCT01425463|564237402|FG000|Overall Study|Withdrawal by Subject|7|||
156412483|NCT01327547|564604856|FG001|Overall Study|Death|2|||
156412484|NCT01327547|564604855|FG000|Overall Study|Lost to Follow-up|6|||
156412485|NCT01327547|564604856|FG001|Overall Study|Lost to Follow-up|6|||
156310491|NCT01425463|564237403|FG001|Overall Study|Withdrawal by Subject|5|||
156412486|NCT01327547|564604855|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
156412487|NCT01327547|564604856|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
156648542|NCT00185211|565459272|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
156648543|NCT00185211|565459271|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
156648544|NCT00185211|565459272|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
156648545|NCT00185211|565459271|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
156648546|NCT00185211|565459272|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
156648547|NCT00185211|565459271|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
156648548|NCT00185211|565459272|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
156310492|NCT01425463|564237402|FG000|Overall Study|Unknown Reason|4|||
156310493|NCT01425463|564237403|FG001|Overall Study|Unknown Reason|7|||
156310494|NCT01236547|564237404|FG000|Overall Study|Protocol Violation|0|||
156310495|NCT01236547|564237405|FG001|Overall Study|Protocol Violation|1|||
156310496|NCT01236547|564237406|FG002|Overall Study|Protocol Violation|1|||
156310497|NCT01236547|564237407|FG003|Overall Study|Protocol Violation|6|||
156310498|NCT01236547|564237408|FG004|Overall Study|Protocol Violation|12|||
156310499|NCT01598129|564237409|FG000|Overall Study|Disease progression|6|||
156310500|NCT01598129|564237409|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
156310501|NCT01598129|564237409|FG000|Overall Study|Withdrawal by Subject|1|||
156310502|NCT04093024|564237410|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
156310503|NCT04093024|564237411|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
156310504|NCT04093024|564237410|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
156310505|NCT04093024|564237411|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
156310506|NCT04093024|564237410|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
156310507|NCT04093024|564237411|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
156310508|NCT04093024|564237410|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
156310509|NCT04093024|564237411|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
156310510|NCT00647270|564237412|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
156310511|NCT00647270|564237413|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
156310512|NCT00647270|564237414|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
156310513|NCT00647270|564237412|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
156310514|NCT00647270|564237413|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
156310515|NCT00647270|564237414|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
156310516|NCT00647270|564237412|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
156310517|NCT00647270|564237413|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
156310518|NCT00647270|564237414|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
156310519|NCT00647270|564237412|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
156310520|NCT00647270|564237413|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
156310521|NCT00647270|564237414|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
156310522|NCT00647270|564237412|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
156310523|NCT00647270|564237413|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
156310524|NCT00647270|564237414|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
156310525|NCT00647270|564237412|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
156310526|NCT00647270|564237413|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
156310527|NCT00647270|564237414|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
156310528|NCT00647270|564237412|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
156310529|NCT00647270|564237413|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
156310530|NCT00647270|564237414|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
156310531|NCT03615040|564237417|FG000|Overall Study|Withdrawal by Subject|2|||
156310532|NCT03615040|564237418|FG001|Overall Study|Withdrawal by Subject|1|||
156310533|NCT03615040|564237417|FG000|Overall Study|Physician Decision|2|||
156310534|NCT03615040|564237418|FG001|Overall Study|Physician Decision|2|||
156310535|NCT03615040|564237417|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
156310536|NCT03615040|564237418|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
156310537|NCT03615040|564237417|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
156310538|NCT03615040|564237418|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
156310539|NCT03615040|564237417|FG000|Overall Study|Death|0|||
156310540|NCT03615040|564237418|FG001|Overall Study|Death|2|||
156310541|NCT01541397|564237419|FG000|Overall Study|Study ended prior to data collection|4|||
156310542|NCT01541397|564237420|FG001|Overall Study|Study ended prior to data collection|2|||
156310543|NCT01989208|564237422|FG000|200 mg (7 Days)|Protocol Violation|0|||
156310544|NCT01989208|564237423|FG001|200 mg (7 Days)|Protocol Violation|1|||
156310545|NCT01276054|564237427|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
156310546|NCT01276054|564237428|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
156310547|NCT04343235|564237429|FG000|Overall Study|Lost to Follow-up|3|||
156310548|NCT04343235|564237430|FG001|Overall Study|Lost to Follow-up|2|||
156310549|NCT00787267|564237431|FG000|Overall Study|Screen failure/Ineligible|10|||
156310550|NCT00787267|564237431|FG000|Overall Study|No Reason Provided|1|||
156310551|NCT00787267|564237431|FG000|Overall Study|Withdrawal by Subject|1|||
156310552|NCT01763996|564237432|FG000|Treatment Period 2|Adverse Event|0|||
156310553|NCT01763996|564237433|FG001|Treatment Period 2|Adverse Event|1|||
156310554|NCT00865280|564237434|FG000|Overall Study|Withdrawal by Subject|4|||
156310555|NCT00865280|564237435|FG001|Overall Study|Withdrawal by Subject|1|||
156310556|NCT00865280|564237434|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
156310557|NCT00865280|564237435|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
156310558|NCT00865280|564237434|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
156310559|NCT00865280|564237435|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
156412488|NCT01327547|564604855|FG000|Overall Study|Withdrawal by Subject|3|||
156412489|NCT01327547|564604856|FG001|Overall Study|Withdrawal by Subject|7|||
156412490|NCT01327547|564604855|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
156412491|NCT01327547|564604856|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
156412492|NCT01327547|564604855|FG000|Overall Study|Protocol Violation|1|||
156412493|NCT01327547|564604856|FG001|Overall Study|Protocol Violation|0|||
156412494|NCT01327547|564604855|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
156412495|NCT01327547|564604856|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
156412496|NCT01327547|564604855|FG000|Overall Study|Required prohibited medication|2|||
156412497|NCT01327547|564604856|FG001|Overall Study|Required prohibited medication|0|||
156412498|NCT01327547|564604855|FG000|Overall Study|Non-compliance with study procedures|1|||
156412499|NCT01327547|564604856|FG001|Overall Study|Non-compliance with study procedures|0|||
156412500|NCT01327547|564604855|FG000|Overall Study|By investigator in subject's interest|0|||
156412501|NCT01327547|564604856|FG001|Overall Study|By investigator in subject's interest|1|||
156412502|NCT00329719|564604857|FG000|Overall Study|Lost to Follow-up|0|||
156412503|NCT00329719|564604858|FG001|Overall Study|Lost to Follow-up|0|||
156412504|NCT00329719|564604859|FG002|Overall Study|Lost to Follow-up|0|||
156412505|NCT00329719|564604860|FG003|Overall Study|Lost to Follow-up|1|||
156412506|NCT01155388|564604865|FG000|Overall Study|Adverse Event|1|||
156412507|NCT01155388|564604866|FG001|Overall Study|Adverse Event|0|||
156412508|NCT03884231|564604867|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
156412509|NCT03884231|564604867|FG000|Overall Study|Subject Withdrew Consent|1|||
156412510|NCT03884231|564604867|FG000|Overall Study|MRI Scan Not Performed|1|||
156412511|NCT00830947|564604868|FG000|Overall Study|Lost to Follow-up|4|||
156412512|NCT00830947|564604869|FG001|Overall Study|Lost to Follow-up|4|||
156412513|NCT04076020|564604882|FG000|Overall Study|Death|4|||
156412514|NCT04076020|564604883|FG001|Overall Study|Death|6|||
156412515|NCT04076020|564604882|FG000|Overall Study|Withdrawal by Subject|12|||
156412516|NCT04076020|564604883|FG001|Overall Study|Withdrawal by Subject|8|||
156412517|NCT00502996|564604888|FG000|Overall Study|Lost to Follow-up|9|||
156412518|NCT00502996|564604888|FG000|Overall Study|Protocol Violation|2|||
156412519|NCT00502996|564604888|FG000|Overall Study|Treatment failure|25|||
156412520|NCT00502996|564604888|FG000|Overall Study|Withdrawal Informed Consent|6|||
156412521|NCT00502996|564604888|FG000|Overall Study|Adverse Event|2|||
156412522|NCT01729728|564604889|FG000|Overall Study|Adverse Event|0|||
156412523|NCT01729728|564604890|FG001|Overall Study|Adverse Event|6|||
156412524|NCT01729728|564604891|FG002|Overall Study|Adverse Event|0|||
156412525|NCT01729728|564604889|FG000|Overall Study|Protocol Violation|1|||
156412526|NCT01729728|564604890|FG001|Overall Study|Protocol Violation|0|||
156412527|NCT01729728|564604891|FG002|Overall Study|Protocol Violation|1|||
156412528|NCT00672958|564604894|FG000|Overall Study|Adverse Event|11|||
156412529|NCT00672958|564604895|FG001|Overall Study|Adverse Event|9|||
156412530|NCT00672958|564604894|FG000|Overall Study|Lack of Efficacy|6|||
156412531|NCT00672958|564604895|FG001|Overall Study|Lack of Efficacy|11|||
156412532|NCT00672958|564604894|FG000|Overall Study|Non-compliance with study drug|2|||
156412533|NCT00672958|564604895|FG001|Overall Study|Non-compliance with study drug|3|||
156412534|NCT00672958|564604894|FG000|Overall Study|Protocol deviations|11|||
156412535|NCT00672958|564604895|FG001|Overall Study|Protocol deviations|5|||
156412536|NCT00672958|564604894|FG000|Overall Study|Voluntary withdrawal|12|||
156412537|NCT00672958|564604895|FG001|Overall Study|Voluntary withdrawal|8|||
156412538|NCT00672958|564604894|FG000|Overall Study|Lost to Follow-up|22|||
156412539|NCT00672958|564604895|FG001|Overall Study|Lost to Follow-up|17|||
156412540|NCT00672958|564604894|FG000|Overall Study|Reason not specified|0|||
156412541|NCT00672958|564604895|FG001|Overall Study|Reason not specified|3|||
156412542|NCT01380990|564604896|FG000|Overall Study|Treatment Failure|1|||
156412543|NCT01380990|564604897|FG001|Overall Study|Treatment Failure|0|||
156412544|NCT01380990|564604896|FG000|Overall Study|Death|0|||
156412545|NCT01380990|564604897|FG001|Overall Study|Death|1|||
156412546|NCT04422639|564604900|FG000|Overall Study|Death|1|||
156310560|NCT00865280|564237434|FG000|Overall Study|Exclusion Condition|1|||
156310561|NCT00865280|564237435|FG001|Overall Study|Exclusion Condition|0|||
156310562|NCT00865280|564237434|FG000|Overall Study|Adverse Event|0|||
156310563|NCT00865280|564237435|FG001|Overall Study|Adverse Event|1|||
156310564|NCT01788215|564237441|FG000|Overall Study|Withdrawal by Subject|0|||
156310565|NCT01788215|564237442|FG001|Overall Study|Withdrawal by Subject|1|||
156310566|NCT01788215|564237441|FG000|Overall Study|Lost to Follow-up|2|||
156412547|NCT04422639|564604901|FG001|Overall Study|Death|0|||
156412548|NCT04422639|564604900|FG000|Overall Study|study closed prior to completion of FU visits|0|||
156412549|NCT04422639|564604901|FG001|Overall Study|study closed prior to completion of FU visits|2|||
156310567|NCT01788215|564237442|FG001|Overall Study|Lost to Follow-up|0|||
156412550|NCT01964521|564604902|FG000|Overall Study|Lost to Follow-up|4|||
156412551|NCT02374593|564604904|FG000|Overall Study|non-compliant|2|||
156412552|NCT02374593|564604905|FG001|Overall Study|non-compliant|0|||
156412553|NCT01463293|564604906|FG000|Overall Study|Lost to Follow-up|1|||
156412554|NCT01463293|564604907|FG001|Overall Study|Lost to Follow-up|4|||
156310568|NCT03116152|564237443|FG000|Overall Study|Disease Progression|49|||
156310569|NCT03116152|564237444|FG001|Overall Study|Disease Progression|47|||
156412555|NCT01463293|564604908|FG002|Overall Study|Lost to Follow-up|5|||
156412556|NCT01463293|564604906|FG000|Overall Study|Adverse Event|1|||
156412557|NCT01463293|564604907|FG001|Overall Study|Adverse Event|2|||
156412558|NCT01463293|564604908|FG002|Overall Study|Adverse Event|0|||
156412559|NCT01463293|564604906|FG000|Overall Study|Withdrawal by Subject|4|||
156412560|NCT01463293|564604907|FG001|Overall Study|Withdrawal by Subject|10|||
156412561|NCT01463293|564604908|FG002|Overall Study|Withdrawal by Subject|5|||
156412562|NCT01463293|564604906|FG000|Overall Study|Other|0|||
156412563|NCT01463293|564604907|FG001|Overall Study|Other|0|||
156412564|NCT01463293|564604908|FG002|Overall Study|Other|2|||
156412565|NCT01284140|564604909|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
156412566|NCT01284140|564604910|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
156412567|NCT01284140|564604909|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
156412568|NCT01284140|564604910|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
156412569|NCT02796963|564604911|FG000|Overall Study|Lost to Follow-up|89|||
156412570|NCT02796963|564604912|FG001|Overall Study|Lost to Follow-up|76|||
156310570|NCT03116152|564237443|FG000|Overall Study|Death|5|||
156310571|NCT03116152|564237444|FG001|Overall Study|Death|2|||
156310572|NCT03116152|564237443|FG000|Overall Study|Adverse Event|21|||
156310573|NCT03116152|564237444|FG001|Overall Study|Adverse Event|7|||
156310574|NCT03116152|564237443|FG000|Overall Study|Protocol Violation|2|||
156310575|NCT03116152|564237444|FG001|Overall Study|Protocol Violation|2|||
156310576|NCT03116152|564237443|FG000|Overall Study|Withdrawal by Subject|0|||
156310577|NCT03116152|564237444|FG001|Overall Study|Withdrawal by Subject|1|||
156310578|NCT03116152|564237443|FG000|Overall Study|Physician Decision|3|||
156310579|NCT03116152|564237444|FG001|Overall Study|Physician Decision|2|||
156310580|NCT03116152|564237443|FG000|Overall Study|other|11|||
156310581|NCT03116152|564237444|FG001|Overall Study|other|34|||
156310582|NCT00862641|564237447|FG000|Overall Study|Randomized, but drug not received|1|||
156310583|NCT00862641|564237448|FG001|Overall Study|Randomized, but drug not received|4|||
156310584|NCT00862641|564237449|FG002|Overall Study|Randomized, but drug not received|1|||
156310585|NCT00862641|564237450|FG003|Overall Study|Randomized, but drug not received|4|||
156310586|NCT01419197|564237451|FG000|Overall Study|Death|247|||
156310587|NCT01419197|564237452|FG001|Overall Study|Death|122|||
156310588|NCT01419197|564237451|FG000|Overall Study|Physician Decision|4|||
156310589|NCT01419197|564237452|FG001|Overall Study|Physician Decision|4|||
156310590|NCT01419197|564237451|FG000|Overall Study|Non-compliance|3|||
156310591|NCT01419197|564237452|FG001|Overall Study|Non-compliance|1|||
156310592|NCT01419197|564237451|FG000|Overall Study|Withdrawal by Subject|33|||
156310593|NCT01419197|564237452|FG001|Overall Study|Withdrawal by Subject|32|||
156310594|NCT01419197|564237451|FG000|Overall Study|Study Completed by Sponsor|103|||
156310595|NCT01419197|564237452|FG001|Overall Study|Study Completed by Sponsor|34|||
156310596|NCT01419197|564237451|FG000|Overall Study|Reason Not Specified|0|||
156310597|NCT01419197|564237452|FG001|Overall Study|Reason Not Specified|1|||
156310598|NCT01419197|564237451|FG000|Overall Study|Lost to Follow-up|14|||
156310599|NCT01419197|564237452|FG001|Overall Study|Lost to Follow-up|4|||
156310600|NCT00146848|564237453|FG000|Pre-randomization|Death|19|||
156310601|NCT00146848|564237454|FG001|Pre-randomization|Death|0|||
156310602|NCT00146848|564237455|FG002|Pre-randomization|Death|0|||
156310603|NCT00146848|564237453|FG000|Pre-randomization|Lost to Follow-up|70|||
156310604|NCT00146848|564237454|FG001|Pre-randomization|Lost to Follow-up|0|||
156310605|NCT00146848|564237455|FG002|Pre-randomization|Lost to Follow-up|0|||
156310606|NCT00146848|564237453|FG000|Pre-randomization|Physician Decision|8|||
156310607|NCT00146848|564237454|FG001|Pre-randomization|Physician Decision|0|||
156310608|NCT00146848|564237455|FG002|Pre-randomization|Physician Decision|0|||
156310609|NCT00146848|564237453|FG000|Pre-randomization|Protocol Violation|172|||
156310610|NCT00146848|564237454|FG001|Pre-randomization|Protocol Violation|0|||
156310611|NCT00146848|564237455|FG002|Pre-randomization|Protocol Violation|0|||
156310612|NCT00146848|564237453|FG000|Pre-randomization|Withdrawal by Subject|40|||
156310613|NCT00146848|564237454|FG001|Pre-randomization|Withdrawal by Subject|0|||
156310614|NCT00146848|564237455|FG002|Pre-randomization|Withdrawal by Subject|0|||
156310615|NCT00146848|564237453|FG000|Post-randomization|Lost to Follow-up|12|||
156310616|NCT00146848|564237454|FG001|Post-randomization|Lost to Follow-up|15|||
156310617|NCT00146848|564237455|FG002|Post-randomization|Lost to Follow-up|12|||
156310618|NCT00146848|564237453|FG000|Post-randomization|Withdrawn|26|||
156310619|NCT00146848|564237454|FG001|Post-randomization|Withdrawn|32|||
156310620|NCT00146848|564237455|FG002|Post-randomization|Withdrawn|27|||
156310621|NCT01798849|564237456|FG000|Overall Study|Physician Decision|0|||
156310622|NCT01798849|564237457|FG001|Overall Study|Physician Decision|0|||
156310623|NCT01798849|564237458|FG002|Overall Study|Physician Decision|1|||
156310624|NCT00717236|564237459|FG000|Double-Blind Period|Adverse Event|33|||
156310625|NCT00717236|564237460|FG001|Double-Blind Period|Adverse Event|6|||
156310626|NCT00717236|564237459|FG000|Double-Blind Period|Lack of Efficacy|6|||
156310627|NCT00717236|564237460|FG001|Double-Blind Period|Lack of Efficacy|6|||
156310628|NCT00717236|564237459|FG000|Double-Blind Period|Lost to Follow-up|3|||
156310629|NCT00717236|564237460|FG001|Double-Blind Period|Lost to Follow-up|5|||
156412571|NCT02796963|564604913|FG002|Overall Study|Lost to Follow-up|69|||
156412572|NCT02796963|564604914|FG003|Overall Study|Lost to Follow-up|72|||
156648549|NCT00185211|565459271|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
156310630|NCT00717236|564237459|FG000|Double-Blind Period|Withdrawal by Subject|10|||
156310631|NCT00717236|564237460|FG001|Double-Blind Period|Withdrawal by Subject|2|||
156310632|NCT00717236|564237459|FG000|Double-Blind Period|Loss of efficacy|3|||
156310633|NCT00717236|564237460|FG001|Double-Blind Period|Loss of efficacy|0|||
156310634|NCT00717236|564237459|FG000|Double-Blind Period|Other: Death|1|||
156310635|NCT00717236|564237460|FG001|Double-Blind Period|Other: Death|0|||
156310636|NCT00717236|564237459|FG000|Double-Blind Period|Other: Pregnancy|1|||
156310637|NCT00717236|564237460|FG001|Double-Blind Period|Other: Pregnancy|0|||
156310638|NCT00717236|564237459|FG000|Double-Blind Period|Other: Protocol Violation|2|||
156310639|NCT00717236|564237460|FG001|Double-Blind Period|Other: Protocol Violation|0|||
156310640|NCT00717236|564237459|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
156310641|NCT00717236|564237460|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
156310642|NCT00717236|564237459|FG000|Double-Blind Period|Other: Site withdrew|2|||
156310643|NCT00717236|564237460|FG001|Double-Blind Period|Other: Site withdrew|0|||
156412573|NCT03192215|564604915|FG000|Overall Study|Death|28|||
156412574|NCT03192215|564604916|FG001|Overall Study|Death|23|||
156412575|NCT03192215|564604915|FG000|Overall Study|Lost to Follow-up|10|||
156412576|NCT03192215|564604916|FG001|Overall Study|Lost to Follow-up|15|||
156412577|NCT03192215|564604915|FG000|Overall Study|Withdrawal by Subject|49|||
156412578|NCT03192215|564604916|FG001|Overall Study|Withdrawal by Subject|48|||
156412579|NCT03192215|564604915|FG000|Overall Study|Other as reported in analysis|4|||
156412580|NCT03192215|564604916|FG001|Overall Study|Other as reported in analysis|1|||
156412581|NCT02038764|564604919|FG000|Overall Study|Adverse Event|0|||
156412582|NCT02038764|564604920|FG001|Overall Study|Adverse Event|0|||
156412583|NCT02038764|564604921|FG002|Overall Study|Adverse Event|1|||
156412584|NCT02038764|564604922|FG003|Overall Study|Adverse Event|0|||
156412585|NCT02038764|564604923|FG004|Overall Study|Adverse Event|0|||
156412586|NCT02038764|564604919|FG000|Overall Study|Lost to Follow-up|0|||
156310644|NCT00717236|564237459|FG000|Double-Blind Period|Other: Screening failure|1|||
156310645|NCT00717236|564237460|FG001|Double-Blind Period|Other: Screening failure|0|||
156310646|NCT00717236|564237459|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
156310647|NCT00717236|564237460|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
156310648|NCT00717236|564237459|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
156310649|NCT00717236|564237460|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
156310650|NCT00717236|564237459|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
156310651|NCT00717236|564237460|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
156310652|NCT00717236|564237459|FG000|Double-Blind Period|Other: History of cancer|1|||
156310653|NCT00717236|564237460|FG001|Double-Blind Period|Other: History of cancer|0|||
156310654|NCT00717236|564237459|FG000|Double-Blind Period|Other: Sponsor request|1|||
156310655|NCT00717236|564237460|FG001|Double-Blind Period|Other: Sponsor request|0|||
156310656|NCT00717236|564237459|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
156310657|NCT00717236|564237460|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
156310658|NCT00717236|564237459|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
156310659|NCT00717236|564237460|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
156310660|NCT00717236|564237459|FG000|Double-Blind Period|Other: Subject moved|1|||
156310661|NCT00717236|564237460|FG001|Double-Blind Period|Other: Subject moved|1|||
156310662|NCT00717236|564237459|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
156310663|NCT00717236|564237460|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
156310664|NCT00717236|564237459|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
156310665|NCT00717236|564237460|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
156310666|NCT00717236|564237459|FG000|Double-Blind Period|Other: Transportation problems|0|||
156412587|NCT02038764|564604920|FG001|Overall Study|Lost to Follow-up|1|||
156412588|NCT02038764|564604921|FG002|Overall Study|Lost to Follow-up|0|||
156412589|NCT02038764|564604922|FG003|Overall Study|Lost to Follow-up|0|||
156412590|NCT02038764|564604923|FG004|Overall Study|Lost to Follow-up|0|||
156412591|NCT02038764|564604919|FG000|Overall Study|Withdrawal by Subject|0|||
156412592|NCT02038764|564604920|FG001|Overall Study|Withdrawal by Subject|0|||
156412593|NCT02038764|564604921|FG002|Overall Study|Withdrawal by Subject|0|||
156412594|NCT02038764|564604922|FG003|Overall Study|Withdrawal by Subject|0|||
156412595|NCT02038764|564604923|FG004|Overall Study|Withdrawal by Subject|1|||
156412596|NCT02038764|564604919|FG000|Overall Study|Other|1|||
156412597|NCT02038764|564604920|FG001|Overall Study|Other|0|||
156412598|NCT02038764|564604921|FG002|Overall Study|Other|1|||
156412599|NCT02038764|564604922|FG003|Overall Study|Other|0|||
156412600|NCT02038764|564604923|FG004|Overall Study|Other|0|||
156412601|NCT03853317|564604924|FG000|Overall Study|Progressive Disease|5|||
156412602|NCT03853317|564604924|FG000|Overall Study|Adverse Event|1|||
156412603|NCT03853317|564604924|FG000|Overall Study|Death|1|||
156412604|NCT03853317|564604924|FG000|Overall Study|other event|2|||
156412605|NCT04844918|564604926|FG000|Overall Study|Adverse Event|7|||
156412606|NCT04844918|564604927|FG001|Overall Study|Adverse Event|8|||
156412607|NCT04844918|564604928|FG002|Overall Study|Adverse Event|5|||
156412608|NCT04844918|564604926|FG000|Overall Study|Physician Decision|0|||
156412609|NCT04844918|564604927|FG001|Overall Study|Physician Decision|1|||
156310667|NCT00717236|564237460|FG001|Double-Blind Period|Other: Transportation problems|1|||
156310668|NCT00717236|564237459|FG000|Double-Blind Period|Other: Investigator Decision|0|||
156310669|NCT00717236|564237460|FG001|Double-Blind Period|Other: Investigator Decision|1|||
156310670|NCT00717236|564237459|FG000|Open-Label Period|Adverse Event|29|||
156648550|NCT00185211|565459272|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
156648551|NCT00185211|565459271|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
156648552|NCT00185211|565459272|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
156648553|NCT00185211|565459271|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
156648554|NCT00185211|565459272|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
156648555|NCT00185211|565459271|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
156648556|NCT00185211|565459272|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
156648557|NCT00185211|565459271|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
156648558|NCT00185211|565459272|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
156310671|NCT00717236|564237460|FG001|Open-Label Period|Adverse Event|4|||
156310672|NCT00717236|564237459|FG000|Open-Label Period|Lack of Efficacy|30|||
156310673|NCT00717236|564237460|FG001|Open-Label Period|Lack of Efficacy|8|||
156310674|NCT00717236|564237459|FG000|Open-Label Period|Lost to Follow-up|28|||
156310675|NCT00717236|564237460|FG001|Open-Label Period|Lost to Follow-up|4|||
156310676|NCT00717236|564237459|FG000|Open-Label Period|Withdrawal by Subject|20|||
156412610|NCT04844918|564604928|FG002|Overall Study|Physician Decision|0|||
156648559|NCT00185211|565459271|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
156648560|NCT00185211|565459272|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
156648561|NCT00458302|565461632|FG000|Overall Study|Adverse Event|4|||
156648562|NCT00458302|565461633|FG001|Overall Study|Adverse Event|14|||
156648563|NCT00458302|565461632|FG000|Overall Study|Pregnancy|2|||
156648564|NCT00458302|565461633|FG001|Overall Study|Pregnancy|1|||
156648565|NCT00458302|565461632|FG000|Overall Study|Protocol Violation|0|||
156648566|NCT00458302|565461633|FG001|Overall Study|Protocol Violation|2|||
156648567|NCT00458302|565461632|FG000|Overall Study|Withdrawal by Subject|6|||
156648568|NCT00458302|565461633|FG001|Overall Study|Withdrawal by Subject|4|||
156648569|NCT00458302|565461632|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
156648570|NCT00458302|565461633|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
156648571|NCT00458302|565461632|FG000|Overall Study|Study Termination By Sponsor|1|||
156648572|NCT00458302|565461633|FG001|Overall Study|Study Termination By Sponsor|0|||
156648573|NCT00458302|565461632|FG000|Overall Study|Lost to Follow-up|2|||
156648574|NCT00458302|565461633|FG001|Overall Study|Lost to Follow-up|0|||
156648575|NCT00458302|565461632|FG000|Overall Study|Other|4|||
156648576|NCT00458302|565461633|FG001|Overall Study|Other|2|||
156648577|NCT01381900|565461640|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
156648578|NCT01381900|565461641|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
156648579|NCT01381900|565461642|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
156648580|NCT01381900|565461640|FG000|Overall Study|Adverse Event|4|||
156648581|NCT01381900|565461641|FG001|Overall Study|Adverse Event|6|||
156648582|NCT01381900|565461642|FG002|Overall Study|Adverse Event|7|||
156648583|NCT01381900|565461640|FG000|Overall Study|Noncompliance with study drug|0|||
156648584|NCT01381900|565461641|FG001|Overall Study|Noncompliance with study drug|0|||
156648585|NCT01381900|565461642|FG002|Overall Study|Noncompliance with study drug|1|||
156648586|NCT01381900|565461640|FG000|Overall Study|Physician Decision|0|||
156648587|NCT01381900|565461641|FG001|Overall Study|Physician Decision|1|||
156648588|NCT01381900|565461642|FG002|Overall Study|Physician Decision|1|||
156648589|NCT01381900|565461640|FG000|Overall Study|Protocol Violation|0|||
156648590|NCT01381900|565461641|FG001|Overall Study|Protocol Violation|1|||
156648591|NCT01381900|565461642|FG002|Overall Study|Protocol Violation|1|||
156648592|NCT01381900|565461640|FG000|Overall Study|Withdrawal by Subject|0|||
156648593|NCT01381900|565461641|FG001|Overall Study|Withdrawal by Subject|0|||
156648594|NCT01381900|565461642|FG002|Overall Study|Withdrawal by Subject|1|||
156648595|NCT01381900|565461640|FG000|Overall Study|Early withdraw|3|||
156648596|NCT01381900|565461641|FG001|Overall Study|Early withdraw|1|||
156648597|NCT01381900|565461642|FG002|Overall Study|Early withdraw|1|||
156648598|NCT02668783|565461644|FG000|Overall Study|Pregnancy|0|||
156648599|NCT02668783|565461645|FG001|Overall Study|Pregnancy|1|||
156648600|NCT02668783|565461644|FG000|Overall Study|Protocol Violation|2|||
156648601|NCT02668783|565461645|FG001|Overall Study|Protocol Violation|1|||
156648602|NCT02668783|565461644|FG000|Overall Study|Study terminated by sponsor|9|||
156648603|NCT02668783|565461645|FG001|Overall Study|Study terminated by sponsor|10|||
156648604|NCT02668783|565461644|FG000|Overall Study|Subject moved|1|||
156648605|NCT02668783|565461645|FG001|Overall Study|Subject moved|0|||
156648606|NCT02668783|565461644|FG000|Overall Study|Withdrawal by Subject|1|||
156648607|NCT02668783|565461645|FG001|Overall Study|Withdrawal by Subject|0|||
156648608|NCT02891200|565461646|FG000|Overall Study|Lost to Follow-up|31|||
156648609|NCT02891200|565461647|FG001|Overall Study|Lost to Follow-up|36|||
156648610|NCT02891200|565461646|FG000|Overall Study|Death|10|||
156412611|NCT04844918|564604926|FG000|Overall Study|Withdrawal by Subject|6|||
156648611|NCT02891200|565461647|FG001|Overall Study|Death|9|||
156648612|NCT02891200|565461646|FG000|Overall Study|Withdrawal by Subject|1|||
156412612|NCT04844918|564604927|FG001|Overall Study|Withdrawal by Subject|3|||
156412613|NCT04844918|564604928|FG002|Overall Study|Withdrawal by Subject|3|||
156412614|NCT04844918|564604926|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
156412615|NCT04844918|564604927|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
156412616|NCT04844918|564604928|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
156412617|NCT01009047|564604932|FG000|Overall Study|Adverse Event|5|||
156412618|NCT01009047|564604933|FG001|Overall Study|Adverse Event|0|||
156412619|NCT01009047|564604932|FG000|Overall Study|Lost to Follow-up|0|||
156412620|NCT01009047|564604933|FG001|Overall Study|Lost to Follow-up|2|||
156412621|NCT01009047|564604932|FG000|Overall Study|Lack of Efficacy|4|||
156412622|NCT01009047|564604933|FG001|Overall Study|Lack of Efficacy|11|||
156412623|NCT01009047|564604932|FG000|Overall Study|Withdrawal by consent|16|||
156412624|NCT01009047|564604933|FG001|Overall Study|Withdrawal by consent|11|||
156412625|NCT01009047|564604932|FG000|Overall Study|Other|3|||
156412626|NCT01009047|564604933|FG001|Overall Study|Other|2|||
156412627|NCT04716881|564604935|FG000|Overall Study|Adverse Event|1|||
156412628|NCT04716881|564604935|FG000|Overall Study|Lost to Follow-up|1|||
156412629|NCT02269943|564604939|FG000|Treatment Period|Death|0|||
156412630|NCT02269943|564604940|FG001|Treatment Period|Death|1|||
156412631|NCT02269943|564604939|FG000|Treatment Period|Adverse Event|1|||
156412632|NCT02269943|564604940|FG001|Treatment Period|Adverse Event|10|||
156412633|NCT02269943|564604939|FG000|Treatment Period|Progressive Disease|5|||
156412634|NCT02269943|564604940|FG001|Treatment Period|Progressive Disease|17|||
156412635|NCT02269943|564604939|FG000|Treatment Period|Symptomatic Deterioration|0|||
156412636|NCT02269943|564604940|FG001|Treatment Period|Symptomatic Deterioration|2|||
156412637|NCT02269943|564604939|FG000|Follow-Up Survival Period|Death|3|||
156412638|NCT02269943|564604940|FG001|Follow-Up Survival Period|Death|16|||
156412639|NCT02269943|564604939|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
156412640|NCT02269943|564604940|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
156412641|NCT02269943|564604939|FG000|Follow-Up Survival Period|Alive|2|||
156412642|NCT02269943|564604940|FG001|Follow-Up Survival Period|Alive|8|||
156412643|NCT05033080|564604941|FG000|Overall Study|Adverse Event|4|||
156412644|NCT05033080|564604942|FG001|Overall Study|Adverse Event|4|||
156412645|NCT05033080|564604941|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
156412646|NCT05033080|564604942|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
156412647|NCT05033080|564604941|FG000|Overall Study|Lost to Follow-up|1|||
156412648|NCT05033080|564604942|FG001|Overall Study|Lost to Follow-up|0|||
156412649|NCT05033080|564604941|FG000|Overall Study|Other non-compliance|0|||
156412650|NCT05033080|564604942|FG001|Overall Study|Other non-compliance|1|||
156412651|NCT05033080|564604941|FG000|Overall Study|Physician Decision|0|||
156412652|NCT05033080|564604942|FG001|Overall Study|Physician Decision|1|||
156412653|NCT05033080|564604941|FG000|Overall Study|Other|1|||
156412654|NCT05033080|564604942|FG001|Overall Study|Other|1|||
156412655|NCT03560245|564604943|FG000|Overall Study|Withdrawal by Subject|3|||
156412656|NCT03560245|564604944|FG001|Overall Study|Withdrawal by Subject|2|||
156412657|NCT03560245|564604943|FG000|Overall Study|Adverse Event|1|||
156412658|NCT03560245|564604944|FG001|Overall Study|Adverse Event|1|||
156412659|NCT03560245|564604943|FG000|Overall Study|Protocol Violation|1|||
156412660|NCT03560245|564604944|FG001|Overall Study|Protocol Violation|0|||
156412661|NCT03560245|564604943|FG000|Overall Study|Death|0|||
156412662|NCT03560245|564604944|FG001|Overall Study|Death|1|||
156412663|NCT03560245|564604943|FG000|Overall Study|Lost to Follow-up|0|||
156412664|NCT03560245|564604944|FG001|Overall Study|Lost to Follow-up|1|||
156648613|NCT02891200|565461647|FG001|Overall Study|Withdrawal by Subject|4|||
156412665|NCT03560245|564604943|FG000|Overall Study|Physician Decision|0|||
156412666|NCT03560245|564604944|FG001|Overall Study|Physician Decision|1|||
156412667|NCT03560245|564604943|FG000|Overall Study|Other|0|||
156412668|NCT03560245|564604944|FG001|Overall Study|Other|1|||
156412669|NCT01680458|564604947|FG000|Overall Study|Protocol Violation|3|||
156412670|NCT03406702|564604948|FG000|Overall Study|Missed Day 27 Dosing|1|||
156412671|NCT00655551|564604950|FG000|All Periods Combined|Adverse Event|0|||
156648614|NCT03907280|565461648|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
156648615|NCT03907280|565461649|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
156412672|NCT00655551|564604951|FG001|All Periods Combined|Adverse Event|3|||
156412673|NCT00655551|564604952|FG002|All Periods Combined|Adverse Event|4|||
156412674|NCT00655551|564604950|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
156412675|NCT00655551|564604951|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
156412676|NCT00655551|564604952|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
156412677|NCT00655551|564604950|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
156412678|NCT00655551|564604951|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
156412679|NCT00655551|564604952|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
156412680|NCT00655551|564604950|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
156412681|NCT00655551|564604951|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
156412682|NCT00655551|564604952|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
156412683|NCT00876460|564604953|FG000|Combination Therapy Phase|Progressive disease|2|||
156412684|NCT00876460|564604954|FG001|Combination Therapy Phase|Progressive disease|3|||
156412685|NCT00876460|564604955|FG002|Combination Therapy Phase|Progressive disease|3|||
156412686|NCT00876460|564604956|FG003|Combination Therapy Phase|Progressive disease|3|||
156412687|NCT00876460|564604957|FG004|Combination Therapy Phase|Progressive disease|3|||
156412688|NCT00876460|564604958|FG005|Combination Therapy Phase|Progressive disease|1|||
156412689|NCT00876460|564604959|FG006|Combination Therapy Phase|Progressive disease|1|||
156412690|NCT00876460|564604960|FG007|Combination Therapy Phase|Progressive disease|1|||
156412691|NCT00876460|564604953|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
156412692|NCT00876460|564604954|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
156412693|NCT00876460|564604955|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
156412694|NCT00876460|564604956|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
156412695|NCT00876460|564604957|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
156412696|NCT00876460|564604958|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
156412697|NCT00876460|564604959|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
156412698|NCT00876460|564604960|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
156412699|NCT00876460|564604953|FG000|Combination Therapy Phase|Adverse Event|0|||
156412700|NCT00876460|564604954|FG001|Combination Therapy Phase|Adverse Event|2|||
156412701|NCT00876460|564604955|FG002|Combination Therapy Phase|Adverse Event|0|||
156412702|NCT00876460|564604956|FG003|Combination Therapy Phase|Adverse Event|2|||
156412703|NCT00876460|564604957|FG004|Combination Therapy Phase|Adverse Event|2|||
156412704|NCT00876460|564604958|FG005|Combination Therapy Phase|Adverse Event|0|||
156412705|NCT00876460|564604959|FG006|Combination Therapy Phase|Adverse Event|3|||
156412706|NCT00876460|564604960|FG007|Combination Therapy Phase|Adverse Event|2|||
156412707|NCT00876460|564604953|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
156412708|NCT00876460|564604954|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
156412709|NCT00876460|564604955|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
156412710|NCT00876460|564604956|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
156412711|NCT00876460|564604957|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
156412712|NCT00876460|564604958|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
156412713|NCT00876460|564604959|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
156412714|NCT00876460|564604960|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
156412715|NCT00876460|564604953|FG000|Combination Therapy Phase|Other reason not defined above|0|||
156412716|NCT00876460|564604954|FG001|Combination Therapy Phase|Other reason not defined above|0|||
156412717|NCT00876460|564604955|FG002|Combination Therapy Phase|Other reason not defined above|0|||
156412718|NCT00876460|564604956|FG003|Combination Therapy Phase|Other reason not defined above|0|||
156412719|NCT00876460|564604957|FG004|Combination Therapy Phase|Other reason not defined above|0|||
156412720|NCT00876460|564604958|FG005|Combination Therapy Phase|Other reason not defined above|0|||
156412721|NCT00876460|564604959|FG006|Combination Therapy Phase|Other reason not defined above|1|||
156412722|NCT00876460|564604960|FG007|Combination Therapy Phase|Other reason not defined above|2|||
156412723|NCT00876460|564604953|FG000|Combination Therapy Phase|Not treated|0|||
156412724|NCT00876460|564604954|FG001|Combination Therapy Phase|Not treated|0|||
156412725|NCT00876460|564604955|FG002|Combination Therapy Phase|Not treated|0|||
156412726|NCT00876460|564604956|FG003|Combination Therapy Phase|Not treated|0|||
156412727|NCT00876460|564604957|FG004|Combination Therapy Phase|Not treated|0|||
156412728|NCT00876460|564604958|FG005|Combination Therapy Phase|Not treated|0|||
156412729|NCT00876460|564604959|FG006|Combination Therapy Phase|Not treated|1|||
156412730|NCT00876460|564604960|FG007|Combination Therapy Phase|Not treated|0|||
156412731|NCT00876460|564604953|FG000|Mono Therapy Phase|Progressive disease|0|||
156648616|NCT03907280|565461650|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
156648617|NCT02231710|565461651|FG000|Overall Study|Physician Decision|1|||
156310677|NCT00717236|564237460|FG001|Open-Label Period|Withdrawal by Subject|2|||
156310678|NCT00717236|564237459|FG000|Open-Label Period|Loss of Efficacy|6|||
156310679|NCT00717236|564237460|FG001|Open-Label Period|Loss of Efficacy|1|||
156310680|NCT00717236|564237459|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
156310681|NCT00717236|564237460|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
156310682|NCT00717236|564237459|FG000|Open-Label Period|Other: Lack of Compliance|1|||
156310683|NCT00717236|564237460|FG001|Open-Label Period|Other: Lack of Compliance|1|||
156310684|NCT00717236|564237459|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
156310685|NCT00717236|564237460|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
156310686|NCT00717236|564237459|FG000|Open-Label Period|Other: Moved|1|||
156412732|NCT00876460|564604954|FG001|Mono Therapy Phase|Progressive disease|0|||
156412733|NCT00876460|564604955|FG002|Mono Therapy Phase|Progressive disease|0|||
156412734|NCT00876460|564604956|FG003|Mono Therapy Phase|Progressive disease|0|||
156412735|NCT00876460|564604957|FG004|Mono Therapy Phase|Progressive disease|2|||
156412736|NCT00876460|564604958|FG005|Mono Therapy Phase|Progressive disease|0|||
156412737|NCT00876460|564604959|FG006|Mono Therapy Phase|Progressive disease|1|||
156412738|NCT00876460|564604960|FG007|Mono Therapy Phase|Progressive disease|3|||
156412739|NCT00876460|564604953|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
156310687|NCT00717236|564237460|FG001|Open-Label Period|Other: Moved|0|||
156412740|NCT00876460|564604954|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
156412741|NCT00876460|564604955|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
156412742|NCT00876460|564604956|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
156412743|NCT00876460|564604957|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
156412744|NCT00876460|564604958|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
156412745|NCT00876460|564604959|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
156412746|NCT00876460|564604960|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
156412747|NCT00876460|564604953|FG000|Mono Therapy Phase|Adverse Event|0|||
156412748|NCT00876460|564604954|FG001|Mono Therapy Phase|Adverse Event|0|||
156412749|NCT00876460|564604955|FG002|Mono Therapy Phase|Adverse Event|0|||
156412750|NCT00876460|564604956|FG003|Mono Therapy Phase|Adverse Event|1|||
156412751|NCT00876460|564604957|FG004|Mono Therapy Phase|Adverse Event|0|||
156412752|NCT00876460|564604958|FG005|Mono Therapy Phase|Adverse Event|0|||
156412753|NCT00876460|564604959|FG006|Mono Therapy Phase|Adverse Event|0|||
156412754|NCT00876460|564604960|FG007|Mono Therapy Phase|Adverse Event|0|||
156412755|NCT02049710|564604961|FG000|Overall Study|Lost to Follow-up|319|||
156412756|NCT02049710|564604962|FG001|Overall Study|Lost to Follow-up|324|||
156412757|NCT00003458|564604963|FG000|Overall Study|Not evaluable|4|||
156412758|NCT01216293|564604964|FG000|Main Study|Adverse Event|1|||
156412759|NCT01216293|564604965|FG001|Main Study|Adverse Event|4|||
156412760|NCT01216293|564604966|FG002|Main Study|Adverse Event|2|||
156412761|NCT01216293|564604964|FG000|Main Study|Major Protocol Deviation|1|||
156412762|NCT01216293|564604965|FG001|Main Study|Major Protocol Deviation|0|||
156412763|NCT01216293|564604966|FG002|Main Study|Major Protocol Deviation|1|||
156412764|NCT01216293|564604964|FG000|Main Study|Lost to Follow-up|3|||
156412765|NCT01216293|564604965|FG001|Main Study|Lost to Follow-up|1|||
156412766|NCT01216293|564604966|FG002|Main Study|Lost to Follow-up|0|||
156412767|NCT01216293|564604964|FG000|Main Study|Voluntary Withdrawal|2|||
156412768|NCT01216293|564604965|FG001|Main Study|Voluntary Withdrawal|2|||
156412769|NCT01216293|564604966|FG002|Main Study|Voluntary Withdrawal|2|||
156412770|NCT01216293|564604964|FG000|Main Study|Other Reason Not Specified|0|||
156412771|NCT01216293|564604965|FG001|Main Study|Other Reason Not Specified|1|||
156412772|NCT01216293|564604966|FG002|Main Study|Other Reason Not Specified|1|||
156412773|NCT01216293|564604964|FG000|Main Study|Randomized, Not Treated|1|||
156412774|NCT01216293|564604965|FG001|Main Study|Randomized, Not Treated|0|||
156412775|NCT01216293|564604966|FG002|Main Study|Randomized, Not Treated|0|||
156412776|NCT01216293|564604964|FG000|Calcium Absorption Substudy|Adverse Event|0|||
156412777|NCT01216293|564604965|FG001|Calcium Absorption Substudy|Adverse Event|2|||
156412778|NCT01216293|564604966|FG002|Calcium Absorption Substudy|Adverse Event|0|||
156412779|NCT01216293|564604964|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
156412780|NCT01216293|564604965|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
156412781|NCT01216293|564604966|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
156412782|NCT01216293|564604964|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
156412783|NCT01216293|564604965|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
156412784|NCT01216293|564604966|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
156412785|NCT01040780|564606637|FG000|Overall Study|Protocol Violation|1|||
156412786|NCT01040780|564606638|FG001|Overall Study|Protocol Violation|3|||
156412787|NCT03681639|564606639|FG000|Overall Study|Death|4|||
156412788|NCT03681639|564606639|FG000|Overall Study|Lost to Follow-up|2|||
156412789|NCT03681639|564606639|FG000|Overall Study|Withdrawal by Subject|1|||
156412790|NCT03681639|564606639|FG000|Overall Study|Adverse Event|2|||
156412791|NCT01818141|564606640|FG000|Overall Study|Withdrawal by Subject|2|||
156412792|NCT01818141|564606641|FG001|Overall Study|Withdrawal by Subject|0|||
156412793|NCT01818141|564606640|FG000|Overall Study|No baseline C.diff colonies|1|||
156412794|NCT01818141|564606641|FG001|Overall Study|No baseline C.diff colonies|1|||
156412795|NCT01818141|564606640|FG000|Overall Study|Lost to Follow-up|0|||
156412796|NCT01818141|564606641|FG001|Overall Study|Lost to Follow-up|2|||
156412797|NCT02169830|564606644|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
156412798|NCT02169830|564606645|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
156412799|NCT02169830|564606646|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
156412800|NCT02169830|564606644|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
156412801|NCT02169830|564606645|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
156412802|NCT02169830|564606646|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
156412803|NCT02169830|564606644|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
156412804|NCT02169830|564606645|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
156412805|NCT02169830|564606646|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
156412806|NCT02169830|564606644|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
156412807|NCT02169830|564606645|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
156412808|NCT02169830|564606646|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
156412809|NCT02169830|564606644|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
156412810|NCT02169830|564606645|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
156412811|NCT02169830|564606646|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
156412812|NCT03204695|564606647|FG000|Overall Study|Death|1|||
156412813|NCT03204695|564606647|FG000|Overall Study|Participant was treated with another device|1|||
156412814|NCT03204695|564606647|FG000|Overall Study|Physician Decision|2|||
156412815|NCT04834362|564606648|FG000|Overall Study|Death|1|||
156412816|NCT04834362|564606649|FG001|Overall Study|Death|2|||
156412817|NCT02555371|564606652|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
156648618|NCT01339910|565461652|FG000|Overall Study|Withdrawal by Subject|1|||
156648619|NCT01339910|565461653|FG001|Overall Study|Withdrawal by Subject|0|||
156648620|NCT01339910|565461652|FG000|Overall Study|Physician Decision|1|||
156648621|NCT01339910|565461653|FG001|Overall Study|Physician Decision|0|||
156648622|NCT01339910|565461652|FG000|Overall Study|Disease relapse|1|||
156648623|NCT01339910|565461653|FG001|Overall Study|Disease relapse|4|||
156648624|NCT01399723|565461654|FG000|Overall Study|Lost to Follow-up|0|||
156648625|NCT01399723|565461655|FG001|Overall Study|Lost to Follow-up|1|||
156648626|NCT00673361|565461656|FG000|Overall Study|Screen Failure|2|||
156648627|NCT00829413|565461657|FG000|Overall Study|No study drug admimnistered|13|||
156648628|NCT00829413|565461657|FG000|Overall Study|Training Patients|67|||
156648629|NCT00829413|565461657|FG000|Overall Study|No truth standard procedure available|9|||
156648630|NCT00829413|565461657|FG000|Overall Study|Technically inadequate truth standard|2|||
156648631|NCT00829413|565461657|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
156648632|NCT00124020|565461665|FG000|Overall Study|Death|67|||
156648633|NCT00124020|565461666|FG001|Overall Study|Death|71|||
156648634|NCT00124020|565461665|FG000|Overall Study|Withdrawal by Subject|13|||
156648635|NCT00124020|565461666|FG001|Overall Study|Withdrawal by Subject|11|||
156648636|NCT00124020|565461665|FG000|Overall Study|Lost to Follow-up|5|||
156648637|NCT00124020|565461666|FG001|Overall Study|Lost to Follow-up|8|||
156648638|NCT00124020|565461665|FG000|Overall Study|Other|1|||
156648639|NCT00124020|565461666|FG001|Overall Study|Other|1|||
156648640|NCT00124020|565461665|FG000|Overall Study|Transfer to another hospital|2|||
156648641|NCT00124020|565461666|FG001|Overall Study|Transfer to another hospital|0|||
156648642|NCT00268346|565461667|FG000|Overall Study|Adverse Event|0|||
156648643|NCT00268346|565461668|FG001|Overall Study|Adverse Event|1|||
156648644|NCT00268346|565461667|FG000|Overall Study|Death|0|||
156648645|NCT00268346|565461668|FG001|Overall Study|Death|1|||
156648646|NCT00268346|565461667|FG000|Overall Study|Withdrawal by Subject|0|||
156648647|NCT00268346|565461668|FG001|Overall Study|Withdrawal by Subject|1|||
156648648|NCT01799590|565461672|FG000|Overall Study|Adverse Event|13|||
156648649|NCT01799590|565461673|FG001|Overall Study|Adverse Event|7|||
156648650|NCT01799590|565461674|FG002|Overall Study|Adverse Event|5|||
156648651|NCT01799590|565461672|FG000|Overall Study|Pregnancy|2|||
156648652|NCT01799590|565461673|FG001|Overall Study|Pregnancy|0|||
156648653|NCT01799590|565461674|FG002|Overall Study|Pregnancy|0|||
156648654|NCT01799590|565461672|FG000|Overall Study|Lack of Efficacy|3|||
156648655|NCT01799590|565461673|FG001|Overall Study|Lack of Efficacy|1|||
156648656|NCT01799590|565461674|FG002|Overall Study|Lack of Efficacy|3|||
156648657|NCT01799590|565461672|FG000|Overall Study|Participants convenience|4|||
156648658|NCT01799590|565461673|FG001|Overall Study|Participants convenience|4|||
156648659|NCT01799590|565461674|FG002|Overall Study|Participants convenience|2|||
156648660|NCT01799590|565461672|FG000|Overall Study|Aggravation of complications|0|||
156648661|NCT01799590|565461673|FG001|Overall Study|Aggravation of complications|1|||
156648662|NCT01799590|565461674|FG002|Overall Study|Aggravation of complications|1|||
156648663|NCT01799590|565461672|FG000|Overall Study|Using drugs with restricted days of use|0|||
156648664|NCT01799590|565461673|FG001|Overall Study|Using drugs with restricted days of use|3|||
156648665|NCT01799590|565461674|FG002|Overall Study|Using drugs with restricted days of use|2|||
156648666|NCT01799590|565461672|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
156648667|NCT01799590|565461673|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
156648668|NCT01799590|565461674|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
156648669|NCT01799590|565461672|FG000|Overall Study|Other|3|||
156648670|NCT01799590|565461673|FG001|Overall Study|Other|0|||
156648671|NCT01799590|565461674|FG002|Overall Study|Other|1|||
156648672|NCT00294723|565461677|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
156648673|NCT00294723|565461678|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
156648674|NCT00294723|565461679|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
156648675|NCT00294723|565461677|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
156648676|NCT00294723|565461678|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
156648677|NCT00294723|565461679|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
156648678|NCT00294723|565461677|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
156648679|NCT00294723|565461678|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
156648680|NCT00294723|565461679|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
156648681|NCT00294723|565461677|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
156648682|NCT00294723|565461678|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
156648683|NCT00294723|565461679|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
156648684|NCT00294723|565461677|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
156648685|NCT00294723|565461678|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
156648686|NCT00294723|565461679|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
156648687|NCT00294723|565461677|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
156648688|NCT00294723|565461678|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
156648689|NCT00294723|565461679|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
156648690|NCT00294723|565461677|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
156648691|NCT00294723|565461678|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
156648692|NCT00294723|565461679|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
156412818|NCT02555371|564606653|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
156412819|NCT02555371|564606654|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
156412820|NCT02555371|564606655|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
156412821|NCT02555371|564606656|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
156412822|NCT02555371|564606652|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
156412823|NCT02555371|564606653|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
156412824|NCT02555371|564606654|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
156412825|NCT02555371|564606655|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
156412826|NCT02555371|564606656|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
156412827|NCT02555371|564606652|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
156412828|NCT02555371|564606653|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
156412829|NCT02555371|564606654|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
156412830|NCT02555371|564606655|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
156412831|NCT02555371|564606656|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
156412832|NCT02555371|564606652|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
156412833|NCT02555371|564606653|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
156412834|NCT02555371|564606654|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
156412835|NCT02555371|564606655|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
156412836|NCT02555371|564606656|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
156412837|NCT02555371|564606652|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
156412838|NCT02555371|564606653|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
156412839|NCT02555371|564606654|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
156412840|NCT02555371|564606655|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
156412841|NCT02555371|564606656|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
156412842|NCT02555371|564606652|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
156412843|NCT02555371|564606653|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
156412844|NCT02555371|564606654|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
156412845|NCT02555371|564606655|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
156412846|NCT02555371|564606656|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
156412847|NCT02555371|564606652|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
156412848|NCT02555371|564606653|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
156412849|NCT02555371|564606654|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
156412850|NCT02555371|564606655|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
156412851|NCT02555371|564606656|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
156412852|NCT02555371|564606652|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
156412853|NCT02555371|564606653|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
156412854|NCT02555371|564606654|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
156412855|NCT02555371|564606655|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
156412856|NCT02555371|564606656|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
156412857|NCT02555371|564606652|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
156412858|NCT02555371|564606653|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
156412859|NCT02555371|564606654|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
156412860|NCT02555371|564606655|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
156412861|NCT02555371|564606656|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
156412862|NCT02555371|564606652|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
156412863|NCT02555371|564606653|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
156412864|NCT02555371|564606654|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
156412865|NCT02555371|564606655|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
156412866|NCT02555371|564606656|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
156412867|NCT02555371|564606652|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
156412868|NCT02555371|564606653|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
156412869|NCT02555371|564606654|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
156412870|NCT02555371|564606655|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
156412871|NCT02555371|564606656|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
156412872|NCT02555371|564606652|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
156412873|NCT02555371|564606653|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
156412874|NCT02555371|564606654|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
156412875|NCT02555371|564606655|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
156412876|NCT02555371|564606656|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
156412877|NCT02555371|564606652|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
156412878|NCT02555371|564606653|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
156412879|NCT02555371|564606654|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
156412880|NCT02555371|564606655|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
156412881|NCT02555371|564606656|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
156412882|NCT02555371|564606652|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
156310688|NCT00717236|564237459|FG000|Open-Label Period|Other: Investigator Decision|1|||
156412883|NCT02555371|564606653|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
156412884|NCT02555371|564606654|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
156412885|NCT02555371|564606655|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
156412886|NCT02555371|564606656|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
156412887|NCT03095599|564606657|FG000|Overall Study|Withdrawal by Subject|1|||
156412888|NCT03095599|564606658|FG001|Overall Study|Withdrawal by Subject|0|||
156412889|NCT03095599|564606657|FG000|Overall Study|Lost to Follow-up|1|||
156412890|NCT03095599|564606658|FG001|Overall Study|Lost to Follow-up|0|||
156412891|NCT03095599|564606657|FG000|Overall Study|Withdrawal prior to vaccination|1|||
156412892|NCT03095599|564606658|FG001|Overall Study|Withdrawal prior to vaccination|0|||
156412893|NCT00742885|564606661|FG000|Overall Study|Lost to Follow-up|1|||
156412894|NCT00742885|564606662|FG001|Overall Study|Lost to Follow-up|0|||
156412895|NCT04781647|564606663|FG000|Overall Study|Study terminated by Sponsor|11|||
156412896|NCT04781647|564606664|FG001|Overall Study|Study terminated by Sponsor|9|||
156412897|NCT04781647|564606665|FG002|Overall Study|Study terminated by Sponsor|9|||
156412898|NCT04781647|564606663|FG000|Overall Study|Withdrawal by Subject|1|||
156412899|NCT04781647|564606664|FG001|Overall Study|Withdrawal by Subject|2|||
156412900|NCT04781647|564606665|FG002|Overall Study|Withdrawal by Subject|0|||
156412901|NCT04781647|564606663|FG000|Overall Study|Adverse Event|0|||
156412902|NCT04781647|564606664|FG001|Overall Study|Adverse Event|1|||
156412903|NCT04781647|564606665|FG002|Overall Study|Adverse Event|1|||
156412904|NCT04781647|564606663|FG000|Overall Study|Protocol Violation|1|||
156412905|NCT04781647|564606664|FG001|Overall Study|Protocol Violation|0|||
156412906|NCT04781647|564606665|FG002|Overall Study|Protocol Violation|0|||
156412907|NCT04781647|564606663|FG000|Overall Study|Pregnancy|0|||
156412908|NCT04781647|564606664|FG001|Overall Study|Pregnancy|0|||
156412909|NCT04781647|564606665|FG002|Overall Study|Pregnancy|1|||
156412910|NCT04781647|564606663|FG000|Overall Study|Virology rebounded|1|||
156412911|NCT04781647|564606664|FG001|Overall Study|Virology rebounded|0|||
156412912|NCT04781647|564606665|FG002|Overall Study|Virology rebounded|0|||
156412913|NCT00777803|564606666|FG000|Overall Study|Lost to Follow-up|12|||
156412914|NCT00777803|564606667|FG001|Overall Study|Lost to Follow-up|5|||
156412915|NCT00777803|564606666|FG000|Overall Study|Adverse Event|1|||
156412916|NCT00777803|564606667|FG001|Overall Study|Adverse Event|0|||
156412917|NCT00777803|564606666|FG000|Overall Study|Non-compliance|2|||
156412918|NCT00777803|564606667|FG001|Overall Study|Non-compliance|2|||
156412919|NCT01755689|564606668|FG000|Overall Study|Withdrawal by Subject|1|||
156412920|NCT01755689|564606669|FG001|Overall Study|Withdrawal by Subject|3|||
156412921|NCT01755689|564606670|FG002|Overall Study|Withdrawal by Subject|2|||
156412922|NCT01755689|564606671|FG003|Overall Study|Withdrawal by Subject|1|||
156412923|NCT01755689|564606672|FG004|Overall Study|Withdrawal by Subject|1|||
156412924|NCT01755689|564606668|FG000|Overall Study|Migrated/moved from study area|0|||
156412925|NCT01755689|564606669|FG001|Overall Study|Migrated/moved from study area|1|||
156412926|NCT01755689|564606670|FG002|Overall Study|Migrated/moved from study area|1|||
156412927|NCT01755689|564606671|FG003|Overall Study|Migrated/moved from study area|1|||
156412928|NCT01755689|564606672|FG004|Overall Study|Migrated/moved from study area|1|||
156412929|NCT01755689|564606668|FG000|Overall Study|Lost to Follow-up|1|||
156412930|NCT01755689|564606669|FG001|Overall Study|Lost to Follow-up|0|||
156412931|NCT01755689|564606670|FG002|Overall Study|Lost to Follow-up|1|||
156412932|NCT01755689|564606671|FG003|Overall Study|Lost to Follow-up|0|||
156412933|NCT01755689|564606672|FG004|Overall Study|Lost to Follow-up|2|||
156412934|NCT01755689|564606668|FG000|Overall Study|Pregnancy|1|||
156310689|NCT00717236|564237460|FG001|Open-Label Period|Other: Investigator Decision|0|||
156310690|NCT00717236|564237459|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
156310691|NCT00717236|564237460|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
156310692|NCT00717236|564237459|FG000|Open-Label Period|Other: Sponsor Request|3|||
156310693|NCT00717236|564237460|FG001|Open-Label Period|Other: Sponsor Request|0|||
156310694|NCT00717236|564237459|FG000|Open-Label Period|Other: Cataract Surgery|1|||
156310695|NCT00717236|564237460|FG001|Open-Label Period|Other: Cataract Surgery|0|||
156310696|NCT00717236|564237459|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
156310697|NCT00717236|564237460|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
156310698|NCT00717236|564237459|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
156412935|NCT01755689|564606669|FG001|Overall Study|Pregnancy|1|||
156412936|NCT01755689|564606670|FG002|Overall Study|Pregnancy|2|||
156412937|NCT01755689|564606671|FG003|Overall Study|Pregnancy|4|||
156412938|NCT01755689|564606672|FG004|Overall Study|Pregnancy|2|||
156412939|NCT01004250|564606675|FG000|Induction Therapy Period|Adverse Event|10|||
156412940|NCT01004250|564606675|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
156412941|NCT01004250|564606675|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
156412942|NCT01004250|564606675|FG000|Induction Therapy Period|Physician Decision|2|||
156412943|NCT01004250|564606675|FG000|Maintenance Therapy Period|Adverse Event|15|||
156412944|NCT01004250|564606675|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
156412945|NCT01004250|564606675|FG000|Maintenance Therapy Period|Protocol Violation|1|||
156412946|NCT01004250|564606675|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
156412947|NCT01004250|564606675|FG000|Maintenance Therapy Period|Physician Decision|4|||
156412948|NCT01004250|564606675|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
156412949|NCT03943589|564606676|FG000|Overall Study|Death|1|||
156412950|NCT03943589|564606676|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
156412951|NCT04329104|564606677|FG000|Efficacy Study|Withdrawal by Subject|0|||
156310699|NCT00717236|564237460|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
156310700|NCT00717236|564237459|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
156310701|NCT00717236|564237460|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
156412952|NCT04329104|564606678|FG001|Efficacy Study|Withdrawal by Subject|0|||
156412953|NCT04329104|564606679|FG002|Efficacy Study|Withdrawal by Subject|0|||
156412954|NCT04329104|564606680|FG003|Efficacy Study|Withdrawal by Subject|5|||
156412955|NCT04329104|564606681|FG004|Efficacy Study|Withdrawal by Subject|6|||
156412956|NCT04329104|564606682|FG005|Efficacy Study|Withdrawal by Subject|8|||
156412957|NCT02254421|564606687|FG000|Overall Study|Randomized but Not Treated|1|||
156412958|NCT02254421|564606688|FG001|Overall Study|Randomized but Not Treated|0|||
156412959|NCT02254421|564606687|FG000|Overall Study|Death|0|||
156412960|NCT02254421|564606688|FG001|Overall Study|Death|2|||
156412961|NCT02254421|564606687|FG000|Overall Study|Withdrew Consent|1|||
156412962|NCT02254421|564606688|FG001|Overall Study|Withdrew Consent|1|||
156412963|NCT00358150|564606689|FG000|Overall Study|Adverse Event|3|||
156412964|NCT00358150|564606689|FG000|Overall Study|Withdrawal by Subject|1|||
156412965|NCT00358150|564606689|FG000|Overall Study|Undefined|3|||
156412966|NCT03537261|564606722|FG000|Overall Study|Lost to Follow-up|4|||
156412967|NCT03537261|564606723|FG001|Overall Study|Lost to Follow-up|5|||
156412968|NCT03537261|564606722|FG000|Overall Study|Withdrawal by Subject|4|||
156412969|NCT03537261|564606723|FG001|Overall Study|Withdrawal by Subject|6|||
156412970|NCT03537261|564606722|FG000|Overall Study|Did not return study questionnaires|0|||
156412971|NCT03537261|564606723|FG001|Overall Study|Did not return study questionnaires|1|||
156412972|NCT01316692|564606726|FG000|Overall Study|Adverse Event|5|||
156412973|NCT01316692|564606726|FG000|Overall Study|Disease Progression|7|||
156412974|NCT02001974|564606727|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
156412975|NCT02001974|564606728|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
156412976|NCT02001974|564606729|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
156412977|NCT02001974|564606727|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
156412978|NCT02001974|564606728|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
156412979|NCT02001974|564606729|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
156412980|NCT02001974|564606727|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
156412981|NCT02001974|564606728|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
156412982|NCT02001974|564606729|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
156412983|NCT02001974|564606727|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
156412984|NCT02001974|564606728|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
156412985|NCT02001974|564606729|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
156412986|NCT00993317|564606730|FG000|Overall Study|Adverse Event|2|||
156412987|NCT00993317|564606731|FG001|Overall Study|Adverse Event|4|||
156412988|NCT00993317|564606730|FG000|Overall Study|Lack of Efficacy|18|||
156310702|NCT00743106|564237461|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
156310703|NCT00743106|564237462|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
156310704|NCT00884741|564237468|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
156310705|NCT00884741|564237469|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
156310706|NCT00884741|564237470|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
156310707|NCT00884741|564237471|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
156310708|NCT00884741|564237468|FG000|Step 1 Registration: Tissue Screening|Death|3|||
156310709|NCT00884741|564237469|FG001|Step 1 Registration: Tissue Screening|Death|0|||
156310710|NCT00884741|564237470|FG002|Step 1 Registration: Tissue Screening|Death|0|||
156310711|NCT00884741|564237471|FG003|Step 1 Registration: Tissue Screening|Death|0|||
156310712|NCT00884741|564237468|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
156310713|NCT00884741|564237469|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
156310714|NCT00884741|564237470|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
156310715|NCT00884741|564237471|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
156310716|NCT00884741|564237468|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
156310717|NCT00884741|564237469|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
156310718|NCT00884741|564237470|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
156310719|NCT00884741|564237471|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
156310720|NCT00884741|564237468|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
156310721|NCT00884741|564237469|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
156310722|NCT00884741|564237470|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
156310723|NCT00884741|564237471|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
156412989|NCT00993317|564606731|FG001|Overall Study|Lack of Efficacy|18|||
156412990|NCT00993317|564606730|FG000|Overall Study|Withdrawal by Subject|0|||
156412991|NCT00993317|564606731|FG001|Overall Study|Withdrawal by Subject|2|||
156412992|NCT00993317|564606730|FG000|Overall Study|Investigator's opinion|0|||
156412993|NCT00993317|564606731|FG001|Overall Study|Investigator's opinion|1|||
156412994|NCT00993317|564606730|FG000|Overall Study|Early study termination at the site|1|||
156412995|NCT00993317|564606731|FG001|Overall Study|Early study termination at the site|0|||
156412996|NCT01630590|564606732|FG000|Overall Study|Adverse Event|9|||
156412997|NCT01630590|564606732|FG000|Overall Study|Lack of Efficacy|37|||
156412998|NCT01630590|564606732|FG000|Overall Study|Withdrawal by Subject|4|||
156412999|NCT01630590|564606732|FG000|Overall Study|2nd primary tumor|2|||
156413000|NCT01630590|564606732|FG000|Overall Study|Automobile accident|1|||
156413001|NCT01630590|564606732|FG000|Overall Study|Maximum benefit|4|||
156413002|NCT02366936|564606734|FG000|Overall Study|Withdrawal by Subject|2|||
156413003|NCT02366936|564606734|FG000|Overall Study|Lost to Follow-up|4|||
156413004|NCT02366936|564606734|FG000|Overall Study|Physician Decision|2|||
156413005|NCT01751113|564606735|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156413006|NCT01751113|564606736|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156413007|NCT01751113|564606737|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156413008|NCT01751113|564606738|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
156413009|NCT01751113|564606739|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
156413010|NCT01751113|564606740|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156413011|NCT01751113|564606735|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156413012|NCT01751113|564606736|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156310724|NCT00884741|564237468|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
156648693|NCT00294723|565461677|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
156648694|NCT00294723|565461678|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
156648695|NCT00294723|565461679|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
156648696|NCT00294723|565461677|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
156648697|NCT00294723|565461678|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
156648698|NCT00294723|565461679|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
156648699|NCT00294723|565461677|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
156648700|NCT00294723|565461678|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
156648701|NCT00294723|565461679|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
156648702|NCT00294723|565461677|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
156648703|NCT00294723|565461678|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
156310725|NCT00884741|564237469|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
156310726|NCT00884741|564237470|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
156310727|NCT00884741|564237471|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
156310728|NCT00884741|564237468|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
156310729|NCT00884741|564237469|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
156310730|NCT00884741|564237470|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
156310731|NCT00884741|564237471|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
156310732|NCT00884741|564237468|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
156310733|NCT00884741|564237469|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
156310734|NCT00884741|564237470|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
156310735|NCT00884741|564237471|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
156310736|NCT00884741|564237468|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
156310737|NCT00884741|564237469|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
156310738|NCT00884741|564237470|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
156310739|NCT00884741|564237471|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
156310740|NCT00884741|564237468|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
156413013|NCT01751113|564606737|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156413014|NCT01751113|564606738|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156413015|NCT01751113|564606739|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156413016|NCT01751113|564606740|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
156413017|NCT00363896|564606741|FG000|Overall Study|Withdrawal by Subject|29|||
156413018|NCT00363896|564606742|FG001|Overall Study|Withdrawal by Subject|16|||
156413019|NCT00363896|564606741|FG000|Overall Study|Adverse Event|24|||
156413020|NCT00363896|564606742|FG001|Overall Study|Adverse Event|13|||
156413021|NCT00363896|564606741|FG000|Overall Study|COPD exacerbation|13|||
156413022|NCT00363896|564606742|FG001|Overall Study|COPD exacerbation|7|||
156413023|NCT00363896|564606741|FG000|Overall Study|Lack of Efficacy|12|||
156413024|NCT00363896|564606742|FG001|Overall Study|Lack of Efficacy|8|||
156413025|NCT00363896|564606741|FG000|Overall Study|Protocol Violation|6|||
156413026|NCT00363896|564606742|FG001|Overall Study|Protocol Violation|1|||
156648704|NCT00294723|565461679|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
156648705|NCT00294723|565461677|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
156648706|NCT00294723|565461678|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
156648707|NCT00294723|565461679|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
156310741|NCT00884741|564237469|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
156310742|NCT00884741|564237470|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
156310743|NCT00884741|564237471|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
156413027|NCT00363896|564606741|FG000|Overall Study|Lost to Follow-up|3|||
156413028|NCT00363896|564606742|FG001|Overall Study|Lost to Follow-up|0|||
156413029|NCT00363896|564606741|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
156413030|NCT00363896|564606742|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
156413031|NCT00363896|564606741|FG000|Overall Study|Other|1|||
156413032|NCT00363896|564606742|FG001|Overall Study|Other|2|||
156413033|NCT02878213|564606743|FG000|Overall Study|Withdrawal by Subject|2|||
156413034|NCT02878213|564606743|FG000|Overall Study|Adverse Event|1|||
156413035|NCT01558674|564606744|FG000|Part 1|Study Terminated by Sponsor|10|||
156413036|NCT01558674|564606745|FG001|Part 1|Study Terminated by Sponsor|0|||
156413037|NCT01558674|564606744|FG000|Part 1|Withdrawal by Subject|1|||
156413038|NCT01558674|564606745|FG001|Part 1|Withdrawal by Subject|0|||
156413039|NCT03051659|564606748|FG000|Treatment Period|Withdrawal by Subject|0|||
156413040|NCT03051659|564606749|FG001|Treatment Period|Withdrawal by Subject|2|||
156413041|NCT03051659|564606748|FG000|Survival Follow-up|Lost to Follow-up|23|||
156413042|NCT03051659|564606749|FG001|Survival Follow-up|Lost to Follow-up|22|||
156413043|NCT02589392|564606750|FG000|Overall Study|Adverse Event|1|||
156413044|NCT02589392|564606751|FG001|Overall Study|Adverse Event|1|||
156413045|NCT02589392|564606750|FG000|Overall Study|Withdrawal by Subject|1|||
156413046|NCT02589392|564606751|FG001|Overall Study|Withdrawal by Subject|2|||
156413047|NCT02589392|564606750|FG000|Overall Study|Protocol Violation|1|||
156413048|NCT02589392|564606751|FG001|Overall Study|Protocol Violation|1|||
156413049|NCT02589392|564606750|FG000|Overall Study|Lost to Follow-up|2|||
156413050|NCT02589392|564606751|FG001|Overall Study|Lost to Follow-up|2|||
156413051|NCT02589392|564606750|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
156413052|NCT02589392|564606751|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
156413053|NCT00849680|564606753|FG000|Overall Study|Adverse Event|0|||
156413054|NCT00849680|564606754|FG001|Overall Study|Adverse Event|0|||
156413055|NCT00849680|564606755|FG002|Overall Study|Adverse Event|0|||
156413056|NCT00849680|564606756|FG003|Overall Study|Adverse Event|0|||
156413057|NCT00849680|564606757|FG004|Overall Study|Adverse Event|0|||
156413058|NCT00849680|564606758|FG005|Overall Study|Adverse Event|0|||
156413059|NCT00849680|564606759|FG006|Overall Study|Adverse Event|2|||
156413060|NCT00849680|564606760|FG007|Overall Study|Adverse Event|0|||
156413061|NCT00849680|564606753|FG000|Overall Study|Lost to Follow-up|7|||
156413062|NCT00849680|564606754|FG001|Overall Study|Lost to Follow-up|3|||
156413063|NCT00849680|564606755|FG002|Overall Study|Lost to Follow-up|12|||
156413064|NCT00849680|564606756|FG003|Overall Study|Lost to Follow-up|11|||
156413065|NCT00849680|564606757|FG004|Overall Study|Lost to Follow-up|8|||
156413066|NCT00849680|564606758|FG005|Overall Study|Lost to Follow-up|11|||
156413067|NCT00849680|564606759|FG006|Overall Study|Lost to Follow-up|12|||
156413068|NCT00849680|564606760|FG007|Overall Study|Lost to Follow-up|5|||
156413069|NCT00849680|564606753|FG000|Overall Study|Subject moved|1|||
156413070|NCT00849680|564606754|FG001|Overall Study|Subject moved|0|||
156413071|NCT00849680|564606755|FG002|Overall Study|Subject moved|3|||
156413072|NCT00849680|564606756|FG003|Overall Study|Subject moved|1|||
156413073|NCT00849680|564606757|FG004|Overall Study|Subject moved|0|||
156413074|NCT00849680|564606758|FG005|Overall Study|Subject moved|2|||
156413075|NCT00849680|564606759|FG006|Overall Study|Subject moved|2|||
156413076|NCT00849680|564606760|FG007|Overall Study|Subject moved|2|||
156413077|NCT00849680|564606753|FG000|Overall Study|Withdrawal by Subject|2|||
156413078|NCT00849680|564606754|FG001|Overall Study|Withdrawal by Subject|0|||
156413079|NCT00849680|564606755|FG002|Overall Study|Withdrawal by Subject|0|||
156413080|NCT00849680|564606756|FG003|Overall Study|Withdrawal by Subject|2|||
156413081|NCT00849680|564606757|FG004|Overall Study|Withdrawal by Subject|2|||
156413082|NCT00849680|564606758|FG005|Overall Study|Withdrawal by Subject|2|||
156413083|NCT00849680|564606759|FG006|Overall Study|Withdrawal by Subject|1|||
156413084|NCT00849680|564606760|FG007|Overall Study|Withdrawal by Subject|1|||
156413085|NCT00849680|564606753|FG000|Overall Study|Subject unable to comply with protocol|1|||
156413086|NCT00849680|564606754|FG001|Overall Study|Subject unable to comply with protocol|0|||
156413087|NCT00849680|564606755|FG002|Overall Study|Subject unable to comply with protocol|0|||
156413088|NCT00849680|564606756|FG003|Overall Study|Subject unable to comply with protocol|0|||
156413089|NCT00849680|564606757|FG004|Overall Study|Subject unable to comply with protocol|0|||
156413090|NCT00849680|564606758|FG005|Overall Study|Subject unable to comply with protocol|0|||
156413091|NCT00849680|564606759|FG006|Overall Study|Subject unable to comply with protocol|0|||
156413092|NCT00849680|564606760|FG007|Overall Study|Subject unable to comply with protocol|0|||
156413093|NCT00785538|564606761|FG000|Treatment Period|Adverse Event|1|||
156413094|NCT00785538|564606762|FG001|Treatment Period|Adverse Event|2|||
156413095|NCT00785538|564606763|FG002|Treatment Period|Adverse Event|2|||
156413096|NCT00785538|564606764|FG003|Treatment Period|Adverse Event|0|||
156413097|NCT00785538|564606761|FG000|Treatment Period|Withdrawal by Subject|0|||
156413098|NCT00785538|564606762|FG001|Treatment Period|Withdrawal by Subject|0|||
156413099|NCT00785538|564606763|FG002|Treatment Period|Withdrawal by Subject|0|||
156413100|NCT00785538|564606764|FG003|Treatment Period|Withdrawal by Subject|1|||
156413101|NCT00322374|564606765|FG000|Starting Dose|Physician Decision|2|||
156413102|NCT00322374|564606766|FG001|Starting Dose|Physician Decision|0|||
156413103|NCT00322374|564606767|FG002|Starting Dose|Physician Decision|0|||
156413104|NCT00322374|564606768|FG003|Starting Dose|Physician Decision|0|||
156413105|NCT00322374|564606765|FG000|Starting Dose|Study Drug Toxicity|4|||
156310744|NCT00884741|564237468|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
156310745|NCT00884741|564237469|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
156310746|NCT00884741|564237470|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
156310747|NCT00884741|564237471|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
156310748|NCT00884741|564237468|FG000|Randomization|Protocol Violation|0|||
156310749|NCT00884741|564237469|FG001|Randomization|Protocol Violation|0|||
156310750|NCT00884741|564237470|FG002|Randomization|Protocol Violation|8|||
156648708|NCT00752791|565461680|FG000|Overall Study|Adverse Event|7|||
156648709|NCT00752791|565461680|FG000|Overall Study|Withdrawal by Subject|1|||
156648710|NCT00752791|565461680|FG000|Overall Study|Physician Decision|1|||
156648711|NCT00752791|565461680|FG000|Overall Study|Death|1|||
156648712|NCT00752791|565461680|FG000|Overall Study|Renal transplant|3|||
156648713|NCT00752791|565461680|FG000|Overall Study|Switched to hemodialysis|2|||
156648714|NCT00752791|565461680|FG000|Overall Study|Protocol deviation|1|||
156648715|NCT01967888|565461683|FG000|Overall Study|Lost to Follow-up|6|||
156648716|NCT01967888|565461684|FG001|Overall Study|Lost to Follow-up|4|||
156648717|NCT01967888|565461683|FG000|Overall Study|Withdrawal by Subject|1|||
156648718|NCT01967888|565461684|FG001|Overall Study|Withdrawal by Subject|1|||
156648719|NCT01967888|565461683|FG000|Overall Study|Did Not Have Transplant|1|||
156648720|NCT01967888|565461684|FG001|Overall Study|Did Not Have Transplant|0|||
156648721|NCT01967888|565461683|FG000|Overall Study|Research visit not done, data recorded|1|||
156648722|NCT01967888|565461684|FG001|Overall Study|Research visit not done, data recorded|0|||
156648723|NCT01967888|565461683|FG000|Overall Study|Subject excluded after randomization|1|||
156648724|NCT01967888|565461684|FG001|Overall Study|Subject excluded after randomization|0|||
156648725|NCT01967888|565461683|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
156648726|NCT01967888|565461684|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
156648727|NCT01967888|565461683|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
156648728|NCT01967888|565461684|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
156648729|NCT00891774|565461685|FG000|Overall Study|Lost to Follow-up|5|||
156648730|NCT00891774|565461685|FG000|Overall Study|Illness (Self/Mother)|3|||
156648731|NCT00891774|565461685|FG000|Overall Study|Withdrawal by Subject|2|||
156648732|NCT00891774|565461685|FG000|Overall Study|Protocol Violation|4|||
156648733|NCT01769378|565461691|FG000|Overall Study|Adverse Event|10|||
156648734|NCT01769378|565461692|FG001|Overall Study|Adverse Event|0|||
156648735|NCT01769378|565461691|FG000|Overall Study|Entry criteria not met|1|||
156648736|NCT01769378|565461692|FG001|Overall Study|Entry criteria not met|0|||
156648737|NCT01769378|565461691|FG000|Overall Study|Protocol Violation|1|||
156648738|NCT01769378|565461692|FG001|Overall Study|Protocol Violation|1|||
156648739|NCT01769378|565461691|FG000|Overall Study|Withdrawal by Subject|10|||
156648740|NCT01769378|565461692|FG001|Overall Study|Withdrawal by Subject|3|||
156648741|NCT01769378|565461691|FG000|Overall Study|Sponsor Decision|1|||
156648742|NCT01769378|565461692|FG001|Overall Study|Sponsor Decision|0|||
156648743|NCT01769378|565461691|FG000|Overall Study|Lost to Follow-up|2|||
156648744|NCT01769378|565461692|FG001|Overall Study|Lost to Follow-up|0|||
156648745|NCT03175120|565461693|FG000|Overall Study|Adverse Event|2|||
156648746|NCT03175120|565461694|FG001|Overall Study|Adverse Event|2|||
156648747|NCT03175120|565461693|FG000|Overall Study|Protocol Violation|5|||
156648748|NCT03175120|565461694|FG001|Overall Study|Protocol Violation|2|||
156648749|NCT03175120|565461693|FG000|Overall Study|Lost to Follow-up|1|||
156648750|NCT03175120|565461694|FG001|Overall Study|Lost to Follow-up|0|||
156648751|NCT03175120|565461693|FG000|Overall Study|Withdrawal by Subject|2|||
156648752|NCT03175120|565461694|FG001|Overall Study|Withdrawal by Subject|5|||
156648753|NCT03175120|565461693|FG000|Overall Study|Other|2|||
156648754|NCT03175120|565461694|FG001|Overall Study|Other|3|||
156648755|NCT01958281|565461695|FG000|Overall Study|Lack of Efficacy|5|||
156648756|NCT01958281|565461696|FG001|Overall Study|Lack of Efficacy|2|||
156648757|NCT01958281|565461697|FG002|Overall Study|Lack of Efficacy|0|||
156648758|NCT01958281|565461695|FG000|Overall Study|Adverse Event|0|||
156648759|NCT01958281|565461696|FG001|Overall Study|Adverse Event|2|||
156648760|NCT01958281|565461697|FG002|Overall Study|Adverse Event|0|||
156648761|NCT01958281|565461695|FG000|Overall Study|Withdrew Consent|1|||
156648762|NCT01958281|565461696|FG001|Overall Study|Withdrew Consent|0|||
156648763|NCT01958281|565461697|FG002|Overall Study|Withdrew Consent|0|||
156648764|NCT03038113|565461698|FG000|Overall Study|Withdrawal by Subject|0|||
156648765|NCT03038113|565461699|FG001|Overall Study|Withdrawal by Subject|0|||
156310751|NCT00884741|564237471|FG003|Randomization|Protocol Violation|8|||
156648766|NCT03038113|565461700|FG002|Overall Study|Withdrawal by Subject|1|||
156648767|NCT03038113|565461701|FG003|Overall Study|Withdrawal by Subject|0|||
156648768|NCT03038113|565461702|FG004|Overall Study|Withdrawal by Subject|0|||
156648769|NCT03038113|565461703|FG005|Overall Study|Withdrawal by Subject|0|||
156648770|NCT03038113|565461704|FG006|Overall Study|Withdrawal by Subject|0|||
156648771|NCT03038113|565461705|FG007|Overall Study|Withdrawal by Subject|0|||
156648772|NCT03038113|565461706|FG008|Overall Study|Withdrawal by Subject|0|||
156648773|NCT03038113|565461707|FG009|Overall Study|Withdrawal by Subject|0|||
156648774|NCT03038113|565461708|FG010|Overall Study|Withdrawal by Subject|0|||
156648775|NCT03038113|565461709|FG011|Overall Study|Withdrawal by Subject|0|||
156648776|NCT03038113|565461710|FG012|Overall Study|Withdrawal by Subject|0|||
156648777|NCT03038113|565461711|FG013|Overall Study|Withdrawal by Subject|1|||
156648778|NCT03038113|565461698|FG000|Overall Study|Lost to Follow-up|0|||
156648779|NCT03038113|565461699|FG001|Overall Study|Lost to Follow-up|0|||
156648780|NCT03038113|565461700|FG002|Overall Study|Lost to Follow-up|0|||
156648781|NCT03038113|565461701|FG003|Overall Study|Lost to Follow-up|0|||
156648782|NCT03038113|565461702|FG004|Overall Study|Lost to Follow-up|0|||
156648783|NCT03038113|565461703|FG005|Overall Study|Lost to Follow-up|0|||
156648784|NCT03038113|565461704|FG006|Overall Study|Lost to Follow-up|1|||
156648785|NCT03038113|565461705|FG007|Overall Study|Lost to Follow-up|0|||
156648786|NCT03038113|565461706|FG008|Overall Study|Lost to Follow-up|0|||
156648787|NCT03038113|565461707|FG009|Overall Study|Lost to Follow-up|0|||
156648788|NCT03038113|565461708|FG010|Overall Study|Lost to Follow-up|0|||
156648789|NCT03038113|565461709|FG011|Overall Study|Lost to Follow-up|0|||
156648790|NCT03038113|565461710|FG012|Overall Study|Lost to Follow-up|0|||
156648791|NCT03038113|565461711|FG013|Overall Study|Lost to Follow-up|0|||
156648792|NCT02784106|565461714|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
156648793|NCT02784106|565461715|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
156648794|NCT02784106|565461716|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156648795|NCT02784106|565461717|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156648796|NCT02784106|565461714|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
156648797|NCT02784106|565461715|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
156648798|NCT02784106|565461716|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156648799|NCT02784106|565461717|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156648800|NCT02784106|565461714|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
156648801|NCT02784106|565461715|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
156648802|NCT02784106|565461716|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
156648803|NCT02784106|565461717|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
156648804|NCT02784106|565461714|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
156648805|NCT02784106|565461715|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
156310752|NCT01994889|564237472|FG000|Overall Study|Adverse Event|5|||
156310753|NCT01994889|564237473|FG001|Overall Study|Adverse Event|12|||
156310754|NCT01994889|564237474|FG002|Overall Study|Adverse Event|11|||
156310755|NCT01994889|564237472|FG000|Overall Study|Cardiac Device Implantation|0|||
156310756|NCT01994889|564237473|FG001|Overall Study|Cardiac Device Implantation|2|||
156310757|NCT01994889|564237474|FG002|Overall Study|Cardiac Device Implantation|0|||
156310758|NCT01994889|564237472|FG000|Overall Study|Organ Transplantation|1|||
156310759|NCT01994889|564237473|FG001|Overall Study|Organ Transplantation|5|||
156310760|NCT01994889|564237474|FG002|Overall Study|Organ Transplantation|5|||
156310761|NCT01994889|564237472|FG000|Overall Study|No longer willing to participate|8|||
156310762|NCT01994889|564237473|FG001|Overall Study|No longer willing to participate|17|||
156310763|NCT01994889|564237474|FG002|Overall Study|No longer willing to participate|37|||
156310764|NCT01994889|564237472|FG000|Overall Study|Lost to Follow-up|0|||
156310765|NCT01994889|564237473|FG001|Overall Study|Lost to Follow-up|1|||
156310766|NCT01994889|564237474|FG002|Overall Study|Lost to Follow-up|0|||
156310767|NCT01994889|564237472|FG000|Overall Study|Protocol Violation|0|||
156310768|NCT01994889|564237473|FG001|Overall Study|Protocol Violation|1|||
156310769|NCT01994889|564237474|FG002|Overall Study|Protocol Violation|1|||
156310770|NCT01994889|564237472|FG000|Overall Study|Death|14|||
156310771|NCT01994889|564237473|FG001|Overall Study|Death|25|||
156310772|NCT01994889|564237474|FG002|Overall Study|Death|38|||
156310773|NCT00145977|564237478|FG000|Overall Study|Lack of Efficacy|0|||
156310774|NCT00145977|564237479|FG001|Overall Study|Lack of Efficacy|4|||
156310775|NCT00145977|564237478|FG000|Overall Study|Lost to Follow-up|1|||
156310776|NCT00145977|564237479|FG001|Overall Study|Lost to Follow-up|0|||
156310777|NCT00145977|564237478|FG000|Overall Study|Withdrawal by Subject|1|||
156310778|NCT00145977|564237479|FG001|Overall Study|Withdrawal by Subject|0|||
156310779|NCT01711216|564237480|FG000|Overall Study|Adverse Event|4|||
156310780|NCT01711216|564237480|FG000|Overall Study|Pregnancy|56|||
156310781|NCT01711216|564237480|FG000|Overall Study|Withdrawal by Subject|6|||
156310782|NCT01711216|564237480|FG000|Overall Study|Lost to Follow-up|46|||
156310783|NCT01711216|564237480|FG000|Overall Study|variety of other minor reasons|83|||
156310784|NCT01711216|564237480|FG000|Overall Study|no reason specified|22|||
156310785|NCT03060551|564237481|FG000|Overall Study|Withdrawal by Subject|1|||
156310786|NCT03060551|564237481|FG000|Overall Study|Adverse Event|1|||
156310787|NCT02660983|564237484|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
156310788|NCT02660983|564237485|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
156310789|NCT02660983|564237484|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
156310790|NCT02660983|564237485|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
156310791|NCT02660983|564237484|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
156648806|NCT02784106|565461716|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
156648807|NCT02784106|565461717|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
156648808|NCT02784106|565461714|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
156310792|NCT02660983|564237485|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
156413106|NCT00322374|564606766|FG001|Starting Dose|Study Drug Toxicity|0|||
156413107|NCT00322374|564606767|FG002|Starting Dose|Study Drug Toxicity|0|||
156413108|NCT00322374|564606768|FG003|Starting Dose|Study Drug Toxicity|0|||
156413109|NCT00322374|564606765|FG000|First Escalation|Documented Disease Progression|0|||
156413110|NCT00322374|564606766|FG001|First Escalation|Documented Disease Progression|6|||
156413111|NCT00322374|564606767|FG002|First Escalation|Documented Disease Progression|0|||
156413112|NCT00322374|564606768|FG003|First Escalation|Documented Disease Progression|0|||
156413113|NCT00322374|564606765|FG000|First Escalation|Physician Decision|0|||
156413114|NCT00322374|564606766|FG001|First Escalation|Physician Decision|12|||
156413115|NCT00322374|564606767|FG002|First Escalation|Physician Decision|0|||
156413116|NCT00322374|564606768|FG003|First Escalation|Physician Decision|0|||
156413117|NCT00322374|564606765|FG000|First Escalation|Study Drug Toxicity|0|||
156413118|NCT00322374|564606766|FG001|First Escalation|Study Drug Toxicity|11|||
156413119|NCT00322374|564606767|FG002|First Escalation|Study Drug Toxicity|0|||
156413120|NCT00322374|564606768|FG003|First Escalation|Study Drug Toxicity|0|||
156413121|NCT00322374|564606765|FG000|First Escalation|Participant Request|0|||
156413122|NCT00322374|564606766|FG001|First Escalation|Participant Request|1|||
156413123|NCT00322374|564606767|FG002|First Escalation|Participant Request|0|||
156413124|NCT00322374|564606768|FG003|First Escalation|Participant Request|0|||
156413125|NCT00322374|564606765|FG000|Second Escalation|Physician Decision|0|||
156413126|NCT00322374|564606766|FG001|Second Escalation|Physician Decision|0|||
156413127|NCT00322374|564606767|FG002|Second Escalation|Physician Decision|5|||
156413128|NCT00322374|564606768|FG003|Second Escalation|Physician Decision|0|||
156413129|NCT00322374|564606765|FG000|Second Escalation|Study Drug Toxicity|0|||
156413130|NCT00322374|564606766|FG001|Second Escalation|Study Drug Toxicity|0|||
156413131|NCT00322374|564606767|FG002|Second Escalation|Study Drug Toxicity|1|||
156413132|NCT00322374|564606768|FG003|Second Escalation|Study Drug Toxicity|0|||
156413133|NCT03382600|564606769|FG000|Overall Study|Adverse Event|3|||
156413134|NCT03382600|564606770|FG001|Overall Study|Adverse Event|3|||
156413135|NCT03382600|564606769|FG000|Overall Study|Clinical Disease Progression|2|||
156413136|NCT03382600|564606770|FG001|Overall Study|Clinical Disease Progression|4|||
156413137|NCT03382600|564606769|FG000|Overall Study|Radiological Progression|40|||
156413138|NCT03382600|564606770|FG001|Overall Study|Radiological Progression|31|||
156413139|NCT03382600|564606769|FG000|Overall Study|Withdrawal by Subject|0|||
156413140|NCT03382600|564606770|FG001|Overall Study|Withdrawal by Subject|1|||
156413141|NCT03382600|564606769|FG000|Overall Study|Other|9|||
156413142|NCT03382600|564606770|FG001|Overall Study|Other|7|||
156413143|NCT01000376|564606774|FG000|Cycle 1 Day 1|Adverse Event|1|||
156413144|NCT01000376|564606775|FG001|Cycle 1 Day 1|Adverse Event|0|||
156413145|NCT01000376|564606774|FG000|Cycle 1 Day 1|Progressive Disease|1|||
156413146|NCT01000376|564606775|FG001|Cycle 1 Day 1|Progressive Disease|0|||
156413147|NCT04285229|564606777|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156413148|NCT04285229|564606778|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156413149|NCT04285229|564606779|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156413150|NCT04285229|564606780|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156413151|NCT04285229|564606781|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156413152|NCT04285229|564606782|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156413153|NCT04285229|564606777|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
156413154|NCT04285229|564606778|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
156413155|NCT04285229|564606779|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
156413156|NCT04285229|564606780|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
156413157|NCT04285229|564606781|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
156413158|NCT04285229|564606782|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
156413159|NCT04285229|564606777|FG000|Extended Treatment Period|Adverse Event|0|||
156413160|NCT04285229|564606778|FG001|Extended Treatment Period|Adverse Event|0|||
156413161|NCT04285229|564606779|FG002|Extended Treatment Period|Adverse Event|0|||
156413162|NCT04285229|564606780|FG003|Extended Treatment Period|Adverse Event|1|||
156413163|NCT04285229|564606781|FG004|Extended Treatment Period|Adverse Event|0|||
156413164|NCT04285229|564606782|FG005|Extended Treatment Period|Adverse Event|0|||
156413165|NCT04285229|564606777|FG000|Extended Treatment Period|Physician Decision|0|||
156413166|NCT04285229|564606778|FG001|Extended Treatment Period|Physician Decision|0|||
156413167|NCT04285229|564606779|FG002|Extended Treatment Period|Physician Decision|1|||
156413168|NCT04285229|564606780|FG003|Extended Treatment Period|Physician Decision|0|||
156413169|NCT04285229|564606781|FG004|Extended Treatment Period|Physician Decision|0|||
156413170|NCT04285229|564606782|FG005|Extended Treatment Period|Physician Decision|0|||
156413171|NCT04285229|564606777|FG000|Follow-up Period|Adverse Event|0|||
156413172|NCT04285229|564606778|FG001|Follow-up Period|Adverse Event|0|||
156413173|NCT04285229|564606779|FG002|Follow-up Period|Adverse Event|0|||
156413174|NCT04285229|564606780|FG003|Follow-up Period|Adverse Event|0|||
156413175|NCT04285229|564606781|FG004|Follow-up Period|Adverse Event|1|||
156413176|NCT04285229|564606782|FG005|Follow-up Period|Adverse Event|4|||
156413177|NCT04285229|564606777|FG000|Follow-up Period|Withdrawal by Subject|0|||
156413178|NCT04285229|564606778|FG001|Follow-up Period|Withdrawal by Subject|0|||
156413179|NCT04285229|564606779|FG002|Follow-up Period|Withdrawal by Subject|0|||
156648809|NCT02784106|565461715|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
156310793|NCT02660983|564237484|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
156310794|NCT02660983|564237485|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
156310795|NCT02660983|564237484|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
156310796|NCT02660983|564237485|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
156310797|NCT02660983|564237484|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
156310798|NCT02660983|564237485|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
156310799|NCT02660983|564237484|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
156310800|NCT02660983|564237485|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
156310801|NCT00334113|564237487|FG000|Overall Study|Lost to Follow-up|2|||
156310802|NCT00334113|564237488|FG001|Overall Study|Lost to Follow-up|2|||
156310803|NCT00334113|564237487|FG000|Overall Study|Withdrawal by Subject|0|||
156310804|NCT00334113|564237488|FG001|Overall Study|Withdrawal by Subject|1|||
156310805|NCT02509026|564237493|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
156310806|NCT02509026|564237493|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
156310807|NCT02509026|564237493|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
156310808|NCT02509026|564237493|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
156310809|NCT02509026|564237493|FG000|Induction Period (24 Weeks)|Other|2|||
156310810|NCT02509026|564237493|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
156310811|NCT02509026|564237493|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
156310812|NCT02509026|564237493|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
156310813|NCT02509026|564237493|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
156310814|NCT02509026|564237493|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
156310815|NCT02509026|564237493|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
156310816|NCT02509026|564237493|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
156310817|NCT02509026|564237493|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
156310818|NCT00243841|564237497|FG000|Overall Study|Physician Decision|0|||
156310819|NCT00243841|564237498|FG001|Overall Study|Physician Decision|0|||
156310820|NCT00243841|564237499|FG002|Overall Study|Physician Decision|1|||
156310821|NCT00243841|564237500|FG003|Overall Study|Physician Decision|0|||
156310822|NCT00243841|564237501|FG004|Overall Study|Physician Decision|0|||
156310823|NCT00243841|564237502|FG005|Overall Study|Physician Decision|2|||
156310824|NCT05601544|564237503|FG000|Phase 2 Period 1|Adverse Event|0|||
156310825|NCT05601544|564237504|FG001|Phase 2 Period 1|Adverse Event|1|||
156310826|NCT05601544|564237505|FG002|Phase 2 Period 1|Adverse Event|0|||
156310827|NCT05601544|564237506|FG003|Phase 2 Period 1|Adverse Event|0|||
156310828|NCT05601544|564237507|FG004|Phase 2 Period 1|Adverse Event|0|||
156310829|NCT05601544|564237508|FG005|Phase 2 Period 1|Adverse Event|0|||
156310830|NCT04303195|564237509|FG000|Overall Study|Adverse Event|1|||
156310831|NCT04303195|564237510|FG001|Overall Study|Adverse Event|3|||
156310832|NCT04303195|564237511|FG002|Overall Study|Adverse Event|7|||
156310833|NCT04303195|564237512|FG003|Overall Study|Adverse Event|0|||
156310834|NCT04303195|564237509|FG000|Overall Study|Lost to Follow-up|1|||
156310835|NCT04303195|564237510|FG001|Overall Study|Lost to Follow-up|0|||
156310836|NCT04303195|564237511|FG002|Overall Study|Lost to Follow-up|1|||
156310837|NCT04303195|564237512|FG003|Overall Study|Lost to Follow-up|4|||
156310838|NCT04303195|564237509|FG000|Overall Study|Withdrawal by Subject|3|||
156310839|NCT04303195|564237510|FG001|Overall Study|Withdrawal by Subject|1|||
156310840|NCT04303195|564237511|FG002|Overall Study|Withdrawal by Subject|1|||
156310841|NCT04303195|564237512|FG003|Overall Study|Withdrawal by Subject|1|||
156310842|NCT04303195|564237509|FG000|Overall Study|No study drug administered or protocol deviation|0|||
156310843|NCT04303195|564237510|FG001|Overall Study|No study drug administered or protocol deviation|2|||
156310844|NCT04303195|564237511|FG002|Overall Study|No study drug administered or protocol deviation|0|||
156310845|NCT04303195|564237512|FG003|Overall Study|No study drug administered or protocol deviation|2|||
156310846|NCT01064947|564237513|FG000|Overall Study|negative culture|41|||
156310847|NCT02970942|564237514|FG000|Overall Study|Death|0|||
156310848|NCT02970942|564237515|FG001|Overall Study|Death|1|||
156310849|NCT02970942|564237516|FG002|Overall Study|Death|0|||
156310850|NCT02970942|564237517|FG003|Overall Study|Death|0|||
156310851|NCT02970942|564237514|FG000|Overall Study|Lost to Follow-up|1|||
156310852|NCT02970942|564237515|FG001|Overall Study|Lost to Follow-up|0|||
156310853|NCT02970942|564237516|FG002|Overall Study|Lost to Follow-up|2|||
156310854|NCT02970942|564237517|FG003|Overall Study|Lost to Follow-up|1|||
156310855|NCT02970942|564237514|FG000|Overall Study|Withdrawal by Subject|3|||
156310856|NCT02970942|564237515|FG001|Overall Study|Withdrawal by Subject|5|||
156310857|NCT02970942|564237516|FG002|Overall Study|Withdrawal by Subject|3|||
156310858|NCT02970942|564237517|FG003|Overall Study|Withdrawal by Subject|2|||
156310859|NCT06457204|564237518|FG000|Washout|Adverse Event|0|||
156310860|NCT06457204|564237519|FG001|Washout|Adverse Event|2|||
156310861|NCT01065454|564237522|FG000|Treatment|Adverse Event|7|||
156310862|NCT01065454|564237523|FG001|Treatment|Adverse Event|4|||
156310863|NCT01065454|564237524|FG002|Treatment|Adverse Event|3|||
156310864|NCT01065454|564237525|FG003|Treatment|Adverse Event|6|||
156310865|NCT01065454|564237522|FG000|Treatment|Death|1|||
156310866|NCT01065454|564237523|FG001|Treatment|Death|0|||
156310867|NCT01065454|564237524|FG002|Treatment|Death|0|||
156310868|NCT01065454|564237525|FG003|Treatment|Death|0|||
156310869|NCT01065454|564237522|FG000|Treatment|Non-compliance|1|||
156310870|NCT01065454|564237523|FG001|Treatment|Non-compliance|0|||
156310871|NCT01065454|564237524|FG002|Treatment|Non-compliance|0|||
156310872|NCT01065454|564237525|FG003|Treatment|Non-compliance|1|||
156310873|NCT01065454|564237522|FG000|Treatment|Protocol Decision|0|||
156310874|NCT01065454|564237523|FG001|Treatment|Protocol Decision|0|||
156310875|NCT01065454|564237524|FG002|Treatment|Protocol Decision|3|||
156310876|NCT01065454|564237525|FG003|Treatment|Protocol Decision|2|||
156310877|NCT01065454|564237522|FG000|Treatment|Protocol Violation|1|||
156310878|NCT01065454|564237523|FG001|Treatment|Protocol Violation|0|||
156310879|NCT01065454|564237524|FG002|Treatment|Protocol Violation|1|||
156310880|NCT01065454|564237525|FG003|Treatment|Protocol Violation|0|||
156310881|NCT01065454|564237522|FG000|Treatment|Withdrawal by Subject|3|||
156310882|NCT01065454|564237523|FG001|Treatment|Withdrawal by Subject|1|||
156310883|NCT01065454|564237524|FG002|Treatment|Withdrawal by Subject|2|||
156310884|NCT01065454|564237525|FG003|Treatment|Withdrawal by Subject|3|||
156310885|NCT01065454|564237522|FG000|Follow up|Adverse Event|1|||
156310886|NCT01065454|564237523|FG001|Follow up|Adverse Event|0|||
156310887|NCT01065454|564237524|FG002|Follow up|Adverse Event|0|||
156310888|NCT01065454|564237525|FG003|Follow up|Adverse Event|1|||
156310889|NCT01065454|564237522|FG000|Follow up|Death|0|||
156310890|NCT01065454|564237523|FG001|Follow up|Death|1|||
156310891|NCT01065454|564237524|FG002|Follow up|Death|1|||
156310892|NCT01065454|564237525|FG003|Follow up|Death|0|||
156310893|NCT01065454|564237522|FG000|Follow up|Lost to Follow-up|0|||
156310894|NCT01065454|564237523|FG001|Follow up|Lost to Follow-up|0|||
156310895|NCT01065454|564237524|FG002|Follow up|Lost to Follow-up|0|||
156310896|NCT01065454|564237525|FG003|Follow up|Lost to Follow-up|1|||
156310897|NCT01065454|564237522|FG000|Follow up|Progressive disease|0|||
156310898|NCT01065454|564237523|FG001|Follow up|Progressive disease|0|||
156310899|NCT01065454|564237524|FG002|Follow up|Progressive disease|0|||
156310900|NCT01065454|564237525|FG003|Follow up|Progressive disease|1|||
156310901|NCT01065454|564237522|FG000|Follow up|Withdrawal by Subject|1|||
156310902|NCT01065454|564237523|FG001|Follow up|Withdrawal by Subject|1|||
156310903|NCT01065454|564237524|FG002|Follow up|Withdrawal by Subject|1|||
156310904|NCT01065454|564237525|FG003|Follow up|Withdrawal by Subject|0|||
156310905|NCT01065454|564237522|FG000|Follow up|study ongoing|37|||
156310906|NCT01065454|564237523|FG001|Follow up|study ongoing|22|||
156310907|NCT01065454|564237524|FG002|Follow up|study ongoing|15|||
156310908|NCT01065454|564237525|FG003|Follow up|study ongoing|41|||
156310909|NCT01601652|564237527|FG000|Overall Study|Death|1|||
156310910|NCT01097005|564237544|FG000|Overall Study|Case Report Form not collected|18|||
156310911|NCT01097005|564237544|FG000|Overall Study|Subjects cannot visit the hospital|1|||
156310912|NCT01097005|564237544|FG000|Overall Study|Poor medication compliance|1|||
156310913|NCT01097005|564237544|FG000|Overall Study|No examination data available|244|||
156310914|NCT01097005|564237544|FG000|Overall Study|Deviation from exclusion criteria|37|||
156310915|NCT01097005|564237544|FG000|Overall Study|Adverse Event|14|||
156310916|NCT01097005|564237544|FG000|Overall Study|Discontinuance by complication|50|||
156310917|NCT03374202|564237549|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
156310918|NCT03374202|564237550|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
156310919|NCT03374202|564237551|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
156310920|NCT03374202|564237549|FG000|Five Year Long Term Follow Up|Death|0|||
156310921|NCT03374202|564237550|FG001|Five Year Long Term Follow Up|Death|1|||
156310922|NCT03374202|564237551|FG002|Five Year Long Term Follow Up|Death|0|||
156310923|NCT00336856|564239222|FG000|Overall Study|Withdrawal by Subject|3|||
156310924|NCT00336856|564239222|FG000|Overall Study|Found ineligible at time of analysis|1|||
156310925|NCT01325337|564239223|FG000|Overall Study|Adverse Event|0|||
156310926|NCT01325337|564239224|FG001|Overall Study|Adverse Event|2|||
156310927|NCT01325337|564239225|FG002|Overall Study|Adverse Event|2|||
156310928|NCT01325337|564239226|FG003|Overall Study|Adverse Event|1|||
156310929|NCT01325337|564239227|FG004|Overall Study|Adverse Event|2|||
156310930|NCT01325337|564239223|FG000|Overall Study|Lost to Follow-up|2|||
156310931|NCT01325337|564239224|FG001|Overall Study|Lost to Follow-up|2|||
156310932|NCT01325337|564239225|FG002|Overall Study|Lost to Follow-up|2|||
156310933|NCT01325337|564239226|FG003|Overall Study|Lost to Follow-up|1|||
156310934|NCT01325337|564239227|FG004|Overall Study|Lost to Follow-up|2|||
156310935|NCT01325337|564239223|FG000|Overall Study|Personal Reasons|2|||
156310936|NCT01325337|564239224|FG001|Overall Study|Personal Reasons|5|||
156310937|NCT01325337|564239225|FG002|Overall Study|Personal Reasons|4|||
156310938|NCT01325337|564239226|FG003|Overall Study|Personal Reasons|8|||
156310939|NCT01325337|564239227|FG004|Overall Study|Personal Reasons|3|||
156310940|NCT01325337|564239223|FG000|Overall Study|Withdrawal by Subject|1|||
156310941|NCT01325337|564239224|FG001|Overall Study|Withdrawal by Subject|0|||
156310942|NCT01325337|564239225|FG002|Overall Study|Withdrawal by Subject|1|||
156310943|NCT01325337|564239226|FG003|Overall Study|Withdrawal by Subject|0|||
156310944|NCT01325337|564239227|FG004|Overall Study|Withdrawal by Subject|1|||
156310945|NCT01332799|564239244|FG000|Overall Study|Insufficient funding|10|||
156310946|NCT01332799|564239245|FG001|Overall Study|Insufficient funding|10|||
156310947|NCT00538785|564239248|FG000|Overall Study|Death|9|||
156310948|NCT00538785|564239249|FG001|Overall Study|Death|10|||
156310949|NCT00538785|564239248|FG000|Overall Study|Withdrawal of consent|9|||
156310950|NCT00538785|564239249|FG001|Overall Study|Withdrawal of consent|7|||
156310951|NCT00538785|564239248|FG000|Overall Study|Lost to Follow-up|1|||
156310952|NCT00538785|564239249|FG001|Overall Study|Lost to Follow-up|0|||
156310953|NCT04022733|564239250|FG000|Overall Study|conversion to open surgery|3|||
156310954|NCT04022733|564239251|FG001|Overall Study|conversion to open surgery|2|||
156310955|NCT04022733|564239250|FG000|Overall Study|bradycardia|0|||
156310956|NCT04022733|564239251|FG001|Overall Study|bradycardia|1|||
156310957|NCT05315908|564239259|FG000|Overall Study|Lost to Follow-up|4477|||
156310958|NCT05315908|564239260|FG001|Overall Study|Lost to Follow-up|4606|||
156310959|NCT00505076|564239269|FG000|Overall Study|Adverse Event|1|||
156310960|NCT00505076|564239270|FG001|Overall Study|Adverse Event|0|||
156310961|NCT00505076|564239271|FG002|Overall Study|Adverse Event|1|||
156310962|NCT00505076|564239269|FG000|Overall Study|Protocol Violation|2|||
156310963|NCT00505076|564239270|FG001|Overall Study|Protocol Violation|1|||
156310964|NCT00505076|564239271|FG002|Overall Study|Protocol Violation|2|||
156310965|NCT00505076|564239269|FG000|Overall Study|Withdrawal by Subject|0|||
156310966|NCT00505076|564239270|FG001|Overall Study|Withdrawal by Subject|1|||
156310967|NCT00505076|564239271|FG002|Overall Study|Withdrawal by Subject|2|||
156310968|NCT01128621|564239278|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
156310969|NCT01128621|564239279|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
156310970|NCT00233454|564239282|FG000|Overall Study|Death|6|||
156310971|NCT00388583|564239283|FG000|Overall Study|Protocol Violation|1|||
156310972|NCT00388583|564239284|FG001|Overall Study|Protocol Violation|0|||
156310973|NCT00388583|564239283|FG000|Overall Study|Withdrawal by Subject|3|||
156310974|NCT00388583|564239284|FG001|Overall Study|Withdrawal by Subject|3|||
156310975|NCT00388583|564239283|FG000|Overall Study|Serious Adverse Event|2|||
156310976|NCT00388583|564239284|FG001|Overall Study|Serious Adverse Event|0|||
156310977|NCT00388583|564239283|FG000|Overall Study|Did not receive vaccine|0|||
156310978|NCT00388583|564239284|FG001|Overall Study|Did not receive vaccine|1|||
156310979|NCT05194579|564239287|FG000|Overall Study|Lost to Follow-up|2|||
156310980|NCT05194579|564239288|FG001|Overall Study|Lost to Follow-up|3|||
156310981|NCT05194579|564239287|FG000|Overall Study|Withdrawal by Subject|3|||
156310982|NCT05194579|564239288|FG001|Overall Study|Withdrawal by Subject|4|||
156310983|NCT05194579|564239287|FG000|Overall Study|Refused further study procedures|0|||
156310984|NCT05194579|564239288|FG001|Overall Study|Refused further study procedures|1|||
156310985|NCT05194579|564239287|FG000|Overall Study|Protocol deviation|1|||
156310986|NCT05194579|564239288|FG001|Overall Study|Protocol deviation|0|||
156310987|NCT03595228|564239293|FG000|Overall Study|Death|2|||
156310988|NCT03595228|564239293|FG000|Overall Study|Lack of Efficacy|13|||
156310989|NCT03595228|564239293|FG000|Overall Study|Withdrawal by Subject|3|||
156310990|NCT03595228|564239293|FG000|Overall Study|Withdrawal by Sponsor|1|||
156310991|NCT01639729|564239294|FG000|Overall Study|Withdrawal by Subject|1|||
156310992|NCT01639729|564239295|FG001|Overall Study|Withdrawal by Subject|0|||
156310993|NCT01639729|564239296|FG002|Overall Study|Withdrawal by Subject|1|||
156310994|NCT01639729|564239297|FG003|Overall Study|Withdrawal by Subject|1|||
156310995|NCT01639729|564239298|FG004|Overall Study|Withdrawal by Subject|0|||
156310996|NCT01639729|564239299|FG005|Overall Study|Withdrawal by Subject|0|||
156310997|NCT03232333|564239300|FG000|Overall Study|Infection or Osteomyelitis|9|||
156310998|NCT03232333|564239300|FG000|Overall Study|Lost to Follow-up|4|||
156310999|NCT03232333|564239300|FG000|Overall Study|Withdrawal by Subject|2|||
156311000|NCT01253811|564239301|FG000|Overall Study|Withdrawal criteria|1|||
156311001|NCT00759564|564239302|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
156311002|NCT00759564|564239303|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
156311003|NCT00759564|564239304|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
156311004|NCT00759564|564239305|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
156311005|NCT00759564|564239306|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
156311006|NCT04975438|564239315|FG000|Overall Study|Lost to Follow-up|1|||
156311007|NCT04975438|564239316|FG001|Overall Study|Lost to Follow-up|0|||
156311008|NCT04975438|564239317|FG002|Overall Study|Lost to Follow-up|1|||
156311009|NCT04975438|564239318|FG003|Overall Study|Lost to Follow-up|0|||
156311010|NCT04975438|564239315|FG000|Overall Study|Withdrawal by Subject|1|||
156311011|NCT04975438|564239316|FG001|Overall Study|Withdrawal by Subject|0|||
156311012|NCT04975438|564239317|FG002|Overall Study|Withdrawal by Subject|0|||
156311013|NCT04975438|564239318|FG003|Overall Study|Withdrawal by Subject|0|||
156311014|NCT04973436|564239319|FG000|Overall Study|Lost to Follow-up|3|||
156311015|NCT04973436|564239319|FG000|Overall Study|Withdrawal by Subject|1|||
156311016|NCT04973436|564239319|FG000|Overall Study|Death|2|||
156311017|NCT02410343|564239320|FG000|Core Period (24 Weeks)|Adverse Event|1|||
156311018|NCT02410343|564239321|FG001|Core Period (24 Weeks)|Adverse Event|0|||
156311019|NCT02410343|564239320|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
156311020|NCT02410343|564239321|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
156311021|NCT02410343|564239320|FG000|Extension Period (12 Months)|Adverse Event|1|||
156311022|NCT02410343|564239321|FG001|Extension Period (12 Months)|Adverse Event|0|||
156311023|NCT02410343|564239320|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
156311024|NCT02410343|564239321|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
156311025|NCT04556383|564239324|FG000|PCP|Lack of Efficacy|28|||
156311026|NCT04556383|564239325|FG001|PCP|Lack of Efficacy|23|||
156311027|NCT04556383|564239326|FG002|PCP|Lack of Efficacy|23|||
156311028|NCT04556383|564239327|FG003|PCP|Lack of Efficacy|0|||
156311029|NCT04556383|564239324|FG000|PCP|Study terminated by sponsor|15|||
156311030|NCT04556383|564239325|FG001|PCP|Study terminated by sponsor|13|||
156311031|NCT04556383|564239326|FG002|PCP|Study terminated by sponsor|16|||
156311032|NCT04556383|564239327|FG003|PCP|Study terminated by sponsor|0|||
156311033|NCT04556383|564239324|FG000|PCP|Withdrawal by Subject|8|||
156311034|NCT04556383|564239325|FG001|PCP|Withdrawal by Subject|6|||
156311035|NCT04556383|564239326|FG002|PCP|Withdrawal by Subject|6|||
156311036|NCT04556383|564239327|FG003|PCP|Withdrawal by Subject|0|||
156413180|NCT04285229|564606780|FG003|Follow-up Period|Withdrawal by Subject|0|||
156311037|NCT04556383|564239324|FG000|PCP|Adverse Event|1|||
156311038|NCT04556383|564239325|FG001|PCP|Adverse Event|7|||
156311039|NCT04556383|564239326|FG002|PCP|Adverse Event|7|||
156311040|NCT04556383|564239327|FG003|PCP|Adverse Event|0|||
156413181|NCT04285229|564606781|FG004|Follow-up Period|Withdrawal by Subject|0|||
156413182|NCT04285229|564606782|FG005|Follow-up Period|Withdrawal by Subject|5|||
156311041|NCT04556383|564239324|FG000|PCP|Other, Not Specified|1|||
156311042|NCT04556383|564239325|FG001|PCP|Other, Not Specified|2|||
156311043|NCT04556383|564239326|FG002|PCP|Other, Not Specified|1|||
156311044|NCT04556383|564239327|FG003|PCP|Other, Not Specified|0|||
156311045|NCT04556383|564239324|FG000|PCP|Protocol Violation|1|||
156311046|NCT04556383|564239325|FG001|PCP|Protocol Violation|0|||
156311047|NCT04556383|564239326|FG002|PCP|Protocol Violation|1|||
156311048|NCT04556383|564239327|FG003|PCP|Protocol Violation|0|||
156311049|NCT04556383|564239324|FG000|PCP|Lost to Follow-up|1|||
156311050|NCT04556383|564239325|FG001|PCP|Lost to Follow-up|0|||
156413183|NCT04285229|564606777|FG000|Follow-up Period|Covid-19|0|||
156413184|NCT04285229|564606778|FG001|Follow-up Period|Covid-19|0|||
156413185|NCT04285229|564606779|FG002|Follow-up Period|Covid-19|0|||
156413186|NCT04285229|564606780|FG003|Follow-up Period|Covid-19|0|||
156413187|NCT04285229|564606781|FG004|Follow-up Period|Covid-19|0|||
156413188|NCT04285229|564606782|FG005|Follow-up Period|Covid-19|2|||
156413189|NCT04285229|564606777|FG000|Follow-up Period|Physician Decision|0|||
156413190|NCT04285229|564606778|FG001|Follow-up Period|Physician Decision|0|||
156413191|NCT04285229|564606779|FG002|Follow-up Period|Physician Decision|0|||
156413192|NCT04285229|564606780|FG003|Follow-up Period|Physician Decision|0|||
156413193|NCT04285229|564606781|FG004|Follow-up Period|Physician Decision|0|||
156413194|NCT04285229|564606782|FG005|Follow-up Period|Physician Decision|1|||
156413195|NCT04793464|564606787|FG000|Overall Study|Lost to Follow-up|458|||
156413196|NCT04793464|564606788|FG001|Overall Study|Lost to Follow-up|168|||
156413197|NCT04793464|564606789|FG002|Overall Study|Lost to Follow-up|5|||
156413198|NCT04793464|564606787|FG000|Overall Study|Withdrawal by Subject|43|||
156413199|NCT04793464|564606788|FG001|Overall Study|Withdrawal by Subject|15|||
156413200|NCT04793464|564606789|FG002|Overall Study|Withdrawal by Subject|0|||
156413201|NCT00845871|564606795|FG000|Assessment Period|Adverse Event|2|||
156413202|NCT00845871|564606795|FG000|Assessment Period|Abnormal laboratory values|1|||
156413203|NCT00845871|564606795|FG000|Assessment Period|Abnormal test procedure results|1|||
156413204|NCT00845871|564606795|FG000|Assessment Period|Patient withdrew consent|3|||
156413205|NCT01291225|564606798|FG000|Overall Study|Lost to Follow-up|85|||
156413206|NCT01291225|564606799|FG001|Overall Study|Lost to Follow-up|39|||
156413207|NCT04318093|564606802|FG000|Overall Study|Adverse Event|2|||
156413208|NCT04318093|564606803|FG001|Overall Study|Adverse Event|2|||
156413209|NCT04318093|564606802|FG000|Overall Study|Participant withdrew consent|1|||
156413210|NCT04318093|564606803|FG001|Overall Study|Participant withdrew consent|0|||
156413211|NCT04318093|564606802|FG000|Overall Study|Other reasons|0|||
156413212|NCT04318093|564606803|FG001|Overall Study|Other reasons|1|||
156413213|NCT00514046|564606808|FG000|Overall Study|transferred to another protocol|2|||
156413214|NCT00514046|564606809|FG001|Overall Study|transferred to another protocol|1|||
156413215|NCT00514046|564606810|FG002|Overall Study|transferred to another protocol|3|||
156413216|NCT00514046|564606811|FG003|Overall Study|transferred to another protocol|0|||
156413217|NCT00514046|564606812|FG004|Overall Study|transferred to another protocol|1|||
156413218|NCT00514046|564606813|FG005|Overall Study|transferred to another protocol|0|||
156413219|NCT00514046|564606814|FG006|Overall Study|transferred to another protocol|0|||
156413220|NCT00514046|564606815|FG007|Overall Study|transferred to another protocol|0|||
156413221|NCT00514046|564606816|FG008|Overall Study|transferred to another protocol|0|||
156413222|NCT00514046|564606808|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
156413223|NCT00514046|564606809|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
156413224|NCT00514046|564606810|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
156413225|NCT00514046|564606811|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
156311051|NCT04556383|564239326|FG002|PCP|Lost to Follow-up|0|||
156311052|NCT04556383|564239327|FG003|PCP|Lost to Follow-up|0|||
156311053|NCT04556383|564239324|FG000|PCP|Physician Decision|0|||
156311054|NCT04556383|564239325|FG001|PCP|Physician Decision|1|||
156311055|NCT04556383|564239326|FG002|PCP|Physician Decision|0|||
156311056|NCT04556383|564239327|FG003|PCP|Physician Decision|0|||
156311057|NCT04556383|564239324|FG000|PCP|Site terminated by sponsor|0|||
156311058|NCT04556383|564239325|FG001|PCP|Site terminated by sponsor|1|||
156311059|NCT04556383|564239326|FG002|PCP|Site terminated by sponsor|0|||
156311060|NCT04556383|564239327|FG003|PCP|Site terminated by sponsor|0|||
156311061|NCT04556383|564239324|FG000|OLE|Study terminated by sponsor|0|||
156311062|NCT04556383|564239325|FG001|OLE|Study terminated by sponsor|0|||
156311063|NCT04556383|564239326|FG002|OLE|Study terminated by sponsor|0|||
156311064|NCT04556383|564239327|FG003|OLE|Study terminated by sponsor|68|||
156311065|NCT04556383|564239324|FG000|OLE|Withdrawal by Subject|0|||
156311066|NCT04556383|564239325|FG001|OLE|Withdrawal by Subject|0|||
156311067|NCT04556383|564239326|FG002|OLE|Withdrawal by Subject|0|||
156311068|NCT04556383|564239327|FG003|OLE|Withdrawal by Subject|10|||
156311069|NCT04556383|564239324|FG000|OLE|Lack of Efficacy|0|||
156311070|NCT04556383|564239325|FG001|OLE|Lack of Efficacy|0|||
156311071|NCT04556383|564239326|FG002|OLE|Lack of Efficacy|0|||
156311072|NCT04556383|564239327|FG003|OLE|Lack of Efficacy|7|||
156311073|NCT04556383|564239324|FG000|OLE|Adverse Event|0|||
156311074|NCT04556383|564239325|FG001|OLE|Adverse Event|0|||
156311075|NCT04556383|564239326|FG002|OLE|Adverse Event|0|||
156311076|NCT04556383|564239327|FG003|OLE|Adverse Event|2|||
156311077|NCT04556383|564239324|FG000|OLE|Other, Not Specified|0|||
156311078|NCT04556383|564239325|FG001|OLE|Other, Not Specified|0|||
156311079|NCT04556383|564239326|FG002|OLE|Other, Not Specified|0|||
156311080|NCT04556383|564239327|FG003|OLE|Other, Not Specified|2|||
156648810|NCT02784106|565461716|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
156311081|NCT04556383|564239324|FG000|OLE|Death|0|||
156311082|NCT04556383|564239325|FG001|OLE|Death|0|||
156311083|NCT04556383|564239326|FG002|OLE|Death|0|||
156311084|NCT04556383|564239327|FG003|OLE|Death|1|||
156648811|NCT02784106|565461717|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
156648812|NCT02784106|565461714|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
156648813|NCT02784106|565461715|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
156648814|NCT02784106|565461716|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
156648815|NCT02784106|565461717|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
156648816|NCT00553540|565461718|FG000|Overall Study|discharged after first visit|2|||
156648817|NCT00553540|565461719|FG001|Overall Study|discharged after first visit|5|||
156648818|NCT01755858|565461720|FG000|Overall Study|Adverse Event|1|||
156648819|NCT01755858|565461721|FG001|Overall Study|Adverse Event|1|||
156648820|NCT03882047|565461722|FG000|Overall Study|Adverse Event|0|||
156648821|NCT03882047|565461723|FG001|Overall Study|Adverse Event|2|||
156648822|NCT03882047|565461724|FG002|Overall Study|Adverse Event|2|||
156648823|NCT03882047|565461722|FG000|Overall Study|Treatment Failure|3|||
156648824|NCT03882047|565461723|FG001|Overall Study|Treatment Failure|3|||
156648825|NCT03882047|565461724|FG002|Overall Study|Treatment Failure|12|||
156648826|NCT03882047|565461722|FG000|Overall Study|Lost to Follow-up|0|||
156648827|NCT03882047|565461723|FG001|Overall Study|Lost to Follow-up|1|||
156648828|NCT03882047|565461724|FG002|Overall Study|Lost to Follow-up|0|||
156648829|NCT03882047|565461722|FG000|Overall Study|Did Not Wish to Continue|1|||
156648830|NCT03882047|565461723|FG001|Overall Study|Did Not Wish to Continue|4|||
156648831|NCT03882047|565461724|FG002|Overall Study|Did Not Wish to Continue|1|||
156648832|NCT03882047|565461722|FG000|Overall Study|Noncompliance With Protocol|2|||
156648833|NCT03882047|565461723|FG001|Overall Study|Noncompliance With Protocol|0|||
156648834|NCT03882047|565461724|FG002|Overall Study|Noncompliance With Protocol|0|||
156648835|NCT03882047|565461722|FG000|Overall Study|Did Not Meet Eligibility|0|||
156648836|NCT03882047|565461723|FG001|Overall Study|Did Not Meet Eligibility|0|||
156648837|NCT03882047|565461724|FG002|Overall Study|Did Not Meet Eligibility|1|||
156648838|NCT00723554|565461725|FG000|Overall Study|Adverse Event|12|||
156648839|NCT00723554|565461725|FG000|Overall Study|Investigator's judgement|5|||
156648840|NCT00723554|565461725|FG000|Overall Study|Inhaled medication other than iloprost|4|||
156648841|NCT00723554|565461725|FG000|Overall Study|Withdrawal of consent|3|||
156648842|NCT00723554|565461725|FG000|Overall Study|Other|3|||
156648843|NCT00723554|565461725|FG000|Overall Study|Lost to Follow-up|1|||
156648844|NCT00723554|565461725|FG000|Overall Study|Non-compliance|1|||
156648845|NCT01894984|565461731|FG000|Overall Study|Other|314|||
156648846|NCT01894984|565461732|FG001|Overall Study|Other|175|||
156648847|NCT00602030|565461735|FG000|Lead-in Phase|Disease Progression|2|||
156648848|NCT00602030|565461736|FG001|Lead-in Phase|Disease Progression|3|||
156311085|NCT04556383|564239324|FG000|OLE|Lost to Follow-up|0|||
156311086|NCT04556383|564239325|FG001|OLE|Lost to Follow-up|0|||
156311087|NCT04556383|564239326|FG002|OLE|Lost to Follow-up|0|||
156311088|NCT04556383|564239327|FG003|OLE|Lost to Follow-up|1|||
156648849|NCT00602030|565461737|FG002|Lead-in Phase|Disease Progression|0|||
156648850|NCT00602030|565461738|FG003|Lead-in Phase|Disease Progression|0|||
156648851|NCT00602030|565461739|FG004|Lead-in Phase|Disease Progression|0|||
156648852|NCT00602030|565461735|FG000|Lead-in Phase|Adverse Event|0|||
156648853|NCT00602030|565461736|FG001|Lead-in Phase|Adverse Event|2|||
156648854|NCT00602030|565461737|FG002|Lead-in Phase|Adverse Event|0|||
156648855|NCT00602030|565461738|FG003|Lead-in Phase|Adverse Event|0|||
156311089|NCT02720042|564239328|FG000|Overall Study|Death|3|||
156311090|NCT02720042|564239328|FG000|Overall Study|Lost to Follow-up|4|||
156311091|NCT02720042|564239328|FG000|Overall Study|Withdrawal by Subject|1|||
156311092|NCT02720042|564239328|FG000|Overall Study|Physician Decision|3|||
156311093|NCT02720042|564239328|FG000|Overall Study|Phasix Mesh explanted|1|||
156311094|NCT02720042|564239328|FG000|Overall Study|unable due to non-study-related illness|3|||
156311095|NCT03704636|564239329|FG000|Overall Study|Inadequate Venous Flow|3|||
156311096|NCT00539188|564239330|FG000|Overall Study|Withdrawal by Subject|1|||
156311097|NCT00539188|564239331|FG001|Overall Study|Withdrawal by Subject|0|||
156311098|NCT00539188|564239330|FG000|Overall Study|Lost to Follow-up|2|||
156311099|NCT00539188|564239331|FG001|Overall Study|Lost to Follow-up|1|||
156311100|NCT04784442|564239334|FG000|Overall Study|Adverse Event|1|||
156311101|NCT04784442|564239335|FG001|Overall Study|Adverse Event|0|||
156311102|NCT04784442|564239336|FG002|Overall Study|Adverse Event|2|||
156311103|NCT04784442|564239337|FG003|Overall Study|Adverse Event|1|||
156311104|NCT04784442|564239334|FG000|Overall Study|Protocol Violation|1|||
156311105|NCT04784442|564239335|FG001|Overall Study|Protocol Violation|0|||
156311106|NCT04784442|564239336|FG002|Overall Study|Protocol Violation|0|||
156311107|NCT04784442|564239337|FG003|Overall Study|Protocol Violation|0|||
156311108|NCT04784442|564239334|FG000|Overall Study|Non-compliance with study drug|1|||
156311109|NCT04784442|564239335|FG001|Overall Study|Non-compliance with study drug|0|||
156311110|NCT04784442|564239336|FG002|Overall Study|Non-compliance with study drug|0|||
156311111|NCT04784442|564239337|FG003|Overall Study|Non-compliance with study drug|0|||
156311112|NCT00509145|564239338|FG000|Overall Study|Death|0|||
156311113|NCT00509145|564239339|FG001|Overall Study|Death|2|||
156311114|NCT00509145|564239338|FG000|Overall Study|Adverse Event|42|||
156311115|NCT00509145|564239339|FG001|Overall Study|Adverse Event|28|||
156311116|NCT00509145|564239338|FG000|Overall Study|Withdrawal by Subject|32|||
156311117|NCT00509145|564239339|FG001|Overall Study|Withdrawal by Subject|38|||
156311118|NCT00509145|564239338|FG000|Overall Study|Physician Decision|11|||
156311119|NCT00509145|564239339|FG001|Overall Study|Physician Decision|14|||
156311120|NCT00509145|564239338|FG000|Overall Study|Protocol Violation|1|||
156311121|NCT00509145|564239339|FG001|Overall Study|Protocol Violation|6|||
156311122|NCT00509145|564239338|FG000|Overall Study|Pregnancy|3|||
156311123|NCT00509145|564239339|FG001|Overall Study|Pregnancy|8|||
156311124|NCT00509145|564239338|FG000|Overall Study|Lost to Follow-up|6|||
156311125|NCT00509145|564239339|FG001|Overall Study|Lost to Follow-up|5|||
156311126|NCT00509145|564239338|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
156311127|NCT00509145|564239339|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
156311128|NCT00509145|564239338|FG000|Overall Study|Other|6|||
156311129|NCT00509145|564239339|FG001|Overall Study|Other|6|||
156311130|NCT00246740|564239340|FG000|Initial Enrollment|Death|1|||
156311131|NCT00246740|564239341|FG001|Initial Enrollment|Death|0|||
156311132|NCT00246740|564239340|FG000|Initial Enrollment|Additional surgery scheduled|0|||
156311133|NCT00246740|564239341|FG001|Initial Enrollment|Additional surgery scheduled|2|||
156311134|NCT00246740|564239340|FG000|Initial Enrollment|Surgery schedule change|4|||
156311135|NCT00246740|564239341|FG001|Initial Enrollment|Surgery schedule change|4|||
156311136|NCT00246740|564239340|FG000|Initial Enrollment|Other|1|||
156311137|NCT00246740|564239341|FG001|Initial Enrollment|Other|2|||
156311138|NCT00101452|564239344|FG000|Overall Study|Adverse Event|2|||
156311139|NCT00101452|564239345|FG001|Overall Study|Adverse Event|0|||
156311140|NCT00101452|564239346|FG002|Overall Study|Adverse Event|1|||
156311141|NCT00101452|564239344|FG000|Overall Study|Lost to Follow-up|13|||
156311142|NCT00101452|564239345|FG001|Overall Study|Lost to Follow-up|8|||
156311143|NCT00101452|564239346|FG002|Overall Study|Lost to Follow-up|14|||
156311144|NCT00101452|564239344|FG000|Overall Study|Withdrawal by Subject|10|||
156311145|NCT00101452|564239345|FG001|Overall Study|Withdrawal by Subject|14|||
156311146|NCT00101452|564239346|FG002|Overall Study|Withdrawal by Subject|9|||
156311147|NCT00101452|564239344|FG000|Overall Study|Baseline Fail|2|||
156311148|NCT00101452|564239345|FG001|Overall Study|Baseline Fail|1|||
156311149|NCT00101452|564239346|FG002|Overall Study|Baseline Fail|2|||
156311150|NCT00101452|564239344|FG000|Overall Study|Physician Decision|0|||
156311151|NCT00101452|564239345|FG001|Overall Study|Physician Decision|3|||
156311152|NCT00101452|564239346|FG002|Overall Study|Physician Decision|2|||
156311153|NCT00101452|564239344|FG000|Overall Study|Protocol Violation|2|||
156311154|NCT00101452|564239345|FG001|Overall Study|Protocol Violation|1|||
156311155|NCT00101452|564239346|FG002|Overall Study|Protocol Violation|3|||
156311156|NCT00101452|564239344|FG000|Overall Study|Other|15|||
156311157|NCT00101452|564239345|FG001|Overall Study|Other|16|||
156311158|NCT00101452|564239346|FG002|Overall Study|Other|12|||
156311159|NCT02969655|564239347|FG000|Overall Study|Withdrawal by Subject|3|||
156311160|NCT02969655|564239348|FG001|Overall Study|Withdrawal by Subject|2|||
156311161|NCT02969655|564239347|FG000|Overall Study|Physician Decision|4|||
156311162|NCT02969655|564239348|FG001|Overall Study|Physician Decision|3|||
156311163|NCT02969655|564239347|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
156311164|NCT02969655|564239348|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
156311165|NCT02969655|564239347|FG000|Overall Study|Adverse Event|10|||
156311166|NCT02969655|564239348|FG001|Overall Study|Adverse Event|8|||
156311167|NCT00929643|564239351|FG000|Overall Study|Protocol Violation|2|||
156311168|NCT01536392|564239352|FG000|Overall Study|Adverse Event|2|||
156311169|NCT01536392|564239353|FG001|Overall Study|Adverse Event|2|||
156311170|NCT01536392|564239352|FG000|Overall Study|Physician Decision|2|||
156311171|NCT01536392|564239353|FG001|Overall Study|Physician Decision|3|||
156311172|NCT01536392|564239352|FG000|Overall Study|Withdrawal by Subject|3|||
156311173|NCT01536392|564239353|FG001|Overall Study|Withdrawal by Subject|6|||
156311174|NCT01536392|564239352|FG000|Overall Study|Non Compliance|3|||
156311175|NCT01536392|564239353|FG001|Overall Study|Non Compliance|4|||
156311176|NCT01536392|564239352|FG000|Overall Study|Completed therapy early|3|||
156311177|NCT01536392|564239353|FG001|Overall Study|Completed therapy early|0|||
156311178|NCT04525885|564239355|FG000|Overall Study|Screen Failure|1|||
156311179|NCT04525885|564239356|FG001|Overall Study|Screen Failure|0|||
156311180|NCT04525885|564239357|FG002|Overall Study|Screen Failure|0|||
156311181|NCT04525885|564239355|FG000|Overall Study|Withdrawal by Subject|14|||
156311182|NCT04525885|564239356|FG001|Overall Study|Withdrawal by Subject|6|||
156311183|NCT04525885|564239357|FG002|Overall Study|Withdrawal by Subject|20|||
156311184|NCT04525885|564239355|FG000|Overall Study|Physician Decision|1|||
156311185|NCT04525885|564239356|FG001|Overall Study|Physician Decision|0|||
156311186|NCT04525885|564239357|FG002|Overall Study|Physician Decision|1|||
156311187|NCT02717832|564239358|FG000|Overall Study|Inability to place IV|3|||
156311188|NCT00750152|564239359|FG000|Overall Study|Adverse Event|2|||
156311189|NCT00750152|564239360|FG001|Overall Study|Adverse Event|1|||
156311190|NCT00750152|564239359|FG000|Overall Study|Lost to Follow-up|8|||
156311191|NCT00750152|564239360|FG001|Overall Study|Lost to Follow-up|13|||
156311192|NCT00750152|564239359|FG000|Overall Study|Withdrawal by Subject|3|||
156311193|NCT00750152|564239360|FG001|Overall Study|Withdrawal by Subject|3|||
156311194|NCT00750152|564239359|FG000|Overall Study|Physician Decision|1|||
156311195|NCT00750152|564239360|FG001|Overall Study|Physician Decision|1|||
156311196|NCT00750152|564239359|FG000|Overall Study|Non-compliance|0|||
156311197|NCT00750152|564239360|FG001|Overall Study|Non-compliance|1|||
156311198|NCT00750152|564239359|FG000|Overall Study|Termination by sponsor|1|||
156311199|NCT00750152|564239360|FG001|Overall Study|Termination by sponsor|0|||
156311200|NCT00750152|564239359|FG000|Overall Study|Other|7|||
156311201|NCT00750152|564239360|FG001|Overall Study|Other|8|||
156311202|NCT03255083|564239361|FG000|Overall Study|Clinical progression|1|||
156311203|NCT03255083|564239362|FG001|Overall Study|Clinical progression|0|||
156311204|NCT03255083|564239363|FG002|Overall Study|Clinical progression|0|||
156311205|NCT03255083|564239364|FG003|Overall Study|Clinical progression|0|||
156311206|NCT03255083|564239361|FG000|Overall Study|Adverse Event|0|||
156311207|NCT03255083|564239362|FG001|Overall Study|Adverse Event|1|||
156311208|NCT03255083|564239363|FG002|Overall Study|Adverse Event|0|||
156311209|NCT03255083|564239364|FG003|Overall Study|Adverse Event|0|||
156311210|NCT03255083|564239361|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
156311211|NCT03255083|564239362|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
156311212|NCT03255083|564239363|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
156311213|NCT03255083|564239364|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
156311214|NCT03255083|564239361|FG000|Overall Study|Withdrawal by Subject|1|||
156311215|NCT03255083|564239362|FG001|Overall Study|Withdrawal by Subject|1|||
156311216|NCT03255083|564239363|FG002|Overall Study|Withdrawal by Subject|1|||
156311217|NCT03255083|564239364|FG003|Overall Study|Withdrawal by Subject|0|||
156311218|NCT01457352|564239369|FG000|Period 1|Adverse Event|2|||
156311219|NCT01457352|564239370|FG001|Period 1|Adverse Event|0|||
156311220|NCT01457352|564239369|FG000|Period 1|Withdrawal by Subject|2|||
156311221|NCT01457352|564239370|FG001|Period 1|Withdrawal by Subject|0|||
156311222|NCT01457352|564239369|FG000|Period 1|Physician Decision|2|||
156311223|NCT01457352|564239370|FG001|Period 1|Physician Decision|0|||
156311224|NCT01457352|564239369|FG000|Period 1|MS related disease progression|1|||
156311225|NCT01457352|564239370|FG001|Period 1|MS related disease progression|0|||
156311226|NCT01457352|564239369|FG000|Period 1|Withdrawn|1|||
156311227|NCT01457352|564239370|FG001|Period 1|Withdrawn|0|||
156311228|NCT01457352|564239369|FG000|Period 1|withdrew per sponsor|1|||
156311229|NCT01457352|564239370|FG001|Period 1|withdrew per sponsor|0|||
156311230|NCT01457352|564239369|FG000|Period 1|Protocol Violation|4|||
156413226|NCT00514046|564606812|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
156413227|NCT00514046|564606813|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
156413228|NCT00514046|564606814|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
156413229|NCT00514046|564606815|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
156413230|NCT00514046|564606816|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
156413231|NCT00514046|564606808|FG000|Overall Study|Disease progression on study|0|||
156413232|NCT00514046|564606809|FG001|Overall Study|Disease progression on study|0|||
156413233|NCT00514046|564606810|FG002|Overall Study|Disease progression on study|2|||
156413234|NCT00514046|564606811|FG003|Overall Study|Disease progression on study|0|||
156413235|NCT00514046|564606812|FG004|Overall Study|Disease progression on study|0|||
156413236|NCT00514046|564606813|FG005|Overall Study|Disease progression on study|1|||
156413237|NCT00514046|564606814|FG006|Overall Study|Disease progression on study|0|||
156311231|NCT01457352|564239370|FG001|Period 1|Protocol Violation|0|||
156311232|NCT01457352|564239369|FG000|Period 1|Did not meet eligibility criteria|3|||
156311233|NCT01457352|564239370|FG001|Period 1|Did not meet eligibility criteria|0|||
156311234|NCT01457352|564239369|FG000|Period 2|Withdrawal by Subject|23|||
156311235|NCT01457352|564239370|FG001|Period 2|Withdrawal by Subject|0|||
156413238|NCT00514046|564606815|FG007|Overall Study|Disease progression on study|0|||
156413239|NCT00514046|564606816|FG008|Overall Study|Disease progression on study|0|||
156413240|NCT01734434|564606818|FG000|Overall Study|Death Infant|3|||
156311236|NCT01457352|564239369|FG000|Period 2|Adverse Event|22|||
156311237|NCT01457352|564239370|FG001|Period 2|Adverse Event|0|||
156311238|NCT01457352|564239369|FG000|Period 2|no analysis|10|||
156311239|NCT01457352|564239370|FG001|Period 2|no analysis|0|||
156311240|NCT01457352|564239369|FG000|Period 2|Lack of Efficacy|8|||
156311241|NCT01457352|564239370|FG001|Period 2|Lack of Efficacy|0|||
156311242|NCT01457352|564239369|FG000|Period 2|Protocol Violation|4|||
156311243|NCT01457352|564239370|FG001|Period 2|Protocol Violation|0|||
156311244|NCT01457352|564239369|FG000|Period 2|Sponsor's withdrawal|7|||
156311245|NCT01457352|564239370|FG001|Period 2|Sponsor's withdrawal|0|||
156311246|NCT01457352|564239369|FG000|Period 2|Lost to Follow-up|1|||
156311247|NCT01457352|564239370|FG001|Period 2|Lost to Follow-up|0|||
156311248|NCT01457352|564239369|FG000|Period 2|dose change|1|||
156311249|NCT01457352|564239370|FG001|Period 2|dose change|0|||
156311250|NCT01457352|564239369|FG000|Period 2|Physician Decision|1|||
156311251|NCT01457352|564239370|FG001|Period 2|Physician Decision|0|||
156311252|NCT01457352|564239369|FG000|Period 2|Did not meet eligibility criteria|3|||
156311253|NCT01457352|564239370|FG001|Period 2|Did not meet eligibility criteria|0|||
156311254|NCT01457352|564239369|FG000|Period 3|Adverse Event|1|||
156311255|NCT01457352|564239370|FG001|Period 3|Adverse Event|1|||
156311256|NCT01457352|564239369|FG000|Period 3|Withdrawal by Subject|0|||
156311257|NCT01457352|564239370|FG001|Period 3|Withdrawal by Subject|2|||
156311258|NCT01457352|564239369|FG000|Period 3|incorrect treatment|0|||
156311259|NCT01457352|564239370|FG001|Period 3|incorrect treatment|1|||
156311260|NCT01457352|564239369|FG000|Period 3|Sponsor's withdrawal|0|||
156311261|NCT01457352|564239370|FG001|Period 3|Sponsor's withdrawal|1|||
156311262|NCT02537015|564239371|FG000|Overall Study|Adverse Event|3|||
156311263|NCT02537015|564239371|FG000|Overall Study|Withdrawal by Subject|2|||
156311264|NCT02537015|564239371|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156311265|NCT01808092|564239372|FG000|Overall Study|Death|39|||
156311266|NCT01808092|564239373|FG001|Overall Study|Death|29|||
156311267|NCT01808092|564239372|FG000|Overall Study|Lost to Follow-up|3|||
156311268|NCT01808092|564239373|FG001|Overall Study|Lost to Follow-up|7|||
156311269|NCT01808092|564239372|FG000|Overall Study|Withdrawal by Subject|9|||
156311270|NCT01808092|564239373|FG001|Overall Study|Withdrawal by Subject|4|||
156311271|NCT01808092|564239372|FG000|Overall Study|Other Eligibility criteria|3|||
156311272|NCT01808092|564239373|FG001|Overall Study|Other Eligibility criteria|5|||
156311273|NCT03425253|564239376|FG000|Overall Study|Adverse Event|2|||
156311274|NCT03425253|564239376|FG000|Overall Study|Lost to Follow-up|3|||
156413241|NCT01734434|564606819|FG001|Overall Study|Death Infant|1|||
156413242|NCT01734434|564606820|FG002|Overall Study|Death Infant|17|||
156413243|NCT01734434|564606821|FG003|Overall Study|Death Infant|5|||
156413244|NCT01734434|564606818|FG000|Overall Study|Lost to Follow-up|2|||
156413245|NCT01734434|564606819|FG001|Overall Study|Lost to Follow-up|9|||
156413246|NCT01734434|564606820|FG002|Overall Study|Lost to Follow-up|67|||
156413247|NCT01734434|564606821|FG003|Overall Study|Lost to Follow-up|11|||
156413248|NCT01734434|564606818|FG000|Overall Study|No Live Birth|1|||
156413249|NCT01734434|564606819|FG001|Overall Study|No Live Birth|2|||
156413250|NCT01734434|564606820|FG002|Overall Study|No Live Birth|32|||
156413251|NCT01734434|564606821|FG003|Overall Study|No Live Birth|6|||
156413252|NCT01734434|564606818|FG000|Overall Study|Withdrawal by Subject|4|||
156413253|NCT01734434|564606819|FG001|Overall Study|Withdrawal by Subject|0|||
156413254|NCT01734434|564606820|FG002|Overall Study|Withdrawal by Subject|8|||
156413255|NCT01734434|564606821|FG003|Overall Study|Withdrawal by Subject|1|||
156413256|NCT01734434|564606818|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
156413257|NCT01734434|564606819|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
156413258|NCT01734434|564606820|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
156413259|NCT01734434|564606821|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
156413260|NCT01734434|564606818|FG000|Overall Study|Subject Not Reachable|0|||
156413261|NCT01734434|564606819|FG001|Overall Study|Subject Not Reachable|0|||
156413262|NCT01734434|564606820|FG002|Overall Study|Subject Not Reachable|1|||
156413263|NCT01734434|564606821|FG003|Overall Study|Subject Not Reachable|0|||
156413264|NCT01734434|564606818|FG000|Overall Study|Treatment Defaulter|0|||
156413265|NCT01734434|564606819|FG001|Overall Study|Treatment Defaulter|0|||
156413266|NCT01734434|564606820|FG002|Overall Study|Treatment Defaulter|1|||
156413267|NCT01734434|564606821|FG003|Overall Study|Treatment Defaulter|0|||
156413268|NCT01734434|564606818|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
156413269|NCT01734434|564606819|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
156413270|NCT01734434|564606820|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
156413271|NCT01734434|564606821|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
156311275|NCT03425253|564239376|FG000|Overall Study|Withdrew Consent|6|||
156311276|NCT03425253|564239376|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
156311277|NCT04614324|564239379|FG000|Overall Study|Lost to Follow-up|3|||
156311278|NCT04614324|564239379|FG000|Overall Study|Physician Decision|1|||
156311279|NCT04614324|564239379|FG000|Overall Study|Withdrawal by Subject|2|||
156413272|NCT01734434|564606818|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
156413273|NCT01734434|564606819|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
156413274|NCT01734434|564606820|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
156413275|NCT01734434|564606821|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
156413276|NCT02855164|564606822|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156413277|NCT02855164|564606823|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156413278|NCT02855164|564606824|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
156413279|NCT02855164|564606825|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
156413280|NCT02855164|564606826|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
156413281|NCT02855164|564606827|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156413282|NCT02855164|564606828|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156413283|NCT02855164|564606829|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156413284|NCT02855164|564606822|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
156413285|NCT02855164|564606823|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
156413286|NCT02855164|564606824|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
156413287|NCT02855164|564606825|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
156413288|NCT02855164|564606826|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
156413289|NCT02855164|564606827|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
156413290|NCT02855164|564606828|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
156413291|NCT02855164|564606829|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
156413292|NCT02855164|564606822|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
156413293|NCT02855164|564606823|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
156413294|NCT02855164|564606824|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
156413295|NCT02855164|564606825|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
156413296|NCT02855164|564606826|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
156413297|NCT02855164|564606827|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
156413298|NCT02855164|564606828|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
156413299|NCT02855164|564606829|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
156413300|NCT02855164|564606822|FG000|Part C (Randomized Set)|Adverse Event|0|||
156413301|NCT02855164|564606823|FG001|Part C (Randomized Set)|Adverse Event|0|||
156413302|NCT02855164|564606824|FG002|Part C (Randomized Set)|Adverse Event|0|||
156413303|NCT02855164|564606825|FG003|Part C (Randomized Set)|Adverse Event|0|||
156413304|NCT02855164|564606826|FG004|Part C (Randomized Set)|Adverse Event|0|||
156413305|NCT02855164|564606827|FG005|Part C (Randomized Set)|Adverse Event|5|||
156413306|NCT02855164|564606828|FG006|Part C (Randomized Set)|Adverse Event|9|||
156413307|NCT02855164|564606829|FG007|Part C (Randomized Set)|Adverse Event|2|||
156413308|NCT02855164|564606822|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
156413309|NCT02855164|564606823|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
156413310|NCT02855164|564606824|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
156413311|NCT02855164|564606825|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
156413312|NCT02855164|564606826|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
156413313|NCT02855164|564606827|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
156413314|NCT02855164|564606828|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
156413315|NCT02855164|564606829|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
156413316|NCT02855164|564606822|FG000|Part C (Randomized Set)|Physician Decision|0|||
156413317|NCT02855164|564606823|FG001|Part C (Randomized Set)|Physician Decision|0|||
156413318|NCT02855164|564606824|FG002|Part C (Randomized Set)|Physician Decision|0|||
156413319|NCT02855164|564606825|FG003|Part C (Randomized Set)|Physician Decision|0|||
156413320|NCT02855164|564606826|FG004|Part C (Randomized Set)|Physician Decision|0|||
156413321|NCT02855164|564606827|FG005|Part C (Randomized Set)|Physician Decision|1|||
156413322|NCT02855164|564606828|FG006|Part C (Randomized Set)|Physician Decision|0|||
156413323|NCT02855164|564606829|FG007|Part C (Randomized Set)|Physician Decision|1|||
156413324|NCT02855164|564606822|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
156413325|NCT02855164|564606823|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
156413326|NCT02855164|564606824|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
156413327|NCT02855164|564606825|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
156413328|NCT02855164|564606826|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
156413329|NCT02855164|564606827|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
156413330|NCT02855164|564606828|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
156413331|NCT02855164|564606829|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
156413332|NCT03391960|564606834|FG000|Overall Study|Protocol Violation|0|||
156413333|NCT03391960|564606835|FG001|Overall Study|Protocol Violation|0|||
156413334|NCT00581113|564608735|FG000|Overall Study|Withdrawal by Subject|0|||
156413335|NCT00581113|564608736|FG001|Overall Study|Withdrawal by Subject|1|||
156413336|NCT02930122|564608742|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
156413337|NCT02930122|564608743|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
156413338|NCT01995357|564608744|FG000|Period 5|Lack of Efficacy|1|||
156413339|NCT01995357|564608745|FG001|Period 5|Lack of Efficacy|0|||
156413340|NCT01995357|564608746|FG002|Period 5|Lack of Efficacy|0|||
156413341|NCT01995357|564608747|FG003|Period 5|Lack of Efficacy|0|||
156413342|NCT01995357|564608748|FG004|Period 5|Lack of Efficacy|0|||
156413343|NCT01995357|564608749|FG005|Period 5|Lack of Efficacy|0|||
156413344|NCT01995357|564608744|FG000|Period 5|Adverse Event|1|||
156413345|NCT01995357|564608745|FG001|Period 5|Adverse Event|0|||
156413346|NCT01995357|564608746|FG002|Period 5|Adverse Event|1|||
156413347|NCT01995357|564608747|FG003|Period 5|Adverse Event|0|||
156413348|NCT01995357|564608748|FG004|Period 5|Adverse Event|0|||
156413349|NCT01995357|564608749|FG005|Period 5|Adverse Event|0|||
156413350|NCT02609659|564608750|FG000|Overall Study|Adverse Event|1|||
156413351|NCT02609659|564608750|FG000|Overall Study|Lost to Follow-up|6|||
156413352|NCT02609659|564608750|FG000|Overall Study|Other|1|||
156413353|NCT01853254|564608753|FG000|Overall Study|Abnormal Laboratory Test|1|||
156413354|NCT01853254|564608753|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
156413355|NCT01853254|564608753|FG000|Overall Study|Death|1|||
156413356|NCT01853254|564608753|FG000|Overall Study|Failure to Return|43|||
156413357|NCT01853254|564608753|FG000|Overall Study|Insufficient Therapeutic Response|22|||
156413358|NCT01853254|564608753|FG000|Overall Study|Refusal of Treatment|1|||
156413359|NCT01853254|564608753|FG000|Overall Study|Other Protocol Violation|1|||
156413360|NCT01853254|564608753|FG000|Overall Study|Withdrawal of Consent|16|||
156413361|NCT01853254|564608753|FG000|Overall Study|Administrative/Other|16|||
156413362|NCT02462083|564608754|FG000|Overall Study|Sponsor request|39|||
156413363|NCT02462083|564608754|FG000|Overall Study|Withdrawal by Subject|87|||
156413364|NCT02462083|564608754|FG000|Overall Study|Lost to Follow-up|41|||
156413365|NCT02462083|564608754|FG000|Overall Study|Lack of Efficacy|151|||
156413366|NCT02462083|564608754|FG000|Overall Study|Pregnancy|1|||
156413367|NCT02462083|564608754|FG000|Overall Study|Protocol Violation|6|||
156413368|NCT02462083|564608754|FG000|Overall Study|Adverse Event|33|||
156413369|NCT02462083|564608754|FG000|Overall Study|Worsening condition|16|||
156413370|NCT02462083|564608754|FG000|Overall Study|Other than specified|45|||
156413371|NCT01642186|564608758|FG000|Overall Study|Death|0|||
156413372|NCT01642186|564608759|FG001|Overall Study|Death|2|||
156413373|NCT01642186|564608760|FG002|Overall Study|Death|2|||
156413374|NCT01642186|564608758|FG000|Overall Study|Lost to Follow-up|0|||
156413375|NCT01642186|564608759|FG001|Overall Study|Lost to Follow-up|0|||
156413376|NCT01642186|564608760|FG002|Overall Study|Lost to Follow-up|1|||
156413377|NCT00163215|564608761|FG000|Overall Study|Lack of Efficacy|3|||
156413378|NCT00163215|564608761|FG000|Overall Study|Withdrawal by Subject|5|||
156413379|NCT00163215|564608761|FG000|Overall Study|Other|7|||
156413380|NCT01809210|564608764|FG000|Overall Study|Withdrawal by Subject|0|||
156413381|NCT01809210|564608765|FG001|Overall Study|Withdrawal by Subject|0|||
156413382|NCT01809210|564608766|FG002|Overall Study|Withdrawal by Subject|1|||
156413383|NCT01809210|564608767|FG003|Overall Study|Withdrawal by Subject|1|||
156413384|NCT01809210|564608768|FG004|Overall Study|Withdrawal by Subject|1|||
156413385|NCT01809210|564608769|FG005|Overall Study|Withdrawal by Subject|0|||
156413386|NCT01809210|564608770|FG006|Overall Study|Withdrawal by Subject|4|||
156413387|NCT01809210|564608764|FG000|Overall Study|Death|1|||
156413388|NCT01809210|564608765|FG001|Overall Study|Death|1|||
156413389|NCT01809210|564608766|FG002|Overall Study|Death|2|||
156413390|NCT01809210|564608767|FG003|Overall Study|Death|0|||
156413391|NCT01809210|564608768|FG004|Overall Study|Death|1|||
156648856|NCT00602030|565461739|FG004|Lead-in Phase|Adverse Event|0|||
156648857|NCT00602030|565461735|FG000|Double-blind Phase|Disease progression|0|||
156648858|NCT00602030|565461736|FG001|Double-blind Phase|Disease progression|0|||
156648859|NCT00602030|565461737|FG002|Double-blind Phase|Disease progression|33|||
156648860|NCT00602030|565461738|FG003|Double-blind Phase|Disease progression|30|||
156648861|NCT00602030|565461739|FG004|Double-blind Phase|Disease progression|0|||
156648862|NCT00602030|565461735|FG000|Double-blind Phase|Adverse Event|0|||
156648863|NCT00602030|565461736|FG001|Double-blind Phase|Adverse Event|0|||
156648864|NCT00602030|565461737|FG002|Double-blind Phase|Adverse Event|9|||
156648865|NCT00602030|565461738|FG003|Double-blind Phase|Adverse Event|18|||
156648866|NCT00602030|565461739|FG004|Double-blind Phase|Adverse Event|0|||
156648867|NCT00602030|565461735|FG000|Double-blind Phase|Consent withdrawal|0|||
156648868|NCT00602030|565461736|FG001|Double-blind Phase|Consent withdrawal|0|||
156648869|NCT00602030|565461737|FG002|Double-blind Phase|Consent withdrawal|4|||
156648870|NCT00602030|565461738|FG003|Double-blind Phase|Consent withdrawal|3|||
156648871|NCT00602030|565461739|FG004|Double-blind Phase|Consent withdrawal|0|||
156413392|NCT01809210|564608769|FG005|Overall Study|Death|3|||
156648872|NCT00602030|565461735|FG000|Double-blind Phase|Death|0|||
156413393|NCT01809210|564608770|FG006|Overall Study|Death|1|||
156413394|NCT01668147|564608771|FG000|Overall Study|Withdrawal by Subject|6|||
156648873|NCT00602030|565461736|FG001|Double-blind Phase|Death|0|||
156648874|NCT00602030|565461737|FG002|Double-blind Phase|Death|3|||
156413395|NCT01115998|564608774|FG000|Overall Study|Lost to Follow-up|6|||
156413396|NCT01115998|564608775|FG001|Overall Study|Lost to Follow-up|6|||
156413397|NCT00224133|564608776|FG000|Overall Study|Adverse Event|93|||
156413398|NCT00224133|564608776|FG000|Overall Study|Protocol Violation|6|||
156413399|NCT00224133|564608776|FG000|Overall Study|Withdrawal by Subject|33|||
156413400|NCT00224133|564608776|FG000|Overall Study|Lack of Efficacy|58|||
156413401|NCT00224133|564608776|FG000|Overall Study|Lost to Follow-up|21|||
156413402|NCT00224133|564608776|FG000|Overall Study|Physician Decision|1|||
156413403|NCT00224133|564608776|FG000|Overall Study|Other|14|||
156648875|NCT00602030|565461738|FG003|Double-blind Phase|Death|3|||
156413404|NCT01474512|564608780|FG000|Induction Period|Adverse Event|6|||
156413405|NCT01474512|564608781|FG001|Induction Period|Adverse Event|10|||
156413406|NCT01474512|564608782|FG002|Induction Period|Adverse Event|10|||
156413407|NCT01474512|564608783|FG003|Induction Period|Adverse Event|0|||
156413408|NCT01474512|564608784|FG004|Induction Period|Adverse Event|0|||
156413409|NCT01474512|564608785|FG005|Induction Period|Adverse Event|0|||
156413410|NCT01474512|564608786|FG006|Induction Period|Adverse Event|0|||
156413411|NCT01474512|564608787|FG007|Induction Period|Adverse Event|0|||
156413412|NCT01474512|564608788|FG008|Induction Period|Adverse Event|0|||
156413413|NCT01474512|564608789|FG009|Induction Period|Adverse Event|0|||
156413414|NCT01474512|564608790|FG010|Induction Period|Adverse Event|0|||
156413415|NCT01474512|564608791|FG011|Induction Period|Adverse Event|0|||
156413416|NCT01474512|564608792|FG012|Induction Period|Adverse Event|0|||
156413417|NCT01474512|564608793|FG013|Induction Period|Adverse Event|0|||
156413418|NCT01474512|564608794|FG014|Induction Period|Adverse Event|0|||
156413419|NCT01474512|564608795|FG015|Induction Period|Adverse Event|0|||
156311280|NCT04614324|564239379|FG000|Overall Study|Remaining in Follow up|123|||
156311281|NCT04627285|564239380|FG000|Overall Study|Adverse Event|0|||
156311282|NCT04627285|564239381|FG001|Overall Study|Adverse Event|2|||
156311283|NCT04627285|564239380|FG000|Overall Study|Lost to Follow-up|1|||
156311284|NCT04627285|564239381|FG001|Overall Study|Lost to Follow-up|0|||
156311285|NCT04627285|564239380|FG000|Overall Study|Withdrawal by Subject|1|||
156311286|NCT04627285|564239381|FG001|Overall Study|Withdrawal by Subject|1|||
156311287|NCT04627285|564239380|FG000|Overall Study|Sponsor decision|5|||
156311288|NCT04627285|564239381|FG001|Overall Study|Sponsor decision|0|||
156311289|NCT04627285|564239380|FG000|Overall Study|Participant left country; aunt informed the site|0|||
156311290|NCT04627285|564239381|FG001|Overall Study|Participant left country; aunt informed the site|1|||
156311291|NCT00294762|564241353|FG000|Overall Study|Did not receive study treatment|3|||
156311292|NCT00294762|564241354|FG001|Overall Study|Did not receive study treatment|3|||
156311293|NCT02937584|564241355|FG000|Period 1|Adverse Event|1|||
156311294|NCT02937584|564241356|FG001|Period 1|Adverse Event|2|||
156311295|NCT02937584|564241355|FG000|Washout|Adverse Event|0|||
156311296|NCT02937584|564241356|FG001|Washout|Adverse Event|1|||
156311297|NCT02238080|564241357|FG000|Overall Study|Death|13|||
156311298|NCT02238080|564241357|FG000|Overall Study|Treatment interrupted|6|||
156311299|NCT02238080|564241357|FG000|Overall Study|Withdrawal by Subject|2|||
156311300|NCT02238080|564241357|FG000|Overall Study|Other|4|||
156311301|NCT04224688|564241361|FG000|Overall Study|Withdrawal by Subject|1|||
156311302|NCT04224688|564241362|FG001|Overall Study|Withdrawal by Subject|3|||
156311303|NCT04224688|564241361|FG000|Overall Study|Lack of Efficacy|1|||
156311304|NCT04224688|564241362|FG001|Overall Study|Lack of Efficacy|1|||
156311305|NCT04224688|564241361|FG000|Overall Study|Adverse event, not fatal|0|||
156311306|NCT04224688|564241362|FG001|Overall Study|Adverse event, not fatal|2|||
156311307|NCT04224688|564241361|FG000|Overall Study|COVID-19|0|||
156311308|NCT04224688|564241362|FG001|Overall Study|COVID-19|1|||
156311309|NCT04074161|564241363|FG000|Overall Study|Withdrawal by Subject|2|||
156311310|NCT04074161|564241364|FG001|Overall Study|Withdrawal by Subject|4|||
156311311|NCT04074161|564241365|FG002|Overall Study|Withdrawal by Subject|1|||
156311312|NCT04074161|564241363|FG000|Overall Study|Lost to Follow-up|4|||
156311313|NCT04074161|564241364|FG001|Overall Study|Lost to Follow-up|5|||
156413420|NCT01474512|564608796|FG016|Induction Period|Adverse Event|0|||
156413421|NCT01474512|564608797|FG017|Induction Period|Adverse Event|0|||
156413422|NCT01474512|564608780|FG000|Induction Period|Lack of Efficacy|7|||
156413423|NCT01474512|564608781|FG001|Induction Period|Lack of Efficacy|1|||
156413424|NCT01474512|564608782|FG002|Induction Period|Lack of Efficacy|0|||
156413425|NCT01474512|564608783|FG003|Induction Period|Lack of Efficacy|0|||
156413426|NCT01474512|564608784|FG004|Induction Period|Lack of Efficacy|0|||
156413427|NCT01474512|564608785|FG005|Induction Period|Lack of Efficacy|0|||
156413428|NCT01474512|564608786|FG006|Induction Period|Lack of Efficacy|0|||
156413429|NCT01474512|564608787|FG007|Induction Period|Lack of Efficacy|0|||
156413430|NCT01474512|564608788|FG008|Induction Period|Lack of Efficacy|0|||
156413431|NCT01474512|564608789|FG009|Induction Period|Lack of Efficacy|0|||
156413432|NCT01474512|564608790|FG010|Induction Period|Lack of Efficacy|0|||
156311314|NCT04074161|564241365|FG002|Overall Study|Lost to Follow-up|3|||
156311315|NCT00796445|564241368|FG000|Overall Study|Protocol Violation|5|||
156311316|NCT00796445|564241369|FG001|Overall Study|Protocol Violation|3|||
156311317|NCT00796445|564241368|FG000|Overall Study|Adverse event, serious fatal|10|||
156311318|NCT00796445|564241369|FG001|Overall Study|Adverse event, serious fatal|5|||
156311319|NCT00796445|564241368|FG000|Overall Study|Adverse event, non-fatal|4|||
156311320|NCT00796445|564241369|FG001|Overall Study|Adverse event, non-fatal|0|||
156311321|NCT00796445|564241368|FG000|Overall Study|Disease progression/recurrence|537|||
156311322|NCT00796445|564241369|FG001|Overall Study|Disease progression/recurrence|268|||
156311323|NCT00796445|564241368|FG000|Overall Study|Other|10|||
156311324|NCT00796445|564241369|FG001|Overall Study|Other|7|||
156311325|NCT00796445|564241368|FG000|Overall Study|Withdrawal by Subject|18|||
156413433|NCT01474512|564608791|FG011|Induction Period|Lack of Efficacy|0|||
156413434|NCT01474512|564608792|FG012|Induction Period|Lack of Efficacy|0|||
156413435|NCT01474512|564608793|FG013|Induction Period|Lack of Efficacy|0|||
156413436|NCT01474512|564608794|FG014|Induction Period|Lack of Efficacy|0|||
156648876|NCT00602030|565461739|FG004|Double-blind Phase|Death|0|||
156311326|NCT00796445|564241369|FG001|Overall Study|Withdrawal by Subject|9|||
156311327|NCT00796445|564241368|FG000|Overall Study|Invalid Informed Consent Form|1|||
156311328|NCT00796445|564241369|FG001|Overall Study|Invalid Informed Consent Form|0|||
156311329|NCT02500056|564241370|FG000|Overall Study|Lost to Follow-up|3|||
156311330|NCT02500056|564241371|FG001|Overall Study|Lost to Follow-up|7|||
156311331|NCT02500056|564241370|FG000|Overall Study|Recurrence|1|||
156311332|NCT02500056|564241371|FG001|Overall Study|Recurrence|0|||
156311333|NCT02500056|564241370|FG000|Overall Study|Death|3|||
156311334|NCT02500056|564241371|FG001|Overall Study|Death|1|||
156311335|NCT01087736|564241372|FG000|Overall Study|Lost to Follow-up|1|||
156311336|NCT01087736|564241373|FG001|Overall Study|Lost to Follow-up|0|||
156311337|NCT01087736|564241372|FG000|Overall Study|Death|0|||
156311338|NCT01087736|564241373|FG001|Overall Study|Death|1|||
156311339|NCT01087736|564241372|FG000|Overall Study|Withdrawal by Subject|0|||
156311340|NCT01087736|564241373|FG001|Overall Study|Withdrawal by Subject|1|||
156311341|NCT01565343|564241375|FG000|Overall Study|Administrative decision/technical issues|1|||
156311342|NCT01565343|564241376|FG001|Overall Study|Administrative decision/technical issues|0|||
156311343|NCT01565343|564241377|FG002|Overall Study|Administrative decision/technical issues|0|||
156648877|NCT00602030|565461735|FG000|Double-blind Phase|Administrative decision|0|||
156648878|NCT00602030|565461736|FG001|Double-blind Phase|Administrative decision|0|||
156648879|NCT00602030|565461737|FG002|Double-blind Phase|Administrative decision|0|||
156648880|NCT00602030|565461738|FG003|Double-blind Phase|Administrative decision|2|||
156648881|NCT00602030|565461739|FG004|Double-blind Phase|Administrative decision|0|||
156648882|NCT00602030|565461735|FG000|Double-blind Phase|Ineligibility|0|||
156648883|NCT00602030|565461736|FG001|Double-blind Phase|Ineligibility|0|||
156648884|NCT00602030|565461737|FG002|Double-blind Phase|Ineligibility|0|||
156648885|NCT00602030|565461738|FG003|Double-blind Phase|Ineligibility|1|||
156648886|NCT00602030|565461739|FG004|Double-blind Phase|Ineligibility|0|||
156648887|NCT00602030|565461735|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
156648888|NCT00602030|565461736|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
156648889|NCT00602030|565461737|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
156648890|NCT00602030|565461738|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
156648891|NCT00602030|565461739|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
156648892|NCT00602030|565461735|FG000|Double-blind Phase|Reason not specified|0|||
156648893|NCT00602030|565461736|FG001|Double-blind Phase|Reason not specified|0|||
156648894|NCT00602030|565461737|FG002|Double-blind Phase|Reason not specified|4|||
156648895|NCT00602030|565461738|FG003|Double-blind Phase|Reason not specified|2|||
156648896|NCT00602030|565461739|FG004|Double-blind Phase|Reason not specified|0|||
156648897|NCT00602030|565461735|FG000|Crossover Phase|Disease Progression|0|||
156648898|NCT00602030|565461736|FG001|Crossover Phase|Disease Progression|0|||
156648899|NCT00602030|565461737|FG002|Crossover Phase|Disease Progression|0|||
156648900|NCT00602030|565461738|FG003|Crossover Phase|Disease Progression|0|||
156648901|NCT00602030|565461739|FG004|Crossover Phase|Disease Progression|11|||
156648902|NCT00602030|565461735|FG000|Crossover Phase|Adverse Event|0|||
156648903|NCT00602030|565461736|FG001|Crossover Phase|Adverse Event|0|||
156648904|NCT00602030|565461737|FG002|Crossover Phase|Adverse Event|0|||
156311344|NCT01853839|564241379|FG000|Overall Study|Violated inclusion criteria|2|||
156311345|NCT01853839|564241379|FG000|Overall Study|Not meet ITT population definition|58|||
156311346|NCT01853839|564241379|FG000|Overall Study|End of treatment visit too early|33|||
156311347|NCT01853839|564241379|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
156311348|NCT00638183|564241380|FG000|Overall Study|Adverse Event|23|||
156311349|NCT00638183|564241380|FG000|Overall Study|Lack of Efficacy|14|||
156311350|NCT00638183|564241380|FG000|Overall Study|Physician Decision|9|||
156311351|NCT00638183|564241380|FG000|Overall Study|Lost to Follow-up|46|||
156311352|NCT00638183|564241380|FG000|Overall Study|Other reason not defined above|27|||
156311353|NCT02059291|564241381|FG000|Epoch 2|Lack of Efficacy|0|||
156311354|NCT02059291|564241382|FG001|Epoch 2|Lack of Efficacy|0|||
156311355|NCT02059291|564241383|FG002|Epoch 2|Lack of Efficacy|0|||
156311356|NCT02059291|564241384|FG003|Epoch 2|Lack of Efficacy|1|||
156311357|NCT02059291|564241385|FG004|Epoch 2|Lack of Efficacy|0|||
156311358|NCT02059291|564241386|FG005|Epoch 2|Lack of Efficacy|1|||
156311359|NCT02059291|564241387|FG006|Epoch 2|Lack of Efficacy|0|||
156311360|NCT02059291|564241388|FG007|Epoch 2|Lack of Efficacy|0|||
156311361|NCT02059291|564241389|FG008|Epoch 2|Lack of Efficacy|0|||
156311362|NCT02059291|564241390|FG009|Epoch 2|Lack of Efficacy|0|||
156311363|NCT02059291|564241391|FG010|Epoch 2|Lack of Efficacy|0|||
156311364|NCT02059291|564241392|FG011|Epoch 2|Lack of Efficacy|0|||
156311365|NCT02059291|564241393|FG012|Epoch 2|Lack of Efficacy|0|||
156311366|NCT02059291|564241394|FG013|Epoch 2|Lack of Efficacy|0|||
156648905|NCT00602030|565461738|FG003|Crossover Phase|Adverse Event|0|||
156648906|NCT00602030|565461739|FG004|Crossover Phase|Adverse Event|3|||
156648907|NCT00602030|565461735|FG000|Crossover Phase|Consent withdrawal|0|||
156311367|NCT02059291|564241395|FG014|Epoch 2|Lack of Efficacy|0|||
156311368|NCT02059291|564241396|FG015|Epoch 2|Lack of Efficacy|0|||
156311369|NCT02059291|564241397|FG016|Epoch 2|Lack of Efficacy|0|||
156311370|NCT02059291|564241398|FG017|Epoch 2|Lack of Efficacy|0|||
156311371|NCT02059291|564241399|FG018|Epoch 2|Lack of Efficacy|0|||
156648908|NCT00602030|565461736|FG001|Crossover Phase|Consent withdrawal|0|||
156648909|NCT00602030|565461737|FG002|Crossover Phase|Consent withdrawal|0|||
156648910|NCT00602030|565461738|FG003|Crossover Phase|Consent withdrawal|0|||
156648911|NCT00602030|565461739|FG004|Crossover Phase|Consent withdrawal|2|||
156648912|NCT01580020|565461740|FG000|Overall Study|Lack of Efficacy|0|||
156648913|NCT01580020|565461741|FG001|Overall Study|Lack of Efficacy|5|||
156648914|NCT01580020|565461742|FG002|Overall Study|Lack of Efficacy|0|||
156648915|NCT01580020|565461743|FG003|Overall Study|Lack of Efficacy|1|||
156648916|NCT01580020|565461740|FG000|Overall Study|Withdrawal by Subject|0|||
156648917|NCT01580020|565461741|FG001|Overall Study|Withdrawal by Subject|1|||
156311372|NCT02059291|564241400|FG019|Epoch 2|Lack of Efficacy|0|||
156311373|NCT02059291|564241401|FG020|Epoch 2|Lack of Efficacy|0|||
156311374|NCT02059291|564241402|FG021|Epoch 2|Lack of Efficacy|0|||
156311375|NCT02059291|564241403|FG022|Epoch 2|Lack of Efficacy|0|||
156311376|NCT02059291|564241404|FG023|Epoch 2|Lack of Efficacy|0|||
156311377|NCT02059291|564241405|FG024|Epoch 2|Lack of Efficacy|0|||
156311378|NCT02059291|564241381|FG000|Epoch 2|Adverse Event|0|||
156311379|NCT02059291|564241382|FG001|Epoch 2|Adverse Event|0|||
156311380|NCT02059291|564241383|FG002|Epoch 2|Adverse Event|1|||
156311381|NCT02059291|564241384|FG003|Epoch 2|Adverse Event|1|||
156311382|NCT02059291|564241385|FG004|Epoch 2|Adverse Event|0|||
156311383|NCT02059291|564241386|FG005|Epoch 2|Adverse Event|0|||
156311384|NCT02059291|564241387|FG006|Epoch 2|Adverse Event|0|||
156311385|NCT02059291|564241388|FG007|Epoch 2|Adverse Event|1|||
156311386|NCT02059291|564241389|FG008|Epoch 2|Adverse Event|1|||
156311387|NCT02059291|564241390|FG009|Epoch 2|Adverse Event|0|||
156311388|NCT02059291|564241391|FG010|Epoch 2|Adverse Event|0|||
156311389|NCT02059291|564241392|FG011|Epoch 2|Adverse Event|0|||
156311390|NCT02059291|564241393|FG012|Epoch 2|Adverse Event|0|||
156311391|NCT02059291|564241394|FG013|Epoch 2|Adverse Event|0|||
156311392|NCT02059291|564241395|FG014|Epoch 2|Adverse Event|0|||
156311393|NCT02059291|564241396|FG015|Epoch 2|Adverse Event|0|||
156311394|NCT02059291|564241397|FG016|Epoch 2|Adverse Event|0|||
156311395|NCT02059291|564241398|FG017|Epoch 2|Adverse Event|0|||
156311396|NCT02059291|564241399|FG018|Epoch 2|Adverse Event|0|||
156311397|NCT02059291|564241400|FG019|Epoch 2|Adverse Event|0|||
156311398|NCT02059291|564241401|FG020|Epoch 2|Adverse Event|0|||
156311399|NCT02059291|564241402|FG021|Epoch 2|Adverse Event|0|||
156311400|NCT02059291|564241403|FG022|Epoch 2|Adverse Event|0|||
156311401|NCT02059291|564241404|FG023|Epoch 2|Adverse Event|0|||
156311402|NCT02059291|564241405|FG024|Epoch 2|Adverse Event|0|||
156311403|NCT02059291|564241381|FG000|Epoch 2|Withdrawal by Subject|0|||
156311404|NCT02059291|564241382|FG001|Epoch 2|Withdrawal by Subject|1|||
156311405|NCT02059291|564241383|FG002|Epoch 2|Withdrawal by Subject|0|||
156311406|NCT02059291|564241384|FG003|Epoch 2|Withdrawal by Subject|0|||
156311407|NCT02059291|564241385|FG004|Epoch 2|Withdrawal by Subject|0|||
156311408|NCT02059291|564241386|FG005|Epoch 2|Withdrawal by Subject|1|||
156311409|NCT02059291|564241387|FG006|Epoch 2|Withdrawal by Subject|0|||
156311410|NCT02059291|564241388|FG007|Epoch 2|Withdrawal by Subject|0|||
156311411|NCT02059291|564241389|FG008|Epoch 2|Withdrawal by Subject|1|||
156311412|NCT02059291|564241390|FG009|Epoch 2|Withdrawal by Subject|0|||
156311413|NCT02059291|564241391|FG010|Epoch 2|Withdrawal by Subject|0|||
156311414|NCT02059291|564241392|FG011|Epoch 2|Withdrawal by Subject|0|||
156311415|NCT02059291|564241393|FG012|Epoch 2|Withdrawal by Subject|0|||
156311416|NCT02059291|564241394|FG013|Epoch 2|Withdrawal by Subject|0|||
156311417|NCT02059291|564241395|FG014|Epoch 2|Withdrawal by Subject|0|||
156311418|NCT02059291|564241396|FG015|Epoch 2|Withdrawal by Subject|0|||
156311419|NCT02059291|564241397|FG016|Epoch 2|Withdrawal by Subject|0|||
156311420|NCT02059291|564241398|FG017|Epoch 2|Withdrawal by Subject|0|||
156311421|NCT02059291|564241399|FG018|Epoch 2|Withdrawal by Subject|0|||
156311422|NCT02059291|564241400|FG019|Epoch 2|Withdrawal by Subject|0|||
156311423|NCT02059291|564241401|FG020|Epoch 2|Withdrawal by Subject|0|||
156311424|NCT02059291|564241402|FG021|Epoch 2|Withdrawal by Subject|0|||
156311425|NCT02059291|564241403|FG022|Epoch 2|Withdrawal by Subject|0|||
156311426|NCT02059291|564241404|FG023|Epoch 2|Withdrawal by Subject|0|||
156648918|NCT01580020|565461742|FG002|Overall Study|Withdrawal by Subject|1|||
156311427|NCT02059291|564241405|FG024|Epoch 2|Withdrawal by Subject|0|||
156311428|NCT02059291|564241381|FG000|Epoch 3|Physician Decision|0|||
156311429|NCT02059291|564241382|FG001|Epoch 3|Physician Decision|0|||
156311430|NCT02059291|564241383|FG002|Epoch 3|Physician Decision|0|||
156311431|NCT02059291|564241384|FG003|Epoch 3|Physician Decision|0|||
156311432|NCT02059291|564241385|FG004|Epoch 3|Physician Decision|0|||
156311433|NCT02059291|564241386|FG005|Epoch 3|Physician Decision|0|||
156311434|NCT02059291|564241387|FG006|Epoch 3|Physician Decision|0|||
156311435|NCT02059291|564241388|FG007|Epoch 3|Physician Decision|0|||
156311436|NCT02059291|564241389|FG008|Epoch 3|Physician Decision|0|||
156311437|NCT02059291|564241390|FG009|Epoch 3|Physician Decision|0|||
156311438|NCT02059291|564241391|FG010|Epoch 3|Physician Decision|0|||
156311439|NCT02059291|564241392|FG011|Epoch 3|Physician Decision|0|||
156311440|NCT02059291|564241393|FG012|Epoch 3|Physician Decision|0|||
156311441|NCT02059291|564241394|FG013|Epoch 3|Physician Decision|1|||
156311442|NCT02059291|564241395|FG014|Epoch 3|Physician Decision|0|||
156311443|NCT02059291|564241396|FG015|Epoch 3|Physician Decision|1|||
156311444|NCT02059291|564241397|FG016|Epoch 3|Physician Decision|0|||
156311445|NCT02059291|564241398|FG017|Epoch 3|Physician Decision|0|||
156311446|NCT02059291|564241399|FG018|Epoch 3|Physician Decision|0|||
156311447|NCT02059291|564241400|FG019|Epoch 3|Physician Decision|0|||
156311448|NCT02059291|564241401|FG020|Epoch 3|Physician Decision|0|||
156311449|NCT02059291|564241402|FG021|Epoch 3|Physician Decision|0|||
156311450|NCT02059291|564241403|FG022|Epoch 3|Physician Decision|0|||
156311451|NCT02059291|564241404|FG023|Epoch 3|Physician Decision|0|||
156311452|NCT02059291|564241405|FG024|Epoch 3|Physician Decision|0|||
156311453|NCT02059291|564241381|FG000|Epoch 3|Adverse Event|0|||
156311454|NCT02059291|564241382|FG001|Epoch 3|Adverse Event|0|||
156311455|NCT02059291|564241383|FG002|Epoch 3|Adverse Event|0|||
156311456|NCT02059291|564241384|FG003|Epoch 3|Adverse Event|0|||
156311457|NCT02059291|564241385|FG004|Epoch 3|Adverse Event|0|||
156311458|NCT02059291|564241386|FG005|Epoch 3|Adverse Event|0|||
156311459|NCT02059291|564241387|FG006|Epoch 3|Adverse Event|0|||
156311460|NCT02059291|564241388|FG007|Epoch 3|Adverse Event|0|||
156311461|NCT02059291|564241389|FG008|Epoch 3|Adverse Event|0|||
156311462|NCT02059291|564241390|FG009|Epoch 3|Adverse Event|0|||
156311463|NCT02059291|564241391|FG010|Epoch 3|Adverse Event|0|||
156311464|NCT02059291|564241392|FG011|Epoch 3|Adverse Event|0|||
156311465|NCT02059291|564241393|FG012|Epoch 3|Adverse Event|0|||
156311466|NCT02059291|564241394|FG013|Epoch 3|Adverse Event|0|||
156311467|NCT02059291|564241395|FG014|Epoch 3|Adverse Event|0|||
156311468|NCT02059291|564241396|FG015|Epoch 3|Adverse Event|1|||
156311469|NCT02059291|564241397|FG016|Epoch 3|Adverse Event|0|||
156311470|NCT02059291|564241398|FG017|Epoch 3|Adverse Event|0|||
156311471|NCT02059291|564241399|FG018|Epoch 3|Adverse Event|0|||
156311472|NCT02059291|564241400|FG019|Epoch 3|Adverse Event|0|||
156311473|NCT02059291|564241401|FG020|Epoch 3|Adverse Event|0|||
156311474|NCT02059291|564241402|FG021|Epoch 3|Adverse Event|0|||
156311475|NCT02059291|564241403|FG022|Epoch 3|Adverse Event|0|||
156311476|NCT02059291|564241404|FG023|Epoch 3|Adverse Event|0|||
156311477|NCT02059291|564241405|FG024|Epoch 3|Adverse Event|0|||
156311478|NCT02059291|564241381|FG000|Epoch 3|Lack of Efficacy|0|||
156311479|NCT02059291|564241382|FG001|Epoch 3|Lack of Efficacy|0|||
156311480|NCT02059291|564241383|FG002|Epoch 3|Lack of Efficacy|0|||
156311481|NCT02059291|564241384|FG003|Epoch 3|Lack of Efficacy|0|||
156311482|NCT02059291|564241385|FG004|Epoch 3|Lack of Efficacy|0|||
156311483|NCT02059291|564241386|FG005|Epoch 3|Lack of Efficacy|0|||
156311484|NCT02059291|564241387|FG006|Epoch 3|Lack of Efficacy|0|||
156311485|NCT02059291|564241388|FG007|Epoch 3|Lack of Efficacy|0|||
156311486|NCT02059291|564241389|FG008|Epoch 3|Lack of Efficacy|0|||
156311487|NCT02059291|564241390|FG009|Epoch 3|Lack of Efficacy|0|||
156311488|NCT02059291|564241391|FG010|Epoch 3|Lack of Efficacy|0|||
156311489|NCT02059291|564241392|FG011|Epoch 3|Lack of Efficacy|0|||
156648919|NCT01580020|565461743|FG003|Overall Study|Withdrawal by Subject|0|||
156648920|NCT01580020|565461740|FG000|Overall Study|Adverse Event|1|||
156648921|NCT01580020|565461741|FG001|Overall Study|Adverse Event|1|||
156648922|NCT01580020|565461742|FG002|Overall Study|Adverse Event|1|||
156648923|NCT01580020|565461743|FG003|Overall Study|Adverse Event|1|||
156648924|NCT01580020|565461740|FG000|Overall Study|Administrative Problems|0|||
156648925|NCT01580020|565461741|FG001|Overall Study|Administrative Problems|0|||
156648926|NCT01580020|565461742|FG002|Overall Study|Administrative Problems|1|||
156648927|NCT01580020|565461743|FG003|Overall Study|Administrative Problems|0|||
156648928|NCT01580020|565461740|FG000|Overall Study|Lost to Follow-up|0|||
156648929|NCT01580020|565461741|FG001|Overall Study|Lost to Follow-up|0|||
156648930|NCT01580020|565461742|FG002|Overall Study|Lost to Follow-up|1|||
156648931|NCT01580020|565461743|FG003|Overall Study|Lost to Follow-up|0|||
156648932|NCT00575328|565461747|FG000|Overall Study|Adverse Event|1|||
156648933|NCT00575328|565461748|FG001|Overall Study|Adverse Event|1|||
156648934|NCT00575328|565461747|FG000|Overall Study|Lost to Follow-up|2|||
156648935|NCT00575328|565461748|FG001|Overall Study|Lost to Follow-up|1|||
156648936|NCT02868281|565461749|FG000|Overall Study|Adverse Event|2|||
156648937|NCT02868281|565461750|FG001|Overall Study|Adverse Event|2|||
156311490|NCT02059291|564241393|FG012|Epoch 3|Lack of Efficacy|0|||
156311491|NCT02059291|564241394|FG013|Epoch 3|Lack of Efficacy|0|||
156311492|NCT02059291|564241395|FG014|Epoch 3|Lack of Efficacy|0|||
156311493|NCT02059291|564241396|FG015|Epoch 3|Lack of Efficacy|3|||
156648938|NCT02868281|565461749|FG000|Overall Study|Protocol Violation|13|||
156311494|NCT02059291|564241397|FG016|Epoch 3|Lack of Efficacy|0|||
156311495|NCT02059291|564241398|FG017|Epoch 3|Lack of Efficacy|0|||
156311496|NCT02059291|564241399|FG018|Epoch 3|Lack of Efficacy|0|||
156311497|NCT02059291|564241400|FG019|Epoch 3|Lack of Efficacy|0|||
156311498|NCT02059291|564241401|FG020|Epoch 3|Lack of Efficacy|0|||
156311499|NCT02059291|564241402|FG021|Epoch 3|Lack of Efficacy|0|||
156648939|NCT02868281|565461750|FG001|Overall Study|Protocol Violation|10|||
156311500|NCT02059291|564241403|FG022|Epoch 3|Lack of Efficacy|0|||
156311501|NCT02059291|564241404|FG023|Epoch 3|Lack of Efficacy|0|||
156311502|NCT02059291|564241405|FG024|Epoch 3|Lack of Efficacy|0|||
156311503|NCT02059291|564241381|FG000|Epoch 3|Withdrawal by Subject|0|||
156311504|NCT02059291|564241382|FG001|Epoch 3|Withdrawal by Subject|0|||
156311505|NCT02059291|564241383|FG002|Epoch 3|Withdrawal by Subject|0|||
156311506|NCT02059291|564241384|FG003|Epoch 3|Withdrawal by Subject|0|||
156648940|NCT02868281|565461749|FG000|Overall Study|Lost to Follow-up|3|||
156413437|NCT01474512|564608795|FG015|Induction Period|Lack of Efficacy|0|||
156413438|NCT01474512|564608796|FG016|Induction Period|Lack of Efficacy|0|||
156413439|NCT01474512|564608797|FG017|Induction Period|Lack of Efficacy|0|||
156413440|NCT01474512|564608780|FG000|Induction Period|Withdrawal by Subject|6|||
156413441|NCT01474512|564608781|FG001|Induction Period|Withdrawal by Subject|6|||
156413442|NCT01474512|564608782|FG002|Induction Period|Withdrawal by Subject|5|||
156413443|NCT01474512|564608783|FG003|Induction Period|Withdrawal by Subject|0|||
156413444|NCT01474512|564608784|FG004|Induction Period|Withdrawal by Subject|0|||
156413445|NCT01474512|564608785|FG005|Induction Period|Withdrawal by Subject|0|||
156413446|NCT01474512|564608786|FG006|Induction Period|Withdrawal by Subject|0|||
156413447|NCT01474512|564608787|FG007|Induction Period|Withdrawal by Subject|0|||
156413448|NCT01474512|564608788|FG008|Induction Period|Withdrawal by Subject|0|||
156413449|NCT01474512|564608789|FG009|Induction Period|Withdrawal by Subject|0|||
156413450|NCT01474512|564608790|FG010|Induction Period|Withdrawal by Subject|0|||
156413451|NCT01474512|564608791|FG011|Induction Period|Withdrawal by Subject|0|||
156413452|NCT01474512|564608792|FG012|Induction Period|Withdrawal by Subject|0|||
156413453|NCT01474512|564608793|FG013|Induction Period|Withdrawal by Subject|0|||
156413454|NCT01474512|564608794|FG014|Induction Period|Withdrawal by Subject|0|||
156413455|NCT01474512|564608795|FG015|Induction Period|Withdrawal by Subject|0|||
156413456|NCT01474512|564608796|FG016|Induction Period|Withdrawal by Subject|0|||
156413457|NCT01474512|564608797|FG017|Induction Period|Withdrawal by Subject|0|||
156413458|NCT01474512|564608780|FG000|Induction Period|Protocol Violation|3|||
156413459|NCT01474512|564608781|FG001|Induction Period|Protocol Violation|6|||
156413460|NCT01474512|564608782|FG002|Induction Period|Protocol Violation|0|||
156413461|NCT01474512|564608783|FG003|Induction Period|Protocol Violation|0|||
156413462|NCT01474512|564608784|FG004|Induction Period|Protocol Violation|0|||
156413463|NCT01474512|564608785|FG005|Induction Period|Protocol Violation|0|||
156413464|NCT01474512|564608786|FG006|Induction Period|Protocol Violation|0|||
156413465|NCT01474512|564608787|FG007|Induction Period|Protocol Violation|0|||
156413466|NCT01474512|564608788|FG008|Induction Period|Protocol Violation|0|||
156413467|NCT01474512|564608789|FG009|Induction Period|Protocol Violation|0|||
156413468|NCT01474512|564608790|FG010|Induction Period|Protocol Violation|0|||
156413469|NCT01474512|564608791|FG011|Induction Period|Protocol Violation|0|||
156413470|NCT01474512|564608792|FG012|Induction Period|Protocol Violation|0|||
156413471|NCT01474512|564608793|FG013|Induction Period|Protocol Violation|0|||
156413472|NCT01474512|564608794|FG014|Induction Period|Protocol Violation|0|||
156413473|NCT01474512|564608795|FG015|Induction Period|Protocol Violation|0|||
156413474|NCT01474512|564608796|FG016|Induction Period|Protocol Violation|0|||
156413475|NCT01474512|564608797|FG017|Induction Period|Protocol Violation|0|||
156413476|NCT01474512|564608780|FG000|Induction Period|Sponsor Decision|1|||
156413477|NCT01474512|564608781|FG001|Induction Period|Sponsor Decision|1|||
156413478|NCT01474512|564608782|FG002|Induction Period|Sponsor Decision|1|||
156413479|NCT01474512|564608783|FG003|Induction Period|Sponsor Decision|0|||
156413480|NCT01474512|564608784|FG004|Induction Period|Sponsor Decision|0|||
156413481|NCT01474512|564608785|FG005|Induction Period|Sponsor Decision|0|||
156413482|NCT01474512|564608786|FG006|Induction Period|Sponsor Decision|0|||
156413483|NCT01474512|564608787|FG007|Induction Period|Sponsor Decision|0|||
156413484|NCT01474512|564608788|FG008|Induction Period|Sponsor Decision|0|||
156413485|NCT01474512|564608789|FG009|Induction Period|Sponsor Decision|0|||
156413486|NCT01474512|564608790|FG010|Induction Period|Sponsor Decision|0|||
156413487|NCT01474512|564608791|FG011|Induction Period|Sponsor Decision|0|||
156413488|NCT01474512|564608792|FG012|Induction Period|Sponsor Decision|0|||
156413489|NCT01474512|564608793|FG013|Induction Period|Sponsor Decision|0|||
156413490|NCT01474512|564608794|FG014|Induction Period|Sponsor Decision|0|||
156413491|NCT01474512|564608795|FG015|Induction Period|Sponsor Decision|0|||
156413492|NCT01474512|564608796|FG016|Induction Period|Sponsor Decision|0|||
156413493|NCT01474512|564608797|FG017|Induction Period|Sponsor Decision|0|||
156413494|NCT01474512|564608780|FG000|Induction Period|Lost to Follow-up|1|||
156413495|NCT01474512|564608781|FG001|Induction Period|Lost to Follow-up|0|||
156413496|NCT01474512|564608782|FG002|Induction Period|Lost to Follow-up|2|||
156413497|NCT01474512|564608783|FG003|Induction Period|Lost to Follow-up|0|||
156413498|NCT01474512|564608784|FG004|Induction Period|Lost to Follow-up|0|||
156413499|NCT01474512|564608785|FG005|Induction Period|Lost to Follow-up|0|||
156413500|NCT01474512|564608786|FG006|Induction Period|Lost to Follow-up|0|||
156413501|NCT01474512|564608787|FG007|Induction Period|Lost to Follow-up|0|||
156413502|NCT01474512|564608788|FG008|Induction Period|Lost to Follow-up|0|||
156413503|NCT01474512|564608789|FG009|Induction Period|Lost to Follow-up|0|||
156413504|NCT01474512|564608790|FG010|Induction Period|Lost to Follow-up|0|||
156413505|NCT01474512|564608791|FG011|Induction Period|Lost to Follow-up|0|||
156413506|NCT01474512|564608792|FG012|Induction Period|Lost to Follow-up|0|||
156413507|NCT01474512|564608793|FG013|Induction Period|Lost to Follow-up|0|||
156413508|NCT01474512|564608794|FG014|Induction Period|Lost to Follow-up|0|||
156413509|NCT01474512|564608795|FG015|Induction Period|Lost to Follow-up|0|||
156413510|NCT01474512|564608796|FG016|Induction Period|Lost to Follow-up|0|||
156413511|NCT01474512|564608797|FG017|Induction Period|Lost to Follow-up|0|||
156413512|NCT01474512|564608780|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413513|NCT01474512|564608781|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413514|NCT01474512|564608782|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413515|NCT01474512|564608783|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
156413516|NCT01474512|564608784|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
156413517|NCT01474512|564608785|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
156413518|NCT01474512|564608786|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
156413519|NCT01474512|564608787|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413520|NCT01474512|564608788|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413521|NCT01474512|564608789|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413522|NCT01474512|564608790|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413523|NCT01474512|564608791|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413524|NCT01474512|564608792|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413525|NCT01474512|564608793|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413526|NCT01474512|564608794|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413527|NCT01474512|564608795|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413528|NCT01474512|564608796|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413529|NCT01474512|564608797|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156413530|NCT01474512|564608780|FG000|Maintenance Period|Adverse Event|0|||
156413531|NCT01474512|564608781|FG001|Maintenance Period|Adverse Event|0|||
156413532|NCT01474512|564608782|FG002|Maintenance Period|Adverse Event|0|||
156413533|NCT01474512|564608783|FG003|Maintenance Period|Adverse Event|4|||
156413534|NCT01474512|564608784|FG004|Maintenance Period|Adverse Event|2|||
156413535|NCT01474512|564608785|FG005|Maintenance Period|Adverse Event|7|||
156413536|NCT01474512|564608786|FG006|Maintenance Period|Adverse Event|0|||
156413537|NCT01474512|564608787|FG007|Maintenance Period|Adverse Event|19|||
156413538|NCT01474512|564608788|FG008|Maintenance Period|Adverse Event|1|||
156413539|NCT01474512|564608789|FG009|Maintenance Period|Adverse Event|3|||
156413540|NCT01474512|564608790|FG010|Maintenance Period|Adverse Event|0|||
156413541|NCT01474512|564608791|FG011|Maintenance Period|Adverse Event|0|||
156413542|NCT01474512|564608792|FG012|Maintenance Period|Adverse Event|0|||
156413543|NCT01474512|564608793|FG013|Maintenance Period|Adverse Event|0|||
156311507|NCT02059291|564241385|FG004|Epoch 3|Withdrawal by Subject|0|||
156311508|NCT02059291|564241386|FG005|Epoch 3|Withdrawal by Subject|0|||
156311509|NCT02059291|564241387|FG006|Epoch 3|Withdrawal by Subject|0|||
156311510|NCT02059291|564241388|FG007|Epoch 3|Withdrawal by Subject|0|||
156311511|NCT02059291|564241389|FG008|Epoch 3|Withdrawal by Subject|0|||
156311512|NCT02059291|564241390|FG009|Epoch 3|Withdrawal by Subject|0|||
156311513|NCT02059291|564241391|FG010|Epoch 3|Withdrawal by Subject|0|||
156311514|NCT02059291|564241392|FG011|Epoch 3|Withdrawal by Subject|0|||
156311515|NCT02059291|564241393|FG012|Epoch 3|Withdrawal by Subject|0|||
156311516|NCT02059291|564241394|FG013|Epoch 3|Withdrawal by Subject|0|||
156311517|NCT02059291|564241395|FG014|Epoch 3|Withdrawal by Subject|0|||
156311518|NCT02059291|564241396|FG015|Epoch 3|Withdrawal by Subject|1|||
156311519|NCT02059291|564241397|FG016|Epoch 3|Withdrawal by Subject|0|||
156311520|NCT02059291|564241398|FG017|Epoch 3|Withdrawal by Subject|0|||
156311521|NCT02059291|564241399|FG018|Epoch 3|Withdrawal by Subject|0|||
156311522|NCT02059291|564241400|FG019|Epoch 3|Withdrawal by Subject|0|||
156311523|NCT02059291|564241401|FG020|Epoch 3|Withdrawal by Subject|0|||
156311524|NCT02059291|564241402|FG021|Epoch 3|Withdrawal by Subject|0|||
156311525|NCT02059291|564241403|FG022|Epoch 3|Withdrawal by Subject|0|||
156311526|NCT02059291|564241404|FG023|Epoch 3|Withdrawal by Subject|0|||
156311527|NCT02059291|564241405|FG024|Epoch 3|Withdrawal by Subject|0|||
156311528|NCT02059291|564241381|FG000|Epoch 4|Adverse Event|0|||
156311529|NCT02059291|564241382|FG001|Epoch 4|Adverse Event|0|||
156311530|NCT02059291|564241383|FG002|Epoch 4|Adverse Event|0|||
156311531|NCT02059291|564241384|FG003|Epoch 4|Adverse Event|0|||
156311532|NCT02059291|564241385|FG004|Epoch 4|Adverse Event|0|||
156311533|NCT02059291|564241386|FG005|Epoch 4|Adverse Event|0|||
156311534|NCT02059291|564241387|FG006|Epoch 4|Adverse Event|0|||
156311535|NCT02059291|564241388|FG007|Epoch 4|Adverse Event|0|||
156311536|NCT02059291|564241389|FG008|Epoch 4|Adverse Event|0|||
156311537|NCT02059291|564241390|FG009|Epoch 4|Adverse Event|0|||
156413544|NCT01474512|564608794|FG014|Maintenance Period|Adverse Event|0|||
156413545|NCT01474512|564608795|FG015|Maintenance Period|Adverse Event|0|||
156413546|NCT01474512|564608796|FG016|Maintenance Period|Adverse Event|0|||
156413547|NCT01474512|564608797|FG017|Maintenance Period|Adverse Event|0|||
156413548|NCT01474512|564608780|FG000|Maintenance Period|Withdrawal by Subject|0|||
156413549|NCT01474512|564608781|FG001|Maintenance Period|Withdrawal by Subject|0|||
156413550|NCT01474512|564608782|FG002|Maintenance Period|Withdrawal by Subject|0|||
156413551|NCT01474512|564608783|FG003|Maintenance Period|Withdrawal by Subject|6|||
156648941|NCT02868281|565461750|FG001|Overall Study|Lost to Follow-up|6|||
156648942|NCT02868281|565461749|FG000|Overall Study|Withdrawal by Subject|11|||
156311538|NCT02059291|564241391|FG010|Epoch 4|Adverse Event|0|||
156311539|NCT02059291|564241392|FG011|Epoch 4|Adverse Event|0|||
156311540|NCT02059291|564241393|FG012|Epoch 4|Adverse Event|0|||
156311541|NCT02059291|564241394|FG013|Epoch 4|Adverse Event|0|||
156311542|NCT02059291|564241395|FG014|Epoch 4|Adverse Event|0|||
156311543|NCT02059291|564241396|FG015|Epoch 4|Adverse Event|0|||
156311544|NCT02059291|564241397|FG016|Epoch 4|Adverse Event|1|||
156311545|NCT02059291|564241398|FG017|Epoch 4|Adverse Event|0|||
156311546|NCT02059291|564241399|FG018|Epoch 4|Adverse Event|0|||
156413552|NCT01474512|564608784|FG004|Maintenance Period|Withdrawal by Subject|2|||
156311547|NCT02059291|564241400|FG019|Epoch 4|Adverse Event|0|||
156311548|NCT02059291|564241401|FG020|Epoch 4|Adverse Event|0|||
156311549|NCT02059291|564241402|FG021|Epoch 4|Adverse Event|0|||
156311550|NCT02059291|564241403|FG022|Epoch 4|Adverse Event|1|||
156311551|NCT02059291|564241404|FG023|Epoch 4|Adverse Event|0|||
156311552|NCT02059291|564241405|FG024|Epoch 4|Adverse Event|0|||
156311553|NCT02059291|564241381|FG000|Epoch 4|Pregnancy|0|||
156311554|NCT02059291|564241382|FG001|Epoch 4|Pregnancy|0|||
156311555|NCT02059291|564241383|FG002|Epoch 4|Pregnancy|0|||
156311556|NCT02059291|564241384|FG003|Epoch 4|Pregnancy|0|||
156311557|NCT02059291|564241385|FG004|Epoch 4|Pregnancy|0|||
156311558|NCT02059291|564241386|FG005|Epoch 4|Pregnancy|0|||
156311559|NCT02059291|564241387|FG006|Epoch 4|Pregnancy|0|||
156311560|NCT02059291|564241388|FG007|Epoch 4|Pregnancy|0|||
156311561|NCT02059291|564241389|FG008|Epoch 4|Pregnancy|0|||
156311562|NCT02059291|564241390|FG009|Epoch 4|Pregnancy|0|||
156311563|NCT02059291|564241391|FG010|Epoch 4|Pregnancy|0|||
156311564|NCT02059291|564241392|FG011|Epoch 4|Pregnancy|0|||
156311565|NCT02059291|564241393|FG012|Epoch 4|Pregnancy|0|||
156311566|NCT02059291|564241394|FG013|Epoch 4|Pregnancy|0|||
156311567|NCT02059291|564241395|FG014|Epoch 4|Pregnancy|0|||
156311568|NCT02059291|564241396|FG015|Epoch 4|Pregnancy|0|||
156311569|NCT02059291|564241397|FG016|Epoch 4|Pregnancy|1|||
156311570|NCT02059291|564241398|FG017|Epoch 4|Pregnancy|0|||
156311571|NCT02059291|564241399|FG018|Epoch 4|Pregnancy|0|||
156311572|NCT02059291|564241400|FG019|Epoch 4|Pregnancy|0|||
156311573|NCT02059291|564241401|FG020|Epoch 4|Pregnancy|0|||
156311574|NCT02059291|564241402|FG021|Epoch 4|Pregnancy|0|||
156311575|NCT02059291|564241403|FG022|Epoch 4|Pregnancy|0|||
156311576|NCT02059291|564241404|FG023|Epoch 4|Pregnancy|0|||
156311577|NCT02059291|564241405|FG024|Epoch 4|Pregnancy|0|||
156311578|NCT02059291|564241381|FG000|Epoch 4|Withdrawal by Subject|0|||
156311579|NCT02059291|564241382|FG001|Epoch 4|Withdrawal by Subject|0|||
156311580|NCT02059291|564241383|FG002|Epoch 4|Withdrawal by Subject|0|||
156311581|NCT02059291|564241384|FG003|Epoch 4|Withdrawal by Subject|0|||
156311582|NCT02059291|564241385|FG004|Epoch 4|Withdrawal by Subject|0|||
156311583|NCT02059291|564241386|FG005|Epoch 4|Withdrawal by Subject|0|||
156311584|NCT02059291|564241387|FG006|Epoch 4|Withdrawal by Subject|0|||
156311585|NCT02059291|564241388|FG007|Epoch 4|Withdrawal by Subject|0|||
156311586|NCT02059291|564241389|FG008|Epoch 4|Withdrawal by Subject|0|||
156311587|NCT02059291|564241390|FG009|Epoch 4|Withdrawal by Subject|0|||
156311588|NCT02059291|564241391|FG010|Epoch 4|Withdrawal by Subject|0|||
156311589|NCT02059291|564241392|FG011|Epoch 4|Withdrawal by Subject|0|||
156311590|NCT02059291|564241393|FG012|Epoch 4|Withdrawal by Subject|0|||
156311591|NCT02059291|564241394|FG013|Epoch 4|Withdrawal by Subject|0|||
156311592|NCT02059291|564241395|FG014|Epoch 4|Withdrawal by Subject|0|||
156311593|NCT02059291|564241396|FG015|Epoch 4|Withdrawal by Subject|0|||
156311594|NCT02059291|564241397|FG016|Epoch 4|Withdrawal by Subject|0|||
156311595|NCT02059291|564241398|FG017|Epoch 4|Withdrawal by Subject|0|||
156311596|NCT02059291|564241399|FG018|Epoch 4|Withdrawal by Subject|0|||
156311597|NCT02059291|564241400|FG019|Epoch 4|Withdrawal by Subject|0|||
156311598|NCT02059291|564241401|FG020|Epoch 4|Withdrawal by Subject|1|||
156311599|NCT02059291|564241402|FG021|Epoch 4|Withdrawal by Subject|0|||
156311600|NCT02059291|564241403|FG022|Epoch 4|Withdrawal by Subject|0|||
156311601|NCT02059291|564241404|FG023|Epoch 4|Withdrawal by Subject|0|||
156311602|NCT02059291|564241405|FG024|Epoch 4|Withdrawal by Subject|0|||
156311603|NCT02059291|564241381|FG000|Epoch 4|Lack of Efficacy|0|||
156311604|NCT02059291|564241382|FG001|Epoch 4|Lack of Efficacy|0|||
156311605|NCT02059291|564241383|FG002|Epoch 4|Lack of Efficacy|0|||
156311606|NCT02059291|564241384|FG003|Epoch 4|Lack of Efficacy|0|||
156311607|NCT02059291|564241385|FG004|Epoch 4|Lack of Efficacy|0|||
156311608|NCT02059291|564241386|FG005|Epoch 4|Lack of Efficacy|0|||
156311609|NCT02059291|564241387|FG006|Epoch 4|Lack of Efficacy|0|||
156311610|NCT02059291|564241388|FG007|Epoch 4|Lack of Efficacy|0|||
156311611|NCT02059291|564241389|FG008|Epoch 4|Lack of Efficacy|0|||
156311612|NCT02059291|564241390|FG009|Epoch 4|Lack of Efficacy|0|||
156311613|NCT02059291|564241391|FG010|Epoch 4|Lack of Efficacy|0|||
156311614|NCT02059291|564241392|FG011|Epoch 4|Lack of Efficacy|0|||
156311615|NCT02059291|564241393|FG012|Epoch 4|Lack of Efficacy|0|||
156311616|NCT02059291|564241394|FG013|Epoch 4|Lack of Efficacy|0|||
156311617|NCT02059291|564241395|FG014|Epoch 4|Lack of Efficacy|0|||
156311618|NCT02059291|564241396|FG015|Epoch 4|Lack of Efficacy|0|||
156311619|NCT02059291|564241397|FG016|Epoch 4|Lack of Efficacy|0|||
156311620|NCT02059291|564241398|FG017|Epoch 4|Lack of Efficacy|0|||
156311621|NCT02059291|564241399|FG018|Epoch 4|Lack of Efficacy|0|||
156311622|NCT02059291|564241400|FG019|Epoch 4|Lack of Efficacy|0|||
156311623|NCT02059291|564241401|FG020|Epoch 4|Lack of Efficacy|0|||
156311624|NCT02059291|564241402|FG021|Epoch 4|Lack of Efficacy|0|||
156311625|NCT02059291|564241403|FG022|Epoch 4|Lack of Efficacy|0|||
156311626|NCT02059291|564241404|FG023|Epoch 4|Lack of Efficacy|1|||
156311627|NCT02059291|564241405|FG024|Epoch 4|Lack of Efficacy|0|||
156311628|NCT03180619|564241406|FG000|Overall Study|Withdrew Consent|5|||
156311629|NCT03180619|564241407|FG001|Overall Study|Withdrew Consent|0|||
156311630|NCT03180619|564241408|FG002|Overall Study|Withdrew Consent|2|||
156311631|NCT03180619|564241406|FG000|Overall Study|Death|2|||
156311632|NCT03180619|564241407|FG001|Overall Study|Death|1|||
156311633|NCT03180619|564241408|FG002|Overall Study|Death|2|||
156311634|NCT03180619|564241406|FG000|Overall Study|Adverse Event|2|||
156413553|NCT01474512|564608785|FG005|Maintenance Period|Withdrawal by Subject|3|||
156413554|NCT01474512|564608786|FG006|Maintenance Period|Withdrawal by Subject|1|||
156413555|NCT01474512|564608787|FG007|Maintenance Period|Withdrawal by Subject|6|||
156413556|NCT01474512|564608788|FG008|Maintenance Period|Withdrawal by Subject|3|||
156413557|NCT01474512|564608789|FG009|Maintenance Period|Withdrawal by Subject|1|||
156413558|NCT01474512|564608790|FG010|Maintenance Period|Withdrawal by Subject|0|||
156413559|NCT01474512|564608791|FG011|Maintenance Period|Withdrawal by Subject|0|||
156413560|NCT01474512|564608792|FG012|Maintenance Period|Withdrawal by Subject|0|||
156413561|NCT01474512|564608793|FG013|Maintenance Period|Withdrawal by Subject|0|||
156413562|NCT01474512|564608794|FG014|Maintenance Period|Withdrawal by Subject|0|||
156413563|NCT01474512|564608795|FG015|Maintenance Period|Withdrawal by Subject|0|||
156413564|NCT01474512|564608796|FG016|Maintenance Period|Withdrawal by Subject|0|||
156413565|NCT01474512|564608797|FG017|Maintenance Period|Withdrawal by Subject|0|||
156413566|NCT01474512|564608780|FG000|Maintenance Period|Lost to Follow-up|0|||
156413567|NCT01474512|564608781|FG001|Maintenance Period|Lost to Follow-up|0|||
156413568|NCT01474512|564608782|FG002|Maintenance Period|Lost to Follow-up|0|||
156413569|NCT01474512|564608783|FG003|Maintenance Period|Lost to Follow-up|3|||
156413570|NCT01474512|564608784|FG004|Maintenance Period|Lost to Follow-up|3|||
156413571|NCT01474512|564608785|FG005|Maintenance Period|Lost to Follow-up|0|||
156413572|NCT01474512|564608786|FG006|Maintenance Period|Lost to Follow-up|0|||
156413573|NCT01474512|564608787|FG007|Maintenance Period|Lost to Follow-up|2|||
156413574|NCT01474512|564608788|FG008|Maintenance Period|Lost to Follow-up|1|||
156413575|NCT01474512|564608789|FG009|Maintenance Period|Lost to Follow-up|1|||
156413576|NCT01474512|564608790|FG010|Maintenance Period|Lost to Follow-up|0|||
156413577|NCT01474512|564608791|FG011|Maintenance Period|Lost to Follow-up|0|||
156413578|NCT01474512|564608792|FG012|Maintenance Period|Lost to Follow-up|0|||
156413579|NCT01474512|564608793|FG013|Maintenance Period|Lost to Follow-up|0|||
156413580|NCT01474512|564608794|FG014|Maintenance Period|Lost to Follow-up|0|||
156413581|NCT01474512|564608795|FG015|Maintenance Period|Lost to Follow-up|0|||
156413582|NCT01474512|564608796|FG016|Maintenance Period|Lost to Follow-up|0|||
156413583|NCT01474512|564608797|FG017|Maintenance Period|Lost to Follow-up|0|||
156413584|NCT01474512|564608780|FG000|Maintenance Period|Death|0|||
156413585|NCT01474512|564608781|FG001|Maintenance Period|Death|0|||
156413586|NCT01474512|564608782|FG002|Maintenance Period|Death|0|||
156413587|NCT01474512|564608783|FG003|Maintenance Period|Death|0|||
156413588|NCT01474512|564608784|FG004|Maintenance Period|Death|0|||
156413589|NCT01474512|564608785|FG005|Maintenance Period|Death|2|||
156648943|NCT02868281|565461750|FG001|Overall Study|Withdrawal by Subject|15|||
156311635|NCT03180619|564241407|FG001|Overall Study|Adverse Event|0|||
156311636|NCT03180619|564241408|FG002|Overall Study|Adverse Event|1|||
156311637|NCT03180619|564241406|FG000|Overall Study|Investigator's discretion|2|||
156311638|NCT03180619|564241407|FG001|Overall Study|Investigator's discretion|0|||
156311639|NCT03180619|564241408|FG002|Overall Study|Investigator's discretion|1|||
156311640|NCT01433289|564241409|FG000|Overall Study|Pregnancy|0|||
156311641|NCT01433289|564241410|FG001|Overall Study|Pregnancy|1|||
156311642|NCT01433289|564241411|FG002|Overall Study|Pregnancy|0|||
156311643|NCT01433289|564241412|FG003|Overall Study|Pregnancy|0|||
156311644|NCT00561977|564241415|FG000|Overall Study|Withdrawal by Subject|0|||
156311645|NCT00561977|564241416|FG001|Overall Study|Withdrawal by Subject|2|||
156311646|NCT00561977|564241417|FG002|Overall Study|Withdrawal by Subject|1|||
156311647|NCT00561977|564241415|FG000|Overall Study|Pregnancy|0|||
156311648|NCT00561977|564241416|FG001|Overall Study|Pregnancy|1|||
156311649|NCT00561977|564241417|FG002|Overall Study|Pregnancy|1|||
156311650|NCT00566696|564241418|FG000|Overall Study|Met Exclusion Criteria|2|||
156311651|NCT00566696|564241418|FG000|Overall Study|Muromonab not available|1|||
156311652|NCT00566696|564241418|FG000|Overall Study|Health Status Change|1|||
156311653|NCT00566696|564241418|FG000|Overall Study|Physician Decision|1|||
156311654|NCT00566696|564241418|FG000|Overall Study|Non-Patient Donors|37|||
156311655|NCT00275340|564241420|FG000|Overall Study|Lost to Follow-up|2|||
156311656|NCT00275340|564241421|FG001|Overall Study|Lost to Follow-up|4|||
156311657|NCT01950013|564241422|FG000|Overall Study|Withdrawal by Subject|0|||
156311658|NCT01950013|564241423|FG001|Overall Study|Withdrawal by Subject|2|||
156413590|NCT01474512|564608786|FG006|Maintenance Period|Death|0|||
156413591|NCT01474512|564608787|FG007|Maintenance Period|Death|0|||
156413592|NCT01474512|564608788|FG008|Maintenance Period|Death|0|||
156413593|NCT01474512|564608789|FG009|Maintenance Period|Death|0|||
156413594|NCT01474512|564608790|FG010|Maintenance Period|Death|0|||
156413595|NCT01474512|564608791|FG011|Maintenance Period|Death|0|||
156413596|NCT01474512|564608792|FG012|Maintenance Period|Death|0|||
156413597|NCT01474512|564608793|FG013|Maintenance Period|Death|0|||
156311659|NCT01950013|564241424|FG002|Overall Study|Withdrawal by Subject|0|||
156311660|NCT02365480|564241425|FG000|Overall Study|Withdrawal by Subject|2|||
156311661|NCT02365480|564241426|FG001|Overall Study|Withdrawal by Subject|0|||
156311662|NCT00706342|564241427|FG000|Overall Study|Adverse Event|3|||
156311663|NCT00706342|564241427|FG000|Overall Study|Not responding to treatment|2|||
156311664|NCT00706342|564241427|FG000|Overall Study|Withdrawn due to failure to respond|1|||
156413598|NCT01474512|564608794|FG014|Maintenance Period|Death|0|||
156413599|NCT01474512|564608795|FG015|Maintenance Period|Death|0|||
156413600|NCT01474512|564608796|FG016|Maintenance Period|Death|0|||
156311665|NCT00706342|564241427|FG000|Overall Study|Death|1|||
156311666|NCT00706342|564241427|FG000|Overall Study|Withdrew from the study on his own.|1|||
156311667|NCT00706342|564241427|FG000|Overall Study|Investigator discretion|2|||
156311668|NCT00706342|564241427|FG000|Overall Study|Non-responder Week 12|1|||
156413601|NCT01474512|564608797|FG017|Maintenance Period|Death|0|||
156413602|NCT01474512|564608780|FG000|Maintenance Period|Physician Decision|0|||
156413603|NCT01474512|564608781|FG001|Maintenance Period|Physician Decision|0|||
156648944|NCT02868281|565461749|FG000|Overall Study|Physician Decision|2|||
156648945|NCT02868281|565461750|FG001|Overall Study|Physician Decision|0|||
156648946|NCT02868281|565461749|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
156311669|NCT00706342|564241427|FG000|Overall Study|Ongoing|6|||
156311670|NCT00706342|564241427|FG000|Overall Study|WIthdrawal of consent|1|||
156311671|NCT01781299|564241432|FG000|Overall Study|Withdrawal by Subject|0|||
156311672|NCT01781299|564241433|FG001|Overall Study|Withdrawal by Subject|1|||
156311673|NCT02395172|564241438|FG000|Overall Study|Participants randomized but not treated|3|||
156311674|NCT02395172|564241439|FG001|Overall Study|Participants randomized but not treated|31|||
156311675|NCT02032238|564241440|FG000|Overall Study|Lost to Follow-up|2|||
156311676|NCT02032238|564241441|FG001|Overall Study|Lost to Follow-up|0|||
156311677|NCT00653939|564241442|FG000|Overall Study|Adverse Event|1|||
156311678|NCT00653939|564241443|FG001|Overall Study|Adverse Event|3|||
156311679|NCT00653939|564241442|FG000|Overall Study|Withdrawal by Subject|3|||
156311680|NCT00653939|564241443|FG001|Overall Study|Withdrawal by Subject|3|||
156311681|NCT00653939|564241442|FG000|Overall Study|Physician Decision|4|||
156311682|NCT00653939|564241443|FG001|Overall Study|Physician Decision|0|||
156311683|NCT00653939|564241442|FG000|Overall Study|Disease Progression|2|||
156311684|NCT00653939|564241443|FG001|Overall Study|Disease Progression|3|||
156311685|NCT00653939|564241442|FG000|Overall Study|Other|2|||
156311686|NCT00653939|564241443|FG001|Overall Study|Other|6|||
156311687|NCT00612105|564241444|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
156311688|NCT00612105|564241445|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
156311689|NCT00612105|564241444|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
156311690|NCT00612105|564241445|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
156311691|NCT00612105|564241444|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
156311692|NCT00612105|564241445|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
156311693|NCT00612105|564241444|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
156311694|NCT00612105|564241445|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
156311695|NCT00612105|564241444|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
156311696|NCT00612105|564241445|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
156311697|NCT00612105|564241444|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
156648947|NCT02868281|565461750|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
156648948|NCT02868281|565461749|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
156648949|NCT02868281|565461750|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
156648950|NCT02868281|565461749|FG000|Overall Study|Long journey/moving away|1|||
156648951|NCT02868281|565461750|FG001|Overall Study|Long journey/moving away|1|||
156648952|NCT01722266|565461755|FG000|Overall Study|Withdrawal by Subject|1|||
156648953|NCT01722266|565461756|FG001|Overall Study|Withdrawal by Subject|2|||
156648954|NCT01722266|565461757|FG002|Overall Study|Withdrawal by Subject|0|||
156648955|NCT01722266|565461758|FG003|Overall Study|Withdrawal by Subject|0|||
156648956|NCT01722266|565461755|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
156648957|NCT01722266|565461756|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
156648958|NCT01722266|565461757|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
156648959|NCT01722266|565461758|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
156648960|NCT01722266|565461755|FG000|Overall Study|Dropped out due to Nausea|0|||
156648961|NCT01722266|565461756|FG001|Overall Study|Dropped out due to Nausea|0|||
156648962|NCT01722266|565461757|FG002|Overall Study|Dropped out due to Nausea|2|||
156648963|NCT01722266|565461758|FG003|Overall Study|Dropped out due to Nausea|0|||
156648964|NCT00124449|565461761|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
156648965|NCT00124449|565461762|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
156648966|NCT00124449|565461761|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
156648967|NCT00124449|565461762|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
156648968|NCT00124449|565461761|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
156648969|NCT00124449|565461762|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
156648970|NCT00124449|565461761|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
156311698|NCT00612105|564241445|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
156311699|NCT00612105|564241444|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
156311700|NCT00612105|564241445|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
156311701|NCT00612105|564241444|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
156413604|NCT01474512|564608782|FG002|Maintenance Period|Physician Decision|0|||
156648971|NCT00124449|565461762|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
156648972|NCT00124449|565461761|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
156311702|NCT00612105|564241445|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
156311703|NCT00612105|564241444|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
156311704|NCT00612105|564241445|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
156311705|NCT00612105|564241444|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
156311706|NCT00612105|564241445|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
156311707|NCT00612105|564241444|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
156311708|NCT00612105|564241445|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
156311709|NCT00612105|564241444|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
156311710|NCT00612105|564241445|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
156311711|NCT01105767|564241446|FG000|Overall Study|Lost to Follow-up|1160|||
156311712|NCT01105767|564241447|FG001|Overall Study|Lost to Follow-up|1614|||
156311713|NCT01105767|564241448|FG002|Overall Study|Lost to Follow-up|1184|||
156311714|NCT00475982|564241449|FG000|Overall Study|surgery rescheduled|7|||
156311715|NCT00475982|564241450|FG001|Overall Study|surgery rescheduled|3|||
156311716|NCT02874144|564241455|FG000|Overall Study|Lost to Follow-up|3|||
156311717|NCT02874144|564241456|FG001|Overall Study|Lost to Follow-up|5|||
156311718|NCT00852371|564241460|FG000|Overall Study|Lost to Follow-up|2|||
156311719|NCT00852371|564241461|FG001|Overall Study|Lost to Follow-up|3|||
156311720|NCT00852371|564241462|FG002|Overall Study|Lost to Follow-up|4|||
156311721|NCT00852371|564241463|FG003|Overall Study|Lost to Follow-up|2|||
156311722|NCT03158285|564241464|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
156311723|NCT03158285|564241465|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
156311724|NCT03158285|564241466|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
156311725|NCT03158285|564241464|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
156311726|NCT03158285|564241465|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
156311727|NCT03158285|564241466|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
156311728|NCT03158285|564241464|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
156311729|NCT03158285|564241465|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
156311730|NCT03158285|564241466|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
156311731|NCT03158285|564241464|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
156311732|NCT03158285|564241465|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
156311733|NCT03158285|564241466|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
156311734|NCT03158285|564241464|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
156311735|NCT03158285|564241465|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
156311736|NCT03158285|564241466|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
156311737|NCT03158285|564241464|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
156311738|NCT03158285|564241465|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
156311739|NCT03158285|564241466|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
156311740|NCT03158285|564241464|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
156311741|NCT03158285|564241465|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
156311742|NCT03158285|564241466|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
156311743|NCT03158285|564241464|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
156311744|NCT03158285|564241465|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
156311745|NCT03158285|564241466|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
156311746|NCT03158285|564241464|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
156311747|NCT03158285|564241465|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
156311748|NCT03158285|564241466|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
156311749|NCT03158285|564241464|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
156311750|NCT03158285|564241465|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
156311751|NCT03158285|564241466|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
156311752|NCT03158285|564241464|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
156311753|NCT03158285|564241465|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
156311754|NCT03158285|564241466|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
156311755|NCT03158285|564241464|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
156311756|NCT03158285|564241465|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
156311757|NCT03158285|564241466|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
156311758|NCT03158285|564241464|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
156311759|NCT03158285|564241465|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
156311760|NCT03158285|564241466|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
156311761|NCT03158285|564241464|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
156311762|NCT03158285|564241465|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
156311763|NCT03158285|564241466|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
156311764|NCT03158285|564241464|FG000|Active Treatment Period: Week 52-100|Death|1|||
156311765|NCT03158285|564241465|FG001|Active Treatment Period: Week 52-100|Death|0|||
156311766|NCT03158285|564241466|FG002|Active Treatment Period: Week 52-100|Death|0|||
156311767|NCT03158285|564241464|FG000|Active Treatment Period: Week 52-100|Other|4|||
156311768|NCT03158285|564241465|FG001|Active Treatment Period: Week 52-100|Other|1|||
156311769|NCT03158285|564241466|FG002|Active Treatment Period: Week 52-100|Other|0|||
156311770|NCT02744040|564241469|FG000|Overall Study|Withdrawal by Subject|3|||
156648973|NCT00124449|565461762|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
156648974|NCT00124449|565461761|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
156648975|NCT00124449|565461762|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
156648976|NCT00124449|565461761|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
156648977|NCT00124449|565461762|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
156648978|NCT00124449|565461761|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
156648979|NCT00124449|565461762|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
156648980|NCT00124449|565461761|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
156648981|NCT00124449|565461762|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
156648982|NCT00124449|565461761|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
156648983|NCT00124449|565461762|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
156648984|NCT00124449|565461761|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
156648985|NCT00124449|565461762|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
156648986|NCT00124449|565461761|FG000|18-Month Untreated Observation Period|Relocated|1|||
156648987|NCT00124449|565461762|FG001|18-Month Untreated Observation Period|Relocated|0|||
156648988|NCT03811249|565461763|FG000|Overall Study|Withdrawal by Subject|44|||
156648989|NCT03811249|565461763|FG000|Overall Study|Missed Visit|24|||
156648990|NCT01783730|565461768|FG000|Overall Study|Failed to meet inclusion criteria|6|||
156648991|NCT02151461|565461769|FG000|Overall Study|Adverse Event|5|||
156648992|NCT02151461|565461770|FG001|Overall Study|Adverse Event|1|||
156648993|NCT02151461|565461771|FG002|Overall Study|Adverse Event|0|||
156648994|NCT02151461|565461772|FG003|Overall Study|Adverse Event|2|||
156648995|NCT02151461|565461769|FG000|Overall Study|Lost to Follow-up|0|||
156311771|NCT02744040|564241470|FG001|Overall Study|Withdrawal by Subject|2|||
156311772|NCT02744040|564241471|FG002|Overall Study|Withdrawal by Subject|2|||
156311773|NCT02744040|564241469|FG000|Overall Study|Physician Decision|0|||
156648996|NCT02151461|565461770|FG001|Overall Study|Lost to Follow-up|0|||
156648997|NCT02151461|565461771|FG002|Overall Study|Lost to Follow-up|1|||
156648998|NCT02151461|565461772|FG003|Overall Study|Lost to Follow-up|1|||
156648999|NCT02151461|565461769|FG000|Overall Study|Withdrawal by Subject|1|||
156649000|NCT02151461|565461770|FG001|Overall Study|Withdrawal by Subject|0|||
156649001|NCT02151461|565461771|FG002|Overall Study|Withdrawal by Subject|1|||
156649002|NCT02151461|565461772|FG003|Overall Study|Withdrawal by Subject|1|||
156649003|NCT02151461|565461769|FG000|Overall Study|Treatment discontinuation|0|||
156649004|NCT02151461|565461770|FG001|Overall Study|Treatment discontinuation|0|||
156649005|NCT02151461|565461771|FG002|Overall Study|Treatment discontinuation|1|||
156649006|NCT02151461|565461772|FG003|Overall Study|Treatment discontinuation|0|||
156649007|NCT04304950|565461773|FG000|Overall Study|Lost to Follow-up|1|||
156649008|NCT04304950|565461774|FG001|Overall Study|Lost to Follow-up|1|||
156649009|NCT00408876|565461779|FG000|Overall Study|Adverse Event|9|||
156649010|NCT00408876|565461780|FG001|Overall Study|Adverse Event|17|||
156649011|NCT00408876|565461781|FG002|Overall Study|Adverse Event|27|||
156649012|NCT00408876|565461782|FG003|Overall Study|Adverse Event|10|||
156649013|NCT00408876|565461779|FG000|Overall Study|Withdrawal by Subject|3|||
156649014|NCT00408876|565461780|FG001|Overall Study|Withdrawal by Subject|6|||
156311774|NCT02744040|564241470|FG001|Overall Study|Physician Decision|8|||
156311775|NCT02744040|564241471|FG002|Overall Study|Physician Decision|13|||
156311776|NCT02744040|564241469|FG000|Overall Study|Lost to Follow-up|3|||
156311777|NCT02744040|564241470|FG001|Overall Study|Lost to Follow-up|1|||
156311778|NCT02744040|564241471|FG002|Overall Study|Lost to Follow-up|7|||
156311779|NCT01642615|564241472|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
156311780|NCT01642615|564241473|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156311781|NCT01642615|564241474|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156311782|NCT01642615|564241472|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
156311783|NCT01642615|564241473|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
156311784|NCT01642615|564241474|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
156311785|NCT01642615|564241472|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
156311786|NCT01642615|564241473|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
156311787|NCT01642615|564241474|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
156311788|NCT01642615|564241472|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
156311789|NCT01642615|564241473|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
156311790|NCT01642615|564241474|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
156311791|NCT01642615|564241472|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
156311792|NCT01642615|564241473|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
156311793|NCT01642615|564241474|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
156311794|NCT01642615|564241472|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
156311795|NCT01642615|564241473|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
156649015|NCT00408876|565461781|FG002|Overall Study|Withdrawal by Subject|6|||
156649016|NCT00408876|565461782|FG003|Overall Study|Withdrawal by Subject|14|||
156649017|NCT00408876|565461779|FG000|Overall Study|Lack of Efficacy|2|||
156649018|NCT00408876|565461780|FG001|Overall Study|Lack of Efficacy|4|||
156649019|NCT00408876|565461781|FG002|Overall Study|Lack of Efficacy|5|||
156311796|NCT01642615|564241474|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
156311797|NCT01642615|564241472|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
156311798|NCT01642615|564241473|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
156311799|NCT01642615|564241474|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
156311800|NCT01642615|564241472|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156311801|NCT01642615|564241473|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
156311802|NCT01642615|564241474|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156311803|NCT01642615|564241472|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
156311804|NCT01642615|564241473|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
156311805|NCT01642615|564241474|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
156311806|NCT00402740|564241477|FG000|Overall Study|Withdrawal by Subject|18|||
156311807|NCT00402740|564241477|FG000|Overall Study|Death|50|||
156311808|NCT00402740|564241477|FG000|Overall Study|Lost to Follow-up|6|||
156311809|NCT00402740|564241477|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
156311810|NCT00402740|564241477|FG000|Overall Study|Subject disposition unknown.|1|||
156311811|NCT01214395|564241480|FG000|Overall Study|All patients had infection|5|||
156311812|NCT00946153|564241484|FG000|Phase 2|Adverse Event|0|||
156311813|NCT00946153|564241485|FG001|Phase 2|Adverse Event|0|||
156311814|NCT00946153|564241486|FG002|Phase 2|Adverse Event|0|||
156311815|NCT00946153|564241487|FG003|Phase 2|Adverse Event|0|||
156311816|NCT00946153|564241488|FG004|Phase 2|Adverse Event|6|||
156311817|NCT00946153|564241484|FG000|Phase 2|Need more reduction of dose|0|||
156311818|NCT00946153|564241485|FG001|Phase 2|Need more reduction of dose|0|||
156311819|NCT00946153|564241486|FG002|Phase 2|Need more reduction of dose|0|||
156311820|NCT00946153|564241487|FG003|Phase 2|Need more reduction of dose|0|||
156311821|NCT00946153|564241488|FG004|Phase 2|Need more reduction of dose|2|||
156311822|NCT00946153|564241484|FG000|Phase 2|Physician Decision|0|||
156311823|NCT00946153|564241485|FG001|Phase 2|Physician Decision|0|||
156311824|NCT00946153|564241486|FG002|Phase 2|Physician Decision|0|||
156311825|NCT00946153|564241487|FG003|Phase 2|Physician Decision|0|||
156311826|NCT00946153|564241488|FG004|Phase 2|Physician Decision|1|||
156311827|NCT00946153|564241484|FG000|Phase 2|14 days washout for recovery due to AE|0|||
156311828|NCT00946153|564241485|FG001|Phase 2|14 days washout for recovery due to AE|0|||
156311829|NCT00946153|564241486|FG002|Phase 2|14 days washout for recovery due to AE|0|||
156311830|NCT00946153|564241487|FG003|Phase 2|14 days washout for recovery due to AE|0|||
156311831|NCT00946153|564241488|FG004|Phase 2|14 days washout for recovery due to AE|4|||
156311832|NCT03698591|564241491|FG000|Overall Study|Withdrawal by Subject|2|||
156311833|NCT03698591|564241492|FG001|Overall Study|Withdrawal by Subject|2|||
156311834|NCT03698591|564241491|FG000|Overall Study|Failed drug screen|1|||
156311835|NCT03698591|564241492|FG001|Overall Study|Failed drug screen|1|||
156311836|NCT03698591|564241491|FG000|Overall Study|Failed health screen|0|||
156311837|NCT03698591|564241492|FG001|Overall Study|Failed health screen|1|||
156311838|NCT03698591|564241491|FG000|Overall Study|Ineligible for financial compensation|1|||
156311839|NCT03698591|564241492|FG001|Overall Study|Ineligible for financial compensation|0|||
156311840|NCT03698591|564241491|FG000|Overall Study|Equipment Error|1|||
156311841|NCT03698591|564241492|FG001|Overall Study|Equipment Error|0|||
156311842|NCT03698591|564241491|FG000|Overall Study|Could not establish TMS dosage|0|||
156311843|NCT03698591|564241492|FG001|Overall Study|Could not establish TMS dosage|1|||
156311844|NCT01165216|564241503|FG000|Overall Study|Adverse Event|6|||
156311845|NCT01165216|564241504|FG001|Overall Study|Adverse Event|3|||
156311846|NCT01165216|564241503|FG000|Overall Study|Withdrawal by Subject|1|||
156311847|NCT01165216|564241504|FG001|Overall Study|Withdrawal by Subject|1|||
156311848|NCT01165216|564241503|FG000|Overall Study|Disease progression|1|||
156311849|NCT01165216|564241504|FG001|Overall Study|Disease progression|3|||
156311850|NCT02626624|564241505|FG000|Overall Study|Adverse Event|1|||
156311851|NCT02626624|564241505|FG000|Overall Study|Lost to Follow-up|3|||
156311852|NCT02626624|564241505|FG000|Overall Study|Protocol Violation|4|||
156311853|NCT02626624|564241505|FG000|Overall Study|Death|2|||
156311854|NCT04174365|564241506|FG000|Overall Study|Lost to Follow-up|1|||
156311855|NCT04174365|564241507|FG001|Overall Study|Lost to Follow-up|2|||
156311856|NCT04174365|564241506|FG000|Overall Study|Adverse Event|2|||
156311857|NCT04174365|564241507|FG001|Overall Study|Adverse Event|1|||
156311858|NCT04174365|564241506|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
156311859|NCT04174365|564241507|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
156311860|NCT04174365|564241506|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
156311861|NCT04174365|564241507|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
156311862|NCT04174365|564241506|FG000|Overall Study|Protocol Deviation|1|||
156311863|NCT04174365|564241507|FG001|Overall Study|Protocol Deviation|0|||
156311864|NCT04174365|564241506|FG000|Overall Study|Lack of Efficacy|0|||
156311865|NCT04174365|564241507|FG001|Overall Study|Lack of Efficacy|2|||
156311866|NCT04174365|564241506|FG000|Overall Study|Disease Relapse|1|||
156311867|NCT04174365|564241507|FG001|Overall Study|Disease Relapse|0|||
156311868|NCT04174365|564241506|FG000|Overall Study|Reason Not Specified|0|||
156311869|NCT04174365|564241507|FG001|Overall Study|Reason Not Specified|1|||
156311870|NCT03472547|564241508|FG000|Overall Study|Withdrawal by Subject|30|||
156311871|NCT05141448|564241509|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156311872|NCT05141448|564241510|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
156311873|NCT05141448|564241511|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156311874|NCT05141448|564241512|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156311875|NCT05141448|564241513|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156311876|NCT05141448|564241514|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156311877|NCT05141448|564241509|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156311878|NCT05141448|564241510|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156311879|NCT05141448|564241511|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156311880|NCT05141448|564241512|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156311881|NCT05141448|564241513|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
156311882|NCT05141448|564241514|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156311883|NCT05141448|564241509|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156311884|NCT05141448|564241510|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
156311885|NCT05141448|564241511|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156311886|NCT05141448|564241512|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156311887|NCT05141448|564241513|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156311888|NCT05141448|564241514|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156311889|NCT05141448|564241509|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156311890|NCT05141448|564241510|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156311891|NCT05141448|564241511|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156311892|NCT05141448|564241512|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156311893|NCT05141448|564241513|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156311894|NCT05141448|564241514|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
156311895|NCT05141448|564241509|FG000|Period 2|COVID-19 Related|0|||
156311896|NCT05141448|564241510|FG001|Period 2|COVID-19 Related|0|||
156311897|NCT05141448|564241511|FG002|Period 2|COVID-19 Related|0|||
156311898|NCT05141448|564241512|FG003|Period 2|COVID-19 Related|1|||
156311899|NCT05141448|564241513|FG004|Period 2|COVID-19 Related|0|||
156311900|NCT05141448|564241514|FG005|Period 2|COVID-19 Related|1|||
156311901|NCT05141448|564241509|FG000|3|Covid-19 related|2|||
156311902|NCT05141448|564241510|FG001|3|Covid-19 related|0|||
156311903|NCT05141448|564241511|FG002|3|Covid-19 related|0|||
156311904|NCT05141448|564241512|FG003|3|Covid-19 related|0|||
156311905|NCT05141448|564241513|FG004|3|Covid-19 related|0|||
156311906|NCT05141448|564241514|FG005|3|Covid-19 related|1|||
156311907|NCT05141448|564241509|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
156311908|NCT05141448|564241510|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
156311909|NCT05141448|564241511|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
156311910|NCT05141448|564241512|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
156311911|NCT05141448|564241513|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
156311912|NCT05141448|564241514|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
156311913|NCT01106092|564243078|FG000|Overall Study|Withdrawal by Subject|0|||
156311914|NCT01106092|564243079|FG001|Overall Study|Withdrawal by Subject|0|||
156311915|NCT01106092|564243080|FG002|Overall Study|Withdrawal by Subject|0|||
156311916|NCT01106092|564243081|FG003|Overall Study|Withdrawal by Subject|1|||
156311917|NCT02434471|564243084|FG000|Overall Study|Physician Decision|9|||
156311918|NCT01604278|564243089|FG000|Overall Study|Lack of Efficacy|0|||
156311919|NCT01604278|564243090|FG001|Overall Study|Lack of Efficacy|1|||
156311920|NCT01604278|564243089|FG000|Overall Study|Lost to Follow-up|1|||
156311921|NCT01604278|564243090|FG001|Overall Study|Lost to Follow-up|0|||
156311922|NCT01604278|564243089|FG000|Overall Study|Administrative problems|2|||
156311923|NCT01604278|564243090|FG001|Overall Study|Administrative problems|1|||
156311924|NCT01604278|564243089|FG000|Overall Study|Withdrawal by Subject|3|||
156311925|NCT01604278|564243090|FG001|Overall Study|Withdrawal by Subject|3|||
156311926|NCT01604278|564243089|FG000|Overall Study|Adverse Event|3|||
156311927|NCT01604278|564243090|FG001|Overall Study|Adverse Event|5|||
156311928|NCT01604278|564243089|FG000|Overall Study|Protocol Deviation|5|||
156311929|NCT01604278|564243090|FG001|Overall Study|Protocol Deviation|3|||
156311930|NCT02870933|564243091|FG000|Overall Study|Death|2|||
156311931|NCT02870933|564243092|FG001|Overall Study|Death|1|||
156311932|NCT02870933|564243091|FG000|Overall Study|Withdrawal by Subject|0|||
156311933|NCT02870933|564243092|FG001|Overall Study|Withdrawal by Subject|1|||
156311934|NCT01659554|564243094|FG000|Overall Study|Study Termination|4|||
156311935|NCT00097981|564243106|FG000|Overall Study|Adverse Event|31|||
156311936|NCT00097981|564243107|FG001|Overall Study|Adverse Event|44|||
156649020|NCT00408876|565461782|FG003|Overall Study|Lack of Efficacy|6|||
156649021|NCT00408876|565461779|FG000|Overall Study|Lost to Follow-up|1|||
156311937|NCT00097981|564243106|FG000|Overall Study|Withdrawal by Subject|10|||
156649022|NCT00408876|565461780|FG001|Overall Study|Lost to Follow-up|6|||
156649023|NCT00408876|565461781|FG002|Overall Study|Lost to Follow-up|5|||
156649024|NCT00408876|565461782|FG003|Overall Study|Lost to Follow-up|2|||
156649025|NCT00408876|565461779|FG000|Overall Study|Protocol Violation|0|||
156649026|NCT00408876|565461780|FG001|Overall Study|Protocol Violation|3|||
156649027|NCT00408876|565461781|FG002|Overall Study|Protocol Violation|4|||
156649028|NCT00408876|565461782|FG003|Overall Study|Protocol Violation|3|||
156311938|NCT00097981|564243107|FG001|Overall Study|Withdrawal by Subject|8|||
156311939|NCT00097981|564243106|FG000|Overall Study|Protocol Violation|1|||
156311940|NCT00097981|564243107|FG001|Overall Study|Protocol Violation|1|||
156311941|NCT00097981|564243106|FG000|Overall Study|Death|2|||
156311942|NCT00097981|564243107|FG001|Overall Study|Death|4|||
156311943|NCT00097981|564243106|FG000|Overall Study|Physician Decision|7|||
156311944|NCT00097981|564243107|FG001|Overall Study|Physician Decision|1|||
156311945|NCT00097981|564243106|FG000|Overall Study|Disease Progression|8|||
156311946|NCT00097981|564243107|FG001|Overall Study|Disease Progression|2|||
156311947|NCT00097981|564243106|FG000|Overall Study|Transplant planned|28|||
156311948|NCT00097981|564243107|FG001|Overall Study|Transplant planned|27|||
156311949|NCT00097981|564243106|FG000|Overall Study|Other|19|||
156311950|NCT00097981|564243107|FG001|Overall Study|Other|13|||
156311951|NCT00412373|564243108|FG000|Overall Study|Adverse Event|8|||
156311952|NCT00412373|564243109|FG001|Overall Study|Adverse Event|13|||
156311953|NCT00412373|564243108|FG000|Overall Study|Lack of Efficacy|16|||
156311954|NCT00412373|564243109|FG001|Overall Study|Lack of Efficacy|22|||
156311955|NCT00412373|564243108|FG000|Overall Study|Lost to Follow-up|7|||
156311956|NCT00412373|564243109|FG001|Overall Study|Lost to Follow-up|13|||
156311957|NCT00412373|564243108|FG000|Overall Study|Withdrawal by Subject|8|||
156311958|NCT00412373|564243109|FG001|Overall Study|Withdrawal by Subject|27|||
156311959|NCT00412373|564243108|FG000|Overall Study|Other|2|||
156311960|NCT00412373|564243109|FG001|Overall Study|Other|2|||
156311961|NCT01252667|564243116|FG000|Overall Study|Transplant aborted post-conditioning|0|||
156311962|NCT01252667|564243117|FG001|Overall Study|Transplant aborted post-conditioning|0|||
156311963|NCT01252667|564243118|FG002|Overall Study|Transplant aborted post-conditioning|0|||
156311964|NCT01252667|564243119|FG003|Overall Study|Transplant aborted post-conditioning|0|||
156311965|NCT01252667|564243120|FG004|Overall Study|Transplant aborted post-conditioning|0|||
156311966|NCT01252667|564243121|FG005|Overall Study|Transplant aborted post-conditioning|1|||
156311967|NCT03032380|564243122|FG000|Overall Study|Adverse Event|0|||
156311968|NCT03032380|564243123|FG001|Overall Study|Adverse Event|1|||
156311969|NCT03032380|564243122|FG000|Overall Study|Lack of Efficacy|1|||
156311970|NCT03032380|564243123|FG001|Overall Study|Lack of Efficacy|0|||
156311971|NCT03032380|564243122|FG000|Overall Study|Withdrawal by Subject|2|||
156311972|NCT03032380|564243123|FG001|Overall Study|Withdrawal by Subject|3|||
156311973|NCT03032380|564243122|FG000|Overall Study|Recovery|0|||
156311974|NCT03032380|564243123|FG001|Overall Study|Recovery|1|||
156311975|NCT03032380|564243122|FG000|Overall Study|Death|39|||
156311976|NCT03032380|564243123|FG001|Overall Study|Death|34|||
156311977|NCT03032380|564243122|FG000|Overall Study|Other - Miscellaneous|0|||
156311978|NCT03032380|564243123|FG001|Overall Study|Other - Miscellaneous|1|||
156311979|NCT01738646|564243124|FG000|Overall Study|Still Receiving Treatment|2|||
156311980|NCT03642132|564243125|FG000|Chemotherapy Period|Adverse Event|1|||
156311981|NCT03642132|564243126|FG001|Chemotherapy Period|Adverse Event|1|||
156311982|NCT03642132|564243127|FG002|Chemotherapy Period|Adverse Event|0|||
156311983|NCT03642132|564243125|FG000|Chemotherapy Period|Physician's decision|4|||
156311984|NCT03642132|564243126|FG001|Chemotherapy Period|Physician's decision|1|||
156311985|NCT03642132|564243127|FG002|Chemotherapy Period|Physician's decision|0|||
156311986|NCT03642132|564243125|FG000|Chemotherapy Period|Progressive disease|0|||
156311987|NCT03642132|564243126|FG001|Chemotherapy Period|Progressive disease|0|||
156311988|NCT03642132|564243127|FG002|Chemotherapy Period|Progressive disease|1|||
156311989|NCT03642132|564243125|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
156311990|NCT03642132|564243126|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
156311991|NCT03642132|564243127|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
156311992|NCT03642132|564243125|FG000|Chemotherapy Period|Other|1|||
156311993|NCT03642132|564243126|FG001|Chemotherapy Period|Other|0|||
156311994|NCT03642132|564243127|FG002|Chemotherapy Period|Other|2|||
156311995|NCT03642132|564243125|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
156311996|NCT03642132|564243126|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
156311997|NCT03642132|564243127|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
156311998|NCT03642132|564243125|FG000|Maintenance Period|Adverse Event|1|||
156311999|NCT03642132|564243126|FG001|Maintenance Period|Adverse Event|2|||
156649029|NCT00408876|565461779|FG000|Overall Study|Physician Decision|1|||
156649030|NCT00408876|565461780|FG001|Overall Study|Physician Decision|0|||
156312000|NCT03642132|564243127|FG002|Maintenance Period|Adverse Event|0|||
156312001|NCT03642132|564243125|FG000|Maintenance Period|Non-compliance with study drug|0|||
156312002|NCT03642132|564243126|FG001|Maintenance Period|Non-compliance with study drug|0|||
156312003|NCT03642132|564243127|FG002|Maintenance Period|Non-compliance with study drug|1|||
156312004|NCT03642132|564243125|FG000|Maintenance Period|Physician's decision|2|||
156312005|NCT03642132|564243126|FG001|Maintenance Period|Physician's decision|2|||
156312006|NCT03642132|564243127|FG002|Maintenance Period|Physician's decision|2|||
156649031|NCT00408876|565461781|FG002|Overall Study|Physician Decision|3|||
156312007|NCT03642132|564243125|FG000|Maintenance Period|Progressive disease|9|||
156413605|NCT01474512|564608783|FG003|Maintenance Period|Physician Decision|0|||
156413606|NCT01474512|564608784|FG004|Maintenance Period|Physician Decision|0|||
156413607|NCT01474512|564608785|FG005|Maintenance Period|Physician Decision|1|||
156413608|NCT01474512|564608786|FG006|Maintenance Period|Physician Decision|0|||
156413609|NCT01474512|564608787|FG007|Maintenance Period|Physician Decision|2|||
156413610|NCT01474512|564608788|FG008|Maintenance Period|Physician Decision|0|||
156413611|NCT01474512|564608789|FG009|Maintenance Period|Physician Decision|0|||
156413612|NCT01474512|564608790|FG010|Maintenance Period|Physician Decision|0|||
156413613|NCT01474512|564608791|FG011|Maintenance Period|Physician Decision|0|||
156413614|NCT01474512|564608792|FG012|Maintenance Period|Physician Decision|0|||
156413615|NCT01474512|564608793|FG013|Maintenance Period|Physician Decision|0|||
156413616|NCT01474512|564608794|FG014|Maintenance Period|Physician Decision|0|||
156413617|NCT01474512|564608795|FG015|Maintenance Period|Physician Decision|0|||
156413618|NCT01474512|564608796|FG016|Maintenance Period|Physician Decision|0|||
156413619|NCT01474512|564608797|FG017|Maintenance Period|Physician Decision|0|||
156413620|NCT01474512|564608780|FG000|Maintenance Period|Clinical Relapse|0|||
156413621|NCT01474512|564608781|FG001|Maintenance Period|Clinical Relapse|0|||
156413622|NCT01474512|564608782|FG002|Maintenance Period|Clinical Relapse|0|||
156413623|NCT01474512|564608783|FG003|Maintenance Period|Clinical Relapse|1|||
156413624|NCT01474512|564608784|FG004|Maintenance Period|Clinical Relapse|0|||
156413625|NCT01474512|564608785|FG005|Maintenance Period|Clinical Relapse|0|||
156413626|NCT01474512|564608786|FG006|Maintenance Period|Clinical Relapse|0|||
156413627|NCT01474512|564608787|FG007|Maintenance Period|Clinical Relapse|0|||
156413628|NCT01474512|564608788|FG008|Maintenance Period|Clinical Relapse|0|||
156413629|NCT01474512|564608789|FG009|Maintenance Period|Clinical Relapse|0|||
156413630|NCT01474512|564608790|FG010|Maintenance Period|Clinical Relapse|0|||
156413631|NCT01474512|564608791|FG011|Maintenance Period|Clinical Relapse|0|||
156413632|NCT01474512|564608792|FG012|Maintenance Period|Clinical Relapse|0|||
156413633|NCT01474512|564608793|FG013|Maintenance Period|Clinical Relapse|0|||
156413634|NCT01474512|564608794|FG014|Maintenance Period|Clinical Relapse|0|||
156413635|NCT01474512|564608795|FG015|Maintenance Period|Clinical Relapse|0|||
156413636|NCT01474512|564608796|FG016|Maintenance Period|Clinical Relapse|0|||
156413637|NCT01474512|564608797|FG017|Maintenance Period|Clinical Relapse|0|||
156413638|NCT01474512|564608780|FG000|Maintenance Period|Lack of Efficacy|0|||
156413639|NCT01474512|564608781|FG001|Maintenance Period|Lack of Efficacy|0|||
156413640|NCT01474512|564608782|FG002|Maintenance Period|Lack of Efficacy|0|||
156413641|NCT01474512|564608783|FG003|Maintenance Period|Lack of Efficacy|1|||
156413642|NCT01474512|564608784|FG004|Maintenance Period|Lack of Efficacy|0|||
156413643|NCT01474512|564608785|FG005|Maintenance Period|Lack of Efficacy|0|||
156413644|NCT01474512|564608786|FG006|Maintenance Period|Lack of Efficacy|0|||
156413645|NCT01474512|564608787|FG007|Maintenance Period|Lack of Efficacy|11|||
156413646|NCT01474512|564608788|FG008|Maintenance Period|Lack of Efficacy|11|||
156413647|NCT01474512|564608789|FG009|Maintenance Period|Lack of Efficacy|12|||
156413648|NCT01474512|564608790|FG010|Maintenance Period|Lack of Efficacy|0|||
156413649|NCT01474512|564608791|FG011|Maintenance Period|Lack of Efficacy|0|||
156413650|NCT01474512|564608792|FG012|Maintenance Period|Lack of Efficacy|0|||
156413651|NCT01474512|564608793|FG013|Maintenance Period|Lack of Efficacy|0|||
156413652|NCT01474512|564608794|FG014|Maintenance Period|Lack of Efficacy|0|||
156413653|NCT01474512|564608795|FG015|Maintenance Period|Lack of Efficacy|0|||
156413654|NCT01474512|564608796|FG016|Maintenance Period|Lack of Efficacy|0|||
156413655|NCT01474512|564608797|FG017|Maintenance Period|Lack of Efficacy|0|||
156413656|NCT01474512|564608780|FG000|Maintenance Period|Protocol Violation|0|||
156413657|NCT01474512|564608781|FG001|Maintenance Period|Protocol Violation|0|||
156413658|NCT01474512|564608782|FG002|Maintenance Period|Protocol Violation|0|||
156413659|NCT01474512|564608783|FG003|Maintenance Period|Protocol Violation|1|||
156413660|NCT01474512|564608784|FG004|Maintenance Period|Protocol Violation|0|||
156413661|NCT01474512|564608785|FG005|Maintenance Period|Protocol Violation|0|||
156413662|NCT01474512|564608786|FG006|Maintenance Period|Protocol Violation|0|||
156413663|NCT01474512|564608787|FG007|Maintenance Period|Protocol Violation|1|||
156413664|NCT01474512|564608788|FG008|Maintenance Period|Protocol Violation|0|||
156413665|NCT01474512|564608789|FG009|Maintenance Period|Protocol Violation|1|||
156413666|NCT01474512|564608790|FG010|Maintenance Period|Protocol Violation|0|||
156413667|NCT01474512|564608791|FG011|Maintenance Period|Protocol Violation|0|||
156413668|NCT01474512|564608792|FG012|Maintenance Period|Protocol Violation|0|||
156413669|NCT01474512|564608793|FG013|Maintenance Period|Protocol Violation|0|||
156413670|NCT01474512|564608794|FG014|Maintenance Period|Protocol Violation|0|||
156413671|NCT01474512|564608795|FG015|Maintenance Period|Protocol Violation|0|||
156413672|NCT01474512|564608796|FG016|Maintenance Period|Protocol Violation|0|||
156413673|NCT01474512|564608797|FG017|Maintenance Period|Protocol Violation|0|||
156413674|NCT01474512|564608780|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
156413675|NCT01474512|564608781|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
156413676|NCT01474512|564608782|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
156413677|NCT01474512|564608783|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
156413678|NCT01474512|564608784|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
156413679|NCT01474512|564608785|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
156413680|NCT01474512|564608786|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
156312008|NCT03642132|564243126|FG001|Maintenance Period|Progressive disease|3|||
156312009|NCT03642132|564243127|FG002|Maintenance Period|Progressive disease|6|||
156312010|NCT03642132|564243125|FG000|Maintenance Period|Other|0|||
156312011|NCT03642132|564243126|FG001|Maintenance Period|Other|0|||
156312012|NCT03642132|564243127|FG002|Maintenance Period|Other|3|||
156312013|NCT03642132|564243125|FG000|Maintenance Period|Withdrawal by Subject|1|||
156312014|NCT03642132|564243126|FG001|Maintenance Period|Withdrawal by Subject|1|||
156312015|NCT03642132|564243127|FG002|Maintenance Period|Withdrawal by Subject|2|||
156312016|NCT03642132|564243125|FG000|Follow-up Period|Other|0|||
156312017|NCT03642132|564243126|FG001|Follow-up Period|Other|0|||
156312018|NCT03642132|564243127|FG002|Follow-up Period|Other|1|||
156312019|NCT03642132|564243125|FG000|Follow-up Period|Withdrawal by Subject|1|||
156312020|NCT03642132|564243126|FG001|Follow-up Period|Withdrawal by Subject|2|||
156312021|NCT03642132|564243127|FG002|Follow-up Period|Withdrawal by Subject|0|||
156312022|NCT03642132|564243125|FG000|Follow-up Period|Study terminated by sponsor|1|||
156312023|NCT03642132|564243126|FG001|Follow-up Period|Study terminated by sponsor|0|||
156312024|NCT03642132|564243127|FG002|Follow-up Period|Study terminated by sponsor|1|||
156413681|NCT01474512|564608787|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
156413682|NCT01474512|564608788|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
156413683|NCT01474512|564608789|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
156413684|NCT01474512|564608790|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
156413685|NCT01474512|564608791|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
156413686|NCT01474512|564608792|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
156413687|NCT01474512|564608793|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
156413688|NCT01474512|564608794|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
156413689|NCT01474512|564608795|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
156413690|NCT01474512|564608796|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
156413691|NCT01474512|564608797|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
156413692|NCT01474512|564608780|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
156413693|NCT01474512|564608781|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
156413694|NCT01474512|564608782|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
156413695|NCT01474512|564608783|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
156413696|NCT01474512|564608784|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
156413697|NCT01474512|564608785|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
156413698|NCT01474512|564608786|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
156413699|NCT01474512|564608787|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
156413700|NCT01474512|564608788|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
156312025|NCT03642132|564243125|FG000|Follow-up Period|Lack of Efficacy|1|||
156312026|NCT03642132|564243126|FG001|Follow-up Period|Lack of Efficacy|0|||
156312027|NCT03642132|564243127|FG002|Follow-up Period|Lack of Efficacy|0|||
156312028|NCT03642132|564243125|FG000|Follow-up Period|Death|1|||
156312029|NCT03642132|564243126|FG001|Follow-up Period|Death|0|||
156312030|NCT03642132|564243127|FG002|Follow-up Period|Death|2|||
156312031|NCT03642132|564243125|FG000|Follow-up Period|Adverse Event|1|||
156312032|NCT03642132|564243126|FG001|Follow-up Period|Adverse Event|0|||
156312033|NCT03642132|564243127|FG002|Follow-up Period|Adverse Event|0|||
156312034|NCT02577887|564243129|FG000|Overall Study|Death|93|||
156312035|NCT02577887|564243129|FG000|Overall Study|Protocol Violation|125|||
156312036|NCT02577887|564243129|FG000|Overall Study|Withdrawal by Subject|80|||
156312037|NCT00864916|564243130|FG000|Overall Study|Lost to Follow-up|4|||
156312038|NCT00864916|564243131|FG001|Overall Study|Lost to Follow-up|4|||
156312039|NCT00864916|564243130|FG000|Overall Study|Protocol Violation|1|||
156312040|NCT00864916|564243131|FG001|Overall Study|Protocol Violation|0|||
156312041|NCT00864916|564243130|FG000|Overall Study|Withdrawal by Subject|1|||
156312042|NCT00864916|564243131|FG001|Overall Study|Withdrawal by Subject|0|||
156312043|NCT03890666|564243132|FG000|Overall Study|Withdrawal by Subject|0|||
156312044|NCT03890666|564243133|FG001|Overall Study|Withdrawal by Subject|1|||
156312045|NCT03890666|564243132|FG000|Overall Study|Protocol deviation|1|||
156312046|NCT03890666|564243133|FG001|Overall Study|Protocol deviation|4|||
156312047|NCT03890666|564243132|FG000|Overall Study|Lost to Follow-up|2|||
156312048|NCT03890666|564243133|FG001|Overall Study|Lost to Follow-up|5|||
156312049|NCT03890666|564243132|FG000|Overall Study|Other than specified|1|||
156312050|NCT03890666|564243133|FG001|Overall Study|Other than specified|8|||
156312051|NCT01155011|564243139|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
156312052|NCT01155011|564243140|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
156312053|NCT01155011|564243139|FG000|Baseline to 6 Months|investigator decision, moved|4|||
156312054|NCT01155011|564243140|FG001|Baseline to 6 Months|investigator decision, moved|5|||
156312055|NCT01155011|564243139|FG000|Baseline to 6 Months|Death|0|||
156413701|NCT01474512|564608789|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
156413702|NCT01474512|564608790|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
156649032|NCT00408876|565461782|FG003|Overall Study|Physician Decision|0|||
156312056|NCT01155011|564243140|FG001|Baseline to 6 Months|Death|1|||
156312057|NCT01155011|564243139|FG000|6 to 12 Months|Withdrawal by Subject|8|||
156413703|NCT01474512|564608791|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
156413704|NCT01474512|564608792|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
156413705|NCT01474512|564608793|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
156413706|NCT01474512|564608794|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
156413707|NCT01474512|564608795|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
156413708|NCT01474512|564608796|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
156413709|NCT01474512|564608797|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
156413710|NCT01474512|564608780|FG000|Long-Term Extension Period|Adverse Event|0|||
156413711|NCT01474512|564608781|FG001|Long-Term Extension Period|Adverse Event|0|||
156413712|NCT01474512|564608782|FG002|Long-Term Extension Period|Adverse Event|0|||
156413713|NCT01474512|564608783|FG003|Long-Term Extension Period|Adverse Event|0|||
156413714|NCT01474512|564608784|FG004|Long-Term Extension Period|Adverse Event|0|||
156413715|NCT01474512|564608785|FG005|Long-Term Extension Period|Adverse Event|0|||
156413716|NCT01474512|564608786|FG006|Long-Term Extension Period|Adverse Event|0|||
156413717|NCT01474512|564608787|FG007|Long-Term Extension Period|Adverse Event|0|||
156413718|NCT01474512|564608788|FG008|Long-Term Extension Period|Adverse Event|0|||
156413719|NCT01474512|564608789|FG009|Long-Term Extension Period|Adverse Event|0|||
156413720|NCT01474512|564608790|FG010|Long-Term Extension Period|Adverse Event|0|||
156413721|NCT01474512|564608791|FG011|Long-Term Extension Period|Adverse Event|1|||
156413722|NCT01474512|564608792|FG012|Long-Term Extension Period|Adverse Event|57|||
156413723|NCT01474512|564608793|FG013|Long-Term Extension Period|Adverse Event|58|||
156413724|NCT01474512|564608794|FG014|Long-Term Extension Period|Adverse Event|0|||
156413725|NCT01474512|564608795|FG015|Long-Term Extension Period|Adverse Event|0|||
156413726|NCT01474512|564608796|FG016|Long-Term Extension Period|Adverse Event|0|||
156413727|NCT01474512|564608797|FG017|Long-Term Extension Period|Adverse Event|0|||
156413728|NCT01474512|564608780|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
156413729|NCT01474512|564608781|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
156413730|NCT01474512|564608782|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
156413731|NCT01474512|564608783|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
156413732|NCT01474512|564608784|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
156413733|NCT01474512|564608785|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
156413734|NCT01474512|564608786|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
156413735|NCT01474512|564608787|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
156413736|NCT01474512|564608788|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
156413737|NCT01474512|564608789|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
156413738|NCT01474512|564608790|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
156413739|NCT01474512|564608791|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
156413740|NCT01474512|564608792|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
156413741|NCT01474512|564608793|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
156413742|NCT01474512|564608794|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
156413743|NCT01474512|564608795|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
156413744|NCT01474512|564608796|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
156413745|NCT01474512|564608797|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
156413746|NCT01474512|564608780|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
156413747|NCT01474512|564608781|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
156413748|NCT01474512|564608782|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
156312058|NCT01155011|564243140|FG001|6 to 12 Months|Withdrawal by Subject|5|||
156312059|NCT01155011|564243139|FG000|6 to 12 Months|Death|1|||
156312060|NCT01155011|564243140|FG001|6 to 12 Months|Death|5|||
156312061|NCT02122783|564243141|FG000|Overall Study|Adverse Event|0|||
156312062|NCT02122783|564243142|FG001|Overall Study|Adverse Event|1|||
156312063|NCT00322621|564243145|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
156312064|NCT00322621|564243146|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
156312065|NCT00322621|564243147|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
156312066|NCT00322621|564243145|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
156312067|NCT00322621|564243146|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
156312068|NCT00322621|564243147|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
156312069|NCT00322621|564243145|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
156312070|NCT00322621|564243146|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
156413749|NCT01474512|564608783|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
156413750|NCT01474512|564608784|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
156413751|NCT01474512|564608785|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
156413752|NCT01474512|564608786|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
156413753|NCT01474512|564608787|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
156413754|NCT01474512|564608788|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
156413755|NCT01474512|564608789|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
156413756|NCT01474512|564608790|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
156413757|NCT01474512|564608791|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
156413758|NCT01474512|564608792|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
156649033|NCT01337050|565461788|FG000|Overall Study|Death|0|||
156312071|NCT00322621|564243147|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
156312072|NCT00322621|564243145|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
156312073|NCT00322621|564243146|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
156312074|NCT00322621|564243147|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
156312075|NCT00322621|564243145|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
156312076|NCT00322621|564243146|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
156312077|NCT00322621|564243147|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
156312078|NCT00322621|564243145|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
156312079|NCT00322621|564243146|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
156312080|NCT00322621|564243147|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
156312081|NCT00322621|564243145|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
156312082|NCT00322621|564243146|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
156312083|NCT00322621|564243147|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
156312084|NCT00322621|564243145|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
156312085|NCT00322621|564243146|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
156312086|NCT00322621|564243147|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
156312087|NCT00322621|564243145|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
156312088|NCT00322621|564243146|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
156312089|NCT00322621|564243147|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
156649034|NCT01337050|565461789|FG001|Overall Study|Death|0|||
156649035|NCT01337050|565461790|FG002|Overall Study|Death|4|||
156649036|NCT01337050|565461788|FG000|Overall Study|Other|4|||
156312090|NCT00322621|564243145|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
156312091|NCT00322621|564243146|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
156312092|NCT00322621|564243147|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
156312093|NCT00322621|564243145|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
156312094|NCT00322621|564243146|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
156413759|NCT01474512|564608793|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
156413760|NCT01474512|564608794|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
156413761|NCT01474512|564608795|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
156413762|NCT01474512|564608796|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
156413763|NCT01474512|564608797|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
156413764|NCT01474512|564608780|FG000|Long-Term Extension Period|Physician Decision|0|||
156413765|NCT01474512|564608781|FG001|Long-Term Extension Period|Physician Decision|0|||
156413766|NCT01474512|564608782|FG002|Long-Term Extension Period|Physician Decision|0|||
156413767|NCT01474512|564608783|FG003|Long-Term Extension Period|Physician Decision|0|||
156413768|NCT01474512|564608784|FG004|Long-Term Extension Period|Physician Decision|0|||
156413769|NCT01474512|564608785|FG005|Long-Term Extension Period|Physician Decision|0|||
156413770|NCT01474512|564608786|FG006|Long-Term Extension Period|Physician Decision|0|||
156413771|NCT01474512|564608787|FG007|Long-Term Extension Period|Physician Decision|0|||
156413772|NCT01474512|564608788|FG008|Long-Term Extension Period|Physician Decision|0|||
156413773|NCT01474512|564608789|FG009|Long-Term Extension Period|Physician Decision|0|||
156413774|NCT01474512|564608790|FG010|Long-Term Extension Period|Physician Decision|0|||
156413775|NCT01474512|564608791|FG011|Long-Term Extension Period|Physician Decision|0|||
156413776|NCT01474512|564608792|FG012|Long-Term Extension Period|Physician Decision|21|||
156312095|NCT00322621|564243147|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
156312096|NCT01038869|564243150|FG000|Overall Study|Withdrawal by Subject|1|||
156312097|NCT01038869|564243150|FG000|Overall Study|Lost to Follow-up|6|||
156312098|NCT02238067|564243151|FG000|Overall Study|Not completed survey at Month 6|45|||
156413777|NCT01474512|564608793|FG013|Long-Term Extension Period|Physician Decision|21|||
156413778|NCT01474512|564608794|FG014|Long-Term Extension Period|Physician Decision|0|||
156649037|NCT01337050|565461789|FG001|Overall Study|Other|6|||
156413779|NCT01474512|564608795|FG015|Long-Term Extension Period|Physician Decision|0|||
156413780|NCT01474512|564608796|FG016|Long-Term Extension Period|Physician Decision|0|||
156413781|NCT01474512|564608797|FG017|Long-Term Extension Period|Physician Decision|0|||
156413782|NCT01474512|564608780|FG000|Long-Term Extension Period|Clinical Relapse|0|||
156413783|NCT01474512|564608781|FG001|Long-Term Extension Period|Clinical Relapse|0|||
156413784|NCT01474512|564608782|FG002|Long-Term Extension Period|Clinical Relapse|0|||
156649038|NCT01337050|565461790|FG002|Overall Study|Other|8|||
156649039|NCT01337050|565461788|FG000|Overall Study|Participants refused further follow-up|0|||
156649040|NCT01337050|565461789|FG001|Overall Study|Participants refused further follow-up|7|||
156649041|NCT01337050|565461790|FG002|Overall Study|Participants refused further follow-up|7|||
156649042|NCT00003102|565461791|FG000|Overall Study|Physician Decision|1|||
156649043|NCT00003102|565461792|FG001|Overall Study|Physician Decision|1|||
156649044|NCT00003102|565461793|FG002|Overall Study|Physician Decision|0|||
156413785|NCT01474512|564608783|FG003|Long-Term Extension Period|Clinical Relapse|0|||
156649045|NCT00003102|565461791|FG000|Overall Study|Progressive Disease|0|||
156649046|NCT00003102|565461792|FG001|Overall Study|Progressive Disease|1|||
156649047|NCT00003102|565461793|FG002|Overall Study|Progressive Disease|0|||
156649048|NCT00003102|565461791|FG000|Overall Study|Adverse Event|0|||
156312099|NCT02743611|564243155|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
156312100|NCT02743611|564243156|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
156413786|NCT01474512|564608784|FG004|Long-Term Extension Period|Clinical Relapse|0|||
156413787|NCT01474512|564608785|FG005|Long-Term Extension Period|Clinical Relapse|0|||
156413788|NCT01474512|564608786|FG006|Long-Term Extension Period|Clinical Relapse|0|||
156413789|NCT01474512|564608787|FG007|Long-Term Extension Period|Clinical Relapse|0|||
156413790|NCT01474512|564608788|FG008|Long-Term Extension Period|Clinical Relapse|0|||
156413791|NCT01474512|564608789|FG009|Long-Term Extension Period|Clinical Relapse|0|||
156413792|NCT01474512|564608790|FG010|Long-Term Extension Period|Clinical Relapse|0|||
156413793|NCT01474512|564608791|FG011|Long-Term Extension Period|Clinical Relapse|0|||
156413794|NCT01474512|564608792|FG012|Long-Term Extension Period|Clinical Relapse|9|||
156413795|NCT01474512|564608793|FG013|Long-Term Extension Period|Clinical Relapse|9|||
156413796|NCT01474512|564608794|FG014|Long-Term Extension Period|Clinical Relapse|0|||
156413797|NCT01474512|564608795|FG015|Long-Term Extension Period|Clinical Relapse|0|||
156413798|NCT01474512|564608796|FG016|Long-Term Extension Period|Clinical Relapse|0|||
156413799|NCT01474512|564608797|FG017|Long-Term Extension Period|Clinical Relapse|0|||
156413800|NCT01474512|564608780|FG000|Long-Term Extension Period|Death|0|||
156413801|NCT01474512|564608781|FG001|Long-Term Extension Period|Death|0|||
156413802|NCT01474512|564608782|FG002|Long-Term Extension Period|Death|0|||
156413803|NCT01474512|564608783|FG003|Long-Term Extension Period|Death|0|||
156413804|NCT01474512|564608784|FG004|Long-Term Extension Period|Death|0|||
156413805|NCT01474512|564608785|FG005|Long-Term Extension Period|Death|0|||
156413806|NCT01474512|564608786|FG006|Long-Term Extension Period|Death|0|||
156413807|NCT01474512|564608787|FG007|Long-Term Extension Period|Death|0|||
156413808|NCT01474512|564608788|FG008|Long-Term Extension Period|Death|0|||
156413809|NCT01474512|564608789|FG009|Long-Term Extension Period|Death|0|||
156413810|NCT01474512|564608790|FG010|Long-Term Extension Period|Death|0|||
156413811|NCT01474512|564608791|FG011|Long-Term Extension Period|Death|0|||
156413812|NCT01474512|564608792|FG012|Long-Term Extension Period|Death|9|||
156413813|NCT01474512|564608793|FG013|Long-Term Extension Period|Death|9|||
156413814|NCT01474512|564608794|FG014|Long-Term Extension Period|Death|0|||
156413815|NCT01474512|564608795|FG015|Long-Term Extension Period|Death|0|||
156413816|NCT01474512|564608796|FG016|Long-Term Extension Period|Death|0|||
156413817|NCT01474512|564608797|FG017|Long-Term Extension Period|Death|0|||
156413818|NCT01474512|564608780|FG000|Long-Term Extension Period|Sponsor Decision|0|||
156413819|NCT01474512|564608781|FG001|Long-Term Extension Period|Sponsor Decision|0|||
156413820|NCT01474512|564608782|FG002|Long-Term Extension Period|Sponsor Decision|0|||
156413821|NCT01474512|564608783|FG003|Long-Term Extension Period|Sponsor Decision|0|||
156413822|NCT01474512|564608784|FG004|Long-Term Extension Period|Sponsor Decision|0|||
156413823|NCT01474512|564608785|FG005|Long-Term Extension Period|Sponsor Decision|0|||
156413824|NCT01474512|564608786|FG006|Long-Term Extension Period|Sponsor Decision|0|||
156413825|NCT01474512|564608787|FG007|Long-Term Extension Period|Sponsor Decision|0|||
156413826|NCT01474512|564608788|FG008|Long-Term Extension Period|Sponsor Decision|0|||
156413827|NCT01474512|564608789|FG009|Long-Term Extension Period|Sponsor Decision|0|||
156413828|NCT01474512|564608790|FG010|Long-Term Extension Period|Sponsor Decision|0|||
156413829|NCT01474512|564608791|FG011|Long-Term Extension Period|Sponsor Decision|0|||
156413830|NCT01474512|564608792|FG012|Long-Term Extension Period|Sponsor Decision|6|||
156413831|NCT01474512|564608793|FG013|Long-Term Extension Period|Sponsor Decision|6|||
156413832|NCT01474512|564608794|FG014|Long-Term Extension Period|Sponsor Decision|0|||
156413833|NCT01474512|564608795|FG015|Long-Term Extension Period|Sponsor Decision|0|||
156413834|NCT01474512|564608796|FG016|Long-Term Extension Period|Sponsor Decision|0|||
156413835|NCT01474512|564608797|FG017|Long-Term Extension Period|Sponsor Decision|0|||
156413836|NCT01474512|564608780|FG000|Long-Term Extension Period|Protocol Violation|0|||
156413837|NCT01474512|564608781|FG001|Long-Term Extension Period|Protocol Violation|0|||
156413838|NCT01474512|564608782|FG002|Long-Term Extension Period|Protocol Violation|0|||
156413839|NCT01474512|564608783|FG003|Long-Term Extension Period|Protocol Violation|0|||
156413840|NCT01474512|564608784|FG004|Long-Term Extension Period|Protocol Violation|0|||
156413841|NCT01474512|564608785|FG005|Long-Term Extension Period|Protocol Violation|0|||
156413842|NCT01474512|564608786|FG006|Long-Term Extension Period|Protocol Violation|0|||
156413843|NCT01474512|564608787|FG007|Long-Term Extension Period|Protocol Violation|0|||
156413844|NCT01474512|564608788|FG008|Long-Term Extension Period|Protocol Violation|0|||
156413845|NCT01474512|564608789|FG009|Long-Term Extension Period|Protocol Violation|0|||
156413846|NCT01474512|564608790|FG010|Long-Term Extension Period|Protocol Violation|0|||
156413847|NCT01474512|564608791|FG011|Long-Term Extension Period|Protocol Violation|0|||
156649049|NCT00003102|565461792|FG001|Overall Study|Adverse Event|1|||
156649050|NCT00003102|565461793|FG002|Overall Study|Adverse Event|1|||
156649051|NCT00003102|565461791|FG000|Overall Study|Death|0|||
156413848|NCT01474512|564608792|FG012|Long-Term Extension Period|Protocol Violation|5|||
156413849|NCT01474512|564608793|FG013|Long-Term Extension Period|Protocol Violation|5|||
156413850|NCT01474512|564608794|FG014|Long-Term Extension Period|Protocol Violation|0|||
156413851|NCT01474512|564608795|FG015|Long-Term Extension Period|Protocol Violation|0|||
156413852|NCT01474512|564608796|FG016|Long-Term Extension Period|Protocol Violation|0|||
156413853|NCT01474512|564608797|FG017|Long-Term Extension Period|Protocol Violation|0|||
156413854|NCT01474512|564608780|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156649052|NCT00003102|565461792|FG001|Overall Study|Death|0|||
156413855|NCT01474512|564608781|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413856|NCT01474512|564608782|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413857|NCT01474512|564608783|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413858|NCT01474512|564608784|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413859|NCT01474512|564608785|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413860|NCT01474512|564608786|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413861|NCT01474512|564608787|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413862|NCT01474512|564608788|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413863|NCT01474512|564608789|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413864|NCT01474512|564608790|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156312101|NCT02743611|564243157|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
156312102|NCT02743611|564243158|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
156312103|NCT00600119|564243159|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
156312104|NCT00600119|564243160|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
156312105|NCT00600119|564243161|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
156312106|NCT00600119|564243162|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
156312107|NCT00600119|564243163|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
156312108|NCT00600119|564243164|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
156312109|NCT00600119|564243159|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156312110|NCT00600119|564243160|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
156312111|NCT00600119|564243161|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
156413865|NCT01474512|564608791|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413866|NCT01474512|564608792|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
156413867|NCT01474512|564608793|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
156413868|NCT01474512|564608794|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413869|NCT01474512|564608795|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413870|NCT01474512|564608796|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413871|NCT01474512|564608797|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156413872|NCT01474512|564608780|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413873|NCT01474512|564608781|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413874|NCT01474512|564608782|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413875|NCT01474512|564608783|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413876|NCT01474512|564608784|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413877|NCT01474512|564608785|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413878|NCT01474512|564608786|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413879|NCT01474512|564608787|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413880|NCT01474512|564608788|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413881|NCT01474512|564608789|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413882|NCT01474512|564608790|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413883|NCT01474512|564608791|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
156413884|NCT01474512|564608792|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413885|NCT01474512|564608793|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413886|NCT01474512|564608794|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413887|NCT01474512|564608795|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413888|NCT01474512|564608796|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413889|NCT01474512|564608797|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156413890|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
156413891|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
156413892|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
156413893|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
156413894|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
156413895|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
156413896|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
156413897|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
156413898|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
156413899|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
156413900|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
156413901|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
156413902|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
156413903|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
156413904|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
156413905|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
156413906|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
156413907|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
156413908|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413909|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413910|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156649053|NCT00003102|565461793|FG002|Overall Study|Death|1|||
156413911|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413912|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413913|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413914|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413915|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413916|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413917|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413918|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413919|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413920|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413921|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156413922|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
156413923|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
156413924|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
156413925|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
156413926|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413927|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413928|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413929|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413930|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413931|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413932|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413933|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413934|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413935|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413936|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413937|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413938|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413939|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156413940|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
156413941|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
156413942|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
156413943|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
156413944|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413945|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413946|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413947|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413948|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413949|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413950|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413951|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413952|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413953|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413954|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413955|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413956|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413957|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413958|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413959|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156413960|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
156413961|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
156413962|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
156413963|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
156413964|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
156413965|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
156413966|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
156413967|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
156413968|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
156413969|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
156413970|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
156413971|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
156413972|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
156413973|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
156413974|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
156649054|NCT00096486|565461796|FG000|Overall Study|Withdrawal by Subject|0|||
156649055|NCT00096486|565461797|FG001|Overall Study|Withdrawal by Subject|0|||
156649056|NCT00096486|565461798|FG002|Overall Study|Withdrawal by Subject|1|||
156649057|NCT00096486|565461799|FG003|Overall Study|Withdrawal by Subject|1|||
156413975|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
156413976|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
156413977|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
156649058|NCT00096486|565461796|FG000|Overall Study|Not Treated|0|||
156413978|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
156649059|NCT00096486|565461797|FG001|Overall Study|Not Treated|0|||
156649060|NCT00096486|565461798|FG002|Overall Study|Not Treated|1|||
156649061|NCT00096486|565461799|FG003|Overall Study|Not Treated|1|||
156649062|NCT01559818|565461800|FG000|Overall Study|Physician Decision|1|||
156649063|NCT01559818|565461800|FG000|Overall Study|Pregnancy|1|||
156649064|NCT01559818|565461800|FG000|Overall Study|Study terminated by Sponsor|4|||
156649065|NCT01559818|565461800|FG000|Overall Study|Withdrawal by Subject|1|||
156649066|NCT01512979|565461801|FG000|Overall Study|Adverse Event|2|||
156649067|NCT01512979|565461802|FG001|Overall Study|Adverse Event|2|||
156649068|NCT01512979|565461801|FG000|Overall Study|Protocol Violation|1|||
156649069|NCT01512979|565461802|FG001|Overall Study|Protocol Violation|4|||
156649070|NCT01512979|565461801|FG000|Overall Study|Lost to Follow-up|2|||
156649071|NCT01512979|565461802|FG001|Overall Study|Lost to Follow-up|5|||
156649072|NCT01512979|565461801|FG000|Overall Study|Withdrawal by Subject|1|||
156649073|NCT01512979|565461802|FG001|Overall Study|Withdrawal by Subject|2|||
156649074|NCT01512979|565461801|FG000|Overall Study|Reason other than stated above|13|||
156649075|NCT01512979|565461802|FG001|Overall Study|Reason other than stated above|9|||
156649076|NCT04071626|565461803|FG000|Overall Study|Withdrawal by Subject|1|||
156649077|NCT04071626|565461804|FG001|Overall Study|Withdrawal by Subject|1|||
156649078|NCT04071626|565461803|FG000|Overall Study|Protocol Violation|0|||
156649079|NCT04071626|565461804|FG001|Overall Study|Protocol Violation|1|||
156649080|NCT00125359|565461805|FG000|Overall Study|Death|4|||
156649081|NCT00125359|565461805|FG000|Overall Study|Adverse Event|5|||
156649082|NCT00125359|565461805|FG000|Overall Study|Physician Decision|14|||
156649083|NCT01201356|565461806|FG000|Overall Study|Adverse Event|170|||
156649084|NCT01201356|565461806|FG000|Overall Study|Abnormal laboratory value(s)|51|||
156649085|NCT01201356|565461806|FG000|Overall Study|Abnormal test procedure result(s)|3|||
156649086|NCT01201356|565461806|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
156649087|NCT01201356|565461806|FG000|Overall Study|Condition no longer requires study drug|12|||
156649088|NCT01201356|565461806|FG000|Overall Study|Withdrawal by Subject|144|||
156649089|NCT01201356|565461806|FG000|Overall Study|Lost to Follow-up|50|||
156649090|NCT01201356|565461806|FG000|Overall Study|administrative problems|74|||
156649091|NCT01201356|565461806|FG000|Overall Study|Death|16|||
156649092|NCT01201356|565461806|FG000|Overall Study|Protocol Violation|12|||
156649093|NCT00811070|565461807|FG000|Overall Study|Death|0|||
156649094|NCT00811070|565461808|FG001|Overall Study|Death|0|||
156649095|NCT00811070|565461809|FG002|Overall Study|Death|0|||
156649096|NCT00811070|565461810|FG003|Overall Study|Death|2|||
156649097|NCT00811070|565461811|FG004|Overall Study|Death|5|||
156649098|NCT00811070|565461812|FG005|Overall Study|Death|0|||
156649099|NCT00811070|565461807|FG000|Overall Study|Other|1|||
156649100|NCT00811070|565461808|FG001|Overall Study|Other|0|||
156649101|NCT00811070|565461809|FG002|Overall Study|Other|0|||
156649102|NCT00811070|565461810|FG003|Overall Study|Other|0|||
156649103|NCT00811070|565461811|FG004|Overall Study|Other|0|||
156649104|NCT00811070|565461812|FG005|Overall Study|Other|0|||
156649105|NCT00811070|565461807|FG000|Overall Study|Withdrawal by Subject|0|||
156649106|NCT00811070|565461808|FG001|Overall Study|Withdrawal by Subject|1|||
156649107|NCT00811070|565461809|FG002|Overall Study|Withdrawal by Subject|0|||
156649108|NCT00811070|565461810|FG003|Overall Study|Withdrawal by Subject|0|||
156649109|NCT00811070|565461811|FG004|Overall Study|Withdrawal by Subject|0|||
156649110|NCT00811070|565461812|FG005|Overall Study|Withdrawal by Subject|0|||
156649111|NCT00811070|565461807|FG000|Overall Study|Physician Decision|0|||
156649112|NCT00811070|565461808|FG001|Overall Study|Physician Decision|0|||
156649113|NCT00811070|565461809|FG002|Overall Study|Physician Decision|0|||
156649114|NCT00811070|565461810|FG003|Overall Study|Physician Decision|0|||
156649115|NCT00811070|565461811|FG004|Overall Study|Physician Decision|0|||
156649116|NCT00811070|565461812|FG005|Overall Study|Physician Decision|1|||
156649117|NCT00665626|565461817|FG000|Overall Study|Lack of Efficacy|8|||
156649118|NCT00665626|565461818|FG001|Overall Study|Lack of Efficacy|5|||
156649119|NCT00665626|565461817|FG000|Overall Study|Lost to Follow-up|0|||
156649120|NCT00665626|565461818|FG001|Overall Study|Lost to Follow-up|2|||
156649121|NCT00665626|565461817|FG000|Overall Study|Withdrawal by Subject|0|||
156649122|NCT00665626|565461818|FG001|Overall Study|Withdrawal by Subject|1|||
156649123|NCT00665626|565461817|FG000|Overall Study|Protocol Violation|0|||
156649124|NCT00665626|565461818|FG001|Overall Study|Protocol Violation|2|||
156649125|NCT00665626|565461817|FG000|Overall Study|Adverse Event|1|||
156649126|NCT00665626|565461818|FG001|Overall Study|Adverse Event|9|||
156649127|NCT00665626|565461817|FG000|Overall Study|Due to exclusion criteria|0|||
156649128|NCT00665626|565461818|FG001|Overall Study|Due to exclusion criteria|1|||
156649129|NCT00665626|565461817|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
156649130|NCT00665626|565461818|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
156649131|NCT00665626|565461817|FG000|Overall Study|Unably to comply with dosing regimen|0|||
156649132|NCT00665626|565461818|FG001|Overall Study|Unably to comply with dosing regimen|1|||
156649133|NCT00665626|565461817|FG000|Overall Study|Death|1|||
156649134|NCT00665626|565461818|FG001|Overall Study|Death|0|||
156649135|NCT00585039|565461819|FG000|Overall Study|medication spilled|2|||
156649136|NCT00585039|565461820|FG001|Overall Study|medication spilled|0|||
156649137|NCT01629693|565461823|FG000|Overall Study|Lost to Follow-up|2|||
156649138|NCT01629693|565461824|FG001|Overall Study|Lost to Follow-up|4|||
156649139|NCT01629693|565461823|FG000|Overall Study|Withdrawal by Subject|2|||
156649140|NCT01629693|565461824|FG001|Overall Study|Withdrawal by Subject|2|||
156649141|NCT01629693|565461823|FG000|Overall Study|Adverse Event|1|||
156649142|NCT01629693|565461824|FG001|Overall Study|Adverse Event|0|||
156649143|NCT01629693|565461823|FG000|Overall Study|Investigator decision|0|||
156649144|NCT01629693|565461824|FG001|Overall Study|Investigator decision|1|||
156649145|NCT01629693|565461823|FG000|Overall Study|Poor comfort of study lenses|0|||
156649146|NCT01629693|565461824|FG001|Overall Study|Poor comfort of study lenses|2|||
156649147|NCT01629693|565461823|FG000|Overall Study|Subject decision unrelated to AE|0|||
156649148|NCT01629693|565461824|FG001|Overall Study|Subject decision unrelated to AE|1|||
156649149|NCT01025193|565461826|FG000|Overall Study|Protocol Violation|1|||
156649150|NCT01025193|565461826|FG000|Overall Study|Adverse Event|3|||
156649151|NCT04079842|565461827|FG000|Overall Study|Request of subject|2|||
156649152|NCT04079842|565461827|FG000|Overall Study|Unable to draw Arterial samples|1|||
156649153|NCT02904200|565461828|FG000|Overall Study|Withdrawal by Subject|1|||
156649154|NCT02904200|565461829|FG001|Overall Study|Withdrawal by Subject|0|||
156649155|NCT01759537|565461832|FG000|Overall Study|Death|1|||
156649156|NCT01759537|565461833|FG001|Overall Study|Death|1|||
156649157|NCT01759537|565461832|FG000|Overall Study|Pregnancy|1|||
156649158|NCT01759537|565461833|FG001|Overall Study|Pregnancy|1|||
156649159|NCT01759537|565461832|FG000|Overall Study|Lost to Follow-up|9|||
156649160|NCT01759537|565461833|FG001|Overall Study|Lost to Follow-up|9|||
156649161|NCT01759537|565461832|FG000|Overall Study|Accident involving jaw fracture|1|||
156649162|NCT01759537|565461833|FG001|Overall Study|Accident involving jaw fracture|1|||
156649163|NCT01759537|565461832|FG000|Overall Study|Subcrestal implant too coronal|1|||
156649164|NCT01759537|565461833|FG001|Overall Study|Subcrestal implant too coronal|1|||
156649165|NCT00420290|565461834|FG000|Overall Study|Adverse Event|3|||
156649166|NCT00420290|565461835|FG001|Overall Study|Adverse Event|1|||
156649167|NCT00420290|565461834|FG000|Overall Study|Withdrawal by Subject|0|||
156649168|NCT00420290|565461835|FG001|Overall Study|Withdrawal by Subject|2|||
156649169|NCT00420290|565461834|FG000|Overall Study|did not meet inclusion/exclusion|1|||
156649170|NCT00420290|565461835|FG001|Overall Study|did not meet inclusion/exclusion|1|||
156649171|NCT01466686|565463317|FG000|Overall Study|Withdrawal by Subject|1|||
156649172|NCT02049359|565463318|FG000|Overall Study|Lost to Follow-up|26|||
156649173|NCT02049359|565463319|FG001|Overall Study|Lost to Follow-up|19|||
156649174|NCT03273387|565463320|FG000|Overall Study|Death|2|||
156649175|NCT03273387|565463321|FG001|Overall Study|Death|2|||
156649176|NCT03273387|565463320|FG000|Overall Study|Withdrawal by Subject|1|||
156649177|NCT03273387|565463321|FG001|Overall Study|Withdrawal by Subject|1|||
156649178|NCT01405950|565463322|FG000|Overall Study|Withdrawal by Subject|1|||
156649179|NCT01405950|565463323|FG001|Overall Study|Withdrawal by Subject|0|||
156649180|NCT01405950|565463324|FG002|Overall Study|Withdrawal by Subject|0|||
156649181|NCT01405950|565463325|FG003|Overall Study|Withdrawal by Subject|0|||
156649182|NCT00387712|565463328|FG000|Overall Study|Physician Decision|6|||
156649183|NCT00387712|565463329|FG001|Overall Study|Physician Decision|4|||
156649184|NCT00387712|565463328|FG000|Overall Study|Lost to Follow-up|17|||
156649185|NCT00387712|565463329|FG001|Overall Study|Lost to Follow-up|20|||
156649186|NCT00387712|565463328|FG000|Overall Study|Withdrawal by Subject|6|||
156649187|NCT00387712|565463329|FG001|Overall Study|Withdrawal by Subject|12|||
156649188|NCT01772368|565463330|FG000|Overall Study|Adverse Event|1|||
156649189|NCT01772368|565463330|FG000|Overall Study|Withdrawal by Subject|3|||
156649190|NCT01772368|565463330|FG000|Overall Study|Protocol Violation|2|||
156649191|NCT01772368|565463330|FG000|Overall Study|Other|1|||
156649192|NCT03347695|565463347|FG000|Overall Study|Death|0|||
156649193|NCT03347695|565463348|FG001|Overall Study|Death|4|||
156649194|NCT03347695|565463347|FG000|Overall Study|Lost to Follow-up|0|||
156649195|NCT03347695|565463348|FG001|Overall Study|Lost to Follow-up|1|||
156649196|NCT04633837|565463349|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
156649197|NCT04633837|565463350|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
156649198|NCT00112489|565463351|FG000|Overall Study|Refused further treatment|8|||
156649199|NCT00112489|565463351|FG000|Overall Study|Adverse Event|12|||
156649200|NCT00112489|565463351|FG000|Overall Study|Death|2|||
156649201|NCT00112489|565463351|FG000|Overall Study|Other, Not Specified|9|||
156649202|NCT00112489|565463351|FG000|Overall Study|Patient never treated|2|||
156649203|NCT00112489|565463351|FG000|Overall Study|Ineligible|7|||
156649204|NCT04467697|565463357|FG000|Overall Study|Adverse Event|2|||
156649205|NCT04467697|565463357|FG000|Overall Study|Lost to Follow-up|6|||
156649206|NCT04467697|565463357|FG000|Overall Study|Withdrawal by Subject|9|||
156649207|NCT04467697|565463357|FG000|Overall Study|Protocol Violation|3|||
156649208|NCT04480463|565463360|FG000|Overall Study|Death|0|||
156649209|NCT04480463|565463361|FG001|Overall Study|Death|1|||
156649210|NCT04480463|565463360|FG000|Overall Study|Adverse Event|6|||
156649211|NCT04480463|565463361|FG001|Overall Study|Adverse Event|8|||
156649212|NCT04480463|565463360|FG000|Overall Study|Lost to Follow-up|3|||
156649213|NCT04480463|565463361|FG001|Overall Study|Lost to Follow-up|2|||
156649214|NCT04480463|565463360|FG000|Overall Study|Physician Decision|2|||
156649215|NCT04480463|565463361|FG001|Overall Study|Physician Decision|5|||
156649216|NCT04480463|565463360|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
156649217|NCT04480463|565463361|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
156649218|NCT04480463|565463360|FG000|Overall Study|Protocol Violation|2|||
156649219|NCT04480463|565463361|FG001|Overall Study|Protocol Violation|1|||
156649220|NCT04480463|565463360|FG000|Overall Study|Withdrawal by Subject|6|||
156649221|NCT04480463|565463361|FG001|Overall Study|Withdrawal by Subject|7|||
156649222|NCT04480463|565463360|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
156649223|NCT04480463|565463361|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
156649224|NCT04480463|565463360|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
156649225|NCT04480463|565463361|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
156649226|NCT04480463|565463360|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
156649227|NCT04480463|565463361|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
156649228|NCT04480463|565463360|FG000|Overall Study|Other|6|||
156649229|NCT04480463|565463361|FG001|Overall Study|Other|4|||
156649230|NCT01977092|565463362|FG000|Overall Study|Death|3|||
156649231|NCT01977092|565463363|FG001|Overall Study|Death|4|||
156649232|NCT01977092|565463362|FG000|Overall Study|Lost to Follow-up|23|||
156649233|NCT01977092|565463363|FG001|Overall Study|Lost to Follow-up|14|||
156649234|NCT01977092|565463362|FG000|Overall Study|Withdrawal by Subject|2|||
156649235|NCT01977092|565463363|FG001|Overall Study|Withdrawal by Subject|1|||
156649236|NCT01977092|565463362|FG000|Overall Study|In prison|3|||
156649237|NCT01977092|565463363|FG001|Overall Study|In prison|11|||
156649238|NCT02927847|565463365|FG000|Overall Study|Lost to Follow-up|1|||
156649239|NCT02927847|565463366|FG001|Overall Study|Lost to Follow-up|0|||
156649240|NCT02927847|565463365|FG000|Overall Study|Withdrawal by Subject|4|||
156649241|NCT02927847|565463366|FG001|Overall Study|Withdrawal by Subject|2|||
156649242|NCT02927847|565463365|FG000|Overall Study|PI withdrawn due to missed visits|1|||
156649243|NCT02927847|565463366|FG001|Overall Study|PI withdrawn due to missed visits|1|||
156649244|NCT00175019|565463370|FG000|Overall Study|Adverse Event|54|||
156649245|NCT00175019|565463371|FG001|Overall Study|Adverse Event|22|||
156649246|NCT00175019|565463372|FG002|Overall Study|Adverse Event|2|||
156649247|NCT00175019|565463370|FG000|Overall Study|Protocol Violation|6|||
156649248|NCT00175019|565463371|FG001|Overall Study|Protocol Violation|3|||
156649249|NCT00175019|565463372|FG002|Overall Study|Protocol Violation|3|||
156649250|NCT00175019|565463370|FG000|Overall Study|Lost to Follow-up|42|||
156649251|NCT00175019|565463371|FG001|Overall Study|Lost to Follow-up|39|||
156649252|NCT00175019|565463372|FG002|Overall Study|Lost to Follow-up|9|||
156649253|NCT00175019|565463370|FG000|Overall Study|Did not continue under Amendment 4|1|||
156649254|NCT00175019|565463371|FG001|Overall Study|Did not continue under Amendment 4|1|||
156649255|NCT00175019|565463372|FG002|Overall Study|Did not continue under Amendment 4|2|||
156649256|NCT00175019|565463370|FG000|Overall Study|Personal Reason(s)|39|||
156649257|NCT00175019|565463371|FG001|Overall Study|Personal Reason(s)|31|||
156649258|NCT00175019|565463372|FG002|Overall Study|Personal Reason(s)|8|||
156649259|NCT00175019|565463370|FG000|Overall Study|Therapeutic Failure|10|||
156649260|NCT00175019|565463371|FG001|Overall Study|Therapeutic Failure|38|||
156649261|NCT00175019|565463372|FG002|Overall Study|Therapeutic Failure|22|||
156649262|NCT00175019|565463370|FG000|Overall Study|Gout Flare|2|||
156649263|NCT00175019|565463371|FG001|Overall Study|Gout Flare|3|||
156649264|NCT00175019|565463372|FG002|Overall Study|Gout Flare|0|||
156649265|NCT00175019|565463370|FG000|Overall Study|Reason Not Specified|40|||
156649266|NCT00175019|565463371|FG001|Overall Study|Reason Not Specified|34|||
156649267|NCT00175019|565463372|FG002|Overall Study|Reason Not Specified|11|||
156649268|NCT01405820|565463373|FG000|Randomized Treatment Period|Adverse Event|3|||
156649269|NCT01405820|565463374|FG001|Randomized Treatment Period|Adverse Event|3|||
156649270|NCT01405820|565463375|FG002|Randomized Treatment Period|Adverse Event|3|||
156649271|NCT01405820|565463376|FG003|Randomized Treatment Period|Adverse Event|0|||
156649272|NCT01405820|565463377|FG004|Randomized Treatment Period|Adverse Event|2|||
156649273|NCT01405820|565463378|FG005|Randomized Treatment Period|Adverse Event|1|||
156649274|NCT01405820|565463373|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
156649275|NCT01405820|565463374|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
156649276|NCT01405820|565463375|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
156649277|NCT01405820|565463376|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
156649278|NCT01405820|565463377|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
156649279|NCT01405820|565463378|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
156649280|NCT01405820|565463373|FG000|Randomized Treatment Period|Other|2|||
156649281|NCT01405820|565463374|FG001|Randomized Treatment Period|Other|2|||
156649282|NCT01405820|565463375|FG002|Randomized Treatment Period|Other|1|||
156649283|NCT01405820|565463376|FG003|Randomized Treatment Period|Other|1|||
156649284|NCT01405820|565463377|FG004|Randomized Treatment Period|Other|0|||
156649285|NCT01405820|565463378|FG005|Randomized Treatment Period|Other|0|||
156649286|NCT01405820|565463373|FG000|Randomized Treatment Period|Physician Decision|0|||
156649287|NCT01405820|565463374|FG001|Randomized Treatment Period|Physician Decision|2|||
156649288|NCT01405820|565463375|FG002|Randomized Treatment Period|Physician Decision|1|||
156649289|NCT01405820|565463376|FG003|Randomized Treatment Period|Physician Decision|0|||
156649290|NCT01405820|565463377|FG004|Randomized Treatment Period|Physician Decision|0|||
156649291|NCT01405820|565463378|FG005|Randomized Treatment Period|Physician Decision|0|||
156649292|NCT01405820|565463373|FG000|Randomized Treatment Period|Rescue|0|||
156649293|NCT01405820|565463374|FG001|Randomized Treatment Period|Rescue|1|||
156649294|NCT01405820|565463375|FG002|Randomized Treatment Period|Rescue|13|||
156649295|NCT01405820|565463376|FG003|Randomized Treatment Period|Rescue|10|||
156649296|NCT01405820|565463377|FG004|Randomized Treatment Period|Rescue|8|||
156649297|NCT01405820|565463378|FG005|Randomized Treatment Period|Rescue|8|||
156649298|NCT01405820|565463373|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
156649299|NCT01405820|565463374|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
156649300|NCT01405820|565463375|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
156649301|NCT01405820|565463376|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
156649302|NCT01405820|565463377|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
156649303|NCT01405820|565463378|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
156649304|NCT01405820|565463373|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
156649305|NCT01405820|565463374|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
156649306|NCT01405820|565463375|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
156649307|NCT01405820|565463376|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
156649308|NCT01405820|565463377|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
156649309|NCT01405820|565463378|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
156649310|NCT01405820|565463373|FG000|Randomized Treatment Period|Death|0|||
156649311|NCT01405820|565463374|FG001|Randomized Treatment Period|Death|0|||
156649312|NCT01405820|565463375|FG002|Randomized Treatment Period|Death|0|||
156649313|NCT01405820|565463376|FG003|Randomized Treatment Period|Death|1|||
156649314|NCT01405820|565463377|FG004|Randomized Treatment Period|Death|0|||
156649315|NCT01405820|565463378|FG005|Randomized Treatment Period|Death|0|||
156649316|NCT01405820|565463373|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
156649317|NCT01405820|565463374|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
156649318|NCT01405820|565463375|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
156649319|NCT01405820|565463376|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
156649320|NCT01405820|565463377|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
156649321|NCT01405820|565463378|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
156649322|NCT01405820|565463373|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
156649323|NCT01405820|565463374|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
156649324|NCT01405820|565463375|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
156649325|NCT01405820|565463376|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
156649326|NCT01405820|565463377|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
156649327|NCT01405820|565463378|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
156649328|NCT01405820|565463373|FG000|Open-Label Treatment Period|Other|1|||
156649329|NCT01405820|565463374|FG001|Open-Label Treatment Period|Other|1|||
156649330|NCT01405820|565463375|FG002|Open-Label Treatment Period|Other|1|||
156649331|NCT01405820|565463376|FG003|Open-Label Treatment Period|Other|1|||
156649332|NCT01405820|565463377|FG004|Open-Label Treatment Period|Other|1|||
156649333|NCT01405820|565463378|FG005|Open-Label Treatment Period|Other|1|||
156649334|NCT01405820|565463373|FG000|Open-Label Treatment Period|Physician Decision|0|||
156649335|NCT01405820|565463374|FG001|Open-Label Treatment Period|Physician Decision|0|||
156649336|NCT01405820|565463375|FG002|Open-Label Treatment Period|Physician Decision|1|||
156649337|NCT01405820|565463376|FG003|Open-Label Treatment Period|Physician Decision|2|||
156649338|NCT01405820|565463377|FG004|Open-Label Treatment Period|Physician Decision|1|||
156649339|NCT01405820|565463378|FG005|Open-Label Treatment Period|Physician Decision|0|||
156649340|NCT01405820|565463373|FG000|Open-Label Treatment Period|Adverse Event|0|||
156649341|NCT01405820|565463374|FG001|Open-Label Treatment Period|Adverse Event|0|||
156649342|NCT01405820|565463375|FG002|Open-Label Treatment Period|Adverse Event|0|||
156649343|NCT01405820|565463376|FG003|Open-Label Treatment Period|Adverse Event|1|||
156649344|NCT01405820|565463377|FG004|Open-Label Treatment Period|Adverse Event|0|||
156649345|NCT01405820|565463378|FG005|Open-Label Treatment Period|Adverse Event|0|||
156649346|NCT00827359|565463383|FG000|Overall Study|Progressive Diseas|19|||
156649347|NCT00827359|565463383|FG000|Overall Study|Unacceptable Toxicity|5|||
156649348|NCT00827359|565463383|FG000|Overall Study|Ineligible|1|||
156649349|NCT02436135|565463384|FG000|Overall Study|Progressive Disease|3|||
156649350|NCT02436135|565463385|FG001|Overall Study|Progressive Disease|1|||
156649351|NCT02436135|565463384|FG000|Overall Study|Investigator Discretion|1|||
156649352|NCT02436135|565463385|FG001|Overall Study|Investigator Discretion|2|||
156649353|NCT02436135|565463384|FG000|Overall Study|Adverse Event|1|||
156649354|NCT02436135|565463385|FG001|Overall Study|Adverse Event|0|||
156649355|NCT02436135|565463384|FG000|Overall Study|Withdrawal by Participant|1|||
156649356|NCT02436135|565463385|FG001|Overall Study|Withdrawal by Participant|0|||
156649357|NCT02436135|565463384|FG000|Overall Study|Study Terminated By Sponsor|0|||
156649358|NCT02436135|565463385|FG001|Overall Study|Study Terminated By Sponsor|1|||
156649359|NCT03255031|565463386|FG000|Overall Study|Adverse Event|5|||
156649360|NCT03255031|565463387|FG001|Overall Study|Adverse Event|3|||
156649361|NCT03255031|565463386|FG000|Overall Study|Physician Decision|2|||
156649362|NCT03255031|565463387|FG001|Overall Study|Physician Decision|1|||
156649363|NCT03255031|565463386|FG000|Overall Study|Withdrawal by Subject|9|||
156649364|NCT03255031|565463387|FG001|Overall Study|Withdrawal by Subject|3|||
156649365|NCT01809314|565463388|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
156649366|NCT01809314|565463388|FG000|Overall Study|Adverse Event|6|||
156649367|NCT01809314|565463388|FG000|Overall Study|Insufficient Therapeutic Response|14|||
156649368|NCT01809314|565463388|FG000|Overall Study|Lost to Follow-up|724|||
156649369|NCT00297479|565463389|FG000|Overall Study|Lost to Follow-up|37|||
156649370|NCT00297479|565463390|FG001|Overall Study|Lost to Follow-up|54|||
156649371|NCT00297479|565463391|FG002|Overall Study|Lost to Follow-up|51|||
156649372|NCT01092702|565463392|FG000|Overall Study|Withdrawal by Subject|7|||
156649373|NCT01092702|565463392|FG000|Overall Study|Lost to Follow-up|2|||
156649374|NCT03263819|565463393|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
156649375|NCT03263819|565463394|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
156649376|NCT01427803|565463395|FG000|Overall Study|Lost to Follow-up|32|||
156649377|NCT01427803|565463396|FG001|Overall Study|Lost to Follow-up|26|||
156649378|NCT01427803|565463395|FG000|Overall Study|Withdrawal by Subject|20|||
156649379|NCT01427803|565463396|FG001|Overall Study|Withdrawal by Subject|0|||
156649380|NCT01427803|565463395|FG000|Overall Study|Unable to complete full treatment period|6|||
156649381|NCT01427803|565463396|FG001|Overall Study|Unable to complete full treatment period|0|||
156649382|NCT01427803|565463395|FG000|Overall Study|Protocol Violation|1|||
156649383|NCT01427803|565463396|FG001|Overall Study|Protocol Violation|0|||
156649384|NCT01427803|565463395|FG000|Overall Study|Physician Decision|3|||
156649385|NCT01427803|565463396|FG001|Overall Study|Physician Decision|0|||
156649386|NCT01427803|565463395|FG000|Overall Study|did not take product|1|||
156649387|NCT01427803|565463396|FG001|Overall Study|did not take product|0|||
156649388|NCT00863057|565463397|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
156649389|NCT00863057|565463398|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
156649390|NCT00863057|565463399|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
156649391|NCT00863057|565463400|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
156649392|NCT00863057|565463397|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
156649393|NCT00863057|565463398|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
156649394|NCT00863057|565463399|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
156649395|NCT00863057|565463400|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
156649396|NCT00863057|565463397|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
156649397|NCT00863057|565463398|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
156649398|NCT00863057|565463399|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
156649399|NCT00863057|565463400|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
156649400|NCT00863057|565463397|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
156649401|NCT00863057|565463398|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
156649402|NCT00863057|565463399|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
156649403|NCT00863057|565463400|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
156649404|NCT03412019|565463403|FG000|Overall Study|Withdrawal by Subject|1|||
156649405|NCT03412019|565463404|FG001|Overall Study|Withdrawal by Subject|1|||
156649406|NCT01698320|565463409|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
156649407|NCT01698320|565463410|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
156649408|NCT01698320|565463411|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
156649409|NCT01698320|565463409|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
156649410|NCT01698320|565463410|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
156649411|NCT01698320|565463411|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
156649412|NCT01698320|565463409|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
156649413|NCT01698320|565463410|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
156649414|NCT01698320|565463411|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
156649415|NCT01698320|565463409|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
156649416|NCT01698320|565463410|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
156649417|NCT01698320|565463411|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
156649418|NCT01698320|565463409|FG000|12-Week Double-Blind Period|Adverse Event|0|||
156649419|NCT01698320|565463410|FG001|12-Week Double-Blind Period|Adverse Event|1|||
156649420|NCT01698320|565463411|FG002|12-Week Double-Blind Period|Adverse Event|1|||
156649421|NCT01698320|565463409|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
156649422|NCT01698320|565463410|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
156649423|NCT01698320|565463411|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
156649424|NCT01698320|565463409|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
156649425|NCT01698320|565463410|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
156649426|NCT01698320|565463411|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
156649427|NCT01698320|565463409|FG000|12-Week Double-Blind Period|Pregnancy|0|||
156649428|NCT01698320|565463410|FG001|12-Week Double-Blind Period|Pregnancy|1|||
156649429|NCT01698320|565463411|FG002|12-Week Double-Blind Period|Pregnancy|1|||
156649430|NCT01698320|565463409|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
156649431|NCT01698320|565463410|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
156649432|NCT01698320|565463411|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
156649433|NCT01698320|565463409|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
156649434|NCT01698320|565463410|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
156649435|NCT01698320|565463411|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
156649436|NCT01698320|565463409|FG000|40-Week Open-Label Period|Adverse Event|0|||
156649437|NCT01698320|565463410|FG001|40-Week Open-Label Period|Adverse Event|3|||
156649438|NCT01698320|565463411|FG002|40-Week Open-Label Period|Adverse Event|2|||
156649439|NCT01698320|565463409|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
156649440|NCT01698320|565463410|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
156649441|NCT01698320|565463411|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
156649442|NCT01698320|565463409|FG000|40-Week Open-Label Period|Pregnancy|0|||
156649443|NCT01698320|565463410|FG001|40-Week Open-Label Period|Pregnancy|2|||
156649444|NCT01698320|565463411|FG002|40-Week Open-Label Period|Pregnancy|1|||
156649445|NCT01698320|565463409|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
156649446|NCT01698320|565463410|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
156649447|NCT01698320|565463411|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
156649448|NCT01698320|565463409|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
156649449|NCT01698320|565463410|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
156649450|NCT01698320|565463411|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
156649451|NCT00686920|565463415|FG000|Overall Study|Death|45|||
156649452|NCT00686920|565463416|FG001|Overall Study|Death|14|||
156649453|NCT00686920|565463415|FG000|Overall Study|Liver Transplant|23|||
156649454|NCT00686920|565463416|FG001|Overall Study|Liver Transplant|8|||
156649455|NCT00686920|565463415|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
156649456|NCT00686920|565463416|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
156649457|NCT00686920|565463415|FG000|Overall Study|Withdrawal by Subject|23|||
156649458|NCT00686920|565463416|FG001|Overall Study|Withdrawal by Subject|5|||
156649459|NCT00686920|565463415|FG000|Overall Study|Protocol Violation|2|||
156649460|NCT00686920|565463416|FG001|Overall Study|Protocol Violation|1|||
156649461|NCT00686920|565463415|FG000|Overall Study|Adverse Event|10|||
156649462|NCT00686920|565463416|FG001|Overall Study|Adverse Event|2|||
156649463|NCT00686920|565463415|FG000|Overall Study|Personal Reason|0|||
156649464|NCT00686920|565463416|FG001|Overall Study|Personal Reason|1|||
156649465|NCT00686920|565463415|FG000|Overall Study|Lost to Follow-up|15|||
156649466|NCT00686920|565463416|FG001|Overall Study|Lost to Follow-up|3|||
156649467|NCT00686920|565463415|FG000|Overall Study|Moved to Another State|1|||
156649468|NCT00686920|565463416|FG001|Overall Study|Moved to Another State|0|||
156312112|NCT00600119|564243162|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156312113|NCT00600119|564243163|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156312114|NCT00600119|564243164|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156312115|NCT00600119|564243159|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
156312116|NCT00600119|564243160|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
156312117|NCT00600119|564243161|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
156312118|NCT00600119|564243162|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
156312119|NCT00600119|564243163|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
156312120|NCT00600119|564243164|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
156649469|NCT00686920|565463415|FG000|Overall Study|Transferred to Nursing Home|1|||
156649470|NCT00686920|565463416|FG001|Overall Study|Transferred to Nursing Home|0|||
156649471|NCT00686920|565463415|FG000|Overall Study|Noncompliance|9|||
156649472|NCT00686920|565463416|FG001|Overall Study|Noncompliance|0|||
156649473|NCT00686920|565463415|FG000|Overall Study|Principal Investigator Decision|2|||
156649474|NCT00686920|565463416|FG001|Overall Study|Principal Investigator Decision|0|||
156649475|NCT02087046|565463420|FG000|Overall Study|Adverse Event|4|||
156649476|NCT02087046|565463420|FG000|Overall Study|Death|1|||
156649477|NCT02087046|565463420|FG000|Overall Study|Lost to Follow-up|3|||
156649478|NCT02087046|565463420|FG000|Overall Study|Withdrawal by Subject|2|||
156649479|NCT02087046|565463420|FG000|Overall Study|Physician Decision|1|||
156649480|NCT01107535|565463421|FG000|Overall Study|Death|5|||
156649481|NCT02444533|565463422|FG000|Overall Study|Not able to complete forms|0|||
156649482|NCT02444533|565463423|FG001|Overall Study|Not able to complete forms|2|||
156649483|NCT02444533|565463422|FG000|Overall Study|Only gave post-procedure complications|2|||
156649484|NCT02444533|565463423|FG001|Overall Study|Only gave post-procedure complications|2|||
156649485|NCT03567057|565463424|FG000|Overall Study|Adverse Event|56|||
156649486|NCT03567057|565463425|FG001|Overall Study|Adverse Event|53|||
156649487|NCT03567057|565463426|FG002|Overall Study|Adverse Event|28|||
156649488|NCT03567057|565463424|FG000|Overall Study|Withdrawal by Subject|22|||
156649489|NCT03567057|565463425|FG001|Overall Study|Withdrawal by Subject|24|||
156649490|NCT03567057|565463426|FG002|Overall Study|Withdrawal by Subject|13|||
156649491|NCT03567057|565463424|FG000|Overall Study|Lost to Follow-up|3|||
156649492|NCT03567057|565463425|FG001|Overall Study|Lost to Follow-up|5|||
156649493|NCT03567057|565463426|FG002|Overall Study|Lost to Follow-up|2|||
156649494|NCT03567057|565463424|FG000|Overall Study|COVID-19 pandemic|4|||
156649495|NCT03567057|565463425|FG001|Overall Study|COVID-19 pandemic|3|||
156649496|NCT03567057|565463426|FG002|Overall Study|COVID-19 pandemic|0|||
156649497|NCT03567057|565463424|FG000|Overall Study|Non-compliance with study drug|4|||
156649498|NCT03567057|565463425|FG001|Overall Study|Non-compliance with study drug|2|||
156649499|NCT03567057|565463426|FG002|Overall Study|Non-compliance with study drug|0|||
156649500|NCT03567057|565463424|FG000|Overall Study|Lack of Efficacy|3|||
156649501|NCT03567057|565463425|FG001|Overall Study|Lack of Efficacy|0|||
156649502|NCT03567057|565463426|FG002|Overall Study|Lack of Efficacy|1|||
156649503|NCT03567057|565463424|FG000|Overall Study|Death|1|||
156649504|NCT03567057|565463425|FG001|Overall Study|Death|0|||
156649505|NCT03567057|565463426|FG002|Overall Study|Death|0|||
156649506|NCT03567057|565463424|FG000|Overall Study|Physician Decision|1|||
156649507|NCT03567057|565463425|FG001|Overall Study|Physician Decision|0|||
156649508|NCT03567057|565463426|FG002|Overall Study|Physician Decision|0|||
156649509|NCT03567057|565463424|FG000|Overall Study|Unstable medical condition|1|||
156413979|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
156413980|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413981|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413982|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413983|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413984|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413985|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413986|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413987|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413988|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413989|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413990|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413991|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413992|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413993|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413994|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413995|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
156413996|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
156413997|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
156413998|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
156413999|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
156414000|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
156649510|NCT03567057|565463425|FG001|Overall Study|Unstable medical condition|0|||
156649511|NCT03567057|565463426|FG002|Overall Study|Unstable medical condition|0|||
156649512|NCT03567057|565463424|FG000|Overall Study|Medical history event|0|||
156649513|NCT03567057|565463425|FG001|Overall Study|Medical history event|0|||
156649514|NCT03567057|565463426|FG002|Overall Study|Medical history event|1|||
156649515|NCT03567057|565463424|FG000|Overall Study|Other|0|||
156649516|NCT03567057|565463425|FG001|Overall Study|Other|0|||
156649517|NCT03567057|565463426|FG002|Overall Study|Other|1|||
156649518|NCT01155583|565463427|FG000|Phase I|Screen failure - did not start treatment|0|||
156649519|NCT01155583|565463428|FG001|Phase I|Screen failure - did not start treatment|0|||
156649520|NCT01155583|565463429|FG002|Phase I|Screen failure - did not start treatment|0|||
156649521|NCT01155583|565463430|FG003|Phase I|Screen failure - did not start treatment|0|||
156649522|NCT01155583|565463431|FG004|Phase I|Screen failure - did not start treatment|1|||
156649523|NCT01155583|565463432|FG005|Phase I|Screen failure - did not start treatment|0|||
156649524|NCT01155583|565463433|FG006|Phase I|Screen failure - did not start treatment|0|||
156649525|NCT01155583|565463434|FG007|Phase I|Screen failure - did not start treatment|2|||
156649526|NCT01155583|565463435|FG008|Phase I|Screen failure - did not start treatment|0|||
156649527|NCT01155583|565463427|FG000|Phase I|Withdrawal by Subject|0|||
156649528|NCT01155583|565463428|FG001|Phase I|Withdrawal by Subject|0|||
156649529|NCT01155583|565463429|FG002|Phase I|Withdrawal by Subject|0|||
156649530|NCT01155583|565463430|FG003|Phase I|Withdrawal by Subject|0|||
156649531|NCT01155583|565463431|FG004|Phase I|Withdrawal by Subject|0|||
156649532|NCT01155583|565463432|FG005|Phase I|Withdrawal by Subject|0|||
156649533|NCT01155583|565463433|FG006|Phase I|Withdrawal by Subject|0|||
156649534|NCT01155583|565463434|FG007|Phase I|Withdrawal by Subject|1|||
156649535|NCT01155583|565463435|FG008|Phase I|Withdrawal by Subject|0|||
156414001|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
156414002|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
156414003|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
156414004|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
156414005|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
156414006|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
156649536|NCT00886483|565463442|FG000|Overall Study|Lost to Follow-up|0|||
156649537|NCT00886483|565463443|FG001|Overall Study|Lost to Follow-up|1|||
156649538|NCT00886483|565463442|FG000|Overall Study|Pursue medications|1|||
156649539|NCT00886483|565463443|FG001|Overall Study|Pursue medications|2|||
156649540|NCT00886483|565463442|FG000|Overall Study|Distance to center, poor grades|1|||
156649541|NCT00886483|565463443|FG001|Overall Study|Distance to center, poor grades|0|||
156649542|NCT02040766|565463444|FG000|Overall Study|Adverse Event|1|||
156649543|NCT02040766|565463445|FG001|Overall Study|Adverse Event|1|||
156414007|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
156414008|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
156414009|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
156414010|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
156414011|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
156414012|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
156414013|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
156649544|NCT02040766|565463446|FG002|Overall Study|Adverse Event|1|||
156649545|NCT02040766|565463447|FG003|Overall Study|Adverse Event|0|||
156649546|NCT02040766|565463448|FG004|Overall Study|Adverse Event|2|||
156649547|NCT02040766|565463444|FG000|Overall Study|Withdrawal by Subject|4|||
156649548|NCT02040766|565463445|FG001|Overall Study|Withdrawal by Subject|3|||
156649549|NCT02040766|565463446|FG002|Overall Study|Withdrawal by Subject|2|||
156649550|NCT02040766|565463447|FG003|Overall Study|Withdrawal by Subject|3|||
156649551|NCT02040766|565463448|FG004|Overall Study|Withdrawal by Subject|2|||
156649552|NCT02040766|565463444|FG000|Overall Study|Non-compliance|0|||
156649553|NCT02040766|565463445|FG001|Overall Study|Non-compliance|1|||
156649554|NCT02040766|565463446|FG002|Overall Study|Non-compliance|0|||
156649555|NCT02040766|565463447|FG003|Overall Study|Non-compliance|0|||
156649556|NCT02040766|565463448|FG004|Overall Study|Non-compliance|0|||
156649557|NCT02040766|565463444|FG000|Overall Study|Protocol Violation|2|||
156649558|NCT02040766|565463445|FG001|Overall Study|Protocol Violation|1|||
156649559|NCT02040766|565463446|FG002|Overall Study|Protocol Violation|2|||
156649560|NCT02040766|565463447|FG003|Overall Study|Protocol Violation|3|||
156649561|NCT02040766|565463448|FG004|Overall Study|Protocol Violation|0|||
156649562|NCT02040766|565463444|FG000|Overall Study|Lost to Follow-up|4|||
156649563|NCT02040766|565463445|FG001|Overall Study|Lost to Follow-up|1|||
156649564|NCT02040766|565463446|FG002|Overall Study|Lost to Follow-up|3|||
156649565|NCT02040766|565463447|FG003|Overall Study|Lost to Follow-up|1|||
156649566|NCT02040766|565463448|FG004|Overall Study|Lost to Follow-up|4|||
156649567|NCT02040766|565463444|FG000|Overall Study|Not reported|1|||
156649568|NCT02040766|565463445|FG001|Overall Study|Not reported|0|||
156649569|NCT02040766|565463446|FG002|Overall Study|Not reported|0|||
156649570|NCT02040766|565463447|FG003|Overall Study|Not reported|0|||
156649571|NCT02040766|565463448|FG004|Overall Study|Not reported|0|||
156649572|NCT02040766|565463444|FG000|Overall Study|Lack of Efficacy|6|||
156649573|NCT02040766|565463445|FG001|Overall Study|Lack of Efficacy|3|||
156649574|NCT02040766|565463446|FG002|Overall Study|Lack of Efficacy|4|||
156649575|NCT02040766|565463447|FG003|Overall Study|Lack of Efficacy|6|||
156649576|NCT02040766|565463448|FG004|Overall Study|Lack of Efficacy|5|||
156649577|NCT01138150|565463449|FG000|Overall Study|blood unable to be processed|0|||
156649578|NCT01138150|565463450|FG001|Overall Study|blood unable to be processed|1|||
156649579|NCT01138150|565463449|FG000|Overall Study|Physician Decision|1|||
156649580|NCT01138150|565463450|FG001|Overall Study|Physician Decision|0|||
156649581|NCT01208402|565463454|FG000|Overall Study|Withdrawal by Subject|1|||
156649582|NCT01208402|565463455|FG001|Overall Study|Withdrawal by Subject|0|||
156649583|NCT01571635|565463456|FG000|Overall Study|Adverse Event|3|||
156649584|NCT01571635|565463457|FG001|Overall Study|Adverse Event|0|||
156649585|NCT01571635|565463458|FG002|Overall Study|Adverse Event|2|||
156649586|NCT01571635|565463459|FG003|Overall Study|Adverse Event|3|||
156649587|NCT01571635|565463460|FG004|Overall Study|Adverse Event|5|||
156649588|NCT01571635|565463456|FG000|Overall Study|Other reasons|2|||
156649589|NCT01571635|565463457|FG001|Overall Study|Other reasons|1|||
156649590|NCT01571635|565463458|FG002|Overall Study|Other reasons|2|||
156649591|NCT01571635|565463459|FG003|Overall Study|Other reasons|2|||
156649592|NCT01571635|565463460|FG004|Overall Study|Other reasons|1|||
156649593|NCT01571635|565463456|FG000|Overall Study|Study terminated by sponsor|0|||
156649594|NCT01571635|565463457|FG001|Overall Study|Study terminated by sponsor|4|||
156649595|NCT01571635|565463458|FG002|Overall Study|Study terminated by sponsor|1|||
156649596|NCT01571635|565463459|FG003|Overall Study|Study terminated by sponsor|3|||
156649597|NCT01571635|565463460|FG004|Overall Study|Study terminated by sponsor|1|||
156414014|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
156414015|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
156414016|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
156649598|NCT01571635|565463456|FG000|Overall Study|Withdrew consent|1|||
156649599|NCT01571635|565463457|FG001|Overall Study|Withdrew consent|1|||
156414017|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414018|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
156649600|NCT01571635|565463458|FG002|Overall Study|Withdrew consent|2|||
156649601|NCT01571635|565463459|FG003|Overall Study|Withdrew consent|3|||
156649602|NCT01571635|565463460|FG004|Overall Study|Withdrew consent|0|||
156649603|NCT01571635|565463456|FG000|Overall Study|Lack of Efficacy|0|||
156649604|NCT01571635|565463457|FG001|Overall Study|Lack of Efficacy|2|||
156649605|NCT01571635|565463458|FG002|Overall Study|Lack of Efficacy|0|||
156649606|NCT01571635|565463459|FG003|Overall Study|Lack of Efficacy|1|||
156649607|NCT01571635|565463460|FG004|Overall Study|Lack of Efficacy|2|||
156649608|NCT01335464|565463461|FG000|Overall Study|Adverse Event|15|||
156649609|NCT01335464|565463462|FG001|Overall Study|Adverse Event|25|||
156649610|NCT01335464|565463461|FG000|Overall Study|Non compliant with protocol|2|||
156649611|NCT01335464|565463462|FG001|Overall Study|Non compliant with protocol|0|||
156649612|NCT01335464|565463461|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
156649613|NCT01335464|565463462|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
156649614|NCT01335464|565463461|FG000|Overall Study|Not treated|2|||
156649615|NCT01335464|565463462|FG001|Overall Study|Not treated|0|||
156312121|NCT00600119|564243159|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
156312122|NCT00600119|564243160|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156312123|NCT00600119|564243161|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156312124|NCT00600119|564243162|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156312125|NCT00600119|564243163|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156312126|NCT00600119|564243164|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156312127|NCT00600119|564243159|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
156312128|NCT00600119|564243160|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
156312129|NCT00600119|564243161|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
156312130|NCT00600119|564243162|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
156312131|NCT00600119|564243163|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
156312132|NCT00600119|564243164|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
156312133|NCT00600119|564243159|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
156312134|NCT00600119|564243160|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
156312135|NCT00600119|564243161|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
156312136|NCT00600119|564243162|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
156312137|NCT00600119|564243163|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
156312138|NCT00600119|564243164|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
156312139|NCT00600119|564243159|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
156312140|NCT00600119|564243160|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
156312141|NCT00600119|564243161|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156312142|NCT00600119|564243162|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
156312143|NCT00600119|564243163|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
156312144|NCT00600119|564243164|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
156312145|NCT00600119|564243159|FG000|Double-blind Treatment Period|Other|0|||
156312146|NCT00600119|564243160|FG001|Double-blind Treatment Period|Other|0|||
156312147|NCT00600119|564243161|FG002|Double-blind Treatment Period|Other|0|||
156312148|NCT00600119|564243162|FG003|Double-blind Treatment Period|Other|0|||
156312149|NCT00600119|564243163|FG004|Double-blind Treatment Period|Other|2|||
156312150|NCT00600119|564243164|FG005|Double-blind Treatment Period|Other|1|||
156312151|NCT00600119|564243159|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
156312152|NCT00600119|564243160|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
156312153|NCT00600119|564243161|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
156312154|NCT00600119|564243162|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
156312155|NCT00600119|564243163|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
156312156|NCT00600119|564243164|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
156312157|NCT00600119|564243159|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156312158|NCT00600119|564243160|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
156312159|NCT00600119|564243161|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156312160|NCT00600119|564243162|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156312161|NCT00600119|564243163|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156312162|NCT00600119|564243164|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156312163|NCT00600119|564243159|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
156312164|NCT00600119|564243160|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
156312165|NCT00600119|564243161|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
156312166|NCT00600119|564243162|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
156312167|NCT00600119|564243163|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
156312168|NCT00600119|564243164|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
156312169|NCT00600119|564243159|FG000|Double-blind Treatment Period|Physician Decision|2|||
156312170|NCT00600119|564243160|FG001|Double-blind Treatment Period|Physician Decision|0|||
156312171|NCT00600119|564243161|FG002|Double-blind Treatment Period|Physician Decision|0|||
156312172|NCT00600119|564243162|FG003|Double-blind Treatment Period|Physician Decision|0|||
156312173|NCT00600119|564243163|FG004|Double-blind Treatment Period|Physician Decision|0|||
156312174|NCT00600119|564243164|FG005|Double-blind Treatment Period|Physician Decision|0|||
156312175|NCT00600119|564243159|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156312176|NCT00600119|564243160|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
156312177|NCT00600119|564243161|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
156312178|NCT00600119|564243162|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
156312179|NCT00600119|564243163|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
156312180|NCT00600119|564243164|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
156312181|NCT00600119|564243159|FG000|Double-blind Treatment Period|Adverse Event|1|||
156414019|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414020|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414021|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414022|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414023|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414024|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414025|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414026|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414027|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414028|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414029|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414030|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
156414031|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414032|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
156414033|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
156414034|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414035|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414036|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414037|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414038|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414039|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414040|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414041|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414042|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414043|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414044|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414045|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414046|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414047|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414048|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
156414049|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414050|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156414051|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
156414052|NCT01474512|564608780|FG000|Post-Treatment Follow-Up|Death|0|||
156414053|NCT01474512|564608781|FG001|Post-Treatment Follow-Up|Death|0|||
156414054|NCT01474512|564608782|FG002|Post-Treatment Follow-Up|Death|0|||
156414055|NCT01474512|564608783|FG003|Post-Treatment Follow-Up|Death|0|||
156414056|NCT01474512|564608784|FG004|Post-Treatment Follow-Up|Death|0|||
156414057|NCT01474512|564608785|FG005|Post-Treatment Follow-Up|Death|0|||
156414058|NCT01474512|564608786|FG006|Post-Treatment Follow-Up|Death|0|||
156414059|NCT01474512|564608787|FG007|Post-Treatment Follow-Up|Death|0|||
156414060|NCT01474512|564608788|FG008|Post-Treatment Follow-Up|Death|0|||
156414061|NCT01474512|564608789|FG009|Post-Treatment Follow-Up|Death|0|||
156414062|NCT01474512|564608790|FG010|Post-Treatment Follow-Up|Death|0|||
156414063|NCT01474512|564608791|FG011|Post-Treatment Follow-Up|Death|0|||
156414064|NCT01474512|564608792|FG012|Post-Treatment Follow-Up|Death|0|||
156414065|NCT01474512|564608793|FG013|Post-Treatment Follow-Up|Death|0|||
156414066|NCT01474512|564608794|FG014|Post-Treatment Follow-Up|Death|0|||
156414067|NCT01474512|564608795|FG015|Post-Treatment Follow-Up|Death|0|||
156414068|NCT01474512|564608796|FG016|Post-Treatment Follow-Up|Death|1|||
156414069|NCT01474512|564608797|FG017|Post-Treatment Follow-Up|Death|0|||
156414070|NCT01118962|564608802|FG000|Overall Study|Adverse Event|2|||
156414071|NCT01118962|564608802|FG000|Overall Study|Lack of Efficacy|1|||
156414072|NCT01118962|564608802|FG000|Overall Study|Protocol Violation|1|||
156414073|NCT01118962|564608802|FG000|Overall Study|Withdrawal by Subject|4|||
156414074|NCT01118962|564608802|FG000|Overall Study|Pregnancy|1|||
156414075|NCT01118962|564608802|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
156414076|NCT01238575|564608803|FG000|Overall Study|Lack of Efficacy|2|||
156414077|NCT01238575|564608804|FG001|Overall Study|Lack of Efficacy|4|||
156414078|NCT01238575|564608803|FG000|Overall Study|Adverse Event|2|||
156414079|NCT01238575|564608804|FG001|Overall Study|Adverse Event|0|||
156414080|NCT00593554|564608805|FG000|Overall Study|Death|1|||
156414081|NCT00593554|564608806|FG001|Overall Study|Death|2|||
156414082|NCT00593554|564608805|FG000|Overall Study|Physician Decision|0|||
156414083|NCT00593554|564608806|FG001|Overall Study|Physician Decision|1|||
156414084|NCT00593554|564608805|FG000|Overall Study|Withdrawal by Subject|1|||
156414085|NCT00593554|564608806|FG001|Overall Study|Withdrawal by Subject|0|||
156414086|NCT00593554|564608805|FG000|Overall Study|Disease Progression|1|||
156414087|NCT00593554|564608806|FG001|Overall Study|Disease Progression|2|||
156414088|NCT00795132|564608809|FG000|Overall Study|Death|1|||
156414089|NCT00795132|564608809|FG000|Overall Study|Relapse|2|||
156414090|NCT00962585|564608811|FG000|Overall Study|Adverse Event|0|||
156414091|NCT00962585|564608812|FG001|Overall Study|Adverse Event|2|||
156414092|NCT00962585|564608813|FG002|Overall Study|Adverse Event|1|||
156414093|NCT00962585|564608814|FG003|Overall Study|Adverse Event|0|||
156414094|NCT00962585|564608811|FG000|Overall Study|Lost to Follow-up|3|||
156414095|NCT00962585|564608812|FG001|Overall Study|Lost to Follow-up|0|||
156414096|NCT00962585|564608813|FG002|Overall Study|Lost to Follow-up|1|||
156414097|NCT00962585|564608814|FG003|Overall Study|Lost to Follow-up|0|||
156649616|NCT01335464|565463461|FG000|Overall Study|Reason other than those stated above|1|||
156649617|NCT01335464|565463462|FG001|Overall Study|Reason other than those stated above|1|||
156649618|NCT01841359|565463463|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
156649619|NCT01841359|565463463|FG000|Overall Study|Concommitant medical issues|2|||
156649620|NCT01841359|565463463|FG000|Overall Study|Adverse Event|3|||
156649621|NCT01841359|565463463|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
156649622|NCT00931385|565463464|FG000|Overall Study|Adverse Event|2|||
156649623|NCT00931385|565463465|FG001|Overall Study|Adverse Event|1|||
156649624|NCT00931385|565463466|FG002|Overall Study|Adverse Event|0|||
156649625|NCT00931385|565463467|FG003|Overall Study|Adverse Event|3|||
156649626|NCT00931385|565463464|FG000|Overall Study|Protocol Violation|0|||
156649627|NCT00931385|565463465|FG001|Overall Study|Protocol Violation|0|||
156649628|NCT00931385|565463466|FG002|Overall Study|Protocol Violation|1|||
156649629|NCT00931385|565463467|FG003|Overall Study|Protocol Violation|0|||
156649630|NCT00931385|565463464|FG000|Overall Study|Withdrawal by Subject|0|||
156649631|NCT00931385|565463465|FG001|Overall Study|Withdrawal by Subject|1|||
156649632|NCT00931385|565463466|FG002|Overall Study|Withdrawal by Subject|0|||
156649633|NCT00931385|565463467|FG003|Overall Study|Withdrawal by Subject|1|||
156649634|NCT00931385|565463464|FG000|Overall Study|Lost to Follow-up|0|||
156649635|NCT00931385|565463465|FG001|Overall Study|Lost to Follow-up|0|||
156649636|NCT00931385|565463466|FG002|Overall Study|Lost to Follow-up|0|||
156649637|NCT00931385|565463467|FG003|Overall Study|Lost to Follow-up|1|||
156649638|NCT02884206|565465233|FG000|Valsartan Run-in Period|Death|1|||
156649639|NCT02884206|565465234|FG001|Valsartan Run-in Period|Death|0|||
156649640|NCT02884206|565465235|FG002|Valsartan Run-in Period|Death|0|||
156649641|NCT02884206|565465233|FG000|Valsartan Run-in Period|Adverse Event|31|||
156649642|NCT02884206|565465234|FG001|Valsartan Run-in Period|Adverse Event|0|||
156649643|NCT02884206|565465235|FG002|Valsartan Run-in Period|Adverse Event|0|||
156649644|NCT02884206|565465233|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
156649645|NCT02884206|565465234|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
156649646|NCT02884206|565465235|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
156649647|NCT02884206|565465233|FG000|Valsartan Run-in Period|Protocol deviation|4|||
156649648|NCT02884206|565465234|FG001|Valsartan Run-in Period|Protocol deviation|0|||
156649649|NCT02884206|565465235|FG002|Valsartan Run-in Period|Protocol deviation|0|||
156649650|NCT02884206|565465233|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
156649651|NCT02884206|565465234|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
156649652|NCT02884206|565465235|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
156649653|NCT02884206|565465233|FG000|Valsartan Run-in Period|Physician Decision|1|||
156649654|NCT02884206|565465234|FG001|Valsartan Run-in Period|Physician Decision|0|||
156649655|NCT02884206|565465235|FG002|Valsartan Run-in Period|Physician Decision|0|||
156649656|NCT02884206|565465233|FG000|LCZ696 Run-in Period|Adverse Event|38|||
156649657|NCT02884206|565465234|FG001|LCZ696 Run-in Period|Adverse Event|0|||
156649658|NCT02884206|565465235|FG002|LCZ696 Run-in Period|Adverse Event|0|||
156649659|NCT02884206|565465233|FG000|LCZ696 Run-in Period|Death|2|||
156649660|NCT02884206|565465234|FG001|LCZ696 Run-in Period|Death|0|||
156649661|NCT02884206|565465235|FG002|LCZ696 Run-in Period|Death|0|||
156649662|NCT02884206|565465233|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
156649663|NCT02884206|565465234|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
156649664|NCT02884206|565465235|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
156649665|NCT02884206|565465233|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
156649666|NCT02884206|565465234|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
156649667|NCT02884206|565465235|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
156649668|NCT02884206|565465233|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
156649669|NCT02884206|565465234|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
156649670|NCT02884206|565465235|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
156414098|NCT00962585|564608811|FG000|Overall Study|Protocol Violation|0|||
156414099|NCT00962585|564608812|FG001|Overall Study|Protocol Violation|0|||
156414100|NCT00962585|564608813|FG002|Overall Study|Protocol Violation|1|||
156414101|NCT00962585|564608814|FG003|Overall Study|Protocol Violation|0|||
156414102|NCT00962585|564608811|FG000|Overall Study|Withdrawal by Subject|1|||
156414103|NCT00962585|564608812|FG001|Overall Study|Withdrawal by Subject|0|||
156414104|NCT00962585|564608813|FG002|Overall Study|Withdrawal by Subject|0|||
156414105|NCT00962585|564608814|FG003|Overall Study|Withdrawal by Subject|0|||
156649671|NCT02884206|565465233|FG000|LCZ696 Run-in Period|Physician Decision|1|||
156649672|NCT02884206|565465234|FG001|LCZ696 Run-in Period|Physician Decision|0|||
156649673|NCT02884206|565465235|FG002|LCZ696 Run-in Period|Physician Decision|0|||
156649674|NCT02884206|565465233|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
156649675|NCT02884206|565465234|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
156649676|NCT02884206|565465235|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
156649677|NCT02884206|565465233|FG000|Double-Blind Period|Death|0|||
156649678|NCT02884206|565465234|FG001|Double-Blind Period|Death|28|||
156649679|NCT02884206|565465235|FG002|Double-Blind Period|Death|39|||
156649680|NCT02884206|565465233|FG000|Double-Blind Period|Patient/guardian decision|0|||
156649681|NCT02884206|565465234|FG001|Double-Blind Period|Patient/guardian decision|10|||
156649682|NCT02884206|565465235|FG002|Double-Blind Period|Patient/guardian decision|13|||
156649683|NCT02884206|565465233|FG000|Double-Blind Period|Lost to Follow-up|0|||
156649684|NCT02884206|565465234|FG001|Double-Blind Period|Lost to Follow-up|4|||
156649685|NCT02884206|565465235|FG002|Double-Blind Period|Lost to Follow-up|4|||
156649686|NCT02884206|565465233|FG000|Double-Blind Period|Physician Decision|0|||
156649687|NCT02884206|565465234|FG001|Double-Blind Period|Physician Decision|2|||
156649688|NCT02884206|565465235|FG002|Double-Blind Period|Physician Decision|0|||
156649689|NCT02884206|565465233|FG000|Double-Blind Period|Adverse Event|0|||
156649690|NCT02884206|565465234|FG001|Double-Blind Period|Adverse Event|0|||
156649691|NCT02884206|565465235|FG002|Double-Blind Period|Adverse Event|3|||
156649692|NCT02884206|565465233|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
156649693|NCT02884206|565465234|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
156649694|NCT02884206|565465235|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
156649695|NCT02322879|565465236|FG000|First Intervention|Physician Decision|1|||
156649696|NCT02322879|565465237|FG001|First Intervention|Physician Decision|0|||
156649697|NCT03487796|565465238|FG000|Overall Study|Lost to Follow-up|18|||
156649698|NCT03487796|565465239|FG001|Overall Study|Lost to Follow-up|6|||
156649699|NCT05487456|565465240|FG000|Overall Study|Withdrawal by Subject|0|||
156649700|NCT05487456|565465241|FG001|Overall Study|Withdrawal by Subject|0|||
156649701|NCT05487456|565465242|FG002|Overall Study|Withdrawal by Subject|1|||
156649702|NCT05487456|565465243|FG003|Overall Study|Withdrawal by Subject|0|||
156649703|NCT02711956|565465244|FG000|Overall Study|Adverse Event|0|||
156649704|NCT02711956|565465245|FG001|Overall Study|Adverse Event|0|||
156649705|NCT02711956|565465246|FG002|Overall Study|Adverse Event|0|||
156649706|NCT02711956|565465247|FG003|Overall Study|Adverse Event|1|||
156312182|NCT00600119|564243160|FG001|Double-blind Treatment Period|Adverse Event|1|||
156312183|NCT00600119|564243161|FG002|Double-blind Treatment Period|Adverse Event|0|||
156312184|NCT00600119|564243162|FG003|Double-blind Treatment Period|Adverse Event|1|||
156312185|NCT00600119|564243163|FG004|Double-blind Treatment Period|Adverse Event|2|||
156312186|NCT00600119|564243164|FG005|Double-blind Treatment Period|Adverse Event|10|||
156312187|NCT00600119|564243159|FG000|Follow-up Period|Adverse Event|0|||
156312188|NCT00600119|564243160|FG001|Follow-up Period|Adverse Event|0|||
156312189|NCT00600119|564243161|FG002|Follow-up Period|Adverse Event|0|||
156312190|NCT00600119|564243162|FG003|Follow-up Period|Adverse Event|0|||
156312191|NCT00600119|564243163|FG004|Follow-up Period|Adverse Event|0|||
156312192|NCT00600119|564243164|FG005|Follow-up Period|Adverse Event|1|||
156312193|NCT00600119|564243159|FG000|Follow-up Period|Other|1|||
156312194|NCT00600119|564243160|FG001|Follow-up Period|Other|0|||
156312195|NCT00600119|564243161|FG002|Follow-up Period|Other|0|||
156312196|NCT00600119|564243162|FG003|Follow-up Period|Other|0|||
156312197|NCT00600119|564243163|FG004|Follow-up Period|Other|0|||
156312198|NCT00600119|564243164|FG005|Follow-up Period|Other|0|||
156312199|NCT00729469|564243165|FG000|Overall Study|Adverse Event|14|||
156312200|NCT00729469|564243166|FG001|Overall Study|Adverse Event|25|||
156312201|NCT00729469|564243165|FG000|Overall Study|Lost to Follow-up|9|||
156312202|NCT00729469|564243166|FG001|Overall Study|Lost to Follow-up|9|||
156312203|NCT00729469|564243165|FG000|Overall Study|Protocol Violation|2|||
156312204|NCT00729469|564243166|FG001|Overall Study|Protocol Violation|1|||
156312205|NCT00729469|564243165|FG000|Overall Study|Withdrawal by Subject|19|||
156312206|NCT00729469|564243166|FG001|Overall Study|Withdrawal by Subject|8|||
156312207|NCT00729469|564243165|FG000|Overall Study|Other-Not mentioned|9|||
156312208|NCT00729469|564243166|FG001|Overall Study|Other-Not mentioned|4|||
156312209|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
156312210|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
156312211|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Adverse Event|7|||
156312212|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Adverse Event|6|||
156312213|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
156312214|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
156312215|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Physician Decision|4|||
156312216|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Physician Decision|4|||
156312217|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
156649707|NCT02711956|565465248|FG004|Overall Study|Adverse Event|2|||
156649708|NCT02711956|565465249|FG005|Overall Study|Adverse Event|0|||
156649709|NCT02711956|565465250|FG006|Overall Study|Adverse Event|0|||
156649710|NCT02711956|565465251|FG007|Overall Study|Adverse Event|1|||
156312218|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
156312219|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
156312220|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
156312221|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
156312222|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
156312223|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Non-compliance|1|||
156312224|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Non-compliance|0|||
156312225|NCT00470834|564243167|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
156649711|NCT02711956|565465252|FG008|Overall Study|Adverse Event|1|||
156649712|NCT02711956|565465253|FG009|Overall Study|Adverse Event|1|||
156649713|NCT02711956|565465254|FG010|Overall Study|Adverse Event|1|||
156649714|NCT02711956|565465255|FG011|Overall Study|Adverse Event|0|||
156649715|NCT02711956|565465256|FG012|Overall Study|Adverse Event|0|||
156649716|NCT02711956|565465257|FG013|Overall Study|Adverse Event|0|||
156649717|NCT02711956|565465258|FG014|Overall Study|Adverse Event|2|||
156649718|NCT02711956|565465244|FG000|Overall Study|Physician Decision|0|||
156649719|NCT02711956|565465245|FG001|Overall Study|Physician Decision|0|||
156649720|NCT02711956|565465246|FG002|Overall Study|Physician Decision|0|||
156649721|NCT02711956|565465247|FG003|Overall Study|Physician Decision|2|||
156649722|NCT02711956|565465248|FG004|Overall Study|Physician Decision|0|||
156649723|NCT02711956|565465249|FG005|Overall Study|Physician Decision|0|||
156649724|NCT02711956|565465250|FG006|Overall Study|Physician Decision|0|||
156649725|NCT02711956|565465251|FG007|Overall Study|Physician Decision|0|||
156649726|NCT02711956|565465252|FG008|Overall Study|Physician Decision|0|||
156649727|NCT02711956|565465253|FG009|Overall Study|Physician Decision|0|||
156649728|NCT02711956|565465254|FG010|Overall Study|Physician Decision|0|||
156649729|NCT02711956|565465255|FG011|Overall Study|Physician Decision|0|||
156649730|NCT02711956|565465256|FG012|Overall Study|Physician Decision|0|||
156649731|NCT02711956|565465257|FG013|Overall Study|Physician Decision|0|||
156649732|NCT02711956|565465258|FG014|Overall Study|Physician Decision|0|||
156649733|NCT02711956|565465244|FG000|Overall Study|Withdrawal by Subject|0|||
156649734|NCT02711956|565465245|FG001|Overall Study|Withdrawal by Subject|0|||
156649735|NCT02711956|565465246|FG002|Overall Study|Withdrawal by Subject|0|||
156649736|NCT02711956|565465247|FG003|Overall Study|Withdrawal by Subject|0|||
156649737|NCT02711956|565465248|FG004|Overall Study|Withdrawal by Subject|0|||
156649738|NCT02711956|565465249|FG005|Overall Study|Withdrawal by Subject|0|||
156649739|NCT02711956|565465250|FG006|Overall Study|Withdrawal by Subject|1|||
156649740|NCT02711956|565465251|FG007|Overall Study|Withdrawal by Subject|0|||
156649741|NCT02711956|565465252|FG008|Overall Study|Withdrawal by Subject|0|||
156649742|NCT02711956|565465253|FG009|Overall Study|Withdrawal by Subject|0|||
156649743|NCT02711956|565465254|FG010|Overall Study|Withdrawal by Subject|0|||
156649744|NCT02711956|565465255|FG011|Overall Study|Withdrawal by Subject|1|||
156649745|NCT02711956|565465256|FG012|Overall Study|Withdrawal by Subject|6|||
156649746|NCT02711956|565465257|FG013|Overall Study|Withdrawal by Subject|0|||
156649747|NCT02711956|565465258|FG014|Overall Study|Withdrawal by Subject|1|||
156751714|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751715|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751716|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751717|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751718|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751719|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751720|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
156751721|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751722|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751723|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
156751724|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751725|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
156751726|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751727|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751728|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751729|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751730|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751731|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751732|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751733|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751734|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
156751735|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751736|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
156751737|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751738|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751739|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
156751740|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751741|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751742|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751743|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751744|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751745|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751746|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751747|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751748|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
156751749|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751750|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751751|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751752|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
156751753|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
156751754|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
156751755|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
156751756|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
156751757|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
156751758|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
156751759|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
156751760|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
156312226|NCT00470834|564243168|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
156312227|NCT00470834|564243167|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
156312228|NCT00470834|564243168|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
156312229|NCT00470834|564243167|FG000|Extension Period (24 Months)|Adverse Event|3|||
156312230|NCT00470834|564243168|FG001|Extension Period (24 Months)|Adverse Event|4|||
156312231|NCT00470834|564243167|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
156312232|NCT00470834|564243168|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
156312233|NCT00470834|564243167|FG000|Extension Period (24 Months)|Physician Decision|4|||
156312234|NCT00470834|564243168|FG001|Extension Period (24 Months)|Physician Decision|3|||
156312235|NCT00470834|564243167|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
156312236|NCT00470834|564243168|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
156312237|NCT00470834|564243167|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
156312238|NCT00470834|564243168|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
156312239|NCT00470834|564243167|FG000|Extension Period (24 Months)|Non-compliance|0|||
156312240|NCT00470834|564243168|FG001|Extension Period (24 Months)|Non-compliance|1|||
156312241|NCT00470834|564243167|FG000|Extension Period (24 Months)|Disease Progression|0|||
156312242|NCT00470834|564243168|FG001|Extension Period (24 Months)|Disease Progression|1|||
156312243|NCT00783198|564243175|FG000|Overall Study|Adverse Event|15|||
156312244|NCT00783198|564243176|FG001|Overall Study|Adverse Event|19|||
156312245|NCT00783198|564243177|FG002|Overall Study|Adverse Event|3|||
156312246|NCT00783198|564243175|FG000|Overall Study|Lost to Follow-up|11|||
156312247|NCT00783198|564243176|FG001|Overall Study|Lost to Follow-up|1|||
156312248|NCT00783198|564243177|FG002|Overall Study|Lost to Follow-up|7|||
156312249|NCT00783198|564243175|FG000|Overall Study|Withdrawal by Subject|22|||
156312250|NCT00783198|564243176|FG001|Overall Study|Withdrawal by Subject|14|||
156312251|NCT00783198|564243177|FG002|Overall Study|Withdrawal by Subject|20|||
156312252|NCT00783198|564243175|FG000|Overall Study|Noncompliance with protocol|7|||
156312253|NCT00783198|564243176|FG001|Overall Study|Noncompliance with protocol|7|||
156312254|NCT00783198|564243177|FG002|Overall Study|Noncompliance with protocol|10|||
156312255|NCT00783198|564243175|FG000|Overall Study|Did not meet protocol eligibility|0|||
156312256|NCT00783198|564243176|FG001|Overall Study|Did not meet protocol eligibility|1|||
156312257|NCT00783198|564243177|FG002|Overall Study|Did not meet protocol eligibility|0|||
156312258|NCT00783198|564243175|FG000|Overall Study|Administrative|2|||
156312259|NCT00783198|564243176|FG001|Overall Study|Administrative|1|||
156312260|NCT00783198|564243177|FG002|Overall Study|Administrative|2|||
156312261|NCT00946985|564243178|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
156312262|NCT00946985|564243178|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
156312263|NCT00946985|564243178|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
156312264|NCT00946985|564243178|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
156312265|NCT00946985|564243178|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
156312266|NCT00946985|564243178|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
156312267|NCT00946985|564243178|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
156312268|NCT00946985|564243178|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
156312269|NCT00946985|564243178|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
156312270|NCT00271505|564243179|FG000|Overall Study|Screen Failure|3|||
156312271|NCT00271505|564243179|FG000|Overall Study|Adverse Event|1|||
156312272|NCT00271505|564243179|FG000|Overall Study|Death|1|||
156312273|NCT00119678|564243180|FG000|Double-blind Treatment Period|Death|1|||
156312274|NCT00119678|564243181|FG001|Double-blind Treatment Period|Death|0|||
156312275|NCT00119678|564243180|FG000|Double-blind Treatment Period|Adverse Event|7|||
156751761|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
156751762|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
156312276|NCT00119678|564243181|FG001|Double-blind Treatment Period|Adverse Event|1|||
156312277|NCT00119678|564243180|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
156312278|NCT00119678|564243181|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
156312279|NCT00119678|564243180|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
156312280|NCT00119678|564243181|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
156414106|NCT00962585|564608811|FG000|Overall Study|Withdrew Consent|2|||
156751763|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
156751764|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
156751765|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
156751766|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
156751767|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
156751768|NCT00401193|565844031|FG000|Overall Study|Adverse Event|1|||
156751769|NCT00401193|565844032|FG001|Overall Study|Adverse Event|3|||
156751770|NCT00401193|565844033|FG002|Overall Study|Adverse Event|1|||
156751771|NCT00401193|565844031|FG000|Overall Study|Protocol Violation|3|||
156751772|NCT00401193|565844032|FG001|Overall Study|Protocol Violation|1|||
156751773|NCT00401193|565844033|FG002|Overall Study|Protocol Violation|1|||
156751774|NCT00401193|565844031|FG000|Overall Study|Lost to Follow-up|6|||
156312281|NCT00119678|564243180|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
156312282|NCT00119678|564243181|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
156312283|NCT00119678|564243180|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
156312284|NCT00119678|564243181|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
156312285|NCT00119678|564243180|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
156312286|NCT00119678|564243181|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
156312287|NCT00119678|564243180|FG000|Double-blind Treatment Period|Pregnancy|0|||
156312288|NCT00119678|564243181|FG001|Double-blind Treatment Period|Pregnancy|2|||
156312289|NCT00119678|564243180|FG000|Double-blind Treatment Period|Not treated|1|||
156312290|NCT00119678|564243181|FG001|Double-blind Treatment Period|Not treated|2|||
156312291|NCT00119678|564243180|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
156312292|NCT00119678|564243181|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
156312293|NCT00119678|564243180|FG000|Open-label Treatment Period|Death|1|||
156312294|NCT00119678|564243181|FG001|Open-label Treatment Period|Death|0|||
156312295|NCT00119678|564243180|FG000|Open-label Treatment Period|Adverse Event|3|||
156312296|NCT00119678|564243181|FG001|Open-label Treatment Period|Adverse Event|0|||
156312297|NCT00119678|564243180|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
156312298|NCT00119678|564243181|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
156312299|NCT00119678|564243180|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
156312300|NCT00119678|564243181|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
156312301|NCT00119678|564243180|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
156312302|NCT00119678|564243181|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
156312303|NCT00119678|564243180|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
156312304|NCT00119678|564243181|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
156312305|NCT00119678|564243180|FG000|Open-label Treatment Period|Pregnancy|1|||
156312306|NCT00119678|564243181|FG001|Open-label Treatment Period|Pregnancy|0|||
156312307|NCT00119678|564243180|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
156312308|NCT00119678|564243181|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
156312309|NCT01134705|564243184|FG000|Overall Study|Adverse Event|1|||
156312310|NCT01134705|564243185|FG001|Overall Study|Adverse Event|7|||
156312311|NCT01134705|564243184|FG000|Overall Study|Withdrawal by Subject|6|||
156312312|NCT01134705|564243185|FG001|Overall Study|Withdrawal by Subject|6|||
156312313|NCT01134705|564243184|FG000|Overall Study|Pregnancy|1|||
156312314|NCT01134705|564243185|FG001|Overall Study|Pregnancy|0|||
156312315|NCT01134705|564243184|FG000|Overall Study|Lost to Follow-up|5|||
156312316|NCT01134705|564243185|FG001|Overall Study|Lost to Follow-up|2|||
156312317|NCT01134705|564243184|FG000|Overall Study|Protocol Violation|1|||
156312318|NCT01134705|564243185|FG001|Overall Study|Protocol Violation|1|||
156312319|NCT01134705|564243184|FG000|Overall Study|Other|1|||
156312320|NCT01134705|564243185|FG001|Overall Study|Other|6|||
156312321|NCT01510769|564243186|FG000|Overall Study|Adverse Event|7|||
156312322|NCT01510769|564243187|FG001|Overall Study|Adverse Event|6|||
156312323|NCT01510769|564243188|FG002|Overall Study|Adverse Event|4|||
156312324|NCT01510769|564243186|FG000|Overall Study|Gout Flare|0|||
156312325|NCT01510769|564243187|FG001|Overall Study|Gout Flare|3|||
156312326|NCT01510769|564243188|FG002|Overall Study|Gout Flare|1|||
156312327|NCT01510769|564243186|FG000|Overall Study|Protocol Violation|11|||
156312328|NCT01510769|564243187|FG001|Overall Study|Protocol Violation|10|||
156751775|NCT00401193|565844032|FG001|Overall Study|Lost to Follow-up|5|||
156312329|NCT01510769|564243188|FG002|Overall Study|Protocol Violation|9|||
156312330|NCT01510769|564243186|FG000|Overall Study|Lost to Follow-up|5|||
156312331|NCT01510769|564243187|FG001|Overall Study|Lost to Follow-up|1|||
156312332|NCT01510769|564243188|FG002|Overall Study|Lost to Follow-up|5|||
156312333|NCT01510769|564243186|FG000|Overall Study|Withdrawal by Subject|3|||
156312334|NCT01510769|564243187|FG001|Overall Study|Withdrawal by Subject|4|||
156312335|NCT01510769|564243188|FG002|Overall Study|Withdrawal by Subject|3|||
156312336|NCT01510769|564243186|FG000|Overall Study|Death|1|||
156312337|NCT01510769|564243187|FG001|Overall Study|Death|1|||
156312338|NCT01510769|564243188|FG002|Overall Study|Death|0|||
156312339|NCT02674204|564243189|FG000|Overall Study|Adverse Event|1|||
156312340|NCT02674204|564243190|FG001|Overall Study|Adverse Event|0|||
156751776|NCT00401193|565844033|FG002|Overall Study|Lost to Follow-up|1|||
156751777|NCT00401193|565844031|FG000|Overall Study|Withdrawal by Subject|2|||
156751778|NCT00401193|565844032|FG001|Overall Study|Withdrawal by Subject|0|||
156751779|NCT00401193|565844033|FG002|Overall Study|Withdrawal by Subject|1|||
156751780|NCT00401193|565844031|FG000|Overall Study|Other Event|3|||
156751781|NCT00401193|565844032|FG001|Overall Study|Other Event|2|||
156751782|NCT00401193|565844033|FG002|Overall Study|Other Event|2|||
156751783|NCT04378569|565844037|FG000|Overall Study|Adverse Event|0|||
156751784|NCT04378569|565844038|FG001|Overall Study|Adverse Event|0|||
156751785|NCT04378569|565844039|FG002|Overall Study|Adverse Event|2|||
156751786|NCT04378569|565844040|FG003|Overall Study|Adverse Event|0|||
156751787|NCT04378569|565844041|FG004|Overall Study|Adverse Event|3|||
156751788|NCT04378569|565844042|FG005|Overall Study|Adverse Event|3|||
156751789|NCT04378569|565844037|FG000|Overall Study|Lost to Follow-up|0|||
156751790|NCT04378569|565844038|FG001|Overall Study|Lost to Follow-up|3|||
156751791|NCT04378569|565844039|FG002|Overall Study|Lost to Follow-up|1|||
156751792|NCT04378569|565844040|FG003|Overall Study|Lost to Follow-up|0|||
156751793|NCT04378569|565844041|FG004|Overall Study|Lost to Follow-up|1|||
156751794|NCT04378569|565844042|FG005|Overall Study|Lost to Follow-up|1|||
156751795|NCT04378569|565844037|FG000|Overall Study|Protocol Violation|0|||
156751796|NCT04378569|565844038|FG001|Overall Study|Protocol Violation|0|||
156751797|NCT04378569|565844039|FG002|Overall Study|Protocol Violation|0|||
156751798|NCT04378569|565844040|FG003|Overall Study|Protocol Violation|0|||
156751799|NCT04378569|565844041|FG004|Overall Study|Protocol Violation|0|||
156751800|NCT04378569|565844042|FG005|Overall Study|Protocol Violation|1|||
156751801|NCT04378569|565844037|FG000|Overall Study|Withdrawal by Subject|0|||
156751802|NCT04378569|565844038|FG001|Overall Study|Withdrawal by Subject|6|||
156751803|NCT04378569|565844039|FG002|Overall Study|Withdrawal by Subject|7|||
156751804|NCT04378569|565844040|FG003|Overall Study|Withdrawal by Subject|4|||
156751805|NCT04378569|565844041|FG004|Overall Study|Withdrawal by Subject|5|||
156751806|NCT04378569|565844042|FG005|Overall Study|Withdrawal by Subject|4|||
156751807|NCT04378569|565844037|FG000|Overall Study|Lack of response|0|||
156751808|NCT04378569|565844038|FG001|Overall Study|Lack of response|0|||
156751809|NCT04378569|565844039|FG002|Overall Study|Lack of response|1|||
156751810|NCT04378569|565844040|FG003|Overall Study|Lack of response|0|||
156751811|NCT04378569|565844041|FG004|Overall Study|Lack of response|1|||
156751812|NCT04378569|565844042|FG005|Overall Study|Lack of response|1|||
156751813|NCT01048944|565844043|FG000|Overall Study|Protocol Violation|8|||
156751814|NCT01048944|565844044|FG001|Overall Study|Protocol Violation|10|||
156751815|NCT01048944|565844045|FG002|Overall Study|Protocol Violation|10|||
156751816|NCT01048944|565844046|FG003|Overall Study|Protocol Violation|2|||
156751817|NCT01962948|565844047|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
156751818|NCT01962948|565844048|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
156751819|NCT01962948|565844049|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
156751820|NCT01962948|565844050|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
156751821|NCT00376532|565844051|FG000|Overall Study|Lack sufficient blood sample|6|||
156751822|NCT00376532|565844052|FG001|Overall Study|Lack sufficient blood sample|6|||
156751823|NCT01844817|565844053|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
156751824|NCT01844817|565844054|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
156751825|NCT01844817|565844053|FG000|Treatment|Progressive Disease|27|||
156751826|NCT01844817|565844054|FG001|Treatment|Progressive Disease|36|||
156751827|NCT01844817|565844053|FG000|Treatment|Adverse Event|17|||
156312341|NCT01008423|564243191|FG000|Overall Study|Adverse Event|13|||
156312342|NCT01008423|564243192|FG001|Overall Study|Adverse Event|6|||
156312343|NCT01008423|564243191|FG000|Overall Study|Withdrawal by Subject|4|||
156312344|NCT01008423|564243192|FG001|Overall Study|Withdrawal by Subject|7|||
156312345|NCT01008423|564243191|FG000|Overall Study|Lost to Follow-up|0|||
156312346|NCT01008423|564243192|FG001|Overall Study|Lost to Follow-up|2|||
156312347|NCT01008423|564243191|FG000|Overall Study|Low Cortisol|0|||
156312348|NCT01008423|564243192|FG001|Overall Study|Low Cortisol|1|||
156312349|NCT01008423|564243191|FG000|Overall Study|Lack of Efficacy|0|||
156312350|NCT01008423|564243192|FG001|Overall Study|Lack of Efficacy|5|||
156312351|NCT01008423|564243191|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
156312352|NCT01008423|564243192|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
156751828|NCT01844817|565844054|FG001|Treatment|Adverse Event|9|||
156751829|NCT01844817|565844053|FG000|Treatment|Withdrawal by Subject|10|||
156751830|NCT01844817|565844054|FG001|Treatment|Withdrawal by Subject|6|||
156751831|NCT01844817|565844053|FG000|Treatment|Death|10|||
156751832|NCT01844817|565844054|FG001|Treatment|Death|8|||
156751833|NCT01844817|565844053|FG000|Treatment|Lost to Follow-up|0|||
156751834|NCT01844817|565844054|FG001|Treatment|Lost to Follow-up|1|||
156751835|NCT01844817|565844053|FG000|Treatment|Other|0|||
156312353|NCT01008423|564243191|FG000|Overall Study|Personal Conflict|1|||
156312354|NCT01008423|564243192|FG001|Overall Study|Personal Conflict|0|||
156312355|NCT01008423|564243191|FG000|Overall Study|Other|0|||
156312356|NCT01008423|564243192|FG001|Overall Study|Other|1|||
156312357|NCT00978757|564243198|FG000|Overall Study|Physician Decision|1|||
156312358|NCT00978757|564243199|FG001|Overall Study|Physician Decision|3|||
156751836|NCT01844817|565844054|FG001|Treatment|Other|3|||
156751837|NCT01133704|565844055|FG000|Overall Study|Death|44|||
156751838|NCT01133704|565844056|FG001|Overall Study|Death|26|||
156751839|NCT01133704|565844055|FG000|Overall Study|Patient refused to continue|4|||
156751840|NCT01133704|565844056|FG001|Overall Study|Patient refused to continue|0|||
156751841|NCT01133704|565844055|FG000|Overall Study|Study Closure|1|||
156751842|NCT01133704|565844056|FG001|Overall Study|Study Closure|0|||
156751843|NCT02207400|565844057|FG000|Overall Study|Adverse Event|1|||
156751844|NCT02207400|565844058|FG001|Overall Study|Adverse Event|1|||
156751845|NCT02207400|565844057|FG000|Overall Study|Lost to Follow-up|6|||
156751846|NCT02207400|565844058|FG001|Overall Study|Lost to Follow-up|7|||
156751847|NCT02207400|565844057|FG000|Overall Study|Protocol Violation|1|||
156751848|NCT02207400|565844058|FG001|Overall Study|Protocol Violation|1|||
156751849|NCT02207400|565844057|FG000|Overall Study|Withdrawal by Subject|8|||
156751850|NCT02207400|565844058|FG001|Overall Study|Withdrawal by Subject|4|||
156751851|NCT02207400|565844057|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
156751852|NCT02207400|565844058|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
156751853|NCT02849704|565844059|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
156751854|NCT02849704|565844060|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
156751855|NCT02849704|565844059|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
156751856|NCT02849704|565844060|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
156751857|NCT02849704|565844059|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
156751858|NCT02849704|565844060|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
156751859|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
156751860|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
156751861|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
156751862|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
156751863|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
156751864|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
156751865|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
156751866|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
156751867|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
156751868|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
156751869|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
156751870|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
156751871|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
156751872|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
156751873|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
156751874|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
156751875|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
156751876|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
156751877|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
156751878|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
156751879|NCT02362425|565844066|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
156751880|NCT02362425|565844067|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
156751881|NCT02362425|565844068|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
156751882|NCT02362425|565844069|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
156751883|NCT02362425|565844066|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
156751884|NCT02362425|565844067|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
156751885|NCT02362425|565844068|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
156751886|NCT02362425|565844069|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
156751887|NCT02362425|565844066|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
156751888|NCT02362425|565844067|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
156751889|NCT02362425|565844068|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
156751890|NCT02362425|565844069|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
156751891|NCT00314808|565844077|FG000|Overall Study|Disease Progression without AE|4|||
156751892|NCT00314808|565844077|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
156751893|NCT04304508|565844078|FG000|Overall Study|Subject Decision|29|||
156751894|NCT04304508|565844079|FG001|Overall Study|Subject Decision|39|||
156751895|NCT04304508|565844080|FG002|Overall Study|Subject Decision|37|||
156751896|NCT04304508|565844081|FG003|Overall Study|Subject Decision|48|||
156751897|NCT04304508|565844078|FG000|Overall Study|Death|6|||
156751898|NCT04304508|565844079|FG001|Overall Study|Death|1|||
156751899|NCT04304508|565844080|FG002|Overall Study|Death|8|||
156751900|NCT04304508|565844081|FG003|Overall Study|Death|5|||
156751901|NCT04304508|565844078|FG000|Overall Study|Non-compliance With Study Drug|3|||
156751902|NCT04304508|565844079|FG001|Overall Study|Non-compliance With Study Drug|1|||
156751903|NCT04304508|565844080|FG002|Overall Study|Non-compliance With Study Drug|2|||
156751904|NCT04304508|565844081|FG003|Overall Study|Non-compliance With Study Drug|0|||
156751905|NCT04304508|565844078|FG000|Overall Study|Switching To Other Therapy|1|||
156751906|NCT04304508|565844079|FG001|Overall Study|Switching To Other Therapy|1|||
156751907|NCT04304508|565844080|FG002|Overall Study|Switching To Other Therapy|1|||
156751908|NCT04304508|565844081|FG003|Overall Study|Switching To Other Therapy|2|||
156751909|NCT04304508|565844078|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
156751910|NCT04304508|565844079|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
156751911|NCT04304508|565844080|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
156751912|NCT04304508|565844081|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
156751913|NCT04304508|565844078|FG000|Overall Study|Withdrawal by Subject|7|||
156751914|NCT04304508|565844079|FG001|Overall Study|Withdrawal by Subject|5|||
156751915|NCT04304508|565844080|FG002|Overall Study|Withdrawal by Subject|11|||
156751916|NCT04304508|565844081|FG003|Overall Study|Withdrawal by Subject|6|||
156751917|NCT04304508|565844078|FG000|Overall Study|Logistical Difficulties|2|||
156751918|NCT04304508|565844079|FG001|Overall Study|Logistical Difficulties|2|||
156751919|NCT04304508|565844080|FG002|Overall Study|Logistical Difficulties|3|||
156751920|NCT04304508|565844081|FG003|Overall Study|Logistical Difficulties|2|||
156751921|NCT04304508|565844078|FG000|Overall Study|Missing Information|1|||
156751922|NCT04304508|565844079|FG001|Overall Study|Missing Information|2|||
156751923|NCT04304508|565844080|FG002|Overall Study|Missing Information|1|||
156751924|NCT04304508|565844081|FG003|Overall Study|Missing Information|3|||
156751925|NCT04304508|565844078|FG000|Overall Study|Other|7|||
156751926|NCT04304508|565844079|FG001|Overall Study|Other|6|||
156751927|NCT04304508|565844080|FG002|Overall Study|Other|5|||
156751928|NCT04304508|565844081|FG003|Overall Study|Other|4|||
156751929|NCT04304508|565844078|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
156751930|NCT04304508|565844079|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
156751931|NCT04304508|565844080|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
156751932|NCT04304508|565844081|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
156751933|NCT04304508|565844078|FG000|Overall Study|Physician Decision|3|||
156751934|NCT04304508|565844079|FG001|Overall Study|Physician Decision|4|||
156751935|NCT04304508|565844080|FG002|Overall Study|Physician Decision|9|||
156751936|NCT04304508|565844081|FG003|Overall Study|Physician Decision|7|||
156751937|NCT04304508|565844078|FG000|Overall Study|Study drug never administered|10|||
156751938|NCT04304508|565844079|FG001|Overall Study|Study drug never administered|4|||
156751939|NCT04304508|565844080|FG002|Overall Study|Study drug never administered|4|||
156751940|NCT04304508|565844081|FG003|Overall Study|Study drug never administered|4|||
156751941|NCT04304508|565844078|FG000|Overall Study|Adverse Event|49|||
156751942|NCT04304508|565844079|FG001|Overall Study|Adverse Event|50|||
156751943|NCT04304508|565844080|FG002|Overall Study|Adverse Event|51|||
156751944|NCT04304508|565844081|FG003|Overall Study|Adverse Event|56|||
156751945|NCT04304508|565844078|FG000|Overall Study|Lost to Follow-up|1|||
156751946|NCT04304508|565844079|FG001|Overall Study|Lost to Follow-up|5|||
156751947|NCT04304508|565844080|FG002|Overall Study|Lost to Follow-up|2|||
156751948|NCT04304508|565844081|FG003|Overall Study|Lost to Follow-up|3|||
156751949|NCT02688764|565844088|FG000|Overall Study|Adverse Event|3|||
156751950|NCT02688764|565844089|FG001|Overall Study|Adverse Event|3|||
156751951|NCT02688764|565844088|FG000|Overall Study|AE/Kidney transplant|1|||
156751952|NCT02688764|565844089|FG001|Overall Study|AE/Kidney transplant|0|||
156751953|NCT02688764|565844088|FG000|Overall Study|AE/Lack of efficacy|1|||
156751954|NCT02688764|565844089|FG001|Overall Study|AE/Lack of efficacy|0|||
156751955|NCT02688764|565844088|FG000|Overall Study|AE/Non-compl.|1|||
156751956|NCT02688764|565844089|FG001|Overall Study|AE/Non-compl.|0|||
156751957|NCT02688764|565844088|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
156751958|NCT02688764|565844089|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
156751959|NCT02688764|565844088|FG000|Overall Study|AE/Other|0|||
156751960|NCT02688764|565844089|FG001|Overall Study|AE/Other|1|||
156751961|NCT02688764|565844088|FG000|Overall Study|AE/Physician decision|1|||
156751962|NCT02688764|565844089|FG001|Overall Study|AE/Physician decision|0|||
156751963|NCT02688764|565844088|FG000|Overall Study|AE/Withd. parent|3|||
156312359|NCT01028300|564243200|FG000|Overall Study|Study Terminated|4|||
156312360|NCT00715910|564243201|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
156312361|NCT00715910|564243202|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
156312362|NCT00715910|564243203|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
156312363|NCT00715910|564243204|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
156312364|NCT00715910|564243205|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
156312365|NCT00715910|564243206|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
156312366|NCT00715910|564243201|FG000|Booster and ESFU Phase|Other|0|||
156312367|NCT00715910|564243202|FG001|Booster and ESFU Phase|Other|0|||
156312368|NCT00715910|564243203|FG002|Booster and ESFU Phase|Other|0|||
156312369|NCT00715910|564243204|FG003|Booster and ESFU Phase|Other|5|||
156312370|NCT00715910|564243205|FG004|Booster and ESFU Phase|Other|1|||
156312371|NCT00715910|564243206|FG005|Booster and ESFU Phase|Other|0|||
156751964|NCT02688764|565844089|FG001|Overall Study|AE/Withd. parent|0|||
156312372|NCT01185353|564243207|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
156751965|NCT02688764|565844088|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
156312373|NCT01185353|564243208|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
156312374|NCT01185353|564243209|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
156414107|NCT00962585|564608812|FG001|Overall Study|Withdrew Consent|0|||
156649748|NCT02711956|565465244|FG000|Overall Study|Clinical progression|1|||
156414108|NCT00962585|564608813|FG002|Overall Study|Withdrew Consent|0|||
156414109|NCT00962585|564608814|FG003|Overall Study|Withdrew Consent|0|||
156414110|NCT00262743|564608815|FG000|Overall Study|Adverse Event|0|||
156414111|NCT00262743|564608816|FG001|Overall Study|Adverse Event|9|||
156414112|NCT00262743|564608815|FG000|Overall Study|Disease progression|0|||
156414113|NCT00262743|564608816|FG001|Overall Study|Disease progression|3|||
156414114|NCT00867490|564608823|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
156414115|NCT00867490|564608823|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
156414116|NCT00867490|564608823|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
156414117|NCT00867490|564608823|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
156414118|NCT00867490|564608823|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
156414119|NCT04430335|564608826|FG000|Overall Study|Withdrawal by Subject|1|||
156414120|NCT00179010|564608829|FG000|Overall Study|Muscle probe defective|1|||
156414121|NCT00179010|564608830|FG001|Overall Study|Muscle probe defective|1|||
156414122|NCT00179010|564608829|FG000|Overall Study|Failure to place arterial line|0|||
156414123|NCT00179010|564608830|FG001|Overall Study|Failure to place arterial line|1|||
156414124|NCT03249376|564608845|FG000|Overall Study|Adverse Event|11|||
156414125|NCT03249376|564608846|FG001|Overall Study|Adverse Event|5|||
156414126|NCT03249376|564608845|FG000|Overall Study|Lack of Efficacy|2|||
156414127|NCT03249376|564608846|FG001|Overall Study|Lack of Efficacy|4|||
156414128|NCT03249376|564608845|FG000|Overall Study|Protocol Violation|3|||
156414129|NCT03249376|564608846|FG001|Overall Study|Protocol Violation|2|||
156414130|NCT03249376|564608845|FG000|Overall Study|Physician Decision|0|||
156414131|NCT03249376|564608846|FG001|Overall Study|Physician Decision|2|||
156414132|NCT03249376|564608845|FG000|Overall Study|Withdrawal by Subject|3|||
156414133|NCT03249376|564608846|FG001|Overall Study|Withdrawal by Subject|9|||
156414134|NCT03249376|564608845|FG000|Overall Study|LTFU|2|||
156414135|NCT03249376|564608846|FG001|Overall Study|LTFU|1|||
156414136|NCT00627042|564608850|FG000|Overall Study|Withdrawal by Subject|2|||
156649749|NCT02711956|565465245|FG001|Overall Study|Clinical progression|0|||
156649750|NCT02711956|565465246|FG002|Overall Study|Clinical progression|0|||
156649751|NCT02711956|565465247|FG003|Overall Study|Clinical progression|0|||
156649752|NCT02711956|565465248|FG004|Overall Study|Clinical progression|0|||
156649753|NCT02711956|565465249|FG005|Overall Study|Clinical progression|0|||
156649754|NCT02711956|565465250|FG006|Overall Study|Clinical progression|1|||
156649755|NCT02711956|565465251|FG007|Overall Study|Clinical progression|0|||
156649756|NCT02711956|565465252|FG008|Overall Study|Clinical progression|1|||
156649757|NCT02711956|565465253|FG009|Overall Study|Clinical progression|0|||
156649758|NCT02711956|565465254|FG010|Overall Study|Clinical progression|0|||
156649759|NCT02711956|565465255|FG011|Overall Study|Clinical progression|2|||
156649760|NCT02711956|565465256|FG012|Overall Study|Clinical progression|4|||
156649761|NCT02711956|565465257|FG013|Overall Study|Clinical progression|1|||
156649762|NCT02711956|565465258|FG014|Overall Study|Clinical progression|1|||
156649763|NCT02711956|565465244|FG000|Overall Study|Radiographic progression|1|||
156649764|NCT02711956|565465245|FG001|Overall Study|Radiographic progression|1|||
156649765|NCT02711956|565465246|FG002|Overall Study|Radiographic progression|2|||
156649766|NCT02711956|565465247|FG003|Overall Study|Radiographic progression|0|||
156649767|NCT02711956|565465248|FG004|Overall Study|Radiographic progression|1|||
156649768|NCT02711956|565465249|FG005|Overall Study|Radiographic progression|0|||
156649769|NCT02711956|565465250|FG006|Overall Study|Radiographic progression|0|||
156649770|NCT02711956|565465251|FG007|Overall Study|Radiographic progression|0|||
156649771|NCT02711956|565465252|FG008|Overall Study|Radiographic progression|2|||
156649772|NCT02711956|565465253|FG009|Overall Study|Radiographic progression|1|||
156649773|NCT02711956|565465254|FG010|Overall Study|Radiographic progression|0|||
156649774|NCT02711956|565465255|FG011|Overall Study|Radiographic progression|5|||
156649775|NCT02711956|565465256|FG012|Overall Study|Radiographic progression|3|||
156649776|NCT02711956|565465257|FG013|Overall Study|Radiographic progression|0|||
156649777|NCT02711956|565465258|FG014|Overall Study|Radiographic progression|1|||
156649778|NCT02711956|565465244|FG000|Overall Study|PSA progression with clinical progression|0|||
156649779|NCT02711956|565465245|FG001|Overall Study|PSA progression with clinical progression|0|||
156649780|NCT02711956|565465246|FG002|Overall Study|PSA progression with clinical progression|0|||
156649781|NCT02711956|565465247|FG003|Overall Study|PSA progression with clinical progression|0|||
156649782|NCT02711956|565465248|FG004|Overall Study|PSA progression with clinical progression|1|||
156649783|NCT02711956|565465249|FG005|Overall Study|PSA progression with clinical progression|0|||
156414137|NCT04747275|564608851|FG000|Overall Study|Study terminated|0|||
156414138|NCT04747275|564608852|FG001|Overall Study|Study terminated|1|||
156414139|NCT03268590|564608855|FG000|Overall Study|Previously unknown exclusion criteria|1|||
156414140|NCT00531011|564608856|FG000|Overall Study|Withdrawal by Subject|2|||
156414141|NCT00531011|564608857|FG001|Overall Study|Withdrawal by Subject|4|||
156414142|NCT00531011|564608856|FG000|Overall Study|Death|1|||
156414143|NCT00531011|564608857|FG001|Overall Study|Death|0|||
156414144|NCT00531011|564608856|FG000|Overall Study|Lost to Follow-up|1|||
156414145|NCT00531011|564608857|FG001|Overall Study|Lost to Follow-up|0|||
156414146|NCT00531011|564608856|FG000|Overall Study|Physician Decision|0|||
156312375|NCT01185353|564243210|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
156312376|NCT01185353|564243211|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
156312377|NCT01185353|564243212|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156312378|NCT01185353|564243213|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156312379|NCT01185353|564243214|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156312380|NCT01185353|564243215|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156312381|NCT01185353|564243216|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156312382|NCT01185353|564243207|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312383|NCT01185353|564243208|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312384|NCT01185353|564243209|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312385|NCT01185353|564243210|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312386|NCT01185353|564243211|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
156312387|NCT01185353|564243212|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312388|NCT01185353|564243213|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312389|NCT01185353|564243214|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312390|NCT01185353|564243215|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312391|NCT01185353|564243216|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156312392|NCT01185353|564243207|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
156312393|NCT01185353|564243208|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156312394|NCT01185353|564243209|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156312395|NCT01185353|564243210|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156312396|NCT01185353|564243211|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
156312397|NCT01185353|564243212|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156414147|NCT00531011|564608857|FG001|Overall Study|Physician Decision|3|||
156649784|NCT02711956|565465250|FG006|Overall Study|PSA progression with clinical progression|0|||
156649785|NCT02711956|565465251|FG007|Overall Study|PSA progression with clinical progression|0|||
156312398|NCT01185353|564243213|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156312399|NCT01185353|564243214|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156312400|NCT01185353|564243215|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156312401|NCT01185353|564243216|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156312402|NCT01185353|564243207|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156312403|NCT01185353|564243208|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156312404|NCT01185353|564243209|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
156312405|NCT01185353|564243210|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156649786|NCT02711956|565465252|FG008|Overall Study|PSA progression with clinical progression|0|||
156649787|NCT02711956|565465253|FG009|Overall Study|PSA progression with clinical progression|0|||
156649788|NCT02711956|565465254|FG010|Overall Study|PSA progression with clinical progression|0|||
156649789|NCT02711956|565465255|FG011|Overall Study|PSA progression with clinical progression|0|||
156649790|NCT02711956|565465256|FG012|Overall Study|PSA progression with clinical progression|1|||
156649791|NCT02711956|565465257|FG013|Overall Study|PSA progression with clinical progression|1|||
156649792|NCT02711956|565465258|FG014|Overall Study|PSA progression with clinical progression|0|||
156649793|NCT02711956|565465244|FG000|Overall Study|PSA progression with radiographic progression|0|||
156649794|NCT02711956|565465245|FG001|Overall Study|PSA progression with radiographic progression|1|||
156649795|NCT02711956|565465246|FG002|Overall Study|PSA progression with radiographic progression|0|||
156649796|NCT02711956|565465247|FG003|Overall Study|PSA progression with radiographic progression|0|||
156649797|NCT02711956|565465248|FG004|Overall Study|PSA progression with radiographic progression|0|||
156649798|NCT02711956|565465249|FG005|Overall Study|PSA progression with radiographic progression|2|||
156649799|NCT02711956|565465250|FG006|Overall Study|PSA progression with radiographic progression|2|||
156649800|NCT02711956|565465251|FG007|Overall Study|PSA progression with radiographic progression|1|||
156649801|NCT02711956|565465252|FG008|Overall Study|PSA progression with radiographic progression|0|||
156649802|NCT02711956|565465253|FG009|Overall Study|PSA progression with radiographic progression|1|||
156649803|NCT02711956|565465254|FG010|Overall Study|PSA progression with radiographic progression|0|||
156649804|NCT02711956|565465255|FG011|Overall Study|PSA progression with radiographic progression|1|||
156649805|NCT02711956|565465256|FG012|Overall Study|PSA progression with radiographic progression|2|||
156649806|NCT02711956|565465257|FG013|Overall Study|PSA progression with radiographic progression|3|||
156649807|NCT02711956|565465258|FG014|Overall Study|PSA progression with radiographic progression|3|||
156649808|NCT02043366|565465261|FG000|Overall Study|Lost to Follow-up|2|||
156649809|NCT02043366|565465262|FG001|Overall Study|Lost to Follow-up|2|||
156649810|NCT02043366|565465263|FG002|Overall Study|Lost to Follow-up|2|||
156649811|NCT02043366|565465264|FG003|Overall Study|Lost to Follow-up|2|||
156649812|NCT02043366|565465265|FG004|Overall Study|Lost to Follow-up|2|||
156649813|NCT02043366|565465266|FG005|Overall Study|Lost to Follow-up|2|||
156649814|NCT03294538|565465269|FG000|Overall Study|Adverse Event|0|||
156649815|NCT03294538|565465270|FG001|Overall Study|Adverse Event|1|||
156649816|NCT03294538|565465271|FG002|Overall Study|Adverse Event|1|||
156649817|NCT03294538|565465269|FG000|Overall Study|Lost to Follow-up|1|||
156649818|NCT03294538|565465270|FG001|Overall Study|Lost to Follow-up|0|||
156312406|NCT01185353|564243211|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
156312407|NCT01185353|564243212|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156312408|NCT01185353|564243213|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156312409|NCT01185353|564243214|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156312410|NCT01185353|564243215|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156312411|NCT01185353|564243216|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156312412|NCT01185353|564243207|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312413|NCT01185353|564243208|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312414|NCT01185353|564243209|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312415|NCT01185353|564243210|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312416|NCT01185353|564243211|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
156312417|NCT01185353|564243212|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312418|NCT01185353|564243213|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312419|NCT01185353|564243214|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312420|NCT01185353|564243215|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312421|NCT01185353|564243216|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156312422|NCT01185353|564243207|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
156312423|NCT01185353|564243208|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156312424|NCT01185353|564243209|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156312425|NCT01185353|564243210|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156312426|NCT01185353|564243211|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
156312427|NCT01185353|564243212|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156312428|NCT01185353|564243213|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156312429|NCT01185353|564243214|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156312430|NCT01185353|564243215|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156312431|NCT01185353|564243216|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156312432|NCT01185353|564243207|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156312433|NCT01185353|564243208|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156312434|NCT01185353|564243209|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
156312435|NCT01185353|564243210|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156312436|NCT01185353|564243211|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156312437|NCT01185353|564243212|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
156312438|NCT01185353|564243213|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156312439|NCT01185353|564243214|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156312440|NCT01185353|564243215|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156312441|NCT01185353|564243216|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156312442|NCT01185353|564243207|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156312443|NCT01185353|564243208|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
156312444|NCT01185353|564243209|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156312445|NCT01185353|564243210|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
156649819|NCT03294538|565465271|FG002|Overall Study|Lost to Follow-up|0|||
156649820|NCT03294538|565465269|FG000|Overall Study|Outside of Visit Window|4|||
156649821|NCT03294538|565465270|FG001|Overall Study|Outside of Visit Window|4|||
156649822|NCT03294538|565465271|FG002|Overall Study|Outside of Visit Window|1|||
156649823|NCT01489956|565465273|FG000|Overall Study|Lost to Follow-up|1|||
156649824|NCT01489956|565465274|FG001|Overall Study|Lost to Follow-up|0|||
156649825|NCT01489956|565465275|FG002|Overall Study|Lost to Follow-up|0|||
156649826|NCT01489956|565465273|FG000|Overall Study|Withdrawal by Subject|0|||
156649827|NCT01489956|565465274|FG001|Overall Study|Withdrawal by Subject|0|||
156649828|NCT01489956|565465275|FG002|Overall Study|Withdrawal by Subject|1|||
156649829|NCT01090765|565465277|FG000|Overall Study|Patient withdrew consent|0|||
156649830|NCT01090765|565465278|FG001|Overall Study|Patient withdrew consent|0|||
156649831|NCT01090765|565465279|FG002|Overall Study|Patient withdrew consent|0|||
156649832|NCT01090765|565465280|FG003|Overall Study|Patient withdrew consent|0|||
156649833|NCT01090765|565465281|FG004|Overall Study|Patient withdrew consent|1|||
156649834|NCT01090765|565465282|FG005|Overall Study|Patient withdrew consent|1|||
156649835|NCT01090765|565465277|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
156649836|NCT01090765|565465278|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
156649837|NCT01090765|565465279|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
156649838|NCT01090765|565465280|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
156649839|NCT01090765|565465281|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
156649840|NCT01090765|565465282|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
156649841|NCT01090765|565465277|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
156649842|NCT01090765|565465278|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
156649843|NCT01090765|565465279|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
156649844|NCT01090765|565465280|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
156649845|NCT01090765|565465281|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
156312446|NCT01185353|564243211|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156312447|NCT01185353|564243212|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156312448|NCT01185353|564243213|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156414148|NCT04254679|564608858|FG000|Overall Study|Protocol Violation|1|||
156414149|NCT04254679|564608859|FG001|Overall Study|Protocol Violation|1|||
156414150|NCT04254679|564608858|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
156414151|NCT04254679|564608859|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
156414152|NCT04011384|564608866|FG000|Overall Study|Withdrawal by Subject|2|||
156414153|NCT04011384|564608867|FG001|Overall Study|Withdrawal by Subject|0|||
156414154|NCT00924469|564608868|FG000|Overall Study|Adverse Event|2|||
156414155|NCT00924469|564608869|FG001|Overall Study|Adverse Event|0|||
156414156|NCT00924469|564608868|FG000|Overall Study|Withdrawal by Subject|0|||
156414157|NCT00924469|564608869|FG001|Overall Study|Withdrawal by Subject|1|||
156414158|NCT00924469|564608868|FG000|Overall Study|Lost to Follow-up|0|||
156414159|NCT00924469|564608869|FG001|Overall Study|Lost to Follow-up|1|||
156414160|NCT04147260|564608870|FG000|Overall Study|Adverse Event|1|||
156414161|NCT04147260|564608871|FG001|Overall Study|Adverse Event|0|||
156414162|NCT04147260|564608872|FG002|Overall Study|Adverse Event|1|||
156414163|NCT04147260|564608873|FG003|Overall Study|Adverse Event|2|||
156414164|NCT04147260|564608874|FG004|Overall Study|Adverse Event|0|||
156414165|NCT04147260|564608870|FG000|Overall Study|Withdrawal by Subject|0|||
156414166|NCT04147260|564608871|FG001|Overall Study|Withdrawal by Subject|0|||
156414167|NCT04147260|564608872|FG002|Overall Study|Withdrawal by Subject|1|||
156414168|NCT04147260|564608873|FG003|Overall Study|Withdrawal by Subject|1|||
156414169|NCT04147260|564608874|FG004|Overall Study|Withdrawal by Subject|0|||
156649846|NCT01090765|565465282|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
156649847|NCT00678392|565465283|FG000|Overall Study|Adverse Event|0|||
156649848|NCT00678392|565465284|FG001|Overall Study|Adverse Event|6|||
156649849|NCT00678392|565465283|FG000|Overall Study|Death|280|||
156649850|NCT00678392|565465284|FG001|Overall Study|Death|269|||
156649851|NCT00678392|565465283|FG000|Overall Study|Lost to Follow-up|15|||
156414170|NCT01651936|564608875|FG000|Base Study|Adverse Event|3|||
156414171|NCT01651936|564608876|FG001|Base Study|Adverse Event|0|||
156414172|NCT01651936|564608877|FG002|Base Study|Adverse Event|0|||
156414173|NCT01651936|564608875|FG000|Base Study|Withdrawal by Subject|1|||
156414174|NCT01651936|564608876|FG001|Base Study|Withdrawal by Subject|1|||
156414175|NCT01651936|564608877|FG002|Base Study|Withdrawal by Subject|0|||
156414176|NCT01651936|564608875|FG000|Base Study|Early Escape|2|||
156414177|NCT01651936|564608876|FG001|Base Study|Early Escape|8|||
156414178|NCT01651936|564608877|FG002|Base Study|Early Escape|0|||
156414179|NCT01651936|564608875|FG000|Base Study|Study terminated by sponsor|21|||
156414180|NCT01651936|564608876|FG001|Base Study|Study terminated by sponsor|16|||
156414181|NCT01651936|564608877|FG002|Base Study|Study terminated by sponsor|0|||
156414182|NCT01651936|564608875|FG000|Extension Study|Lack of Efficacy|0|||
156414183|NCT01651936|564608876|FG001|Extension Study|Lack of Efficacy|0|||
156414184|NCT01651936|564608877|FG002|Extension Study|Lack of Efficacy|1|||
156414185|NCT01651936|564608875|FG000|Extension Study|Study terminated by sponsor|0|||
156414186|NCT01651936|564608876|FG001|Extension Study|Study terminated by sponsor|0|||
156414187|NCT01651936|564608877|FG002|Extension Study|Study terminated by sponsor|13|||
156414188|NCT03044353|564608878|FG000|Overall Study|Adverse Event|0|||
156414189|NCT03044353|564608879|FG001|Overall Study|Adverse Event|1|||
156414190|NCT03044353|564608880|FG002|Overall Study|Adverse Event|0|||
156414191|NCT01555021|564608885|FG000|Overall Study|Lost to Follow-up|1|||
156414192|NCT01555021|564608886|FG001|Overall Study|Lost to Follow-up|2|||
156414193|NCT01388530|564608890|FG000|Overall Study|Lost to Follow-up|5|||
156414194|NCT05284019|564608891|FG000|Overall Study|Study terminated|2|||
156414195|NCT05284019|564608892|FG001|Overall Study|Study terminated|2|||
156414196|NCT05284019|564608893|FG002|Overall Study|Study terminated|2|||
156414197|NCT05284019|564608894|FG003|Overall Study|Study terminated|5|||
156414198|NCT05284019|564608895|FG004|Overall Study|Study terminated|15|||
156414199|NCT05284019|564608891|FG000|Overall Study|Withdrawal by Subject|0|||
156414200|NCT05284019|564608892|FG001|Overall Study|Withdrawal by Subject|0|||
156414201|NCT05284019|564608893|FG002|Overall Study|Withdrawal by Subject|0|||
156414202|NCT05284019|564608894|FG003|Overall Study|Withdrawal by Subject|1|||
156414203|NCT05284019|564608895|FG004|Overall Study|Withdrawal by Subject|1|||
156414204|NCT05284019|564608891|FG000|Overall Study|Lost to Follow-up|1|||
156414205|NCT05284019|564608892|FG001|Overall Study|Lost to Follow-up|0|||
156414206|NCT05284019|564608893|FG002|Overall Study|Lost to Follow-up|0|||
156414207|NCT05284019|564608894|FG003|Overall Study|Lost to Follow-up|2|||
156414208|NCT05284019|564608895|FG004|Overall Study|Lost to Follow-up|1|||
156414209|NCT02204293|564608896|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
156414210|NCT02204293|564608897|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
156414211|NCT02204293|564608898|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
156414212|NCT02204293|564608899|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
156414213|NCT02204293|564608900|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
156414214|NCT02204293|564608901|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
156414215|NCT02204293|564608896|FG000|Core Study Part I|Adverse Event|1|||
156649852|NCT00678392|565465284|FG001|Overall Study|Lost to Follow-up|13|||
156649853|NCT00678392|565465283|FG000|Overall Study|Objective Progression or Relapse|3|||
156649854|NCT00678392|565465284|FG001|Overall Study|Objective Progression or Relapse|8|||
156414216|NCT02204293|564608897|FG001|Core Study Part I|Adverse Event|0|||
156414217|NCT02204293|564608898|FG002|Core Study Part I|Adverse Event|0|||
156414218|NCT02204293|564608899|FG003|Core Study Part I|Adverse Event|0|||
156414219|NCT02204293|564608900|FG004|Core Study Part I|Adverse Event|0|||
156751966|NCT02688764|565844089|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
156751967|NCT02688764|565844088|FG000|Overall Study|AE/Withd. subject|1|||
156414220|NCT02204293|564608901|FG005|Core Study Part I|Adverse Event|0|||
156414221|NCT02204293|564608896|FG000|Core Study Part I|Physician Decision|0|||
156414222|NCT02204293|564608897|FG001|Core Study Part I|Physician Decision|3|||
156414223|NCT02204293|564608898|FG002|Core Study Part I|Physician Decision|0|||
156414224|NCT02204293|564608899|FG003|Core Study Part I|Physician Decision|0|||
156414225|NCT02204293|564608900|FG004|Core Study Part I|Physician Decision|0|||
156649855|NCT00678392|565465283|FG000|Overall Study|Sponsor's Decision|1|||
156649856|NCT00678392|565465284|FG001|Overall Study|Sponsor's Decision|2|||
156649857|NCT00678392|565465283|FG000|Overall Study|Withdrawal by Subject|4|||
156649858|NCT00678392|565465284|FG001|Overall Study|Withdrawal by Subject|4|||
156649859|NCT00678392|565465283|FG000|Overall Study|Randomized But Not Treated|2|||
156649860|NCT00678392|565465284|FG001|Overall Study|Randomized But Not Treated|7|||
156649861|NCT00678392|565465283|FG000|Overall Study|Other|56|||
156649862|NCT00678392|565465284|FG001|Overall Study|Other|53|||
156649863|NCT03341507|565465285|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
156649864|NCT00718159|565465290|FG000|Overall Study|Progressive Disease|3|||
156649865|NCT00718159|565465291|FG001|Overall Study|Progressive Disease|3|||
156649866|NCT00718159|565465292|FG002|Overall Study|Progressive Disease|2|||
156649867|NCT00718159|565465293|FG003|Overall Study|Progressive Disease|0|||
156649868|NCT00718159|565465294|FG004|Overall Study|Progressive Disease|6|||
156649869|NCT00718159|565465295|FG005|Overall Study|Progressive Disease|0|||
156649870|NCT00718159|565465296|FG006|Overall Study|Progressive Disease|0|||
156649871|NCT00718159|565465290|FG000|Overall Study|Death due to Adverse Event|0|||
156649872|NCT00718159|565465291|FG001|Overall Study|Death due to Adverse Event|0|||
156649873|NCT00718159|565465292|FG002|Overall Study|Death due to Adverse Event|0|||
156649874|NCT00718159|565465293|FG003|Overall Study|Death due to Adverse Event|2|||
156649875|NCT00718159|565465294|FG004|Overall Study|Death due to Adverse Event|2|||
156649876|NCT00718159|565465295|FG005|Overall Study|Death due to Adverse Event|0|||
156649877|NCT00718159|565465296|FG006|Overall Study|Death due to Adverse Event|0|||
156649878|NCT00718159|565465290|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
156649879|NCT00718159|565465291|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
156649880|NCT00718159|565465292|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
156649881|NCT00718159|565465293|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
156649882|NCT00718159|565465294|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
156649883|NCT00718159|565465295|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
156649884|NCT00718159|565465296|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
156649885|NCT00718159|565465290|FG000|Overall Study|Investigator Decision|0|||
156649886|NCT00718159|565465291|FG001|Overall Study|Investigator Decision|0|||
156649887|NCT00718159|565465292|FG002|Overall Study|Investigator Decision|0|||
156649888|NCT00718159|565465293|FG003|Overall Study|Investigator Decision|0|||
156649889|NCT00718159|565465294|FG004|Overall Study|Investigator Decision|0|||
156649890|NCT00718159|565465295|FG005|Overall Study|Investigator Decision|1|||
156649891|NCT00718159|565465296|FG006|Overall Study|Investigator Decision|1|||
156649892|NCT01401478|565465308|FG000|Overall Study|Study drug not available|6|||
156649893|NCT01401478|565465308|FG000|Overall Study|Adverse Event|5|||
156649894|NCT01401478|565465308|FG000|Overall Study|Hyperphosphatemia|5|||
156649895|NCT01401478|565465308|FG000|Overall Study|Lost to Follow-up|5|||
156649896|NCT01401478|565465308|FG000|Overall Study|Kidney transplantation|3|||
156649897|NCT01401478|565465308|FG000|Overall Study|Withdrawal by Subject|3|||
156649898|NCT01401478|565465308|FG000|Overall Study|Blood samples not available|1|||
156649899|NCT01401478|565465308|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
156649900|NCT01401478|565465308|FG000|Overall Study|Low intact parathyroid hormone|1|||
156649901|NCT01401478|565465308|FG000|Overall Study|Serious adverse event|1|||
156649902|NCT01001169|565465309|FG000|Overall Study|Withdrawal by Subject|2|||
156649903|NCT01001169|565465310|FG001|Overall Study|Withdrawal by Subject|1|||
156649904|NCT02168270|565465311|FG000|Overall Study|Lack of Efficacy|4|||
156649905|NCT00706706|565465312|FG000|Overall Study|Death|53|||
156649906|NCT00706706|565465312|FG000|Overall Study|Lost to Follow-up|7|||
156649907|NCT00706706|565465312|FG000|Overall Study|Study endpoint had reached|45|||
156649908|NCT01752920|565465313|FG000|Overall Study|Adverse Event|1|||
156649909|NCT01752920|565465314|FG001|Overall Study|Adverse Event|0|||
156649910|NCT01752920|565465315|FG002|Overall Study|Adverse Event|5|||
156414226|NCT02204293|564608901|FG005|Core Study Part I|Physician Decision|0|||
156414227|NCT02204293|564608896|FG000|LTE Phase|Study Suspended|0|||
156649911|NCT01752920|565465316|FG003|Overall Study|Adverse Event|10|||
156649912|NCT01752920|565465313|FG000|Overall Study|Clinical Disease Progression|6|||
156649913|NCT01752920|565465314|FG001|Overall Study|Clinical Disease Progression|4|||
156649914|NCT01752920|565465315|FG002|Overall Study|Clinical Disease Progression|1|||
156649915|NCT01752920|565465316|FG003|Overall Study|Clinical Disease Progression|13|||
156649916|NCT01752920|565465313|FG000|Overall Study|Physician Decision|1|||
156414228|NCT02204293|564608897|FG001|LTE Phase|Study Suspended|0|||
156414229|NCT02204293|564608898|FG002|LTE Phase|Study Suspended|0|||
156312449|NCT01185353|564243214|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156312450|NCT01185353|564243215|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156312451|NCT01185353|564243216|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156312452|NCT01185353|564243207|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156312453|NCT01185353|564243208|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156312454|NCT01185353|564243209|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156312455|NCT01185353|564243210|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
156312456|NCT01185353|564243211|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156312457|NCT01185353|564243212|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156312458|NCT01185353|564243213|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
156312459|NCT01185353|564243214|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156312460|NCT01185353|564243215|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156312461|NCT01185353|564243216|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156312462|NCT01185353|564243207|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156312463|NCT01185353|564243208|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156312464|NCT01185353|564243209|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
156312465|NCT01185353|564243210|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
156312466|NCT01185353|564243211|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156312467|NCT01185353|564243212|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
156312468|NCT01185353|564243213|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
156312469|NCT01185353|564243214|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156312470|NCT01185353|564243215|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156312471|NCT01185353|564243216|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156312472|NCT01185353|564243207|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312473|NCT01185353|564243208|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312474|NCT01185353|564243209|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312475|NCT01185353|564243210|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312476|NCT01185353|564243211|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312477|NCT01185353|564243212|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312478|NCT01185353|564243213|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
156312479|NCT01185353|564243214|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312480|NCT01185353|564243215|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312481|NCT01185353|564243216|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156312482|NCT01185353|564243207|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156312483|NCT01185353|564243208|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156312484|NCT01185353|564243209|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156312485|NCT01185353|564243210|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156312486|NCT01185353|564243211|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156312487|NCT01185353|564243212|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156312488|NCT01185353|564243213|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156414230|NCT02204293|564608899|FG003|LTE Phase|Study Suspended|0|||
156414231|NCT02204293|564608900|FG004|LTE Phase|Study Suspended|0|||
156649917|NCT01752920|565465314|FG001|Overall Study|Physician Decision|0|||
156649918|NCT01752920|565465315|FG002|Overall Study|Physician Decision|0|||
156649919|NCT01752920|565465316|FG003|Overall Study|Physician Decision|3|||
156649920|NCT01752920|565465313|FG000|Overall Study|Radiographic Disease Progression|20|||
156649921|NCT01752920|565465314|FG001|Overall Study|Radiographic Disease Progression|7|||
156649922|NCT01752920|565465315|FG002|Overall Study|Radiographic Disease Progression|12|||
156649923|NCT01752920|565465316|FG003|Overall Study|Radiographic Disease Progression|29|||
156649924|NCT01752920|565465313|FG000|Overall Study|Study Terminated by Sponsor|0|||
156649925|NCT01752920|565465314|FG001|Overall Study|Study Terminated by Sponsor|0|||
156649926|NCT01752920|565465315|FG002|Overall Study|Study Terminated by Sponsor|0|||
156649927|NCT01752920|565465316|FG003|Overall Study|Study Terminated by Sponsor|1|||
156649928|NCT01752920|565465313|FG000|Overall Study|Withdrawal by Subject|0|||
156649929|NCT01752920|565465314|FG001|Overall Study|Withdrawal by Subject|1|||
156649930|NCT01752920|565465315|FG002|Overall Study|Withdrawal by Subject|0|||
156649931|NCT01752920|565465316|FG003|Overall Study|Withdrawal by Subject|1|||
156649932|NCT01752920|565465313|FG000|Overall Study|Lack of clinical benefit|1|||
156649933|NCT01752920|565465314|FG001|Overall Study|Lack of clinical benefit|1|||
156649934|NCT01752920|565465315|FG002|Overall Study|Lack of clinical benefit|1|||
156649935|NCT01752920|565465316|FG003|Overall Study|Lack of clinical benefit|1|||
156649936|NCT00947856|565465323|FG000|Treatment Period|Progressive Disease|33|||
156649937|NCT00947856|565465324|FG001|Treatment Period|Progressive Disease|12|||
156414232|NCT02204293|564608901|FG005|LTE Phase|Study Suspended|7|||
156414233|NCT01990300|564608902|FG000|Overall Study|Case Report Forms Uncollected|89|||
156649938|NCT00947856|565465323|FG000|Treatment Period|Adverse Event|15|||
156649939|NCT00947856|565465324|FG001|Treatment Period|Adverse Event|9|||
156649940|NCT00947856|565465323|FG000|Treatment Period|Physician Decision|14|||
156751968|NCT02688764|565844089|FG001|Overall Study|AE/Withd. subject|0|||
156751969|NCT02688764|565844088|FG000|Overall Study|Kidney transplant|10|||
156751970|NCT02688764|565844089|FG001|Overall Study|Kidney transplant|4|||
156751971|NCT02688764|565844088|FG000|Overall Study|Lack of Efficacy|3|||
156751972|NCT02688764|565844089|FG001|Overall Study|Lack of Efficacy|2|||
156751973|NCT02688764|565844088|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
156751974|NCT02688764|565844089|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
156751975|NCT02688764|565844088|FG000|Overall Study|Non-compliance with study drug|4|||
156751976|NCT02688764|565844089|FG001|Overall Study|Non-compliance with study drug|0|||
156751977|NCT02688764|565844088|FG000|Overall Study|Non-compl./Physician decision|2|||
156751978|NCT02688764|565844089|FG001|Overall Study|Non-compl./Physician decision|0|||
156312489|NCT01185353|564243214|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
156312490|NCT01185353|564243215|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
156312491|NCT01185353|564243216|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
156312492|NCT01185353|564243207|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156312493|NCT01185353|564243208|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156312494|NCT01185353|564243209|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156312495|NCT01185353|564243210|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156312496|NCT01185353|564243211|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156312497|NCT01185353|564243212|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156312498|NCT01185353|564243213|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156312499|NCT01185353|564243214|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
156312500|NCT01185353|564243215|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
156312501|NCT01185353|564243216|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
156312502|NCT01185353|564243207|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156312503|NCT01185353|564243208|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156312504|NCT01185353|564243209|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156312505|NCT01185353|564243210|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156312506|NCT01185353|564243211|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156312507|NCT01185353|564243212|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156312508|NCT01185353|564243213|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156312509|NCT01185353|564243214|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
156312510|NCT01185353|564243215|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
156312511|NCT01185353|564243216|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
156312512|NCT01185353|564243207|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312513|NCT01185353|564243208|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312514|NCT01185353|564243209|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312515|NCT01185353|564243210|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312516|NCT01185353|564243211|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312517|NCT01185353|564243212|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312518|NCT01185353|564243213|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312519|NCT01185353|564243214|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312520|NCT01185353|564243215|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
156312521|NCT01185353|564243216|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156312522|NCT01185353|564243207|FG000|Part C (Weeks 24 Through 76)|Death|0|||
156312523|NCT01185353|564243208|FG001|Part C (Weeks 24 Through 76)|Death|0|||
156312524|NCT01185353|564243209|FG002|Part C (Weeks 24 Through 76)|Death|0|||
156312525|NCT01185353|564243210|FG003|Part C (Weeks 24 Through 76)|Death|0|||
156312526|NCT01185353|564243211|FG004|Part C (Weeks 24 Through 76)|Death|0|||
156312527|NCT01185353|564243212|FG005|Part C (Weeks 24 Through 76)|Death|0|||
156312528|NCT01185353|564243213|FG006|Part C (Weeks 24 Through 76)|Death|0|||
156312529|NCT01185353|564243214|FG007|Part C (Weeks 24 Through 76)|Death|0|||
156312530|NCT01185353|564243215|FG008|Part C (Weeks 24 Through 76)|Death|0|||
156312531|NCT01185353|564243216|FG009|Part C (Weeks 24 Through 76)|Death|1|||
156312532|NCT01185353|564243207|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312533|NCT01185353|564243208|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312534|NCT01185353|564243209|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312535|NCT01185353|564243210|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312536|NCT01185353|564243211|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312537|NCT01185353|564243212|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312538|NCT01185353|564243213|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312539|NCT01185353|564243214|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312540|NCT01185353|564243215|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156312541|NCT01185353|564243216|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
156312542|NCT01185353|564243207|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156312543|NCT01185353|564243208|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156312544|NCT01185353|564243209|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156312545|NCT01185353|564243210|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156312546|NCT01185353|564243211|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156751979|NCT02688764|565844088|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
156751980|NCT02688764|565844089|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
156751981|NCT02688764|565844088|FG000|Overall Study|Non-compl./Withd. subject|0|||
156414234|NCT01990300|564608902|FG000|Overall Study|Protocol Deviation|53|||
156414235|NCT02420327|564608903|FG000|Overall Study|Adverse Event|7|||
156414236|NCT02420327|564608903|FG000|Overall Study|Pregnancy|1|||
156414237|NCT02420327|564608903|FG000|Overall Study|Withdrawal by Subject|6|||
156414238|NCT02420327|564608903|FG000|Overall Study|Lost to Follow-up|1|||
156414239|NCT02420327|564608903|FG000|Overall Study|Protocol Violation|1|||
156414240|NCT01225835|564608906|FG000|Overall Study|Completed protocol|2|||
156414241|NCT01225835|564608907|FG001|Overall Study|Completed protocol|1|||
156414242|NCT01225835|564608906|FG000|Overall Study|Did not meet hCG criterion|2|||
156414243|NCT01225835|564608907|FG001|Overall Study|Did not meet hCG criterion|0|||
156414244|NCT01225835|564608906|FG000|Overall Study|Adverse Event|2|||
156414245|NCT01225835|564608907|FG001|Overall Study|Adverse Event|1|||
156414246|NCT01225835|564608906|FG000|Overall Study|Other|1|||
156414247|NCT01225835|564608907|FG001|Overall Study|Other|1|||
156414248|NCT01146574|564608908|FG000|Overall Study|Death|0|||
156414249|NCT01146574|564608909|FG001|Overall Study|Death|1|||
156414250|NCT01146574|564608910|FG002|Overall Study|Death|1|||
156414251|NCT01146574|564608911|FG003|Overall Study|Death|0|||
156414252|NCT01146574|564608912|FG004|Overall Study|Death|0|||
156414253|NCT01146574|564608913|FG005|Overall Study|Death|0|||
156414254|NCT01146574|564608914|FG006|Overall Study|Death|0|||
156414255|NCT01146574|564608908|FG000|Overall Study|Other reasons|0|||
156414256|NCT01146574|564608909|FG001|Overall Study|Other reasons|0|||
156414257|NCT01146574|564608910|FG002|Overall Study|Other reasons|3|||
156414258|NCT01146574|564608911|FG003|Overall Study|Other reasons|0|||
156414259|NCT01146574|564608912|FG004|Overall Study|Other reasons|0|||
156414260|NCT01146574|564608913|FG005|Overall Study|Other reasons|0|||
156414261|NCT01146574|564608914|FG006|Overall Study|Other reasons|0|||
156414262|NCT01146574|564608908|FG000|Overall Study|Kidney transplant|0|||
156649941|NCT00947856|565465324|FG001|Treatment Period|Physician Decision|6|||
156649942|NCT00947856|565465323|FG000|Treatment Period|Study Stopped by Sponsor|4|||
156649943|NCT00947856|565465324|FG001|Treatment Period|Study Stopped by Sponsor|4|||
156649944|NCT00947856|565465323|FG000|Treatment Period|Withdrawal by Subject|12|||
156649945|NCT00947856|565465324|FG001|Treatment Period|Withdrawal by Subject|1|||
156649946|NCT00947856|565465323|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
156649947|NCT00947856|565465324|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
156649948|NCT00947856|565465323|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
156649949|NCT00947856|565465324|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
156649950|NCT00947856|565465323|FG000|Follow-up Period|Lost to Follow-up|7|||
156649951|NCT00947856|565465324|FG001|Follow-up Period|Lost to Follow-up|0|||
156649952|NCT00947856|565465323|FG000|Follow-up Period|Patient unavailable for site visits|1|||
156649953|NCT00947856|565465324|FG001|Follow-up Period|Patient unavailable for site visits|0|||
156649954|NCT00947856|565465323|FG000|Follow-up Period|Withdrawal by Subject|1|||
156649955|NCT00947856|565465324|FG001|Follow-up Period|Withdrawal by Subject|0|||
156649956|NCT00771901|565465325|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
156649957|NCT00771901|565465326|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
156649958|NCT00771901|565465327|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
156649959|NCT02280356|565465328|FG000|Overall Study|Not Treated|2|||
156649960|NCT02280356|565465328|FG000|Overall Study|Withdrawal by Subject|1|||
156649961|NCT02280356|565465328|FG000|Overall Study|Not evaluable|2|||
156649962|NCT03493698|565465336|FG000|Treatment Period C|Adverse Event|1|||
156649963|NCT03493698|565465336|FG000|Treatment Period C|Withdrawal by Subject|1|||
156649964|NCT00291330|565465337|FG000|Overall Study|Adverse Event|47|||
156649965|NCT00291330|565465338|FG001|Overall Study|Adverse Event|40|||
156649966|NCT00291330|565465337|FG000|Overall Study|Protocol Violation|13|||
156649967|NCT00291330|565465338|FG001|Overall Study|Protocol Violation|20|||
156649968|NCT00291330|565465337|FG000|Overall Study|Lost to Follow-up|16|||
156649969|NCT00291330|565465338|FG001|Overall Study|Lost to Follow-up|11|||
156649970|NCT00291330|565465337|FG000|Overall Study|Withdrawal by Subject|22|||
156649971|NCT00291330|565465338|FG001|Overall Study|Withdrawal by Subject|25|||
156414263|NCT01146574|564608909|FG001|Overall Study|Kidney transplant|0|||
156414264|NCT01146574|564608910|FG002|Overall Study|Kidney transplant|1|||
156414265|NCT01146574|564608911|FG003|Overall Study|Kidney transplant|1|||
156414266|NCT01146574|564608912|FG004|Overall Study|Kidney transplant|0|||
156649972|NCT00291330|565465337|FG000|Overall Study|Other|3|||
156649973|NCT00291330|565465338|FG001|Overall Study|Other|1|||
156649974|NCT02629965|565465341|FG000|Period 1|Adverse Event|1|||
156414267|NCT01146574|564608913|FG005|Overall Study|Kidney transplant|0|||
156414268|NCT01146574|564608914|FG006|Overall Study|Kidney transplant|0|||
156414269|NCT01146574|564608908|FG000|Overall Study|Withdrew consent|0|||
156414270|NCT01146574|564608909|FG001|Overall Study|Withdrew consent|0|||
156414271|NCT01146574|564608910|FG002|Overall Study|Withdrew consent|1|||
156414272|NCT01146574|564608911|FG003|Overall Study|Withdrew consent|1|||
156414273|NCT01146574|564608912|FG004|Overall Study|Withdrew consent|2|||
156414274|NCT01146574|564608913|FG005|Overall Study|Withdrew consent|1|||
156414275|NCT01146574|564608914|FG006|Overall Study|Withdrew consent|1|||
156649975|NCT02629965|565465342|FG001|Period 1|Adverse Event|0|||
156649976|NCT02629965|565465341|FG000|Period 1|Unexpected worsening of disease|2|||
156649977|NCT02629965|565465342|FG001|Period 1|Unexpected worsening of disease|0|||
156751982|NCT02688764|565844089|FG001|Overall Study|Non-compl./Withd. subject|2|||
156751983|NCT02688764|565844088|FG000|Overall Study|Phosphorus level outside safe range|0|||
156751984|NCT02688764|565844089|FG001|Overall Study|Phosphorus level outside safe range|1|||
156751985|NCT02688764|565844088|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
156751986|NCT02688764|565844089|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
156751987|NCT02688764|565844088|FG000|Overall Study|Study drug taste/Withd. parent|1|||
156751988|NCT02688764|565844089|FG001|Overall Study|Study drug taste/Withd. parent|0|||
156751989|NCT02688764|565844088|FG000|Overall Study|Subject moving out|2|||
156751990|NCT02688764|565844089|FG001|Overall Study|Subject moving out|0|||
156751991|NCT02688764|565844088|FG000|Overall Study|Subject taken off dialysis|1|||
156751992|NCT02688764|565844089|FG001|Overall Study|Subject taken off dialysis|0|||
156751993|NCT02688764|565844088|FG000|Overall Study|Withdrawal by parent|3|||
156751994|NCT02688764|565844089|FG001|Overall Study|Withdrawal by parent|0|||
156751995|NCT02113007|565844090|FG000|Overall Study|Progressive disease|2|||
156751996|NCT00885378|565844091|FG000|Overall Study|Lack of Efficacy|2|||
156751997|NCT00885378|565844092|FG001|Overall Study|Lack of Efficacy|2|||
156751998|NCT00885378|565844091|FG000|Overall Study|Withdrawal by Subject|1|||
156751999|NCT00885378|565844092|FG001|Overall Study|Withdrawal by Subject|2|||
156752000|NCT00885378|565844091|FG000|Overall Study|Lost to Follow-up|1|||
156752001|NCT00885378|565844092|FG001|Overall Study|Lost to Follow-up|2|||
156752002|NCT00885378|565844091|FG000|Overall Study|Poor/Noncompliance|2|||
156752003|NCT00885378|565844092|FG001|Overall Study|Poor/Noncompliance|2|||
156752004|NCT00885378|565844091|FG000|Overall Study|Protocol Violation|2|||
156752005|NCT00885378|565844092|FG001|Overall Study|Protocol Violation|0|||
156752006|NCT02579382|565844093|FG000|Main Study Phase|Lost to Follow-up|0|||
156752007|NCT02579382|565844094|FG001|Main Study Phase|Lost to Follow-up|0|||
156752008|NCT02579382|565844095|FG002|Main Study Phase|Lost to Follow-up|2|||
156752009|NCT02579382|565844096|FG003|Main Study Phase|Lost to Follow-up|0|||
156752010|NCT02579382|565844093|FG000|Main Study Phase|Withdrew Consent|0|||
156752011|NCT02579382|565844094|FG001|Main Study Phase|Withdrew Consent|0|||
156414276|NCT01266993|564608915|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
156649978|NCT02629965|565465341|FG000|Period 1|Other than listed above|1|||
156649979|NCT02629965|565465342|FG001|Period 1|Other than listed above|2|||
156649980|NCT02629965|565465341|FG000|Period 2|Adverse Event|1|||
156649981|NCT02629965|565465342|FG001|Period 2|Adverse Event|0|||
156649982|NCT03443869|565465343|FG000|Overall Study|Death|3|||
156649983|NCT03443869|565465344|FG001|Overall Study|Death|3|||
156649984|NCT03443869|565465343|FG000|Overall Study|Withdrawal by Subject|34|||
156649985|NCT03443869|565465344|FG001|Overall Study|Withdrawal by Subject|22|||
156649986|NCT03443869|565465343|FG000|Overall Study|Lost to Follow-up|1|||
156649987|NCT03443869|565465344|FG001|Overall Study|Lost to Follow-up|2|||
156649988|NCT03443869|565465343|FG000|Overall Study|Physician Decision|3|||
156649989|NCT03443869|565465344|FG001|Overall Study|Physician Decision|3|||
156649990|NCT03443869|565465343|FG000|Overall Study|Other|4|||
156649991|NCT03443869|565465344|FG001|Overall Study|Other|4|||
156649992|NCT02390219|565465345|FG000|Overall Study|Death|1|||
156649993|NCT02390219|565465345|FG000|Overall Study|Physician Decision|1|||
156649994|NCT02390219|565465345|FG000|Overall Study|Adverse Event|6|||
156649995|NCT02390219|565465345|FG000|Overall Study|Withdrawal by Subject|1|||
156649996|NCT02390219|565465345|FG000|Overall Study|Lost to Follow-up|2|||
156649997|NCT02390219|565465345|FG000|Overall Study|Other|2|||
156649998|NCT00299728|565465346|FG000|Overall Study|Lost to Follow-up|0|||
156649999|NCT00299728|565465347|FG001|Overall Study|Lost to Follow-up|1|||
156650000|NCT00299728|565465346|FG000|Overall Study|Withdrawal by Subject|0|||
156650001|NCT00299728|565465347|FG001|Overall Study|Withdrawal by Subject|1|||
156650002|NCT00299728|565465346|FG000|Overall Study|Progressive disease|0|||
156650003|NCT00299728|565465347|FG001|Overall Study|Progressive disease|1|||
156650004|NCT01855126|565465350|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
156650005|NCT01855126|565465351|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
156650006|NCT01855126|565465350|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
156650007|NCT01855126|565465351|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
156650008|NCT02230085|565465354|FG000|Overall Study|Physician Decision|1|||
156650009|NCT02230085|565465354|FG000|Overall Study|Withdrawal by Subject|3|||
156650010|NCT00580983|565465355|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
156650011|NCT01360632|565465356|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
156650012|NCT01360632|565465357|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
156650013|NCT01360632|565465358|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
156650014|NCT01360632|565465359|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
156650015|NCT01360632|565465360|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
156650016|NCT01360632|565465356|FG000|Phase A (8 Weeks)|Adverse Event|60|||
156650017|NCT01360632|565465357|FG001|Phase A (8 Weeks)|Adverse Event|0|||
156650018|NCT01360632|565465358|FG002|Phase A (8 Weeks)|Adverse Event|0|||
156650019|NCT01360632|565465359|FG003|Phase A (8 Weeks)|Adverse Event|0|||
156650020|NCT01360632|565465360|FG004|Phase A (8 Weeks)|Adverse Event|0|||
156650021|NCT01360632|565465356|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
156650022|NCT01360632|565465357|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
156312547|NCT01185353|564243212|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156312548|NCT01185353|564243213|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156312549|NCT01185353|564243214|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156312550|NCT01185353|564243215|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156312551|NCT01185353|564243216|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
156312552|NCT01185353|564243207|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312553|NCT01185353|564243208|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312554|NCT01185353|564243209|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312555|NCT01185353|564243210|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312556|NCT01185353|564243211|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312557|NCT01185353|564243212|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312558|NCT01185353|564243213|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312559|NCT01185353|564243214|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312560|NCT01185353|564243215|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
156312561|NCT01185353|564243216|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
156312562|NCT01185353|564243207|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156312563|NCT01185353|564243208|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156312564|NCT01185353|564243209|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156312565|NCT01185353|564243210|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156312566|NCT01185353|564243211|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156312567|NCT01185353|564243212|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156312568|NCT01185353|564243213|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156312569|NCT01185353|564243214|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
156312570|NCT01185353|564243215|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
156312571|NCT01185353|564243216|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156312572|NCT01185353|564243207|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156312573|NCT01185353|564243208|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156312574|NCT01185353|564243209|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156312575|NCT01185353|564243210|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156312576|NCT01185353|564243211|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156312577|NCT01185353|564243212|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156312578|NCT01185353|564243213|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156312579|NCT01185353|564243214|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
156312580|NCT01185353|564243215|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
156312581|NCT01185353|564243216|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
156312582|NCT01185353|564243207|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156312583|NCT01185353|564243208|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156312584|NCT01185353|564243209|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156312585|NCT01185353|564243210|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156312586|NCT01185353|564243211|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156312587|NCT01185353|564243212|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156312588|NCT01185353|564243213|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156312589|NCT01185353|564243214|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
156312590|NCT01185353|564243215|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
156312591|NCT01185353|564243216|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156312592|NCT01030666|564243217|FG000|Overall Study|Lost to Follow-up|3|||
156312593|NCT01030666|564243218|FG001|Overall Study|Lost to Follow-up|2|||
156312594|NCT04002908|564243219|FG000|Overall Study|Death|41|||
156312595|NCT04002908|564243220|FG001|Overall Study|Death|0|||
156312596|NCT04002908|564243221|FG002|Overall Study|Death|0|||
156312597|NCT04002908|564243222|FG003|Overall Study|Death|0|||
156312598|NCT04002908|564243219|FG000|Overall Study|Withdrawal by Subject|112|||
156312599|NCT04002908|564243220|FG001|Overall Study|Withdrawal by Subject|0|||
156312600|NCT04002908|564243221|FG002|Overall Study|Withdrawal by Subject|0|||
156650023|NCT01360632|565465358|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
156650024|NCT01360632|565465359|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
156650025|NCT01360632|565465360|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
156650026|NCT01360632|565465356|FG000|Phase A (8 Weeks)|Physician Decision|10|||
156650027|NCT01360632|565465357|FG001|Phase A (8 Weeks)|Physician Decision|0|||
156650028|NCT01360632|565465358|FG002|Phase A (8 Weeks)|Physician Decision|0|||
156650029|NCT01360632|565465359|FG003|Phase A (8 Weeks)|Physician Decision|0|||
156650030|NCT01360632|565465360|FG004|Phase A (8 Weeks)|Physician Decision|0|||
156650031|NCT01360632|565465356|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
156312601|NCT04002908|564243222|FG003|Overall Study|Withdrawal by Subject|0|||
156312602|NCT04002908|564243219|FG000|Overall Study|Lost to Follow-up|72|||
156312603|NCT04002908|564243220|FG001|Overall Study|Lost to Follow-up|0|||
156312604|NCT04002908|564243221|FG002|Overall Study|Lost to Follow-up|0|||
156312605|NCT04002908|564243222|FG003|Overall Study|Lost to Follow-up|0|||
156312606|NCT04002908|564243219|FG000|Overall Study|Infant died, so mother withdrawn|34|||
156312607|NCT04002908|564243220|FG001|Overall Study|Infant died, so mother withdrawn|0|||
156650032|NCT01360632|565465357|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
156650033|NCT01360632|565465358|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
156414277|NCT01266993|564608916|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
156414278|NCT01266993|564608915|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
156752012|NCT02579382|565844095|FG002|Main Study Phase|Withdrew Consent|0|||
156752013|NCT02579382|565844096|FG003|Main Study Phase|Withdrew Consent|2|||
156752014|NCT02579382|565844093|FG000|Main Study Phase|Lack of Efficacy|0|||
156414279|NCT01266993|564608916|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
156414280|NCT02293837|564608917|FG000|Overall Study|Lost to Follow-up|0|||
156752015|NCT02579382|565844094|FG001|Main Study Phase|Lack of Efficacy|0|||
156752016|NCT02579382|565844095|FG002|Main Study Phase|Lack of Efficacy|0|||
156752017|NCT02579382|565844096|FG003|Main Study Phase|Lack of Efficacy|1|||
156752018|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
156752019|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
156752020|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
156752021|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
156752022|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
156752023|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
156752024|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
156752025|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
156752026|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
156752027|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
156752028|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
156752029|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
156752030|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
156752031|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
156752032|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
156752033|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
156752034|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
156752035|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
156752036|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
156752037|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
156752038|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
156752039|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
156752040|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
156752041|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
156752042|NCT01775787|565844097|FG000|First 7-10 Days|Adverse Event|0|||
156752043|NCT01775787|565844098|FG001|First 7-10 Days|Adverse Event|1|||
156752044|NCT01775787|565844097|FG000|First 7-10 Days|family emergency|0|||
156752045|NCT01775787|565844098|FG001|First 7-10 Days|family emergency|1|||
156752046|NCT01775787|565844097|FG000|First 7-10 Days|time commitment|0|||
156752047|NCT01775787|565844098|FG001|First 7-10 Days|time commitment|2|||
156752048|NCT01775787|565844097|FG000|First 7-10 Days|concerns with using IV|1|||
156752049|NCT01775787|565844098|FG001|First 7-10 Days|concerns with using IV|2|||
156752050|NCT01775787|565844097|FG000|Second 7-10 Days|time commitment|0|||
156752051|NCT01775787|565844098|FG001|Second 7-10 Days|time commitment|1|||
156752052|NCT01775787|565844097|FG000|Second 7-10 Days|concerns with using IV|0|||
156752053|NCT01775787|565844098|FG001|Second 7-10 Days|concerns with using IV|1|||
156752054|NCT03026283|565844099|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
156752055|NCT03026283|565844100|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
156752056|NCT03026283|565844101|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
156752057|NCT03026283|565844102|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
156752058|NCT03026283|565844103|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
156752059|NCT03026283|565844104|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
156752060|NCT03026283|565844105|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
156752061|NCT03026283|565844106|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
156752062|NCT03026283|565844099|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
156752063|NCT03026283|565844100|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
156752064|NCT03026283|565844101|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
156752065|NCT03026283|565844102|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
156752066|NCT03026283|565844103|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
156752067|NCT03026283|565844104|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
156752068|NCT03026283|565844105|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
156414281|NCT02293837|564608918|FG001|Overall Study|Lost to Follow-up|2|||
156752069|NCT03026283|565844106|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
156752070|NCT03026283|565844099|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156414282|NCT02293837|564608919|FG002|Overall Study|Lost to Follow-up|1|||
156414283|NCT02293837|564608920|FG003|Overall Study|Lost to Follow-up|0|||
156414284|NCT02293837|564608917|FG000|Overall Study|Withdrawal by Subject|2|||
156752071|NCT03026283|565844100|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
156752072|NCT03026283|565844101|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156414285|NCT02293837|564608918|FG001|Overall Study|Withdrawal by Subject|1|||
156752073|NCT03026283|565844102|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156414286|NCT02293837|564608919|FG002|Overall Study|Withdrawal by Subject|2|||
156414287|NCT02293837|564608920|FG003|Overall Study|Withdrawal by Subject|1|||
156414288|NCT02293837|564608917|FG000|Overall Study|COVID-19 Related|1|||
156414289|NCT02293837|564608918|FG001|Overall Study|COVID-19 Related|1|||
156414290|NCT02293837|564608919|FG002|Overall Study|COVID-19 Related|0|||
156414291|NCT02293837|564608920|FG003|Overall Study|COVID-19 Related|0|||
156414292|NCT02293837|564608917|FG000|Overall Study|Participant ill and could not be infused|0|||
156414293|NCT02293837|564608918|FG001|Overall Study|Participant ill and could not be infused|0|||
156752074|NCT03026283|565844103|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752075|NCT03026283|565844104|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752076|NCT03026283|565844105|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752077|NCT03026283|565844106|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752078|NCT03026283|565844099|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752079|NCT03026283|565844100|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752080|NCT03026283|565844101|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
156752081|NCT03026283|565844102|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752082|NCT03026283|565844103|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752083|NCT03026283|565844104|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752084|NCT03026283|565844105|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752085|NCT03026283|565844106|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752086|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752087|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752088|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752089|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
156752090|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
156752091|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752092|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752093|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752094|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752095|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752096|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752097|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
156752098|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
156752099|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
156752100|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752101|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752102|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752103|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752104|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752105|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
156752106|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752107|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
156752108|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752109|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752110|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752111|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752112|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752113|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
156752114|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752115|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752116|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752117|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752118|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752119|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752120|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752121|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752122|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
156752123|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
156752124|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752125|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752126|NCT00824655|565844107|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
156414294|NCT02293837|564608919|FG002|Overall Study|Participant ill and could not be infused|1|||
156414295|NCT02293837|564608920|FG003|Overall Study|Participant ill and could not be infused|0|||
156312608|NCT04002908|564243221|FG002|Overall Study|Infant died, so mother withdrawn|0|||
156312609|NCT04002908|564243222|FG003|Overall Study|Infant died, so mother withdrawn|0|||
156312610|NCT03952039|564243225|FG000|Overall Study|Adverse Event|22|||
156312611|NCT03952039|564243226|FG001|Overall Study|Adverse Event|8|||
156312612|NCT03952039|564243225|FG000|Overall Study|Withdrawal by Participant|17|||
156312613|NCT03952039|564243226|FG001|Overall Study|Withdrawal by Participant|12|||
156312614|NCT03952039|564243225|FG000|Overall Study|Death|13|||
156312615|NCT03952039|564243226|FG001|Overall Study|Death|6|||
156312616|NCT03952039|564243225|FG000|Overall Study|Lack of Efficacy|12|||
156312617|NCT03952039|564243226|FG001|Overall Study|Lack of Efficacy|2|||
156312618|NCT03952039|564243225|FG000|Overall Study|Physician Decision|9|||
156312619|NCT03952039|564243226|FG001|Overall Study|Physician Decision|3|||
156312620|NCT03952039|564243225|FG000|Overall Study|Progressive Disease|6|||
156312621|NCT03952039|564243226|FG001|Overall Study|Progressive Disease|4|||
156312622|NCT03952039|564243225|FG000|Overall Study|Other Reasons|12|||
156312623|NCT03952039|564243226|FG001|Overall Study|Other Reasons|4|||
156312624|NCT03865316|564244871|FG000|Overall Study|Procedure Cancelled|4|||
156312625|NCT03865316|564244871|FG000|Overall Study|Equipment failure|4|||
156312626|NCT01330017|564244876|FG000|Overall Study|Adverse Event|0|||
156312627|NCT01330017|564244877|FG001|Overall Study|Adverse Event|1|||
156312628|NCT01330017|564244878|FG002|Overall Study|Adverse Event|1|||
156312629|NCT01330017|564244879|FG003|Overall Study|Adverse Event|4|||
156312630|NCT01330017|564244880|FG004|Overall Study|Adverse Event|0|||
156312631|NCT01330017|564244876|FG000|Overall Study|Withdrawal by Subject|0|||
156312632|NCT01330017|564244877|FG001|Overall Study|Withdrawal by Subject|0|||
156414296|NCT04779242|564608921|FG000|Overall Study|Adverse Event|1|||
156650034|NCT01360632|565465359|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
156650035|NCT01360632|565465360|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
156650036|NCT01360632|565465356|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
156650037|NCT01360632|565465357|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
156650038|NCT01360632|565465358|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
156650039|NCT01360632|565465359|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
156650040|NCT01360632|565465360|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
156650041|NCT01360632|565465356|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
156650042|NCT01360632|565465357|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
156650043|NCT01360632|565465358|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
156650044|NCT01360632|565465359|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
156650045|NCT01360632|565465360|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
156650046|NCT01360632|565465356|FG000|Phase B (6 Weeks)|Adverse Event|0|||
156650047|NCT01360632|565465357|FG001|Phase B (6 Weeks)|Adverse Event|3|||
156650048|NCT01360632|565465358|FG002|Phase B (6 Weeks)|Adverse Event|9|||
156650049|NCT01360632|565465359|FG003|Phase B (6 Weeks)|Adverse Event|3|||
156650050|NCT01360632|565465360|FG004|Phase B (6 Weeks)|Adverse Event|0|||
156650051|NCT01360632|565465356|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
156650052|NCT01360632|565465357|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
156650053|NCT01360632|565465358|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
156650054|NCT01360632|565465359|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
156650055|NCT01360632|565465360|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
156650056|NCT01360632|565465356|FG000|Phase B (6 Weeks)|Physician Decision|0|||
156650057|NCT01360632|565465357|FG001|Phase B (6 Weeks)|Physician Decision|0|||
156650058|NCT01360632|565465358|FG002|Phase B (6 Weeks)|Physician Decision|0|||
156650059|NCT01360632|565465359|FG003|Phase B (6 Weeks)|Physician Decision|1|||
156650060|NCT01360632|565465360|FG004|Phase B (6 Weeks)|Physician Decision|0|||
156650061|NCT01360632|565465356|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
156650062|NCT01360632|565465357|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
156650063|NCT01360632|565465358|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
156650064|NCT01360632|565465359|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
156650065|NCT01360632|565465360|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
156650066|NCT01360632|565465356|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
156650067|NCT01360632|565465357|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
156650068|NCT01360632|565465358|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
156650069|NCT01360632|565465359|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
156650070|NCT01360632|565465360|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
156650071|NCT01360632|565465356|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
156650072|NCT01360632|565465357|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
156650073|NCT01360632|565465358|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
156650074|NCT01360632|565465359|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
156650075|NCT01360632|565465360|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
156650076|NCT01360632|565465356|FG000|Phase A+|Lost to Follow-up|0|||
156650077|NCT01360632|565465357|FG001|Phase A+|Lost to Follow-up|0|||
156650078|NCT01360632|565465358|FG002|Phase A+|Lost to Follow-up|0|||
156650079|NCT01360632|565465359|FG003|Phase A+|Lost to Follow-up|0|||
156650080|NCT01360632|565465360|FG004|Phase A+|Lost to Follow-up|2|||
156650081|NCT01360632|565465356|FG000|Phase A+|Adverse Event|0|||
156650082|NCT01360632|565465357|FG001|Phase A+|Adverse Event|0|||
156650083|NCT01360632|565465358|FG002|Phase A+|Adverse Event|0|||
156650084|NCT01360632|565465359|FG003|Phase A+|Adverse Event|0|||
156312633|NCT01330017|564244878|FG002|Overall Study|Withdrawal by Subject|1|||
156752127|NCT00824655|565844108|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
156752128|NCT00824655|565844107|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
156752129|NCT00824655|565844108|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
156752130|NCT03252145|565844109|FG000|Overall Study|Withdrawal by Subject|1|||
156752131|NCT03252145|565844110|FG001|Overall Study|Withdrawal by Subject|0|||
156752132|NCT03252145|565844109|FG000|Overall Study|Complicating Disease|1|||
156752133|NCT03252145|565844110|FG001|Overall Study|Complicating Disease|2|||
156752134|NCT03091738|565844111|FG000|Overall Study|Adverse Event|1|||
156752135|NCT03091738|565844111|FG000|Overall Study|Lost to Follow-up|1|||
156752136|NCT01763827|565844119|FG000|Overall Study|Withdrawal by Subject|1|||
156752137|NCT01763827|565844120|FG001|Overall Study|Withdrawal by Subject|0|||
156752138|NCT01763827|565844121|FG002|Overall Study|Withdrawal by Subject|0|||
156752139|NCT01763827|565844122|FG003|Overall Study|Withdrawal by Subject|0|||
156752140|NCT01763827|565844123|FG004|Overall Study|Withdrawal by Subject|2|||
156752141|NCT01763827|565844124|FG005|Overall Study|Withdrawal by Subject|0|||
156752142|NCT01763827|565844119|FG000|Overall Study|Decision by sponsor|2|||
156752143|NCT01763827|565844120|FG001|Overall Study|Decision by sponsor|0|||
156752144|NCT01763827|565844121|FG002|Overall Study|Decision by sponsor|3|||
156752145|NCT01763827|565844122|FG003|Overall Study|Decision by sponsor|0|||
156752146|NCT01763827|565844123|FG004|Overall Study|Decision by sponsor|2|||
156752147|NCT01763827|565844124|FG005|Overall Study|Decision by sponsor|1|||
156752148|NCT01763827|565844119|FG000|Overall Study|Lost to Follow-up|0|||
156752149|NCT01763827|565844120|FG001|Overall Study|Lost to Follow-up|1|||
156752150|NCT01763827|565844121|FG002|Overall Study|Lost to Follow-up|1|||
156752151|NCT01763827|565844122|FG003|Overall Study|Lost to Follow-up|1|||
156752152|NCT01763827|565844123|FG004|Overall Study|Lost to Follow-up|2|||
156752153|NCT01763827|565844124|FG005|Overall Study|Lost to Follow-up|1|||
156752154|NCT01826981|565844127|FG000|Overall Study|Lack of Efficacy|0|||
156752155|NCT01826981|565844128|FG001|Overall Study|Lack of Efficacy|1|||
156752156|NCT01826981|565844129|FG002|Overall Study|Lack of Efficacy|0|||
156752157|NCT01826981|565844130|FG003|Overall Study|Lack of Efficacy|0|||
156752158|NCT01826981|565844131|FG004|Overall Study|Lack of Efficacy|5|||
156752159|NCT01826981|565844132|FG005|Overall Study|Lack of Efficacy|0|||
156752160|NCT01826981|565844133|FG006|Overall Study|Lack of Efficacy|0|||
156752161|NCT01826981|565844134|FG007|Overall Study|Lack of Efficacy|8|||
156752162|NCT01826981|565844135|FG008|Overall Study|Lack of Efficacy|7|||
156752163|NCT01826981|565844136|FG009|Overall Study|Lack of Efficacy|0|||
156752164|NCT01826981|565844137|FG010|Overall Study|Lack of Efficacy|1|||
156752165|NCT01826981|565844138|FG011|Overall Study|Lack of Efficacy|0|||
156752166|NCT01826981|565844139|FG012|Overall Study|Lack of Efficacy|0|||
156752167|NCT01826981|565844140|FG013|Overall Study|Lack of Efficacy|3|||
156752168|NCT01826981|565844141|FG014|Overall Study|Lack of Efficacy|0|||
156752169|NCT01826981|565844127|FG000|Overall Study|Lost to Follow-up|0|||
156752170|NCT01826981|565844128|FG001|Overall Study|Lost to Follow-up|0|||
156312634|NCT01330017|564244879|FG003|Overall Study|Withdrawal by Subject|0|||
156312635|NCT01330017|564244880|FG004|Overall Study|Withdrawal by Subject|1|||
156312636|NCT01330017|564244876|FG000|Overall Study|Lost to Follow-up|0|||
156312637|NCT01330017|564244877|FG001|Overall Study|Lost to Follow-up|0|||
156312638|NCT01330017|564244878|FG002|Overall Study|Lost to Follow-up|1|||
156312639|NCT01330017|564244879|FG003|Overall Study|Lost to Follow-up|0|||
156312640|NCT01330017|564244880|FG004|Overall Study|Lost to Follow-up|0|||
156312641|NCT01330017|564244876|FG000|Overall Study|Protocol Violation|0|||
156312642|NCT01330017|564244877|FG001|Overall Study|Protocol Violation|0|||
156312643|NCT01330017|564244878|FG002|Overall Study|Protocol Violation|0|||
156312644|NCT01330017|564244879|FG003|Overall Study|Protocol Violation|1|||
156312645|NCT01330017|564244880|FG004|Overall Study|Protocol Violation|0|||
156312646|NCT01330017|564244876|FG000|Overall Study|Unknown Reason|5|||
156312647|NCT01330017|564244877|FG001|Overall Study|Unknown Reason|3|||
156312648|NCT01330017|564244878|FG002|Overall Study|Unknown Reason|5|||
156312649|NCT01330017|564244879|FG003|Overall Study|Unknown Reason|7|||
156312650|NCT01330017|564244880|FG004|Overall Study|Unknown Reason|2|||
156312651|NCT03137069|564244882|FG000|Overall Study|Withdrawal by Subject|1|||
156752171|NCT01826981|565844129|FG002|Overall Study|Lost to Follow-up|0|||
156752172|NCT01826981|565844130|FG003|Overall Study|Lost to Follow-up|0|||
156752173|NCT01826981|565844131|FG004|Overall Study|Lost to Follow-up|1|||
156752174|NCT01826981|565844132|FG005|Overall Study|Lost to Follow-up|1|||
156752175|NCT01826981|565844133|FG006|Overall Study|Lost to Follow-up|0|||
156752176|NCT01826981|565844134|FG007|Overall Study|Lost to Follow-up|1|||
156752177|NCT01826981|565844135|FG008|Overall Study|Lost to Follow-up|0|||
156752178|NCT01826981|565844136|FG009|Overall Study|Lost to Follow-up|1|||
156312652|NCT03137069|564244883|FG001|Overall Study|Withdrawal by Subject|2|||
156312653|NCT03137069|564244884|FG002|Overall Study|Withdrawal by Subject|2|||
156312654|NCT03137069|564244885|FG003|Overall Study|Withdrawal by Subject|2|||
156312655|NCT03137069|564244886|FG004|Overall Study|Withdrawal by Subject|0|||
156312656|NCT03137069|564244887|FG005|Overall Study|Withdrawal by Subject|0|||
156312657|NCT03137069|564244882|FG000|Overall Study|Adverse Event|0|||
156752179|NCT01826981|565844137|FG010|Overall Study|Lost to Follow-up|1|||
156312658|NCT03137069|564244883|FG001|Overall Study|Adverse Event|3|||
156752180|NCT01826981|565844138|FG011|Overall Study|Lost to Follow-up|1|||
156414297|NCT04779242|564608922|FG001|Overall Study|Adverse Event|1|||
156752181|NCT01826981|565844139|FG012|Overall Study|Lost to Follow-up|1|||
156752182|NCT01826981|565844140|FG013|Overall Study|Lost to Follow-up|0|||
156752183|NCT01826981|565844141|FG014|Overall Study|Lost to Follow-up|0|||
156752184|NCT01826981|565844127|FG000|Overall Study|Withdrew Consent|0|||
156752185|NCT01826981|565844128|FG001|Overall Study|Withdrew Consent|0|||
156752186|NCT01826981|565844129|FG002|Overall Study|Withdrew Consent|0|||
156752187|NCT01826981|565844130|FG003|Overall Study|Withdrew Consent|0|||
156752188|NCT01826981|565844131|FG004|Overall Study|Withdrew Consent|0|||
156752189|NCT01826981|565844132|FG005|Overall Study|Withdrew Consent|0|||
156752190|NCT01826981|565844133|FG006|Overall Study|Withdrew Consent|1|||
156752191|NCT01826981|565844134|FG007|Overall Study|Withdrew Consent|1|||
156752192|NCT01826981|565844135|FG008|Overall Study|Withdrew Consent|0|||
156752193|NCT01826981|565844136|FG009|Overall Study|Withdrew Consent|0|||
156752194|NCT01826981|565844137|FG010|Overall Study|Withdrew Consent|0|||
156752195|NCT01826981|565844138|FG011|Overall Study|Withdrew Consent|1|||
156752196|NCT01826981|565844139|FG012|Overall Study|Withdrew Consent|0|||
156752197|NCT01826981|565844140|FG013|Overall Study|Withdrew Consent|1|||
156752198|NCT01826981|565844141|FG014|Overall Study|Withdrew Consent|0|||
156752199|NCT01826981|565844127|FG000|Overall Study|Adverse Event|0|||
156752200|NCT01826981|565844128|FG001|Overall Study|Adverse Event|0|||
156752201|NCT01826981|565844129|FG002|Overall Study|Adverse Event|0|||
156752202|NCT01826981|565844130|FG003|Overall Study|Adverse Event|0|||
156752203|NCT01826981|565844131|FG004|Overall Study|Adverse Event|1|||
156752204|NCT01826981|565844132|FG005|Overall Study|Adverse Event|0|||
156752205|NCT01826981|565844133|FG006|Overall Study|Adverse Event|0|||
156752206|NCT01826981|565844134|FG007|Overall Study|Adverse Event|0|||
156752207|NCT01826981|565844135|FG008|Overall Study|Adverse Event|0|||
156752208|NCT01826981|565844136|FG009|Overall Study|Adverse Event|0|||
156752209|NCT01826981|565844137|FG010|Overall Study|Adverse Event|0|||
156752210|NCT01826981|565844138|FG011|Overall Study|Adverse Event|0|||
156752211|NCT01826981|565844139|FG012|Overall Study|Adverse Event|0|||
156752212|NCT01826981|565844140|FG013|Overall Study|Adverse Event|0|||
156752213|NCT01826981|565844141|FG014|Overall Study|Adverse Event|0|||
156752214|NCT01826981|565844127|FG000|Overall Study|Upper G-I Haemorrhage|0|||
156752215|NCT01826981|565844128|FG001|Overall Study|Upper G-I Haemorrhage|0|||
156752216|NCT01826981|565844129|FG002|Overall Study|Upper G-I Haemorrhage|0|||
156752217|NCT01826981|565844130|FG003|Overall Study|Upper G-I Haemorrhage|0|||
156752218|NCT01826981|565844131|FG004|Overall Study|Upper G-I Haemorrhage|0|||
156752219|NCT01826981|565844132|FG005|Overall Study|Upper G-I Haemorrhage|0|||
156752220|NCT01826981|565844133|FG006|Overall Study|Upper G-I Haemorrhage|0|||
156752221|NCT01826981|565844134|FG007|Overall Study|Upper G-I Haemorrhage|0|||
156752222|NCT01826981|565844135|FG008|Overall Study|Upper G-I Haemorrhage|0|||
156752223|NCT01826981|565844136|FG009|Overall Study|Upper G-I Haemorrhage|0|||
156752224|NCT01826981|565844137|FG010|Overall Study|Upper G-I Haemorrhage|0|||
156752225|NCT01826981|565844138|FG011|Overall Study|Upper G-I Haemorrhage|0|||
156752226|NCT01826981|565844139|FG012|Overall Study|Upper G-I Haemorrhage|0|||
156752227|NCT01826981|565844140|FG013|Overall Study|Upper G-I Haemorrhage|1|||
156752228|NCT01826981|565844141|FG014|Overall Study|Upper G-I Haemorrhage|0|||
156752229|NCT01826981|565844127|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752230|NCT01826981|565844128|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
156312659|NCT03137069|564244884|FG002|Overall Study|Adverse Event|1|||
156312660|NCT03137069|564244885|FG003|Overall Study|Adverse Event|1|||
156312661|NCT03137069|564244886|FG004|Overall Study|Adverse Event|0|||
156312662|NCT03137069|564244887|FG005|Overall Study|Adverse Event|1|||
156312663|NCT03137069|564244882|FG000|Overall Study|Protocol Violation|0|||
156312664|NCT03137069|564244883|FG001|Overall Study|Protocol Violation|1|||
156312665|NCT03137069|564244884|FG002|Overall Study|Protocol Violation|0|||
156312666|NCT03137069|564244885|FG003|Overall Study|Protocol Violation|1|||
156312667|NCT03137069|564244886|FG004|Overall Study|Protocol Violation|1|||
156312668|NCT03137069|564244887|FG005|Overall Study|Protocol Violation|1|||
156312669|NCT03137069|564244882|FG000|Overall Study|Physician Decision|0|||
156312670|NCT03137069|564244883|FG001|Overall Study|Physician Decision|0|||
156312671|NCT03137069|564244884|FG002|Overall Study|Physician Decision|0|||
156312672|NCT03137069|564244885|FG003|Overall Study|Physician Decision|1|||
156312673|NCT03137069|564244886|FG004|Overall Study|Physician Decision|0|||
156312674|NCT03137069|564244887|FG005|Overall Study|Physician Decision|0|||
156312675|NCT03137069|564244882|FG000|Overall Study|Study Terminated by Sponsor|0|||
156752231|NCT01826981|565844129|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752232|NCT01826981|565844130|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
156312676|NCT03137069|564244883|FG001|Overall Study|Study Terminated by Sponsor|0|||
156312677|NCT03137069|564244884|FG002|Overall Study|Study Terminated by Sponsor|0|||
156312678|NCT03137069|564244885|FG003|Overall Study|Study Terminated by Sponsor|0|||
156752233|NCT01826981|565844131|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752234|NCT01826981|565844132|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752235|NCT01826981|565844133|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752236|NCT01826981|565844134|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
156752237|NCT01826981|565844135|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752238|NCT01826981|565844136|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752239|NCT01826981|565844137|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752240|NCT01826981|565844138|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752241|NCT01826981|565844139|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752242|NCT01826981|565844140|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752243|NCT01826981|565844141|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752244|NCT03746405|565844146|FG000|Overall Study|Withdrawal by Subject|3|||
156752245|NCT03746405|565844147|FG001|Overall Study|Withdrawal by Subject|0|||
156752246|NCT03746405|565844146|FG000|Overall Study|technical difficulties|0|||
156752247|NCT03746405|565844147|FG001|Overall Study|technical difficulties|2|||
156752248|NCT03479008|565844148|FG000|Overall Study|Withdrawal by Subject|3|||
156752249|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
156752250|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
156752251|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
156752252|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
156752253|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Other|1|||
156752254|NCT00412932|565844149|FG000|Olmesartan 40 mg|Adverse Event|4|||
156752255|NCT00412932|565844149|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
156752256|NCT00412932|565844149|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
156752257|NCT00412932|565844149|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
156752258|NCT00412932|565844149|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
156312679|NCT03137069|564244886|FG004|Overall Study|Study Terminated by Sponsor|1|||
156312680|NCT03137069|564244887|FG005|Overall Study|Study Terminated by Sponsor|0|||
156752259|NCT00412932|565844149|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
156752260|NCT00412932|565844149|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
156752261|NCT00667563|565844150|FG000|Overall Study|Protocol Violation|24|||
156752262|NCT02384538|565844167|FG000|Overall Study|Adverse Event|1|||
156752263|NCT02384538|565844168|FG001|Overall Study|Adverse Event|4|||
156752264|NCT02384538|565844167|FG000|Overall Study|Lack of Efficacy|4|||
156312681|NCT03137069|564244882|FG000|Overall Study|Data Entry Error|0|||
156312682|NCT03137069|564244883|FG001|Overall Study|Data Entry Error|0|||
156312683|NCT03137069|564244884|FG002|Overall Study|Data Entry Error|0|||
156312684|NCT03137069|564244885|FG003|Overall Study|Data Entry Error|1|||
156312685|NCT03137069|564244886|FG004|Overall Study|Data Entry Error|0|||
156312686|NCT03137069|564244887|FG005|Overall Study|Data Entry Error|0|||
156312687|NCT02043899|564244889|FG000|Overall Study|Adverse Event|3|||
156312688|NCT02043899|564244889|FG000|Overall Study|Physician Decision|1|||
156312689|NCT02043899|564244889|FG000|Overall Study|Withdrawal by Subject|2|||
156312690|NCT02043899|564244889|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
156312691|NCT02043899|564244889|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
156312692|NCT02043899|564244889|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
156312693|NCT02043899|564244889|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
156312694|NCT02043899|564244889|FG000|Overall Study|Treatment delayed|1|||
156312695|NCT02522624|564244891|FG000|Overall Study|Technical failure|1|||
156312696|NCT02522624|564244892|FG001|Overall Study|Technical failure|0|||
156312697|NCT00369629|564244893|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
156312698|NCT00369629|564244894|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
156312699|NCT00369629|564244895|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
156312700|NCT00369629|564244896|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
156312701|NCT00369629|564244893|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
156312702|NCT00369629|564244894|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
156312703|NCT00369629|564244895|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
156312704|NCT00369629|564244896|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
156312705|NCT00369629|564244893|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
156312706|NCT00369629|564244894|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
156312707|NCT00369629|564244895|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
156312708|NCT00369629|564244896|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
156312709|NCT00369629|564244893|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
156312710|NCT00369629|564244894|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
156312711|NCT00369629|564244895|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
156312712|NCT00369629|564244896|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
156312713|NCT00369629|564244893|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
156312714|NCT00369629|564244894|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
156312715|NCT00369629|564244895|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
156312716|NCT00369629|564244896|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
156312717|NCT00369629|564244893|FG000|Completed 4 More Cycles|Progressive disease|2|||
156312718|NCT00369629|564244894|FG001|Completed 4 More Cycles|Progressive disease|1|||
156312719|NCT00369629|564244895|FG002|Completed 4 More Cycles|Progressive disease|2|||
156312720|NCT00369629|564244896|FG003|Completed 4 More Cycles|Progressive disease|0|||
156752265|NCT02384538|565844168|FG001|Overall Study|Lack of Efficacy|4|||
156752266|NCT02384538|565844167|FG000|Overall Study|Withdrew Consent|0|||
156752267|NCT02384538|565844168|FG001|Overall Study|Withdrew Consent|4|||
156752268|NCT02384538|565844167|FG000|Overall Study|Other|1|||
156752269|NCT02384538|565844168|FG001|Overall Study|Other|3|||
156752270|NCT01763203|565844173|FG000|Overall Study|Death|4|||
156752271|NCT01763203|565844174|FG001|Overall Study|Death|7|||
156752272|NCT01763203|565844173|FG000|Overall Study|Lost to Follow-up|12|||
156752273|NCT01763203|565844174|FG001|Overall Study|Lost to Follow-up|12|||
156752274|NCT01763203|565844173|FG000|Overall Study|Withdrawal by Subject|8|||
156752275|NCT01763203|565844174|FG001|Overall Study|Withdrawal by Subject|12|||
156752276|NCT01763203|565844173|FG000|Overall Study|Moved out of study region|7|||
156752277|NCT01763203|565844174|FG001|Overall Study|Moved out of study region|10|||
156752278|NCT01763203|565844173|FG000|Overall Study|Physician Decision|2|||
156752279|NCT01763203|565844174|FG001|Overall Study|Physician Decision|1|||
156752280|NCT02187861|565844175|FG000|Overall Study|Adverse Event|2|||
156752281|NCT02187861|565844176|FG001|Overall Study|Adverse Event|1|||
156752282|NCT02187861|565844177|FG002|Overall Study|Adverse Event|2|||
156752283|NCT02187861|565844178|FG003|Overall Study|Adverse Event|1|||
156752284|NCT02187861|565844175|FG000|Overall Study|Death|0|||
156752285|NCT02187861|565844176|FG001|Overall Study|Death|3|||
156752286|NCT02187861|565844177|FG002|Overall Study|Death|1|||
156752287|NCT02187861|565844178|FG003|Overall Study|Death|2|||
156752288|NCT02187861|565844175|FG000|Overall Study|Physician Decision|0|||
156752289|NCT02187861|565844176|FG001|Overall Study|Physician Decision|1|||
156752290|NCT02187861|565844177|FG002|Overall Study|Physician Decision|0|||
156752291|NCT02187861|565844178|FG003|Overall Study|Physician Decision|3|||
156752292|NCT02187861|565844175|FG000|Overall Study|Progressive Disease|4|||
156752293|NCT02187861|565844176|FG001|Overall Study|Progressive Disease|42|||
156752294|NCT02187861|565844177|FG002|Overall Study|Progressive Disease|19|||
156752295|NCT02187861|565844178|FG003|Overall Study|Progressive Disease|22|||
156752296|NCT02187861|565844175|FG000|Overall Study|Withdrawal by Subject|0|||
156752297|NCT02187861|565844176|FG001|Overall Study|Withdrawal by Subject|0|||
156752298|NCT02187861|565844177|FG002|Overall Study|Withdrawal by Subject|3|||
156752299|NCT02187861|565844178|FG003|Overall Study|Withdrawal by Subject|3|||
156752300|NCT02187861|565844175|FG000|Overall Study|Other|0|||
156752301|NCT02187861|565844176|FG001|Overall Study|Other|1|||
156752302|NCT02187861|565844177|FG002|Overall Study|Other|7|||
156752303|NCT02187861|565844178|FG003|Overall Study|Other|1|||
156752304|NCT02756819|565844179|FG000|Overall Study|Lost for observation|23|||
156752305|NCT02756819|565844179|FG000|Overall Study|Patient's unwillingness|16|||
156752306|NCT02756819|565844179|FG000|Overall Study|Insufficient efficacy|2|||
156752307|NCT02756819|565844179|FG000|Overall Study|Adverse Event|2|||
156752308|NCT02756819|565844179|FG000|Overall Study|Reason not Specified|9|||
156752309|NCT01491841|565844181|FG000|Overall Study|Screen Failure|10|||
156752310|NCT01491841|565844181|FG000|Overall Study|Withdrawal by Subject|1|||
156752311|NCT00741598|565844182|FG000|Overall Study|Lost to Follow-up|3|||
156752312|NCT00741598|565844183|FG001|Overall Study|Lost to Follow-up|4|||
156752313|NCT00741598|565844182|FG000|Overall Study|Lack of Efficacy|1|||
156752314|NCT00741598|565844183|FG001|Overall Study|Lack of Efficacy|2|||
156752315|NCT00741598|565844182|FG000|Overall Study|Physician Decision|1|||
156752316|NCT00741598|565844183|FG001|Overall Study|Physician Decision|1|||
156752317|NCT00741598|565844182|FG000|Overall Study|Pregnancy|1|||
156752318|NCT00741598|565844183|FG001|Overall Study|Pregnancy|0|||
156752319|NCT00741598|565844182|FG000|Overall Study|Withdrawal by Subject|3|||
156312721|NCT00369629|564244893|FG000|Follow up for 1 Year|Death|2|||
156312722|NCT00369629|564244894|FG001|Follow up for 1 Year|Death|1|||
156312723|NCT00369629|564244895|FG002|Follow up for 1 Year|Death|1|||
156312724|NCT00369629|564244896|FG003|Follow up for 1 Year|Death|0|||
156312725|NCT00369629|564244893|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
156312726|NCT00369629|564244894|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
156312727|NCT00369629|564244895|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
156312728|NCT00369629|564244896|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
156312729|NCT00369629|564244893|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
156312730|NCT00369629|564244894|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
156312731|NCT00369629|564244895|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
156312732|NCT00369629|564244896|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
156312733|NCT04839562|564244897|FG000|Overall Study|Withdrawal by Subject|0|||
156312734|NCT04839562|564244898|FG001|Overall Study|Withdrawal by Subject|1|||
156312735|NCT04839562|564244897|FG000|Overall Study|Physician Decision|0|||
156312736|NCT04839562|564244898|FG001|Overall Study|Physician Decision|1|||
156312737|NCT00877773|564244899|FG000|Overall Study|Disease Progression|44|||
156312738|NCT01347580|564244900|FG000|Overall Study|Withdrawal by Subject|13|||
156312739|NCT01347580|564244901|FG001|Overall Study|Withdrawal by Subject|23|||
156312740|NCT01347580|564244900|FG000|Overall Study|Death|30|||
156312741|NCT01347580|564244901|FG001|Overall Study|Death|19|||
156312742|NCT01347580|564244900|FG000|Overall Study|Protocol Violation|10|||
156312743|NCT01347580|564244901|FG001|Overall Study|Protocol Violation|7|||
156752320|NCT00741598|565844183|FG001|Overall Study|Withdrawal by Subject|2|||
156752321|NCT01951573|565844188|FG000|Washout Period|Adverse Event|0|||
156752322|NCT01951573|565844189|FG001|Washout Period|Adverse Event|1|||
156752323|NCT04217317|565844192|FG000|Overall Study|Lack of Efficacy|4|||
156752324|NCT04217317|565844192|FG000|Overall Study|Physician Decision|1|||
156752325|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
156752326|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
156752327|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
156752328|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
156752329|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
156752330|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
156752331|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
156752332|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
156752333|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
156752334|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
156752335|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
156752336|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
156752337|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
156752338|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
156752339|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
156752340|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
156752341|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
156752342|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
156752343|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
156752344|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
156752345|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
156752346|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
156752347|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
156752348|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
156752349|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
156752350|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
156752351|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
156752352|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
156752353|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
156752354|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
156752355|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
156752356|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
156752357|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
156752358|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
156752359|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
156752360|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
156752361|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
156752362|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
156752363|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
156752364|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
156752365|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
156752366|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
156752367|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
156752368|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
156752369|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
156752370|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
156752371|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
156312744|NCT01347580|564244900|FG000|Overall Study|Lost to Follow-up|3|||
156312745|NCT01347580|564244901|FG001|Overall Study|Lost to Follow-up|1|||
156312746|NCT01347580|564244900|FG000|Overall Study|Had other reason|9|||
156312747|NCT01347580|564244901|FG001|Overall Study|Had other reason|6|||
156312748|NCT01964755|564244902|FG000|Overall Study|Death|2|||
156312749|NCT01122264|564244903|FG000|Overall Study|Adverse Event|6|||
156312750|NCT01122264|564244904|FG001|Overall Study|Adverse Event|5|||
156312751|NCT01122264|564244905|FG002|Overall Study|Adverse Event|7|||
156312752|NCT01122264|564244903|FG000|Overall Study|Death|1|||
156312753|NCT01122264|564244904|FG001|Overall Study|Death|0|||
156312754|NCT01122264|564244905|FG002|Overall Study|Death|0|||
156312755|NCT01122264|564244903|FG000|Overall Study|Lost to Follow-up|5|||
156312756|NCT01122264|564244904|FG001|Overall Study|Lost to Follow-up|9|||
156312757|NCT01122264|564244905|FG002|Overall Study|Lost to Follow-up|13|||
156312758|NCT01122264|564244903|FG000|Overall Study|Entry Criteria Not Met|1|||
156312759|NCT01122264|564244904|FG001|Overall Study|Entry Criteria Not Met|0|||
156312760|NCT01122264|564244905|FG002|Overall Study|Entry Criteria Not Met|0|||
156312761|NCT01122264|564244903|FG000|Overall Study|Protocol Violation|7|||
156312762|NCT01122264|564244904|FG001|Overall Study|Protocol Violation|7|||
156312763|NCT01122264|564244905|FG002|Overall Study|Protocol Violation|9|||
156312764|NCT01122264|564244903|FG000|Overall Study|Withdrawal by Subject|6|||
156752372|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
156752373|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
156752374|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
156752375|NCT01690299|565844198|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
156752376|NCT01690299|565844199|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
156752377|NCT01690299|565844200|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
156752378|NCT01690299|565844201|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
156752379|NCT01690299|565844202|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
156752380|NCT01690299|565844203|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
156752381|NCT01690299|565844198|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
156752382|NCT01690299|565844199|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752383|NCT01690299|565844200|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752384|NCT01690299|565844201|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752385|NCT01690299|565844202|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752386|NCT01690299|565844203|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752387|NCT01690299|565844198|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
156752388|NCT01690299|565844199|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
156752389|NCT01690299|565844200|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156752390|NCT01690299|565844201|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156752391|NCT01690299|565844202|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156752392|NCT01690299|565844203|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156752393|NCT01690299|565844198|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
156752394|NCT01690299|565844199|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
156752395|NCT01690299|565844200|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
156752396|NCT01690299|565844201|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
156752397|NCT01690299|565844202|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
156752398|NCT01690299|565844203|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
156752399|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
156752400|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
156752401|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
156752402|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
156752403|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
156752404|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
156752405|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
156752406|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
156752407|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
156752408|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
156752409|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
156752410|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
156752411|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
156752412|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
156752413|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
156752414|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
156752415|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
156752416|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
156752417|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
156752418|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
156752419|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
156752420|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
156752421|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
156752422|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
156752423|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
156752424|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
156752425|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
156752426|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
156752427|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
156752428|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
156752429|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156752430|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156752431|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156752432|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156312765|NCT01122264|564244904|FG001|Overall Study|Withdrawal by Subject|6|||
156752433|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156752434|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
156752435|NCT03836209|565844204|FG000|Overall Study|Adverse Event|5|||
156752436|NCT03836209|565844205|FG001|Overall Study|Adverse Event|2|||
156752437|NCT03836209|565844204|FG000|Overall Study|Death|4|||
156752438|NCT03836209|565844205|FG001|Overall Study|Death|1|||
156752439|NCT03836209|565844204|FG000|Overall Study|Lack of Efficacy|7|||
156752440|NCT03836209|565844205|FG001|Overall Study|Lack of Efficacy|10|||
156752441|NCT03836209|565844204|FG000|Overall Study|Physician Decision|7|||
156752442|NCT03836209|565844205|FG001|Overall Study|Physician Decision|11|||
156752443|NCT03836209|565844204|FG000|Overall Study|Protocol Violation|0|||
156752444|NCT03836209|565844205|FG001|Overall Study|Protocol Violation|3|||
156752445|NCT03836209|565844204|FG000|Overall Study|Withdrawal by Subject|2|||
156752446|NCT03836209|565844205|FG001|Overall Study|Withdrawal by Subject|10|||
156752447|NCT03836209|565844204|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
156752448|NCT03836209|565844205|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
156752449|NCT03739710|565844206|FG000|Overall Study|Screen Failed|81|||
156752450|NCT01753115|565844207|FG000|Overall Study|Lost to Follow-up|3|||
156752451|NCT01753115|565844208|FG001|Overall Study|Lost to Follow-up|6|||
156752452|NCT01753115|565844209|FG002|Overall Study|Lost to Follow-up|8|||
156752453|NCT01753115|565844207|FG000|Overall Study|Withdrawal by Subject|6|||
156752454|NCT01753115|565844208|FG001|Overall Study|Withdrawal by Subject|5|||
156752455|NCT01753115|565844209|FG002|Overall Study|Withdrawal by Subject|6|||
156752456|NCT01753115|565844207|FG000|Overall Study|Subject non-compliant|3|||
156752457|NCT01753115|565844208|FG001|Overall Study|Subject non-compliant|3|||
156752458|NCT01753115|565844209|FG002|Overall Study|Subject non-compliant|0|||
156752459|NCT01753115|565844207|FG000|Overall Study|Used excluded drug|0|||
156752460|NCT01753115|565844208|FG001|Overall Study|Used excluded drug|1|||
156752461|NCT01753115|565844209|FG002|Overall Study|Used excluded drug|0|||
156752462|NCT04313400|565844213|FG000|Overall Study|Withdrawal by Subject|0|||
156752463|NCT04313400|565844214|FG001|Overall Study|Withdrawal by Subject|0|||
156752464|NCT04313400|565844215|FG002|Overall Study|Withdrawal by Subject|0|||
156752465|NCT04313400|565844216|FG003|Overall Study|Withdrawal by Subject|0|||
156752466|NCT04313400|565844217|FG004|Overall Study|Withdrawal by Subject|0|||
156752467|NCT04313400|565844218|FG005|Overall Study|Withdrawal by Subject|4|||
156752468|NCT04313400|565844219|FG006|Overall Study|Withdrawal by Subject|1|||
156752469|NCT04313400|565844213|FG000|Overall Study|Adverse Event|0|||
156752470|NCT04313400|565844214|FG001|Overall Study|Adverse Event|0|||
156752471|NCT04313400|565844215|FG002|Overall Study|Adverse Event|0|||
156752472|NCT04313400|565844216|FG003|Overall Study|Adverse Event|0|||
156752473|NCT04313400|565844217|FG004|Overall Study|Adverse Event|0|||
156752474|NCT04313400|565844218|FG005|Overall Study|Adverse Event|1|||
156312766|NCT01122264|564244905|FG002|Overall Study|Withdrawal by Subject|16|||
156312767|NCT01122264|564244903|FG000|Overall Study|Physician Decision|3|||
156312768|NCT01122264|564244904|FG001|Overall Study|Physician Decision|1|||
156312769|NCT01122264|564244905|FG002|Overall Study|Physician Decision|1|||
156312770|NCT01122264|564244903|FG000|Overall Study|Lack of Efficacy|3|||
156312771|NCT01122264|564244904|FG001|Overall Study|Lack of Efficacy|1|||
156312772|NCT01122264|564244905|FG002|Overall Study|Lack of Efficacy|1|||
156312773|NCT00640224|564244906|FG000|Overall Study|Lost to Follow-up|5|||
156312774|NCT00640224|564244907|FG001|Overall Study|Lost to Follow-up|2|||
156312775|NCT00640224|564244908|FG002|Overall Study|Lost to Follow-up|0|||
156312776|NCT00640224|564244909|FG003|Overall Study|Lost to Follow-up|0|||
156312777|NCT00640224|564244906|FG000|Overall Study|Withdrawal by Subject|1|||
156312778|NCT00640224|564244907|FG001|Overall Study|Withdrawal by Subject|0|||
156312779|NCT00640224|564244908|FG002|Overall Study|Withdrawal by Subject|0|||
156312780|NCT00640224|564244909|FG003|Overall Study|Withdrawal by Subject|0|||
156312781|NCT00640224|564244906|FG000|Overall Study|Headaches|0|||
156312782|NCT00640224|564244907|FG001|Overall Study|Headaches|1|||
156752475|NCT04313400|565844219|FG006|Overall Study|Adverse Event|0|||
156752476|NCT04313400|565844213|FG000|Overall Study|Lost to Follow-up|0|||
156752477|NCT04313400|565844214|FG001|Overall Study|Lost to Follow-up|0|||
156752478|NCT04313400|565844215|FG002|Overall Study|Lost to Follow-up|0|||
156312783|NCT00640224|564244908|FG002|Overall Study|Headaches|0|||
156312784|NCT00640224|564244909|FG003|Overall Study|Headaches|0|||
156312785|NCT00422513|564244910|FG000|Overall Study|Lack of Efficacy|4|||
156312786|NCT00422513|564244911|FG001|Overall Study|Lack of Efficacy|5|||
156312787|NCT00422513|564244910|FG000|Overall Study|Protocol Violation|23|||
156312788|NCT00422513|564244911|FG001|Overall Study|Protocol Violation|7|||
156312789|NCT00422513|564244910|FG000|Overall Study|Refused Treatment|4|||
156752479|NCT04313400|565844216|FG003|Overall Study|Lost to Follow-up|0|||
156752480|NCT04313400|565844217|FG004|Overall Study|Lost to Follow-up|0|||
156752481|NCT04313400|565844218|FG005|Overall Study|Lost to Follow-up|1|||
156312790|NCT00422513|564244911|FG001|Overall Study|Refused Treatment|2|||
156312791|NCT00422513|564244910|FG000|Overall Study|Withdrawal by Subject|2|||
156312792|NCT00422513|564244911|FG001|Overall Study|Withdrawal by Subject|1|||
156312793|NCT00422513|564244910|FG000|Overall Study|early termination of the study|67|||
156752482|NCT04313400|565844219|FG006|Overall Study|Lost to Follow-up|0|||
156752483|NCT01882803|565844224|FG000|Overall Study|Disease Progression|1|||
156312794|NCT00422513|564244911|FG001|Overall Study|early termination of the study|80|||
156414298|NCT04779242|564608921|FG000|Overall Study|Lost to Follow-up|2|||
156414299|NCT04779242|564608922|FG001|Overall Study|Lost to Follow-up|4|||
156414300|NCT04779242|564608921|FG000|Overall Study|Withdrawal by Subject|7|||
156414301|NCT04779242|564608922|FG001|Overall Study|Withdrawal by Subject|9|||
156414302|NCT04779242|564608921|FG000|Overall Study|Death|6|||
156414303|NCT04779242|564608922|FG001|Overall Study|Death|6|||
156414304|NCT04779242|564608921|FG000|Overall Study|COVID-19 related reasons|2|||
156414305|NCT04779242|564608922|FG001|Overall Study|COVID-19 related reasons|1|||
156414306|NCT04779242|564608921|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
156414307|NCT04779242|564608922|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
156414308|NCT04779242|564608921|FG000|Overall Study|Martial Law in Ukraine|2|||
156414309|NCT04779242|564608922|FG001|Overall Study|Martial Law in Ukraine|3|||
156414310|NCT01076088|564608925|FG000|Overall Study|Adverse Event|1|||
156414311|NCT01076088|564608926|FG001|Overall Study|Adverse Event|6|||
156414312|NCT01076088|564608927|FG002|Overall Study|Adverse Event|3|||
156414313|NCT01076088|564608928|FG003|Overall Study|Adverse Event|2|||
156414314|NCT01076088|564608929|FG004|Overall Study|Adverse Event|3|||
156414315|NCT01076088|564608930|FG005|Overall Study|Adverse Event|3|||
156650085|NCT01360632|565465360|FG004|Phase A+|Adverse Event|2|||
156650086|NCT01360632|565465356|FG000|Phase A+|Met Withdrawal Criteria|0|||
156650087|NCT01360632|565465357|FG001|Phase A+|Met Withdrawal Criteria|0|||
156650088|NCT01360632|565465358|FG002|Phase A+|Met Withdrawal Criteria|0|||
156650089|NCT01360632|565465359|FG003|Phase A+|Met Withdrawal Criteria|0|||
156650090|NCT01360632|565465360|FG004|Phase A+|Met Withdrawal Criteria|7|||
156650091|NCT01360632|565465356|FG000|Phase A+|Physician Decision|0|||
156650092|NCT01360632|565465357|FG001|Phase A+|Physician Decision|0|||
156650093|NCT01360632|565465358|FG002|Phase A+|Physician Decision|0|||
156650094|NCT01360632|565465359|FG003|Phase A+|Physician Decision|0|||
156650095|NCT01360632|565465360|FG004|Phase A+|Physician Decision|3|||
156650096|NCT01360632|565465356|FG000|Phase A+|Withdrawal by Subject|0|||
156650097|NCT01360632|565465357|FG001|Phase A+|Withdrawal by Subject|0|||
156650098|NCT01360632|565465358|FG002|Phase A+|Withdrawal by Subject|0|||
156650099|NCT01360632|565465359|FG003|Phase A+|Withdrawal by Subject|0|||
156650100|NCT01360632|565465360|FG004|Phase A+|Withdrawal by Subject|8|||
156650101|NCT01360632|565465356|FG000|Phase A+|Protocol Deviation|0|||
156650102|NCT01360632|565465357|FG001|Phase A+|Protocol Deviation|0|||
156650103|NCT01360632|565465358|FG002|Phase A+|Protocol Deviation|0|||
156650104|NCT01360632|565465359|FG003|Phase A+|Protocol Deviation|0|||
156650105|NCT01360632|565465360|FG004|Phase A+|Protocol Deviation|3|||
156650106|NCT01298596|565465363|FG000|Overall Study|Withdrawal by Subject|1|||
156650107|NCT01298596|565465364|FG001|Overall Study|Withdrawal by Subject|1|||
156650108|NCT01298596|565465363|FG000|Overall Study|Death|5|||
156650109|NCT01298596|565465364|FG001|Overall Study|Death|3|||
156650110|NCT01298596|565465363|FG000|Overall Study|Lost to Follow-up|6|||
156650111|NCT01298596|565465364|FG001|Overall Study|Lost to Follow-up|14|||
156650112|NCT01298596|565465363|FG000|Overall Study|Referred for further management|16|||
156650113|NCT01298596|565465364|FG001|Overall Study|Referred for further management|15|||
156650114|NCT02173301|565465365|FG000|Overall Study|Adverse Event|7|||
156650115|NCT02173301|565465366|FG001|Overall Study|Adverse Event|8|||
156650116|NCT02173301|565465367|FG002|Overall Study|Adverse Event|13|||
156650117|NCT02173301|565465368|FG003|Overall Study|Adverse Event|5|||
156650118|NCT02173301|565465365|FG000|Overall Study|Withdrawal by Subject|8|||
156650119|NCT02173301|565465366|FG001|Overall Study|Withdrawal by Subject|10|||
156650120|NCT02173301|565465367|FG002|Overall Study|Withdrawal by Subject|4|||
156650121|NCT02173301|565465368|FG003|Overall Study|Withdrawal by Subject|8|||
156650122|NCT02173301|565465365|FG000|Overall Study|Lost to Follow-up|4|||
156650123|NCT02173301|565465366|FG001|Overall Study|Lost to Follow-up|4|||
156650124|NCT02173301|565465367|FG002|Overall Study|Lost to Follow-up|2|||
156650125|NCT02173301|565465368|FG003|Overall Study|Lost to Follow-up|2|||
156650126|NCT02173301|565465365|FG000|Overall Study|Protocol Violation|0|||
156650127|NCT02173301|565465366|FG001|Overall Study|Protocol Violation|1|||
156650128|NCT02173301|565465367|FG002|Overall Study|Protocol Violation|0|||
156650129|NCT02173301|565465368|FG003|Overall Study|Protocol Violation|0|||
156650130|NCT02173301|565465365|FG000|Overall Study|Physician Decision|0|||
156650131|NCT02173301|565465366|FG001|Overall Study|Physician Decision|0|||
156650132|NCT02173301|565465367|FG002|Overall Study|Physician Decision|1|||
156650133|NCT02173301|565465368|FG003|Overall Study|Physician Decision|0|||
156650134|NCT02173301|565465365|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
156650135|NCT02173301|565465366|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
156650136|NCT02173301|565465367|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
156650137|NCT02173301|565465368|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
156650138|NCT03740100|565465369|FG000|Overall Study|Adverse Event|1|||
156650139|NCT03740100|565465369|FG000|Overall Study|Death|1|||
156650140|NCT02046369|565465370|FG000|Overall Study|Adverse Event|3|||
156650141|NCT02046369|565465371|FG001|Overall Study|Adverse Event|3|||
156414316|NCT01076088|564608925|FG000|Overall Study|Lost to Follow-up|1|||
156752484|NCT01882803|565844224|FG000|Overall Study|Withdrawal by Subject|9|||
156752485|NCT01882803|565844224|FG000|Overall Study|Death|68|||
156752486|NCT01882803|565844224|FG000|Overall Study|Physician Decision|3|||
156752487|NCT01882803|565844224|FG000|Overall Study|Lost to Follow-up|3|||
156752488|NCT01882803|565844224|FG000|Overall Study|Follow-up Completed|39|||
156752489|NCT01882803|565844224|FG000|Overall Study|Study Terminated by the Sponsor|6|||
156752490|NCT02869893|565844225|FG000|Overall Study|participant aversion to IV|5|||
156752491|NCT02869893|565844225|FG000|Overall Study|participant fear of MRI scanner|2|||
156752492|NCT01563913|565844226|FG000|Overall Study|Physician Decision|1|||
156752493|NCT01563913|565844227|FG001|Overall Study|Physician Decision|0|||
156752494|NCT01563913|565844226|FG000|Overall Study|Spouse Passed Away|1|||
156752495|NCT01563913|565844227|FG001|Overall Study|Spouse Passed Away|0|||
156752496|NCT03066778|565844228|FG000|Overall Study|Death|195|||
156752497|NCT03066778|565844229|FG001|Overall Study|Death|205|||
156752498|NCT03066778|565844228|FG000|Overall Study|Withdrawal by Subject|5|||
156752499|NCT03066778|565844229|FG001|Overall Study|Withdrawal by Subject|7|||
156752500|NCT00329745|565844230|FG000|Overall Study|Protocol Violation|1|||
156752501|NCT00329745|565844231|FG001|Overall Study|Protocol Violation|0|||
156752502|NCT00329745|565844230|FG000|Overall Study|Withdrawal by Subject|0|||
156752503|NCT00329745|565844231|FG001|Overall Study|Withdrawal by Subject|1|||
156752504|NCT00329745|565844230|FG000|Overall Study|Lost to Follow-up|86|||
156752505|NCT00329745|565844231|FG001|Overall Study|Lost to Follow-up|101|||
156752506|NCT03146741|565844232|FG000|Overall Study|Txp with non-HCV+ heart|4|||
156752507|NCT03146741|565844232|FG000|Overall Study|Listeted for MOT|2|||
156752508|NCT03146741|565844232|FG000|Overall Study|Physician Decision|2|||
156752509|NCT03146741|565844232|FG000|Overall Study|Awaiting txp|2|||
156752510|NCT03224624|565844233|FG000|Overall Study|Lost to Follow-up|9|||
156752511|NCT03224624|565844234|FG001|Overall Study|Lost to Follow-up|4|||
156752512|NCT03224624|565844233|FG000|Overall Study|Death|1|||
156752513|NCT03224624|565844234|FG001|Overall Study|Death|0|||
156752514|NCT05980013|565845745|FG000|Overall Study|Withdrawal by Subject|0|||
156752515|NCT05980013|565845746|FG001|Overall Study|Withdrawal by Subject|1|||
156752516|NCT05980013|565845745|FG000|Overall Study|Device Error|0|||
156312795|NCT00422513|564244910|FG000|Overall Study|Adverse Event|4|||
156312796|NCT00422513|564244911|FG001|Overall Study|Adverse Event|4|||
156752517|NCT05980013|565845746|FG001|Overall Study|Device Error|1|||
156752518|NCT02091414|565845753|FG000|Overall Study|Withdrawal by Subject|2|||
156312797|NCT00422513|564244910|FG000|Overall Study|Death|3|||
156752519|NCT02091414|565845753|FG000|Overall Study|Death|2|||
156312798|NCT00422513|564244911|FG001|Overall Study|Death|7|||
156312799|NCT03135119|564244912|FG000|Overall Study|Lost to Follow-up|2|||
156312800|NCT03135119|564244913|FG001|Overall Study|Lost to Follow-up|0|||
156312801|NCT03135119|564244912|FG000|Overall Study|Physician Decision|1|||
156312802|NCT03135119|564244913|FG001|Overall Study|Physician Decision|1|||
156312803|NCT03135119|564244912|FG000|Overall Study|COVID-19 Shutdown|2|||
156312804|NCT03135119|564244913|FG001|Overall Study|COVID-19 Shutdown|2|||
156312805|NCT01478048|564244914|FG000|Overall Study|Disease Progression|52|||
156312806|NCT01478048|564244915|FG001|Overall Study|Disease Progression|35|||
156312807|NCT01478048|564244914|FG000|Overall Study|study drug toxicity|11|||
156312808|NCT01478048|564244915|FG001|Overall Study|study drug toxicity|14|||
156312809|NCT01478048|564244914|FG000|Overall Study|Adverse Event|2|||
156312810|NCT01478048|564244915|FG001|Overall Study|Adverse Event|11|||
156312811|NCT01478048|564244914|FG000|Overall Study|subject request to discontinue treatment|3|||
156312812|NCT01478048|564244915|FG001|Overall Study|subject request to discontinue treatment|5|||
156312813|NCT01478048|564244914|FG000|Overall Study|Withdrawal by Subject|2|||
156312814|NCT01478048|564244915|FG001|Overall Study|Withdrawal by Subject|5|||
156312815|NCT01478048|564244914|FG000|Overall Study|non-specified|6|||
156312816|NCT01478048|564244915|FG001|Overall Study|non-specified|4|||
156312817|NCT01478048|564244914|FG000|Overall Study|poor/non-compliance|0|||
156312818|NCT01478048|564244915|FG001|Overall Study|poor/non-compliance|1|||
156312819|NCT01478048|564244914|FG000|Overall Study|no longer meets study criteria|1|||
156312820|NCT01478048|564244915|FG001|Overall Study|no longer meets study criteria|0|||
156312821|NCT01369329|564244917|FG000|Overall Study|Withdrawal by Subject|8|||
156312822|NCT01369329|564244918|FG001|Overall Study|Withdrawal by Subject|6|||
156312823|NCT01369329|564244919|FG002|Overall Study|Withdrawal by Subject|10|||
156312824|NCT01369329|564244917|FG000|Overall Study|Lost to Follow-up|2|||
156312825|NCT01369329|564244918|FG001|Overall Study|Lost to Follow-up|2|||
156312826|NCT01369329|564244919|FG002|Overall Study|Lost to Follow-up|2|||
156752520|NCT04676724|565845758|FG000|Overall Study|Adverse Event|2|||
156752521|NCT04676724|565845759|FG001|Overall Study|Adverse Event|0|||
156312827|NCT01369329|564244917|FG000|Overall Study|Other|2|||
156312828|NCT01369329|564244918|FG001|Overall Study|Other|3|||
156312829|NCT01369329|564244919|FG002|Overall Study|Other|2|||
156312830|NCT04644315|564244920|FG000|Overall Study|Subject withdrawal of consent|1|||
156312831|NCT01836276|564244921|FG000|Overall Study|Lost to Follow-up|28|||
156312832|NCT01836276|564244922|FG001|Overall Study|Lost to Follow-up|51|||
156312833|NCT00913458|564244928|FG000|Phase 1|Non-Responder|54|||
156752522|NCT04676724|565845758|FG000|Overall Study|Lost to Follow-up|1|||
156752523|NCT04676724|565845759|FG001|Overall Study|Lost to Follow-up|0|||
156752524|NCT04676724|565845758|FG000|Overall Study|Physician Decision|0|||
156752525|NCT04676724|565845759|FG001|Overall Study|Physician Decision|1|||
156752526|NCT04676724|565845758|FG000|Overall Study|Withdrawal by Subject|3|||
156752527|NCT04676724|565845759|FG001|Overall Study|Withdrawal by Subject|2|||
156752528|NCT02782377|565845762|FG000|Overall Study|Physician Decision|5|||
156752529|NCT00398047|565845766|FG000|Overall Study|all patient progressed before completion|3|||
156312834|NCT00913458|564244929|FG001|Phase 1|Non-Responder|0|||
156312835|NCT00913458|564244930|FG002|Phase 1|Non-Responder|0|||
156312836|NCT00913458|564244931|FG003|Phase 1|Non-Responder|0|||
156312837|NCT00913458|564244932|FG004|Phase 1|Non-Responder|0|||
156312838|NCT00913458|564244933|FG005|Phase 1|Non-Responder|0|||
156312839|NCT00913458|564244934|FG006|Phase 1|Non-Responder|0|||
156312840|NCT00913458|564244928|FG000|Phase 1|Subject Request|17|||
156312841|NCT00913458|564244929|FG001|Phase 1|Subject Request|0|||
156312842|NCT00913458|564244930|FG002|Phase 1|Subject Request|0|||
156312843|NCT00913458|564244931|FG003|Phase 1|Subject Request|0|||
156312844|NCT00913458|564244932|FG004|Phase 1|Subject Request|0|||
156312845|NCT00913458|564244933|FG005|Phase 1|Subject Request|0|||
156312846|NCT00913458|564244934|FG006|Phase 1|Subject Request|0|||
156312847|NCT00913458|564244928|FG000|Phase 1|Adverse Event|20|||
156312848|NCT00913458|564244929|FG001|Phase 1|Adverse Event|0|||
156312849|NCT00913458|564244930|FG002|Phase 1|Adverse Event|0|||
156312850|NCT00913458|564244931|FG003|Phase 1|Adverse Event|0|||
156312851|NCT00913458|564244932|FG004|Phase 1|Adverse Event|0|||
156312852|NCT00913458|564244933|FG005|Phase 1|Adverse Event|0|||
156312853|NCT00913458|564244934|FG006|Phase 1|Adverse Event|0|||
156312854|NCT00913458|564244928|FG000|Phase 1|Lost to Follow-up|2|||
156312855|NCT00913458|564244929|FG001|Phase 1|Lost to Follow-up|0|||
156312856|NCT00913458|564244930|FG002|Phase 1|Lost to Follow-up|0|||
156312857|NCT00913458|564244931|FG003|Phase 1|Lost to Follow-up|0|||
156312858|NCT00913458|564244932|FG004|Phase 1|Lost to Follow-up|0|||
156312859|NCT00913458|564244933|FG005|Phase 1|Lost to Follow-up|0|||
156312860|NCT00913458|564244934|FG006|Phase 1|Lost to Follow-up|0|||
156312861|NCT00913458|564244928|FG000|Phase 1|Protocol Violation|10|||
156312862|NCT00913458|564244929|FG001|Phase 1|Protocol Violation|0|||
156312863|NCT00913458|564244930|FG002|Phase 1|Protocol Violation|0|||
156312864|NCT00913458|564244931|FG003|Phase 1|Protocol Violation|0|||
156312865|NCT00913458|564244932|FG004|Phase 1|Protocol Violation|0|||
156312866|NCT00913458|564244933|FG005|Phase 1|Protocol Violation|0|||
156312867|NCT00913458|564244934|FG006|Phase 1|Protocol Violation|0|||
156312868|NCT00913458|564244928|FG000|Phase 1|Sponsor|2|||
156312869|NCT00913458|564244929|FG001|Phase 1|Sponsor|0|||
156312870|NCT00913458|564244930|FG002|Phase 1|Sponsor|0|||
156312871|NCT00913458|564244931|FG003|Phase 1|Sponsor|0|||
156312872|NCT00913458|564244932|FG004|Phase 1|Sponsor|0|||
156312873|NCT00913458|564244933|FG005|Phase 1|Sponsor|0|||
156312874|NCT00913458|564244934|FG006|Phase 1|Sponsor|0|||
156312875|NCT00913458|564244928|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
156312876|NCT00913458|564244929|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
156312877|NCT00913458|564244930|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
156312878|NCT00913458|564244931|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
156312879|NCT00913458|564244932|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
156312880|NCT00913458|564244933|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
156312881|NCT00913458|564244934|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
156312882|NCT00913458|564244928|FG000|Phase 2|Non-Responder|0|||
156312883|NCT00913458|564244929|FG001|Phase 2|Non-Responder|5|||
156312884|NCT00913458|564244930|FG002|Phase 2|Non-Responder|7|||
156312885|NCT00913458|564244931|FG003|Phase 2|Non-Responder|12|||
156312886|NCT00913458|564244932|FG004|Phase 2|Non-Responder|0|||
156312887|NCT00913458|564244933|FG005|Phase 2|Non-Responder|0|||
156312888|NCT00913458|564244934|FG006|Phase 2|Non-Responder|0|||
156312889|NCT00913458|564244928|FG000|Phase 2|Subject Request|0|||
156312890|NCT00913458|564244929|FG001|Phase 2|Subject Request|0|||
156312891|NCT00913458|564244930|FG002|Phase 2|Subject Request|1|||
156312892|NCT00913458|564244931|FG003|Phase 2|Subject Request|2|||
156312893|NCT00913458|564244932|FG004|Phase 2|Subject Request|0|||
156312894|NCT00913458|564244933|FG005|Phase 2|Subject Request|0|||
156752530|NCT02521792|565845767|FG000|Overall Study|Study Terminated|6|||
156312895|NCT00913458|564244934|FG006|Phase 2|Subject Request|0|||
156312896|NCT00913458|564244928|FG000|Phase 2|Adverse Event|0|||
156312897|NCT00913458|564244929|FG001|Phase 2|Adverse Event|3|||
156312898|NCT00913458|564244930|FG002|Phase 2|Adverse Event|0|||
156312899|NCT00913458|564244931|FG003|Phase 2|Adverse Event|1|||
156312900|NCT00913458|564244932|FG004|Phase 2|Adverse Event|0|||
156312901|NCT00913458|564244933|FG005|Phase 2|Adverse Event|0|||
156312902|NCT00913458|564244934|FG006|Phase 2|Adverse Event|0|||
156312903|NCT00913458|564244928|FG000|Phase 2|Lost to Follow-up|0|||
156312904|NCT00913458|564244929|FG001|Phase 2|Lost to Follow-up|0|||
156312905|NCT00913458|564244930|FG002|Phase 2|Lost to Follow-up|0|||
156312906|NCT00913458|564244931|FG003|Phase 2|Lost to Follow-up|1|||
156312907|NCT00913458|564244932|FG004|Phase 2|Lost to Follow-up|0|||
156312908|NCT00913458|564244933|FG005|Phase 2|Lost to Follow-up|0|||
156312909|NCT00913458|564244934|FG006|Phase 2|Lost to Follow-up|0|||
156312910|NCT00913458|564244928|FG000|Phase 2|Protocol Violation|0|||
156312911|NCT00913458|564244929|FG001|Phase 2|Protocol Violation|2|||
156312912|NCT00913458|564244930|FG002|Phase 2|Protocol Violation|0|||
156752531|NCT01188668|565845768|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
156752532|NCT01188668|565845768|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
156752533|NCT01188668|565845768|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
156752534|NCT00902746|565845769|FG000|Overall Study|Protocol Violation|7|||
156752535|NCT00902746|565845769|FG000|Overall Study|Withdrawal by Subject|16|||
156752536|NCT00902746|565845769|FG000|Overall Study|Adverse Event|8|||
156752537|NCT00902746|565845769|FG000|Overall Study|Lost to Follow-up|3|||
156752538|NCT00902746|565845769|FG000|Overall Study|Physician Decision|2|||
156752539|NCT02081001|565845771|FG000|Overall Study|Adverse Event|0|||
156752540|NCT02081001|565845772|FG001|Overall Study|Adverse Event|0|||
156752541|NCT02081001|565845773|FG002|Overall Study|Adverse Event|0|||
156752542|NCT02081001|565845774|FG003|Overall Study|Adverse Event|0|||
156752543|NCT02081001|565845775|FG004|Overall Study|Adverse Event|1|||
156752544|NCT02081001|565845776|FG005|Overall Study|Adverse Event|0|||
156752545|NCT02081001|565845777|FG006|Overall Study|Adverse Event|0|||
156752546|NCT02081001|565845778|FG007|Overall Study|Adverse Event|0|||
156752547|NCT02081001|565845779|FG008|Overall Study|Adverse Event|0|||
156752548|NCT02081001|565845780|FG009|Overall Study|Adverse Event|0|||
156752549|NCT02081001|565845781|FG010|Overall Study|Adverse Event|0|||
156752550|NCT02081001|565845782|FG011|Overall Study|Adverse Event|0|||
156752551|NCT00359294|565845783|FG000|Overall Study|Progressive disease|1|||
156752552|NCT00359294|565845784|FG001|Overall Study|Progressive disease|1|||
156752553|NCT00359294|565845785|FG002|Overall Study|Progressive disease|2|||
156752554|NCT00359294|565845786|FG003|Overall Study|Progressive disease|3|||
156752555|NCT00359294|565845787|FG004|Overall Study|Progressive disease|2|||
156752556|NCT00359294|565845783|FG000|Overall Study|Withdrawal by Subject|0|||
156752557|NCT00359294|565845784|FG001|Overall Study|Withdrawal by Subject|0|||
156752558|NCT00359294|565845785|FG002|Overall Study|Withdrawal by Subject|0|||
156752559|NCT00359294|565845786|FG003|Overall Study|Withdrawal by Subject|0|||
156752560|NCT00359294|565845787|FG004|Overall Study|Withdrawal by Subject|1|||
156752561|NCT00359294|565845783|FG000|Overall Study|Not treated|0|||
156752562|NCT00359294|565845784|FG001|Overall Study|Not treated|0|||
156752563|NCT00359294|565845785|FG002|Overall Study|Not treated|0|||
156752564|NCT00359294|565845786|FG003|Overall Study|Not treated|1|||
156752565|NCT00359294|565845787|FG004|Overall Study|Not treated|0|||
156752566|NCT00359294|565845783|FG000|Overall Study|Physician Decision|0|||
156752567|NCT00359294|565845784|FG001|Overall Study|Physician Decision|0|||
156752568|NCT00359294|565845785|FG002|Overall Study|Physician Decision|1|||
156752569|NCT00359294|565845786|FG003|Overall Study|Physician Decision|0|||
156752570|NCT00359294|565845787|FG004|Overall Study|Physician Decision|0|||
156312913|NCT00913458|564244931|FG003|Phase 2|Protocol Violation|0|||
156312914|NCT00913458|564244932|FG004|Phase 2|Protocol Violation|0|||
156312915|NCT00913458|564244933|FG005|Phase 2|Protocol Violation|0|||
156312916|NCT00913458|564244934|FG006|Phase 2|Protocol Violation|0|||
156312917|NCT00913458|564244928|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
156312918|NCT00913458|564244929|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
156312919|NCT00913458|564244930|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
156312920|NCT00913458|564244931|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
156312921|NCT00913458|564244932|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
156312922|NCT00913458|564244933|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
156312923|NCT00913458|564244934|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
156312924|NCT00913458|564244928|FG000|Phase 3|Adverse Event|0|||
156312925|NCT00913458|564244929|FG001|Phase 3|Adverse Event|0|||
156312926|NCT00913458|564244930|FG002|Phase 3|Adverse Event|0|||
156312927|NCT00913458|564244931|FG003|Phase 3|Adverse Event|0|||
156312928|NCT00913458|564244932|FG004|Phase 3|Adverse Event|5|||
156312929|NCT00913458|564244933|FG005|Phase 3|Adverse Event|4|||
156312930|NCT00913458|564244934|FG006|Phase 3|Adverse Event|1|||
156312931|NCT00913458|564244928|FG000|Phase 3|Lost to Follow-up|0|||
156312932|NCT00913458|564244929|FG001|Phase 3|Lost to Follow-up|0|||
156312933|NCT00913458|564244930|FG002|Phase 3|Lost to Follow-up|0|||
156312934|NCT00913458|564244931|FG003|Phase 3|Lost to Follow-up|0|||
156312935|NCT00913458|564244932|FG004|Phase 3|Lost to Follow-up|2|||
156312936|NCT00913458|564244933|FG005|Phase 3|Lost to Follow-up|0|||
156312937|NCT00913458|564244934|FG006|Phase 3|Lost to Follow-up|0|||
156312938|NCT00913458|564244928|FG000|Phase 3|Non-Responder|0|||
156312939|NCT00913458|564244929|FG001|Phase 3|Non-Responder|0|||
156414317|NCT01076088|564608926|FG001|Overall Study|Lost to Follow-up|1|||
156752571|NCT04208412|565845794|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
156752572|NCT04208412|565845795|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
156752573|NCT04208412|565845794|FG000|Overall Study|Withdrawal by Subject|1|||
156752574|NCT04208412|565845795|FG001|Overall Study|Withdrawal by Subject|0|||
156312940|NCT00913458|564244930|FG002|Phase 3|Non-Responder|0|||
156312941|NCT00913458|564244931|FG003|Phase 3|Non-Responder|0|||
156312942|NCT00913458|564244932|FG004|Phase 3|Non-Responder|0|||
156312943|NCT00913458|564244933|FG005|Phase 3|Non-Responder|1|||
156312944|NCT00913458|564244934|FG006|Phase 3|Non-Responder|3|||
156312945|NCT00913458|564244928|FG000|Phase 3|Withdrawal by Subject|0|||
156312946|NCT00913458|564244929|FG001|Phase 3|Withdrawal by Subject|0|||
156752575|NCT04208412|565845794|FG000|Overall Study|Lost to Follow-up|0|||
156752576|NCT04208412|565845795|FG001|Overall Study|Lost to Follow-up|1|||
156752577|NCT02588092|565845798|FG000|Overall Study|Death|4|||
156752578|NCT02588092|565845799|FG001|Overall Study|Death|3|||
156414318|NCT01076088|564608927|FG002|Overall Study|Lost to Follow-up|0|||
156414319|NCT01076088|564608928|FG003|Overall Study|Lost to Follow-up|1|||
156414320|NCT01076088|564608929|FG004|Overall Study|Lost to Follow-up|1|||
156414321|NCT01076088|564608930|FG005|Overall Study|Lost to Follow-up|2|||
156414322|NCT01076088|564608925|FG000|Overall Study|Non-compliance with study drug|0|||
156414323|NCT01076088|564608926|FG001|Overall Study|Non-compliance with study drug|0|||
156414324|NCT01076088|564608927|FG002|Overall Study|Non-compliance with study drug|0|||
156414325|NCT01076088|564608928|FG003|Overall Study|Non-compliance with study drug|1|||
156414326|NCT01076088|564608929|FG004|Overall Study|Non-compliance with study drug|0|||
156414327|NCT01076088|564608930|FG005|Overall Study|Non-compliance with study drug|0|||
156414328|NCT01076088|564608925|FG000|Overall Study|Physician Decision|1|||
156650142|NCT02046369|565465370|FG000|Overall Study|Lack of Efficacy|3|||
156650143|NCT02046369|565465371|FG001|Overall Study|Lack of Efficacy|3|||
156650144|NCT02046369|565465370|FG000|Overall Study|Lost to Follow-up|3|||
156650145|NCT02046369|565465371|FG001|Overall Study|Lost to Follow-up|3|||
156650146|NCT02046369|565465370|FG000|Overall Study|Protocol Violation|1|||
156650147|NCT02046369|565465371|FG001|Overall Study|Protocol Violation|2|||
156650148|NCT02046369|565465370|FG000|Overall Study|Withdrawal by Subject|3|||
156650149|NCT02046369|565465371|FG001|Overall Study|Withdrawal by Subject|6|||
156650150|NCT02046369|565465370|FG000|Overall Study|never received study drug|0|||
156650151|NCT02046369|565465371|FG001|Overall Study|never received study drug|1|||
156650152|NCT02046369|565465370|FG000|Overall Study|non compliance|1|||
156650153|NCT02046369|565465371|FG001|Overall Study|non compliance|0|||
156650154|NCT03120520|565465372|FG000|Overall Study|Lost to Follow-up|1|||
156650155|NCT03120520|565465373|FG001|Overall Study|Lost to Follow-up|1|||
156650156|NCT03120520|565465374|FG002|Overall Study|Lost to Follow-up|1|||
156650157|NCT03120520|565465375|FG003|Overall Study|Lost to Follow-up|1|||
156650158|NCT03120520|565465372|FG000|Overall Study|Withdrawal by Subject|3|||
156650159|NCT03120520|565465373|FG001|Overall Study|Withdrawal by Subject|2|||
156650160|NCT03120520|565465374|FG002|Overall Study|Withdrawal by Subject|3|||
156650161|NCT03120520|565465375|FG003|Overall Study|Withdrawal by Subject|2|||
156650162|NCT03120520|565465372|FG000|Overall Study|Other|0|||
156650163|NCT03120520|565465373|FG001|Overall Study|Other|1|||
156650164|NCT03120520|565465374|FG002|Overall Study|Other|0|||
156650165|NCT03120520|565465375|FG003|Overall Study|Other|0|||
156650166|NCT04345471|565465377|FG000|Overall Study|Adverse Event|8|||
156650167|NCT04345471|565465378|FG001|Overall Study|Adverse Event|5|||
156650168|NCT04345471|565465379|FG002|Overall Study|Adverse Event|6|||
156650169|NCT04345471|565465377|FG000|Overall Study|Lack of Efficacy|1|||
156650170|NCT04345471|565465378|FG001|Overall Study|Lack of Efficacy|1|||
156650171|NCT04345471|565465379|FG002|Overall Study|Lack of Efficacy|0|||
156650172|NCT04345471|565465377|FG000|Overall Study|Protocol Violation|0|||
156650173|NCT04345471|565465378|FG001|Overall Study|Protocol Violation|1|||
156650174|NCT04345471|565465379|FG002|Overall Study|Protocol Violation|2|||
156650175|NCT04345471|565465377|FG000|Overall Study|Withdrawal by Subject|10|||
156650176|NCT04345471|565465378|FG001|Overall Study|Withdrawal by Subject|5|||
156650177|NCT04345471|565465379|FG002|Overall Study|Withdrawal by Subject|10|||
156650178|NCT02378506|565465383|FG000|Overall Study|Lack of Efficacy|3|||
156650179|NCT02378506|565465383|FG000|Overall Study|Withdrawal by Subject|4|||
156650180|NCT02378506|565465383|FG000|Overall Study|Protocol Violation|2|||
156650181|NCT02378506|565465383|FG000|Overall Study|Death|1|||
156650182|NCT02378506|565465383|FG000|Overall Study|Adverse Event|14|||
156650183|NCT02378506|565465383|FG000|Overall Study|Randomized But Not Treated|1|||
156650184|NCT03387059|565465384|FG000|Overall Study|Study termination|5|||
156650185|NCT03387059|565465385|FG001|Overall Study|Study termination|4|||
156650186|NCT01606137|565465386|FG000|Overall Study|Adverse Event|85|||
156650187|NCT01606137|565465386|FG000|Overall Study|Withdrawal by Subject|74|||
156650188|NCT01606137|565465386|FG000|Overall Study|Lack of Efficacy|56|||
156752579|NCT02588092|565845800|FG002|Overall Study|Death|3|||
156650189|NCT01606137|565465386|FG000|Overall Study|Lost to Follow-up|15|||
156650190|NCT01606137|565465386|FG000|Overall Study|Protocol Violation|1|||
156650191|NCT01606137|565465386|FG000|Overall Study|Patient non-compliance|9|||
156650192|NCT01606137|565465386|FG000|Overall Study|Death|1|||
156650193|NCT01606137|565465386|FG000|Overall Study|Decreased/no pain|4|||
156650194|NCT01606137|565465386|FG000|Overall Study|Issues with driving|4|||
156650195|NCT01606137|565465386|FG000|Overall Study|multiple sclerosis less stable|1|||
156752580|NCT02588092|565845801|FG003|Overall Study|Death|3|||
156650196|NCT01606137|565465386|FG000|Overall Study|Increased bilirubin|1|||
156650197|NCT01606137|565465386|FG000|Overall Study|Spray causes nausea|1|||
156650198|NCT01606137|565465386|FG000|Overall Study|Not enough improvement|4|||
156414329|NCT01076088|564608926|FG001|Overall Study|Physician Decision|3|||
156650199|NCT01606137|565465386|FG000|Overall Study|Wanted to try another treatment|1|||
156414330|NCT01076088|564608927|FG002|Overall Study|Physician Decision|0|||
156650200|NCT01606137|565465386|FG000|Overall Study|Patient leaving country|1|||
156650201|NCT01606137|565465386|FG000|Overall Study|Personal reasons|1|||
156752581|NCT02588092|565845802|FG004|Overall Study|Death|2|||
156752582|NCT02588092|565845803|FG005|Overall Study|Death|2|||
156752583|NCT02588092|565845804|FG006|Overall Study|Death|2|||
156752584|NCT02588092|565845805|FG007|Overall Study|Death|1|||
156752585|NCT02588092|565845806|FG008|Overall Study|Death|5|||
156752586|NCT02588092|565845807|FG009|Overall Study|Death|2|||
156752587|NCT02588092|565845798|FG000|Overall Study|Withdrawal by Subject|0|||
156752588|NCT02588092|565845799|FG001|Overall Study|Withdrawal by Subject|0|||
156752589|NCT02588092|565845800|FG002|Overall Study|Withdrawal by Subject|0|||
156752590|NCT02588092|565845801|FG003|Overall Study|Withdrawal by Subject|0|||
156752591|NCT02588092|565845802|FG004|Overall Study|Withdrawal by Subject|0|||
156752592|NCT02588092|565845803|FG005|Overall Study|Withdrawal by Subject|1|||
156752593|NCT02588092|565845804|FG006|Overall Study|Withdrawal by Subject|1|||
156752594|NCT02588092|565845805|FG007|Overall Study|Withdrawal by Subject|2|||
156752595|NCT02588092|565845806|FG008|Overall Study|Withdrawal by Subject|0|||
156752596|NCT02588092|565845807|FG009|Overall Study|Withdrawal by Subject|0|||
156752597|NCT02588092|565845798|FG000|Overall Study|Started Another Treatment|0|||
156752598|NCT02588092|565845799|FG001|Overall Study|Started Another Treatment|0|||
156752599|NCT02588092|565845800|FG002|Overall Study|Started Another Treatment|0|||
156752600|NCT02588092|565845801|FG003|Overall Study|Started Another Treatment|0|||
156752601|NCT02588092|565845802|FG004|Overall Study|Started Another Treatment|1|||
156752602|NCT02588092|565845803|FG005|Overall Study|Started Another Treatment|0|||
156752603|NCT02588092|565845804|FG006|Overall Study|Started Another Treatment|0|||
156752604|NCT02588092|565845805|FG007|Overall Study|Started Another Treatment|1|||
156752605|NCT02588092|565845806|FG008|Overall Study|Started Another Treatment|0|||
156752606|NCT02588092|565845807|FG009|Overall Study|Started Another Treatment|0|||
156752607|NCT02588092|565845798|FG000|Overall Study|Sponsor Decision|0|||
156752608|NCT02588092|565845799|FG001|Overall Study|Sponsor Decision|0|||
156752609|NCT02588092|565845800|FG002|Overall Study|Sponsor Decision|0|||
156752610|NCT02588092|565845801|FG003|Overall Study|Sponsor Decision|0|||
156752611|NCT02588092|565845802|FG004|Overall Study|Sponsor Decision|0|||
156752612|NCT02588092|565845803|FG005|Overall Study|Sponsor Decision|0|||
156752613|NCT02588092|565845804|FG006|Overall Study|Sponsor Decision|0|||
156752614|NCT02588092|565845805|FG007|Overall Study|Sponsor Decision|0|||
156752615|NCT02588092|565845806|FG008|Overall Study|Sponsor Decision|1|||
156752616|NCT02588092|565845807|FG009|Overall Study|Sponsor Decision|1|||
156752617|NCT01348100|565845808|FG000|Overall Study|Subject Withdrew Consent|0|||
156752618|NCT01348100|565845809|FG001|Overall Study|Subject Withdrew Consent|0|||
156752619|NCT01348100|565845810|FG002|Overall Study|Subject Withdrew Consent|2|||
156752620|NCT01348100|565845811|FG003|Overall Study|Subject Withdrew Consent|0|||
156752621|NCT01348100|565845812|FG004|Overall Study|Subject Withdrew Consent|1|||
156752622|NCT01348100|565845813|FG005|Overall Study|Subject Withdrew Consent|0|||
156752623|NCT01348100|565845814|FG006|Overall Study|Subject Withdrew Consent|1|||
156752624|NCT01348100|565845808|FG000|Overall Study|Protocol Deviation|0|||
156752625|NCT01348100|565845809|FG001|Overall Study|Protocol Deviation|0|||
156752626|NCT01348100|565845810|FG002|Overall Study|Protocol Deviation|0|||
156752627|NCT01348100|565845811|FG003|Overall Study|Protocol Deviation|1|||
156752628|NCT01348100|565845812|FG004|Overall Study|Protocol Deviation|0|||
156752629|NCT01348100|565845813|FG005|Overall Study|Protocol Deviation|0|||
156752630|NCT01348100|565845814|FG006|Overall Study|Protocol Deviation|0|||
156752631|NCT01348100|565845808|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156312947|NCT00913458|564244930|FG002|Phase 3|Withdrawal by Subject|0|||
156312948|NCT00913458|564244931|FG003|Phase 3|Withdrawal by Subject|0|||
156312949|NCT00913458|564244932|FG004|Phase 3|Withdrawal by Subject|1|||
156312950|NCT00913458|564244933|FG005|Phase 3|Withdrawal by Subject|2|||
156312951|NCT00913458|564244934|FG006|Phase 3|Withdrawal by Subject|0|||
156312952|NCT00913458|564244928|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
156312953|NCT00913458|564244929|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
156312954|NCT00913458|564244930|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
156312955|NCT00913458|564244931|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
156312956|NCT00913458|564244932|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
156312957|NCT00913458|564244933|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
156752632|NCT01348100|565845809|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752633|NCT01348100|565845810|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752634|NCT01348100|565845811|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752635|NCT01348100|565845812|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752636|NCT01348100|565845813|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
156752637|NCT01348100|565845814|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752638|NCT01348100|565845808|FG000|Overall Study|Lost to Follow-up|0|||
156752639|NCT01348100|565845809|FG001|Overall Study|Lost to Follow-up|0|||
156752640|NCT01348100|565845810|FG002|Overall Study|Lost to Follow-up|0|||
156752641|NCT01348100|565845811|FG003|Overall Study|Lost to Follow-up|0|||
156752642|NCT01348100|565845812|FG004|Overall Study|Lost to Follow-up|0|||
156752643|NCT01348100|565845813|FG005|Overall Study|Lost to Follow-up|0|||
156312958|NCT00913458|564244934|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
156312959|NCT02366091|564244935|FG000|Overall Study|Withdrawal by Subject|3|||
156752644|NCT01348100|565845814|FG006|Overall Study|Lost to Follow-up|1|||
156752645|NCT01348100|565845808|FG000|Overall Study|Administrative Problems|0|||
156752646|NCT01348100|565845809|FG001|Overall Study|Administrative Problems|0|||
156752647|NCT01348100|565845810|FG002|Overall Study|Administrative Problems|0|||
156414331|NCT01076088|564608928|FG003|Overall Study|Physician Decision|1|||
156414332|NCT01076088|564608929|FG004|Overall Study|Physician Decision|1|||
156414333|NCT01076088|564608930|FG005|Overall Study|Physician Decision|0|||
156414334|NCT01076088|564608925|FG000|Overall Study|Withdrawal by Subject|8|||
156414335|NCT01076088|564608926|FG001|Overall Study|Withdrawal by Subject|8|||
156414336|NCT01076088|564608927|FG002|Overall Study|Withdrawal by Subject|14|||
156414337|NCT01076088|564608928|FG003|Overall Study|Withdrawal by Subject|10|||
156414338|NCT01076088|564608929|FG004|Overall Study|Withdrawal by Subject|11|||
156414339|NCT01076088|564608930|FG005|Overall Study|Withdrawal by Subject|17|||
156414340|NCT01076088|564608925|FG000|Overall Study|Other protocol specified criteria|0|||
156414341|NCT01076088|564608926|FG001|Overall Study|Other protocol specified criteria|0|||
156414342|NCT01076088|564608927|FG002|Overall Study|Other protocol specified criteria|0|||
156414343|NCT01076088|564608928|FG003|Overall Study|Other protocol specified criteria|0|||
156414344|NCT01076088|564608929|FG004|Overall Study|Other protocol specified criteria|0|||
156414345|NCT01076088|564608930|FG005|Overall Study|Other protocol specified criteria|1|||
156414346|NCT03053492|564608933|FG000|Overall Study|Adverse Event|1|||
156414347|NCT03053492|564608934|FG001|Overall Study|Adverse Event|1|||
156414348|NCT03053492|564608933|FG000|Overall Study|Withdrawal by Subject|7|||
156414349|NCT03053492|564608934|FG001|Overall Study|Withdrawal by Subject|5|||
156414350|NCT00683449|564608938|FG000|Overall Study|Lost to Follow-up|0|||
156414351|NCT00683449|564608939|FG001|Overall Study|Lost to Follow-up|1|||
156414352|NCT00683449|564608940|FG002|Overall Study|Lost to Follow-up|0|||
156414353|NCT00683449|564608941|FG003|Overall Study|Lost to Follow-up|0|||
156414354|NCT00683449|564608942|FG004|Overall Study|Lost to Follow-up|0|||
156414355|NCT01857622|564608945|FG000|Overall Study|Adverse Event|5|||
156414356|NCT01857622|564608946|FG001|Overall Study|Adverse Event|0|||
156414357|NCT01857622|564608947|FG002|Overall Study|Adverse Event|2|||
156414358|NCT01857622|564608945|FG000|Overall Study|Physician Decision|1|||
156414359|NCT01857622|564608946|FG001|Overall Study|Physician Decision|0|||
156752648|NCT01348100|565845811|FG003|Overall Study|Administrative Problems|0|||
156752649|NCT01348100|565845812|FG004|Overall Study|Administrative Problems|0|||
156752650|NCT01348100|565845813|FG005|Overall Study|Administrative Problems|1|||
156752651|NCT01348100|565845814|FG006|Overall Study|Administrative Problems|1|||
156752652|NCT03882957|565845817|FG000|Overall Study|Did not complete all three arms|1|||
156752653|NCT03762681|565845821|FG000|Part 1|Withdrawal by Subject|0|||
156752654|NCT03762681|565845822|FG001|Part 1|Withdrawal by Subject|0|||
156752655|NCT03762681|565845823|FG002|Part 1|Withdrawal by Subject|0|||
156752656|NCT03762681|565845824|FG003|Part 1|Withdrawal by Subject|1|||
156752657|NCT03762681|565845825|FG004|Part 1|Withdrawal by Subject|0|||
156752658|NCT03762681|565845826|FG005|Part 1|Withdrawal by Subject|0|||
156752659|NCT03762681|565845827|FG006|Part 1|Withdrawal by Subject|0|||
156752660|NCT03762681|565845828|FG007|Part 1|Withdrawal by Subject|0|||
156752661|NCT03762681|565845821|FG000|Part 2a|Pandemic Travel Restrictions|0|||
156752662|NCT03762681|565845822|FG001|Part 2a|Pandemic Travel Restrictions|0|||
156752663|NCT03762681|565845823|FG002|Part 2a|Pandemic Travel Restrictions|0|||
156752664|NCT03762681|565845824|FG003|Part 2a|Pandemic Travel Restrictions|0|||
156752665|NCT03762681|565845825|FG004|Part 2a|Pandemic Travel Restrictions|0|||
156752666|NCT03762681|565845826|FG005|Part 2a|Pandemic Travel Restrictions|0|||
156752667|NCT03762681|565845827|FG006|Part 2a|Pandemic Travel Restrictions|0|||
156752668|NCT03762681|565845828|FG007|Part 2a|Pandemic Travel Restrictions|1|||
156752669|NCT03148067|565845830|FG000|Overall Study|Lost to Follow-up|3|||
156752670|NCT03148067|565845830|FG000|Overall Study|Death|1|||
156752671|NCT00524680|565845832|FG000|Overall Study|progression|0|||
156752672|NCT00524680|565845833|FG001|Overall Study|progression|0|||
156752673|NCT00524680|565845834|FG002|Overall Study|progression|0|||
156752674|NCT00524680|565845835|FG003|Overall Study|progression|1|||
156752675|NCT00524680|565845832|FG000|Overall Study|Adverse Event|2|||
156752676|NCT00524680|565845833|FG001|Overall Study|Adverse Event|0|||
156752677|NCT00524680|565845834|FG002|Overall Study|Adverse Event|0|||
156414360|NCT01857622|564608947|FG002|Overall Study|Physician Decision|0|||
156414361|NCT01857622|564608945|FG000|Overall Study|Protocol Violation|4|||
156414362|NCT01857622|564608946|FG001|Overall Study|Protocol Violation|1|||
156414363|NCT01857622|564608947|FG002|Overall Study|Protocol Violation|0|||
156752678|NCT00524680|565845835|FG003|Overall Study|Adverse Event|1|||
156752679|NCT00524680|565845832|FG000|Overall Study|Other|0|||
156752680|NCT00524680|565845833|FG001|Overall Study|Other|1|||
156752681|NCT00524680|565845834|FG002|Overall Study|Other|2|||
156752682|NCT00524680|565845835|FG003|Overall Study|Other|3|||
156752683|NCT00524680|565845832|FG000|Overall Study|Withdrawal by Subject|1|||
156752684|NCT00524680|565845833|FG001|Overall Study|Withdrawal by Subject|0|||
156752685|NCT00524680|565845834|FG002|Overall Study|Withdrawal by Subject|1|||
156752686|NCT00524680|565845835|FG003|Overall Study|Withdrawal by Subject|1|||
156414364|NCT01857622|564608945|FG000|Overall Study|Withdrawal by Subject|1|||
156414365|NCT01857622|564608946|FG001|Overall Study|Withdrawal by Subject|0|||
156752687|NCT01146561|565845836|FG000|Overall Study|Withdrawal by Subject|1|||
156752688|NCT01146561|565845836|FG000|Overall Study|Lost to Follow-up|1|||
156752689|NCT00830518|565845844|FG000|Overall Study|Progressive Disease|18|||
156752690|NCT00830518|565845845|FG001|Overall Study|Progressive Disease|8|||
156752691|NCT00830518|565845844|FG000|Overall Study|Symptomatic Deterioration|4|||
156752692|NCT00830518|565845845|FG001|Overall Study|Symptomatic Deterioration|1|||
156752693|NCT00830518|565845844|FG000|Overall Study|Adverse Event|14|||
156752694|NCT00830518|565845845|FG001|Overall Study|Adverse Event|1|||
156752695|NCT00830518|565845844|FG000|Overall Study|Withdrawal by Patient|2|||
156752696|NCT00830518|565845845|FG001|Overall Study|Withdrawal by Patient|0|||
156752697|NCT00830518|565845844|FG000|Overall Study|Reason not Specified|8|||
156752698|NCT00830518|565845845|FG001|Overall Study|Reason not Specified|1|||
156752699|NCT04318132|565845846|FG000|Overall Study|Protocol Violation|0|||
156752700|NCT04318132|565845847|FG001|Overall Study|Protocol Violation|0|||
156752701|NCT04318132|565845848|FG002|Overall Study|Protocol Violation|3|||
156752702|NCT04318132|565845849|FG003|Overall Study|Protocol Violation|0|||
156752703|NCT03337048|565845850|FG000|Overall Study|Withdrawal by Subject|2|||
156752704|NCT03337048|565845851|FG001|Overall Study|Withdrawal by Subject|0|||
156752705|NCT03337048|565845852|FG002|Overall Study|Withdrawal by Subject|0|||
156752706|NCT00586898|565845855|FG000|Overall Study|Adverse Event|1|||
156752707|NCT00586898|565845855|FG000|Overall Study|Patiemt Non-compliance|1|||
156752708|NCT00586898|565845855|FG000|Overall Study|Evaluable for Toxicity Only|5|||
156752709|NCT00492232|565845856|FG000|Placebo Run-in|Adverse Event|0|||
156752710|NCT00492232|565845857|FG001|Placebo Run-in|Adverse Event|2|||
156752711|NCT00492232|565845856|FG000|Placebo Run-in|Protocol Violation|0|||
156752712|NCT00492232|565845857|FG001|Placebo Run-in|Protocol Violation|3|||
156752713|NCT00492232|565845856|FG000|Placebo Run-in|Lost to Follow-up|0|||
156752714|NCT00492232|565845857|FG001|Placebo Run-in|Lost to Follow-up|3|||
156752715|NCT00492232|565845856|FG000|Placebo Run-in|Withdrawal by Subject|0|||
156752716|NCT00492232|565845857|FG001|Placebo Run-in|Withdrawal by Subject|8|||
156752717|NCT00492232|565845856|FG000|Placebo Run-in|Pregnancy|0|||
156752718|NCT00492232|565845857|FG001|Placebo Run-in|Pregnancy|1|||
156752719|NCT00492232|565845856|FG000|Placebo Run-in|Entrance criteria not met|0|||
156752720|NCT00492232|565845857|FG001|Placebo Run-in|Entrance criteria not met|45|||
156752721|NCT00492232|565845856|FG000|Placebo Run-in|Other|0|||
156752722|NCT00492232|565845857|FG001|Placebo Run-in|Other|6|||
156752723|NCT00492232|565845856|FG000|Placebo Run-in|Missing|0|||
156752724|NCT00492232|565845857|FG001|Placebo Run-in|Missing|2|||
156752725|NCT00492232|565845856|FG000|Double-Blind Treatment|Adverse Event|1|||
156752726|NCT00492232|565845857|FG001|Double-Blind Treatment|Adverse Event|2|||
156752727|NCT00492232|565845856|FG000|Double-Blind Treatment|Protocol Violation|3|||
156752728|NCT00492232|565845857|FG001|Double-Blind Treatment|Protocol Violation|7|||
156752729|NCT00492232|565845856|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
156752730|NCT00492232|565845857|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
156752731|NCT00492232|565845856|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
156752732|NCT00492232|565845857|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
156752733|NCT00492232|565845856|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
156752734|NCT00492232|565845857|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
156752735|NCT00492232|565845856|FG000|Double-Blind Treatment|Other|6|||
156752736|NCT00492232|565845857|FG001|Double-Blind Treatment|Other|5|||
156752737|NCT00492232|565845856|FG000|Double-Blind Treatment|Randomized not treated|1|||
156752738|NCT00492232|565845857|FG001|Double-Blind Treatment|Randomized not treated|0|||
156752739|NCT00492232|565845856|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
156752740|NCT00492232|565845857|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
156752741|NCT01994902|565845859|FG000|Test Period 1|Withdrawal by Subject|3|||
156752742|NCT01994902|565845860|FG001|Test Period 1|Withdrawal by Subject|0|||
156752743|NCT01994902|565845859|FG000|Test Period 1|device deficiency with adverse event|0|||
156752744|NCT01994902|565845860|FG001|Test Period 1|device deficiency with adverse event|1|||
156752745|NCT01994902|565845859|FG000|Test Period 1|Adverse Event|2|||
156752746|NCT01994902|565845860|FG001|Test Period 1|Adverse Event|1|||
156752747|NCT01994902|565845859|FG000|Test Period 1|Lack of Efficacy|0|||
156752748|NCT01994902|565845860|FG001|Test Period 1|Lack of Efficacy|1|||
156752749|NCT01994902|565845859|FG000|Test Period 1|bag too small|1|||
156752750|NCT01994902|565845860|FG001|Test Period 1|bag too small|0|||
156312960|NCT02366091|564244936|FG001|Overall Study|Withdrawal by Subject|7|||
156312961|NCT02366091|564244937|FG002|Overall Study|Withdrawal by Subject|3|||
156312962|NCT02366091|564244938|FG003|Overall Study|Withdrawal by Subject|1|||
156312963|NCT02338232|564244939|FG000|Overall Study|Screen Failure|3|||
156312964|NCT02338232|564244939|FG000|Overall Study|Withdrawal by Subject|6|||
156312965|NCT02338232|564244939|FG000|Overall Study|Adverse Event|2|||
156752751|NCT01994902|565845859|FG000|Test Period 2|Withdrawal by Subject|0|||
156752752|NCT01994902|565845860|FG001|Test Period 2|Withdrawal by Subject|2|||
156752753|NCT01994902|565845859|FG000|Test Period 2|Lack of Efficacy|0|||
156312966|NCT02213133|564244940|FG000|Overall Study|Participant discontinued study therapy|2|||
156312967|NCT02213133|564244941|FG001|Overall Study|Participant discontinued study therapy|0|||
156752754|NCT01994902|565845860|FG001|Test Period 2|Lack of Efficacy|1|||
156752755|NCT01994902|565845859|FG000|Test Period 2|Other|0|||
156752756|NCT01994902|565845860|FG001|Test Period 2|Other|3|||
156312968|NCT02213133|564244942|FG002|Overall Study|Participant discontinued study therapy|0|||
156312969|NCT02213133|564244940|FG000|Overall Study|Participant withdrew informed consent|2|||
156312970|NCT02213133|564244941|FG001|Overall Study|Participant withdrew informed consent|1|||
156312971|NCT02213133|564244942|FG002|Overall Study|Participant withdrew informed consent|2|||
156312972|NCT02213133|564244940|FG000|Overall Study|Disease progression|11|||
156312973|NCT02213133|564244941|FG001|Overall Study|Disease progression|2|||
156312974|NCT02213133|564244942|FG002|Overall Study|Disease progression|0|||
156312975|NCT02213133|564244940|FG000|Overall Study|Adverse Event (AE)|1|||
156312976|NCT02213133|564244941|FG001|Overall Study|Adverse Event (AE)|0|||
156312977|NCT02213133|564244942|FG002|Overall Study|Adverse Event (AE)|0|||
156312978|NCT02213133|564244940|FG000|Overall Study|Death|16|||
156312979|NCT02213133|564244941|FG001|Overall Study|Death|2|||
156312980|NCT02213133|564244942|FG002|Overall Study|Death|1|||
156312981|NCT02213133|564244940|FG000|Overall Study|Other|5|||
156414366|NCT01857622|564608947|FG002|Overall Study|Withdrawal by Subject|0|||
156650202|NCT01606137|565465386|FG000|Overall Study|Unable to tolerate study med. taste|1|||
156650203|NCT01606137|565465386|FG000|Overall Study|Patient moving|1|||
156650204|NCT01606137|565465386|FG000|Overall Study|Unable to collect consistent data|1|||
156650205|NCT01070394|565465388|FG000|Overall Study|Adverse Event|6|||
156650206|NCT01070394|565465388|FG000|Overall Study|Withdrawal by Subject|1|||
156650207|NCT01715415|565465400|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
156650208|NCT01715415|565465401|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
156650209|NCT01715415|565465400|FG000|Double-blind Treatment|Adverse Event|3|||
156650210|NCT01715415|565465401|FG001|Double-blind Treatment|Adverse Event|0|||
156650211|NCT01715415|565465400|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
156650212|NCT01715415|565465401|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
156650213|NCT01715415|565465400|FG000|Double-blind Treatment|Other|1|||
156650214|NCT01715415|565465401|FG001|Double-blind Treatment|Other|0|||
156650215|NCT01715415|565465400|FG000|Open-label Treatment|Adverse Event|0|||
156650216|NCT01715415|565465401|FG001|Open-label Treatment|Adverse Event|1|||
156650217|NCT01715415|565465400|FG000|Open-label Treatment|Subject Noncompliant|0|||
156650218|NCT01715415|565465401|FG001|Open-label Treatment|Subject Noncompliant|1|||
156312982|NCT02213133|564244941|FG001|Overall Study|Other|0|||
156312983|NCT02213133|564244942|FG002|Overall Study|Other|0|||
156414367|NCT02955277|564610936|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
156414368|NCT02955277|564610937|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
156414369|NCT02955277|564610936|FG000|Post to Follow-up|Lost to Follow-up|8|||
156414370|NCT02955277|564610937|FG001|Post to Follow-up|Lost to Follow-up|11|||
156414371|NCT04212169|564610938|FG000|Overall Study|Adverse Event|0|||
156414372|NCT04212169|564610939|FG001|Overall Study|Adverse Event|0|||
156414373|NCT04212169|564610940|FG002|Overall Study|Adverse Event|0|||
156414374|NCT04212169|564610941|FG003|Overall Study|Adverse Event|2|||
156414375|NCT04212169|564610938|FG000|Overall Study|Lost to Follow-up|1|||
156414376|NCT04212169|564610939|FG001|Overall Study|Lost to Follow-up|0|||
156414377|NCT04212169|564610940|FG002|Overall Study|Lost to Follow-up|0|||
156414378|NCT04212169|564610941|FG003|Overall Study|Lost to Follow-up|2|||
156414379|NCT04212169|564610938|FG000|Overall Study|Withdrawal by Subject|10|||
156414380|NCT04212169|564610939|FG001|Overall Study|Withdrawal by Subject|2|||
156414381|NCT04212169|564610940|FG002|Overall Study|Withdrawal by Subject|5|||
156414382|NCT04212169|564610941|FG003|Overall Study|Withdrawal by Subject|7|||
156414383|NCT04212169|564610938|FG000|Overall Study|Other reason, unspecified|3|||
156414384|NCT04212169|564610939|FG001|Overall Study|Other reason, unspecified|1|||
156414385|NCT04212169|564610940|FG002|Overall Study|Other reason, unspecified|0|||
156414386|NCT04212169|564610941|FG003|Overall Study|Other reason, unspecified|2|||
156414387|NCT02176928|564610942|FG000|Overall Study|Lost to Follow-up|2|||
156414388|NCT02176928|564610943|FG001|Overall Study|Lost to Follow-up|4|||
156414389|NCT01023308|564610944|FG000|Overall Study|Abnormal test proceedure results|3|||
156414390|NCT01023308|564610945|FG001|Overall Study|Abnormal test proceedure results|8|||
156414391|NCT01023308|564610944|FG000|Overall Study|Administrative problems|2|||
156414392|NCT01023308|564610945|FG001|Overall Study|Administrative problems|1|||
156414393|NCT01023308|564610944|FG000|Overall Study|Adverse Event|130|||
156414394|NCT01023308|564610945|FG001|Overall Study|Adverse Event|66|||
156414395|NCT01023308|564610944|FG000|Overall Study|Death|21|||
156414396|NCT01023308|564610945|FG001|Overall Study|Death|17|||
156414397|NCT01023308|564610944|FG000|Overall Study|Disease progression|82|||
156414398|NCT01023308|564610945|FG001|Overall Study|Disease progression|153|||
156414399|NCT01023308|564610944|FG000|Overall Study|New Cancer therapy|4|||
156414400|NCT01023308|564610945|FG001|Overall Study|New Cancer therapy|7|||
156414401|NCT01023308|564610944|FG000|Overall Study|Protocol Violation|3|||
156312984|NCT02350764|564244943|FG000|Overall Study|Adverse Event|4|||
156312985|NCT02350764|564244943|FG000|Overall Study|Death|3|||
156312986|NCT02350764|564244943|FG000|Overall Study|Physician Decision|2|||
156414402|NCT01023308|564610945|FG001|Overall Study|Protocol Violation|4|||
156414403|NCT01023308|564610944|FG000|Overall Study|Untreated|5|||
156414404|NCT01023308|564610945|FG001|Overall Study|Untreated|5|||
156414405|NCT01023308|564610944|FG000|Overall Study|Lost to Follow-up|1|||
156414406|NCT01023308|564610945|FG001|Overall Study|Lost to Follow-up|0|||
156650219|NCT01015612|565465402|FG000|Overall Study|Death|113|||
156752757|NCT03796676|565845861|FG000|Overall Study|Adverse Event|2|||
156752758|NCT03796676|565845862|FG001|Overall Study|Adverse Event|1|||
156752759|NCT03796676|565845863|FG002|Overall Study|Adverse Event|2|||
156752760|NCT03796676|565845861|FG000|Overall Study|Lost to Follow-up|2|||
156752761|NCT03796676|565845862|FG001|Overall Study|Lost to Follow-up|1|||
156752762|NCT03796676|565845863|FG002|Overall Study|Lost to Follow-up|0|||
156752763|NCT03796676|565845861|FG000|Overall Study|Protocol Violation|0|||
156752764|NCT03796676|565845862|FG001|Overall Study|Protocol Violation|0|||
156752765|NCT03796676|565845863|FG002|Overall Study|Protocol Violation|1|||
156752766|NCT03796676|565845861|FG000|Overall Study|Withdrawal by Subject|1|||
156752767|NCT03796676|565845862|FG001|Overall Study|Withdrawal by Subject|1|||
156752768|NCT03796676|565845863|FG002|Overall Study|Withdrawal by Subject|0|||
156752769|NCT03796676|565845861|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
156752770|NCT03796676|565845862|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
156752771|NCT03796676|565845863|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
156752772|NCT02772809|565845865|FG000|Overall Study|not completed some tasks|6|||
156752773|NCT00723697|565845871|FG000|Overall Study|Physician questionnaires not received|2|||
156752774|NCT00723697|565845871|FG000|Overall Study|Missing Informed Consent Form|10|||
156752775|NCT00723697|565845871|FG000|Overall Study|Other exclusion criteria applied|6|||
156752776|NCT00534105|565845872|FG000|Overall Study|Lost to Follow-up|23|||
156752777|NCT00534105|565845873|FG001|Overall Study|Lost to Follow-up|39|||
156752778|NCT01289574|565845874|FG000|Overall Study|Lack of Efficacy|4|||
156752779|NCT01289574|565845875|FG001|Overall Study|Lack of Efficacy|0|||
156752780|NCT01289574|565845876|FG002|Overall Study|Lack of Efficacy|1|||
156752781|NCT01289574|565845874|FG000|Overall Study|Lost to Follow-up|2|||
156752782|NCT01289574|565845875|FG001|Overall Study|Lost to Follow-up|0|||
156752783|NCT01289574|565845876|FG002|Overall Study|Lost to Follow-up|1|||
156752784|NCT01289574|565845874|FG000|Overall Study|Withdrawal by Subject|1|||
156752785|NCT01289574|565845875|FG001|Overall Study|Withdrawal by Subject|1|||
156752786|NCT01289574|565845876|FG002|Overall Study|Withdrawal by Subject|1|||
156752787|NCT01289574|565845874|FG000|Overall Study|Adverse Event|0|||
156752788|NCT01289574|565845875|FG001|Overall Study|Adverse Event|1|||
156752789|NCT01289574|565845876|FG002|Overall Study|Adverse Event|0|||
156752790|NCT01289574|565845874|FG000|Overall Study|Subject wanted alternate treatment|0|||
156752791|NCT01289574|565845875|FG001|Overall Study|Subject wanted alternate treatment|1|||
156752792|NCT01289574|565845876|FG002|Overall Study|Subject wanted alternate treatment|0|||
156752793|NCT00978341|565845881|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
156752794|NCT00978341|565845882|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
156752795|NCT02452554|565845883|FG000|Overall Study|Death|2|||
156752796|NCT02452554|565845884|FG001|Overall Study|Death|1|||
156752797|NCT02452554|565845885|FG002|Overall Study|Death|0|||
156752798|NCT02452554|565845886|FG003|Overall Study|Death|0|||
156752799|NCT02452554|565845887|FG004|Overall Study|Death|0|||
156752800|NCT02452554|565845888|FG005|Overall Study|Death|0|||
156752801|NCT02452554|565845883|FG000|Overall Study|Lack of Efficacy|13|||
156752802|NCT02452554|565845884|FG001|Overall Study|Lack of Efficacy|14|||
156752803|NCT02452554|565845885|FG002|Overall Study|Lack of Efficacy|9|||
156752804|NCT02452554|565845886|FG003|Overall Study|Lack of Efficacy|1|||
156752805|NCT02452554|565845887|FG004|Overall Study|Lack of Efficacy|5|||
156752806|NCT02452554|565845888|FG005|Overall Study|Lack of Efficacy|8|||
156752807|NCT02452554|565845883|FG000|Overall Study|Physician Decision|0|||
156752808|NCT02452554|565845884|FG001|Overall Study|Physician Decision|1|||
156752809|NCT02452554|565845885|FG002|Overall Study|Physician Decision|0|||
156752810|NCT02452554|565845886|FG003|Overall Study|Physician Decision|0|||
156752811|NCT02452554|565845887|FG004|Overall Study|Physician Decision|0|||
156752812|NCT02452554|565845888|FG005|Overall Study|Physician Decision|0|||
156752813|NCT02452554|565845883|FG000|Overall Study|Withdrawal by Subject|1|||
156752814|NCT02452554|565845884|FG001|Overall Study|Withdrawal by Subject|0|||
156752815|NCT02452554|565845885|FG002|Overall Study|Withdrawal by Subject|2|||
156752816|NCT02452554|565845886|FG003|Overall Study|Withdrawal by Subject|0|||
156752817|NCT02452554|565845887|FG004|Overall Study|Withdrawal by Subject|0|||
156752818|NCT02452554|565845888|FG005|Overall Study|Withdrawal by Subject|1|||
156752819|NCT02452554|565845883|FG000|Overall Study|Ineligible|0|||
156752820|NCT02452554|565845884|FG001|Overall Study|Ineligible|1|||
156752821|NCT02452554|565845885|FG002|Overall Study|Ineligible|0|||
156752822|NCT02452554|565845886|FG003|Overall Study|Ineligible|0|||
156752823|NCT02452554|565845887|FG004|Overall Study|Ineligible|0|||
156752824|NCT02452554|565845888|FG005|Overall Study|Ineligible|0|||
156752825|NCT02452554|565845883|FG000|Overall Study|Never Received Treatment|1|||
156752826|NCT02452554|565845884|FG001|Overall Study|Never Received Treatment|0|||
156752827|NCT02452554|565845885|FG002|Overall Study|Never Received Treatment|0|||
156752828|NCT02452554|565845886|FG003|Overall Study|Never Received Treatment|0|||
156752829|NCT02452554|565845887|FG004|Overall Study|Never Received Treatment|0|||
156752830|NCT02452554|565845888|FG005|Overall Study|Never Received Treatment|0|||
156752831|NCT01451554|565845889|FG000|Overall Study|Withdrawal by Subject|14|||
156752832|NCT01451554|565845890|FG001|Overall Study|Withdrawal by Subject|9|||
156752833|NCT01790516|565845891|FG000|Overall Study|Physician Decision|1|||
156752834|NCT01790516|565845892|FG001|Overall Study|Physician Decision|0|||
156752835|NCT01085084|565845893|FG000|Overall Study|Withdrawal by Subject|1|||
156752836|NCT01085084|565845894|FG001|Overall Study|Withdrawal by Subject|0|||
156752837|NCT01085084|565845895|FG002|Overall Study|Withdrawal by Subject|0|||
156752838|NCT01085084|565845893|FG000|Overall Study|Lost to Follow-up|2|||
156752839|NCT01085084|565845894|FG001|Overall Study|Lost to Follow-up|1|||
156752840|NCT01085084|565845895|FG002|Overall Study|Lost to Follow-up|1|||
156752841|NCT01085084|565845893|FG000|Overall Study|Adverse Event|4|||
156752842|NCT01085084|565845894|FG001|Overall Study|Adverse Event|3|||
156752843|NCT01085084|565845895|FG002|Overall Study|Adverse Event|6|||
156752844|NCT01085084|565845893|FG000|Overall Study|Treatment Failure|0|||
156752845|NCT01085084|565845894|FG001|Overall Study|Treatment Failure|1|||
156752846|NCT01085084|565845895|FG002|Overall Study|Treatment Failure|2|||
156752847|NCT02749799|565845896|FG000|Overall Study|Adverse Event|2|||
156752848|NCT02749799|565845896|FG000|Overall Study|Lost to Follow-up|4|||
156752849|NCT02749799|565845896|FG000|Overall Study|Protocol Violation|1|||
156752850|NCT02749799|565845896|FG000|Overall Study|Withdrawal by Subject|1|||
156752851|NCT02070978|565845897|FG000|Overall Study|Adverse Event|6|||
156752852|NCT02070978|565845898|FG001|Overall Study|Adverse Event|2|||
156752853|NCT02070978|565845899|FG002|Overall Study|Adverse Event|0|||
156752854|NCT02070978|565845897|FG000|Overall Study|Lost to Follow-up|1|||
156752855|NCT02070978|565845898|FG001|Overall Study|Lost to Follow-up|3|||
156752856|NCT02070978|565845899|FG002|Overall Study|Lost to Follow-up|4|||
156752857|NCT02070978|565845897|FG000|Overall Study|Withdrawal by Subject|3|||
156752858|NCT02070978|565845898|FG001|Overall Study|Withdrawal by Subject|5|||
156752859|NCT02070978|565845899|FG002|Overall Study|Withdrawal by Subject|3|||
156752860|NCT02070978|565845897|FG000|Overall Study|Protocol Violation|1|||
156752861|NCT02070978|565845898|FG001|Overall Study|Protocol Violation|0|||
156752862|NCT02070978|565845899|FG002|Overall Study|Protocol Violation|3|||
156752863|NCT02070978|565845897|FG000|Overall Study|Lack of Efficacy|0|||
156752864|NCT02070978|565845898|FG001|Overall Study|Lack of Efficacy|1|||
156312987|NCT02350764|564244943|FG000|Overall Study|Withdrawal by Subject|2|||
156312988|NCT00977080|564244944|FG000|Overall Study|Adverse Event|2|||
156312989|NCT00977080|564244945|FG001|Overall Study|Adverse Event|7|||
156312990|NCT00977080|564244946|FG002|Overall Study|Adverse Event|7|||
156312991|NCT00977080|564244947|FG003|Overall Study|Adverse Event|7|||
156312992|NCT00977080|564244944|FG000|Overall Study|Withdrawal by Subject|1|||
156312993|NCT00977080|564244945|FG001|Overall Study|Withdrawal by Subject|5|||
156312994|NCT00977080|564244946|FG002|Overall Study|Withdrawal by Subject|1|||
156312995|NCT00977080|564244947|FG003|Overall Study|Withdrawal by Subject|5|||
156312996|NCT00977080|564244944|FG000|Overall Study|Protocol Violation|7|||
156312997|NCT00977080|564244945|FG001|Overall Study|Protocol Violation|3|||
156312998|NCT00977080|564244946|FG002|Overall Study|Protocol Violation|4|||
156312999|NCT00977080|564244947|FG003|Overall Study|Protocol Violation|3|||
156313000|NCT00977080|564244944|FG000|Overall Study|Noncompliance|0|||
156313001|NCT00977080|564244945|FG001|Overall Study|Noncompliance|2|||
156313002|NCT00977080|564244946|FG002|Overall Study|Noncompliance|1|||
156313003|NCT00977080|564244947|FG003|Overall Study|Noncompliance|0|||
156313004|NCT00977080|564244944|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
156313005|NCT00977080|564244945|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
156313006|NCT00977080|564244946|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
156313007|NCT00977080|564244947|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
156313008|NCT00977080|564244944|FG000|Overall Study|Required kidney transplantation|1|||
156313009|NCT00977080|564244945|FG001|Overall Study|Required kidney transplantation|3|||
156313010|NCT00977080|564244946|FG002|Overall Study|Required kidney transplantation|3|||
156313011|NCT00977080|564244947|FG003|Overall Study|Required kidney transplantation|1|||
156313012|NCT00977080|564244944|FG000|Overall Study|Travel for family reasons|1|||
156313013|NCT00977080|564244945|FG001|Overall Study|Travel for family reasons|0|||
156313014|NCT00977080|564244946|FG002|Overall Study|Travel for family reasons|0|||
156313015|NCT00977080|564244947|FG003|Overall Study|Travel for family reasons|0|||
156313016|NCT00313781|564244948|FG000|Before Crossover|Death|22|||
156313017|NCT00313781|564244949|FG001|Before Crossover|Death|8|||
156313018|NCT00313781|564244950|FG002|Before Crossover|Death|0|||
156313019|NCT00313781|564244948|FG000|Before Crossover|Lost to Follow-up|0|||
156313020|NCT00313781|564244949|FG001|Before Crossover|Lost to Follow-up|3|||
156313021|NCT00313781|564244950|FG002|Before Crossover|Lost to Follow-up|0|||
156313022|NCT00313781|564244948|FG000|Before Crossover|Withdrawal by Subject|3|||
156313023|NCT00313781|564244949|FG001|Before Crossover|Withdrawal by Subject|1|||
156313024|NCT00313781|564244950|FG002|Before Crossover|Withdrawal by Subject|0|||
156752865|NCT02070978|565845899|FG002|Overall Study|Lack of Efficacy|0|||
156752866|NCT02070978|565845897|FG000|Overall Study|Death|0|||
156752867|NCT02070978|565845898|FG001|Overall Study|Death|0|||
156752868|NCT02070978|565845899|FG002|Overall Study|Death|2|||
156313025|NCT00313781|564244948|FG000|Before Crossover|Other|45|||
156313026|NCT00313781|564244949|FG001|Before Crossover|Other|30|||
156313027|NCT00313781|564244950|FG002|Before Crossover|Other|0|||
156313028|NCT00313781|564244948|FG000|Before Crossover|Crossover|0|||
156752869|NCT02070978|565845897|FG000|Overall Study|Un-specified|3|||
156752870|NCT02070978|565845898|FG001|Overall Study|Un-specified|2|||
156752871|NCT02070978|565845899|FG002|Overall Study|Un-specified|2|||
156752872|NCT02070978|565845897|FG000|Overall Study|Terminated by Sponsor|33|||
156752873|NCT02070978|565845898|FG001|Overall Study|Terminated by Sponsor|40|||
156752874|NCT02070978|565845899|FG002|Overall Study|Terminated by Sponsor|39|||
156752875|NCT02669043|565845905|FG000|Overall Study|Didn't meet I/E criteria|4|||
156752876|NCT00520767|565845908|FG000|Overall Study|Death|2|||
156752877|NCT02753816|565848204|FG000|Overall Study|Protocol Violation|0|||
156752878|NCT02753816|565848205|FG001|Overall Study|Protocol Violation|1|||
156752879|NCT02753816|565848206|FG002|Overall Study|Protocol Violation|0|||
156752880|NCT01473940|565848207|FG000|Induction Therapy|Death|0|||
156752881|NCT01473940|565848208|FG001|Induction Therapy|Death|0|||
156752882|NCT01473940|565848209|FG002|Induction Therapy|Death|1|||
156752883|NCT01473940|565848210|FG003|Induction Therapy|Death|1|||
156752884|NCT01473940|565848207|FG000|Induction Therapy|Progressive Disease|0|||
156752885|NCT01473940|565848208|FG001|Induction Therapy|Progressive Disease|1|||
156752886|NCT01473940|565848209|FG002|Induction Therapy|Progressive Disease|1|||
156752887|NCT01473940|565848210|FG003|Induction Therapy|Progressive Disease|0|||
156752888|NCT01473940|565848207|FG000|Maintenance Therapy|Progressive Disease|1|||
156752889|NCT01473940|565848208|FG001|Maintenance Therapy|Progressive Disease|2|||
156752890|NCT01473940|565848209|FG002|Maintenance Therapy|Progressive Disease|1|||
156752891|NCT01473940|565848210|FG003|Maintenance Therapy|Progressive Disease|4|||
156752892|NCT02849171|565848211|FG000|Overall Study|Withdrawal by Subject|1|||
156752893|NCT02849171|565848211|FG000|Overall Study|Not treated|1|||
156752894|NCT02630563|565848218|FG000|Overall Study|Administrative|1|||
156752895|NCT03084302|565848219|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
156752896|NCT03084302|565848219|FG000|Overall Study|No valid objective monitor data|6|||
156752897|NCT00621257|565848220|FG000|Overall Study|Lost to Follow-up|4|||
156752898|NCT00621257|565848221|FG001|Overall Study|Lost to Follow-up|0|||
156752899|NCT00621257|565848222|FG002|Overall Study|Lost to Follow-up|2|||
156752900|NCT00621257|565848223|FG003|Overall Study|Lost to Follow-up|4|||
156752901|NCT00621257|565848224|FG004|Overall Study|Lost to Follow-up|7|||
156752902|NCT00621257|565848220|FG000|Overall Study|Adverse Event|0|||
156752903|NCT00621257|565848221|FG001|Overall Study|Adverse Event|1|||
156752904|NCT00621257|565848222|FG002|Overall Study|Adverse Event|1|||
156752905|NCT00621257|565848223|FG003|Overall Study|Adverse Event|0|||
156752906|NCT00621257|565848224|FG004|Overall Study|Adverse Event|0|||
156752907|NCT00621257|565848220|FG000|Overall Study|Physician Decision|0|||
156752908|NCT00621257|565848221|FG001|Overall Study|Physician Decision|2|||
156752909|NCT00621257|565848222|FG002|Overall Study|Physician Decision|0|||
156752910|NCT00621257|565848223|FG003|Overall Study|Physician Decision|1|||
156752911|NCT00621257|565848224|FG004|Overall Study|Physician Decision|1|||
156752912|NCT00621257|565848220|FG000|Overall Study|Withdrawal by Subject|0|||
156752913|NCT00621257|565848221|FG001|Overall Study|Withdrawal by Subject|0|||
156752914|NCT00621257|565848222|FG002|Overall Study|Withdrawal by Subject|0|||
156752915|NCT00621257|565848223|FG003|Overall Study|Withdrawal by Subject|1|||
156752916|NCT00621257|565848224|FG004|Overall Study|Withdrawal by Subject|1|||
156752917|NCT01255904|565848225|FG000|Overall Study|Physician Decision|1|||
156752918|NCT01255904|565848226|FG001|Overall Study|Physician Decision|4|||
156752919|NCT02061813|565848228|FG000|Overall Study|Withdrawal by Subject|1|||
156752920|NCT02061813|565848228|FG000|Overall Study|Protocol Violation|2|||
156752921|NCT01705080|565848229|FG000|Overall Study|Missed visit|10|||
156752922|NCT01705080|565848230|FG001|Overall Study|Missed visit|4|||
156752923|NCT01705080|565848231|FG002|Overall Study|Missed visit|1|||
156752924|NCT01705080|565848229|FG000|Overall Study|Death|4|||
156752925|NCT01705080|565848230|FG001|Overall Study|Death|4|||
156752926|NCT01705080|565848231|FG002|Overall Study|Death|6|||
156752927|NCT01705080|565848229|FG000|Overall Study|Withdrawal by Subject|61|||
156752928|NCT01705080|565848230|FG001|Overall Study|Withdrawal by Subject|44|||
156752929|NCT01705080|565848231|FG002|Overall Study|Withdrawal by Subject|9|||
156313029|NCT00313781|564244949|FG001|Before Crossover|Crossover|37|||
156313030|NCT00313781|564244950|FG002|Before Crossover|Crossover|0|||
156313031|NCT00313781|564244948|FG000|Before Crossover|Randomized, not treated|5|||
156313032|NCT00313781|564244949|FG001|Before Crossover|Randomized, not treated|0|||
156313033|NCT00313781|564244950|FG002|Before Crossover|Randomized, not treated|0|||
156313034|NCT00313781|564244948|FG000|After Crossover|Death|0|||
156313035|NCT00313781|564244949|FG001|After Crossover|Death|0|||
156313036|NCT00313781|564244950|FG002|After Crossover|Death|6|||
156313037|NCT00313781|564244948|FG000|After Crossover|Withdrawal by Subject|0|||
156313038|NCT00313781|564244949|FG001|After Crossover|Withdrawal by Subject|0|||
156313039|NCT00313781|564244950|FG002|After Crossover|Withdrawal by Subject|3|||
156313040|NCT00313781|564244948|FG000|After Crossover|Other|0|||
156313041|NCT00313781|564244949|FG001|After Crossover|Other|0|||
156313042|NCT00313781|564244950|FG002|After Crossover|Other|18|||
156313043|NCT01546623|564244951|FG000|Overall Study|Adverse Event|2|||
156313044|NCT01546623|564244952|FG001|Overall Study|Adverse Event|3|||
156313045|NCT01546623|564244951|FG000|Overall Study|Major Protocol Deviation|1|||
156313046|NCT01546623|564244952|FG001|Overall Study|Major Protocol Deviation|1|||
156313047|NCT01546623|564244951|FG000|Overall Study|High Prostate specific antigen|2|||
156313048|NCT01546623|564244952|FG001|Overall Study|High Prostate specific antigen|1|||
156752930|NCT01704755|565848236|FG000|Overall Study|Adverse Event|4|||
156752931|NCT01704755|565848237|FG001|Overall Study|Adverse Event|1|||
156752932|NCT01704755|565848236|FG000|Overall Study|Lost to Follow-up|3|||
156752933|NCT01704755|565848237|FG001|Overall Study|Lost to Follow-up|4|||
156752934|NCT01704755|565848236|FG000|Overall Study|Withdrew consent|1|||
156752935|NCT01704755|565848237|FG001|Overall Study|Withdrew consent|1|||
156752936|NCT01704755|565848236|FG000|Overall Study|Other (not specified)|3|||
156752937|NCT01704755|565848237|FG001|Overall Study|Other (not specified)|1|||
156752938|NCT01704755|565848236|FG000|Overall Study|Withdrew consent and personal issues|1|||
156752939|NCT01704755|565848237|FG001|Overall Study|Withdrew consent and personal issues|0|||
156752940|NCT02075008|565848250|FG000|Overall Study|Technical problems|1|||
156752941|NCT02075008|565848250|FG000|Overall Study|Pregnancy|1|||
156752942|NCT02075008|565848250|FG000|Overall Study|Physician Decision|1|||
156752943|NCT02075008|565848250|FG000|Overall Study|Lost to Follow-up|1|||
156752944|NCT02075008|565848250|FG000|Overall Study|Lack of Efficacy|1|||
156752945|NCT02075008|565848250|FG000|Overall Study|Death|1|||
156752946|NCT02075008|565848250|FG000|Overall Study|Adverse Event|5|||
156752947|NCT02075008|565848250|FG000|Overall Study|Withdrawal by Subject|6|||
156752948|NCT02075008|565848250|FG000|Overall Study|Study terminated by Sponsor|159|||
156752949|NCT03130959|565848251|FG000|Overall Study|Disease progression|19|||
156752950|NCT03130959|565848252|FG001|Overall Study|Disease progression|7|||
156752951|NCT03130959|565848253|FG002|Overall Study|Disease progression|12|||
156752952|NCT03130959|565848254|FG003|Overall Study|Disease progression|7|||
156752953|NCT03130959|565848255|FG004|Overall Study|Disease progression|12|||
156752954|NCT03130959|565848256|FG005|Overall Study|Disease progression|3|||
156752955|NCT03130959|565848257|FG006|Overall Study|Disease progression|6|||
156752956|NCT03130959|565848258|FG007|Overall Study|Disease progression|3|||
156752957|NCT03130959|565848259|FG008|Overall Study|Disease progression|15|||
156752958|NCT03130959|565848260|FG009|Overall Study|Disease progression|8|||
156752959|NCT03130959|565848251|FG000|Overall Study|Study drug toxicity|2|||
156752960|NCT03130959|565848252|FG001|Overall Study|Study drug toxicity|2|||
156752961|NCT03130959|565848253|FG002|Overall Study|Study drug toxicity|1|||
156752962|NCT03130959|565848254|FG003|Overall Study|Study drug toxicity|2|||
156752963|NCT03130959|565848255|FG004|Overall Study|Study drug toxicity|1|||
156752964|NCT03130959|565848256|FG005|Overall Study|Study drug toxicity|1|||
156752965|NCT03130959|565848257|FG006|Overall Study|Study drug toxicity|3|||
156752966|NCT03130959|565848258|FG007|Overall Study|Study drug toxicity|0|||
156752967|NCT03130959|565848259|FG008|Overall Study|Study drug toxicity|3|||
156752968|NCT03130959|565848260|FG009|Overall Study|Study drug toxicity|3|||
156752969|NCT03130959|565848251|FG000|Overall Study|Other reasons|0|||
156752970|NCT03130959|565848252|FG001|Overall Study|Other reasons|0|||
156752971|NCT03130959|565848253|FG002|Overall Study|Other reasons|0|||
156752972|NCT03130959|565848254|FG003|Overall Study|Other reasons|0|||
156752973|NCT03130959|565848255|FG004|Overall Study|Other reasons|0|||
156752974|NCT03130959|565848256|FG005|Overall Study|Other reasons|1|||
156752975|NCT03130959|565848257|FG006|Overall Study|Other reasons|1|||
156752976|NCT03130959|565848258|FG007|Overall Study|Other reasons|0|||
156752977|NCT03130959|565848259|FG008|Overall Study|Other reasons|0|||
156752978|NCT03130959|565848260|FG009|Overall Study|Other reasons|0|||
156752979|NCT03130959|565848251|FG000|Overall Study|Subject request to discontinue therapy|0|||
156752980|NCT03130959|565848252|FG001|Overall Study|Subject request to discontinue therapy|0|||
156752981|NCT03130959|565848253|FG002|Overall Study|Subject request to discontinue therapy|1|||
156752982|NCT03130959|565848254|FG003|Overall Study|Subject request to discontinue therapy|1|||
156752983|NCT03130959|565848255|FG004|Overall Study|Subject request to discontinue therapy|0|||
156752984|NCT03130959|565848256|FG005|Overall Study|Subject request to discontinue therapy|0|||
156752985|NCT03130959|565848257|FG006|Overall Study|Subject request to discontinue therapy|1|||
156752986|NCT03130959|565848258|FG007|Overall Study|Subject request to discontinue therapy|1|||
156752987|NCT03130959|565848259|FG008|Overall Study|Subject request to discontinue therapy|0|||
156752988|NCT03130959|565848260|FG009|Overall Study|Subject request to discontinue therapy|0|||
156752989|NCT03130959|565848251|FG000|Overall Study|Not reported|0|||
156752990|NCT03130959|565848252|FG001|Overall Study|Not reported|0|||
156313049|NCT01546623|564244951|FG000|Overall Study|Did Not Receive Study Drug|1|||
156752991|NCT03130959|565848253|FG002|Overall Study|Not reported|0|||
156752992|NCT03130959|565848254|FG003|Overall Study|Not reported|1|||
156752993|NCT03130959|565848255|FG004|Overall Study|Not reported|0|||
156313050|NCT01546623|564244952|FG001|Overall Study|Did Not Receive Study Drug|1|||
156313051|NCT03567343|564244953|FG000|Overall Study|Lost to Follow-up|2|||
156313052|NCT03567343|564244954|FG001|Overall Study|Lost to Follow-up|1|||
156313053|NCT03567343|564244953|FG000|Overall Study|No longer eligible|2|||
156752994|NCT03130959|565848256|FG005|Overall Study|Not reported|1|||
156752995|NCT03130959|565848257|FG006|Overall Study|Not reported|0|||
156752996|NCT03130959|565848258|FG007|Overall Study|Not reported|0|||
156752997|NCT03130959|565848259|FG008|Overall Study|Not reported|0|||
156752998|NCT03130959|565848260|FG009|Overall Study|Not reported|1|||
156752999|NCT03130959|565848251|FG000|Overall Study|Adverse Event unrelated to drug|0|||
156753000|NCT03130959|565848252|FG001|Overall Study|Adverse Event unrelated to drug|0|||
156753001|NCT03130959|565848253|FG002|Overall Study|Adverse Event unrelated to drug|1|||
156753002|NCT03130959|565848254|FG003|Overall Study|Adverse Event unrelated to drug|1|||
156753003|NCT03130959|565848255|FG004|Overall Study|Adverse Event unrelated to drug|1|||
156753004|NCT03130959|565848256|FG005|Overall Study|Adverse Event unrelated to drug|0|||
156753005|NCT03130959|565848257|FG006|Overall Study|Adverse Event unrelated to drug|1|||
156753006|NCT03130959|565848258|FG007|Overall Study|Adverse Event unrelated to drug|0|||
156753007|NCT03130959|565848259|FG008|Overall Study|Adverse Event unrelated to drug|1|||
156753008|NCT03130959|565848260|FG009|Overall Study|Adverse Event unrelated to drug|1|||
156753009|NCT03130959|565848251|FG000|Overall Study|Participant withdrew consent|0|||
156753010|NCT03130959|565848252|FG001|Overall Study|Participant withdrew consent|1|||
156753011|NCT03130959|565848253|FG002|Overall Study|Participant withdrew consent|0|||
156753012|NCT03130959|565848254|FG003|Overall Study|Participant withdrew consent|2|||
156753013|NCT03130959|565848255|FG004|Overall Study|Participant withdrew consent|1|||
156753014|NCT03130959|565848256|FG005|Overall Study|Participant withdrew consent|0|||
156753015|NCT03130959|565848257|FG006|Overall Study|Participant withdrew consent|0|||
156753016|NCT03130959|565848258|FG007|Overall Study|Participant withdrew consent|0|||
156753017|NCT03130959|565848259|FG008|Overall Study|Participant withdrew consent|0|||
156753018|NCT03130959|565848260|FG009|Overall Study|Participant withdrew consent|2|||
156753019|NCT03130959|565848251|FG000|Overall Study|Administrative reason by sponsor|1|||
156753020|NCT03130959|565848252|FG001|Overall Study|Administrative reason by sponsor|0|||
156753021|NCT03130959|565848253|FG002|Overall Study|Administrative reason by sponsor|1|||
156753022|NCT03130959|565848254|FG003|Overall Study|Administrative reason by sponsor|0|||
156753023|NCT03130959|565848255|FG004|Overall Study|Administrative reason by sponsor|0|||
156753024|NCT03130959|565848256|FG005|Overall Study|Administrative reason by sponsor|0|||
156753025|NCT03130959|565848257|FG006|Overall Study|Administrative reason by sponsor|0|||
156753026|NCT03130959|565848258|FG007|Overall Study|Administrative reason by sponsor|0|||
156753027|NCT03130959|565848259|FG008|Overall Study|Administrative reason by sponsor|0|||
156753028|NCT03130959|565848260|FG009|Overall Study|Administrative reason by sponsor|0|||
156753029|NCT03130959|565848251|FG000|Overall Study|Lost to Follow-up|1|||
156753030|NCT03130959|565848252|FG001|Overall Study|Lost to Follow-up|0|||
156753031|NCT03130959|565848253|FG002|Overall Study|Lost to Follow-up|0|||
156753032|NCT03130959|565848254|FG003|Overall Study|Lost to Follow-up|0|||
156753033|NCT03130959|565848255|FG004|Overall Study|Lost to Follow-up|0|||
156753034|NCT03130959|565848256|FG005|Overall Study|Lost to Follow-up|0|||
156753035|NCT03130959|565848257|FG006|Overall Study|Lost to Follow-up|0|||
156753036|NCT03130959|565848258|FG007|Overall Study|Lost to Follow-up|0|||
156753037|NCT03130959|565848259|FG008|Overall Study|Lost to Follow-up|0|||
156753038|NCT03130959|565848260|FG009|Overall Study|Lost to Follow-up|0|||
156753039|NCT04446429|565848261|FG000|Overall Study|Lost to Follow-up|6|||
156753040|NCT04446429|565848262|FG001|Overall Study|Lost to Follow-up|0|||
156753041|NCT05205005|565848263|FG000|Overall Study|Withdrawal by Subject|1|||
156753042|NCT05205005|565848264|FG001|Overall Study|Withdrawal by Subject|0|||
156753043|NCT05205005|565848263|FG000|Overall Study|Adverse Event|1|||
156753044|NCT05205005|565848264|FG001|Overall Study|Adverse Event|0|||
156753045|NCT02821416|565848265|FG000|Overall Study|Adverse Event|0|||
156753046|NCT02821416|565848266|FG001|Overall Study|Adverse Event|1|||
156753047|NCT02821416|565848265|FG000|Overall Study|Withdrawal by Subject|2|||
156753048|NCT02821416|565848266|FG001|Overall Study|Withdrawal by Subject|0|||
156753049|NCT02821416|565848265|FG000|Overall Study|Lost to Follow-up|1|||
156753050|NCT02821416|565848266|FG001|Overall Study|Lost to Follow-up|0|||
156753051|NCT03042910|565848271|FG000|Overall Study|Adverse Event|1|||
156753052|NCT03042910|565848271|FG000|Overall Study|Disease Progression|2|||
156753053|NCT03042910|565848271|FG000|Overall Study|Withdrawal by Subject|3|||
156753054|NCT03042910|565848271|FG000|Overall Study|Enrolled but not treated|1|||
156753055|NCT02256917|565848272|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
156753056|NCT02256917|565848272|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
156753057|NCT02256917|565848272|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
156753058|NCT02256917|565848272|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
156753059|NCT02256917|565848272|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
156753060|NCT02933528|565848273|FG000|Overall Study|Lost to Follow-up|2|||
156753061|NCT01301079|565848276|FG000|Overall Study|Lost to Follow-up|2|||
156753062|NCT01301079|565848277|FG001|Overall Study|Lost to Follow-up|2|||
156753063|NCT00313586|565848278|FG000|Overall Study|Disease progression|14|||
156753064|NCT00313586|565848279|FG001|Overall Study|Disease progression|19|||
156753065|NCT00313586|565848280|FG002|Overall Study|Disease progression|10|||
156753066|NCT00313586|565848281|FG003|Overall Study|Disease progression|3|||
156753067|NCT00313586|565848278|FG000|Overall Study|Adverse Event|12|||
156753068|NCT00313586|565848279|FG001|Overall Study|Adverse Event|18|||
156753069|NCT00313586|565848280|FG002|Overall Study|Adverse Event|3|||
156753070|NCT00313586|565848281|FG003|Overall Study|Adverse Event|10|||
156753071|NCT00313586|565848278|FG000|Overall Study|Death|11|||
156753072|NCT00313586|565848279|FG001|Overall Study|Death|8|||
156753073|NCT00313586|565848280|FG002|Overall Study|Death|1|||
156753074|NCT00313586|565848281|FG003|Overall Study|Death|7|||
156753075|NCT00313586|565848278|FG000|Overall Study|Withdrawal by Subject|13|||
156753076|NCT00313586|565848279|FG001|Overall Study|Withdrawal by Subject|6|||
156414407|NCT01023308|564610944|FG000|Overall Study|Withdrawal by Subject|34|||
156414408|NCT01023308|564610945|FG001|Overall Study|Withdrawal by Subject|18|||
156414409|NCT01890967|564610946|FG000|Overall Study|Adverse Event|3|||
156414410|NCT01890967|564610947|FG001|Overall Study|Adverse Event|3|||
156414411|NCT01890967|564610948|FG002|Overall Study|Adverse Event|3|||
156414412|NCT01890967|564610949|FG003|Overall Study|Adverse Event|2|||
156414413|NCT01890967|564610950|FG004|Overall Study|Adverse Event|1|||
156414414|NCT01890967|564610951|FG005|Overall Study|Adverse Event|7|||
156414415|NCT01890967|564610946|FG000|Overall Study|Death|1|||
156414416|NCT01890967|564610947|FG001|Overall Study|Death|0|||
156414417|NCT01890967|564610948|FG002|Overall Study|Death|0|||
156414418|NCT01890967|564610949|FG003|Overall Study|Death|0|||
156414419|NCT01890967|564610950|FG004|Overall Study|Death|0|||
156414420|NCT01890967|564610951|FG005|Overall Study|Death|0|||
156414421|NCT01890967|564610946|FG000|Overall Study|Lost to Follow-up|1|||
156414422|NCT01890967|564610947|FG001|Overall Study|Lost to Follow-up|1|||
156414423|NCT01890967|564610948|FG002|Overall Study|Lost to Follow-up|1|||
156414424|NCT01890967|564610949|FG003|Overall Study|Lost to Follow-up|1|||
156650220|NCT01015612|565465402|FG000|Overall Study|Withdrawal by Subject|40|||
156650221|NCT00066807|565465403|FG000|Overall Study|Study was terminated early|14|||
156650222|NCT00066807|565465404|FG001|Overall Study|Study was terminated early|15|||
156650223|NCT03586830|565465406|FG000|Overall Study|Site terminated by Sponsor|1|||
156650224|NCT03586830|565465407|FG001|Overall Study|Site terminated by Sponsor|4|||
156650225|NCT03586830|565465408|FG002|Overall Study|Site terminated by Sponsor|3|||
156650226|NCT03586830|565465409|FG003|Overall Study|Site terminated by Sponsor|3|||
156650227|NCT03586830|565465406|FG000|Overall Study|Lost to Follow-up|0|||
156650228|NCT03586830|565465407|FG001|Overall Study|Lost to Follow-up|2|||
156650229|NCT03586830|565465408|FG002|Overall Study|Lost to Follow-up|2|||
156650230|NCT03586830|565465409|FG003|Overall Study|Lost to Follow-up|1|||
156650231|NCT03586830|565465406|FG000|Overall Study|Withdrawal by Subject|1|||
156650232|NCT03586830|565465407|FG001|Overall Study|Withdrawal by Subject|0|||
156650233|NCT03586830|565465408|FG002|Overall Study|Withdrawal by Subject|3|||
156650234|NCT03586830|565465409|FG003|Overall Study|Withdrawal by Subject|1|||
156650235|NCT04578548|565465410|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
156650236|NCT04578548|565465411|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
156650237|NCT04578548|565465410|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
156650238|NCT04578548|565465411|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
156650239|NCT04578548|565465410|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
156650240|NCT04578548|565465411|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
156650241|NCT04578548|565465410|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
156650242|NCT04578548|565465411|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
156650243|NCT04578548|565465410|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
156650244|NCT04578548|565465411|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
156650245|NCT04578548|565465410|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
156650246|NCT04578548|565465411|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
156650247|NCT00972153|565465414|FG000|Overall Study|Equipment malfunction during case|0|||
156650248|NCT00972153|565465415|FG001|Overall Study|Equipment malfunction during case|1|||
156650249|NCT00972153|565465416|FG002|Overall Study|Equipment malfunction during case|0|||
156650250|NCT01077713|565465421|FG000|Overall Study|Withdrawal by Subject|1|||
156650251|NCT01077713|565465422|FG001|Overall Study|Withdrawal by Subject|2|||
156650252|NCT01077713|565465421|FG000|Overall Study|Progressive Disease (PD)|0|||
156650253|NCT01077713|565465422|FG001|Overall Study|Progressive Disease (PD)|1|||
156650254|NCT01077713|565465421|FG000|Overall Study|Death|28|||
156650255|NCT01077713|565465422|FG001|Overall Study|Death|29|||
156650256|NCT01077713|565465421|FG000|Overall Study|Lost to Follow-up|1|||
156650257|NCT01077713|565465422|FG001|Overall Study|Lost to Follow-up|1|||
156650258|NCT01077713|565465421|FG000|Overall Study|Adverse Event|2|||
156650259|NCT01077713|565465422|FG001|Overall Study|Adverse Event|1|||
156650260|NCT01077713|565465421|FG000|Overall Study|Other|4|||
156650261|NCT01077713|565465422|FG001|Overall Study|Other|2|||
156650262|NCT04136626|565465423|FG000|Treatment Phase|Withdrawal by Subject|1|||
156650263|NCT04136626|565465424|FG001|Treatment Phase|Withdrawal by Subject|9|||
156650264|NCT04136626|565465423|FG000|Treatment Phase|Adverse Event|1|||
156650265|NCT04136626|565465424|FG001|Treatment Phase|Adverse Event|0|||
156650266|NCT04136626|565465423|FG000|Treatment Phase|Lost to Follow-up|1|||
156650267|NCT04136626|565465424|FG001|Treatment Phase|Lost to Follow-up|5|||
156650268|NCT04136626|565465423|FG000|12-month Follow-up|Lost to Follow-up|8|||
156650269|NCT04136626|565465424|FG001|12-month Follow-up|Lost to Follow-up|7|||
156650270|NCT00628745|565465425|FG000|Overall Study|Withdrawal by Subject|63|||
156650271|NCT00628745|565465426|FG001|Overall Study|Withdrawal by Subject|3|||
156650272|NCT00628745|565465427|FG002|Overall Study|Withdrawal by Subject|9|||
156650273|NCT00628745|565465428|FG003|Overall Study|Withdrawal by Subject|2|||
156650274|NCT00628745|565465429|FG004|Overall Study|Withdrawal by Subject|69|||
156650275|NCT00628745|565465425|FG000|Overall Study|Does not meet inclusion criteria|0|||
156650276|NCT00628745|565465426|FG001|Overall Study|Does not meet inclusion criteria|12|||
156753077|NCT00313586|565848280|FG002|Overall Study|Withdrawal by Subject|6|||
156753078|NCT00313586|565848281|FG003|Overall Study|Withdrawal by Subject|2|||
156753079|NCT00313586|565848278|FG000|Overall Study|Alternative therapy|3|||
156753080|NCT00313586|565848279|FG001|Overall Study|Alternative therapy|6|||
156753081|NCT00313586|565848280|FG002|Overall Study|Alternative therapy|2|||
156753082|NCT00313586|565848281|FG003|Overall Study|Alternative therapy|0|||
156753083|NCT00313586|565848278|FG000|Overall Study|Other complicating disease|2|||
156753084|NCT00313586|565848279|FG001|Overall Study|Other complicating disease|2|||
156753085|NCT00313586|565848280|FG002|Overall Study|Other complicating disease|0|||
156753086|NCT00313586|565848281|FG003|Overall Study|Other complicating disease|0|||
156753087|NCT00313586|565848278|FG000|Overall Study|Did not achieve HI-major/better response|10|||
156753088|NCT00313586|565848279|FG001|Overall Study|Did not achieve HI-major/better response|7|||
156753089|NCT00313586|565848280|FG002|Overall Study|Did not achieve HI-major/better response|2|||
156753090|NCT00313586|565848281|FG003|Overall Study|Did not achieve HI-major/better response|1|||
156753091|NCT00313586|565848278|FG000|Overall Study|Physician Decision|2|||
156753092|NCT00313586|565848279|FG001|Overall Study|Physician Decision|1|||
156753093|NCT00313586|565848280|FG002|Overall Study|Physician Decision|0|||
156753094|NCT00313586|565848281|FG003|Overall Study|Physician Decision|0|||
156753095|NCT00313586|565848278|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
156753096|NCT00313586|565848279|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
156753097|NCT00313586|565848280|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
156753098|NCT00313586|565848281|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
156753099|NCT00313586|565848278|FG000|Overall Study|Lost insurance|0|||
156753100|NCT00313586|565848279|FG001|Overall Study|Lost insurance|1|||
156753101|NCT00313586|565848280|FG002|Overall Study|Lost insurance|0|||
156753102|NCT00313586|565848281|FG003|Overall Study|Lost insurance|0|||
156753103|NCT00313586|565848278|FG000|Overall Study|Moved|0|||
156753104|NCT00313586|565848279|FG001|Overall Study|Moved|1|||
156753105|NCT00313586|565848280|FG002|Overall Study|Moved|0|||
156753106|NCT00313586|565848281|FG003|Overall Study|Moved|0|||
156753107|NCT00313586|565848278|FG000|Overall Study|Death before starting treatment|1|||
156753108|NCT00313586|565848279|FG001|Overall Study|Death before starting treatment|0|||
156753109|NCT00313586|565848280|FG002|Overall Study|Death before starting treatment|0|||
156753110|NCT00313586|565848281|FG003|Overall Study|Death before starting treatment|0|||
156753111|NCT01639703|565848282|FG000|Overall Study|Withdrawal by Subject|5|||
156753112|NCT01639703|565848282|FG000|Overall Study|Other reason|7|||
156753113|NCT02087670|565848283|FG000|Overall Study|Withdrawal by Subject|3|||
156753114|NCT02087670|565848284|FG001|Overall Study|Withdrawal by Subject|2|||
156753115|NCT00264290|565848286|FG000|Intervention (8 Weeks)|Adverse Event|1|||
156753116|NCT00264290|565848287|FG001|Intervention (8 Weeks)|Adverse Event|0|||
156753117|NCT04472494|565848288|FG000|Pre-treatment|Other reasons|2|||
156753118|NCT04472494|565848289|FG001|Pre-treatment|Other reasons|0|||
156753119|NCT04472494|565848288|FG000|Treatment|Death|5|||
156753120|NCT04472494|565848289|FG001|Treatment|Death|2|||
156313054|NCT03567343|564244954|FG001|Overall Study|No longer eligible|1|||
156313055|NCT03567343|564244953|FG000|Overall Study|Adverse Event|1|||
156313056|NCT03567343|564244954|FG001|Overall Study|Adverse Event|0|||
156313057|NCT03567343|564244953|FG000|Overall Study|Protocol Violation|1|||
156313058|NCT03567343|564244954|FG001|Overall Study|Protocol Violation|1|||
156313059|NCT02466659|564244955|FG000|Overall Study|Lost to Follow-up|5|||
156313060|NCT02466659|564244956|FG001|Overall Study|Lost to Follow-up|2|||
156313061|NCT00486811|564244957|FG000|Overall Study|Adverse Event|28|||
156313062|NCT00486811|564244958|FG001|Overall Study|Adverse Event|60|||
156313063|NCT00486811|564244959|FG002|Overall Study|Adverse Event|135|||
156313064|NCT00486811|564244957|FG000|Overall Study|Lack of Efficacy|34|||
156313065|NCT00486811|564244958|FG001|Overall Study|Lack of Efficacy|14|||
156313066|NCT00486811|564244959|FG002|Overall Study|Lack of Efficacy|7|||
156313067|NCT00486811|564244957|FG000|Overall Study|Lost to Follow-up|4|||
156313068|NCT00486811|564244958|FG001|Overall Study|Lost to Follow-up|6|||
156313069|NCT00486811|564244959|FG002|Overall Study|Lost to Follow-up|4|||
156313070|NCT00486811|564244957|FG000|Overall Study|Withdrawal by Subject|33|||
156313071|NCT00486811|564244958|FG001|Overall Study|Withdrawal by Subject|44|||
156313072|NCT00486811|564244959|FG002|Overall Study|Withdrawal by Subject|58|||
156313073|NCT00486811|564244957|FG000|Overall Study|Study drug non-compliant|5|||
156313074|NCT00486811|564244958|FG001|Overall Study|Study drug non-compliant|6|||
156313075|NCT00486811|564244959|FG002|Overall Study|Study drug non-compliant|3|||
156753121|NCT04472494|565848288|FG000|Treatment|Hospital discharge|1|||
156753122|NCT04472494|565848289|FG001|Treatment|Hospital discharge|1|||
156753123|NCT03519919|565848290|FG000|Overall Study|Withdrawal by Subject|1|||
156753124|NCT03519919|565848290|FG000|Overall Study|Lack of Efficacy|1|||
156753125|NCT03519919|565848290|FG000|Overall Study|Screen Failure|1|||
156753126|NCT03076996|565848291|FG000|Overall Study|Withdrawal by Subject|2|||
156753127|NCT03076996|565848291|FG000|Overall Study|Lost to Follow-up|3|||
156753128|NCT03076996|565848291|FG000|Overall Study|Literacy precluded participation|1|||
156753129|NCT00587795|565848292|FG000|Overall Study|Withdrawal by Subject|1|||
156313076|NCT00486811|564244957|FG000|Overall Study|All other|18|||
156313077|NCT00486811|564244958|FG001|Overall Study|All other|11|||
156313078|NCT00486811|564244959|FG002|Overall Study|All other|7|||
156753130|NCT00587795|565848293|FG001|Overall Study|Withdrawal by Subject|0|||
156753131|NCT02144077|565848294|FG000|Overall Study|Withdrawal by Subject|3|||
156753132|NCT02144077|565848295|FG001|Overall Study|Withdrawal by Subject|3|||
156753133|NCT02144077|565848294|FG000|Overall Study|Adverse Event|2|||
156753134|NCT02144077|565848295|FG001|Overall Study|Adverse Event|3|||
156753135|NCT02144077|565848294|FG000|Overall Study|Lost to Follow-up|2|||
156753136|NCT02144077|565848295|FG001|Overall Study|Lost to Follow-up|2|||
156753137|NCT02144077|565848294|FG000|Overall Study|Protocol Violation|1|||
156753138|NCT02144077|565848295|FG001|Overall Study|Protocol Violation|2|||
156753139|NCT02144077|565848294|FG000|Overall Study|Death|0|||
156753140|NCT02144077|565848295|FG001|Overall Study|Death|1|||
156753141|NCT02144077|565848294|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
156753142|NCT02144077|565848295|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
156753143|NCT01869777|565848296|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
156753144|NCT00943592|565848297|FG000|Overall Study|Death|3|||
156753145|NCT01909973|565848298|FG000|Overall Study|Lost to Follow-up|1|||
156753146|NCT01909973|565848299|FG001|Overall Study|Lost to Follow-up|0|||
156753147|NCT02072941|565848300|FG000|Overall Study|Withdrawal by Subject|29|||
156753148|NCT02072941|565848301|FG001|Overall Study|Withdrawal by Subject|21|||
156753149|NCT02072941|565848300|FG000|Overall Study|Lost to Follow-up|4|||
156753150|NCT02072941|565848301|FG001|Overall Study|Lost to Follow-up|4|||
156753151|NCT02072941|565848300|FG000|Overall Study|Death|3|||
156753152|NCT02072941|565848301|FG001|Overall Study|Death|2|||
156753153|NCT02072941|565848300|FG000|Overall Study|Removed by Study Staff|2|||
156753154|NCT02072941|565848301|FG001|Overall Study|Removed by Study Staff|2|||
156753155|NCT01247350|565848304|FG000|Overall Study|Adverse Event|0|||
156753156|NCT01247350|565848305|FG001|Overall Study|Adverse Event|0|||
156753157|NCT01247350|565848306|FG002|Overall Study|Adverse Event|1|||
156753158|NCT01247350|565848307|FG003|Overall Study|Adverse Event|0|||
156753159|NCT01247350|565848308|FG004|Overall Study|Adverse Event|0|||
156753160|NCT01247350|565848304|FG000|Overall Study|Withdrawal by Subject|0|||
156753161|NCT01247350|565848305|FG001|Overall Study|Withdrawal by Subject|0|||
156753162|NCT01247350|565848306|FG002|Overall Study|Withdrawal by Subject|0|||
156753163|NCT01247350|565848307|FG003|Overall Study|Withdrawal by Subject|1|||
156753164|NCT01247350|565848308|FG004|Overall Study|Withdrawal by Subject|0|||
156753165|NCT01247350|565848304|FG000|Overall Study|Entry criteria not met|0|||
156753166|NCT01247350|565848305|FG001|Overall Study|Entry criteria not met|0|||
156753167|NCT01247350|565848306|FG002|Overall Study|Entry criteria not met|0|||
156753168|NCT01247350|565848307|FG003|Overall Study|Entry criteria not met|0|||
156753169|NCT01247350|565848308|FG004|Overall Study|Entry criteria not met|1|||
156753170|NCT00169104|565848309|FG000|Overall Study|Withdrawal by Subject|2|||
156753171|NCT00169104|565848310|FG001|Overall Study|Withdrawal by Subject|0|||
156753172|NCT00169104|565848309|FG000|Overall Study|Protocol Violation|0|||
156753173|NCT00169104|565848310|FG001|Overall Study|Protocol Violation|1|||
156753174|NCT00169104|565848309|FG000|Overall Study|Physician Decision|0|||
156753175|NCT00169104|565848310|FG001|Overall Study|Physician Decision|1|||
156753176|NCT00715299|565848317|FG000|Overall Study|Withdrawal by Subject|1|||
156753177|NCT00715299|565848317|FG000|Overall Study|Adverse Event|3|||
156753178|NCT00715299|565848317|FG000|Overall Study|failed the pre-screen exercise test|2|||
156753179|NCT02020889|565848318|FG000|Overall Study|Adverse Event|0|||
156753180|NCT02020889|565848319|FG001|Overall Study|Adverse Event|1|||
156753181|NCT02020889|565848318|FG000|Overall Study|Lack of Efficacy|1|||
156753182|NCT02020889|565848319|FG001|Overall Study|Lack of Efficacy|0|||
156753183|NCT02020889|565848318|FG000|Overall Study|Lost to Follow-up|1|||
156753184|NCT02020889|565848319|FG001|Overall Study|Lost to Follow-up|0|||
156753185|NCT02020889|565848318|FG000|Overall Study|Physician Decision|2|||
156753186|NCT02020889|565848319|FG001|Overall Study|Physician Decision|0|||
156753187|NCT02020889|565848318|FG000|Overall Study|Withdrawal by Subject|3|||
156753188|NCT02020889|565848319|FG001|Overall Study|Withdrawal by Subject|2|||
156753189|NCT01540981|565848320|FG000|Overall Study|Withdrawal by Subject|1|||
156753190|NCT01540981|565848321|FG001|Overall Study|Withdrawal by Subject|0|||
156753191|NCT00809094|565848322|FG000|Overall Study|Lost to Follow-up|0|||
156753192|NCT00809094|565848323|FG001|Overall Study|Lost to Follow-up|1|||
156753193|NCT00232557|565848324|FG000|Overall Study|Lost to Follow-up|3|||
156753194|NCT00232557|565848325|FG001|Overall Study|Lost to Follow-up|5|||
156753195|NCT02438280|565848328|FG000|Overall Study|Physician Decision|1|||
156753196|NCT02438280|565848329|FG001|Overall Study|Physician Decision|0|||
156753197|NCT04435808|565848332|FG000|Overall Study|Study stopped by DSMB|0|||
156753198|NCT04435808|565848333|FG001|Overall Study|Study stopped by DSMB|1|||
156753199|NCT02457195|565848334|FG000|Overall Study|Adverse Event|3|||
156753200|NCT02457195|565848334|FG000|Overall Study|Protocol Violation|2|||
156753201|NCT02457195|565848334|FG000|Overall Study|Withdrawal by Subject|4|||
156753202|NCT02768792|565848336|FG000|Overall Study|Adverse Event|1|||
156753203|NCT04819438|565848337|FG000|Overall Study|Withdrawal by Subject|1|||
156753204|NCT04819438|565848338|FG001|Overall Study|Withdrawal by Subject|0|||
156753205|NCT04819438|565848337|FG000|Overall Study|Adverse Event|0|||
156753206|NCT04819438|565848338|FG001|Overall Study|Adverse Event|1|||
156753207|NCT04819438|565848337|FG000|Overall Study|Protocol Violation|0|||
156313079|NCT01590758|564244962|FG000|Overall Study|Withdrawal by Subject|0|||
156313080|NCT01590758|564244963|FG001|Overall Study|Withdrawal by Subject|3|||
156313081|NCT01590758|564244962|FG000|Overall Study|Physician Decision|1|||
156313082|NCT01590758|564244963|FG001|Overall Study|Physician Decision|2|||
156313083|NCT01590758|564244962|FG000|Overall Study|Lost to Follow-up|4|||
156313084|NCT01590758|564244963|FG001|Overall Study|Lost to Follow-up|2|||
156313085|NCT02756806|564244964|FG000|Overall Study|Study terminated early|5|||
156313086|NCT02228980|564244965|FG000|Overall Study|Adverse Event|14|||
156313087|NCT02228980|564244966|FG001|Overall Study|Adverse Event|0|||
156313088|NCT02228980|564244967|FG002|Overall Study|Adverse Event|0|||
156313089|NCT02228980|564244968|FG003|Overall Study|Adverse Event|0|||
156313090|NCT02228980|564244965|FG000|Overall Study|Protocol Violation|7|||
156313091|NCT02228980|564244966|FG001|Overall Study|Protocol Violation|0|||
156313092|NCT02228980|564244967|FG002|Overall Study|Protocol Violation|0|||
156313093|NCT02228980|564244968|FG003|Overall Study|Protocol Violation|0|||
156313094|NCT02228980|564244965|FG000|Overall Study|Withdrawal by Subject|3|||
156313095|NCT02228980|564244966|FG001|Overall Study|Withdrawal by Subject|3|||
156313096|NCT02228980|564244967|FG002|Overall Study|Withdrawal by Subject|2|||
156313097|NCT02228980|564244968|FG003|Overall Study|Withdrawal by Subject|3|||
156313098|NCT02929498|564244969|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
156313099|NCT02929498|564244970|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
156313100|NCT02929498|564244971|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
156313101|NCT02929498|564244969|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
156313102|NCT02929498|564244970|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
156313103|NCT02929498|564244971|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
156313104|NCT00096356|564244974|FG000|Overall Study|Adverse Event|11|||
156313105|NCT00096356|564244975|FG001|Overall Study|Adverse Event|9|||
156313106|NCT00096356|564244974|FG000|Overall Study|Physician Decision|5|||
156313107|NCT00096356|564244975|FG001|Overall Study|Physician Decision|3|||
156313108|NCT00096356|564244974|FG000|Overall Study|Withdrawal by Subject|17|||
156313109|NCT00096356|564244975|FG001|Overall Study|Withdrawal by Subject|23|||
156313110|NCT00096356|564244974|FG000|Overall Study|Lack of Efficacy|1|||
156313111|NCT00096356|564244975|FG001|Overall Study|Lack of Efficacy|0|||
156313112|NCT00096356|564244974|FG000|Overall Study|multiple reasons|10|||
156313113|NCT00096356|564244975|FG001|Overall Study|multiple reasons|18|||
156313114|NCT03288142|564244977|FG000|Overall Study|Lost to Follow-up|22|||
156313115|NCT03288142|564244978|FG001|Overall Study|Lost to Follow-up|15|||
156313116|NCT02034409|564244979|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
156313117|NCT02034409|564244980|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
156313118|NCT02034409|564244979|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
156313119|NCT02034409|564244980|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
156313120|NCT02034409|564244979|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
156313121|NCT02034409|564244980|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
156313122|NCT02034409|564244979|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
156313123|NCT02034409|564244980|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
156313124|NCT02034409|564244979|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
156313125|NCT02034409|564244980|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
156313126|NCT02034409|564244979|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
156313127|NCT02034409|564244980|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
156313128|NCT02270944|564244984|FG000|Overall Study|Lost to Follow-up|9|||
156313129|NCT02270944|564244985|FG001|Overall Study|Lost to Follow-up|4|||
156313130|NCT02270944|564244984|FG000|Overall Study|Withdrawal by Subject|2|||
156313131|NCT02270944|564244985|FG001|Overall Study|Withdrawal by Subject|1|||
156313132|NCT01699867|564244986|FG000|Overall Study|Screening Failure|3|||
156313133|NCT00530504|564244999|FG000|Overall Study|Death|54|||
156313134|NCT00530504|564244999|FG000|Overall Study|Lost to Follow-up|26|||
156313135|NCT00530504|564244999|FG000|Overall Study|Withdrawal by Subject|39|||
156313136|NCT00530504|564244999|FG000|Overall Study|Exited study due to other reasons|33|||
156313137|NCT00006289|564245000|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
156313138|NCT00006289|564245001|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
156313139|NCT00006289|564245000|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
156313140|NCT00006289|564245001|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
156313141|NCT04359901|564245010|FG000|Overall Study|Withdrawal by Subject|0|||
156313142|NCT04359901|564245011|FG001|Overall Study|Withdrawal by Subject|1|||
156313143|NCT04359901|564245010|FG000|Overall Study|Death|6|||
156313144|NCT04359901|564245011|FG001|Overall Study|Death|2|||
156313145|NCT00557856|564245014|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
156313146|NCT00557856|564245015|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
156313147|NCT00557856|564245016|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
156313148|NCT00557856|564245017|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
156313149|NCT00557856|564245018|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
156313150|NCT00557856|564245019|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
156414425|NCT01890967|564610950|FG004|Overall Study|Lost to Follow-up|0|||
156753208|NCT04819438|565848338|FG001|Overall Study|Protocol Violation|1|||
156753209|NCT05359952|565848340|FG000|Overall Study|Lost to Follow-up|1|||
156753210|NCT05359952|565848341|FG001|Overall Study|Lost to Follow-up|0|||
156753211|NCT00237692|565848343|FG000|Overall Study|Lost to Follow-up|9|||
156753212|NCT00237692|565848344|FG001|Overall Study|Lost to Follow-up|3|||
156753213|NCT00237692|565848345|FG002|Overall Study|Lost to Follow-up|5|||
156753214|NCT00237692|565848346|FG003|Overall Study|Lost to Follow-up|3|||
156753215|NCT00237692|565848343|FG000|Overall Study|Death|1|||
156753216|NCT00237692|565848344|FG001|Overall Study|Death|2|||
156753217|NCT00237692|565848345|FG002|Overall Study|Death|2|||
156753218|NCT00237692|565848346|FG003|Overall Study|Death|3|||
156753219|NCT00237692|565848343|FG000|Overall Study|Excluded - did not meet criteria|4|||
156753220|NCT00237692|565848344|FG001|Overall Study|Excluded - did not meet criteria|3|||
156753221|NCT00237692|565848345|FG002|Overall Study|Excluded - did not meet criteria|5|||
156753222|NCT00237692|565848346|FG003|Overall Study|Excluded - did not meet criteria|9|||
156753223|NCT00237692|565848343|FG000|Overall Study|Withdrawal by Subject|4|||
156753224|NCT00237692|565848344|FG001|Overall Study|Withdrawal by Subject|6|||
156753225|NCT00237692|565848345|FG002|Overall Study|Withdrawal by Subject|10|||
156753226|NCT00237692|565848346|FG003|Overall Study|Withdrawal by Subject|4|||
156753227|NCT01386944|565848353|FG000|Overall Study|Adverse Event|26|||
156753228|NCT01386944|565848353|FG000|Overall Study|Lack of Efficacy|14|||
156753229|NCT01386944|565848353|FG000|Overall Study|Lost to Follow-up|8|||
156753230|NCT01386944|565848353|FG000|Overall Study|Unspecified reason|8|||
156753231|NCT04186221|565848354|FG000|Overall Study|Death|1|||
156753232|NCT00531947|565848355|FG000|Overall Study|Adverse Event|5|||
156753233|NCT00531947|565848356|FG001|Overall Study|Adverse Event|10|||
156753234|NCT00531947|565848355|FG000|Overall Study|Lost to Follow-up|12|||
156753235|NCT00531947|565848356|FG001|Overall Study|Lost to Follow-up|9|||
156753236|NCT00531947|565848355|FG000|Overall Study|Withdrawal by Subject|14|||
156753237|NCT00531947|565848356|FG001|Overall Study|Withdrawal by Subject|19|||
156753238|NCT00531947|565848355|FG000|Overall Study|Protocol Violation|2|||
156753239|NCT00531947|565848356|FG001|Overall Study|Protocol Violation|1|||
156753240|NCT00531947|565848355|FG000|Overall Study|Non-Compliance|4|||
156753241|NCT00531947|565848356|FG001|Overall Study|Non-Compliance|7|||
156753242|NCT00531947|565848355|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
156753243|NCT00531947|565848356|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
156753244|NCT02348008|565848357|FG000|Overall Study|Adverse Event|2|||
156753245|NCT02348008|565848358|FG001|Overall Study|Adverse Event|3|||
156753246|NCT02348008|565848359|FG002|Overall Study|Adverse Event|3|||
156753247|NCT02348008|565848357|FG000|Overall Study|Disease Progression|1|||
156753248|NCT02348008|565848358|FG001|Overall Study|Disease Progression|5|||
156753249|NCT02348008|565848359|FG002|Overall Study|Disease Progression|16|||
156753250|NCT02348008|565848357|FG000|Overall Study|Withdrawal by Subject|0|||
156753251|NCT02348008|565848358|FG001|Overall Study|Withdrawal by Subject|1|||
156753252|NCT02348008|565848359|FG002|Overall Study|Withdrawal by Subject|0|||
156753253|NCT02348008|565848357|FG000|Overall Study|Symptomatic Deterioration|0|||
156753254|NCT02348008|565848358|FG001|Overall Study|Symptomatic Deterioration|1|||
156753255|NCT02348008|565848359|FG002|Overall Study|Symptomatic Deterioration|0|||
156753256|NCT00893971|565848360|FG000|Overall Study|Physician Decision|3|||
156753257|NCT03268005|565848361|FG000|Overall Study|Death|2|||
156753258|NCT03268005|565848362|FG001|Overall Study|Death|1|||
156753259|NCT03268005|565848361|FG000|Overall Study|Lost to Follow-up|2|||
156753260|NCT03268005|565848362|FG001|Overall Study|Lost to Follow-up|2|||
156753261|NCT03268005|565848361|FG000|Overall Study|Withdrawal by Subject|11|||
156753262|NCT03268005|565848362|FG001|Overall Study|Withdrawal by Subject|11|||
156753263|NCT01926197|565848364|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
156753264|NCT01926197|565848365|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
156753265|NCT01926197|565848364|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
156753266|NCT01926197|565848365|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
156753267|NCT02756364|565848366|FG000|Overall Study|Site Terminated by Sponsor|24|||
156753268|NCT02756364|565848367|FG001|Overall Study|Site Terminated by Sponsor|30|||
156753269|NCT02756364|565848368|FG002|Overall Study|Site Terminated by Sponsor|21|||
156753270|NCT02756364|565848366|FG000|Overall Study|Death|20|||
156753271|NCT02756364|565848367|FG001|Overall Study|Death|15|||
156753272|NCT02756364|565848368|FG002|Overall Study|Death|18|||
156753273|NCT02756364|565848366|FG000|Overall Study|Withdrawal by Patient|2|||
156753274|NCT02756364|565848367|FG001|Overall Study|Withdrawal by Patient|1|||
156753275|NCT02756364|565848368|FG002|Overall Study|Withdrawal by Patient|8|||
156753276|NCT02756364|565848366|FG000|Overall Study|Lost to Follow-up|0|||
156753277|NCT02756364|565848367|FG001|Overall Study|Lost to Follow-up|1|||
156753278|NCT02756364|565848368|FG002|Overall Study|Lost to Follow-up|1|||
156753279|NCT02223364|565848369|FG000|Overall Study|Protocol Violation|3|||
156753280|NCT02223364|565848370|FG001|Overall Study|Protocol Violation|0|||
156753281|NCT02223364|565848371|FG002|Overall Study|Protocol Violation|3|||
156753282|NCT02223364|565848369|FG000|Overall Study|subject expired before surgery|1|||
156753283|NCT02223364|565848370|FG001|Overall Study|subject expired before surgery|0|||
156753284|NCT02223364|565848371|FG002|Overall Study|subject expired before surgery|0|||
156753285|NCT02223364|565848369|FG000|Overall Study|Physician Decision|1|||
156753286|NCT02223364|565848370|FG001|Overall Study|Physician Decision|0|||
156753287|NCT02223364|565848371|FG002|Overall Study|Physician Decision|0|||
156753288|NCT01416155|565848372|FG000|Overall Study|Adverse Event|8|||
156753289|NCT01416155|565848372|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
156753290|NCT01416155|565848372|FG000|Overall Study|Withdrawal by Subject|33|||
156753291|NCT01416155|565848372|FG000|Overall Study|Investigator decision|8|||
156753292|NCT01416155|565848372|FG000|Overall Study|Other|7|||
156753293|NCT00829829|565848376|FG000|Overall Study|Protocol Violation|0|||
156753294|NCT00829829|565848377|FG001|Overall Study|Protocol Violation|3|||
156753295|NCT00829829|565848378|FG002|Overall Study|Protocol Violation|0|||
156753296|NCT00829829|565848376|FG000|Overall Study|Adverse Event|4|||
156753297|NCT00829829|565848377|FG001|Overall Study|Adverse Event|4|||
156753298|NCT00829829|565848378|FG002|Overall Study|Adverse Event|3|||
156753299|NCT00829829|565848376|FG000|Overall Study|Withdrawal by Subject|8|||
156753300|NCT00829829|565848377|FG001|Overall Study|Withdrawal by Subject|4|||
156753301|NCT00829829|565848378|FG002|Overall Study|Withdrawal by Subject|2|||
156753302|NCT00829829|565848376|FG000|Overall Study|Decision by the Sponsor|1|||
156753303|NCT00829829|565848377|FG001|Overall Study|Decision by the Sponsor|0|||
156753304|NCT00829829|565848378|FG002|Overall Study|Decision by the Sponsor|2|||
156753305|NCT00829829|565848376|FG000|Overall Study|Lost to Follow-up|7|||
156753306|NCT00829829|565848377|FG001|Overall Study|Lost to Follow-up|3|||
156753307|NCT00829829|565848378|FG002|Overall Study|Lost to Follow-up|3|||
156753308|NCT00829829|565848376|FG000|Overall Study|Other than specified above|2|||
156753309|NCT00829829|565848377|FG001|Overall Study|Other than specified above|2|||
156753310|NCT00829829|565848378|FG002|Overall Study|Other than specified above|1|||
156753311|NCT02685072|565848379|FG000|Treatment Period|Lost to Follow-up|12|||
156753312|NCT02685072|565848380|FG001|Treatment Period|Lost to Follow-up|6|||
156753313|NCT02685072|565848379|FG000|Treatment Period|Withdrawal by Subject|1|||
156753314|NCT02685072|565848380|FG001|Treatment Period|Withdrawal by Subject|3|||
156753315|NCT02685072|565848379|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
156753316|NCT02685072|565848380|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
156753317|NCT00382109|565848383|FG000|Overall Study|Adverse Event|3|||
156753318|NCT00382109|565848384|FG001|Overall Study|Adverse Event|0|||
156753319|NCT00382109|565848383|FG000|Overall Study|Physician Decision|6|||
156753320|NCT00382109|565848384|FG001|Overall Study|Physician Decision|1|||
156753321|NCT00382109|565848383|FG000|Overall Study|Withdrawal by Subject|1|||
156753322|NCT00382109|565848384|FG001|Overall Study|Withdrawal by Subject|0|||
156753323|NCT00382109|565848383|FG000|Overall Study|ineligible|2|||
156753324|NCT00382109|565848384|FG001|Overall Study|ineligible|0|||
156753325|NCT00382109|565848383|FG000|Overall Study|Other|0|||
156753326|NCT00382109|565848384|FG001|Overall Study|Other|2|||
156753327|NCT00382109|565848383|FG000|Overall Study|consent withdrawal|0|||
156753328|NCT00382109|565848384|FG001|Overall Study|consent withdrawal|1|||
156753329|NCT01249833|565848385|FG000|Overall Study|Lost to Follow-up|0|||
156753330|NCT01249833|565848386|FG001|Overall Study|Lost to Follow-up|1|||
156753331|NCT02774005|565848387|FG000|Overall Study|Adverse Event|8|||
156753332|NCT02774005|565848387|FG000|Overall Study|Withdrawal by Subject|23|||
156753333|NCT02774005|565848387|FG000|Overall Study|Lost to Follow-up|7|||
156753334|NCT02774005|565848387|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
156753335|NCT02774005|565848387|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
156753336|NCT02774005|565848387|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
156753337|NCT02774005|565848387|FG000|Overall Study|Death|1|||
156753338|NCT02774005|565848387|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
156753339|NCT02774005|565848387|FG000|Overall Study|Lack of compliance with study medication|4|||
156753340|NCT02774005|565848387|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
156753341|NCT02774005|565848387|FG000|Overall Study|another study|1|||
156753342|NCT02774005|565848387|FG000|Overall Study|cardiologist imposed travel restriction|1|||
156753343|NCT03885999|565848388|FG000|Overall Study|Adverse Event|1|||
156753344|NCT01402986|565848389|FG000|Overall Study|Withdrawal by Subject|7|||
156753345|NCT01402986|565848390|FG001|Overall Study|Withdrawal by Subject|10|||
156753346|NCT01402986|565848391|FG002|Overall Study|Withdrawal by Subject|7|||
156753347|NCT01402986|565848392|FG003|Overall Study|Withdrawal by Subject|13|||
156753348|NCT01402986|565848389|FG000|Overall Study|Death|0|||
156753349|NCT01402986|565848390|FG001|Overall Study|Death|0|||
156753350|NCT01402986|565848391|FG002|Overall Study|Death|0|||
156753351|NCT01402986|565848392|FG003|Overall Study|Death|2|||
156753352|NCT01402986|565848389|FG000|Overall Study|Lost to Follow-up|0|||
156753353|NCT01402986|565848390|FG001|Overall Study|Lost to Follow-up|0|||
156753354|NCT01402986|565848391|FG002|Overall Study|Lost to Follow-up|0|||
156753355|NCT01402986|565848392|FG003|Overall Study|Lost to Follow-up|1|||
156753356|NCT01402986|565848389|FG000|Overall Study|Other|2|||
156753357|NCT01402986|565848390|FG001|Overall Study|Other|5|||
156753358|NCT01402986|565848391|FG002|Overall Study|Other|1|||
156753359|NCT01402986|565848392|FG003|Overall Study|Other|6|||
156753360|NCT03749109|565848393|FG000|Overall Study|Adverse Event|2|||
156753361|NCT03749109|565848394|FG001|Overall Study|Adverse Event|0|||
156753362|NCT03178851|565848395|FG000|Overall Study|Death|48|||
156313151|NCT00557856|564245020|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
156313152|NCT00557856|564245021|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
156313153|NCT00557856|564245022|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
156313154|NCT00557856|564245014|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
156313155|NCT00557856|564245015|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156313156|NCT00557856|564245016|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
156313157|NCT00557856|564245017|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156313158|NCT00557856|564245018|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156313159|NCT00557856|564245019|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156313160|NCT00557856|564245020|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156313161|NCT00557856|564245021|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156313162|NCT00557856|564245022|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156313163|NCT00557856|564245014|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
156313164|NCT00557856|564245015|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
156313165|NCT00557856|564245016|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
156313166|NCT00557856|564245017|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
156313167|NCT00557856|564245018|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
156313168|NCT00557856|564245019|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
156313169|NCT00557856|564245020|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
156313170|NCT00557856|564245021|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
156313171|NCT00557856|564245022|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
156313172|NCT00557856|564245014|FG000|Part 1: Dose Escalation Phase|Other|0|||
156313173|NCT00557856|564245015|FG001|Part 1: Dose Escalation Phase|Other|0|||
156313174|NCT00557856|564245016|FG002|Part 1: Dose Escalation Phase|Other|1|||
156313175|NCT00557856|564245017|FG003|Part 1: Dose Escalation Phase|Other|1|||
156313176|NCT00557856|564245018|FG004|Part 1: Dose Escalation Phase|Other|0|||
156313177|NCT00557856|564245019|FG005|Part 1: Dose Escalation Phase|Other|0|||
156313178|NCT00557856|564245020|FG006|Part 1: Dose Escalation Phase|Other|0|||
156313179|NCT00557856|564245021|FG007|Part 1: Dose Escalation Phase|Other|1|||
156313180|NCT00557856|564245022|FG008|Part 1: Dose Escalation Phase|Other|0|||
156313181|NCT00557856|564245014|FG000|Part 1: Dose Escalation Phase|Death|0|||
156313182|NCT00557856|564245015|FG001|Part 1: Dose Escalation Phase|Death|0|||
156313183|NCT00557856|564245016|FG002|Part 1: Dose Escalation Phase|Death|0|||
156313184|NCT00557856|564245017|FG003|Part 1: Dose Escalation Phase|Death|0|||
156313185|NCT00557856|564245018|FG004|Part 1: Dose Escalation Phase|Death|0|||
156313186|NCT00557856|564245019|FG005|Part 1: Dose Escalation Phase|Death|1|||
156313187|NCT00557856|564245020|FG006|Part 1: Dose Escalation Phase|Death|0|||
156313188|NCT00557856|564245021|FG007|Part 1: Dose Escalation Phase|Death|0|||
156313189|NCT00557856|564245022|FG008|Part 1: Dose Escalation Phase|Death|0|||
156313190|NCT00557856|564245014|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156313191|NCT00557856|564245015|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156313192|NCT00557856|564245016|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156313193|NCT00557856|564245017|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156313194|NCT00557856|564245018|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156313195|NCT00557856|564245019|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
156313196|NCT00557856|564245020|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
156313197|NCT00557856|564245021|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156313198|NCT00557856|564245022|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156313199|NCT00557856|564245014|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
156313200|NCT00557856|564245015|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156313201|NCT00557856|564245016|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156313202|NCT00557856|564245017|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156313203|NCT00557856|564245018|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156313204|NCT00557856|564245019|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156313205|NCT00557856|564245020|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156313206|NCT00557856|564245021|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156313207|NCT00557856|564245022|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156313208|NCT00557856|564245014|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
156313209|NCT00557856|564245015|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
156313210|NCT00557856|564245016|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
156313211|NCT00557856|564245017|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
156313212|NCT00557856|564245018|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
156313213|NCT00557856|564245019|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
156414426|NCT01890967|564610951|FG005|Overall Study|Lost to Follow-up|1|||
156414427|NCT01890967|564610946|FG000|Overall Study|Protocol Violation|0|||
156414428|NCT01890967|564610947|FG001|Overall Study|Protocol Violation|3|||
156414429|NCT01890967|564610948|FG002|Overall Study|Protocol Violation|3|||
156414430|NCT01890967|564610949|FG003|Overall Study|Protocol Violation|2|||
156753363|NCT03178851|565848396|FG001|Overall Study|Death|2|||
156753364|NCT03178851|565848397|FG002|Overall Study|Death|25|||
156753365|NCT03178851|565848395|FG000|Overall Study|Withdrawal by Subject|8|||
156753366|NCT03178851|565848396|FG001|Overall Study|Withdrawal by Subject|0|||
156753367|NCT03178851|565848397|FG002|Overall Study|Withdrawal by Subject|0|||
156753368|NCT03178851|565848395|FG000|Overall Study|Lost to Follow-up|5|||
156753369|NCT03178851|565848396|FG001|Overall Study|Lost to Follow-up|2|||
156753370|NCT03178851|565848397|FG002|Overall Study|Lost to Follow-up|0|||
156753371|NCT03178851|565848395|FG000|Overall Study|Adverse Event|0|||
156753372|NCT03178851|565848396|FG001|Overall Study|Adverse Event|0|||
156753373|NCT03178851|565848397|FG002|Overall Study|Adverse Event|1|||
156753374|NCT03178851|565848395|FG000|Overall Study|Study Termination by Sponsor|31|||
156753375|NCT03178851|565848396|FG001|Overall Study|Study Termination by Sponsor|7|||
156753376|NCT03178851|565848397|FG002|Overall Study|Study Termination by Sponsor|26|||
156753377|NCT02226120|565848398|FG000|Overall Study|Adverse Event|60|||
156753378|NCT02226120|565848398|FG000|Overall Study|Death|172|||
156753379|NCT02226120|565848398|FG000|Overall Study|Study terminated by sponsor|1|||
156753380|NCT02226120|565848398|FG000|Overall Study|Technical problems|4|||
156753381|NCT02226120|565848398|FG000|Overall Study|Lost to Follow-up|13|||
156753382|NCT02226120|565848398|FG000|Overall Study|Physician Decision|21|||
156753383|NCT02226120|565848398|FG000|Overall Study|Withdrawal by parent/guardian|36|||
156753384|NCT02226120|565848398|FG000|Overall Study|Non-compliance with study drug|10|||
156753385|NCT02226120|565848398|FG000|Overall Study|Protocol deviation|1|||
156753386|NCT02226120|565848398|FG000|Overall Study|missing treatment disposition pages|2|||
156753387|NCT03034135|565848399|FG000|Overall Study|Withdrawal by Subject|2|||
156753388|NCT02447328|565851327|FG000|Overall Study|Withdrawal by Subject|1|||
156753389|NCT03859648|565851330|FG000|Overall Study|Lost to Follow-up|1|||
156753390|NCT03859648|565851330|FG000|Overall Study|Adverse Event|1|||
156753391|NCT02501161|565851331|FG000|Overall Study|Adverse Event|2|||
156753392|NCT02501161|565851332|FG001|Overall Study|Adverse Event|6|||
156753393|NCT02501161|565851331|FG000|Overall Study|Lost to Follow-up|7|||
156753394|NCT02501161|565851332|FG001|Overall Study|Lost to Follow-up|4|||
156753395|NCT02501161|565851331|FG000|Overall Study|Withdrawal by Subject|10|||
156753396|NCT02501161|565851332|FG001|Overall Study|Withdrawal by Subject|15|||
156753397|NCT02501161|565851331|FG000|Overall Study|Other|3|||
156753398|NCT02501161|565851332|FG001|Overall Study|Other|0|||
156753399|NCT04336475|565851333|FG000|Overall Study|pain|1|||
156753400|NCT04336475|565851334|FG001|Overall Study|pain|0|||
156753401|NCT04336475|565851333|FG000|Overall Study|upper respiratory infection|1|||
156753402|NCT04336475|565851334|FG001|Overall Study|upper respiratory infection|0|||
156753403|NCT04336475|565851333|FG000|Overall Study|Lost to Follow-up|0|||
156753404|NCT04336475|565851334|FG001|Overall Study|Lost to Follow-up|2|||
156753405|NCT02906579|565851339|FG000|Overall Study|Adverse Event|1|||
156753406|NCT02906579|565851339|FG000|Overall Study|Physician Decision|1|||
156753407|NCT02030119|565851340|FG000|Overall Study|Withdrawal by Subject|3|||
156753408|NCT02030119|565851341|FG001|Overall Study|Withdrawal by Subject|1|||
156753409|NCT02030119|565851342|FG002|Overall Study|Withdrawal by Subject|5|||
156753410|NCT02030119|565851343|FG003|Overall Study|Withdrawal by Subject|3|||
156753411|NCT02030119|565851340|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
156753412|NCT02030119|565851341|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
156753413|NCT02030119|565851342|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
156753414|NCT02030119|565851343|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
156753415|NCT00759655|565851344|FG000|Overall Study|Termination of the study by sponsor|1|||
156753416|NCT00905567|565851353|FG000|Washout|Withdrawal by Subject|0|||
156753417|NCT00905567|565851354|FG001|Washout|Withdrawal by Subject|1|||
156753418|NCT01465230|565851355|FG000|Overall Study|Withdrawal by Subject|2|||
156753419|NCT01738919|565851356|FG000|Overall Study|Lost to Follow-up|1|||
156753420|NCT01738919|565851357|FG001|Overall Study|Lost to Follow-up|0|||
156753421|NCT01738919|565851356|FG000|Overall Study|Immigrated|0|||
156753422|NCT01738919|565851357|FG001|Overall Study|Immigrated|1|||
156753423|NCT01738919|565851356|FG000|Overall Study|Withdrawal by Subject|0|||
156753424|NCT01738919|565851357|FG001|Overall Study|Withdrawal by Subject|1|||
156753425|NCT01738919|565851356|FG000|Overall Study|Not treated in accordance to guidelines|0|||
156753426|NCT01738919|565851357|FG001|Overall Study|Not treated in accordance to guidelines|1|||
156753427|NCT00534248|565851358|FG000|Overall Study|Adverse Event|19|||
156753428|NCT00534248|565851359|FG001|Overall Study|Adverse Event|29|||
156753429|NCT00534248|565851358|FG000|Overall Study|Lost to Follow-up|353|||
156753430|NCT00534248|565851359|FG001|Overall Study|Lost to Follow-up|375|||
156753431|NCT00534248|565851358|FG000|Overall Study|Other protocol specified criteria|13|||
156753432|NCT00534248|565851359|FG001|Overall Study|Other protocol specified criteria|3|||
156753433|NCT00534248|565851358|FG000|Overall Study|Physician Decision|10|||
156753434|NCT00534248|565851359|FG001|Overall Study|Physician Decision|7|||
156753435|NCT00534248|565851358|FG000|Overall Study|Protocol Violation|3|||
156753436|NCT00534248|565851359|FG001|Overall Study|Protocol Violation|4|||
156753437|NCT00534248|565851358|FG000|Overall Study|Withdrawal by Subject|263|||
156753438|NCT00534248|565851359|FG001|Overall Study|Withdrawal by Subject|255|||
156753439|NCT02532257|565851360|FG000|Overall Study|Adverse Event|2|||
156753440|NCT02532257|565851360|FG000|Overall Study|Physician Decision|4|||
156313214|NCT00557856|564245020|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
156313215|NCT00557856|564245021|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
156313216|NCT00557856|564245022|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
156313217|NCT00557856|564245014|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156313218|NCT00557856|564245015|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156313219|NCT00557856|564245016|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156313220|NCT00557856|564245017|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156313221|NCT00557856|564245018|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156313222|NCT00557856|564245019|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156313223|NCT00557856|564245020|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156313224|NCT00557856|564245021|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156313225|NCT00557856|564245022|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
156313226|NCT00557856|564245014|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
156313227|NCT00557856|564245015|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
156313228|NCT00557856|564245016|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
156313229|NCT00557856|564245017|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
156313230|NCT00557856|564245018|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
156313231|NCT00557856|564245019|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
156313232|NCT00557856|564245020|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
156313233|NCT00557856|564245021|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
156313234|NCT00557856|564245022|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
156313235|NCT00557856|564245014|FG000|Part 2: Exploratory Phase|Other|0|||
156313236|NCT00557856|564245015|FG001|Part 2: Exploratory Phase|Other|0|||
156313237|NCT00557856|564245016|FG002|Part 2: Exploratory Phase|Other|0|||
156313238|NCT00557856|564245017|FG003|Part 2: Exploratory Phase|Other|0|||
156313239|NCT00557856|564245018|FG004|Part 2: Exploratory Phase|Other|0|||
156313240|NCT00557856|564245019|FG005|Part 2: Exploratory Phase|Other|0|||
156313241|NCT00557856|564245020|FG006|Part 2: Exploratory Phase|Other|0|||
156313242|NCT00557856|564245021|FG007|Part 2: Exploratory Phase|Other|0|||
156313243|NCT00557856|564245022|FG008|Part 2: Exploratory Phase|Other|1|||
156313244|NCT00557856|564245014|FG000|Part 2: Exploratory Phase|Death|0|||
156313245|NCT00557856|564245015|FG001|Part 2: Exploratory Phase|Death|0|||
156313246|NCT00557856|564245016|FG002|Part 2: Exploratory Phase|Death|0|||
156313247|NCT00557856|564245017|FG003|Part 2: Exploratory Phase|Death|0|||
156313248|NCT00557856|564245018|FG004|Part 2: Exploratory Phase|Death|0|||
156313249|NCT00557856|564245019|FG005|Part 2: Exploratory Phase|Death|0|||
156313250|NCT00557856|564245020|FG006|Part 2: Exploratory Phase|Death|0|||
156313251|NCT00557856|564245021|FG007|Part 2: Exploratory Phase|Death|0|||
156313252|NCT00557856|564245022|FG008|Part 2: Exploratory Phase|Death|2|||
156313253|NCT00557856|564245014|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
156313254|NCT00557856|564245015|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
156313255|NCT00557856|564245016|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
156313256|NCT00557856|564245017|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
156313257|NCT00557856|564245018|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
156313258|NCT00557856|564245019|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
156313259|NCT00557856|564245020|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
156313260|NCT00557856|564245021|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
156313261|NCT00557856|564245022|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
156313262|NCT05092360|564245023|FG000|Overall Study|Withdrawal by Subject|21|||
156313263|NCT05092360|564245024|FG001|Overall Study|Withdrawal by Subject|4|||
156313264|NCT05092360|564245025|FG002|Overall Study|Withdrawal by Subject|9|||
156313265|NCT05092360|564245026|FG003|Overall Study|Withdrawal by Subject|26|||
156313266|NCT05092360|564245023|FG000|Overall Study|Death|97|||
156313267|NCT05092360|564245024|FG001|Overall Study|Death|14|||
156650277|NCT00628745|565465427|FG002|Overall Study|Does not meet inclusion criteria|0|||
156650278|NCT00628745|565465428|FG003|Overall Study|Does not meet inclusion criteria|0|||
156650279|NCT00628745|565465429|FG004|Overall Study|Does not meet inclusion criteria|18|||
156650280|NCT00628745|565465425|FG000|Overall Study|Participation in an interventional clinical trial|81|||
156650281|NCT00628745|565465426|FG001|Overall Study|Participation in an interventional clinical trial|4|||
156650282|NCT00628745|565465427|FG002|Overall Study|Participation in an interventional clinical trial|7|||
156650283|NCT00628745|565465428|FG003|Overall Study|Participation in an interventional clinical trial|0|||
156650284|NCT00628745|565465429|FG004|Overall Study|Participation in an interventional clinical trial|63|||
156650285|NCT00628745|565465425|FG000|Overall Study|Physician Decision|8|||
156650286|NCT00628745|565465426|FG001|Overall Study|Physician Decision|4|||
156650287|NCT00628745|565465427|FG002|Overall Study|Physician Decision|3|||
156650288|NCT00628745|565465428|FG003|Overall Study|Physician Decision|0|||
156650289|NCT00628745|565465429|FG004|Overall Study|Physician Decision|30|||
156650290|NCT00628745|565465425|FG000|Overall Study|Lost to Follow-up|109|||
156650291|NCT00628745|565465426|FG001|Overall Study|Lost to Follow-up|7|||
156650292|NCT00628745|565465427|FG002|Overall Study|Lost to Follow-up|7|||
156313268|NCT05092360|564245025|FG002|Overall Study|Death|31|||
156313269|NCT05092360|564245026|FG003|Overall Study|Death|101|||
156650293|NCT00628745|565465428|FG003|Overall Study|Lost to Follow-up|0|||
156753441|NCT02532257|565851360|FG000|Overall Study|Withdrawal by Subject|3|||
156753442|NCT02532257|565851360|FG000|Overall Study|Progressive Disease|10|||
156753443|NCT02259400|565851361|FG000|Overall Study|Death|0|||
156753444|NCT02259400|565851362|FG001|Overall Study|Death|2|||
156753445|NCT03498313|565851366|FG000|Experimental Period 1|Adverse Event|1|||
156753446|NCT03498313|565851367|FG001|Experimental Period 1|Adverse Event|0|||
156753447|NCT03498313|565851368|FG002|Experimental Period 1|Adverse Event|0|||
156753448|NCT03498313|565851369|FG003|Experimental Period 1|Adverse Event|1|||
156753449|NCT03498313|565851370|FG004|Experimental Period 1|Adverse Event|0|||
156753450|NCT03498313|565851371|FG005|Experimental Period 1|Adverse Event|0|||
156753451|NCT03498313|565851366|FG000|Experimental Period 1|Withdrawal by Subject|0|||
156753452|NCT03498313|565851367|FG001|Experimental Period 1|Withdrawal by Subject|1|||
156753453|NCT03498313|565851368|FG002|Experimental Period 1|Withdrawal by Subject|0|||
156753454|NCT03498313|565851369|FG003|Experimental Period 1|Withdrawal by Subject|0|||
156753455|NCT03498313|565851370|FG004|Experimental Period 1|Withdrawal by Subject|0|||
156753456|NCT03498313|565851371|FG005|Experimental Period 1|Withdrawal by Subject|0|||
156753457|NCT03498313|565851366|FG000|Washout Period 1|Anovulation|1|||
156753458|NCT03498313|565851367|FG001|Washout Period 1|Anovulation|0|||
156753459|NCT03498313|565851368|FG002|Washout Period 1|Anovulation|0|||
156753460|NCT03498313|565851369|FG003|Washout Period 1|Anovulation|0|||
156753461|NCT03498313|565851370|FG004|Washout Period 1|Anovulation|0|||
156753462|NCT03498313|565851371|FG005|Washout Period 1|Anovulation|0|||
156753463|NCT03498313|565851366|FG000|Washout Period 1|Withdrawal by Subject|0|||
156753464|NCT03498313|565851367|FG001|Washout Period 1|Withdrawal by Subject|3|||
156753465|NCT03498313|565851368|FG002|Washout Period 1|Withdrawal by Subject|0|||
156753466|NCT03498313|565851369|FG003|Washout Period 1|Withdrawal by Subject|1|||
156753467|NCT03498313|565851370|FG004|Washout Period 1|Withdrawal by Subject|0|||
156753468|NCT03498313|565851371|FG005|Washout Period 1|Withdrawal by Subject|1|||
156753469|NCT03498313|565851366|FG000|Experimental Period 2|Adverse Event|0|||
156753470|NCT03498313|565851367|FG001|Experimental Period 2|Adverse Event|0|||
156753471|NCT03498313|565851368|FG002|Experimental Period 2|Adverse Event|0|||
156753472|NCT03498313|565851369|FG003|Experimental Period 2|Adverse Event|0|||
156753473|NCT03498313|565851370|FG004|Experimental Period 2|Adverse Event|1|||
156753474|NCT03498313|565851371|FG005|Experimental Period 2|Adverse Event|2|||
156753475|NCT03498313|565851366|FG000|Washout Period 2|Physician Decision|1|||
156753476|NCT03498313|565851367|FG001|Washout Period 2|Physician Decision|0|||
156753477|NCT03498313|565851368|FG002|Washout Period 2|Physician Decision|0|||
156753478|NCT03498313|565851369|FG003|Washout Period 2|Physician Decision|1|||
156753479|NCT03498313|565851370|FG004|Washout Period 2|Physician Decision|0|||
156753480|NCT03498313|565851371|FG005|Washout Period 2|Physician Decision|1|||
156753481|NCT03498313|565851366|FG000|Washout Period 2|Withdrawal by Subject|3|||
156753482|NCT03498313|565851367|FG001|Washout Period 2|Withdrawal by Subject|2|||
156753483|NCT03498313|565851368|FG002|Washout Period 2|Withdrawal by Subject|0|||
156753484|NCT03498313|565851369|FG003|Washout Period 2|Withdrawal by Subject|0|||
156753485|NCT03498313|565851370|FG004|Washout Period 2|Withdrawal by Subject|2|||
156753486|NCT03498313|565851371|FG005|Washout Period 2|Withdrawal by Subject|0|||
156753487|NCT03498313|565851366|FG000|Washout Period 2|Anovulation|0|||
156753488|NCT03498313|565851367|FG001|Washout Period 2|Anovulation|0|||
156753489|NCT03498313|565851368|FG002|Washout Period 2|Anovulation|0|||
156753490|NCT03498313|565851369|FG003|Washout Period 2|Anovulation|0|||
156753491|NCT03498313|565851370|FG004|Washout Period 2|Anovulation|0|||
156753492|NCT03498313|565851371|FG005|Washout Period 2|Anovulation|1|||
156753493|NCT02372383|565851375|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
156753494|NCT02372383|565851376|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
156753495|NCT02372383|565851377|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
156753496|NCT00929994|565851378|FG000|Overall Study|Withdrawal by Subject|1|||
156753497|NCT00929994|565851378|FG000|Overall Study|medical issue unrelated to intervention|4|||
156753498|NCT00929994|565851378|FG000|Overall Study|employment|1|||
156753499|NCT00184002|565851379|FG000|Overall Study|Adverse Event|9|||
156753500|NCT00184002|565851379|FG000|Overall Study|Death|3|||
156753501|NCT00184002|565851379|FG000|Overall Study|Physician Decision|1|||
156753502|NCT00184002|565851379|FG000|Overall Study|Withdrawal by Subject|4|||
156753503|NCT00694356|565851380|FG000|Overall Study|Adverse Event|1|||
156753504|NCT00694356|565851381|FG001|Overall Study|Adverse Event|0|||
156753505|NCT00694356|565851382|FG002|Overall Study|Adverse Event|0|||
156753506|NCT00694356|565851380|FG000|Overall Study|Progressive Disease|2|||
156753507|NCT00694356|565851381|FG001|Overall Study|Progressive Disease|6|||
156753508|NCT00694356|565851382|FG002|Overall Study|Progressive Disease|6|||
156753509|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
156753510|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
156753511|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
156753512|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
156753513|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
156753514|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
156753515|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
156753516|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
156753517|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
156753518|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
156753519|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
156753520|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
156753521|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
156753522|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
156753523|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
156753524|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
156753525|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
156753526|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
156753527|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
156753528|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
156753529|NCT01042392|565851383|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
156753530|NCT01042392|565851384|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
156753531|NCT01042392|565851385|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
156753532|NCT01042392|565851386|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
156753533|NCT01042392|565851383|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
156753534|NCT01042392|565851384|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
156753535|NCT01042392|565851385|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
156753536|NCT01042392|565851386|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
156753537|NCT01042392|565851383|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
156753538|NCT01042392|565851384|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
156753539|NCT01042392|565851385|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
156753540|NCT01042392|565851386|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
156753541|NCT01042392|565851383|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
156753542|NCT01042392|565851384|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
156753543|NCT01042392|565851385|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
156753544|NCT01042392|565851386|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
156753545|NCT03117361|565851387|FG000|Overall Study|Progressive disease|5|||
156753546|NCT03117361|565851387|FG000|Overall Study|Death|1|||
156753547|NCT03117361|565851387|FG000|Overall Study|Physician Decision|2|||
156753548|NCT03117361|565851387|FG000|Overall Study|On study treatment at the end of study|1|||
156753549|NCT03117361|565851387|FG000|Overall Study|Treatment-related adverse event|1|||
156753550|NCT00878800|565851388|FG000|Overall Study|Adverse Event|0|||
156753551|NCT00878800|565851389|FG001|Overall Study|Adverse Event|0|||
156753552|NCT00878800|565851390|FG002|Overall Study|Adverse Event|2|||
156753553|NCT00878800|565851391|FG003|Overall Study|Adverse Event|0|||
156753554|NCT00878800|565851392|FG004|Overall Study|Adverse Event|1|||
156753555|NCT00878800|565851388|FG000|Overall Study|Progressive disease|1|||
156753556|NCT00878800|565851389|FG001|Overall Study|Progressive disease|5|||
156753557|NCT00878800|565851390|FG002|Overall Study|Progressive disease|6|||
156753558|NCT00878800|565851391|FG003|Overall Study|Progressive disease|5|||
156753559|NCT00878800|565851392|FG004|Overall Study|Progressive disease|13|||
156753560|NCT00878800|565851388|FG000|Overall Study|Withdrew consent|1|||
156753561|NCT00878800|565851389|FG001|Overall Study|Withdrew consent|1|||
156753562|NCT00878800|565851390|FG002|Overall Study|Withdrew consent|0|||
156753563|NCT00878800|565851391|FG003|Overall Study|Withdrew consent|1|||
156753564|NCT00878800|565851392|FG004|Overall Study|Withdrew consent|1|||
156753565|NCT00878800|565851388|FG000|Overall Study|Death|0|||
156753566|NCT00878800|565851389|FG001|Overall Study|Death|0|||
156753567|NCT00878800|565851390|FG002|Overall Study|Death|1|||
156753568|NCT00878800|565851391|FG003|Overall Study|Death|0|||
156753569|NCT00878800|565851392|FG004|Overall Study|Death|0|||
156753570|NCT00878800|565851388|FG000|Overall Study|Other|1|||
156753571|NCT00878800|565851389|FG001|Overall Study|Other|1|||
156753572|NCT00878800|565851390|FG002|Overall Study|Other|0|||
156753573|NCT00878800|565851391|FG003|Overall Study|Other|0|||
156753574|NCT00878800|565851392|FG004|Overall Study|Other|1|||
156753575|NCT02982863|565851393|FG000|Overall Study|Not eligible patients|809|||
156753576|NCT02982863|565851394|FG001|Overall Study|Not eligible patients|4261|||
156753577|NCT02982863|565851395|FG002|Overall Study|Not eligible patients|1852|||
156753578|NCT02982863|565851396|FG003|Overall Study|Not eligible patients|1400|||
156753579|NCT02982863|565851397|FG004|Overall Study|Not eligible patients|492|||
156753580|NCT02328937|565851399|FG000|Period 1|Lost to Follow-up|0|||
156753581|NCT02328937|565851400|FG001|Period 1|Lost to Follow-up|0|||
156313270|NCT05092360|564245023|FG000|Overall Study|Lost to Follow-up|1|||
156313271|NCT05092360|564245024|FG001|Overall Study|Lost to Follow-up|2|||
156753582|NCT02328937|565851401|FG002|Period 1|Lost to Follow-up|0|||
156753583|NCT02328937|565851402|FG003|Period 1|Lost to Follow-up|1|||
156753584|NCT02328937|565851403|FG004|Period 1|Lost to Follow-up|0|||
156753585|NCT02328937|565851404|FG005|Period 1|Lost to Follow-up|0|||
156753586|NCT02328937|565851399|FG000|Period 2|Adverse Event|0|||
156753587|NCT02328937|565851400|FG001|Period 2|Adverse Event|0|||
156753588|NCT02328937|565851401|FG002|Period 2|Adverse Event|1|||
156753589|NCT02328937|565851402|FG003|Period 2|Adverse Event|0|||
156753590|NCT02328937|565851403|FG004|Period 2|Adverse Event|0|||
156753591|NCT02328937|565851404|FG005|Period 2|Adverse Event|0|||
156753592|NCT00435461|565851405|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
156753593|NCT00435461|565851406|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
156753594|NCT00435461|565851407|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
156753595|NCT00435461|565851405|FG000|Overall Study|Protocol Violation|6|||
156753596|NCT00435461|565851406|FG001|Overall Study|Protocol Violation|9|||
156753597|NCT00435461|565851407|FG002|Overall Study|Protocol Violation|10|||
156753598|NCT00435461|565851405|FG000|Overall Study|Participant randomized(inadequate score)|1|||
156753599|NCT00435461|565851406|FG001|Overall Study|Participant randomized(inadequate score)|0|||
156753600|NCT00435461|565851407|FG002|Overall Study|Participant randomized(inadequate score)|0|||
156753601|NCT00435461|565851405|FG000|Overall Study|Compliance less than 80 percent|1|||
156753602|NCT00435461|565851406|FG001|Overall Study|Compliance less than 80 percent|0|||
156753603|NCT00435461|565851407|FG002|Overall Study|Compliance less than 80 percent|0|||
156753604|NCT00435461|565851405|FG000|Overall Study|In error, two study medications switched|1|||
156753605|NCT00435461|565851406|FG001|Overall Study|In error, two study medications switched|0|||
156753606|NCT00435461|565851407|FG002|Overall Study|In error, two study medications switched|0|||
156753607|NCT00435461|565851405|FG000|Overall Study|Lack of Efficacy|2|||
156753608|NCT00435461|565851406|FG001|Overall Study|Lack of Efficacy|1|||
156753609|NCT00435461|565851407|FG002|Overall Study|Lack of Efficacy|0|||
156753610|NCT00435461|565851405|FG000|Overall Study|Withdrawal by Subject|1|||
156753611|NCT00435461|565851406|FG001|Overall Study|Withdrawal by Subject|0|||
156753612|NCT00435461|565851407|FG002|Overall Study|Withdrawal by Subject|2|||
156753613|NCT00435461|565851405|FG000|Overall Study|Randomized in error|1|||
156753614|NCT00435461|565851406|FG001|Overall Study|Randomized in error|0|||
156753615|NCT00435461|565851407|FG002|Overall Study|Randomized in error|0|||
156753616|NCT00435461|565851405|FG000|Overall Study|Participant could not tolerate symptoms|0|||
156753617|NCT00435461|565851406|FG001|Overall Study|Participant could not tolerate symptoms|0|||
156753618|NCT00435461|565851407|FG002|Overall Study|Participant could not tolerate symptoms|1|||
156753619|NCT00435461|565851405|FG000|Overall Study|Participant could not swallow capsule|0|||
156753620|NCT00435461|565851406|FG001|Overall Study|Participant could not swallow capsule|0|||
156313272|NCT05092360|564245025|FG002|Overall Study|Lost to Follow-up|2|||
156313273|NCT05092360|564245026|FG003|Overall Study|Lost to Follow-up|2|||
156313274|NCT05092360|564245023|FG000|Overall Study|Study terminated by sponsor|65|||
156313275|NCT05092360|564245024|FG001|Overall Study|Study terminated by sponsor|7|||
156313276|NCT05092360|564245025|FG002|Overall Study|Study terminated by sponsor|13|||
156313277|NCT05092360|564245026|FG003|Overall Study|Study terminated by sponsor|61|||
156313278|NCT01675167|564245027|FG000|Open-label Titration Phase|Adverse Event|81|||
156313279|NCT01675167|564245028|FG001|Open-label Titration Phase|Adverse Event|0|||
156313280|NCT01675167|564245029|FG002|Open-label Titration Phase|Adverse Event|0|||
156313281|NCT01675167|564245027|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
156313282|NCT01675167|564245028|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
156313283|NCT01675167|564245029|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
156313284|NCT01675167|564245027|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
156313285|NCT01675167|564245028|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
156313286|NCT01675167|564245029|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
156313287|NCT01675167|564245027|FG000|Open-label Titration Phase|Protocol Violation|43|||
156313288|NCT01675167|564245028|FG001|Open-label Titration Phase|Protocol Violation|0|||
156313289|NCT01675167|564245029|FG002|Open-label Titration Phase|Protocol Violation|0|||
156313290|NCT01675167|564245027|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
156313291|NCT01675167|564245028|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
156313292|NCT01675167|564245029|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
156313293|NCT01675167|564245027|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
156313294|NCT01675167|564245028|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
156313295|NCT01675167|564245029|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
156313296|NCT01675167|564245027|FG000|Open-label Titration Phase|Other|55|||
156313297|NCT01675167|564245028|FG001|Open-label Titration Phase|Other|0|||
156313298|NCT01675167|564245029|FG002|Open-label Titration Phase|Other|0|||
156313299|NCT01675167|564245027|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
156313300|NCT01675167|564245028|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
156313301|NCT01675167|564245029|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
156313302|NCT01675167|564245027|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156313303|NCT01675167|564245028|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
156313304|NCT01675167|564245029|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
156753621|NCT00435461|565851407|FG002|Overall Study|Participant could not swallow capsule|1|||
156753622|NCT00435461|565851405|FG000|Overall Study|Pregnancy|2|||
156753623|NCT00435461|565851406|FG001|Overall Study|Pregnancy|0|||
156753624|NCT00435461|565851407|FG002|Overall Study|Pregnancy|0|||
156753625|NCT00435461|565851405|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
156650294|NCT00628745|565465429|FG004|Overall Study|Lost to Follow-up|498|||
156650295|NCT00628745|565465425|FG000|Overall Study|Death|197|||
156650296|NCT00628745|565465426|FG001|Overall Study|Death|81|||
156650297|NCT00628745|565465427|FG002|Overall Study|Death|12|||
156650298|NCT00628745|565465428|FG003|Overall Study|Death|4|||
156650299|NCT00628745|565465429|FG004|Overall Study|Death|939|||
156650300|NCT00628745|565465425|FG000|Overall Study|Participant transferred to another THAOS site|6|||
156650301|NCT00628745|565465426|FG001|Overall Study|Participant transferred to another THAOS site|0|||
156650302|NCT00628745|565465427|FG002|Overall Study|Participant transferred to another THAOS site|0|||
156650303|NCT00628745|565465428|FG003|Overall Study|Participant transferred to another THAOS site|0|||
156650304|NCT00628745|565465429|FG004|Overall Study|Participant transferred to another THAOS site|7|||
156650305|NCT00628745|565465425|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
156650306|NCT00628745|565465426|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
156650307|NCT00628745|565465427|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
156650308|NCT00628745|565465428|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
156650309|NCT00628745|565465429|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
156650310|NCT00628745|565465425|FG000|Overall Study|Site closure|152|||
156650311|NCT00628745|565465426|FG001|Overall Study|Site closure|146|||
156650312|NCT00628745|565465427|FG002|Overall Study|Site closure|6|||
156650313|NCT00628745|565465428|FG003|Overall Study|Site closure|8|||
156650314|NCT00628745|565465429|FG004|Overall Study|Site closure|691|||
156650315|NCT00628745|565465425|FG000|Overall Study|Duplicate participant|0|||
156650316|NCT00628745|565465426|FG001|Overall Study|Duplicate participant|0|||
156650317|NCT00628745|565465427|FG002|Overall Study|Duplicate participant|0|||
156650318|NCT00628745|565465428|FG003|Overall Study|Duplicate participant|0|||
156650319|NCT00628745|565465429|FG004|Overall Study|Duplicate participant|1|||
156650320|NCT00628745|565465425|FG000|Overall Study|Missing|4|||
156650321|NCT00628745|565465426|FG001|Overall Study|Missing|3|||
156650322|NCT00628745|565465427|FG002|Overall Study|Missing|0|||
156650323|NCT00628745|565465428|FG003|Overall Study|Missing|0|||
156650324|NCT00628745|565465429|FG004|Overall Study|Missing|10|||
156650325|NCT00628745|565465425|FG000|Overall Study|Othe reasons|987|||
156650326|NCT00628745|565465426|FG001|Overall Study|Othe reasons|373|||
156650327|NCT00628745|565465427|FG002|Overall Study|Othe reasons|105|||
156650328|NCT00628745|565465428|FG003|Overall Study|Othe reasons|1|||
156650329|NCT00628745|565465429|FG004|Overall Study|Othe reasons|1772|||
156650330|NCT00982410|565467041|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
156650331|NCT00982410|565467042|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
156650332|NCT00982410|565467041|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
156650333|NCT00982410|565467042|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
156650334|NCT00982410|565467041|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
156650335|NCT00982410|565467042|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
156650336|NCT00982410|565467041|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
156650337|NCT00982410|565467042|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
156650338|NCT00982410|565467041|FG000|6-month Follow-up Assessment|participant no transportation|1|||
156650339|NCT00982410|565467042|FG001|6-month Follow-up Assessment|participant no transportation|0|||
156650340|NCT00982410|565467041|FG000|6-month Follow-up Assessment|incarceration|0|||
156650341|NCT00982410|565467042|FG001|6-month Follow-up Assessment|incarceration|2|||
156650342|NCT00982410|565467041|FG000|6-month Follow-up Assessment|patent surgery|0|||
156650343|NCT00982410|565467042|FG001|6-month Follow-up Assessment|patent surgery|1|||
156650344|NCT00982410|565467041|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
156650345|NCT00982410|565467042|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
156650346|NCT00982410|565467041|FG000|12-month Follow-up Assessment|Death|0|||
156650347|NCT00982410|565467042|FG001|12-month Follow-up Assessment|Death|2|||
156650348|NCT00982410|565467041|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
156650349|NCT00982410|565467042|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
156650350|NCT00982410|565467041|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
156650351|NCT00982410|565467042|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
156650352|NCT00982410|565467041|FG000|12-month Follow-up Assessment|incarceration|2|||
156650353|NCT00982410|565467042|FG001|12-month Follow-up Assessment|incarceration|1|||
156650354|NCT00982410|565467041|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
156650355|NCT00982410|565467042|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
156650356|NCT02034799|565467045|FG000|Overall Study|Withdrawal by Subject|0|||
156650357|NCT02034799|565467046|FG001|Overall Study|Withdrawal by Subject|2|||
156650358|NCT02034799|565467045|FG000|Overall Study|Lost to Follow-up|0|||
156650359|NCT02034799|565467046|FG001|Overall Study|Lost to Follow-up|1|||
156650360|NCT02034799|565467045|FG000|Overall Study|Death|2|||
156650361|NCT02034799|565467046|FG001|Overall Study|Death|1|||
156650362|NCT04582266|565467058|FG000|Overall Study|Lost to Follow-up|7|||
156650363|NCT04582266|565467059|FG001|Overall Study|Lost to Follow-up|5|||
156650364|NCT04582266|565467058|FG000|Overall Study|Withdrawal by Subject|1|||
156650365|NCT04582266|565467059|FG001|Overall Study|Withdrawal by Subject|0|||
156753626|NCT00435461|565851406|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
156753627|NCT00435461|565851407|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
156753628|NCT00435461|565851405|FG000|Overall Study|Participant ended study one day early|1|||
156753629|NCT00435461|565851406|FG001|Overall Study|Participant ended study one day early|0|||
156753630|NCT00435461|565851407|FG002|Overall Study|Participant ended study one day early|0|||
156753631|NCT00435461|565851405|FG000|Overall Study|Noncompliance with study requirements|1|||
156753632|NCT00435461|565851406|FG001|Overall Study|Noncompliance with study requirements|1|||
156753633|NCT00435461|565851407|FG002|Overall Study|Noncompliance with study requirements|1|||
156753634|NCT00435461|565851405|FG000|Overall Study|Adverse Event|1|||
156753635|NCT00435461|565851406|FG001|Overall Study|Adverse Event|2|||
156753636|NCT00435461|565851407|FG002|Overall Study|Adverse Event|6|||
156753637|NCT00435461|565851405|FG000|Overall Study|Non-Compliance of diary|2|||
156753638|NCT00435461|565851406|FG001|Overall Study|Non-Compliance of diary|0|||
156753639|NCT00435461|565851407|FG002|Overall Study|Non-Compliance of diary|1|||
156753640|NCT00435461|565851405|FG000|Overall Study|Lost to Follow-up|1|||
156753641|NCT00435461|565851406|FG001|Overall Study|Lost to Follow-up|1|||
156753642|NCT00435461|565851407|FG002|Overall Study|Lost to Follow-up|2|||
156753643|NCT01768559|565851408|FG000|Overall Study|Randomized but not treated|0|||
156753644|NCT01768559|565851409|FG001|Overall Study|Randomized but not treated|0|||
156753645|NCT01768559|565851410|FG002|Overall Study|Randomized but not treated|1|||
156753646|NCT01768559|565851408|FG000|Overall Study|Adverse Event|15|||
156753647|NCT01768559|565851409|FG001|Overall Study|Adverse Event|2|||
156753648|NCT01768559|565851410|FG002|Overall Study|Adverse Event|5|||
156753649|NCT01768559|565851408|FG000|Overall Study|Lack of Efficacy|6|||
156753650|NCT01768559|565851409|FG001|Overall Study|Lack of Efficacy|4|||
156753651|NCT01768559|565851410|FG002|Overall Study|Lack of Efficacy|0|||
156753652|NCT01768559|565851408|FG000|Overall Study|Poor compliance to protocol|0|||
156753653|NCT01768559|565851409|FG001|Overall Study|Poor compliance to protocol|3|||
156753654|NCT01768559|565851410|FG002|Overall Study|Poor compliance to protocol|2|||
156753655|NCT01768559|565851408|FG000|Overall Study|Other than specified|9|||
156753656|NCT01768559|565851409|FG001|Overall Study|Other than specified|8|||
156753657|NCT01768559|565851410|FG002|Overall Study|Other than specified|5|||
156753658|NCT01737879|565851413|FG000|Overall Study|Death|1|||
156753659|NCT01737879|565851413|FG000|Overall Study|Sponsor decision|40|||
156753660|NCT03883477|565851414|FG000|Overall Study|Death|1|||
156753661|NCT03883477|565851415|FG001|Overall Study|Death|0|||
156753662|NCT03883477|565851414|FG000|Overall Study|Protocol Violation|0|||
156753663|NCT03883477|565851415|FG001|Overall Study|Protocol Violation|1|||
156753664|NCT04399538|565851424|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
156753665|NCT04399538|565851425|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
156753666|NCT04399538|565851426|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
156753667|NCT04399538|565851427|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
156753668|NCT04399538|565851428|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
156753669|NCT04399538|565851424|FG000|Double-Blind Treatment|Adverse Event|0|||
156753670|NCT04399538|565851425|FG001|Double-Blind Treatment|Adverse Event|0|||
156753671|NCT04399538|565851426|FG002|Double-Blind Treatment|Adverse Event|0|||
156753672|NCT04399538|565851427|FG003|Double-Blind Treatment|Adverse Event|0|||
156753673|NCT04399538|565851428|FG004|Double-Blind Treatment|Adverse Event|1|||
156753674|NCT04399538|565851424|FG000|Follow-Up|Adverse Event|0|||
156753675|NCT04399538|565851425|FG001|Follow-Up|Adverse Event|0|||
156753676|NCT04399538|565851426|FG002|Follow-Up|Adverse Event|0|||
156753677|NCT04399538|565851427|FG003|Follow-Up|Adverse Event|0|||
156753678|NCT04399538|565851428|FG004|Follow-Up|Adverse Event|1|||
156753679|NCT04399538|565851424|FG000|Follow-Up|Withdrawal by Subject|0|||
156753680|NCT04399538|565851425|FG001|Follow-Up|Withdrawal by Subject|0|||
156753681|NCT04399538|565851426|FG002|Follow-Up|Withdrawal by Subject|0|||
156753682|NCT04399538|565851427|FG003|Follow-Up|Withdrawal by Subject|2|||
156753683|NCT04399538|565851428|FG004|Follow-Up|Withdrawal by Subject|0|||
156753684|NCT01588405|565851430|FG000|Overall Study|Adverse Event|1|||
156753685|NCT01588405|565851430|FG000|Overall Study|Clinical Worsening|1|||
156753686|NCT00980655|565851432|FG000|Overall Study|Adverse Event|13|||
156753687|NCT00980655|565851433|FG001|Overall Study|Adverse Event|31|||
156753688|NCT00980655|565851432|FG000|Overall Study|Death|0|||
156753689|NCT00980655|565851433|FG001|Overall Study|Death|7|||
156753690|NCT00980655|565851432|FG000|Overall Study|Protocol Violation|2|||
156753691|NCT00980655|565851433|FG001|Overall Study|Protocol Violation|7|||
156753692|NCT00980655|565851432|FG000|Overall Study|Withdrawal by Subject|0|||
156753693|NCT00980655|565851433|FG001|Overall Study|Withdrawal by Subject|4|||
156414431|NCT01890967|564610950|FG004|Overall Study|Protocol Violation|4|||
156753694|NCT00980655|565851432|FG000|Overall Study|Lost to Follow-up|0|||
156753695|NCT00980655|565851433|FG001|Overall Study|Lost to Follow-up|1|||
156753696|NCT00980655|565851432|FG000|Overall Study|Parent/legal guardian request|1|||
156753697|NCT00980655|565851433|FG001|Overall Study|Parent/legal guardian request|0|||
156753698|NCT00980655|565851432|FG000|Overall Study|Other|0|||
156753699|NCT00980655|565851433|FG001|Overall Study|Other|1|||
156753700|NCT04162795|565851434|FG000|Overall Study|Other|16|||
156753701|NCT04162795|565851434|FG000|Overall Study|Screen failures|10|||
156753702|NCT02029274|565851438|FG000|Overall Study|Adverse Event|1|||
156753703|NCT02029274|565851439|FG001|Overall Study|Adverse Event|0|||
156753704|NCT02029274|565851440|FG002|Overall Study|Adverse Event|2|||
156753705|NCT02029274|565851441|FG003|Overall Study|Adverse Event|2|||
156753706|NCT00845676|565851444|FG000|Overall Study|Virologic breakthrough at week 20|1|||
156753707|NCT00845676|565851444|FG000|Overall Study|Adverse Event|1|||
156753708|NCT02984267|565851445|FG000|Overall Study|Protocol Violation|1|||
156650366|NCT04582266|565467058|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
156650367|NCT04582266|565467059|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
156650368|NCT02224456|565467060|FG000|Overall Study|Lack of Efficacy|1|||
156650369|NCT02224456|565467060|FG000|Overall Study|Lost to Follow-up|15|||
156650370|NCT02224456|565467060|FG000|Overall Study|Withdrawal by Subject|9|||
156650371|NCT02224456|565467060|FG000|Overall Study|Physician Decision|3|||
156650372|NCT02224456|565467060|FG000|Overall Study|Death|2|||
156650373|NCT02224456|565467060|FG000|Overall Study|Pregnancy|4|||
156650374|NCT02224456|565467060|FG000|Overall Study|Protocol Violation|1|||
156650375|NCT02224456|565467060|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
156650376|NCT01241461|565467061|FG000|Overall Study|Progressive Disease|3|||
156650377|NCT01241461|565467062|FG001|Overall Study|Progressive Disease|6|||
156650378|NCT01379781|565467063|FG000|Overall Study|Lost to Follow-up|11|||
156650379|NCT01379781|565467064|FG001|Overall Study|Lost to Follow-up|8|||
156650380|NCT02247479|565467065|FG000|Overall Study|Adverse Event|8|||
156650381|NCT02247479|565467066|FG001|Overall Study|Adverse Event|9|||
156650382|NCT02247479|565467067|FG002|Overall Study|Adverse Event|8|||
156650383|NCT02247479|565467065|FG000|Overall Study|Death|5|||
156650384|NCT02247479|565467066|FG001|Overall Study|Death|4|||
156650385|NCT02247479|565467067|FG002|Overall Study|Death|6|||
156650386|NCT02247479|565467065|FG000|Overall Study|Lost to Follow-up|3|||
156650387|NCT02247479|565467066|FG001|Overall Study|Lost to Follow-up|3|||
156650388|NCT02247479|565467067|FG002|Overall Study|Lost to Follow-up|1|||
156650389|NCT02247479|565467065|FG000|Overall Study|Non-compliance|0|||
156650390|NCT02247479|565467066|FG001|Overall Study|Non-compliance|0|||
156650391|NCT02247479|565467067|FG002|Overall Study|Non-compliance|1|||
156650392|NCT02247479|565467065|FG000|Overall Study|Withdrawal by Subject|25|||
156650393|NCT02247479|565467066|FG001|Overall Study|Withdrawal by Subject|29|||
156650394|NCT02247479|565467067|FG002|Overall Study|Withdrawal by Subject|24|||
156650395|NCT02247479|565467065|FG000|Overall Study|Study Terminated by Sponsor|98|||
156650396|NCT02247479|565467066|FG001|Overall Study|Study Terminated by Sponsor|88|||
156650397|NCT02247479|565467067|FG002|Overall Study|Study Terminated by Sponsor|94|||
156650398|NCT02247479|565467065|FG000|Overall Study|Physician Decision|1|||
156650399|NCT02247479|565467066|FG001|Overall Study|Physician Decision|0|||
156650400|NCT02247479|565467067|FG002|Overall Study|Physician Decision|2|||
156650401|NCT02247479|565467065|FG000|Overall Study|Unspecified Reason|2|||
156650402|NCT02247479|565467066|FG001|Overall Study|Unspecified Reason|5|||
156650403|NCT02247479|565467067|FG002|Overall Study|Unspecified Reason|2|||
156650404|NCT03740698|565467068|FG000|Overall Study|Physician Decision|0|||
156650405|NCT03740698|565467069|FG001|Overall Study|Physician Decision|1|||
156650406|NCT03740698|565467070|FG002|Overall Study|Physician Decision|1|||
156650407|NCT01007916|565467073|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
156650408|NCT01007916|565467074|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
156650409|NCT01007916|565467073|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
156650410|NCT01007916|565467074|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
156650411|NCT01162499|565467075|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
156650412|NCT01162499|565467076|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
156650413|NCT02058628|565467077|FG000|Overall Study|Adverse Event|1|||
156650414|NCT02058628|565467078|FG001|Overall Study|Adverse Event|0|||
156650415|NCT02058628|565467077|FG000|Overall Study|Withdrawal by Subject|2|||
156650416|NCT02058628|565467078|FG001|Overall Study|Withdrawal by Subject|2|||
156650417|NCT02058628|565467077|FG000|Overall Study|Lost to Follow-up|2|||
156650418|NCT02058628|565467078|FG001|Overall Study|Lost to Follow-up|4|||
156650419|NCT02058628|565467077|FG000|Overall Study|Not in time schedule|0|||
156650420|NCT02058628|565467078|FG001|Overall Study|Not in time schedule|1|||
156650421|NCT02058628|565467077|FG000|Overall Study|The visit date was not in timeline|0|||
156650422|NCT02058628|565467078|FG001|Overall Study|The visit date was not in timeline|1|||
156650423|NCT02058628|565467077|FG000|Overall Study|A lot of time for study for participant|1|||
156650424|NCT02058628|565467078|FG001|Overall Study|A lot of time for study for participant|0|||
156650425|NCT02058628|565467077|FG000|Overall Study|Non compliance|1|||
156650426|NCT02058628|565467078|FG001|Overall Study|Non compliance|0|||
156650427|NCT00671879|565467079|FG000|Overall Study|Withdrawal by Subject|0|||
156650428|NCT00671879|565467080|FG001|Overall Study|Withdrawal by Subject|4|||
156650429|NCT00671879|565467081|FG002|Overall Study|Withdrawal by Subject|6|||
156753709|NCT02984267|565851446|FG001|Overall Study|Protocol Violation|0|||
156650430|NCT01628120|565467082|FG000|Overall Study|Withdrawal by Subject|7|||
156650431|NCT01628120|565467082|FG000|Overall Study|Adverse Event|12|||
156650432|NCT01628120|565467082|FG000|Overall Study|Lost to Follow-up|1|||
156650433|NCT01628120|565467082|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
156650434|NCT01628120|565467082|FG000|Overall Study|Non-compliant with Study Procedures|1|||
156650435|NCT01628120|565467082|FG000|Overall Study|Not Treated|3|||
156753710|NCT02984267|565851445|FG000|Overall Study|Withdrawal by Subject|0|||
156753711|NCT02984267|565851446|FG001|Overall Study|Withdrawal by Subject|1|||
156753712|NCT03597139|565851448|FG000|Overall Study|Adverse Event|3|||
156753713|NCT03597139|565851449|FG001|Overall Study|Adverse Event|0|||
156753714|NCT03597139|565851448|FG000|Overall Study|Protocol Non-compliance|1|||
156753715|NCT03597139|565851449|FG001|Overall Study|Protocol Non-compliance|0|||
156753716|NCT04811664|565851450|FG000|Overall Study|Lost to Follow-up|78|||
156753717|NCT04811664|565851451|FG001|Overall Study|Lost to Follow-up|125|||
156753718|NCT04811664|565851452|FG002|Overall Study|Lost to Follow-up|46|||
156753719|NCT04811664|565851450|FG000|Overall Study|Withdrawal by Subject|39|||
156753720|NCT04811664|565851451|FG001|Overall Study|Withdrawal by Subject|76|||
156753721|NCT04811664|565851452|FG002|Overall Study|Withdrawal by Subject|12|||
156753722|NCT04811664|565851450|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
156753723|NCT04811664|565851451|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
156753724|NCT04811664|565851452|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
156753725|NCT04811664|565851450|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
156753726|NCT04811664|565851451|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
156753727|NCT04811664|565851452|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
156753728|NCT04811664|565851450|FG000|Overall Study|Protocol Violation|0|||
156753729|NCT04811664|565851451|FG001|Overall Study|Protocol Violation|5|||
156753730|NCT04811664|565851452|FG002|Overall Study|Protocol Violation|11|||
156753731|NCT04811664|565851450|FG000|Overall Study|Study Terminated by Sponsor|4|||
156753732|NCT04811664|565851451|FG001|Overall Study|Study Terminated by Sponsor|3|||
156753733|NCT04811664|565851452|FG002|Overall Study|Study Terminated by Sponsor|34|||
156753734|NCT04811664|565851450|FG000|Overall Study|Early Study Closure|3|||
156753735|NCT04811664|565851451|FG001|Overall Study|Early Study Closure|7|||
156753736|NCT04811664|565851452|FG002|Overall Study|Early Study Closure|79|||
156753737|NCT04811664|565851450|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
156753738|NCT04811664|565851451|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
156753739|NCT04811664|565851452|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
156753740|NCT02717442|565851453|FG000|Overall Study|Study Terminated by Sponsor|31|||
156753741|NCT02717442|565851454|FG001|Overall Study|Study Terminated by Sponsor|29|||
156753742|NCT02717442|565851453|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
156753743|NCT02717442|565851454|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
156753744|NCT02717442|565851453|FG000|Overall Study|Other - Not Specified|2|||
156753745|NCT02717442|565851454|FG001|Overall Study|Other - Not Specified|0|||
156753746|NCT05052697|565851455|FG000|Substudy A|Lost to Follow-up|0|||
156753747|NCT05052697|565851456|FG001|Substudy A|Lost to Follow-up|0|||
156753748|NCT05052697|565851457|FG002|Substudy A|Lost to Follow-up|0|||
156753749|NCT05052697|565851458|FG003|Substudy A|Lost to Follow-up|0|||
156753750|NCT05052697|565851459|FG004|Substudy A|Lost to Follow-up|0|||
156753751|NCT05052697|565851460|FG005|Substudy A|Lost to Follow-up|1|||
156753752|NCT05052697|565851461|FG006|Substudy A|Lost to Follow-up|0|||
156753753|NCT05052697|565851462|FG007|Substudy A|Lost to Follow-up|0|||
156753754|NCT05052697|565851463|FG008|Substudy A|Lost to Follow-up|0|||
156753755|NCT05052697|565851464|FG009|Substudy A|Lost to Follow-up|0|||
156753756|NCT05052697|565851465|FG010|Substudy A|Lost to Follow-up|0|||
156753757|NCT05052697|565851466|FG011|Substudy A|Lost to Follow-up|0|||
156753758|NCT05052697|565851467|FG012|Substudy A|Lost to Follow-up|0|||
156753759|NCT05052697|565851468|FG013|Substudy A|Lost to Follow-up|0|||
156753760|NCT05052697|565851469|FG014|Substudy A|Lost to Follow-up|0|||
156753761|NCT05052697|565851470|FG015|Substudy A|Lost to Follow-up|2|||
156753762|NCT05052697|565851471|FG016|Substudy A|Lost to Follow-up|0|||
156753763|NCT05052697|565851472|FG017|Substudy A|Lost to Follow-up|0|||
156753764|NCT05052697|565851473|FG018|Substudy A|Lost to Follow-up|0|||
156753765|NCT05052697|565851474|FG019|Substudy A|Lost to Follow-up|0|||
156753766|NCT05052697|565851475|FG020|Substudy A|Lost to Follow-up|0|||
156753767|NCT05052697|565851476|FG021|Substudy A|Lost to Follow-up|0|||
156753768|NCT05052697|565851477|FG022|Substudy A|Lost to Follow-up|0|||
156753769|NCT05052697|565851478|FG023|Substudy A|Lost to Follow-up|0|||
156753770|NCT05052697|565851479|FG024|Substudy A|Lost to Follow-up|0|||
156753771|NCT05052697|565851480|FG025|Substudy A|Lost to Follow-up|0|||
156753772|NCT05052697|565851481|FG026|Substudy A|Lost to Follow-up|0|||
156753773|NCT05052697|565851482|FG027|Substudy A|Lost to Follow-up|0|||
156753774|NCT05052697|565851483|FG028|Substudy A|Lost to Follow-up|0|||
156753775|NCT05052697|565851484|FG029|Substudy A|Lost to Follow-up|0|||
156414432|NCT01890967|564610951|FG005|Overall Study|Protocol Violation|1|||
156753776|NCT05052697|565851485|FG030|Substudy A|Lost to Follow-up|0|||
156753777|NCT05052697|565851486|FG031|Substudy A|Lost to Follow-up|0|||
156753778|NCT05052697|565851487|FG032|Substudy A|Lost to Follow-up|0|||
156753779|NCT05052697|565851488|FG033|Substudy A|Lost to Follow-up|0|||
156753780|NCT05052697|565851455|FG000|Substudy A|No longer met eligibility criteria|0|||
156753781|NCT05052697|565851456|FG001|Substudy A|No longer met eligibility criteria|0|||
156753782|NCT05052697|565851457|FG002|Substudy A|No longer met eligibility criteria|0|||
156753783|NCT05052697|565851458|FG003|Substudy A|No longer met eligibility criteria|0|||
156753784|NCT05052697|565851459|FG004|Substudy A|No longer met eligibility criteria|0|||
156753785|NCT05052697|565851460|FG005|Substudy A|No longer met eligibility criteria|0|||
156753786|NCT05052697|565851461|FG006|Substudy A|No longer met eligibility criteria|0|||
156753787|NCT05052697|565851462|FG007|Substudy A|No longer met eligibility criteria|0|||
156753788|NCT05052697|565851463|FG008|Substudy A|No longer met eligibility criteria|0|||
156753789|NCT05052697|565851464|FG009|Substudy A|No longer met eligibility criteria|0|||
156753790|NCT05052697|565851465|FG010|Substudy A|No longer met eligibility criteria|0|||
156753791|NCT05052697|565851466|FG011|Substudy A|No longer met eligibility criteria|0|||
156753792|NCT05052697|565851467|FG012|Substudy A|No longer met eligibility criteria|0|||
156753793|NCT05052697|565851468|FG013|Substudy A|No longer met eligibility criteria|1|||
156753794|NCT05052697|565851469|FG014|Substudy A|No longer met eligibility criteria|0|||
156753795|NCT05052697|565851470|FG015|Substudy A|No longer met eligibility criteria|0|||
156753796|NCT05052697|565851471|FG016|Substudy A|No longer met eligibility criteria|0|||
156753797|NCT05052697|565851472|FG017|Substudy A|No longer met eligibility criteria|0|||
156753798|NCT05052697|565851473|FG018|Substudy A|No longer met eligibility criteria|0|||
156753799|NCT05052697|565851474|FG019|Substudy A|No longer met eligibility criteria|0|||
156650436|NCT01628120|565467082|FG000|Overall Study|Sponsor Decision|5|||
156650437|NCT01628120|565467082|FG000|Overall Study|Switched Dialysis Method|2|||
156650438|NCT01628120|565467082|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
156650439|NCT01628120|565467082|FG000|Overall Study|Moved or Relocated|5|||
156650440|NCT01628120|565467082|FG000|Overall Study|Kidney Transplant|2|||
156650441|NCT01628120|565467082|FG000|Overall Study|Use of Standard of Care|1|||
156650442|NCT01927757|565467085|FG000|Overall Study|Withdrawal by Subject|14|||
156650443|NCT01927757|565467085|FG000|Overall Study|Lost to Follow-up|2|||
156650444|NCT01927757|565467085|FG000|Overall Study|Decision by Sponsor|2|||
156650445|NCT01927757|565467085|FG000|Overall Study|Other|1|||
156650446|NCT01927757|565467085|FG000|Overall Study|Ethical Reasons|4|||
156650447|NCT00444795|565467086|FG000|Overall Study|Not Treated|1|||
156650448|NCT00444795|565467086|FG000|Overall Study|Treated Prior to the Contract Date|2|||
156650449|NCT00988169|565467087|FG000|Overall Study|Withdrawal by Subject|1|||
156650450|NCT00704418|565467089|FG000|Overall Study|Withdrawal by Subject|2|||
156650451|NCT00704418|565467090|FG001|Overall Study|Withdrawal by Subject|0|||
156650452|NCT00704418|565467089|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
156650453|NCT00704418|565467090|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
156650454|NCT02637076|565467091|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
156650455|NCT02637076|565467092|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
156650456|NCT02637076|565467091|FG000|Overall Study|Withdrawal by Subject|0|||
156650457|NCT02637076|565467092|FG001|Overall Study|Withdrawal by Subject|4|||
156650458|NCT00130520|565467093|FG000|Overall Study|Adverse Event|11|||
156650459|NCT00130520|565467093|FG000|Overall Study|Death|1|||
156650460|NCT00130520|565467093|FG000|Overall Study|Physician Decision|1|||
156650461|NCT00130520|565467093|FG000|Overall Study|Withdrawal by Subject|1|||
156650462|NCT00130520|565467093|FG000|Overall Study|Disease Progression|23|||
156650463|NCT00130520|565467093|FG000|Overall Study|Protocol non-compliance|1|||
156650464|NCT00130520|565467093|FG000|Overall Study|Did not meet re-treatment criteria|1|||
156650465|NCT00415532|565467095|FG000|Treatment Period|Adverse Event|2|||
156650466|NCT00415532|565467096|FG001|Treatment Period|Adverse Event|3|||
156650467|NCT00415532|565467095|FG000|Treatment Period|Death|2|||
156650468|NCT00415532|565467096|FG001|Treatment Period|Death|1|||
156650469|NCT00415532|565467095|FG000|Treatment Period|Lost to Follow-up|1|||
156650470|NCT00415532|565467096|FG001|Treatment Period|Lost to Follow-up|1|||
156650471|NCT00415532|565467095|FG000|Treatment Period|Protocol Violation|1|||
156650472|NCT00415532|565467096|FG001|Treatment Period|Protocol Violation|0|||
156650473|NCT00415532|565467095|FG000|Treatment Period|Withdrawal by Subject|6|||
156650474|NCT00415532|565467096|FG001|Treatment Period|Withdrawal by Subject|6|||
156650475|NCT00415532|565467095|FG000|Treatment Period|Other|2|||
156650476|NCT00415532|565467096|FG001|Treatment Period|Other|2|||
156650477|NCT00415532|565467095|FG000|Treatment Period|Ineligibility determined|1|||
156650478|NCT00415532|565467096|FG001|Treatment Period|Ineligibility determined|1|||
156650479|NCT00415532|565467095|FG000|Treatment Period|Noncompliance|1|||
156650480|NCT00415532|565467096|FG001|Treatment Period|Noncompliance|1|||
156650481|NCT00415532|565467095|FG000|Treatment Period|Requirement for alternative therapy|1|||
156650482|NCT00415532|565467096|FG001|Treatment Period|Requirement for alternative therapy|0|||
156650483|NCT00415532|565467095|FG000|Safety Follow Up Period|Adverse Event|1|||
156650484|NCT00415532|565467096|FG001|Safety Follow Up Period|Adverse Event|3|||
156650485|NCT00415532|565467095|FG000|Safety Follow Up Period|Death|3|||
156650486|NCT00415532|565467096|FG001|Safety Follow Up Period|Death|0|||
156650487|NCT00415532|565467095|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
156650488|NCT00415532|565467096|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
156650489|NCT00415532|565467095|FG000|Safety Follow Up Period|Other|1|||
156650490|NCT00415532|565467096|FG001|Safety Follow Up Period|Other|4|||
156753800|NCT05052697|565851475|FG020|Substudy A|No longer met eligibility criteria|0|||
156753801|NCT05052697|565851476|FG021|Substudy A|No longer met eligibility criteria|0|||
156753802|NCT05052697|565851477|FG022|Substudy A|No longer met eligibility criteria|0|||
156753803|NCT05052697|565851478|FG023|Substudy A|No longer met eligibility criteria|0|||
156753804|NCT05052697|565851479|FG024|Substudy A|No longer met eligibility criteria|0|||
156753805|NCT05052697|565851480|FG025|Substudy A|No longer met eligibility criteria|0|||
156753806|NCT05052697|565851481|FG026|Substudy A|No longer met eligibility criteria|0|||
156753807|NCT05052697|565851482|FG027|Substudy A|No longer met eligibility criteria|0|||
156753808|NCT05052697|565851483|FG028|Substudy A|No longer met eligibility criteria|0|||
156753809|NCT05052697|565851484|FG029|Substudy A|No longer met eligibility criteria|0|||
156753810|NCT05052697|565851485|FG030|Substudy A|No longer met eligibility criteria|0|||
156753811|NCT05052697|565851486|FG031|Substudy A|No longer met eligibility criteria|0|||
156753812|NCT05052697|565851487|FG032|Substudy A|No longer met eligibility criteria|0|||
156753813|NCT05052697|565851488|FG033|Substudy A|No longer met eligibility criteria|0|||
156753814|NCT05052697|565851455|FG000|Substudy A|Not vaccinated|0|||
156753815|NCT05052697|565851456|FG001|Substudy A|Not vaccinated|0|||
156753816|NCT05052697|565851457|FG002|Substudy A|Not vaccinated|0|||
156753817|NCT05052697|565851458|FG003|Substudy A|Not vaccinated|1|||
156753818|NCT05052697|565851459|FG004|Substudy A|Not vaccinated|0|||
156753819|NCT05052697|565851460|FG005|Substudy A|Not vaccinated|0|||
156753820|NCT05052697|565851461|FG006|Substudy A|Not vaccinated|0|||
156753821|NCT05052697|565851462|FG007|Substudy A|Not vaccinated|0|||
156753822|NCT05052697|565851463|FG008|Substudy A|Not vaccinated|1|||
156753823|NCT05052697|565851464|FG009|Substudy A|Not vaccinated|0|||
156753824|NCT05052697|565851465|FG010|Substudy A|Not vaccinated|0|||
156753825|NCT05052697|565851466|FG011|Substudy A|Not vaccinated|0|||
156753826|NCT05052697|565851467|FG012|Substudy A|Not vaccinated|0|||
156753827|NCT05052697|565851468|FG013|Substudy A|Not vaccinated|0|||
156753828|NCT05052697|565851469|FG014|Substudy A|Not vaccinated|0|||
156753829|NCT05052697|565851470|FG015|Substudy A|Not vaccinated|0|||
156753830|NCT05052697|565851471|FG016|Substudy A|Not vaccinated|0|||
156753831|NCT05052697|565851472|FG017|Substudy A|Not vaccinated|0|||
156753832|NCT05052697|565851473|FG018|Substudy A|Not vaccinated|0|||
156753833|NCT05052697|565851474|FG019|Substudy A|Not vaccinated|0|||
156753834|NCT05052697|565851475|FG020|Substudy A|Not vaccinated|0|||
156753835|NCT05052697|565851476|FG021|Substudy A|Not vaccinated|0|||
156753836|NCT05052697|565851477|FG022|Substudy A|Not vaccinated|0|||
156753837|NCT05052697|565851478|FG023|Substudy A|Not vaccinated|0|||
156753838|NCT05052697|565851479|FG024|Substudy A|Not vaccinated|0|||
156753839|NCT05052697|565851480|FG025|Substudy A|Not vaccinated|0|||
156753840|NCT05052697|565851481|FG026|Substudy A|Not vaccinated|0|||
156753841|NCT05052697|565851482|FG027|Substudy A|Not vaccinated|0|||
156753842|NCT05052697|565851483|FG028|Substudy A|Not vaccinated|0|||
156753843|NCT05052697|565851484|FG029|Substudy A|Not vaccinated|0|||
156753844|NCT05052697|565851485|FG030|Substudy A|Not vaccinated|0|||
156753845|NCT05052697|565851486|FG031|Substudy A|Not vaccinated|0|||
156753846|NCT05052697|565851487|FG032|Substudy A|Not vaccinated|0|||
156753847|NCT05052697|565851488|FG033|Substudy A|Not vaccinated|0|||
156753848|NCT05052697|565851455|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753849|NCT05052697|565851456|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753850|NCT05052697|565851457|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753851|NCT05052697|565851458|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753852|NCT05052697|565851459|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753853|NCT05052697|565851460|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753854|NCT05052697|565851461|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753855|NCT05052697|565851462|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753856|NCT05052697|565851463|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753857|NCT05052697|565851464|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753858|NCT05052697|565851465|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753859|NCT05052697|565851466|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753860|NCT05052697|565851467|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753861|NCT05052697|565851468|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753862|NCT05052697|565851469|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753863|NCT05052697|565851470|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753864|NCT05052697|565851471|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753865|NCT05052697|565851472|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753866|NCT05052697|565851473|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
156313305|NCT01675167|564245027|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156313306|NCT01675167|564245028|FG001|Double-blind Treatment Phase|Adverse Event|5|||
156313307|NCT01675167|564245029|FG002|Double-blind Treatment Phase|Adverse Event|13|||
156313308|NCT01675167|564245027|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
156313309|NCT01675167|564245028|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
156313310|NCT01675167|564245029|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
156753867|NCT05052697|565851474|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
156753868|NCT05052697|565851475|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753869|NCT05052697|565851476|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
156313311|NCT01675167|564245027|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156753870|NCT05052697|565851477|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
156753871|NCT05052697|565851478|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753872|NCT05052697|565851479|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753873|NCT05052697|565851480|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753874|NCT05052697|565851481|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753875|NCT05052697|565851482|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753876|NCT05052697|565851483|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753877|NCT05052697|565851484|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753878|NCT05052697|565851485|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753879|NCT05052697|565851486|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753880|NCT05052697|565851487|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753881|NCT05052697|565851488|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753882|NCT05052697|565851455|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753883|NCT05052697|565851456|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753884|NCT05052697|565851457|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753885|NCT05052697|565851458|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753886|NCT05052697|565851459|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753887|NCT05052697|565851460|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753888|NCT05052697|565851461|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753889|NCT05052697|565851462|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753890|NCT05052697|565851463|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753891|NCT05052697|565851464|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753892|NCT05052697|565851465|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753893|NCT05052697|565851466|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753894|NCT05052697|565851467|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753895|NCT05052697|565851468|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753896|NCT05052697|565851469|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753897|NCT05052697|565851470|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753898|NCT05052697|565851471|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753899|NCT05052697|565851472|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
156753900|NCT05052697|565851473|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753901|NCT05052697|565851474|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753902|NCT05052697|565851475|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753903|NCT05052697|565851476|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753904|NCT05052697|565851477|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753905|NCT05052697|565851478|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753906|NCT05052697|565851479|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753907|NCT05052697|565851480|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753908|NCT05052697|565851481|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753909|NCT05052697|565851482|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753910|NCT05052697|565851483|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753911|NCT05052697|565851484|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753912|NCT05052697|565851485|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753913|NCT05052697|565851486|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753914|NCT05052697|565851487|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753915|NCT05052697|565851488|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753916|NCT05052697|565851455|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753917|NCT05052697|565851456|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753918|NCT05052697|565851457|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753919|NCT05052697|565851458|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753920|NCT05052697|565851459|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753921|NCT05052697|565851460|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753922|NCT05052697|565851461|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753923|NCT05052697|565851462|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753924|NCT05052697|565851463|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753925|NCT05052697|565851464|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753926|NCT05052697|565851465|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753927|NCT05052697|565851466|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753928|NCT05052697|565851467|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753929|NCT05052697|565851468|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753930|NCT05052697|565851469|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753931|NCT05052697|565851470|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753932|NCT05052697|565851471|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753933|NCT05052697|565851472|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753934|NCT05052697|565851473|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753935|NCT05052697|565851474|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
156753936|NCT05052697|565851475|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753937|NCT05052697|565851476|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753938|NCT05052697|565851477|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753939|NCT05052697|565851478|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753940|NCT05052697|565851479|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753941|NCT05052697|565851480|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753942|NCT05052697|565851481|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753943|NCT05052697|565851482|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753944|NCT05052697|565851483|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753945|NCT05052697|565851484|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753946|NCT05052697|565851485|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753947|NCT05052697|565851486|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753948|NCT05052697|565851487|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753949|NCT05052697|565851488|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753950|NCT05052697|565851455|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753951|NCT05052697|565851456|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753952|NCT05052697|565851457|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753953|NCT05052697|565851458|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753954|NCT05052697|565851459|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753955|NCT05052697|565851460|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753956|NCT05052697|565851461|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753957|NCT05052697|565851462|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753958|NCT05052697|565851463|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753959|NCT05052697|565851464|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753960|NCT05052697|565851465|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753961|NCT05052697|565851466|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753962|NCT05052697|565851467|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753963|NCT05052697|565851468|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753964|NCT05052697|565851469|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753965|NCT05052697|565851470|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753966|NCT05052697|565851471|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753967|NCT05052697|565851472|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
156753968|NCT05052697|565851473|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753969|NCT05052697|565851474|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753970|NCT05052697|565851475|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753971|NCT05052697|565851476|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753972|NCT05052697|565851477|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753973|NCT05052697|565851478|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753974|NCT05052697|565851479|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753975|NCT05052697|565851480|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
156753976|NCT05052697|565851481|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753977|NCT05052697|565851482|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
156753978|NCT05052697|565851483|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753979|NCT05052697|565851484|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753980|NCT05052697|565851485|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753981|NCT05052697|565851486|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753982|NCT05052697|565851487|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753983|NCT05052697|565851488|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753984|NCT05052697|565851455|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753985|NCT05052697|565851456|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753986|NCT05052697|565851457|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753987|NCT05052697|565851458|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753988|NCT05052697|565851459|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753989|NCT05052697|565851460|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753990|NCT05052697|565851461|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753991|NCT05052697|565851462|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753992|NCT05052697|565851463|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753993|NCT05052697|565851464|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753994|NCT05052697|565851465|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753995|NCT05052697|565851466|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753996|NCT05052697|565851467|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753997|NCT05052697|565851468|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753998|NCT05052697|565851469|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753999|NCT05052697|565851470|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754000|NCT05052697|565851471|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754001|NCT05052697|565851472|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754002|NCT05052697|565851473|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754003|NCT05052697|565851474|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754004|NCT05052697|565851475|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156414433|NCT01890967|564610946|FG000|Overall Study|Sponsor Decision|2|||
156414434|NCT01890967|564610947|FG001|Overall Study|Sponsor Decision|0|||
156414435|NCT01890967|564610948|FG002|Overall Study|Sponsor Decision|1|||
156754005|NCT05052697|565851476|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754006|NCT05052697|565851477|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754007|NCT05052697|565851478|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754008|NCT05052697|565851479|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754009|NCT05052697|565851480|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754010|NCT05052697|565851481|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754011|NCT05052697|565851482|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754012|NCT05052697|565851483|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
156754013|NCT05052697|565851484|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754014|NCT05052697|565851485|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
156754015|NCT05052697|565851486|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
156754016|NCT05052697|565851487|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
156754017|NCT05052697|565851488|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754018|NCT05052697|565851455|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754019|NCT05052697|565851456|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754020|NCT05052697|565851457|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754021|NCT05052697|565851458|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754022|NCT05052697|565851459|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754023|NCT05052697|565851460|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754024|NCT05052697|565851461|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754025|NCT05052697|565851462|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754026|NCT05052697|565851463|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754027|NCT05052697|565851464|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754028|NCT05052697|565851465|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754029|NCT05052697|565851466|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754030|NCT05052697|565851467|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754031|NCT05052697|565851468|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754032|NCT05052697|565851469|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754033|NCT05052697|565851470|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754034|NCT05052697|565851471|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754035|NCT05052697|565851472|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754036|NCT05052697|565851473|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754037|NCT05052697|565851474|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754038|NCT05052697|565851475|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754039|NCT05052697|565851476|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754040|NCT05052697|565851477|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754041|NCT05052697|565851478|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754042|NCT05052697|565851479|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754043|NCT05052697|565851480|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754044|NCT05052697|565851481|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754045|NCT05052697|565851482|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754046|NCT05052697|565851483|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
156754047|NCT05052697|565851484|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
156754048|NCT05052697|565851485|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
156754049|NCT05052697|565851486|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
156754050|NCT05052697|565851487|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
156754051|NCT05052697|565851488|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754052|NCT05052697|565851455|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754053|NCT05052697|565851456|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754054|NCT05052697|565851457|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754055|NCT05052697|565851458|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754056|NCT05052697|565851459|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754057|NCT05052697|565851460|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754058|NCT05052697|565851461|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754059|NCT05052697|565851462|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754060|NCT05052697|565851463|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754061|NCT05052697|565851464|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754062|NCT05052697|565851465|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754063|NCT05052697|565851466|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754064|NCT05052697|565851467|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754065|NCT05052697|565851468|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754066|NCT05052697|565851469|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754067|NCT05052697|565851470|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754068|NCT05052697|565851471|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754069|NCT05052697|565851472|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156313312|NCT01675167|564245028|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
156313313|NCT01675167|564245029|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
156754070|NCT05052697|565851473|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754071|NCT05052697|565851474|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754072|NCT05052697|565851475|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754073|NCT05052697|565851476|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754074|NCT05052697|565851477|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754075|NCT05052697|565851478|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754076|NCT05052697|565851479|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754077|NCT05052697|565851480|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754078|NCT05052697|565851481|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754079|NCT05052697|565851482|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754080|NCT05052697|565851483|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754081|NCT05052697|565851484|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754082|NCT05052697|565851485|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754083|NCT05052697|565851486|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754084|NCT05052697|565851487|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
156754085|NCT05052697|565851488|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754086|NCT05052697|565851455|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754087|NCT05052697|565851456|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754088|NCT05052697|565851457|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754089|NCT05052697|565851458|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156650491|NCT00415532|565467095|FG000|Safety Follow Up Period|Ineligibility determined|1|||
156650492|NCT00415532|565467096|FG001|Safety Follow Up Period|Ineligibility determined|1|||
156650493|NCT00415532|565467095|FG000|Safety Follow Up Period|Noncompliance|1|||
156650494|NCT00415532|565467096|FG001|Safety Follow Up Period|Noncompliance|0|||
156650495|NCT00415532|565467095|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
156650496|NCT00415532|565467096|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
156650497|NCT01798485|565467097|FG000|Overall Study|Adverse Event|32|||
156650498|NCT01798485|565467098|FG001|Overall Study|Adverse Event|40|||
156650499|NCT01798485|565467097|FG000|Overall Study|Withdrawal by Subject|27|||
156650500|NCT01798485|565467098|FG001|Overall Study|Withdrawal by Subject|31|||
156650501|NCT01798485|565467097|FG000|Overall Study|Lost to Follow-up|0|||
156650502|NCT01798485|565467098|FG001|Overall Study|Lost to Follow-up|3|||
156650503|NCT01798485|565467097|FG000|Overall Study|Physician Decision|14|||
156650504|NCT01798485|565467098|FG001|Overall Study|Physician Decision|10|||
156650505|NCT01798485|565467097|FG000|Overall Study|Objective Disease Progression|152|||
156650506|NCT01798485|565467098|FG001|Overall Study|Objective Disease Progression|106|||
156650507|NCT01798485|565467097|FG000|Overall Study|Death|25|||
156650508|NCT01798485|565467098|FG001|Overall Study|Death|22|||
156650509|NCT01798485|565467097|FG000|Overall Study|Sponsor Decision|61|||
156650510|NCT01798485|565467098|FG001|Overall Study|Sponsor Decision|54|||
156650511|NCT01798485|565467097|FG000|Overall Study|Clinical Progression|35|||
156650512|NCT01798485|565467098|FG001|Overall Study|Clinical Progression|24|||
156650513|NCT01952574|565467099|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
156650514|NCT01952574|565467100|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
156650515|NCT01952574|565467101|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
156650516|NCT01952574|565467102|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
156650517|NCT01952574|565467103|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156650518|NCT01952574|565467104|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156650519|NCT01952574|565467105|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156650520|NCT01952574|565467099|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
156650521|NCT01952574|565467100|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
156650522|NCT01952574|565467101|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
156650523|NCT01952574|565467102|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
156650524|NCT01952574|565467103|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
156650525|NCT01952574|565467104|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
156650526|NCT01952574|565467105|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
156650527|NCT01952574|565467099|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
156650528|NCT01952574|565467100|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
156650529|NCT01952574|565467101|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
156650530|NCT01952574|565467102|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
156650531|NCT01952574|565467103|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
156650532|NCT01952574|565467104|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
156650533|NCT01952574|565467105|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
156650534|NCT01952574|565467099|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
156650535|NCT01952574|565467100|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
156650536|NCT01952574|565467101|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
156650537|NCT01952574|565467102|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
156650538|NCT01952574|565467103|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
156754090|NCT05052697|565851459|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754091|NCT05052697|565851460|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754092|NCT05052697|565851461|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754093|NCT05052697|565851462|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754094|NCT05052697|565851463|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754095|NCT05052697|565851464|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754096|NCT05052697|565851465|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754097|NCT05052697|565851466|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754098|NCT05052697|565851467|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754099|NCT05052697|565851468|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754100|NCT05052697|565851469|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754101|NCT05052697|565851470|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754102|NCT05052697|565851471|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754103|NCT05052697|565851472|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754104|NCT05052697|565851473|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754105|NCT05052697|565851474|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754106|NCT05052697|565851475|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754107|NCT05052697|565851476|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754108|NCT05052697|565851477|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754109|NCT05052697|565851478|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754110|NCT05052697|565851479|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754111|NCT05052697|565851480|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754112|NCT05052697|565851481|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754113|NCT05052697|565851482|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754114|NCT05052697|565851483|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
156754115|NCT05052697|565851484|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
156754116|NCT05052697|565851485|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
156754117|NCT05052697|565851486|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754118|NCT05052697|565851487|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754119|NCT05052697|565851488|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754120|NCT01900899|565851491|FG000|Overall Study|Withdrawal by Subject|7|||
156313314|NCT01675167|564245027|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
156313315|NCT01675167|564245028|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
156313316|NCT01675167|564245029|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
156313317|NCT01675167|564245027|FG000|Double-blind Treatment Phase|Other|0|||
156313318|NCT01675167|564245028|FG001|Double-blind Treatment Phase|Other|7|||
156650539|NCT01952574|565467104|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
156650540|NCT01952574|565467105|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
156650541|NCT01952574|565467099|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
156650542|NCT01952574|565467100|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
156650543|NCT01952574|565467101|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
156650544|NCT01952574|565467102|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
156650545|NCT01952574|565467103|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
156650546|NCT01952574|565467104|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
156650547|NCT01952574|565467105|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
156650548|NCT01952574|565467099|FG000|Open-label Treatment Phase|Missing|0|||
156650549|NCT01952574|565467100|FG001|Open-label Treatment Phase|Missing|0|||
156650550|NCT01952574|565467101|FG002|Open-label Treatment Phase|Missing|0|||
156650551|NCT01952574|565467102|FG003|Open-label Treatment Phase|Missing|0|||
156650552|NCT01952574|565467103|FG004|Open-label Treatment Phase|Missing|4|||
156650553|NCT01952574|565467104|FG005|Open-label Treatment Phase|Missing|0|||
156650554|NCT01952574|565467105|FG006|Open-label Treatment Phase|Missing|0|||
156650555|NCT01952574|565467099|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
156313319|NCT01675167|564245029|FG002|Double-blind Treatment Phase|Other|5|||
156313320|NCT01379508|564245030|FG000|Treatment to Week 104|Adverse Event|2|||
156313321|NCT01379508|564245031|FG001|Treatment to Week 104|Adverse Event|0|||
156313322|NCT01379508|564245032|FG002|Treatment to Week 104|Adverse Event|5|||
156313323|NCT01379508|564245033|FG003|Treatment to Week 104|Adverse Event|0|||
156313324|NCT01379508|564245030|FG000|Treatment to Week 104|Abnormal lab value|1|||
156313325|NCT01379508|564245031|FG001|Treatment to Week 104|Abnormal lab value|0|||
156313326|NCT01379508|564245032|FG002|Treatment to Week 104|Abnormal lab value|0|||
156313327|NCT01379508|564245033|FG003|Treatment to Week 104|Abnormal lab value|0|||
156313328|NCT01379508|564245030|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
156313329|NCT01379508|564245031|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
156313330|NCT01379508|564245032|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
156313331|NCT01379508|564245033|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
156313332|NCT01379508|564245030|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
156313333|NCT01379508|564245031|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
156313334|NCT01379508|564245032|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
156313335|NCT01379508|564245033|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
156313336|NCT01379508|564245030|FG000|Treatment to Week 104|Lost to Follow-up|5|||
156313337|NCT01379508|564245031|FG001|Treatment to Week 104|Lost to Follow-up|0|||
156313338|NCT01379508|564245032|FG002|Treatment to Week 104|Lost to Follow-up|3|||
156650556|NCT01952574|565467100|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
156650557|NCT01952574|565467101|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
156650558|NCT01952574|565467102|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
156650559|NCT01952574|565467103|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
156650560|NCT01952574|565467104|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
156650561|NCT01952574|565467105|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
156650562|NCT01952574|565467099|FG000|Open-label Treatment Phase|Death|0|||
156650563|NCT01952574|565467100|FG001|Open-label Treatment Phase|Death|0|||
156650564|NCT01952574|565467101|FG002|Open-label Treatment Phase|Death|0|||
156650565|NCT01952574|565467102|FG003|Open-label Treatment Phase|Death|0|||
156650566|NCT01952574|565467103|FG004|Open-label Treatment Phase|Death|1|||
156650567|NCT01952574|565467104|FG005|Open-label Treatment Phase|Death|0|||
156650568|NCT01952574|565467105|FG006|Open-label Treatment Phase|Death|0|||
156650569|NCT01952574|565467099|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
156650570|NCT01952574|565467100|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
156650571|NCT01952574|565467101|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
156650572|NCT01952574|565467102|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
156650573|NCT01952574|565467103|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
156650574|NCT01952574|565467104|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
156650575|NCT01952574|565467105|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
156313339|NCT01379508|564245033|FG003|Treatment to Week 104|Lost to Follow-up|0|||
156313340|NCT01379508|564245030|FG000|Treatment to Week 104|Administrative problems|3|||
156313341|NCT01379508|564245031|FG001|Treatment to Week 104|Administrative problems|1|||
156313342|NCT01379508|564245032|FG002|Treatment to Week 104|Administrative problems|0|||
156313343|NCT01379508|564245033|FG003|Treatment to Week 104|Administrative problems|0|||
156313344|NCT01379508|564245030|FG000|Treatment to Week 104|Protocol Violation|1|||
156313345|NCT01379508|564245031|FG001|Treatment to Week 104|Protocol Violation|1|||
156313346|NCT01379508|564245032|FG002|Treatment to Week 104|Protocol Violation|1|||
156313347|NCT01379508|564245033|FG003|Treatment to Week 104|Protocol Violation|0|||
156313348|NCT01379508|564245030|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
156313349|NCT01379508|564245031|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
156313350|NCT01379508|564245032|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
156313351|NCT01379508|564245033|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
156313352|NCT01379508|564245030|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
156313353|NCT01379508|564245031|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
156313354|NCT01379508|564245032|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
156313355|NCT01379508|564245033|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
156313356|NCT01379508|564245030|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
156313357|NCT01379508|564245031|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
156313358|NCT01379508|564245032|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
156313359|NCT01379508|564245033|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
156313360|NCT01379508|564245030|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
156313361|NCT01379508|564245031|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
156313362|NCT01379508|564245032|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
156313363|NCT01379508|564245033|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
156313364|NCT05009979|564245037|FG000|Overall Study|Withdrawal by Subject|1|||
156313365|NCT01561898|564246308|FG000|Overall Study|Withdrawal by Subject|0|||
156313366|NCT01561898|564246309|FG001|Overall Study|Withdrawal by Subject|8|||
156313367|NCT01561898|564246310|FG002|Overall Study|Withdrawal by Subject|12|||
156313368|NCT01561898|564246311|FG003|Overall Study|Withdrawal by Subject|5|||
156313369|NCT01561898|564246308|FG000|Overall Study|Lack of Efficacy|0|||
156313370|NCT01561898|564246309|FG001|Overall Study|Lack of Efficacy|8|||
156313371|NCT01561898|564246310|FG002|Overall Study|Lack of Efficacy|10|||
156313372|NCT01561898|564246311|FG003|Overall Study|Lack of Efficacy|5|||
156313373|NCT01561898|564246308|FG000|Overall Study|Worsening of complications|0|||
156313374|NCT01561898|564246309|FG001|Overall Study|Worsening of complications|1|||
156313375|NCT01561898|564246310|FG002|Overall Study|Worsening of complications|0|||
156313376|NCT01561898|564246311|FG003|Overall Study|Worsening of complications|0|||
156313377|NCT01561898|564246308|FG000|Overall Study|Lost to Follow-up|0|||
156313378|NCT01561898|564246309|FG001|Overall Study|Lost to Follow-up|0|||
156313379|NCT01561898|564246310|FG002|Overall Study|Lost to Follow-up|1|||
156313380|NCT01561898|564246311|FG003|Overall Study|Lost to Follow-up|0|||
156313381|NCT01561898|564246308|FG000|Overall Study|Adverse Event|1|||
156313382|NCT01561898|564246309|FG001|Overall Study|Adverse Event|19|||
156313383|NCT01561898|564246310|FG002|Overall Study|Adverse Event|14|||
156313384|NCT01561898|564246311|FG003|Overall Study|Adverse Event|9|||
156313385|NCT01561898|564246308|FG000|Overall Study|Physician Decision|1|||
156313386|NCT01561898|564246309|FG001|Overall Study|Physician Decision|5|||
156313387|NCT01561898|564246310|FG002|Overall Study|Physician Decision|7|||
156414436|NCT01890967|564610949|FG003|Overall Study|Sponsor Decision|3|||
156650576|NCT01952574|565467099|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
156650577|NCT01952574|565467100|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
156650578|NCT01952574|565467101|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
156650579|NCT01952574|565467102|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
156754121|NCT01900899|565851492|FG001|Overall Study|Withdrawal by Subject|1|||
156754122|NCT01900899|565851491|FG000|Overall Study|Migrated from study area|2|||
156754123|NCT01900899|565851492|FG001|Overall Study|Migrated from study area|0|||
156754124|NCT03275389|565851493|FG000|Overall Study|Lost to Follow-up|10|||
156754125|NCT03275389|565851494|FG001|Overall Study|Lost to Follow-up|10|||
156754126|NCT03275389|565851495|FG002|Overall Study|Lost to Follow-up|19|||
156754127|NCT03275389|565851496|FG003|Overall Study|Lost to Follow-up|12|||
156754128|NCT03275389|565851497|FG004|Overall Study|Lost to Follow-up|11|||
156754129|NCT03275389|565851498|FG005|Overall Study|Lost to Follow-up|12|||
156754130|NCT03275389|565851499|FG006|Overall Study|Lost to Follow-up|21|||
156754131|NCT03275389|565851500|FG007|Overall Study|Lost to Follow-up|15|||
156754132|NCT03275389|565851501|FG008|Overall Study|Lost to Follow-up|12|||
156754133|NCT03275389|565851502|FG009|Overall Study|Lost to Follow-up|14|||
156754134|NCT03275389|565851493|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754135|NCT03275389|565851494|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754136|NCT03275389|565851495|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754137|NCT03275389|565851496|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754138|NCT03275389|565851497|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754139|NCT03275389|565851498|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
156754140|NCT03275389|565851499|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754141|NCT03275389|565851500|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754142|NCT03275389|565851501|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754143|NCT03275389|565851502|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
156754144|NCT03275389|565851493|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
156754145|NCT03275389|565851494|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156754146|NCT03275389|565851495|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156754147|NCT03275389|565851496|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
156754148|NCT03275389|565851497|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
156754149|NCT03275389|565851498|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
156754150|NCT03275389|565851499|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
156754151|NCT03275389|565851500|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
156754152|NCT03275389|565851501|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
156754153|NCT03275389|565851502|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
156754154|NCT03275389|565851493|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754155|NCT03275389|565851494|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156754156|NCT03275389|565851495|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754157|NCT03275389|565851496|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
156754158|NCT03275389|565851497|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754159|NCT03275389|565851498|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754160|NCT03275389|565851499|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156754161|NCT03275389|565851500|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754162|NCT03275389|565851501|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754163|NCT03275389|565851502|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754164|NCT03275389|565851493|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754165|NCT03275389|565851494|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754166|NCT03275389|565851495|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
156754167|NCT03275389|565851496|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754168|NCT03275389|565851497|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754169|NCT03275389|565851498|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754170|NCT03275389|565851499|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754171|NCT03275389|565851500|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754172|NCT03275389|565851501|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754173|NCT03275389|565851502|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
156754174|NCT03275389|565851493|FG000|Overall Study|Other|0|||
156754175|NCT03275389|565851494|FG001|Overall Study|Other|4|||
156754176|NCT03275389|565851495|FG002|Overall Study|Other|3|||
156754177|NCT03275389|565851496|FG003|Overall Study|Other|2|||
156754178|NCT03275389|565851497|FG004|Overall Study|Other|2|||
156754179|NCT03275389|565851498|FG005|Overall Study|Other|2|||
156754180|NCT03275389|565851499|FG006|Overall Study|Other|0|||
156754181|NCT03275389|565851500|FG007|Overall Study|Other|0|||
156754182|NCT03275389|565851501|FG008|Overall Study|Other|1|||
156754183|NCT03275389|565851502|FG009|Overall Study|Other|0|||
156754184|NCT03035916|565851503|FG000|Overall Study|Puncture failed|0|||
156754185|NCT03035916|565851504|FG001|Overall Study|Puncture failed|2|||
156754186|NCT03035916|565851505|FG002|Overall Study|Puncture failed|0|||
156754187|NCT02427802|565851506|FG000|Overall Study|Adverse Event|11|||
156754188|NCT02427802|565851507|FG001|Overall Study|Adverse Event|3|||
156754189|NCT02427802|565851508|FG002|Overall Study|Adverse Event|7|||
156754190|NCT02427802|565851506|FG000|Overall Study|Death|0|||
156754191|NCT02427802|565851507|FG001|Overall Study|Death|4|||
156754192|NCT02427802|565851508|FG002|Overall Study|Death|1|||
156754193|NCT02427802|565851506|FG000|Overall Study|Lost to Follow-up|13|||
156754194|NCT02427802|565851507|FG001|Overall Study|Lost to Follow-up|8|||
156754195|NCT02427802|565851508|FG002|Overall Study|Lost to Follow-up|8|||
156754196|NCT02427802|565851506|FG000|Overall Study|Physician Decision|4|||
156754197|NCT02427802|565851507|FG001|Overall Study|Physician Decision|2|||
156754198|NCT02427802|565851508|FG002|Overall Study|Physician Decision|4|||
156754199|NCT02427802|565851506|FG000|Overall Study|Withdrawal by Subject|10|||
156754200|NCT02427802|565851507|FG001|Overall Study|Withdrawal by Subject|5|||
156754201|NCT02427802|565851508|FG002|Overall Study|Withdrawal by Subject|11|||
156754202|NCT02427802|565851506|FG000|Overall Study|Protocol Violation|3|||
156754203|NCT02427802|565851507|FG001|Overall Study|Protocol Violation|1|||
156754204|NCT02427802|565851508|FG002|Overall Study|Protocol Violation|1|||
156754205|NCT02427802|565851506|FG000|Overall Study|protocol specific treatment unrelated|18|||
156754206|NCT02427802|565851507|FG001|Overall Study|protocol specific treatment unrelated|11|||
156754207|NCT02427802|565851508|FG002|Overall Study|protocol specific treatment unrelated|11|||
156754208|NCT02634983|565851509|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
156754209|NCT02634983|565851510|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
156754210|NCT00467558|565851512|FG000|Overall Study|Lost to Follow-up|2|||
156754211|NCT00467558|565851513|FG001|Overall Study|Lost to Follow-up|0|||
156754212|NCT05188729|565851515|FG000|Overall Study|Withdrawal by Subject|0|||
156754213|NCT05188729|565851516|FG001|Overall Study|Withdrawal by Subject|0|||
156754214|NCT05188729|565851517|FG002|Overall Study|Withdrawal by Subject|0|||
156754215|NCT05188729|565851518|FG003|Overall Study|Withdrawal by Subject|0|||
156754216|NCT05188729|565851519|FG004|Overall Study|Withdrawal by Subject|0|||
156754217|NCT05188729|565851520|FG005|Overall Study|Withdrawal by Subject|0|||
156754218|NCT05188729|565851521|FG006|Overall Study|Withdrawal by Subject|0|||
156754219|NCT05188729|565851522|FG007|Overall Study|Withdrawal by Subject|0|||
156754220|NCT05188729|565851523|FG008|Overall Study|Withdrawal by Subject|0|||
156754221|NCT05188729|565851524|FG009|Overall Study|Withdrawal by Subject|1|||
156754222|NCT05188729|565851525|FG010|Overall Study|Withdrawal by Subject|0|||
156754223|NCT05188729|565851526|FG011|Overall Study|Withdrawal by Subject|0|||
156754224|NCT05188729|565851527|FG012|Overall Study|Withdrawal by Subject|0|||
156754225|NCT05188729|565851515|FG000|Overall Study|Lost to Follow-up|0|||
156754226|NCT05188729|565851516|FG001|Overall Study|Lost to Follow-up|0|||
156754227|NCT05188729|565851517|FG002|Overall Study|Lost to Follow-up|0|||
156754228|NCT05188729|565851518|FG003|Overall Study|Lost to Follow-up|0|||
156754229|NCT05188729|565851519|FG004|Overall Study|Lost to Follow-up|0|||
156754230|NCT05188729|565851520|FG005|Overall Study|Lost to Follow-up|0|||
156754231|NCT05188729|565851521|FG006|Overall Study|Lost to Follow-up|0|||
156754232|NCT05188729|565851522|FG007|Overall Study|Lost to Follow-up|0|||
156754233|NCT05188729|565851523|FG008|Overall Study|Lost to Follow-up|0|||
156754234|NCT05188729|565851524|FG009|Overall Study|Lost to Follow-up|0|||
156754235|NCT05188729|565851525|FG010|Overall Study|Lost to Follow-up|1|||
156754236|NCT05188729|565851526|FG011|Overall Study|Lost to Follow-up|1|||
156754237|NCT05188729|565851527|FG012|Overall Study|Lost to Follow-up|0|||
156754238|NCT03638466|565853131|FG000|Overall Study|Early Termination|0|||
156754239|NCT03638466|565853132|FG001|Overall Study|Early Termination|1|||
156754240|NCT02576977|565853133|FG000|Overall Study|Adverse Event|13|||
156754241|NCT02576977|565853134|FG001|Overall Study|Adverse Event|2|||
156754242|NCT02576977|565853133|FG000|Overall Study|Death|73|||
156754243|NCT02576977|565853134|FG001|Overall Study|Death|60|||
156754244|NCT02576977|565853133|FG000|Overall Study|Screen failure|1|||
156754245|NCT02576977|565853134|FG001|Overall Study|Screen failure|0|||
156754246|NCT02576977|565853133|FG000|Overall Study|Study Terminated at Selected Sites|27|||
156754247|NCT02576977|565853134|FG001|Overall Study|Study Terminated at Selected Sites|50|||
156754248|NCT02576977|565853133|FG000|Overall Study|Withdrawal by Subject|11|||
156754249|NCT02576977|565853134|FG001|Overall Study|Withdrawal by Subject|11|||
156754250|NCT02576977|565853133|FG000|Overall Study|Final Disposition Unknown|0|||
156754251|NCT02576977|565853134|FG001|Overall Study|Final Disposition Unknown|1|||
156754252|NCT02576977|565853133|FG000|Overall Study|Lost to Follow-up|1|||
156754253|NCT02576977|565853134|FG001|Overall Study|Lost to Follow-up|0|||
156754254|NCT02576977|565853133|FG000|Overall Study|Progressive Disease|0|||
156754255|NCT02576977|565853134|FG001|Overall Study|Progressive Disease|1|||
156754256|NCT03251482|565853135|FG000|Overall Study|Withdrawal by Subject|0|||
156754257|NCT03251482|565853136|FG001|Overall Study|Withdrawal by Subject|1|||
156754258|NCT03251482|565853137|FG002|Overall Study|Withdrawal by Subject|0|||
156754259|NCT03251482|565853138|FG003|Overall Study|Withdrawal by Subject|0|||
156754260|NCT03251482|565853139|FG004|Overall Study|Withdrawal by Subject|0|||
156754261|NCT02823470|565853146|FG000|Overall Study|Adverse Event|1|||
156754262|NCT02823470|565853147|FG001|Overall Study|Adverse Event|0|||
156754263|NCT02823470|565853146|FG000|Overall Study|Study terminated by sponsor|8|||
156754264|NCT02823470|565853147|FG001|Overall Study|Study terminated by sponsor|15|||
156754265|NCT02155309|565853148|FG000|Overall Study|Protocol Violation|0|||
156754266|NCT02155309|565853149|FG001|Overall Study|Protocol Violation|0|||
156754267|NCT02155309|565853150|FG002|Overall Study|Protocol Violation|1|||
156754268|NCT01073163|565853151|FG000|Overall Study|Adverse Event|1|||
156754269|NCT01073163|565853151|FG000|Overall Study|Disease Progression|1|||
156754270|NCT01073163|565853151|FG000|Overall Study|Early termination|1|||
156754271|NCT00802672|565853152|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
156650580|NCT01952574|565467103|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
156650581|NCT01952574|565467104|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
156650582|NCT01952574|565467105|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
156650583|NCT00770991|565467109|FG000|Overall Study|Physician Decision|2|||
156650584|NCT00770991|565467110|FG001|Overall Study|Physician Decision|0|||
156650585|NCT00770991|565467109|FG000|Overall Study|Withdrawal by Subject|1|||
156650586|NCT00770991|565467110|FG001|Overall Study|Withdrawal by Subject|0|||
156650587|NCT00770991|565467109|FG000|Overall Study|Adverse Event|1|||
156650588|NCT00770991|565467110|FG001|Overall Study|Adverse Event|5|||
156650589|NCT00770991|565467109|FG000|Overall Study|Pregnancy|1|||
156650590|NCT00770991|565467110|FG001|Overall Study|Pregnancy|0|||
156650591|NCT03687125|565467111|FG000|Overall Study|Progressive Disease|2|||
156650592|NCT03687125|565467112|FG001|Overall Study|Progressive Disease|1|||
156650593|NCT03687125|565467111|FG000|Overall Study|Protocol Violation|1|||
156650594|NCT03687125|565467112|FG001|Overall Study|Protocol Violation|0|||
156650595|NCT01992107|565467113|FG000|Overall Study|Administrative reasons|2|||
156650596|NCT01992107|565467114|FG001|Overall Study|Administrative reasons|0|||
156650597|NCT01992107|565467115|FG002|Overall Study|Administrative reasons|0|||
156650598|NCT01992107|565467113|FG000|Overall Study|Adverse Event|0|||
156650599|NCT01992107|565467114|FG001|Overall Study|Adverse Event|1|||
156650600|NCT01992107|565467115|FG002|Overall Study|Adverse Event|0|||
156650601|NCT01992107|565467113|FG000|Overall Study|Lost to Follow-up|46|||
156650602|NCT01992107|565467114|FG001|Overall Study|Lost to Follow-up|22|||
156650603|NCT01992107|565467115|FG002|Overall Study|Lost to Follow-up|26|||
156650604|NCT01992107|565467113|FG000|Overall Study|noncompliance and were unavailable|7|||
156650605|NCT01992107|565467114|FG001|Overall Study|noncompliance and were unavailable|3|||
156650606|NCT01992107|565467115|FG002|Overall Study|noncompliance and were unavailable|2|||
156650607|NCT01992107|565467113|FG000|Overall Study|Withdrawal by Subject|13|||
156650608|NCT01992107|565467114|FG001|Overall Study|Withdrawal by Subject|7|||
156650609|NCT01992107|565467115|FG002|Overall Study|Withdrawal by Subject|8|||
156650610|NCT02022007|565467116|FG000|Overall Study|Withdrawal by Subject|1|||
156650611|NCT02022007|565467117|FG001|Overall Study|Withdrawal by Subject|1|||
156650612|NCT02022007|565467118|FG002|Overall Study|Withdrawal by Subject|1|||
156650613|NCT02022007|565467116|FG000|Overall Study|Noncompliant|0|||
156650614|NCT02022007|565467117|FG001|Overall Study|Noncompliant|0|||
156650615|NCT02022007|565467118|FG002|Overall Study|Noncompliant|1|||
156650616|NCT01214603|565467120|FG000|Overall Study|Adverse Event|0|||
156650617|NCT01214603|565467121|FG001|Overall Study|Adverse Event|0|||
156650618|NCT01214603|565467122|FG002|Overall Study|Adverse Event|1|||
156650619|NCT01214603|565467120|FG000|Overall Study|Death|1|||
156650620|NCT01214603|565467121|FG001|Overall Study|Death|0|||
156650621|NCT01214603|565467122|FG002|Overall Study|Death|0|||
156650622|NCT01214603|565467120|FG000|Overall Study|Progressive Disease|4|||
156650623|NCT01214603|565467121|FG001|Overall Study|Progressive Disease|1|||
156650624|NCT01214603|565467122|FG002|Overall Study|Progressive Disease|3|||
156650625|NCT02536378|565467125|FG000|Overall Study|Physician Decision|0|||
156650626|NCT02536378|565467126|FG001|Overall Study|Physician Decision|2|||
156650627|NCT02536378|565467125|FG000|Overall Study|Withdrawal by Subject|0|||
156650628|NCT02536378|565467126|FG001|Overall Study|Withdrawal by Subject|1|||
156650629|NCT02536378|565467125|FG000|Overall Study|Death|1|||
156650630|NCT02536378|565467126|FG001|Overall Study|Death|2|||
156650631|NCT02536378|565467125|FG000|Overall Study|Patient refused further follow up|6|||
156650632|NCT02536378|565467126|FG001|Overall Study|Patient refused further follow up|2|||
156650633|NCT01271933|565467127|FG000|Single-Blind Phase|Lack of Efficacy|37|||
156650634|NCT01271933|565467128|FG001|Single-Blind Phase|Lack of Efficacy|0|||
156650635|NCT01271933|565467129|FG002|Single-Blind Phase|Lack of Efficacy|0|||
156650636|NCT01271933|565467127|FG000|Single-Blind Phase|Lost to Follow-up|10|||
156650637|NCT01271933|565467128|FG001|Single-Blind Phase|Lost to Follow-up|0|||
156650638|NCT01271933|565467129|FG002|Single-Blind Phase|Lost to Follow-up|0|||
156650639|NCT01271933|565467127|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
156650640|NCT01271933|565467128|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
156650641|NCT01271933|565467129|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
156650642|NCT01271933|565467127|FG000|Single-Blind Phase|Protocol Violation|3|||
156650643|NCT01271933|565467128|FG001|Single-Blind Phase|Protocol Violation|0|||
156650644|NCT01271933|565467129|FG002|Single-Blind Phase|Protocol Violation|0|||
156650645|NCT01271933|565467127|FG000|Single-Blind Phase|Adverse Event|52|||
156650646|NCT01271933|565467128|FG001|Single-Blind Phase|Adverse Event|0|||
156650647|NCT01271933|565467129|FG002|Single-Blind Phase|Adverse Event|0|||
156650648|NCT01271933|565467127|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
156650649|NCT01271933|565467128|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
156650650|NCT01271933|565467129|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
156650651|NCT01271933|565467127|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
156650652|NCT01271933|565467128|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
156650653|NCT01271933|565467129|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
156650654|NCT01271933|565467127|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
156650655|NCT01271933|565467128|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
156650656|NCT01271933|565467129|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
156754272|NCT00802672|565853153|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
156754273|NCT00802672|565853154|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
156754274|NCT00802672|565853152|FG000|Overall Study|Adverse Event|1|||
156754275|NCT00802672|565853153|FG001|Overall Study|Adverse Event|1|||
156754276|NCT00802672|565853154|FG002|Overall Study|Adverse Event|1|||
156754277|NCT00802672|565853152|FG000|Overall Study|Protocol Violation|2|||
156754278|NCT00802672|565853153|FG001|Overall Study|Protocol Violation|1|||
156754279|NCT00802672|565853154|FG002|Overall Study|Protocol Violation|1|||
156754280|NCT00802672|565853152|FG000|Overall Study|Lost to Follow-up|5|||
156754281|NCT00802672|565853153|FG001|Overall Study|Lost to Follow-up|5|||
156754282|NCT00802672|565853154|FG002|Overall Study|Lost to Follow-up|3|||
156754283|NCT00802672|565853152|FG000|Overall Study|Withdrawal by Subject|1|||
156754284|NCT00802672|565853153|FG001|Overall Study|Withdrawal by Subject|1|||
156754285|NCT00802672|565853154|FG002|Overall Study|Withdrawal by Subject|2|||
156754286|NCT00802672|565853152|FG000|Overall Study|other|3|||
156754287|NCT00802672|565853153|FG001|Overall Study|other|1|||
156754288|NCT00802672|565853154|FG002|Overall Study|other|2|||
156754289|NCT00703677|565853156|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
156754290|NCT04441788|565853157|FG000|Overall Study|Voluntary Withdrawl|0|||
156754291|NCT04441788|565853158|FG001|Overall Study|Voluntary Withdrawl|1|||
156754292|NCT04441788|565853159|FG002|Overall Study|Voluntary Withdrawl|0|||
156754293|NCT04441788|565853157|FG000|Overall Study|Ineligibility|1|||
156754294|NCT04441788|565853158|FG001|Overall Study|Ineligibility|0|||
156754295|NCT04441788|565853159|FG002|Overall Study|Ineligibility|0|||
156754296|NCT04441788|565853157|FG000|Overall Study|Adverse Event|0|||
156754297|NCT04441788|565853158|FG001|Overall Study|Adverse Event|0|||
156754298|NCT04441788|565853159|FG002|Overall Study|Adverse Event|4|||
156754299|NCT04441788|565853157|FG000|Overall Study|Study Terminated by Sponsor|16|||
156754300|NCT04441788|565853158|FG001|Overall Study|Study Terminated by Sponsor|16|||
156754301|NCT04441788|565853159|FG002|Overall Study|Study Terminated by Sponsor|12|||
156754302|NCT02315664|565853160|FG000|Overall Study|Lost to Follow-up|1|||
156754303|NCT02315664|565853161|FG001|Overall Study|Lost to Follow-up|1|||
156754304|NCT02315664|565853160|FG000|Overall Study|Withdrawal by Subject|0|||
156754305|NCT02315664|565853161|FG001|Overall Study|Withdrawal by Subject|3|||
156754306|NCT01677182|565853162|FG000|Overall Study|Adverse Event|2|||
156754307|NCT01677182|565853163|FG001|Overall Study|Adverse Event|1|||
156754308|NCT01677182|565853164|FG002|Overall Study|Adverse Event|8|||
156754309|NCT01677182|565853162|FG000|Overall Study|Protocol Violation|5|||
156754310|NCT01677182|565853163|FG001|Overall Study|Protocol Violation|1|||
156754311|NCT01677182|565853164|FG002|Overall Study|Protocol Violation|4|||
156754312|NCT01677182|565853162|FG000|Overall Study|Lost to Follow-up|4|||
156754313|NCT01677182|565853163|FG001|Overall Study|Lost to Follow-up|0|||
156754314|NCT01677182|565853164|FG002|Overall Study|Lost to Follow-up|3|||
156754315|NCT01677182|565853162|FG000|Overall Study|Withdrawal by Subject|7|||
156754316|NCT01677182|565853163|FG001|Overall Study|Withdrawal by Subject|12|||
156754317|NCT01677182|565853164|FG002|Overall Study|Withdrawal by Subject|10|||
156754318|NCT01677182|565853162|FG000|Overall Study|Study termination|12|||
156754319|NCT01677182|565853163|FG001|Overall Study|Study termination|9|||
156754320|NCT01677182|565853164|FG002|Overall Study|Study termination|11|||
156754321|NCT01677182|565853162|FG000|Overall Study|Lack of Efficacy|3|||
156754322|NCT01677182|565853163|FG001|Overall Study|Lack of Efficacy|0|||
156754323|NCT01677182|565853164|FG002|Overall Study|Lack of Efficacy|1|||
156754324|NCT01677182|565853162|FG000|Overall Study|Other reasons|1|||
156754325|NCT01677182|565853163|FG001|Overall Study|Other reasons|5|||
156754326|NCT01677182|565853164|FG002|Overall Study|Other reasons|2|||
156754327|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
156754328|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
156754329|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
156754330|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
156754331|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
156754332|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
156754333|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
156754334|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
156754335|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
156754336|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
156754337|NCT00667992|565853169|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
156754338|NCT00667992|565853170|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
156754339|NCT00667992|565853169|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
156754340|NCT00667992|565853170|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
156754341|NCT00667992|565853169|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
156754342|NCT00667992|565853170|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
156754343|NCT00667992|565853169|FG000|Wash-out|Not within one doubling dilution|4|||
156754344|NCT00667992|565853170|FG001|Wash-out|Not within one doubling dilution|3|||
156754345|NCT00667992|565853169|FG000|Wash-out|Failure to wash-out|2|||
156754346|NCT00667992|565853170|FG001|Wash-out|Failure to wash-out|2|||
156754347|NCT00667992|565853169|FG000|Wash-out|Withdrawal by Subject|1|||
156754348|NCT00667992|565853170|FG001|Wash-out|Withdrawal by Subject|0|||
156754349|NCT00667992|565853169|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
156754350|NCT00667992|565853170|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
156754351|NCT00667992|565853169|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
156754352|NCT00667992|565853170|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
156754353|NCT00762762|565853173|FG000|Overall Study|Did not return for appointments|6|||
156754354|NCT00762762|565853174|FG001|Overall Study|Did not return for appointments|8|||
156754355|NCT02489448|565853175|FG000|Overall Study|Death|3|||
156754356|NCT02489448|565853175|FG000|Overall Study|Withdrawal by Subject|2|||
156754357|NCT02748057|565853176|FG000|Overall Study|Adverse Event|1|||
156754358|NCT02748057|565853177|FG001|Overall Study|Adverse Event|0|||
156754359|NCT02748057|565853176|FG000|Overall Study|Physician Decision|0|||
156754360|NCT02748057|565853177|FG001|Overall Study|Physician Decision|1|||
156754361|NCT02748057|565853176|FG000|Overall Study|Protocol Violation|2|||
156754362|NCT02748057|565853177|FG001|Overall Study|Protocol Violation|1|||
156754363|NCT02748057|565853176|FG000|Overall Study|Participant Moved|1|||
156754364|NCT02748057|565853177|FG001|Overall Study|Participant Moved|0|||
156754365|NCT02748057|565853176|FG000|Overall Study|Withdrawal by Subject|1|||
156754366|NCT02748057|565853177|FG001|Overall Study|Withdrawal by Subject|0|||
156754367|NCT01990573|565853178|FG000|Overall Study|Physician Decision|0|||
156754368|NCT01990573|565853179|FG001|Overall Study|Physician Decision|0|||
156754369|NCT01990573|565853180|FG002|Overall Study|Physician Decision|1|||
156754370|NCT02793947|565853194|FG000|Overall Study|Death|1|||
156754371|NCT02793947|565853195|FG001|Overall Study|Death|0|||
156754372|NCT02793947|565853194|FG000|Overall Study|Physician Decision|1|||
156754373|NCT02793947|565853195|FG001|Overall Study|Physician Decision|5|||
156754374|NCT02213380|565853197|FG000|Underwent Randomization|Withdrawal by Subject|2|||
156754375|NCT02213380|565853198|FG001|Underwent Randomization|Withdrawal by Subject|0|||
156754376|NCT02213380|565853197|FG000|Underwent Randomization|Not treated|3|||
156754377|NCT02213380|565853198|FG001|Underwent Randomization|Not treated|3|||
156754378|NCT02213380|565853197|FG000|Per-protocol Analysis|Protocol Violation|32|||
156754379|NCT02213380|565853198|FG001|Per-protocol Analysis|Protocol Violation|36|||
156754380|NCT01310127|565853202|FG000|Overall Study|Protocol Violation|1|||
156754381|NCT01310127|565853203|FG001|Overall Study|Protocol Violation|1|||
156754382|NCT01310127|565853202|FG000|Overall Study|advanced psc cataract outlier|1|||
156754383|NCT01310127|565853203|FG001|Overall Study|advanced psc cataract outlier|0|||
156754384|NCT01490840|565853204|FG000|Phase 1|Lost to Follow-up|1|||
156754385|NCT01490840|565853205|FG001|Phase 1|Lost to Follow-up|0|||
156754386|NCT01490840|565853204|FG000|Phase 1|Adverse Event|2|||
156754387|NCT01490840|565853205|FG001|Phase 1|Adverse Event|1|||
156754388|NCT01490840|565853204|FG000|Phase 1|Withdrawal by Subject|6|||
156754389|NCT01490840|565853205|FG001|Phase 1|Withdrawal by Subject|5|||
156754390|NCT01490840|565853204|FG000|Phase 1|Visit 6a omitted|1|||
156754391|NCT01490840|565853205|FG001|Phase 1|Visit 6a omitted|0|||
156754392|NCT01490840|565853204|FG000|Phase 2|Withdrawal by Subject|4|||
156754393|NCT01490840|565853205|FG001|Phase 2|Withdrawal by Subject|3|||
156754394|NCT01490840|565853204|FG000|Phase 2|Permanent interruption of fingolimod|0|||
156754395|NCT01490840|565853205|FG001|Phase 2|Permanent interruption of fingolimod|1|||
156754396|NCT01490840|565853204|FG000|Phase 2|Lost to Follow-up|1|||
156754397|NCT01490840|565853205|FG001|Phase 2|Lost to Follow-up|1|||
156754398|NCT01490840|565853204|FG000|Phase 2|Adverse Event|1|||
156754399|NCT01490840|565853205|FG001|Phase 2|Adverse Event|1|||
156754400|NCT01025284|565853209|FG000|Overall Study|Investigator Decision|0|||
156754401|NCT01025284|565853210|FG001|Overall Study|Investigator Decision|1|||
156754402|NCT01025284|565853211|FG002|Overall Study|Investigator Decision|0|||
156754403|NCT01025284|565853209|FG000|Overall Study|Withdrawal by Subject|0|||
156754404|NCT01025284|565853210|FG001|Overall Study|Withdrawal by Subject|1|||
156754405|NCT01025284|565853211|FG002|Overall Study|Withdrawal by Subject|0|||
156754406|NCT02542397|565853212|FG000|Overall Study|Death|2|||
156754407|NCT02542397|565853212|FG000|Overall Study|Physician Decision|6|||
156754408|NCT02542397|565853212|FG000|Overall Study|Withdrawal by Subject|6|||
156754409|NCT02542397|565853212|FG000|Overall Study|Lost to Follow-up|2|||
156754410|NCT00547248|565853219|FG000|Overall Study|Protocol Violation|0|||
156754411|NCT00547248|565853220|FG001|Overall Study|Protocol Violation|0|||
156414437|NCT01890967|564610950|FG004|Overall Study|Sponsor Decision|2|||
156414438|NCT01890967|564610951|FG005|Overall Study|Sponsor Decision|3|||
156414439|NCT01890967|564610946|FG000|Overall Study|Withdrawal by Subject|3|||
156414440|NCT01890967|564610947|FG001|Overall Study|Withdrawal by Subject|4|||
156414441|NCT01890967|564610948|FG002|Overall Study|Withdrawal by Subject|2|||
156754412|NCT00547248|565853221|FG002|Overall Study|Protocol Violation|1|||
156754413|NCT00547248|565853222|FG003|Overall Study|Protocol Violation|1|||
156754414|NCT00547248|565853219|FG000|Overall Study|Migrated/moved from study area|0|||
156754415|NCT00547248|565853220|FG001|Overall Study|Migrated/moved from study area|0|||
156754416|NCT00547248|565853221|FG002|Overall Study|Migrated/moved from study area|2|||
156754417|NCT00547248|565853222|FG003|Overall Study|Migrated/moved from study area|0|||
156754418|NCT00547248|565853219|FG000|Overall Study|Withdrawal by Subject|0|||
156754419|NCT00547248|565853220|FG001|Overall Study|Withdrawal by Subject|0|||
156754420|NCT00547248|565853221|FG002|Overall Study|Withdrawal by Subject|7|||
156754421|NCT00547248|565853222|FG003|Overall Study|Withdrawal by Subject|1|||
156754422|NCT02090283|565853225|FG000|Overall Study|Withdrawal by Subject|6|||
156754423|NCT02090283|565853226|FG001|Overall Study|Withdrawal by Subject|6|||
156754424|NCT02090283|565853227|FG002|Overall Study|Withdrawal by Subject|6|||
156754425|NCT02090283|565853225|FG000|Overall Study|Sponsor Terminated Study|6|||
156754426|NCT02090283|565853226|FG001|Overall Study|Sponsor Terminated Study|6|||
156754427|NCT02090283|565853227|FG002|Overall Study|Sponsor Terminated Study|1|||
156754428|NCT02090283|565853225|FG000|Overall Study|Lost to Follow-up|2|||
156754429|NCT02090283|565853226|FG001|Overall Study|Lost to Follow-up|2|||
156754430|NCT02090283|565853227|FG002|Overall Study|Lost to Follow-up|3|||
156754431|NCT02090283|565853225|FG000|Overall Study|Adverse Event|1|||
156754432|NCT02090283|565853226|FG001|Overall Study|Adverse Event|1|||
156754433|NCT02090283|565853227|FG002|Overall Study|Adverse Event|0|||
156754434|NCT02090283|565853225|FG000|Overall Study|Protocol Violation|2|||
156754435|NCT02090283|565853226|FG001|Overall Study|Protocol Violation|0|||
156754436|NCT02090283|565853227|FG002|Overall Study|Protocol Violation|0|||
156754437|NCT00697593|565853230|FG000|Overall Study|Adverse Event|3|||
156754438|NCT00697593|565853230|FG000|Overall Study|Protocol Violation|1|||
156754439|NCT00697593|565853230|FG000|Overall Study|Lack of Efficacy|3|||
156754440|NCT00697593|565853230|FG000|Overall Study|Suspension of the study by sponsor|12|||
156754441|NCT00540644|565853231|FG000|Overall Study|Adverse Event|3|||
156754442|NCT00540644|565853232|FG001|Overall Study|Adverse Event|1|||
156754443|NCT00540644|565853231|FG000|Overall Study|Disease Progression|3|||
156754444|NCT00540644|565853232|FG001|Overall Study|Disease Progression|1|||
156754445|NCT00540644|565853231|FG000|Overall Study|Physician Decision|0|||
156754446|NCT00540644|565853232|FG001|Overall Study|Physician Decision|5|||
156754447|NCT00540644|565853231|FG000|Overall Study|Withdrawal by Subject|2|||
156754448|NCT00540644|565853232|FG001|Overall Study|Withdrawal by Subject|2|||
156754449|NCT00540644|565853231|FG000|Overall Study|Noncomplilance|1|||
156754450|NCT00540644|565853232|FG001|Overall Study|Noncomplilance|0|||
156754451|NCT01765569|565853243|FG000|Period B|Withdrawal by Subject|1|||
156754452|NCT01765569|565853243|FG000|Period C|Death|1|||
156754453|NCT01030718|565853244|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
156754454|NCT01030718|565853245|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
156754455|NCT01030718|565853246|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
156754456|NCT01030718|565853244|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
156754457|NCT01030718|565853245|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
156754458|NCT01030718|565853246|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
156754459|NCT01030718|565853244|FG000|Studies CA180-031 and -036 Combined|Death|0|||
156754460|NCT01030718|565853245|FG001|Studies CA180-031 and -036 Combined|Death|1|||
156754461|NCT01030718|565853246|FG002|Studies CA180-031 and -036 Combined|Death|0|||
156754462|NCT01030718|565853244|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
156754463|NCT01030718|565853245|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
156754464|NCT01030718|565853246|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
156754465|NCT01030718|565853244|FG000|Study CA180-036 Only|insufficient effect|1|||
156754466|NCT01030718|565853245|FG001|Study CA180-036 Only|insufficient effect|1|||
156754467|NCT01030718|565853246|FG002|Study CA180-036 Only|insufficient effect|5|||
156754468|NCT01030718|565853244|FG000|Study CA180-036 Only|Adverse Event|2|||
156754469|NCT01030718|565853245|FG001|Study CA180-036 Only|Adverse Event|3|||
156754470|NCT01030718|565853246|FG002|Study CA180-036 Only|Adverse Event|0|||
156754471|NCT01030718|565853244|FG000|Study CA180-036 Only|Death|0|||
156754472|NCT01030718|565853245|FG001|Study CA180-036 Only|Death|1|||
156754473|NCT01030718|565853246|FG002|Study CA180-036 Only|Death|0|||
156754474|NCT01030718|565853244|FG000|Study CA180-036 Only|Other Reasons|0|||
156754475|NCT01030718|565853245|FG001|Study CA180-036 Only|Other Reasons|2|||
156754476|NCT01030718|565853246|FG002|Study CA180-036 Only|Other Reasons|0|||
156754477|NCT03853291|565853247|FG000|Overall Study|Lost to Follow-up|1|||
156754478|NCT03853291|565853248|FG001|Overall Study|Lost to Follow-up|2|||
156754479|NCT03853291|565853249|FG002|Overall Study|Lost to Follow-up|0|||
156754480|NCT03853291|565853250|FG003|Overall Study|Lost to Follow-up|0|||
156754481|NCT03853291|565853251|FG004|Overall Study|Lost to Follow-up|0|||
156754482|NCT03853291|565853252|FG005|Overall Study|Lost to Follow-up|0|||
156754483|NCT03853291|565853247|FG000|Overall Study|Determined to be ineligible|1|||
156754484|NCT03853291|565853248|FG001|Overall Study|Determined to be ineligible|1|||
156754485|NCT03853291|565853249|FG002|Overall Study|Determined to be ineligible|0|||
156754486|NCT03853291|565853250|FG003|Overall Study|Determined to be ineligible|0|||
156754487|NCT03853291|565853251|FG004|Overall Study|Determined to be ineligible|0|||
156754488|NCT03853291|565853252|FG005|Overall Study|Determined to be ineligible|0|||
156754489|NCT02383355|565853253|FG000|Overall Study|Adverse Event|2|||
156754490|NCT02383355|565853254|FG001|Overall Study|Adverse Event|0|||
156754491|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
156754492|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
156754493|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
156754494|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
156754495|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
156754496|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
156754497|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
156754498|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
156754499|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
156754500|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
156754501|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
156754502|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
156754503|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
156754504|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
156754505|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
156754506|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
156754507|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
156754508|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
156754509|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
156754510|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
156754511|NCT03092791|565853260|FG000|Overall Study|Lost to Follow-up|0|||
156754512|NCT03092791|565853261|FG001|Overall Study|Lost to Follow-up|0|||
156754513|NCT03092791|565853262|FG002|Overall Study|Lost to Follow-up|0|||
156754514|NCT03092791|565853263|FG003|Overall Study|Lost to Follow-up|0|||
156754515|NCT03092791|565853264|FG004|Overall Study|Lost to Follow-up|0|||
156754516|NCT03092791|565853265|FG005|Overall Study|Lost to Follow-up|0|||
156754517|NCT03092791|565853266|FG006|Overall Study|Lost to Follow-up|1|||
156754518|NCT03092791|565853267|FG007|Overall Study|Lost to Follow-up|0|||
156754519|NCT03092791|565853260|FG000|Overall Study|Withdrawal of Consent|0|||
156754520|NCT03092791|565853261|FG001|Overall Study|Withdrawal of Consent|0|||
156754521|NCT03092791|565853262|FG002|Overall Study|Withdrawal of Consent|0|||
156754522|NCT03092791|565853263|FG003|Overall Study|Withdrawal of Consent|0|||
156754523|NCT03092791|565853264|FG004|Overall Study|Withdrawal of Consent|4|||
156754524|NCT03092791|565853265|FG005|Overall Study|Withdrawal of Consent|12|||
156754525|NCT03092791|565853266|FG006|Overall Study|Withdrawal of Consent|6|||
156754526|NCT03092791|565853267|FG007|Overall Study|Withdrawal of Consent|4|||
156754527|NCT03092791|565853260|FG000|Overall Study|Study Termination|0|||
156754528|NCT03092791|565853261|FG001|Overall Study|Study Termination|0|||
156754529|NCT03092791|565853262|FG002|Overall Study|Study Termination|0|||
156754530|NCT03092791|565853263|FG003|Overall Study|Study Termination|0|||
156754531|NCT03092791|565853264|FG004|Overall Study|Study Termination|55|||
156754532|NCT03092791|565853265|FG005|Overall Study|Study Termination|46|||
156754533|NCT03092791|565853266|FG006|Overall Study|Study Termination|53|||
156754534|NCT03092791|565853267|FG007|Overall Study|Study Termination|55|||
156754535|NCT03092791|565853260|FG000|Overall Study|Death|0|||
156754536|NCT03092791|565853261|FG001|Overall Study|Death|0|||
156754537|NCT03092791|565853262|FG002|Overall Study|Death|0|||
156754538|NCT03092791|565853263|FG003|Overall Study|Death|0|||
156754539|NCT03092791|565853264|FG004|Overall Study|Death|0|||
156754540|NCT03092791|565853265|FG005|Overall Study|Death|1|||
156754541|NCT03092791|565853266|FG006|Overall Study|Death|0|||
156754542|NCT03092791|565853267|FG007|Overall Study|Death|1|||
156754543|NCT03092791|565853260|FG000|Overall Study|Reason Not Specified|0|||
156754544|NCT03092791|565853261|FG001|Overall Study|Reason Not Specified|0|||
156754545|NCT03092791|565853262|FG002|Overall Study|Reason Not Specified|0|||
156754546|NCT03092791|565853263|FG003|Overall Study|Reason Not Specified|0|||
156754547|NCT03092791|565853264|FG004|Overall Study|Reason Not Specified|1|||
156754548|NCT03092791|565853265|FG005|Overall Study|Reason Not Specified|1|||
156754549|NCT03092791|565853266|FG006|Overall Study|Reason Not Specified|0|||
156754550|NCT03092791|565853267|FG007|Overall Study|Reason Not Specified|0|||
156754551|NCT02182830|565853268|FG000|Overall Study|Not Treated|1|||
156754552|NCT02182830|565853269|FG001|Overall Study|Not Treated|1|||
156754553|NCT02182830|565853268|FG000|Overall Study|Trial stopped, reason missing|3|||
156754554|NCT02182830|565853269|FG001|Overall Study|Trial stopped, reason missing|3|||
156754555|NCT02182830|565853268|FG000|Overall Study|Consent withdrawn|8|||
156754556|NCT02182830|565853269|FG001|Overall Study|Consent withdrawn|8|||
156754557|NCT02182830|565853268|FG000|Overall Study|Lost to Follow-up|3|||
156754558|NCT02182830|565853269|FG001|Overall Study|Lost to Follow-up|3|||
156754559|NCT00913770|565853270|FG000|Overall Study|Unable to contact|24|||
156754560|NCT00913770|565853271|FG001|Overall Study|Unable to contact|19|||
156754561|NCT00913770|565853272|FG002|Overall Study|Unable to contact|13|||
156754562|NCT00913770|565853270|FG000|Overall Study|Refused|11|||
156754563|NCT00913770|565853271|FG001|Overall Study|Refused|10|||
156754564|NCT00913770|565853272|FG002|Overall Study|Refused|8|||
156754565|NCT01990768|565853273|FG000|Intervention Started|Found to be ineligible|14|||
156754566|NCT01990768|565853274|FG001|Intervention Started|Found to be ineligible|13|||
156754567|NCT01990768|565853275|FG002|Intervention Started|Found to be ineligible|11|||
156754568|NCT01990768|565853273|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
156754569|NCT01990768|565853274|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
156754570|NCT01990768|565853275|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
156754571|NCT01990768|565853273|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
156650657|NCT01271933|565467127|FG000|Double-Blind Phase|Randomized but not treated|0|||
156650658|NCT01271933|565467128|FG001|Double-Blind Phase|Randomized but not treated|0|||
156650659|NCT01271933|565467129|FG002|Double-Blind Phase|Randomized but not treated|1|||
156650660|NCT01271933|565467127|FG000|Double-Blind Phase|Lack of Efficacy|0|||
156650661|NCT01271933|565467128|FG001|Double-Blind Phase|Lack of Efficacy|6|||
156650662|NCT01271933|565467129|FG002|Double-Blind Phase|Lack of Efficacy|9|||
156650663|NCT01271933|565467127|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156650664|NCT01271933|565467128|FG001|Double-Blind Phase|Lost to Follow-up|1|||
156650665|NCT01271933|565467129|FG002|Double-Blind Phase|Lost to Follow-up|1|||
156650666|NCT01271933|565467127|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156650667|NCT01271933|565467128|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
156650668|NCT01271933|565467129|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
156650669|NCT01271933|565467127|FG000|Double-Blind Phase|Adverse Event|0|||
156650670|NCT01271933|565467128|FG001|Double-Blind Phase|Adverse Event|3|||
156650671|NCT01271933|565467129|FG002|Double-Blind Phase|Adverse Event|0|||
156650672|NCT01271933|565467127|FG000|Double-Blind Phase|Participant request-personal reason|0|||
156650673|NCT01271933|565467128|FG001|Double-Blind Phase|Participant request-personal reason|1|||
156650674|NCT01271933|565467129|FG002|Double-Blind Phase|Participant request-personal reason|0|||
156650675|NCT01620983|565467130|FG000|Overall Study|Lost to Follow-up|8|||
156650676|NCT01620983|565467131|FG001|Overall Study|Lost to Follow-up|4|||
156650677|NCT01620983|565467132|FG002|Overall Study|Lost to Follow-up|9|||
156650678|NCT01620983|565467130|FG000|Overall Study|Withdrawal by Subject|6|||
156650679|NCT01620983|565467131|FG001|Overall Study|Withdrawal by Subject|8|||
156650680|NCT01620983|565467132|FG002|Overall Study|Withdrawal by Subject|1|||
156650681|NCT01620983|565467130|FG000|Overall Study|Death|2|||
156650682|NCT01620983|565467131|FG001|Overall Study|Death|0|||
156650683|NCT01620983|565467132|FG002|Overall Study|Death|0|||
156650684|NCT01620983|565467130|FG000|Overall Study|Physician Decision|3|||
156650685|NCT01620983|565467131|FG001|Overall Study|Physician Decision|10|||
156650686|NCT01620983|565467132|FG002|Overall Study|Physician Decision|5|||
156650687|NCT00798889|565467134|FG000|Overall Study|Adverse Event|53|||
156650688|NCT00798889|565467134|FG000|Overall Study|Protocol Violation|2|||
156650689|NCT00798889|565467134|FG000|Overall Study|Withdrawal by Subject|31|||
156650690|NCT00798889|565467134|FG000|Overall Study|Lost to Follow-up|1|||
156650691|NCT00798889|565467134|FG000|Overall Study|Lack of Efficacy|213|||
156650692|NCT00798889|565467134|FG000|Overall Study|Decision of Sponsor|11|||
156650693|NCT00798889|565467134|FG000|Overall Study|Enrolled, Not treated|3|||
156650694|NCT00617461|565467135|FG000|First Treatment Intervention Period|Adverse Event|2|||
156650695|NCT00617461|565467136|FG001|First Treatment Intervention Period|Adverse Event|0|||
156650696|NCT00617461|565467135|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
156650697|NCT00617461|565467136|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
156650698|NCT00617461|565467135|FG000|First Treatment Intervention Period|Protocol Violation|2|||
156650699|NCT00617461|565467136|FG001|First Treatment Intervention Period|Protocol Violation|1|||
156650700|NCT00617461|565467135|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
156650701|NCT00617461|565467136|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
156650702|NCT00617461|565467135|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
156650703|NCT00617461|565467136|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
156650704|NCT00617461|565467135|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
156650705|NCT00617461|565467136|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
156650706|NCT00617461|565467135|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
156650707|NCT00617461|565467136|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
156650708|NCT00617461|565467135|FG000|Second Treatment Intervention Period|Adverse Event|0|||
156650709|NCT00617461|565467136|FG001|Second Treatment Intervention Period|Adverse Event|1|||
156650710|NCT00617461|565467135|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
156650711|NCT00617461|565467136|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
156650712|NCT00617461|565467135|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
156650713|NCT00617461|565467136|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
156650714|NCT00617461|565467135|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
156650715|NCT00617461|565467136|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
156650716|NCT01724359|565467137|FG000|Overall Study|Adverse Event|10|||
156650717|NCT01724359|565467137|FG000|Overall Study|Death|1|||
156650718|NCT01724359|565467137|FG000|Overall Study|Other|20|||
156650719|NCT05085964|565467138|FG000|Overall Study|Premature termination of study|21|||
156650720|NCT05085964|565467139|FG001|Overall Study|Premature termination of study|0|||
156650721|NCT03156270|565467144|FG000|Overall Study|Failed pre-treatment screening|1|||
156650722|NCT03156270|565467144|FG000|Overall Study|Lost to Follow-up|1|||
156650723|NCT00591253|565467145|FG000|Overall Study|Adverse Event|3|||
156650724|NCT00591253|565467146|FG001|Overall Study|Adverse Event|3|||
156650725|NCT00591253|565467147|FG002|Overall Study|Adverse Event|1|||
156650726|NCT00591253|565467145|FG000|Overall Study|Protocol Violation|2|||
156650727|NCT00591253|565467146|FG001|Overall Study|Protocol Violation|2|||
156650728|NCT00591253|565467147|FG002|Overall Study|Protocol Violation|2|||
156650729|NCT00591253|565467145|FG000|Overall Study|Lost to Follow-up|2|||
156650730|NCT00591253|565467146|FG001|Overall Study|Lost to Follow-up|4|||
156754572|NCT01990768|565853274|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
156754573|NCT01990768|565853275|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
156754574|NCT01990768|565853273|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
156754575|NCT01990768|565853274|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
156754576|NCT01990768|565853275|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
156754577|NCT01990768|565853273|FG000|Intervention Started|Patient care priority|1|||
156754578|NCT01990768|565853274|FG001|Intervention Started|Patient care priority|2|||
156754579|NCT01990768|565853275|FG002|Intervention Started|Patient care priority|3|||
156754580|NCT01990768|565853273|FG000|Intervention Started|IV lost|2|||
156754581|NCT01990768|565853274|FG001|Intervention Started|IV lost|2|||
156754582|NCT01990768|565853275|FG002|Intervention Started|IV lost|2|||
156754583|NCT01990768|565853273|FG000|Intervention Started|Required CPR|1|||
156754584|NCT01990768|565853274|FG001|Intervention Started|Required CPR|1|||
156754585|NCT01990768|565853275|FG002|Intervention Started|Required CPR|0|||
156754586|NCT01990768|565853273|FG000|Intervention Started|Seizure or hx of seizure|0|||
156754587|NCT01990768|565853274|FG001|Intervention Started|Seizure or hx of seizure|0|||
156754588|NCT01990768|565853275|FG002|Intervention Started|Seizure or hx of seizure|2|||
156754589|NCT01990768|565853273|FG000|Intervention Started|Discovered to be pregnant|0|||
156754590|NCT01990768|565853274|FG001|Intervention Started|Discovered to be pregnant|1|||
156754591|NCT01990768|565853275|FG002|Intervention Started|Discovered to be pregnant|0|||
156754592|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
156754593|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
156754594|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
156754595|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
156754596|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
156754597|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
156754598|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
156754599|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
156754600|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
156754601|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
156754602|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
156754603|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
156754604|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Death|3|||
156754605|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Death|1|||
156754606|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Death|1|||
156754607|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Discharged|2|||
156754608|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Discharged|1|||
156754609|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Discharged|0|||
156754610|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
156754611|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
156754612|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
156754613|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
156754614|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
156754615|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
156754616|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
156754617|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
156754618|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
156754619|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
156754620|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
156754621|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
156754622|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
156754623|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
156754624|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
156754625|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
156754626|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
156754627|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
156754628|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
156754629|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
156754630|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
156754631|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
156754632|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
156754633|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
156754634|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
156754635|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
156754636|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
156754637|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
156754638|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
156754639|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
156754640|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
156754641|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
156754642|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
156754643|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
156754644|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
156754645|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
156754646|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
156754647|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
156754648|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
156754649|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
156754650|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
156754651|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
156754652|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
156754653|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
156754654|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
156754655|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
156754656|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
156754657|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
156754658|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
156754659|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
156754660|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
156754661|NCT01990768|565853273|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
156754662|NCT01990768|565853274|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
156754663|NCT01990768|565853275|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
156754664|NCT01990768|565853273|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
156754665|NCT01990768|565853274|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
156754666|NCT01990768|565853275|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
156754667|NCT01990768|565853273|FG000|6-Month Follow-up|No contact information|5|||
156754668|NCT01990768|565853274|FG001|6-Month Follow-up|No contact information|6|||
156754669|NCT01990768|565853275|FG002|6-Month Follow-up|No contact information|5|||
156754670|NCT01990768|565853273|FG000|6-Month Follow-up|Homeless|4|||
156754671|NCT01990768|565853274|FG001|6-Month Follow-up|Homeless|3|||
156754672|NCT01990768|565853275|FG002|6-Month Follow-up|Homeless|6|||
156754673|NCT01990768|565853273|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
156754674|NCT01990768|565853274|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
156754675|NCT01990768|565853275|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
156754676|NCT01990768|565853273|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
156754677|NCT01990768|565853274|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
156754678|NCT01990768|565853275|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
156754679|NCT01990768|565853273|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
156754680|NCT01990768|565853274|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
156754681|NCT01990768|565853275|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
156754682|NCT00334295|565853276|FG000|Overall Study|Patients received fewer than 3 injection|5|||
156754683|NCT00248833|565853281|FG000|Overall Study|Adverse Event|2|||
156754684|NCT00248833|565853282|FG001|Overall Study|Adverse Event|0|||
156754685|NCT00248833|565853283|FG002|Overall Study|Adverse Event|0|||
156754686|NCT00248833|565853281|FG000|Overall Study|Withdrawal by Subject|0|||
156754687|NCT00248833|565853282|FG001|Overall Study|Withdrawal by Subject|1|||
156754688|NCT00248833|565853283|FG002|Overall Study|Withdrawal by Subject|1|||
156754689|NCT00248833|565853281|FG000|Overall Study|Lost to Follow-up|1|||
156754690|NCT00248833|565853282|FG001|Overall Study|Lost to Follow-up|1|||
156754691|NCT00248833|565853283|FG002|Overall Study|Lost to Follow-up|1|||
156754692|NCT00248833|565853281|FG000|Overall Study|Other|0|||
156754693|NCT00248833|565853282|FG001|Overall Study|Other|1|||
156754694|NCT00248833|565853283|FG002|Overall Study|Other|0|||
156754695|NCT02636439|565853284|FG000|Overall Study|Adverse Event|2|||
156754696|NCT02636439|565853285|FG001|Overall Study|Adverse Event|2|||
156754697|NCT02636439|565853284|FG000|Overall Study|Lost to Follow-up|1|||
156754698|NCT02636439|565853285|FG001|Overall Study|Lost to Follow-up|0|||
156754699|NCT02636439|565853284|FG000|Overall Study|Non-compliance|1|||
156754700|NCT02636439|565853285|FG001|Overall Study|Non-compliance|1|||
156754701|NCT02636439|565853284|FG000|Overall Study|Personal reasons|2|||
156754702|NCT02636439|565853285|FG001|Overall Study|Personal reasons|0|||
156754703|NCT02494401|565853286|FG000|Overall Study|Lost to Follow-up|22|||
156754704|NCT02494401|565853287|FG001|Overall Study|Lost to Follow-up|25|||
156754705|NCT02494401|565853286|FG000|Overall Study|Withdrawal by Subject|3|||
156754706|NCT02494401|565853287|FG001|Overall Study|Withdrawal by Subject|2|||
156754707|NCT04530838|565855005|FG000|Overall Study|Other|2|||
156754708|NCT04530838|565855006|FG001|Overall Study|Other|1|||
156754709|NCT04530838|565855007|FG002|Overall Study|Other|0|||
156754710|NCT04530838|565855005|FG000|Overall Study|Physician Decision|0|||
156754711|NCT04530838|565855006|FG001|Overall Study|Physician Decision|0|||
156754712|NCT04530838|565855007|FG002|Overall Study|Physician Decision|1|||
156754713|NCT04530838|565855005|FG000|Overall Study|Death|0|||
156754714|NCT04530838|565855006|FG001|Overall Study|Death|0|||
156754715|NCT04530838|565855007|FG002|Overall Study|Death|1|||
156754716|NCT04530838|565855005|FG000|Overall Study|Adverse Event|0|||
156754717|NCT04530838|565855006|FG001|Overall Study|Adverse Event|1|||
156754718|NCT04530838|565855007|FG002|Overall Study|Adverse Event|0|||
156754719|NCT04530838|565855005|FG000|Overall Study|No longer meets eligibility criteria|1|||
156754720|NCT04530838|565855006|FG001|Overall Study|No longer meets eligibility criteria|0|||
156754721|NCT04530838|565855007|FG002|Overall Study|No longer meets eligibility criteria|2|||
156754722|NCT04530838|565855005|FG000|Overall Study|Withdrawal by parent/guardian|5|||
156754723|NCT04530838|565855006|FG001|Overall Study|Withdrawal by parent/guardian|2|||
156754724|NCT04530838|565855007|FG002|Overall Study|Withdrawal by parent/guardian|2|||
156754725|NCT00803712|565855008|FG000|Overall Study|Noncompliance|3|||
156754726|NCT00803712|565855009|FG001|Overall Study|Noncompliance|0|||
156754727|NCT00803712|565855008|FG000|Overall Study|Adverse Event|5|||
156754728|NCT00803712|565855009|FG001|Overall Study|Adverse Event|0|||
156754729|NCT00803712|565855008|FG000|Overall Study|Death|8|||
156754730|NCT00803712|565855009|FG001|Overall Study|Death|7|||
156650731|NCT00591253|565467147|FG002|Overall Study|Lost to Follow-up|0|||
156650732|NCT00591253|565467145|FG000|Overall Study|Withdrawal by Subject|1|||
156650733|NCT00591253|565467146|FG001|Overall Study|Withdrawal by Subject|7|||
156650734|NCT00591253|565467147|FG002|Overall Study|Withdrawal by Subject|6|||
156650735|NCT00591253|565467145|FG000|Overall Study|Lack of Efficacy|1|||
156650736|NCT00591253|565467146|FG001|Overall Study|Lack of Efficacy|0|||
156650737|NCT00591253|565467147|FG002|Overall Study|Lack of Efficacy|3|||
156650738|NCT00591253|565467145|FG000|Overall Study|Other|5|||
156650739|NCT00591253|565467146|FG001|Overall Study|Other|5|||
156650740|NCT00591253|565467147|FG002|Overall Study|Other|3|||
156650741|NCT00871169|565467149|FG000|Overall Study|Protocol Violation|1|||
156650742|NCT00871169|565467149|FG000|Overall Study|Patient did not receive study treatment|2|||
156650743|NCT00252187|565467150|FG000|Overall Study|Adverse Event|3|||
156650744|NCT00252187|565467151|FG001|Overall Study|Adverse Event|1|||
156650745|NCT00252187|565467150|FG000|Overall Study|Withdrawal by Subject|1|||
156650746|NCT00252187|565467151|FG001|Overall Study|Withdrawal by Subject|0|||
156650747|NCT01102777|565467154|FG000|Overall Study|Death|2|||
156650748|NCT01102777|565467155|FG001|Overall Study|Death|6|||
156650749|NCT01102777|565467154|FG000|Overall Study|Lost to Follow-up|7|||
156650750|NCT01102777|565467155|FG001|Overall Study|Lost to Follow-up|10|||
156650751|NCT01875445|565467156|FG000|Overall Study|Lost to Follow-up|5|||
156650752|NCT01875445|565467157|FG001|Overall Study|Lost to Follow-up|0|||
156650753|NCT01875445|565467156|FG000|Overall Study|Withdrawal by Subject|2|||
156650754|NCT01875445|565467157|FG001|Overall Study|Withdrawal by Subject|0|||
156650755|NCT00593333|565467162|FG000|Overall Study|Lost to Follow-up|10|||
156650756|NCT00593333|565467163|FG001|Overall Study|Lost to Follow-up|11|||
156650757|NCT02175966|565467164|FG000|Follow-up Period|Lack of Efficacy|10|||
156650758|NCT02175966|565467165|FG001|Follow-up Period|Lack of Efficacy|6|||
156650759|NCT01738581|565467166|FG000|Overall Study|Lost to Follow-up|1|||
156650760|NCT01738581|565467167|FG001|Overall Study|Lost to Follow-up|0|||
156650761|NCT02191579|565467168|FG000|Treatment 1|Multiple Reasons Specified|27|||
156650762|NCT02191579|565467169|FG001|Treatment 1|Multiple Reasons Specified|58|||
156650763|NCT02191579|565467168|FG000|Treatment 2|Multiple Reasons Specified|0|||
156650764|NCT02191579|565467169|FG001|Treatment 2|Multiple Reasons Specified|25|||
156650765|NCT02862535|565467172|FG000|Overall Study|Death|7|||
156650766|NCT02862535|565467173|FG001|Overall Study|Death|3|||
156650767|NCT02862535|565467174|FG002|Overall Study|Death|2|||
156650768|NCT02862535|565467175|FG003|Overall Study|Death|5|||
156650769|NCT02862535|565467172|FG000|Overall Study|Study Terminated by Sponsor|1|||
156650770|NCT02862535|565467173|FG001|Overall Study|Study Terminated by Sponsor|3|||
156650771|NCT02862535|565467174|FG002|Overall Study|Study Terminated by Sponsor|8|||
156650772|NCT02862535|565467175|FG003|Overall Study|Study Terminated by Sponsor|5|||
156650773|NCT02862535|565467172|FG000|Overall Study|Enrolled, not Treated|1|||
156650774|NCT02862535|565467173|FG001|Overall Study|Enrolled, not Treated|0|||
156650775|NCT02862535|565467174|FG002|Overall Study|Enrolled, not Treated|0|||
156650776|NCT02862535|565467175|FG003|Overall Study|Enrolled, not Treated|1|||
156650777|NCT01086215|565467178|FG000|Overall Study|Death|14|||
156650778|NCT01086215|565467179|FG001|Overall Study|Death|8|||
156650779|NCT01086215|565467180|FG002|Overall Study|Death|8|||
156650780|NCT01086215|565467181|FG003|Overall Study|Death|1|||
156650781|NCT01086215|565467178|FG000|Overall Study|Lost to Follow-up|22|||
156650782|NCT01086215|565467179|FG001|Overall Study|Lost to Follow-up|39|||
156650783|NCT01086215|565467180|FG002|Overall Study|Lost to Follow-up|18|||
156650784|NCT01086215|565467181|FG003|Overall Study|Lost to Follow-up|2|||
156650785|NCT01965652|565467182|FG000|Overall Study|Adverse Event|40|||
156650786|NCT01965652|565467183|FG001|Overall Study|Adverse Event|37|||
156650787|NCT01965652|565467182|FG000|Overall Study|Withdrawal by Subject|62|||
156754731|NCT00803712|565855008|FG000|Overall Study|Lost to Follow-up|3|||
156754732|NCT00803712|565855009|FG001|Overall Study|Lost to Follow-up|1|||
156754733|NCT00803712|565855008|FG000|Overall Study|Withdrawal by Subject|2|||
156754734|NCT00803712|565855009|FG001|Overall Study|Withdrawal by Subject|4|||
156754735|NCT00803712|565855008|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
156754736|NCT00803712|565855009|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
156754737|NCT00803712|565855008|FG000|Overall Study|Protocol criteria (other)|0|||
156754738|NCT00803712|565855009|FG001|Overall Study|Protocol criteria (other)|2|||
156754739|NCT00803712|565855008|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
156754740|NCT00803712|565855009|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
156754741|NCT00803712|565855008|FG000|Overall Study|Administrative decision|2|||
156754742|NCT00803712|565855009|FG001|Overall Study|Administrative decision|3|||
156754743|NCT00803712|565855008|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
156754744|NCT00803712|565855009|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
156754745|NCT00305227|565855024|FG000|Overall Study|Lost to Follow-up|7|||
156754746|NCT00305227|565855025|FG001|Overall Study|Lost to Follow-up|6|||
156754747|NCT05133323|565855027|FG000|Overall Study|Lack of Efficacy|0|||
156754748|NCT05133323|565855028|FG001|Overall Study|Lack of Efficacy|0|||
156754749|NCT05133323|565855029|FG002|Overall Study|Lack of Efficacy|1|||
156754750|NCT05133323|565855027|FG000|Overall Study|Withdrawal by Subject|2|||
156754751|NCT05133323|565855028|FG001|Overall Study|Withdrawal by Subject|1|||
156754752|NCT05133323|565855029|FG002|Overall Study|Withdrawal by Subject|0|||
156754753|NCT00632125|565855030|FG000|Overall Study|Death|82|||
156754754|NCT00632125|565855030|FG000|Overall Study|Withdrawal by Subject|44|||
156754755|NCT00632125|565855030|FG000|Overall Study|Adverse Event|36|||
156754756|NCT00632125|565855030|FG000|Overall Study|Renal transplantation|17|||
156754757|NCT00632125|565855030|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
156754758|NCT00632125|565855030|FG000|Overall Study|Non-compliance|8|||
156754759|NCT00632125|565855030|FG000|Overall Study|Development of uncontrolled hypertension|5|||
156754760|NCT00632125|565855030|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
156754761|NCT00577772|565855037|FG000|Overall Study|Lost to Follow-up|0|||
156754762|NCT00577772|565855038|FG001|Overall Study|Lost to Follow-up|1|||
156754763|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
156754764|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
156754765|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
156754766|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
156754767|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
156754768|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
156754769|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
156754770|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
156754771|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
156754772|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
156754773|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
156754774|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
156754775|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
156754776|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
156754777|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Death|1|||
156754778|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Death|0|||
156754779|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
156754780|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
156754781|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
156754782|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
156754783|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
156754784|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
156754785|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
156754786|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
156754787|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
156754788|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
156754789|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
156754790|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
156754791|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
156754792|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
156754793|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
156754794|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
156754795|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
156754796|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
156754797|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Death|0|||
156754798|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Death|0|||
156754799|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
156754800|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
156754801|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
156754802|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
156754803|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
156650788|NCT01965652|565467183|FG001|Overall Study|Withdrawal by Subject|69|||
156650789|NCT01965652|565467182|FG000|Overall Study|Lost to Follow-up|53|||
156650790|NCT01965652|565467183|FG001|Overall Study|Lost to Follow-up|40|||
156650791|NCT01965652|565467182|FG000|Overall Study|Protocol Violation|34|||
156650792|NCT01965652|565467183|FG001|Overall Study|Protocol Violation|38|||
156650793|NCT01965652|565467182|FG000|Overall Study|Death|3|||
156650794|NCT01965652|565467183|FG001|Overall Study|Death|4|||
156650795|NCT01965652|565467182|FG000|Overall Study|Other - Miscellaneous|18|||
156754804|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
156754805|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
156754806|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
156754807|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
156754808|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
156754809|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
156754810|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
156754811|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
156754812|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
156754813|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
156754814|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
156754815|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
156754816|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
156754817|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
156754818|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
156754819|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
156754820|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
156754821|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
156754822|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
156754823|NCT01716663|565855047|FG000|Overall Study|Withdrawn prior to procedure|4|||
156754824|NCT01716663|565855047|FG000|Overall Study|Treated with non-study catheter|2|||
156754825|NCT01029262|565855050|FG000|Overall Study|Adverse Event|9|||
156754826|NCT01029262|565855051|FG001|Overall Study|Adverse Event|52|||
156754827|NCT01029262|565855050|FG000|Overall Study|Lack of therapeutic effect|57|||
156754828|NCT01029262|565855051|FG001|Overall Study|Lack of therapeutic effect|76|||
156754829|NCT01029262|565855050|FG000|Overall Study|Withdrawal by Subject|10|||
156754830|NCT01029262|565855051|FG001|Overall Study|Withdrawal by Subject|17|||
156754831|NCT01029262|565855050|FG000|Overall Study|Protocol Violation|2|||
156754832|NCT01029262|565855051|FG001|Overall Study|Protocol Violation|3|||
156754833|NCT01029262|565855050|FG000|Overall Study|Miscellaneous|1|||
156754834|NCT01029262|565855051|FG001|Overall Study|Miscellaneous|9|||
156754835|NCT01029262|565855050|FG000|Overall Study|Death|0|||
156754836|NCT01029262|565855051|FG001|Overall Study|Death|3|||
156754837|NCT00807612|565855055|FG000|Overall Study|Death|8|||
156754838|NCT00807612|565855055|FG000|Overall Study|Study early termination|5|||
156754839|NCT00807612|565855055|FG000|Overall Study|Withdrawal by Subject|1|||
156754840|NCT04607135|565855056|FG000|Overall Study|Physician Decision|1|||
156650796|NCT01965652|565467183|FG001|Overall Study|Other - Miscellaneous|21|||
156650797|NCT01965652|565467182|FG000|Overall Study|Pregnancy|0|||
156650798|NCT01965652|565467183|FG001|Overall Study|Pregnancy|1|||
156650799|NCT00566709|565467184|FG000|Overall Study|Protocol Violation|5|||
156650800|NCT00566709|565467185|FG001|Overall Study|Protocol Violation|0|||
156650801|NCT01829295|565467186|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
156650802|NCT01829295|565467187|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
156650803|NCT01829295|565467188|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
156754841|NCT04607135|565855056|FG000|Overall Study|Withdrawal by Subject|1|||
156754842|NCT04607135|565855056|FG000|Overall Study|Equipment not working|3|||
156313388|NCT01561898|564246311|FG003|Overall Study|Physician Decision|1|||
156313389|NCT00331552|564246314|FG000|Period 3: Phase II|Neurological Symptoms|1|||
156313390|NCT00331552|564246315|FG001|Period 3: Phase II|Neurological Symptoms|0|||
156313391|NCT00331552|564246314|FG000|Period 3: Phase II|Severe Nausea|1|||
156313392|NCT00331552|564246315|FG001|Period 3: Phase II|Severe Nausea|0|||
156650804|NCT01829295|565467189|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
156650805|NCT01829295|565467186|FG000|6-12 Months|Adverse Event|0|||
156754843|NCT03465709|565855057|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
156754844|NCT03465709|565855057|FG000|Overall Study|Withdrawal by Subject|3|||
156754845|NCT04892446|565855058|FG000|Overall Study|Death|4|||
156754846|NCT04892446|565855059|FG001|Overall Study|Death|4|||
156313393|NCT01883453|564246316|FG000|Overall Study|No episode of common cold|25|||
156313394|NCT01883453|564246317|FG001|Overall Study|No episode of common cold|23|||
156650806|NCT01829295|565467187|FG001|6-12 Months|Adverse Event|0|||
156650807|NCT01829295|565467188|FG002|6-12 Months|Adverse Event|3|||
156754847|NCT04892446|565855060|FG002|Overall Study|Death|0|||
156754848|NCT04892446|565855058|FG000|Overall Study|Withdrew consent|3|||
156754849|NCT04892446|565855059|FG001|Overall Study|Withdrew consent|0|||
156754850|NCT04892446|565855060|FG002|Overall Study|Withdrew consent|1|||
156754851|NCT04892446|565855058|FG000|Overall Study|Investigator's discretion|1|||
156754852|NCT04892446|565855059|FG001|Overall Study|Investigator's discretion|1|||
156754853|NCT04892446|565855060|FG002|Overall Study|Investigator's discretion|0|||
156754854|NCT04892446|565855058|FG000|Overall Study|Study terminated by sponsor|0|||
156754855|NCT04892446|565855059|FG001|Overall Study|Study terminated by sponsor|0|||
156754856|NCT04892446|565855060|FG002|Overall Study|Study terminated by sponsor|2|||
156754857|NCT00705341|565855061|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
156754858|NCT00705341|565855062|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
156754859|NCT00705341|565855063|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
156650808|NCT01829295|565467189|FG003|6-12 Months|Adverse Event|2|||
156650809|NCT01829295|565467186|FG000|6-12 Months|Lost to Follow-up|2|||
156650810|NCT01829295|565467187|FG001|6-12 Months|Lost to Follow-up|0|||
156650811|NCT01829295|565467188|FG002|6-12 Months|Lost to Follow-up|0|||
156650812|NCT01829295|565467189|FG003|6-12 Months|Lost to Follow-up|0|||
156650813|NCT01829295|565467186|FG000|6-12 Months|Withdrawal by Subject|2|||
156650814|NCT01829295|565467187|FG001|6-12 Months|Withdrawal by Subject|2|||
156650815|NCT01829295|565467188|FG002|6-12 Months|Withdrawal by Subject|0|||
156650816|NCT01829295|565467189|FG003|6-12 Months|Withdrawal by Subject|0|||
156650817|NCT02123459|565467190|FG000|Washout Period (1 Day)|Adverse Event|1|||
156650818|NCT02123459|565467191|FG001|Washout Period (1 Day)|Adverse Event|0|||
156650819|NCT02196506|565467196|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
156650820|NCT02196506|565467197|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
156650821|NCT02196506|565467198|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
156650822|NCT02196506|565467199|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
156650823|NCT02196506|565467196|FG000|Phase A|Withdrawal by Subject|34|||
156650824|NCT02196506|565467197|FG001|Phase A|Withdrawal by Subject|0|||
156650825|NCT02196506|565467198|FG002|Phase A|Withdrawal by Subject|0|||
156650826|NCT02196506|565467199|FG003|Phase A|Withdrawal by Subject|0|||
156650827|NCT02196506|565467196|FG000|Phase A|Adverse Event|22|||
156650828|NCT02196506|565467197|FG001|Phase A|Adverse Event|0|||
156650829|NCT02196506|565467198|FG002|Phase A|Adverse Event|0|||
156650830|NCT02196506|565467199|FG003|Phase A|Adverse Event|0|||
156650831|NCT02196506|565467196|FG000|Phase A|Lost to Follow-up|9|||
156650832|NCT02196506|565467197|FG001|Phase A|Lost to Follow-up|0|||
156650833|NCT02196506|565467198|FG002|Phase A|Lost to Follow-up|0|||
156650834|NCT02196506|565467199|FG003|Phase A|Lost to Follow-up|0|||
156650835|NCT02196506|565467196|FG000|Phase A|Protocol deviation|12|||
156650836|NCT02196506|565467197|FG001|Phase A|Protocol deviation|0|||
156650837|NCT02196506|565467198|FG002|Phase A|Protocol deviation|0|||
156650838|NCT02196506|565467199|FG003|Phase A|Protocol deviation|0|||
156650839|NCT02196506|565467196|FG000|Phase A|Participant withdrawn by investigator|10|||
156650840|NCT02196506|565467197|FG001|Phase A|Participant withdrawn by investigator|0|||
156650841|NCT02196506|565467198|FG002|Phase A|Participant withdrawn by investigator|0|||
156650842|NCT02196506|565467199|FG003|Phase A|Participant withdrawn by investigator|0|||
156650843|NCT02196506|565467196|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
156650844|NCT02196506|565467197|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
156650845|NCT02196506|565467198|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
156650846|NCT02196506|565467199|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
156650847|NCT02196506|565467196|FG000|Phase B|Lack of Efficacy|0|||
156650848|NCT02196506|565467197|FG001|Phase B|Lack of Efficacy|1|||
156650849|NCT02196506|565467198|FG002|Phase B|Lack of Efficacy|2|||
156650850|NCT02196506|565467199|FG003|Phase B|Lack of Efficacy|0|||
156650851|NCT02196506|565467196|FG000|Phase B|Withdrawal by Participant|0|||
156650852|NCT02196506|565467197|FG001|Phase B|Withdrawal by Participant|8|||
156650853|NCT02196506|565467198|FG002|Phase B|Withdrawal by Participant|1|||
156650854|NCT02196506|565467199|FG003|Phase B|Withdrawal by Participant|0|||
156650855|NCT02196506|565467196|FG000|Phase B|Adverse Event|0|||
156650856|NCT02196506|565467197|FG001|Phase B|Adverse Event|4|||
156650857|NCT02196506|565467198|FG002|Phase B|Adverse Event|1|||
156650858|NCT02196506|565467199|FG003|Phase B|Adverse Event|0|||
156650859|NCT02196506|565467196|FG000|Phase B|Lost to Follow-up|0|||
156650860|NCT02196506|565467197|FG001|Phase B|Lost to Follow-up|2|||
156650861|NCT02196506|565467198|FG002|Phase B|Lost to Follow-up|1|||
156650862|NCT02196506|565467199|FG003|Phase B|Lost to Follow-up|0|||
156650863|NCT02196506|565467196|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
156650864|NCT02196506|565467197|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
156754860|NCT00705341|565855064|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
156754861|NCT00705341|565855061|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
156754862|NCT00705341|565855062|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
156754863|NCT00705341|565855063|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
156650865|NCT02196506|565467198|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
156650866|NCT02196506|565467199|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
156650867|NCT02196506|565467196|FG000|Phase A+|Withdrawal by Participant|0|||
156754864|NCT00705341|565855064|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
156313395|NCT04493892|564246321|FG000|Overall Study|Withdrawal by Subject|15|||
156313396|NCT02267317|564246324|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
156650868|NCT02196506|565467197|FG001|Phase A+|Withdrawal by Participant|0|||
156650869|NCT02196506|565467198|FG002|Phase A+|Withdrawal by Participant|0|||
156650870|NCT02196506|565467199|FG003|Phase A+|Withdrawal by Participant|5|||
156650871|NCT02196506|565467196|FG000|Phase A+|Adverse Event|0|||
156650872|NCT02196506|565467197|FG001|Phase A+|Adverse Event|0|||
156650873|NCT02196506|565467198|FG002|Phase A+|Adverse Event|0|||
156650874|NCT02196506|565467199|FG003|Phase A+|Adverse Event|1|||
156650875|NCT02196506|565467196|FG000|Phase A+|Lost to Follow-up|0|||
156650876|NCT02196506|565467197|FG001|Phase A+|Lost to Follow-up|0|||
156650877|NCT02196506|565467198|FG002|Phase A+|Lost to Follow-up|0|||
156650878|NCT02196506|565467199|FG003|Phase A+|Lost to Follow-up|6|||
156650879|NCT02196506|565467196|FG000|Phase A+|Participant withdrawn by investigator|0|||
156650880|NCT02196506|565467197|FG001|Phase A+|Participant withdrawn by investigator|0|||
156650881|NCT02196506|565467198|FG002|Phase A+|Participant withdrawn by investigator|0|||
156650882|NCT02196506|565467199|FG003|Phase A+|Participant withdrawn by investigator|1|||
156650883|NCT00254397|565467200|FG000|Overall Study|Disease Progression|4|||
156650884|NCT00254397|565467201|FG001|Overall Study|Disease Progression|1|||
156650885|NCT00254397|565467202|FG002|Overall Study|Disease Progression|16|||
156650886|NCT00254397|565467203|FG003|Overall Study|Disease Progression|23|||
156650887|NCT00254397|565467200|FG000|Overall Study|Non-Compliant|0|||
156650888|NCT00254397|565467201|FG001|Overall Study|Non-Compliant|0|||
156650889|NCT00254397|565467202|FG002|Overall Study|Non-Compliant|0|||
156650890|NCT00254397|565467203|FG003|Overall Study|Non-Compliant|1|||
156650891|NCT00254397|565467200|FG000|Overall Study|Adverse Event|2|||
156650892|NCT00254397|565467201|FG001|Overall Study|Adverse Event|0|||
156650893|NCT00254397|565467202|FG002|Overall Study|Adverse Event|3|||
156650894|NCT00254397|565467203|FG003|Overall Study|Adverse Event|1|||
156650895|NCT05028751|565467204|FG000|Overall Study|Study Terminated by Sponsor|3|||
156650896|NCT05028751|565467205|FG001|Overall Study|Study Terminated by Sponsor|0|||
156650897|NCT05028751|565467206|FG002|Overall Study|Study Terminated by Sponsor|0|||
156650898|NCT05028751|565467207|FG003|Overall Study|Study Terminated by Sponsor|0|||
156650899|NCT05028751|565467204|FG000|Overall Study|Death|9|||
156650900|NCT05028751|565467205|FG001|Overall Study|Death|3|||
156650901|NCT05028751|565467206|FG002|Overall Study|Death|2|||
156650902|NCT05028751|565467207|FG003|Overall Study|Death|4|||
156650903|NCT05028751|565467204|FG000|Overall Study|Withdrawal by Subject|0|||
156650904|NCT05028751|565467205|FG001|Overall Study|Withdrawal by Subject|0|||
156650905|NCT05028751|565467206|FG002|Overall Study|Withdrawal by Subject|1|||
156650906|NCT05028751|565467207|FG003|Overall Study|Withdrawal by Subject|0|||
156650907|NCT05028751|565467204|FG000|Overall Study|Miscellaneous|2|||
156650908|NCT05028751|565467205|FG001|Overall Study|Miscellaneous|0|||
156650909|NCT05028751|565467206|FG002|Overall Study|Miscellaneous|0|||
156650910|NCT05028751|565467207|FG003|Overall Study|Miscellaneous|0|||
156650911|NCT00395083|565467208|FG000|Overall Study|Withdrawal by Subject|6|||
156650912|NCT00395083|565467209|FG001|Overall Study|Withdrawal by Subject|5|||
156650913|NCT00395083|565467208|FG000|Overall Study|Developed another disease|4|||
156650914|NCT00395083|565467209|FG001|Overall Study|Developed another disease|3|||
156650915|NCT00658320|565469209|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
156650916|NCT00658320|565469210|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
156650917|NCT00658320|565469209|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
156650918|NCT00658320|565469210|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
156650919|NCT00658320|565469209|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
156650920|NCT00658320|565469210|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
156650921|NCT00658320|565469209|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
156650922|NCT00658320|565469210|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
156650923|NCT03433001|565469224|FG000|Overall Study|Lack of Efficacy|109|||
156650924|NCT03433001|565469224|FG000|Overall Study|Adverse Event|69|||
156650925|NCT03433001|565469224|FG000|Overall Study|Withdrawal by Subject|10|||
156650926|NCT03433001|565469224|FG000|Overall Study|Death|12|||
156650927|NCT03433001|565469224|FG000|Overall Study|Lost to Follow-up|4|||
156650928|NCT03433001|565469224|FG000|Overall Study|Other|25|||
156650929|NCT01299038|565469228|FG000|Overall Study|Withdrawal by Subject|1|||
156650930|NCT01299038|565469229|FG001|Overall Study|Withdrawal by Subject|0|||
156650931|NCT00322556|565469234|FG000|Overall Study|Adverse Event|1|||
156650932|NCT00322556|565469234|FG000|Overall Study|Withdrawal by Subject|1|||
156650933|NCT00322556|565469234|FG000|Overall Study|Lost to Follow-up|3|||
156650934|NCT00322556|565469234|FG000|Overall Study|Other Reason|7|||
156650935|NCT02040428|565469235|FG000|Overall Study|Death|4|||
156650936|NCT02040428|565469236|FG001|Overall Study|Death|3|||
156650937|NCT02040428|565469235|FG000|Overall Study|Withdrawal by Subject|1|||
156650938|NCT02040428|565469236|FG001|Overall Study|Withdrawal by Subject|1|||
156650939|NCT01464827|565469237|FG000|Overall Study|Adverse Event|0|||
156650940|NCT01464827|565469238|FG001|Overall Study|Adverse Event|0|||
156650941|NCT01464827|565469239|FG002|Overall Study|Adverse Event|0|||
156650942|NCT01464827|565469240|FG003|Overall Study|Adverse Event|0|||
156754865|NCT03665077|565855067|FG000|Overall Study|Lost to Follow-up|2|||
156754866|NCT03665077|565855067|FG000|Overall Study|Physician Decision|2|||
156414442|NCT01890967|564610949|FG003|Overall Study|Withdrawal by Subject|3|||
156414443|NCT01890967|564610950|FG004|Overall Study|Withdrawal by Subject|3|||
156414444|NCT01890967|564610951|FG005|Overall Study|Withdrawal by Subject|1|||
156414445|NCT01383993|564610955|FG000|Overall Study|Adverse Event|1|||
156414446|NCT01383993|564610956|FG001|Overall Study|Adverse Event|1|||
156414447|NCT01383993|564610957|FG002|Overall Study|Adverse Event|0|||
156650943|NCT01464827|565469241|FG004|Overall Study|Adverse Event|0|||
156650944|NCT01464827|565469242|FG005|Overall Study|Adverse Event|0|||
156650945|NCT01464827|565469243|FG006|Overall Study|Adverse Event|0|||
156650946|NCT01464827|565469244|FG007|Overall Study|Adverse Event|0|||
156650947|NCT01464827|565469245|FG008|Overall Study|Adverse Event|0|||
156650948|NCT01464827|565469246|FG009|Overall Study|Adverse Event|0|||
156650949|NCT01464827|565469247|FG010|Overall Study|Adverse Event|0|||
156650950|NCT01464827|565469248|FG011|Overall Study|Adverse Event|0|||
156650951|NCT01464827|565469249|FG012|Overall Study|Adverse Event|1|||
156650952|NCT01464827|565469250|FG013|Overall Study|Adverse Event|0|||
156650953|NCT01464827|565469237|FG000|Overall Study|Withdrawal by Subject|1|||
156650954|NCT01464827|565469238|FG001|Overall Study|Withdrawal by Subject|0|||
156650955|NCT01464827|565469239|FG002|Overall Study|Withdrawal by Subject|0|||
156650956|NCT01464827|565469240|FG003|Overall Study|Withdrawal by Subject|0|||
156650957|NCT01464827|565469241|FG004|Overall Study|Withdrawal by Subject|1|||
156650958|NCT01464827|565469242|FG005|Overall Study|Withdrawal by Subject|0|||
156650959|NCT01464827|565469243|FG006|Overall Study|Withdrawal by Subject|0|||
156650960|NCT01464827|565469244|FG007|Overall Study|Withdrawal by Subject|1|||
156650961|NCT01464827|565469245|FG008|Overall Study|Withdrawal by Subject|0|||
156650962|NCT01464827|565469246|FG009|Overall Study|Withdrawal by Subject|0|||
156650963|NCT01464827|565469247|FG010|Overall Study|Withdrawal by Subject|0|||
156650964|NCT01464827|565469248|FG011|Overall Study|Withdrawal by Subject|0|||
156650965|NCT01464827|565469249|FG012|Overall Study|Withdrawal by Subject|0|||
156650966|NCT01464827|565469250|FG013|Overall Study|Withdrawal by Subject|0|||
156650967|NCT01464827|565469237|FG000|Overall Study|Lost to Follow-up|0|||
156650968|NCT01464827|565469238|FG001|Overall Study|Lost to Follow-up|2|||
156650969|NCT01464827|565469239|FG002|Overall Study|Lost to Follow-up|0|||
156650970|NCT01464827|565469240|FG003|Overall Study|Lost to Follow-up|2|||
156650971|NCT01464827|565469241|FG004|Overall Study|Lost to Follow-up|3|||
156650972|NCT01464827|565469242|FG005|Overall Study|Lost to Follow-up|1|||
156650973|NCT01464827|565469243|FG006|Overall Study|Lost to Follow-up|2|||
156650974|NCT01464827|565469244|FG007|Overall Study|Lost to Follow-up|2|||
156650975|NCT01464827|565469245|FG008|Overall Study|Lost to Follow-up|0|||
156650976|NCT01464827|565469246|FG009|Overall Study|Lost to Follow-up|0|||
156650977|NCT01464827|565469247|FG010|Overall Study|Lost to Follow-up|0|||
156650978|NCT01464827|565469248|FG011|Overall Study|Lost to Follow-up|1|||
156650979|NCT01464827|565469249|FG012|Overall Study|Lost to Follow-up|0|||
156650980|NCT01464827|565469250|FG013|Overall Study|Lost to Follow-up|1|||
156650981|NCT01464827|565469237|FG000|Overall Study|Other|2|||
156650982|NCT01464827|565469238|FG001|Overall Study|Other|3|||
156650983|NCT01464827|565469239|FG002|Overall Study|Other|0|||
156650984|NCT01464827|565469240|FG003|Overall Study|Other|2|||
156650985|NCT01464827|565469241|FG004|Overall Study|Other|3|||
156650986|NCT01464827|565469242|FG005|Overall Study|Other|0|||
156650987|NCT01464827|565469243|FG006|Overall Study|Other|1|||
156650988|NCT01464827|565469244|FG007|Overall Study|Other|0|||
156650989|NCT01464827|565469245|FG008|Overall Study|Other|3|||
156650990|NCT01464827|565469246|FG009|Overall Study|Other|1|||
156650991|NCT01464827|565469247|FG010|Overall Study|Other|2|||
156650992|NCT01464827|565469248|FG011|Overall Study|Other|0|||
156650993|NCT01464827|565469249|FG012|Overall Study|Other|1|||
156650994|NCT01464827|565469250|FG013|Overall Study|Other|0|||
156650995|NCT01464827|565469237|FG000|Overall Study|Not Treated|0|||
156650996|NCT01464827|565469238|FG001|Overall Study|Not Treated|2|||
156414448|NCT01383993|564610955|FG000|Overall Study|Withdrawal by Subject|0|||
156414449|NCT01383993|564610956|FG001|Overall Study|Withdrawal by Subject|0|||
156650997|NCT01464827|565469239|FG002|Overall Study|Not Treated|0|||
156650998|NCT01464827|565469240|FG003|Overall Study|Not Treated|0|||
156650999|NCT01464827|565469241|FG004|Overall Study|Not Treated|1|||
156651000|NCT01464827|565469242|FG005|Overall Study|Not Treated|0|||
156651001|NCT01464827|565469243|FG006|Overall Study|Not Treated|1|||
156651002|NCT01464827|565469244|FG007|Overall Study|Not Treated|0|||
156651003|NCT01464827|565469245|FG008|Overall Study|Not Treated|0|||
156651004|NCT01464827|565469246|FG009|Overall Study|Not Treated|2|||
156651005|NCT01464827|565469247|FG010|Overall Study|Not Treated|0|||
156651006|NCT01464827|565469248|FG011|Overall Study|Not Treated|1|||
156651007|NCT01464827|565469249|FG012|Overall Study|Not Treated|0|||
156651008|NCT01464827|565469250|FG013|Overall Study|Not Treated|2|||
156651009|NCT00613574|565469251|FG000|Overall Study|Adverse Event|3|||
156651010|NCT00613574|565469251|FG000|Overall Study|Lost to Follow-up|2|||
156651011|NCT00613574|565469251|FG000|Overall Study|Other|1|||
156651012|NCT04604184|565469253|FG000|Overall Study|Adverse Event|5|||
156651013|NCT04604184|565469254|FG001|Overall Study|Adverse Event|5|||
156651014|NCT04604184|565469253|FG000|Overall Study|Death|2|||
156651015|NCT04604184|565469254|FG001|Overall Study|Death|1|||
156651016|NCT04604184|565469253|FG000|Overall Study|Withdrawal by Subject|1|||
156651017|NCT04604184|565469254|FG001|Overall Study|Withdrawal by Subject|3|||
156651018|NCT04604184|565469253|FG000|Overall Study|Not treated|2|||
156651019|NCT04604184|565469254|FG001|Overall Study|Not treated|2|||
156651020|NCT04604184|565469253|FG000|Overall Study|Due to sponsor decision|9|||
156651021|NCT04604184|565469254|FG001|Overall Study|Due to sponsor decision|7|||
156651022|NCT04604184|565469253|FG000|Overall Study|Physician Decision|0|||
156651023|NCT04604184|565469254|FG001|Overall Study|Physician Decision|1|||
156651024|NCT04604184|565469253|FG000|Overall Study|Transfer to healthcare|1|||
156651025|NCT04604184|565469254|FG001|Overall Study|Transfer to healthcare|0|||
156651026|NCT00582036|565469255|FG000|Overall Study|Withdrawal by Subject|0|||
156651027|NCT00582036|565469256|FG001|Overall Study|Withdrawal by Subject|1|||
156651028|NCT01625377|565469257|FG000|Overall Study|Death|1|||
156651029|NCT01625377|565469258|FG001|Overall Study|Death|1|||
156651030|NCT01625377|565469257|FG000|Overall Study|Administrative Problem|1|||
156651031|NCT01625377|565469258|FG001|Overall Study|Administrative Problem|1|||
156651032|NCT01625377|565469257|FG000|Overall Study|Protocol Violation|0|||
156651033|NCT01625377|565469258|FG001|Overall Study|Protocol Violation|3|||
156651034|NCT01625377|565469257|FG000|Overall Study|Adverse Event|3|||
156651035|NCT01625377|565469258|FG001|Overall Study|Adverse Event|16|||
156651036|NCT01625377|565469257|FG000|Overall Study|Graft loss|1|||
156651037|NCT01625377|565469258|FG001|Overall Study|Graft loss|0|||
156651038|NCT01625377|565469257|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156651039|NCT01625377|565469258|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156651040|NCT01625377|565469257|FG000|Overall Study|Abnormal laboratory values|1|||
156651041|NCT01625377|565469258|FG001|Overall Study|Abnormal laboratory values|0|||
156651042|NCT01787825|565469261|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
156651043|NCT01787825|565469262|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
156651044|NCT01787825|565469261|FG000|Overall Study|Data Not Analyzable|5|||
156651045|NCT01787825|565469262|FG001|Overall Study|Data Not Analyzable|1|||
156651046|NCT01238848|565469264|FG000|Overall Study|Physician Decision|13|||
156651047|NCT01238848|565469265|FG001|Overall Study|Physician Decision|5|||
156651048|NCT00782509|565469266|FG000|Overall Study|Adverse Event|20|||
156651049|NCT00782509|565469267|FG001|Overall Study|Adverse Event|10|||
156651050|NCT00782509|565469268|FG002|Overall Study|Adverse Event|20|||
156651051|NCT00782509|565469266|FG000|Overall Study|Lost to Follow-up|1|||
156651052|NCT00782509|565469267|FG001|Overall Study|Lost to Follow-up|2|||
156651053|NCT00782509|565469268|FG002|Overall Study|Lost to Follow-up|3|||
156651054|NCT00782509|565469266|FG000|Overall Study|Withdrawal by Subject|3|||
156651055|NCT00782509|565469267|FG001|Overall Study|Withdrawal by Subject|5|||
156651056|NCT00782509|565469268|FG002|Overall Study|Withdrawal by Subject|8|||
156651057|NCT00782509|565469266|FG000|Overall Study|Non compliance with protocol|2|||
156651058|NCT00782509|565469267|FG001|Overall Study|Non compliance with protocol|0|||
156651059|NCT00782509|565469268|FG002|Overall Study|Non compliance with protocol|0|||
156651060|NCT00782509|565469266|FG000|Overall Study|Other reasons not stated above|5|||
156651061|NCT00782509|565469267|FG001|Overall Study|Other reasons not stated above|2|||
156651062|NCT00782509|565469268|FG002|Overall Study|Other reasons not stated above|3|||
156651063|NCT00782509|565469266|FG000|Overall Study|Lack of Efficacy|10|||
156651064|NCT00782509|565469267|FG001|Overall Study|Lack of Efficacy|5|||
156651065|NCT00782509|565469268|FG002|Overall Study|Lack of Efficacy|2|||
156651066|NCT03222141|565469269|FG000|Overall Study|Death|15|||
156651067|NCT03222141|565469269|FG000|Overall Study|Lost to Follow-up|3|||
156651068|NCT01418352|565469272|FG000|Overall Study|Lost to Follow-up|2|||
156651069|NCT01418352|565469273|FG001|Overall Study|Lost to Follow-up|0|||
156651070|NCT01418352|565469274|FG002|Overall Study|Lost to Follow-up|0|||
156651071|NCT01418352|565469275|FG003|Overall Study|Lost to Follow-up|0|||
156651072|NCT01418352|565469272|FG000|Overall Study|Adverse Event|0|||
156651073|NCT01418352|565469273|FG001|Overall Study|Adverse Event|1|||
156651074|NCT01418352|565469274|FG002|Overall Study|Adverse Event|0|||
156651075|NCT01418352|565469275|FG003|Overall Study|Adverse Event|0|||
156651076|NCT01418352|565469272|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
156651077|NCT01418352|565469273|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
156651078|NCT01418352|565469274|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
156651079|NCT01418352|565469275|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
156651080|NCT01418352|565469272|FG000|Overall Study|Subject Withdrew Consent|0|||
156651081|NCT01418352|565469273|FG001|Overall Study|Subject Withdrew Consent|1|||
156651082|NCT01418352|565469274|FG002|Overall Study|Subject Withdrew Consent|2|||
156651083|NCT01418352|565469275|FG003|Overall Study|Subject Withdrew Consent|1|||
156651084|NCT01418352|565469272|FG000|Overall Study|Protocol Deviation|0|||
156651085|NCT01418352|565469273|FG001|Overall Study|Protocol Deviation|0|||
156651086|NCT01418352|565469274|FG002|Overall Study|Protocol Deviation|1|||
156651087|NCT01418352|565469275|FG003|Overall Study|Protocol Deviation|0|||
156651088|NCT01418352|565469272|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
156651089|NCT01418352|565469273|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
156651090|NCT01418352|565469274|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
156651091|NCT01418352|565469275|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
156754867|NCT03173456|565855070|FG000|Baseline|Medication dispensing system malfunction'|0|||
156754868|NCT03173456|565855071|FG001|Baseline|Medication dispensing system malfunction'|1|||
156754869|NCT03173456|565855072|FG002|Baseline|Medication dispensing system malfunction'|0|||
156754870|NCT03173456|565855073|FG003|Baseline|Medication dispensing system malfunction'|0|||
156754871|NCT03173456|565855074|FG004|Baseline|Medication dispensing system malfunction'|2|||
156754872|NCT03173456|565855070|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
156754873|NCT03173456|565855071|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
156754874|NCT03173456|565855072|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
156754875|NCT03173456|565855073|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
156754876|NCT03173456|565855074|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
156754877|NCT00685360|565855075|FG000|Overall Study|Lost to Follow-up|0|||
156754878|NCT00685360|565855076|FG001|Overall Study|Lost to Follow-up|1|||
156754879|NCT00685360|565855077|FG002|Overall Study|Lost to Follow-up|2|||
156754880|NCT00685360|565855075|FG000|Overall Study|Adverse Event|4|||
156754881|NCT00685360|565855076|FG001|Overall Study|Adverse Event|6|||
156754882|NCT00685360|565855077|FG002|Overall Study|Adverse Event|4|||
156754883|NCT00685360|565855075|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
156754884|NCT00685360|565855076|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
156754885|NCT00685360|565855077|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
156754886|NCT00685360|565855075|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
156754887|NCT00685360|565855076|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
156754888|NCT00685360|565855077|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
156754889|NCT00685360|565855075|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
156754890|NCT00685360|565855076|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
156754891|NCT00685360|565855077|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
156754892|NCT00685360|565855075|FG000|Overall Study|Protocol Deviation|0|||
156754893|NCT00685360|565855076|FG001|Overall Study|Protocol Deviation|1|||
156754894|NCT00685360|565855077|FG002|Overall Study|Protocol Deviation|1|||
156754895|NCT04978337|565855078|FG000|Overall Study|Withdrawal by Subject|0|||
156754896|NCT04978337|565855079|FG001|Overall Study|Withdrawal by Subject|1|||
156754897|NCT01408901|565855080|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
156754898|NCT01408901|565855081|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
156754899|NCT01408901|565855082|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
156754900|NCT01408901|565855083|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
156754901|NCT01408901|565855080|FG000|6-Week Follow-Up|Death|1|||
156754902|NCT01408901|565855081|FG001|6-Week Follow-Up|Death|0|||
156754903|NCT01408901|565855082|FG002|6-Week Follow-Up|Death|0|||
156754904|NCT01408901|565855083|FG003|6-Week Follow-Up|Death|0|||
156754905|NCT01408901|565855080|FG000|6-Week Follow-Up|Cancelled visit|0|||
156754906|NCT01408901|565855081|FG001|6-Week Follow-Up|Cancelled visit|1|||
156754907|NCT01408901|565855082|FG002|6-Week Follow-Up|Cancelled visit|0|||
156754908|NCT01408901|565855083|FG003|6-Week Follow-Up|Cancelled visit|2|||
156754909|NCT01408901|565855080|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
156754910|NCT01408901|565855081|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
156754911|NCT01408901|565855082|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
156754912|NCT01408901|565855083|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
156754913|NCT01408901|565855080|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
156754914|NCT01408901|565855081|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
156754915|NCT01408901|565855082|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
156754916|NCT01408901|565855083|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
156754917|NCT01408901|565855080|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
156754918|NCT01408901|565855081|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
156754919|NCT01408901|565855082|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
156754920|NCT01408901|565855083|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
156754921|NCT01408901|565855080|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
156754922|NCT01408901|565855081|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
156754923|NCT01408901|565855082|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
156754924|NCT01408901|565855083|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
156754925|NCT01408901|565855080|FG000|26-Week Follow-Up|Death|0|||
156754926|NCT01408901|565855081|FG001|26-Week Follow-Up|Death|1|||
156754927|NCT01408901|565855082|FG002|26-Week Follow-Up|Death|0|||
156754928|NCT01408901|565855083|FG003|26-Week Follow-Up|Death|0|||
156754929|NCT01436227|565855086|FG000|Overall Study|Adverse Event|7|||
156754930|NCT01436227|565855086|FG000|Overall Study|Death|1|||
156754931|NCT01436227|565855086|FG000|Overall Study|Lack of Efficacy|1|||
156754932|NCT01436227|565855086|FG000|Overall Study|Lost to Follow-up|3|||
156754933|NCT01436227|565855086|FG000|Overall Study|Physician Decision|1|||
156754934|NCT01436227|565855086|FG000|Overall Study|Withdrawal by Subject|7|||
156754935|NCT01436227|565855086|FG000|Overall Study|Disease progression, relapse|6|||
156754936|NCT04865419|565855087|FG000|Overall Study|Other|1|||
156754937|NCT04865419|565855088|FG001|Overall Study|Other|2|||
156754938|NCT04865419|565855089|FG002|Overall Study|Other|2|||
156754939|NCT04865419|565855090|FG003|Overall Study|Other|1|||
156754940|NCT04865419|565855091|FG004|Overall Study|Other|3|||
156651092|NCT01814137|565469276|FG000|Overall Study|Adverse Event|0|||
156651093|NCT01814137|565469277|FG001|Overall Study|Adverse Event|1|||
156651094|NCT01814137|565469276|FG000|Overall Study|Withdrawal by Subject|2|||
156651095|NCT01814137|565469277|FG001|Overall Study|Withdrawal by Subject|2|||
156651096|NCT01814137|565469276|FG000|Overall Study|Physician Decision|1|||
156651097|NCT01814137|565469277|FG001|Overall Study|Physician Decision|1|||
156651098|NCT01814137|565469276|FG000|Overall Study|Unclassified|2|||
156651099|NCT01814137|565469277|FG001|Overall Study|Unclassified|1|||
156651100|NCT01507896|565469278|FG000|Overall Study|Withdrawal by Subject|1|||
156651101|NCT01507896|565469278|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
156651102|NCT00490061|565469279|FG000|Overall Study|Physician Decision|1|||
156651103|NCT00585351|565469286|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
156651104|NCT00585351|565469287|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
156651105|NCT00585351|565469288|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
156651106|NCT00585351|565469289|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
156651107|NCT00585351|565469290|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
156651108|NCT00585351|565469291|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
156651109|NCT00585351|565469292|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
156651110|NCT00585351|565469293|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
156651111|NCT00585351|565469286|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
156651112|NCT00585351|565469287|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
156651113|NCT00585351|565469288|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
156651114|NCT00585351|565469289|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
156651115|NCT00585351|565469290|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
156651116|NCT00585351|565469291|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
156651117|NCT00585351|565469292|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
156651118|NCT00585351|565469293|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
156651119|NCT00585351|565469286|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
156651120|NCT00585351|565469287|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
156651121|NCT00585351|565469288|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
156651122|NCT00585351|565469289|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
156651123|NCT00585351|565469290|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
156651124|NCT00585351|565469291|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
156651125|NCT00585351|565469292|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
156651126|NCT00585351|565469293|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
156651127|NCT00585351|565469286|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
156651128|NCT00585351|565469287|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
156651129|NCT00585351|565469288|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156651130|NCT00585351|565469289|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156651131|NCT00585351|565469290|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156651132|NCT00585351|565469291|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156651133|NCT00585351|565469292|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156651134|NCT00585351|565469293|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156651135|NCT00585351|565469286|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156651136|NCT00585351|565469287|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156651137|NCT00585351|565469288|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156651138|NCT00585351|565469289|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156651139|NCT00585351|565469290|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156651140|NCT00585351|565469291|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156651141|NCT00585351|565469292|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
156651142|NCT00585351|565469293|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
156651143|NCT00585351|565469286|FG000|Enrollment Period (Intervention)|Death|0|||
156651144|NCT00585351|565469287|FG001|Enrollment Period (Intervention)|Death|0|||
156651145|NCT00585351|565469288|FG002|Enrollment Period (Intervention)|Death|0|||
156651146|NCT00585351|565469289|FG003|Enrollment Period (Intervention)|Death|0|||
156651147|NCT00585351|565469290|FG004|Enrollment Period (Intervention)|Death|1|||
156651148|NCT00585351|565469291|FG005|Enrollment Period (Intervention)|Death|0|||
156651149|NCT00585351|565469292|FG006|Enrollment Period (Intervention)|Death|1|||
156651150|NCT00585351|565469293|FG007|Enrollment Period (Intervention)|Death|0|||
156651151|NCT00585351|565469286|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
156651152|NCT00585351|565469287|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
156651153|NCT00585351|565469288|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
156651154|NCT00585351|565469289|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
156651155|NCT00585351|565469290|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
156651156|NCT00585351|565469291|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
156651157|NCT00585351|565469292|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
156754941|NCT04865419|565855092|FG005|Overall Study|Other|0|||
156754942|NCT04865419|565855093|FG006|Overall Study|Other|0|||
156754943|NCT04865419|565855094|FG007|Overall Study|Other|1|||
156754944|NCT04865419|565855095|FG008|Overall Study|Other|0|||
156754945|NCT04865419|565855096|FG009|Overall Study|Other|0|||
156754946|NCT04865419|565855097|FG010|Overall Study|Other|0|||
156754947|NCT04865419|565855087|FG000|Overall Study|Withdrawal by Subject|0|||
156754948|NCT04865419|565855088|FG001|Overall Study|Withdrawal by Subject|1|||
156754949|NCT04865419|565855089|FG002|Overall Study|Withdrawal by Subject|1|||
156754950|NCT04865419|565855090|FG003|Overall Study|Withdrawal by Subject|0|||
156754951|NCT04865419|565855091|FG004|Overall Study|Withdrawal by Subject|0|||
156754952|NCT04865419|565855092|FG005|Overall Study|Withdrawal by Subject|0|||
156754953|NCT04865419|565855093|FG006|Overall Study|Withdrawal by Subject|0|||
156754954|NCT04865419|565855094|FG007|Overall Study|Withdrawal by Subject|1|||
156754955|NCT04865419|565855095|FG008|Overall Study|Withdrawal by Subject|2|||
156754956|NCT04865419|565855096|FG009|Overall Study|Withdrawal by Subject|1|||
156754957|NCT04865419|565855097|FG010|Overall Study|Withdrawal by Subject|0|||
156754958|NCT04865419|565855087|FG000|Overall Study|Study terminated by Sponsor|0|||
156754959|NCT04865419|565855088|FG001|Overall Study|Study terminated by Sponsor|0|||
156754960|NCT04865419|565855089|FG002|Overall Study|Study terminated by Sponsor|0|||
156754961|NCT04865419|565855090|FG003|Overall Study|Study terminated by Sponsor|2|||
156754962|NCT04865419|565855091|FG004|Overall Study|Study terminated by Sponsor|2|||
156754963|NCT04865419|565855092|FG005|Overall Study|Study terminated by Sponsor|0|||
156754964|NCT04865419|565855093|FG006|Overall Study|Study terminated by Sponsor|0|||
156754965|NCT04865419|565855094|FG007|Overall Study|Study terminated by Sponsor|0|||
156754966|NCT04865419|565855095|FG008|Overall Study|Study terminated by Sponsor|0|||
156754967|NCT04865419|565855096|FG009|Overall Study|Study terminated by Sponsor|0|||
156754968|NCT04865419|565855097|FG010|Overall Study|Study terminated by Sponsor|1|||
156754969|NCT04865419|565855087|FG000|Overall Study|Death|3|||
156754970|NCT04865419|565855088|FG001|Overall Study|Death|1|||
156754971|NCT04865419|565855089|FG002|Overall Study|Death|4|||
156754972|NCT04865419|565855090|FG003|Overall Study|Death|2|||
156754973|NCT04865419|565855091|FG004|Overall Study|Death|5|||
156754974|NCT04865419|565855092|FG005|Overall Study|Death|2|||
156754975|NCT04865419|565855093|FG006|Overall Study|Death|1|||
156754976|NCT04865419|565855094|FG007|Overall Study|Death|1|||
156754977|NCT04865419|565855095|FG008|Overall Study|Death|2|||
156754978|NCT04865419|565855096|FG009|Overall Study|Death|2|||
156754979|NCT04865419|565855097|FG010|Overall Study|Death|1|||
156754980|NCT04865419|565855087|FG000|Overall Study|Lost to Follow-up|0|||
156754981|NCT04865419|565855088|FG001|Overall Study|Lost to Follow-up|0|||
156754982|NCT04865419|565855089|FG002|Overall Study|Lost to Follow-up|0|||
156754983|NCT04865419|565855090|FG003|Overall Study|Lost to Follow-up|0|||
156754984|NCT04865419|565855091|FG004|Overall Study|Lost to Follow-up|0|||
156754985|NCT04865419|565855092|FG005|Overall Study|Lost to Follow-up|0|||
156754986|NCT04865419|565855093|FG006|Overall Study|Lost to Follow-up|0|||
156754987|NCT04865419|565855094|FG007|Overall Study|Lost to Follow-up|0|||
156754988|NCT04865419|565855095|FG008|Overall Study|Lost to Follow-up|0|||
156754989|NCT04865419|565855096|FG009|Overall Study|Lost to Follow-up|1|||
156754990|NCT04865419|565855097|FG010|Overall Study|Lost to Follow-up|0|||
156754991|NCT05446142|565855098|FG000|Period 2|Adverse Event|1|||
156754992|NCT05446142|565855099|FG001|Period 2|Adverse Event|0|||
156754993|NCT05446142|565855100|FG002|Period 2|Adverse Event|0|||
156754994|NCT05446142|565855101|FG003|Period 2|Adverse Event|0|||
156754995|NCT05446142|565855102|FG004|Period 2|Adverse Event|0|||
156754996|NCT05446142|565855103|FG005|Period 2|Adverse Event|0|||
156754997|NCT00547157|565855104|FG000|Overall Study|Other|1|||
156754998|NCT00547157|565855105|FG001|Overall Study|Other|0|||
156754999|NCT00547157|565855104|FG000|Overall Study|Death|38|||
156755000|NCT00547157|565855105|FG001|Overall Study|Death|18|||
156755001|NCT00547157|565855104|FG000|Overall Study|Withdrawal by Subject|3|||
156755002|NCT00547157|565855105|FG001|Overall Study|Withdrawal by Subject|1|||
156755003|NCT00547157|565855104|FG000|Overall Study|Administrative decision|3|||
156755004|NCT00547157|565855105|FG001|Overall Study|Administrative decision|2|||
156755005|NCT00547157|565855104|FG000|Overall Study|Lost to Follow-up|4|||
156755006|NCT00547157|565855105|FG001|Overall Study|Lost to Follow-up|2|||
156755007|NCT01151345|565855107|FG000|First Intervention Period|Protocol Violation|0|||
156755008|NCT01151345|565855108|FG001|First Intervention Period|Protocol Violation|1|||
156755009|NCT00423813|565855109|FG000|Overall Study|Adverse Event|11|||
156755010|NCT00423813|565855110|FG001|Overall Study|Adverse Event|30|||
156755011|NCT00423813|565855111|FG002|Overall Study|Adverse Event|40|||
156755012|NCT00423813|565855109|FG000|Overall Study|Withdrawal by Subject|6|||
156755013|NCT00423813|565855110|FG001|Overall Study|Withdrawal by Subject|8|||
156755014|NCT00423813|565855111|FG002|Overall Study|Withdrawal by Subject|5|||
156755015|NCT00423813|565855109|FG000|Overall Study|Lost to Follow-up|5|||
156755016|NCT00423813|565855110|FG001|Overall Study|Lost to Follow-up|4|||
156755017|NCT00423813|565855111|FG002|Overall Study|Lost to Follow-up|4|||
156755018|NCT00423813|565855109|FG000|Overall Study|Lack of Efficacy|23|||
156755019|NCT00423813|565855110|FG001|Overall Study|Lack of Efficacy|18|||
156755020|NCT00423813|565855111|FG002|Overall Study|Lack of Efficacy|19|||
156755021|NCT00423813|565855109|FG000|Overall Study|Physician Decision|2|||
156755022|NCT00423813|565855110|FG001|Overall Study|Physician Decision|0|||
156755023|NCT00423813|565855111|FG002|Overall Study|Physician Decision|0|||
156755024|NCT00423813|565855109|FG000|Overall Study|Sponsor Decision|0|||
156755025|NCT00423813|565855110|FG001|Overall Study|Sponsor Decision|1|||
156755026|NCT00423813|565855111|FG002|Overall Study|Sponsor Decision|0|||
156755027|NCT00423813|565855109|FG000|Overall Study|Protocol Violation|9|||
156755028|NCT00423813|565855110|FG001|Overall Study|Protocol Violation|4|||
156755029|NCT00423813|565855111|FG002|Overall Study|Protocol Violation|4|||
156755030|NCT00423813|565855109|FG000|Overall Study|Pregnancy|0|||
156755031|NCT00423813|565855110|FG001|Overall Study|Pregnancy|0|||
156755032|NCT00423813|565855111|FG002|Overall Study|Pregnancy|1|||
156755033|NCT00423813|565855109|FG000|Overall Study|Subject started night shift work|1|||
156755034|NCT00423813|565855110|FG001|Overall Study|Subject started night shift work|0|||
156755035|NCT00423813|565855111|FG002|Overall Study|Subject started night shift work|0|||
156755036|NCT00423813|565855109|FG000|Overall Study|Will start exclusionary medications|0|||
156755037|NCT00423813|565855110|FG001|Overall Study|Will start exclusionary medications|1|||
156755038|NCT00423813|565855111|FG002|Overall Study|Will start exclusionary medications|0|||
156755039|NCT00423813|565855109|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
156755040|NCT00423813|565855110|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
156755041|NCT00423813|565855111|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
156755042|NCT01904032|565855119|FG000|Overall Study|Adverse Event|3|||
156755043|NCT01904032|565855120|FG001|Overall Study|Adverse Event|1|||
156755044|NCT01904032|565855119|FG000|Overall Study|Lost to Follow-up|4|||
156755045|NCT01904032|565855120|FG001|Overall Study|Lost to Follow-up|2|||
156755046|NCT01658904|565855121|FG000|Overall Study|Principal Investigator discretion|2|||
156755047|NCT01658904|565855122|FG001|Overall Study|Principal Investigator discretion|0|||
156755048|NCT01658904|565855123|FG002|Overall Study|Principal Investigator discretion|0|||
156755049|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
156755050|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
156755051|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
156755052|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
156755053|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
156755054|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
156755055|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
156755056|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
156755057|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
156755058|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
156755059|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
156755060|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
156755061|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
156755062|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
156755063|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
156755064|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
156755065|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
156755066|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
156755067|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
156755068|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
156755069|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755070|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755071|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
156755072|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755073|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755074|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755075|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755076|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755077|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755078|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755079|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755080|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755081|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755082|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755083|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755084|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
156755085|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755086|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
156755087|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755088|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755089|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
156651158|NCT00585351|565469293|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
156651159|NCT01821625|565469302|FG000|Overall Study|Withdrawal by Subject|2|||
156651160|NCT01821625|565469302|FG000|Overall Study|Lack of Efficacy|2|||
156651161|NCT01821625|565469302|FG000|Overall Study|Adverse Event|1|||
156651162|NCT01821625|565469302|FG000|Overall Study|Medical contraindication|1|||
156651163|NCT00457665|565469307|FG000|12 Months|Drug allergy|1|||
156651164|NCT00457665|565469308|FG001|12 Months|Drug allergy|1|||
156651165|NCT00457665|565469307|FG000|12 Months|High HIV viral load|5|||
156651166|NCT00457665|565469308|FG001|12 Months|High HIV viral load|1|||
156651167|NCT00457665|565469307|FG000|12 Months|Lipodystrophy|2|||
156651168|NCT00457665|565469308|FG001|12 Months|Lipodystrophy|0|||
156651169|NCT00457665|565469307|FG000|12 Months|Withdrawal by Subject|0|||
156651170|NCT00457665|565469308|FG001|12 Months|Withdrawal by Subject|2|||
156651171|NCT00457665|565469307|FG000|12 Months|Abnormal Liver function tests|0|||
156651172|NCT00457665|565469308|FG001|12 Months|Abnormal Liver function tests|5|||
156651173|NCT00457665|565469307|FG000|24 Months|Withdrawal by Subject|3|||
156651174|NCT00457665|565469308|FG001|24 Months|Withdrawal by Subject|2|||
156651175|NCT00457665|565469307|FG000|24 Months|Lipodystrophy|1|||
156651176|NCT00457665|565469308|FG001|24 Months|Lipodystrophy|1|||
156651177|NCT00457665|565469307|FG000|24 Months|Abnormal liver function tests|1|||
156651178|NCT00457665|565469308|FG001|24 Months|Abnormal liver function tests|5|||
156651179|NCT00446654|565469310|FG000|Overall Study|Withdrawal by Subject|1|||
156651180|NCT00446654|565469311|FG001|Overall Study|Withdrawal by Subject|0|||
156651181|NCT00446654|565469310|FG000|Overall Study|Adverse Event|1|||
156651182|NCT00446654|565469311|FG001|Overall Study|Adverse Event|0|||
156651183|NCT02535000|565469312|FG000|Overall Study|Cancellation of surgery.|1|||
156651184|NCT02535000|565469313|FG001|Overall Study|Cancellation of surgery.|2|||
156651185|NCT01620489|565469317|FG000|Overall Study|Adverse Event|17|||
156651186|NCT01620489|565469318|FG001|Overall Study|Adverse Event|4|||
156651187|NCT01620489|565469317|FG000|Overall Study|Protocol Violation|0|||
156651188|NCT01620489|565469318|FG001|Overall Study|Protocol Violation|3|||
156651189|NCT01620489|565469317|FG000|Overall Study|Withdrawal Criteria|17|||
156651190|NCT01620489|565469318|FG001|Overall Study|Withdrawal Criteria|25|||
156651191|NCT01620489|565469317|FG000|Overall Study|Unclassified|1|||
156651192|NCT01620489|565469318|FG001|Overall Study|Unclassified|2|||
156651193|NCT00210626|565469319|FG000|Overall Study|Adverse Event|1|||
156651194|NCT00210626|565469320|FG001|Overall Study|Adverse Event|2|||
156651195|NCT00210626|565469319|FG000|Overall Study|Protocol Violation|1|||
156651196|NCT00210626|565469320|FG001|Overall Study|Protocol Violation|5|||
156651197|NCT00210626|565469319|FG000|Overall Study|Lost to Follow-up|11|||
156651198|NCT00210626|565469320|FG001|Overall Study|Lost to Follow-up|11|||
156651199|NCT00210626|565469319|FG000|Overall Study|Death|1|||
156651200|NCT00210626|565469320|FG001|Overall Study|Death|0|||
156651201|NCT00210626|565469319|FG000|Overall Study|Withdrawal by Subject|29|||
156651202|NCT00210626|565469320|FG001|Overall Study|Withdrawal by Subject|20|||
156651203|NCT00210626|565469319|FG000|Overall Study|Physician Decision|0|||
156651204|NCT00210626|565469320|FG001|Overall Study|Physician Decision|2|||
156651205|NCT00210626|565469319|FG000|Overall Study|Sponser Request|1|||
156651206|NCT00210626|565469320|FG001|Overall Study|Sponser Request|0|||
156651207|NCT00210626|565469319|FG000|Overall Study|Other|4|||
156651208|NCT00210626|565469320|FG001|Overall Study|Other|5|||
156651209|NCT01121900|565469321|FG000|First Intervention Period|Adverse Event|1|||
156651210|NCT01121900|565469322|FG001|First Intervention Period|Adverse Event|1|||
156651211|NCT01121900|565469321|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156651212|NCT01121900|565469322|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156651213|NCT03469271|565469323|FG000|Overall Study|Withdrawal by Subject|2|||
156651214|NCT03469271|565469324|FG001|Overall Study|Withdrawal by Subject|0|||
156651215|NCT03469271|565469325|FG002|Overall Study|Withdrawal by Subject|0|||
156651216|NCT03469271|565469326|FG003|Overall Study|Withdrawal by Subject|1|||
156651217|NCT01328054|565469329|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
156651218|NCT01328054|565469330|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
156651219|NCT01328054|565469329|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
156651220|NCT01328054|565469330|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
156651221|NCT01328054|565469329|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
156651222|NCT01328054|565469330|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
156651223|NCT03361956|565469331|FG000|Overall Study|Adverse Event|1|||
156651224|NCT03361956|565469332|FG001|Overall Study|Adverse Event|0|||
156651225|NCT03361956|565469333|FG002|Overall Study|Adverse Event|1|||
156651226|NCT03361956|565469334|FG003|Overall Study|Adverse Event|1|||
156651227|NCT03361956|565469335|FG004|Overall Study|Adverse Event|0|||
156651228|NCT03361956|565469331|FG000|Overall Study|Other|0|||
156651229|NCT03361956|565469332|FG001|Overall Study|Other|0|||
156651230|NCT03361956|565469333|FG002|Overall Study|Other|0|||
156651231|NCT03361956|565469334|FG003|Overall Study|Other|1|||
156651232|NCT03361956|565469335|FG004|Overall Study|Other|0|||
156651233|NCT03361956|565469331|FG000|Overall Study|Withdrawal by Subject|2|||
156651234|NCT03361956|565469332|FG001|Overall Study|Withdrawal by Subject|2|||
156651235|NCT03361956|565469333|FG002|Overall Study|Withdrawal by Subject|2|||
156755090|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
156755091|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
156755092|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755093|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
156755094|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
156755095|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755096|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755097|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755098|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755099|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755100|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
156755101|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
156755102|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
156755103|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755104|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
156755105|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755106|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755107|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755108|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755109|NCT04074330|565855133|FG000|Dose Expansion (up to 42 Months)|Death|0|||
156755110|NCT04074330|565855134|FG001|Dose Expansion (up to 42 Months)|Death|0|||
156755111|NCT04074330|565855135|FG002|Dose Expansion (up to 42 Months)|Death|0|||
156755112|NCT04074330|565855136|FG003|Dose Expansion (up to 42 Months)|Death|0|||
156755113|NCT04074330|565855137|FG004|Dose Expansion (up to 42 Months)|Death|0|||
156755114|NCT04074330|565855138|FG005|Dose Expansion (up to 42 Months)|Death|0|||
156755115|NCT04074330|565855139|FG006|Dose Expansion (up to 42 Months)|Death|0|||
156755116|NCT04074330|565855140|FG007|Dose Expansion (up to 42 Months)|Death|0|||
156755117|NCT04074330|565855141|FG008|Dose Expansion (up to 42 Months)|Death|1|||
156755118|NCT04074330|565855142|FG009|Dose Expansion (up to 42 Months)|Death|0|||
156755119|NCT04074330|565855133|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755120|NCT04074330|565855134|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755121|NCT04074330|565855135|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755122|NCT04074330|565855136|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755123|NCT04074330|565855137|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755124|NCT04074330|565855138|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755125|NCT04074330|565855139|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755126|NCT04074330|565855140|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755127|NCT04074330|565855141|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
156755128|NCT04074330|565855142|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
156755129|NCT03124537|565855146|FG000|Overall Study|Lost to Follow-up|3|||
156755130|NCT03124537|565855147|FG001|Overall Study|Lost to Follow-up|5|||
156755131|NCT03124537|565855146|FG000|Overall Study|App Crash, Incomplete Data|7|||
156755132|NCT03124537|565855147|FG001|Overall Study|App Crash, Incomplete Data|8|||
156755133|NCT02903420|565855152|FG000|Overall Study|Death|3|||
156755134|NCT02787083|565855153|FG000|Overall Study|Adverse Event|1|||
156755135|NCT02787083|565855154|FG001|Overall Study|Adverse Event|0|||
156755136|NCT02787083|565855153|FG000|Overall Study|Withdrawal by Subject|2|||
156755137|NCT02787083|565855154|FG001|Overall Study|Withdrawal by Subject|2|||
156755138|NCT03162328|565855155|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
156313397|NCT02267317|564246325|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156313398|NCT02267317|564246326|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156313399|NCT02267317|564246327|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156313400|NCT02267317|564246328|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156651236|NCT03361956|565469334|FG003|Overall Study|Withdrawal by Subject|0|||
156651237|NCT03361956|565469335|FG004|Overall Study|Withdrawal by Subject|3|||
156651238|NCT03361956|565469331|FG000|Overall Study|Disease Relapse|0|||
156651239|NCT03361956|565469332|FG001|Overall Study|Disease Relapse|0|||
156651240|NCT03361956|565469333|FG002|Overall Study|Disease Relapse|1|||
156651241|NCT03361956|565469334|FG003|Overall Study|Disease Relapse|0|||
156651242|NCT03361956|565469335|FG004|Overall Study|Disease Relapse|0|||
156651243|NCT03361956|565469331|FG000|Overall Study|Physician Decision|0|||
156651244|NCT03361956|565469332|FG001|Overall Study|Physician Decision|2|||
156651245|NCT03361956|565469333|FG002|Overall Study|Physician Decision|0|||
156651246|NCT03361956|565469334|FG003|Overall Study|Physician Decision|1|||
156651247|NCT03361956|565469335|FG004|Overall Study|Physician Decision|0|||
156651248|NCT03361956|565469331|FG000|Overall Study|Lost to Follow-up|0|||
156651249|NCT03361956|565469332|FG001|Overall Study|Lost to Follow-up|0|||
156651250|NCT03361956|565469333|FG002|Overall Study|Lost to Follow-up|1|||
156651251|NCT03361956|565469334|FG003|Overall Study|Lost to Follow-up|1|||
156651252|NCT03361956|565469335|FG004|Overall Study|Lost to Follow-up|2|||
156755139|NCT03162328|565855156|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
156755140|NCT03162328|565855157|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
156755141|NCT03162328|565855155|FG000|Screening Period|Withdrawal by Subject|1|||
156755142|NCT03162328|565855156|FG001|Screening Period|Withdrawal by Subject|0|||
156755143|NCT03162328|565855157|FG002|Screening Period|Withdrawal by Subject|0|||
156755144|NCT03162328|565855155|FG000|Study Period|Withdrawal by Subject|0|||
156755145|NCT03162328|565855156|FG001|Study Period|Withdrawal by Subject|0|||
156755146|NCT03162328|565855157|FG002|Study Period|Withdrawal by Subject|1|||
156755147|NCT03373461|565855160|FG000|Part 2|Adverse Event|0|||
156755148|NCT03373461|565855161|FG001|Part 2|Adverse Event|1|||
156755149|NCT03373461|565855162|FG002|Part 2|Adverse Event|0|||
156755150|NCT03373461|565855163|FG003|Part 2|Adverse Event|0|||
156755151|NCT03373461|565855164|FG004|Part 2|Adverse Event|1|||
156755152|NCT01243177|565855166|FG000|Overall Study|Lack of Efficacy|47|||
156755153|NCT01243177|565855167|FG001|Overall Study|Lack of Efficacy|31|||
156755154|NCT01243177|565855166|FG000|Overall Study|Protocol Violation|11|||
156755155|NCT01243177|565855167|FG001|Overall Study|Protocol Violation|10|||
156755156|NCT01243177|565855166|FG000|Overall Study|Lost to Follow-up|15|||
156755157|NCT01243177|565855167|FG001|Overall Study|Lost to Follow-up|18|||
156755158|NCT01243177|565855166|FG000|Overall Study|Withdrawal by Subject|46|||
156755159|NCT01243177|565855167|FG001|Overall Study|Withdrawal by Subject|38|||
156755160|NCT01243177|565855166|FG000|Overall Study|AE, serious fatal|0|||
156755161|NCT01243177|565855167|FG001|Overall Study|AE, serious fatal|1|||
156755162|NCT01243177|565855166|FG000|Overall Study|SAE, non-fatal|7|||
156755163|NCT01243177|565855167|FG001|Overall Study|SAE, non-fatal|9|||
156755164|NCT01243177|565855166|FG000|Overall Study|AE, non-serious non-fatal|40|||
156755165|NCT01243177|565855167|FG001|Overall Study|AE, non-serious non-fatal|58|||
156755166|NCT01243177|565855166|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
156755167|NCT01243177|565855167|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
156755168|NCT01243177|565855166|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156755169|NCT01243177|565855167|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
156755170|NCT01243177|565855166|FG000|Overall Study|Other Reason|11|||
156755171|NCT01243177|565855167|FG001|Overall Study|Other Reason|12|||
156755172|NCT03335813|565856924|FG000|Overall Study|Withdrawal by Subject|1|||
156755173|NCT02861664|565856925|FG000|Overall Study|Withdrawal of Consent|0|||
156755174|NCT02861664|565856926|FG001|Overall Study|Withdrawal of Consent|1|||
156755175|NCT00905632|565856927|FG000|Overall Study|Adverse Event|0|||
156755176|NCT00905632|565856928|FG001|Overall Study|Adverse Event|0|||
156755177|NCT00905632|565856929|FG002|Overall Study|Adverse Event|0|||
156755178|NCT00905632|565856930|FG003|Overall Study|Adverse Event|0|||
156755179|NCT00905632|565856931|FG004|Overall Study|Adverse Event|0|||
156755180|NCT00905632|565856932|FG005|Overall Study|Adverse Event|1|||
156755181|NCT00905632|565856933|FG006|Overall Study|Adverse Event|4|||
156755182|NCT02964338|565856936|FG000|Overall Study|Sponsor terminated study for futility|12|||
156755183|NCT02964338|565856937|FG001|Overall Study|Sponsor terminated study for futility|15|||
156755184|NCT02964338|565856938|FG002|Overall Study|Sponsor terminated study for futility|14|||
156755185|NCT02964338|565856936|FG000|Overall Study|Lack of Efficacy|0|||
156755186|NCT02964338|565856937|FG001|Overall Study|Lack of Efficacy|3|||
156755187|NCT02964338|565856938|FG002|Overall Study|Lack of Efficacy|0|||
156755188|NCT02964338|565856936|FG000|Overall Study|Lost to Follow-up|1|||
156755189|NCT02964338|565856937|FG001|Overall Study|Lost to Follow-up|0|||
156755190|NCT02964338|565856938|FG002|Overall Study|Lost to Follow-up|3|||
156755191|NCT02964338|565856936|FG000|Overall Study|Protocol Violation|0|||
156755192|NCT02964338|565856937|FG001|Overall Study|Protocol Violation|1|||
156755193|NCT02964338|565856938|FG002|Overall Study|Protocol Violation|0|||
156755194|NCT02964338|565856936|FG000|Overall Study|Withdrawal by Subject|1|||
156755195|NCT02964338|565856937|FG001|Overall Study|Withdrawal by Subject|3|||
156755196|NCT02964338|565856938|FG002|Overall Study|Withdrawal by Subject|1|||
156755197|NCT02964338|565856936|FG000|Overall Study|Adverse Event|2|||
156755198|NCT02964338|565856937|FG001|Overall Study|Adverse Event|1|||
156755199|NCT02964338|565856938|FG002|Overall Study|Adverse Event|1|||
156755200|NCT02964338|565856936|FG000|Overall Study|Non-compliant with e-diary|0|||
156755201|NCT02964338|565856937|FG001|Overall Study|Non-compliant with e-diary|1|||
156755202|NCT02964338|565856938|FG002|Overall Study|Non-compliant with e-diary|0|||
156755203|NCT02964338|565856936|FG000|Overall Study|Did not meet criteria|1|||
156755204|NCT02964338|565856937|FG001|Overall Study|Did not meet criteria|0|||
156755205|NCT02964338|565856938|FG002|Overall Study|Did not meet criteria|0|||
156755206|NCT02239640|565856939|FG000|Overall Study|Withdrawal by Subject|3|||
156755207|NCT02239640|565856939|FG000|Overall Study|Lost to Follow-up|72|||
156313401|NCT02267317|564246329|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156755208|NCT02239640|565856939|FG000|Overall Study|Death|142|||
156755209|NCT02171429|565856945|FG000|Overall Study|Other|0|||
156755210|NCT02171429|565856946|FG001|Overall Study|Other|1|||
156755211|NCT02171429|565856947|FG002|Overall Study|Other|1|||
156755212|NCT02171429|565856945|FG000|Overall Study|Non-Compliance|0|||
156755213|NCT02171429|565856946|FG001|Overall Study|Non-Compliance|0|||
156755214|NCT02171429|565856947|FG002|Overall Study|Non-Compliance|1|||
156755215|NCT02171429|565856945|FG000|Overall Study|Physician Decision|0|||
156755216|NCT02171429|565856946|FG001|Overall Study|Physician Decision|0|||
156755217|NCT02171429|565856947|FG002|Overall Study|Physician Decision|1|||
156755218|NCT02171429|565856945|FG000|Overall Study|Withdrawal by Subject|1|||
156755219|NCT02171429|565856946|FG001|Overall Study|Withdrawal by Subject|1|||
156755220|NCT02171429|565856947|FG002|Overall Study|Withdrawal by Subject|1|||
156755221|NCT02171429|565856945|FG000|Overall Study|Lost to Follow-up|0|||
156755222|NCT02171429|565856946|FG001|Overall Study|Lost to Follow-up|1|||
156755223|NCT02171429|565856947|FG002|Overall Study|Lost to Follow-up|0|||
156755224|NCT02171429|565856945|FG000|Overall Study|Death|0|||
156755225|NCT02171429|565856946|FG001|Overall Study|Death|0|||
156755226|NCT02171429|565856947|FG002|Overall Study|Death|1|||
156755227|NCT01724177|565856948|FG000|Overall Study|Adverse Event|8|||
156755228|NCT01724177|565856948|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
156755229|NCT01724177|565856948|FG000|Overall Study|Nervous participant|1|||
156755230|NCT01724177|565856948|FG000|Overall Study|Serious Adverse Event Related|1|||
156755231|NCT00327340|565856953|FG000|Overall Study|Withdrawal by Subject|1|||
156755232|NCT00327340|565856954|FG001|Overall Study|Withdrawal by Subject|5|||
156755233|NCT00327340|565856953|FG000|Overall Study|Physician Decision|1|||
156755234|NCT00327340|565856954|FG001|Overall Study|Physician Decision|1|||
156755235|NCT00327340|565856953|FG000|Overall Study|Disease Progression|10|||
156755236|NCT00327340|565856954|FG001|Overall Study|Disease Progression|19|||
156755237|NCT00327340|565856953|FG000|Overall Study|Symptomatic Disease|0|||
156755238|NCT00327340|565856954|FG001|Overall Study|Symptomatic Disease|2|||
156755239|NCT00327340|565856953|FG000|Overall Study|Adverse Event|3|||
156755240|NCT00327340|565856954|FG001|Overall Study|Adverse Event|3|||
156755241|NCT00206427|565856958|FG000|Overall Study|Adverse Event|2|||
156755242|NCT04085601|565856959|FG000|Overall Study|Lost to Follow-up|1|||
156755243|NCT04085601|565856960|FG001|Overall Study|Lost to Follow-up|0|||
156755244|NCT04085601|565856959|FG000|Overall Study|Death|1|||
156755245|NCT04085601|565856960|FG001|Overall Study|Death|1|||
156755246|NCT03872843|565856961|FG000|Overall Study|Lost to Follow-up|5|||
156755247|NCT03872843|565856962|FG001|Overall Study|Lost to Follow-up|7|||
156755248|NCT00281697|565856963|FG000|Overall Study|> 60 days since last dose of study drug|4|||
156755249|NCT00281697|565856964|FG001|Overall Study|> 60 days since last dose of study drug|4|||
156755250|NCT00281697|565856963|FG000|Overall Study|Adverse Event|54|||
156755251|NCT00281697|565856964|FG001|Overall Study|Adverse Event|15|||
156755252|NCT00281697|565856963|FG000|Overall Study|Death|8|||
156755253|NCT00281697|565856964|FG001|Overall Study|Death|3|||
156755254|NCT00281697|565856963|FG000|Overall Study|Disease progression|279|||
156755255|NCT00281697|565856964|FG001|Overall Study|Disease progression|149|||
156755256|NCT00281697|565856963|FG000|Overall Study|Other|5|||
156755257|NCT00281697|565856964|FG001|Overall Study|Other|6|||
156755258|NCT00281697|565856963|FG000|Overall Study|Physician's decision to withdraw|15|||
156755259|NCT00281697|565856964|FG001|Overall Study|Physician's decision to withdraw|12|||
156755260|NCT00281697|565856963|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
156755261|NCT00281697|565856964|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
156755262|NCT00281697|565856963|FG000|Overall Study|Did not receive study drug|3|||
156755263|NCT00281697|565856964|FG001|Overall Study|Did not receive study drug|2|||
156755264|NCT00572455|565856967|FG000|Stage I (14 Days)|Adverse Event|0|||
156755265|NCT00572455|565856968|FG001|Stage I (14 Days)|Adverse Event|0|||
156755266|NCT00572455|565856969|FG002|Stage I (14 Days)|Adverse Event|0|||
156755267|NCT00572455|565856970|FG003|Stage I (14 Days)|Adverse Event|0|||
156755268|NCT00572455|565856971|FG004|Stage I (14 Days)|Adverse Event|0|||
156755269|NCT00572455|565856972|FG005|Stage I (14 Days)|Adverse Event|3|||
156755270|NCT00572455|565856973|FG006|Stage I (14 Days)|Adverse Event|0|||
156755271|NCT00572455|565856974|FG007|Stage I (14 Days)|Adverse Event|0|||
156755272|NCT00572455|565856975|FG008|Stage I (14 Days)|Adverse Event|0|||
156755273|NCT00572455|565856976|FG009|Stage I (14 Days)|Adverse Event|0|||
156755274|NCT00572455|565856977|FG010|Stage I (14 Days)|Adverse Event|0|||
156755275|NCT00572455|565856978|FG011|Stage I (14 Days)|Adverse Event|0|||
156755276|NCT00572455|565856979|FG012|Stage I (14 Days)|Adverse Event|0|||
156755277|NCT00572455|565856980|FG013|Stage I (14 Days)|Adverse Event|0|||
156755278|NCT00572455|565856967|FG000|Stage I (14 Days)|Other|0|||
156755279|NCT00572455|565856968|FG001|Stage I (14 Days)|Other|0|||
156755280|NCT00572455|565856969|FG002|Stage I (14 Days)|Other|0|||
156755281|NCT00572455|565856970|FG003|Stage I (14 Days)|Other|0|||
156755282|NCT00572455|565856971|FG004|Stage I (14 Days)|Other|1|||
156755283|NCT00572455|565856972|FG005|Stage I (14 Days)|Other|0|||
156755284|NCT00572455|565856973|FG006|Stage I (14 Days)|Other|0|||
156755285|NCT00572455|565856974|FG007|Stage I (14 Days)|Other|0|||
156755286|NCT00572455|565856975|FG008|Stage I (14 Days)|Other|0|||
156755287|NCT00572455|565856976|FG009|Stage I (14 Days)|Other|0|||
156755288|NCT00572455|565856977|FG010|Stage I (14 Days)|Other|0|||
156755289|NCT00572455|565856978|FG011|Stage I (14 Days)|Other|0|||
156755290|NCT00572455|565856979|FG012|Stage I (14 Days)|Other|0|||
156755291|NCT00572455|565856980|FG013|Stage I (14 Days)|Other|0|||
156755292|NCT00572455|565856967|FG000|Stage II (28 Days)|Adverse Event|0|||
156755293|NCT00572455|565856968|FG001|Stage II (28 Days)|Adverse Event|0|||
156755294|NCT00572455|565856969|FG002|Stage II (28 Days)|Adverse Event|0|||
156755295|NCT00572455|565856970|FG003|Stage II (28 Days)|Adverse Event|0|||
156755296|NCT00572455|565856971|FG004|Stage II (28 Days)|Adverse Event|0|||
156651253|NCT03760510|565469336|FG000|Overall Study|Not ventilated for 24 hours|105|||
156651254|NCT03760510|565469337|FG001|Overall Study|Not ventilated for 24 hours|97|||
156651255|NCT00871728|565469339|FG000|Overall Study|Adverse Event|1|||
156651256|NCT00871728|565469339|FG000|Overall Study|Protocol Violation|7|||
156651257|NCT00871728|565469339|FG000|Overall Study|Lost to Follow-up|2|||
156651258|NCT00871728|565469339|FG000|Overall Study|Failed to Visit Hospital|4|||
156651259|NCT00871728|565469339|FG000|Overall Study|Participant Non-compliance|1|||
156651260|NCT00871728|565469339|FG000|Overall Study|Withdrawal of Informed Consent|5|||
156651261|NCT04147715|565469340|FG000|Overall Study|Adverse Event|0|||
156651262|NCT04147715|565469341|FG001|Overall Study|Adverse Event|0|||
156651263|NCT04147715|565469342|FG002|Overall Study|Adverse Event|0|||
156651264|NCT04147715|565469343|FG003|Overall Study|Adverse Event|0|||
156651265|NCT04147715|565469344|FG004|Overall Study|Adverse Event|0|||
156651266|NCT04147715|565469345|FG005|Overall Study|Adverse Event|0|||
156651267|NCT04147715|565469346|FG006|Overall Study|Adverse Event|0|||
156651268|NCT04147715|565469347|FG007|Overall Study|Adverse Event|2|||
156651269|NCT04147715|565469348|FG008|Overall Study|Adverse Event|1|||
156651270|NCT04147715|565469349|FG009|Overall Study|Adverse Event|0|||
156651271|NCT04147715|565469350|FG010|Overall Study|Adverse Event|0|||
156651272|NCT04147715|565469351|FG011|Overall Study|Adverse Event|0|||
156651273|NCT02418910|565469355|FG000|Overall Study|Lost to Follow-up|3|||
156651274|NCT02418910|565469355|FG000|Overall Study|Withdrawal by Subject|4|||
156651275|NCT02472977|565469359|FG000|Overall Study|Disease progression|4|||
156651276|NCT02472977|565469360|FG001|Overall Study|Disease progression|25|||
156651277|NCT02472977|565469361|FG002|Overall Study|Disease progression|6|||
156651278|NCT02472977|565469359|FG000|Overall Study|Withdrawal by Subject|0|||
156651279|NCT02472977|565469360|FG001|Overall Study|Withdrawal by Subject|1|||
156651280|NCT02472977|565469361|FG002|Overall Study|Withdrawal by Subject|0|||
156651281|NCT02472977|565469359|FG000|Overall Study|Study drug toxicity|2|||
156651282|NCT02472977|565469360|FG001|Overall Study|Study drug toxicity|0|||
156651283|NCT02472977|565469361|FG002|Overall Study|Study drug toxicity|2|||
156651284|NCT02472977|565469359|FG000|Overall Study|Subject request to discontinue treatment|0|||
156651285|NCT02472977|565469360|FG001|Overall Study|Subject request to discontinue treatment|1|||
156651286|NCT02472977|565469361|FG002|Overall Study|Subject request to discontinue treatment|0|||
156651287|NCT03775681|565469368|FG000|Overall Study|Physician Decision|3|||
156651288|NCT00616928|565469369|FG000|Overall Study|Adverse Event|6|||
156651289|NCT00616928|565469370|FG001|Overall Study|Adverse Event|3|||
156651290|NCT00616928|565469371|FG002|Overall Study|Adverse Event|2|||
156651291|NCT00616928|565469372|FG003|Overall Study|Adverse Event|2|||
156651292|NCT00616928|565469369|FG000|Overall Study|Other|51|||
156651293|NCT00616928|565469370|FG001|Overall Study|Other|8|||
156651294|NCT00616928|565469371|FG002|Overall Study|Other|15|||
156651295|NCT00616928|565469372|FG003|Overall Study|Other|5|||
156651296|NCT00616928|565469369|FG000|Overall Study|Lost to Follow-up|5|||
156651297|NCT00616928|565469370|FG001|Overall Study|Lost to Follow-up|7|||
156651298|NCT00616928|565469371|FG002|Overall Study|Lost to Follow-up|0|||
156651299|NCT00616928|565469372|FG003|Overall Study|Lost to Follow-up|0|||
156651300|NCT00895583|565469373|FG000|Overall Study|Adverse Event|28|||
156651301|NCT00895583|565469374|FG001|Overall Study|Adverse Event|4|||
156651302|NCT00895583|565469373|FG000|Overall Study|Death|2|||
156651303|NCT00895583|565469374|FG001|Overall Study|Death|1|||
156651304|NCT00895583|565469373|FG000|Overall Study|Physician Decision|3|||
156651305|NCT00895583|565469374|FG001|Overall Study|Physician Decision|1|||
156651306|NCT00895583|565469373|FG000|Overall Study|Lost to Follow-up|1|||
156651307|NCT00895583|565469374|FG001|Overall Study|Lost to Follow-up|3|||
156651308|NCT00895583|565469373|FG000|Overall Study|Protocol Violation|1|||
156651309|NCT00895583|565469374|FG001|Overall Study|Protocol Violation|0|||
156651310|NCT00895583|565469373|FG000|Overall Study|Withdrawal by Subject|4|||
156651311|NCT00895583|565469374|FG001|Overall Study|Withdrawal by Subject|2|||
156651312|NCT00895583|565469373|FG000|Overall Study|Lack of Efficacy|5|||
156651313|NCT00895583|565469374|FG001|Overall Study|Lack of Efficacy|0|||
156651314|NCT00895583|565469373|FG000|Overall Study|Other|0|||
156651315|NCT00895583|565469374|FG001|Overall Study|Other|1|||
156651316|NCT04535583|565469385|FG000|Overall Study|Lost to Follow-up|1|||
156651317|NCT04535583|565469385|FG000|Overall Study|Physician Decision|1|||
156651318|NCT04535583|565469385|FG000|Overall Study|Withdrawal by Subject|1|||
156651319|NCT01078090|565469386|FG000|Overall Study|Lost to Follow-up|2363|||
156651320|NCT01078090|565469386|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
156651321|NCT01078090|565469386|FG000|Overall Study|Lack of Efficacy|1193|||
156651322|NCT01078090|565469386|FG000|Overall Study|ADR and lack of efficacy|61|||
156651323|NCT01078090|565469386|FG000|Overall Study|Other|523|||
156651324|NCT01748890|565469388|FG000|Overall Study|Insufficient recruitment for analysis|4|||
156651325|NCT02669264|565469389|FG000|Overall Study|Death|5|||
156651326|NCT02669264|565469390|FG001|Overall Study|Death|5|||
156651327|NCT02669264|565469391|FG002|Overall Study|Death|3|||
156651328|NCT02669264|565469392|FG003|Overall Study|Death|3|||
156651329|NCT02669264|565469393|FG004|Overall Study|Death|3|||
156651330|NCT02669264|565469394|FG005|Overall Study|Death|6|||
156651331|NCT02669264|565469395|FG006|Overall Study|Death|3|||
156651332|NCT02669264|565469389|FG000|Overall Study|Withdrawal by Subject|0|||
156755297|NCT00572455|565856972|FG005|Stage II (28 Days)|Adverse Event|0|||
156755298|NCT00572455|565856973|FG006|Stage II (28 Days)|Adverse Event|0|||
156755299|NCT00572455|565856974|FG007|Stage II (28 Days)|Adverse Event|0|||
156755300|NCT00572455|565856975|FG008|Stage II (28 Days)|Adverse Event|1|||
156755301|NCT00572455|565856976|FG009|Stage II (28 Days)|Adverse Event|3|||
156755302|NCT00572455|565856977|FG010|Stage II (28 Days)|Adverse Event|3|||
156755303|NCT00572455|565856978|FG011|Stage II (28 Days)|Adverse Event|4|||
156755304|NCT00572455|565856979|FG012|Stage II (28 Days)|Adverse Event|5|||
156755305|NCT00572455|565856980|FG013|Stage II (28 Days)|Adverse Event|1|||
156755306|NCT00572455|565856967|FG000|Stage II (28 Days)|Death|0|||
156755307|NCT00572455|565856968|FG001|Stage II (28 Days)|Death|0|||
156755308|NCT00572455|565856969|FG002|Stage II (28 Days)|Death|0|||
156755309|NCT00572455|565856970|FG003|Stage II (28 Days)|Death|0|||
156755310|NCT00572455|565856971|FG004|Stage II (28 Days)|Death|0|||
156755311|NCT00572455|565856972|FG005|Stage II (28 Days)|Death|0|||
156755312|NCT00572455|565856973|FG006|Stage II (28 Days)|Death|0|||
156755313|NCT00572455|565856974|FG007|Stage II (28 Days)|Death|0|||
156755314|NCT00572455|565856975|FG008|Stage II (28 Days)|Death|1|||
156755315|NCT00572455|565856976|FG009|Stage II (28 Days)|Death|0|||
156755316|NCT00572455|565856977|FG010|Stage II (28 Days)|Death|0|||
156755317|NCT00572455|565856978|FG011|Stage II (28 Days)|Death|0|||
156755318|NCT00572455|565856979|FG012|Stage II (28 Days)|Death|0|||
156755319|NCT00572455|565856980|FG013|Stage II (28 Days)|Death|0|||
156755320|NCT00572455|565856967|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
156755321|NCT00572455|565856968|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
156755322|NCT00572455|565856969|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
156755323|NCT00572455|565856970|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
156755324|NCT00572455|565856971|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
156755325|NCT00572455|565856972|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
156755326|NCT00572455|565856973|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
156755327|NCT00572455|565856974|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
156755328|NCT00572455|565856975|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
156755329|NCT00572455|565856976|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
156755330|NCT00572455|565856977|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
156755331|NCT00572455|565856978|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
156755332|NCT00572455|565856979|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
156755333|NCT00572455|565856980|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
156755334|NCT00572455|565856967|FG000|Stage II (28 Days)|Other|0|||
156755335|NCT00572455|565856968|FG001|Stage II (28 Days)|Other|0|||
156755336|NCT00572455|565856969|FG002|Stage II (28 Days)|Other|0|||
156755337|NCT00572455|565856970|FG003|Stage II (28 Days)|Other|0|||
156755338|NCT00572455|565856971|FG004|Stage II (28 Days)|Other|0|||
156755339|NCT00572455|565856972|FG005|Stage II (28 Days)|Other|0|||
156755340|NCT00572455|565856973|FG006|Stage II (28 Days)|Other|0|||
156755341|NCT00572455|565856974|FG007|Stage II (28 Days)|Other|0|||
156755342|NCT00572455|565856975|FG008|Stage II (28 Days)|Other|1|||
156755343|NCT00572455|565856976|FG009|Stage II (28 Days)|Other|0|||
156755344|NCT00572455|565856977|FG010|Stage II (28 Days)|Other|0|||
156755345|NCT00572455|565856978|FG011|Stage II (28 Days)|Other|0|||
156755346|NCT00572455|565856979|FG012|Stage II (28 Days)|Other|0|||
156755347|NCT00572455|565856980|FG013|Stage II (28 Days)|Other|0|||
156755348|NCT00572455|565856967|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
156755349|NCT00572455|565856968|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
156755350|NCT00572455|565856969|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
156755351|NCT00572455|565856970|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
156755352|NCT00572455|565856971|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
156755353|NCT00572455|565856972|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
156414450|NCT01383993|564610957|FG002|Overall Study|Withdrawal by Subject|1|||
156414451|NCT01383993|564610955|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
156755354|NCT00572455|565856973|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
156755355|NCT00572455|565856974|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
156755356|NCT00572455|565856975|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
156755357|NCT00572455|565856976|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
156755358|NCT00572455|565856977|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
156755359|NCT00572455|565856978|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
156755360|NCT00572455|565856979|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
156755361|NCT00572455|565856980|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
156755362|NCT04152083|565856983|FG000|Overall Study|Lost to Follow-up|2|||
156755363|NCT04152083|565856984|FG001|Overall Study|Lost to Follow-up|1|||
156755364|NCT04152083|565856983|FG000|Overall Study|Adverse Event|1|||
156755365|NCT04152083|565856984|FG001|Overall Study|Adverse Event|0|||
156755366|NCT04152083|565856983|FG000|Overall Study|Randomized but not treated|3|||
156755367|NCT04152083|565856984|FG001|Overall Study|Randomized but not treated|2|||
156755368|NCT00856999|565856985|FG000|Overall Study|Withdrawal by Subject|5|||
156755369|NCT02465437|565856986|FG000|Overall Study|Physician Decision|0|||
156755370|NCT02465437|565856987|FG001|Overall Study|Physician Decision|0|||
156755371|NCT02465437|565856988|FG002|Overall Study|Physician Decision|1|||
156755372|NCT02465437|565856989|FG003|Overall Study|Physician Decision|0|||
156755373|NCT02465437|565856986|FG000|Overall Study|Withdrawal by Subject|1|||
156651333|NCT02669264|565469390|FG001|Overall Study|Withdrawal by Subject|1|||
156651334|NCT02669264|565469391|FG002|Overall Study|Withdrawal by Subject|0|||
156651335|NCT02669264|565469392|FG003|Overall Study|Withdrawal by Subject|0|||
156651336|NCT02669264|565469393|FG004|Overall Study|Withdrawal by Subject|1|||
156651337|NCT02669264|565469394|FG005|Overall Study|Withdrawal by Subject|0|||
156651338|NCT02669264|565469395|FG006|Overall Study|Withdrawal by Subject|0|||
156651339|NCT02669264|565469389|FG000|Overall Study|Lost to Follow-up|0|||
156651340|NCT02669264|565469390|FG001|Overall Study|Lost to Follow-up|0|||
156651341|NCT02669264|565469391|FG002|Overall Study|Lost to Follow-up|0|||
156651342|NCT02669264|565469392|FG003|Overall Study|Lost to Follow-up|0|||
156651343|NCT02669264|565469393|FG004|Overall Study|Lost to Follow-up|1|||
156651344|NCT02669264|565469394|FG005|Overall Study|Lost to Follow-up|0|||
156651345|NCT02669264|565469395|FG006|Overall Study|Lost to Follow-up|0|||
156651346|NCT02669264|565469389|FG000|Overall Study|Miscellaneous|0|||
156651347|NCT02669264|565469390|FG001|Overall Study|Miscellaneous|0|||
156651348|NCT02669264|565469391|FG002|Overall Study|Miscellaneous|0|||
156651349|NCT02669264|565469392|FG003|Overall Study|Miscellaneous|0|||
156651350|NCT02669264|565469393|FG004|Overall Study|Miscellaneous|0|||
156651351|NCT02669264|565469394|FG005|Overall Study|Miscellaneous|0|||
156651352|NCT02669264|565469395|FG006|Overall Study|Miscellaneous|2|||
156651353|NCT03529955|565469396|FG000|Overall Study|Adverse Event|1|||
156651354|NCT03529955|565469396|FG000|Overall Study|Lack of Efficacy|1|||
156651355|NCT03016078|565469400|FG000|Overall Study|Protocol Violation|1|||
156651356|NCT03016078|565469400|FG000|Overall Study|Protocol Violation|1|||
156651357|NCT03507439|565469401|FG000|Overall Study|Other|2|||
156651358|NCT03507439|565469402|FG001|Overall Study|Other|1|||
156651359|NCT03507439|565469401|FG000|Overall Study|Withdrawal by Subject|1|||
156651360|NCT03507439|565469402|FG001|Overall Study|Withdrawal by Subject|0|||
156651361|NCT03507439|565469401|FG000|Overall Study|Death|1|||
156651362|NCT03507439|565469402|FG001|Overall Study|Death|1|||
156651363|NCT03381248|565470882|FG000|0-6 Months|Withdrawal by Subject|4|||
156651364|NCT03381248|565470883|FG001|0-6 Months|Withdrawal by Subject|1|||
156651365|NCT03381248|565470882|FG000|0-6 Months|Lost to Follow-up|3|||
156651366|NCT03381248|565470883|FG001|0-6 Months|Lost to Follow-up|2|||
156651367|NCT03381248|565470882|FG000|0-6 Months|Lack of Efficacy|1|||
156651368|NCT03381248|565470883|FG001|0-6 Months|Lack of Efficacy|0|||
156651369|NCT03381248|565470882|FG000|0-6 Months|Adverse Event|1|||
156651370|NCT03381248|565470883|FG001|0-6 Months|Adverse Event|0|||
156651371|NCT03381248|565470882|FG000|0-6 Months|Protocol Violation|2|||
156651372|NCT03381248|565470883|FG001|0-6 Months|Protocol Violation|1|||
156651373|NCT03381248|565470882|FG000|0-6 Months|Physician Decision|1|||
156651374|NCT03381248|565470883|FG001|0-6 Months|Physician Decision|0|||
156651375|NCT03381248|565470882|FG000|0-6 Months|Planning another procedure|1|||
156651376|NCT03381248|565470883|FG001|0-6 Months|Planning another procedure|2|||
156651377|NCT03381248|565470882|FG000|6-12 Months|Withdrawal by Subject|1|||
156651378|NCT03381248|565470883|FG001|6-12 Months|Withdrawal by Subject|3|||
156651379|NCT03381248|565470882|FG000|6-12 Months|Lost to Follow-up|0|||
156651380|NCT03381248|565470883|FG001|6-12 Months|Lost to Follow-up|2|||
156651381|NCT03381248|565470882|FG000|6-12 Months|Protocol Violation|3|||
156651382|NCT03381248|565470883|FG001|6-12 Months|Protocol Violation|2|||
156651383|NCT03381248|565470882|FG000|6-12 Months|Planning another procedure|6|||
156651384|NCT03381248|565470883|FG001|6-12 Months|Planning another procedure|2|||
156651385|NCT03381248|565470882|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
156651386|NCT03381248|565470883|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
156651387|NCT03381248|565470882|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
156651388|NCT03381248|565470883|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
156651389|NCT03381248|565470882|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
156651390|NCT03381248|565470883|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
156651391|NCT05188521|565470884|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
156651392|NCT05188521|565470885|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
156651393|NCT01341639|565470886|FG000|Infant Series|Protocol Violation|1|||
156651394|NCT01341639|565470887|FG001|Infant Series|Protocol Violation|0|||
156651395|NCT01341639|565470886|FG000|Infant Series|Not Vaccinated|0|||
156651396|NCT01341639|565470887|FG001|Infant Series|Not Vaccinated|1|||
156651397|NCT01341639|565470886|FG000|Infant Series|Adverse Event|0|||
156651398|NCT01341639|565470887|FG001|Infant Series|Adverse Event|5|||
156651399|NCT01341639|565470886|FG000|Infant Series|Withdrawal by Subject|11|||
156651400|NCT01341639|565470887|FG001|Infant Series|Withdrawal by Subject|8|||
156651401|NCT01341639|565470886|FG000|Infant Series|Lost to Follow-up|0|||
156651402|NCT01341639|565470887|FG001|Infant Series|Lost to Follow-up|2|||
156651403|NCT01341639|565470886|FG000|Infant Series|Site 0048 Participants|17|||
156651404|NCT01341639|565470887|FG001|Infant Series|Site 0048 Participants|16|||
156651405|NCT01341639|565470886|FG000|Interim Period|Withdrawal by Subject|6|||
156651406|NCT01341639|565470887|FG001|Interim Period|Withdrawal by Subject|7|||
156651407|NCT01341639|565470886|FG000|Interim Period|Lost to Follow-up|2|||
156651408|NCT01341639|565470887|FG001|Interim Period|Lost to Follow-up|0|||
156651409|NCT01341639|565470886|FG000|Interim Period|Physician Decision|0|||
156651410|NCT01341639|565470887|FG001|Interim Period|Physician Decision|1|||
156651411|NCT01341639|565470886|FG000|Interim Period|Protocol Violation|0|||
156651412|NCT01341639|565470887|FG001|Interim Period|Protocol Violation|1|||
156651413|NCT01341639|565470886|FG000|Post-Treatment|Withdrawal by Subject|0|||
156651414|NCT01341639|565470887|FG001|Post-Treatment|Withdrawal by Subject|1|||
156651415|NCT01341639|565470886|FG000|Post-Treatment|Adverse Event|0|||
156651416|NCT01341639|565470887|FG001|Post-Treatment|Adverse Event|2|||
156651417|NCT02497391|565470893|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
156651418|NCT02497391|565470894|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
156651419|NCT02497391|565470895|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
156651420|NCT02497391|565470896|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
156651421|NCT02497391|565470897|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
156651422|NCT02497391|565470898|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
156651423|NCT02497391|565470893|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
156651424|NCT02497391|565470894|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
156651425|NCT02497391|565470895|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
156651426|NCT02497391|565470896|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
156651427|NCT02497391|565470897|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
156651428|NCT02497391|565470898|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
156651429|NCT02497391|565470893|FG000|Period 3 (14 Days)|Adverse Event|0|||
156651430|NCT02497391|565470894|FG001|Period 3 (14 Days)|Adverse Event|1|||
156651431|NCT02497391|565470895|FG002|Period 3 (14 Days)|Adverse Event|0|||
156651432|NCT02497391|565470896|FG003|Period 3 (14 Days)|Adverse Event|0|||
156651433|NCT02497391|565470897|FG004|Period 3 (14 Days)|Adverse Event|0|||
156651434|NCT02497391|565470898|FG005|Period 3 (14 Days)|Adverse Event|0|||
156651435|NCT02497391|565470893|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
156651436|NCT02497391|565470894|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
156651437|NCT02497391|565470895|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
156651438|NCT02497391|565470896|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
156651439|NCT02497391|565470897|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
156651440|NCT02497391|565470898|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
156651441|NCT02497391|565470893|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
156651442|NCT02497391|565470894|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
156651443|NCT02497391|565470895|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
156651444|NCT02497391|565470896|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
156651445|NCT02497391|565470897|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
156651446|NCT02497391|565470898|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
156651447|NCT01664052|565470899|FG000|Phase 1|No device placement|6|||
156651448|NCT01664052|565470900|FG001|Phase 1|No device placement|0|||
156651449|NCT01664052|565470899|FG000|Phase 1|No HSG 1 hr post placement|1|||
156651450|NCT01664052|565470900|FG001|Phase 1|No HSG 1 hr post placement|0|||
156651451|NCT01664052|565470899|FG000|Phase 2|No device placement|0|||
156651452|NCT01664052|565470900|FG001|Phase 2|No device placement|4|||
156651453|NCT05216978|565470911|FG000|Overall Study|Withdrawal by Subject|3|||
156651454|NCT05216978|565470911|FG000|Overall Study|Lost to Follow-up|5|||
156651455|NCT02410252|565470917|FG000|Overall Study|Withdrawal by Subject|4|||
156651456|NCT02410252|565470917|FG000|Overall Study|Physician Decision|2|||
156651457|NCT00832078|565470918|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
156651458|NCT00832078|565470919|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
156651459|NCT00832078|565470918|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
156651460|NCT00832078|565470919|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
156651461|NCT02961920|565470920|FG000|Overall Study|did not achive stydy protocol schedule|1|||
156651462|NCT02961920|565470921|FG001|Overall Study|did not achive stydy protocol schedule|1|||
156651463|NCT01452529|565470922|FG000|Run-in Period|Adverse Event|96|||
156651464|NCT01452529|565470923|FG001|Run-in Period|Adverse Event|0|||
156651465|NCT01452529|565470924|FG002|Run-in Period|Adverse Event|0|||
156651466|NCT01452529|565470922|FG000|Run-in Period|Withdrawal by Subject|49|||
156651467|NCT01452529|565470923|FG001|Run-in Period|Withdrawal by Subject|0|||
156651468|NCT01452529|565470924|FG002|Run-in Period|Withdrawal by Subject|0|||
156651469|NCT01452529|565470922|FG000|Run-in Period|Lost to Follow-up|19|||
156651470|NCT01452529|565470923|FG001|Run-in Period|Lost to Follow-up|0|||
156651471|NCT01452529|565470924|FG002|Run-in Period|Lost to Follow-up|0|||
156651472|NCT01452529|565470922|FG000|Run-in Period|Lack of Efficacy|46|||
156651473|NCT01452529|565470923|FG001|Run-in Period|Lack of Efficacy|0|||
156651474|NCT01452529|565470924|FG002|Run-in Period|Lack of Efficacy|0|||
156651475|NCT01452529|565470922|FG000|Run-in Period|Confirmed or suspected diversion|23|||
156651476|NCT01452529|565470923|FG001|Run-in Period|Confirmed or suspected diversion|0|||
156651477|NCT01452529|565470924|FG002|Run-in Period|Confirmed or suspected diversion|0|||
156651478|NCT01452529|565470922|FG000|Run-in Period|Administrative|21|||
156651479|NCT01452529|565470923|FG001|Run-in Period|Administrative|0|||
156651480|NCT01452529|565470924|FG002|Run-in Period|Administrative|0|||
156651481|NCT01452529|565470922|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
156651482|NCT01452529|565470923|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
156651483|NCT01452529|565470924|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
156651484|NCT01452529|565470922|FG000|Double-blind (DB) Period|Adverse Event|0|||
156651485|NCT01452529|565470923|FG001|Double-blind (DB) Period|Adverse Event|18|||
156651486|NCT01452529|565470924|FG002|Double-blind (DB) Period|Adverse Event|11|||
156651487|NCT01452529|565470922|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
156651488|NCT01452529|565470923|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
156651489|NCT01452529|565470924|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
156651490|NCT01452529|565470922|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
156651491|NCT01452529|565470923|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
156651492|NCT01452529|565470924|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
156651493|NCT01452529|565470922|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
156651494|NCT01452529|565470923|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
156651495|NCT01452529|565470924|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
156651496|NCT01452529|565470922|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
156651497|NCT01452529|565470923|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
156651498|NCT01452529|565470924|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
156651499|NCT01452529|565470922|FG000|Double-blind (DB) Period|Administrative|0|||
156651500|NCT01452529|565470923|FG001|Double-blind (DB) Period|Administrative|11|||
156651501|NCT01452529|565470924|FG002|Double-blind (DB) Period|Administrative|7|||
156651502|NCT03551730|565470925|FG000|Overall Study|Adverse Event|1|||
156651503|NCT03551730|565470926|FG001|Overall Study|Adverse Event|0|||
156651504|NCT03551730|565470927|FG002|Overall Study|Adverse Event|0|||
156651505|NCT03551730|565470928|FG003|Overall Study|Adverse Event|0|||
156651506|NCT04527471|565470931|FG000|Overall Study|Adverse Event|1|||
156651507|NCT04527471|565470932|FG001|Overall Study|Adverse Event|0|||
156651508|NCT04527471|565470931|FG000|Overall Study|Lost to Follow-up|1|||
156651509|NCT04527471|565470932|FG001|Overall Study|Lost to Follow-up|0|||
156651510|NCT01165996|565470938|FG000|Overall Study|Death|1|||
156651511|NCT01165996|565470938|FG000|Overall Study|Physician Decision|1|||
156651512|NCT00096265|565470939|FG000|Overall Study|Ineligible|1|||
156651513|NCT00096265|565470940|FG001|Overall Study|Ineligible|0|||
156651514|NCT00096265|565470941|FG002|Overall Study|Ineligible|0|||
156651515|NCT01506323|565470942|FG000|Overall Study|Lost to Follow-up|5|||
156651516|NCT01506323|565470943|FG001|Overall Study|Lost to Follow-up|4|||
156651517|NCT01506323|565470942|FG000|Overall Study|Withdrawal by Subject|4|||
156651518|NCT01506323|565470943|FG001|Overall Study|Withdrawal by Subject|4|||
156651519|NCT01506323|565470942|FG000|Overall Study|Lack of Efficacy|1|||
156651520|NCT01506323|565470943|FG001|Overall Study|Lack of Efficacy|3|||
156651521|NCT01506323|565470942|FG000|Overall Study|Moved out of area|5|||
156651522|NCT01506323|565470943|FG001|Overall Study|Moved out of area|2|||
156651523|NCT01506323|565470942|FG000|Overall Study|Schedule or Transportation conflict|8|||
156651524|NCT01506323|565470943|FG001|Overall Study|Schedule or Transportation conflict|0|||
156651525|NCT01506323|565470942|FG000|Overall Study|Started another treatment|1|||
156651526|NCT01506323|565470943|FG001|Overall Study|Started another treatment|0|||
156651527|NCT02232074|565470944|FG000|Overall Study|Withdrawal by Subject|5|||
156651528|NCT02232074|565470945|FG001|Overall Study|Withdrawal by Subject|3|||
156651529|NCT02232074|565470944|FG000|Overall Study|No legal concerns at baseline|36|||
156651530|NCT02232074|565470945|FG001|Overall Study|No legal concerns at baseline|41|||
156651531|NCT02232074|565470944|FG000|Overall Study|deemed ineligible|0|||
156651532|NCT02232074|565470945|FG001|Overall Study|deemed ineligible|1|||
156651533|NCT04081337|565470947|FG000|Overall Study|Adverse Event|0|||
156651534|NCT04081337|565470948|FG001|Overall Study|Adverse Event|1|||
156651535|NCT04081337|565470947|FG000|Overall Study|Withdrawal by Subject|2|||
156651536|NCT04081337|565470948|FG001|Overall Study|Withdrawal by Subject|0|||
156651537|NCT04081337|565470947|FG000|Overall Study|Physician Decision|1|||
156651538|NCT04081337|565470948|FG001|Overall Study|Physician Decision|2|||
156651539|NCT04081337|565470947|FG000|Overall Study|Lost to Follow-up|1|||
156651540|NCT04081337|565470948|FG001|Overall Study|Lost to Follow-up|0|||
156651541|NCT01579474|565470949|FG000|Overall Study|Adverse Event|1|||
156651542|NCT01579474|565470950|FG001|Overall Study|Adverse Event|13|||
156651543|NCT01579474|565470951|FG002|Overall Study|Adverse Event|2|||
156651544|NCT01579474|565470952|FG003|Overall Study|Adverse Event|0|||
156651545|NCT01579474|565470953|FG004|Overall Study|Adverse Event|0|||
156651546|NCT01579474|565470954|FG005|Overall Study|Adverse Event|1|||
156651547|NCT01579474|565470949|FG000|Overall Study|Lack of Efficacy|1|||
156651548|NCT01579474|565470950|FG001|Overall Study|Lack of Efficacy|0|||
156651549|NCT01579474|565470951|FG002|Overall Study|Lack of Efficacy|0|||
156651550|NCT01579474|565470952|FG003|Overall Study|Lack of Efficacy|0|||
156651551|NCT01579474|565470953|FG004|Overall Study|Lack of Efficacy|1|||
156651552|NCT01579474|565470954|FG005|Overall Study|Lack of Efficacy|0|||
156651553|NCT01579474|565470949|FG000|Overall Study|Withdrawal by Subject|1|||
156651554|NCT01579474|565470950|FG001|Overall Study|Withdrawal by Subject|0|||
156651555|NCT01579474|565470951|FG002|Overall Study|Withdrawal by Subject|0|||
156651556|NCT01579474|565470952|FG003|Overall Study|Withdrawal by Subject|0|||
156651557|NCT01579474|565470953|FG004|Overall Study|Withdrawal by Subject|0|||
156651558|NCT01579474|565470954|FG005|Overall Study|Withdrawal by Subject|0|||
156651559|NCT02295774|565470956|FG000|Overall Study|Physician Decision|1|||
156651560|NCT02295774|565470956|FG000|Overall Study|Withdrawal by Subject|2|||
156651561|NCT01075763|565470957|FG000|Overall Study|Lost to Follow-up|2|||
156651562|NCT01075763|565470958|FG001|Overall Study|Lost to Follow-up|1|||
156651563|NCT01075763|565470957|FG000|Overall Study|Lack of Efficacy|0|||
156651564|NCT01075763|565470958|FG001|Overall Study|Lack of Efficacy|1|||
156414452|NCT01383993|564610956|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
156414453|NCT01383993|564610957|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
156414454|NCT01154036|564610970|FG000|Phase I|Physician Decision|0|||
156651565|NCT01075763|565470957|FG000|Overall Study|Withdrawal by Subject|2|||
156651566|NCT01075763|565470958|FG001|Overall Study|Withdrawal by Subject|2|||
156651567|NCT00586521|565470959|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
156651568|NCT03083483|565470963|FG000|Overall Study|Adverse Event|1|||
156651569|NCT03083483|565470964|FG001|Overall Study|Adverse Event|1|||
156651570|NCT03083483|565470965|FG002|Overall Study|Adverse Event|1|||
156651571|NCT03083483|565470963|FG000|Overall Study|Lost to Follow-up|2|||
156651572|NCT03083483|565470964|FG001|Overall Study|Lost to Follow-up|1|||
156651573|NCT03083483|565470965|FG002|Overall Study|Lost to Follow-up|1|||
156651574|NCT03083483|565470963|FG000|Overall Study|technological issues|1|||
156651575|NCT03083483|565470964|FG001|Overall Study|technological issues|0|||
156651576|NCT03083483|565470965|FG002|Overall Study|technological issues|1|||
156651577|NCT02710071|565470966|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
156651578|NCT02710071|565470967|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
156651579|NCT02710071|565470966|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
156651580|NCT02710071|565470967|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
156651581|NCT00958256|565470975|FG000|Overall Study|Adverse Event|3|||
156651582|NCT00449072|565470976|FG000|Overall Study|Adverse Event|3|||
156651583|NCT00449072|565470977|FG001|Overall Study|Adverse Event|1|||
156651584|NCT00449072|565470976|FG000|Overall Study|Protocol Violation|14|||
156651585|NCT00449072|565470977|FG001|Overall Study|Protocol Violation|12|||
156651586|NCT00449072|565470976|FG000|Overall Study|Lost to Follow-up|5|||
156651587|NCT00449072|565470977|FG001|Overall Study|Lost to Follow-up|7|||
156651588|NCT00449072|565470976|FG000|Overall Study|Withdrawal by Subject|11|||
156651589|NCT00449072|565470977|FG001|Overall Study|Withdrawal by Subject|8|||
156651590|NCT00449072|565470976|FG000|Overall Study|Lack of Efficacy|1|||
156651591|NCT00449072|565470977|FG001|Overall Study|Lack of Efficacy|1|||
156651592|NCT00449072|565470976|FG000|Overall Study|Physician Decision|1|||
156651593|NCT00449072|565470977|FG001|Overall Study|Physician Decision|0|||
156651594|NCT00449072|565470976|FG000|Overall Study|Not treated|0|||
156651595|NCT00449072|565470977|FG001|Overall Study|Not treated|1|||
156651596|NCT00449072|565470976|FG000|Overall Study|Excluded medication|0|||
156651597|NCT00449072|565470977|FG001|Overall Study|Excluded medication|2|||
156651598|NCT00449072|565470976|FG000|Overall Study|Non-compliance|2|||
156651599|NCT00449072|565470977|FG001|Overall Study|Non-compliance|5|||
156651600|NCT00449072|565470976|FG000|Overall Study|Sponsor decision|1|||
156651601|NCT00449072|565470977|FG001|Overall Study|Sponsor decision|3|||
156651602|NCT00449072|565470976|FG000|Overall Study|Relocation|3|||
156651603|NCT00449072|565470977|FG001|Overall Study|Relocation|2|||
156651604|NCT02623959|565470978|FG000|Overall Study|Progression|0|||
156651605|NCT02623959|565470979|FG001|Overall Study|Progression|1|||
156651606|NCT00989261|565470980|FG000|Overall Study|Still in follow up|12|||
156651607|NCT00989261|565470981|FG001|Overall Study|Still in follow up|21|||
156651608|NCT00989261|565470980|FG000|Overall Study|Withdrawal by Subject|0|||
156651609|NCT00989261|565470981|FG001|Overall Study|Withdrawal by Subject|1|||
156651610|NCT00989261|565470980|FG000|Overall Study|Lost to Follow-up|3|||
156651611|NCT00989261|565470981|FG001|Overall Study|Lost to Follow-up|0|||
156651612|NCT02330081|565470993|FG000|Overall Study|Adverse Event|1|||
156651613|NCT02330081|565470993|FG000|Overall Study|Donation did not meet criteria|1|||
156651614|NCT02330081|565470993|FG000|Overall Study|Protocol Violation|6|||
156651615|NCT02277769|565470994|FG000|Overall Study|Protocol Violation|3|||
156651616|NCT02277769|565470995|FG001|Overall Study|Protocol Violation|3|||
156651617|NCT02277769|565470996|FG002|Overall Study|Protocol Violation|5|||
156651618|NCT02277769|565470994|FG000|Overall Study|Lack of Efficacy|17|||
156651619|NCT02277769|565470995|FG001|Overall Study|Lack of Efficacy|0|||
156651620|NCT02277769|565470996|FG002|Overall Study|Lack of Efficacy|4|||
156651621|NCT02277769|565470994|FG000|Overall Study|Adverse Event|14|||
156651622|NCT02277769|565470995|FG001|Overall Study|Adverse Event|2|||
156651623|NCT02277769|565470996|FG002|Overall Study|Adverse Event|4|||
156651624|NCT02277769|565470994|FG000|Overall Study|Other than specified above|12|||
156651625|NCT02277769|565470995|FG001|Overall Study|Other than specified above|8|||
156651626|NCT02277769|565470996|FG002|Overall Study|Other than specified above|5|||
156651627|NCT02668302|565470997|FG000|Overall Study|Withdrawal by Subject|1|||
156651628|NCT02668302|565470998|FG001|Overall Study|Withdrawal by Subject|0|||
156651629|NCT03558997|565470999|FG000|Overall Study|Adverse Event|0|||
156651630|NCT03558997|565471000|FG001|Overall Study|Adverse Event|2|||
156651631|NCT03558997|565471001|FG002|Overall Study|Adverse Event|5|||
156651632|NCT03558997|565471002|FG003|Overall Study|Adverse Event|1|||
156651633|NCT03558997|565470999|FG000|Overall Study|Physician Decision|0|||
156651634|NCT03558997|565471000|FG001|Overall Study|Physician Decision|0|||
156755374|NCT02465437|565856987|FG001|Overall Study|Withdrawal by Subject|0|||
156755375|NCT02465437|565856988|FG002|Overall Study|Withdrawal by Subject|0|||
156651635|NCT03558997|565471001|FG002|Overall Study|Physician Decision|1|||
156651636|NCT03558997|565471002|FG003|Overall Study|Physician Decision|0|||
156651637|NCT03558997|565470999|FG000|Overall Study|Withdrawal by Subject|1|||
156414455|NCT01154036|564610971|FG001|Phase I|Physician Decision|1|||
156651638|NCT03558997|565471000|FG001|Overall Study|Withdrawal by Subject|0|||
156651639|NCT03558997|565471001|FG002|Overall Study|Withdrawal by Subject|1|||
156651640|NCT03558997|565471002|FG003|Overall Study|Withdrawal by Subject|1|||
156651641|NCT03558997|565470999|FG000|Overall Study|Lost to Follow-up|0|||
156651642|NCT03558997|565471000|FG001|Overall Study|Lost to Follow-up|0|||
156651643|NCT03558997|565471001|FG002|Overall Study|Lost to Follow-up|1|||
156651644|NCT03558997|565471002|FG003|Overall Study|Lost to Follow-up|0|||
156651645|NCT01626885|565471003|FG000|Overall Study|Adverse Event|8|||
156651646|NCT01626885|565471003|FG000|Overall Study|Withdrawal by Subject|4|||
156651647|NCT03035227|565471007|FG000|Overall Study|study stopped due to PI leaving institut|1|||
156651648|NCT03035227|565471008|FG001|Overall Study|study stopped due to PI leaving institut|1|||
156651649|NCT02100956|565471009|FG000|At Least One Week Between Injections|Adverse Event|0|||
156651650|NCT02100956|565471010|FG001|At Least One Week Between Injections|Adverse Event|1|||
156651651|NCT02220907|565471011|FG000|Overall Study|Adverse Event|7|||
156651652|NCT02220907|565471011|FG000|Overall Study|Physician Decision|1|||
156651653|NCT02220907|565471011|FG000|Overall Study|Withdrawal by Subject|2|||
156651654|NCT02220907|565471011|FG000|Overall Study|Conflict with the stopping criteria|1|||
156651655|NCT04128696|565471012|FG000|Overall Study|Lost to Follow-up|3|||
156651656|NCT04128696|565471013|FG001|Overall Study|Lost to Follow-up|7|||
156651657|NCT04128696|565471012|FG000|Overall Study|Withdrawal by Subject|12|||
156651658|NCT04128696|565471013|FG001|Overall Study|Withdrawal by Subject|11|||
156651659|NCT04128696|565471012|FG000|Overall Study|Study Closed/Terminated|26|||
156651660|NCT04128696|565471013|FG001|Overall Study|Study Closed/Terminated|38|||
156651661|NCT04128696|565471012|FG000|Overall Study|Physician Decision|2|||
156651662|NCT04128696|565471013|FG001|Overall Study|Physician Decision|3|||
156651663|NCT01098240|565471014|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
156651664|NCT01098240|565471015|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
156651665|NCT01098240|565471016|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
156651666|NCT01098240|565471014|FG000|Open-Label Phase|Protocol Violation|4|||
156651667|NCT01098240|565471015|FG001|Open-Label Phase|Protocol Violation|0|||
156651668|NCT01098240|565471016|FG002|Open-Label Phase|Protocol Violation|0|||
156651669|NCT01098240|565471014|FG000|Open-Label Phase|Lost to Follow-up|13|||
156651670|NCT01098240|565471015|FG001|Open-Label Phase|Lost to Follow-up|0|||
156651671|NCT01098240|565471016|FG002|Open-Label Phase|Lost to Follow-up|0|||
156651672|NCT01098240|565471014|FG000|Open-Label Phase|Other|19|||
156651673|NCT01098240|565471015|FG001|Open-Label Phase|Other|0|||
156651674|NCT01098240|565471016|FG002|Open-Label Phase|Other|0|||
156651675|NCT01098240|565471014|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
156651676|NCT01098240|565471015|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
156651677|NCT01098240|565471016|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
156651678|NCT01098240|565471014|FG000|Open-Label Phase|Pregnancy|1|||
156651679|NCT01098240|565471015|FG001|Open-Label Phase|Pregnancy|0|||
156651680|NCT01098240|565471016|FG002|Open-Label Phase|Pregnancy|0|||
156651681|NCT01098240|565471014|FG000|Open-Label Phase|Withdrawal by Subject|9|||
156651682|NCT01098240|565471015|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156651683|NCT01098240|565471016|FG002|Open-Label Phase|Withdrawal by Subject|0|||
156651684|NCT01098240|565471014|FG000|Open-Label Phase|Adverse Event|12|||
156651685|NCT01098240|565471015|FG001|Open-Label Phase|Adverse Event|0|||
156651686|NCT01098240|565471016|FG002|Open-Label Phase|Adverse Event|0|||
156651687|NCT01098240|565471014|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
156651688|NCT01098240|565471015|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
156651689|NCT01098240|565471016|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
156651690|NCT01098240|565471014|FG000|Double-Blind Phase|Protocol Violation|0|||
156651691|NCT01098240|565471015|FG001|Double-Blind Phase|Protocol Violation|2|||
156651692|NCT01098240|565471016|FG002|Double-Blind Phase|Protocol Violation|4|||
156651693|NCT01098240|565471014|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156651694|NCT01098240|565471015|FG001|Double-Blind Phase|Lost to Follow-up|2|||
156651695|NCT01098240|565471016|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156651696|NCT01098240|565471014|FG000|Double-Blind Phase|Other|0|||
156651697|NCT01098240|565471015|FG001|Double-Blind Phase|Other|2|||
156651698|NCT01098240|565471016|FG002|Double-Blind Phase|Other|2|||
156651699|NCT01098240|565471014|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
156651700|NCT01098240|565471015|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
156651701|NCT01098240|565471016|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
156651702|NCT01098240|565471014|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
156651703|NCT01098240|565471015|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
156651704|NCT01098240|565471016|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
156651705|NCT01098240|565471014|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156651706|NCT01098240|565471015|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
156651707|NCT01098240|565471016|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
156651708|NCT01098240|565471014|FG000|Double-Blind Phase|Adverse Event|0|||
156651709|NCT01098240|565471015|FG001|Double-Blind Phase|Adverse Event|3|||
156651710|NCT01098240|565471016|FG002|Double-Blind Phase|Adverse Event|3|||
156651711|NCT03280537|565471017|FG000|Overall Study|Withdrawal by Subject|2|||
156651712|NCT03280537|565471018|FG001|Overall Study|Withdrawal by Subject|4|||
156651713|NCT01588106|565471019|FG000|Overall Study|Withdrawal by Subject|5|||
156651714|NCT01588106|565471020|FG001|Overall Study|Withdrawal by Subject|4|||
156651715|NCT03083132|565471021|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
156651716|NCT03083132|565471022|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
156651717|NCT03083132|565471021|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
156651718|NCT03083132|565471022|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
156651719|NCT03083132|565471021|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
156651720|NCT03083132|565471022|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
156651721|NCT02995837|565471023|FG000|Overall Study|Lost to Follow-up|9|||
156651722|NCT02995837|565471024|FG001|Overall Study|Lost to Follow-up|8|||
156651723|NCT03118739|565471025|FG000|Overall Study|Physician Decision|0|||
156651724|NCT03118739|565471026|FG001|Overall Study|Physician Decision|1|||
156651725|NCT03118739|565471025|FG000|Overall Study|Withdrawal by Subject|5|||
156651726|NCT03118739|565471026|FG001|Overall Study|Withdrawal by Subject|3|||
156651727|NCT03118739|565471025|FG000|Overall Study|Lost to Follow-up|2|||
156651728|NCT03118739|565471026|FG001|Overall Study|Lost to Follow-up|0|||
156651729|NCT01859702|565471027|FG000|Overall Study|Protocol deviation|3|||
156651730|NCT01859702|565471027|FG000|Overall Study|Adverse Event|2|||
156651731|NCT01893138|565471028|FG000|Double-Blind Period|Withdrawal by Subject|1|||
156651732|NCT01893138|565471029|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156651733|NCT01893138|565471028|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
156651734|NCT01893138|565471029|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
156651735|NCT01893138|565471028|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
156651736|NCT01893138|565471029|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
156651737|NCT01893138|565471028|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
156651738|NCT01893138|565471029|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
156651739|NCT01893138|565471028|FG000|Open Label - Unblinded Period|Adverse Event|1|||
156651740|NCT01893138|565471029|FG001|Open Label - Unblinded Period|Adverse Event|0|||
156651741|NCT03705351|565472615|FG000|Overall Study|Study termination|3|||
156651742|NCT03705351|565472615|FG000|Overall Study|Death|1|||
156651743|NCT03705351|565472615|FG000|Overall Study|Lack of Efficacy|2|||
156651744|NCT03705351|565472615|FG000|Overall Study|Withdrawal by Subject|1|||
156651745|NCT00633152|565472620|FG000|Overall Study|Adverse Event|1|||
156651746|NCT00633152|565472621|FG001|Overall Study|Adverse Event|0|||
156651747|NCT00633152|565472620|FG000|Overall Study|Randomized, did not receive study drug|5|||
156651748|NCT00633152|565472621|FG001|Overall Study|Randomized, did not receive study drug|2|||
156651749|NCT00633152|565472620|FG000|Overall Study|Withdrawal by Subject|1|||
156651750|NCT00633152|565472621|FG001|Overall Study|Withdrawal by Subject|1|||
156651751|NCT00633152|565472620|FG000|Overall Study|Lost to Follow-up|4|||
156651752|NCT00633152|565472621|FG001|Overall Study|Lost to Follow-up|1|||
156651753|NCT00633152|565472620|FG000|Overall Study|Miscellaneous Other|3|||
156651754|NCT00633152|565472621|FG001|Overall Study|Miscellaneous Other|2|||
156651755|NCT02180061|565472622|FG000|Overall Study|Adverse Event|4|||
156651756|NCT02180061|565472623|FG001|Overall Study|Adverse Event|2|||
156651757|NCT02180061|565472622|FG000|Overall Study|Clinical Progression|5|||
156651758|NCT02180061|565472623|FG001|Overall Study|Clinical Progression|1|||
156651759|NCT02180061|565472622|FG000|Overall Study|Progressive Disease|15|||
156651760|NCT02180061|565472623|FG001|Overall Study|Progressive Disease|5|||
156651761|NCT02180061|565472622|FG000|Overall Study|Physician Decision|1|||
156651762|NCT02180061|565472623|FG001|Overall Study|Physician Decision|0|||
156651763|NCT00056160|565472626|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
156651764|NCT00056160|565472627|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
156651765|NCT00056160|565472626|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
156651766|NCT00056160|565472627|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
156651767|NCT00056160|565472626|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
156651768|NCT00056160|565472627|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
156651769|NCT00056160|565472626|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
156651770|NCT00056160|565472627|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
156651771|NCT00056160|565472626|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
156651772|NCT00056160|565472627|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
156651773|NCT00056160|565472626|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
156651774|NCT00056160|565472627|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
156651775|NCT00056160|565472626|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
156651776|NCT00056160|565472627|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
156651777|NCT00056160|565472626|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
156651778|NCT00056160|565472627|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
156755376|NCT02465437|565856989|FG003|Overall Study|Withdrawal by Subject|1|||
156651779|NCT00056160|565472626|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
156651780|NCT00056160|565472627|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
156651781|NCT00056160|565472626|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
156755377|NCT02465437|565856986|FG000|Overall Study|Adverse Event|0|||
156414456|NCT01154036|564610972|FG002|Phase I|Physician Decision|0|||
156755378|NCT02465437|565856987|FG001|Overall Study|Adverse Event|1|||
156755379|NCT02465437|565856988|FG002|Overall Study|Adverse Event|0|||
156755380|NCT02465437|565856989|FG003|Overall Study|Adverse Event|0|||
156755381|NCT00003483|565856990|FG000|Overall Study|Not evaluable|1|||
156755382|NCT02609386|565856991|FG000|Overall Study|Withdrawal by Subject|6|||
156755383|NCT02609386|565856992|FG001|Overall Study|Withdrawal by Subject|1|||
156755384|NCT02609386|565856991|FG000|Overall Study|Lost to Follow-up|3|||
156755385|NCT02609386|565856992|FG001|Overall Study|Lost to Follow-up|5|||
156755386|NCT02609386|565856991|FG000|Overall Study|Death|19|||
156755387|NCT02609386|565856992|FG001|Overall Study|Death|9|||
156755388|NCT02609386|565856991|FG000|Overall Study|Physician Decision|0|||
156755389|NCT02609386|565856992|FG001|Overall Study|Physician Decision|2|||
156755390|NCT01308463|565856993|FG000|Overall Study|Study Discontinued|23|||
156755391|NCT01308463|565856993|FG000|Overall Study|Death|4|||
156755392|NCT01308463|565856993|FG000|Overall Study|Revision|2|||
156755393|NCT00103662|565856994|FG000|Overall Study|Entered Rescue Procedure|0|||
156755394|NCT00103662|565856995|FG001|Overall Study|Entered Rescue Procedure|7|||
156755395|NCT00103662|565856994|FG000|Overall Study|Death|7|||
156755396|NCT00103662|565856995|FG001|Overall Study|Death|7|||
156755397|NCT00103662|565856994|FG000|Overall Study|Elective Withdrawal|5|||
156755398|NCT00103662|565856995|FG001|Overall Study|Elective Withdrawal|5|||
156755399|NCT00103662|565856994|FG000|Overall Study|Lost to Follow-up|0|||
156755400|NCT00103662|565856995|FG001|Overall Study|Lost to Follow-up|1|||
156755401|NCT00103662|565856994|FG000|Overall Study|Other|6|||
156755402|NCT00103662|565856995|FG001|Overall Study|Other|9|||
156755403|NCT00103662|565856994|FG000|Overall Study|Failed mobilization|0|||
156755404|NCT00103662|565856995|FG001|Overall Study|Failed mobilization|4|||
156755405|NCT00103662|565856994|FG000|Overall Study|Intercurrent illness|1|||
156755406|NCT00103662|565856995|FG001|Overall Study|Intercurrent illness|0|||
156755407|NCT03280056|565856997|FG000|Overall Study|Withdrawal by Subject|12|||
156755408|NCT03280056|565856998|FG001|Overall Study|Withdrawal by Subject|14|||
156755409|NCT03280056|565856997|FG000|Overall Study|Death|9|||
156755410|NCT03280056|565856998|FG001|Overall Study|Death|2|||
156755411|NCT03280056|565856997|FG000|Overall Study|Adverse Event|1|||
156755412|NCT03280056|565856998|FG001|Overall Study|Adverse Event|3|||
156755413|NCT03280056|565856997|FG000|Overall Study|Lost to Follow-up|1|||
156755414|NCT03280056|565856998|FG001|Overall Study|Lost to Follow-up|1|||
156755415|NCT03280056|565856997|FG000|Overall Study|Physician Decision|0|||
156755416|NCT03280056|565856998|FG001|Overall Study|Physician Decision|1|||
156755417|NCT03280056|565856997|FG000|Overall Study|Early Discontinuation|1|||
156755418|NCT03280056|565856998|FG001|Overall Study|Early Discontinuation|0|||
156755419|NCT00610168|565856999|FG000|Overall Study|Withdrawal by Subject|2|||
156755420|NCT00610168|565857000|FG001|Overall Study|Withdrawal by Subject|0|||
156755421|NCT01135524|565857001|FG000|Overall Study|Withdrawal by Subject|14|||
156755422|NCT01135524|565857001|FG000|Overall Study|Adverse Event|20|||
156755423|NCT01135524|565857001|FG000|Overall Study|Lost to Follow-up|3|||
156755424|NCT01135524|565857001|FG000|Overall Study|Administrative|151|||
156313402|NCT02267317|564246324|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
156313403|NCT02267317|564246325|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156651782|NCT00056160|565472627|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
156651783|NCT00056160|565472626|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
156651784|NCT00056160|565472627|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
156651785|NCT00056160|565472626|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
156651786|NCT00056160|565472627|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
156651787|NCT00056160|565472626|FG000|Final Follow-up|Transferred into expanded access study.|3|||
156651788|NCT00056160|565472627|FG001|Final Follow-up|Transferred into expanded access study.|0|||
156651789|NCT00056160|565472626|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
156651790|NCT00056160|565472627|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
156651791|NCT00056160|565472626|FG000|Final Follow-up|Adverse Event|1|||
156651792|NCT00056160|565472627|FG001|Final Follow-up|Adverse Event|0|||
156651793|NCT01469364|565472628|FG000|Overall Study|Adverse Event|1|||
156651794|NCT01469364|565472628|FG000|Overall Study|Withdrawal by Subject|1|||
156651795|NCT01590433|565472632|FG000|Overall Study|Lost to Follow-up|20|||
156651796|NCT01590433|565472633|FG001|Overall Study|Lost to Follow-up|8|||
156651797|NCT01590433|565472632|FG000|Overall Study|Withdrawal by Subject|21|||
156651798|NCT01590433|565472633|FG001|Overall Study|Withdrawal by Subject|11|||
156651799|NCT01590433|565472632|FG000|Overall Study|Adverse Event|11|||
156651800|NCT01590433|565472633|FG001|Overall Study|Adverse Event|3|||
156651801|NCT00555009|565472634|FG000|Overall Study|Withdrawal by Subject|0|||
156651802|NCT00555009|565472635|FG001|Overall Study|Withdrawal by Subject|1|||
156755425|NCT01135524|565857001|FG000|Overall Study|Lack of Efficacy|8|||
156755426|NCT03318003|565857002|FG000|Overall Study|Withdrawal by Subject|1|||
156755427|NCT03318003|565857003|FG001|Overall Study|Withdrawal by Subject|1|||
156651803|NCT00555009|565472634|FG000|Overall Study|Terminated by Sponsor|2|||
156755428|NCT03318003|565857002|FG000|Overall Study|fetal loss|0|||
156755429|NCT03318003|565857003|FG001|Overall Study|fetal loss|1|||
156755430|NCT00411450|565857004|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
156755431|NCT00397189|565857005|FG000|3 Weeks Period|Lost to Follow-up|5|||
156755432|NCT00397189|565857006|FG001|3 Weeks Period|Lost to Follow-up|4|||
156755433|NCT00397189|565857005|FG000|3 Weeks Period|Adverse Event|3|||
156755434|NCT00397189|565857006|FG001|3 Weeks Period|Adverse Event|2|||
156755435|NCT00397189|565857005|FG000|3 Weeks Period|Withdrawal by Subject|13|||
156755436|NCT00397189|565857006|FG001|3 Weeks Period|Withdrawal by Subject|9|||
156755437|NCT00397189|565857005|FG000|3 Weeks Period|Physician Decision|0|||
156755438|NCT00397189|565857006|FG001|3 Weeks Period|Physician Decision|2|||
156755439|NCT00397189|565857005|FG000|3 Weeks Period|Protocol Violation|0|||
156755440|NCT00397189|565857006|FG001|3 Weeks Period|Protocol Violation|3|||
156755441|NCT00397189|565857005|FG000|3 Weeks Period|Other|0|||
156755442|NCT00397189|565857006|FG001|3 Weeks Period|Other|2|||
156755443|NCT01059773|565857007|FG000|Overall Study|Adverse Event|2|||
156755444|NCT01059773|565857008|FG001|Overall Study|Adverse Event|2|||
156651804|NCT00555009|565472635|FG001|Overall Study|Terminated by Sponsor|5|||
156651805|NCT03731182|565472644|FG000|Overall Study|Lost to Follow-up|2|||
156651806|NCT03731182|565472645|FG001|Overall Study|Lost to Follow-up|0|||
156651807|NCT03731182|565472644|FG000|Overall Study|Physician Decision|1|||
156651808|NCT03731182|565472645|FG001|Overall Study|Physician Decision|0|||
156651809|NCT03731182|565472644|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
156651810|NCT03731182|565472645|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
156651811|NCT01751412|565472646|FG000|Overall Study|Disease Progression Before Treatment|1|||
156651812|NCT03734237|565472649|FG000|Overall Study|Lost to Follow-up|1|||
156651813|NCT03734237|565472650|FG001|Overall Study|Lost to Follow-up|3|||
156651814|NCT03734237|565472651|FG002|Overall Study|Lost to Follow-up|0|||
156651815|NCT03734237|565472649|FG000|Overall Study|Withdrawal by Subject|7|||
156651816|NCT03734237|565472650|FG001|Overall Study|Withdrawal by Subject|9|||
156651817|NCT03734237|565472651|FG002|Overall Study|Withdrawal by Subject|10|||
156651818|NCT01844583|565472652|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
156651819|NCT01844583|565472653|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
156651820|NCT03036579|565472657|FG000|2 Years|Lost to Follow-up|1|||
156651821|NCT03036579|565472658|FG001|2 Years|Lost to Follow-up|0|||
156651822|NCT03036579|565472657|FG000|3 Years|Lost to Follow-up|0|||
156651823|NCT03036579|565472658|FG001|3 Years|Lost to Follow-up|1|||
156651824|NCT05431153|565472659|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156651825|NCT05431153|565472660|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156651826|NCT05431153|565472661|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156651827|NCT05431153|565472662|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156651828|NCT05431153|565472663|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
156651829|NCT05431153|565472664|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156651830|NCT04041570|565472667|FG000|Overall Study|Moved from Area|0|||
156651831|NCT04041570|565472668|FG001|Overall Study|Moved from Area|2|||
156651832|NCT01338636|565472669|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
156651833|NCT02385526|565472670|FG000|Overall Study|Withdrawal by Subject|0|||
156651834|NCT02385526|565472671|FG001|Overall Study|Withdrawal by Subject|2|||
156651835|NCT02385526|565472672|FG002|Overall Study|Withdrawal by Subject|0|||
156651836|NCT02385526|565472670|FG000|Overall Study|Lost to Follow-up|0|||
156651837|NCT02385526|565472671|FG001|Overall Study|Lost to Follow-up|1|||
156651838|NCT02385526|565472672|FG002|Overall Study|Lost to Follow-up|0|||
156651839|NCT02385526|565472670|FG000|Overall Study|Physician Decision|1|||
156651840|NCT02385526|565472671|FG001|Overall Study|Physician Decision|0|||
156651841|NCT02385526|565472672|FG002|Overall Study|Physician Decision|0|||
156651842|NCT02385526|565472670|FG000|Overall Study|Protocol Violation|1|||
156651843|NCT02385526|565472671|FG001|Overall Study|Protocol Violation|0|||
156651844|NCT02385526|565472672|FG002|Overall Study|Protocol Violation|0|||
156651845|NCT00441584|565472673|FG000|Overall Study|Lack of Efficacy|79|||
156651846|NCT00441584|565472673|FG000|Overall Study|Withdrawal by Subject|8|||
156651847|NCT00441584|565472673|FG000|Overall Study|Adverse Event|6|||
156651848|NCT00441584|565472673|FG000|Overall Study|Protocol Violation|5|||
156651849|NCT00441584|565472673|FG000|Overall Study|Lost to Follow-up|4|||
156651850|NCT00441584|565472673|FG000|Overall Study|Failure to meet eligibility criteria|3|||
156651851|NCT03532009|565472674|FG000|Overall Study|Other|1|||
156651852|NCT03532009|565472675|FG001|Overall Study|Other|1|||
156651853|NCT03532009|565472674|FG000|Overall Study|Death|1|||
156651854|NCT03532009|565472675|FG001|Overall Study|Death|1|||
156651855|NCT03532009|565472674|FG000|Overall Study|Withdrawal by Patient|0|||
156651856|NCT03532009|565472675|FG001|Overall Study|Withdrawal by Patient|2|||
156651857|NCT00368966|565472676|FG000|Infant Series|Withdrawal by Subject|11|||
156651858|NCT00368966|565472677|FG001|Infant Series|Withdrawal by Subject|6|||
156651859|NCT00368966|565472676|FG000|Infant Series|Protocol Violation|2|||
156651860|NCT00368966|565472677|FG001|Infant Series|Protocol Violation|1|||
156651861|NCT00368966|565472676|FG000|Infant Series|Lost to Follow-up|2|||
156651862|NCT00368966|565472677|FG001|Infant Series|Lost to Follow-up|0|||
156651863|NCT00368966|565472676|FG000|Infant Series|Randomization error|0|||
156755445|NCT01059773|565857007|FG000|Overall Study|Withdrawal by Subject|1|||
156651864|NCT00368966|565472677|FG001|Infant Series|Randomization error|1|||
156651865|NCT00368966|565472676|FG000|Infant Series|Failed to meet eligibility criteria|0|||
156651866|NCT00368966|565472677|FG001|Infant Series|Failed to meet eligibility criteria|1|||
156755446|NCT01059773|565857008|FG001|Overall Study|Withdrawal by Subject|5|||
156755447|NCT01059773|565857007|FG000|Overall Study|Lost to Follow-up|1|||
156755448|NCT01059773|565857008|FG001|Overall Study|Lost to Follow-up|1|||
156755449|NCT01059773|565857007|FG000|Overall Study|Pregnancy|1|||
156755450|NCT01059773|565857008|FG001|Overall Study|Pregnancy|1|||
156755451|NCT01059773|565857007|FG000|Overall Study|Protocol Violation|6|||
156755452|NCT01059773|565857008|FG001|Overall Study|Protocol Violation|2|||
156755453|NCT01059773|565857007|FG000|Overall Study|Physician Decision|5|||
156755454|NCT01059773|565857008|FG001|Overall Study|Physician Decision|4|||
156755455|NCT01059773|565857007|FG000|Overall Study|Lack of Efficacy|3|||
156755456|NCT01059773|565857008|FG001|Overall Study|Lack of Efficacy|3|||
156755457|NCT01059773|565857007|FG000|Overall Study|Death|0|||
156755458|NCT01059773|565857008|FG001|Overall Study|Death|1|||
156755459|NCT01059773|565857007|FG000|Overall Study|Malignancy including squamous cell skin|0|||
156755460|NCT01059773|565857008|FG001|Overall Study|Malignancy including squamous cell skin|1|||
156755461|NCT01059773|565857007|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
156755462|NCT01059773|565857008|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
156755463|NCT01059773|565857007|FG000|Overall Study|Other|1|||
156755464|NCT01059773|565857008|FG001|Overall Study|Other|3|||
156755465|NCT00141518|565857012|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
156755466|NCT00141518|565857013|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
156755467|NCT00141518|565857014|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
156755468|NCT00141518|565857012|FG000|Overall Study|Adverse Event|7|||
156755469|NCT00141518|565857013|FG001|Overall Study|Adverse Event|5|||
156755470|NCT00141518|565857014|FG002|Overall Study|Adverse Event|2|||
156755471|NCT00141518|565857012|FG000|Overall Study|Withdrawal by Subject|2|||
156755472|NCT00141518|565857013|FG001|Overall Study|Withdrawal by Subject|0|||
156755473|NCT00141518|565857014|FG002|Overall Study|Withdrawal by Subject|2|||
156755474|NCT00141518|565857012|FG000|Overall Study|Protocol Violation|1|||
156755475|NCT00141518|565857013|FG001|Overall Study|Protocol Violation|1|||
156755476|NCT00141518|565857014|FG002|Overall Study|Protocol Violation|2|||
156755477|NCT00141518|565857012|FG000|Overall Study|Lack of Efficacy|5|||
156755478|NCT00141518|565857013|FG001|Overall Study|Lack of Efficacy|0|||
156755479|NCT00141518|565857014|FG002|Overall Study|Lack of Efficacy|0|||
156755480|NCT01806168|565857015|FG000|Overall Study|Adverse Event|1|||
156755481|NCT01806168|565857016|FG001|Overall Study|Adverse Event|0|||
156755482|NCT01806168|565857017|FG002|Overall Study|Adverse Event|0|||
156755483|NCT01806168|565857015|FG000|Overall Study|Withdrawal by Subject|0|||
156755484|NCT01806168|565857016|FG001|Overall Study|Withdrawal by Subject|1|||
156755485|NCT01806168|565857017|FG002|Overall Study|Withdrawal by Subject|2|||
156755486|NCT01806168|565857015|FG000|Overall Study|Protocol Violation|0|||
156755487|NCT01806168|565857016|FG001|Overall Study|Protocol Violation|0|||
156755488|NCT01806168|565857017|FG002|Overall Study|Protocol Violation|1|||
156755489|NCT03904420|565857020|FG000|Overall Study|Study terminated|2|||
156755490|NCT03904420|565857021|FG001|Overall Study|Study terminated|2|||
156755491|NCT00614874|565857022|FG000|Overall Study|Protocol Violation|1|||
156755492|NCT00614874|565857022|FG000|Overall Study|Withdrawal by Subject|1|||
156755493|NCT01468454|565857023|FG000|Overall Study|Did not have surgery after PET|9|||
156755494|NCT02620787|565857024|FG000|Overall Study|Adverse Event|1|||
156755495|NCT02620787|565857025|FG001|Overall Study|Adverse Event|0|||
156755496|NCT02620787|565857024|FG000|Overall Study|Eligibility Criteria Not Met|1|||
156755497|NCT02620787|565857025|FG001|Overall Study|Eligibility Criteria Not Met|0|||
156755498|NCT01509664|565857026|FG000|Overall Study|Lost to Follow-up|15|||
156755499|NCT01509664|565857027|FG001|Overall Study|Lost to Follow-up|21|||
156755500|NCT02959918|565857030|FG000|Overall Study|Adverse Event|1|||
156755501|NCT02959918|565857031|FG001|Overall Study|Adverse Event|1|||
156755502|NCT02959918|565857032|FG002|Overall Study|Adverse Event|2|||
156755503|NCT02959918|565857033|FG003|Overall Study|Adverse Event|0|||
156755504|NCT02959918|565857034|FG004|Overall Study|Adverse Event|0|||
156755505|NCT02959918|565857035|FG005|Overall Study|Adverse Event|2|||
156755506|NCT02959918|565857036|FG006|Overall Study|Adverse Event|2|||
156755507|NCT02959918|565857037|FG007|Overall Study|Adverse Event|1|||
156755508|NCT02959918|565857038|FG008|Overall Study|Adverse Event|2|||
156755509|NCT02959918|565857039|FG009|Overall Study|Adverse Event|1|||
156755510|NCT02959918|565857040|FG010|Overall Study|Adverse Event|1|||
156755511|NCT02959918|565857041|FG011|Overall Study|Adverse Event|3|||
156755512|NCT02959918|565857042|FG012|Overall Study|Adverse Event|2|||
156755513|NCT02959918|565857043|FG013|Overall Study|Adverse Event|4|||
156755514|NCT02959918|565857030|FG000|Overall Study|Lost to Follow-up|0|||
156755515|NCT02959918|565857031|FG001|Overall Study|Lost to Follow-up|0|||
156755516|NCT02959918|565857032|FG002|Overall Study|Lost to Follow-up|0|||
156755517|NCT02959918|565857033|FG003|Overall Study|Lost to Follow-up|0|||
156755518|NCT02959918|565857034|FG004|Overall Study|Lost to Follow-up|0|||
156755519|NCT02959918|565857035|FG005|Overall Study|Lost to Follow-up|0|||
156755520|NCT02959918|565857036|FG006|Overall Study|Lost to Follow-up|0|||
156755521|NCT02959918|565857037|FG007|Overall Study|Lost to Follow-up|0|||
156755522|NCT02959918|565857038|FG008|Overall Study|Lost to Follow-up|0|||
156755523|NCT02959918|565857039|FG009|Overall Study|Lost to Follow-up|1|||
156755524|NCT02959918|565857040|FG010|Overall Study|Lost to Follow-up|0|||
156755525|NCT02959918|565857041|FG011|Overall Study|Lost to Follow-up|0|||
156755526|NCT02959918|565857042|FG012|Overall Study|Lost to Follow-up|1|||
156755527|NCT02959918|565857043|FG013|Overall Study|Lost to Follow-up|0|||
156755528|NCT02959918|565857030|FG000|Overall Study|Withdrawal by Subject|0|||
156755529|NCT02959918|565857031|FG001|Overall Study|Withdrawal by Subject|0|||
156755530|NCT02959918|565857032|FG002|Overall Study|Withdrawal by Subject|1|||
156755531|NCT02959918|565857033|FG003|Overall Study|Withdrawal by Subject|2|||
156755532|NCT02959918|565857034|FG004|Overall Study|Withdrawal by Subject|0|||
156755533|NCT02959918|565857035|FG005|Overall Study|Withdrawal by Subject|0|||
156755534|NCT02959918|565857036|FG006|Overall Study|Withdrawal by Subject|1|||
156755535|NCT02959918|565857037|FG007|Overall Study|Withdrawal by Subject|0|||
156755536|NCT02959918|565857038|FG008|Overall Study|Withdrawal by Subject|1|||
156755537|NCT02959918|565857039|FG009|Overall Study|Withdrawal by Subject|1|||
156755538|NCT02959918|565857040|FG010|Overall Study|Withdrawal by Subject|2|||
156755539|NCT02959918|565857041|FG011|Overall Study|Withdrawal by Subject|3|||
156755540|NCT02959918|565857042|FG012|Overall Study|Withdrawal by Subject|1|||
156755541|NCT02959918|565857043|FG013|Overall Study|Withdrawal by Subject|1|||
156755542|NCT02959918|565857030|FG000|Overall Study|Protocol Violation|0|||
156755543|NCT02959918|565857031|FG001|Overall Study|Protocol Violation|0|||
156755544|NCT02959918|565857032|FG002|Overall Study|Protocol Violation|1|||
156755545|NCT02959918|565857033|FG003|Overall Study|Protocol Violation|0|||
156755546|NCT02959918|565857034|FG004|Overall Study|Protocol Violation|0|||
156755547|NCT02959918|565857035|FG005|Overall Study|Protocol Violation|1|||
156755548|NCT02959918|565857036|FG006|Overall Study|Protocol Violation|0|||
156755549|NCT02959918|565857037|FG007|Overall Study|Protocol Violation|0|||
156755550|NCT02959918|565857038|FG008|Overall Study|Protocol Violation|2|||
156755551|NCT02959918|565857039|FG009|Overall Study|Protocol Violation|1|||
156313404|NCT02267317|564246326|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156313405|NCT02267317|564246327|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156313406|NCT02267317|564246328|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156313407|NCT02267317|564246329|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156313408|NCT02208063|564246332|FG000|Overall Study|Death|3|||
156313409|NCT02208063|564246333|FG001|Overall Study|Death|5|||
156313410|NCT02208063|564246332|FG000|Overall Study|Not Specified in report|3|||
156313411|NCT02208063|564246333|FG001|Overall Study|Not Specified in report|4|||
156651867|NCT00368966|565472676|FG000|Infant Series|Adverse Event|0|||
156651868|NCT00368966|565472677|FG001|Infant Series|Adverse Event|1|||
156651869|NCT00368966|565472676|FG000|Infant Series|Failed to return|1|||
156651870|NCT00368966|565472677|FG001|Infant Series|Failed to return|0|||
156651871|NCT00368966|565472676|FG000|After Infant|Failed to return|3|||
156651872|NCT00368966|565472677|FG001|After Infant|Failed to return|1|||
156651873|NCT00368966|565472676|FG000|After Infant|Adverse Event|1|||
156651874|NCT00368966|565472677|FG001|After Infant|Adverse Event|2|||
156651875|NCT00368966|565472676|FG000|After Infant|Withdrawal by Subject|1|||
156651876|NCT00368966|565472677|FG001|After Infant|Withdrawal by Subject|1|||
156651877|NCT00368966|565472676|FG000|After Infant|Death|1|||
156651878|NCT00368966|565472677|FG001|After Infant|Death|0|||
156651879|NCT00368966|565472676|FG000|After Infant|Lost to Follow-up|0|||
156651880|NCT00368966|565472677|FG001|After Infant|Lost to Follow-up|1|||
156651881|NCT00368966|565472676|FG000|Toddler Dose|Withdrawal by Subject|1|||
156651882|NCT00368966|565472677|FG001|Toddler Dose|Withdrawal by Subject|1|||
156651883|NCT00368966|565472676|FG000|Toddler Dose|Lost to Follow-up|0|||
156651884|NCT00368966|565472677|FG001|Toddler Dose|Lost to Follow-up|2|||
156651885|NCT02866175|565472678|FG000|Overall Study|Adverse Event|56|||
156651886|NCT02866175|565472679|FG001|Overall Study|Adverse Event|54|||
156651887|NCT02866175|565472678|FG000|Overall Study|Withdrawal by Subject|31|||
156651888|NCT02866175|565472679|FG001|Overall Study|Withdrawal by Subject|52|||
156651889|NCT02866175|565472678|FG000|Overall Study|Death|30|||
156651890|NCT02866175|565472679|FG001|Overall Study|Death|23|||
156651891|NCT02866175|565472678|FG000|Overall Study|Other|7|||
156651892|NCT02866175|565472679|FG001|Overall Study|Other|14|||
156651893|NCT02866175|565472678|FG000|Overall Study|Progressive disease|1|||
156651894|NCT02866175|565472679|FG001|Overall Study|Progressive disease|1|||
156651895|NCT02866175|565472678|FG000|Overall Study|Lost to Follow-up|2|||
156651896|NCT02866175|565472679|FG001|Overall Study|Lost to Follow-up|0|||
156651897|NCT02866175|565472678|FG000|Overall Study|Lack of Efficacy|0|||
156651898|NCT02866175|565472679|FG001|Overall Study|Lack of Efficacy|1|||
156651899|NCT02866175|565472678|FG000|Overall Study|Physician Decision|3|||
156755552|NCT02959918|565857040|FG010|Overall Study|Protocol Violation|0|||
156755553|NCT02959918|565857041|FG011|Overall Study|Protocol Violation|1|||
156755554|NCT02959918|565857042|FG012|Overall Study|Protocol Violation|1|||
156755555|NCT02959918|565857043|FG013|Overall Study|Protocol Violation|0|||
156313412|NCT02208063|564246332|FG000|Overall Study|Withdrawal by Subject|5|||
156313413|NCT02208063|564246333|FG001|Overall Study|Withdrawal by Subject|2|||
156755556|NCT02959918|565857030|FG000|Overall Study|Stopping Rule Met|1|||
156755557|NCT02959918|565857031|FG001|Overall Study|Stopping Rule Met|0|||
156651900|NCT02866175|565472679|FG001|Overall Study|Physician Decision|15|||
156651901|NCT02866175|565472678|FG000|Overall Study|Did not receive treatment|5|||
156651902|NCT02866175|565472679|FG001|Overall Study|Did not receive treatment|15|||
156755558|NCT02959918|565857032|FG002|Overall Study|Stopping Rule Met|3|||
156755559|NCT02959918|565857033|FG003|Overall Study|Stopping Rule Met|4|||
156755560|NCT02959918|565857034|FG004|Overall Study|Stopping Rule Met|5|||
156755561|NCT02959918|565857035|FG005|Overall Study|Stopping Rule Met|3|||
156755562|NCT02959918|565857036|FG006|Overall Study|Stopping Rule Met|2|||
156755563|NCT02959918|565857037|FG007|Overall Study|Stopping Rule Met|4|||
156755564|NCT02959918|565857038|FG008|Overall Study|Stopping Rule Met|1|||
156755565|NCT02959918|565857039|FG009|Overall Study|Stopping Rule Met|1|||
156755566|NCT02959918|565857040|FG010|Overall Study|Stopping Rule Met|3|||
156755567|NCT02959918|565857041|FG011|Overall Study|Stopping Rule Met|5|||
156755568|NCT02959918|565857042|FG012|Overall Study|Stopping Rule Met|2|||
156755569|NCT02959918|565857043|FG013|Overall Study|Stopping Rule Met|1|||
156755570|NCT02959918|565857030|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
156755571|NCT02959918|565857031|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
156755572|NCT02959918|565857032|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
156755573|NCT02959918|565857033|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
156755574|NCT02959918|565857034|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755575|NCT02959918|565857035|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755576|NCT02959918|565857036|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755577|NCT02959918|565857037|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755578|NCT02959918|565857038|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755579|NCT02959918|565857039|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755580|NCT02959918|565857040|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755581|NCT02959918|565857041|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755582|NCT02959918|565857042|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755583|NCT02959918|565857043|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755584|NCT02959918|565857030|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755585|NCT02959918|565857031|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755586|NCT02959918|565857032|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755587|NCT02959918|565857033|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755588|NCT02959918|565857034|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755589|NCT02959918|565857035|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755590|NCT02959918|565857036|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755591|NCT02959918|565857037|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
156755592|NCT02959918|565857038|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755593|NCT02959918|565857039|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755594|NCT02959918|565857040|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755595|NCT02959918|565857041|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755596|NCT02959918|565857042|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755597|NCT02959918|565857043|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755598|NCT02959918|565857030|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755599|NCT02959918|565857031|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755600|NCT02959918|565857032|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755601|NCT02959918|565857033|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755602|NCT02959918|565857034|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755603|NCT02959918|565857035|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755604|NCT02959918|565857036|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755605|NCT02959918|565857037|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755606|NCT02959918|565857038|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
156755607|NCT02959918|565857039|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755608|NCT02959918|565857040|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755609|NCT02959918|565857041|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755610|NCT02959918|565857042|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755611|NCT02959918|565857043|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755612|NCT02959918|565857030|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755613|NCT02959918|565857031|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755614|NCT02959918|565857032|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755615|NCT02959918|565857033|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755616|NCT02959918|565857034|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755617|NCT02959918|565857035|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755618|NCT02959918|565857036|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755619|NCT02959918|565857037|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755620|NCT02959918|565857038|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755621|NCT02959918|565857039|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
156755622|NCT02959918|565857040|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755623|NCT02959918|565857041|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755624|NCT02959918|565857042|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755625|NCT02959918|565857043|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755626|NCT00837967|565857044|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
156755627|NCT00837967|565857045|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
156755628|NCT01733121|565857047|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
156755629|NCT01733121|565857048|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
156755630|NCT01733121|565857047|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
156755631|NCT01733121|565857048|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
156755632|NCT01733121|565857047|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
156755633|NCT01733121|565857048|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
156755634|NCT01733121|565857047|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
156755635|NCT01733121|565857048|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
156755636|NCT03061188|565857051|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
156755637|NCT03061188|565857052|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
156755638|NCT03061188|565857053|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
156755639|NCT03061188|565857054|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
156755640|NCT03061188|565857051|FG000|On Follow-up for 3 Years|Death|0|||
156755641|NCT03061188|565857052|FG001|On Follow-up for 3 Years|Death|3|||
156755642|NCT03061188|565857053|FG002|On Follow-up for 3 Years|Death|5|||
156755643|NCT03061188|565857054|FG003|On Follow-up for 3 Years|Death|4|||
156755644|NCT03061188|565857051|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
156755645|NCT03061188|565857052|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
156755646|NCT03061188|565857053|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
156755647|NCT03061188|565857054|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
156755648|NCT02504320|565857058|FG000|Treatment Period 1|Positive Drug Screen|0|||
156755649|NCT02504320|565857059|FG001|Treatment Period 1|Positive Drug Screen|0|||
156755650|NCT02504320|565857060|FG002|Treatment Period 1|Positive Drug Screen|1|||
156755651|NCT02504320|565857061|FG003|Treatment Period 1|Positive Drug Screen|0|||
156755652|NCT02504320|565857058|FG000|Treatment Period 2|Positive Drug Screen|0|||
156755653|NCT02504320|565857059|FG001|Treatment Period 2|Positive Drug Screen|1|||
156755654|NCT02504320|565857060|FG002|Treatment Period 2|Positive Drug Screen|0|||
156755655|NCT02504320|565857061|FG003|Treatment Period 2|Positive Drug Screen|0|||
156755656|NCT02504320|565857058|FG000|Treatment Period 3|Positive Drug Screen|0|||
156755657|NCT02504320|565857059|FG001|Treatment Period 3|Positive Drug Screen|0|||
156755658|NCT02504320|565857060|FG002|Treatment Period 3|Positive Drug Screen|0|||
156755659|NCT02504320|565857061|FG003|Treatment Period 3|Positive Drug Screen|1|||
156755660|NCT02504320|565857058|FG000|Treatment Period 3|Adverse Event|0|||
156755661|NCT02504320|565857059|FG001|Treatment Period 3|Adverse Event|0|||
156755662|NCT02504320|565857060|FG002|Treatment Period 3|Adverse Event|1|||
156755663|NCT02504320|565857061|FG003|Treatment Period 3|Adverse Event|0|||
156755664|NCT02306850|565857064|FG000|Overall Study|Lack of Efficacy|2|||
156755665|NCT02420262|565857065|FG000|Overall Study|Adverse Event|1|||
156755666|NCT02420262|565857066|FG001|Overall Study|Adverse Event|0|||
156755667|NCT02420262|565857065|FG000|Overall Study|Withdrawal by Subject|1|||
156755668|NCT02420262|565857066|FG001|Overall Study|Withdrawal by Subject|4|||
156755669|NCT02420262|565857065|FG000|Overall Study|Unclassified|0|||
156755670|NCT02420262|565857066|FG001|Overall Study|Unclassified|1|||
156755671|NCT00941304|565857067|FG000|Overall Study|Lost to Follow-up|1|||
156755672|NCT00941304|565857068|FG001|Overall Study|Lost to Follow-up|0|||
156755673|NCT00941304|565857069|FG002|Overall Study|Lost to Follow-up|0|||
156755674|NCT00941304|565857070|FG003|Overall Study|Lost to Follow-up|0|||
156755675|NCT00941304|565857071|FG004|Overall Study|Lost to Follow-up|0|||
156755676|NCT03293394|565857072|FG000|Follow-up (6 Months)|Adverse Event|4|||
156755677|NCT03293394|565857073|FG001|Follow-up (6 Months)|Adverse Event|2|||
156755678|NCT02497404|565857074|FG000|Overall Study|Adverse Event|1|||
156755679|NCT00110357|565857081|FG000|Overall Study|Deterioration without progression|2|||
156755680|NCT00110357|565857082|FG001|Overall Study|Deterioration without progression|0|||
156755681|NCT00110357|565857081|FG000|Overall Study|Disease progression/relapse|20|||
156755682|NCT00110357|565857082|FG001|Overall Study|Disease progression/relapse|15|||
156755683|NCT00110357|565857081|FG000|Overall Study|Study Closure|1|||
156755684|NCT00110357|565857082|FG001|Overall Study|Study Closure|0|||
156755685|NCT00110357|565857081|FG000|Overall Study|Study Drug Toxicity|1|||
156755686|NCT00110357|565857082|FG001|Overall Study|Study Drug Toxicity|3|||
156755687|NCT00110357|565857081|FG000|Overall Study|Withdrawal by Subject|3|||
156755688|NCT00110357|565857082|FG001|Overall Study|Withdrawal by Subject|1|||
156755689|NCT04004260|565857086|FG000|Overall Study|Withdrawal by Subject|7|||
156755690|NCT04004260|565857087|FG001|Overall Study|Withdrawal by Subject|3|||
156755691|NCT04004260|565857086|FG000|Overall Study|Lost to Follow-up|22|||
156755692|NCT04004260|565857087|FG001|Overall Study|Lost to Follow-up|12|||
156755693|NCT04004260|565857086|FG000|Overall Study|Did not engage in intervention|13|||
156755694|NCT04004260|565857087|FG001|Overall Study|Did not engage in intervention|17|||
156755695|NCT04633226|565857091|FG000|Overall Study|Withdrawal by parent/guardian|4|||
156313414|NCT02208063|564246332|FG000|Overall Study|Lost to Follow-up|1|||
156313415|NCT02208063|564246333|FG001|Overall Study|Lost to Follow-up|0|||
156313416|NCT03595618|564246334|FG000|Overall Study|Adverse Event|16|||
156313417|NCT03595618|564246335|FG001|Overall Study|Adverse Event|17|||
156313418|NCT03595618|564246336|FG002|Overall Study|Adverse Event|20|||
156313419|NCT03595618|564246337|FG003|Overall Study|Adverse Event|8|||
156313420|NCT03595618|564246334|FG000|Overall Study|Withdrawal by Subject|12|||
156313421|NCT03595618|564246335|FG001|Overall Study|Withdrawal by Subject|14|||
156313422|NCT03595618|564246336|FG002|Overall Study|Withdrawal by Subject|14|||
156313423|NCT03595618|564246337|FG003|Overall Study|Withdrawal by Subject|10|||
156313424|NCT03595618|564246334|FG000|Overall Study|Lost to Follow-up|6|||
156313425|NCT03595618|564246335|FG001|Overall Study|Lost to Follow-up|4|||
156313426|NCT03595618|564246336|FG002|Overall Study|Lost to Follow-up|5|||
156313427|NCT03595618|564246337|FG003|Overall Study|Lost to Follow-up|6|||
156313428|NCT03595618|564246334|FG000|Overall Study|Protocol Violation|2|||
156313429|NCT03595618|564246335|FG001|Overall Study|Protocol Violation|0|||
156313430|NCT03595618|564246336|FG002|Overall Study|Protocol Violation|6|||
156313431|NCT03595618|564246337|FG003|Overall Study|Protocol Violation|2|||
156313432|NCT03595618|564246334|FG000|Overall Study|Physician Decision|0|||
156651903|NCT01694485|565472686|FG000|Overall Study|Withdrawal by Subject|20|||
156313433|NCT03595618|564246335|FG001|Overall Study|Physician Decision|0|||
156313434|NCT03595618|564246336|FG002|Overall Study|Physician Decision|1|||
156313435|NCT03595618|564246337|FG003|Overall Study|Physician Decision|2|||
156313436|NCT03595618|564246334|FG000|Overall Study|Miscellaneous|7|||
156313437|NCT03595618|564246335|FG001|Overall Study|Miscellaneous|5|||
156313438|NCT03595618|564246336|FG002|Overall Study|Miscellaneous|10|||
156313439|NCT03595618|564246337|FG003|Overall Study|Miscellaneous|6|||
156313440|NCT02279407|564246340|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
156313441|NCT02279407|564246341|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
156313442|NCT02279407|564246342|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
156313443|NCT02279407|564246343|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
156313444|NCT02279407|564246340|FG000|Overall Study|Withdrawal by Subject|1|||
156313445|NCT02279407|564246341|FG001|Overall Study|Withdrawal by Subject|0|||
156313446|NCT02279407|564246342|FG002|Overall Study|Withdrawal by Subject|1|||
156313447|NCT02279407|564246343|FG003|Overall Study|Withdrawal by Subject|1|||
156651904|NCT01694485|565472687|FG001|Overall Study|Withdrawal by Subject|6|||
156651905|NCT01694485|565472688|FG002|Overall Study|Withdrawal by Subject|7|||
156651906|NCT01694485|565472689|FG003|Overall Study|Withdrawal by Subject|25|||
156651907|NCT01694485|565472690|FG004|Overall Study|Withdrawal by Subject|18|||
156651908|NCT01694485|565472686|FG000|Overall Study|Sponsor Decision|3|||
156651909|NCT01694485|565472687|FG001|Overall Study|Sponsor Decision|0|||
156651910|NCT01694485|565472688|FG002|Overall Study|Sponsor Decision|0|||
156651911|NCT01694485|565472689|FG003|Overall Study|Sponsor Decision|2|||
156651912|NCT01694485|565472690|FG004|Overall Study|Sponsor Decision|0|||
156651913|NCT01694485|565472686|FG000|Overall Study|Lost to Follow-up|9|||
156651914|NCT01694485|565472687|FG001|Overall Study|Lost to Follow-up|1|||
156651915|NCT01694485|565472688|FG002|Overall Study|Lost to Follow-up|6|||
156651916|NCT01694485|565472689|FG003|Overall Study|Lost to Follow-up|10|||
156651917|NCT01694485|565472690|FG004|Overall Study|Lost to Follow-up|7|||
156651918|NCT01694485|565472686|FG000|Overall Study|Death|1|||
156651919|NCT01694485|565472687|FG001|Overall Study|Death|0|||
156651920|NCT01694485|565472688|FG002|Overall Study|Death|0|||
156651921|NCT01694485|565472689|FG003|Overall Study|Death|1|||
156651922|NCT01694485|565472690|FG004|Overall Study|Death|0|||
156651923|NCT02907203|565472691|FG000|Overall Study|Death|1|||
156651924|NCT02907203|565472691|FG000|Overall Study|Lost to Follow-up|3|||
156651925|NCT02907203|565472691|FG000|Overall Study|Withdrawal by Subject|3|||
156651926|NCT02907203|565472691|FG000|Overall Study|Surgical bypass|1|||
156651927|NCT00619619|565472692|FG000|Overall Study|Physician Decision|0|||
156651928|NCT00619619|565472693|FG001|Overall Study|Physician Decision|0|||
156651929|NCT00619619|565472694|FG002|Overall Study|Physician Decision|1|||
156651930|NCT00619619|565472695|FG003|Overall Study|Physician Decision|0|||
156651931|NCT00619619|565472696|FG004|Overall Study|Physician Decision|0|||
156651932|NCT00619619|565472697|FG005|Overall Study|Physician Decision|0|||
156651933|NCT00619619|565472698|FG006|Overall Study|Physician Decision|0|||
156651934|NCT00619619|565472699|FG007|Overall Study|Physician Decision|0|||
156651935|NCT00619619|565472692|FG000|Overall Study|Protocol Violation|0|||
156651936|NCT00619619|565472693|FG001|Overall Study|Protocol Violation|0|||
156651937|NCT00619619|565472694|FG002|Overall Study|Protocol Violation|0|||
156313448|NCT02279407|564246340|FG000|Overall Study|Adverse Event|1|||
156313449|NCT02279407|564246341|FG001|Overall Study|Adverse Event|1|||
156313450|NCT02279407|564246342|FG002|Overall Study|Adverse Event|2|||
156313451|NCT02279407|564246343|FG003|Overall Study|Adverse Event|0|||
156313452|NCT01105065|564246344|FG000|Overall Study|Adverse Event|5|||
156313453|NCT01105065|564246344|FG000|Overall Study|Technical Problems|1|||
156313454|NCT00422084|564246345|FG000|Overall Study|Adverse Event|21|||
156651938|NCT00619619|565472695|FG003|Overall Study|Protocol Violation|1|||
156651939|NCT00619619|565472696|FG004|Overall Study|Protocol Violation|0|||
156651940|NCT00619619|565472697|FG005|Overall Study|Protocol Violation|0|||
156651941|NCT00619619|565472698|FG006|Overall Study|Protocol Violation|1|||
156651942|NCT00619619|565472699|FG007|Overall Study|Protocol Violation|1|||
156755696|NCT04633226|565857091|FG000|Overall Study|Randomized by mistake without study treatment|1|||
156755697|NCT05415462|565857096|FG000|Overall Study|Death|18|||
156755698|NCT05415462|565857097|FG001|Overall Study|Death|10|||
156755699|NCT05415462|565857096|FG000|Overall Study|Lost to Follow-up|72|||
156755700|NCT05415462|565857097|FG001|Overall Study|Lost to Follow-up|64|||
156755701|NCT05415462|565857096|FG000|Overall Study|Physician Decision|5|||
156755702|NCT05415462|565857097|FG001|Overall Study|Physician Decision|5|||
156755703|NCT05415462|565857096|FG000|Overall Study|Protocol Deviation|1|||
156755704|NCT05415462|565857097|FG001|Overall Study|Protocol Deviation|0|||
156755705|NCT05415462|565857096|FG000|Overall Study|Withdrawal by Subject|129|||
156755706|NCT05415462|565857097|FG001|Overall Study|Withdrawal by Subject|101|||
156755707|NCT05415462|565857096|FG000|Overall Study|Other Than Specified|8|||
156755708|NCT05415462|565857097|FG001|Overall Study|Other Than Specified|8|||
156755709|NCT02998996|565857099|FG000|Overall Study|Lost to Follow-up|0|||
156755710|NCT02998996|565857100|FG001|Overall Study|Lost to Follow-up|0|||
156755711|NCT02998996|565857101|FG002|Overall Study|Lost to Follow-up|1|||
156755712|NCT02998996|565857102|FG003|Overall Study|Lost to Follow-up|0|||
156755713|NCT02998996|565857103|FG004|Overall Study|Lost to Follow-up|0|||
156755714|NCT02998996|565857104|FG005|Overall Study|Lost to Follow-up|0|||
156755715|NCT02998996|565857099|FG000|Overall Study|Pregnancy|0|||
156755716|NCT02998996|565857100|FG001|Overall Study|Pregnancy|1|||
156755717|NCT02998996|565857101|FG002|Overall Study|Pregnancy|0|||
156755718|NCT02998996|565857102|FG003|Overall Study|Pregnancy|0|||
156755719|NCT02998996|565857103|FG004|Overall Study|Pregnancy|0|||
156755720|NCT02998996|565857104|FG005|Overall Study|Pregnancy|0|||
156755721|NCT02998996|565857099|FG000|Overall Study|Family reasons|0|||
156755722|NCT02998996|565857100|FG001|Overall Study|Family reasons|0|||
156755723|NCT02998996|565857101|FG002|Overall Study|Family reasons|0|||
156755724|NCT02998996|565857102|FG003|Overall Study|Family reasons|0|||
156755725|NCT02998996|565857103|FG004|Overall Study|Family reasons|1|||
156755726|NCT02998996|565857104|FG005|Overall Study|Family reasons|0|||
156755727|NCT01087203|565857105|FG000|Overall Study|Lost to Follow-up|2|||
156755728|NCT01087203|565857106|FG001|Overall Study|Lost to Follow-up|0|||
156755729|NCT01087203|565857105|FG000|Overall Study|Withdrawal by Subject|2|||
156755730|NCT01087203|565857106|FG001|Overall Study|Withdrawal by Subject|6|||
156755731|NCT01087203|565857105|FG000|Overall Study|Lack of Efficacy|1|||
156755732|NCT01087203|565857106|FG001|Overall Study|Lack of Efficacy|2|||
156755733|NCT01087203|565857105|FG000|Overall Study|Study terminated by sponsor|27|||
156755734|NCT01087203|565857106|FG001|Overall Study|Study terminated by sponsor|27|||
156755735|NCT05259163|565858484|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
156755736|NCT05259163|565858485|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
156755737|NCT05251233|565858486|FG000|Overall Study|Disease progression - did not start treatment|0|||
156755738|NCT05251233|565858487|FG001|Overall Study|Disease progression - did not start treatment|0|||
156755739|NCT05251233|565858488|FG002|Overall Study|Disease progression - did not start treatment|5|||
156755740|NCT05251233|565858486|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
156755741|NCT05251233|565858487|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
156755742|NCT05251233|565858488|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
156755743|NCT05251233|565858486|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
156755744|NCT05251233|565858487|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
156755745|NCT05251233|565858488|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
156755746|NCT05251233|565858486|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
156755747|NCT05251233|565858487|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
156755748|NCT05251233|565858488|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
156755749|NCT05251233|565858486|FG000|Overall Study|Death - did not start treatment|3|||
156755750|NCT05251233|565858487|FG001|Overall Study|Death - did not start treatment|0|||
156755751|NCT05251233|565858488|FG002|Overall Study|Death - did not start treatment|0|||
156755752|NCT05251233|565858486|FG000|Overall Study|Withdrawal by Subject|2|||
156755753|NCT05251233|565858487|FG001|Overall Study|Withdrawal by Subject|2|||
156755754|NCT05251233|565858488|FG002|Overall Study|Withdrawal by Subject|0|||
156755755|NCT05251233|565858486|FG000|Overall Study|Other complicating disease|2|||
156755756|NCT05251233|565858487|FG001|Overall Study|Other complicating disease|1|||
156755757|NCT05251233|565858488|FG002|Overall Study|Other complicating disease|0|||
156755758|NCT05251233|565858486|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
156755759|NCT05251233|565858487|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
156755760|NCT05251233|565858488|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
156755761|NCT05251233|565858486|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
156755762|NCT05251233|565858487|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
156755763|NCT05251233|565858488|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
156755764|NCT00452439|565858490|FG000|Overall Study|Lost to Follow-up|1|||
156755765|NCT00452439|565858491|FG001|Overall Study|Lost to Follow-up|1|||
156755766|NCT00452439|565858490|FG000|Overall Study|Refused Treatment|4|||
156755767|NCT00452439|565858491|FG001|Overall Study|Refused Treatment|3|||
156755768|NCT00452439|565858490|FG000|Overall Study|Death|3|||
156755769|NCT00452439|565858491|FG001|Overall Study|Death|1|||
156755770|NCT00452439|565858490|FG000|Overall Study|Bone Marrow Transplant|0|||
156755771|NCT00452439|565858491|FG001|Overall Study|Bone Marrow Transplant|1|||
156755772|NCT00452439|565858490|FG000|Overall Study|Too Ill to Continue|0|||
156755773|NCT00452439|565858491|FG001|Overall Study|Too Ill to Continue|1|||
156755774|NCT00452439|565858490|FG000|Overall Study|Failed to achieve complete response|2|||
156755775|NCT00452439|565858491|FG001|Overall Study|Failed to achieve complete response|0|||
156755776|NCT00452439|565858490|FG000|Overall Study|Relapse|3|||
156755777|NCT00452439|565858491|FG001|Overall Study|Relapse|0|||
156755778|NCT00452439|565858490|FG000|Overall Study|Fracture|1|||
156755779|NCT00452439|565858491|FG001|Overall Study|Fracture|0|||
156755780|NCT00463801|565858495|FG000|Overall Study|Protocol Violation|1|||
156755781|NCT00463801|565858495|FG000|Overall Study|Lack of Efficacy|2|||
156755782|NCT00463801|565858495|FG000|Overall Study|Adverse Event|4|||
156755783|NCT00463801|565858495|FG000|Overall Study|Lost to Follow-up|5|||
156755784|NCT00463801|565858495|FG000|Overall Study|No longer require therapy|1|||
156755785|NCT00669318|565858496|FG000|Overall Study|Withdrawal by Subject|2|||
156755786|NCT03512353|565858501|FG000|Overall Study|Sponsor Decision|3|||
156755787|NCT03512353|565858501|FG000|Overall Study|Death|1|||
156755788|NCT02581488|565858504|FG000|Overall Study|Adverse Event|6|||
156755789|NCT02581488|565858505|FG001|Overall Study|Adverse Event|7|||
156755790|NCT02581488|565858504|FG000|Overall Study|Lost to Follow-up|1|||
156755791|NCT02581488|565858505|FG001|Overall Study|Lost to Follow-up|0|||
156755792|NCT02581488|565858504|FG000|Overall Study|Withdrawal by Subject|1|||
156755793|NCT02581488|565858505|FG001|Overall Study|Withdrawal by Subject|0|||
156755794|NCT02581488|565858504|FG000|Overall Study|Non-Compliance|1|||
156755795|NCT02581488|565858505|FG001|Overall Study|Non-Compliance|0|||
156755796|NCT02581488|565858504|FG000|Overall Study|Protocol Violation|0|||
156755797|NCT02581488|565858505|FG001|Overall Study|Protocol Violation|4|||
156755798|NCT01639144|565858506|FG000|Overall Study|Withdrawal by Subject|4|||
156755799|NCT01639144|565858507|FG001|Overall Study|Withdrawal by Subject|2|||
156755800|NCT01639144|565858506|FG000|Overall Study|Physician Decision|2|||
156755801|NCT01639144|565858507|FG001|Overall Study|Physician Decision|0|||
156755802|NCT01639144|565858506|FG000|Overall Study|Met postoperative exclusion criteria|4|||
156755803|NCT01639144|565858507|FG001|Overall Study|Met postoperative exclusion criteria|3|||
156755804|NCT03492437|565858508|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156755805|NCT03492437|565858509|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156755806|NCT01048541|565858512|FG000|Overall Study|Withdrawal by Subject|1|||
156755807|NCT01048541|565858513|FG001|Overall Study|Withdrawal by Subject|0|||
156755808|NCT03060291|565858515|FG000|3-month Follow-up|Declined to respond|8|||
156414457|NCT01154036|564610973|FG003|Phase I|Physician Decision|0|||
156414458|NCT01154036|564610974|FG004|Phase I|Physician Decision|0|||
156414459|NCT01154036|564610975|FG005|Phase I|Physician Decision|0|||
156414460|NCT01154036|564610976|FG006|Phase I|Physician Decision|0|||
156414461|NCT01154036|564610977|FG007|Phase I|Physician Decision|0|||
156414462|NCT01154036|564610970|FG000|Phase I|Lost to Follow-up|0|||
156414463|NCT01154036|564610971|FG001|Phase I|Lost to Follow-up|3|||
156414464|NCT01154036|564610972|FG002|Phase I|Lost to Follow-up|6|||
156414465|NCT01154036|564610973|FG003|Phase I|Lost to Follow-up|0|||
156414466|NCT01154036|564610974|FG004|Phase I|Lost to Follow-up|0|||
156414467|NCT01154036|564610975|FG005|Phase I|Lost to Follow-up|0|||
156414468|NCT01154036|564610976|FG006|Phase I|Lost to Follow-up|0|||
156414469|NCT01154036|564610977|FG007|Phase I|Lost to Follow-up|0|||
156414470|NCT01154036|564610970|FG000|Phase I|Protocol Violation|0|||
156414471|NCT01154036|564610971|FG001|Phase I|Protocol Violation|3|||
156414472|NCT01154036|564610972|FG002|Phase I|Protocol Violation|9|||
156414473|NCT01154036|564610973|FG003|Phase I|Protocol Violation|0|||
156414474|NCT01154036|564610974|FG004|Phase I|Protocol Violation|0|||
156414475|NCT01154036|564610975|FG005|Phase I|Protocol Violation|0|||
156755809|NCT03060291|565858516|FG001|3-month Follow-up|Declined to respond|10|||
156755810|NCT03060291|565858517|FG002|3-month Follow-up|Declined to respond|2|||
156755811|NCT03060291|565858515|FG000|6-month Follow-up|Declined to respond|7|||
156755812|NCT03060291|565858516|FG001|6-month Follow-up|Declined to respond|13|||
156755813|NCT03060291|565858517|FG002|6-month Follow-up|Declined to respond|4|||
156755814|NCT03060291|565858515|FG000|12-month Follow-up|Declined to respond|7|||
156414476|NCT01154036|564610976|FG006|Phase I|Protocol Violation|0|||
156414477|NCT01154036|564610977|FG007|Phase I|Protocol Violation|0|||
156414478|NCT01154036|564610970|FG000|Phase I|Withdrawal by Subject|2|||
156755815|NCT03060291|565858516|FG001|12-month Follow-up|Declined to respond|16|||
156755816|NCT03060291|565858517|FG002|12-month Follow-up|Declined to respond|6|||
156755817|NCT00618826|565858520|FG000|Overall Study|Adverse Event|1|||
156755818|NCT03193047|565858521|FG000|Overall Study|Physician Decision|1|||
156755819|NCT03193047|565858522|FG001|Overall Study|Physician Decision|0|||
156414479|NCT01154036|564610971|FG001|Phase I|Withdrawal by Subject|10|||
156414480|NCT01154036|564610972|FG002|Phase I|Withdrawal by Subject|29|||
156414481|NCT01154036|564610973|FG003|Phase I|Withdrawal by Subject|0|||
156414482|NCT01154036|564610974|FG004|Phase I|Withdrawal by Subject|0|||
156755820|NCT03193047|565858521|FG000|Overall Study|Participant Left State|1|||
156755821|NCT03193047|565858522|FG001|Overall Study|Participant Left State|0|||
156755822|NCT02105285|565858526|FG000|Overall Study|Adverse Event|1|||
156755823|NCT02105285|565858527|FG001|Overall Study|Adverse Event|1|||
156755824|NCT02105285|565858528|FG002|Overall Study|Adverse Event|0|||
156755825|NCT02105285|565858526|FG000|Overall Study|Protocol Violation|0|||
156755826|NCT02105285|565858527|FG001|Overall Study|Protocol Violation|1|||
156755827|NCT02105285|565858528|FG002|Overall Study|Protocol Violation|0|||
156755828|NCT02105285|565858526|FG000|Overall Study|Withdrawal by Subject|1|||
156755829|NCT02105285|565858527|FG001|Overall Study|Withdrawal by Subject|0|||
156755830|NCT02105285|565858528|FG002|Overall Study|Withdrawal by Subject|0|||
156755831|NCT01210222|565858529|FG000|Overall Study|Ineligible|2|||
156755832|NCT01210222|565858529|FG000|Overall Study|Never treated|1|||
156755833|NCT02098395|565858530|FG000|Overall Study|Protocol Violation|2|||
156755834|NCT02098395|565858531|FG001|Overall Study|Protocol Violation|2|||
156755835|NCT02098395|565858532|FG002|Overall Study|Protocol Violation|0|||
156755836|NCT02098395|565858533|FG003|Overall Study|Protocol Violation|7|||
156755837|NCT02098395|565858530|FG000|Overall Study|Withdrawal by Subject|10|||
156755838|NCT02098395|565858531|FG001|Overall Study|Withdrawal by Subject|10|||
156755839|NCT02098395|565858532|FG002|Overall Study|Withdrawal by Subject|5|||
156755840|NCT02098395|565858533|FG003|Overall Study|Withdrawal by Subject|13|||
156755841|NCT02098395|565858530|FG000|Overall Study|Adverse Event|12|||
156755842|NCT02098395|565858531|FG001|Overall Study|Adverse Event|19|||
156755843|NCT02098395|565858532|FG002|Overall Study|Adverse Event|34|||
156755844|NCT02098395|565858533|FG003|Overall Study|Adverse Event|2|||
156755845|NCT02098395|565858530|FG000|Overall Study|Lost to Follow-up|2|||
156755846|NCT02098395|565858531|FG001|Overall Study|Lost to Follow-up|1|||
156755847|NCT02098395|565858532|FG002|Overall Study|Lost to Follow-up|0|||
156755848|NCT02098395|565858533|FG003|Overall Study|Lost to Follow-up|3|||
156755849|NCT02098395|565858530|FG000|Overall Study|Unclassified|0|||
156755850|NCT02098395|565858531|FG001|Overall Study|Unclassified|0|||
156755851|NCT02098395|565858532|FG002|Overall Study|Unclassified|3|||
156755852|NCT02098395|565858533|FG003|Overall Study|Unclassified|2|||
156755853|NCT02360280|565858535|FG000|Overall Study|Withdrawal by Subject|2|||
156755854|NCT02360280|565858536|FG001|Overall Study|Withdrawal by Subject|0|||
156755855|NCT02360280|565858535|FG000|Overall Study|Adverse Event|0|||
156755856|NCT02360280|565858536|FG001|Overall Study|Adverse Event|1|||
156755857|NCT02360280|565858535|FG000|Overall Study|Lost to Follow-up|1|||
156755858|NCT02360280|565858536|FG001|Overall Study|Lost to Follow-up|0|||
156755859|NCT00003896|565858544|FG000|Overall Study|Adverse Event|16|||
156755860|NCT00003896|565858544|FG000|Overall Study|Withdrawal by Subject|1|||
156755861|NCT00003896|565858544|FG000|Overall Study|Lack of Efficacy|1|||
156755862|NCT00003896|565858544|FG000|Overall Study|Death|3|||
156755863|NCT00003896|565858544|FG000|Overall Study|not protocol specified|3|||
156755864|NCT00003896|565858544|FG000|Overall Study|ineligible|5|||
156755865|NCT01398358|565858545|FG000|Overall Study|Lost to Follow-up|11|||
156755866|NCT01398358|565858546|FG001|Overall Study|Lost to Follow-up|21|||
156755867|NCT01398358|565858547|FG002|Overall Study|Lost to Follow-up|18|||
156755868|NCT01398358|565858545|FG000|Overall Study|Withdrawal by Subject|3|||
156755869|NCT01398358|565858546|FG001|Overall Study|Withdrawal by Subject|2|||
156755870|NCT01398358|565858547|FG002|Overall Study|Withdrawal by Subject|2|||
156755871|NCT01398358|565858545|FG000|Overall Study|no longer eligible|1|||
156755872|NCT01398358|565858546|FG001|Overall Study|no longer eligible|0|||
156755873|NCT01398358|565858547|FG002|Overall Study|no longer eligible|1|||
156755874|NCT02559570|565858549|FG000|Overall Study|Adverse Event|0|||
156755875|NCT02559570|565858550|FG001|Overall Study|Adverse Event|2|||
156755876|NCT02559570|565858551|FG002|Overall Study|Adverse Event|0|||
156313455|NCT00422084|564246346|FG001|Overall Study|Adverse Event|7|||
156313456|NCT00422084|564246345|FG000|Overall Study|Withdrawal by Subject|12|||
156313457|NCT00422084|564246346|FG001|Overall Study|Withdrawal by Subject|9|||
156313458|NCT00422084|564246345|FG000|Overall Study|Lost to Follow-up|14|||
156313459|NCT00422084|564246346|FG001|Overall Study|Lost to Follow-up|9|||
156313460|NCT00422084|564246345|FG000|Overall Study|Protocol Violation|4|||
156313461|NCT00422084|564246346|FG001|Overall Study|Protocol Violation|1|||
156313462|NCT00422084|564246345|FG000|Overall Study|Lack of Efficacy|40|||
156313463|NCT00422084|564246346|FG001|Overall Study|Lack of Efficacy|42|||
156755877|NCT02559570|565858552|FG003|Overall Study|Adverse Event|1|||
156755878|NCT02559570|565858553|FG004|Overall Study|Adverse Event|0|||
156755879|NCT02559570|565858549|FG000|Overall Study|Withdrawal of Consent|0|||
156755880|NCT02559570|565858550|FG001|Overall Study|Withdrawal of Consent|0|||
156755881|NCT02559570|565858551|FG002|Overall Study|Withdrawal of Consent|1|||
156755882|NCT02559570|565858552|FG003|Overall Study|Withdrawal of Consent|2|||
156755883|NCT02559570|565858553|FG004|Overall Study|Withdrawal of Consent|1|||
156755884|NCT02559570|565858549|FG000|Overall Study|Lost to Follow-up|1|||
156755885|NCT02559570|565858550|FG001|Overall Study|Lost to Follow-up|0|||
156755886|NCT02559570|565858551|FG002|Overall Study|Lost to Follow-up|0|||
156755887|NCT02559570|565858552|FG003|Overall Study|Lost to Follow-up|0|||
156755888|NCT02559570|565858553|FG004|Overall Study|Lost to Follow-up|0|||
156755889|NCT02559570|565858549|FG000|Overall Study|Protocol Violation|1|||
156755890|NCT02559570|565858550|FG001|Overall Study|Protocol Violation|0|||
156651943|NCT00619619|565472692|FG000|Overall Study|Adverse Event|0|||
156651944|NCT00619619|565472693|FG001|Overall Study|Adverse Event|0|||
156651945|NCT00619619|565472694|FG002|Overall Study|Adverse Event|0|||
156651946|NCT00619619|565472695|FG003|Overall Study|Adverse Event|0|||
156651947|NCT00619619|565472696|FG004|Overall Study|Adverse Event|2|||
156651948|NCT00619619|565472697|FG005|Overall Study|Adverse Event|0|||
156651949|NCT00619619|565472698|FG006|Overall Study|Adverse Event|0|||
156651950|NCT00619619|565472699|FG007|Overall Study|Adverse Event|2|||
156651951|NCT01689974|565472700|FG000|Overall Study|Termination of Study|5|||
156651952|NCT01689974|565472701|FG001|Overall Study|Termination of Study|5|||
156651953|NCT01388647|565472704|FG000|Overall Study|Adverse Event|1|||
156651954|NCT01388647|565472705|FG001|Overall Study|Adverse Event|2|||
156651955|NCT01006707|565472706|FG000|Study Session 1|Lost to Follow-up|2|||
156651956|NCT01006707|565472707|FG001|Study Session 1|Lost to Follow-up|0|||
156651957|NCT01006707|565472708|FG002|Study Session 1|Lost to Follow-up|0|||
156651958|NCT01006707|565472706|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
156651959|NCT01006707|565472707|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
156651960|NCT01006707|565472708|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
156651961|NCT00952484|565472709|FG000|Overall Study|Withdrawal by Subject|0|||
156651962|NCT00952484|565472710|FG001|Overall Study|Withdrawal by Subject|1|||
156651963|NCT00952484|565472711|FG002|Overall Study|Withdrawal by Subject|0|||
156651964|NCT02750306|565472712|FG000|Overall Study|Withdrawal by Subject|5|||
156651965|NCT02750306|565472713|FG001|Overall Study|Withdrawal by Subject|2|||
156651966|NCT02750306|565472712|FG000|Overall Study|Protocol Violation|1|||
156651967|NCT02750306|565472713|FG001|Overall Study|Protocol Violation|0|||
156651968|NCT00192296|565472716|FG000|Overall Study|Withdrawal by Subject|0|||
156651969|NCT00192296|565472717|FG001|Overall Study|Withdrawal by Subject|1|||
156651970|NCT00192296|565472718|FG002|Overall Study|Withdrawal by Subject|0|||
156651971|NCT00192296|565472719|FG003|Overall Study|Withdrawal by Subject|0|||
156651972|NCT04317781|565472723|FG000|Overall Study|Adverse Event|1|||
156651973|NCT04317781|565472723|FG000|Overall Study|Disease relapse|1|||
156651974|NCT04317781|565472723|FG000|Overall Study|Withdrawal by Subject|1|||
156651975|NCT02087059|565472725|FG000|Overall Study|Disease Progression|1|||
156651976|NCT02087059|565472725|FG000|Overall Study|Adverse Event|5|||
156651977|NCT02087059|565472725|FG000|Overall Study|Lost to Follow-up|1|||
156651978|NCT01851590|565472727|FG000|Overall Study|Withdrawal by Subject|0|||
156651979|NCT01851590|565472728|FG001|Overall Study|Withdrawal by Subject|0|||
156313464|NCT00422084|564246345|FG000|Overall Study|P. vivax infection|3|||
156313465|NCT00422084|564246346|FG001|Overall Study|P. vivax infection|6|||
156313466|NCT00422084|564246345|FG000|Overall Study|Cyesis|1|||
156313467|NCT00422084|564246346|FG001|Overall Study|Cyesis|0|||
156313468|NCT00422084|564246345|FG000|Overall Study|Withdrawn from study accidentally|1|||
156313469|NCT00422084|564246346|FG001|Overall Study|Withdrawn from study accidentally|0|||
156313470|NCT00422084|564246345|FG000|Overall Study|Non-compliance|1|||
156313471|NCT00422084|564246346|FG001|Overall Study|Non-compliance|0|||
156313472|NCT00422084|564246345|FG000|Overall Study|Re-location|0|||
156313473|NCT00422084|564246346|FG001|Overall Study|Re-location|1|||
156313474|NCT00422084|564246345|FG000|Overall Study|Not defined|1|||
156313475|NCT00422084|564246346|FG001|Overall Study|Not defined|1|||
156313476|NCT03774823|564246347|FG000|Overall Study|Withdrawal by Subject|1|||
156313477|NCT03774823|564246348|FG001|Overall Study|Withdrawal by Subject|1|||
156313478|NCT03996369|564246357|FG000|Overall Study|Protocol deviation|1|||
156313479|NCT03996369|564246358|FG001|Overall Study|Protocol deviation|1|||
156313480|NCT03996369|564246357|FG000|Overall Study|Physician Decision|4|||
156313481|NCT03996369|564246358|FG001|Overall Study|Physician Decision|2|||
156313482|NCT03996369|564246357|FG000|Overall Study|Participant decision|0|||
156313483|NCT03996369|564246358|FG001|Overall Study|Participant decision|1|||
156313484|NCT03996369|564246357|FG000|Overall Study|Lack of Efficacy|4|||
156313485|NCT03996369|564246358|FG001|Overall Study|Lack of Efficacy|0|||
156313486|NCT03996369|564246357|FG000|Overall Study|Adverse Event|9|||
156313487|NCT03996369|564246358|FG001|Overall Study|Adverse Event|0|||
156313488|NCT03996369|564246357|FG000|Overall Study|Withdrawal by Subject|6|||
156313489|NCT03996369|564246358|FG001|Overall Study|Withdrawal by Subject|8|||
156313490|NCT03996369|564246357|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
156313491|NCT03996369|564246358|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
156313492|NCT03996369|564246357|FG000|Overall Study|Lost to Follow-up|0|||
156313493|NCT03996369|564246358|FG001|Overall Study|Lost to Follow-up|1|||
156313494|NCT00329849|564246359|FG000|Overall Study|Withdrawal by Subject|6|||
156313495|NCT00329849|564246360|FG001|Overall Study|Withdrawal by Subject|4|||
156313496|NCT01579812|564246366|FG000|Overall Study|Ineligible after treatment start|40|||
156313497|NCT01579812|564246366|FG000|Overall Study|Patient choice|3|||
156313498|NCT01579812|564246366|FG000|Overall Study|Noncompliance|3|||
156313499|NCT01579812|564246366|FG000|Overall Study|Withdrawal by Subject|6|||
156313500|NCT00653432|564246368|FG000|Overall Study|Adverse Event|4|||
156313501|NCT00653432|564246369|FG001|Overall Study|Adverse Event|1|||
156313502|NCT00653432|564246368|FG000|Overall Study|Withdrawal by Subject|4|||
156313503|NCT00653432|564246369|FG001|Overall Study|Withdrawal by Subject|5|||
156313504|NCT00653432|564246368|FG000|Overall Study|Lost to Follow-up|7|||
156755891|NCT02559570|565858551|FG002|Overall Study|Protocol Violation|0|||
156755892|NCT02559570|565858552|FG003|Overall Study|Protocol Violation|0|||
156755893|NCT02559570|565858553|FG004|Overall Study|Protocol Violation|1|||
156755894|NCT02559570|565858549|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156755895|NCT02559570|565858550|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156755896|NCT02559570|565858551|FG002|Overall Study|Other Miscellaneous Reasons|1|||
156755897|NCT02559570|565858552|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156755898|NCT02559570|565858553|FG004|Overall Study|Other Miscellaneous Reasons|0|||
156755899|NCT00184093|565858557|FG000|Overall Study|Adverse Event|3|||
156755900|NCT00184093|565858557|FG000|Overall Study|Lost to Follow-up|3|||
156755901|NCT00184093|565858557|FG000|Overall Study|Physician Decision|1|||
156755902|NCT00184093|565858557|FG000|Overall Study|Withdrawal by Subject|2|||
156755903|NCT01903993|565858558|FG000|Overall Study|Death|118|||
156313505|NCT00653432|564246369|FG001|Overall Study|Lost to Follow-up|6|||
156313506|NCT00653432|564246368|FG000|Overall Study|Use/Need of Con Therapy|2|||
156313507|NCT00653432|564246369|FG001|Overall Study|Use/Need of Con Therapy|1|||
156313508|NCT00653432|564246368|FG000|Overall Study|Other - Reason Not Provided|5|||
156313509|NCT00653432|564246369|FG001|Overall Study|Other - Reason Not Provided|3|||
156313510|NCT01133990|564246370|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
156313511|NCT01133990|564246371|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156313512|NCT01133990|564246372|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156313513|NCT01133990|564246373|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156313514|NCT01133990|564246374|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156313515|NCT01133990|564246375|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156313516|NCT01133990|564246370|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
156313517|NCT01133990|564246371|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156313518|NCT01133990|564246372|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156313519|NCT01133990|564246373|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156313520|NCT01133990|564246374|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156313521|NCT01133990|564246375|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156313522|NCT01133990|564246370|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
156313523|NCT01133990|564246371|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156313524|NCT01133990|564246372|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156313525|NCT01133990|564246373|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156313526|NCT01133990|564246374|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156313527|NCT01133990|564246375|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156313528|NCT01133990|564246370|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
156313529|NCT01133990|564246371|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156313530|NCT01133990|564246372|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156313531|NCT01133990|564246373|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156313532|NCT01133990|564246374|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156313533|NCT01133990|564246375|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156313534|NCT05277337|564246376|FG000|Overall Study|Lost to Follow-up|2|||
156313535|NCT05277337|564246377|FG001|Overall Study|Lost to Follow-up|0|||
156313536|NCT05277337|564246376|FG000|Overall Study|Withdrawal by Subject|1|||
156313537|NCT05277337|564246377|FG001|Overall Study|Withdrawal by Subject|0|||
156313538|NCT01782469|564246378|FG000|Overall Study|Lost to Follow-up|1|||
156313539|NCT01185301|564246379|FG000|Overall Study|Adverse Event|3|||
156313540|NCT01185301|564246380|FG001|Overall Study|Adverse Event|0|||
156313541|NCT01185301|564246381|FG002|Overall Study|Adverse Event|2|||
156313542|NCT01185301|564246382|FG003|Overall Study|Adverse Event|3|||
156313543|NCT01185301|564246379|FG000|Overall Study|Withdrawal by Subject|7|||
156313544|NCT01185301|564246380|FG001|Overall Study|Withdrawal by Subject|5|||
156313545|NCT01185301|564246381|FG002|Overall Study|Withdrawal by Subject|2|||
156313546|NCT01185301|564246382|FG003|Overall Study|Withdrawal by Subject|3|||
156313547|NCT01185301|564246379|FG000|Overall Study|Lost to Follow-up|2|||
156313548|NCT01185301|564246380|FG001|Overall Study|Lost to Follow-up|0|||
156313549|NCT01185301|564246381|FG002|Overall Study|Lost to Follow-up|0|||
156313550|NCT01185301|564246382|FG003|Overall Study|Lost to Follow-up|1|||
156313551|NCT01185301|564246379|FG000|Overall Study|Other Reason|3|||
156313552|NCT01185301|564246380|FG001|Overall Study|Other Reason|2|||
156313553|NCT01185301|564246381|FG002|Overall Study|Other Reason|2|||
156313554|NCT01185301|564246382|FG003|Overall Study|Other Reason|2|||
156313555|NCT03726996|564246383|FG000|Overall Study|Parent's decision|2|||
156313556|NCT03726996|564246383|FG000|Overall Study|Study early termination|2|||
156313557|NCT03531632|564246388|FG000|Overall Study|Adverse Event|0|||
156313558|NCT03531632|564246389|FG001|Overall Study|Adverse Event|0|||
156313559|NCT03531632|564246390|FG002|Overall Study|Adverse Event|1|||
156313560|NCT03531632|564246388|FG000|Overall Study|Death|4|||
156755904|NCT01903993|565858559|FG001|Overall Study|Death|121|||
156755905|NCT01903993|565858558|FG000|Overall Study|Withdrawal by Subject|15|||
156755906|NCT01903993|565858559|FG001|Overall Study|Withdrawal by Subject|4|||
156755907|NCT01903993|565858558|FG000|Overall Study|Lost to Follow-up|2|||
156755908|NCT01903993|565858559|FG001|Overall Study|Lost to Follow-up|3|||
156755909|NCT01903993|565858558|FG000|Overall Study|Study Terminated by Sponsor|8|||
156651980|NCT01851590|565472729|FG002|Overall Study|Withdrawal by Subject|1|||
156651981|NCT01851590|565472727|FG000|Overall Study|Adverse Event|0|||
156651982|NCT01851590|565472728|FG001|Overall Study|Adverse Event|0|||
156651983|NCT01851590|565472729|FG002|Overall Study|Adverse Event|2|||
156651984|NCT01851590|565472727|FG000|Overall Study|Lack of Efficacy|0|||
156651985|NCT01851590|565472728|FG001|Overall Study|Lack of Efficacy|1|||
156651986|NCT01851590|565472729|FG002|Overall Study|Lack of Efficacy|0|||
156651987|NCT00696709|565472731|FG000|Overall Study|Withdrawal by Subject|1|||
156651988|NCT00696709|565472732|FG001|Overall Study|Withdrawal by Subject|2|||
156651989|NCT00696709|565472733|FG002|Overall Study|Withdrawal by Subject|1|||
156651990|NCT00696709|565472734|FG003|Overall Study|Withdrawal by Subject|4|||
156651991|NCT00696709|565472735|FG004|Overall Study|Withdrawal by Subject|3|||
156651992|NCT00696709|565472731|FG000|Overall Study|Protocol Violation|1|||
156651993|NCT00696709|565472732|FG001|Overall Study|Protocol Violation|0|||
156651994|NCT00696709|565472733|FG002|Overall Study|Protocol Violation|0|||
156651995|NCT00696709|565472734|FG003|Overall Study|Protocol Violation|0|||
156651996|NCT00696709|565472735|FG004|Overall Study|Protocol Violation|0|||
156651997|NCT00696709|565472731|FG000|Overall Study|Lost to Follow-up|1|||
156651998|NCT00696709|565472732|FG001|Overall Study|Lost to Follow-up|1|||
156651999|NCT00696709|565472733|FG002|Overall Study|Lost to Follow-up|0|||
156652000|NCT00696709|565472734|FG003|Overall Study|Lost to Follow-up|0|||
156652001|NCT00696709|565472735|FG004|Overall Study|Lost to Follow-up|0|||
156652002|NCT00696709|565472731|FG000|Overall Study|Adverse Event|0|||
156652003|NCT00696709|565472732|FG001|Overall Study|Adverse Event|0|||
156652004|NCT00696709|565472733|FG002|Overall Study|Adverse Event|0|||
156652005|NCT00696709|565472734|FG003|Overall Study|Adverse Event|1|||
156652006|NCT00696709|565472735|FG004|Overall Study|Adverse Event|0|||
156652007|NCT00310856|565472736|FG000|Overall Study|Withdrawal by Subject|2|||
156652008|NCT00310856|565472737|FG001|Overall Study|Withdrawal by Subject|2|||
156652009|NCT00310856|565472738|FG002|Overall Study|Withdrawal by Subject|2|||
156652010|NCT00310856|565472736|FG000|Overall Study|Lost to Follow-up|1|||
156652011|NCT00310856|565472737|FG001|Overall Study|Lost to Follow-up|2|||
156652012|NCT00310856|565472738|FG002|Overall Study|Lost to Follow-up|6|||
156652013|NCT00310856|565472736|FG000|Overall Study|Inappropriate enrollment|1|||
156652014|NCT00310856|565472737|FG001|Overall Study|Inappropriate enrollment|1|||
156652015|NCT00310856|565472738|FG002|Overall Study|Inappropriate enrollment|0|||
156652016|NCT00310856|565472736|FG000|Overall Study|Unable to classify|1|||
156652017|NCT00310856|565472737|FG001|Overall Study|Unable to classify|0|||
156652018|NCT00310856|565472738|FG002|Overall Study|Unable to classify|0|||
156652019|NCT00321711|565472742|FG000|Part A|Adverse Event|3|||
156652020|NCT00321711|565472743|FG001|Part A|Adverse Event|3|||
156652021|NCT00321711|565472744|FG002|Part A|Adverse Event|2|||
156652022|NCT00321711|565472745|FG003|Part A|Adverse Event|0|||
156652023|NCT00321711|565472746|FG004|Part A|Adverse Event|0|||
156652024|NCT00321711|565472742|FG000|Part A|Withdrawal by Subject|1|||
156652025|NCT00321711|565472743|FG001|Part A|Withdrawal by Subject|1|||
156652026|NCT00321711|565472744|FG002|Part A|Withdrawal by Subject|1|||
156652027|NCT00321711|565472745|FG003|Part A|Withdrawal by Subject|0|||
156652028|NCT00321711|565472746|FG004|Part A|Withdrawal by Subject|0|||
156652029|NCT00321711|565472742|FG000|Part A|Disease progression|0|||
156652030|NCT00321711|565472743|FG001|Part A|Disease progression|1|||
156652031|NCT00321711|565472744|FG002|Part A|Disease progression|0|||
156652032|NCT00321711|565472745|FG003|Part A|Disease progression|0|||
156652033|NCT00321711|565472746|FG004|Part A|Disease progression|0|||
156652034|NCT00321711|565472742|FG000|Part A|Requirement for alternative therapy|0|||
156652035|NCT00321711|565472743|FG001|Part A|Requirement for alternative therapy|2|||
156652036|NCT00321711|565472744|FG002|Part A|Requirement for alternative therapy|1|||
156652037|NCT00321711|565472745|FG003|Part A|Requirement for alternative therapy|0|||
156652038|NCT00321711|565472746|FG004|Part A|Requirement for alternative therapy|0|||
156652039|NCT00321711|565472742|FG000|Part A|Physician Decision|0|||
156652040|NCT00321711|565472743|FG001|Part A|Physician Decision|1|||
156652041|NCT00321711|565472744|FG002|Part A|Physician Decision|3|||
156652042|NCT00321711|565472745|FG003|Part A|Physician Decision|0|||
156652043|NCT00321711|565472746|FG004|Part A|Physician Decision|0|||
156652044|NCT00321711|565472742|FG000|Part A|Other|1|||
156652045|NCT00321711|565472743|FG001|Part A|Other|2|||
156652046|NCT00321711|565472744|FG002|Part A|Other|3|||
156652047|NCT00321711|565472745|FG003|Part A|Other|0|||
156652048|NCT00321711|565472746|FG004|Part A|Other|0|||
156652049|NCT00321711|565472742|FG000|Part A|Protocol deviation|0|||
156755910|NCT01903993|565858559|FG001|Overall Study|Study Terminated by Sponsor|14|||
156652050|NCT00321711|565472743|FG001|Part A|Protocol deviation|0|||
156652051|NCT00321711|565472744|FG002|Part A|Protocol deviation|1|||
156652052|NCT00321711|565472745|FG003|Part A|Protocol deviation|0|||
156652053|NCT00321711|565472746|FG004|Part A|Protocol deviation|0|||
156652054|NCT00321711|565472742|FG000|Part B|Noncompliance|0|||
156652055|NCT00321711|565472743|FG001|Part B|Noncompliance|0|||
156652056|NCT00321711|565472744|FG002|Part B|Noncompliance|0|||
156652057|NCT00321711|565472745|FG003|Part B|Noncompliance|0|||
156652058|NCT00321711|565472746|FG004|Part B|Noncompliance|1|||
156652059|NCT00321711|565472742|FG000|Part B|Adverse Event|0|||
156652060|NCT00321711|565472743|FG001|Part B|Adverse Event|0|||
156755911|NCT01903993|565858558|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
156755912|NCT01903993|565858559|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
156755913|NCT05095311|565858560|FG000|Overall Study|Lost to Follow-up|7|||
156755914|NCT05095311|565858561|FG001|Overall Study|Lost to Follow-up|0|||
156755915|NCT05095311|565858562|FG002|Overall Study|Lost to Follow-up|0|||
156755916|NCT03283930|565858564|FG000|Overall Study|Scheduling conflict|8|||
156755917|NCT03283930|565858565|FG001|Overall Study|Scheduling conflict|10|||
156755918|NCT03283930|565858564|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
156755919|NCT03283930|565858565|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
156755920|NCT03283930|565858564|FG000|Overall Study|Technical software issue|2|||
156755921|NCT03283930|565858565|FG001|Overall Study|Technical software issue|2|||
156755922|NCT00805129|565858566|FG000|Overall Study|Not treated|1|||
156755923|NCT00571662|565858569|FG000|Overall Study|Withdrawal by Subject|2|||
156755924|NCT00571662|565858569|FG000|Overall Study|psychiatric instability|1|||
156755925|NCT00571662|565858569|FG000|Overall Study|Adverse Event|5|||
156755926|NCT02588664|565858572|FG000|Overall Study|Death|56|||
156755927|NCT02588664|565858573|FG001|Overall Study|Death|55|||
156755928|NCT02588664|565858572|FG000|Overall Study|Lost to Follow-up|1305|||
156755929|NCT02588664|565858573|FG001|Overall Study|Lost to Follow-up|990|||
156755930|NCT01429298|565858574|FG000|Overall Study|Protocol Violation|4|||
156755931|NCT01429298|565858575|FG001|Overall Study|Protocol Violation|6|||
156755932|NCT03681184|565858576|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
156755933|NCT03681184|565858577|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
156755934|NCT02500719|565858580|FG000|Overall Study|Lost to Follow-up|2|||
156755935|NCT02500719|565858581|FG001|Overall Study|Lost to Follow-up|3|||
156755936|NCT02500719|565858580|FG000|Overall Study|Trauma history|1|||
156755937|NCT02500719|565858581|FG001|Overall Study|Trauma history|0|||
156755938|NCT02500719|565858580|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
156755939|NCT02500719|565858581|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
156755940|NCT02500719|565858580|FG000|Overall Study|Did not meet criteria for PTSD|0|||
156755941|NCT02500719|565858581|FG001|Overall Study|Did not meet criteria for PTSD|1|||
156755942|NCT02500719|565858580|FG000|Overall Study|Claustrophobia|0|||
156755943|NCT02500719|565858581|FG001|Overall Study|Claustrophobia|1|||
156755944|NCT02500719|565858580|FG000|Overall Study|History of head trauma|0|||
156755945|NCT02500719|565858581|FG001|Overall Study|History of head trauma|1|||
156755946|NCT02710084|565858582|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
156755947|NCT02710084|565858583|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
156755948|NCT00181883|565858584|FG000|Overall Study|Lack of Efficacy|2|||
156755949|NCT00181883|565858584|FG000|Overall Study|Treatment Limiting AEs|3|||
156755950|NCT00181883|565858584|FG000|Overall Study|Withdrawal by Subject|4|||
156755951|NCT00181883|565858584|FG000|Overall Study|Lost to Follow-up|1|||
156755952|NCT05305989|565858585|FG000|Overall Study|Other|3|||
156755953|NCT05305989|565858586|FG001|Overall Study|Other|2|||
156755954|NCT05305989|565858587|FG002|Overall Study|Other|0|||
156755955|NCT05305989|565858585|FG000|Overall Study|Sponsor decision|2|||
156755956|NCT05305989|565858586|FG001|Overall Study|Sponsor decision|1|||
156755957|NCT05305989|565858587|FG002|Overall Study|Sponsor decision|0|||
156755958|NCT05305989|565858585|FG000|Overall Study|Protocol Violation|0|||
156755959|NCT05305989|565858586|FG001|Overall Study|Protocol Violation|1|||
156755960|NCT05305989|565858587|FG002|Overall Study|Protocol Violation|0|||
156755961|NCT05305989|565858585|FG000|Overall Study|Investigator decision|1|||
156755962|NCT05305989|565858586|FG001|Overall Study|Investigator decision|2|||
156755963|NCT05305989|565858587|FG002|Overall Study|Investigator decision|0|||
156755964|NCT05305989|565858585|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
156755965|NCT05305989|565858586|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
156755966|NCT05305989|565858587|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
156755967|NCT05305989|565858585|FG000|Overall Study|Adverse Event|1|||
156755968|NCT05305989|565858586|FG001|Overall Study|Adverse Event|1|||
156755969|NCT05305989|565858587|FG002|Overall Study|Adverse Event|0|||
156755970|NCT05305989|565858585|FG000|Overall Study|Enrolled but never dosed|3|||
156755971|NCT05305989|565858586|FG001|Overall Study|Enrolled but never dosed|2|||
156313561|NCT03531632|564246389|FG001|Overall Study|Death|0|||
156755972|NCT05305989|565858587|FG002|Overall Study|Enrolled but never dosed|1|||
156755973|NCT00282152|565858588|FG000|Overall Study|Withdrawal by Subject|1|||
156755974|NCT00282152|565858589|FG001|Overall Study|Withdrawal by Subject|0|||
156755975|NCT03301831|565858590|FG000|Overall Study|Lost to Follow-up|5|||
156755976|NCT03301831|565858591|FG001|Overall Study|Lost to Follow-up|3|||
156755977|NCT03301831|565858590|FG000|Overall Study|Protocol Violation|4|||
156755978|NCT03301831|565858591|FG001|Overall Study|Protocol Violation|0|||
156755979|NCT03301831|565858590|FG000|Overall Study|Withdrawal by Subject|11|||
156755980|NCT03301831|565858591|FG001|Overall Study|Withdrawal by Subject|0|||
156755981|NCT00585325|565858592|FG000|Overall Study|Withdrawal by Subject|1|||
156755982|NCT00585325|565858593|FG001|Overall Study|Withdrawal by Subject|1|||
156755983|NCT00154375|565858594|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
156755984|NCT00154375|565858595|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
156755985|NCT00154375|565858594|FG000|Overall Study|Adverse Event|18|||
156755986|NCT00154375|565858595|FG001|Overall Study|Adverse Event|20|||
156755987|NCT00154375|565858594|FG000|Overall Study|Withdrawal by Subject|14|||
156755988|NCT00154375|565858595|FG001|Overall Study|Withdrawal by Subject|10|||
156755989|NCT00154375|565858594|FG000|Overall Study|Death|5|||
156755990|NCT00154375|565858595|FG001|Overall Study|Death|13|||
156755991|NCT00154375|565858594|FG000|Overall Study|Study drug no longer required|5|||
156755992|NCT00154375|565858595|FG001|Overall Study|Study drug no longer required|3|||
156755993|NCT00154375|565858594|FG000|Overall Study|Lost to Follow-up|2|||
156755994|NCT00154375|565858595|FG001|Overall Study|Lost to Follow-up|1|||
156755995|NCT00154375|565858594|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156755996|NCT00154375|565858595|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156755997|NCT00154375|565858594|FG000|Overall Study|Protocol Violation|0|||
156755998|NCT00154375|565858595|FG001|Overall Study|Protocol Violation|1|||
156755999|NCT00154375|565858594|FG000|Overall Study|Suspected progression of disease|44|||
156756000|NCT00154375|565858595|FG001|Overall Study|Suspected progression of disease|30|||
156756001|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
156756002|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
156756003|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
156756004|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
156756005|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
156756006|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
156756007|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
156756008|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
156756009|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
156756010|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
156756011|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
156756012|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
156756013|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
156756014|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
156756015|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
156756016|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
156756017|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
156756018|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
156756019|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
156756020|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
156756021|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
156756022|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
156756023|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
156756024|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
156756025|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
156756026|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
156756027|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
156756028|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
156756029|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
156756030|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
156756031|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
156756032|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
156756033|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
156756034|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
156756035|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
156756036|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
156756037|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
156756038|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
156756039|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
156414483|NCT01154036|564610975|FG005|Phase I|Withdrawal by Subject|0|||
156756040|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
156756041|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
156756042|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
156756043|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
156756044|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
156756045|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
156756046|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
156414484|NCT01154036|564610976|FG006|Phase I|Withdrawal by Subject|0|||
156414485|NCT01154036|564610977|FG007|Phase I|Withdrawal by Subject|0|||
156414486|NCT01154036|564610970|FG000|Phase I|Adverse Event|1|||
156414487|NCT01154036|564610971|FG001|Phase I|Adverse Event|11|||
156414488|NCT01154036|564610972|FG002|Phase I|Adverse Event|12|||
156414489|NCT01154036|564610973|FG003|Phase I|Adverse Event|0|||
156414490|NCT01154036|564610974|FG004|Phase I|Adverse Event|0|||
156414491|NCT01154036|564610975|FG005|Phase I|Adverse Event|0|||
156414492|NCT01154036|564610976|FG006|Phase I|Adverse Event|0|||
156414493|NCT01154036|564610977|FG007|Phase I|Adverse Event|0|||
156414494|NCT01154036|564610970|FG000|Phase II|Adverse Event|0|||
156652061|NCT00321711|565472744|FG002|Part B|Adverse Event|0|||
156652062|NCT00321711|565472745|FG003|Part B|Adverse Event|2|||
156652063|NCT00321711|565472746|FG004|Part B|Adverse Event|1|||
156652064|NCT00321711|565472742|FG000|Part B|Disease progression|0|||
156652065|NCT00321711|565472743|FG001|Part B|Disease progression|0|||
156652066|NCT00321711|565472744|FG002|Part B|Disease progression|0|||
156652067|NCT00321711|565472745|FG003|Part B|Disease progression|1|||
156652068|NCT00321711|565472746|FG004|Part B|Disease progression|0|||
156652069|NCT00321711|565472742|FG000|Part B|Physician Decision|0|||
156652070|NCT00321711|565472743|FG001|Part B|Physician Decision|0|||
156652071|NCT00321711|565472744|FG002|Part B|Physician Decision|0|||
156652072|NCT00321711|565472745|FG003|Part B|Physician Decision|1|||
156652073|NCT00321711|565472746|FG004|Part B|Physician Decision|2|||
156652074|NCT00321711|565472742|FG000|Part B|Death|0|||
156652075|NCT00321711|565472743|FG001|Part B|Death|0|||
156652076|NCT00321711|565472744|FG002|Part B|Death|0|||
156652077|NCT00321711|565472745|FG003|Part B|Death|2|||
156652078|NCT00321711|565472746|FG004|Part B|Death|1|||
156652079|NCT02843074|565472747|FG000|Overall Study|Withdrawal by Subject|5|||
156652080|NCT02843074|565472747|FG000|Overall Study|Progressive disease|1|||
156652081|NCT02843074|565472747|FG000|Overall Study|Physician Decision|1|||
156652082|NCT02843074|565472747|FG000|Overall Study|Lost to Follow-up|1|||
156652083|NCT02843074|565472747|FG000|Overall Study|Death|9|||
156652084|NCT01564758|565472748|FG000|Overall Study|Death|8|||
156652085|NCT01564758|565472748|FG000|Overall Study|Adverse Event|3|||
156652086|NCT01564758|565472748|FG000|Overall Study|Other|3|||
156652087|NCT01186978|565472749|FG000|Overall Study|Withdrawal by Subject|1|||
156652088|NCT01227668|565472750|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
156652089|NCT01227668|565472751|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
156652090|NCT01227668|565472750|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
156652091|NCT01227668|565472751|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
156652092|NCT01227668|565472750|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
156652093|NCT01227668|565472751|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
156652094|NCT01227668|565472750|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
156652095|NCT01227668|565472751|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
156652096|NCT01227668|565472750|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
156652097|NCT01227668|565472751|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
156652098|NCT01227668|565472750|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
156652099|NCT01227668|565472751|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
156652100|NCT01227668|565472750|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
156652101|NCT01227668|565472751|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
156652102|NCT01227668|565472750|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
156652103|NCT01227668|565472751|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
156652104|NCT01227668|565472750|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
156652105|NCT01227668|565472751|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
156652106|NCT01227668|565472750|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
156652107|NCT01227668|565472751|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
156652108|NCT01227668|565472750|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
156652109|NCT01227668|565472751|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
156652110|NCT01227668|565472750|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
156652111|NCT01227668|565472751|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
156652112|NCT01306253|565472755|FG000|Overall Study|Lost to Follow-up|1|||
156652113|NCT01306253|565472756|FG001|Overall Study|Lost to Follow-up|1|||
156652114|NCT01261325|565472757|FG000|Overall Study|Lack of Efficacy|1|||
156652115|NCT01261325|565472758|FG001|Overall Study|Lack of Efficacy|1|||
156652116|NCT01261325|565472759|FG002|Overall Study|Lack of Efficacy|0|||
156652117|NCT01261325|565472757|FG000|Overall Study|Withdrawal by Subject|2|||
156652118|NCT01261325|565472758|FG001|Overall Study|Withdrawal by Subject|2|||
156414495|NCT01154036|564610971|FG001|Phase II|Adverse Event|0|||
156414496|NCT01154036|564610972|FG002|Phase II|Adverse Event|0|||
156414497|NCT01154036|564610973|FG003|Phase II|Adverse Event|0|||
156652119|NCT01261325|565472759|FG002|Overall Study|Withdrawal by Subject|4|||
156652120|NCT01261325|565472757|FG000|Overall Study|SAE, non-fatal|1|||
156652121|NCT01261325|565472758|FG001|Overall Study|SAE, non-fatal|5|||
156652122|NCT01261325|565472759|FG002|Overall Study|SAE, non-fatal|1|||
156652123|NCT01261325|565472757|FG000|Overall Study|AE, non-serious non-fatal|9|||
156652124|NCT01261325|565472758|FG001|Overall Study|AE, non-serious non-fatal|15|||
156652125|NCT01261325|565472759|FG002|Overall Study|AE, non-serious non-fatal|13|||
156756047|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
156756048|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
156756049|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
156756050|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
156756051|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
156756052|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
156756053|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
156756054|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
156756055|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
156756056|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
156756057|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
156756058|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
156756059|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
156756060|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
156756061|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
156756062|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
156756063|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
156756064|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
156756065|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
156756066|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
156756067|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
156756068|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
156756069|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
156756070|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
156756071|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
156756072|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
156756073|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756074|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
156756075|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756076|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756077|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
156756078|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
156756079|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
156756080|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
156756081|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
156756082|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
156313562|NCT03531632|564246390|FG002|Overall Study|Death|14|||
156313563|NCT03531632|564246388|FG000|Overall Study|Study Terminated|1|||
156313564|NCT03531632|564246389|FG001|Overall Study|Study Terminated|3|||
156313565|NCT03531632|564246390|FG002|Overall Study|Study Terminated|11|||
156313566|NCT01224782|564246393|FG000|Overall Study|Lost to Follow-up|177|||
156313567|NCT01224782|564246393|FG000|Overall Study|Withdrawal by Subject|16|||
156313568|NCT01224782|564246393|FG000|Overall Study|Death|14|||
156313569|NCT01224782|564246393|FG000|Overall Study|Improvement|13|||
156313570|NCT01224782|564246393|FG000|Overall Study|Adverse Event|12|||
156313571|NCT01224782|564246393|FG000|Overall Study|Adverse Reaction|11|||
156313572|NCT01224782|564246393|FG000|Overall Study|Noncompliance|10|||
156313573|NCT01224782|564246393|FG000|Overall Study|Other|4|||
156313574|NCT01224782|564246393|FG000|Overall Study|Start of Dialysis|3|||
156313575|NCT01224782|564246393|FG000|Overall Study|Change of Treatment|1|||
156313576|NCT01224782|564246393|FG000|Overall Study|Financial Reasons|1|||
156313577|NCT01224782|564246393|FG000|Overall Study|Deterioration|1|||
156313578|NCT01224782|564246393|FG000|Overall Study|Transplantation|1|||
156313579|NCT00065429|564246394|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156313580|NCT00065429|564246395|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156313581|NCT00065429|564246396|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156313582|NCT00065429|564246397|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156313583|NCT00065429|564246398|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156313584|NCT00065429|564246399|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
156313585|NCT00065429|564246400|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156313586|NCT00065429|564246394|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156313587|NCT00065429|564246395|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156313588|NCT00065429|564246396|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
156313589|NCT00065429|564246397|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156414498|NCT01154036|564610974|FG004|Phase II|Adverse Event|1|||
156313590|NCT00065429|564246398|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156313591|NCT00065429|564246399|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156414499|NCT01154036|564610975|FG005|Phase II|Adverse Event|1|||
156414500|NCT01154036|564610976|FG006|Phase II|Adverse Event|1|||
156414501|NCT01154036|564610977|FG007|Phase II|Adverse Event|1|||
156414502|NCT01154036|564610970|FG000|Phase II|Physician Decision|0|||
156414503|NCT01154036|564610971|FG001|Phase II|Physician Decision|0|||
156414504|NCT01154036|564610972|FG002|Phase II|Physician Decision|0|||
156652126|NCT01261325|565472757|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156652127|NCT01261325|565472758|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156652128|NCT01261325|565472759|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156652129|NCT01261325|565472757|FG000|Overall Study|Non Compliance|2|||
156652130|NCT01261325|565472758|FG001|Overall Study|Non Compliance|0|||
156652131|NCT01261325|565472759|FG002|Overall Study|Non Compliance|0|||
156652132|NCT01261325|565472757|FG000|Overall Study|Patient Randomized by Mistake|0|||
156652133|NCT01261325|565472758|FG001|Overall Study|Patient Randomized by Mistake|1|||
156652134|NCT01261325|565472759|FG002|Overall Study|Patient Randomized by Mistake|0|||
156652135|NCT01261325|565472757|FG000|Overall Study|Erroneously Randomized|1|||
156652136|NCT01261325|565472758|FG001|Overall Study|Erroneously Randomized|0|||
156652137|NCT01261325|565472759|FG002|Overall Study|Erroneously Randomized|0|||
156652138|NCT01261325|565472757|FG000|Overall Study|Screen Failure|1|||
156652139|NCT01261325|565472758|FG001|Overall Study|Screen Failure|0|||
156652140|NCT01261325|565472759|FG002|Overall Study|Screen Failure|0|||
156652141|NCT01261325|565472757|FG000|Overall Study|Randomized in Error|0|||
156652142|NCT01261325|565472758|FG001|Overall Study|Randomized in Error|0|||
156652143|NCT01261325|565472759|FG002|Overall Study|Randomized in Error|1|||
156652144|NCT01261325|565472757|FG000|Overall Study|Protocol Violation|0|||
156652145|NCT01261325|565472758|FG001|Overall Study|Protocol Violation|3|||
156652146|NCT01261325|565472759|FG002|Overall Study|Protocol Violation|1|||
156652147|NCT01261325|565472757|FG000|Overall Study|Lost to Follow-up|0|||
156652148|NCT01261325|565472758|FG001|Overall Study|Lost to Follow-up|1|||
156652149|NCT01261325|565472759|FG002|Overall Study|Lost to Follow-up|3|||
156652150|NCT01261325|565472757|FG000|Overall Study|AE, serious fatal|0|||
156652151|NCT01261325|565472758|FG001|Overall Study|AE, serious fatal|0|||
156652152|NCT01261325|565472759|FG002|Overall Study|AE, serious fatal|2|||
156652153|NCT00543439|565472760|FG000|Period 1|Adverse Event|0|||
156652154|NCT00543439|565472761|FG001|Period 1|Adverse Event|2|||
156652155|NCT00543439|565472762|FG002|Period 1|Adverse Event|1|||
156652156|NCT00543439|565472760|FG000|Period 1|Withdrawal by Subject|1|||
156652157|NCT00543439|565472761|FG001|Period 1|Withdrawal by Subject|1|||
156652158|NCT00543439|565472762|FG002|Period 1|Withdrawal by Subject|0|||
156652159|NCT00543439|565472760|FG000|Period 1|Physician Decision|0|||
156652160|NCT00543439|565472761|FG001|Period 1|Physician Decision|0|||
156652161|NCT00543439|565472762|FG002|Period 1|Physician Decision|1|||
156652162|NCT00543439|565472760|FG000|Period 2|Protocol Violation|1|||
156652163|NCT00543439|565472761|FG001|Period 2|Protocol Violation|0|||
156652164|NCT00543439|565472762|FG002|Period 2|Protocol Violation|1|||
156652165|NCT00543439|565472760|FG000|Period 2|Adverse Event|0|||
156652166|NCT00543439|565472761|FG001|Period 2|Adverse Event|1|||
156652167|NCT00543439|565472762|FG002|Period 2|Adverse Event|1|||
156652168|NCT01193517|565472780|FG000|Overall Study|Early Progression|1|||
156652169|NCT01193517|565472781|FG001|Overall Study|Early Progression|0|||
156652170|NCT01193517|565472782|FG002|Overall Study|Early Progression|0|||
156652171|NCT00526890|565472783|FG000|Overall Study|Adverse Event|2|||
156652172|NCT01688037|565472784|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
156652173|NCT01688037|565472785|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
156652174|NCT01688037|565472786|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
156652175|NCT01688037|565472784|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
156652176|NCT01688037|565472785|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
156652177|NCT01688037|565472786|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
156652178|NCT01688037|565472784|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
156652179|NCT01688037|565472785|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
156652180|NCT01688037|565472786|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
156652181|NCT01688037|565472784|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
156756083|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
156652182|NCT01688037|565472785|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
156652183|NCT01688037|565472786|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
156652184|NCT01688037|565472784|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
156652185|NCT01688037|565472785|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
156756084|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
156414505|NCT01154036|564610973|FG003|Phase II|Physician Decision|0|||
156652186|NCT01688037|565472786|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
156652187|NCT01688037|565472784|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
156652188|NCT01688037|565472785|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
156652189|NCT01688037|565472786|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
156652190|NCT01688037|565472784|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
156652191|NCT01688037|565472785|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
156652192|NCT01688037|565472786|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
156652193|NCT01688037|565472784|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
156414506|NCT01154036|564610974|FG004|Phase II|Physician Decision|0|||
156414507|NCT01154036|564610975|FG005|Phase II|Physician Decision|0|||
156414508|NCT01154036|564610976|FG006|Phase II|Physician Decision|1|||
156414509|NCT01154036|564610977|FG007|Phase II|Physician Decision|0|||
156414510|NCT01154036|564610970|FG000|Phase II|Lost to Follow-up|0|||
156414511|NCT01154036|564610971|FG001|Phase II|Lost to Follow-up|0|||
156652194|NCT01688037|565472785|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
156652195|NCT01688037|565472786|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
156652196|NCT01688037|565472784|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
156652197|NCT01688037|565472785|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
156652198|NCT01688037|565472786|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
156652199|NCT01688037|565472784|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
156652200|NCT01688037|565472785|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
156652201|NCT01688037|565472786|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
156652202|NCT01326026|565472791|FG000|Overall Study|Adverse Event|4|||
156652203|NCT01326026|565472792|FG001|Overall Study|Adverse Event|3|||
156652204|NCT01326026|565472791|FG000|Overall Study|Withdrawal Criteria|5|||
156652205|NCT01326026|565472792|FG001|Overall Study|Withdrawal Criteria|7|||
156652206|NCT01326026|565472791|FG000|Overall Study|Other|3|||
156652207|NCT01326026|565472792|FG001|Overall Study|Other|3|||
156652208|NCT04317053|565472793|FG000|Overall Study|Withdrawn (screen failure)|4|||
156652209|NCT04317053|565472794|FG001|Overall Study|Withdrawn (screen failure)|2|||
156652210|NCT00289458|565472795|FG000|Overall Study|Death|1|||
156652211|NCT00289458|565472796|FG001|Overall Study|Death|0|||
156652212|NCT00289458|565472797|FG002|Overall Study|Death|0|||
156652213|NCT00289458|565472795|FG000|Overall Study|Physician Decision|3|||
156652214|NCT00289458|565472796|FG001|Overall Study|Physician Decision|4|||
156652215|NCT00289458|565472797|FG002|Overall Study|Physician Decision|2|||
156652216|NCT00289458|565472795|FG000|Overall Study|Withdrawal by Subject|2|||
156652217|NCT00289458|565472796|FG001|Overall Study|Withdrawal by Subject|2|||
156652218|NCT00289458|565472797|FG002|Overall Study|Withdrawal by Subject|4|||
156652219|NCT04274192|565472798|FG000|Overall Study|Protocol Violation|1|||
156652220|NCT04274192|565472799|FG001|Overall Study|Protocol Violation|0|||
156652221|NCT00874757|565472800|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
156652222|NCT04014959|565474334|FG000|Baseline MRI and Assessments|Physician Decision|2|||
156652223|NCT04014959|565474334|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
156652224|NCT04014959|565474334|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
156652225|NCT02004847|565474336|FG000|Overall Study|Protocol Violation|1|||
156652226|NCT02004847|565474337|FG001|Overall Study|Protocol Violation|1|||
156652227|NCT00759148|565474338|FG000|Overall Study|Adverse Event|1|||
156652228|NCT00759148|565474339|FG001|Overall Study|Adverse Event|6|||
156652229|NCT00759148|565474338|FG000|Overall Study|Withdrawal by Subject|3|||
156652230|NCT00759148|565474339|FG001|Overall Study|Withdrawal by Subject|7|||
156652231|NCT00759148|565474338|FG000|Overall Study|Lost to Follow-up|3|||
156652232|NCT00759148|565474339|FG001|Overall Study|Lost to Follow-up|9|||
156652233|NCT00759148|565474338|FG000|Overall Study|Treatment Failure|6|||
156652234|NCT00759148|565474339|FG001|Overall Study|Treatment Failure|10|||
156652235|NCT00759148|565474338|FG000|Overall Study|Reason not given|1|||
156652236|NCT00759148|565474339|FG001|Overall Study|Reason not given|0|||
156652237|NCT01132118|565474340|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
156652238|NCT01132118|565474341|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
156313592|NCT00065429|564246400|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156313593|NCT00065429|564246394|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
156313594|NCT00065429|564246395|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156313595|NCT00065429|564246396|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156313596|NCT00065429|564246397|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156313597|NCT00065429|564246398|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156313598|NCT00065429|564246399|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156313599|NCT00065429|564246400|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156313600|NCT00065429|564246394|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
156313601|NCT00065429|564246395|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
156313602|NCT00065429|564246396|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
156313603|NCT00065429|564246397|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
156313604|NCT00065429|564246398|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
156313605|NCT00065429|564246399|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
156313606|NCT00065429|564246400|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
156652239|NCT01132118|565474340|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156652240|NCT01132118|565474341|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
156652241|NCT01132118|565474340|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
156652242|NCT01132118|565474341|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
156652243|NCT01644890|565474342|FG000|Overall Study|Adverse Event|7|||
156313607|NCT00065429|564246394|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
156313608|NCT00065429|564246395|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
156313609|NCT00065429|564246396|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
156414512|NCT01154036|564610972|FG002|Phase II|Lost to Follow-up|0|||
156756085|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
156756086|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
156756087|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
156756088|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
156756089|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
156756090|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
156756091|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
156756092|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
156756093|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
156756094|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
156756095|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
156756096|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
156756097|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
156756098|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
156756099|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
156756100|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
156756101|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
156756102|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
156756103|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
156756104|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
156756105|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
156756106|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
156756107|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
156756108|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
156756109|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756110|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756111|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
156756112|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
156756113|NCT00792116|565858604|FG000|Overall Study|Lost to Follow-up|0|||
156313610|NCT00065429|564246397|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
156313611|NCT00065429|564246398|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
156313612|NCT00065429|564246399|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
156313613|NCT00065429|564246400|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
156313614|NCT00065429|564246394|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156313615|NCT00065429|564246395|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156313616|NCT00065429|564246396|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156313617|NCT00065429|564246397|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156313618|NCT00065429|564246398|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
156313619|NCT00065429|564246399|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156313620|NCT00065429|564246400|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156313621|NCT00065429|564246394|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156313622|NCT00065429|564246395|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156313623|NCT00065429|564246396|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156313624|NCT00065429|564246397|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156313625|NCT00065429|564246398|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
156313626|NCT00065429|564246399|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156313627|NCT00065429|564246400|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156313628|NCT03554486|564246401|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
156313629|NCT03554486|564246402|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
156313630|NCT03554486|564246403|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
156313631|NCT03554486|564246401|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
156313632|NCT03554486|564246402|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
156313633|NCT03554486|564246403|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
156313634|NCT03554486|564246401|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156313635|NCT03554486|564246402|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
156313636|NCT03554486|564246403|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
156313637|NCT01616693|564246405|FG000|Evaluated for Safety|Physician Decision|1|||
156313638|NCT01616693|564246406|FG001|Evaluated for Safety|Physician Decision|0|||
156313639|NCT01616693|564246407|FG002|Evaluated for Safety|Physician Decision|1|||
156313640|NCT01616693|564246408|FG003|Evaluated for Safety|Physician Decision|0|||
156313641|NCT01616693|564246405|FG000|Received Both Vaccines|Adverse Event|2|||
156313642|NCT01616693|564246406|FG001|Received Both Vaccines|Adverse Event|0|||
156313643|NCT01616693|564246407|FG002|Received Both Vaccines|Adverse Event|0|||
156313644|NCT01616693|564246408|FG003|Received Both Vaccines|Adverse Event|0|||
156313645|NCT01616693|564246405|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
156756114|NCT00792116|565858605|FG001|Overall Study|Lost to Follow-up|1|||
156756115|NCT00792116|565858604|FG000|Overall Study|Discontnued intervention|1|||
156756116|NCT00792116|565858605|FG001|Overall Study|Discontnued intervention|0|||
156756117|NCT02453256|565858606|FG000|Double Blind Period|Death|1|||
156756118|NCT02453256|565858607|FG001|Double Blind Period|Death|1|||
156756119|NCT02453256|565858606|FG000|Double Blind Period|Adverse Event|3|||
156756120|NCT02453256|565858607|FG001|Double Blind Period|Adverse Event|2|||
156756121|NCT02453256|565858606|FG000|Double Blind Period|Withdrawal by Subject|9|||
156756122|NCT02453256|565858607|FG001|Double Blind Period|Withdrawal by Subject|5|||
156756123|NCT02453256|565858606|FG000|Double Blind Period|Other|0|||
156756124|NCT02453256|565858607|FG001|Double Blind Period|Other|1|||
156756125|NCT02453256|565858606|FG000|Open Label Period|Adverse Event|1|||
156756126|NCT02453256|565858607|FG001|Open Label Period|Adverse Event|3|||
156756127|NCT02453256|565858606|FG000|Open Label Period|Death|0|||
156756128|NCT02453256|565858607|FG001|Open Label Period|Death|1|||
156756129|NCT02453256|565858606|FG000|Open Label Period|Lost to Follow-up|1|||
156756130|NCT02453256|565858607|FG001|Open Label Period|Lost to Follow-up|0|||
156756131|NCT02453256|565858606|FG000|Open Label Period|Other|0|||
156756132|NCT02453256|565858607|FG001|Open Label Period|Other|2|||
156756133|NCT02453256|565858606|FG000|Open Label Period|Withdrawal by Subject|5|||
156756134|NCT02453256|565858607|FG001|Open Label Period|Withdrawal by Subject|1|||
156756135|NCT01066871|565858609|FG000|Overall Study|Lost to Follow-up|0|||
156756136|NCT01066871|565858610|FG001|Overall Study|Lost to Follow-up|2|||
156756137|NCT01066871|565858611|FG002|Overall Study|Lost to Follow-up|2|||
156756138|NCT01066871|565858612|FG003|Overall Study|Lost to Follow-up|0|||
156756139|NCT01066871|565858609|FG000|Overall Study|Protocol Violation|1|||
156756140|NCT01066871|565858610|FG001|Overall Study|Protocol Violation|0|||
156756141|NCT01066871|565858611|FG002|Overall Study|Protocol Violation|3|||
156756142|NCT01066871|565858612|FG003|Overall Study|Protocol Violation|2|||
156756143|NCT01066871|565858609|FG000|Overall Study|Lack of Efficacy|0|||
156756144|NCT01066871|565858610|FG001|Overall Study|Lack of Efficacy|0|||
156756145|NCT01066871|565858611|FG002|Overall Study|Lack of Efficacy|0|||
156756146|NCT01066871|565858612|FG003|Overall Study|Lack of Efficacy|1|||
156756147|NCT01066871|565858609|FG000|Overall Study|Withdrawal by Subject|3|||
156756148|NCT01066871|565858610|FG001|Overall Study|Withdrawal by Subject|1|||
156756149|NCT01066871|565858611|FG002|Overall Study|Withdrawal by Subject|0|||
156756150|NCT01066871|565858612|FG003|Overall Study|Withdrawal by Subject|0|||
156756151|NCT01066871|565858609|FG000|Overall Study|Other|0|||
156756152|NCT01066871|565858610|FG001|Overall Study|Other|2|||
156756153|NCT01066871|565858611|FG002|Overall Study|Other|1|||
156756154|NCT01066871|565858612|FG003|Overall Study|Other|2|||
156756155|NCT01366638|565858616|FG000|Overall Study|Withdrawal by Subject|0|||
156756156|NCT01366638|565858617|FG001|Overall Study|Withdrawal by Subject|0|||
156756157|NCT01366638|565858618|FG002|Overall Study|Withdrawal by Subject|6|||
156756158|NCT01366638|565858616|FG000|Overall Study|Other|1|||
156756159|NCT01366638|565858617|FG001|Overall Study|Other|0|||
156756160|NCT01366638|565858618|FG002|Overall Study|Other|0|||
156756161|NCT01554163|565858619|FG000|Overall Study|Adverse Event|3|||
156756162|NCT01554163|565858620|FG001|Overall Study|Adverse Event|0|||
156756163|NCT01554163|565858619|FG000|Overall Study|Lack of Efficacy|1|||
156756164|NCT01554163|565858620|FG001|Overall Study|Lack of Efficacy|0|||
156756165|NCT01554163|565858619|FG000|Overall Study|Lost to Follow-up|1|||
156756166|NCT01554163|565858620|FG001|Overall Study|Lost to Follow-up|0|||
156756167|NCT01554163|565858619|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156756168|NCT01554163|565858620|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156756169|NCT01554163|565858619|FG000|Overall Study|Protocol Violation|0|||
156756170|NCT01554163|565858620|FG001|Overall Study|Protocol Violation|4|||
156756171|NCT01554163|565858619|FG000|Overall Study|Withdrawal by Subject|1|||
156756172|NCT01554163|565858620|FG001|Overall Study|Withdrawal by Subject|5|||
156756173|NCT01554163|565858619|FG000|Overall Study|Not Treated|1|||
156756174|NCT01554163|565858620|FG001|Overall Study|Not Treated|0|||
156756175|NCT01941537|565858621|FG000|Overall Study|Lack of Efficacy|1|||
156756176|NCT01941537|565858622|FG001|Overall Study|Lack of Efficacy|2|||
156756177|NCT01941537|565858621|FG000|Overall Study|Lost to Follow-up|1|||
156756178|NCT01941537|565858622|FG001|Overall Study|Lost to Follow-up|0|||
156756179|NCT01941537|565858621|FG000|Overall Study|Pregnancy|1|||
156756180|NCT01941537|565858622|FG001|Overall Study|Pregnancy|0|||
156756181|NCT01941537|565858621|FG000|Overall Study|Adverse Event|1|||
156756182|NCT01941537|565858622|FG001|Overall Study|Adverse Event|0|||
156756183|NCT01941537|565858621|FG000|Overall Study|Withdrawal by Subject|0|||
156756184|NCT01941537|565858622|FG001|Overall Study|Withdrawal by Subject|1|||
156756185|NCT01972464|565858626|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
156756186|NCT01972464|565858627|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
156756187|NCT01972464|565858626|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
156756188|NCT01972464|565858627|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
156756189|NCT01972464|565858626|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
156414513|NCT01154036|564610973|FG003|Phase II|Lost to Follow-up|1|||
156756190|NCT01972464|565858627|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
156756191|NCT01972464|565858626|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
156756192|NCT01972464|565858627|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
156756193|NCT01381926|565860507|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
156756194|NCT01381926|565860508|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
156756195|NCT01381926|565860507|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
156756196|NCT01381926|565860508|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
156756197|NCT02624947|565860513|FG000|Maternal Participants|Adverse Event|5|||
156756198|NCT02624947|565860514|FG001|Maternal Participants|Adverse Event|0|||
156756199|NCT02624947|565860513|FG000|Maternal Participants|Investigator Decision|5|||
156313646|NCT01616693|564246406|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
156313647|NCT01616693|564246407|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
156313648|NCT01616693|564246408|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
156313649|NCT01616693|564246405|FG000|Received Both Vaccines|Lost to Follow-up|4|||
156313650|NCT01616693|564246406|FG001|Received Both Vaccines|Lost to Follow-up|3|||
156313651|NCT01616693|564246407|FG002|Received Both Vaccines|Lost to Follow-up|4|||
156313652|NCT01616693|564246408|FG003|Received Both Vaccines|Lost to Follow-up|4|||
156313653|NCT01616693|564246405|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
156313654|NCT01616693|564246406|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
156313655|NCT01616693|564246407|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
156313656|NCT01616693|564246408|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
156313657|NCT00441116|564246412|FG000|Overall Study|Adverse Event|1|||
156313658|NCT00441116|564246413|FG001|Overall Study|Adverse Event|1|||
156313659|NCT00441116|564246412|FG000|Overall Study|Withdrawal by Subject|1|||
156313660|NCT00441116|564246413|FG001|Overall Study|Withdrawal by Subject|0|||
156313661|NCT00441116|564246412|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
156313662|NCT00441116|564246413|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
156313663|NCT02925338|564246414|FG000|Overall Study|Death|0|||
156313664|NCT02925338|564246415|FG001|Overall Study|Death|2|||
156313665|NCT02925338|564246416|FG002|Overall Study|Death|1|||
156313666|NCT02925338|564246417|FG003|Overall Study|Death|0|||
156313667|NCT02925338|564246418|FG004|Overall Study|Death|0|||
156313668|NCT02925338|564246414|FG000|Overall Study|Lost to Follow-up|30|||
156313669|NCT02925338|564246415|FG001|Overall Study|Lost to Follow-up|10|||
156313670|NCT02925338|564246416|FG002|Overall Study|Lost to Follow-up|1|||
156313671|NCT02925338|564246417|FG003|Overall Study|Lost to Follow-up|16|||
156313672|NCT02925338|564246418|FG004|Overall Study|Lost to Follow-up|3|||
156313673|NCT02925338|564246414|FG000|Overall Study|Withdrawal by Subject|3|||
156313674|NCT02925338|564246415|FG001|Overall Study|Withdrawal by Subject|0|||
156313675|NCT02925338|564246416|FG002|Overall Study|Withdrawal by Subject|3|||
156313676|NCT02925338|564246417|FG003|Overall Study|Withdrawal by Subject|2|||
156313677|NCT02925338|564246418|FG004|Overall Study|Withdrawal by Subject|2|||
156313678|NCT02925338|564246414|FG000|Overall Study|Missing|38|||
156313679|NCT02925338|564246415|FG001|Overall Study|Missing|27|||
156313680|NCT02925338|564246416|FG002|Overall Study|Missing|0|||
156313681|NCT02925338|564246417|FG003|Overall Study|Missing|3|||
156313682|NCT02925338|564246418|FG004|Overall Study|Missing|2|||
156313683|NCT02925338|564246414|FG000|Overall Study|Participant's Decision|11|||
156313684|NCT02925338|564246415|FG001|Overall Study|Participant's Decision|7|||
156313685|NCT02925338|564246416|FG002|Overall Study|Participant's Decision|3|||
156313686|NCT02925338|564246417|FG003|Overall Study|Participant's Decision|8|||
156313687|NCT02925338|564246418|FG004|Overall Study|Participant's Decision|1|||
156313688|NCT02925338|564246414|FG000|Overall Study|Treatment Discontinuation|144|||
156313689|NCT02925338|564246415|FG001|Overall Study|Treatment Discontinuation|65|||
156313690|NCT02925338|564246416|FG002|Overall Study|Treatment Discontinuation|56|||
156313691|NCT02925338|564246417|FG003|Overall Study|Treatment Discontinuation|131|||
156313692|NCT02925338|564246418|FG004|Overall Study|Treatment Discontinuation|22|||
156313693|NCT00636363|564246421|FG000|Overall Study|Conjunctivitis|0|||
156313694|NCT00636363|564246422|FG001|Overall Study|Conjunctivitis|0|||
156313695|NCT00636363|564246423|FG002|Overall Study|Conjunctivitis|1|||
156313696|NCT00636363|564246421|FG000|Overall Study|Adverse Event|0|||
156313697|NCT00636363|564246422|FG001|Overall Study|Adverse Event|0|||
156313698|NCT00636363|564246423|FG002|Overall Study|Adverse Event|1|||
156313699|NCT00636363|564246421|FG000|Overall Study|Positive slit lamp finding|0|||
156313700|NCT00636363|564246422|FG001|Overall Study|Positive slit lamp finding|2|||
156313701|NCT00636363|564246423|FG002|Overall Study|Positive slit lamp finding|1|||
156313702|NCT00636363|564246421|FG000|Overall Study|Study related symptoms/complaints|8|||
156313703|NCT00636363|564246422|FG001|Overall Study|Study related symptoms/complaints|7|||
156756200|NCT02624947|565860514|FG001|Maternal Participants|Investigator Decision|3|||
156313704|NCT00636363|564246423|FG002|Overall Study|Study related symptoms/complaints|4|||
156313705|NCT00636363|564246421|FG000|Overall Study|Met ineligibility criteria|0|||
156313706|NCT00636363|564246422|FG001|Overall Study|Met ineligibility criteria|0|||
156313707|NCT00636363|564246423|FG002|Overall Study|Met ineligibility criteria|3|||
156313708|NCT00636363|564246421|FG000|Overall Study|Missed > 1 visit|0|||
156313709|NCT00636363|564246422|FG001|Overall Study|Missed > 1 visit|1|||
156313710|NCT00636363|564246423|FG002|Overall Study|Missed > 1 visit|3|||
156313711|NCT00636363|564246421|FG000|Overall Study|Lack of motivation|1|||
156313712|NCT00636363|564246422|FG001|Overall Study|Lack of motivation|0|||
156756201|NCT02624947|565860513|FG000|Maternal Participants|Lost to Follow-up|54|||
156756202|NCT02624947|565860514|FG001|Maternal Participants|Lost to Follow-up|24|||
156756203|NCT02624947|565860513|FG000|Maternal Participants|Non Compliance|8|||
156756204|NCT02624947|565860514|FG001|Maternal Participants|Non Compliance|5|||
156756205|NCT02624947|565860513|FG000|Maternal Participants|Sponsor Request|1|||
156756206|NCT02624947|565860514|FG001|Maternal Participants|Sponsor Request|1|||
156756207|NCT02624947|565860513|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
156756208|NCT02624947|565860514|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
156756209|NCT02624947|565860513|FG000|Maternal Participants|Miscellaneous|23|||
156756210|NCT02624947|565860514|FG001|Maternal Participants|Miscellaneous|15|||
156756211|NCT02624947|565860513|FG000|Infant Participants|Adverse Event|18|||
156756212|NCT02624947|565860514|FG001|Infant Participants|Adverse Event|11|||
156756213|NCT02624947|565860513|FG000|Infant Participants|Investigator Decision|5|||
156756214|NCT02624947|565860514|FG001|Infant Participants|Investigator Decision|4|||
156756215|NCT02624947|565860513|FG000|Infant Participants|Lost to Follow-up|93|||
156756216|NCT02624947|565860514|FG001|Infant Participants|Lost to Follow-up|58|||
156756217|NCT02624947|565860513|FG000|Infant Participants|Non Compliance|17|||
156756218|NCT02624947|565860514|FG001|Infant Participants|Non Compliance|7|||
156756219|NCT02624947|565860513|FG000|Infant Participants|Sponsor Request|0|||
156756220|NCT02624947|565860514|FG001|Infant Participants|Sponsor Request|1|||
156756221|NCT02624947|565860513|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
156756222|NCT02624947|565860514|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
156756223|NCT02624947|565860513|FG000|Infant Participants|Miscellaneous|50|||
156756224|NCT02624947|565860514|FG001|Infant Participants|Miscellaneous|26|||
156756225|NCT03654729|565860523|FG000|Overall Study|Death|9|||
156756226|NCT03654729|565860524|FG001|Overall Study|Death|9|||
156756227|NCT03654729|565860525|FG002|Overall Study|Death|16|||
156756228|NCT03654729|565860523|FG000|Overall Study|Withdrawal by Subject|8|||
156756229|NCT03654729|565860524|FG001|Overall Study|Withdrawal by Subject|6|||
156756230|NCT03654729|565860525|FG002|Overall Study|Withdrawal by Subject|4|||
156756231|NCT03654729|565860523|FG000|Overall Study|Study terminated by Sponsor|3|||
156756232|NCT03654729|565860524|FG001|Overall Study|Study terminated by Sponsor|5|||
156756233|NCT03654729|565860525|FG002|Overall Study|Study terminated by Sponsor|4|||
156756234|NCT03654729|565860523|FG000|Overall Study|Not reported|2|||
156756235|NCT03654729|565860524|FG001|Overall Study|Not reported|4|||
156756236|NCT03654729|565860525|FG002|Overall Study|Not reported|5|||
156756237|NCT03654729|565860523|FG000|Overall Study|Progressive disease|3|||
156756238|NCT03654729|565860524|FG001|Overall Study|Progressive disease|0|||
156756239|NCT03654729|565860525|FG002|Overall Study|Progressive disease|0|||
156756240|NCT03654729|565860523|FG000|Overall Study|Lost to Follow-up|2|||
156756241|NCT03654729|565860524|FG001|Overall Study|Lost to Follow-up|0|||
156756242|NCT03654729|565860525|FG002|Overall Study|Lost to Follow-up|0|||
156756243|NCT03654729|565860523|FG000|Overall Study|Physician Decision|2|||
156756244|NCT03654729|565860524|FG001|Overall Study|Physician Decision|0|||
156756245|NCT03654729|565860525|FG002|Overall Study|Physician Decision|0|||
156756246|NCT03654729|565860523|FG000|Overall Study|Protocol Violation|1|||
156756247|NCT03654729|565860524|FG001|Overall Study|Protocol Violation|1|||
156756248|NCT03654729|565860525|FG002|Overall Study|Protocol Violation|0|||
156756249|NCT03654729|565860523|FG000|Overall Study|Non-compliance with study drug|0|||
156652244|NCT01644890|565474343|FG001|Overall Study|Adverse Event|20|||
156652245|NCT01644890|565474342|FG000|Overall Study|Death|1|||
156652246|NCT01644890|565474343|FG001|Overall Study|Death|3|||
156652247|NCT01644890|565474342|FG000|Overall Study|Physician Decision|3|||
156652248|NCT01644890|565474343|FG001|Overall Study|Physician Decision|9|||
156652249|NCT01644890|565474342|FG000|Overall Study|Protocol Violation|6|||
156652250|NCT01644890|565474343|FG001|Overall Study|Protocol Violation|7|||
156652251|NCT01644890|565474342|FG000|Overall Study|Withdrawal by Subject|19|||
156652252|NCT01644890|565474343|FG001|Overall Study|Withdrawal by Subject|27|||
156652253|NCT01644890|565474342|FG000|Overall Study|Progression Disease|160|||
156756250|NCT03654729|565860524|FG001|Overall Study|Non-compliance with study drug|1|||
156652254|NCT01644890|565474343|FG001|Overall Study|Progression Disease|131|||
156652255|NCT01644890|565474342|FG000|Overall Study|Clinical Progression|6|||
156652256|NCT01644890|565474343|FG001|Overall Study|Clinical Progression|6|||
156652257|NCT01644890|565474342|FG000|Overall Study|> 28 days since last dose of study drug|6|||
156652258|NCT01644890|565474343|FG001|Overall Study|> 28 days since last dose of study drug|3|||
156756251|NCT03654729|565860525|FG002|Overall Study|Non-compliance with study drug|0|||
156756252|NCT03654729|565860523|FG000|Overall Study|Site terminated by Sponsor|1|||
156756253|NCT03654729|565860524|FG001|Overall Study|Site terminated by Sponsor|0|||
156756254|NCT03654729|565860525|FG002|Overall Study|Site terminated by Sponsor|0|||
156756255|NCT00215644|565860531|FG000|Overall Study|Disease Progression|28|||
156756256|NCT00215644|565860532|FG001|Overall Study|Disease Progression|10|||
156756257|NCT00215644|565860531|FG000|Overall Study|Adverse Event|2|||
156756258|NCT00215644|565860532|FG001|Overall Study|Adverse Event|9|||
156756259|NCT00215644|565860531|FG000|Overall Study|Death|1|||
156756260|NCT00215644|565860532|FG001|Overall Study|Death|2|||
156313713|NCT00636363|564246423|FG002|Overall Study|Lack of motivation|1|||
156313714|NCT00636363|564246421|FG000|Overall Study|Protocol Violation|0|||
156756261|NCT00215644|565860531|FG000|Overall Study|Withdrawal by Subject|1|||
156414514|NCT01154036|564610974|FG004|Phase II|Lost to Follow-up|2|||
156414515|NCT01154036|564610975|FG005|Phase II|Lost to Follow-up|0|||
156414516|NCT01154036|564610976|FG006|Phase II|Lost to Follow-up|2|||
156414517|NCT01154036|564610977|FG007|Phase II|Lost to Follow-up|1|||
156756262|NCT00215644|565860532|FG001|Overall Study|Withdrawal by Subject|0|||
156756263|NCT00215644|565860531|FG000|Overall Study|Other|3|||
156756264|NCT00215644|565860532|FG001|Overall Study|Other|15|||
156756265|NCT00215644|565860531|FG000|Overall Study|Randomized but Not Treated|1|||
156756266|NCT00215644|565860532|FG001|Overall Study|Randomized but Not Treated|0|||
156756267|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
156756268|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
156756269|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
156756270|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
156756271|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
156756272|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
156756273|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
156756274|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
156756275|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
156756276|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
156756277|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
156756278|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
156756279|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
156756280|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
156756281|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
156756282|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
156756283|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
156756284|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
156756285|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Other|1|||
156756286|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Other|0|||
156756287|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Other|1|||
156756288|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
156756289|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
156756290|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
156756291|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
156414518|NCT01154036|564610970|FG000|Phase II|Protocol Violation|0|||
156414519|NCT01154036|564610971|FG001|Phase II|Protocol Violation|0|||
156414520|NCT01154036|564610972|FG002|Phase II|Protocol Violation|0|||
156756292|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
156756293|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
156756294|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
156756295|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
156756296|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
156756297|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
156756298|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
156756299|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
156756300|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
156756301|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
156756302|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
156414521|NCT01154036|564610973|FG003|Phase II|Protocol Violation|0|||
156414522|NCT01154036|564610974|FG004|Phase II|Protocol Violation|1|||
156414523|NCT01154036|564610975|FG005|Phase II|Protocol Violation|2|||
156414524|NCT01154036|564610976|FG006|Phase II|Protocol Violation|0|||
156414525|NCT01154036|564610977|FG007|Phase II|Protocol Violation|0|||
156414526|NCT01154036|564610970|FG000|Phase II|Withdrawal by Subject|0|||
156414527|NCT01154036|564610971|FG001|Phase II|Withdrawal by Subject|0|||
156414528|NCT01154036|564610972|FG002|Phase II|Withdrawal by Subject|0|||
156414529|NCT01154036|564610973|FG003|Phase II|Withdrawal by Subject|0|||
156414530|NCT01154036|564610974|FG004|Phase II|Withdrawal by Subject|4|||
156414531|NCT01154036|564610975|FG005|Phase II|Withdrawal by Subject|2|||
156414532|NCT01154036|564610976|FG006|Phase II|Withdrawal by Subject|5|||
156414533|NCT01154036|564610977|FG007|Phase II|Withdrawal by Subject|4|||
156414534|NCT02264574|564610978|FG000|Overall Study|Death|21|||
156414535|NCT02264574|564610979|FG001|Overall Study|Death|21|||
156414536|NCT02264574|564610978|FG000|Overall Study|Withdrawal by Subject|8|||
156414537|NCT02264574|564610979|FG001|Overall Study|Withdrawal by Subject|6|||
156414538|NCT02264574|564610978|FG000|Overall Study|Other, Not Specified|0|||
156756303|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
156414539|NCT02264574|564610979|FG001|Overall Study|Other, Not Specified|3|||
156414540|NCT02823964|564610980|FG000|Overall Study|Adverse Event|2|||
156414541|NCT02823964|564610980|FG000|Overall Study|Physician Decision|1|||
156414542|NCT02823964|564610980|FG000|Overall Study|Lack of Efficacy|1|||
156414543|NCT02823964|564610980|FG000|Overall Study|Withdrawal by Subject|1|||
156313715|NCT00636363|564246422|FG001|Overall Study|Protocol Violation|3|||
156313716|NCT00636363|564246423|FG002|Overall Study|Protocol Violation|0|||
156313717|NCT00636363|564246421|FG000|Overall Study|Lost to Follow-up|3|||
156313718|NCT00636363|564246422|FG001|Overall Study|Lost to Follow-up|4|||
156313719|NCT00636363|564246423|FG002|Overall Study|Lost to Follow-up|2|||
156313720|NCT00636363|564246421|FG000|Overall Study|Withdrawal by Subject|1|||
156313721|NCT00636363|564246422|FG001|Overall Study|Withdrawal by Subject|3|||
156414544|NCT00794820|564610985|FG000|Overall Study|Adverse Event|11|||
156414545|NCT00794820|564610985|FG000|Overall Study|Secondary Malignancies|2|||
156414546|NCT00794820|564610985|FG000|Overall Study|Resistant Disease|2|||
156414547|NCT00794820|564610985|FG000|Overall Study|Ineligible/Screen Failure|1|||
156756304|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
156756305|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
156756306|NCT00493012|565860543|FG000|Overall Study|Lost to Follow-up|18|||
156756307|NCT00493012|565860544|FG001|Overall Study|Lost to Follow-up|17|||
156756308|NCT02915159|565860545|FG000|Overall Study|Participant no longer meets criteria|2|||
156756309|NCT02915159|565860546|FG001|Overall Study|Participant no longer meets criteria|0|||
156756310|NCT02915159|565860545|FG000|Overall Study|poor/non-compliance|1|||
156756311|NCT02915159|565860546|FG001|Overall Study|poor/non-compliance|0|||
156756312|NCT02915159|565860545|FG000|Overall Study|Participant withdrew consent|5|||
156756313|NCT02915159|565860546|FG001|Overall Study|Participant withdrew consent|1|||
156756314|NCT02915159|565860545|FG000|Overall Study|Request to discontinue treatment|1|||
156756315|NCT02915159|565860546|FG001|Overall Study|Request to discontinue treatment|2|||
156756316|NCT02915159|565860545|FG000|Overall Study|Adverse Event|2|||
156756317|NCT02915159|565860546|FG001|Overall Study|Adverse Event|2|||
156756318|NCT02915159|565860545|FG000|Overall Study|Lack of Efficacy|0|||
156756319|NCT02915159|565860546|FG001|Overall Study|Lack of Efficacy|3|||
156756320|NCT04534517|565860547|FG000|Overall Study|Adverse Event|1|||
156756321|NCT04534517|565860547|FG000|Overall Study|Withdrawal by Subject|1|||
156756322|NCT04534517|565860547|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
156756323|NCT04534517|565860547|FG000|Overall Study|COVID-19 Related|1|||
156756324|NCT02121795|565860548|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
156756325|NCT02121795|565860549|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
156756326|NCT02121795|565860548|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
156756327|NCT02121795|565860549|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
156756328|NCT02121795|565860548|FG000|Double-Blind Phase|Lost to Follow-up|7|||
156756329|NCT02121795|565860549|FG001|Double-Blind Phase|Lost to Follow-up|4|||
156756330|NCT02121795|565860548|FG000|Double-Blind Phase|Physician Decision|2|||
156756331|NCT02121795|565860549|FG001|Double-Blind Phase|Physician Decision|5|||
156756332|NCT02121795|565860548|FG000|Double-Blind Phase|Adverse Event|5|||
156756333|NCT02121795|565860549|FG001|Double-Blind Phase|Adverse Event|0|||
156756334|NCT02121795|565860548|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
156756335|NCT02121795|565860549|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
156756336|NCT02121795|565860548|FG000|Double-Blind Phase|Protocol Violation|0|||
156756337|NCT02121795|565860549|FG001|Double-Blind Phase|Protocol Violation|3|||
156756338|NCT02121795|565860548|FG000|Double-Blind Phase|Death|1|||
156756339|NCT02121795|565860549|FG001|Double-Blind Phase|Death|1|||
156756340|NCT02121795|565860548|FG000|Open-Label Phase|Physician Decision|8|||
156756341|NCT02121795|565860549|FG001|Open-Label Phase|Physician Decision|8|||
156756342|NCT02121795|565860548|FG000|Open-Label Phase|Withdrawal by Subject|3|||
156756343|NCT02121795|565860549|FG001|Open-Label Phase|Withdrawal by Subject|2|||
156756344|NCT02121795|565860548|FG000|Open-Label Phase|Lost to Follow-up|1|||
156756345|NCT02121795|565860549|FG001|Open-Label Phase|Lost to Follow-up|0|||
156756346|NCT00613821|565860562|FG000|Overall Study|Withdrawal by Subject|1|||
156313722|NCT00636363|564246423|FG002|Overall Study|Withdrawal by Subject|2|||
156313723|NCT00029146|564246426|FG000|Overall Study|Lost to Follow-up|2|||
156313724|NCT00029146|564246427|FG001|Overall Study|Lost to Follow-up|1|||
156313725|NCT01765218|564246428|FG000|Overall Study|Protocol Violation|1|||
156313726|NCT01765218|564246429|FG001|Overall Study|Protocol Violation|2|||
156313727|NCT01144299|564246430|FG000|Overall Study|Lost to Follow-up|1|||
156313728|NCT01144299|564246431|FG001|Overall Study|Lost to Follow-up|0|||
156313729|NCT01144299|564246430|FG000|Overall Study|Withdrawal by Subject|1|||
156313730|NCT01144299|564246431|FG001|Overall Study|Withdrawal by Subject|0|||
156313731|NCT02342418|564246434|FG000|Overall Study|Adverse Event|0|||
156313732|NCT02342418|564246435|FG001|Overall Study|Adverse Event|1|||
156313733|NCT04255394|564246436|FG000|Overall Study|Death|35|||
156313734|NCT04255394|564246437|FG001|Overall Study|Death|25|||
156313735|NCT04255394|564246436|FG000|Overall Study|Device removed|2|||
156414548|NCT03230864|564610988|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
156313736|NCT04255394|564246437|FG001|Overall Study|Device removed|10|||
156313737|NCT04255394|564246436|FG000|Overall Study|Withdrawal by Subject|9|||
156313738|NCT04255394|564246437|FG001|Overall Study|Withdrawal by Subject|8|||
156414549|NCT03230864|564610989|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
156756347|NCT00613821|565860563|FG001|Overall Study|Withdrawal by Subject|0|||
156756348|NCT00613821|565860562|FG000|Overall Study|Physician Decision|1|||
156756349|NCT00613821|565860563|FG001|Overall Study|Physician Decision|1|||
156313739|NCT04255394|564246436|FG000|Overall Study|Screen Failure/Not treated|12|||
156313740|NCT04255394|564246437|FG001|Overall Study|Screen Failure/Not treated|8|||
156313741|NCT04255394|564246436|FG000|Overall Study|Lost to Follow-up|123|||
156313742|NCT04255394|564246437|FG001|Overall Study|Lost to Follow-up|265|||
156313743|NCT04255394|564246436|FG000|Overall Study|Adverse Event|1|||
156313744|NCT04255394|564246437|FG001|Overall Study|Adverse Event|3|||
156313745|NCT01011309|564246440|FG000|Overall Study|Adverse Event|2|||
156313746|NCT01011309|564246441|FG001|Overall Study|Adverse Event|1|||
156313747|NCT01011309|564246442|FG002|Overall Study|Adverse Event|2|||
156313748|NCT01011309|564246440|FG000|Overall Study|Lack of Efficacy|0|||
156313749|NCT01011309|564246441|FG001|Overall Study|Lack of Efficacy|1|||
156313750|NCT01011309|564246442|FG002|Overall Study|Lack of Efficacy|0|||
156313751|NCT01011309|564246440|FG000|Overall Study|Protocol Violation|0|||
156313752|NCT01011309|564246441|FG001|Overall Study|Protocol Violation|1|||
156313753|NCT01011309|564246442|FG002|Overall Study|Protocol Violation|3|||
156313754|NCT01525225|564246450|FG000|Enrollment|No longer met study criteria|1|||
156313755|NCT01525225|564246450|FG000|Enrollment|Other|1|||
156313756|NCT00363545|564246451|FG000|Overall Study|Serious Adverse Event|0|||
156313757|NCT00363545|564246452|FG001|Overall Study|Serious Adverse Event|1|||
156313758|NCT00363545|564246451|FG000|Overall Study|Withdrawal by Subject|12|||
156313759|NCT00363545|564246452|FG001|Overall Study|Withdrawal by Subject|15|||
156313760|NCT00363545|564246451|FG000|Overall Study|Migrated/moved from study area|3|||
156313761|NCT00363545|564246452|FG001|Overall Study|Migrated/moved from study area|6|||
156313762|NCT00363545|564246451|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
156313763|NCT00363545|564246452|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
156313764|NCT00363545|564246451|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
156313765|NCT00363545|564246452|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
156313766|NCT00363545|564246451|FG000|Overall Study|Others|1|||
156313767|NCT00363545|564246452|FG001|Overall Study|Others|0|||
156313768|NCT01182844|564246453|FG000|Overall Study|Withdrawal by Subject|0|||
156313769|NCT01182844|564246454|FG001|Overall Study|Withdrawal by Subject|2|||
156313770|NCT03658876|564248262|FG000|Overall Study|Protocol Violation|3|||
156313771|NCT03658876|564248263|FG001|Overall Study|Protocol Violation|2|||
156313772|NCT03658876|564248262|FG000|Overall Study|Withdrawal by Subject|2|||
156313773|NCT03658876|564248263|FG001|Overall Study|Withdrawal by Subject|0|||
156313774|NCT03658876|564248262|FG000|Overall Study|Death|0|||
156313775|NCT03658876|564248263|FG001|Overall Study|Death|1|||
156313776|NCT03658876|564248262|FG000|Overall Study|Intercurrent illness|6|||
156313777|NCT03658876|564248263|FG001|Overall Study|Intercurrent illness|4|||
156313778|NCT03658876|564248262|FG000|Overall Study|Transplantation/other operation|1|||
156313779|NCT03658876|564248263|FG001|Overall Study|Transplantation/other operation|5|||
156313780|NCT00576420|564248264|FG000|Overall Study|Death|0|||
156313781|NCT00576420|564248265|FG001|Overall Study|Death|0|||
156313782|NCT00576420|564248266|FG002|Overall Study|Death|1|||
156313783|NCT02616146|564248267|FG000|Overall Study|Adverse Event|64|||
156313784|NCT02616146|564248268|FG001|Overall Study|Adverse Event|24|||
156313785|NCT02616146|564248267|FG000|Overall Study|Lost to Follow-up|23|||
156313786|NCT02616146|564248268|FG001|Overall Study|Lost to Follow-up|13|||
156313787|NCT02616146|564248267|FG000|Overall Study|Non-compliance with study protocol|2|||
156313788|NCT02616146|564248268|FG001|Overall Study|Non-compliance with study protocol|0|||
156313789|NCT02616146|564248267|FG000|Overall Study|Non-compliance with study drug|4|||
156313790|NCT02616146|564248268|FG001|Overall Study|Non-compliance with study drug|2|||
156313791|NCT02616146|564248267|FG000|Overall Study|Pregnancy|2|||
156313792|NCT02616146|564248268|FG001|Overall Study|Pregnancy|2|||
156313793|NCT02616146|564248267|FG000|Overall Study|Pregnancy wish|3|||
156313794|NCT02616146|564248268|FG001|Overall Study|Pregnancy wish|0|||
156313795|NCT02616146|564248267|FG000|Overall Study|Protocol Violation|6|||
156313796|NCT02616146|564248268|FG001|Overall Study|Protocol Violation|3|||
156313797|NCT02616146|564248267|FG000|Overall Study|Study terminated by sponsor|1372|||
156313798|NCT02616146|564248268|FG001|Overall Study|Study terminated by sponsor|432|||
156313799|NCT02616146|564248267|FG000|Overall Study|Participant moved|4|||
156313800|NCT02616146|564248268|FG001|Overall Study|Participant moved|3|||
156313801|NCT02616146|564248267|FG000|Overall Study|Withdrawal by Subject|30|||
156313802|NCT02616146|564248268|FG001|Overall Study|Withdrawal by Subject|24|||
156313803|NCT02616146|564248267|FG000|Overall Study|Physician Decision|2|||
156313804|NCT02616146|564248268|FG001|Overall Study|Physician Decision|1|||
156313805|NCT01221272|564248270|FG000|Period 1|Adverse Event|2|||
156313806|NCT01221272|564248271|FG001|Period 1|Adverse Event|0|||
156313807|NCT01221272|564248270|FG000|Period 1|Consent Withdrawal|0|||
156313808|NCT01221272|564248271|FG001|Period 1|Consent Withdrawal|1|||
156313809|NCT01221272|564248270|FG000|Period 1|Significant Dosing Noncompliance|0|||
156313810|NCT01221272|564248271|FG001|Period 1|Significant Dosing Noncompliance|1|||
156313811|NCT01221272|564248270|FG000|Period 2|Adverse Event|0|||
156313812|NCT01221272|564248271|FG001|Period 2|Adverse Event|2|||
156313813|NCT01340872|564248272|FG000|Double-blind Phase|Adverse Event|6|||
156313814|NCT01340872|564248273|FG001|Double-blind Phase|Adverse Event|4|||
156313815|NCT01340872|564248274|FG002|Double-blind Phase|Adverse Event|0|||
156313816|NCT01340872|564248275|FG003|Double-blind Phase|Adverse Event|0|||
156652259|NCT01644890|565474342|FG000|Overall Study|Other|8|||
156652260|NCT01644890|565474343|FG001|Overall Study|Other|9|||
156652261|NCT00313703|565474345|FG000|Overall Study|Lost to Follow-up|11|||
156652262|NCT00313703|565474346|FG001|Overall Study|Lost to Follow-up|2|||
156652263|NCT00313703|565474347|FG002|Overall Study|Lost to Follow-up|5|||
156652264|NCT00313703|565474348|FG003|Overall Study|Lost to Follow-up|12|||
156652265|NCT03031899|565474351|FG000|Overall Study|Protocol Violation|1|||
156652266|NCT03031899|565474351|FG000|Overall Study|lesion disappeared after stopping habit|1|||
156652267|NCT01060670|565474352|FG000|Run In|screen failure|0|||
156652268|NCT01060670|565474353|FG001|Run In|screen failure|238|||
156652269|NCT00094302|565474354|FG000|Overall Study|Lost to Follow-up|43|||
156652270|NCT00094302|565474355|FG001|Overall Study|Lost to Follow-up|41|||
156652271|NCT00094302|565474354|FG000|Overall Study|Physician Decision|5|||
156652272|NCT00094302|565474355|FG001|Overall Study|Physician Decision|8|||
156652273|NCT00094302|565474354|FG000|Overall Study|Withdrawal by Subject|103|||
156652274|NCT00094302|565474355|FG001|Overall Study|Withdrawal by Subject|111|||
156652275|NCT00094302|565474354|FG000|Overall Study|Death|266|||
156652276|NCT00094302|565474355|FG001|Overall Study|Death|246|||
156652277|NCT02207621|565474363|FG000|Overall Study|Adverse Event|71|||
156652278|NCT02207621|565474364|FG001|Overall Study|Adverse Event|15|||
156652279|NCT02207621|565474365|FG002|Overall Study|Adverse Event|132|||
156652280|NCT02207621|565474363|FG000|Overall Study|Withdrawal by Subject|9|||
156652281|NCT02207621|565474364|FG001|Overall Study|Withdrawal by Subject|9|||
156652282|NCT02207621|565474365|FG002|Overall Study|Withdrawal by Subject|13|||
156652283|NCT02207621|565474363|FG000|Overall Study|Non-Compliant|3|||
156652284|NCT02207621|565474364|FG001|Overall Study|Non-Compliant|3|||
156652285|NCT02207621|565474365|FG002|Overall Study|Non-Compliant|1|||
156652286|NCT02207621|565474363|FG000|Overall Study|Lost to Follow-up|1|||
156652287|NCT02207621|565474364|FG001|Overall Study|Lost to Follow-up|0|||
156652288|NCT02207621|565474365|FG002|Overall Study|Lost to Follow-up|3|||
156652289|NCT02207621|565474363|FG000|Overall Study|Lack of Efficacy|10|||
156652290|NCT02207621|565474364|FG001|Overall Study|Lack of Efficacy|2|||
156652291|NCT02207621|565474365|FG002|Overall Study|Lack of Efficacy|4|||
156652292|NCT02207621|565474363|FG000|Overall Study|Disallowed Concurrent Medication|2|||
156652293|NCT02207621|565474364|FG001|Overall Study|Disallowed Concurrent Medication|5|||
156652294|NCT02207621|565474365|FG002|Overall Study|Disallowed Concurrent Medication|2|||
156652295|NCT02207621|565474363|FG000|Overall Study|Physician Decision|1|||
156652296|NCT02207621|565474364|FG001|Overall Study|Physician Decision|2|||
156652297|NCT02207621|565474365|FG002|Overall Study|Physician Decision|2|||
156652298|NCT02207621|565474363|FG000|Overall Study|Protocol Violation|4|||
156652299|NCT02207621|565474364|FG001|Overall Study|Protocol Violation|10|||
156652300|NCT02207621|565474365|FG002|Overall Study|Protocol Violation|6|||
156652301|NCT02207621|565474363|FG000|Overall Study|Death|2|||
156652302|NCT02207621|565474364|FG001|Overall Study|Death|0|||
156652303|NCT02207621|565474365|FG002|Overall Study|Death|0|||
156652304|NCT02207621|565474363|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
156652305|NCT02207621|565474364|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
156652306|NCT02207621|565474365|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
156652307|NCT02848599|565474368|FG000|Overall Study|Protocol Violation|7|||
156652308|NCT02848599|565474369|FG001|Overall Study|Protocol Violation|9|||
156652309|NCT04828161|565474370|FG000|Overall Study|Withdrawal by Subject|0|||
156652310|NCT04828161|565474371|FG001|Overall Study|Withdrawal by Subject|3|||
156652311|NCT04828161|565474372|FG002|Overall Study|Withdrawal by Subject|3|||
156652312|NCT04828161|565474373|FG003|Overall Study|Withdrawal by Subject|4|||
156652313|NCT04828161|565474370|FG000|Overall Study|Lost to Follow-up|1|||
156652314|NCT04828161|565474371|FG001|Overall Study|Lost to Follow-up|4|||
156652315|NCT04828161|565474372|FG002|Overall Study|Lost to Follow-up|2|||
156652316|NCT04828161|565474373|FG003|Overall Study|Lost to Follow-up|2|||
156652317|NCT04828161|565474370|FG000|Overall Study|Other|2|||
156652318|NCT04828161|565474371|FG001|Overall Study|Other|0|||
156652319|NCT04828161|565474372|FG002|Overall Study|Other|2|||
156652320|NCT04828161|565474373|FG003|Overall Study|Other|0|||
156652321|NCT04828161|565474370|FG000|Overall Study|Death|0|||
156652322|NCT04828161|565474371|FG001|Overall Study|Death|0|||
156652323|NCT04828161|565474372|FG002|Overall Study|Death|0|||
156652324|NCT04828161|565474373|FG003|Overall Study|Death|2|||
156652325|NCT02352337|565474374|FG000|Overall Study|Patients never treated|4|||
156652326|NCT02352337|565474375|FG001|Overall Study|Patients never treated|1|||
156652327|NCT02352337|565474376|FG002|Overall Study|Patients never treated|2|||
156652328|NCT02458638|565474379|FG000|Overall Study|Death|309|||
156652329|NCT02458638|565474379|FG000|Overall Study|End of Cohort/End of Study|67|||
156652330|NCT02458638|565474379|FG000|Overall Study|Lost to Follow-up|31|||
156756350|NCT01266824|565860565|FG000|Overall Study|Study terminated prior to completion|2|||
156652331|NCT02458638|565474379|FG000|Overall Study|Other Reasons|4|||
156652332|NCT02458638|565474379|FG000|Overall Study|Physician Decision|1|||
156652333|NCT02458638|565474379|FG000|Overall Study|Withdrawal by Subject|47|||
156652334|NCT00135707|565474393|FG000|Overall Study|Lost to Follow-up|94|||
156652335|NCT00135707|565474394|FG001|Overall Study|Lost to Follow-up|89|||
156652336|NCT00135707|565474393|FG000|Overall Study|Withdrawal by Subject|0|||
156652337|NCT00135707|565474394|FG001|Overall Study|Withdrawal by Subject|1|||
156756351|NCT01266824|565860566|FG001|Overall Study|Study terminated prior to completion|3|||
156756352|NCT02302846|565860567|FG000|Overall Study|Withdrawal by Subject|1|||
156756353|NCT00872521|565860568|FG000|Completed PAD Induction|Patient choice|0|||
156756354|NCT00872521|565860569|FG001|Completed PAD Induction|Patient choice|1|||
156756355|NCT00872521|565860570|FG002|Completed PAD Induction|Patient choice|0|||
156756356|NCT00872521|565860568|FG000|Completed PAD Induction|Disease progression|0|||
156756357|NCT00872521|565860569|FG001|Completed PAD Induction|Disease progression|2|||
156756358|NCT00872521|565860570|FG002|Completed PAD Induction|Disease progression|0|||
156756359|NCT00872521|565860568|FG000|Completed PAD Induction|Adverse Event|4|||
156756360|NCT00872521|565860569|FG001|Completed PAD Induction|Adverse Event|0|||
156756361|NCT00872521|565860570|FG002|Completed PAD Induction|Adverse Event|0|||
156756362|NCT00872521|565860568|FG000|Completed PAD Induction|Death|1|||
156756363|NCT00872521|565860569|FG001|Completed PAD Induction|Death|1|||
156756364|NCT00872521|565860570|FG002|Completed PAD Induction|Death|0|||
156756365|NCT00872521|565860568|FG000|Primary Endpoint Analysis|Other|1|||
156756366|NCT00872521|565860569|FG001|Primary Endpoint Analysis|Other|2|||
156756367|NCT00872521|565860570|FG002|Primary Endpoint Analysis|Other|0|||
156756368|NCT00872521|565860568|FG000|Primary Endpoint Analysis|Patient choice|0|||
156756369|NCT00872521|565860569|FG001|Primary Endpoint Analysis|Patient choice|1|||
156756370|NCT00872521|565860570|FG002|Primary Endpoint Analysis|Patient choice|0|||
156756371|NCT00872521|565860568|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
156756372|NCT00872521|565860569|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
156756373|NCT00872521|565860570|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
156756374|NCT00872521|565860568|FG000|Primary Endpoint Analysis|Patient response missing|0|||
156756375|NCT00872521|565860569|FG001|Primary Endpoint Analysis|Patient response missing|0|||
156756376|NCT00872521|565860570|FG002|Primary Endpoint Analysis|Patient response missing|1|||
156756377|NCT00872521|565860568|FG000|Completed 3-month Follow up|Other|0|||
156756378|NCT00872521|565860569|FG001|Completed 3-month Follow up|Other|2|||
156756379|NCT00872521|565860570|FG002|Completed 3-month Follow up|Other|0|||
156756380|NCT00872521|565860568|FG000|Completed 3-month Follow up|Physician Decision|0|||
156756381|NCT00872521|565860569|FG001|Completed 3-month Follow up|Physician Decision|1|||
156756382|NCT00872521|565860570|FG002|Completed 3-month Follow up|Physician Decision|0|||
156756383|NCT00872521|565860568|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
156756384|NCT00872521|565860569|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
156756385|NCT00872521|565860570|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
156756386|NCT05225558|565860574|FG000|Overall Study|Withdrawal by Subject|4|||
156756387|NCT05225558|565860575|FG001|Overall Study|Withdrawal by Subject|3|||
156756388|NCT05225558|565860574|FG000|Overall Study|Adverse Event|1|||
156756389|NCT05225558|565860575|FG001|Overall Study|Adverse Event|0|||
156756390|NCT05225558|565860574|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
156756391|NCT05225558|565860575|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
156756392|NCT05225558|565860574|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
156756393|NCT05225558|565860575|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
156756394|NCT01001910|565860576|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
156756395|NCT01089127|565860577|FG000|Overall Study|Adverse Event|5|||
156756396|NCT01089127|565860578|FG001|Overall Study|Adverse Event|1|||
156756397|NCT01089127|565860579|FG002|Overall Study|Adverse Event|1|||
156756398|NCT01089127|565860580|FG003|Overall Study|Adverse Event|0|||
156756399|NCT01089127|565860581|FG004|Overall Study|Adverse Event|0|||
156756400|NCT01089127|565860582|FG005|Overall Study|Adverse Event|1|||
156756401|NCT01089127|565860577|FG000|Overall Study|Subject withdrew consent|0|||
156756402|NCT01089127|565860578|FG001|Overall Study|Subject withdrew consent|1|||
156756403|NCT01089127|565860579|FG002|Overall Study|Subject withdrew consent|1|||
156756404|NCT01089127|565860580|FG003|Overall Study|Subject withdrew consent|1|||
156756405|NCT01089127|565860581|FG004|Overall Study|Subject withdrew consent|0|||
156756406|NCT01089127|565860582|FG005|Overall Study|Subject withdrew consent|2|||
156756407|NCT01089127|565860577|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156756408|NCT01089127|565860578|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156756409|NCT01089127|565860579|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156756410|NCT01089127|565860580|FG003|Overall Study|Abnormal test procedure result(s)|0|||
156756411|NCT01089127|565860581|FG004|Overall Study|Abnormal test procedure result(s)|0|||
156756412|NCT01089127|565860582|FG005|Overall Study|Abnormal test procedure result(s)|0|||
156756413|NCT01089127|565860577|FG000|Overall Study|Lost to Follow-up|1|||
156756414|NCT01089127|565860578|FG001|Overall Study|Lost to Follow-up|1|||
156756415|NCT01089127|565860579|FG002|Overall Study|Lost to Follow-up|0|||
156756416|NCT01089127|565860580|FG003|Overall Study|Lost to Follow-up|0|||
156756417|NCT01089127|565860581|FG004|Overall Study|Lost to Follow-up|1|||
156756418|NCT01089127|565860582|FG005|Overall Study|Lost to Follow-up|0|||
156756419|NCT01089127|565860577|FG000|Overall Study|Protocol deviation|0|||
156756420|NCT01089127|565860578|FG001|Overall Study|Protocol deviation|1|||
156756421|NCT01089127|565860579|FG002|Overall Study|Protocol deviation|0|||
156756422|NCT01089127|565860580|FG003|Overall Study|Protocol deviation|0|||
156756423|NCT01089127|565860581|FG004|Overall Study|Protocol deviation|1|||
156756424|NCT01089127|565860582|FG005|Overall Study|Protocol deviation|0|||
156756425|NCT03200548|565860583|FG000|Overall Study|Withdrawal by Subject|5|||
156756426|NCT03200548|565860584|FG001|Overall Study|Withdrawal by Subject|11|||
156756427|NCT03200548|565860585|FG002|Overall Study|Withdrawal by Subject|7|||
156756428|NCT03200548|565860586|FG003|Overall Study|Withdrawal by Subject|6|||
156756429|NCT00511810|565860589|FG000|Overall Study|Lost to Follow-up|1|||
156756430|NCT00511810|565860590|FG001|Overall Study|Lost to Follow-up|2|||
156756431|NCT00511810|565860589|FG000|Overall Study|Lack of Efficacy|0|||
156756432|NCT00511810|565860590|FG001|Overall Study|Lack of Efficacy|2|||
156756433|NCT00511810|565860589|FG000|Overall Study|Refused second scn|0|||
156756434|NCT00511810|565860590|FG001|Overall Study|Refused second scn|1|||
156756435|NCT02896569|565860591|FG000|Overall Study|Lost to Follow-up|2|||
156756436|NCT02896569|565860592|FG001|Overall Study|Lost to Follow-up|1|||
156756437|NCT02896569|565860591|FG000|Overall Study|Physician Decision|1|||
156756438|NCT02896569|565860592|FG001|Overall Study|Physician Decision|3|||
156756439|NCT02896569|565860591|FG000|Overall Study|Adverse Event|0|||
156756440|NCT02896569|565860592|FG001|Overall Study|Adverse Event|1|||
156756441|NCT02896569|565860591|FG000|Overall Study|Withdrawal by Subject|1|||
156756442|NCT02896569|565860592|FG001|Overall Study|Withdrawal by Subject|0|||
156756443|NCT01462630|565860593|FG000|Overall Study|Did not initiate therapy|3|||
156756444|NCT01462630|565860593|FG000|Overall Study|Death|1|||
156756445|NCT01462630|565860593|FG000|Overall Study|Protocol Violation|2|||
156756446|NCT01462630|565860593|FG000|Overall Study|Adverse Event|1|||
156756447|NCT01896193|565860594|FG000|Overall Study|Lack of Efficacy|20|||
156756448|NCT01896193|565860595|FG001|Overall Study|Lack of Efficacy|11|||
156756449|NCT01896193|565860594|FG000|Overall Study|Protocol Violation|0|||
156756450|NCT01896193|565860595|FG001|Overall Study|Protocol Violation|1|||
156756451|NCT01896193|565860594|FG000|Overall Study|Withdrew Consent|1|||
156756452|NCT01896193|565860595|FG001|Overall Study|Withdrew Consent|0|||
156756453|NCT02592447|565860598|FG000|Overall Study|Lost to Follow-up|1|||
156756454|NCT02592447|565860599|FG001|Overall Study|Lost to Follow-up|0|||
156756455|NCT02592447|565860598|FG000|Overall Study|Ineligible after randomization|1|||
156756456|NCT02592447|565860599|FG001|Overall Study|Ineligible after randomization|0|||
156756457|NCT02592447|565860598|FG000|Overall Study|Withdrawal by Subject|0|||
156756458|NCT02592447|565860599|FG001|Overall Study|Withdrawal by Subject|1|||
156756459|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
156756460|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756461|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
156756462|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
156756463|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756464|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756465|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756466|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756467|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756468|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756469|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756470|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756471|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756472|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756473|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756474|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756475|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756476|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756477|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756478|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
156756479|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
156756480|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
156756481|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
156756482|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756483|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756484|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756485|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756486|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756487|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756488|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756489|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756490|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756491|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756492|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756493|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156313817|NCT01340872|564248272|FG000|Double-blind Phase|Withdrawal by Subject|3|||
156414550|NCT03230864|564610990|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
156414551|NCT03230864|564610991|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
156414552|NCT03230864|564610988|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156414553|NCT03230864|564610989|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
156414554|NCT03230864|564610990|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156414555|NCT03230864|564610991|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156414556|NCT03230864|564610988|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
156414557|NCT03230864|564610989|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
156652338|NCT00135707|565474393|FG000|Overall Study|Institutional review board request|1|||
156652339|NCT00135707|565474394|FG001|Overall Study|Institutional review board request|0|||
156652340|NCT00576901|565474405|FG000|Overall Study|Withdrawal by Subject|1|||
156652341|NCT00576901|565474405|FG000|Overall Study|Disease course|1|||
156652342|NCT00576901|565474405|FG000|Overall Study|Protocol Violation|1|||
156652343|NCT02398188|565474406|FG000|Overall Study|Adverse Event|2|||
156652344|NCT02398188|565474407|FG001|Overall Study|Adverse Event|3|||
156652345|NCT02398188|565474406|FG000|Overall Study|Lost to Follow-up|5|||
156652346|NCT02398188|565474407|FG001|Overall Study|Lost to Follow-up|0|||
156652347|NCT02398188|565474406|FG000|Overall Study|Non-compliance|4|||
156652348|NCT02398188|565474407|FG001|Overall Study|Non-compliance|4|||
156652349|NCT02398188|565474406|FG000|Overall Study|Protocol Violation|6|||
156652350|NCT02398188|565474407|FG001|Overall Study|Protocol Violation|10|||
156652351|NCT02398188|565474406|FG000|Overall Study|Sponsor Decision|2|||
156652352|NCT02398188|565474407|FG001|Overall Study|Sponsor Decision|1|||
156652353|NCT02398188|565474406|FG000|Overall Study|Pregnancy|1|||
156652354|NCT02398188|565474407|FG001|Overall Study|Pregnancy|0|||
156652355|NCT02398188|565474406|FG000|Overall Study|Withdrawal by Subject|7|||
156652356|NCT02398188|565474407|FG001|Overall Study|Withdrawal by Subject|16|||
156652357|NCT01259869|565474408|FG000|Overall Study|Duplicated registration|1|||
156652358|NCT03209570|565474409|FG000|Overall Study|Death|1|||
156652359|NCT03209570|565474410|FG001|Overall Study|Death|0|||
156652360|NCT03209570|565474409|FG000|Overall Study|Incomplete Data|8|||
156652361|NCT03209570|565474410|FG001|Overall Study|Incomplete Data|10|||
156652362|NCT03209570|565474409|FG000|Overall Study|Protocol Violation|1|||
156652363|NCT03209570|565474410|FG001|Overall Study|Protocol Violation|0|||
156652364|NCT03209570|565474409|FG000|Overall Study|Withdrawal by Subject|0|||
156652365|NCT03209570|565474410|FG001|Overall Study|Withdrawal by Subject|3|||
156652366|NCT00220701|565474411|FG000|Overall Study|Lost to Follow-up|5|||
156652367|NCT00220701|565474412|FG001|Overall Study|Lost to Follow-up|4|||
156652368|NCT00755326|565474414|FG000|Overall Study|Lost to Follow-up|2|||
156652369|NCT00755326|565474415|FG001|Overall Study|Lost to Follow-up|3|||
156652370|NCT01612000|565474417|FG000|Overall Study|Lost to Follow-up|6|||
156652371|NCT01612000|565474418|FG001|Overall Study|Lost to Follow-up|4|||
156652372|NCT01612000|565474419|FG002|Overall Study|Lost to Follow-up|4|||
156652373|NCT01612000|565474420|FG003|Overall Study|Lost to Follow-up|8|||
156652374|NCT01612000|565474417|FG000|Overall Study|Physician Decision|0|||
156652375|NCT01612000|565474418|FG001|Overall Study|Physician Decision|0|||
156652376|NCT01612000|565474419|FG002|Overall Study|Physician Decision|1|||
156652377|NCT01612000|565474420|FG003|Overall Study|Physician Decision|0|||
156652378|NCT01612000|565474417|FG000|Overall Study|Withdrawal by Subject|3|||
156652379|NCT01612000|565474418|FG001|Overall Study|Withdrawal by Subject|1|||
156652380|NCT01612000|565474419|FG002|Overall Study|Withdrawal by Subject|2|||
156652381|NCT01612000|565474420|FG003|Overall Study|Withdrawal by Subject|2|||
156652382|NCT02173704|565474421|FG000|Overall Study|Adverse Event|1|||
156652383|NCT02173704|565474422|FG001|Overall Study|Adverse Event|0|||
156652384|NCT02173704|565474421|FG000|Overall Study|Lost to Follow-up|1|||
156652385|NCT02173704|565474422|FG001|Overall Study|Lost to Follow-up|0|||
156652386|NCT02173704|565474421|FG000|Overall Study|Other|1|||
156652387|NCT02173704|565474422|FG001|Overall Study|Other|0|||
156652388|NCT02173704|565474421|FG000|Overall Study|Protocol Violation|1|||
156652389|NCT02173704|565474422|FG001|Overall Study|Protocol Violation|0|||
156652390|NCT02173704|565474421|FG000|Overall Study|Withdrawal by Subject|9|||
156414558|NCT03230864|564610990|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156652391|NCT02173704|565474422|FG001|Overall Study|Withdrawal by Subject|4|||
156652392|NCT00634907|565474428|FG000|Overall Study|Withdrawal by Subject|3|||
156652393|NCT00634907|565474429|FG001|Overall Study|Withdrawal by Subject|0|||
156652394|NCT00634907|565474428|FG000|Overall Study|Physician Decision|3|||
156652395|NCT00634907|565474429|FG001|Overall Study|Physician Decision|9|||
156652396|NCT00634907|565474428|FG000|Overall Study|Withdrawal by Subject|11|||
156652397|NCT00634907|565474429|FG001|Overall Study|Withdrawal by Subject|8|||
156652398|NCT01180244|565474436|FG000|Overall Study|Lack of Efficacy|0|||
156652399|NCT01180244|565474437|FG001|Overall Study|Lack of Efficacy|7|||
156652400|NCT01180244|565474436|FG000|Overall Study|Physician Decision|3|||
156652401|NCT01180244|565474437|FG001|Overall Study|Physician Decision|0|||
156652402|NCT01180244|565474436|FG000|Overall Study|Adverse Event|1|||
156652403|NCT01180244|565474437|FG001|Overall Study|Adverse Event|0|||
156652404|NCT01180244|565474436|FG000|Overall Study|Withdrawal by Subject|0|||
156652405|NCT01180244|565474437|FG001|Overall Study|Withdrawal by Subject|1|||
156652406|NCT01180244|565474436|FG000|Overall Study|Protocol Violation|1|||
156414559|NCT03230864|564610991|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156414560|NCT03230864|564610988|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
156414561|NCT03230864|564610989|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
156414562|NCT03230864|564610990|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156414563|NCT03230864|564610991|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156414564|NCT03230864|564610988|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
156414565|NCT03230864|564610989|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
156414566|NCT03230864|564610990|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
156414567|NCT03230864|564610991|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
156414568|NCT03230864|564610988|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
156414569|NCT03230864|564610989|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
156414570|NCT03230864|564610990|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
156414571|NCT03230864|564610991|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
156414572|NCT03230864|564610988|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
156414573|NCT03230864|564610989|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
156414574|NCT03230864|564610990|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
156414575|NCT03230864|564610991|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
156414576|NCT03230864|564610988|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
156414577|NCT03230864|564610989|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
156313818|NCT01340872|564248273|FG001|Double-blind Phase|Withdrawal by Subject|5|||
156313819|NCT01340872|564248274|FG002|Double-blind Phase|Withdrawal by Subject|0|||
156414578|NCT03230864|564610990|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
156414579|NCT03230864|564610991|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
156414580|NCT03230864|564610988|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156414581|NCT03230864|564610989|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156414582|NCT03230864|564610990|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
156414583|NCT03230864|564610991|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
156414584|NCT03230864|564610988|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
156414585|NCT03230864|564610989|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
156414586|NCT03230864|564610990|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
156414587|NCT03230864|564610991|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
156414588|NCT00432679|564610994|FG000|Overall Study|Adverse Event|2|||
156414589|NCT00432679|564610995|FG001|Overall Study|Adverse Event|1|||
156414590|NCT00432679|564610994|FG000|Overall Study|Withdrawal by Subject|3|||
156414591|NCT00432679|564610995|FG001|Overall Study|Withdrawal by Subject|2|||
156414592|NCT04102540|564610996|FG000|Overall Study|Withdrawn by PI|2|||
156414593|NCT04102540|564610996|FG000|Overall Study|Lost to Follow-up|6|||
156414594|NCT00280293|564610997|FG000|Overall Study|Protocol Violation|3|||
156414595|NCT00280293|564610998|FG001|Overall Study|Protocol Violation|0|||
156414596|NCT00280293|564610997|FG000|Overall Study|Physician Decision|5|||
156414597|NCT00280293|564610998|FG001|Overall Study|Physician Decision|4|||
156414598|NCT00280293|564610997|FG000|Overall Study|Lost to Follow-up|14|||
156414599|NCT00280293|564610998|FG001|Overall Study|Lost to Follow-up|12|||
156414600|NCT00280293|564610997|FG000|Overall Study|Withdrawal by Subject|3|||
156414601|NCT00280293|564610998|FG001|Overall Study|Withdrawal by Subject|5|||
156414602|NCT00280293|564610997|FG000|Overall Study|Incarceration/Legal Reasons|1|||
156313820|NCT01340872|564248275|FG003|Double-blind Phase|Withdrawal by Subject|0|||
156313821|NCT01340872|564248272|FG000|Double-blind Phase|Lost to Follow-up|0|||
156313822|NCT01340872|564248273|FG001|Double-blind Phase|Lost to Follow-up|1|||
156313823|NCT01340872|564248274|FG002|Double-blind Phase|Lost to Follow-up|0|||
156313824|NCT01340872|564248275|FG003|Double-blind Phase|Lost to Follow-up|0|||
156313825|NCT01340872|564248272|FG000|Double-blind Phase|Protocol Violation|0|||
156313826|NCT01340872|564248273|FG001|Double-blind Phase|Protocol Violation|1|||
156313827|NCT01340872|564248274|FG002|Double-blind Phase|Protocol Violation|0|||
156313828|NCT01340872|564248275|FG003|Double-blind Phase|Protocol Violation|0|||
156313829|NCT01340872|564248272|FG000|Open-label Phase|Physician Decision|0|||
156313830|NCT01340872|564248273|FG001|Open-label Phase|Physician Decision|0|||
156313831|NCT01340872|564248274|FG002|Open-label Phase|Physician Decision|2|||
156313832|NCT01340872|564248275|FG003|Open-label Phase|Physician Decision|1|||
156313833|NCT01340872|564248272|FG000|Open-label Phase|Pregnancy|0|||
156313834|NCT01340872|564248273|FG001|Open-label Phase|Pregnancy|0|||
156313835|NCT01340872|564248274|FG002|Open-label Phase|Pregnancy|1|||
156313836|NCT01340872|564248275|FG003|Open-label Phase|Pregnancy|0|||
156313837|NCT01340872|564248272|FG000|Open-label Phase|Adverse Event|0|||
156313838|NCT01340872|564248273|FG001|Open-label Phase|Adverse Event|0|||
156313839|NCT01340872|564248274|FG002|Open-label Phase|Adverse Event|8|||
156313840|NCT01340872|564248275|FG003|Open-label Phase|Adverse Event|4|||
156313841|NCT01340872|564248272|FG000|Open-label Phase|Withdrawal by Subject|0|||
156414603|NCT00280293|564610998|FG001|Overall Study|Incarceration/Legal Reasons|1|||
156652407|NCT01180244|565474437|FG001|Overall Study|Protocol Violation|0|||
156414604|NCT00280293|564610997|FG000|Overall Study|Adverse Event|0|||
156652408|NCT01180244|565474436|FG000|Overall Study|Lost to Follow-up|1|||
156414605|NCT00280293|564610998|FG001|Overall Study|Adverse Event|1|||
156414606|NCT01177813|564610999|FG000|Overall Study|Adverse Event|8|||
156414607|NCT01177813|564611000|FG001|Overall Study|Adverse Event|2|||
156414608|NCT01177813|564611001|FG002|Overall Study|Adverse Event|4|||
156414609|NCT01177813|564611002|FG003|Overall Study|Adverse Event|6|||
156414610|NCT01177813|564611003|FG004|Overall Study|Adverse Event|3|||
156414611|NCT01177813|564610999|FG000|Overall Study|Lack of Efficacy|1|||
156414612|NCT01177813|564611000|FG001|Overall Study|Lack of Efficacy|0|||
156414613|NCT01177813|564611001|FG002|Overall Study|Lack of Efficacy|0|||
156414614|NCT01177813|564611002|FG003|Overall Study|Lack of Efficacy|0|||
156414615|NCT01177813|564611003|FG004|Overall Study|Lack of Efficacy|0|||
156414616|NCT01177813|564610999|FG000|Overall Study|Protocol Violation|3|||
156414617|NCT01177813|564611000|FG001|Overall Study|Protocol Violation|2|||
156414618|NCT01177813|564611001|FG002|Overall Study|Protocol Violation|2|||
156414619|NCT01177813|564611002|FG003|Overall Study|Protocol Violation|0|||
156414620|NCT01177813|564611003|FG004|Overall Study|Protocol Violation|1|||
156414621|NCT01177813|564610999|FG000|Overall Study|Lost to Follow-up|12|||
156414622|NCT01177813|564611000|FG001|Overall Study|Lost to Follow-up|5|||
156414623|NCT01177813|564611001|FG002|Overall Study|Lost to Follow-up|6|||
156414624|NCT01177813|564611002|FG003|Overall Study|Lost to Follow-up|3|||
156414625|NCT01177813|564611003|FG004|Overall Study|Lost to Follow-up|0|||
156414626|NCT01177813|564610999|FG000|Overall Study|Withdrawal by Subject|12|||
156414627|NCT01177813|564611000|FG001|Overall Study|Withdrawal by Subject|7|||
156414628|NCT01177813|564611001|FG002|Overall Study|Withdrawal by Subject|6|||
156414629|NCT01177813|564611002|FG003|Overall Study|Withdrawal by Subject|5|||
156414630|NCT01177813|564611003|FG004|Overall Study|Withdrawal by Subject|3|||
156414631|NCT01177813|564610999|FG000|Overall Study|Other reason not defined above|5|||
156414632|NCT01177813|564611000|FG001|Overall Study|Other reason not defined above|2|||
156414633|NCT01177813|564611001|FG002|Overall Study|Other reason not defined above|2|||
156414634|NCT01177813|564611002|FG003|Overall Study|Other reason not defined above|3|||
156414635|NCT01177813|564611003|FG004|Overall Study|Other reason not defined above|2|||
156414636|NCT00610675|564611008|FG000|Overall Study|Untreated|4|||
156414637|NCT00610675|564611008|FG000|Overall Study|Adverse Event|67|||
156414638|NCT00610675|564611008|FG000|Overall Study|Insufficient Effect|31|||
156414639|NCT00610675|564611008|FG000|Overall Study|Withdrawal by Subject|28|||
156414640|NCT00610675|564611008|FG000|Overall Study|Reasons unrelated to trial|27|||
156414641|NCT00610675|564611008|FG000|Overall Study|Lack of Compliance|7|||
156414642|NCT00610675|564611008|FG000|Overall Study|Lost to Follow-up|31|||
156414643|NCT00610675|564611008|FG000|Overall Study|Other reason (not specified)|25|||
156414644|NCT01458249|564611009|FG000|Overall Study|Not treated|1|||
156414645|NCT01458249|564611009|FG000|Overall Study|Adverse Event|4|||
156414646|NCT01458249|564611009|FG000|Overall Study|Other|2|||
156414647|NCT01458249|564611009|FG000|Overall Study|Ongoing|1|||
156414648|NCT02056119|564611012|FG000|Overall Study|Death|1|||
156414649|NCT02056119|564611013|FG001|Overall Study|Death|2|||
156414650|NCT02056119|564611012|FG000|Overall Study|Intubated for less than 24 hrs|2|||
156414651|NCT02056119|564611013|FG001|Overall Study|Intubated for less than 24 hrs|7|||
156414652|NCT02056119|564611012|FG000|Overall Study|No aerosol treatments were given.|3|||
156414653|NCT02056119|564611013|FG001|Overall Study|No aerosol treatments were given.|2|||
156414654|NCT02056119|564611012|FG000|Overall Study|Received Metaneb treatment|0|||
156414655|NCT02056119|564611013|FG001|Overall Study|Received Metaneb treatment|2|||
156414656|NCT02056119|564611012|FG000|Overall Study|Protocol Violation|4|||
156414657|NCT02056119|564611013|FG001|Overall Study|Protocol Violation|7|||
156414658|NCT03220737|564611014|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
156414659|NCT03220737|564611015|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
156414660|NCT03220737|564611016|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
156414661|NCT03220737|564611017|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
156414662|NCT03220737|564611018|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
156414663|NCT03220737|564611019|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
156414664|NCT03220737|564611020|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
156414665|NCT03220737|564611014|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
156414666|NCT03220737|564611015|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
156414667|NCT03220737|564611016|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
156414668|NCT03220737|564611017|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
156414669|NCT03220737|564611018|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
156414670|NCT03220737|564611019|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
156414671|NCT03220737|564611020|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
156414672|NCT03220737|564611014|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
156414673|NCT03220737|564611015|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
156414674|NCT03220737|564611016|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
156414675|NCT03220737|564611017|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
156414676|NCT03220737|564611018|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
156414677|NCT03220737|564611019|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
156414678|NCT03220737|564611020|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
156414679|NCT03220737|564611014|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156652409|NCT01180244|565474437|FG001|Overall Study|Lost to Follow-up|0|||
156313842|NCT01340872|564248273|FG001|Open-label Phase|Withdrawal by Subject|0|||
156313843|NCT01340872|564248274|FG002|Open-label Phase|Withdrawal by Subject|1|||
156313844|NCT01340872|564248275|FG003|Open-label Phase|Withdrawal by Subject|6|||
156313845|NCT01340872|564248272|FG000|Open-label Phase|Worsening of IBD|0|||
156313846|NCT01340872|564248273|FG001|Open-label Phase|Worsening of IBD|0|||
156313847|NCT01340872|564248274|FG002|Open-label Phase|Worsening of IBD|1|||
156313848|NCT01340872|564248275|FG003|Open-label Phase|Worsening of IBD|0|||
156313849|NCT03039621|564248280|FG000|Overall Study|Violation of inclusion criteria|3|||
156313850|NCT03039621|564248281|FG001|Overall Study|Violation of inclusion criteria|2|||
156313851|NCT03039621|564248280|FG000|Overall Study|Non-compliance with protocol requirement|4|||
156313852|NCT03039621|564248281|FG001|Overall Study|Non-compliance with protocol requirement|5|||
156313853|NCT03039621|564248280|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
156313854|NCT03039621|564248281|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
156313855|NCT03039621|564248280|FG000|Overall Study|Violation of non-inclusion criteria|1|||
156313856|NCT03039621|564248281|FG001|Overall Study|Violation of non-inclusion criteria|2|||
156313857|NCT03254108|564248282|FG000|Overall Study|Adverse Event|0|||
156313858|NCT03254108|564248283|FG001|Overall Study|Adverse Event|2|||
156313859|NCT03254108|564248284|FG002|Overall Study|Adverse Event|0|||
156313860|NCT03254108|564248285|FG003|Overall Study|Adverse Event|1|||
156313861|NCT03254108|564248286|FG004|Overall Study|Adverse Event|1|||
156313862|NCT03254108|564248282|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
156313863|NCT03254108|564248283|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
156313864|NCT03254108|564248284|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
156313865|NCT03254108|564248285|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
156313866|NCT03254108|564248286|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
156313867|NCT01771809|564248287|FG000|Overall Study|Adverse Event|4|||
156313868|NCT01771809|564248288|FG001|Overall Study|Adverse Event|12|||
156313869|NCT01771809|564248287|FG000|Overall Study|Protocol Violation|0|||
156313870|NCT01771809|564248288|FG001|Overall Study|Protocol Violation|1|||
156313871|NCT01771809|564248287|FG000|Overall Study|Withdrawal by Subject|34|||
156313872|NCT01771809|564248288|FG001|Overall Study|Withdrawal by Subject|42|||
156313873|NCT01771809|564248287|FG000|Overall Study|Lost to Follow-up|1|||
156313874|NCT01771809|564248288|FG001|Overall Study|Lost to Follow-up|3|||
156313875|NCT01771809|564248287|FG000|Overall Study|Other (Insufficient clinical response)|22|||
156313876|NCT01771809|564248288|FG001|Overall Study|Other (Insufficient clinical response)|20|||
156313877|NCT01771809|564248287|FG000|Overall Study|Death|1|||
156313878|NCT01771809|564248288|FG001|Overall Study|Death|0|||
156313879|NCT01771809|564248287|FG000|Overall Study|Other (other)|9|||
156313880|NCT01771809|564248288|FG001|Overall Study|Other (other)|5|||
156313881|NCT00362180|564248289|FG000|Treated Period|Withdrawal by Subject|1|||
156313882|NCT00362180|564248290|FG001|Treated Period|Withdrawal by Subject|0|||
156313883|NCT00362180|564248291|FG002|Treated Period|Withdrawal by Subject|0|||
156313884|NCT00362180|564248292|FG003|Treated Period|Withdrawal by Subject|0|||
156313885|NCT00362180|564248293|FG004|Treated Period|Withdrawal by Subject|0|||
156313886|NCT00362180|564248294|FG005|Treated Period|Withdrawal by Subject|0|||
156313887|NCT00362180|564248295|FG006|Treated Period|Withdrawal by Subject|0|||
156313888|NCT00362180|564248296|FG007|Treated Period|Withdrawal by Subject|0|||
156313889|NCT00362180|564248297|FG008|Treated Period|Withdrawal by Subject|0|||
156313890|NCT00362180|564248289|FG000|Treated Period|Adverse Event|0|||
156313891|NCT00362180|564248290|FG001|Treated Period|Adverse Event|0|||
156313892|NCT00362180|564248291|FG002|Treated Period|Adverse Event|0|||
156313893|NCT00362180|564248292|FG003|Treated Period|Adverse Event|0|||
156313894|NCT00362180|564248293|FG004|Treated Period|Adverse Event|0|||
156313895|NCT00362180|564248294|FG005|Treated Period|Adverse Event|1|||
156313896|NCT00362180|564248295|FG006|Treated Period|Adverse Event|0|||
156313897|NCT00362180|564248296|FG007|Treated Period|Adverse Event|1|||
156313898|NCT00362180|564248297|FG008|Treated Period|Adverse Event|0|||
156313899|NCT02168387|564248307|FG000|Overall Study|Planned exubation|6|||
156313900|NCT02168387|564248308|FG001|Overall Study|Planned exubation|3|||
156313901|NCT02168387|564248307|FG000|Overall Study|Death|1|||
156313902|NCT02168387|564248308|FG001|Overall Study|Death|0|||
156313903|NCT01350544|564248310|FG000|Overall Study|Administrative Withdrawal|0|||
156313904|NCT01350544|564248311|FG001|Overall Study|Administrative Withdrawal|1|||
156313905|NCT01350544|564248310|FG000|Overall Study|Death|1|||
156313906|NCT01350544|564248311|FG001|Overall Study|Death|2|||
156313907|NCT01350544|564248310|FG000|Overall Study|Moved out of LA County|2|||
156313908|NCT01350544|564248311|FG001|Overall Study|Moved out of LA County|2|||
156313909|NCT01350544|564248310|FG000|Overall Study|Medical Issues|1|||
156313910|NCT01350544|564248311|FG001|Overall Study|Medical Issues|1|||
156313911|NCT01350544|564248310|FG000|Overall Study|Withdrawal by Subject|0|||
156313912|NCT01350544|564248311|FG001|Overall Study|Withdrawal by Subject|1|||
156313913|NCT01350544|564248310|FG000|Overall Study|Incarceration|1|||
156313914|NCT01350544|564248311|FG001|Overall Study|Incarceration|0|||
156313915|NCT01350544|564248310|FG000|Overall Study|Lost to Follow-up|18|||
156313916|NCT01350544|564248311|FG001|Overall Study|Lost to Follow-up|15|||
156313917|NCT00910624|564248315|FG000|Treatment Phase|Adverse Event|2|||
156414680|NCT03220737|564611015|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156414681|NCT03220737|564611016|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
156414682|NCT03220737|564611017|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156414683|NCT03220737|564611018|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156414684|NCT03220737|564611019|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156414685|NCT03220737|564611020|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156414686|NCT03220737|564611014|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156414687|NCT03220737|564611015|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156414688|NCT03220737|564611016|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156414689|NCT03220737|564611017|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156414690|NCT03220737|564611018|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
156414691|NCT03220737|564611019|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156414692|NCT03220737|564611020|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156414693|NCT03220737|564611014|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
156414694|NCT03220737|564611015|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156414695|NCT03220737|564611016|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156414696|NCT03220737|564611017|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156414697|NCT03220737|564611018|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156414698|NCT03220737|564611019|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156414699|NCT03220737|564611020|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156414700|NCT03220737|564611014|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
156414701|NCT03220737|564611015|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156414702|NCT03220737|564611016|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156414703|NCT03220737|564611017|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156414704|NCT03220737|564611018|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156414705|NCT03220737|564611019|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156414706|NCT03220737|564611020|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156414707|NCT03220737|564611014|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
156414708|NCT03220737|564611015|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156414709|NCT03220737|564611016|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156414710|NCT03220737|564611017|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156414711|NCT03220737|564611018|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156414712|NCT03220737|564611019|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156414713|NCT03220737|564611020|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156414714|NCT01686932|564611032|FG000|Period 1|Adverse Event|1|||
156414715|NCT01686932|564611033|FG001|Period 1|Adverse Event|1|||
156414716|NCT00630058|564611041|FG000|Overall Study|Adverse Event|1|||
156414717|NCT00630058|564611042|FG001|Overall Study|Adverse Event|1|||
156414718|NCT00630058|564611041|FG000|Overall Study|Withdrawal by Subject|0|||
156414719|NCT00630058|564611042|FG001|Overall Study|Withdrawal by Subject|1|||
156414720|NCT00630058|564611041|FG000|Overall Study|stopping criteria|3|||
156414721|NCT00630058|564611042|FG001|Overall Study|stopping criteria|2|||
156414722|NCT01313923|564611045|FG000|Overall Study|Physician Decision|3|||
156414723|NCT03358329|564611046|FG000|Overall Study|Lost to Follow-up|2|||
156414724|NCT03358329|564611046|FG000|Overall Study|Withdrawal by Subject|2|||
156414725|NCT02982720|564611047|FG000|Overall Study|Adverse Event|3|||
156414726|NCT02982720|564611047|FG000|Overall Study|Death|1|||
156414727|NCT03875911|564611048|FG000|Overall Study|Lost to Follow-up|3|||
156414728|NCT03875911|564611049|FG001|Overall Study|Lost to Follow-up|6|||
156414729|NCT03875911|564611050|FG002|Overall Study|Lost to Follow-up|2|||
156414730|NCT03875911|564611048|FG000|Overall Study|Surgery cancelled|1|||
156414731|NCT03875911|564611049|FG001|Overall Study|Surgery cancelled|0|||
156414732|NCT03875911|564611050|FG002|Overall Study|Surgery cancelled|1|||
156414733|NCT03875911|564611048|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
156414734|NCT03875911|564611049|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
156414735|NCT03875911|564611050|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
156652410|NCT00620763|565474440|FG000|Period: First Intervention|Withdrawal by Subject|0|||
156414736|NCT03285113|564611051|FG000|Overall Study|Unable to implant leads|2|||
156414737|NCT02087150|564611055|FG000|Overall Study|Death|0|||
156414738|NCT02087150|564611056|FG001|Overall Study|Death|1|||
156414739|NCT02087150|564611057|FG002|Overall Study|Death|0|||
156414740|NCT02087150|564611055|FG000|Overall Study|Lost to Follow-up|6|||
156414741|NCT02087150|564611056|FG001|Overall Study|Lost to Follow-up|13|||
156414742|NCT02087150|564611057|FG002|Overall Study|Lost to Follow-up|7|||
156414743|NCT02087150|564611055|FG000|Overall Study|Withdrawal by Subject|2|||
156414744|NCT02087150|564611056|FG001|Overall Study|Withdrawal by Subject|5|||
156414745|NCT02087150|564611057|FG002|Overall Study|Withdrawal by Subject|3|||
156652411|NCT00620763|565474441|FG001|Period: First Intervention|Withdrawal by Subject|2|||
156652412|NCT00620763|565474440|FG000|Period: First Intervention|Protocol Violation|0|||
156652413|NCT00620763|565474441|FG001|Period: First Intervention|Protocol Violation|3|||
156414746|NCT02087150|564611055|FG000|Overall Study|Physician Decision|0|||
156414747|NCT02087150|564611056|FG001|Overall Study|Physician Decision|1|||
156414748|NCT02087150|564611057|FG002|Overall Study|Physician Decision|0|||
156414749|NCT02087150|564611055|FG000|Overall Study|Procedure not done|1|||
156414750|NCT02087150|564611056|FG001|Overall Study|Procedure not done|13|||
156414751|NCT02087150|564611057|FG002|Overall Study|Procedure not done|0|||
156414752|NCT02087150|564611055|FG000|Overall Study|F/U not completed w/in study window|0|||
156414753|NCT02087150|564611056|FG001|Overall Study|F/U not completed w/in study window|0|||
156414754|NCT02087150|564611057|FG002|Overall Study|F/U not completed w/in study window|1|||
156414755|NCT02087150|564611055|FG000|Overall Study|Other|1|||
156414756|NCT02087150|564611056|FG001|Overall Study|Other|0|||
156414757|NCT02087150|564611057|FG002|Overall Study|Other|0|||
156414758|NCT02087150|564611055|FG000|Overall Study|Pt moved out of town|0|||
156414759|NCT02087150|564611056|FG001|Overall Study|Pt moved out of town|1|||
156414760|NCT02087150|564611057|FG002|Overall Study|Pt moved out of town|0|||
156414761|NCT02019602|564611060|FG000|Screening Period|Ineligibility|4|||
156414762|NCT02019602|564611061|FG001|Screening Period|Ineligibility|0|||
156414763|NCT02019602|564611060|FG000|Screening Period|Adverse Event|1|||
156414764|NCT02019602|564611061|FG001|Screening Period|Adverse Event|0|||
156414765|NCT01448044|564611064|FG000|Treatment Period|Adverse Event|4|||
156414766|NCT01448044|564611065|FG001|Treatment Period|Adverse Event|3|||
156414767|NCT01448044|564611064|FG000|Treatment Period|Lack of Efficacy|5|||
156414768|NCT01448044|564611065|FG001|Treatment Period|Lack of Efficacy|12|||
156414769|NCT01448044|564611064|FG000|Treatment Period|Subject requested discontinue study drug|1|||
156414770|NCT01448044|564611065|FG001|Treatment Period|Subject requested discontinue study drug|0|||
156414771|NCT01448044|564611064|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
156414772|NCT01448044|564611065|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
156414773|NCT01448044|564611064|FG000|Treatment Period|Participant does not meet study criteria|1|||
156414774|NCT01448044|564611065|FG001|Treatment Period|Participant does not meet study criteria|0|||
156414775|NCT01448044|564611064|FG000|Treatment Period|Lost to Follow-up|2|||
156414776|NCT01448044|564611065|FG001|Treatment Period|Lost to Follow-up|1|||
156414777|NCT01448044|564611064|FG000|Treatment Period|Other reason|2|||
156414778|NCT01448044|564611065|FG001|Treatment Period|Other reason|0|||
156414779|NCT01448044|564611064|FG000|Follow Up Period|Withdrawal by Subject|1|||
156414780|NCT01448044|564611065|FG001|Follow Up Period|Withdrawal by Subject|1|||
156414781|NCT01448044|564611064|FG000|Follow Up Period|Lost to Follow-up|6|||
156414782|NCT01448044|564611065|FG001|Follow Up Period|Lost to Follow-up|2|||
156414783|NCT01448044|564611064|FG000|Follow Up Period|Other|5|||
156414784|NCT01448044|564611065|FG001|Follow Up Period|Other|11|||
156414785|NCT00507026|564611066|FG000|Overall Study|Lack of Efficacy|6|||
156414786|NCT00507026|564611067|FG001|Overall Study|Lack of Efficacy|4|||
156414787|NCT00507026|564611068|FG002|Overall Study|Lack of Efficacy|21|||
156414788|NCT00507026|564611066|FG000|Overall Study|Withdrawal by Subject|2|||
156414789|NCT00507026|564611067|FG001|Overall Study|Withdrawal by Subject|0|||
156414790|NCT00507026|564611068|FG002|Overall Study|Withdrawal by Subject|0|||
156414791|NCT00507026|564611066|FG000|Overall Study|Investigator Decision|1|||
156414792|NCT00507026|564611067|FG001|Overall Study|Investigator Decision|0|||
156414793|NCT00507026|564611068|FG002|Overall Study|Investigator Decision|0|||
156414794|NCT00507026|564611066|FG000|Overall Study|Adverse Event|2|||
156414795|NCT00507026|564611067|FG001|Overall Study|Adverse Event|0|||
156414796|NCT00507026|564611068|FG002|Overall Study|Adverse Event|0|||
156414797|NCT00507026|564611066|FG000|Overall Study|Protocol Violation|1|||
156414798|NCT00507026|564611067|FG001|Overall Study|Protocol Violation|0|||
156414799|NCT00507026|564611068|FG002|Overall Study|Protocol Violation|0|||
156414800|NCT00507026|564611066|FG000|Overall Study|Other|1|||
156414801|NCT00507026|564611067|FG001|Overall Study|Other|0|||
156414802|NCT00507026|564611068|FG002|Overall Study|Other|0|||
156414803|NCT04230980|564611071|FG000|Overall Study|Lost to Follow-up|1|||
156414804|NCT04230980|564611072|FG001|Overall Study|Lost to Follow-up|2|||
156414805|NCT04230980|564611071|FG000|Overall Study|Adverse Event|0|||
156414806|NCT04230980|564611072|FG001|Overall Study|Adverse Event|1|||
156756494|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156414807|NCT02372058|564611073|FG000|Overall Study|Withdrawal by Subject|3|||
156414808|NCT00318149|564611074|FG000|Overall Study|Adverse Event|0|||
156414809|NCT00318149|564611075|FG001|Overall Study|Adverse Event|0|||
156414810|NCT00318149|564611076|FG002|Overall Study|Adverse Event|0|||
156756495|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156414811|NCT00318149|564611077|FG003|Overall Study|Adverse Event|0|||
156414812|NCT00318149|564611078|FG004|Overall Study|Adverse Event|0|||
156414813|NCT00318149|564611079|FG005|Overall Study|Adverse Event|2|||
156414814|NCT03541642|564611080|FG000|Overall Study|Withdrawal by Subject|1|||
156414815|NCT03541642|564611081|FG001|Overall Study|Withdrawal by Subject|2|||
156414816|NCT03541642|564611080|FG000|Overall Study|Lost to Follow-up|16|||
156414817|NCT03541642|564611081|FG001|Overall Study|Lost to Follow-up|12|||
156414818|NCT03541642|564611080|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
156414819|NCT03541642|564611081|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
156414820|NCT03523871|564611082|FG000|Overall Study|Death|1|||
156414821|NCT00219141|564611083|FG000|Overall Study|Adverse Event|4|||
156414822|NCT00219141|564611084|FG001|Overall Study|Adverse Event|10|||
156414823|NCT00219141|564611085|FG002|Overall Study|Adverse Event|5|||
156414824|NCT00219141|564611083|FG000|Overall Study|Lack of Efficacy|3|||
156414825|NCT00219141|564611084|FG001|Overall Study|Lack of Efficacy|2|||
156414826|NCT00219141|564611085|FG002|Overall Study|Lack of Efficacy|0|||
156414827|NCT00219141|564611083|FG000|Overall Study|Administrative problems|0|||
156414828|NCT00219141|564611084|FG001|Overall Study|Administrative problems|1|||
156414829|NCT00219141|564611085|FG002|Overall Study|Administrative problems|0|||
156414830|NCT00219141|564611083|FG000|Overall Study|Lost to Follow-up|2|||
156414831|NCT00219141|564611084|FG001|Overall Study|Lost to Follow-up|4|||
156414832|NCT00219141|564611085|FG002|Overall Study|Lost to Follow-up|1|||
156414833|NCT00219141|564611083|FG000|Overall Study|Protocol Violation|3|||
156414834|NCT00219141|564611084|FG001|Overall Study|Protocol Violation|1|||
156414835|NCT00219141|564611085|FG002|Overall Study|Protocol Violation|1|||
156414836|NCT00219141|564611083|FG000|Overall Study|Withdrawal by Subject|1|||
156414837|NCT00219141|564611084|FG001|Overall Study|Withdrawal by Subject|3|||
156414838|NCT00219141|564611085|FG002|Overall Study|Withdrawal by Subject|5|||
156414839|NCT00219141|564611083|FG000|Overall Study|Condition no longer requires study drug|1|||
156414840|NCT00219141|564611084|FG001|Overall Study|Condition no longer requires study drug|0|||
156414841|NCT00219141|564611085|FG002|Overall Study|Condition no longer requires study drug|0|||
156414842|NCT01994720|564611086|FG000|Overall Study|Withdrawal by Subject|46|||
156414843|NCT01994720|564611087|FG001|Overall Study|Withdrawal by Subject|56|||
156414844|NCT02061761|564611089|FG000|Overall Study|Disease progression|2|||
156414845|NCT02061761|564611090|FG001|Overall Study|Disease progression|8|||
156414846|NCT02061761|564611091|FG002|Overall Study|Disease progression|4|||
156414847|NCT02061761|564611092|FG003|Overall Study|Disease progression|5|||
156414848|NCT02061761|564611093|FG004|Overall Study|Disease progression|9|||
156414849|NCT02061761|564611094|FG005|Overall Study|Disease progression|3|||
156414850|NCT02061761|564611095|FG006|Overall Study|Disease progression|1|||
156414851|NCT02061761|564611096|FG007|Overall Study|Disease progression|2|||
156414852|NCT02061761|564611097|FG008|Overall Study|Disease progression|28|||
156414853|NCT02061761|564611089|FG000|Overall Study|Study Drug toxicity|0|||
156414854|NCT02061761|564611090|FG001|Overall Study|Study Drug toxicity|0|||
156414855|NCT02061761|564611091|FG002|Overall Study|Study Drug toxicity|0|||
156414856|NCT02061761|564611092|FG003|Overall Study|Study Drug toxicity|0|||
156414857|NCT02061761|564611093|FG004|Overall Study|Study Drug toxicity|0|||
156414858|NCT02061761|564611094|FG005|Overall Study|Study Drug toxicity|1|||
156414859|NCT02061761|564611095|FG006|Overall Study|Study Drug toxicity|0|||
156414860|NCT02061761|564611096|FG007|Overall Study|Study Drug toxicity|2|||
156414861|NCT02061761|564611097|FG008|Overall Study|Study Drug toxicity|6|||
156414862|NCT02061761|564611089|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
156414863|NCT02061761|564611090|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
156414864|NCT02061761|564611091|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
156414865|NCT02061761|564611092|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
156414866|NCT02061761|564611093|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
156414867|NCT02061761|564611094|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
156414868|NCT02061761|564611095|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
156414869|NCT02061761|564611096|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
156414870|NCT02061761|564611097|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
156414871|NCT02061761|564611089|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156414872|NCT02061761|564611090|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156414873|NCT02061761|564611091|FG002|Overall Study|Participant request to discontinue study treatment|2|||
156414874|NCT02061761|564611092|FG003|Overall Study|Participant request to discontinue study treatment|2|||
156414875|NCT02061761|564611093|FG004|Overall Study|Participant request to discontinue study treatment|0|||
156414876|NCT02061761|564611094|FG005|Overall Study|Participant request to discontinue study treatment|1|||
156414877|NCT02061761|564611095|FG006|Overall Study|Participant request to discontinue study treatment|0|||
156414878|NCT02061761|564611096|FG007|Overall Study|Participant request to discontinue study treatment|0|||
156414879|NCT02061761|564611097|FG008|Overall Study|Participant request to discontinue study treatment|2|||
156414880|NCT02061761|564611089|FG000|Overall Study|Withdrawal by Subject|0|||
156414881|NCT02061761|564611090|FG001|Overall Study|Withdrawal by Subject|0|||
156414882|NCT02061761|564611091|FG002|Overall Study|Withdrawal by Subject|0|||
156414883|NCT02061761|564611092|FG003|Overall Study|Withdrawal by Subject|0|||
156414884|NCT02061761|564611093|FG004|Overall Study|Withdrawal by Subject|0|||
156414885|NCT02061761|564611094|FG005|Overall Study|Withdrawal by Subject|0|||
156414886|NCT02061761|564611095|FG006|Overall Study|Withdrawal by Subject|0|||
156414887|NCT02061761|564611096|FG007|Overall Study|Withdrawal by Subject|0|||
156414888|NCT02061761|564611097|FG008|Overall Study|Withdrawal by Subject|2|||
156414889|NCT02061761|564611089|FG000|Overall Study|Maximum clinical benefit|0|||
156414890|NCT02061761|564611090|FG001|Overall Study|Maximum clinical benefit|0|||
156414891|NCT02061761|564611091|FG002|Overall Study|Maximum clinical benefit|0|||
156414892|NCT02061761|564611092|FG003|Overall Study|Maximum clinical benefit|1|||
156414893|NCT02061761|564611093|FG004|Overall Study|Maximum clinical benefit|0|||
156756496|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756497|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756498|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
156756499|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
156313918|NCT00910624|564248316|FG001|Treatment Phase|Adverse Event|6|||
156313919|NCT00910624|564248317|FG002|Treatment Phase|Adverse Event|6|||
156313920|NCT00910624|564248318|FG003|Treatment Phase|Adverse Event|0|||
156313921|NCT00910624|564248315|FG000|Treatment Phase|Treatment Failure|23|||
156313922|NCT00910624|564248316|FG001|Treatment Phase|Treatment Failure|10|||
156313923|NCT00910624|564248317|FG002|Treatment Phase|Treatment Failure|0|||
156313924|NCT00910624|564248318|FG003|Treatment Phase|Treatment Failure|0|||
156313925|NCT00910624|564248315|FG000|Treatment Phase|Lost to Follow-up|0|||
156313926|NCT00910624|564248316|FG001|Treatment Phase|Lost to Follow-up|0|||
156313927|NCT00910624|564248317|FG002|Treatment Phase|Lost to Follow-up|1|||
156313928|NCT00910624|564248318|FG003|Treatment Phase|Lost to Follow-up|0|||
156313929|NCT00910624|564248315|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
156313930|NCT00910624|564248316|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
156313931|NCT00910624|564248317|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
156313932|NCT00910624|564248318|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
156313933|NCT00910624|564248315|FG000|Treatment Phase|Withdrawal by Subject|2|||
156313934|NCT00910624|564248316|FG001|Treatment Phase|Withdrawal by Subject|1|||
156313935|NCT00910624|564248317|FG002|Treatment Phase|Withdrawal by Subject|0|||
156313936|NCT00910624|564248318|FG003|Treatment Phase|Withdrawal by Subject|0|||
156313937|NCT00910624|564248315|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
156313938|NCT00910624|564248316|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
156313939|NCT00910624|564248317|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
156313940|NCT00910624|564248318|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
156313941|NCT00910624|564248315|FG000|Follow-Up Phase|Adverse Event|0|||
156313942|NCT00910624|564248316|FG001|Follow-Up Phase|Adverse Event|0|||
156313943|NCT00910624|564248317|FG002|Follow-Up Phase|Adverse Event|1|||
156313944|NCT00910624|564248318|FG003|Follow-Up Phase|Adverse Event|0|||
156313945|NCT00910624|564248315|FG000|Follow-Up Phase|Lost to Follow-up|3|||
156313946|NCT00910624|564248316|FG001|Follow-Up Phase|Lost to Follow-up|1|||
156313947|NCT00910624|564248317|FG002|Follow-Up Phase|Lost to Follow-up|2|||
156313948|NCT00910624|564248318|FG003|Follow-Up Phase|Lost to Follow-up|0|||
156313949|NCT00910624|564248315|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
156313950|NCT00910624|564248316|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
156313951|NCT00910624|564248317|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
156313952|NCT00910624|564248318|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
156313953|NCT00910624|564248315|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
156313954|NCT00910624|564248316|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
156313955|NCT00910624|564248317|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
156313956|NCT00910624|564248318|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
156313957|NCT00910624|564248315|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
156313958|NCT00910624|564248316|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
156313959|NCT00910624|564248317|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
156313960|NCT00910624|564248318|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
156313961|NCT00910624|564248315|FG000|Follow-Up Phase|Administrative|0|||
156313962|NCT00910624|564248316|FG001|Follow-Up Phase|Administrative|1|||
156313963|NCT00910624|564248317|FG002|Follow-Up Phase|Administrative|1|||
156313964|NCT00910624|564248318|FG003|Follow-Up Phase|Administrative|0|||
156313965|NCT04585009|564248319|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
156313966|NCT04585009|564248320|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313967|NCT04585009|564248321|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313968|NCT04585009|564248322|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313969|NCT04585009|564248323|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313970|NCT04585009|564248324|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313971|NCT04585009|564248325|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313972|NCT04585009|564248326|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313973|NCT04585009|564248327|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313974|NCT04585009|564248328|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313975|NCT04585009|564248329|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313976|NCT04585009|564248330|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156313977|NCT04585009|564248319|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
156313978|NCT04585009|564248320|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313979|NCT04585009|564248321|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313980|NCT04585009|564248322|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313981|NCT04585009|564248323|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313982|NCT04585009|564248324|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313983|NCT04585009|564248325|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313984|NCT04585009|564248326|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313985|NCT04585009|564248327|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313986|NCT04585009|564248328|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313987|NCT04585009|564248329|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313988|NCT04585009|564248330|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156313989|NCT04585009|564248319|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313990|NCT04585009|564248320|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313991|NCT04585009|564248321|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313992|NCT04585009|564248322|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313993|NCT04585009|564248323|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313994|NCT04585009|564248324|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313995|NCT04585009|564248325|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313996|NCT04585009|564248326|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
156313997|NCT04585009|564248327|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313998|NCT04585009|564248328|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156313999|NCT04585009|564248329|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156314000|NCT04585009|564248330|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156314001|NCT04585009|564248319|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314002|NCT04585009|564248320|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314003|NCT04585009|564248321|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314004|NCT04585009|564248322|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314005|NCT04585009|564248323|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
156314006|NCT04585009|564248324|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314007|NCT04585009|564248325|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314008|NCT04585009|564248326|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314009|NCT04585009|564248327|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314010|NCT04585009|564248328|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314011|NCT04585009|564248329|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314012|NCT04585009|564248330|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156314013|NCT04585009|564248319|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314014|NCT04585009|564248320|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314015|NCT04585009|564248321|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314016|NCT04585009|564248322|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314017|NCT04585009|564248323|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314018|NCT04585009|564248324|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314019|NCT04585009|564248325|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314020|NCT04585009|564248326|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314021|NCT04585009|564248327|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314022|NCT04585009|564248328|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
156314023|NCT04585009|564248329|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314024|NCT04585009|564248330|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156314025|NCT04585009|564248319|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314026|NCT04585009|564248320|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314027|NCT04585009|564248321|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314028|NCT04585009|564248322|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314029|NCT04585009|564248323|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314030|NCT04585009|564248324|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314031|NCT04585009|564248325|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314032|NCT04585009|564248326|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314033|NCT04585009|564248327|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314034|NCT04585009|564248328|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314035|NCT04585009|564248329|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156314036|NCT04585009|564248330|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
156314037|NCT01104376|564248331|FG000|Overall Study|Withdrawal by Subject|15|||
156314038|NCT01104376|564248331|FG000|Overall Study|Consented but excluded after labs|13|||
156314039|NCT01002820|564248332|FG000|Overall Study|Adverse Event|1|||
156314040|NCT01002820|564248332|FG000|Overall Study|Withdrawal by Subject|2|||
156314041|NCT01002820|564248332|FG000|Overall Study|Lack of Efficacy|1|||
156314042|NCT01673347|564248333|FG000|Overall Study|failure of allograft|7|||
156314043|NCT00895011|564248339|FG000|Overall Study|Withdrawal by Subject|14|||
156314044|NCT00895011|564248340|FG001|Overall Study|Withdrawal by Subject|7|||
156314045|NCT00895011|564248341|FG002|Overall Study|Withdrawal by Subject|2|||
156756500|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156314046|NCT00895011|564248339|FG000|Overall Study|Lost to Follow-up|5|||
156314047|NCT00895011|564248340|FG001|Overall Study|Lost to Follow-up|4|||
156314048|NCT00895011|564248341|FG002|Overall Study|Lost to Follow-up|1|||
156314049|NCT00895011|564248339|FG000|Overall Study|Protocol Violation|3|||
156314050|NCT00895011|564248340|FG001|Overall Study|Protocol Violation|1|||
156314051|NCT00895011|564248341|FG002|Overall Study|Protocol Violation|3|||
156314052|NCT00895011|564248339|FG000|Overall Study|Adverse Event|1|||
156314053|NCT00895011|564248340|FG001|Overall Study|Adverse Event|2|||
156314054|NCT00895011|564248341|FG002|Overall Study|Adverse Event|2|||
156314055|NCT00895011|564248339|FG000|Overall Study|schedule conflict|1|||
156314056|NCT00895011|564248340|FG001|Overall Study|schedule conflict|0|||
156314057|NCT00895011|564248341|FG002|Overall Study|schedule conflict|0|||
156314058|NCT03859973|564248342|FG000|Overall Study|Other reason than listed|3|||
156314059|NCT03859973|564248343|FG001|Overall Study|Other reason than listed|2|||
156314060|NCT03859973|564248342|FG000|Overall Study|COVID-19 related, not due to AE|3|||
156314061|NCT03859973|564248343|FG001|Overall Study|COVID-19 related, not due to AE|4|||
156314062|NCT03859973|564248342|FG000|Overall Study|Withdrawal by Subject|8|||
156314063|NCT03859973|564248343|FG001|Overall Study|Withdrawal by Subject|9|||
156314064|NCT03859973|564248342|FG000|Overall Study|Lost to Follow-up|2|||
156314065|NCT03859973|564248343|FG001|Overall Study|Lost to Follow-up|3|||
156314066|NCT03859973|564248342|FG000|Overall Study|Protocol Violation|1|||
156314067|NCT03859973|564248343|FG001|Overall Study|Protocol Violation|3|||
156314068|NCT03859973|564248342|FG000|Overall Study|Adverse Event|3|||
156314069|NCT03859973|564248343|FG001|Overall Study|Adverse Event|5|||
156314070|NCT02855541|564248344|FG000|Overall Study|Change in health status|2|||
156314071|NCT02855541|564248344|FG000|Overall Study|Withdrawal by Subject|2|||
156314072|NCT03085914|564248345|FG000|Overall Study|Death|6|||
156314073|NCT03085914|564248346|FG001|Overall Study|Death|6|||
156314074|NCT03085914|564248347|FG002|Overall Study|Death|4|||
156314075|NCT03085914|564248348|FG003|Overall Study|Death|1|||
156314076|NCT03085914|564248349|FG004|Overall Study|Death|5|||
156314077|NCT03085914|564248350|FG005|Overall Study|Death|2|||
156314078|NCT03085914|564248351|FG006|Overall Study|Death|2|||
156314079|NCT03085914|564248345|FG000|Overall Study|Withdrawal by Subject|1|||
156314080|NCT03085914|564248346|FG001|Overall Study|Withdrawal by Subject|1|||
156314081|NCT03085914|564248347|FG002|Overall Study|Withdrawal by Subject|2|||
156314082|NCT03085914|564248348|FG003|Overall Study|Withdrawal by Subject|2|||
156314083|NCT03085914|564248349|FG004|Overall Study|Withdrawal by Subject|2|||
156314084|NCT03085914|564248350|FG005|Overall Study|Withdrawal by Subject|0|||
156314085|NCT03085914|564248351|FG006|Overall Study|Withdrawal by Subject|1|||
156314086|NCT03085914|564248345|FG000|Overall Study|Lost to Follow-up|0|||
156314087|NCT03085914|564248346|FG001|Overall Study|Lost to Follow-up|0|||
156314088|NCT03085914|564248347|FG002|Overall Study|Lost to Follow-up|1|||
156314089|NCT03085914|564248348|FG003|Overall Study|Lost to Follow-up|0|||
156314090|NCT03085914|564248349|FG004|Overall Study|Lost to Follow-up|0|||
156314091|NCT03085914|564248350|FG005|Overall Study|Lost to Follow-up|1|||
156314092|NCT03085914|564248351|FG006|Overall Study|Lost to Follow-up|1|||
156314093|NCT03085914|564248345|FG000|Overall Study|Reason was not specified,|2|||
156314094|NCT03085914|564248346|FG001|Overall Study|Reason was not specified,|2|||
156314095|NCT03085914|564248347|FG002|Overall Study|Reason was not specified,|2|||
156314096|NCT03085914|564248348|FG003|Overall Study|Reason was not specified,|3|||
156314097|NCT03085914|564248349|FG004|Overall Study|Reason was not specified,|3|||
156314098|NCT03085914|564248350|FG005|Overall Study|Reason was not specified,|3|||
156314099|NCT03085914|564248351|FG006|Overall Study|Reason was not specified,|6|||
156314100|NCT03085914|564248345|FG000|Overall Study|Progressive Disease|0|||
156314101|NCT03085914|564248346|FG001|Overall Study|Progressive Disease|0|||
156314102|NCT03085914|564248347|FG002|Overall Study|Progressive Disease|2|||
156314103|NCT03085914|564248348|FG003|Overall Study|Progressive Disease|2|||
156314104|NCT03085914|564248349|FG004|Overall Study|Progressive Disease|1|||
156314105|NCT03085914|564248350|FG005|Overall Study|Progressive Disease|1|||
156314106|NCT03085914|564248351|FG006|Overall Study|Progressive Disease|1|||
156314107|NCT03085914|564248345|FG000|Overall Study|Study Terminated by the Sponsor|0|||
156314108|NCT03085914|564248346|FG001|Overall Study|Study Terminated by the Sponsor|0|||
156314109|NCT03085914|564248347|FG002|Overall Study|Study Terminated by the Sponsor|0|||
156314110|NCT03085914|564248348|FG003|Overall Study|Study Terminated by the Sponsor|1|||
156314111|NCT03085914|564248349|FG004|Overall Study|Study Terminated by the Sponsor|2|||
156314112|NCT03085914|564248350|FG005|Overall Study|Study Terminated by the Sponsor|1|||
156314113|NCT03085914|564248351|FG006|Overall Study|Study Terminated by the Sponsor|0|||
156314114|NCT01445548|564248353|FG000|Overall Study|Adverse Event|1|||
156314115|NCT03560518|564248355|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
156314116|NCT03560518|564248356|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
156314117|NCT03560518|564248357|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
156314118|NCT03560518|564248355|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
156314119|NCT03560518|564248356|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
156314120|NCT03560518|564248357|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
156314121|NCT03560518|564248355|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156314122|NCT03560518|564248356|FG001|Double Blind Treatment Period|Protocol Violation|2|||
156314123|NCT03560518|564248357|FG002|Double Blind Treatment Period|Protocol Violation|0|||
156314124|NCT03560518|564248355|FG000|Double Blind Treatment Period|Pregnancy|0|||
156314125|NCT03560518|564248356|FG001|Double Blind Treatment Period|Pregnancy|2|||
156414894|NCT02061761|564611094|FG005|Overall Study|Maximum clinical benefit|0|||
156414895|NCT02061761|564611095|FG006|Overall Study|Maximum clinical benefit|0|||
156314126|NCT03560518|564248357|FG002|Double Blind Treatment Period|Pregnancy|0|||
156314127|NCT03560518|564248355|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
156314128|NCT03560518|564248356|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
156314129|NCT03560518|564248357|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
156314130|NCT03560518|564248355|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
156314131|NCT03560518|564248356|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
156314132|NCT03560518|564248357|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
156314133|NCT03560518|564248355|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
156314134|NCT03560518|564248356|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
156314135|NCT03560518|564248357|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
156314136|NCT03560518|564248355|FG000|Double Blind Treatment Period|Adverse Event|0|||
156314137|NCT03560518|564248356|FG001|Double Blind Treatment Period|Adverse Event|3|||
156314138|NCT03560518|564248357|FG002|Double Blind Treatment Period|Adverse Event|1|||
156314139|NCT00159822|564248358|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
156314140|NCT00159822|564248358|FG000|Voriconazole Treatment Period|Adverse Event|9|||
156314141|NCT00159822|564248358|FG000|Voriconazole Treatment Period|Death|4|||
156314142|NCT00159822|564248358|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
156314143|NCT00159822|564248358|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
156314144|NCT00159822|564248358|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
156314145|NCT00159822|564248358|FG000|Post-treatment Follow-up Period|Death|1|||
156314146|NCT00159822|564248358|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
156314147|NCT00159822|564248358|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
156314148|NCT00275821|564248359|FG000|Overall Study|Adverse Event|4|||
156314149|NCT00275821|564248360|FG001|Overall Study|Adverse Event|12|||
156314150|NCT00275821|564248361|FG002|Overall Study|Adverse Event|5|||
156314151|NCT00275821|564248359|FG000|Overall Study|Administrative problems|3|||
156314152|NCT00275821|564248360|FG001|Overall Study|Administrative problems|4|||
156314153|NCT00275821|564248361|FG002|Overall Study|Administrative problems|4|||
156314154|NCT00275821|564248359|FG000|Overall Study|Withdrawal by Subject|0|||
156314155|NCT00275821|564248360|FG001|Overall Study|Withdrawal by Subject|2|||
156314156|NCT00275821|564248361|FG002|Overall Study|Withdrawal by Subject|1|||
156314157|NCT00275821|564248359|FG000|Overall Study|Lost to Follow-up|0|||
156314158|NCT00275821|564248360|FG001|Overall Study|Lost to Follow-up|1|||
156314159|NCT00275821|564248361|FG002|Overall Study|Lost to Follow-up|1|||
156314160|NCT00275821|564248359|FG000|Overall Study|Death|0|||
156314161|NCT00275821|564248360|FG001|Overall Study|Death|2|||
156314162|NCT00275821|564248361|FG002|Overall Study|Death|1|||
156314163|NCT00275821|564248359|FG000|Overall Study|Lack of Efficacy|2|||
156314164|NCT00275821|564248360|FG001|Overall Study|Lack of Efficacy|1|||
156314165|NCT00275821|564248361|FG002|Overall Study|Lack of Efficacy|0|||
156314166|NCT00275821|564248359|FG000|Overall Study|Protocol Violation|5|||
156314167|NCT00275821|564248360|FG001|Overall Study|Protocol Violation|1|||
156314168|NCT00275821|564248361|FG002|Overall Study|Protocol Violation|0|||
156314169|NCT01215916|564248362|FG000|Overall Study|Progressive Disease|0|||
156314170|NCT01215916|564248363|FG001|Overall Study|Progressive Disease|2|||
156314171|NCT01215916|564248364|FG002|Overall Study|Progressive Disease|1|||
156314172|NCT01215916|564248365|FG003|Overall Study|Progressive Disease|2|||
156314173|NCT01215916|564248366|FG004|Overall Study|Progressive Disease|5|||
156314174|NCT01215916|564248367|FG005|Overall Study|Progressive Disease|4|||
156314175|NCT01215916|564248368|FG006|Overall Study|Progressive Disease|5|||
156314176|NCT01215916|564248369|FG007|Overall Study|Progressive Disease|3|||
156314177|NCT01215916|564248370|FG008|Overall Study|Progressive Disease|1|||
156314178|NCT01215916|564248362|FG000|Overall Study|Adverse Event|1|||
156314179|NCT01215916|564248363|FG001|Overall Study|Adverse Event|1|||
156314180|NCT01215916|564248364|FG002|Overall Study|Adverse Event|0|||
156314181|NCT01215916|564248365|FG003|Overall Study|Adverse Event|1|||
156314182|NCT01215916|564248366|FG004|Overall Study|Adverse Event|0|||
156314183|NCT01215916|564248367|FG005|Overall Study|Adverse Event|0|||
156314184|NCT01215916|564248368|FG006|Overall Study|Adverse Event|3|||
156314185|NCT01215916|564248369|FG007|Overall Study|Adverse Event|0|||
156314186|NCT01215916|564248370|FG008|Overall Study|Adverse Event|0|||
156414896|NCT02061761|564611096|FG007|Overall Study|Maximum clinical benefit|0|||
156414897|NCT02061761|564611097|FG008|Overall Study|Maximum clinical benefit|6|||
156414898|NCT02061761|564611089|FG000|Overall Study|Participant no longer meets study criteria|0|||
156414899|NCT02061761|564611090|FG001|Overall Study|Participant no longer meets study criteria|0|||
156314187|NCT01215916|564248362|FG000|Overall Study|Withdrawal by Subject|0|||
156314188|NCT01215916|564248363|FG001|Overall Study|Withdrawal by Subject|1|||
156314189|NCT01215916|564248364|FG002|Overall Study|Withdrawal by Subject|1|||
156414900|NCT02061761|564611091|FG002|Overall Study|Participant no longer meets study criteria|0|||
156414901|NCT02061761|564611092|FG003|Overall Study|Participant no longer meets study criteria|0|||
156314190|NCT01215916|564248365|FG003|Overall Study|Withdrawal by Subject|2|||
156314191|NCT01215916|564248366|FG004|Overall Study|Withdrawal by Subject|0|||
156314192|NCT01215916|564248367|FG005|Overall Study|Withdrawal by Subject|0|||
156314193|NCT01215916|564248368|FG006|Overall Study|Withdrawal by Subject|1|||
156314194|NCT01215916|564248369|FG007|Overall Study|Withdrawal by Subject|0|||
156314195|NCT01215916|564248370|FG008|Overall Study|Withdrawal by Subject|0|||
156314196|NCT01215916|564248362|FG000|Overall Study|Death|0|||
156314197|NCT01215916|564248363|FG001|Overall Study|Death|1|||
156314198|NCT01215916|564248364|FG002|Overall Study|Death|0|||
156314199|NCT01215916|564248365|FG003|Overall Study|Death|0|||
156314200|NCT01215916|564248366|FG004|Overall Study|Death|1|||
156314201|NCT01215916|564248367|FG005|Overall Study|Death|0|||
156314202|NCT01215916|564248368|FG006|Overall Study|Death|0|||
156314203|NCT01215916|564248369|FG007|Overall Study|Death|0|||
156314204|NCT01215916|564248370|FG008|Overall Study|Death|1|||
156314205|NCT01215916|564248362|FG000|Overall Study|Physician Decision|0|||
156314206|NCT01215916|564248363|FG001|Overall Study|Physician Decision|0|||
156314207|NCT01215916|564248364|FG002|Overall Study|Physician Decision|1|||
156314208|NCT01215916|564248365|FG003|Overall Study|Physician Decision|1|||
156314209|NCT01215916|564248366|FG004|Overall Study|Physician Decision|0|||
156314210|NCT01215916|564248367|FG005|Overall Study|Physician Decision|0|||
156314211|NCT01215916|564248368|FG006|Overall Study|Physician Decision|0|||
156314212|NCT01215916|564248369|FG007|Overall Study|Physician Decision|0|||
156314213|NCT01215916|564248370|FG008|Overall Study|Physician Decision|0|||
156314214|NCT00958438|564248374|FG000|Overall Study|Protocol Violation|3|||
156314215|NCT00958438|564248375|FG001|Overall Study|Protocol Violation|2|||
156314216|NCT00958438|564248376|FG002|Overall Study|Protocol Violation|2|||
156314217|NCT00958438|564248374|FG000|Overall Study|Withdrawal by Subject|4|||
156314218|NCT00958438|564248375|FG001|Overall Study|Withdrawal by Subject|2|||
156314219|NCT00958438|564248376|FG002|Overall Study|Withdrawal by Subject|1|||
156314220|NCT00958438|564248374|FG000|Overall Study|Adverse Event|0|||
156314221|NCT00958438|564248375|FG001|Overall Study|Adverse Event|3|||
156314222|NCT00958438|564248376|FG002|Overall Study|Adverse Event|0|||
156314223|NCT00958438|564248374|FG000|Overall Study|Physician Decision|1|||
156314224|NCT00958438|564248375|FG001|Overall Study|Physician Decision|0|||
156314225|NCT00958438|564248376|FG002|Overall Study|Physician Decision|1|||
156314226|NCT00958438|564248374|FG000|Overall Study|Other than specified above|2|||
156314227|NCT00958438|564248375|FG001|Overall Study|Other than specified above|3|||
156314228|NCT00958438|564248376|FG002|Overall Study|Other than specified above|2|||
156314229|NCT02788279|564248377|FG000|Overall Study|Death|62|||
156314230|NCT02788279|564248378|FG001|Overall Study|Death|136|||
156314231|NCT02788279|564248379|FG002|Overall Study|Death|72|||
156314232|NCT02788279|564248377|FG000|Overall Study|Withdrawal by Subject|10|||
156314233|NCT02788279|564248378|FG001|Overall Study|Withdrawal by Subject|15|||
156314234|NCT02788279|564248379|FG002|Overall Study|Withdrawal by Subject|5|||
156314235|NCT02788279|564248377|FG000|Overall Study|Lost to Follow-up|0|||
156314236|NCT02788279|564248378|FG001|Overall Study|Lost to Follow-up|3|||
156314237|NCT02788279|564248379|FG002|Overall Study|Lost to Follow-up|2|||
156314238|NCT02788279|564248377|FG000|Overall Study|Sponsor decision|18|||
156314239|NCT02788279|564248378|FG001|Overall Study|Sponsor decision|29|||
156314240|NCT02788279|564248379|FG002|Overall Study|Sponsor decision|11|||
156314241|NCT04987944|564248381|FG000|Overall Study|Adverse Event|0|||
156314242|NCT04987944|564248382|FG001|Overall Study|Adverse Event|1|||
156314243|NCT04987944|564248381|FG000|Overall Study|Withdrawal by Subject|0|||
156314244|NCT04987944|564248382|FG001|Overall Study|Withdrawal by Subject|1|||
156314245|NCT00357760|564248387|FG000|Overall Study|Disease progression|44|||
156314246|NCT00357760|564248388|FG001|Overall Study|Disease progression|17|||
156314247|NCT00357760|564248387|FG000|Overall Study|Adverse Event|10|||
156314248|NCT00357760|564248388|FG001|Overall Study|Adverse Event|7|||
156314249|NCT00357760|564248387|FG000|Overall Study|Death|0|||
156314250|NCT00357760|564248388|FG001|Overall Study|Death|3|||
156314251|NCT00357760|564248387|FG000|Overall Study|Alternative therapy|1|||
156414902|NCT02061761|564611093|FG004|Overall Study|Participant no longer meets study criteria|0|||
156314252|NCT00357760|564248388|FG001|Overall Study|Alternative therapy|0|||
156314253|NCT00357760|564248387|FG000|Overall Study|Withdrawal by Subject|0|||
156314254|NCT00357760|564248388|FG001|Overall Study|Withdrawal by Subject|2|||
156314255|NCT00357760|564248387|FG000|Overall Study|Never started treatment|2|||
156314256|NCT00357760|564248388|FG001|Overall Study|Never started treatment|1|||
156314257|NCT00357760|564248387|FG000|Overall Study|Ineligible|0|||
156314258|NCT00357760|564248388|FG001|Overall Study|Ineligible|2|||
156314259|NCT00357760|564248387|FG000|Overall Study|Physician Decision|2|||
156314260|NCT00357760|564248388|FG001|Overall Study|Physician Decision|1|||
156314261|NCT00357760|564248387|FG000|Overall Study|Protocol Violation|0|||
156314262|NCT00357760|564248388|FG001|Overall Study|Protocol Violation|1|||
156314263|NCT00357760|564248387|FG000|Overall Study|To receive hospice care|0|||
156314264|NCT00357760|564248388|FG001|Overall Study|To receive hospice care|1|||
156314265|NCT04136444|564248389|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
156314266|NCT04136444|564248390|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
156314267|NCT00869778|564248394|FG000|Overall Study|Adverse Event|2|||
156314268|NCT00869778|564248395|FG001|Overall Study|Adverse Event|0|||
156314269|NCT00869778|564248396|FG002|Overall Study|Adverse Event|0|||
156314270|NCT00869778|564248394|FG000|Overall Study|Withdrawal by Subject|3|||
156756501|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756502|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756503|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756504|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756505|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756506|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756507|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756508|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756509|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756510|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756511|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156314271|NCT00869778|564248395|FG001|Overall Study|Withdrawal by Subject|4|||
156314272|NCT00869778|564248396|FG002|Overall Study|Withdrawal by Subject|5|||
156314273|NCT00869778|564248394|FG000|Overall Study|Pregnancy|1|||
156314274|NCT00869778|564248395|FG001|Overall Study|Pregnancy|0|||
156314275|NCT00869778|564248396|FG002|Overall Study|Pregnancy|0|||
156314276|NCT00869778|564248394|FG000|Overall Study|Protocol Violation|5|||
156314277|NCT00869778|564248395|FG001|Overall Study|Protocol Violation|3|||
156314278|NCT00869778|564248396|FG002|Overall Study|Protocol Violation|5|||
156314279|NCT00869778|564248394|FG000|Overall Study|Unblinding|1|||
156314280|NCT00869778|564248395|FG001|Overall Study|Unblinding|0|||
156314281|NCT00869778|564248396|FG002|Overall Study|Unblinding|0|||
156314282|NCT01328444|564248397|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
156314283|NCT01328444|564248398|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156314284|NCT01328444|564248399|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156314285|NCT01328444|564248400|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
156314286|NCT01328444|564248401|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
156314287|NCT01328444|564248402|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
156314288|NCT01328444|564248397|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
156314289|NCT01328444|564248398|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
156314290|NCT01328444|564248399|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
156314291|NCT01328444|564248400|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
156314292|NCT01328444|564248401|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
156314293|NCT01328444|564248402|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
156314294|NCT01328444|564248397|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156314295|NCT01328444|564248398|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156314296|NCT01328444|564248399|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156314297|NCT01328444|564248400|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156314298|NCT01328444|564248401|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156314299|NCT01328444|564248402|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156314300|NCT01328444|564248397|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
156314301|NCT01328444|564248398|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
156314302|NCT01328444|564248399|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
156314303|NCT01328444|564248400|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
156314304|NCT01328444|564248401|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
156314305|NCT01328444|564248402|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
156314306|NCT01328444|564248397|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
156314307|NCT01328444|564248398|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156314308|NCT01328444|564248399|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156314309|NCT01328444|564248400|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156314310|NCT01328444|564248401|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156314311|NCT01328444|564248402|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156314312|NCT01328444|564248397|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156314313|NCT01328444|564248398|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
156314314|NCT01328444|564248399|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156314315|NCT01328444|564248400|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
156314316|NCT01328444|564248401|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156314317|NCT01328444|564248402|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156314318|NCT01328444|564248397|FG000|Washout Period (14 Days)|Adverse Event|1|||
156314319|NCT01328444|564248398|FG001|Washout Period (14 Days)|Adverse Event|1|||
156314320|NCT01328444|564248399|FG002|Washout Period (14 Days)|Adverse Event|0|||
156314321|NCT01328444|564248400|FG003|Washout Period (14 Days)|Adverse Event|1|||
156314322|NCT01328444|564248401|FG004|Washout Period (14 Days)|Adverse Event|1|||
156314323|NCT01328444|564248402|FG005|Washout Period (14 Days)|Adverse Event|2|||
156314324|NCT01328444|564248397|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
156314325|NCT01328444|564248398|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
156314326|NCT01328444|564248399|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
156314327|NCT01328444|564248400|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
156314328|NCT01328444|564248401|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
156314329|NCT01328444|564248402|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
156314330|NCT01328444|564248397|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
156314331|NCT01328444|564248398|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
156314332|NCT01328444|564248399|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
156314333|NCT01328444|564248400|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
156314334|NCT01328444|564248401|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
156314335|NCT01328444|564248402|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
156314336|NCT01328444|564248397|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
156314337|NCT01328444|564248398|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156314338|NCT01328444|564248399|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156314339|NCT01328444|564248400|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156314340|NCT01328444|564248401|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156314341|NCT01328444|564248402|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156314342|NCT01328444|564248397|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
156314343|NCT01328444|564248398|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156314344|NCT01328444|564248399|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156314345|NCT01328444|564248400|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
156314346|NCT01328444|564248401|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
156314347|NCT01328444|564248402|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
156314348|NCT01328444|564248397|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
156314349|NCT01328444|564248398|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
156314350|NCT01328444|564248399|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
156314351|NCT01328444|564248400|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
156314352|NCT01328444|564248401|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
156314353|NCT01328444|564248402|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
156314354|NCT01328444|564248397|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
156314355|NCT01328444|564248398|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
156314356|NCT01328444|564248399|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
156314357|NCT01328444|564248400|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
156314358|NCT01328444|564248401|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
156314359|NCT01328444|564248402|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
156314360|NCT01328444|564248397|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156314361|NCT01328444|564248398|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156314362|NCT01328444|564248399|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156314363|NCT01328444|564248400|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156314364|NCT01328444|564248401|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156314365|NCT01328444|564248402|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
156314366|NCT01328444|564248397|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156314367|NCT01328444|564248398|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156314368|NCT01328444|564248399|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156314369|NCT01328444|564248400|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156314370|NCT01328444|564248401|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156314371|NCT01328444|564248402|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156314372|NCT03241368|564248407|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
156314373|NCT03241368|564248407|FG000|Overall Study|Lost to Follow-up|1|||
156314374|NCT03241368|564248407|FG000|Overall Study|Physician Decision|6|||
156314375|NCT03241368|564248407|FG000|Overall Study|Withdrawal by Subject|6|||
156314376|NCT03241368|564248407|FG000|Overall Study|Protocol Violation|1|||
156314377|NCT04740905|564248408|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
156314378|NCT04740905|564248409|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
156314379|NCT04740905|564248408|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
156314380|NCT04740905|564248409|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
156314381|NCT04740905|564248408|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
156314382|NCT04740905|564248409|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
156314383|NCT04740905|564248408|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
156314384|NCT04740905|564248409|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
156314385|NCT04740905|564248408|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
156314386|NCT04740905|564248409|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
156314387|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
156314388|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
156314389|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
156652414|NCT00620763|565474440|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
156314390|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
156314391|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
156314392|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
156314393|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
156314394|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
156314395|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
156652415|NCT00620763|565474441|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
156756512|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756513|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756514|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756515|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756516|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
156756517|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756518|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756519|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756520|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756521|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756522|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756523|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156314396|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
156314397|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
156314398|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
156314399|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
156314400|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
156314401|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
156314402|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
156314403|NCT04740905|564248408|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
156314404|NCT04740905|564248409|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
156314405|NCT01534182|564248413|FG000|Overall Study|Administrative problems|1|||
156314406|NCT01534182|564248414|FG001|Overall Study|Administrative problems|0|||
156314407|NCT01534182|564248413|FG000|Overall Study|Withdrawal by Subject|4|||
156314408|NCT01534182|564248414|FG001|Overall Study|Withdrawal by Subject|7|||
156314409|NCT01534182|564248413|FG000|Overall Study|Adverse Event|7|||
156314410|NCT01534182|564248414|FG001|Overall Study|Adverse Event|3|||
156314411|NCT03077087|564248415|FG000|Overall Study|Physician Decision|2|||
156314412|NCT02412488|564248416|FG000|Overall Study|Lost to Follow-up|10|||
156314413|NCT02412488|564248416|FG000|Overall Study|Withdrawal by Subject|5|||
156314414|NCT02412488|564248416|FG000|Overall Study|Physician Decision|1|||
156314415|NCT02412488|564248416|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
156314416|NCT02412488|564248416|FG000|Overall Study|Reveal LINQ explant|1|||
156314417|NCT01989468|564248417|FG000|Overall Study|Adverse Event|10|||
156314418|NCT01989468|564248418|FG001|Overall Study|Adverse Event|15|||
156314419|NCT01989468|564248419|FG002|Overall Study|Adverse Event|4|||
156314420|NCT01989468|564248420|FG003|Overall Study|Adverse Event|5|||
156314421|NCT01989468|564248421|FG004|Overall Study|Adverse Event|4|||
156314422|NCT01989468|564248417|FG000|Overall Study|Lack of Efficacy|11|||
156314423|NCT01989468|564248418|FG001|Overall Study|Lack of Efficacy|11|||
156314424|NCT01989468|564248419|FG002|Overall Study|Lack of Efficacy|7|||
156314425|NCT01989468|564248420|FG003|Overall Study|Lack of Efficacy|4|||
156314426|NCT01989468|564248421|FG004|Overall Study|Lack of Efficacy|2|||
156314427|NCT01989468|564248417|FG000|Overall Study|Lost to Follow-up|5|||
156314428|NCT01989468|564248418|FG001|Overall Study|Lost to Follow-up|2|||
156314429|NCT01989468|564248419|FG002|Overall Study|Lost to Follow-up|0|||
156314430|NCT01989468|564248420|FG003|Overall Study|Lost to Follow-up|1|||
156314431|NCT01989468|564248421|FG004|Overall Study|Lost to Follow-up|1|||
156314432|NCT01989468|564248417|FG000|Overall Study|Physician Decision|4|||
156314433|NCT01989468|564248418|FG001|Overall Study|Physician Decision|1|||
156314434|NCT01989468|564248419|FG002|Overall Study|Physician Decision|0|||
156314435|NCT01989468|564248420|FG003|Overall Study|Physician Decision|1|||
156314436|NCT01989468|564248421|FG004|Overall Study|Physician Decision|0|||
156314437|NCT01989468|564248417|FG000|Overall Study|Pregnancy|0|||
156314438|NCT01989468|564248418|FG001|Overall Study|Pregnancy|1|||
156314439|NCT01989468|564248419|FG002|Overall Study|Pregnancy|0|||
156314440|NCT01989468|564248420|FG003|Overall Study|Pregnancy|0|||
156314441|NCT01989468|564248421|FG004|Overall Study|Pregnancy|0|||
156314442|NCT01989468|564248417|FG000|Overall Study|Technical Problems|3|||
156756524|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756525|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756526|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756527|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156314443|NCT01989468|564248418|FG001|Overall Study|Technical Problems|1|||
156314444|NCT01989468|564248419|FG002|Overall Study|Technical Problems|3|||
156314445|NCT01989468|564248420|FG003|Overall Study|Technical Problems|1|||
156314446|NCT01989468|564248421|FG004|Overall Study|Technical Problems|0|||
156314447|NCT01989468|564248417|FG000|Overall Study|Subject Guardian Decision|11|||
156314448|NCT01989468|564248418|FG001|Overall Study|Subject Guardian Decision|6|||
156314449|NCT01989468|564248419|FG002|Overall Study|Subject Guardian Decision|4|||
156314450|NCT01989468|564248420|FG003|Overall Study|Subject Guardian Decision|4|||
156314451|NCT01989468|564248421|FG004|Overall Study|Subject Guardian Decision|1|||
156414903|NCT02061761|564611094|FG005|Overall Study|Participant no longer meets study criteria|0|||
156414904|NCT02061761|564611095|FG006|Overall Study|Participant no longer meets study criteria|0|||
156414905|NCT02061761|564611096|FG007|Overall Study|Participant no longer meets study criteria|0|||
156414906|NCT02061761|564611097|FG008|Overall Study|Participant no longer meets study criteria|1|||
156414907|NCT02061761|564611089|FG000|Overall Study|Other reasons|0|||
156414908|NCT02061761|564611090|FG001|Overall Study|Other reasons|0|||
156414909|NCT02061761|564611091|FG002|Overall Study|Other reasons|0|||
156414910|NCT02061761|564611092|FG003|Overall Study|Other reasons|0|||
156414911|NCT02061761|564611093|FG004|Overall Study|Other reasons|2|||
156414912|NCT02061761|564611094|FG005|Overall Study|Other reasons|0|||
156414913|NCT02061761|564611095|FG006|Overall Study|Other reasons|0|||
156414914|NCT02061761|564611096|FG007|Overall Study|Other reasons|0|||
156414915|NCT02061761|564611097|FG008|Overall Study|Other reasons|6|||
156414916|NCT04170296|564611104|FG000|Overall Study|Adverse Event|1|||
156414917|NCT04170296|564611105|FG001|Overall Study|Adverse Event|0|||
156414918|NCT04170296|564611104|FG000|Overall Study|Withdrawal by Subject|3|||
156414919|NCT04170296|564611105|FG001|Overall Study|Withdrawal by Subject|2|||
156414920|NCT04170296|564611104|FG000|Overall Study|Lost to Follow-up|4|||
156414921|NCT04170296|564611105|FG001|Overall Study|Lost to Follow-up|2|||
156414922|NCT03567993|564611106|FG000|Overall Study|Lost to Follow-up|4|||
156414923|NCT03567993|564611107|FG001|Overall Study|Lost to Follow-up|2|||
156414924|NCT03567993|564611106|FG000|Overall Study|Death|1|||
156414925|NCT03567993|564611107|FG001|Overall Study|Death|1|||
156414926|NCT03567993|564611106|FG000|Overall Study|Withdrawal by Subject|1|||
156414927|NCT03567993|564611107|FG001|Overall Study|Withdrawal by Subject|0|||
156414928|NCT00383240|564611110|FG000|Overall Study|Adverse Event|4|||
156414929|NCT00383240|564611111|FG001|Overall Study|Adverse Event|6|||
156414930|NCT00383240|564611112|FG002|Overall Study|Adverse Event|9|||
156414931|NCT00383240|564611113|FG003|Overall Study|Adverse Event|7|||
156414932|NCT00383240|564611110|FG000|Overall Study|Treatment Failure|8|||
156414933|NCT00383240|564611111|FG001|Overall Study|Treatment Failure|13|||
156414934|NCT00383240|564611112|FG002|Overall Study|Treatment Failure|47|||
156414935|NCT00383240|564611113|FG003|Overall Study|Treatment Failure|46|||
156414936|NCT00383240|564611110|FG000|Overall Study|Lost to Follow-up|3|||
156414937|NCT00383240|564611111|FG001|Overall Study|Lost to Follow-up|0|||
156414938|NCT00383240|564611112|FG002|Overall Study|Lost to Follow-up|0|||
156414939|NCT00383240|564611113|FG003|Overall Study|Lost to Follow-up|2|||
156414940|NCT00383240|564611110|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
156414941|NCT00383240|564611111|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
156414942|NCT00383240|564611112|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
156414943|NCT00383240|564611113|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
156414944|NCT00383240|564611110|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
156414945|NCT00383240|564611111|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
156414946|NCT00383240|564611112|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
156414947|NCT00383240|564611113|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
156414948|NCT00383240|564611110|FG000|Overall Study|Protocol Violation|4|||
156414949|NCT00383240|564611111|FG001|Overall Study|Protocol Violation|5|||
156414950|NCT00383240|564611112|FG002|Overall Study|Protocol Violation|9|||
156414951|NCT00383240|564611113|FG003|Overall Study|Protocol Violation|6|||
156414952|NCT00383240|564611110|FG000|Overall Study|Did not meet protocol eligibility|9|||
156414953|NCT00383240|564611111|FG001|Overall Study|Did not meet protocol eligibility|4|||
156414954|NCT00383240|564611112|FG002|Overall Study|Did not meet protocol eligibility|9|||
156414955|NCT00383240|564611113|FG003|Overall Study|Did not meet protocol eligibility|3|||
156414956|NCT00383240|564611110|FG000|Overall Study|Administrative|1|||
156414957|NCT00383240|564611111|FG001|Overall Study|Administrative|1|||
156414958|NCT00383240|564611112|FG002|Overall Study|Administrative|0|||
156414959|NCT00383240|564611113|FG003|Overall Study|Administrative|0|||
156414960|NCT01370603|564611114|FG000|Period 1|Adverse Event|5|||
156414961|NCT01370603|564611115|FG001|Period 1|Adverse Event|3|||
156414962|NCT01370603|564611114|FG000|Period 1|Lost to Follow-up|2|||
156414963|NCT01370603|564611115|FG001|Period 1|Lost to Follow-up|0|||
156414964|NCT01370603|564611114|FG000|Period 1|Protocol Violation|2|||
156652416|NCT01595009|565474444|FG000|Core|Patients completed per protocol|85|||
156414965|NCT01370603|564611115|FG001|Period 1|Protocol Violation|2|||
156414966|NCT01370603|564611114|FG000|Period 1|Withdrawal by Subject|5|||
156414967|NCT01370603|564611115|FG001|Period 1|Withdrawal by Subject|5|||
156414968|NCT01370603|564611114|FG000|Crossover Washout|Adverse Event|2|||
156414969|NCT01370603|564611115|FG001|Crossover Washout|Adverse Event|1|||
156414970|NCT01370603|564611114|FG000|Crossover Washout|Lost to Follow-up|2|||
156414971|NCT01370603|564611115|FG001|Crossover Washout|Lost to Follow-up|0|||
156414972|NCT01370603|564611114|FG000|Crossover Washout|Protocol Violation|1|||
156414973|NCT01370603|564611115|FG001|Crossover Washout|Protocol Violation|0|||
156414974|NCT01370603|564611114|FG000|Crossover Washout|Withdrawal by Subject|4|||
156414975|NCT01370603|564611115|FG001|Crossover Washout|Withdrawal by Subject|1|||
156414976|NCT01370603|564611114|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
156414977|NCT01370603|564611115|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
156414978|NCT01370603|564611114|FG000|Period 2|Adverse Event|1|||
156414979|NCT01370603|564611115|FG001|Period 2|Adverse Event|4|||
156414980|NCT01370603|564611114|FG000|Period 2|Lost to Follow-up|1|||
156414981|NCT01370603|564611115|FG001|Period 2|Lost to Follow-up|0|||
156414982|NCT01370603|564611114|FG000|Period 2|Withdrawal by Subject|1|||
156414983|NCT01370603|564611115|FG001|Period 2|Withdrawal by Subject|0|||
156414984|NCT02133924|564611116|FG000|Overall Study|Death|38|||
156414985|NCT02133924|564611116|FG000|Overall Study|Physician Decision|1|||
156414986|NCT02133924|564611116|FG000|Overall Study|Withdrawal by Subject|3|||
156414987|NCT01644474|564611117|FG000|Overall Study|Poor compliance to protocol|1|||
156414988|NCT01644474|564611118|FG001|Overall Study|Poor compliance to protocol|0|||
156414989|NCT01644474|564611117|FG000|Overall Study|Consent withdrawn by participant|0|||
156414990|NCT01644474|564611118|FG001|Overall Study|Consent withdrawn by participant|1|||
156414991|NCT01644474|564611117|FG000|Overall Study|Participant moved|0|||
156414992|NCT01644474|564611118|FG001|Overall Study|Participant moved|1|||
156414993|NCT01644474|564611117|FG000|Overall Study|Adverse Event|4|||
156414994|NCT01644474|564611118|FG001|Overall Study|Adverse Event|5|||
156414995|NCT01644474|564611117|FG000|Overall Study|Site scheduling error|1|||
156414996|NCT01644474|564611118|FG001|Overall Study|Site scheduling error|1|||
156414997|NCT01644474|564611117|FG000|Overall Study|Protocol Violation|1|||
156414998|NCT01644474|564611118|FG001|Overall Study|Protocol Violation|0|||
156414999|NCT01163747|564611124|FG000|Overall Study|Adverse Event|0|||
156415000|NCT01163747|564611125|FG001|Overall Study|Adverse Event|5|||
156415001|NCT01163747|564611124|FG000|Overall Study|Insufficient Therapeutic Response|0|||
156415002|NCT01163747|564611125|FG001|Overall Study|Insufficient Therapeutic Response|1|||
156415003|NCT01163747|564611124|FG000|Overall Study|Protocol Violation|0|||
156415004|NCT01163747|564611125|FG001|Overall Study|Protocol Violation|1|||
156415005|NCT01163747|564611124|FG000|Overall Study|Refused Treatment|6|||
156415006|NCT01163747|564611125|FG001|Overall Study|Refused Treatment|4|||
156415007|NCT02044458|564611126|FG000|Overall Study|Protocol Violation|3|||
156415008|NCT02044458|564611127|FG001|Overall Study|Protocol Violation|8|||
156415009|NCT04714216|564613281|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
156415010|NCT04714216|564613281|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
156415011|NCT01349829|564613282|FG000|Overall Study|Lost to Follow-up|4|||
156415012|NCT01349829|564613283|FG001|Overall Study|Lost to Follow-up|8|||
156415013|NCT01349829|564613282|FG000|Overall Study|Consent withdrawal|3|||
156415014|NCT01349829|564613283|FG001|Overall Study|Consent withdrawal|8|||
156415015|NCT01349829|564613282|FG000|Overall Study|Migrated/moved|2|||
156415016|NCT01349829|564613283|FG001|Overall Study|Migrated/moved|7|||
156415017|NCT02711995|564613288|FG000|Washout (90 Days)|Conflicting medication|1|||
156415018|NCT03615482|564613291|FG000|Overall Study|Death|1|||
156415019|NCT03615482|564613292|FG001|Overall Study|Death|0|||
156415020|NCT03615482|564613291|FG000|Overall Study|Lost to Follow-up|7|||
156415021|NCT03615482|564613292|FG001|Overall Study|Lost to Follow-up|7|||
156415022|NCT03615482|564613291|FG000|Overall Study|Physician Decision|2|||
156415023|NCT03615482|564613292|FG001|Overall Study|Physician Decision|3|||
156415024|NCT03615482|564613291|FG000|Overall Study|Withdrawal by Subject|7|||
156415025|NCT03615482|564613292|FG001|Overall Study|Withdrawal by Subject|7|||
156415026|NCT00322868|564613293|FG000|Overall Study|disease progression|1|||
156415027|NCT01852162|564613295|FG000|Overall Study|Adverse Event|1|||
156415028|NCT01852162|564613296|FG001|Overall Study|Adverse Event|0|||
156415029|NCT01852162|564613295|FG000|Overall Study|Withdrawal by Subject|3|||
156415030|NCT01852162|564613296|FG001|Overall Study|Withdrawal by Subject|1|||
156415031|NCT01500226|564613299|FG000|Overall Study|Adverse Event|31|||
156415032|NCT01500226|564613300|FG001|Overall Study|Adverse Event|38|||
156415033|NCT01500226|564613299|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
156415034|NCT01500226|564613300|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
156415035|NCT01500226|564613299|FG000|Overall Study|Withdrawal by Subject|93|||
156415036|NCT01500226|564613300|FG001|Overall Study|Withdrawal by Subject|96|||
156415037|NCT01500226|564613299|FG000|Overall Study|Death|12|||
156415038|NCT01500226|564613300|FG001|Overall Study|Death|4|||
156415039|NCT01500226|564613299|FG000|Overall Study|Disease Progression|16|||
156415040|NCT01500226|564613300|FG001|Overall Study|Disease Progression|14|||
156415041|NCT01500226|564613299|FG000|Overall Study|Protocol Violation|53|||
156415042|NCT01500226|564613300|FG001|Overall Study|Protocol Violation|39|||
156415043|NCT01500226|564613299|FG000|Overall Study|Physician Decision|17|||
156415044|NCT01500226|564613300|FG001|Overall Study|Physician Decision|15|||
156415045|NCT01500226|564613299|FG000|Overall Study|Lack of Efficacy|14|||
156415046|NCT01500226|564613300|FG001|Overall Study|Lack of Efficacy|30|||
156415047|NCT01500226|564613299|FG000|Overall Study|Lost to Follow-up|9|||
156415048|NCT01500226|564613300|FG001|Overall Study|Lost to Follow-up|5|||
156415049|NCT01500226|564613299|FG000|Overall Study|Other Reasons|19|||
156415050|NCT01500226|564613300|FG001|Overall Study|Other Reasons|16|||
156415051|NCT02018861|564613312|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156415052|NCT02018861|564613313|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
156415053|NCT02018861|564613314|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
156415054|NCT02018861|564613315|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
156415055|NCT02018861|564613316|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
156415056|NCT02018861|564613317|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
156314452|NCT01989468|564248417|FG000|Overall Study|Death|3|||
156314453|NCT01989468|564248418|FG001|Overall Study|Death|0|||
156314454|NCT01989468|564248419|FG002|Overall Study|Death|1|||
156314455|NCT01989468|564248420|FG003|Overall Study|Death|0|||
156314456|NCT01989468|564248421|FG004|Overall Study|Death|0|||
156314457|NCT01960907|564248429|FG000|Overall Study|Death|4|||
156314458|NCT01960907|564248430|FG001|Overall Study|Death|3|||
156314459|NCT01960907|564248429|FG000|Overall Study|Withdrawal by Subject|32|||
156314460|NCT01960907|564248430|FG001|Overall Study|Withdrawal by Subject|42|||
156314461|NCT03612856|564248435|FG000|Pre-dose Period|Physician Decision|0|||
156314462|NCT03612856|564248436|FG001|Pre-dose Period|Physician Decision|1|||
156314463|NCT03612856|564248437|FG002|Pre-dose Period|Physician Decision|1|||
156314464|NCT03612856|564248435|FG000|Pre-dose Period|Withdrawal by Subject|0|||
156314465|NCT03612856|564248436|FG001|Pre-dose Period|Withdrawal by Subject|1|||
156314466|NCT03612856|564248437|FG002|Pre-dose Period|Withdrawal by Subject|0|||
156314467|NCT01181986|564248438|FG000|Phase 1|Lost to Follow-up|0|||
156314468|NCT01181986|564248439|FG001|Phase 1|Lost to Follow-up|1|||
156314469|NCT01181986|564248440|FG002|Phase 1|Lost to Follow-up|1|||
156314470|NCT01181986|564248438|FG000|Phase 1|Adverse Event|0|||
156314471|NCT01181986|564248439|FG001|Phase 1|Adverse Event|0|||
156314472|NCT01181986|564248440|FG002|Phase 1|Adverse Event|1|||
156314473|NCT01181986|564248438|FG000|Phase 1|Protocol Violation|1|||
156314474|NCT01181986|564248439|FG001|Phase 1|Protocol Violation|0|||
156314475|NCT01181986|564248440|FG002|Phase 1|Protocol Violation|0|||
156314476|NCT01181986|564248438|FG000|Phase 2|Adverse Event|0|||
156314477|NCT01181986|564248439|FG001|Phase 2|Adverse Event|3|||
156314478|NCT01181986|564248440|FG002|Phase 2|Adverse Event|0|||
156314479|NCT01181986|564248438|FG000|Phase 2|Medical condition|0|||
156314480|NCT01181986|564248439|FG001|Phase 2|Medical condition|1|||
156314481|NCT01181986|564248440|FG002|Phase 2|Medical condition|0|||
156314482|NCT00831493|564248442|FG000|Overall Study|Intractable nausea and vomiting|1|||
156314483|NCT02656680|564250082|FG000|Overall Study|Lost to Follow-up|0|||
156314484|NCT02656680|564250083|FG001|Overall Study|Lost to Follow-up|1|||
156314485|NCT02656680|564250084|FG002|Overall Study|Lost to Follow-up|7|||
156314486|NCT02600871|564250087|FG000|Overall Study|Lost to Follow-up|13|||
156314487|NCT02600871|564250088|FG001|Overall Study|Lost to Follow-up|10|||
156314488|NCT00002931|564250090|FG000|Overall Study|rapidly progressing disease during|2|||
156314489|NCT01246466|564250093|FG000|Overall Study|Death|1|||
156314490|NCT01246466|564250093|FG000|Overall Study|Withdrawal by Subject|1|||
156314491|NCT01142089|564250094|FG000|Overall Study|Physician Decision|1|||
156314492|NCT01142089|564250095|FG001|Overall Study|Physician Decision|0|||
156314493|NCT01142089|564250094|FG000|Overall Study|Withdrawal by Subject|1|||
156314494|NCT01142089|564250095|FG001|Overall Study|Withdrawal by Subject|2|||
156314495|NCT01142089|564250094|FG000|Overall Study|Use of prohibited medications|0|||
156314496|NCT01142089|564250095|FG001|Overall Study|Use of prohibited medications|1|||
156314497|NCT01142089|564250094|FG000|Overall Study|Noncompliance with study procedures|2|||
156314498|NCT01142089|564250095|FG001|Overall Study|Noncompliance with study procedures|1|||
156314499|NCT01142089|564250094|FG000|Overall Study|Patient required rescue medication|8|||
156314500|NCT01142089|564250095|FG001|Overall Study|Patient required rescue medication|17|||
156314501|NCT02907892|564250100|FG000|Overall Study|Lost to Follow-up|27|||
156314502|NCT02907892|564250101|FG001|Overall Study|Lost to Follow-up|40|||
156314503|NCT01974765|564250102|FG000|Overall Study|Withdrawal by Subject|1|||
156314504|NCT01974765|564250102|FG000|Overall Study|Death|1|||
156314505|NCT01974765|564250102|FG000|Overall Study|Adverse Event|2|||
156314506|NCT04531462|564250103|FG000|Overall Study|Withdrawal by Subject|3|||
156314507|NCT04531462|564250104|FG001|Overall Study|Withdrawal by Subject|1|||
156314508|NCT04531462|564250103|FG000|Overall Study|Adverse Event|3|||
156314509|NCT04531462|564250104|FG001|Overall Study|Adverse Event|3|||
156314510|NCT00348933|564250107|FG000|Overall Study|Withdrawal by Subject|10|||
156314511|NCT00348933|564250107|FG000|Overall Study|Lost to Follow-up|6|||
156314512|NCT00348933|564250107|FG000|Overall Study|Protocol Violation|2|||
156314513|NCT00348933|564250107|FG000|Overall Study|Adverse Event|7|||
156314514|NCT01489111|564250108|FG000|Overall Study|Withdrawal criterion|1|||
156314515|NCT01727700|564250109|FG000|Overall Study|Adverse Event|0|||
156314516|NCT01727700|564250110|FG001|Overall Study|Adverse Event|7|||
156314517|NCT01727700|564250111|FG002|Overall Study|Adverse Event|1|||
156652417|NCT01595009|565474445|FG001|Core|Patients completed per protocol|44|||
156652418|NCT01595009|565474446|FG002|Core|Patients completed per protocol|0|||
156652419|NCT01595009|565474447|FG003|Core|Patients completed per protocol|0|||
156652420|NCT01595009|565474444|FG000|Core|Adverse Event|19|||
156314518|NCT01727700|564250109|FG000|Overall Study|Particpant withdrew consent|0|||
156314519|NCT01727700|564250110|FG001|Overall Study|Particpant withdrew consent|3|||
156314520|NCT01727700|564250111|FG002|Overall Study|Particpant withdrew consent|1|||
156314521|NCT01727700|564250109|FG000|Overall Study|Protocol Violation|2|||
156314522|NCT01727700|564250110|FG001|Overall Study|Protocol Violation|0|||
156314523|NCT01727700|564250111|FG002|Overall Study|Protocol Violation|0|||
156314524|NCT01757691|564250116|FG000|Overall Study|Administrative problems|2|||
156314525|NCT01757691|564250117|FG001|Overall Study|Administrative problems|0|||
156314526|NCT00003472|564250118|FG000|Overall Study|Not evaluable|3|||
156652421|NCT01595009|565474445|FG001|Core|Adverse Event|23|||
156314527|NCT01012219|564250119|FG000|Period 1|Withdrawal by Subject|1|||
156314528|NCT01012219|564250119|FG000|Period 2|Withdrawal by Subject|1|||
156314529|NCT00874939|564250120|FG000|Overall Study|Study terminated|4|||
156314530|NCT01909791|564250121|FG000|Overall Study|Death|9|||
156314531|NCT01909791|564250122|FG001|Overall Study|Death|8|||
156314532|NCT01909791|564250123|FG002|Overall Study|Death|4|||
156314533|NCT01909791|564250121|FG000|Overall Study|Withdrawal by Subject|5|||
156314534|NCT01909791|564250122|FG001|Overall Study|Withdrawal by Subject|9|||
156314535|NCT01909791|564250123|FG002|Overall Study|Withdrawal by Subject|13|||
156314536|NCT01909791|564250121|FG000|Overall Study|Lost to Follow-up|5|||
156314537|NCT01909791|564250122|FG001|Overall Study|Lost to Follow-up|11|||
156314538|NCT01909791|564250123|FG002|Overall Study|Lost to Follow-up|10|||
156314539|NCT01909791|564250121|FG000|Overall Study|Missed Visit|2|||
156314540|NCT01909791|564250122|FG001|Overall Study|Missed Visit|0|||
156314541|NCT01909791|564250123|FG002|Overall Study|Missed Visit|1|||
156314542|NCT01444092|564250126|FG000|Overall Study|Adverse Event|8|||
156314543|NCT01444092|564250126|FG000|Overall Study|Protocol Violation|1|||
156314544|NCT01444092|564250126|FG000|Overall Study|Withdrawal by Subject|1|||
156314545|NCT01444092|564250126|FG000|Overall Study|Other Eligibility criteria|7|||
156314546|NCT01328366|564250127|FG000|Overall Study|Death|1|||
156314547|NCT01328366|564250127|FG000|Overall Study|Withdrawal by Subject|2|||
156314548|NCT01328366|564250127|FG000|Overall Study|Lost to Follow-up|7|||
156314549|NCT00603590|564250128|FG000|Overall Study|Did not attend study clinic|39|||
156314550|NCT00603590|564250129|FG001|Overall Study|Did not attend study clinic|30|||
156314551|NCT00603590|564250128|FG000|Overall Study|Refused blood test|5|||
156314552|NCT00603590|564250129|FG001|Overall Study|Refused blood test|1|||
156314553|NCT00603590|564250128|FG000|Overall Study|Patient discontinued study drug|22|||
156314554|NCT00603590|564250129|FG001|Overall Study|Patient discontinued study drug|15|||
156314555|NCT00603590|564250128|FG000|Overall Study|Adverse Event|2|||
156314556|NCT00603590|564250129|FG001|Overall Study|Adverse Event|0|||
156314557|NCT00603590|564250128|FG000|Overall Study|Lost to Follow-up|8|||
156314558|NCT00603590|564250129|FG001|Overall Study|Lost to Follow-up|4|||
156314559|NCT00603590|564250128|FG000|Overall Study|Cardiovascular event|0|||
156314560|NCT00603590|564250129|FG001|Overall Study|Cardiovascular event|1|||
156314561|NCT03005873|564250130|FG000|Overall Study|Prohibited medication use post radnomization|1|||
156314562|NCT03005873|564250131|FG001|Overall Study|Prohibited medication use post radnomization|1|||
156314563|NCT03005873|564250132|FG002|Overall Study|Prohibited medication use post radnomization|1|||
156314564|NCT03005873|564250130|FG000|Overall Study|Withdrew consent|0|||
156314565|NCT03005873|564250131|FG001|Overall Study|Withdrew consent|1|||
156314566|NCT03005873|564250132|FG002|Overall Study|Withdrew consent|2|||
156415057|NCT02018861|564613318|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156415058|NCT02018861|564613319|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156415059|NCT02018861|564613320|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156415060|NCT02018861|564613321|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156415061|NCT02018861|564613312|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156415062|NCT02018861|564613313|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156652422|NCT01595009|565474446|FG002|Core|Adverse Event|0|||
156314567|NCT03005873|564250130|FG000|Overall Study|Lost to Follow-up|0|||
156314568|NCT03005873|564250131|FG001|Overall Study|Lost to Follow-up|1|||
156314569|NCT03005873|564250132|FG002|Overall Study|Lost to Follow-up|0|||
156314570|NCT03005873|564250130|FG000|Overall Study|Ineligible post randomization|0|||
156314571|NCT03005873|564250131|FG001|Overall Study|Ineligible post randomization|0|||
156652423|NCT01595009|565474447|FG003|Core|Adverse Event|0|||
156314572|NCT03005873|564250132|FG002|Overall Study|Ineligible post randomization|1|||
156314573|NCT03699475|564250133|FG000|Overall Study|Death|1|||
156314574|NCT01713933|564250134|FG000|Overall Study|Lost to Follow-up|2|||
156314575|NCT01713933|564250134|FG000|Overall Study|Withdrawal by Subject|3|||
156314576|NCT01713933|564250134|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
156652424|NCT01595009|565474444|FG000|Core|Disease progression|14|||
156652425|NCT01595009|565474445|FG001|Core|Disease progression|26|||
156652426|NCT01595009|565474446|FG002|Core|Disease progression|0|||
156652427|NCT01595009|565474447|FG003|Core|Disease progression|0|||
156652428|NCT01595009|565474444|FG000|Core|Withdrawal by Subject|4|||
156652429|NCT01595009|565474445|FG001|Core|Withdrawal by Subject|17|||
156652430|NCT01595009|565474446|FG002|Core|Withdrawal by Subject|0|||
156652431|NCT01595009|565474447|FG003|Core|Withdrawal by Subject|0|||
156652432|NCT01595009|565474444|FG000|Core|Death|3|||
156652433|NCT01595009|565474445|FG001|Core|Death|6|||
156652434|NCT01595009|565474446|FG002|Core|Death|0|||
156652435|NCT01595009|565474447|FG003|Core|Death|0|||
156652436|NCT01595009|565474444|FG000|Core|Lost to Follow-up|1|||
156652437|NCT01595009|565474445|FG001|Core|Lost to Follow-up|2|||
156652438|NCT01595009|565474446|FG002|Core|Lost to Follow-up|0|||
156652439|NCT01595009|565474447|FG003|Core|Lost to Follow-up|0|||
156652440|NCT01595009|565474444|FG000|Core|Protocol deviation|0|||
156652441|NCT01595009|565474445|FG001|Core|Protocol deviation|1|||
156652442|NCT01595009|565474446|FG002|Core|Protocol deviation|0|||
156652443|NCT01595009|565474447|FG003|Core|Protocol deviation|0|||
156756528|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756529|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756530|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756531|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756532|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756533|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756534|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756535|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756536|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
156756537|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756538|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756539|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756540|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756541|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756542|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756543|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756544|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756545|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756546|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756547|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756548|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756549|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756550|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756551|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756552|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756553|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756554|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756555|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756556|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756557|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756558|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756559|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
156756560|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756561|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
156756562|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756563|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756564|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756565|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756566|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
156756567|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756568|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756569|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756570|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
156756571|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756572|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756573|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
156756574|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
156756575|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
156756576|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
156756577|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
156756578|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
156756579|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
156756580|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
156756581|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
156756582|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
156756583|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
156756584|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
156756585|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
156756586|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
156756587|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
156756588|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
156314577|NCT00528970|564250137|FG000|Overall Study|Adverse Event|6|||
156314578|NCT00528970|564250138|FG001|Overall Study|Adverse Event|8|||
156314579|NCT00528970|564250139|FG002|Overall Study|Adverse Event|5|||
156314580|NCT00528970|564250137|FG000|Overall Study|Lost to Follow-up|0|||
156415063|NCT02018861|564613314|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156415064|NCT02018861|564613315|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
156415065|NCT02018861|564613316|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
156415066|NCT02018861|564613317|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156415067|NCT02018861|564613318|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156415068|NCT02018861|564613319|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156415069|NCT02018861|564613320|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156415070|NCT02018861|564613321|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156415071|NCT02018861|564613312|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156415072|NCT02018861|564613313|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
156415073|NCT02018861|564613314|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
156415074|NCT02018861|564613315|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
156415075|NCT02018861|564613316|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
156415076|NCT02018861|564613317|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
156415077|NCT02018861|564613318|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156415078|NCT02018861|564613319|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156415079|NCT02018861|564613320|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156415080|NCT02018861|564613321|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156314581|NCT00528970|564250138|FG001|Overall Study|Lost to Follow-up|0|||
156314582|NCT00528970|564250139|FG002|Overall Study|Lost to Follow-up|1|||
156314583|NCT00528970|564250137|FG000|Overall Study|Other than specified|2|||
156314584|NCT00528970|564250138|FG001|Overall Study|Other than specified|3|||
156314585|NCT00528970|564250139|FG002|Overall Study|Other than specified|3|||
156314586|NCT00528970|564250137|FG000|Overall Study|Protocol Violation|2|||
156314587|NCT00528970|564250138|FG001|Overall Study|Protocol Violation|1|||
156314588|NCT00528970|564250139|FG002|Overall Study|Protocol Violation|4|||
156314589|NCT00528970|564250137|FG000|Overall Study|Lack of Efficacy|0|||
156314590|NCT00528970|564250138|FG001|Overall Study|Lack of Efficacy|0|||
156314591|NCT00528970|564250139|FG002|Overall Study|Lack of Efficacy|1|||
156314592|NCT00528970|564250137|FG000|Overall Study|Withdrawal by Subject|4|||
156314593|NCT00528970|564250138|FG001|Overall Study|Withdrawal by Subject|3|||
156314594|NCT00528970|564250139|FG002|Overall Study|Withdrawal by Subject|5|||
156314595|NCT00528970|564250137|FG000|Overall Study|Randomized but not treated|0|||
156314596|NCT00528970|564250138|FG001|Overall Study|Randomized but not treated|0|||
156314597|NCT00528970|564250139|FG002|Overall Study|Randomized but not treated|1|||
156314598|NCT02882152|564250140|FG000|Overall Study|Lost to Follow-up|1|||
156314599|NCT02882152|564250141|FG001|Overall Study|Lost to Follow-up|0|||
156314600|NCT01009840|564250144|FG000|Overall Study|Lost to Follow-up|1|||
156314601|NCT01009840|564250144|FG000|Overall Study|Adverse Event|4|||
156314602|NCT01009840|564250144|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
156314603|NCT01009840|564250144|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
156314604|NCT01009840|564250144|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
156314605|NCT00797966|564250149|FG000|Phase A|Lost to Follow-up|0|||
156314606|NCT00797966|564250150|FG001|Phase A|Lost to Follow-up|0|||
156314607|NCT00797966|564250151|FG002|Phase A|Lost to Follow-up|0|||
156314608|NCT00797966|564250152|FG003|Phase A|Lost to Follow-up|0|||
156314609|NCT00797966|564250153|FG004|Phase A|Lost to Follow-up|33|||
156314610|NCT00797966|564250154|FG005|Phase A|Lost to Follow-up|0|||
156314611|NCT00797966|564250149|FG000|Phase A|Adverse Event|0|||
156314612|NCT00797966|564250150|FG001|Phase A|Adverse Event|0|||
156314613|NCT00797966|564250151|FG002|Phase A|Adverse Event|0|||
156314614|NCT00797966|564250152|FG003|Phase A|Adverse Event|0|||
156314615|NCT00797966|564250153|FG004|Phase A|Adverse Event|46|||
156314616|NCT00797966|564250154|FG005|Phase A|Adverse Event|0|||
156314617|NCT00797966|564250149|FG000|Phase A|Met withdrawal criteria|0|||
156314618|NCT00797966|564250150|FG001|Phase A|Met withdrawal criteria|0|||
156314619|NCT00797966|564250151|FG002|Phase A|Met withdrawal criteria|0|||
156314620|NCT00797966|564250152|FG003|Phase A|Met withdrawal criteria|0|||
156314621|NCT00797966|564250153|FG004|Phase A|Met withdrawal criteria|4|||
156314622|NCT00797966|564250154|FG005|Phase A|Met withdrawal criteria|0|||
156314623|NCT00797966|564250149|FG000|Phase A|Physician Decision|0|||
156314624|NCT00797966|564250150|FG001|Phase A|Physician Decision|0|||
156314625|NCT00797966|564250151|FG002|Phase A|Physician Decision|0|||
156415081|NCT02018861|564613312|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
156314626|NCT00797966|564250152|FG003|Phase A|Physician Decision|0|||
156314627|NCT00797966|564250153|FG004|Phase A|Physician Decision|13|||
156314628|NCT00797966|564250154|FG005|Phase A|Physician Decision|0|||
156314629|NCT00797966|564250149|FG000|Phase A|Withdrawal by Subject|0|||
156314630|NCT00797966|564250150|FG001|Phase A|Withdrawal by Subject|0|||
156314631|NCT00797966|564250151|FG002|Phase A|Withdrawal by Subject|0|||
156314632|NCT00797966|564250152|FG003|Phase A|Withdrawal by Subject|0|||
156314633|NCT00797966|564250153|FG004|Phase A|Withdrawal by Subject|33|||
156314634|NCT00797966|564250154|FG005|Phase A|Withdrawal by Subject|0|||
156314635|NCT00797966|564250149|FG000|Phase A|Protocol deviation|0|||
156756589|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
156756590|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
156314636|NCT00797966|564250150|FG001|Phase A|Protocol deviation|0|||
156314637|NCT00797966|564250151|FG002|Phase A|Protocol deviation|0|||
156314638|NCT00797966|564250152|FG003|Phase A|Protocol deviation|0|||
156314639|NCT00797966|564250153|FG004|Phase A|Protocol deviation|56|||
156314640|NCT00797966|564250154|FG005|Phase A|Protocol deviation|0|||
156314641|NCT00797966|564250149|FG000|Phase B|Lost to Follow-up|0|||
156314642|NCT00797966|564250150|FG001|Phase B|Lost to Follow-up|1|||
156314643|NCT00797966|564250151|FG002|Phase B|Lost to Follow-up|3|||
156314644|NCT00797966|564250152|FG003|Phase B|Lost to Follow-up|0|||
156314645|NCT00797966|564250153|FG004|Phase B|Lost to Follow-up|0|||
156314646|NCT00797966|564250154|FG005|Phase B|Lost to Follow-up|0|||
156314647|NCT00797966|564250149|FG000|Phase B|Adverse Event|2|||
156314648|NCT00797966|564250150|FG001|Phase B|Adverse Event|1|||
156314649|NCT00797966|564250151|FG002|Phase B|Adverse Event|3|||
156314650|NCT00797966|564250152|FG003|Phase B|Adverse Event|1|||
156314651|NCT00797966|564250153|FG004|Phase B|Adverse Event|0|||
156314652|NCT00797966|564250154|FG005|Phase B|Adverse Event|0|||
156314653|NCT00797966|564250149|FG000|Phase B|Met Withdrawal Criteria|3|||
156314654|NCT00797966|564250150|FG001|Phase B|Met Withdrawal Criteria|3|||
156314655|NCT00797966|564250151|FG002|Phase B|Met Withdrawal Criteria|6|||
156314656|NCT00797966|564250152|FG003|Phase B|Met Withdrawal Criteria|1|||
156314657|NCT00797966|564250153|FG004|Phase B|Met Withdrawal Criteria|0|||
156314658|NCT00797966|564250154|FG005|Phase B|Met Withdrawal Criteria|0|||
156314659|NCT00797966|564250149|FG000|Phase B|Physician Decision|1|||
156314660|NCT00797966|564250150|FG001|Phase B|Physician Decision|0|||
156314661|NCT00797966|564250151|FG002|Phase B|Physician Decision|3|||
156314662|NCT00797966|564250152|FG003|Phase B|Physician Decision|1|||
156314663|NCT00797966|564250153|FG004|Phase B|Physician Decision|0|||
156314664|NCT00797966|564250154|FG005|Phase B|Physician Decision|0|||
156314665|NCT00797966|564250149|FG000|Phase B|Withdrawal by Subject|1|||
156314666|NCT00797966|564250150|FG001|Phase B|Withdrawal by Subject|4|||
156314667|NCT00797966|564250151|FG002|Phase B|Withdrawal by Subject|3|||
156314668|NCT00797966|564250152|FG003|Phase B|Withdrawal by Subject|3|||
156314669|NCT00797966|564250153|FG004|Phase B|Withdrawal by Subject|0|||
156314670|NCT00797966|564250154|FG005|Phase B|Withdrawal by Subject|0|||
156314671|NCT00797966|564250149|FG000|Phase B|Protocol Deviation|4|||
156314672|NCT00797966|564250150|FG001|Phase B|Protocol Deviation|8|||
156314673|NCT00797966|564250151|FG002|Phase B|Protocol Deviation|2|||
156314674|NCT00797966|564250152|FG003|Phase B|Protocol Deviation|6|||
156314675|NCT00797966|564250153|FG004|Phase B|Protocol Deviation|0|||
156314676|NCT00797966|564250154|FG005|Phase B|Protocol Deviation|0|||
156314677|NCT00797966|564250149|FG000|Phase B|Lack of Efficacy|0|||
156314678|NCT00797966|564250150|FG001|Phase B|Lack of Efficacy|1|||
156314679|NCT00797966|564250151|FG002|Phase B|Lack of Efficacy|1|||
156314680|NCT00797966|564250152|FG003|Phase B|Lack of Efficacy|4|||
156314681|NCT00797966|564250153|FG004|Phase B|Lack of Efficacy|0|||
156314682|NCT00797966|564250154|FG005|Phase B|Lack of Efficacy|0|||
156652444|NCT01595009|565474444|FG000|Core|Administrative problems|0|||
156652445|NCT01595009|565474445|FG001|Core|Administrative problems|1|||
156652446|NCT01595009|565474446|FG002|Core|Administrative problems|0|||
156652447|NCT01595009|565474447|FG003|Core|Administrative problems|0|||
156652448|NCT01595009|565474444|FG000|Extension|Administrative problems|0|||
156652449|NCT01595009|565474445|FG001|Extension|Administrative problems|0|||
156652450|NCT01595009|565474446|FG002|Extension|Administrative problems|0|||
156652451|NCT01595009|565474447|FG003|Extension|Administrative problems|1|||
156652452|NCT01595009|565474444|FG000|Extension|Patients completed per protocol|0|||
156652453|NCT01595009|565474445|FG001|Extension|Patients completed per protocol|0|||
156652454|NCT01595009|565474446|FG002|Extension|Patients completed per protocol|0|||
156652455|NCT01595009|565474447|FG003|Extension|Patients completed per protocol|2|||
156652456|NCT01595009|565474444|FG000|Extension|Disease progression|0|||
156652457|NCT01595009|565474445|FG001|Extension|Disease progression|0|||
156756591|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
156756592|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156314683|NCT00797966|564250149|FG000|Phase A+|Lost to Follow-up|0|||
156314684|NCT00797966|564250150|FG001|Phase A+|Lost to Follow-up|0|||
156314685|NCT00797966|564250151|FG002|Phase A+|Lost to Follow-up|0|||
156314686|NCT00797966|564250152|FG003|Phase A+|Lost to Follow-up|0|||
156314687|NCT00797966|564250153|FG004|Phase A+|Lost to Follow-up|0|||
156314688|NCT00797966|564250154|FG005|Phase A+|Lost to Follow-up|9|||
156314689|NCT00797966|564250149|FG000|Phase A+|Met withdrawal criteria|0|||
156314690|NCT00797966|564250150|FG001|Phase A+|Met withdrawal criteria|0|||
156314691|NCT00797966|564250151|FG002|Phase A+|Met withdrawal criteria|0|||
156314692|NCT00797966|564250152|FG003|Phase A+|Met withdrawal criteria|0|||
156314693|NCT00797966|564250153|FG004|Phase A+|Met withdrawal criteria|0|||
156314694|NCT00797966|564250154|FG005|Phase A+|Met withdrawal criteria|5|||
156314695|NCT00797966|564250149|FG000|Phase A+|Withdrawal by Subject|0|||
156314696|NCT00797966|564250150|FG001|Phase A+|Withdrawal by Subject|0|||
156652458|NCT01595009|565474446|FG002|Extension|Disease progression|4|||
156652459|NCT01595009|565474447|FG003|Extension|Disease progression|7|||
156415082|NCT02018861|564613313|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156415083|NCT02018861|564613314|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156756593|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756594|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756595|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756596|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
156756597|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
156756598|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
156756599|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756600|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756601|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756602|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756603|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156415084|NCT02018861|564613315|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
156415085|NCT02018861|564613316|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
156415086|NCT02018861|564613317|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156415087|NCT02018861|564613318|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156415088|NCT02018861|564613319|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156415089|NCT02018861|564613320|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156415090|NCT02018861|564613321|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156415091|NCT02018861|564613312|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156415092|NCT02018861|564613313|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156415093|NCT02018861|564613314|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
156415094|NCT02018861|564613315|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
156415095|NCT02018861|564613316|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156415096|NCT02018861|564613317|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156415097|NCT02018861|564613318|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156415098|NCT02018861|564613319|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156415099|NCT02018861|564613320|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156415100|NCT02018861|564613321|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156415101|NCT02018861|564613312|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415102|NCT02018861|564613313|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415103|NCT02018861|564613314|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415104|NCT02018861|564613315|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415105|NCT02018861|564613316|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
156415106|NCT02018861|564613317|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415107|NCT02018861|564613318|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415108|NCT02018861|564613319|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415109|NCT02018861|564613320|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415110|NCT02018861|564613321|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156415111|NCT02018861|564613312|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156415112|NCT02018861|564613313|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156415113|NCT02018861|564613314|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156415114|NCT02018861|564613315|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
156415115|NCT02018861|564613316|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
156415116|NCT02018861|564613317|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
156415117|NCT02018861|564613318|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156415118|NCT02018861|564613319|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156415119|NCT02018861|564613320|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156415120|NCT02018861|564613321|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156415121|NCT02018861|564613312|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156415122|NCT02018861|564613313|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156415123|NCT02018861|564613314|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156415124|NCT02018861|564613315|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
156415125|NCT02018861|564613316|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
156415126|NCT02018861|564613317|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156415127|NCT02018861|564613318|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156415128|NCT02018861|564613319|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156415129|NCT02018861|564613320|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156415130|NCT02018861|564613321|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156756604|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
156756605|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
156756606|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
156756607|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
156756608|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756609|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756610|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
156756611|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756612|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756613|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756614|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156314697|NCT00797966|564250151|FG002|Phase A+|Withdrawal by Subject|0|||
156314698|NCT00797966|564250152|FG003|Phase A+|Withdrawal by Subject|0|||
156314699|NCT00797966|564250153|FG004|Phase A+|Withdrawal by Subject|0|||
156314700|NCT00797966|564250154|FG005|Phase A+|Withdrawal by Subject|6|||
156314701|NCT00797966|564250149|FG000|Phase A+|Adverse Event|0|||
156314702|NCT00797966|564250150|FG001|Phase A+|Adverse Event|0|||
156314703|NCT00797966|564250151|FG002|Phase A+|Adverse Event|0|||
156314704|NCT00797966|564250152|FG003|Phase A+|Adverse Event|0|||
156314705|NCT00797966|564250153|FG004|Phase A+|Adverse Event|0|||
156314706|NCT00797966|564250154|FG005|Phase A+|Adverse Event|4|||
156314707|NCT00797966|564250149|FG000|Phase A+|Protocol deviation|0|||
156314708|NCT00797966|564250150|FG001|Phase A+|Protocol deviation|0|||
156314709|NCT00797966|564250151|FG002|Phase A+|Protocol deviation|0|||
156314710|NCT00797966|564250152|FG003|Phase A+|Protocol deviation|0|||
156314711|NCT00797966|564250153|FG004|Phase A+|Protocol deviation|0|||
156314712|NCT00797966|564250154|FG005|Phase A+|Protocol deviation|4|||
156314713|NCT01430754|564250162|FG000|Run-In Phase|Circadian Period Ineligible|24|||
156314714|NCT01430754|564250163|FG001|Run-In Phase|Circadian Period Ineligible|0|||
156314715|NCT01430754|564250162|FG000|Run-In Phase|Protocol Violation|6|||
156314716|NCT01430754|564250163|FG001|Run-In Phase|Protocol Violation|0|||
156314717|NCT01430754|564250162|FG000|Run-In Phase|Adverse Event|2|||
156314718|NCT01430754|564250163|FG001|Run-In Phase|Adverse Event|0|||
156314719|NCT01430754|564250162|FG000|Run-In Phase|Other|2|||
156314720|NCT01430754|564250163|FG001|Run-In Phase|Other|0|||
156314721|NCT01430754|564250162|FG000|Run-In Phase|Withdrawal by Subject|2|||
156314722|NCT01430754|564250163|FG001|Run-In Phase|Withdrawal by Subject|0|||
156314723|NCT01430754|564250162|FG000|Run-In Phase|Lost to Follow-up|1|||
156314724|NCT01430754|564250163|FG001|Run-In Phase|Lost to Follow-up|0|||
156314725|NCT02661178|564250171|FG000|Part 1|Protocol Violation|1|||
156314726|NCT02661178|564250172|FG001|Part 1|Protocol Violation|0|||
156314727|NCT02661178|564250173|FG002|Part 1|Protocol Violation|0|||
156314728|NCT02661178|564250174|FG003|Part 1|Protocol Violation|0|||
156314729|NCT02661178|564250175|FG004|Part 1|Protocol Violation|0|||
156314730|NCT02661178|564250176|FG005|Part 1|Protocol Violation|0|||
156314731|NCT02661178|564250177|FG006|Part 1|Protocol Violation|0|||
156314732|NCT02661178|564250178|FG007|Part 1|Protocol Violation|0|||
156314733|NCT02661178|564250179|FG008|Part 1|Protocol Violation|0|||
156314734|NCT02661178|564250180|FG009|Part 1|Protocol Violation|0|||
156314735|NCT02661178|564250181|FG010|Part 1|Protocol Violation|0|||
156314736|NCT02661178|564250182|FG011|Part 1|Protocol Violation|0|||
156314737|NCT02661178|564250183|FG012|Part 1|Protocol Violation|0|||
156314738|NCT02661178|564250184|FG013|Part 1|Protocol Violation|0|||
156314739|NCT02661178|564250185|FG014|Part 1|Protocol Violation|0|||
156314740|NCT05338671|564250186|FG000|Overall Study|Lost to Follow-up|2|||
156314741|NCT05338671|564250187|FG001|Overall Study|Lost to Follow-up|2|||
156314742|NCT05338671|564250186|FG000|Overall Study|Root canal completed in a single visit|1|||
156314743|NCT05338671|564250187|FG001|Overall Study|Root canal completed in a single visit|0|||
156314744|NCT01242813|564250190|FG000|Overall Study|Lost to Follow-up|2|||
156314745|NCT00701662|564250191|FG000|Overall Study|Lack of Efficacy|1|||
156314746|NCT02683746|564250193|FG000|Overall Study|Adverse Event|3|||
156314747|NCT02683746|564250194|FG001|Overall Study|Adverse Event|2|||
156314748|NCT02683746|564250193|FG000|Overall Study|Lost to Follow-up|5|||
156314749|NCT02683746|564250194|FG001|Overall Study|Lost to Follow-up|6|||
156314750|NCT02683746|564250193|FG000|Overall Study|Withdrawal by Subject|6|||
156314751|NCT02683746|564250194|FG001|Overall Study|Withdrawal by Subject|5|||
156314752|NCT02683746|564250193|FG000|Overall Study|Physician Decision|2|||
156314753|NCT02683746|564250194|FG001|Overall Study|Physician Decision|1|||
156314754|NCT02353143|564250200|FG000|Overall Study|Withdrawal by Subject|1|||
156314755|NCT02353143|564250201|FG001|Overall Study|Withdrawal by Subject|0|||
156314756|NCT02353143|564250202|FG002|Overall Study|Withdrawal by Subject|0|||
156314757|NCT02353143|564250203|FG003|Overall Study|Withdrawal by Subject|0|||
156314758|NCT02353143|564250204|FG004|Overall Study|Withdrawal by Subject|1|||
156314759|NCT02353143|564250205|FG005|Overall Study|Withdrawal by Subject|0|||
156314760|NCT02353143|564250206|FG006|Overall Study|Withdrawal by Subject|0|||
156314761|NCT02353143|564250207|FG007|Overall Study|Withdrawal by Subject|1|||
156314762|NCT02353143|564250208|FG008|Overall Study|Withdrawal by Subject|1|||
156314763|NCT02353143|564250200|FG000|Overall Study|Lack of Efficacy|2|||
156314764|NCT02353143|564250201|FG001|Overall Study|Lack of Efficacy|1|||
156314765|NCT02353143|564250202|FG002|Overall Study|Lack of Efficacy|2|||
156314766|NCT02353143|564250203|FG003|Overall Study|Lack of Efficacy|4|||
156314767|NCT02353143|564250204|FG004|Overall Study|Lack of Efficacy|13|||
156415131|NCT02018861|564613312|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156415132|NCT02018861|564613313|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156415133|NCT02018861|564613314|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156415134|NCT02018861|564613315|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156415135|NCT02018861|564613316|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156415136|NCT02018861|564613317|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156415137|NCT02018861|564613318|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
156415138|NCT02018861|564613319|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
156415139|NCT02018861|564613320|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156415140|NCT02018861|564613321|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156415141|NCT02018861|564613312|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156415142|NCT02018861|564613313|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156415143|NCT02018861|564613314|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156415144|NCT02018861|564613315|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156415145|NCT02018861|564613316|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156415146|NCT02018861|564613317|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156415147|NCT02018861|564613318|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
156415148|NCT02018861|564613319|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
156415149|NCT02018861|564613320|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156415150|NCT02018861|564613321|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156415151|NCT02018861|564613312|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415152|NCT02018861|564613313|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415153|NCT02018861|564613314|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415154|NCT02018861|564613315|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415155|NCT02018861|564613316|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415156|NCT02018861|564613317|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415157|NCT02018861|564613318|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415158|NCT02018861|564613319|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415159|NCT02018861|564613320|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
156415160|NCT02018861|564613321|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156415161|NCT02018861|564613312|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415162|NCT02018861|564613313|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415163|NCT02018861|564613314|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415164|NCT02018861|564613315|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415165|NCT02018861|564613316|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415166|NCT02018861|564613317|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415167|NCT02018861|564613318|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415168|NCT02018861|564613319|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415169|NCT02018861|564613320|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
156415170|NCT02018861|564613321|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156415171|NCT02018861|564613312|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415172|NCT02018861|564613313|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415173|NCT02018861|564613314|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415174|NCT02018861|564613315|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415175|NCT02018861|564613316|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415176|NCT02018861|564613317|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415177|NCT02018861|564613318|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415178|NCT02018861|564613319|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415179|NCT02018861|564613320|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
156415180|NCT02018861|564613321|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156415181|NCT00590980|564613332|FG000|Overall Study|Did not meet all inclusion criteria|10|||
156415182|NCT00504348|564613333|FG000|Overall Study|Adverse Event|3|||
156415183|NCT00504348|564613333|FG000|Overall Study|Lack of Efficacy|4|||
156415184|NCT00504348|564613333|FG000|Overall Study|Physician Decision|1|||
156415185|NCT02819479|564613334|FG000|Overall Study|Adverse Event|2|||
156652460|NCT01595009|565474444|FG000|Extension|Adverse Event|0|||
156652461|NCT01595009|565474445|FG001|Extension|Adverse Event|0|||
156652462|NCT01595009|565474446|FG002|Extension|Adverse Event|0|||
156652463|NCT01595009|565474447|FG003|Extension|Adverse Event|1|||
156652464|NCT00729859|565474448|FG000|Overall Study|Adverse Event|0|||
156652465|NCT00729859|565474449|FG001|Overall Study|Adverse Event|1|||
156652466|NCT00729859|565474450|FG002|Overall Study|Adverse Event|0|||
156652467|NCT00729859|565474448|FG000|Overall Study|Withdrawal by Subject|0|||
156652468|NCT00729859|565474449|FG001|Overall Study|Withdrawal by Subject|1|||
156652469|NCT00729859|565474450|FG002|Overall Study|Withdrawal by Subject|0|||
156415186|NCT02718417|564613337|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
156415187|NCT02718417|564613338|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
156652470|NCT04956666|565474451|FG000|Overall Study|Adverse Event|18|||
156652471|NCT04956666|565474451|FG000|Overall Study|Physician Decision|5|||
156652472|NCT00681863|565474457|FG000|Overall Study|Adverse Event|1|||
156652473|NCT00681863|565474457|FG000|Overall Study|Lost to Follow-up|2|||
156652474|NCT00681863|565474457|FG000|Overall Study|Lack of Efficacy|2|||
156652475|NCT00681863|565474457|FG000|Overall Study|Other|18|||
156652476|NCT01333033|565474461|FG000|Overall Study|Ineligible|0|||
156652477|NCT01333033|565474462|FG001|Overall Study|Ineligible|0|||
156652478|NCT01333033|565474463|FG002|Overall Study|Ineligible|0|||
156652479|NCT01333033|565474464|FG003|Overall Study|Ineligible|0|||
156652480|NCT01333033|565474465|FG004|Overall Study|Ineligible|6|||
156652481|NCT01333033|565474466|FG005|Overall Study|Ineligible|8|||
156652482|NCT01333033|565474461|FG000|Overall Study|Withdrawal by Subject|0|||
156652483|NCT01333033|565474462|FG001|Overall Study|Withdrawal by Subject|0|||
156652484|NCT01333033|565474463|FG002|Overall Study|Withdrawal by Subject|0|||
156652485|NCT01333033|565474464|FG003|Overall Study|Withdrawal by Subject|0|||
156652486|NCT01333033|565474465|FG004|Overall Study|Withdrawal by Subject|4|||
156652487|NCT01333033|565474466|FG005|Overall Study|Withdrawal by Subject|2|||
156652488|NCT01333033|565474461|FG000|Overall Study|PET inevaluable|0|||
156652489|NCT01333033|565474462|FG001|Overall Study|PET inevaluable|0|||
156652490|NCT01333033|565474463|FG002|Overall Study|PET inevaluable|0|||
156652491|NCT01333033|565474464|FG003|Overall Study|PET inevaluable|0|||
156652492|NCT01333033|565474465|FG004|Overall Study|PET inevaluable|2|||
156652493|NCT01333033|565474466|FG005|Overall Study|PET inevaluable|4|||
156652494|NCT01333033|565474461|FG000|Overall Study|Adverse Event|0|||
156652495|NCT01333033|565474462|FG001|Overall Study|Adverse Event|0|||
156652496|NCT01333033|565474463|FG002|Overall Study|Adverse Event|0|||
156652497|NCT01333033|565474464|FG003|Overall Study|Adverse Event|0|||
156652498|NCT01333033|565474465|FG004|Overall Study|Adverse Event|2|||
156652499|NCT01333033|565474466|FG005|Overall Study|Adverse Event|1|||
156652500|NCT01333033|565474461|FG000|Overall Study|Progression|0|||
156652501|NCT01333033|565474462|FG001|Overall Study|Progression|0|||
156652502|NCT01333033|565474463|FG002|Overall Study|Progression|0|||
156652503|NCT01333033|565474464|FG003|Overall Study|Progression|0|||
156652504|NCT01333033|565474465|FG004|Overall Study|Progression|0|||
156652505|NCT01333033|565474466|FG005|Overall Study|Progression|1|||
156756615|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756616|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156314768|NCT02353143|564250205|FG005|Overall Study|Lack of Efficacy|2|||
156314769|NCT02353143|564250206|FG006|Overall Study|Lack of Efficacy|2|||
156314770|NCT02353143|564250207|FG007|Overall Study|Lack of Efficacy|2|||
156314771|NCT02353143|564250208|FG008|Overall Study|Lack of Efficacy|1|||
156314772|NCT02353143|564250200|FG000|Overall Study|reason not specified|1|||
156314773|NCT02353143|564250201|FG001|Overall Study|reason not specified|2|||
156314774|NCT02353143|564250202|FG002|Overall Study|reason not specified|0|||
156314775|NCT02353143|564250203|FG003|Overall Study|reason not specified|0|||
156314776|NCT02353143|564250204|FG004|Overall Study|reason not specified|6|||
156314777|NCT02353143|564250205|FG005|Overall Study|reason not specified|1|||
156314778|NCT02353143|564250206|FG006|Overall Study|reason not specified|0|||
156314779|NCT02353143|564250207|FG007|Overall Study|reason not specified|3|||
156314780|NCT02353143|564250208|FG008|Overall Study|reason not specified|1|||
156314781|NCT02353143|564250200|FG000|Overall Study|Physician Decision|0|||
156314782|NCT02353143|564250201|FG001|Overall Study|Physician Decision|4|||
156314783|NCT02353143|564250202|FG002|Overall Study|Physician Decision|2|||
156314784|NCT02353143|564250203|FG003|Overall Study|Physician Decision|3|||
156314785|NCT02353143|564250204|FG004|Overall Study|Physician Decision|4|||
156314786|NCT02353143|564250205|FG005|Overall Study|Physician Decision|0|||
156314787|NCT02353143|564250206|FG006|Overall Study|Physician Decision|1|||
156314788|NCT02353143|564250207|FG007|Overall Study|Physician Decision|2|||
156314789|NCT02353143|564250208|FG008|Overall Study|Physician Decision|0|||
156314790|NCT02353143|564250200|FG000|Overall Study|Adverse Event|0|||
156314791|NCT02353143|564250201|FG001|Overall Study|Adverse Event|0|||
156314792|NCT02353143|564250202|FG002|Overall Study|Adverse Event|1|||
156314793|NCT02353143|564250203|FG003|Overall Study|Adverse Event|0|||
156314794|NCT02353143|564250204|FG004|Overall Study|Adverse Event|1|||
156314795|NCT02353143|564250205|FG005|Overall Study|Adverse Event|1|||
156314796|NCT02353143|564250206|FG006|Overall Study|Adverse Event|0|||
156314797|NCT02353143|564250207|FG007|Overall Study|Adverse Event|0|||
156314798|NCT02353143|564250208|FG008|Overall Study|Adverse Event|0|||
156314799|NCT02353143|564250200|FG000|Overall Study|patient receiving other treatment for AML|0|||
156314800|NCT02353143|564250201|FG001|Overall Study|patient receiving other treatment for AML|0|||
156314801|NCT02353143|564250202|FG002|Overall Study|patient receiving other treatment for AML|1|||
156314802|NCT02353143|564250203|FG003|Overall Study|patient receiving other treatment for AML|0|||
156314803|NCT02353143|564250204|FG004|Overall Study|patient receiving other treatment for AML|0|||
156314804|NCT02353143|564250205|FG005|Overall Study|patient receiving other treatment for AML|0|||
156314805|NCT02353143|564250206|FG006|Overall Study|patient receiving other treatment for AML|0|||
156314806|NCT02353143|564250207|FG007|Overall Study|patient receiving other treatment for AML|0|||
156314807|NCT02353143|564250208|FG008|Overall Study|patient receiving other treatment for AML|0|||
156314808|NCT02353143|564250200|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
156314809|NCT02353143|564250201|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
156314810|NCT02353143|564250202|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
156314811|NCT02353143|564250203|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
156314812|NCT02353143|564250204|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
156314813|NCT02353143|564250205|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
156314814|NCT02353143|564250206|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
156314815|NCT02353143|564250207|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
156314816|NCT02353143|564250208|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
156652506|NCT01333033|565474461|FG000|Overall Study|MD Decision|0|||
156652507|NCT01333033|565474462|FG001|Overall Study|MD Decision|0|||
156652508|NCT01333033|565474463|FG002|Overall Study|MD Decision|0|||
156652509|NCT01333033|565474464|FG003|Overall Study|MD Decision|0|||
156652510|NCT01333033|565474465|FG004|Overall Study|MD Decision|0|||
156652511|NCT01333033|565474466|FG005|Overall Study|MD Decision|2|||
156652512|NCT00760383|565474467|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
156652513|NCT00760383|565474468|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
156652514|NCT01842958|565474469|FG000|Overall Study|Lost to Follow-up|1|||
156652515|NCT01842958|565474470|FG001|Overall Study|Lost to Follow-up|1|||
156652516|NCT01829477|565474471|FG000|Overall Study|Study Terminated by Sponsor|15|||
156652517|NCT01829477|565474472|FG001|Overall Study|Study Terminated by Sponsor|15|||
156652518|NCT01829477|565474471|FG000|Overall Study|Withdrawal by Subject|1|||
156652519|NCT01829477|565474472|FG001|Overall Study|Withdrawal by Subject|0|||
156652520|NCT03465891|565474473|FG000|Overall Study|Withdrawal by Subject|0|||
156652521|NCT03465891|565474474|FG001|Overall Study|Withdrawal by Subject|1|||
156652522|NCT03465891|565474473|FG000|Overall Study|Disease progression|1|||
156652523|NCT03465891|565474474|FG001|Overall Study|Disease progression|0|||
156652524|NCT02737306|565474476|FG000|Overall Study|Adverse Event|3|||
156652525|NCT02737306|565474477|FG001|Overall Study|Adverse Event|0|||
156652526|NCT02737306|565474476|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
156652527|NCT02737306|565474477|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
156652528|NCT03361423|565474478|FG000|Overall Study|Withdrawal by Subject|4|||
156652529|NCT03361423|565474479|FG001|Overall Study|Withdrawal by Subject|3|||
156652530|NCT03361423|565474478|FG000|Overall Study|Did not treat|19|||
156652531|NCT03361423|565474479|FG001|Overall Study|Did not treat|18|||
156652532|NCT03361423|565474478|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
156652533|NCT03361423|565474479|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
156652534|NCT03361423|565474478|FG000|Overall Study|Missing data|4|||
156652535|NCT03361423|565474479|FG001|Overall Study|Missing data|1|||
156652536|NCT01336894|565474480|FG000|Follow-up|Study terminated prematurely|2|||
156652537|NCT01336894|565474481|FG001|Follow-up|Study terminated prematurely|7|||
156652538|NCT05034731|565474482|FG000|Overall Study|Screen fail|1|||
156652539|NCT05034731|565474483|FG001|Overall Study|Screen fail|1|||
156652540|NCT00818623|565474484|FG000|Overall Study|Adverse Event|1|||
156652541|NCT00818623|565474485|FG001|Overall Study|Adverse Event|0|||
156652542|NCT00818623|565474486|FG002|Overall Study|Adverse Event|1|||
156652543|NCT00818623|565474487|FG003|Overall Study|Adverse Event|0|||
156652544|NCT00818623|565474488|FG004|Overall Study|Adverse Event|0|||
156652545|NCT00818623|565474489|FG005|Overall Study|Adverse Event|1|||
156652546|NCT00818623|565474490|FG006|Overall Study|Adverse Event|0|||
156652547|NCT00818623|565474491|FG007|Overall Study|Adverse Event|0|||
156652548|NCT00818623|565474484|FG000|Overall Study|Bad prostate specific antigen response|0|||
156652549|NCT00818623|565474485|FG001|Overall Study|Bad prostate specific antigen response|3|||
156652550|NCT00818623|565474486|FG002|Overall Study|Bad prostate specific antigen response|2|||
156652551|NCT00818623|565474487|FG003|Overall Study|Bad prostate specific antigen response|5|||
156652552|NCT00818623|565474488|FG004|Overall Study|Bad prostate specific antigen response|0|||
156652553|NCT00818623|565474489|FG005|Overall Study|Bad prostate specific antigen response|1|||
156652554|NCT00818623|565474490|FG006|Overall Study|Bad prostate specific antigen response|0|||
156652555|NCT00818623|565474491|FG007|Overall Study|Bad prostate specific antigen response|0|||
156652556|NCT00818623|565474484|FG000|Overall Study|Withdrawal by Subject|0|||
156652557|NCT00818623|565474485|FG001|Overall Study|Withdrawal by Subject|1|||
156652558|NCT00818623|565474486|FG002|Overall Study|Withdrawal by Subject|1|||
156652559|NCT00818623|565474487|FG003|Overall Study|Withdrawal by Subject|0|||
156652560|NCT00818623|565474488|FG004|Overall Study|Withdrawal by Subject|0|||
156652561|NCT00818623|565474489|FG005|Overall Study|Withdrawal by Subject|1|||
156652562|NCT00818623|565474490|FG006|Overall Study|Withdrawal by Subject|1|||
156652563|NCT00818623|565474491|FG007|Overall Study|Withdrawal by Subject|1|||
156652564|NCT00818623|565474484|FG000|Overall Study|Protocol Violation|1|||
156652565|NCT00818623|565474485|FG001|Overall Study|Protocol Violation|0|||
156652566|NCT00818623|565474486|FG002|Overall Study|Protocol Violation|0|||
156652567|NCT00818623|565474487|FG003|Overall Study|Protocol Violation|0|||
156314817|NCT02946931|564250213|FG000|Overall Study|Did not require collection of CRFs|588|||
156652568|NCT00818623|565474488|FG004|Overall Study|Protocol Violation|1|||
156652569|NCT00818623|565474489|FG005|Overall Study|Protocol Violation|0|||
156652570|NCT00818623|565474490|FG006|Overall Study|Protocol Violation|1|||
156415188|NCT02718417|564613339|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
156415189|NCT02718417|564613337|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
156415190|NCT02718417|564613338|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
156415191|NCT02718417|564613339|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
156415192|NCT02718417|564613337|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
156415193|NCT02718417|564613338|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
156415194|NCT02718417|564613339|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
156415195|NCT02718417|564613337|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
156415196|NCT02718417|564613338|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
156415197|NCT02718417|564613339|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
156415198|NCT02718417|564613337|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
156415199|NCT02718417|564613338|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
156415200|NCT02718417|564613339|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
156415201|NCT02718417|564613337|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
156415202|NCT02718417|564613338|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
156415203|NCT02718417|564613339|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
156415204|NCT02718417|564613337|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
156415205|NCT02718417|564613338|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
156415206|NCT02718417|564613339|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
156415207|NCT02718417|564613337|FG000|Chemotherapy Phase (CP)|Other|2|||
156415208|NCT02718417|564613338|FG001|Chemotherapy Phase (CP)|Other|0|||
156415209|NCT02718417|564613339|FG002|Chemotherapy Phase (CP)|Other|1|||
156415210|NCT02718417|564613337|FG000|Maintenance Phase (MP)|Adverse Event|21|||
156415211|NCT02718417|564613338|FG001|Maintenance Phase (MP)|Adverse Event|26|||
156415212|NCT02718417|564613339|FG002|Maintenance Phase (MP)|Adverse Event|0|||
156415213|NCT02718417|564613337|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
156415214|NCT02718417|564613338|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
156415215|NCT02718417|564613339|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
156415216|NCT02718417|564613337|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
156415217|NCT02718417|564613338|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
156415218|NCT02718417|564613339|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
156415219|NCT02718417|564613337|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
156415220|NCT02718417|564613338|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
156415221|NCT02718417|564613339|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
156415222|NCT02718417|564613337|FG000|Maintenance Phase (MP)|Physician's decision|6|||
156415223|NCT02718417|564613338|FG001|Maintenance Phase (MP)|Physician's decision|7|||
156652571|NCT00818623|565474491|FG007|Overall Study|Protocol Violation|0|||
156652572|NCT00818623|565474484|FG000|Overall Study|Need of additional treatment|0|||
156652573|NCT00818623|565474485|FG001|Overall Study|Need of additional treatment|0|||
156652574|NCT00818623|565474486|FG002|Overall Study|Need of additional treatment|0|||
156652575|NCT00818623|565474487|FG003|Overall Study|Need of additional treatment|0|||
156652576|NCT00818623|565474488|FG004|Overall Study|Need of additional treatment|1|||
156652577|NCT00818623|565474489|FG005|Overall Study|Need of additional treatment|0|||
156652578|NCT00818623|565474490|FG006|Overall Study|Need of additional treatment|0|||
156652579|NCT00818623|565474491|FG007|Overall Study|Need of additional treatment|0|||
156652580|NCT00818623|565474484|FG000|Overall Study|Lack of trial drug at site|0|||
156652581|NCT00818623|565474485|FG001|Overall Study|Lack of trial drug at site|0|||
156652582|NCT00818623|565474486|FG002|Overall Study|Lack of trial drug at site|0|||
156652583|NCT00818623|565474487|FG003|Overall Study|Lack of trial drug at site|0|||
156652584|NCT00818623|565474488|FG004|Overall Study|Lack of trial drug at site|2|||
156652585|NCT00818623|565474489|FG005|Overall Study|Lack of trial drug at site|0|||
156652586|NCT00818623|565474490|FG006|Overall Study|Lack of trial drug at site|1|||
156652587|NCT00818623|565474491|FG007|Overall Study|Lack of trial drug at site|0|||
156652588|NCT00818623|565474484|FG000|Overall Study|Disease progression|0|||
156652589|NCT00818623|565474485|FG001|Overall Study|Disease progression|0|||
156652590|NCT00818623|565474486|FG002|Overall Study|Disease progression|0|||
156652591|NCT00818623|565474487|FG003|Overall Study|Disease progression|0|||
156652592|NCT00818623|565474488|FG004|Overall Study|Disease progression|0|||
156652593|NCT00818623|565474489|FG005|Overall Study|Disease progression|0|||
156652594|NCT00818623|565474490|FG006|Overall Study|Disease progression|1|||
156652595|NCT00818623|565474491|FG007|Overall Study|Disease progression|0|||
156652596|NCT01709383|565474492|FG000|Overall Study|Lost to Follow-up|1|||
156756617|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756618|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
156756619|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156415224|NCT02718417|564613339|FG002|Maintenance Phase (MP)|Physician's decision|0|||
156415225|NCT02718417|564613337|FG000|Maintenance Phase (MP)|Progressive disease|100|||
156652597|NCT01709383|565474493|FG001|Overall Study|Lost to Follow-up|0|||
156652598|NCT03264066|565474494|FG000|Overall Study|Adverse Event|1|||
156652599|NCT03264066|565474495|FG001|Overall Study|Adverse Event|1|||
156652600|NCT03264066|565474496|FG002|Overall Study|Adverse Event|0|||
156314818|NCT02946931|564250213|FG000|Overall Study|Other than listed|37|||
156314819|NCT02946931|564250213|FG000|Overall Study|Discharge from hospital|118|||
156314820|NCT02946931|564250213|FG000|Overall Study|Adverse Event|81|||
156314821|NCT02946931|564250213|FG000|Overall Study|CRFs not valid|1|||
156314822|NCT02946931|564250213|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
156314823|NCT03339297|564250214|FG000|Overall Study|Relapse of Hematologic Disease|1|||
156314824|NCT03339297|564250215|FG001|Overall Study|Relapse of Hematologic Disease|0|||
156314825|NCT03339297|564250214|FG000|Overall Study|Death|10|||
156314826|NCT03339297|564250215|FG001|Overall Study|Death|7|||
156314827|NCT03339297|564250214|FG000|Overall Study|Hepatic Candidosis|1|||
156314828|NCT03339297|564250215|FG001|Overall Study|Hepatic Candidosis|0|||
156314829|NCT03339297|564250214|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
156314830|NCT03339297|564250215|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
156314831|NCT03339297|564250214|FG000|Overall Study|Consent Withdrawn by Participant|3|||
156314832|NCT03339297|564250215|FG001|Overall Study|Consent Withdrawn by Participant|3|||
156314833|NCT03339297|564250214|FG000|Overall Study|Disease Relapse|2|||
156314834|NCT03339297|564250215|FG001|Overall Study|Disease Relapse|0|||
156314835|NCT03339297|564250214|FG000|Overall Study|Physician Decision|1|||
156314836|NCT03339297|564250215|FG001|Overall Study|Physician Decision|1|||
156314837|NCT03339297|564250214|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
156314838|NCT03339297|564250215|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
156314839|NCT03339297|564250214|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
156314840|NCT03339297|564250215|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
156314841|NCT03339297|564250214|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
156314842|NCT03339297|564250215|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
156314843|NCT03339297|564250214|FG000|Overall Study|Adverse Event, Non-fatal|1|||
156314844|NCT03339297|564250215|FG001|Overall Study|Adverse Event, Non-fatal|0|||
156314845|NCT03339297|564250214|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
156314846|NCT03339297|564250215|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
156314847|NCT03339297|564250214|FG000|Overall Study|Patient Was Not Eligible|1|||
156314848|NCT03339297|564250215|FG001|Overall Study|Patient Was Not Eligible|0|||
156314849|NCT01566214|564250222|FG000|Overall Study|Lost to Follow-up|3|||
156314850|NCT01566214|564250223|FG001|Overall Study|Lost to Follow-up|0|||
156314851|NCT03051620|564250224|FG000|Overall Study|Lost to Follow-up|6|||
156314852|NCT03051620|564250224|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
156314853|NCT00393510|564250225|FG000|Overall Study|Physician Decision|3|||
156314854|NCT00393510|564250226|FG001|Overall Study|Physician Decision|9|||
156314855|NCT00770146|564250229|FG000|Treatment Period|Withdrawal by Subject|6|||
156314856|NCT00770146|564250230|FG001|Treatment Period|Withdrawal by Subject|13|||
156314857|NCT00770146|564250229|FG000|Treatment Period|Adverse Event|2|||
156314858|NCT00770146|564250230|FG001|Treatment Period|Adverse Event|26|||
156314859|NCT00770146|564250229|FG000|Treatment Period|Other|1|||
156314860|NCT00770146|564250230|FG001|Treatment Period|Other|5|||
156314861|NCT00770146|564250229|FG000|Treatment Period|Protocol non-compliance|0|||
156314862|NCT00770146|564250230|FG001|Treatment Period|Protocol non-compliance|1|||
156314863|NCT00770146|564250229|FG000|Follow-up Period|Withdrawal by Subject|7|||
156314864|NCT00770146|564250230|FG001|Follow-up Period|Withdrawal by Subject|13|||
156314865|NCT00770146|564250229|FG000|Follow-up Period|Adverse Event|0|||
156314866|NCT00770146|564250230|FG001|Follow-up Period|Adverse Event|2|||
156314867|NCT00770146|564250229|FG000|Follow-up Period|Other|4|||
156314868|NCT00770146|564250230|FG001|Follow-up Period|Other|5|||
156314869|NCT04620798|564250233|FG000|Overall Study|Lost to Follow-up|126|||
156314870|NCT04620798|564250234|FG001|Overall Study|Lost to Follow-up|138|||
156314871|NCT03222492|564250236|FG000|Overall Study|Withdrawal by Subject|0|||
156314872|NCT03222492|564250237|FG001|Overall Study|Withdrawal by Subject|0|||
156314873|NCT03222492|564250238|FG002|Overall Study|Withdrawal by Subject|1|||
156314874|NCT03222492|564250239|FG003|Overall Study|Withdrawal by Subject|0|||
156314875|NCT03222492|564250236|FG000|Overall Study|COVID-19 related|0|||
156314876|NCT03222492|564250237|FG001|Overall Study|COVID-19 related|0|||
156314877|NCT03222492|564250238|FG002|Overall Study|COVID-19 related|1|||
156314878|NCT03222492|564250239|FG003|Overall Study|COVID-19 related|0|||
156314879|NCT00674154|564250240|FG000|Overall Study|Withdrawal by Subject|3|||
156314880|NCT00674154|564250241|FG001|Overall Study|Withdrawal by Subject|1|||
156314881|NCT00674154|564250240|FG000|Overall Study|Did not want parathyroidectomy|0|||
156314882|NCT00674154|564250241|FG001|Overall Study|Did not want parathyroidectomy|2|||
156314883|NCT00816023|564250242|FG000|Overall Study|Lost to Follow-up|1|||
156314884|NCT00816023|564250243|FG001|Overall Study|Lost to Follow-up|1|||
156314885|NCT00816023|564250244|FG002|Overall Study|Lost to Follow-up|0|||
156314886|NCT00816023|564250245|FG003|Overall Study|Lost to Follow-up|0|||
156314887|NCT00816023|564250242|FG000|Overall Study|Withdrawal by Subject|1|||
156314888|NCT00816023|564250243|FG001|Overall Study|Withdrawal by Subject|0|||
156314889|NCT00816023|564250244|FG002|Overall Study|Withdrawal by Subject|0|||
156314890|NCT00816023|564250245|FG003|Overall Study|Withdrawal by Subject|0|||
156314891|NCT00816023|564250242|FG000|Overall Study|Physician Decision|0|||
156314892|NCT00816023|564250243|FG001|Overall Study|Physician Decision|0|||
156314893|NCT00816023|564250244|FG002|Overall Study|Physician Decision|1|||
156314894|NCT00816023|564250245|FG003|Overall Study|Physician Decision|0|||
156314895|NCT00816023|564250242|FG000|Overall Study|assessments complete prior to window|1|||
156314896|NCT00816023|564250243|FG001|Overall Study|assessments complete prior to window|1|||
156314897|NCT00816023|564250244|FG002|Overall Study|assessments complete prior to window|2|||
156314898|NCT00816023|564250245|FG003|Overall Study|assessments complete prior to window|1|||
156314899|NCT00816023|564250242|FG000|Overall Study|Randomized Not Treated|6|||
156314900|NCT00816023|564250243|FG001|Overall Study|Randomized Not Treated|4|||
156314901|NCT00816023|564250244|FG002|Overall Study|Randomized Not Treated|6|||
156314902|NCT00816023|564250245|FG003|Overall Study|Randomized Not Treated|11|||
156314903|NCT01011478|564251842|FG000|Overall Study|No follow up data|12|||
156314904|NCT01011478|564251843|FG001|Overall Study|No follow up data|7|||
156314905|NCT04461600|564251844|FG000|Overall Study|Death|6|||
156314906|NCT04461600|564251845|FG001|Overall Study|Death|5|||
156314907|NCT04461600|564251844|FG000|Overall Study|Withdrawal by Subject|0|||
156314908|NCT04461600|564251845|FG001|Overall Study|Withdrawal by Subject|1|||
156314909|NCT02278471|564251849|FG000|Overall Study|Lost to Follow-up|6|||
156314910|NCT02278471|564251850|FG001|Overall Study|Lost to Follow-up|15|||
156314911|NCT02278471|564251849|FG000|Overall Study|Death|2|||
156314912|NCT02278471|564251850|FG001|Overall Study|Death|2|||
156314913|NCT02278471|564251849|FG000|Overall Study|Withdrawal by Subject|0|||
156314914|NCT02278471|564251850|FG001|Overall Study|Withdrawal by Subject|3|||
156314915|NCT01437995|564251853|FG000|Overall Study|Lost to Follow-up|11|||
156314916|NCT01437995|564251854|FG001|Overall Study|Lost to Follow-up|18|||
156314917|NCT01437995|564251855|FG002|Overall Study|Lost to Follow-up|20|||
156314918|NCT04618770|564251856|FG000|Overall Study|Censored from Analysis|12|||
156314919|NCT04618770|564251856|FG000|Overall Study|Early Termination|25|||
156314920|NCT04456673|564251857|FG000|Overall Study|Adverse Event|7|||
156314921|NCT04456673|564251858|FG001|Overall Study|Adverse Event|14|||
156314922|NCT04456673|564251857|FG000|Overall Study|Poor compliance to protocol|1|||
156314923|NCT04456673|564251858|FG001|Overall Study|Poor compliance to protocol|0|||
156314924|NCT04456673|564251857|FG000|Overall Study|Withdrawal by Subject|31|||
156314925|NCT04456673|564251858|FG001|Overall Study|Withdrawal by Subject|23|||
156314926|NCT04456673|564251857|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
156314927|NCT04456673|564251858|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
156314928|NCT04391049|564251859|FG000|Overall Study|Protocol Violation|1|||
156314929|NCT03874429|564251860|FG000|Overall Study|Adverse Event|2|||
156314930|NCT03874429|564251861|FG001|Overall Study|Adverse Event|2|||
156314931|NCT03874429|564251860|FG000|Overall Study|Lack of Efficacy|0|||
156314932|NCT03874429|564251861|FG001|Overall Study|Lack of Efficacy|1|||
156314933|NCT03874429|564251860|FG000|Overall Study|Covid-19 pandemic|4|||
156314934|NCT03874429|564251861|FG001|Overall Study|Covid-19 pandemic|2|||
156314935|NCT03337490|564251862|FG000|Overall Study|Withdrawal by Subject|1|||
156314936|NCT03337490|564251863|FG001|Overall Study|Withdrawal by Subject|0|||
156314937|NCT03337490|564251864|FG002|Overall Study|Withdrawal by Subject|0|||
156314938|NCT03337490|564251862|FG000|Overall Study|Lack of Efficacy|10|||
156314939|NCT03337490|564251863|FG001|Overall Study|Lack of Efficacy|12|||
156314940|NCT03337490|564251864|FG002|Overall Study|Lack of Efficacy|35|||
156314941|NCT03337490|564251862|FG000|Overall Study|Physician Decision|0|||
156314942|NCT03337490|564251863|FG001|Overall Study|Physician Decision|1|||
156314943|NCT03337490|564251864|FG002|Overall Study|Physician Decision|0|||
156314944|NCT03337490|564251862|FG000|Overall Study|Lost to Follow-up|0|||
156314945|NCT03337490|564251863|FG001|Overall Study|Lost to Follow-up|1|||
156314946|NCT03337490|564251864|FG002|Overall Study|Lost to Follow-up|0|||
156314947|NCT04905498|564251870|FG000|Overall Study|Lost to Follow-up|0|||
156314948|NCT04905498|564251871|FG001|Overall Study|Lost to Follow-up|2|||
156314949|NCT04905498|564251870|FG000|Overall Study|COVID lockdown|1|||
156314950|NCT04905498|564251871|FG001|Overall Study|COVID lockdown|0|||
156314951|NCT01525901|564251875|FG000|Period 2: 12 Weeks|Adverse Event|0|||
156314952|NCT01525901|564251876|FG001|Period 2: 12 Weeks|Adverse Event|1|||
156314953|NCT01525901|564251877|FG002|Period 2: 12 Weeks|Adverse Event|0|||
156314954|NCT01525901|564251878|FG003|Period 2: 12 Weeks|Adverse Event|0|||
156314955|NCT04449029|564251879|FG000|Overall Study|Adverse Event|0|||
156314956|NCT04449029|564251880|FG001|Overall Study|Adverse Event|1|||
156314957|NCT04449029|564251881|FG002|Overall Study|Adverse Event|1|||
156314958|NCT04449029|564251882|FG003|Overall Study|Adverse Event|0|||
156314959|NCT04449029|564251883|FG004|Overall Study|Adverse Event|1|||
156652601|NCT03264066|565474497|FG003|Overall Study|Adverse Event|0|||
156652602|NCT03264066|565474498|FG004|Overall Study|Adverse Event|0|||
156652603|NCT03264066|565474499|FG005|Overall Study|Adverse Event|0|||
156652604|NCT03264066|565474494|FG000|Overall Study|Death|12|||
156652605|NCT03264066|565474495|FG001|Overall Study|Death|12|||
156652606|NCT03264066|565474496|FG002|Overall Study|Death|8|||
156652607|NCT03264066|565474497|FG003|Overall Study|Death|10|||
156314960|NCT04449029|564251884|FG005|Overall Study|Adverse Event|0|||
156314961|NCT04449029|564251885|FG006|Overall Study|Adverse Event|1|||
156314962|NCT04449029|564251886|FG007|Overall Study|Adverse Event|0|||
156314963|NCT04449029|564251879|FG000|Overall Study|Lost to Follow-up|0|||
156314964|NCT04449029|564251880|FG001|Overall Study|Lost to Follow-up|1|||
156652608|NCT03264066|565474498|FG004|Overall Study|Death|6|||
156415226|NCT02718417|564613338|FG001|Maintenance Phase (MP)|Progressive disease|88|||
156415227|NCT02718417|564613339|FG002|Maintenance Phase (MP)|Progressive disease|0|||
156415228|NCT02718417|564613337|FG000|Maintenance Phase (MP)|Other|2|||
156415229|NCT02718417|564613338|FG001|Maintenance Phase (MP)|Other|1|||
156415230|NCT02718417|564613339|FG002|Maintenance Phase (MP)|Other|0|||
156415231|NCT02718417|564613337|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
156415232|NCT02718417|564613338|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
156415233|NCT02718417|564613339|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
156415234|NCT02718417|564613337|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
156415235|NCT02718417|564613338|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
156415236|NCT02718417|564613339|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
156415237|NCT02718417|564613337|FG000|Observation Phase (OP)|Adverse Event|0|||
156415238|NCT02718417|564613338|FG001|Observation Phase (OP)|Adverse Event|0|||
156415239|NCT02718417|564613339|FG002|Observation Phase (OP)|Adverse Event|1|||
156415240|NCT02718417|564613337|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
156415241|NCT02718417|564613338|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
156415242|NCT02718417|564613339|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
156756620|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756621|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756622|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
156756623|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
156756624|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756625|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
156756626|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756627|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756628|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
156756629|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756630|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
156756631|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
156756632|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
156756633|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
156756634|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
156756635|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
156756636|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
156756637|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
156756638|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
156756639|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
156756640|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
156756641|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
156756642|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
156756643|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
156415243|NCT02718417|564613337|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
156415244|NCT02718417|564613338|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
156415245|NCT02718417|564613339|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
156415246|NCT02718417|564613337|FG000|Observation Phase (OP)|Physician Decision|0|||
156415247|NCT02718417|564613338|FG001|Observation Phase (OP)|Physician Decision|0|||
156415248|NCT02718417|564613339|FG002|Observation Phase (OP)|Physician Decision|9|||
156652609|NCT03264066|565474499|FG005|Overall Study|Death|1|||
156652610|NCT03264066|565474494|FG000|Overall Study|Lost to Follow-up|1|||
156652611|NCT03264066|565474495|FG001|Overall Study|Lost to Follow-up|0|||
156652612|NCT03264066|565474496|FG002|Overall Study|Lost to Follow-up|0|||
156652613|NCT03264066|565474497|FG003|Overall Study|Lost to Follow-up|0|||
156652614|NCT03264066|565474498|FG004|Overall Study|Lost to Follow-up|0|||
156652615|NCT03264066|565474499|FG005|Overall Study|Lost to Follow-up|0|||
156652616|NCT03264066|565474494|FG000|Overall Study|Progressive Disease|0|||
156652617|NCT03264066|565474495|FG001|Overall Study|Progressive Disease|2|||
156652618|NCT03264066|565474496|FG002|Overall Study|Progressive Disease|1|||
156652619|NCT03264066|565474497|FG003|Overall Study|Progressive Disease|0|||
156652620|NCT03264066|565474498|FG004|Overall Study|Progressive Disease|0|||
156652621|NCT03264066|565474499|FG005|Overall Study|Progressive Disease|0|||
156652622|NCT03264066|565474494|FG000|Overall Study|Study Terminated by Sponsor|5|||
156652623|NCT03264066|565474495|FG001|Overall Study|Study Terminated by Sponsor|5|||
156652624|NCT03264066|565474496|FG002|Overall Study|Study Terminated by Sponsor|8|||
156652625|NCT03264066|565474497|FG003|Overall Study|Study Terminated by Sponsor|5|||
156652626|NCT03264066|565474498|FG004|Overall Study|Study Terminated by Sponsor|1|||
156652627|NCT03264066|565474499|FG005|Overall Study|Study Terminated by Sponsor|2|||
156652628|NCT03264066|565474494|FG000|Overall Study|Withdrawal by Subject|1|||
156652629|NCT03264066|565474495|FG001|Overall Study|Withdrawal by Subject|0|||
156652630|NCT03264066|565474496|FG002|Overall Study|Withdrawal by Subject|0|||
156652631|NCT03264066|565474497|FG003|Overall Study|Withdrawal by Subject|5|||
156652632|NCT03264066|565474498|FG004|Overall Study|Withdrawal by Subject|0|||
156652633|NCT03264066|565474499|FG005|Overall Study|Withdrawal by Subject|0|||
156652634|NCT01484028|565474500|FG000|Period 1|Lost to Follow-up|0|||
156314965|NCT04449029|564251881|FG002|Overall Study|Lost to Follow-up|0|||
156314966|NCT04449029|564251882|FG003|Overall Study|Lost to Follow-up|0|||
156314967|NCT04449029|564251883|FG004|Overall Study|Lost to Follow-up|0|||
156314968|NCT04449029|564251884|FG005|Overall Study|Lost to Follow-up|0|||
156314969|NCT04449029|564251885|FG006|Overall Study|Lost to Follow-up|0|||
156314970|NCT04449029|564251886|FG007|Overall Study|Lost to Follow-up|0|||
156314971|NCT04449029|564251879|FG000|Overall Study|Protocol Violation|0|||
156314972|NCT04449029|564251880|FG001|Overall Study|Protocol Violation|1|||
156314973|NCT04449029|564251881|FG002|Overall Study|Protocol Violation|0|||
156314974|NCT04449029|564251882|FG003|Overall Study|Protocol Violation|0|||
156314975|NCT04449029|564251883|FG004|Overall Study|Protocol Violation|0|||
156314976|NCT04449029|564251884|FG005|Overall Study|Protocol Violation|0|||
156314977|NCT04449029|564251885|FG006|Overall Study|Protocol Violation|0|||
156314978|NCT04449029|564251886|FG007|Overall Study|Protocol Violation|0|||
156314979|NCT04449029|564251879|FG000|Overall Study|Physician Decision|0|||
156314980|NCT04449029|564251880|FG001|Overall Study|Physician Decision|0|||
156314981|NCT04449029|564251881|FG002|Overall Study|Physician Decision|0|||
156314982|NCT04449029|564251882|FG003|Overall Study|Physician Decision|0|||
156314983|NCT04449029|564251883|FG004|Overall Study|Physician Decision|0|||
156314984|NCT04449029|564251884|FG005|Overall Study|Physician Decision|1|||
156314985|NCT04449029|564251885|FG006|Overall Study|Physician Decision|0|||
156314986|NCT04449029|564251886|FG007|Overall Study|Physician Decision|0|||
156314987|NCT04449029|564251879|FG000|Overall Study|Withdrawal by Subject|3|||
156314988|NCT04449029|564251880|FG001|Overall Study|Withdrawal by Subject|0|||
156314989|NCT04449029|564251881|FG002|Overall Study|Withdrawal by Subject|1|||
156314990|NCT04449029|564251882|FG003|Overall Study|Withdrawal by Subject|1|||
156314991|NCT04449029|564251883|FG004|Overall Study|Withdrawal by Subject|5|||
156314992|NCT04449029|564251884|FG005|Overall Study|Withdrawal by Subject|1|||
156314993|NCT04449029|564251885|FG006|Overall Study|Withdrawal by Subject|4|||
156314994|NCT04449029|564251886|FG007|Overall Study|Withdrawal by Subject|0|||
156314995|NCT02486627|564251887|FG000|Overall Study|Death|1|||
156314996|NCT02486627|564251888|FG001|Overall Study|Death|0|||
156314997|NCT02486627|564251887|FG000|Overall Study|Other Unspecified|0|||
156314998|NCT02486627|564251888|FG001|Overall Study|Other Unspecified|2|||
156314999|NCT02486627|564251887|FG000|Overall Study|Consent Withdrawn by Participant|4|||
156315000|NCT02486627|564251888|FG001|Overall Study|Consent Withdrawn by Participant|3|||
156315001|NCT02486627|564251887|FG000|Overall Study|Significant Participant Noncompliance|1|||
156315002|NCT02486627|564251888|FG001|Overall Study|Significant Participant Noncompliance|1|||
156315003|NCT02486627|564251887|FG000|Overall Study|Lost to Follow-up|1|||
156315004|NCT02486627|564251888|FG001|Overall Study|Lost to Follow-up|3|||
156315005|NCT02112045|564251891|FG000|Overall Study|Withdrawal by Subject|1|||
156315006|NCT02112045|564251892|FG001|Overall Study|Withdrawal by Subject|0|||
156315007|NCT01073462|564251893|FG000|Overall Study|Death|14|||
156315008|NCT01073462|564251893|FG000|Overall Study|Kidney transplant|10|||
156315009|NCT01073462|564251893|FG000|Overall Study|Low parathyroid hormone levels|8|||
156315010|NCT01073462|564251893|FG000|Overall Study|Serious adverse event|2|||
156315011|NCT01073462|564251893|FG000|Overall Study|Lost to Follow-up|7|||
156315012|NCT00247611|564251898|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
156315013|NCT00247611|564251899|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
156315014|NCT00247611|564251898|FG000|Baselined|Completed baseline only|9|||
156315015|NCT00247611|564251899|FG001|Baselined|Completed baseline only|8|||
156315016|NCT05395091|564251900|FG000|Baseline to Month 12|Adverse Event|7|||
156315017|NCT05395091|564251901|FG001|Baseline to Month 12|Adverse Event|2|||
156315018|NCT05395091|564251902|FG002|Baseline to Month 12|Adverse Event|0|||
156315019|NCT05395091|564251900|FG000|Baseline to Month 12|Death|3|||
156315020|NCT05395091|564251901|FG001|Baseline to Month 12|Death|1|||
156315021|NCT05395091|564251902|FG002|Baseline to Month 12|Death|0|||
156315022|NCT05395091|564251900|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
156315023|NCT05395091|564251901|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
156315024|NCT05395091|564251902|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
156315025|NCT05395091|564251900|FG000|Baseline to Month 12|Protocol Violation|2|||
156315026|NCT05395091|564251901|FG001|Baseline to Month 12|Protocol Violation|3|||
156315027|NCT05395091|564251902|FG002|Baseline to Month 12|Protocol Violation|0|||
156415249|NCT02718417|564613337|FG000|Observation Phase (OP)|Progressive disease|0|||
156315028|NCT05395091|564251900|FG000|Baseline to Month 12|Physician Decision|1|||
156315029|NCT05395091|564251901|FG001|Baseline to Month 12|Physician Decision|0|||
156315030|NCT05395091|564251902|FG002|Baseline to Month 12|Physician Decision|0|||
156315031|NCT05395091|564251900|FG000|Month 12 to Month 18|Death|1|||
156315032|NCT05395091|564251901|FG001|Month 12 to Month 18|Death|0|||
156315033|NCT05395091|564251902|FG002|Month 12 to Month 18|Death|0|||
156315034|NCT05395091|564251900|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
156756644|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
156315035|NCT05395091|564251901|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
156315036|NCT05395091|564251902|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
156315037|NCT05395091|564251900|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
156315038|NCT05395091|564251901|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
156315039|NCT05395091|564251902|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
156415250|NCT02718417|564613338|FG001|Observation Phase (OP)|Progressive disease|0|||
156415251|NCT02718417|564613339|FG002|Observation Phase (OP)|Progressive disease|92|||
156415252|NCT02718417|564613337|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
156415253|NCT02718417|564613338|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
156415254|NCT02718417|564613339|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
156415255|NCT02718417|564613337|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
156415256|NCT02718417|564613338|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
156415257|NCT02718417|564613339|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
156415258|NCT02718417|564613337|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
156415259|NCT02718417|564613338|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
156415260|NCT02718417|564613339|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
156415261|NCT02718417|564613337|FG000|Observation Phase (OP)|Other|0|||
156415262|NCT02718417|564613338|FG001|Observation Phase (OP)|Other|0|||
156415263|NCT02718417|564613339|FG002|Observation Phase (OP)|Other|7|||
156415264|NCT02718417|564613337|FG000|Follow-up Phase|Adverse Event|3|||
156415265|NCT02718417|564613338|FG001|Follow-up Phase|Adverse Event|1|||
156415266|NCT02718417|564613339|FG002|Follow-up Phase|Adverse Event|1|||
156415267|NCT02718417|564613337|FG000|Follow-up Phase|Other|4|||
156415268|NCT02718417|564613338|FG001|Follow-up Phase|Other|6|||
156415269|NCT02718417|564613339|FG002|Follow-up Phase|Other|4|||
156415270|NCT02718417|564613337|FG000|Follow-up Phase|Withdrawal by Subject|19|||
156415271|NCT02718417|564613338|FG001|Follow-up Phase|Withdrawal by Subject|17|||
156415272|NCT02718417|564613339|FG002|Follow-up Phase|Withdrawal by Subject|5|||
156415273|NCT02718417|564613337|FG000|Follow-up Phase|Study terminated by sponsor|100|||
156415274|NCT02718417|564613338|FG001|Follow-up Phase|Study terminated by sponsor|138|||
156415275|NCT02718417|564613339|FG002|Follow-up Phase|Study terminated by sponsor|6|||
156415276|NCT02718417|564613337|FG000|Follow-up Phase|Lost to Follow-up|2|||
156415277|NCT02718417|564613338|FG001|Follow-up Phase|Lost to Follow-up|3|||
156415278|NCT02718417|564613339|FG002|Follow-up Phase|Lost to Follow-up|0|||
156415279|NCT02718417|564613337|FG000|Follow-up Phase|Death leading to discontinuation|7|||
156415280|NCT02718417|564613338|FG001|Follow-up Phase|Death leading to discontinuation|7|||
156415281|NCT02718417|564613339|FG002|Follow-up Phase|Death leading to discontinuation|3|||
156415282|NCT02718417|564613337|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
156415283|NCT02718417|564613338|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
156415284|NCT02718417|564613339|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
156415285|NCT02718417|564613337|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
156415286|NCT02718417|564613338|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
156415287|NCT02718417|564613339|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
156415288|NCT02718417|564613337|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
156415289|NCT02718417|564613338|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
156415290|NCT02718417|564613339|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
156415291|NCT02718417|564613337|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
156415292|NCT02718417|564613338|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
156415293|NCT02718417|564613339|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
156415294|NCT02718417|564613337|FG000|Long-term Follow-up Phase|Other|0|||
156415295|NCT02718417|564613338|FG001|Long-term Follow-up Phase|Other|2|||
156415296|NCT02718417|564613339|FG002|Long-term Follow-up Phase|Other|0|||
156415297|NCT00506285|564613340|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
156415298|NCT00506285|564613341|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
156415299|NCT00506285|564613340|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
156415300|NCT00506285|564613341|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
156415301|NCT00506285|564613340|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
156415302|NCT00506285|564613341|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
156415303|NCT00506285|564613340|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
156415304|NCT00506285|564613341|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
156415305|NCT00506285|564613340|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
156415306|NCT00506285|564613341|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
156415307|NCT00551213|564613344|FG000|Overall Study|Adverse Event|6|||
156415308|NCT00551213|564613345|FG001|Overall Study|Adverse Event|3|||
156415309|NCT00551213|564613344|FG000|Overall Study|Progressive Disease|41|||
156415310|NCT00551213|564613345|FG001|Overall Study|Progressive Disease|12|||
156415311|NCT00551213|564613344|FG000|Overall Study|Withdrawal by Subject|2|||
156415312|NCT00551213|564613345|FG001|Overall Study|Withdrawal by Subject|0|||
156415313|NCT00551213|564613344|FG000|Overall Study|Not Treated|1|||
156652635|NCT01484028|565474501|FG001|Period 1|Lost to Follow-up|1|||
156652636|NCT01484028|565474502|FG002|Period 1|Lost to Follow-up|0|||
156652637|NCT01484028|565474503|FG003|Period 1|Lost to Follow-up|0|||
156415314|NCT00551213|564613345|FG001|Overall Study|Not Treated|2|||
156415315|NCT01646320|564613350|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
156415316|NCT01646320|564613351|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
156415317|NCT01646320|564613350|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
156415318|NCT01646320|564613351|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
156415319|NCT01646320|564613350|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
156415320|NCT01646320|564613351|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
156415321|NCT01646320|564613350|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
156415322|NCT01646320|564613351|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
156415323|NCT01646320|564613350|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
156415324|NCT01646320|564613351|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
156415325|NCT01646320|564613350|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
156415326|NCT01646320|564613351|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
156415327|NCT01646320|564613350|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
156415328|NCT01646320|564613351|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
156415329|NCT01646320|564613350|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
156415330|NCT01646320|564613351|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
156415331|NCT01646320|564613350|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
156415332|NCT01646320|564613351|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
156415333|NCT01646320|564613350|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
156415334|NCT01646320|564613351|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
156415335|NCT01646320|564613350|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
156315040|NCT05395091|564251900|FG000|Month 12 to Month 18|Other reasons|0|||
156315041|NCT05395091|564251901|FG001|Month 12 to Month 18|Other reasons|0|||
156315042|NCT05395091|564251902|FG002|Month 12 to Month 18|Other reasons|1|||
156315043|NCT01509053|564251904|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
156315044|NCT01509053|564251904|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
156315045|NCT01509053|564251904|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
156315046|NCT01509053|564251904|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
156315047|NCT01509053|564251904|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
156315048|NCT01509053|564251904|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
156315049|NCT01915303|564251909|FG000|Core Phase|Adverse Event|7|||
156315050|NCT01915303|564251909|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
156315051|NCT01915303|564251909|FG000|Core Phase|Death|2|||
156315052|NCT01915303|564251909|FG000|Core Phase|Protocol Violation|2|||
156315053|NCT01915303|564251909|FG000|Core Phase|Abnormal lab value|1|||
156315054|NCT01915303|564251909|FG000|Core Phase|Withdrawal by Subject|1|||
156315055|NCT01915303|564251909|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
156315056|NCT01915303|564251909|FG000|Extension Phase|Withdrawal by Subject|4|||
156315057|NCT01915303|564251909|FG000|Extension Phase|Adverse Event|3|||
156315058|NCT01915303|564251909|FG000|Extension Phase|Death|1|||
156315059|NCT01915303|564251909|FG000|Extension Phase|Protocol Violation|1|||
156315060|NCT02509117|564251911|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156315061|NCT02509117|564251912|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
156315062|NCT02509117|564251913|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156315063|NCT02509117|564251914|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156315064|NCT02509117|564251915|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156415336|NCT01646320|564613351|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
156652638|NCT01484028|565474500|FG000|Period 1|Non-Compliance to Protocol|0|||
156652639|NCT01484028|565474501|FG001|Period 1|Non-Compliance to Protocol|1|||
156652640|NCT01484028|565474502|FG002|Period 1|Non-Compliance to Protocol|0|||
156652641|NCT01484028|565474503|FG003|Period 1|Non-Compliance to Protocol|1|||
156652642|NCT01484028|565474500|FG000|Period 1|Lens Discomfort|0|||
156652643|NCT01484028|565474501|FG001|Period 1|Lens Discomfort|1|||
156652644|NCT01484028|565474502|FG002|Period 1|Lens Discomfort|0|||
156652645|NCT01484028|565474503|FG003|Period 1|Lens Discomfort|0|||
156652646|NCT01073020|565476035|FG000|Overall Study|Withdrawal by Subject|6|||
156652647|NCT01073020|565476036|FG001|Overall Study|Withdrawal by Subject|4|||
156652648|NCT01073020|565476037|FG002|Overall Study|Withdrawal by Subject|1|||
156652649|NCT01073020|565476038|FG003|Overall Study|Withdrawal by Subject|2|||
156652650|NCT01073020|565476035|FG000|Overall Study|Physician Decision|1|||
156652651|NCT01073020|565476036|FG001|Overall Study|Physician Decision|0|||
156652652|NCT01073020|565476037|FG002|Overall Study|Physician Decision|2|||
156652653|NCT01073020|565476038|FG003|Overall Study|Physician Decision|0|||
156652654|NCT01073020|565476035|FG000|Overall Study|Death|0|||
156652655|NCT01073020|565476036|FG001|Overall Study|Death|1|||
156652656|NCT01073020|565476037|FG002|Overall Study|Death|0|||
156652657|NCT01073020|565476038|FG003|Overall Study|Death|0|||
156652658|NCT01829464|565476044|FG000|Overall Study|Adverse Event|1|||
156652659|NCT01829464|565476045|FG001|Overall Study|Adverse Event|0|||
156652660|NCT01829464|565476046|FG002|Overall Study|Adverse Event|0|||
156652661|NCT01829464|565476044|FG000|Overall Study|Lost to Follow-up|0|||
156652662|NCT01829464|565476045|FG001|Overall Study|Lost to Follow-up|0|||
156652663|NCT01829464|565476046|FG002|Overall Study|Lost to Follow-up|1|||
156652664|NCT01829464|565476044|FG000|Overall Study|Withdrawal by Subject|2|||
156652665|NCT01829464|565476045|FG001|Overall Study|Withdrawal by Subject|0|||
156652666|NCT01829464|565476046|FG002|Overall Study|Withdrawal by Subject|0|||
156415337|NCT01489020|564613352|FG000|Overall Study|Withdrawal by Subject|1|||
156415338|NCT01489020|564613353|FG001|Overall Study|Withdrawal by Subject|0|||
156415339|NCT01489020|564613354|FG002|Overall Study|Withdrawal by Subject|0|||
156415340|NCT01489020|564613355|FG003|Overall Study|Withdrawal by Subject|0|||
156415341|NCT01489020|564613356|FG004|Overall Study|Withdrawal by Subject|0|||
156415342|NCT01489020|564613357|FG005|Overall Study|Withdrawal by Subject|0|||
156415343|NCT01489020|564613352|FG000|Overall Study|Adverse Event|0|||
156415344|NCT01489020|564613353|FG001|Overall Study|Adverse Event|0|||
156415345|NCT01489020|564613354|FG002|Overall Study|Adverse Event|3|||
156415346|NCT01489020|564613355|FG003|Overall Study|Adverse Event|0|||
156415347|NCT01489020|564613356|FG004|Overall Study|Adverse Event|3|||
156415348|NCT01489020|564613357|FG005|Overall Study|Adverse Event|0|||
156415349|NCT01489020|564613352|FG000|Overall Study|Concomitant disease|0|||
156415350|NCT01489020|564613353|FG001|Overall Study|Concomitant disease|0|||
156415351|NCT01489020|564613354|FG002|Overall Study|Concomitant disease|0|||
156415352|NCT01489020|564613355|FG003|Overall Study|Concomitant disease|0|||
156415353|NCT01489020|564613356|FG004|Overall Study|Concomitant disease|3|||
156415354|NCT01489020|564613357|FG005|Overall Study|Concomitant disease|0|||
156415355|NCT02892409|564613358|FG000|Overall Study|Adverse Event|1|||
156415356|NCT02892409|564613359|FG001|Overall Study|Adverse Event|0|||
156415357|NCT02892409|564613358|FG000|Overall Study|Withdrawal by Subject|2|||
156415358|NCT02892409|564613359|FG001|Overall Study|Withdrawal by Subject|1|||
156415359|NCT02451930|564613361|FG000|Overall Study|Death|0|||
156415360|NCT02451930|564613362|FG001|Overall Study|Death|15|||
156415361|NCT02451930|564613361|FG000|Overall Study|Lost to Follow-up|0|||
156415362|NCT02451930|564613362|FG001|Overall Study|Lost to Follow-up|3|||
156415363|NCT02451930|564613361|FG000|Overall Study|Sponsor Decision|2|||
156415364|NCT02451930|564613362|FG001|Overall Study|Sponsor Decision|10|||
156415365|NCT02451930|564613361|FG000|Overall Study|Withdrawal by Subject|0|||
156415366|NCT02451930|564613362|FG001|Overall Study|Withdrawal by Subject|1|||
156415367|NCT02451930|564613361|FG000|Overall Study|Other|0|||
156415368|NCT02451930|564613362|FG001|Overall Study|Other|1|||
156415369|NCT02485353|564613365|FG000|Overall Study|Death|1|||
156415370|NCT02485353|564613365|FG000|Overall Study|Disease Progression|1|||
156415371|NCT01567163|564613371|FG000|Overall Study|Progressive Disease|2|||
156415372|NCT01567163|564613371|FG000|Overall Study|Lost to Follow-up|2|||
156415373|NCT03405662|564613372|FG000|Overall Study|COVID-19 restriction|1|||
156415374|NCT03405662|564613373|FG001|Overall Study|COVID-19 restriction|0|||
156415375|NCT03405662|564613372|FG000|Overall Study|unblinding|0|||
156415376|NCT03405662|564613373|FG001|Overall Study|unblinding|1|||
156415377|NCT03405662|564613372|FG000|Overall Study|placement in memory care facility|0|||
156415378|NCT03405662|564613373|FG001|Overall Study|placement in memory care facility|2|||
156415379|NCT00983619|564613374|FG000|Overall Study|Lost to Follow-up|0|||
156415380|NCT00983619|564613375|FG001|Overall Study|Lost to Follow-up|1|||
156415381|NCT00983619|564613376|FG002|Overall Study|Lost to Follow-up|0|||
156415382|NCT00983619|564613377|FG003|Overall Study|Lost to Follow-up|0|||
156415383|NCT00983619|564613378|FG004|Overall Study|Lost to Follow-up|0|||
156415384|NCT00983619|564613379|FG005|Overall Study|Lost to Follow-up|2|||
156415385|NCT00983619|564613380|FG006|Overall Study|Lost to Follow-up|0|||
156415386|NCT00983619|564613381|FG007|Overall Study|Lost to Follow-up|0|||
156415387|NCT00983619|564613382|FG008|Overall Study|Lost to Follow-up|0|||
156415388|NCT00983619|564613383|FG009|Overall Study|Lost to Follow-up|0|||
156415389|NCT00983619|564613384|FG010|Overall Study|Lost to Follow-up|0|||
156415390|NCT00983619|564613385|FG011|Overall Study|Lost to Follow-up|2|||
156415391|NCT00983619|564613374|FG000|Overall Study|Withdrawal by Subject|2|||
156415392|NCT00983619|564613375|FG001|Overall Study|Withdrawal by Subject|1|||
156415393|NCT00983619|564613376|FG002|Overall Study|Withdrawal by Subject|1|||
156415394|NCT00983619|564613377|FG003|Overall Study|Withdrawal by Subject|3|||
156652667|NCT01829464|565476044|FG000|Overall Study|Study terminated by sponsor|25|||
156652668|NCT01829464|565476045|FG001|Overall Study|Study terminated by sponsor|28|||
156652669|NCT01829464|565476046|FG002|Overall Study|Study terminated by sponsor|25|||
156652670|NCT01829464|565476044|FG000|Overall Study|Lack of Efficacy|0|||
156652671|NCT01829464|565476045|FG001|Overall Study|Lack of Efficacy|1|||
156415395|NCT00983619|564613378|FG004|Overall Study|Withdrawal by Subject|1|||
156415396|NCT00983619|564613379|FG005|Overall Study|Withdrawal by Subject|23|||
156415397|NCT00983619|564613380|FG006|Overall Study|Withdrawal by Subject|0|||
156415398|NCT00983619|564613381|FG007|Overall Study|Withdrawal by Subject|0|||
156415399|NCT00983619|564613382|FG008|Overall Study|Withdrawal by Subject|0|||
156415400|NCT00983619|564613383|FG009|Overall Study|Withdrawal by Subject|0|||
156415401|NCT00983619|564613384|FG010|Overall Study|Withdrawal by Subject|1|||
156415402|NCT00983619|564613385|FG011|Overall Study|Withdrawal by Subject|1|||
156415403|NCT00983619|564613374|FG000|Overall Study|Death|0|||
156652672|NCT01829464|565476046|FG002|Overall Study|Lack of Efficacy|0|||
156652673|NCT00635778|565476047|FG000|Overall Study|Adverse Event|1|||
156415404|NCT00983619|564613375|FG001|Overall Study|Death|2|||
156415405|NCT00983619|564613376|FG002|Overall Study|Death|2|||
156415406|NCT00983619|564613377|FG003|Overall Study|Death|1|||
156415407|NCT00983619|564613378|FG004|Overall Study|Death|2|||
156415408|NCT00983619|564613379|FG005|Overall Study|Death|30|||
156415409|NCT00983619|564613380|FG006|Overall Study|Death|1|||
156415410|NCT00983619|564613381|FG007|Overall Study|Death|0|||
156415411|NCT00983619|564613382|FG008|Overall Study|Death|1|||
156415412|NCT00983619|564613383|FG009|Overall Study|Death|2|||
156415413|NCT00983619|564613384|FG010|Overall Study|Death|9|||
156415414|NCT00983619|564613385|FG011|Overall Study|Death|8|||
156415415|NCT00983619|564613374|FG000|Overall Study|Other|1|||
156415416|NCT00983619|564613375|FG001|Overall Study|Other|0|||
156415417|NCT00983619|564613376|FG002|Overall Study|Other|0|||
156415418|NCT00983619|564613377|FG003|Overall Study|Other|1|||
156415419|NCT00983619|564613378|FG004|Overall Study|Other|0|||
156415420|NCT00983619|564613379|FG005|Overall Study|Other|12|||
156415421|NCT00983619|564613380|FG006|Overall Study|Other|2|||
156415422|NCT00983619|564613381|FG007|Overall Study|Other|2|||
156415423|NCT00983619|564613382|FG008|Overall Study|Other|0|||
156415424|NCT00983619|564613383|FG009|Overall Study|Other|1|||
156415425|NCT00983619|564613384|FG010|Overall Study|Other|1|||
156415426|NCT00983619|564613385|FG011|Overall Study|Other|0|||
156415427|NCT00724061|564613386|FG000|Dose Escalation Phase|Adverse Event|2|||
156415428|NCT00724061|564613386|FG000|Dose Escalation Phase|Disease Progression|3|||
156415429|NCT04827134|564613387|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
156415430|NCT04827134|564613388|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
156415431|NCT04827134|564613389|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
156415432|NCT04827134|564613390|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
156415433|NCT02443103|564613391|FG000|Overall Study|Adverse Event|2|||
156415434|NCT02443103|564613391|FG000|Overall Study|Noncompliance|1|||
156415435|NCT01231503|564613396|FG000|Overall Study|Adverse Event|0|||
156415436|NCT01231503|564613397|FG001|Overall Study|Adverse Event|0|||
156415437|NCT01231503|564613398|FG002|Overall Study|Adverse Event|0|||
156415438|NCT01231503|564613399|FG003|Overall Study|Adverse Event|0|||
156415439|NCT01231503|564613400|FG004|Overall Study|Adverse Event|0|||
156415440|NCT01231503|564613401|FG005|Overall Study|Adverse Event|1|||
156415441|NCT01231503|564613402|FG006|Overall Study|Adverse Event|0|||
156415442|NCT01231503|564613403|FG007|Overall Study|Adverse Event|0|||
156415443|NCT01231503|564613396|FG000|Overall Study|Adverse event, serious fatal|0|||
156415444|NCT01231503|564613397|FG001|Overall Study|Adverse event, serious fatal|0|||
156415445|NCT01231503|564613398|FG002|Overall Study|Adverse event, serious fatal|1|||
156415446|NCT01231503|564613399|FG003|Overall Study|Adverse event, serious fatal|1|||
156415447|NCT01231503|564613400|FG004|Overall Study|Adverse event, serious fatal|0|||
156415448|NCT01231503|564613401|FG005|Overall Study|Adverse event, serious fatal|1|||
156415449|NCT01231503|564613402|FG006|Overall Study|Adverse event, serious fatal|0|||
156415450|NCT01231503|564613403|FG007|Overall Study|Adverse event, serious fatal|0|||
156415451|NCT01231503|564613396|FG000|Overall Study|Withdrawal by Subject|6|||
156415452|NCT01231503|564613397|FG001|Overall Study|Withdrawal by Subject|3|||
156415453|NCT01231503|564613398|FG002|Overall Study|Withdrawal by Subject|3|||
156415454|NCT01231503|564613399|FG003|Overall Study|Withdrawal by Subject|1|||
156415455|NCT01231503|564613400|FG004|Overall Study|Withdrawal by Subject|3|||
156415456|NCT01231503|564613401|FG005|Overall Study|Withdrawal by Subject|5|||
156415457|NCT01231503|564613402|FG006|Overall Study|Withdrawal by Subject|1|||
156415458|NCT01231503|564613403|FG007|Overall Study|Withdrawal by Subject|2|||
156415459|NCT01231503|564613396|FG000|Overall Study|Lost to Follow-up|8|||
156415460|NCT01231503|564613397|FG001|Overall Study|Lost to Follow-up|10|||
156415461|NCT01231503|564613398|FG002|Overall Study|Lost to Follow-up|8|||
156415462|NCT01231503|564613399|FG003|Overall Study|Lost to Follow-up|5|||
156415463|NCT01231503|564613400|FG004|Overall Study|Lost to Follow-up|7|||
156415464|NCT01231503|564613401|FG005|Overall Study|Lost to Follow-up|9|||
156415465|NCT01231503|564613402|FG006|Overall Study|Lost to Follow-up|6|||
156415466|NCT01231503|564613403|FG007|Overall Study|Lost to Follow-up|6|||
156415467|NCT01231503|564613396|FG000|Overall Study|Protocol Violation|0|||
156415468|NCT01231503|564613397|FG001|Overall Study|Protocol Violation|0|||
156415469|NCT01231503|564613398|FG002|Overall Study|Protocol Violation|0|||
156415470|NCT01231503|564613399|FG003|Overall Study|Protocol Violation|1|||
156415471|NCT01231503|564613400|FG004|Overall Study|Protocol Violation|0|||
156415472|NCT01231503|564613401|FG005|Overall Study|Protocol Violation|0|||
156415473|NCT01231503|564613402|FG006|Overall Study|Protocol Violation|0|||
156415474|NCT01231503|564613403|FG007|Overall Study|Protocol Violation|0|||
156415475|NCT00287469|564613404|FG000|Overall Study|serious adverse event|1|||
156415476|NCT00287469|564613405|FG001|Overall Study|serious adverse event|6|||
156415477|NCT00287469|564613404|FG000|Overall Study|Adverse Event|1|||
156415478|NCT00287469|564613405|FG001|Overall Study|Adverse Event|1|||
156415479|NCT00287469|564613404|FG000|Overall Study|moved from area|144|||
156415480|NCT00287469|564613405|FG001|Overall Study|moved from area|138|||
156415481|NCT00287469|564613404|FG000|Overall Study|Lost to Follow-up|74|||
156415482|NCT00287469|564613405|FG001|Overall Study|Lost to Follow-up|69|||
156415483|NCT02207374|564613406|FG000|Overall Study|Withdrawal by Subject|5|||
156415484|NCT02207374|564613407|FG001|Overall Study|Withdrawal by Subject|9|||
156652674|NCT00635778|565476048|FG001|Overall Study|Adverse Event|0|||
156652675|NCT00635778|565476049|FG002|Overall Study|Adverse Event|0|||
156652676|NCT00635778|565476050|FG003|Overall Study|Adverse Event|3|||
156652677|NCT00635778|565476051|FG004|Overall Study|Adverse Event|3|||
156756645|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
156756646|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
156756647|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
156756648|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
156756649|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756650|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756651|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756652|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756653|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156415485|NCT02207374|564613408|FG002|Overall Study|Withdrawal by Subject|4|||
156415486|NCT02207374|564613406|FG000|Overall Study|Death|1|||
156415487|NCT02207374|564613407|FG001|Overall Study|Death|0|||
156415488|NCT02207374|564613408|FG002|Overall Study|Death|1|||
156415489|NCT02207374|564613406|FG000|Overall Study|Missing follow-up information|0|||
156415490|NCT02207374|564613407|FG001|Overall Study|Missing follow-up information|1|||
156415491|NCT02207374|564613408|FG002|Overall Study|Missing follow-up information|1|||
156415492|NCT00393094|564613410|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
156415493|NCT00393094|564613410|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
156415494|NCT03653416|564613413|FG000|Overall Study|Protocol Violation|6|||
156415495|NCT03653416|564613414|FG001|Overall Study|Protocol Violation|1|||
156415496|NCT00681187|564613415|FG000|Overall Study|Withdrawal by Subject|1|||
156415497|NCT00681187|564613416|FG001|Overall Study|Withdrawal by Subject|0|||
156415498|NCT00681187|564613415|FG000|Overall Study|Death|0|||
156756654|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156315065|NCT02509117|564251916|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156315066|NCT02509117|564251917|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156315067|NCT02509117|564251918|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156315068|NCT02509117|564251919|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156315069|NCT02509117|564251920|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156315070|NCT02509117|564251911|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315071|NCT02509117|564251912|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315072|NCT02509117|564251913|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315073|NCT02509117|564251914|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315074|NCT02509117|564251915|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315075|NCT02509117|564251916|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315076|NCT02509117|564251917|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315077|NCT02509117|564251918|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315078|NCT02509117|564251919|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156315079|NCT02509117|564251920|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
156315080|NCT02509117|564251911|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315081|NCT02509117|564251912|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315082|NCT02509117|564251913|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315083|NCT02509117|564251914|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315084|NCT02509117|564251915|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315085|NCT02509117|564251916|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315086|NCT02509117|564251917|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315087|NCT02509117|564251918|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315088|NCT02509117|564251919|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156315089|NCT02509117|564251920|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
156315090|NCT00832624|564251921|FG000|Overall Study|Study Terminated|10|||
156315091|NCT00548184|564251924|FG000|Overall Study|Adverse Event|3|||
156315092|NCT00548184|564251924|FG000|Overall Study|took other drug|1|||
156315093|NCT00548184|564251924|FG000|Overall Study|Found Her2 negative|1|||
156315094|NCT00280748|564251928|FG000|Overall Study|Decline in performance|3|||
156315095|NCT00280748|564251928|FG000|Overall Study|Extra-cranial disease progression|1|||
156315096|NCT01433250|564251929|FG000|Overall Study|Protocol Violation|0|||
156315097|NCT01433250|564251930|FG001|Overall Study|Protocol Violation|1|||
156315098|NCT01433250|564251929|FG000|Overall Study|Withdrawal by Subject|3|||
156315099|NCT01433250|564251930|FG001|Overall Study|Withdrawal by Subject|2|||
156315100|NCT03148691|564251931|FG000|Overall Study|Protocol Violation|1|||
156315101|NCT03148691|564251932|FG001|Overall Study|Protocol Violation|2|||
156315102|NCT03148691|564251933|FG002|Overall Study|Protocol Violation|7|||
156315103|NCT03148691|564251931|FG000|Overall Study|Lost to Follow-up|0|||
156315104|NCT03148691|564251932|FG001|Overall Study|Lost to Follow-up|0|||
156315105|NCT03148691|564251933|FG002|Overall Study|Lost to Follow-up|1|||
156415499|NCT00681187|564613416|FG001|Overall Study|Death|1|||
156415500|NCT00681187|564613415|FG000|Overall Study|Adverse Event|0|||
156415501|NCT00681187|564613416|FG001|Overall Study|Adverse Event|1|||
156415502|NCT02788006|564613420|FG000|Overall Study|Patient not treated|1|||
156415503|NCT01083160|564613423|FG000|Overall Study|Adverse Event|1|||
156415504|NCT00972179|564613424|FG000|Overall Study|Noncompliance|1|||
156415505|NCT00972179|564613425|FG001|Overall Study|Noncompliance|0|||
156415506|NCT00972179|564613426|FG002|Overall Study|Noncompliance|0|||
156415507|NCT00972179|564613427|FG003|Overall Study|Noncompliance|0|||
156415508|NCT00972179|564613428|FG004|Overall Study|Noncompliance|1|||
156415509|NCT00972179|564613429|FG005|Overall Study|Noncompliance|0|||
156415510|NCT00972179|564613430|FG006|Overall Study|Noncompliance|1|||
156415511|NCT00972179|564613424|FG000|Overall Study|Withdrawal by Subject|0|||
156415512|NCT00972179|564613425|FG001|Overall Study|Withdrawal by Subject|3|||
156415513|NCT00972179|564613426|FG002|Overall Study|Withdrawal by Subject|0|||
156415514|NCT00972179|564613427|FG003|Overall Study|Withdrawal by Subject|1|||
156415515|NCT00972179|564613428|FG004|Overall Study|Withdrawal by Subject|0|||
156415516|NCT00972179|564613429|FG005|Overall Study|Withdrawal by Subject|0|||
156415517|NCT00972179|564613430|FG006|Overall Study|Withdrawal by Subject|2|||
156415518|NCT00972179|564613424|FG000|Overall Study|Administrative Decision|0|||
156415519|NCT00972179|564613425|FG001|Overall Study|Administrative Decision|0|||
156415520|NCT00972179|564613426|FG002|Overall Study|Administrative Decision|0|||
156415521|NCT00972179|564613427|FG003|Overall Study|Administrative Decision|0|||
156415522|NCT00972179|564613428|FG004|Overall Study|Administrative Decision|1|||
156415523|NCT00972179|564613429|FG005|Overall Study|Administrative Decision|0|||
156415524|NCT00972179|564613430|FG006|Overall Study|Administrative Decision|0|||
156415525|NCT00972179|564613424|FG000|Overall Study|Lost to Follow-up|0|||
156415526|NCT00972179|564613425|FG001|Overall Study|Lost to Follow-up|0|||
156415527|NCT00972179|564613426|FG002|Overall Study|Lost to Follow-up|1|||
156415528|NCT00972179|564613427|FG003|Overall Study|Lost to Follow-up|0|||
156415529|NCT00972179|564613428|FG004|Overall Study|Lost to Follow-up|0|||
156415530|NCT00972179|564613429|FG005|Overall Study|Lost to Follow-up|3|||
156415531|NCT00972179|564613430|FG006|Overall Study|Lost to Follow-up|1|||
156415532|NCT03055832|564613431|FG000|Week 2|Withdrawal by Subject|1|||
156415533|NCT03055832|564613432|FG001|Week 2|Withdrawal by Subject|0|||
156415534|NCT03619174|564613433|FG000|Overall Study|Lost to Follow-up|3|||
156415535|NCT03619174|564613434|FG001|Overall Study|Lost to Follow-up|0|||
156415536|NCT03619174|564613433|FG000|Overall Study|Withdrawal by Subject|4|||
156415537|NCT03619174|564613434|FG001|Overall Study|Withdrawal by Subject|3|||
156415538|NCT03619174|564613433|FG000|Overall Study|Pregnancy|1|||
156415539|NCT03619174|564613434|FG001|Overall Study|Pregnancy|1|||
156415540|NCT03619174|564613433|FG000|Overall Study|Discomfort during treatment|1|||
156415541|NCT03619174|564613434|FG001|Overall Study|Discomfort during treatment|0|||
156415542|NCT01012973|564613437|FG000|Overall Study|Adverse Event|5|||
156415543|NCT01012973|564613438|FG001|Overall Study|Adverse Event|5|||
156415544|NCT01012973|564613437|FG000|Overall Study|Lack of Efficacy|0|||
156415545|NCT01012973|564613438|FG001|Overall Study|Lack of Efficacy|5|||
156415546|NCT01012973|564613437|FG000|Overall Study|Lost to Follow-up|1|||
156415547|NCT01012973|564613438|FG001|Overall Study|Lost to Follow-up|0|||
156415548|NCT01012973|564613437|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
156415549|NCT01012973|564613438|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
156415550|NCT01012973|564613437|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
156415551|NCT01012973|564613438|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
156415552|NCT01012973|564613437|FG000|Overall Study|Protocol Violation|5|||
156415553|NCT01012973|564613438|FG001|Overall Study|Protocol Violation|2|||
156415554|NCT01012973|564613437|FG000|Overall Study|Withdrawal by Subject|4|||
156415555|NCT01012973|564613438|FG001|Overall Study|Withdrawal by Subject|6|||
156415556|NCT00967018|564613439|FG000|Overall Study|Adverse Event|2|||
156415557|NCT00967018|564613439|FG000|Overall Study|Physician Decision|7|||
156652678|NCT00635778|565476052|FG005|Overall Study|Adverse Event|6|||
156652679|NCT00635778|565476053|FG006|Overall Study|Adverse Event|1|||
156652680|NCT00635778|565476047|FG000|Overall Study|Withdrawal by Subject|0|||
156652681|NCT00635778|565476048|FG001|Overall Study|Withdrawal by Subject|0|||
156652682|NCT00635778|565476049|FG002|Overall Study|Withdrawal by Subject|0|||
156415558|NCT00967018|564613439|FG000|Overall Study|Lost to Follow-up|2|||
156415559|NCT00967018|564613439|FG000|Overall Study|Withdrawal by Subject|1|||
156415560|NCT00967018|564613439|FG000|Overall Study|Miscellaneous Reasons|9|||
156415561|NCT00064025|564613447|FG000|Overall Study|Ineligible|4|||
156415562|NCT00064025|564613447|FG000|Overall Study|Inevaluable|3|||
156415563|NCT02468934|564613448|FG000|Overall Study|Withdrawal by Subject|4|||
156415564|NCT02468934|564613448|FG000|Overall Study|Screen Failure|3|||
156415565|NCT02924389|564613454|FG000|Overall Study|Lost to Follow-up|1|||
156652683|NCT00635778|565476050|FG003|Overall Study|Withdrawal by Subject|1|||
156652684|NCT00635778|565476051|FG004|Overall Study|Withdrawal by Subject|0|||
156652685|NCT00635778|565476052|FG005|Overall Study|Withdrawal by Subject|1|||
156415566|NCT02924389|564613455|FG001|Overall Study|Lost to Follow-up|0|||
156415567|NCT02924389|564613454|FG000|Overall Study|Physician Decision|2|||
156415568|NCT02924389|564613455|FG001|Overall Study|Physician Decision|0|||
156415569|NCT02924389|564613454|FG000|Overall Study|Withdrawal by Subject|3|||
156415570|NCT02924389|564613455|FG001|Overall Study|Withdrawal by Subject|0|||
156415571|NCT02924389|564613454|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
156415572|NCT02924389|564613455|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
156415573|NCT04129580|564614899|FG000|Overall Study|Lost to Follow-up|14|||
156415574|NCT04129580|564614900|FG001|Overall Study|Lost to Follow-up|25|||
156415575|NCT03699124|564614901|FG000|Overall Study|Adverse Event|6|||
156415576|NCT03699124|564614902|FG001|Overall Study|Adverse Event|5|||
156415577|NCT03699124|564614903|FG002|Overall Study|Adverse Event|2|||
156415578|NCT03699124|564614901|FG000|Overall Study|Death|0|||
156415579|NCT03699124|564614902|FG001|Overall Study|Death|2|||
156415580|NCT03699124|564614903|FG002|Overall Study|Death|0|||
156415581|NCT03699124|564614901|FG000|Overall Study|Lost to Follow-up|20|||
156415582|NCT03699124|564614902|FG001|Overall Study|Lost to Follow-up|16|||
156415583|NCT03699124|564614903|FG002|Overall Study|Lost to Follow-up|15|||
156415584|NCT03699124|564614901|FG000|Overall Study|Protocol Violation|1|||
156415585|NCT03699124|564614902|FG001|Overall Study|Protocol Violation|0|||
156415586|NCT03699124|564614903|FG002|Overall Study|Protocol Violation|0|||
156415587|NCT03699124|564614901|FG000|Overall Study|Withdrawal by Subject|13|||
156415588|NCT03699124|564614902|FG001|Overall Study|Withdrawal by Subject|14|||
156415589|NCT03699124|564614903|FG002|Overall Study|Withdrawal by Subject|13|||
156415590|NCT03699124|564614901|FG000|Overall Study|Other reasons|5|||
156415591|NCT03699124|564614902|FG001|Overall Study|Other reasons|3|||
156415592|NCT03699124|564614903|FG002|Overall Study|Other reasons|10|||
156415593|NCT03595683|564614904|FG000|Overall Study|Adverse Event|1|||
156415594|NCT03595683|564614905|FG001|Overall Study|Adverse Event|0|||
156415595|NCT03595683|564614904|FG000|Overall Study|Pursue alternative therapy|1|||
156415596|NCT03595683|564614905|FG001|Overall Study|Pursue alternative therapy|1|||
156415597|NCT03595683|564614904|FG000|Overall Study|Progressive disease|1|||
156415598|NCT03595683|564614905|FG001|Overall Study|Progressive disease|3|||
156415599|NCT01950273|564614909|FG000|Overall Study|Protocol Violation|1|||
156415600|NCT01950273|564614910|FG001|Overall Study|Protocol Violation|0|||
156415601|NCT01950273|564614909|FG000|Overall Study|Withdrawal by Subject|2|||
156415602|NCT01950273|564614910|FG001|Overall Study|Withdrawal by Subject|0|||
156415603|NCT01950273|564614909|FG000|Overall Study|Other not defined above|1|||
156415604|NCT01950273|564614910|FG001|Overall Study|Other not defined above|0|||
156415605|NCT01254565|564614911|FG000|Overall Study|Non-compliance to Study Procedures|0|||
156415606|NCT01254565|564614912|FG001|Overall Study|Non-compliance to Study Procedures|0|||
156415607|NCT01254565|564614913|FG002|Overall Study|Non-compliance to Study Procedures|0|||
156415608|NCT01254565|564614914|FG003|Overall Study|Non-compliance to Study Procedures|0|||
156415609|NCT01254565|564614915|FG004|Overall Study|Non-compliance to Study Procedures|1|||
156415610|NCT01254565|564614916|FG005|Overall Study|Non-compliance to Study Procedures|0|||
156415611|NCT01254565|564614911|FG000|Overall Study|Did not Receive Treatment|1|||
156415612|NCT01254565|564614912|FG001|Overall Study|Did not Receive Treatment|1|||
156415613|NCT01254565|564614913|FG002|Overall Study|Did not Receive Treatment|0|||
156415614|NCT01254565|564614914|FG003|Overall Study|Did not Receive Treatment|0|||
156415615|NCT01254565|564614915|FG004|Overall Study|Did not Receive Treatment|3|||
156415616|NCT01254565|564614916|FG005|Overall Study|Did not Receive Treatment|4|||
156415617|NCT01254565|564614911|FG000|Overall Study|Other|0|||
156415618|NCT01254565|564614912|FG001|Overall Study|Other|0|||
156415619|NCT01254565|564614913|FG002|Overall Study|Other|0|||
156415620|NCT01254565|564614914|FG003|Overall Study|Other|1|||
156415621|NCT01254565|564614915|FG004|Overall Study|Other|0|||
156315106|NCT03148691|564251931|FG000|Overall Study|Other|1|||
156315107|NCT03148691|564251932|FG001|Overall Study|Other|0|||
156315108|NCT03148691|564251933|FG002|Overall Study|Other|0|||
156315109|NCT03148691|564251931|FG000|Overall Study|Withdrawal by Subject|1|||
156315110|NCT03148691|564251932|FG001|Overall Study|Withdrawal by Subject|0|||
156315111|NCT03148691|564251933|FG002|Overall Study|Withdrawal by Subject|0|||
156315112|NCT00321646|564251940|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
156315113|NCT00321646|564251940|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
156315114|NCT00321646|564251940|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
156315115|NCT00392379|564251944|FG000|Overall Study|Withdrawal by Subject|17|||
156315116|NCT00392379|564251945|FG001|Overall Study|Withdrawal by Subject|28|||
156315117|NCT00392379|564251944|FG000|Overall Study|Lost to Follow-up|4|||
156315118|NCT00392379|564251945|FG001|Overall Study|Lost to Follow-up|9|||
156415622|NCT01254565|564614916|FG005|Overall Study|Other|0|||
156415623|NCT04006366|564614923|FG000|Overall Study|Withdrawal by Subject|1|||
156415624|NCT02086552|564614924|FG000|Overall Study|Withdrawal by Subject|1|||
156315119|NCT00392379|564251944|FG000|Overall Study|Adverse Event|1|||
156315120|NCT00392379|564251945|FG001|Overall Study|Adverse Event|1|||
156315121|NCT01700387|564251951|FG000|Overall Study|Withdrawal by Subject|1|||
156415625|NCT02206152|564614925|FG000|Pre-Randomization|Withdrawal by Subject|2|||
156415626|NCT00478608|564614926|FG000|Overall Study|Adverse Event|1|||
156415627|NCT00478608|564614926|FG000|Overall Study|Serious Adverse Event|14|||
156415628|NCT00478608|564614926|FG000|Overall Study|Withdrawal by Subject|2|||
156415629|NCT00478608|564614926|FG000|Overall Study|Protocol Violation|3|||
156415630|NCT02080520|564614927|FG000|Overall Study|Self-reported symptoms|5|||
156415631|NCT02080520|564614928|FG001|Overall Study|Self-reported symptoms|6|||
156415632|NCT02080520|564614927|FG000|Overall Study|Unable to contact|2|||
156415633|NCT02080520|564614928|FG001|Overall Study|Unable to contact|1|||
156415634|NCT02080520|564614927|FG000|Overall Study|Initiated aspirin|2|||
156415635|NCT02080520|564614928|FG001|Overall Study|Initiated aspirin|0|||
156415636|NCT02080520|564614927|FG000|Overall Study|Atrial fibrillation|1|||
156415637|NCT02080520|564614928|FG001|Overall Study|Atrial fibrillation|1|||
156415638|NCT02080520|564614927|FG000|Overall Study|Cancer|1|||
156415639|NCT02080520|564614928|FG001|Overall Study|Cancer|2|||
156415640|NCT02080520|564614927|FG000|Overall Study|Not interested in study|1|||
156415641|NCT02080520|564614928|FG001|Overall Study|Not interested in study|3|||
156415642|NCT02080520|564614927|FG000|Overall Study|Too busy|1|||
156415643|NCT02080520|564614928|FG001|Overall Study|Too busy|1|||
156415644|NCT02080520|564614927|FG000|Overall Study|Work-related injury|1|||
156415645|NCT02080520|564614928|FG001|Overall Study|Work-related injury|0|||
156415646|NCT02080520|564614927|FG000|Overall Study|Personal reasons|0|||
156415647|NCT02080520|564614928|FG001|Overall Study|Personal reasons|3|||
156415648|NCT00390455|564614929|FG000|Overall Study|Adverse Event|17|||
156415649|NCT00390455|564614930|FG001|Overall Study|Adverse Event|3|||
156415650|NCT00390455|564614929|FG000|Overall Study|Withdrawal by Subject|8|||
156415651|NCT00390455|564614930|FG001|Overall Study|Withdrawal by Subject|8|||
156415652|NCT00390455|564614929|FG000|Overall Study|Alternate Treatment|0|||
156415653|NCT00390455|564614930|FG001|Overall Study|Alternate Treatment|1|||
156415654|NCT00390455|564614929|FG000|Overall Study|Other Medical Reasons|7|||
156415655|NCT00390455|564614930|FG001|Overall Study|Other Medical Reasons|11|||
156415656|NCT02406261|564614933|FG000|Period 1|Lost to Follow-up|2|||
156415657|NCT02406261|564614934|FG001|Period 1|Lost to Follow-up|0|||
156415658|NCT02406261|564614933|FG000|Period 1|Adverse Event|1|||
156415659|NCT02406261|564614934|FG001|Period 1|Adverse Event|0|||
156415660|NCT02406261|564614933|FG000|Period 2|Physician Decision|0|||
156415661|NCT02406261|564614934|FG001|Period 2|Physician Decision|1|||
156415662|NCT02406261|564614933|FG000|Period 2|Protocol Violation|0|||
156415663|NCT02406261|564614934|FG001|Period 2|Protocol Violation|1|||
156415664|NCT02406261|564614933|FG000|Period 2|Withdrawal by Subject|0|||
156415665|NCT02406261|564614934|FG001|Period 2|Withdrawal by Subject|1|||
156415666|NCT01591460|564614940|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
156415667|NCT01591460|564614940|FG000|Overall Study|Futility Rule (Week 12)|7|||
156415668|NCT01591460|564614940|FG000|Overall Study|Futility Rule (Week 24)|3|||
156415669|NCT01591460|564614940|FG000|Overall Study|Rebound or Breakthrough|3|||
156415670|NCT01591460|564614940|FG000|Overall Study|Treatment Discontinued by Error|1|||
156415671|NCT01591460|564614940|FG000|Overall Study|Lost to Follow-up|1|||
156415672|NCT01591460|564614940|FG000|Overall Study|Noncompliance|1|||
156415673|NCT01591460|564614940|FG000|Overall Study|Participant Refusal|3|||
156415674|NCT01591460|564614940|FG000|Overall Study|Withdrawal by Subject|1|||
156415675|NCT01591460|564614940|FG000|Overall Study|Protocol Violation|1|||
156415676|NCT01348854|564614943|FG000|Overall Study|Lost to Follow-up|2|||
156415677|NCT01348854|564614944|FG001|Overall Study|Lost to Follow-up|1|||
156415678|NCT01348854|564614943|FG000|Overall Study|Withdrawal by Subject|1|||
156415679|NCT01348854|564614944|FG001|Overall Study|Withdrawal by Subject|0|||
156415680|NCT01720797|564614945|FG000|Overall Study|Withdrawal by Subject|3|||
156415681|NCT01720797|564614946|FG001|Overall Study|Withdrawal by Subject|0|||
156415682|NCT00688259|564614953|FG000|Overall Study|Lost to Follow-up|2|||
156415683|NCT00688259|564614954|FG001|Overall Study|Lost to Follow-up|4|||
156415684|NCT00688259|564614953|FG000|Overall Study|Physician Decision|1|||
156415685|NCT00688259|564614954|FG001|Overall Study|Physician Decision|0|||
156415686|NCT00688259|564614953|FG000|Overall Study|Withdrawal by Subject|2|||
156415687|NCT00688259|564614954|FG001|Overall Study|Withdrawal by Subject|0|||
156415688|NCT00688259|564614953|FG000|Overall Study|Declined Interview|2|||
156415689|NCT00688259|564614954|FG001|Overall Study|Declined Interview|3|||
156415690|NCT00688259|564614953|FG000|Overall Study|Hospitalized at Follow-up|0|||
156415691|NCT00688259|564614954|FG001|Overall Study|Hospitalized at Follow-up|1|||
156415692|NCT03207711|564614957|FG000|Overall Study|Withdrawal by Subject|1|||
156415693|NCT03207711|564614958|FG001|Overall Study|Withdrawal by Subject|2|||
156415694|NCT01951092|564614959|FG000|Overall Study|Lost to Follow-up|10|||
156415695|NCT01951092|564614959|FG000|Overall Study|Incarceration|1|||
156415696|NCT01951092|564614959|FG000|Overall Study|Transfer of Care|1|||
156415697|NCT00136916|564614960|FG000|Overall Study|Never received study treatment|3|||
156415698|NCT00136916|564614961|FG001|Overall Study|Never received study treatment|5|||
156415699|NCT00136916|564614960|FG000|Overall Study|Death|1|||
156415700|NCT00136916|564614961|FG001|Overall Study|Death|3|||
156415701|NCT00136916|564614960|FG000|Overall Study|Adverse Event|27|||
156415702|NCT00136916|564614961|FG001|Overall Study|Adverse Event|8|||
156415703|NCT00136916|564614960|FG000|Overall Study|Laboratory abnormality|0|||
156415704|NCT00136916|564614961|FG001|Overall Study|Laboratory abnormality|1|||
156415705|NCT00136916|564614960|FG000|Overall Study|Lack of Efficacy|13|||
156415706|NCT00136916|564614961|FG001|Overall Study|Lack of Efficacy|3|||
156652686|NCT00635778|565476053|FG006|Overall Study|Withdrawal by Subject|1|||
156415707|NCT00136916|564614960|FG000|Overall Study|Lost to Follow-up|12|||
156415708|NCT00136916|564614961|FG001|Overall Study|Lost to Follow-up|14|||
156415709|NCT00136916|564614960|FG000|Overall Study|Withdrawal by Subject|44|||
156415710|NCT00136916|564614961|FG001|Overall Study|Withdrawal by Subject|46|||
156415711|NCT00136916|564614960|FG000|Overall Study|Other|22|||
156756655|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
156315122|NCT01700387|564251952|FG001|Overall Study|Withdrawal by Subject|2|||
156315123|NCT01700387|564251951|FG000|Overall Study|Adverse Event|1|||
156315124|NCT01700387|564251952|FG001|Overall Study|Adverse Event|1|||
156315125|NCT01700387|564251951|FG000|Overall Study|Lost to Follow-up|2|||
156315126|NCT01700387|564251952|FG001|Overall Study|Lost to Follow-up|1|||
156315127|NCT00934843|564251955|FG000|Overall Study|Protocol Violation|0|||
156315128|NCT00934843|564251956|FG001|Overall Study|Protocol Violation|1|||
156315129|NCT00995566|564251964|FG000|Overall Study|Adverse Event|2|||
156315130|NCT00995566|564251964|FG000|Overall Study|Early study termination|52|||
156315131|NCT01375075|564251971|FG000|Overall Study|Adverse Event|0|||
156315132|NCT01375075|564251972|FG001|Overall Study|Adverse Event|0|||
156315133|NCT01375075|564251973|FG002|Overall Study|Adverse Event|3|||
156315134|NCT01375075|564251974|FG003|Overall Study|Adverse Event|1|||
156315135|NCT01375075|564251975|FG004|Overall Study|Adverse Event|0|||
156315136|NCT01375075|564251976|FG005|Overall Study|Adverse Event|1|||
156315137|NCT01375075|564251971|FG000|Overall Study|Entry Criterion Not Met|1|||
156315138|NCT01375075|564251972|FG001|Overall Study|Entry Criterion Not Met|0|||
156315139|NCT01375075|564251973|FG002|Overall Study|Entry Criterion Not Met|0|||
156315140|NCT01375075|564251974|FG003|Overall Study|Entry Criterion Not Met|0|||
156315141|NCT01375075|564251975|FG004|Overall Study|Entry Criterion Not Met|0|||
156315142|NCT01375075|564251976|FG005|Overall Study|Entry Criterion Not Met|1|||
156315143|NCT01375075|564251971|FG000|Overall Study|Withdrawal by Subject|0|||
156315144|NCT01375075|564251972|FG001|Overall Study|Withdrawal by Subject|1|||
156315145|NCT01375075|564251973|FG002|Overall Study|Withdrawal by Subject|0|||
156315146|NCT01375075|564251974|FG003|Overall Study|Withdrawal by Subject|0|||
156315147|NCT01375075|564251975|FG004|Overall Study|Withdrawal by Subject|0|||
156315148|NCT01375075|564251976|FG005|Overall Study|Withdrawal by Subject|1|||
156315149|NCT00384111|564251977|FG000|Overall Study|Disease Progression|3|||
156315150|NCT00384111|564251977|FG000|Overall Study|Adverse Event|1|||
156315151|NCT00384111|564251977|FG000|Overall Study|Investigator Decision|3|||
156315152|NCT00384111|564251977|FG000|Overall Study|Study Terminated by the Sponsor|19|||
156315153|NCT01576159|564251978|FG000|Overall Study|Withdrawal by Subject|0|||
156315154|NCT01576159|564251979|FG001|Overall Study|Withdrawal by Subject|1|||
156315155|NCT01576159|564251980|FG002|Overall Study|Withdrawal by Subject|0|||
156315156|NCT01576159|564251981|FG003|Overall Study|Withdrawal by Subject|0|||
156315157|NCT01576159|564251978|FG000|Overall Study|Physician Decision|0|||
156315158|NCT01576159|564251979|FG001|Overall Study|Physician Decision|0|||
156315159|NCT01576159|564251980|FG002|Overall Study|Physician Decision|1|||
156315160|NCT01576159|564251981|FG003|Overall Study|Physician Decision|0|||
156315161|NCT01576159|564251978|FG000|Overall Study|Lost to Follow-up|0|||
156315162|NCT01576159|564251979|FG001|Overall Study|Lost to Follow-up|0|||
156315163|NCT01576159|564251980|FG002|Overall Study|Lost to Follow-up|0|||
156315164|NCT01576159|564251981|FG003|Overall Study|Lost to Follow-up|1|||
156315165|NCT01576159|564251978|FG000|Overall Study|Protocol Violation|1|||
156315166|NCT01576159|564251979|FG001|Overall Study|Protocol Violation|0|||
156315167|NCT01576159|564251980|FG002|Overall Study|Protocol Violation|0|||
156315168|NCT01576159|564251981|FG003|Overall Study|Protocol Violation|0|||
156315169|NCT00311584|564251982|FG000|Overall Study|Death|1|||
156315170|NCT00311584|564251983|FG001|Overall Study|Death|0|||
156315171|NCT00311584|564251982|FG000|Overall Study|Lack of Efficacy|12|||
156315172|NCT00311584|564251983|FG001|Overall Study|Lack of Efficacy|15|||
156315173|NCT00311584|564251982|FG000|Overall Study|Physician Decision|4|||
156315174|NCT00311584|564251983|FG001|Overall Study|Physician Decision|5|||
156315175|NCT00311584|564251982|FG000|Overall Study|Withdrawal by Subject|1|||
156315176|NCT00311584|564251983|FG001|Overall Study|Withdrawal by Subject|1|||
156315177|NCT00311584|564251982|FG000|Overall Study|ineligible|2|||
156315178|NCT00311584|564251983|FG001|Overall Study|ineligible|2|||
156756656|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156315179|NCT01454778|564251984|FG000|Overall Study|Lost to Follow-up|2|||
156315180|NCT01454778|564251984|FG000|Overall Study|Death|1|||
156315181|NCT01227629|564251986|FG000|Overall Study|Adverse Event|2|||
156315182|NCT01227629|564251987|FG001|Overall Study|Adverse Event|2|||
156315183|NCT01227629|564251988|FG002|Overall Study|Adverse Event|1|||
156315184|NCT01227629|564251989|FG003|Overall Study|Adverse Event|6|||
156415712|NCT00136916|564614961|FG001|Overall Study|Other|24|||
156315185|NCT01227629|564251990|FG004|Overall Study|Adverse Event|1|||
156315186|NCT01227629|564251991|FG005|Overall Study|Adverse Event|1|||
156315187|NCT01227629|564251992|FG006|Overall Study|Adverse Event|6|||
156315188|NCT01227629|564251993|FG007|Overall Study|Adverse Event|6|||
156315189|NCT01227629|564251994|FG008|Overall Study|Adverse Event|4|||
156315190|NCT01227629|564251995|FG009|Overall Study|Adverse Event|0|||
156315191|NCT01227629|564251986|FG000|Overall Study|Protocol Violation|0|||
156315192|NCT01227629|564251987|FG001|Overall Study|Protocol Violation|0|||
156315193|NCT01227629|564251988|FG002|Overall Study|Protocol Violation|0|||
156315194|NCT01227629|564251989|FG003|Overall Study|Protocol Violation|1|||
156315195|NCT01227629|564251990|FG004|Overall Study|Protocol Violation|0|||
156315196|NCT01227629|564251991|FG005|Overall Study|Protocol Violation|0|||
156315197|NCT01227629|564251992|FG006|Overall Study|Protocol Violation|0|||
156315198|NCT01227629|564251993|FG007|Overall Study|Protocol Violation|0|||
156315199|NCT01227629|564251994|FG008|Overall Study|Protocol Violation|0|||
156315200|NCT01227629|564251995|FG009|Overall Study|Protocol Violation|0|||
156315201|NCT01227629|564251986|FG000|Overall Study|Lost to Follow-up|0|||
156315202|NCT01227629|564251987|FG001|Overall Study|Lost to Follow-up|0|||
156315203|NCT01227629|564251988|FG002|Overall Study|Lost to Follow-up|0|||
156315204|NCT01227629|564251989|FG003|Overall Study|Lost to Follow-up|0|||
156315205|NCT01227629|564251990|FG004|Overall Study|Lost to Follow-up|1|||
156315206|NCT01227629|564251991|FG005|Overall Study|Lost to Follow-up|0|||
156315207|NCT01227629|564251992|FG006|Overall Study|Lost to Follow-up|0|||
156315208|NCT01227629|564251993|FG007|Overall Study|Lost to Follow-up|0|||
156315209|NCT01227629|564251994|FG008|Overall Study|Lost to Follow-up|0|||
156315210|NCT01227629|564251995|FG009|Overall Study|Lost to Follow-up|0|||
156315211|NCT01227629|564251986|FG000|Overall Study|Withdrawal by Subject|0|||
156315212|NCT01227629|564251987|FG001|Overall Study|Withdrawal by Subject|0|||
156315213|NCT01227629|564251988|FG002|Overall Study|Withdrawal by Subject|0|||
156315214|NCT01227629|564251989|FG003|Overall Study|Withdrawal by Subject|0|||
156315215|NCT01227629|564251990|FG004|Overall Study|Withdrawal by Subject|0|||
156315216|NCT01227629|564251991|FG005|Overall Study|Withdrawal by Subject|0|||
156315217|NCT01227629|564251992|FG006|Overall Study|Withdrawal by Subject|2|||
156315218|NCT01227629|564251993|FG007|Overall Study|Withdrawal by Subject|0|||
156315219|NCT01227629|564251994|FG008|Overall Study|Withdrawal by Subject|0|||
156315220|NCT01227629|564251995|FG009|Overall Study|Withdrawal by Subject|1|||
156315221|NCT01227629|564251986|FG000|Overall Study|Other|0|||
156315222|NCT01227629|564251987|FG001|Overall Study|Other|0|||
156315223|NCT01227629|564251988|FG002|Overall Study|Other|0|||
156315224|NCT01227629|564251989|FG003|Overall Study|Other|1|||
156315225|NCT01227629|564251990|FG004|Overall Study|Other|0|||
156315226|NCT01227629|564251991|FG005|Overall Study|Other|0|||
156315227|NCT01227629|564251992|FG006|Overall Study|Other|0|||
156315228|NCT01227629|564251993|FG007|Overall Study|Other|0|||
156315229|NCT01227629|564251994|FG008|Overall Study|Other|2|||
156315230|NCT01227629|564251995|FG009|Overall Study|Other|1|||
156315231|NCT02055365|564254239|FG000|Overall Study|Prematurely Withdrawn|1|||
156315232|NCT01258998|564254242|FG000|Overall Study|Ineligible|1|||
156315233|NCT03224598|564254243|FG000|Overall Study|Lost to Follow-up|0|||
156315234|NCT03224598|564254244|FG001|Overall Study|Lost to Follow-up|2|||
156315235|NCT03224598|564254245|FG002|Overall Study|Lost to Follow-up|0|||
156315236|NCT03224598|564254243|FG000|Overall Study|Other|0|||
156315237|NCT03224598|564254244|FG001|Overall Study|Other|1|||
156315238|NCT03224598|564254245|FG002|Overall Study|Other|0|||
156315239|NCT01264081|564254255|FG000|Participants Screened|Screening failures|30|||
156315240|NCT01264081|564254255|FG000|Started Treatment|Withdrawal by Subject|1|||
156315241|NCT01264081|564254255|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
156315242|NCT02716896|564254256|FG000|Overall Study|Physician Decision|0|||
156315243|NCT02716896|564254257|FG001|Overall Study|Physician Decision|1|||
156315244|NCT02054481|564254263|FG000|Overall Study|Adverse Event|1|||
156315245|NCT02054481|564254264|FG001|Overall Study|Adverse Event|1|||
156315246|NCT02054481|564254265|FG002|Overall Study|Adverse Event|0|||
156315247|NCT02054481|564254266|FG003|Overall Study|Adverse Event|1|||
156315248|NCT02054481|564254263|FG000|Overall Study|Lost to Follow-up|1|||
156315249|NCT02054481|564254264|FG001|Overall Study|Lost to Follow-up|0|||
156315250|NCT02054481|564254265|FG002|Overall Study|Lost to Follow-up|0|||
156315251|NCT02054481|564254266|FG003|Overall Study|Lost to Follow-up|0|||
156315252|NCT02054481|564254263|FG000|Overall Study|Other reason|2|||
156315253|NCT02054481|564254264|FG001|Overall Study|Other reason|1|||
156315254|NCT02054481|564254265|FG002|Overall Study|Other reason|2|||
156315255|NCT02054481|564254266|FG003|Overall Study|Other reason|0|||
156315256|NCT02320903|564254267|FG000|Overall Study|Withdrawal by Subject|0|||
156315257|NCT02320903|564254268|FG001|Overall Study|Withdrawal by Subject|9|||
156315258|NCT02320903|564254269|FG002|Overall Study|Withdrawal by Subject|9|||
156315259|NCT02320903|564254267|FG000|Overall Study|Exited therapy; no longer eligible|8|||
156315260|NCT02320903|564254268|FG001|Overall Study|Exited therapy; no longer eligible|2|||
156315261|NCT02320903|564254269|FG002|Overall Study|Exited therapy; no longer eligible|2|||
156315262|NCT02320903|564254267|FG000|Overall Study|Lost to Follow-up|0|||
156315263|NCT02320903|564254268|FG001|Overall Study|Lost to Follow-up|5|||
156315264|NCT02320903|564254269|FG002|Overall Study|Lost to Follow-up|5|||
156315265|NCT01475071|564254291|FG000|Overall Study|Physician Decision|1|||
156315266|NCT01475071|564254291|FG000|Overall Study|Withdrawal by Subject|6|||
156315267|NCT01475071|564254291|FG000|Overall Study|Lost to Follow-up|1|||
156315268|NCT01689532|564254292|FG000|Overall Study|Adverse Event|9|||
156315269|NCT01689532|564254293|FG001|Overall Study|Adverse Event|5|||
156315270|NCT01689532|564254292|FG000|Overall Study|Lack of Efficacy|2|||
156315271|NCT01689532|564254293|FG001|Overall Study|Lack of Efficacy|2|||
156315272|NCT01689532|564254292|FG000|Overall Study|Withdrawal by Subject|1|||
156315273|NCT01689532|564254293|FG001|Overall Study|Withdrawal by Subject|2|||
156315274|NCT01689532|564254292|FG000|Overall Study|Physician Decision|2|||
156315275|NCT01689532|564254293|FG001|Overall Study|Physician Decision|0|||
156315276|NCT01363349|564254294|FG000|Overall Study|Adverse Event|6|||
156315277|NCT01363349|564254295|FG001|Overall Study|Adverse Event|7|||
156315278|NCT01363349|564254294|FG000|Overall Study|Lack of Efficacy|3|||
156315279|NCT01363349|564254295|FG001|Overall Study|Lack of Efficacy|10|||
156315280|NCT01363349|564254294|FG000|Overall Study|Non compliance/Protocol deviations|2|||
156315281|NCT01363349|564254295|FG001|Overall Study|Non compliance/Protocol deviations|2|||
156315282|NCT01363349|564254294|FG000|Overall Study|Withdrawal by Subject|14|||
156315283|NCT01363349|564254295|FG001|Overall Study|Withdrawal by Subject|6|||
156315284|NCT01363349|564254294|FG000|Overall Study|Lost to Follow-up|5|||
156315285|NCT01363349|564254295|FG001|Overall Study|Lost to Follow-up|6|||
156315286|NCT01363349|564254294|FG000|Overall Study|Not reported|36|||
156315287|NCT01363349|564254295|FG001|Overall Study|Not reported|37|||
156315288|NCT01363349|564254294|FG000|Overall Study|missing|1|||
156315289|NCT01363349|564254295|FG001|Overall Study|missing|2|||
156315290|NCT01958489|564254296|FG000|Period 2|Adverse Event|0|||
156315291|NCT01958489|564254297|FG001|Period 2|Adverse Event|1|||
156315292|NCT00917644|564254298|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
156315293|NCT00917644|564254299|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
156315294|NCT00917644|564254298|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
156315295|NCT00917644|564254299|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
156315296|NCT00917644|564254298|FG000|Period 2: Second Intervention|family emergency|1|||
156315297|NCT00917644|564254299|FG001|Period 2: Second Intervention|family emergency|0|||
156315298|NCT01101308|564254300|FG000|Period 1|Adverse Event|2|||
156315299|NCT01101308|564254301|FG001|Period 1|Adverse Event|1|||
156315300|NCT01101308|564254300|FG000|Period 1|Positive for cotinine|1|||
156315301|NCT01101308|564254301|FG001|Period 1|Positive for cotinine|0|||
156315302|NCT02282345|564254306|FG000|Overall Study|Progression|0|||
156315303|NCT02282345|564254307|FG001|Overall Study|Progression|1|||
156315304|NCT00711516|564254308|FG000|Overall Study|Adverse Event|1|||
156315305|NCT00711516|564254309|FG001|Overall Study|Adverse Event|1|||
156315306|NCT00711516|564254308|FG000|Overall Study|Withdrawal by Subject|0|||
156315307|NCT00711516|564254309|FG001|Overall Study|Withdrawal by Subject|1|||
156315308|NCT00711516|564254308|FG000|Overall Study|Protocol Violation|0|||
156315309|NCT00711516|564254309|FG001|Overall Study|Protocol Violation|1|||
156315310|NCT04575597|564254310|FG000|Overall Study|Death|0|||
156315311|NCT04575597|564254311|FG001|Overall Study|Death|0|||
156315312|NCT04575597|564254312|FG002|Overall Study|Death|0|||
156315313|NCT04575597|564254313|FG003|Overall Study|Death|1|||
156315314|NCT04575597|564254314|FG004|Overall Study|Death|3|||
156315315|NCT04575597|564254315|FG005|Overall Study|Death|14|||
156315316|NCT04575597|564254310|FG000|Overall Study|Lost to Follow-up|2|||
156315317|NCT04575597|564254311|FG001|Overall Study|Lost to Follow-up|1|||
156315318|NCT04575597|564254312|FG002|Overall Study|Lost to Follow-up|1|||
156315319|NCT04575597|564254313|FG003|Overall Study|Lost to Follow-up|2|||
156315320|NCT04575597|564254314|FG004|Overall Study|Lost to Follow-up|10|||
156315321|NCT04575597|564254315|FG005|Overall Study|Lost to Follow-up|8|||
156315322|NCT04575597|564254310|FG000|Overall Study|Withdrawal by Subject|2|||
156315323|NCT04575597|564254311|FG001|Overall Study|Withdrawal by Subject|2|||
156315324|NCT04575597|564254312|FG002|Overall Study|Withdrawal by Subject|4|||
156315325|NCT04575597|564254313|FG003|Overall Study|Withdrawal by Subject|2|||
156315326|NCT04575597|564254314|FG004|Overall Study|Withdrawal by Subject|25|||
156315327|NCT04575597|564254315|FG005|Overall Study|Withdrawal by Subject|28|||
156315328|NCT04575597|564254310|FG000|Overall Study|Not Recorded|0|||
156315329|NCT04575597|564254311|FG001|Overall Study|Not Recorded|0|||
156315330|NCT04575597|564254312|FG002|Overall Study|Not Recorded|0|||
156315331|NCT04575597|564254313|FG003|Overall Study|Not Recorded|0|||
156315332|NCT04575597|564254314|FG004|Overall Study|Not Recorded|0|||
156315333|NCT04575597|564254315|FG005|Overall Study|Not Recorded|2|||
156315334|NCT04575597|564254310|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156315335|NCT04575597|564254311|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156315336|NCT04575597|564254312|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156315337|NCT04575597|564254313|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156315338|NCT04575597|564254314|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
156315339|NCT04575597|564254315|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
156756657|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156315340|NCT02095132|564254318|FG000|Overall Study|Adverse Event|0|||
156315341|NCT02095132|564254319|FG001|Overall Study|Adverse Event|0|||
156315342|NCT02095132|564254320|FG002|Overall Study|Adverse Event|0|||
156315343|NCT02095132|564254321|FG003|Overall Study|Adverse Event|0|||
156315344|NCT02095132|564254322|FG004|Overall Study|Adverse Event|1|||
156315345|NCT02095132|564254323|FG005|Overall Study|Adverse Event|0|||
156315346|NCT02095132|564254324|FG006|Overall Study|Adverse Event|1|||
156315347|NCT02095132|564254325|FG007|Overall Study|Adverse Event|0|||
156315348|NCT02095132|564254326|FG008|Overall Study|Adverse Event|0|||
156315349|NCT02095132|564254318|FG000|Overall Study|Death|0|||
156315350|NCT02095132|564254319|FG001|Overall Study|Death|0|||
156315351|NCT02095132|564254320|FG002|Overall Study|Death|0|||
156315352|NCT02095132|564254321|FG003|Overall Study|Death|0|||
156415713|NCT00136916|564614960|FG000|Overall Study|Discontinued in follow up period|3|||
156415714|NCT00136916|564614961|FG001|Overall Study|Discontinued in follow up period|0|||
156415715|NCT01991197|564614962|FG000|Overall Study|Lost to Follow-up|1|||
156415716|NCT01991197|564614963|FG001|Overall Study|Lost to Follow-up|1|||
156415717|NCT01991197|564614962|FG000|Overall Study|Physician Decision|0|||
156415718|NCT01991197|564614963|FG001|Overall Study|Physician Decision|2|||
156415719|NCT01991197|564614962|FG000|Overall Study|Withdrawal by Subject|2|||
156415720|NCT01991197|564614963|FG001|Overall Study|Withdrawal by Subject|0|||
156415721|NCT01010217|564614964|FG000|Overall Study|Lost to Follow-up|4|||
156415722|NCT01010217|564614965|FG001|Overall Study|Lost to Follow-up|5|||
156415723|NCT01010217|564614966|FG002|Overall Study|Lost to Follow-up|1|||
156415724|NCT01010217|564614967|FG003|Overall Study|Lost to Follow-up|0|||
156415725|NCT01010217|564614968|FG004|Overall Study|Lost to Follow-up|0|||
156415726|NCT01010217|564614964|FG000|Overall Study|Withdrawal by Subject|1|||
156415727|NCT01010217|564614965|FG001|Overall Study|Withdrawal by Subject|0|||
156415728|NCT01010217|564614966|FG002|Overall Study|Withdrawal by Subject|0|||
156415729|NCT01010217|564614967|FG003|Overall Study|Withdrawal by Subject|0|||
156415730|NCT01010217|564614968|FG004|Overall Study|Withdrawal by Subject|0|||
156415731|NCT01010217|564614964|FG000|Overall Study|Physician Decision|0|||
156415732|NCT01010217|564614965|FG001|Overall Study|Physician Decision|0|||
156415733|NCT01010217|564614966|FG002|Overall Study|Physician Decision|0|||
156415734|NCT01010217|564614967|FG003|Overall Study|Physician Decision|6|||
156415735|NCT01010217|564614968|FG004|Overall Study|Physician Decision|3|||
156415736|NCT03246672|564614972|FG000|Overall Study|Lost to Follow-up|2|||
156415737|NCT03260504|564614973|FG000|Overall Study|Adverse Event|0|||
156415738|NCT03260504|564614974|FG001|Overall Study|Adverse Event|1|||
156415739|NCT01932996|564614975|FG000|Overall Study|Protocol Violation|2|||
156415740|NCT01932996|564614976|FG001|Overall Study|Protocol Violation|0|||
156415741|NCT00846742|564614979|FG000|Overall Study|Withdrawal by Subject|1|||
156415742|NCT05868954|564614985|FG000|Overall Study|Lost to Follow-up|0|||
156415743|NCT05868954|564614986|FG001|Overall Study|Lost to Follow-up|1|||
156415744|NCT05868954|564614985|FG000|Overall Study|Withdrawal by Subject|2|||
156415745|NCT05868954|564614986|FG001|Overall Study|Withdrawal by Subject|2|||
156415746|NCT05868954|564614985|FG000|Overall Study|Participant delivered|1|||
156415747|NCT05868954|564614986|FG001|Overall Study|Participant delivered|1|||
156415748|NCT05868954|564614985|FG000|Overall Study|Miscarriage|0|||
156415749|NCT05868954|564614986|FG001|Overall Study|Miscarriage|1|||
156415750|NCT01435798|564614989|FG000|Overall Study|Withdrawal by Subject|1|||
156415751|NCT03257995|564614993|FG000|Overall Study|Adverse Event|0|||
156415752|NCT03257995|564614994|FG001|Overall Study|Adverse Event|1|||
156415753|NCT03257995|564614995|FG002|Overall Study|Adverse Event|0|||
156415754|NCT03257995|564614996|FG003|Overall Study|Adverse Event|0|||
156415755|NCT03257995|564614997|FG004|Overall Study|Adverse Event|0|||
156415756|NCT03257995|564614998|FG005|Overall Study|Adverse Event|0|||
156415757|NCT03257995|564614993|FG000|Overall Study|Protocol deviation|0|||
156415758|NCT03257995|564614994|FG001|Overall Study|Protocol deviation|0|||
156415759|NCT03257995|564614995|FG002|Overall Study|Protocol deviation|0|||
156415760|NCT03257995|564614996|FG003|Overall Study|Protocol deviation|0|||
156415761|NCT03257995|564614997|FG004|Overall Study|Protocol deviation|0|||
156415762|NCT03257995|564614998|FG005|Overall Study|Protocol deviation|2|||
156415763|NCT02275533|564614999|FG000|Overall Study|Protocol Violation|2|||
156415764|NCT02275533|564615000|FG001|Overall Study|Protocol Violation|0|||
156415765|NCT02275533|564614999|FG000|Overall Study|Never received study treatment|1|||
156415766|NCT02275533|564615000|FG001|Overall Study|Never received study treatment|0|||
156415767|NCT01570868|564615001|FG000|Overall Study|Adverse Event|8|||
156415768|NCT01570868|564615002|FG001|Overall Study|Adverse Event|1|||
156415769|NCT01570868|564615001|FG000|Overall Study|FDA Recommendation|23|||
156415770|NCT01570868|564615002|FG001|Overall Study|FDA Recommendation|3|||
156415771|NCT01570868|564615001|FG000|Overall Study|Physician Decision|10|||
156415772|NCT01570868|564615002|FG001|Overall Study|Physician Decision|4|||
156415773|NCT01570868|564615001|FG000|Overall Study|Lost to Follow-up|1|||
156415774|NCT01570868|564615002|FG001|Overall Study|Lost to Follow-up|0|||
156415775|NCT01570868|564615001|FG000|Overall Study|Withdrawal by Subject|1|||
156415776|NCT01570868|564615002|FG001|Overall Study|Withdrawal by Subject|0|||
156415777|NCT04936308|564615003|FG000|Overall Study|Death|0|||
156415778|NCT04936308|564615004|FG001|Overall Study|Death|0|||
156415779|NCT04936308|564615005|FG002|Overall Study|Death|1|||
156415780|NCT04936308|564615003|FG000|Overall Study|Withdrawal by Subject|6|||
156415781|NCT04936308|564615004|FG001|Overall Study|Withdrawal by Subject|3|||
156415782|NCT04936308|564615005|FG002|Overall Study|Withdrawal by Subject|0|||
156415783|NCT04936308|564615003|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
156415784|NCT04936308|564615004|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
156415785|NCT04936308|564615005|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
156415786|NCT04936308|564615003|FG000|Overall Study|Completed protocol-required follow-up|1|||
156415787|NCT04936308|564615004|FG001|Overall Study|Completed protocol-required follow-up|2|||
156415788|NCT04936308|564615005|FG002|Overall Study|Completed protocol-required follow-up|2|||
156415789|NCT04936308|564615003|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
156415790|NCT04936308|564615004|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
156315353|NCT02095132|564254322|FG004|Overall Study|Death|0|||
156315354|NCT02095132|564254323|FG005|Overall Study|Death|0|||
156315355|NCT02095132|564254324|FG006|Overall Study|Death|1|||
156315356|NCT02095132|564254325|FG007|Overall Study|Death|0|||
156315357|NCT02095132|564254326|FG008|Overall Study|Death|0|||
156315358|NCT02095132|564254318|FG000|Overall Study|Lack of Efficacy|3|||
156315359|NCT02095132|564254319|FG001|Overall Study|Lack of Efficacy|5|||
156315360|NCT02095132|564254320|FG002|Overall Study|Lack of Efficacy|2|||
156315361|NCT02095132|564254321|FG003|Overall Study|Lack of Efficacy|8|||
156315362|NCT02095132|564254322|FG004|Overall Study|Lack of Efficacy|3|||
156315363|NCT02095132|564254323|FG005|Overall Study|Lack of Efficacy|6|||
156315364|NCT02095132|564254324|FG006|Overall Study|Lack of Efficacy|10|||
156315365|NCT02095132|564254325|FG007|Overall Study|Lack of Efficacy|9|||
156315366|NCT02095132|564254326|FG008|Overall Study|Lack of Efficacy|8|||
156315367|NCT02095132|564254318|FG000|Overall Study|Physician Decision|1|||
156315368|NCT02095132|564254319|FG001|Overall Study|Physician Decision|0|||
156315369|NCT02095132|564254320|FG002|Overall Study|Physician Decision|0|||
156315370|NCT02095132|564254321|FG003|Overall Study|Physician Decision|0|||
156315371|NCT02095132|564254322|FG004|Overall Study|Physician Decision|0|||
156315372|NCT02095132|564254323|FG005|Overall Study|Physician Decision|0|||
156315373|NCT02095132|564254324|FG006|Overall Study|Physician Decision|1|||
156315374|NCT02095132|564254325|FG007|Overall Study|Physician Decision|0|||
156315375|NCT02095132|564254326|FG008|Overall Study|Physician Decision|2|||
156315376|NCT02095132|564254318|FG000|Overall Study|Withdrawal by Subject|0|||
156315377|NCT02095132|564254319|FG001|Overall Study|Withdrawal by Subject|0|||
156315378|NCT02095132|564254320|FG002|Overall Study|Withdrawal by Subject|2|||
156315379|NCT02095132|564254321|FG003|Overall Study|Withdrawal by Subject|2|||
156315380|NCT02095132|564254322|FG004|Overall Study|Withdrawal by Subject|3|||
156315381|NCT02095132|564254323|FG005|Overall Study|Withdrawal by Subject|0|||
156315382|NCT02095132|564254324|FG006|Overall Study|Withdrawal by Subject|5|||
156315383|NCT02095132|564254325|FG007|Overall Study|Withdrawal by Subject|0|||
156315384|NCT02095132|564254326|FG008|Overall Study|Withdrawal by Subject|0|||
156315385|NCT01029405|564254327|FG000|Overall Study|Withdrawal by Subject|0|||
156315386|NCT01029405|564254328|FG001|Overall Study|Withdrawal by Subject|1|||
156315387|NCT01029405|564254329|FG002|Overall Study|Withdrawal by Subject|2|||
156315388|NCT01029405|564254330|FG003|Overall Study|Withdrawal by Subject|0|||
156315389|NCT01029405|564254327|FG000|Overall Study|Protocol Violation|0|||
156315390|NCT01029405|564254328|FG001|Overall Study|Protocol Violation|0|||
156315391|NCT01029405|564254329|FG002|Overall Study|Protocol Violation|0|||
156315392|NCT01029405|564254330|FG003|Overall Study|Protocol Violation|1|||
156315393|NCT01029405|564254327|FG000|Overall Study|Adverse Event|0|||
156652687|NCT00635778|565476047|FG000|Overall Study|Progressive disease|0|||
156315394|NCT01029405|564254328|FG001|Overall Study|Adverse Event|0|||
156315395|NCT01029405|564254329|FG002|Overall Study|Adverse Event|1|||
156315396|NCT01029405|564254330|FG003|Overall Study|Adverse Event|1|||
156315397|NCT01029405|564254327|FG000|Overall Study|Lost to Follow-up|2|||
156315398|NCT01029405|564254328|FG001|Overall Study|Lost to Follow-up|1|||
156315399|NCT01029405|564254329|FG002|Overall Study|Lost to Follow-up|1|||
156315400|NCT01029405|564254330|FG003|Overall Study|Lost to Follow-up|2|||
156315401|NCT01029405|564254327|FG000|Overall Study|Other|0|||
156315402|NCT01029405|564254328|FG001|Overall Study|Other|1|||
156652688|NCT00635778|565476048|FG001|Overall Study|Progressive disease|3|||
156652689|NCT00635778|565476049|FG002|Overall Study|Progressive disease|3|||
156652690|NCT00635778|565476050|FG003|Overall Study|Progressive disease|4|||
156652691|NCT00635778|565476051|FG004|Overall Study|Progressive disease|5|||
156652692|NCT00635778|565476052|FG005|Overall Study|Progressive disease|14|||
156652693|NCT00635778|565476053|FG006|Overall Study|Progressive disease|4|||
156652694|NCT01884025|565476054|FG000|Overall Study|Lost to Follow-up|3|||
156652695|NCT01884025|565476055|FG001|Overall Study|Lost to Follow-up|4|||
156652696|NCT02623829|565476060|FG000|Overall Study|Lost to Follow-up|1|||
156652697|NCT02623829|565476061|FG001|Overall Study|Lost to Follow-up|1|||
156652698|NCT00662025|565476062|FG000|Overall Study|Objective progression or relapse|51|||
156652699|NCT00662025|565476062|FG000|Overall Study|Adverse Event|7|||
156652700|NCT00662025|565476062|FG000|Overall Study|Withdrawal by Subject|1|||
156652701|NCT00662025|565476062|FG000|Overall Study|Results of other clinical study|2|||
156652702|NCT00662025|565476062|FG000|Overall Study|Target lesion cannot be evaluated|1|||
156652703|NCT00662025|565476062|FG000|Overall Study|Domestic circumstances|1|||
156652704|NCT00622908|565476072|FG000|Overall Study|Protocol Violation|1|||
156652705|NCT00622908|565476073|FG001|Overall Study|Protocol Violation|0|||
156652706|NCT00622908|565476072|FG000|Overall Study|Adverse Event|0|||
156652707|NCT00622908|565476073|FG001|Overall Study|Adverse Event|1|||
156652708|NCT00622908|565476072|FG000|Overall Study|Lack of Efficacy|1|||
156652709|NCT00622908|565476073|FG001|Overall Study|Lack of Efficacy|7|||
156652710|NCT00622908|565476072|FG000|Overall Study|Lost to Follow-up|1|||
156652711|NCT00622908|565476073|FG001|Overall Study|Lost to Follow-up|0|||
156652712|NCT00622908|565476072|FG000|Overall Study|Refusal|0|||
156652713|NCT00622908|565476073|FG001|Overall Study|Refusal|1|||
156652714|NCT00622908|565476072|FG000|Overall Study|Termination by study sponser|0|||
156415791|NCT04936308|564615005|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
156415792|NCT04936308|564615003|FG000|Overall Study|Other|3|||
156415793|NCT04936308|564615004|FG001|Overall Study|Other|0|||
156415794|NCT04936308|564615005|FG002|Overall Study|Other|2|||
156415795|NCT01556763|564615006|FG000|Overall Study|Withdrawal by Subject|0|||
156415796|NCT01556763|564615007|FG001|Overall Study|Withdrawal by Subject|1|||
156415797|NCT01556763|564615008|FG002|Overall Study|Withdrawal by Subject|0|||
156415798|NCT02258464|564615009|FG000|Overall Study|Progressive disease (PD)|9|||
156415799|NCT02258464|564615010|FG001|Overall Study|Progressive disease (PD)|17|||
156415800|NCT02258464|564615009|FG000|Overall Study|Study drug never administered|1|||
156415801|NCT02258464|564615010|FG001|Overall Study|Study drug never administered|1|||
156415802|NCT02258464|564615009|FG000|Overall Study|AE not related to clinical PD|1|||
156415803|NCT02258464|564615010|FG001|Overall Study|AE not related to clinical PD|3|||
156415804|NCT02258464|564615009|FG000|Overall Study|Withdrawal by Subject|5|||
156415805|NCT02258464|564615010|FG001|Overall Study|Withdrawal by Subject|4|||
156415806|NCT02258464|564615009|FG000|Overall Study|AE related to clinical PD|1|||
156415807|NCT02258464|564615010|FG001|Overall Study|AE related to clinical PD|0|||
156415808|NCT00776100|564615011|FG000|Overall Study|Disease Progression|1|||
156415809|NCT00776100|564615012|FG001|Overall Study|Disease Progression|0|||
156415810|NCT00903786|564615013|FG000|Overall Study|Physician Decision|6|||
156415811|NCT00903786|564615013|FG000|Overall Study|Lack of Efficacy|5|||
156415812|NCT00903786|564615013|FG000|Overall Study|Reason other than lack of efficacy|4|||
156415813|NCT02285595|564615014|FG000|Overall Study|Lost to Follow-up|14|||
156415814|NCT02285595|564615014|FG000|Overall Study|Withdrawal by Subject|1|||
156415815|NCT01960790|564615015|FG000|Overall Study|Survey forms could not be recovered|3|||
156415816|NCT01960790|564615015|FG000|Overall Study|Treat with Humira outside survey period|3|||
156415817|NCT01960790|564615015|FG000|Overall Study|Transferred to another hospital|4|||
156415818|NCT01960790|564615015|FG000|Overall Study|Unevaluable for safety|1|||
156415819|NCT05822921|564615016|FG000|Overall Study|Lost to Follow-up|1|||
156415820|NCT05822921|564615017|FG001|Overall Study|Lost to Follow-up|1|||
156415821|NCT01267253|564615019|FG000|Overall Study|Ineligible - required test not done|1|||
156415822|NCT01267253|564615019|FG000|Overall Study|Inevaluable-never received study treatme|2|||
156415823|NCT00547911|564615027|FG000|Overall Study|Adverse Event|0|||
156415824|NCT00547911|564615028|FG001|Overall Study|Adverse Event|0|||
156415825|NCT00547911|564615029|FG002|Overall Study|Adverse Event|0|||
156415826|NCT00547911|564615030|FG003|Overall Study|Adverse Event|1|||
156415827|NCT00547911|564615031|FG004|Overall Study|Adverse Event|0|||
156415828|NCT00547911|564615032|FG005|Overall Study|Adverse Event|0|||
156415829|NCT02561455|564616767|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
156415830|NCT02561455|564616768|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
156415831|NCT02561455|564616769|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
156415832|NCT02561455|564616770|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
156415833|NCT02561455|564616767|FG000|Overall Study|Withdrawal by Subject|1|||
156415834|NCT02561455|564616768|FG001|Overall Study|Withdrawal by Subject|0|||
156415835|NCT02561455|564616769|FG002|Overall Study|Withdrawal by Subject|1|||
156415836|NCT02561455|564616770|FG003|Overall Study|Withdrawal by Subject|0|||
156415837|NCT02561455|564616767|FG000|Overall Study|Disease Progression|0|||
156415838|NCT02561455|564616768|FG001|Overall Study|Disease Progression|1|||
156415839|NCT02561455|564616769|FG002|Overall Study|Disease Progression|0|||
156415840|NCT02561455|564616770|FG003|Overall Study|Disease Progression|0|||
156415841|NCT00472186|564616774|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
156415842|NCT00472186|564616775|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
156415843|NCT03354637|564616776|FG000|Double-blind Period|Protocol Violation|2|||
156415844|NCT03354637|564616777|FG001|Double-blind Period|Protocol Violation|0|||
156415845|NCT03354637|564616778|FG002|Double-blind Period|Protocol Violation|0|||
156415846|NCT03354637|564616776|FG000|Double-blind Period|Adverse Event|1|||
156415847|NCT03354637|564616777|FG001|Double-blind Period|Adverse Event|2|||
156415848|NCT03354637|564616778|FG002|Double-blind Period|Adverse Event|0|||
156415849|NCT03354637|564616776|FG000|Double-blind Period|Lost to Follow-up|3|||
156415850|NCT03354637|564616777|FG001|Double-blind Period|Lost to Follow-up|4|||
156415851|NCT03354637|564616778|FG002|Double-blind Period|Lost to Follow-up|3|||
156415852|NCT03354637|564616776|FG000|Double-blind Period|Withdrawal by Subject|10|||
156415853|NCT03354637|564616777|FG001|Double-blind Period|Withdrawal by Subject|6|||
156415854|NCT03354637|564616778|FG002|Double-blind Period|Withdrawal by Subject|4|||
156415855|NCT03354637|564616776|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
156415856|NCT03354637|564616777|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
156415857|NCT03354637|564616778|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
156415858|NCT03354637|564616776|FG000|Open Label Extension|Adverse Event|0|||
156415859|NCT03354637|564616777|FG001|Open Label Extension|Adverse Event|0|||
156415860|NCT03354637|564616778|FG002|Open Label Extension|Adverse Event|1|||
156415861|NCT03354637|564616776|FG000|Open Label Extension|Lost to Follow-up|0|||
156415862|NCT03354637|564616777|FG001|Open Label Extension|Lost to Follow-up|0|||
156415863|NCT03354637|564616778|FG002|Open Label Extension|Lost to Follow-up|2|||
156415864|NCT03354637|564616776|FG000|Open Label Extension|Withdrawal by Subject|0|||
156415865|NCT03354637|564616777|FG001|Open Label Extension|Withdrawal by Subject|0|||
156415866|NCT03354637|564616778|FG002|Open Label Extension|Withdrawal by Subject|5|||
156415867|NCT03354637|564616776|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
156415868|NCT03354637|564616777|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
156415869|NCT03354637|564616778|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
156415870|NCT03354637|564616776|FG000|Open Label Extension|Subject Noncompliance|0|||
156415871|NCT03354637|564616777|FG001|Open Label Extension|Subject Noncompliance|0|||
156415872|NCT03354637|564616778|FG002|Open Label Extension|Subject Noncompliance|1|||
156415873|NCT03354637|564616776|FG000|Open Label Extension|Lack of Efficacy|0|||
156415874|NCT03354637|564616777|FG001|Open Label Extension|Lack of Efficacy|0|||
156415875|NCT03354637|564616778|FG002|Open Label Extension|Lack of Efficacy|1|||
156415876|NCT03354637|564616776|FG000|Open Label Extension|Physician Decision|0|||
156415877|NCT03354637|564616777|FG001|Open Label Extension|Physician Decision|0|||
156415878|NCT03354637|564616778|FG002|Open Label Extension|Physician Decision|1|||
156415879|NCT02726399|564616779|FG000|Overall Study|Participant Non-Compliance|1|||
156415880|NCT02726399|564616779|FG000|Overall Study|Adverse Event|2|||
156415881|NCT02726399|564616779|FG000|Overall Study|Progression of disease|4|||
156415882|NCT00997243|564616783|FG000|Overall Study|Early termination of study by sponsor|7|||
156415883|NCT03415022|564616786|FG000|Overall Study|Withdrawal by Subject|1|||
156415884|NCT03415022|564616787|FG001|Overall Study|Withdrawal by Subject|2|||
156415885|NCT03415022|564616786|FG000|Overall Study|COVID-19 Suspension|2|||
156415886|NCT03415022|564616787|FG001|Overall Study|COVID-19 Suspension|3|||
156415887|NCT03415022|564616786|FG000|Overall Study|Lost to Follow-up|2|||
156415888|NCT03415022|564616787|FG001|Overall Study|Lost to Follow-up|0|||
156415889|NCT03583541|564616791|FG000|Overall Study|Lost to Follow-up|31|||
156415890|NCT03583541|564616792|FG001|Overall Study|Lost to Follow-up|65|||
156415891|NCT00884286|564616794|FG000|Overall Study|Progressive disease|21|||
156415892|NCT00884286|564616795|FG001|Overall Study|Progressive disease|28|||
156415893|NCT00884286|564616794|FG000|Overall Study|Toxicity|4|||
156415894|NCT00884286|564616795|FG001|Overall Study|Toxicity|1|||
156415895|NCT00884286|564616794|FG000|Overall Study|Death|2|||
156415896|NCT00884286|564616795|FG001|Overall Study|Death|2|||
156415897|NCT00884286|564616794|FG000|Overall Study|Physician Decision|1|||
156415898|NCT00884286|564616795|FG001|Overall Study|Physician Decision|0|||
156415899|NCT00884286|564616794|FG000|Overall Study|Septic shock|1|||
156415900|NCT00884286|564616795|FG001|Overall Study|Septic shock|0|||
156415901|NCT00884286|564616794|FG000|Overall Study|Thrombus in right auricle|1|||
156415902|NCT00884286|564616795|FG001|Overall Study|Thrombus in right auricle|0|||
156415903|NCT00884286|564616794|FG000|Overall Study|Not treated|2|||
156415904|NCT00884286|564616795|FG001|Overall Study|Not treated|1|||
156415905|NCT00884286|564616794|FG000|Overall Study|Comprised lung carcinoma|0|||
156415906|NCT00884286|564616795|FG001|Overall Study|Comprised lung carcinoma|1|||
156415907|NCT01196104|564616796|FG000|Overall Study|Lost to Follow-up|1|||
156415908|NCT01196104|564616797|FG001|Overall Study|Lost to Follow-up|0|||
156415909|NCT01196104|564616796|FG000|Overall Study|Physician Decision|0|||
156415910|NCT01196104|564616797|FG001|Overall Study|Physician Decision|1|||
156415911|NCT01196104|564616796|FG000|Overall Study|Withdrawal by Subject|3|||
156415912|NCT01196104|564616797|FG001|Overall Study|Withdrawal by Subject|3|||
156415913|NCT01196104|564616796|FG000|Overall Study|Various|0|||
156415914|NCT01196104|564616797|FG001|Overall Study|Various|1|||
156415915|NCT00594932|564616800|FG000|First 3 Months|Withdrawal by Subject|1|||
156415916|NCT00594932|564616801|FG001|First 3 Months|Withdrawal by Subject|3|||
156415917|NCT00594932|564616800|FG000|Final 3 Months|Withdrawal by Subject|4|||
156415918|NCT00594932|564616801|FG001|Final 3 Months|Withdrawal by Subject|3|||
156415919|NCT01094171|564616802|FG000|Overall Study|Lost to Follow-up|2|||
156415920|NCT01094171|564616802|FG000|Overall Study|Informed consent withdrawal|4|||
156415921|NCT01094171|564616802|FG000|Overall Study|Migration from the study area|3|||
156415922|NCT01094171|564616802|FG000|Overall Study|Other|1|||
156415923|NCT01536145|564616803|FG000|Overall Study|Progressive disease|3|||
156415924|NCT01536145|564616804|FG001|Overall Study|Progressive disease|4|||
156415925|NCT01536145|564616805|FG002|Overall Study|Progressive disease|1|||
156415926|NCT01536145|564616806|FG003|Overall Study|Progressive disease|2|||
156415927|NCT01536145|564616807|FG004|Overall Study|Progressive disease|1|||
156415928|NCT01536145|564616808|FG005|Overall Study|Progressive disease|2|||
156415929|NCT01536145|564616809|FG006|Overall Study|Progressive disease|1|||
156415930|NCT01536145|564616810|FG007|Overall Study|Progressive disease|2|||
156415931|NCT01536145|564616811|FG008|Overall Study|Progressive disease|1|||
156415932|NCT01536145|564616812|FG009|Overall Study|Progressive disease|3|||
156415933|NCT01536145|564616813|FG010|Overall Study|Progressive disease|3|||
156415934|NCT01536145|564616803|FG000|Overall Study|Withdrawal by Subject|0|||
156415935|NCT01536145|564616804|FG001|Overall Study|Withdrawal by Subject|0|||
156415936|NCT01536145|564616805|FG002|Overall Study|Withdrawal by Subject|1|||
156415937|NCT01536145|564616806|FG003|Overall Study|Withdrawal by Subject|0|||
156415938|NCT01536145|564616807|FG004|Overall Study|Withdrawal by Subject|0|||
156415939|NCT01536145|564616808|FG005|Overall Study|Withdrawal by Subject|1|||
156415940|NCT01536145|564616809|FG006|Overall Study|Withdrawal by Subject|0|||
156415941|NCT01536145|564616810|FG007|Overall Study|Withdrawal by Subject|0|||
156415942|NCT01536145|564616811|FG008|Overall Study|Withdrawal by Subject|2|||
156415943|NCT01536145|564616812|FG009|Overall Study|Withdrawal by Subject|0|||
156415944|NCT01536145|564616813|FG010|Overall Study|Withdrawal by Subject|2|||
156415945|NCT01536145|564616803|FG000|Overall Study|Other|0|||
156415946|NCT01536145|564616804|FG001|Overall Study|Other|0|||
156415947|NCT01536145|564616805|FG002|Overall Study|Other|0|||
156415948|NCT01536145|564616806|FG003|Overall Study|Other|0|||
156415949|NCT01536145|564616807|FG004|Overall Study|Other|1|||
156415950|NCT01536145|564616808|FG005|Overall Study|Other|0|||
156415951|NCT01536145|564616809|FG006|Overall Study|Other|0|||
156415952|NCT01536145|564616810|FG007|Overall Study|Other|0|||
156415953|NCT01536145|564616811|FG008|Overall Study|Other|0|||
156415954|NCT01536145|564616812|FG009|Overall Study|Other|3|||
156415955|NCT01536145|564616813|FG010|Overall Study|Other|2|||
156415956|NCT01536145|564616803|FG000|Overall Study|Death|0|||
156415957|NCT01536145|564616804|FG001|Overall Study|Death|0|||
156415958|NCT01536145|564616805|FG002|Overall Study|Death|0|||
156415959|NCT01536145|564616806|FG003|Overall Study|Death|0|||
156415960|NCT01536145|564616807|FG004|Overall Study|Death|0|||
156415961|NCT01536145|564616808|FG005|Overall Study|Death|0|||
156415962|NCT01536145|564616809|FG006|Overall Study|Death|1|||
156415963|NCT01536145|564616810|FG007|Overall Study|Death|0|||
156415964|NCT01536145|564616811|FG008|Overall Study|Death|0|||
156415965|NCT01536145|564616812|FG009|Overall Study|Death|0|||
156415966|NCT01536145|564616813|FG010|Overall Study|Death|0|||
156415967|NCT01536145|564616803|FG000|Overall Study|Adverse Event|0|||
156415968|NCT01536145|564616804|FG001|Overall Study|Adverse Event|0|||
156415969|NCT01536145|564616805|FG002|Overall Study|Adverse Event|0|||
156415970|NCT01536145|564616806|FG003|Overall Study|Adverse Event|0|||
156415971|NCT01536145|564616807|FG004|Overall Study|Adverse Event|0|||
156415972|NCT01536145|564616808|FG005|Overall Study|Adverse Event|0|||
156415973|NCT01536145|564616809|FG006|Overall Study|Adverse Event|0|||
156415974|NCT01536145|564616810|FG007|Overall Study|Adverse Event|2|||
156415975|NCT01536145|564616811|FG008|Overall Study|Adverse Event|0|||
156415976|NCT01536145|564616812|FG009|Overall Study|Adverse Event|0|||
156415977|NCT01536145|564616813|FG010|Overall Study|Adverse Event|3|||
156415978|NCT00088205|564616818|FG000|Overall Study|Adverse Event|4|||
156415979|NCT00088205|564616818|FG000|Overall Study|Progressive Disease|51|||
156415980|NCT00088205|564616818|FG000|Overall Study|Physician Decision|1|||
156415981|NCT00088205|564616818|FG000|Overall Study|Death Due to Study Disease|4|||
156415982|NCT05199233|564616819|FG000|Overall Study|Lack of Efficacy|1|||
156415983|NCT02491892|564616824|FG000|Overall Study|Adverse Event|1|||
156415984|NCT02491892|564616825|FG001|Overall Study|Adverse Event|1|||
156415985|NCT02491892|564616824|FG000|Overall Study|Death|1|||
156415986|NCT02491892|564616825|FG001|Overall Study|Death|1|||
156415987|NCT02491892|564616824|FG000|Overall Study|Lack of Efficacy|37|||
156415988|NCT02491892|564616825|FG001|Overall Study|Lack of Efficacy|36|||
156415989|NCT02491892|564616824|FG000|Overall Study|Refused Treatment|1|||
156415990|NCT02491892|564616825|FG001|Overall Study|Refused Treatment|0|||
156415991|NCT02491892|564616824|FG000|Overall Study|Lost to Follow-up|1|||
156415992|NCT02491892|564616825|FG001|Overall Study|Lost to Follow-up|0|||
156415993|NCT01734850|564616826|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
156415994|NCT01734850|564616827|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
156415995|NCT01734850|564616828|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
156415996|NCT01734850|564616826|FG000|Overall Study|Not infused due to manufacturing failure|0|||
156415997|NCT01734850|564616827|FG001|Overall Study|Not infused due to manufacturing failure|0|||
156415998|NCT01734850|564616828|FG002|Overall Study|Not infused due to manufacturing failure|1|||
156415999|NCT03824938|564616829|FG000|Overall Study|Withdrawal by Subject|2|||
156416000|NCT03824938|564616830|FG001|Overall Study|Withdrawal by Subject|1|||
156652715|NCT00622908|565476073|FG001|Overall Study|Termination by study sponser|1|||
156652716|NCT03937466|565476074|FG000|Overall Study|not eligbile after the 2-week diary|9|||
156652717|NCT03937466|565476074|FG000|Overall Study|never returned their diary|6|||
156416001|NCT03824938|564616831|FG002|Overall Study|Withdrawal by Subject|0|||
156416002|NCT03824938|564616832|FG003|Overall Study|Withdrawal by Subject|2|||
156416003|NCT03824938|564616833|FG004|Overall Study|Withdrawal by Subject|0|||
156416004|NCT03824938|564616834|FG005|Overall Study|Withdrawal by Subject|1|||
156416005|NCT03824938|564616829|FG000|Overall Study|Lost to Follow-up|0|||
156416006|NCT03824938|564616830|FG001|Overall Study|Lost to Follow-up|1|||
156416007|NCT03824938|564616831|FG002|Overall Study|Lost to Follow-up|0|||
156416008|NCT03824938|564616832|FG003|Overall Study|Lost to Follow-up|0|||
156416009|NCT03824938|564616833|FG004|Overall Study|Lost to Follow-up|1|||
156416010|NCT03824938|564616834|FG005|Overall Study|Lost to Follow-up|0|||
156416011|NCT00065468|564616838|FG000|Overall Study|Death|172|||
156416012|NCT00065468|564616839|FG001|Overall Study|Death|169|||
156416013|NCT00065468|564616840|FG002|Overall Study|Death|171|||
156416014|NCT00065468|564616838|FG000|Overall Study|Withdrawal by Subject|3|||
156416015|NCT00065468|564616839|FG001|Overall Study|Withdrawal by Subject|4|||
156416016|NCT00065468|564616840|FG002|Overall Study|Withdrawal by Subject|5|||
156416017|NCT00065468|564616838|FG000|Overall Study|Lost to Follow-up|5|||
156416018|NCT00065468|564616839|FG001|Overall Study|Lost to Follow-up|3|||
156416019|NCT00065468|564616840|FG002|Overall Study|Lost to Follow-up|2|||
156315403|NCT01029405|564254329|FG002|Overall Study|Other|0|||
156315404|NCT01029405|564254330|FG003|Overall Study|Other|1|||
156315405|NCT00409175|564254331|FG000|Overall Study|Adverse Event|4|||
156315406|NCT00409175|564254332|FG001|Overall Study|Adverse Event|3|||
156315407|NCT00409175|564254331|FG000|Overall Study|Withdrawal by Subject|1|||
156315408|NCT00409175|564254332|FG001|Overall Study|Withdrawal by Subject|2|||
156315409|NCT00409175|564254331|FG000|Overall Study|Negative genotype|0|||
156315410|NCT00409175|564254332|FG001|Overall Study|Negative genotype|1|||
156315411|NCT00409175|564254331|FG000|Overall Study|Liver transplantation|13|||
156315412|NCT00409175|564254332|FG001|Overall Study|Liver transplantation|13|||
156315413|NCT02108262|564254337|FG000|Overall Study|Non-compliance|0|||
156315414|NCT02108262|564254338|FG001|Overall Study|Non-compliance|2|||
156315415|NCT02108262|564254339|FG002|Overall Study|Non-compliance|1|||
156315416|NCT02108262|564254340|FG003|Overall Study|Non-compliance|1|||
156315417|NCT02108262|564254337|FG000|Overall Study|Randomized by error/screen failure|0|||
156315418|NCT02108262|564254338|FG001|Overall Study|Randomized by error/screen failure|0|||
156315419|NCT02108262|564254339|FG002|Overall Study|Randomized by error/screen failure|1|||
156315420|NCT02108262|564254340|FG003|Overall Study|Randomized by error/screen failure|0|||
156315421|NCT02108262|564254337|FG000|Overall Study|Distance to center|0|||
156315422|NCT02108262|564254338|FG001|Overall Study|Distance to center|1|||
156315423|NCT02108262|564254339|FG002|Overall Study|Distance to center|1|||
156315424|NCT02108262|564254340|FG003|Overall Study|Distance to center|0|||
156315425|NCT02108262|564254337|FG000|Overall Study|Adverse Event|0|||
156315426|NCT02108262|564254338|FG001|Overall Study|Adverse Event|11|||
156315427|NCT02108262|564254339|FG002|Overall Study|Adverse Event|6|||
156315428|NCT02108262|564254340|FG003|Overall Study|Adverse Event|12|||
156315429|NCT02108262|564254337|FG000|Overall Study|Death|0|||
156315430|NCT02108262|564254338|FG001|Overall Study|Death|2|||
156315431|NCT02108262|564254339|FG002|Overall Study|Death|2|||
156315432|NCT02108262|564254340|FG003|Overall Study|Death|1|||
156315433|NCT02108262|564254337|FG000|Overall Study|Lost to Follow-up|0|||
156315434|NCT02108262|564254338|FG001|Overall Study|Lost to Follow-up|0|||
156315435|NCT02108262|564254339|FG002|Overall Study|Lost to Follow-up|1|||
156315436|NCT02108262|564254340|FG003|Overall Study|Lost to Follow-up|0|||
156315437|NCT02108262|564254337|FG000|Overall Study|Physician Decision|0|||
156315438|NCT02108262|564254338|FG001|Overall Study|Physician Decision|0|||
156315439|NCT02108262|564254339|FG002|Overall Study|Physician Decision|2|||
156315440|NCT02108262|564254340|FG003|Overall Study|Physician Decision|0|||
156315441|NCT02108262|564254337|FG000|Overall Study|Withdrawal by Subject|0|||
156315442|NCT02108262|564254338|FG001|Overall Study|Withdrawal by Subject|7|||
156315443|NCT02108262|564254339|FG002|Overall Study|Withdrawal by Subject|3|||
156315444|NCT02108262|564254340|FG003|Overall Study|Withdrawal by Subject|4|||
156315445|NCT02108262|564254337|FG000|Overall Study|Due to key hepatic values|0|||
156315446|NCT02108262|564254338|FG001|Overall Study|Due to key hepatic values|1|||
156315447|NCT02108262|564254339|FG002|Overall Study|Due to key hepatic values|0|||
156315448|NCT02108262|564254340|FG003|Overall Study|Due to key hepatic values|0|||
156315449|NCT02108262|564254337|FG000|Overall Study|Unable to contact patient|0|||
156315450|NCT02108262|564254338|FG001|Overall Study|Unable to contact patient|3|||
156315451|NCT02108262|564254339|FG002|Overall Study|Unable to contact patient|1|||
156315452|NCT02108262|564254340|FG003|Overall Study|Unable to contact patient|2|||
156315453|NCT02108262|564254337|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
156315454|NCT02108262|564254338|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
156315455|NCT02108262|564254339|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
156315456|NCT02108262|564254340|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
156315457|NCT02108262|564254337|FG000|Overall Study|Patient did not want another infusion|0|||
156315458|NCT02108262|564254338|FG001|Overall Study|Patient did not want another infusion|3|||
156315459|NCT02108262|564254339|FG002|Overall Study|Patient did not want another infusion|3|||
156315460|NCT02108262|564254340|FG003|Overall Study|Patient did not want another infusion|2|||
156315461|NCT02108262|564254337|FG000|Overall Study|Vacation|0|||
156315462|NCT02108262|564254338|FG001|Overall Study|Vacation|1|||
156315463|NCT02108262|564254339|FG002|Overall Study|Vacation|0|||
156315464|NCT02108262|564254340|FG003|Overall Study|Vacation|0|||
156652718|NCT03937466|565476074|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
156652719|NCT03937466|565476074|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
156315465|NCT02108262|564254337|FG000|Overall Study|Patient decision|0|||
156315466|NCT02108262|564254338|FG001|Overall Study|Patient decision|7|||
156315467|NCT02108262|564254339|FG002|Overall Study|Patient decision|9|||
156315468|NCT02108262|564254340|FG003|Overall Study|Patient decision|14|||
156315469|NCT02108262|564254337|FG000|Overall Study|Missed IV due to pharmacy error|0|||
156315470|NCT02108262|564254338|FG001|Overall Study|Missed IV due to pharmacy error|0|||
156315471|NCT02108262|564254339|FG002|Overall Study|Missed IV due to pharmacy error|1|||
156315472|NCT02108262|564254340|FG003|Overall Study|Missed IV due to pharmacy error|0|||
156315473|NCT03316911|564254341|FG000|Overall Study|Lost to Follow-up|33|||
156315474|NCT03316911|564254342|FG001|Overall Study|Lost to Follow-up|29|||
156315475|NCT01119937|564254343|FG000|Overall Study|Adverse Event|11|||
156315476|NCT01119937|564254344|FG001|Overall Study|Adverse Event|5|||
156315477|NCT01119937|564254343|FG000|Overall Study|Protocol deviation|3|||
156416020|NCT00065468|564616838|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
156416021|NCT00065468|564616839|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
156416022|NCT00065468|564616840|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
156416023|NCT00065468|564616838|FG000|Overall Study|Disease progression|0|||
156416024|NCT00065468|564616839|FG001|Overall Study|Disease progression|0|||
156416025|NCT00065468|564616840|FG002|Overall Study|Disease progression|1|||
156416026|NCT00065468|564616838|FG000|Overall Study|Other|14|||
156416027|NCT00065468|564616839|FG001|Overall Study|Other|24|||
156416028|NCT00065468|564616840|FG002|Overall Study|Other|18|||
156416029|NCT04496167|564616841|FG000|Overall Study|Adverse Event|6|||
156416030|NCT04496167|564616842|FG001|Overall Study|Adverse Event|2|||
156416031|NCT04496167|564616841|FG000|Overall Study|Withdrawal by Subject|7|||
156416032|NCT04496167|564616842|FG001|Overall Study|Withdrawal by Subject|6|||
156416033|NCT04496167|564616841|FG000|Overall Study|Lost to Follow-up|3|||
156416034|NCT04496167|564616842|FG001|Overall Study|Lost to Follow-up|5|||
156416035|NCT04496167|564616841|FG000|Overall Study|Not Treated|1|||
156416036|NCT04496167|564616842|FG001|Overall Study|Not Treated|2|||
156416037|NCT04496167|564616841|FG000|Overall Study|Other Than Specified|1|||
156416038|NCT04496167|564616842|FG001|Overall Study|Other Than Specified|1|||
156416039|NCT01058863|564616843|FG000|Overall Study|Lost to Follow-up|1|||
156416040|NCT01058863|564616843|FG000|Overall Study|Withdrawal by Subject|1|||
156416041|NCT01058863|564616843|FG000|Overall Study|Sponsor requested withdrawal|1|||
156416042|NCT01058863|564616843|FG000|Overall Study|Randomized in error|1|||
156416043|NCT03050398|564616848|FG000|Overall Study|Study terminated by sponsor|8|||
156416044|NCT05108649|564616849|FG000|Overall Study|Lost to Follow-up|0|||
156416045|NCT05108649|564616850|FG001|Overall Study|Lost to Follow-up|4|||
156416046|NCT05108649|564616851|FG002|Overall Study|Lost to Follow-up|3|||
156416047|NCT05108649|564616852|FG003|Overall Study|Lost to Follow-up|6|||
156416048|NCT05108649|564616849|FG000|Overall Study|Not Interested|1|||
156416049|NCT05108649|564616850|FG001|Overall Study|Not Interested|1|||
156416050|NCT05108649|564616851|FG002|Overall Study|Not Interested|0|||
156416051|NCT05108649|564616852|FG003|Overall Study|Not Interested|1|||
156416052|NCT05108649|564616849|FG000|Overall Study|Out of area|0|||
156416053|NCT05108649|564616850|FG001|Overall Study|Out of area|0|||
156416054|NCT05108649|564616851|FG002|Overall Study|Out of area|0|||
156416055|NCT05108649|564616852|FG003|Overall Study|Out of area|1|||
156416056|NCT05108649|564616849|FG000|Overall Study|PI decision|1|||
156416057|NCT05108649|564616850|FG001|Overall Study|PI decision|0|||
156416058|NCT05108649|564616851|FG002|Overall Study|PI decision|0|||
156416059|NCT05108649|564616852|FG003|Overall Study|PI decision|0|||
156416060|NCT05108649|564616849|FG000|Overall Study|Significant Non-Compliance|0|||
156416061|NCT05108649|564616850|FG001|Overall Study|Significant Non-Compliance|1|||
156416062|NCT05108649|564616851|FG002|Overall Study|Significant Non-Compliance|0|||
156416063|NCT05108649|564616852|FG003|Overall Study|Significant Non-Compliance|0|||
156416064|NCT05108649|564616849|FG000|Overall Study|Unable to adhere to study protocol|0|||
156416065|NCT05108649|564616850|FG001|Overall Study|Unable to adhere to study protocol|2|||
156416066|NCT05108649|564616851|FG002|Overall Study|Unable to adhere to study protocol|0|||
156416067|NCT05108649|564616852|FG003|Overall Study|Unable to adhere to study protocol|0|||
156416068|NCT00918749|564616855|FG000|Overall Study|Adverse Event|1|||
156416069|NCT00918749|564616856|FG001|Overall Study|Adverse Event|0|||
156416070|NCT00918749|564616857|FG002|Overall Study|Adverse Event|1|||
156416071|NCT00918749|564616855|FG000|Overall Study|Lost to Follow-up|0|||
156416072|NCT00918749|564616856|FG001|Overall Study|Lost to Follow-up|0|||
156416073|NCT00918749|564616857|FG002|Overall Study|Lost to Follow-up|1|||
156416074|NCT00918749|564616855|FG000|Overall Study|Withdrawal by Subject|5|||
156416075|NCT00918749|564616856|FG001|Overall Study|Withdrawal by Subject|3|||
156416076|NCT00918749|564616857|FG002|Overall Study|Withdrawal by Subject|5|||
156416077|NCT00918749|564616855|FG000|Overall Study|No Study Medication Taken|1|||
156416078|NCT00918749|564616856|FG001|Overall Study|No Study Medication Taken|0|||
156416079|NCT00918749|564616857|FG002|Overall Study|No Study Medication Taken|0|||
156416080|NCT01712789|564616858|FG000|Overall Study|Lack of Efficacy|2|||
156416081|NCT01712789|564616858|FG000|Overall Study|Lost to Follow-up|1|||
156416082|NCT01712789|564616858|FG000|Overall Study|Progressive Disease|504|||
156416083|NCT01712789|564616858|FG000|Overall Study|Death|57|||
156416084|NCT01712789|564616858|FG000|Overall Study|Adverse Event|52|||
156416085|NCT01712789|564616858|FG000|Overall Study|Miscellaneous|31|||
156416086|NCT01712789|564616858|FG000|Overall Study|Withdrawal by Subject|21|||
156416087|NCT01712789|564616858|FG000|Overall Study|Transition to Commercial Treatment|8|||
156652720|NCT00299156|565476077|FG000|Period 2 (Randomized)|Screen Failure|0|||
156416088|NCT01712789|564616858|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
156416089|NCT03018106|564616859|FG000|Overall Study|Lost to Follow-up|0|||
156416090|NCT03018106|564616860|FG001|Overall Study|Lost to Follow-up|1|||
156416091|NCT02213055|564616863|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
156416092|NCT02213055|564616864|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
156416093|NCT02213055|564616863|FG000|Overall Study|Protocol was not Followed during Study|1|||
156416094|NCT02213055|564616864|FG001|Overall Study|Protocol was not Followed during Study|0|||
156416095|NCT02213055|564616863|FG000|Overall Study|Documentation Issue at Enrollment|1|||
156416096|NCT02213055|564616864|FG001|Overall Study|Documentation Issue at Enrollment|0|||
156416097|NCT02213055|564616863|FG000|Overall Study|Documentation Issue during Study|10|||
156416098|NCT02213055|564616864|FG001|Overall Study|Documentation Issue during Study|0|||
156416099|NCT02213055|564616863|FG000|Overall Study|Did not have Live Lice|8|||
156416100|NCT02213055|564616864|FG001|Overall Study|Did not have Live Lice|0|||
156416101|NCT02213055|564616863|FG000|Overall Study|Had another Treatment during the Study|3|||
156416102|NCT02213055|564616864|FG001|Overall Study|Had another Treatment during the Study|0|||
156416103|NCT02213055|564616863|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
156416104|NCT02213055|564616864|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
156416105|NCT02213055|564616863|FG000|Overall Study|Did not Return to School|5|||
156416106|NCT02213055|564616864|FG001|Overall Study|Did not Return to School|0|||
156416107|NCT02025205|564616866|FG000|Overall Study|Withdrawal by Subject|1|||
156416108|NCT02025205|564616867|FG001|Overall Study|Withdrawal by Subject|1|||
156416109|NCT02025205|564616866|FG000|Overall Study|Protocol Violation|2|||
156416110|NCT02025205|564616867|FG001|Overall Study|Protocol Violation|1|||
156416111|NCT02025205|564616866|FG000|Overall Study|Death|0|||
156416112|NCT02025205|564616867|FG001|Overall Study|Death|1|||
156416113|NCT02448719|564616870|FG000|Overall Study|Withdrawal by Subject|0|||
156416114|NCT02448719|564616871|FG001|Overall Study|Withdrawal by Subject|0|||
156416115|NCT02448719|564616872|FG002|Overall Study|Withdrawal by Subject|0|||
156416116|NCT02448719|564616873|FG003|Overall Study|Withdrawal by Subject|0|||
156416117|NCT02448719|564616874|FG004|Overall Study|Withdrawal by Subject|1|||
156416118|NCT02448719|564616875|FG005|Overall Study|Withdrawal by Subject|0|||
156416119|NCT02448719|564616876|FG006|Overall Study|Withdrawal by Subject|0|||
156416120|NCT02448719|564616877|FG007|Overall Study|Withdrawal by Subject|0|||
156416121|NCT02448719|564616878|FG008|Overall Study|Withdrawal by Subject|0|||
156416122|NCT02448719|564616879|FG009|Overall Study|Withdrawal by Subject|0|||
156416123|NCT02448719|564616880|FG010|Overall Study|Withdrawal by Subject|0|||
156416124|NCT01024751|564616881|FG000|Enrolled Participants|Ineligible at baseline|3|||
156416125|NCT01024751|564616882|FG001|Enrolled Participants|Ineligible at baseline|4|||
156416126|NCT01024751|564616881|FG000|Eligible Participants|Withdrawal by Subject|0|||
156416127|NCT01024751|564616882|FG001|Eligible Participants|Withdrawal by Subject|1|||
156416128|NCT01024751|564616881|FG000|Eligible Participants|Lost to Follow-up|0|||
156652721|NCT00299156|565476078|FG001|Period 2 (Randomized)|Screen Failure|1|||
156652722|NCT00299156|565476079|FG002|Period 2 (Randomized)|Screen Failure|0|||
156652723|NCT01166568|565476085|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
156652724|NCT01166568|565476086|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
156652725|NCT01166568|565476087|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
156652726|NCT01166568|565476085|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
156652727|NCT01166568|565476086|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
156652728|NCT01166568|565476087|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
156416129|NCT01024751|564616882|FG001|Eligible Participants|Lost to Follow-up|1|||
156416130|NCT01024751|564616881|FG000|Eligible Participants|Ineligible|0|||
156416131|NCT01024751|564616882|FG001|Eligible Participants|Ineligible|1|||
156416132|NCT00577720|564616887|FG000|Overall Study|Adverse Event|2|||
156416133|NCT00577720|564616888|FG001|Overall Study|Adverse Event|1|||
156416134|NCT00577720|564616889|FG002|Overall Study|Adverse Event|0|||
156416135|NCT00577720|564616890|FG003|Overall Study|Adverse Event|4|||
156416136|NCT00577720|564616887|FG000|Overall Study|Lost to Follow-up|0|||
156416137|NCT00577720|564616888|FG001|Overall Study|Lost to Follow-up|0|||
156416138|NCT00577720|564616889|FG002|Overall Study|Lost to Follow-up|1|||
156416139|NCT00577720|564616890|FG003|Overall Study|Lost to Follow-up|0|||
156416140|NCT00577720|564616887|FG000|Overall Study|Protocol Violation|0|||
156416141|NCT00577720|564616888|FG001|Overall Study|Protocol Violation|0|||
156652729|NCT01166568|565476085|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
156652730|NCT01166568|565476086|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
156652731|NCT01166568|565476087|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
156416142|NCT00577720|564616889|FG002|Overall Study|Protocol Violation|0|||
156416143|NCT00577720|564616890|FG003|Overall Study|Protocol Violation|1|||
156416144|NCT00577720|564616887|FG000|Overall Study|Withdrawal by Subject|2|||
156416145|NCT00577720|564616888|FG001|Overall Study|Withdrawal by Subject|0|||
156416146|NCT00577720|564616889|FG002|Overall Study|Withdrawal by Subject|0|||
156416147|NCT00577720|564616890|FG003|Overall Study|Withdrawal by Subject|2|||
156416148|NCT00653263|564616893|FG000|Overall Study|Withdrawal by Subject|1|||
156416149|NCT00653263|564616893|FG000|Overall Study|Physician Decision|1|||
156416150|NCT04759885|564616898|FG000|Overall Study|Other|1|||
156416151|NCT04759885|564616899|FG001|Overall Study|Other|0|||
156416152|NCT04759885|564616900|FG002|Overall Study|Other|2|||
156416153|NCT04759885|564616901|FG003|Overall Study|Other|0|||
156416154|NCT04759885|564616902|FG004|Overall Study|Other|0|||
156416155|NCT04759885|564616898|FG000|Overall Study|Withdrawal by Subject|0|||
156416156|NCT04759885|564616899|FG001|Overall Study|Withdrawal by Subject|0|||
156416157|NCT04759885|564616900|FG002|Overall Study|Withdrawal by Subject|1|||
156416158|NCT04759885|564616901|FG003|Overall Study|Withdrawal by Subject|9|||
156652732|NCT01725451|565476088|FG000|Period 1|Withdrawal by Subject|1|||
156652733|NCT01725451|565476089|FG001|Period 1|Withdrawal by Subject|0|||
156416159|NCT04759885|564616902|FG004|Overall Study|Withdrawal by Subject|6|||
156416160|NCT04759885|564616898|FG000|Overall Study|Adverse Event|0|||
156416161|NCT04759885|564616899|FG001|Overall Study|Adverse Event|0|||
156416162|NCT04759885|564616900|FG002|Overall Study|Adverse Event|0|||
156416163|NCT04759885|564616901|FG003|Overall Study|Adverse Event|3|||
156416164|NCT04759885|564616902|FG004|Overall Study|Adverse Event|0|||
156416165|NCT04759885|564616898|FG000|Overall Study|Physician Decision|0|||
156416166|NCT04759885|564616899|FG001|Overall Study|Physician Decision|0|||
156416167|NCT04759885|564616900|FG002|Overall Study|Physician Decision|0|||
156416168|NCT04759885|564616901|FG003|Overall Study|Physician Decision|2|||
156416169|NCT04759885|564616902|FG004|Overall Study|Physician Decision|0|||
156416170|NCT00195715|564616903|FG000|Overall Study|Adverse Event|122|||
156416171|NCT00195715|564616903|FG000|Overall Study|Withdrawal by Subject|58|||
156416172|NCT00195715|564616903|FG000|Overall Study|Lost to Follow-up|27|||
156416173|NCT00195715|564616903|FG000|Overall Study|Protocol Violation|13|||
156416174|NCT00195715|564616903|FG000|Overall Study|Lack of Efficacy|93|||
156416175|NCT00195715|564616903|FG000|Overall Study|Pregnancy|14|||
156416176|NCT00195715|564616903|FG000|Overall Study|Investigative site closure|8|||
156416177|NCT00195715|564616903|FG000|Overall Study|Subject moved/relocated|7|||
156416178|NCT00195715|564616903|FG000|Overall Study|Subject non-compliance|6|||
156416179|NCT00195715|564616903|FG000|Overall Study|Subject started commercial Humira|5|||
156416180|NCT00195715|564616903|FG000|Overall Study|Subject choice|3|||
156416181|NCT00195715|564616903|FG000|Overall Study|Loss of response/no improvement|3|||
156416182|NCT00195715|564616903|FG000|Overall Study|Sponsor stopped study|1|||
156416183|NCT00195715|564616903|FG000|Overall Study|Administrative reasons|2|||
156416184|NCT00195715|564616903|FG000|Overall Study|Investigator's decision|2|||
156416185|NCT00195715|564616903|FG000|Overall Study|Subject wants to get pregnant|4|||
156416186|NCT00195715|564616903|FG000|Overall Study|Use of prohibited medication|2|||
156416187|NCT00195715|564616903|FG000|Overall Study|Planned surgery|2|||
156416188|NCT00195715|564616903|FG000|Overall Study|Increased infection rate|1|||
156416189|NCT00195715|564616903|FG000|Overall Study|Ineligible|1|||
156416190|NCT00195715|564616903|FG000|Overall Study|Colonic stricture|1|||
156416191|NCT00195715|564616903|FG000|Overall Study|Sponsor discontinued trial|1|||
156416192|NCT00195715|564616903|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
156416193|NCT02036515|564616908|FG000|Overall Study|Adverse Event|1|||
156416194|NCT02036515|564616909|FG001|Overall Study|Adverse Event|1|||
156416195|NCT02036515|564616910|FG002|Overall Study|Adverse Event|2|||
156416196|NCT02036515|564616908|FG000|Overall Study|Lost to Follow-up|0|||
156416197|NCT02036515|564616909|FG001|Overall Study|Lost to Follow-up|2|||
156416198|NCT02036515|564616910|FG002|Overall Study|Lost to Follow-up|0|||
156416199|NCT02036515|564616908|FG000|Overall Study|Non-compliance with study drug|0|||
156416200|NCT02036515|564616909|FG001|Overall Study|Non-compliance with study drug|0|||
156416201|NCT02036515|564616910|FG002|Overall Study|Non-compliance with study drug|2|||
156416202|NCT02036515|564616908|FG000|Overall Study|Screen failure|0|||
156416203|NCT02036515|564616909|FG001|Overall Study|Screen failure|2|||
156416204|NCT02036515|564616910|FG002|Overall Study|Screen failure|0|||
156416205|NCT02036515|564616908|FG000|Overall Study|Withdrawal by Subject|4|||
156416206|NCT02036515|564616909|FG001|Overall Study|Withdrawal by Subject|7|||
156416207|NCT02036515|564616910|FG002|Overall Study|Withdrawal by Subject|9|||
156652734|NCT01725451|565476090|FG002|Period 1|Withdrawal by Subject|0|||
156652735|NCT01725451|565476091|FG003|Period 1|Withdrawal by Subject|0|||
156652736|NCT01725451|565476088|FG000|Washout From Period 3|Protocol Violation|0|||
156652737|NCT01725451|565476089|FG001|Washout From Period 3|Protocol Violation|0|||
156652738|NCT01725451|565476090|FG002|Washout From Period 3|Protocol Violation|1|||
156652739|NCT01725451|565476091|FG003|Washout From Period 3|Protocol Violation|0|||
156652740|NCT01725451|565476088|FG000|Washout From Period 3|Adverse Event|0|||
156652741|NCT01725451|565476089|FG001|Washout From Period 3|Adverse Event|1|||
156652742|NCT01725451|565476090|FG002|Washout From Period 3|Adverse Event|0|||
156652743|NCT01725451|565476091|FG003|Washout From Period 3|Adverse Event|0|||
156652744|NCT01725451|565476088|FG000|Period 4|Adverse Event|0|||
156652745|NCT01725451|565476089|FG001|Period 4|Adverse Event|0|||
156652746|NCT01725451|565476090|FG002|Period 4|Adverse Event|1|||
156652747|NCT01725451|565476091|FG003|Period 4|Adverse Event|0|||
156652748|NCT00358826|565476095|FG000|Core Study|Adverse Event|1|||
156416208|NCT02036515|564616908|FG000|Overall Study|Hyperglycemia|0|||
156416209|NCT02036515|564616909|FG001|Overall Study|Hyperglycemia|0|||
156416210|NCT02036515|564616910|FG002|Overall Study|Hyperglycemia|1|||
156416211|NCT02601937|564616918|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416212|NCT02601937|564616919|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416213|NCT02601937|564616920|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416214|NCT02601937|564616921|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416215|NCT02601937|564616922|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416216|NCT02601937|564616923|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
156416217|NCT02601937|564616924|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
156652749|NCT00358826|565476096|FG001|Core Study|Adverse Event|3|||
156652750|NCT00358826|565476097|FG002|Core Study|Adverse Event|1|||
156652751|NCT00358826|565476098|FG003|Core Study|Adverse Event|1|||
156652752|NCT00358826|565476099|FG004|Core Study|Adverse Event|0|||
156416218|NCT02601937|564616925|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416219|NCT02601937|564616926|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416220|NCT02601937|564616927|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416221|NCT02601937|564616928|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
156416222|NCT02601937|564616918|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
156416223|NCT02601937|564616919|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416224|NCT02601937|564616920|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416225|NCT02601937|564616921|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416226|NCT02601937|564616922|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416227|NCT02601937|564616923|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416228|NCT02601937|564616924|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
156416229|NCT02601937|564616925|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416230|NCT02601937|564616926|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416231|NCT02601937|564616927|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416232|NCT02601937|564616928|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156416233|NCT02601937|564616918|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416234|NCT02601937|564616919|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416235|NCT02601937|564616920|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
156416236|NCT02601937|564616921|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416237|NCT02601937|564616922|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416238|NCT02601937|564616923|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416239|NCT02601937|564616924|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416240|NCT02601937|564616925|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416241|NCT02601937|564616926|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416242|NCT02601937|564616927|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416243|NCT02601937|564616928|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156416244|NCT02601937|564616918|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
156416245|NCT02601937|564616919|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
156416246|NCT02601937|564616920|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
156416247|NCT02601937|564616921|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
156416248|NCT02601937|564616922|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
156416249|NCT02601937|564616923|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
156416250|NCT02601937|564616924|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
156416251|NCT02601937|564616925|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
156416252|NCT02601937|564616926|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
156416253|NCT02601937|564616927|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
156416254|NCT02601937|564616928|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
156416255|NCT02601937|564616918|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416256|NCT02601937|564616919|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416257|NCT02601937|564616920|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416258|NCT02601937|564616921|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416259|NCT02601937|564616922|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416260|NCT02601937|564616923|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416261|NCT02601937|564616924|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416262|NCT02601937|564616925|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416263|NCT02601937|564616926|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416264|NCT02601937|564616927|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
156416265|NCT02601937|564616928|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156416266|NCT02601937|564616918|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416267|NCT02601937|564616919|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416268|NCT02601937|564616920|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416269|NCT02601937|564616921|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156315478|NCT01119937|564254344|FG001|Overall Study|Protocol deviation|1|||
156315479|NCT01119937|564254343|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156315480|NCT01119937|564254344|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156315481|NCT01119937|564254343|FG000|Overall Study|Withdrawal by Subject|2|||
156315482|NCT01119937|564254344|FG001|Overall Study|Withdrawal by Subject|1|||
156315483|NCT01270802|564254345|FG000|Overall Study|Withdrawal by Subject|1|||
156315484|NCT01270802|564254346|FG001|Overall Study|Withdrawal by Subject|0|||
156315485|NCT01270802|564254345|FG000|Overall Study|Adverse Event|1|||
156315486|NCT01270802|564254346|FG001|Overall Study|Adverse Event|0|||
156315487|NCT01270802|564254345|FG000|Overall Study|Lost to Follow-up|0|||
156315488|NCT01270802|564254346|FG001|Overall Study|Lost to Follow-up|1|||
156315489|NCT05027971|564254359|FG000|Overall Study|Physician Decision|7|||
156315490|NCT05027971|564254360|FG001|Overall Study|Physician Decision|3|||
156416270|NCT02601937|564616922|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416271|NCT02601937|564616923|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416272|NCT02601937|564616924|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416273|NCT02601937|564616925|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
156416274|NCT02601937|564616926|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416275|NCT02601937|564616927|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416276|NCT02601937|564616928|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156416277|NCT02601937|564616918|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416278|NCT02601937|564616919|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416279|NCT02601937|564616920|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416280|NCT02601937|564616921|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416281|NCT02601937|564616922|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416282|NCT02601937|564616923|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416283|NCT02601937|564616924|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416284|NCT02601937|564616925|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416285|NCT02601937|564616926|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156416286|NCT02601937|564616927|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
156416287|NCT02601937|564616928|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
156416288|NCT02601937|564616918|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156416289|NCT02601937|564616919|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156416290|NCT02601937|564616920|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156416291|NCT02601937|564616921|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156416292|NCT02601937|564616922|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156416293|NCT02601937|564616923|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156756658|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756659|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756660|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756661|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756662|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756663|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756664|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756665|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756666|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756667|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
156756668|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
156756669|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
156416294|NCT02601937|564616924|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156416295|NCT02601937|564616925|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
156416296|NCT02601937|564616926|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
156416297|NCT02601937|564616927|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
156416298|NCT02601937|564616928|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
156416299|NCT02601937|564616918|FG000|Period 2: Dose Expansion Cohort|Other|0|||
156756670|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
156756671|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
156756672|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
156315491|NCT05027971|564254359|FG000|Overall Study|Lost to Follow-up|1|||
156315492|NCT05027971|564254360|FG001|Overall Study|Lost to Follow-up|1|||
156315493|NCT05027971|564254359|FG000|Overall Study|Withdrawal by Subject|0|||
156315494|NCT05027971|564254360|FG001|Overall Study|Withdrawal by Subject|2|||
156315495|NCT05027971|564254359|FG000|Overall Study|Non-study fiber used.|0|||
156315496|NCT05027971|564254360|FG001|Overall Study|Non-study fiber used.|1|||
156315497|NCT05027971|564254359|FG000|Overall Study|Protocol Violation|0|||
156315498|NCT05027971|564254360|FG001|Overall Study|Protocol Violation|2|||
156315499|NCT02025556|564254361|FG000|Overall Study|Adverse Event|0|||
156315500|NCT02025556|564254362|FG001|Overall Study|Adverse Event|4|||
156315501|NCT02025556|564254363|FG002|Overall Study|Adverse Event|2|||
156315502|NCT02025556|564254361|FG000|Overall Study|Lack of Efficacy|2|||
156315503|NCT02025556|564254362|FG001|Overall Study|Lack of Efficacy|1|||
156315504|NCT02025556|564254363|FG002|Overall Study|Lack of Efficacy|0|||
156315505|NCT02025556|564254361|FG000|Overall Study|Protocol Violation|2|||
156315506|NCT02025556|564254362|FG001|Overall Study|Protocol Violation|1|||
156315507|NCT02025556|564254363|FG002|Overall Study|Protocol Violation|0|||
156315508|NCT02025556|564254361|FG000|Overall Study|Withdrawal by Subject|0|||
156315509|NCT02025556|564254362|FG001|Overall Study|Withdrawal by Subject|3|||
156315510|NCT02025556|564254363|FG002|Overall Study|Withdrawal by Subject|6|||
156315511|NCT02025556|564254361|FG000|Overall Study|Lost to Follow-up|2|||
156416300|NCT02601937|564616919|FG001|Period 2: Dose Expansion Cohort|Other|0|||
156416301|NCT02601937|564616920|FG002|Period 2: Dose Expansion Cohort|Other|0|||
156416302|NCT02601937|564616921|FG003|Period 2: Dose Expansion Cohort|Other|0|||
156416303|NCT02601937|564616922|FG004|Period 2: Dose Expansion Cohort|Other|0|||
156416304|NCT02601937|564616923|FG005|Period 2: Dose Expansion Cohort|Other|0|||
156416305|NCT02601937|564616924|FG006|Period 2: Dose Expansion Cohort|Other|0|||
156416306|NCT02601937|564616925|FG007|Period 2: Dose Expansion Cohort|Other|0|||
156756673|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
156416307|NCT02601937|564616926|FG008|Period 2: Dose Expansion Cohort|Other|2|||
156416308|NCT02601937|564616927|FG009|Period 2: Dose Expansion Cohort|Other|2|||
156416309|NCT02601937|564616928|FG010|Period 2: Dose Expansion Cohort|Other|0|||
156416310|NCT02601937|564616918|FG000|Period 2: Dose Expansion Cohort|Death|0|||
156416311|NCT02601937|564616919|FG001|Period 2: Dose Expansion Cohort|Death|0|||
156416312|NCT02601937|564616920|FG002|Period 2: Dose Expansion Cohort|Death|0|||
156416313|NCT02601937|564616921|FG003|Period 2: Dose Expansion Cohort|Death|0|||
156416314|NCT02601937|564616922|FG004|Period 2: Dose Expansion Cohort|Death|0|||
156416315|NCT02601937|564616923|FG005|Period 2: Dose Expansion Cohort|Death|0|||
156416316|NCT02601937|564616924|FG006|Period 2: Dose Expansion Cohort|Death|0|||
156416317|NCT02601937|564616925|FG007|Period 2: Dose Expansion Cohort|Death|0|||
156416318|NCT02601937|564616926|FG008|Period 2: Dose Expansion Cohort|Death|1|||
156416319|NCT02601937|564616927|FG009|Period 2: Dose Expansion Cohort|Death|0|||
156416320|NCT02601937|564616928|FG010|Period 2: Dose Expansion Cohort|Death|0|||
156416321|NCT00513019|564617811|FG000|Overall Study|Adverse Event|1|||
156416322|NCT00513019|564617812|FG001|Overall Study|Adverse Event|0|||
156416323|NCT00513019|564617811|FG000|Overall Study|Withdrawal by Subject|4|||
156416324|NCT00513019|564617812|FG001|Overall Study|Withdrawal by Subject|5|||
156416325|NCT00932646|564617823|FG000|Overall Study|Adverse Event|2|||
156416326|NCT00932646|564617824|FG001|Overall Study|Adverse Event|1|||
156416327|NCT00932646|564617825|FG002|Overall Study|Adverse Event|1|||
156416328|NCT00932646|564617826|FG003|Overall Study|Adverse Event|1|||
156416329|NCT00932646|564617823|FG000|Overall Study|Lost to Follow-up|2|||
156416330|NCT00932646|564617824|FG001|Overall Study|Lost to Follow-up|1|||
156416331|NCT00932646|564617825|FG002|Overall Study|Lost to Follow-up|0|||
156416332|NCT00932646|564617826|FG003|Overall Study|Lost to Follow-up|0|||
156416333|NCT00932646|564617823|FG000|Overall Study|Withdrawal by Subject|1|||
156416334|NCT00932646|564617824|FG001|Overall Study|Withdrawal by Subject|1|||
156416335|NCT00932646|564617825|FG002|Overall Study|Withdrawal by Subject|3|||
156416336|NCT00932646|564617826|FG003|Overall Study|Withdrawal by Subject|0|||
156416337|NCT02611830|564617827|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
156416338|NCT02611830|564617828|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
156416339|NCT02611830|564617829|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
156416340|NCT02611830|564617830|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
156416341|NCT02611830|564617827|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
156416342|NCT02611830|564617828|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
156416343|NCT02611830|564617829|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
156416344|NCT02611830|564617830|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
156416345|NCT02611830|564617827|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
156416346|NCT02611830|564617828|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
156416347|NCT02611830|564617829|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
156416348|NCT02611830|564617830|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
156756674|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
156756675|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
156756676|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
156756677|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
156756678|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
156756679|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
156756680|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
156756681|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
156756682|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
156756683|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
156756684|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
156416349|NCT02611830|564617827|FG000|OL Induction Phase|Lack of Efficacy|9|||
156416350|NCT02611830|564617828|FG001|OL Induction Phase|Lack of Efficacy|0|||
156416351|NCT02611830|564617829|FG002|OL Induction Phase|Lack of Efficacy|0|||
156416352|NCT02611830|564617830|FG003|OL Induction Phase|Lack of Efficacy|0|||
156416353|NCT02611830|564617827|FG000|OL Induction Phase|Reason not specified|3|||
156416354|NCT02611830|564617828|FG001|OL Induction Phase|Reason not specified|0|||
156416355|NCT02611830|564617829|FG002|OL Induction Phase|Reason not specified|0|||
156416356|NCT02611830|564617830|FG003|OL Induction Phase|Reason not specified|0|||
156416357|NCT02611830|564617827|FG000|Maintenance Phase|Lack of Efficacy|0|||
156416358|NCT02611830|564617828|FG001|Maintenance Phase|Lack of Efficacy|29|||
156416359|NCT02611830|564617829|FG002|Maintenance Phase|Lack of Efficacy|18|||
156416360|NCT02611830|564617830|FG003|Maintenance Phase|Lack of Efficacy|6|||
156416361|NCT02611830|564617827|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156416362|NCT02611830|564617828|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
156416363|NCT02611830|564617829|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
156416364|NCT02611830|564617830|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
156416365|NCT02611830|564617827|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
156416366|NCT02611830|564617828|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
156416367|NCT02611830|564617829|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
156416368|NCT02611830|564617830|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
156416369|NCT02611830|564617827|FG000|Maintenance Phase|Lost to Follow-up|0|||
156416370|NCT02611830|564617828|FG001|Maintenance Phase|Lost to Follow-up|0|||
156416371|NCT02611830|564617829|FG002|Maintenance Phase|Lost to Follow-up|0|||
156416372|NCT02611830|564617830|FG003|Maintenance Phase|Lost to Follow-up|1|||
156416373|NCT02611830|564617827|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
156416374|NCT02611830|564617828|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
156416375|NCT02611830|564617829|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
156416376|NCT02611830|564617830|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
156416377|NCT02611830|564617827|FG000|Maintenance Phase|Pregnancy|0|||
156416378|NCT02611830|564617828|FG001|Maintenance Phase|Pregnancy|0|||
156416379|NCT02611830|564617829|FG002|Maintenance Phase|Pregnancy|1|||
156416380|NCT02611830|564617830|FG003|Maintenance Phase|Pregnancy|0|||
156416381|NCT02611830|564617827|FG000|Maintenance Phase|Reason not specified|0|||
156416382|NCT02611830|564617828|FG001|Maintenance Phase|Reason not specified|1|||
156416383|NCT02611830|564617829|FG002|Maintenance Phase|Reason not specified|4|||
156416384|NCT02611830|564617830|FG003|Maintenance Phase|Reason not specified|0|||
156416385|NCT04963062|564617833|FG000|Overall Study|withdrew by the study team|4|||
156416386|NCT04963062|564617834|FG001|Overall Study|withdrew by the study team|2|||
156416387|NCT03500172|564617835|FG000|Period 1: Baseline Randomization|Death|0|||
156416388|NCT03500172|564617836|FG001|Period 1: Baseline Randomization|Death|0|||
156416389|NCT03500172|564617837|FG002|Period 1: Baseline Randomization|Death|0|||
156416390|NCT03500172|564617838|FG003|Period 1: Baseline Randomization|Death|0|||
156416391|NCT03500172|564617839|FG004|Period 1: Baseline Randomization|Death|0|||
156416392|NCT03500172|564617840|FG005|Period 1: Baseline Randomization|Death|0|||
156416393|NCT03500172|564617841|FG006|Period 1: Baseline Randomization|Death|0|||
156416394|NCT03500172|564617842|FG007|Period 1: Baseline Randomization|Death|0|||
156416395|NCT03500172|564617843|FG008|Period 1: Baseline Randomization|Death|0|||
156416396|NCT03500172|564617844|FG009|Period 1: Baseline Randomization|Death|2|||
156416397|NCT03500172|564617845|FG010|Period 1: Baseline Randomization|Death|0|||
156416398|NCT03500172|564617835|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
156416399|NCT03500172|564617836|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
156416400|NCT03500172|564617837|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
156416401|NCT03500172|564617838|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
156416402|NCT03500172|564617839|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
156416403|NCT03500172|564617840|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
156416404|NCT03500172|564617841|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
156416405|NCT03500172|564617842|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
156416406|NCT03500172|564617843|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
156416407|NCT03500172|564617844|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
156416408|NCT03500172|564617845|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
156416409|NCT03500172|564617835|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
156416410|NCT03500172|564617836|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
156416411|NCT03500172|564617837|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
156416412|NCT03500172|564617838|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
156416413|NCT03500172|564617839|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
156416414|NCT03500172|564617840|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
156416415|NCT03500172|564617841|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
156416416|NCT03500172|564617842|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
156416417|NCT03500172|564617843|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
156416418|NCT03500172|564617844|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
156416419|NCT03500172|564617845|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
156416420|NCT03500172|564617835|FG000|Period 2: Re-Randomization|Death|0|||
156416421|NCT03500172|564617836|FG001|Period 2: Re-Randomization|Death|0|||
156416422|NCT03500172|564617837|FG002|Period 2: Re-Randomization|Death|0|||
156416423|NCT03500172|564617838|FG003|Period 2: Re-Randomization|Death|4|||
156416424|NCT03500172|564617839|FG004|Period 2: Re-Randomization|Death|2|||
156416425|NCT03500172|564617840|FG005|Period 2: Re-Randomization|Death|0|||
156416426|NCT03500172|564617841|FG006|Period 2: Re-Randomization|Death|5|||
156416427|NCT03500172|564617842|FG007|Period 2: Re-Randomization|Death|2|||
156416428|NCT03500172|564617843|FG008|Period 2: Re-Randomization|Death|0|||
156416429|NCT03500172|564617844|FG009|Period 2: Re-Randomization|Death|0|||
156416430|NCT03500172|564617845|FG010|Period 2: Re-Randomization|Death|0|||
156416431|NCT00544544|564617846|FG000|Overall Study|Withdrawal by Subject|1|||
156416432|NCT00544544|564617846|FG000|Overall Study|Adverse Event|1|||
156416433|NCT00544544|564617846|FG000|Overall Study|Lost to Follow-up|1|||
156416434|NCT00996580|564617847|FG000|Overall Study|Adverse Event|466|||
156416435|NCT00996580|564617847|FG000|Overall Study|Lost to Follow-up|480|||
156416436|NCT00996580|564617847|FG000|Overall Study|Noncompliance with the protocol|137|||
156416437|NCT00996580|564617847|FG000|Overall Study|Physician Decision|5|||
156416438|NCT00996580|564617847|FG000|Overall Study|Pregnancy|68|||
156416439|NCT00996580|564617847|FG000|Overall Study|Protocol Violation|16|||
156416440|NCT00996580|564617847|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
156416441|NCT00996580|564617847|FG000|Overall Study|Withdrawal by Subject|217|||
156416442|NCT00996580|564617847|FG000|Overall Study|Other|29|||
156416443|NCT02218489|564617848|FG000|Overall Study|Withdrawal by Subject|4|||
156416444|NCT02218489|564617849|FG001|Overall Study|Withdrawal by Subject|3|||
156416445|NCT02218489|564617848|FG000|Overall Study|Lost to Follow-up|1|||
156416446|NCT02218489|564617849|FG001|Overall Study|Lost to Follow-up|0|||
156416447|NCT01778062|564617850|FG000|Overall Study|Adverse Event|1|||
156416448|NCT01778062|564617851|FG001|Overall Study|Adverse Event|3|||
156416449|NCT01778062|564617850|FG000|Overall Study|Consent Withdrawal|1|||
156416450|NCT01778062|564617851|FG001|Overall Study|Consent Withdrawal|5|||
156416451|NCT01778062|564617850|FG000|Overall Study|major protocol deviation|4|||
156416452|NCT01778062|564617851|FG001|Overall Study|major protocol deviation|3|||
156416453|NCT03958630|564617852|FG000|Overall Study|Withdrawal by Subject|0|||
156416454|NCT03958630|564617853|FG001|Overall Study|Withdrawal by Subject|0|||
156416455|NCT03958630|564617854|FG002|Overall Study|Withdrawal by Subject|1|||
156416456|NCT03958630|564617852|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
156416457|NCT03958630|564617853|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
156416458|NCT03958630|564617854|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
156416459|NCT04039503|564617855|FG000|Overall Study|Adverse Event|3|||
156416460|NCT04039503|564617856|FG001|Overall Study|Adverse Event|0|||
156416461|NCT04039503|564617857|FG002|Overall Study|Adverse Event|2|||
156416462|NCT04039503|564617858|FG003|Overall Study|Adverse Event|0|||
156416463|NCT04039503|564617855|FG000|Overall Study|Lost to Follow-up|0|||
156416464|NCT04039503|564617856|FG001|Overall Study|Lost to Follow-up|0|||
156416465|NCT04039503|564617857|FG002|Overall Study|Lost to Follow-up|1|||
156416466|NCT04039503|564617858|FG003|Overall Study|Lost to Follow-up|0|||
156416467|NCT04039503|564617855|FG000|Overall Study|Protocol Violation|0|||
156416468|NCT04039503|564617856|FG001|Overall Study|Protocol Violation|1|||
156416469|NCT04039503|564617857|FG002|Overall Study|Protocol Violation|2|||
156416470|NCT04039503|564617858|FG003|Overall Study|Protocol Violation|1|||
156416471|NCT04039503|564617855|FG000|Overall Study|Withdrawal by Subject|4|||
156416472|NCT04039503|564617856|FG001|Overall Study|Withdrawal by Subject|3|||
156416473|NCT04039503|564617857|FG002|Overall Study|Withdrawal by Subject|5|||
156416474|NCT04039503|564617858|FG003|Overall Study|Withdrawal by Subject|2|||
156416475|NCT01815736|564617859|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
156416476|NCT01815736|564617860|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
156416477|NCT01815736|564617859|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
156416478|NCT01815736|564617860|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
156416479|NCT01815736|564617859|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
156416480|NCT01815736|564617860|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
156416481|NCT01815736|564617859|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
156416482|NCT01815736|564617860|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
156416483|NCT01815736|564617859|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
156416484|NCT01815736|564617860|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
156416485|NCT01815736|564617859|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
156416486|NCT01815736|564617860|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
156416487|NCT01815736|564617859|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
156416488|NCT01815736|564617860|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
156416489|NCT01815736|564617859|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
156416490|NCT01815736|564617860|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
156416491|NCT01815736|564617859|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
156416492|NCT01815736|564617860|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
156416493|NCT01815736|564617859|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
156416494|NCT01815736|564617860|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
156416495|NCT01815736|564617859|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
156416496|NCT01815736|564617860|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
156416497|NCT01815736|564617859|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
156416498|NCT01815736|564617860|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
156416499|NCT01815736|564617859|FG000|Extension Treatment Phase- After Week 96|Death|1|||
156416500|NCT01815736|564617860|FG001|Extension Treatment Phase- After Week 96|Death|0|||
156416501|NCT03387514|564617864|FG000|Overall Study|Withdrawal by Subject|2|||
156416502|NCT03387514|564617864|FG000|Overall Study|Physician Decision|1|||
156416503|NCT03387514|564617864|FG000|Overall Study|Lost to Follow-up|2|||
156416504|NCT04157686|564617869|FG000|Overall Study|Adverse Event|1|||
156416505|NCT04157686|564617870|FG001|Overall Study|Adverse Event|0|||
156416506|NCT04157686|564617871|FG002|Overall Study|Adverse Event|1|||
156416507|NCT04157686|564617872|FG003|Overall Study|Adverse Event|0|||
156416508|NCT04157686|564617873|FG004|Overall Study|Adverse Event|1|||
156416509|NCT04157686|564617874|FG005|Overall Study|Adverse Event|0|||
156416510|NCT04157686|564617875|FG006|Overall Study|Adverse Event|0|||
156416511|NCT04157686|564617876|FG007|Overall Study|Adverse Event|0|||
156416512|NCT04157686|564617869|FG000|Overall Study|Pregnancy|0|||
156416513|NCT04157686|564617870|FG001|Overall Study|Pregnancy|1|||
156416514|NCT04157686|564617871|FG002|Overall Study|Pregnancy|3|||
156416515|NCT04157686|564617872|FG003|Overall Study|Pregnancy|0|||
156416516|NCT04157686|564617873|FG004|Overall Study|Pregnancy|0|||
156416517|NCT04157686|564617874|FG005|Overall Study|Pregnancy|0|||
156416518|NCT04157686|564617875|FG006|Overall Study|Pregnancy|3|||
156416519|NCT04157686|564617876|FG007|Overall Study|Pregnancy|0|||
156416520|NCT04157686|564617869|FG000|Overall Study|Lost to Follow-up|1|||
156416521|NCT04157686|564617870|FG001|Overall Study|Lost to Follow-up|2|||
156416522|NCT04157686|564617871|FG002|Overall Study|Lost to Follow-up|8|||
156416523|NCT04157686|564617872|FG003|Overall Study|Lost to Follow-up|6|||
156416524|NCT04157686|564617873|FG004|Overall Study|Lost to Follow-up|6|||
156416525|NCT04157686|564617874|FG005|Overall Study|Lost to Follow-up|3|||
156416526|NCT04157686|564617875|FG006|Overall Study|Lost to Follow-up|7|||
156416527|NCT04157686|564617876|FG007|Overall Study|Lost to Follow-up|9|||
156416528|NCT04157686|564617869|FG000|Overall Study|Lack of Efficacy|0|||
156416529|NCT04157686|564617870|FG001|Overall Study|Lack of Efficacy|0|||
156416530|NCT04157686|564617871|FG002|Overall Study|Lack of Efficacy|0|||
156416531|NCT04157686|564617872|FG003|Overall Study|Lack of Efficacy|0|||
156416532|NCT04157686|564617873|FG004|Overall Study|Lack of Efficacy|0|||
156416533|NCT04157686|564617874|FG005|Overall Study|Lack of Efficacy|2|||
156416534|NCT04157686|564617875|FG006|Overall Study|Lack of Efficacy|0|||
156416535|NCT04157686|564617876|FG007|Overall Study|Lack of Efficacy|1|||
156416536|NCT04157686|564617869|FG000|Overall Study|Withdrawal by Subject|10|||
156416537|NCT04157686|564617870|FG001|Overall Study|Withdrawal by Subject|10|||
156416538|NCT04157686|564617871|FG002|Overall Study|Withdrawal by Subject|12|||
156416539|NCT04157686|564617872|FG003|Overall Study|Withdrawal by Subject|20|||
156416540|NCT04157686|564617873|FG004|Overall Study|Withdrawal by Subject|12|||
156416541|NCT04157686|564617874|FG005|Overall Study|Withdrawal by Subject|11|||
156416542|NCT04157686|564617875|FG006|Overall Study|Withdrawal by Subject|18|||
156416543|NCT04157686|564617876|FG007|Overall Study|Withdrawal by Subject|24|||
156416544|NCT04157686|564617869|FG000|Overall Study|Physician Decision|0|||
156416545|NCT04157686|564617870|FG001|Overall Study|Physician Decision|0|||
156416546|NCT04157686|564617871|FG002|Overall Study|Physician Decision|1|||
156416547|NCT04157686|564617872|FG003|Overall Study|Physician Decision|0|||
156416548|NCT04157686|564617873|FG004|Overall Study|Physician Decision|1|||
156416549|NCT04157686|564617874|FG005|Overall Study|Physician Decision|0|||
156416550|NCT04157686|564617875|FG006|Overall Study|Physician Decision|3|||
156416551|NCT04157686|564617876|FG007|Overall Study|Physician Decision|0|||
156416552|NCT04157686|564617869|FG000|Overall Study|Death|0|||
156416553|NCT04157686|564617870|FG001|Overall Study|Death|0|||
156416554|NCT04157686|564617871|FG002|Overall Study|Death|0|||
156416555|NCT04157686|564617872|FG003|Overall Study|Death|2|||
156416556|NCT04157686|564617873|FG004|Overall Study|Death|0|||
156416557|NCT04157686|564617874|FG005|Overall Study|Death|0|||
156416558|NCT04157686|564617875|FG006|Overall Study|Death|0|||
156416559|NCT04157686|564617876|FG007|Overall Study|Death|0|||
156416560|NCT04157686|564617869|FG000|Overall Study|Protocol Violation|0|||
156416561|NCT04157686|564617870|FG001|Overall Study|Protocol Violation|0|||
156652753|NCT00358826|565476100|FG005|Core Study|Adverse Event|0|||
156652754|NCT00358826|565476101|FG006|Core Study|Adverse Event|0|||
156652755|NCT00358826|565476102|FG007|Core Study|Adverse Event|0|||
156652756|NCT00358826|565476095|FG000|Core Study|Withdrawal by Subject|2|||
156652757|NCT00358826|565476096|FG001|Core Study|Withdrawal by Subject|2|||
156416562|NCT04157686|564617871|FG002|Overall Study|Protocol Violation|0|||
156652758|NCT00358826|565476097|FG002|Core Study|Withdrawal by Subject|0|||
156652759|NCT00358826|565476098|FG003|Core Study|Withdrawal by Subject|0|||
156652760|NCT00358826|565476099|FG004|Core Study|Withdrawal by Subject|0|||
156652761|NCT00358826|565476100|FG005|Core Study|Withdrawal by Subject|0|||
156416563|NCT04157686|564617872|FG003|Overall Study|Protocol Violation|0|||
156416564|NCT04157686|564617873|FG004|Overall Study|Protocol Violation|1|||
156416565|NCT04157686|564617874|FG005|Overall Study|Protocol Violation|0|||
156416566|NCT04157686|564617875|FG006|Overall Study|Protocol Violation|0|||
156416567|NCT04157686|564617876|FG007|Overall Study|Protocol Violation|0|||
156416568|NCT04157686|564617869|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
156416569|NCT04157686|564617870|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
156652762|NCT00358826|565476101|FG006|Core Study|Withdrawal by Subject|0|||
156416570|NCT04157686|564617871|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
156416571|NCT04157686|564617872|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
156416572|NCT04157686|564617873|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
156416573|NCT04157686|564617874|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
156652763|NCT00358826|565476102|FG007|Core Study|Withdrawal by Subject|0|||
156652764|NCT00358826|565476095|FG000|Core Study|Lost to Follow-up|0|||
156652765|NCT00358826|565476096|FG001|Core Study|Lost to Follow-up|0|||
156652766|NCT00358826|565476097|FG002|Core Study|Lost to Follow-up|0|||
156652767|NCT00358826|565476098|FG003|Core Study|Lost to Follow-up|1|||
156416574|NCT04157686|564617875|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
156416575|NCT04157686|564617876|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
156416576|NCT01556243|564617881|FG000|Overall Study|Ineligible|34|||
156416577|NCT01556243|564617881|FG000|Overall Study|Converted to mastectomy|14|||
156416578|NCT01556243|564617881|FG000|Overall Study|Unable to achieve negative margins|2|||
156416579|NCT01556243|564617881|FG000|Overall Study|Withdrawal by Subject|16|||
156416580|NCT01388543|564617882|FG000|Day 14|Adverse Event|1|||
156416581|NCT01388543|564617883|FG001|Day 14|Adverse Event|4|||
156416582|NCT04684914|564617884|FG000|Overall Study|Withdrawal by Subject|1|||
156416583|NCT04684914|564617885|FG001|Overall Study|Withdrawal by Subject|0|||
156416584|NCT04684914|564617884|FG000|Overall Study|Discontinued before receiving study treatment|1|||
156416585|NCT04684914|564617885|FG001|Overall Study|Discontinued before receiving study treatment|2|||
156416586|NCT01671748|564617886|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
156416587|NCT01671748|564617887|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
156416588|NCT01671748|564617886|FG000|4 Week run-in Phase|Adverse Event|1|||
156416589|NCT01671748|564617887|FG001|4 Week run-in Phase|Adverse Event|0|||
156416590|NCT01671748|564617886|FG000|4 Week run-in Phase|Not eligible|9|||
156416591|NCT01671748|564617887|FG001|4 Week run-in Phase|Not eligible|0|||
156416592|NCT03872388|564617890|FG000|Overall Study|Disease Progression|0|||
156416593|NCT03872388|564617891|FG001|Overall Study|Disease Progression|0|||
156416594|NCT03872388|564617892|FG002|Overall Study|Disease Progression|0|||
156416595|NCT03872388|564617893|FG003|Overall Study|Disease Progression|0|||
156416596|NCT03872388|564617894|FG004|Overall Study|Disease Progression|0|||
156416597|NCT03872388|564617895|FG005|Overall Study|Disease Progression|0|||
156416598|NCT03872388|564617896|FG006|Overall Study|Disease Progression|1|||
156416599|NCT03872388|564617897|FG007|Overall Study|Disease Progression|1|||
156416600|NCT05089656|564617899|FG000|Period 1 - First Intervention (52 Weeks)|Physician Decision|1|||
156416601|NCT05089656|564617900|FG001|Period 1 - First Intervention (52 Weeks)|Physician Decision|0|||
156416602|NCT05089656|564617899|FG000|Period 1 - First Intervention (52 Weeks)|Guardian decision|1|||
156416603|NCT05089656|564617900|FG001|Period 1 - First Intervention (52 Weeks)|Guardian decision|0|||
156416604|NCT05089656|564617899|FG000|Period 1 - First Intervention (52 Weeks)|Adverse Event|0|||
156416605|NCT05089656|564617900|FG001|Period 1 - First Intervention (52 Weeks)|Adverse Event|1|||
156416606|NCT05089656|564617899|FG000|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|6|||
156416607|NCT05089656|564617900|FG001|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|4|||
156416608|NCT04191135|564617901|FG000|Induction Treatment|Not Treated|2|||
156416609|NCT04191135|564617902|FG001|Induction Treatment|Not Treated|0|||
156416610|NCT04191135|564617903|FG002|Induction Treatment|Not Treated|0|||
156416611|NCT04191135|564617901|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
156416612|NCT04191135|564617902|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
156416613|NCT04191135|564617903|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
156416614|NCT04191135|564617901|FG000|Induction Treatment|Adverse Event|25|||
156416615|NCT04191135|564617902|FG001|Induction Treatment|Adverse Event|0|||
156416616|NCT04191135|564617903|FG002|Induction Treatment|Adverse Event|0|||
156416617|NCT04191135|564617901|FG000|Induction Treatment|Clinical Progression|8|||
156416618|NCT04191135|564617902|FG001|Induction Treatment|Clinical Progression|0|||
156416619|NCT04191135|564617903|FG002|Induction Treatment|Clinical Progression|0|||
156416620|NCT04191135|564617901|FG000|Induction Treatment|Excluded Medication|1|||
156416621|NCT04191135|564617902|FG001|Induction Treatment|Excluded Medication|0|||
156416622|NCT04191135|564617903|FG002|Induction Treatment|Excluded Medication|0|||
156416623|NCT04191135|564617901|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
156416624|NCT04191135|564617902|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
156416625|NCT04191135|564617903|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
156416626|NCT04191135|564617901|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
156416627|NCT04191135|564617902|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
156416628|NCT04191135|564617903|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
156416629|NCT04191135|564617901|FG000|Induction Treatment|Physician Decision|2|||
156416630|NCT04191135|564617902|FG001|Induction Treatment|Physician Decision|0|||
156416631|NCT04191135|564617903|FG002|Induction Treatment|Physician Decision|0|||
156416632|NCT04191135|564617901|FG000|Induction Treatment|Progressive Disease|135|||
156416633|NCT04191135|564617902|FG001|Induction Treatment|Progressive Disease|0|||
156416634|NCT04191135|564617903|FG002|Induction Treatment|Progressive Disease|0|||
156416635|NCT04191135|564617901|FG000|Induction Treatment|Protocol Violation|10|||
156416636|NCT04191135|564617902|FG001|Induction Treatment|Protocol Violation|0|||
156416637|NCT04191135|564617903|FG002|Induction Treatment|Protocol Violation|0|||
156416638|NCT04191135|564617901|FG000|Induction Treatment|Withdrawal by Subject|4|||
156652768|NCT00358826|565476099|FG004|Core Study|Lost to Follow-up|0|||
156652769|NCT00358826|565476100|FG005|Core Study|Lost to Follow-up|0|||
156416639|NCT04191135|564617902|FG001|Induction Treatment|Withdrawal by Subject|0|||
156416640|NCT04191135|564617903|FG002|Induction Treatment|Withdrawal by Subject|0|||
156416641|NCT04191135|564617901|FG000|Randomized Treatment|Death|0|||
156416642|NCT04191135|564617902|FG001|Randomized Treatment|Death|50|||
156416643|NCT04191135|564617903|FG002|Randomized Treatment|Death|54|||
156416644|NCT04191135|564617901|FG000|Randomized Treatment|Lost to Follow-up|0|||
156416645|NCT04191135|564617902|FG001|Randomized Treatment|Lost to Follow-up|0|||
156416646|NCT04191135|564617903|FG002|Randomized Treatment|Lost to Follow-up|1|||
156416647|NCT04191135|564617901|FG000|Randomized Treatment|Withdrawal by Subject|0|||
156416648|NCT04191135|564617902|FG001|Randomized Treatment|Withdrawal by Subject|2|||
156416649|NCT04191135|564617903|FG002|Randomized Treatment|Withdrawal by Subject|0|||
156756685|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
156756686|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
156756687|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756688|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756689|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756690|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756691|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
156756692|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756693|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
156756694|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
156756695|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756696|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
156756697|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
156756698|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
156756699|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
156756700|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
156756701|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
156756702|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756703|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
156756704|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
156756705|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756706|NCT01300247|565860624|FG000|Overall Study|Death|1|||
156756707|NCT01300247|565860625|FG001|Overall Study|Death|1|||
156756708|NCT01300247|565860624|FG000|Overall Study|Lost to Follow-up|2|||
156756709|NCT01300247|565860625|FG001|Overall Study|Lost to Follow-up|0|||
156756710|NCT01300247|565860624|FG000|Overall Study|Withdrawal by Subject|1|||
156756711|NCT01300247|565860625|FG001|Overall Study|Withdrawal by Subject|0|||
156756712|NCT01300247|565860624|FG000|Overall Study|Non-Compliance|0|||
156756713|NCT01300247|565860625|FG001|Overall Study|Non-Compliance|1|||
156756714|NCT00922116|565860626|FG000|Overall Study|Adverse Event|4|||
156756715|NCT00922116|565860626|FG000|Overall Study|Death|1|||
156756716|NCT00922116|565860626|FG000|Overall Study|Lost to Follow-up|1|||
156756717|NCT00922116|565860626|FG000|Overall Study|Withdrawal by Subject|4|||
156756718|NCT00922116|565860626|FG000|Overall Study|Other|5|||
156756719|NCT02364388|565860627|FG000|Overall Study|Protocol Violation|1|||
156756720|NCT02364388|565860627|FG000|Overall Study|Technical Failure|3|||
156756721|NCT02364388|565860627|FG000|Overall Study|No OA/US data|2|||
156756722|NCT02364388|565860627|FG000|Overall Study|No Biopsy|2|||
156756723|NCT03231306|565860628|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
156756724|NCT03231306|565860628|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
156756725|NCT03231306|565860628|FG000|Overall Study|Treatment delay > 21 days|2|||
156756726|NCT03231306|565860628|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
156756727|NCT03231306|565860628|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
156756728|NCT03231306|565860628|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
156756729|NCT03231306|565860628|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
156756730|NCT03231306|565860628|FG000|Overall Study|More than 1 Reason|2|||
156756731|NCT02585713|565860629|FG000|Overall Study|Withdrew prior to treatment|2|||
156756732|NCT02585713|565860630|FG001|Overall Study|Withdrew prior to treatment|7|||
156756733|NCT02585713|565860629|FG000|Overall Study|Other|3|||
156756734|NCT02585713|565860630|FG001|Overall Study|Other|1|||
156756735|NCT02609984|565860636|FG000|Overall Study|Death|29|||
156416650|NCT04191135|564617901|FG000|Randomized Treatment|Ongoing in Trial|0|||
156416651|NCT04191135|564617902|FG001|Randomized Treatment|Ongoing in Trial|83|||
156416652|NCT04191135|564617903|FG002|Randomized Treatment|Ongoing in Trial|81|||
156416653|NCT04145349|564619846|FG000|Overall Study|Withdrawal by Subject|3|||
156416654|NCT04145349|564619847|FG001|Overall Study|Withdrawal by Subject|0|||
156756736|NCT02609984|565860637|FG001|Overall Study|Death|26|||
156756737|NCT02609984|565860636|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
156756738|NCT02609984|565860637|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
156756739|NCT02609984|565860636|FG000|Overall Study|Lost to Follow-up|1|||
156756740|NCT02609984|565860637|FG001|Overall Study|Lost to Follow-up|2|||
156756741|NCT02609984|565860636|FG000|Overall Study|Withdrawal by Subject|0|||
156756742|NCT02609984|565860637|FG001|Overall Study|Withdrawal by Subject|1|||
156756743|NCT02609984|565860636|FG000|Overall Study|Disease Progression|2|||
156756744|NCT02609984|565860637|FG001|Overall Study|Disease Progression|0|||
156756745|NCT01843803|565860639|FG000|Overall Study|not a Veteran, did not see provider|1|||
156756746|NCT01843803|565860640|FG001|Overall Study|not a Veteran, did not see provider|3|||
156756747|NCT00784719|565860646|FG000|Overall Study|Adverse Event|0|||
156756748|NCT00784719|565860647|FG001|Overall Study|Adverse Event|2|||
156756749|NCT00784719|565860648|FG002|Overall Study|Adverse Event|0|||
156315512|NCT02025556|564254362|FG001|Overall Study|Lost to Follow-up|4|||
156315513|NCT02025556|564254363|FG002|Overall Study|Lost to Follow-up|0|||
156315514|NCT02025556|564254361|FG000|Overall Study|Reason not reported|0|||
156315515|NCT02025556|564254362|FG001|Overall Study|Reason not reported|0|||
156315516|NCT02025556|564254363|FG002|Overall Study|Reason not reported|1|||
156315517|NCT00627445|564254365|FG000|Overall Study|Adverse Event|3|||
156315518|NCT00627445|564254366|FG001|Overall Study|Adverse Event|3|||
156315519|NCT00627445|564254365|FG000|Overall Study|Lack of Efficacy|0|||
156315520|NCT00627445|564254366|FG001|Overall Study|Lack of Efficacy|1|||
156315521|NCT00627445|564254365|FG000|Overall Study|Other|6|||
156315522|NCT00627445|564254366|FG001|Overall Study|Other|8|||
156315523|NCT01238588|564254368|FG000|Overall Study|Withdrawal by Subject|1|||
156315524|NCT01238588|564254368|FG000|Overall Study|Physician Decision|2|||
156315525|NCT00796991|564254373|FG000|Overall Study|Adverse Event|0|||
156315526|NCT00796991|564254374|FG001|Overall Study|Adverse Event|0|||
156315527|NCT00796991|564254375|FG002|Overall Study|Adverse Event|1|||
156315528|NCT00796991|564254373|FG000|Overall Study|Death|2|||
156315529|NCT00796991|564254374|FG001|Overall Study|Death|0|||
156315530|NCT00796991|564254375|FG002|Overall Study|Death|0|||
156315531|NCT00796991|564254373|FG000|Overall Study|Disease Progression|10|||
156315532|NCT00796991|564254374|FG001|Overall Study|Disease Progression|9|||
156315533|NCT00796991|564254375|FG002|Overall Study|Disease Progression|7|||
156315534|NCT00796991|564254373|FG000|Overall Study|Study Drug Toxicity|3|||
156315535|NCT00796991|564254374|FG001|Overall Study|Study Drug Toxicity|3|||
156315536|NCT00796991|564254375|FG002|Overall Study|Study Drug Toxicity|5|||
156315537|NCT00796991|564254373|FG000|Overall Study|Withdrawal by Subject|0|||
156315538|NCT00796991|564254374|FG001|Overall Study|Withdrawal by Subject|0|||
156315539|NCT00796991|564254375|FG002|Overall Study|Withdrawal by Subject|1|||
156315540|NCT00834080|564254377|FG000|Overall Study|Adverse Event|7|||
156315541|NCT00834080|564254377|FG000|Overall Study|Lost to Follow-up|7|||
156315542|NCT00834080|564254377|FG000|Overall Study|Withdrawal by Subject|5|||
156315543|NCT00834080|564254377|FG000|Overall Study|Other - Pregnancy|1|||
156315544|NCT00834080|564254377|FG000|Overall Study|Other - False positive tests of the UDS|1|||
156315545|NCT00834080|564254377|FG000|Overall Study|Physician Decision|1|||
156315546|NCT00834080|564254377|FG000|Overall Study|Subject Relocated|1|||
156315547|NCT04345367|564254379|FG000|Overall Study|Other|3|||
156315548|NCT04345367|564254380|FG001|Overall Study|Other|4|||
156315549|NCT04345367|564254379|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
156315550|NCT04345367|564254380|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
156315551|NCT04345367|564254379|FG000|Overall Study|Withdrawal by Subject|11|||
156315552|NCT04345367|564254380|FG001|Overall Study|Withdrawal by Subject|11|||
156315553|NCT04345367|564254379|FG000|Overall Study|Protocol Violation|4|||
156315554|NCT04345367|564254380|FG001|Overall Study|Protocol Violation|3|||
156315555|NCT04345367|564254379|FG000|Overall Study|Lost to Follow-up|2|||
156315556|NCT04345367|564254380|FG001|Overall Study|Lost to Follow-up|4|||
156315557|NCT04345367|564254379|FG000|Overall Study|Lack of Efficacy|2|||
156315558|NCT04345367|564254380|FG001|Overall Study|Lack of Efficacy|0|||
156315559|NCT04345367|564254379|FG000|Overall Study|Death|2|||
156315560|NCT04345367|564254380|FG001|Overall Study|Death|0|||
156315561|NCT04345367|564254379|FG000|Overall Study|Adverse Event|10|||
156315562|NCT04345367|564254380|FG001|Overall Study|Adverse Event|9|||
156315563|NCT00796523|564254381|FG000|Overall Study|Lost to Follow-up|9|||
156315564|NCT00796523|564254382|FG001|Overall Study|Lost to Follow-up|7|||
156315565|NCT02431260|564254383|FG000|Overall Study|Subject Decision|0|||
156315566|NCT02431260|564254384|FG001|Overall Study|Subject Decision|1|||
156315567|NCT02431260|564254385|FG002|Overall Study|Subject Decision|1|||
156315568|NCT02431260|564254386|FG003|Overall Study|Subject Decision|0|||
156315569|NCT02431260|564254387|FG004|Overall Study|Subject Decision|0|||
156315570|NCT02431260|564254388|FG005|Overall Study|Subject Decision|0|||
156315571|NCT02431260|564254389|FG006|Overall Study|Subject Decision|0|||
156315572|NCT02431260|564254390|FG007|Overall Study|Subject Decision|0|||
156315573|NCT02431260|564254391|FG008|Overall Study|Subject Decision|1|||
156315574|NCT02431260|564254392|FG009|Overall Study|Subject Decision|1|||
156315575|NCT02431260|564254393|FG010|Overall Study|Subject Decision|0|||
156315576|NCT02431260|564254394|FG011|Overall Study|Subject Decision|1|||
156315577|NCT02431260|564254395|FG012|Overall Study|Subject Decision|0|||
156315578|NCT02431260|564254396|FG013|Overall Study|Subject Decision|0|||
156315579|NCT02431260|564254383|FG000|Overall Study|Death|4|||
156315580|NCT02431260|564254384|FG001|Overall Study|Death|4|||
156756750|NCT00784719|565860649|FG003|Overall Study|Adverse Event|0|||
156756751|NCT00784719|565860650|FG004|Overall Study|Adverse Event|1|||
156756752|NCT00784719|565860651|FG005|Overall Study|Adverse Event|1|||
156756753|NCT00784719|565860652|FG006|Overall Study|Adverse Event|1|||
156756754|NCT00784719|565860646|FG000|Overall Study|Lost to Follow-up|0|||
156315581|NCT02431260|564254385|FG002|Overall Study|Death|3|||
156315582|NCT02431260|564254386|FG003|Overall Study|Death|4|||
156315583|NCT02431260|564254387|FG004|Overall Study|Death|2|||
156315584|NCT02431260|564254388|FG005|Overall Study|Death|2|||
156315585|NCT02431260|564254389|FG006|Overall Study|Death|3|||
156315586|NCT02431260|564254390|FG007|Overall Study|Death|1|||
156315587|NCT02431260|564254391|FG008|Overall Study|Death|6|||
156315588|NCT02431260|564254392|FG009|Overall Study|Death|6|||
156315589|NCT02431260|564254393|FG010|Overall Study|Death|3|||
156315590|NCT02431260|564254394|FG011|Overall Study|Death|2|||
156315591|NCT02431260|564254395|FG012|Overall Study|Death|5|||
156315592|NCT02431260|564254396|FG013|Overall Study|Death|1|||
156315593|NCT02431260|564254383|FG000|Overall Study|Lost to Follow-up|0|||
156315594|NCT02431260|564254384|FG001|Overall Study|Lost to Follow-up|0|||
156315595|NCT02431260|564254385|FG002|Overall Study|Lost to Follow-up|0|||
156315596|NCT02431260|564254386|FG003|Overall Study|Lost to Follow-up|0|||
156315597|NCT02431260|564254387|FG004|Overall Study|Lost to Follow-up|0|||
156315598|NCT02431260|564254388|FG005|Overall Study|Lost to Follow-up|1|||
156315599|NCT02431260|564254389|FG006|Overall Study|Lost to Follow-up|0|||
156315600|NCT02431260|564254390|FG007|Overall Study|Lost to Follow-up|0|||
156315601|NCT02431260|564254391|FG008|Overall Study|Lost to Follow-up|0|||
156315602|NCT02431260|564254392|FG009|Overall Study|Lost to Follow-up|0|||
156315603|NCT02431260|564254393|FG010|Overall Study|Lost to Follow-up|0|||
156315604|NCT02431260|564254394|FG011|Overall Study|Lost to Follow-up|0|||
156315605|NCT02431260|564254395|FG012|Overall Study|Lost to Follow-up|0|||
156315606|NCT02431260|564254396|FG013|Overall Study|Lost to Follow-up|0|||
156315607|NCT02431260|564254383|FG000|Overall Study|Study Terminated by the Sponsor|0|||
156315608|NCT02431260|564254384|FG001|Overall Study|Study Terminated by the Sponsor|0|||
156315609|NCT02431260|564254385|FG002|Overall Study|Study Terminated by the Sponsor|2|||
156315610|NCT02431260|564254386|FG003|Overall Study|Study Terminated by the Sponsor|1|||
156315611|NCT02431260|564254387|FG004|Overall Study|Study Terminated by the Sponsor|1|||
156315612|NCT02431260|564254388|FG005|Overall Study|Study Terminated by the Sponsor|0|||
156315613|NCT02431260|564254389|FG006|Overall Study|Study Terminated by the Sponsor|1|||
156315614|NCT02431260|564254390|FG007|Overall Study|Study Terminated by the Sponsor|2|||
156315615|NCT02431260|564254391|FG008|Overall Study|Study Terminated by the Sponsor|1|||
156315616|NCT02431260|564254392|FG009|Overall Study|Study Terminated by the Sponsor|1|||
156315617|NCT02431260|564254393|FG010|Overall Study|Study Terminated by the Sponsor|1|||
156315618|NCT02431260|564254394|FG011|Overall Study|Study Terminated by the Sponsor|0|||
156315619|NCT02431260|564254395|FG012|Overall Study|Study Terminated by the Sponsor|4|||
156315620|NCT02431260|564254396|FG013|Overall Study|Study Terminated by the Sponsor|0|||
156315621|NCT02431260|564254383|FG000|Overall Study|Physician Decision|0|||
156315622|NCT02431260|564254384|FG001|Overall Study|Physician Decision|0|||
156315623|NCT02431260|564254385|FG002|Overall Study|Physician Decision|0|||
156315624|NCT02431260|564254386|FG003|Overall Study|Physician Decision|0|||
156315625|NCT02431260|564254387|FG004|Overall Study|Physician Decision|0|||
156315626|NCT02431260|564254388|FG005|Overall Study|Physician Decision|1|||
156315627|NCT02431260|564254389|FG006|Overall Study|Physician Decision|0|||
156315628|NCT02431260|564254390|FG007|Overall Study|Physician Decision|0|||
156315629|NCT02431260|564254391|FG008|Overall Study|Physician Decision|0|||
156315630|NCT02431260|564254392|FG009|Overall Study|Physician Decision|0|||
156315631|NCT02431260|564254393|FG010|Overall Study|Physician Decision|0|||
156315632|NCT02431260|564254394|FG011|Overall Study|Physician Decision|0|||
156315633|NCT02431260|564254395|FG012|Overall Study|Physician Decision|0|||
156315634|NCT02431260|564254396|FG013|Overall Study|Physician Decision|0|||
156315635|NCT02431260|564254383|FG000|Overall Study|Other Unspecified|0|||
156315636|NCT02431260|564254384|FG001|Overall Study|Other Unspecified|0|||
156315637|NCT02431260|564254385|FG002|Overall Study|Other Unspecified|0|||
156315638|NCT02431260|564254386|FG003|Overall Study|Other Unspecified|0|||
156416655|NCT04145349|564619846|FG000|Overall Study|Lost to Follow-up|0|||
156756755|NCT00784719|565860647|FG001|Overall Study|Lost to Follow-up|0|||
156756756|NCT00784719|565860648|FG002|Overall Study|Lost to Follow-up|0|||
156315639|NCT02431260|564254387|FG004|Overall Study|Other Unspecified|0|||
156315640|NCT02431260|564254388|FG005|Overall Study|Other Unspecified|0|||
156315641|NCT02431260|564254389|FG006|Overall Study|Other Unspecified|0|||
156315642|NCT02431260|564254390|FG007|Overall Study|Other Unspecified|0|||
156315643|NCT02431260|564254391|FG008|Overall Study|Other Unspecified|0|||
156315644|NCT02431260|564254392|FG009|Overall Study|Other Unspecified|0|||
156315645|NCT02431260|564254393|FG010|Overall Study|Other Unspecified|0|||
156315646|NCT02431260|564254394|FG011|Overall Study|Other Unspecified|1|||
156315647|NCT02431260|564254395|FG012|Overall Study|Other Unspecified|1|||
156315648|NCT02431260|564254396|FG013|Overall Study|Other Unspecified|0|||
156315649|NCT00439738|564254398|FG000|Overall Study|Withdrawal by Subject|16|||
156315650|NCT00439738|564254399|FG001|Overall Study|Withdrawal by Subject|13|||
156315651|NCT00439738|564254398|FG000|Overall Study|Adverse Event|6|||
156315652|NCT00439738|564254399|FG001|Overall Study|Adverse Event|4|||
156756757|NCT00784719|565860649|FG003|Overall Study|Lost to Follow-up|0|||
156756758|NCT00784719|565860650|FG004|Overall Study|Lost to Follow-up|1|||
156416656|NCT04145349|564619847|FG001|Overall Study|Lost to Follow-up|1|||
156416657|NCT04145349|564619846|FG000|Overall Study|On study treatment (Ongoing)|0|||
156416658|NCT04145349|564619847|FG001|Overall Study|On study treatment (Ongoing)|1|||
156416659|NCT03038672|564619848|FG000|Initial Treatment|Unacceptable chemistry|0|||
156416660|NCT03038672|564619849|FG001|Initial Treatment|Unacceptable chemistry|1|||
156416661|NCT03038672|564619848|FG000|Initial Treatment|Progression prior to treatment|1|||
156416662|NCT03038672|564619849|FG001|Initial Treatment|Progression prior to treatment|0|||
156416663|NCT03038672|564619848|FG000|Initial Treatment|No treatment per protocol|1|||
156416664|NCT03038672|564619849|FG001|Initial Treatment|No treatment per protocol|0|||
156416665|NCT04423393|564619850|FG000|Overall Study|Withdrawal by Subject|0|||
156416666|NCT04423393|564619851|FG001|Overall Study|Withdrawal by Subject|0|||
156416667|NCT04423393|564619852|FG002|Overall Study|Withdrawal by Subject|0|||
156416668|NCT04423393|564619853|FG003|Overall Study|Withdrawal by Subject|0|||
156416669|NCT04423393|564619854|FG004|Overall Study|Withdrawal by Subject|0|||
156416670|NCT04423393|564619855|FG005|Overall Study|Withdrawal by Subject|1|||
156416671|NCT04423393|564619856|FG006|Overall Study|Withdrawal by Subject|0|||
156416672|NCT04423393|564619857|FG007|Overall Study|Withdrawal by Subject|0|||
156416673|NCT04423393|564619858|FG008|Overall Study|Withdrawal by Subject|0|||
156416674|NCT04423393|564619859|FG009|Overall Study|Withdrawal by Subject|0|||
156416675|NCT04423393|564619860|FG010|Overall Study|Withdrawal by Subject|0|||
156416676|NCT04423393|564619861|FG011|Overall Study|Withdrawal by Subject|0|||
156416677|NCT04423393|564619862|FG012|Overall Study|Withdrawal by Subject|0|||
156416678|NCT04423393|564619863|FG013|Overall Study|Withdrawal by Subject|1|||
156416679|NCT04423393|564619864|FG014|Overall Study|Withdrawal by Subject|0|||
156416680|NCT04423393|564619865|FG015|Overall Study|Withdrawal by Subject|0|||
156416681|NCT04423393|564619866|FG016|Overall Study|Withdrawal by Subject|0|||
156416682|NCT04423393|564619867|FG017|Overall Study|Withdrawal by Subject|0|||
156416683|NCT04423393|564619850|FG000|Overall Study|Sponsor Decision|0|||
156416684|NCT04423393|564619851|FG001|Overall Study|Sponsor Decision|0|||
156416685|NCT04423393|564619852|FG002|Overall Study|Sponsor Decision|0|||
156416686|NCT04423393|564619853|FG003|Overall Study|Sponsor Decision|0|||
156416687|NCT04423393|564619854|FG004|Overall Study|Sponsor Decision|0|||
156416688|NCT04423393|564619855|FG005|Overall Study|Sponsor Decision|0|||
156416689|NCT04423393|564619856|FG006|Overall Study|Sponsor Decision|0|||
156416690|NCT04423393|564619857|FG007|Overall Study|Sponsor Decision|0|||
156416691|NCT04423393|564619858|FG008|Overall Study|Sponsor Decision|0|||
156416692|NCT04423393|564619859|FG009|Overall Study|Sponsor Decision|0|||
156416693|NCT04423393|564619860|FG010|Overall Study|Sponsor Decision|0|||
156416694|NCT04423393|564619861|FG011|Overall Study|Sponsor Decision|0|||
156416695|NCT04423393|564619862|FG012|Overall Study|Sponsor Decision|0|||
156416696|NCT04423393|564619863|FG013|Overall Study|Sponsor Decision|1|||
156416697|NCT04423393|564619864|FG014|Overall Study|Sponsor Decision|0|||
156416698|NCT04423393|564619865|FG015|Overall Study|Sponsor Decision|0|||
156416699|NCT04423393|564619866|FG016|Overall Study|Sponsor Decision|0|||
156416700|NCT04423393|564619867|FG017|Overall Study|Sponsor Decision|0|||
156416701|NCT05220501|564619868|FG000|Overall Study|Withdrawal by Subject|11|||
156416702|NCT05220501|564619869|FG001|Overall Study|Withdrawal by Subject|21|||
156416703|NCT05220501|564619870|FG002|Overall Study|Withdrawal by Subject|32|||
156416704|NCT05220501|564619868|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
156416705|NCT05220501|564619869|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
156416706|NCT05220501|564619870|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
156416707|NCT01929993|564619871|FG000|Overall Study|Protocol Violation|4|||
156416708|NCT01929993|564619872|FG001|Overall Study|Protocol Violation|6|||
156416709|NCT01929993|564619871|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
156416710|NCT01929993|564619872|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
156416711|NCT03673098|564619873|FG000|Overall Study|Lost to Follow-up|2|||
156416712|NCT03673098|564619874|FG001|Overall Study|Lost to Follow-up|3|||
156416713|NCT03673098|564619873|FG000|Overall Study|Withdrawal by Subject|6|||
156416714|NCT03673098|564619874|FG001|Overall Study|Withdrawal by Subject|1|||
156416715|NCT03673098|564619873|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
156416716|NCT03673098|564619874|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
156416717|NCT01268059|564619875|FG000|Overall Study|Lost to Follow-up|0|||
156416718|NCT01268059|564619876|FG001|Overall Study|Lost to Follow-up|1|||
156416719|NCT01268059|564619877|FG002|Overall Study|Lost to Follow-up|0|||
156416720|NCT01268059|564619878|FG003|Overall Study|Lost to Follow-up|0|||
156416721|NCT01268059|564619875|FG000|Overall Study|Withdrawal by Subject|7|||
156416722|NCT01268059|564619876|FG001|Overall Study|Withdrawal by Subject|4|||
156416723|NCT01268059|564619877|FG002|Overall Study|Withdrawal by Subject|0|||
156416724|NCT01268059|564619878|FG003|Overall Study|Withdrawal by Subject|0|||
156416725|NCT01268059|564619875|FG000|Overall Study|Death|20|||
156756759|NCT00784719|565860651|FG005|Overall Study|Lost to Follow-up|1|||
156416726|NCT01268059|564619876|FG001|Overall Study|Death|30|||
156416727|NCT01268059|564619877|FG002|Overall Study|Death|3|||
156416728|NCT01268059|564619878|FG003|Overall Study|Death|5|||
156756760|NCT00784719|565860652|FG006|Overall Study|Lost to Follow-up|0|||
156416729|NCT01268059|564619875|FG000|Overall Study|Progression of disease|1|||
156416730|NCT01268059|564619876|FG001|Overall Study|Progression of disease|0|||
156416731|NCT01268059|564619877|FG002|Overall Study|Progression of disease|0|||
156416732|NCT01268059|564619878|FG003|Overall Study|Progression of disease|0|||
156416733|NCT03660943|564619879|FG000|Overall Study|Adverse Event|5|||
156416734|NCT03660943|564619880|FG001|Overall Study|Adverse Event|3|||
156416735|NCT03660943|564619879|FG000|Overall Study|Death|0|||
156416736|NCT03660943|564619880|FG001|Overall Study|Death|2|||
156416737|NCT03660943|564619879|FG000|Overall Study|Lost to Follow-up|7|||
156416738|NCT03660943|564619880|FG001|Overall Study|Lost to Follow-up|3|||
156416739|NCT03660943|564619879|FG000|Overall Study|Protocol Violation|3|||
156416740|NCT03660943|564619880|FG001|Overall Study|Protocol Violation|5|||
156416741|NCT03660943|564619879|FG000|Overall Study|Withdrawal by Subject|8|||
156416742|NCT03660943|564619880|FG001|Overall Study|Withdrawal by Subject|15|||
156416743|NCT03660943|564619879|FG000|Overall Study|Lack of Efficacy|9|||
156416744|NCT03660943|564619880|FG001|Overall Study|Lack of Efficacy|12|||
156416745|NCT03660943|564619879|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
156416746|NCT03660943|564619880|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
156416747|NCT01021878|564619881|FG000|Overall Study|Lost to Follow-up|4|||
156416748|NCT01021878|564619882|FG001|Overall Study|Lost to Follow-up|3|||
156652770|NCT00358826|565476101|FG006|Core Study|Lost to Follow-up|0|||
156652771|NCT00358826|565476102|FG007|Core Study|Lost to Follow-up|0|||
156652772|NCT00358826|565476095|FG000|Core Study|Physician Decision|0|||
156652773|NCT00358826|565476096|FG001|Core Study|Physician Decision|0|||
156652774|NCT00358826|565476097|FG002|Core Study|Physician Decision|1|||
156652775|NCT00358826|565476098|FG003|Core Study|Physician Decision|0|||
156652776|NCT00358826|565476099|FG004|Core Study|Physician Decision|0|||
156652777|NCT00358826|565476100|FG005|Core Study|Physician Decision|0|||
156652778|NCT00358826|565476101|FG006|Core Study|Physician Decision|0|||
156652779|NCT00358826|565476102|FG007|Core Study|Physician Decision|0|||
156652780|NCT00358826|565476095|FG000|MDCT Substudy|Adverse Event|0|||
156652781|NCT00358826|565476096|FG001|MDCT Substudy|Adverse Event|0|||
156652782|NCT00358826|565476097|FG002|MDCT Substudy|Adverse Event|0|||
156652783|NCT00358826|565476098|FG003|MDCT Substudy|Adverse Event|0|||
156652784|NCT00358826|565476099|FG004|MDCT Substudy|Adverse Event|1|||
156652785|NCT00358826|565476100|FG005|MDCT Substudy|Adverse Event|0|||
156652786|NCT00358826|565476101|FG006|MDCT Substudy|Adverse Event|0|||
156652787|NCT00358826|565476102|FG007|MDCT Substudy|Adverse Event|0|||
156652788|NCT00358826|565476095|FG000|MDCT Substudy|Lost to Follow-up|0|||
156652789|NCT00358826|565476096|FG001|MDCT Substudy|Lost to Follow-up|0|||
156652790|NCT00358826|565476097|FG002|MDCT Substudy|Lost to Follow-up|0|||
156652791|NCT00358826|565476098|FG003|MDCT Substudy|Lost to Follow-up|0|||
156652792|NCT00358826|565476099|FG004|MDCT Substudy|Lost to Follow-up|0|||
156652793|NCT00358826|565476100|FG005|MDCT Substudy|Lost to Follow-up|1|||
156652794|NCT00358826|565476101|FG006|MDCT Substudy|Lost to Follow-up|0|||
156652795|NCT00358826|565476102|FG007|MDCT Substudy|Lost to Follow-up|0|||
156652796|NCT00358826|565476095|FG000|MDCT Substudy|Withdrawal by Subject|0|||
156652797|NCT00358826|565476096|FG001|MDCT Substudy|Withdrawal by Subject|0|||
156652798|NCT00358826|565476097|FG002|MDCT Substudy|Withdrawal by Subject|0|||
156652799|NCT00358826|565476098|FG003|MDCT Substudy|Withdrawal by Subject|0|||
156652800|NCT00358826|565476099|FG004|MDCT Substudy|Withdrawal by Subject|0|||
156652801|NCT00358826|565476100|FG005|MDCT Substudy|Withdrawal by Subject|1|||
156652802|NCT00358826|565476101|FG006|MDCT Substudy|Withdrawal by Subject|0|||
156652803|NCT00358826|565476102|FG007|MDCT Substudy|Withdrawal by Subject|0|||
156652804|NCT00903383|565476106|FG000|Overall Study|Adverse Event|1|||
156652805|NCT00903383|565476107|FG001|Overall Study|Adverse Event|2|||
156652806|NCT00903383|565476108|FG002|Overall Study|Adverse Event|3|||
156652807|NCT00903383|565476109|FG003|Overall Study|Adverse Event|1|||
156652808|NCT00903383|565476106|FG000|Overall Study|Physician Decision|1|||
156652809|NCT00903383|565476107|FG001|Overall Study|Physician Decision|2|||
156652810|NCT00903383|565476108|FG002|Overall Study|Physician Decision|0|||
156652811|NCT00903383|565476109|FG003|Overall Study|Physician Decision|0|||
156652812|NCT00903383|565476106|FG000|Overall Study|Lost to Follow-up|0|||
156652813|NCT00903383|565476107|FG001|Overall Study|Lost to Follow-up|0|||
156652814|NCT00903383|565476108|FG002|Overall Study|Lost to Follow-up|0|||
156652815|NCT00903383|565476109|FG003|Overall Study|Lost to Follow-up|1|||
156652816|NCT00903383|565476106|FG000|Overall Study|Decision of Sponsor|1|||
156652817|NCT00903383|565476107|FG001|Overall Study|Decision of Sponsor|0|||
156652818|NCT00903383|565476108|FG002|Overall Study|Decision of Sponsor|0|||
156652819|NCT00903383|565476109|FG003|Overall Study|Decision of Sponsor|0|||
156652820|NCT00903383|565476106|FG000|Overall Study|Withdrawal by Subject|4|||
156416749|NCT01021878|564619881|FG000|Overall Study|Death|0|||
156416750|NCT01021878|564619882|FG001|Overall Study|Death|1|||
156416751|NCT01021878|564619881|FG000|Overall Study|Adverse Event|6|||
156416752|NCT01021878|564619882|FG001|Overall Study|Adverse Event|5|||
156652821|NCT00903383|565476107|FG001|Overall Study|Withdrawal by Subject|1|||
156652822|NCT00903383|565476108|FG002|Overall Study|Withdrawal by Subject|0|||
156652823|NCT00903383|565476109|FG003|Overall Study|Withdrawal by Subject|2|||
156652824|NCT00903383|565476106|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
156416753|NCT01021878|564619881|FG000|Overall Study|Transplantation|6|||
156416754|NCT01021878|564619882|FG001|Overall Study|Transplantation|1|||
156416755|NCT01155726|564619883|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
156416756|NCT01155726|564619884|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
156416757|NCT01155726|564619885|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
156416758|NCT01155726|564619886|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
156416759|NCT05675709|564619889|FG000|Overall Study|incomplete outcome data|2|||
156416760|NCT05675709|564619890|FG001|Overall Study|incomplete outcome data|8|||
156416761|NCT05876351|564619891|FG000|Overall Study|Other than specified|2|||
156416762|NCT05876351|564619891|FG000|Overall Study|Study specific discontinuation criteria|1|||
156416763|NCT02268552|564619892|FG000|Part 1|Death|1|||
156416764|NCT02268552|564619893|FG001|Part 1|Death|1|||
156416765|NCT02268552|564619894|FG002|Part 1|Death|1|||
156416766|NCT02268552|564619895|FG003|Part 1|Death|2|||
156416767|NCT02268552|564619896|FG004|Part 1|Death|0|||
156416768|NCT02268552|564619897|FG005|Part 1|Death|0|||
156416769|NCT02268552|564619898|FG006|Part 1|Death|0|||
156416770|NCT02268552|564619892|FG000|Part 1|Subject/guardian decision|0|||
156416771|NCT02268552|564619893|FG001|Part 1|Subject/guardian decision|0|||
156416772|NCT02268552|564619894|FG002|Part 1|Subject/guardian decision|0|||
156416773|NCT02268552|564619895|FG003|Part 1|Subject/guardian decision|1|||
156416774|NCT02268552|564619896|FG004|Part 1|Subject/guardian decision|0|||
156416775|NCT02268552|564619897|FG005|Part 1|Subject/guardian decision|0|||
156416776|NCT02268552|564619898|FG006|Part 1|Subject/guardian decision|0|||
156416777|NCT02268552|564619892|FG000|Part 2|Death|0|||
156416778|NCT02268552|564619893|FG001|Part 2|Death|0|||
156416779|NCT02268552|564619894|FG002|Part 2|Death|0|||
156416780|NCT02268552|564619895|FG003|Part 2|Death|0|||
156416781|NCT02268552|564619896|FG004|Part 2|Death|0|||
156416782|NCT02268552|564619897|FG005|Part 2|Death|0|||
156416783|NCT02268552|564619898|FG006|Part 2|Death|2|||
156416784|NCT02268552|564619892|FG000|Part 2|Subject/guardian decision|0|||
156416785|NCT02268552|564619893|FG001|Part 2|Subject/guardian decision|0|||
156416786|NCT02268552|564619894|FG002|Part 2|Subject/guardian decision|0|||
156416787|NCT02268552|564619895|FG003|Part 2|Subject/guardian decision|0|||
156416788|NCT02268552|564619896|FG004|Part 2|Subject/guardian decision|0|||
156416789|NCT02268552|564619897|FG005|Part 2|Subject/guardian decision|0|||
156416790|NCT02268552|564619898|FG006|Part 2|Subject/guardian decision|1|||
156416791|NCT02268552|564619892|FG000|Part 3 Extension|Death|0|||
156416792|NCT02268552|564619893|FG001|Part 3 Extension|Death|1|||
156416793|NCT02268552|564619894|FG002|Part 3 Extension|Death|1|||
156416794|NCT02268552|564619895|FG003|Part 3 Extension|Death|1|||
156652825|NCT00903383|565476107|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
156652826|NCT00903383|565476108|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
156652827|NCT00903383|565476109|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
156652828|NCT00903383|565476106|FG000|Overall Study|Patient Decision|0|||
156652829|NCT00903383|565476107|FG001|Overall Study|Patient Decision|0|||
156652830|NCT00903383|565476108|FG002|Overall Study|Patient Decision|0|||
156652831|NCT00903383|565476109|FG003|Overall Study|Patient Decision|1|||
156652832|NCT02015793|565476114|FG000|Overall Study|Adverse Event|3|||
156652833|NCT02015793|565476115|FG001|Overall Study|Adverse Event|3|||
156652834|NCT02015793|565476114|FG000|Overall Study|Withdrawal by Subject|1|||
156652835|NCT02015793|565476115|FG001|Overall Study|Withdrawal by Subject|1|||
156652836|NCT00320593|565476116|FG000|Overall Study|Lost to Follow-up|3|||
156652837|NCT00320593|565476117|FG001|Overall Study|Lost to Follow-up|0|||
156652838|NCT00320593|565476116|FG000|Overall Study|Moved to another state|1|||
156652839|NCT00320593|565476117|FG001|Overall Study|Moved to another state|0|||
156652840|NCT00320593|565476116|FG000|Overall Study|Withdrawal by Subject|2|||
156652841|NCT00320593|565476117|FG001|Overall Study|Withdrawal by Subject|1|||
156652842|NCT00320593|565476116|FG000|Overall Study|Withdrawal by clinical center|1|||
156652843|NCT00320593|565476117|FG001|Overall Study|Withdrawal by clinical center|0|||
156652844|NCT00283686|565476118|FG000|Overall Study|Death|1|||
156652845|NCT00283686|565476119|FG001|Overall Study|Death|1|||
156652846|NCT00283686|565476120|FG002|Overall Study|Death|1|||
156652847|NCT00283686|565476121|FG003|Overall Study|Death|0|||
156652848|NCT00283686|565476118|FG000|Overall Study|Lost to Follow-up|21|||
156652849|NCT00283686|565476119|FG001|Overall Study|Lost to Follow-up|31|||
156416795|NCT02268552|564619896|FG004|Part 3 Extension|Death|1|||
156416796|NCT02268552|564619897|FG005|Part 3 Extension|Death|1|||
156416797|NCT02268552|564619898|FG006|Part 3 Extension|Death|0|||
156416798|NCT02268552|564619892|FG000|Part 3 Extension|Early termination of trial|1|||
156416799|NCT02268552|564619893|FG001|Part 3 Extension|Early termination of trial|0|||
156416800|NCT02268552|564619894|FG002|Part 3 Extension|Early termination of trial|0|||
156416801|NCT02268552|564619895|FG003|Part 3 Extension|Early termination of trial|0|||
156416802|NCT02268552|564619896|FG004|Part 3 Extension|Early termination of trial|2|||
156416803|NCT02268552|564619897|FG005|Part 3 Extension|Early termination of trial|9|||
156416804|NCT02268552|564619898|FG006|Part 3 Extension|Early termination of trial|11|||
156652850|NCT00283686|565476120|FG002|Overall Study|Lost to Follow-up|26|||
156652851|NCT00283686|565476121|FG003|Overall Study|Lost to Follow-up|20|||
156416805|NCT02268552|564619892|FG000|Part 3 Extension|Subject/guardian decision|0|||
156416806|NCT02268552|564619893|FG001|Part 3 Extension|Subject/guardian decision|0|||
156416807|NCT02268552|564619894|FG002|Part 3 Extension|Subject/guardian decision|0|||
156416808|NCT02268552|564619895|FG003|Part 3 Extension|Subject/guardian decision|0|||
156416809|NCT02268552|564619896|FG004|Part 3 Extension|Subject/guardian decision|0|||
156416810|NCT02268552|564619897|FG005|Part 3 Extension|Subject/guardian decision|0|||
156416811|NCT02268552|564619898|FG006|Part 3 Extension|Subject/guardian decision|1|||
156416812|NCT04168385|564619899|FG000|Overall Study|Withdrawal by Subject|1|||
156416813|NCT04168385|564619900|FG001|Overall Study|Withdrawal by Subject|0|||
156416814|NCT04168385|564619899|FG000|Overall Study|Adverse Event|2|||
156416815|NCT04168385|564619900|FG001|Overall Study|Adverse Event|1|||
156416816|NCT04168385|564619899|FG000|Overall Study|Liver transplant|3|||
156416817|NCT04168385|564619900|FG001|Overall Study|Liver transplant|1|||
156416818|NCT04168385|564619899|FG000|Overall Study|Listed for liver transplant|1|||
156416819|NCT04168385|564619900|FG001|Overall Study|Listed for liver transplant|0|||
156416820|NCT02748512|564619901|FG000|Overall Study|Lost to Follow-up|1|||
156416821|NCT02748512|564619902|FG001|Overall Study|Lost to Follow-up|1|||
156416822|NCT00109928|564619913|FG000|Overall Study|Adverse Event|2|||
156416823|NCT00109928|564619913|FG000|Overall Study|Progression|6|||
156416824|NCT00109928|564619913|FG000|Overall Study|Death|2|||
156416825|NCT00109928|564619913|FG000|Overall Study|not protocol specified|2|||
156416826|NCT00109928|564619913|FG000|Overall Study|not eligible|1|||
156416827|NCT00661258|564619920|FG000|Overall Study|Death|1|||
156416828|NCT00661258|564619921|FG001|Overall Study|Death|0|||
156416829|NCT00661258|564619920|FG000|Overall Study|caught by police and in detox center|2|||
156416830|NCT00661258|564619921|FG001|Overall Study|caught by police and in detox center|1|||
156416831|NCT02408549|564619923|FG000|Overall Study|Adverse Event|15|||
156416832|NCT02408549|564619923|FG000|Overall Study|Death|4|||
156416833|NCT02408549|564619923|FG000|Overall Study|Lack of Efficacy|17|||
156416834|NCT02408549|564619923|FG000|Overall Study|Protocol Violation|4|||
156416835|NCT02408549|564619923|FG000|Overall Study|Lost to Follow-up|6|||
156416836|NCT02408549|564619923|FG000|Overall Study|Consent withdrawn|30|||
156416837|NCT02408549|564619923|FG000|Overall Study|Neurology research program closing at site|1|||
156416838|NCT02408549|564619923|FG000|Overall Study|Site closure|1|||
156416839|NCT02408549|564619923|FG000|Overall Study|Pregnancy|1|||
156416840|NCT02408549|564619923|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
156416841|NCT02408549|564619923|FG000|Overall Study|Subject moved to another place, far from site|1|||
156416842|NCT02408549|564619923|FG000|Overall Study|Study terminated at site|1|||
156416843|NCT00231894|564619924|FG000|Overall Study|Withdrawal by Subject|1|||
156416844|NCT00231894|564619925|FG001|Overall Study|Withdrawal by Subject|1|||
156416845|NCT01232556|564619928|FG000|Overall Study|Withdrawal by Subject|21|||
156416846|NCT01232556|564619929|FG001|Overall Study|Withdrawal by Subject|17|||
156416847|NCT01232556|564619928|FG000|Overall Study|Death|97|||
156416848|NCT01232556|564619929|FG001|Overall Study|Death|97|||
156416849|NCT01232556|564619928|FG000|Overall Study|Lost to Follow-up|0|||
156416850|NCT01232556|564619929|FG001|Overall Study|Lost to Follow-up|2|||
156416851|NCT01232556|564619928|FG000|Overall Study|Terminated by Sponsor|35|||
156416852|NCT01232556|564619929|FG001|Overall Study|Terminated by Sponsor|51|||
156416853|NCT01232556|564619928|FG000|Overall Study|Other|6|||
156416854|NCT01232556|564619929|FG001|Overall Study|Other|4|||
156416855|NCT01628510|564619930|FG000|Overall Study|Withdrawal by Subject|0|||
156416856|NCT01628510|564619931|FG001|Overall Study|Withdrawal by Subject|4|||
156416857|NCT01628510|564619930|FG000|Overall Study|Death|3|||
156416858|NCT01628510|564619931|FG001|Overall Study|Death|1|||
156416859|NCT04707391|564619932|FG000|Overall Study|Adverse Event|5|||
156416860|NCT04707391|564619933|FG001|Overall Study|Adverse Event|8|||
156416861|NCT04707391|564619932|FG000|Overall Study|Lost to Follow-up|44|||
156416862|NCT04707391|564619933|FG001|Overall Study|Lost to Follow-up|31|||
156416863|NCT04707391|564619932|FG000|Overall Study|Protocol Violation|1|||
156416864|NCT04707391|564619933|FG001|Overall Study|Protocol Violation|5|||
156416865|NCT04707391|564619932|FG000|Overall Study|Withdrawal by Subject|27|||
156416866|NCT04707391|564619933|FG001|Overall Study|Withdrawal by Subject|25|||
156416867|NCT04707391|564619932|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
156416868|NCT04707391|564619933|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
156416869|NCT04707391|564619932|FG000|Overall Study|Other|0|||
156416870|NCT04707391|564619933|FG001|Overall Study|Other|2|||
156416871|NCT02500316|564619936|FG000|Overall Study|Adverse Event|3|||
156416872|NCT02500316|564619936|FG000|Overall Study|Lost to Follow-up|2|||
156416873|NCT02500316|564619936|FG000|Overall Study|Protocol Violation|1|||
156416874|NCT02500316|564619936|FG000|Overall Study|Withdrawal by Subject|15|||
156416875|NCT02500316|564619936|FG000|Overall Study|Final height achieved|5|||
156416876|NCT02500316|564619936|FG000|Overall Study|Due to war activity|1|||
156416877|NCT01406717|564619937|FG000|Overall Study|Subject non-compliance|4|||
156416878|NCT01406717|564619938|FG001|Overall Study|Subject non-compliance|3|||
156416879|NCT01406717|564619937|FG000|Overall Study|Protocol Violation|5|||
156416880|NCT01406717|564619938|FG001|Overall Study|Protocol Violation|1|||
156416881|NCT01406717|564619937|FG000|Overall Study|Lost to Follow-up|14|||
156416882|NCT01406717|564619938|FG001|Overall Study|Lost to Follow-up|8|||
156416883|NCT01406717|564619937|FG000|Overall Study|Withdrawal by Subject|19|||
156416884|NCT01406717|564619938|FG001|Overall Study|Withdrawal by Subject|15|||
156315653|NCT00439738|564254398|FG000|Overall Study|Lost to Follow-up|5|||
156315654|NCT00439738|564254399|FG001|Overall Study|Lost to Follow-up|6|||
156315655|NCT00439738|564254398|FG000|Overall Study|Protocol Violation|6|||
156315656|NCT00439738|564254399|FG001|Overall Study|Protocol Violation|3|||
156315657|NCT00439738|564254398|FG000|Overall Study|Lack of Efficacy|2|||
156315658|NCT00439738|564254399|FG001|Overall Study|Lack of Efficacy|2|||
156315659|NCT00439738|564254398|FG000|Overall Study|Abnormal Lab Values|1|||
156315660|NCT00439738|564254399|FG001|Overall Study|Abnormal Lab Values|0|||
156315661|NCT01227824|564254402|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
156315662|NCT01227824|564254403|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
156315663|NCT01227824|564254404|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
156315664|NCT01227824|564254402|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
156315665|NCT01227824|564254403|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
156315666|NCT01227824|564254404|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
156315667|NCT01227824|564254402|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
156315668|NCT01227824|564254403|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
156315669|NCT01227824|564254404|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
156315670|NCT01227824|564254402|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
156315671|NCT01227824|564254403|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
156315672|NCT01227824|564254404|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
156315673|NCT01227824|564254402|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
156315674|NCT01227824|564254403|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
156315675|NCT01227824|564254404|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
156315676|NCT01227824|564254402|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
156315677|NCT01227824|564254403|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
156315678|NCT01227824|564254404|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
156315679|NCT01227824|564254402|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
156315680|NCT01227824|564254403|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
156315681|NCT01227824|564254404|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
156315682|NCT01227824|564254402|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
156315683|NCT01227824|564254403|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
156315684|NCT01227824|564254404|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
156315685|NCT01227824|564254402|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
156315686|NCT01227824|564254403|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
156315687|NCT01227824|564254404|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
156315688|NCT01227824|564254402|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
156315689|NCT01227824|564254403|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
156315690|NCT01227824|564254404|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
156315691|NCT01227824|564254402|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
156315692|NCT01227824|564254403|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
156315693|NCT01227824|564254404|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
156315694|NCT01227824|564254402|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
156315695|NCT01227824|564254403|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
156315696|NCT01227824|564254404|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
156315697|NCT01227824|564254402|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
156315698|NCT01227824|564254403|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
156315699|NCT01227824|564254404|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
156315700|NCT01227824|564254402|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
156315701|NCT01227824|564254403|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
156315702|NCT01227824|564254404|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
156315703|NCT01227824|564254402|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
156315704|NCT01227824|564254403|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
156315705|NCT01227824|564254404|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
156315706|NCT02576145|564254405|FG000|Overall Study|Adverse Event|1|||
156315707|NCT02576145|564254406|FG001|Overall Study|Adverse Event|0|||
156315708|NCT02576145|564254405|FG000|Overall Study|Withdrawal by Subject|1|||
156652852|NCT00283686|565476118|FG000|Overall Study|Less than full participation|7|||
156652853|NCT00283686|565476119|FG001|Overall Study|Less than full participation|9|||
156652854|NCT00283686|565476120|FG002|Overall Study|Less than full participation|6|||
156652855|NCT00283686|565476121|FG003|Overall Study|Less than full participation|12|||
156652856|NCT01076166|565476122|FG000|Overall Study|Adverse Event|3|||
156652857|NCT01076166|565476122|FG000|Overall Study|Symptoms improved/resolved|6|||
156652858|NCT01716754|565476123|FG000|Overall Study|Death|0|||
156652859|NCT01716754|565476124|FG001|Overall Study|Death|0|||
156652860|NCT01716754|565476125|FG002|Overall Study|Death|0|||
156652861|NCT01716754|565476126|FG003|Overall Study|Death|1|||
156652862|NCT01716754|565476123|FG000|Overall Study|Protocol deviation|0|||
156652863|NCT01716754|565476124|FG001|Overall Study|Protocol deviation|2|||
156756761|NCT00784719|565860646|FG000|Overall Study|Other|2|||
156756762|NCT00784719|565860647|FG001|Overall Study|Other|1|||
156756763|NCT00784719|565860648|FG002|Overall Study|Other|1|||
156756764|NCT00784719|565860649|FG003|Overall Study|Other|0|||
156756765|NCT00784719|565860650|FG004|Overall Study|Other|2|||
156756766|NCT00784719|565860651|FG005|Overall Study|Other|1|||
156756767|NCT00784719|565860652|FG006|Overall Study|Other|3|||
156315709|NCT02576145|564254406|FG001|Overall Study|Withdrawal by Subject|0|||
156315710|NCT02576145|564254405|FG000|Overall Study|Acute rejection|1|||
156315711|NCT02576145|564254406|FG001|Overall Study|Acute rejection|0|||
156315712|NCT02576145|564254405|FG000|Overall Study|Tetanus Titers Decreased|0|||
156315713|NCT02576145|564254406|FG001|Overall Study|Tetanus Titers Decreased|1|||
156315714|NCT00781885|564254407|FG000|Overall Study|Physician Decision|1|||
156315715|NCT01755026|564254408|FG000|Overall Study|Adverse Event|1|||
156315716|NCT01755026|564254409|FG001|Overall Study|Adverse Event|0|||
156315717|NCT01755026|564254408|FG000|Overall Study|Withdrawal by Subject|1|||
156315718|NCT01755026|564254409|FG001|Overall Study|Withdrawal by Subject|1|||
156315719|NCT02730793|564254412|FG000|Overall Study|Physician Decision|0|||
156315720|NCT02730793|564254413|FG001|Overall Study|Physician Decision|1|||
156315721|NCT02730793|564254412|FG000|Overall Study|Withdrawal by Subject|0|||
156315722|NCT02730793|564254413|FG001|Overall Study|Withdrawal by Subject|1|||
156315723|NCT02365233|564254414|FG000|Overall Study|IRB withheld the data|1|||
156315724|NCT02365233|564254415|FG001|Overall Study|IRB withheld the data|2|||
156315725|NCT02365233|564254416|FG002|Overall Study|IRB withheld the data|2|||
156315726|NCT00160667|564254417|FG000|Overall Study|Adverse Event|3|||
156315727|NCT00160667|564254418|FG001|Overall Study|Adverse Event|1|||
156315728|NCT00160667|564254419|FG002|Overall Study|Adverse Event|4|||
156315729|NCT00160667|564254417|FG000|Overall Study|Withdrawal by Subject|2|||
156315730|NCT00160667|564254418|FG001|Overall Study|Withdrawal by Subject|0|||
156315731|NCT00160667|564254419|FG002|Overall Study|Withdrawal by Subject|1|||
156315732|NCT00160667|564254417|FG000|Overall Study|Lack of Efficacy|0|||
156315733|NCT00160667|564254418|FG001|Overall Study|Lack of Efficacy|1|||
156315734|NCT00160667|564254419|FG002|Overall Study|Lack of Efficacy|0|||
156315735|NCT00160667|564254417|FG000|Overall Study|Protocol Violation|0|||
156315736|NCT00160667|564254418|FG001|Overall Study|Protocol Violation|1|||
156315737|NCT00160667|564254419|FG002|Overall Study|Protocol Violation|0|||
156315738|NCT00160667|564254417|FG000|Overall Study|Patient decision|0|||
156315739|NCT00160667|564254418|FG001|Overall Study|Patient decision|0|||
156315740|NCT00160667|564254419|FG002|Overall Study|Patient decision|1|||
156315741|NCT00336583|564256124|FG000|Overall Study|Lost to Follow-up|1|||
156315742|NCT00336583|564256124|FG000|Overall Study|Death|1|||
156315743|NCT03603509|564256125|FG000|Overall Study|Lost to Follow-up|3|||
156315744|NCT03603509|564256126|FG001|Overall Study|Lost to Follow-up|4|||
156315745|NCT01143389|564256129|FG000|Overall Study|Lost to Follow-up|26|||
156315746|NCT01143389|564256130|FG001|Overall Study|Lost to Follow-up|25|||
156315747|NCT04966910|564256131|FG000|Baseline|Participant did not complete measure|0|||
156315748|NCT04966910|564256132|FG001|Baseline|Participant did not complete measure|0|||
156315749|NCT04966910|564256133|FG002|Baseline|Participant did not complete measure|1|||
156315750|NCT04966910|564256134|FG003|Baseline|Participant did not complete measure|0|||
156416885|NCT01406717|564619937|FG000|Overall Study|Adverse Event|1|||
156416886|NCT01406717|564619938|FG001|Overall Study|Adverse Event|2|||
156416887|NCT01406717|564619937|FG000|Overall Study|Lack of Efficacy|0|||
156416888|NCT01406717|564619938|FG001|Overall Study|Lack of Efficacy|1|||
156756768|NCT00784719|565860646|FG000|Overall Study|Withdrawal by Subject|1|||
156756769|NCT00784719|565860647|FG001|Overall Study|Withdrawal by Subject|0|||
156756770|NCT00784719|565860648|FG002|Overall Study|Withdrawal by Subject|0|||
156756771|NCT00784719|565860649|FG003|Overall Study|Withdrawal by Subject|0|||
156756772|NCT00784719|565860650|FG004|Overall Study|Withdrawal by Subject|2|||
156756773|NCT00784719|565860651|FG005|Overall Study|Withdrawal by Subject|0|||
156756774|NCT00784719|565860652|FG006|Overall Study|Withdrawal by Subject|1|||
156756775|NCT05285787|565860655|FG000|Overall Study|Withdrawal by Subject|1|||
156756776|NCT03382418|565860656|FG000|Overall Study|Withdrawal by Subject|1|||
156756777|NCT03382418|565860657|FG001|Overall Study|Withdrawal by Subject|0|||
156756778|NCT03382418|565860658|FG002|Overall Study|Withdrawal by Subject|0|||
156756779|NCT03382418|565860656|FG000|Overall Study|Lost to Follow-up|2|||
156315751|NCT04966910|564256131|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
156315752|NCT04966910|564256132|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
156315753|NCT04966910|564256133|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
156315754|NCT04966910|564256134|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
156315755|NCT04966910|564256131|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
156315756|NCT04966910|564256132|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
156416889|NCT01406717|564619937|FG000|Overall Study|Non-completion of visit activity|0|||
156756780|NCT03382418|565860657|FG001|Overall Study|Lost to Follow-up|3|||
156756781|NCT03382418|565860658|FG002|Overall Study|Lost to Follow-up|0|||
156756782|NCT01051817|565860659|FG000|Overall Study|Adverse Event|0|||
156756783|NCT01051817|565860660|FG001|Overall Study|Adverse Event|2|||
156756784|NCT01051817|565860659|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
156315757|NCT04966910|564256133|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
156315758|NCT04966910|564256134|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
156315759|NCT04966910|564256131|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
156315760|NCT04966910|564256132|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
156315761|NCT04966910|564256133|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
156315762|NCT04966910|564256134|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
156315763|NCT02446171|564256137|FG000|Overall Study|Withdrawal by Subject|0|||
156315764|NCT02446171|564256138|FG001|Overall Study|Withdrawal by Subject|0|||
156315765|NCT02446171|564256139|FG002|Overall Study|Withdrawal by Subject|2|||
156315766|NCT02446171|564256140|FG003|Overall Study|Withdrawal by Subject|0|||
156315767|NCT03328182|564256141|FG000|Overall Study|Withdrawal by Subject|1|||
156315768|NCT03328182|564256141|FG000|Overall Study|Protocol Violation|2|||
156315769|NCT03328182|564256141|FG000|Overall Study|No Product Evaluated|1|||
156315770|NCT00504582|564256142|FG000|Overall Study|Lost to Follow-up|1|||
156315771|NCT00504582|564256143|FG001|Overall Study|Lost to Follow-up|0|||
156315772|NCT00504582|564256144|FG002|Overall Study|Lost to Follow-up|0|||
156315773|NCT00883688|564256145|FG000|Overall Study|Ineligible|2|||
156315774|NCT03811093|564256146|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
156315775|NCT03811093|564256147|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
156315776|NCT03811093|564256146|FG000|Overall Study|Unable to measure body fat percentage|2|||
156315777|NCT03811093|564256147|FG001|Overall Study|Unable to measure body fat percentage|0|||
156315778|NCT01095094|564256148|FG000|Overall Study|Withdrawal by Subject|1|||
156315779|NCT01095094|564256148|FG000|Overall Study|Death|1|||
156315780|NCT01095094|564256148|FG000|Overall Study|Physician Decision|1|||
156315781|NCT00464490|564256149|FG000|Overall Study|Physician Decision|11|||
156315782|NCT00464490|564256150|FG001|Overall Study|Physician Decision|11|||
156315783|NCT03188042|564256153|FG000|Overall Study|Withdrawal by Subject|1|||
156315784|NCT03188042|564256154|FG001|Overall Study|Withdrawal by Subject|1|||
156315785|NCT00137839|564256161|FG000|Overall Study|Adverse Event|7|||
156315786|NCT00137839|564256161|FG000|Overall Study|Physician Decision|7|||
156315787|NCT00137839|564256161|FG000|Overall Study|Death|8|||
156315788|NCT00137839|564256161|FG000|Overall Study|Disease Progression|60|||
156315789|NCT00137839|564256161|FG000|Overall Study|Not Start Treatment|1|||
156315790|NCT00137839|564256161|FG000|Overall Study|Prolonged Treatment Delay|1|||
156315791|NCT02446743|564256162|FG000|Overall Study|Withdrawal by Subject|1|||
156315792|NCT02446743|564256163|FG001|Overall Study|Withdrawal by Subject|1|||
156315793|NCT02446743|564256162|FG000|Overall Study|Lost to Follow-up|1|||
156315794|NCT02446743|564256163|FG001|Overall Study|Lost to Follow-up|0|||
156315795|NCT02446743|564256162|FG000|Overall Study|Adverse Event|1|||
156315796|NCT02446743|564256163|FG001|Overall Study|Adverse Event|1|||
156315797|NCT02446743|564256162|FG000|Overall Study|Other|2|||
156315798|NCT02446743|564256163|FG001|Overall Study|Other|3|||
156315799|NCT03086967|564256164|FG000|Overall Study|Screen Failure|2|||
156315800|NCT03086967|564256165|FG001|Overall Study|Screen Failure|2|||
156315801|NCT01752036|564256167|FG000|Overall Study|Death|2|||
156315802|NCT02230527|564256168|FG000|Overall Study|Withdrawal by Subject|1|||
156315803|NCT02230527|564256169|FG001|Overall Study|Withdrawal by Subject|1|||
156315804|NCT02230527|564256168|FG000|Overall Study|Death|1|||
156315805|NCT02230527|564256169|FG001|Overall Study|Death|0|||
156315806|NCT02230527|564256168|FG000|Overall Study|Lost to Follow-up|2|||
156315807|NCT02230527|564256169|FG001|Overall Study|Lost to Follow-up|1|||
156315808|NCT02230527|564256168|FG000|Overall Study|Other|1|||
156315809|NCT02230527|564256169|FG001|Overall Study|Other|0|||
156315810|NCT01205581|564256171|FG000|Overall Study|Withdrawal by Subject|1|||
156315811|NCT01205581|564256172|FG001|Overall Study|Withdrawal by Subject|0|||
156315812|NCT01205581|564256173|FG002|Overall Study|Withdrawal by Subject|0|||
156315813|NCT01205581|564256174|FG003|Overall Study|Withdrawal by Subject|0|||
156315814|NCT01205581|564256175|FG004|Overall Study|Withdrawal by Subject|0|||
156315815|NCT01205581|564256176|FG005|Overall Study|Withdrawal by Subject|0|||
156315816|NCT04896229|564256178|FG000|Overall Study|Lost to Follow-up|113|||
156315817|NCT04896229|564256179|FG001|Overall Study|Lost to Follow-up|113|||
156315818|NCT00045942|564256180|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
156315819|NCT00045942|564256181|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156315820|NCT00045942|564256182|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156652864|NCT01716754|565476125|FG002|Overall Study|Protocol deviation|7|||
156315821|NCT00045942|564256183|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156315822|NCT00045942|564256184|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156315823|NCT00045942|564256185|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156315824|NCT00045942|564256186|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156315825|NCT00045942|564256187|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156315826|NCT00045942|564256188|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156315827|NCT00045942|564256180|FG000|PKC412A2104 (Core)|Adverse Event|5|||
156315828|NCT00045942|564256181|FG001|PKC412A2104 (Core)|Adverse Event|0|||
156315829|NCT00045942|564256182|FG002|PKC412A2104 (Core)|Adverse Event|0|||
156315830|NCT00045942|564256183|FG003|PKC412A2104 (Core)|Adverse Event|0|||
156315831|NCT00045942|564256184|FG004|PKC412A2104 (Core)|Adverse Event|0|||
156315832|NCT00045942|564256185|FG005|PKC412A2104 (Core)|Adverse Event|0|||
156315833|NCT00045942|564256186|FG006|PKC412A2104 (Core)|Adverse Event|0|||
156416890|NCT01406717|564619938|FG001|Overall Study|Non-completion of visit activity|1|||
156416891|NCT02040090|564619939|FG000|Overall Study|Adverse Event|2|||
156416892|NCT02040090|564619940|FG001|Overall Study|Adverse Event|0|||
156416893|NCT02040090|564619939|FG000|Overall Study|Physician Decision|1|||
156416894|NCT02040090|564619940|FG001|Overall Study|Physician Decision|0|||
156416895|NCT02040090|564619939|FG000|Overall Study|Withdrawal by Subject|0|||
156416896|NCT02040090|564619940|FG001|Overall Study|Withdrawal by Subject|1|||
156416897|NCT02040090|564619939|FG000|Overall Study|Lost to Follow-up|0|||
156416898|NCT02040090|564619940|FG001|Overall Study|Lost to Follow-up|1|||
156416899|NCT03370276|564619943|FG000|Overall Study|Death|0|||
156416900|NCT03370276|564619944|FG001|Overall Study|Death|2|||
156416901|NCT03370276|564619945|FG002|Overall Study|Death|5|||
156416902|NCT02584855|564619949|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
156416903|NCT02584855|564619950|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
156416904|NCT02584855|564619951|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
156315834|NCT00045942|564256187|FG007|PKC412A2104 (Core)|Adverse Event|0|||
156315835|NCT00045942|564256188|FG008|PKC412A2104 (Core)|Adverse Event|0|||
156315836|NCT00045942|564256180|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
156315837|NCT00045942|564256181|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
156315838|NCT00045942|564256182|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
156315839|NCT00045942|564256183|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
156315840|NCT00045942|564256184|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
156315841|NCT00045942|564256185|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
156315842|NCT00045942|564256186|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
156315843|NCT00045942|564256187|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
156315844|NCT00045942|564256188|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
156416905|NCT02584855|564619952|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
156416906|NCT02584855|564619953|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
156315845|NCT00045942|564256180|FG000|PKC412A2104 (Core)|Death|1|||
156416907|NCT02584855|564619954|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
156416908|NCT02584855|564619949|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
156652865|NCT01716754|565476126|FG003|Overall Study|Protocol deviation|2|||
156652866|NCT01716754|565476123|FG000|Overall Study|Non-compliance with study treatment|0|||
156652867|NCT01716754|565476124|FG001|Overall Study|Non-compliance with study treatment|0|||
156652868|NCT01716754|565476125|FG002|Overall Study|Non-compliance with study treatment|1|||
156652869|NCT01716754|565476126|FG003|Overall Study|Non-compliance with study treatment|0|||
156652870|NCT01716754|565476123|FG000|Overall Study|Physician Decision|1|||
156652871|NCT01716754|565476124|FG001|Overall Study|Physician Decision|0|||
156652872|NCT01716754|565476125|FG002|Overall Study|Physician Decision|0|||
156652873|NCT01716754|565476126|FG003|Overall Study|Physician Decision|0|||
156652874|NCT01716754|565476123|FG000|Overall Study|Lost to Follow-up|1|||
156652875|NCT01716754|565476124|FG001|Overall Study|Lost to Follow-up|0|||
156652876|NCT01716754|565476125|FG002|Overall Study|Lost to Follow-up|0|||
156652877|NCT01716754|565476126|FG003|Overall Study|Lost to Follow-up|1|||
156652878|NCT01716754|565476123|FG000|Overall Study|Adverse Event|4|||
156652879|NCT01716754|565476124|FG001|Overall Study|Adverse Event|2|||
156652880|NCT01716754|565476125|FG002|Overall Study|Adverse Event|2|||
156652881|NCT01716754|565476126|FG003|Overall Study|Adverse Event|1|||
156652882|NCT01716754|565476123|FG000|Overall Study|Withdrawal by Subject|5|||
156652883|NCT01716754|565476124|FG001|Overall Study|Withdrawal by Subject|0|||
156652884|NCT01716754|565476125|FG002|Overall Study|Withdrawal by Subject|4|||
156652885|NCT01716754|565476126|FG003|Overall Study|Withdrawal by Subject|3|||
156652886|NCT02110706|565476144|FG000|Overall Study|Adverse Event|2|||
156652887|NCT02110706|565476145|FG001|Overall Study|Adverse Event|3|||
156652888|NCT02110706|565476144|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
156652889|NCT02110706|565476145|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
156652890|NCT01211769|565476150|FG000|Overall Study|Lost to Follow-up|7|||
156652891|NCT01211769|565476151|FG001|Overall Study|Lost to Follow-up|9|||
156652892|NCT01211769|565476152|FG002|Overall Study|Lost to Follow-up|5|||
156652893|NCT01211769|565476153|FG003|Overall Study|Lost to Follow-up|9|||
156652894|NCT01211769|565476150|FG000|Overall Study|Physician Decision|2|||
156652895|NCT01211769|565476151|FG001|Overall Study|Physician Decision|0|||
156652896|NCT01211769|565476152|FG002|Overall Study|Physician Decision|2|||
156652897|NCT01211769|565476153|FG003|Overall Study|Physician Decision|1|||
156652898|NCT01211769|565476150|FG000|Overall Study|Adverse Event|0|||
156652899|NCT01211769|565476151|FG001|Overall Study|Adverse Event|1|||
156652900|NCT01211769|565476152|FG002|Overall Study|Adverse Event|1|||
156652901|NCT01211769|565476153|FG003|Overall Study|Adverse Event|1|||
156652902|NCT00947427|565476154|FG000|Overall Study|Withdrawal by Subject|1|||
156652903|NCT00947427|565476155|FG001|Overall Study|Withdrawal by Subject|3|||
156652904|NCT00947427|565476154|FG000|Overall Study|Protocol Violation|0|||
156652905|NCT00947427|565476155|FG001|Overall Study|Protocol Violation|1|||
156652906|NCT01348542|565476159|FG000|Overall Study|Withdrawal by Subject|3|||
156652907|NCT01348542|565476160|FG001|Overall Study|Withdrawal by Subject|0|||
156652908|NCT02115256|565476167|FG000|Overall Study|Withdrawal by Subject|0|||
156652909|NCT02115256|565476168|FG001|Overall Study|Withdrawal by Subject|1|||
156756785|NCT01051817|565860660|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
156756786|NCT01051817|565860659|FG000|Overall Study|Withdrawal by Subject|3|||
156315846|NCT00045942|564256181|FG001|PKC412A2104 (Core)|Death|0|||
156315847|NCT00045942|564256182|FG002|PKC412A2104 (Core)|Death|0|||
156315848|NCT00045942|564256183|FG003|PKC412A2104 (Core)|Death|0|||
156315849|NCT00045942|564256184|FG004|PKC412A2104 (Core)|Death|0|||
156315850|NCT00045942|564256185|FG005|PKC412A2104 (Core)|Death|0|||
156315851|NCT00045942|564256186|FG006|PKC412A2104 (Core)|Death|0|||
156315852|NCT00045942|564256187|FG007|PKC412A2104 (Core)|Death|0|||
156315853|NCT00045942|564256188|FG008|PKC412A2104 (Core)|Death|0|||
156315854|NCT00045942|564256180|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
156315855|NCT00045942|564256181|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
156315856|NCT00045942|564256182|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
156315857|NCT00045942|564256183|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
156315858|NCT00045942|564256184|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
156315859|NCT00045942|564256185|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
156315860|NCT00045942|564256186|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
156315861|NCT00045942|564256187|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
156315862|NCT00045942|564256188|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
156315863|NCT00045942|564256180|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
156315864|NCT00045942|564256181|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
156315865|NCT00045942|564256182|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
156315866|NCT00045942|564256183|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
156315867|NCT00045942|564256184|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
156315868|NCT00045942|564256185|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
156315869|NCT00045942|564256186|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
156315870|NCT00045942|564256187|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
156315871|NCT00045942|564256188|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
156315872|NCT00045942|564256180|FG000|PKC412A2104E1|Lack of Efficacy|0|||
156315873|NCT00045942|564256181|FG001|PKC412A2104E1|Lack of Efficacy|11|||
156315874|NCT00045942|564256182|FG002|PKC412A2104E1|Lack of Efficacy|11|||
156315875|NCT00045942|564256183|FG003|PKC412A2104E1|Lack of Efficacy|23|||
156315876|NCT00045942|564256184|FG004|PKC412A2104E1|Lack of Efficacy|17|||
156315877|NCT00045942|564256185|FG005|PKC412A2104E1|Lack of Efficacy|0|||
156315878|NCT00045942|564256186|FG006|PKC412A2104E1|Lack of Efficacy|0|||
156315879|NCT00045942|564256187|FG007|PKC412A2104E1|Lack of Efficacy|0|||
156315880|NCT00045942|564256188|FG008|PKC412A2104E1|Lack of Efficacy|0|||
156315881|NCT00045942|564256180|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
156315882|NCT00045942|564256181|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
156315883|NCT00045942|564256182|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
156315884|NCT00045942|564256183|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
156315885|NCT00045942|564256184|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
156315886|NCT00045942|564256185|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
156315887|NCT00045942|564256186|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
156315888|NCT00045942|564256187|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
156315889|NCT00045942|564256188|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
156315890|NCT00045942|564256180|FG000|PKC412A2104E1|Adverse Event|0|||
156315891|NCT00045942|564256181|FG001|PKC412A2104E1|Adverse Event|1|||
156315892|NCT00045942|564256182|FG002|PKC412A2104E1|Adverse Event|1|||
156315893|NCT00045942|564256183|FG003|PKC412A2104E1|Adverse Event|3|||
156315894|NCT00045942|564256184|FG004|PKC412A2104E1|Adverse Event|6|||
156315895|NCT00045942|564256185|FG005|PKC412A2104E1|Adverse Event|0|||
156315896|NCT00045942|564256186|FG006|PKC412A2104E1|Adverse Event|0|||
156315897|NCT00045942|564256187|FG007|PKC412A2104E1|Adverse Event|0|||
156315898|NCT00045942|564256188|FG008|PKC412A2104E1|Adverse Event|0|||
156315899|NCT00045942|564256180|FG000|PKC412A2104E1|Death|0|||
156315900|NCT00045942|564256181|FG001|PKC412A2104E1|Death|4|||
156315901|NCT00045942|564256182|FG002|PKC412A2104E1|Death|1|||
156315902|NCT00045942|564256183|FG003|PKC412A2104E1|Death|1|||
156315903|NCT00045942|564256184|FG004|PKC412A2104E1|Death|1|||
156315904|NCT00045942|564256185|FG005|PKC412A2104E1|Death|0|||
156315905|NCT00045942|564256186|FG006|PKC412A2104E1|Death|0|||
156315906|NCT00045942|564256187|FG007|PKC412A2104E1|Death|0|||
156315907|NCT00045942|564256188|FG008|PKC412A2104E1|Death|0|||
156315908|NCT00045942|564256180|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156315909|NCT00045942|564256181|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156315910|NCT00045942|564256182|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
156315911|NCT00045942|564256183|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
156315912|NCT00045942|564256184|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156315913|NCT00045942|564256185|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156315914|NCT00045942|564256186|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156756787|NCT01051817|565860660|FG001|Overall Study|Withdrawal by Subject|5|||
156315915|NCT00045942|564256187|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156315916|NCT00045942|564256188|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156315917|NCT00045942|564256180|FG000|PKC412A2104E2|Lost to Follow-up|0|||
156315918|NCT00045942|564256181|FG001|PKC412A2104E2|Lost to Follow-up|0|||
156315919|NCT00045942|564256182|FG002|PKC412A2104E2|Lost to Follow-up|0|||
156315920|NCT00045942|564256183|FG003|PKC412A2104E2|Lost to Follow-up|0|||
156416909|NCT02584855|564619950|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
156416910|NCT02584855|564619951|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
156416911|NCT02584855|564619952|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
156416912|NCT02584855|564619953|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
156416913|NCT02584855|564619954|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
156416914|NCT02584855|564619949|FG000|Open-Label Treatment Period|Adverse Event|14|||
156416915|NCT02584855|564619950|FG001|Open-Label Treatment Period|Adverse Event|0|||
156416916|NCT02584855|564619951|FG002|Open-Label Treatment Period|Adverse Event|0|||
156416917|NCT02584855|564619952|FG003|Open-Label Treatment Period|Adverse Event|0|||
156416918|NCT02584855|564619953|FG004|Open-Label Treatment Period|Adverse Event|0|||
156416919|NCT02584855|564619954|FG005|Open-Label Treatment Period|Adverse Event|0|||
156416920|NCT02584855|564619949|FG000|Open-Label Treatment Period|Death|2|||
156416921|NCT02584855|564619950|FG001|Open-Label Treatment Period|Death|0|||
156416922|NCT02584855|564619951|FG002|Open-Label Treatment Period|Death|0|||
156416923|NCT02584855|564619952|FG003|Open-Label Treatment Period|Death|0|||
156416924|NCT02584855|564619953|FG004|Open-Label Treatment Period|Death|0|||
156416925|NCT02584855|564619954|FG005|Open-Label Treatment Period|Death|0|||
156416926|NCT02584855|564619949|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
156416927|NCT02584855|564619950|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
156416928|NCT02584855|564619951|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
156416929|NCT02584855|564619952|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
156416930|NCT02584855|564619953|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
156416931|NCT02584855|564619954|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
156416932|NCT02584855|564619949|FG000|Open-Label Treatment Period|Protocol Violation|1|||
156416933|NCT02584855|564619950|FG001|Open-Label Treatment Period|Protocol Violation|0|||
156416934|NCT02584855|564619951|FG002|Open-Label Treatment Period|Protocol Violation|0|||
156416935|NCT02584855|564619952|FG003|Open-Label Treatment Period|Protocol Violation|0|||
156416936|NCT02584855|564619953|FG004|Open-Label Treatment Period|Protocol Violation|0|||
156416937|NCT02584855|564619954|FG005|Open-Label Treatment Period|Protocol Violation|0|||
156416938|NCT02584855|564619949|FG000|Open-Label Treatment Period|No PI Available|2|||
156416939|NCT02584855|564619950|FG001|Open-Label Treatment Period|No PI Available|0|||
156416940|NCT02584855|564619951|FG002|Open-Label Treatment Period|No PI Available|0|||
156416941|NCT02584855|564619952|FG003|Open-Label Treatment Period|No PI Available|0|||
156416942|NCT02584855|564619953|FG004|Open-Label Treatment Period|No PI Available|0|||
156416943|NCT02584855|564619954|FG005|Open-Label Treatment Period|No PI Available|0|||
156416944|NCT02584855|564619949|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
156416945|NCT02584855|564619950|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
156416946|NCT02584855|564619951|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
156416947|NCT02584855|564619952|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
156416948|NCT02584855|564619953|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
156416949|NCT02584855|564619954|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
156416950|NCT02584855|564619949|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156416951|NCT02584855|564619950|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156416952|NCT02584855|564619951|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
156416953|NCT02584855|564619952|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156416954|NCT02584855|564619953|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156416955|NCT02584855|564619954|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156416956|NCT02584855|564619949|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
156416957|NCT02584855|564619950|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
156416958|NCT02584855|564619951|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
156416959|NCT02584855|564619952|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
156416960|NCT02584855|564619953|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
156416961|NCT02584855|564619954|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
156416962|NCT02584855|564619949|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156416963|NCT02584855|564619950|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
156416964|NCT02584855|564619951|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156416965|NCT02584855|564619952|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156416966|NCT02584855|564619953|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156416967|NCT02584855|564619954|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156416968|NCT02584855|564619949|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156416969|NCT02584855|564619950|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
156416970|NCT02584855|564619951|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156416971|NCT02584855|564619952|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156416972|NCT02584855|564619953|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156416973|NCT02584855|564619954|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156416974|NCT02584855|564619949|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156416975|NCT02584855|564619950|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156416976|NCT02584855|564619951|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156416977|NCT02584855|564619952|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156756788|NCT01051817|565860659|FG000|Overall Study|Protocol Violation|0|||
156756789|NCT01051817|565860660|FG001|Overall Study|Protocol Violation|1|||
156416978|NCT02584855|564619953|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
156416979|NCT02584855|564619954|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156416980|NCT02584855|564619949|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
156416981|NCT02584855|564619950|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
156416982|NCT02584855|564619951|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
156416983|NCT02584855|564619952|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
156416984|NCT02584855|564619953|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
156416985|NCT02584855|564619954|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
156416986|NCT02337478|564619955|FG000|Overall Study|Lack of Efficacy|5|||
156416987|NCT00895843|564619956|FG000|Overall Study|Protocol Violation|12|||
156416988|NCT00895843|564619957|FG001|Overall Study|Protocol Violation|12|||
156416989|NCT00057811|564619966|FG000|Overall Study|Lack of Efficacy|1|||
156416990|NCT00057811|564619967|FG001|Overall Study|Lack of Efficacy|4|||
156416991|NCT00057811|564619966|FG000|Overall Study|Physician Decision|1|||
156416992|NCT00057811|564619967|FG001|Overall Study|Physician Decision|0|||
156416993|NCT00057811|564619966|FG000|Overall Study|Withdrawal by Subject|3|||
156416994|NCT00057811|564619967|FG001|Overall Study|Withdrawal by Subject|4|||
156416995|NCT00057811|564619966|FG000|Overall Study|Ineligible|4|||
156416996|NCT00057811|564619967|FG001|Overall Study|Ineligible|2|||
156416997|NCT00057811|564619966|FG000|Overall Study|Inevaluable|1|||
156416998|NCT00057811|564619967|FG001|Overall Study|Inevaluable|2|||
156416999|NCT04131907|564619968|FG000|Overall Study|Adverse Event|2|||
156417000|NCT04131907|564619969|FG001|Overall Study|Adverse Event|0|||
156417001|NCT04131907|564619970|FG002|Overall Study|Adverse Event|0|||
156417002|NCT04131907|564619968|FG000|Overall Study|Physician Decision|4|||
156417003|NCT04131907|564619969|FG001|Overall Study|Physician Decision|22|||
156417004|NCT04131907|564619970|FG002|Overall Study|Physician Decision|0|||
156417005|NCT04131907|564619968|FG000|Overall Study|Withdrawal by Subject|2|||
156417006|NCT04131907|564619969|FG001|Overall Study|Withdrawal by Subject|0|||
156756790|NCT02472886|565860662|FG000|Overall Study|Lack of Efficacy|0|||
156756791|NCT02472886|565860663|FG001|Overall Study|Lack of Efficacy|2|||
156756792|NCT02472886|565860664|FG002|Overall Study|Lack of Efficacy|1|||
156756793|NCT00320788|565860665|FG000|Overall Study|Adverse Event|0|||
156756794|NCT00320788|565860666|FG001|Overall Study|Adverse Event|0|||
156756795|NCT00320788|565860667|FG002|Overall Study|Adverse Event|0|||
156756796|NCT00320788|565860668|FG003|Overall Study|Adverse Event|1|||
156756797|NCT00320788|565860669|FG004|Overall Study|Adverse Event|0|||
156756798|NCT00320788|565860665|FG000|Overall Study|Death|0|||
156756799|NCT00320788|565860666|FG001|Overall Study|Death|0|||
156756800|NCT00320788|565860667|FG002|Overall Study|Death|1|||
156756801|NCT00320788|565860668|FG003|Overall Study|Death|0|||
156756802|NCT00320788|565860669|FG004|Overall Study|Death|1|||
156756803|NCT00320788|565860665|FG000|Overall Study|Lost to Follow-up|0|||
156756804|NCT00320788|565860666|FG001|Overall Study|Lost to Follow-up|2|||
156756805|NCT00320788|565860667|FG002|Overall Study|Lost to Follow-up|1|||
156315921|NCT00045942|564256184|FG004|PKC412A2104E2|Lost to Follow-up|0|||
156315922|NCT00045942|564256185|FG005|PKC412A2104E2|Lost to Follow-up|0|||
156315923|NCT00045942|564256186|FG006|PKC412A2104E2|Lost to Follow-up|0|||
156315924|NCT00045942|564256187|FG007|PKC412A2104E2|Lost to Follow-up|3|||
156315925|NCT00045942|564256188|FG008|PKC412A2104E2|Lost to Follow-up|0|||
156315926|NCT00045942|564256180|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
156315927|NCT00045942|564256181|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
156315928|NCT00045942|564256182|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
156315929|NCT00045942|564256183|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
156315930|NCT00045942|564256184|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
156315931|NCT00045942|564256185|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
156315932|NCT00045942|564256186|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
156315933|NCT00045942|564256187|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
156315934|NCT00045942|564256188|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
156315935|NCT00045942|564256180|FG000|PKC412A2104E2|Lack of Efficacy|0|||
156315936|NCT00045942|564256181|FG001|PKC412A2104E2|Lack of Efficacy|0|||
156315937|NCT00045942|564256182|FG002|PKC412A2104E2|Lack of Efficacy|0|||
156417007|NCT04131907|564619970|FG002|Overall Study|Withdrawal by Subject|1|||
156756806|NCT00320788|565860668|FG003|Overall Study|Lost to Follow-up|0|||
156756807|NCT00320788|565860669|FG004|Overall Study|Lost to Follow-up|0|||
156756808|NCT00320788|565860665|FG000|Overall Study|Decision by the Sponsor|1|||
156315938|NCT00045942|564256183|FG003|PKC412A2104E2|Lack of Efficacy|0|||
156417008|NCT04131907|564619968|FG000|Overall Study|Treatment failure|2|||
156417009|NCT04131907|564619969|FG001|Overall Study|Treatment failure|0|||
156417010|NCT04131907|564619970|FG002|Overall Study|Treatment failure|1|||
156417011|NCT05294419|564619971|FG000|Overall Study|Protocol Violation|4|||
156417012|NCT05294419|564619972|FG001|Overall Study|Protocol Violation|0|||
156417013|NCT05294419|564619973|FG002|Overall Study|Protocol Violation|0|||
156315939|NCT00045942|564256184|FG004|PKC412A2104E2|Lack of Efficacy|0|||
156417014|NCT05294419|564619971|FG000|Overall Study|Lost to Follow-up|6|||
156756809|NCT00320788|565860666|FG001|Overall Study|Decision by the Sponsor|1|||
156756810|NCT00320788|565860667|FG002|Overall Study|Decision by the Sponsor|0|||
156315940|NCT00045942|564256185|FG005|PKC412A2104E2|Lack of Efficacy|3|||
156315941|NCT00045942|564256186|FG006|PKC412A2104E2|Lack of Efficacy|2|||
156315942|NCT00045942|564256187|FG007|PKC412A2104E2|Lack of Efficacy|2|||
156315943|NCT00045942|564256188|FG008|PKC412A2104E2|Lack of Efficacy|6|||
156315944|NCT00045942|564256180|FG000|PKC412A2104E2|Adverse Event|0|||
156315945|NCT00045942|564256181|FG001|PKC412A2104E2|Adverse Event|0|||
156315946|NCT00045942|564256182|FG002|PKC412A2104E2|Adverse Event|0|||
156315947|NCT00045942|564256183|FG003|PKC412A2104E2|Adverse Event|0|||
156315948|NCT00045942|564256184|FG004|PKC412A2104E2|Adverse Event|0|||
156315949|NCT00045942|564256185|FG005|PKC412A2104E2|Adverse Event|4|||
156315950|NCT00045942|564256186|FG006|PKC412A2104E2|Adverse Event|3|||
156315951|NCT00045942|564256187|FG007|PKC412A2104E2|Adverse Event|1|||
156315952|NCT00045942|564256188|FG008|PKC412A2104E2|Adverse Event|0|||
156315953|NCT00045942|564256180|FG000|PKC412A2104E2|Death|0|||
156315954|NCT00045942|564256181|FG001|PKC412A2104E2|Death|0|||
156315955|NCT00045942|564256182|FG002|PKC412A2104E2|Death|0|||
156315956|NCT00045942|564256183|FG003|PKC412A2104E2|Death|0|||
156315957|NCT00045942|564256184|FG004|PKC412A2104E2|Death|0|||
156315958|NCT00045942|564256185|FG005|PKC412A2104E2|Death|1|||
156315959|NCT00045942|564256186|FG006|PKC412A2104E2|Death|2|||
156417015|NCT05294419|564619972|FG001|Overall Study|Lost to Follow-up|0|||
156417016|NCT05294419|564619973|FG002|Overall Study|Lost to Follow-up|0|||
156417017|NCT05294419|564619971|FG000|Overall Study|Results voided after publishing|2|||
156417018|NCT05294419|564619972|FG001|Overall Study|Results voided after publishing|0|||
156652910|NCT00146770|565476171|FG000|Overall Study|Adverse Event|2|||
156652911|NCT00146770|565476172|FG001|Overall Study|Adverse Event|0|||
156652912|NCT00146770|565476171|FG000|Overall Study|Pregnancy|1|||
156652913|NCT00146770|565476172|FG001|Overall Study|Pregnancy|0|||
156652914|NCT00146770|565476171|FG000|Overall Study|Withdrawal by Subject|2|||
156652915|NCT00146770|565476172|FG001|Overall Study|Withdrawal by Subject|0|||
156652916|NCT02427607|565476173|FG000|Overall Study|Withdrawal by Subject|1|||
156652917|NCT01789320|565476174|FG000|Overall Study|Re-enrolled into study|1|||
156652918|NCT01789320|565476174|FG000|Overall Study|Lost to Follow-up|1|||
156652919|NCT02826603|565476175|FG000|Overall Study|Adverse Event|17|||
156652920|NCT02826603|565476176|FG001|Overall Study|Adverse Event|9|||
156652921|NCT02826603|565476175|FG000|Overall Study|Lack of Efficacy|4|||
156652922|NCT02826603|565476176|FG001|Overall Study|Lack of Efficacy|9|||
156652923|NCT02826603|565476175|FG000|Overall Study|Lost to Follow-up|13|||
156652924|NCT02826603|565476176|FG001|Overall Study|Lost to Follow-up|12|||
156652925|NCT02826603|565476175|FG000|Overall Study|Noncompliance with treatment|0|||
156652926|NCT02826603|565476176|FG001|Overall Study|Noncompliance with treatment|2|||
156652927|NCT02826603|565476175|FG000|Overall Study|Physician Decision|1|||
156652928|NCT02826603|565476176|FG001|Overall Study|Physician Decision|7|||
156652929|NCT02826603|565476175|FG000|Overall Study|Pregnancy|1|||
156652930|NCT02826603|565476176|FG001|Overall Study|Pregnancy|2|||
156652931|NCT02826603|565476175|FG000|Overall Study|Protocol Violation|3|||
156652932|NCT02826603|565476176|FG001|Overall Study|Protocol Violation|3|||
156652933|NCT02826603|565476175|FG000|Overall Study|Withdrawal by Subject|20|||
156652934|NCT02826603|565476176|FG001|Overall Study|Withdrawal by Subject|19|||
156652935|NCT02826603|565476175|FG000|Overall Study|Death|2|||
156652936|NCT02826603|565476176|FG001|Overall Study|Death|0|||
156652937|NCT02826603|565476175|FG000|Overall Study|New therapy for study indication|0|||
156652938|NCT02826603|565476176|FG001|Overall Study|New therapy for study indication|1|||
156652939|NCT00905489|565476177|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
156652940|NCT00905489|565476177|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
156652941|NCT00905489|565476177|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
156652942|NCT00583596|565476180|FG000|Overall Study|Lost to Follow-up|110|||
156652943|NCT00583596|565476180|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
156652944|NCT00583596|565476180|FG000|Overall Study|Death|2|||
156652945|NCT00583596|565476180|FG000|Overall Study|Withdrawal by Subject|6|||
156652946|NCT00583596|565476180|FG000|Overall Study|Lost to Follow-up|94|||
156652947|NCT00583596|565476180|FG000|Overall Study|Data not complete|1|||
156652948|NCT00583596|565476180|FG000|Overall Study|Not consented|15|||
156652949|NCT00583596|565476180|FG000|Overall Study|Outside f-up window|26|||
156652950|NCT01533428|565476183|FG000|Overall Study|Adverse Event|0|||
156652951|NCT01533428|565476184|FG001|Overall Study|Adverse Event|1|||
156652952|NCT01533428|565476183|FG000|Overall Study|Lost to Follow-up|2|||
156652953|NCT01533428|565476184|FG001|Overall Study|Lost to Follow-up|1|||
156652954|NCT01533428|565476183|FG000|Overall Study|Withdrawal by Subject|7|||
156652955|NCT01533428|565476184|FG001|Overall Study|Withdrawal by Subject|6|||
156652956|NCT00859469|565476186|FG000|Overall Study|Adverse Event|2|||
156652957|NCT00859469|565476186|FG000|Overall Study|Lack of Efficacy|9|||
156652958|NCT00859469|565476186|FG000|Overall Study|Withdrawal by Subject|1|||
156652959|NCT00859469|565476186|FG000|Overall Study|Death|16|||
156652960|NCT02102490|565476192|FG000|Overall Study|Death|6|||
156652961|NCT02102490|565476192|FG000|Overall Study|Lost to Follow-up|1|||
156652962|NCT00095199|565476193|FG000|Overall Study|Adverse Event|40|||
156652963|NCT00095199|565476194|FG001|Overall Study|Adverse Event|22|||
156652964|NCT00095199|565476195|FG002|Overall Study|Adverse Event|26|||
156652965|NCT00095199|565476196|FG003|Overall Study|Adverse Event|11|||
156417019|NCT05294419|564619973|FG002|Overall Study|Results voided after publishing|0|||
156417020|NCT05708846|564619974|FG000|Overall Study|Death|5|||
156417021|NCT05708846|564619974|FG000|Overall Study|Withdrawal by Subject|20|||
156417022|NCT03621982|564619975|FG000|Overall Study|Withdrawal by Subject|1|||
156417023|NCT03621982|564619976|FG001|Overall Study|Withdrawal by Subject|0|||
156417024|NCT03621982|564619977|FG002|Overall Study|Withdrawal by Subject|0|||
156417025|NCT03621982|564619978|FG003|Overall Study|Withdrawal by Subject|1|||
156417026|NCT03621982|564619979|FG004|Overall Study|Withdrawal by Subject|0|||
156417027|NCT03621982|564619980|FG005|Overall Study|Withdrawal by Subject|1|||
156417028|NCT03621982|564619981|FG006|Overall Study|Withdrawal by Subject|1|||
156417029|NCT03621982|564619982|FG007|Overall Study|Withdrawal by Subject|0|||
156417030|NCT03621982|564619983|FG008|Overall Study|Withdrawal by Subject|1|||
156417031|NCT03621982|564619984|FG009|Overall Study|Withdrawal by Subject|0|||
156417032|NCT03621982|564619985|FG010|Overall Study|Withdrawal by Subject|2|||
156417033|NCT03621982|564619986|FG011|Overall Study|Withdrawal by Subject|1|||
156417034|NCT03621982|564619987|FG012|Overall Study|Withdrawal by Subject|2|||
156417035|NCT03621982|564619988|FG013|Overall Study|Withdrawal by Subject|2|||
156417036|NCT03621982|564619975|FG000|Overall Study|Investigator/Sponsor decision|0|||
156417037|NCT03621982|564619976|FG001|Overall Study|Investigator/Sponsor decision|0|||
156417038|NCT03621982|564619977|FG002|Overall Study|Investigator/Sponsor decision|0|||
156417039|NCT03621982|564619978|FG003|Overall Study|Investigator/Sponsor decision|0|||
156417040|NCT03621982|564619979|FG004|Overall Study|Investigator/Sponsor decision|0|||
156417041|NCT03621982|564619980|FG005|Overall Study|Investigator/Sponsor decision|0|||
156417042|NCT03621982|564619981|FG006|Overall Study|Investigator/Sponsor decision|0|||
156417043|NCT03621982|564619982|FG007|Overall Study|Investigator/Sponsor decision|0|||
156417044|NCT03621982|564619983|FG008|Overall Study|Investigator/Sponsor decision|0|||
156417045|NCT03621982|564619984|FG009|Overall Study|Investigator/Sponsor decision|0|||
156417046|NCT03621982|564619985|FG010|Overall Study|Investigator/Sponsor decision|0|||
156417047|NCT03621982|564619986|FG011|Overall Study|Investigator/Sponsor decision|4|||
156417048|NCT03621982|564619987|FG012|Overall Study|Investigator/Sponsor decision|0|||
156417049|NCT03621982|564619988|FG013|Overall Study|Investigator/Sponsor decision|2|||
156417050|NCT03621982|564619975|FG000|Overall Study|Death|2|||
156417051|NCT03621982|564619976|FG001|Overall Study|Death|4|||
156417052|NCT03621982|564619977|FG002|Overall Study|Death|4|||
156417053|NCT03621982|564619978|FG003|Overall Study|Death|3|||
156417054|NCT03621982|564619979|FG004|Overall Study|Death|8|||
156417055|NCT03621982|564619980|FG005|Overall Study|Death|4|||
156417056|NCT03621982|564619981|FG006|Overall Study|Death|6|||
156417057|NCT03621982|564619982|FG007|Overall Study|Death|3|||
156417058|NCT03621982|564619983|FG008|Overall Study|Death|0|||
156417059|NCT03621982|564619984|FG009|Overall Study|Death|3|||
156417060|NCT03621982|564619985|FG010|Overall Study|Death|8|||
156417061|NCT03621982|564619986|FG011|Overall Study|Death|4|||
156417062|NCT03621982|564619987|FG012|Overall Study|Death|2|||
156417063|NCT03621982|564619988|FG013|Overall Study|Death|2|||
156417064|NCT03621982|564619975|FG000|Overall Study|Lost to Follow-up|0|||
156417065|NCT03621982|564619976|FG001|Overall Study|Lost to Follow-up|0|||
156417066|NCT03621982|564619977|FG002|Overall Study|Lost to Follow-up|1|||
156417067|NCT03621982|564619978|FG003|Overall Study|Lost to Follow-up|0|||
156417068|NCT03621982|564619979|FG004|Overall Study|Lost to Follow-up|0|||
156417069|NCT03621982|564619980|FG005|Overall Study|Lost to Follow-up|0|||
156417070|NCT03621982|564619981|FG006|Overall Study|Lost to Follow-up|1|||
156417071|NCT03621982|564619982|FG007|Overall Study|Lost to Follow-up|0|||
156417072|NCT03621982|564619983|FG008|Overall Study|Lost to Follow-up|0|||
156417073|NCT03621982|564619984|FG009|Overall Study|Lost to Follow-up|1|||
156417074|NCT03621982|564619985|FG010|Overall Study|Lost to Follow-up|0|||
156417075|NCT03621982|564619986|FG011|Overall Study|Lost to Follow-up|0|||
156417076|NCT03621982|564619987|FG012|Overall Study|Lost to Follow-up|0|||
156417077|NCT03621982|564619988|FG013|Overall Study|Lost to Follow-up|0|||
156417078|NCT00238420|564619989|FG000|Overall Study|Protocol Violation|1|||
156652966|NCT00095199|565476193|FG000|Overall Study|Progressive disease|213|||
156652967|NCT00095199|565476194|FG001|Overall Study|Progressive disease|179|||
156417079|NCT00238420|564619990|FG001|Overall Study|Protocol Violation|1|||
156652968|NCT00095199|565476195|FG002|Overall Study|Progressive disease|105|||
156652969|NCT00095199|565476196|FG003|Overall Study|Progressive disease|98|||
156652970|NCT00095199|565476193|FG000|Overall Study|Death|10|||
156652971|NCT00095199|565476194|FG001|Overall Study|Death|6|||
156652972|NCT00095199|565476195|FG002|Overall Study|Death|11|||
156417080|NCT03428815|564619993|FG000|Overall Study|Lost to Follow-up|2|||
156417081|NCT03428815|564619994|FG001|Overall Study|Lost to Follow-up|2|||
156417082|NCT03428815|564619993|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
156652973|NCT00095199|565476196|FG003|Overall Study|Death|9|||
156417083|NCT03428815|564619994|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
156417084|NCT03428815|564619993|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
156417085|NCT03428815|564619994|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
156417086|NCT02102464|564619997|FG000|Randomized Study|Withdrawal by Subject|0|||
156652974|NCT00095199|565476193|FG000|Overall Study|Withdrawal by Subject|21|||
156756811|NCT00320788|565860668|FG003|Overall Study|Decision by the Sponsor|0|||
156756812|NCT00320788|565860669|FG004|Overall Study|Decision by the Sponsor|1|||
156756813|NCT00320788|565860665|FG000|Overall Study|Other|1|||
156756814|NCT00320788|565860666|FG001|Overall Study|Other|2|||
156756815|NCT00320788|565860667|FG002|Overall Study|Other|1|||
156756816|NCT00320788|565860668|FG003|Overall Study|Other|1|||
156756817|NCT00320788|565860669|FG004|Overall Study|Other|1|||
156756818|NCT00320788|565860665|FG000|Overall Study|Physician Decision|1|||
156756819|NCT00320788|565860666|FG001|Overall Study|Physician Decision|1|||
156756820|NCT00320788|565860667|FG002|Overall Study|Physician Decision|0|||
156756821|NCT00320788|565860668|FG003|Overall Study|Physician Decision|0|||
156756822|NCT00320788|565860669|FG004|Overall Study|Physician Decision|0|||
156756823|NCT00320788|565860665|FG000|Overall Study|Protocol Violation|0|||
156756824|NCT00320788|565860666|FG001|Overall Study|Protocol Violation|0|||
156756825|NCT00320788|565860667|FG002|Overall Study|Protocol Violation|0|||
156756826|NCT00320788|565860668|FG003|Overall Study|Protocol Violation|0|||
156315960|NCT00045942|564256187|FG007|PKC412A2104E2|Death|0|||
156315961|NCT00045942|564256188|FG008|PKC412A2104E2|Death|0|||
156315962|NCT05508074|564256189|FG000|Overall Study|Death|2|||
156315963|NCT05508074|564256190|FG001|Overall Study|Death|5|||
156315964|NCT05508074|564256189|FG000|Overall Study|Withdrawal by Subject|1|||
156315965|NCT05508074|564256190|FG001|Overall Study|Withdrawal by Subject|2|||
156315966|NCT05508074|564256189|FG000|Overall Study|Adverse Event|0|||
156315967|NCT05508074|564256190|FG001|Overall Study|Adverse Event|1|||
156315968|NCT05508074|564256189|FG000|Overall Study|Physician Decision|0|||
156315969|NCT05508074|564256190|FG001|Overall Study|Physician Decision|1|||
156315970|NCT05508074|564256189|FG000|Overall Study|wrongly randomized|0|||
156315971|NCT05508074|564256190|FG001|Overall Study|wrongly randomized|1|||
156315972|NCT05508074|564256189|FG000|Overall Study|non-compliance|0|||
156315973|NCT05508074|564256190|FG001|Overall Study|non-compliance|1|||
156315974|NCT02395302|564256191|FG000|Overall Study|Screen Failure|3|||
156315975|NCT02395302|564256191|FG000|Overall Study|Run In Failure|7|||
156315976|NCT02395302|564256191|FG000|Overall Study|Withdrawal by Subject|2|||
156315977|NCT02395302|564256191|FG000|Overall Study|Physician Decision|2|||
156315978|NCT01806662|564256192|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
156315979|NCT01806662|564256193|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
156315980|NCT01806662|564256192|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
156315981|NCT01806662|564256193|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
156315982|NCT01806662|564256192|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
156315983|NCT01806662|564256193|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
156315984|NCT01806662|564256192|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
156315985|NCT01806662|564256193|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
156315986|NCT00043550|564256194|FG000|Overall Study|Withdrawal by Subject|22|||
156315987|NCT00043550|564256195|FG001|Overall Study|Withdrawal by Subject|12|||
156315988|NCT00043550|564256196|FG002|Overall Study|Withdrawal by Subject|20|||
156315989|NCT02285062|564256199|FG000|Pre-Treatment Period|Protocol Violation|0|||
156315990|NCT02285062|564256200|FG001|Pre-Treatment Period|Protocol Violation|2|||
156315991|NCT02285062|564256199|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
156315992|NCT02285062|564256200|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
156315993|NCT00545129|564256206|FG000|Overall Study|Lack of Efficacy|2|||
156315994|NCT00545129|564256207|FG001|Overall Study|Lack of Efficacy|5|||
156315995|NCT00545129|564256206|FG000|Overall Study|Death|2|||
156315996|NCT00545129|564256207|FG001|Overall Study|Death|1|||
156315997|NCT00545129|564256206|FG000|Overall Study|Adverse Event|1|||
156315998|NCT00545129|564256207|FG001|Overall Study|Adverse Event|1|||
156315999|NCT00545129|564256206|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
156316000|NCT00545129|564256207|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
156316001|NCT00545129|564256206|FG000|Overall Study|Other|3|||
156316002|NCT00545129|564256207|FG001|Overall Study|Other|3|||
156316003|NCT00821509|564256208|FG000|Overall Study|Withdrawal by Subject|12|||
156316004|NCT00821509|564256209|FG001|Overall Study|Withdrawal by Subject|11|||
156316005|NCT00821509|564256210|FG002|Overall Study|Withdrawal by Subject|34|||
156316006|NCT00807573|564256212|FG000|Overall Study|Withdrawal by Subject|1|||
156756827|NCT00320788|565860669|FG004|Overall Study|Protocol Violation|1|||
156316007|NCT00807573|564256212|FG000|Overall Study|Adverse Event|1|||
156316008|NCT01551420|564256213|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
156316009|NCT01551420|564256214|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
156756828|NCT00320788|565860665|FG000|Overall Study|Withdrawal by Subject|3|||
156756829|NCT00320788|565860666|FG001|Overall Study|Withdrawal by Subject|0|||
156756830|NCT00320788|565860667|FG002|Overall Study|Withdrawal by Subject|0|||
156756831|NCT00320788|565860668|FG003|Overall Study|Withdrawal by Subject|3|||
156316010|NCT01551420|564256213|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
156316011|NCT01551420|564256214|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
156316012|NCT01551420|564256213|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
156316013|NCT01551420|564256214|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
156316014|NCT01551420|564256213|FG000|Screened for Part B Eligibility|Declined participation|8|||
156756832|NCT00320788|565860669|FG004|Overall Study|Withdrawal by Subject|1|||
156417087|NCT02102464|564619998|FG001|Randomized Study|Withdrawal by Subject|1|||
156417088|NCT02102464|564619999|FG002|Randomized Study|Withdrawal by Subject|0|||
156417089|NCT02404493|564620000|FG000|Overall Study|Adverse Event|1|||
156417090|NCT02404493|564620001|FG001|Overall Study|Adverse Event|1|||
156417091|NCT04140890|564620002|FG000|Overall Study|Withdrawal by Subject|0|||
156417092|NCT04140890|564620003|FG001|Overall Study|Withdrawal by Subject|1|||
156417093|NCT01700348|564620004|FG000|Overall Study|Withdrawal by Subject|22|||
156417094|NCT01700348|564620004|FG000|Overall Study|Lost to Follow-up|1|||
156417095|NCT01824472|564620011|FG000|Overall Study|Lost to Follow-up|0|||
156417096|NCT01824472|564620012|FG001|Overall Study|Lost to Follow-up|0|||
156417097|NCT01824472|564620013|FG002|Overall Study|Lost to Follow-up|1|||
156417098|NCT01824472|564620011|FG000|Overall Study|Withdrawal by Subject|1|||
156417099|NCT01824472|564620012|FG001|Overall Study|Withdrawal by Subject|5|||
156417100|NCT01824472|564620013|FG002|Overall Study|Withdrawal by Subject|3|||
156417101|NCT01824472|564620011|FG000|Overall Study|Ineligible post randomization&screening|0|||
156417102|NCT01824472|564620012|FG001|Overall Study|Ineligible post randomization&screening|2|||
156417103|NCT01824472|564620013|FG002|Overall Study|Ineligible post randomization&screening|0|||
156417104|NCT03317379|564620016|FG000|Overall Study|Lost to Follow-up|0|||
156417105|NCT03317379|564620017|FG001|Overall Study|Lost to Follow-up|3|||
156417106|NCT03317379|564620018|FG002|Overall Study|Lost to Follow-up|2|||
156417107|NCT03040687|564620019|FG000|Overall Study|Withdrawal by Subject|1|||
156417108|NCT03040687|564620020|FG001|Overall Study|Withdrawal by Subject|0|||
156417109|NCT03040687|564620021|FG002|Overall Study|Withdrawal by Subject|0|||
156417110|NCT02846558|564620022|FG000|Overall Study|Adverse Event|1|||
156417111|NCT02846558|564620023|FG001|Overall Study|Adverse Event|0|||
156417112|NCT02846558|564620024|FG002|Overall Study|Adverse Event|0|||
156417113|NCT02846558|564620025|FG003|Overall Study|Adverse Event|0|||
156417114|NCT02846558|564620022|FG000|Overall Study|Withdrawal by Subject|5|||
156417115|NCT02846558|564620023|FG001|Overall Study|Withdrawal by Subject|4|||
156417116|NCT02846558|564620024|FG002|Overall Study|Withdrawal by Subject|2|||
156417117|NCT02846558|564620025|FG003|Overall Study|Withdrawal by Subject|2|||
156417118|NCT02846558|564620022|FG000|Overall Study|Lost to Follow-up|2|||
156417119|NCT02846558|564620023|FG001|Overall Study|Lost to Follow-up|0|||
156417120|NCT02846558|564620024|FG002|Overall Study|Lost to Follow-up|0|||
156417121|NCT02846558|564620025|FG003|Overall Study|Lost to Follow-up|0|||
156417122|NCT04445155|564620026|FG000|Overall Study|Lost to Follow-up|11|||
156417123|NCT04445155|564620027|FG001|Overall Study|Lost to Follow-up|2|||
156417124|NCT04445155|564620028|FG002|Overall Study|Lost to Follow-up|3|||
156417125|NCT04445155|564620029|FG003|Overall Study|Lost to Follow-up|0|||
156417126|NCT04445155|564620026|FG000|Overall Study|Withdrawal by Subject|8|||
156652975|NCT00095199|565476194|FG001|Overall Study|Withdrawal by Subject|16|||
156652976|NCT00095199|565476195|FG002|Overall Study|Withdrawal by Subject|13|||
156652977|NCT00095199|565476196|FG003|Overall Study|Withdrawal by Subject|22|||
156652978|NCT00095199|565476193|FG000|Overall Study|Protocol Violation|4|||
156652979|NCT00095199|565476194|FG001|Overall Study|Protocol Violation|4|||
156652980|NCT00095199|565476195|FG002|Overall Study|Protocol Violation|2|||
156652981|NCT00095199|565476196|FG003|Overall Study|Protocol Violation|0|||
156652982|NCT00095199|565476193|FG000|Overall Study|Liver function test results elevated|0|||
156652983|NCT00095199|565476194|FG001|Overall Study|Liver function test results elevated|0|||
156652984|NCT00095199|565476195|FG002|Overall Study|Liver function test results elevated|1|||
156652985|NCT00095199|565476196|FG003|Overall Study|Liver function test results elevated|1|||
156652986|NCT00095199|565476193|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
156652987|NCT00095199|565476194|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
156652988|NCT00095199|565476195|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
156652989|NCT00095199|565476196|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
156652990|NCT00095199|565476193|FG000|Overall Study|Physician Decision|5|||
156652991|NCT00095199|565476194|FG001|Overall Study|Physician Decision|6|||
156652992|NCT00095199|565476195|FG002|Overall Study|Physician Decision|1|||
156652993|NCT00095199|565476196|FG003|Overall Study|Physician Decision|1|||
156652994|NCT00095199|565476193|FG000|Overall Study|Not eligible|1|||
156652995|NCT00095199|565476194|FG001|Overall Study|Not eligible|7|||
156652996|NCT00095199|565476195|FG002|Overall Study|Not eligible|0|||
156652997|NCT00095199|565476196|FG003|Overall Study|Not eligible|1|||
156652998|NCT00095199|565476193|FG000|Overall Study|Started Palliative Radiotherapy|1|||
156652999|NCT00095199|565476194|FG001|Overall Study|Started Palliative Radiotherapy|0|||
156653000|NCT00095199|565476195|FG002|Overall Study|Started Palliative Radiotherapy|0|||
156653001|NCT00095199|565476196|FG003|Overall Study|Started Palliative Radiotherapy|0|||
156653002|NCT00095199|565476193|FG000|Overall Study|Started radiotherapy regimen|0|||
156653003|NCT00095199|565476194|FG001|Overall Study|Started radiotherapy regimen|1|||
156653004|NCT00095199|565476195|FG002|Overall Study|Started radiotherapy regimen|0|||
156653005|NCT00095199|565476196|FG003|Overall Study|Started radiotherapy regimen|0|||
156653006|NCT00095199|565476193|FG000|Overall Study|Primary tumor removed in other surgery|0|||
156417127|NCT04445155|564620027|FG001|Overall Study|Withdrawal by Subject|0|||
156417128|NCT04445155|564620028|FG002|Overall Study|Withdrawal by Subject|0|||
156653007|NCT00095199|565476194|FG001|Overall Study|Primary tumor removed in other surgery|1|||
156417129|NCT04445155|564620029|FG003|Overall Study|Withdrawal by Subject|0|||
156417130|NCT04445155|564620026|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
156417131|NCT04445155|564620027|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
156417132|NCT04445155|564620028|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
156417133|NCT04445155|564620029|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
156417134|NCT04445155|564620026|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
156417135|NCT04445155|564620027|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
156417136|NCT04445155|564620028|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
156417137|NCT04445155|564620029|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
156417138|NCT00810641|564620032|FG000|Overall Study|Withdrawal by Subject|0|||
156417139|NCT00810641|564620033|FG001|Overall Study|Withdrawal by Subject|1|||
156417140|NCT00810641|564620034|FG002|Overall Study|Withdrawal by Subject|2|||
156417141|NCT02325713|564620037|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417142|NCT02325713|564620038|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417143|NCT02325713|564620039|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417144|NCT02325713|564620040|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417145|NCT02325713|564620041|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417146|NCT02325713|564620042|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417147|NCT02325713|564620043|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417148|NCT02325713|564620044|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417149|NCT02325713|564620045|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417150|NCT02325713|564620046|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417151|NCT02325713|564620047|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
156417152|NCT02325713|564620048|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417153|NCT02325713|564620049|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417154|NCT02325713|564620050|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417155|NCT02325713|564620051|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417156|NCT02325713|564620052|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156417157|NCT02325713|564620037|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
156417158|NCT02325713|564620038|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417159|NCT02325713|564620039|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417160|NCT02325713|564620040|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417161|NCT02325713|564620041|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417162|NCT02325713|564620042|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417163|NCT02325713|564620043|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417164|NCT02325713|564620044|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417165|NCT02325713|564620045|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417166|NCT02325713|564620046|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417167|NCT02325713|564620047|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417168|NCT02325713|564620048|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417169|NCT02325713|564620049|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417170|NCT02325713|564620050|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417171|NCT02325713|564620051|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417172|NCT02325713|564620052|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156417173|NCT02325713|564620037|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156653008|NCT00095199|565476195|FG002|Overall Study|Primary tumor removed in other surgery|0|||
156653009|NCT00095199|565476196|FG003|Overall Study|Primary tumor removed in other surgery|0|||
156653010|NCT00095199|565476193|FG000|Overall Study|Data inadvertently lost by site|1|||
156653011|NCT00095199|565476194|FG001|Overall Study|Data inadvertently lost by site|0|||
156653012|NCT00095199|565476195|FG002|Overall Study|Data inadvertently lost by site|0|||
156653013|NCT00095199|565476196|FG003|Overall Study|Data inadvertently lost by site|0|||
156653014|NCT01890707|565476231|FG000|Overall Study|Lost to Follow-up|1|||
156653015|NCT01890707|565476232|FG001|Overall Study|Lost to Follow-up|1|||
156653016|NCT00669955|565476233|FG000|Overall Study|Adverse Event|3|||
156653017|NCT00669955|565476234|FG001|Overall Study|Adverse Event|5|||
156653018|NCT00669955|565476233|FG000|Overall Study|Death|0|||
156653019|NCT00669955|565476234|FG001|Overall Study|Death|1|||
156653020|NCT00669955|565476233|FG000|Overall Study|Withdrawal by Subject|2|||
156653021|NCT00669955|565476234|FG001|Overall Study|Withdrawal by Subject|3|||
156653022|NCT00669955|565476233|FG000|Overall Study|Lost to Follow-up|5|||
156653023|NCT00669955|565476234|FG001|Overall Study|Lost to Follow-up|7|||
156653024|NCT00669955|565476233|FG000|Overall Study|Protocol Violation|2|||
156653025|NCT00669955|565476234|FG001|Overall Study|Protocol Violation|7|||
156417174|NCT02325713|564620038|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156653026|NCT00669955|565476233|FG000|Overall Study|Investigator Sponsor Judgement|0|||
156653027|NCT00669955|565476234|FG001|Overall Study|Investigator Sponsor Judgement|1|||
156417175|NCT02325713|564620039|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417176|NCT02325713|564620040|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417177|NCT02325713|564620041|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417178|NCT02325713|564620042|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417179|NCT02325713|564620043|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417180|NCT02325713|564620044|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417181|NCT02325713|564620045|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417182|NCT02325713|564620046|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
156417183|NCT02325713|564620047|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417184|NCT02325713|564620048|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417185|NCT02325713|564620049|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417186|NCT02325713|564620050|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417187|NCT02325713|564620051|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417188|NCT02325713|564620052|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156417189|NCT03363659|564620053|FG000|Overall Study|Adverse Event|1|||
156417190|NCT03363659|564620053|FG000|Overall Study|Screen fail|1|||
156417191|NCT03363659|564620053|FG000|Overall Study|Withdrawal by Subject|1|||
156417192|NCT01213173|564620055|FG000|Overall Study|Protocol Violation|2|||
156417193|NCT01213173|564620056|FG001|Overall Study|Protocol Violation|0|||
156417194|NCT01213173|564620055|FG000|Overall Study|Adverse Event|4|||
156417195|NCT01213173|564620056|FG001|Overall Study|Adverse Event|8|||
156417196|NCT01213173|564620055|FG000|Overall Study|Withdrawal by Subject|5|||
156417197|NCT01213173|564620056|FG001|Overall Study|Withdrawal by Subject|5|||
156417198|NCT01213173|564620055|FG000|Overall Study|Incorrect Enrollment|1|||
156417199|NCT01213173|564620056|FG001|Overall Study|Incorrect Enrollment|3|||
156417200|NCT02253316|564620057|FG000|Consolidation|Progression|4|||
156417201|NCT02253316|564620058|FG001|Consolidation|Progression|0|||
156417202|NCT02253316|564620059|FG002|Consolidation|Progression|0|||
156417203|NCT02253316|564620057|FG000|Consolidation|Non-Compliance|1|||
156417204|NCT02253316|564620058|FG001|Consolidation|Non-Compliance|0|||
156417205|NCT02253316|564620059|FG002|Consolidation|Non-Compliance|0|||
156417206|NCT02253316|564620057|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
156417207|NCT02253316|564620058|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
156417208|NCT02253316|564620059|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
156417209|NCT02253316|564620057|FG000|Consolidation|Secondary Malignancy|2|||
156417210|NCT02253316|564620058|FG001|Consolidation|Secondary Malignancy|0|||
156417211|NCT02253316|564620059|FG002|Consolidation|Secondary Malignancy|0|||
156417212|NCT02253316|564620057|FG000|Consolidation|Adverse Event|7|||
156417213|NCT02253316|564620058|FG001|Consolidation|Adverse Event|0|||
156417214|NCT02253316|564620059|FG002|Consolidation|Adverse Event|0|||
156417215|NCT02253316|564620057|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
156417216|NCT02253316|564620058|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
156417217|NCT02253316|564620059|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
156417218|NCT02253316|564620057|FG000|Maintenance|Physician Decision|0|||
156417219|NCT02253316|564620058|FG001|Maintenance|Physician Decision|7|||
156417220|NCT02253316|564620059|FG002|Maintenance|Physician Decision|16|||
156653028|NCT00669955|565476233|FG000|Overall Study|not compliant with study drug/visit|2|||
156653029|NCT00669955|565476234|FG001|Overall Study|not compliant with study drug/visit|3|||
156653030|NCT00385541|565476236|FG000|Overall Study|severe pain, clinician requested unblind|0|||
156653031|NCT00385541|565476237|FG001|Overall Study|severe pain, clinician requested unblind|1|||
156653032|NCT03329027|565477867|FG000|Overall Study|Lost to Follow-up|1|||
156653033|NCT03329027|565477868|FG001|Overall Study|Lost to Follow-up|0|||
156653034|NCT03329027|565477869|FG002|Overall Study|Lost to Follow-up|1|||
156653035|NCT03329027|565477867|FG000|Overall Study|Protocol Violation|9|||
156653036|NCT03329027|565477868|FG001|Overall Study|Protocol Violation|5|||
156653037|NCT03329027|565477869|FG002|Overall Study|Protocol Violation|7|||
156653038|NCT02761980|565477872|FG000|Overall Study|Adverse Event|4|||
156653039|NCT02761980|565477873|FG001|Overall Study|Adverse Event|6|||
156653040|NCT02761980|565477874|FG002|Overall Study|Adverse Event|5|||
156653041|NCT02761980|565477875|FG003|Overall Study|Adverse Event|6|||
156653042|NCT02761980|565477872|FG000|Overall Study|Withdrawal by Subject|0|||
156653043|NCT02761980|565477873|FG001|Overall Study|Withdrawal by Subject|1|||
156653044|NCT02761980|565477874|FG002|Overall Study|Withdrawal by Subject|0|||
156653045|NCT02761980|565477875|FG003|Overall Study|Withdrawal by Subject|0|||
156653046|NCT02761980|565477872|FG000|Overall Study|Other|0|||
156653047|NCT02761980|565477873|FG001|Overall Study|Other|0|||
156653048|NCT02761980|565477874|FG002|Overall Study|Other|1|||
156653049|NCT02761980|565477875|FG003|Overall Study|Other|0|||
156653050|NCT00101582|565477882|FG000|Overall Study|Ineligibility determined|0|||
156653051|NCT00101582|565477883|FG001|Overall Study|Ineligibility determined|1|||
156653052|NCT00101582|565477882|FG000|Overall Study|Adverse Event|1|||
156653053|NCT00101582|565477883|FG001|Overall Study|Adverse Event|4|||
156417221|NCT02253316|564620057|FG000|Maintenance|Non-Compliance|0|||
156417222|NCT02253316|564620058|FG001|Maintenance|Non-Compliance|1|||
156417223|NCT02253316|564620059|FG002|Maintenance|Non-Compliance|1|||
156653054|NCT00101582|565477882|FG000|Overall Study|Withdrawal by Subject|6|||
156316015|NCT01551420|564256214|FG001|Screened for Part B Eligibility|Declined participation|1|||
156316016|NCT01551420|564256213|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
156316017|NCT01551420|564256214|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
156316018|NCT01551420|564256213|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
156316019|NCT01551420|564256214|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
156316020|NCT01551420|564256213|FG000|Home Use (Part B)|Withdrawal by staff|0|||
156316021|NCT01551420|564256214|FG001|Home Use (Part B)|Withdrawal by staff|1|||
156316022|NCT00169442|564256215|FG000|Overall Study|Withdrawal by Subject|0|||
156316023|NCT00169442|564256216|FG001|Overall Study|Withdrawal by Subject|0|||
156316024|NCT00169442|564256217|FG002|Overall Study|Withdrawal by Subject|1|||
156316025|NCT00169442|564256218|FG003|Overall Study|Withdrawal by Subject|0|||
156316026|NCT00169442|564256219|FG004|Overall Study|Withdrawal by Subject|0|||
156316027|NCT00169442|564256220|FG005|Overall Study|Withdrawal by Subject|0|||
156316028|NCT00169442|564256215|FG000|Overall Study|Migrated/moved from study area|0|||
156316029|NCT00169442|564256216|FG001|Overall Study|Migrated/moved from study area|0|||
156316030|NCT00169442|564256217|FG002|Overall Study|Migrated/moved from study area|0|||
156316031|NCT00169442|564256218|FG003|Overall Study|Migrated/moved from study area|0|||
156316032|NCT00169442|564256219|FG004|Overall Study|Migrated/moved from study area|0|||
156316033|NCT00169442|564256220|FG005|Overall Study|Migrated/moved from study area|2|||
156316034|NCT00169442|564256215|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156316035|NCT00169442|564256216|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156316036|NCT00169442|564256217|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156316037|NCT00169442|564256218|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156316038|NCT00169442|564256219|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
156316039|NCT00169442|564256220|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156316040|NCT00169442|564256215|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156316041|NCT00169442|564256216|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
156316042|NCT00169442|564256217|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156316043|NCT00169442|564256218|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156316044|NCT00169442|564256219|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156316045|NCT00169442|564256220|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156316046|NCT01426789|564256221|FG000|Part 1|Protocol deviation|0|||
156316047|NCT01426789|564256222|FG001|Part 1|Protocol deviation|1|||
156316048|NCT01426789|564256223|FG002|Part 1|Protocol deviation|0|||
156316049|NCT01426789|564256224|FG003|Part 1|Protocol deviation|0|||
156316050|NCT01426789|564256225|FG004|Part 1|Protocol deviation|0|||
156316051|NCT01426789|564256226|FG005|Part 1|Protocol deviation|0|||
156316052|NCT01426789|564256221|FG000|Part 1|Lost to Follow-up|1|||
156316053|NCT01426789|564256222|FG001|Part 1|Lost to Follow-up|2|||
156316054|NCT01426789|564256223|FG002|Part 1|Lost to Follow-up|0|||
156316055|NCT01426789|564256224|FG003|Part 1|Lost to Follow-up|0|||
156316056|NCT01426789|564256225|FG004|Part 1|Lost to Follow-up|0|||
156316057|NCT01426789|564256226|FG005|Part 1|Lost to Follow-up|0|||
156316058|NCT01426789|564256221|FG000|Part 1|Lack of Efficacy|2|||
156316059|NCT01426789|564256222|FG001|Part 1|Lack of Efficacy|1|||
156316060|NCT01426789|564256223|FG002|Part 1|Lack of Efficacy|0|||
156316061|NCT01426789|564256224|FG003|Part 1|Lack of Efficacy|0|||
156316062|NCT01426789|564256225|FG004|Part 1|Lack of Efficacy|0|||
156316063|NCT01426789|564256226|FG005|Part 1|Lack of Efficacy|0|||
156653055|NCT00101582|565477883|FG001|Overall Study|Withdrawal by Subject|4|||
156653056|NCT00101582|565477882|FG000|Overall Study|Physician Decision|1|||
156653057|NCT00101582|565477883|FG001|Overall Study|Physician Decision|0|||
156653058|NCT00101582|565477882|FG000|Overall Study|Death|3|||
156653059|NCT00101582|565477883|FG001|Overall Study|Death|5|||
156653060|NCT00101582|565477882|FG000|Overall Study|Other|0|||
156653061|NCT00101582|565477883|FG001|Overall Study|Other|1|||
156653062|NCT01907087|565477884|FG000|Overall Study|Withdrawal by Subject|1|||
156653063|NCT01919190|565477886|FG000|Overall Study|Intra-op findings, etc.|3|||
156653064|NCT01919190|565477887|FG001|Overall Study|Intra-op findings, etc.|0|||
156653065|NCT01767597|565477888|FG000|Overall Study|Incomplete intervention|3|||
156653066|NCT01767597|565477889|FG001|Overall Study|Incomplete intervention|1|||
156653067|NCT01767597|565477888|FG000|Overall Study|Withdrawal by Subject|1|||
156653068|NCT01767597|565477889|FG001|Overall Study|Withdrawal by Subject|0|||
156653069|NCT03355742|565477890|FG000|Overall Study|Lost to Follow-up|4|||
156316064|NCT01426789|564256221|FG000|Part 1|Adverse Event|3|||
156316065|NCT01426789|564256222|FG001|Part 1|Adverse Event|0|||
156316066|NCT01426789|564256223|FG002|Part 1|Adverse Event|0|||
156316067|NCT01426789|564256224|FG003|Part 1|Adverse Event|0|||
156316068|NCT01426789|564256225|FG004|Part 1|Adverse Event|0|||
156316069|NCT01426789|564256226|FG005|Part 1|Adverse Event|0|||
156316070|NCT01426789|564256221|FG000|Part 2|Protocol deviation|0|||
156316071|NCT01426789|564256222|FG001|Part 2|Protocol deviation|0|||
156316072|NCT01426789|564256223|FG002|Part 2|Protocol deviation|1|||
156316073|NCT01426789|564256224|FG003|Part 2|Protocol deviation|0|||
156653070|NCT03355742|565477890|FG000|Overall Study|Withdrawal by Subject|29|||
156316074|NCT01426789|564256225|FG004|Part 2|Protocol deviation|0|||
156417224|NCT02253316|564620057|FG000|Maintenance|Secondary Malignancy|0|||
156417225|NCT02253316|564620058|FG001|Maintenance|Secondary Malignancy|2|||
156417226|NCT02253316|564620059|FG002|Maintenance|Secondary Malignancy|6|||
156417227|NCT02253316|564620057|FG000|Maintenance|Adverse Event|0|||
156417228|NCT02253316|564620058|FG001|Maintenance|Adverse Event|8|||
156417229|NCT02253316|564620059|FG002|Maintenance|Adverse Event|12|||
156417230|NCT02253316|564620057|FG000|Maintenance|Still receiving active treatment|0|||
156417231|NCT02253316|564620058|FG001|Maintenance|Still receiving active treatment|4|||
156417232|NCT02253316|564620059|FG002|Maintenance|Still receiving active treatment|0|||
156417233|NCT02353832|564620060|FG000|Overall Study|Ineligible after enrollment|1|||
156417234|NCT02353832|564620060|FG000|Overall Study|Lost to Follow-up|1|||
156417235|NCT00904150|564620061|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
156417236|NCT00904150|564620062|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
156417237|NCT00904150|564620061|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
156417238|NCT00904150|564620062|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
156417239|NCT02692235|564621638|FG000|Overall Study|Withdrawal by Subject|2|||
156417240|NCT02692235|564621639|FG001|Overall Study|Withdrawal by Subject|1|||
156417241|NCT02692235|564621638|FG000|Overall Study|Adverse Event|1|||
156417242|NCT02692235|564621639|FG001|Overall Study|Adverse Event|2|||
156417243|NCT00107380|564621641|FG000|Overall Study|Adverse Event|7|||
156417244|NCT00107380|564621641|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
156417245|NCT00107380|564621641|FG000|Overall Study|Progression/relapse|4|||
156417246|NCT00107380|564621641|FG000|Overall Study|Death|3|||
156417247|NCT00107380|564621641|FG000|Overall Study|Other - not protocol specified|7|||
156417248|NCT00107380|564621641|FG000|Overall Study|Ineligible|2|||
156417249|NCT03850444|564621642|FG000|Overall Study|Adverse Event|16|||
156417250|NCT03850444|564621643|FG001|Overall Study|Adverse Event|10|||
156417251|NCT03850444|564621642|FG000|Overall Study|Death|87|||
156417252|NCT03850444|564621643|FG001|Overall Study|Death|107|||
156417253|NCT03850444|564621642|FG000|Overall Study|Lost to Follow-up|1|||
156417254|NCT03850444|564621643|FG001|Overall Study|Lost to Follow-up|1|||
156417255|NCT03850444|564621642|FG000|Overall Study|Withdrawal by Subject|1|||
156417256|NCT03850444|564621643|FG001|Overall Study|Withdrawal by Subject|5|||
156417257|NCT03850444|564621642|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
156417258|NCT03850444|564621643|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
156417259|NCT01518257|564621644|FG000|Overall Study|Lost to Follow-up|1|||
156417260|NCT01518257|564621645|FG001|Overall Study|Lost to Follow-up|0|||
156417261|NCT01518257|564621644|FG000|Overall Study|Other Miscellaneous Reason|1|||
156417262|NCT01518257|564621645|FG001|Overall Study|Other Miscellaneous Reason|0|||
156417263|NCT02107274|564621648|FG000|Treatment vs. Placebo|Adverse Event|3|||
156417264|NCT02107274|564621649|FG001|Treatment vs. Placebo|Adverse Event|0|||
156417265|NCT02107274|564621648|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
156417266|NCT02107274|564621649|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
156417267|NCT02107274|564621648|FG000|Control Phase|Lost to Follow-up|1|||
156417268|NCT02107274|564621649|FG001|Control Phase|Lost to Follow-up|1|||
156417269|NCT02107274|564621648|FG000|Control Phase|Death|2|||
156417270|NCT02107274|564621649|FG001|Control Phase|Death|0|||
156417271|NCT02107274|564621648|FG000|Control Phase|Adverse Event|0|||
156417272|NCT02107274|564621649|FG001|Control Phase|Adverse Event|1|||
156417273|NCT03158948|564621651|FG000|Overall Study|Death|1|||
156417274|NCT03158948|564621652|FG001|Overall Study|Death|1|||
156417275|NCT03158948|564621653|FG002|Overall Study|Death|3|||
156417276|NCT03158948|564621654|FG003|Overall Study|Death|2|||
156417277|NCT03158948|564621651|FG000|Overall Study|Physician Decision|0|||
156417278|NCT03158948|564621652|FG001|Overall Study|Physician Decision|0|||
156417279|NCT03158948|564621653|FG002|Overall Study|Physician Decision|0|||
156417280|NCT03158948|564621654|FG003|Overall Study|Physician Decision|1|||
156417281|NCT02424344|564621658|FG000|Overall Study|Lack of Efficacy|0|||
156417282|NCT02424344|564621659|FG001|Overall Study|Lack of Efficacy|1|||
156417283|NCT02424344|564621658|FG000|Overall Study|Withdrawal by Subject|2|||
156417284|NCT02424344|564621659|FG001|Overall Study|Withdrawal by Subject|1|||
156417285|NCT02424344|564621658|FG000|Overall Study|Lost to Follow-up|1|||
156417286|NCT02424344|564621659|FG001|Overall Study|Lost to Follow-up|0|||
156417287|NCT02424344|564621658|FG000|Overall Study|Adverse Event|4|||
156417288|NCT02424344|564621659|FG001|Overall Study|Adverse Event|8|||
156417289|NCT04730947|564621660|FG000|Overall Study|Withdrawal by Subject|0|||
156417290|NCT04730947|564621661|FG001|Overall Study|Withdrawal by Subject|1|||
156417291|NCT02123966|564621662|FG000|Overall Study|Intercurrent Illness|1|||
156417292|NCT01460381|564621663|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
156417293|NCT01460381|564621664|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
156417294|NCT01097655|564621665|FG000|Overall Study|Withdrawal by Subject|1|||
156417295|NCT01097655|564621665|FG000|Overall Study|Subject Documented Twice|1|||
156417296|NCT01097655|564621665|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
156417297|NCT05257837|564621666|FG000|Overall Study|Excluded (did not find the guns)|4|||
156417298|NCT05257837|564621667|FG001|Overall Study|Excluded (did not find the guns)|2|||
156417299|NCT05257837|564621668|FG002|Overall Study|Excluded (did not find the guns)|4|||
156417300|NCT05257837|564621669|FG003|Overall Study|Excluded (did not find the guns)|0|||
156417301|NCT03639675|564621670|FG000|Overall Study|Withdrawal by Subject|1|||
156417302|NCT02459587|564621671|FG000|3-Month Follow-up Assessment|Death|0|||
156417303|NCT02459587|564621672|FG001|3-Month Follow-up Assessment|Death|2|||
156417304|NCT02459587|564621671|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
156417305|NCT02459587|564621672|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
156417306|NCT02459587|564621671|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
156417307|NCT02459587|564621672|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
156417308|NCT02459587|564621671|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
156417309|NCT02459587|564621672|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
156417310|NCT02459587|564621671|FG000|6-month Follow-up Assessment|Death|2|||
156417311|NCT02459587|564621672|FG001|6-month Follow-up Assessment|Death|1|||
156417312|NCT02459587|564621671|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
156417313|NCT02459587|564621672|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
156417314|NCT02459587|564621671|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
156417315|NCT02459587|564621672|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
156417316|NCT02459587|564621671|FG000|12-month Follow-up Assessment|Death|2|||
156417317|NCT02459587|564621672|FG001|12-month Follow-up Assessment|Death|0|||
156417318|NCT02459587|564621671|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
156417319|NCT02459587|564621672|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
156417320|NCT02459587|564621671|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
156417321|NCT02459587|564621672|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
156417322|NCT02459587|564621671|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
156417323|NCT02459587|564621672|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
156417324|NCT01021332|564621673|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
156417325|NCT01021332|564621673|FG000|Overall Study|Adverse Event|43|||
156417326|NCT01021332|564621673|FG000|Overall Study|Lack of Efficacy|19|||
156417327|NCT01021332|564621673|FG000|Overall Study|Withdrawal of Consent|23|||
156417328|NCT01021332|564621673|FG000|Overall Study|Lost to Follow-up|4|||
156417329|NCT01021332|564621673|FG000|Overall Study|Protocol Violation|9|||
156417330|NCT01021332|564621673|FG000|Overall Study|Miscellaneous|3|||
156417331|NCT05343455|564621677|FG000|Overall Study|Withdrawal by Subject|4|||
156417332|NCT05343455|564621678|FG001|Overall Study|Withdrawal by Subject|9|||
156417333|NCT05343455|564621679|FG002|Overall Study|Withdrawal by Subject|7|||
156417334|NCT05343455|564621677|FG000|Overall Study|Adverse Event|2|||
156417335|NCT05343455|564621678|FG001|Overall Study|Adverse Event|1|||
156417336|NCT05343455|564621679|FG002|Overall Study|Adverse Event|2|||
156417337|NCT05343455|564621677|FG000|Overall Study|Lost to Follow-up|1|||
156417338|NCT05343455|564621678|FG001|Overall Study|Lost to Follow-up|1|||
156417339|NCT05343455|564621679|FG002|Overall Study|Lost to Follow-up|3|||
156417340|NCT05343455|564621677|FG000|Overall Study|Pregnancy|1|||
156417341|NCT05343455|564621678|FG001|Overall Study|Pregnancy|0|||
156417342|NCT05343455|564621679|FG002|Overall Study|Pregnancy|0|||
156417343|NCT05343455|564621677|FG000|Overall Study|Physician Decision|0|||
156417344|NCT05343455|564621678|FG001|Overall Study|Physician Decision|0|||
156417345|NCT05343455|564621679|FG002|Overall Study|Physician Decision|1|||
156417346|NCT05343455|564621677|FG000|Overall Study|Protocol Violation|0|||
156417347|NCT05343455|564621678|FG001|Overall Study|Protocol Violation|1|||
156417348|NCT05343455|564621679|FG002|Overall Study|Protocol Violation|1|||
156417349|NCT00839917|564621680|FG000|Overall Study|Lost to Follow-up|1|||
156417350|NCT00839917|564621681|FG001|Overall Study|Lost to Follow-up|0|||
156417351|NCT00839917|564621680|FG000|Overall Study|Did not receive vaccine|0|||
156417352|NCT00839917|564621681|FG001|Overall Study|Did not receive vaccine|1|||
156417353|NCT03468426|564621684|FG000|Overall Study|Progressive disease|3|||
156417354|NCT03468426|564621685|FG001|Overall Study|Progressive disease|0|||
156417355|NCT03468426|564621686|FG002|Overall Study|Progressive disease|4|||
156417356|NCT03468426|564621687|FG003|Overall Study|Progressive disease|20|||
156417357|NCT03468426|564621688|FG004|Overall Study|Progressive disease|23|||
156417358|NCT03468426|564621689|FG005|Overall Study|Progressive disease|15|||
156417359|NCT03468426|564621690|FG006|Overall Study|Progressive disease|24|||
156417360|NCT03468426|564621691|FG007|Overall Study|Progressive disease|27|||
156417361|NCT03468426|564621692|FG008|Overall Study|Progressive disease|13|||
156417362|NCT03468426|564621693|FG009|Overall Study|Progressive disease|13|||
156417363|NCT03468426|564621694|FG010|Overall Study|Progressive disease|0|||
156417364|NCT03468426|564621684|FG000|Overall Study|Other adverse event or clinical progression|0|||
156417365|NCT03468426|564621685|FG001|Overall Study|Other adverse event or clinical progression|1|||
156417366|NCT03468426|564621686|FG002|Overall Study|Other adverse event or clinical progression|3|||
156417367|NCT03468426|564621687|FG003|Overall Study|Other adverse event or clinical progression|14|||
156417368|NCT03468426|564621688|FG004|Overall Study|Other adverse event or clinical progression|10|||
156417369|NCT03468426|564621689|FG005|Overall Study|Other adverse event or clinical progression|8|||
156417370|NCT03468426|564621690|FG006|Overall Study|Other adverse event or clinical progression|5|||
156653071|NCT03355742|565477890|FG000|Overall Study|Physician Decision|6|||
156417371|NCT03468426|564621691|FG007|Overall Study|Other adverse event or clinical progression|4|||
156653072|NCT03355742|565477890|FG000|Overall Study|Death|55|||
156653073|NCT03355742|565477890|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
156653074|NCT00836927|565477891|FG000|Overall Study|Progressive disease|2|||
156756833|NCT04533438|565860673|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
156756834|NCT04533438|565860674|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
156756835|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
156756836|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
156756837|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
156756838|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
156756839|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
156756840|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
156756841|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
156756842|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
156756843|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
156756844|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
156756845|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
156756846|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
156756847|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
156756848|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
156756849|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
156756850|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
156756851|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
156756852|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
156756853|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
156756854|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
156756855|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
156756856|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
156756857|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
156756858|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
156756859|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
156756860|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
156756861|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
156756862|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
156756863|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
156756864|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
156756865|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
156756866|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
156756867|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
156756868|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
156316075|NCT01426789|564256226|FG005|Part 2|Protocol deviation|0|||
156316076|NCT01426789|564256221|FG000|Part 2|Death|0|||
156316077|NCT01426789|564256222|FG001|Part 2|Death|0|||
156316078|NCT01426789|564256223|FG002|Part 2|Death|1|||
156316079|NCT01426789|564256224|FG003|Part 2|Death|0|||
156316080|NCT01426789|564256225|FG004|Part 2|Death|1|||
156316081|NCT01426789|564256226|FG005|Part 2|Death|0|||
156316082|NCT01426789|564256221|FG000|Part 2|Administrative problems|0|||
156316083|NCT01426789|564256222|FG001|Part 2|Administrative problems|0|||
156316084|NCT01426789|564256223|FG002|Part 2|Administrative problems|2|||
156316085|NCT01426789|564256224|FG003|Part 2|Administrative problems|0|||
156316086|NCT01426789|564256225|FG004|Part 2|Administrative problems|1|||
156316087|NCT01426789|564256226|FG005|Part 2|Administrative problems|0|||
156316088|NCT01426789|564256221|FG000|Part 2|Lost to Follow-up|0|||
156316089|NCT01426789|564256222|FG001|Part 2|Lost to Follow-up|0|||
156316090|NCT01426789|564256223|FG002|Part 2|Lost to Follow-up|4|||
156316091|NCT01426789|564256224|FG003|Part 2|Lost to Follow-up|0|||
156316092|NCT01426789|564256225|FG004|Part 2|Lost to Follow-up|1|||
156316093|NCT01426789|564256226|FG005|Part 2|Lost to Follow-up|0|||
156316094|NCT01426789|564256221|FG000|Part 2|Withdrawal by Subject|0|||
156316095|NCT01426789|564256222|FG001|Part 2|Withdrawal by Subject|0|||
156316096|NCT01426789|564256223|FG002|Part 2|Withdrawal by Subject|0|||
156316097|NCT01426789|564256224|FG003|Part 2|Withdrawal by Subject|1|||
156316098|NCT01426789|564256225|FG004|Part 2|Withdrawal by Subject|2|||
156316099|NCT01426789|564256226|FG005|Part 2|Withdrawal by Subject|0|||
156316100|NCT01426789|564256221|FG000|Part 2|Lack of Efficacy|0|||
156316101|NCT01426789|564256222|FG001|Part 2|Lack of Efficacy|0|||
156756869|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
156756870|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
156756871|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
156316102|NCT01426789|564256223|FG002|Part 2|Lack of Efficacy|5|||
156316103|NCT01426789|564256224|FG003|Part 2|Lack of Efficacy|0|||
156316104|NCT01426789|564256225|FG004|Part 2|Lack of Efficacy|2|||
156316105|NCT01426789|564256226|FG005|Part 2|Lack of Efficacy|0|||
156316106|NCT01426789|564256221|FG000|Part 2|Adverse Event|0|||
156316107|NCT01426789|564256222|FG001|Part 2|Adverse Event|0|||
156316108|NCT01426789|564256223|FG002|Part 2|Adverse Event|2|||
156316109|NCT01426789|564256224|FG003|Part 2|Adverse Event|0|||
156316110|NCT01426789|564256225|FG004|Part 2|Adverse Event|1|||
156316111|NCT01426789|564256226|FG005|Part 2|Adverse Event|0|||
156417372|NCT03468426|564621692|FG008|Overall Study|Other adverse event or clinical progression|6|||
156417373|NCT03468426|564621693|FG009|Overall Study|Other adverse event or clinical progression|11|||
156417374|NCT03468426|564621694|FG010|Overall Study|Other adverse event or clinical progression|0|||
156417375|NCT03468426|564621684|FG000|Overall Study|Refused to continue taking trial medication|0|||
156417376|NCT03468426|564621685|FG001|Overall Study|Refused to continue taking trial medication|0|||
156417377|NCT03468426|564621686|FG002|Overall Study|Refused to continue taking trial medication|0|||
156417378|NCT03468426|564621687|FG003|Overall Study|Refused to continue taking trial medication|2|||
156417379|NCT03468426|564621688|FG004|Overall Study|Refused to continue taking trial medication|0|||
156417380|NCT03468426|564621689|FG005|Overall Study|Refused to continue taking trial medication|3|||
156417381|NCT03468426|564621690|FG006|Overall Study|Refused to continue taking trial medication|0|||
156417382|NCT03468426|564621691|FG007|Overall Study|Refused to continue taking trial medication|0|||
156417383|NCT03468426|564621692|FG008|Overall Study|Refused to continue taking trial medication|1|||
156417384|NCT03468426|564621693|FG009|Overall Study|Refused to continue taking trial medication|0|||
156417385|NCT03468426|564621694|FG010|Overall Study|Refused to continue taking trial medication|0|||
156417386|NCT03468426|564621684|FG000|Overall Study|Other than listed|0|||
156417387|NCT03468426|564621685|FG001|Overall Study|Other than listed|1|||
156417388|NCT03468426|564621686|FG002|Overall Study|Other than listed|0|||
156417389|NCT03468426|564621687|FG003|Overall Study|Other than listed|0|||
156417390|NCT03468426|564621688|FG004|Overall Study|Other than listed|2|||
156417391|NCT03468426|564621689|FG005|Overall Study|Other than listed|2|||
156417392|NCT03468426|564621690|FG006|Overall Study|Other than listed|0|||
156417393|NCT03468426|564621691|FG007|Overall Study|Other than listed|0|||
156417394|NCT03468426|564621692|FG008|Overall Study|Other than listed|4|||
156417395|NCT03468426|564621693|FG009|Overall Study|Other than listed|4|||
156417396|NCT03468426|564621694|FG010|Overall Study|Other than listed|1|||
156417397|NCT03468426|564621684|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417398|NCT03468426|564621685|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417399|NCT03468426|564621686|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156417400|NCT03468426|564621687|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417401|NCT03468426|564621688|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417402|NCT03468426|564621689|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417403|NCT03468426|564621690|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417404|NCT03468426|564621691|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417405|NCT03468426|564621692|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417406|NCT03468426|564621693|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417407|NCT03468426|564621694|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156417408|NCT03468426|564621684|FG000|Overall Study|missing reason|0|||
156417409|NCT03468426|564621685|FG001|Overall Study|missing reason|0|||
156417410|NCT03468426|564621686|FG002|Overall Study|missing reason|0|||
156417411|NCT03468426|564621687|FG003|Overall Study|missing reason|0|||
156417412|NCT03468426|564621688|FG004|Overall Study|missing reason|0|||
156417413|NCT03468426|564621689|FG005|Overall Study|missing reason|0|||
156417414|NCT03468426|564621690|FG006|Overall Study|missing reason|0|||
156417415|NCT03468426|564621691|FG007|Overall Study|missing reason|0|||
156417416|NCT03468426|564621692|FG008|Overall Study|missing reason|0|||
156417417|NCT03468426|564621693|FG009|Overall Study|missing reason|1|||
156417418|NCT03468426|564621694|FG010|Overall Study|missing reason|0|||
156417419|NCT01440049|564621695|FG000|Overall Study|Adverse Event|5|||
156417420|NCT02139982|564621696|FG000|Overall Study|Lack of Efficacy|0|||
156417421|NCT02139982|564621697|FG001|Overall Study|Lack of Efficacy|1|||
156417422|NCT02139982|564621698|FG002|Overall Study|Lack of Efficacy|0|||
156417423|NCT02139982|564621699|FG003|Overall Study|Lack of Efficacy|1|||
156417424|NCT02139982|564621700|FG004|Overall Study|Lack of Efficacy|0|||
156417425|NCT02139982|564621701|FG005|Overall Study|Lack of Efficacy|0|||
156417426|NCT02139982|564621702|FG006|Overall Study|Lack of Efficacy|0|||
156417427|NCT02139982|564621703|FG007|Overall Study|Lack of Efficacy|0|||
156417428|NCT02139982|564621704|FG008|Overall Study|Lack of Efficacy|0|||
156417429|NCT02139982|564621705|FG009|Overall Study|Lack of Efficacy|0|||
156417430|NCT04466618|564621715|FG000|Overall Study|Withdrawal by Subject|0|||
156417431|NCT04466618|564621716|FG001|Overall Study|Withdrawal by Subject|1|||
156417432|NCT01349907|564621717|FG000|Overall Study|Adverse Event|37|||
156417433|NCT01349907|564621718|FG001|Overall Study|Adverse Event|11|||
156653075|NCT00836927|565477892|FG001|Overall Study|Progressive disease|0|||
156653076|NCT00836927|565477893|FG002|Overall Study|Progressive disease|0|||
156653077|NCT00836927|565477894|FG003|Overall Study|Progressive disease|1|||
156417434|NCT01349907|564621717|FG000|Overall Study|Treatment failure|13|||
156417435|NCT01349907|564621718|FG001|Overall Study|Treatment failure|4|||
156417436|NCT01349907|564621717|FG000|Overall Study|Lost to Follow-up|25|||
156417437|NCT01349907|564621718|FG001|Overall Study|Lost to Follow-up|6|||
156417438|NCT01349907|564621717|FG000|Overall Study|Withdrawal by Subject|30|||
156417439|NCT01349907|564621718|FG001|Overall Study|Withdrawal by Subject|8|||
156417440|NCT01349907|564621717|FG000|Overall Study|Protocol Violation|33|||
156417441|NCT01349907|564621718|FG001|Overall Study|Protocol Violation|13|||
156417442|NCT01349907|564621717|FG000|Overall Study|Administrative|1|||
156417443|NCT01349907|564621718|FG001|Overall Study|Administrative|1|||
156417444|NCT02800928|564621721|FG000|Overall Study|Withdrawal by Subject|1|||
156756872|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
156756873|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
156756874|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
156756875|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
156756876|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
156756877|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
156756878|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
156756879|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
156756880|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
156756881|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
156756882|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
156756883|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
156756884|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
156756885|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
156756886|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
156756887|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
156756888|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
156756889|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
156756890|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
156756891|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
156756892|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
156756893|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
156756894|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
156756895|NCT00985686|565860703|FG000|Overall Study|Lost to Follow-up|1|||
156756896|NCT00985686|565860704|FG001|Overall Study|Lost to Follow-up|1|||
156756897|NCT00985686|565860705|FG002|Overall Study|Lost to Follow-up|0|||
156756898|NCT00985686|565860706|FG003|Overall Study|Lost to Follow-up|2|||
156756899|NCT03134911|565860707|FG000|Overall Study|Screen failure|31|||
156756900|NCT03134911|565860707|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
156756901|NCT00588146|565862753|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
156316112|NCT04054947|564256227|FG000|Overall Study|Withdrawal by Subject|1|||
156316113|NCT04054947|564256228|FG001|Overall Study|Withdrawal by Subject|0|||
156316114|NCT04054947|564256227|FG000|Overall Study|Lost to Follow-up|2|||
156316115|NCT04054947|564256228|FG001|Overall Study|Lost to Follow-up|5|||
156316116|NCT04463069|564256231|FG000|Overall Study|Withdrawal by Subject|2|||
156316117|NCT04463069|564256232|FG001|Overall Study|Withdrawal by Subject|10|||
156316118|NCT04463069|564256231|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
156316119|NCT04463069|564256232|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
156316120|NCT03073733|564256239|FG000|Overall Study|Lost to Follow-up|1|||
156316121|NCT03073733|564256240|FG001|Overall Study|Lost to Follow-up|0|||
156316122|NCT03073733|564256241|FG002|Overall Study|Lost to Follow-up|0|||
156316123|NCT03073733|564256239|FG000|Overall Study|Physician Decision|0|||
156316124|NCT03073733|564256240|FG001|Overall Study|Physician Decision|1|||
156316125|NCT03073733|564256241|FG002|Overall Study|Physician Decision|0|||
156316126|NCT03073733|564256239|FG000|Overall Study|Withdrawal by Subject|0|||
156316127|NCT03073733|564256240|FG001|Overall Study|Withdrawal by Subject|0|||
156316128|NCT03073733|564256241|FG002|Overall Study|Withdrawal by Subject|1|||
156316129|NCT00835731|564256242|FG000|Overall Study|Withdrawal by Subject|1|||
156316130|NCT00835731|564256243|FG001|Overall Study|Withdrawal by Subject|0|||
156316131|NCT00835731|564256242|FG000|Overall Study|Physician Decision|1|||
156316132|NCT00835731|564256243|FG001|Overall Study|Physician Decision|1|||
156316133|NCT00348881|564256244|FG000|Overall Study|Lost to Follow-up|12|||
156316134|NCT00348881|564256245|FG001|Overall Study|Lost to Follow-up|6|||
156316135|NCT00348881|564256244|FG000|Overall Study|Withdrawal by Subject|3|||
156316136|NCT00348881|564256245|FG001|Overall Study|Withdrawal by Subject|4|||
156316137|NCT00348881|564256244|FG000|Overall Study|Adverse Event|2|||
156316138|NCT00348881|564256245|FG001|Overall Study|Adverse Event|0|||
156316139|NCT00348881|564256244|FG000|Overall Study|Serious Adverse Event|0|||
156316140|NCT00348881|564256245|FG001|Overall Study|Serious Adverse Event|2|||
156316141|NCT00129311|564256246|FG000|Overall Study|Withdrawal by Subject|12|||
156316142|NCT00129311|564256247|FG001|Overall Study|Withdrawal by Subject|19|||
156316143|NCT00881868|564256250|FG000|Overall Study|Adverse Event|0|||
156756902|NCT00588146|565862754|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
156756903|NCT01239394|565862756|FG000|Overall Study|Adverse Event|1|||
156756904|NCT01000974|565862761|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
156756905|NCT01000974|565862762|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
156316144|NCT00881868|564256251|FG001|Overall Study|Adverse Event|1|||
156316145|NCT00881868|564256250|FG000|Overall Study|Lost to Follow-up|2|||
156316146|NCT00881868|564256251|FG001|Overall Study|Lost to Follow-up|1|||
156316147|NCT00881868|564256250|FG000|Overall Study|Physician Decision|4|||
156316148|NCT00881868|564256251|FG001|Overall Study|Physician Decision|0|||
156316149|NCT00881868|564256250|FG000|Overall Study|Protocol Violation|2|||
156316150|NCT00881868|564256251|FG001|Overall Study|Protocol Violation|0|||
156316151|NCT01981551|564256252|FG000|Overall Study|Refused further treatment|8|||
156756906|NCT01000974|565862763|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
156756907|NCT01000974|565862761|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
156756908|NCT01000974|565862762|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
156756909|NCT01000974|565862763|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
156756910|NCT01000974|565862761|FG000|Primary Vaccination Phase|Protocol Violation|40|||
156756911|NCT01000974|565862762|FG001|Primary Vaccination Phase|Protocol Violation|3|||
156756912|NCT01000974|565862763|FG002|Primary Vaccination Phase|Protocol Violation|2|||
156756913|NCT01000974|565862761|FG000|Primary Vaccination Phase|Adverse Event|14|||
156756914|NCT01000974|565862762|FG001|Primary Vaccination Phase|Adverse Event|2|||
156756915|NCT01000974|565862763|FG002|Primary Vaccination Phase|Adverse Event|2|||
156756916|NCT01000974|565862761|FG000|Primary Vaccination Phase|Other|4|||
156756917|NCT01000974|565862762|FG001|Primary Vaccination Phase|Other|9|||
156756918|NCT01000974|565862763|FG002|Primary Vaccination Phase|Other|12|||
156756919|NCT01000974|565862761|FG000|Booster Vaccination Phase|Protocol Violation|0|||
156756920|NCT01000974|565862762|FG001|Booster Vaccination Phase|Protocol Violation|0|||
156756921|NCT01000974|565862763|FG002|Booster Vaccination Phase|Protocol Violation|2|||
156756922|NCT01000974|565862761|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
156756923|NCT01000974|565862762|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
156756924|NCT01000974|565862763|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
156756925|NCT01000974|565862761|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
156756926|NCT01000974|565862762|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
156756927|NCT01000974|565862763|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
156756928|NCT01000974|565862761|FG000|Booster Vaccination Phase|Other|24|||
156756929|NCT01000974|565862762|FG001|Booster Vaccination Phase|Other|6|||
156756930|NCT01000974|565862763|FG002|Booster Vaccination Phase|Other|4|||
156756931|NCT01307891|565862764|FG000|Overall Study|Progressive Disease|3|||
156756932|NCT01307891|565862765|FG001|Overall Study|Progressive Disease|1|||
156756933|NCT03365934|565862766|FG000|Overall Study|Adverse Event|1|||
156756934|NCT03365934|565862766|FG000|Overall Study|Withdrawal by Subject|1|||
156756935|NCT02937740|565862767|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
156756936|NCT02937740|565862768|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
156756937|NCT02937740|565862767|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
156756938|NCT02937740|565862768|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
156756939|NCT02937740|565862767|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
156756940|NCT02937740|565862768|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
156756941|NCT02937740|565862767|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
156756942|NCT02937740|565862768|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
156756943|NCT02937740|565862767|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
156756944|NCT02937740|565862768|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
156756945|NCT02937740|565862767|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
156756946|NCT02937740|565862768|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
156756947|NCT02291029|565862771|FG000|Overall Study|Withdrawal by Subject|0|||
156756948|NCT02291029|565862772|FG001|Overall Study|Withdrawal by Subject|0|||
156756949|NCT02291029|565862773|FG002|Overall Study|Withdrawal by Subject|1|||
156756950|NCT02291029|565862774|FG003|Overall Study|Withdrawal by Subject|0|||
156756951|NCT02291029|565862775|FG004|Overall Study|Withdrawal by Subject|0|||
156756952|NCT02291029|565862776|FG005|Overall Study|Withdrawal by Subject|0|||
156756953|NCT02291029|565862771|FG000|Overall Study|Adverse Event|0|||
156756954|NCT02291029|565862772|FG001|Overall Study|Adverse Event|1|||
156756955|NCT02291029|565862773|FG002|Overall Study|Adverse Event|0|||
156756956|NCT02291029|565862774|FG003|Overall Study|Adverse Event|0|||
156756957|NCT02291029|565862775|FG004|Overall Study|Adverse Event|0|||
156756958|NCT02291029|565862776|FG005|Overall Study|Adverse Event|0|||
156756959|NCT04147247|565862777|FG000|Overall Study|Progressive disease|3|||
156756960|NCT04147247|565862778|FG001|Overall Study|Progressive disease|3|||
156756961|NCT04147247|565862779|FG002|Overall Study|Progressive disease|4|||
156756962|NCT04147247|565862780|FG003|Overall Study|Progressive disease|4|||
156756963|NCT04147247|565862781|FG004|Overall Study|Progressive disease|3|||
156756964|NCT04147247|565862777|FG000|Overall Study|Physician Decision|0|||
156756965|NCT04147247|565862778|FG001|Overall Study|Physician Decision|1|||
156756966|NCT04147247|565862779|FG002|Overall Study|Physician Decision|0|||
156756967|NCT04147247|565862780|FG003|Overall Study|Physician Decision|0|||
156756968|NCT04147247|565862781|FG004|Overall Study|Physician Decision|0|||
156756969|NCT04147247|565862777|FG000|Overall Study|Clinical Disease Progression|0|||
156756970|NCT04147247|565862778|FG001|Overall Study|Clinical Disease Progression|0|||
156756971|NCT04147247|565862779|FG002|Overall Study|Clinical Disease Progression|0|||
156756972|NCT04147247|565862780|FG003|Overall Study|Clinical Disease Progression|0|||
156756973|NCT04147247|565862781|FG004|Overall Study|Clinical Disease Progression|1|||
156756974|NCT04147247|565862777|FG000|Overall Study|Adverse Event|0|||
156756975|NCT04147247|565862778|FG001|Overall Study|Adverse Event|0|||
156756976|NCT04147247|565862779|FG002|Overall Study|Adverse Event|1|||
156756977|NCT04147247|565862780|FG003|Overall Study|Adverse Event|0|||
156756978|NCT04147247|565862781|FG004|Overall Study|Adverse Event|1|||
156756979|NCT03373760|565862782|FG000|Overall Study|Adverse Event|8|||
156756980|NCT03373760|565862782|FG000|Overall Study|Disease Progression|46|||
156417445|NCT02800928|564621722|FG001|Overall Study|Withdrawal by Subject|1|||
156417446|NCT02800928|564621721|FG000|Overall Study|Protocol Violation|1|||
156417447|NCT02800928|564621722|FG001|Overall Study|Protocol Violation|1|||
156417448|NCT02886728|564621723|FG000|Overall Study|Withdrew Consent|31|||
156417449|NCT02886728|564621724|FG001|Overall Study|Withdrew Consent|13|||
156417450|NCT02886728|564621725|FG002|Overall Study|Withdrew Consent|11|||
156417451|NCT02886728|564621726|FG003|Overall Study|Withdrew Consent|47|||
156417452|NCT02886728|564621723|FG000|Overall Study|Lost to Follow-up|12|||
156417453|NCT02886728|564621724|FG001|Overall Study|Lost to Follow-up|6|||
156417454|NCT02886728|564621725|FG002|Overall Study|Lost to Follow-up|13|||
156417455|NCT02886728|564621726|FG003|Overall Study|Lost to Follow-up|12|||
156417456|NCT02886728|564621723|FG000|Overall Study|Adverse Event|13|||
156417457|NCT02886728|564621724|FG001|Overall Study|Adverse Event|5|||
156417458|NCT02886728|564621725|FG002|Overall Study|Adverse Event|5|||
156417459|NCT02886728|564621726|FG003|Overall Study|Adverse Event|11|||
156417460|NCT02886728|564621723|FG000|Overall Study|Investigator's Discretion|11|||
156417461|NCT02886728|564621724|FG001|Overall Study|Investigator's Discretion|7|||
156417462|NCT02886728|564621725|FG002|Overall Study|Investigator's Discretion|5|||
156417463|NCT02886728|564621726|FG003|Overall Study|Investigator's Discretion|11|||
156417464|NCT02886728|564621723|FG000|Overall Study|Death|3|||
156417465|NCT02886728|564621724|FG001|Overall Study|Death|1|||
156417466|NCT02886728|564621725|FG002|Overall Study|Death|0|||
156417467|NCT02886728|564621726|FG003|Overall Study|Death|0|||
156417468|NCT02886728|564621723|FG000|Overall Study|Protocol Violation|0|||
156417469|NCT02886728|564621724|FG001|Overall Study|Protocol Violation|0|||
156417470|NCT02886728|564621725|FG002|Overall Study|Protocol Violation|0|||
156417471|NCT02886728|564621726|FG003|Overall Study|Protocol Violation|4|||
156417472|NCT02886728|564621723|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156417473|NCT02886728|564621724|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156417474|NCT02886728|564621725|FG002|Overall Study|Non-Compliance with Study Drug|1|||
156756981|NCT03373760|565862782|FG000|Overall Study|Death|4|||
156756982|NCT02907463|565862783|FG000|Overall Study|Lost to Follow-up|17|||
156756983|NCT02907463|565862783|FG000|Overall Study|Death|10|||
156756984|NCT02907463|565862783|FG000|Overall Study|Withdrawal by Subject|4|||
156756985|NCT02907463|565862783|FG000|Overall Study|MIS Approach was not used|2|||
156756986|NCT02907463|565862783|FG000|Overall Study|Not Implanted with Study Device|2|||
156756987|NCT02907463|565862783|FG000|Overall Study|Device Explanted|1|||
156756988|NCT02907463|565862783|FG000|Overall Study|Missing Exit Form|1|||
156756989|NCT01447407|565862784|FG000|Overall Study|Withdrawal by Subject|2|||
156756990|NCT01447407|565862785|FG001|Overall Study|Withdrawal by Subject|0|||
156756991|NCT01447407|565862786|FG002|Overall Study|Withdrawal by Subject|0|||
156756992|NCT01447407|565862787|FG003|Overall Study|Withdrawal by Subject|1|||
156756993|NCT01447407|565862784|FG000|Overall Study|Physician Decision|0|||
156756994|NCT01447407|565862785|FG001|Overall Study|Physician Decision|0|||
156756995|NCT01447407|565862786|FG002|Overall Study|Physician Decision|1|||
156756996|NCT01447407|565862787|FG003|Overall Study|Physician Decision|1|||
156756997|NCT00875563|565862791|FG000|Overall Study|Death|4|||
156756998|NCT00875563|565862791|FG000|Overall Study|Withdrawal by Subject|7|||
156756999|NCT00875563|565862791|FG000|Overall Study|No long-term (3-5 year) consent|6|||
156757000|NCT00875563|565862791|FG000|Overall Study|Still be eligible for follow-up|7|||
156757001|NCT02258659|565862794|FG000|Overall Study|Withdrawal by Subject|1|||
156757002|NCT03990051|565862795|FG000|Masked Period|Lost to Follow-up|1|||
156757003|NCT03990051|565862796|FG001|Masked Period|Lost to Follow-up|0|||
156757004|NCT03990051|565862795|FG000|Long Term Period|Death|1|||
156757005|NCT03990051|565862796|FG001|Long Term Period|Death|1|||
156757006|NCT03990051|565862795|FG000|Long Term Period|Lost to Follow-up|7|||
156757007|NCT03990051|565862796|FG001|Long Term Period|Lost to Follow-up|2|||
156757008|NCT01411852|565862797|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
156757009|NCT01411852|565862798|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
156757010|NCT01411852|565862797|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
156757011|NCT01411852|565862798|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
156757012|NCT01411852|565862797|FG000|Prehospital Intervention Phase|Found to be under age|0|||
156757013|NCT01411852|565862798|FG001|Prehospital Intervention Phase|Found to be under age|1|||
156757014|NCT01411852|565862797|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
156757015|NCT01411852|565862798|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
156757016|NCT01411852|565862797|FG000|Hospital Intervention Phase|Severe head injury|5|||
156757017|NCT01411852|565862798|FG001|Hospital Intervention Phase|Severe head injury|4|||
156757018|NCT01411852|565862797|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
156417475|NCT02886728|564621726|FG003|Overall Study|Non-Compliance with Study Drug|0|||
156417476|NCT02886728|564621723|FG000|Overall Study|Pregnancy|0|||
156417477|NCT02886728|564621724|FG001|Overall Study|Pregnancy|0|||
156417478|NCT02886728|564621725|FG002|Overall Study|Pregnancy|1|||
156417479|NCT02886728|564621726|FG003|Overall Study|Pregnancy|0|||
156757019|NCT01411852|565862798|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
156417480|NCT02886728|564621723|FG000|Overall Study|Randomized but Not Dosed|1|||
156417481|NCT02886728|564621724|FG001|Overall Study|Randomized but Not Dosed|0|||
156417482|NCT02886728|564621725|FG002|Overall Study|Randomized but Not Dosed|0|||
156316152|NCT01981551|564256252|FG000|Overall Study|Adverse Event|1|||
156316153|NCT02880956|564256253|FG000|Overall Study|Adverse Event|3|||
156316154|NCT02880956|564256254|FG001|Overall Study|Adverse Event|6|||
156316155|NCT02880956|564256255|FG002|Overall Study|Adverse Event|5|||
156316156|NCT02880956|564256256|FG003|Overall Study|Adverse Event|4|||
156316157|NCT02880956|564256253|FG000|Overall Study|Withdrawal by Subject|9|||
156316158|NCT02880956|564256254|FG001|Overall Study|Withdrawal by Subject|4|||
156316159|NCT02880956|564256255|FG002|Overall Study|Withdrawal by Subject|6|||
156316160|NCT02880956|564256256|FG003|Overall Study|Withdrawal by Subject|11|||
156316161|NCT02880956|564256253|FG000|Overall Study|Lost to Follow-up|0|||
156316162|NCT02880956|564256254|FG001|Overall Study|Lost to Follow-up|1|||
156316163|NCT02880956|564256255|FG002|Overall Study|Lost to Follow-up|0|||
156316164|NCT02880956|564256256|FG003|Overall Study|Lost to Follow-up|0|||
156316165|NCT02880956|564256253|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
156316166|NCT02880956|564256254|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
156316167|NCT02880956|564256255|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
156316168|NCT02880956|564256256|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
156316169|NCT02880956|564256253|FG000|Overall Study|Other, Not Specified|4|||
156316170|NCT02880956|564256254|FG001|Overall Study|Other, Not Specified|2|||
156316171|NCT02880956|564256255|FG002|Overall Study|Other, Not Specified|0|||
156316172|NCT02880956|564256256|FG003|Overall Study|Other, Not Specified|3|||
156316173|NCT02081859|564256257|FG000|Overall Study|No fertilization|2|||
156316174|NCT02081859|564256258|FG001|Overall Study|No fertilization|2|||
156316175|NCT02081859|564256257|FG000|Overall Study|No sperm|1|||
156316176|NCT02081859|564256258|FG001|Overall Study|No sperm|0|||
156316177|NCT02081859|564256257|FG000|Overall Study|Unanticipated freeze all cycle|2|||
156316178|NCT02081859|564256258|FG001|Overall Study|Unanticipated freeze all cycle|6|||
156316179|NCT02081859|564256257|FG000|Overall Study|< 4 embryos|27|||
156316180|NCT02081859|564256258|FG001|Overall Study|< 4 embryos|23|||
156316181|NCT02081859|564256257|FG000|Overall Study|Other reasons|2|||
156316182|NCT02081859|564256258|FG001|Overall Study|Other reasons|0|||
156316183|NCT02276027|564257650|FG000|Overall Study|Death|1|||
156316184|NCT02276027|564257651|FG001|Overall Study|Death|0|||
156316185|NCT02276027|564257652|FG002|Overall Study|Death|0|||
156316186|NCT02276027|564257653|FG003|Overall Study|Death|2|||
156316187|NCT02276027|564257650|FG000|Overall Study|Physician Decision|0|||
156316188|NCT02276027|564257651|FG001|Overall Study|Physician Decision|0|||
156316189|NCT02276027|564257652|FG002|Overall Study|Physician Decision|0|||
156316190|NCT02276027|564257653|FG003|Overall Study|Physician Decision|1|||
156316191|NCT02276027|564257650|FG000|Overall Study|Progressive disease|1|||
156316192|NCT02276027|564257651|FG001|Overall Study|Progressive disease|13|||
156316193|NCT02276027|564257652|FG002|Overall Study|Progressive disease|12|||
156316194|NCT02276027|564257653|FG003|Overall Study|Progressive disease|14|||
156316195|NCT02276027|564257650|FG000|Overall Study|Subject/guardian decision|0|||
156316196|NCT02276027|564257651|FG001|Overall Study|Subject/guardian decision|1|||
156316197|NCT02276027|564257652|FG002|Overall Study|Subject/guardian decision|0|||
156316198|NCT02276027|564257653|FG003|Overall Study|Subject/guardian decision|3|||
156316199|NCT02276027|564257650|FG000|Overall Study|Adverse Event|0|||
156316200|NCT02276027|564257651|FG001|Overall Study|Adverse Event|2|||
156316201|NCT02276027|564257652|FG002|Overall Study|Adverse Event|8|||
156316202|NCT02276027|564257653|FG003|Overall Study|Adverse Event|2|||
156316203|NCT00773383|564257656|FG000|Overall Study|Adverse Event|4|||
156316204|NCT00773383|564257656|FG000|Overall Study|Death|1|||
156316205|NCT00773383|564257656|FG000|Overall Study|Progression of Disease|23|||
156316206|NCT00773383|564257656|FG000|Overall Study|Other|2|||
156316207|NCT00773383|564257656|FG000|Overall Study|No study dose received|1|||
156316208|NCT00003830|564257659|FG000|Overall Study|No follow up data|3|||
156316209|NCT00003830|564257660|FG001|Overall Study|No follow up data|0|||
156316210|NCT00003830|564257659|FG000|Overall Study|Sentinel node positive patients|829|||
156316211|NCT00003830|564257660|FG001|Overall Study|Sentinel node positive patients|793|||
156316212|NCT03860935|564257661|FG000|Overall Study|Withdrawal of Consent|15|||
156316213|NCT03860935|564257662|FG001|Overall Study|Withdrawal of Consent|6|||
156316214|NCT03860935|564257661|FG000|Overall Study|Death|75|||
156316215|NCT03860935|564257662|FG001|Overall Study|Death|51|||
156316216|NCT01122394|564257666|FG000|Overall Study|Withdrawal by Subject|1|||
156316217|NCT01122394|564257667|FG001|Overall Study|Withdrawal by Subject|1|||
156417483|NCT02886728|564621726|FG003|Overall Study|Randomized but Not Dosed|2|||
156417484|NCT02411591|564621728|FG000|Overall Study|Adverse Event|0|||
156316218|NCT01122394|564257666|FG000|Overall Study|Lost to Follow-up|2|||
156316219|NCT01122394|564257667|FG001|Overall Study|Lost to Follow-up|2|||
156316220|NCT01122394|564257666|FG000|Overall Study|Adverse Event|0|||
156417485|NCT02411591|564621729|FG001|Overall Study|Adverse Event|4|||
156316221|NCT01122394|564257667|FG001|Overall Study|Adverse Event|1|||
156316222|NCT03739242|564257668|FG000|Overall Study|Withdrawal by Subject|1|||
156316223|NCT03739242|564257669|FG001|Overall Study|Withdrawal by Subject|1|||
156417486|NCT02411591|564621730|FG002|Overall Study|Adverse Event|2|||
156316224|NCT03739242|564257668|FG000|Overall Study|Protocol Violation|0|||
156316225|NCT03739242|564257669|FG001|Overall Study|Protocol Violation|1|||
156417487|NCT02411591|564621728|FG000|Overall Study|Withdrawal by Subject|0|||
156417488|NCT02411591|564621729|FG001|Overall Study|Withdrawal by Subject|3|||
156417489|NCT02411591|564621730|FG002|Overall Study|Withdrawal by Subject|0|||
156417490|NCT02411591|564621728|FG000|Overall Study|Physician Decision|0|||
156417491|NCT02411591|564621729|FG001|Overall Study|Physician Decision|3|||
156417492|NCT02411591|564621730|FG002|Overall Study|Physician Decision|1|||
156417493|NCT00598481|564621732|FG000|Treatment|Physician Decision|1|||
156417494|NCT01708187|564621733|FG000|Overall Study|Lost to Follow-up|0|||
156417495|NCT01708187|564621734|FG001|Overall Study|Lost to Follow-up|1|||
156417496|NCT01439711|564621735|FG000|Overall Study|Ineligible|13|||
156417497|NCT01439711|564621735|FG000|Overall Study|Cancel|3|||
156417498|NCT01439711|564621735|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
156417499|NCT01439711|564621735|FG000|Overall Study|Adverse Event|5|||
156417500|NCT01439711|564621735|FG000|Overall Study|Withdrawal by Subject|3|||
156417501|NCT01439711|564621735|FG000|Overall Study|Progression During Active Tx|3|||
156417502|NCT01439711|564621735|FG000|Overall Study|Noncompliance|3|||
156417503|NCT01439711|564621735|FG000|Overall Study|No MRI|9|||
156417504|NCT04242875|564621736|FG000|Overall Study|Adverse Event|2|||
156417505|NCT01603121|564621737|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
156417506|NCT01603121|564621738|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
156757020|NCT01411852|565862797|FG000|Hospital Intervention Phase|Miscommunication error|1|||
156757021|NCT01411852|565862798|FG001|Hospital Intervention Phase|Miscommunication error|2|||
156757022|NCT01411852|565862797|FG000|Hospital Intervention Phase|CPR administered|3|||
156757023|NCT01411852|565862798|FG001|Hospital Intervention Phase|CPR administered|1|||
156757024|NCT01411852|565862797|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
156757025|NCT01411852|565862798|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
156757026|NCT01411852|565862797|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
156757027|NCT01411852|565862798|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
156757028|NCT01411852|565862797|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
156757029|NCT01411852|565862798|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
156757030|NCT01411852|565862797|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
156757031|NCT01411852|565862798|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
156757032|NCT01411852|565862797|FG000|Hospital Intervention Phase|Other ineligible|2|||
156757033|NCT01411852|565862798|FG001|Hospital Intervention Phase|Other ineligible|2|||
156757034|NCT01411852|565862797|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
156757035|NCT01411852|565862798|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
156757036|NCT01411852|565862797|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
156757037|NCT01411852|565862798|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
156757038|NCT01411852|565862797|FG000|Hospital Intervention Phase|Vascular access failed|1|||
156757039|NCT01411852|565862798|FG001|Hospital Intervention Phase|Vascular access failed|0|||
156757040|NCT00272844|565862799|FG000|Overall Study|Withdrawal by Subject|5|||
156757041|NCT03743025|565862802|FG000|Overall Study|Surgery was cancelled|2|||
156757042|NCT03743025|565862803|FG001|Overall Study|Surgery was cancelled|1|||
156757043|NCT00791700|565862804|FG000|Overall Study|Insufficient clinical response|1|||
156757044|NCT00791700|565862805|FG001|Overall Study|Insufficient clinical response|4|||
156757045|NCT00791700|565862806|FG002|Overall Study|Insufficient clinical response|1|||
156757046|NCT00791700|565862807|FG003|Overall Study|Insufficient clinical response|8|||
156757047|NCT00791700|565862804|FG000|Overall Study|No longer willing to participate|1|||
156757048|NCT00791700|565862805|FG001|Overall Study|No longer willing to participate|1|||
156757049|NCT00791700|565862806|FG002|Overall Study|No longer willing to participate|0|||
156757050|NCT00791700|565862807|FG003|Overall Study|No longer willing to participate|8|||
156757051|NCT00791700|565862804|FG000|Overall Study|Non-compliance with study treatment|0|||
156757052|NCT00791700|565862805|FG001|Overall Study|Non-compliance with study treatment|2|||
156757053|NCT00791700|565862806|FG002|Overall Study|Non-compliance with study treatment|0|||
156757054|NCT00791700|565862807|FG003|Overall Study|Non-compliance with study treatment|4|||
156757055|NCT00791700|565862804|FG000|Overall Study|Withdrawn due to pregnancy|0|||
156757056|NCT00791700|565862805|FG001|Overall Study|Withdrawn due to pregnancy|0|||
156757057|NCT00791700|565862806|FG002|Overall Study|Withdrawn due to pregnancy|0|||
156757058|NCT00791700|565862807|FG003|Overall Study|Withdrawn due to pregnancy|1|||
156757059|NCT00791700|565862804|FG000|Overall Study|Other|0|||
156757060|NCT00791700|565862805|FG001|Overall Study|Other|1|||
156417507|NCT00738530|564621739|FG000|Overall Study|Death|220|||
156417508|NCT00738530|564621740|FG001|Overall Study|Death|224|||
156417509|NCT00738530|564621739|FG000|Overall Study|Lost to Follow-up|8|||
156417510|NCT00738530|564621740|FG001|Overall Study|Lost to Follow-up|6|||
156417511|NCT00738530|564621739|FG000|Overall Study|Withdrawal by Subject|6|||
156417512|NCT00738530|564621740|FG001|Overall Study|Withdrawal by Subject|8|||
156417513|NCT04179461|564621741|FG000|Overall Study|Lost to Follow-up|4|||
156417514|NCT03785340|564621742|FG000|Overall Study|Lost to Follow-up|2|||
156417515|NCT03785340|564621743|FG001|Overall Study|Lost to Follow-up|0|||
156417516|NCT03785340|564621742|FG000|Overall Study|Adverse Event|1|||
156417517|NCT03785340|564621743|FG001|Overall Study|Adverse Event|0|||
156417518|NCT01848834|564621744|FG000|Overall Study|Adverse Event|3|||
156417519|NCT01848834|564621745|FG001|Overall Study|Adverse Event|11|||
156417520|NCT01848834|564621746|FG002|Overall Study|Adverse Event|3|||
156757061|NCT00791700|565862806|FG002|Overall Study|Other|0|||
156757062|NCT00791700|565862807|FG003|Overall Study|Other|1|||
156757063|NCT00791700|565862804|FG000|Overall Study|Death|0|||
156757064|NCT00791700|565862805|FG001|Overall Study|Death|0|||
156757065|NCT00791700|565862806|FG002|Overall Study|Death|0|||
156757066|NCT00791700|565862807|FG003|Overall Study|Death|1|||
156757067|NCT00791700|565862804|FG000|Overall Study|Lost to Follow-up|4|||
156757068|NCT00791700|565862805|FG001|Overall Study|Lost to Follow-up|3|||
156757069|NCT00791700|565862806|FG002|Overall Study|Lost to Follow-up|4|||
156757070|NCT00791700|565862807|FG003|Overall Study|Lost to Follow-up|6|||
156757071|NCT00791700|565862804|FG000|Overall Study|Adverse Event|0|||
156757072|NCT00791700|565862805|FG001|Overall Study|Adverse Event|0|||
156757073|NCT00791700|565862806|FG002|Overall Study|Adverse Event|1|||
156757074|NCT00791700|565862807|FG003|Overall Study|Adverse Event|1|||
156757075|NCT00996034|565862810|FG000|Overall Study|Lost to Follow-up|2|||
156757076|NCT00996034|565862810|FG000|Overall Study|withdrawn by PI|1|||
156757077|NCT01720524|565862811|FG000|Part A|Insufficient Clinical Response|2|||
156757078|NCT01720524|565862812|FG001|Part A|Insufficient Clinical Response|4|||
156316226|NCT00039871|564257670|FG000|Overall Study|Adverse Event|165|||
156316227|NCT00039871|564257670|FG000|Overall Study|Lost to Follow-up|18|||
156316228|NCT00039871|564257670|FG000|Overall Study|Protocol Violation|24|||
156316229|NCT00039871|564257670|FG000|Overall Study|Withdrawal by Subject|97|||
156316230|NCT00039871|564257670|FG000|Overall Study|Did not meet eligibility criteria|11|||
156316231|NCT00039871|564257670|FG000|Overall Study|Administrative|1|||
156316232|NCT00039871|564257670|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
156316233|NCT00039871|564257670|FG000|Overall Study|Never entered follow-up|7|||
156316234|NCT03361176|564257671|FG000|Overall Study|Lost to Follow-up|1|||
156316235|NCT03361176|564257672|FG001|Overall Study|Lost to Follow-up|2|||
156316236|NCT03361176|564257671|FG000|Overall Study|Adverse Event|0|||
156316237|NCT03361176|564257672|FG001|Overall Study|Adverse Event|2|||
156316238|NCT03361176|564257671|FG000|Overall Study|Withdrawal by Subject|0|||
156316239|NCT03361176|564257672|FG001|Overall Study|Withdrawal by Subject|1|||
156316240|NCT02478398|564257673|FG000|Overall Study|Adverse Event|20|||
156316241|NCT02478398|564257674|FG001|Overall Study|Adverse Event|5|||
156316242|NCT02478398|564257673|FG000|Overall Study|Lost to Follow-up|5|||
156316243|NCT02478398|564257674|FG001|Overall Study|Lost to Follow-up|4|||
156316244|NCT02478398|564257673|FG000|Overall Study|Non-Compliance With Study Drug|5|||
156316245|NCT02478398|564257674|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156316246|NCT02478398|564257673|FG000|Overall Study|Protocol Violation|3|||
156316247|NCT02478398|564257674|FG001|Overall Study|Protocol Violation|1|||
156316248|NCT02478398|564257673|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
156316249|NCT02478398|564257674|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
156316250|NCT02478398|564257673|FG000|Overall Study|Withdrawal By Participant|10|||
156316251|NCT02478398|564257674|FG001|Overall Study|Withdrawal By Participant|4|||
156316252|NCT02160002|564257677|FG000|Overall Study|Withdrawal by Subject|2|||
156316253|NCT02160002|564257678|FG001|Overall Study|Withdrawal by Subject|1|||
156316254|NCT00704522|564257679|FG000|Overall Study|Lack of Efficacy|65|||
156316255|NCT00704522|564257680|FG001|Overall Study|Lack of Efficacy|17|||
156316256|NCT00704522|564257679|FG000|Overall Study|Failure to appear again at hospital|56|||
156316257|NCT00704522|564257680|FG001|Overall Study|Failure to appear again at hospital|10|||
156316258|NCT00704522|564257679|FG000|Overall Study|Withdrawal by Subject|17|||
156316259|NCT00704522|564257680|FG001|Overall Study|Withdrawal by Subject|8|||
156316260|NCT00704522|564257679|FG000|Overall Study|Adverse Event|9|||
156316261|NCT00704522|564257680|FG001|Overall Study|Adverse Event|1|||
156316262|NCT00704522|564257679|FG000|Overall Study|Undefined causes|9|||
156316263|NCT00704522|564257680|FG001|Overall Study|Undefined causes|7|||
156316264|NCT00704522|564257679|FG000|Overall Study|No information on therapy end|27|||
156316265|NCT00704522|564257680|FG001|Overall Study|No information on therapy end|2|||
156316266|NCT04395001|564257681|FG000|Overall Study|Lost to Follow-up|8|||
156316267|NCT04395001|564257682|FG001|Overall Study|Lost to Follow-up|9|||
156316268|NCT04395001|564257683|FG002|Overall Study|Lost to Follow-up|5|||
156316269|NCT04395001|564257681|FG000|Overall Study|Withdrawal by Subject|3|||
156316270|NCT04395001|564257682|FG001|Overall Study|Withdrawal by Subject|1|||
156316271|NCT04395001|564257683|FG002|Overall Study|Withdrawal by Subject|3|||
156316272|NCT04395001|564257681|FG000|Overall Study|missed appointment|7|||
156316273|NCT04395001|564257682|FG001|Overall Study|missed appointment|4|||
156316274|NCT04395001|564257683|FG002|Overall Study|missed appointment|1|||
156417521|NCT01848834|564621747|FG003|Overall Study|Adverse Event|5|||
156417522|NCT01848834|564621748|FG004|Overall Study|Adverse Event|9|||
156316275|NCT04418661|564257684|FG000|Overall Study|Adverse Event|0|||
156316276|NCT04418661|564257685|FG001|Overall Study|Adverse Event|1|||
156316277|NCT04418661|564257686|FG002|Overall Study|Adverse Event|5|||
156316278|NCT04418661|564257687|FG003|Overall Study|Adverse Event|3|||
156316279|NCT04418661|564257688|FG004|Overall Study|Adverse Event|0|||
156316280|NCT04418661|564257689|FG005|Overall Study|Adverse Event|2|||
156316281|NCT04418661|564257684|FG000|Overall Study|Progressive disease|4|||
156316282|NCT04418661|564257685|FG001|Overall Study|Progressive disease|11|||
156757079|NCT01720524|565862811|FG000|Part A|Adverse Event|2|||
156757080|NCT01720524|565862812|FG001|Part A|Adverse Event|2|||
156417523|NCT01848834|564621744|FG000|Overall Study|Death|2|||
156417524|NCT01848834|564621745|FG001|Overall Study|Death|11|||
156417525|NCT01848834|564621746|FG002|Overall Study|Death|1|||
156417526|NCT01848834|564621747|FG003|Overall Study|Death|8|||
156417527|NCT01848834|564621748|FG004|Overall Study|Death|27|||
156417528|NCT01848834|564621744|FG000|Overall Study|Excluded Medication|5|||
156417529|NCT01848834|564621745|FG001|Overall Study|Excluded Medication|4|||
156417530|NCT01848834|564621746|FG002|Overall Study|Excluded Medication|3|||
156417531|NCT01848834|564621747|FG003|Overall Study|Excluded Medication|6|||
156417532|NCT01848834|564621748|FG004|Overall Study|Excluded Medication|6|||
156417533|NCT01848834|564621744|FG000|Overall Study|Lost to Follow-up|5|||
156417534|NCT01848834|564621745|FG001|Overall Study|Lost to Follow-up|5|||
156417535|NCT01848834|564621746|FG002|Overall Study|Lost to Follow-up|3|||
156417536|NCT01848834|564621747|FG003|Overall Study|Lost to Follow-up|0|||
156417537|NCT01848834|564621748|FG004|Overall Study|Lost to Follow-up|3|||
156417538|NCT01848834|564621744|FG000|Overall Study|Physician Decision|1|||
156417539|NCT01848834|564621745|FG001|Overall Study|Physician Decision|3|||
156417540|NCT01848834|564621746|FG002|Overall Study|Physician Decision|4|||
156417541|NCT01848834|564621747|FG003|Overall Study|Physician Decision|0|||
156417542|NCT01848834|564621748|FG004|Overall Study|Physician Decision|11|||
156417543|NCT01848834|564621744|FG000|Overall Study|Protocol Violation|0|||
156417544|NCT01848834|564621745|FG001|Overall Study|Protocol Violation|0|||
156417545|NCT01848834|564621746|FG002|Overall Study|Protocol Violation|0|||
156417546|NCT01848834|564621747|FG003|Overall Study|Protocol Violation|0|||
156417547|NCT01848834|564621748|FG004|Overall Study|Protocol Violation|1|||
156417548|NCT01848834|564621744|FG000|Overall Study|Sponsor Decision|1|||
156417549|NCT01848834|564621745|FG001|Overall Study|Sponsor Decision|1|||
156417550|NCT01848834|564621746|FG002|Overall Study|Sponsor Decision|0|||
156417551|NCT01848834|564621747|FG003|Overall Study|Sponsor Decision|1|||
156417552|NCT01848834|564621748|FG004|Overall Study|Sponsor Decision|1|||
156417553|NCT01848834|564621744|FG000|Overall Study|Withdrawal by Subject|2|||
156417554|NCT01848834|564621745|FG001|Overall Study|Withdrawal by Subject|13|||
156653078|NCT00836927|565477895|FG004|Overall Study|Progressive disease|1|||
156653079|NCT00836927|565477891|FG000|Overall Study|Withdrawal by Subject|1|||
156653080|NCT00836927|565477892|FG001|Overall Study|Withdrawal by Subject|0|||
156653081|NCT00836927|565477893|FG002|Overall Study|Withdrawal by Subject|0|||
156653082|NCT00836927|565477894|FG003|Overall Study|Withdrawal by Subject|0|||
156653083|NCT00836927|565477895|FG004|Overall Study|Withdrawal by Subject|0|||
156653084|NCT00614055|565477899|FG000|Overall Study|Adverse Event|1|||
156653085|NCT00614055|565477900|FG001|Overall Study|Adverse Event|0|||
156653086|NCT00614055|565477901|FG002|Overall Study|Adverse Event|0|||
156653087|NCT00614055|565477899|FG000|Overall Study|Protocol Violation|2|||
156653088|NCT00614055|565477900|FG001|Overall Study|Protocol Violation|2|||
156653089|NCT00614055|565477901|FG002|Overall Study|Protocol Violation|1|||
156653090|NCT00614055|565477899|FG000|Overall Study|Lack of Efficacy|0|||
156653091|NCT00614055|565477900|FG001|Overall Study|Lack of Efficacy|0|||
156653092|NCT00614055|565477901|FG002|Overall Study|Lack of Efficacy|2|||
156653093|NCT00614055|565477899|FG000|Overall Study|Unclassified|1|||
156653094|NCT00614055|565477900|FG001|Overall Study|Unclassified|4|||
156653095|NCT00614055|565477901|FG002|Overall Study|Unclassified|2|||
156653096|NCT04820842|565477904|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
156653097|NCT04820842|565477905|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
156653098|NCT04820842|565477906|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
156653099|NCT04820842|565477907|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
156653100|NCT04820842|565477908|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
156653101|NCT04820842|565477909|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
156653102|NCT04820842|565477910|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
156653103|NCT04820842|565477904|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
156653104|NCT04820842|565477905|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
156653105|NCT04820842|565477906|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
156653106|NCT04820842|565477907|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156653107|NCT04820842|565477908|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156653108|NCT04820842|565477909|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156653109|NCT04820842|565477910|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156417555|NCT01848834|564621746|FG002|Overall Study|Withdrawal by Subject|10|||
156417556|NCT01848834|564621747|FG003|Overall Study|Withdrawal by Subject|6|||
156417557|NCT01848834|564621748|FG004|Overall Study|Withdrawal by Subject|36|||
156417558|NCT01513967|564621763|FG000|Overall Study|Pregnancy|0|||
156417559|NCT01513967|564621764|FG001|Overall Study|Pregnancy|0|||
156417560|NCT01513967|564621765|FG002|Overall Study|Pregnancy|0|||
156417561|NCT01513967|564621766|FG003|Overall Study|Pregnancy|0|||
156417562|NCT01513967|564621767|FG004|Overall Study|Pregnancy|0|||
156417563|NCT01513967|564621768|FG005|Overall Study|Pregnancy|0|||
156757081|NCT01720524|565862811|FG000|Part A|Death|2|||
156757082|NCT01720524|565862812|FG001|Part A|Death|1|||
156757083|NCT01720524|565862811|FG000|Part A|Lost to Follow-up|0|||
156757084|NCT01720524|565862812|FG001|Part A|Lost to Follow-up|1|||
156757085|NCT01720524|565862811|FG000|Part A|Missed 28 day follow-up visit|1|||
156757086|NCT01720524|565862812|FG001|Part A|Missed 28 day follow-up visit|1|||
156757087|NCT01720524|565862811|FG000|Part A|Withdrawal by Subject|0|||
156757088|NCT01720524|565862812|FG001|Part A|Withdrawal by Subject|1|||
156757089|NCT01720524|565862811|FG000|Part A|Other|0|||
156757090|NCT01720524|565862812|FG001|Part A|Other|1|||
156757091|NCT01720524|565862811|FG000|Part A|Lost to Follow-up|0|||
156757092|NCT01720524|565862812|FG001|Part A|Lost to Follow-up|1|||
156757093|NCT01720524|565862811|FG000|Part B|No longer willing to participate in study|1|||
156757094|NCT01720524|565862812|FG001|Part B|No longer willing to participate in study|4|||
156757095|NCT01720524|565862811|FG000|Part B|Other|2|||
156757096|NCT01720524|565862812|FG001|Part B|Other|0|||
156757097|NCT01720524|565862811|FG000|Part B|Lost to Follow-up|2|||
156757098|NCT01720524|565862812|FG001|Part B|Lost to Follow-up|3|||
156757099|NCT01720524|565862811|FG000|Part B|Death|0|||
156757100|NCT01720524|565862812|FG001|Part B|Death|2|||
156757101|NCT00527826|565862816|FG000|Overall Study|Adverse Event|10|||
156757102|NCT00527826|565862817|FG001|Overall Study|Adverse Event|10|||
156757103|NCT00527826|565862816|FG000|Overall Study|Lost to Follow-up|3|||
156757104|NCT00527826|565862817|FG001|Overall Study|Lost to Follow-up|2|||
156757105|NCT00527826|565862816|FG000|Overall Study|Withdrawal by Subject|5|||
156757106|NCT00527826|565862817|FG001|Overall Study|Withdrawal by Subject|8|||
156757107|NCT00527826|565862816|FG000|Overall Study|Inclusion Criteria Not Met|3|||
156757108|NCT00527826|565862817|FG001|Overall Study|Inclusion Criteria Not Met|3|||
156757109|NCT00527826|565862816|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
156757110|NCT00527826|565862817|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
156757111|NCT00527826|565862816|FG000|Overall Study|Additional Intake of Viani forte|0|||
156757112|NCT00527826|565862817|FG001|Overall Study|Additional Intake of Viani forte|1|||
156757113|NCT00527826|565862816|FG000|Overall Study|Participant moved away|0|||
156757114|NCT00527826|565862817|FG001|Overall Study|Participant moved away|1|||
156757115|NCT00158262|565862818|FG000|Overall Study|Lost to Follow-up|1|||
156757116|NCT00158262|565862819|FG001|Overall Study|Lost to Follow-up|1|||
156757117|NCT01421641|565862820|FG000|Overall Study|Protocol Violation|2|||
156757118|NCT01421641|565862821|FG001|Overall Study|Protocol Violation|2|||
156316283|NCT04418661|564257686|FG002|Overall Study|Progressive disease|6|||
156316284|NCT04418661|564257687|FG003|Overall Study|Progressive disease|11|||
156316285|NCT04418661|564257688|FG004|Overall Study|Progressive disease|1|||
156316286|NCT04418661|564257689|FG005|Overall Study|Progressive disease|12|||
156316287|NCT04418661|564257684|FG000|Overall Study|Withdrawal by Subject|0|||
156316288|NCT04418661|564257685|FG001|Overall Study|Withdrawal by Subject|1|||
156316289|NCT04418661|564257686|FG002|Overall Study|Withdrawal by Subject|0|||
156316290|NCT04418661|564257687|FG003|Overall Study|Withdrawal by Subject|1|||
156316291|NCT04418661|564257688|FG004|Overall Study|Withdrawal by Subject|0|||
156316292|NCT04418661|564257689|FG005|Overall Study|Withdrawal by Subject|0|||
156316293|NCT04418661|564257684|FG000|Overall Study|Other|0|||
156316294|NCT04418661|564257685|FG001|Overall Study|Other|0|||
156316295|NCT04418661|564257686|FG002|Overall Study|Other|1|||
156316296|NCT04418661|564257687|FG003|Overall Study|Other|3|||
156316297|NCT04418661|564257688|FG004|Overall Study|Other|0|||
156316298|NCT04418661|564257689|FG005|Overall Study|Other|1|||
156316299|NCT02984943|564257691|FG000|Overall Study|Withdrawal by Subject|3|||
156316300|NCT02984943|564257691|FG000|Overall Study|Physician Decision|1|||
156316301|NCT02480712|564257698|FG000|Overall Study|Enrolled but Never Treated|1|||
156316302|NCT02480712|564257698|FG000|Overall Study|Lost to Follow-up|5|||
156316303|NCT02480712|564257698|FG000|Overall Study|Withdrew Consent|3|||
156757119|NCT02420119|565862823|FG000|Overall Study|insufficient laboratory data|5|||
156757120|NCT01808261|565862824|FG000|Overall Study|Physician Decision|0|||
156757121|NCT01808261|565862825|FG001|Overall Study|Physician Decision|2|||
156757122|NCT01808261|565862824|FG000|Overall Study|Study Closed/Terminated|25|||
156757123|NCT01808261|565862825|FG001|Overall Study|Study Closed/Terminated|23|||
156757124|NCT01808261|565862824|FG000|Overall Study|Adverse event, non-fatal|2|||
156757125|NCT01808261|565862825|FG001|Overall Study|Adverse event, non-fatal|0|||
156757126|NCT01808261|565862824|FG000|Overall Study|Consent withdrawn by subject|6|||
156757127|NCT01808261|565862825|FG001|Overall Study|Consent withdrawn by subject|7|||
156757128|NCT01808261|565862824|FG000|Overall Study|Lost to Follow-up|3|||
156757129|NCT01808261|565862825|FG001|Overall Study|Lost to Follow-up|1|||
156757130|NCT04501952|565862828|FG000|Overall Study|Adverse Event|0|||
156757131|NCT04501952|565862829|FG001|Overall Study|Adverse Event|3|||
156757132|NCT04501952|565862828|FG000|Overall Study|Investigator's Discretion|0|||
156316304|NCT02480712|564257698|FG000|Overall Study|Death|1|||
156316305|NCT02480712|564257698|FG000|Overall Study|Lack of Efficacy|1|||
156316306|NCT01860846|564257699|FG000|Overall Study|Lost to Follow-up|33|||
156316307|NCT00466687|564257700|FG000|Overall Study|Adverse Event|1|||
156316308|NCT00466687|564257700|FG000|Overall Study|Other complicating illness|3|||
156757133|NCT04501952|565862829|FG001|Overall Study|Investigator's Discretion|1|||
156757134|NCT04501952|565862828|FG000|Overall Study|Protocol Violation|1|||
156757135|NCT04501952|565862829|FG001|Overall Study|Protocol Violation|1|||
156757136|NCT04501952|565862828|FG000|Overall Study|Withdrew Consent|5|||
156757137|NCT04501952|565862829|FG001|Overall Study|Withdrew Consent|4|||
156757138|NCT04501952|565862828|FG000|Overall Study|Lost to Follow-up|7|||
156757139|NCT04501952|565862829|FG001|Overall Study|Lost to Follow-up|2|||
156757140|NCT04501952|565862828|FG000|Overall Study|Randomized and Never Treated|13|||
156757141|NCT04501952|565862829|FG001|Overall Study|Randomized and Never Treated|9|||
156757142|NCT02080364|565862830|FG000|Baseline Period|Protocol Violation|2|||
156757143|NCT02080364|565862831|FG001|Baseline Period|Protocol Violation|1|||
156757144|NCT02080364|565862832|FG002|Baseline Period|Protocol Violation|0|||
156757145|NCT02080364|565862833|FG003|Baseline Period|Protocol Violation|0|||
156757146|NCT02080364|565862830|FG000|Baseline Period|Other|0|||
156757147|NCT02080364|565862831|FG001|Baseline Period|Other|1|||
156757148|NCT02080364|565862832|FG002|Baseline Period|Other|1|||
156757149|NCT02080364|565862833|FG003|Baseline Period|Other|0|||
156757150|NCT02080364|565862830|FG000|Treatment Period|Adverse Event|10|||
156757151|NCT02080364|565862831|FG001|Treatment Period|Adverse Event|15|||
156757152|NCT02080364|565862832|FG002|Treatment Period|Adverse Event|11|||
156757153|NCT02080364|565862833|FG003|Treatment Period|Adverse Event|14|||
156757154|NCT02080364|565862830|FG000|Treatment Period|Lost to Follow-up|2|||
156757155|NCT02080364|565862831|FG001|Treatment Period|Lost to Follow-up|3|||
156757156|NCT02080364|565862832|FG002|Treatment Period|Lost to Follow-up|5|||
156757157|NCT02080364|565862833|FG003|Treatment Period|Lost to Follow-up|0|||
156757158|NCT02080364|565862830|FG000|Treatment Period|Protocol Violation|5|||
156757159|NCT02080364|565862831|FG001|Treatment Period|Protocol Violation|3|||
156757160|NCT02080364|565862832|FG002|Treatment Period|Protocol Violation|5|||
156757161|NCT02080364|565862833|FG003|Treatment Period|Protocol Violation|1|||
156757162|NCT02080364|565862830|FG000|Treatment Period|Withdrawal by Subject|16|||
156757163|NCT02080364|565862831|FG001|Treatment Period|Withdrawal by Subject|16|||
156757164|NCT02080364|565862832|FG002|Treatment Period|Withdrawal by Subject|15|||
156757165|NCT02080364|565862833|FG003|Treatment Period|Withdrawal by Subject|10|||
156757166|NCT02080364|565862830|FG000|Treatment Period|Study Terminated by Sponsor|0|||
156757167|NCT02080364|565862831|FG001|Treatment Period|Study Terminated by Sponsor|0|||
156757168|NCT02080364|565862832|FG002|Treatment Period|Study Terminated by Sponsor|180|||
156757169|NCT02080364|565862833|FG003|Treatment Period|Study Terminated by Sponsor|183|||
156757170|NCT02080364|565862830|FG000|Treatment Period|Other|14|||
156757171|NCT02080364|565862831|FG001|Treatment Period|Other|12|||
156757172|NCT02080364|565862832|FG002|Treatment Period|Other|21|||
156757173|NCT02080364|565862833|FG003|Treatment Period|Other|16|||
156757174|NCT02256839|565862834|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
156757175|NCT02256839|565862835|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
156757176|NCT00436826|565862836|FG000|Double Blind Period (DBP)|Adverse Event|2|||
156757177|NCT00436826|565862837|FG001|Double Blind Period (DBP)|Adverse Event|0|||
156757178|NCT00436826|565862838|FG002|Double Blind Period (DBP)|Adverse Event|0|||
156757179|NCT00436826|565862839|FG003|Double Blind Period (DBP)|Adverse Event|0|||
156757180|NCT00436826|565862840|FG004|Double Blind Period (DBP)|Adverse Event|0|||
156757181|NCT00436826|565862841|FG005|Double Blind Period (DBP)|Adverse Event|0|||
156757182|NCT00436826|565862836|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
156757183|NCT00436826|565862837|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
156757184|NCT00436826|565862838|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
156757185|NCT00436826|565862839|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
156316309|NCT00466687|564257700|FG000|Overall Study|Withdrawal by Subject|1|||
156316310|NCT00466687|564257700|FG000|Overall Study|Disease progression|29|||
156316311|NCT01944839|564257704|FG000|Overall Study|Physician Decision|2|||
156316312|NCT01944839|564257705|FG001|Overall Study|Physician Decision|2|||
156316313|NCT01944839|564257704|FG000|Overall Study|Protocol Violation|0|||
156316314|NCT01944839|564257705|FG001|Overall Study|Protocol Violation|1|||
156316315|NCT01944839|564257704|FG000|Overall Study|Adverse Event|10|||
156316316|NCT01944839|564257705|FG001|Overall Study|Adverse Event|5|||
156316317|NCT01944839|564257704|FG000|Overall Study|Withdrawal by Subject|9|||
156316318|NCT01944839|564257705|FG001|Overall Study|Withdrawal by Subject|17|||
156316319|NCT01944839|564257704|FG000|Overall Study|Lost to Follow-up|1|||
156316320|NCT01944839|564257705|FG001|Overall Study|Lost to Follow-up|0|||
156316321|NCT01944839|564257704|FG000|Overall Study|Subject non-compliance|0|||
156417564|NCT01513967|564621769|FG006|Overall Study|Pregnancy|1|||
156757186|NCT00436826|565862840|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
156757187|NCT00436826|565862841|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
156757188|NCT00436826|565862836|FG000|Double Blind Period (DBP)|Other|10|||
156417565|NCT01513967|564621770|FG007|Overall Study|Pregnancy|0|||
156757189|NCT00436826|565862837|FG001|Double Blind Period (DBP)|Other|11|||
156757190|NCT00436826|565862838|FG002|Double Blind Period (DBP)|Other|0|||
156757191|NCT00436826|565862839|FG003|Double Blind Period (DBP)|Other|0|||
156757192|NCT00436826|565862840|FG004|Double Blind Period (DBP)|Other|0|||
156757193|NCT00436826|565862841|FG005|Double Blind Period (DBP)|Other|0|||
156316322|NCT01944839|564257705|FG001|Overall Study|Subject non-compliance|3|||
156316323|NCT00171834|564257706|FG000|Overall Study|Adverse Event|2|||
156316324|NCT00171834|564257707|FG001|Overall Study|Adverse Event|1|||
156316325|NCT00171834|564257708|FG002|Overall Study|Adverse Event|3|||
156316326|NCT00171834|564257709|FG003|Overall Study|Adverse Event|2|||
156316327|NCT00171834|564257710|FG004|Overall Study|Adverse Event|2|||
156316328|NCT00171834|564257711|FG005|Overall Study|Adverse Event|15|||
156316329|NCT00171834|564257712|FG006|Overall Study|Adverse Event|1|||
156316330|NCT00171834|564257706|FG000|Overall Study|Withdrawal by Subject|0|||
156316331|NCT00171834|564257707|FG001|Overall Study|Withdrawal by Subject|2|||
156316332|NCT00171834|564257708|FG002|Overall Study|Withdrawal by Subject|0|||
156316333|NCT00171834|564257709|FG003|Overall Study|Withdrawal by Subject|1|||
156316334|NCT00171834|564257710|FG004|Overall Study|Withdrawal by Subject|1|||
156316335|NCT00171834|564257711|FG005|Overall Study|Withdrawal by Subject|1|||
156316336|NCT00171834|564257712|FG006|Overall Study|Withdrawal by Subject|0|||
156316337|NCT00171834|564257706|FG000|Overall Study|Death from study indication|0|||
156316338|NCT00171834|564257707|FG001|Overall Study|Death from study indication|1|||
156316339|NCT00171834|564257708|FG002|Overall Study|Death from study indication|0|||
156316340|NCT00171834|564257709|FG003|Overall Study|Death from study indication|0|||
156316341|NCT00171834|564257710|FG004|Overall Study|Death from study indication|1|||
156316342|NCT00171834|564257711|FG005|Overall Study|Death from study indication|0|||
156316343|NCT00171834|564257712|FG006|Overall Study|Death from study indication|0|||
156316344|NCT00171834|564257706|FG000|Overall Study|Disease Progression|4|||
156316345|NCT00171834|564257707|FG001|Overall Study|Disease Progression|8|||
156316346|NCT00171834|564257708|FG002|Overall Study|Disease Progression|8|||
156316347|NCT00171834|564257709|FG003|Overall Study|Disease Progression|9|||
156316348|NCT00171834|564257710|FG004|Overall Study|Disease Progression|2|||
156316349|NCT00171834|564257711|FG005|Overall Study|Disease Progression|18|||
156316350|NCT00171834|564257712|FG006|Overall Study|Disease Progression|3|||
156316351|NCT00171834|564257706|FG000|Overall Study|Treatment Duration Completed|0|||
156316352|NCT00171834|564257707|FG001|Overall Study|Treatment Duration Completed|0|||
156316353|NCT00171834|564257708|FG002|Overall Study|Treatment Duration Completed|1|||
156316354|NCT00171834|564257709|FG003|Overall Study|Treatment Duration Completed|0|||
156316355|NCT00171834|564257710|FG004|Overall Study|Treatment Duration Completed|2|||
156316356|NCT00171834|564257711|FG005|Overall Study|Treatment Duration Completed|1|||
156316357|NCT00171834|564257712|FG006|Overall Study|Treatment Duration Completed|0|||
156316358|NCT01284491|564257715|FG000|Overall Study|Study termination|13|||
156316359|NCT01978938|564257716|FG000|Overall Study|Lost to Follow-up|12|||
156316360|NCT01978938|564257717|FG001|Overall Study|Lost to Follow-up|6|||
156316361|NCT01978938|564257716|FG000|Overall Study|Withdrawal by Subject|8|||
156316362|NCT01978938|564257717|FG001|Overall Study|Withdrawal by Subject|4|||
156316363|NCT01978938|564257716|FG000|Overall Study|Adverse Event, non-fatal|2|||
156316364|NCT01978938|564257717|FG001|Overall Study|Adverse Event, non-fatal|1|||
156316365|NCT01978938|564257716|FG000|Overall Study|Participant noncompliance|1|||
156316366|NCT01978938|564257717|FG001|Overall Study|Participant noncompliance|1|||
156316367|NCT01978938|564257716|FG000|Overall Study|Did not meet inclusion criteria|0|||
156316368|NCT01978938|564257717|FG001|Overall Study|Did not meet inclusion criteria|1|||
156316369|NCT01978938|564257716|FG000|Overall Study|Previously scheduled procedure|0|||
156316370|NCT01978938|564257717|FG001|Overall Study|Previously scheduled procedure|1|||
156316371|NCT02694757|564257718|FG000|Overall Study|Lack of Efficacy|3|||
156316372|NCT02650921|564257719|FG000|Overall Study|Withdrawal by Subject|4|||
156316373|NCT02650921|564257719|FG000|Overall Study|Lost to Follow-up|2|||
156316374|NCT02650921|564257719|FG000|Overall Study|Adverse Event|1|||
156316375|NCT02650921|564257719|FG000|Overall Study|Due to Medical Condition|1|||
156316376|NCT00783302|564257720|FG000|Overall Study|Lost to Follow-up|17|||
156316377|NCT00783302|564257720|FG000|Overall Study|Technical Problems|11|||
156316378|NCT00783302|564257720|FG000|Overall Study|Protocol Violation|3|||
156316379|NCT00783302|564257720|FG000|Overall Study|Physician Decision|1|||
156316380|NCT00783302|564257720|FG000|Overall Study|Withdrawal by Subject|3|||
156316381|NCT01087788|564257721|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
156316382|NCT01087788|564257722|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
156316383|NCT01087788|564257723|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
156316384|NCT01087788|564257721|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
156316385|NCT01087788|564257722|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
156316386|NCT01087788|564257723|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
156316387|NCT01087788|564257721|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
156316388|NCT01087788|564257722|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
156316389|NCT01087788|564257723|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
156316390|NCT01087788|564257721|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
156417566|NCT01513967|564621763|FG000|Overall Study|missed a study visit|0|||
156316391|NCT01087788|564257722|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
156316392|NCT01087788|564257723|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
156316393|NCT01087788|564257721|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
156316394|NCT01087788|564257722|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
156316395|NCT01087788|564257723|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
156316396|NCT01087788|564257721|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
156316397|NCT01087788|564257722|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
156316398|NCT01087788|564257723|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
156417567|NCT01513967|564621764|FG001|Overall Study|missed a study visit|0|||
156417568|NCT01513967|564621765|FG002|Overall Study|missed a study visit|0|||
156417569|NCT01513967|564621766|FG003|Overall Study|missed a study visit|0|||
156417570|NCT01513967|564621767|FG004|Overall Study|missed a study visit|0|||
156417571|NCT01513967|564621768|FG005|Overall Study|missed a study visit|0|||
156417572|NCT01513967|564621769|FG006|Overall Study|missed a study visit|1|||
156417573|NCT01513967|564621770|FG007|Overall Study|missed a study visit|0|||
156417574|NCT01513967|564621763|FG000|Overall Study|excluded due to positive drug screen|0|||
156417575|NCT01513967|564621764|FG001|Overall Study|excluded due to positive drug screen|0|||
156417576|NCT01513967|564621765|FG002|Overall Study|excluded due to positive drug screen|0|||
156417577|NCT01513967|564621766|FG003|Overall Study|excluded due to positive drug screen|0|||
156417578|NCT01513967|564621767|FG004|Overall Study|excluded due to positive drug screen|0|||
156417579|NCT01513967|564621768|FG005|Overall Study|excluded due to positive drug screen|0|||
156417580|NCT01513967|564621769|FG006|Overall Study|excluded due to positive drug screen|0|||
156417581|NCT01513967|564621770|FG007|Overall Study|excluded due to positive drug screen|2|||
156417582|NCT01513967|564621763|FG000|Overall Study|Physician Decision|0|||
156417583|NCT01513967|564621764|FG001|Overall Study|Physician Decision|0|||
156417584|NCT01513967|564621765|FG002|Overall Study|Physician Decision|0|||
156417585|NCT01513967|564621766|FG003|Overall Study|Physician Decision|0|||
156417586|NCT01513967|564621767|FG004|Overall Study|Physician Decision|0|||
156417587|NCT01513967|564621768|FG005|Overall Study|Physician Decision|1|||
156417588|NCT01513967|564621769|FG006|Overall Study|Physician Decision|0|||
156417589|NCT01513967|564621770|FG007|Overall Study|Physician Decision|0|||
156417590|NCT02906202|564621771|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
156417591|NCT01987830|564621772|FG000|Overall Study|Never received baseline scan|1|||
156417592|NCT01563978|564621773|FG000|Overall Study|Physician Decision|1|||
156757194|NCT00436826|565862836|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156757195|NCT00436826|565862837|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156757196|NCT00436826|565862838|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156757197|NCT00436826|565862839|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
156316399|NCT01087788|564257721|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
156316400|NCT01087788|564257722|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
156316401|NCT01087788|564257723|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
156316402|NCT01087788|564257721|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
156316403|NCT01087788|564257722|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
156316404|NCT01087788|564257723|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
156316405|NCT01087788|564257721|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
156316406|NCT01087788|564257722|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
156316407|NCT01087788|564257723|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
156316408|NCT01087788|564257721|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
156316409|NCT01087788|564257722|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
156316410|NCT01087788|564257723|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
156316411|NCT01087788|564257721|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
156316412|NCT01087788|564257722|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
156316413|NCT01087788|564257723|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
156316414|NCT01087788|564257721|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
156316415|NCT01087788|564257722|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
156316416|NCT01087788|564257723|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
156316417|NCT01087788|564257721|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
156316418|NCT01087788|564257722|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
156316419|NCT01087788|564257723|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
156316420|NCT01087788|564257721|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
156316421|NCT01087788|564257722|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
156316422|NCT01087788|564257723|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
156316423|NCT01087788|564257721|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
156316424|NCT01087788|564257722|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
156316425|NCT01087788|564257723|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
156316426|NCT01087788|564257721|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
156316427|NCT01087788|564257722|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
156316428|NCT01087788|564257723|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
156316429|NCT01087788|564257721|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
156316430|NCT01087788|564257722|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
156316431|NCT01087788|564257723|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
156316432|NCT01087788|564257721|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
156316433|NCT01087788|564257722|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
156417593|NCT01563978|564621774|FG001|Overall Study|Physician Decision|0|||
156417594|NCT01563978|564621773|FG000|Overall Study|Lost to Follow-up|1|||
156417595|NCT01563978|564621774|FG001|Overall Study|Lost to Follow-up|0|||
156417596|NCT01563978|564621773|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
156316434|NCT01087788|564257723|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
156316435|NCT01087788|564257721|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
156316436|NCT01087788|564257722|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
156316437|NCT01087788|564257723|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
156316438|NCT01087788|564257721|FG000|24-weeks Dose-blind Period|Patient moved|0|||
156316439|NCT01087788|564257722|FG001|24-weeks Dose-blind Period|Patient moved|0|||
156316440|NCT01087788|564257723|FG002|24-weeks Dose-blind Period|Patient moved|1|||
156316441|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
156316442|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
156316443|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
156316444|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
156316445|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
156316446|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
156316447|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
156316448|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
156316449|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
156316450|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
156316451|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
156316452|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
156316453|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
156316454|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
156316455|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
156316456|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
156316457|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
156316458|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
156316459|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
156316460|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
156316461|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
156316462|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
156316463|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
156316464|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
156316465|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
156316466|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
156316467|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
156316468|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
156316469|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
156316470|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
156316471|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
156316472|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
156316473|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
156316474|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
156316475|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
156316476|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
156316477|NCT01087788|564257721|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
156316478|NCT01087788|564257722|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
156316479|NCT01087788|564257723|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
156316480|NCT01917656|564257730|FG000|Overall Study|Adverse Event|11|||
156316481|NCT01917656|564257731|FG001|Overall Study|Adverse Event|0|||
156316482|NCT01917656|564257730|FG000|Overall Study|Withdrawal criteria|8|||
156316483|NCT01917656|564257731|FG001|Overall Study|Withdrawal criteria|14|||
156316484|NCT01917656|564257730|FG000|Overall Study|Unclassified|0|||
156316485|NCT01917656|564257731|FG001|Overall Study|Unclassified|3|||
156316486|NCT01917656|564257730|FG000|Overall Study|Withdrawal by Subject|4|||
156653110|NCT04820842|565477904|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156653111|NCT04820842|565477905|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
156653112|NCT04820842|565477906|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156653113|NCT04820842|565477907|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156653114|NCT04820842|565477908|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156653115|NCT04820842|565477909|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156653116|NCT04820842|565477910|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156653117|NCT04820842|565477904|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156653118|NCT04820842|565477905|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156653119|NCT04820842|565477906|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156653120|NCT04820842|565477907|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
156757198|NCT00436826|565862840|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156316487|NCT01917656|564257731|FG001|Overall Study|Withdrawal by Subject|3|||
156417597|NCT01563978|564621774|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
156417598|NCT01563978|564621773|FG000|Overall Study|Adverse Event|1|||
156417599|NCT01563978|564621774|FG001|Overall Study|Adverse Event|2|||
156417600|NCT05764239|564621775|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
156417601|NCT05764239|564621775|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
156417602|NCT05764239|564621775|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
156417603|NCT05764239|564621775|FG000|DEP (Part 1)|Adverse Event|1|||
156417604|NCT05764239|564621775|FG000|DEP (Part 1)|Lost to Follow-up|1|||
156417605|NCT05764239|564621775|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
156417606|NCT05764239|564621775|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
156417607|NCT05764239|564621775|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
156417608|NCT05764239|564621775|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
156417609|NCT00556374|564621776|FG000|Overall Study|Withdrawal by Subject|235|||
156417610|NCT00556374|564621777|FG001|Overall Study|Withdrawal by Subject|205|||
156417611|NCT00556374|564621776|FG000|Overall Study|Death|158|||
156417612|NCT00556374|564621777|FG001|Overall Study|Death|127|||
156417613|NCT00556374|564621776|FG000|Overall Study|Lost to Follow-up|24|||
156417614|NCT00556374|564621777|FG001|Overall Study|Lost to Follow-up|17|||
156417615|NCT00556374|564621776|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
156417616|NCT00556374|564621777|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
156417617|NCT00847301|564621778|FG000|Overall Study|Adverse Event|35|||
156417618|NCT00847301|564621778|FG000|Overall Study|Switch to other anticoagulants|16|||
156417619|NCT00847301|564621778|FG000|Overall Study|Lost to Follow-up|1|||
156417620|NCT00847301|564621778|FG000|Overall Study|No prescription after hospital discharge|1|||
156417621|NCT00847301|564621778|FG000|Overall Study|Other reason not defined above|1|||
156417622|NCT00641186|564621779|FG000|Overall Study|Adverse Event|3|||
156417623|NCT00442286|564621780|FG000|Overall Study|Death|2|||
156417624|NCT00442286|564621781|FG001|Overall Study|Death|2|||
156417625|NCT00442286|564621780|FG000|Overall Study|Lost to Follow-up|1|||
156417626|NCT00442286|564621781|FG001|Overall Study|Lost to Follow-up|0|||
156417627|NCT00442286|564621780|FG000|Overall Study|Withdrawal by Subject|2|||
156417628|NCT00442286|564621781|FG001|Overall Study|Withdrawal by Subject|0|||
156417629|NCT00442286|564621780|FG000|Overall Study|System explanted|1|||
156417630|NCT00442286|564621781|FG001|Overall Study|System explanted|0|||
156417631|NCT00442286|564621780|FG000|Overall Study|Patient Injury|1|||
156417632|NCT00442286|564621781|FG001|Overall Study|Patient Injury|0|||
156417633|NCT05221749|564621782|FG000|Overall Study|Lost to Follow-up|2|||
156417634|NCT05221749|564621783|FG001|Overall Study|Lost to Follow-up|3|||
156417635|NCT05567952|564623523|FG000|Overall Study|Lost to Follow-up|3|||
156417636|NCT05567952|564623524|FG001|Overall Study|Lost to Follow-up|2|||
156417637|NCT05567952|564623523|FG000|Overall Study|Withdrawal by Subject|6|||
156417638|NCT05567952|564623524|FG001|Overall Study|Withdrawal by Subject|3|||
156417639|NCT05567952|564623523|FG000|Overall Study|Other|3|||
156417640|NCT05567952|564623524|FG001|Overall Study|Other|1|||
156417641|NCT03280563|564623526|FG000|Stage 1|Death|2|||
156417642|NCT03280563|564623527|FG001|Stage 1|Death|1|||
156417643|NCT03280563|564623528|FG002|Stage 1|Death|0|||
156417644|NCT03280563|564623529|FG003|Stage 1|Death|0|||
156417645|NCT03280563|564623530|FG004|Stage 1|Death|0|||
156417646|NCT03280563|564623531|FG005|Stage 1|Death|3|||
156417647|NCT03280563|564623532|FG006|Stage 1|Death|0|||
156417648|NCT03280563|564623533|FG007|Stage 1|Death|0|||
156417649|NCT03280563|564623534|FG008|Stage 1|Death|0|||
156417650|NCT03280563|564623526|FG000|Stage 1|Study Ended by Sponsor|0|||
156417651|NCT03280563|564623527|FG001|Stage 1|Study Ended by Sponsor|0|||
156417652|NCT03280563|564623528|FG002|Stage 1|Study Ended by Sponsor|1|||
156417653|NCT03280563|564623529|FG003|Stage 1|Study Ended by Sponsor|0|||
156417654|NCT03280563|564623530|FG004|Stage 1|Study Ended by Sponsor|0|||
156417655|NCT03280563|564623531|FG005|Stage 1|Study Ended by Sponsor|1|||
156417656|NCT03280563|564623532|FG006|Stage 1|Study Ended by Sponsor|0|||
156417657|NCT03280563|564623533|FG007|Stage 1|Study Ended by Sponsor|0|||
156417658|NCT03280563|564623534|FG008|Stage 1|Study Ended by Sponsor|0|||
156417659|NCT03280563|564623526|FG000|Stage 1|Withdrawal by Subject|5|||
156417660|NCT03280563|564623527|FG001|Stage 1|Withdrawal by Subject|1|||
156417661|NCT03280563|564623528|FG002|Stage 1|Withdrawal by Subject|2|||
156417662|NCT03280563|564623529|FG003|Stage 1|Withdrawal by Subject|0|||
156417663|NCT03280563|564623530|FG004|Stage 1|Withdrawal by Subject|0|||
156417664|NCT03280563|564623531|FG005|Stage 1|Withdrawal by Subject|2|||
156653121|NCT04820842|565477908|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156653122|NCT04820842|565477909|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
156653123|NCT04820842|565477910|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
156653124|NCT01691508|565477911|FG000|Overall Study|Adverse Event|3|||
156653125|NCT01691508|565477912|FG001|Overall Study|Adverse Event|3|||
156417665|NCT03280563|564623532|FG006|Stage 1|Withdrawal by Subject|0|||
156417666|NCT03280563|564623533|FG007|Stage 1|Withdrawal by Subject|0|||
156417667|NCT03280563|564623534|FG008|Stage 1|Withdrawal by Subject|0|||
156417668|NCT03280563|564623526|FG000|Stage 1|Reason Not Specified|0|||
156757199|NCT00436826|565862841|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156757200|NCT00436826|565862836|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
156757201|NCT00436826|565862837|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
156757202|NCT00436826|565862838|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
156757203|NCT00436826|565862839|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
156757204|NCT00436826|565862840|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
156316488|NCT01917656|564257730|FG000|Overall Study|Lost to Follow-up|3|||
156316489|NCT01917656|564257731|FG001|Overall Study|Lost to Follow-up|4|||
156316490|NCT02015221|564257732|FG000|Overall Study|Withdrawal by Subject|8|||
156316491|NCT02015221|564257733|FG001|Overall Study|Withdrawal by Subject|6|||
156316492|NCT02015221|564257732|FG000|Overall Study|Lost to Follow-up|1|||
156316493|NCT02015221|564257733|FG001|Overall Study|Lost to Follow-up|0|||
156316494|NCT01306929|564257734|FG000|Overall Study|Withdrawal by Subject|23|||
156316495|NCT01306929|564257734|FG000|Overall Study|Adverse Event|21|||
156316496|NCT01306929|564257734|FG000|Overall Study|Physician Decision|13|||
156316497|NCT01306929|564257734|FG000|Overall Study|Death|8|||
156316498|NCT01306929|564257734|FG000|Overall Study|Withdrawal by parent/guardian|5|||
156316499|NCT01306929|564257734|FG000|Overall Study|Protocol Violation|3|||
156316500|NCT01306929|564257734|FG000|Overall Study|Non-compliance with study drug|2|||
156316501|NCT01306929|564257734|FG000|Overall Study|Lost to Follow-up|2|||
156316502|NCT01306929|564257734|FG000|Overall Study|Various|17|||
156316503|NCT03709576|564257735|FG000|Overall Study|progression prior to enrollment|1|||
156316504|NCT03041129|564257743|FG000|Overall Study|Withdrawal by Subject|2|||
156316505|NCT03041129|564257744|FG001|Overall Study|Withdrawal by Subject|0|||
156316506|NCT03041129|564257745|FG002|Overall Study|Withdrawal by Subject|0|||
156316507|NCT03041129|564257746|FG003|Overall Study|Withdrawal by Subject|0|||
156316508|NCT00510653|564257749|FG000|Overall Study|Withdrawal by Subject|8|||
156316509|NCT00510653|564257749|FG000|Overall Study|Monetary|3|||
156316510|NCT00483756|564257752|FG000|Overall Study|Death|2|||
156316511|NCT00483756|564257753|FG001|Overall Study|Death|0|||
156316512|NCT00483756|564257754|FG002|Overall Study|Death|1|||
156316513|NCT00483756|564257752|FG000|Overall Study|Adverse Event|19|||
156316514|NCT00483756|564257753|FG001|Overall Study|Adverse Event|38|||
156316515|NCT00483756|564257754|FG002|Overall Study|Adverse Event|40|||
156316516|NCT00483756|564257752|FG000|Overall Study|Lack of Efficacy|1|||
156316517|NCT00483756|564257753|FG001|Overall Study|Lack of Efficacy|0|||
156316518|NCT00483756|564257754|FG002|Overall Study|Lack of Efficacy|0|||
156316519|NCT00483756|564257752|FG000|Overall Study|Lost to Follow-up|3|||
156316520|NCT00483756|564257753|FG001|Overall Study|Lost to Follow-up|1|||
156316521|NCT00483756|564257754|FG002|Overall Study|Lost to Follow-up|0|||
156316522|NCT00483756|564257752|FG000|Overall Study|Withdrawal by Subject|5|||
156316523|NCT00483756|564257753|FG001|Overall Study|Withdrawal by Subject|3|||
156316524|NCT00483756|564257754|FG002|Overall Study|Withdrawal by Subject|4|||
156316525|NCT00483756|564257752|FG000|Overall Study|Other|2|||
156316526|NCT00483756|564257753|FG001|Overall Study|Other|4|||
156316527|NCT00483756|564257754|FG002|Overall Study|Other|3|||
156316528|NCT00483756|564257752|FG000|Overall Study|Randomized, Not Treated|1|||
156316529|NCT00483756|564257753|FG001|Overall Study|Randomized, Not Treated|4|||
156316530|NCT00483756|564257754|FG002|Overall Study|Randomized, Not Treated|4|||
156316531|NCT00710762|564257755|FG000|Overall Study|Progressive disease|27|||
156316532|NCT00710762|564257756|FG001|Overall Study|Progressive disease|30|||
156316533|NCT00710762|564257755|FG000|Overall Study|Adverse Event other disease worsening|2|||
156316534|NCT00710762|564257756|FG001|Overall Study|Adverse Event other disease worsening|1|||
156316535|NCT00710762|564257755|FG000|Overall Study|Other Adverse Event|7|||
156316536|NCT00710762|564257756|FG001|Overall Study|Other Adverse Event|7|||
156316537|NCT00710762|564257755|FG000|Overall Study|Lost to Follow-up|1|||
156316538|NCT00710762|564257756|FG001|Overall Study|Lost to Follow-up|0|||
156316539|NCT00710762|564257755|FG000|Overall Study|Reason other than listed above|2|||
156316540|NCT00710762|564257756|FG001|Overall Study|Reason other than listed above|2|||
156316541|NCT00436501|564257757|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
156316542|NCT00436501|564257758|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
156316543|NCT00436501|564257757|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
156316544|NCT00436501|564257758|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
156316545|NCT00495040|564257759|FG000|Overall Study|Withdrawal by Subject|3|||
156757205|NCT00436826|565862841|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
156316546|NCT02282293|564257764|FG000|Overall Study|Lost to Follow-up|2|||
156316547|NCT02282293|564257765|FG001|Overall Study|Lost to Follow-up|2|||
156316548|NCT02282293|564257764|FG000|Overall Study|Unable to comply with study procedures|1|||
156316549|NCT02282293|564257765|FG001|Overall Study|Unable to comply with study procedures|0|||
156316550|NCT02282293|564257764|FG000|Overall Study|Moved out of study area|0|||
156316551|NCT02282293|564257765|FG001|Overall Study|Moved out of study area|1|||
156316552|NCT03011892|564257766|FG000|Double Blind (DB) Period|Adverse Event|0|||
156316553|NCT03011892|564257767|FG001|Double Blind (DB) Period|Adverse Event|1|||
156316554|NCT03011892|564257768|FG002|Double Blind (DB) Period|Adverse Event|1|||
156316555|NCT03011892|564257769|FG003|Double Blind (DB) Period|Adverse Event|0|||
156417669|NCT03280563|564623527|FG001|Stage 1|Reason Not Specified|0|||
156417670|NCT03280563|564623528|FG002|Stage 1|Reason Not Specified|0|||
156417671|NCT03280563|564623529|FG003|Stage 1|Reason Not Specified|0|||
156417672|NCT03280563|564623530|FG004|Stage 1|Reason Not Specified|0|||
156417673|NCT03280563|564623531|FG005|Stage 1|Reason Not Specified|1|||
156417674|NCT03280563|564623532|FG006|Stage 1|Reason Not Specified|0|||
156417675|NCT03280563|564623533|FG007|Stage 1|Reason Not Specified|0|||
156417676|NCT03280563|564623534|FG008|Stage 1|Reason Not Specified|0|||
156417677|NCT03280563|564623526|FG000|Stage 1|Physician Decision|0|||
156417678|NCT03280563|564623527|FG001|Stage 1|Physician Decision|1|||
156417679|NCT03280563|564623528|FG002|Stage 1|Physician Decision|0|||
156417680|NCT03280563|564623529|FG003|Stage 1|Physician Decision|0|||
156417681|NCT03280563|564623530|FG004|Stage 1|Physician Decision|0|||
156417682|NCT03280563|564623531|FG005|Stage 1|Physician Decision|0|||
156417683|NCT03280563|564623532|FG006|Stage 1|Physician Decision|0|||
156417684|NCT03280563|564623533|FG007|Stage 1|Physician Decision|0|||
156417685|NCT03280563|564623534|FG008|Stage 1|Physician Decision|0|||
156417686|NCT03280563|564623526|FG000|Stage 2|Death|0|||
156417687|NCT03280563|564623527|FG001|Stage 2|Death|0|||
156417688|NCT03280563|564623528|FG002|Stage 2|Death|0|||
156417689|NCT03280563|564623529|FG003|Stage 2|Death|0|||
156417690|NCT03280563|564623530|FG004|Stage 2|Death|0|||
156417691|NCT03280563|564623531|FG005|Stage 2|Death|0|||
156417692|NCT03280563|564623532|FG006|Stage 2|Death|0|||
156417693|NCT03280563|564623533|FG007|Stage 2|Death|1|||
156417694|NCT03280563|564623534|FG008|Stage 2|Death|0|||
156417695|NCT03280563|564623526|FG000|Stage 2|Progressive Disease|0|||
156417696|NCT03280563|564623527|FG001|Stage 2|Progressive Disease|0|||
156417697|NCT03280563|564623528|FG002|Stage 2|Progressive Disease|0|||
156417698|NCT03280563|564623529|FG003|Stage 2|Progressive Disease|0|||
156417699|NCT03280563|564623530|FG004|Stage 2|Progressive Disease|0|||
156417700|NCT03280563|564623531|FG005|Stage 2|Progressive Disease|0|||
156417701|NCT03280563|564623532|FG006|Stage 2|Progressive Disease|2|||
156417702|NCT03280563|564623533|FG007|Stage 2|Progressive Disease|0|||
156417703|NCT03280563|564623534|FG008|Stage 2|Progressive Disease|0|||
156417704|NCT03280563|564623526|FG000|Long-term Survival Follow-up|Death|10|||
156417705|NCT03280563|564623527|FG001|Long-term Survival Follow-up|Death|14|||
156417706|NCT03280563|564623528|FG002|Long-term Survival Follow-up|Death|15|||
156417707|NCT03280563|564623529|FG003|Long-term Survival Follow-up|Death|3|||
156417708|NCT03280563|564623530|FG004|Long-term Survival Follow-up|Death|6|||
156417709|NCT03280563|564623531|FG005|Long-term Survival Follow-up|Death|18|||
156417710|NCT03280563|564623532|FG006|Long-term Survival Follow-up|Death|11|||
156417711|NCT03280563|564623533|FG007|Long-term Survival Follow-up|Death|1|||
156417712|NCT03280563|564623534|FG008|Long-term Survival Follow-up|Death|3|||
156417713|NCT03280563|564623526|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
156417714|NCT03280563|564623527|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
156417715|NCT03280563|564623528|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
156417716|NCT03280563|564623529|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
156417717|NCT03280563|564623530|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
156417718|NCT03280563|564623531|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
156417719|NCT03280563|564623532|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
156417720|NCT03280563|564623533|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
156417721|NCT03280563|564623534|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
156417722|NCT03280563|564623526|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
156417723|NCT03280563|564623527|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
156417724|NCT03280563|564623528|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
156417725|NCT03280563|564623529|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156417726|NCT03280563|564623530|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
156417727|NCT03280563|564623531|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156417728|NCT03280563|564623532|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156417729|NCT03280563|564623533|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156417730|NCT03280563|564623534|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156417731|NCT03280563|564623526|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
156417732|NCT03280563|564623527|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
156417733|NCT03280563|564623528|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
156417734|NCT03280563|564623529|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
156417735|NCT03280563|564623530|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
156417736|NCT03280563|564623531|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
156417737|NCT03280563|564623532|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
156417738|NCT03280563|564623533|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
156417739|NCT03280563|564623534|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
156417740|NCT00802841|564623535|FG000|Overall Study|Administrative problems|1|||
156417741|NCT00802841|564623536|FG001|Overall Study|Administrative problems|0|||
156417742|NCT00802841|564623535|FG000|Overall Study|Lost to Follow-up|2|||
156417743|NCT00802841|564623536|FG001|Overall Study|Lost to Follow-up|1|||
156417744|NCT00802841|564623535|FG000|Overall Study|Death|1|||
156757206|NCT00436826|565862836|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
156757207|NCT00436826|565862837|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
156757208|NCT00436826|565862838|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
156757209|NCT00436826|565862839|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
156417745|NCT00802841|564623536|FG001|Overall Study|Death|2|||
156417746|NCT00802841|564623535|FG000|Overall Study|Adverse Event|8|||
156417747|NCT00802841|564623536|FG001|Overall Study|Adverse Event|2|||
156417748|NCT00802841|564623535|FG000|Overall Study|Disease progression|7|||
156417749|NCT00802841|564623536|FG001|Overall Study|Disease progression|3|||
156417750|NCT00802841|564623535|FG000|Overall Study|Withdrawal by Subject|9|||
156417751|NCT00802841|564623536|FG001|Overall Study|Withdrawal by Subject|5|||
156417752|NCT00802841|564623535|FG000|Overall Study|Protocol deviation|2|||
156417753|NCT00802841|564623536|FG001|Overall Study|Protocol deviation|6|||
156417754|NCT00802841|564623535|FG000|Overall Study|Treatment duration completed|66|||
156417755|NCT00802841|564623536|FG001|Overall Study|Treatment duration completed|76|||
156417756|NCT00432159|564623537|FG000|Overall Study|Death|0|||
156417757|NCT00432159|564623538|FG001|Overall Study|Death|1|||
156417758|NCT00432159|564623539|FG002|Overall Study|Death|0|||
156417759|NCT00432159|564623540|FG003|Overall Study|Death|0|||
156417760|NCT00432159|564623541|FG004|Overall Study|Death|0|||
156417761|NCT00432159|564623537|FG000|Overall Study|Failure|9|||
156417762|NCT00432159|564623538|FG001|Overall Study|Failure|5|||
156417763|NCT00432159|564623539|FG002|Overall Study|Failure|3|||
156417764|NCT00432159|564623540|FG003|Overall Study|Failure|2|||
156417765|NCT00432159|564623541|FG004|Overall Study|Failure|3|||
156417766|NCT00432159|564623537|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
156417767|NCT00432159|564623538|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
156417768|NCT00432159|564623539|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
156417769|NCT00432159|564623540|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
156417770|NCT00432159|564623541|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
156417771|NCT02065245|564623548|FG000|Infusion 1|Lost to Follow-up|0|||
156417772|NCT02065245|564623549|FG001|Infusion 1|Lost to Follow-up|0|||
156417773|NCT02065245|564623550|FG002|Infusion 1|Lost to Follow-up|0|||
156417774|NCT02065245|564623551|FG003|Infusion 1|Lost to Follow-up|0|||
156417775|NCT02065245|564623552|FG004|Infusion 1|Lost to Follow-up|0|||
156417776|NCT02065245|564623553|FG005|Infusion 1|Lost to Follow-up|0|||
156417777|NCT02065245|564623554|FG006|Infusion 1|Lost to Follow-up|1|||
156417778|NCT02065245|564623548|FG000|Infusion 1|Death|0|||
156417779|NCT02065245|564623549|FG001|Infusion 1|Death|0|||
156417780|NCT02065245|564623550|FG002|Infusion 1|Death|1|||
156417781|NCT02065245|564623551|FG003|Infusion 1|Death|0|||
156417782|NCT02065245|564623552|FG004|Infusion 1|Death|1|||
156417783|NCT02065245|564623553|FG005|Infusion 1|Death|0|||
156417784|NCT02065245|564623554|FG006|Infusion 1|Death|0|||
156417785|NCT02065245|564623548|FG000|Infusion 2|Death|0|||
156417786|NCT02065245|564623549|FG001|Infusion 2|Death|0|||
156417787|NCT02065245|564623550|FG002|Infusion 2|Death|0|||
156417788|NCT02065245|564623551|FG003|Infusion 2|Death|0|||
156417789|NCT02065245|564623552|FG004|Infusion 2|Death|0|||
156417790|NCT02065245|564623553|FG005|Infusion 2|Death|0|||
156417791|NCT02065245|564623554|FG006|Infusion 2|Death|1|||
156417792|NCT02065245|564623548|FG000|Infusion 3|Lost to Follow-up|1|||
156417793|NCT02065245|564623549|FG001|Infusion 3|Lost to Follow-up|1|||
156417794|NCT02065245|564623550|FG002|Infusion 3|Lost to Follow-up|0|||
156417795|NCT02065245|564623551|FG003|Infusion 3|Lost to Follow-up|0|||
156417796|NCT02065245|564623552|FG004|Infusion 3|Lost to Follow-up|0|||
156417797|NCT02065245|564623553|FG005|Infusion 3|Lost to Follow-up|0|||
156417798|NCT02065245|564623554|FG006|Infusion 3|Lost to Follow-up|0|||
156417799|NCT05305040|564623557|FG000|Overall Study|Not Dosed|37|||
156757210|NCT00436826|565862840|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
156417800|NCT05305040|564623558|FG001|Overall Study|Not Dosed|37|||
156757211|NCT00436826|565862841|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
156417801|NCT05305040|564623557|FG000|Overall Study|Study Closure|34|||
156417802|NCT05305040|564623558|FG001|Overall Study|Study Closure|46|||
156417803|NCT05305040|564623557|FG000|Overall Study|Death|14|||
156417804|NCT05305040|564623558|FG001|Overall Study|Death|13|||
156757212|NCT04346199|565862850|FG000|Overall Study|Death|8|||
156757213|NCT04346199|565862851|FG001|Overall Study|Death|9|||
156757214|NCT04346199|565862850|FG000|Overall Study|Lost to Follow-up|0|||
156757215|NCT04346199|565862851|FG001|Overall Study|Lost to Follow-up|1|||
156417805|NCT05305040|564623557|FG000|Overall Study|Withdrawal by Subject|15|||
156417806|NCT05305040|564623558|FG001|Overall Study|Withdrawal by Subject|10|||
156417807|NCT05305040|564623557|FG000|Overall Study|Other|13|||
156417808|NCT05305040|564623558|FG001|Overall Study|Other|10|||
156417809|NCT05305040|564623557|FG000|Overall Study|Primary Malignancy Relapse|3|||
156417810|NCT05305040|564623558|FG001|Overall Study|Primary Malignancy Relapse|4|||
156417811|NCT05305040|564623557|FG000|Overall Study|Adverse Event|3|||
156417812|NCT05305040|564623558|FG001|Overall Study|Adverse Event|3|||
156417813|NCT05305040|564623557|FG000|Overall Study|Lost to Follow-up|2|||
156417814|NCT05305040|564623558|FG001|Overall Study|Lost to Follow-up|1|||
156417815|NCT05305040|564623557|FG000|Overall Study|Graft versus host disease|2|||
156417816|NCT05305040|564623558|FG001|Overall Study|Graft versus host disease|0|||
156417817|NCT05305040|564623557|FG000|Overall Study|Investigator's Decision|1|||
156417818|NCT05305040|564623558|FG001|Overall Study|Investigator's Decision|1|||
156417819|NCT05305040|564623557|FG000|Overall Study|COVID-19 Reasons|1|||
156417820|NCT05305040|564623558|FG001|Overall Study|COVID-19 Reasons|0|||
156417821|NCT01195675|564623559|FG000|Overall Study|Adverse Event|1|||
156417822|NCT01195675|564623559|FG000|Overall Study|Withdrawal by Subject|2|||
156417823|NCT01174550|564623560|FG000|Overall Study|Death|75|||
156417824|NCT01174550|564623561|FG001|Overall Study|Death|74|||
156417825|NCT01174550|564623560|FG000|Overall Study|Lost to Follow-up|652|||
156417826|NCT01174550|564623561|FG001|Overall Study|Lost to Follow-up|510|||
156417827|NCT01174550|564623560|FG000|Overall Study|Withdrawal by Subject|543|||
156417828|NCT01174550|564623561|FG001|Overall Study|Withdrawal by Subject|289|||
156417829|NCT01536262|564623562|FG000|Overall Study|Adverse Event|6|||
156417830|NCT01536262|564623563|FG001|Overall Study|Adverse Event|1|||
156417831|NCT01536262|564623564|FG002|Overall Study|Adverse Event|2|||
156417832|NCT01536262|564623562|FG000|Overall Study|Withdrawal by Subject|1|||
156417833|NCT01536262|564623563|FG001|Overall Study|Withdrawal by Subject|1|||
156417834|NCT01536262|564623564|FG002|Overall Study|Withdrawal by Subject|0|||
156417835|NCT01536262|564623562|FG000|Overall Study|Other than stated above|1|||
156417836|NCT01536262|564623563|FG001|Overall Study|Other than stated above|0|||
156417837|NCT01536262|564623564|FG002|Overall Study|Other than stated above|0|||
156417838|NCT01033643|564623568|FG000|Overall Study|Withdrew Consent|0|||
156417839|NCT01033643|564623569|FG001|Overall Study|Withdrew Consent|3|||
156417840|NCT01033643|564623570|FG002|Overall Study|Withdrew Consent|0|||
156417841|NCT01033643|564623571|FG003|Overall Study|Withdrew Consent|0|||
156417842|NCT01033643|564623572|FG004|Overall Study|Withdrew Consent|0|||
156417843|NCT01033643|564623573|FG005|Overall Study|Withdrew Consent|1|||
156417844|NCT01364727|564623588|FG000|Overall Study|Not Eligible|2|||
156417845|NCT01676220|564623589|FG000|Overall Study|Randomized But Not Treated|4|||
156417846|NCT01676220|564623590|FG001|Overall Study|Randomized But Not Treated|1|||
156417847|NCT01676220|564623589|FG000|Overall Study|Adverse Event|10|||
156417848|NCT01676220|564623590|FG001|Overall Study|Adverse Event|8|||
156417849|NCT01676220|564623589|FG000|Overall Study|Lack of Efficacy|2|||
156417850|NCT01676220|564623590|FG001|Overall Study|Lack of Efficacy|5|||
156417851|NCT01676220|564623589|FG000|Overall Study|Protocol Violation|11|||
156417852|NCT01676220|564623590|FG001|Overall Study|Protocol Violation|12|||
156417853|NCT01676220|564623589|FG000|Overall Study|Received Rescue Therapy|14|||
156417854|NCT01676220|564623590|FG001|Overall Study|Received Rescue Therapy|22|||
156417855|NCT01676220|564623589|FG000|Overall Study|Personal Reason|34|||
156417856|NCT01676220|564623590|FG001|Overall Study|Personal Reason|45|||
156417857|NCT01676220|564623589|FG000|Overall Study|Lost to Follow-up|11|||
156417858|NCT01676220|564623590|FG001|Overall Study|Lost to Follow-up|18|||
156417859|NCT01676220|564623589|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
156417860|NCT01676220|564623590|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
156417861|NCT01676220|564623589|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
156417862|NCT01676220|564623590|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
156417863|NCT01676220|564623589|FG000|Overall Study|Perceived Lack of Efficacy|3|||
156417864|NCT01676220|564623590|FG001|Overall Study|Perceived Lack of Efficacy|1|||
156417865|NCT01676220|564623589|FG000|Overall Study|Non Serious Hypoglycemia|2|||
156417866|NCT01676220|564623590|FG001|Overall Study|Non Serious Hypoglycemia|0|||
156417867|NCT01676220|564623589|FG000|Overall Study|No More Need of Insulin|1|||
156417868|NCT01676220|564623590|FG001|Overall Study|No More Need of Insulin|0|||
156417869|NCT01310868|564623591|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
156417870|NCT04227340|564623592|FG000|Overall Study|Withdrawal by Subject|3|||
156417871|NCT00750893|564623595|FG000|Overall Study|Adverse Event|5|||
156417872|NCT00750893|564623595|FG000|Overall Study|Withdrawal by Subject|10|||
156417873|NCT00750893|564623595|FG000|Overall Study|Lost to Follow-up|510|||
156417874|NCT00750893|564623595|FG000|Overall Study|Other|17|||
156417875|NCT01628874|564623602|FG000|Overall Study|Physician Decision|1|||
156417876|NCT01628874|564623603|FG001|Overall Study|Physician Decision|1|||
156417877|NCT01628874|564623602|FG000|Overall Study|Age >4 months|4|||
156417878|NCT01628874|564623603|FG001|Overall Study|Age >4 months|2|||
156417879|NCT00873093|564623604|FG000|Overall Study|Adverse Event|0|||
156417880|NCT00873093|564623605|FG001|Overall Study|Adverse Event|2|||
156417881|NCT00873093|564623606|FG002|Overall Study|Adverse Event|0|||
156417882|NCT00873093|564623607|FG003|Overall Study|Adverse Event|0|||
156417883|NCT00873093|564623608|FG004|Overall Study|Adverse Event|0|||
156417884|NCT00873093|564623604|FG000|Overall Study|Death|0|||
156417885|NCT00873093|564623605|FG001|Overall Study|Death|3|||
156417886|NCT00873093|564623606|FG002|Overall Study|Death|2|||
156417887|NCT00873093|564623607|FG003|Overall Study|Death|0|||
156417888|NCT00873093|564623608|FG004|Overall Study|Death|0|||
156417889|NCT00873093|564623604|FG000|Overall Study|Physician Decision|0|||
156417890|NCT00873093|564623605|FG001|Overall Study|Physician Decision|17|||
156417891|NCT00873093|564623606|FG002|Overall Study|Physician Decision|10|||
156417892|NCT00873093|564623607|FG003|Overall Study|Physician Decision|10|||
156417893|NCT00873093|564623608|FG004|Overall Study|Physician Decision|2|||
156757216|NCT04346199|565862850|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
156757217|NCT04346199|565862851|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
156316556|NCT03011892|564257770|FG004|Double Blind (DB) Period|Adverse Event|0|||
156316557|NCT03011892|564257771|FG005|Double Blind (DB) Period|Adverse Event|0|||
156316558|NCT03011892|564257772|FG006|Double Blind (DB) Period|Adverse Event|0|||
156316559|NCT03011892|564257773|FG007|Double Blind (DB) Period|Adverse Event|0|||
156316560|NCT03011892|564257774|FG008|Double Blind (DB) Period|Adverse Event|0|||
156316561|NCT03011892|564257775|FG009|Double Blind (DB) Period|Adverse Event|0|||
156316562|NCT03011892|564257776|FG010|Double Blind (DB) Period|Adverse Event|0|||
156316563|NCT03011892|564257777|FG011|Double Blind (DB) Period|Adverse Event|0|||
156316564|NCT03011892|564257766|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
156316565|NCT03011892|564257767|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
156316566|NCT03011892|564257768|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
156316567|NCT03011892|564257769|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
156316568|NCT03011892|564257770|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
156316569|NCT03011892|564257771|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
156316570|NCT03011892|564257772|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
156316571|NCT03011892|564257773|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
156316572|NCT03011892|564257774|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
156316573|NCT03011892|564257775|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
156316574|NCT03011892|564257776|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
156316575|NCT03011892|564257777|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
156316576|NCT03011892|564257766|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
156316577|NCT03011892|564257767|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
156316578|NCT03011892|564257768|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
156316579|NCT03011892|564257769|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
156316580|NCT03011892|564257770|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
156316581|NCT03011892|564257771|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
156316582|NCT03011892|564257772|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
156316583|NCT03011892|564257773|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
156316584|NCT03011892|564257774|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
156316585|NCT03011892|564257775|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
156316586|NCT03011892|564257776|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
156316587|NCT03011892|564257777|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
156316588|NCT03011892|564257766|FG000|Double Blind (DB) Period|Other|1|||
156316589|NCT03011892|564257767|FG001|Double Blind (DB) Period|Other|1|||
156316590|NCT03011892|564257768|FG002|Double Blind (DB) Period|Other|1|||
156316591|NCT03011892|564257769|FG003|Double Blind (DB) Period|Other|0|||
156316592|NCT03011892|564257770|FG004|Double Blind (DB) Period|Other|1|||
156316593|NCT03011892|564257771|FG005|Double Blind (DB) Period|Other|0|||
156316594|NCT03011892|564257772|FG006|Double Blind (DB) Period|Other|0|||
156316595|NCT03011892|564257773|FG007|Double Blind (DB) Period|Other|0|||
156316596|NCT03011892|564257774|FG008|Double Blind (DB) Period|Other|0|||
156316597|NCT03011892|564257775|FG009|Double Blind (DB) Period|Other|0|||
156316598|NCT03011892|564257776|FG010|Double Blind (DB) Period|Other|0|||
156316599|NCT03011892|564257777|FG011|Double Blind (DB) Period|Other|0|||
156316600|NCT03011892|564257766|FG000|Double Blind (DB) Period|Physician Decision|1|||
156316601|NCT03011892|564257767|FG001|Double Blind (DB) Period|Physician Decision|0|||
156316602|NCT03011892|564257768|FG002|Double Blind (DB) Period|Physician Decision|1|||
156316603|NCT03011892|564257769|FG003|Double Blind (DB) Period|Physician Decision|0|||
156316604|NCT03011892|564257770|FG004|Double Blind (DB) Period|Physician Decision|0|||
156316605|NCT03011892|564257771|FG005|Double Blind (DB) Period|Physician Decision|0|||
156316606|NCT03011892|564257772|FG006|Double Blind (DB) Period|Physician Decision|0|||
156316607|NCT03011892|564257773|FG007|Double Blind (DB) Period|Physician Decision|0|||
156316608|NCT03011892|564257774|FG008|Double Blind (DB) Period|Physician Decision|0|||
156316609|NCT03011892|564257775|FG009|Double Blind (DB) Period|Physician Decision|0|||
156316610|NCT03011892|564257776|FG010|Double Blind (DB) Period|Physician Decision|0|||
156316611|NCT03011892|564257777|FG011|Double Blind (DB) Period|Physician Decision|0|||
156316612|NCT03011892|564257766|FG000|Double Blind (DB) Period|Pregnancy|0|||
156316613|NCT03011892|564257767|FG001|Double Blind (DB) Period|Pregnancy|0|||
156316614|NCT03011892|564257768|FG002|Double Blind (DB) Period|Pregnancy|0|||
156316615|NCT03011892|564257769|FG003|Double Blind (DB) Period|Pregnancy|0|||
156316616|NCT03011892|564257770|FG004|Double Blind (DB) Period|Pregnancy|1|||
156316617|NCT03011892|564257771|FG005|Double Blind (DB) Period|Pregnancy|0|||
156316618|NCT03011892|564257772|FG006|Double Blind (DB) Period|Pregnancy|0|||
156316619|NCT03011892|564257773|FG007|Double Blind (DB) Period|Pregnancy|0|||
156316620|NCT03011892|564257774|FG008|Double Blind (DB) Period|Pregnancy|0|||
156316621|NCT03011892|564257775|FG009|Double Blind (DB) Period|Pregnancy|0|||
156316622|NCT03011892|564257776|FG010|Double Blind (DB) Period|Pregnancy|0|||
156316623|NCT03011892|564257777|FG011|Double Blind (DB) Period|Pregnancy|0|||
156316624|NCT03011892|564257766|FG000|Double Blind (DB) Period|Protocol Violation|1|||
156316625|NCT03011892|564257767|FG001|Double Blind (DB) Period|Protocol Violation|0|||
156417894|NCT00873093|564623604|FG000|Overall Study|Withdrawal by Subject|1|||
156417895|NCT00873093|564623605|FG001|Overall Study|Withdrawal by Subject|4|||
156417896|NCT00873093|564623606|FG002|Overall Study|Withdrawal by Subject|4|||
156417897|NCT00873093|564623607|FG003|Overall Study|Withdrawal by Subject|0|||
156417898|NCT00873093|564623608|FG004|Overall Study|Withdrawal by Subject|0|||
156417899|NCT00873093|564623604|FG000|Overall Study|Ineligible|0|||
156417900|NCT00873093|564623605|FG001|Overall Study|Ineligible|1|||
156417901|NCT00873093|564623606|FG002|Overall Study|Ineligible|0|||
156417902|NCT00873093|564623607|FG003|Overall Study|Ineligible|1|||
156417903|NCT00873093|564623608|FG004|Overall Study|Ineligible|0|||
156417904|NCT01152554|564623610|FG000|Overall Study|Withdrawal by Subject|73|||
156417905|NCT01152554|564623611|FG001|Overall Study|Withdrawal by Subject|28|||
156417906|NCT01152554|564623610|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
156417907|NCT01152554|564623611|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
156417908|NCT01152554|564623610|FG000|Overall Study|Adverse Event|67|||
156417909|NCT01152554|564623611|FG001|Overall Study|Adverse Event|14|||
156417910|NCT01152554|564623610|FG000|Overall Study|Severe non-compliance to protocol|36|||
156417911|NCT01152554|564623611|FG001|Overall Study|Severe non-compliance to protocol|14|||
156417912|NCT01152554|564623610|FG000|Overall Study|Condition under investigation worsened|5|||
156417913|NCT01152554|564623611|FG001|Overall Study|Condition under investigation worsened|2|||
156417914|NCT01152554|564623610|FG000|Overall Study|Lack of Efficacy|20|||
156417915|NCT01152554|564623611|FG001|Overall Study|Lack of Efficacy|3|||
156417916|NCT01152554|564623610|FG000|Overall Study|Study-specific withdrawal criteria|17|||
156417917|NCT01152554|564623611|FG001|Overall Study|Study-specific withdrawal criteria|8|||
156417918|NCT01152554|564623610|FG000|Overall Study|Lost to Follow-up|87|||
156417919|NCT01152554|564623611|FG001|Overall Study|Lost to Follow-up|32|||
156417920|NCT01152554|564623610|FG000|Overall Study|Other|28|||
156417921|NCT01152554|564623611|FG001|Overall Study|Other|8|||
156417922|NCT01152554|564623610|FG000|Overall Study|Death|1|||
156417923|NCT01152554|564623611|FG001|Overall Study|Death|1|||
156417924|NCT00146640|564623614|FG000|Overall Study|Adverse Event|12|||
156417925|NCT00146640|564623615|FG001|Overall Study|Adverse Event|10|||
156417926|NCT00146640|564623614|FG000|Overall Study|Medical Reasons|3|||
156417927|NCT00146640|564623615|FG001|Overall Study|Medical Reasons|0|||
156417928|NCT00146640|564623614|FG000|Overall Study|Non-Medical Reasons|8|||
156417929|NCT00146640|564623615|FG001|Overall Study|Non-Medical Reasons|4|||
156417930|NCT02117544|564623616|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
156417931|NCT02117544|564623617|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
156417932|NCT03486899|564623618|FG000|Overall Study|Lost to Follow-up|4|||
156417933|NCT03486899|564623619|FG001|Overall Study|Lost to Follow-up|1|||
156417934|NCT03486899|564623620|FG002|Overall Study|Lost to Follow-up|4|||
156417935|NCT03486899|564623621|FG003|Overall Study|Lost to Follow-up|3|||
156417936|NCT03486899|564623618|FG000|Overall Study|Death|1|||
156417937|NCT03486899|564623619|FG001|Overall Study|Death|0|||
156417938|NCT03486899|564623620|FG002|Overall Study|Death|0|||
156417939|NCT03486899|564623621|FG003|Overall Study|Death|1|||
156417940|NCT03486899|564623618|FG000|Overall Study|Adverse Event|0|||
156417941|NCT03486899|564623619|FG001|Overall Study|Adverse Event|2|||
156417942|NCT03486899|564623620|FG002|Overall Study|Adverse Event|0|||
156417943|NCT03486899|564623621|FG003|Overall Study|Adverse Event|2|||
156417944|NCT03486899|564623618|FG000|Overall Study|Withdrawal by Subject|3|||
156417945|NCT03486899|564623619|FG001|Overall Study|Withdrawal by Subject|7|||
156417946|NCT03486899|564623620|FG002|Overall Study|Withdrawal by Subject|4|||
156417947|NCT03486899|564623621|FG003|Overall Study|Withdrawal by Subject|3|||
156417948|NCT03486899|564623618|FG000|Overall Study|Other Reasons|0|||
156417949|NCT03486899|564623619|FG001|Overall Study|Other Reasons|1|||
156417950|NCT03486899|564623620|FG002|Overall Study|Other Reasons|0|||
156417951|NCT03486899|564623621|FG003|Overall Study|Other Reasons|1|||
156417952|NCT02397460|564623622|FG000|Treatment Period 2|Adverse Event|0|||
156417953|NCT02397460|564623623|FG001|Treatment Period 2|Adverse Event|0|||
156417954|NCT02397460|564623624|FG002|Treatment Period 2|Adverse Event|0|||
156417955|NCT02397460|564623625|FG003|Treatment Period 2|Adverse Event|0|||
156417956|NCT02397460|564623626|FG004|Treatment Period 2|Adverse Event|0|||
156417957|NCT02397460|564623627|FG005|Treatment Period 2|Adverse Event|0|||
156653126|NCT01691508|565477911|FG000|Overall Study|Withdrawal by Subject|1|||
156653127|NCT01691508|565477912|FG001|Overall Study|Withdrawal by Subject|0|||
156417958|NCT02397460|564623628|FG006|Treatment Period 2|Adverse Event|0|||
156417959|NCT02397460|564623629|FG007|Treatment Period 2|Adverse Event|1|||
156417960|NCT02397460|564623622|FG000|Treatment Period 4|Adverse Event|0|||
156417961|NCT02397460|564623623|FG001|Treatment Period 4|Adverse Event|1|||
156417962|NCT02397460|564623624|FG002|Treatment Period 4|Adverse Event|0|||
156417963|NCT02397460|564623625|FG003|Treatment Period 4|Adverse Event|0|||
156417964|NCT02397460|564623626|FG004|Treatment Period 4|Adverse Event|0|||
156417965|NCT02397460|564623627|FG005|Treatment Period 4|Adverse Event|0|||
156417966|NCT02397460|564623628|FG006|Treatment Period 4|Adverse Event|0|||
156417967|NCT02397460|564623629|FG007|Treatment Period 4|Adverse Event|0|||
156417968|NCT02397460|564623622|FG000|Treatment Period 4|Physician Decision|0|||
156417969|NCT02397460|564623623|FG001|Treatment Period 4|Physician Decision|0|||
156417970|NCT02397460|564623624|FG002|Treatment Period 4|Physician Decision|0|||
156417971|NCT02397460|564623625|FG003|Treatment Period 4|Physician Decision|0|||
156757218|NCT04346199|565862850|FG000|Overall Study|Withdrawal by Subject|5|||
156757219|NCT04346199|565862851|FG001|Overall Study|Withdrawal by Subject|1|||
156757220|NCT00627926|565862852|FG000|Overall Study|Adverse Event|26|||
156757221|NCT00627926|565862853|FG001|Overall Study|Adverse Event|37|||
156757222|NCT00627926|565862854|FG002|Overall Study|Adverse Event|36|||
156757223|NCT00627926|565862852|FG000|Overall Study|Death|1|||
156757224|NCT00627926|565862853|FG001|Overall Study|Death|0|||
156757225|NCT00627926|565862854|FG002|Overall Study|Death|0|||
156757226|NCT00627926|565862852|FG000|Overall Study|Lost to Follow-up|4|||
156757227|NCT00627926|565862853|FG001|Overall Study|Lost to Follow-up|3|||
156757228|NCT00627926|565862854|FG002|Overall Study|Lost to Follow-up|4|||
156757229|NCT00627926|565862852|FG000|Overall Study|Withdrawal by Subject|2|||
156757230|NCT00627926|565862853|FG001|Overall Study|Withdrawal by Subject|1|||
156757231|NCT00627926|565862854|FG002|Overall Study|Withdrawal by Subject|0|||
156757232|NCT00627926|565862852|FG000|Overall Study|Lack of Efficacy|118|||
156757233|NCT00627926|565862853|FG001|Overall Study|Lack of Efficacy|40|||
156757234|NCT00627926|565862854|FG002|Overall Study|Lack of Efficacy|38|||
156757235|NCT00627926|565862852|FG000|Overall Study|Noncompliance/unspecified|8|||
156757236|NCT00627926|565862853|FG001|Overall Study|Noncompliance/unspecified|23|||
156757237|NCT00627926|565862854|FG002|Overall Study|Noncompliance/unspecified|17|||
156757238|NCT01189461|565862856|FG000|Overall Study|Lack of Efficacy|13|||
156757239|NCT01189461|565862856|FG000|Overall Study|Lost to Follow-up|1|||
156757240|NCT01189461|565862856|FG000|Overall Study|Withdrawal by Subject|6|||
156757241|NCT01189461|565862856|FG000|Overall Study|Protocol Violation|1|||
156757242|NCT01189461|565862856|FG000|Overall Study|Adverse Event|2|||
156757243|NCT01189461|565862856|FG000|Overall Study|Did not meet entrance criteria|3|||
156757244|NCT01189461|565862856|FG000|Overall Study|Other|8|||
156757245|NCT01868165|565862862|FG000|Overall Study|Withdrawal by Subject|36|||
156757246|NCT01868165|565862862|FG000|Overall Study|Physician Decision|2|||
156757247|NCT01868165|565862862|FG000|Overall Study|Lost to Follow-up|3|||
156757248|NCT01868165|565862862|FG000|Overall Study|Death|4|||
156757249|NCT00396383|565862863|FG000|Overall Study|Death|2|||
156757250|NCT00396383|565862863|FG000|Overall Study|Lost to Follow-up|1|||
156757251|NCT01839916|565862864|FG000|Overall Study|Death|9|||
156757252|NCT01839916|565862864|FG000|Overall Study|Physician Decision|17|||
156757253|NCT01839916|565862864|FG000|Overall Study|Relapse|12|||
156757254|NCT01839916|565862864|FG000|Overall Study|GVHD|2|||
156757255|NCT01839916|565862864|FG000|Overall Study|Graft Failure|1|||
156757256|NCT02385110|565862867|FG000|Overall Study|Early Death|1|||
156757257|NCT02385110|565862868|FG001|Overall Study|Early Death|0|||
156757258|NCT00534638|565862869|FG000|Overall Study|Withdrawal by Subject|3|||
156757259|NCT00534638|565862870|FG001|Overall Study|Withdrawal by Subject|4|||
156757260|NCT00534638|565862869|FG000|Overall Study|Migrated/moved from study area|13|||
156757261|NCT00534638|565862870|FG001|Overall Study|Migrated/moved from study area|11|||
156757262|NCT00534638|565862869|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
156757263|NCT00534638|565862870|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
156757264|NCT00534638|565862869|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
156757265|NCT00534638|565862870|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
156757266|NCT00534638|565862869|FG000|Overall Study|Other|1685|||
156757267|NCT00534638|565862870|FG001|Overall Study|Other|902|||
156757268|NCT01124292|565862872|FG000|Overall Study|Lost to Follow-up|2|||
156757269|NCT01124292|565862873|FG001|Overall Study|Lost to Follow-up|4|||
156757270|NCT01124292|565862874|FG002|Overall Study|Lost to Follow-up|3|||
156757271|NCT01124292|565862872|FG000|Overall Study|Physician Decision|0|||
156757272|NCT01124292|565862873|FG001|Overall Study|Physician Decision|3|||
156757273|NCT01124292|565862874|FG002|Overall Study|Physician Decision|2|||
156757274|NCT01124292|565862872|FG000|Overall Study|Withdrawal by Subject|0|||
156757275|NCT01124292|565862873|FG001|Overall Study|Withdrawal by Subject|6|||
156757276|NCT01124292|565862874|FG002|Overall Study|Withdrawal by Subject|2|||
156757277|NCT01124292|565862872|FG000|Overall Study|medical issue unrelated to the study|0|||
156757278|NCT01124292|565862873|FG001|Overall Study|medical issue unrelated to the study|0|||
156757279|NCT01124292|565862874|FG002|Overall Study|medical issue unrelated to the study|2|||
156757280|NCT01124292|565862872|FG000|Overall Study|piercing track closed|0|||
156757281|NCT01124292|565862873|FG001|Overall Study|piercing track closed|2|||
156757282|NCT01124292|565862874|FG002|Overall Study|piercing track closed|1|||
156757283|NCT00481767|565862875|FG000|Overall Study|Withdrawal by Subject|16|||
156757284|NCT00481767|565862876|FG001|Overall Study|Withdrawal by Subject|11|||
156757285|NCT00481767|565862875|FG000|Overall Study|Lost to Follow-up|16|||
156757286|NCT00481767|565862876|FG001|Overall Study|Lost to Follow-up|10|||
156757287|NCT00636636|565862877|FG000|Overall Study|Other reason|4|||
156757288|NCT00636636|565862878|FG001|Overall Study|Other reason|6|||
156757289|NCT00636636|565862877|FG000|Overall Study|Adverse Event|19|||
156757290|NCT00636636|565862878|FG001|Overall Study|Adverse Event|8|||
156757291|NCT00636636|565862877|FG000|Overall Study|Lack of Efficacy|7|||
156757292|NCT00636636|565862878|FG001|Overall Study|Lack of Efficacy|12|||
156757293|NCT00636636|565862877|FG000|Overall Study|Protocol Violation|2|||
156757294|NCT00636636|565862878|FG001|Overall Study|Protocol Violation|2|||
156757295|NCT00636636|565862877|FG000|Overall Study|Lost to Follow-up|0|||
156316626|NCT03011892|564257768|FG002|Double Blind (DB) Period|Protocol Violation|0|||
156316627|NCT03011892|564257769|FG003|Double Blind (DB) Period|Protocol Violation|0|||
156316628|NCT03011892|564257770|FG004|Double Blind (DB) Period|Protocol Violation|0|||
156316629|NCT03011892|564257771|FG005|Double Blind (DB) Period|Protocol Violation|0|||
156316630|NCT03011892|564257772|FG006|Double Blind (DB) Period|Protocol Violation|0|||
156316631|NCT03011892|564257773|FG007|Double Blind (DB) Period|Protocol Violation|0|||
156316632|NCT03011892|564257774|FG008|Double Blind (DB) Period|Protocol Violation|0|||
156316633|NCT03011892|564257775|FG009|Double Blind (DB) Period|Protocol Violation|0|||
156316634|NCT03011892|564257776|FG010|Double Blind (DB) Period|Protocol Violation|0|||
156316635|NCT03011892|564257777|FG011|Double Blind (DB) Period|Protocol Violation|0|||
156316636|NCT03011892|564257766|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
156316637|NCT03011892|564257767|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
156316638|NCT03011892|564257768|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
156316639|NCT03011892|564257769|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
156316640|NCT03011892|564257770|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
156316641|NCT03011892|564257771|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
156316642|NCT03011892|564257772|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
156316643|NCT03011892|564257773|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
156316644|NCT03011892|564257774|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
156316645|NCT03011892|564257775|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
156316646|NCT03011892|564257776|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
156316647|NCT03011892|564257777|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
156316648|NCT03011892|564257766|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
156316649|NCT03011892|564257767|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
156316650|NCT03011892|564257768|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
156316651|NCT03011892|564257769|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
156653128|NCT01296932|565477913|FG000|Overall Study|Dose limiting toxicity|0|||
156653129|NCT01296932|565477914|FG001|Overall Study|Dose limiting toxicity|0|||
156653130|NCT01296932|565477915|FG002|Overall Study|Dose limiting toxicity|0|||
156653131|NCT01296932|565477916|FG003|Overall Study|Dose limiting toxicity|0|||
156653132|NCT01296932|565477917|FG004|Overall Study|Dose limiting toxicity|0|||
156653133|NCT01296932|565477918|FG005|Overall Study|Dose limiting toxicity|0|||
156653134|NCT01296932|565477919|FG006|Overall Study|Dose limiting toxicity|1|||
156653135|NCT01296932|565477920|FG007|Overall Study|Dose limiting toxicity|0|||
156653136|NCT01296932|565477921|FG008|Overall Study|Dose limiting toxicity|1|||
156653137|NCT01296932|565477913|FG000|Overall Study|Progressive disease|2|||
156653138|NCT01296932|565477914|FG001|Overall Study|Progressive disease|0|||
156653139|NCT01296932|565477915|FG002|Overall Study|Progressive disease|1|||
156653140|NCT01296932|565477916|FG003|Overall Study|Progressive disease|1|||
156653141|NCT01296932|565477917|FG004|Overall Study|Progressive disease|2|||
156653142|NCT01296932|565477918|FG005|Overall Study|Progressive disease|3|||
156653143|NCT01296932|565477919|FG006|Overall Study|Progressive disease|1|||
156653144|NCT01296932|565477920|FG007|Overall Study|Progressive disease|0|||
156653145|NCT01296932|565477921|FG008|Overall Study|Progressive disease|0|||
156653146|NCT01296932|565477913|FG000|Overall Study|Withdrawal by Subject|0|||
156653147|NCT01296932|565477914|FG001|Overall Study|Withdrawal by Subject|0|||
156653148|NCT01296932|565477915|FG002|Overall Study|Withdrawal by Subject|1|||
156653149|NCT01296932|565477916|FG003|Overall Study|Withdrawal by Subject|1|||
156653150|NCT01296932|565477917|FG004|Overall Study|Withdrawal by Subject|0|||
156653151|NCT01296932|565477918|FG005|Overall Study|Withdrawal by Subject|0|||
156653152|NCT01296932|565477919|FG006|Overall Study|Withdrawal by Subject|3|||
156653153|NCT01296932|565477920|FG007|Overall Study|Withdrawal by Subject|0|||
156653154|NCT01296932|565477921|FG008|Overall Study|Withdrawal by Subject|0|||
156653155|NCT01296932|565477913|FG000|Overall Study|Adverse Event|1|||
156653156|NCT01296932|565477914|FG001|Overall Study|Adverse Event|1|||
156653157|NCT01296932|565477915|FG002|Overall Study|Adverse Event|1|||
156653158|NCT01296932|565477916|FG003|Overall Study|Adverse Event|2|||
156653159|NCT01296932|565477917|FG004|Overall Study|Adverse Event|1|||
156653160|NCT01296932|565477918|FG005|Overall Study|Adverse Event|0|||
156653161|NCT01296932|565477919|FG006|Overall Study|Adverse Event|0|||
156653162|NCT01296932|565477920|FG007|Overall Study|Adverse Event|0|||
156653163|NCT01296932|565477921|FG008|Overall Study|Adverse Event|1|||
156653164|NCT01296932|565477913|FG000|Overall Study|Investigator decision|0|||
156653165|NCT01296932|565477914|FG001|Overall Study|Investigator decision|1|||
156653166|NCT01296932|565477915|FG002|Overall Study|Investigator decision|0|||
156653167|NCT01296932|565477916|FG003|Overall Study|Investigator decision|1|||
156653168|NCT01296932|565477917|FG004|Overall Study|Investigator decision|0|||
156757296|NCT00636636|565862878|FG001|Overall Study|Lost to Follow-up|1|||
156316652|NCT03011892|564257770|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
156316653|NCT03011892|564257771|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
156316654|NCT03011892|564257772|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
156653169|NCT01296932|565477918|FG005|Overall Study|Investigator decision|0|||
156653170|NCT01296932|565477919|FG006|Overall Study|Investigator decision|1|||
156653171|NCT01296932|565477920|FG007|Overall Study|Investigator decision|0|||
156417972|NCT02397460|564623626|FG004|Treatment Period 4|Physician Decision|1|||
156417973|NCT02397460|564623627|FG005|Treatment Period 4|Physician Decision|0|||
156417974|NCT02397460|564623628|FG006|Treatment Period 4|Physician Decision|0|||
156417975|NCT02397460|564623629|FG007|Treatment Period 4|Physician Decision|0|||
156417976|NCT01723826|564623633|FG000|Overall Study|Adverse Event|4|||
156417977|NCT01723826|564623634|FG001|Overall Study|Adverse Event|1|||
156417978|NCT01723826|564623635|FG002|Overall Study|Adverse Event|4|||
156417979|NCT01723826|564623636|FG003|Overall Study|Adverse Event|5|||
156417980|NCT01723826|564623633|FG000|Overall Study|Death according to AE eCRF|2|||
156417981|NCT01723826|564623634|FG001|Overall Study|Death according to AE eCRF|3|||
156417982|NCT01723826|564623635|FG002|Overall Study|Death according to AE eCRF|3|||
156417983|NCT01723826|564623636|FG003|Overall Study|Death according to AE eCRF|7|||
156417984|NCT01723826|564623633|FG000|Overall Study|Lost to Follow-up|1|||
156417985|NCT01723826|564623634|FG001|Overall Study|Lost to Follow-up|3|||
156417986|NCT01723826|564623635|FG002|Overall Study|Lost to Follow-up|1|||
156417987|NCT01723826|564623636|FG003|Overall Study|Lost to Follow-up|1|||
156417988|NCT01723826|564623633|FG000|Overall Study|Non-compliance|0|||
156417989|NCT01723826|564623634|FG001|Overall Study|Non-compliance|1|||
156417990|NCT01723826|564623635|FG002|Overall Study|Non-compliance|3|||
156417991|NCT01723826|564623636|FG003|Overall Study|Non-compliance|3|||
156417992|NCT01723826|564623633|FG000|Overall Study|Non-compliance With Study Drug|0|||
156417993|NCT01723826|564623634|FG001|Overall Study|Non-compliance With Study Drug|1|||
156417994|NCT01723826|564623635|FG002|Overall Study|Non-compliance With Study Drug|0|||
156417995|NCT01723826|564623636|FG003|Overall Study|Non-compliance With Study Drug|0|||
156417996|NCT01723826|564623633|FG000|Overall Study|Other Reason|8|||
156417997|NCT01723826|564623634|FG001|Overall Study|Other Reason|6|||
156417998|NCT01723826|564623635|FG002|Overall Study|Other Reason|12|||
156417999|NCT01723826|564623636|FG003|Overall Study|Other Reason|14|||
156418000|NCT01723826|564623633|FG000|Overall Study|Physician Decision|1|||
156418001|NCT01723826|564623634|FG001|Overall Study|Physician Decision|3|||
156418002|NCT01723826|564623635|FG002|Overall Study|Physician Decision|4|||
156418003|NCT01723826|564623636|FG003|Overall Study|Physician Decision|11|||
156418004|NCT01723826|564623633|FG000|Overall Study|Protocol Violation|1|||
156418005|NCT01723826|564623634|FG001|Overall Study|Protocol Violation|1|||
156418006|NCT01723826|564623635|FG002|Overall Study|Protocol Violation|3|||
156418007|NCT01723826|564623636|FG003|Overall Study|Protocol Violation|1|||
156418008|NCT01723826|564623633|FG000|Overall Study|Withdrawal by Subject|10|||
156418009|NCT01723826|564623634|FG001|Overall Study|Withdrawal by Subject|17|||
156418010|NCT01723826|564623635|FG002|Overall Study|Withdrawal by Subject|27|||
156418011|NCT01723826|564623636|FG003|Overall Study|Withdrawal by Subject|48|||
156418012|NCT01767129|564623637|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
156418013|NCT01767129|564623638|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
156418014|NCT01473420|564623642|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
156418015|NCT01473420|564623643|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
156418016|NCT01473420|564623642|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
156418017|NCT01473420|564623643|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
156418018|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
156418019|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
156418020|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
156418021|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
156418022|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
156418023|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
156418024|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
156418025|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
156418026|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
156418027|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
156418028|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
156418029|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
156418030|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
156418031|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
156418032|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
156418033|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
156418034|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
156418035|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
156418036|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
156418037|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
156418038|NCT01473420|564623642|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
156418039|NCT01473420|564623643|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
156418040|NCT04172987|564623644|FG000|Lead In Period|Adverse Event|1|||
156757297|NCT00636636|565862877|FG000|Overall Study|Death|0|||
156418041|NCT04172987|564623644|FG000|Lead In Period|Protocol Violation|1|||
156418042|NCT04172987|564623644|FG000|Period 1|Physician Decision|1|||
156418043|NCT04172987|564623644|FG000|Period 2|Adverse Event|5|||
156418044|NCT04172987|564623644|FG000|Period 2|Dosing Termination by Sponsor|4|||
156418045|NCT01656759|564623645|FG000|Overall Study|Protocol Violation|2|||
156418046|NCT01656759|564623646|FG001|Overall Study|Protocol Violation|3|||
156418047|NCT03160079|564623657|FG000|Overall Study|Adverse Event|2|||
156418048|NCT03160079|564623658|FG001|Overall Study|Adverse Event|0|||
156418049|NCT03160079|564623657|FG000|Overall Study|Disease Progression|1|||
156418050|NCT03160079|564623658|FG001|Overall Study|Disease Progression|0|||
156418051|NCT03160079|564623657|FG000|Overall Study|Physician Decision|1|||
156418052|NCT03160079|564623658|FG001|Overall Study|Physician Decision|0|||
156418053|NCT01923428|564623669|FG000|Overall Study|Adverse Event|8|||
156418054|NCT01923428|564623670|FG001|Overall Study|Adverse Event|6|||
156418055|NCT01923428|564623671|FG002|Overall Study|Adverse Event|3|||
156418056|NCT01923428|564623672|FG003|Overall Study|Adverse Event|3|||
156418057|NCT01923428|564623669|FG000|Overall Study|Withdrawal by Subject|5|||
156418058|NCT01923428|564623670|FG001|Overall Study|Withdrawal by Subject|3|||
156418059|NCT01923428|564623671|FG002|Overall Study|Withdrawal by Subject|0|||
156418060|NCT01923428|564623672|FG003|Overall Study|Withdrawal by Subject|4|||
156418061|NCT01923428|564623669|FG000|Overall Study|Lost to Follow-up|2|||
156418062|NCT01923428|564623670|FG001|Overall Study|Lost to Follow-up|1|||
156418063|NCT01923428|564623671|FG002|Overall Study|Lost to Follow-up|5|||
156418064|NCT01923428|564623672|FG003|Overall Study|Lost to Follow-up|0|||
156418065|NCT01923428|564623669|FG000|Overall Study|Protocol Violation|3|||
156418066|NCT01923428|564623670|FG001|Overall Study|Protocol Violation|0|||
156418067|NCT01923428|564623671|FG002|Overall Study|Protocol Violation|2|||
156418068|NCT01923428|564623672|FG003|Overall Study|Protocol Violation|1|||
156418069|NCT01923428|564623669|FG000|Overall Study|Non Compliance to treatment|1|||
156418070|NCT01923428|564623670|FG001|Overall Study|Non Compliance to treatment|2|||
156418071|NCT01923428|564623671|FG002|Overall Study|Non Compliance to treatment|0|||
156418072|NCT01923428|564623672|FG003|Overall Study|Non Compliance to treatment|1|||
156418073|NCT01923428|564623669|FG000|Overall Study|Lack of Efficacy|0|||
156418074|NCT01923428|564623670|FG001|Overall Study|Lack of Efficacy|0|||
156418075|NCT01923428|564623671|FG002|Overall Study|Lack of Efficacy|1|||
156418076|NCT01923428|564623672|FG003|Overall Study|Lack of Efficacy|1|||
156418077|NCT00946647|564623676|FG000|Phase 1 Part|Adverse Event|2|||
156757298|NCT00636636|565862878|FG001|Overall Study|Death|1|||
156757299|NCT00636636|565862877|FG000|Overall Study|Withdrawal by Subject|4|||
156757300|NCT00636636|565862878|FG001|Overall Study|Withdrawal by Subject|9|||
156757301|NCT00524173|565862879|FG000|Overall Study|Lost to Follow-up|0|||
156757302|NCT00524173|565862880|FG001|Overall Study|Lost to Follow-up|1|||
156757303|NCT00524173|565862879|FG000|Overall Study|Death|1|||
156757304|NCT00524173|565862880|FG001|Overall Study|Death|0|||
156757305|NCT00524173|565862879|FG000|Overall Study|Had not reached endpoint at study close|4|||
156757306|NCT00524173|565862880|FG001|Overall Study|Had not reached endpoint at study close|1|||
156757307|NCT00103285|565864737|FG000|Induction|Adverse Event|14|||
156757308|NCT00103285|565864738|FG001|Induction|Adverse Event|0|||
156757309|NCT00103285|565864739|FG002|Induction|Adverse Event|0|||
156757310|NCT00103285|565864740|FG003|Induction|Adverse Event|0|||
156757311|NCT00103285|565864741|FG004|Induction|Adverse Event|0|||
156757312|NCT00103285|565864742|FG005|Induction|Adverse Event|0|||
156757313|NCT00103285|565864743|FG006|Induction|Adverse Event|0|||
156757314|NCT00103285|565864744|FG007|Induction|Adverse Event|0|||
156757315|NCT00103285|565864737|FG000|Induction|Death|24|||
156757316|NCT00103285|565864738|FG001|Induction|Death|0|||
156757317|NCT00103285|565864739|FG002|Induction|Death|0|||
156757318|NCT00103285|565864740|FG003|Induction|Death|0|||
156757319|NCT00103285|565864741|FG004|Induction|Death|0|||
156757320|NCT00103285|565864742|FG005|Induction|Death|0|||
156757321|NCT00103285|565864743|FG006|Induction|Death|0|||
156757322|NCT00103285|565864744|FG007|Induction|Death|0|||
156757323|NCT00103285|565864737|FG000|Induction|Physician Decision|103|||
156757324|NCT00103285|565864738|FG001|Induction|Physician Decision|0|||
156418078|NCT00946647|564623677|FG001|Phase 1 Part|Adverse Event|5|||
156418079|NCT00946647|564623678|FG002|Phase 1 Part|Adverse Event|3|||
156418080|NCT00946647|564623679|FG003|Phase 1 Part|Adverse Event|0|||
156757325|NCT00103285|565864739|FG002|Induction|Physician Decision|0|||
156757326|NCT00103285|565864740|FG003|Induction|Physician Decision|0|||
156757327|NCT00103285|565864741|FG004|Induction|Physician Decision|0|||
156418081|NCT00946647|564623680|FG004|Phase 1 Part|Adverse Event|0|||
156418082|NCT00946647|564623676|FG000|Phase 1 Part|Disease progression|3|||
156418083|NCT00946647|564623677|FG001|Phase 1 Part|Disease progression|6|||
156757328|NCT00103285|565864742|FG005|Induction|Physician Decision|0|||
156757329|NCT00103285|565864743|FG006|Induction|Physician Decision|0|||
156757330|NCT00103285|565864744|FG007|Induction|Physician Decision|0|||
156757331|NCT00103285|565864737|FG000|Induction|Withdrawal by Subject|1|||
156757332|NCT00103285|565864738|FG001|Induction|Withdrawal by Subject|0|||
156757333|NCT00103285|565864739|FG002|Induction|Withdrawal by Subject|0|||
156757334|NCT00103285|565864740|FG003|Induction|Withdrawal by Subject|0|||
156757335|NCT00103285|565864741|FG004|Induction|Withdrawal by Subject|0|||
156757336|NCT00103285|565864742|FG005|Induction|Withdrawal by Subject|0|||
156418084|NCT00946647|564623678|FG002|Phase 1 Part|Disease progression|1|||
156418085|NCT00946647|564623679|FG003|Phase 1 Part|Disease progression|0|||
156418086|NCT00946647|564623680|FG004|Phase 1 Part|Disease progression|0|||
156757337|NCT00103285|565864743|FG006|Induction|Withdrawal by Subject|0|||
156757338|NCT00103285|565864744|FG007|Induction|Withdrawal by Subject|0|||
156316655|NCT03011892|564257773|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
156316656|NCT03011892|564257774|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
156316657|NCT03011892|564257775|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
156316658|NCT03011892|564257776|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
156316659|NCT03011892|564257777|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
156316660|NCT03011892|564257766|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
156316661|NCT03011892|564257767|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
156316662|NCT03011892|564257768|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
156316663|NCT03011892|564257769|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
156316664|NCT03011892|564257770|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
156316665|NCT03011892|564257771|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
156316666|NCT03011892|564257772|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
156316667|NCT03011892|564257773|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
156316668|NCT03011892|564257774|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
156316669|NCT03011892|564257775|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
156316670|NCT03011892|564257776|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
156316671|NCT03011892|564257777|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
156316672|NCT03011892|564257766|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
156316673|NCT03011892|564257767|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
156316674|NCT03011892|564257768|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
156316675|NCT03011892|564257769|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
156316676|NCT03011892|564257770|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
156316677|NCT03011892|564257771|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
156316678|NCT03011892|564257772|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
156316679|NCT03011892|564257773|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
156316680|NCT03011892|564257774|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
156316681|NCT03011892|564257775|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
156316682|NCT03011892|564257776|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
156316683|NCT03011892|564257777|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
156316684|NCT03011892|564257766|FG000|Open Label (OL) Period|Reason not specified|0|||
156316685|NCT03011892|564257767|FG001|Open Label (OL) Period|Reason not specified|0|||
156316686|NCT03011892|564257768|FG002|Open Label (OL) Period|Reason not specified|0|||
156316687|NCT03011892|564257769|FG003|Open Label (OL) Period|Reason not specified|0|||
156316688|NCT03011892|564257770|FG004|Open Label (OL) Period|Reason not specified|0|||
156316689|NCT03011892|564257771|FG005|Open Label (OL) Period|Reason not specified|0|||
156316690|NCT03011892|564257772|FG006|Open Label (OL) Period|Reason not specified|0|||
156316691|NCT03011892|564257773|FG007|Open Label (OL) Period|Reason not specified|1|||
156316692|NCT03011892|564257774|FG008|Open Label (OL) Period|Reason not specified|0|||
156316693|NCT03011892|564257775|FG009|Open Label (OL) Period|Reason not specified|0|||
156316694|NCT03011892|564257776|FG010|Open Label (OL) Period|Reason not specified|0|||
156316695|NCT03011892|564257777|FG011|Open Label (OL) Period|Reason not specified|0|||
156316696|NCT00906971|564257788|FG000|Overall Study|Withdrawal by Subject|8|||
156316697|NCT00906971|564257789|FG001|Overall Study|Withdrawal by Subject|2|||
156316698|NCT00906971|564257788|FG000|Overall Study|Lost to Follow-up|0|||
156316699|NCT00906971|564257789|FG001|Overall Study|Lost to Follow-up|1|||
156316700|NCT03678870|564257790|FG000|Overall Study|prescribed non- protocol medications|10|||
156316701|NCT03678870|564257791|FG001|Overall Study|prescribed non- protocol medications|6|||
156316702|NCT03678870|564257790|FG000|Overall Study|Lost to Follow-up|3|||
156316703|NCT03678870|564257791|FG001|Overall Study|Lost to Follow-up|2|||
156316704|NCT03104816|564257792|FG000|Overall Study|Lack of Efficacy|0|||
156316705|NCT03104816|564257793|FG001|Overall Study|Lack of Efficacy|2|||
156316706|NCT03104816|564257794|FG002|Overall Study|Lack of Efficacy|0|||
156316707|NCT03104816|564257792|FG000|Overall Study|Protocol Violation|2|||
156316708|NCT03104816|564257793|FG001|Overall Study|Protocol Violation|0|||
156316709|NCT03104816|564257794|FG002|Overall Study|Protocol Violation|2|||
156316710|NCT01894568|564257797|FG000|Overall Study|Adverse Event|2|||
156316711|NCT01894568|564257798|FG001|Overall Study|Adverse Event|3|||
156316712|NCT01894568|564257797|FG000|Overall Study|Protocol required discontinuation|2|||
156316713|NCT01894568|564257798|FG001|Overall Study|Protocol required discontinuation|1|||
156653172|NCT01296932|565477921|FG008|Overall Study|Investigator decision|1|||
156653173|NCT01296932|565477913|FG000|Overall Study|No clinical benefit anymore|0|||
156653174|NCT01296932|565477914|FG001|Overall Study|No clinical benefit anymore|1|||
156653175|NCT01296932|565477915|FG002|Overall Study|No clinical benefit anymore|0|||
156653176|NCT01296932|565477916|FG003|Overall Study|No clinical benefit anymore|0|||
156653177|NCT01296932|565477917|FG004|Overall Study|No clinical benefit anymore|0|||
156653178|NCT01296932|565477918|FG005|Overall Study|No clinical benefit anymore|0|||
156653179|NCT01296932|565477919|FG006|Overall Study|No clinical benefit anymore|0|||
156653180|NCT01296932|565477920|FG007|Overall Study|No clinical benefit anymore|0|||
156653181|NCT01296932|565477921|FG008|Overall Study|No clinical benefit anymore|0|||
156653182|NCT01296932|565477913|FG000|Overall Study|Physician Decision|0|||
156653183|NCT01296932|565477914|FG001|Overall Study|Physician Decision|0|||
156653184|NCT01296932|565477915|FG002|Overall Study|Physician Decision|1|||
156653185|NCT01296932|565477916|FG003|Overall Study|Physician Decision|0|||
156757339|NCT00103285|565864737|FG000|Induction|Ineligible|43|||
156757340|NCT00103285|565864738|FG001|Induction|Ineligible|0|||
156757341|NCT00103285|565864739|FG002|Induction|Ineligible|0|||
156757342|NCT00103285|565864740|FG003|Induction|Ineligible|0|||
156757343|NCT00103285|565864741|FG004|Induction|Ineligible|0|||
156757344|NCT00103285|565864742|FG005|Induction|Ineligible|0|||
156757345|NCT00103285|565864743|FG006|Induction|Ineligible|0|||
156757346|NCT00103285|565864744|FG007|Induction|Ineligible|0|||
156757347|NCT00103285|565864737|FG000|Induction|Refusal|906|||
156757348|NCT00103285|565864738|FG001|Induction|Refusal|0|||
156757349|NCT00103285|565864739|FG002|Induction|Refusal|0|||
156757350|NCT00103285|565864740|FG003|Induction|Refusal|0|||
156757351|NCT00103285|565864741|FG004|Induction|Refusal|0|||
156757352|NCT00103285|565864742|FG005|Induction|Refusal|0|||
156757353|NCT00103285|565864743|FG006|Induction|Refusal|0|||
156757354|NCT00103285|565864744|FG007|Induction|Refusal|0|||
156757355|NCT00103285|565864737|FG000|Induction|Other|258|||
156757356|NCT00103285|565864738|FG001|Induction|Other|0|||
156757357|NCT00103285|565864739|FG002|Induction|Other|0|||
156757358|NCT00103285|565864740|FG003|Induction|Other|0|||
156757359|NCT00103285|565864741|FG004|Induction|Other|0|||
156757360|NCT00103285|565864742|FG005|Induction|Other|0|||
156757361|NCT00103285|565864743|FG006|Induction|Other|0|||
156757362|NCT00103285|565864744|FG007|Induction|Other|0|||
156757363|NCT00103285|565864737|FG000|Response Assignment|Adverse Event|0|||
156757364|NCT00103285|565864738|FG001|Response Assignment|Adverse Event|8|||
156757365|NCT00103285|565864739|FG002|Response Assignment|Adverse Event|3|||
156757366|NCT00103285|565864740|FG003|Response Assignment|Adverse Event|2|||
156757367|NCT00103285|565864741|FG004|Response Assignment|Adverse Event|3|||
156757368|NCT00103285|565864742|FG005|Response Assignment|Adverse Event|1|||
156757369|NCT00103285|565864743|FG006|Response Assignment|Adverse Event|1|||
156757370|NCT00103285|565864744|FG007|Response Assignment|Adverse Event|2|||
156757371|NCT00103285|565864737|FG000|Response Assignment|Death|0|||
156757372|NCT00103285|565864738|FG001|Response Assignment|Death|5|||
156757373|NCT00103285|565864739|FG002|Response Assignment|Death|2|||
156757374|NCT00103285|565864740|FG003|Response Assignment|Death|2|||
156757375|NCT00103285|565864741|FG004|Response Assignment|Death|3|||
156757376|NCT00103285|565864742|FG005|Response Assignment|Death|1|||
156757377|NCT00103285|565864743|FG006|Response Assignment|Death|0|||
156757378|NCT00103285|565864744|FG007|Response Assignment|Death|8|||
156316714|NCT01894568|564257797|FG000|Overall Study|Withdrawal by Subject|5|||
156316715|NCT01894568|564257798|FG001|Overall Study|Withdrawal by Subject|5|||
156316716|NCT01894568|564257797|FG000|Overall Study|Physician Decision|1|||
156316717|NCT01894568|564257798|FG001|Overall Study|Physician Decision|0|||
156316718|NCT01894568|564257797|FG000|Overall Study|Lost to Follow-up|0|||
156316719|NCT01894568|564257798|FG001|Overall Study|Lost to Follow-up|1|||
156316720|NCT03720652|564257799|FG000|Overall Study|Withdrawal by Subject|2|||
156316721|NCT03720652|564257800|FG001|Overall Study|Withdrawal by Subject|7|||
156316722|NCT03720652|564257799|FG000|Overall Study|Lost to Follow-up|0|||
156316723|NCT03720652|564257800|FG001|Overall Study|Lost to Follow-up|4|||
156316724|NCT03353740|564257804|FG000|Overall Study|Images for these participants not viable|52|||
156316725|NCT03976648|564257805|FG000|Overall Study|Adverse Event|0|||
156316726|NCT03976648|564257806|FG001|Overall Study|Adverse Event|2|||
156316727|NCT03976648|564257805|FG000|Overall Study|Study terminated by sponsor|21|||
156316728|NCT03976648|564257806|FG001|Overall Study|Study terminated by sponsor|8|||
156316729|NCT01155167|564257807|FG000|Overall Study|Insufficient ultrasound data|2|||
156316730|NCT01155167|564257808|FG001|Overall Study|Insufficient ultrasound data|0|||
156316731|NCT01155167|564257807|FG000|Overall Study|Access site changed to femoral artery|1|||
156316732|NCT01155167|564257808|FG001|Overall Study|Access site changed to femoral artery|0|||
156316733|NCT05347147|564259397|FG000|Overall Study|Lost to Follow-up|0|||
156316734|NCT05347147|564259398|FG001|Overall Study|Lost to Follow-up|1|||
156316735|NCT05347147|564259397|FG000|Overall Study|Sponsor request|3|||
156316736|NCT05347147|564259398|FG001|Overall Study|Sponsor request|3|||
156757379|NCT00103285|565864737|FG000|Response Assignment|Lost to Follow-up|0|||
156757380|NCT00103285|565864738|FG001|Response Assignment|Lost to Follow-up|9|||
156757381|NCT00103285|565864739|FG002|Response Assignment|Lost to Follow-up|5|||
156757382|NCT00103285|565864740|FG003|Response Assignment|Lost to Follow-up|5|||
156757383|NCT00103285|565864741|FG004|Response Assignment|Lost to Follow-up|1|||
156316737|NCT05347147|564259397|FG000|Overall Study|Study termination|2|||
156316738|NCT05347147|564259398|FG001|Overall Study|Study termination|1|||
156316739|NCT00992589|564259406|FG000|Open-Label Phase|Adverse Event|4|||
156757384|NCT00103285|565864742|FG005|Response Assignment|Lost to Follow-up|2|||
156316740|NCT00992589|564259407|FG001|Open-Label Phase|Adverse Event|0|||
156316741|NCT00992589|564259408|FG002|Open-Label Phase|Adverse Event|0|||
156316742|NCT00992589|564259409|FG003|Open-Label Phase|Adverse Event|0|||
156316743|NCT00992589|564259406|FG000|Open-Label Phase|Withdrawal by Subject|20|||
156316744|NCT00992589|564259407|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156316745|NCT00992589|564259408|FG002|Open-Label Phase|Withdrawal by Subject|0|||
156316746|NCT00992589|564259409|FG003|Open-Label Phase|Withdrawal by Subject|0|||
156316747|NCT00992589|564259406|FG000|Open-Label Phase|Lost to Follow-up|1|||
156316748|NCT00992589|564259407|FG001|Open-Label Phase|Lost to Follow-up|0|||
156316749|NCT00992589|564259408|FG002|Open-Label Phase|Lost to Follow-up|0|||
156418087|NCT00946647|564623676|FG000|Phase 1 Part|Withdrawal by Subject|1|||
156418088|NCT00946647|564623677|FG001|Phase 1 Part|Withdrawal by Subject|4|||
156418089|NCT00946647|564623678|FG002|Phase 1 Part|Withdrawal by Subject|3|||
156418090|NCT00946647|564623679|FG003|Phase 1 Part|Withdrawal by Subject|0|||
156418091|NCT00946647|564623680|FG004|Phase 1 Part|Withdrawal by Subject|0|||
156418092|NCT00946647|564623676|FG000|Phase 1 Part|Abnormal values|0|||
156418093|NCT00946647|564623677|FG001|Phase 1 Part|Abnormal values|2|||
156418094|NCT00946647|564623678|FG002|Phase 1 Part|Abnormal values|0|||
156418095|NCT00946647|564623679|FG003|Phase 1 Part|Abnormal values|0|||
156418096|NCT00946647|564623680|FG004|Phase 1 Part|Abnormal values|0|||
156418097|NCT00946647|564623676|FG000|Phase 1 Part|Reason missing|0|||
156418098|NCT00946647|564623677|FG001|Phase 1 Part|Reason missing|1|||
156418099|NCT00946647|564623678|FG002|Phase 1 Part|Reason missing|0|||
156418100|NCT00946647|564623679|FG003|Phase 1 Part|Reason missing|0|||
156418101|NCT00946647|564623680|FG004|Phase 1 Part|Reason missing|0|||
156418102|NCT00946647|564623676|FG000|Phase ll Part|Untreated|0|||
156418103|NCT00946647|564623677|FG001|Phase ll Part|Untreated|0|||
156418104|NCT00946647|564623678|FG002|Phase ll Part|Untreated|0|||
156418105|NCT00946647|564623679|FG003|Phase ll Part|Untreated|0|||
156418106|NCT00946647|564623680|FG004|Phase ll Part|Untreated|2|||
156418107|NCT00946647|564623676|FG000|Phase ll Part|Adverse Event|0|||
156418108|NCT00946647|564623677|FG001|Phase ll Part|Adverse Event|0|||
156418109|NCT00946647|564623678|FG002|Phase ll Part|Adverse Event|0|||
156418110|NCT00946647|564623679|FG003|Phase ll Part|Adverse Event|10|||
156418111|NCT00946647|564623680|FG004|Phase ll Part|Adverse Event|6|||
156418112|NCT00946647|564623676|FG000|Phase ll Part|Withdrawal by Subject|0|||
156418113|NCT00946647|564623677|FG001|Phase ll Part|Withdrawal by Subject|0|||
156418114|NCT00946647|564623678|FG002|Phase ll Part|Withdrawal by Subject|0|||
156418115|NCT00946647|564623679|FG003|Phase ll Part|Withdrawal by Subject|8|||
156418116|NCT00946647|564623680|FG004|Phase ll Part|Withdrawal by Subject|6|||
156418117|NCT00946647|564623676|FG000|Phase ll Part|Administrative problems|0|||
156418118|NCT00946647|564623677|FG001|Phase ll Part|Administrative problems|0|||
156418119|NCT00946647|564623678|FG002|Phase ll Part|Administrative problems|0|||
156418120|NCT00946647|564623679|FG003|Phase ll Part|Administrative problems|3|||
156418121|NCT00946647|564623680|FG004|Phase ll Part|Administrative problems|8|||
156418122|NCT00946647|564623676|FG000|Phase ll Part|Death|0|||
156418123|NCT00946647|564623677|FG001|Phase ll Part|Death|0|||
156418124|NCT00946647|564623678|FG002|Phase ll Part|Death|0|||
156418125|NCT00946647|564623679|FG003|Phase ll Part|Death|7|||
156418126|NCT00946647|564623680|FG004|Phase ll Part|Death|4|||
156418127|NCT00946647|564623676|FG000|Phase ll Part|Disease progression|0|||
156418128|NCT00946647|564623677|FG001|Phase ll Part|Disease progression|0|||
156418129|NCT00946647|564623678|FG002|Phase ll Part|Disease progression|0|||
156418130|NCT00946647|564623679|FG003|Phase ll Part|Disease progression|6|||
156418131|NCT00946647|564623680|FG004|Phase ll Part|Disease progression|14|||
156418132|NCT00946647|564623676|FG000|Phase ll Part|Protocol Violation|0|||
156418133|NCT00946647|564623677|FG001|Phase ll Part|Protocol Violation|0|||
156418134|NCT00946647|564623678|FG002|Phase ll Part|Protocol Violation|0|||
156418135|NCT00946647|564623679|FG003|Phase ll Part|Protocol Violation|4|||
156418136|NCT00946647|564623680|FG004|Phase ll Part|Protocol Violation|2|||
156418137|NCT00946647|564623676|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
156418138|NCT00946647|564623677|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
156418139|NCT00946647|564623678|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
156418140|NCT00946647|564623679|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
156418141|NCT00946647|564623680|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
156418142|NCT01368211|564623681|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
156418143|NCT01368211|564623682|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
156418144|NCT03990363|564623683|FG000|Overall Study|Withdrawal by Subject|10|||
156418145|NCT03990363|564623684|FG001|Overall Study|Withdrawal by Subject|9|||
156418146|NCT03990363|564623685|FG002|Overall Study|Withdrawal by Subject|18|||
156418147|NCT03990363|564623686|FG003|Overall Study|Withdrawal by Subject|11|||
156418148|NCT03990363|564623687|FG004|Overall Study|Withdrawal by Subject|9|||
156418149|NCT03990363|564623683|FG000|Overall Study|Physician Decision|1|||
156418150|NCT03990363|564623684|FG001|Overall Study|Physician Decision|0|||
156418151|NCT03990363|564623685|FG002|Overall Study|Physician Decision|0|||
156418152|NCT03990363|564623686|FG003|Overall Study|Physician Decision|0|||
156418153|NCT03990363|564623687|FG004|Overall Study|Physician Decision|0|||
156418154|NCT03990363|564623683|FG000|Overall Study|Adverse Event|1|||
156418155|NCT03990363|564623684|FG001|Overall Study|Adverse Event|3|||
156418156|NCT03990363|564623685|FG002|Overall Study|Adverse Event|2|||
156418157|NCT03990363|564623686|FG003|Overall Study|Adverse Event|2|||
156418158|NCT03990363|564623687|FG004|Overall Study|Adverse Event|0|||
156418159|NCT03990363|564623683|FG000|Overall Study|Death|14|||
156418160|NCT03990363|564623684|FG001|Overall Study|Death|8|||
156418161|NCT03990363|564623685|FG002|Overall Study|Death|14|||
156418162|NCT03990363|564623686|FG003|Overall Study|Death|10|||
156418163|NCT03990363|564623687|FG004|Overall Study|Death|11|||
156418164|NCT03990363|564623683|FG000|Overall Study|Failure to meet randomization criteria|0|||
156418165|NCT03990363|564623684|FG001|Overall Study|Failure to meet randomization criteria|1|||
156418166|NCT03990363|564623685|FG002|Overall Study|Failure to meet randomization criteria|1|||
156418167|NCT03990363|564623686|FG003|Overall Study|Failure to meet randomization criteria|0|||
156418168|NCT03990363|564623687|FG004|Overall Study|Failure to meet randomization criteria|0|||
156418169|NCT03990363|564623683|FG000|Overall Study|Lost to Follow-up|0|||
156418170|NCT03990363|564623684|FG001|Overall Study|Lost to Follow-up|0|||
156418171|NCT03990363|564623685|FG002|Overall Study|Lost to Follow-up|0|||
156418172|NCT03990363|564623686|FG003|Overall Study|Lost to Follow-up|1|||
156418173|NCT03990363|564623687|FG004|Overall Study|Lost to Follow-up|2|||
156418174|NCT03990363|564623683|FG000|Overall Study|Non-compliance with study drug|2|||
156418175|NCT03990363|564623684|FG001|Overall Study|Non-compliance with study drug|1|||
156418176|NCT03990363|564623685|FG002|Overall Study|Non-compliance with study drug|2|||
156418177|NCT03990363|564623686|FG003|Overall Study|Non-compliance with study drug|0|||
156418178|NCT03990363|564623687|FG004|Overall Study|Non-compliance with study drug|0|||
156418179|NCT03990363|564623683|FG000|Overall Study|Study terminated by sponsor|0|||
156418180|NCT03990363|564623684|FG001|Overall Study|Study terminated by sponsor|1|||
156418181|NCT03990363|564623685|FG002|Overall Study|Study terminated by sponsor|0|||
156418182|NCT03990363|564623686|FG003|Overall Study|Study terminated by sponsor|0|||
156418183|NCT03990363|564623687|FG004|Overall Study|Study terminated by sponsor|0|||
156418184|NCT03990363|564623683|FG000|Overall Study|Site terminated by sponsor|2|||
156418185|NCT03990363|564623684|FG001|Overall Study|Site terminated by sponsor|1|||
156418186|NCT03990363|564623685|FG002|Overall Study|Site terminated by sponsor|2|||
156418187|NCT03990363|564623686|FG003|Overall Study|Site terminated by sponsor|0|||
156418188|NCT03990363|564623687|FG004|Overall Study|Site terminated by sponsor|2|||
156418189|NCT03990363|564623683|FG000|Overall Study|Not categorized|5|||
156418190|NCT03990363|564623684|FG001|Overall Study|Not categorized|5|||
156418191|NCT03990363|564623685|FG002|Overall Study|Not categorized|3|||
156418192|NCT03990363|564623686|FG003|Overall Study|Not categorized|2|||
156418193|NCT03990363|564623687|FG004|Overall Study|Not categorized|2|||
156418194|NCT01349660|564623690|FG000|Overall Study|Still Receiving Study Treatment|0|||
156418195|NCT01349660|564623691|FG001|Overall Study|Still Receiving Study Treatment|0|||
156418196|NCT01349660|564623692|FG002|Overall Study|Still Receiving Study Treatment|1|||
156418197|NCT01349660|564623690|FG000|Overall Study|Disease Progression|2|||
156418198|NCT01349660|564623691|FG001|Overall Study|Disease Progression|4|||
156418199|NCT01349660|564623692|FG002|Overall Study|Disease Progression|50|||
156418200|NCT01349660|564623690|FG000|Overall Study|Adverse Event|1|||
156418201|NCT01349660|564623691|FG001|Overall Study|Adverse Event|1|||
156418202|NCT01349660|564623692|FG002|Overall Study|Adverse Event|12|||
156418203|NCT01349660|564623690|FG000|Overall Study|Withdrawal by Subject|2|||
156418204|NCT01349660|564623691|FG001|Overall Study|Withdrawal by Subject|0|||
156418205|NCT01349660|564623692|FG002|Overall Study|Withdrawal by Subject|9|||
156418206|NCT01349660|564623690|FG000|Overall Study|Death|1|||
156418207|NCT01349660|564623691|FG001|Overall Study|Death|1|||
156418208|NCT01349660|564623692|FG002|Overall Study|Death|0|||
156418209|NCT01349660|564623690|FG000|Overall Study|Non-Permitted Interventions|0|||
156418210|NCT01349660|564623691|FG001|Overall Study|Non-Permitted Interventions|0|||
156418211|NCT01349660|564623692|FG002|Overall Study|Non-Permitted Interventions|2|||
156418212|NCT01349660|564623690|FG000|Overall Study|Study Compliance|0|||
156418213|NCT01349660|564623691|FG001|Overall Study|Study Compliance|0|||
156418214|NCT01349660|564623692|FG002|Overall Study|Study Compliance|1|||
156653186|NCT01296932|565477917|FG004|Overall Study|Physician Decision|0|||
156653187|NCT01296932|565477918|FG005|Overall Study|Physician Decision|0|||
156653188|NCT01296932|565477919|FG006|Overall Study|Physician Decision|0|||
156653189|NCT01296932|565477920|FG007|Overall Study|Physician Decision|0|||
156653190|NCT01296932|565477921|FG008|Overall Study|Physician Decision|0|||
156653191|NCT01296932|565477913|FG000|Overall Study|IV problems, administration not possible|0|||
156653192|NCT01296932|565477914|FG001|Overall Study|IV problems, administration not possible|0|||
156653193|NCT01296932|565477915|FG002|Overall Study|IV problems, administration not possible|1|||
156653194|NCT01296932|565477916|FG003|Overall Study|IV problems, administration not possible|0|||
156653195|NCT01296932|565477917|FG004|Overall Study|IV problems, administration not possible|0|||
156653196|NCT01296932|565477918|FG005|Overall Study|IV problems, administration not possible|0|||
156653197|NCT01296932|565477919|FG006|Overall Study|IV problems, administration not possible|0|||
156653198|NCT01296932|565477920|FG007|Overall Study|IV problems, administration not possible|0|||
156653199|NCT01296932|565477921|FG008|Overall Study|IV problems, administration not possible|0|||
156653200|NCT01296932|565477913|FG000|Overall Study|per protocol|0|||
156653201|NCT01296932|565477914|FG001|Overall Study|per protocol|0|||
156653202|NCT01296932|565477915|FG002|Overall Study|per protocol|1|||
156653203|NCT01296932|565477916|FG003|Overall Study|per protocol|1|||
156653204|NCT01296932|565477917|FG004|Overall Study|per protocol|0|||
156653205|NCT01296932|565477918|FG005|Overall Study|per protocol|0|||
156653206|NCT01296932|565477919|FG006|Overall Study|per protocol|0|||
156653207|NCT01296932|565477920|FG007|Overall Study|per protocol|0|||
156653208|NCT01296932|565477921|FG008|Overall Study|per protocol|0|||
156653209|NCT01296932|565477913|FG000|Overall Study|Low benefit and too many side effects|0|||
156653210|NCT01296932|565477914|FG001|Overall Study|Low benefit and too many side effects|0|||
156757385|NCT00103285|565864743|FG006|Response Assignment|Lost to Follow-up|2|||
156757386|NCT00103285|565864744|FG007|Response Assignment|Lost to Follow-up|5|||
156757387|NCT00103285|565864737|FG000|Response Assignment|Physician Decision|0|||
156757388|NCT00103285|565864738|FG001|Response Assignment|Physician Decision|13|||
156757389|NCT00103285|565864739|FG002|Response Assignment|Physician Decision|14|||
156757390|NCT00103285|565864740|FG003|Response Assignment|Physician Decision|9|||
156316750|NCT00992589|564259409|FG003|Open-Label Phase|Lost to Follow-up|0|||
156316751|NCT00992589|564259406|FG000|Open-Label Phase|Protocol Violation|3|||
156316752|NCT00992589|564259407|FG001|Open-Label Phase|Protocol Violation|0|||
156316753|NCT00992589|564259408|FG002|Open-Label Phase|Protocol Violation|0|||
156316754|NCT00992589|564259409|FG003|Open-Label Phase|Protocol Violation|0|||
156316755|NCT00992589|564259406|FG000|Open-Label Phase|Physician Decision|4|||
156316756|NCT00992589|564259407|FG001|Open-Label Phase|Physician Decision|0|||
156316757|NCT00992589|564259408|FG002|Open-Label Phase|Physician Decision|0|||
156316758|NCT00992589|564259409|FG003|Open-Label Phase|Physician Decision|0|||
156316759|NCT00992589|564259406|FG000|Open-Label Phase|Other|45|||
156316760|NCT00992589|564259407|FG001|Open-Label Phase|Other|0|||
156316761|NCT00992589|564259408|FG002|Open-Label Phase|Other|0|||
156316762|NCT00992589|564259409|FG003|Open-Label Phase|Other|0|||
156316763|NCT00992589|564259406|FG000|Double-Blind Phase|Adverse Event|0|||
156316764|NCT00992589|564259407|FG001|Double-Blind Phase|Adverse Event|6|||
156316765|NCT00992589|564259408|FG002|Double-Blind Phase|Adverse Event|2|||
156316766|NCT00992589|564259409|FG003|Double-Blind Phase|Adverse Event|3|||
156316767|NCT00992589|564259406|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156316768|NCT00992589|564259407|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
156316769|NCT00992589|564259408|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
156316770|NCT00992589|564259409|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
156316771|NCT00992589|564259406|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156316772|NCT00992589|564259407|FG001|Double-Blind Phase|Lost to Follow-up|0|||
156316773|NCT00992589|564259408|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156316774|NCT00992589|564259409|FG003|Double-Blind Phase|Lost to Follow-up|2|||
156316775|NCT00992589|564259406|FG000|Double-Blind Phase|Other|0|||
156316776|NCT00992589|564259407|FG001|Double-Blind Phase|Other|1|||
156316777|NCT00992589|564259408|FG002|Double-Blind Phase|Other|6|||
156316778|NCT00992589|564259409|FG003|Double-Blind Phase|Other|3|||
156316779|NCT02142387|564259410|FG000|Overall Study|<19 years old|49|||
156316780|NCT02142387|564259411|FG001|Overall Study|<19 years old|326|||
156316781|NCT02142387|564259410|FG000|Overall Study|non-cardiac etiology|504|||
156316782|NCT02142387|564259411|FG001|Overall Study|non-cardiac etiology|3431|||
156316783|NCT02142387|564259410|FG000|Overall Study|CPR not performed|74|||
156316784|NCT02142387|564259411|FG001|Overall Study|CPR not performed|473|||
156316785|NCT02142387|564259410|FG000|Overall Study|witnessed by paramedic|139|||
156316786|NCT02142387|564259411|FG001|Overall Study|witnessed by paramedic|917|||
156316787|NCT02142387|564259410|FG000|Overall Study|incomplete data|1|||
156316788|NCT02142387|564259411|FG001|Overall Study|incomplete data|9|||
156316789|NCT02142387|564259410|FG000|Overall Study|occurred not at home|298|||
156316790|NCT02142387|564259411|FG001|Overall Study|occurred not at home|2474|||
156316791|NCT01895361|564259415|FG000|Overall Study|Adverse Event|1|||
156316792|NCT01895361|564259416|FG001|Overall Study|Adverse Event|1|||
156316793|NCT01895361|564259417|FG002|Overall Study|Adverse Event|3|||
156316794|NCT01895361|564259415|FG000|Overall Study|Death|2|||
156316795|NCT01895361|564259416|FG001|Overall Study|Death|1|||
156316796|NCT01895361|564259417|FG002|Overall Study|Death|2|||
156316797|NCT01895361|564259415|FG000|Overall Study|Lost to Follow-up|4|||
156316798|NCT01895361|564259416|FG001|Overall Study|Lost to Follow-up|4|||
156316799|NCT01895361|564259417|FG002|Overall Study|Lost to Follow-up|6|||
156316800|NCT01895361|564259415|FG000|Overall Study|Non-compliance with study|1|||
156316801|NCT01895361|564259416|FG001|Overall Study|Non-compliance with study|3|||
156316802|NCT01895361|564259417|FG002|Overall Study|Non-compliance with study|1|||
156316803|NCT01895361|564259415|FG000|Overall Study|Physician Decision|2|||
156316804|NCT01895361|564259416|FG001|Overall Study|Physician Decision|2|||
156316805|NCT01895361|564259417|FG002|Overall Study|Physician Decision|2|||
156316806|NCT01895361|564259415|FG000|Overall Study|Withdrawal by Subject|7|||
156757391|NCT00103285|565864741|FG004|Response Assignment|Physician Decision|13|||
156316807|NCT01895361|564259416|FG001|Overall Study|Withdrawal by Subject|6|||
156316808|NCT01895361|564259417|FG002|Overall Study|Withdrawal by Subject|6|||
156316809|NCT01895361|564259415|FG000|Overall Study|Lack of Efficacy|0|||
156316810|NCT01895361|564259416|FG001|Overall Study|Lack of Efficacy|1|||
156316811|NCT01895361|564259417|FG002|Overall Study|Lack of Efficacy|0|||
156316812|NCT01895361|564259415|FG000|Overall Study|Reasons different from categories above|7|||
156316813|NCT01895361|564259416|FG001|Overall Study|Reasons different from categories above|3|||
156316814|NCT01895361|564259417|FG002|Overall Study|Reasons different from categories above|4|||
156316815|NCT01268579|564259421|FG000|Overall Study|Adverse Event|1|||
156316816|NCT01268579|564259421|FG000|Overall Study|Withdrawal by Subject|2|||
156316817|NCT01209832|564259422|FG000|Period 1|Sponsor Decision and was not dosed|1|||
156316818|NCT01209832|564259422|FG000|Period 2|Sponsor Decision|1|||
156316819|NCT02692651|564259423|FG000|Study Treatment|Death|7|||
156316820|NCT02692651|564259424|FG001|Study Treatment|Death|3|||
156316821|NCT02692651|564259423|FG000|Study Treatment|comfort care|1|||
156316822|NCT02692651|564259424|FG001|Study Treatment|comfort care|1|||
156316823|NCT02692651|564259423|FG000|Study Treatment|Protocol violation per treating team preference|8|||
156316824|NCT02692651|564259424|FG001|Study Treatment|Protocol violation per treating team preference|6|||
156316825|NCT02692651|564259423|FG000|Post Study Treatment Follow-up|Death|4|||
156316826|NCT02692651|564259424|FG001|Post Study Treatment Follow-up|Death|4|||
156316827|NCT03490981|564259425|FG000|Overall Study|Lost to Follow-up|1|||
156316828|NCT03490981|564259426|FG001|Overall Study|Lost to Follow-up|2|||
156316829|NCT05463198|564259427|FG000|Overall Study|Withdrawal by Subject|19|||
156316830|NCT05463198|564259427|FG000|Overall Study|Procedure Notes Missing|18|||
156316831|NCT02239120|564259430|FG000|Overall Study|Death|56|||
156316832|NCT02239120|564259431|FG001|Overall Study|Death|58|||
156316833|NCT02239120|564259430|FG000|Overall Study|Lost to Follow-up|19|||
156316834|NCT02239120|564259431|FG001|Overall Study|Lost to Follow-up|14|||
156316835|NCT00046891|564259434|FG000|Overall Study|Cancels|5|||
156316836|NCT00046891|564259435|FG001|Overall Study|Cancels|9|||
156316837|NCT00046891|564259434|FG000|Overall Study|Ineligible|1|||
156316838|NCT00046891|564259435|FG001|Overall Study|Ineligible|1|||
156316839|NCT00046891|564259434|FG000|Overall Study|Withdrawal by Subject|18|||
156316840|NCT00046891|564259435|FG001|Overall Study|Withdrawal by Subject|15|||
156316841|NCT00046891|564259434|FG000|Overall Study|Adverse Event|5|||
156316842|NCT00046891|564259435|FG001|Overall Study|Adverse Event|5|||
156316843|NCT00420641|564259438|FG000|Overall Study|Adverse Event|3|||
156316844|NCT00420641|564259439|FG001|Overall Study|Adverse Event|25|||
156316845|NCT00420641|564259440|FG002|Overall Study|Adverse Event|10|||
156316846|NCT00420641|564259438|FG000|Overall Study|Lost to Follow-up|2|||
156316847|NCT00420641|564259439|FG001|Overall Study|Lost to Follow-up|4|||
156316848|NCT00420641|564259440|FG002|Overall Study|Lost to Follow-up|2|||
156316849|NCT00420641|564259438|FG000|Overall Study|Protocol Violation|8|||
156316850|NCT00420641|564259439|FG001|Overall Study|Protocol Violation|8|||
156316851|NCT00420641|564259440|FG002|Overall Study|Protocol Violation|7|||
156316852|NCT00420641|564259438|FG000|Overall Study|Withdrawal by Subject|15|||
156316853|NCT00420641|564259439|FG001|Overall Study|Withdrawal by Subject|21|||
156316854|NCT00420641|564259440|FG002|Overall Study|Withdrawal by Subject|14|||
156316855|NCT00420641|564259438|FG000|Overall Study|Lack of Efficacy|6|||
156316856|NCT00420641|564259439|FG001|Overall Study|Lack of Efficacy|5|||
156316857|NCT00420641|564259440|FG002|Overall Study|Lack of Efficacy|4|||
156316858|NCT00420641|564259438|FG000|Overall Study|Non-compliance|7|||
156316859|NCT00420641|564259439|FG001|Overall Study|Non-compliance|5|||
156316860|NCT00420641|564259440|FG002|Overall Study|Non-compliance|4|||
156316861|NCT00420641|564259438|FG000|Overall Study|Other|4|||
156316862|NCT00420641|564259439|FG001|Overall Study|Other|4|||
156316863|NCT00420641|564259440|FG002|Overall Study|Other|3|||
156316864|NCT02586506|564259446|FG000|Overall Study|Protocol Violation|6|||
156316865|NCT02586506|564259446|FG000|Overall Study|Lost to Follow-up|1|||
156316866|NCT02586506|564259446|FG000|Overall Study|Other Reason|2|||
156316867|NCT02815280|564259448|FG000|Double-Blind Phase|Adverse Event|1|||
156316868|NCT02815280|564259449|FG001|Double-Blind Phase|Adverse Event|1|||
156316869|NCT02815280|564259448|FG000|Double-Blind Phase|Lost to Follow-up|10|||
156316870|NCT02815280|564259449|FG001|Double-Blind Phase|Lost to Follow-up|9|||
156316871|NCT02815280|564259448|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
156316872|NCT02815280|564259449|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
156316873|NCT02815280|564259448|FG000|Double-Blind Phase|Protocol Violation|2|||
156316874|NCT02815280|564259449|FG001|Double-Blind Phase|Protocol Violation|2|||
156316875|NCT02815280|564259448|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
156316876|NCT02815280|564259449|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
156316877|NCT02815280|564259448|FG000|Open-Label Phase|Adverse Event|2|||
156316878|NCT02815280|564259449|FG001|Open-Label Phase|Adverse Event|3|||
156316879|NCT02815280|564259448|FG000|Open-Label Phase|Lost to Follow-up|18|||
156316880|NCT02815280|564259449|FG001|Open-Label Phase|Lost to Follow-up|9|||
156316881|NCT02815280|564259448|FG000|Open-Label Phase|Withdrawal by Subject|33|||
156316882|NCT02815280|564259449|FG001|Open-Label Phase|Withdrawal by Subject|18|||
156316883|NCT02815280|564259448|FG000|Open-Label Phase|Protocol Violation|3|||
156316884|NCT02815280|564259449|FG001|Open-Label Phase|Protocol Violation|0|||
156316885|NCT02815280|564259448|FG000|Open-Label Phase|Administrative|26|||
156316886|NCT02815280|564259449|FG001|Open-Label Phase|Administrative|12|||
156316887|NCT02815280|564259448|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
156316888|NCT02815280|564259449|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
156418215|NCT01349660|564623690|FG000|Overall Study|Declining Performance Status|0|||
156418216|NCT01349660|564623691|FG001|Overall Study|Declining Performance Status|0|||
156418217|NCT01349660|564623692|FG002|Overall Study|Declining Performance Status|1|||
156316889|NCT02514473|564259459|FG000|Overall Study|Adverse Event|0|||
156316890|NCT02514473|564259460|FG001|Overall Study|Adverse Event|2|||
156316891|NCT02514473|564259459|FG000|Overall Study|Withdrawal by Subject|2|||
156316892|NCT02514473|564259460|FG001|Overall Study|Withdrawal by Subject|1|||
156316893|NCT02514473|564259459|FG000|Overall Study|Lost to Follow-up|0|||
156418218|NCT04630756|564623693|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
156418219|NCT04630756|564623694|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
156418220|NCT04630756|564623695|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
156418221|NCT02388074|564623698|FG000|Overall Study|Lost in Transit|2|||
156418222|NCT02388074|564623698|FG000|Overall Study|Sample Not Returned|1|||
156418223|NCT07083843|564623703|FG000|Intervention period.|Withdrawal by Subject|1|||
156418224|NCT07083843|564623704|FG001|Intervention period.|Withdrawal by Subject|0|||
156418225|NCT07083843|564623703|FG000|Intervention period.|Death|0|||
156418226|NCT07083843|564623704|FG001|Intervention period.|Death|1|||
156418227|NCT01939158|564625225|FG000|Overall Study|Adverse Event|1|||
156418228|NCT01939158|564625226|FG001|Overall Study|Adverse Event|0|||
156418229|NCT01939158|564625227|FG002|Overall Study|Adverse Event|0|||
156418230|NCT01939158|564625228|FG003|Overall Study|Adverse Event|0|||
156418231|NCT01939158|564625225|FG000|Overall Study|Withdrawal by Subject|22|||
156418232|NCT01939158|564625226|FG001|Overall Study|Withdrawal by Subject|25|||
156418233|NCT01939158|564625227|FG002|Overall Study|Withdrawal by Subject|15|||
156418234|NCT01939158|564625228|FG003|Overall Study|Withdrawal by Subject|17|||
156418235|NCT01939158|564625225|FG000|Overall Study|Migrated/moved from study area|5|||
156418236|NCT01939158|564625226|FG001|Overall Study|Migrated/moved from study area|7|||
156418237|NCT01939158|564625227|FG002|Overall Study|Migrated/moved from study area|3|||
156418238|NCT01939158|564625228|FG003|Overall Study|Migrated/moved from study area|6|||
156418239|NCT01939158|564625225|FG000|Overall Study|Lost to Follow-up|18|||
156418240|NCT01939158|564625226|FG001|Overall Study|Lost to Follow-up|17|||
156418241|NCT01939158|564625227|FG002|Overall Study|Lost to Follow-up|17|||
156418242|NCT01939158|564625228|FG003|Overall Study|Lost to Follow-up|17|||
156418243|NCT01939158|564625225|FG000|Overall Study|Death|0|||
156418244|NCT01939158|564625226|FG001|Overall Study|Death|0|||
156418245|NCT01939158|564625227|FG002|Overall Study|Death|1|||
156418246|NCT01939158|564625228|FG003|Overall Study|Death|1|||
156418247|NCT01939158|564625225|FG000|Overall Study|No longer meets eligibility criteria|0|||
156418248|NCT01939158|564625226|FG001|Overall Study|No longer meets eligibility criteria|0|||
156418249|NCT01939158|564625227|FG002|Overall Study|No longer meets eligibility criteria|1|||
156418250|NCT01939158|564625228|FG003|Overall Study|No longer meets eligibility criteria|0|||
156418251|NCT01939158|564625225|FG000|Overall Study|Other|1|||
156418252|NCT01939158|564625226|FG001|Overall Study|Other|3|||
156418253|NCT01939158|564625227|FG002|Overall Study|Other|4|||
156418254|NCT01939158|564625228|FG003|Overall Study|Other|3|||
156418255|NCT05310084|564625229|FG000|Overall Study|Withdrawal by Subject|2|||
156418256|NCT05310084|564625230|FG001|Overall Study|Withdrawal by Subject|3|||
156418257|NCT05310084|564625229|FG000|Overall Study|Participant availability|0|||
156418258|NCT05310084|564625230|FG001|Overall Study|Participant availability|4|||
156418259|NCT05310084|564625229|FG000|Overall Study|Lost to Follow-up|1|||
156418260|NCT05310084|564625230|FG001|Overall Study|Lost to Follow-up|1|||
156418261|NCT05310084|564625229|FG000|Overall Study|Adverse Event|1|||
156757392|NCT00103285|565864742|FG005|Response Assignment|Physician Decision|7|||
156757393|NCT00103285|565864743|FG006|Response Assignment|Physician Decision|4|||
156757394|NCT00103285|565864744|FG007|Response Assignment|Physician Decision|35|||
156757395|NCT00103285|565864737|FG000|Response Assignment|Protocol Violation|0|||
156757396|NCT00103285|565864738|FG001|Response Assignment|Protocol Violation|2|||
156757397|NCT00103285|565864739|FG002|Response Assignment|Protocol Violation|0|||
156757398|NCT00103285|565864740|FG003|Response Assignment|Protocol Violation|0|||
156757399|NCT00103285|565864741|FG004|Response Assignment|Protocol Violation|0|||
156757400|NCT00103285|565864742|FG005|Response Assignment|Protocol Violation|0|||
156757401|NCT00103285|565864743|FG006|Response Assignment|Protocol Violation|0|||
156757402|NCT00103285|565864744|FG007|Response Assignment|Protocol Violation|0|||
156757403|NCT00103285|565864737|FG000|Response Assignment|Withdrawal by Subject|0|||
156757404|NCT00103285|565864738|FG001|Response Assignment|Withdrawal by Subject|4|||
156757405|NCT00103285|565864739|FG002|Response Assignment|Withdrawal by Subject|1|||
156757406|NCT00103285|565864740|FG003|Response Assignment|Withdrawal by Subject|1|||
156757407|NCT00103285|565864741|FG004|Response Assignment|Withdrawal by Subject|2|||
156757408|NCT00103285|565864742|FG005|Response Assignment|Withdrawal by Subject|2|||
156757409|NCT00103285|565864743|FG006|Response Assignment|Withdrawal by Subject|0|||
156757410|NCT00103285|565864744|FG007|Response Assignment|Withdrawal by Subject|2|||
156757411|NCT00103285|565864737|FG000|Response Assignment|Ineligible|0|||
156757412|NCT00103285|565864738|FG001|Response Assignment|Ineligible|8|||
156757413|NCT00103285|565864739|FG002|Response Assignment|Ineligible|6|||
156757414|NCT00103285|565864740|FG003|Response Assignment|Ineligible|2|||
156757415|NCT00103285|565864741|FG004|Response Assignment|Ineligible|0|||
156757416|NCT00103285|565864742|FG005|Response Assignment|Ineligible|3|||
156418262|NCT05310084|564625230|FG001|Overall Study|Adverse Event|1|||
156418263|NCT05310084|564625229|FG000|Overall Study|Randomized but not vaccinated|4|||
156418264|NCT05310084|564625230|FG001|Overall Study|Randomized but not vaccinated|2|||
156418265|NCT01598987|564625232|FG000|Baseline to Month 12|Administrative problems|2|||
156418266|NCT01598987|564625232|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
156418267|NCT01598987|564625232|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
156757417|NCT00103285|565864743|FG006|Response Assignment|Ineligible|1|||
156757418|NCT00103285|565864744|FG007|Response Assignment|Ineligible|5|||
156757419|NCT00103285|565864737|FG000|Response Assignment|Refusal|0|||
156757420|NCT00103285|565864738|FG001|Response Assignment|Refusal|53|||
156757421|NCT00103285|565864739|FG002|Response Assignment|Refusal|5|||
156757422|NCT00103285|565864740|FG003|Response Assignment|Refusal|3|||
156418268|NCT01598987|564625232|FG000|Baseline to 24 Month|Administrative problems|2|||
156418269|NCT01598987|564625232|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
156418270|NCT00924664|564625233|FG000|Overall Study|Adverse Event|23|||
156418271|NCT00924664|564625234|FG001|Overall Study|Adverse Event|39|||
156418272|NCT00924664|564625233|FG000|Overall Study|Lack of Efficacy|10|||
156418273|NCT00924664|564625234|FG001|Overall Study|Lack of Efficacy|15|||
156418274|NCT00924664|564625233|FG000|Overall Study|Lost to Follow-up|10|||
156418275|NCT00924664|564625234|FG001|Overall Study|Lost to Follow-up|12|||
156418276|NCT00924664|564625233|FG000|Overall Study|Withdrawal by Subject|47|||
156418277|NCT00924664|564625234|FG001|Overall Study|Withdrawal by Subject|71|||
156418278|NCT00924664|564625233|FG000|Overall Study|Protocol Violation|2|||
156418279|NCT00924664|564625234|FG001|Overall Study|Protocol Violation|5|||
156418280|NCT00924664|564625233|FG000|Overall Study|Pregnancy|1|||
156418281|NCT00924664|564625234|FG001|Overall Study|Pregnancy|1|||
156418282|NCT00924664|564625233|FG000|Overall Study|Death|0|||
156418283|NCT00924664|564625234|FG001|Overall Study|Death|2|||
156418284|NCT00924664|564625233|FG000|Overall Study|Study terminated by sponsor|199|||
156418285|NCT00924664|564625234|FG001|Overall Study|Study terminated by sponsor|330|||
156418286|NCT00924664|564625233|FG000|Overall Study|Other|29|||
156418287|NCT00924664|564625234|FG001|Overall Study|Other|52|||
156418288|NCT00924664|564625233|FG000|Overall Study|Randomized but not Treated|1|||
156418289|NCT00924664|564625234|FG001|Overall Study|Randomized but not Treated|0|||
156418290|NCT03531905|564625235|FG000|Overall Study|Withdrawal by Subject|3|||
156418291|NCT03531905|564625236|FG001|Overall Study|Withdrawal by Subject|3|||
156418292|NCT03531905|564625237|FG002|Overall Study|Withdrawal by Subject|2|||
156418293|NCT03531905|564625235|FG000|Overall Study|Lost to Follow-up|2|||
156418294|NCT03531905|564625236|FG001|Overall Study|Lost to Follow-up|2|||
156418295|NCT03531905|564625237|FG002|Overall Study|Lost to Follow-up|1|||
156418296|NCT03531905|564625235|FG000|Overall Study|Participant was out of town|1|||
156418297|NCT03531905|564625236|FG001|Overall Study|Participant was out of town|0|||
156418298|NCT03531905|564625237|FG002|Overall Study|Participant was out of town|0|||
156418299|NCT03531905|564625235|FG000|Overall Study|Could not speak with the participant|1|||
156418300|NCT03531905|564625236|FG001|Overall Study|Could not speak with the participant|0|||
156418301|NCT03531905|564625237|FG002|Overall Study|Could not speak with the participant|0|||
156418302|NCT03303105|564625242|FG000|Overall Study|Adverse Event|0|||
156418303|NCT03303105|564625243|FG001|Overall Study|Adverse Event|2|||
156418304|NCT03303105|564625242|FG000|Overall Study|Lack of Efficacy|1|||
156418305|NCT03303105|564625243|FG001|Overall Study|Lack of Efficacy|0|||
156418306|NCT03303105|564625242|FG000|Overall Study|Protocol Violation|1|||
156418307|NCT03303105|564625243|FG001|Overall Study|Protocol Violation|0|||
156418308|NCT03303105|564625242|FG000|Overall Study|Withdrawal by Subject|0|||
156418309|NCT03303105|564625243|FG001|Overall Study|Withdrawal by Subject|2|||
156418310|NCT03527277|564625247|FG000|Overall Study|Withdrawal by Subject|5|||
156418311|NCT03527277|564625248|FG001|Overall Study|Withdrawal by Subject|0|||
156418312|NCT03527277|564625247|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
156418313|NCT03527277|564625248|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
156418314|NCT03527277|564625247|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
156418315|NCT03527277|564625248|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
156418316|NCT01781611|564625249|FG000|Overall Study|Adverse Event|4|||
156418317|NCT01781611|564625250|FG001|Overall Study|Adverse Event|0|||
156418318|NCT01333943|564625251|FG000|Overall Study|Known neuropathy|1|||
156418319|NCT01333943|564625252|FG001|Overall Study|Known neuropathy|0|||
156418320|NCT02652130|564625259|FG000|Overall Study|Death|1|||
156418321|NCT02028884|564625260|FG000|Double-blind Period|Adverse Event|5|||
156418322|NCT02028884|564625261|FG001|Double-blind Period|Adverse Event|3|||
156418323|NCT02028884|564625262|FG002|Double-blind Period|Adverse Event|0|||
156418324|NCT02028884|564625260|FG000|Double-blind Period|Eligibility Violation|1|||
156418325|NCT02028884|564625261|FG001|Double-blind Period|Eligibility Violation|0|||
156418326|NCT02028884|564625262|FG002|Double-blind Period|Eligibility Violation|0|||
156418327|NCT02028884|564625260|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
156418328|NCT02028884|564625261|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
156418329|NCT02028884|564625262|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
156418330|NCT02028884|564625260|FG000|Double-blind Period|Withdrawal by Subject|2|||
156418331|NCT02028884|564625261|FG001|Double-blind Period|Withdrawal by Subject|0|||
156418332|NCT02028884|564625262|FG002|Double-blind Period|Withdrawal by Subject|0|||
156418333|NCT02028884|564625260|FG000|Open-label Extension Period|Adverse Event|3|||
156418334|NCT02028884|564625261|FG001|Open-label Extension Period|Adverse Event|1|||
156418335|NCT02028884|564625262|FG002|Open-label Extension Period|Adverse Event|0|||
156418336|NCT02028884|564625260|FG000|Open-label Extension Period|Lack of Efficacy|3|||
156418337|NCT02028884|564625261|FG001|Open-label Extension Period|Lack of Efficacy|0|||
156418338|NCT02028884|564625262|FG002|Open-label Extension Period|Lack of Efficacy|0|||
156316894|NCT02514473|564259460|FG001|Overall Study|Lost to Follow-up|1|||
156316895|NCT02514473|564259459|FG000|Overall Study|Other|1|||
156316896|NCT02514473|564259460|FG001|Overall Study|Other|1|||
156316897|NCT02158364|564259461|FG000|Overall Study|Case report forms uncollected|10|||
156316898|NCT02158364|564259461|FG000|Overall Study|Protocol Deviation|50|||
156316899|NCT04381988|564259464|FG000|Overall Study|The study was terminated|4|||
156316900|NCT04381988|564259465|FG001|Overall Study|The study was terminated|0|||
156316901|NCT00609362|564259466|FG000|Overall Study|Withdrawal by Subject|2|||
156316902|NCT00609362|564259467|FG001|Overall Study|Withdrawal by Subject|1|||
156316903|NCT00609362|564259466|FG000|Overall Study|Adverse Event|1|||
156316904|NCT00609362|564259467|FG001|Overall Study|Adverse Event|0|||
156316905|NCT05093790|564259468|FG000|Overall Study|Failure to meet continuation criteria|0|||
156316906|NCT05093790|564259469|FG001|Overall Study|Failure to meet continuation criteria|0|||
156316907|NCT05093790|564259470|FG002|Overall Study|Failure to meet continuation criteria|1|||
156316908|NCT05093790|564259471|FG003|Overall Study|Failure to meet continuation criteria|0|||
156316909|NCT05093790|564259468|FG000|Overall Study|Adverse Event|1|||
156316910|NCT05093790|564259469|FG001|Overall Study|Adverse Event|0|||
156316911|NCT05093790|564259470|FG002|Overall Study|Adverse Event|0|||
156316912|NCT05093790|564259471|FG003|Overall Study|Adverse Event|0|||
156316913|NCT01624870|564259472|FG000|Overall Study|Death|19|||
156316914|NCT01624870|564259472|FG000|Overall Study|Withdrawal by Subject|1|||
156316915|NCT01624870|564259472|FG000|Overall Study|CoreValve not implanted|6|||
156316916|NCT01624870|564259472|FG000|Overall Study|Lost to follow up|1|||
156316917|NCT00827931|564259473|FG000|Overall Study|Death|3|||
156316918|NCT00827931|564259474|FG001|Overall Study|Death|5|||
156316919|NCT00827931|564259473|FG000|Overall Study|Adverse Event|1|||
156316920|NCT00827931|564259474|FG001|Overall Study|Adverse Event|0|||
156316921|NCT00827931|564259473|FG000|Overall Study|Lost to Follow-up|1|||
156316922|NCT00827931|564259474|FG001|Overall Study|Lost to Follow-up|0|||
156316923|NCT00827931|564259473|FG000|Overall Study|Withdrawal by Subject|0|||
156316924|NCT00827931|564259474|FG001|Overall Study|Withdrawal by Subject|1|||
156316925|NCT00827931|564259473|FG000|Overall Study|Other|1|||
156316926|NCT00827931|564259474|FG001|Overall Study|Other|0|||
156316927|NCT01700439|564259478|FG000|Overall Study|Lost to Follow-up|47|||
156316928|NCT01700439|564259478|FG000|Overall Study|Withdrawal by Subject|183|||
156316929|NCT01700439|564259478|FG000|Overall Study|Death|186|||
156316930|NCT01892384|564259479|FG000|Overall Study|Withdrawal by Subject|1|||
156316931|NCT01892384|564259480|FG001|Overall Study|Withdrawal by Subject|1|||
156316932|NCT01892384|564259481|FG002|Overall Study|Withdrawal by Subject|0|||
156316933|NCT01892384|564259482|FG003|Overall Study|Withdrawal by Subject|0|||
156316934|NCT00592774|564259483|FG000|Overall Study|Adverse Event|5|||
156316935|NCT00592774|564259484|FG001|Overall Study|Adverse Event|19|||
156316936|NCT00592774|564259485|FG002|Overall Study|Adverse Event|2|||
156316937|NCT00592774|564259486|FG003|Overall Study|Adverse Event|14|||
156316938|NCT00592774|564259487|FG004|Overall Study|Adverse Event|8|||
156316939|NCT00592774|564259483|FG000|Overall Study|Protocol Violation|0|||
156316940|NCT00592774|564259484|FG001|Overall Study|Protocol Violation|1|||
156316941|NCT00592774|564259485|FG002|Overall Study|Protocol Violation|0|||
156316942|NCT00592774|564259486|FG003|Overall Study|Protocol Violation|0|||
156316943|NCT00592774|564259487|FG004|Overall Study|Protocol Violation|1|||
156316944|NCT00592774|564259483|FG000|Overall Study|Withdrawal by Subject|3|||
156316945|NCT00592774|564259484|FG001|Overall Study|Withdrawal by Subject|7|||
156316946|NCT00592774|564259485|FG002|Overall Study|Withdrawal by Subject|0|||
156316947|NCT00592774|564259486|FG003|Overall Study|Withdrawal by Subject|0|||
156316948|NCT00592774|564259487|FG004|Overall Study|Withdrawal by Subject|0|||
156316949|NCT00592774|564259483|FG000|Overall Study|Lack of Efficacy|3|||
156316950|NCT00592774|564259484|FG001|Overall Study|Lack of Efficacy|3|||
156316951|NCT00592774|564259485|FG002|Overall Study|Lack of Efficacy|0|||
156316952|NCT00592774|564259486|FG003|Overall Study|Lack of Efficacy|0|||
156316953|NCT00592774|564259487|FG004|Overall Study|Lack of Efficacy|2|||
156316954|NCT00592774|564259483|FG000|Overall Study|Physician Decision|0|||
156316955|NCT00592774|564259484|FG001|Overall Study|Physician Decision|1|||
156653211|NCT01296932|565477915|FG002|Overall Study|Low benefit and too many side effects|0|||
156316956|NCT00592774|564259485|FG002|Overall Study|Physician Decision|1|||
156316957|NCT00592774|564259486|FG003|Overall Study|Physician Decision|0|||
156316958|NCT00592774|564259487|FG004|Overall Study|Physician Decision|1|||
156316959|NCT00592774|564259483|FG000|Overall Study|Other|0|||
156316960|NCT00592774|564259484|FG001|Overall Study|Other|1|||
156316961|NCT00592774|564259485|FG002|Overall Study|Other|1|||
156316962|NCT00592774|564259486|FG003|Overall Study|Other|0|||
156316963|NCT00592774|564259487|FG004|Overall Study|Other|2|||
156316964|NCT02312687|564259494|FG000|Overall Study|Other, Not Specified|1|||
156316965|NCT01089361|564259497|FG000|Overall Study|Death|1|||
156316966|NCT01089361|564259498|FG001|Overall Study|Death|0|||
156316967|NCT01514370|564259499|FG000|Overall Study|Protocol Violation|2|||
156316968|NCT01514370|564259500|FG001|Overall Study|Protocol Violation|3|||
156316969|NCT01514370|564259499|FG000|Overall Study|Lost to Follow-up|0|||
156316970|NCT01514370|564259500|FG001|Overall Study|Lost to Follow-up|2|||
156316971|NCT01514370|564259499|FG000|Overall Study|Withdrawal by Subject|2|||
156757423|NCT00103285|565864741|FG004|Response Assignment|Refusal|25|||
156757424|NCT00103285|565864742|FG005|Response Assignment|Refusal|15|||
156757425|NCT00103285|565864743|FG006|Response Assignment|Refusal|30|||
156757426|NCT00103285|565864744|FG007|Response Assignment|Refusal|10|||
156757427|NCT00103285|565864737|FG000|Response Assignment|Other|0|||
156757428|NCT00103285|565864738|FG001|Response Assignment|Other|30|||
156757429|NCT00103285|565864739|FG002|Response Assignment|Other|48|||
156316972|NCT01514370|564259500|FG001|Overall Study|Withdrawal by Subject|1|||
156316973|NCT01514370|564259499|FG000|Overall Study|Adverse Event|1|||
156316974|NCT01514370|564259500|FG001|Overall Study|Adverse Event|3|||
156316975|NCT01514370|564259499|FG000|Overall Study|Other|6|||
156316976|NCT01514370|564259500|FG001|Overall Study|Other|7|||
156316977|NCT01606878|564259501|FG000|Overall Study|Adverse Event|1|||
156316978|NCT01606878|564259502|FG001|Overall Study|Adverse Event|1|||
156316979|NCT01606878|564259503|FG002|Overall Study|Adverse Event|0|||
156316980|NCT01606878|564259504|FG003|Overall Study|Adverse Event|0|||
156316981|NCT01606878|564259505|FG004|Overall Study|Adverse Event|0|||
156316982|NCT01606878|564259506|FG005|Overall Study|Adverse Event|0|||
156316983|NCT01606878|564259507|FG006|Overall Study|Adverse Event|1|||
156316984|NCT01606878|564259508|FG007|Overall Study|Adverse Event|0|||
156316985|NCT01606878|564259509|FG008|Overall Study|Adverse Event|1|||
156316986|NCT01606878|564259510|FG009|Overall Study|Adverse Event|3|||
156316987|NCT01606878|564259511|FG010|Overall Study|Adverse Event|0|||
156316988|NCT01606878|564259501|FG000|Overall Study|Lack of Efficacy|1|||
156316989|NCT01606878|564259502|FG001|Overall Study|Lack of Efficacy|1|||
156316990|NCT01606878|564259503|FG002|Overall Study|Lack of Efficacy|1|||
156316991|NCT01606878|564259504|FG003|Overall Study|Lack of Efficacy|2|||
156316992|NCT01606878|564259505|FG004|Overall Study|Lack of Efficacy|1|||
156316993|NCT01606878|564259506|FG005|Overall Study|Lack of Efficacy|2|||
156316994|NCT01606878|564259507|FG006|Overall Study|Lack of Efficacy|1|||
156316995|NCT01606878|564259508|FG007|Overall Study|Lack of Efficacy|2|||
156316996|NCT01606878|564259509|FG008|Overall Study|Lack of Efficacy|2|||
156316997|NCT01606878|564259510|FG009|Overall Study|Lack of Efficacy|0|||
156316998|NCT01606878|564259511|FG010|Overall Study|Lack of Efficacy|1|||
156316999|NCT01606878|564259501|FG000|Overall Study|Physician Decision|1|||
156317000|NCT01606878|564259502|FG001|Overall Study|Physician Decision|0|||
156317001|NCT01606878|564259503|FG002|Overall Study|Physician Decision|2|||
156317002|NCT01606878|564259504|FG003|Overall Study|Physician Decision|1|||
156317003|NCT01606878|564259505|FG004|Overall Study|Physician Decision|1|||
156317004|NCT01606878|564259506|FG005|Overall Study|Physician Decision|1|||
156317005|NCT01606878|564259507|FG006|Overall Study|Physician Decision|2|||
156317006|NCT01606878|564259508|FG007|Overall Study|Physician Decision|0|||
156317007|NCT01606878|564259509|FG008|Overall Study|Physician Decision|1|||
156317008|NCT01606878|564259510|FG009|Overall Study|Physician Decision|0|||
156317009|NCT01606878|564259511|FG010|Overall Study|Physician Decision|0|||
156317010|NCT01606878|564259501|FG000|Overall Study|Withdrawal by Subject|3|||
156317011|NCT01606878|564259502|FG001|Overall Study|Withdrawal by Subject|2|||
156317012|NCT01606878|564259503|FG002|Overall Study|Withdrawal by Subject|2|||
156317013|NCT01606878|564259504|FG003|Overall Study|Withdrawal by Subject|0|||
156317014|NCT01606878|564259505|FG004|Overall Study|Withdrawal by Subject|1|||
156317015|NCT01606878|564259506|FG005|Overall Study|Withdrawal by Subject|1|||
156317016|NCT01606878|564259507|FG006|Overall Study|Withdrawal by Subject|2|||
156317017|NCT01606878|564259508|FG007|Overall Study|Withdrawal by Subject|1|||
156317018|NCT01606878|564259509|FG008|Overall Study|Withdrawal by Subject|2|||
156317019|NCT01606878|564259510|FG009|Overall Study|Withdrawal by Subject|0|||
156317020|NCT01606878|564259511|FG010|Overall Study|Withdrawal by Subject|2|||
156317021|NCT01007253|564259512|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
156317022|NCT01007253|564259513|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
156317023|NCT01007253|564259514|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
156317024|NCT01007253|564259515|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
156317025|NCT01159431|564259518|FG000|Overall Study|Adverse Event|1|||
156317026|NCT01159431|564259519|FG001|Overall Study|Adverse Event|2|||
156317027|NCT01159431|564259518|FG000|Overall Study|non-compliance|1|||
156317028|NCT01159431|564259519|FG001|Overall Study|non-compliance|1|||
156317029|NCT01159431|564259518|FG000|Overall Study|Lack of Efficacy|0|||
156317030|NCT01159431|564259519|FG001|Overall Study|Lack of Efficacy|3|||
156317031|NCT02232880|564259522|FG000|Overall Study|study stopped prior to randomization|1|||
156317032|NCT00604214|564259523|FG000|Baseline to Day 28|Death|223|||
156317033|NCT00604214|564259524|FG001|Baseline to Day 28|Death|202|||
156317034|NCT00604214|564259523|FG000|Baseline to Day 28|Lost to Follow-up|2|||
156317035|NCT00604214|564259524|FG001|Baseline to Day 28|Lost to Follow-up|4|||
156317036|NCT00604214|564259523|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
156317037|NCT00604214|564259524|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
156317038|NCT00604214|564259523|FG000|Day 29 to Day 90|Death|64|||
156317039|NCT00604214|564259524|FG001|Day 29 to Day 90|Death|67|||
156317040|NCT00604214|564259523|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
156317041|NCT00604214|564259524|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
156317042|NCT00604214|564259523|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
156757430|NCT00103285|565864740|FG003|Response Assignment|Other|38|||
156757431|NCT00103285|565864741|FG004|Response Assignment|Other|37|||
156418339|NCT02028884|564625260|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
156418340|NCT02028884|564625261|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
156418341|NCT02028884|564625262|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
156418342|NCT02028884|564625260|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
156418343|NCT02028884|564625261|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
156418344|NCT02028884|564625262|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
156418345|NCT02028884|564625260|FG000|Open-label Extension Period|Switched to another treatment option|3|||
156418346|NCT02028884|564625261|FG001|Open-label Extension Period|Switched to another treatment option|0|||
156418347|NCT02028884|564625262|FG002|Open-label Extension Period|Switched to another treatment option|0|||
156418348|NCT00354029|564625263|FG000|Overall Study|Protocol Violation|4|||
156418349|NCT00354029|564625264|FG001|Overall Study|Protocol Violation|2|||
156418350|NCT00826280|564625265|FG000|Overall Study|Randomized but drug not received|1|||
156418351|NCT00826280|564625266|FG001|Overall Study|Randomized but drug not received|0|||
156317043|NCT00604214|564259524|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
156317044|NCT00604214|564259523|FG000|Day 91 to Day 180|Death|19|||
156317045|NCT00604214|564259524|FG001|Day 91 to Day 180|Death|23|||
156317046|NCT00604214|564259523|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
156317047|NCT00604214|564259524|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
156317048|NCT00604214|564259523|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
156317049|NCT00604214|564259524|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
156317050|NCT03645434|564259527|FG000|Period 1|Adverse Event|0|||
156317051|NCT03645434|564259528|FG001|Period 1|Adverse Event|0|||
156317052|NCT03645434|564259529|FG002|Period 1|Adverse Event|0|||
156317053|NCT03645434|564259530|FG003|Period 1|Adverse Event|1|||
156317054|NCT03645434|564259531|FG004|Period 1|Adverse Event|0|||
156317055|NCT03645434|564259532|FG005|Period 1|Adverse Event|0|||
156317056|NCT03645434|564259527|FG000|Period 1|COPD exacerbation|0|||
156317057|NCT03645434|564259528|FG001|Period 1|COPD exacerbation|0|||
156317058|NCT03645434|564259529|FG002|Period 1|COPD exacerbation|0|||
156317059|NCT03645434|564259530|FG003|Period 1|COPD exacerbation|0|||
156317060|NCT03645434|564259531|FG004|Period 1|COPD exacerbation|1|||
156317061|NCT03645434|564259532|FG005|Period 1|COPD exacerbation|0|||
156317062|NCT02654717|564259533|FG000|Overall Study|Adverse Event|2|||
156317063|NCT02654717|564259534|FG001|Overall Study|Adverse Event|2|||
156317064|NCT02654717|564259533|FG000|Overall Study|Protocol Violation|1|||
156317065|NCT02654717|564259534|FG001|Overall Study|Protocol Violation|2|||
156317066|NCT02654717|564259533|FG000|Overall Study|Withdrawal by Subject|0|||
156317067|NCT02654717|564259534|FG001|Overall Study|Withdrawal by Subject|1|||
156317068|NCT02654717|564259533|FG000|Overall Study|Non-permitted medication|3|||
156317069|NCT02654717|564259534|FG001|Overall Study|Non-permitted medication|0|||
156317070|NCT00960570|564259537|FG000|21 Day Washout Period|Adverse Event|1|||
156317071|NCT00960570|564259537|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
156317072|NCT00960570|564259537|FG000|1 Day Period Between Dosing|Adverse Event|2|||
156317073|NCT00960570|564259537|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
156317074|NCT01451437|564259540|FG000|Overall Study|Adverse Event|0|||
156317075|NCT01451437|564259541|FG001|Overall Study|Adverse Event|0|||
156317076|NCT01451437|564259542|FG002|Overall Study|Adverse Event|0|||
156317077|NCT01451437|564259543|FG003|Overall Study|Adverse Event|0|||
156317078|NCT01451437|564259544|FG004|Overall Study|Adverse Event|0|||
156317079|NCT01451437|564259545|FG005|Overall Study|Adverse Event|1|||
156317080|NCT01451437|564259546|FG006|Overall Study|Adverse Event|1|||
156317081|NCT01451437|564259547|FG007|Overall Study|Adverse Event|2|||
156317082|NCT01451437|564259548|FG008|Overall Study|Adverse Event|1|||
156317083|NCT01451437|564259540|FG000|Overall Study|Physician Decision|1|||
156317084|NCT01451437|564259541|FG001|Overall Study|Physician Decision|1|||
156317085|NCT01451437|564259542|FG002|Overall Study|Physician Decision|2|||
156317086|NCT01451437|564259543|FG003|Overall Study|Physician Decision|0|||
156317087|NCT01451437|564259544|FG004|Overall Study|Physician Decision|0|||
156317088|NCT01451437|564259545|FG005|Overall Study|Physician Decision|0|||
156317089|NCT01451437|564259546|FG006|Overall Study|Physician Decision|0|||
156317090|NCT01451437|564259547|FG007|Overall Study|Physician Decision|0|||
156317091|NCT01451437|564259548|FG008|Overall Study|Physician Decision|0|||
156317092|NCT01451437|564259540|FG000|Overall Study|Disease Progression|0|||
156317093|NCT01451437|564259541|FG001|Overall Study|Disease Progression|0|||
156317094|NCT01451437|564259542|FG002|Overall Study|Disease Progression|1|||
156317095|NCT01451437|564259543|FG003|Overall Study|Disease Progression|1|||
156317096|NCT01451437|564259544|FG004|Overall Study|Disease Progression|3|||
156317097|NCT01451437|564259545|FG005|Overall Study|Disease Progression|2|||
156317098|NCT01451437|564259546|FG006|Overall Study|Disease Progression|3|||
156317099|NCT01451437|564259547|FG007|Overall Study|Disease Progression|1|||
156418352|NCT00826280|564625267|FG002|Overall Study|Randomized but drug not received|1|||
156317100|NCT01451437|564259548|FG008|Overall Study|Disease Progression|3|||
156317101|NCT01451437|564259540|FG000|Overall Study|Protocol Violation|0|||
156317102|NCT01451437|564259541|FG001|Overall Study|Protocol Violation|0|||
156317103|NCT01451437|564259542|FG002|Overall Study|Protocol Violation|0|||
156317104|NCT01451437|564259543|FG003|Overall Study|Protocol Violation|0|||
156317105|NCT01451437|564259544|FG004|Overall Study|Protocol Violation|0|||
156317106|NCT01451437|564259545|FG005|Overall Study|Protocol Violation|0|||
156418353|NCT00826280|564625265|FG000|Overall Study|Adverse Event|1|||
156418354|NCT00826280|564625266|FG001|Overall Study|Adverse Event|3|||
156418355|NCT00826280|564625267|FG002|Overall Study|Adverse Event|0|||
156418356|NCT00826280|564625265|FG000|Overall Study|Lost to Follow-up|0|||
156418357|NCT00826280|564625266|FG001|Overall Study|Lost to Follow-up|1|||
156418358|NCT00826280|564625267|FG002|Overall Study|Lost to Follow-up|0|||
156418359|NCT00826280|564625265|FG000|Overall Study|Sponsor discontinued subject or study|1|||
156418360|NCT00826280|564625266|FG001|Overall Study|Sponsor discontinued subject or study|0|||
156418361|NCT00826280|564625267|FG002|Overall Study|Sponsor discontinued subject or study|0|||
156418362|NCT00826280|564625265|FG000|Overall Study|Reversible ischemic defect not present|43|||
156418363|NCT00826280|564625266|FG001|Overall Study|Reversible ischemic defect not present|40|||
156418364|NCT00826280|564625267|FG002|Overall Study|Reversible ischemic defect not present|44|||
156418365|NCT00826280|564625265|FG000|Overall Study|Interpretation Failure|1|||
156418366|NCT00826280|564625266|FG001|Overall Study|Interpretation Failure|0|||
156418367|NCT00826280|564625267|FG002|Overall Study|Interpretation Failure|0|||
156418368|NCT00826280|564625265|FG000|Overall Study|Machine Failure|1|||
156418369|NCT00826280|564625266|FG001|Overall Study|Machine Failure|1|||
156418370|NCT00826280|564625267|FG002|Overall Study|Machine Failure|0|||
156418371|NCT00826280|564625265|FG000|Overall Study|One or more non-interpretable scan|0|||
156418372|NCT00826280|564625266|FG001|Overall Study|One or more non-interpretable scan|1|||
156418373|NCT00826280|564625267|FG002|Overall Study|One or more non-interpretable scan|1|||
156418374|NCT01477749|564625273|FG000|Overall Study|Physician Decision|4|||
156418375|NCT04004208|564625274|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156418376|NCT04004208|564625275|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156418377|NCT04004208|564625274|FG000|Overall Study|Death|3|||
156418378|NCT04004208|564625275|FG001|Overall Study|Death|0|||
156418379|NCT04004208|564625274|FG000|Overall Study|COVID-19 pandemic|1|||
156418380|NCT04004208|564625275|FG001|Overall Study|COVID-19 pandemic|0|||
156418381|NCT04004208|564625274|FG000|Overall Study|Physician Decision|1|||
156418382|NCT04004208|564625275|FG001|Overall Study|Physician Decision|0|||
156418383|NCT04004208|564625274|FG000|Overall Study|Adverse Event|1|||
156418384|NCT04004208|564625275|FG001|Overall Study|Adverse Event|1|||
156418385|NCT02724020|564625278|FG000|Overall Study|Death|16|||
156418386|NCT02724020|564625279|FG001|Overall Study|Death|18|||
156418387|NCT02724020|564625280|FG002|Overall Study|Death|19|||
156418388|NCT02724020|564625278|FG000|Overall Study|Lost to Follow-up|0|||
156418389|NCT02724020|564625279|FG001|Overall Study|Lost to Follow-up|3|||
156418390|NCT02724020|564625280|FG002|Overall Study|Lost to Follow-up|0|||
156418391|NCT02724020|564625278|FG000|Overall Study|Site Terminated by Sponsor|15|||
156418392|NCT02724020|564625279|FG001|Overall Study|Site Terminated by Sponsor|8|||
156418393|NCT02724020|564625280|FG002|Overall Study|Site Terminated by Sponsor|8|||
156418394|NCT02724020|564625278|FG000|Overall Study|Withdrawal by Subject|1|||
156418395|NCT02724020|564625279|FG001|Overall Study|Withdrawal by Subject|3|||
156418396|NCT02724020|564625280|FG002|Overall Study|Withdrawal by Subject|5|||
156418397|NCT03100838|564625283|FG000|Overall Study|Adverse Event|1|||
156418398|NCT03100838|564625284|FG001|Overall Study|Adverse Event|0|||
156418399|NCT03100838|564625285|FG002|Overall Study|Adverse Event|0|||
156418400|NCT03100838|564625286|FG003|Overall Study|Adverse Event|0|||
156418401|NCT03100838|564625283|FG000|Overall Study|Physician Decision|1|||
156418402|NCT03100838|564625284|FG001|Overall Study|Physician Decision|1|||
156418403|NCT03100838|564625285|FG002|Overall Study|Physician Decision|1|||
156418404|NCT03100838|564625286|FG003|Overall Study|Physician Decision|1|||
156418405|NCT03100838|564625283|FG000|Overall Study|Pregnancy|0|||
156418406|NCT03100838|564625284|FG001|Overall Study|Pregnancy|1|||
156418407|NCT03100838|564625285|FG002|Overall Study|Pregnancy|0|||
156418408|NCT03100838|564625286|FG003|Overall Study|Pregnancy|0|||
156418409|NCT03100838|564625283|FG000|Overall Study|Lost to Follow-up|0|||
156418410|NCT03100838|564625284|FG001|Overall Study|Lost to Follow-up|0|||
156418411|NCT03100838|564625285|FG002|Overall Study|Lost to Follow-up|1|||
156757432|NCT00103285|565864742|FG005|Response Assignment|Other|17|||
156757433|NCT00103285|565864743|FG006|Response Assignment|Other|11|||
156757434|NCT00103285|565864744|FG007|Response Assignment|Other|53|||
156757435|NCT02100839|565864748|FG000|Multiple Ascending Dose|Adverse Event|2|||
156757436|NCT02100839|565864749|FG001|Multiple Ascending Dose|Adverse Event|0|||
156418412|NCT03100838|564625286|FG003|Overall Study|Lost to Follow-up|0|||
156418413|NCT00801242|564625290|FG000|Overall Study|Adverse Event|10|||
156418414|NCT00801242|564625290|FG000|Overall Study|Withdrawal by Subject|13|||
156418415|NCT00801242|564625290|FG000|Overall Study|Protocol Violation|5|||
156418416|NCT00801242|564625290|FG000|Overall Study|Physician Decision|3|||
156418417|NCT00801242|564625290|FG000|Overall Study|Lost to Follow-up|1|||
156418418|NCT00801242|564625290|FG000|Overall Study|Miscellaneous reasons|20|||
156418419|NCT01347645|564625291|FG000|Overall Study|Death|1|||
156418420|NCT01347645|564625292|FG001|Overall Study|Death|5|||
156418421|NCT01347645|564625293|FG002|Overall Study|Death|2|||
156418422|NCT01347645|564625294|FG003|Overall Study|Death|7|||
156418423|NCT01347645|564625295|FG004|Overall Study|Death|7|||
156418424|NCT01347645|564625291|FG000|Overall Study|Lost to Follow-up|1|||
156418425|NCT01347645|564625292|FG001|Overall Study|Lost to Follow-up|1|||
156418426|NCT01347645|564625293|FG002|Overall Study|Lost to Follow-up|0|||
156757437|NCT02100839|565864748|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
156757438|NCT02100839|565864749|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
156757439|NCT03272347|565864752|FG000|Overall Study|Death|0|||
156757440|NCT03272347|565864753|FG001|Overall Study|Death|0|||
156757441|NCT03272347|565864754|FG002|Overall Study|Death|0|||
156757442|NCT03272347|565864755|FG003|Overall Study|Death|1|||
156757443|NCT03272347|565864752|FG000|Overall Study|Lost to Follow-up|1|||
156757444|NCT03272347|565864753|FG001|Overall Study|Lost to Follow-up|3|||
156757445|NCT03272347|565864754|FG002|Overall Study|Lost to Follow-up|5|||
156757446|NCT03272347|565864755|FG003|Overall Study|Lost to Follow-up|1|||
156757447|NCT03272347|565864752|FG000|Overall Study|Physician Decision|4|||
156757448|NCT03272347|565864753|FG001|Overall Study|Physician Decision|2|||
156757449|NCT03272347|565864754|FG002|Overall Study|Physician Decision|5|||
156757450|NCT03272347|565864755|FG003|Overall Study|Physician Decision|4|||
156757451|NCT03272347|565864752|FG000|Overall Study|Screen Failure|1|||
156757452|NCT03272347|565864753|FG001|Overall Study|Screen Failure|0|||
156757453|NCT03272347|565864754|FG002|Overall Study|Screen Failure|0|||
156757454|NCT03272347|565864755|FG003|Overall Study|Screen Failure|0|||
156757455|NCT03272347|565864752|FG000|Overall Study|Withdrawal by Subject|5|||
156757456|NCT03272347|565864753|FG001|Overall Study|Withdrawal by Subject|1|||
156757457|NCT03272347|565864754|FG002|Overall Study|Withdrawal by Subject|2|||
156757458|NCT03272347|565864755|FG003|Overall Study|Withdrawal by Subject|1|||
156317107|NCT01451437|564259546|FG006|Overall Study|Protocol Violation|1|||
156317108|NCT01451437|564259547|FG007|Overall Study|Protocol Violation|0|||
156317109|NCT01451437|564259548|FG008|Overall Study|Protocol Violation|0|||
156317110|NCT01451437|564259540|FG000|Overall Study|Withdrawal by Subject|0|||
156317111|NCT01451437|564259541|FG001|Overall Study|Withdrawal by Subject|0|||
156317112|NCT01451437|564259542|FG002|Overall Study|Withdrawal by Subject|0|||
156317113|NCT01451437|564259543|FG003|Overall Study|Withdrawal by Subject|0|||
156317114|NCT01451437|564259544|FG004|Overall Study|Withdrawal by Subject|1|||
156317115|NCT01451437|564259545|FG005|Overall Study|Withdrawal by Subject|0|||
156317116|NCT01451437|564259546|FG006|Overall Study|Withdrawal by Subject|1|||
156317117|NCT01451437|564259547|FG007|Overall Study|Withdrawal by Subject|0|||
156317118|NCT01451437|564259548|FG008|Overall Study|Withdrawal by Subject|0|||
156317119|NCT00853970|564259554|FG000|Overall Study|Withdrawal by Subject|2|||
156317120|NCT00853970|564259555|FG001|Overall Study|Withdrawal by Subject|1|||
156317121|NCT00853970|564259554|FG000|Overall Study|Cancelled surgery|4|||
156317122|NCT00853970|564259555|FG001|Overall Study|Cancelled surgery|2|||
156317123|NCT01275339|564261704|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
156317124|NCT01275339|564261705|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
156317125|NCT01275339|564261706|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
156317126|NCT01275339|564261707|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
156317127|NCT01275339|564261704|FG000|Overall Study|Withdrawal by Subject|0|||
156317128|NCT01275339|564261705|FG001|Overall Study|Withdrawal by Subject|0|||
156317129|NCT01275339|564261706|FG002|Overall Study|Withdrawal by Subject|1|||
156317130|NCT01275339|564261707|FG003|Overall Study|Withdrawal by Subject|0|||
156317131|NCT03718299|564261708|FG000|Overall Study|Adverse Event|1|||
156317132|NCT03718299|564261708|FG000|Overall Study|Withdrawal by Subject|6|||
156317133|NCT03718299|564261708|FG000|Overall Study|Physician Decision|2|||
156317134|NCT03718299|564261708|FG000|Overall Study|Lost to Follow-up|1|||
156317135|NCT04389970|564261709|FG000|Overall Study|Lost to Follow-up|1|||
156317136|NCT03123185|564261710|FG000|Overall Study|Withdrawal by Subject|0|||
156317137|NCT03123185|564261711|FG001|Overall Study|Withdrawal by Subject|0|||
156317138|NCT03123185|564261712|FG002|Overall Study|Withdrawal by Subject|0|||
156317139|NCT03123185|564261713|FG003|Overall Study|Withdrawal by Subject|0|||
156317140|NCT03123185|564261714|FG004|Overall Study|Withdrawal by Subject|0|||
156317141|NCT03123185|564261715|FG005|Overall Study|Withdrawal by Subject|0|||
156317142|NCT03123185|564261716|FG006|Overall Study|Withdrawal by Subject|0|||
156317143|NCT03123185|564261717|FG007|Overall Study|Withdrawal by Subject|0|||
156317144|NCT03123185|564261718|FG008|Overall Study|Withdrawal by Subject|0|||
156317145|NCT03123185|564261719|FG009|Overall Study|Withdrawal by Subject|0|||
156317146|NCT03123185|564261720|FG010|Overall Study|Withdrawal by Subject|0|||
156317147|NCT03123185|564261721|FG011|Overall Study|Withdrawal by Subject|0|||
156317148|NCT03123185|564261722|FG012|Overall Study|Withdrawal by Subject|1|||
156317149|NCT03123185|564261723|FG013|Overall Study|Withdrawal by Subject|0|||
156317150|NCT00923364|564261725|FG000|Overall Study|Death|3|||
156317151|NCT00923364|564261726|FG001|Overall Study|Death|0|||
156317152|NCT00923364|564261725|FG000|Overall Study|Did not go to transplant|1|||
156317153|NCT00923364|564261726|FG001|Overall Study|Did not go to transplant|0|||
156317154|NCT04352127|564261728|FG000|Overall Study|Unable to obtain readings|4|||
156317155|NCT04352127|564261729|FG001|Overall Study|Unable to obtain readings|1|||
156317156|NCT03023046|564261730|FG000|Overall Study|Withdrawal by Subject|1|||
156317157|NCT00640835|564261731|FG000|Overall Study|Adverse Event|5|||
156317158|NCT00640835|564261732|FG001|Overall Study|Adverse Event|3|||
156317159|NCT00640835|564261731|FG000|Overall Study|Withdrawal by Subject|12|||
156317160|NCT00640835|564261732|FG001|Overall Study|Withdrawal by Subject|14|||
156757459|NCT00940888|565864756|FG000|Overall Study|Unsuccessful Implant|4|||
156317161|NCT00640835|564261731|FG000|Overall Study|Physician Decision|10|||
156317162|NCT00640835|564261732|FG001|Overall Study|Physician Decision|14|||
156317163|NCT00640835|564261731|FG000|Overall Study|Sponsor's Decision|11|||
156317164|NCT00640835|564261732|FG001|Overall Study|Sponsor's Decision|7|||
156317165|NCT00640835|564261731|FG000|Overall Study|Protocol Violation|2|||
156317166|NCT00640835|564261732|FG001|Overall Study|Protocol Violation|2|||
156317167|NCT00640835|564261731|FG000|Overall Study|Lost to Follow-up|17|||
156317168|NCT00640835|564261732|FG001|Overall Study|Lost to Follow-up|13|||
156317169|NCT00640835|564261731|FG000|Overall Study|Other Reason|19|||
156317170|NCT00640835|564261732|FG001|Overall Study|Other Reason|4|||
156317171|NCT00775203|564261733|FG000|Overall Study|Adverse Event|25|||
156317172|NCT00775203|564261734|FG001|Overall Study|Adverse Event|6|||
156317173|NCT00775203|564261733|FG000|Overall Study|Lack of Efficacy|8|||
156317174|NCT00775203|564261734|FG001|Overall Study|Lack of Efficacy|9|||
156317175|NCT00775203|564261733|FG000|Overall Study|Withdrawal by Subject|11|||
156317176|NCT00775203|564261734|FG001|Overall Study|Withdrawal by Subject|9|||
156317177|NCT00775203|564261733|FG000|Overall Study|Lost to Follow-up|11|||
156317178|NCT00775203|564261734|FG001|Overall Study|Lost to Follow-up|15|||
156317179|NCT00775203|564261733|FG000|Overall Study|Administrative reason|2|||
156317180|NCT00775203|564261734|FG001|Overall Study|Administrative reason|0|||
156317181|NCT00775203|564261733|FG000|Overall Study|Noncompliance|4|||
156317182|NCT00775203|564261734|FG001|Overall Study|Noncompliance|2|||
156317183|NCT00775203|564261733|FG000|Overall Study|Protocol Violation|0|||
156317184|NCT00775203|564261734|FG001|Overall Study|Protocol Violation|1|||
156317185|NCT00775203|564261733|FG000|Overall Study|Entered other study|1|||
156317186|NCT00775203|564261734|FG001|Overall Study|Entered other study|0|||
156317187|NCT00775203|564261733|FG000|Overall Study|Physician Decision|0|||
156317188|NCT00775203|564261734|FG001|Overall Study|Physician Decision|1|||
156317189|NCT00635024|564261737|FG000|Overall Study|Adverse Event|1|||
156317190|NCT00713310|564261738|FG000|Overall Study|Adverse Event|5|||
156317191|NCT00713310|564261739|FG001|Overall Study|Adverse Event|2|||
156317192|NCT00713310|564261738|FG000|Overall Study|Lack of Efficacy|0|||
156317193|NCT00713310|564261739|FG001|Overall Study|Lack of Efficacy|2|||
156317194|NCT00713310|564261738|FG000|Overall Study|Withdrawal by Subject|0|||
156317195|NCT00713310|564261739|FG001|Overall Study|Withdrawal by Subject|2|||
156317196|NCT00686634|564261740|FG000|Overall Study|Protocol Violation|6|||
156317197|NCT00779259|564261741|FG000|Quinine Alone|Adverse Event|2|||
156317198|NCT03312751|564261744|FG000|Overall Study|Death|7|||
156317199|NCT03312751|564261745|FG001|Overall Study|Death|9|||
156317200|NCT03312751|564261744|FG000|Overall Study|Study discontinuation due to other reason|0|||
156317201|NCT03312751|564261745|FG001|Overall Study|Study discontinuation due to other reason|1|||
156317202|NCT00282464|564261746|FG000|Overall Study|Adverse Event|26|||
156317203|NCT00282464|564261747|FG001|Overall Study|Adverse Event|20|||
156317204|NCT00282464|564261746|FG000|Overall Study|Lack of Efficacy|8|||
156317205|NCT00282464|564261747|FG001|Overall Study|Lack of Efficacy|8|||
156317206|NCT00282464|564261746|FG000|Overall Study|Lost to Follow-up|10|||
156317207|NCT00282464|564261747|FG001|Overall Study|Lost to Follow-up|10|||
156317208|NCT00282464|564261746|FG000|Overall Study|Withdrawal by Subject|24|||
156317209|NCT00282464|564261747|FG001|Overall Study|Withdrawal by Subject|10|||
156317210|NCT00282464|564261746|FG000|Overall Study|laboratory abnormality|1|||
156317211|NCT00282464|564261747|FG001|Overall Study|laboratory abnormality|2|||
156317212|NCT00282464|564261746|FG000|Overall Study|Protocol Violation|0|||
156317213|NCT00282464|564261747|FG001|Overall Study|Protocol Violation|7|||
156317214|NCT00282464|564261746|FG000|Overall Study|Patient moved|1|||
156317215|NCT00282464|564261747|FG001|Overall Study|Patient moved|0|||
156317216|NCT00282464|564261746|FG000|Overall Study|patient non-compliant|3|||
156317217|NCT00282464|564261747|FG001|Overall Study|patient non-compliant|0|||
156317218|NCT00282464|564261746|FG000|Overall Study|patient no show|0|||
156317219|NCT00282464|564261747|FG001|Overall Study|patient no show|1|||
156317220|NCT00282464|564261746|FG000|Overall Study|patient incarcerated|0|||
156317221|NCT00282464|564261747|FG001|Overall Study|patient incarcerated|1|||
156317222|NCT00282464|564261746|FG000|Overall Study|family crisis|0|||
156317223|NCT00282464|564261747|FG001|Overall Study|family crisis|1|||
156317224|NCT00282464|564261746|FG000|Overall Study|dispensed wrong kit|0|||
156317225|NCT00282464|564261747|FG001|Overall Study|dispensed wrong kit|1|||
156317226|NCT00282464|564261746|FG000|Overall Study|dropped due to missed visits|0|||
156317227|NCT00282464|564261747|FG001|Overall Study|dropped due to missed visits|1|||
156317228|NCT00475423|564261748|FG000|Overall Study|Protocol Violation|5|||
156317229|NCT00475423|564261748|FG000|Overall Study|Adverse Event|4|||
156418427|NCT01347645|564625294|FG003|Overall Study|Lost to Follow-up|1|||
156418428|NCT01347645|564625295|FG004|Overall Study|Lost to Follow-up|1|||
156317230|NCT00475423|564261748|FG000|Overall Study|Withdrawal by Subject|6|||
156317231|NCT00475423|564261748|FG000|Overall Study|Lack of Efficacy|8|||
156317232|NCT00475423|564261748|FG000|Overall Study|Death|1|||
156317233|NCT00475423|564261748|FG000|Overall Study|Reason not specified|1|||
156317234|NCT00475423|564261748|FG000|Overall Study|Lost to Follow-up|7|||
156317235|NCT04098224|564261753|FG000|Overall Study|Adverse Event|1|||
156317236|NCT04098224|564261754|FG001|Overall Study|Adverse Event|0|||
156317237|NCT04098224|564261753|FG000|Overall Study|Physician Decision|1|||
156757460|NCT00940888|565864756|FG000|Overall Study|Death|461|||
156757461|NCT00940888|565864756|FG000|Overall Study|Withdrawn - Non-Death|364|||
156757462|NCT00940888|565864756|FG000|Overall Study|Lost to Follow-up|6|||
156757463|NCT00391872|565864757|FG000|Overall Study|Protocol Violation|7|||
156757464|NCT00391872|565864758|FG001|Overall Study|Protocol Violation|2|||
156757465|NCT00391872|565864757|FG000|Overall Study|Withdrawal by Subject|296|||
156757466|NCT00391872|565864758|FG001|Overall Study|Withdrawal by Subject|249|||
156757467|NCT00391872|565864757|FG000|Overall Study|Reason unknown|2|||
156757468|NCT00391872|565864758|FG001|Overall Study|Reason unknown|4|||
156757469|NCT00391872|565864757|FG000|Overall Study|Lost to Follow-up|2|||
156757470|NCT00391872|565864758|FG001|Overall Study|Lost to Follow-up|0|||
156757471|NCT01409915|565864759|FG000|Overall Study|Adverse Event|0|||
156757472|NCT01409915|565864760|FG001|Overall Study|Adverse Event|2|||
156757473|NCT01409915|565864759|FG000|Overall Study|Withdrawal by Subject|0|||
156757474|NCT01409915|565864760|FG001|Overall Study|Withdrawal by Subject|1|||
156757475|NCT01409915|565864759|FG000|Overall Study|Protocol Violation|1|||
156757476|NCT01409915|565864760|FG001|Overall Study|Protocol Violation|0|||
156757477|NCT04826484|565864761|FG000|Overall Study|Lost to Follow-up|2|||
156757478|NCT04826484|565864762|FG001|Overall Study|Lost to Follow-up|0|||
156757479|NCT01516736|565864769|FG000|Overall Study|Withdrawal by Subject|10|||
156757480|NCT01516736|565864770|FG001|Overall Study|Withdrawal by Subject|4|||
156757481|NCT01516736|565864769|FG000|Overall Study|Adverse Event|4|||
156757482|NCT01516736|565864770|FG001|Overall Study|Adverse Event|5|||
156757483|NCT01516736|565864769|FG000|Overall Study|Death|3|||
156757484|NCT01516736|565864770|FG001|Overall Study|Death|1|||
156757485|NCT01516736|565864769|FG000|Overall Study|Physician Decision|2|||
156757486|NCT01516736|565864770|FG001|Overall Study|Physician Decision|1|||
156757487|NCT01516736|565864769|FG000|Overall Study|Lack of Efficacy|1|||
156757488|NCT01516736|565864770|FG001|Overall Study|Lack of Efficacy|0|||
156757489|NCT01516736|565864769|FG000|Overall Study|Protocol Violation|0|||
156757490|NCT01516736|565864770|FG001|Overall Study|Protocol Violation|1|||
156757491|NCT01516736|565864769|FG000|Overall Study|Other (not specified)|0|||
156757492|NCT01516736|565864770|FG001|Overall Study|Other (not specified)|1|||
156757493|NCT02781818|565864771|FG000|Overall Study|Lost to Follow-up|4|||
156757494|NCT02781818|565864772|FG001|Overall Study|Lost to Follow-up|2|||
156757495|NCT02781818|565864773|FG002|Overall Study|Lost to Follow-up|1|||
156757496|NCT00524771|565864774|FG000|Overall Study|Protocol Violation|220|||
156757497|NCT00524771|565864775|FG001|Overall Study|Protocol Violation|585|||
156757498|NCT01877668|565864776|FG000|Overall Study|Death|0|||
156757499|NCT01877668|565864777|FG001|Overall Study|Death|0|||
156317238|NCT04098224|564261754|FG001|Overall Study|Physician Decision|0|||
156317239|NCT04098224|564261753|FG000|Overall Study|Patient not required enteral feeding|1|||
156317240|NCT04098224|564261754|FG001|Overall Study|Patient not required enteral feeding|0|||
156317241|NCT04098224|564261753|FG000|Overall Study|Patient failure nasogastric tube|1|||
156317242|NCT04098224|564261754|FG001|Overall Study|Patient failure nasogastric tube|0|||
156317243|NCT04098224|564261753|FG000|Overall Study|Patient early extubation|1|||
156317244|NCT04098224|564261754|FG001|Overall Study|Patient early extubation|3|||
156317245|NCT01587898|564261764|FG000|Overall Study|Adverse Event|1|||
156317246|NCT01587898|564261765|FG001|Overall Study|Adverse Event|1|||
156317247|NCT01587898|564261766|FG002|Overall Study|Adverse Event|0|||
156317248|NCT01587898|564261767|FG003|Overall Study|Adverse Event|0|||
156317249|NCT01587898|564261764|FG000|Overall Study|Protocol Violation|0|||
156317250|NCT01587898|564261765|FG001|Overall Study|Protocol Violation|2|||
156317251|NCT01587898|564261766|FG002|Overall Study|Protocol Violation|1|||
156317252|NCT01587898|564261767|FG003|Overall Study|Protocol Violation|1|||
156317253|NCT01587898|564261764|FG000|Overall Study|Lost to Follow-up|0|||
156317254|NCT01587898|564261765|FG001|Overall Study|Lost to Follow-up|0|||
156317255|NCT01587898|564261766|FG002|Overall Study|Lost to Follow-up|0|||
156317256|NCT01587898|564261767|FG003|Overall Study|Lost to Follow-up|1|||
156317257|NCT01587898|564261764|FG000|Overall Study|Withdrawal by Subject|2|||
156757500|NCT01877668|565864778|FG002|Overall Study|Death|0|||
156757501|NCT01877668|565864779|FG003|Overall Study|Death|1|||
156757502|NCT01877668|565864780|FG004|Overall Study|Death|0|||
156757503|NCT01877668|565864776|FG000|Overall Study|No longer met study criteria|1|||
156757504|NCT01877668|565864777|FG001|Overall Study|No longer met study criteria|0|||
156757505|NCT01877668|565864778|FG002|Overall Study|No longer met study criteria|1|||
156757506|NCT01877668|565864779|FG003|Overall Study|No longer met study criteria|0|||
156757507|NCT01877668|565864780|FG004|Overall Study|No longer met study criteria|0|||
156757508|NCT01877668|565864776|FG000|Overall Study|Insufficient clinical response|0|||
156757509|NCT01877668|565864777|FG001|Overall Study|Insufficient clinical response|1|||
156317258|NCT01587898|564261765|FG001|Overall Study|Withdrawal by Subject|1|||
156317259|NCT01587898|564261766|FG002|Overall Study|Withdrawal by Subject|0|||
156317260|NCT01587898|564261767|FG003|Overall Study|Withdrawal by Subject|0|||
156317261|NCT01587898|564261764|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
156757510|NCT01877668|565864778|FG002|Overall Study|Insufficient clinical response|2|||
156757511|NCT01877668|565864779|FG003|Overall Study|Insufficient clinical response|2|||
156757512|NCT01877668|565864780|FG004|Overall Study|Insufficient clinical response|0|||
156757513|NCT01877668|565864776|FG000|Overall Study|Lost to Follow-up|0|||
156317262|NCT01587898|564261765|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
156317263|NCT01587898|564261766|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
156317264|NCT01587898|564261767|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
156317265|NCT01738477|564261768|FG000|Overall Study|Lost to Follow-up|1|||
156317266|NCT01738477|564261769|FG001|Overall Study|Lost to Follow-up|4|||
156317267|NCT00502203|564261770|FG000|Overall Study|Inevaluable|1|||
156317268|NCT02720094|564261771|FG000|Overall Study|Ongoing|2210|||
156317269|NCT02720094|564261772|FG001|Overall Study|Ongoing|2203|||
156317270|NCT02720094|564261771|FG000|Overall Study|Scheduled exit visit/end of study|2|||
156317271|NCT02720094|564261772|FG001|Overall Study|Scheduled exit visit/end of study|1|||
156317272|NCT02720094|564261771|FG000|Overall Study|Death|4|||
156317273|NCT02720094|564261772|FG001|Overall Study|Death|7|||
156317274|NCT02720094|564261771|FG000|Overall Study|Withdrawal by Subject|55|||
156317275|NCT02720094|564261772|FG001|Overall Study|Withdrawal by Subject|56|||
156317276|NCT02720094|564261771|FG000|Overall Study|Lost to Follow-up|2|||
156317277|NCT02720094|564261772|FG001|Overall Study|Lost to Follow-up|7|||
156317278|NCT02720094|564261771|FG000|Overall Study|Physician Decision|1|||
156317279|NCT02720094|564261772|FG001|Overall Study|Physician Decision|3|||
156317280|NCT02720094|564261771|FG000|Overall Study|Inappropriate enrollment|1|||
156317281|NCT02720094|564261772|FG001|Overall Study|Inappropriate enrollment|3|||
156317282|NCT02720094|564261771|FG000|Overall Study|Relocation|1|||
156317283|NCT02720094|564261772|FG001|Overall Study|Relocation|1|||
156317284|NCT02437110|564261777|FG000|Screening|Lost to Follow-up|3|||
156317285|NCT02437110|564261777|FG000|Screening|Physician Decision|1|||
156317286|NCT02437110|564261777|FG000|ART|Adverse Event|3|||
156317287|NCT02437110|564261777|FG000|ART|Protocol Violation|3|||
156317288|NCT02437110|564261777|FG000|ART|Withdrawal by Subject|4|||
156317289|NCT02437110|564261777|FG000|ART|Lost to follow-up prior to start of intervention|1|||
156317290|NCT02437110|564261777|FG000|ART|Physician decision prior to start of intervention|2|||
156317291|NCT02437110|564261777|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
156317292|NCT02437110|564261777|FG000|Post-ART|Lost to Follow-up|3|||
156317293|NCT02437110|564261777|FG000|Post-ART|Protocol Violation|4|||
156317294|NCT02437110|564261777|FG000|Post-ART|Withdrawal by Subject|3|||
156317295|NCT03735238|564261778|FG000|Overall Study|Did not want to participate in research|3|||
156317296|NCT03735238|564261778|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
156317297|NCT01431638|564261779|FG000|Overall Study|Adverse Event|1|||
156317298|NCT01431638|564261780|FG001|Overall Study|Adverse Event|3|||
156317299|NCT01431638|564261781|FG002|Overall Study|Adverse Event|1|||
156317300|NCT01431638|564261779|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156317301|NCT01431638|564261780|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156317302|NCT01431638|564261781|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
156317303|NCT01431638|564261779|FG000|Overall Study|Participants condition no longer requires study drug|0|||
156317304|NCT01431638|564261780|FG001|Overall Study|Participants condition no longer requires study drug|1|||
156317305|NCT01431638|564261781|FG002|Overall Study|Participants condition no longer requires study drug|0|||
156317306|NCT01431638|564261779|FG000|Overall Study|Participant withdrew consent|14|||
156317307|NCT01431638|564261780|FG001|Overall Study|Participant withdrew consent|5|||
156317308|NCT01431638|564261781|FG002|Overall Study|Participant withdrew consent|8|||
156317309|NCT01431638|564261779|FG000|Overall Study|Lost to Follow-up|7|||
156317310|NCT01431638|564261780|FG001|Overall Study|Lost to Follow-up|9|||
156317311|NCT01431638|564261781|FG002|Overall Study|Lost to Follow-up|7|||
156653212|NCT01296932|565477916|FG003|Overall Study|Low benefit and too many side effects|0|||
156653213|NCT01296932|565477917|FG004|Overall Study|Low benefit and too many side effects|0|||
156653214|NCT01296932|565477918|FG005|Overall Study|Low benefit and too many side effects|0|||
156653215|NCT01296932|565477919|FG006|Overall Study|Low benefit and too many side effects|0|||
156653216|NCT01296932|565477920|FG007|Overall Study|Low benefit and too many side effects|1|||
156653217|NCT01296932|565477921|FG008|Overall Study|Low benefit and too many side effects|0|||
156653218|NCT01296932|565477913|FG000|Overall Study|No adequate treatment response|0|||
156653219|NCT01296932|565477914|FG001|Overall Study|No adequate treatment response|0|||
156653220|NCT01296932|565477915|FG002|Overall Study|No adequate treatment response|0|||
156653221|NCT01296932|565477916|FG003|Overall Study|No adequate treatment response|0|||
156653222|NCT01296932|565477917|FG004|Overall Study|No adequate treatment response|0|||
156653223|NCT01296932|565477918|FG005|Overall Study|No adequate treatment response|0|||
156653224|NCT01296932|565477919|FG006|Overall Study|No adequate treatment response|0|||
156653225|NCT01296932|565477920|FG007|Overall Study|No adequate treatment response|1|||
156653226|NCT01296932|565477921|FG008|Overall Study|No adequate treatment response|0|||
156653227|NCT01296932|565477913|FG000|Overall Study|Dosage already reduced, AE still present|0|||
156653228|NCT01296932|565477914|FG001|Overall Study|Dosage already reduced, AE still present|0|||
156317312|NCT01431638|564261779|FG000|Overall Study|Administrative problems|1|||
156317313|NCT01431638|564261780|FG001|Overall Study|Administrative problems|4|||
156317314|NCT01431638|564261781|FG002|Overall Study|Administrative problems|6|||
156317315|NCT01431638|564261779|FG000|Overall Study|Death|1|||
156317316|NCT01431638|564261780|FG001|Overall Study|Death|0|||
156317317|NCT01431638|564261781|FG002|Overall Study|Death|0|||
156317318|NCT01431638|564261779|FG000|Overall Study|Protocol deviation|1|||
156418429|NCT01347645|564625291|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
156418430|NCT01347645|564625292|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
156418431|NCT01347645|564625293|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
156418432|NCT01347645|564625294|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
156418433|NCT01347645|564625295|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
156418434|NCT01347645|564625291|FG000|Overall Study|Other|1|||
156418435|NCT01347645|564625292|FG001|Overall Study|Other|0|||
156418436|NCT01347645|564625293|FG002|Overall Study|Other|0|||
156418437|NCT01347645|564625294|FG003|Overall Study|Other|0|||
156418438|NCT01347645|564625295|FG004|Overall Study|Other|1|||
156418439|NCT01347645|564625291|FG000|Overall Study|Withdrawal by Subject|0|||
156418440|NCT01347645|564625292|FG001|Overall Study|Withdrawal by Subject|0|||
156418441|NCT01347645|564625293|FG002|Overall Study|Withdrawal by Subject|0|||
156418442|NCT01347645|564625294|FG003|Overall Study|Withdrawal by Subject|3|||
156418443|NCT01347645|564625295|FG004|Overall Study|Withdrawal by Subject|3|||
156418444|NCT01347645|564625291|FG000|Overall Study|Physician Decision|0|||
156418445|NCT01347645|564625292|FG001|Overall Study|Physician Decision|0|||
156418446|NCT01347645|564625293|FG002|Overall Study|Physician Decision|0|||
156418447|NCT01347645|564625294|FG003|Overall Study|Physician Decision|0|||
156418448|NCT01347645|564625295|FG004|Overall Study|Physician Decision|1|||
156418449|NCT01347645|564625291|FG000|Overall Study|Adverse Event|0|||
156418450|NCT01347645|564625292|FG001|Overall Study|Adverse Event|0|||
156418451|NCT01347645|564625293|FG002|Overall Study|Adverse Event|0|||
156418452|NCT01347645|564625294|FG003|Overall Study|Adverse Event|1|||
156418453|NCT01347645|564625295|FG004|Overall Study|Adverse Event|1|||
156418454|NCT00184028|564625296|FG000|Overall Study|Death|1|||
156418455|NCT00184028|564625296|FG000|Overall Study|Lack of Efficacy|4|||
156418456|NCT00184028|564625296|FG000|Overall Study|Adverse Event|2|||
156418457|NCT00184028|564625296|FG000|Overall Study|Withdrawal by Subject|1|||
156418458|NCT00184028|564625296|FG000|Overall Study|Non-compliance|2|||
156418459|NCT00388362|564625297|FG000|Enrolled|Ineligible|1|||
156418460|NCT00388362|564625297|FG000|Enrolled|Adverse Event|9|||
156418461|NCT00388362|564625297|FG000|Enrolled|Death|1|||
156418462|NCT00388362|564625297|FG000|Enrolled|Loss insurance|1|||
156418463|NCT00388362|564625297|FG000|Enrolled|Withdrawal by Subject|1|||
156418464|NCT00388362|564625297|FG000|Remained on Study Median of 514 Days|Death|2|||
156418465|NCT01141660|564625298|FG000|Overall Study|Physician Decision|0|||
156418466|NCT01141660|564625299|FG001|Overall Study|Physician Decision|12|||
156418467|NCT00209027|564625301|FG000|Overall Study|study terminated|10|||
156418468|NCT00209027|564625302|FG001|Overall Study|study terminated|0|||
156418469|NCT02335268|564625303|FG000|Overall Study|Physician Decision|5|||
156418470|NCT02335268|564625304|FG001|Overall Study|Physician Decision|1|||
156418471|NCT02335268|564625303|FG000|Overall Study|Lack of Efficacy|2|||
156418472|NCT02335268|564625304|FG001|Overall Study|Lack of Efficacy|1|||
156418473|NCT02335268|564625303|FG000|Overall Study|Adverse Event|5|||
156418474|NCT02335268|564625304|FG001|Overall Study|Adverse Event|2|||
156418475|NCT02335268|564625303|FG000|Overall Study|increase blasts|2|||
156418476|NCT02335268|564625304|FG001|Overall Study|increase blasts|0|||
156418477|NCT02335268|564625303|FG000|Overall Study|Withdrawal by Subject|3|||
156418478|NCT02335268|564625304|FG001|Overall Study|Withdrawal by Subject|2|||
156418479|NCT03259373|564625307|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
156418480|NCT03259373|564625308|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
156418481|NCT03259373|564625307|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
156418482|NCT03259373|564625308|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
156418483|NCT03259373|564625307|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
156418484|NCT03259373|564625308|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
156418485|NCT03259373|564625307|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
156418486|NCT03259373|564625308|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
156418487|NCT03259373|564625307|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
156418488|NCT03259373|564625308|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
156418489|NCT03259373|564625307|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
156757514|NCT01877668|565864777|FG001|Overall Study|Lost to Follow-up|2|||
156757515|NCT01877668|565864778|FG002|Overall Study|Lost to Follow-up|1|||
156757516|NCT01877668|565864779|FG003|Overall Study|Lost to Follow-up|0|||
156757517|NCT01877668|565864780|FG004|Overall Study|Lost to Follow-up|0|||
156418490|NCT03259373|564625308|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
156418491|NCT05893797|564625309|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
156757518|NCT01877668|565864776|FG000|Overall Study|Withdrawal by Subject|2|||
156757519|NCT01877668|565864777|FG001|Overall Study|Withdrawal by Subject|0|||
156757520|NCT01877668|565864778|FG002|Overall Study|Withdrawal by Subject|3|||
156418492|NCT05893797|564625309|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
156418493|NCT05893797|564625309|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
156418494|NCT05893797|564625309|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
156418495|NCT04770220|564625310|FG000|Overall Study|Adverse Event|2|||
156418496|NCT04770220|564625311|FG001|Overall Study|Adverse Event|11|||
156418497|NCT04770220|564625310|FG000|Overall Study|Withdrawal by Subject|5|||
156418498|NCT04770220|564625311|FG001|Overall Study|Withdrawal by Subject|11|||
156418499|NCT04770220|564625310|FG000|Overall Study|Lost to Follow-up|4|||
156418500|NCT04770220|564625311|FG001|Overall Study|Lost to Follow-up|3|||
156418501|NCT04770220|564625310|FG000|Overall Study|not otherwise specified|2|||
156418502|NCT04770220|564625311|FG001|Overall Study|not otherwise specified|3|||
156418503|NCT04770220|564625310|FG000|Overall Study|Physician Decision|1|||
156418504|NCT04770220|564625311|FG001|Overall Study|Physician Decision|3|||
156418505|NCT04894903|564625313|FG000|Overall Study|Death|1|||
156418506|NCT04894903|564625314|FG001|Overall Study|Death|0|||
156418507|NCT04894903|564625313|FG000|Overall Study|Pregnancy|1|||
156418508|NCT04894903|564625314|FG001|Overall Study|Pregnancy|0|||
156418509|NCT04894903|564625313|FG000|Overall Study|Withdrawal by Subject|1|||
156418510|NCT04894903|564625314|FG001|Overall Study|Withdrawal by Subject|1|||
156418511|NCT04894903|564625313|FG000|Overall Study|moved or exited health system|1|||
156418512|NCT04894903|564625314|FG001|Overall Study|moved or exited health system|3|||
156418513|NCT04320615|564625315|FG000|Overall Study|Withdrawal by Subject|4|||
156418514|NCT04320615|564625316|FG001|Overall Study|Withdrawal by Subject|10|||
156418515|NCT04320615|564625315|FG000|Overall Study|Physician Decision|2|||
156418516|NCT04320615|564625316|FG001|Overall Study|Physician Decision|0|||
156418517|NCT04320615|564625315|FG000|Overall Study|Other|2|||
156418518|NCT04320615|564625316|FG001|Overall Study|Other|0|||
156418519|NCT04320615|564625315|FG000|Overall Study|Lost to Follow-up|5|||
156418520|NCT04320615|564625316|FG001|Overall Study|Lost to Follow-up|23|||
156418521|NCT04320615|564625315|FG000|Overall Study|Death|35|||
156418522|NCT04320615|564625316|FG001|Overall Study|Death|71|||
156418523|NCT03873246|564625318|FG000|Overall Study|Adverse Event|1|||
156418524|NCT03873246|564625319|FG001|Overall Study|Adverse Event|3|||
156418525|NCT03873246|564625320|FG002|Overall Study|Adverse Event|3|||
156418526|NCT03873246|564625318|FG000|Overall Study|Lost to Follow-up|4|||
156418527|NCT03873246|564625319|FG001|Overall Study|Lost to Follow-up|4|||
156418528|NCT03873246|564625320|FG002|Overall Study|Lost to Follow-up|5|||
156418529|NCT03873246|564625318|FG000|Overall Study|Protocol Violation|0|||
156418530|NCT03873246|564625319|FG001|Overall Study|Protocol Violation|1|||
156418531|NCT03873246|564625320|FG002|Overall Study|Protocol Violation|0|||
156418532|NCT03873246|564625318|FG000|Overall Study|Withdrawal by Subject|0|||
156418533|NCT03873246|564625319|FG001|Overall Study|Withdrawal by Subject|4|||
156418534|NCT03873246|564625320|FG002|Overall Study|Withdrawal by Subject|1|||
156418535|NCT01857323|564625321|FG000|Overall Study|Adverse Event|1|||
156418536|NCT01857323|564625321|FG000|Overall Study|Withdrawal by Subject|3|||
156418537|NCT01857323|564625321|FG000|Overall Study|Non-compliance|1|||
156418538|NCT01857323|564625321|FG000|Overall Study|Protocol Violation|6|||
156418539|NCT01857323|564625321|FG000|Overall Study|Lost to Follow-up|1|||
156418540|NCT01857323|564625321|FG000|Overall Study|Other|4|||
156418541|NCT01857323|564625321|FG000|Overall Study|Did not complete 180 doses|48|||
156418542|NCT02107443|564625322|FG000|Overall Study|Death|42|||
156418543|NCT02107443|564625323|FG001|Overall Study|Death|30|||
156418544|NCT02107443|564625322|FG000|Overall Study|Study Protocol Violation|3|||
156418545|NCT02107443|564625323|FG001|Overall Study|Study Protocol Violation|1|||
156418546|NCT02107443|564625322|FG000|Overall Study|Registered but Not Eligible|0|||
156418547|NCT02107443|564625323|FG001|Overall Study|Registered but Not Eligible|1|||
156418548|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
156418549|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
156418550|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
156418551|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
156418552|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Changed Mind|2|||
156418553|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Changed Mind|0|||
156418554|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
156418555|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
156653229|NCT01296932|565477915|FG002|Overall Study|Dosage already reduced, AE still present|0|||
156418556|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
156418557|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
156418558|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
156418559|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
156653230|NCT01296932|565477916|FG003|Overall Study|Dosage already reduced, AE still present|0|||
156418560|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
156418561|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
156418562|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Other Medical|9|||
156653231|NCT01296932|565477917|FG004|Overall Study|Dosage already reduced, AE still present|0|||
156418563|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Other Medical|5|||
156418564|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Disease Progression|4|||
156757521|NCT01877668|565864779|FG003|Overall Study|Withdrawal by Subject|2|||
156757522|NCT01877668|565864780|FG004|Overall Study|Withdrawal by Subject|2|||
156757523|NCT01877668|565864776|FG000|Overall Study|Other|1|||
156757524|NCT01877668|565864777|FG001|Overall Study|Other|1|||
156757525|NCT01877668|565864778|FG002|Overall Study|Other|1|||
156757526|NCT01877668|565864779|FG003|Overall Study|Other|1|||
156757527|NCT01877668|565864780|FG004|Overall Study|Other|3|||
156757528|NCT01877668|565864776|FG000|Overall Study|Protocol Violation|1|||
156757529|NCT01877668|565864777|FG001|Overall Study|Protocol Violation|1|||
156757530|NCT01877668|565864778|FG002|Overall Study|Protocol Violation|0|||
156757531|NCT01877668|565864779|FG003|Overall Study|Protocol Violation|0|||
156757532|NCT01877668|565864780|FG004|Overall Study|Protocol Violation|3|||
156757533|NCT01877668|565864776|FG000|Overall Study|Adverse event related to study drug|2|||
156757534|NCT01877668|565864777|FG001|Overall Study|Adverse event related to study drug|2|||
156757535|NCT01877668|565864778|FG002|Overall Study|Adverse event related to study drug|2|||
156757536|NCT01877668|565864779|FG003|Overall Study|Adverse event related to study drug|2|||
156757537|NCT01877668|565864780|FG004|Overall Study|Adverse event related to study drug|1|||
156757538|NCT01877668|565864776|FG000|Overall Study|Adverse event unrelated to study drug|4|||
156757539|NCT01877668|565864777|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156757540|NCT01877668|565864778|FG002|Overall Study|Adverse event unrelated to study drug|2|||
156757541|NCT01877668|565864779|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156757542|NCT01877668|565864780|FG004|Overall Study|Adverse event unrelated to study drug|1|||
156317319|NCT01431638|564261780|FG001|Overall Study|Protocol deviation|1|||
156317320|NCT01431638|564261781|FG002|Overall Study|Protocol deviation|4|||
156317321|NCT01431638|564261779|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
156317322|NCT01431638|564261780|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
156317323|NCT01431638|564261781|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
156317324|NCT01261780|564261782|FG000|Overall Study|Withdrawal by Subject|1|||
156317325|NCT01261780|564261783|FG001|Overall Study|Withdrawal by Subject|0|||
156317326|NCT01261780|564261782|FG000|Overall Study|Event not related to subject|1|||
156317327|NCT01261780|564261783|FG001|Overall Study|Event not related to subject|2|||
156317328|NCT01239732|564261784|FG000|Overall Study|Termination of study per protocol|667|||
156317329|NCT01239732|564261784|FG000|Overall Study|Death|226|||
156317330|NCT01239732|564261784|FG000|Overall Study|Withdrawal by Subject|87|||
156317331|NCT01239732|564261784|FG000|Overall Study|Adverse Event|6|||
156317332|NCT01239732|564261784|FG000|Overall Study|Protocol Violation|3|||
156317333|NCT01239732|564261784|FG000|Overall Study|Participant non compliance|5|||
156317334|NCT01239732|564261784|FG000|Overall Study|Study termination by sponsor|2|||
156317335|NCT01239732|564261784|FG000|Overall Study|Investigator's decision|4|||
156317336|NCT01239732|564261784|FG000|Overall Study|Treatment failure|2|||
156317337|NCT01239732|564261784|FG000|Overall Study|Other|19|||
156317338|NCT03836001|564261785|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
156317339|NCT03836001|564261786|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
156317340|NCT03836001|564261787|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
156317341|NCT03836001|564261785|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
156317342|NCT03836001|564261786|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
156317343|NCT03836001|564261787|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
156317344|NCT03836001|564261785|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
156317345|NCT03836001|564261786|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
156317346|NCT03836001|564261787|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
156317347|NCT03836001|564261785|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
156317348|NCT03836001|564261786|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
156317349|NCT03836001|564261787|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
156317350|NCT01381562|564261788|FG000|Overall Study|Adverse Event|0|||
156317351|NCT01381562|564261789|FG001|Overall Study|Adverse Event|1|||
156317352|NCT01381562|564261790|FG002|Overall Study|Adverse Event|0|||
156317353|NCT02660138|564261791|FG000|Overall Study|Adverse Event|0|||
156317354|NCT02660138|564261792|FG001|Overall Study|Adverse Event|3|||
156317355|NCT02660138|564261793|FG002|Overall Study|Adverse Event|2|||
156317356|NCT02660138|564261791|FG000|Overall Study|Lack of Efficacy|1|||
156317357|NCT02660138|564261792|FG001|Overall Study|Lack of Efficacy|2|||
156317358|NCT02660138|564261793|FG002|Overall Study|Lack of Efficacy|1|||
156317359|NCT02660138|564261791|FG000|Overall Study|Withdrawal by Subject|7|||
156317360|NCT02660138|564261792|FG001|Overall Study|Withdrawal by Subject|6|||
156317361|NCT02660138|564261793|FG002|Overall Study|Withdrawal by Subject|6|||
156317362|NCT02660138|564261791|FG000|Overall Study|Lost to Follow-up|4|||
156757543|NCT00954122|565864781|FG000|Overall Study|Withdrawal by Subject|5|||
156757544|NCT00954122|565864781|FG000|Overall Study|Adverse Event|1|||
156757545|NCT00954122|565864781|FG000|Overall Study|Safety Reason|1|||
156757546|NCT01957579|565864784|FG000|Overall Study|Withdrawal of concent|0|||
156317363|NCT02660138|564261792|FG001|Overall Study|Lost to Follow-up|4|||
156317364|NCT02660138|564261793|FG002|Overall Study|Lost to Follow-up|1|||
156317365|NCT02660138|564261791|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
156317366|NCT02660138|564261792|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
156317367|NCT02660138|564261793|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
156317368|NCT02660138|564261791|FG000|Overall Study|Other|1|||
156317369|NCT02660138|564261792|FG001|Overall Study|Other|1|||
156317370|NCT02660138|564261793|FG002|Overall Study|Other|0|||
156317371|NCT02660138|564261791|FG000|Overall Study|Not treated|0|||
156317372|NCT02660138|564261792|FG001|Overall Study|Not treated|1|||
156317373|NCT02660138|564261793|FG002|Overall Study|Not treated|0|||
156317374|NCT00308581|564261798|FG000|Induction Phase|Adverse Event|0|||
156317375|NCT00308581|564261799|FG001|Induction Phase|Adverse Event|0|||
156317376|NCT00308581|564261800|FG002|Induction Phase|Adverse Event|37|||
156317377|NCT00308581|564261798|FG000|Induction Phase|Lack of Efficacy|0|||
156317378|NCT00308581|564261799|FG001|Induction Phase|Lack of Efficacy|0|||
156317379|NCT00308581|564261800|FG002|Induction Phase|Lack of Efficacy|121|||
156317380|NCT00308581|564261798|FG000|Induction Phase|Withdrawal by Subject|0|||
156317381|NCT00308581|564261799|FG001|Induction Phase|Withdrawal by Subject|0|||
156317382|NCT00308581|564261800|FG002|Induction Phase|Withdrawal by Subject|5|||
156317383|NCT00308581|564261798|FG000|Induction Phase|Unknown reason|0|||
156317384|NCT00308581|564261799|FG001|Induction Phase|Unknown reason|0|||
156317385|NCT00308581|564261800|FG002|Induction Phase|Unknown reason|3|||
156317386|NCT00308581|564261798|FG000|Randomized Maintenance Phase|Adverse Event|10|||
156317387|NCT00308581|564261799|FG001|Randomized Maintenance Phase|Adverse Event|17|||
156317388|NCT00308581|564261800|FG002|Randomized Maintenance Phase|Adverse Event|0|||
156317389|NCT00308581|564261798|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
156317390|NCT00308581|564261799|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
156317391|NCT00308581|564261800|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
156317392|NCT00308581|564261798|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
156317393|NCT00308581|564261799|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
156317394|NCT00308581|564261800|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
156317395|NCT00308581|564261798|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
156317396|NCT00308581|564261799|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
156317397|NCT00308581|564261800|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
156317398|NCT00308581|564261798|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
156317399|NCT00308581|564261799|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
156317400|NCT00308581|564261800|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
156317401|NCT00308581|564261798|FG000|Randomized Maintenance Phase|Unknown reason|3|||
156317402|NCT00308581|564261799|FG001|Randomized Maintenance Phase|Unknown reason|0|||
156317403|NCT00308581|564261800|FG002|Randomized Maintenance Phase|Unknown reason|0|||
156317404|NCT00899353|564261803|FG000|Overall Study|Adverse Event|2|||
156317405|NCT00899353|564261803|FG000|Overall Study|Lost to Follow-up|1|||
156317406|NCT00899353|564261803|FG000|Overall Study|Withdrawal by Subject|2|||
156317407|NCT00095147|564261812|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
156317408|NCT00095147|564261813|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
156317409|NCT00095147|564261814|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
156317410|NCT00095147|564261815|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
156317411|NCT00095147|564261816|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
156317412|NCT00095147|564261812|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
156317413|NCT00095147|564261813|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
156317414|NCT00095147|564261814|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
156317415|NCT00095147|564261815|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
156317416|NCT00095147|564261816|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
156317417|NCT00095147|564261812|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
156317418|NCT00095147|564261813|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
156317419|NCT00095147|564261814|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
156317420|NCT00095147|564261815|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
156317421|NCT00095147|564261816|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
156317422|NCT00095147|564261812|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
156317423|NCT00095147|564261813|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
156317424|NCT00095147|564261814|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
156317425|NCT00095147|564261815|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
156317426|NCT00095147|564261816|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
156317427|NCT00095147|564261812|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
156317428|NCT00095147|564261813|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
156653232|NCT01296932|565477918|FG005|Overall Study|Dosage already reduced, AE still present|0|||
156653233|NCT01296932|565477919|FG006|Overall Study|Dosage already reduced, AE still present|0|||
156653234|NCT01296932|565477920|FG007|Overall Study|Dosage already reduced, AE still present|0|||
156317429|NCT00095147|564261814|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
156317430|NCT00095147|564261815|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
156317431|NCT00095147|564261816|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
156317432|NCT00095147|564261812|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
156317433|NCT00095147|564261813|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
156317434|NCT00095147|564261814|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
156418565|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Disease Progression|2|||
156418566|NCT02107443|564625322|FG000|Overall Study|Withdrawal: Personal Issues|0|||
156418567|NCT02107443|564625323|FG001|Overall Study|Withdrawal: Personal Issues|3|||
156418568|NCT03057834|564625326|FG000|Overall Study|Withdrawal by Subject|25|||
156418569|NCT03057834|564625327|FG001|Overall Study|Withdrawal by Subject|29|||
156418570|NCT05593211|564625336|FG000|Overall Study|Withdrawal by Subject|1|||
156418571|NCT03077620|564625340|FG000|Overall Study|Unable to place lumbar catheter|1|||
156418572|NCT03077620|564625341|FG001|Overall Study|Unable to place lumbar catheter|0|||
156418573|NCT03077620|564625342|FG002|Overall Study|Unable to place lumbar catheter|1|||
156418574|NCT03077620|564625343|FG003|Overall Study|Unable to place lumbar catheter|0|||
156418575|NCT03077620|564625340|FG000|Overall Study|Withdrawal by Subject|0|||
156418576|NCT03077620|564625341|FG001|Overall Study|Withdrawal by Subject|1|||
156418577|NCT03077620|564625342|FG002|Overall Study|Withdrawal by Subject|0|||
156418578|NCT03077620|564625343|FG003|Overall Study|Withdrawal by Subject|0|||
156418579|NCT03077620|564625340|FG000|Overall Study|Physician Decision|0|||
156418580|NCT03077620|564625341|FG001|Overall Study|Physician Decision|0|||
156418581|NCT03077620|564625342|FG002|Overall Study|Physician Decision|1|||
156418582|NCT03077620|564625343|FG003|Overall Study|Physician Decision|0|||
156418583|NCT03225846|564625344|FG000|Overall Study|Adverse Event|0|||
156418584|NCT03225846|564625345|FG001|Overall Study|Adverse Event|0|||
156418585|NCT03225846|564625346|FG002|Overall Study|Adverse Event|0|||
156418586|NCT03225846|564625347|FG003|Overall Study|Adverse Event|0|||
156418587|NCT03225846|564625348|FG004|Overall Study|Adverse Event|0|||
156418588|NCT03225846|564625349|FG005|Overall Study|Adverse Event|0|||
156418589|NCT03225846|564625350|FG006|Overall Study|Adverse Event|6|||
156418590|NCT03225846|564625344|FG000|Overall Study|Withdrawal by Subject|0|||
156418591|NCT03225846|564625345|FG001|Overall Study|Withdrawal by Subject|1|||
156418592|NCT03225846|564625346|FG002|Overall Study|Withdrawal by Subject|0|||
156418593|NCT03225846|564625347|FG003|Overall Study|Withdrawal by Subject|0|||
156418594|NCT03225846|564625348|FG004|Overall Study|Withdrawal by Subject|0|||
156418595|NCT03225846|564625349|FG005|Overall Study|Withdrawal by Subject|0|||
156418596|NCT03225846|564625350|FG006|Overall Study|Withdrawal by Subject|0|||
156418597|NCT03225846|564625344|FG000|Overall Study|Death|0|||
156418598|NCT03225846|564625345|FG001|Overall Study|Death|1|||
156418599|NCT03225846|564625346|FG002|Overall Study|Death|0|||
156418600|NCT03225846|564625347|FG003|Overall Study|Death|0|||
156418601|NCT03225846|564625348|FG004|Overall Study|Death|0|||
156418602|NCT03225846|564625349|FG005|Overall Study|Death|0|||
156418603|NCT03225846|564625350|FG006|Overall Study|Death|0|||
156418604|NCT03225846|564625344|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
156418605|NCT03225846|564625345|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
156418606|NCT03225846|564625346|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
156418607|NCT03225846|564625347|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
156418608|NCT03225846|564625348|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
156418609|NCT03225846|564625349|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
156418610|NCT03225846|564625350|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
156418611|NCT03225846|564625344|FG000|Overall Study|Patient decision|0|||
156418612|NCT03225846|564625345|FG001|Overall Study|Patient decision|0|||
156418613|NCT03225846|564625346|FG002|Overall Study|Patient decision|0|||
156418614|NCT03225846|564625347|FG003|Overall Study|Patient decision|0|||
156418615|NCT03225846|564625348|FG004|Overall Study|Patient decision|0|||
156418616|NCT03225846|564625349|FG005|Overall Study|Patient decision|0|||
156418617|NCT03225846|564625350|FG006|Overall Study|Patient decision|1|||
156418618|NCT04248465|564625351|FG000|Randomized-Controlled Period|Death|12|||
156418619|NCT04248465|564625352|FG001|Randomized-Controlled Period|Death|5|||
156418620|NCT04248465|564625351|FG000|Randomized-Controlled Period|Adverse Event|2|||
156418621|NCT04248465|564625352|FG001|Randomized-Controlled Period|Adverse Event|0|||
156418622|NCT04248465|564625351|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
156418623|NCT04248465|564625352|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
156418624|NCT04248465|564625351|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
156418625|NCT04248465|564625352|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
156418626|NCT04248465|564625351|FG000|Randomized-Controlled Period|Physician Decision|1|||
156418627|NCT04248465|564625352|FG001|Randomized-Controlled Period|Physician Decision|1|||
156418628|NCT04248465|564625351|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
156418629|NCT04248465|564625352|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
156418630|NCT04248465|564625351|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
156418631|NCT04248465|564625352|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
156418632|NCT04248465|564625351|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
156418633|NCT04248465|564625352|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
156418634|NCT01254890|564625353|FG000|Overall Study|Ineligible|0|||
156418635|NCT01254890|564625354|FG001|Overall Study|Ineligible|3|||
156418636|NCT01254890|564625353|FG000|Overall Study|Withdrawal by Subject|1|||
156418637|NCT01254890|564625354|FG001|Overall Study|Withdrawal by Subject|2|||
156418638|NCT01254890|564625353|FG000|Overall Study|Disease Progression|0|||
156418639|NCT01254890|564625354|FG001|Overall Study|Disease Progression|5|||
156757547|NCT01957579|565864785|FG001|Overall Study|Withdrawal of concent|1|||
156757548|NCT01957579|565864786|FG002|Overall Study|Withdrawal of concent|0|||
156757549|NCT01957579|565864787|FG003|Overall Study|Withdrawal of concent|0|||
156757550|NCT01957579|565864784|FG000|Overall Study|Death|0|||
156757551|NCT01957579|565864785|FG001|Overall Study|Death|0|||
156757552|NCT01957579|565864786|FG002|Overall Study|Death|2|||
156757553|NCT01957579|565864787|FG003|Overall Study|Death|0|||
156757554|NCT00377637|565864788|FG000|Induction Phase|Adverse Event|12|||
156757555|NCT00377637|565864789|FG001|Induction Phase|Adverse Event|21|||
156757556|NCT00377637|565864790|FG002|Induction Phase|Adverse Event|0|||
156757557|NCT00377637|565864791|FG003|Induction Phase|Adverse Event|0|||
156757558|NCT00377637|565864788|FG000|Induction Phase|Deterioration/serum creatinine|2|||
156757559|NCT00377637|565864789|FG001|Induction Phase|Deterioration/serum creatinine|0|||
156757560|NCT00377637|565864790|FG002|Induction Phase|Deterioration/serum creatinine|0|||
156757561|NCT00377637|565864791|FG003|Induction Phase|Deterioration/serum creatinine|0|||
156757562|NCT00377637|565864788|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
156757563|NCT00377637|565864789|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
156757564|NCT00377637|565864790|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
156757565|NCT00377637|565864791|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
156757566|NCT00377637|565864788|FG000|Induction Phase|Lost to Follow-up|2|||
156757567|NCT00377637|565864789|FG001|Induction Phase|Lost to Follow-up|1|||
156757568|NCT00377637|565864790|FG002|Induction Phase|Lost to Follow-up|0|||
156757569|NCT00377637|565864791|FG003|Induction Phase|Lost to Follow-up|0|||
156757570|NCT00377637|565864788|FG000|Induction Phase|Death|1|||
156757571|NCT00377637|565864789|FG001|Induction Phase|Death|3|||
156317435|NCT00095147|564261815|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
156317436|NCT00095147|564261816|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
156317437|NCT00095147|564261812|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
156317438|NCT00095147|564261813|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
156317439|NCT00095147|564261814|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
156317440|NCT00095147|564261815|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
156317441|NCT00095147|564261816|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
156317442|NCT00095147|564261812|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
156317443|NCT00095147|564261813|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
156317444|NCT00095147|564261814|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
156317445|NCT00095147|564261815|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
156317446|NCT00095147|564261816|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
156317447|NCT00095147|564261812|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
156317448|NCT00095147|564261813|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
156317449|NCT00095147|564261814|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
156317450|NCT00095147|564261815|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
156317451|NCT00095147|564261816|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
156418640|NCT04988477|564625360|FG000|Overall Study|Death|1|||
156418641|NCT04988477|564625361|FG001|Overall Study|Death|0|||
156418642|NCT04988477|564625362|FG002|Overall Study|Death|0|||
156653235|NCT01296932|565477921|FG008|Overall Study|Dosage already reduced, AE still present|1|||
156653236|NCT02637557|565477930|FG000|Overall Study|Adverse Event|3|||
156653237|NCT02637557|565477931|FG001|Overall Study|Adverse Event|1|||
156653238|NCT02637557|565477932|FG002|Overall Study|Adverse Event|3|||
156653239|NCT02637557|565477933|FG003|Overall Study|Adverse Event|3|||
156653240|NCT02637557|565477930|FG000|Overall Study|Lost to Follow-up|1|||
156653241|NCT02637557|565477931|FG001|Overall Study|Lost to Follow-up|1|||
156653242|NCT02637557|565477932|FG002|Overall Study|Lost to Follow-up|0|||
156653243|NCT02637557|565477933|FG003|Overall Study|Lost to Follow-up|1|||
156653244|NCT02637557|565477930|FG000|Overall Study|Physician Decision|1|||
156653245|NCT02637557|565477931|FG001|Overall Study|Physician Decision|0|||
156653246|NCT02637557|565477932|FG002|Overall Study|Physician Decision|0|||
156653247|NCT02637557|565477933|FG003|Overall Study|Physician Decision|0|||
156653248|NCT02637557|565477930|FG000|Overall Study|Protocol Violation|2|||
156653249|NCT02637557|565477931|FG001|Overall Study|Protocol Violation|0|||
156653250|NCT02637557|565477932|FG002|Overall Study|Protocol Violation|2|||
156653251|NCT02637557|565477933|FG003|Overall Study|Protocol Violation|1|||
156653252|NCT02637557|565477930|FG000|Overall Study|Withdrawal by Subject|1|||
156653253|NCT02637557|565477931|FG001|Overall Study|Withdrawal by Subject|3|||
156653254|NCT02637557|565477932|FG002|Overall Study|Withdrawal by Subject|4|||
156653255|NCT02637557|565477933|FG003|Overall Study|Withdrawal by Subject|2|||
156653256|NCT02006706|565477934|FG000|Overall Study|Lost to Follow-up|1|||
156653257|NCT01673009|565477935|FG000|Overall Study|Physician Decision|5|||
156757572|NCT00377637|565864790|FG002|Induction Phase|Death|0|||
156757573|NCT00377637|565864791|FG003|Induction Phase|Death|0|||
156757574|NCT00377637|565864788|FG000|Induction Phase|Withdrawal by Subject|5|||
156757575|NCT00377637|565864789|FG001|Induction Phase|Withdrawal by Subject|6|||
156757576|NCT00377637|565864790|FG002|Induction Phase|Withdrawal by Subject|0|||
156418643|NCT04988477|564625360|FG000|Overall Study|Lost to Follow-up|5|||
156757577|NCT00377637|565864791|FG003|Induction Phase|Withdrawal by Subject|0|||
156757578|NCT00377637|565864788|FG000|Induction Phase|Physician Decision|3|||
156653258|NCT01673009|565477935|FG000|Overall Study|Withdrawal by Subject|8|||
156317452|NCT00095147|564261812|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
156317453|NCT00095147|564261813|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
156317454|NCT00095147|564261814|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
156317455|NCT00095147|564261815|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
156317456|NCT00095147|564261816|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
156317457|NCT00095147|564261812|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
156317458|NCT00095147|564261813|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
156317459|NCT00095147|564261814|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
156317460|NCT00095147|564261815|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
156317461|NCT00095147|564261816|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
156317462|NCT00095147|564261812|FG000|Long-term Extension Period|Death|0|||
156317463|NCT00095147|564261813|FG001|Long-term Extension Period|Death|0|||
156317464|NCT00095147|564261814|FG002|Long-term Extension Period|Death|0|||
156317465|NCT00095147|564261815|FG003|Long-term Extension Period|Death|0|||
156317466|NCT00095147|564261816|FG004|Long-term Extension Period|Death|3|||
156317467|NCT00095147|564261812|FG000|Long-term Extension Period|Adverse Event|0|||
156317468|NCT00095147|564261813|FG001|Long-term Extension Period|Adverse Event|0|||
156317469|NCT00095147|564261814|FG002|Long-term Extension Period|Adverse Event|0|||
156317470|NCT00095147|564261815|FG003|Long-term Extension Period|Adverse Event|0|||
156317471|NCT00095147|564261816|FG004|Long-term Extension Period|Adverse Event|11|||
156317472|NCT00095147|564261812|FG000|Long-term Extension Period|Lack of Efficacy|0|||
156317473|NCT00095147|564261813|FG001|Long-term Extension Period|Lack of Efficacy|0|||
156317474|NCT00095147|564261814|FG002|Long-term Extension Period|Lack of Efficacy|0|||
156317475|NCT00095147|564261815|FG003|Long-term Extension Period|Lack of Efficacy|0|||
156317476|NCT00095147|564261816|FG004|Long-term Extension Period|Lack of Efficacy|9|||
156317477|NCT00095147|564261812|FG000|Long-term Extension Period|Lost to Follow-up|0|||
156317478|NCT00095147|564261813|FG001|Long-term Extension Period|Lost to Follow-up|0|||
156317479|NCT00095147|564261814|FG002|Long-term Extension Period|Lost to Follow-up|0|||
156317480|NCT00095147|564261815|FG003|Long-term Extension Period|Lost to Follow-up|0|||
156317481|NCT00095147|564261816|FG004|Long-term Extension Period|Lost to Follow-up|6|||
156317482|NCT00095147|564261812|FG000|Long-term Extension Period|Withdrawal of consent|0|||
156317483|NCT00095147|564261813|FG001|Long-term Extension Period|Withdrawal of consent|0|||
156317484|NCT00095147|564261814|FG002|Long-term Extension Period|Withdrawal of consent|0|||
156317485|NCT00095147|564261815|FG003|Long-term Extension Period|Withdrawal of consent|0|||
156317486|NCT00095147|564261816|FG004|Long-term Extension Period|Withdrawal of consent|12|||
156317487|NCT00095147|564261812|FG000|Long-term Extension Period|Pregnancy|0|||
156653259|NCT04161144|565477936|FG000|Overall Study|Withdrawal by Subject|0|||
156653260|NCT04161144|565477937|FG001|Overall Study|Withdrawal by Subject|1|||
156653261|NCT04161144|565477936|FG000|Overall Study|Protocol Violation|1|||
156653262|NCT04161144|565477937|FG001|Overall Study|Protocol Violation|0|||
156653263|NCT03093454|565477941|FG000|Overall Study|Withdrawal by Subject|1|||
156653264|NCT03093454|565477942|FG001|Overall Study|Withdrawal by Subject|1|||
156653265|NCT03093454|565477941|FG000|Overall Study|Scheduling conflict|3|||
156653266|NCT03093454|565477942|FG001|Overall Study|Scheduling conflict|1|||
156653267|NCT03093454|565477941|FG000|Overall Study|Physician Decision|2|||
156653268|NCT03093454|565477942|FG001|Overall Study|Physician Decision|1|||
156653269|NCT02524379|565477943|FG000|Overall Study|Death|1|||
156653270|NCT00812253|565477944|FG000|Overall Study|Withdrawal by Subject|3|||
156653271|NCT00812253|565477945|FG001|Overall Study|Withdrawal by Subject|2|||
156653272|NCT00812253|565477944|FG000|Overall Study|Protocol Violation|1|||
156653273|NCT00812253|565477945|FG001|Overall Study|Protocol Violation|1|||
156653274|NCT00812253|565477944|FG000|Overall Study|Lost to Follow-up|2|||
156653275|NCT00812253|565477945|FG001|Overall Study|Lost to Follow-up|0|||
156653276|NCT00384033|565477949|FG000|Overall Study|Adverse Event|10|||
156653277|NCT00384033|565477950|FG001|Overall Study|Adverse Event|8|||
156653278|NCT00384033|565477951|FG002|Overall Study|Adverse Event|11|||
156653279|NCT00384033|565477952|FG003|Overall Study|Adverse Event|20|||
156653280|NCT00384033|565477949|FG000|Overall Study|Failed to return|1|||
156653281|NCT00384033|565477950|FG001|Overall Study|Failed to return|3|||
156653282|NCT00384033|565477951|FG002|Overall Study|Failed to return|2|||
156653283|NCT00384033|565477952|FG003|Overall Study|Failed to return|2|||
156653284|NCT00384033|565477949|FG000|Overall Study|Physician Decision|1|||
156653285|NCT00384033|565477950|FG001|Overall Study|Physician Decision|0|||
156653286|NCT00384033|565477951|FG002|Overall Study|Physician Decision|0|||
156653287|NCT00384033|565477952|FG003|Overall Study|Physician Decision|0|||
156653288|NCT00384033|565477949|FG000|Overall Study|Lost to Follow-up|6|||
156653289|NCT00384033|565477950|FG001|Overall Study|Lost to Follow-up|12|||
156653290|NCT00384033|565477951|FG002|Overall Study|Lost to Follow-up|7|||
156653291|NCT00384033|565477952|FG003|Overall Study|Lost to Follow-up|7|||
156653292|NCT00384033|565477949|FG000|Overall Study|Other|2|||
156653293|NCT00384033|565477950|FG001|Overall Study|Other|0|||
156653294|NCT00384033|565477951|FG002|Overall Study|Other|0|||
156653295|NCT00384033|565477952|FG003|Overall Study|Other|0|||
156653296|NCT00384033|565477949|FG000|Overall Study|Protocol Violation|5|||
156317488|NCT00095147|564261813|FG001|Long-term Extension Period|Pregnancy|0|||
156317489|NCT00095147|564261814|FG002|Long-term Extension Period|Pregnancy|0|||
156317490|NCT00095147|564261815|FG003|Long-term Extension Period|Pregnancy|0|||
156317491|NCT00095147|564261816|FG004|Long-term Extension Period|Pregnancy|1|||
156317492|NCT00095147|564261812|FG000|Long-term Extension Period|No longer meets study criteria|0|||
156317493|NCT00095147|564261813|FG001|Long-term Extension Period|No longer meets study criteria|0|||
156317494|NCT00095147|564261814|FG002|Long-term Extension Period|No longer meets study criteria|0|||
156317495|NCT00095147|564261815|FG003|Long-term Extension Period|No longer meets study criteria|0|||
156317496|NCT00095147|564261816|FG004|Long-term Extension Period|No longer meets study criteria|1|||
156317497|NCT00095147|564261812|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
156317498|NCT00095147|564261813|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
156317499|NCT00095147|564261814|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
156317500|NCT00095147|564261815|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
156317501|NCT00095147|564261816|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
156317502|NCT00095147|564261812|FG000|Long-term Extension Period|Leaving country|0|||
156317503|NCT00095147|564261813|FG001|Long-term Extension Period|Leaving country|0|||
156317504|NCT00095147|564261814|FG002|Long-term Extension Period|Leaving country|0|||
156317505|NCT00095147|564261815|FG003|Long-term Extension Period|Leaving country|0|||
156317506|NCT00095147|564261816|FG004|Long-term Extension Period|Leaving country|1|||
156317507|NCT04604132|564261817|FG000|Overall Study|Adverse Event|2|||
156317508|NCT04604132|564261818|FG001|Overall Study|Adverse Event|0|||
156317509|NCT04604132|564261819|FG002|Overall Study|Adverse Event|0|||
156317510|NCT04604132|564261820|FG003|Overall Study|Adverse Event|1|||
156317511|NCT04604132|564261821|FG004|Overall Study|Adverse Event|2|||
156317512|NCT04604132|564261817|FG000|Overall Study|Study terminated by sponsor|0|||
156317513|NCT04604132|564261818|FG001|Overall Study|Study terminated by sponsor|0|||
156317514|NCT04604132|564261819|FG002|Overall Study|Study terminated by sponsor|0|||
156317515|NCT04604132|564261820|FG003|Overall Study|Study terminated by sponsor|0|||
156317516|NCT04604132|564261821|FG004|Overall Study|Study terminated by sponsor|1|||
156317517|NCT04604132|564261817|FG000|Overall Study|Progressive disease: Clinical progression|0|||
156317518|NCT04604132|564261818|FG001|Overall Study|Progressive disease: Clinical progression|0|||
156317519|NCT04604132|564261819|FG002|Overall Study|Progressive disease: Clinical progression|1|||
156317520|NCT04604132|564261820|FG003|Overall Study|Progressive disease: Clinical progression|0|||
156317521|NCT04604132|564261821|FG004|Overall Study|Progressive disease: Clinical progression|0|||
156317522|NCT04604132|564261817|FG000|Overall Study|Progressive disease: Radiological progression|8|||
156317523|NCT04604132|564261818|FG001|Overall Study|Progressive disease: Radiological progression|7|||
156317524|NCT04604132|564261819|FG002|Overall Study|Progressive disease: Radiological progression|10|||
156317525|NCT04604132|564261820|FG003|Overall Study|Progressive disease: Radiological progression|4|||
156317526|NCT04604132|564261821|FG004|Overall Study|Progressive disease: Radiological progression|3|||
156317527|NCT04604132|564261817|FG000|Overall Study|Death|3|||
156317528|NCT04604132|564261818|FG001|Overall Study|Death|1|||
156317529|NCT04604132|564261819|FG002|Overall Study|Death|2|||
156317530|NCT04604132|564261820|FG003|Overall Study|Death|1|||
156317531|NCT04604132|564261821|FG004|Overall Study|Death|0|||
156317532|NCT00952380|564261822|FG000|Overall Study|Other|0|||
156317533|NCT00952380|564261823|FG001|Overall Study|Other|0|||
156317534|NCT00952380|564261824|FG002|Overall Study|Other|0|||
156317535|NCT00952380|564261825|FG003|Overall Study|Other|0|||
156317536|NCT00952380|564261826|FG004|Overall Study|Other|1|||
156317537|NCT00952380|564261822|FG000|Overall Study|Withdrawal by Subject|0|||
156317538|NCT00952380|564261823|FG001|Overall Study|Withdrawal by Subject|0|||
156317539|NCT00952380|564261824|FG002|Overall Study|Withdrawal by Subject|1|||
156317540|NCT00952380|564261825|FG003|Overall Study|Withdrawal by Subject|0|||
156317541|NCT00952380|564261826|FG004|Overall Study|Withdrawal by Subject|2|||
156317542|NCT00952380|564261822|FG000|Overall Study|Adverse Event|0|||
156317543|NCT00952380|564261823|FG001|Overall Study|Adverse Event|1|||
156317544|NCT00952380|564261824|FG002|Overall Study|Adverse Event|0|||
156317545|NCT00952380|564261825|FG003|Overall Study|Adverse Event|0|||
156317546|NCT00952380|564261826|FG004|Overall Study|Adverse Event|3|||
156317547|NCT00952380|564261822|FG000|Overall Study|Physician Decision|0|||
156317548|NCT00952380|564261823|FG001|Overall Study|Physician Decision|0|||
156317549|NCT00952380|564261824|FG002|Overall Study|Physician Decision|1|||
156317550|NCT00952380|564261825|FG003|Overall Study|Physician Decision|2|||
156317551|NCT00952380|564261826|FG004|Overall Study|Physician Decision|0|||
156317552|NCT00952380|564261822|FG000|Overall Study|Non-compliant to protocol|0|||
156317553|NCT00952380|564261823|FG001|Overall Study|Non-compliant to protocol|0|||
156317554|NCT00952380|564261824|FG002|Overall Study|Non-compliant to protocol|0|||
156317555|NCT00952380|564261825|FG003|Overall Study|Non-compliant to protocol|1|||
156317556|NCT00952380|564261826|FG004|Overall Study|Non-compliant to protocol|0|||
156317557|NCT03400956|564261827|FG000|Treatment Period 1|Adverse Event|0|||
156317558|NCT03400956|564261828|FG001|Treatment Period 1|Adverse Event|1|||
156317559|NCT03400956|564261829|FG002|Treatment Period 1|Adverse Event|0|||
156317560|NCT03400956|564261827|FG000|Treatment Period 1|Lost to Follow-up|0|||
156317561|NCT03400956|564261828|FG001|Treatment Period 1|Lost to Follow-up|0|||
156757579|NCT00377637|565864789|FG001|Induction Phase|Physician Decision|1|||
156757580|NCT00377637|565864790|FG002|Induction Phase|Physician Decision|0|||
156757581|NCT00377637|565864791|FG003|Induction Phase|Physician Decision|0|||
156757582|NCT00377637|565864788|FG000|Induction Phase|Sponsor decision|1|||
156757583|NCT00377637|565864789|FG001|Induction Phase|Sponsor decision|2|||
156757584|NCT00377637|565864790|FG002|Induction Phase|Sponsor decision|0|||
156757585|NCT00377637|565864791|FG003|Induction Phase|Sponsor decision|0|||
156317562|NCT03400956|564261829|FG002|Treatment Period 1|Lost to Follow-up|1|||
156317563|NCT03400956|564261827|FG000|Treatment Period 1|Protocol Violation|0|||
156317564|NCT03400956|564261828|FG001|Treatment Period 1|Protocol Violation|2|||
156317565|NCT03400956|564261829|FG002|Treatment Period 1|Protocol Violation|0|||
156317566|NCT03400956|564261827|FG000|Treatment Period 1|Study terminated by sponsor|3|||
156317567|NCT03400956|564261828|FG001|Treatment Period 1|Study terminated by sponsor|1|||
156317568|NCT03400956|564261829|FG002|Treatment Period 1|Study terminated by sponsor|1|||
156317569|NCT03400956|564261827|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156317570|NCT03400956|564261828|FG001|Treatment Period 1|Withdrawal by Subject|2|||
156317571|NCT03400956|564261829|FG002|Treatment Period 1|Withdrawal by Subject|4|||
156317572|NCT03400956|564261827|FG000|Treatment Period 1|Other|1|||
156317573|NCT03400956|564261828|FG001|Treatment Period 1|Other|2|||
156317574|NCT03400956|564261829|FG002|Treatment Period 1|Other|3|||
156317575|NCT03400956|564261827|FG000|Post-treatment Period 1|Adverse Event|0|||
156317576|NCT03400956|564261828|FG001|Post-treatment Period 1|Adverse Event|0|||
156317577|NCT03400956|564261829|FG002|Post-treatment Period 1|Adverse Event|1|||
156317578|NCT03400956|564261827|FG000|Post-treatment Period 1|Physician Decision|2|||
156317579|NCT03400956|564261828|FG001|Post-treatment Period 1|Physician Decision|3|||
156317580|NCT03400956|564261829|FG002|Post-treatment Period 1|Physician Decision|0|||
156317581|NCT03400956|564261827|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
156317582|NCT03400956|564261828|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
156317583|NCT03400956|564261829|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
156317584|NCT03400956|564261827|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
156317585|NCT03400956|564261828|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
156317586|NCT03400956|564261829|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
156317587|NCT03400956|564261827|FG000|Post-treatment Period 1|Other|4|||
156317588|NCT03400956|564261828|FG001|Post-treatment Period 1|Other|3|||
156317589|NCT03400956|564261829|FG002|Post-treatment Period 1|Other|4|||
156317590|NCT03400956|564261827|FG000|Treatment Period 2|Adverse Event|2|||
156317591|NCT03400956|564261828|FG001|Treatment Period 2|Adverse Event|1|||
156317592|NCT03400956|564261829|FG002|Treatment Period 2|Adverse Event|1|||
156317593|NCT03400956|564261827|FG000|Treatment Period 2|Lost to Follow-up|1|||
156317594|NCT03400956|564261828|FG001|Treatment Period 2|Lost to Follow-up|1|||
156317595|NCT03400956|564261829|FG002|Treatment Period 2|Lost to Follow-up|0|||
156317596|NCT03400956|564261827|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156317597|NCT03400956|564261828|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156317598|NCT03400956|564261829|FG002|Treatment Period 2|Withdrawal by Subject|3|||
156317599|NCT03400956|564261827|FG000|Treatment Period 2|Other|1|||
156317600|NCT03400956|564261828|FG001|Treatment Period 2|Other|1|||
156317601|NCT03400956|564261829|FG002|Treatment Period 2|Other|0|||
156317602|NCT03400956|564261827|FG000|Follow-up Period|Withdrawal by Subject|0|||
156317603|NCT03400956|564261828|FG001|Follow-up Period|Withdrawal by Subject|0|||
156317604|NCT03400956|564261829|FG002|Follow-up Period|Withdrawal by Subject|1|||
156317605|NCT03400956|564261827|FG000|Follow-up Period|Other|0|||
156317606|NCT03400956|564261828|FG001|Follow-up Period|Other|0|||
156317607|NCT03400956|564261829|FG002|Follow-up Period|Other|1|||
156317608|NCT02048241|564261831|FG000|Overall Study|Withdrawal by Subject|0|||
156317609|NCT02048241|564261832|FG001|Overall Study|Withdrawal by Subject|1|||
156317610|NCT00534313|564261833|FG000|Short-term Period|Adverse Event|1|||
156317611|NCT00534313|564261834|FG001|Short-term Period|Adverse Event|2|||
156317612|NCT00534313|564261835|FG002|Short-term Period|Adverse Event|1|||
156317613|NCT00534313|564261836|FG003|Short-term Period|Adverse Event|3|||
156317614|NCT00534313|564261833|FG000|Short-term Period|Lack of Efficacy|3|||
156317615|NCT00534313|564261834|FG001|Short-term Period|Lack of Efficacy|4|||
156317616|NCT00534313|564261835|FG002|Short-term Period|Lack of Efficacy|0|||
156317617|NCT00534313|564261836|FG003|Short-term Period|Lack of Efficacy|3|||
156757586|NCT00377637|565864788|FG000|Induction Phase|Non-Compliance|1|||
156757587|NCT00377637|565864789|FG001|Induction Phase|Non-Compliance|0|||
156757588|NCT00377637|565864790|FG002|Induction Phase|Non-Compliance|0|||
156317618|NCT00534313|564261833|FG000|Short-term Period|Participant not meeting study criteria|0|||
156317619|NCT00534313|564261834|FG001|Short-term Period|Participant not meeting study criteria|0|||
156317620|NCT00534313|564261835|FG002|Short-term Period|Participant not meeting study criteria|0|||
156317621|NCT00534313|564261836|FG003|Short-term Period|Participant not meeting study criteria|1|||
156317622|NCT00534313|564261833|FG000|Short-term Period|Participant withdrew consent|2|||
156317623|NCT00534313|564261834|FG001|Short-term Period|Participant withdrew consent|0|||
156317624|NCT00534313|564261835|FG002|Short-term Period|Participant withdrew consent|0|||
156317625|NCT00534313|564261836|FG003|Short-term Period|Participant withdrew consent|2|||
156757589|NCT00377637|565864791|FG003|Induction Phase|Non-Compliance|0|||
156757590|NCT00377637|565864788|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
156317626|NCT00534313|564261833|FG000|Short-term Period|Pregnancy|0|||
156317627|NCT00534313|564261834|FG001|Short-term Period|Pregnancy|0|||
156653297|NCT00384033|565477950|FG001|Overall Study|Protocol Violation|0|||
156317628|NCT00534313|564261835|FG002|Short-term Period|Pregnancy|1|||
156317629|NCT00534313|564261836|FG003|Short-term Period|Pregnancy|0|||
156317630|NCT00534313|564261833|FG000|Long-term Period|Adverse Event|2|||
156317631|NCT00534313|564261834|FG001|Long-term Period|Adverse Event|1|||
156317632|NCT00534313|564261835|FG002|Long-term Period|Adverse Event|0|||
156317633|NCT00534313|564261836|FG003|Long-term Period|Adverse Event|1|||
156317634|NCT00534313|564261833|FG000|Long-term Period|Lack of Efficacy|14|||
156317635|NCT00534313|564261834|FG001|Long-term Period|Lack of Efficacy|10|||
156317636|NCT00534313|564261835|FG002|Long-term Period|Lack of Efficacy|14|||
156317637|NCT00534313|564261836|FG003|Long-term Period|Lack of Efficacy|12|||
156317638|NCT00534313|564261833|FG000|Long-term Period|Lost to Follow-up|1|||
156317639|NCT00534313|564261834|FG001|Long-term Period|Lost to Follow-up|2|||
156317640|NCT00534313|564261835|FG002|Long-term Period|Lost to Follow-up|0|||
156317641|NCT00534313|564261836|FG003|Long-term Period|Lost to Follow-up|0|||
156317642|NCT00534313|564261833|FG000|Long-term Period|Withdrawal by Subject|2|||
156317643|NCT00534313|564261834|FG001|Long-term Period|Withdrawal by Subject|2|||
156317644|NCT00534313|564261835|FG002|Long-term Period|Withdrawal by Subject|0|||
156317645|NCT00534313|564261836|FG003|Long-term Period|Withdrawal by Subject|0|||
156317646|NCT00534313|564261833|FG000|Long-term Period|No longer meets study criteria|0|||
156317647|NCT00534313|564261834|FG001|Long-term Period|No longer meets study criteria|1|||
156317648|NCT00534313|564261835|FG002|Long-term Period|No longer meets study criteria|0|||
156317649|NCT00534313|564261836|FG003|Long-term Period|No longer meets study criteria|0|||
156317650|NCT00534313|564261833|FG000|Long-term Period|Poor compliance/noncompliance|0|||
156317651|NCT00534313|564261834|FG001|Long-term Period|Poor compliance/noncompliance|1|||
156418644|NCT04988477|564625361|FG001|Overall Study|Lost to Follow-up|2|||
156653298|NCT00384033|565477951|FG002|Overall Study|Protocol Violation|5|||
156653299|NCT00384033|565477952|FG003|Overall Study|Protocol Violation|6|||
156653300|NCT00384033|565477949|FG000|Overall Study|Withdrawal by Subject|6|||
156653301|NCT00384033|565477950|FG001|Overall Study|Withdrawal by Subject|2|||
156653302|NCT00384033|565477951|FG002|Overall Study|Withdrawal by Subject|5|||
156653303|NCT00384033|565477952|FG003|Overall Study|Withdrawal by Subject|2|||
156653304|NCT00384033|565477949|FG000|Overall Study|Lack of Efficacy|7|||
156653305|NCT00384033|565477950|FG001|Overall Study|Lack of Efficacy|3|||
156653306|NCT00384033|565477951|FG002|Overall Study|Lack of Efficacy|3|||
156653307|NCT00384033|565477952|FG003|Overall Study|Lack of Efficacy|1|||
156653308|NCT00384033|565477949|FG000|Overall Study|Randomized but not treated|3|||
156653309|NCT00384033|565477950|FG001|Overall Study|Randomized but not treated|7|||
156653310|NCT00384033|565477951|FG002|Overall Study|Randomized but not treated|10|||
156653311|NCT00384033|565477952|FG003|Overall Study|Randomized but not treated|2|||
156653312|NCT03349333|565477953|FG000|Overall Study|Progression of Disease|36|||
156653313|NCT03349333|565477953|FG000|Overall Study|Adverse Event|11|||
156653314|NCT03349333|565477953|FG000|Overall Study|Other|6|||
156653315|NCT03349333|565477953|FG000|Overall Study|Withdrawal by Subject|5|||
156653316|NCT03349333|565477953|FG000|Overall Study|Conditions interfere with participation|2|||
156653317|NCT03349333|565477953|FG000|Overall Study|Physician Decision|2|||
156653318|NCT03349333|565477953|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
156653319|NCT03349333|565477953|FG000|Overall Study|Patients in treatment less than 24 month|8|||
156653320|NCT02985151|565477955|FG000|Original Randomization|Withdrawal by Subject|0|||
156653321|NCT02985151|565477956|FG001|Original Randomization|Withdrawal by Subject|1|||
156653322|NCT02752776|565477963|FG000|Overall Study|Adverse Event|15|||
156653323|NCT02752776|565477964|FG001|Overall Study|Adverse Event|23|||
156653324|NCT02752776|565477965|FG002|Overall Study|Adverse Event|11|||
156653325|NCT02752776|565477963|FG000|Overall Study|Lack of Efficacy|2|||
156653326|NCT02752776|565477964|FG001|Overall Study|Lack of Efficacy|6|||
156653327|NCT02752776|565477965|FG002|Overall Study|Lack of Efficacy|14|||
156653328|NCT02752776|565477963|FG000|Overall Study|Lost to Follow-up|11|||
156653329|NCT02752776|565477964|FG001|Overall Study|Lost to Follow-up|12|||
156653330|NCT02752776|565477965|FG002|Overall Study|Lost to Follow-up|4|||
156653331|NCT02752776|565477963|FG000|Overall Study|Non-compliance with study treatment|0|||
156653332|NCT02752776|565477964|FG001|Overall Study|Non-compliance with study treatment|0|||
156653333|NCT02752776|565477965|FG002|Overall Study|Non-compliance with study treatment|1|||
156653334|NCT02752776|565477963|FG000|Overall Study|Physician Decision|2|||
156653335|NCT02752776|565477964|FG001|Overall Study|Physician Decision|6|||
156653336|NCT02752776|565477965|FG002|Overall Study|Physician Decision|2|||
156653337|NCT02752776|565477963|FG000|Overall Study|Pregnancy|1|||
156653338|NCT02752776|565477964|FG001|Overall Study|Pregnancy|6|||
156653339|NCT02752776|565477965|FG002|Overall Study|Pregnancy|3|||
156653340|NCT02752776|565477963|FG000|Overall Study|Protocol Violation|10|||
156653341|NCT02752776|565477964|FG001|Overall Study|Protocol Violation|13|||
156653342|NCT02752776|565477965|FG002|Overall Study|Protocol Violation|6|||
156317652|NCT00534313|564261835|FG002|Long-term Period|Poor compliance/noncompliance|1|||
156317653|NCT00534313|564261836|FG003|Long-term Period|Poor compliance/noncompliance|0|||
156317654|NCT00534313|564261833|FG000|Long-term Period|Administrative reason by sponsor|17|||
156418645|NCT04988477|564625362|FG002|Overall Study|Lost to Follow-up|0|||
156418646|NCT04988477|564625360|FG000|Overall Study|Withdrawal by Subject|2|||
156418647|NCT04988477|564625361|FG001|Overall Study|Withdrawal by Subject|0|||
156418648|NCT04988477|564625362|FG002|Overall Study|Withdrawal by Subject|0|||
156418649|NCT04096365|564626416|FG000|Overall Study|Adverse Event|1|||
156418650|NCT01036087|564626419|FG000|Overall Study|Adverse Event|2|||
156418651|NCT01036087|564626419|FG000|Overall Study|Lack of Efficacy|1|||
156418652|NCT02206685|564626421|FG000|Overall Study|Surgery cancelled/changed|2|||
156418653|NCT02206685|564626422|FG001|Overall Study|Surgery cancelled/changed|3|||
156418654|NCT02206685|564626421|FG000|Overall Study|Withdrawal by Subject|1|||
156418655|NCT02206685|564626422|FG001|Overall Study|Withdrawal by Subject|2|||
156418656|NCT02206685|564626421|FG000|Overall Study|Protocol Violation|2|||
156418657|NCT02206685|564626422|FG001|Overall Study|Protocol Violation|2|||
156418658|NCT01616563|564626423|FG000|Overall Study|Lost to Follow-up|40|||
156418659|NCT00072475|564626424|FG000|Overall Study|Adverse Event|44|||
156418660|NCT00072475|564626424|FG000|Overall Study|Death|3|||
156418661|NCT00072475|564626424|FG000|Overall Study|Withdrawal by Subject|46|||
156418662|NCT00072475|564626424|FG000|Overall Study|Patient/Investigator Decision|4|||
156418663|NCT01450943|564626425|FG000|Overall Study|Screen failure, loss to follow-up|2|||
156418664|NCT01450943|564626426|FG001|Overall Study|Screen failure, loss to follow-up|7|||
156418665|NCT01450943|564626427|FG002|Overall Study|Screen failure, loss to follow-up|6|||
156418666|NCT00051311|564626446|FG000|Overall Study|Starting new study|0|||
156418667|NCT00051311|564626447|FG001|Overall Study|Starting new study|1|||
156418668|NCT00051311|564626446|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
156418669|NCT00051311|564626447|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
156418670|NCT00051311|564626446|FG000|Overall Study|Death of recipient|8|||
156418671|NCT00051311|564626447|FG001|Overall Study|Death of recipient|8|||
156418672|NCT00051311|564626446|FG000|Overall Study|Recipient taken off study|4|||
156418673|NCT00051311|564626447|FG001|Overall Study|Recipient taken off study|4|||
156418674|NCT04990440|564626448|FG000|Overall Study|Sponsor's Decision|0|||
156418675|NCT04990440|564626449|FG001|Overall Study|Sponsor's Decision|0|||
156418676|NCT04990440|564626450|FG002|Overall Study|Sponsor's Decision|1|||
156418677|NCT04170023|564626451|FG000|LTE Period|Withdrawal by Subject|1|||
156418678|NCT04170023|564626452|FG001|LTE Period|Withdrawal by Subject|0|||
156418679|NCT04170023|564626453|FG002|LTE Period|Withdrawal by Subject|0|||
156418680|NCT04170023|564626451|FG000|LTE Period|Study Termination|11|||
156418681|NCT04170023|564626452|FG001|LTE Period|Study Termination|11|||
156418682|NCT04170023|564626453|FG002|LTE Period|Study Termination|5|||
156418683|NCT03712098|564626454|FG000|Overall Study|Lost to Follow-up|3|||
156418684|NCT03712098|564626455|FG001|Overall Study|Lost to Follow-up|7|||
156418685|NCT03712098|564626454|FG000|Overall Study|Withdrawal by Subject|9|||
156418686|NCT03712098|564626455|FG001|Overall Study|Withdrawal by Subject|4|||
156418687|NCT03712098|564626454|FG000|Overall Study|Protocol Violation|2|||
156418688|NCT03712098|564626455|FG001|Overall Study|Protocol Violation|1|||
156418689|NCT03566680|564626462|FG000|Overall Study|Pregnancy|1|||
156418690|NCT03566680|564626462|FG000|Overall Study|Lost to Follow-up|13|||
156418691|NCT03566680|564626462|FG000|Overall Study|Withdrawal by Subject|3|||
156418692|NCT03836664|564626463|FG000|Overall Study|Didn't complete forms and lost drug|3|||
156418693|NCT03836664|564626464|FG001|Overall Study|Didn't complete forms and lost drug|3|||
156418694|NCT00425503|564626469|FG000|Overall Study|Adverse Event|2|||
156418695|NCT00425503|564626469|FG000|Overall Study|Protocol Violation|1|||
156418696|NCT02059161|564626470|FG000|Overall Study|Pregnancy|0|||
156418697|NCT02059161|564626471|FG001|Overall Study|Pregnancy|2|||
156418698|NCT02059161|564626470|FG000|Overall Study|Adverse Event|2|||
156418699|NCT02059161|564626471|FG001|Overall Study|Adverse Event|6|||
156418700|NCT02059161|564626470|FG000|Overall Study|Lost to Follow-up|20|||
156418701|NCT02059161|564626471|FG001|Overall Study|Lost to Follow-up|12|||
156418702|NCT02059161|564626470|FG000|Overall Study|Physician Decision|4|||
156418703|NCT02059161|564626471|FG001|Overall Study|Physician Decision|4|||
156418704|NCT02059161|564626470|FG000|Overall Study|Protocol Violation|1|||
156418705|NCT02059161|564626471|FG001|Overall Study|Protocol Violation|1|||
156418706|NCT02059161|564626470|FG000|Overall Study|Withdrawal by Subject|16|||
156418707|NCT02059161|564626471|FG001|Overall Study|Withdrawal by Subject|13|||
156418708|NCT02059161|564626470|FG000|Overall Study|Randomized in error, no study drug|0|||
156418709|NCT02059161|564626471|FG001|Overall Study|Randomized in error, no study drug|1|||
156418710|NCT02059161|564626470|FG000|Overall Study|Non-compliance with study drug|6|||
156418711|NCT02059161|564626471|FG001|Overall Study|Non-compliance with study drug|2|||
156418712|NCT01925170|564626474|FG000|Overall Study|Unverified cancer status|53|||
156418713|NCT02839681|564626482|FG000|Overall Study|Death|2|||
156418714|NCT01653847|564626483|FG000|Overall Study|Withdrawal by Subject|1|||
156418715|NCT01653847|564626484|FG001|Overall Study|Withdrawal by Subject|0|||
156418716|NCT02554513|564626485|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
156653343|NCT02752776|565477963|FG000|Overall Study|Subject/guardian decision|8|||
156653344|NCT02752776|565477964|FG001|Overall Study|Subject/guardian decision|6|||
156653345|NCT02752776|565477965|FG002|Overall Study|Subject/guardian decision|4|||
156653346|NCT02752776|565477963|FG000|Overall Study|Death|0|||
156653347|NCT02752776|565477964|FG001|Overall Study|Death|0|||
156653348|NCT02752776|565477965|FG002|Overall Study|Death|1|||
156653349|NCT02752776|565477963|FG000|Overall Study|Withdrawal by Subject|3|||
156757591|NCT00377637|565864789|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
156757592|NCT00377637|565864790|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
156757593|NCT00377637|565864791|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
156757594|NCT00377637|565864788|FG000|Maintenance Phase|Adverse Event|0|||
156757595|NCT00377637|565864789|FG001|Maintenance Phase|Adverse Event|0|||
156757596|NCT00377637|565864790|FG002|Maintenance Phase|Adverse Event|29|||
156757597|NCT00377637|565864791|FG003|Maintenance Phase|Adverse Event|43|||
156757598|NCT00377637|565864788|FG000|Maintenance Phase|Physician Decision|0|||
156757599|NCT00377637|565864789|FG001|Maintenance Phase|Physician Decision|0|||
156757600|NCT00377637|565864790|FG002|Maintenance Phase|Physician Decision|5|||
156757601|NCT00377637|565864791|FG003|Maintenance Phase|Physician Decision|4|||
156757602|NCT00377637|565864788|FG000|Maintenance Phase|Lost to Follow-up|0|||
156757603|NCT00377637|565864789|FG001|Maintenance Phase|Lost to Follow-up|0|||
156757604|NCT00377637|565864790|FG002|Maintenance Phase|Lost to Follow-up|3|||
156757605|NCT00377637|565864791|FG003|Maintenance Phase|Lost to Follow-up|1|||
156757606|NCT00377637|565864788|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156757607|NCT00377637|565864789|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156757608|NCT00377637|565864790|FG002|Maintenance Phase|Withdrawal by Subject|3|||
156757609|NCT00377637|565864791|FG003|Maintenance Phase|Withdrawal by Subject|3|||
156757610|NCT00377637|565864788|FG000|Maintenance Phase|Sponsor decision|0|||
156757611|NCT00377637|565864789|FG001|Maintenance Phase|Sponsor decision|0|||
156757612|NCT00377637|565864790|FG002|Maintenance Phase|Sponsor decision|2|||
156757613|NCT00377637|565864791|FG003|Maintenance Phase|Sponsor decision|3|||
156757614|NCT00377637|565864788|FG000|Maintenance Phase|Non-compliance|0|||
156757615|NCT00377637|565864789|FG001|Maintenance Phase|Non-compliance|0|||
156757616|NCT00377637|565864790|FG002|Maintenance Phase|Non-compliance|1|||
156757617|NCT00377637|565864791|FG003|Maintenance Phase|Non-compliance|1|||
156757618|NCT00377637|565864788|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
156757619|NCT00377637|565864789|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
156757620|NCT00377637|565864790|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
156757621|NCT00377637|565864791|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
156757622|NCT00377637|565864788|FG000|Maintenance Phase|Death|0|||
156757623|NCT00377637|565864789|FG001|Maintenance Phase|Death|0|||
156757624|NCT00377637|565864790|FG002|Maintenance Phase|Death|0|||
156757625|NCT00377637|565864791|FG003|Maintenance Phase|Death|1|||
156757626|NCT00003537|565864804|FG000|Overall Study|Not evalauable|1|||
156757627|NCT01001520|565864805|FG000|Medication Period 1|Withdrawal by Subject|2|||
156757628|NCT01001520|565864806|FG001|Medication Period 1|Withdrawal by Subject|2|||
156757629|NCT01001520|565864805|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
156757630|NCT01001520|565864806|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
156757631|NCT01001520|565864805|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
156757632|NCT01001520|565864806|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
156757633|NCT01001520|565864805|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
156757634|NCT01001520|565864806|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
156757635|NCT01001520|565864805|FG000|Washout Period|Withdrawal by Subject|2|||
156757636|NCT01001520|565864806|FG001|Washout Period|Withdrawal by Subject|1|||
156757637|NCT01001520|565864805|FG000|Medication Period 2|Withdrawal by Subject|0|||
156757638|NCT01001520|565864806|FG001|Medication Period 2|Withdrawal by Subject|3|||
156757639|NCT04668209|565864807|FG000|Overall Study|Withdrawal by Subject|2|||
156757640|NCT04668209|565864808|FG001|Overall Study|Withdrawal by Subject|2|||
156757641|NCT04668209|565864807|FG000|Overall Study|Lost to Follow-up|3|||
156757642|NCT04668209|565864808|FG001|Overall Study|Lost to Follow-up|4|||
156757643|NCT04668209|565864807|FG000|Overall Study|Subject Expired|2|||
156317655|NCT00534313|564261834|FG001|Long-term Period|Administrative reason by sponsor|15|||
156317656|NCT00534313|564261835|FG002|Long-term Period|Administrative reason by sponsor|26|||
156317657|NCT00534313|564261836|FG003|Long-term Period|Administrative reason by sponsor|18|||
156317658|NCT00534313|564261833|FG000|Long-term Period|Other|1|||
156317659|NCT00534313|564261834|FG001|Long-term Period|Other|2|||
156317660|NCT00534313|564261835|FG002|Long-term Period|Other|2|||
156317661|NCT00534313|564261836|FG003|Long-term Period|Other|2|||
156317662|NCT00402233|564261837|FG000|Overall Study|Adverse Event|1|||
156418717|NCT02554513|564626486|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
156757644|NCT04668209|565864808|FG001|Overall Study|Subject Expired|0|||
156757645|NCT04668209|565864807|FG000|Overall Study|Withdrawn from study|0|||
156757646|NCT04668209|565864808|FG001|Overall Study|Withdrawn from study|1|||
156757647|NCT04668209|565864807|FG000|Overall Study|Adverse Event|0|||
156757648|NCT04668209|565864808|FG001|Overall Study|Adverse Event|1|||
156418718|NCT01822353|564626487|FG000|Overall Study|Adverse Event|1|||
156418719|NCT01822353|564626488|FG001|Overall Study|Adverse Event|3|||
156757649|NCT00268983|565864815|FG000|Overall Study|Death|3|||
156317663|NCT00402233|564261838|FG001|Overall Study|Adverse Event|7|||
156317664|NCT00402233|564261839|FG002|Overall Study|Adverse Event|9|||
156418720|NCT01822353|564626489|FG002|Overall Study|Adverse Event|1|||
156757650|NCT00268983|565864816|FG001|Overall Study|Death|0|||
156757651|NCT00313846|565864819|FG000|Overall Study|Withdrawal by Subject|2|||
156757652|NCT00313846|565864820|FG001|Overall Study|Withdrawal by Subject|0|||
156418721|NCT01822353|564626487|FG000|Overall Study|Pregnancy|0|||
156418722|NCT01822353|564626488|FG001|Overall Study|Pregnancy|1|||
156418723|NCT01822353|564626489|FG002|Overall Study|Pregnancy|0|||
156418724|NCT01822353|564626487|FG000|Overall Study|Withdrawal by Subject|3|||
156418725|NCT01822353|564626488|FG001|Overall Study|Withdrawal by Subject|1|||
156418726|NCT01822353|564626489|FG002|Overall Study|Withdrawal by Subject|0|||
156418727|NCT02550873|564626490|FG000|Randomized Double Blind|Adverse Event|3|||
156418728|NCT02550873|564626491|FG001|Randomized Double Blind|Adverse Event|1|||
156757653|NCT00313846|565864819|FG000|Overall Study|Adverse Event|1|||
156757654|NCT00313846|565864820|FG001|Overall Study|Adverse Event|8|||
156757655|NCT00313846|565864819|FG000|Overall Study|Administrative|2|||
156418729|NCT02550873|564626492|FG002|Randomized Double Blind|Adverse Event|0|||
156418730|NCT02550873|564626490|FG000|Randomized Double Blind|Disease progression|1|||
156418731|NCT02550873|564626491|FG001|Randomized Double Blind|Disease progression|1|||
156418732|NCT02550873|564626492|FG002|Randomized Double Blind|Disease progression|0|||
156418733|NCT02550873|564626490|FG000|Open Label Extension|Study ongoing|0|||
156418734|NCT02550873|564626491|FG001|Open Label Extension|Study ongoing|0|||
156418735|NCT02550873|564626492|FG002|Open Label Extension|Study ongoing|111|||
156418736|NCT00885495|564626493|FG000|Overall Study|Adverse Event|1|||
156418737|NCT00885495|564626494|FG001|Overall Study|Adverse Event|2|||
156418738|NCT00885495|564626493|FG000|Overall Study|Protocol Violation|0|||
156418739|NCT00885495|564626494|FG001|Overall Study|Protocol Violation|1|||
156418740|NCT00885495|564626493|FG000|Overall Study|Withdrawal by Subject|1|||
156418741|NCT00885495|564626494|FG001|Overall Study|Withdrawal by Subject|0|||
156418742|NCT01400893|564626495|FG000|Overall Study|Death|27|||
156757656|NCT00313846|565864820|FG001|Overall Study|Administrative|3|||
156757657|NCT03478371|565864821|FG000|Overall Study|non-compliance|1|||
156757658|NCT03478371|565864821|FG000|Overall Study|Lost to Follow-up|4|||
156757659|NCT01096160|565864825|FG000|Overall Study|Adverse Event|0|||
156757660|NCT01096160|565864826|FG001|Overall Study|Adverse Event|0|||
156757661|NCT01096160|565864827|FG002|Overall Study|Adverse Event|1|||
156757662|NCT01096160|565864828|FG003|Overall Study|Adverse Event|0|||
156757663|NCT01096160|565864829|FG004|Overall Study|Adverse Event|0|||
156757664|NCT01096160|565864830|FG005|Overall Study|Adverse Event|0|||
156757665|NCT01096160|565864831|FG006|Overall Study|Adverse Event|0|||
156757666|NCT01096160|565864832|FG007|Overall Study|Adverse Event|0|||
156757667|NCT01096160|565864833|FG008|Overall Study|Adverse Event|0|||
156757668|NCT01096160|565864834|FG009|Overall Study|Adverse Event|1|||
156757669|NCT01096160|565864825|FG000|Overall Study|Met stopping criteria per protocol|0|||
156757670|NCT01096160|565864826|FG001|Overall Study|Met stopping criteria per protocol|0|||
156757671|NCT01096160|565864827|FG002|Overall Study|Met stopping criteria per protocol|0|||
156757672|NCT01096160|565864828|FG003|Overall Study|Met stopping criteria per protocol|0|||
156757673|NCT01096160|565864829|FG004|Overall Study|Met stopping criteria per protocol|1|||
156757674|NCT01096160|565864830|FG005|Overall Study|Met stopping criteria per protocol|0|||
156757675|NCT01096160|565864831|FG006|Overall Study|Met stopping criteria per protocol|2|||
156757676|NCT01096160|565864832|FG007|Overall Study|Met stopping criteria per protocol|0|||
156757677|NCT01096160|565864833|FG008|Overall Study|Met stopping criteria per protocol|2|||
156757678|NCT01096160|565864834|FG009|Overall Study|Met stopping criteria per protocol|0|||
156757679|NCT00627497|565864835|FG000|Overall Study|Lost to Follow-up|1|||
156757680|NCT00627497|565864836|FG001|Overall Study|Lost to Follow-up|1|||
156757681|NCT00627497|565864837|FG002|Overall Study|Lost to Follow-up|0|||
156757682|NCT00627497|565864838|FG003|Overall Study|Lost to Follow-up|0|||
156757683|NCT02028507|565864839|FG000|Overall Study|Progressive Disease|122|||
156757684|NCT02028507|565864840|FG001|Overall Study|Progressive Disease|90|||
156757685|NCT02028507|565864841|FG002|Overall Study|Progressive Disease|102|||
156757686|NCT02028507|565864842|FG003|Overall Study|Progressive Disease|89|||
156757687|NCT02028507|565864839|FG000|Overall Study|Adverse Event|8|||
156757688|NCT02028507|565864840|FG001|Overall Study|Adverse Event|25|||
156757689|NCT02028507|565864841|FG002|Overall Study|Adverse Event|3|||
156757690|NCT02028507|565864842|FG003|Overall Study|Adverse Event|16|||
156757691|NCT02028507|565864839|FG000|Overall Study|Withdrawal by Subject|6|||
156757692|NCT02028507|565864840|FG001|Overall Study|Withdrawal by Subject|8|||
156757693|NCT02028507|565864841|FG002|Overall Study|Withdrawal by Subject|5|||
156757694|NCT02028507|565864842|FG003|Overall Study|Withdrawal by Subject|9|||
156757695|NCT02028507|565864839|FG000|Overall Study|Protocol Violation|2|||
156757696|NCT02028507|565864840|FG001|Overall Study|Protocol Violation|4|||
156418743|NCT01400893|564626496|FG001|Overall Study|Death|21|||
156418744|NCT01400893|564626495|FG000|Overall Study|Lost to Follow-up|0|||
156418745|NCT01400893|564626496|FG001|Overall Study|Lost to Follow-up|6|||
156418746|NCT00519636|564626497|FG000|Treatment Period 1|Adverse Event|1|||
156757697|NCT02028507|565864841|FG002|Overall Study|Protocol Violation|1|||
156757698|NCT02028507|565864842|FG003|Overall Study|Protocol Violation|3|||
156757699|NCT02028507|565864839|FG000|Overall Study|Physician Decision|0|||
156757700|NCT02028507|565864840|FG001|Overall Study|Physician Decision|4|||
156757701|NCT02028507|565864841|FG002|Overall Study|Physician Decision|0|||
156418747|NCT00519636|564626498|FG001|Treatment Period 1|Adverse Event|0|||
156418748|NCT00519636|564626499|FG002|Treatment Period 1|Adverse Event|1|||
156418749|NCT00519636|564626500|FG003|Treatment Period 1|Adverse Event|0|||
156757702|NCT02028507|565864842|FG003|Overall Study|Physician Decision|0|||
156757703|NCT02028507|565864839|FG000|Overall Study|Death|1|||
156757704|NCT02028507|565864840|FG001|Overall Study|Death|0|||
156757705|NCT02028507|565864841|FG002|Overall Study|Death|1|||
156757706|NCT02028507|565864842|FG003|Overall Study|Death|3|||
156757707|NCT02028507|565864839|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
156757708|NCT02028507|565864840|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
156757709|NCT02028507|565864841|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
156757710|NCT02028507|565864842|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
156757711|NCT02028507|565864839|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
156757712|NCT02028507|565864840|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
156757713|NCT02028507|565864841|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
156757714|NCT02028507|565864842|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
156757715|NCT02028507|565864839|FG000|Overall Study|Randomized But Not Treated|3|||
156757716|NCT02028507|565864840|FG001|Overall Study|Randomized But Not Treated|6|||
156757717|NCT02028507|565864841|FG002|Overall Study|Randomized But Not Treated|0|||
156757718|NCT02028507|565864842|FG003|Overall Study|Randomized But Not Treated|4|||
156757719|NCT02028507|565864839|FG000|Overall Study|Enzyme defect|0|||
156757720|NCT02028507|565864840|FG001|Overall Study|Enzyme defect|0|||
156757721|NCT02028507|565864841|FG002|Overall Study|Enzyme defect|0|||
156757722|NCT02028507|565864842|FG003|Overall Study|Enzyme defect|1|||
156757723|NCT02028507|565864839|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
156757724|NCT02028507|565864840|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
156757725|NCT02028507|565864841|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
156757726|NCT02028507|565864842|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
156757727|NCT02028507|565864839|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
156757728|NCT02028507|565864840|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
156757729|NCT02028507|565864841|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
156757730|NCT02028507|565864842|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
156757731|NCT01556932|565864843|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
156757732|NCT01556932|565864844|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
156757733|NCT00991289|565864847|FG000|Overall Study|Adverse Event|1|||
156757734|NCT00991289|565864847|FG000|Overall Study|Physician Decision|2|||
156757735|NCT00991289|565864847|FG000|Overall Study|Withdrawal by Subject|3|||
156757736|NCT00991289|565864847|FG000|Overall Study|Lost to Follow-up|4|||
156757737|NCT00991289|565864847|FG000|Overall Study|Protocol Violation|2|||
156757738|NCT05464420|565864849|FG000|Overall Study|Death|0|||
156757739|NCT05464420|565864850|FG001|Overall Study|Death|0|||
156757740|NCT05464420|565864851|FG002|Overall Study|Death|0|||
156757741|NCT05464420|565864852|FG003|Overall Study|Death|1|||
156757742|NCT05464420|565864849|FG000|Overall Study|Lost to Follow-up|16|||
156757743|NCT05464420|565864850|FG001|Overall Study|Lost to Follow-up|11|||
156757744|NCT05464420|565864851|FG002|Overall Study|Lost to Follow-up|11|||
156757745|NCT05464420|565864852|FG003|Overall Study|Lost to Follow-up|11|||
156757746|NCT05464420|565864849|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
156757747|NCT05464420|565864850|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
156757748|NCT05464420|565864851|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
156757749|NCT05464420|565864852|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
156757750|NCT05464420|565864849|FG000|Overall Study|Withdrawal by Subject|4|||
156757751|NCT05464420|565864850|FG001|Overall Study|Withdrawal by Subject|8|||
156757752|NCT05464420|565864851|FG002|Overall Study|Withdrawal by Subject|3|||
156757753|NCT05464420|565864852|FG003|Overall Study|Withdrawal by Subject|1|||
156757754|NCT05464420|565864849|FG000|Overall Study|Protocol Violation|0|||
156757755|NCT05464420|565864850|FG001|Overall Study|Protocol Violation|0|||
156757756|NCT05464420|565864851|FG002|Overall Study|Protocol Violation|1|||
156757757|NCT05464420|565864852|FG003|Overall Study|Protocol Violation|1|||
156418750|NCT00519636|564626497|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
156418751|NCT00519636|564626498|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
156418752|NCT00519636|564626499|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
156418753|NCT00519636|564626500|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
156418754|NCT00519636|564626497|FG000|Washout Period|Adverse Event|2|||
156418755|NCT00519636|564626498|FG001|Washout Period|Adverse Event|1|||
156418756|NCT00519636|564626499|FG002|Washout Period|Adverse Event|1|||
156418757|NCT00519636|564626500|FG003|Washout Period|Adverse Event|0|||
156418758|NCT00519636|564626497|FG000|Washout Period|Lost to Follow-up|1|||
156757758|NCT05464420|565864849|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
156757759|NCT05464420|565864850|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
156757760|NCT05464420|565864851|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
156757761|NCT05464420|565864852|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
156757762|NCT01383018|565864853|FG000|Overall Study|Adverse Event|14|||
156757763|NCT01383018|565864853|FG000|Overall Study|Death|10|||
156757764|NCT01383018|565864853|FG000|Overall Study|Lost to Follow-up|5|||
156757765|NCT01383018|565864853|FG000|Overall Study|Physician Decision|5|||
156418759|NCT00519636|564626498|FG001|Washout Period|Lost to Follow-up|0|||
156418760|NCT00519636|564626499|FG002|Washout Period|Lost to Follow-up|0|||
156418761|NCT00519636|564626500|FG003|Washout Period|Lost to Follow-up|0|||
156418762|NCT00519636|564626497|FG000|Washout Period|Protocol Violation|0|||
156418763|NCT00519636|564626498|FG001|Washout Period|Protocol Violation|0|||
156418764|NCT00519636|564626499|FG002|Washout Period|Protocol Violation|1|||
156418765|NCT00519636|564626500|FG003|Washout Period|Protocol Violation|2|||
156418766|NCT00519636|564626497|FG000|Washout Period|Withdrawal by Subject|1|||
156418767|NCT00519636|564626498|FG001|Washout Period|Withdrawal by Subject|0|||
156418768|NCT00519636|564626499|FG002|Washout Period|Withdrawal by Subject|1|||
156418769|NCT00519636|564626500|FG003|Washout Period|Withdrawal by Subject|0|||
156418770|NCT00519636|564626497|FG000|Washout Period|Failed to meet continuation criteria|14|||
156418771|NCT00519636|564626498|FG001|Washout Period|Failed to meet continuation criteria|11|||
156418772|NCT00519636|564626499|FG002|Washout Period|Failed to meet continuation criteria|9|||
156418773|NCT00519636|564626500|FG003|Washout Period|Failed to meet continuation criteria|3|||
156418774|NCT00519636|564626497|FG000|Washout Period|Out of pollen area > 48 hours|1|||
156418775|NCT00519636|564626498|FG001|Washout Period|Out of pollen area > 48 hours|0|||
156418776|NCT00519636|564626499|FG002|Washout Period|Out of pollen area > 48 hours|0|||
156418777|NCT00519636|564626500|FG003|Washout Period|Out of pollen area > 48 hours|0|||
156418778|NCT00519636|564626497|FG000|Washout Period|Participating in study at another site|1|||
156418779|NCT00519636|564626498|FG001|Washout Period|Participating in study at another site|0|||
156418780|NCT00519636|564626499|FG002|Washout Period|Participating in study at another site|0|||
156418781|NCT00519636|564626500|FG003|Washout Period|Participating in study at another site|0|||
156418782|NCT00519636|564626497|FG000|Washout Period|Non-compliant|0|||
156418783|NCT00519636|564626498|FG001|Washout Period|Non-compliant|1|||
156418784|NCT00519636|564626499|FG002|Washout Period|Non-compliant|0|||
156418785|NCT00519636|564626500|FG003|Washout Period|Non-compliant|0|||
156418786|NCT00519636|564626497|FG000|Washout Period|Per doctors request|0|||
156418787|NCT00519636|564626498|FG001|Washout Period|Per doctors request|1|||
156418788|NCT00519636|564626499|FG002|Washout Period|Per doctors request|0|||
156418789|NCT00519636|564626500|FG003|Washout Period|Per doctors request|0|||
156418790|NCT00519636|564626497|FG000|Washout Period|Subject randomized in error|0|||
156418791|NCT00519636|564626498|FG001|Washout Period|Subject randomized in error|0|||
156418792|NCT00519636|564626499|FG002|Washout Period|Subject randomized in error|1|||
156418793|NCT00519636|564626500|FG003|Washout Period|Subject randomized in error|0|||
156418794|NCT00519636|564626497|FG000|Washout Period|Prohibited medications|0|||
156418795|NCT00519636|564626498|FG001|Washout Period|Prohibited medications|0|||
156418796|NCT00519636|564626499|FG002|Washout Period|Prohibited medications|1|||
156418797|NCT00519636|564626500|FG003|Washout Period|Prohibited medications|0|||
156418798|NCT00519636|564626497|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
156418799|NCT00519636|564626498|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
156418800|NCT00519636|564626499|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
156418801|NCT00519636|564626500|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
156418802|NCT00519636|564626497|FG000|Treatment Period 2|Subject randomized in error|0|||
156418803|NCT00519636|564626498|FG001|Treatment Period 2|Subject randomized in error|1|||
156418804|NCT00519636|564626499|FG002|Treatment Period 2|Subject randomized in error|0|||
156418805|NCT00519636|564626500|FG003|Treatment Period 2|Subject randomized in error|0|||
156418806|NCT00519636|564626497|FG000|Treatment Period 2|Per doctors request|0|||
156418807|NCT00519636|564626498|FG001|Treatment Period 2|Per doctors request|0|||
156418808|NCT00519636|564626499|FG002|Treatment Period 2|Per doctors request|1|||
156418809|NCT00519636|564626500|FG003|Treatment Period 2|Per doctors request|0|||
156418810|NCT00519636|564626497|FG000|Treatment Period 2|Subject misrandomized|0|||
156418811|NCT00519636|564626498|FG001|Treatment Period 2|Subject misrandomized|0|||
156418812|NCT00519636|564626499|FG002|Treatment Period 2|Subject misrandomized|0|||
156418813|NCT00519636|564626500|FG003|Treatment Period 2|Subject misrandomized|1|||
156418814|NCT00519636|564626497|FG000|Post Study Period|Subject randomized in error|0|||
156418815|NCT00519636|564626498|FG001|Post Study Period|Subject randomized in error|0|||
156418816|NCT00519636|564626499|FG002|Post Study Period|Subject randomized in error|0|||
156418817|NCT00519636|564626500|FG003|Post Study Period|Subject randomized in error|1|||
156418818|NCT04504916|564626501|FG000|Overall Study|Study terminated|7|||
156418819|NCT04504916|564626502|FG001|Overall Study|Study terminated|8|||
156418820|NCT04504916|564626501|FG000|Overall Study|Death|54|||
156418821|NCT04504916|564626502|FG001|Overall Study|Death|18|||
156418822|NCT04504916|564626501|FG000|Overall Study|Lost to Follow-up|1|||
156418823|NCT04504916|564626502|FG001|Overall Study|Lost to Follow-up|1|||
156418824|NCT04504916|564626501|FG000|Overall Study|Withdrawal by Subject|8|||
156418825|NCT04504916|564626502|FG001|Overall Study|Withdrawal by Subject|4|||
156418826|NCT04504916|564626501|FG000|Overall Study|Did not agree to follow-up|0|||
156418827|NCT04504916|564626502|FG001|Overall Study|Did not agree to follow-up|1|||
156418828|NCT00003509|564626503|FG000|Overall Study|Not evaluable|5|||
156653350|NCT02752776|565477964|FG001|Overall Study|Withdrawal by Subject|4|||
156653351|NCT02752776|565477965|FG002|Overall Study|Withdrawal by Subject|2|||
156418829|NCT00245011|564626505|FG000|Overall Study|Lack of Efficacy|1|||
156418830|NCT00550173|564626506|FG000|Overall Study|Death|45|||
156418831|NCT00550173|564626507|FG001|Overall Study|Death|38|||
156757766|NCT01383018|565864853|FG000|Overall Study|Withdrawal by Subject|9|||
156757767|NCT01383018|565864853|FG000|Overall Study|Subject not implanted|76|||
156757768|NCT01383018|565864853|FG000|Overall Study|Missed Visit|247|||
156757769|NCT01383018|565864853|FG000|Overall Study|Site closed early-not compliance related|7|||
156418832|NCT00550173|564626508|FG002|Overall Study|Death|50|||
156418833|NCT00550173|564626506|FG000|Overall Study|Physician Decision|1|||
156418834|NCT00550173|564626507|FG001|Overall Study|Physician Decision|2|||
156418835|NCT00550173|564626508|FG002|Overall Study|Physician Decision|2|||
156418836|NCT00550173|564626506|FG000|Overall Study|Withdrawal by Subject|9|||
156418837|NCT00550173|564626507|FG001|Overall Study|Withdrawal by Subject|12|||
156418838|NCT00550173|564626508|FG002|Overall Study|Withdrawal by Subject|17|||
156418839|NCT00550173|564626506|FG000|Overall Study|Sponsor Decision|13|||
156418840|NCT00550173|564626507|FG001|Overall Study|Sponsor Decision|7|||
156418841|NCT00550173|564626508|FG002|Overall Study|Sponsor Decision|1|||
156418842|NCT00550173|564626506|FG000|Overall Study|Lost to Follow-up|4|||
156418843|NCT00550173|564626507|FG001|Overall Study|Lost to Follow-up|4|||
156418844|NCT00550173|564626508|FG002|Overall Study|Lost to Follow-up|3|||
156418845|NCT02419755|564626512|FG000|Overall Study|Death|1|||
156418846|NCT02419755|564626513|FG001|Overall Study|Death|3|||
156418847|NCT02419755|564626512|FG000|Overall Study|Relapse|0|||
156418848|NCT02419755|564626513|FG001|Overall Study|Relapse|1|||
156418849|NCT02419755|564626512|FG000|Overall Study|Ineligible|1|||
156418850|NCT02419755|564626513|FG001|Overall Study|Ineligible|0|||
156418851|NCT02419755|564626512|FG000|Overall Study|Withdrawal by Subject|1|||
156418852|NCT02419755|564626513|FG001|Overall Study|Withdrawal by Subject|0|||
156418853|NCT02684903|564626516|FG000|Overall Study|COVID-19 shutdown of lab|4|||
156418854|NCT02684903|564626517|FG001|Overall Study|COVID-19 shutdown of lab|6|||
156418855|NCT02684903|564626516|FG000|Overall Study|Lost to Follow-up|31|||
156418856|NCT02684903|564626517|FG001|Overall Study|Lost to Follow-up|41|||
156418857|NCT06403605|564626522|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
156418858|NCT06403605|564626523|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
156418859|NCT06403605|564626522|FG000|Follow-up|Adverse Event|4|||
156418860|NCT06403605|564626523|FG001|Follow-up|Adverse Event|2|||
156418861|NCT06403605|564626522|FG000|Follow-up|Withdrawal by Subject|2|||
156418862|NCT06403605|564626523|FG001|Follow-up|Withdrawal by Subject|3|||
156418863|NCT06403605|564626522|FG000|Follow-up|Lost to Follow-up|1|||
156418864|NCT06403605|564626523|FG001|Follow-up|Lost to Follow-up|0|||
156418865|NCT06403605|564626522|FG000|Follow-up|Death|1|||
156418866|NCT06403605|564626523|FG001|Follow-up|Death|0|||
156418867|NCT06403605|564626522|FG000|Follow-up|Other reasons|0|||
156418868|NCT06403605|564626523|FG001|Follow-up|Other reasons|4|||
156418869|NCT00394095|564628056|FG000|Screening|Withdrawal by Subject|1|||
156418870|NCT00394095|564628057|FG001|Screening|Withdrawal by Subject|0|||
156418871|NCT00394095|564628056|FG000|Randomized|Withdrawal by Subject|5|||
156418872|NCT00394095|564628057|FG001|Randomized|Withdrawal by Subject|1|||
156418873|NCT00394095|564628056|FG000|Randomized|Adverse Event|1|||
156418874|NCT00394095|564628057|FG001|Randomized|Adverse Event|1|||
156418875|NCT00394095|564628056|FG000|Randomized|Overdose|1|||
156418876|NCT00394095|564628057|FG001|Randomized|Overdose|0|||
156418877|NCT00394095|564628056|FG000|Randomized|Lost to Follow-up|1|||
156418878|NCT00394095|564628057|FG001|Randomized|Lost to Follow-up|2|||
156418879|NCT04213846|564628058|FG000|Overall Study|Withdrawal by Subject|7|||
156418880|NCT04213846|564628059|FG001|Overall Study|Withdrawal by Subject|6|||
156418881|NCT04213846|564628058|FG000|Overall Study|Lost to Follow-up|15|||
156418882|NCT04213846|564628059|FG001|Overall Study|Lost to Follow-up|21|||
156418883|NCT02401529|564628067|FG000|Overall Study|Lost to Follow-up|2|||
156418884|NCT02401529|564628068|FG001|Overall Study|Lost to Follow-up|1|||
156418885|NCT02401529|564628067|FG000|Overall Study|Physician Decision|2|||
156418886|NCT02401529|564628068|FG001|Overall Study|Physician Decision|6|||
156757770|NCT01383018|565864853|FG000|Overall Study|Patient moved away from site|1|||
156757771|NCT01383018|565864853|FG000|Overall Study|Subject Incarcerated|1|||
156418887|NCT02401529|564628067|FG000|Overall Study|Protocol Violation|5|||
156418888|NCT02401529|564628068|FG001|Overall Study|Protocol Violation|0|||
156418889|NCT02491411|564628069|FG000|Overall Study|Physician Decision|4|||
156418890|NCT01106287|564628071|FG000|Overall Study|Adverse Event|1|||
156418891|NCT01106287|564628072|FG001|Overall Study|Adverse Event|0|||
156418892|NCT01106287|564628073|FG002|Overall Study|Adverse Event|0|||
156418893|NCT01106287|564628074|FG003|Overall Study|Adverse Event|0|||
156418894|NCT04822298|564628078|FG000|Overall Study|Death|3|||
156418895|NCT00465361|564628081|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
156757772|NCT03414229|565864854|FG000|Overall Study|Adverse Event|1|||
156418896|NCT05406791|564628082|FG000|Overall Study|Lost to Follow-up|13|||
156418897|NCT05406791|564628083|FG001|Overall Study|Lost to Follow-up|10|||
156418898|NCT01625338|564628084|FG000|Overall Study|Enrolled but not Treated|0|||
156418899|NCT01625338|564628085|FG001|Overall Study|Enrolled but not Treated|0|||
156418900|NCT01625338|564628086|FG002|Overall Study|Enrolled but not Treated|1|||
156418901|NCT01625338|564628084|FG000|Overall Study|Efficacy Failure|27|||
156418902|NCT01625338|564628085|FG001|Overall Study|Efficacy Failure|39|||
156418903|NCT01625338|564628086|FG002|Overall Study|Efficacy Failure|31|||
156418904|NCT01625338|564628084|FG000|Overall Study|Lost to Follow-up|3|||
156418905|NCT01625338|564628085|FG001|Overall Study|Lost to Follow-up|3|||
156418906|NCT01625338|564628086|FG002|Overall Study|Lost to Follow-up|2|||
156418907|NCT01625338|564628084|FG000|Overall Study|Investigator Decision|0|||
156418908|NCT01625338|564628085|FG001|Overall Study|Investigator Decision|2|||
156418909|NCT01625338|564628086|FG002|Overall Study|Investigator Decision|1|||
156418910|NCT01625338|564628084|FG000|Overall Study|Subject Withdrew Consent|1|||
156418911|NCT01625338|564628085|FG001|Overall Study|Subject Withdrew Consent|0|||
156418912|NCT01625338|564628086|FG002|Overall Study|Subject Withdrew Consent|2|||
156418913|NCT01625338|564628084|FG000|Overall Study|Adverse Event|1|||
156418914|NCT01625338|564628085|FG001|Overall Study|Adverse Event|0|||
156418915|NCT01625338|564628086|FG002|Overall Study|Adverse Event|1|||
156418916|NCT01625338|564628084|FG000|Overall Study|Study Discontinued by Sponsor|0|||
156418917|NCT01625338|564628085|FG001|Overall Study|Study Discontinued by Sponsor|0|||
156418918|NCT01625338|564628086|FG002|Overall Study|Study Discontinued by Sponsor|1|||
156418919|NCT01789203|564628090|FG000|Overall Study|Adverse Event|2|||
156418920|NCT01789203|564628091|FG001|Overall Study|Adverse Event|2|||
156418921|NCT01789203|564628090|FG000|Overall Study|Withdrawal by Subject|1|||
156418922|NCT01789203|564628091|FG001|Overall Study|Withdrawal by Subject|0|||
156418923|NCT01789203|564628090|FG000|Overall Study|Death|1|||
156418924|NCT01789203|564628091|FG001|Overall Study|Death|0|||
156418925|NCT01789203|564628090|FG000|Overall Study|Protocol Violation|2|||
156418926|NCT01789203|564628091|FG001|Overall Study|Protocol Violation|1|||
156418927|NCT01789203|564628090|FG000|Overall Study|Other|1|||
156418928|NCT01789203|564628091|FG001|Overall Study|Other|1|||
156418929|NCT01789203|564628090|FG000|Overall Study|patient non-adherent|2|||
156418930|NCT01789203|564628091|FG001|Overall Study|patient non-adherent|0|||
156418931|NCT00515086|564628096|FG000|Overall Study|Adverse Event|1|||
156418932|NCT00515086|564628097|FG001|Overall Study|Adverse Event|1|||
156418933|NCT00515086|564628098|FG002|Overall Study|Adverse Event|2|||
156418934|NCT00515086|564628099|FG003|Overall Study|Adverse Event|3|||
156418935|NCT00515086|564628096|FG000|Overall Study|Administrative|1|||
156418936|NCT00515086|564628097|FG001|Overall Study|Administrative|1|||
156418937|NCT00515086|564628098|FG002|Overall Study|Administrative|0|||
156418938|NCT00515086|564628099|FG003|Overall Study|Administrative|0|||
156418939|NCT00515086|564628096|FG000|Overall Study|Withdrawal by Subject|1|||
156418940|NCT00515086|564628097|FG001|Overall Study|Withdrawal by Subject|0|||
156418941|NCT00515086|564628098|FG002|Overall Study|Withdrawal by Subject|0|||
156418942|NCT00515086|564628099|FG003|Overall Study|Withdrawal by Subject|1|||
156418943|NCT00515086|564628096|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
156418944|NCT00515086|564628097|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156418945|NCT00515086|564628098|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
156418946|NCT00515086|564628099|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
156418947|NCT00515086|564628096|FG000|Overall Study|Lost to Follow-up|1|||
156418948|NCT00515086|564628097|FG001|Overall Study|Lost to Follow-up|0|||
156418949|NCT00515086|564628098|FG002|Overall Study|Lost to Follow-up|0|||
156418950|NCT00515086|564628099|FG003|Overall Study|Lost to Follow-up|0|||
156418951|NCT00515086|564628096|FG000|Overall Study|Study drug no longer required|0|||
156418952|NCT00515086|564628097|FG001|Overall Study|Study drug no longer required|1|||
156418953|NCT00515086|564628098|FG002|Overall Study|Study drug no longer required|0|||
156418954|NCT00515086|564628099|FG003|Overall Study|Study drug no longer required|0|||
156418955|NCT00515086|564628096|FG000|Overall Study|Death|2|||
156418956|NCT00515086|564628097|FG001|Overall Study|Death|0|||
156418957|NCT00515086|564628098|FG002|Overall Study|Death|0|||
156418958|NCT00515086|564628099|FG003|Overall Study|Death|0|||
156418959|NCT02403674|564628102|FG000|Base Study|Death|1|||
156418960|NCT02403674|564628103|FG001|Base Study|Death|4|||
156418961|NCT02403674|564628102|FG000|Base Study|Adverse Event|11|||
156418962|NCT02403674|564628103|FG001|Base Study|Adverse Event|26|||
156418963|NCT02403674|564628102|FG000|Base Study|Lack of Efficacy|31|||
156418964|NCT02403674|564628103|FG001|Base Study|Lack of Efficacy|23|||
156757773|NCT03414229|565864855|FG001|Overall Study|Adverse Event|0|||
156757774|NCT03414229|565864856|FG002|Overall Study|Adverse Event|2|||
156757775|NCT03414229|565864857|FG003|Overall Study|Adverse Event|1|||
156757776|NCT03414229|565864854|FG000|Overall Study|Lack of Efficacy|7|||
156757777|NCT03414229|565864855|FG001|Overall Study|Lack of Efficacy|4|||
156418965|NCT02403674|564628102|FG000|Base Study|Lost to Follow-up|6|||
156418966|NCT02403674|564628103|FG001|Base Study|Lost to Follow-up|8|||
156418967|NCT02403674|564628102|FG000|Base Study|Withdrawal by Subject|10|||
156418968|NCT02403674|564628103|FG001|Base Study|Withdrawal by Subject|17|||
156418969|NCT02403674|564628102|FG000|Base Study|Physician Decision|2|||
156418970|NCT02403674|564628103|FG001|Base Study|Physician Decision|2|||
156418971|NCT02403674|564628102|FG000|Base Study|Pregnancy|2|||
156418972|NCT02403674|564628103|FG001|Base Study|Pregnancy|2|||
156418973|NCT02403674|564628102|FG000|Base Study|Protocol Violation|8|||
156418974|NCT02403674|564628103|FG001|Base Study|Protocol Violation|4|||
156418975|NCT02403674|564628102|FG000|Base Study|Non-Compliance with study drug|1|||
156757778|NCT03414229|565864856|FG002|Overall Study|Lack of Efficacy|1|||
156757779|NCT03414229|565864857|FG003|Overall Study|Lack of Efficacy|9|||
156418976|NCT02403674|564628103|FG001|Base Study|Non-Compliance with study drug|4|||
156418977|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
156757780|NCT03414229|565864854|FG000|Overall Study|Change in therapy|1|||
156757781|NCT03414229|565864855|FG001|Overall Study|Change in therapy|0|||
156757782|NCT03414229|565864856|FG002|Overall Study|Change in therapy|0|||
156757783|NCT03414229|565864857|FG003|Overall Study|Change in therapy|0|||
156757784|NCT03414229|565864854|FG000|Overall Study|Pregnancy|0|||
156757785|NCT03414229|565864855|FG001|Overall Study|Pregnancy|0|||
156757786|NCT03414229|565864856|FG002|Overall Study|Pregnancy|1|||
156757787|NCT03414229|565864857|FG003|Overall Study|Pregnancy|0|||
156757788|NCT03414229|565864854|FG000|Overall Study|Withdrawal by Subject|0|||
156757789|NCT03414229|565864855|FG001|Overall Study|Withdrawal by Subject|1|||
156757790|NCT03414229|565864856|FG002|Overall Study|Withdrawal by Subject|1|||
156757791|NCT03414229|565864857|FG003|Overall Study|Withdrawal by Subject|0|||
156757792|NCT05568797|565864860|FG000|Overall Study|Adverse Event|0|||
156757793|NCT05568797|565864861|FG001|Overall Study|Adverse Event|8|||
156757794|NCT05568797|565864860|FG000|Overall Study|Lost to Follow-up|2|||
156757795|NCT05568797|565864861|FG001|Overall Study|Lost to Follow-up|3|||
156757796|NCT05568797|565864860|FG000|Overall Study|Withdrawal by Subject|1|||
156757797|NCT05568797|565864861|FG001|Overall Study|Withdrawal by Subject|10|||
156757798|NCT05568797|565864860|FG000|Overall Study|Other|2|||
156757799|NCT05568797|565864861|FG001|Overall Study|Other|2|||
156757800|NCT00099632|565864862|FG000|Overall Study|Lost to Follow-up|1|||
156757801|NCT00099632|565864863|FG001|Overall Study|Lost to Follow-up|0|||
156757802|NCT00099632|565864864|FG002|Overall Study|Lost to Follow-up|3|||
156757803|NCT00099632|565864865|FG003|Overall Study|Lost to Follow-up|1|||
156757804|NCT00099632|565864866|FG004|Overall Study|Lost to Follow-up|1|||
156757805|NCT00099632|565864867|FG005|Overall Study|Lost to Follow-up|0|||
156757806|NCT00099632|565864862|FG000|Overall Study|Withdrawal by Subject|0|||
156757807|NCT00099632|565864863|FG001|Overall Study|Withdrawal by Subject|1|||
156757808|NCT00099632|565864864|FG002|Overall Study|Withdrawal by Subject|0|||
156757809|NCT00099632|565864865|FG003|Overall Study|Withdrawal by Subject|0|||
156757810|NCT00099632|565864866|FG004|Overall Study|Withdrawal by Subject|0|||
156757811|NCT00099632|565864867|FG005|Overall Study|Withdrawal by Subject|1|||
156757812|NCT00099632|565864862|FG000|Overall Study|Protocol Violation|0|||
156757813|NCT00099632|565864863|FG001|Overall Study|Protocol Violation|0|||
156757814|NCT00099632|565864864|FG002|Overall Study|Protocol Violation|0|||
156757815|NCT00099632|565864865|FG003|Overall Study|Protocol Violation|0|||
156757816|NCT00099632|565864866|FG004|Overall Study|Protocol Violation|0|||
156757817|NCT00099632|565864867|FG005|Overall Study|Protocol Violation|1|||
156757818|NCT03131687|565864868|FG000|Overall Study|Adverse Event|0|||
156757819|NCT03131687|565864869|FG001|Overall Study|Adverse Event|1|||
156757820|NCT03131687|565864870|FG002|Overall Study|Adverse Event|0|||
156757821|NCT03131687|565864871|FG003|Overall Study|Adverse Event|1|||
156757822|NCT03131687|565864872|FG004|Overall Study|Adverse Event|2|||
156757823|NCT03131687|565864873|FG005|Overall Study|Adverse Event|2|||
156757824|NCT03131687|565864868|FG000|Overall Study|Death|1|||
156757825|NCT03131687|565864869|FG001|Overall Study|Death|0|||
156418978|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
156418979|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
156418980|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
156418981|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
156418982|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
156418983|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
156418984|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
156418985|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
156418986|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
156418987|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
156418988|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
156418989|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Death|1|||
156418990|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Death|0|||
156418991|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
156418992|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
156418993|NCT02403674|564628102|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
156757826|NCT03131687|565864870|FG002|Overall Study|Death|0|||
156757827|NCT03131687|565864871|FG003|Overall Study|Death|0|||
156418994|NCT02403674|564628103|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
156757828|NCT03131687|565864872|FG004|Overall Study|Death|0|||
156418995|NCT02403674|564628102|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
156418996|NCT02403674|564628103|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
156757829|NCT03131687|565864873|FG005|Overall Study|Death|0|||
156757830|NCT03131687|565864868|FG000|Overall Study|Withdrawal by Subject|3|||
156757831|NCT03131687|565864869|FG001|Overall Study|Withdrawal by Subject|3|||
156418997|NCT02403674|564628102|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
156418998|NCT02403674|564628103|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
156757832|NCT03131687|565864870|FG002|Overall Study|Withdrawal by Subject|3|||
156757833|NCT03131687|565864871|FG003|Overall Study|Withdrawal by Subject|1|||
156757834|NCT03131687|565864872|FG004|Overall Study|Withdrawal by Subject|2|||
156757835|NCT03131687|565864873|FG005|Overall Study|Withdrawal by Subject|1|||
156757836|NCT03131687|565864868|FG000|Overall Study|Lost to Follow-up|1|||
156757837|NCT03131687|565864869|FG001|Overall Study|Lost to Follow-up|4|||
156757838|NCT03131687|565864870|FG002|Overall Study|Lost to Follow-up|0|||
156757839|NCT03131687|565864871|FG003|Overall Study|Lost to Follow-up|1|||
156757840|NCT03131687|565864872|FG004|Overall Study|Lost to Follow-up|4|||
156757841|NCT03131687|565864873|FG005|Overall Study|Lost to Follow-up|2|||
156757842|NCT03131687|565864868|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
156757843|NCT03131687|565864869|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
156757844|NCT03131687|565864870|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
156757845|NCT03131687|565864871|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
156757846|NCT03131687|565864872|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
156757847|NCT03131687|565864873|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
156757848|NCT03131687|565864868|FG000|Overall Study|Principle Investigator Decision|0|||
156757849|NCT03131687|565864869|FG001|Overall Study|Principle Investigator Decision|1|||
156757850|NCT03131687|565864870|FG002|Overall Study|Principle Investigator Decision|0|||
156757851|NCT03131687|565864871|FG003|Overall Study|Principle Investigator Decision|0|||
156757852|NCT03131687|565864872|FG004|Overall Study|Principle Investigator Decision|0|||
156757853|NCT03131687|565864873|FG005|Overall Study|Principle Investigator Decision|0|||
156757854|NCT03131687|565864868|FG000|Overall Study|Inadvertent Enrollment|0|||
156757855|NCT03131687|565864869|FG001|Overall Study|Inadvertent Enrollment|0|||
156757856|NCT03131687|565864870|FG002|Overall Study|Inadvertent Enrollment|0|||
156757857|NCT03131687|565864871|FG003|Overall Study|Inadvertent Enrollment|1|||
156757858|NCT03131687|565864872|FG004|Overall Study|Inadvertent Enrollment|0|||
156757859|NCT03131687|565864873|FG005|Overall Study|Inadvertent Enrollment|0|||
156757860|NCT02797678|565864874|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
156757861|NCT02797678|565864875|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
156757862|NCT02797678|565864876|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
156757863|NCT02797678|565864877|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
156757864|NCT02797678|565864874|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
156317665|NCT00402233|564261840|FG003|Overall Study|Adverse Event|9|||
156317666|NCT00402233|564261837|FG000|Overall Study|Protocol Violation|0|||
156317667|NCT00402233|564261838|FG001|Overall Study|Protocol Violation|1|||
156317668|NCT00402233|564261839|FG002|Overall Study|Protocol Violation|0|||
156317669|NCT00402233|564261840|FG003|Overall Study|Protocol Violation|0|||
156317670|NCT00402233|564261837|FG000|Overall Study|Withdrawal by Subject|2|||
156317671|NCT00402233|564261838|FG001|Overall Study|Withdrawal by Subject|1|||
156317672|NCT00402233|564261839|FG002|Overall Study|Withdrawal by Subject|2|||
156317673|NCT00402233|564261840|FG003|Overall Study|Withdrawal by Subject|2|||
156317674|NCT00402233|564261837|FG000|Overall Study|Worsening of disease under study|2|||
156317675|NCT00402233|564261838|FG001|Overall Study|Worsening of disease under study|0|||
156317676|NCT00402233|564261839|FG002|Overall Study|Worsening of disease under study|0|||
156317677|NCT00402233|564261840|FG003|Overall Study|Worsening of disease under study|0|||
156317678|NCT00402233|564261837|FG000|Overall Study|Worsening of other pre-existing disease|0|||
156317679|NCT00402233|564261838|FG001|Overall Study|Worsening of other pre-existing disease|1|||
156317680|NCT00402233|564261839|FG002|Overall Study|Worsening of other pre-existing disease|0|||
156317681|NCT00402233|564261840|FG003|Overall Study|Worsening of other pre-existing disease|0|||
156317682|NCT03007888|564261841|FG000|First Intervention (14 Days)|Adverse Event|1|||
156317683|NCT03007888|564261842|FG001|First Intervention (14 Days)|Adverse Event|0|||
156317684|NCT00927940|564261843|FG000|Overall Study|Death|1|||
156317685|NCT00492063|564261846|FG000|Overall Study|Death|0|||
156317686|NCT00492063|564261847|FG001|Overall Study|Death|0|||
156317687|NCT00492063|564261848|FG002|Overall Study|Death|1|||
156317688|NCT00492063|564261849|FG003|Overall Study|Death|2|||
156317689|NCT00492063|564261846|FG000|Overall Study|Withdrawal by Subject|4|||
156317690|NCT00492063|564261847|FG001|Overall Study|Withdrawal by Subject|3|||
156317691|NCT00492063|564261848|FG002|Overall Study|Withdrawal by Subject|5|||
156317692|NCT00492063|564261849|FG003|Overall Study|Withdrawal by Subject|4|||
156317693|NCT00492063|564261846|FG000|Overall Study|Lost to Follow-up|6|||
156317694|NCT00492063|564261847|FG001|Overall Study|Lost to Follow-up|11|||
156317695|NCT00492063|564261848|FG002|Overall Study|Lost to Follow-up|5|||
156317696|NCT00492063|564261849|FG003|Overall Study|Lost to Follow-up|3|||
156317697|NCT00492063|564261846|FG000|Overall Study|Protocol Violation|0|||
156317698|NCT00492063|564261847|FG001|Overall Study|Protocol Violation|0|||
156317699|NCT00492063|564261848|FG002|Overall Study|Protocol Violation|0|||
156317700|NCT00492063|564261849|FG003|Overall Study|Protocol Violation|1|||
156317701|NCT01870076|564261850|FG000|Overall Study|Withdrawal by Subject|1|||
156317702|NCT01870076|564261851|FG001|Overall Study|Withdrawal by Subject|0|||
156317703|NCT01870076|564261852|FG002|Overall Study|Withdrawal by Subject|1|||
156317704|NCT01870076|564261853|FG003|Overall Study|Withdrawal by Subject|0|||
156317705|NCT00890045|564261858|FG000|Overall Study|Death|0|||
156757865|NCT02797678|565864875|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
156757866|NCT02797678|565864876|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
156317706|NCT00890045|564261859|FG001|Overall Study|Death|1|||
156317707|NCT00890045|564261858|FG000|Overall Study|Did not receive HeRO Graft|0|||
156757867|NCT02797678|565864877|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
156418999|NCT02403674|564628102|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
156419000|NCT02403674|564628103|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
156419001|NCT02403674|564628102|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
156419002|NCT02403674|564628103|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
156757868|NCT02797678|565864874|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
156757869|NCT02797678|565864875|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
156757870|NCT02797678|565864876|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
156757871|NCT02797678|565864877|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
156757872|NCT02401035|565864878|FG000|Overall Study|Withdrawal by Subject|1|||
156757873|NCT02401035|565864879|FG001|Overall Study|Withdrawal by Subject|0|||
156757874|NCT00869128|565864880|FG000|Overall Study|lack of Compliance|6|||
156757875|NCT00869128|565864881|FG001|Overall Study|lack of Compliance|6|||
156757876|NCT01118663|565864888|FG000|Overall Study|Adverse Event|2|||
156757877|NCT01118663|565864889|FG001|Overall Study|Adverse Event|1|||
156757878|NCT01118663|565864888|FG000|Overall Study|Withdrawal by Subject|0|||
156757879|NCT01118663|565864889|FG001|Overall Study|Withdrawal by Subject|1|||
156757880|NCT03046953|565864896|FG000|Overall Study|Relapse/progressive disease|21|||
156757881|NCT03046953|565864896|FG000|Overall Study|Death|2|||
156757882|NCT03046953|565864896|FG000|Overall Study|Withdrawal by Subject|3|||
156757883|NCT04039204|565864897|FG000|Overall Study|Withdrawal by Subject|0|||
156757884|NCT04039204|565864898|FG001|Overall Study|Withdrawal by Subject|2|||
156757885|NCT00420628|565864899|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
156757886|NCT00420628|565864900|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
156757887|NCT00420628|565864899|FG000|Overall Study|Lost to Follow-up|3|||
156757888|NCT00420628|565864900|FG001|Overall Study|Lost to Follow-up|2|||
156757889|NCT00420628|565864899|FG000|Overall Study|Adverse Event|1|||
156757890|NCT00420628|565864900|FG001|Overall Study|Adverse Event|0|||
156757891|NCT02716584|565864901|FG000|Overall Study|Lost to Follow-up|8|||
156757892|NCT02716584|565864902|FG001|Overall Study|Lost to Follow-up|5|||
156757893|NCT00656175|565864905|FG000|Overall Study|Adverse Event|1|||
156419003|NCT02403674|564628102|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
156419004|NCT02403674|564628103|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
156419005|NCT02403674|564628102|FG000|Study Extension 2 (Open-Label)|Death|2|||
156419006|NCT02403674|564628103|FG001|Study Extension 2 (Open-Label)|Death|2|||
156419007|NCT02403674|564628102|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
156419008|NCT02403674|564628103|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
156419009|NCT02403674|564628102|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
156419010|NCT02403674|564628103|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
156419011|NCT02403674|564628102|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
156419012|NCT02403674|564628103|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
156419013|NCT02403674|564628102|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
156419014|NCT02403674|564628103|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
156419015|NCT02403674|564628102|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
156419016|NCT02403674|564628103|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
156419017|NCT02403674|564628102|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
156419018|NCT02403674|564628103|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
156419019|NCT02403674|564628102|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
156419020|NCT02403674|564628103|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
156419021|NCT03487666|564628105|FG000|Overall Study|Disease progression|4|||
156419022|NCT03487666|564628106|FG001|Overall Study|Disease progression|2|||
156419023|NCT03487666|564628107|FG002|Overall Study|Disease progression|0|||
156419024|NCT03487666|564628105|FG000|Overall Study|Adverse Event|0|||
156419025|NCT03487666|564628106|FG001|Overall Study|Adverse Event|0|||
156419026|NCT03487666|564628107|FG002|Overall Study|Adverse Event|1|||
156419027|NCT03201757|564628108|FG000|Overall Study|Withdrawal by Subject|133|||
156757894|NCT00656175|565864906|FG001|Overall Study|Adverse Event|0|||
156757895|NCT00656175|565864905|FG000|Overall Study|Transportation issues|0|||
156757896|NCT00656175|565864906|FG001|Overall Study|Transportation issues|1|||
156757897|NCT01216332|565864907|FG000|Overall Study|Withdrawal by Subject|4|||
156757898|NCT01216332|565864908|FG001|Overall Study|Withdrawal by Subject|0|||
156757899|NCT01237327|565864909|FG000|Overall Study|Protocol Violation: Core Study|1|||
156757900|NCT01237327|565864910|FG001|Overall Study|Protocol Violation: Core Study|0|||
156757901|NCT01237327|565864909|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
156419028|NCT03201757|564628108|FG000|Overall Study|Adverse Event|44|||
156419029|NCT03201757|564628108|FG000|Overall Study|Lost to Follow-up|37|||
156757902|NCT01237327|565864910|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
156419030|NCT03201757|564628108|FG000|Overall Study|Pregnancy|2|||
156419031|NCT03201757|564628108|FG000|Overall Study|Lack of Efficacy|1|||
156757903|NCT01237327|565864909|FG000|Overall Study|Progression of Disease: Core Study|18|||
156757904|NCT01237327|565864910|FG001|Overall Study|Progression of Disease: Core Study|22|||
156757905|NCT01237327|565864909|FG000|Overall Study|Progression of Disease: Extension Study|15|||
156419032|NCT03201757|564628108|FG000|Overall Study|Protocol Violation|20|||
156419033|NCT03201757|564628108|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
156419034|NCT03201757|564628108|FG000|Overall Study|Not Yet Determined|5|||
156419035|NCT03201757|564628108|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
156419036|NCT03201757|564628108|FG000|Overall Study|Other|20|||
156419037|NCT01254305|564628109|FG000|Overall Study|Adverse Event|6|||
156419038|NCT01254305|564628110|FG001|Overall Study|Adverse Event|3|||
156419039|NCT01254305|564628111|FG002|Overall Study|Adverse Event|2|||
156419040|NCT01254305|564628109|FG000|Overall Study|Lack of Efficacy|1|||
156419041|NCT01254305|564628110|FG001|Overall Study|Lack of Efficacy|0|||
156419042|NCT01254305|564628111|FG002|Overall Study|Lack of Efficacy|1|||
156757906|NCT01237327|565864910|FG001|Overall Study|Progression of Disease: Extension Study|13|||
156757907|NCT01237327|565864909|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
156757908|NCT01237327|565864910|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
156757909|NCT01237327|565864909|FG000|Overall Study|Withdrawal by Subject|1|||
156757910|NCT01237327|565864910|FG001|Overall Study|Withdrawal by Subject|3|||
156757911|NCT01237327|565864909|FG000|Overall Study|Lost to Follow-up|3|||
156757912|NCT01237327|565864910|FG001|Overall Study|Lost to Follow-up|0|||
156757913|NCT03300180|565864911|FG000|Baseline|Withdrawal by Subject|4|||
156757914|NCT03300180|565864912|FG001|Baseline|Withdrawal by Subject|6|||
156757915|NCT03300180|565864913|FG002|Baseline|Withdrawal by Subject|4|||
156757916|NCT03300180|565864911|FG000|6 Month Outcome|Withdrawal by Subject|12|||
156757917|NCT03300180|565864912|FG001|6 Month Outcome|Withdrawal by Subject|12|||
156757918|NCT03300180|565864913|FG002|6 Month Outcome|Withdrawal by Subject|19|||
156757919|NCT03300180|565864911|FG000|6 Month Outcome|Death|2|||
156757920|NCT03300180|565864912|FG001|6 Month Outcome|Death|4|||
156757921|NCT03300180|565864913|FG002|6 Month Outcome|Death|3|||
156757922|NCT03300180|565864911|FG000|6 Month Outcome|Missed Assessment|43|||
156757923|NCT03300180|565864912|FG001|6 Month Outcome|Missed Assessment|52|||
156757924|NCT03300180|565864913|FG002|6 Month Outcome|Missed Assessment|46|||
156419043|NCT01254305|564628109|FG000|Overall Study|Protocol Violation|1|||
156419044|NCT01254305|564628110|FG001|Overall Study|Protocol Violation|7|||
156419045|NCT01254305|564628111|FG002|Overall Study|Protocol Violation|3|||
156419046|NCT01254305|564628109|FG000|Overall Study|Withdrawal by Subject|4|||
156419047|NCT01254305|564628110|FG001|Overall Study|Withdrawal by Subject|2|||
156419048|NCT01254305|564628111|FG002|Overall Study|Withdrawal by Subject|4|||
156419049|NCT01254305|564628109|FG000|Overall Study|Lost to Follow-up|10|||
156419050|NCT01254305|564628110|FG001|Overall Study|Lost to Follow-up|6|||
156419051|NCT01254305|564628111|FG002|Overall Study|Lost to Follow-up|5|||
156419052|NCT01254305|564628109|FG000|Overall Study|Other Reasons|0|||
156419053|NCT01254305|564628110|FG001|Overall Study|Other Reasons|0|||
156419054|NCT01254305|564628111|FG002|Overall Study|Other Reasons|2|||
156419055|NCT02297503|564628112|FG000|Overall Study|Withdrawal by Subject|1|||
156419056|NCT02297503|564628113|FG001|Overall Study|Withdrawal by Subject|1|||
156419057|NCT02297503|564628112|FG000|Overall Study|Protocol Violation|1|||
156419058|NCT02297503|564628113|FG001|Overall Study|Protocol Violation|0|||
156419059|NCT02297503|564628112|FG000|Overall Study|Pregnancy|0|||
156419060|NCT02297503|564628113|FG001|Overall Study|Pregnancy|1|||
156419061|NCT02297503|564628112|FG000|Overall Study|Lost to Follow-up|0|||
156419062|NCT02297503|564628113|FG001|Overall Study|Lost to Follow-up|1|||
156419063|NCT02297503|564628112|FG000|Overall Study|Medical reason|0|||
156419064|NCT02297503|564628113|FG001|Overall Study|Medical reason|1|||
156419065|NCT00765362|564628114|FG000|Overall Study|Death|9|||
156419066|NCT00765362|564628114|FG000|Overall Study|Adverse Event|2|||
156419067|NCT00765362|564628114|FG000|Overall Study|Protocol Violation|18|||
156419068|NCT00765362|564628114|FG000|Overall Study|Withdrawal by Subject|13|||
156419069|NCT00765362|564628114|FG000|Overall Study|Lost to Follow-up|95|||
156419070|NCT03930186|564628115|FG000|Weeks 0 to 16|Adverse Event|6|||
156419071|NCT03930186|564628115|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
156757925|NCT03300180|565864911|FG000|12 Month Outcome|Withdrawal by Subject|3|||
156757926|NCT03300180|565864912|FG001|12 Month Outcome|Withdrawal by Subject|6|||
156757927|NCT03300180|565864913|FG002|12 Month Outcome|Withdrawal by Subject|6|||
156757928|NCT03300180|565864911|FG000|12 Month Outcome|Death|9|||
156757929|NCT03300180|565864912|FG001|12 Month Outcome|Death|6|||
156757930|NCT03300180|565864913|FG002|12 Month Outcome|Death|6|||
156757931|NCT03300180|565864911|FG000|12 Month Outcome|Missed Assessment|62|||
156419072|NCT03930186|564628115|FG000|Weeks 16 to 32|Adverse Event|1|||
156419073|NCT03930186|564628115|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
156419074|NCT00557505|564628120|FG000|Overall Study|Death|0|||
156419075|NCT00557505|564628121|FG001|Overall Study|Death|0|||
156419076|NCT00557505|564628122|FG002|Overall Study|Death|0|||
156419077|NCT00557505|564628123|FG003|Overall Study|Death|0|||
156757932|NCT03300180|565864912|FG001|12 Month Outcome|Missed Assessment|59|||
156757933|NCT03300180|565864913|FG002|12 Month Outcome|Missed Assessment|58|||
156757934|NCT03300180|565864911|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
156419078|NCT00557505|564628124|FG004|Overall Study|Death|0|||
156419079|NCT00557505|564628125|FG005|Overall Study|Death|0|||
156419080|NCT00557505|564628126|FG006|Overall Study|Death|0|||
156419081|NCT00557505|564628127|FG007|Overall Study|Death|0|||
156757935|NCT03300180|565864912|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
156757936|NCT03300180|565864913|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
156757937|NCT03300180|565864911|FG000|18 Month Outcome Assessment|Death|8|||
156757938|NCT03300180|565864912|FG001|18 Month Outcome Assessment|Death|5|||
156757939|NCT03300180|565864913|FG002|18 Month Outcome Assessment|Death|5|||
156757940|NCT03300180|565864911|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
156419082|NCT00557505|564628128|FG008|Overall Study|Death|1|||
156419083|NCT00557505|564628120|FG000|Overall Study|Adverse Event|0|||
156757941|NCT03300180|565864912|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
156757942|NCT03300180|565864913|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
156757943|NCT03300180|565864911|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
156757944|NCT03300180|565864912|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
156757945|NCT03300180|565864913|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
156419084|NCT00557505|564628121|FG001|Overall Study|Adverse Event|0|||
156419085|NCT00557505|564628122|FG002|Overall Study|Adverse Event|1|||
156419086|NCT00557505|564628123|FG003|Overall Study|Adverse Event|0|||
156419087|NCT00557505|564628124|FG004|Overall Study|Adverse Event|0|||
156419088|NCT00557505|564628125|FG005|Overall Study|Adverse Event|0|||
156419089|NCT00557505|564628126|FG006|Overall Study|Adverse Event|1|||
156419090|NCT00557505|564628127|FG007|Overall Study|Adverse Event|0|||
156419091|NCT00557505|564628128|FG008|Overall Study|Adverse Event|0|||
156419092|NCT00557505|564628120|FG000|Overall Study|Global deterioration of health|1|||
156419093|NCT00557505|564628121|FG001|Overall Study|Global deterioration of health|0|||
156419094|NCT00557505|564628122|FG002|Overall Study|Global deterioration of health|0|||
156419095|NCT00557505|564628123|FG003|Overall Study|Global deterioration of health|0|||
156419096|NCT00557505|564628124|FG004|Overall Study|Global deterioration of health|0|||
156419097|NCT00557505|564628125|FG005|Overall Study|Global deterioration of health|0|||
156419098|NCT00557505|564628126|FG006|Overall Study|Global deterioration of health|0|||
156419099|NCT00557505|564628127|FG007|Overall Study|Global deterioration of health|0|||
156419100|NCT00557505|564628128|FG008|Overall Study|Global deterioration of health|0|||
156419101|NCT00557505|564628120|FG000|Overall Study|Objective progression or relapse|2|||
156419102|NCT00557505|564628121|FG001|Overall Study|Objective progression or relapse|3|||
156419103|NCT00557505|564628122|FG002|Overall Study|Objective progression or relapse|3|||
156419104|NCT00557505|564628123|FG003|Overall Study|Objective progression or relapse|2|||
156419105|NCT00557505|564628124|FG004|Overall Study|Objective progression or relapse|2|||
156419106|NCT00557505|564628125|FG005|Overall Study|Objective progression or relapse|3|||
156419107|NCT00557505|564628126|FG006|Overall Study|Objective progression or relapse|2|||
156419108|NCT00557505|564628127|FG007|Overall Study|Objective progression or relapse|5|||
156419109|NCT00557505|564628128|FG008|Overall Study|Objective progression or relapse|15|||
156419110|NCT00557505|564628120|FG000|Overall Study|Withdrawal by Subject|0|||
156419111|NCT00557505|564628121|FG001|Overall Study|Withdrawal by Subject|0|||
156419112|NCT00557505|564628122|FG002|Overall Study|Withdrawal by Subject|0|||
156419113|NCT00557505|564628123|FG003|Overall Study|Withdrawal by Subject|1|||
156419114|NCT00557505|564628124|FG004|Overall Study|Withdrawal by Subject|0|||
156419115|NCT00557505|564628125|FG005|Overall Study|Withdrawal by Subject|0|||
156419116|NCT00557505|564628126|FG006|Overall Study|Withdrawal by Subject|0|||
156419117|NCT00557505|564628127|FG007|Overall Study|Withdrawal by Subject|0|||
156419118|NCT00557505|564628128|FG008|Overall Study|Withdrawal by Subject|1|||
156419119|NCT03019458|564628129|FG000|Overall Study|Death|0|||
156757946|NCT03300180|565864911|FG000|24 Month Outcome Assessment|Death|13|||
156757947|NCT03300180|565864912|FG001|24 Month Outcome Assessment|Death|13|||
156757948|NCT03300180|565864913|FG002|24 Month Outcome Assessment|Death|3|||
156757949|NCT03300180|565864911|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
156757950|NCT03300180|565864912|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
156757951|NCT03300180|565864913|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
156757952|NCT02557516|565864918|FG000|Overall Study|Adverse Event|1|||
156757953|NCT02557516|565864919|FG001|Overall Study|Adverse Event|0|||
156757954|NCT02557516|565864920|FG002|Overall Study|Adverse Event|2|||
156757955|NCT02557516|565864921|FG003|Overall Study|Adverse Event|1|||
156757956|NCT02557516|565864918|FG000|Overall Study|Disease progression|0|||
156757957|NCT02557516|565864919|FG001|Overall Study|Disease progression|2|||
156757958|NCT02557516|565864920|FG002|Overall Study|Disease progression|0|||
156419120|NCT03019458|564628130|FG001|Overall Study|Death|1|||
156419121|NCT00031447|564628131|FG000|Overall Study|Lost to Follow-up|0|||
156419122|NCT00031447|564628132|FG001|Overall Study|Lost to Follow-up|1|||
156419123|NCT00031447|564628131|FG000|Overall Study|Non-compliant|1|||
156419124|NCT00031447|564628132|FG001|Overall Study|Non-compliant|1|||
156757959|NCT02557516|565864921|FG003|Overall Study|Disease progression|0|||
156419125|NCT00031447|564628131|FG000|Overall Study|Re-activation of Disease|2|||
156419126|NCT00031447|564628132|FG001|Overall Study|Re-activation of Disease|1|||
156419127|NCT00031447|564628131|FG000|Overall Study|Disruption of blinded study drug supply|7|||
156757960|NCT02557516|565864918|FG000|Overall Study|Physician Decision|0|||
156757961|NCT02557516|565864919|FG001|Overall Study|Physician Decision|2|||
156757962|NCT02557516|565864920|FG002|Overall Study|Physician Decision|0|||
156757963|NCT02557516|565864921|FG003|Overall Study|Physician Decision|0|||
156757964|NCT02557516|565864918|FG000|Overall Study|Sponsor decision|0|||
156317708|NCT00890045|564261859|FG001|Overall Study|Did not receive HeRO Graft|2|||
156317709|NCT00890045|564261858|FG000|Overall Study|Lost to Follow-up|5|||
156317710|NCT00890045|564261859|FG001|Overall Study|Lost to Follow-up|7|||
156317711|NCT01947855|564261860|FG000|Overall Study|Withdrawal by Subject|1|||
156317712|NCT01947855|564261861|FG001|Overall Study|Withdrawal by Subject|0|||
156317713|NCT01947855|564261862|FG002|Overall Study|Withdrawal by Subject|0|||
156317714|NCT00621621|564261869|FG000|Overall Study|Subjects were exited at EP study|30|||
156317715|NCT00621621|564261870|FG001|Overall Study|Subjects were exited at EP study|0|||
156317716|NCT01829243|564261871|FG000|First Intervention|Screen Failure|4|||
156317717|NCT01829243|564261872|FG001|First Intervention|Screen Failure|2|||
156317718|NCT00608569|564261873|FG000|Overall Study|Death|4|||
156317719|NCT00608569|564261874|FG001|Overall Study|Death|3|||
156317720|NCT00608569|564261873|FG000|Overall Study|Lost to Follow-up|4|||
156317721|NCT00608569|564261874|FG001|Overall Study|Lost to Follow-up|5|||
156317722|NCT00608569|564261873|FG000|Overall Study|Withdrawal by Subject|1|||
156317723|NCT00608569|564261874|FG001|Overall Study|Withdrawal by Subject|0|||
156317724|NCT00608569|564261873|FG000|Overall Study|Adverse Event|1|||
156317725|NCT00608569|564261874|FG001|Overall Study|Adverse Event|0|||
156317726|NCT00608569|564261873|FG000|Overall Study|Unable to adhere with study requirements|0|||
156317727|NCT00608569|564261874|FG001|Overall Study|Unable to adhere with study requirements|1|||
156317728|NCT03985878|564261882|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
156317729|NCT03985878|564261882|FG000|Overall Study|Study Terminated by Sponsor|12|||
156317730|NCT03985878|564261882|FG000|Overall Study|Withdrawal by Subject|1|||
156317731|NCT00534599|564261883|FG000|Overall Study|Adverse Event|25|||
156317732|NCT00534599|564261884|FG001|Overall Study|Adverse Event|4|||
156317733|NCT00534599|564261883|FG000|Overall Study|Incorrect enrollment|2|||
156317734|NCT00534599|564261884|FG001|Overall Study|Incorrect enrollment|1|||
156317735|NCT00534599|564261883|FG000|Overall Study|Mis-randomization|2|||
156317736|NCT00534599|564261884|FG001|Overall Study|Mis-randomization|2|||
156317737|NCT00534599|564261883|FG000|Overall Study|Developed study-specific d/c criteria|5|||
156317738|NCT00534599|564261884|FG001|Overall Study|Developed study-specific d/c criteria|0|||
156317739|NCT00534599|564261883|FG000|Overall Study|Lack of Efficacy|0|||
156317740|NCT00534599|564261884|FG001|Overall Study|Lack of Efficacy|1|||
156317741|NCT00534599|564261883|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
156317742|NCT00534599|564261884|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
156317743|NCT00534599|564261883|FG000|Overall Study|Protocol Violation|1|||
156317744|NCT00534599|564261884|FG001|Overall Study|Protocol Violation|3|||
156317745|NCT00534599|564261883|FG000|Overall Study|Lost to Follow-up|11|||
156317746|NCT00534599|564261884|FG001|Overall Study|Lost to Follow-up|14|||
156317747|NCT00534599|564261883|FG000|Overall Study|Withdrawal by Subject|4|||
156317748|NCT00534599|564261884|FG001|Overall Study|Withdrawal by Subject|6|||
156317749|NCT00534599|564261883|FG000|Overall Study|Other|7|||
156317750|NCT00534599|564261884|FG001|Overall Study|Other|0|||
156317751|NCT00167778|564261887|FG000|Overall Study|Withdrawal by Subject|1|||
156317752|NCT00814333|564262893|FG000|Enrollment|Lost to Follow-up|1|||
156317753|NCT00814333|564262894|FG001|Enrollment|Lost to Follow-up|0|||
156317754|NCT01879579|564262895|FG000|Overall Study|Phone incompatible with texting platform|3|||
156317755|NCT01879579|564262896|FG001|Overall Study|Phone incompatible with texting platform|0|||
156317756|NCT01879579|564262895|FG000|Overall Study|Did not enroll in texting platform|1|||
156317757|NCT01879579|564262896|FG001|Overall Study|Did not enroll in texting platform|0|||
156317758|NCT01879579|564262895|FG000|Overall Study|Did not initiate insulin treatment|1|||
156317759|NCT01879579|564262896|FG001|Overall Study|Did not initiate insulin treatment|0|||
156317760|NCT01879579|564262895|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
156317761|NCT01879579|564262896|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
156317762|NCT01879579|564262895|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
156317763|NCT01879579|564262896|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
156317764|NCT02927067|564262897|FG000|Overall Study|Withdrawn Consent|20|||
156317765|NCT02927067|564262898|FG001|Overall Study|Withdrawn Consent|12|||
156317766|NCT02927067|564262897|FG000|Overall Study|Death|18|||
156317767|NCT02927067|564262898|FG001|Overall Study|Death|31|||
156317768|NCT02927067|564262897|FG000|Overall Study|Adverse Event|13|||
156317769|NCT02927067|564262898|FG001|Overall Study|Adverse Event|10|||
156317770|NCT02927067|564262897|FG000|Overall Study|Noncompliance|5|||
156317771|NCT02927067|564262898|FG001|Overall Study|Noncompliance|2|||
156317772|NCT02927067|564262897|FG000|Overall Study|Reason not Specified|4|||
156317773|NCT02927067|564262898|FG001|Overall Study|Reason not Specified|6|||
156317774|NCT00134784|564262901|FG000|Overall Study|Withdrawal by Subject|2|||
156317775|NCT00134784|564262902|FG001|Overall Study|Withdrawal by Subject|2|||
156317776|NCT00134784|564262903|FG002|Overall Study|Withdrawal by Subject|2|||
156317777|NCT00134784|564262904|FG003|Overall Study|Withdrawal by Subject|1|||
156419128|NCT00031447|564628132|FG001|Overall Study|Disruption of blinded study drug supply|4|||
156317778|NCT03384693|564262905|FG000|Overall Study|Adverse Event|3|||
156317779|NCT01099709|564262908|FG000|Period 1|Withdrawal by Subject|0|||
156317780|NCT01099709|564262909|FG001|Period 1|Withdrawal by Subject|1|||
156317781|NCT01099709|564262908|FG000|Period 1|Positive cotinine test|0|||
156317782|NCT01099709|564262909|FG001|Period 1|Positive cotinine test|1|||
156757965|NCT02557516|565864919|FG001|Overall Study|Sponsor decision|1|||
156757966|NCT02557516|565864920|FG002|Overall Study|Sponsor decision|2|||
156757967|NCT02557516|565864921|FG003|Overall Study|Sponsor decision|8|||
156317783|NCT01099709|564262908|FG000|Period 1|Adverse Event|1|||
156317784|NCT01099709|564262909|FG001|Period 1|Adverse Event|0|||
156317785|NCT01397825|564262912|FG000|Overall Study|Progressive Disease|10|||
156317786|NCT01397825|564262913|FG001|Overall Study|Progressive Disease|3|||
156317787|NCT01397825|564262914|FG002|Overall Study|Progressive Disease|11|||
156317788|NCT01397825|564262915|FG003|Overall Study|Progressive Disease|1|||
156317789|NCT01397825|564262916|FG004|Overall Study|Progressive Disease|0|||
156317790|NCT01397825|564262912|FG000|Overall Study|Symptomatic Deterioration|2|||
156317791|NCT01397825|564262913|FG001|Overall Study|Symptomatic Deterioration|0|||
156317792|NCT01397825|564262914|FG002|Overall Study|Symptomatic Deterioration|4|||
156317793|NCT01397825|564262915|FG003|Overall Study|Symptomatic Deterioration|0|||
156317794|NCT01397825|564262916|FG004|Overall Study|Symptomatic Deterioration|0|||
156317795|NCT01397825|564262912|FG000|Overall Study|Adverse Event|0|||
156317796|NCT01397825|564262913|FG001|Overall Study|Adverse Event|1|||
156317797|NCT01397825|564262914|FG002|Overall Study|Adverse Event|5|||
156317798|NCT01397825|564262915|FG003|Overall Study|Adverse Event|1|||
156317799|NCT01397825|564262916|FG004|Overall Study|Adverse Event|0|||
156317800|NCT01397825|564262912|FG000|Overall Study|Withdrawal by Subject|1|||
156317801|NCT01397825|564262913|FG001|Overall Study|Withdrawal by Subject|0|||
156317802|NCT01397825|564262914|FG002|Overall Study|Withdrawal by Subject|5|||
156317803|NCT01397825|564262915|FG003|Overall Study|Withdrawal by Subject|1|||
156317804|NCT01397825|564262916|FG004|Overall Study|Withdrawal by Subject|0|||
156317805|NCT00976508|564262917|FG000|Overall Study|Death|7|||
156317806|NCT00976508|564262918|FG001|Overall Study|Death|1|||
156317807|NCT00976508|564262917|FG000|Overall Study|Lost to Follow-up|1|||
156317808|NCT00976508|564262918|FG001|Overall Study|Lost to Follow-up|0|||
156317809|NCT00976508|564262917|FG000|Overall Study|Withdrawal by Subject|1|||
156317810|NCT00976508|564262918|FG001|Overall Study|Withdrawal by Subject|0|||
156317811|NCT00976508|564262917|FG000|Overall Study|Disease Progression|4|||
156317812|NCT00976508|564262918|FG001|Overall Study|Disease Progression|4|||
156317813|NCT00976508|564262917|FG000|Overall Study|Subject Enrolled in Hospice|1|||
156317814|NCT00976508|564262918|FG001|Overall Study|Subject Enrolled in Hospice|0|||
156317815|NCT00976508|564262917|FG000|Overall Study|Terminated by the Sponsor|0|||
156317816|NCT00976508|564262918|FG001|Overall Study|Terminated by the Sponsor|1|||
156317817|NCT05028361|564262920|FG000|Overall Study|Withdrawal by Subject|1|||
156317818|NCT05028361|564262921|FG001|Overall Study|Withdrawal by Subject|0|||
156317819|NCT01993836|564262922|FG000|Overall Study|Surgery Cancelled|3|||
156317820|NCT01993836|564262923|FG001|Overall Study|Surgery Cancelled|0|||
156317821|NCT01993836|564262924|FG002|Overall Study|Surgery Cancelled|0|||
156317822|NCT01993836|564262922|FG000|Overall Study|Physician Decision|2|||
156317823|NCT01993836|564262923|FG001|Overall Study|Physician Decision|1|||
156317824|NCT01993836|564262924|FG002|Overall Study|Physician Decision|0|||
156317825|NCT01993836|564262922|FG000|Overall Study|Death|0|||
156317826|NCT01993836|564262923|FG001|Overall Study|Death|2|||
156317827|NCT01993836|564262924|FG002|Overall Study|Death|0|||
156317828|NCT01993836|564262922|FG000|Overall Study|Withdrawal by Subject|12|||
156317829|NCT01993836|564262923|FG001|Overall Study|Withdrawal by Subject|10|||
156317830|NCT01993836|564262924|FG002|Overall Study|Withdrawal by Subject|5|||
156317831|NCT02195687|564262925|FG000|Overall Study|Personal Reasons|1|||
156317832|NCT02195687|564262926|FG001|Overall Study|Personal Reasons|1|||
156317833|NCT02195687|564262925|FG000|Overall Study|Lost to Follow-up|4|||
156317834|NCT02195687|564262926|FG001|Overall Study|Lost to Follow-up|1|||
156317835|NCT04369924|564262929|FG000|Overall Study|Lost to Follow-up|302|||
156317836|NCT04369924|564262930|FG001|Overall Study|Lost to Follow-up|339|||
156317837|NCT01653132|564262931|FG000|First Intervention|Protocol Violation|1|||
156317838|NCT01653132|564262932|FG001|First Intervention|Protocol Violation|0|||
156317839|NCT03828370|564262933|FG000|3 Month Follow-up|Lost to Follow-up|4|||
156757968|NCT01919164|565866322|FG000|Overall Study|Adverse Event|6|||
156757969|NCT01919164|565866323|FG001|Overall Study|Adverse Event|4|||
156317840|NCT03828370|564262934|FG001|3 Month Follow-up|Lost to Follow-up|12|||
156317841|NCT03828370|564262933|FG000|9 Month Follow up|Lost to Follow-up|12|||
156317842|NCT03828370|564262934|FG001|9 Month Follow up|Lost to Follow-up|20|||
156317843|NCT02677324|564262935|FG000|Overall Study|Disease Progression|6|||
156317844|NCT02677324|564262935|FG000|Overall Study|Inability to Swallow pills|1|||
156317845|NCT02677324|564262935|FG000|Overall Study|Non-compliance|1|||
156317846|NCT02677324|564262935|FG000|Overall Study|Lack of Efficacy|1|||
156317847|NCT02677324|564262935|FG000|Overall Study|Medical insurance coverage|1|||
156317848|NCT02677324|564262935|FG000|Overall Study|Adverse Event|1|||
156317849|NCT02677324|564262935|FG000|Overall Study|IgM Myeloma diagnosis|1|||
156317850|NCT00761150|564262938|FG000|Open-label Period|Adverse Event|36|||
156317851|NCT00761150|564262939|FG001|Open-label Period|Adverse Event|0|||
156317852|NCT00761150|564262940|FG002|Open-label Period|Adverse Event|0|||
156757970|NCT01919164|565866324|FG002|Overall Study|Adverse Event|9|||
156317853|NCT00761150|564262938|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
156317854|NCT00761150|564262939|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
156757971|NCT01919164|565866325|FG003|Overall Study|Adverse Event|3|||
156419129|NCT01636362|564628136|FG000|Overall Study|Physician Decision|6|||
156419130|NCT01636362|564628136|FG000|Overall Study|Subject healed, not returning|1|||
156419131|NCT01636362|564628136|FG000|Overall Study|Withdrawal by Subject|1|||
156419132|NCT00519779|564628139|FG000|Overall Study|Withdrawal by Subject|0|||
156419133|NCT00519779|564628140|FG001|Overall Study|Withdrawal by Subject|1|||
156419134|NCT01561079|564628141|FG000|Overall Study|Physician Decision|17|||
156419135|NCT01561079|564628141|FG000|Overall Study|Withdrawal by Subject|59|||
156419136|NCT01561079|564628141|FG000|Overall Study|Protocol Violation|2|||
156419137|NCT03330119|564628142|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
156419138|NCT03330119|564628143|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
156419139|NCT01123161|564628149|FG000|Overall Study|Lost to Follow-up|1|||
156419140|NCT01123161|564628150|FG001|Overall Study|Lost to Follow-up|0|||
156419141|NCT01123161|564628149|FG000|Overall Study|Withdrawal by Subject|1|||
156419142|NCT01123161|564628150|FG001|Overall Study|Withdrawal by Subject|0|||
156419143|NCT00664521|564628151|FG000|Overall Study|Adverse Event|4|||
156419144|NCT00664521|564628152|FG001|Overall Study|Adverse Event|1|||
156419145|NCT00664521|564628151|FG000|Overall Study|Lost to Follow-up|1|||
156419146|NCT00664521|564628152|FG001|Overall Study|Lost to Follow-up|0|||
156419147|NCT00664521|564628151|FG000|Overall Study|Other|1|||
156419148|NCT00664521|564628152|FG001|Overall Study|Other|0|||
156419149|NCT00550732|564628153|FG000|Overall Study|Death|4|||
156419150|NCT00550732|564628153|FG000|Overall Study|Withdrawal by Subject|2|||
156419151|NCT00550732|564628153|FG000|Overall Study|Physician Decision|2|||
156419152|NCT00550732|564628153|FG000|Overall Study|Lost to Follow-up|1|||
156419153|NCT00550732|564628153|FG000|Overall Study|Palliative care|1|||
156419154|NCT00550732|564628153|FG000|Overall Study|Adverse Event|1|||
156419155|NCT01323660|564628155|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
156419156|NCT01323660|564628156|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156419157|NCT01323660|564628157|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156419158|NCT01323660|564628158|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
156419159|NCT01323660|564628159|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
156419160|NCT01323660|564628160|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
156419161|NCT01323660|564628155|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
156419162|NCT01323660|564628156|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
156419163|NCT01323660|564628157|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
156419164|NCT01323660|564628158|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
156419165|NCT01323660|564628159|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
156419166|NCT01323660|564628160|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
156419167|NCT01323660|564628155|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
156419168|NCT01323660|564628156|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156419169|NCT01323660|564628157|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156419170|NCT01323660|564628158|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156419171|NCT01323660|564628159|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156419172|NCT01323660|564628160|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
156419173|NCT01323660|564628155|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156419174|NCT01323660|564628156|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156419175|NCT01323660|564628157|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156419176|NCT01323660|564628158|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156419177|NCT01323660|564628159|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
156419178|NCT01323660|564628160|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156419179|NCT01323660|564628155|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156419180|NCT01323660|564628156|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156419181|NCT01323660|564628157|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156419182|NCT01323660|564628158|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156419183|NCT01323660|564628159|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156419184|NCT01323660|564628160|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156419185|NCT01323660|564628155|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
156419186|NCT01323660|564628156|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156419187|NCT01323660|564628157|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156419188|NCT01323660|564628158|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156419189|NCT01323660|564628159|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
156419190|NCT01323660|564628160|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156419191|NCT01323660|564628155|FG000|Washout Period (14 Days)|Adverse Event|0|||
156419192|NCT01323660|564628156|FG001|Washout Period (14 Days)|Adverse Event|0|||
156419193|NCT01323660|564628157|FG002|Washout Period (14 Days)|Adverse Event|0|||
156419194|NCT01323660|564628158|FG003|Washout Period (14 Days)|Adverse Event|0|||
156419195|NCT01323660|564628159|FG004|Washout Period (14 Days)|Adverse Event|1|||
156419196|NCT01323660|564628160|FG005|Washout Period (14 Days)|Adverse Event|0|||
156419197|NCT01323660|564628155|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
156757972|NCT01919164|565866326|FG004|Overall Study|Adverse Event|2|||
156757973|NCT01919164|565866322|FG000|Overall Study|Lost to Follow-up|2|||
156757974|NCT01919164|565866323|FG001|Overall Study|Lost to Follow-up|2|||
156757975|NCT01919164|565866324|FG002|Overall Study|Lost to Follow-up|2|||
156757976|NCT01919164|565866325|FG003|Overall Study|Lost to Follow-up|0|||
156757977|NCT01919164|565866326|FG004|Overall Study|Lost to Follow-up|4|||
156757978|NCT01919164|565866322|FG000|Overall Study|Death|1|||
156757979|NCT01919164|565866323|FG001|Overall Study|Death|0|||
156419198|NCT01323660|564628156|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
156419199|NCT01323660|564628157|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
156419200|NCT01323660|564628158|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
156419201|NCT01323660|564628159|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
156419202|NCT01323660|564628160|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
156419203|NCT01323660|564628155|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156419204|NCT01323660|564628156|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156419205|NCT01323660|564628157|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156419206|NCT01323660|564628158|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156419207|NCT01323660|564628159|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156419208|NCT01323660|564628160|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
156419209|NCT01323660|564628155|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
156419210|NCT01323660|564628156|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
156419211|NCT01323660|564628157|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
156419212|NCT01323660|564628158|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
156419213|NCT01323660|564628159|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156419214|NCT01323660|564628160|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
156419215|NCT01323660|564628155|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156419216|NCT01323660|564628156|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156419217|NCT01323660|564628157|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156419218|NCT01323660|564628158|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156419219|NCT01323660|564628159|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156419220|NCT01323660|564628160|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
156419221|NCT01323660|564628155|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156419222|NCT01323660|564628156|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156419223|NCT01323660|564628157|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156419224|NCT01323660|564628158|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156419225|NCT01323660|564628159|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156419226|NCT01323660|564628160|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156419227|NCT01323660|564628155|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156419228|NCT01323660|564628156|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156419229|NCT01323660|564628157|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156419230|NCT01323660|564628158|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156419231|NCT01323660|564628159|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
156419232|NCT01323660|564628160|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156419233|NCT00926393|564628161|FG000|Overall Study|Withdrawal by Subject|1|||
156419234|NCT00926393|564628162|FG001|Overall Study|Withdrawal by Subject|2|||
156419235|NCT00926393|564628161|FG000|Overall Study|Adverse Event|1|||
156419236|NCT00926393|564628162|FG001|Overall Study|Adverse Event|1|||
156419237|NCT01403987|564628164|FG000|Overall Study|Residents forgot their secret PIN|18|||
156419238|NCT01403987|564628165|FG001|Overall Study|Residents forgot their secret PIN|17|||
156419239|NCT01403987|564628166|FG002|Overall Study|Residents forgot their secret PIN|18|||
156419240|NCT00751790|564628168|FG000|Overall Study|Lost to Follow-up|1|||
156419241|NCT00751790|564628168|FG000|Overall Study|Death|3|||
156419242|NCT00751790|564628168|FG000|Overall Study|Withdrawal by Subject|1|||
156419243|NCT00180674|564628169|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
156419244|NCT00180674|564628169|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
156419245|NCT03302910|564628170|FG000|Overall Study|Protocol Violation|1|||
156419246|NCT03302910|564628171|FG001|Overall Study|Protocol Violation|0|||
156419247|NCT01106976|564628174|FG000|Overall Study|Lost to Follow-up|8|||
156419248|NCT00953160|564628178|FG000|Overall Study|Lost to Follow-up|23|||
156419249|NCT00953160|564628178|FG000|Overall Study|Withdrawal by Subject|4|||
156419250|NCT02179918|564628179|FG000|Overall Study|Death|0|||
156419251|NCT02179918|564628180|FG001|Overall Study|Death|0|||
156419252|NCT02179918|564628181|FG002|Overall Study|Death|0|||
156419253|NCT02179918|564628182|FG003|Overall Study|Death|1|||
156419254|NCT02179918|564628183|FG004|Overall Study|Death|0|||
156757980|NCT01919164|565866324|FG002|Overall Study|Death|0|||
156419255|NCT02179918|564628179|FG000|Overall Study|Lost to Follow-up|0|||
156419256|NCT02179918|564628180|FG001|Overall Study|Lost to Follow-up|0|||
156419257|NCT02179918|564628181|FG002|Overall Study|Lost to Follow-up|1|||
156419258|NCT02179918|564628182|FG003|Overall Study|Lost to Follow-up|0|||
156419259|NCT02179918|564628183|FG004|Overall Study|Lost to Follow-up|0|||
156419260|NCT02179918|564628179|FG000|Overall Study|Progressive Disease|4|||
156419261|NCT02179918|564628180|FG001|Overall Study|Progressive Disease|1|||
156419262|NCT02179918|564628181|FG002|Overall Study|Progressive Disease|1|||
156419263|NCT02179918|564628182|FG003|Overall Study|Progressive Disease|2|||
156419264|NCT02179918|564628183|FG004|Overall Study|Progressive Disease|6|||
156757981|NCT01919164|565866325|FG003|Overall Study|Death|0|||
156757982|NCT01919164|565866326|FG004|Overall Study|Death|0|||
156757983|NCT01919164|565866322|FG000|Overall Study|Protocol Violation|6|||
156757984|NCT01919164|565866323|FG001|Overall Study|Protocol Violation|0|||
156757985|NCT01919164|565866324|FG002|Overall Study|Protocol Violation|3|||
156757986|NCT01919164|565866325|FG003|Overall Study|Protocol Violation|2|||
156757987|NCT01919164|565866326|FG004|Overall Study|Protocol Violation|2|||
156757988|NCT01919164|565866322|FG000|Overall Study|Disease progression|2|||
156757989|NCT01919164|565866323|FG001|Overall Study|Disease progression|2|||
156757990|NCT01919164|565866324|FG002|Overall Study|Disease progression|1|||
156757991|NCT01919164|565866325|FG003|Overall Study|Disease progression|2|||
156757992|NCT01919164|565866326|FG004|Overall Study|Disease progression|1|||
156757993|NCT01919164|565866322|FG000|Overall Study|Withdrew consent|13|||
156757994|NCT01919164|565866323|FG001|Overall Study|Withdrew consent|13|||
156757995|NCT01919164|565866324|FG002|Overall Study|Withdrew consent|14|||
156757996|NCT01919164|565866325|FG003|Overall Study|Withdrew consent|14|||
156757997|NCT01919164|565866326|FG004|Overall Study|Withdrew consent|9|||
156757998|NCT01919164|565866322|FG000|Overall Study|Other Un-specified|13|||
156757999|NCT01919164|565866323|FG001|Overall Study|Other Un-specified|9|||
156758000|NCT01919164|565866324|FG002|Overall Study|Other Un-specified|8|||
156758001|NCT01919164|565866325|FG003|Overall Study|Other Un-specified|7|||
156758002|NCT01919164|565866326|FG004|Overall Study|Other Un-specified|15|||
156758003|NCT01971567|565866331|FG000|Overall Study|Withdrawal by Subject|3|||
156758004|NCT01971567|565866332|FG001|Overall Study|Withdrawal by Subject|2|||
156758005|NCT01971567|565866331|FG000|Overall Study|Lost to Follow-up|1|||
156758006|NCT01971567|565866332|FG001|Overall Study|Lost to Follow-up|0|||
156758007|NCT02019550|565866335|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156758008|NCT02019550|565866336|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
156758009|NCT02750332|565866338|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156758010|NCT02750332|565866339|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156758011|NCT04194489|565866340|FG000|Overall Study|Withdrawal by Subject|5|||
156758012|NCT04194489|565866340|FG000|Overall Study|Lost to Follow-up|48|||
156758013|NCT02485483|565866344|FG000|Overall Study|Depression at baseline|15|||
156758014|NCT02485483|565866345|FG001|Overall Study|Depression at baseline|0|||
156758015|NCT02485483|565866344|FG000|Overall Study|Discontinued after baseline|39|||
156758016|NCT02485483|565866345|FG001|Overall Study|Discontinued after baseline|0|||
156758017|NCT00823264|565866347|FG000|Overall Study|Protocol Violation|2|||
156758018|NCT00823264|565866348|FG001|Overall Study|Protocol Violation|0|||
156758019|NCT00113295|565866349|FG000|Overall Study|Adverse Event|4|||
156758020|NCT00113295|565866350|FG001|Overall Study|Adverse Event|1|||
156758021|NCT00113295|565866349|FG000|Overall Study|Unrelated Medical Illness|1|||
156758022|NCT00113295|565866350|FG001|Overall Study|Unrelated Medical Illness|0|||
156758023|NCT01714544|565866351|FG000|Overall Study|Lost to Follow-up|1|||
156758024|NCT01714544|565866351|FG000|Overall Study|Physician Decision|1|||
156758025|NCT01714544|565866351|FG000|Overall Study|Withdrawal by Subject|1|||
156758026|NCT01914393|565866352|FG000|Overall Study|Protocol Violation|11|||
156758027|NCT01914393|565866353|FG001|Overall Study|Protocol Violation|3|||
156758028|NCT01914393|565866354|FG002|Overall Study|Protocol Violation|19|||
156758029|NCT01914393|565866352|FG000|Overall Study|Lack of Efficacy|11|||
156758030|NCT01914393|565866353|FG001|Overall Study|Lack of Efficacy|16|||
156758031|NCT01914393|565866354|FG002|Overall Study|Lack of Efficacy|5|||
156758032|NCT01914393|565866352|FG000|Overall Study|no reason given|14|||
156758033|NCT01914393|565866353|FG001|Overall Study|no reason given|8|||
156758034|NCT01914393|565866354|FG002|Overall Study|no reason given|16|||
156758035|NCT01914393|565866352|FG000|Overall Study|Adverse Event|29|||
156317855|NCT00761150|564262940|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
156317856|NCT00761150|564262938|FG000|Open-label Period|Lost to Follow-up|7|||
156317857|NCT00761150|564262939|FG001|Open-label Period|Lost to Follow-up|0|||
156317858|NCT00761150|564262940|FG002|Open-label Period|Lost to Follow-up|0|||
156317859|NCT00761150|564262938|FG000|Open-label Period|Lack of Efficacy|4|||
156317860|NCT00761150|564262939|FG001|Open-label Period|Lack of Efficacy|0|||
156317861|NCT00761150|564262940|FG002|Open-label Period|Lack of Efficacy|0|||
156317862|NCT00761150|564262938|FG000|Open-label Period|Withdrawal by Subject|5|||
156317863|NCT00761150|564262939|FG001|Open-label Period|Withdrawal by Subject|0|||
156317864|NCT00761150|564262940|FG002|Open-label Period|Withdrawal by Subject|0|||
156317865|NCT00761150|564262938|FG000|Open-label Period|Noncompliance|2|||
156317866|NCT00761150|564262939|FG001|Open-label Period|Noncompliance|0|||
156317867|NCT00761150|564262940|FG002|Open-label Period|Noncompliance|0|||
156317868|NCT00761150|564262938|FG000|Open-label Period|Other|5|||
156317869|NCT00761150|564262939|FG001|Open-label Period|Other|0|||
156317870|NCT00761150|564262940|FG002|Open-label Period|Other|0|||
156317871|NCT00761150|564262938|FG000|Double-blind Period|Lack of Efficacy|0|||
156317872|NCT00761150|564262939|FG001|Double-blind Period|Lack of Efficacy|2|||
156317873|NCT00761150|564262940|FG002|Double-blind Period|Lack of Efficacy|19|||
156419265|NCT02179918|564628179|FG000|Overall Study|Other|0|||
156317874|NCT00761150|564262938|FG000|Double-blind Period|Adverse Event|0|||
156758036|NCT01914393|565866353|FG001|Overall Study|Adverse Event|18|||
156758037|NCT01914393|565866354|FG002|Overall Study|Adverse Event|31|||
156758038|NCT01914393|565866352|FG000|Overall Study|Withdrawal by Subject|38|||
156758039|NCT01914393|565866353|FG001|Overall Study|Withdrawal by Subject|20|||
156419266|NCT02179918|564628180|FG001|Overall Study|Other|1|||
156419267|NCT02179918|564628181|FG002|Overall Study|Other|0|||
156419268|NCT02179918|564628182|FG003|Overall Study|Other|0|||
156419269|NCT02179918|564628183|FG004|Overall Study|Other|1|||
156419270|NCT02179918|564628179|FG000|Overall Study|Subject refused further follow-up|0|||
156419271|NCT02179918|564628180|FG001|Overall Study|Subject refused further follow-up|1|||
156419272|NCT02179918|564628181|FG002|Overall Study|Subject refused further follow-up|0|||
156419273|NCT02179918|564628182|FG003|Overall Study|Subject refused further follow-up|0|||
156419274|NCT02179918|564628183|FG004|Overall Study|Subject refused further follow-up|1|||
156419275|NCT02118714|564628188|FG000|Overall Study|Lost to Follow-up|2|||
156419276|NCT02118714|564628188|FG000|Overall Study|Protocol Violation|1|||
156419277|NCT02954575|564628189|FG000|Overall Study|Withdrawal by Subject|2|||
156419278|NCT02954575|564628189|FG000|Overall Study|Adverse Event|1|||
156419279|NCT01066156|564628191|FG000|Overall Study|ineligible|2|||
156419280|NCT01066156|564628191|FG000|Overall Study|Lost to Follow-up|7|||
156419281|NCT01066156|564628191|FG000|Overall Study|Withdrawal by Subject|1|||
156419282|NCT00570661|564628192|FG000|Overall Study|Disease worsening|5|||
156419283|NCT00570661|564628192|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
156419284|NCT00570661|564628192|FG000|Overall Study|Adverse Event|1|||
156419285|NCT01734382|564628196|FG000|Part 1|Adverse Event|2|||
156419286|NCT01734382|564628197|FG001|Part 1|Adverse Event|0|||
156419287|NCT01734382|564628198|FG002|Part 1|Adverse Event|0|||
156419288|NCT01734382|564628196|FG000|Part 2|Adverse Event|0|||
156419289|NCT01734382|564628197|FG001|Part 2|Adverse Event|0|||
156419290|NCT01734382|564628198|FG002|Part 2|Adverse Event|1|||
156419291|NCT01734382|564628196|FG000|Part 2|Lack of Efficacy|0|||
156419292|NCT01734382|564628197|FG001|Part 2|Lack of Efficacy|1|||
156419293|NCT01734382|564628198|FG002|Part 2|Lack of Efficacy|1|||
156419294|NCT01734382|564628196|FG000|Part 2|Other|0|||
156419295|NCT01734382|564628197|FG001|Part 2|Other|0|||
156419296|NCT01734382|564628198|FG002|Part 2|Other|1|||
156419297|NCT01734382|564628196|FG000|Part 2|Physician Decision|0|||
156419298|NCT01734382|564628197|FG001|Part 2|Physician Decision|0|||
156419299|NCT01734382|564628198|FG002|Part 2|Physician Decision|3|||
156419300|NCT01734382|564628196|FG000|Part 2|Protocol Violation|0|||
156419301|NCT01734382|564628197|FG001|Part 2|Protocol Violation|1|||
156419302|NCT01734382|564628198|FG002|Part 2|Protocol Violation|0|||
156419303|NCT01734382|564628196|FG000|Part 2|Withdrawal by Subject|0|||
156419304|NCT01734382|564628197|FG001|Part 2|Withdrawal by Subject|0|||
156419305|NCT01734382|564628198|FG002|Part 2|Withdrawal by Subject|1|||
156419306|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
156419307|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
156419308|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
156419309|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
156419310|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
156419311|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
156419312|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
156419313|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
156419314|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
156419315|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
156419316|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
156419317|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
156419318|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
156419319|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
156419320|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
156419321|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
156419322|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
156419323|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
156419324|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
156419325|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
156419326|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
156419327|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
156419328|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
156419329|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
156419330|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
156419331|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
156419332|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
156419333|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
156419334|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
156419335|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
156419336|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
156419337|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
156419338|NCT03890120|564628199|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
156758040|NCT01914393|565866354|FG002|Overall Study|Withdrawal by Subject|47|||
156758041|NCT01914393|565866352|FG000|Overall Study|Lost to Follow-up|12|||
156758042|NCT01914393|565866353|FG001|Overall Study|Lost to Follow-up|6|||
156758043|NCT01914393|565866354|FG002|Overall Study|Lost to Follow-up|19|||
156758044|NCT01914393|565866352|FG000|Overall Study|subject never dosed|0|||
156758045|NCT01914393|565866353|FG001|Overall Study|subject never dosed|0|||
156758046|NCT01914393|565866354|FG002|Overall Study|subject never dosed|1|||
156758047|NCT00666211|565866355|FG000|Overall Study|Withdrawal by Subject|10|||
156758048|NCT00666211|565866356|FG001|Overall Study|Withdrawal by Subject|13|||
156758049|NCT00666211|565866355|FG000|Overall Study|went off medication, no more pain|1|||
156758050|NCT00666211|565866356|FG001|Overall Study|went off medication, no more pain|0|||
156758051|NCT00666211|565866355|FG000|Overall Study|patient non-compliant|6|||
156758052|NCT00666211|565866356|FG001|Overall Study|patient non-compliant|6|||
156758053|NCT00666211|565866355|FG000|Overall Study|disease progression|1|||
156758054|NCT00666211|565866356|FG001|Overall Study|disease progression|8|||
156758055|NCT00666211|565866355|FG000|Overall Study|Lost to Follow-up|2|||
156758056|NCT00666211|565866356|FG001|Overall Study|Lost to Follow-up|0|||
156758057|NCT00666211|565866355|FG000|Overall Study|toxicity|0|||
156758058|NCT00666211|565866356|FG001|Overall Study|toxicity|2|||
156758059|NCT00666211|565866355|FG000|Overall Study|hospital admission|0|||
156758060|NCT00666211|565866356|FG001|Overall Study|hospital admission|5|||
156758061|NCT00666211|565866355|FG000|Overall Study|Death|0|||
156758062|NCT00666211|565866356|FG001|Overall Study|Death|2|||
156758063|NCT00666211|565866355|FG000|Overall Study|off tx for other complicating disease|0|||
156758064|NCT00666211|565866356|FG001|Overall Study|off tx for other complicating disease|1|||
156758065|NCT00666211|565866355|FG000|Overall Study|Physician Decision|0|||
156758066|NCT00666211|565866356|FG001|Overall Study|Physician Decision|1|||
156758067|NCT02806713|565866357|FG000|Overall Study|Urethral injury during procedure|1|||
156758068|NCT02806713|565866358|FG001|Overall Study|Urethral injury during procedure|0|||
156758069|NCT02806713|565866357|FG000|Overall Study|cancelled surgery|1|||
156758070|NCT02806713|565866358|FG001|Overall Study|cancelled surgery|2|||
156758071|NCT02999789|565866361|FG000|Overall Study|Withdrawal by Subject|0|||
156758072|NCT02999789|565866362|FG001|Overall Study|Withdrawal by Subject|1|||
156758073|NCT02999789|565866361|FG000|Overall Study|Became ineligible|1|||
156758074|NCT02999789|565866362|FG001|Overall Study|Became ineligible|2|||
156758075|NCT02824224|565866365|FG000|Overall Study|Discontinued, IUS expulsion|0|||
156758076|NCT02824224|565866366|FG001|Overall Study|Discontinued, IUS expulsion|1|||
156758077|NCT02824224|565866365|FG000|Overall Study|Did not show up for allocation visit|2|||
156758078|NCT02824224|565866366|FG001|Overall Study|Did not show up for allocation visit|0|||
156758079|NCT00613366|565866367|FG000|Overall Study|Withdrawal by Subject|3|||
156758080|NCT00613366|565866368|FG001|Overall Study|Withdrawal by Subject|2|||
156758081|NCT01178125|565866370|FG000|Overall Study|Lost to Follow-up|397|||
156758082|NCT01178125|565866370|FG000|Overall Study|Adverse Event|244|||
156758083|NCT01178125|565866370|FG000|Overall Study|Withdrawal by Subject|209|||
156758084|NCT01178125|565866370|FG000|Overall Study|Noncompliance|184|||
156758085|NCT01178125|565866370|FG000|Overall Study|Pregnancy|55|||
156758086|NCT01178125|565866370|FG000|Overall Study|Other Reason|39|||
156758087|NCT01178125|565866370|FG000|Overall Study|Sponsor Decision|28|||
156758088|NCT01178125|565866370|FG000|Overall Study|Protocol Violation|17|||
156758089|NCT01178125|565866370|FG000|Overall Study|Investigator Decision|5|||
156758090|NCT01719380|565866371|FG000|Overall Study|Adverse Event|0|||
156758091|NCT01719380|565866372|FG001|Overall Study|Adverse Event|0|||
156758092|NCT01719380|565866373|FG002|Overall Study|Adverse Event|1|||
156758093|NCT01719380|565866374|FG003|Overall Study|Adverse Event|2|||
156758094|NCT01719380|565866375|FG004|Overall Study|Adverse Event|0|||
156758095|NCT01719380|565866376|FG005|Overall Study|Adverse Event|1|||
156758096|NCT01719380|565866377|FG006|Overall Study|Adverse Event|0|||
156758097|NCT01719380|565866378|FG007|Overall Study|Adverse Event|1|||
156758098|NCT01719380|565866379|FG008|Overall Study|Adverse Event|4|||
156758099|NCT01719380|565866380|FG009|Overall Study|Adverse Event|3|||
156758100|NCT01719380|565866371|FG000|Overall Study|Death|0|||
156758101|NCT01719380|565866372|FG001|Overall Study|Death|1|||
156758102|NCT01719380|565866373|FG002|Overall Study|Death|0|||
156758103|NCT01719380|565866374|FG003|Overall Study|Death|0|||
156758104|NCT01719380|565866375|FG004|Overall Study|Death|0|||
156758105|NCT01719380|565866376|FG005|Overall Study|Death|0|||
156758106|NCT01719380|565866377|FG006|Overall Study|Death|0|||
156758107|NCT01719380|565866378|FG007|Overall Study|Death|0|||
156758108|NCT01719380|565866379|FG008|Overall Study|Death|3|||
156758109|NCT01719380|565866380|FG009|Overall Study|Death|3|||
156758110|NCT01719380|565866371|FG000|Overall Study|Participant/Guardian Decision|0|||
156758111|NCT01719380|565866372|FG001|Overall Study|Participant/Guardian Decision|0|||
156758112|NCT01719380|565866373|FG002|Overall Study|Participant/Guardian Decision|1|||
156758113|NCT01719380|565866374|FG003|Overall Study|Participant/Guardian Decision|0|||
156758114|NCT01719380|565866375|FG004|Overall Study|Participant/Guardian Decision|0|||
156758115|NCT01719380|565866376|FG005|Overall Study|Participant/Guardian Decision|0|||
156758116|NCT01719380|565866377|FG006|Overall Study|Participant/Guardian Decision|0|||
156758117|NCT01719380|565866378|FG007|Overall Study|Participant/Guardian Decision|0|||
156758118|NCT01719380|565866379|FG008|Overall Study|Participant/Guardian Decision|2|||
156758119|NCT01719380|565866380|FG009|Overall Study|Participant/Guardian Decision|2|||
156758120|NCT01719380|565866371|FG000|Overall Study|Physician Decision|0|||
156758121|NCT01719380|565866372|FG001|Overall Study|Physician Decision|0|||
156758122|NCT01719380|565866373|FG002|Overall Study|Physician Decision|2|||
156758123|NCT01719380|565866374|FG003|Overall Study|Physician Decision|0|||
156758124|NCT01719380|565866375|FG004|Overall Study|Physician Decision|0|||
156758125|NCT01719380|565866376|FG005|Overall Study|Physician Decision|0|||
156758126|NCT01719380|565866377|FG006|Overall Study|Physician Decision|0|||
156758127|NCT01719380|565866378|FG007|Overall Study|Physician Decision|0|||
156758128|NCT01719380|565866379|FG008|Overall Study|Physician Decision|1|||
156758129|NCT01719380|565866380|FG009|Overall Study|Physician Decision|1|||
156758130|NCT01719380|565866371|FG000|Overall Study|Lack of Efficacy|2|||
156758131|NCT01719380|565866372|FG001|Overall Study|Lack of Efficacy|6|||
156758132|NCT01719380|565866373|FG002|Overall Study|Lack of Efficacy|5|||
156758133|NCT01719380|565866374|FG003|Overall Study|Lack of Efficacy|6|||
156758134|NCT01719380|565866375|FG004|Overall Study|Lack of Efficacy|3|||
156758135|NCT01719380|565866376|FG005|Overall Study|Lack of Efficacy|7|||
156758136|NCT01719380|565866377|FG006|Overall Study|Lack of Efficacy|10|||
156758137|NCT01719380|565866378|FG007|Overall Study|Lack of Efficacy|6|||
156758138|NCT01719380|565866379|FG008|Overall Study|Lack of Efficacy|39|||
156758139|NCT01719380|565866380|FG009|Overall Study|Lack of Efficacy|42|||
156758140|NCT01719380|565866371|FG000|Overall Study|Progressive Disease|0|||
156758141|NCT01719380|565866372|FG001|Overall Study|Progressive Disease|0|||
156758142|NCT01719380|565866373|FG002|Overall Study|Progressive Disease|0|||
156758143|NCT01719380|565866374|FG003|Overall Study|Progressive Disease|0|||
156758144|NCT01719380|565866375|FG004|Overall Study|Progressive Disease|0|||
156758145|NCT01719380|565866376|FG005|Overall Study|Progressive Disease|0|||
156758146|NCT01719380|565866377|FG006|Overall Study|Progressive Disease|0|||
156758147|NCT01719380|565866378|FG007|Overall Study|Progressive Disease|0|||
156758148|NCT01719380|565866379|FG008|Overall Study|Progressive Disease|1|||
156758149|NCT01719380|565866380|FG009|Overall Study|Progressive Disease|0|||
156758150|NCT02532374|565866381|FG000|Overall Study|Withdrawal by Subject|1|||
156758151|NCT02532374|565866381|FG000|Overall Study|Physician Decision|1|||
156758152|NCT02762084|565866382|FG000|Overall Study|Withdrawal by Subject|1|||
156758153|NCT02762084|565866383|FG001|Overall Study|Withdrawal by Subject|0|||
156758154|NCT02762084|565866384|FG002|Overall Study|Withdrawal by Subject|0|||
156758155|NCT02762084|565866382|FG000|Overall Study|Adverse Event|0|||
156758156|NCT02762084|565866383|FG001|Overall Study|Adverse Event|0|||
156758157|NCT02762084|565866384|FG002|Overall Study|Adverse Event|1|||
156758158|NCT01348139|565866385|FG000|Period 1|Adverse Event|1|||
156758159|NCT01348139|565866386|FG001|Period 1|Adverse Event|0|||
156758160|NCT01348139|565866387|FG002|Period 1|Adverse Event|0|||
156758161|NCT01348139|565866388|FG003|Period 1|Adverse Event|0|||
156758162|NCT01348139|565866389|FG004|Period 1|Adverse Event|0|||
156758163|NCT01348139|565866390|FG005|Period 1|Adverse Event|0|||
156758164|NCT02254772|565866393|FG000|Overall Study|Ineligible|1|||
156758165|NCT02254772|565866393|FG000|Overall Study|Withdrawal by Subject|1|||
156758166|NCT03006562|565866394|FG000|Overall Study|Lost to Follow-up|0|||
156758167|NCT03006562|565866395|FG001|Overall Study|Lost to Follow-up|1|||
156758168|NCT02427841|565866404|FG000|Overall Study|Lack of Efficacy|5|||
156758169|NCT02427841|565866404|FG000|Overall Study|Physician Decision|2|||
156317875|NCT00761150|564262939|FG001|Double-blind Period|Adverse Event|3|||
156317876|NCT00761150|564262940|FG002|Double-blind Period|Adverse Event|3|||
156317877|NCT00761150|564262938|FG000|Double-blind Period|Withdrawal by Subject|0|||
156317878|NCT00761150|564262939|FG001|Double-blind Period|Withdrawal by Subject|3|||
156317879|NCT00761150|564262940|FG002|Double-blind Period|Withdrawal by Subject|2|||
156317880|NCT00761150|564262938|FG000|Double-blind Period|Lost to Follow-up|0|||
156317881|NCT00761150|564262939|FG001|Double-blind Period|Lost to Follow-up|2|||
156317882|NCT00761150|564262940|FG002|Double-blind Period|Lost to Follow-up|1|||
156317883|NCT00761150|564262938|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
156317884|NCT00761150|564262939|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
156758170|NCT02427841|565866404|FG000|Overall Study|Withdrawal by Subject|1|||
156758171|NCT01765296|565866405|FG000|Overall Study|Protocol Violation|0|||
156758172|NCT01765296|565866406|FG001|Overall Study|Protocol Violation|5|||
156758173|NCT01765296|565866407|FG002|Overall Study|Protocol Violation|4|||
156758174|NCT01765296|565866405|FG000|Overall Study|Withdrawal by Subject|4|||
156758175|NCT01765296|565866406|FG001|Overall Study|Withdrawal by Subject|2|||
156758176|NCT01765296|565866407|FG002|Overall Study|Withdrawal by Subject|2|||
156758177|NCT01765296|565866405|FG000|Overall Study|Adverse Event|1|||
156758178|NCT01765296|565866406|FG001|Overall Study|Adverse Event|13|||
156317885|NCT00761150|564262940|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
156758179|NCT01765296|565866407|FG002|Overall Study|Adverse Event|5|||
156758180|NCT01765296|565866405|FG000|Overall Study|Lack of Efficacy|0|||
156758181|NCT01765296|565866406|FG001|Overall Study|Lack of Efficacy|0|||
156758182|NCT01765296|565866407|FG002|Overall Study|Lack of Efficacy|2|||
156758183|NCT03257436|565866408|FG000|Overall Study|Withdrawal by Subject|76|||
156758184|NCT03257436|565866408|FG000|Overall Study|Death|19|||
156758185|NCT01619852|565866409|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
156758186|NCT01619852|565866410|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
156758187|NCT01619852|565866409|FG000|3 Month Follow up|Lost to Follow-up|31|||
156758188|NCT01619852|565866410|FG001|3 Month Follow up|Lost to Follow-up|34|||
156758189|NCT00970489|565866411|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
156758190|NCT00970489|565866412|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
156758191|NCT02659943|565866413|FG000|Overall Study|Switched to alternative treatment|1|||
156758192|NCT02659943|565866414|FG001|Overall Study|Switched to alternative treatment|1|||
156758193|NCT02659943|565866415|FG002|Overall Study|Switched to alternative treatment|0|||
156758194|NCT02659943|565866416|FG003|Overall Study|Switched to alternative treatment|2|||
156758195|NCT02659943|565866417|FG004|Overall Study|Switched to alternative treatment|1|||
156758196|NCT02659943|565866418|FG005|Overall Study|Switched to alternative treatment|0|||
156758197|NCT02659943|565866419|FG006|Overall Study|Switched to alternative treatment|1|||
156758198|NCT02659943|565866413|FG000|Overall Study|Disease progression on study|0|||
156758199|NCT02659943|565866414|FG001|Overall Study|Disease progression on study|1|||
156758200|NCT02659943|565866415|FG002|Overall Study|Disease progression on study|1|||
156758201|NCT02659943|565866416|FG003|Overall Study|Disease progression on study|1|||
156758202|NCT02659943|565866417|FG004|Overall Study|Disease progression on study|1|||
156758203|NCT02659943|565866418|FG005|Overall Study|Disease progression on study|4|||
156758204|NCT02659943|565866419|FG006|Overall Study|Disease progression on study|0|||
156758205|NCT02659943|565866413|FG000|Overall Study|Patient's condition per principal investigator|0|||
156758206|NCT02659943|565866414|FG001|Overall Study|Patient's condition per principal investigator|0|||
156758207|NCT02659943|565866415|FG002|Overall Study|Patient's condition per principal investigator|0|||
156758208|NCT02659943|565866416|FG003|Overall Study|Patient's condition per principal investigator|0|||
156758209|NCT02659943|565866417|FG004|Overall Study|Patient's condition per principal investigator|0|||
156758210|NCT02659943|565866418|FG005|Overall Study|Patient's condition per principal investigator|1|||
156758211|NCT02659943|565866419|FG006|Overall Study|Patient's condition per principal investigator|0|||
156758212|NCT02659943|565866413|FG000|Overall Study|Ineligible|0|||
156758213|NCT02659943|565866414|FG001|Overall Study|Ineligible|0|||
156758214|NCT02659943|565866415|FG002|Overall Study|Ineligible|0|||
156758215|NCT02659943|565866416|FG003|Overall Study|Ineligible|0|||
156758216|NCT02659943|565866417|FG004|Overall Study|Ineligible|0|||
156758217|NCT02659943|565866418|FG005|Overall Study|Ineligible|0|||
156758218|NCT02659943|565866419|FG006|Overall Study|Ineligible|1|||
156758219|NCT02659943|565866413|FG000|Overall Study|No longer meets eligibility|0|||
156758220|NCT02659943|565866414|FG001|Overall Study|No longer meets eligibility|0|||
156758221|NCT02659943|565866415|FG002|Overall Study|No longer meets eligibility|0|||
156758222|NCT02659943|565866416|FG003|Overall Study|No longer meets eligibility|0|||
156758223|NCT02659943|565866417|FG004|Overall Study|No longer meets eligibility|0|||
156758224|NCT02659943|565866418|FG005|Overall Study|No longer meets eligibility|0|||
156758225|NCT02659943|565866419|FG006|Overall Study|No longer meets eligibility|1|||
156758226|NCT02659943|565866413|FG000|Overall Study|No treatment, per protocol|0|||
156758227|NCT02659943|565866414|FG001|Overall Study|No treatment, per protocol|0|||
156758228|NCT02659943|565866415|FG002|Overall Study|No treatment, per protocol|0|||
156758229|NCT02659943|565866416|FG003|Overall Study|No treatment, per protocol|0|||
156758230|NCT02659943|565866417|FG004|Overall Study|No treatment, per protocol|0|||
156758231|NCT02659943|565866418|FG005|Overall Study|No treatment, per protocol|0|||
156758232|NCT02659943|565866419|FG006|Overall Study|No treatment, per protocol|3|||
156758233|NCT06060496|565866424|FG000|Overall Study|Withdrawal by Subject|2|||
156758234|NCT06060496|565866424|FG000|Overall Study|Lost to Follow-up|2|||
156758235|NCT03361306|565866425|FG000|Overall Study|Death|6|||
156758236|NCT02282163|565866428|FG000|Overall Study|Protocol Violation|1|||
156758237|NCT03472521|565866429|FG000|Overall Study|Lost to Follow-up|3|||
156758238|NCT03472521|565866430|FG001|Overall Study|Lost to Follow-up|2|||
156758239|NCT03472521|565866429|FG000|Overall Study|Discontinued intervention|3|||
156758240|NCT03472521|565866430|FG001|Overall Study|Discontinued intervention|1|||
156758241|NCT01603407|565866431|FG000|Overall Study|Adverse Event|1|||
156758242|NCT01603407|565866432|FG001|Overall Study|Adverse Event|1|||
156758243|NCT01603407|565866433|FG002|Overall Study|Adverse Event|1|||
156758244|NCT01603407|565866431|FG000|Overall Study|Protocol Violation|2|||
156758245|NCT01603407|565866432|FG001|Overall Study|Protocol Violation|2|||
156758246|NCT01603407|565866433|FG002|Overall Study|Protocol Violation|0|||
156317886|NCT00761150|564262938|FG000|Double-blind Period|Noncompliance|0|||
156758247|NCT01603407|565866431|FG000|Overall Study|Withdrawal by Subject|8|||
156758248|NCT01603407|565866432|FG001|Overall Study|Withdrawal by Subject|5|||
156758249|NCT01603407|565866433|FG002|Overall Study|Withdrawal by Subject|7|||
156758250|NCT01603407|565866431|FG000|Overall Study|Lost to Follow-up|0|||
156758251|NCT01603407|565866432|FG001|Overall Study|Lost to Follow-up|3|||
156758252|NCT01603407|565866433|FG002|Overall Study|Lost to Follow-up|2|||
156758253|NCT01801111|565866441|FG000|Overall Study|Adverse Event|12|||
156758254|NCT01801111|565866441|FG000|Overall Study|Death|8|||
156758255|NCT01801111|565866441|FG000|Overall Study|Physician Decision|5|||
156758256|NCT01801111|565866441|FG000|Overall Study|Other|1|||
156758257|NCT01801111|565866441|FG000|Overall Study|Withdrawal by Subject|4|||
156758258|NCT01801111|565866441|FG000|Overall Study|Study Terminated by Sponsor|27|||
156317887|NCT00761150|564262939|FG001|Double-blind Period|Noncompliance|1|||
156758259|NCT01801111|565866441|FG000|Overall Study|Progressive Disease|81|||
156758260|NCT01210482|565866442|FG000|Overall Study|Protocol Violation|1|||
156758261|NCT01210482|565866442|FG000|Overall Study|Case Report Forms were not collected|18|||
156758262|NCT01210482|565866442|FG000|Overall Study|Duplicated|2|||
156758263|NCT01210482|565866442|FG000|Overall Study|No Drug Administration|28|||
156758264|NCT01223937|565866443|FG000|Overall Study|Withdrawal by Subject|3|||
156758265|NCT01223937|565866444|FG001|Overall Study|Withdrawal by Subject|2|||
156758266|NCT01223937|565866443|FG000|Overall Study|Lost to Follow-up|1|||
156758267|NCT01223937|565866444|FG001|Overall Study|Lost to Follow-up|4|||
156758268|NCT01223937|565866443|FG000|Overall Study|Adverse Event|1|||
156758269|NCT01223937|565866444|FG001|Overall Study|Adverse Event|4|||
156758270|NCT01223937|565866443|FG000|Overall Study|Protocol Violation|8|||
156758271|NCT01223937|565866444|FG001|Overall Study|Protocol Violation|7|||
156758272|NCT01223937|565866443|FG000|Overall Study|Other|4|||
156758273|NCT01223937|565866444|FG001|Overall Study|Other|1|||
156758274|NCT03284853|565866445|FG000|Overall Study|Adverse Event|40|||
156758275|NCT03284853|565866446|FG001|Overall Study|Adverse Event|4|||
156758276|NCT03284853|565866445|FG000|Overall Study|Withdrawal by Subject|5|||
156758277|NCT03284853|565866446|FG001|Overall Study|Withdrawal by Subject|1|||
156758278|NCT03284853|565866445|FG000|Overall Study|Lost to Follow-up|1|||
156758279|NCT03284853|565866446|FG001|Overall Study|Lost to Follow-up|0|||
156758280|NCT03284853|565866445|FG000|Overall Study|Lack of Efficacy|1|||
156758281|NCT03284853|565866446|FG001|Overall Study|Lack of Efficacy|0|||
156758282|NCT03284853|565866445|FG000|Overall Study|Disallowed Concurrent Medication|1|||
156758283|NCT03284853|565866446|FG001|Overall Study|Disallowed Concurrent Medication|1|||
156758284|NCT03284853|565866445|FG000|Overall Study|Protocol Violation|3|||
156758285|NCT03284853|565866446|FG001|Overall Study|Protocol Violation|3|||
156758286|NCT03284853|565866445|FG000|Overall Study|Death|0|||
156758287|NCT03284853|565866446|FG001|Overall Study|Death|1|||
156758288|NCT03284853|565866445|FG000|Overall Study|Other - Reason not reported in CSR|4|||
156758289|NCT03284853|565866446|FG001|Overall Study|Other - Reason not reported in CSR|3|||
156758290|NCT03677869|565866448|FG000|Overall Study|Withdrawal by Subject|1|||
156758291|NCT05219968|565866449|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
156758292|NCT05219968|565866450|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
156758293|NCT05219968|565866451|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
156758294|NCT05219968|565866452|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
156758295|NCT05219968|565866453|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
156758296|NCT05219968|565866449|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
156758297|NCT05219968|565866450|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
156758298|NCT05219968|565866451|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
156758299|NCT05219968|565866452|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
156758300|NCT05219968|565866453|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
156758301|NCT05219968|565866449|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
156758302|NCT05219968|565866450|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
156758303|NCT05219968|565866451|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
156758304|NCT05219968|565866452|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
156758305|NCT05219968|565866453|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
156758306|NCT05219968|565866449|FG000|Week 24 Treatment Period|Adverse Event|3|||
156758307|NCT05219968|565866450|FG001|Week 24 Treatment Period|Adverse Event|0|||
156758308|NCT05219968|565866451|FG002|Week 24 Treatment Period|Adverse Event|0|||
156758309|NCT05219968|565866452|FG003|Week 24 Treatment Period|Adverse Event|0|||
156758310|NCT05219968|565866453|FG004|Week 24 Treatment Period|Adverse Event|0|||
156758311|NCT05219968|565866449|FG000|Week 24 Treatment Period|Physician Decision|0|||
156758312|NCT05219968|565866450|FG001|Week 24 Treatment Period|Physician Decision|1|||
156758313|NCT05219968|565866451|FG002|Week 24 Treatment Period|Physician Decision|0|||
156758314|NCT05219968|565866452|FG003|Week 24 Treatment Period|Physician Decision|0|||
156758315|NCT05219968|565866453|FG004|Week 24 Treatment Period|Physician Decision|0|||
156758316|NCT05219968|565866449|FG000|Week 24 Treatment Period|Other, not specified|3|||
156758317|NCT05219968|565866450|FG001|Week 24 Treatment Period|Other, not specified|0|||
156758318|NCT05219968|565866451|FG002|Week 24 Treatment Period|Other, not specified|0|||
156758319|NCT05219968|565866452|FG003|Week 24 Treatment Period|Other, not specified|0|||
156758320|NCT05219968|565866453|FG004|Week 24 Treatment Period|Other, not specified|0|||
156758321|NCT05219968|565866449|FG000|Safety Extension Period|Treatment administration failure|0|||
156758322|NCT05219968|565866450|FG001|Safety Extension Period|Treatment administration failure|0|||
156758323|NCT05219968|565866451|FG002|Safety Extension Period|Treatment administration failure|0|||
156758324|NCT05219968|565866452|FG003|Safety Extension Period|Treatment administration failure|1|||
156758325|NCT05219968|565866453|FG004|Safety Extension Period|Treatment administration failure|4|||
156758326|NCT05219968|565866449|FG000|Safety Extension Period|Bilateral dislodgement|0|||
156758327|NCT05219968|565866450|FG001|Safety Extension Period|Bilateral dislodgement|0|||
156758328|NCT05219968|565866451|FG002|Safety Extension Period|Bilateral dislodgement|4|||
156758329|NCT05219968|565866452|FG003|Safety Extension Period|Bilateral dislodgement|0|||
156758330|NCT05219968|565866453|FG004|Safety Extension Period|Bilateral dislodgement|1|||
156758331|NCT05219968|565866449|FG000|Safety Extension Period|Withdrawal by Subject|0|||
156758332|NCT05219968|565866450|FG001|Safety Extension Period|Withdrawal by Subject|0|||
156758333|NCT05219968|565866451|FG002|Safety Extension Period|Withdrawal by Subject|2|||
156758334|NCT05219968|565866452|FG003|Safety Extension Period|Withdrawal by Subject|0|||
156758335|NCT05219968|565866453|FG004|Safety Extension Period|Withdrawal by Subject|4|||
156758336|NCT05219968|565866449|FG000|Safety Extension Period|Adverse Event|0|||
156758337|NCT05219968|565866450|FG001|Safety Extension Period|Adverse Event|0|||
156758338|NCT05219968|565866451|FG002|Safety Extension Period|Adverse Event|2|||
156758339|NCT05219968|565866452|FG003|Safety Extension Period|Adverse Event|1|||
156758340|NCT05219968|565866453|FG004|Safety Extension Period|Adverse Event|1|||
156758341|NCT05219968|565866449|FG000|Safety Extension Period|Lost to Follow-up|0|||
156758342|NCT05219968|565866450|FG001|Safety Extension Period|Lost to Follow-up|0|||
156758343|NCT05219968|565866451|FG002|Safety Extension Period|Lost to Follow-up|0|||
156758344|NCT05219968|565866452|FG003|Safety Extension Period|Lost to Follow-up|1|||
156758345|NCT05219968|565866453|FG004|Safety Extension Period|Lost to Follow-up|0|||
156758346|NCT04587336|565866456|FG000|Overall Study|Lost to Follow-up|1|||
156758347|NCT04587336|565866457|FG001|Overall Study|Lost to Follow-up|0|||
156758348|NCT02250300|565867984|FG000|Expansion Phase|Death|6|||
156758349|NCT02250300|565867985|FG001|Expansion Phase|Death|7|||
156758350|NCT02250300|565867986|FG002|Expansion Phase|Death|0|||
156758351|NCT02250300|565867987|FG003|Expansion Phase|Death|0|||
156758352|NCT01845597|565867990|FG000|Overall Study|Death|8|||
156758353|NCT01845597|565867990|FG000|Overall Study|Lost to Follow-up|22|||
156758354|NCT01223404|565867991|FG000|First Intervention (1 Day)|Adverse Event|0|||
156758355|NCT01223404|565867992|FG001|First Intervention (1 Day)|Adverse Event|0|||
156758356|NCT01223404|565867993|FG002|First Intervention (1 Day)|Adverse Event|0|||
156758357|NCT01223404|565867994|FG003|First Intervention (1 Day)|Adverse Event|1|||
156758358|NCT01223404|565867995|FG004|First Intervention (1 Day)|Adverse Event|0|||
156758359|NCT01223404|565867996|FG005|First Intervention (1 Day)|Adverse Event|0|||
156758360|NCT01223404|565867991|FG000|Second Intervention (1 Day)|Adverse Event|1|||
156758361|NCT01223404|565867992|FG001|Second Intervention (1 Day)|Adverse Event|0|||
156758362|NCT01223404|565867993|FG002|Second Intervention (1 Day)|Adverse Event|0|||
156758363|NCT01223404|565867994|FG003|Second Intervention (1 Day)|Adverse Event|0|||
156758364|NCT01223404|565867995|FG004|Second Intervention (1 Day)|Adverse Event|0|||
156758365|NCT01223404|565867996|FG005|Second Intervention (1 Day)|Adverse Event|0|||
156758366|NCT01223404|565867991|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758367|NCT01223404|565867992|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758368|NCT01223404|565867993|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758369|NCT01223404|565867994|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
156758370|NCT01223404|565867995|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758371|NCT01223404|565867996|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758372|NCT02922153|565867997|FG000|Overall Study|Death|8|||
156758373|NCT02922153|565867998|FG001|Overall Study|Death|1|||
156758374|NCT02922153|565867997|FG000|Overall Study|Lost to Follow-up|1|||
156758375|NCT02922153|565867998|FG001|Overall Study|Lost to Follow-up|0|||
156758376|NCT02922153|565867997|FG000|Overall Study|Physician Decision|1|||
156758377|NCT02922153|565867998|FG001|Overall Study|Physician Decision|1|||
156758378|NCT00522548|565867999|FG000|Overall Study|Adverse Event|2|||
156758379|NCT00522548|565868000|FG001|Overall Study|Adverse Event|2|||
156758380|NCT00522548|565867999|FG000|Overall Study|Withdrawal by Subject|0|||
156758381|NCT00522548|565868000|FG001|Overall Study|Withdrawal by Subject|2|||
156758382|NCT03506438|565868001|FG000|Overall Study|Lost to Follow-up|8|||
156758383|NCT03506438|565868002|FG001|Overall Study|Lost to Follow-up|7|||
156758384|NCT03506438|565868003|FG002|Overall Study|Lost to Follow-up|8|||
156758385|NCT03506438|565868004|FG003|Overall Study|Lost to Follow-up|7|||
156758386|NCT03506438|565868005|FG004|Overall Study|Lost to Follow-up|0|||
156758387|NCT03506438|565868006|FG005|Overall Study|Lost to Follow-up|0|||
156758388|NCT01128296|565868007|FG000|Overall Study|Physician Decision|0|||
156758389|NCT01128296|565868008|FG001|Overall Study|Physician Decision|0|||
156758390|NCT01128296|565868009|FG002|Overall Study|Physician Decision|0|||
156758391|NCT01128296|565868010|FG003|Overall Study|Physician Decision|0|||
156758392|NCT01128296|565868011|FG004|Overall Study|Physician Decision|0|||
156758393|NCT01128296|565868012|FG005|Overall Study|Physician Decision|3|||
156758394|NCT01128296|565868007|FG000|Overall Study|Withdrawal by Subject|0|||
156758395|NCT01128296|565868008|FG001|Overall Study|Withdrawal by Subject|0|||
156758396|NCT01128296|565868009|FG002|Overall Study|Withdrawal by Subject|0|||
156758397|NCT01128296|565868010|FG003|Overall Study|Withdrawal by Subject|0|||
156758398|NCT01128296|565868011|FG004|Overall Study|Withdrawal by Subject|0|||
156758399|NCT01128296|565868012|FG005|Overall Study|Withdrawal by Subject|2|||
156758400|NCT04155463|565868013|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
156758401|NCT04155463|565868014|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
156758402|NCT01053741|565868015|FG000|2nd Study Intervention|Physician Decision|0|||
156419339|NCT03890120|564628200|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
156758403|NCT01053741|565868016|FG001|2nd Study Intervention|Physician Decision|1|||
156758404|NCT00368108|565868017|FG000|Overall Study|Adverse Event|38|||
156758405|NCT00368108|565868018|FG001|Overall Study|Adverse Event|26|||
156419340|NCT03890120|564628201|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
156419341|NCT03890120|564628202|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
156419342|NCT03890120|564628199|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
156758406|NCT00368108|565868019|FG002|Overall Study|Adverse Event|44|||
156758407|NCT00368108|565868017|FG000|Overall Study|Abnormal Laboratory Value|0|||
156758408|NCT00368108|565868018|FG001|Overall Study|Abnormal Laboratory Value|0|||
156758409|NCT00368108|565868019|FG002|Overall Study|Abnormal Laboratory Value|3|||
156758410|NCT00368108|565868017|FG000|Overall Study|Protocol Violation|5|||
156758411|NCT00368108|565868018|FG001|Overall Study|Protocol Violation|9|||
156758412|NCT00368108|565868019|FG002|Overall Study|Protocol Violation|9|||
156758413|NCT00368108|565868017|FG000|Overall Study|Withdrawal by Subject|9|||
156758414|NCT00368108|565868018|FG001|Overall Study|Withdrawal by Subject|3|||
156758415|NCT00368108|565868019|FG002|Overall Study|Withdrawal by Subject|5|||
156758416|NCT00368108|565868017|FG000|Overall Study|Lack of Efficacy|7|||
156758417|NCT00368108|565868018|FG001|Overall Study|Lack of Efficacy|8|||
156758418|NCT00368108|565868019|FG002|Overall Study|Lack of Efficacy|5|||
156758419|NCT00368108|565868017|FG000|Overall Study|Physician Decision|2|||
156758420|NCT00368108|565868018|FG001|Overall Study|Physician Decision|0|||
156758421|NCT00368108|565868019|FG002|Overall Study|Physician Decision|1|||
156758422|NCT00368108|565868017|FG000|Overall Study|Other|3|||
156758423|NCT00368108|565868018|FG001|Overall Study|Other|7|||
156758424|NCT00368108|565868019|FG002|Overall Study|Other|1|||
156758425|NCT02299388|565868022|FG000|Overall Study|Withdrawal by Subject|0|||
156758426|NCT02299388|565868023|FG001|Overall Study|Withdrawal by Subject|1|||
156758427|NCT03334188|565868024|FG000|Overall Study|Withdrawal by Subject|0|||
156758428|NCT03334188|565868025|FG001|Overall Study|Withdrawal by Subject|1|||
156758429|NCT03334188|565868024|FG000|Overall Study|Death|1|||
156758430|NCT03334188|565868025|FG001|Overall Study|Death|0|||
156758431|NCT03334188|565868024|FG000|Overall Study|Never had qualifying clinic visit|7|||
156758432|NCT03334188|565868025|FG001|Overall Study|Never had qualifying clinic visit|7|||
156758433|NCT01093586|565868030|FG000|Overall Study|Failed to engraft|3|||
156758434|NCT03442088|565868031|FG000|Overall Study|Adverse Event|1|||
156758435|NCT03442088|565868031|FG000|Overall Study|Lack of Efficacy|2|||
156758436|NCT03442088|565868031|FG000|Overall Study|Lost to Follow-up|2|||
156758437|NCT00357877|565868032|FG000|Overall Study|Death|2|||
156758438|NCT00357877|565868033|FG001|Overall Study|Death|1|||
156758439|NCT00357877|565868032|FG000|Overall Study|Lost to Follow-up|20|||
156758440|NCT00357877|565868033|FG001|Overall Study|Lost to Follow-up|23|||
156758441|NCT00357877|565868032|FG000|Overall Study|Withdrawal by Subject|3|||
156758442|NCT00357877|565868033|FG001|Overall Study|Withdrawal by Subject|3|||
156758443|NCT00357877|565868032|FG000|Overall Study|Administrative withdrawal|1|||
156758444|NCT00357877|565868033|FG001|Overall Study|Administrative withdrawal|1|||
156758445|NCT00357877|565868032|FG000|Overall Study|Other|0|||
156758446|NCT00357877|565868033|FG001|Overall Study|Other|2|||
156758447|NCT01051557|565868036|FG000|Overall Study|Physician Decision|1|||
156758448|NCT01051557|565868037|FG001|Overall Study|Physician Decision|0|||
156758449|NCT01051557|565868038|FG002|Overall Study|Physician Decision|0|||
156758450|NCT01051557|565868039|FG003|Overall Study|Physician Decision|0|||
156758451|NCT01051557|565868040|FG004|Overall Study|Physician Decision|0|||
156758452|NCT01051557|565868041|FG005|Overall Study|Physician Decision|0|||
156758453|NCT01051557|565868042|FG006|Overall Study|Physician Decision|0|||
156758454|NCT01051557|565868036|FG000|Overall Study|disease progression|3|||
156758455|NCT01051557|565868037|FG001|Overall Study|disease progression|3|||
156758456|NCT01051557|565868038|FG002|Overall Study|disease progression|5|||
156758457|NCT01051557|565868039|FG003|Overall Study|disease progression|2|||
156758458|NCT01051557|565868040|FG004|Overall Study|disease progression|4|||
156758459|NCT01051557|565868041|FG005|Overall Study|disease progression|3|||
156758460|NCT01051557|565868042|FG006|Overall Study|disease progression|1|||
156419343|NCT03890120|564628200|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
156419344|NCT03890120|564628201|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
156419345|NCT03890120|564628202|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
156419346|NCT03890120|564628199|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
156419347|NCT03890120|564628200|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
156419348|NCT03890120|564628201|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
156758461|NCT01051557|565868036|FG000|Overall Study|Withdrawal by Subject|0|||
156758462|NCT01051557|565868037|FG001|Overall Study|Withdrawal by Subject|0|||
156758463|NCT01051557|565868038|FG002|Overall Study|Withdrawal by Subject|1|||
156758464|NCT01051557|565868039|FG003|Overall Study|Withdrawal by Subject|0|||
156758465|NCT01051557|565868040|FG004|Overall Study|Withdrawal by Subject|2|||
156758466|NCT01051557|565868041|FG005|Overall Study|Withdrawal by Subject|0|||
156758467|NCT01051557|565868042|FG006|Overall Study|Withdrawal by Subject|1|||
156758468|NCT01051557|565868036|FG000|Overall Study|Adverse Event|0|||
156758469|NCT01051557|565868037|FG001|Overall Study|Adverse Event|0|||
156758470|NCT01051557|565868038|FG002|Overall Study|Adverse Event|0|||
156758471|NCT01051557|565868039|FG003|Overall Study|Adverse Event|1|||
156758472|NCT01051557|565868040|FG004|Overall Study|Adverse Event|1|||
156758473|NCT01051557|565868041|FG005|Overall Study|Adverse Event|3|||
156758474|NCT01051557|565868042|FG006|Overall Study|Adverse Event|4|||
156758475|NCT00943397|565868049|FG000|Overall Study|Adverse Event|0|||
156758476|NCT00943397|565868050|FG001|Overall Study|Adverse Event|6|||
156758477|NCT00943397|565868049|FG000|Overall Study|Lost to Follow-up|0|||
156758478|NCT00943397|565868050|FG001|Overall Study|Lost to Follow-up|4|||
156758479|NCT00943397|565868049|FG000|Overall Study|Protocol Violation|2|||
156758480|NCT00943397|565868050|FG001|Overall Study|Protocol Violation|5|||
156758481|NCT00943397|565868049|FG000|Overall Study|Withdrawal by Subject|1|||
156758482|NCT00943397|565868050|FG001|Overall Study|Withdrawal by Subject|1|||
156758483|NCT00943397|565868049|FG000|Overall Study|Site terminated and other|12|||
156758484|NCT00943397|565868050|FG001|Overall Study|Site terminated and other|56|||
156758485|NCT04878055|565868051|FG000|Overall Study|Patient transferred in another department|0|||
156758486|NCT04878055|565868052|FG001|Overall Study|Patient transferred in another department|2|||
156758487|NCT04878055|565868051|FG000|Overall Study|Physician Decision|1|||
156758488|NCT04878055|565868052|FG001|Overall Study|Physician Decision|1|||
156758489|NCT04878055|565868051|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
156758490|NCT04878055|565868052|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
156758491|NCT04878055|565868051|FG000|Overall Study|Adverse Event|12|||
156758492|NCT04878055|565868052|FG001|Overall Study|Adverse Event|7|||
156758493|NCT04878055|565868051|FG000|Overall Study|Other|5|||
156758494|NCT04878055|565868052|FG001|Overall Study|Other|0|||
156758495|NCT04878055|565868051|FG000|Overall Study|Withdrawal by Subject|7|||
156758496|NCT04878055|565868052|FG001|Overall Study|Withdrawal by Subject|3|||
156758497|NCT04878055|565868051|FG000|Overall Study|Lost to Follow-up|10|||
156758498|NCT04878055|565868052|FG001|Overall Study|Lost to Follow-up|1|||
156758499|NCT01968811|565868053|FG000|Overall Study|Protocol Violation|4|||
156758500|NCT01968811|565868053|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
156758501|NCT00369915|565868054|FG000|Overall Study|expected side effects|2|||
156758502|NCT00369915|565868055|FG001|Overall Study|expected side effects|1|||
156758503|NCT00369915|565868054|FG000|Overall Study|Withdrawal by Subject|4|||
156419349|NCT03890120|564628202|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
156758504|NCT00369915|565868055|FG001|Overall Study|Withdrawal by Subject|1|||
156419350|NCT03890120|564628199|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
156419351|NCT03890120|564628200|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
156419352|NCT03890120|564628201|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
156419353|NCT03890120|564628202|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
156419354|NCT03890120|564628199|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
156419355|NCT03890120|564628200|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
156419356|NCT03890120|564628201|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
156419357|NCT03890120|564628202|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
156758505|NCT00369915|565868054|FG000|Overall Study|W/drawl by investigators|0|||
156758506|NCT00369915|565868055|FG001|Overall Study|W/drawl by investigators|1|||
156758507|NCT00249873|565868058|FG000|Overall Study|Not treated|7|||
156758508|NCT00249873|565868059|FG001|Overall Study|Not treated|8|||
156758509|NCT00249873|565868058|FG000|Overall Study|Significant thrombocytopenia|9|||
156758510|NCT00249873|565868059|FG001|Overall Study|Significant thrombocytopenia|8|||
156758511|NCT00249873|565868058|FG000|Overall Study|Severe allergic reaction|8|||
156758512|NCT00249873|565868059|FG001|Overall Study|Severe allergic reaction|1|||
156758513|NCT00249873|565868058|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
156758514|NCT00249873|565868059|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
156758515|NCT00249873|565868058|FG000|Overall Study|Other Serious Adverse Event|86|||
156758516|NCT00249873|565868059|FG001|Overall Study|Other Serious Adverse Event|97|||
156758517|NCT00249873|565868058|FG000|Overall Study|Qualifying condition not present|20|||
156758518|NCT00249873|565868059|FG001|Overall Study|Qualifying condition not present|23|||
156758519|NCT00249873|565868058|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
156758520|NCT00249873|565868059|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
156758521|NCT00249873|565868058|FG000|Overall Study|Withdrawal by Subject|504|||
156758522|NCT00249873|565868059|FG001|Overall Study|Withdrawal by Subject|466|||
156758523|NCT00249873|565868058|FG000|Overall Study|Lost to Follow-up|4|||
156758524|NCT00249873|565868059|FG001|Overall Study|Lost to Follow-up|7|||
156758525|NCT00249873|565868058|FG000|Overall Study|Minor bleeding|99|||
156758526|NCT00249873|565868059|FG001|Overall Study|Minor bleeding|37|||
156419358|NCT04537949|564628203|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
156758527|NCT00249873|565868058|FG000|Overall Study|Non-compliance|41|||
156758528|NCT00249873|565868059|FG001|Overall Study|Non-compliance|46|||
156758529|NCT00249873|565868058|FG000|Overall Study|Other non serious Adverse Event|112|||
156758530|NCT00249873|565868059|FG001|Overall Study|Other non serious Adverse Event|108|||
156758531|NCT00249873|565868058|FG000|Overall Study|Other contraindicated medication|1|||
156758532|NCT00249873|565868059|FG001|Overall Study|Other contraindicated medication|0|||
156419359|NCT04537949|564628204|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
156419360|NCT04537949|564628205|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
156758533|NCT00249873|565868058|FG000|Overall Study|Patient not wish to continue after May08|3|||
156758534|NCT00249873|565868059|FG001|Overall Study|Patient not wish to continue after May08|4|||
156758535|NCT00249873|565868058|FG000|Overall Study|Physician withdrew consent|59|||
156758536|NCT00249873|565868059|FG001|Overall Study|Physician withdrew consent|60|||
156758537|NCT00249873|565868058|FG000|Overall Study|Open label clopidogrel required|31|||
156758538|NCT00249873|565868059|FG001|Overall Study|Open label clopidogrel required|42|||
156758539|NCT00249873|565868058|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
156758540|NCT00249873|565868059|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
156758541|NCT00249873|565868058|FG000|Overall Study|Oral anticoagulant required|159|||
156758542|NCT00249873|565868059|FG001|Overall Study|Oral anticoagulant required|157|||
156758543|NCT00249873|565868058|FG000|Overall Study|Study drug intolerance|5|||
156758544|NCT00249873|565868059|FG001|Overall Study|Study drug intolerance|0|||
156758545|NCT00249873|565868058|FG000|Overall Study|Surgery/ procedure|9|||
156758546|NCT00249873|565868059|FG001|Overall Study|Surgery/ procedure|9|||
156758547|NCT00249873|565868058|FG000|Overall Study|Event related to cardiac condition|12|||
156758548|NCT00249873|565868059|FG001|Overall Study|Event related to cardiac condition|21|||
156758549|NCT00249873|565868058|FG000|Overall Study|Thromboembolic/outcome event|82|||
156758550|NCT00249873|565868059|FG001|Overall Study|Thromboembolic/outcome event|122|||
156758551|NCT00447772|565868060|FG000|Overall Study|Lack of Efficacy|3|||
156758552|NCT00447772|565868060|FG000|Overall Study|Insufficient compliance|6|||
156758553|NCT00447772|565868060|FG000|Overall Study|Discontinuation of drug therapy|1|||
156758554|NCT00447772|565868060|FG000|Overall Study|Lost to Follow-up|9|||
156758555|NCT00447772|565868060|FG000|Overall Study|Withdrawal by Subject|1|||
156758556|NCT00447772|565868060|FG000|Overall Study|Unable to attend all study visits|2|||
156758557|NCT00447772|565868060|FG000|Overall Study|Adverse Event|1|||
156758558|NCT00447772|565868060|FG000|Overall Study|Patient relocated|1|||
156758559|NCT00447772|565868060|FG000|Overall Study|Incomplete documentation at visit 1|1|||
156758560|NCT00447772|565868060|FG000|Overall Study|Chemotherapy for lung cancer|1|||
156758561|NCT00447772|565868060|FG000|Overall Study|Premature re-injection required|1|||
156758562|NCT01576575|565868061|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
156758563|NCT01576575|565868061|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
156758564|NCT01576575|565868061|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
156758565|NCT01723072|565868066|FG000|Overall Study|Withdrawal by Subject|7|||
156758566|NCT01723072|565868067|FG001|Overall Study|Withdrawal by Subject|13|||
156758567|NCT01723072|565868066|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
156758568|NCT01723072|565868067|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
156758569|NCT01723072|565868066|FG000|Overall Study|Other|4|||
156758570|NCT01723072|565868067|FG001|Overall Study|Other|3|||
156758571|NCT01841970|565868068|FG000|Overall Study|Withdrawal by Subject|1|||
156758572|NCT01841970|565868068|FG000|Overall Study|Physician Decision|2|||
156758573|NCT01841970|565868068|FG000|Overall Study|Lost to Follow-up|8|||
156758574|NCT01610037|565868074|FG000|All Patients|Adverse Event|27|||
156758575|NCT01610037|565868075|FG001|All Patients|Adverse Event|22|||
156758576|NCT01610037|565868076|FG002|All Patients|Adverse Event|26|||
156758577|NCT01610037|565868074|FG000|All Patients|Withdrawal by Subject|12|||
156758578|NCT01610037|565868075|FG001|All Patients|Withdrawal by Subject|10|||
156758579|NCT01610037|565868076|FG002|All Patients|Withdrawal by Subject|20|||
156758580|NCT01610037|565868074|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
156317888|NCT00761150|564262940|FG002|Double-blind Period|Noncompliance|0|||
156317889|NCT00761150|564262938|FG000|Double-blind Period|Other|0|||
156317890|NCT00761150|564262939|FG001|Double-blind Period|Other|3|||
156317891|NCT00761150|564262940|FG002|Double-blind Period|Other|3|||
156317892|NCT01214174|564262941|FG000|Overall Study|Withdrawal by Subject|0|||
156317893|NCT01214174|564262942|FG001|Overall Study|Withdrawal by Subject|0|||
156317894|NCT01214174|564262943|FG002|Overall Study|Withdrawal by Subject|1|||
156317895|NCT00290407|564262944|FG000|Overall Study|Physician Decision|2|||
156317896|NCT01925989|564262953|FG000|Period 1|Sponsor Decision|1|||
156317897|NCT01925989|564262954|FG001|Period 1|Sponsor Decision|1|||
156317898|NCT01925989|564262955|FG002|Period 1|Sponsor Decision|0|||
156317899|NCT01925989|564262953|FG000|Period 1|Withdrawal by Subject|0|||
156317900|NCT01925989|564262954|FG001|Period 1|Withdrawal by Subject|1|||
156317901|NCT01925989|564262955|FG002|Period 1|Withdrawal by Subject|0|||
156317902|NCT00868517|564262957|FG000|Overall Study|Withdrawal by Subject|3|||
156317903|NCT00868517|564262958|FG001|Overall Study|Withdrawal by Subject|3|||
156317904|NCT00868517|564262959|FG002|Overall Study|Withdrawal by Subject|2|||
156317905|NCT00868517|564262957|FG000|Overall Study|Protocol Violation|1|||
156758581|NCT01610037|565868075|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
156758582|NCT01610037|565868076|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
156758583|NCT01610037|565868074|FG000|All Patients|Death|4|||
156758584|NCT01610037|565868075|FG001|All Patients|Death|2|||
156758585|NCT01610037|565868076|FG002|All Patients|Death|1|||
156758586|NCT01610037|565868074|FG000|All Patients|Protocol deviation|4|||
156317906|NCT00868517|564262958|FG001|Overall Study|Protocol Violation|1|||
156317907|NCT00868517|564262959|FG002|Overall Study|Protocol Violation|0|||
156317908|NCT02496676|564262961|FG000|Phase 1 - Period 1|Adverse Event|0|||
156758587|NCT01610037|565868075|FG001|All Patients|Protocol deviation|3|||
156758588|NCT01610037|565868076|FG002|All Patients|Protocol deviation|3|||
156317909|NCT02496676|564262962|FG001|Phase 1 - Period 1|Adverse Event|1|||
156317910|NCT02496676|564262961|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
156317911|NCT02496676|564262962|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
156419361|NCT04537949|564628206|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
156419362|NCT04537949|564628207|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
156419363|NCT04537949|564628208|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
156419364|NCT04537949|564628209|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
156419365|NCT04537949|564628210|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
156419366|NCT04537949|564628203|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
156419367|NCT04537949|564628204|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
156419368|NCT04537949|564628205|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
156419369|NCT04537949|564628206|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
156419370|NCT04537949|564628207|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
156419371|NCT04537949|564628208|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
156419372|NCT04537949|564628209|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
156419373|NCT04537949|564628210|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
156758589|NCT01610037|565868074|FG000|All Patients|Abnormal laboratory value|1|||
156758590|NCT01610037|565868075|FG001|All Patients|Abnormal laboratory value|1|||
156758591|NCT01610037|565868076|FG002|All Patients|Abnormal laboratory value|0|||
156758592|NCT01610037|565868074|FG000|All Patients|Administrative problems|1|||
156758593|NCT01610037|565868075|FG001|All Patients|Administrative problems|4|||
156758594|NCT01610037|565868076|FG002|All Patients|Administrative problems|4|||
156758595|NCT01610037|565868074|FG000|All Patients|Lost to Follow-up|1|||
156758596|NCT01610037|565868075|FG001|All Patients|Lost to Follow-up|0|||
156758597|NCT01610037|565868076|FG002|All Patients|Lost to Follow-up|0|||
156758598|NCT01610037|565868074|FG000|All Patients|Abnormal test procedure result(s)|0|||
156758599|NCT01610037|565868075|FG001|All Patients|Abnormal test procedure result(s)|1|||
156758600|NCT01610037|565868076|FG002|All Patients|Abnormal test procedure result(s)|3|||
156758601|NCT01610037|565868074|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
156758602|NCT01610037|565868075|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
156758603|NCT01610037|565868076|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
156758604|NCT01610037|565868074|FG000|Treatment and Follow up Period|Death|10|||
156758605|NCT01610037|565868075|FG001|Treatment and Follow up Period|Death|5|||
156758606|NCT01610037|565868076|FG002|Treatment and Follow up Period|Death|4|||
156758607|NCT01610037|565868074|FG000|Treatment and Follow up Period|Administrative problems|1|||
156758608|NCT01610037|565868075|FG001|Treatment and Follow up Period|Administrative problems|3|||
156758609|NCT01610037|565868076|FG002|Treatment and Follow up Period|Administrative problems|2|||
156758610|NCT01610037|565868074|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
156758611|NCT01610037|565868075|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
156758612|NCT01610037|565868076|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
156758613|NCT00274742|565868077|FG000|Overall Study|Adverse Event|0|||
156758614|NCT00274742|565868078|FG001|Overall Study|Adverse Event|4|||
156758615|NCT00274742|565868079|FG002|Overall Study|Adverse Event|1|||
156758616|NCT00274742|565868080|FG003|Overall Study|Adverse Event|4|||
156758617|NCT00274742|565868081|FG004|Overall Study|Adverse Event|12|||
156758618|NCT00274742|565868082|FG005|Overall Study|Adverse Event|3|||
156758619|NCT00274742|565868077|FG000|Overall Study|Lost to Follow-up|0|||
156758620|NCT00274742|565868078|FG001|Overall Study|Lost to Follow-up|0|||
156758621|NCT00274742|565868079|FG002|Overall Study|Lost to Follow-up|0|||
156758622|NCT00274742|565868080|FG003|Overall Study|Lost to Follow-up|0|||
156758623|NCT00274742|565868081|FG004|Overall Study|Lost to Follow-up|1|||
156758624|NCT00274742|565868082|FG005|Overall Study|Lost to Follow-up|0|||
156758625|NCT00274742|565868077|FG000|Overall Study|End of Study|0|||
156758626|NCT00274742|565868078|FG001|Overall Study|End of Study|0|||
156758627|NCT00274742|565868079|FG002|Overall Study|End of Study|0|||
156758628|NCT00274742|565868080|FG003|Overall Study|End of Study|1|||
156758629|NCT00274742|565868081|FG004|Overall Study|End of Study|0|||
156758630|NCT00274742|565868082|FG005|Overall Study|End of Study|0|||
156758631|NCT00274742|565868077|FG000|Overall Study|Disease Progression|0|||
156758632|NCT00274742|565868078|FG001|Overall Study|Disease Progression|1|||
156758633|NCT00274742|565868079|FG002|Overall Study|Disease Progression|1|||
156419374|NCT04537949|564628203|FG000|Follow-up Phase|Lost to Follow-up|0|||
156419375|NCT04537949|564628204|FG001|Follow-up Phase|Lost to Follow-up|3|||
156758634|NCT00274742|565868080|FG003|Overall Study|Disease Progression|0|||
156758635|NCT00274742|565868081|FG004|Overall Study|Disease Progression|1|||
156758636|NCT00274742|565868082|FG005|Overall Study|Disease Progression|0|||
156758637|NCT00274742|565868077|FG000|Overall Study|Other|0|||
156758638|NCT00274742|565868078|FG001|Overall Study|Other|3|||
156758639|NCT00274742|565868079|FG002|Overall Study|Other|0|||
156758640|NCT00274742|565868080|FG003|Overall Study|Other|0|||
156758641|NCT00274742|565868081|FG004|Overall Study|Other|2|||
156758642|NCT00274742|565868082|FG005|Overall Study|Other|0|||
156758643|NCT00149396|565868089|FG000|Overall Study|Death|15|||
156758644|NCT00149396|565868089|FG000|Overall Study|Withdrawal by Subject|1|||
156758645|NCT00149396|565868089|FG000|Overall Study|Subject noncompliance|2|||
156758646|NCT00149396|565868089|FG000|Overall Study|other treatment|5|||
156758647|NCT00807885|565868090|FG000|Overall Study|Lost to Follow-up|0|||
156758648|NCT00807885|565868091|FG001|Overall Study|Lost to Follow-up|0|||
156758649|NCT00807885|565868092|FG002|Overall Study|Lost to Follow-up|0|||
156758650|NCT00807885|565868093|FG003|Overall Study|Lost to Follow-up|0|||
156758651|NCT00807885|565868094|FG004|Overall Study|Lost to Follow-up|0|||
156758652|NCT00807885|565868095|FG005|Overall Study|Lost to Follow-up|1|||
156758653|NCT00807885|565868096|FG006|Overall Study|Lost to Follow-up|0|||
156758654|NCT00807885|565868097|FG007|Overall Study|Lost to Follow-up|0|||
156758655|NCT00807885|565868098|FG008|Overall Study|Lost to Follow-up|0|||
156758656|NCT03489343|565868099|FG000|Overall Study|Documented progressive disease|1|||
156758657|NCT03489343|565868100|FG001|Overall Study|Documented progressive disease|0|||
156758658|NCT03489343|565868101|FG002|Overall Study|Documented progressive disease|3|||
156758659|NCT03489343|565868102|FG003|Overall Study|Documented progressive disease|1|||
156758660|NCT03489343|565868103|FG004|Overall Study|Documented progressive disease|3|||
156758661|NCT03489343|565868104|FG005|Overall Study|Documented progressive disease|5|||
156758662|NCT03489343|565868105|FG006|Overall Study|Documented progressive disease|4|||
156758663|NCT03489343|565868099|FG000|Overall Study|Adverse Event|0|||
156758664|NCT03489343|565868100|FG001|Overall Study|Adverse Event|1|||
156758665|NCT03489343|565868101|FG002|Overall Study|Adverse Event|0|||
156758666|NCT03489343|565868102|FG003|Overall Study|Adverse Event|0|||
156758667|NCT03489343|565868103|FG004|Overall Study|Adverse Event|0|||
156758668|NCT03489343|565868104|FG005|Overall Study|Adverse Event|1|||
156758669|NCT03489343|565868105|FG006|Overall Study|Adverse Event|0|||
156758670|NCT03489343|565868099|FG000|Overall Study|Withdrawal by Subject|0|||
156758671|NCT03489343|565868100|FG001|Overall Study|Withdrawal by Subject|0|||
156758672|NCT03489343|565868101|FG002|Overall Study|Withdrawal by Subject|0|||
156758673|NCT03489343|565868102|FG003|Overall Study|Withdrawal by Subject|1|||
156758674|NCT03489343|565868103|FG004|Overall Study|Withdrawal by Subject|0|||
156758675|NCT03489343|565868104|FG005|Overall Study|Withdrawal by Subject|1|||
156758676|NCT03489343|565868105|FG006|Overall Study|Withdrawal by Subject|1|||
156758677|NCT03489343|565868099|FG000|Overall Study|Clinical progression|0|||
156758678|NCT03489343|565868100|FG001|Overall Study|Clinical progression|0|||
156758679|NCT03489343|565868101|FG002|Overall Study|Clinical progression|0|||
156758680|NCT03489343|565868102|FG003|Overall Study|Clinical progression|1|||
156758681|NCT03489343|565868103|FG004|Overall Study|Clinical progression|0|||
156758682|NCT03489343|565868104|FG005|Overall Study|Clinical progression|0|||
156758683|NCT03489343|565868105|FG006|Overall Study|Clinical progression|1|||
156758684|NCT00327717|565868106|FG000|Overall Study|Adverse Event|6|||
156758685|NCT00327717|565868107|FG001|Overall Study|Adverse Event|6|||
156758686|NCT00327717|565868106|FG000|Overall Study|Lack of Efficacy|0|||
156758687|NCT00327717|565868107|FG001|Overall Study|Lack of Efficacy|1|||
156758688|NCT00327717|565868106|FG000|Overall Study|Withdrawal by Subject|3|||
156758689|NCT00327717|565868107|FG001|Overall Study|Withdrawal by Subject|7|||
156758690|NCT01630135|565868109|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
156758691|NCT01630135|565868110|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
156758692|NCT04767373|565868112|FG000|Overall Study|Death|6|||
156758693|NCT04767373|565868113|FG001|Overall Study|Death|3|||
156758694|NCT04767373|565868112|FG000|Overall Study|Lost to Follow-up|67|||
156758695|NCT04767373|565868113|FG001|Overall Study|Lost to Follow-up|35|||
156758696|NCT04767373|565868112|FG000|Overall Study|Physician Decision|15|||
156758697|NCT04767373|565868113|FG001|Overall Study|Physician Decision|4|||
156758698|NCT04767373|565868112|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156758699|NCT04767373|565868113|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156758700|NCT04767373|565868112|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
156758701|NCT04767373|565868113|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
156758702|NCT04767373|565868112|FG000|Overall Study|Other|1|||
156758703|NCT04767373|565868113|FG001|Overall Study|Other|2|||
156758704|NCT01502033|565868114|FG000|Overall Study|1 participant had scalp discomfort|1|||
156758705|NCT01502033|565868114|FG000|Overall Study|1 participant had worsening depression|1|||
156419376|NCT04537949|564628205|FG002|Follow-up Phase|Lost to Follow-up|0|||
156419377|NCT04537949|564628206|FG003|Follow-up Phase|Lost to Follow-up|0|||
156419378|NCT04537949|564628207|FG004|Follow-up Phase|Lost to Follow-up|0|||
156419379|NCT04537949|564628208|FG005|Follow-up Phase|Lost to Follow-up|0|||
156419380|NCT04537949|564628209|FG006|Follow-up Phase|Lost to Follow-up|0|||
156419381|NCT04537949|564628210|FG007|Follow-up Phase|Lost to Follow-up|0|||
156419382|NCT04537949|564628203|FG000|Follow-up Phase|personal reasons|0|||
156419383|NCT04537949|564628204|FG001|Follow-up Phase|personal reasons|0|||
156758706|NCT01502033|565868114|FG000|Overall Study|1 participant went back to school|1|||
156758707|NCT02983045|565868115|FG000|Overall Study|Withdrawal by Subject|0|||
156758708|NCT02983045|565868116|FG001|Overall Study|Withdrawal by Subject|1|||
156758709|NCT02983045|565868117|FG002|Overall Study|Withdrawal by Subject|0|||
156758710|NCT02983045|565868118|FG003|Overall Study|Withdrawal by Subject|5|||
156758711|NCT02983045|565868119|FG004|Overall Study|Withdrawal by Subject|0|||
156758712|NCT02983045|565868120|FG005|Overall Study|Withdrawal by Subject|72|||
156758713|NCT02983045|565868121|FG006|Overall Study|Withdrawal by Subject|0|||
156758714|NCT02983045|565868122|FG007|Overall Study|Withdrawal by Subject|0|||
156758715|NCT02983045|565868123|FG008|Overall Study|Withdrawal by Subject|0|||
156758716|NCT02983045|565868124|FG009|Overall Study|Withdrawal by Subject|2|||
156419384|NCT04537949|564628205|FG002|Follow-up Phase|personal reasons|0|||
156758717|NCT02983045|565868115|FG000|Overall Study|Lost to Follow-up|0|||
156758718|NCT02983045|565868116|FG001|Overall Study|Lost to Follow-up|0|||
156758719|NCT02983045|565868117|FG002|Overall Study|Lost to Follow-up|0|||
156758720|NCT02983045|565868118|FG003|Overall Study|Lost to Follow-up|0|||
156758721|NCT02983045|565868119|FG004|Overall Study|Lost to Follow-up|0|||
156758722|NCT02983045|565868120|FG005|Overall Study|Lost to Follow-up|10|||
156758723|NCT02983045|565868121|FG006|Overall Study|Lost to Follow-up|0|||
156758724|NCT02983045|565868122|FG007|Overall Study|Lost to Follow-up|0|||
156317912|NCT05442775|564262963|FG000|Overall Study|Trial terminated|61|||
156317913|NCT05442775|564262963|FG000|Overall Study|Lack of Efficacy|4|||
156317914|NCT05442775|564262963|FG000|Overall Study|Withdrawal by Subject|4|||
156317915|NCT05442775|564262963|FG000|Overall Study|Death|1|||
156317916|NCT05442775|564262963|FG000|Overall Study|Participant removed at Sponsor request|1|||
156317917|NCT03459690|564262965|FG000|Overall Study|Lost to Follow-up|0|||
156317918|NCT03459690|564262966|FG001|Overall Study|Lost to Follow-up|1|||
156317919|NCT03459690|564262965|FG000|Overall Study|Withdrawal by Subject|1|||
156317920|NCT03459690|564262966|FG001|Overall Study|Withdrawal by Subject|1|||
156317921|NCT02963831|564262967|FG000|Overall Study|Progressive Disease|3|||
156317922|NCT02963831|564262968|FG001|Overall Study|Progressive Disease|3|||
156317923|NCT02963831|564262969|FG002|Overall Study|Progressive Disease|16|||
156317924|NCT02963831|564262970|FG003|Overall Study|Progressive Disease|27|||
156317925|NCT02963831|564262967|FG000|Overall Study|Withdrawal by Subject|1|||
156317926|NCT02963831|564262968|FG001|Overall Study|Withdrawal by Subject|0|||
156317927|NCT02963831|564262969|FG002|Overall Study|Withdrawal by Subject|2|||
156317928|NCT02963831|564262970|FG003|Overall Study|Withdrawal by Subject|4|||
156317929|NCT02963831|564262967|FG000|Overall Study|Adverse Event|0|||
156317930|NCT02963831|564262968|FG001|Overall Study|Adverse Event|1|||
156317931|NCT02963831|564262969|FG002|Overall Study|Adverse Event|1|||
156317932|NCT02963831|564262970|FG003|Overall Study|Adverse Event|2|||
156317933|NCT02963831|564262967|FG000|Overall Study|Death|0|||
156317934|NCT02963831|564262968|FG001|Overall Study|Death|0|||
156317935|NCT02963831|564262969|FG002|Overall Study|Death|0|||
156317936|NCT02963831|564262970|FG003|Overall Study|Death|2|||
156317937|NCT01966432|564262971|FG000|Overall Study|Lost to Follow-up|3|||
156317938|NCT01966432|564262972|FG001|Overall Study|Lost to Follow-up|2|||
156317939|NCT01966432|564262973|FG002|Overall Study|Lost to Follow-up|5|||
156317940|NCT01966432|564262971|FG000|Overall Study|Withdrawal by Subject|1|||
156317941|NCT01966432|564262972|FG001|Overall Study|Withdrawal by Subject|3|||
156317942|NCT01966432|564262973|FG002|Overall Study|Withdrawal by Subject|0|||
156317943|NCT01966432|564262971|FG000|Overall Study|Subject Incarcerated|0|||
156317944|NCT01966432|564262972|FG001|Overall Study|Subject Incarcerated|0|||
156317945|NCT01966432|564262973|FG002|Overall Study|Subject Incarcerated|1|||
156317946|NCT01966432|564262971|FG000|Overall Study|SBIRT program ended|1|||
156317947|NCT01966432|564262972|FG001|Overall Study|SBIRT program ended|8|||
156317948|NCT01966432|564262973|FG002|Overall Study|SBIRT program ended|20|||
156317949|NCT02536404|564262983|FG000|Overall Study|Adverse Event|5|||
156317950|NCT02536404|564262984|FG001|Overall Study|Adverse Event|0|||
156317951|NCT02536404|564262983|FG000|Overall Study|Withdrawal by Subject|4|||
156317952|NCT02536404|564262984|FG001|Overall Study|Withdrawal by Subject|1|||
156317953|NCT02536404|564262983|FG000|Overall Study|Physician Decision|10|||
156317954|NCT02536404|564262984|FG001|Overall Study|Physician Decision|0|||
156317955|NCT02536404|564262983|FG000|Overall Study|Sponsor decision|1|||
156317956|NCT02536404|564262984|FG001|Overall Study|Sponsor decision|0|||
156317957|NCT03915860|564262985|FG000|Overall Study|Adverse Event|3|||
156317958|NCT03915860|564262985|FG000|Overall Study|Withdrawal by Subject|6|||
156317959|NCT03915860|564262985|FG000|Overall Study|Lost to Follow-up|2|||
156317960|NCT03915860|564262985|FG000|Overall Study|Other than specified|3|||
156317961|NCT04559529|564262986|FG000|First Intervention (1 Day)|Adverse Event|0|||
156317962|NCT04559529|564262987|FG001|First Intervention (1 Day)|Adverse Event|0|||
156317963|NCT04559529|564262988|FG002|First Intervention (1 Day)|Adverse Event|0|||
156419385|NCT04537949|564628206|FG003|Follow-up Phase|personal reasons|1|||
156317964|NCT04559529|564262989|FG003|First Intervention (1 Day)|Adverse Event|1|||
156317965|NCT04559529|564262986|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
156317966|NCT04559529|564262987|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
156317967|NCT04559529|564262988|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
156758725|NCT02983045|565868123|FG008|Overall Study|Lost to Follow-up|0|||
156758726|NCT02983045|565868124|FG009|Overall Study|Lost to Follow-up|0|||
156317968|NCT04559529|564262989|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
156317969|NCT04559529|564262986|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
156317970|NCT04559529|564262987|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
156317971|NCT04559529|564262988|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
156317972|NCT04559529|564262989|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
156317973|NCT01009281|564262990|FG000|Overall Study|Administrative problems|7|||
156317974|NCT03901456|564262993|FG000|Overall Study|Withdrawal by Subject|0|||
156317975|NCT03901456|564262994|FG001|Overall Study|Withdrawal by Subject|0|||
156419386|NCT04537949|564628207|FG004|Follow-up Phase|personal reasons|1|||
156758727|NCT02658669|565868125|FG000|Overall Study|Lost to Follow-up|7|||
156758728|NCT02658669|565868126|FG001|Overall Study|Lost to Follow-up|5|||
156758729|NCT00838097|565868127|FG000|Overall Study|Ineligibility determined|6|||
156758730|NCT00838097|565868127|FG000|Overall Study|Adverse Event|2|||
156758731|NCT00838097|565868127|FG000|Overall Study|Withdrawal by Subject|3|||
156758732|NCT00838097|565868127|FG000|Overall Study|Requirement for alternative therapy|2|||
156758733|NCT00838097|565868127|FG000|Overall Study|Physician Decision|4|||
156758734|NCT00838097|565868127|FG000|Overall Study|Lost to Follow-up|11|||
156758735|NCT00838097|565868127|FG000|Overall Study|Death|6|||
156758736|NCT00838097|565868127|FG000|Overall Study|Protocol-specified criteria|142|||
156758737|NCT02149264|565868133|FG000|Overall Study|Withdrawal by Subject|9|||
156758738|NCT02149264|565868133|FG000|Overall Study|Adverse Event|7|||
156758739|NCT02149264|565868133|FG000|Overall Study|Physician Decision|3|||
156758740|NCT02149264|565868133|FG000|Overall Study|Protocol Violation|1|||
156758741|NCT02824627|565868137|FG000|Overall Study|Adverse Event|1|||
156758742|NCT02824627|565868138|FG001|Overall Study|Adverse Event|2|||
156758743|NCT02824627|565868137|FG000|Overall Study|Lost to Follow-up|2|||
156758744|NCT02824627|565868138|FG001|Overall Study|Lost to Follow-up|1|||
156758745|NCT00672633|565868139|FG000|Overall Study|Withdrawal by Subject|0|||
156758746|NCT00672633|565868140|FG001|Overall Study|Withdrawal by Subject|1|||
156758747|NCT01938846|565868141|FG000|Overall Study|Progressive disease|26|||
156758748|NCT01938846|565868142|FG001|Overall Study|Progressive disease|18|||
156758749|NCT01938846|565868143|FG002|Overall Study|Progressive disease|16|||
156758750|NCT01938846|565868141|FG000|Overall Study|Adverse Event|8|||
156758751|NCT01938846|565868142|FG001|Overall Study|Adverse Event|4|||
156758752|NCT01938846|565868143|FG002|Overall Study|Adverse Event|3|||
156758753|NCT01938846|565868141|FG000|Overall Study|Withdrawal by Subject|2|||
156758754|NCT01938846|565868142|FG001|Overall Study|Withdrawal by Subject|2|||
156758755|NCT01938846|565868143|FG002|Overall Study|Withdrawal by Subject|1|||
156758756|NCT01938846|565868141|FG000|Overall Study|Other than listed|5|||
156758757|NCT01938846|565868142|FG001|Overall Study|Other than listed|1|||
156758758|NCT01938846|565868143|FG002|Overall Study|Other than listed|4|||
156758759|NCT02499120|565868149|FG000|Overall Study|Death|52|||
156758760|NCT02499120|565868150|FG001|Overall Study|Death|43|||
156758761|NCT02499120|565868149|FG000|Overall Study|Lost to Follow-up|1|||
156758762|NCT02499120|565868150|FG001|Overall Study|Lost to Follow-up|2|||
156758763|NCT02499120|565868149|FG000|Overall Study|Participant refused further follow-up|1|||
156758764|NCT02499120|565868150|FG001|Overall Study|Participant refused further follow-up|0|||
156758765|NCT02499120|565868149|FG000|Overall Study|Withdrawal by Subject|2|||
156758766|NCT02499120|565868150|FG001|Overall Study|Withdrawal by Subject|5|||
156758767|NCT02499120|565868149|FG000|Overall Study|Other|9|||
156758768|NCT02499120|565868150|FG001|Overall Study|Other|10|||
156758769|NCT05176717|565868155|FG000|Overall Study|Sponsor Decision|1|||
156758770|NCT05176717|565868156|FG001|Overall Study|Sponsor Decision|2|||
156758771|NCT05176717|565868157|FG002|Overall Study|Sponsor Decision|2|||
156758772|NCT00765817|565868158|FG000|Overall Study|Adverse Event|13|||
156758773|NCT00765817|565868159|FG001|Overall Study|Adverse Event|1|||
156758774|NCT00765817|565868158|FG000|Overall Study|Death|0|||
156758775|NCT00765817|565868159|FG001|Overall Study|Death|1|||
156758776|NCT00765817|565868158|FG000|Overall Study|Entry criteria not met|2|||
156758777|NCT00765817|565868159|FG001|Overall Study|Entry criteria not met|2|||
156758778|NCT00765817|565868158|FG000|Overall Study|Loss of glucose control|0|||
156758779|NCT00765817|565868159|FG001|Overall Study|Loss of glucose control|2|||
156758780|NCT00765817|565868158|FG000|Overall Study|Lost to Follow-up|1|||
156758781|NCT00765817|565868159|FG001|Overall Study|Lost to Follow-up|3|||
156758782|NCT00765817|565868158|FG000|Overall Study|Physician Decision|2|||
156758783|NCT00765817|565868159|FG001|Overall Study|Physician Decision|1|||
156758784|NCT00765817|565868158|FG000|Overall Study|Protocol Violation|1|||
156758785|NCT00765817|565868159|FG001|Overall Study|Protocol Violation|1|||
156758786|NCT00765817|565868158|FG000|Overall Study|Subject decision|7|||
156758787|NCT00765817|565868159|FG001|Overall Study|Subject decision|11|||
156758788|NCT02143024|565868161|FG000|Overall Study|Lost to Follow-up|1|||
156317976|NCT03901456|564262995|FG002|Overall Study|Withdrawal by Subject|1|||
156317977|NCT03901456|564262993|FG000|Overall Study|Lost to Follow-up|0|||
156758789|NCT02143024|565868162|FG001|Overall Study|Lost to Follow-up|1|||
156758790|NCT02143024|565868161|FG000|Overall Study|Withdrawal by Subject|1|||
156758791|NCT02143024|565868162|FG001|Overall Study|Withdrawal by Subject|0|||
156758792|NCT02308228|565868163|FG000|Overall Study|Adverse Event|3|||
156758793|NCT02308228|565868164|FG001|Overall Study|Adverse Event|4|||
156758794|NCT02308228|565868163|FG000|Overall Study|Withdrawal by Subject|5|||
156758795|NCT02308228|565868164|FG001|Overall Study|Withdrawal by Subject|3|||
156758796|NCT06597084|565868165|FG000|Overall Study|Withdrawal by Subject|4|||
156758797|NCT06597084|565868166|FG001|Overall Study|Withdrawal by Subject|9|||
156758798|NCT06597084|565868165|FG000|Overall Study|Consent was not given by the patient until V2|0|||
156758799|NCT06597084|565868166|FG001|Overall Study|Consent was not given by the patient until V2|3|||
156758800|NCT06597084|565868165|FG000|Overall Study|Physician Decision|1|||
156758801|NCT06597084|565868166|FG001|Overall Study|Physician Decision|0|||
156758802|NCT06597084|565868165|FG000|Overall Study|Adverse Event|3|||
156758803|NCT06597084|565868166|FG001|Overall Study|Adverse Event|2|||
156758804|NCT06597084|565868165|FG000|Overall Study|Death|4|||
156758805|NCT06597084|565868166|FG001|Overall Study|Death|0|||
156758806|NCT06597084|565868165|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
156758807|NCT06597084|565868166|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
156758808|NCT06597084|565868165|FG000|Overall Study|Lost to Follow-up|4|||
156758809|NCT06597084|565868166|FG001|Overall Study|Lost to Follow-up|2|||
156758810|NCT06597084|565868165|FG000|Overall Study|Other. Not specified|1|||
156758811|NCT06597084|565868166|FG001|Overall Study|Other. Not specified|0|||
156758812|NCT03999749|565868169|FG000|Overall Study|Toxicity|16|||
156758813|NCT03999749|565868169|FG000|Overall Study|Withdrawal by Subject|3|||
156758814|NCT03999749|565868169|FG000|Overall Study|Disease progression|26|||
156758815|NCT03999749|565868169|FG000|Overall Study|Physician Decision|4|||
156758816|NCT03999749|565868169|FG000|Overall Study|Death|5|||
156758817|NCT03999749|565868169|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
156758818|NCT00758498|565869763|FG000|Overall Study|Adverse Event|2|||
156758819|NCT00758498|565869764|FG001|Overall Study|Adverse Event|2|||
156758820|NCT00758498|565869765|FG002|Overall Study|Adverse Event|3|||
156758821|NCT00758498|565869763|FG000|Overall Study|Subject legally detained out of state|1|||
156758822|NCT00758498|565869764|FG001|Overall Study|Subject legally detained out of state|0|||
156758823|NCT00758498|565869765|FG002|Overall Study|Subject legally detained out of state|0|||
156758824|NCT00758498|565869763|FG000|Overall Study|Withdrawal by Subject|0|||
156758825|NCT00758498|565869764|FG001|Overall Study|Withdrawal by Subject|0|||
156758826|NCT00758498|565869765|FG002|Overall Study|Withdrawal by Subject|1|||
156758827|NCT00758498|565869763|FG000|Overall Study|Noncompliance to study procedures|0|||
156758828|NCT00758498|565869764|FG001|Overall Study|Noncompliance to study procedures|0|||
156758829|NCT00758498|565869765|FG002|Overall Study|Noncompliance to study procedures|1|||
156758830|NCT02317991|565869766|FG000|Overall Study|Adverse Event|12|||
156758831|NCT02317991|565869766|FG000|Overall Study|Death|4|||
156758832|NCT02317991|565869766|FG000|Overall Study|Withdrawal by Subject|8|||
156758833|NCT02317991|565869766|FG000|Overall Study|Progressive Disease|41|||
156758834|NCT02492165|565869767|FG000|Overall Study|Withdrawal by Subject|0|||
156758835|NCT02492165|565869768|FG001|Overall Study|Withdrawal by Subject|1|||
156758836|NCT02492165|565869769|FG002|Overall Study|Withdrawal by Subject|0|||
156758837|NCT02492165|565869770|FG003|Overall Study|Withdrawal by Subject|0|||
156758838|NCT00707057|565869771|FG000|Overall Study|Withdrawal by Subject|8|||
156758839|NCT00707057|565869772|FG001|Overall Study|Withdrawal by Subject|3|||
156758840|NCT00707057|565869771|FG000|Overall Study|Dosed incorrectly|0|||
156758841|NCT00707057|565869772|FG001|Overall Study|Dosed incorrectly|1|||
156758842|NCT01697800|565869773|FG000|Overall Study|Death|0|||
156758843|NCT01697800|565869774|FG001|Overall Study|Death|1|||
156758844|NCT00823134|565869777|FG000|Overall Study|Invalid measurement|1|||
156758845|NCT02692586|565869782|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
156758846|NCT02692586|565869782|FG000|Overall Study|Received adjunctive thrombolytics|2|||
156758847|NCT00956839|565869783|FG000|Overall Study|Lost to Follow-up|3|||
156758848|NCT00956839|565869784|FG001|Overall Study|Lost to Follow-up|0|||
156758849|NCT00956839|565869785|FG002|Overall Study|Lost to Follow-up|3|||
156758850|NCT03316586|565869793|FG000|Overall Study|Adverse Event|2|||
156419387|NCT04537949|564628208|FG005|Follow-up Phase|personal reasons|0|||
156419388|NCT04537949|564628209|FG006|Follow-up Phase|personal reasons|0|||
156419389|NCT04537949|564628210|FG007|Follow-up Phase|personal reasons|0|||
156419390|NCT04537949|564628203|FG000|Follow-up Phase|Withdrawal by Subject|0|||
156419391|NCT04537949|564628204|FG001|Follow-up Phase|Withdrawal by Subject|0|||
156419392|NCT04537949|564628205|FG002|Follow-up Phase|Withdrawal by Subject|0|||
156419393|NCT04537949|564628206|FG003|Follow-up Phase|Withdrawal by Subject|0|||
156419394|NCT04537949|564628207|FG004|Follow-up Phase|Withdrawal by Subject|1|||
156419395|NCT04537949|564628208|FG005|Follow-up Phase|Withdrawal by Subject|0|||
156419396|NCT04537949|564628209|FG006|Follow-up Phase|Withdrawal by Subject|0|||
156419397|NCT04537949|564628210|FG007|Follow-up Phase|Withdrawal by Subject|0|||
156419398|NCT05194735|564630051|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
156758851|NCT03316586|565869793|FG000|Overall Study|Physician Decision|3|||
156758852|NCT03316586|565869793|FG000|Overall Study|Lack of Efficacy|10|||
156419399|NCT05194735|564630052|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
156419400|NCT05194735|564630053|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
156419401|NCT05194735|564630051|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
156419402|NCT05194735|564630052|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
156419403|NCT05194735|564630053|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
156758853|NCT03316586|565869793|FG000|Overall Study|still on treatment|1|||
156758854|NCT03316586|565869793|FG000|Overall Study|Patient needed radiation therapy|1|||
156758855|NCT03316586|565869793|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
156758856|NCT00994110|565869794|FG000|Overall Study|Withdrawal by Subject|9|||
156758857|NCT00994110|565869795|FG001|Overall Study|Withdrawal by Subject|9|||
156758858|NCT00994110|565869794|FG000|Overall Study|Not Treated|4|||
156758859|NCT00994110|565869795|FG001|Overall Study|Not Treated|8|||
156758860|NCT00994110|565869794|FG000|Overall Study|Adverse Event|1|||
156653352|NCT01816477|565477966|FG000|Overall Study|Withdrawal by Subject|13|||
156653353|NCT01816477|565477967|FG001|Overall Study|Withdrawal by Subject|1|||
156653354|NCT01816477|565477966|FG000|Overall Study|Unable to tolerate catheter placement|3|||
156653355|NCT01816477|565477967|FG001|Overall Study|Unable to tolerate catheter placement|0|||
156653356|NCT02162758|565477968|FG000|Overall Study|Study termination|0|||
156653357|NCT02162758|565477969|FG001|Overall Study|Study termination|1|||
156653358|NCT02116803|565477970|FG000|Overall Study|Adverse Event|2|||
156653359|NCT02116803|565477971|FG001|Overall Study|Adverse Event|1|||
156653360|NCT02116803|565477970|FG000|Overall Study|Physician Decision|1|||
156653361|NCT02116803|565477971|FG001|Overall Study|Physician Decision|0|||
156653362|NCT02116803|565477970|FG000|Overall Study|Progressive disease|4|||
156653363|NCT02116803|565477971|FG001|Overall Study|Progressive disease|0|||
156653364|NCT02116803|565477970|FG000|Overall Study|Study terminated by sponsor|2|||
156653365|NCT02116803|565477971|FG001|Overall Study|Study terminated by sponsor|1|||
156653366|NCT02116803|565477970|FG000|Overall Study|Death|1|||
156653367|NCT02116803|565477971|FG001|Overall Study|Death|0|||
156653368|NCT03213210|565477972|FG000|Overall Study|Lost to Follow-up|2|||
156653369|NCT03213210|565477972|FG000|Overall Study|Study termination|3|||
156653370|NCT00481247|565477975|FG000|Overall Study|Death|0|||
156653371|NCT00481247|565477976|FG001|Overall Study|Death|1|||
156653372|NCT00481247|565477975|FG000|Overall Study|Disease progression|18|||
156653373|NCT00481247|565477976|FG001|Overall Study|Disease progression|22|||
156653374|NCT00481247|565477975|FG000|Overall Study|Intolerance|42|||
156653375|NCT00481247|565477976|FG001|Overall Study|Intolerance|17|||
156653376|NCT00481247|565477975|FG000|Overall Study|Treatment failure|10|||
156653377|NCT00481247|565477976|FG001|Overall Study|Treatment failure|14|||
156653378|NCT00481247|565477975|FG000|Overall Study|AE unrelated to study drug|13|||
156653379|NCT00481247|565477976|FG001|Overall Study|AE unrelated to study drug|4|||
156653380|NCT00481247|565477975|FG000|Overall Study|Withdrawal by Subject|8|||
156653381|NCT00481247|565477976|FG001|Overall Study|Withdrawal by Subject|13|||
156653382|NCT00481247|565477975|FG000|Overall Study|Pregnancy|2|||
156653383|NCT00481247|565477976|FG001|Overall Study|Pregnancy|1|||
156653384|NCT00481247|565477975|FG000|Overall Study|Lost to Follow-up|1|||
156653385|NCT00481247|565477976|FG001|Overall Study|Lost to Follow-up|2|||
156653386|NCT00481247|565477975|FG000|Overall Study|Poor compliance/noncompliance|1|||
156653387|NCT00481247|565477976|FG001|Overall Study|Poor compliance/noncompliance|7|||
156653388|NCT00481247|565477975|FG000|Overall Study|Administrative reason by sponsor|157|||
156653389|NCT00481247|565477976|FG001|Overall Study|Administrative reason by sponsor|162|||
156653390|NCT00481247|565477975|FG000|Overall Study|Varied|6|||
156653391|NCT00481247|565477976|FG001|Overall Study|Varied|15|||
156653392|NCT00481247|565477975|FG000|Overall Study|Did not receive treatment|1|||
156653393|NCT00481247|565477976|FG001|Overall Study|Did not receive treatment|2|||
156653394|NCT02649231|565477979|FG000|Overall Study|Adverse Event|0|||
156653395|NCT02649231|565477980|FG001|Overall Study|Adverse Event|0|||
156653396|NCT02649231|565477981|FG002|Overall Study|Adverse Event|0|||
156653397|NCT02649231|565477982|FG003|Overall Study|Adverse Event|1|||
156653398|NCT02649231|565477979|FG000|Overall Study|Lost to Follow-up|2|||
156317978|NCT03901456|564262994|FG001|Overall Study|Lost to Follow-up|1|||
156317979|NCT03901456|564262995|FG002|Overall Study|Lost to Follow-up|0|||
156317980|NCT02217527|564262996|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
156317981|NCT02217527|564262997|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
156317982|NCT02217527|564262996|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
156317983|NCT02217527|564262997|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
156317984|NCT01203852|564262998|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
156317985|NCT01203852|564262998|FG000|Washout 2 Weeks|Physician Decision|46|||
156317986|NCT02582684|564262999|FG000|Overall Study|Unable to contact subject/parent|4|||
156317987|NCT02582684|564262999|FG000|Overall Study|Subject not able to get to clinic|10|||
156317988|NCT02582684|564262999|FG000|Overall Study|Subject withdrew consent|1|||
156317989|NCT02582684|564262999|FG000|Overall Study|Found to be ineligible after enrollment|2|||
156317990|NCT01878149|564263000|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
156317991|NCT01878149|564263001|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
156317992|NCT06390839|564263006|FG000|Overall Study|Ineligible|2|||
156317993|NCT06390839|564263006|FG000|Overall Study|Never start protocol therapy|3|||
156317994|NCT06390839|564263006|FG000|Overall Study|Adverse Event|1|||
156317995|NCT06390839|564263006|FG000|Overall Study|Alternative therapy|2|||
156317996|NCT06390839|564263006|FG000|Overall Study|Death|3|||
156317997|NCT06390839|564263006|FG000|Overall Study|Disease progression|28|||
156317998|NCT06390839|564263006|FG000|Overall Study|Withdrawal by Subject|2|||
156317999|NCT06390839|564263006|FG000|Overall Study|Complicating disease|1|||
156318000|NCT06390839|564263006|FG000|Overall Study|Noncompliance|1|||
156318001|NCT04658940|564263009|FG000|Overall Study|Withdrawal by Subject|1|||
156318002|NCT03579602|564263010|FG000|Overall Study|Subject unable to receive study drug|0|||
156318003|NCT03579602|564263011|FG001|Overall Study|Subject unable to receive study drug|2|||
156653399|NCT02649231|565477980|FG001|Overall Study|Lost to Follow-up|1|||
156653400|NCT02649231|565477981|FG002|Overall Study|Lost to Follow-up|1|||
156653401|NCT02649231|565477982|FG003|Overall Study|Lost to Follow-up|0|||
156653402|NCT02649231|565477979|FG000|Overall Study|Withdrawal by Subject|0|||
156758861|NCT00994110|565869795|FG001|Overall Study|Adverse Event|0|||
156758862|NCT00994110|565869794|FG000|Overall Study|Patient not resected|41|||
156758863|NCT00994110|565869795|FG001|Overall Study|Patient not resected|52|||
156758864|NCT00994110|565869794|FG000|Overall Study|Pt not eligible|10|||
156758865|NCT00994110|565869795|FG001|Overall Study|Pt not eligible|5|||
156758866|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
156758867|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
156758868|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
156758869|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
156758870|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
156758871|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
156758872|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
156758873|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
156758874|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
156758875|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
156758876|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
156758877|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
156758878|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
156758879|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
156758880|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
156758881|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
156758882|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
156758883|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
156758884|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
156758885|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
156758886|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
156758887|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
156318004|NCT03579602|564263010|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
156318005|NCT03579602|564263011|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
156318006|NCT00053898|564263012|FG000|Overall Study|No follow-up data from any source|9|||
156318007|NCT00053898|564263013|FG001|Overall Study|No follow-up data from any source|12|||
156318008|NCT00053898|564263012|FG000|Overall Study|Follow-up from telephone contact only|5|||
156318009|NCT00053898|564263013|FG001|Overall Study|Follow-up from telephone contact only|1|||
156318010|NCT02889562|564263018|FG000|Overall Study|Physician Decision|0|||
156318011|NCT02889562|564263019|FG001|Overall Study|Physician Decision|1|||
156318012|NCT02889562|564263018|FG000|Overall Study|Withdrawal by Subject|0|||
156318013|NCT02889562|564263019|FG001|Overall Study|Withdrawal by Subject|1|||
156318014|NCT00217464|564263023|FG000|Overall Study|Progression|15|||
156318015|NCT00217464|564263023|FG000|Overall Study|Other|2|||
156318016|NCT00884377|564264479|FG000|Overall Study|Withdrawal by Subject|1|||
156318017|NCT00884377|564264480|FG001|Overall Study|Withdrawal by Subject|0|||
156318018|NCT00884377|564264479|FG000|Overall Study|Could not confirm diagnosis|1|||
156318019|NCT00884377|564264480|FG001|Overall Study|Could not confirm diagnosis|0|||
156318020|NCT00884377|564264479|FG000|Overall Study|Physician Decision|0|||
156318021|NCT00884377|564264480|FG001|Overall Study|Physician Decision|1|||
156318022|NCT04085367|564264481|FG000|Overall Study|Adverse Event|1|||
156318023|NCT04085367|564264482|FG001|Overall Study|Adverse Event|1|||
156318024|NCT04085367|564264481|FG000|Overall Study|Withdrawal by Subject|13|||
156318025|NCT04085367|564264482|FG001|Overall Study|Withdrawal by Subject|4|||
156318026|NCT04085367|564264481|FG000|Overall Study|Lost to Follow-up|3|||
156318027|NCT04085367|564264482|FG001|Overall Study|Lost to Follow-up|1|||
156318028|NCT04085367|564264481|FG000|Overall Study|Other unspecified|2|||
156318029|NCT04085367|564264482|FG001|Overall Study|Other unspecified|1|||
156318030|NCT04085367|564264481|FG000|Overall Study|Status Unknown|1|||
156318031|NCT04085367|564264482|FG001|Overall Study|Status Unknown|1|||
156318032|NCT00130442|564264485|FG000|Overall Study|Withdrawal by Subject|0|||
156318033|NCT00130442|564264486|FG001|Overall Study|Withdrawal by Subject|1|||
156318034|NCT00130442|564264485|FG000|Overall Study|did not meet criteria|1|||
156318035|NCT00130442|564264486|FG001|Overall Study|did not meet criteria|1|||
156318036|NCT02233946|564264489|FG000|Baseline|Withdrawal by Subject|2|||
156318037|NCT02233946|564264490|FG001|Baseline|Withdrawal by Subject|0|||
156318038|NCT02233946|564264489|FG000|3-months Follow-up|Lost to Follow-up|53|||
156419404|NCT05194735|564630051|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
156419405|NCT05194735|564630052|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
156419406|NCT05194735|564630053|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
156419407|NCT05194735|564630051|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
156419408|NCT05194735|564630052|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
156758888|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
156758889|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
156758890|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
156758891|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
156758892|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
156419409|NCT05194735|564630053|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
156758893|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
156758894|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
156758895|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
156758896|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
156758897|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
156758898|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
156758899|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
156758900|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
156758901|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156758902|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156758903|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156758904|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
156758905|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156758906|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156758907|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156758908|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
156758909|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156758910|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156758911|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
156758912|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
156758913|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
156758914|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
156758915|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
156758916|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
156758917|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
156758918|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
156758919|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
156758920|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
156758921|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
156758922|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
156758923|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
156758924|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
156758925|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
156758926|NCT04131712|565869801|FG000|Overall Study|COVID related|0|||
156758927|NCT04131712|565869802|FG001|Overall Study|COVID related|0|||
156758928|NCT04131712|565869803|FG002|Overall Study|COVID related|2|||
156758929|NCT04131712|565869804|FG003|Overall Study|COVID related|0|||
156758930|NCT04131712|565869801|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
156758931|NCT04131712|565869802|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
156758932|NCT04131712|565869803|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
156758933|NCT04131712|565869804|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
156758934|NCT00130689|565869808|FG000|Overall Study|Progressive Disease|29|||
156758935|NCT00130689|565869808|FG000|Overall Study|Death|1|||
156758936|NCT00130689|565869808|FG000|Overall Study|Clinical Deterioration|4|||
156758937|NCT00130689|565869808|FG000|Overall Study|Withdrawal by Subject|3|||
156758938|NCT00130689|565869808|FG000|Overall Study|Ineligible|6|||
156419410|NCT00731042|564630054|FG000|Second Intervention|Did not meet inclusion criteria|0|||
156419411|NCT00731042|564630055|FG001|Second Intervention|Did not meet inclusion criteria|2|||
156419412|NCT01256476|564630056|FG000|Overall Study|Adverse Event|2|||
156419413|NCT01256476|564630057|FG001|Overall Study|Adverse Event|1|||
156419414|NCT01256476|564630056|FG000|Overall Study|Withdrawal by Subject|2|||
156419415|NCT01256476|564630057|FG001|Overall Study|Withdrawal by Subject|1|||
156419416|NCT01256476|564630056|FG000|Overall Study|Lost to Follow-up|1|||
156419417|NCT01256476|564630057|FG001|Overall Study|Lost to Follow-up|2|||
156419418|NCT01256476|564630056|FG000|Overall Study|Persistent ALT or AST elevation|1|||
156419419|NCT01256476|564630057|FG001|Overall Study|Persistent ALT or AST elevation|0|||
156419420|NCT01256476|564630056|FG000|Overall Study|Physician Decision|0|||
156419421|NCT01256476|564630057|FG001|Overall Study|Physician Decision|1|||
156758939|NCT00766597|565869809|FG000|Overall Study|Unexpected closure of study|4|||
156758940|NCT00766597|565869809|FG000|Overall Study|Without CCR5-tropic virus|5|||
156758941|NCT01254656|565869810|FG000|Overall Study|Discontinued due to termination of study|40|||
156758942|NCT01254656|565869811|FG001|Overall Study|Discontinued due to termination of study|39|||
156758943|NCT01254656|565869812|FG002|Overall Study|Discontinued due to termination of study|13|||
156419422|NCT01256476|564630056|FG000|Overall Study|Subject non-compliance|0|||
156419423|NCT01256476|564630057|FG001|Overall Study|Subject non-compliance|1|||
156419424|NCT01256476|564630056|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
156653403|NCT02649231|565477980|FG001|Overall Study|Withdrawal by Subject|1|||
156653404|NCT02649231|565477981|FG002|Overall Study|Withdrawal by Subject|0|||
156653405|NCT02649231|565477982|FG003|Overall Study|Withdrawal by Subject|1|||
156653406|NCT02649231|565477979|FG000|Overall Study|Protocol Violation|2|||
156653407|NCT02649231|565477980|FG001|Overall Study|Protocol Violation|1|||
156653408|NCT02649231|565477981|FG002|Overall Study|Protocol Violation|1|||
156653409|NCT02649231|565477982|FG003|Overall Study|Protocol Violation|0|||
156653410|NCT00876733|565477987|FG000|Overall Study|Adverse Event|34|||
156653411|NCT00876733|565477988|FG001|Overall Study|Adverse Event|20|||
156653412|NCT00876733|565477989|FG002|Overall Study|Adverse Event|10|||
156653413|NCT00876733|565477990|FG003|Overall Study|Adverse Event|3|||
156653414|NCT00876733|565477987|FG000|Overall Study|Lack of Efficacy|17|||
156653415|NCT00876733|565477988|FG001|Overall Study|Lack of Efficacy|9|||
156653416|NCT00876733|565477989|FG002|Overall Study|Lack of Efficacy|10|||
156653417|NCT00876733|565477990|FG003|Overall Study|Lack of Efficacy|1|||
156653418|NCT00876733|565477987|FG000|Overall Study|Lost to Follow-up|26|||
156653419|NCT00876733|565477988|FG001|Overall Study|Lost to Follow-up|10|||
156653420|NCT00876733|565477989|FG002|Overall Study|Lost to Follow-up|3|||
156653421|NCT00876733|565477990|FG003|Overall Study|Lost to Follow-up|2|||
156653422|NCT00876733|565477987|FG000|Overall Study|Data not available|14|||
156653423|NCT00876733|565477988|FG001|Overall Study|Data not available|3|||
156653424|NCT00876733|565477989|FG002|Overall Study|Data not available|7|||
156653425|NCT00876733|565477990|FG003|Overall Study|Data not available|1|||
156653426|NCT05476679|565477993|FG000|Overall Study|Withdrawal by Subject|0|||
156653427|NCT05476679|565477994|FG001|Overall Study|Withdrawal by Subject|0|||
156653428|NCT05476679|565477995|FG002|Overall Study|Withdrawal by Subject|0|||
156653429|NCT05476679|565477996|FG003|Overall Study|Withdrawal by Subject|1|||
156653430|NCT05476679|565477997|FG004|Overall Study|Withdrawal by Subject|0|||
156653431|NCT05476679|565477993|FG000|Overall Study|Lost to Follow-up|0|||
156653432|NCT05476679|565477994|FG001|Overall Study|Lost to Follow-up|0|||
156653433|NCT05476679|565477995|FG002|Overall Study|Lost to Follow-up|0|||
156653434|NCT05476679|565477996|FG003|Overall Study|Lost to Follow-up|1|||
156653435|NCT05476679|565477997|FG004|Overall Study|Lost to Follow-up|0|||
156653436|NCT01214330|565477998|FG000|Overall Study|Withdrawal by Subject|2|||
156653437|NCT01214330|565477998|FG000|Overall Study|Withdrawal by Subject|2|||
156653438|NCT00249821|565477999|FG000|Overall Study|Technical problem|0|||
156653439|NCT00249821|565478000|FG001|Overall Study|Technical problem|1|||
156653440|NCT00686036|565478003|FG000|Overall Study|Adverse Event|3|||
156653441|NCT00686036|565478004|FG001|Overall Study|Adverse Event|0|||
156653442|NCT00686036|565478003|FG000|Overall Study|Withdrawal by Subject|3|||
156653443|NCT00686036|565478004|FG001|Overall Study|Withdrawal by Subject|1|||
156653444|NCT00686036|565478003|FG000|Overall Study|Study terminated by AstraZeneca|2|||
156653445|NCT00686036|565478004|FG001|Overall Study|Study terminated by AstraZeneca|1|||
156653446|NCT00686036|565478003|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
156653447|NCT00686036|565478004|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
156653448|NCT00686036|565478003|FG000|Overall Study|Other reasons not identified|0|||
156653449|NCT00686036|565478004|FG001|Overall Study|Other reasons not identified|4|||
156653450|NCT00656019|565478007|FG000|Overall Study|Not Eligible|10|||
156653451|NCT00656019|565478008|FG001|Overall Study|Not Eligible|0|||
156653452|NCT00656019|565478009|FG002|Overall Study|Not Eligible|0|||
156653453|NCT00656019|565478010|FG003|Overall Study|Not Eligible|0|||
156653454|NCT00656019|565478007|FG000|Overall Study|Withdrawal by Subject|2|||
156653455|NCT00656019|565478008|FG001|Overall Study|Withdrawal by Subject|0|||
156653456|NCT00656019|565478009|FG002|Overall Study|Withdrawal by Subject|0|||
156653457|NCT00656019|565478010|FG003|Overall Study|Withdrawal by Subject|0|||
156653458|NCT00656019|565478007|FG000|Overall Study|Lost to Follow-up|2|||
156653459|NCT00656019|565478008|FG001|Overall Study|Lost to Follow-up|1|||
156653460|NCT00656019|565478009|FG002|Overall Study|Lost to Follow-up|0|||
156653461|NCT00656019|565478010|FG003|Overall Study|Lost to Follow-up|0|||
156653462|NCT01309919|565478021|FG000|Overall Study|Did not receive a postpartum IUD|17|||
156653463|NCT01309919|565478022|FG001|Overall Study|Did not receive a postpartum IUD|48|||
156653464|NCT03896490|565478023|FG000|Overall Study|Withdrawal by Subject|1|||
156653465|NCT03896490|565478024|FG001|Overall Study|Withdrawal by Subject|1|||
156653466|NCT00929708|565478026|FG000|Overall Study|Protocol Violation|2|||
156653467|NCT00929708|565478027|FG001|Overall Study|Protocol Violation|1|||
156653468|NCT00929708|565478028|FG002|Overall Study|Protocol Violation|1|||
156653469|NCT00929708|565478029|FG003|Overall Study|Protocol Violation|1|||
156653470|NCT00929708|565478030|FG004|Overall Study|Protocol Violation|1|||
156653471|NCT00929708|565478026|FG000|Overall Study|Withdrawal by Subject|2|||
156653472|NCT00929708|565478027|FG001|Overall Study|Withdrawal by Subject|0|||
156653473|NCT00929708|565478028|FG002|Overall Study|Withdrawal by Subject|0|||
156653474|NCT00929708|565478029|FG003|Overall Study|Withdrawal by Subject|2|||
156653475|NCT00929708|565478030|FG004|Overall Study|Withdrawal by Subject|1|||
156758944|NCT01254656|565869810|FG000|Overall Study|Lack of Efficacy|3|||
156653476|NCT00929708|565478026|FG000|Overall Study|Adverse Event|0|||
156653477|NCT00929708|565478027|FG001|Overall Study|Adverse Event|0|||
156653478|NCT00929708|565478028|FG002|Overall Study|Adverse Event|0|||
156653479|NCT00929708|565478029|FG003|Overall Study|Adverse Event|0|||
156758945|NCT01254656|565869811|FG001|Overall Study|Lack of Efficacy|0|||
156419425|NCT01256476|564630057|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
156758946|NCT01254656|565869812|FG002|Overall Study|Lack of Efficacy|0|||
156758947|NCT01254656|565869810|FG000|Overall Study|Lost to Follow-up|1|||
156758948|NCT01254656|565869811|FG001|Overall Study|Lost to Follow-up|0|||
156758949|NCT01254656|565869812|FG002|Overall Study|Lost to Follow-up|2|||
156758950|NCT01254656|565869810|FG000|Overall Study|Withdrawal by Subject|2|||
156758951|NCT01254656|565869811|FG001|Overall Study|Withdrawal by Subject|2|||
156758952|NCT01254656|565869812|FG002|Overall Study|Withdrawal by Subject|1|||
156758953|NCT01254656|565869810|FG000|Overall Study|Pregnancy|0|||
156758954|NCT01254656|565869811|FG001|Overall Study|Pregnancy|0|||
156758955|NCT01254656|565869812|FG002|Overall Study|Pregnancy|2|||
156758956|NCT01254656|565869810|FG000|Overall Study|Adverse Event|1|||
156758957|NCT01254656|565869811|FG001|Overall Study|Adverse Event|1|||
156758958|NCT01254656|565869812|FG002|Overall Study|Adverse Event|0|||
156758959|NCT01254656|565869810|FG000|Overall Study|Death|0|||
156758960|NCT01254656|565869811|FG001|Overall Study|Death|1|||
156758961|NCT01254656|565869812|FG002|Overall Study|Death|0|||
156758962|NCT02948829|565869815|FG000|Overall Study|Lost to Follow-up|2|||
156758963|NCT02948829|565869815|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
156419426|NCT04034238|564630060|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
156419427|NCT04034238|564630061|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
156419428|NCT04034238|564630062|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
156758964|NCT02948829|565869815|FG000|Overall Study|Pregnancy|1|||
156758965|NCT02948829|565869815|FG000|Overall Study|Other: Reason not Specified|8|||
156758966|NCT01004978|565869816|FG000|Overall Study|Disease progression|31|||
156758967|NCT01004978|565869817|FG001|Overall Study|Disease progression|48|||
156758968|NCT01004978|565869816|FG000|Overall Study|Adverse Event|42|||
156758969|NCT01004978|565869817|FG001|Overall Study|Adverse Event|22|||
156758970|NCT01004978|565869816|FG000|Overall Study|Death|3|||
156758971|NCT01004978|565869817|FG001|Overall Study|Death|2|||
156758972|NCT01004978|565869816|FG000|Overall Study|Withdrawal by Subject|16|||
156758973|NCT01004978|565869817|FG001|Overall Study|Withdrawal by Subject|16|||
156758974|NCT01004978|565869816|FG000|Overall Study|Alternative therapy|4|||
156758975|NCT01004978|565869817|FG001|Overall Study|Alternative therapy|8|||
156758976|NCT01004978|565869816|FG000|Overall Study|Physician Decision|6|||
156758977|NCT01004978|565869817|FG001|Overall Study|Physician Decision|3|||
156758978|NCT01004978|565869816|FG000|Overall Study|Other complicating disease|2|||
156758979|NCT01004978|565869817|FG001|Overall Study|Other complicating disease|2|||
156758980|NCT01004978|565869816|FG000|Overall Study|Protocol Violation|2|||
156758981|NCT01004978|565869817|FG001|Overall Study|Protocol Violation|3|||
156758982|NCT01004978|565869816|FG000|Overall Study|Non-compliance|3|||
156758983|NCT01004978|565869817|FG001|Overall Study|Non-compliance|2|||
156758984|NCT01004978|565869816|FG000|Overall Study|Ineligible|1|||
156758985|NCT01004978|565869817|FG001|Overall Study|Ineligible|0|||
156758986|NCT01004978|565869816|FG000|Overall Study|Unblinded|0|||
156758987|NCT01004978|565869817|FG001|Overall Study|Unblinded|1|||
156758988|NCT01004978|565869816|FG000|Overall Study|Performance status worsening|0|||
156758989|NCT01004978|565869817|FG001|Overall Study|Performance status worsening|1|||
156758990|NCT01004978|565869816|FG000|Overall Study|Never started treatment|8|||
156758991|NCT01004978|565869817|FG001|Overall Study|Never started treatment|9|||
156758992|NCT03311841|565869834|FG000|14-day Wash-out|Adverse Event|0|||
156758993|NCT03311841|565869835|FG001|14-day Wash-out|Adverse Event|1|||
156758994|NCT03311841|565869836|FG002|14-day Wash-out|Adverse Event|0|||
156758995|NCT03311841|565869837|FG003|14-day Wash-out|Adverse Event|0|||
156758996|NCT03311841|565869838|FG004|14-day Wash-out|Adverse Event|0|||
156758997|NCT03311841|565869834|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
156758998|NCT03311841|565869835|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
156758999|NCT03311841|565869836|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
156759000|NCT03311841|565869837|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
156759001|NCT03311841|565869838|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
156759002|NCT00977613|565869855|FG000|Overall Study|Lost to Follow-up|16|||
156759003|NCT01598610|565869860|FG000|Overall Study|Adverse Event|1|||
156759004|NCT02989402|565869868|FG000|Overall Study|Adverse event, or serious adverse event|4|||
156759005|NCT02989402|565869868|FG000|Overall Study|Death|2|||
156759006|NCT02989402|565869868|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
156759007|NCT02989402|565869868|FG000|Overall Study|Lost to Follow-up|8|||
156419429|NCT04034238|564630063|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156759008|NCT02989402|565869868|FG000|Overall Study|Patient no longer on monotherapy|1|||
156419430|NCT04034238|564630060|FG000|Dose Escalation Phase|Screen failures|0|||
156759009|NCT02989402|565869868|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
156759010|NCT02989402|565869868|FG000|Overall Study|Withdrawal by Subject|7|||
156759011|NCT02989402|565869868|FG000|Overall Study|Other|2|||
156759012|NCT03066830|565869869|FG000|Overall Study|At the Participant's own Request|16|||
156759013|NCT03066830|565869870|FG001|Overall Study|At the Participant's own Request|17|||
156759014|NCT03066830|565869869|FG000|Overall Study|Other|3|||
156759015|NCT03066830|565869870|FG001|Overall Study|Other|0|||
156419431|NCT04034238|564630061|FG001|Dose Escalation Phase|Screen failures|0|||
156419432|NCT04034238|564630062|FG002|Dose Escalation Phase|Screen failures|0|||
156419433|NCT04034238|564630063|FG003|Dose Escalation Phase|Screen failures|2|||
156419434|NCT04034238|564630060|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
156419435|NCT04034238|564630061|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
156419436|NCT04034238|564630062|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
156419437|NCT04034238|564630063|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
156419438|NCT04034238|564630060|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
156419439|NCT04034238|564630061|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
156419440|NCT04034238|564630062|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
156419441|NCT04034238|564630063|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
156419442|NCT01345292|564630064|FG000|Overall Study|Withdrawal by Subject|2|||
156419443|NCT01345292|564630065|FG001|Overall Study|Withdrawal by Subject|0|||
156419444|NCT01345292|564630066|FG002|Overall Study|Withdrawal by Subject|1|||
156419445|NCT01244763|564630072|FG000|Overall Study|Adverse Event|1|||
156419446|NCT01244763|564630073|FG001|Overall Study|Adverse Event|0|||
156759016|NCT03066830|565869869|FG000|Overall Study|Poor Compliance to Protocol|1|||
156759017|NCT03066830|565869870|FG001|Overall Study|Poor Compliance to Protocol|0|||
156419447|NCT01244763|564630074|FG002|Overall Study|Adverse Event|0|||
156419448|NCT01244763|564630075|FG003|Overall Study|Adverse Event|0|||
156419449|NCT01244763|564630076|FG004|Overall Study|Adverse Event|0|||
156419450|NCT01244763|564630077|FG005|Overall Study|Adverse Event|1|||
156419451|NCT01244763|564630072|FG000|Overall Study|Death|1|||
156419452|NCT01244763|564630073|FG001|Overall Study|Death|0|||
156419453|NCT01244763|564630074|FG002|Overall Study|Death|1|||
156419454|NCT01244763|564630075|FG003|Overall Study|Death|0|||
156419455|NCT01244763|564630076|FG004|Overall Study|Death|2|||
156419456|NCT01244763|564630077|FG005|Overall Study|Death|0|||
156419457|NCT01244763|564630072|FG000|Overall Study|Physician Decision|0|||
156759018|NCT03066830|565869869|FG000|Overall Study|Adverse Event|2|||
156759019|NCT03066830|565869870|FG001|Overall Study|Adverse Event|2|||
156759020|NCT03066830|565869869|FG000|Overall Study|Lost to Follow-up|11|||
156759021|NCT03066830|565869870|FG001|Overall Study|Lost to Follow-up|3|||
156759022|NCT02039778|565869872|FG000|Overall Study|Death|2|||
156759023|NCT02039778|565869872|FG000|Overall Study|Withdrawal by Subject|1|||
156759024|NCT02039778|565869872|FG000|Overall Study|Never started the protocol treatment|1|||
156759025|NCT01670045|565869878|FG000|Overall Study|Withdrawal by Subject|3|||
156759026|NCT01670045|565869878|FG000|Overall Study|Adverse Event|1|||
156759027|NCT01670045|565869878|FG000|Overall Study|Death|1|||
156759028|NCT01670045|565869878|FG000|Overall Study|Lost to Follow-up|11|||
156759029|NCT03360019|565869879|FG000|Overall Study|Withdrawal by Subject|2|||
156759030|NCT03360019|565869880|FG001|Overall Study|Withdrawal by Subject|0|||
156759031|NCT03360019|565869881|FG002|Overall Study|Withdrawal by Subject|0|||
156759032|NCT03360019|565869879|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
156759033|NCT03360019|565869880|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
156759034|NCT03360019|565869881|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
156759035|NCT00753675|565869882|FG000|Overall Study|other reason|11|||
156759036|NCT00753675|565869883|FG001|Overall Study|other reason|12|||
156759037|NCT00753675|565869884|FG002|Overall Study|other reason|13|||
156759038|NCT00753675|565869882|FG000|Overall Study|Death|1|||
156759039|NCT00753675|565869883|FG001|Overall Study|Death|2|||
156759040|NCT00753675|565869884|FG002|Overall Study|Death|4|||
156759041|NCT00753675|565869882|FG000|Overall Study|Adverse Event|11|||
156759042|NCT00753675|565869883|FG001|Overall Study|Adverse Event|9|||
156419458|NCT01244763|564630073|FG001|Overall Study|Physician Decision|0|||
156419459|NCT01244763|564630074|FG002|Overall Study|Physician Decision|1|||
156419460|NCT01244763|564630075|FG003|Overall Study|Physician Decision|0|||
156419461|NCT01244763|564630076|FG004|Overall Study|Physician Decision|0|||
156419462|NCT01244763|564630077|FG005|Overall Study|Physician Decision|0|||
156419463|NCT01244763|564630072|FG000|Overall Study|Withdrawal by Subject|1|||
156653480|NCT00929708|565478030|FG004|Overall Study|Adverse Event|3|||
156653481|NCT00929708|565478026|FG000|Overall Study|Physician Decision|0|||
156653482|NCT00929708|565478027|FG001|Overall Study|Physician Decision|2|||
156653483|NCT00929708|565478028|FG002|Overall Study|Physician Decision|2|||
156653484|NCT00929708|565478029|FG003|Overall Study|Physician Decision|2|||
156653485|NCT00929708|565478030|FG004|Overall Study|Physician Decision|1|||
156653486|NCT00929708|565478026|FG000|Overall Study|Lost to Follow-up|0|||
156653487|NCT00929708|565478027|FG001|Overall Study|Lost to Follow-up|0|||
156653488|NCT00929708|565478028|FG002|Overall Study|Lost to Follow-up|0|||
156653489|NCT00929708|565478029|FG003|Overall Study|Lost to Follow-up|1|||
156653490|NCT00929708|565478030|FG004|Overall Study|Lost to Follow-up|0|||
156759043|NCT00753675|565869884|FG002|Overall Study|Adverse Event|4|||
156759044|NCT00753675|565869882|FG000|Overall Study|Objective progression of disease|35|||
156759045|NCT00753675|565869883|FG001|Overall Study|Objective progression of disease|35|||
156759046|NCT00753675|565869884|FG002|Overall Study|Objective progression of disease|35|||
156759047|NCT00753675|565869882|FG000|Overall Study|Withdrawal by Subject|0|||
156318039|NCT02233946|564264490|FG001|3-months Follow-up|Lost to Follow-up|29|||
156318040|NCT02233946|564264489|FG000|6-months Follow-up|Lost to Follow-up|21|||
156318041|NCT02233946|564264490|FG001|6-months Follow-up|Lost to Follow-up|2|||
156318042|NCT02233946|564264489|FG000|9-month Follow-up|Lost to Follow-up|20|||
156318043|NCT02233946|564264490|FG001|9-month Follow-up|Lost to Follow-up|11|||
156318044|NCT02233946|564264489|FG000|12-month Follow-up|Lost to Follow-up|28|||
156318045|NCT02233946|564264490|FG001|12-month Follow-up|Lost to Follow-up|11|||
156318046|NCT01527357|564264491|FG000|Overall Study|Death|8|||
156318047|NCT01527357|564264492|FG001|Overall Study|Death|2|||
156318048|NCT01527357|564264491|FG000|Overall Study|Lost to Follow-up|6|||
156318049|NCT01527357|564264492|FG001|Overall Study|Lost to Follow-up|4|||
156318050|NCT01527357|564264491|FG000|Overall Study|Withdrew Consent|1|||
156318051|NCT01527357|564264492|FG001|Overall Study|Withdrew Consent|1|||
156318052|NCT01527357|564264491|FG000|Overall Study|Non-compliance|0|||
156318053|NCT01527357|564264492|FG001|Overall Study|Non-compliance|1|||
156318054|NCT01527357|564264491|FG000|Overall Study|No Day 29 Visit|0|||
156318055|NCT01527357|564264492|FG001|Overall Study|No Day 29 Visit|1|||
156318056|NCT01527357|564264491|FG000|Overall Study|Did Not Receive Treatment|2|||
156318057|NCT01527357|564264492|FG001|Overall Study|Did Not Receive Treatment|0|||
156318058|NCT00910247|564264493|FG000|Overall Study|Adverse Event|15|||
156318059|NCT00910247|564264493|FG000|Overall Study|Death|2|||
156318060|NCT00910247|564264493|FG000|Overall Study|Lost to Follow-up|10|||
156318061|NCT00910247|564264493|FG000|Overall Study|Physician Decision|3|||
156318062|NCT00910247|564264493|FG000|Overall Study|Protocol Violation|10|||
156318063|NCT00910247|564264493|FG000|Overall Study|Withdrawal by Subject|25|||
156318064|NCT00910247|564264493|FG000|Overall Study|Not collected|4|||
156318065|NCT02292784|564264494|FG000|Overall Study|Lost to Follow-up|1|||
156318066|NCT02292784|564264495|FG001|Overall Study|Lost to Follow-up|17|||
156318067|NCT02292784|564264496|FG002|Overall Study|Lost to Follow-up|18|||
156318068|NCT02292784|564264494|FG000|Overall Study|Withdrawal by Subject|0|||
156318069|NCT02292784|564264495|FG001|Overall Study|Withdrawal by Subject|3|||
156318070|NCT02292784|564264496|FG002|Overall Study|Withdrawal by Subject|3|||
156318071|NCT00622739|564264497|FG000|Overall Study|Physician Decision|1|||
156318072|NCT00622739|564264498|FG001|Overall Study|Physician Decision|0|||
156318073|NCT00622739|564264497|FG000|Overall Study|Adverse Event|1|||
156318074|NCT00622739|564264498|FG001|Overall Study|Adverse Event|2|||
156318075|NCT00622739|564264497|FG000|Overall Study|Lack of Efficacy|0|||
156318076|NCT00622739|564264498|FG001|Overall Study|Lack of Efficacy|2|||
156318077|NCT00622739|564264497|FG000|Overall Study|Withdrawal by Subject|0|||
156318078|NCT00622739|564264498|FG001|Overall Study|Withdrawal by Subject|1|||
156318079|NCT00622739|564264497|FG000|Overall Study|Lost to Follow-up|0|||
156318080|NCT00622739|564264498|FG001|Overall Study|Lost to Follow-up|1|||
156318081|NCT02519855|564264499|FG000|Overall Study|Adverse Event|0|||
156318082|NCT02519855|564264500|FG001|Overall Study|Adverse Event|1|||
156318083|NCT02519855|564264499|FG000|Overall Study|Lost to Follow-up|3|||
156318084|NCT02519855|564264500|FG001|Overall Study|Lost to Follow-up|3|||
156318085|NCT02919969|564264501|FG000|Overall Study|Lack of Efficacy|22|||
156318086|NCT02919969|564264501|FG000|Overall Study|Death|4|||
156318087|NCT02919969|564264501|FG000|Overall Study|Physician Decision|3|||
156318088|NCT02919969|564264501|FG000|Overall Study|Withdrawal by Subject|2|||
156318089|NCT03621475|564264502|FG000|Overall Study|No longer required restraints at initiation|0|||
156318090|NCT03621475|564264503|FG001|Overall Study|No longer required restraints at initiation|1|||
156318091|NCT02093351|564264507|FG000|Part A|Adverse Event|0|||
156318092|NCT02093351|564264508|FG001|Part A|Adverse Event|1|||
156318093|NCT02093351|564264509|FG002|Part A|Adverse Event|1|||
156318094|NCT02093351|564264510|FG003|Part A|Adverse Event|0|||
156318095|NCT02093351|564264507|FG000|Part A|Condition under investigation worsened|2|||
156318096|NCT02093351|564264508|FG001|Part A|Condition under investigation worsened|0|||
156318097|NCT02093351|564264509|FG002|Part A|Condition under investigation worsened|2|||
156318098|NCT02093351|564264510|FG003|Part A|Condition under investigation worsened|0|||
156318099|NCT02093351|564264507|FG000|Part A|Death|0|||
156318100|NCT02093351|564264508|FG001|Part A|Death|1|||
156318101|NCT02093351|564264509|FG002|Part A|Death|0|||
156318102|NCT02093351|564264510|FG003|Part A|Death|0|||
156318103|NCT02093351|564264507|FG000|Part B|Patient decision|0|||
156318104|NCT02093351|564264508|FG001|Part B|Patient decision|0|||
156318105|NCT02093351|564264509|FG002|Part B|Patient decision|0|||
156318106|NCT02093351|564264510|FG003|Part B|Patient decision|3|||
156318107|NCT02093351|564264507|FG000|Part B|Disease progression|0|||
156318108|NCT02093351|564264508|FG001|Part B|Disease progression|0|||
156318109|NCT02093351|564264509|FG002|Part B|Disease progression|0|||
156653491|NCT03495869|565478031|FG000|Overall Study|Lost to Follow-up|4|||
156653492|NCT03495869|565478032|FG001|Overall Study|Lost to Follow-up|17|||
156653493|NCT03495869|565478033|FG002|Overall Study|Lost to Follow-up|8|||
156653494|NCT03495869|565478034|FG003|Overall Study|Lost to Follow-up|14|||
156653495|NCT03495869|565478031|FG000|Overall Study|Withdrawal by Subject|0|||
156653496|NCT03495869|565478032|FG001|Overall Study|Withdrawal by Subject|3|||
156653497|NCT03495869|565478033|FG002|Overall Study|Withdrawal by Subject|0|||
156653498|NCT03495869|565478034|FG003|Overall Study|Withdrawal by Subject|3|||
156653499|NCT03495869|565478031|FG000|Overall Study|Dropped from study|0|||
156759048|NCT00753675|565869883|FG001|Overall Study|Withdrawal by Subject|1|||
156759049|NCT00753675|565869884|FG002|Overall Study|Withdrawal by Subject|0|||
156759050|NCT00753675|565869882|FG000|Overall Study|Lost to Follow-up|1|||
156759051|NCT00753675|565869883|FG001|Overall Study|Lost to Follow-up|0|||
156759052|NCT00753675|565869884|FG002|Overall Study|Lost to Follow-up|0|||
156759053|NCT01462110|565869885|FG000|Overall Study|Adverse Event|1|||
156759054|NCT01462110|565869886|FG001|Overall Study|Adverse Event|0|||
156759055|NCT05279131|565869888|FG000|Overall Study|Lost to Follow-up|1|||
156759056|NCT05279131|565869888|FG000|Overall Study|Death|1|||
156759057|NCT05279131|565869888|FG000|Overall Study|Physician Decision|1|||
156759058|NCT00964028|565869894|FG000|Overall Study|Withdrawal by Subject|0|||
156759059|NCT00964028|565869895|FG001|Overall Study|Withdrawal by Subject|1|||
156759060|NCT02106351|565869896|FG000|Treatment Cycle 1|Adverse Event|2|||
156759061|NCT02106351|565869897|FG001|Treatment Cycle 1|Adverse Event|0|||
156759062|NCT02106351|565869898|FG002|Treatment Cycle 1|Adverse Event|0|||
156759063|NCT02106351|565869896|FG000|Treatment Cycle 1|Consent withdrawn|1|||
156759064|NCT02106351|565869897|FG001|Treatment Cycle 1|Consent withdrawn|0|||
156759065|NCT02106351|565869898|FG002|Treatment Cycle 1|Consent withdrawn|2|||
156759066|NCT02106351|565869896|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
156759067|NCT02106351|565869897|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
156759068|NCT02106351|565869898|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
156759069|NCT02106351|565869896|FG000|Treatment Cycle 1|Other|0|||
156759070|NCT02106351|565869897|FG001|Treatment Cycle 1|Other|3|||
156759071|NCT02106351|565869898|FG002|Treatment Cycle 1|Other|1|||
156759072|NCT02106351|565869896|FG000|Treatment Cycle 1|Randomised but not treated|1|||
156759073|NCT02106351|565869897|FG001|Treatment Cycle 1|Randomised but not treated|0|||
156759074|NCT02106351|565869898|FG002|Treatment Cycle 1|Randomised but not treated|1|||
156759075|NCT02106351|565869896|FG000|Treatment Cycle 2|Adverse Event|0|||
156759076|NCT02106351|565869897|FG001|Treatment Cycle 2|Adverse Event|2|||
156759077|NCT02106351|565869898|FG002|Treatment Cycle 2|Adverse Event|0|||
156759078|NCT02106351|565869896|FG000|Treatment Cycle 2|Consent withdrawn|0|||
156759079|NCT02106351|565869897|FG001|Treatment Cycle 2|Consent withdrawn|1|||
156759080|NCT02106351|565869898|FG002|Treatment Cycle 2|Consent withdrawn|1|||
156759081|NCT02106351|565869896|FG000|Treatment Cycle 2|Other|0|||
156759082|NCT02106351|565869897|FG001|Treatment Cycle 2|Other|2|||
156759083|NCT02106351|565869898|FG002|Treatment Cycle 2|Other|2|||
156759084|NCT02106351|565869896|FG000|Treatment Cycle 3|Adverse Event|0|||
156759085|NCT02106351|565869897|FG001|Treatment Cycle 3|Adverse Event|1|||
156759086|NCT02106351|565869898|FG002|Treatment Cycle 3|Adverse Event|0|||
156759087|NCT02106351|565869896|FG000|Treatment Cycle 3|Consent withdrawn|0|||
156759088|NCT02106351|565869897|FG001|Treatment Cycle 3|Consent withdrawn|0|||
156759089|NCT02106351|565869898|FG002|Treatment Cycle 3|Consent withdrawn|2|||
156759090|NCT02106351|565869896|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
156759091|NCT02106351|565869897|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
156759092|NCT02106351|565869898|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
156759093|NCT02106351|565869896|FG000|Treatment Cycle 3|Other|0|||
156759094|NCT02106351|565869897|FG001|Treatment Cycle 3|Other|2|||
156759095|NCT02106351|565869898|FG002|Treatment Cycle 3|Other|3|||
156759096|NCT02106351|565869896|FG000|Treatment Cycle 4|Consent withdrawn|0|||
156759097|NCT02106351|565869897|FG001|Treatment Cycle 4|Consent withdrawn|0|||
156759098|NCT02106351|565869898|FG002|Treatment Cycle 4|Consent withdrawn|2|||
156759099|NCT02106351|565869896|FG000|Treatment Cycle 4|Other|0|||
156759100|NCT02106351|565869897|FG001|Treatment Cycle 4|Other|1|||
156759101|NCT02106351|565869898|FG002|Treatment Cycle 4|Other|0|||
156759102|NCT00069823|565869899|FG000|Overall Study|Did not have follow-up diary cards|6|||
156759103|NCT00069823|565869900|FG001|Overall Study|Did not have follow-up diary cards|3|||
156759104|NCT02058589|565869902|FG000|Overall Study|Serious Adverse Event|1|||
156759105|NCT02058589|565869903|FG001|Overall Study|Serious Adverse Event|1|||
156759106|NCT02058589|565869902|FG000|Overall Study|Non-Serious Adverse Event|1|||
156759107|NCT02058589|565869903|FG001|Overall Study|Non-Serious Adverse Event|0|||
156759108|NCT02058589|565869902|FG000|Overall Study|Withdrawal by Subject|0|||
156759109|NCT02058589|565869903|FG001|Overall Study|Withdrawal by Subject|1|||
156318110|NCT02093351|564264510|FG003|Part B|Disease progression|4|||
156318111|NCT02093351|564264507|FG000|Part B|Complete response|0|||
156318112|NCT02093351|564264508|FG001|Part B|Complete response|0|||
156318113|NCT02093351|564264509|FG002|Part B|Complete response|0|||
156759110|NCT00490971|565869906|FG000|Acute/Continuation|Adverse Event|62|||
156759111|NCT00490971|565869907|FG001|Acute/Continuation|Adverse Event|13|||
156759112|NCT00490971|565869908|FG002|Acute/Continuation|Adverse Event|0|||
156759113|NCT00490971|565869909|FG003|Acute/Continuation|Adverse Event|0|||
156759114|NCT00490971|565869910|FG004|Acute/Continuation|Adverse Event|0|||
156759115|NCT00490971|565869906|FG000|Acute/Continuation|Death|2|||
156759116|NCT00490971|565869907|FG001|Acute/Continuation|Death|0|||
156759117|NCT00490971|565869908|FG002|Acute/Continuation|Death|0|||
156759118|NCT00490971|565869909|FG003|Acute/Continuation|Death|0|||
156759119|NCT00490971|565869910|FG004|Acute/Continuation|Death|0|||
156759120|NCT00490971|565869906|FG000|Acute/Continuation|Lack of Efficacy|106|||
156759121|NCT00490971|565869907|FG001|Acute/Continuation|Lack of Efficacy|12|||
156759122|NCT00490971|565869908|FG002|Acute/Continuation|Lack of Efficacy|0|||
156318114|NCT02093351|564264510|FG003|Part B|Complete response|1|||
156653500|NCT03495869|565478032|FG001|Overall Study|Dropped from study|7|||
156653501|NCT03495869|565478033|FG002|Overall Study|Dropped from study|2|||
156653502|NCT03495869|565478034|FG003|Overall Study|Dropped from study|4|||
156653503|NCT02154529|565478035|FG000|Overall Study|Death|1|||
156653504|NCT02154529|565478036|FG001|Overall Study|Death|1|||
156653505|NCT02154529|565478037|FG002|Overall Study|Death|5|||
156653506|NCT02154529|565478038|FG003|Overall Study|Death|1|||
156653507|NCT02154529|565478035|FG000|Overall Study|Termination of study by sponsor|2|||
156653508|NCT02154529|565478036|FG001|Overall Study|Termination of study by sponsor|2|||
156653509|NCT02154529|565478037|FG002|Overall Study|Termination of study by sponsor|3|||
156653510|NCT02154529|565478038|FG003|Overall Study|Termination of study by sponsor|1|||
156653511|NCT02154529|565478035|FG000|Overall Study|Lost to Follow-up|1|||
156653512|NCT02154529|565478036|FG001|Overall Study|Lost to Follow-up|0|||
156653513|NCT02154529|565478037|FG002|Overall Study|Lost to Follow-up|0|||
156653514|NCT02154529|565478038|FG003|Overall Study|Lost to Follow-up|0|||
156653515|NCT04680052|565479470|FG000|Overall Study|Ongoing|244|||
156653516|NCT04680052|565479471|FG001|Overall Study|Ongoing|229|||
156653517|NCT04680052|565479472|FG002|Overall Study|Ongoing|39|||
156653518|NCT04680052|565479473|FG003|Overall Study|Ongoing|46|||
156653519|NCT04680052|565479470|FG000|Overall Study|Death|15|||
156653520|NCT04680052|565479471|FG001|Overall Study|Death|22|||
156318115|NCT02093351|564264507|FG000|Part B|Adverse event + disease progression|0|||
156318116|NCT02093351|564264508|FG001|Part B|Adverse event + disease progression|0|||
156318117|NCT02093351|564264509|FG002|Part B|Adverse event + disease progression|0|||
156318118|NCT02093351|564264510|FG003|Part B|Adverse event + disease progression|1|||
156318119|NCT02093351|564264507|FG000|Part B|Lack of therapeutic response|0|||
156318120|NCT02093351|564264508|FG001|Part B|Lack of therapeutic response|0|||
156318121|NCT02093351|564264509|FG002|Part B|Lack of therapeutic response|0|||
156318122|NCT02093351|564264510|FG003|Part B|Lack of therapeutic response|12|||
156318123|NCT02093351|564264507|FG000|Part B|Condition under investigation worsened|0|||
156318124|NCT02093351|564264508|FG001|Part B|Condition under investigation worsened|0|||
156318125|NCT02093351|564264509|FG002|Part B|Condition under investigation worsened|0|||
156318126|NCT02093351|564264510|FG003|Part B|Condition under investigation worsened|39|||
156318127|NCT02093351|564264507|FG000|Part B|Adverse Event|0|||
156318128|NCT02093351|564264508|FG001|Part B|Adverse Event|0|||
156318129|NCT02093351|564264509|FG002|Part B|Adverse Event|0|||
156318130|NCT02093351|564264510|FG003|Part B|Adverse Event|2|||
156318131|NCT02093351|564264507|FG000|Part B|Death|0|||
156318132|NCT02093351|564264508|FG001|Part B|Death|0|||
156318133|NCT02093351|564264509|FG002|Part B|Death|0|||
156318134|NCT02093351|564264510|FG003|Part B|Death|1|||
156318135|NCT03565367|564264511|FG000|Overall Study|No scan due to technical issues|4|||
156318136|NCT03565367|564264512|FG001|Overall Study|No scan due to technical issues|0|||
156318137|NCT00706849|564264519|FG000|Treatment Period|Adverse Event|0|||
156318138|NCT00706849|564264520|FG001|Treatment Period|Adverse Event|9|||
156653521|NCT04680052|565479472|FG002|Overall Study|Death|7|||
156653522|NCT04680052|565479473|FG003|Overall Study|Death|1|||
156653523|NCT04680052|565479470|FG000|Overall Study|Lost to Follow-up|3|||
156653524|NCT04680052|565479471|FG001|Overall Study|Lost to Follow-up|2|||
156653525|NCT04680052|565479472|FG002|Overall Study|Lost to Follow-up|0|||
156653526|NCT04680052|565479473|FG003|Overall Study|Lost to Follow-up|1|||
156653527|NCT04680052|565479470|FG000|Overall Study|Withdrawal by Subject|11|||
156653528|NCT04680052|565479471|FG001|Overall Study|Withdrawal by Subject|19|||
156653529|NCT04680052|565479472|FG002|Overall Study|Withdrawal by Subject|7|||
156653530|NCT04680052|565479473|FG003|Overall Study|Withdrawal by Subject|5|||
156653531|NCT04680052|565479470|FG000|Overall Study|Missing|0|||
156653532|NCT04680052|565479471|FG001|Overall Study|Missing|1|||
156653533|NCT04680052|565479472|FG002|Overall Study|Missing|0|||
156653534|NCT04680052|565479473|FG003|Overall Study|Missing|0|||
156653535|NCT04680052|565479470|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
156653536|NCT04680052|565479471|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
156653537|NCT04680052|565479472|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
156653538|NCT04680052|565479473|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
156653539|NCT04680052|565479470|FG000|Overall Study|Physician Decision|0|||
156653540|NCT04680052|565479471|FG001|Overall Study|Physician Decision|1|||
156653541|NCT04680052|565479472|FG002|Overall Study|Physician Decision|0|||
156653542|NCT04680052|565479473|FG003|Overall Study|Physician Decision|0|||
156653543|NCT02146430|565479479|FG000|Overall Study|Protocol Violation|5|||
156653544|NCT02146430|565479480|FG001|Overall Study|Protocol Violation|4|||
156759123|NCT00490971|565869909|FG003|Acute/Continuation|Lack of Efficacy|0|||
156318139|NCT00706849|564264519|FG000|Treatment Period|Other|0|||
156318140|NCT00706849|564264520|FG001|Treatment Period|Other|1|||
156653545|NCT02146430|565479481|FG002|Overall Study|Protocol Violation|8|||
156318141|NCT00706849|564264519|FG000|Follow-up Period|Withdrawal by Subject|0|||
156653546|NCT02146430|565479482|FG003|Overall Study|Protocol Violation|6|||
156653547|NCT02146430|565479479|FG000|Overall Study|Lack of Efficacy|13|||
156653548|NCT02146430|565479480|FG001|Overall Study|Lack of Efficacy|11|||
156653549|NCT02146430|565479481|FG002|Overall Study|Lack of Efficacy|8|||
156653550|NCT02146430|565479482|FG003|Overall Study|Lack of Efficacy|5|||
156759124|NCT00490971|565869910|FG004|Acute/Continuation|Lack of Efficacy|0|||
156759125|NCT00490971|565869906|FG000|Acute/Continuation|Lost to Follow-up|23|||
156759126|NCT00490971|565869907|FG001|Acute/Continuation|Lost to Follow-up|7|||
156759127|NCT00490971|565869908|FG002|Acute/Continuation|Lost to Follow-up|0|||
156759128|NCT00490971|565869909|FG003|Acute/Continuation|Lost to Follow-up|0|||
156759129|NCT00490971|565869910|FG004|Acute/Continuation|Lost to Follow-up|0|||
156419464|NCT01244763|564630073|FG001|Overall Study|Withdrawal by Subject|2|||
156419465|NCT01244763|564630074|FG002|Overall Study|Withdrawal by Subject|0|||
156419466|NCT01244763|564630075|FG003|Overall Study|Withdrawal by Subject|1|||
156419467|NCT01244763|564630076|FG004|Overall Study|Withdrawal by Subject|1|||
156419468|NCT01244763|564630077|FG005|Overall Study|Withdrawal by Subject|2|||
156419469|NCT01244763|564630072|FG000|Overall Study|Lost to Follow-up|0|||
156419470|NCT01244763|564630073|FG001|Overall Study|Lost to Follow-up|1|||
156419471|NCT01244763|564630074|FG002|Overall Study|Lost to Follow-up|0|||
156419472|NCT01244763|564630075|FG003|Overall Study|Lost to Follow-up|0|||
156419473|NCT01244763|564630076|FG004|Overall Study|Lost to Follow-up|0|||
156419474|NCT01244763|564630077|FG005|Overall Study|Lost to Follow-up|0|||
156419475|NCT01244763|564630072|FG000|Overall Study|Enrolled into the Extension Study|0|||
156419476|NCT01244763|564630073|FG001|Overall Study|Enrolled into the Extension Study|0|||
156419477|NCT01244763|564630074|FG002|Overall Study|Enrolled into the Extension Study|0|||
156419478|NCT01244763|564630075|FG003|Overall Study|Enrolled into the Extension Study|0|||
156419479|NCT01244763|564630076|FG004|Overall Study|Enrolled into the Extension Study|0|||
156419480|NCT01244763|564630077|FG005|Overall Study|Enrolled into the Extension Study|1|||
156419481|NCT02271594|564630078|FG000|Overall Study|Study closed; recruiting failure|19|||
156419482|NCT02271594|564630079|FG001|Overall Study|Study closed; recruiting failure|12|||
156419483|NCT04003974|564630090|FG000|Overall Study|Missing|1|||
156759130|NCT00490971|565869906|FG000|Acute/Continuation|Protocol Violation|10|||
156759131|NCT00490971|565869907|FG001|Acute/Continuation|Protocol Violation|2|||
156759132|NCT00490971|565869908|FG002|Acute/Continuation|Protocol Violation|0|||
156759133|NCT00490971|565869909|FG003|Acute/Continuation|Protocol Violation|0|||
156759134|NCT00490971|565869910|FG004|Acute/Continuation|Protocol Violation|0|||
156759135|NCT00490971|565869906|FG000|Acute/Continuation|Withdrawal by Subject|92|||
156759136|NCT00490971|565869907|FG001|Acute/Continuation|Withdrawal by Subject|24|||
156759137|NCT00490971|565869908|FG002|Acute/Continuation|Withdrawal by Subject|0|||
156759138|NCT00490971|565869909|FG003|Acute/Continuation|Withdrawal by Subject|0|||
156759139|NCT00490971|565869910|FG004|Acute/Continuation|Withdrawal by Subject|0|||
156759140|NCT00490971|565869906|FG000|Acute/Continuation|Other|11|||
156759141|NCT00490971|565869907|FG001|Acute/Continuation|Other|4|||
156759142|NCT00490971|565869908|FG002|Acute/Continuation|Other|0|||
156759143|NCT00490971|565869909|FG003|Acute/Continuation|Other|0|||
156759144|NCT00490971|565869910|FG004|Acute/Continuation|Other|0|||
156759145|NCT00490971|565869906|FG000|Maintenance|Adverse Event|0|||
156759146|NCT00490971|565869907|FG001|Maintenance|Adverse Event|0|||
156759147|NCT00490971|565869908|FG002|Maintenance|Adverse Event|4|||
156759148|NCT00490971|565869909|FG003|Maintenance|Adverse Event|5|||
156759149|NCT00490971|565869910|FG004|Maintenance|Adverse Event|7|||
156759150|NCT00490971|565869906|FG000|Maintenance|Death|0|||
156759151|NCT00490971|565869907|FG001|Maintenance|Death|0|||
156759152|NCT00490971|565869908|FG002|Maintenance|Death|0|||
156759153|NCT00490971|565869909|FG003|Maintenance|Death|2|||
156759154|NCT00490971|565869910|FG004|Maintenance|Death|0|||
156759155|NCT00490971|565869906|FG000|Maintenance|Lost to Follow-up|0|||
156759156|NCT00490971|565869907|FG001|Maintenance|Lost to Follow-up|0|||
156759157|NCT00490971|565869908|FG002|Maintenance|Lost to Follow-up|5|||
156759158|NCT00490971|565869909|FG003|Maintenance|Lost to Follow-up|8|||
156759159|NCT00490971|565869910|FG004|Maintenance|Lost to Follow-up|10|||
156759160|NCT00490971|565869906|FG000|Maintenance|Pregnancy|0|||
156759161|NCT00490971|565869907|FG001|Maintenance|Pregnancy|0|||
156759162|NCT00490971|565869908|FG002|Maintenance|Pregnancy|1|||
156759163|NCT00490971|565869909|FG003|Maintenance|Pregnancy|0|||
156759164|NCT00490971|565869910|FG004|Maintenance|Pregnancy|0|||
156419484|NCT04003974|564630091|FG001|Overall Study|Missing|0|||
156759165|NCT00490971|565869906|FG000|Maintenance|Protocol Violation|0|||
156759166|NCT00490971|565869907|FG001|Maintenance|Protocol Violation|0|||
156759167|NCT00490971|565869908|FG002|Maintenance|Protocol Violation|4|||
156759168|NCT00490971|565869909|FG003|Maintenance|Protocol Violation|1|||
156419485|NCT04003974|564630090|FG000|Overall Study|Withdrawal by Subject|0|||
156419486|NCT04003974|564630091|FG001|Overall Study|Withdrawal by Subject|2|||
156419487|NCT02400307|564630092|FG000|Overall Study|Enrolled and Never Dosed|1|||
156419488|NCT02400307|564630093|FG001|Overall Study|Enrolled and Never Dosed|0|||
156419489|NCT01052662|564630096|FG000|Overall Study|Lost to Follow-up|15|||
156759169|NCT00490971|565869910|FG004|Maintenance|Protocol Violation|1|||
156759170|NCT00490971|565869906|FG000|Maintenance|Withdrawal by Subject|0|||
156759171|NCT00490971|565869907|FG001|Maintenance|Withdrawal by Subject|0|||
156759172|NCT00490971|565869908|FG002|Maintenance|Withdrawal by Subject|26|||
156759173|NCT00490971|565869909|FG003|Maintenance|Withdrawal by Subject|28|||
156759174|NCT00490971|565869910|FG004|Maintenance|Withdrawal by Subject|18|||
156759175|NCT00490971|565869906|FG000|Maintenance|Other|0|||
156759176|NCT00490971|565869907|FG001|Maintenance|Other|0|||
156759177|NCT00490971|565869908|FG002|Maintenance|Other|11|||
156759178|NCT00490971|565869909|FG003|Maintenance|Other|9|||
156318142|NCT00706849|564264520|FG001|Follow-up Period|Withdrawal by Subject|2|||
156318143|NCT00706849|564264519|FG000|Follow-up Period|Protocol non-compliance|0|||
156318144|NCT00706849|564264520|FG001|Follow-up Period|Protocol non-compliance|1|||
156318145|NCT01611454|564264522|FG000|Overall Study|Lack of Efficacy|18|||
156318146|NCT01611454|564264523|FG001|Overall Study|Lack of Efficacy|10|||
156318147|NCT00920907|564264524|FG000|Induction Period|Adverse Event|0|||
156653551|NCT02146430|565479479|FG000|Overall Study|Adverse Event|20|||
156653552|NCT02146430|565479480|FG001|Overall Study|Adverse Event|40|||
156653553|NCT02146430|565479481|FG002|Overall Study|Adverse Event|32|||
156653554|NCT02146430|565479482|FG003|Overall Study|Adverse Event|49|||
156653555|NCT02146430|565479479|FG000|Overall Study|Reason missing or not reported|2|||
156653556|NCT02146430|565479480|FG001|Overall Study|Reason missing or not reported|3|||
156653557|NCT02146430|565479481|FG002|Overall Study|Reason missing or not reported|4|||
156653558|NCT02146430|565479482|FG003|Overall Study|Reason missing or not reported|5|||
156653559|NCT02146430|565479479|FG000|Overall Study|Withdrawal by Subject|27|||
156653560|NCT02146430|565479480|FG001|Overall Study|Withdrawal by Subject|29|||
156653561|NCT02146430|565479481|FG002|Overall Study|Withdrawal by Subject|30|||
156653562|NCT02146430|565479482|FG003|Overall Study|Withdrawal by Subject|34|||
156653563|NCT03312530|565479483|FG000|Overall Study|Death|5|||
156653564|NCT03312530|565479484|FG001|Overall Study|Death|5|||
156653565|NCT03312530|565479485|FG002|Overall Study|Death|4|||
156653566|NCT03312530|565479486|FG003|Overall Study|Death|10|||
156653567|NCT03312530|565479487|FG004|Overall Study|Death|8|||
156653568|NCT03312530|565479483|FG000|Overall Study|Lost to Follow-up|0|||
156653569|NCT03312530|565479484|FG001|Overall Study|Lost to Follow-up|0|||
156653570|NCT03312530|565479485|FG002|Overall Study|Lost to Follow-up|0|||
156653571|NCT03312530|565479486|FG003|Overall Study|Lost to Follow-up|1|||
156653572|NCT03312530|565479487|FG004|Overall Study|Lost to Follow-up|0|||
156653573|NCT03312530|565479483|FG000|Overall Study|Participant in another sponsor study.|0|||
156653574|NCT03312530|565479484|FG001|Overall Study|Participant in another sponsor study.|0|||
156653575|NCT03312530|565479485|FG002|Overall Study|Participant in another sponsor study.|0|||
156653576|NCT03312530|565479486|FG003|Overall Study|Participant in another sponsor study.|1|||
156653577|NCT03312530|565479487|FG004|Overall Study|Participant in another sponsor study.|0|||
156653578|NCT03312530|565479483|FG000|Overall Study|Study terminated by sponsor|1|||
156653579|NCT03312530|565479484|FG001|Overall Study|Study terminated by sponsor|0|||
156653580|NCT03312530|565479485|FG002|Overall Study|Study terminated by sponsor|2|||
156653581|NCT03312530|565479486|FG003|Overall Study|Study terminated by sponsor|3|||
156653582|NCT03312530|565479487|FG004|Overall Study|Study terminated by sponsor|7|||
156653583|NCT03312530|565479483|FG000|Overall Study|Withdrawal by Subject|0|||
156653584|NCT03312530|565479484|FG001|Overall Study|Withdrawal by Subject|1|||
156653585|NCT03312530|565479485|FG002|Overall Study|Withdrawal by Subject|0|||
156653586|NCT03312530|565479486|FG003|Overall Study|Withdrawal by Subject|0|||
156653587|NCT03312530|565479487|FG004|Overall Study|Withdrawal by Subject|0|||
156653588|NCT03312530|565479483|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
156653589|NCT03312530|565479484|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
156653590|NCT03312530|565479485|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
156653591|NCT03312530|565479486|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
156653592|NCT03312530|565479487|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
156653593|NCT03093324|565479488|FG000|Overall Study|Adverse Event|4|||
156653594|NCT03093324|565479489|FG001|Overall Study|Adverse Event|15|||
156653595|NCT03093324|565479488|FG000|Overall Study|Lost to Follow-up|1|||
156653596|NCT03093324|565479489|FG001|Overall Study|Lost to Follow-up|0|||
156653597|NCT03093324|565479488|FG000|Overall Study|Protocol Deviation|2|||
156653598|NCT03093324|565479489|FG001|Overall Study|Protocol Deviation|2|||
156653599|NCT03093324|565479488|FG000|Overall Study|Withdrawal by Subject|2|||
156653600|NCT03093324|565479489|FG001|Overall Study|Withdrawal by Subject|2|||
156653601|NCT05342753|565479490|FG000|Overall Study|Withdrawal by Subject|6|||
156653602|NCT05342753|565479490|FG000|Overall Study|Lost to Follow-up|1|||
156653603|NCT04583579|565479492|FG000|Overall Study|Lost to Follow-up|4|||
156653604|NCT02489318|565479493|FG000|Randomized|Withdrawal by Subject|0|||
156653605|NCT02489318|565479494|FG001|Randomized|Withdrawal by Subject|1|||
156653606|NCT02489318|565479493|FG000|Treated|Adverse Event|19|||
156653607|NCT02489318|565479494|FG001|Treated|Adverse Event|62|||
156653608|NCT02489318|565479493|FG000|Treated|Death|13|||
156653609|NCT02489318|565479494|FG001|Treated|Death|11|||
156653610|NCT02489318|565479493|FG000|Treated|Physician Decision|4|||
156653611|NCT02489318|565479494|FG001|Treated|Physician Decision|6|||
156653612|NCT02489318|565479493|FG000|Treated|Protocol Violation|1|||
156653613|NCT02489318|565479494|FG001|Treated|Protocol Violation|2|||
156653614|NCT02489318|565479493|FG000|Treated|Withdrawal by Subject|37|||
156653615|NCT02489318|565479494|FG001|Treated|Withdrawal by Subject|36|||
156653616|NCT02489318|565479493|FG000|Treated|Other: Progressive Disease|245|||
156653617|NCT02489318|565479494|FG001|Treated|Other: Progressive Disease|138|||
156318148|NCT00920907|564264525|FG001|Induction Period|Adverse Event|2|||
156759179|NCT00490971|565869910|FG004|Maintenance|Other|3|||
156759180|NCT00255164|565869912|FG000|Overall Study|Adverse Event|10|||
156759181|NCT00255164|565869913|FG001|Overall Study|Adverse Event|6|||
156759182|NCT00255164|565869914|FG002|Overall Study|Adverse Event|9|||
156759183|NCT00255164|565869912|FG000|Overall Study|Lost to Follow-up|4|||
156759184|NCT00255164|565869913|FG001|Overall Study|Lost to Follow-up|3|||
156759185|NCT00255164|565869914|FG002|Overall Study|Lost to Follow-up|4|||
156759186|NCT00255164|565869912|FG000|Overall Study|Withdrawal by Subject|18|||
156759187|NCT00255164|565869913|FG001|Overall Study|Withdrawal by Subject|17|||
156759188|NCT00255164|565869914|FG002|Overall Study|Withdrawal by Subject|8|||
156759189|NCT00255164|565869912|FG000|Overall Study|Noncompliance|0|||
156759190|NCT00255164|565869913|FG001|Overall Study|Noncompliance|1|||
156759191|NCT00255164|565869914|FG002|Overall Study|Noncompliance|2|||
156759192|NCT00255164|565869912|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
156759193|NCT00255164|565869913|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
156759194|NCT00255164|565869914|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
156759195|NCT00255164|565869912|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
156759196|NCT00255164|565869913|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
156759197|NCT00255164|565869914|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
156759198|NCT00255164|565869912|FG000|Overall Study|Possible Barrett's Esophagus|1|||
156759199|NCT00255164|565869913|FG001|Overall Study|Possible Barrett's Esophagus|3|||
156759200|NCT00255164|565869914|FG002|Overall Study|Possible Barrett's Esophagus|8|||
156759201|NCT00255164|565869912|FG000|Overall Study|Esophageal Stricture|0|||
156759202|NCT00255164|565869913|FG001|Overall Study|Esophageal Stricture|0|||
156759203|NCT00255164|565869914|FG002|Overall Study|Esophageal Stricture|1|||
156759204|NCT00255164|565869912|FG000|Overall Study|Therapeutic Failure|11|||
156759205|NCT00255164|565869913|FG001|Overall Study|Therapeutic Failure|2|||
156759206|NCT00255164|565869914|FG002|Overall Study|Therapeutic Failure|3|||
156759207|NCT02358031|565871950|FG000|Overall Study|Death|253|||
156759208|NCT02358031|565871951|FG001|Overall Study|Death|237|||
156759209|NCT02358031|565871952|FG002|Overall Study|Death|266|||
156759210|NCT02358031|565871950|FG000|Overall Study|Lost to Follow-up|1|||
156759211|NCT02358031|565871951|FG001|Overall Study|Lost to Follow-up|1|||
156759212|NCT02358031|565871952|FG002|Overall Study|Lost to Follow-up|0|||
156759213|NCT02358031|565871950|FG000|Overall Study|Withdrawal by Subject|19|||
156759214|NCT02358031|565871951|FG001|Overall Study|Withdrawal by Subject|14|||
156759215|NCT02358031|565871952|FG002|Overall Study|Withdrawal by Subject|18|||
156759216|NCT02358031|565871950|FG000|Overall Study|Sponsor Decision|26|||
156759217|NCT02358031|565871951|FG001|Overall Study|Sponsor Decision|28|||
156759218|NCT02358031|565871952|FG002|Overall Study|Sponsor Decision|16|||
156759219|NCT01212094|565871953|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
156759220|NCT01212094|565871954|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
156759221|NCT01212094|565871955|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
156759222|NCT01212094|565871953|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
156759223|NCT01212094|565871954|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
156759224|NCT01212094|565871955|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
156759225|NCT01212094|565871953|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
156759226|NCT01212094|565871954|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
156759227|NCT01212094|565871955|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
156759228|NCT01212094|565871953|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
156759229|NCT01212094|565871954|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
156759230|NCT01212094|565871955|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
156759231|NCT01212094|565871953|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
156759232|NCT01212094|565871954|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
156318149|NCT00920907|564264524|FG000|Induction Period|Death|1|||
156318150|NCT00920907|564264525|FG001|Induction Period|Death|1|||
156318151|NCT00920907|564264524|FG000|Induction Period|Disease Progression|12|||
156318152|NCT00920907|564264525|FG001|Induction Period|Disease Progression|11|||
156318153|NCT00920907|564264524|FG000|Induction Period|Study Drug Toxicity|8|||
156318154|NCT00920907|564264525|FG001|Induction Period|Study Drug Toxicity|6|||
156318155|NCT00920907|564264524|FG000|Induction Period|No longer meets study criteria|0|||
156318156|NCT00920907|564264525|FG001|Induction Period|No longer meets study criteria|1|||
156318157|NCT00920907|564264524|FG000|Induction Period|Withdrawal by Subject|1|||
156318158|NCT00920907|564264525|FG001|Induction Period|Withdrawal by Subject|1|||
156318159|NCT00920907|564264524|FG000|Maintenance Period|Disease Progression|3|||
156759233|NCT01212094|565871955|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
156759234|NCT01212094|565871953|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
156318160|NCT00920907|564264525|FG001|Maintenance Period|Disease Progression|7|||
156318161|NCT00920907|564264524|FG000|Maintenance Period|Administrative (study closure)|7|||
156759235|NCT01212094|565871954|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
156759236|NCT01212094|565871955|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
156759237|NCT05664581|565871959|FG000|Overall Study|Withdrawal by Subject|2|||
156759238|NCT03101150|565871962|FG000|Overall Study|Lost to Follow-up|2|||
156759239|NCT03101150|565871963|FG001|Overall Study|Lost to Follow-up|4|||
156759240|NCT03101150|565871962|FG000|Overall Study|Miscarriage|3|||
156759241|NCT03101150|565871963|FG001|Overall Study|Miscarriage|6|||
156759242|NCT01317641|565871969|FG000|Overall Study|Not treated|0|||
156759243|NCT01317641|565871970|FG001|Overall Study|Not treated|0|||
156759244|NCT01317641|565871971|FG002|Overall Study|Not treated|0|||
156759245|NCT01317641|565871972|FG003|Overall Study|Not treated|0|||
156759246|NCT01317641|565871973|FG004|Overall Study|Not treated|0|||
156759247|NCT01317641|565871974|FG005|Overall Study|Not treated|0|||
156759248|NCT01317641|565871975|FG006|Overall Study|Not treated|0|||
156759249|NCT01317641|565871976|FG007|Overall Study|Not treated|1|||
156759250|NCT01317641|565871977|FG008|Overall Study|Not treated|1|||
156759251|NCT01317641|565871969|FG000|Overall Study|Adverse Event|0|||
156759252|NCT01317641|565871970|FG001|Overall Study|Adverse Event|1|||
156759253|NCT01317641|565871971|FG002|Overall Study|Adverse Event|0|||
156759254|NCT01317641|565871972|FG003|Overall Study|Adverse Event|1|||
156759255|NCT01317641|565871973|FG004|Overall Study|Adverse Event|0|||
156759256|NCT01317641|565871974|FG005|Overall Study|Adverse Event|0|||
156759257|NCT01317641|565871975|FG006|Overall Study|Adverse Event|2|||
156759258|NCT01317641|565871976|FG007|Overall Study|Adverse Event|1|||
156759259|NCT01317641|565871977|FG008|Overall Study|Adverse Event|0|||
156759260|NCT01317641|565871969|FG000|Overall Study|Protocol Violation|1|||
156759261|NCT01317641|565871970|FG001|Overall Study|Protocol Violation|0|||
156759262|NCT01317641|565871971|FG002|Overall Study|Protocol Violation|0|||
156759263|NCT01317641|565871972|FG003|Overall Study|Protocol Violation|0|||
156759264|NCT01317641|565871973|FG004|Overall Study|Protocol Violation|0|||
156759265|NCT01317641|565871974|FG005|Overall Study|Protocol Violation|0|||
156759266|NCT01317641|565871975|FG006|Overall Study|Protocol Violation|0|||
156759267|NCT01317641|565871976|FG007|Overall Study|Protocol Violation|0|||
156759268|NCT01317641|565871977|FG008|Overall Study|Protocol Violation|0|||
156759269|NCT01317641|565871969|FG000|Overall Study|Disease progression|0|||
156759270|NCT01317641|565871970|FG001|Overall Study|Disease progression|0|||
156759271|NCT01317641|565871971|FG002|Overall Study|Disease progression|0|||
156759272|NCT01317641|565871972|FG003|Overall Study|Disease progression|0|||
156759273|NCT01317641|565871973|FG004|Overall Study|Disease progression|0|||
156318162|NCT00920907|564264525|FG001|Maintenance Period|Administrative (study closure)|2|||
156318163|NCT00920907|564264524|FG000|Maintenance Period|Study Drug Toxicity|0|||
156318164|NCT00920907|564264525|FG001|Maintenance Period|Study Drug Toxicity|2|||
156318165|NCT00920907|564264524|FG000|Maintenance Period|Death|1|||
156318166|NCT00920907|564264525|FG001|Maintenance Period|Death|1|||
156318167|NCT00920907|564264524|FG000|Maintenance Period|Withdrawal by Subject|1|||
156318168|NCT00920907|564264525|FG001|Maintenance Period|Withdrawal by Subject|0|||
156318169|NCT00920907|564264524|FG000|Maintenance Period|Adverse Event|0|||
156318170|NCT00920907|564264525|FG001|Maintenance Period|Adverse Event|1|||
156318171|NCT02616601|564264526|FG000|Overall Study|Withdrawal by Subject|4|||
156318172|NCT02616601|564264527|FG001|Overall Study|Withdrawal by Subject|4|||
156318173|NCT02616601|564264528|FG002|Overall Study|Withdrawal by Subject|3|||
156318174|NCT02616601|564264526|FG000|Overall Study|Adverse Event|2|||
156318175|NCT02616601|564264527|FG001|Overall Study|Adverse Event|0|||
156318176|NCT02616601|564264528|FG002|Overall Study|Adverse Event|2|||
156318177|NCT02616601|564264526|FG000|Overall Study|Death|1|||
156318178|NCT02616601|564264527|FG001|Overall Study|Death|0|||
156318179|NCT02616601|564264528|FG002|Overall Study|Death|0|||
156318180|NCT02616601|564264526|FG000|Overall Study|Lost to Follow-up|1|||
156318181|NCT02616601|564264527|FG001|Overall Study|Lost to Follow-up|0|||
156318182|NCT02616601|564264528|FG002|Overall Study|Lost to Follow-up|1|||
156318183|NCT02616601|564264526|FG000|Overall Study|Non-Compliance with Test Article|1|||
156318184|NCT02616601|564264527|FG001|Overall Study|Non-Compliance with Test Article|0|||
156318185|NCT02616601|564264528|FG002|Overall Study|Non-Compliance with Test Article|1|||
156318186|NCT00718081|564264529|FG000|Overall Study|Adverse Event|0|||
156759274|NCT01317641|565871974|FG005|Overall Study|Disease progression|0|||
156759275|NCT01317641|565871975|FG006|Overall Study|Disease progression|0|||
156318187|NCT00718081|564264530|FG001|Overall Study|Adverse Event|1|||
156318188|NCT00718081|564264531|FG002|Overall Study|Adverse Event|0|||
156318189|NCT00718081|564264529|FG000|Overall Study|Lack of Efficacy|7|||
156318190|NCT00718081|564264530|FG001|Overall Study|Lack of Efficacy|3|||
156318191|NCT00718081|564264531|FG002|Overall Study|Lack of Efficacy|21|||
156318192|NCT01931670|564264534|FG000|Treatment Period|Exclusionary Medication Received|1|||
156318193|NCT01931670|564264535|FG001|Treatment Period|Exclusionary Medication Received|1|||
156759276|NCT01317641|565871976|FG007|Overall Study|Disease progression|3|||
156759277|NCT01317641|565871977|FG008|Overall Study|Disease progression|4|||
156759278|NCT01317641|565871969|FG000|Overall Study|Withdrawal by Subject|0|||
156318194|NCT01931670|564264536|FG002|Treatment Period|Exclusionary Medication Received|1|||
156318195|NCT01931670|564264534|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
156318196|NCT01931670|564264535|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
156318197|NCT01931670|564264536|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
156318198|NCT01931670|564264534|FG000|Treatment Period|Subject Noncompliant|4|||
156318199|NCT01931670|564264535|FG001|Treatment Period|Subject Noncompliant|9|||
156318200|NCT01931670|564264536|FG002|Treatment Period|Subject Noncompliant|5|||
156759279|NCT01317641|565871970|FG001|Overall Study|Withdrawal by Subject|0|||
156759280|NCT01317641|565871971|FG002|Overall Study|Withdrawal by Subject|0|||
156759281|NCT01317641|565871972|FG003|Overall Study|Withdrawal by Subject|0|||
156419490|NCT01052662|564630097|FG001|Overall Study|Lost to Follow-up|13|||
156419491|NCT01052662|564630098|FG002|Overall Study|Lost to Follow-up|18|||
156419492|NCT01052662|564630096|FG000|Overall Study|Withdrawal by Subject|3|||
156419493|NCT01052662|564630097|FG001|Overall Study|Withdrawal by Subject|2|||
156419494|NCT01052662|564630098|FG002|Overall Study|Withdrawal by Subject|1|||
156419495|NCT01052662|564630096|FG000|Overall Study|Pharmacy issue|1|||
156419496|NCT01052662|564630097|FG001|Overall Study|Pharmacy issue|3|||
156419497|NCT01052662|564630098|FG002|Overall Study|Pharmacy issue|3|||
156419498|NCT01052662|564630096|FG000|Overall Study|Adverse Event|1|||
156419499|NCT01052662|564630097|FG001|Overall Study|Adverse Event|1|||
156419500|NCT01052662|564630098|FG002|Overall Study|Adverse Event|0|||
156419501|NCT01052662|564630096|FG000|Overall Study|Legal Problem|2|||
156419502|NCT01052662|564630097|FG001|Overall Study|Legal Problem|0|||
156419503|NCT01052662|564630098|FG002|Overall Study|Legal Problem|0|||
156419504|NCT01052662|564630096|FG000|Overall Study|Administrative|0|||
156419505|NCT01052662|564630097|FG001|Overall Study|Administrative|3|||
156419506|NCT01052662|564630098|FG002|Overall Study|Administrative|0|||
156419507|NCT02015663|564630100|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
156419508|NCT02015663|564630101|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
156419509|NCT02015663|564630100|FG000|Overall Study|Withdrawal by Subject|1|||
156759282|NCT01317641|565871973|FG004|Overall Study|Withdrawal by Subject|0|||
156759283|NCT01317641|565871974|FG005|Overall Study|Withdrawal by Subject|0|||
156759284|NCT01317641|565871975|FG006|Overall Study|Withdrawal by Subject|1|||
156759285|NCT01317641|565871976|FG007|Overall Study|Withdrawal by Subject|0|||
156759286|NCT01317641|565871977|FG008|Overall Study|Withdrawal by Subject|0|||
156759287|NCT04980014|565871978|FG000|Overall Study|Participants who are Duplicated|1|||
156759288|NCT04980014|565871978|FG000|Overall Study|Follow-up Failure|13|||
156759289|NCT04980014|565871978|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
156759290|NCT04980014|565871978|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
156759291|NCT04980014|565871978|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
156759292|NCT00715559|565871979|FG000|Overall Study|medication not tolerated - nausea|1|||
156759293|NCT01302418|565871980|FG000|Overall Study|Protocol Violation|9|||
156759294|NCT01302418|565871980|FG000|Overall Study|Non-evaluable|9|||
156759295|NCT02787304|565871985|FG000|Overall Study|Adverse Event|9|||
156759296|NCT02787304|565871986|FG001|Overall Study|Adverse Event|3|||
156759297|NCT02787304|565871987|FG002|Overall Study|Adverse Event|8|||
156759298|NCT02787304|565871988|FG003|Overall Study|Adverse Event|1|||
156759299|NCT02787304|565871985|FG000|Overall Study|Withdrawal by Subject|1|||
156759300|NCT02787304|565871986|FG001|Overall Study|Withdrawal by Subject|4|||
156759301|NCT02787304|565871987|FG002|Overall Study|Withdrawal by Subject|0|||
156759302|NCT02787304|565871988|FG003|Overall Study|Withdrawal by Subject|0|||
156759303|NCT02787304|565871985|FG000|Overall Study|Lost to Follow-up|1|||
156759304|NCT02787304|565871986|FG001|Overall Study|Lost to Follow-up|0|||
156759305|NCT02787304|565871987|FG002|Overall Study|Lost to Follow-up|0|||
156759306|NCT02787304|565871988|FG003|Overall Study|Lost to Follow-up|1|||
156759307|NCT02787304|565871985|FG000|Overall Study|Noncompliance with study drug|0|||
156759308|NCT02787304|565871986|FG001|Overall Study|Noncompliance with study drug|0|||
156759309|NCT02787304|565871987|FG002|Overall Study|Noncompliance with study drug|1|||
156759310|NCT02787304|565871988|FG003|Overall Study|Noncompliance with study drug|0|||
156759311|NCT02787304|565871985|FG000|Overall Study|Physician Decision|0|||
156759312|NCT02787304|565871986|FG001|Overall Study|Physician Decision|0|||
156759313|NCT02787304|565871987|FG002|Overall Study|Physician Decision|1|||
156759314|NCT02787304|565871988|FG003|Overall Study|Physician Decision|0|||
156759315|NCT02787304|565871985|FG000|Overall Study|Study terminated by sponsor|25|||
156759316|NCT02787304|565871986|FG001|Overall Study|Study terminated by sponsor|31|||
156759317|NCT02787304|565871987|FG002|Overall Study|Study terminated by sponsor|31|||
156759318|NCT02787304|565871988|FG003|Overall Study|Study terminated by sponsor|32|||
156759319|NCT04771013|565871992|FG000|Overall Study|Withdrawal by Subject|2|||
156759320|NCT04771013|565871993|FG001|Overall Study|Withdrawal by Subject|0|||
156759321|NCT04771013|565871992|FG000|Overall Study|Death|0|||
156759322|NCT04771013|565871993|FG001|Overall Study|Death|5|||
156419510|NCT02015663|564630101|FG001|Overall Study|Withdrawal by Subject|0|||
156419511|NCT02015663|564630100|FG000|Overall Study|Protocol Violation|0|||
156759323|NCT04771013|565871992|FG000|Overall Study|Referred to another hospital before day 20|0|||
156419512|NCT02015663|564630101|FG001|Overall Study|Protocol Violation|1|||
156419513|NCT02015663|564630100|FG000|Overall Study|Adverse Event|3|||
156419514|NCT02015663|564630101|FG001|Overall Study|Adverse Event|0|||
156419515|NCT02015663|564630100|FG000|Overall Study|Administrative problems|10|||
156419516|NCT02015663|564630101|FG001|Overall Study|Administrative problems|11|||
156759324|NCT04771013|565871993|FG001|Overall Study|Referred to another hospital before day 20|1|||
156759325|NCT00419757|565871995|FG000|Overall Study|Adverse Event|1|||
156759326|NCT00419757|565871996|FG001|Overall Study|Adverse Event|4|||
156759327|NCT00419757|565871995|FG000|Overall Study|Lost to Follow-up|1|||
156759328|NCT00419757|565871996|FG001|Overall Study|Lost to Follow-up|4|||
156759329|NCT00419757|565871995|FG000|Overall Study|Withdrawal by Subject|7|||
156759330|NCT00419757|565871996|FG001|Overall Study|Withdrawal by Subject|1|||
156653618|NCT02489318|565479493|FG000|Treated|Other|0|||
156653619|NCT02489318|565479494|FG001|Treated|Other|2|||
156653620|NCT02489318|565479493|FG000|Treated|Ongoing|0|||
156653621|NCT02489318|565479494|FG001|Treated|Ongoing|267|||
156653622|NCT05218655|565479495|FG000|Overall Study|Adverse Event|6|||
156653623|NCT05218655|565479495|FG000|Overall Study|Sponsor's decision|85|||
156653624|NCT05218655|565479495|FG000|Overall Study|Death|1|||
156653625|NCT05218655|565479495|FG000|Overall Study|Lost to Follow-up|3|||
156653626|NCT05218655|565479495|FG000|Overall Study|Withdrawal by Subject|3|||
156318201|NCT01931670|564264534|FG000|Treatment Period|Adverse Event|19|||
156318202|NCT01931670|564264535|FG001|Treatment Period|Adverse Event|8|||
156318203|NCT01931670|564264536|FG002|Treatment Period|Adverse Event|21|||
156318204|NCT01931670|564264534|FG000|Treatment Period|Lack of Efficacy|11|||
156653627|NCT05218655|565479495|FG000|Overall Study|Other than specified|3|||
156653628|NCT04700449|565479498|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
156653629|NCT04700449|565479499|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
156653630|NCT04700449|565479500|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
156653631|NCT04700449|565479501|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
156653632|NCT04700449|565479498|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
156653633|NCT04700449|565479499|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
156653634|NCT04700449|565479500|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
156318205|NCT01931670|564264535|FG001|Treatment Period|Lack of Efficacy|2|||
156318206|NCT01931670|564264536|FG002|Treatment Period|Lack of Efficacy|2|||
156318207|NCT01931670|564264534|FG000|Treatment Period|Pregnancy|7|||
156318208|NCT01931670|564264535|FG001|Treatment Period|Pregnancy|2|||
156318209|NCT01931670|564264536|FG002|Treatment Period|Pregnancy|0|||
156318210|NCT01931670|564264534|FG000|Treatment Period|Other|8|||
156318211|NCT01931670|564264535|FG001|Treatment Period|Other|7|||
156318212|NCT01931670|564264536|FG002|Treatment Period|Other|2|||
156318213|NCT01931670|564264534|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
156653635|NCT04700449|565479501|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
156653636|NCT04700449|565479498|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
156653637|NCT04700449|565479499|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
156653638|NCT04700449|565479500|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
156653639|NCT04700449|565479501|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
156759331|NCT00419757|565871995|FG000|Overall Study|Protocol Violation|2|||
156759332|NCT00419757|565871996|FG001|Overall Study|Protocol Violation|3|||
156759333|NCT00419757|565871995|FG000|Overall Study|Study specific discontinuation criteria|4|||
156759334|NCT00419757|565871996|FG001|Overall Study|Study specific discontinuation criteria|8|||
156759335|NCT00419757|565871995|FG000|Overall Study|Multiple reasons|3|||
156759336|NCT00419757|565871996|FG001|Overall Study|Multiple reasons|1|||
156759337|NCT01051921|565871997|FG000|Overall Study|Physician Decision|9|||
156759338|NCT01051921|565871997|FG000|Overall Study|Adverse Event|8|||
156759339|NCT01051921|565871997|FG000|Overall Study|Withdrawal by Subject|7|||
156759340|NCT01051921|565871997|FG000|Overall Study|Lost to Follow-up|4|||
156759341|NCT01051921|565871997|FG000|Overall Study|virological failure|1|||
156759342|NCT01051921|565871997|FG000|Overall Study|patient moved|1|||
156759343|NCT00379834|565872001|FG000|Overall Study|Time constraints|2|||
156759344|NCT01519817|565872002|FG000|Overall Study|Withdrawal by Subject|1|||
156318214|NCT01931670|564264535|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
156318215|NCT01931670|564264536|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
156318216|NCT01931670|564264534|FG000|Treatment Period|Lost to Follow-up|19|||
156318217|NCT01931670|564264535|FG001|Treatment Period|Lost to Follow-up|5|||
156318218|NCT01931670|564264536|FG002|Treatment Period|Lost to Follow-up|7|||
156318219|NCT01931670|564264534|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
156318220|NCT01931670|564264535|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
156318221|NCT01931670|564264536|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
156318222|NCT01931670|564264534|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
156318223|NCT01931670|564264535|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
156318224|NCT01931670|564264536|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
156318225|NCT01931670|564264534|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
156318226|NCT01931670|564264535|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
156318227|NCT01931670|564264536|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
156318228|NCT01931670|564264534|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
156318229|NCT01931670|564264535|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
156318230|NCT01931670|564264536|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
156653640|NCT04700449|565479498|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
156653641|NCT04700449|565479499|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
156759345|NCT01519817|565872003|FG001|Overall Study|Withdrawal by Subject|0|||
156318231|NCT01931670|564264534|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
156318232|NCT01931670|564264535|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
156653642|NCT04700449|565479500|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
156653643|NCT04700449|565479501|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
156759346|NCT01519817|565872004|FG002|Overall Study|Withdrawal by Subject|0|||
156759347|NCT01519817|565872005|FG003|Overall Study|Withdrawal by Subject|0|||
156759348|NCT01519817|565872002|FG000|Overall Study|Off study due to infection|0|||
156759349|NCT01519817|565872003|FG001|Overall Study|Off study due to infection|0|||
156759350|NCT01519817|565872004|FG002|Overall Study|Off study due to infection|0|||
156759351|NCT01519817|565872005|FG003|Overall Study|Off study due to infection|1|||
156759352|NCT01325350|565872008|FG000|Overall Study|Adverse Event|3|||
156759353|NCT01325350|565872009|FG001|Overall Study|Adverse Event|3|||
156759354|NCT01325350|565872010|FG002|Overall Study|Adverse Event|3|||
156759355|NCT01325350|565872011|FG003|Overall Study|Adverse Event|1|||
156759356|NCT01325350|565872012|FG004|Overall Study|Adverse Event|2|||
156759357|NCT01325350|565872008|FG000|Overall Study|Pregnancy|0|||
156759358|NCT01325350|565872009|FG001|Overall Study|Pregnancy|0|||
156759359|NCT01325350|565872010|FG002|Overall Study|Pregnancy|1|||
156759360|NCT01325350|565872011|FG003|Overall Study|Pregnancy|0|||
156759361|NCT01325350|565872012|FG004|Overall Study|Pregnancy|1|||
156759362|NCT01325350|565872008|FG000|Overall Study|Lost to Follow-up|1|||
156759363|NCT01325350|565872009|FG001|Overall Study|Lost to Follow-up|0|||
156759364|NCT01325350|565872010|FG002|Overall Study|Lost to Follow-up|5|||
156759365|NCT01325350|565872011|FG003|Overall Study|Lost to Follow-up|1|||
156759366|NCT01325350|565872012|FG004|Overall Study|Lost to Follow-up|5|||
156759367|NCT01325350|565872008|FG000|Overall Study|Personal Reasons|2|||
156759368|NCT01325350|565872009|FG001|Overall Study|Personal Reasons|1|||
156759369|NCT01325350|565872010|FG002|Overall Study|Personal Reasons|6|||
156759370|NCT01325350|565872011|FG003|Overall Study|Personal Reasons|5|||
156759371|NCT01325350|565872012|FG004|Overall Study|Personal Reasons|3|||
156759372|NCT01325350|565872008|FG000|Overall Study|Protocol Violation|0|||
156759373|NCT01325350|565872009|FG001|Overall Study|Protocol Violation|0|||
156759374|NCT01325350|565872010|FG002|Overall Study|Protocol Violation|0|||
156759375|NCT01325350|565872011|FG003|Overall Study|Protocol Violation|1|||
156759376|NCT01325350|565872012|FG004|Overall Study|Protocol Violation|0|||
156759377|NCT01325350|565872008|FG000|Overall Study|Withdrawal by Subject|0|||
156759378|NCT01325350|565872009|FG001|Overall Study|Withdrawal by Subject|0|||
156759379|NCT01325350|565872010|FG002|Overall Study|Withdrawal by Subject|1|||
156759380|NCT01325350|565872011|FG003|Overall Study|Withdrawal by Subject|1|||
156759381|NCT01325350|565872012|FG004|Overall Study|Withdrawal by Subject|0|||
156759382|NCT01325350|565872008|FG000|Overall Study|Did Not Receive Treatment|0|||
156759383|NCT01325350|565872009|FG001|Overall Study|Did Not Receive Treatment|1|||
156759384|NCT01325350|565872010|FG002|Overall Study|Did Not Receive Treatment|1|||
156759385|NCT01325350|565872011|FG003|Overall Study|Did Not Receive Treatment|0|||
156759386|NCT01325350|565872012|FG004|Overall Study|Did Not Receive Treatment|1|||
156759387|NCT01716806|565872017|FG000|Overall Study|Patient withdrawal of consent|4|||
156759388|NCT01716806|565872018|FG001|Overall Study|Patient withdrawal of consent|2|||
156759389|NCT01716806|565872019|FG002|Overall Study|Patient withdrawal of consent|4|||
156759390|NCT01716806|565872020|FG003|Overall Study|Patient withdrawal of consent|3|||
156759391|NCT01716806|565872021|FG004|Overall Study|Patient withdrawal of consent|2|||
156759392|NCT01716806|565872022|FG005|Overall Study|Patient withdrawal of consent|0|||
156759393|NCT01716806|565872017|FG000|Overall Study|Lost to Follow-up|3|||
156759394|NCT01716806|565872018|FG001|Overall Study|Lost to Follow-up|3|||
156759395|NCT01716806|565872019|FG002|Overall Study|Lost to Follow-up|0|||
156759396|NCT01716806|565872020|FG003|Overall Study|Lost to Follow-up|2|||
156759397|NCT01716806|565872021|FG004|Overall Study|Lost to Follow-up|1|||
156759398|NCT01716806|565872022|FG005|Overall Study|Lost to Follow-up|0|||
156759399|NCT01716806|565872017|FG000|Overall Study|Death|13|||
156759400|NCT01716806|565872018|FG001|Overall Study|Death|9|||
156759401|NCT01716806|565872019|FG002|Overall Study|Death|12|||
156759402|NCT01716806|565872020|FG003|Overall Study|Death|4|||
156759403|NCT01716806|565872021|FG004|Overall Study|Death|10|||
156759404|NCT01716806|565872022|FG005|Overall Study|Death|5|||
156759405|NCT01716806|565872017|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
156759406|NCT01716806|565872018|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
156759407|NCT01716806|565872019|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
156759408|NCT01716806|565872020|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
156759409|NCT01716806|565872021|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
156759410|NCT01716806|565872022|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
156759411|NCT01716806|565872017|FG000|Overall Study|PI decision|0|||
156759412|NCT01716806|565872018|FG001|Overall Study|PI decision|0|||
156759413|NCT01716806|565872019|FG002|Overall Study|PI decision|0|||
156759414|NCT01716806|565872020|FG003|Overall Study|PI decision|0|||
156759415|NCT01716806|565872021|FG004|Overall Study|PI decision|1|||
156759416|NCT01716806|565872022|FG005|Overall Study|PI decision|0|||
156759417|NCT01716806|565872017|FG000|Overall Study|Change in performance status|1|||
156759418|NCT01716806|565872018|FG001|Overall Study|Change in performance status|0|||
156759419|NCT01716806|565872019|FG002|Overall Study|Change in performance status|0|||
156759420|NCT01716806|565872020|FG003|Overall Study|Change in performance status|0|||
156759421|NCT01716806|565872021|FG004|Overall Study|Change in performance status|0|||
156759422|NCT01716806|565872022|FG005|Overall Study|Change in performance status|0|||
156759423|NCT01716806|565872017|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759424|NCT01716806|565872018|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759425|NCT01716806|565872019|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
156759426|NCT01716806|565872020|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759427|NCT01716806|565872021|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759428|NCT01716806|565872022|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759429|NCT01716806|565872017|FG000|Overall Study|Sponsor direction|7|||
156759430|NCT01716806|565872018|FG001|Overall Study|Sponsor direction|8|||
156759431|NCT01716806|565872019|FG002|Overall Study|Sponsor direction|5|||
156759432|NCT01716806|565872020|FG003|Overall Study|Sponsor direction|12|||
156759433|NCT01716806|565872021|FG004|Overall Study|Sponsor direction|16|||
156759434|NCT01716806|565872022|FG005|Overall Study|Sponsor direction|1|||
156759435|NCT03934216|565872025|FG000|Overall Study|Other Reasons|5|||
156759436|NCT03934216|565872026|FG001|Overall Study|Other Reasons|5|||
156759437|NCT03934216|565872025|FG000|Overall Study|Adverse Event|22|||
156759438|NCT03934216|565872026|FG001|Overall Study|Adverse Event|11|||
156759439|NCT03934216|565872025|FG000|Overall Study|Lack of Efficacy|8|||
156759440|NCT03934216|565872026|FG001|Overall Study|Lack of Efficacy|7|||
156759441|NCT03934216|565872025|FG000|Overall Study|Lost to Follow-up|2|||
156759442|NCT03934216|565872026|FG001|Overall Study|Lost to Follow-up|0|||
156759443|NCT03934216|565872025|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156759444|NCT03934216|565872026|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156759445|NCT03934216|565872025|FG000|Overall Study|Pregnancy|1|||
156759446|NCT03934216|565872026|FG001|Overall Study|Pregnancy|0|||
156759447|NCT03934216|565872025|FG000|Overall Study|Withdrawal by Subject|18|||
156759448|NCT03934216|565872026|FG001|Overall Study|Withdrawal by Subject|6|||
156759449|NCT03934216|565872025|FG000|Overall Study|Randomized but not treated|1|||
156759450|NCT03934216|565872026|FG001|Overall Study|Randomized but not treated|1|||
156759451|NCT01396083|565872032|FG000|Overall Study|Adverse Event|2|||
156759452|NCT01396083|565872033|FG001|Overall Study|Adverse Event|28|||
156759453|NCT01396083|565872032|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156759454|NCT01396083|565872033|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
156759455|NCT01396083|565872032|FG000|Overall Study|Consent withdrawn|4|||
156759456|NCT01396083|565872033|FG001|Overall Study|Consent withdrawn|5|||
156759457|NCT01396083|565872032|FG000|Overall Study|Protocol deviation(s)|0|||
156759458|NCT01396083|565872033|FG001|Overall Study|Protocol deviation(s)|1|||
156759459|NCT01396083|565872032|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156759460|NCT01396083|565872033|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156759461|NCT01396083|565872032|FG000|Overall Study|Administrative problems|1|||
156759462|NCT01396083|565872033|FG001|Overall Study|Administrative problems|0|||
156759463|NCT01396083|565872032|FG000|Overall Study|Lost to Follow-up|1|||
156759464|NCT01396083|565872033|FG001|Overall Study|Lost to Follow-up|0|||
156759465|NCT00619827|565872034|FG000|Overall Study|Adverse Event|1|||
156759466|NCT00619827|565872035|FG001|Overall Study|Adverse Event|2|||
156759467|NCT00619827|565872034|FG000|Overall Study|Withdrawal by Subject|2|||
156759468|NCT00619827|565872035|FG001|Overall Study|Withdrawal by Subject|2|||
156759469|NCT01063855|565872037|FG000|Overall Study|Adverse Event|4|||
156759470|NCT01063855|565872038|FG001|Overall Study|Adverse Event|4|||
156759471|NCT01063855|565872037|FG000|Overall Study|Death|0|||
156759472|NCT01063855|565872038|FG001|Overall Study|Death|1|||
156759473|NCT01063855|565872037|FG000|Overall Study|Lost to Follow-up|8|||
156759474|NCT01063855|565872038|FG001|Overall Study|Lost to Follow-up|4|||
156759475|NCT01063855|565872037|FG000|Overall Study|Pregnancy|1|||
156759476|NCT01063855|565872038|FG001|Overall Study|Pregnancy|0|||
156759477|NCT01063855|565872037|FG000|Overall Study|Lack of Efficacy|0|||
156759478|NCT01063855|565872038|FG001|Overall Study|Lack of Efficacy|1|||
156759479|NCT01063855|565872037|FG000|Overall Study|Withdrawal by Subject|11|||
156759480|NCT01063855|565872038|FG001|Overall Study|Withdrawal by Subject|8|||
156759481|NCT01063855|565872037|FG000|Overall Study|Reason not specified|13|||
156759482|NCT01063855|565872038|FG001|Overall Study|Reason not specified|11|||
156759483|NCT00735709|565872039|FG000|Overall Study|Adverse Event|2|||
156759484|NCT00735709|565872040|FG001|Overall Study|Adverse Event|3|||
156759485|NCT00735709|565872041|FG002|Overall Study|Adverse Event|1|||
156759486|NCT00735709|565872042|FG003|Overall Study|Adverse Event|5|||
156759487|NCT00735709|565872039|FG000|Overall Study|Lack of Efficacy|8|||
156759488|NCT00735709|565872040|FG001|Overall Study|Lack of Efficacy|4|||
156759489|NCT00735709|565872041|FG002|Overall Study|Lack of Efficacy|2|||
156759490|NCT00735709|565872042|FG003|Overall Study|Lack of Efficacy|3|||
156759491|NCT00735709|565872039|FG000|Overall Study|Noncompliance|0|||
156759492|NCT00735709|565872040|FG001|Overall Study|Noncompliance|0|||
156759493|NCT00735709|565872041|FG002|Overall Study|Noncompliance|1|||
156759494|NCT00735709|565872042|FG003|Overall Study|Noncompliance|0|||
156759495|NCT00735709|565872039|FG000|Overall Study|Protocol deviations|1|||
156759496|NCT00735709|565872040|FG001|Overall Study|Protocol deviations|2|||
156759497|NCT00735709|565872041|FG002|Overall Study|Protocol deviations|1|||
156759498|NCT00735709|565872042|FG003|Overall Study|Protocol deviations|1|||
156759499|NCT00735709|565872039|FG000|Overall Study|Voluntary Withdrawal|1|||
156759500|NCT00735709|565872040|FG001|Overall Study|Voluntary Withdrawal|3|||
156759501|NCT00735709|565872041|FG002|Overall Study|Voluntary Withdrawal|5|||
156759502|NCT00735709|565872042|FG003|Overall Study|Voluntary Withdrawal|7|||
156759503|NCT00735709|565872039|FG000|Overall Study|Lost to Follow-up|0|||
156759504|NCT00735709|565872040|FG001|Overall Study|Lost to Follow-up|1|||
156759505|NCT00735709|565872041|FG002|Overall Study|Lost to Follow-up|1|||
156759506|NCT00735709|565872042|FG003|Overall Study|Lost to Follow-up|1|||
156759507|NCT00735709|565872039|FG000|Overall Study|Excluded medication|1|||
156759508|NCT00735709|565872040|FG001|Overall Study|Excluded medication|0|||
156759509|NCT00735709|565872041|FG002|Overall Study|Excluded medication|0|||
156759510|NCT00735709|565872042|FG003|Overall Study|Excluded medication|1|||
156759511|NCT01165307|565872043|FG000|Overall Study|Lost to Follow-up|11|||
156759512|NCT01165307|565872044|FG001|Overall Study|Lost to Follow-up|3|||
156759513|NCT01165307|565872043|FG000|Overall Study|Withdrawal by Subject|2|||
156759514|NCT01165307|565872044|FG001|Overall Study|Withdrawal by Subject|0|||
156759515|NCT01165307|565872043|FG000|Overall Study|Subject not available for contact|1|||
156759516|NCT01165307|565872044|FG001|Overall Study|Subject not available for contact|0|||
156759517|NCT03234036|565872046|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
156759518|NCT03234036|565872047|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
156759519|NCT03234036|565872048|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
156759520|NCT03234036|565872049|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
156759521|NCT02163395|565872054|FG000|Overall Study|Withdrawal by Subject|1|||
156759522|NCT02163395|565872054|FG000|Overall Study|Lost to Follow-up|3|||
156759523|NCT02163395|565872054|FG000|Overall Study|Adverse Event|1|||
156759524|NCT02683239|565872072|FG000|Overall Study|Protocol Violation|35|||
156759525|NCT02683239|565872073|FG001|Overall Study|Protocol Violation|23|||
156759526|NCT02683239|565872074|FG002|Overall Study|Protocol Violation|26|||
156759527|NCT02683239|565872075|FG003|Overall Study|Protocol Violation|4|||
156759528|NCT02683239|565872076|FG004|Overall Study|Protocol Violation|35|||
156759529|NCT02683239|565872077|FG005|Overall Study|Protocol Violation|4|||
156759530|NCT02683239|565872078|FG006|Overall Study|Protocol Violation|5|||
156759531|NCT02683239|565872072|FG000|Overall Study|Adverse Event|64|||
156759532|NCT02683239|565872073|FG001|Overall Study|Adverse Event|39|||
156759533|NCT02683239|565872074|FG002|Overall Study|Adverse Event|42|||
156759534|NCT02683239|565872075|FG003|Overall Study|Adverse Event|16|||
156759535|NCT02683239|565872076|FG004|Overall Study|Adverse Event|189|||
156759536|NCT02683239|565872077|FG005|Overall Study|Adverse Event|9|||
156759537|NCT02683239|565872078|FG006|Overall Study|Adverse Event|9|||
156759538|NCT02683239|565872072|FG000|Overall Study|Physician Decision|38|||
156759539|NCT02683239|565872073|FG001|Overall Study|Physician Decision|19|||
156759540|NCT02683239|565872074|FG002|Overall Study|Physician Decision|14|||
156759541|NCT02683239|565872075|FG003|Overall Study|Physician Decision|73|||
156759542|NCT02683239|565872076|FG004|Overall Study|Physician Decision|143|||
156759543|NCT02683239|565872077|FG005|Overall Study|Physician Decision|14|||
156759544|NCT02683239|565872078|FG006|Overall Study|Physician Decision|15|||
156759545|NCT02683239|565872072|FG000|Overall Study|Withdrawal by Subject|187|||
156759546|NCT02683239|565872073|FG001|Overall Study|Withdrawal by Subject|99|||
156759547|NCT02683239|565872074|FG002|Overall Study|Withdrawal by Subject|91|||
156759548|NCT02683239|565872075|FG003|Overall Study|Withdrawal by Subject|18|||
156759549|NCT02683239|565872076|FG004|Overall Study|Withdrawal by Subject|248|||
156759550|NCT02683239|565872077|FG005|Overall Study|Withdrawal by Subject|22|||
156318233|NCT01931670|564264536|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
156318234|NCT01931670|564264534|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
156318235|NCT01931670|564264535|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
156318236|NCT01931670|564264536|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
156318237|NCT00815516|564264537|FG000|Overall Study|Death|3|||
156318238|NCT00815516|564264538|FG001|Overall Study|Death|1|||
156318239|NCT00815516|564264537|FG000|Overall Study|Physician Decision|1|||
156318240|NCT00815516|564264538|FG001|Overall Study|Physician Decision|0|||
156318241|NCT01992159|564264548|FG000|Overall Study|Withdrawal by Subject|4|||
156318242|NCT01992159|564264549|FG001|Overall Study|Withdrawal by Subject|7|||
156759551|NCT02683239|565872078|FG006|Overall Study|Withdrawal by Subject|28|||
156759552|NCT02683239|565872072|FG000|Overall Study|Lost to Follow-up|77|||
156759553|NCT02683239|565872073|FG001|Overall Study|Lost to Follow-up|24|||
156759554|NCT02683239|565872074|FG002|Overall Study|Lost to Follow-up|25|||
156759555|NCT02683239|565872075|FG003|Overall Study|Lost to Follow-up|7|||
156759556|NCT02683239|565872076|FG004|Overall Study|Lost to Follow-up|88|||
156759557|NCT02683239|565872077|FG005|Overall Study|Lost to Follow-up|8|||
156759558|NCT02683239|565872078|FG006|Overall Study|Lost to Follow-up|11|||
156759559|NCT02683239|565872072|FG000|Overall Study|Death|9|||
156759560|NCT02683239|565872073|FG001|Overall Study|Death|5|||
156759561|NCT02683239|565872074|FG002|Overall Study|Death|8|||
156759562|NCT02683239|565872075|FG003|Overall Study|Death|0|||
156318243|NCT01992159|564264550|FG002|Overall Study|Withdrawal by Subject|0|||
156318244|NCT01992159|564264551|FG003|Overall Study|Withdrawal by Subject|3|||
156318245|NCT01992159|564264548|FG000|Overall Study|Adverse Event|0|||
156759563|NCT02683239|565872076|FG004|Overall Study|Death|12|||
156759564|NCT02683239|565872077|FG005|Overall Study|Death|1|||
156759565|NCT02683239|565872078|FG006|Overall Study|Death|0|||
156759566|NCT02683239|565872072|FG000|Overall Study|Lack of Efficacy|50|||
156759567|NCT02683239|565872073|FG001|Overall Study|Lack of Efficacy|23|||
156759568|NCT02683239|565872074|FG002|Overall Study|Lack of Efficacy|12|||
156419517|NCT00479674|564630103|FG000|Overall Study|Adverse Event|18|||
156419518|NCT00479674|564630103|FG000|Overall Study|Withdrawal by Subject|6|||
156419519|NCT00479674|564630103|FG000|Overall Study|Physician Decision|14|||
156419520|NCT00479674|564630103|FG000|Overall Study|none provided|3|||
156419521|NCT02478359|564630107|FG000|Overall Study|Disenrolled from health plan|106|||
156419522|NCT02478359|564630108|FG001|Overall Study|Disenrolled from health plan|65|||
156419523|NCT03293485|564630110|FG000|Overall Study|Death|1|||
156419524|NCT03293485|564630110|FG000|Overall Study|Screen Failure|2|||
156419525|NCT03293485|564630110|FG000|Overall Study|Withdrawal by Subject|2|||
156419526|NCT01818700|564630111|FG000|Overall Study|Adverse Event|67|||
156419527|NCT01818700|564630111|FG000|Overall Study|Lack of Efficacy|2|||
156419528|NCT01818700|564630111|FG000|Overall Study|Lost to Follow-up|5|||
156419529|NCT01818700|564630111|FG000|Overall Study|Withdrawal by Subject|27|||
156419530|NCT01818700|564630111|FG000|Overall Study|Protocol Violation|2|||
156419531|NCT01818700|564630111|FG000|Overall Study|Other|1|||
156419532|NCT05968482|564630112|FG000|First Crossover Period|Withdrawal by Subject|0|||
156419533|NCT05968482|564630113|FG001|First Crossover Period|Withdrawal by Subject|0|||
156419534|NCT05968482|564630114|FG002|First Crossover Period|Withdrawal by Subject|1|||
156419535|NCT05968482|564630115|FG003|First Crossover Period|Withdrawal by Subject|0|||
156419536|NCT05968482|564630116|FG004|First Crossover Period|Withdrawal by Subject|0|||
156419537|NCT05968482|564630117|FG005|First Crossover Period|Withdrawal by Subject|0|||
156419538|NCT05968482|564630112|FG000|First Crossover Period|Adverse Event|0|||
156419539|NCT05968482|564630113|FG001|First Crossover Period|Adverse Event|0|||
156419540|NCT05968482|564630114|FG002|First Crossover Period|Adverse Event|0|||
156419541|NCT05968482|564630115|FG003|First Crossover Period|Adverse Event|0|||
156419542|NCT05968482|564630116|FG004|First Crossover Period|Adverse Event|0|||
156419543|NCT05968482|564630117|FG005|First Crossover Period|Adverse Event|1|||
156419544|NCT05968482|564630112|FG000|Second Crossover Period|Withdrawal by Subject|0|||
156759569|NCT02683239|565872075|FG003|Overall Study|Lack of Efficacy|2|||
156759570|NCT02683239|565872076|FG004|Overall Study|Lack of Efficacy|29|||
156759571|NCT02683239|565872077|FG005|Overall Study|Lack of Efficacy|2|||
156759572|NCT02683239|565872078|FG006|Overall Study|Lack of Efficacy|3|||
156759573|NCT02683239|565872072|FG000|Overall Study|Missing data|0|||
156759574|NCT02683239|565872073|FG001|Overall Study|Missing data|1|||
156759575|NCT02683239|565872074|FG002|Overall Study|Missing data|1|||
156759576|NCT02683239|565872075|FG003|Overall Study|Missing data|0|||
156759577|NCT02683239|565872076|FG004|Overall Study|Missing data|1|||
156759578|NCT02683239|565872077|FG005|Overall Study|Missing data|0|||
156759579|NCT02683239|565872078|FG006|Overall Study|Missing data|0|||
156759580|NCT00521365|565872081|FG000|Overall Study|Adverse Event|3|||
156759581|NCT00521365|565872081|FG000|Overall Study|Lost to Follow-up|6|||
156759582|NCT00521365|565872081|FG000|Overall Study|Protocol deviation|2|||
156759583|NCT00521365|565872081|FG000|Overall Study|Drug compliance|3|||
156759584|NCT00521365|565872081|FG000|Overall Study|Usage of not allowed drugs|6|||
156759585|NCT03627832|565872082|FG000|Overall Study|Withdrawal by Subject|10|||
156759586|NCT03627832|565872083|FG001|Overall Study|Withdrawal by Subject|1|||
156759587|NCT03150082|565872087|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
156759588|NCT03150082|565872088|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
156759589|NCT01718483|565872089|FG000|Overall Study|Withdrawal by Subject|14|||
156759590|NCT01718483|565872090|FG001|Overall Study|Withdrawal by Subject|12|||
156759591|NCT01718483|565872089|FG000|Overall Study|Adverse Event|5|||
156759592|NCT01718483|565872090|FG001|Overall Study|Adverse Event|12|||
156759593|NCT01718483|565872089|FG000|Overall Study|Lost to Follow-up|8|||
156759594|NCT01718483|565872090|FG001|Overall Study|Lost to Follow-up|3|||
156759595|NCT01718483|565872089|FG000|Overall Study|Protocol Violation|4|||
156759596|NCT01718483|565872090|FG001|Overall Study|Protocol Violation|2|||
156759597|NCT01718483|565872089|FG000|Overall Study|Other|1|||
156759598|NCT01718483|565872090|FG001|Overall Study|Other|4|||
156759599|NCT01718483|565872089|FG000|Overall Study|Pregnancy|1|||
156759600|NCT01718483|565872090|FG001|Overall Study|Pregnancy|1|||
156759601|NCT01718483|565872089|FG000|Overall Study|Lack of Efficacy|1|||
156759602|NCT01718483|565872090|FG001|Overall Study|Lack of Efficacy|0|||
156759603|NCT04547140|565872093|FG000|Overall Study|Adverse Event|0|||
156759604|NCT04547140|565872094|FG001|Overall Study|Adverse Event|1|||
156419545|NCT05968482|564630113|FG001|Second Crossover Period|Withdrawal by Subject|0|||
156419546|NCT05968482|564630114|FG002|Second Crossover Period|Withdrawal by Subject|0|||
156419547|NCT05968482|564630115|FG003|Second Crossover Period|Withdrawal by Subject|0|||
156419548|NCT05968482|564630116|FG004|Second Crossover Period|Withdrawal by Subject|1|||
156759605|NCT04547140|565872093|FG000|Overall Study|Withdrawal by Subject|0|||
156759606|NCT04547140|565872094|FG001|Overall Study|Withdrawal by Subject|1|||
156759607|NCT04547140|565872093|FG000|Overall Study|Lost to Follow-up|3|||
156759608|NCT04547140|565872094|FG001|Overall Study|Lost to Follow-up|1|||
156759609|NCT04547140|565872093|FG000|Overall Study|Death|2|||
156759610|NCT04547140|565872094|FG001|Overall Study|Death|1|||
156759611|NCT04547140|565872093|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
156759612|NCT04547140|565872094|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
156759613|NCT04547140|565872093|FG000|Overall Study|Pregnancy|1|||
156759614|NCT04547140|565872094|FG001|Overall Study|Pregnancy|0|||
156759615|NCT04547140|565872093|FG000|Overall Study|Reason Not Specified|4|||
156759616|NCT04547140|565872094|FG001|Overall Study|Reason Not Specified|1|||
156759617|NCT02119299|565872095|FG000|Overall Study|Withdrawal by Subject|7|||
156759618|NCT02119299|565872095|FG000|Overall Study|Lack of Efficacy|1|||
156759619|NCT02119299|565872095|FG000|Overall Study|Pregnancy|1|||
156759620|NCT04613739|565872098|FG000|Overall Study|Lost to Follow-up|6|||
156759621|NCT04613739|565872099|FG001|Overall Study|Lost to Follow-up|9|||
156759622|NCT04613739|565872098|FG000|Overall Study|potentially duplicative/fraudulent|1|||
156759623|NCT04613739|565872099|FG001|Overall Study|potentially duplicative/fraudulent|3|||
156759624|NCT01265394|565872119|FG000|Overall Study|Subjects withdrawn|37|||
156759625|NCT04754542|565872132|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
156759626|NCT04754542|565872133|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
156759627|NCT00873730|565873828|FG000|Overall Study|Protocol Deviation|5|||
156759628|NCT00873730|565873829|FG001|Overall Study|Protocol Deviation|2|||
156759629|NCT00873730|565873828|FG000|Overall Study|Adverse Event|0|||
156759630|NCT00873730|565873829|FG001|Overall Study|Adverse Event|2|||
156759631|NCT00873730|565873828|FG000|Overall Study|Withdrawal by Subject|0|||
156759632|NCT00873730|565873829|FG001|Overall Study|Withdrawal by Subject|1|||
156759633|NCT00873730|565873828|FG000|Overall Study|Sponsor decision|1|||
156759634|NCT00873730|565873829|FG001|Overall Study|Sponsor decision|0|||
156759635|NCT00048035|565873830|FG000|Core Period|Early Withdrawals|4|||
156759636|NCT00048035|565873831|FG001|Core Period|Early Withdrawals|2|||
156759637|NCT00048035|565873832|FG002|Core Period|Early Withdrawals|1|||
156759638|NCT00048035|565873833|FG003|Core Period|Early Withdrawals|1|||
156759639|NCT00048035|565873834|FG004|Core Period|Early Withdrawals|1|||
156759640|NCT00048035|565873835|FG005|Core Period|Early Withdrawals|1|||
156759641|NCT00048035|565873836|FG006|Core Period|Early Withdrawals|0|||
156759642|NCT00048035|565873837|FG007|Core Period|Early Withdrawals|0|||
156759643|NCT00048035|565873830|FG000|Extension Year 1|Early Withdrawals|0|||
156759644|NCT00048035|565873831|FG001|Extension Year 1|Early Withdrawals|0|||
156759645|NCT00048035|565873832|FG002|Extension Year 1|Early Withdrawals|0|||
156759646|NCT00048035|565873833|FG003|Extension Year 1|Early Withdrawals|0|||
156759647|NCT00048035|565873834|FG004|Extension Year 1|Early Withdrawals|0|||
156759648|NCT00048035|565873835|FG005|Extension Year 1|Early Withdrawals|0|||
156318246|NCT01992159|564264549|FG001|Overall Study|Adverse Event|1|||
156318247|NCT01992159|564264550|FG002|Overall Study|Adverse Event|0|||
156318248|NCT01992159|564264551|FG003|Overall Study|Adverse Event|1|||
156318249|NCT01992159|564264548|FG000|Overall Study|Death|0|||
156318250|NCT01992159|564264549|FG001|Overall Study|Death|0|||
156318251|NCT01992159|564264550|FG002|Overall Study|Death|1|||
156318252|NCT01992159|564264551|FG003|Overall Study|Death|0|||
156318253|NCT00470158|564264559|FG000|Overall Study|Death|0|||
156318254|NCT00470158|564264560|FG001|Overall Study|Death|0|||
156318255|NCT00470158|564264561|FG002|Overall Study|Death|0|||
156318256|NCT00470158|564264562|FG003|Overall Study|Death|0|||
156318257|NCT00470158|564264563|FG004|Overall Study|Death|2|||
156318258|NCT00470158|564264559|FG000|Overall Study|Lost to Follow-up|7|||
156318259|NCT00470158|564264560|FG001|Overall Study|Lost to Follow-up|8|||
156318260|NCT00470158|564264561|FG002|Overall Study|Lost to Follow-up|8|||
156318261|NCT00470158|564264562|FG003|Overall Study|Lost to Follow-up|5|||
156318262|NCT00470158|564264563|FG004|Overall Study|Lost to Follow-up|4|||
156318263|NCT00470158|564264559|FG000|Overall Study|Protocol Violation|1|||
156318264|NCT00470158|564264560|FG001|Overall Study|Protocol Violation|0|||
156318265|NCT00470158|564264561|FG002|Overall Study|Protocol Violation|0|||
156318266|NCT00470158|564264562|FG003|Overall Study|Protocol Violation|0|||
156318267|NCT00470158|564264563|FG004|Overall Study|Protocol Violation|0|||
156318268|NCT00880685|564264564|FG000|Memantine 10mg|Lost to Follow-up|2|||
156318269|NCT00880685|564264564|FG000|Memantine 20mg|Withdrawal by Subject|1|||
156318270|NCT00329901|564264568|FG000|Overall Study|Withdrawal by Subject|4|||
156318271|NCT00329901|564264569|FG001|Overall Study|Withdrawal by Subject|3|||
156759649|NCT00048035|565873836|FG006|Extension Year 1|Early Withdrawals|11|||
156759650|NCT00048035|565873837|FG007|Extension Year 1|Early Withdrawals|11|||
156759651|NCT00048035|565873830|FG000|Extension Year 2|Early Withdrawals|0|||
156318272|NCT00329901|564264570|FG002|Overall Study|Withdrawal by Subject|2|||
156318273|NCT00329901|564264568|FG000|Overall Study|Lost to Follow-up|2|||
156318274|NCT00329901|564264569|FG001|Overall Study|Lost to Follow-up|0|||
156759652|NCT00048035|565873831|FG001|Extension Year 2|Early Withdrawals|0|||
156759653|NCT00048035|565873832|FG002|Extension Year 2|Early Withdrawals|0|||
156759654|NCT00048035|565873833|FG003|Extension Year 2|Early Withdrawals|0|||
156318275|NCT00329901|564264570|FG002|Overall Study|Lost to Follow-up|1|||
156318276|NCT00329901|564264568|FG000|Overall Study|Protocol Violation|1|||
156318277|NCT00329901|564264569|FG001|Overall Study|Protocol Violation|0|||
156318278|NCT00329901|564264570|FG002|Overall Study|Protocol Violation|1|||
156318279|NCT00329901|564264568|FG000|Overall Study|Unable to classify|2|||
156318280|NCT00329901|564264569|FG001|Overall Study|Unable to classify|2|||
156318281|NCT00329901|564264570|FG002|Overall Study|Unable to classify|0|||
156318282|NCT02296138|564264571|FG000|Overall Study|Adverse Event|348|||
156318283|NCT02296138|564264572|FG001|Overall Study|Adverse Event|259|||
156318284|NCT02296138|564264571|FG000|Overall Study|Lack of Efficacy|59|||
156318285|NCT02296138|564264572|FG001|Overall Study|Lack of Efficacy|37|||
156318286|NCT02296138|564264571|FG000|Overall Study|Protocol Violation|35|||
156318287|NCT02296138|564264572|FG001|Overall Study|Protocol Violation|36|||
156318288|NCT02296138|564264571|FG000|Overall Study|Lost to Follow-up|9|||
156318289|NCT02296138|564264572|FG001|Overall Study|Lost to Follow-up|12|||
156318290|NCT02296138|564264571|FG000|Overall Study|Withdrawal by Subject|184|||
156318291|NCT02296138|564264572|FG001|Overall Study|Withdrawal by Subject|131|||
156318292|NCT02296138|564264571|FG000|Overall Study|Not Treated|1|||
156318293|NCT02296138|564264572|FG001|Overall Study|Not Treated|1|||
156318294|NCT02296138|564264571|FG000|Overall Study|Patients with data irregularities|10|||
156318295|NCT02296138|564264572|FG001|Overall Study|Patients with data irregularities|11|||
156318296|NCT02296138|564264571|FG000|Overall Study|Other than specified|15|||
156318297|NCT02296138|564264572|FG001|Overall Study|Other than specified|13|||
156318298|NCT00584740|564264574|FG000|Overall Study|Adverse Event|1|||
156318299|NCT00584740|564264575|FG001|Overall Study|Adverse Event|1|||
156318300|NCT00584740|564264574|FG000|Overall Study|Lack of Efficacy|8|||
156318301|NCT00584740|564264575|FG001|Overall Study|Lack of Efficacy|2|||
156318302|NCT00584740|564264574|FG000|Overall Study|Withdrawal by Subject|3|||
156318303|NCT00584740|564264575|FG001|Overall Study|Withdrawal by Subject|2|||
156318304|NCT00584740|564264574|FG000|Overall Study|Lost to Follow-up|0|||
156318305|NCT00584740|564264575|FG001|Overall Study|Lost to Follow-up|1|||
156318306|NCT02106923|564264576|FG000|Overall Study|Protocol Violation|0|||
156318307|NCT02106923|564264577|FG001|Overall Study|Protocol Violation|0|||
156318308|NCT02106923|564264578|FG002|Overall Study|Protocol Violation|0|||
156318309|NCT02106923|564264579|FG003|Overall Study|Protocol Violation|0|||
156318310|NCT02106923|564264580|FG004|Overall Study|Protocol Violation|0|||
156318311|NCT02106923|564264581|FG005|Overall Study|Protocol Violation|1|||
156318312|NCT03485495|564264582|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
156318313|NCT03485495|564264583|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
156318314|NCT01107379|564264587|FG000|Overall Study|Withdrawal by Subject|18|||
156318315|NCT01107379|564264587|FG000|Overall Study|Lost to Follow-up|3|||
156318316|NCT00548405|564264588|FG000|Overall Study|Adverse Event|6|||
156318317|NCT00548405|564264589|FG001|Overall Study|Adverse Event|2|||
156318318|NCT00548405|564264590|FG002|Overall Study|Adverse Event|0|||
156318319|NCT00548405|564264588|FG000|Overall Study|Lack of Efficacy|6|||
156318320|NCT00548405|564264589|FG001|Overall Study|Lack of Efficacy|0|||
156318321|NCT00548405|564264590|FG002|Overall Study|Lack of Efficacy|0|||
156318322|NCT00548405|564264588|FG000|Overall Study|Physician Decision|3|||
156318323|NCT00548405|564264589|FG001|Overall Study|Physician Decision|4|||
156318324|NCT00548405|564264590|FG002|Overall Study|Physician Decision|1|||
156318325|NCT00548405|564264588|FG000|Overall Study|Pregnancy|1|||
156318326|NCT00548405|564264589|FG001|Overall Study|Pregnancy|0|||
156318327|NCT00548405|564264590|FG002|Overall Study|Pregnancy|0|||
156318328|NCT00548405|564264588|FG000|Overall Study|Protocol Violation|1|||
156318329|NCT00548405|564264589|FG001|Overall Study|Protocol Violation|0|||
156318330|NCT00548405|564264590|FG002|Overall Study|Protocol Violation|0|||
156318331|NCT00548405|564264588|FG000|Overall Study|Withdrawal by Subject|36|||
156318332|NCT00548405|564264589|FG001|Overall Study|Withdrawal by Subject|12|||
156318333|NCT00548405|564264590|FG002|Overall Study|Withdrawal by Subject|5|||
156318334|NCT00548405|564264588|FG000|Overall Study|Lost to Follow-up|1|||
156318335|NCT00548405|564264589|FG001|Overall Study|Lost to Follow-up|1|||
156318336|NCT00548405|564264590|FG002|Overall Study|Lost to Follow-up|2|||
156318337|NCT00548405|564264588|FG000|Overall Study|Death|0|||
156318338|NCT00548405|564264589|FG001|Overall Study|Death|1|||
156318339|NCT00548405|564264590|FG002|Overall Study|Death|1|||
156318340|NCT00548405|564264588|FG000|Overall Study|Sponsor decision|1|||
156318341|NCT00548405|564264589|FG001|Overall Study|Sponsor decision|0|||
156318342|NCT00548405|564264590|FG002|Overall Study|Sponsor decision|0|||
156318343|NCT00548405|564264588|FG000|Overall Study|Randomized but not treated|1|||
156318344|NCT00548405|564264589|FG001|Overall Study|Randomized but not treated|0|||
156318345|NCT00548405|564264590|FG002|Overall Study|Randomized but not treated|0|||
156318346|NCT00924170|564264591|FG000|Overall Study|Refused further treatment|0|||
156318347|NCT00924170|564264592|FG001|Overall Study|Refused further treatment|1|||
156759655|NCT00048035|565873834|FG004|Extension Year 2|Early Withdrawals|0|||
156318348|NCT00924170|564264591|FG000|Overall Study|Physician Decision|0|||
156318349|NCT00924170|564264592|FG001|Overall Study|Physician Decision|1|||
156318350|NCT00924170|564264591|FG000|Overall Study|Progressive disease|3|||
156318351|NCT00924170|564264592|FG001|Overall Study|Progressive disease|6|||
156318352|NCT00924170|564264591|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
156318353|NCT00924170|564264592|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
156318354|NCT00924170|564264591|FG000|Overall Study|Death|1|||
156318355|NCT00924170|564264592|FG001|Overall Study|Death|0|||
156318356|NCT05318183|564264593|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
156759656|NCT00048035|565873835|FG005|Extension Year 2|Early Withdrawals|0|||
156759657|NCT00048035|565873836|FG006|Extension Year 2|Early Withdrawals|3|||
156759658|NCT00048035|565873837|FG007|Extension Year 2|Early Withdrawals|3|||
156759659|NCT04110314|565873838|FG000|Overall Study|Did not meet inclusion criteria|35255|||
156759660|NCT04110314|565873839|FG001|Overall Study|Did not meet inclusion criteria|35104|||
156759661|NCT04110314|565873840|FG002|Overall Study|Did not meet inclusion criteria|35636|||
156759662|NCT04110314|565873841|FG003|Overall Study|Did not meet inclusion criteria|35135|||
156759663|NCT04110314|565873842|FG004|Overall Study|Did not meet inclusion criteria|35247|||
156759664|NCT04110314|565873843|FG005|Overall Study|Did not meet inclusion criteria|35727|||
156759665|NCT05137717|565873848|FG000|Overall Study|Death|2|||
156759666|NCT05137717|565873848|FG000|Overall Study|Withdrawal by Subject|6|||
156759667|NCT02619617|565873849|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
156759668|NCT02619617|565873850|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
156759669|NCT02619617|565873849|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
156759670|NCT02619617|565873850|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
156759671|NCT00509899|565873851|FG000|Overall Study|Progressive disease|1|||
156759672|NCT00509899|565873852|FG001|Overall Study|Progressive disease|3|||
156759673|NCT00509899|565873853|FG002|Overall Study|Progressive disease|5|||
156759674|NCT00509899|565873854|FG003|Overall Study|Progressive disease|1|||
156759675|NCT00509899|565873855|FG004|Overall Study|Progressive disease|0|||
156759676|NCT00509899|565873856|FG005|Overall Study|Progressive disease|1|||
156759677|NCT00509899|565873857|FG006|Overall Study|Progressive disease|0|||
156759678|NCT00509899|565873858|FG007|Overall Study|Progressive disease|0|||
156759679|NCT00509899|565873851|FG000|Overall Study|Unacceptable Toxicity|1|||
156759680|NCT00509899|565873852|FG001|Overall Study|Unacceptable Toxicity|0|||
156759681|NCT00509899|565873853|FG002|Overall Study|Unacceptable Toxicity|0|||
156759682|NCT00509899|565873854|FG003|Overall Study|Unacceptable Toxicity|2|||
156759683|NCT00509899|565873855|FG004|Overall Study|Unacceptable Toxicity|0|||
156759684|NCT00509899|565873856|FG005|Overall Study|Unacceptable Toxicity|0|||
156759685|NCT00509899|565873857|FG006|Overall Study|Unacceptable Toxicity|0|||
156759686|NCT00509899|565873858|FG007|Overall Study|Unacceptable Toxicity|0|||
156759687|NCT00509899|565873851|FG000|Overall Study|Withdrawal by Subject|6|||
156759688|NCT00509899|565873852|FG001|Overall Study|Withdrawal by Subject|2|||
156759689|NCT00509899|565873853|FG002|Overall Study|Withdrawal by Subject|3|||
156759690|NCT00509899|565873854|FG003|Overall Study|Withdrawal by Subject|0|||
156759691|NCT00509899|565873855|FG004|Overall Study|Withdrawal by Subject|3|||
156759692|NCT00509899|565873856|FG005|Overall Study|Withdrawal by Subject|2|||
156759693|NCT00509899|565873857|FG006|Overall Study|Withdrawal by Subject|0|||
156759694|NCT00509899|565873858|FG007|Overall Study|Withdrawal by Subject|0|||
156759695|NCT00509899|565873851|FG000|Overall Study|Physician Decision|4|||
156759696|NCT00509899|565873852|FG001|Overall Study|Physician Decision|2|||
156759697|NCT00509899|565873853|FG002|Overall Study|Physician Decision|7|||
156759698|NCT00509899|565873854|FG003|Overall Study|Physician Decision|0|||
156759699|NCT00509899|565873855|FG004|Overall Study|Physician Decision|1|||
156759700|NCT00509899|565873856|FG005|Overall Study|Physician Decision|4|||
156759701|NCT00509899|565873857|FG006|Overall Study|Physician Decision|0|||
156759702|NCT00509899|565873858|FG007|Overall Study|Physician Decision|0|||
156759703|NCT00509899|565873851|FG000|Overall Study|Intercurrent Illness|1|||
156759704|NCT00509899|565873852|FG001|Overall Study|Intercurrent Illness|0|||
156759705|NCT00509899|565873853|FG002|Overall Study|Intercurrent Illness|0|||
156759706|NCT00509899|565873854|FG003|Overall Study|Intercurrent Illness|1|||
156759707|NCT00509899|565873855|FG004|Overall Study|Intercurrent Illness|0|||
156759708|NCT00509899|565873856|FG005|Overall Study|Intercurrent Illness|1|||
156759709|NCT00509899|565873857|FG006|Overall Study|Intercurrent Illness|0|||
156759710|NCT00509899|565873858|FG007|Overall Study|Intercurrent Illness|0|||
156759711|NCT00509899|565873851|FG000|Overall Study|Death|2|||
156419549|NCT05968482|564630117|FG005|Second Crossover Period|Withdrawal by Subject|0|||
156419550|NCT05968482|564630112|FG000|Third Crossover Period|Adverse Event|0|||
156419551|NCT05968482|564630113|FG001|Third Crossover Period|Adverse Event|0|||
156419552|NCT05968482|564630114|FG002|Third Crossover Period|Adverse Event|0|||
156759712|NCT00509899|565873852|FG001|Overall Study|Death|2|||
156759713|NCT00509899|565873853|FG002|Overall Study|Death|3|||
156759714|NCT00509899|565873854|FG003|Overall Study|Death|0|||
156759715|NCT00509899|565873855|FG004|Overall Study|Death|1|||
156759716|NCT00509899|565873856|FG005|Overall Study|Death|1|||
156759717|NCT00509899|565873857|FG006|Overall Study|Death|1|||
156759718|NCT00509899|565873858|FG007|Overall Study|Death|1|||
156759719|NCT00509899|565873851|FG000|Overall Study|Lack of Efficacy|1|||
156759720|NCT00509899|565873852|FG001|Overall Study|Lack of Efficacy|0|||
156759721|NCT00509899|565873853|FG002|Overall Study|Lack of Efficacy|2|||
156759722|NCT00509899|565873854|FG003|Overall Study|Lack of Efficacy|0|||
156759723|NCT00509899|565873855|FG004|Overall Study|Lack of Efficacy|0|||
156759724|NCT00509899|565873856|FG005|Overall Study|Lack of Efficacy|1|||
156759725|NCT00509899|565873857|FG006|Overall Study|Lack of Efficacy|0|||
156759726|NCT00509899|565873858|FG007|Overall Study|Lack of Efficacy|0|||
156759727|NCT01711983|565873861|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
156759728|NCT01711983|565873861|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
156759729|NCT01711983|565873861|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
156759730|NCT01711983|565873861|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
156759731|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759732|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
156759733|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
156759734|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759735|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759736|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759737|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759738|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759739|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759740|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759741|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759742|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759743|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759744|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759745|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759746|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
156759747|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
156759748|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759749|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759750|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759751|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759752|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759753|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759754|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759755|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759756|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759757|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759758|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759759|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759760|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759761|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
156759762|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
156759763|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
156759764|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759765|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759766|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759767|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759768|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759769|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759770|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759771|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759772|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759773|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759774|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759775|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759776|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759777|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759778|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
156759779|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759780|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759781|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759782|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759783|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759784|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759785|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156318357|NCT05318183|564264594|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
156318358|NCT05318183|564264593|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
156318359|NCT05318183|564264594|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156759786|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759787|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759788|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759789|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759790|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759791|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759792|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759793|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
156759794|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759795|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759796|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759797|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156318360|NCT05318183|564264593|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
156318361|NCT05318183|564264594|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
156318362|NCT05318183|564264593|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156318363|NCT05318183|564264594|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
156318364|NCT06400251|564264595|FG000|Overall Study|Never Start Protocol Therapy|1|||
156318365|NCT06400251|564264595|FG000|Overall Study|Ineligible|2|||
156318366|NCT06400251|564264595|FG000|Overall Study|Mutation Status Not Confirmed|3|||
156318367|NCT06400251|564264595|FG000|Overall Study|Disease Progression|25|||
156318368|NCT06400251|564264595|FG000|Overall Study|Adverse Event|1|||
156318369|NCT06400251|564264595|FG000|Overall Study|Complicating Disease|1|||
156318370|NCT06400251|564264595|FG000|Overall Study|Physician Decision|2|||
156318371|NCT04672252|564264596|FG000|Overall Study|Protocol Violation|1|||
156318372|NCT04672252|564264597|FG001|Overall Study|Protocol Violation|0|||
156318373|NCT00899392|564264598|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
156318374|NCT00899392|564264599|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
156318375|NCT01903252|564264600|FG000|Double-Blind Induction|Adverse Event|20|||
156318376|NCT01903252|564264601|FG001|Double-Blind Induction|Adverse Event|18|||
156318377|NCT01903252|564264602|FG002|Double-Blind Induction|Adverse Event|0|||
156318378|NCT01903252|564264603|FG003|Double-Blind Induction|Adverse Event|0|||
156318379|NCT01903252|564264604|FG004|Double-Blind Induction|Adverse Event|0|||
156318380|NCT01903252|564264605|FG005|Double-Blind Induction|Adverse Event|0|||
156318381|NCT01903252|564264600|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
156318382|NCT01903252|564264601|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
156318383|NCT01903252|564264602|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
156318384|NCT01903252|564264603|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
156318385|NCT01903252|564264604|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
156318386|NCT01903252|564264605|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
156318387|NCT01903252|564264600|FG000|Double-Blind Induction|Physician Decision|2|||
156318388|NCT01903252|564264601|FG001|Double-Blind Induction|Physician Decision|3|||
156318389|NCT01903252|564264602|FG002|Double-Blind Induction|Physician Decision|0|||
156318390|NCT01903252|564264603|FG003|Double-Blind Induction|Physician Decision|0|||
156318391|NCT01903252|564264604|FG004|Double-Blind Induction|Physician Decision|0|||
156318392|NCT01903252|564264605|FG005|Double-Blind Induction|Physician Decision|0|||
156318393|NCT01903252|564264600|FG000|Double-Blind Induction|non-compliance,|7|||
156318394|NCT01903252|564264601|FG001|Double-Blind Induction|non-compliance,|7|||
156318395|NCT01903252|564264602|FG002|Double-Blind Induction|non-compliance,|0|||
156318396|NCT01903252|564264603|FG003|Double-Blind Induction|non-compliance,|0|||
156318397|NCT01903252|564264604|FG004|Double-Blind Induction|non-compliance,|0|||
156318398|NCT01903252|564264605|FG005|Double-Blind Induction|non-compliance,|0|||
156318399|NCT01903252|564264600|FG000|Extended Induction, Open-Label|Adverse Event|0|||
156318400|NCT01903252|564264601|FG001|Extended Induction, Open-Label|Adverse Event|0|||
156318401|NCT01903252|564264602|FG002|Extended Induction, Open-Label|Adverse Event|17|||
156318402|NCT01903252|564264603|FG003|Extended Induction, Open-Label|Adverse Event|0|||
156318403|NCT01903252|564264604|FG004|Extended Induction, Open-Label|Adverse Event|0|||
156318404|NCT01903252|564264605|FG005|Extended Induction, Open-Label|Adverse Event|0|||
156318405|NCT01903252|564264600|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156318406|NCT01903252|564264601|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156318407|NCT01903252|564264602|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
156318408|NCT01903252|564264603|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156318409|NCT01903252|564264604|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156318410|NCT01903252|564264605|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156318411|NCT01903252|564264600|FG000|Extended Induction, Open-Label|Physician Decision|0|||
156318412|NCT01903252|564264601|FG001|Extended Induction, Open-Label|Physician Decision|0|||
156318413|NCT01903252|564264602|FG002|Extended Induction, Open-Label|Physician Decision|1|||
156318414|NCT01903252|564264603|FG003|Extended Induction, Open-Label|Physician Decision|0|||
156318415|NCT01903252|564264604|FG004|Extended Induction, Open-Label|Physician Decision|0|||
156318416|NCT01903252|564264605|FG005|Extended Induction, Open-Label|Physician Decision|0|||
156318417|NCT01903252|564264600|FG000|Maintenance, Open-Label|Adverse Event|0|||
156318418|NCT01903252|564264601|FG001|Maintenance, Open-Label|Adverse Event|0|||
156318419|NCT01903252|564264602|FG002|Maintenance, Open-Label|Adverse Event|0|||
156318420|NCT01903252|564264603|FG003|Maintenance, Open-Label|Adverse Event|3|||
156318421|NCT01903252|564264604|FG004|Maintenance, Open-Label|Adverse Event|9|||
156759798|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759799|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759800|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759801|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759802|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759803|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759804|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759805|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759806|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759807|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759808|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
156759809|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759810|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759811|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759812|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759813|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759814|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759815|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759816|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759817|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759818|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759819|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759820|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759821|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759822|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759823|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
156759824|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759825|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759826|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759827|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759828|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759829|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759830|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759831|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759832|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759833|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759834|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759835|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759836|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759837|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759838|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759839|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759840|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
156759841|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
156759842|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
156759843|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
156759844|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156759845|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759846|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759847|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759848|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759849|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759850|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759851|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759852|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759853|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759854|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759855|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759856|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
156759857|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
156759858|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759859|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
156759860|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
156759861|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759862|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759863|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759864|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759865|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759866|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156419553|NCT05968482|564630115|FG003|Third Crossover Period|Adverse Event|0|||
156419554|NCT05968482|564630116|FG004|Third Crossover Period|Adverse Event|1|||
156419555|NCT05968482|564630117|FG005|Third Crossover Period|Adverse Event|0|||
156419556|NCT05968482|564630112|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
156419557|NCT05968482|564630113|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
156419558|NCT05968482|564630114|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
156419559|NCT05968482|564630115|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
156419560|NCT05968482|564630116|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
156419561|NCT05968482|564630117|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
156419562|NCT02559817|564630118|FG000|Treatment Period|Adverse Event|1|||
156419563|NCT02559817|564630119|FG001|Treatment Period|Adverse Event|0|||
156419564|NCT02559817|564630120|FG002|Treatment Period|Adverse Event|1|||
156419565|NCT02559817|564630121|FG003|Treatment Period|Adverse Event|0|||
156419566|NCT02559817|564630122|FG004|Treatment Period|Adverse Event|0|||
156419567|NCT02559817|564630118|FG000|Treatment Period|Lack of Efficacy|0|||
156419568|NCT02559817|564630119|FG001|Treatment Period|Lack of Efficacy|1|||
156419569|NCT02559817|564630120|FG002|Treatment Period|Lack of Efficacy|0|||
156419570|NCT02559817|564630121|FG003|Treatment Period|Lack of Efficacy|0|||
156419571|NCT02559817|564630122|FG004|Treatment Period|Lack of Efficacy|0|||
156419572|NCT02559817|564630118|FG000|Treatment Period|Lost to Follow-up|0|||
156419573|NCT02559817|564630119|FG001|Treatment Period|Lost to Follow-up|1|||
156419574|NCT02559817|564630120|FG002|Treatment Period|Lost to Follow-up|0|||
156419575|NCT02559817|564630121|FG003|Treatment Period|Lost to Follow-up|1|||
156419576|NCT02559817|564630122|FG004|Treatment Period|Lost to Follow-up|0|||
156419577|NCT02559817|564630118|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
156419578|NCT02559817|564630119|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
156419579|NCT02559817|564630120|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
156419580|NCT02559817|564630121|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
156419581|NCT02559817|564630122|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
156419582|NCT02559817|564630118|FG000|Treatment Period|Protocol Violation|0|||
156419583|NCT02559817|564630119|FG001|Treatment Period|Protocol Violation|0|||
156419584|NCT02559817|564630120|FG002|Treatment Period|Protocol Violation|0|||
156419585|NCT02559817|564630121|FG003|Treatment Period|Protocol Violation|1|||
156419586|NCT02559817|564630122|FG004|Treatment Period|Protocol Violation|0|||
156419587|NCT03389893|564630123|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
156419588|NCT03389893|564630124|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
156759867|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156419589|NCT03389893|564630125|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
156419590|NCT03389893|564630126|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
156419591|NCT03389893|564630123|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
156419592|NCT03389893|564630124|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
156419593|NCT03389893|564630125|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
156419594|NCT03389893|564630126|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
156419595|NCT03389893|564630123|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
156419596|NCT03389893|564630124|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
156419597|NCT03389893|564630125|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
156419598|NCT03389893|564630126|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
156419599|NCT03389893|564630123|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
156419600|NCT03389893|564630124|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
156419601|NCT03389893|564630125|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
156419602|NCT03389893|564630126|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
156419603|NCT01719861|564630130|FG000|Cycle 1|Death|4|||
156419604|NCT01719861|564630130|FG000|Cycle 2|Death|1|||
156419605|NCT00958009|564630131|FG000|Overall Study|Adverse Event|1|||
156419606|NCT00958009|564630131|FG000|Overall Study|Subject found device difficult to use|1|||
156419607|NCT01077024|564630142|FG000|Overall Study|Lost to Follow-up|20|||
156419608|NCT01077024|564630143|FG001|Overall Study|Lost to Follow-up|14|||
156759868|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759869|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759870|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759871|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
156419609|NCT01077024|564630142|FG000|Overall Study|Withdrawal by Subject|0|||
156419610|NCT01077024|564630143|FG001|Overall Study|Withdrawal by Subject|2|||
156419611|NCT01077024|564630142|FG000|Overall Study|Incarcerated|7|||
156759872|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156419612|NCT01077024|564630143|FG001|Overall Study|Incarcerated|8|||
156759873|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
156759874|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759875|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759876|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759877|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759878|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759879|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759880|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759881|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759882|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759883|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759884|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156759885|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759886|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
156759887|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156759888|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156759889|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759890|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156759891|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759892|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759893|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759894|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759895|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759896|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759897|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759898|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759899|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759900|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759901|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759902|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759903|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
156759904|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759905|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759906|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759907|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759908|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759909|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759910|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759911|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759912|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759913|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759914|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759915|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759916|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759917|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
156759918|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759919|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759920|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759921|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759922|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759923|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759924|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156318422|NCT01903252|564264605|FG005|Maintenance, Open-Label|Adverse Event|14|||
156318423|NCT01903252|564264600|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
156318424|NCT01903252|564264601|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
156318425|NCT01903252|564264602|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
156318426|NCT01903252|564264603|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
156318427|NCT01903252|564264604|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
156318428|NCT01903252|564264605|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
156318429|NCT01903252|564264600|FG000|Maintenance, Open-Label|Other|0|||
156419613|NCT01077024|564630142|FG000|Overall Study|Other|4|||
156419614|NCT01077024|564630143|FG001|Overall Study|Other|4|||
156419615|NCT02034435|564630144|FG000|Overall Study|Withdrawal by Subject|1|||
156419616|NCT02034435|564630145|FG001|Overall Study|Withdrawal by Subject|0|||
156759925|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759926|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759927|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759928|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759929|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759930|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759931|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759932|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759933|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759934|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
156759935|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759936|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759937|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759938|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759939|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759940|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759941|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759942|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759943|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759944|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759945|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759946|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
156759947|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
156759948|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
156759949|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
156759950|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759951|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759952|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759953|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759954|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759955|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759956|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759957|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759958|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759959|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759960|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759961|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
156759962|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759963|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759964|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759965|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759966|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759967|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759968|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759969|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759970|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759971|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759972|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759973|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759974|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759975|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759976|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759977|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
156759978|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759979|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759980|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759981|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759982|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759983|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759984|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156318430|NCT01903252|564264601|FG001|Maintenance, Open-Label|Other|0|||
156318431|NCT01903252|564264602|FG002|Maintenance, Open-Label|Other|0|||
156318432|NCT01903252|564264603|FG003|Maintenance, Open-Label|Other|2|||
156318433|NCT01903252|564264604|FG004|Maintenance, Open-Label|Other|6|||
156318434|NCT01903252|564264605|FG005|Maintenance, Open-Label|Other|2|||
156318435|NCT01642732|564264606|FG000|Overall Study|Withdrawal by Subject|1|||
156318436|NCT03044574|564264614|FG000|Overall Study|Lost to Follow-up|37|||
156318437|NCT03044574|564264615|FG001|Overall Study|Lost to Follow-up|45|||
156318438|NCT01077375|564264618|FG000|Overall Study|Adverse Event|2|||
156318439|NCT01077375|564264619|FG001|Overall Study|Adverse Event|15|||
156318440|NCT01077375|564264618|FG000|Overall Study|Lack of Efficacy|6|||
156318441|NCT01077375|564264619|FG001|Overall Study|Lack of Efficacy|8|||
156318442|NCT01077375|564264618|FG000|Overall Study|Withdrawal by Subject|0|||
156318443|NCT01077375|564264619|FG001|Overall Study|Withdrawal by Subject|6|||
156318444|NCT01077375|564264618|FG000|Overall Study|Lost to Follow-up|2|||
156318445|NCT01077375|564264619|FG001|Overall Study|Lost to Follow-up|5|||
156318446|NCT01077375|564264618|FG000|Overall Study|Other Reason|0|||
156318447|NCT01077375|564264619|FG001|Overall Study|Other Reason|1|||
156318448|NCT01924429|564264622|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
156318449|NCT01924429|564264623|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
156318450|NCT00278915|564264626|FG000|Overall Study|Disease progression|1|||
156318451|NCT05214573|564264627|FG000|Overall Study|Physician Decision|5924|||
156318452|NCT05214573|564264628|FG001|Overall Study|Physician Decision|0|||
156318453|NCT02520089|564264629|FG000|Overall Study|Lost to Follow-up|3|||
156318454|NCT02520089|564264630|FG001|Overall Study|Lost to Follow-up|4|||
156318455|NCT01842633|564266339|FG000|Overall Study|Screen Failure|1|||
156318456|NCT01842633|564266340|FG001|Overall Study|Screen Failure|0|||
156318457|NCT01842633|564266341|FG002|Overall Study|Screen Failure|0|||
156318458|NCT01842633|564266339|FG000|Overall Study|Adverse Event|1|||
156318459|NCT01842633|564266340|FG001|Overall Study|Adverse Event|1|||
156318460|NCT01842633|564266341|FG002|Overall Study|Adverse Event|0|||
156318461|NCT01842633|564266339|FG000|Overall Study|Withdrawal by Subject|0|||
156318462|NCT01842633|564266340|FG001|Overall Study|Withdrawal by Subject|1|||
156318463|NCT01842633|564266341|FG002|Overall Study|Withdrawal by Subject|0|||
156318464|NCT01842633|564266339|FG000|Overall Study|Technical issues|1|||
156318465|NCT01842633|564266340|FG001|Overall Study|Technical issues|0|||
156318466|NCT01842633|564266341|FG002|Overall Study|Technical issues|0|||
156318467|NCT04179890|564266343|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
156318468|NCT04179890|564266344|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
156318469|NCT04179890|564266343|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
156318470|NCT04179890|564266344|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
156318471|NCT04179890|564266343|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
156318472|NCT04179890|564266344|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
156318473|NCT04179890|564266343|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
156318474|NCT04179890|564266344|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
156318475|NCT04179890|564266343|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
156318476|NCT04179890|564266344|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
156318477|NCT04179890|564266343|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
156318478|NCT04179890|564266344|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
156318479|NCT04179890|564266343|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
156318480|NCT04179890|564266344|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
156318481|NCT04179890|564266343|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
156318482|NCT04179890|564266344|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
156318483|NCT04179890|564266343|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
156318484|NCT04179890|564266344|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
156318485|NCT01236118|564266345|FG000|Overall Study|Adverse Event|2|||
156318486|NCT01236118|564266346|FG001|Overall Study|Adverse Event|0|||
156318487|NCT01236118|564266347|FG002|Overall Study|Adverse Event|2|||
156318488|NCT01236118|564266345|FG000|Overall Study|Physician Decision|0|||
156318489|NCT01236118|564266346|FG001|Overall Study|Physician Decision|1|||
156318490|NCT01236118|564266347|FG002|Overall Study|Physician Decision|0|||
156318491|NCT01236118|564266345|FG000|Overall Study|Withdrawal by Subject|0|||
156318492|NCT01236118|564266346|FG001|Overall Study|Withdrawal by Subject|0|||
156318493|NCT01236118|564266347|FG002|Overall Study|Withdrawal by Subject|1|||
156318494|NCT04535167|564266348|FG000|Treatment|Adverse Event|0|||
156318495|NCT04535167|564266349|FG001|Treatment|Adverse Event|0|||
156419617|NCT02034435|564630146|FG002|Overall Study|Withdrawal by Subject|0|||
156318496|NCT04535167|564266350|FG002|Treatment|Adverse Event|0|||
156419618|NCT02034435|564630147|FG003|Overall Study|Withdrawal by Subject|0|||
156419619|NCT02034435|564630144|FG000|Overall Study|Illness|0|||
156759985|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759986|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
156759987|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
156759988|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
156759989|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
156759990|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
156759991|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
156759992|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
156759993|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
156759994|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
156759995|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
156759996|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
156759997|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
156759998|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
156759999|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
156760000|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
156760001|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760002|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760003|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760004|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760005|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760006|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760007|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760008|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760009|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760010|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760011|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
156760012|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
156760013|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
156760014|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760015|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
156760016|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760017|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760018|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760019|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760020|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760021|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760022|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760023|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760024|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760025|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760026|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156760027|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760028|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156760029|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760030|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760031|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760032|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760033|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760034|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760035|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760036|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760037|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760038|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760039|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760040|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760041|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760042|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
156760043|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760044|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760045|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760046|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760047|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760048|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156419620|NCT02034435|564630145|FG001|Overall Study|Illness|2|||
156419621|NCT02034435|564630146|FG002|Overall Study|Illness|0|||
156419622|NCT02034435|564630147|FG003|Overall Study|Illness|0|||
156419623|NCT02034435|564630144|FG000|Overall Study|Inadequate IV access|1|||
156419624|NCT02034435|564630145|FG001|Overall Study|Inadequate IV access|0|||
156419625|NCT02034435|564630146|FG002|Overall Study|Inadequate IV access|0|||
156419626|NCT02034435|564630147|FG003|Overall Study|Inadequate IV access|1|||
156419627|NCT02300311|564630148|FG000|Overall Study|Other than the reason specified|1|||
156419628|NCT02300311|564630149|FG001|Overall Study|Other than the reason specified|0|||
156419629|NCT02300311|564630148|FG000|Overall Study|Refused to continue taking medication|18|||
156419630|NCT02300311|564630149|FG001|Overall Study|Refused to continue taking medication|0|||
156419631|NCT00419003|564630150|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
156419632|NCT00419003|564630151|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
156419633|NCT00419003|564630150|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
156419634|NCT00419003|564630151|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
156653644|NCT04700449|565479498|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
156653645|NCT04700449|565479499|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
156653646|NCT04700449|565479500|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
156318497|NCT04535167|564266351|FG003|Treatment|Adverse Event|0|||
156318498|NCT04535167|564266352|FG004|Treatment|Adverse Event|0|||
156318499|NCT04535167|564266353|FG005|Treatment|Adverse Event|0|||
156318500|NCT04535167|564266354|FG006|Treatment|Adverse Event|1|||
156318501|NCT04535167|564266348|FG000|Follow-Up|Death|0|||
156318502|NCT04535167|564266349|FG001|Follow-Up|Death|0|||
156318503|NCT04535167|564266350|FG002|Follow-Up|Death|0|||
156318504|NCT04535167|564266351|FG003|Follow-Up|Death|0|||
156318505|NCT04535167|564266352|FG004|Follow-Up|Death|0|||
156318506|NCT04535167|564266353|FG005|Follow-Up|Death|0|||
156318507|NCT04535167|564266354|FG006|Follow-Up|Death|1|||
156318508|NCT04535167|564266348|FG000|Follow-Up|Lost to Follow-up|0|||
156318509|NCT04535167|564266349|FG001|Follow-Up|Lost to Follow-up|0|||
156318510|NCT04535167|564266350|FG002|Follow-Up|Lost to Follow-up|0|||
156318511|NCT04535167|564266351|FG003|Follow-Up|Lost to Follow-up|1|||
156318512|NCT04535167|564266352|FG004|Follow-Up|Lost to Follow-up|0|||
156318513|NCT04535167|564266353|FG005|Follow-Up|Lost to Follow-up|0|||
156318514|NCT04535167|564266354|FG006|Follow-Up|Lost to Follow-up|0|||
156318515|NCT00978432|564266355|FG000|Overall Study|Withdrawal by Subject|0|||
156318516|NCT00978432|564266356|FG001|Overall Study|Withdrawal by Subject|0|||
156318517|NCT00978432|564266357|FG002|Overall Study|Withdrawal by Subject|1|||
156318518|NCT00978432|564266355|FG000|Overall Study|Lack of Efficacy|1|||
156318519|NCT00978432|564266356|FG001|Overall Study|Lack of Efficacy|1|||
156318520|NCT00978432|564266357|FG002|Overall Study|Lack of Efficacy|3|||
156318521|NCT00978432|564266355|FG000|Overall Study|Adverse Event|2|||
156318522|NCT00978432|564266356|FG001|Overall Study|Adverse Event|0|||
156318523|NCT00978432|564266357|FG002|Overall Study|Adverse Event|1|||
156318524|NCT02579928|564266358|FG000|Overall Study|Withdrawal by Subject|1|||
156318525|NCT02579928|564266359|FG001|Overall Study|Withdrawal by Subject|0|||
156318526|NCT03404960|564266363|FG000|Overall Study|Adverse Event|0|||
156318527|NCT03404960|564266364|FG001|Overall Study|Adverse Event|2|||
156318528|NCT03404960|564266363|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
156318529|NCT03404960|564266364|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
156318530|NCT03404960|564266363|FG000|Overall Study|Bowel obstruction|0|||
156318531|NCT03404960|564266364|FG001|Overall Study|Bowel obstruction|1|||
156318532|NCT03404960|564266363|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
156318533|NCT03404960|564266364|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
156318534|NCT00075270|564266367|FG000|Overall Study|Withdrawal by Subject|28|||
156318535|NCT00075270|564266368|FG001|Overall Study|Withdrawal by Subject|21|||
156318536|NCT00075270|564266367|FG000|Overall Study|Lost to Follow-up|25|||
156318537|NCT00075270|564266368|FG001|Overall Study|Lost to Follow-up|28|||
156318538|NCT00075270|564266367|FG000|Overall Study|Protocol Violation|0|||
156318539|NCT00075270|564266368|FG001|Overall Study|Protocol Violation|2|||
156318540|NCT00075270|564266367|FG000|Overall Study|Death|198|||
156318541|NCT00075270|564266368|FG001|Overall Study|Death|215|||
156318542|NCT00075270|564266367|FG000|Overall Study|Other/Unknown|9|||
156318543|NCT00075270|564266368|FG001|Overall Study|Other/Unknown|5|||
156318544|NCT00075270|564266367|FG000|Overall Study|Missing|26|||
156318545|NCT00075270|564266368|FG001|Overall Study|Missing|13|||
156318546|NCT00246571|564266369|FG000|Overall Study|Adverse Event|7|||
156419635|NCT02687919|564630152|FG000|Overall Study|Withdrawal by Subject|6|||
156653647|NCT04700449|565479501|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
156653648|NCT04700449|565479498|FG000|Stage 1: Double-Blind Period|Other|0|||
156653649|NCT04700449|565479499|FG001|Stage 1: Double-Blind Period|Other|0|||
156318547|NCT00246571|564266370|FG001|Overall Study|Adverse Event|0|||
156318548|NCT00246571|564266369|FG000|Overall Study|Protocol Violation|0|||
156318549|NCT00246571|564266370|FG001|Overall Study|Protocol Violation|1|||
156318550|NCT00246571|564266369|FG000|Overall Study|Withdrawal by Subject|2|||
156318551|NCT00246571|564266370|FG001|Overall Study|Withdrawal by Subject|3|||
156318552|NCT00246571|564266369|FG000|Overall Study|Lack of Efficacy|84|||
156318553|NCT00246571|564266370|FG001|Overall Study|Lack of Efficacy|21|||
156318554|NCT00246571|564266369|FG000|Overall Study|Death|17|||
156419636|NCT02687919|564630153|FG001|Overall Study|Withdrawal by Subject|6|||
156419637|NCT02687919|564630152|FG000|Overall Study|Protocol Violation|2|||
156419638|NCT02687919|564630153|FG001|Overall Study|Protocol Violation|0|||
156419639|NCT00848211|564630154|FG000|Overall Study|Protocol Violation|0|||
156419640|NCT00848211|564630155|FG001|Overall Study|Protocol Violation|1|||
156419641|NCT00848211|564630156|FG002|Overall Study|Protocol Violation|1|||
156419642|NCT00848211|564630157|FG003|Overall Study|Protocol Violation|0|||
156419643|NCT00848211|564630154|FG000|Overall Study|Adverse Event|0|||
156419644|NCT00848211|564630155|FG001|Overall Study|Adverse Event|0|||
156419645|NCT00848211|564630156|FG002|Overall Study|Adverse Event|0|||
156653650|NCT04700449|565479500|FG002|Stage 1: Double-Blind Period|Other|1|||
156653651|NCT04700449|565479501|FG003|Stage 1: Double-Blind Period|Other|0|||
156653652|NCT04700449|565479498|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
156653653|NCT04700449|565479499|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
156653654|NCT04700449|565479500|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
156653655|NCT04700449|565479501|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
156653656|NCT04700449|565479498|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
156653657|NCT04700449|565479499|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
156653658|NCT04700449|565479500|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
156653659|NCT04700449|565479501|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
156653660|NCT04700449|565479498|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
156653661|NCT04700449|565479499|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
156653662|NCT04700449|565479500|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
156653663|NCT04700449|565479501|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
156760049|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156318555|NCT00246571|564266370|FG001|Overall Study|Death|3|||
156419646|NCT00848211|564630157|FG003|Overall Study|Adverse Event|0|||
156419647|NCT00772928|564630158|FG000|Overall Study|Lost to Follow-up|9|||
156419648|NCT00772928|564630159|FG001|Overall Study|Lost to Follow-up|6|||
156419649|NCT00772928|564630158|FG000|Overall Study|Protocol Violation|10|||
156419650|NCT00772928|564630159|FG001|Overall Study|Protocol Violation|12|||
156419651|NCT00772928|564630158|FG000|Overall Study|Withdrawal by Subject|25|||
156419652|NCT00772928|564630159|FG001|Overall Study|Withdrawal by Subject|22|||
156419653|NCT00772928|564630158|FG000|Overall Study|Did not receive vaccine|0|||
156419654|NCT00772928|564630159|FG001|Overall Study|Did not receive vaccine|1|||
156419655|NCT01653743|564630163|FG000|Overall Study|Withdrawal by Subject|1|||
156419656|NCT01653743|564630164|FG001|Overall Study|Withdrawal by Subject|0|||
156419657|NCT01653743|564630163|FG000|Overall Study|Investigator discretion|3|||
156419658|NCT01653743|564630164|FG001|Overall Study|Investigator discretion|0|||
156419659|NCT00811187|564630167|FG000|Overall Study|Unable to place device / procedure abort|3|||
156419660|NCT00811187|564630168|FG001|Overall Study|Unable to place device / procedure abort|3|||
156419661|NCT00558753|564630172|FG000|Overall Study|Lost to Follow-up|5|||
156419662|NCT00558753|564630173|FG001|Overall Study|Lost to Follow-up|7|||
156419663|NCT01670500|564630179|FG000|Overall Study|Withdrawal by Subject|1|||
156419664|NCT01670500|564630180|FG001|Overall Study|Withdrawal by Subject|0|||
156419665|NCT04955626|564630181|FG000|Blinded Period|Lost to Follow-up|28|||
156419666|NCT04955626|564630182|FG001|Blinded Period|Lost to Follow-up|28|||
156419667|NCT04955626|564630183|FG002|Blinded Period|Lost to Follow-up|7|||
156419668|NCT04955626|564630184|FG003|Blinded Period|Lost to Follow-up|14|||
156419669|NCT04955626|564630185|FG004|Blinded Period|Lost to Follow-up|3|||
156419670|NCT04955626|564630186|FG005|Blinded Period|Lost to Follow-up|2|||
156419671|NCT04955626|564630187|FG006|Blinded Period|Lost to Follow-up|6|||
156419672|NCT04955626|564630188|FG007|Blinded Period|Lost to Follow-up|4|||
156419673|NCT04955626|564630189|FG008|Blinded Period|Lost to Follow-up|5|||
156419674|NCT04955626|564630190|FG009|Blinded Period|Lost to Follow-up|8|||
156419675|NCT04955626|564630191|FG010|Blinded Period|Lost to Follow-up|10|||
156419676|NCT04955626|564630192|FG011|Blinded Period|Lost to Follow-up|32|||
156419677|NCT04955626|564630193|FG012|Blinded Period|Lost to Follow-up|0|||
156419678|NCT04955626|564630194|FG013|Blinded Period|Lost to Follow-up|0|||
156653664|NCT04700449|565479498|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
156653665|NCT04700449|565479499|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
156318556|NCT00246571|564266369|FG000|Overall Study|Sponsor|0|||
156318557|NCT00246571|564266370|FG001|Overall Study|Sponsor|1|||
156318558|NCT00246571|564266369|FG000|Overall Study|Did not meet entrance criteria|2|||
156318559|NCT00246571|564266370|FG001|Overall Study|Did not meet entrance criteria|1|||
156318560|NCT00246571|564266369|FG000|Overall Study|Laboratory abnormalities|1|||
156318561|NCT00246571|564266370|FG001|Overall Study|Laboratory abnormalities|0|||
156318562|NCT00246571|564266369|FG000|Overall Study|Crossover participants|0|||
156318563|NCT00246571|564266370|FG001|Overall Study|Crossover participants|74|||
156318564|NCT05247398|564266371|FG000|Overall Study|Withdrawal by Subject|1|||
156318565|NCT04251156|564266372|FG000|Overall Study|Lost to Follow-up|1|||
156318566|NCT04251156|564266373|FG001|Overall Study|Lost to Follow-up|1|||
156318567|NCT04251156|564266372|FG000|Overall Study|Withdrawal by Subject|4|||
156318568|NCT04251156|564266373|FG001|Overall Study|Withdrawal by Subject|4|||
156318569|NCT02455557|564266374|FG000|Overall Study|Withdrawal by Subject|2|||
156318570|NCT04656275|564266375|FG000|Overall Study|Study terminated by sponsor|2|||
156653666|NCT04700449|565479500|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
156653667|NCT04700449|565479501|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
156419679|NCT04955626|564630195|FG014|Blinded Period|Lost to Follow-up|0|||
156419680|NCT04955626|564630196|FG015|Blinded Period|Lost to Follow-up|12|||
156419681|NCT04955626|564630197|FG016|Blinded Period|Lost to Follow-up|2|||
156419682|NCT04955626|564630198|FG017|Blinded Period|Lost to Follow-up|5|||
156419683|NCT04955626|564630199|FG018|Blinded Period|Lost to Follow-up|0|||
156419684|NCT04955626|564630200|FG019|Blinded Period|Lost to Follow-up|0|||
156419685|NCT04955626|564630201|FG020|Blinded Period|Lost to Follow-up|0|||
156419686|NCT04955626|564630202|FG021|Blinded Period|Lost to Follow-up|0|||
156419687|NCT04955626|564630203|FG022|Blinded Period|Lost to Follow-up|0|||
156419688|NCT04955626|564630204|FG023|Blinded Period|Lost to Follow-up|0|||
156419689|NCT04955626|564630205|FG024|Blinded Period|Lost to Follow-up|3|||
156419690|NCT04955626|564630206|FG025|Blinded Period|Lost to Follow-up|1|||
156419691|NCT04955626|564630207|FG026|Blinded Period|Lost to Follow-up|2|||
156419692|NCT04955626|564630208|FG027|Blinded Period|Lost to Follow-up|2|||
156419693|NCT04955626|564630209|FG028|Blinded Period|Lost to Follow-up|2|||
156760050|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760051|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760052|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760053|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760054|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760055|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760056|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
156760057|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760058|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
156419694|NCT04955626|564630210|FG029|Blinded Period|Lost to Follow-up|0|||
156419695|NCT04955626|564630211|FG030|Blinded Period|Lost to Follow-up|0|||
156419696|NCT04955626|564630212|FG031|Blinded Period|Lost to Follow-up|0|||
156419697|NCT04955626|564630213|FG032|Blinded Period|Lost to Follow-up|0|||
156419698|NCT04955626|564630214|FG033|Blinded Period|Lost to Follow-up|0|||
156419699|NCT04955626|564630215|FG034|Blinded Period|Lost to Follow-up|0|||
156419700|NCT04955626|564630216|FG035|Blinded Period|Lost to Follow-up|0|||
156419701|NCT04955626|564630181|FG000|Blinded Period|Protocol Violation|5|||
156419702|NCT04955626|564630182|FG001|Blinded Period|Protocol Violation|14|||
156419703|NCT04955626|564630183|FG002|Blinded Period|Protocol Violation|0|||
156419704|NCT04955626|564630184|FG003|Blinded Period|Protocol Violation|1|||
156419705|NCT04955626|564630185|FG004|Blinded Period|Protocol Violation|2|||
156419706|NCT04955626|564630186|FG005|Blinded Period|Protocol Violation|2|||
156419707|NCT04955626|564630187|FG006|Blinded Period|Protocol Violation|0|||
156419708|NCT04955626|564630188|FG007|Blinded Period|Protocol Violation|0|||
156419709|NCT04955626|564630189|FG008|Blinded Period|Protocol Violation|0|||
156419710|NCT04955626|564630190|FG009|Blinded Period|Protocol Violation|4|||
156419711|NCT04955626|564630191|FG010|Blinded Period|Protocol Violation|6|||
156419712|NCT04955626|564630192|FG011|Blinded Period|Protocol Violation|1|||
156419713|NCT04955626|564630193|FG012|Blinded Period|Protocol Violation|0|||
156419714|NCT04955626|564630194|FG013|Blinded Period|Protocol Violation|0|||
156419715|NCT04955626|564630195|FG014|Blinded Period|Protocol Violation|2|||
156419716|NCT04955626|564630196|FG015|Blinded Period|Protocol Violation|6|||
156419717|NCT04955626|564630197|FG016|Blinded Period|Protocol Violation|4|||
156419718|NCT04955626|564630198|FG017|Blinded Period|Protocol Violation|6|||
156419719|NCT04955626|564630199|FG018|Blinded Period|Protocol Violation|0|||
156419720|NCT04955626|564630200|FG019|Blinded Period|Protocol Violation|1|||
156419721|NCT04955626|564630201|FG020|Blinded Period|Protocol Violation|0|||
156419722|NCT04955626|564630202|FG021|Blinded Period|Protocol Violation|1|||
156419723|NCT04955626|564630203|FG022|Blinded Period|Protocol Violation|0|||
156419724|NCT04955626|564630204|FG023|Blinded Period|Protocol Violation|0|||
156419725|NCT04955626|564630205|FG024|Blinded Period|Protocol Violation|4|||
156419726|NCT04955626|564630206|FG025|Blinded Period|Protocol Violation|6|||
156419727|NCT04955626|564630207|FG026|Blinded Period|Protocol Violation|5|||
156419728|NCT04955626|564630208|FG027|Blinded Period|Protocol Violation|3|||
156419729|NCT04955626|564630209|FG028|Blinded Period|Protocol Violation|4|||
156419730|NCT04955626|564630210|FG029|Blinded Period|Protocol Violation|3|||
156419731|NCT04955626|564630211|FG030|Blinded Period|Protocol Violation|0|||
156419732|NCT04955626|564630212|FG031|Blinded Period|Protocol Violation|0|||
156419733|NCT04955626|564630213|FG032|Blinded Period|Protocol Violation|0|||
156419734|NCT04955626|564630214|FG033|Blinded Period|Protocol Violation|0|||
156419735|NCT04955626|564630215|FG034|Blinded Period|Protocol Violation|0|||
156419736|NCT04955626|564630216|FG035|Blinded Period|Protocol Violation|0|||
156419737|NCT04955626|564630181|FG000|Blinded Period|Death|0|||
156419738|NCT04955626|564630182|FG001|Blinded Period|Death|2|||
156419739|NCT04955626|564630183|FG002|Blinded Period|Death|0|||
156419740|NCT04955626|564630184|FG003|Blinded Period|Death|0|||
156419741|NCT04955626|564630185|FG004|Blinded Period|Death|0|||
156419742|NCT04955626|564630186|FG005|Blinded Period|Death|0|||
156419743|NCT04955626|564630187|FG006|Blinded Period|Death|0|||
156419744|NCT04955626|564630188|FG007|Blinded Period|Death|2|||
156419745|NCT04955626|564630189|FG008|Blinded Period|Death|1|||
156419746|NCT04955626|564630190|FG009|Blinded Period|Death|1|||
156419747|NCT04955626|564630191|FG010|Blinded Period|Death|0|||
156419748|NCT04955626|564630192|FG011|Blinded Period|Death|2|||
156419749|NCT04955626|564630193|FG012|Blinded Period|Death|0|||
156760059|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760060|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
156760061|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760062|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156419750|NCT04955626|564630194|FG013|Blinded Period|Death|0|||
156760063|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760064|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760065|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760066|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156419751|NCT04955626|564630195|FG014|Blinded Period|Death|0|||
156419752|NCT04955626|564630196|FG015|Blinded Period|Death|0|||
156419753|NCT04955626|564630197|FG016|Blinded Period|Death|0|||
156419754|NCT04955626|564630198|FG017|Blinded Period|Death|0|||
156653668|NCT04700449|565479498|FG000|Stage 2 Sub-study 1|Other|1|||
156653669|NCT04700449|565479499|FG001|Stage 2 Sub-study 1|Other|2|||
156653670|NCT04700449|565479500|FG002|Stage 2 Sub-study 1|Other|0|||
156653671|NCT04700449|565479501|FG003|Stage 2 Sub-study 1|Other|0|||
156653672|NCT04700449|565479498|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
156653673|NCT04700449|565479499|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
156653674|NCT04700449|565479500|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
156653675|NCT04700449|565479501|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
156653676|NCT04700449|565479498|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
156653677|NCT04700449|565479499|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
156653678|NCT04700449|565479500|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
156653679|NCT04700449|565479501|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
156653680|NCT04700449|565479498|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
156653681|NCT04700449|565479499|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
156653682|NCT04700449|565479500|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
156653683|NCT04700449|565479501|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
156653684|NCT04700449|565479498|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
156653685|NCT04700449|565479499|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
156653686|NCT04700449|565479500|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
156653687|NCT04700449|565479501|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
156653688|NCT04700449|565479498|FG000|Stage 2 Sub-study 2|Other|0|||
156653689|NCT04700449|565479499|FG001|Stage 2 Sub-study 2|Other|0|||
156653690|NCT04700449|565479500|FG002|Stage 2 Sub-study 2|Other|0|||
156653691|NCT04700449|565479501|FG003|Stage 2 Sub-study 2|Other|5|||
156653692|NCT00356200|565479502|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
156653693|NCT00356200|565479503|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
156653694|NCT00356200|565479502|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
156653695|NCT00356200|565479503|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
156653696|NCT01000337|565479504|FG000|Overall Study|Lost to Follow-up|4|||
156653697|NCT01000337|565479505|FG001|Overall Study|Lost to Follow-up|3|||
156653698|NCT03901963|565479506|FG000|Overall Study|Lost to Follow-up|1|||
156653699|NCT03901963|565479507|FG001|Overall Study|Lost to Follow-up|1|||
156653700|NCT03901963|565479506|FG000|Overall Study|Physician Decision|1|||
156653701|NCT03901963|565479507|FG001|Overall Study|Physician Decision|2|||
156653702|NCT03901963|565479506|FG000|Overall Study|Protocol Violation|1|||
156653703|NCT03901963|565479507|FG001|Overall Study|Protocol Violation|1|||
156653704|NCT03901963|565479506|FG000|Overall Study|Withdrawal by Subject|4|||
156653705|NCT03901963|565479507|FG001|Overall Study|Withdrawal by Subject|11|||
156653706|NCT03901963|565479506|FG000|Overall Study|Ongoing|84|||
156653707|NCT03901963|565479507|FG001|Overall Study|Ongoing|73|||
156653708|NCT03901963|565479506|FG000|Overall Study|Randomized but not treated|3|||
156653709|NCT03901963|565479507|FG001|Overall Study|Randomized but not treated|3|||
156653710|NCT02854436|565479508|FG000|Overall Study|Adverse Event|1|||
156653711|NCT02854436|565479508|FG000|Overall Study|Death|208|||
156653712|NCT02854436|565479508|FG000|Overall Study|Lost to Follow-up|5|||
156653713|NCT02854436|565479508|FG000|Overall Study|Withdrawal by Subject|24|||
156653714|NCT02854436|565479508|FG000|Overall Study|Other|45|||
156653715|NCT02854436|565479508|FG000|Overall Study|Physician Decision|6|||
156653716|NCT01700621|565479509|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
156653717|NCT01700621|565479510|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
156653718|NCT01700621|565479509|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
156653719|NCT01700621|565479510|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
156653720|NCT01700621|565479509|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
156653721|NCT01700621|565479510|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
156653722|NCT02909673|565479511|FG000|Overall Study|Did not meet inclusion criteria|129|||
156760067|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156419755|NCT04955626|564630199|FG018|Blinded Period|Death|0|||
156653723|NCT02909673|565479512|FG001|Overall Study|Did not meet inclusion criteria|29|||
156653724|NCT02909673|565479511|FG000|Overall Study|Surveys lost by scanner|95|||
156653725|NCT02909673|565479512|FG001|Overall Study|Surveys lost by scanner|2|||
156653726|NCT02909673|565479511|FG000|Overall Study|Tracking info missing|0|||
156653727|NCT02909673|565479512|FG001|Overall Study|Tracking info missing|5|||
156653728|NCT02035137|565479515|FG000|Overall Study|Physician Decision|0|||
156760068|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760069|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760070|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760071|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760072|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
156760073|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760074|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760075|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
156760076|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760077|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760078|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760079|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760080|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760081|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760082|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760083|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760084|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760085|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760086|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760087|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
156760088|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
156760089|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760090|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
156760091|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760092|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760093|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156318571|NCT04656275|564266376|FG001|Overall Study|Study terminated by sponsor|4|||
156318572|NCT05954143|564266380|FG000|Overall Study|Progressive Disease|1|||
156318573|NCT05954143|564266381|FG001|Overall Study|Progressive Disease|0|||
156318574|NCT05954143|564266380|FG000|Overall Study|Physician Decision|1|||
156318575|NCT05954143|564266381|FG001|Overall Study|Physician Decision|0|||
156318576|NCT05954143|564266380|FG000|Overall Study|Study Terminated by Sponsor|2|||
156318577|NCT05954143|564266381|FG001|Overall Study|Study Terminated by Sponsor|4|||
156318578|NCT05954143|564266380|FG000|Overall Study|Death|1|||
156318579|NCT05954143|564266381|FG001|Overall Study|Death|0|||
156318580|NCT05954143|564266380|FG000|Overall Study|Withdrawal by Subject|0|||
156318581|NCT05954143|564266381|FG001|Overall Study|Withdrawal by Subject|1|||
156318582|NCT05954143|564266380|FG000|Overall Study|Other|1|||
156318583|NCT05954143|564266381|FG001|Overall Study|Other|0|||
156318584|NCT01129024|564266384|FG000|Overall Study|Physician Decision|5|||
156318585|NCT01129024|564266384|FG000|Overall Study|Study Terminated by Sponsor|8|||
156318586|NCT01129024|564266384|FG000|Overall Study|Withdrawal by Subject|2|||
156318587|NCT01129024|564266384|FG000|Overall Study|Lack of Efficacy|3|||
156318588|NCT01129024|564266384|FG000|Overall Study|Needed a Platelet Transfusion|1|||
156318589|NCT00708201|564266392|FG000|Overall Study|Adverse Event|4|||
156318590|NCT00708201|564266393|FG001|Overall Study|Adverse Event|4|||
156318591|NCT00708201|564266392|FG000|Overall Study|Withdrawal by Subject|1|||
156318592|NCT00708201|564266393|FG001|Overall Study|Withdrawal by Subject|1|||
156318593|NCT00708201|564266392|FG000|Overall Study|Lost to Follow-up|2|||
156318594|NCT00708201|564266393|FG001|Overall Study|Lost to Follow-up|0|||
156318595|NCT00708201|564266392|FG000|Overall Study|Protocol Violation|0|||
156318596|NCT00708201|564266393|FG001|Overall Study|Protocol Violation|1|||
156318597|NCT00761748|564266394|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
156318598|NCT00761748|564266395|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
156318599|NCT00761748|564266394|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
156318600|NCT00761748|564266395|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
156318601|NCT01857310|564266396|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
156318602|NCT01857310|564266397|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
156318603|NCT02554279|564266398|FG000|Overall Study|Adverse Event|2|||
156318604|NCT02554279|564266399|FG001|Overall Study|Adverse Event|5|||
156318605|NCT02554279|564266398|FG000|Overall Study|Lost to Follow-up|3|||
156318606|NCT02554279|564266399|FG001|Overall Study|Lost to Follow-up|2|||
156318607|NCT02554279|564266398|FG000|Overall Study|Withdrawal by Subject|6|||
156318608|NCT02554279|564266399|FG001|Overall Study|Withdrawal by Subject|4|||
156318609|NCT02554279|564266398|FG000|Overall Study|Protocol Violation|2|||
156318610|NCT02554279|564266399|FG001|Overall Study|Protocol Violation|1|||
156318611|NCT02554279|564266398|FG000|Overall Study|Other reason|19|||
156318612|NCT02554279|564266399|FG001|Overall Study|Other reason|6|||
156318613|NCT00812487|564266400|FG000|Overall Study|Lost to Follow-up|2|||
156318614|NCT00812487|564266401|FG001|Overall Study|Lost to Follow-up|0|||
156318615|NCT00812487|564266400|FG000|Overall Study|Withdrawal by Subject|3|||
156419756|NCT04955626|564630200|FG019|Blinded Period|Death|0|||
156419757|NCT04955626|564630201|FG020|Blinded Period|Death|0|||
156419758|NCT04955626|564630202|FG021|Blinded Period|Death|0|||
156419759|NCT04955626|564630203|FG022|Blinded Period|Death|0|||
156419760|NCT04955626|564630204|FG023|Blinded Period|Death|1|||
156419761|NCT04955626|564630205|FG024|Blinded Period|Death|0|||
156419762|NCT04955626|564630206|FG025|Blinded Period|Death|0|||
156419763|NCT04955626|564630207|FG026|Blinded Period|Death|1|||
156419764|NCT04955626|564630208|FG027|Blinded Period|Death|1|||
156419765|NCT04955626|564630209|FG028|Blinded Period|Death|0|||
156419766|NCT04955626|564630210|FG029|Blinded Period|Death|1|||
156419767|NCT04955626|564630211|FG030|Blinded Period|Death|0|||
156419768|NCT04955626|564630212|FG031|Blinded Period|Death|0|||
156419769|NCT04955626|564630213|FG032|Blinded Period|Death|0|||
156419770|NCT04955626|564630214|FG033|Blinded Period|Death|0|||
156419771|NCT04955626|564630215|FG034|Blinded Period|Death|0|||
156419772|NCT04955626|564630216|FG035|Blinded Period|Death|0|||
156419773|NCT04955626|564630181|FG000|Blinded Period|Adverse Event|0|||
156419774|NCT04955626|564630182|FG001|Blinded Period|Adverse Event|1|||
156419775|NCT04955626|564630183|FG002|Blinded Period|Adverse Event|1|||
156419776|NCT04955626|564630184|FG003|Blinded Period|Adverse Event|1|||
156419777|NCT04955626|564630185|FG004|Blinded Period|Adverse Event|0|||
156419778|NCT04955626|564630186|FG005|Blinded Period|Adverse Event|0|||
156419779|NCT04955626|564630187|FG006|Blinded Period|Adverse Event|0|||
156419780|NCT04955626|564630188|FG007|Blinded Period|Adverse Event|0|||
156419781|NCT04955626|564630189|FG008|Blinded Period|Adverse Event|0|||
156419782|NCT04955626|564630190|FG009|Blinded Period|Adverse Event|1|||
156419783|NCT04955626|564630191|FG010|Blinded Period|Adverse Event|1|||
156419784|NCT04955626|564630192|FG011|Blinded Period|Adverse Event|0|||
156419785|NCT04955626|564630193|FG012|Blinded Period|Adverse Event|0|||
156419786|NCT04955626|564630194|FG013|Blinded Period|Adverse Event|0|||
156419787|NCT04955626|564630195|FG014|Blinded Period|Adverse Event|0|||
156419788|NCT04955626|564630196|FG015|Blinded Period|Adverse Event|0|||
156419789|NCT04955626|564630197|FG016|Blinded Period|Adverse Event|0|||
156419790|NCT04955626|564630198|FG017|Blinded Period|Adverse Event|0|||
156419791|NCT04955626|564630199|FG018|Blinded Period|Adverse Event|1|||
156419792|NCT04955626|564630200|FG019|Blinded Period|Adverse Event|0|||
156419793|NCT04955626|564630201|FG020|Blinded Period|Adverse Event|0|||
156419794|NCT04955626|564630202|FG021|Blinded Period|Adverse Event|0|||
156419795|NCT04955626|564630203|FG022|Blinded Period|Adverse Event|0|||
156419796|NCT04955626|564630204|FG023|Blinded Period|Adverse Event|0|||
156419797|NCT04955626|564630205|FG024|Blinded Period|Adverse Event|0|||
156419798|NCT04955626|564630206|FG025|Blinded Period|Adverse Event|0|||
156419799|NCT04955626|564630207|FG026|Blinded Period|Adverse Event|1|||
156419800|NCT04955626|564630208|FG027|Blinded Period|Adverse Event|0|||
156419801|NCT04955626|564630209|FG028|Blinded Period|Adverse Event|0|||
156419802|NCT04955626|564630210|FG029|Blinded Period|Adverse Event|0|||
156419803|NCT04955626|564630211|FG030|Blinded Period|Adverse Event|0|||
156419804|NCT04955626|564630212|FG031|Blinded Period|Adverse Event|0|||
156419805|NCT04955626|564630213|FG032|Blinded Period|Adverse Event|0|||
156419806|NCT04955626|564630214|FG033|Blinded Period|Adverse Event|0|||
156419807|NCT04955626|564630215|FG034|Blinded Period|Adverse Event|0|||
156419808|NCT04955626|564630216|FG035|Blinded Period|Adverse Event|0|||
156419809|NCT04955626|564630181|FG000|Blinded Period|No longer meets eligibility criteria|1|||
156419810|NCT04955626|564630182|FG001|Blinded Period|No longer meets eligibility criteria|2|||
156419811|NCT04955626|564630183|FG002|Blinded Period|No longer meets eligibility criteria|0|||
156419812|NCT04955626|564630184|FG003|Blinded Period|No longer meets eligibility criteria|1|||
156760094|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760095|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760096|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760097|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760098|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156419813|NCT04955626|564630185|FG004|Blinded Period|No longer meets eligibility criteria|0|||
156419814|NCT04955626|564630186|FG005|Blinded Period|No longer meets eligibility criteria|0|||
156419815|NCT04955626|564630187|FG006|Blinded Period|No longer meets eligibility criteria|0|||
156419816|NCT04955626|564630188|FG007|Blinded Period|No longer meets eligibility criteria|0|||
156419817|NCT04955626|564630189|FG008|Blinded Period|No longer meets eligibility criteria|1|||
156419818|NCT04955626|564630190|FG009|Blinded Period|No longer meets eligibility criteria|0|||
156419819|NCT04955626|564630191|FG010|Blinded Period|No longer meets eligibility criteria|1|||
156419820|NCT04955626|564630192|FG011|Blinded Period|No longer meets eligibility criteria|1|||
156419821|NCT04955626|564630193|FG012|Blinded Period|No longer meets eligibility criteria|0|||
156419822|NCT04955626|564630194|FG013|Blinded Period|No longer meets eligibility criteria|0|||
156419823|NCT04955626|564630195|FG014|Blinded Period|No longer meets eligibility criteria|0|||
156419824|NCT04955626|564630196|FG015|Blinded Period|No longer meets eligibility criteria|3|||
156419825|NCT04955626|564630197|FG016|Blinded Period|No longer meets eligibility criteria|0|||
156419826|NCT04955626|564630198|FG017|Blinded Period|No longer meets eligibility criteria|2|||
156419827|NCT04955626|564630199|FG018|Blinded Period|No longer meets eligibility criteria|0|||
156760099|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156419828|NCT04955626|564630200|FG019|Blinded Period|No longer meets eligibility criteria|0|||
156760100|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156419829|NCT04955626|564630201|FG020|Blinded Period|No longer meets eligibility criteria|0|||
156419830|NCT04955626|564630202|FG021|Blinded Period|No longer meets eligibility criteria|0|||
156419831|NCT04955626|564630203|FG022|Blinded Period|No longer meets eligibility criteria|0|||
156419832|NCT04955626|564630204|FG023|Blinded Period|No longer meets eligibility criteria|0|||
156419833|NCT04955626|564630205|FG024|Blinded Period|No longer meets eligibility criteria|1|||
156760101|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760102|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
156760103|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156419834|NCT04955626|564630206|FG025|Blinded Period|No longer meets eligibility criteria|0|||
156419835|NCT04955626|564630207|FG026|Blinded Period|No longer meets eligibility criteria|0|||
156419836|NCT04955626|564630208|FG027|Blinded Period|No longer meets eligibility criteria|1|||
156419837|NCT04955626|564630209|FG028|Blinded Period|No longer meets eligibility criteria|0|||
156760104|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760105|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760106|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760107|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760108|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760109|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760110|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760111|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760112|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760113|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760114|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760115|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760116|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760117|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760118|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
156760119|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760120|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760121|NCT00737100|565873877|FG000|Overall Study|Adverse Event|6|||
156760122|NCT00737100|565873878|FG001|Overall Study|Adverse Event|5|||
156760123|NCT00737100|565873879|FG002|Overall Study|Adverse Event|3|||
156760124|NCT00737100|565873877|FG000|Overall Study|Lost to Follow-up|0|||
156760125|NCT00737100|565873878|FG001|Overall Study|Lost to Follow-up|1|||
156760126|NCT00737100|565873879|FG002|Overall Study|Lost to Follow-up|0|||
156760127|NCT00737100|565873877|FG000|Overall Study|Withdrawal by Subject|0|||
156760128|NCT00737100|565873878|FG001|Overall Study|Withdrawal by Subject|0|||
156760129|NCT00737100|565873879|FG002|Overall Study|Withdrawal by Subject|3|||
156760130|NCT00737100|565873877|FG000|Overall Study|Reason discontinued not explained above|1|||
156760131|NCT00737100|565873878|FG001|Overall Study|Reason discontinued not explained above|1|||
156760132|NCT00737100|565873879|FG002|Overall Study|Reason discontinued not explained above|1|||
156760133|NCT00735943|565873884|FG000|Overall Study|Lost to Follow-up|1|||
156760134|NCT00735943|565873884|FG000|Overall Study|Adverse Event|1|||
156760135|NCT00115778|565873887|FG000|Overall Study|Withdrawal by Subject|0|||
156760136|NCT00115778|565873888|FG001|Overall Study|Withdrawal by Subject|1|||
156760137|NCT01607593|565873889|FG000|Overall Study|Adverse Event|15|||
156760138|NCT01607593|565873889|FG000|Overall Study|Lack of Efficacy|16|||
156760139|NCT01607593|565873889|FG000|Overall Study|Lost to Follow-up|25|||
156419838|NCT04955626|564630210|FG029|Blinded Period|No longer meets eligibility criteria|0|||
156419839|NCT04955626|564630211|FG030|Blinded Period|No longer meets eligibility criteria|0|||
156419840|NCT04955626|564630212|FG031|Blinded Period|No longer meets eligibility criteria|0|||
156760140|NCT01607593|565873889|FG000|Overall Study|Continuation|33|||
156760141|NCT01607593|565873889|FG000|Overall Study|Other|4|||
156760142|NCT03713684|565873894|FG000|Overall Study|Adverse Event|1|||
156760143|NCT03713684|565873895|FG001|Overall Study|Adverse Event|3|||
156760144|NCT03713684|565873896|FG002|Overall Study|Adverse Event|1|||
156760145|NCT03713684|565873897|FG003|Overall Study|Adverse Event|0|||
156760146|NCT03713684|565873894|FG000|Overall Study|Poor compliance to protocol|2|||
156419841|NCT04955626|564630213|FG032|Blinded Period|No longer meets eligibility criteria|0|||
156419842|NCT04955626|564630214|FG033|Blinded Period|No longer meets eligibility criteria|0|||
156419843|NCT04955626|564630215|FG034|Blinded Period|No longer meets eligibility criteria|0|||
156760147|NCT03713684|565873895|FG001|Overall Study|Poor compliance to protocol|1|||
156760148|NCT03713684|565873896|FG002|Overall Study|Poor compliance to protocol|0|||
156760149|NCT03713684|565873897|FG003|Overall Study|Poor compliance to protocol|1|||
156760150|NCT03713684|565873894|FG000|Overall Study|Withdrawal by Subject|14|||
156760151|NCT03713684|565873895|FG001|Overall Study|Withdrawal by Subject|6|||
156760152|NCT03713684|565873896|FG002|Overall Study|Withdrawal by Subject|14|||
156419844|NCT04955626|564630216|FG035|Blinded Period|No longer meets eligibility criteria|0|||
156760153|NCT03713684|565873897|FG003|Overall Study|Withdrawal by Subject|16|||
156760154|NCT03713684|565873894|FG000|Overall Study|Other than specified|69|||
156760155|NCT03713684|565873895|FG001|Overall Study|Other than specified|77|||
156760156|NCT03713684|565873896|FG002|Overall Study|Other than specified|73|||
156760157|NCT03713684|565873897|FG003|Overall Study|Other than specified|70|||
156760158|NCT00528424|565873898|FG000|Overall Study|Lost to Follow-up|13|||
156760159|NCT00528424|565873898|FG000|Overall Study|Withdrew consent|2|||
156760160|NCT00528424|565873898|FG000|Overall Study|Administrative reason|2|||
156760161|NCT00528424|565873898|FG000|Overall Study|Other|12|||
156760162|NCT02515630|565873899|FG000|Overall Study|Withdrawal by Subject|5|||
156760163|NCT02515630|565873899|FG000|Overall Study|Adverse Event|4|||
156760164|NCT02515630|565873899|FG000|Overall Study|Physician Decision|4|||
156760165|NCT02515630|565873899|FG000|Overall Study|Death|2|||
156760166|NCT02515630|565873899|FG000|Overall Study|Disease Progression|1|||
156760167|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
156760168|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
156760169|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
156760170|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Death|0|||
156760171|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Death|1|||
156760172|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Death|0|||
156760173|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
156760174|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
156760175|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
156760176|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
156760177|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
156760178|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
156760179|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156760180|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
156760181|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156760182|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Other|4|||
156760183|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Other|7|||
156760184|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Other|2|||
156760185|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
156760186|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156760187|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
156760188|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Death|0|||
156760189|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Death|1|||
156760190|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Death|0|||
156760191|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
156760192|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156760193|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156760194|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
156760195|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156760196|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156760197|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156760198|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156760199|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156760200|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
156760201|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
156760202|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
156760203|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156760204|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156760205|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156760206|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Other|5|||
156760207|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Other|2|||
156760208|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Other|1|||
156760209|NCT02185417|565873905|FG000|Overall Study|Death|448|||
156760210|NCT02185417|565873906|FG001|Overall Study|Death|446|||
156760211|NCT02185417|565873907|FG002|Overall Study|Death|0|||
156760212|NCT02185417|565873905|FG000|Overall Study|Withdrawal by Subject|7|||
156760213|NCT02185417|565873906|FG001|Overall Study|Withdrawal by Subject|12|||
156760214|NCT02185417|565873907|FG002|Overall Study|Withdrawal by Subject|0|||
156760215|NCT02595502|565873910|FG000|Period 1|Adverse Event|0|||
156760216|NCT02595502|565873911|FG001|Period 1|Adverse Event|1|||
156760217|NCT02595502|565873910|FG000|Period 1|Withdrawal by Subject|1|||
156760218|NCT02595502|565873911|FG001|Period 1|Withdrawal by Subject|0|||
156760219|NCT02595502|565873910|FG000|Period 1|Lost to Follow-up|0|||
156760220|NCT02595502|565873911|FG001|Period 1|Lost to Follow-up|1|||
156760221|NCT02595502|565873910|FG000|Period 2|Adverse Event|1|||
156760222|NCT02595502|565873911|FG001|Period 2|Adverse Event|1|||
156760223|NCT02595502|565873910|FG000|Period 2|Received incorrect lens at Period 1|0|||
156419845|NCT04955626|564630181|FG000|Blinded Period|Other|54|||
156419846|NCT04955626|564630182|FG001|Blinded Period|Other|3|||
156419847|NCT04955626|564630183|FG002|Blinded Period|Other|4|||
156419848|NCT04955626|564630184|FG003|Blinded Period|Other|2|||
156419849|NCT04955626|564630185|FG004|Blinded Period|Other|0|||
156419850|NCT04955626|564630186|FG005|Blinded Period|Other|0|||
156419851|NCT04955626|564630187|FG006|Blinded Period|Other|2|||
156419852|NCT04955626|564630188|FG007|Blinded Period|Other|2|||
156419853|NCT04955626|564630189|FG008|Blinded Period|Other|1|||
156419854|NCT04955626|564630190|FG009|Blinded Period|Other|0|||
156419855|NCT04955626|564630191|FG010|Blinded Period|Other|1|||
156419856|NCT04955626|564630192|FG011|Blinded Period|Other|1|||
156419857|NCT04955626|564630193|FG012|Blinded Period|Other|0|||
156419858|NCT04955626|564630194|FG013|Blinded Period|Other|0|||
156419859|NCT04955626|564630195|FG014|Blinded Period|Other|0|||
156419860|NCT04955626|564630196|FG015|Blinded Period|Other|0|||
156419861|NCT04955626|564630197|FG016|Blinded Period|Other|0|||
156419862|NCT04955626|564630198|FG017|Blinded Period|Other|1|||
156419863|NCT04955626|564630199|FG018|Blinded Period|Other|0|||
156419864|NCT04955626|564630200|FG019|Blinded Period|Other|0|||
156419865|NCT04955626|564630201|FG020|Blinded Period|Other|0|||
156419866|NCT04955626|564630202|FG021|Blinded Period|Other|0|||
156419867|NCT04955626|564630203|FG022|Blinded Period|Other|0|||
156419868|NCT04955626|564630204|FG023|Blinded Period|Other|0|||
156419869|NCT04955626|564630205|FG024|Blinded Period|Other|0|||
156419870|NCT04955626|564630206|FG025|Blinded Period|Other|0|||
156419871|NCT04955626|564630207|FG026|Blinded Period|Other|2|||
156419872|NCT04955626|564630208|FG027|Blinded Period|Other|0|||
156419873|NCT04955626|564630209|FG028|Blinded Period|Other|0|||
156419874|NCT04955626|564630210|FG029|Blinded Period|Other|0|||
156419875|NCT04955626|564630211|FG030|Blinded Period|Other|0|||
156419876|NCT04955626|564630212|FG031|Blinded Period|Other|0|||
156419877|NCT04955626|564630213|FG032|Blinded Period|Other|0|||
156419878|NCT04955626|564630214|FG033|Blinded Period|Other|0|||
156419879|NCT04955626|564630215|FG034|Blinded Period|Other|0|||
156419880|NCT04955626|564630216|FG035|Blinded Period|Other|0|||
156653729|NCT02035137|565479516|FG001|Overall Study|Physician Decision|0|||
156653730|NCT02035137|565479517|FG002|Overall Study|Physician Decision|1|||
156653731|NCT02035137|565479515|FG000|Overall Study|Withdrawal by Subject|0|||
156653732|NCT02035137|565479516|FG001|Overall Study|Withdrawal by Subject|1|||
156653733|NCT02035137|565479517|FG002|Overall Study|Withdrawal by Subject|2|||
156653734|NCT02035137|565479515|FG000|Overall Study|Ineligible|0|||
156653735|NCT02035137|565479516|FG001|Overall Study|Ineligible|1|||
156653736|NCT02035137|565479517|FG002|Overall Study|Ineligible|2|||
156653737|NCT02035137|565479515|FG000|Overall Study|Disease progression prior to treatment start|2|||
156653738|NCT02035137|565479516|FG001|Overall Study|Disease progression prior to treatment start|0|||
156653739|NCT02035137|565479517|FG002|Overall Study|Disease progression prior to treatment start|0|||
156653740|NCT02540356|565479524|FG000|Overall Study|Terminated due to disease progression|1|||
156653741|NCT02540356|565479525|FG001|Overall Study|Terminated due to disease progression|0|||
156653742|NCT00684671|565479526|FG000|Overall Study|Adverse Event|1|||
156653743|NCT00684671|565479527|FG001|Overall Study|Adverse Event|0|||
156653744|NCT00684671|565479528|FG002|Overall Study|Adverse Event|0|||
156653745|NCT00684671|565479526|FG000|Overall Study|Lost to Follow-up|1|||
156653746|NCT00684671|565479527|FG001|Overall Study|Lost to Follow-up|0|||
156653747|NCT00684671|565479528|FG002|Overall Study|Lost to Follow-up|0|||
156653748|NCT00684671|565479526|FG000|Overall Study|Alcoholic dependance|1|||
156653749|NCT00684671|565479527|FG001|Overall Study|Alcoholic dependance|0|||
156653750|NCT00684671|565479528|FG002|Overall Study|Alcoholic dependance|0|||
156653751|NCT04128007|565479529|FG000|Overall Study|Withdrawal by Subject|9|||
156653752|NCT04128007|565479530|FG001|Overall Study|Withdrawal by Subject|6|||
156653753|NCT04128007|565479529|FG000|Overall Study|Protocol Violation|1|||
156653754|NCT04128007|565479530|FG001|Overall Study|Protocol Violation|0|||
156653755|NCT04128007|565479529|FG000|Overall Study|Lost to Follow-up|8|||
156653756|NCT04128007|565479530|FG001|Overall Study|Lost to Follow-up|7|||
156653757|NCT04128007|565479529|FG000|Overall Study|Adverse Event|5|||
156419881|NCT04955626|564630181|FG000|Blinded Period|Physician Decision|1|||
156419882|NCT04955626|564630182|FG001|Blinded Period|Physician Decision|1|||
156419883|NCT04955626|564630183|FG002|Blinded Period|Physician Decision|0|||
156419884|NCT04955626|564630184|FG003|Blinded Period|Physician Decision|3|||
156419885|NCT04955626|564630185|FG004|Blinded Period|Physician Decision|0|||
156419886|NCT04955626|564630186|FG005|Blinded Period|Physician Decision|0|||
156419887|NCT04955626|564630187|FG006|Blinded Period|Physician Decision|1|||
156419888|NCT04955626|564630188|FG007|Blinded Period|Physician Decision|1|||
156419889|NCT04955626|564630189|FG008|Blinded Period|Physician Decision|0|||
156419890|NCT04955626|564630190|FG009|Blinded Period|Physician Decision|0|||
156419891|NCT04955626|564630191|FG010|Blinded Period|Physician Decision|0|||
156419892|NCT04955626|564630192|FG011|Blinded Period|Physician Decision|5|||
156419893|NCT04955626|564630193|FG012|Blinded Period|Physician Decision|0|||
156419894|NCT04955626|564630194|FG013|Blinded Period|Physician Decision|0|||
156653758|NCT04128007|565479530|FG001|Overall Study|Adverse Event|2|||
156653759|NCT04128007|565479529|FG000|Overall Study|Not reported|0|||
156653760|NCT04128007|565479530|FG001|Overall Study|Not reported|2|||
156760224|NCT02595502|565873911|FG001|Period 2|Received incorrect lens at Period 1|1|||
156760225|NCT02595502|565873910|FG000|Period 3|Protocol Violation|0|||
156760226|NCT02595502|565873911|FG001|Period 3|Protocol Violation|1|||
156760227|NCT02595502|565873910|FG000|Period 3|Lost to Follow-up|1|||
156760228|NCT02595502|565873911|FG001|Period 3|Lost to Follow-up|0|||
156760229|NCT02595502|565873910|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
156760230|NCT02595502|565873911|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
156760231|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
156760232|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
156760233|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Death|561|||
156760234|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Death|298|||
156760235|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
156760236|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
156760237|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
156760238|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
156760239|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Other|1|||
156760240|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Other|0|||
156760241|NCT00974311|565873912|FG000|OLE Phase (up to 77 Months)|Death|14|||
156760242|NCT00974311|565873913|FG001|OLE Phase (up to 77 Months)|Death|21|||
156760243|NCT00974311|565873912|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
156760244|NCT00974311|565873913|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
156760245|NCT00974311|565873912|FG000|OLE Phase (up to 77 Months)|Other|15|||
156760246|NCT00974311|565873913|FG001|OLE Phase (up to 77 Months)|Other|2|||
156760247|NCT00974311|565873912|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
156760248|NCT00974311|565873913|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
156760249|NCT03131167|565873914|FG000|Overall Study|Other (Unspecified)|0|||
156760250|NCT03131167|565873915|FG001|Overall Study|Other (Unspecified)|0|||
156760251|NCT03131167|565873916|FG002|Overall Study|Other (Unspecified)|0|||
156760252|NCT03131167|565873917|FG003|Overall Study|Other (Unspecified)|0|||
156760253|NCT03131167|565873918|FG004|Overall Study|Other (Unspecified)|0|||
156760254|NCT03131167|565873919|FG005|Overall Study|Other (Unspecified)|1|||
156760255|NCT03131167|565873920|FG006|Overall Study|Other (Unspecified)|0|||
156760256|NCT03131167|565873921|FG007|Overall Study|Other (Unspecified)|0|||
156760257|NCT03131167|565873922|FG008|Overall Study|Other (Unspecified)|0|||
156760258|NCT03131167|565873923|FG009|Overall Study|Other (Unspecified)|0|||
156760259|NCT03131167|565873924|FG010|Overall Study|Other (Unspecified)|0|||
156760260|NCT03131167|565873925|FG011|Overall Study|Other (Unspecified)|0|||
156760261|NCT03131167|565873926|FG012|Overall Study|Other (Unspecified)|0|||
156760262|NCT03286218|565873927|FG000|Qualification Phase Period 1|Adverse Event|1|||
156760263|NCT03286218|565873928|FG001|Qualification Phase Period 1|Adverse Event|0|||
156760264|NCT03286218|565873929|FG002|Qualification Phase Period 1|Adverse Event|0|||
156760265|NCT03286218|565873930|FG003|Qualification Phase Period 1|Adverse Event|0|||
156760266|NCT03286218|565873931|FG004|Qualification Phase Period 1|Adverse Event|0|||
156760267|NCT03286218|565873932|FG005|Qualification Phase Period 1|Adverse Event|0|||
156760268|NCT03286218|565873933|FG006|Qualification Phase Period 1|Adverse Event|0|||
156760269|NCT03286218|565873934|FG007|Qualification Phase Period 1|Adverse Event|0|||
156760270|NCT03286218|565873935|FG008|Qualification Phase Period 1|Adverse Event|0|||
156760271|NCT03286218|565873936|FG009|Qualification Phase Period 1|Adverse Event|0|||
156760272|NCT03286218|565873937|FG010|Qualification Phase Period 1|Adverse Event|0|||
156760273|NCT03286218|565873938|FG011|Qualification Phase Period 1|Adverse Event|0|||
156760274|NCT03286218|565873927|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760275|NCT03286218|565873928|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
156760276|NCT03286218|565873929|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
156318616|NCT00812487|564266401|FG001|Overall Study|Withdrawal by Subject|2|||
156318617|NCT00812487|564266400|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
156318618|NCT00812487|564266401|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
156318619|NCT00812487|564266400|FG000|Overall Study|Protocol Violation|0|||
156318620|NCT00812487|564266401|FG001|Overall Study|Protocol Violation|1|||
156318621|NCT00998764|564266402|FG000|Overall Study|Lack of Efficacy|3|||
156318622|NCT00998764|564266403|FG001|Overall Study|Lack of Efficacy|6|||
156318623|NCT00998764|564266402|FG000|Overall Study|Adverse Event|17|||
156760277|NCT03286218|565873930|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
156318624|NCT00998764|564266403|FG001|Overall Study|Adverse Event|12|||
156760278|NCT03286218|565873931|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760279|NCT03286218|565873932|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760280|NCT03286218|565873933|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760281|NCT03286218|565873934|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760282|NCT03286218|565873935|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760283|NCT03286218|565873936|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760284|NCT03286218|565873937|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760285|NCT03286218|565873938|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760286|NCT03286218|565873927|FG000|Qualification Phase Period 2|Adverse Event|0|||
156318625|NCT00998764|564266402|FG000|Overall Study|Withdrawal by Subject|19|||
156760287|NCT03286218|565873928|FG001|Qualification Phase Period 2|Adverse Event|1|||
156760288|NCT03286218|565873929|FG002|Qualification Phase Period 2|Adverse Event|0|||
156760289|NCT03286218|565873930|FG003|Qualification Phase Period 2|Adverse Event|0|||
156760290|NCT03286218|565873931|FG004|Qualification Phase Period 2|Adverse Event|0|||
156760291|NCT03286218|565873932|FG005|Qualification Phase Period 2|Adverse Event|0|||
156760292|NCT03286218|565873933|FG006|Qualification Phase Period 2|Adverse Event|0|||
156760293|NCT03286218|565873934|FG007|Qualification Phase Period 2|Adverse Event|0|||
156760294|NCT03286218|565873935|FG008|Qualification Phase Period 2|Adverse Event|0|||
156760295|NCT03286218|565873936|FG009|Qualification Phase Period 2|Adverse Event|0|||
156760296|NCT03286218|565873937|FG010|Qualification Phase Period 2|Adverse Event|0|||
156760297|NCT03286218|565873938|FG011|Qualification Phase Period 2|Adverse Event|0|||
156760298|NCT03286218|565873927|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
156760299|NCT03286218|565873928|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
156760300|NCT03286218|565873929|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760301|NCT03286218|565873930|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760302|NCT03286218|565873931|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760303|NCT03286218|565873932|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760304|NCT03286218|565873933|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760305|NCT03286218|565873934|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760306|NCT03286218|565873935|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760307|NCT03286218|565873936|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760308|NCT03286218|565873937|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760309|NCT03286218|565873938|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760310|NCT03286218|565873927|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
156760311|NCT03286218|565873928|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
156760312|NCT03286218|565873929|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
156760313|NCT03286218|565873930|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
156760314|NCT03286218|565873931|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
156760315|NCT03286218|565873932|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
156760316|NCT03286218|565873933|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
156760317|NCT03286218|565873934|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
156760318|NCT03286218|565873935|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
156760319|NCT03286218|565873936|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
156760320|NCT03286218|565873937|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
156760321|NCT03286218|565873938|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
156760322|NCT03286218|565873927|FG000|Qualification Phase Period 2|Protocol Violation|2|||
156760323|NCT03286218|565873928|FG001|Qualification Phase Period 2|Protocol Violation|0|||
156760324|NCT03286218|565873929|FG002|Qualification Phase Period 2|Protocol Violation|0|||
156760325|NCT03286218|565873930|FG003|Qualification Phase Period 2|Protocol Violation|0|||
156760326|NCT03286218|565873931|FG004|Qualification Phase Period 2|Protocol Violation|0|||
156760327|NCT03286218|565873932|FG005|Qualification Phase Period 2|Protocol Violation|0|||
156760328|NCT03286218|565873933|FG006|Qualification Phase Period 2|Protocol Violation|0|||
156760329|NCT03286218|565873934|FG007|Qualification Phase Period 2|Protocol Violation|0|||
156760330|NCT03286218|565873935|FG008|Qualification Phase Period 2|Protocol Violation|0|||
156760331|NCT03286218|565873936|FG009|Qualification Phase Period 2|Protocol Violation|0|||
156760332|NCT03286218|565873937|FG010|Qualification Phase Period 2|Protocol Violation|0|||
156760333|NCT03286218|565873938|FG011|Qualification Phase Period 2|Protocol Violation|0|||
156760334|NCT03286218|565873927|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
156760335|NCT03286218|565873928|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
156760336|NCT03286218|565873929|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760337|NCT03286218|565873930|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760338|NCT03286218|565873931|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760339|NCT03286218|565873932|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760340|NCT03286218|565873933|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760341|NCT03286218|565873934|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760342|NCT03286218|565873935|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760343|NCT03286218|565873936|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
156318626|NCT00998764|564266403|FG001|Overall Study|Withdrawal by Subject|25|||
156318627|NCT00998764|564266402|FG000|Overall Study|Physician Decision|3|||
156318628|NCT00998764|564266403|FG001|Overall Study|Physician Decision|3|||
156318629|NCT00998764|564266402|FG000|Overall Study|Death|3|||
156318630|NCT00998764|564266403|FG001|Overall Study|Death|1|||
156318631|NCT00998764|564266402|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
156318632|NCT00998764|564266403|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
156318633|NCT00998764|564266402|FG000|Overall Study|Protocol Violation|0|||
156318634|NCT00998764|564266403|FG001|Overall Study|Protocol Violation|1|||
156318635|NCT00998764|564266402|FG000|Overall Study|Failed to Return|1|||
156318636|NCT00998764|564266403|FG001|Overall Study|Failed to Return|1|||
156318637|NCT00998764|564266402|FG000|Overall Study|Lost to Follow-up|1|||
156318638|NCT00998764|564266403|FG001|Overall Study|Lost to Follow-up|1|||
156318639|NCT00998764|564266402|FG000|Overall Study|Loss of Caregiver|0|||
156318640|NCT00998764|564266403|FG001|Overall Study|Loss of Caregiver|3|||
156318641|NCT00998764|564266402|FG000|Overall Study|Other|4|||
156318642|NCT00998764|564266403|FG001|Overall Study|Other|4|||
156318643|NCT00998764|564266402|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
156318644|NCT00998764|564266403|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
156653761|NCT02970669|565479533|FG000|Double-blind Period|Adverse Event|4|||
156653762|NCT02970669|565479534|FG001|Double-blind Period|Adverse Event|0|||
156653763|NCT02970669|565479533|FG000|Double-blind Period|Death|1|||
156653764|NCT02970669|565479534|FG001|Double-blind Period|Death|0|||
156653765|NCT02970669|565479533|FG000|Double-blind Period|Study terminated by sponsor|1|||
156653766|NCT02970669|565479534|FG001|Double-blind Period|Study terminated by sponsor|2|||
156653767|NCT02970669|565479533|FG000|Double-blind Period|Physician Decision|0|||
156653768|NCT02970669|565479534|FG001|Double-blind Period|Physician Decision|2|||
156653769|NCT02970669|565479533|FG000|Double-blind Period|Withdrawal by Subject|2|||
156653770|NCT02970669|565479534|FG001|Double-blind Period|Withdrawal by Subject|2|||
156653771|NCT02970669|565479533|FG000|Open-label Period|Withdrawal by Subject|2|||
156653772|NCT02970669|565479534|FG001|Open-label Period|Withdrawal by Subject|2|||
156653773|NCT02970669|565479533|FG000|Open-label Period|Adverse Event|1|||
156653774|NCT02970669|565479534|FG001|Open-label Period|Adverse Event|0|||
156653775|NCT02970669|565479533|FG000|Open-label Period|Physician Decision|1|||
156653776|NCT02970669|565479534|FG001|Open-label Period|Physician Decision|0|||
156653777|NCT02611752|565479535|FG000|Overall Study|Adverse Event|0|||
156653778|NCT02611752|565479536|FG001|Overall Study|Adverse Event|1|||
156653779|NCT03521999|565479537|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
156653780|NCT03521999|565479538|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
156653781|NCT03521999|565479537|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
156653782|NCT03521999|565479538|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
156653783|NCT03521999|565479537|FG000|Completed 3 Month Follow up|Death|0|||
156653784|NCT03521999|565479538|FG001|Completed 3 Month Follow up|Death|1|||
156653785|NCT03521999|565479537|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
156653786|NCT03521999|565479538|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
156653787|NCT01411995|565479539|FG000|Overall Study|Failed IUD insertion|0|||
156653788|NCT01411995|565479540|FG001|Overall Study|Failed IUD insertion|1|||
156653789|NCT01937364|565479541|FG000|Overall Study|Adverse Event|2|||
156653790|NCT01937364|565479542|FG001|Overall Study|Adverse Event|1|||
156653791|NCT00467584|565479543|FG000|Overall Study|Withdrawal by Subject|4|||
156653792|NCT00467584|565479544|FG001|Overall Study|Withdrawal by Subject|5|||
156653793|NCT00467584|565479545|FG002|Overall Study|Withdrawal by Subject|1|||
156653794|NCT02482571|565479546|FG000|Overall Study|Adverse Event|1|||
156653795|NCT02482571|565479546|FG000|Overall Study|Scanner or Respiract failure|3|||
156653796|NCT02482571|565479546|FG000|Overall Study|Withdrawal by Subject|4|||
156653797|NCT01498484|565479547|FG000|Overall Study|Death|6|||
156653798|NCT01498484|565479548|FG001|Overall Study|Death|3|||
156653799|NCT01498484|565479549|FG002|Overall Study|Death|1|||
156653800|NCT01498484|565479550|FG003|Overall Study|Death|1|||
156653801|NCT01498484|565479551|FG004|Overall Study|Death|0|||
156653802|NCT01498484|565479552|FG005|Overall Study|Death|0|||
156653803|NCT01498484|565479553|FG006|Overall Study|Death|10|||
156653804|NCT01498484|565479554|FG007|Overall Study|Death|1|||
156653805|NCT01498484|565479555|FG008|Overall Study|Death|0|||
156653806|NCT01498484|565479547|FG000|Overall Study|Physician Decision|3|||
156653807|NCT01498484|565479548|FG001|Overall Study|Physician Decision|2|||
156653808|NCT01498484|565479549|FG002|Overall Study|Physician Decision|1|||
156653809|NCT01498484|565479550|FG003|Overall Study|Physician Decision|1|||
156653810|NCT01498484|565479551|FG004|Overall Study|Physician Decision|0|||
156653811|NCT01498484|565479552|FG005|Overall Study|Physician Decision|0|||
156653812|NCT01498484|565479553|FG006|Overall Study|Physician Decision|8|||
156653813|NCT01498484|565479554|FG007|Overall Study|Physician Decision|13|||
156653814|NCT01498484|565479555|FG008|Overall Study|Physician Decision|1|||
156653815|NCT01498484|565479547|FG000|Overall Study|Adverse Event|0|||
156653816|NCT01498484|565479548|FG001|Overall Study|Adverse Event|0|||
156653817|NCT01498484|565479549|FG002|Overall Study|Adverse Event|0|||
156653818|NCT01498484|565479550|FG003|Overall Study|Adverse Event|0|||
156653819|NCT01498484|565479551|FG004|Overall Study|Adverse Event|0|||
156653820|NCT01498484|565479552|FG005|Overall Study|Adverse Event|1|||
156653821|NCT01498484|565479553|FG006|Overall Study|Adverse Event|0|||
156653822|NCT01498484|565479554|FG007|Overall Study|Adverse Event|0|||
156653823|NCT01498484|565479555|FG008|Overall Study|Adverse Event|0|||
156653824|NCT01498484|565479547|FG000|Overall Study|Withdrawal by Subject|0|||
156653825|NCT01498484|565479548|FG001|Overall Study|Withdrawal by Subject|0|||
156653826|NCT01498484|565479549|FG002|Overall Study|Withdrawal by Subject|0|||
156653827|NCT01498484|565479550|FG003|Overall Study|Withdrawal by Subject|1|||
156318645|NCT04761627|564266406|FG000|Run-in Period|Death|1|||
156653828|NCT01498484|565479551|FG004|Overall Study|Withdrawal by Subject|0|||
156653829|NCT01498484|565479552|FG005|Overall Study|Withdrawal by Subject|0|||
156653830|NCT01498484|565479553|FG006|Overall Study|Withdrawal by Subject|1|||
156419895|NCT04955626|564630195|FG014|Blinded Period|Physician Decision|0|||
156419896|NCT04955626|564630196|FG015|Blinded Period|Physician Decision|0|||
156419897|NCT04955626|564630197|FG016|Blinded Period|Physician Decision|0|||
156419898|NCT04955626|564630198|FG017|Blinded Period|Physician Decision|0|||
156419899|NCT04955626|564630199|FG018|Blinded Period|Physician Decision|0|||
156419900|NCT04955626|564630200|FG019|Blinded Period|Physician Decision|0|||
156419901|NCT04955626|564630201|FG020|Blinded Period|Physician Decision|0|||
156419902|NCT04955626|564630202|FG021|Blinded Period|Physician Decision|0|||
156760344|NCT03286218|565873937|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760345|NCT03286218|565873938|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760346|NCT03286218|565873927|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760347|NCT03286218|565873928|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760348|NCT03286218|565873929|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
156760349|NCT03286218|565873930|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
156760350|NCT03286218|565873931|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760351|NCT03286218|565873932|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
156760352|NCT03286218|565873933|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760353|NCT03286218|565873934|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760354|NCT03286218|565873935|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760355|NCT03286218|565873936|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760356|NCT03286218|565873937|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760357|NCT03286218|565873938|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
156760358|NCT03286218|565873927|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760359|NCT03286218|565873928|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760360|NCT03286218|565873929|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760361|NCT03286218|565873930|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760362|NCT03286218|565873931|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760363|NCT03286218|565873932|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760364|NCT03286218|565873933|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760365|NCT03286218|565873934|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760366|NCT03286218|565873935|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760367|NCT03286218|565873936|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760368|NCT03286218|565873937|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760369|NCT03286218|565873938|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
156760370|NCT02346708|565873941|FG000|Overall Study|Adverse Event|2|||
156760371|NCT02346708|565873942|FG001|Overall Study|Adverse Event|0|||
156760372|NCT02346708|565873941|FG000|Overall Study|Protocol Violation|0|||
156760373|NCT02346708|565873942|FG001|Overall Study|Protocol Violation|1|||
156760374|NCT00483652|565873945|FG000|Double-blind Treatment Period|Protocol Violation|2|||
156760375|NCT00483652|565873946|FG001|Double-blind Treatment Period|Protocol Violation|1|||
156760376|NCT00483652|565873945|FG000|Double-blind Treatment Period|Adverse Event|3|||
156760377|NCT00483652|565873946|FG001|Double-blind Treatment Period|Adverse Event|4|||
156760378|NCT00483652|565873945|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
156760379|NCT00483652|565873946|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
156760380|NCT00483652|565873945|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
156760381|NCT00483652|565873946|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
156760382|NCT00928434|565873947|FG000|Overall Study|Adverse Event|14|||
156760383|NCT00928434|565873948|FG001|Overall Study|Adverse Event|5|||
156760384|NCT00928434|565873949|FG002|Overall Study|Adverse Event|18|||
156760385|NCT00928434|565873947|FG000|Overall Study|Protocol Violation|5|||
156760386|NCT00928434|565873948|FG001|Overall Study|Protocol Violation|0|||
156760387|NCT00928434|565873949|FG002|Overall Study|Protocol Violation|8|||
156760388|NCT00928434|565873947|FG000|Overall Study|Physician Decision|2|||
156760389|NCT00928434|565873948|FG001|Overall Study|Physician Decision|0|||
156760390|NCT00928434|565873949|FG002|Overall Study|Physician Decision|3|||
156760391|NCT00928434|565873947|FG000|Overall Study|Lost to Follow-up|1|||
156760392|NCT00928434|565873948|FG001|Overall Study|Lost to Follow-up|0|||
156760393|NCT00928434|565873949|FG002|Overall Study|Lost to Follow-up|3|||
156760394|NCT00928434|565873947|FG000|Overall Study|Withdrawal by Subject|5|||
156760395|NCT00928434|565873948|FG001|Overall Study|Withdrawal by Subject|3|||
156760396|NCT00928434|565873949|FG002|Overall Study|Withdrawal by Subject|2|||
156760397|NCT00928434|565873947|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
156760398|NCT00928434|565873948|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
156760399|NCT00928434|565873949|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
156419903|NCT04955626|564630203|FG022|Blinded Period|Physician Decision|0|||
156419904|NCT04955626|564630204|FG023|Blinded Period|Physician Decision|0|||
156419905|NCT04955626|564630205|FG024|Blinded Period|Physician Decision|0|||
156419906|NCT04955626|564630206|FG025|Blinded Period|Physician Decision|0|||
156419907|NCT04955626|564630207|FG026|Blinded Period|Physician Decision|0|||
156419908|NCT04955626|564630208|FG027|Blinded Period|Physician Decision|0|||
156419909|NCT04955626|564630209|FG028|Blinded Period|Physician Decision|0|||
156419910|NCT04955626|564630210|FG029|Blinded Period|Physician Decision|0|||
156760400|NCT00928434|565873947|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
156760401|NCT00928434|565873948|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
156760402|NCT00928434|565873949|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
156760403|NCT00928434|565873947|FG000|Overall Study|Other (not meeting above criteria)|5|||
156760404|NCT00928434|565873948|FG001|Overall Study|Other (not meeting above criteria)|1|||
156760405|NCT00928434|565873949|FG002|Overall Study|Other (not meeting above criteria)|2|||
156760406|NCT01781962|565873950|FG000|Overall Study|Other Miscellaneous Reasons|5|||
156760407|NCT00716456|565873953|FG000|Overall Study|Adverse Event|0|||
156760408|NCT00716456|565873954|FG001|Overall Study|Adverse Event|2|||
156760409|NCT00716456|565873955|FG002|Overall Study|Adverse Event|0|||
156760410|NCT02154139|565873958|FG000|Overall Study|Injection not administered|2|||
156760411|NCT02154139|565873958|FG000|Overall Study|Other|2|||
156760412|NCT02154139|565873958|FG000|Overall Study|Investigator transferred|3|||
156760413|NCT05417412|565873962|FG000|Overall Study|Lost to Follow-up|2|||
156760414|NCT04556760|565873965|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760415|NCT04556760|565873966|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
156760416|NCT04556760|565873967|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760417|NCT04556760|565873968|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760418|NCT04556760|565873969|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760419|NCT04556760|565873970|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760420|NCT04556760|565873965|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760421|NCT04556760|565873966|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760422|NCT04556760|565873967|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760423|NCT04556760|565873968|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
156760424|NCT04556760|565873969|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760425|NCT04556760|565873970|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760426|NCT02849743|565873972|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
156760427|NCT02849743|565873973|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
156760428|NCT02849743|565873972|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
156760429|NCT02849743|565873973|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
156760430|NCT03075267|565873981|FG000|Overall Study|Protocol Violation|1|||
156760431|NCT03075267|565873982|FG001|Overall Study|Protocol Violation|0|||
156760432|NCT03075267|565873983|FG002|Overall Study|Protocol Violation|0|||
156760433|NCT02168491|565873984|FG000|Overall Study|Withdrawal by Subject|1|||
156760434|NCT00809445|565873985|FG000|1 Month Follow-up|Lost contact|1|||
156760435|NCT00809445|565873986|FG001|1 Month Follow-up|Lost contact|2|||
156760436|NCT00809445|565873987|FG002|1 Month Follow-up|Lost contact|1|||
156760437|NCT00809445|565873985|FG000|1 Month Follow-up|Withdrew consent|1|||
156760438|NCT00809445|565873986|FG001|1 Month Follow-up|Withdrew consent|1|||
156760439|NCT00809445|565873987|FG002|1 Month Follow-up|Withdrew consent|1|||
156760440|NCT00809445|565873985|FG000|1 Month Follow-up|Death|0|||
156760441|NCT00809445|565873986|FG001|1 Month Follow-up|Death|1|||
156760442|NCT00809445|565873987|FG002|1 Month Follow-up|Death|1|||
156760443|NCT00809445|565873985|FG000|1 Month Follow-up|Incarcerated|0|||
156760444|NCT00809445|565873986|FG001|1 Month Follow-up|Incarcerated|0|||
156760445|NCT00809445|565873987|FG002|1 Month Follow-up|Incarcerated|1|||
156760446|NCT00809445|565873985|FG000|6 Month Follow-up|Lost contact|16|||
156760447|NCT00809445|565873986|FG001|6 Month Follow-up|Lost contact|14|||
156760448|NCT00809445|565873987|FG002|6 Month Follow-up|Lost contact|14|||
156760449|NCT00809445|565873985|FG000|6 Month Follow-up|Death|2|||
156760450|NCT00809445|565873986|FG001|6 Month Follow-up|Death|1|||
156760451|NCT00809445|565873987|FG002|6 Month Follow-up|Death|1|||
156760452|NCT00809445|565873985|FG000|6 Month Follow-up|Incarcerated|6|||
156760453|NCT00809445|565873986|FG001|6 Month Follow-up|Incarcerated|8|||
156760454|NCT00809445|565873987|FG002|6 Month Follow-up|Incarcerated|8|||
156760455|NCT00809445|565873985|FG000|6 Month Follow-up|Withdrew consent|0|||
156760456|NCT00809445|565873986|FG001|6 Month Follow-up|Withdrew consent|0|||
156760457|NCT00809445|565873987|FG002|6 Month Follow-up|Withdrew consent|1|||
156760458|NCT03874013|565873988|FG000|Overall Study|Adverse Event|0|||
156760459|NCT03874013|565873989|FG001|Overall Study|Adverse Event|1|||
156760460|NCT04919317|565873990|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
156760461|NCT04919317|565873991|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
156318646|NCT04761627|564266407|FG001|Run-in Period|Death|0|||
156318647|NCT04761627|564266408|FG002|Run-in Period|Death|0|||
156318648|NCT04761627|564266406|FG000|Run-in Period|Required alternative therapy|2|||
156318649|NCT04761627|564266407|FG001|Run-in Period|Required alternative therapy|0|||
156760462|NCT04919317|565873990|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
156760463|NCT04919317|565873991|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
156760464|NCT01566604|565873994|FG000|Overall Study|Patient's inability to use the device|1|||
156760465|NCT01566604|565873995|FG001|Overall Study|Patient's inability to use the device|0|||
156760466|NCT01566604|565873994|FG000|Overall Study|Administrative problems|1|||
156318650|NCT04761627|564266408|FG002|Run-in Period|Required alternative therapy|0|||
156318651|NCT04761627|564266406|FG000|Run-in Period|Lost to Follow-up|2|||
156318652|NCT04761627|564266407|FG001|Run-in Period|Lost to Follow-up|0|||
156760467|NCT01566604|565873995|FG001|Overall Study|Administrative problems|0|||
156760468|NCT01566604|565873994|FG000|Overall Study|Lack of Efficacy|1|||
156760469|NCT01566604|565873995|FG001|Overall Study|Lack of Efficacy|2|||
156760470|NCT01566604|565873994|FG000|Overall Study|Protocol deviation|2|||
156760471|NCT01566604|565873995|FG001|Overall Study|Protocol deviation|0|||
156760472|NCT01566604|565873994|FG000|Overall Study|Abnormal laboratory value|2|||
156760473|NCT01566604|565873995|FG001|Overall Study|Abnormal laboratory value|0|||
156760474|NCT01566604|565873994|FG000|Overall Study|Death|4|||
156760475|NCT01566604|565873995|FG001|Overall Study|Death|1|||
156760476|NCT01566604|565873994|FG000|Overall Study|Adverse Event|4|||
156760477|NCT01566604|565873995|FG001|Overall Study|Adverse Event|2|||
156760478|NCT01566604|565873994|FG000|Overall Study|Withdrawal by Subject|9|||
156760479|NCT01566604|565873995|FG001|Overall Study|Withdrawal by Subject|6|||
156760480|NCT00661089|565874000|FG000|Overall Study|1 subject withdrawal|0|||
156760481|NCT00661089|565874001|FG001|Overall Study|1 subject withdrawal|1|||
156760482|NCT00661089|565874000|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
156760483|NCT00661089|565874001|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
156760484|NCT01443858|565874005|FG000|Overall Study|Withdrawal by Subject|9|||
156760485|NCT01443858|565874006|FG001|Overall Study|Withdrawal by Subject|8|||
156760486|NCT01443858|565874007|FG002|Overall Study|Withdrawal by Subject|5|||
156760487|NCT01443858|565874005|FG000|Overall Study|Lack of Efficacy|1|||
156760488|NCT01443858|565874006|FG001|Overall Study|Lack of Efficacy|0|||
156760489|NCT01443858|565874007|FG002|Overall Study|Lack of Efficacy|0|||
156760490|NCT01443858|565874005|FG000|Overall Study|Lost to Follow-up|5|||
156760491|NCT01443858|565874006|FG001|Overall Study|Lost to Follow-up|5|||
156760492|NCT01443858|565874007|FG002|Overall Study|Lost to Follow-up|2|||
156760493|NCT00321906|565874010|FG000|Overall Study|Adverse Event|36|||
156760494|NCT00321906|565874011|FG001|Overall Study|Adverse Event|44|||
156760495|NCT00321906|565874010|FG000|Overall Study|Death|9|||
156760496|NCT00321906|565874011|FG001|Overall Study|Death|6|||
156760497|NCT00321906|565874010|FG000|Overall Study|Lost to Follow-up|1|||
156760498|NCT00321906|565874011|FG001|Overall Study|Lost to Follow-up|2|||
156760499|NCT00321906|565874010|FG000|Overall Study|Withdrawal by Subject|0|||
156760500|NCT00321906|565874011|FG001|Overall Study|Withdrawal by Subject|4|||
156760501|NCT02899065|565874012|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
156760502|NCT02899065|565874013|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
156760503|NCT02899065|565874012|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
156760504|NCT02899065|565874013|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
156760505|NCT02899065|565874012|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
156760506|NCT02899065|565874013|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
156760507|NCT00186485|565874014|FG000|Overall Study|Lost to Follow-up|3|||
156760508|NCT03771963|565874021|FG000|Overall Study|Lost to Follow-up|22|||
156760509|NCT03771963|565874021|FG000|Overall Study|Withdrawal of Consent|10|||
156760510|NCT01026948|565874022|FG000|Overall Study|Physician Decision|8|||
156760511|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
156760512|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
156760513|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Adverse Event|57|||
156760514|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Adverse Event|49|||
156760515|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
156760516|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
156760517|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Site closure|3|||
156760518|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Site closure|2|||
156760519|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
156760520|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
156760521|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Physician Decision|48|||
156760522|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Physician Decision|38|||
156760523|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
156760524|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
156760525|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
156760526|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
156760527|NCT01705977|565874023|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
156760528|NCT01705977|565874024|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
156760529|NCT01705977|565874023|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
156760530|NCT01705977|565874024|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
156760531|NCT01705977|565874023|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
156760532|NCT01705977|565874024|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
156760533|NCT01705977|565874023|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
156760534|NCT01705977|565874024|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
156419911|NCT04955626|564630211|FG030|Blinded Period|Physician Decision|0|||
156760535|NCT00520039|565874028|FG000|Overall Study|Exclusion criteria met at first visit|7|||
156760536|NCT00520039|565874029|FG001|Overall Study|Exclusion criteria met at first visit|5|||
156760537|NCT03560869|565874030|FG000|Overall Study|Withdrawal by Subject|3|||
156760538|NCT03560869|565874031|FG001|Overall Study|Withdrawal by Subject|4|||
156760539|NCT03560869|565874030|FG000|Overall Study|Screening failure|4|||
156760540|NCT03560869|565874031|FG001|Overall Study|Screening failure|4|||
156760541|NCT03560869|565874030|FG000|Overall Study|Withdrawal by PI|0|||
156760542|NCT03560869|565874031|FG001|Overall Study|Withdrawal by PI|1|||
156760543|NCT00325819|565874032|FG000|Overall Study|Study product lost in mail|2|||
156760544|NCT00325819|565874033|FG001|Overall Study|Study product lost in mail|1|||
156760545|NCT00325819|565874032|FG000|Overall Study|Did not take a dose of study product|4|||
156760546|NCT00325819|565874033|FG001|Overall Study|Did not take a dose of study product|9|||
156760547|NCT00325819|565874032|FG000|Overall Study|Lost to Follow-up|3|||
156760548|NCT00325819|565874033|FG001|Overall Study|Lost to Follow-up|3|||
156760549|NCT00458003|565875708|FG000|Overall Study|Non protocol spinal anesthesia|1|||
156760550|NCT00458003|565875709|FG001|Overall Study|Non protocol spinal anesthesia|1|||
156760551|NCT01272908|565875719|FG000|Initial Treatment Period|Adverse Event|1|||
156760552|NCT01272908|565875719|FG000|Initial Treatment Period|Lack of Efficacy|5|||
156760553|NCT01272908|565875719|FG000|Initial Treatment Period|Protocol Violation|1|||
156760554|NCT01272908|565875719|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
156760555|NCT01272908|565875719|FG000|Re-Treatment Period|Adverse Event|2|||
156760556|NCT01272908|565875719|FG000|Re-Treatment Period|Lack of Efficacy|3|||
156760557|NCT01272908|565875719|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
156760558|NCT02221648|565875720|FG000|Overall Study|Withdrawal by Subject|3|||
156760559|NCT02221648|565875721|FG001|Overall Study|Withdrawal by Subject|3|||
156760560|NCT00810069|565875723|FG000|Lead-in Period I|Adverse Event|43|||
156760561|NCT00810069|565875724|FG001|Lead-in Period I|Adverse Event|0|||
156760562|NCT00810069|565875725|FG002|Lead-in Period I|Adverse Event|0|||
156760563|NCT00810069|565875723|FG000|Lead-in Period I|Lack of Efficacy|1|||
156760564|NCT00810069|565875724|FG001|Lead-in Period I|Lack of Efficacy|0|||
156760565|NCT00810069|565875725|FG002|Lead-in Period I|Lack of Efficacy|0|||
156760566|NCT00810069|565875723|FG000|Lead-in Period I|Lost to Follow-up|19|||
156760567|NCT00810069|565875724|FG001|Lead-in Period I|Lost to Follow-up|0|||
156760568|NCT00810069|565875725|FG002|Lead-in Period I|Lost to Follow-up|0|||
156760569|NCT00810069|565875723|FG000|Lead-in Period I|Physician Decision|1|||
156760570|NCT00810069|565875724|FG001|Lead-in Period I|Physician Decision|0|||
156760571|NCT00810069|565875725|FG002|Lead-in Period I|Physician Decision|0|||
156760572|NCT00810069|565875723|FG000|Lead-in Period I|Protocol Violation|1|||
156760573|NCT00810069|565875724|FG001|Lead-in Period I|Protocol Violation|0|||
156760574|NCT00810069|565875725|FG002|Lead-in Period I|Protocol Violation|0|||
156760575|NCT00810069|565875723|FG000|Lead-in Period I|Withdrawal by Subject|46|||
156760576|NCT00810069|565875724|FG001|Lead-in Period I|Withdrawal by Subject|0|||
156760577|NCT00810069|565875725|FG002|Lead-in Period I|Withdrawal by Subject|0|||
156760578|NCT00810069|565875723|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
156760579|NCT00810069|565875724|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
156760580|NCT00810069|565875725|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
156760581|NCT00810069|565875723|FG000|Lead-in Period I|Randomization criteria not met|158|||
156760582|NCT00810069|565875724|FG001|Lead-in Period I|Randomization criteria not met|0|||
156760583|NCT00810069|565875725|FG002|Lead-in Period I|Randomization criteria not met|0|||
156760584|NCT00810069|565875723|FG000|Double-Blind Period II|Adverse Event|0|||
156760585|NCT00810069|565875724|FG001|Double-Blind Period II|Adverse Event|9|||
156760586|NCT00810069|565875725|FG002|Double-Blind Period II|Adverse Event|8|||
156760587|NCT00810069|565875723|FG000|Double-Blind Period II|Lack of Efficacy|0|||
156760588|NCT00810069|565875724|FG001|Double-Blind Period II|Lack of Efficacy|7|||
156760589|NCT00810069|565875725|FG002|Double-Blind Period II|Lack of Efficacy|12|||
156760590|NCT00810069|565875723|FG000|Double-Blind Period II|Lost to Follow-up|0|||
156760591|NCT00810069|565875724|FG001|Double-Blind Period II|Lost to Follow-up|9|||
156760592|NCT00810069|565875725|FG002|Double-Blind Period II|Lost to Follow-up|9|||
156760593|NCT00810069|565875723|FG000|Double-Blind Period II|Physician Decision|0|||
156760594|NCT00810069|565875724|FG001|Double-Blind Period II|Physician Decision|0|||
156760595|NCT00810069|565875725|FG002|Double-Blind Period II|Physician Decision|1|||
156318653|NCT04761627|564266408|FG002|Run-in Period|Lost to Follow-up|0|||
156318654|NCT04761627|564266406|FG000|Run-in Period|Protocol Violation|3|||
156318655|NCT04761627|564266407|FG001|Run-in Period|Protocol Violation|0|||
156318656|NCT04761627|564266408|FG002|Run-in Period|Protocol Violation|0|||
156318657|NCT04761627|564266406|FG000|Run-in Period|Abnormal liver function|1|||
156760596|NCT00810069|565875723|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
156760597|NCT00810069|565875724|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
156760598|NCT00810069|565875725|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
156760599|NCT00810069|565875723|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
156760600|NCT00810069|565875724|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
156760601|NCT00810069|565875725|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
156760602|NCT00810069|565875723|FG000|Double-Blind Period II|Clinical relapse|0|||
156760603|NCT00810069|565875724|FG001|Double-Blind Period II|Clinical relapse|3|||
156760604|NCT00810069|565875725|FG002|Double-Blind Period II|Clinical relapse|0|||
156760605|NCT00810069|565875723|FG000|Double-Blind Period II|Protocol Violation|0|||
156760606|NCT00810069|565875724|FG001|Double-Blind Period II|Protocol Violation|7|||
156318658|NCT04761627|564266407|FG001|Run-in Period|Abnormal liver function|0|||
156760607|NCT00810069|565875725|FG002|Double-Blind Period II|Protocol Violation|6|||
156760608|NCT00905424|565875729|FG000|Overall Study|Lost to Follow-up|3|||
156760609|NCT00905424|565875730|FG001|Overall Study|Lost to Follow-up|3|||
156760610|NCT00905424|565875729|FG000|Overall Study|Withdrawal by Subject|1|||
156760611|NCT00905424|565875730|FG001|Overall Study|Withdrawal by Subject|2|||
156760612|NCT00905424|565875729|FG000|Overall Study|Adverse Event|4|||
156760613|NCT00905424|565875730|FG001|Overall Study|Adverse Event|2|||
156760614|NCT00905424|565875729|FG000|Overall Study|Non-compliance with study medication|2|||
156760615|NCT00905424|565875730|FG001|Overall Study|Non-compliance with study medication|0|||
156760616|NCT00905424|565875729|FG000|Overall Study|Sponsor decision|1|||
156760617|NCT00905424|565875730|FG001|Overall Study|Sponsor decision|0|||
156760618|NCT00905424|565875729|FG000|Overall Study|Positive urine drug screen|0|||
156760619|NCT00905424|565875730|FG001|Overall Study|Positive urine drug screen|1|||
156760620|NCT00905424|565875729|FG000|Overall Study|Non-adherence to visit schedule|0|||
156760621|NCT00905424|565875730|FG001|Overall Study|Non-adherence to visit schedule|1|||
156760622|NCT00426764|565875731|FG000|Overall Study|Protocol Violation|1|||
156760623|NCT00426764|565875731|FG000|Overall Study|Withdrawal by Subject|4|||
156760624|NCT00426764|565875731|FG000|Overall Study|Physician Decision|6|||
156760625|NCT00426764|565875731|FG000|Overall Study|Compassionate Use|1|||
156760626|NCT00426764|565875731|FG000|Overall Study|Progressive Disease|83|||
156760627|NCT00426764|565875731|FG000|Overall Study|Adverse Event|24|||
156760628|NCT00426764|565875731|FG000|Overall Study|Other|1|||
156760629|NCT00426764|565875731|FG000|Overall Study|Death|1|||
156760630|NCT00426764|565875731|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
156760631|NCT00379899|565875732|FG000|Overall Study|Adverse Event|7|||
156760632|NCT00379899|565875733|FG001|Overall Study|Adverse Event|3|||
156760633|NCT00379899|565875732|FG000|Overall Study|Death|10|||
156760634|NCT00379899|565875733|FG001|Overall Study|Death|10|||
156760635|NCT00379899|565875732|FG000|Overall Study|Lost to Follow-up|2|||
156760636|NCT00379899|565875733|FG001|Overall Study|Lost to Follow-up|4|||
156760637|NCT00379899|565875732|FG000|Overall Study|Physician Decision|3|||
156760638|NCT00379899|565875733|FG001|Overall Study|Physician Decision|4|||
156760639|NCT00379899|565875732|FG000|Overall Study|Withdrawal by Subject|5|||
156760640|NCT00379899|565875733|FG001|Overall Study|Withdrawal by Subject|5|||
156760641|NCT00379899|565875732|FG000|Overall Study|Ineligibility determined|0|||
156760642|NCT00379899|565875733|FG001|Overall Study|Ineligibility determined|1|||
156760643|NCT00379899|565875732|FG000|Overall Study|Noncompliance|1|||
156760644|NCT00379899|565875733|FG001|Overall Study|Noncompliance|1|||
156760645|NCT00379899|565875732|FG000|Overall Study|Parathyroidectomy|0|||
156760646|NCT00379899|565875733|FG001|Overall Study|Parathyroidectomy|2|||
156760647|NCT00379899|565875732|FG000|Overall Study|Renal transplantation|5|||
156760648|NCT00379899|565875733|FG001|Overall Study|Renal transplantation|4|||
156760649|NCT00379899|565875732|FG000|Overall Study|Coronary artery bypass graft|1|||
156760650|NCT00379899|565875733|FG001|Overall Study|Coronary artery bypass graft|1|||
156760651|NCT00379899|565875732|FG000|Overall Study|Other protocol-specified criteria|3|||
156760652|NCT00379899|565875733|FG001|Overall Study|Other protocol-specified criteria|4|||
156760653|NCT00379899|565875732|FG000|Overall Study|Other|3|||
156760654|NCT00379899|565875733|FG001|Overall Study|Other|1|||
156760655|NCT01922258|565875734|FG000|Overall Study|Lost to Follow-up|1|||
156760656|NCT01922258|565875735|FG001|Overall Study|Lost to Follow-up|1|||
156760657|NCT01922258|565875734|FG000|Overall Study|Adverse Event|9|||
156760658|NCT01922258|565875735|FG001|Overall Study|Adverse Event|2|||
156760659|NCT01922258|565875734|FG000|Overall Study|Met Withdrawal Criteria|0|||
156760660|NCT01922258|565875735|FG001|Overall Study|Met Withdrawal Criteria|4|||
156760661|NCT01922258|565875734|FG000|Overall Study|Withdrawn by the Investigator|1|||
156760662|NCT01922258|565875735|FG001|Overall Study|Withdrawn by the Investigator|4|||
156760663|NCT01922258|565875734|FG000|Overall Study|Withdrawal by participant|5|||
156760664|NCT01922258|565875735|FG001|Overall Study|Withdrawal by participant|5|||
156760665|NCT01166750|565875736|FG000|Overall Study|Lost to Follow-up|1|||
156760666|NCT01166750|565875737|FG001|Overall Study|Lost to Follow-up|0|||
156760667|NCT05225389|565875738|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
156760668|NCT02417753|565875739|FG000|Overall Study|Death|1|||
156760669|NCT03113968|565875740|FG000|Overall Study|Withdrawal by Subject|31|||
156760670|NCT03113968|565875741|FG001|Overall Study|Withdrawal by Subject|4|||
156760671|NCT04805671|565875744|FG000|Overall Study|Death|2|||
156760672|NCT04805671|565875745|FG001|Overall Study|Death|7|||
156760673|NCT04805671|565875744|FG000|Overall Study|Lost to Follow-up|1|||
156760674|NCT04805671|565875745|FG001|Overall Study|Lost to Follow-up|0|||
156760675|NCT04805671|565875744|FG000|Overall Study|Withdrawal by Subject|9|||
156760676|NCT04805671|565875745|FG001|Overall Study|Withdrawal by Subject|7|||
156760677|NCT04805671|565875744|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
156760678|NCT04805671|565875745|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
156419912|NCT04955626|564630212|FG031|Blinded Period|Physician Decision|0|||
156760679|NCT00901342|565875746|FG000|Overall Study|Adverse Event|1|||
156760680|NCT00901342|565875746|FG000|Overall Study|Death|4|||
156760681|NCT00901342|565875746|FG000|Overall Study|Disease progression|1|||
156760682|NCT00901342|565875746|FG000|Overall Study|Withdrawal by Subject|9|||
156419913|NCT04955626|564630213|FG032|Blinded Period|Physician Decision|0|||
156419914|NCT04955626|564630214|FG033|Blinded Period|Physician Decision|0|||
156419915|NCT04955626|564630215|FG034|Blinded Period|Physician Decision|0|||
156419916|NCT04955626|564630216|FG035|Blinded Period|Physician Decision|0|||
156419917|NCT04955626|564630181|FG000|Blinded Period|Withdrawal by Subject|26|||
156419918|NCT04955626|564630182|FG001|Blinded Period|Withdrawal by Subject|62|||
156419919|NCT04955626|564630183|FG002|Blinded Period|Withdrawal by Subject|14|||
156419920|NCT04955626|564630184|FG003|Blinded Period|Withdrawal by Subject|16|||
156419921|NCT04955626|564630185|FG004|Blinded Period|Withdrawal by Subject|1|||
156419922|NCT04955626|564630186|FG005|Blinded Period|Withdrawal by Subject|2|||
156419923|NCT04955626|564630187|FG006|Blinded Period|Withdrawal by Subject|9|||
156419924|NCT04955626|564630188|FG007|Blinded Period|Withdrawal by Subject|5|||
156419925|NCT04955626|564630189|FG008|Blinded Period|Withdrawal by Subject|3|||
156419926|NCT04955626|564630190|FG009|Blinded Period|Withdrawal by Subject|15|||
156419927|NCT04955626|564630191|FG010|Blinded Period|Withdrawal by Subject|11|||
156419928|NCT04955626|564630192|FG011|Blinded Period|Withdrawal by Subject|7|||
156419929|NCT04955626|564630193|FG012|Blinded Period|Withdrawal by Subject|2|||
156419930|NCT04955626|564630194|FG013|Blinded Period|Withdrawal by Subject|0|||
156419931|NCT04955626|564630195|FG014|Blinded Period|Withdrawal by Subject|1|||
156419932|NCT04955626|564630196|FG015|Blinded Period|Withdrawal by Subject|11|||
156419933|NCT04955626|564630197|FG016|Blinded Period|Withdrawal by Subject|2|||
156419934|NCT04955626|564630198|FG017|Blinded Period|Withdrawal by Subject|5|||
156419935|NCT04955626|564630199|FG018|Blinded Period|Withdrawal by Subject|0|||
156653831|NCT01498484|565479554|FG007|Overall Study|Withdrawal by Subject|0|||
156653832|NCT01498484|565479555|FG008|Overall Study|Withdrawal by Subject|0|||
156653833|NCT01498484|565479547|FG000|Overall Study|Other|5|||
156653834|NCT01498484|565479548|FG001|Overall Study|Other|2|||
156653835|NCT01498484|565479549|FG002|Overall Study|Other|0|||
156653836|NCT01498484|565479550|FG003|Overall Study|Other|0|||
156653837|NCT01498484|565479551|FG004|Overall Study|Other|1|||
156653838|NCT01498484|565479552|FG005|Overall Study|Other|0|||
156653839|NCT01498484|565479553|FG006|Overall Study|Other|3|||
156653840|NCT01498484|565479554|FG007|Overall Study|Other|0|||
156653841|NCT01498484|565479555|FG008|Overall Study|Other|1|||
156653842|NCT01199601|565479556|FG000|Overall Study|Lost to Follow-up|47|||
156653843|NCT01199601|565479557|FG001|Overall Study|Lost to Follow-up|66|||
156653844|NCT01199601|565479556|FG000|Overall Study|Withdrawal by Subject|15|||
156653845|NCT01199601|565479557|FG001|Overall Study|Withdrawal by Subject|3|||
156653846|NCT01199601|565479556|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
156653847|NCT01199601|565479557|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
156653848|NCT01185288|565479558|FG000|Overall Study|Adverse Event|7|||
156653849|NCT01185288|565479559|FG001|Overall Study|Adverse Event|6|||
156653850|NCT01185288|565479558|FG000|Overall Study|Withdrawal by Subject|6|||
156653851|NCT01185288|565479559|FG001|Overall Study|Withdrawal by Subject|4|||
156653852|NCT01185288|565479558|FG000|Overall Study|Lost to Follow-up|2|||
156653853|NCT01185288|565479559|FG001|Overall Study|Lost to Follow-up|5|||
156653854|NCT01185288|565479558|FG000|Overall Study|Lack of Efficacy|2|||
156653855|NCT01185288|565479559|FG001|Overall Study|Lack of Efficacy|0|||
156653856|NCT01185288|565479558|FG000|Overall Study|Investigator discretion|1|||
156653857|NCT01185288|565479559|FG001|Overall Study|Investigator discretion|0|||
156653858|NCT01185288|565479558|FG000|Overall Study|Did not meet inclusion criteria|1|||
156653859|NCT01185288|565479559|FG001|Overall Study|Did not meet inclusion criteria|0|||
156653860|NCT01185288|565479558|FG000|Overall Study|Noncompliance|0|||
156653861|NCT01185288|565479559|FG001|Overall Study|Noncompliance|1|||
156653862|NCT00278512|565479560|FG000|Overall Study|Death|1|||
156653863|NCT00278512|565479561|FG001|Overall Study|Death|0|||
156653864|NCT01626859|565479562|FG000|Overall Study|Adverse Event|1|||
156653865|NCT01626859|565479563|FG001|Overall Study|Adverse Event|3|||
156653866|NCT01626859|565479564|FG002|Overall Study|Adverse Event|2|||
156653867|NCT01626859|565479562|FG000|Overall Study|Physician Decision|0|||
156653868|NCT01626859|565479563|FG001|Overall Study|Physician Decision|1|||
156653869|NCT01626859|565479564|FG002|Overall Study|Physician Decision|0|||
156653870|NCT01626859|565479562|FG000|Overall Study|Withdrawal by Subject|1|||
156653871|NCT01626859|565479563|FG001|Overall Study|Withdrawal by Subject|4|||
156653872|NCT01626859|565479564|FG002|Overall Study|Withdrawal by Subject|2|||
156653873|NCT01620177|565479565|FG000|Overall Study|Failure at Screening Visit|43|||
156653874|NCT01620177|565479565|FG000|Overall Study|Withdrawal by Subject|26|||
156419936|NCT04955626|564630200|FG019|Blinded Period|Withdrawal by Subject|0|||
156419937|NCT04955626|564630201|FG020|Blinded Period|Withdrawal by Subject|1|||
156419938|NCT04955626|564630202|FG021|Blinded Period|Withdrawal by Subject|0|||
156419939|NCT04955626|564630203|FG022|Blinded Period|Withdrawal by Subject|0|||
156419940|NCT04955626|564630204|FG023|Blinded Period|Withdrawal by Subject|0|||
156653875|NCT01620177|565479565|FG000|Overall Study|Lost to Follow-up|7|||
156653876|NCT01620177|565479565|FG000|Overall Study|Physician Decision|2|||
156653877|NCT01620177|565479565|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
156653878|NCT00814320|565479570|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
156653879|NCT00814320|565479571|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
156653880|NCT00814320|565479570|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
156760683|NCT03804268|565875747|FG000|Overall Study|Adverse Event|2|||
156760684|NCT03804268|565875748|FG001|Overall Study|Adverse Event|2|||
156760685|NCT03804268|565875747|FG000|Overall Study|Withdrawal by Subject|2|||
156760686|NCT03804268|565875748|FG001|Overall Study|Withdrawal by Subject|0|||
156760687|NCT03804268|565875747|FG000|Overall Study|Lost to Follow-up|1|||
156760688|NCT03804268|565875748|FG001|Overall Study|Lost to Follow-up|0|||
156760689|NCT03804268|565875747|FG000|Overall Study|Physician Decision|2|||
156760690|NCT03804268|565875748|FG001|Overall Study|Physician Decision|0|||
156760691|NCT02849587|565875749|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
156318659|NCT04761627|564266408|FG002|Run-in Period|Abnormal liver function|0|||
156318660|NCT04761627|564266406|FG000|Run-in Period|Adverse Event|6|||
156318661|NCT04761627|564266407|FG001|Run-in Period|Adverse Event|0|||
156318662|NCT04761627|564266408|FG002|Run-in Period|Adverse Event|0|||
156318663|NCT04761627|564266406|FG000|Run-in Period|Withdrawal by Subject|7|||
156318664|NCT04761627|564266407|FG001|Run-in Period|Withdrawal by Subject|0|||
156318665|NCT04761627|564266408|FG002|Run-in Period|Withdrawal by Subject|0|||
156318666|NCT04761627|564266406|FG000|Run-in Period|Did not meet PASI 50|15|||
156318667|NCT04761627|564266407|FG001|Run-in Period|Did not meet PASI 50|0|||
156318668|NCT04761627|564266408|FG002|Run-in Period|Did not meet PASI 50|0|||
156318669|NCT04761627|564266406|FG000|Run-in Period|Study site closure|2|||
156318670|NCT04761627|564266407|FG001|Run-in Period|Study site closure|0|||
156318671|NCT04761627|564266408|FG002|Run-in Period|Study site closure|0|||
156318672|NCT04761627|564266406|FG000|Run-in Period|Pregnancy|2|||
156318673|NCT04761627|564266407|FG001|Run-in Period|Pregnancy|0|||
156318674|NCT04761627|564266408|FG002|Run-in Period|Pregnancy|0|||
156318675|NCT04761627|564266406|FG000|Post-randomization Period|Military service|0|||
156318676|NCT04761627|564266407|FG001|Post-randomization Period|Military service|1|||
156318677|NCT04761627|564266408|FG002|Post-randomization Period|Military service|0|||
156318678|NCT04761627|564266406|FG000|Post-randomization Period|Adverse Event|0|||
156318679|NCT04761627|564266407|FG001|Post-randomization Period|Adverse Event|4|||
156318680|NCT04761627|564266408|FG002|Post-randomization Period|Adverse Event|2|||
156318681|NCT04761627|564266406|FG000|Post-randomization Period|Lost to Follow-up|0|||
156318682|NCT04761627|564266407|FG001|Post-randomization Period|Lost to Follow-up|6|||
156318683|NCT04761627|564266408|FG002|Post-randomization Period|Lost to Follow-up|6|||
156318684|NCT04761627|564266406|FG000|Post-randomization Period|Withdrawal by Subject|0|||
156318685|NCT04761627|564266407|FG001|Post-randomization Period|Withdrawal by Subject|7|||
156318686|NCT04761627|564266408|FG002|Post-randomization Period|Withdrawal by Subject|6|||
156318687|NCT04761627|564266406|FG000|Post-randomization Period|Pregnancy|0|||
156318688|NCT04761627|564266407|FG001|Post-randomization Period|Pregnancy|0|||
156318689|NCT04761627|564266408|FG002|Post-randomization Period|Pregnancy|1|||
156318690|NCT04761627|564266406|FG000|Post-randomization Period|Study site closure|0|||
156318691|NCT04761627|564266407|FG001|Post-randomization Period|Study site closure|0|||
156318692|NCT04761627|564266408|FG002|Post-randomization Period|Study site closure|1|||
156318693|NCT04761627|564266406|FG000|Post-randomization Period|Family planning|0|||
156318694|NCT04761627|564266407|FG001|Post-randomization Period|Family planning|1|||
156318695|NCT04761627|564266408|FG002|Post-randomization Period|Family planning|0|||
156318696|NCT01933789|564266409|FG000|Overall Study|Death|0|||
156318697|NCT01933789|564266410|FG001|Overall Study|Death|0|||
156318698|NCT01933789|564266411|FG002|Overall Study|Death|0|||
156318699|NCT01933789|564266412|FG003|Overall Study|Death|0|||
156318700|NCT01933789|564266413|FG004|Overall Study|Death|21|||
156318701|NCT01933789|564266414|FG005|Overall Study|Death|32|||
156318702|NCT01933789|564266415|FG006|Overall Study|Death|0|||
156318703|NCT01933789|564266416|FG007|Overall Study|Death|0|||
156318704|NCT01933789|564266417|FG008|Overall Study|Death|0|||
156318705|NCT01933789|564266409|FG000|Overall Study|Lost to Follow-up|0|||
156318706|NCT01933789|564266410|FG001|Overall Study|Lost to Follow-up|0|||
156318707|NCT01933789|564266411|FG002|Overall Study|Lost to Follow-up|0|||
156318708|NCT01933789|564266412|FG003|Overall Study|Lost to Follow-up|1|||
156318709|NCT01933789|564266413|FG004|Overall Study|Lost to Follow-up|8|||
156318710|NCT01933789|564266414|FG005|Overall Study|Lost to Follow-up|9|||
156318711|NCT01933789|564266415|FG006|Overall Study|Lost to Follow-up|1|||
156318712|NCT01933789|564266416|FG007|Overall Study|Lost to Follow-up|4|||
156318713|NCT01933789|564266417|FG008|Overall Study|Lost to Follow-up|0|||
156318714|NCT01933789|564266409|FG000|Overall Study|Withdrawal by Subject|2|||
156419941|NCT04955626|564630205|FG024|Blinded Period|Withdrawal by Subject|5|||
156760692|NCT02849587|565875750|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
156760693|NCT02849587|565875751|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
156760694|NCT02849587|565875749|FG000|Overall Study|Withdrawal by Subject|0|||
156419942|NCT04955626|564630206|FG025|Blinded Period|Withdrawal by Subject|1|||
156318715|NCT01933789|564266410|FG001|Overall Study|Withdrawal by Subject|1|||
156318716|NCT01933789|564266411|FG002|Overall Study|Withdrawal by Subject|0|||
156318717|NCT01933789|564266412|FG003|Overall Study|Withdrawal by Subject|0|||
156318718|NCT01933789|564266413|FG004|Overall Study|Withdrawal by Subject|17|||
156318719|NCT01933789|564266414|FG005|Overall Study|Withdrawal by Subject|16|||
156318720|NCT01933789|564266415|FG006|Overall Study|Withdrawal by Subject|1|||
156760695|NCT02849587|565875750|FG001|Overall Study|Withdrawal by Subject|1|||
156760696|NCT02849587|565875751|FG002|Overall Study|Withdrawal by Subject|0|||
156760697|NCT03380377|565875754|FG000|Overall Study|Physician Decision|1|||
156760698|NCT03380377|565875754|FG000|Overall Study|Withdrawal by Subject|1|||
156760699|NCT02716779|565875755|FG000|Monotherapy|Adverse Event|0|||
156760700|NCT02716779|565875756|FG001|Monotherapy|Adverse Event|1|||
156760701|NCT02716779|565875757|FG002|Monotherapy|Adverse Event|1|||
156760702|NCT02716779|565875755|FG000|Combination Therapy|Adverse Event|0|||
156760703|NCT02716779|565875756|FG001|Combination Therapy|Adverse Event|2|||
156760704|NCT02716779|565875757|FG002|Combination Therapy|Adverse Event|1|||
156760705|NCT00385918|565875762|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
156760706|NCT00385918|565875763|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
156760707|NCT00385918|565875764|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
156760708|NCT00385918|565875762|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
156760709|NCT00385918|565875763|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
156760710|NCT00385918|565875764|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
156760711|NCT00385918|565875762|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
156760712|NCT00385918|565875763|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
156760713|NCT00385918|565875764|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
156760714|NCT00385918|565875762|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
156760715|NCT00385918|565875763|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
156760716|NCT00385918|565875764|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
156760717|NCT00385918|565875762|FG000|Intervention Phase After Randomization|Physician Decision|1|||
156760718|NCT00385918|565875763|FG001|Intervention Phase After Randomization|Physician Decision|0|||
156760719|NCT00385918|565875764|FG002|Intervention Phase After Randomization|Physician Decision|0|||
156760720|NCT00385918|565875762|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
156760721|NCT00385918|565875763|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
156760722|NCT00385918|565875764|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
156760723|NCT00128661|565875765|FG000|Overall Study|Adverse Event|14|||
156760724|NCT00128661|565875766|FG001|Overall Study|Adverse Event|11|||
156760725|NCT00128661|565875765|FG000|Overall Study|Lost to Follow-up|10|||
156760726|NCT00128661|565875766|FG001|Overall Study|Lost to Follow-up|7|||
156760727|NCT00128661|565875765|FG000|Overall Study|Withdrawal by Subject|243|||
156760728|NCT00128661|565875766|FG001|Overall Study|Withdrawal by Subject|232|||
156760729|NCT00128661|565875765|FG000|Overall Study|Other|7|||
156760730|NCT00128661|565875766|FG001|Overall Study|Other|8|||
156760731|NCT03421379|565875767|FG000|Period 1|Withdrawal by Subject|0|||
156760732|NCT03421379|565875768|FG001|Period 1|Withdrawal by Subject|1|||
156760733|NCT03421379|565875767|FG000|Period 1|Physician Decision|1|||
156760734|NCT03421379|565875768|FG001|Period 1|Physician Decision|1|||
156318721|NCT01933789|564266416|FG007|Overall Study|Withdrawal by Subject|4|||
156318722|NCT01933789|564266417|FG008|Overall Study|Withdrawal by Subject|0|||
156318723|NCT01933789|564266409|FG000|Overall Study|Became Ineligible|4|||
156318724|NCT01933789|564266410|FG001|Overall Study|Became Ineligible|0|||
156318725|NCT01933789|564266411|FG002|Overall Study|Became Ineligible|0|||
156318726|NCT01933789|564266412|FG003|Overall Study|Became Ineligible|0|||
156318727|NCT01933789|564266413|FG004|Overall Study|Became Ineligible|13|||
156318728|NCT01933789|564266414|FG005|Overall Study|Became Ineligible|10|||
156318729|NCT01933789|564266415|FG006|Overall Study|Became Ineligible|13|||
156318730|NCT01933789|564266416|FG007|Overall Study|Became Ineligible|6|||
156318731|NCT01933789|564266417|FG008|Overall Study|Became Ineligible|0|||
156318732|NCT00723203|564266422|FG000|Overall Study|Withdrawal by Subject|3|||
156318733|NCT00274924|564266423|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
156318734|NCT00274924|564266424|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
156318735|NCT00274924|564266425|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
156318736|NCT00274924|564266423|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
156318737|NCT00274924|564266424|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
156318738|NCT00274924|564266425|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
156318739|NCT00274924|564266423|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
156318740|NCT00274924|564266424|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
156760735|NCT03421379|565875767|FG000|Period 1|Did not receive treatment|1|||
156760736|NCT03421379|565875768|FG001|Period 1|Did not receive treatment|2|||
156760737|NCT01951417|565875770|FG000|Overall Study|Withdrawal by Subject|1|||
156760738|NCT01951417|565875770|FG000|Overall Study|Protocol Violation|2|||
156760739|NCT01951417|565875770|FG000|Overall Study|Lost to Follow-up|6|||
156760740|NCT04010461|565875771|FG000|Overall Study|COVID based withdrawal|5|||
156760741|NCT04010461|565875771|FG000|Overall Study|Withdrawal by Subject|5|||
156760742|NCT04010461|565875771|FG000|Overall Study|Adverse Event|1|||
156318741|NCT00274924|564266425|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
156318742|NCT00274924|564266423|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
156760743|NCT04010461|565875771|FG000|Overall Study|No Motor Threshold obtainable|1|||
156760744|NCT04010461|565875771|FG000|Overall Study|Physician Decision|1|||
156760745|NCT02324361|565875776|FG000|Overall Study|Lost to Follow-up|5|||
156760746|NCT02324361|565875777|FG001|Overall Study|Lost to Follow-up|2|||
156760747|NCT00715403|565875785|FG000|Overall Study|Progressive disease|0|||
156760748|NCT00715403|565875786|FG001|Overall Study|Progressive disease|1|||
156760749|NCT00715403|565875787|FG002|Overall Study|Progressive disease|3|||
156760750|NCT00715403|565875788|FG003|Overall Study|Progressive disease|9|||
156760751|NCT00715403|565875789|FG004|Overall Study|Progressive disease|5|||
156760752|NCT00715403|565875790|FG005|Overall Study|Progressive disease|14|||
156760753|NCT00715403|565875791|FG006|Overall Study|Progressive disease|1|||
156760754|NCT00715403|565875785|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760755|NCT00715403|565875786|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760756|NCT00715403|565875787|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760757|NCT00715403|565875788|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760758|NCT00715403|565875789|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760759|NCT00715403|565875790|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
156760760|NCT00715403|565875791|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760761|NCT00715403|565875785|FG000|Overall Study|Other Adverse Event than DLT|1|||
156760762|NCT00715403|565875786|FG001|Overall Study|Other Adverse Event than DLT|0|||
156760763|NCT00715403|565875787|FG002|Overall Study|Other Adverse Event than DLT|0|||
156760764|NCT00715403|565875788|FG003|Overall Study|Other Adverse Event than DLT|0|||
156760765|NCT00715403|565875789|FG004|Overall Study|Other Adverse Event than DLT|0|||
156760766|NCT00715403|565875790|FG005|Overall Study|Other Adverse Event than DLT|2|||
156760767|NCT00715403|565875791|FG006|Overall Study|Other Adverse Event than DLT|0|||
156760768|NCT00715403|565875785|FG000|Overall Study|Protocol Violation|0|||
156760769|NCT00715403|565875786|FG001|Overall Study|Protocol Violation|0|||
156760770|NCT00715403|565875787|FG002|Overall Study|Protocol Violation|0|||
156760771|NCT00715403|565875788|FG003|Overall Study|Protocol Violation|0|||
156760772|NCT00715403|565875789|FG004|Overall Study|Protocol Violation|0|||
156760773|NCT00715403|565875790|FG005|Overall Study|Protocol Violation|1|||
156760774|NCT00715403|565875791|FG006|Overall Study|Protocol Violation|0|||
156760775|NCT00715403|565875785|FG000|Overall Study|Other reason not defined above|0|||
156760776|NCT00715403|565875786|FG001|Overall Study|Other reason not defined above|0|||
156760777|NCT00715403|565875787|FG002|Overall Study|Other reason not defined above|1|||
156760778|NCT00715403|565875788|FG003|Overall Study|Other reason not defined above|0|||
156760779|NCT00715403|565875789|FG004|Overall Study|Other reason not defined above|1|||
156760780|NCT00715403|565875790|FG005|Overall Study|Other reason not defined above|1|||
156760781|NCT00715403|565875791|FG006|Overall Study|Other reason not defined above|0|||
156760782|NCT00101868|565875799|FG000|Overall Study|Death|10|||
156760783|NCT00101868|565875800|FG001|Overall Study|Death|10|||
156760784|NCT00101868|565875799|FG000|Overall Study|Withdrawal by Subject|8|||
156760785|NCT00101868|565875800|FG001|Overall Study|Withdrawal by Subject|9|||
156760786|NCT00101868|565875799|FG000|Overall Study|Protocol Violation|3|||
156760787|NCT00101868|565875800|FG001|Overall Study|Protocol Violation|0|||
156760788|NCT00101868|565875799|FG000|Overall Study|Lost to Follow-up|8|||
156760789|NCT00101868|565875800|FG001|Overall Study|Lost to Follow-up|13|||
156760790|NCT04001803|565875801|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
156760791|NCT04001803|565875801|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
156760792|NCT04001803|565875801|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
156760793|NCT04001803|565875801|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
156760794|NCT04001803|565875801|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
156760795|NCT04001803|565875801|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
156760796|NCT04001803|565875801|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
156760797|NCT04001803|565875801|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
156760798|NCT04001803|565875801|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
156760799|NCT04001803|565875801|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
156318743|NCT00274924|564266424|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
156318744|NCT00274924|564266425|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
156318745|NCT00274924|564266423|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
156318746|NCT00274924|564266424|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
156318747|NCT00274924|564266425|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
156318748|NCT00274924|564266423|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
156318749|NCT00274924|564266424|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
156318750|NCT00274924|564266425|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
156760800|NCT01931397|565875804|FG000|Overall Study|Physician Decision|2|||
156760801|NCT01931397|565875804|FG000|Overall Study|Withdrawal by Subject|8|||
156760802|NCT01931397|565875804|FG000|Overall Study|moved out of state|1|||
156760803|NCT02329327|565875808|FG000|Overall Study|Death|78|||
156760804|NCT02329327|565875809|FG001|Overall Study|Death|0|||
156760805|NCT02329327|565875808|FG000|Overall Study|Withdrawal by Subject|3|||
156760806|NCT02329327|565875809|FG001|Overall Study|Withdrawal by Subject|0|||
156760807|NCT02329327|565875808|FG000|Overall Study|Lost to Follow-up|4|||
156760808|NCT02329327|565875809|FG001|Overall Study|Lost to Follow-up|0|||
156760809|NCT02493517|565875810|FG000|Overall Study|Protocol Violation|1|||
156760810|NCT02493517|565875811|FG001|Overall Study|Protocol Violation|2|||
156760811|NCT02493517|565875810|FG000|Overall Study|Withdrawal by Subject|1|||
156760812|NCT02493517|565875811|FG001|Overall Study|Withdrawal by Subject|2|||
156760813|NCT02493517|565875810|FG000|Overall Study|Adverse Event|0|||
156760814|NCT02493517|565875811|FG001|Overall Study|Adverse Event|2|||
156760815|NCT02493517|565875810|FG000|Overall Study|Missed study visit|0|||
156760816|NCT02493517|565875811|FG001|Overall Study|Missed study visit|1|||
156760817|NCT01367249|565875812|FG000|Overall Study|Withdrawal by Subject|6|||
156760818|NCT01367249|565875813|FG001|Overall Study|Withdrawal by Subject|6|||
156760819|NCT01367249|565875812|FG000|Overall Study|Other|3|||
156419943|NCT04955626|564630207|FG026|Blinded Period|Withdrawal by Subject|5|||
156419944|NCT04955626|564630208|FG027|Blinded Period|Withdrawal by Subject|1|||
156419945|NCT04955626|564630209|FG028|Blinded Period|Withdrawal by Subject|4|||
156419946|NCT04955626|564630210|FG029|Blinded Period|Withdrawal by Subject|2|||
156419947|NCT04955626|564630211|FG030|Blinded Period|Withdrawal by Subject|0|||
156419948|NCT04955626|564630212|FG031|Blinded Period|Withdrawal by Subject|0|||
156419949|NCT04955626|564630213|FG032|Blinded Period|Withdrawal by Subject|0|||
156419950|NCT04955626|564630214|FG033|Blinded Period|Withdrawal by Subject|0|||
156419951|NCT04955626|564630215|FG034|Blinded Period|Withdrawal by Subject|0|||
156419952|NCT04955626|564630216|FG035|Blinded Period|Withdrawal by Subject|0|||
156419953|NCT04955626|564630181|FG000|Blinded Period|Refused further study procedures|0|||
156419954|NCT04955626|564630182|FG001|Blinded Period|Refused further study procedures|0|||
156318751|NCT00274924|564266423|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
156318752|NCT00274924|564266424|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
156318753|NCT00274924|564266425|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
156318754|NCT00274924|564266423|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
156318755|NCT00274924|564266424|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
156318756|NCT00274924|564266425|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
156318757|NCT00274924|564266423|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
156318758|NCT00274924|564266424|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
156419955|NCT04955626|564630183|FG002|Blinded Period|Refused further study procedures|0|||
156419956|NCT04955626|564630184|FG003|Blinded Period|Refused further study procedures|0|||
156419957|NCT04955626|564630185|FG004|Blinded Period|Refused further study procedures|0|||
156419958|NCT04955626|564630186|FG005|Blinded Period|Refused further study procedures|0|||
156419959|NCT04955626|564630187|FG006|Blinded Period|Refused further study procedures|1|||
156419960|NCT04955626|564630188|FG007|Blinded Period|Refused further study procedures|0|||
156419961|NCT04955626|564630189|FG008|Blinded Period|Refused further study procedures|0|||
156419962|NCT04955626|564630190|FG009|Blinded Period|Refused further study procedures|0|||
156760820|NCT01367249|565875813|FG001|Overall Study|Other|10|||
156760821|NCT03718429|565875814|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
156760822|NCT03718429|565875815|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
156760823|NCT03718429|565875816|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
156760824|NCT03718429|565875817|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
156760825|NCT05404711|565875818|FG000|Completed Study Visit|Withdrawal by Subject|1|||
156760826|NCT05404711|565875818|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
156760827|NCT05404711|565875818|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
156760828|NCT05404711|565875818|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
156760829|NCT05404711|565875818|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
156760830|NCT05404711|565875818|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
156760831|NCT02346877|565875819|FG000|Overall Study|Adverse Event|1|||
156760832|NCT02346877|565875820|FG001|Overall Study|Adverse Event|0|||
156760833|NCT02346877|565875819|FG000|Overall Study|Administrative Decision|1|||
156760834|NCT02346877|565875820|FG001|Overall Study|Administrative Decision|0|||
156760835|NCT02346877|565875819|FG000|Overall Study|Sponsor Decision|12|||
156760836|NCT02346877|565875820|FG001|Overall Study|Sponsor Decision|0|||
156760837|NCT02346877|565875819|FG000|Overall Study|Missing|5|||
156760838|NCT02346877|565875820|FG001|Overall Study|Missing|0|||
156760839|NCT01683604|565875823|FG000|Overall Study|Adverse Event|2|||
156760840|NCT01683604|565875823|FG000|Overall Study|Lack of Efficacy|1|||
156760841|NCT01683604|565875823|FG000|Overall Study|Other|2|||
156318759|NCT00274924|564266425|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
156318760|NCT00274924|564266423|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
156318761|NCT00274924|564266424|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
156318762|NCT00274924|564266425|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
156419963|NCT04955626|564630191|FG010|Blinded Period|Refused further study procedures|0|||
156760842|NCT03430856|565875824|FG000|Overall Study|Adverse Event|0|||
156419964|NCT04955626|564630192|FG011|Blinded Period|Refused further study procedures|2|||
156419965|NCT04955626|564630193|FG012|Blinded Period|Refused further study procedures|0|||
156419966|NCT04955626|564630194|FG013|Blinded Period|Refused further study procedures|0|||
156419967|NCT04955626|564630195|FG014|Blinded Period|Refused further study procedures|0|||
156760843|NCT03430856|565875825|FG001|Overall Study|Adverse Event|1|||
156760844|NCT03430856|565875826|FG002|Overall Study|Adverse Event|0|||
156760845|NCT03430856|565875824|FG000|Overall Study|Rescue criteria|1|||
156760846|NCT03430856|565875825|FG001|Overall Study|Rescue criteria|1|||
156419968|NCT04955626|564630196|FG015|Blinded Period|Refused further study procedures|0|||
156419969|NCT04955626|564630197|FG016|Blinded Period|Refused further study procedures|0|||
156419970|NCT04955626|564630198|FG017|Blinded Period|Refused further study procedures|0|||
156419971|NCT04955626|564630199|FG018|Blinded Period|Refused further study procedures|0|||
156419972|NCT04955626|564630200|FG019|Blinded Period|Refused further study procedures|0|||
156419973|NCT04955626|564630201|FG020|Blinded Period|Refused further study procedures|0|||
156419974|NCT04955626|564630202|FG021|Blinded Period|Refused further study procedures|0|||
156419975|NCT04955626|564630203|FG022|Blinded Period|Refused further study procedures|0|||
156419976|NCT04955626|564630204|FG023|Blinded Period|Refused further study procedures|0|||
156419977|NCT04955626|564630205|FG024|Blinded Period|Refused further study procedures|0|||
156419978|NCT04955626|564630206|FG025|Blinded Period|Refused further study procedures|0|||
156419979|NCT04955626|564630207|FG026|Blinded Period|Refused further study procedures|0|||
156419980|NCT04955626|564630208|FG027|Blinded Period|Refused further study procedures|0|||
156419981|NCT04955626|564630209|FG028|Blinded Period|Refused further study procedures|0|||
156419982|NCT04955626|564630210|FG029|Blinded Period|Refused further study procedures|0|||
156419983|NCT04955626|564630211|FG030|Blinded Period|Refused further study procedures|0|||
156419984|NCT04955626|564630212|FG031|Blinded Period|Refused further study procedures|0|||
156760847|NCT03430856|565875826|FG002|Overall Study|Rescue criteria|0|||
156760848|NCT03430856|565875824|FG000|Overall Study|Voluntary withdrawal of consent|1|||
156760849|NCT03430856|565875825|FG001|Overall Study|Voluntary withdrawal of consent|1|||
156760850|NCT03430856|565875826|FG002|Overall Study|Voluntary withdrawal of consent|1|||
156760851|NCT02481050|565877838|FG000|Overall Study|Adverse Event|1|||
156760852|NCT02481050|565877838|FG000|Overall Study|Disease Progression|47|||
156760853|NCT02481050|565877838|FG000|Overall Study|Withdrawal by Subject|7|||
156760854|NCT02481050|565877838|FG000|Overall Study|Other|3|||
156760855|NCT01386606|565877839|FG000|Overall Study|Adverse Event|0|||
156760856|NCT01386606|565877840|FG001|Overall Study|Adverse Event|1|||
156760857|NCT01386606|565877841|FG002|Overall Study|Adverse Event|0|||
156760858|NCT01386606|565877842|FG003|Overall Study|Adverse Event|0|||
156760859|NCT01386606|565877839|FG000|Overall Study|Withdrawal by Subject|0|||
156760860|NCT01386606|565877840|FG001|Overall Study|Withdrawal by Subject|1|||
156760861|NCT01386606|565877841|FG002|Overall Study|Withdrawal by Subject|1|||
156760862|NCT01386606|565877842|FG003|Overall Study|Withdrawal by Subject|0|||
156760863|NCT01386606|565877839|FG000|Overall Study|Protocol Violation|1|||
156760864|NCT01386606|565877840|FG001|Overall Study|Protocol Violation|0|||
156760865|NCT01386606|565877841|FG002|Overall Study|Protocol Violation|1|||
156760866|NCT01386606|565877842|FG003|Overall Study|Protocol Violation|1|||
156760867|NCT01386606|565877839|FG000|Overall Study|Lost to Follow-up|2|||
156760868|NCT01386606|565877840|FG001|Overall Study|Lost to Follow-up|0|||
156760869|NCT01386606|565877841|FG002|Overall Study|Lost to Follow-up|0|||
156760870|NCT01386606|565877842|FG003|Overall Study|Lost to Follow-up|0|||
156760871|NCT01386606|565877839|FG000|Overall Study|Subject incarcerated|0|||
156760872|NCT01386606|565877840|FG001|Overall Study|Subject incarcerated|1|||
156760873|NCT01386606|565877841|FG002|Overall Study|Subject incarcerated|0|||
156760874|NCT01386606|565877842|FG003|Overall Study|Subject incarcerated|0|||
156760875|NCT01386606|565877839|FG000|Overall Study|Unable to draw PK|1|||
156760876|NCT01386606|565877840|FG001|Overall Study|Unable to draw PK|0|||
156760877|NCT01386606|565877841|FG002|Overall Study|Unable to draw PK|0|||
156760878|NCT01386606|565877842|FG003|Overall Study|Unable to draw PK|0|||
156760879|NCT01386606|565877839|FG000|Overall Study|T levels too high|0|||
156760880|NCT01386606|565877840|FG001|Overall Study|T levels too high|1|||
156760881|NCT01386606|565877841|FG002|Overall Study|T levels too high|1|||
156760882|NCT01386606|565877842|FG003|Overall Study|T levels too high|0|||
156760883|NCT01548599|565877845|FG000|Overall Study|Lost to Follow-up|0|||
156760884|NCT01548599|565877846|FG001|Overall Study|Lost to Follow-up|1|||
156760885|NCT01548599|565877845|FG000|Overall Study|Withdrawal by Subject|4|||
156760886|NCT01548599|565877846|FG001|Overall Study|Withdrawal by Subject|0|||
156760887|NCT01548599|565877845|FG000|Overall Study|Death|2|||
156760888|NCT01548599|565877846|FG001|Overall Study|Death|1|||
156760889|NCT03638128|565877847|FG000|Overall Study|Withdrawal by Subject|1|||
156419985|NCT04955626|564630213|FG032|Blinded Period|Refused further study procedures|0|||
156419986|NCT04955626|564630214|FG033|Blinded Period|Refused further study procedures|0|||
156760890|NCT03638128|565877848|FG001|Overall Study|Withdrawal by Subject|7|||
156760891|NCT03638128|565877849|FG002|Overall Study|Withdrawal by Subject|6|||
156760892|NCT03638128|565877847|FG000|Overall Study|Sponsor Decision|15|||
156760893|NCT03638128|565877848|FG001|Overall Study|Sponsor Decision|12|||
156760894|NCT03638128|565877849|FG002|Overall Study|Sponsor Decision|19|||
156760895|NCT03638128|565877847|FG000|Overall Study|Lost to Follow-up|0|||
156419987|NCT04955626|564630215|FG034|Blinded Period|Refused further study procedures|0|||
156419988|NCT04955626|564630216|FG035|Blinded Period|Refused further study procedures|0|||
156760896|NCT03638128|565877848|FG001|Overall Study|Lost to Follow-up|0|||
156760897|NCT03638128|565877849|FG002|Overall Study|Lost to Follow-up|1|||
156760898|NCT00611806|565877850|FG000|Overall Study|Withdrawal by Subject|8|||
156760899|NCT00611806|565877851|FG001|Overall Study|Withdrawal by Subject|2|||
156760900|NCT00611806|565877850|FG000|Overall Study|Adverse Event|2|||
156760901|NCT00611806|565877851|FG001|Overall Study|Adverse Event|1|||
156760902|NCT00611806|565877850|FG000|Overall Study|Lost to Follow-up|6|||
156760903|NCT00611806|565877851|FG001|Overall Study|Lost to Follow-up|0|||
156760904|NCT00329108|565877853|FG000|Overall Study|Adverse Event|2|||
156760905|NCT00329108|565877854|FG001|Overall Study|Adverse Event|2|||
156760906|NCT00329108|565877853|FG000|Overall Study|Lack of Efficacy|3|||
156760907|NCT00329108|565877854|FG001|Overall Study|Lack of Efficacy|3|||
156760908|NCT00329108|565877853|FG000|Overall Study|Withdrawal by Subject|0|||
156760909|NCT00329108|565877854|FG001|Overall Study|Withdrawal by Subject|2|||
156760910|NCT00329108|565877853|FG000|Overall Study|symptomatic deterioration|1|||
156760911|NCT00329108|565877854|FG001|Overall Study|symptomatic deterioration|1|||
156760912|NCT00329108|565877853|FG000|Overall Study|Subject no longer willing to participate|2|||
156760913|NCT00329108|565877854|FG001|Overall Study|Subject no longer willing to participate|2|||
156760914|NCT00329108|565877853|FG000|Overall Study|study terminated by sponsor|1|||
156760915|NCT00329108|565877854|FG001|Overall Study|study terminated by sponsor|0|||
156760916|NCT00329108|565877853|FG000|Overall Study|withdrew patient after SAE resolved|1|||
156760917|NCT00329108|565877854|FG001|Overall Study|withdrew patient after SAE resolved|0|||
156760918|NCT00329108|565877853|FG000|Overall Study|Protocol Violation|0|||
156760919|NCT00329108|565877854|FG001|Overall Study|Protocol Violation|2|||
156760920|NCT00754741|565877855|FG000|Overall Study|Died or disenrolled|57|||
156760921|NCT00754741|565877856|FG001|Overall Study|Died or disenrolled|69|||
156760922|NCT00754741|565877857|FG002|Overall Study|Died or disenrolled|54|||
156760923|NCT04152200|565877859|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
156760924|NCT04152200|565877860|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
156760925|NCT04969289|565877861|FG000|Overall Study|Lost to Follow-up|13|||
156760926|NCT04969289|565877862|FG001|Overall Study|Lost to Follow-up|9|||
156760927|NCT00593814|565877863|FG000|Overall Study|Death|7|||
156760928|NCT00593814|565877864|FG001|Overall Study|Death|0|||
156760929|NCT00593814|565877863|FG000|Overall Study|Withdrawal by Subject|7|||
156760930|NCT00593814|565877864|FG001|Overall Study|Withdrawal by Subject|0|||
156760931|NCT00593814|565877863|FG000|Overall Study|Lost to Follow-up|7|||
156760932|NCT00593814|565877864|FG001|Overall Study|Lost to Follow-up|0|||
156760933|NCT00593814|565877863|FG000|Overall Study|Physician Decision|3|||
156760934|NCT00593814|565877864|FG001|Overall Study|Physician Decision|0|||
156760935|NCT01921517|565877865|FG000|Overall Study|Lost to Follow-up|5|||
156760936|NCT01921517|565877866|FG001|Overall Study|Lost to Follow-up|0|||
156760937|NCT01921517|565877865|FG000|Overall Study|Newly diagnosed health concern|2|||
156760938|NCT01921517|565877866|FG001|Overall Study|Newly diagnosed health concern|0|||
156760939|NCT01921517|565877865|FG000|Overall Study|Physician Decision|0|||
156760940|NCT01921517|565877866|FG001|Overall Study|Physician Decision|2|||
156760941|NCT01921517|565877865|FG000|Overall Study|Withdrawal by Subject|7|||
156760942|NCT01921517|565877866|FG001|Overall Study|Withdrawal by Subject|3|||
156760943|NCT01921517|565877865|FG000|Overall Study|Subject missed final imaging|1|||
156760944|NCT01921517|565877866|FG001|Overall Study|Subject missed final imaging|4|||
156760945|NCT04069715|565877869|FG000|Overall Study|Lost to Follow-up|1|||
156760946|NCT04069715|565877870|FG001|Overall Study|Lost to Follow-up|1|||
156760947|NCT04069715|565877869|FG000|Overall Study|Physician Decision|1|||
156760948|NCT04069715|565877870|FG001|Overall Study|Physician Decision|1|||
156760949|NCT04069715|565877869|FG000|Overall Study|Withdrawal by Subject|3|||
156760950|NCT04069715|565877870|FG001|Overall Study|Withdrawal by Subject|3|||
156760951|NCT02723188|565877871|FG000|Overall Study|Withdrawal by Subject|1|||
156760952|NCT02723188|565877872|FG001|Overall Study|Withdrawal by Subject|0|||
156760953|NCT02723188|565877873|FG002|Overall Study|Withdrawal by Subject|0|||
156760954|NCT03110354|565877874|FG000|Overall Study|Death|1|||
156760955|NCT03110354|565877875|FG001|Overall Study|Death|0|||
156760956|NCT03110354|565877876|FG002|Overall Study|Death|0|||
156760957|NCT03110354|565877877|FG003|Overall Study|Death|1|||
156760958|NCT03110354|565877878|FG004|Overall Study|Death|0|||
156760959|NCT03110354|565877874|FG000|Overall Study|Start of new therapy|0|||
156760960|NCT03110354|565877875|FG001|Overall Study|Start of new therapy|0|||
156760961|NCT03110354|565877876|FG002|Overall Study|Start of new therapy|0|||
156760962|NCT03110354|565877877|FG003|Overall Study|Start of new therapy|0|||
156760963|NCT03110354|565877878|FG004|Overall Study|Start of new therapy|1|||
156760964|NCT03110354|565877874|FG000|Overall Study|Failure to achieve response|2|||
156318763|NCT00274924|564266423|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
156318764|NCT00274924|564266424|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
156760965|NCT03110354|565877875|FG001|Overall Study|Failure to achieve response|3|||
156760966|NCT03110354|565877876|FG002|Overall Study|Failure to achieve response|0|||
156760967|NCT03110354|565877877|FG003|Overall Study|Failure to achieve response|2|||
156760968|NCT03110354|565877878|FG004|Overall Study|Failure to achieve response|1|||
156760969|NCT03110354|565877874|FG000|Overall Study|Progressive disease|1|||
156760970|NCT03110354|565877875|FG001|Overall Study|Progressive disease|1|||
156760971|NCT03110354|565877876|FG002|Overall Study|Progressive disease|3|||
156760972|NCT03110354|565877877|FG003|Overall Study|Progressive disease|4|||
156760973|NCT03110354|565877878|FG004|Overall Study|Progressive disease|2|||
156760974|NCT03110354|565877874|FG000|Overall Study|Adverse Event|0|||
156760975|NCT03110354|565877875|FG001|Overall Study|Adverse Event|0|||
156760976|NCT03110354|565877876|FG002|Overall Study|Adverse Event|0|||
156760977|NCT03110354|565877877|FG003|Overall Study|Adverse Event|2|||
156760978|NCT03110354|565877878|FG004|Overall Study|Adverse Event|2|||
156760979|NCT03110354|565877874|FG000|Overall Study|Other|0|||
156760980|NCT03110354|565877875|FG001|Overall Study|Other|0|||
156760981|NCT03110354|565877876|FG002|Overall Study|Other|0|||
156760982|NCT03110354|565877877|FG003|Overall Study|Other|1|||
156760983|NCT03110354|565877878|FG004|Overall Study|Other|1|||
156760984|NCT01965327|565877882|FG000|Overall Study|Physician Decision|2|||
156760985|NCT01145482|565877884|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
156760986|NCT01145482|565877885|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
156760987|NCT00165503|565877886|FG000|Overall Study|Death|1|||
156760988|NCT00165503|565877886|FG000|Overall Study|Lost to Follow-up|12|||
156760989|NCT00165503|565877886|FG000|Overall Study|Unresectable|3|||
156760990|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Death|20|||
156760991|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Death|26|||
156760992|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
156760993|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
156760994|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
156760995|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
156760996|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
156760997|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
156760998|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
156760999|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
156761000|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
156761001|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
156761002|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
156761003|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
156761004|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
156761005|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
156761006|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Other|107|||
156761007|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Other|107|||
156761008|NCT00643201|565877887|FG000|Completed Study Follow Up|Death|28|||
156761009|NCT00643201|565877888|FG001|Completed Study Follow Up|Death|34|||
156761010|NCT00643201|565877887|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
156761011|NCT00643201|565877888|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
156761012|NCT00643201|565877887|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
156761013|NCT00643201|565877888|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
156761014|NCT00643201|565877887|FG000|Completed Study Follow Up|non-specified|1|||
156761015|NCT00643201|565877888|FG001|Completed Study Follow Up|non-specified|0|||
156761016|NCT02976519|565877889|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761017|NCT02976519|565877890|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
156761018|NCT02976519|565877891|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761019|NCT02976519|565877892|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761020|NCT02976519|565877893|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761021|NCT02976519|565877894|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761022|NCT02976519|565877895|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761023|NCT02976519|565877889|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761024|NCT02976519|565877890|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761025|NCT02976519|565877891|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761026|NCT02976519|565877892|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
156761027|NCT02976519|565877893|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761028|NCT02976519|565877894|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761029|NCT02976519|565877895|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761030|NCT02976519|565877889|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761031|NCT02976519|565877890|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761032|NCT02976519|565877891|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761033|NCT02976519|565877892|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761034|NCT02976519|565877893|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761035|NCT02976519|565877894|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761036|NCT02976519|565877895|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
156761037|NCT02976519|565877889|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761038|NCT02976519|565877890|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761039|NCT02976519|565877891|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761040|NCT02976519|565877892|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761041|NCT02976519|565877893|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156419989|NCT04955626|564630181|FG000|Blinded Period|Participants entered open label period|4544|||
156419990|NCT04955626|564630182|FG001|Blinded Period|Participants entered open label period|4906|||
156419991|NCT04955626|564630183|FG002|Blinded Period|Participants entered open label period|0|||
156761042|NCT02976519|565877894|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761043|NCT02976519|565877895|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
156761044|NCT02976519|565877889|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761045|NCT02976519|565877890|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761046|NCT02976519|565877891|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761047|NCT02976519|565877892|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761048|NCT02976519|565877893|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761049|NCT02976519|565877894|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761050|NCT02976519|565877895|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
156761051|NCT01278342|565877896|FG000|Overall Study|Physician Decision|0|||
156761052|NCT01278342|565877897|FG001|Overall Study|Physician Decision|1|||
156761053|NCT01278342|565877898|FG002|Overall Study|Physician Decision|0|||
156761054|NCT01278342|565877896|FG000|Overall Study|Lost to Follow-up|1|||
156761055|NCT01278342|565877897|FG001|Overall Study|Lost to Follow-up|0|||
156761056|NCT01278342|565877898|FG002|Overall Study|Lost to Follow-up|0|||
156761057|NCT01278342|565877896|FG000|Overall Study|Administrative problems|2|||
156761058|NCT01278342|565877897|FG001|Overall Study|Administrative problems|0|||
156761059|NCT01278342|565877898|FG002|Overall Study|Administrative problems|0|||
156761060|NCT01278342|565877896|FG000|Overall Study|Other|1|||
156761061|NCT01278342|565877897|FG001|Overall Study|Other|0|||
156761062|NCT01278342|565877898|FG002|Overall Study|Other|0|||
156761063|NCT00473655|565877906|FG000|Overall Study|Lost to Follow-up|9|||
156761064|NCT00473655|565877907|FG001|Overall Study|Lost to Follow-up|5|||
156761065|NCT00473655|565877908|FG002|Overall Study|Lost to Follow-up|8|||
156761066|NCT00891813|565877909|FG000|Overall Study|Adverse Event|3|||
156761067|NCT00891813|565877909|FG000|Overall Study|Withdrawal by Subject|1|||
156761068|NCT00891813|565877909|FG000|Overall Study|Patient Noncompliance|6|||
156761069|NCT00891813|565877909|FG000|Overall Study|Protocol Violation|2|||
156761070|NCT00243919|565877917|FG000|Overall Study|Death|3|||
156761071|NCT00243919|565877918|FG001|Overall Study|Death|4|||
156761072|NCT00243919|565877919|FG002|Overall Study|Death|6|||
156761073|NCT00243919|565877917|FG000|Overall Study|Withdrawal by Subject|6|||
156761074|NCT00243919|565877918|FG001|Overall Study|Withdrawal by Subject|6|||
156761075|NCT00243919|565877919|FG002|Overall Study|Withdrawal by Subject|2|||
156761076|NCT00243919|565877917|FG000|Overall Study|Lost to Follow-up|6|||
156761077|NCT00243919|565877918|FG001|Overall Study|Lost to Follow-up|7|||
156761078|NCT00243919|565877919|FG002|Overall Study|Lost to Follow-up|3|||
156761079|NCT00243919|565877917|FG000|Overall Study|Administrative Error|1|||
156761080|NCT00243919|565877918|FG001|Overall Study|Administrative Error|0|||
156761081|NCT00243919|565877919|FG002|Overall Study|Administrative Error|0|||
156761082|NCT00243919|565877917|FG000|Overall Study|Physician Decision|1|||
156761083|NCT00243919|565877918|FG001|Overall Study|Physician Decision|1|||
156761084|NCT00243919|565877919|FG002|Overall Study|Physician Decision|0|||
156761085|NCT02513550|565877920|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
156761086|NCT02513550|565877921|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
156761087|NCT02513550|565877922|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
156761088|NCT02513550|565877923|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
156761089|NCT02513550|565877924|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
156761090|NCT02513550|565877925|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
156761091|NCT02513550|565877920|FG000|Double Blind Treatment Period|Adverse Event|5|||
156761092|NCT02513550|565877921|FG001|Double Blind Treatment Period|Adverse Event|13|||
156761093|NCT02513550|565877922|FG002|Double Blind Treatment Period|Adverse Event|17|||
156761094|NCT02513550|565877923|FG003|Double Blind Treatment Period|Adverse Event|0|||
156761095|NCT02513550|565877924|FG004|Double Blind Treatment Period|Adverse Event|1|||
156761096|NCT02513550|565877925|FG005|Double Blind Treatment Period|Adverse Event|0|||
156761097|NCT02513550|565877920|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
156761098|NCT02513550|565877921|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
156761099|NCT02513550|565877922|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
156761100|NCT02513550|565877923|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
156761101|NCT02513550|565877924|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
156761102|NCT02513550|565877925|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
156761103|NCT02513550|565877920|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
156761104|NCT02513550|565877921|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
156761105|NCT02513550|565877922|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
156761106|NCT02513550|565877923|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
156761107|NCT02513550|565877924|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
156761108|NCT02513550|565877925|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
156761109|NCT02513550|565877920|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156761110|NCT02513550|565877921|FG001|Double Blind Treatment Period|Protocol Violation|1|||
156761111|NCT02513550|565877922|FG002|Double Blind Treatment Period|Protocol Violation|4|||
156761112|NCT02513550|565877923|FG003|Double Blind Treatment Period|Protocol Violation|0|||
156761113|NCT02513550|565877924|FG004|Double Blind Treatment Period|Protocol Violation|0|||
156761114|NCT02513550|565877925|FG005|Double Blind Treatment Period|Protocol Violation|0|||
156761115|NCT02513550|565877920|FG000|Double Blind Treatment Period|Physician Decision|2|||
156761116|NCT02513550|565877921|FG001|Double Blind Treatment Period|Physician Decision|0|||
156761117|NCT02513550|565877922|FG002|Double Blind Treatment Period|Physician Decision|4|||
156761118|NCT02513550|565877923|FG003|Double Blind Treatment Period|Physician Decision|0|||
156761119|NCT02513550|565877924|FG004|Double Blind Treatment Period|Physician Decision|0|||
156761120|NCT02513550|565877925|FG005|Double Blind Treatment Period|Physician Decision|0|||
156761121|NCT02513550|565877920|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
156761122|NCT02513550|565877921|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
156761123|NCT02513550|565877922|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
156761124|NCT02513550|565877923|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
156761125|NCT02513550|565877924|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
156761126|NCT02513550|565877925|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
156761127|NCT02513550|565877920|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761128|NCT02513550|565877921|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761129|NCT02513550|565877922|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
156761130|NCT02513550|565877923|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761131|NCT02513550|565877924|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761132|NCT02513550|565877925|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761133|NCT02513550|565877920|FG000|Double Blind Treatment Period|Due to personal business|2|||
156761134|NCT02513550|565877921|FG001|Double Blind Treatment Period|Due to personal business|0|||
156761135|NCT02513550|565877922|FG002|Double Blind Treatment Period|Due to personal business|1|||
156761136|NCT02513550|565877923|FG003|Double Blind Treatment Period|Due to personal business|0|||
156761137|NCT02513550|565877924|FG004|Double Blind Treatment Period|Due to personal business|0|||
156761138|NCT02513550|565877925|FG005|Double Blind Treatment Period|Due to personal business|0|||
156419992|NCT04955626|564630184|FG003|Blinded Period|Participants entered open label period|0|||
156419993|NCT04955626|564630185|FG004|Blinded Period|Participants entered open label period|0|||
156419994|NCT04955626|564630186|FG005|Blinded Period|Participants entered open label period|0|||
156419995|NCT04955626|564630187|FG006|Blinded Period|Participants entered open label period|0|||
156419996|NCT04955626|564630188|FG007|Blinded Period|Participants entered open label period|0|||
156419997|NCT04955626|564630189|FG008|Blinded Period|Participants entered open label period|0|||
156419998|NCT04955626|564630190|FG009|Blinded Period|Participants entered open label period|0|||
156419999|NCT04955626|564630191|FG010|Blinded Period|Participants entered open label period|0|||
156420000|NCT04955626|564630192|FG011|Blinded Period|Participants entered open label period|0|||
156420001|NCT04955626|564630193|FG012|Blinded Period|Participants entered open label period|0|||
156420002|NCT04955626|564630194|FG013|Blinded Period|Participants entered open label period|0|||
156420003|NCT04955626|564630195|FG014|Blinded Period|Participants entered open label period|0|||
156420004|NCT04955626|564630196|FG015|Blinded Period|Participants entered open label period|0|||
156420005|NCT04955626|564630197|FG016|Blinded Period|Participants entered open label period|0|||
156420006|NCT04955626|564630198|FG017|Blinded Period|Participants entered open label period|0|||
156420007|NCT04955626|564630199|FG018|Blinded Period|Participants entered open label period|0|||
156420008|NCT04955626|564630200|FG019|Blinded Period|Participants entered open label period|0|||
156420009|NCT04955626|564630201|FG020|Blinded Period|Participants entered open label period|0|||
156420010|NCT04955626|564630202|FG021|Blinded Period|Participants entered open label period|0|||
156420011|NCT04955626|564630203|FG022|Blinded Period|Participants entered open label period|0|||
156420012|NCT04955626|564630204|FG023|Blinded Period|Participants entered open label period|0|||
156420013|NCT04955626|564630205|FG024|Blinded Period|Participants entered open label period|0|||
156420014|NCT04955626|564630206|FG025|Blinded Period|Participants entered open label period|0|||
156420015|NCT04955626|564630207|FG026|Blinded Period|Participants entered open label period|0|||
156761139|NCT02513550|565877920|FG000|Double Blind Treatment Period|Death|1|||
156761140|NCT02513550|565877921|FG001|Double Blind Treatment Period|Death|0|||
156761141|NCT02513550|565877922|FG002|Double Blind Treatment Period|Death|2|||
156761142|NCT02513550|565877923|FG003|Double Blind Treatment Period|Death|0|||
156761143|NCT02513550|565877924|FG004|Double Blind Treatment Period|Death|0|||
156761144|NCT02513550|565877925|FG005|Double Blind Treatment Period|Death|0|||
156761145|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
156761146|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
156761147|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
156761148|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156761149|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156761150|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156761151|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
156761152|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
156761153|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
156761154|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
156761155|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
156761156|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
156761157|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
156761158|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
156761159|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
156761160|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156761161|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156761162|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156761163|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
156761164|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
156761165|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
156761166|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
156761167|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
156761168|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
156761169|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
156761170|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
156761171|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
156761172|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
156761173|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
156761174|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
156761175|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Death|0|||
156761176|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Death|0|||
156761177|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Death|1|||
156761178|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Death|0|||
156761179|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Death|0|||
156761180|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Death|0|||
156761181|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761182|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761183|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
156761184|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761185|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761186|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761187|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761188|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761189|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
156761190|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761191|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761192|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761193|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761194|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761195|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
156761196|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761197|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761198|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761199|NCT04176939|565877926|FG000|Overall Study|Withdrawal by Subject|5|||
156761200|NCT04176939|565877926|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
156761201|NCT04176939|565877926|FG000|Overall Study|Lost to Follow-up|2|||
156318765|NCT00274924|564266425|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
156318766|NCT00274924|564266423|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
156318767|NCT00274924|564266424|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
156318768|NCT00274924|564266425|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
156318769|NCT00274924|564266423|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
156318770|NCT00274924|564266424|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
156318771|NCT00274924|564266425|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
156318772|NCT01055496|564266426|FG000|Overall Study|Withdrawal by Subject|2|||
156318773|NCT01055496|564266427|FG001|Overall Study|Withdrawal by Subject|4|||
156318774|NCT01055496|564266426|FG000|Overall Study|Death|13|||
156318775|NCT01055496|564266427|FG001|Overall Study|Death|23|||
156318776|NCT01055496|564266426|FG000|Overall Study|Lost to Follow-up|0|||
156318777|NCT01055496|564266427|FG001|Overall Study|Lost to Follow-up|2|||
156318778|NCT01055496|564266426|FG000|Overall Study|Other - Unspecified|0|||
156318779|NCT01055496|564266427|FG001|Overall Study|Other - Unspecified|1|||
156318780|NCT02915874|564266431|FG000|Overall Study|Lost to Follow-up|5|||
156318781|NCT02915874|564266432|FG001|Overall Study|Lost to Follow-up|4|||
156318782|NCT02915874|564266431|FG000|Overall Study|Withdrawal by Subject|1|||
156761202|NCT04176939|565877926|FG000|Overall Study|Unspecified reason|4|||
156761203|NCT04176939|565877926|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
156761204|NCT02157519|565877927|FG000|Overall Study|Death|3|||
156761205|NCT02157519|565877928|FG001|Overall Study|Death|1|||
156761206|NCT02157519|565877927|FG000|Overall Study|Withdrawal by Subject|7|||
156761207|NCT02157519|565877928|FG001|Overall Study|Withdrawal by Subject|0|||
156318783|NCT02915874|564266432|FG001|Overall Study|Withdrawal by Subject|1|||
156318784|NCT02915874|564266431|FG000|Overall Study|Started New Anxiety Medication|0|||
156318785|NCT02915874|564266432|FG001|Overall Study|Started New Anxiety Medication|1|||
156318786|NCT02518464|564266440|FG000|Overall Study|Adverse Event|2|||
156318787|NCT03761797|564266443|FG000|Overall Study|Changing hospital|11|||
156318788|NCT03761797|564266443|FG000|Overall Study|Improvement/remission|6|||
156318789|NCT03761797|564266443|FG000|Overall Study|Withdrawal by Subject|19|||
156318790|NCT03761797|564266443|FG000|Overall Study|Lost to Follow-up|33|||
156318791|NCT03761797|564266443|FG000|Overall Study|Adverse Event|37|||
156318792|NCT03761797|564266443|FG000|Overall Study|Case report form (CRF) not collected|5|||
156318793|NCT03761797|564266443|FG000|Overall Study|No patient visit after entry|13|||
156318794|NCT03761797|564266443|FG000|Overall Study|Switch to other diabetes medication|10|||
156318795|NCT03761797|564266443|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
156318796|NCT03761797|564266443|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
156318797|NCT03761797|564266443|FG000|Overall Study|Insufficient effectives|2|||
156318798|NCT03761797|564266443|FG000|Overall Study|Excessive alcohol intake|1|||
156653881|NCT00814320|565479571|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
156653882|NCT00814320|565479570|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
156653883|NCT00814320|565479571|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
156653884|NCT00814320|565479570|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
156653885|NCT00814320|565479571|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
156653886|NCT00814320|565479570|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
156653887|NCT00814320|565479571|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
156653888|NCT00814320|565479570|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
156653889|NCT00814320|565479571|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
156653890|NCT00814320|565479570|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
156653891|NCT00814320|565479571|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
156653892|NCT00814320|565479570|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
156653893|NCT00814320|565479571|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
156653894|NCT00814320|565479570|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
156653895|NCT00814320|565479571|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
156653896|NCT00814320|565479570|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
156653897|NCT00814320|565479571|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
156653898|NCT00491504|565479572|FG000|Overall Study|Adverse Event|0|||
156653899|NCT00491504|565479573|FG001|Overall Study|Adverse Event|1|||
156653900|NCT00491504|565479574|FG002|Overall Study|Adverse Event|0|||
156653901|NCT00491504|565479575|FG003|Overall Study|Adverse Event|0|||
156653902|NCT00491504|565479572|FG000|Overall Study|Withdrawal by Subject|0|||
156653903|NCT00491504|565479573|FG001|Overall Study|Withdrawal by Subject|0|||
156653904|NCT00491504|565479574|FG002|Overall Study|Withdrawal by Subject|1|||
156653905|NCT00491504|565479575|FG003|Overall Study|Withdrawal by Subject|2|||
156653906|NCT00491504|565479572|FG000|Overall Study|Protocol Violation|0|||
156653907|NCT00491504|565479573|FG001|Overall Study|Protocol Violation|0|||
156653908|NCT00491504|565479574|FG002|Overall Study|Protocol Violation|3|||
156653909|NCT00491504|565479575|FG003|Overall Study|Protocol Violation|2|||
156653910|NCT02789111|565479576|FG000|Overall Study|Withdrawal by Subject|1|||
156653911|NCT02789111|565479577|FG001|Overall Study|Withdrawal by Subject|4|||
156653912|NCT03271528|565479579|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
156653913|NCT03271528|565479580|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
156653914|NCT03271528|565479579|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
156653915|NCT03271528|565479580|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
156653916|NCT03271528|565479579|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
156653917|NCT03271528|565479580|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
156653918|NCT03271528|565479579|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
156653919|NCT03271528|565479580|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
156653920|NCT03271528|565479579|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
156653921|NCT03271528|565479580|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
156653922|NCT03271528|565479579|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
156653923|NCT03271528|565479580|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
156653924|NCT03271528|565479579|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
156653925|NCT03271528|565479580|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
156653926|NCT01618305|565479582|FG000|Overall Study|Death|0|||
156653927|NCT01618305|565479583|FG001|Overall Study|Death|1|||
156653928|NCT01618305|565479582|FG000|Overall Study|Lost to Follow-up|11|||
156653929|NCT01618305|565479583|FG001|Overall Study|Lost to Follow-up|7|||
156653930|NCT01618305|565479582|FG000|Overall Study|Protocol Violation|1|||
156653931|NCT01618305|565479583|FG001|Overall Study|Protocol Violation|0|||
156318799|NCT00266877|564266445|FG000|Overall Study|Death|1|||
156318800|NCT00266877|564266446|FG001|Overall Study|Death|1|||
156653932|NCT01618305|565479582|FG000|Overall Study|Withdrawal by Subject|3|||
156653933|NCT01618305|565479583|FG001|Overall Study|Withdrawal by Subject|2|||
156318801|NCT00266877|564266447|FG002|Overall Study|Death|1|||
156318802|NCT00266877|564266445|FG000|Overall Study|Adverse Event|6|||
156318803|NCT00266877|564266446|FG001|Overall Study|Adverse Event|4|||
156318804|NCT00266877|564266447|FG002|Overall Study|Adverse Event|1|||
156318805|NCT00266877|564266445|FG000|Overall Study|Physician Decision|2|||
156318806|NCT00266877|564266446|FG001|Overall Study|Physician Decision|1|||
156318807|NCT00266877|564266447|FG002|Overall Study|Physician Decision|1|||
156318808|NCT00266877|564266445|FG000|Overall Study|Withdrawal by Subject|3|||
156318809|NCT00266877|564266446|FG001|Overall Study|Withdrawal by Subject|1|||
156318810|NCT00266877|564266447|FG002|Overall Study|Withdrawal by Subject|1|||
156318811|NCT00266877|564266445|FG000|Overall Study|Disease Progression|72|||
156318812|NCT00266877|564266446|FG001|Overall Study|Disease Progression|37|||
156318813|NCT00266877|564266447|FG002|Overall Study|Disease Progression|23|||
156318814|NCT00266877|564266445|FG000|Overall Study|Symptomatic Deterioration|6|||
156318815|NCT00266877|564266446|FG001|Overall Study|Symptomatic Deterioration|3|||
156318816|NCT00266877|564266447|FG002|Overall Study|Symptomatic Deterioration|1|||
156318817|NCT00266877|564266445|FG000|Overall Study|Hospitalization|1|||
156318818|NCT00266877|564266446|FG001|Overall Study|Hospitalization|0|||
156318819|NCT00266877|564266447|FG002|Overall Study|Hospitalization|0|||
156318820|NCT00266877|564266445|FG000|Overall Study|Concomitant Radiotherapy|0|||
156318821|NCT00266877|564266446|FG001|Overall Study|Concomitant Radiotherapy|1|||
156653934|NCT01960816|565479584|FG000|Overall Study|Lost to Follow-up|1|||
156653935|NCT01736553|565479605|FG000|Overall Study|Death|12|||
156653936|NCT01736553|565479606|FG001|Overall Study|Death|0|||
156653937|NCT01736553|565479605|FG000|Overall Study|Withdrawal by Subject|5|||
156653938|NCT01736553|565479606|FG001|Overall Study|Withdrawal by Subject|2|||
156653939|NCT01736553|565479605|FG000|Overall Study|Lost to Follow-up|2|||
156653940|NCT01736553|565479606|FG001|Overall Study|Lost to Follow-up|2|||
156653941|NCT01896297|565479607|FG000|Overall Study|Died in post treatment phase|1|||
156653942|NCT00003782|565479608|FG000|Overall Study|No follow up data|30|||
156653943|NCT00003782|565479609|FG001|Overall Study|No follow up data|31|||
156653944|NCT00003782|565479610|FG002|Overall Study|No follow up data|26|||
156653945|NCT05014204|565481568|FG000|Overall Study|Withdrawal by Subject|1|||
156653946|NCT05014204|565481568|FG000|Overall Study|Physician Decision|1|||
156653947|NCT04471935|565481569|FG000|Overall Study|Withdrawal by Subject|1|||
156653948|NCT04471935|565481569|FG000|Overall Study|Deemed ineligible to participate|1|||
156653949|NCT01399736|565481570|FG000|Overall Study|Withdrawal by Subject|4|||
156653950|NCT01399736|565481571|FG001|Overall Study|Withdrawal by Subject|2|||
156653951|NCT01399736|565481570|FG000|Overall Study|Lost to Follow-up|0|||
156653952|NCT01399736|565481571|FG001|Overall Study|Lost to Follow-up|2|||
156653953|NCT03335371|565481572|FG000|Overall Study|Lost to Follow-up|0|||
156653954|NCT03335371|565481573|FG001|Overall Study|Lost to Follow-up|0|||
156653955|NCT03335371|565481574|FG002|Overall Study|Lost to Follow-up|0|||
156653956|NCT03335371|565481575|FG003|Overall Study|Lost to Follow-up|0|||
156653957|NCT03335371|565481576|FG004|Overall Study|Lost to Follow-up|1|||
156653958|NCT03335371|565481572|FG000|Overall Study|Withdrawal by Subject|0|||
156653959|NCT03335371|565481573|FG001|Overall Study|Withdrawal by Subject|0|||
156653960|NCT03335371|565481574|FG002|Overall Study|Withdrawal by Subject|0|||
156653961|NCT03335371|565481575|FG003|Overall Study|Withdrawal by Subject|0|||
156653962|NCT03335371|565481576|FG004|Overall Study|Withdrawal by Subject|1|||
156653963|NCT03335371|565481572|FG000|Overall Study|Randomization Error|0|||
156653964|NCT03335371|565481573|FG001|Overall Study|Randomization Error|0|||
156653965|NCT03335371|565481574|FG002|Overall Study|Randomization Error|1|||
156653966|NCT03335371|565481575|FG003|Overall Study|Randomization Error|0|||
156653967|NCT03335371|565481576|FG004|Overall Study|Randomization Error|0|||
156653968|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
156653969|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
156653970|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653971|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653972|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653973|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
156653974|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
156653975|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653976|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653977|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653978|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653979|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653980|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653981|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
156653982|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653983|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653984|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653985|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653986|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156318822|NCT00266877|564266447|FG002|Overall Study|Concomitant Radiotherapy|0|||
156420016|NCT04955626|564630208|FG027|Blinded Period|Participants entered open label period|0|||
156761208|NCT02157519|565877927|FG000|Overall Study|Lost to Follow-up|1|||
156761209|NCT02157519|565877928|FG001|Overall Study|Lost to Follow-up|0|||
156761210|NCT01656395|565877929|FG000|Overall Study|Adverse Event|1|||
156761211|NCT01656395|565877930|FG001|Overall Study|Adverse Event|14|||
156761212|NCT01656395|565877931|FG002|Overall Study|Adverse Event|5|||
156761213|NCT01656395|565877932|FG003|Overall Study|Adverse Event|4|||
156761214|NCT01656395|565877933|FG004|Overall Study|Adverse Event|5|||
156761215|NCT01656395|565877934|FG005|Overall Study|Adverse Event|7|||
156761216|NCT01656395|565877935|FG006|Overall Study|Adverse Event|0|||
156761217|NCT01656395|565877936|FG007|Overall Study|Adverse Event|0|||
156761218|NCT01656395|565877929|FG000|Overall Study|Lack of Efficacy|1|||
156761219|NCT01656395|565877930|FG001|Overall Study|Lack of Efficacy|8|||
156761220|NCT01656395|565877931|FG002|Overall Study|Lack of Efficacy|6|||
156761221|NCT01656395|565877932|FG003|Overall Study|Lack of Efficacy|1|||
156761222|NCT01656395|565877933|FG004|Overall Study|Lack of Efficacy|1|||
156761223|NCT01656395|565877934|FG005|Overall Study|Lack of Efficacy|6|||
156761224|NCT01656395|565877935|FG006|Overall Study|Lack of Efficacy|0|||
156761225|NCT01656395|565877936|FG007|Overall Study|Lack of Efficacy|0|||
156761226|NCT01656395|565877929|FG000|Overall Study|Lost to Follow-up|1|||
156761227|NCT01656395|565877930|FG001|Overall Study|Lost to Follow-up|0|||
156761228|NCT01656395|565877931|FG002|Overall Study|Lost to Follow-up|0|||
156761229|NCT01656395|565877932|FG003|Overall Study|Lost to Follow-up|0|||
156761230|NCT01656395|565877933|FG004|Overall Study|Lost to Follow-up|0|||
156761231|NCT01656395|565877934|FG005|Overall Study|Lost to Follow-up|0|||
156761232|NCT01656395|565877935|FG006|Overall Study|Lost to Follow-up|0|||
156761233|NCT01656395|565877936|FG007|Overall Study|Lost to Follow-up|0|||
156761234|NCT01656395|565877929|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156761235|NCT01656395|565877930|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156761236|NCT01656395|565877931|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156761237|NCT01656395|565877932|FG003|Overall Study|Non-Compliance with Study Drug|0|||
156761238|NCT01656395|565877933|FG004|Overall Study|Non-Compliance with Study Drug|1|||
156761239|NCT01656395|565877934|FG005|Overall Study|Non-Compliance with Study Drug|1|||
156761240|NCT01656395|565877935|FG006|Overall Study|Non-Compliance with Study Drug|0|||
156761241|NCT01656395|565877936|FG007|Overall Study|Non-Compliance with Study Drug|0|||
156761242|NCT01656395|565877929|FG000|Overall Study|Other|0|||
156761243|NCT01656395|565877930|FG001|Overall Study|Other|0|||
156761244|NCT01656395|565877931|FG002|Overall Study|Other|1|||
156761245|NCT01656395|565877932|FG003|Overall Study|Other|0|||
156761246|NCT01656395|565877933|FG004|Overall Study|Other|0|||
156761247|NCT01656395|565877934|FG005|Overall Study|Other|1|||
156761248|NCT01656395|565877935|FG006|Overall Study|Other|0|||
156761249|NCT01656395|565877936|FG007|Overall Study|Other|0|||
156761250|NCT01656395|565877929|FG000|Overall Study|Physician Decision|2|||
156761251|NCT01656395|565877930|FG001|Overall Study|Physician Decision|3|||
156318823|NCT01150474|564266451|FG000|Overall Study|Withdrawal by Subject|5|||
156318824|NCT01150474|564266452|FG001|Overall Study|Withdrawal by Subject|2|||
156318825|NCT01150474|564266451|FG000|Overall Study|Cancer found|1|||
156318826|NCT01150474|564266452|FG001|Overall Study|Cancer found|0|||
156318827|NCT01150474|564266451|FG000|Overall Study|Multiple Studies|0|||
156318828|NCT01150474|564266452|FG001|Overall Study|Multiple Studies|1|||
156318829|NCT01150474|564266451|FG000|Overall Study|Rectotomy|1|||
156318830|NCT01150474|564266452|FG001|Overall Study|Rectotomy|0|||
156318831|NCT01150474|564266451|FG000|Overall Study|Drug did not arrive in time|1|||
156318832|NCT01150474|564266452|FG001|Overall Study|Drug did not arrive in time|0|||
156318833|NCT01150474|564266451|FG000|Overall Study|Drug not administered|1|||
156318834|NCT01150474|564266452|FG001|Overall Study|Drug not administered|0|||
156318835|NCT01150474|564266451|FG000|Overall Study|Surgery Changed|1|||
156318836|NCT01150474|564266452|FG001|Overall Study|Surgery Changed|0|||
156318837|NCT03021564|564266453|FG000|Overall Study|Death|84|||
156318838|NCT03021564|564266454|FG001|Overall Study|Death|466|||
156318839|NCT03021564|564266453|FG000|Overall Study|Lost to Follow-up|0|||
156318840|NCT03021564|564266454|FG001|Overall Study|Lost to Follow-up|2|||
156318841|NCT00969280|564266455|FG000|Overall Study|Protocol Violation|2|||
156420017|NCT04955626|564630209|FG028|Blinded Period|Participants entered open label period|0|||
156420018|NCT04955626|564630210|FG029|Blinded Period|Participants entered open label period|0|||
156761252|NCT01656395|565877931|FG002|Overall Study|Physician Decision|3|||
156761253|NCT01656395|565877932|FG003|Overall Study|Physician Decision|2|||
156761254|NCT01656395|565877933|FG004|Overall Study|Physician Decision|3|||
156761255|NCT01656395|565877934|FG005|Overall Study|Physician Decision|3|||
156318842|NCT00969280|564266456|FG001|Overall Study|Protocol Violation|1|||
156318843|NCT00969280|564266455|FG000|Overall Study|Withdrawal by Subject|0|||
156420019|NCT04955626|564630211|FG030|Blinded Period|Participants entered open label period|0|||
156761256|NCT01656395|565877935|FG006|Overall Study|Physician Decision|0|||
156761257|NCT01656395|565877936|FG007|Overall Study|Physician Decision|0|||
156761258|NCT01656395|565877929|FG000|Overall Study|Pregnancy|0|||
156761259|NCT01656395|565877930|FG001|Overall Study|Pregnancy|0|||
156761260|NCT01656395|565877931|FG002|Overall Study|Pregnancy|1|||
156761261|NCT01656395|565877932|FG003|Overall Study|Pregnancy|0|||
156761262|NCT01656395|565877933|FG004|Overall Study|Pregnancy|0|||
156761263|NCT01656395|565877934|FG005|Overall Study|Pregnancy|0|||
156761264|NCT01656395|565877935|FG006|Overall Study|Pregnancy|0|||
156761265|NCT01656395|565877936|FG007|Overall Study|Pregnancy|0|||
156761266|NCT01656395|565877929|FG000|Overall Study|Progressive Disease|0|||
156761267|NCT01656395|565877930|FG001|Overall Study|Progressive Disease|0|||
156761268|NCT01656395|565877931|FG002|Overall Study|Progressive Disease|0|||
156761269|NCT01656395|565877932|FG003|Overall Study|Progressive Disease|0|||
156761270|NCT01656395|565877933|FG004|Overall Study|Progressive Disease|0|||
156761271|NCT01656395|565877934|FG005|Overall Study|Progressive Disease|1|||
156761272|NCT01656395|565877935|FG006|Overall Study|Progressive Disease|0|||
156761273|NCT01656395|565877936|FG007|Overall Study|Progressive Disease|0|||
156761274|NCT01656395|565877929|FG000|Overall Study|Protocol Violation|6|||
156761275|NCT01656395|565877930|FG001|Overall Study|Protocol Violation|6|||
156761276|NCT01656395|565877931|FG002|Overall Study|Protocol Violation|9|||
156761277|NCT01656395|565877932|FG003|Overall Study|Protocol Violation|2|||
156761278|NCT01656395|565877933|FG004|Overall Study|Protocol Violation|4|||
156761279|NCT01656395|565877934|FG005|Overall Study|Protocol Violation|10|||
156420020|NCT04955626|564630212|FG031|Blinded Period|Participants entered open label period|0|||
156761280|NCT01656395|565877935|FG006|Overall Study|Protocol Violation|0|||
156761281|NCT01656395|565877936|FG007|Overall Study|Protocol Violation|0|||
156761282|NCT01656395|565877929|FG000|Overall Study|Screen Failure|2|||
156761283|NCT01656395|565877930|FG001|Overall Study|Screen Failure|1|||
156761284|NCT01656395|565877931|FG002|Overall Study|Screen Failure|7|||
156761285|NCT01656395|565877932|FG003|Overall Study|Screen Failure|1|||
156761286|NCT01656395|565877933|FG004|Overall Study|Screen Failure|0|||
156761287|NCT01656395|565877934|FG005|Overall Study|Screen Failure|8|||
156761288|NCT01656395|565877935|FG006|Overall Study|Screen Failure|0|||
156761289|NCT01656395|565877936|FG007|Overall Study|Screen Failure|0|||
156761290|NCT01656395|565877929|FG000|Overall Study|Withdrawal by Subject|3|||
156761291|NCT01656395|565877930|FG001|Overall Study|Withdrawal by Subject|1|||
156761292|NCT01656395|565877931|FG002|Overall Study|Withdrawal by Subject|4|||
156761293|NCT01656395|565877932|FG003|Overall Study|Withdrawal by Subject|2|||
156761294|NCT01656395|565877933|FG004|Overall Study|Withdrawal by Subject|0|||
156761295|NCT01656395|565877934|FG005|Overall Study|Withdrawal by Subject|3|||
156761296|NCT01656395|565877935|FG006|Overall Study|Withdrawal by Subject|0|||
156761297|NCT01656395|565877936|FG007|Overall Study|Withdrawal by Subject|0|||
156761298|NCT00230048|565877940|FG000|Overall Study|Lost to Follow-up|13|||
156761299|NCT00230048|565877941|FG001|Overall Study|Lost to Follow-up|18|||
156761300|NCT00676403|565877942|FG000|Overall Study|Adverse Event|1|||
156761301|NCT00676403|565877943|FG001|Overall Study|Adverse Event|2|||
156761302|NCT00676403|565877944|FG002|Overall Study|Adverse Event|0|||
156761303|NCT00676403|565877945|FG003|Overall Study|Adverse Event|5|||
156761304|NCT00676403|565877946|FG004|Overall Study|Adverse Event|1|||
156761305|NCT00676403|565877947|FG005|Overall Study|Adverse Event|2|||
156761306|NCT00676403|565877942|FG000|Overall Study|Lost to Follow-up|0|||
156761307|NCT00676403|565877943|FG001|Overall Study|Lost to Follow-up|0|||
156761308|NCT00676403|565877944|FG002|Overall Study|Lost to Follow-up|0|||
156761309|NCT00676403|565877945|FG003|Overall Study|Lost to Follow-up|0|||
156761310|NCT00676403|565877946|FG004|Overall Study|Lost to Follow-up|0|||
156761311|NCT00676403|565877947|FG005|Overall Study|Lost to Follow-up|1|||
156761312|NCT00676403|565877942|FG000|Overall Study|Reason Unspecified|1|||
156761313|NCT00676403|565877943|FG001|Overall Study|Reason Unspecified|0|||
156761314|NCT00676403|565877944|FG002|Overall Study|Reason Unspecified|1|||
156761315|NCT00676403|565877945|FG003|Overall Study|Reason Unspecified|0|||
156761316|NCT00676403|565877946|FG004|Overall Study|Reason Unspecified|0|||
156761317|NCT00676403|565877947|FG005|Overall Study|Reason Unspecified|1|||
156761318|NCT00676403|565877942|FG000|Overall Study|Withdrawal by Subject|0|||
156761319|NCT00676403|565877943|FG001|Overall Study|Withdrawal by Subject|0|||
156761320|NCT00676403|565877944|FG002|Overall Study|Withdrawal by Subject|0|||
156420021|NCT04955626|564630213|FG032|Blinded Period|Participants entered open label period|0|||
156420022|NCT04955626|564630214|FG033|Blinded Period|Participants entered open label period|0|||
156420023|NCT04955626|564630215|FG034|Blinded Period|Participants entered open label period|0|||
156420024|NCT04955626|564630216|FG035|Blinded Period|Participants entered open label period|0|||
156420025|NCT04955626|564630181|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
156761321|NCT00676403|565877945|FG003|Overall Study|Withdrawal by Subject|0|||
156761322|NCT00676403|565877946|FG004|Overall Study|Withdrawal by Subject|0|||
156761323|NCT00676403|565877947|FG005|Overall Study|Withdrawal by Subject|1|||
156761324|NCT03225170|565877948|FG000|Overall Study|Lost to Follow-up|4|||
156761325|NCT03225170|565877949|FG001|Overall Study|Lost to Follow-up|4|||
156761326|NCT03225170|565877950|FG002|Overall Study|Lost to Follow-up|0|||
156761327|NCT03225170|565877948|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
156761328|NCT03225170|565877949|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
156761329|NCT03225170|565877950|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
156761330|NCT00971867|565877951|FG000|Overall Study|Adverse Event|4|||
156420026|NCT04955626|564630182|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
156761331|NCT00971867|565877951|FG000|Overall Study|Participant Withdrew Consent|1|||
156761332|NCT00971867|565877951|FG000|Overall Study|Disease Progression|6|||
156761333|NCT00673257|565877955|FG000|Overall Study|Withdrawal by Subject|4|||
156761334|NCT00673257|565877955|FG000|Overall Study|Unable to obtain specimen|1|||
156761335|NCT01585246|565877962|FG000|Overall Study|Lost to Follow-up|0|||
156761336|NCT01585246|565877963|FG001|Overall Study|Lost to Follow-up|0|||
156761337|NCT01585246|565877964|FG002|Overall Study|Lost to Follow-up|2|||
156761338|NCT01585246|565877965|FG003|Overall Study|Lost to Follow-up|1|||
156761339|NCT01585246|565877966|FG004|Overall Study|Lost to Follow-up|0|||
156761340|NCT01585246|565877962|FG000|Overall Study|Protocol Violation|0|||
156761341|NCT01585246|565877963|FG001|Overall Study|Protocol Violation|0|||
156761342|NCT01585246|565877964|FG002|Overall Study|Protocol Violation|0|||
156761343|NCT01585246|565877965|FG003|Overall Study|Protocol Violation|0|||
156761344|NCT01585246|565877966|FG004|Overall Study|Protocol Violation|1|||
156761345|NCT01585246|565877962|FG000|Overall Study|Withdrawal by Subject|0|||
156761346|NCT01585246|565877963|FG001|Overall Study|Withdrawal by Subject|0|||
156761347|NCT01585246|565877964|FG002|Overall Study|Withdrawal by Subject|1|||
156761348|NCT01585246|565877965|FG003|Overall Study|Withdrawal by Subject|2|||
156761349|NCT01585246|565877966|FG004|Overall Study|Withdrawal by Subject|1|||
156761350|NCT01585246|565877962|FG000|Overall Study|Other|0|||
156761351|NCT01585246|565877963|FG001|Overall Study|Other|1|||
156761352|NCT01585246|565877964|FG002|Overall Study|Other|1|||
156761353|NCT01585246|565877965|FG003|Overall Study|Other|1|||
156761354|NCT01585246|565877966|FG004|Overall Study|Other|0|||
156761355|NCT04396626|565877967|FG000|Overall Study|Premature termination of study|975|||
156761356|NCT02111174|565877970|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
156761357|NCT02111174|565877971|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
156761358|NCT02111174|565877970|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
156761359|NCT02111174|565877971|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
156761360|NCT02111174|565877970|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
156761361|NCT02111174|565877971|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
156761362|NCT02111174|565877970|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
156761363|NCT02111174|565877971|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
156761364|NCT04552132|565877972|FG000|Overall Study|Lost to Follow-up|4|||
156761365|NCT04552132|565877973|FG001|Overall Study|Lost to Follow-up|3|||
156761366|NCT04552132|565877972|FG000|Overall Study|Protocol Violation|1|||
156761367|NCT04552132|565877973|FG001|Overall Study|Protocol Violation|0|||
156761368|NCT01657162|565877974|FG000|Overall Study|Adverse Event|26|||
156761369|NCT01657162|565877975|FG001|Overall Study|Adverse Event|36|||
156761370|NCT01657162|565877974|FG000|Overall Study|Withdrawal by Subject|13|||
156761371|NCT01657162|565877975|FG001|Overall Study|Withdrawal by Subject|13|||
156761372|NCT01657162|565877974|FG000|Overall Study|Continuing Significant Deterioration|9|||
156761373|NCT01657162|565877975|FG001|Overall Study|Continuing Significant Deterioration|3|||
156761374|NCT01657162|565877974|FG000|Overall Study|Refusal of Treatment|4|||
156761375|NCT01657162|565877975|FG001|Overall Study|Refusal of Treatment|6|||
156761376|NCT01657162|565877974|FG000|Overall Study|Lost to Follow-up|3|||
156761377|NCT01657162|565877975|FG001|Overall Study|Lost to Follow-up|4|||
156761378|NCT01657162|565877974|FG000|Overall Study|Death|2|||
156761379|NCT01657162|565877975|FG001|Overall Study|Death|3|||
156761380|NCT01657162|565877974|FG000|Overall Study|Inability to Complete Study Procedures|1|||
156761381|NCT01657162|565877975|FG001|Overall Study|Inability to Complete Study Procedures|7|||
156761382|NCT01657162|565877974|FG000|Overall Study|Protocol Violation|1|||
156761383|NCT01657162|565877975|FG001|Overall Study|Protocol Violation|0|||
156761384|NCT01657162|565877974|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
156761385|NCT01657162|565877975|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
156318844|NCT00969280|564266456|FG001|Overall Study|Withdrawal by Subject|1|||
156318845|NCT00969280|564266455|FG000|Overall Study|infection of influenza A(H1N1)|0|||
156318846|NCT00969280|564266456|FG001|Overall Study|infection of influenza A(H1N1)|1|||
156318847|NCT00459979|564266457|FG000|Overall Study|Withdrawal by Subject|1|||
156318848|NCT00459979|564266457|FG000|Overall Study|Protocol Violation|1|||
156318849|NCT00814801|564266458|FG000|Overall Study|Adverse Event|15|||
156318850|NCT00814801|564266459|FG001|Overall Study|Adverse Event|16|||
156318851|NCT00814801|564266460|FG002|Overall Study|Adverse Event|19|||
156318852|NCT00814801|564266458|FG000|Overall Study|Withdrawal by Subject|9|||
156318853|NCT00814801|564266459|FG001|Overall Study|Withdrawal by Subject|11|||
156318854|NCT00814801|564266460|FG002|Overall Study|Withdrawal by Subject|14|||
156318855|NCT00814801|564266458|FG000|Overall Study|Inappropriate as a subject|1|||
156318856|NCT00814801|564266459|FG001|Overall Study|Inappropriate as a subject|1|||
156318857|NCT00814801|564266460|FG002|Overall Study|Inappropriate as a subject|1|||
156318858|NCT00814801|564266458|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
156318859|NCT00814801|564266459|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
156761386|NCT01657162|565877974|FG000|Overall Study|Other than Specified|0|||
156761387|NCT01657162|565877975|FG001|Overall Study|Other than Specified|2|||
156761388|NCT02600923|565877978|FG000|Overall Study|Death|10|||
156761389|NCT02600923|565877978|FG000|Overall Study|Adverse Event|3|||
156761390|NCT02600923|565877978|FG000|Overall Study|Global deterioration of health status|2|||
156761391|NCT02600923|565877978|FG000|Overall Study|Insufficient clinical response|6|||
156761392|NCT02600923|565877978|FG000|Overall Study|Lost to Follow-up|1|||
156653987|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
156653988|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
156653989|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653990|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653991|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653992|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653993|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653994|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653995|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
156653996|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
156653997|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156653998|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156653999|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654000|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654001|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654002|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
156654003|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654004|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654005|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654006|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654007|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654008|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654009|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
156654010|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654011|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654012|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654013|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654014|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654015|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
156654016|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
156654017|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654018|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654019|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654020|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654021|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654022|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654023|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
156654024|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654025|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654026|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654027|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654028|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654029|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654030|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
156654031|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654032|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654033|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654034|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654035|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654036|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654037|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
156654038|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
156654039|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
156654040|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
156654041|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654042|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654043|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
156654044|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
156654045|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654046|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654047|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654048|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654049|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654050|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654051|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
156654052|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156420027|NCT04955626|564630183|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
156420028|NCT04955626|564630184|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
156420029|NCT04955626|564630185|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
156420030|NCT04955626|564630186|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
156420031|NCT04955626|564630187|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
156420032|NCT04955626|564630188|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
156420033|NCT04955626|564630189|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
156420034|NCT04955626|564630190|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
156420035|NCT04955626|564630191|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
156420036|NCT04955626|564630192|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
156420037|NCT04955626|564630193|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
156654053|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
156654054|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654055|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654056|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654057|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
156654058|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654059|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654060|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654061|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654062|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654063|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654064|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654065|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
156654066|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
156654067|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654068|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654069|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654070|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654071|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
156654072|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654073|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654074|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654075|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654076|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654077|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654078|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654079|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
156654080|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654081|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654082|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654083|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
156654084|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
156654085|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654086|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654087|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
156654088|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
156654089|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654090|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654091|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654092|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654093|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
156654094|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654095|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654096|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654097|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654098|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654099|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654100|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654101|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
156654102|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
156654103|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654104|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654105|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156761393|NCT02600923|565877978|FG000|Overall Study|Withdrawal by Subject|5|||
156420038|NCT04955626|564630194|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
156654106|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654107|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
156654108|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654109|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654110|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654111|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654112|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654113|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654114|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654115|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654116|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
156654117|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654118|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654119|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654120|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654121|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
156654122|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654123|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654124|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654125|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
156654126|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654127|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654128|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654129|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654130|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654131|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654132|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654133|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654134|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654135|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
156654136|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654137|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654138|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654139|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654140|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654141|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654142|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654143|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
156654144|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
156654145|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654146|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654147|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654148|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654149|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
156654150|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654151|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654152|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654153|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654154|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654155|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654156|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654157|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
156654158|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654159|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654160|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654161|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654162|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654163|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156654164|NCT04033445|565481577|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654165|NCT04033445|565481578|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654166|NCT04033445|565481579|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654167|NCT04033445|565481580|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654168|NCT04033445|565481581|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654169|NCT04033445|565481582|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156761394|NCT02600923|565877978|FG000|Overall Study|Objective progression or relapse|50|||
156318860|NCT00814801|564266460|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
156318861|NCT00814801|564266458|FG000|Overall Study|Missing or change of caregiver|6|||
156318862|NCT00814801|564266459|FG001|Overall Study|Missing or change of caregiver|2|||
156318863|NCT00814801|564266460|FG002|Overall Study|Missing or change of caregiver|4|||
156318864|NCT00814801|564266458|FG000|Overall Study|Non-compliance|0|||
156318865|NCT00814801|564266459|FG001|Overall Study|Non-compliance|1|||
156318866|NCT00814801|564266460|FG002|Overall Study|Non-compliance|1|||
156318867|NCT00814801|564266458|FG000|Overall Study|Other|2|||
156420039|NCT04955626|564630195|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
156420040|NCT04955626|564630196|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
156420041|NCT04955626|564630197|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
156420042|NCT04955626|564630198|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
156420043|NCT04955626|564630199|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
156420044|NCT04955626|564630200|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
156420045|NCT04955626|564630201|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
156420046|NCT04955626|564630202|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
156420047|NCT04955626|564630203|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
156420048|NCT04955626|564630204|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
156420049|NCT04955626|564630205|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
156420050|NCT04955626|564630206|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
156654170|NCT04033445|565481583|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654171|NCT04033445|565481584|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
156654172|NCT04033445|565481585|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654173|NCT04033445|565481586|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654174|NCT04033445|565481587|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654175|NCT04033445|565481588|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654176|NCT04033445|565481589|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654177|NCT04033445|565481590|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
156654178|NCT04033445|565481577|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654179|NCT04033445|565481578|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654180|NCT04033445|565481579|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654181|NCT04033445|565481580|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654182|NCT04033445|565481581|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654183|NCT04033445|565481582|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654184|NCT04033445|565481583|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654185|NCT04033445|565481584|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654186|NCT04033445|565481585|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
156654187|NCT04033445|565481586|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
156654188|NCT04033445|565481587|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
156654189|NCT04033445|565481588|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
156654190|NCT04033445|565481589|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
156654191|NCT04033445|565481590|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
156654192|NCT04033445|565481577|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654193|NCT04033445|565481578|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654194|NCT04033445|565481579|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654195|NCT04033445|565481580|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654196|NCT04033445|565481581|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654197|NCT04033445|565481582|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654198|NCT04033445|565481583|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654199|NCT04033445|565481584|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654200|NCT04033445|565481585|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
156654201|NCT04033445|565481586|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
156654202|NCT04033445|565481587|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
156654203|NCT04033445|565481588|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
156654204|NCT04033445|565481589|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
156654205|NCT04033445|565481590|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
156654206|NCT04033445|565481577|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654207|NCT04033445|565481578|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654208|NCT04033445|565481579|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654209|NCT04033445|565481580|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654210|NCT04033445|565481581|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654211|NCT04033445|565481582|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654212|NCT04033445|565481583|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654213|NCT04033445|565481584|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654214|NCT04033445|565481585|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156420051|NCT04955626|564630207|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
156761395|NCT02600923|565877978|FG000|Overall Study|Study terminated by Sponsor|53|||
156761396|NCT02600923|565877978|FG000|Overall Study|Not treated|1|||
156761397|NCT00792909|565877979|FG000|Overall Study|Withdrawal by Subject|0|||
156761398|NCT00792909|565877980|FG001|Overall Study|Withdrawal by Subject|1|||
156761399|NCT00792909|565877981|FG002|Overall Study|Withdrawal by Subject|0|||
156761400|NCT01261390|565877985|FG000|Overall Study|Significant Concurrent Illness|1|||
156761401|NCT01261390|565877986|FG001|Overall Study|Significant Concurrent Illness|0|||
156761402|NCT01261390|565877987|FG002|Overall Study|Significant Concurrent Illness|1|||
156761403|NCT01261390|565877988|FG003|Overall Study|Significant Concurrent Illness|0|||
156761404|NCT01261390|565877985|FG000|Overall Study|Dissatisfaction with Treatment|2|||
156761405|NCT01261390|565877986|FG001|Overall Study|Dissatisfaction with Treatment|1|||
156761406|NCT01261390|565877987|FG002|Overall Study|Dissatisfaction with Treatment|1|||
156761407|NCT01261390|565877988|FG003|Overall Study|Dissatisfaction with Treatment|2|||
156761408|NCT01261390|565877985|FG000|Overall Study|Relocation|0|||
156761409|NCT01261390|565877986|FG001|Overall Study|Relocation|1|||
156761410|NCT01261390|565877987|FG002|Overall Study|Relocation|0|||
156761411|NCT01261390|565877988|FG003|Overall Study|Relocation|0|||
156761412|NCT01261390|565877985|FG000|Overall Study|Loss of Interest in the Study|3|||
156761413|NCT01261390|565877986|FG001|Overall Study|Loss of Interest in the Study|1|||
156761414|NCT01261390|565877987|FG002|Overall Study|Loss of Interest in the Study|0|||
156761415|NCT01261390|565877988|FG003|Overall Study|Loss of Interest in the Study|0|||
156761416|NCT01261390|565877985|FG000|Overall Study|Lost to Follow-up|1|||
156761417|NCT01261390|565877986|FG001|Overall Study|Lost to Follow-up|6|||
156761418|NCT01261390|565877987|FG002|Overall Study|Lost to Follow-up|5|||
156761419|NCT01261390|565877988|FG003|Overall Study|Lost to Follow-up|6|||
156761420|NCT02421419|565877989|FG000|Overall Study|Physician Decision|0|||
156761421|NCT02421419|565877990|FG001|Overall Study|Physician Decision|0|||
156318868|NCT00814801|564266459|FG001|Overall Study|Other|6|||
156318869|NCT00814801|564266460|FG002|Overall Study|Other|4|||
156318870|NCT02486718|564266463|FG000|Enrollment Phase|Death|19|||
156318871|NCT02486718|564266464|FG001|Enrollment Phase|Death|0|||
156318872|NCT02486718|564266465|FG002|Enrollment Phase|Death|0|||
156318873|NCT02486718|564266463|FG000|Enrollment Phase|Symptomatic deterioration|1|||
156318874|NCT02486718|564266464|FG001|Enrollment Phase|Symptomatic deterioration|0|||
156318875|NCT02486718|564266465|FG002|Enrollment Phase|Symptomatic deterioration|0|||
156318876|NCT02486718|564266463|FG000|Enrollment Phase|Withdrawal by Subject|86|||
156318877|NCT02486718|564266464|FG001|Enrollment Phase|Withdrawal by Subject|0|||
156318878|NCT02486718|564266465|FG002|Enrollment Phase|Withdrawal by Subject|0|||
156318879|NCT02486718|564266463|FG000|Enrollment Phase|Protocol Violation|18|||
156318880|NCT02486718|564266464|FG001|Enrollment Phase|Protocol Violation|0|||
156318881|NCT02486718|564266465|FG002|Enrollment Phase|Protocol Violation|0|||
156318882|NCT02486718|564266463|FG000|Enrollment Phase|Physician Decision|18|||
156318883|NCT02486718|564266464|FG001|Enrollment Phase|Physician Decision|0|||
156318884|NCT02486718|564266465|FG002|Enrollment Phase|Physician Decision|0|||
156318885|NCT02486718|564266463|FG000|Enrollment Phase|Reason not provided|41|||
156318886|NCT02486718|564266464|FG001|Enrollment Phase|Reason not provided|0|||
156318887|NCT02486718|564266465|FG002|Enrollment Phase|Reason not provided|0|||
156318888|NCT02486718|564266463|FG000|Enrollment Phase|Disease relapse|54|||
156318889|NCT02486718|564266464|FG001|Enrollment Phase|Disease relapse|0|||
156318890|NCT02486718|564266465|FG002|Enrollment Phase|Disease relapse|0|||
156318891|NCT02486718|564266463|FG000|Enrollment Phase|Lost to Follow-up|4|||
156318892|NCT02486718|564266464|FG001|Enrollment Phase|Lost to Follow-up|0|||
156318893|NCT02486718|564266465|FG002|Enrollment Phase|Lost to Follow-up|0|||
156318894|NCT02486718|564266463|FG000|Enrollment Phase|Adverse Event|34|||
156318895|NCT02486718|564266464|FG001|Enrollment Phase|Adverse Event|0|||
156318896|NCT02486718|564266465|FG002|Enrollment Phase|Adverse Event|0|||
156318897|NCT02486718|564266463|FG000|Randomized Phase|Withdrawal by Subject|0|||
156318898|NCT02486718|564266464|FG001|Randomized Phase|Withdrawal by Subject|44|||
156318899|NCT02486718|564266465|FG002|Randomized Phase|Withdrawal by Subject|47|||
156318900|NCT02486718|564266463|FG000|Randomized Phase|Protocol Violation|0|||
156318901|NCT02486718|564266464|FG001|Randomized Phase|Protocol Violation|2|||
156420052|NCT04955626|564630208|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
156420053|NCT04955626|564630209|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
156761422|NCT02421419|565877991|FG002|Overall Study|Physician Decision|1|||
156761423|NCT04058028|565877993|FG000|Overall Study|Withdrawal of Consent from Study|12|||
156318902|NCT02486718|564266465|FG002|Randomized Phase|Protocol Violation|0|||
156318903|NCT02486718|564266463|FG000|Randomized Phase|Physician Decision|0|||
156761424|NCT04058028|565877994|FG001|Overall Study|Withdrawal of Consent from Study|8|||
156761425|NCT04058028|565877995|FG002|Overall Study|Withdrawal of Consent from Study|6|||
156761426|NCT04058028|565877996|FG003|Overall Study|Withdrawal of Consent from Study|7|||
156761427|NCT04058028|565877993|FG000|Overall Study|Decision by Sponsor|13|||
156761428|NCT04058028|565877994|FG001|Overall Study|Decision by Sponsor|4|||
156761429|NCT04058028|565877995|FG002|Overall Study|Decision by Sponsor|1|||
156318904|NCT02486718|564266464|FG001|Randomized Phase|Physician Decision|0|||
156318905|NCT02486718|564266465|FG002|Randomized Phase|Physician Decision|3|||
156318906|NCT02486718|564266463|FG000|Randomized Phase|Lost to Follow-up|0|||
156761430|NCT04058028|565877996|FG003|Overall Study|Decision by Sponsor|35|||
156761431|NCT04058028|565877993|FG000|Overall Study|Lost to Follow-up|1|||
156761432|NCT04058028|565877994|FG001|Overall Study|Lost to Follow-up|1|||
156761433|NCT04058028|565877995|FG002|Overall Study|Lost to Follow-up|1|||
156761434|NCT04058028|565877996|FG003|Overall Study|Lost to Follow-up|0|||
156761435|NCT04058028|565877993|FG000|Overall Study|Death|0|||
156761436|NCT04058028|565877994|FG001|Overall Study|Death|1|||
156761437|NCT04058028|565877995|FG002|Overall Study|Death|0|||
156761438|NCT04058028|565877996|FG003|Overall Study|Death|0|||
156761439|NCT02227784|565877997|FG000|Double-Blind Phase|Adverse Event|3|||
156761440|NCT02227784|565877998|FG001|Double-Blind Phase|Adverse Event|2|||
156761441|NCT02227784|565877999|FG002|Double-Blind Phase|Adverse Event|1|||
156761442|NCT02227784|565878000|FG003|Double-Blind Phase|Adverse Event|3|||
156761443|NCT02227784|565878001|FG004|Double-Blind Phase|Adverse Event|0|||
156761444|NCT02227784|565877997|FG000|Double-Blind Phase|Physician Decision|1|||
156761445|NCT02227784|565877998|FG001|Double-Blind Phase|Physician Decision|0|||
156761446|NCT02227784|565877999|FG002|Double-Blind Phase|Physician Decision|0|||
156761447|NCT02227784|565878000|FG003|Double-Blind Phase|Physician Decision|1|||
156761448|NCT02227784|565878001|FG004|Double-Blind Phase|Physician Decision|0|||
156761449|NCT02227784|565877997|FG000|Double-Blind Phase|Protocol Violation|0|||
156761450|NCT02227784|565877998|FG001|Double-Blind Phase|Protocol Violation|0|||
156761451|NCT02227784|565877999|FG002|Double-Blind Phase|Protocol Violation|1|||
156761452|NCT02227784|565878000|FG003|Double-Blind Phase|Protocol Violation|1|||
156761453|NCT02227784|565878001|FG004|Double-Blind Phase|Protocol Violation|0|||
156761454|NCT02227784|565877997|FG000|Double-Blind Phase|Sponsor Decision|34|||
156761455|NCT02227784|565877998|FG001|Double-Blind Phase|Sponsor Decision|15|||
156761456|NCT02227784|565877999|FG002|Double-Blind Phase|Sponsor Decision|14|||
156761457|NCT02227784|565878000|FG003|Double-Blind Phase|Sponsor Decision|32|||
156761458|NCT02227784|565878001|FG004|Double-Blind Phase|Sponsor Decision|0|||
156761459|NCT02227784|565877997|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
156761460|NCT02227784|565877998|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
156761461|NCT02227784|565877999|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
156761462|NCT02227784|565878000|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
156761463|NCT02227784|565878001|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156761464|NCT02227784|565877997|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
156761465|NCT02227784|565877998|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
156318907|NCT02486718|564266464|FG001|Randomized Phase|Lost to Follow-up|5|||
156318908|NCT02486718|564266465|FG002|Randomized Phase|Lost to Follow-up|11|||
156318909|NCT02486718|564266463|FG000|Randomized Phase|Disease Relapse|0|||
156318910|NCT02486718|564266464|FG001|Randomized Phase|Disease Relapse|1|||
156318911|NCT02486718|564266465|FG002|Randomized Phase|Disease Relapse|0|||
156318912|NCT02486718|564266463|FG000|Randomized Phase|Death|0|||
156318913|NCT02486718|564266464|FG001|Randomized Phase|Death|154|||
156318914|NCT02486718|564266465|FG002|Randomized Phase|Death|155|||
156318915|NCT02486718|564266463|FG000|Randomized Phase|Ongoing|0|||
156318916|NCT02486718|564266464|FG001|Randomized Phase|Ongoing|301|||
156318917|NCT02486718|564266465|FG002|Randomized Phase|Ongoing|282|||
156318918|NCT01037088|564266468|FG000|Overall Study|Withdrawal by Subject|3|||
156318919|NCT02545543|564266469|FG000|Overall Study|Lost to Follow-up|67|||
156318920|NCT02545543|564266470|FG001|Overall Study|Lost to Follow-up|25|||
156318921|NCT02545543|564266469|FG000|Overall Study|Physician Decision|3|||
156318922|NCT02545543|564266470|FG001|Overall Study|Physician Decision|0|||
156318923|NCT02545543|564266469|FG000|Overall Study|Withdrawal by Subject|9|||
156318924|NCT02545543|564266470|FG001|Overall Study|Withdrawal by Subject|8|||
156318925|NCT02545543|564266469|FG000|Overall Study|Noncomplaince|1|||
156318926|NCT02545543|564266470|FG001|Overall Study|Noncomplaince|0|||
156318927|NCT02545543|564266469|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
156318928|NCT02545543|564266470|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
156318929|NCT00811642|564266471|FG000|Overall Study|Adverse Event|3|||
156318930|NCT00811642|564266471|FG000|Overall Study|Protocol Violation|1|||
156318931|NCT00811642|564266471|FG000|Overall Study|Death|2|||
156318932|NCT00811642|564266471|FG000|Overall Study|Withdrawal by Subject|7|||
156318933|NCT00811642|564266471|FG000|Overall Study|Cumulative use of antifungal agent|2|||
156318934|NCT04268823|564266478|FG000|Overall Study|Adverse Event|1|||
156318935|NCT04268823|564266479|FG001|Overall Study|Adverse Event|0|||
156318936|NCT04268823|564266478|FG000|Overall Study|Participant Decision|1|||
156318937|NCT04268823|564266479|FG001|Overall Study|Participant Decision|0|||
156318938|NCT00371761|564267747|FG000|Overall Study|Adverse Event|1|||
156318939|NCT00371761|564267748|FG001|Overall Study|Adverse Event|1|||
156318940|NCT00371761|564267747|FG000|Overall Study|Withdrawal by Subject|1|||
156318941|NCT00371761|564267748|FG001|Overall Study|Withdrawal by Subject|3|||
156318942|NCT00371761|564267747|FG000|Overall Study|Investigator Judgment|2|||
156761466|NCT02227784|565877999|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
156318943|NCT00371761|564267748|FG001|Overall Study|Investigator Judgment|3|||
156761467|NCT02227784|565878000|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
156761468|NCT02227784|565878001|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
156318944|NCT00371761|564267747|FG000|Overall Study|Study termination|4|||
156761469|NCT02227784|565877997|FG000|Open-Label Extension Phase (OLE)|Death|0|||
156761470|NCT02227784|565877998|FG001|Open-Label Extension Phase (OLE)|Death|0|||
156761471|NCT02227784|565877999|FG002|Open-Label Extension Phase (OLE)|Death|0|||
156761472|NCT02227784|565878000|FG003|Open-Label Extension Phase (OLE)|Death|0|||
156761473|NCT02227784|565878001|FG004|Open-Label Extension Phase (OLE)|Death|1|||
156761474|NCT02227784|565877997|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156761475|NCT02227784|565877998|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156761476|NCT02227784|565877999|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156761477|NCT02227784|565878000|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156761478|NCT02227784|565878001|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
156761479|NCT02227784|565877997|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
156761480|NCT02227784|565877998|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
156761481|NCT02227784|565877999|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
156761482|NCT02227784|565878000|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
156761483|NCT02227784|565878001|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
156761484|NCT00102596|565878002|FG000|Part A|Screen failures|6|||
156761485|NCT00102596|565878003|FG001|Part A|Screen failures|0|||
156761486|NCT00102596|565878002|FG000|Part A|Adverse Event|1|||
156761487|NCT00102596|565878003|FG001|Part A|Adverse Event|0|||
156761488|NCT00248651|565878006|FG000|Overall Study|Withdrawal by Subject|28|||
156761489|NCT00248651|565878007|FG001|Overall Study|Withdrawal by Subject|40|||
156761490|NCT00248651|565878008|FG002|Overall Study|Withdrawal by Subject|32|||
156761491|NCT01275144|565878009|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
156761492|NCT01275144|565878010|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
156761493|NCT00828113|565878011|FG000|Overall Study|Withdrawal by Subject|27|||
156761494|NCT00828113|565878012|FG001|Overall Study|Withdrawal by Subject|26|||
156761495|NCT00828113|565878011|FG000|Overall Study|Lost to Follow-up|3|||
156761496|NCT00828113|565878012|FG001|Overall Study|Lost to Follow-up|5|||
156761497|NCT01365130|565878013|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
156761498|NCT05607576|565878014|FG000|Overall Study|immediate sensor error|2|||
156761499|NCT05607576|565878014|FG000|Overall Study|Physician Decision|2|||
156761500|NCT05116202|565878015|FG000|Overall Study|Study Terminated by Sponsor|21|||
156761501|NCT05116202|565878016|FG001|Overall Study|Study Terminated by Sponsor|38|||
156761502|NCT05116202|565878017|FG002|Overall Study|Study Terminated by Sponsor|17|||
156761503|NCT05116202|565878018|FG003|Overall Study|Study Terminated by Sponsor|18|||
156761504|NCT05116202|565878019|FG004|Overall Study|Study Terminated by Sponsor|0|||
156761505|NCT05116202|565878015|FG000|Overall Study|Withdrawal by Subject|0|||
156761506|NCT05116202|565878016|FG001|Overall Study|Withdrawal by Subject|1|||
156761507|NCT05116202|565878017|FG002|Overall Study|Withdrawal by Subject|1|||
156761508|NCT05116202|565878018|FG003|Overall Study|Withdrawal by Subject|1|||
156761509|NCT05116202|565878019|FG004|Overall Study|Withdrawal by Subject|1|||
156761510|NCT05116202|565878015|FG000|Overall Study|Lost to Follow-up|0|||
156761511|NCT05116202|565878016|FG001|Overall Study|Lost to Follow-up|0|||
156761512|NCT05116202|565878017|FG002|Overall Study|Lost to Follow-up|0|||
156761513|NCT05116202|565878018|FG003|Overall Study|Lost to Follow-up|0|||
156761514|NCT05116202|565878019|FG004|Overall Study|Lost to Follow-up|2|||
156761515|NCT05116202|565878015|FG000|Overall Study|Death|1|||
156761516|NCT05116202|565878016|FG001|Overall Study|Death|1|||
156761517|NCT05116202|565878017|FG002|Overall Study|Death|2|||
156761518|NCT05116202|565878018|FG003|Overall Study|Death|1|||
156761519|NCT05116202|565878019|FG004|Overall Study|Death|5|||
156761520|NCT05067972|565878020|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
156761521|NCT05067972|565878021|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
156761522|NCT05067972|565878022|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
156761523|NCT05067972|565878023|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
156761524|NCT05067972|565878024|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
156761525|NCT05067972|565878025|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
156761526|NCT05067972|565878026|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
156761527|NCT05067972|565878020|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
156761528|NCT05067972|565878021|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
156761529|NCT05067972|565878022|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
156761530|NCT05067972|565878023|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
156761531|NCT05067972|565878024|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
156761532|NCT05067972|565878025|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
156761533|NCT05067972|565878026|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
156761534|NCT05067972|565878020|FG000|Part 1: Treatment|Progressive Disease|3|||
156761535|NCT05067972|565878021|FG001|Part 1: Treatment|Progressive Disease|3|||
156761536|NCT05067972|565878022|FG002|Part 1: Treatment|Progressive Disease|4|||
156761537|NCT05067972|565878023|FG003|Part 1: Treatment|Progressive Disease|2|||
156761538|NCT05067972|565878024|FG004|Part 1: Treatment|Progressive Disease|3|||
156761539|NCT05067972|565878025|FG005|Part 1: Treatment|Progressive Disease|0|||
156318945|NCT00371761|564267748|FG001|Overall Study|Study termination|3|||
156318946|NCT04972630|564267751|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
156318947|NCT04972630|564267752|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
156761540|NCT05067972|565878026|FG006|Part 1: Treatment|Progressive Disease|2|||
156318948|NCT04972630|564267753|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
156318949|NCT05171816|564267756|FG000|Overall Study|Death|18|||
156318950|NCT05171816|564267757|FG001|Overall Study|Death|16|||
156318951|NCT02937571|564267758|FG000|Overall Study|Adverse Event|0|||
156654215|NCT04033445|565481586|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654216|NCT04033445|565481587|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
156654217|NCT04033445|565481588|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
156654218|NCT04033445|565481589|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
156654219|NCT04033445|565481590|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
156654220|NCT04033445|565481577|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654221|NCT04033445|565481578|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654222|NCT04033445|565481579|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654223|NCT04033445|565481580|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654224|NCT04033445|565481581|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654225|NCT04033445|565481582|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654226|NCT04033445|565481583|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654227|NCT04033445|565481584|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654228|NCT04033445|565481585|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654229|NCT04033445|565481586|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
156654230|NCT04033445|565481587|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
156654231|NCT04033445|565481588|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
156654232|NCT04033445|565481589|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
156654233|NCT04033445|565481590|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
156654234|NCT04033445|565481577|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654235|NCT04033445|565481578|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654236|NCT04033445|565481579|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654237|NCT04033445|565481580|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654238|NCT04033445|565481581|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654239|NCT04033445|565481582|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654240|NCT04033445|565481583|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654241|NCT04033445|565481584|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654242|NCT04033445|565481585|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
156654243|NCT04033445|565481586|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
156654244|NCT04033445|565481587|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
156654245|NCT04033445|565481588|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
156654246|NCT04033445|565481589|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
156654247|NCT04033445|565481590|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
156654248|NCT04033445|565481577|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654249|NCT04033445|565481578|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654250|NCT04033445|565481579|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654251|NCT04033445|565481580|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654252|NCT04033445|565481581|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654253|NCT04033445|565481582|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654254|NCT04033445|565481583|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654255|NCT04033445|565481584|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654256|NCT04033445|565481585|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654257|NCT04033445|565481586|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654258|NCT04033445|565481587|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654259|NCT04033445|565481588|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654260|NCT04033445|565481589|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
156654261|NCT04033445|565481590|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
156654262|NCT04033445|565481577|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654263|NCT04033445|565481578|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654264|NCT04033445|565481579|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654265|NCT04033445|565481580|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654266|NCT04033445|565481581|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654267|NCT04033445|565481582|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654268|NCT04033445|565481583|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654269|NCT04033445|565481584|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654270|NCT04033445|565481585|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
156654271|NCT04033445|565481586|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
156654272|NCT04033445|565481587|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
156761541|NCT05067972|565878020|FG000|Part 1: Treatment|Physician Decision|0|||
156318952|NCT02937571|564267759|FG001|Overall Study|Adverse Event|0|||
156761542|NCT05067972|565878021|FG001|Part 1: Treatment|Physician Decision|0|||
156761543|NCT05067972|565878022|FG002|Part 1: Treatment|Physician Decision|0|||
156761544|NCT05067972|565878023|FG003|Part 1: Treatment|Physician Decision|1|||
156761545|NCT05067972|565878024|FG004|Part 1: Treatment|Physician Decision|0|||
156761546|NCT05067972|565878025|FG005|Part 1: Treatment|Physician Decision|0|||
156761547|NCT05067972|565878026|FG006|Part 1: Treatment|Physician Decision|0|||
156761548|NCT05067972|565878020|FG000|Part 1: Treatment|Death|0|||
156761549|NCT05067972|565878021|FG001|Part 1: Treatment|Death|0|||
156761550|NCT05067972|565878022|FG002|Part 1: Treatment|Death|0|||
156761551|NCT05067972|565878023|FG003|Part 1: Treatment|Death|2|||
156761552|NCT05067972|565878024|FG004|Part 1: Treatment|Death|0|||
156761553|NCT05067972|565878025|FG005|Part 1: Treatment|Death|0|||
156761554|NCT05067972|565878026|FG006|Part 1: Treatment|Death|0|||
156761555|NCT05067972|565878020|FG000|Part 1: Treatment|Adverse Event|0|||
156761556|NCT05067972|565878021|FG001|Part 1: Treatment|Adverse Event|0|||
156761557|NCT05067972|565878022|FG002|Part 1: Treatment|Adverse Event|0|||
156761558|NCT05067972|565878023|FG003|Part 1: Treatment|Adverse Event|0|||
156761559|NCT05067972|565878024|FG004|Part 1: Treatment|Adverse Event|0|||
156761560|NCT05067972|565878025|FG005|Part 1: Treatment|Adverse Event|2|||
156761561|NCT05067972|565878026|FG006|Part 1: Treatment|Adverse Event|1|||
156761562|NCT05067972|565878020|FG000|Part 1: Follow-up|Adverse Event|0|||
156761563|NCT05067972|565878021|FG001|Part 1: Follow-up|Adverse Event|0|||
156761564|NCT05067972|565878022|FG002|Part 1: Follow-up|Adverse Event|0|||
156761565|NCT05067972|565878023|FG003|Part 1: Follow-up|Adverse Event|0|||
156761566|NCT05067972|565878024|FG004|Part 1: Follow-up|Adverse Event|0|||
156761567|NCT05067972|565878025|FG005|Part 1: Follow-up|Adverse Event|1|||
156761568|NCT05067972|565878026|FG006|Part 1: Follow-up|Adverse Event|0|||
156761569|NCT05067972|565878020|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
156761570|NCT05067972|565878021|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
156761571|NCT05067972|565878022|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
156761572|NCT05067972|565878023|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
156761573|NCT05067972|565878024|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
156761574|NCT05067972|565878025|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
156761575|NCT05067972|565878026|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
156761576|NCT05067972|565878020|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761577|NCT05067972|565878021|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761578|NCT05067972|565878022|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761579|NCT05067972|565878023|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761580|NCT05067972|565878024|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761581|NCT05067972|565878025|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
156761582|NCT05067972|565878026|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761583|NCT05067972|565878020|FG000|Part 1: Follow-up|Physician Decision|0|||
156761584|NCT05067972|565878021|FG001|Part 1: Follow-up|Physician Decision|0|||
156761585|NCT05067972|565878022|FG002|Part 1: Follow-up|Physician Decision|0|||
156761586|NCT05067972|565878023|FG003|Part 1: Follow-up|Physician Decision|1|||
156761587|NCT05067972|565878024|FG004|Part 1: Follow-up|Physician Decision|0|||
156761588|NCT05067972|565878025|FG005|Part 1: Follow-up|Physician Decision|0|||
156761589|NCT05067972|565878026|FG006|Part 1: Follow-up|Physician Decision|0|||
156761590|NCT05067972|565878020|FG000|Part 1: Follow-up|Death|1|||
156761591|NCT05067972|565878021|FG001|Part 1: Follow-up|Death|2|||
156761592|NCT05067972|565878022|FG002|Part 1: Follow-up|Death|1|||
156761593|NCT05067972|565878023|FG003|Part 1: Follow-up|Death|0|||
156761594|NCT05067972|565878024|FG004|Part 1: Follow-up|Death|1|||
156761595|NCT05067972|565878025|FG005|Part 1: Follow-up|Death|0|||
156761596|NCT05067972|565878026|FG006|Part 1: Follow-up|Death|1|||
156761597|NCT00096538|565878033|FG000|Overall Study|Withdrawal by Subject|1|||
156761598|NCT00003471|565878036|FG000|Overall Study|Not evaluable|4|||
156761599|NCT00735007|565878037|FG000|Overall Study|Adverse Event|4|||
156761600|NCT00735007|565878037|FG000|Overall Study|Protocol Violation|1|||
156761601|NCT03839394|565878038|FG000|Overall Study|Lost to Follow-up|6|||
156318953|NCT02937571|564267760|FG002|Overall Study|Adverse Event|4|||
156318954|NCT02937571|564267758|FG000|Overall Study|Withdrawal by Subject|0|||
156318955|NCT02937571|564267759|FG001|Overall Study|Withdrawal by Subject|0|||
156318956|NCT02937571|564267760|FG002|Overall Study|Withdrawal by Subject|3|||
156318957|NCT00934648|564267762|FG000|Overall Study|Failure to return|8|||
156318958|NCT00934648|564267762|FG000|Overall Study|Withdrawal by Subject|1|||
156318959|NCT02361580|564267763|FG000|Overall Study|Lost to Follow-up|6|||
156318960|NCT02361580|564267764|FG001|Overall Study|Lost to Follow-up|3|||
156318961|NCT02047318|564267765|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
156761602|NCT03839394|565878039|FG001|Overall Study|Lost to Follow-up|8|||
156420054|NCT04955626|564630210|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
156761603|NCT03839394|565878038|FG000|Overall Study|Withdrawal by Subject|0|||
156761604|NCT03839394|565878039|FG001|Overall Study|Withdrawal by Subject|2|||
156420055|NCT04955626|564630211|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
156761605|NCT00565604|565878042|FG000|Overall Study|Failure to treat|2|||
156761606|NCT00565604|565878042|FG000|Overall Study|Lost to Follow-up|2|||
156761607|NCT03877224|565878043|FG000|Overall Study|Death|3|||
156761608|NCT03877224|565878044|FG001|Overall Study|Death|2|||
156761609|NCT03877224|565878043|FG000|Overall Study|Withdrawal by Subject|1|||
156318962|NCT02047318|564267765|FG000|Core Study Period|Adverse Event|1|||
156318963|NCT02047318|564267765|FG000|Core Study Period|Withdrawal by caregiver|3|||
156318964|NCT02047318|564267765|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
156318965|NCT00924781|564267766|FG000|Overall Study|Study terminated by sponsor|12|||
156318966|NCT00924781|564267767|FG001|Overall Study|Study terminated by sponsor|10|||
156318967|NCT01479985|564267768|FG000|Overall Study|Tablet malfunction, no data saved|1|||
156318968|NCT01479985|564267769|FG001|Overall Study|Tablet malfunction, no data saved|1|||
156654273|NCT04033445|565481588|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
156654274|NCT04033445|565481589|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
156654275|NCT04033445|565481590|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
156654276|NCT04033445|565481577|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654277|NCT04033445|565481578|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654278|NCT04033445|565481579|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654279|NCT04033445|565481580|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654280|NCT04033445|565481581|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654281|NCT04033445|565481582|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654282|NCT04033445|565481583|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654283|NCT04033445|565481584|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654284|NCT04033445|565481585|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654285|NCT04033445|565481586|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
156654286|NCT04033445|565481587|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654287|NCT04033445|565481588|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
156654288|NCT04033445|565481589|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
156654289|NCT04033445|565481590|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
156654290|NCT02985957|565481591|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156654291|NCT02985957|565481592|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156654292|NCT02985957|565481593|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156654293|NCT02985957|565481594|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156654294|NCT02985957|565481595|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156654295|NCT02985957|565481596|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156654296|NCT02985957|565481597|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156654297|NCT02985957|565481591|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
156654298|NCT02985957|565481592|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
156654299|NCT02985957|565481593|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
156654300|NCT02985957|565481594|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
156654301|NCT02985957|565481595|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
156654302|NCT02985957|565481596|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
156654303|NCT02985957|565481597|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
156654304|NCT02985957|565481591|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156654305|NCT02985957|565481592|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156654306|NCT02985957|565481593|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156654307|NCT02985957|565481594|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156654308|NCT02985957|565481595|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156654309|NCT02985957|565481596|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156654310|NCT02985957|565481597|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
156654311|NCT02985957|565481591|FG000|Treatment Period|Death|0|||
156654312|NCT02985957|565481592|FG001|Treatment Period|Death|0|||
156654313|NCT02985957|565481593|FG002|Treatment Period|Death|0|||
156654314|NCT02985957|565481594|FG003|Treatment Period|Death|0|||
156654315|NCT02985957|565481595|FG004|Treatment Period|Death|1|||
156654316|NCT02985957|565481596|FG005|Treatment Period|Death|0|||
156654317|NCT02985957|565481597|FG006|Treatment Period|Death|0|||
156654318|NCT02985957|565481591|FG000|Treatment Period|Participant withdrew consent|0|||
156654319|NCT02985957|565481592|FG001|Treatment Period|Participant withdrew consent|0|||
156654320|NCT02985957|565481593|FG002|Treatment Period|Participant withdrew consent|0|||
156654321|NCT02985957|565481594|FG003|Treatment Period|Participant withdrew consent|1|||
156654322|NCT02985957|565481595|FG004|Treatment Period|Participant withdrew consent|3|||
156654323|NCT02985957|565481596|FG005|Treatment Period|Participant withdrew consent|0|||
156654324|NCT02985957|565481597|FG006|Treatment Period|Participant withdrew consent|1|||
156654325|NCT02985957|565481591|FG000|Treatment Period|Lost to Follow-up|0|||
156654326|NCT02985957|565481592|FG001|Treatment Period|Lost to Follow-up|0|||
156654327|NCT02985957|565481593|FG002|Treatment Period|Lost to Follow-up|0|||
156654328|NCT02985957|565481594|FG003|Treatment Period|Lost to Follow-up|0|||
156654329|NCT02985957|565481595|FG004|Treatment Period|Lost to Follow-up|1|||
156654330|NCT02985957|565481596|FG005|Treatment Period|Lost to Follow-up|0|||
156654331|NCT02985957|565481597|FG006|Treatment Period|Lost to Follow-up|0|||
156654332|NCT02985957|565481591|FG000|Treatment Period|Other reasons|0|||
156654333|NCT02985957|565481592|FG001|Treatment Period|Other reasons|0|||
156654334|NCT02985957|565481593|FG002|Treatment Period|Other reasons|1|||
156654335|NCT02985957|565481594|FG003|Treatment Period|Other reasons|3|||
156654336|NCT02985957|565481595|FG004|Treatment Period|Other reasons|5|||
156654337|NCT02985957|565481596|FG005|Treatment Period|Other reasons|0|||
156654338|NCT02985957|565481597|FG006|Treatment Period|Other reasons|1|||
156654339|NCT02985957|565481591|FG000|Treatment Period|Not reported|0|||
156654340|NCT02985957|565481592|FG001|Treatment Period|Not reported|2|||
156654341|NCT02985957|565481593|FG002|Treatment Period|Not reported|2|||
156654342|NCT02985957|565481594|FG003|Treatment Period|Not reported|5|||
156654343|NCT02985957|565481595|FG004|Treatment Period|Not reported|0|||
156654344|NCT02985957|565481596|FG005|Treatment Period|Not reported|0|||
156654345|NCT02985957|565481597|FG006|Treatment Period|Not reported|0|||
156654346|NCT02985957|565481591|FG000|Treatment Period|Maximum clinical benefit|0|||
156654347|NCT02985957|565481592|FG001|Treatment Period|Maximum clinical benefit|0|||
156654348|NCT02985957|565481593|FG002|Treatment Period|Maximum clinical benefit|1|||
156654349|NCT02985957|565481594|FG003|Treatment Period|Maximum clinical benefit|1|||
156654350|NCT02985957|565481595|FG004|Treatment Period|Maximum clinical benefit|0|||
156654351|NCT02985957|565481596|FG005|Treatment Period|Maximum clinical benefit|0|||
156654352|NCT02985957|565481597|FG006|Treatment Period|Maximum clinical benefit|2|||
156654353|NCT02985957|565481591|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
156654354|NCT02985957|565481592|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
156654355|NCT02985957|565481593|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
156654356|NCT02985957|565481594|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
156654357|NCT02985957|565481595|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
156654358|NCT02985957|565481596|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
156654359|NCT02985957|565481597|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
156654360|NCT02985957|565481591|FG000|Treatment Period|Study drug toxicity|1|||
156654361|NCT02985957|565481592|FG001|Treatment Period|Study drug toxicity|23|||
156654362|NCT02985957|565481593|FG002|Treatment Period|Study drug toxicity|20|||
156654363|NCT02985957|565481594|FG003|Treatment Period|Study drug toxicity|12|||
156654364|NCT02985957|565481595|FG004|Treatment Period|Study drug toxicity|20|||
156654365|NCT02985957|565481596|FG005|Treatment Period|Study drug toxicity|3|||
156654366|NCT02985957|565481597|FG006|Treatment Period|Study drug toxicity|5|||
156654367|NCT02985957|565481591|FG000|Treatment Period|Disease progression|0|||
156654368|NCT02985957|565481592|FG001|Treatment Period|Disease progression|16|||
156654369|NCT02985957|565481593|FG002|Treatment Period|Disease progression|20|||
156654370|NCT02985957|565481594|FG003|Treatment Period|Disease progression|40|||
156654371|NCT02985957|565481595|FG004|Treatment Period|Disease progression|29|||
156654372|NCT02985957|565481596|FG005|Treatment Period|Disease progression|11|||
156654373|NCT02985957|565481597|FG006|Treatment Period|Disease progression|28|||
156654374|NCT02985957|565481591|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
156654375|NCT02985957|565481592|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
156654376|NCT02985957|565481593|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
156654377|NCT02985957|565481594|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
156654378|NCT02985957|565481595|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
156654379|NCT02985957|565481596|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
156654380|NCT02985957|565481597|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
156654381|NCT02985957|565481591|FG000|Treatment Period|Poor/Non-Compliance|0|||
156654382|NCT02985957|565481592|FG001|Treatment Period|Poor/Non-Compliance|0|||
156654383|NCT02985957|565481593|FG002|Treatment Period|Poor/Non-Compliance|0|||
156654384|NCT02985957|565481594|FG003|Treatment Period|Poor/Non-Compliance|0|||
156654385|NCT02985957|565481595|FG004|Treatment Period|Poor/Non-Compliance|1|||
156654386|NCT02985957|565481596|FG005|Treatment Period|Poor/Non-Compliance|1|||
156654387|NCT02985957|565481597|FG006|Treatment Period|Poor/Non-Compliance|0|||
156654388|NCT05845645|565481598|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654389|NCT05845645|565481599|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654390|NCT05845645|565481600|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
156654391|NCT05845645|565481601|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654392|NCT05845645|565481602|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654393|NCT05845645|565481603|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654394|NCT05845645|565481604|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654395|NCT05845645|565481605|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654396|NCT05845645|565481606|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654397|NCT05845645|565481607|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654398|NCT05845645|565481608|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654399|NCT05845645|565481609|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
156654400|NCT05845645|565481598|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654401|NCT05845645|565481599|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654402|NCT05845645|565481600|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
156761610|NCT03877224|565878044|FG001|Overall Study|Withdrawal by Subject|6|||
156761611|NCT03877224|565878043|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
156761612|NCT03877224|565878044|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
156761613|NCT02486692|565879815|FG000|Overall Study|did not login for randomization|4|||
156761614|NCT02486692|565879816|FG001|Overall Study|did not login for randomization|7|||
156761615|NCT00116688|565879820|FG000|Overall Study|Protocol deviation|1|||
156761616|NCT00116688|565879821|FG001|Overall Study|Protocol deviation|0|||
156761617|NCT00116688|565879820|FG000|Overall Study|Noncompliance|3|||
156761618|NCT00116688|565879821|FG001|Overall Study|Noncompliance|1|||
156761619|NCT00116688|565879820|FG000|Overall Study|Adverse Event|11|||
156761620|NCT00116688|565879821|FG001|Overall Study|Adverse Event|0|||
156761621|NCT00116688|565879820|FG000|Overall Study|Withdrawal by Subject|26|||
156761622|NCT00116688|565879821|FG001|Overall Study|Withdrawal by Subject|2|||
156761623|NCT00116688|565879820|FG000|Overall Study|Requirement for alternative therapy|11|||
156761624|NCT00116688|565879821|FG001|Overall Study|Requirement for alternative therapy|1|||
156761625|NCT00116688|565879820|FG000|Overall Study|Physician Decision|7|||
156761626|NCT00116688|565879821|FG001|Overall Study|Physician Decision|0|||
156761627|NCT00116688|565879820|FG000|Overall Study|Lost to Follow-up|3|||
156761628|NCT00116688|565879821|FG001|Overall Study|Lost to Follow-up|0|||
156761629|NCT00116688|565879820|FG000|Overall Study|Death|15|||
156761630|NCT00116688|565879821|FG001|Overall Study|Death|0|||
156761631|NCT00116688|565879820|FG000|Overall Study|Protocol-specified criteria|3|||
156761632|NCT00116688|565879821|FG001|Overall Study|Protocol-specified criteria|0|||
156761633|NCT00116688|565879820|FG000|Overall Study|Pregnancy|1|||
156761634|NCT00116688|565879821|FG001|Overall Study|Pregnancy|0|||
156761635|NCT00116688|565879820|FG000|Overall Study|Other|11|||
156761636|NCT00116688|565879821|FG001|Overall Study|Other|0|||
156761637|NCT01775670|565879823|FG000|Overall Study|Lost to Follow-up|1|||
156761638|NCT01775670|565879824|FG001|Overall Study|Lost to Follow-up|1|||
156761639|NCT01298700|565879826|FG000|Overall Study|Adverse Event|50|||
156761640|NCT01298700|565879827|FG001|Overall Study|Adverse Event|51|||
156761641|NCT01298700|565879826|FG000|Overall Study|Lack of Efficacy|9|||
156761642|NCT01298700|565879827|FG001|Overall Study|Lack of Efficacy|14|||
156761643|NCT01298700|565879826|FG000|Overall Study|Lost to Follow-up|5|||
156761644|NCT01298700|565879827|FG001|Overall Study|Lost to Follow-up|2|||
156761645|NCT01298700|565879826|FG000|Overall Study|Withdrawal by Subject|12|||
156761646|NCT01298700|565879827|FG001|Overall Study|Withdrawal by Subject|9|||
156761647|NCT01298700|565879826|FG000|Overall Study|Protocol Violation|6|||
156761648|NCT01298700|565879827|FG001|Overall Study|Protocol Violation|4|||
156761649|NCT01298700|565879826|FG000|Overall Study|Other Miscellaneous Reasons|16|||
156761650|NCT01298700|565879827|FG001|Overall Study|Other Miscellaneous Reasons|15|||
156761651|NCT01298700|565879826|FG000|Overall Study|Did not Receive Study Drug|3|||
156761652|NCT01298700|565879827|FG001|Overall Study|Did not Receive Study Drug|5|||
156761653|NCT04006145|565879828|FG000|Overall Study|Lost to Follow-up|0|||
156761654|NCT04006145|565879829|FG001|Overall Study|Lost to Follow-up|1|||
156761655|NCT04006145|565879828|FG000|Overall Study|Other|1|||
156761656|NCT04006145|565879829|FG001|Overall Study|Other|2|||
156761657|NCT01001429|565879830|FG000|Overall Study|surgery cancelled|0|||
156761658|NCT01001429|565879831|FG001|Overall Study|surgery cancelled|1|||
156761659|NCT00010257|565879834|FG000|Overall Study|Withdrawal by Subject|1|||
156761660|NCT00010257|565879835|FG001|Overall Study|Withdrawal by Subject|0|||
156761661|NCT00643760|565879838|FG000|Overall Study|Adverse Event|11|||
156761662|NCT00643760|565879839|FG001|Overall Study|Adverse Event|5|||
156761663|NCT00643760|565879840|FG002|Overall Study|Adverse Event|12|||
156761664|NCT00643760|565879841|FG003|Overall Study|Adverse Event|21|||
156761665|NCT00643760|565879842|FG004|Overall Study|Adverse Event|6|||
156761666|NCT00643760|565879838|FG000|Overall Study|Lack of Efficacy|3|||
156761667|NCT00643760|565879839|FG001|Overall Study|Lack of Efficacy|1|||
156761668|NCT00643760|565879840|FG002|Overall Study|Lack of Efficacy|0|||
156761669|NCT00643760|565879841|FG003|Overall Study|Lack of Efficacy|4|||
156761670|NCT00643760|565879842|FG004|Overall Study|Lack of Efficacy|3|||
156761671|NCT00643760|565879838|FG000|Overall Study|Protocol Violation|7|||
156761672|NCT00643760|565879839|FG001|Overall Study|Protocol Violation|6|||
156761673|NCT00643760|565879840|FG002|Overall Study|Protocol Violation|4|||
156761674|NCT00643760|565879841|FG003|Overall Study|Protocol Violation|4|||
156761675|NCT00643760|565879842|FG004|Overall Study|Protocol Violation|6|||
156761676|NCT00643760|565879838|FG000|Overall Study|Lost to Follow-up|6|||
156761677|NCT00643760|565879839|FG001|Overall Study|Lost to Follow-up|2|||
156761678|NCT00643760|565879840|FG002|Overall Study|Lost to Follow-up|1|||
156761679|NCT00643760|565879841|FG003|Overall Study|Lost to Follow-up|3|||
156761680|NCT00643760|565879842|FG004|Overall Study|Lost to Follow-up|3|||
156761681|NCT00643760|565879838|FG000|Overall Study|Investigator Discretion|0|||
156761682|NCT00643760|565879839|FG001|Overall Study|Investigator Discretion|0|||
156761683|NCT00643760|565879840|FG002|Overall Study|Investigator Discretion|0|||
156761684|NCT00643760|565879841|FG003|Overall Study|Investigator Discretion|2|||
156761685|NCT00643760|565879842|FG004|Overall Study|Investigator Discretion|0|||
156761686|NCT00643760|565879838|FG000|Overall Study|Withdrawal by Subject|3|||
156761687|NCT00643760|565879839|FG001|Overall Study|Withdrawal by Subject|1|||
156761688|NCT00643760|565879840|FG002|Overall Study|Withdrawal by Subject|2|||
156761689|NCT00643760|565879841|FG003|Overall Study|Withdrawal by Subject|4|||
156761690|NCT00643760|565879842|FG004|Overall Study|Withdrawal by Subject|1|||
156761691|NCT02063672|565879846|FG000|Overall Study|Ongoing Follow-up|27|||
156761692|NCT02063672|565879847|FG001|Overall Study|Ongoing Follow-up|14|||
156761693|NCT02063672|565879846|FG000|Overall Study|Death|5|||
156761694|NCT02063672|565879847|FG001|Overall Study|Death|3|||
156761695|NCT02063672|565879846|FG000|Overall Study|Lost to Follow-up|1|||
156761696|NCT02063672|565879847|FG001|Overall Study|Lost to Follow-up|3|||
156761697|NCT02063672|565879846|FG000|Overall Study|Withdrawal by Subject|2|||
156761698|NCT02063672|565879847|FG001|Overall Study|Withdrawal by Subject|2|||
156761699|NCT01307787|565879849|FG000|Overall Study|Withdrawal by Subject|2|||
156761700|NCT01307787|565879850|FG001|Overall Study|Withdrawal by Subject|0|||
156761701|NCT03353792|565879854|FG000|Overall Study|Lost to Follow-up|1|||
156761702|NCT03353792|565879855|FG001|Overall Study|Lost to Follow-up|0|||
156761703|NCT03353792|565879854|FG000|Overall Study|Participant Unable to Manage Device|1|||
156761704|NCT03353792|565879855|FG001|Overall Study|Participant Unable to Manage Device|0|||
156761705|NCT00789321|565879856|FG000|Overall Study|Adverse Event|0|||
156761706|NCT00789321|565879857|FG001|Overall Study|Adverse Event|1|||
156761707|NCT00104052|565879858|FG000|Overall Study|Adverse Event|1|||
156761708|NCT00104052|565879858|FG000|Overall Study|Lack of Efficacy|26|||
156761709|NCT00104052|565879858|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
156761710|NCT02498678|565879861|FG000|Overall Study|interference from the surgical team|0|||
156761711|NCT02498678|565879862|FG001|Overall Study|interference from the surgical team|2|||
156761712|NCT03652818|565879863|FG000|Overall Study|Adverse Event|1|||
156761713|NCT03652818|565879864|FG001|Overall Study|Adverse Event|0|||
156761714|NCT03652818|565879865|FG002|Overall Study|Adverse Event|0|||
156761715|NCT03652818|565879866|FG003|Overall Study|Adverse Event|0|||
156761716|NCT03652818|565879867|FG004|Overall Study|Adverse Event|0|||
156761717|NCT03652818|565879863|FG000|Overall Study|Physician Decision|1|||
156761718|NCT03652818|565879864|FG001|Overall Study|Physician Decision|0|||
156761719|NCT03652818|565879865|FG002|Overall Study|Physician Decision|0|||
156761720|NCT03652818|565879866|FG003|Overall Study|Physician Decision|0|||
156761721|NCT03652818|565879867|FG004|Overall Study|Physician Decision|0|||
156761722|NCT03652818|565879863|FG000|Overall Study|Lost to Follow-up|0|||
156761723|NCT03652818|565879864|FG001|Overall Study|Lost to Follow-up|1|||
156761724|NCT03652818|565879865|FG002|Overall Study|Lost to Follow-up|2|||
156761725|NCT03652818|565879866|FG003|Overall Study|Lost to Follow-up|1|||
156761726|NCT03652818|565879867|FG004|Overall Study|Lost to Follow-up|1|||
156761727|NCT01294423|565879872|FG000|Overall Study|Adverse Event|1|||
156761728|NCT01294423|565879873|FG001|Overall Study|Adverse Event|2|||
156420056|NCT04955626|564630212|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
156420057|NCT04955626|564630213|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
156420058|NCT04955626|564630214|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
156420059|NCT04955626|564630215|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
156420060|NCT04955626|564630216|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
156420061|NCT04955626|564630181|FG000|Blinded Period|Medication error|0|||
156420062|NCT04955626|564630182|FG001|Blinded Period|Medication error|0|||
156420063|NCT04955626|564630183|FG002|Blinded Period|Medication error|0|||
156420064|NCT04955626|564630184|FG003|Blinded Period|Medication error|0|||
156420065|NCT04955626|564630185|FG004|Blinded Period|Medication error|0|||
156420066|NCT04955626|564630186|FG005|Blinded Period|Medication error|0|||
156420067|NCT04955626|564630187|FG006|Blinded Period|Medication error|0|||
156420068|NCT04955626|564630188|FG007|Blinded Period|Medication error|0|||
156420069|NCT04955626|564630189|FG008|Blinded Period|Medication error|0|||
156420070|NCT04955626|564630190|FG009|Blinded Period|Medication error|0|||
156420071|NCT04955626|564630191|FG010|Blinded Period|Medication error|2|||
156420072|NCT04955626|564630192|FG011|Blinded Period|Medication error|0|||
156420073|NCT04955626|564630193|FG012|Blinded Period|Medication error|0|||
156420074|NCT04955626|564630194|FG013|Blinded Period|Medication error|0|||
156420075|NCT04955626|564630195|FG014|Blinded Period|Medication error|0|||
156420076|NCT04955626|564630196|FG015|Blinded Period|Medication error|0|||
156420077|NCT04955626|564630197|FG016|Blinded Period|Medication error|0|||
156420078|NCT04955626|564630198|FG017|Blinded Period|Medication error|0|||
156420079|NCT04955626|564630199|FG018|Blinded Period|Medication error|0|||
156761729|NCT01294423|565879874|FG002|Overall Study|Adverse Event|3|||
156761730|NCT01294423|565879872|FG000|Overall Study|Withdrawal by Subject|1|||
156761731|NCT01294423|565879873|FG001|Overall Study|Withdrawal by Subject|2|||
156761732|NCT01294423|565879874|FG002|Overall Study|Withdrawal by Subject|2|||
156761733|NCT01294423|565879872|FG000|Overall Study|subject no longer meets study criteria|2|||
156761734|NCT01294423|565879873|FG001|Overall Study|subject no longer meets study criteria|5|||
156761735|NCT01294423|565879874|FG002|Overall Study|subject no longer meets study criteria|2|||
156761736|NCT01294423|565879872|FG000|Overall Study|poor/non-compliance|1|||
156420080|NCT04955626|564630200|FG019|Blinded Period|Medication error|0|||
156420081|NCT04955626|564630201|FG020|Blinded Period|Medication error|0|||
156420082|NCT04955626|564630202|FG021|Blinded Period|Medication error|0|||
156420083|NCT04955626|564630203|FG022|Blinded Period|Medication error|0|||
156420084|NCT04955626|564630204|FG023|Blinded Period|Medication error|0|||
156761737|NCT01294423|565879873|FG001|Overall Study|poor/non-compliance|0|||
156654403|NCT05845645|565481601|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654404|NCT05845645|565481602|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654405|NCT05845645|565481603|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654406|NCT05845645|565481604|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654407|NCT05845645|565481605|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654408|NCT05845645|565481606|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654409|NCT05845645|565481607|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
156654410|NCT05845645|565481608|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654411|NCT05845645|565481609|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
156654412|NCT03748641|565481613|FG000|Overall Study|Ongoing|155|||
156654413|NCT03748641|565481614|FG001|Overall Study|Ongoing|148|||
156654414|NCT03748641|565481615|FG002|Overall Study|Ongoing|66|||
156654415|NCT03748641|565481616|FG003|Overall Study|Ongoing|79|||
156654416|NCT03748641|565481617|FG004|Overall Study|Ongoing|84|||
156654417|NCT03748641|565481613|FG000|Overall Study|Death|54|||
156654418|NCT03748641|565481614|FG001|Overall Study|Death|59|||
156654419|NCT03748641|565481615|FG002|Overall Study|Death|51|||
156654420|NCT03748641|565481616|FG003|Overall Study|Death|42|||
156654421|NCT03748641|565481617|FG004|Overall Study|Death|9|||
156654422|NCT03748641|565481613|FG000|Overall Study|Lost to Follow-up|0|||
156654423|NCT03748641|565481614|FG001|Overall Study|Lost to Follow-up|2|||
156654424|NCT03748641|565481615|FG002|Overall Study|Lost to Follow-up|1|||
156654425|NCT03748641|565481616|FG003|Overall Study|Lost to Follow-up|0|||
156654426|NCT03748641|565481617|FG004|Overall Study|Lost to Follow-up|0|||
156654427|NCT03748641|565481613|FG000|Overall Study|Withdrawal by Subject|3|||
156654428|NCT03748641|565481614|FG001|Overall Study|Withdrawal by Subject|2|||
156654429|NCT03748641|565481615|FG002|Overall Study|Withdrawal by Subject|5|||
156654430|NCT03748641|565481616|FG003|Overall Study|Withdrawal by Subject|3|||
156654431|NCT03748641|565481617|FG004|Overall Study|Withdrawal by Subject|2|||
156654432|NCT02549495|565481618|FG000|Overall Study|Death|2|||
156654433|NCT02549495|565481618|FG000|Overall Study|Withdrawal by Subject|5|||
156654434|NCT02549495|565481618|FG000|Overall Study|Physician Decision|22|||
156654435|NCT02549495|565481618|FG000|Overall Study|Lost to Follow-up|6|||
156654436|NCT02549495|565481618|FG000|Overall Study|Protocol Violation|6|||
156654437|NCT00638157|565481619|FG000|Overall Study|Adverse Event|0|||
156654438|NCT00638157|565481620|FG001|Overall Study|Adverse Event|1|||
156654439|NCT00638157|565481619|FG000|Overall Study|Clinical (symptomatic) failure|1|||
156654440|NCT00638157|565481620|FG001|Overall Study|Clinical (symptomatic) failure|1|||
156654441|NCT00638157|565481619|FG000|Overall Study|Microbiological failure|1|||
156654442|NCT00638157|565481620|FG001|Overall Study|Microbiological failure|0|||
156654443|NCT00638157|565481619|FG000|Overall Study|Lost to Follow-up|1|||
156654444|NCT00638157|565481620|FG001|Overall Study|Lost to Follow-up|0|||
156654445|NCT00638157|565481619|FG000|Overall Study|Physician Decision|1|||
156654446|NCT00638157|565481620|FG001|Overall Study|Physician Decision|0|||
156654447|NCT00638157|565481619|FG000|Overall Study|Other|1|||
156654448|NCT00638157|565481620|FG001|Overall Study|Other|2|||
156654449|NCT00638157|565481619|FG000|Overall Study|Randomized, not treated|2|||
156654450|NCT00638157|565481620|FG001|Overall Study|Randomized, not treated|0|||
156654451|NCT00437281|565481621|FG000|Overall Study|Adverse Event|0|||
156654452|NCT00437281|565481622|FG001|Overall Study|Adverse Event|0|||
156654453|NCT00437281|565481623|FG002|Overall Study|Adverse Event|0|||
156654454|NCT00437281|565481624|FG003|Overall Study|Adverse Event|1|||
156654455|NCT00437281|565481625|FG004|Overall Study|Adverse Event|0|||
156654456|NCT00437281|565481626|FG005|Overall Study|Adverse Event|1|||
156654457|NCT00437281|565481627|FG006|Overall Study|Adverse Event|0|||
156654458|NCT00437281|565481628|FG007|Overall Study|Adverse Event|0|||
156654459|NCT00437281|565481629|FG008|Overall Study|Adverse Event|0|||
156654460|NCT00437281|565481630|FG009|Overall Study|Adverse Event|1|||
156654461|NCT00437281|565481631|FG010|Overall Study|Adverse Event|0|||
156654462|NCT00437281|565481632|FG011|Overall Study|Adverse Event|0|||
156654463|NCT00437281|565481633|FG012|Overall Study|Adverse Event|0|||
156654464|NCT00437281|565481634|FG013|Overall Study|Adverse Event|1|||
156654465|NCT00437281|565481635|FG014|Overall Study|Adverse Event|1|||
156654466|NCT00437281|565481636|FG015|Overall Study|Adverse Event|0|||
156654467|NCT00437281|565481637|FG016|Overall Study|Adverse Event|0|||
156654468|NCT00437281|565481638|FG017|Overall Study|Adverse Event|0|||
156654469|NCT00437281|565481639|FG018|Overall Study|Adverse Event|1|||
156654470|NCT00437281|565481640|FG019|Overall Study|Adverse Event|0|||
156654471|NCT00437281|565481621|FG000|Overall Study|Lost to Follow-up|0|||
156654472|NCT00437281|565481622|FG001|Overall Study|Lost to Follow-up|0|||
156654473|NCT00437281|565481623|FG002|Overall Study|Lost to Follow-up|0|||
156654474|NCT00437281|565481624|FG003|Overall Study|Lost to Follow-up|0|||
156654475|NCT00437281|565481625|FG004|Overall Study|Lost to Follow-up|0|||
156654476|NCT00437281|565481626|FG005|Overall Study|Lost to Follow-up|0|||
156654477|NCT00437281|565481627|FG006|Overall Study|Lost to Follow-up|0|||
156654478|NCT00437281|565481628|FG007|Overall Study|Lost to Follow-up|0|||
156654479|NCT00437281|565481629|FG008|Overall Study|Lost to Follow-up|0|||
156654480|NCT00437281|565481630|FG009|Overall Study|Lost to Follow-up|0|||
156654481|NCT00437281|565481631|FG010|Overall Study|Lost to Follow-up|0|||
156654482|NCT00437281|565481632|FG011|Overall Study|Lost to Follow-up|0|||
156654483|NCT00437281|565481633|FG012|Overall Study|Lost to Follow-up|0|||
156654484|NCT00437281|565481634|FG013|Overall Study|Lost to Follow-up|0|||
156654485|NCT00437281|565481635|FG014|Overall Study|Lost to Follow-up|0|||
156654486|NCT00437281|565481636|FG015|Overall Study|Lost to Follow-up|0|||
156654487|NCT00437281|565481637|FG016|Overall Study|Lost to Follow-up|0|||
156654488|NCT00437281|565481638|FG017|Overall Study|Lost to Follow-up|0|||
156654489|NCT00437281|565481639|FG018|Overall Study|Lost to Follow-up|0|||
156654490|NCT00437281|565481640|FG019|Overall Study|Lost to Follow-up|1|||
156654491|NCT03495986|565481641|FG000|Overall Study|Physician Decision|1|||
156654492|NCT03495986|565481642|FG001|Overall Study|Physician Decision|0|||
156654493|NCT03495986|565481641|FG000|Overall Study|Withdrawal by Subject|1|||
156654494|NCT03495986|565481642|FG001|Overall Study|Withdrawal by Subject|1|||
156654495|NCT03495986|565481641|FG000|Overall Study|Withdrawal by Subject|1|||
156654496|NCT03495986|565481642|FG001|Overall Study|Withdrawal by Subject|0|||
156654497|NCT02365597|565481643|FG000|Overall Study|Lost to Follow-up|0|||
156654498|NCT02365597|565481644|FG001|Overall Study|Lost to Follow-up|1|||
156654499|NCT02365597|565481645|FG002|Overall Study|Lost to Follow-up|0|||
156654500|NCT02365597|565481646|FG003|Overall Study|Lost to Follow-up|1|||
156654501|NCT02365597|565481643|FG000|Overall Study|Withdrawal by Subject|1|||
156654502|NCT02365597|565481644|FG001|Overall Study|Withdrawal by Subject|8|||
156654503|NCT02365597|565481645|FG002|Overall Study|Withdrawal by Subject|5|||
156654504|NCT02365597|565481646|FG003|Overall Study|Withdrawal by Subject|1|||
156654505|NCT02365597|565481643|FG000|Overall Study|Sponsor's decision|1|||
156654506|NCT02365597|565481644|FG001|Overall Study|Sponsor's decision|3|||
156654507|NCT02365597|565481645|FG002|Overall Study|Sponsor's decision|13|||
156654508|NCT02365597|565481646|FG003|Overall Study|Sponsor's decision|0|||
156654509|NCT02365597|565481643|FG000|Overall Study|Other|0|||
156654510|NCT02365597|565481644|FG001|Overall Study|Other|4|||
156654511|NCT02365597|565481645|FG002|Overall Study|Other|0|||
156654512|NCT02365597|565481646|FG003|Overall Study|Other|0|||
156654513|NCT02365597|565481643|FG000|Overall Study|Enrolled but not treated|0|||
156654514|NCT02365597|565481644|FG001|Overall Study|Enrolled but not treated|1|||
156654515|NCT02365597|565481645|FG002|Overall Study|Enrolled but not treated|1|||
156654516|NCT02365597|565481646|FG003|Overall Study|Enrolled but not treated|0|||
156654517|NCT02365597|565481643|FG000|Overall Study|Ongoing|0|||
156654518|NCT02365597|565481644|FG001|Overall Study|Ongoing|0|||
156654519|NCT02365597|565481645|FG002|Overall Study|Ongoing|0|||
156654520|NCT02365597|565481646|FG003|Overall Study|Ongoing|17|||
156654521|NCT04309474|565481647|FG000|Overall Study|Randomized but not treated|0|||
156654522|NCT04309474|565481648|FG001|Overall Study|Randomized but not treated|2|||
156654523|NCT04309474|565481647|FG000|Overall Study|Adverse Event|4|||
156654524|NCT04309474|565481648|FG001|Overall Study|Adverse Event|1|||
156654525|NCT04309474|565481647|FG000|Overall Study|Withdrawal by Subject|6|||
156654526|NCT04309474|565481648|FG001|Overall Study|Withdrawal by Subject|9|||
156654527|NCT04309474|565481647|FG000|Overall Study|Lost to Follow-up|1|||
156654528|NCT04309474|565481648|FG001|Overall Study|Lost to Follow-up|2|||
156654529|NCT04309474|565481647|FG000|Overall Study|Not disclosed|10|||
156654530|NCT04309474|565481648|FG001|Overall Study|Not disclosed|6|||
156654531|NCT04670068|565481649|FG000|Overall Study|Progressive Disease|1|||
156654532|NCT04670068|565481650|FG001|Overall Study|Progressive Disease|1|||
156654533|NCT04670068|565481649|FG000|Overall Study|Withdrawal by Subject|1|||
156654534|NCT04670068|565481650|FG001|Overall Study|Withdrawal by Subject|0|||
156654535|NCT04684524|565481651|FG000|Overall Study|Other|2|||
156654536|NCT04684524|565481652|FG001|Overall Study|Other|0|||
156654537|NCT04684524|565481651|FG000|Overall Study|Withdrawal by Subject|5|||
156654538|NCT04684524|565481652|FG001|Overall Study|Withdrawal by Subject|3|||
156654539|NCT04684524|565481651|FG000|Overall Study|Adverse Event|1|||
156654540|NCT04684524|565481652|FG001|Overall Study|Adverse Event|1|||
156654541|NCT04182204|565481656|FG000|Safety Run-in|Lost to Follow-up|1|||
156654542|NCT04182204|565481657|FG001|Safety Run-in|Lost to Follow-up|0|||
156654543|NCT04182204|565481658|FG002|Safety Run-in|Lost to Follow-up|0|||
156654544|NCT04182204|565481656|FG000|Safety Run-in|Withdrawal by Subject|2|||
156654545|NCT04182204|565481657|FG001|Safety Run-in|Withdrawal by Subject|0|||
156654546|NCT04182204|565481658|FG002|Safety Run-in|Withdrawal by Subject|0|||
156654547|NCT04182204|565481656|FG000|Safety Run-in|Death|7|||
156654548|NCT04182204|565481657|FG001|Safety Run-in|Death|0|||
156654549|NCT04182204|565481658|FG002|Safety Run-in|Death|0|||
156654550|NCT04182204|565481656|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
156654551|NCT04182204|565481657|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
156654552|NCT04182204|565481658|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
156654553|NCT04182204|565481656|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
156654554|NCT04182204|565481657|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
156654555|NCT04182204|565481658|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
156654556|NCT04182204|565481656|FG000|Randomized Controlled Trial|Death|0|||
156654557|NCT04182204|565481657|FG001|Randomized Controlled Trial|Death|83|||
156654558|NCT04182204|565481658|FG002|Randomized Controlled Trial|Death|66|||
156654559|NCT05876091|565481659|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
156654560|NCT03402893|565481660|FG000|Overall Study|Withdrawal by Subject|1|||
156654561|NCT03466411|565481661|FG000|Overall Study|Lost to Follow-up|0|||
156654562|NCT03466411|565481662|FG001|Overall Study|Lost to Follow-up|1|||
156654563|NCT03466411|565481663|FG002|Overall Study|Lost to Follow-up|1|||
156654564|NCT03466411|565481664|FG003|Overall Study|Lost to Follow-up|0|||
156654565|NCT03466411|565481665|FG004|Overall Study|Lost to Follow-up|0|||
156654566|NCT03466411|565481666|FG005|Overall Study|Lost to Follow-up|0|||
156654567|NCT03466411|565481667|FG006|Overall Study|Lost to Follow-up|1|||
156654568|NCT03466411|565481668|FG007|Overall Study|Lost to Follow-up|1|||
156654569|NCT03466411|565481669|FG008|Overall Study|Lost to Follow-up|0|||
156654570|NCT03466411|565481670|FG009|Overall Study|Lost to Follow-up|1|||
156654571|NCT03466411|565481671|FG010|Overall Study|Lost to Follow-up|1|||
156654572|NCT03466411|565481672|FG011|Overall Study|Lost to Follow-up|1|||
156654573|NCT03466411|565481673|FG012|Overall Study|Lost to Follow-up|0|||
156654574|NCT03466411|565481661|FG000|Overall Study|Withdrawal by Subject|14|||
156654575|NCT03466411|565481662|FG001|Overall Study|Withdrawal by Subject|7|||
156654576|NCT03466411|565481663|FG002|Overall Study|Withdrawal by Subject|8|||
156654577|NCT03466411|565481664|FG003|Overall Study|Withdrawal by Subject|4|||
156654578|NCT03466411|565481665|FG004|Overall Study|Withdrawal by Subject|6|||
156654579|NCT03466411|565481666|FG005|Overall Study|Withdrawal by Subject|3|||
156654580|NCT03466411|565481667|FG006|Overall Study|Withdrawal by Subject|6|||
156654581|NCT03466411|565481668|FG007|Overall Study|Withdrawal by Subject|9|||
156654582|NCT03466411|565481669|FG008|Overall Study|Withdrawal by Subject|6|||
156654583|NCT03466411|565481670|FG009|Overall Study|Withdrawal by Subject|11|||
156654584|NCT03466411|565481671|FG010|Overall Study|Withdrawal by Subject|14|||
156654585|NCT03466411|565481672|FG011|Overall Study|Withdrawal by Subject|12|||
156654586|NCT03466411|565481673|FG012|Overall Study|Withdrawal by Subject|7|||
156654587|NCT03466411|565481661|FG000|Overall Study|Other|1|||
156654588|NCT03466411|565481662|FG001|Overall Study|Other|1|||
156654589|NCT03466411|565481663|FG002|Overall Study|Other|0|||
156654590|NCT03466411|565481664|FG003|Overall Study|Other|1|||
156654591|NCT03466411|565481665|FG004|Overall Study|Other|2|||
156654592|NCT03466411|565481666|FG005|Overall Study|Other|0|||
156654593|NCT03466411|565481667|FG006|Overall Study|Other|0|||
156654594|NCT03466411|565481668|FG007|Overall Study|Other|0|||
156654595|NCT03466411|565481669|FG008|Overall Study|Other|0|||
156654596|NCT03466411|565481670|FG009|Overall Study|Other|1|||
156654597|NCT03466411|565481671|FG010|Overall Study|Other|2|||
156654598|NCT03466411|565481672|FG011|Overall Study|Other|0|||
156654599|NCT03466411|565481673|FG012|Overall Study|Other|0|||
156654600|NCT03466411|565481661|FG000|Overall Study|Randomized but not Treated|0|||
156654601|NCT03466411|565481662|FG001|Overall Study|Randomized but not Treated|0|||
156654602|NCT03466411|565481663|FG002|Overall Study|Randomized but not Treated|0|||
156654603|NCT03466411|565481664|FG003|Overall Study|Randomized but not Treated|0|||
156654604|NCT03466411|565481665|FG004|Overall Study|Randomized but not Treated|0|||
156654605|NCT03466411|565481666|FG005|Overall Study|Randomized but not Treated|0|||
156654606|NCT03466411|565481667|FG006|Overall Study|Randomized but not Treated|1|||
156654607|NCT03466411|565481668|FG007|Overall Study|Randomized but not Treated|0|||
156654608|NCT03466411|565481669|FG008|Overall Study|Randomized but not Treated|0|||
156654609|NCT03466411|565481670|FG009|Overall Study|Randomized but not Treated|0|||
156654610|NCT03466411|565481671|FG010|Overall Study|Randomized but not Treated|0|||
156654611|NCT03466411|565481672|FG011|Overall Study|Randomized but not Treated|0|||
156654612|NCT03466411|565481673|FG012|Overall Study|Randomized but not Treated|0|||
156654613|NCT00926289|565481677|FG000|Overall Study|Adverse Event|9|||
156654614|NCT00926289|565481678|FG001|Overall Study|Adverse Event|11|||
156654615|NCT00926289|565481677|FG000|Overall Study|Protocol Violation|8|||
156654616|NCT00926289|565481678|FG001|Overall Study|Protocol Violation|12|||
156654617|NCT00926289|565481677|FG000|Overall Study|Lost to Follow-up|3|||
156654618|NCT00926289|565481678|FG001|Overall Study|Lost to Follow-up|6|||
156654619|NCT00926289|565481677|FG000|Overall Study|Withdrawal by Subject|4|||
156654620|NCT00926289|565481678|FG001|Overall Study|Withdrawal by Subject|4|||
156654621|NCT00926289|565481677|FG000|Overall Study|Other|1|||
156654622|NCT00926289|565481678|FG001|Overall Study|Other|3|||
156654623|NCT04104646|565481679|FG000|Overall Study|Withdrawal by Subject|1|||
156654624|NCT04104646|565481680|FG001|Overall Study|Withdrawal by Subject|1|||
156654625|NCT04104646|565481679|FG000|Overall Study|Lost to Follow-up|1|||
156654626|NCT04104646|565481680|FG001|Overall Study|Lost to Follow-up|0|||
156654627|NCT04104646|565481679|FG000|Overall Study|Physician Decision|2|||
156654628|NCT04104646|565481680|FG001|Overall Study|Physician Decision|0|||
156654629|NCT00319956|565481681|FG000|Overall Study|Death|20|||
156654630|NCT00319956|565481682|FG001|Overall Study|Death|24|||
156654631|NCT02607800|565481683|FG000|Overall Study|Lost to Follow-up|7|||
156654632|NCT02607800|565481684|FG001|Overall Study|Lost to Follow-up|10|||
156654633|NCT02607800|565481683|FG000|Overall Study|Withdrew Consent|2|||
156654634|NCT02607800|565481684|FG001|Overall Study|Withdrew Consent|0|||
156654635|NCT02607800|565481683|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
156654636|NCT02607800|565481684|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
156654637|NCT00753714|565481685|FG000|Overall Study|Lack of Efficacy|21|||
156654638|NCT00753714|565481686|FG001|Overall Study|Lack of Efficacy|34|||
156654639|NCT00753714|565481685|FG000|Overall Study|Adverse Event|26|||
156654640|NCT00753714|565481686|FG001|Overall Study|Adverse Event|18|||
156654641|NCT00753714|565481685|FG000|Overall Study|Protocol Violation|1|||
156761738|NCT01294423|565879874|FG002|Overall Study|poor/non-compliance|1|||
156761739|NCT01241279|565879875|FG000|Overall Study|Lost to Follow-up|0|||
156761740|NCT01241279|565879876|FG001|Overall Study|Lost to Follow-up|1|||
156761741|NCT00705757|565879879|FG000|Overall Study|Lack of Efficacy|5|||
156761742|NCT00705757|565879880|FG001|Overall Study|Lack of Efficacy|1|||
156761743|NCT00705757|565879881|FG002|Overall Study|Lack of Efficacy|3|||
156761744|NCT00705757|565879879|FG000|Overall Study|Lost to Follow-up|7|||
156761745|NCT00705757|565879880|FG001|Overall Study|Lost to Follow-up|6|||
156761746|NCT00705757|565879881|FG002|Overall Study|Lost to Follow-up|6|||
156761747|NCT00705757|565879879|FG000|Overall Study|Withdrawal by Subject|1|||
156761748|NCT00705757|565879880|FG001|Overall Study|Withdrawal by Subject|1|||
156761749|NCT00705757|565879881|FG002|Overall Study|Withdrawal by Subject|2|||
156761750|NCT04742673|565879882|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
156761751|NCT04742673|565879883|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
156761752|NCT04073303|565879888|FG000|Overall Study|Adverse Event|0|||
156761753|NCT04073303|565879889|FG001|Overall Study|Adverse Event|2|||
156761754|NCT04073303|565879888|FG000|Overall Study|Withdrawal by Subject|16|||
156761755|NCT04073303|565879889|FG001|Overall Study|Withdrawal by Subject|36|||
156761756|NCT04073303|565879888|FG000|Overall Study|Lost to Follow-up|6|||
156761757|NCT04073303|565879889|FG001|Overall Study|Lost to Follow-up|1|||
156761758|NCT04073303|565879888|FG000|Overall Study|Protocol Deviation|0|||
156761759|NCT04073303|565879889|FG001|Overall Study|Protocol Deviation|4|||
156761760|NCT04073303|565879888|FG000|Overall Study|Other|1|||
156761761|NCT04073303|565879889|FG001|Overall Study|Other|1|||
156761762|NCT01158261|565879895|FG000|Overall Study|Lost to Follow-up|9|||
156761763|NCT01158261|565879895|FG000|Overall Study|Death|7|||
156761764|NCT01158261|565879895|FG000|Overall Study|Withdrawal by Subject|1|||
156761765|NCT05227118|565879896|FG000|Overall Study|Adverse Event|0|||
156761766|NCT05227118|565879897|FG001|Overall Study|Adverse Event|0|||
156761767|NCT05227118|565879898|FG002|Overall Study|Adverse Event|1|||
156761768|NCT05227118|565879899|FG003|Overall Study|Adverse Event|0|||
156761769|NCT05227118|565879896|FG000|Overall Study|Withdrawal by Subject|0|||
156761770|NCT05227118|565879897|FG001|Overall Study|Withdrawal by Subject|0|||
156761771|NCT05227118|565879898|FG002|Overall Study|Withdrawal by Subject|2|||
156761772|NCT05227118|565879899|FG003|Overall Study|Withdrawal by Subject|0|||
156318969|NCT01479985|564267768|FG000|Overall Study|No decisional conflict scale responses|0|||
156318970|NCT01479985|564267769|FG001|Overall Study|No decisional conflict scale responses|2|||
156420085|NCT04955626|564630205|FG024|Blinded Period|Medication error|0|||
156420086|NCT04955626|564630206|FG025|Blinded Period|Medication error|0|||
156420087|NCT04955626|564630207|FG026|Blinded Period|Medication error|0|||
156420088|NCT04955626|564630208|FG027|Blinded Period|Medication error|0|||
156420089|NCT04955626|564630209|FG028|Blinded Period|Medication error|4|||
156420090|NCT04955626|564630210|FG029|Blinded Period|Medication error|0|||
156420091|NCT04955626|564630211|FG030|Blinded Period|Medication error|0|||
156420092|NCT04955626|564630212|FG031|Blinded Period|Medication error|0|||
156420093|NCT04955626|564630213|FG032|Blinded Period|Medication error|0|||
156420094|NCT04955626|564630214|FG033|Blinded Period|Medication error|0|||
156420095|NCT04955626|564630215|FG034|Blinded Period|Medication error|0|||
156420096|NCT04955626|564630216|FG035|Blinded Period|Medication error|0|||
156420097|NCT04955626|564630181|FG000|Open-Label Period|Lost to Follow-up|109|||
156761773|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
156761774|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
156318971|NCT01479985|564267768|FG000|Overall Study|No post-visit survey|5|||
156318972|NCT01479985|564267769|FG001|Overall Study|No post-visit survey|3|||
156318973|NCT01117792|564267770|FG000|Overall Study|Death|1|||
156318974|NCT01117792|564267770|FG000|Overall Study|Adverse Event|3|||
156318975|NCT01721577|564267771|FG000|Overall Study|Lack of Efficacy|1|||
156318976|NCT01721577|564267772|FG001|Overall Study|Lack of Efficacy|0|||
156318977|NCT01721577|564267771|FG000|Overall Study|Death|1|||
156318978|NCT01721577|564267772|FG001|Overall Study|Death|0|||
156318979|NCT01721577|564267771|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
156318980|NCT01721577|564267772|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
156318981|NCT01721577|564267771|FG000|Overall Study|Adverse Event|0|||
156318982|NCT01721577|564267772|FG001|Overall Study|Adverse Event|2|||
156420098|NCT04955626|564630182|FG001|Open-Label Period|Lost to Follow-up|41|||
156420099|NCT04955626|564630183|FG002|Open-Label Period|Lost to Follow-up|0|||
156420100|NCT04955626|564630184|FG003|Open-Label Period|Lost to Follow-up|0|||
156420101|NCT04955626|564630185|FG004|Open-Label Period|Lost to Follow-up|0|||
156420102|NCT04955626|564630186|FG005|Open-Label Period|Lost to Follow-up|0|||
156420103|NCT04955626|564630187|FG006|Open-Label Period|Lost to Follow-up|0|||
156420104|NCT04955626|564630188|FG007|Open-Label Period|Lost to Follow-up|0|||
156420105|NCT04955626|564630189|FG008|Open-Label Period|Lost to Follow-up|0|||
156420106|NCT04955626|564630190|FG009|Open-Label Period|Lost to Follow-up|0|||
156420107|NCT04955626|564630191|FG010|Open-Label Period|Lost to Follow-up|0|||
156420108|NCT04955626|564630192|FG011|Open-Label Period|Lost to Follow-up|0|||
156761775|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
156761776|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
156420109|NCT04955626|564630193|FG012|Open-Label Period|Lost to Follow-up|0|||
156420110|NCT04955626|564630194|FG013|Open-Label Period|Lost to Follow-up|0|||
156420111|NCT04955626|564630195|FG014|Open-Label Period|Lost to Follow-up|0|||
156420112|NCT04955626|564630196|FG015|Open-Label Period|Lost to Follow-up|0|||
156420113|NCT04955626|564630197|FG016|Open-Label Period|Lost to Follow-up|0|||
156420114|NCT04955626|564630198|FG017|Open-Label Period|Lost to Follow-up|0|||
156420115|NCT04955626|564630199|FG018|Open-Label Period|Lost to Follow-up|0|||
156420116|NCT04955626|564630200|FG019|Open-Label Period|Lost to Follow-up|0|||
156420117|NCT04955626|564630201|FG020|Open-Label Period|Lost to Follow-up|0|||
156420118|NCT04955626|564630202|FG021|Open-Label Period|Lost to Follow-up|0|||
156420119|NCT04955626|564630203|FG022|Open-Label Period|Lost to Follow-up|0|||
156420120|NCT04955626|564630204|FG023|Open-Label Period|Lost to Follow-up|0|||
156420121|NCT04955626|564630205|FG024|Open-Label Period|Lost to Follow-up|0|||
156420122|NCT04955626|564630206|FG025|Open-Label Period|Lost to Follow-up|0|||
156420123|NCT04955626|564630207|FG026|Open-Label Period|Lost to Follow-up|0|||
156420124|NCT04955626|564630208|FG027|Open-Label Period|Lost to Follow-up|0|||
156420125|NCT04955626|564630209|FG028|Open-Label Period|Lost to Follow-up|0|||
156420126|NCT04955626|564630210|FG029|Open-Label Period|Lost to Follow-up|0|||
156420127|NCT04955626|564630211|FG030|Open-Label Period|Lost to Follow-up|0|||
156420128|NCT04955626|564630212|FG031|Open-Label Period|Lost to Follow-up|0|||
156420129|NCT04955626|564630213|FG032|Open-Label Period|Lost to Follow-up|0|||
156420130|NCT04955626|564630214|FG033|Open-Label Period|Lost to Follow-up|0|||
156420131|NCT04955626|564630215|FG034|Open-Label Period|Lost to Follow-up|0|||
156420132|NCT04955626|564630216|FG035|Open-Label Period|Lost to Follow-up|0|||
156420133|NCT04955626|564630181|FG000|Open-Label Period|Protocol Violation|377|||
156420134|NCT04955626|564630182|FG001|Open-Label Period|Protocol Violation|48|||
156420135|NCT04955626|564630183|FG002|Open-Label Period|Protocol Violation|0|||
156420136|NCT04955626|564630184|FG003|Open-Label Period|Protocol Violation|0|||
156420137|NCT04955626|564630185|FG004|Open-Label Period|Protocol Violation|0|||
156420138|NCT04955626|564630186|FG005|Open-Label Period|Protocol Violation|0|||
156420139|NCT04955626|564630187|FG006|Open-Label Period|Protocol Violation|0|||
156420140|NCT04955626|564630188|FG007|Open-Label Period|Protocol Violation|0|||
156420141|NCT04955626|564630189|FG008|Open-Label Period|Protocol Violation|0|||
156420142|NCT04955626|564630190|FG009|Open-Label Period|Protocol Violation|0|||
156420143|NCT04955626|564630191|FG010|Open-Label Period|Protocol Violation|0|||
156420144|NCT04955626|564630192|FG011|Open-Label Period|Protocol Violation|0|||
156420145|NCT04955626|564630193|FG012|Open-Label Period|Protocol Violation|0|||
156420146|NCT04955626|564630194|FG013|Open-Label Period|Protocol Violation|0|||
156420147|NCT04955626|564630195|FG014|Open-Label Period|Protocol Violation|0|||
156420148|NCT04955626|564630196|FG015|Open-Label Period|Protocol Violation|0|||
156420149|NCT04955626|564630197|FG016|Open-Label Period|Protocol Violation|0|||
156420150|NCT04955626|564630198|FG017|Open-Label Period|Protocol Violation|0|||
156420151|NCT04955626|564630199|FG018|Open-Label Period|Protocol Violation|0|||
156420152|NCT04955626|564630200|FG019|Open-Label Period|Protocol Violation|0|||
156420153|NCT04955626|564630201|FG020|Open-Label Period|Protocol Violation|0|||
156420154|NCT04955626|564630202|FG021|Open-Label Period|Protocol Violation|0|||
156420155|NCT04955626|564630203|FG022|Open-Label Period|Protocol Violation|0|||
156420156|NCT04955626|564630204|FG023|Open-Label Period|Protocol Violation|0|||
156420157|NCT04955626|564630205|FG024|Open-Label Period|Protocol Violation|0|||
156420158|NCT04955626|564630206|FG025|Open-Label Period|Protocol Violation|0|||
156420159|NCT04955626|564630207|FG026|Open-Label Period|Protocol Violation|0|||
156420160|NCT04955626|564630208|FG027|Open-Label Period|Protocol Violation|0|||
156420161|NCT04955626|564630209|FG028|Open-Label Period|Protocol Violation|0|||
156318983|NCT01673282|564267773|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
156318984|NCT01673282|564267774|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
156318985|NCT01673282|564267773|FG000|Overall Study|Lack of Efficacy|9|||
156318986|NCT01673282|564267774|FG001|Overall Study|Lack of Efficacy|2|||
156318987|NCT01673282|564267773|FG000|Overall Study|Lost to Follow-up|11|||
156318988|NCT01673282|564267774|FG001|Overall Study|Lost to Follow-up|10|||
156318989|NCT01673282|564267773|FG000|Overall Study|Withdrawal by Subject|3|||
156318990|NCT01673282|564267774|FG001|Overall Study|Withdrawal by Subject|3|||
156318991|NCT01673282|564267773|FG000|Overall Study|Other|1|||
156318992|NCT01673282|564267774|FG001|Overall Study|Other|6|||
156420162|NCT04955626|564630210|FG029|Open-Label Period|Protocol Violation|0|||
156420163|NCT04955626|564630211|FG030|Open-Label Period|Protocol Violation|0|||
156420164|NCT04955626|564630212|FG031|Open-Label Period|Protocol Violation|0|||
156420165|NCT04955626|564630213|FG032|Open-Label Period|Protocol Violation|0|||
156420166|NCT04955626|564630214|FG033|Open-Label Period|Protocol Violation|0|||
156420167|NCT04955626|564630215|FG034|Open-Label Period|Protocol Violation|0|||
156420168|NCT04955626|564630216|FG035|Open-Label Period|Protocol Violation|0|||
156420169|NCT04955626|564630181|FG000|Open-Label Period|Death|5|||
156420170|NCT04955626|564630182|FG001|Open-Label Period|Death|5|||
156420171|NCT04955626|564630183|FG002|Open-Label Period|Death|0|||
156420172|NCT04955626|564630184|FG003|Open-Label Period|Death|0|||
156420173|NCT04955626|564630185|FG004|Open-Label Period|Death|0|||
156420174|NCT04955626|564630186|FG005|Open-Label Period|Death|0|||
156420175|NCT04955626|564630187|FG006|Open-Label Period|Death|0|||
156420176|NCT04955626|564630188|FG007|Open-Label Period|Death|0|||
156420177|NCT04955626|564630189|FG008|Open-Label Period|Death|0|||
156420178|NCT04955626|564630190|FG009|Open-Label Period|Death|0|||
156420179|NCT04955626|564630191|FG010|Open-Label Period|Death|0|||
156420180|NCT04955626|564630192|FG011|Open-Label Period|Death|0|||
156420181|NCT04955626|564630193|FG012|Open-Label Period|Death|0|||
156420182|NCT04955626|564630194|FG013|Open-Label Period|Death|0|||
156420183|NCT04955626|564630195|FG014|Open-Label Period|Death|0|||
156420184|NCT04955626|564630196|FG015|Open-Label Period|Death|0|||
156420185|NCT04955626|564630197|FG016|Open-Label Period|Death|0|||
156420186|NCT04955626|564630198|FG017|Open-Label Period|Death|0|||
156420187|NCT04955626|564630199|FG018|Open-Label Period|Death|0|||
156420188|NCT04955626|564630200|FG019|Open-Label Period|Death|0|||
156420189|NCT04955626|564630201|FG020|Open-Label Period|Death|0|||
156420190|NCT04955626|564630202|FG021|Open-Label Period|Death|0|||
156420191|NCT04955626|564630203|FG022|Open-Label Period|Death|0|||
156420192|NCT04955626|564630204|FG023|Open-Label Period|Death|0|||
156420193|NCT04955626|564630205|FG024|Open-Label Period|Death|0|||
156420194|NCT04955626|564630206|FG025|Open-Label Period|Death|0|||
156420195|NCT04955626|564630207|FG026|Open-Label Period|Death|0|||
156420196|NCT04955626|564630208|FG027|Open-Label Period|Death|0|||
156420197|NCT04955626|564630209|FG028|Open-Label Period|Death|0|||
156420198|NCT04955626|564630210|FG029|Open-Label Period|Death|0|||
156420199|NCT04955626|564630211|FG030|Open-Label Period|Death|0|||
156420200|NCT04955626|564630212|FG031|Open-Label Period|Death|0|||
156420201|NCT04955626|564630213|FG032|Open-Label Period|Death|0|||
156420202|NCT04955626|564630214|FG033|Open-Label Period|Death|0|||
156420203|NCT04955626|564630215|FG034|Open-Label Period|Death|0|||
156420204|NCT04955626|564630216|FG035|Open-Label Period|Death|0|||
156318993|NCT00732940|564267783|FG000|Overall Study|Withdrawal by Subject|1|||
156318994|NCT00732940|564267784|FG001|Overall Study|Withdrawal by Subject|2|||
156318995|NCT00732940|564267783|FG000|Overall Study|Adverse Event|0|||
156318996|NCT00732940|564267784|FG001|Overall Study|Adverse Event|1|||
156318997|NCT00732940|564267783|FG000|Overall Study|Lost to Follow-up|1|||
156318998|NCT00732940|564267784|FG001|Overall Study|Lost to Follow-up|0|||
156318999|NCT03562767|564267785|FG000|Overall Study|Physician Decision|2|||
156319000|NCT03562767|564267786|FG001|Overall Study|Physician Decision|0|||
156319001|NCT03562767|564267787|FG002|Overall Study|Physician Decision|0|||
156319002|NCT03562767|564267785|FG000|Overall Study|Logistic Reason|1|||
156319003|NCT03562767|564267786|FG001|Overall Study|Logistic Reason|3|||
156319004|NCT03562767|564267787|FG002|Overall Study|Logistic Reason|0|||
156319005|NCT01589770|564267788|FG000|Overall Study|EGFR <60ml/min|6|||
156319006|NCT01589770|564267789|FG001|Overall Study|EGFR <60ml/min|4|||
156319007|NCT01589770|564267788|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
156319008|NCT01589770|564267789|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
156319009|NCT00938886|564267792|FG000|Overall Study|Death|0|||
156319010|NCT00938886|564267793|FG001|Overall Study|Death|1|||
156319011|NCT00938886|564267792|FG000|Overall Study|Withdrawal by Subject|4|||
156319012|NCT00938886|564267793|FG001|Overall Study|Withdrawal by Subject|7|||
156319013|NCT00938886|564267792|FG000|Overall Study|Lost to Follow-up|3|||
156319014|NCT00938886|564267793|FG001|Overall Study|Lost to Follow-up|2|||
156319015|NCT01120067|564267794|FG000|Overall Study|Lost to Follow-up|3|||
156319016|NCT01120067|564267795|FG001|Overall Study|Lost to Follow-up|1|||
156319017|NCT01120067|564267794|FG000|Overall Study|fail to engage >3 sessions|2|||
156319018|NCT01120067|564267795|FG001|Overall Study|fail to engage >3 sessions|0|||
156319019|NCT00821327|564267796|FG000|Overall Study|Adverse Event|13|||
156319020|NCT00821327|564267796|FG000|Overall Study|Patient Request|1|||
156319021|NCT00821327|564267796|FG000|Overall Study|Investigator Request|2|||
156319022|NCT00821327|564267796|FG000|Overall Study|Sponsor Request|1|||
156319023|NCT00821327|564267796|FG000|Overall Study|Disease Progression|13|||
156319024|NCT00821327|564267796|FG000|Overall Study|Other/Unknown|5|||
156319025|NCT00989573|564267797|FG000|Overall Study|Adverse Event|8|||
156420205|NCT04955626|564630181|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
156420206|NCT04955626|564630182|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
156319026|NCT00989573|564267798|FG001|Overall Study|Adverse Event|12|||
156319027|NCT00989573|564267799|FG002|Overall Study|Adverse Event|4|||
156420207|NCT04955626|564630183|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
156420208|NCT04955626|564630184|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
156420209|NCT04955626|564630185|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
156420210|NCT04955626|564630186|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
156420211|NCT04955626|564630187|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
156420212|NCT04955626|564630188|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
156420213|NCT04955626|564630189|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
156420214|NCT04955626|564630190|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
156420215|NCT04955626|564630191|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
156319028|NCT00989573|564267797|FG000|Overall Study|Physician Decision|0|||
156319029|NCT00989573|564267798|FG001|Overall Study|Physician Decision|2|||
156319030|NCT00989573|564267799|FG002|Overall Study|Physician Decision|0|||
156319031|NCT00989573|564267797|FG000|Overall Study|Protocol Violation|1|||
156420216|NCT04955626|564630192|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
156319032|NCT00989573|564267798|FG001|Overall Study|Protocol Violation|1|||
156420217|NCT04955626|564630193|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
156420218|NCT04955626|564630194|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
156420219|NCT04955626|564630195|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
156420220|NCT04955626|564630196|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
156420221|NCT04955626|564630197|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
156420222|NCT04955626|564630198|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
156420223|NCT04955626|564630199|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
156420224|NCT04955626|564630200|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
156420225|NCT04955626|564630201|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
156420226|NCT04955626|564630202|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
156420227|NCT04955626|564630203|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
156420228|NCT04955626|564630204|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
156420229|NCT04955626|564630205|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
156420230|NCT04955626|564630206|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
156420231|NCT04955626|564630207|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
156420232|NCT04955626|564630208|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
156420233|NCT04955626|564630209|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
156420234|NCT04955626|564630210|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
156420235|NCT04955626|564630211|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
156420236|NCT04955626|564630212|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
156420237|NCT04955626|564630213|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
156420238|NCT04955626|564630214|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
156420239|NCT04955626|564630215|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
156420240|NCT04955626|564630216|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
156420241|NCT04955626|564630181|FG000|Open-Label Period|Other|621|||
156420242|NCT04955626|564630182|FG001|Open-Label Period|Other|429|||
156420243|NCT04955626|564630183|FG002|Open-Label Period|Other|0|||
156420244|NCT04955626|564630184|FG003|Open-Label Period|Other|0|||
156420245|NCT04955626|564630185|FG004|Open-Label Period|Other|0|||
156420246|NCT04955626|564630186|FG005|Open-Label Period|Other|0|||
156420247|NCT04955626|564630187|FG006|Open-Label Period|Other|0|||
156420248|NCT04955626|564630188|FG007|Open-Label Period|Other|0|||
156420249|NCT04955626|564630189|FG008|Open-Label Period|Other|0|||
156420250|NCT04955626|564630190|FG009|Open-Label Period|Other|0|||
156319033|NCT00989573|564267799|FG002|Overall Study|Protocol Violation|1|||
156319034|NCT00989573|564267797|FG000|Overall Study|Withdrawal by Subject|4|||
156319035|NCT00989573|564267798|FG001|Overall Study|Withdrawal by Subject|7|||
156319036|NCT00989573|564267799|FG002|Overall Study|Withdrawal by Subject|3|||
156319037|NCT02216812|564267802|FG000|Overall Study|Lost to Follow-up|10|||
156319038|NCT02216812|564267803|FG001|Overall Study|Lost to Follow-up|5|||
156319039|NCT00527488|564267808|FG000|Overall Study|Withdrawn prior to dosing|0|||
156319040|NCT00527488|564267809|FG001|Overall Study|Withdrawn prior to dosing|1|||
156319041|NCT00527488|564267810|FG002|Overall Study|Withdrawn prior to dosing|1|||
156319042|NCT00527488|564267811|FG003|Overall Study|Withdrawn prior to dosing|0|||
156319043|NCT01958827|564267812|FG000|Overall Study|Adverse Event|3|||
156319044|NCT01958827|564267812|FG000|Overall Study|Lack of Efficacy|6|||
156319045|NCT01958827|564267812|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
156319046|NCT03036800|564267813|FG000|Overall Study|Protocol Violation|1|||
156319047|NCT03036800|564267814|FG001|Overall Study|Protocol Violation|0|||
156319048|NCT03036800|564267813|FG000|Overall Study|Non-compliance|1|||
156319049|NCT03036800|564267814|FG001|Overall Study|Non-compliance|0|||
156319050|NCT03036800|564267813|FG000|Overall Study|Lost to Follow-up|1|||
156319051|NCT03036800|564267814|FG001|Overall Study|Lost to Follow-up|0|||
156319052|NCT03036800|564267813|FG000|Overall Study|Death|1|||
156319053|NCT03036800|564267814|FG001|Overall Study|Death|0|||
156319054|NCT03036800|564267813|FG000|Overall Study|Tolerance|5|||
156319055|NCT03036800|564267814|FG001|Overall Study|Tolerance|0|||
156319056|NCT03036800|564267813|FG000|Overall Study|Unknown/no reason given|50|||
156319057|NCT03036800|564267814|FG001|Overall Study|Unknown/no reason given|39|||
156319058|NCT01986933|564267815|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
156319059|NCT01986933|564267816|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
156319060|NCT01986933|564267817|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
156319061|NCT01986933|564267818|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
156319062|NCT01986933|564267819|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
156319063|NCT01986933|564267815|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
156319064|NCT01986933|564267816|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
156319065|NCT01986933|564267817|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
156319066|NCT01986933|564267818|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
156420251|NCT04955626|564630191|FG010|Open-Label Period|Other|0|||
156420252|NCT04955626|564630192|FG011|Open-Label Period|Other|0|||
156420253|NCT04955626|564630193|FG012|Open-Label Period|Other|0|||
156420254|NCT04955626|564630194|FG013|Open-Label Period|Other|0|||
156420255|NCT04955626|564630195|FG014|Open-Label Period|Other|0|||
156319067|NCT01986933|564267819|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
156420256|NCT04955626|564630196|FG015|Open-Label Period|Other|0|||
156420257|NCT04955626|564630197|FG016|Open-Label Period|Other|0|||
156420258|NCT04955626|564630198|FG017|Open-Label Period|Other|0|||
156420259|NCT04955626|564630199|FG018|Open-Label Period|Other|0|||
156420260|NCT04955626|564630200|FG019|Open-Label Period|Other|0|||
156420261|NCT04955626|564630201|FG020|Open-Label Period|Other|0|||
156420262|NCT04955626|564630202|FG021|Open-Label Period|Other|0|||
156420263|NCT04955626|564630203|FG022|Open-Label Period|Other|0|||
156420264|NCT04955626|564630204|FG023|Open-Label Period|Other|0|||
156420265|NCT04955626|564630205|FG024|Open-Label Period|Other|0|||
156420266|NCT04955626|564630206|FG025|Open-Label Period|Other|0|||
156420267|NCT04955626|564630207|FG026|Open-Label Period|Other|0|||
156420268|NCT04955626|564630208|FG027|Open-Label Period|Other|0|||
156420269|NCT04955626|564630209|FG028|Open-Label Period|Other|0|||
156420270|NCT04955626|564630210|FG029|Open-Label Period|Other|0|||
156420271|NCT04955626|564630211|FG030|Open-Label Period|Other|0|||
156420272|NCT04955626|564630212|FG031|Open-Label Period|Other|0|||
156420273|NCT04955626|564630213|FG032|Open-Label Period|Other|0|||
156420274|NCT04955626|564630214|FG033|Open-Label Period|Other|0|||
156420275|NCT04955626|564630215|FG034|Open-Label Period|Other|0|||
156420276|NCT04955626|564630216|FG035|Open-Label Period|Other|0|||
156420277|NCT04955626|564630181|FG000|Open-Label Period|Physician Decision|2|||
156420278|NCT04955626|564630182|FG001|Open-Label Period|Physician Decision|0|||
156420279|NCT04955626|564630183|FG002|Open-Label Period|Physician Decision|0|||
156420280|NCT04955626|564630184|FG003|Open-Label Period|Physician Decision|0|||
156420281|NCT04955626|564630185|FG004|Open-Label Period|Physician Decision|0|||
156420282|NCT04955626|564630186|FG005|Open-Label Period|Physician Decision|0|||
156420283|NCT04955626|564630187|FG006|Open-Label Period|Physician Decision|0|||
156420284|NCT04955626|564630188|FG007|Open-Label Period|Physician Decision|0|||
156420285|NCT04955626|564630189|FG008|Open-Label Period|Physician Decision|0|||
156420286|NCT04955626|564630190|FG009|Open-Label Period|Physician Decision|0|||
156420287|NCT04955626|564630191|FG010|Open-Label Period|Physician Decision|0|||
156420288|NCT04955626|564630192|FG011|Open-Label Period|Physician Decision|0|||
156420289|NCT04955626|564630193|FG012|Open-Label Period|Physician Decision|0|||
156420290|NCT04955626|564630194|FG013|Open-Label Period|Physician Decision|0|||
156420291|NCT04955626|564630195|FG014|Open-Label Period|Physician Decision|0|||
156420292|NCT04955626|564630196|FG015|Open-Label Period|Physician Decision|0|||
156420293|NCT04955626|564630197|FG016|Open-Label Period|Physician Decision|0|||
156420294|NCT04955626|564630198|FG017|Open-Label Period|Physician Decision|0|||
156420295|NCT04955626|564630199|FG018|Open-Label Period|Physician Decision|0|||
156420296|NCT04955626|564630200|FG019|Open-Label Period|Physician Decision|0|||
156420297|NCT04955626|564630201|FG020|Open-Label Period|Physician Decision|0|||
156420298|NCT04955626|564630202|FG021|Open-Label Period|Physician Decision|0|||
156420299|NCT04955626|564630203|FG022|Open-Label Period|Physician Decision|0|||
156420300|NCT04955626|564630204|FG023|Open-Label Period|Physician Decision|0|||
156420301|NCT04955626|564630205|FG024|Open-Label Period|Physician Decision|0|||
156420302|NCT04955626|564630206|FG025|Open-Label Period|Physician Decision|0|||
156420303|NCT04955626|564630207|FG026|Open-Label Period|Physician Decision|0|||
156420304|NCT04955626|564630208|FG027|Open-Label Period|Physician Decision|0|||
156420305|NCT04955626|564630209|FG028|Open-Label Period|Physician Decision|0|||
156420306|NCT04955626|564630210|FG029|Open-Label Period|Physician Decision|0|||
156420307|NCT04955626|564630211|FG030|Open-Label Period|Physician Decision|0|||
156420308|NCT04955626|564630212|FG031|Open-Label Period|Physician Decision|0|||
156420309|NCT04955626|564630213|FG032|Open-Label Period|Physician Decision|0|||
156420310|NCT04955626|564630214|FG033|Open-Label Period|Physician Decision|0|||
156420311|NCT04955626|564630215|FG034|Open-Label Period|Physician Decision|0|||
156420312|NCT04955626|564630216|FG035|Open-Label Period|Physician Decision|0|||
156420313|NCT04955626|564630181|FG000|Open-Label Period|Withdrawal by Subject|135|||
156420314|NCT04955626|564630182|FG001|Open-Label Period|Withdrawal by Subject|25|||
156420315|NCT04955626|564630183|FG002|Open-Label Period|Withdrawal by Subject|0|||
156420316|NCT04955626|564630184|FG003|Open-Label Period|Withdrawal by Subject|0|||
156420317|NCT04955626|564630185|FG004|Open-Label Period|Withdrawal by Subject|0|||
156420318|NCT04955626|564630186|FG005|Open-Label Period|Withdrawal by Subject|0|||
156420319|NCT04955626|564630187|FG006|Open-Label Period|Withdrawal by Subject|0|||
156420320|NCT04955626|564630188|FG007|Open-Label Period|Withdrawal by Subject|0|||
156420321|NCT04955626|564630189|FG008|Open-Label Period|Withdrawal by Subject|0|||
156420322|NCT04955626|564630190|FG009|Open-Label Period|Withdrawal by Subject|0|||
156420323|NCT04955626|564630191|FG010|Open-Label Period|Withdrawal by Subject|0|||
156420324|NCT04955626|564630192|FG011|Open-Label Period|Withdrawal by Subject|0|||
156420325|NCT04955626|564630193|FG012|Open-Label Period|Withdrawal by Subject|0|||
156420326|NCT04955626|564630194|FG013|Open-Label Period|Withdrawal by Subject|0|||
156420327|NCT04955626|564630195|FG014|Open-Label Period|Withdrawal by Subject|0|||
156420328|NCT04955626|564630196|FG015|Open-Label Period|Withdrawal by Subject|0|||
156420329|NCT04955626|564630197|FG016|Open-Label Period|Withdrawal by Subject|0|||
156420330|NCT04955626|564630198|FG017|Open-Label Period|Withdrawal by Subject|0|||
156420331|NCT04955626|564630199|FG018|Open-Label Period|Withdrawal by Subject|0|||
156420332|NCT04955626|564630200|FG019|Open-Label Period|Withdrawal by Subject|0|||
156420333|NCT04955626|564630201|FG020|Open-Label Period|Withdrawal by Subject|0|||
156761777|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
156761778|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
156761779|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
156761780|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761781|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761782|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761783|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761784|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761785|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
156761786|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761787|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761788|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761789|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761790|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761791|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
156761792|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761793|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761794|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761795|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761796|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761797|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
156761798|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761799|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156319068|NCT01986933|564267815|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
156319069|NCT01986933|564267816|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
156319070|NCT01986933|564267817|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
156319071|NCT01986933|564267818|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
156319072|NCT01986933|564267819|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
156319073|NCT01986933|564267815|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
156319074|NCT01986933|564267816|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
156319075|NCT01986933|564267817|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
156319076|NCT01986933|564267818|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
156319077|NCT01986933|564267819|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
156319078|NCT01986933|564267815|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
156319079|NCT01986933|564267816|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
156319080|NCT01986933|564267817|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
156319081|NCT01986933|564267818|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
156319082|NCT01986933|564267819|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
156319083|NCT01986933|564267815|FG000|Active-to-active (Part B)|Adverse Event|0|||
156319084|NCT01986933|564267816|FG001|Active-to-active (Part B)|Adverse Event|2|||
156319085|NCT01986933|564267817|FG002|Active-to-active (Part B)|Adverse Event|0|||
156319086|NCT01986933|564267818|FG003|Active-to-active (Part B)|Adverse Event|1|||
156319087|NCT01986933|564267819|FG004|Active-to-active (Part B)|Adverse Event|3|||
156319088|NCT01986933|564267815|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
156319089|NCT01986933|564267816|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
156319090|NCT01986933|564267817|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
156319091|NCT01986933|564267818|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
156319092|NCT01986933|564267819|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
156319093|NCT01986933|564267815|FG000|Active-to-active (Part B)|Pregnancy|0|||
156319094|NCT01986933|564267816|FG001|Active-to-active (Part B)|Pregnancy|0|||
156319095|NCT01986933|564267817|FG002|Active-to-active (Part B)|Pregnancy|0|||
156319096|NCT01986933|564267818|FG003|Active-to-active (Part B)|Pregnancy|0|||
156319097|NCT01986933|564267819|FG004|Active-to-active (Part B)|Pregnancy|1|||
156319098|NCT01986933|564267815|FG000|Active-to-active (Part B)|Physician Decision|0|||
156319099|NCT01986933|564267816|FG001|Active-to-active (Part B)|Physician Decision|0|||
156319100|NCT01986933|564267817|FG002|Active-to-active (Part B)|Physician Decision|1|||
156319101|NCT01986933|564267818|FG003|Active-to-active (Part B)|Physician Decision|1|||
156319102|NCT01986933|564267819|FG004|Active-to-active (Part B)|Physician Decision|0|||
156319103|NCT01986933|564267815|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
156319104|NCT01986933|564267816|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
156319105|NCT01986933|564267817|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
156319106|NCT01986933|564267818|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
156319107|NCT01986933|564267819|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
156319108|NCT01986933|564267815|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
156319109|NCT01986933|564267816|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
156319110|NCT01986933|564267817|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
156319111|NCT01986933|564267818|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
156319112|NCT01986933|564267819|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
156319113|NCT01986933|564267815|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
156761800|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761801|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761802|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761803|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Other|119|||
156761804|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Other|0|||
156761805|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Other|0|||
156761806|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Other|0|||
156761807|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Other|0|||
156761808|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Other|0|||
156761809|NCT01435759|565879900|FG000|Double-blind Phase|Adverse Event|7|||
156761810|NCT01435759|565879901|FG001|Double-blind Phase|Adverse Event|0|||
156761811|NCT01435759|565879902|FG002|Double-blind Phase|Adverse Event|1|||
156761812|NCT01435759|565879903|FG003|Double-blind Phase|Adverse Event|1|||
156761813|NCT01435759|565879904|FG004|Double-blind Phase|Adverse Event|1|||
156761814|NCT01435759|565879905|FG005|Double-blind Phase|Adverse Event|3|||
156761815|NCT01435759|565879900|FG000|Double-blind Phase|Protocol Violation|2|||
156761816|NCT01435759|565879901|FG001|Double-blind Phase|Protocol Violation|0|||
156761817|NCT01435759|565879902|FG002|Double-blind Phase|Protocol Violation|1|||
156761818|NCT01435759|565879903|FG003|Double-blind Phase|Protocol Violation|2|||
156761819|NCT01435759|565879904|FG004|Double-blind Phase|Protocol Violation|0|||
156761820|NCT01435759|565879905|FG005|Double-blind Phase|Protocol Violation|1|||
156761821|NCT01435759|565879900|FG000|Double-blind Phase|Withdrawal by Subject|17|||
156761822|NCT01435759|565879901|FG001|Double-blind Phase|Withdrawal by Subject|4|||
156761823|NCT01435759|565879902|FG002|Double-blind Phase|Withdrawal by Subject|3|||
156761824|NCT01435759|565879903|FG003|Double-blind Phase|Withdrawal by Subject|4|||
156761825|NCT01435759|565879904|FG004|Double-blind Phase|Withdrawal by Subject|2|||
156761826|NCT01435759|565879905|FG005|Double-blind Phase|Withdrawal by Subject|2|||
156761827|NCT01435759|565879900|FG000|Double-blind Phase|Lost to Follow-up|31|||
156761828|NCT01435759|565879901|FG001|Double-blind Phase|Lost to Follow-up|1|||
156761829|NCT01435759|565879902|FG002|Double-blind Phase|Lost to Follow-up|2|||
156761830|NCT01435759|565879903|FG003|Double-blind Phase|Lost to Follow-up|0|||
156761831|NCT01435759|565879904|FG004|Double-blind Phase|Lost to Follow-up|3|||
156761832|NCT01435759|565879905|FG005|Double-blind Phase|Lost to Follow-up|3|||
156761833|NCT01435759|565879900|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
156761834|NCT01435759|565879901|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761835|NCT01435759|565879902|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761836|NCT01435759|565879903|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761837|NCT01435759|565879904|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
156761838|NCT01435759|565879905|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761839|NCT01435759|565879900|FG000|Double-blind Phase|Other|8|||
156761840|NCT01435759|565879901|FG001|Double-blind Phase|Other|2|||
156761841|NCT01435759|565879902|FG002|Double-blind Phase|Other|0|||
156761842|NCT01435759|565879903|FG003|Double-blind Phase|Other|2|||
156761843|NCT01435759|565879904|FG004|Double-blind Phase|Other|0|||
156761844|NCT01435759|565879905|FG005|Double-blind Phase|Other|0|||
156761845|NCT03727841|565879908|FG000|Overall Study|Physician Decision|3|||
156761846|NCT03727841|565879909|FG001|Overall Study|Physician Decision|1|||
156761847|NCT03126786|565879910|FG000|Overall Study|Adverse Event|3|||
156761848|NCT03126786|565879911|FG001|Overall Study|Adverse Event|0|||
156761849|NCT03126786|565879910|FG000|Overall Study|Lost to Follow-up|0|||
156761850|NCT03126786|565879911|FG001|Overall Study|Lost to Follow-up|1|||
156761851|NCT03126786|565879910|FG000|Overall Study|Withdrawal by Subject|3|||
156761852|NCT03126786|565879911|FG001|Overall Study|Withdrawal by Subject|1|||
156761853|NCT01601496|565879912|FG000|Overall Study|Physician Decision|1|||
156761854|NCT01601496|565879912|FG000|Overall Study|Withdrawal by Subject|1|||
156761855|NCT01601496|565879912|FG000|Overall Study|Lost to Follow-up|6|||
156761856|NCT01601496|565879912|FG000|Overall Study|Death|4|||
156761857|NCT01601496|565879912|FG000|Overall Study|Other: patient refusal to continue|3|||
156761858|NCT03243305|565879913|FG000|Overall Study|Lost to Follow-up|250|||
156761859|NCT03243305|565879913|FG000|Overall Study|Withdrawal by Subject|170|||
156761860|NCT03243305|565879913|FG000|Overall Study|Pregnancy|104|||
156761861|NCT03243305|565879913|FG000|Overall Study|Non-Compliance with Study Drug|38|||
156761862|NCT03243305|565879913|FG000|Overall Study|Adverse Event|23|||
156761863|NCT03243305|565879913|FG000|Overall Study|No sexually active|26|||
156761864|NCT03243305|565879913|FG000|Overall Study|Physician Decision|22|||
156420334|NCT04955626|564630202|FG021|Open-Label Period|Withdrawal by Subject|0|||
156420335|NCT04955626|564630203|FG022|Open-Label Period|Withdrawal by Subject|0|||
156420336|NCT04955626|564630204|FG023|Open-Label Period|Withdrawal by Subject|0|||
156420337|NCT04955626|564630205|FG024|Open-Label Period|Withdrawal by Subject|0|||
156420338|NCT04955626|564630206|FG025|Open-Label Period|Withdrawal by Subject|0|||
156420339|NCT04955626|564630207|FG026|Open-Label Period|Withdrawal by Subject|0|||
156420340|NCT04955626|564630208|FG027|Open-Label Period|Withdrawal by Subject|0|||
156420341|NCT04955626|564630209|FG028|Open-Label Period|Withdrawal by Subject|0|||
156420342|NCT04955626|564630210|FG029|Open-Label Period|Withdrawal by Subject|0|||
156420343|NCT04955626|564630211|FG030|Open-Label Period|Withdrawal by Subject|0|||
156420344|NCT04955626|564630212|FG031|Open-Label Period|Withdrawal by Subject|0|||
156761865|NCT03243305|565879913|FG000|Overall Study|Protocol Violation|22|||
156761866|NCT03243305|565879913|FG000|Overall Study|Study method no longer primary method|12|||
156761867|NCT03243305|565879913|FG000|Overall Study|Study Terminated by Sponsor|1|||
156761868|NCT03243305|565879913|FG000|Overall Study|Early terminations|267|||
156319114|NCT01986933|564267816|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
156319115|NCT01986933|564267817|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
156319116|NCT01986933|564267818|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
156319117|NCT01986933|564267819|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
156319118|NCT01986933|564267815|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
156319119|NCT01986933|564267816|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
156319120|NCT01986933|564267817|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
156319121|NCT01986933|564267818|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
156319122|NCT01986933|564267819|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
156319123|NCT01986933|564267815|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
156319124|NCT01986933|564267816|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
156319125|NCT01986933|564267817|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
156319126|NCT01986933|564267818|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
156319127|NCT01986933|564267819|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
156319128|NCT01986933|564267815|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
156319129|NCT01986933|564267816|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
156319130|NCT01986933|564267817|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
156319131|NCT01986933|564267818|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
156319132|NCT01986933|564267819|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
156319133|NCT01986933|564267815|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
156319134|NCT01986933|564267816|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
156319135|NCT01986933|564267817|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
156319136|NCT01986933|564267818|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
156319137|NCT01986933|564267819|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
156319138|NCT01986933|564267815|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
156319139|NCT01986933|564267816|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
156319140|NCT01986933|564267817|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
156319141|NCT01986933|564267818|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
156319142|NCT01986933|564267819|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
156319143|NCT01077154|564267820|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
156319144|NCT01077154|564267821|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
156319145|NCT01077154|564267820|FG000|Overall Study|Withdrawal by Subject|369|||
156319146|NCT01077154|564267821|FG001|Overall Study|Withdrawal by Subject|385|||
156319147|NCT01077154|564267820|FG000|Overall Study|Death|215|||
156319148|NCT01077154|564267821|FG001|Overall Study|Death|214|||
156319149|NCT01077154|564267820|FG000|Overall Study|Lost to Follow-up|43|||
156319150|NCT01077154|564267821|FG001|Overall Study|Lost to Follow-up|35|||
156319151|NCT01077154|564267820|FG000|Overall Study|Noncompliance|22|||
156319152|NCT01077154|564267821|FG001|Overall Study|Noncompliance|20|||
156319153|NCT01077154|564267820|FG000|Overall Study|Disease Progression|18|||
156319154|NCT01077154|564267821|FG001|Overall Study|Disease Progression|20|||
156319155|NCT01077154|564267820|FG000|Overall Study|Ineligibility Determined|10|||
156319156|NCT01077154|564267821|FG001|Overall Study|Ineligibility Determined|14|||
156319157|NCT01077154|564267820|FG000|Overall Study|Other|14|||
156319158|NCT01077154|564267821|FG001|Overall Study|Other|11|||
156319159|NCT01077154|564267820|FG000|Overall Study|Adverse Event|9|||
156319160|NCT01077154|564267821|FG001|Overall Study|Adverse Event|9|||
156319161|NCT01077154|564267820|FG000|Overall Study|Administrative Decision|1|||
156319162|NCT01077154|564267821|FG001|Overall Study|Administrative Decision|6|||
156319163|NCT01077154|564267820|FG000|Overall Study|Protocol Deviation|1|||
156319164|NCT01077154|564267821|FG001|Overall Study|Protocol Deviation|0|||
156319165|NCT04030026|564267822|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
156319166|NCT04030026|564267823|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
156319167|NCT04030026|564267822|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
156319168|NCT04030026|564267823|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
156319169|NCT04030026|564267822|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
156319170|NCT04030026|564267823|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
156319171|NCT04030026|564267822|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
156319172|NCT04030026|564267823|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
156319173|NCT04030026|564267822|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
156319174|NCT04030026|564267823|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
156319175|NCT04030026|564267822|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
156319176|NCT04030026|564267823|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
156319177|NCT04030026|564267822|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
156319178|NCT04030026|564267823|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
156319179|NCT02207946|564267824|FG000|Overall Study|Lost to Follow-up|1|||
156319180|NCT02207946|564267825|FG001|Overall Study|Lost to Follow-up|0|||
156319181|NCT02207946|564267824|FG000|Overall Study|Adverse Event|0|||
156420345|NCT04955626|564630213|FG032|Open-Label Period|Withdrawal by Subject|0|||
156420346|NCT04955626|564630214|FG033|Open-Label Period|Withdrawal by Subject|0|||
156420347|NCT04955626|564630215|FG034|Open-Label Period|Withdrawal by Subject|0|||
156420348|NCT04955626|564630216|FG035|Open-Label Period|Withdrawal by Subject|0|||
156420349|NCT04955626|564630181|FG000|Open-Label Period|Refused further study procedures|1|||
156420350|NCT04955626|564630182|FG001|Open-Label Period|Refused further study procedures|0|||
156420351|NCT04955626|564630183|FG002|Open-Label Period|Refused further study procedures|0|||
156420352|NCT04955626|564630184|FG003|Open-Label Period|Refused further study procedures|0|||
156420353|NCT04955626|564630185|FG004|Open-Label Period|Refused further study procedures|0|||
156420354|NCT04955626|564630186|FG005|Open-Label Period|Refused further study procedures|0|||
156420355|NCT04955626|564630187|FG006|Open-Label Period|Refused further study procedures|0|||
156420356|NCT04955626|564630188|FG007|Open-Label Period|Refused further study procedures|0|||
156420357|NCT04955626|564630189|FG008|Open-Label Period|Refused further study procedures|0|||
156420358|NCT04955626|564630190|FG009|Open-Label Period|Refused further study procedures|0|||
156420359|NCT04955626|564630191|FG010|Open-Label Period|Refused further study procedures|0|||
156420360|NCT04955626|564630192|FG011|Open-Label Period|Refused further study procedures|0|||
156420361|NCT04955626|564630193|FG012|Open-Label Period|Refused further study procedures|0|||
156420362|NCT04955626|564630194|FG013|Open-Label Period|Refused further study procedures|0|||
156420363|NCT04955626|564630195|FG014|Open-Label Period|Refused further study procedures|0|||
156420364|NCT04955626|564630196|FG015|Open-Label Period|Refused further study procedures|0|||
156420365|NCT04955626|564630197|FG016|Open-Label Period|Refused further study procedures|0|||
156420366|NCT04955626|564630198|FG017|Open-Label Period|Refused further study procedures|0|||
156420367|NCT04955626|564630199|FG018|Open-Label Period|Refused further study procedures|0|||
156420368|NCT04955626|564630200|FG019|Open-Label Period|Refused further study procedures|0|||
156420369|NCT04955626|564630201|FG020|Open-Label Period|Refused further study procedures|0|||
156420370|NCT04955626|564630202|FG021|Open-Label Period|Refused further study procedures|0|||
156420371|NCT04955626|564630203|FG022|Open-Label Period|Refused further study procedures|0|||
156420372|NCT04955626|564630204|FG023|Open-Label Period|Refused further study procedures|0|||
156420373|NCT04955626|564630205|FG024|Open-Label Period|Refused further study procedures|0|||
156420374|NCT04955626|564630206|FG025|Open-Label Period|Refused further study procedures|0|||
156420375|NCT04955626|564630207|FG026|Open-Label Period|Refused further study procedures|0|||
156420376|NCT04955626|564630208|FG027|Open-Label Period|Refused further study procedures|0|||
156420377|NCT04955626|564630209|FG028|Open-Label Period|Refused further study procedures|0|||
156420378|NCT04955626|564630210|FG029|Open-Label Period|Refused further study procedures|0|||
156420379|NCT04955626|564630211|FG030|Open-Label Period|Refused further study procedures|0|||
156420380|NCT04955626|564630212|FG031|Open-Label Period|Refused further study procedures|0|||
156420381|NCT04955626|564630213|FG032|Open-Label Period|Refused further study procedures|0|||
156420382|NCT04955626|564630214|FG033|Open-Label Period|Refused further study procedures|0|||
156420383|NCT04955626|564630215|FG034|Open-Label Period|Refused further study procedures|0|||
156420384|NCT04955626|564630216|FG035|Open-Label Period|Refused further study procedures|0|||
156420385|NCT04955626|564630181|FG000|Open-Label Period|Adverse Event|1|||
156420386|NCT04955626|564630182|FG001|Open-Label Period|Adverse Event|0|||
156420387|NCT04955626|564630183|FG002|Open-Label Period|Adverse Event|0|||
156420388|NCT04955626|564630184|FG003|Open-Label Period|Adverse Event|0|||
156420389|NCT04955626|564630185|FG004|Open-Label Period|Adverse Event|0|||
156420390|NCT04955626|564630186|FG005|Open-Label Period|Adverse Event|0|||
156420391|NCT04955626|564630187|FG006|Open-Label Period|Adverse Event|0|||
156420392|NCT04955626|564630188|FG007|Open-Label Period|Adverse Event|0|||
156420393|NCT04955626|564630189|FG008|Open-Label Period|Adverse Event|0|||
156420394|NCT04955626|564630190|FG009|Open-Label Period|Adverse Event|0|||
156420395|NCT04955626|564630191|FG010|Open-Label Period|Adverse Event|0|||
156420396|NCT04955626|564630192|FG011|Open-Label Period|Adverse Event|0|||
156420397|NCT04955626|564630193|FG012|Open-Label Period|Adverse Event|0|||
156420398|NCT04955626|564630194|FG013|Open-Label Period|Adverse Event|0|||
156420399|NCT04955626|564630195|FG014|Open-Label Period|Adverse Event|0|||
156420400|NCT04955626|564630196|FG015|Open-Label Period|Adverse Event|0|||
156420401|NCT04955626|564630197|FG016|Open-Label Period|Adverse Event|0|||
156420402|NCT04955626|564630198|FG017|Open-Label Period|Adverse Event|0|||
156420403|NCT04955626|564630199|FG018|Open-Label Period|Adverse Event|0|||
156420404|NCT04955626|564630200|FG019|Open-Label Period|Adverse Event|0|||
156420405|NCT04955626|564630201|FG020|Open-Label Period|Adverse Event|0|||
156420406|NCT04955626|564630202|FG021|Open-Label Period|Adverse Event|0|||
156420407|NCT04955626|564630203|FG022|Open-Label Period|Adverse Event|0|||
156420408|NCT04955626|564630204|FG023|Open-Label Period|Adverse Event|0|||
156420409|NCT04955626|564630205|FG024|Open-Label Period|Adverse Event|0|||
156420410|NCT04955626|564630206|FG025|Open-Label Period|Adverse Event|0|||
156420411|NCT04955626|564630207|FG026|Open-Label Period|Adverse Event|0|||
156420412|NCT04955626|564630208|FG027|Open-Label Period|Adverse Event|0|||
156420413|NCT04955626|564630209|FG028|Open-Label Period|Adverse Event|0|||
156420414|NCT04955626|564630210|FG029|Open-Label Period|Adverse Event|0|||
156420415|NCT04955626|564630211|FG030|Open-Label Period|Adverse Event|0|||
156420416|NCT04955626|564630212|FG031|Open-Label Period|Adverse Event|0|||
156420417|NCT04955626|564630213|FG032|Open-Label Period|Adverse Event|0|||
156420418|NCT04955626|564630214|FG033|Open-Label Period|Adverse Event|0|||
156420419|NCT04955626|564630215|FG034|Open-Label Period|Adverse Event|0|||
156420420|NCT04955626|564630216|FG035|Open-Label Period|Adverse Event|0|||
156420421|NCT04955626|564630181|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
156420422|NCT04955626|564630182|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
156420423|NCT04955626|564630183|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
156420424|NCT04955626|564630184|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
156420425|NCT04955626|564630185|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
156420426|NCT04955626|564630186|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
156420427|NCT04955626|564630187|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
156420428|NCT04955626|564630188|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
156420429|NCT04955626|564630189|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
156420430|NCT04955626|564630190|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
156420431|NCT04955626|564630191|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
156420432|NCT04955626|564630192|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
156761869|NCT02689804|565879914|FG000|Overall Study|Withdrawal by Subject|2|||
156761870|NCT02689804|565879915|FG001|Overall Study|Withdrawal by Subject|0|||
156761871|NCT00227539|565879916|FG000|Overall Study|Protocol Violation|1|||
156761872|NCT02782741|565879919|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
156761873|NCT02782741|565879920|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
156761874|NCT02782741|565879921|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
156319182|NCT02207946|564267825|FG001|Overall Study|Adverse Event|1|||
156761875|NCT02782741|565879919|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
156761876|NCT02782741|565879920|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
156761877|NCT02782741|565879921|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
156761878|NCT02782741|565879919|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
156761879|NCT02782741|565879920|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
156761880|NCT02782741|565879921|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
156761881|NCT02782741|565879919|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
156761882|NCT02782741|565879920|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
156761883|NCT02782741|565879921|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
156761884|NCT02782741|565879919|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
156761885|NCT02782741|565879920|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
156761886|NCT02782741|565879921|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
156761887|NCT04157088|565879922|FG000|Overall Study|Study terminated by sponsor|23|||
156319183|NCT02829944|564267829|FG000|Overall Study|Physician Decision|0|||
156319184|NCT02829944|564267830|FG001|Overall Study|Physician Decision|1|||
156319185|NCT02829944|564267829|FG000|Overall Study|Screen Failure|2|||
156319186|NCT02829944|564267830|FG001|Overall Study|Screen Failure|2|||
156420433|NCT04955626|564630193|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
156420434|NCT04955626|564630194|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
156420435|NCT04955626|564630195|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
156420436|NCT04955626|564630196|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
156420437|NCT04955626|564630197|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
156420438|NCT04955626|564630198|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
156420439|NCT04955626|564630199|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
156420440|NCT04955626|564630200|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
156420441|NCT04955626|564630201|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
156420442|NCT04955626|564630202|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
156420443|NCT04955626|564630203|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
156420444|NCT04955626|564630204|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
156420445|NCT04955626|564630205|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
156420446|NCT04955626|564630206|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
156420447|NCT04955626|564630207|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
156420448|NCT04955626|564630208|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
156420449|NCT04955626|564630209|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
156319187|NCT02829944|564267829|FG000|Overall Study|Inadequate Neuraxial Block|1|||
156319188|NCT02829944|564267830|FG001|Overall Study|Inadequate Neuraxial Block|1|||
156319189|NCT02829944|564267829|FG000|Overall Study|Withdrawal by Subject|2|||
156319190|NCT02829944|564267830|FG001|Overall Study|Withdrawal by Subject|1|||
156319191|NCT02829944|564267829|FG000|Overall Study|Catheter Displacement|1|||
156319192|NCT02829944|564267830|FG001|Overall Study|Catheter Displacement|0|||
156319193|NCT02829944|564267829|FG000|Overall Study|Catheter broke|0|||
156319194|NCT02829944|564267830|FG001|Overall Study|Catheter broke|1|||
156420450|NCT04955626|564630210|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
156420451|NCT04955626|564630211|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
156420452|NCT04955626|564630212|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
156420453|NCT04955626|564630213|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
156420454|NCT04955626|564630214|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
156420455|NCT04955626|564630215|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
156420456|NCT04955626|564630216|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
156420457|NCT04955626|564630181|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420458|NCT04955626|564630182|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
156420459|NCT04955626|564630183|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420460|NCT04955626|564630184|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420461|NCT04955626|564630185|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420462|NCT04955626|564630186|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420463|NCT04955626|564630187|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156761888|NCT04157088|565879922|FG000|Overall Study|Withdrawal by Subject|4|||
156420464|NCT04955626|564630188|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420465|NCT04955626|564630189|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156761889|NCT04157088|565879922|FG000|Overall Study|Lost to Follow-up|2|||
156761890|NCT04157088|565879922|FG000|Overall Study|Death|1|||
156420466|NCT04955626|564630190|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420467|NCT04955626|564630191|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420468|NCT04955626|564630192|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420469|NCT04955626|564630193|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420470|NCT04955626|564630194|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420471|NCT04955626|564630195|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420472|NCT04955626|564630196|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420473|NCT04955626|564630197|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420474|NCT04955626|564630198|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420475|NCT04955626|564630199|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420476|NCT04955626|564630200|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420477|NCT04955626|564630201|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420478|NCT04955626|564630202|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420479|NCT04955626|564630203|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420480|NCT04955626|564630204|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420481|NCT04955626|564630205|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420482|NCT04955626|564630206|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420483|NCT04955626|564630207|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420484|NCT04955626|564630208|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420485|NCT04955626|564630209|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420486|NCT04955626|564630210|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420487|NCT04955626|564630211|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420488|NCT04955626|564630212|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420489|NCT04955626|564630213|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420490|NCT04955626|564630214|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420491|NCT04955626|564630215|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420492|NCT04955626|564630216|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156420493|NCT04951479|564630217|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
156420494|NCT05617040|564630219|FG000|Overall Study|Adverse Event|0|||
156420495|NCT05617040|564630220|FG001|Overall Study|Adverse Event|1|||
156420496|NCT05617040|564630221|FG002|Overall Study|Adverse Event|0|||
156420497|NCT05617040|564630219|FG000|Overall Study|Death|0|||
156420498|NCT05617040|564630220|FG001|Overall Study|Death|0|||
156420499|NCT05617040|564630221|FG002|Overall Study|Death|1|||
156420500|NCT02711826|564630222|FG000|Overall Study|Physician Decision|0|||
156420501|NCT02711826|564630223|FG001|Overall Study|Physician Decision|0|||
156420502|NCT02711826|564630224|FG002|Overall Study|Physician Decision|0|||
156420503|NCT02711826|564630225|FG003|Overall Study|Physician Decision|1|||
156420504|NCT02711826|564630226|FG004|Overall Study|Physician Decision|0|||
156420505|NCT02711826|564630222|FG000|Overall Study|Withdrawal by Subject|0|||
156420506|NCT02711826|564630223|FG001|Overall Study|Withdrawal by Subject|1|||
156420507|NCT02711826|564630224|FG002|Overall Study|Withdrawal by Subject|0|||
156420508|NCT02711826|564630225|FG003|Overall Study|Withdrawal by Subject|4|||
156420509|NCT02711826|564630226|FG004|Overall Study|Withdrawal by Subject|0|||
156420510|NCT02711826|564630222|FG000|Overall Study|Failure to manufacture cellular product|0|||
156420511|NCT02711826|564630223|FG001|Overall Study|Failure to manufacture cellular product|0|||
156420512|NCT02711826|564630224|FG002|Overall Study|Failure to manufacture cellular product|5|||
156420513|NCT02711826|564630225|FG003|Overall Study|Failure to manufacture cellular product|0|||
156420514|NCT02711826|564630226|FG004|Overall Study|Failure to manufacture cellular product|0|||
156420515|NCT02711826|564630222|FG000|Overall Study|Infusion canceled for active infection|0|||
156420516|NCT02711826|564630223|FG001|Overall Study|Infusion canceled for active infection|1|||
156420517|NCT02711826|564630224|FG002|Overall Study|Infusion canceled for active infection|0|||
156420518|NCT02711826|564630225|FG003|Overall Study|Infusion canceled for active infection|0|||
156420519|NCT02711826|564630226|FG004|Overall Study|Infusion canceled for active infection|0|||
156319195|NCT02829944|564267829|FG000|Overall Study|Staff unavailable|0|||
156319196|NCT02829944|564267830|FG001|Overall Study|Staff unavailable|1|||
156319197|NCT04675151|564267832|FG000|Overall Study|Protocol Violation|1|||
156319198|NCT04675151|564267833|FG001|Overall Study|Protocol Violation|0|||
156319199|NCT04675151|564267834|FG002|Overall Study|Protocol Violation|0|||
156319200|NCT04675151|564267835|FG003|Overall Study|Protocol Violation|1|||
156319201|NCT01730937|564267836|FG000|Overall Study|Protocol Violation|5|||
156319202|NCT01730937|564267837|FG001|Overall Study|Protocol Violation|11|||
156319203|NCT03947684|564267838|FG000|Overall Study|Lost to Follow-up|13|||
156319204|NCT03947684|564267839|FG001|Overall Study|Lost to Follow-up|5|||
156319205|NCT03947684|564267840|FG002|Overall Study|Lost to Follow-up|1|||
156319206|NCT03947684|564267838|FG000|Overall Study|Withdrawal by Subject|11|||
156319207|NCT03947684|564267839|FG001|Overall Study|Withdrawal by Subject|4|||
156319208|NCT03947684|564267840|FG002|Overall Study|Withdrawal by Subject|0|||
156319209|NCT03947684|564267838|FG000|Overall Study|Physician Decision|1|||
156319210|NCT03947684|564267839|FG001|Overall Study|Physician Decision|0|||
156319211|NCT03947684|564267840|FG002|Overall Study|Physician Decision|0|||
156319212|NCT03947684|564267838|FG000|Overall Study|Lack of adherence to study protocol|2|||
156319213|NCT03947684|564267839|FG001|Overall Study|Lack of adherence to study protocol|0|||
156319214|NCT03947684|564267840|FG002|Overall Study|Lack of adherence to study protocol|0|||
156319215|NCT03875235|564267842|FG000|Overall Study|Ongoing study treatment|63|||
156319216|NCT03875235|564267843|FG001|Overall Study|Ongoing study treatment|20|||
156319217|NCT03875235|564267842|FG000|Overall Study|Off treatment|77|||
156319218|NCT03875235|564267843|FG001|Overall Study|Off treatment|91|||
156319219|NCT03875235|564267842|FG000|Overall Study|Withdrawal by Subject|3|||
156319220|NCT03875235|564267843|FG001|Overall Study|Withdrawal by Subject|10|||
156319221|NCT03875235|564267842|FG000|Overall Study|Death|198|||
156319222|NCT03875235|564267843|FG001|Overall Study|Death|223|||
156319223|NCT01395784|564267855|FG000|Overall Study|Lost to Follow-up|7|||
156319224|NCT01395784|564267855|FG000|Overall Study|Withdrawal by Subject|3|||
156319225|NCT01395784|564267855|FG000|Overall Study|Physician Decision|5|||
156319226|NCT05772702|564267856|FG000|Overall Study|Adverse Event|1|||
156319227|NCT04153149|564267857|FG000|Double Blind Period|Death|63|||
156319228|NCT04153149|564267858|FG001|Double Blind Period|Death|49|||
156319229|NCT04153149|564267859|FG002|Double Blind Period|Death|0|||
156420520|NCT02711826|564630222|FG000|Overall Study|Screen failures|0|||
156420521|NCT02711826|564630223|FG001|Overall Study|Screen failures|0|||
156420522|NCT02711826|564630224|FG002|Overall Study|Screen failures|0|||
156420523|NCT02711826|564630225|FG003|Overall Study|Screen failures|4|||
156420524|NCT02711826|564630226|FG004|Overall Study|Screen failures|0|||
156420525|NCT02507219|564630230|FG000|Overall Study|Physician Decision|1|||
156420526|NCT02507219|564630231|FG001|Overall Study|Physician Decision|0|||
156420527|NCT02507219|564630232|FG002|Overall Study|Physician Decision|0|||
156420528|NCT02507219|564630233|FG003|Overall Study|Physician Decision|0|||
156420529|NCT02507219|564630234|FG004|Overall Study|Physician Decision|0|||
156420530|NCT02507219|564630235|FG005|Overall Study|Physician Decision|0|||
156420531|NCT02507219|564630230|FG000|Overall Study|Withdrawal by Subject|0|||
156420532|NCT02507219|564630231|FG001|Overall Study|Withdrawal by Subject|0|||
156420533|NCT02507219|564630232|FG002|Overall Study|Withdrawal by Subject|0|||
156420534|NCT02507219|564630233|FG003|Overall Study|Withdrawal by Subject|0|||
156420535|NCT02507219|564630234|FG004|Overall Study|Withdrawal by Subject|1|||
156420536|NCT02507219|564630235|FG005|Overall Study|Withdrawal by Subject|0|||
156420537|NCT02886936|564630236|FG000|Overall Study|Lost to Follow-up|4|||
156420538|NCT02886936|564630237|FG001|Overall Study|Lost to Follow-up|3|||
156420539|NCT02886936|564630238|FG002|Overall Study|Lost to Follow-up|0|||
156420540|NCT04562779|564630239|FG000|Overall Study|Lost to Follow-up|7|||
156420541|NCT04562779|564630240|FG001|Overall Study|Lost to Follow-up|5|||
156420542|NCT04562779|564630241|FG002|Overall Study|Lost to Follow-up|10|||
156420543|NCT04562779|564630239|FG000|Overall Study|Protocol Violation|2|||
156420544|NCT04562779|564630240|FG001|Overall Study|Protocol Violation|2|||
156420545|NCT04562779|564630241|FG002|Overall Study|Protocol Violation|0|||
156420546|NCT03173248|564630242|FG000|Overall Study|Death|28|||
156420547|NCT03173248|564630243|FG001|Overall Study|Death|46|||
156420548|NCT03173248|564630242|FG000|Overall Study|Lost to Follow-up|0|||
156420549|NCT03173248|564630243|FG001|Overall Study|Lost to Follow-up|1|||
156420550|NCT03173248|564630242|FG000|Overall Study|Withdrawal by Subject|6|||
156420551|NCT03173248|564630243|FG001|Overall Study|Withdrawal by Subject|4|||
156420552|NCT03173248|564630242|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
156420553|NCT03173248|564630243|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
156420554|NCT01544582|564630244|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
156420555|NCT01544582|564630245|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
156420556|NCT01544582|564630246|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
156420557|NCT01544582|564630247|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
156420558|NCT01544582|564630244|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
156420559|NCT01544582|564630245|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
156420560|NCT01544582|564630246|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
156420561|NCT01544582|564630247|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
156654642|NCT00753714|565481686|FG001|Overall Study|Protocol Violation|0|||
156654643|NCT00753714|565481685|FG000|Overall Study|Lost to Follow-up|0|||
156654644|NCT00753714|565481686|FG001|Overall Study|Lost to Follow-up|1|||
156654645|NCT00753714|565481685|FG000|Overall Study|Withdrawal by Subject|2|||
156654646|NCT00753714|565481686|FG001|Overall Study|Withdrawal by Subject|1|||
156654647|NCT00753714|565481685|FG000|Overall Study|Death|3|||
156654648|NCT00753714|565481686|FG001|Overall Study|Death|3|||
156654649|NCT00753714|565481685|FG000|Overall Study|Other|7|||
156654650|NCT00753714|565481686|FG001|Overall Study|Other|5|||
156654651|NCT03387098|565481687|FG000|Overall Study|progressive disease|1|||
156654652|NCT03387098|565481687|FG000|Overall Study|Withdrawal by Subject|2|||
156654653|NCT03387098|565481687|FG000|Overall Study|study terminated by sponsor|1|||
156654654|NCT02974153|565481688|FG000|Overall Study|Adverse Event|6|||
156654655|NCT02974153|565481689|FG001|Overall Study|Adverse Event|0|||
156654656|NCT02974153|565481690|FG002|Overall Study|Adverse Event|1|||
156654657|NCT02974153|565481688|FG000|Overall Study|Lack of Efficacy|6|||
156654658|NCT02974153|565481689|FG001|Overall Study|Lack of Efficacy|5|||
156654659|NCT02974153|565481690|FG002|Overall Study|Lack of Efficacy|10|||
156654660|NCT02974153|565481688|FG000|Overall Study|Lost to Follow-up|9|||
156654661|NCT02974153|565481689|FG001|Overall Study|Lost to Follow-up|10|||
156654662|NCT02974153|565481690|FG002|Overall Study|Lost to Follow-up|17|||
156319230|NCT04153149|564267860|FG003|Double Blind Period|Death|0|||
156319231|NCT04153149|564267857|FG000|Double Blind Period|Withdrawal by Subject|16|||
156319232|NCT04153149|564267858|FG001|Double Blind Period|Withdrawal by Subject|11|||
156319233|NCT04153149|564267859|FG002|Double Blind Period|Withdrawal by Subject|0|||
156319234|NCT04153149|564267860|FG003|Double Blind Period|Withdrawal by Subject|0|||
156319235|NCT04153149|564267857|FG000|Double Blind Period|Adverse Event|6|||
156319236|NCT04153149|564267858|FG001|Double Blind Period|Adverse Event|2|||
156319237|NCT04153149|564267859|FG002|Double Blind Period|Adverse Event|0|||
156319238|NCT04153149|564267860|FG003|Double Blind Period|Adverse Event|0|||
156319239|NCT04153149|564267857|FG000|Double Blind Period|Lost to Follow-up|2|||
156319240|NCT04153149|564267858|FG001|Double Blind Period|Lost to Follow-up|1|||
156319241|NCT04153149|564267859|FG002|Double Blind Period|Lost to Follow-up|0|||
156319242|NCT04153149|564267860|FG003|Double Blind Period|Lost to Follow-up|0|||
156319243|NCT04153149|564267857|FG000|Double Blind Period|Withdrawal by guardian|0|||
156319244|NCT04153149|564267858|FG001|Double Blind Period|Withdrawal by guardian|2|||
156319245|NCT04153149|564267859|FG002|Double Blind Period|Withdrawal by guardian|0|||
156319246|NCT04153149|564267860|FG003|Double Blind Period|Withdrawal by guardian|0|||
156319247|NCT04153149|564267857|FG000|Double Blind Period|Reason Not Specified|5|||
156319248|NCT04153149|564267858|FG001|Double Blind Period|Reason Not Specified|4|||
156319249|NCT04153149|564267859|FG002|Double Blind Period|Reason Not Specified|0|||
156319250|NCT04153149|564267860|FG003|Double Blind Period|Reason Not Specified|0|||
156319251|NCT04153149|564267857|FG000|Double Blind Period|Physician Decision|2|||
156319252|NCT04153149|564267858|FG001|Double Blind Period|Physician Decision|0|||
156319253|NCT04153149|564267859|FG002|Double Blind Period|Physician Decision|0|||
156319254|NCT04153149|564267860|FG003|Double Blind Period|Physician Decision|0|||
156319255|NCT04153149|564267857|FG000|Open Label Extension Period|Death|0|||
156319256|NCT04153149|564267858|FG001|Open Label Extension Period|Death|0|||
156319257|NCT04153149|564267859|FG002|Open Label Extension Period|Death|7|||
156319258|NCT04153149|564267860|FG003|Open Label Extension Period|Death|3|||
156319259|NCT04153149|564267857|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
156319260|NCT04153149|564267858|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
156319261|NCT04153149|564267859|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
156319262|NCT04153149|564267860|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
156319263|NCT04153149|564267857|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
156319264|NCT04153149|564267858|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
156319265|NCT04153149|564267859|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
156319266|NCT04153149|564267860|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
156319267|NCT04153149|564267857|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
156319268|NCT04153149|564267858|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
156319269|NCT04153149|564267859|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
156319270|NCT04153149|564267860|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
156319271|NCT00625742|564269324|FG000|Overall Study|Disease Progression|2|||
156319272|NCT00625742|564269324|FG000|Overall Study|Withdrawal by Subject|1|||
156319273|NCT00625742|564269324|FG000|Overall Study|Adverse Event|4|||
156319274|NCT00625742|564269324|FG000|Overall Study|Lost to Follow-up|4|||
156319275|NCT00625742|564269324|FG000|Overall Study|Ineligible|1|||
156319276|NCT02316548|564269325|FG000|Overall Study|Protocol Violation|0|||
156319277|NCT02316548|564269326|FG001|Overall Study|Protocol Violation|1|||
156319278|NCT01343823|564269327|FG000|Overall Study|Study Terminated|1|||
156319279|NCT01343823|564269328|FG001|Overall Study|Study Terminated|0|||
156654663|NCT02974153|565481688|FG000|Overall Study|Physician Decision|0|||
156654664|NCT02974153|565481689|FG001|Overall Study|Physician Decision|2|||
156654665|NCT02974153|565481690|FG002|Overall Study|Physician Decision|1|||
156654666|NCT02974153|565481688|FG000|Overall Study|Withdrawal by Subject|9|||
156654667|NCT02974153|565481689|FG001|Overall Study|Withdrawal by Subject|16|||
156319280|NCT01343823|564269329|FG002|Overall Study|Study Terminated|0|||
156319281|NCT01343823|564269330|FG003|Overall Study|Study Terminated|1|||
156319282|NCT01343823|564269327|FG000|Overall Study|Withdrawal by Subject|1|||
156319283|NCT01343823|564269328|FG001|Overall Study|Withdrawal by Subject|0|||
156319284|NCT01343823|564269329|FG002|Overall Study|Withdrawal by Subject|0|||
156319285|NCT01343823|564269330|FG003|Overall Study|Withdrawal by Subject|0|||
156319286|NCT03468543|564269331|FG000|Overall Study|Protocol stopping rules met|3|||
156319287|NCT01249118|564269332|FG000|First Washout Period|Physician Decision|0|||
156319288|NCT01249118|564269333|FG001|First Washout Period|Physician Decision|1|||
156319289|NCT01249118|564269334|FG002|First Washout Period|Physician Decision|0|||
156319290|NCT00997438|564269335|FG000|Overall Study|Blood draw difficulty|2|||
156319291|NCT00997438|564269336|FG001|Overall Study|Blood draw difficulty|0|||
156319292|NCT00997438|564269337|FG002|Overall Study|Blood draw difficulty|1|||
156319293|NCT00997438|564269335|FG000|Overall Study|Withdrawal by Subject|1|||
156319294|NCT00997438|564269336|FG001|Overall Study|Withdrawal by Subject|1|||
156319295|NCT00997438|564269337|FG002|Overall Study|Withdrawal by Subject|0|||
156319296|NCT00997438|564269335|FG000|Overall Study|Exclusion criteria at visit 1|2|||
156319297|NCT00997438|564269336|FG001|Overall Study|Exclusion criteria at visit 1|2|||
156319298|NCT00997438|564269337|FG002|Overall Study|Exclusion criteria at visit 1|3|||
156319299|NCT00095238|564269338|FG000|Overall Study|Lack of Efficacy|9|||
156319300|NCT00095238|564269339|FG001|Overall Study|Lack of Efficacy|9|||
156319301|NCT00095238|564269338|FG000|Overall Study|Adverse Event|331|||
156319302|NCT00095238|564269339|FG001|Overall Study|Adverse Event|287|||
156319303|NCT00095238|564269338|FG000|Overall Study|Subject Withdrew Consent|208|||
156319304|NCT00095238|564269339|FG001|Overall Study|Subject Withdrew Consent|223|||
156319305|NCT00095238|564269338|FG000|Overall Study|Death|154|||
156319306|NCT00095238|564269339|FG001|Overall Study|Death|170|||
156319307|NCT00095238|564269338|FG000|Overall Study|Lost to Follow-up|19|||
156319308|NCT00095238|564269339|FG001|Overall Study|Lost to Follow-up|24|||
156319309|NCT00095238|564269338|FG000|Overall Study|Noncompliance|44|||
156319310|NCT00095238|564269339|FG001|Overall Study|Noncompliance|45|||
156319311|NCT00095238|564269338|FG000|Overall Study|No longer met study criteria|4|||
156319312|NCT00095238|564269339|FG001|Overall Study|No longer met study criteria|5|||
156319313|NCT00095238|564269338|FG000|Overall Study|Study terminated by sponsor|0|||
156319314|NCT00095238|564269339|FG001|Overall Study|Study terminated by sponsor|1|||
156319315|NCT00095238|564269338|FG000|Overall Study|Missing|1|||
156319316|NCT00095238|564269339|FG001|Overall Study|Missing|0|||
156319317|NCT00095238|564269338|FG000|Overall Study|Other Reasons|87|||
156319318|NCT00095238|564269339|FG001|Overall Study|Other Reasons|88|||
156319319|NCT04300751|564269340|FG000|Overall Study|Withdrawal by Subject|1|||
156319320|NCT02311582|564269343|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
156319321|NCT02311582|564269344|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
156319322|NCT02311582|564269345|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
156319323|NCT02311582|564269346|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
156319324|NCT02311582|564269347|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
156319325|NCT03422627|564269348|FG000|Overall Study|Protocol-specified Criteria|1|||
156319326|NCT03422627|564269349|FG001|Overall Study|Protocol-specified Criteria|1|||
156319327|NCT03422627|564269350|FG002|Overall Study|Protocol-specified Criteria|0|||
156319328|NCT03422627|564269351|FG003|Overall Study|Protocol-specified Criteria|0|||
156319329|NCT03422627|564269352|FG004|Overall Study|Protocol-specified Criteria|2|||
156319330|NCT03422627|564269348|FG000|Overall Study|Requirement for Alternative Therapy|1|||
156319331|NCT03422627|564269349|FG001|Overall Study|Requirement for Alternative Therapy|1|||
156319332|NCT03422627|564269350|FG002|Overall Study|Requirement for Alternative Therapy|2|||
156319333|NCT03422627|564269351|FG003|Overall Study|Requirement for Alternative Therapy|0|||
156319334|NCT03422627|564269352|FG004|Overall Study|Requirement for Alternative Therapy|0|||
156319335|NCT03422627|564269348|FG000|Overall Study|Disease Progression|1|||
156319336|NCT03422627|564269349|FG001|Overall Study|Disease Progression|0|||
156319337|NCT03422627|564269350|FG002|Overall Study|Disease Progression|1|||
156319338|NCT03422627|564269351|FG003|Overall Study|Disease Progression|2|||
156319339|NCT03422627|564269352|FG004|Overall Study|Disease Progression|0|||
156319340|NCT03422627|564269348|FG000|Overall Study|Adverse Event|2|||
156319341|NCT03422627|564269349|FG001|Overall Study|Adverse Event|1|||
156420562|NCT01544582|564630244|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
156420563|NCT01544582|564630245|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
156420564|NCT01544582|564630246|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
156420565|NCT01544582|564630247|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
156420566|NCT01544582|564630244|FG000|Analysis Population|Physician Decision|0|||
156420567|NCT01544582|564630245|FG001|Analysis Population|Physician Decision|13|||
156420568|NCT01544582|564630246|FG002|Analysis Population|Physician Decision|10|||
156420569|NCT01544582|564630247|FG003|Analysis Population|Physician Decision|9|||
156420570|NCT01544582|564630244|FG000|Analysis Population|Safety Reason|0|||
156420571|NCT01544582|564630245|FG001|Analysis Population|Safety Reason|33|||
156319342|NCT03422627|564269350|FG002|Overall Study|Adverse Event|0|||
156319343|NCT03422627|564269351|FG003|Overall Study|Adverse Event|0|||
156319344|NCT03422627|564269352|FG004|Overall Study|Adverse Event|2|||
156420572|NCT01544582|564630246|FG002|Analysis Population|Safety Reason|31|||
156420573|NCT01544582|564630247|FG003|Analysis Population|Safety Reason|8|||
156420574|NCT01544582|564630244|FG000|Analysis Population|Effectiveness Reason|0|||
156420575|NCT01544582|564630245|FG001|Analysis Population|Effectiveness Reason|48|||
156420576|NCT01544582|564630246|FG002|Analysis Population|Effectiveness Reason|29|||
156420577|NCT01544582|564630247|FG003|Analysis Population|Effectiveness Reason|12|||
156420578|NCT01544582|564630244|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
156420579|NCT01544582|564630245|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
156420580|NCT01544582|564630246|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
156420581|NCT01544582|564630247|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
156420582|NCT01544582|564630244|FG000|Analysis Population|Lost to Follow-up|0|||
156420583|NCT01544582|564630245|FG001|Analysis Population|Lost to Follow-up|6|||
156420584|NCT01544582|564630246|FG002|Analysis Population|Lost to Follow-up|6|||
156420585|NCT01544582|564630247|FG003|Analysis Population|Lost to Follow-up|5|||
156420586|NCT01544582|564630244|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
156420587|NCT01544582|564630245|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
156420588|NCT01544582|564630246|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
156420589|NCT01544582|564630247|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
156420590|NCT01544582|564630244|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
156420591|NCT01544582|564630245|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
156420592|NCT01544582|564630246|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
156420593|NCT01544582|564630247|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
156420594|NCT01544582|564630244|FG000|Analysis Population|Intolerance|0|||
156420595|NCT01544582|564630245|FG001|Analysis Population|Intolerance|1|||
156420596|NCT01544582|564630246|FG002|Analysis Population|Intolerance|0|||
156420597|NCT01544582|564630247|FG003|Analysis Population|Intolerance|0|||
156420598|NCT01544582|564630244|FG000|Analysis Population|Liver Transplantation|0|||
156420599|NCT01544582|564630245|FG001|Analysis Population|Liver Transplantation|0|||
156420600|NCT01544582|564630246|FG002|Analysis Population|Liver Transplantation|1|||
156420601|NCT01544582|564630247|FG003|Analysis Population|Liver Transplantation|0|||
156420602|NCT01544582|564630244|FG000|Analysis Population|No Social Insurance|0|||
156420603|NCT01544582|564630245|FG001|Analysis Population|No Social Insurance|0|||
156420604|NCT01544582|564630246|FG002|Analysis Population|No Social Insurance|1|||
156420605|NCT01544582|564630247|FG003|Analysis Population|No Social Insurance|0|||
156420606|NCT01544582|564630244|FG000|Analysis Population|Poor Adherence|0|||
156420607|NCT01544582|564630245|FG001|Analysis Population|Poor Adherence|0|||
156420608|NCT01544582|564630246|FG002|Analysis Population|Poor Adherence|1|||
156420609|NCT01544582|564630247|FG003|Analysis Population|Poor Adherence|0|||
156420610|NCT01544582|564630244|FG000|Analysis Population|Poor Participant Compliance|0|||
156420611|NCT01544582|564630245|FG001|Analysis Population|Poor Participant Compliance|1|||
156420612|NCT01544582|564630246|FG002|Analysis Population|Poor Participant Compliance|0|||
156420613|NCT01544582|564630247|FG003|Analysis Population|Poor Participant Compliance|0|||
156420614|NCT01544582|564630244|FG000|Analysis Population|Programmed Surgery|0|||
156420615|NCT01544582|564630245|FG001|Analysis Population|Programmed Surgery|1|||
156420616|NCT01544582|564630246|FG002|Analysis Population|Programmed Surgery|0|||
156420617|NCT01544582|564630247|FG003|Analysis Population|Programmed Surgery|0|||
156420618|NCT01544582|564630244|FG000|Analysis Population|Participant in Jail|0|||
156420619|NCT01544582|564630245|FG001|Analysis Population|Participant in Jail|0|||
156420620|NCT01544582|564630246|FG002|Analysis Population|Participant in Jail|1|||
156420621|NCT01544582|564630247|FG003|Analysis Population|Participant in Jail|0|||
156420622|NCT01511536|564632792|FG000|Phase 1|Other|0|||
156420623|NCT01511536|564632793|FG001|Phase 1|Other|1|||
156420624|NCT01511536|564632794|FG002|Phase 1|Other|0|||
156420625|NCT01511536|564632792|FG000|Phase 2|Other|0|||
156420626|NCT01511536|564632793|FG001|Phase 2|Other|0|||
156420627|NCT01511536|564632794|FG002|Phase 2|Other|9|||
156420628|NCT01764386|564632795|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
156420629|NCT01764386|564632796|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
156420630|NCT01764386|564632795|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
156420631|NCT01764386|564632796|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
156420632|NCT01764386|564632795|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
156420633|NCT01764386|564632796|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
156420634|NCT01764386|564632795|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
156420635|NCT01764386|564632796|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
156420636|NCT01764386|564632795|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
156420637|NCT01764386|564632796|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
156420638|NCT01764386|564632795|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
156420639|NCT01764386|564632796|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
156420640|NCT01764386|564632795|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
156420641|NCT01764386|564632796|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
156420642|NCT01764386|564632795|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
156420643|NCT01764386|564632796|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
156420644|NCT03738241|564632797|FG000|Overall Study|Withdrawal by Subject|0|||
156420645|NCT03738241|564632798|FG001|Overall Study|Withdrawal by Subject|0|||
156420646|NCT03738241|564632799|FG002|Overall Study|Withdrawal by Subject|0|||
156420647|NCT03738241|564632800|FG003|Overall Study|Withdrawal by Subject|0|||
156420648|NCT03738241|564632801|FG004|Overall Study|Withdrawal by Subject|0|||
156420649|NCT03738241|564632802|FG005|Overall Study|Withdrawal by Subject|0|||
156420650|NCT03738241|564632803|FG006|Overall Study|Withdrawal by Subject|0|||
156420651|NCT03738241|564632804|FG007|Overall Study|Withdrawal by Subject|0|||
156420652|NCT03738241|564632805|FG008|Overall Study|Withdrawal by Subject|0|||
156420653|NCT03738241|564632806|FG009|Overall Study|Withdrawal by Subject|1|||
156420654|NCT03738241|564632797|FG000|Overall Study|Physician Decision|0|||
156420655|NCT03738241|564632798|FG001|Overall Study|Physician Decision|0|||
156420656|NCT03738241|564632799|FG002|Overall Study|Physician Decision|0|||
156420657|NCT03738241|564632800|FG003|Overall Study|Physician Decision|0|||
156420658|NCT03738241|564632801|FG004|Overall Study|Physician Decision|0|||
156420659|NCT03738241|564632802|FG005|Overall Study|Physician Decision|0|||
156420660|NCT03738241|564632803|FG006|Overall Study|Physician Decision|0|||
156420661|NCT03738241|564632804|FG007|Overall Study|Physician Decision|0|||
156420662|NCT03738241|564632805|FG008|Overall Study|Physician Decision|1|||
156420663|NCT03738241|564632806|FG009|Overall Study|Physician Decision|0|||
156420664|NCT03738241|564632797|FG000|Overall Study|Adverse Event|1|||
156420665|NCT03738241|564632798|FG001|Overall Study|Adverse Event|0|||
156420666|NCT03738241|564632799|FG002|Overall Study|Adverse Event|0|||
156420667|NCT03738241|564632800|FG003|Overall Study|Adverse Event|0|||
156420668|NCT03738241|564632801|FG004|Overall Study|Adverse Event|0|||
156420669|NCT03738241|564632802|FG005|Overall Study|Adverse Event|0|||
156420670|NCT03738241|564632803|FG006|Overall Study|Adverse Event|0|||
156420671|NCT03738241|564632804|FG007|Overall Study|Adverse Event|0|||
156420672|NCT03738241|564632805|FG008|Overall Study|Adverse Event|0|||
156420673|NCT03738241|564632806|FG009|Overall Study|Adverse Event|0|||
156420674|NCT02788656|564632807|FG000|Overall Study|Withdrawal by Subject|1|||
156420675|NCT02788656|564632808|FG001|Overall Study|Withdrawal by Subject|0|||
156420676|NCT00495469|564632813|FG000|Overall Study|Adverse Event|0|||
156420677|NCT00495469|564632814|FG001|Overall Study|Adverse Event|1|||
156420678|NCT00495469|564632815|FG002|Overall Study|Adverse Event|3|||
156420679|NCT00495469|564632816|FG003|Overall Study|Adverse Event|0|||
156420680|NCT00495469|564632817|FG004|Overall Study|Adverse Event|1|||
156420681|NCT00495469|564632818|FG005|Overall Study|Adverse Event|1|||
156420682|NCT00495469|564632819|FG006|Overall Study|Adverse Event|1|||
156420683|NCT00495469|564632813|FG000|Overall Study|Lost to Follow-up|1|||
156420684|NCT00495469|564632814|FG001|Overall Study|Lost to Follow-up|1|||
156420685|NCT00495469|564632815|FG002|Overall Study|Lost to Follow-up|3|||
156420686|NCT00495469|564632816|FG003|Overall Study|Lost to Follow-up|1|||
156420687|NCT00495469|564632817|FG004|Overall Study|Lost to Follow-up|0|||
156420688|NCT00495469|564632818|FG005|Overall Study|Lost to Follow-up|0|||
156420689|NCT00495469|564632819|FG006|Overall Study|Lost to Follow-up|0|||
156420690|NCT00495469|564632813|FG000|Overall Study|Protocol Violation|0|||
156420691|NCT00495469|564632814|FG001|Overall Study|Protocol Violation|0|||
156420692|NCT00495469|564632815|FG002|Overall Study|Protocol Violation|0|||
156420693|NCT00495469|564632816|FG003|Overall Study|Protocol Violation|0|||
156420694|NCT00495469|564632817|FG004|Overall Study|Protocol Violation|1|||
156420695|NCT00495469|564632818|FG005|Overall Study|Protocol Violation|2|||
156420696|NCT00495469|564632819|FG006|Overall Study|Protocol Violation|0|||
156420697|NCT00495469|564632813|FG000|Overall Study|Withdrawal by Subject|5|||
156420698|NCT00495469|564632814|FG001|Overall Study|Withdrawal by Subject|3|||
156420699|NCT00495469|564632815|FG002|Overall Study|Withdrawal by Subject|1|||
156420700|NCT00495469|564632816|FG003|Overall Study|Withdrawal by Subject|3|||
156420701|NCT00495469|564632817|FG004|Overall Study|Withdrawal by Subject|3|||
156420702|NCT00495469|564632818|FG005|Overall Study|Withdrawal by Subject|2|||
156420703|NCT00495469|564632819|FG006|Overall Study|Withdrawal by Subject|3|||
156420704|NCT00495469|564632813|FG000|Overall Study|Lack of Efficacy|0|||
156420705|NCT00495469|564632814|FG001|Overall Study|Lack of Efficacy|0|||
156420706|NCT00495469|564632815|FG002|Overall Study|Lack of Efficacy|0|||
156420707|NCT00495469|564632816|FG003|Overall Study|Lack of Efficacy|0|||
156420708|NCT00495469|564632817|FG004|Overall Study|Lack of Efficacy|0|||
156420709|NCT00495469|564632818|FG005|Overall Study|Lack of Efficacy|0|||
156420710|NCT00495469|564632819|FG006|Overall Study|Lack of Efficacy|1|||
156420711|NCT00495469|564632813|FG000|Overall Study|Liver function test abnormality|0|||
156420712|NCT00495469|564632814|FG001|Overall Study|Liver function test abnormality|1|||
156420713|NCT00495469|564632815|FG002|Overall Study|Liver function test abnormality|0|||
156420714|NCT00495469|564632816|FG003|Overall Study|Liver function test abnormality|0|||
156420715|NCT00495469|564632817|FG004|Overall Study|Liver function test abnormality|0|||
156420716|NCT00495469|564632818|FG005|Overall Study|Liver function test abnormality|0|||
156420717|NCT00495469|564632819|FG006|Overall Study|Liver function test abnormality|0|||
156420718|NCT00495469|564632813|FG000|Overall Study|ST depression at randomisation in ECG|0|||
156420719|NCT00495469|564632814|FG001|Overall Study|ST depression at randomisation in ECG|1|||
156420720|NCT00495469|564632815|FG002|Overall Study|ST depression at randomisation in ECG|0|||
156420721|NCT00495469|564632816|FG003|Overall Study|ST depression at randomisation in ECG|0|||
156420722|NCT00495469|564632817|FG004|Overall Study|ST depression at randomisation in ECG|0|||
156420723|NCT00495469|564632818|FG005|Overall Study|ST depression at randomisation in ECG|0|||
156420724|NCT00495469|564632819|FG006|Overall Study|ST depression at randomisation in ECG|0|||
156420725|NCT03929302|564632824|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
156420726|NCT03929302|564632825|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
156420727|NCT03929302|564632826|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
156420728|NCT03929302|564632824|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
156420729|NCT03929302|564632825|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
156420730|NCT03929302|564632826|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
156420731|NCT03929302|564632824|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
156420732|NCT03929302|564632825|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
156420733|NCT03929302|564632826|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
156420734|NCT02459964|564632828|FG000|Overall Study|Withdrawal by Subject|0|||
156420735|NCT02459964|564632829|FG001|Overall Study|Withdrawal by Subject|0|||
156420736|NCT02459964|564632830|FG002|Overall Study|Withdrawal by Subject|1|||
156420737|NCT02459964|564632828|FG000|Overall Study|Abnormal EKG changes|0|||
156420738|NCT02459964|564632829|FG001|Overall Study|Abnormal EKG changes|0|||
156420739|NCT02459964|564632830|FG002|Overall Study|Abnormal EKG changes|1|||
156420740|NCT02256969|564632838|FG000|Overall Study|Screenfailed or withdrew|2|||
156420741|NCT02256969|564632839|FG001|Overall Study|Screenfailed or withdrew|1|||
156420742|NCT02256969|564632840|FG002|Overall Study|Screenfailed or withdrew|1|||
156420743|NCT01427907|564632844|FG000|Overall Study|Withdrawal by Subject|3|||
156420744|NCT01427907|564632845|FG001|Overall Study|Withdrawal by Subject|4|||
156420745|NCT03023332|564632846|FG000|Overall Study|Withdrawal by Subject|10|||
156420746|NCT03023332|564632847|FG001|Overall Study|Withdrawal by Subject|5|||
156420747|NCT03023332|564632848|FG002|Overall Study|Withdrawal by Subject|4|||
156420748|NCT03023332|564632849|FG003|Overall Study|Withdrawal by Subject|7|||
156420749|NCT03023332|564632846|FG000|Overall Study|Lost to Follow-up|13|||
156420750|NCT03023332|564632847|FG001|Overall Study|Lost to Follow-up|16|||
156761891|NCT01747499|565879923|FG000|Overall Study|Steroid refractory aGvHD|1|||
156761892|NCT01747499|565879924|FG001|Overall Study|Steroid refractory aGvHD|0|||
156761893|NCT01747499|565879925|FG002|Overall Study|Steroid refractory aGvHD|0|||
156761894|NCT01747499|565879926|FG003|Overall Study|Steroid refractory aGvHD|1|||
156420751|NCT03023332|564632848|FG002|Overall Study|Lost to Follow-up|8|||
156761895|NCT01747499|565879927|FG004|Overall Study|Steroid refractory aGvHD|4|||
156420752|NCT03023332|564632849|FG003|Overall Study|Lost to Follow-up|13|||
156420753|NCT03023332|564632846|FG000|Overall Study|Death|1|||
156420754|NCT03023332|564632847|FG001|Overall Study|Death|0|||
156420755|NCT03023332|564632848|FG002|Overall Study|Death|0|||
156420756|NCT03023332|564632849|FG003|Overall Study|Death|0|||
156420757|NCT02412761|564632850|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156420758|NCT02412761|564632851|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156420759|NCT02412761|564632852|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156420760|NCT02412761|564632853|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156420761|NCT02412761|564632854|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156420762|NCT02412761|564632855|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156420763|NCT01627340|564632858|FG000|Overall Study|Adverse Event|1|||
156420764|NCT01627340|564632859|FG001|Overall Study|Adverse Event|0|||
156420765|NCT01627340|564632858|FG000|Overall Study|Lost to Follow-up|8|||
156420766|NCT01627340|564632859|FG001|Overall Study|Lost to Follow-up|4|||
156420767|NCT01627340|564632858|FG000|Overall Study|Pregnancy|1|||
156420768|NCT01627340|564632859|FG001|Overall Study|Pregnancy|0|||
156420769|NCT01627340|564632858|FG000|Overall Study|Withdrawal by Subject|2|||
156420770|NCT01627340|564632859|FG001|Overall Study|Withdrawal by Subject|0|||
156420771|NCT02013687|564632860|FG000|Overall Study|Lost to Follow-up|0|||
156420772|NCT02013687|564632861|FG001|Overall Study|Lost to Follow-up|0|||
156420773|NCT02013687|564632862|FG002|Overall Study|Lost to Follow-up|1|||
156420774|NCT02013687|564632863|FG003|Overall Study|Lost to Follow-up|0|||
156420775|NCT02013687|564632860|FG000|Overall Study|Protocol Violation|0|||
156420776|NCT02013687|564632861|FG001|Overall Study|Protocol Violation|0|||
156420777|NCT02013687|564632862|FG002|Overall Study|Protocol Violation|0|||
156420778|NCT02013687|564632863|FG003|Overall Study|Protocol Violation|1|||
156420779|NCT02013687|564632860|FG000|Overall Study|Withdrawal by Subject|0|||
156420780|NCT02013687|564632861|FG001|Overall Study|Withdrawal by Subject|0|||
156420781|NCT02013687|564632862|FG002|Overall Study|Withdrawal by Subject|0|||
156420782|NCT02013687|564632863|FG003|Overall Study|Withdrawal by Subject|1|||
156420783|NCT02013687|564632860|FG000|Overall Study|Missed visits due to patient travel|0|||
156420784|NCT02013687|564632861|FG001|Overall Study|Missed visits due to patient travel|0|||
156420785|NCT02013687|564632862|FG002|Overall Study|Missed visits due to patient travel|1|||
156420786|NCT02013687|564632863|FG003|Overall Study|Missed visits due to patient travel|0|||
156420787|NCT01272011|564632864|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
156420788|NCT01272011|564632865|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
156420789|NCT01272011|564632866|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
156420790|NCT02240680|564632869|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
156420791|NCT02240680|564632870|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
156420792|NCT02240680|564632871|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
156420793|NCT02240680|564632872|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
156420794|NCT02240680|564632869|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
156420795|NCT02240680|564632870|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
156420796|NCT02240680|564632871|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
156420797|NCT02240680|564632872|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
156420798|NCT02240680|564632869|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
156420799|NCT02240680|564632870|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
156420800|NCT02240680|564632871|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
156420801|NCT02240680|564632872|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
156420802|NCT02240680|564632869|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
156420803|NCT02240680|564632870|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
156420804|NCT02240680|564632871|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
156420805|NCT02240680|564632872|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
156420806|NCT02240680|564632869|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
156420807|NCT02240680|564632870|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
156420808|NCT02240680|564632871|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
156420809|NCT02240680|564632872|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
156420810|NCT02240680|564632869|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
156420811|NCT02240680|564632870|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
156420812|NCT02240680|564632871|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
156420813|NCT02240680|564632872|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
156420814|NCT02240680|564632869|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
156420815|NCT02240680|564632870|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
156420816|NCT02240680|564632871|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
156420817|NCT02240680|564632872|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
156420818|NCT02240680|564632869|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
156420819|NCT02240680|564632870|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
156420820|NCT02240680|564632871|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
156420821|NCT02240680|564632872|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
156420822|NCT01657032|564632873|FG000|Overall Study|Lost to Follow-up|0|||
156420823|NCT01657032|564632874|FG001|Overall Study|Lost to Follow-up|7|||
156420824|NCT01782326|564632875|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
156420825|NCT01782326|564632876|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
156420826|NCT01782326|564632875|FG000|Planned Treatment Epoch|Death|29|||
156420827|NCT01782326|564632876|FG001|Planned Treatment Epoch|Death|30|||
156420828|NCT01782326|564632875|FG000|Planned Treatment Epoch|Physician Decision|18|||
156420829|NCT01782326|564632876|FG001|Planned Treatment Epoch|Physician Decision|16|||
156420830|NCT01782326|564632875|FG000|Planned Treatment Epoch|Protocol deviation|2|||
156420831|NCT01782326|564632876|FG001|Planned Treatment Epoch|Protocol deviation|3|||
156420832|NCT01782326|564632875|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
156420833|NCT01782326|564632876|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
156420834|NCT01782326|564632875|FG000|Planned Treatment Epoch|Technical problems|0|||
156420835|NCT01782326|564632876|FG001|Planned Treatment Epoch|Technical problems|4|||
156420836|NCT01782326|564632875|FG000|Double-blind Treatment|Adverse Event|129|||
156420837|NCT01782326|564632876|FG001|Double-blind Treatment|Adverse Event|145|||
156420838|NCT01782326|564632875|FG000|Double-blind Treatment|Subject/guardian decision|111|||
156420839|NCT01782326|564632876|FG001|Double-blind Treatment|Subject/guardian decision|125|||
156420840|NCT01782326|564632875|FG000|Double-blind Treatment|Lack of Efficacy|17|||
156420841|NCT01782326|564632876|FG001|Double-blind Treatment|Lack of Efficacy|22|||
156420842|NCT01782326|564632875|FG000|Double-blind Treatment|Physician Decision|13|||
156420843|NCT01782326|564632876|FG001|Double-blind Treatment|Physician Decision|16|||
156420844|NCT01782326|564632875|FG000|Double-blind Treatment|Protocol deviation|8|||
156420845|NCT01782326|564632876|FG001|Double-blind Treatment|Protocol deviation|7|||
156420846|NCT01782326|564632875|FG000|Double-blind Treatment|Technical problems|0|||
156420847|NCT01782326|564632876|FG001|Double-blind Treatment|Technical problems|5|||
156420848|NCT03633903|564632877|FG000|Overall Study|Withdrawal by Subject|1|||
156420849|NCT03633903|564632878|FG001|Overall Study|Withdrawal by Subject|2|||
156420850|NCT03633903|564632877|FG000|Overall Study|Lost to Follow-up|5|||
156420851|NCT03633903|564632878|FG001|Overall Study|Lost to Follow-up|5|||
156420852|NCT01657682|564632885|FG000|Overall Study|Lost to Follow-up|1|||
156420853|NCT01657682|564632886|FG001|Overall Study|Lost to Follow-up|0|||
156420854|NCT01657682|564632887|FG002|Overall Study|Lost to Follow-up|0|||
156420855|NCT01657682|564632885|FG000|Overall Study|Withdrawal by Subject|0|||
156420856|NCT01657682|564632886|FG001|Overall Study|Withdrawal by Subject|1|||
156420857|NCT01657682|564632887|FG002|Overall Study|Withdrawal by Subject|1|||
156420858|NCT01657682|564632885|FG000|Overall Study|Adverse Event|0|||
156420859|NCT01657682|564632886|FG001|Overall Study|Adverse Event|1|||
156420860|NCT01657682|564632887|FG002|Overall Study|Adverse Event|0|||
156420861|NCT00087490|564632888|FG000|Overall Study|Death|6|||
156420862|NCT00087490|564632889|FG001|Overall Study|Death|4|||
156420863|NCT00087490|564632888|FG000|Overall Study|Adverse Event|3|||
156420864|NCT00087490|564632889|FG001|Overall Study|Adverse Event|8|||
156420865|NCT00087490|564632888|FG000|Overall Study|Lack of Efficacy|0|||
156420866|NCT00087490|564632889|FG001|Overall Study|Lack of Efficacy|2|||
156420867|NCT00087490|564632888|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
156420868|NCT00087490|564632889|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
156420869|NCT00087490|564632888|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
156420870|NCT00087490|564632889|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
156420871|NCT00087490|564632888|FG000|Overall Study|Randomized but not treated|7|||
156420872|NCT00087490|564632889|FG001|Overall Study|Randomized but not treated|18|||
156420873|NCT03379233|564632893|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
156420874|NCT03379233|564632894|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
156420875|NCT02531438|564632895|FG000|Overall Study|Adverse Event|7|||
156420876|NCT02531438|564632896|FG001|Overall Study|Adverse Event|9|||
156420877|NCT02531438|564632895|FG000|Overall Study|Lost to Follow-up|0|||
156420878|NCT02531438|564632896|FG001|Overall Study|Lost to Follow-up|3|||
156420879|NCT02531438|564632895|FG000|Overall Study|Withdrawal by Subject|7|||
156420880|NCT02531438|564632896|FG001|Overall Study|Withdrawal by Subject|8|||
156420881|NCT02531438|564632895|FG000|Overall Study|Physician Decision|0|||
156420882|NCT02531438|564632896|FG001|Overall Study|Physician Decision|1|||
156420883|NCT02531438|564632895|FG000|Overall Study|Death|6|||
156420884|NCT02531438|564632896|FG001|Overall Study|Death|3|||
156420885|NCT02531438|564632895|FG000|Overall Study|Randomized, but Not Treated|4|||
156420886|NCT02531438|564632896|FG001|Overall Study|Randomized, but Not Treated|0|||
156420887|NCT02531438|564632895|FG000|Overall Study|Missed EOT/PTE Visit|5|||
156420888|NCT02531438|564632896|FG001|Overall Study|Missed EOT/PTE Visit|2|||
156420889|NCT02531438|564632895|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
156420890|NCT02531438|564632896|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
156420891|NCT02015195|564632897|FG000|Overall Study|Adverse Event|0|||
156420892|NCT02015195|564632898|FG001|Overall Study|Adverse Event|0|||
156420893|NCT02015195|564632899|FG002|Overall Study|Adverse Event|0|||
156420894|NCT02015195|564632900|FG003|Overall Study|Adverse Event|1|||
156420895|NCT02015195|564632901|FG004|Overall Study|Adverse Event|0|||
156420896|NCT02015195|564632902|FG005|Overall Study|Adverse Event|0|||
156420897|NCT02015195|564632903|FG006|Overall Study|Adverse Event|0|||
156420898|NCT01318811|564632904|FG000|Overall Study|Physician Decision|1|||
156420899|NCT01318811|564632905|FG001|Overall Study|Physician Decision|1|||
156420900|NCT01318811|564632904|FG000|Overall Study|CRRT stopped for head CT|0|||
156420901|NCT01318811|564632905|FG001|Overall Study|CRRT stopped for head CT|1|||
156420902|NCT01318811|564632904|FG000|Overall Study|Death|0|||
156420903|NCT01318811|564632905|FG001|Overall Study|Death|1|||
156420904|NCT01318811|564632904|FG000|Overall Study|CRRT stopped for head MRI|0|||
156420905|NCT01318811|564632905|FG001|Overall Study|CRRT stopped for head MRI|1|||
156420906|NCT00131911|564632906|FG000|Overall Study|Withdrawal by Subject|1|||
156420907|NCT00131911|564632907|FG001|Overall Study|Withdrawal by Subject|0|||
156420908|NCT02825043|564632908|FG000|Overall Study|Lost to Follow-up|4|||
156420909|NCT00329303|564632909|FG000|Overall Study|Lack of Efficacy|1|||
156420910|NCT00329303|564632910|FG001|Overall Study|Lack of Efficacy|0|||
156420911|NCT00329303|564632909|FG000|Overall Study|Decision of the sponsor|0|||
156420912|NCT00329303|564632910|FG001|Overall Study|Decision of the sponsor|1|||
156420913|NCT00329303|564632909|FG000|Overall Study|Patient no longer available|1|||
156420914|NCT00329303|564632910|FG001|Overall Study|Patient no longer available|0|||
156420915|NCT00329303|564632909|FG000|Overall Study|Patient relocated|0|||
156420916|NCT00329303|564632910|FG001|Overall Study|Patient relocated|1|||
156420917|NCT03582137|564632913|FG000|Overall Study|Adverse Event|1|||
156420918|NCT03582137|564632914|FG001|Overall Study|Adverse Event|0|||
156420919|NCT03704298|564632915|FG000|Overall Study|Death|3|||
156420920|NCT03704298|564632916|FG001|Overall Study|Death|1|||
156420921|NCT03704298|564632917|FG002|Overall Study|Death|1|||
156420922|NCT03704298|564632918|FG003|Overall Study|Death|0|||
156420923|NCT03704298|564632915|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
156420924|NCT03704298|564632916|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
156420925|NCT03704298|564632917|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
156420926|NCT03704298|564632918|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
156420927|NCT03704298|564632915|FG000|Overall Study|Withdrawal by Subject|1|||
156420928|NCT03704298|564632916|FG001|Overall Study|Withdrawal by Subject|0|||
156420929|NCT03704298|564632917|FG002|Overall Study|Withdrawal by Subject|0|||
156420930|NCT03704298|564632918|FG003|Overall Study|Withdrawal by Subject|0|||
156420931|NCT03704298|564632915|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
156420932|NCT03704298|564632916|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
156420933|NCT03704298|564632917|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
156420934|NCT03704298|564632918|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
156420935|NCT02303574|564632924|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420936|NCT02303574|564632925|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420937|NCT02303574|564632926|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
156420938|NCT02303574|564632927|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420939|NCT02303574|564632928|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420940|NCT02303574|564632929|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420941|NCT02303574|564632930|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420942|NCT02303574|564632931|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420943|NCT02303574|564632932|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420944|NCT02303574|564632933|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156420945|NCT02303574|564632924|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420946|NCT02303574|564632925|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420947|NCT02303574|564632926|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420948|NCT02303574|564632927|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420949|NCT02303574|564632928|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420950|NCT02303574|564632929|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420951|NCT02303574|564632930|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420952|NCT02303574|564632931|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
156420953|NCT02303574|564632932|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420954|NCT02303574|564632933|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156420955|NCT01606189|564632936|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
156420956|NCT01606189|564632937|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
156420957|NCT01606189|564632938|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
156420958|NCT01606189|564632939|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
156420959|NCT01606189|564632940|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
156420960|NCT01606189|564632941|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
156420961|NCT01606189|564632936|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156319345|NCT03422627|564269348|FG000|Overall Study|Ineligibility Determined|0|||
156319346|NCT03422627|564269349|FG001|Overall Study|Ineligibility Determined|1|||
156319347|NCT03422627|564269350|FG002|Overall Study|Ineligibility Determined|0|||
156319348|NCT03422627|564269351|FG003|Overall Study|Ineligibility Determined|0|||
156319349|NCT03422627|564269352|FG004|Overall Study|Ineligibility Determined|0|||
156319350|NCT03422627|564269348|FG000|Overall Study|Death|0|||
156319351|NCT03422627|564269349|FG001|Overall Study|Death|1|||
156319352|NCT03422627|564269350|FG002|Overall Study|Death|1|||
156319353|NCT03422627|564269351|FG003|Overall Study|Death|0|||
156319354|NCT03422627|564269352|FG004|Overall Study|Death|0|||
156319355|NCT03422627|564269348|FG000|Overall Study|Withdrawal by Subject|0|||
156319356|NCT03422627|564269349|FG001|Overall Study|Withdrawal by Subject|0|||
156319357|NCT03422627|564269350|FG002|Overall Study|Withdrawal by Subject|0|||
156319358|NCT03422627|564269351|FG003|Overall Study|Withdrawal by Subject|1|||
156319359|NCT03422627|564269352|FG004|Overall Study|Withdrawal by Subject|0|||
156319360|NCT04214288|564269353|FG000|Overall Study|Ongoing in the study|41|||
156319361|NCT04214288|564269354|FG001|Overall Study|Ongoing in the study|51|||
156319362|NCT04214288|564269355|FG002|Overall Study|Ongoing in the study|12|||
156319363|NCT04214288|564269356|FG003|Overall Study|Ongoing in the study|39|||
156319364|NCT04214288|564269353|FG000|Overall Study|Adverse Event|1|||
156319365|NCT04214288|564269354|FG001|Overall Study|Adverse Event|0|||
156319366|NCT04214288|564269355|FG002|Overall Study|Adverse Event|0|||
156319367|NCT04214288|564269356|FG003|Overall Study|Adverse Event|0|||
156319368|NCT04214288|564269353|FG000|Overall Study|Death|22|||
156319369|NCT04214288|564269354|FG001|Overall Study|Death|13|||
156319370|NCT04214288|564269355|FG002|Overall Study|Death|7|||
156319371|NCT04214288|564269356|FG003|Overall Study|Death|19|||
156319372|NCT04214288|564269353|FG000|Overall Study|Lost to Follow-up|1|||
156319373|NCT04214288|564269354|FG001|Overall Study|Lost to Follow-up|2|||
156319374|NCT04214288|564269355|FG002|Overall Study|Lost to Follow-up|1|||
156319375|NCT04214288|564269356|FG003|Overall Study|Lost to Follow-up|0|||
156319376|NCT04214288|564269353|FG000|Overall Study|Other|1|||
156319377|NCT04214288|564269354|FG001|Overall Study|Other|2|||
156420962|NCT01606189|564632937|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156420963|NCT01606189|564632938|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156420964|NCT01606189|564632939|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156420965|NCT01606189|564632940|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156420966|NCT01606189|564632941|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
156420967|NCT00162942|564632942|FG000|Overall Study|Adverse Event|10|||
156420968|NCT00162942|564632943|FG001|Overall Study|Adverse Event|6|||
156420969|NCT00162942|564632942|FG000|Overall Study|Death|1|||
156420970|NCT00162942|564632943|FG001|Overall Study|Death|0|||
156420971|NCT00162942|564632942|FG000|Overall Study|Withdrawal by Subject|3|||
156420972|NCT00162942|564632943|FG001|Overall Study|Withdrawal by Subject|6|||
156420973|NCT00162942|564632942|FG000|Overall Study|Physician Decision|1|||
156420974|NCT00162942|564632943|FG001|Overall Study|Physician Decision|0|||
156420975|NCT00162942|564632942|FG000|Overall Study|Enter Open-Label Study|76|||
156420976|NCT00162942|564632943|FG001|Overall Study|Enter Open-Label Study|35|||
156420977|NCT00162942|564632942|FG000|Overall Study|Alternate Therapy|6|||
156420978|NCT00162942|564632943|FG001|Overall Study|Alternate Therapy|2|||
156319378|NCT04214288|564269355|FG002|Overall Study|Other|0|||
156420979|NCT00162942|564632942|FG000|Overall Study|Lack of Efficacy|1|||
156420980|NCT00162942|564632943|FG001|Overall Study|Lack of Efficacy|0|||
156420981|NCT00162942|564632942|FG000|Overall Study|Flare During Active Treatment|7|||
156420982|NCT00162942|564632943|FG001|Overall Study|Flare During Active Treatment|3|||
156420983|NCT00162942|564632942|FG000|Overall Study|2 or more consecutive treatments missed|1|||
156420984|NCT00162942|564632943|FG001|Overall Study|2 or more consecutive treatments missed|0|||
156420985|NCT01167023|564632944|FG000|Overall Study|Lost to Follow-up|0|||
156420986|NCT01167023|564632945|FG001|Overall Study|Lost to Follow-up|1|||
156420987|NCT01167023|564632946|FG002|Overall Study|Lost to Follow-up|1|||
156420988|NCT01167023|564632944|FG000|Overall Study|Screen Failure|0|||
156420989|NCT01167023|564632945|FG001|Overall Study|Screen Failure|1|||
156420990|NCT01167023|564632946|FG002|Overall Study|Screen Failure|0|||
156420991|NCT01167023|564632944|FG000|Overall Study|Sponsor Decision|0|||
156420992|NCT01167023|564632945|FG001|Overall Study|Sponsor Decision|1|||
156420993|NCT01167023|564632946|FG002|Overall Study|Sponsor Decision|0|||
156420994|NCT01167023|564632944|FG000|Overall Study|Withdrawal by Subject|0|||
156420995|NCT01167023|564632945|FG001|Overall Study|Withdrawal by Subject|0|||
156420996|NCT01167023|564632946|FG002|Overall Study|Withdrawal by Subject|1|||
156420997|NCT00410384|564632947|FG000|Overall Study|Withdrawal by Subject|28|||
156420998|NCT00410384|564632948|FG001|Overall Study|Withdrawal by Subject|17|||
156420999|NCT00410384|564632949|FG002|Overall Study|Withdrawal by Subject|20|||
156421000|NCT00410384|564632947|FG000|Overall Study|Adverse Event|23|||
156421001|NCT00410384|564632948|FG001|Overall Study|Adverse Event|18|||
156421002|NCT00410384|564632949|FG002|Overall Study|Adverse Event|23|||
156421003|NCT00410384|564632947|FG000|Overall Study|Lack of Efficacy|20|||
156421004|NCT00410384|564632948|FG001|Overall Study|Lack of Efficacy|12|||
156421005|NCT00410384|564632949|FG002|Overall Study|Lack of Efficacy|17|||
156761896|NCT01747499|565879923|FG000|Overall Study|Physician Decision|0|||
156761897|NCT01747499|565879924|FG001|Overall Study|Physician Decision|1|||
156761898|NCT01747499|565879925|FG002|Overall Study|Physician Decision|0|||
156421006|NCT00410384|564632947|FG000|Overall Study|Lack of Compliance|2|||
156421007|NCT00410384|564632948|FG001|Overall Study|Lack of Compliance|2|||
156421008|NCT00410384|564632949|FG002|Overall Study|Lack of Compliance|2|||
156421009|NCT00410384|564632947|FG000|Overall Study|Lost to Follow-up|4|||
156421010|NCT00410384|564632948|FG001|Overall Study|Lost to Follow-up|6|||
156421011|NCT00410384|564632949|FG002|Overall Study|Lost to Follow-up|6|||
156421012|NCT00410384|564632947|FG000|Overall Study|Protocol Violation|6|||
156421013|NCT00410384|564632948|FG001|Overall Study|Protocol Violation|6|||
156421014|NCT00410384|564632949|FG002|Overall Study|Protocol Violation|6|||
156421015|NCT00410384|564632947|FG000|Overall Study|Physician Decision|3|||
156421016|NCT00410384|564632948|FG001|Overall Study|Physician Decision|3|||
156421017|NCT00410384|564632949|FG002|Overall Study|Physician Decision|4|||
156421018|NCT00410384|564632947|FG000|Overall Study|Other|3|||
156421019|NCT00410384|564632948|FG001|Overall Study|Other|8|||
156421020|NCT00410384|564632949|FG002|Overall Study|Other|4|||
156421021|NCT00577629|564632950|FG000|Treatment Period|Death|1|||
156421022|NCT00577629|564632950|FG000|Long Term Follow-Up|Death|15|||
156421023|NCT00577629|564632950|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
156421024|NCT00577629|564632950|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
156421025|NCT00577629|564632950|FG000|Long Term Follow-Up|Physician Decision|1|||
156421026|NCT04887285|564632951|FG000|Overall Study|Lost to Follow-up|0|||
156421027|NCT04887285|564632952|FG001|Overall Study|Lost to Follow-up|2|||
156421028|NCT04887285|564632953|FG002|Overall Study|Lost to Follow-up|3|||
156421029|NCT04640571|564632954|FG000|Overall Study|Withdrawal by Subject|0|||
156421030|NCT04640571|564632955|FG001|Overall Study|Withdrawal by Subject|0|||
156421031|NCT04640571|564632956|FG002|Overall Study|Withdrawal by Subject|0|||
156421032|NCT04640571|564632957|FG003|Overall Study|Withdrawal by Subject|0|||
156421033|NCT04640571|564632958|FG004|Overall Study|Withdrawal by Subject|0|||
156421034|NCT04640571|564632959|FG005|Overall Study|Withdrawal by Subject|2|||
156421035|NCT02820051|564632960|FG000|Overall Study|Lost to Follow-up|7|||
156761899|NCT01747499|565879926|FG003|Overall Study|Physician Decision|0|||
156761900|NCT01747499|565879927|FG004|Overall Study|Physician Decision|2|||
156761901|NCT01747499|565879923|FG000|Overall Study|Death|0|||
156421036|NCT02820051|564632961|FG001|Overall Study|Lost to Follow-up|4|||
156421037|NCT00832780|564632963|FG000|Overall Study|Death|16|||
156421038|NCT00832780|564632963|FG000|Overall Study|Lost to Follow-up|4|||
156421039|NCT00832780|564632963|FG000|Overall Study|no reason given|2|||
156421040|NCT00832780|564632963|FG000|Overall Study|other complicating condition|2|||
156421041|NCT00832780|564632963|FG000|Overall Study|Physician Decision|1|||
156421042|NCT05705167|564632966|FG000|Overall Study|Randomised but not Treated|0|||
156421043|NCT05705167|564632967|FG001|Overall Study|Randomised but not Treated|2|||
156421044|NCT05705167|564632968|FG002|Overall Study|Randomised but not Treated|0|||
156421045|NCT05705167|564632969|FG003|Overall Study|Randomised but not Treated|7|||
156421046|NCT05705167|564632970|FG004|Overall Study|Randomised but not Treated|0|||
156421047|NCT05705167|564632971|FG005|Overall Study|Randomised but not Treated|0|||
156421048|NCT05705167|564632972|FG006|Overall Study|Randomised but not Treated|0|||
156421049|NCT05705167|564632966|FG000|Overall Study|Death|0|||
156421050|NCT05705167|564632967|FG001|Overall Study|Death|0|||
156421051|NCT05705167|564632968|FG002|Overall Study|Death|3|||
156761902|NCT01747499|565879924|FG001|Overall Study|Death|0|||
156761903|NCT01747499|565879925|FG002|Overall Study|Death|0|||
156761904|NCT01747499|565879926|FG003|Overall Study|Death|1|||
156761905|NCT01747499|565879927|FG004|Overall Study|Death|1|||
156761906|NCT01747499|565879923|FG000|Overall Study|Withdrawal by Subject|0|||
156761907|NCT01747499|565879924|FG001|Overall Study|Withdrawal by Subject|0|||
156761908|NCT01747499|565879925|FG002|Overall Study|Withdrawal by Subject|0|||
156761909|NCT01747499|565879926|FG003|Overall Study|Withdrawal by Subject|0|||
156761910|NCT01747499|565879927|FG004|Overall Study|Withdrawal by Subject|6|||
156761911|NCT01747499|565879923|FG000|Overall Study|Developed AML and death|0|||
156761912|NCT01747499|565879924|FG001|Overall Study|Developed AML and death|0|||
156761913|NCT01747499|565879925|FG002|Overall Study|Developed AML and death|0|||
156761914|NCT01747499|565879926|FG003|Overall Study|Developed AML and death|0|||
156761915|NCT01747499|565879927|FG004|Overall Study|Developed AML and death|1|||
156761916|NCT01747499|565879923|FG000|Overall Study|Determined not to be eligible|0|||
156761917|NCT01747499|565879924|FG001|Overall Study|Determined not to be eligible|0|||
156761918|NCT01747499|565879925|FG002|Overall Study|Determined not to be eligible|0|||
156761919|NCT01747499|565879926|FG003|Overall Study|Determined not to be eligible|0|||
156761920|NCT01747499|565879927|FG004|Overall Study|Determined not to be eligible|1|||
156761921|NCT01676701|565879928|FG000|Overall Study|Protocol Violation|1|||
156761922|NCT01676701|565879929|FG001|Overall Study|Protocol Violation|0|||
156761923|NCT01676701|565879928|FG000|Overall Study|Sponsor Decision|3|||
156761924|NCT01676701|565879929|FG001|Overall Study|Sponsor Decision|4|||
156761925|NCT02115607|565879930|FG000|Overall Study|Withdrawal by Subject|1|||
156761926|NCT00196105|565879934|FG000|Overall Study|Lost to Follow-up|4|||
156761927|NCT00196105|565879935|FG001|Overall Study|Lost to Follow-up|5|||
156761928|NCT00196105|565879936|FG002|Overall Study|Lost to Follow-up|7|||
156761929|NCT04863872|565879937|FG000|Overall Study|Withdrawal by Subject|4|||
156761930|NCT04863872|565879938|FG001|Overall Study|Withdrawal by Subject|15|||
156761931|NCT04863872|565879937|FG000|Overall Study|Death|5|||
156761932|NCT04863872|565879938|FG001|Overall Study|Death|2|||
156761933|NCT04863872|565879937|FG000|Overall Study|Lost to Follow-up|2|||
156319379|NCT04214288|564269356|FG003|Overall Study|Other|6|||
156761934|NCT04863872|565879938|FG001|Overall Study|Lost to Follow-up|1|||
156761935|NCT01497067|565879939|FG000|Overall Study|Lost to Follow-up|56|||
156761936|NCT01497067|565879939|FG000|Overall Study|Adverse Event|3|||
156761937|NCT01497067|565879939|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
156761938|NCT01497067|565879939|FG000|Overall Study|Other|13|||
156761939|NCT05616013|565879944|FG000|Overall Study|Adverse Event|6|||
156761940|NCT05616013|565879945|FG001|Overall Study|Adverse Event|12|||
156761941|NCT05616013|565879946|FG002|Overall Study|Adverse Event|8|||
156761942|NCT05616013|565879947|FG003|Overall Study|Adverse Event|4|||
156761943|NCT05616013|565879948|FG004|Overall Study|Adverse Event|6|||
156761944|NCT05616013|565879949|FG005|Overall Study|Adverse Event|8|||
156761945|NCT05616013|565879950|FG006|Overall Study|Adverse Event|3|||
156761946|NCT05616013|565879951|FG007|Overall Study|Adverse Event|6|||
156761947|NCT05616013|565879952|FG008|Overall Study|Adverse Event|1|||
156761948|NCT05616013|565879944|FG000|Overall Study|Lost to Follow-up|5|||
156319380|NCT04214288|564269353|FG000|Overall Study|Protocol Violation|0|||
156319381|NCT04214288|564269354|FG001|Overall Study|Protocol Violation|1|||
156319382|NCT04214288|564269355|FG002|Overall Study|Protocol Violation|0|||
156319383|NCT04214288|564269356|FG003|Overall Study|Protocol Violation|0|||
156319384|NCT04214288|564269353|FG000|Overall Study|Withdrawal by Subject|8|||
156319385|NCT04214288|564269354|FG001|Overall Study|Withdrawal by Subject|4|||
156319386|NCT04214288|564269355|FG002|Overall Study|Withdrawal by Subject|0|||
156319387|NCT04214288|564269356|FG003|Overall Study|Withdrawal by Subject|9|||
156319388|NCT03675321|564269357|FG000|Overall Study|Lack of Efficacy|2|||
156319389|NCT03675321|564269358|FG001|Overall Study|Lack of Efficacy|2|||
156319390|NCT03675321|564269357|FG000|Overall Study|Withdrawal by Subject|1|||
156319391|NCT03675321|564269358|FG001|Overall Study|Withdrawal by Subject|3|||
156319392|NCT00807027|564269359|FG000|Overall Study|Withdrawal by Subject|13|||
156319393|NCT00807027|564269360|FG001|Overall Study|Withdrawal by Subject|14|||
156319394|NCT00807027|564269359|FG000|Overall Study|Protocol Violation|1|||
156319395|NCT00807027|564269360|FG001|Overall Study|Protocol Violation|1|||
156761949|NCT05616013|565879945|FG001|Overall Study|Lost to Follow-up|4|||
156761950|NCT05616013|565879946|FG002|Overall Study|Lost to Follow-up|3|||
156761951|NCT05616013|565879947|FG003|Overall Study|Lost to Follow-up|2|||
156761952|NCT05616013|565879948|FG004|Overall Study|Lost to Follow-up|0|||
156761953|NCT05616013|565879949|FG005|Overall Study|Lost to Follow-up|5|||
156761954|NCT05616013|565879950|FG006|Overall Study|Lost to Follow-up|2|||
156319396|NCT00807027|564269359|FG000|Overall Study|Adverse Event|2|||
156319397|NCT00807027|564269360|FG001|Overall Study|Adverse Event|2|||
156319398|NCT03997383|564269361|FG000|Double-blind Treatment Period|Adverse Event|4|||
156319399|NCT03997383|564269362|FG001|Double-blind Treatment Period|Adverse Event|3|||
156761955|NCT05616013|565879951|FG007|Overall Study|Lost to Follow-up|1|||
156761956|NCT05616013|565879952|FG008|Overall Study|Lost to Follow-up|2|||
156761957|NCT05616013|565879944|FG000|Overall Study|Non-compliance with study requirements|2|||
156761958|NCT05616013|565879945|FG001|Overall Study|Non-compliance with study requirements|2|||
156319400|NCT03997383|564269361|FG000|Double-blind Treatment Period|Death|4|||
156319401|NCT03997383|564269362|FG001|Double-blind Treatment Period|Death|4|||
156319402|NCT03997383|564269361|FG000|Double-blind Treatment Period|Physician Decision|2|||
156319403|NCT03997383|564269362|FG001|Double-blind Treatment Period|Physician Decision|0|||
156319404|NCT03997383|564269361|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
156319405|NCT03997383|564269362|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
156319406|NCT03997383|564269361|FG000|Open-label Extension Period|Ongoing|148|||
156319407|NCT03997383|564269362|FG001|Open-label Extension Period|Ongoing|151|||
156319408|NCT03997383|564269361|FG000|Open-label Extension Period|Adverse Event|4|||
156319409|NCT03997383|564269362|FG001|Open-label Extension Period|Adverse Event|1|||
156319410|NCT03997383|564269361|FG000|Open-label Extension Period|Death|8|||
156319411|NCT03997383|564269362|FG001|Open-label Extension Period|Death|9|||
156319412|NCT03997383|564269361|FG000|Open-label Extension Period|Physician Decision|1|||
156319413|NCT03997383|564269362|FG001|Open-label Extension Period|Physician Decision|1|||
156319414|NCT03997383|564269361|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
156319415|NCT03997383|564269362|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
156319416|NCT03997383|564269361|FG000|Open-label Extension Period|Reason Not Specified|2|||
156319417|NCT03997383|564269362|FG001|Open-label Extension Period|Reason Not Specified|0|||
156654668|NCT02974153|565481690|FG002|Overall Study|Withdrawal by Subject|11|||
156654669|NCT02974153|565481688|FG000|Overall Study|Study Burden|8|||
156319418|NCT02278341|564269363|FG000|Overall Study|Randomized but never received study drug|1|||
156319419|NCT02278341|564269364|FG001|Overall Study|Randomized but never received study drug|1|||
156319420|NCT02278341|564269363|FG000|Overall Study|Adverse Event|3|||
156319421|NCT02278341|564269364|FG001|Overall Study|Adverse Event|0|||
156319422|NCT02278341|564269363|FG000|Overall Study|Death|68|||
156319423|NCT02278341|564269364|FG001|Overall Study|Death|56|||
156319424|NCT02278341|564269363|FG000|Overall Study|Withdrawal by Subject|30|||
156319425|NCT02278341|564269364|FG001|Overall Study|Withdrawal by Subject|19|||
156319426|NCT02278341|564269363|FG000|Overall Study|Lost to Follow-up|0|||
156319427|NCT02278341|564269364|FG001|Overall Study|Lost to Follow-up|1|||
156319428|NCT02278341|564269363|FG000|Overall Study|Physician Decision|1|||
156319429|NCT02278341|564269364|FG001|Overall Study|Physician Decision|1|||
156319430|NCT02278341|564269363|FG000|Overall Study|Miscellaneous|15|||
156319431|NCT02278341|564269364|FG001|Overall Study|Miscellaneous|14|||
156654670|NCT02974153|565481689|FG001|Overall Study|Study Burden|7|||
156654671|NCT02974153|565481690|FG002|Overall Study|Study Burden|3|||
156654672|NCT02974153|565481688|FG000|Overall Study|Other|14|||
156654673|NCT02974153|565481689|FG001|Overall Study|Other|8|||
156654674|NCT02974153|565481690|FG002|Overall Study|Other|7|||
156654675|NCT01202747|565481691|FG000|Overall Study|Withdrawal by Subject|1|||
156654676|NCT01446913|565481692|FG000|Overall Study|Significant illness|1|||
156654677|NCT01446913|565481693|FG001|Overall Study|Significant illness|1|||
156654678|NCT01446913|565481694|FG002|Overall Study|Significant illness|1|||
156654679|NCT01446913|565481692|FG000|Overall Study|Withdrawal by Subject|5|||
156654680|NCT01446913|565481693|FG001|Overall Study|Withdrawal by Subject|3|||
156654681|NCT01446913|565481694|FG002|Overall Study|Withdrawal by Subject|5|||
156654682|NCT01446913|565481692|FG000|Overall Study|Physician Decision|0|||
156654683|NCT01446913|565481693|FG001|Overall Study|Physician Decision|0|||
156654684|NCT01446913|565481694|FG002|Overall Study|Physician Decision|2|||
156654685|NCT01446913|565481692|FG000|Overall Study|Lost to Follow-up|3|||
156654686|NCT01446913|565481693|FG001|Overall Study|Lost to Follow-up|5|||
156654687|NCT01446913|565481694|FG002|Overall Study|Lost to Follow-up|3|||
156654688|NCT02521948|565481695|FG000|Overall Study|Adverse Event|2|||
156654689|NCT02521948|565481695|FG000|Overall Study|Death|4|||
156654690|NCT02521948|565481695|FG000|Overall Study|Lost to Follow-up|1|||
156654691|NCT02521948|565481695|FG000|Overall Study|Did not attend one or both follow-ups|6|||
156654692|NCT00423800|565481696|FG000|Overall Study|Protocol Violation|0|||
156654693|NCT00423800|565481697|FG001|Overall Study|Protocol Violation|1|||
156654694|NCT02292238|565481698|FG000|Overall Study|Protocol Violation|1|||
156654695|NCT02292238|565481699|FG001|Overall Study|Protocol Violation|2|||
156654696|NCT02292238|565481698|FG000|Overall Study|Withdrawal by Subject|2|||
156654697|NCT02292238|565481699|FG001|Overall Study|Withdrawal by Subject|1|||
156654698|NCT02292238|565481698|FG000|Overall Study|Lost to Follow-up|1|||
156654699|NCT02292238|565481699|FG001|Overall Study|Lost to Follow-up|0|||
156654700|NCT02292238|565481698|FG000|Overall Study|Physician Decision|0|||
156654701|NCT02292238|565481699|FG001|Overall Study|Physician Decision|1|||
156654702|NCT04000009|565481700|FG000|Overall Study|Adverse Event|13|||
156654703|NCT04000009|565481700|FG000|Overall Study|Lack of Efficacy|7|||
156654704|NCT04000009|565481700|FG000|Overall Study|Lost to Follow-up|8|||
156654705|NCT04000009|565481700|FG000|Overall Study|Noncompliance with study drug|4|||
156654706|NCT04000009|565481700|FG000|Overall Study|Physician Decision|1|||
156654707|NCT04000009|565481700|FG000|Overall Study|Use of prohibited medication|3|||
156654708|NCT04000009|565481700|FG000|Overall Study|Pregnancy|1|||
156654709|NCT04000009|565481700|FG000|Overall Study|Withdrawal by Subject|22|||
156654710|NCT04000009|565481700|FG000|Overall Study|Study terminated by sponsor|98|||
156654711|NCT04000009|565481700|FG000|Overall Study|Not further specified|8|||
156654712|NCT01754259|565481703|FG000|Overall Study|Withdrawal by Subject|2|||
156761959|NCT05616013|565879946|FG002|Overall Study|Non-compliance with study requirements|2|||
156319432|NCT04902326|564269367|FG000|Overall Study|Withdrawal by Subject|1|||
156319433|NCT04902326|564269368|FG001|Overall Study|Withdrawal by Subject|3|||
156319434|NCT04902326|564269369|FG002|Overall Study|Withdrawal by Subject|0|||
156319435|NCT04902326|564269370|FG003|Overall Study|Withdrawal by Subject|1|||
156319436|NCT04902326|564269367|FG000|Overall Study|Lost to Follow-up|14|||
156319437|NCT04902326|564269368|FG001|Overall Study|Lost to Follow-up|14|||
156319438|NCT04902326|564269369|FG002|Overall Study|Lost to Follow-up|14|||
156319439|NCT04902326|564269370|FG003|Overall Study|Lost to Follow-up|6|||
156319440|NCT01487577|564269371|FG000|Overall Study|Became ineligible after signing consent|1|||
156319441|NCT01653782|564269374|FG000|Overall Study|Withdrawal by Subject|9|||
156319442|NCT01653782|564269375|FG001|Overall Study|Withdrawal by Subject|15|||
156319443|NCT01653782|564269376|FG002|Overall Study|Withdrawal by Subject|4|||
156319444|NCT01653782|564269374|FG000|Overall Study|Lost to Follow-up|7|||
156319445|NCT01653782|564269375|FG001|Overall Study|Lost to Follow-up|3|||
156319446|NCT01653782|564269376|FG002|Overall Study|Lost to Follow-up|2|||
156319447|NCT01155479|564269382|FG000|Part I|Adverse Event|13|||
156319448|NCT01155479|564269383|FG001|Part I|Adverse Event|8|||
156319449|NCT01155479|564269384|FG002|Part I|Adverse Event|18|||
156319450|NCT01155479|564269385|FG003|Part I|Adverse Event|7|||
156319451|NCT01155479|564269386|FG004|Part I|Adverse Event|6|||
156319452|NCT01155479|564269382|FG000|Part I|Administrative|2|||
156319453|NCT01155479|564269383|FG001|Part I|Administrative|2|||
156319454|NCT01155479|564269384|FG002|Part I|Administrative|2|||
156319455|NCT01155479|564269385|FG003|Part I|Administrative|0|||
156319456|NCT01155479|564269386|FG004|Part I|Administrative|0|||
156319457|NCT01155479|564269382|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
156319458|NCT01155479|564269383|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
156319459|NCT01155479|564269384|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
156319460|NCT01155479|564269385|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
156319461|NCT01155479|564269386|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
156319462|NCT01155479|564269382|FG000|Part I|Withdrawal by Subject|11|||
156319463|NCT01155479|564269383|FG001|Part I|Withdrawal by Subject|13|||
156319464|NCT01155479|564269384|FG002|Part I|Withdrawal by Subject|8|||
156319465|NCT01155479|564269385|FG003|Part I|Withdrawal by Subject|8|||
156319466|NCT01155479|564269386|FG004|Part I|Withdrawal by Subject|9|||
156319467|NCT01155479|564269382|FG000|Part I|Lost to Follow-up|0|||
156319468|NCT01155479|564269383|FG001|Part I|Lost to Follow-up|0|||
156319469|NCT01155479|564269384|FG002|Part I|Lost to Follow-up|1|||
156319470|NCT01155479|564269385|FG003|Part I|Lost to Follow-up|1|||
156319471|NCT01155479|564269386|FG004|Part I|Lost to Follow-up|0|||
156319472|NCT01155479|564269382|FG000|Part I|Treatment Failure|3|||
156319473|NCT01155479|564269383|FG001|Part I|Treatment Failure|0|||
156319474|NCT01155479|564269384|FG002|Part I|Treatment Failure|3|||
156319475|NCT01155479|564269385|FG003|Part I|Treatment Failure|1|||
156319476|NCT01155479|564269386|FG004|Part I|Treatment Failure|2|||
156319477|NCT01155479|564269382|FG000|Part I|Did Not Receive Treatment|4|||
156319478|NCT01155479|564269383|FG001|Part I|Did Not Receive Treatment|2|||
156319479|NCT01155479|564269384|FG002|Part I|Did Not Receive Treatment|2|||
156319480|NCT01155479|564269385|FG003|Part I|Did Not Receive Treatment|6|||
156319481|NCT01155479|564269386|FG004|Part I|Did Not Receive Treatment|1|||
156319482|NCT01155479|564269382|FG000|Part I|Non-Compliance with Protocol|2|||
156319483|NCT01155479|564269383|FG001|Part I|Non-Compliance with Protocol|1|||
156319484|NCT01155479|564269384|FG002|Part I|Non-Compliance with Protocol|3|||
156319485|NCT01155479|564269385|FG003|Part I|Non-Compliance with Protocol|3|||
156319486|NCT01155479|564269386|FG004|Part I|Non-Compliance with Protocol|2|||
156319487|NCT01155479|564269382|FG000|Part II|Adverse Event|7|||
156319488|NCT01155479|564269383|FG001|Part II|Adverse Event|6|||
156319489|NCT01155479|564269384|FG002|Part II|Adverse Event|8|||
156319490|NCT01155479|564269385|FG003|Part II|Adverse Event|3|||
156319491|NCT01155479|564269386|FG004|Part II|Adverse Event|4|||
156319492|NCT01155479|564269382|FG000|Part II|Administrative|43|||
156421052|NCT05705167|564632969|FG003|Overall Study|Death|0|||
156319493|NCT01155479|564269383|FG001|Part II|Administrative|49|||
156319494|NCT01155479|564269384|FG002|Part II|Administrative|36|||
156319495|NCT01155479|564269385|FG003|Part II|Administrative|38|||
156654713|NCT01754259|565481704|FG001|Overall Study|Withdrawal by Subject|4|||
156654714|NCT01754259|565481703|FG000|Overall Study|Adverse Event|3|||
156654715|NCT01754259|565481704|FG001|Overall Study|Adverse Event|1|||
156654716|NCT01754259|565481703|FG000|Overall Study|Lost to Follow-up|0|||
156654717|NCT01754259|565481704|FG001|Overall Study|Lost to Follow-up|1|||
156654718|NCT00619385|565481705|FG000|Overall Study|Adverse Event|0|||
156654719|NCT00619385|565481706|FG001|Overall Study|Adverse Event|0|||
156654720|NCT00619385|565481707|FG002|Overall Study|Adverse Event|3|||
156654721|NCT00619385|565481705|FG000|Overall Study|Other|1|||
156654722|NCT00619385|565481706|FG001|Overall Study|Other|2|||
156654723|NCT00619385|565481707|FG002|Overall Study|Other|1|||
156319496|NCT01155479|564269386|FG004|Part II|Administrative|46|||
156319497|NCT01155479|564269382|FG000|Part II|Withdrawal by Subject|8|||
156319498|NCT01155479|564269383|FG001|Part II|Withdrawal by Subject|4|||
156319499|NCT01155479|564269384|FG002|Part II|Withdrawal by Subject|12|||
156654724|NCT02041702|565481710|FG000|Overall Study|Lost to Follow-up|1|||
156421053|NCT05705167|564632970|FG004|Overall Study|Death|1|||
156421054|NCT05705167|564632971|FG005|Overall Study|Death|1|||
156421055|NCT05705167|564632972|FG006|Overall Study|Death|1|||
156421056|NCT05705167|564632966|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
156421057|NCT05705167|564632967|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
156421058|NCT05705167|564632968|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
156421059|NCT05705167|564632969|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
156421060|NCT05705167|564632970|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
156421061|NCT05705167|564632971|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
156421062|NCT05705167|564632972|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
156421063|NCT04529538|564632973|FG000|Overall Study|Lost to Follow-up|3|||
156421064|NCT04529538|564632974|FG001|Overall Study|Lost to Follow-up|2|||
156421065|NCT04529538|564632975|FG002|Overall Study|Lost to Follow-up|1|||
156421066|NCT04529538|564632976|FG003|Overall Study|Lost to Follow-up|0|||
156421067|NCT04529538|564632977|FG004|Overall Study|Lost to Follow-up|1|||
156421068|NCT04529538|564632978|FG005|Overall Study|Lost to Follow-up|1|||
156421069|NCT04529538|564632979|FG006|Overall Study|Lost to Follow-up|2|||
156421070|NCT04529538|564632980|FG007|Overall Study|Lost to Follow-up|0|||
156421071|NCT04529538|564632973|FG000|Overall Study|Not eligible at enrollment|0|||
156421072|NCT04529538|564632974|FG001|Overall Study|Not eligible at enrollment|1|||
156421073|NCT04529538|564632975|FG002|Overall Study|Not eligible at enrollment|2|||
156654725|NCT02041702|565481711|FG001|Overall Study|Lost to Follow-up|6|||
156654726|NCT02041702|565481710|FG000|Overall Study|Death|4|||
156654727|NCT02041702|565481711|FG001|Overall Study|Death|0|||
156654728|NCT02041702|565481710|FG000|Overall Study|Withdrawal by Subject|4|||
156654729|NCT02041702|565481711|FG001|Overall Study|Withdrawal by Subject|3|||
156654730|NCT02041702|565481710|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
156654731|NCT02041702|565481711|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
156654732|NCT02041702|565481710|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
156654733|NCT02041702|565481711|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
156654734|NCT00203307|565481712|FG000|First Intervention|Adverse Event|2|||
156654735|NCT00203307|565481713|FG001|First Intervention|Adverse Event|0|||
156654736|NCT03730103|565481714|FG000|Overall Study|Did not meet inclusion criteria|0|||
156654737|NCT03730103|565481715|FG001|Overall Study|Did not meet inclusion criteria|5|||
156654738|NCT01488578|565481716|FG000|Overall Study|Protocol Violation|1836|||
156654739|NCT02308111|565481717|FG000|Overall Study|Adverse Event|31|||
156654740|NCT02308111|565481718|FG001|Overall Study|Adverse Event|19|||
156654741|NCT02308111|565481717|FG000|Overall Study|Death|9|||
156654742|NCT02308111|565481718|FG001|Overall Study|Death|6|||
156654743|NCT02308111|565481717|FG000|Overall Study|Lost to Follow-up|2|||
156654744|NCT02308111|565481718|FG001|Overall Study|Lost to Follow-up|7|||
156654745|NCT02308111|565481717|FG000|Overall Study|Physician Decision|6|||
156654746|NCT02308111|565481718|FG001|Overall Study|Physician Decision|17|||
156654747|NCT02308111|565481717|FG000|Overall Study|Protocol Violation|0|||
156654748|NCT02308111|565481718|FG001|Overall Study|Protocol Violation|1|||
156654749|NCT02308111|565481717|FG000|Overall Study|Withdrawal by Subject|28|||
156654750|NCT02308111|565481718|FG001|Overall Study|Withdrawal by Subject|38|||
156654751|NCT02308111|565481717|FG000|Overall Study|Study Terminated by Sponsor|72|||
156654752|NCT02308111|565481718|FG001|Overall Study|Study Terminated by Sponsor|61|||
156654753|NCT02308111|565481717|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
156654754|NCT02308111|565481718|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
156654755|NCT02308111|565481717|FG000|Overall Study|Site Closure|3|||
156654756|NCT02308111|565481718|FG001|Overall Study|Site Closure|3|||
156654757|NCT02308111|565481717|FG000|Overall Study|Non-compliance with Study Drug|3|||
156654758|NCT02308111|565481718|FG001|Overall Study|Non-compliance with Study Drug|1|||
156654759|NCT02308111|565481717|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
156654760|NCT02308111|565481718|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
156654761|NCT02308111|565481717|FG000|Overall Study|Liver Transplant|3|||
156654762|NCT02308111|565481718|FG001|Overall Study|Liver Transplant|3|||
156654763|NCT02308111|565481717|FG000|Overall Study|Liver Transplant Waitlist|2|||
156654764|NCT02308111|565481718|FG001|Overall Study|Liver Transplant Waitlist|2|||
156654765|NCT02308111|565481717|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
156654766|NCT02308111|565481718|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
156654767|NCT00717756|565481719|FG000|Overall Study|Withdrawal by Subject|1|||
156654768|NCT01873859|565481724|FG000|Overall Study|Withdrawal by Subject|0|||
156654769|NCT01873859|565481725|FG001|Overall Study|Withdrawal by Subject|4|||
156654770|NCT01364870|565481726|FG000|Overall Study|Withdrawal by Subject|13|||
156654771|NCT01364870|565481727|FG001|Overall Study|Withdrawal by Subject|24|||
156421074|NCT04529538|564632976|FG003|Overall Study|Not eligible at enrollment|1|||
156421075|NCT04529538|564632977|FG004|Overall Study|Not eligible at enrollment|0|||
156421076|NCT04529538|564632978|FG005|Overall Study|Not eligible at enrollment|0|||
156654772|NCT01364870|565481728|FG002|Overall Study|Withdrawal by Subject|10|||
156654773|NCT01364870|565481726|FG000|Overall Study|Adverse Event|8|||
156654774|NCT01364870|565481727|FG001|Overall Study|Adverse Event|6|||
156654775|NCT01364870|565481728|FG002|Overall Study|Adverse Event|4|||
156421077|NCT04529538|564632979|FG006|Overall Study|Not eligible at enrollment|0|||
156421078|NCT04529538|564632980|FG007|Overall Study|Not eligible at enrollment|1|||
156421079|NCT04529538|564632973|FG000|Overall Study|Withdrawal by Subject|0|||
156421080|NCT04529538|564632974|FG001|Overall Study|Withdrawal by Subject|1|||
156421081|NCT04529538|564632975|FG002|Overall Study|Withdrawal by Subject|1|||
156421082|NCT04529538|564632976|FG003|Overall Study|Withdrawal by Subject|2|||
156421083|NCT04529538|564632977|FG004|Overall Study|Withdrawal by Subject|0|||
156421084|NCT04529538|564632978|FG005|Overall Study|Withdrawal by Subject|2|||
156421085|NCT04529538|564632979|FG006|Overall Study|Withdrawal by Subject|3|||
156421086|NCT04529538|564632980|FG007|Overall Study|Withdrawal by Subject|0|||
156421087|NCT04529538|564632973|FG000|Overall Study|Other|0|||
156421088|NCT04529538|564632974|FG001|Overall Study|Other|1|||
156421089|NCT04529538|564632975|FG002|Overall Study|Other|0|||
156421090|NCT04529538|564632976|FG003|Overall Study|Other|0|||
156421091|NCT04529538|564632977|FG004|Overall Study|Other|0|||
156421092|NCT04529538|564632978|FG005|Overall Study|Other|0|||
156421093|NCT04529538|564632979|FG006|Overall Study|Other|0|||
156421094|NCT04529538|564632980|FG007|Overall Study|Other|0|||
156421095|NCT04529538|564632973|FG000|Overall Study|Adverse Event|0|||
156421096|NCT04529538|564632974|FG001|Overall Study|Adverse Event|0|||
156421097|NCT04529538|564632975|FG002|Overall Study|Adverse Event|0|||
156421098|NCT04529538|564632976|FG003|Overall Study|Adverse Event|1|||
156421099|NCT04529538|564632977|FG004|Overall Study|Adverse Event|0|||
156421100|NCT04529538|564632978|FG005|Overall Study|Adverse Event|0|||
156421101|NCT04529538|564632979|FG006|Overall Study|Adverse Event|0|||
156421102|NCT04529538|564632980|FG007|Overall Study|Adverse Event|0|||
156421103|NCT04529538|564632973|FG000|Overall Study|Protocol Deviation|0|||
156421104|NCT04529538|564632974|FG001|Overall Study|Protocol Deviation|0|||
156421105|NCT04529538|564632975|FG002|Overall Study|Protocol Deviation|0|||
156421106|NCT04529538|564632976|FG003|Overall Study|Protocol Deviation|1|||
156421107|NCT04529538|564632977|FG004|Overall Study|Protocol Deviation|0|||
156421108|NCT04529538|564632978|FG005|Overall Study|Protocol Deviation|0|||
156421109|NCT04529538|564632979|FG006|Overall Study|Protocol Deviation|0|||
156421110|NCT04529538|564632980|FG007|Overall Study|Protocol Deviation|0|||
156421111|NCT04529538|564632973|FG000|Overall Study|Physician Decision|0|||
156421112|NCT04529538|564632974|FG001|Overall Study|Physician Decision|0|||
156421113|NCT04529538|564632975|FG002|Overall Study|Physician Decision|0|||
156421114|NCT04529538|564632976|FG003|Overall Study|Physician Decision|0|||
156421115|NCT04529538|564632977|FG004|Overall Study|Physician Decision|0|||
156421116|NCT04529538|564632978|FG005|Overall Study|Physician Decision|1|||
156421117|NCT04529538|564632979|FG006|Overall Study|Physician Decision|0|||
156421118|NCT04529538|564632980|FG007|Overall Study|Physician Decision|1|||
156421119|NCT03658811|564632984|FG000|Overall Study|Lost to Follow-up|3|||
156421120|NCT04209790|564632987|FG000|Overall Study|Physician Decision|1|||
156421121|NCT04060680|564632988|FG000|Overall Study|Unsuccessful implant|17|||
156421122|NCT04060680|564632989|FG001|Overall Study|Unsuccessful implant|2|||
156421123|NCT04060680|564632988|FG000|Overall Study|Adverse Event|3|||
156421124|NCT04060680|564632989|FG001|Overall Study|Adverse Event|0|||
156421125|NCT04060680|564632988|FG000|Overall Study|Death|2|||
156421126|NCT04060680|564632989|FG001|Overall Study|Death|0|||
156421127|NCT04060680|564632988|FG000|Overall Study|Study product no longer in use|1|||
156421128|NCT04060680|564632989|FG001|Overall Study|Study product no longer in use|0|||
156421129|NCT04060680|564632988|FG000|Overall Study|Withdrawal by Subject|1|||
156421130|NCT04060680|564632989|FG001|Overall Study|Withdrawal by Subject|0|||
156421131|NCT03803774|564632990|FG000|Dose Escalation|Withdrawal by Subject|0|||
156421132|NCT03803774|564632991|FG001|Dose Escalation|Withdrawal by Subject|0|||
156421133|NCT03803774|564632992|FG002|Dose Escalation|Withdrawal by Subject|0|||
156421134|NCT03803774|564632993|FG003|Dose Escalation|Withdrawal by Subject|1|||
156421135|NCT03803774|564632994|FG004|Dose Escalation|Withdrawal by Subject|0|||
156421136|NCT00729690|564632998|FG000|Overall Study|IT Catheter Malfunction|0|||
156421137|NCT00729690|564632999|FG001|Overall Study|IT Catheter Malfunction|2|||
156421138|NCT00729690|564633000|FG002|Overall Study|IT Catheter Malfunction|2|||
156421139|NCT02169219|564633001|FG000|Overall Study|Lack of Efficacy|6|||
156421140|NCT04482855|564633002|FG000|Overall Study|Lost to Follow-up|1|||
156421141|NCT04482855|564633003|FG001|Overall Study|Lost to Follow-up|0|||
156421142|NCT04482855|564633002|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
156421143|NCT04482855|564633003|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
156421144|NCT04482855|564633002|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
156421145|NCT04482855|564633003|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
156421146|NCT02320721|564633008|FG000|Overall Study|Adverse Event|6|||
156421147|NCT02320721|564633009|FG001|Overall Study|Adverse Event|6|||
156421148|NCT02320721|564633008|FG000|Overall Study|Lack of Efficacy|2|||
156421149|NCT02320721|564633009|FG001|Overall Study|Lack of Efficacy|0|||
156421150|NCT02320721|564633008|FG000|Overall Study|Poor compliance to protocol|3|||
156654776|NCT01364870|565481726|FG000|Overall Study|Protocol Violation|1|||
156421151|NCT02320721|564633009|FG001|Overall Study|Poor compliance to protocol|7|||
156319500|NCT01155479|564269385|FG003|Part II|Withdrawal by Subject|7|||
156319501|NCT01155479|564269386|FG004|Part II|Withdrawal by Subject|3|||
156319502|NCT01155479|564269382|FG000|Part II|Lost to Follow-up|1|||
156319503|NCT01155479|564269383|FG001|Part II|Lost to Follow-up|0|||
156319504|NCT01155479|564269384|FG002|Part II|Lost to Follow-up|0|||
156319505|NCT01155479|564269385|FG003|Part II|Lost to Follow-up|0|||
156319506|NCT01155479|564269386|FG004|Part II|Lost to Follow-up|1|||
156319507|NCT01155479|564269382|FG000|Part II|Treatment Failure|0|||
156319508|NCT01155479|564269383|FG001|Part II|Treatment Failure|1|||
156319509|NCT01155479|564269384|FG002|Part II|Treatment Failure|2|||
156319510|NCT01155479|564269385|FG003|Part II|Treatment Failure|0|||
156319511|NCT01155479|564269386|FG004|Part II|Treatment Failure|1|||
156319512|NCT01155479|564269382|FG000|Part II|Non-Compliance with Protocol|0|||
156319513|NCT01155479|564269383|FG001|Part II|Non-Compliance with Protocol|1|||
156319514|NCT01155479|564269384|FG002|Part II|Non-Compliance with Protocol|0|||
156319515|NCT01155479|564269385|FG003|Part II|Non-Compliance with Protocol|2|||
156319516|NCT01155479|564269386|FG004|Part II|Non-Compliance with Protocol|0|||
156319517|NCT02360605|564269387|FG000|Overall Study|Withdrawal by Subject|4|||
156319518|NCT02360605|564269388|FG001|Overall Study|Withdrawal by Subject|9|||
156319519|NCT02360605|564269387|FG000|Overall Study|Lost to Follow-up|7|||
156319520|NCT02360605|564269388|FG001|Overall Study|Lost to Follow-up|8|||
156319521|NCT02360605|564269387|FG000|Overall Study|Death|0|||
156319522|NCT02360605|564269388|FG001|Overall Study|Death|1|||
156319523|NCT05867342|564269391|FG000|Overall Study|Investigator Decision|3|||
156319524|NCT05867342|564269392|FG001|Overall Study|Investigator Decision|3|||
156319525|NCT04365257|564269393|FG000|Overall Study|Physician Decision|1|||
156319526|NCT04365257|564269394|FG001|Overall Study|Physician Decision|0|||
156319527|NCT04365257|564269393|FG000|Overall Study|Patient Noncompliance|1|||
156319528|NCT04365257|564269394|FG001|Overall Study|Patient Noncompliance|0|||
156319529|NCT04365257|564269393|FG000|Overall Study|Withdrawal by Subject|0|||
156319530|NCT04365257|564269394|FG001|Overall Study|Withdrawal by Subject|1|||
156319531|NCT02129777|564269395|FG000|Double-Blind Period|Adverse Event|0|||
156319532|NCT02129777|564269396|FG001|Double-Blind Period|Adverse Event|0|||
156319533|NCT02129777|564269397|FG002|Double-Blind Period|Adverse Event|0|||
156319534|NCT02129777|564269398|FG003|Double-Blind Period|Adverse Event|0|||
156319535|NCT02129777|564269399|FG004|Double-Blind Period|Adverse Event|1|||
156319536|NCT02129777|564269400|FG005|Double-Blind Period|Adverse Event|0|||
156319537|NCT02129777|564269401|FG006|Double-Blind Period|Adverse Event|0|||
156319538|NCT02129777|564269395|FG000|Double-Blind Period|Lost to Follow-up|1|||
156319539|NCT02129777|564269396|FG001|Double-Blind Period|Lost to Follow-up|1|||
156319540|NCT02129777|564269397|FG002|Double-Blind Period|Lost to Follow-up|1|||
156319541|NCT02129777|564269398|FG003|Double-Blind Period|Lost to Follow-up|2|||
156319542|NCT02129777|564269399|FG004|Double-Blind Period|Lost to Follow-up|0|||
156319543|NCT02129777|564269400|FG005|Double-Blind Period|Lost to Follow-up|0|||
156319544|NCT02129777|564269401|FG006|Double-Blind Period|Lost to Follow-up|0|||
156319545|NCT02129777|564269395|FG000|Double-Blind Period|Withdrawal by Subject|2|||
156319546|NCT02129777|564269396|FG001|Double-Blind Period|Withdrawal by Subject|4|||
156319547|NCT02129777|564269397|FG002|Double-Blind Period|Withdrawal by Subject|3|||
156319548|NCT02129777|564269398|FG003|Double-Blind Period|Withdrawal by Subject|2|||
156319549|NCT02129777|564269399|FG004|Double-Blind Period|Withdrawal by Subject|3|||
156319550|NCT02129777|564269400|FG005|Double-Blind Period|Withdrawal by Subject|0|||
156319551|NCT02129777|564269401|FG006|Double-Blind Period|Withdrawal by Subject|0|||
156319552|NCT02129777|564269395|FG000|Double-Blind Period|Pregnancy|0|||
156319553|NCT02129777|564269396|FG001|Double-Blind Period|Pregnancy|0|||
156319554|NCT02129777|564269397|FG002|Double-Blind Period|Pregnancy|0|||
156319555|NCT02129777|564269398|FG003|Double-Blind Period|Pregnancy|0|||
156319556|NCT02129777|564269399|FG004|Double-Blind Period|Pregnancy|1|||
156319557|NCT02129777|564269400|FG005|Double-Blind Period|Pregnancy|0|||
156319558|NCT02129777|564269401|FG006|Double-Blind Period|Pregnancy|0|||
156319559|NCT02129777|564269395|FG000|Double-Blind Period|Lack of Efficacy|3|||
156319560|NCT02129777|564269396|FG001|Double-Blind Period|Lack of Efficacy|1|||
156319561|NCT02129777|564269397|FG002|Double-Blind Period|Lack of Efficacy|0|||
156319562|NCT02129777|564269398|FG003|Double-Blind Period|Lack of Efficacy|3|||
156319563|NCT02129777|564269399|FG004|Double-Blind Period|Lack of Efficacy|2|||
156319564|NCT02129777|564269400|FG005|Double-Blind Period|Lack of Efficacy|0|||
156319565|NCT02129777|564269401|FG006|Double-Blind Period|Lack of Efficacy|0|||
156319566|NCT02129777|564269395|FG000|Double-Blind Period|Other|1|||
156319567|NCT02129777|564269396|FG001|Double-Blind Period|Other|2|||
156319568|NCT02129777|564269397|FG002|Double-Blind Period|Other|0|||
156319569|NCT02129777|564269398|FG003|Double-Blind Period|Other|0|||
156319570|NCT02129777|564269399|FG004|Double-Blind Period|Other|0|||
156319571|NCT02129777|564269400|FG005|Double-Blind Period|Other|0|||
156319572|NCT02129777|564269401|FG006|Double-Blind Period|Other|0|||
156319573|NCT02129777|564269395|FG000|Open-Label Period|Lack of Efficacy|0|||
156319574|NCT02129777|564269396|FG001|Open-Label Period|Lack of Efficacy|0|||
156319575|NCT02129777|564269397|FG002|Open-Label Period|Lack of Efficacy|0|||
156319576|NCT02129777|564269398|FG003|Open-Label Period|Lack of Efficacy|0|||
156319577|NCT02129777|564269399|FG004|Open-Label Period|Lack of Efficacy|0|||
156319578|NCT02129777|564269400|FG005|Open-Label Period|Lack of Efficacy|0|||
156421152|NCT02320721|564633008|FG000|Overall Study|Randomized but not treated|0|||
156421153|NCT02320721|564633009|FG001|Overall Study|Randomized but not treated|1|||
156421154|NCT02320721|564633008|FG000|Overall Study|Hypoglycemia|1|||
156421155|NCT02320721|564633009|FG001|Overall Study|Hypoglycemia|0|||
156421156|NCT02320721|564633008|FG000|Overall Study|Other than specified above|15|||
156421157|NCT02320721|564633009|FG001|Overall Study|Other than specified above|20|||
156421158|NCT02624778|564634448|FG000|Overall Study|Lost to Follow-up|0|||
156421159|NCT02624778|564634449|FG001|Overall Study|Lost to Follow-up|0|||
156421160|NCT02624778|564634450|FG002|Overall Study|Lost to Follow-up|1|||
156421161|NCT02624778|564634451|FG003|Overall Study|Lost to Follow-up|0|||
156421162|NCT02624778|564634452|FG004|Overall Study|Lost to Follow-up|0|||
156421163|NCT02624778|564634453|FG005|Overall Study|Lost to Follow-up|0|||
156421164|NCT02624778|564634454|FG006|Overall Study|Lost to Follow-up|0|||
156421165|NCT02624778|564634455|FG007|Overall Study|Lost to Follow-up|0|||
156421166|NCT02624778|564634456|FG008|Overall Study|Lost to Follow-up|0|||
156421167|NCT02624778|564634448|FG000|Overall Study|Withdrawal by Subject|0|||
156421168|NCT02624778|564634449|FG001|Overall Study|Withdrawal by Subject|1|||
156421169|NCT02624778|564634450|FG002|Overall Study|Withdrawal by Subject|0|||
156421170|NCT02624778|564634451|FG003|Overall Study|Withdrawal by Subject|0|||
156421171|NCT02624778|564634452|FG004|Overall Study|Withdrawal by Subject|0|||
156421172|NCT02624778|564634453|FG005|Overall Study|Withdrawal by Subject|1|||
156421173|NCT02624778|564634454|FG006|Overall Study|Withdrawal by Subject|1|||
156421174|NCT02624778|564634455|FG007|Overall Study|Withdrawal by Subject|1|||
156421175|NCT02624778|564634456|FG008|Overall Study|Withdrawal by Subject|1|||
156421176|NCT02624778|564634448|FG000|Overall Study|Adverse Event|0|||
156421177|NCT02624778|564634449|FG001|Overall Study|Adverse Event|0|||
156421178|NCT02624778|564634450|FG002|Overall Study|Adverse Event|0|||
156421179|NCT02624778|564634451|FG003|Overall Study|Adverse Event|0|||
156421180|NCT02624778|564634452|FG004|Overall Study|Adverse Event|0|||
156421181|NCT02624778|564634453|FG005|Overall Study|Adverse Event|0|||
156421182|NCT02624778|564634454|FG006|Overall Study|Adverse Event|0|||
156421183|NCT02624778|564634455|FG007|Overall Study|Adverse Event|0|||
156421184|NCT02624778|564634456|FG008|Overall Study|Adverse Event|2|||
156421185|NCT02624778|564634448|FG000|Overall Study|Death|0|||
156421186|NCT02624778|564634449|FG001|Overall Study|Death|0|||
156421187|NCT02624778|564634450|FG002|Overall Study|Death|0|||
156421188|NCT02624778|564634451|FG003|Overall Study|Death|0|||
156421189|NCT02624778|564634452|FG004|Overall Study|Death|0|||
156421190|NCT02624778|564634453|FG005|Overall Study|Death|0|||
156421191|NCT02624778|564634454|FG006|Overall Study|Death|1|||
156421192|NCT02624778|564634455|FG007|Overall Study|Death|0|||
156421193|NCT02624778|564634456|FG008|Overall Study|Death|0|||
156421194|NCT02624778|564634448|FG000|Overall Study|Physician Decision|0|||
156421195|NCT02624778|564634449|FG001|Overall Study|Physician Decision|0|||
156421196|NCT02624778|564634450|FG002|Overall Study|Physician Decision|0|||
156421197|NCT02624778|564634451|FG003|Overall Study|Physician Decision|0|||
156421198|NCT02624778|564634452|FG004|Overall Study|Physician Decision|0|||
156421199|NCT02624778|564634453|FG005|Overall Study|Physician Decision|0|||
156421200|NCT02624778|564634454|FG006|Overall Study|Physician Decision|0|||
156421201|NCT02624778|564634455|FG007|Overall Study|Physician Decision|3|||
156421202|NCT02624778|564634456|FG008|Overall Study|Physician Decision|3|||
156421203|NCT05296629|564634457|FG000|Overall Study|Withdrawal by Subject|3|||
156421204|NCT05296629|564634458|FG001|Overall Study|Withdrawal by Subject|10|||
156421205|NCT05296629|564634459|FG002|Overall Study|Withdrawal by Subject|4|||
156319579|NCT02129777|564269401|FG006|Open-Label Period|Lack of Efficacy|5|||
156319580|NCT02129777|564269395|FG000|Open-Label Period|Lost to Follow-up|0|||
156319581|NCT02129777|564269396|FG001|Open-Label Period|Lost to Follow-up|0|||
156319582|NCT02129777|564269397|FG002|Open-Label Period|Lost to Follow-up|0|||
156319583|NCT02129777|564269398|FG003|Open-Label Period|Lost to Follow-up|0|||
156319584|NCT02129777|564269399|FG004|Open-Label Period|Lost to Follow-up|0|||
156319585|NCT02129777|564269400|FG005|Open-Label Period|Lost to Follow-up|1|||
156319586|NCT02129777|564269401|FG006|Open-Label Period|Lost to Follow-up|1|||
156319587|NCT02129777|564269395|FG000|Open-Label Period|Withdrawal by Subject|0|||
156319588|NCT02129777|564269396|FG001|Open-Label Period|Withdrawal by Subject|0|||
156319589|NCT02129777|564269397|FG002|Open-Label Period|Withdrawal by Subject|0|||
156421206|NCT05296629|564634457|FG000|Overall Study|Lost to Follow-up|2|||
156421207|NCT05296629|564634458|FG001|Overall Study|Lost to Follow-up|7|||
156421208|NCT05296629|564634459|FG002|Overall Study|Lost to Follow-up|1|||
156421209|NCT05296629|564634457|FG000|Overall Study|Adverse Event|0|||
156421210|NCT05296629|564634458|FG001|Overall Study|Adverse Event|4|||
156421211|NCT05296629|564634459|FG002|Overall Study|Adverse Event|2|||
156421212|NCT05296629|564634457|FG000|Overall Study|Protocol Violation|0|||
156421213|NCT05296629|564634458|FG001|Overall Study|Protocol Violation|2|||
156421214|NCT05296629|564634459|FG002|Overall Study|Protocol Violation|0|||
156421215|NCT00231179|564634460|FG000|Overall Study|Lost to Follow-up|21|||
156421216|NCT00231179|564634461|FG001|Overall Study|Lost to Follow-up|21|||
156421217|NCT00231179|564634460|FG000|Overall Study|Withdrawal by Subject|3|||
156421218|NCT00231179|564634461|FG001|Overall Study|Withdrawal by Subject|3|||
156421219|NCT04610684|564634464|FG000|Study Treatment|Withdrawal by Subject|1|||
156654777|NCT01364870|565481727|FG001|Overall Study|Protocol Violation|0|||
156421220|NCT04610684|564634464|FG000|Study Treatment|Disease Progression|2|||
156421221|NCT04610684|564634464|FG000|Follow up|Death|2|||
156421222|NCT04610684|564634464|FG000|Follow up|Withdrawal by Subject|1|||
156421223|NCT02153788|564634465|FG000|Overall Study|Physician Decision|2|||
156421224|NCT02153788|564634466|FG001|Overall Study|Physician Decision|1|||
156421225|NCT04672460|564634467|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
156421226|NCT04672460|564634468|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
156421227|NCT04672460|564634467|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
156421228|NCT04672460|564634468|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
156421229|NCT04672460|564634467|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
156421230|NCT04672460|564634468|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
156421231|NCT04672460|564634467|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
156421232|NCT04672460|564634468|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
156421233|NCT04672460|564634467|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
156421234|NCT04672460|564634468|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
156421235|NCT04672460|564634467|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
156421236|NCT04672460|564634468|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
156421237|NCT04672460|564634467|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
156421238|NCT04672460|564634468|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
156421239|NCT04672460|564634467|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
156421240|NCT04672460|564634468|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
156421241|NCT04672460|564634467|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
156421242|NCT04672460|564634468|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
156421243|NCT04672460|564634467|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
156421244|NCT04672460|564634468|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
156421245|NCT04672460|564634467|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
156421246|NCT04672460|564634468|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
156421247|NCT04672460|564634467|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
156421248|NCT04672460|564634468|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
156421249|NCT04672460|564634467|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
156421250|NCT04672460|564634468|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
156421251|NCT04672460|564634467|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
156421252|NCT04672460|564634468|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
156421253|NCT04672460|564634467|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
156421254|NCT04672460|564634468|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
156421255|NCT04672460|564634467|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
156421256|NCT04672460|564634468|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
156421257|NCT04672460|564634467|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
156421258|NCT04672460|564634468|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
156421259|NCT02949271|564634473|FG000|Overall Study|Lack of Efficacy|5|||
156421260|NCT02949271|564634474|FG001|Overall Study|Lack of Efficacy|4|||
156421261|NCT02949271|564634473|FG000|Overall Study|Lost to Follow-up|3|||
156421262|NCT02949271|564634474|FG001|Overall Study|Lost to Follow-up|6|||
156421263|NCT02949271|564634473|FG000|Overall Study|Physician Decision|5|||
156421264|NCT02949271|564634474|FG001|Overall Study|Physician Decision|5|||
156421265|NCT02949271|564634473|FG000|Overall Study|Protocol Violation|6|||
156421266|NCT02949271|564634474|FG001|Overall Study|Protocol Violation|3|||
156421267|NCT02949271|564634473|FG000|Overall Study|Withdrawal by Subject|1|||
156319590|NCT02129777|564269398|FG003|Open-Label Period|Withdrawal by Subject|0|||
156319591|NCT02129777|564269399|FG004|Open-Label Period|Withdrawal by Subject|0|||
156319592|NCT02129777|564269400|FG005|Open-Label Period|Withdrawal by Subject|1|||
156319593|NCT02129777|564269401|FG006|Open-Label Period|Withdrawal by Subject|3|||
156319594|NCT02129777|564269395|FG000|Open-Label Period|Study Termination|0|||
156319595|NCT02129777|564269396|FG001|Open-Label Period|Study Termination|0|||
156319596|NCT02129777|564269397|FG002|Open-Label Period|Study Termination|0|||
156319597|NCT02129777|564269398|FG003|Open-Label Period|Study Termination|0|||
156319598|NCT02129777|564269399|FG004|Open-Label Period|Study Termination|0|||
156319599|NCT02129777|564269400|FG005|Open-Label Period|Study Termination|10|||
156319600|NCT02129777|564269401|FG006|Open-Label Period|Study Termination|39|||
156319601|NCT04391569|564269402|FG000|Overall Study|Death|15|||
156319602|NCT04391569|564269403|FG001|Overall Study|Death|10|||
156319603|NCT04391569|564269402|FG000|Overall Study|Withdrawal by Subject|1|||
156319604|NCT04391569|564269403|FG001|Overall Study|Withdrawal by Subject|0|||
156319605|NCT04391569|564269402|FG000|Overall Study|Lost to Follow-up|3|||
156319606|NCT04391569|564269403|FG001|Overall Study|Lost to Follow-up|2|||
156319607|NCT04391569|564269402|FG000|Overall Study|Lack of Efficacy|0|||
156319608|NCT04391569|564269403|FG001|Overall Study|Lack of Efficacy|1|||
156319609|NCT04391569|564269402|FG000|Overall Study|Participant discharged to hospice facility|0|||
156319610|NCT04391569|564269403|FG001|Overall Study|Participant discharged to hospice facility|1|||
156319611|NCT04391569|564269402|FG000|Overall Study|Participant family decision|1|||
156421268|NCT02949271|564634474|FG001|Overall Study|Withdrawal by Subject|0|||
156421269|NCT02949271|564634473|FG000|Overall Study|Delivered prior to intervention|7|||
156421270|NCT02949271|564634474|FG001|Overall Study|Delivered prior to intervention|9|||
156421271|NCT02949271|564634473|FG000|Overall Study|Outside the window for cervical dilation|2|||
156421272|NCT02949271|564634474|FG001|Overall Study|Outside the window for cervical dilation|3|||
156421273|NCT05458102|564634477|FG000|Overall Study|Withdrew consent|2|||
156421274|NCT05458102|564634478|FG001|Overall Study|Withdrew consent|0|||
156421275|NCT05458102|564634477|FG000|Overall Study|Adverse Event|1|||
156421276|NCT05458102|564634478|FG001|Overall Study|Adverse Event|0|||
156421277|NCT05458102|564634477|FG000|Overall Study|Enrolled but never treated|1|||
156421278|NCT05458102|564634478|FG001|Overall Study|Enrolled but never treated|0|||
156421279|NCT05458102|564634477|FG000|Overall Study|Protocol Violation|1|||
156421280|NCT05458102|564634478|FG001|Overall Study|Protocol Violation|0|||
156421281|NCT02373813|564634481|FG000|Run-In Period|Other, Not Specified|5|||
156421282|NCT02373813|564634482|FG001|Run-In Period|Other, Not Specified|0|||
156421283|NCT02373813|564634483|FG002|Run-In Period|Other, Not Specified|0|||
156421284|NCT02373813|564634484|FG003|Run-In Period|Other, Not Specified|0|||
156421285|NCT02373813|564634481|FG000|Run-In Period|Withdrawal by Subject|16|||
156421286|NCT02373813|564634482|FG001|Run-In Period|Withdrawal by Subject|0|||
156421287|NCT02373813|564634483|FG002|Run-In Period|Withdrawal by Subject|0|||
156421288|NCT02373813|564634484|FG003|Run-In Period|Withdrawal by Subject|0|||
156421289|NCT02373813|564634481|FG000|Run-In Period|Decision by Sponsor|11|||
156421290|NCT02373813|564634482|FG001|Run-In Period|Decision by Sponsor|0|||
156421291|NCT02373813|564634483|FG002|Run-In Period|Decision by Sponsor|0|||
156421292|NCT02373813|564634484|FG003|Run-In Period|Decision by Sponsor|0|||
156421293|NCT02373813|564634481|FG000|Run-In Period|Protocol Violation|75|||
156421294|NCT02373813|564634482|FG001|Run-In Period|Protocol Violation|0|||
156421295|NCT02373813|564634483|FG002|Run-In Period|Protocol Violation|0|||
156421296|NCT02373813|564634484|FG003|Run-In Period|Protocol Violation|0|||
156421297|NCT02373813|564634481|FG000|Run-In Period|Lost to Follow-up|2|||
156421298|NCT02373813|564634482|FG001|Run-In Period|Lost to Follow-up|0|||
156421299|NCT02373813|564634483|FG002|Run-In Period|Lost to Follow-up|0|||
156421300|NCT02373813|564634484|FG003|Run-In Period|Lost to Follow-up|0|||
156421301|NCT02373813|564634481|FG000|Run-In Period|Adverse Event|3|||
156421302|NCT02373813|564634482|FG001|Run-In Period|Adverse Event|0|||
156319612|NCT04391569|564269403|FG001|Overall Study|Participant family decision|0|||
156319613|NCT04391569|564269402|FG000|Overall Study|Participant discharged prematurely|1|||
156319614|NCT04391569|564269403|FG001|Overall Study|Participant discharged prematurely|0|||
156319615|NCT00645788|564269423|FG000|Overall Study|Did not receive study drug|1|||
156319616|NCT00645788|564269424|FG001|Overall Study|Did not receive study drug|1|||
156319617|NCT00645788|564269425|FG002|Overall Study|Did not receive study drug|0|||
156319618|NCT00645788|564269426|FG003|Overall Study|Did not receive study drug|0|||
156319619|NCT00645788|564269423|FG000|Overall Study|Adverse Event|4|||
156319620|NCT00645788|564269424|FG001|Overall Study|Adverse Event|9|||
156319621|NCT00645788|564269425|FG002|Overall Study|Adverse Event|5|||
156319622|NCT00645788|564269426|FG003|Overall Study|Adverse Event|3|||
156319623|NCT00645788|564269423|FG000|Overall Study|Lost to Follow-up|1|||
156319624|NCT00645788|564269424|FG001|Overall Study|Lost to Follow-up|0|||
156319625|NCT00645788|564269425|FG002|Overall Study|Lost to Follow-up|0|||
156319626|NCT00645788|564269426|FG003|Overall Study|Lost to Follow-up|0|||
156319627|NCT00645788|564269423|FG000|Overall Study|Protocol Violation|1|||
156319628|NCT00645788|564269424|FG001|Overall Study|Protocol Violation|0|||
156319629|NCT00645788|564269425|FG002|Overall Study|Protocol Violation|2|||
156319630|NCT00645788|564269426|FG003|Overall Study|Protocol Violation|0|||
156319631|NCT00645788|564269423|FG000|Overall Study|Withdrawal by Subject|0|||
156319632|NCT00645788|564269424|FG001|Overall Study|Withdrawal by Subject|1|||
156319633|NCT00645788|564269425|FG002|Overall Study|Withdrawal by Subject|0|||
156319634|NCT00645788|564269426|FG003|Overall Study|Withdrawal by Subject|2|||
156319635|NCT00645788|564269423|FG000|Overall Study|Pulmonary exacerbation|13|||
156319636|NCT00645788|564269424|FG001|Overall Study|Pulmonary exacerbation|16|||
156319637|NCT00645788|564269425|FG002|Overall Study|Pulmonary exacerbation|11|||
156319638|NCT00645788|564269426|FG003|Overall Study|Pulmonary exacerbation|9|||
156319639|NCT04231981|564269429|FG000|Overall Study|Adverse Event|1|||
156319640|NCT04231981|564269429|FG000|Overall Study|Death|16|||
156319641|NCT04231981|564269429|FG000|Overall Study|Lost to Follow-up|1|||
156319642|NCT01470989|564269430|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
156319643|NCT01470989|564269431|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
156319644|NCT01470989|564269430|FG000|Overall Study|Adverse Event|2|||
156319645|NCT01470989|564269431|FG001|Overall Study|Adverse Event|5|||
156421303|NCT02373813|564634483|FG002|Run-In Period|Adverse Event|0|||
156421304|NCT02373813|564634484|FG003|Run-In Period|Adverse Event|0|||
156761960|NCT05616013|565879947|FG003|Overall Study|Non-compliance with study requirements|3|||
156319646|NCT01470989|564269430|FG000|Overall Study|Abnormal laboratory value|1|||
156421305|NCT02373813|564634481|FG000|Run-In Period|Noncompliance|1|||
156421306|NCT02373813|564634482|FG001|Run-In Period|Noncompliance|0|||
156421307|NCT02373813|564634483|FG002|Run-In Period|Noncompliance|0|||
156421308|NCT02373813|564634484|FG003|Run-In Period|Noncompliance|0|||
156421309|NCT02373813|564634481|FG000|Run-In Period|Ineligibility Determined|3|||
156421310|NCT02373813|564634482|FG001|Run-In Period|Ineligibility Determined|0|||
156421311|NCT02373813|564634483|FG002|Run-In Period|Ineligibility Determined|0|||
156421312|NCT02373813|564634484|FG003|Run-In Period|Ineligibility Determined|0|||
156421313|NCT02373813|564634481|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
156421314|NCT02373813|564634482|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
156421315|NCT02373813|564634483|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
156421316|NCT02373813|564634484|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
156421317|NCT02373813|564634481|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156421318|NCT02373813|564634482|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
156421319|NCT02373813|564634483|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
156421320|NCT02373813|564634484|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
156421321|NCT02373813|564634481|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156421322|NCT02373813|564634482|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
156421323|NCT02373813|564634483|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
156421324|NCT02373813|564634484|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
156421325|NCT02373813|564634481|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156421326|NCT02373813|564634482|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
156421327|NCT02373813|564634483|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
156421328|NCT02373813|564634484|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
156421329|NCT02703532|564634489|FG000|Overall Study|Withdrawal by Subject|0|||
156421330|NCT02703532|564634490|FG001|Overall Study|Withdrawal by Subject|1|||
156421331|NCT02703532|564634491|FG002|Overall Study|Withdrawal by Subject|0|||
156421332|NCT02703532|564634492|FG003|Overall Study|Withdrawal by Subject|1|||
156421333|NCT02703532|564634489|FG000|Overall Study|Lost to Follow-up|2|||
156421334|NCT02703532|564634490|FG001|Overall Study|Lost to Follow-up|0|||
156421335|NCT02703532|564634491|FG002|Overall Study|Lost to Follow-up|2|||
156421336|NCT02703532|564634492|FG003|Overall Study|Lost to Follow-up|0|||
156421337|NCT03169361|564634493|FG000|Overall Study|Protocol Violation|32|||
156421338|NCT03239210|564634494|FG000|Overall Study|Lost to Follow-up|2|||
156421339|NCT03239210|564634495|FG001|Overall Study|Lost to Follow-up|2|||
156421340|NCT03239210|564634494|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
156421341|NCT03239210|564634495|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
156421342|NCT03239210|564634494|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
156421343|NCT03239210|564634495|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
156421344|NCT01575860|564634496|FG000|Overall Study|Withdrawal by Subject|1|||
156421345|NCT01575860|564634496|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
156421346|NCT00278564|564634498|FG000|Overall Study|Lack of Efficacy|4|||
156421347|NCT01094743|564634499|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
156421348|NCT02851511|564634500|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
156421349|NCT02851511|564634501|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
156421350|NCT02851511|564634502|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
156421351|NCT02851511|564634503|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
156421352|NCT02851511|564634500|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
156421353|NCT02851511|564634501|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
156421354|NCT02851511|564634502|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
156421355|NCT02851511|564634503|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
156421356|NCT02851511|564634500|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
156421357|NCT02851511|564634501|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
156421358|NCT02851511|564634502|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
156421359|NCT02851511|564634503|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
156421360|NCT02851511|564634500|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
156421361|NCT02851511|564634501|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
156421362|NCT02851511|564634502|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
156421363|NCT02851511|564634503|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
156421364|NCT02851511|564634500|FG000|Phase I|Physician Decision|0|||
156421365|NCT02851511|564634501|FG001|Phase I|Physician Decision|0|||
156421366|NCT02851511|564634502|FG002|Phase I|Physician Decision|0|||
156421367|NCT02851511|564634503|FG003|Phase I|Physician Decision|1|||
156421368|NCT02851511|564634500|FG000|Phase I|Withdrawal by Subject|2|||
156421369|NCT02851511|564634501|FG001|Phase I|Withdrawal by Subject|1|||
156421370|NCT02851511|564634502|FG002|Phase I|Withdrawal by Subject|0|||
156421371|NCT02851511|564634503|FG003|Phase I|Withdrawal by Subject|3|||
156421372|NCT02851511|564634500|FG000|Phase II|Physician Decision|18|||
156421373|NCT02851511|564634501|FG001|Phase II|Physician Decision|16|||
156421374|NCT02851511|564634502|FG002|Phase II|Physician Decision|0|||
156421375|NCT02851511|564634503|FG003|Phase II|Physician Decision|0|||
156421376|NCT02851511|564634500|FG000|Phase II|Withdrawal by Subject|18|||
156421377|NCT02851511|564634501|FG001|Phase II|Withdrawal by Subject|16|||
156421378|NCT02851511|564634502|FG002|Phase II|Withdrawal by Subject|0|||
156421379|NCT02851511|564634503|FG003|Phase II|Withdrawal by Subject|0|||
156421380|NCT02851511|564634500|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
156421381|NCT02851511|564634501|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
156421382|NCT02851511|564634502|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
156421383|NCT02851511|564634503|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
156421384|NCT02851511|564634500|FG000|Phase II|Lost to Follow-up|0|||
156421385|NCT02851511|564634501|FG001|Phase II|Lost to Follow-up|1|||
156421386|NCT02851511|564634502|FG002|Phase II|Lost to Follow-up|0|||
156421387|NCT02851511|564634503|FG003|Phase II|Lost to Follow-up|0|||
156421388|NCT00372567|564634504|FG000|Phase 3 Study|Adverse Event|5|||
156421389|NCT00372567|564634505|FG001|Phase 3 Study|Adverse Event|1|||
156319647|NCT01470989|564269431|FG001|Overall Study|Abnormal laboratory value|1|||
156319648|NCT01470989|564269430|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156319649|NCT01470989|564269431|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156319650|NCT01470989|564269430|FG000|Overall Study|Withdrawal by Subject|19|||
156319651|NCT01470989|564269431|FG001|Overall Study|Withdrawal by Subject|17|||
156319652|NCT01470989|564269430|FG000|Overall Study|Lost to Follow-up|18|||
156319653|NCT01470989|564269431|FG001|Overall Study|Lost to Follow-up|13|||
156319654|NCT01470989|564269430|FG000|Overall Study|Administrative problems|2|||
156319655|NCT01470989|564269431|FG001|Overall Study|Administrative problems|4|||
156319656|NCT01470989|564269430|FG000|Overall Study|Death|2|||
156319657|NCT01470989|564269431|FG001|Overall Study|Death|2|||
156319658|NCT01470989|564269430|FG000|Overall Study|Protocol deviation|1|||
156319659|NCT01470989|564269431|FG001|Overall Study|Protocol deviation|2|||
156319660|NCT01233687|564269432|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
156319661|NCT01233687|564269432|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
156319662|NCT01233687|564269432|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
156319663|NCT02197234|564269435|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
156319664|NCT02197234|564269435|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
156319665|NCT02197234|564269435|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
156319666|NCT02197234|564269435|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
156319667|NCT02197234|564269435|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
156319668|NCT02197234|564269435|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
156319669|NCT02119676|564269436|FG000|Overall Study|Adverse Event|9|||
156319670|NCT02119676|564269437|FG001|Overall Study|Adverse Event|17|||
156319671|NCT02119676|564269438|FG002|Overall Study|Adverse Event|10|||
156319672|NCT02119676|564269439|FG003|Overall Study|Adverse Event|10|||
156319673|NCT02119676|564269436|FG000|Overall Study|Disease progression|53|||
156319674|NCT02119676|564269437|FG001|Overall Study|Disease progression|55|||
156319675|NCT02119676|564269438|FG002|Overall Study|Disease progression|68|||
156319676|NCT02119676|564269439|FG003|Overall Study|Disease progression|73|||
156319677|NCT02119676|564269436|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
156319678|NCT02119676|564269437|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
156319679|NCT02119676|564269438|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
156319680|NCT02119676|564269439|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
156319681|NCT02119676|564269436|FG000|Overall Study|Physician Decision|4|||
156319682|NCT02119676|564269437|FG001|Overall Study|Physician Decision|2|||
156319683|NCT02119676|564269438|FG002|Overall Study|Physician Decision|3|||
156319684|NCT02119676|564269439|FG003|Overall Study|Physician Decision|2|||
156319685|NCT02119676|564269436|FG000|Overall Study|Death|9|||
156319686|NCT02119676|564269437|FG001|Overall Study|Death|3|||
156319687|NCT02119676|564269438|FG002|Overall Study|Death|2|||
156319688|NCT02119676|564269439|FG003|Overall Study|Death|1|||
156319689|NCT02119676|564269436|FG000|Overall Study|Noncompliance|0|||
156319690|NCT02119676|564269437|FG001|Overall Study|Noncompliance|1|||
156319691|NCT02119676|564269438|FG002|Overall Study|Noncompliance|0|||
156319692|NCT02119676|564269439|FG003|Overall Study|Noncompliance|0|||
156319693|NCT02119676|564269436|FG000|Overall Study|Lost to Follow-up|0|||
156319694|NCT02119676|564269437|FG001|Overall Study|Lost to Follow-up|0|||
156319695|NCT02119676|564269438|FG002|Overall Study|Lost to Follow-up|1|||
156319696|NCT02119676|564269439|FG003|Overall Study|Lost to Follow-up|0|||
156319697|NCT02119676|564269436|FG000|Overall Study|Protocol deviation|0|||
156319698|NCT02119676|564269437|FG001|Overall Study|Protocol deviation|0|||
156319699|NCT02119676|564269438|FG002|Overall Study|Protocol deviation|1|||
156319700|NCT02119676|564269439|FG003|Overall Study|Protocol deviation|0|||
156319701|NCT02119676|564269436|FG000|Overall Study|Other, unspecified|2|||
156319702|NCT02119676|564269437|FG001|Overall Study|Other, unspecified|1|||
156319703|NCT02119676|564269438|FG002|Overall Study|Other, unspecified|3|||
156319704|NCT02119676|564269439|FG003|Overall Study|Other, unspecified|4|||
156319705|NCT02119676|564269436|FG000|Overall Study|Did not receive study med|2|||
156319706|NCT02119676|564269437|FG001|Overall Study|Did not receive study med|2|||
156319707|NCT02119676|564269438|FG002|Overall Study|Did not receive study med|4|||
156319708|NCT02119676|564269439|FG003|Overall Study|Did not receive study med|5|||
156421390|NCT00372567|564634506|FG002|Phase 3 Study|Adverse Event|1|||
156421391|NCT00372567|564634504|FG000|Phase 3 Study|Death|1|||
156319709|NCT00219544|564269440|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
156319710|NCT00219544|564269441|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
156319711|NCT00219544|564269440|FG000|Single Blind Treatment Period|Adverse Event|9|||
156421392|NCT00372567|564634505|FG001|Phase 3 Study|Death|1|||
156421393|NCT00372567|564634506|FG002|Phase 3 Study|Death|0|||
156421394|NCT00372567|564634504|FG000|Phase 3 Study|Protocol Violation|0|||
156421395|NCT00372567|564634505|FG001|Phase 3 Study|Protocol Violation|0|||
156421396|NCT00372567|564634506|FG002|Phase 3 Study|Protocol Violation|1|||
156421397|NCT00372567|564634504|FG000|Phase 3 Study|Objective progression or relapse|10|||
156421398|NCT00372567|564634505|FG001|Phase 3 Study|Objective progression or relapse|13|||
156421399|NCT00372567|564634506|FG002|Phase 3 Study|Objective progression or relapse|4|||
156421400|NCT00372567|564634504|FG000|Phase 3 Study|Global deterioration of health status|0|||
156421401|NCT00372567|564634505|FG001|Phase 3 Study|Global deterioration of health status|1|||
156421402|NCT00372567|564634506|FG002|Phase 3 Study|Global deterioration of health status|0|||
156421403|NCT00372567|564634504|FG000|Phase 3 Study|Other|2|||
156421404|NCT00372567|564634505|FG001|Phase 3 Study|Other|2|||
156421405|NCT00372567|564634506|FG002|Phase 3 Study|Other|1|||
156421406|NCT00372567|564634504|FG000|Phase 3 Study|study terminated by sponsor|13|||
156421407|NCT00372567|564634505|FG001|Phase 3 Study|study terminated by sponsor|8|||
156421408|NCT00372567|564634506|FG002|Phase 3 Study|study terminated by sponsor|5|||
156421409|NCT03278028|564634510|FG000|Overall Study|Lost to Follow-up|1|||
156421410|NCT03278028|564634511|FG001|Overall Study|Lost to Follow-up|0|||
156421411|NCT03278028|564634510|FG000|Overall Study|Withdrawal by Subject|3|||
156421412|NCT03278028|564634511|FG001|Overall Study|Withdrawal by Subject|1|||
156421413|NCT03278028|564634510|FG000|Overall Study|Pregnancy|0|||
156421414|NCT03278028|564634511|FG001|Overall Study|Pregnancy|1|||
156421415|NCT00761774|564634515|FG000|Overall Study|Adverse Event|17|||
156421416|NCT00761774|564634515|FG000|Overall Study|Lack of Efficacy|37|||
156421417|NCT00761774|564634515|FG000|Overall Study|Lost to Follow-up|2|||
156421418|NCT00761774|564634515|FG000|Overall Study|Withdrawal by Subject|9|||
156421419|NCT00761774|564634515|FG000|Overall Study|Non-compliance|4|||
156421420|NCT00761774|564634515|FG000|Overall Study|End of study|2|||
156421421|NCT00761774|564634515|FG000|Overall Study|Reclassification of seizures|1|||
156421422|NCT00761774|564634515|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
156421423|NCT00761774|564634515|FG000|Overall Study|Sponsor decision|1|||
156421424|NCT00761774|564634515|FG000|Overall Study|Investigator clinical judgement|1|||
156421425|NCT00761774|564634515|FG000|Overall Study|Patient moved out of study area|1|||
156421426|NCT00761774|564634515|FG000|Overall Study|Coordinator leaving site|1|||
156421427|NCT00761774|564634515|FG000|Overall Study|Subject IP non-compliance|1|||
156421428|NCT00761774|564634515|FG000|Overall Study|IP stopped by hospital physician|1|||
156421429|NCT01124617|564634516|FG000|Overall Study|Adverse Event|5|||
156421430|NCT01124617|564634517|FG001|Overall Study|Adverse Event|2|||
156421431|NCT01124617|564634516|FG000|Overall Study|Lack of Efficacy|2|||
156421432|NCT01124617|564634517|FG001|Overall Study|Lack of Efficacy|1|||
156421433|NCT01124617|564634516|FG000|Overall Study|Protocol Violation|1|||
156421434|NCT01124617|564634517|FG001|Overall Study|Protocol Violation|1|||
156421435|NCT01124617|564634516|FG000|Overall Study|Withdrawal by Subject|9|||
156421436|NCT01124617|564634517|FG001|Overall Study|Withdrawal by Subject|1|||
156421437|NCT01124617|564634516|FG000|Overall Study|Other|2|||
156421438|NCT01124617|564634517|FG001|Overall Study|Other|1|||
156421439|NCT01813422|564634518|FG000|Overall Study|Withdrawal by Subject|14|||
156421440|NCT01813422|564634519|FG001|Overall Study|Withdrawal by Subject|8|||
156421441|NCT01813422|564634518|FG000|Overall Study|Death|2|||
156421442|NCT01813422|564634519|FG001|Overall Study|Death|3|||
156421443|NCT01813422|564634518|FG000|Overall Study|Sponsor Decision|2|||
156421444|NCT01813422|564634519|FG001|Overall Study|Sponsor Decision|1|||
156421445|NCT01813422|564634518|FG000|Overall Study|Lost to Follow-up|2|||
156421446|NCT01813422|564634519|FG001|Overall Study|Lost to Follow-up|4|||
156421447|NCT00994279|564634524|FG000|Overall Study|Withdrawal by Subject|2|||
156421448|NCT00994279|564634525|FG001|Overall Study|Withdrawal by Subject|2|||
156421449|NCT00994279|564634524|FG000|Overall Study|Toxicity|1|||
156421450|NCT00994279|564634525|FG001|Overall Study|Toxicity|0|||
156421451|NCT00994279|564634524|FG000|Overall Study|Multiple reasons|1|||
156421452|NCT00994279|564634525|FG001|Overall Study|Multiple reasons|3|||
156421453|NCT00859014|564634526|FG000|Overall Study|Death|4|||
156421454|NCT00859014|564634526|FG000|Overall Study|Lost to Follow-up|1|||
156421455|NCT04796935|564634527|FG000|Overall Study|Withdrawal by Subject|0|||
156421456|NCT04796935|564634528|FG001|Overall Study|Withdrawal by Subject|1|||
156421457|NCT04796935|564634527|FG000|Overall Study|Physician Decision|0|||
156421458|NCT04796935|564634528|FG001|Overall Study|Physician Decision|1|||
156421459|NCT04796935|564634527|FG000|Overall Study|Device not available|1|||
156421460|NCT04796935|564634528|FG001|Overall Study|Device not available|0|||
156421461|NCT04796935|564634527|FG000|Overall Study|Trained provider not available|1|||
156421462|NCT04796935|564634528|FG001|Overall Study|Trained provider not available|0|||
156421463|NCT01354938|564634529|FG000|Overall Study|Lost to Follow-up|1|||
156421464|NCT01253200|564634530|FG000|Overall Study|Death|1|||
156421465|NCT01253200|564634531|FG001|Overall Study|Death|0|||
156421466|NCT01253200|564634532|FG002|Overall Study|Death|0|||
156421467|NCT01253200|564634533|FG003|Overall Study|Death|0|||
156421468|NCT01253200|564634534|FG004|Overall Study|Death|0|||
156421469|NCT01253200|564634530|FG000|Overall Study|Lost to Follow-up|1|||
156421470|NCT01253200|564634531|FG001|Overall Study|Lost to Follow-up|1|||
156421471|NCT01253200|564634532|FG002|Overall Study|Lost to Follow-up|0|||
156654778|NCT01364870|565481728|FG002|Overall Study|Protocol Violation|0|||
156654779|NCT03977584|565481729|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
156654780|NCT03977584|565481730|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
156654781|NCT03977584|565481731|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
156654782|NCT00745251|565481735|FG000|Overall Study|Adverse Event|1|||
156654783|NCT00745251|565481736|FG001|Overall Study|Adverse Event|2|||
156319712|NCT00219544|564269441|FG001|Single Blind Treatment Period|Adverse Event|0|||
156319713|NCT00219544|564269440|FG000|Single Blind Treatment Period|Protocol Violation|4|||
156319714|NCT00219544|564269441|FG001|Single Blind Treatment Period|Protocol Violation|0|||
156319715|NCT00219544|564269440|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
156319716|NCT00219544|564269441|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
156319717|NCT00219544|564269440|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
156319718|NCT00219544|564269441|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
156319719|NCT00219544|564269440|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
156319720|NCT00219544|564269441|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
156319721|NCT01445886|564269442|FG000|Overall Study|Lost to Follow-up|2|||
156319722|NCT01445886|564269442|FG000|Overall Study|Protocol Violation|3|||
156319723|NCT04090411|564269447|FG000|Induction Period|Adverse Event|3|||
156319724|NCT04090411|564269448|FG001|Induction Period|Adverse Event|1|||
156319725|NCT04090411|564269449|FG002|Induction Period|Adverse Event|1|||
156319726|NCT04090411|564269450|FG003|Induction Period|Adverse Event|1|||
156319727|NCT04090411|564269451|FG004|Induction Period|Adverse Event|0|||
156319728|NCT04090411|564269452|FG005|Induction Period|Adverse Event|0|||
156319729|NCT04090411|564269453|FG006|Induction Period|Adverse Event|0|||
156319730|NCT04090411|564269454|FG007|Induction Period|Adverse Event|0|||
156319731|NCT04090411|564269455|FG008|Induction Period|Adverse Event|0|||
156319732|NCT04090411|564269456|FG009|Induction Period|Adverse Event|0|||
156319733|NCT04090411|564269457|FG010|Induction Period|Adverse Event|0|||
156319734|NCT04090411|564269458|FG011|Induction Period|Adverse Event|0|||
156319735|NCT04090411|564269459|FG012|Induction Period|Adverse Event|0|||
156319736|NCT04090411|564269447|FG000|Induction Period|Lack of Efficacy|0|||
156319737|NCT04090411|564269448|FG001|Induction Period|Lack of Efficacy|0|||
156319738|NCT04090411|564269449|FG002|Induction Period|Lack of Efficacy|1|||
156319739|NCT04090411|564269450|FG003|Induction Period|Lack of Efficacy|1|||
156319740|NCT04090411|564269451|FG004|Induction Period|Lack of Efficacy|0|||
156319741|NCT04090411|564269452|FG005|Induction Period|Lack of Efficacy|0|||
156319742|NCT04090411|564269453|FG006|Induction Period|Lack of Efficacy|0|||
156319743|NCT04090411|564269454|FG007|Induction Period|Lack of Efficacy|0|||
156319744|NCT04090411|564269455|FG008|Induction Period|Lack of Efficacy|0|||
156319745|NCT04090411|564269456|FG009|Induction Period|Lack of Efficacy|0|||
156319746|NCT04090411|564269457|FG010|Induction Period|Lack of Efficacy|0|||
156319747|NCT04090411|564269458|FG011|Induction Period|Lack of Efficacy|0|||
156319748|NCT04090411|564269459|FG012|Induction Period|Lack of Efficacy|0|||
156319749|NCT04090411|564269447|FG000|Induction Period|Physician Decision|0|||
156319750|NCT04090411|564269448|FG001|Induction Period|Physician Decision|0|||
156319751|NCT04090411|564269449|FG002|Induction Period|Physician Decision|1|||
156319752|NCT04090411|564269450|FG003|Induction Period|Physician Decision|0|||
156319753|NCT04090411|564269451|FG004|Induction Period|Physician Decision|0|||
156319754|NCT04090411|564269452|FG005|Induction Period|Physician Decision|0|||
156319755|NCT04090411|564269453|FG006|Induction Period|Physician Decision|0|||
156319756|NCT04090411|564269454|FG007|Induction Period|Physician Decision|0|||
156319757|NCT04090411|564269455|FG008|Induction Period|Physician Decision|0|||
156319758|NCT04090411|564269456|FG009|Induction Period|Physician Decision|0|||
156319759|NCT04090411|564269457|FG010|Induction Period|Physician Decision|0|||
156319760|NCT04090411|564269458|FG011|Induction Period|Physician Decision|0|||
156319761|NCT04090411|564269459|FG012|Induction Period|Physician Decision|0|||
156319762|NCT04090411|564269447|FG000|Induction Period|Protocol Violation|0|||
156319763|NCT04090411|564269448|FG001|Induction Period|Protocol Violation|0|||
156319764|NCT04090411|564269449|FG002|Induction Period|Protocol Violation|0|||
156319765|NCT04090411|564269450|FG003|Induction Period|Protocol Violation|1|||
156319766|NCT04090411|564269451|FG004|Induction Period|Protocol Violation|0|||
156319767|NCT04090411|564269452|FG005|Induction Period|Protocol Violation|0|||
156319768|NCT04090411|564269453|FG006|Induction Period|Protocol Violation|0|||
156319769|NCT04090411|564269454|FG007|Induction Period|Protocol Violation|0|||
156319770|NCT04090411|564269455|FG008|Induction Period|Protocol Violation|0|||
156319771|NCT04090411|564269456|FG009|Induction Period|Protocol Violation|0|||
156319772|NCT04090411|564269457|FG010|Induction Period|Protocol Violation|0|||
156319773|NCT04090411|564269458|FG011|Induction Period|Protocol Violation|0|||
156319774|NCT04090411|564269459|FG012|Induction Period|Protocol Violation|0|||
156319775|NCT04090411|564269447|FG000|Induction Period|Withdrawal by Subject|2|||
156319776|NCT04090411|564269448|FG001|Induction Period|Withdrawal by Subject|0|||
156319777|NCT04090411|564269449|FG002|Induction Period|Withdrawal by Subject|1|||
156319778|NCT04090411|564269450|FG003|Induction Period|Withdrawal by Subject|5|||
156319779|NCT04090411|564269451|FG004|Induction Period|Withdrawal by Subject|0|||
156319780|NCT04090411|564269452|FG005|Induction Period|Withdrawal by Subject|0|||
156654784|NCT00745251|565481735|FG000|Overall Study|Withdrawal by Subject|1|||
156421472|NCT01253200|564634533|FG003|Overall Study|Lost to Follow-up|0|||
156421473|NCT01253200|564634534|FG004|Overall Study|Lost to Follow-up|0|||
156421474|NCT01253200|564634530|FG000|Overall Study|Withdrawal by Subject|2|||
156421475|NCT01253200|564634531|FG001|Overall Study|Withdrawal by Subject|0|||
156421476|NCT01253200|564634532|FG002|Overall Study|Withdrawal by Subject|0|||
156421477|NCT01253200|564634533|FG003|Overall Study|Withdrawal by Subject|0|||
156421478|NCT01253200|564634534|FG004|Overall Study|Withdrawal by Subject|0|||
156421479|NCT01253200|564634530|FG000|Overall Study|Protocol Violation|1|||
156421480|NCT01253200|564634531|FG001|Overall Study|Protocol Violation|4|||
156421481|NCT01253200|564634532|FG002|Overall Study|Protocol Violation|0|||
156421482|NCT01253200|564634533|FG003|Overall Study|Protocol Violation|0|||
156421483|NCT01253200|564634534|FG004|Overall Study|Protocol Violation|5|||
156421484|NCT01253200|564634530|FG000|Overall Study|intents|10|||
156421485|NCT01253200|564634531|FG001|Overall Study|intents|10|||
156421486|NCT01253200|564634532|FG002|Overall Study|intents|1|||
156421487|NCT01253200|564634533|FG003|Overall Study|intents|3|||
156421488|NCT01253200|564634534|FG004|Overall Study|intents|0|||
156421489|NCT01253200|564634530|FG000|Overall Study|Attempts|6|||
156421490|NCT01253200|564634531|FG001|Overall Study|Attempts|4|||
156421491|NCT01253200|564634532|FG002|Overall Study|Attempts|1|||
156421492|NCT01253200|564634533|FG003|Overall Study|Attempts|2|||
156421493|NCT01253200|564634534|FG004|Overall Study|Attempts|0|||
156421494|NCT02049437|564634535|FG000|Period 1|Adverse Event|1|||
156421495|NCT02049437|564634536|FG001|Period 1|Adverse Event|1|||
156421496|NCT02049437|564634535|FG000|Period 1|Adverse Event|1|||
156421497|NCT02049437|564634536|FG001|Period 1|Adverse Event|0|||
156421498|NCT00783718|564634537|FG000|Induction Phase|Adverse Event|4|||
156421499|NCT00783718|564634538|FG001|Induction Phase|Adverse Event|0|||
156421500|NCT00783718|564634539|FG002|Induction Phase|Adverse Event|7|||
156421501|NCT00783718|564634540|FG003|Induction Phase|Adverse Event|0|||
156421502|NCT00783718|564634541|FG004|Induction Phase|Adverse Event|0|||
156421503|NCT00783718|564634542|FG005|Induction Phase|Adverse Event|0|||
156421504|NCT00783718|564634543|FG006|Induction Phase|Adverse Event|0|||
156421505|NCT00783718|564634537|FG000|Induction Phase|Protocol Violation|1|||
156421506|NCT00783718|564634538|FG001|Induction Phase|Protocol Violation|1|||
156421507|NCT00783718|564634539|FG002|Induction Phase|Protocol Violation|6|||
156421508|NCT00783718|564634540|FG003|Induction Phase|Protocol Violation|0|||
156421509|NCT00783718|564634541|FG004|Induction Phase|Protocol Violation|0|||
156421510|NCT00783718|564634542|FG005|Induction Phase|Protocol Violation|0|||
156319781|NCT04090411|564269453|FG006|Induction Period|Withdrawal by Subject|0|||
156319782|NCT04090411|564269454|FG007|Induction Period|Withdrawal by Subject|0|||
156319783|NCT04090411|564269455|FG008|Induction Period|Withdrawal by Subject|0|||
156319784|NCT04090411|564269456|FG009|Induction Period|Withdrawal by Subject|0|||
156319785|NCT04090411|564269457|FG010|Induction Period|Withdrawal by Subject|0|||
156319786|NCT04090411|564269458|FG011|Induction Period|Withdrawal by Subject|0|||
156319787|NCT04090411|564269459|FG012|Induction Period|Withdrawal by Subject|0|||
156319788|NCT04090411|564269447|FG000|Chronic Period|Adverse Event|0|||
156319789|NCT04090411|564269448|FG001|Chronic Period|Adverse Event|0|||
156319790|NCT04090411|564269449|FG002|Chronic Period|Adverse Event|0|||
156319791|NCT04090411|564269450|FG003|Chronic Period|Adverse Event|0|||
156319792|NCT04090411|564269451|FG004|Chronic Period|Adverse Event|0|||
156319793|NCT04090411|564269452|FG005|Chronic Period|Adverse Event|1|||
156319794|NCT04090411|564269453|FG006|Chronic Period|Adverse Event|0|||
156319795|NCT04090411|564269454|FG007|Chronic Period|Adverse Event|3|||
156319796|NCT04090411|564269455|FG008|Chronic Period|Adverse Event|0|||
156319797|NCT04090411|564269456|FG009|Chronic Period|Adverse Event|0|||
156319798|NCT04090411|564269457|FG010|Chronic Period|Adverse Event|5|||
156319799|NCT04090411|564269458|FG011|Chronic Period|Adverse Event|1|||
156319800|NCT04090411|564269459|FG012|Chronic Period|Adverse Event|1|||
156319801|NCT04090411|564269447|FG000|Chronic Period|Lack of Efficacy|0|||
156319802|NCT04090411|564269448|FG001|Chronic Period|Lack of Efficacy|0|||
156319803|NCT04090411|564269449|FG002|Chronic Period|Lack of Efficacy|0|||
156319804|NCT04090411|564269450|FG003|Chronic Period|Lack of Efficacy|0|||
156421511|NCT00783718|564634543|FG006|Induction Phase|Protocol Violation|0|||
156421512|NCT00783718|564634537|FG000|Induction Phase|Lack of Efficacy|5|||
156421513|NCT00783718|564634538|FG001|Induction Phase|Lack of Efficacy|2|||
156421514|NCT00783718|564634539|FG002|Induction Phase|Lack of Efficacy|14|||
156421515|NCT00783718|564634540|FG003|Induction Phase|Lack of Efficacy|0|||
156421516|NCT00783718|564634541|FG004|Induction Phase|Lack of Efficacy|0|||
156421517|NCT00783718|564634542|FG005|Induction Phase|Lack of Efficacy|0|||
156421518|NCT00783718|564634543|FG006|Induction Phase|Lack of Efficacy|0|||
156421519|NCT00783718|564634537|FG000|Induction Phase|Withdrawal by Subject|3|||
156421520|NCT00783718|564634538|FG001|Induction Phase|Withdrawal by Subject|4|||
156421521|NCT00783718|564634539|FG002|Induction Phase|Withdrawal by Subject|8|||
156421522|NCT00783718|564634540|FG003|Induction Phase|Withdrawal by Subject|0|||
156319805|NCT04090411|564269451|FG004|Chronic Period|Lack of Efficacy|0|||
156319806|NCT04090411|564269452|FG005|Chronic Period|Lack of Efficacy|0|||
156319807|NCT04090411|564269453|FG006|Chronic Period|Lack of Efficacy|1|||
156421523|NCT00783718|564634541|FG004|Induction Phase|Withdrawal by Subject|0|||
156421524|NCT00783718|564634542|FG005|Induction Phase|Withdrawal by Subject|0|||
156421525|NCT00783718|564634543|FG006|Induction Phase|Withdrawal by Subject|0|||
156421526|NCT00783718|564634537|FG000|Induction Phase|Lost to Follow-up|1|||
156421527|NCT00783718|564634538|FG001|Induction Phase|Lost to Follow-up|0|||
156421528|NCT00783718|564634539|FG002|Induction Phase|Lost to Follow-up|1|||
156421529|NCT00783718|564634540|FG003|Induction Phase|Lost to Follow-up|0|||
156421530|NCT00783718|564634541|FG004|Induction Phase|Lost to Follow-up|0|||
156421531|NCT00783718|564634542|FG005|Induction Phase|Lost to Follow-up|0|||
156421532|NCT00783718|564634543|FG006|Induction Phase|Lost to Follow-up|0|||
156421533|NCT00783718|564634537|FG000|Maintenance Phase|Adverse Event|12|||
156421534|NCT00783718|564634538|FG001|Maintenance Phase|Adverse Event|0|||
156421535|NCT00783718|564634539|FG002|Maintenance Phase|Adverse Event|0|||
156421536|NCT00783718|564634540|FG003|Maintenance Phase|Adverse Event|15|||
156421537|NCT00783718|564634541|FG004|Maintenance Phase|Adverse Event|7|||
156421538|NCT00783718|564634542|FG005|Maintenance Phase|Adverse Event|6|||
156421539|NCT00783718|564634543|FG006|Maintenance Phase|Adverse Event|16|||
156421540|NCT00783718|564634537|FG000|Maintenance Phase|Protocol Violation|1|||
156421541|NCT00783718|564634538|FG001|Maintenance Phase|Protocol Violation|0|||
156319808|NCT04090411|564269454|FG007|Chronic Period|Lack of Efficacy|4|||
156319809|NCT04090411|564269455|FG008|Chronic Period|Lack of Efficacy|2|||
156319810|NCT04090411|564269456|FG009|Chronic Period|Lack of Efficacy|2|||
156319811|NCT04090411|564269457|FG010|Chronic Period|Lack of Efficacy|2|||
156319812|NCT04090411|564269458|FG011|Chronic Period|Lack of Efficacy|1|||
156319813|NCT04090411|564269459|FG012|Chronic Period|Lack of Efficacy|2|||
156319814|NCT04090411|564269447|FG000|Chronic Period|Relocation|0|||
156319815|NCT04090411|564269448|FG001|Chronic Period|Relocation|0|||
156319816|NCT04090411|564269449|FG002|Chronic Period|Relocation|0|||
156319817|NCT04090411|564269450|FG003|Chronic Period|Relocation|0|||
156319818|NCT04090411|564269451|FG004|Chronic Period|Relocation|0|||
156319819|NCT04090411|564269452|FG005|Chronic Period|Relocation|0|||
156319820|NCT04090411|564269453|FG006|Chronic Period|Relocation|0|||
156319821|NCT04090411|564269454|FG007|Chronic Period|Relocation|1|||
156319822|NCT04090411|564269455|FG008|Chronic Period|Relocation|0|||
156319823|NCT04090411|564269456|FG009|Chronic Period|Relocation|0|||
156319824|NCT04090411|564269457|FG010|Chronic Period|Relocation|0|||
156319825|NCT04090411|564269458|FG011|Chronic Period|Relocation|0|||
156319826|NCT04090411|564269459|FG012|Chronic Period|Relocation|0|||
156319827|NCT04090411|564269447|FG000|Chronic Period|Physician Decision|0|||
156319828|NCT04090411|564269448|FG001|Chronic Period|Physician Decision|0|||
156319829|NCT04090411|564269449|FG002|Chronic Period|Physician Decision|0|||
156319830|NCT04090411|564269450|FG003|Chronic Period|Physician Decision|0|||
156319831|NCT04090411|564269451|FG004|Chronic Period|Physician Decision|1|||
156319832|NCT04090411|564269452|FG005|Chronic Period|Physician Decision|0|||
156319833|NCT04090411|564269453|FG006|Chronic Period|Physician Decision|0|||
156319834|NCT04090411|564269454|FG007|Chronic Period|Physician Decision|1|||
156319835|NCT04090411|564269455|FG008|Chronic Period|Physician Decision|0|||
156319836|NCT04090411|564269456|FG009|Chronic Period|Physician Decision|0|||
156319837|NCT04090411|564269457|FG010|Chronic Period|Physician Decision|0|||
156319838|NCT04090411|564269458|FG011|Chronic Period|Physician Decision|1|||
156319839|NCT04090411|564269459|FG012|Chronic Period|Physician Decision|1|||
156319840|NCT04090411|564269447|FG000|Chronic Period|Protocol Violation|0|||
156319841|NCT04090411|564269448|FG001|Chronic Period|Protocol Violation|0|||
156319842|NCT04090411|564269449|FG002|Chronic Period|Protocol Violation|0|||
156319843|NCT04090411|564269450|FG003|Chronic Period|Protocol Violation|0|||
156319844|NCT04090411|564269451|FG004|Chronic Period|Protocol Violation|0|||
156319845|NCT04090411|564269452|FG005|Chronic Period|Protocol Violation|0|||
156319846|NCT04090411|564269453|FG006|Chronic Period|Protocol Violation|0|||
156319847|NCT04090411|564269454|FG007|Chronic Period|Protocol Violation|0|||
156319848|NCT04090411|564269455|FG008|Chronic Period|Protocol Violation|0|||
156319849|NCT04090411|564269456|FG009|Chronic Period|Protocol Violation|0|||
156319850|NCT04090411|564269457|FG010|Chronic Period|Protocol Violation|0|||
156319851|NCT04090411|564269458|FG011|Chronic Period|Protocol Violation|0|||
156319852|NCT04090411|564269459|FG012|Chronic Period|Protocol Violation|1|||
156319853|NCT04090411|564269447|FG000|Chronic Period|Withdrawal by Subject|0|||
156319854|NCT04090411|564269448|FG001|Chronic Period|Withdrawal by Subject|0|||
156319855|NCT04090411|564269449|FG002|Chronic Period|Withdrawal by Subject|0|||
156319856|NCT04090411|564269450|FG003|Chronic Period|Withdrawal by Subject|0|||
156319857|NCT04090411|564269451|FG004|Chronic Period|Withdrawal by Subject|0|||
156421542|NCT00783718|564634539|FG002|Maintenance Phase|Protocol Violation|0|||
156421543|NCT00783718|564634540|FG003|Maintenance Phase|Protocol Violation|0|||
156421544|NCT00783718|564634541|FG004|Maintenance Phase|Protocol Violation|0|||
156421545|NCT00783718|564634542|FG005|Maintenance Phase|Protocol Violation|0|||
156319858|NCT04090411|564269452|FG005|Chronic Period|Withdrawal by Subject|1|||
156319859|NCT04090411|564269453|FG006|Chronic Period|Withdrawal by Subject|1|||
156319860|NCT04090411|564269454|FG007|Chronic Period|Withdrawal by Subject|3|||
156319861|NCT04090411|564269455|FG008|Chronic Period|Withdrawal by Subject|3|||
156319862|NCT04090411|564269456|FG009|Chronic Period|Withdrawal by Subject|3|||
156319863|NCT04090411|564269457|FG010|Chronic Period|Withdrawal by Subject|1|||
156319864|NCT04090411|564269458|FG011|Chronic Period|Withdrawal by Subject|3|||
156319865|NCT04090411|564269459|FG012|Chronic Period|Withdrawal by Subject|0|||
156319866|NCT03473548|564269461|FG000|Overall Study|Did not attempt HST testing|3|||
156421546|NCT00783718|564634543|FG006|Maintenance Phase|Protocol Violation|2|||
156421547|NCT00783718|564634537|FG000|Maintenance Phase|Lack of Efficacy|83|||
156421548|NCT00783718|564634538|FG001|Maintenance Phase|Lack of Efficacy|0|||
156421549|NCT00783718|564634539|FG002|Maintenance Phase|Lack of Efficacy|0|||
156421550|NCT00783718|564634540|FG003|Maintenance Phase|Lack of Efficacy|61|||
156421551|NCT00783718|564634541|FG004|Maintenance Phase|Lack of Efficacy|31|||
156421552|NCT00783718|564634542|FG005|Maintenance Phase|Lack of Efficacy|33|||
156421553|NCT00783718|564634543|FG006|Maintenance Phase|Lack of Efficacy|155|||
156421554|NCT00783718|564634537|FG000|Maintenance Phase|Withdrawal by Subject|6|||
156421555|NCT00783718|564634538|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156421556|NCT00783718|564634539|FG002|Maintenance Phase|Withdrawal by Subject|0|||
156421557|NCT00783718|564634540|FG003|Maintenance Phase|Withdrawal by Subject|2|||
156421558|NCT00783718|564634541|FG004|Maintenance Phase|Withdrawal by Subject|5|||
156421559|NCT00783718|564634542|FG005|Maintenance Phase|Withdrawal by Subject|2|||
156421560|NCT00783718|564634543|FG006|Maintenance Phase|Withdrawal by Subject|20|||
156421561|NCT00783718|564634537|FG000|Maintenance Phase|Lost to Follow-up|3|||
156421562|NCT00783718|564634538|FG001|Maintenance Phase|Lost to Follow-up|0|||
156421563|NCT00783718|564634539|FG002|Maintenance Phase|Lost to Follow-up|0|||
156421564|NCT00783718|564634540|FG003|Maintenance Phase|Lost to Follow-up|0|||
156421565|NCT00783718|564634541|FG004|Maintenance Phase|Lost to Follow-up|2|||
156421566|NCT00783718|564634542|FG005|Maintenance Phase|Lost to Follow-up|0|||
156421567|NCT00783718|564634543|FG006|Maintenance Phase|Lost to Follow-up|2|||
156421568|NCT01163149|564634549|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
156421569|NCT01163149|564634550|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
156421570|NCT01163149|564634551|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
156421571|NCT01163149|564634549|FG000|Extension Treatment Period|Adverse Event|0|||
156421572|NCT01163149|564634550|FG001|Extension Treatment Period|Adverse Event|1|||
156421573|NCT01163149|564634551|FG002|Extension Treatment Period|Adverse Event|0|||
156421574|NCT01163149|564634549|FG000|Extension Treatment Period|Noncompliance|0|||
156421575|NCT01163149|564634550|FG001|Extension Treatment Period|Noncompliance|0|||
156421576|NCT01163149|564634551|FG002|Extension Treatment Period|Noncompliance|1|||
156421577|NCT01192295|564634552|FG000|Overall Study|Adverse Event|3|||
156421578|NCT01192295|564634553|FG001|Overall Study|Adverse Event|7|||
156421579|NCT01192295|564634552|FG000|Overall Study|Withdrawal by Subject|3|||
156421580|NCT01192295|564634553|FG001|Overall Study|Withdrawal by Subject|4|||
156421581|NCT01192295|564634552|FG000|Overall Study|Lost to Follow-up|0|||
156421582|NCT01192295|564634553|FG001|Overall Study|Lost to Follow-up|1|||
156421583|NCT01192295|564634552|FG000|Overall Study|Lack of Efficacy|0|||
156421584|NCT01192295|564634553|FG001|Overall Study|Lack of Efficacy|5|||
156319867|NCT03473548|564269462|FG001|Overall Study|Did not attempt HST testing|0|||
156319868|NCT05856760|564269469|FG000|Overall Study|Adverse Event|2|||
156319869|NCT05856760|564269469|FG000|Overall Study|Physician Decision|1|||
156319870|NCT05856760|564269469|FG000|Overall Study|Protocol Violation|1|||
156319871|NCT05856760|564269469|FG000|Overall Study|Withdrawal by Subject|3|||
156319872|NCT04035486|564269470|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
156319873|NCT04035486|564269471|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
156319874|NCT04035486|564269472|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
156319875|NCT04035486|564269473|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
156319876|NCT04035486|564269470|FG000|Overall Study|Death|6|||
156319877|NCT04035486|564269471|FG001|Overall Study|Death|3|||
156319878|NCT04035486|564269472|FG002|Overall Study|Death|70|||
156319879|NCT04035486|564269473|FG003|Overall Study|Death|77|||
156319880|NCT04035486|564269470|FG000|Overall Study|Screen Failure|0|||
156319881|NCT04035486|564269471|FG001|Overall Study|Screen Failure|0|||
156319882|NCT04035486|564269472|FG002|Overall Study|Screen Failure|1|||
156319883|NCT04035486|564269473|FG003|Overall Study|Screen Failure|1|||
156319884|NCT04035486|564269470|FG000|Overall Study|Withdrawal by Subject|1|||
156319885|NCT04035486|564269471|FG001|Overall Study|Withdrawal by Subject|1|||
156319886|NCT04035486|564269472|FG002|Overall Study|Withdrawal by Subject|11|||
156319887|NCT04035486|564269473|FG003|Overall Study|Withdrawal by Subject|9|||
156319888|NCT01006603|564269474|FG000|Overall Study|Withdrawal by Subject|17|||
156319889|NCT01006603|564269475|FG001|Overall Study|Withdrawal by Subject|19|||
156319890|NCT01006603|564269474|FG000|Overall Study|Lost to Follow-up|0|||
156319891|NCT01006603|564269475|FG001|Overall Study|Lost to Follow-up|1|||
156319892|NCT01006603|564269474|FG000|Overall Study|Safety reason|1|||
156319893|NCT01006603|564269475|FG001|Overall Study|Safety reason|1|||
156421585|NCT01192295|564634552|FG000|Overall Study|Administrative|4|||
156319894|NCT01006603|564269474|FG000|Overall Study|Protocol Violation|1|||
156319895|NCT01006603|564269475|FG001|Overall Study|Protocol Violation|3|||
156421586|NCT01192295|564634553|FG001|Overall Study|Administrative|6|||
156421587|NCT01700530|564634554|FG000|Overall Study|Withdrawal by Subject|0|||
156421588|NCT01700530|564634555|FG001|Overall Study|Withdrawal by Subject|3|||
156319896|NCT01006603|564269474|FG000|Overall Study|Incorrect enrolment|0|||
156421589|NCT01700530|564634556|FG002|Overall Study|Withdrawal by Subject|1|||
156421590|NCT01027871|564634560|FG000|Overall Study|Physician Decision|1|||
156421591|NCT01027871|564634561|FG001|Overall Study|Physician Decision|5|||
156421592|NCT01027871|564634562|FG002|Overall Study|Physician Decision|0|||
156421593|NCT01027871|564634560|FG000|Overall Study|Protocol Violation|0|||
156421594|NCT01027871|564634561|FG001|Overall Study|Protocol Violation|2|||
156421595|NCT01027871|564634562|FG002|Overall Study|Protocol Violation|2|||
156421596|NCT01027871|564634560|FG000|Overall Study|Withdrawal by Subject|1|||
156421597|NCT01027871|564634561|FG001|Overall Study|Withdrawal by Subject|2|||
156421598|NCT01027871|564634562|FG002|Overall Study|Withdrawal by Subject|2|||
156421599|NCT01027871|564634560|FG000|Overall Study|Adverse Event|0|||
156421600|NCT01027871|564634561|FG001|Overall Study|Adverse Event|2|||
156421601|NCT01027871|564634562|FG002|Overall Study|Adverse Event|2|||
156421602|NCT01027871|564634560|FG000|Overall Study|Sponsor Decision|0|||
156421603|NCT01027871|564634561|FG001|Overall Study|Sponsor Decision|2|||
156421604|NCT01027871|564634562|FG002|Overall Study|Sponsor Decision|0|||
156421605|NCT01027871|564634560|FG000|Overall Study|Discontinued Prior to Treatment|0|||
156421606|NCT01027871|564634561|FG001|Overall Study|Discontinued Prior to Treatment|0|||
156421607|NCT01027871|564634562|FG002|Overall Study|Discontinued Prior to Treatment|1|||
156421608|NCT03782727|564634563|FG000|Overall Study|Lost to Follow-up|32|||
156421609|NCT04159896|564634568|FG000|Overall Study|Lack of Efficacy|7|||
156421610|NCT04159896|564634568|FG000|Overall Study|Withdrawal by Subject|1|||
156421611|NCT04159896|564634568|FG000|Overall Study|Adverse Event|1|||
156421612|NCT04159896|564634568|FG000|Overall Study|A transient ischaemic attack|1|||
156421613|NCT02338609|564634569|FG000|Overall Study|Physician Decision|1|||
156421614|NCT02338609|564634569|FG000|Overall Study|Death|1|||
156421615|NCT04736056|564634570|FG000|Overall Study|Death|0|||
156319897|NCT01006603|564269475|FG001|Overall Study|Incorrect enrolment|2|||
156319898|NCT01006603|564269474|FG000|Overall Study|Adverse Event|15|||
156319899|NCT01006603|564269475|FG001|Overall Study|Adverse Event|7|||
156319900|NCT01006603|564269474|FG000|Overall Study|Death|1|||
156319901|NCT01006603|564269475|FG001|Overall Study|Death|1|||
156319902|NCT01006603|564269474|FG000|Overall Study|Study specific discontinuation criteria|33|||
156319903|NCT01006603|564269475|FG001|Overall Study|Study specific discontinuation criteria|34|||
156319904|NCT01006603|564269474|FG000|Overall Study|Other|3|||
156319905|NCT01006603|564269475|FG001|Overall Study|Other|7|||
156319906|NCT00562627|564270679|FG000|Overall Study|Protocol Violation|1|||
156319907|NCT00562627|564270680|FG001|Overall Study|Protocol Violation|1|||
156319908|NCT00562627|564270681|FG002|Overall Study|Protocol Violation|1|||
156319909|NCT03387150|564270683|FG000|Overall Study|Withdrawal by Subject|3|||
156319910|NCT03387150|564270684|FG001|Overall Study|Withdrawal by Subject|0|||
156319911|NCT03387150|564270685|FG002|Overall Study|Withdrawal by Subject|3|||
156319912|NCT03387150|564270686|FG003|Overall Study|Withdrawal by Subject|4|||
156319913|NCT03387150|564270687|FG004|Overall Study|Withdrawal by Subject|1|||
156319914|NCT03387150|564270688|FG005|Overall Study|Withdrawal by Subject|2|||
156319915|NCT03387150|564270689|FG006|Overall Study|Withdrawal by Subject|0|||
156319916|NCT03387150|564270683|FG000|Overall Study|Lost to Follow-up|3|||
156319917|NCT03387150|564270684|FG001|Overall Study|Lost to Follow-up|2|||
156319918|NCT03387150|564270685|FG002|Overall Study|Lost to Follow-up|2|||
156319919|NCT03387150|564270686|FG003|Overall Study|Lost to Follow-up|3|||
156319920|NCT03387150|564270687|FG004|Overall Study|Lost to Follow-up|3|||
156319921|NCT03387150|564270688|FG005|Overall Study|Lost to Follow-up|3|||
156319922|NCT03387150|564270689|FG006|Overall Study|Lost to Follow-up|0|||
156319923|NCT03387150|564270683|FG000|Overall Study|Participant unable to adhere to visit|0|||
156319924|NCT03387150|564270684|FG001|Overall Study|Participant unable to adhere to visit|1|||
156319925|NCT03387150|564270685|FG002|Overall Study|Participant unable to adhere to visit|0|||
156319926|NCT03387150|564270686|FG003|Overall Study|Participant unable to adhere to visit|0|||
156319927|NCT03387150|564270687|FG004|Overall Study|Participant unable to adhere to visit|2|||
156319928|NCT03387150|564270688|FG005|Overall Study|Participant unable to adhere to visit|2|||
156319929|NCT03387150|564270689|FG006|Overall Study|Participant unable to adhere to visit|0|||
156319930|NCT04078178|564270690|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
156319931|NCT04078178|564270691|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
156319932|NCT04078178|564270690|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
156421616|NCT04736056|564634571|FG001|Overall Study|Death|0|||
156421617|NCT04736056|564634572|FG002|Overall Study|Death|0|||
156421618|NCT04736056|564634573|FG003|Overall Study|Death|1|||
156421619|NCT04736056|564634570|FG000|Overall Study|Lost to Follow-up|1|||
156421620|NCT04736056|564634571|FG001|Overall Study|Lost to Follow-up|0|||
156421621|NCT04736056|564634572|FG002|Overall Study|Lost to Follow-up|1|||
156421622|NCT04736056|564634573|FG003|Overall Study|Lost to Follow-up|1|||
156421623|NCT04736056|564634570|FG000|Overall Study|Withdrawal by Subject|2|||
156421624|NCT04736056|564634571|FG001|Overall Study|Withdrawal by Subject|0|||
156421625|NCT04736056|564634572|FG002|Overall Study|Withdrawal by Subject|0|||
156319933|NCT04078178|564270691|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
156319934|NCT04078178|564270690|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
156319935|NCT04078178|564270691|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
156319936|NCT04078178|564270690|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
156319937|NCT04078178|564270691|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
156319938|NCT04078178|564270690|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
156421626|NCT04736056|564634573|FG003|Overall Study|Withdrawal by Subject|0|||
156421627|NCT04736056|564634570|FG000|Overall Study|Physician Decision|1|||
156421628|NCT04736056|564634571|FG001|Overall Study|Physician Decision|0|||
156421629|NCT04736056|564634572|FG002|Overall Study|Physician Decision|1|||
156421630|NCT04736056|564634573|FG003|Overall Study|Physician Decision|0|||
156421631|NCT00114959|564634574|FG000|Overall Study|Lack of Efficacy|6|||
156421632|NCT00114959|564634574|FG000|Overall Study|Physician Decision|1|||
156421633|NCT00114959|564634574|FG000|Overall Study|Death|1|||
156421634|NCT03706690|564634575|FG000|Overall Study|Withdrawal by Subject|8|||
156421635|NCT03706690|564634576|FG001|Overall Study|Withdrawal by Subject|8|||
156421636|NCT03706690|564634575|FG000|Overall Study|Death|143|||
156421637|NCT03706690|564634576|FG001|Overall Study|Death|75|||
156421638|NCT03706690|564634575|FG000|Overall Study|Ongoing at DCO|121|||
156421639|NCT03706690|564634576|FG001|Overall Study|Ongoing at DCO|52|||
156421640|NCT03212365|564634577|FG000|Overall Study|Discharged prior to Xa level|12|||
156421641|NCT03212365|564634578|FG001|Overall Study|Discharged prior to Xa level|8|||
156421642|NCT03212365|564634577|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
156421643|NCT03212365|564634578|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
156421644|NCT03212365|564634577|FG000|Overall Study|Refused study medication|3|||
156421645|NCT03212365|564634578|FG001|Overall Study|Refused study medication|0|||
156421646|NCT03212365|564634577|FG000|Overall Study|Initiated heparin infusion on floor|1|||
156421647|NCT03212365|564634578|FG001|Overall Study|Initiated heparin infusion on floor|1|||
156421648|NCT03212365|564634577|FG000|Overall Study|Unexpected return to OR|1|||
156421649|NCT03212365|564634578|FG001|Overall Study|Unexpected return to OR|1|||
156421650|NCT03212365|564634577|FG000|Overall Study|Medication distribution error|1|||
156421651|NCT03212365|564634578|FG001|Overall Study|Medication distribution error|0|||
156421652|NCT03212365|564634577|FG000|Overall Study|Required epidural placement|1|||
156421653|NCT03212365|564634578|FG001|Overall Study|Required epidural placement|0|||
156421654|NCT03212365|564634577|FG000|Overall Study|Withdrawal by Subject|0|||
156421655|NCT03212365|564634578|FG001|Overall Study|Withdrawal by Subject|1|||
156421656|NCT03212365|564634577|FG000|Overall Study|developed acute renal failure|0|||
156421657|NCT03212365|564634578|FG001|Overall Study|developed acute renal failure|1|||
156421658|NCT00665561|564634579|FG000|Overall Study|Death recorded on subject summary pages|75|||
156421659|NCT00665561|564634580|FG001|Overall Study|Death recorded on subject summary pages|75|||
156421660|NCT00665561|564634579|FG000|Overall Study|Does not meet entrance criteria|19|||
156421661|NCT00665561|564634580|FG001|Overall Study|Does not meet entrance criteria|21|||
156421662|NCT00665561|564634579|FG000|Overall Study|Lost to Follow-up|203|||
156421663|NCT00665561|564634580|FG001|Overall Study|Lost to Follow-up|264|||
156421664|NCT00665561|564634579|FG000|Overall Study|Withdrawal by Subject|74|||
156421665|NCT00665561|564634580|FG001|Overall Study|Withdrawal by Subject|65|||
156421666|NCT00665561|564634579|FG000|Overall Study|Other|123|||
156421667|NCT00665561|564634580|FG001|Overall Study|Other|108|||
156421668|NCT00665561|564634579|FG000|Overall Study|Site closed|8|||
156421669|NCT00665561|564634580|FG001|Overall Study|Site closed|0|||
156421670|NCT00665561|564634579|FG000|Overall Study|Withdrawn due to pregnancy|0|||
156421671|NCT00665561|564634580|FG001|Overall Study|Withdrawn due to pregnancy|1|||
156421672|NCT02337361|564634581|FG000|3-month Follow-up|Lost to Follow-up|19|||
156421673|NCT02337361|564634582|FG001|3-month Follow-up|Lost to Follow-up|14|||
156421674|NCT02337361|564634581|FG000|6-month Follow-up|Lost to Follow-up|2|||
156421675|NCT02337361|564634582|FG001|6-month Follow-up|Lost to Follow-up|4|||
156421676|NCT01354106|564634585|FG000|Overall Study|Withdrawal by Subject|2|||
156421677|NCT00901485|564634586|FG000|Overall Study|Lack of Efficacy|0|||
156421678|NCT00901485|564634587|FG001|Overall Study|Lack of Efficacy|2|||
156421679|NCT00901485|564634586|FG000|Overall Study|Withdrawal by Subject|1|||
156421680|NCT00901485|564634587|FG001|Overall Study|Withdrawal by Subject|2|||
156421681|NCT01871285|564634588|FG000|First Intervention (1 Day)|Adverse Event|1|||
156421682|NCT01871285|564634589|FG001|First Intervention (1 Day)|Adverse Event|0|||
156421683|NCT01871285|564634590|FG002|First Intervention (1 Day)|Adverse Event|0|||
156421684|NCT01871285|564634591|FG003|First Intervention (1 Day)|Adverse Event|0|||
156421685|NCT01871285|564634588|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
156654785|NCT00745251|565481736|FG001|Overall Study|Withdrawal by Subject|1|||
156654786|NCT03850509|565481737|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
156654787|NCT03850509|565481738|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
156654788|NCT02666430|565481739|FG000|Period 1|Lost to Follow-up|1|||
156654789|NCT02666430|565481740|FG001|Period 1|Lost to Follow-up|0|||
156654790|NCT02666430|565481739|FG000|Period 1|Adverse Event|0|||
156421686|NCT01871285|564634589|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
156421687|NCT01871285|564634590|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
156421688|NCT01871285|564634591|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
156421689|NCT05397470|564634592|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
156421690|NCT05397470|564634593|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
156421691|NCT05397470|564634594|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
156421692|NCT05397470|564634592|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
156654791|NCT02666430|565481740|FG001|Period 1|Adverse Event|1|||
156421693|NCT05397470|564634593|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
156421694|NCT05397470|564634594|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
156421695|NCT05397470|564634592|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
156421696|NCT05397470|564634593|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
156421697|NCT05397470|564634594|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
156421698|NCT05397470|564634592|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
156421699|NCT05397470|564634593|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
156421700|NCT05397470|564634594|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
156421701|NCT05397470|564634592|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
156421702|NCT05397470|564634593|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
156421703|NCT05397470|564634594|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
156421704|NCT05397470|564634592|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
156421705|NCT05397470|564634593|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
156421706|NCT05397470|564634594|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
156421707|NCT05397470|564634592|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
156421708|NCT05397470|564634593|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
156421709|NCT05397470|564634594|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
156421710|NCT03015740|564634595|FG000|Overall Study|Adverse Event|1|||
156421711|NCT03015740|564634596|FG001|Overall Study|Adverse Event|0|||
156421712|NCT03015740|564634597|FG002|Overall Study|Adverse Event|0|||
156421713|NCT03015740|564634595|FG000|Overall Study|Death|3|||
156421714|NCT03015740|564634596|FG001|Overall Study|Death|5|||
156421715|NCT03015740|564634597|FG002|Overall Study|Death|0|||
156421716|NCT03015740|564634595|FG000|Overall Study|Withdrawal by Subject|2|||
156421717|NCT03015740|564634596|FG001|Overall Study|Withdrawal by Subject|0|||
156421718|NCT03015740|564634597|FG002|Overall Study|Withdrawal by Subject|0|||
156421719|NCT03253653|564634598|FG000|Overall Study|Withdrawal by Subject|4|||
156421720|NCT03253653|564634599|FG001|Overall Study|Withdrawal by Subject|1|||
156421721|NCT03253653|564634598|FG000|Overall Study|Protocol Violation|0|||
156421722|NCT03253653|564634599|FG001|Overall Study|Protocol Violation|5|||
156421723|NCT02263885|564636591|FG000|Overall Study|Withdrawal by Subject|7|||
156421724|NCT02263885|564636591|FG000|Overall Study|Alternative Treatment|3|||
156421725|NCT00003377|564636594|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
156421726|NCT00003377|564636595|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
156421727|NCT00003377|564636596|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
156421728|NCT00003377|564636597|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
156421729|NCT00003377|564636598|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
156421730|NCT00003377|564636594|FG000|Period II|Ureteral stent complications|0|||
156421731|NCT00003377|564636595|FG001|Period II|Ureteral stent complications|0|||
156421732|NCT00003377|564636596|FG002|Period II|Ureteral stent complications|0|||
156421733|NCT00003377|564636597|FG003|Period II|Ureteral stent complications|0|||
156421734|NCT00003377|564636598|FG004|Period II|Ureteral stent complications|1|||
156421735|NCT00480441|564636602|FG000|Screening|Not Eligible|37|||
156421736|NCT00480441|564636603|FG001|Screening|Not Eligible|0|||
156421737|NCT00480441|564636604|FG002|Screening|Not Eligible|0|||
156421738|NCT00480441|564636602|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
156421739|NCT00480441|564636603|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
156421740|NCT00480441|564636604|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
156421741|NCT00480441|564636602|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
156421742|NCT00480441|564636603|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
156421743|NCT00480441|564636604|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
156421744|NCT00480441|564636602|FG000|Baseline Functional MRI|physical contraindication|4|||
156421745|NCT00480441|564636603|FG001|Baseline Functional MRI|physical contraindication|0|||
156421746|NCT00480441|564636604|FG002|Baseline Functional MRI|physical contraindication|0|||
156421747|NCT00480441|564636602|FG000|Randomization|Lost to Follow-up|0|||
156654792|NCT02666430|565481739|FG000|Period 2|Withdrawal by Subject|1|||
156654793|NCT02666430|565481740|FG001|Period 2|Withdrawal by Subject|4|||
156421748|NCT00480441|564636603|FG001|Randomization|Lost to Follow-up|7|||
156421749|NCT00480441|564636604|FG002|Randomization|Lost to Follow-up|2|||
156421750|NCT03532178|564636605|FG000|First Period|Withdrawal by Subject|1|||
156421751|NCT03532178|564636606|FG001|First Period|Withdrawal by Subject|3|||
156421752|NCT03532178|564636605|FG000|First Period|technical issues in data collection Technical issues|0|||
156421753|NCT03532178|564636606|FG001|First Period|technical issues in data collection Technical issues|1|||
156654794|NCT02666430|565481739|FG000|Period 3|Lost to Follow-up|1|||
156654795|NCT02666430|565481740|FG001|Period 3|Lost to Follow-up|0|||
156654796|NCT03828461|565481741|FG000|Overall Study|Lost to Follow-up|1|||
156654797|NCT03828461|565481741|FG000|Overall Study|Withdrawal by Subject|3|||
156654798|NCT03095352|565481745|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
156654799|NCT03095352|565481746|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
156654800|NCT01565083|565481747|FG000|Overall Study|Withdrawal by Subject|6|||
156761961|NCT05616013|565879948|FG004|Overall Study|Non-compliance with study requirements|0|||
156421754|NCT03532178|564636605|FG000|Second Period|Withdrawal by Subject|1|||
156421755|NCT03532178|564636606|FG001|Second Period|Withdrawal by Subject|1|||
156421756|NCT03532178|564636605|FG000|Second Period|Technical issues|0|||
156421757|NCT03532178|564636606|FG001|Second Period|Technical issues|1|||
156421758|NCT01113463|564636609|FG000|Overall Study|Physician Decision|5|||
156421759|NCT00372528|564636611|FG000|Overall Study|Lack of Efficacy|1|||
156421760|NCT00372528|564636611|FG000|Overall Study|Adverse Event|1|||
156421761|NCT00372528|564636611|FG000|Overall Study|Study Terminated by Sponsor|18|||
156421762|NCT00372528|564636611|FG000|Overall Study|Other|1|||
156421763|NCT01417000|564636612|FG000|Overall Study|Death|59|||
156421764|NCT01417000|564636613|FG001|Overall Study|Death|28|||
156421765|NCT01417000|564636612|FG000|Overall Study|Lost to Follow-up|1|||
156421766|NCT01417000|564636613|FG001|Overall Study|Lost to Follow-up|0|||
156421767|NCT01417000|564636612|FG000|Overall Study|Study Terminated by Sponsor|1|||
156421768|NCT01417000|564636613|FG001|Overall Study|Study Terminated by Sponsor|1|||
156421769|NCT00562965|564636614|FG000|Overall Study|Withdrawal by Subject|0|||
156421770|NCT00562965|564636615|FG001|Overall Study|Withdrawal by Subject|1|||
156421771|NCT00562965|564636614|FG000|Overall Study|Death|2|||
156421772|NCT00562965|564636615|FG001|Overall Study|Death|4|||
156421773|NCT00562965|564636614|FG000|Overall Study|Lost to Follow-up|1|||
156421774|NCT00562965|564636615|FG001|Overall Study|Lost to Follow-up|0|||
156421775|NCT00562965|564636614|FG000|Overall Study|Other|0|||
156421776|NCT00562965|564636615|FG001|Overall Study|Other|1|||
156421777|NCT00965484|564636616|FG000|Overall Study|Protocol Violation|1|||
156421778|NCT00965484|564636616|FG000|Overall Study|Withdrawal by Subject|1|||
156421779|NCT00630539|564636621|FG000|Overall Study|Adverse Event|1|||
156421780|NCT00630539|564636622|FG001|Overall Study|Adverse Event|3|||
156421781|NCT00630539|564636623|FG002|Overall Study|Adverse Event|1|||
156421782|NCT00630539|564636624|FG003|Overall Study|Adverse Event|2|||
156421783|NCT00630539|564636621|FG000|Overall Study|Withdrawal by Subject|0|||
156421784|NCT00630539|564636622|FG001|Overall Study|Withdrawal by Subject|1|||
156421785|NCT00630539|564636623|FG002|Overall Study|Withdrawal by Subject|0|||
156421786|NCT00630539|564636624|FG003|Overall Study|Withdrawal by Subject|1|||
156421787|NCT00578227|564636629|FG000|Overall Study|Lost to Follow-up|0|||
156421788|NCT00578227|564636630|FG001|Overall Study|Lost to Follow-up|1|||
156421789|NCT00578227|564636631|FG002|Overall Study|Lost to Follow-up|1|||
156421790|NCT00578227|564636629|FG000|Overall Study|Withdrawal by Subject|5|||
156421791|NCT00578227|564636630|FG001|Overall Study|Withdrawal by Subject|1|||
156421792|NCT00578227|564636631|FG002|Overall Study|Withdrawal by Subject|3|||
156421793|NCT00916006|564636640|FG000|Overall Study|Adverse Event|1|||
156421794|NCT00916006|564636641|FG001|Overall Study|Adverse Event|1|||
156421795|NCT00916006|564636640|FG000|Overall Study|Withdrawal by Subject|2|||
156421796|NCT00916006|564636641|FG001|Overall Study|Withdrawal by Subject|5|||
156421797|NCT00916006|564636640|FG000|Overall Study|Protocol Violation|0|||
156421798|NCT00916006|564636641|FG001|Overall Study|Protocol Violation|1|||
156421799|NCT01605136|564636646|FG000|Study Period|Withdrawal by Subject|2|||
156421800|NCT01605136|564636647|FG001|Study Period|Withdrawal by Subject|0|||
156421801|NCT01605136|564636646|FG000|Study Period|Physician Decision|1|||
156421802|NCT01605136|564636647|FG001|Study Period|Physician Decision|1|||
156421803|NCT01605136|564636646|FG000|Study Period|Lost to Follow-up|0|||
156421804|NCT01605136|564636647|FG001|Study Period|Lost to Follow-up|2|||
156421805|NCT01605136|564636646|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
156421806|NCT01605136|564636647|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
156421807|NCT02929108|564636648|FG000|Overall Study|Hospice patient death|100|||
156421808|NCT02929108|564636649|FG001|Overall Study|Hospice patient death|64|||
156421809|NCT02929108|564636650|FG002|Overall Study|Hospice patient death|28|||
156421810|NCT02929108|564636651|FG003|Overall Study|Hospice patient death|46|||
156421811|NCT02929108|564636652|FG004|Overall Study|Hospice patient death|55|||
156421812|NCT02929108|564636653|FG005|Overall Study|Hospice patient death|28|||
156421813|NCT02929108|564636654|FG006|Overall Study|Hospice patient death|78|||
156421814|NCT00052962|564636655|FG000|Overall Study|Not evaluable|0|||
156421815|NCT00052962|564636656|FG001|Overall Study|Not evaluable|2|||
156421816|NCT00052962|564636655|FG000|Overall Study|Not randomized/not evaluable|1|||
156421817|NCT00052962|564636656|FG001|Overall Study|Not randomized/not evaluable|0|||
156421818|NCT01414166|564636657|FG000|Overall Study|Adverse Event|10|||
156421819|NCT01414166|564636658|FG001|Overall Study|Adverse Event|2|||
156421820|NCT01414166|564636657|FG000|Overall Study|Lost to Follow-up|4|||
156421821|NCT01414166|564636658|FG001|Overall Study|Lost to Follow-up|1|||
156421822|NCT01414166|564636657|FG000|Overall Study|Non-compliance with study drug|2|||
156421823|NCT01414166|564636658|FG001|Overall Study|Non-compliance with study drug|0|||
156421824|NCT01414166|564636657|FG000|Overall Study|Physician Decision|2|||
156421825|NCT01414166|564636658|FG001|Overall Study|Physician Decision|0|||
156421826|NCT01414166|564636657|FG000|Overall Study|Protocol Violation|2|||
156421827|NCT01414166|564636658|FG001|Overall Study|Protocol Violation|0|||
156421828|NCT01414166|564636657|FG000|Overall Study|Study terminated by Sponsor|68|||
156421829|NCT01414166|564636658|FG001|Overall Study|Study terminated by Sponsor|75|||
156421830|NCT01414166|564636657|FG000|Overall Study|Withdrawal by Subject|3|||
156421831|NCT01414166|564636658|FG001|Overall Study|Withdrawal by Subject|5|||
156421832|NCT05489224|564636659|FG000|Treatment Period I|Withdrawal by Subject|6|||
156421833|NCT05489224|564636660|FG001|Treatment Period I|Withdrawal by Subject|5|||
156421834|NCT05489224|564636661|FG002|Treatment Period I|Withdrawal by Subject|0|||
156421835|NCT05489224|564636659|FG000|Treatment Period I|Adverse Event|3|||
156421836|NCT05489224|564636660|FG001|Treatment Period I|Adverse Event|11|||
156421837|NCT05489224|564636661|FG002|Treatment Period I|Adverse Event|0|||
156421838|NCT05489224|564636659|FG000|Treatment Period I|Lost to Follow-up|0|||
156421839|NCT05489224|564636660|FG001|Treatment Period I|Lost to Follow-up|1|||
156421840|NCT05489224|564636661|FG002|Treatment Period I|Lost to Follow-up|0|||
156421841|NCT05489224|564636659|FG000|Treatment Period I|Physician Decision|0|||
156421842|NCT05489224|564636660|FG001|Treatment Period I|Physician Decision|1|||
156421843|NCT05489224|564636661|FG002|Treatment Period I|Physician Decision|0|||
156421844|NCT05489224|564636659|FG000|Treatment Period II up to Week 32|Ongoing|222|||
156421845|NCT05489224|564636660|FG001|Treatment Period II up to Week 32|Ongoing|107|||
156421846|NCT05489224|564636661|FG002|Treatment Period II up to Week 32|Ongoing|107|||
156421847|NCT05489224|564636659|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
156421848|NCT05489224|564636660|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
156421849|NCT05489224|564636661|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
156421850|NCT05489224|564636659|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
156421851|NCT05489224|564636660|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
156421852|NCT05489224|564636661|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
156421853|NCT03008122|564636670|FG000|Overall Study|Physician Decision|3|||
156421854|NCT03008122|564636671|FG001|Overall Study|Physician Decision|2|||
156421855|NCT03008122|564636672|FG002|Overall Study|Physician Decision|0|||
156421856|NCT03008122|564636670|FG000|Overall Study|Withdrawal by Subject|1|||
156421857|NCT03008122|564636671|FG001|Overall Study|Withdrawal by Subject|3|||
156421858|NCT03008122|564636672|FG002|Overall Study|Withdrawal by Subject|0|||
156421859|NCT03008122|564636670|FG000|Overall Study|Lost to Follow-up|4|||
156421860|NCT03008122|564636671|FG001|Overall Study|Lost to Follow-up|8|||
156421861|NCT03008122|564636672|FG002|Overall Study|Lost to Follow-up|3|||
156421862|NCT03008122|564636670|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
156421863|NCT03008122|564636671|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
156421864|NCT03008122|564636672|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
156421865|NCT03008122|564636670|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
156421866|NCT03008122|564636671|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
156421867|NCT03008122|564636672|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
156421868|NCT03008122|564636670|FG000|Overall Study|Death|0|||
156421869|NCT03008122|564636671|FG001|Overall Study|Death|0|||
156421870|NCT03008122|564636672|FG002|Overall Study|Death|1|||
156421871|NCT01222247|564636674|FG000|Overall Study|Lost to Follow-up|2|||
156421872|NCT01222247|564636675|FG001|Overall Study|Lost to Follow-up|2|||
156421873|NCT02084082|564636676|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
156421874|NCT02084082|564636677|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
156421875|NCT02084082|564636678|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
156421876|NCT02084082|564636679|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
156421877|NCT02084082|564636676|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156421878|NCT02084082|564636677|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156421879|NCT02084082|564636678|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156421880|NCT02084082|564636679|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
156421881|NCT02223182|564636684|FG000|Double-Blind Period|Adverse Event|0|||
156421882|NCT02223182|564636685|FG001|Double-Blind Period|Adverse Event|2|||
156421883|NCT02223182|564636686|FG002|Double-Blind Period|Adverse Event|1|||
156421884|NCT02223182|564636687|FG003|Double-Blind Period|Adverse Event|0|||
156421885|NCT02223182|564636684|FG000|Double-Blind Period|Withdrawal by Subject|1|||
156421886|NCT02223182|564636685|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156421887|NCT02223182|564636686|FG002|Double-Blind Period|Withdrawal by Subject|1|||
156421888|NCT02223182|564636687|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156421889|NCT02223182|564636684|FG000|Double-Blind Period|Lost to Follow-up|0|||
156421890|NCT02223182|564636685|FG001|Double-Blind Period|Lost to Follow-up|1|||
156421891|NCT02223182|564636686|FG002|Double-Blind Period|Lost to Follow-up|0|||
156654801|NCT01565083|565481748|FG001|Overall Study|Withdrawal by Subject|4|||
156654802|NCT01565083|565481747|FG000|Overall Study|Lost to Follow-up|2|||
156654803|NCT01565083|565481748|FG001|Overall Study|Lost to Follow-up|7|||
156654804|NCT01565083|565481747|FG000|Overall Study|Death|22|||
156654805|NCT01565083|565481748|FG001|Overall Study|Death|23|||
156654806|NCT01565083|565481747|FG000|Overall Study|Other|3|||
156654807|NCT01565083|565481748|FG001|Overall Study|Other|5|||
156654808|NCT05431686|565481749|FG000|Overall Study|unable to schedule|10|||
156654809|NCT01118728|565481750|FG000|Overall Study|Adverse Event|17|||
156421892|NCT02223182|564636687|FG003|Double-Blind Period|Lost to Follow-up|0|||
156421893|NCT02223182|564636684|FG000|Double-Blind Period|Non Compliance|0|||
156421894|NCT02223182|564636685|FG001|Double-Blind Period|Non Compliance|0|||
156421895|NCT02223182|564636686|FG002|Double-Blind Period|Non Compliance|0|||
156421896|NCT02223182|564636687|FG003|Double-Blind Period|Non Compliance|1|||
156421897|NCT02223182|564636684|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
156421898|NCT02223182|564636685|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
156654810|NCT01118728|565481750|FG000|Overall Study|Lack of Efficacy|27|||
156421899|NCT02223182|564636686|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
156654811|NCT01118728|565481750|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
156421900|NCT02223182|564636687|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
156421901|NCT02223182|564636684|FG000|Open-Label 500 Period|Adverse Event|1|||
156421902|NCT02223182|564636685|FG001|Open-Label 500 Period|Adverse Event|0|||
156421903|NCT02223182|564636686|FG002|Open-Label 500 Period|Adverse Event|2|||
156421904|NCT02223182|564636687|FG003|Open-Label 500 Period|Adverse Event|1|||
156421905|NCT02223182|564636684|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
156421906|NCT02223182|564636685|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
156421907|NCT02223182|564636686|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
156421908|NCT02223182|564636687|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
156421909|NCT02223182|564636684|FG000|Open-Label 500 Period|Physician Decision|0|||
156421910|NCT02223182|564636685|FG001|Open-Label 500 Period|Physician Decision|0|||
156421911|NCT02223182|564636686|FG002|Open-Label 500 Period|Physician Decision|0|||
156421912|NCT02223182|564636687|FG003|Open-Label 500 Period|Physician Decision|1|||
156421913|NCT02223182|564636684|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
156421914|NCT02223182|564636685|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
156421915|NCT02223182|564636686|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
156421916|NCT02223182|564636687|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
156319939|NCT04078178|564270691|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
156319940|NCT04006119|564270692|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
156319941|NCT04006119|564270692|FG000|End of Treatment Veledimex|Adverse Event|2|||
156319942|NCT04006119|564270692|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
156319943|NCT04006119|564270692|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
156319944|NCT04006119|564270692|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
156319945|NCT04006119|564270692|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
156319946|NCT03269552|564270693|FG000|Overall Study|Adverse Event|2|||
156319947|NCT02186301|564270694|FG000|Overall Study|Progressive Disease|7|||
156319948|NCT02186301|564270695|FG001|Overall Study|Progressive Disease|22|||
156319949|NCT02186301|564270696|FG002|Overall Study|Progressive Disease|27|||
156319950|NCT02186301|564270694|FG000|Overall Study|Adverse Event|5|||
156319951|NCT02186301|564270695|FG001|Overall Study|Adverse Event|5|||
156319952|NCT02186301|564270696|FG002|Overall Study|Adverse Event|5|||
156319953|NCT02186301|564270694|FG000|Overall Study|Death|1|||
156319954|NCT02186301|564270695|FG001|Overall Study|Death|0|||
156319955|NCT02186301|564270696|FG002|Overall Study|Death|0|||
156319956|NCT02186301|564270694|FG000|Overall Study|Withdrawal by Subject|5|||
156319957|NCT02186301|564270695|FG001|Overall Study|Withdrawal by Subject|1|||
156319958|NCT02186301|564270696|FG002|Overall Study|Withdrawal by Subject|3|||
156319959|NCT02186301|564270694|FG000|Overall Study|Physician Decision|1|||
156319960|NCT02186301|564270695|FG001|Overall Study|Physician Decision|0|||
156319961|NCT02186301|564270696|FG002|Overall Study|Physician Decision|1|||
156319962|NCT02186301|564270694|FG000|Overall Study|Study Terminated by Sponsor|1|||
156319963|NCT02186301|564270695|FG001|Overall Study|Study Terminated by Sponsor|0|||
156319964|NCT02186301|564270696|FG002|Overall Study|Study Terminated by Sponsor|11|||
156319965|NCT02186301|564270694|FG000|Overall Study|Protocol Deviation|0|||
156319966|NCT02186301|564270695|FG001|Overall Study|Protocol Deviation|2|||
156319967|NCT02186301|564270696|FG002|Overall Study|Protocol Deviation|0|||
156319968|NCT02186301|564270694|FG000|Overall Study|Missing|0|||
156319969|NCT02186301|564270695|FG001|Overall Study|Missing|0|||
156319970|NCT02186301|564270696|FG002|Overall Study|Missing|2|||
156319971|NCT02186301|564270694|FG000|Overall Study|Other|0|||
156319972|NCT02186301|564270695|FG001|Overall Study|Other|0|||
156319973|NCT02186301|564270696|FG002|Overall Study|Other|1|||
156319974|NCT00749580|564270701|FG000|Overall Study|Lost to Follow-up|4|||
156319975|NCT00749580|564270702|FG001|Overall Study|Lost to Follow-up|8|||
156319976|NCT00749580|564270701|FG000|Overall Study|Adverse Event|0|||
156319977|NCT00749580|564270702|FG001|Overall Study|Adverse Event|1|||
156319978|NCT04393298|564270703|FG000|Overall Study|Adverse Event|0|||
156319979|NCT04393298|564270704|FG001|Overall Study|Adverse Event|0|||
156319980|NCT04393298|564270705|FG002|Overall Study|Adverse Event|0|||
156319981|NCT04393298|564270706|FG003|Overall Study|Adverse Event|0|||
156319982|NCT04393298|564270707|FG004|Overall Study|Adverse Event|1|||
156319983|NCT04393298|564270708|FG005|Overall Study|Adverse Event|0|||
156319984|NCT04393298|564270709|FG006|Overall Study|Adverse Event|0|||
156319985|NCT04393298|564270710|FG007|Overall Study|Adverse Event|0|||
156319986|NCT04393298|564270711|FG008|Overall Study|Adverse Event|2|||
156319987|NCT04393298|564270712|FG009|Overall Study|Adverse Event|0|||
156319988|NCT04393298|564270713|FG010|Overall Study|Adverse Event|0|||
156319989|NCT04393298|564270714|FG011|Overall Study|Adverse Event|0|||
156421917|NCT02223182|564636684|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
156319990|NCT04393298|564270715|FG012|Overall Study|Adverse Event|1|||
156319991|NCT04393298|564270716|FG013|Overall Study|Adverse Event|1|||
156319992|NCT04393298|564270717|FG014|Overall Study|Adverse Event|0|||
156319993|NCT04393298|564270703|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156319994|NCT04393298|564270704|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156319995|NCT04393298|564270705|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
156319996|NCT04393298|564270706|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156654812|NCT01118728|565481750|FG000|Overall Study|Withdrawal by Subject|3|||
156654813|NCT01118728|565481750|FG000|Overall Study|Lost to Follow-up|4|||
156654814|NCT02227862|565482593|FG000|Overall Study|Protocol Violation|7|||
156654815|NCT02227862|565482594|FG001|Overall Study|Protocol Violation|9|||
156654816|NCT02227862|565482593|FG000|Overall Study|Other|0|||
156654817|NCT02227862|565482594|FG001|Overall Study|Other|2|||
156319997|NCT04393298|564270707|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156319998|NCT04393298|564270708|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156319999|NCT04393298|564270709|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156320000|NCT04393298|564270710|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156320001|NCT04393298|564270711|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156320002|NCT04393298|564270712|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156320003|NCT04393298|564270713|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156320004|NCT04393298|564270714|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156320005|NCT04393298|564270715|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156320006|NCT04393298|564270716|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156320007|NCT04393298|564270717|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
156320008|NCT04393298|564270703|FG000|Overall Study|Lack of Efficacy|0|||
156320009|NCT04393298|564270704|FG001|Overall Study|Lack of Efficacy|0|||
156320010|NCT04393298|564270705|FG002|Overall Study|Lack of Efficacy|0|||
156320011|NCT04393298|564270706|FG003|Overall Study|Lack of Efficacy|0|||
156320012|NCT04393298|564270707|FG004|Overall Study|Lack of Efficacy|0|||
156320013|NCT04393298|564270708|FG005|Overall Study|Lack of Efficacy|0|||
156320014|NCT04393298|564270709|FG006|Overall Study|Lack of Efficacy|0|||
156320015|NCT04393298|564270710|FG007|Overall Study|Lack of Efficacy|0|||
156320016|NCT04393298|564270711|FG008|Overall Study|Lack of Efficacy|0|||
156320017|NCT04393298|564270712|FG009|Overall Study|Lack of Efficacy|0|||
156320018|NCT04393298|564270713|FG010|Overall Study|Lack of Efficacy|0|||
156320019|NCT04393298|564270714|FG011|Overall Study|Lack of Efficacy|0|||
156320020|NCT04393298|564270715|FG012|Overall Study|Lack of Efficacy|0|||
156320021|NCT04393298|564270716|FG013|Overall Study|Lack of Efficacy|0|||
156320022|NCT04393298|564270717|FG014|Overall Study|Lack of Efficacy|1|||
156320023|NCT04393298|564270703|FG000|Overall Study|Progression|1|||
156320024|NCT04393298|564270704|FG001|Overall Study|Progression|0|||
156320025|NCT04393298|564270705|FG002|Overall Study|Progression|0|||
156320026|NCT04393298|564270706|FG003|Overall Study|Progression|0|||
156320027|NCT04393298|564270707|FG004|Overall Study|Progression|0|||
156320028|NCT04393298|564270708|FG005|Overall Study|Progression|0|||
156320029|NCT04393298|564270709|FG006|Overall Study|Progression|0|||
156320030|NCT04393298|564270710|FG007|Overall Study|Progression|0|||
156320031|NCT04393298|564270711|FG008|Overall Study|Progression|0|||
156320032|NCT04393298|564270712|FG009|Overall Study|Progression|0|||
156320033|NCT04393298|564270713|FG010|Overall Study|Progression|1|||
156320034|NCT04393298|564270714|FG011|Overall Study|Progression|1|||
156320035|NCT04393298|564270715|FG012|Overall Study|Progression|0|||
156320036|NCT04393298|564270716|FG013|Overall Study|Progression|0|||
156320037|NCT04393298|564270717|FG014|Overall Study|Progression|0|||
156320038|NCT04393298|564270703|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
156320039|NCT04393298|564270704|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
156421918|NCT02223182|564636685|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
156421919|NCT02223182|564636686|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
156421920|NCT02223182|564636687|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
156421921|NCT02223182|564636684|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
156654818|NCT02227862|565482593|FG000|Overall Study|Adverse Event|4|||
156654819|NCT02227862|565482594|FG001|Overall Study|Adverse Event|3|||
156654820|NCT02227862|565482593|FG000|Overall Study|Withdrawal by Subject|7|||
156654821|NCT02227862|565482594|FG001|Overall Study|Withdrawal by Subject|6|||
156654822|NCT02227862|565482593|FG000|Overall Study|Lost to Follow-up|1|||
156654823|NCT02227862|565482594|FG001|Overall Study|Lost to Follow-up|2|||
156654824|NCT00783796|565482595|FG000|Overall Study|Did not receive any stent|4|||
156654825|NCT00783796|565482595|FG000|Overall Study|Received non-XIENCE V stent|1|||
156421922|NCT02223182|564636685|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
156421923|NCT02223182|564636686|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
156421924|NCT02223182|564636687|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
156421925|NCT02223182|564636684|FG000|Open-Label 300 Period|Non Compliance|0|||
156421926|NCT02223182|564636685|FG001|Open-Label 300 Period|Non Compliance|2|||
156421927|NCT02223182|564636686|FG002|Open-Label 300 Period|Non Compliance|1|||
156654826|NCT00783796|565482595|FG000|Overall Study|Received commercial XIENCE V stent|1|||
156654827|NCT01215942|565482599|FG000|Treatment Period|Adverse Event|15|||
156320040|NCT04393298|564270705|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320041|NCT04393298|564270706|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320042|NCT04393298|564270707|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320043|NCT04393298|564270708|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320044|NCT04393298|564270709|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320045|NCT04393298|564270710|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320046|NCT04393298|564270711|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
156654828|NCT01215942|565482600|FG001|Treatment Period|Adverse Event|26|||
156320047|NCT04393298|564270712|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320048|NCT04393298|564270713|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320049|NCT04393298|564270714|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320050|NCT04393298|564270715|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320051|NCT04393298|564270716|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320052|NCT04393298|564270717|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
156320053|NCT04393298|564270703|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320054|NCT04393298|564270704|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
156320055|NCT04393298|564270705|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320056|NCT04393298|564270706|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320057|NCT04393298|564270707|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320058|NCT04393298|564270708|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320059|NCT04393298|564270709|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320060|NCT04393298|564270710|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320061|NCT04393298|564270711|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320062|NCT04393298|564270712|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320063|NCT04393298|564270713|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320064|NCT04393298|564270714|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320065|NCT04393298|564270715|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320066|NCT04393298|564270716|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320067|NCT04393298|564270717|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156320068|NCT04393298|564270703|FG000|Overall Study|Clinical Progression|0|||
156320069|NCT04393298|564270704|FG001|Overall Study|Clinical Progression|2|||
156320070|NCT04393298|564270705|FG002|Overall Study|Clinical Progression|0|||
156320071|NCT04393298|564270706|FG003|Overall Study|Clinical Progression|0|||
156320072|NCT04393298|564270707|FG004|Overall Study|Clinical Progression|0|||
156320073|NCT04393298|564270708|FG005|Overall Study|Clinical Progression|0|||
156320074|NCT04393298|564270709|FG006|Overall Study|Clinical Progression|0|||
156320075|NCT04393298|564270710|FG007|Overall Study|Clinical Progression|0|||
156320076|NCT04393298|564270711|FG008|Overall Study|Clinical Progression|0|||
156320077|NCT04393298|564270712|FG009|Overall Study|Clinical Progression|0|||
156320078|NCT04393298|564270713|FG010|Overall Study|Clinical Progression|0|||
156320079|NCT04393298|564270714|FG011|Overall Study|Clinical Progression|0|||
156320080|NCT04393298|564270715|FG012|Overall Study|Clinical Progression|0|||
156320081|NCT04393298|564270716|FG013|Overall Study|Clinical Progression|0|||
156320082|NCT04393298|564270717|FG014|Overall Study|Clinical Progression|0|||
156320083|NCT04393298|564270703|FG000|Overall Study|Disease Progression|0|||
156320084|NCT04393298|564270704|FG001|Overall Study|Disease Progression|1|||
156320085|NCT04393298|564270705|FG002|Overall Study|Disease Progression|0|||
156320086|NCT04393298|564270706|FG003|Overall Study|Disease Progression|0|||
156320087|NCT04393298|564270707|FG004|Overall Study|Disease Progression|0|||
156320088|NCT04393298|564270708|FG005|Overall Study|Disease Progression|3|||
156320089|NCT04393298|564270709|FG006|Overall Study|Disease Progression|2|||
156320090|NCT04393298|564270710|FG007|Overall Study|Disease Progression|1|||
156320091|NCT04393298|564270711|FG008|Overall Study|Disease Progression|2|||
156320092|NCT04393298|564270712|FG009|Overall Study|Disease Progression|1|||
156320093|NCT04393298|564270713|FG010|Overall Study|Disease Progression|0|||
156320094|NCT04393298|564270714|FG011|Overall Study|Disease Progression|3|||
156320095|NCT04393298|564270715|FG012|Overall Study|Disease Progression|0|||
156320096|NCT04393298|564270716|FG013|Overall Study|Disease Progression|0|||
156320097|NCT04393298|564270717|FG014|Overall Study|Disease Progression|1|||
156320098|NCT04393298|564270703|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320099|NCT04393298|564270704|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320100|NCT04393298|564270705|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
156320101|NCT04393298|564270706|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320102|NCT04393298|564270707|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320103|NCT04393298|564270708|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320104|NCT04393298|564270709|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320105|NCT04393298|564270710|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320106|NCT04393298|564270711|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320107|NCT04393298|564270712|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320108|NCT04393298|564270713|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320109|NCT04393298|564270714|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320110|NCT04393298|564270715|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320111|NCT04393298|564270716|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320112|NCT04393298|564270717|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156320113|NCT04393298|564270703|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320114|NCT04393298|564270704|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
156421928|NCT02223182|564636687|FG003|Open-Label 300 Period|Non Compliance|0|||
156421929|NCT04956692|564636694|FG000|Overall Study|Death|115|||
156421930|NCT04956692|564636695|FG001|Overall Study|Death|47|||
156421931|NCT04956692|564636694|FG000|Overall Study|Lost to Follow-up|0|||
156421932|NCT04956692|564636695|FG001|Overall Study|Lost to Follow-up|1|||
156421933|NCT04956692|564636694|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156421934|NCT04956692|564636695|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156421935|NCT04956692|564636694|FG000|Overall Study|Withdrawal by Subject|5|||
156421936|NCT04956692|564636695|FG001|Overall Study|Withdrawal by Subject|2|||
156421937|NCT04956692|564636694|FG000|Overall Study|Ongoing in Study|236|||
156421938|NCT04956692|564636695|FG001|Overall Study|Ongoing in Study|123|||
156421939|NCT02099539|564636700|FG000|Overall Study|Progressive Disease|3|||
156421940|NCT02099539|564636701|FG001|Overall Study|Progressive Disease|2|||
156421941|NCT02099539|564636702|FG002|Overall Study|Progressive Disease|2|||
156421942|NCT02099539|564636703|FG003|Overall Study|Progressive Disease|1|||
156421943|NCT02099539|564636704|FG004|Overall Study|Progressive Disease|4|||
156421944|NCT02099539|564636705|FG005|Overall Study|Progressive Disease|2|||
156421945|NCT02099539|564636706|FG006|Overall Study|Progressive Disease|0|||
156421946|NCT02099539|564636700|FG000|Overall Study|Adverse Event|0|||
156421947|NCT02099539|564636701|FG001|Overall Study|Adverse Event|0|||
156421948|NCT02099539|564636702|FG002|Overall Study|Adverse Event|1|||
156421949|NCT02099539|564636703|FG003|Overall Study|Adverse Event|1|||
156421950|NCT02099539|564636704|FG004|Overall Study|Adverse Event|0|||
156421951|NCT02099539|564636705|FG005|Overall Study|Adverse Event|0|||
156421952|NCT02099539|564636706|FG006|Overall Study|Adverse Event|0|||
156421953|NCT02099539|564636700|FG000|Overall Study|Physician Decision|0|||
156421954|NCT02099539|564636701|FG001|Overall Study|Physician Decision|0|||
156421955|NCT02099539|564636702|FG002|Overall Study|Physician Decision|0|||
156421956|NCT02099539|564636703|FG003|Overall Study|Physician Decision|0|||
156421957|NCT02099539|564636704|FG004|Overall Study|Physician Decision|0|||
156421958|NCT02099539|564636705|FG005|Overall Study|Physician Decision|1|||
156421959|NCT02099539|564636706|FG006|Overall Study|Physician Decision|0|||
156421960|NCT03473756|564636708|FG000|Overall Study|Withdrawal by Subject|1|||
156421961|NCT03473756|564636709|FG001|Overall Study|Withdrawal by Subject|4|||
156421962|NCT03473756|564636708|FG000|Overall Study|Adverse Event|6|||
156421963|NCT03473756|564636709|FG001|Overall Study|Adverse Event|7|||
156421964|NCT03473756|564636708|FG000|Overall Study|Lack of Efficacy|3|||
156421965|NCT03473756|564636709|FG001|Overall Study|Lack of Efficacy|10|||
156421966|NCT03473756|564636708|FG000|Overall Study|Physician Decision|0|||
156421967|NCT03473756|564636709|FG001|Overall Study|Physician Decision|2|||
156421968|NCT03473756|564636708|FG000|Overall Study|End of study treatment|0|||
156421969|NCT03473756|564636709|FG001|Overall Study|End of study treatment|2|||
156421970|NCT03473756|564636708|FG000|Overall Study|Lost to Follow-up|0|||
156421971|NCT03473756|564636709|FG001|Overall Study|Lost to Follow-up|1|||
156421972|NCT03714022|564636710|FG000|Overall Study|Adverse Event|1|||
156421973|NCT03714022|564636711|FG001|Overall Study|Adverse Event|0|||
156421974|NCT03714022|564636710|FG000|Overall Study|Consent withdrawal|0|||
156421975|NCT03714022|564636711|FG001|Overall Study|Consent withdrawal|1|||
156421976|NCT03714022|564636710|FG000|Overall Study|Lost to Follow-up|3|||
156421977|NCT03714022|564636711|FG001|Overall Study|Lost to Follow-up|2|||
156421978|NCT01449721|564636712|FG000|Overall Study|Physician Decision|0|||
156421979|NCT01449721|564636713|FG001|Overall Study|Physician Decision|1|||
156421980|NCT01449721|564636712|FG000|Overall Study|Physician Decision|0|||
156421981|NCT01449721|564636713|FG001|Overall Study|Physician Decision|1|||
156421982|NCT02148718|564636716|FG000|Overall Study|Protocol Violation|26|||
156421983|NCT02148718|564636716|FG000|Overall Study|Discontinued Study Prematurely|5|||
156421984|NCT01342887|564636718|FG000|Overall Study|Death|2|||
156421985|NCT02698436|564636723|FG000|Overall Study|Adverse Event|1|||
156421986|NCT02698436|564636724|FG001|Overall Study|Adverse Event|0|||
156421987|NCT02698436|564636723|FG000|Overall Study|Withdrawal by Subject|3|||
156421988|NCT02698436|564636724|FG001|Overall Study|Withdrawal by Subject|3|||
156421989|NCT02698436|564636723|FG000|Overall Study|Lost to Follow-up|2|||
156421990|NCT02698436|564636724|FG001|Overall Study|Lost to Follow-up|4|||
156421991|NCT02698436|564636723|FG000|Overall Study|Non-compliance with study regimen|1|||
156421992|NCT02698436|564636724|FG001|Overall Study|Non-compliance with study regimen|0|||
156421993|NCT01394991|564636729|FG000|Overall Study|Adverse Event|0|||
156421994|NCT01394991|564636730|FG001|Overall Study|Adverse Event|4|||
156421995|NCT01394991|564636729|FG000|Overall Study|Lack of Efficacy|5|||
156421996|NCT01394991|564636730|FG001|Overall Study|Lack of Efficacy|7|||
156421997|NCT01394991|564636729|FG000|Overall Study|Lost to Follow-up|6|||
156421998|NCT01394991|564636730|FG001|Overall Study|Lost to Follow-up|8|||
156421999|NCT01394991|564636729|FG000|Overall Study|Physician Decision|1|||
156422000|NCT01394991|564636730|FG001|Overall Study|Physician Decision|3|||
156422001|NCT01394991|564636729|FG000|Overall Study|Protocol Violation|1|||
156422002|NCT01394991|564636730|FG001|Overall Study|Protocol Violation|1|||
156422003|NCT01394991|564636729|FG000|Overall Study|Withdrawal by Subject|20|||
156422004|NCT01394991|564636730|FG001|Overall Study|Withdrawal by Subject|17|||
156422005|NCT01394991|564636729|FG000|Overall Study|Chemotherapy Termination|10|||
156422006|NCT01394991|564636730|FG001|Overall Study|Chemotherapy Termination|15|||
156422007|NCT01394991|564636729|FG000|Overall Study|Disease Progression|7|||
156422008|NCT01394991|564636730|FG001|Overall Study|Disease Progression|7|||
156422009|NCT01394991|564636729|FG000|Overall Study|Prematurely Termination of Trial|9|||
156422010|NCT01394991|564636730|FG001|Overall Study|Prematurely Termination of Trial|10|||
156422011|NCT00097370|564636731|FG000|Stage 1|Adverse Event|3|||
156422012|NCT00097370|564636731|FG000|Stage 1|Withdrawal by Subject|1|||
156422013|NCT00097370|564636731|FG000|Stage 1|Lack of Efficacy|2|||
156422014|NCT00097370|564636731|FG000|Stage 2|Adverse Event|5|||
156422015|NCT00097370|564636731|FG000|Stage 2|Withdrawal by Subject|1|||
156422016|NCT00097370|564636731|FG000|Stage 2|Lack of Efficacy|3|||
156422017|NCT00097370|564636731|FG000|Stage 2|Pregnancy|1|||
156422018|NCT00097370|564636731|FG000|Stage 2|Sponsor Terminated Study|2|||
156422019|NCT00097370|564636731|FG000|Stage 2|Lost to Follow-up|1|||
156422020|NCT00097370|564636731|FG000|Stage 3|Adverse Event|2|||
156422021|NCT00097370|564636731|FG000|Stage 3|Withdrawal by Subject|3|||
156422022|NCT00097370|564636731|FG000|Stage 3|Lack of Efficacy|1|||
156422023|NCT00097370|564636731|FG000|Stage 3|Sponsor Terminated Study|52|||
156422024|NCT00097370|564636731|FG000|Stage 3|Lost to Follow-up|1|||
156422025|NCT03073005|564636733|FG000|Overall Study|Death|6|||
156422026|NCT03073005|564636734|FG001|Overall Study|Death|0|||
156422027|NCT03073005|564636735|FG002|Overall Study|Death|7|||
156422028|NCT03073005|564636736|FG003|Overall Study|Death|0|||
156422029|NCT03073005|564636733|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
156422030|NCT03073005|564636734|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
156422031|NCT03073005|564636735|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
156422032|NCT03073005|564636736|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
156422033|NCT03073005|564636733|FG000|Overall Study|Lost to Follow-up|2|||
156422034|NCT03073005|564636734|FG001|Overall Study|Lost to Follow-up|2|||
156422035|NCT03073005|564636735|FG002|Overall Study|Lost to Follow-up|1|||
156422036|NCT03073005|564636736|FG003|Overall Study|Lost to Follow-up|2|||
156422037|NCT03073005|564636733|FG000|Overall Study|Withdrawal by Subject|0|||
156422038|NCT03073005|564636734|FG001|Overall Study|Withdrawal by Subject|4|||
156422039|NCT03073005|564636735|FG002|Overall Study|Withdrawal by Subject|4|||
156422040|NCT03073005|564636736|FG003|Overall Study|Withdrawal by Subject|4|||
156422041|NCT02427646|564636737|FG000|Overall Study|Lack of Efficacy|2|||
156422042|NCT02427646|564636738|FG001|Overall Study|Lack of Efficacy|3|||
156422043|NCT02427646|564636737|FG000|Overall Study|Physician Decision|1|||
156422044|NCT02427646|564636738|FG001|Overall Study|Physician Decision|4|||
156422045|NCT02427646|564636737|FG000|Overall Study|Protocol Violation|3|||
156422046|NCT02427646|564636738|FG001|Overall Study|Protocol Violation|3|||
156422047|NCT02427646|564636737|FG000|Overall Study|Bothersome hand weakness|2|||
156422048|NCT02427646|564636738|FG001|Overall Study|Bothersome hand weakness|4|||
156422049|NCT01734811|564636739|FG000|Overall Study|Lost to Follow-up|2|||
156422050|NCT01734811|564636740|FG001|Overall Study|Lost to Follow-up|3|||
156422051|NCT01734811|564636739|FG000|Overall Study|Withdrawal by Subject|2|||
156422052|NCT01734811|564636740|FG001|Overall Study|Withdrawal by Subject|0|||
156422053|NCT03824236|564636741|FG000|Overall Study|Lost to Follow-up|0|||
156422054|NCT03824236|564636742|FG001|Overall Study|Lost to Follow-up|0|||
156422055|NCT03824236|564636743|FG002|Overall Study|Lost to Follow-up|1|||
156422056|NCT01290094|564636744|FG000|Overall Study|Withdrawal by Subject|1|||
156422057|NCT01290094|564636744|FG000|Overall Study|Lost to Follow-up|5|||
156422058|NCT01101542|564636745|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
156422059|NCT01101542|564636745|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
156422060|NCT01101542|564636745|FG000|Year 4 Surveillance Period|Other|287|||
156422061|NCT01101542|564636745|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
156422062|NCT01101542|564636745|FG000|Year 5 Surveillance Period|Pregnancy|1|||
156422063|NCT01101542|564636745|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
156422064|NCT01101542|564636745|FG000|Year 6 Surveillance Period|Pregnancy|1|||
156422065|NCT01101542|564636745|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
156422066|NCT00701311|564636746|FG000|Overall Study|Lack of Efficacy|3|||
156422067|NCT00701311|564636746|FG000|Overall Study|Adverse Event|3|||
156422068|NCT00701311|564636746|FG000|Overall Study|Withdrawal by Subject|2|||
156422069|NCT00814489|564636747|FG000|Overall Study|Other|2|||
156422070|NCT00814489|564636748|FG001|Overall Study|Other|0|||
156422071|NCT00814489|564636749|FG002|Overall Study|Other|1|||
156422072|NCT04880161|564636775|FG000|Overall Study|Withdrawal by Subject|1|||
156422073|NCT04880161|564636776|FG001|Overall Study|Withdrawal by Subject|0|||
156422074|NCT04880161|564636775|FG000|Overall Study|Lack of Compliance|1|||
156422075|NCT04880161|564636776|FG001|Overall Study|Lack of Compliance|1|||
156422076|NCT04880161|564636775|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
156422077|NCT04880161|564636776|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
156422078|NCT04880161|564636775|FG000|Overall Study|Screen Failure|0|||
156422079|NCT04880161|564636776|FG001|Overall Study|Screen Failure|1|||
156422080|NCT01876043|564638969|FG000|Overall Study|Death|1|||
156422081|NCT01876043|564638969|FG000|Overall Study|Withdrawal by Subject|1|||
156422082|NCT00049517|564638970|FG000|Induction|Disease progression|0|||
156422083|NCT00049517|564638971|FG001|Induction|Disease progression|0|||
156422084|NCT00049517|564638972|FG002|Induction|Disease progression|0|||
156422085|NCT00049517|564638973|FG003|Induction|Disease progression|0|||
156422086|NCT00049517|564638974|FG004|Induction|Disease progression|18|||
156422087|NCT00049517|564638975|FG005|Induction|Disease progression|11|||
156320115|NCT04393298|564270705|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
156320116|NCT04393298|564270706|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320117|NCT04393298|564270707|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320118|NCT04393298|564270708|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320119|NCT04393298|564270709|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320120|NCT04393298|564270710|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320121|NCT04393298|564270711|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320122|NCT04393298|564270712|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320123|NCT04393298|564270713|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320124|NCT04393298|564270714|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320125|NCT04393298|564270715|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320126|NCT04393298|564270716|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320127|NCT04393298|564270717|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
156320128|NCT04393298|564270703|FG000|Overall Study|Progressive Disease (PD)|0|||
156320129|NCT04393298|564270704|FG001|Overall Study|Progressive Disease (PD)|0|||
156320130|NCT04393298|564270705|FG002|Overall Study|Progressive Disease (PD)|0|||
156320131|NCT04393298|564270706|FG003|Overall Study|Progressive Disease (PD)|3|||
156320132|NCT04393298|564270707|FG004|Overall Study|Progressive Disease (PD)|0|||
156320133|NCT04393298|564270708|FG005|Overall Study|Progressive Disease (PD)|0|||
156320134|NCT04393298|564270709|FG006|Overall Study|Progressive Disease (PD)|0|||
156320135|NCT04393298|564270710|FG007|Overall Study|Progressive Disease (PD)|0|||
156320136|NCT04393298|564270711|FG008|Overall Study|Progressive Disease (PD)|0|||
156320137|NCT04393298|564270712|FG009|Overall Study|Progressive Disease (PD)|0|||
156320138|NCT04393298|564270713|FG010|Overall Study|Progressive Disease (PD)|0|||
156320139|NCT04393298|564270714|FG011|Overall Study|Progressive Disease (PD)|0|||
156320140|NCT04393298|564270715|FG012|Overall Study|Progressive Disease (PD)|0|||
156320141|NCT04393298|564270716|FG013|Overall Study|Progressive Disease (PD)|0|||
156320142|NCT04393298|564270717|FG014|Overall Study|Progressive Disease (PD)|0|||
156320143|NCT04393298|564270703|FG000|Overall Study|Started a New Cancer Treatment|0|||
156320144|NCT04393298|564270704|FG001|Overall Study|Started a New Cancer Treatment|0|||
156320145|NCT04393298|564270705|FG002|Overall Study|Started a New Cancer Treatment|0|||
156320146|NCT04393298|564270706|FG003|Overall Study|Started a New Cancer Treatment|0|||
156320147|NCT04393298|564270707|FG004|Overall Study|Started a New Cancer Treatment|1|||
156320148|NCT04393298|564270708|FG005|Overall Study|Started a New Cancer Treatment|0|||
156320149|NCT04393298|564270709|FG006|Overall Study|Started a New Cancer Treatment|0|||
156320150|NCT04393298|564270710|FG007|Overall Study|Started a New Cancer Treatment|0|||
156320151|NCT04393298|564270711|FG008|Overall Study|Started a New Cancer Treatment|0|||
156320152|NCT04393298|564270712|FG009|Overall Study|Started a New Cancer Treatment|0|||
156320153|NCT04393298|564270713|FG010|Overall Study|Started a New Cancer Treatment|0|||
156320154|NCT04393298|564270714|FG011|Overall Study|Started a New Cancer Treatment|0|||
156320155|NCT04393298|564270715|FG012|Overall Study|Started a New Cancer Treatment|0|||
156320156|NCT04393298|564270716|FG013|Overall Study|Started a New Cancer Treatment|0|||
156320157|NCT04393298|564270717|FG014|Overall Study|Started a New Cancer Treatment|0|||
156320158|NCT04393298|564270703|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320159|NCT04393298|564270704|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320160|NCT04393298|564270705|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320161|NCT04393298|564270706|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320162|NCT04393298|564270707|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
156320163|NCT04393298|564270708|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320164|NCT04393298|564270709|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320165|NCT04393298|564270710|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320166|NCT04393298|564270711|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320167|NCT04393298|564270712|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320168|NCT04393298|564270713|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320169|NCT04393298|564270714|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156422088|NCT00049517|564638970|FG000|Induction|Adverse Event|0|||
156422089|NCT00049517|564638971|FG001|Induction|Adverse Event|0|||
156422090|NCT00049517|564638972|FG002|Induction|Adverse Event|0|||
156422091|NCT00049517|564638973|FG003|Induction|Adverse Event|0|||
156422092|NCT00049517|564638974|FG004|Induction|Adverse Event|5|||
156422093|NCT00049517|564638975|FG005|Induction|Adverse Event|7|||
156422094|NCT00049517|564638970|FG000|Induction|Death|0|||
156422095|NCT00049517|564638971|FG001|Induction|Death|0|||
156422096|NCT00049517|564638972|FG002|Induction|Death|0|||
156422097|NCT00049517|564638973|FG003|Induction|Death|0|||
156320170|NCT04393298|564270715|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320171|NCT04393298|564270716|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156320172|NCT04393298|564270717|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156422098|NCT00049517|564638974|FG004|Induction|Death|9|||
156422099|NCT00049517|564638975|FG005|Induction|Death|6|||
156422100|NCT00049517|564638970|FG000|Induction|Withdrawal by Subject|0|||
156422101|NCT00049517|564638971|FG001|Induction|Withdrawal by Subject|0|||
156422102|NCT00049517|564638972|FG002|Induction|Withdrawal by Subject|0|||
156422103|NCT00049517|564638973|FG003|Induction|Withdrawal by Subject|0|||
156422104|NCT00049517|564638974|FG004|Induction|Withdrawal by Subject|1|||
156422105|NCT00049517|564638975|FG005|Induction|Withdrawal by Subject|3|||
156422106|NCT00049517|564638970|FG000|Induction|Alternative therapy|0|||
156422107|NCT00049517|564638971|FG001|Induction|Alternative therapy|0|||
156422108|NCT00049517|564638972|FG002|Induction|Alternative therapy|0|||
156422109|NCT00049517|564638973|FG003|Induction|Alternative therapy|0|||
156422110|NCT00049517|564638974|FG004|Induction|Alternative therapy|2|||
156422111|NCT00049517|564638975|FG005|Induction|Alternative therapy|2|||
156422112|NCT00049517|564638970|FG000|Induction|Other complicating disease|0|||
156422113|NCT00049517|564638971|FG001|Induction|Other complicating disease|0|||
156422114|NCT00049517|564638972|FG002|Induction|Other complicating disease|0|||
156320173|NCT04393298|564270703|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156422115|NCT00049517|564638973|FG003|Induction|Other complicating disease|0|||
156422116|NCT00049517|564638974|FG004|Induction|Other complicating disease|3|||
156422117|NCT00049517|564638975|FG005|Induction|Other complicating disease|0|||
156422118|NCT00049517|564638970|FG000|Induction|Reasons not reported|0|||
156320174|NCT04393298|564270704|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320175|NCT04393298|564270705|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320176|NCT04393298|564270706|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320177|NCT04393298|564270707|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320178|NCT04393298|564270708|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
156320179|NCT04393298|564270709|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320180|NCT04393298|564270710|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320181|NCT04393298|564270711|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320182|NCT04393298|564270712|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320183|NCT04393298|564270713|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320184|NCT04393298|564270714|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320185|NCT04393298|564270715|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320186|NCT04393298|564270716|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320187|NCT04393298|564270717|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156320188|NCT04393298|564270703|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320189|NCT04393298|564270704|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320190|NCT04393298|564270705|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320191|NCT04393298|564270706|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320192|NCT04393298|564270707|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320193|NCT04393298|564270708|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
156320194|NCT04393298|564270709|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320195|NCT04393298|564270710|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320196|NCT04393298|564270711|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320197|NCT04393298|564270712|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320198|NCT04393298|564270713|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320199|NCT04393298|564270714|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320200|NCT04393298|564270715|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320201|NCT04393298|564270716|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156320202|NCT04393298|564270717|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
156320203|NCT04393298|564270703|FG000|Overall Study|Death|0|||
156320204|NCT04393298|564270704|FG001|Overall Study|Death|0|||
156320205|NCT04393298|564270705|FG002|Overall Study|Death|0|||
156320206|NCT04393298|564270706|FG003|Overall Study|Death|0|||
156320207|NCT04393298|564270707|FG004|Overall Study|Death|0|||
156320208|NCT04393298|564270708|FG005|Overall Study|Death|1|||
156320209|NCT04393298|564270709|FG006|Overall Study|Death|1|||
156320210|NCT04393298|564270710|FG007|Overall Study|Death|0|||
156320211|NCT04393298|564270711|FG008|Overall Study|Death|1|||
156320212|NCT04393298|564270712|FG009|Overall Study|Death|1|||
156320213|NCT04393298|564270713|FG010|Overall Study|Death|0|||
156320214|NCT04393298|564270714|FG011|Overall Study|Death|1|||
156320215|NCT04393298|564270715|FG012|Overall Study|Death|1|||
156320216|NCT04393298|564270716|FG013|Overall Study|Death|0|||
156320217|NCT04393298|564270717|FG014|Overall Study|Death|1|||
156320218|NCT04393298|564270703|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320219|NCT04393298|564270704|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320220|NCT04393298|564270705|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320221|NCT04393298|564270706|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156422119|NCT00049517|564638971|FG001|Induction|Reasons not reported|0|||
156422120|NCT00049517|564638972|FG002|Induction|Reasons not reported|0|||
156422121|NCT00049517|564638973|FG003|Induction|Reasons not reported|0|||
156422122|NCT00049517|564638974|FG004|Induction|Reasons not reported|22|||
156422123|NCT00049517|564638975|FG005|Induction|Reasons not reported|25|||
156422124|NCT00049517|564638970|FG000|Conditioning/Transplant|Disease progression|14|||
156422125|NCT00049517|564638971|FG001|Conditioning/Transplant|Disease progression|6|||
156422126|NCT00049517|564638972|FG002|Conditioning/Transplant|Disease progression|10|||
156422127|NCT00049517|564638973|FG003|Conditioning/Transplant|Disease progression|6|||
156422128|NCT00049517|564638974|FG004|Conditioning/Transplant|Disease progression|0|||
156422129|NCT00049517|564638975|FG005|Conditioning/Transplant|Disease progression|0|||
156422130|NCT00049517|564638970|FG000|Conditioning/Transplant|Adverse Event|2|||
156422131|NCT00049517|564638971|FG001|Conditioning/Transplant|Adverse Event|1|||
156422132|NCT00049517|564638972|FG002|Conditioning/Transplant|Adverse Event|4|||
156422133|NCT00049517|564638973|FG003|Conditioning/Transplant|Adverse Event|8|||
156422134|NCT00049517|564638974|FG004|Conditioning/Transplant|Adverse Event|0|||
156422135|NCT00049517|564638975|FG005|Conditioning/Transplant|Adverse Event|0|||
156654829|NCT01215942|565482599|FG000|Treatment Period|Death|2|||
156654830|NCT01215942|565482600|FG001|Treatment Period|Death|4|||
156320222|NCT04393298|564270707|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320223|NCT04393298|564270708|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
156320224|NCT04393298|564270709|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320225|NCT04393298|564270710|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320226|NCT04393298|564270711|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320227|NCT04393298|564270712|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320228|NCT04393298|564270713|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320229|NCT04393298|564270714|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320230|NCT04393298|564270715|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320231|NCT04393298|564270716|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320232|NCT04393298|564270717|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156320233|NCT04393298|564270703|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
156320234|NCT04393298|564270704|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
156320235|NCT04393298|564270705|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
156320236|NCT04393298|564270706|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
156320237|NCT04393298|564270707|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
156320238|NCT04393298|564270708|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
156320239|NCT04393298|564270709|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
156320240|NCT04393298|564270710|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
156320241|NCT04393298|564270711|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
156320242|NCT04393298|564270712|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
156320243|NCT04393298|564270713|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
156320244|NCT04393298|564270714|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
156320245|NCT04393298|564270715|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
156320246|NCT04393298|564270716|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
156320247|NCT04393298|564270717|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
156320248|NCT04393298|564270703|FG000|Overall Study|Patient Passed Away|0|||
156320249|NCT04393298|564270704|FG001|Overall Study|Patient Passed Away|0|||
156320250|NCT04393298|564270705|FG002|Overall Study|Patient Passed Away|0|||
156320251|NCT04393298|564270706|FG003|Overall Study|Patient Passed Away|0|||
156320252|NCT04393298|564270707|FG004|Overall Study|Patient Passed Away|0|||
156320253|NCT04393298|564270708|FG005|Overall Study|Patient Passed Away|0|||
156320254|NCT04393298|564270709|FG006|Overall Study|Patient Passed Away|0|||
156320255|NCT04393298|564270710|FG007|Overall Study|Patient Passed Away|1|||
156320256|NCT04393298|564270711|FG008|Overall Study|Patient Passed Away|0|||
156320257|NCT04393298|564270712|FG009|Overall Study|Patient Passed Away|0|||
156320258|NCT04393298|564270713|FG010|Overall Study|Patient Passed Away|0|||
156320259|NCT04393298|564270714|FG011|Overall Study|Patient Passed Away|0|||
156320260|NCT04393298|564270715|FG012|Overall Study|Patient Passed Away|0|||
156320261|NCT04393298|564270716|FG013|Overall Study|Patient Passed Away|0|||
156320262|NCT04393298|564270717|FG014|Overall Study|Patient Passed Away|0|||
156320263|NCT04393298|564270703|FG000|Overall Study|Patient Deceased|0|||
156320264|NCT04393298|564270704|FG001|Overall Study|Patient Deceased|0|||
156320265|NCT04393298|564270705|FG002|Overall Study|Patient Deceased|0|||
156320266|NCT04393298|564270706|FG003|Overall Study|Patient Deceased|0|||
156320267|NCT04393298|564270707|FG004|Overall Study|Patient Deceased|0|||
156320268|NCT04393298|564270708|FG005|Overall Study|Patient Deceased|0|||
156320269|NCT04393298|564270709|FG006|Overall Study|Patient Deceased|0|||
156320270|NCT04393298|564270710|FG007|Overall Study|Patient Deceased|1|||
156422136|NCT00049517|564638970|FG000|Conditioning/Transplant|Death|1|||
156422137|NCT00049517|564638971|FG001|Conditioning/Transplant|Death|0|||
156320271|NCT04393298|564270711|FG008|Overall Study|Patient Deceased|0|||
156320272|NCT04393298|564270712|FG009|Overall Study|Patient Deceased|0|||
156320273|NCT04393298|564270713|FG010|Overall Study|Patient Deceased|0|||
156320274|NCT04393298|564270714|FG011|Overall Study|Patient Deceased|0|||
156320275|NCT04393298|564270715|FG012|Overall Study|Patient Deceased|0|||
156320276|NCT04393298|564270716|FG013|Overall Study|Patient Deceased|0|||
156422138|NCT00049517|564638972|FG002|Conditioning/Transplant|Death|0|||
156422139|NCT00049517|564638973|FG003|Conditioning/Transplant|Death|2|||
156422140|NCT00049517|564638974|FG004|Conditioning/Transplant|Death|0|||
156422141|NCT00049517|564638975|FG005|Conditioning/Transplant|Death|0|||
156422142|NCT00049517|564638970|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
156422143|NCT00049517|564638971|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
156422144|NCT00049517|564638972|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
156422145|NCT00049517|564638973|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
156422146|NCT00049517|564638974|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
156422147|NCT00049517|564638975|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
156422148|NCT00049517|564638970|FG000|Conditioning/Transplant|Alternative therapy|4|||
156422149|NCT00049517|564638971|FG001|Conditioning/Transplant|Alternative therapy|4|||
156422150|NCT00049517|564638972|FG002|Conditioning/Transplant|Alternative therapy|2|||
156422151|NCT00049517|564638973|FG003|Conditioning/Transplant|Alternative therapy|1|||
156422152|NCT00049517|564638974|FG004|Conditioning/Transplant|Alternative therapy|1|||
156422153|NCT00049517|564638975|FG005|Conditioning/Transplant|Alternative therapy|0|||
156422154|NCT00049517|564638970|FG000|Conditioning/Transplant|Other complicating disease|2|||
156422155|NCT00049517|564638971|FG001|Conditioning/Transplant|Other complicating disease|0|||
156422156|NCT00049517|564638972|FG002|Conditioning/Transplant|Other complicating disease|0|||
156422157|NCT00049517|564638973|FG003|Conditioning/Transplant|Other complicating disease|4|||
156422158|NCT00049517|564638974|FG004|Conditioning/Transplant|Other complicating disease|0|||
156422159|NCT00049517|564638975|FG005|Conditioning/Transplant|Other complicating disease|1|||
156422160|NCT00049517|564638970|FG000|Conditioning/Transplant|Reasons not reported|25|||
156422161|NCT00049517|564638971|FG001|Conditioning/Transplant|Reasons not reported|31|||
156422162|NCT00049517|564638972|FG002|Conditioning/Transplant|Reasons not reported|18|||
156422163|NCT00049517|564638973|FG003|Conditioning/Transplant|Reasons not reported|15|||
156422164|NCT00049517|564638974|FG004|Conditioning/Transplant|Reasons not reported|5|||
156422165|NCT00049517|564638975|FG005|Conditioning/Transplant|Reasons not reported|5|||
156422166|NCT00079937|564638976|FG000|Overall Study|Adverse Event|2|||
156422167|NCT00079937|564638977|FG001|Overall Study|Adverse Event|1|||
156422168|NCT00079937|564638976|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156422169|NCT00079937|564638977|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156422170|NCT00079937|564638976|FG000|Overall Study|Subject no longer requires study drug|3|||
156422171|NCT00079937|564638977|FG001|Overall Study|Subject no longer requires study drug|0|||
156422172|NCT00079937|564638976|FG000|Overall Study|Protocol Violation|8|||
156422173|NCT00079937|564638977|FG001|Overall Study|Protocol Violation|6|||
156422174|NCT00079937|564638976|FG000|Overall Study|Withdrawal by Subject|21|||
156422175|NCT00079937|564638977|FG001|Overall Study|Withdrawal by Subject|7|||
156422176|NCT00079937|564638976|FG000|Overall Study|Lost to Follow-up|12|||
156422177|NCT00079937|564638977|FG001|Overall Study|Lost to Follow-up|5|||
156422178|NCT00079937|564638976|FG000|Overall Study|Administrative problems|22|||
156422179|NCT00079937|564638977|FG001|Overall Study|Administrative problems|11|||
156422180|NCT02857283|564638978|FG000|First Exposure|Withdrawal by Subject|1|||
156422181|NCT02857283|564638979|FG001|First Exposure|Withdrawal by Subject|0|||
156422182|NCT00093795|564638980|FG000|Overall Study|No follow up data|20|||
156422183|NCT00093795|564638981|FG001|Overall Study|No follow up data|16|||
156422184|NCT00093795|564638982|FG002|Overall Study|No follow up data|17|||
156422185|NCT00940017|564638983|FG000|Overall Study|did not meet entrance criteria|3|||
156422186|NCT00940017|564638983|FG000|Overall Study|Adverse Event|1|||
156422187|NCT00613301|564638984|FG000|Overall Study|Adverse Event|49|||
156422188|NCT00613301|564638984|FG000|Overall Study|Lost to Follow-up|88|||
156422189|NCT00613301|564638984|FG000|Overall Study|Withdrawal by Subject|5|||
156422190|NCT00613301|564638984|FG000|Overall Study|Death|6|||
156422191|NCT00613301|564638984|FG000|Overall Study|Lack of Efficacy|13|||
156422192|NCT00613301|564638984|FG000|Overall Study|Physician Decision|2|||
156422193|NCT00613301|564638984|FG000|Overall Study|No data was collected|53|||
156422194|NCT00613301|564638984|FG000|Overall Study|Irregularly enrolled patients|12|||
156422195|NCT00569946|564638985|FG000|Overall Study|Adverse Event|16|||
156422196|NCT00569946|564638985|FG000|Overall Study|Objective Progression or Relapse|42|||
156422197|NCT00569946|564638985|FG000|Overall Study|Global Deterioration of Health Status|1|||
156422198|NCT01684046|564638988|FG000|Period 1, First 30 Days|Adverse Event|0|||
156422199|NCT01684046|564638989|FG001|Period 1, First 30 Days|Adverse Event|2|||
156422200|NCT01306331|564638990|FG000|Overall Study|Adverse Event|28|||
156422201|NCT01306331|564638991|FG001|Overall Study|Adverse Event|25|||
156422202|NCT01306331|564638990|FG000|Overall Study|Lost to Follow-up|321|||
156422203|NCT01306331|564638991|FG001|Overall Study|Lost to Follow-up|323|||
156422204|NCT01306331|564638990|FG000|Overall Study|Physician Decision|26|||
156422205|NCT01306331|564638991|FG001|Overall Study|Physician Decision|22|||
156422206|NCT01306331|564638990|FG000|Overall Study|Pregnancy|136|||
156422207|NCT01306331|564638991|FG001|Overall Study|Pregnancy|151|||
156422208|NCT01306331|564638990|FG000|Overall Study|Protocol Violation|154|||
156422209|NCT01306331|564638991|FG001|Overall Study|Protocol Violation|124|||
156422210|NCT01306331|564638990|FG000|Overall Study|Withdrawal by Subject|163|||
156422211|NCT01306331|564638991|FG001|Overall Study|Withdrawal by Subject|152|||
156422212|NCT01306331|564638990|FG000|Overall Study|Not sexually active|29|||
156422213|NCT01306331|564638991|FG001|Overall Study|Not sexually active|28|||
156320277|NCT04393298|564270717|FG014|Overall Study|Patient Deceased|0|||
156320278|NCT04393298|564270703|FG000|Overall Study|Patient Discharged to Hospice|0|||
156320279|NCT04393298|564270704|FG001|Overall Study|Patient Discharged to Hospice|0|||
156320280|NCT04393298|564270705|FG002|Overall Study|Patient Discharged to Hospice|0|||
156320281|NCT04393298|564270706|FG003|Overall Study|Patient Discharged to Hospice|0|||
156320282|NCT04393298|564270707|FG004|Overall Study|Patient Discharged to Hospice|0|||
156320283|NCT04393298|564270708|FG005|Overall Study|Patient Discharged to Hospice|0|||
156320284|NCT04393298|564270709|FG006|Overall Study|Patient Discharged to Hospice|0|||
156320285|NCT04393298|564270710|FG007|Overall Study|Patient Discharged to Hospice|0|||
156320286|NCT04393298|564270711|FG008|Overall Study|Patient Discharged to Hospice|1|||
156320287|NCT04393298|564270712|FG009|Overall Study|Patient Discharged to Hospice|0|||
156320288|NCT04393298|564270713|FG010|Overall Study|Patient Discharged to Hospice|0|||
156320289|NCT04393298|564270714|FG011|Overall Study|Patient Discharged to Hospice|0|||
156320290|NCT04393298|564270715|FG012|Overall Study|Patient Discharged to Hospice|0|||
156320291|NCT04393298|564270716|FG013|Overall Study|Patient Discharged to Hospice|0|||
156320292|NCT04393298|564270717|FG014|Overall Study|Patient Discharged to Hospice|0|||
156320293|NCT04393298|564270703|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320294|NCT04393298|564270704|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320295|NCT04393298|564270705|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320296|NCT04393298|564270706|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320297|NCT04393298|564270707|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320298|NCT04393298|564270708|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320299|NCT04393298|564270709|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320300|NCT04393298|564270710|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320301|NCT04393298|564270711|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320302|NCT04393298|564270712|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
156320303|NCT04393298|564270713|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320304|NCT04393298|564270714|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320305|NCT04393298|564270715|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320306|NCT04393298|564270716|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320307|NCT04393298|564270717|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156320308|NCT04393298|564270703|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
156320309|NCT04393298|564270704|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
156320310|NCT04393298|564270705|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
156320311|NCT04393298|564270706|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
156320312|NCT04393298|564270707|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
156320313|NCT04393298|564270708|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
156320314|NCT04393298|564270709|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
156320315|NCT04393298|564270710|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
156320316|NCT04393298|564270711|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
156320317|NCT04393298|564270712|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
156320318|NCT04393298|564270713|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
156422214|NCT01306331|564638990|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
156422215|NCT01306331|564638991|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
156422216|NCT01306331|564638990|FG000|Overall Study|Other|34|||
156422217|NCT01306331|564638991|FG001|Overall Study|Other|32|||
156422218|NCT04048135|564638999|FG000|Overall Study|Withdrawal by Subject|1|||
156422219|NCT04048135|564639000|FG001|Overall Study|Withdrawal by Subject|1|||
156320319|NCT04393298|564270714|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
156320320|NCT04393298|564270715|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
156320321|NCT04393298|564270716|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
156320322|NCT04393298|564270717|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
156320323|NCT03754972|564270720|FG000|Overall Study|Protocol Violation|25|||
156320324|NCT06460493|564270721|FG000|Overall Study|Withdrawal by Subject|2|||
156320325|NCT01634178|564270723|FG000|Treatment Period 1|Adverse Event|0|||
156320326|NCT01634178|564270724|FG001|Treatment Period 1|Adverse Event|1|||
156320327|NCT01634178|564270723|FG000|Treatment Period 2|Adverse Event|1|||
156320328|NCT01634178|564270724|FG001|Treatment Period 2|Adverse Event|0|||
156320329|NCT02497976|564270725|FG000|Overall Study|Withdrawal by Subject|2|||
156320330|NCT02497976|564270726|FG001|Overall Study|Withdrawal by Subject|0|||
156320331|NCT02497976|564270725|FG000|Overall Study|Moved out of area|0|||
156320332|NCT02497976|564270726|FG001|Overall Study|Moved out of area|1|||
156320333|NCT00058539|564270730|FG000|Overall Study|Disease progression|24|||
156320334|NCT00058539|564270730|FG000|Overall Study|Adverse Event|3|||
156422220|NCT04048135|564639001|FG002|Overall Study|Withdrawal by Subject|1|||
156320335|NCT00058539|564270730|FG000|Overall Study|Withdrawal by Subject|5|||
156422221|NCT04048135|564639002|FG003|Overall Study|Withdrawal by Subject|2|||
156320336|NCT00058539|564270730|FG000|Overall Study|Physician Decision|9|||
156320337|NCT00058539|564270730|FG000|Overall Study|Death|1|||
156422222|NCT04048135|564639003|FG004|Overall Study|Withdrawal by Subject|0|||
156422223|NCT04048135|564639004|FG005|Overall Study|Withdrawal by Subject|0|||
156422224|NCT04048135|564639005|FG006|Overall Study|Withdrawal by Subject|1|||
156422225|NCT04048135|564639006|FG007|Overall Study|Withdrawal by Subject|1|||
156422226|NCT04048135|564638999|FG000|Overall Study|Adverse Event|0|||
156422227|NCT04048135|564639000|FG001|Overall Study|Adverse Event|0|||
156422228|NCT04048135|564639001|FG002|Overall Study|Adverse Event|0|||
156422229|NCT04048135|564639002|FG003|Overall Study|Adverse Event|1|||
156422230|NCT04048135|564639003|FG004|Overall Study|Adverse Event|1|||
156422231|NCT04048135|564639004|FG005|Overall Study|Adverse Event|0|||
156422232|NCT04048135|564639005|FG006|Overall Study|Adverse Event|0|||
156422233|NCT04048135|564639006|FG007|Overall Study|Adverse Event|0|||
156422234|NCT04048135|564638999|FG000|Overall Study|Protocol Violation|0|||
156422235|NCT04048135|564639000|FG001|Overall Study|Protocol Violation|0|||
156422236|NCT04048135|564639001|FG002|Overall Study|Protocol Violation|0|||
156422237|NCT04048135|564639002|FG003|Overall Study|Protocol Violation|0|||
156422238|NCT04048135|564639003|FG004|Overall Study|Protocol Violation|0|||
156422239|NCT04048135|564639004|FG005|Overall Study|Protocol Violation|1|||
156422240|NCT04048135|564639005|FG006|Overall Study|Protocol Violation|0|||
156422241|NCT04048135|564639006|FG007|Overall Study|Protocol Violation|0|||
156422242|NCT00172185|564639007|FG000|Overall Study|Adverse Event|0|||
156422243|NCT00172185|564639008|FG001|Overall Study|Adverse Event|1|||
156422244|NCT00172185|564639009|FG002|Overall Study|Adverse Event|3|||
156422245|NCT00172185|564639010|FG003|Overall Study|Adverse Event|4|||
156422246|NCT00172185|564639007|FG000|Overall Study|Physician Decision|0|||
156422247|NCT00172185|564639008|FG001|Overall Study|Physician Decision|0|||
156422248|NCT00172185|564639009|FG002|Overall Study|Physician Decision|1|||
156422249|NCT00172185|564639010|FG003|Overall Study|Physician Decision|0|||
156422250|NCT00172185|564639007|FG000|Overall Study|SPONSOR Decision|0|||
156422251|NCT00172185|564639008|FG001|Overall Study|SPONSOR Decision|1|||
156422252|NCT00172185|564639009|FG002|Overall Study|SPONSOR Decision|0|||
156422253|NCT00172185|564639010|FG003|Overall Study|SPONSOR Decision|0|||
156422254|NCT00172185|564639007|FG000|Overall Study|Withdrawal by Subject|0|||
156422255|NCT00172185|564639008|FG001|Overall Study|Withdrawal by Subject|0|||
156422256|NCT00172185|564639009|FG002|Overall Study|Withdrawal by Subject|1|||
156422257|NCT00172185|564639010|FG003|Overall Study|Withdrawal by Subject|0|||
156422258|NCT02790606|564639013|FG000|Overall Study|Death|27|||
156422259|NCT02790606|564639013|FG000|Overall Study|Lost to Follow-up|4|||
156422260|NCT02790606|564639013|FG000|Overall Study|Physician Decision|3|||
156422261|NCT02790606|564639013|FG000|Overall Study|Withdrawal by Subject|1|||
156422262|NCT02735915|564639014|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
156422263|NCT02735915|564639014|FG000|Overall Study|Withdrawal following SAE|2|||
156422264|NCT02735915|564639014|FG000|Overall Study|Withdrawal by Subject|1|||
156422265|NCT05328973|564639015|FG000|Overall Study|Withdrawal by Subject|0|||
156422266|NCT05328973|564639016|FG001|Overall Study|Withdrawal by Subject|1|||
156422267|NCT00852475|564639022|FG000|Overall Study|Lost to Follow-up|3|||
156422268|NCT00852475|564639023|FG001|Overall Study|Lost to Follow-up|4|||
156422269|NCT00409708|564639024|FG000|Treatment|Abnormal test procedure result(s)|1|||
156422270|NCT00409708|564639025|FG001|Treatment|Abnormal test procedure result(s)|0|||
156422271|NCT00409708|564639024|FG000|Treatment|Lack of Efficacy|0|||
156422272|NCT00409708|564639025|FG001|Treatment|Lack of Efficacy|1|||
156422273|NCT00409708|564639024|FG000|Treatment|Protocol Violation|6|||
156422274|NCT00409708|564639025|FG001|Treatment|Protocol Violation|2|||
156422275|NCT00409708|564639024|FG000|Treatment|Withdrawal by Subject|3|||
156422276|NCT00409708|564639025|FG001|Treatment|Withdrawal by Subject|8|||
156422277|NCT00409708|564639024|FG000|Treatment|Lost to Follow-up|0|||
156422278|NCT00409708|564639025|FG001|Treatment|Lost to Follow-up|6|||
156422279|NCT00409708|564639024|FG000|Treatment|Administrative problems|5|||
156422280|NCT00409708|564639025|FG001|Treatment|Administrative problems|0|||
156422281|NCT00409708|564639024|FG000|Washout|Lack of Efficacy|9|||
156422282|NCT00409708|564639025|FG001|Washout|Lack of Efficacy|1|||
156422283|NCT00409708|564639024|FG000|Washout|Protocol Violation|0|||
156422284|NCT00409708|564639025|FG001|Washout|Protocol Violation|1|||
156422285|NCT00409708|564639024|FG000|Washout|Withdrawal by Subject|11|||
156422286|NCT00409708|564639025|FG001|Washout|Withdrawal by Subject|5|||
156422287|NCT00409708|564639024|FG000|Washout|Lost to Follow-up|1|||
156422288|NCT00409708|564639025|FG001|Washout|Lost to Follow-up|3|||
156422289|NCT00946114|564639026|FG000|Overall Study|Death|5|||
156422290|NCT00946114|564639027|FG001|Overall Study|Death|2|||
156422291|NCT00946114|564639026|FG000|Overall Study|Other|1|||
156422292|NCT00946114|564639027|FG001|Overall Study|Other|0|||
156422293|NCT00946114|564639026|FG000|Overall Study|Withdrawal by Subject|2|||
156422294|NCT00946114|564639027|FG001|Overall Study|Withdrawal by Subject|0|||
156422295|NCT01175707|564639028|FG000|Overall Study|Adverse Event|4|||
156422296|NCT01175707|564639029|FG001|Overall Study|Adverse Event|6|||
156422297|NCT04531540|564639032|FG000|Overall Study|Adverse Event|1|||
156422298|NCT04531540|564639032|FG000|Overall Study|Protocol Violation|3|||
156422299|NCT04531540|564639032|FG000|Overall Study|Withdrawal by Subject|4|||
156422300|NCT04531540|564639032|FG000|Overall Study|Found to be Ineligible|1|||
156422301|NCT00582790|564639033|FG000|Overall Study|Rapid progression of disease|1|||
156422302|NCT02374957|564639037|FG000|Overall Study|Patient did not complete forms correctly|1|||
156422303|NCT02374957|564639038|FG001|Overall Study|Patient did not complete forms correctly|0|||
156320338|NCT01903525|564270731|FG000|Overall Study|Lost to Follow-up|5|||
156320339|NCT01903525|564270732|FG001|Overall Study|Lost to Follow-up|9|||
156320340|NCT01903525|564270731|FG000|Overall Study|Adverse Event|0|||
156320341|NCT01903525|564270732|FG001|Overall Study|Adverse Event|1|||
156320342|NCT03977454|564270733|FG000|Overall Study|immediate postoperative revision|2|||
156320343|NCT03977454|564270734|FG001|Overall Study|immediate postoperative revision|2|||
156320344|NCT02483533|564270737|FG000|Overall Study|Lack of Efficacy|50|||
156320345|NCT02483533|564270738|FG001|Overall Study|Lack of Efficacy|50|||
156320346|NCT01323920|564270741|FG000|Overall Study|Death|5|||
156320347|NCT01323920|564270741|FG000|Overall Study|Withdrawal by Subject|1|||
156320348|NCT01609478|564270748|FG000|Overall Study|Adverse Event|3|||
156320349|NCT01609478|564270749|FG001|Overall Study|Adverse Event|1|||
156320350|NCT01609478|564270750|FG002|Overall Study|Adverse Event|5|||
156320351|NCT01609478|564270748|FG000|Overall Study|Protocol Deviation|0|||
156320352|NCT01609478|564270749|FG001|Overall Study|Protocol Deviation|1|||
156320353|NCT01609478|564270750|FG002|Overall Study|Protocol Deviation|1|||
156320354|NCT01609478|564270748|FG000|Overall Study|Non-Compliance with study treatment|1|||
156320355|NCT01609478|564270749|FG001|Overall Study|Non-Compliance with study treatment|0|||
156320356|NCT01609478|564270750|FG002|Overall Study|Non-Compliance with study treatment|0|||
156320357|NCT01609478|564270748|FG000|Overall Study|Physician Decision|1|||
156320358|NCT01609478|564270749|FG001|Overall Study|Physician Decision|0|||
156320359|NCT01609478|564270750|FG002|Overall Study|Physician Decision|1|||
156320360|NCT01609478|564270748|FG000|Overall Study|Withdrawal by Subject|2|||
156320361|NCT01609478|564270749|FG001|Overall Study|Withdrawal by Subject|0|||
156320362|NCT01609478|564270750|FG002|Overall Study|Withdrawal by Subject|2|||
156320363|NCT05040971|564270751|FG000|Overall Study|Withdrawal by Subject|0|||
156320364|NCT05040971|564270752|FG001|Overall Study|Withdrawal by Subject|2|||
156320365|NCT05040971|564270751|FG000|Overall Study|Lost to Follow-up|8|||
156320366|NCT05040971|564270752|FG001|Overall Study|Lost to Follow-up|3|||
156320367|NCT05040971|564270751|FG000|Overall Study|Death|2|||
156320368|NCT05040971|564270752|FG001|Overall Study|Death|0|||
156320369|NCT02283177|564270760|FG000|Overall Study|Withdrawal by Subject|1|||
156320370|NCT02283177|564270761|FG001|Overall Study|Withdrawal by Subject|1|||
156320371|NCT01101191|564270762|FG000|Period 1|Withdrawal by Subject|1|||
156320372|NCT01101191|564270763|FG001|Period 1|Withdrawal by Subject|0|||
156320373|NCT01101191|564270762|FG000|Period 1|Adverse Event|1|||
156320374|NCT01101191|564270763|FG001|Period 1|Adverse Event|2|||
156320375|NCT00879879|564270769|FG000|Overall Study|Death|1|||
156320376|NCT00879879|564270769|FG000|Overall Study|Withdrawal by Subject|1|||
156320377|NCT00879879|564270769|FG000|Overall Study|Physician Decision|1|||
156320378|NCT00327470|564270772|FG000|Overall Study|Randomized, but not treated|0|||
156320379|NCT00327470|564270773|FG001|Overall Study|Randomized, but not treated|2|||
156320380|NCT00327470|564270772|FG000|Overall Study|Adverse Event|9|||
156320381|NCT00327470|564270773|FG001|Overall Study|Adverse Event|14|||
156320382|NCT00327470|564270772|FG000|Overall Study|Lack of Efficacy|7|||
156320383|NCT00327470|564270773|FG001|Overall Study|Lack of Efficacy|19|||
156320384|NCT00327470|564270772|FG000|Overall Study|Other|5|||
156320385|NCT00327470|564270773|FG001|Overall Study|Other|9|||
156320386|NCT00327470|564270772|FG000|Overall Study|Lost to Follow-up|1|||
156320387|NCT00327470|564270773|FG001|Overall Study|Lost to Follow-up|3|||
156320388|NCT00327470|564270772|FG000|Overall Study|Withdrawal by Subject|6|||
156320389|NCT00327470|564270773|FG001|Overall Study|Withdrawal by Subject|12|||
156320390|NCT00327470|564270772|FG000|Overall Study|Death|1|||
156320391|NCT00327470|564270773|FG001|Overall Study|Death|4|||
156320392|NCT02581943|564270774|FG000|Overall Study|Death|5|||
156320393|NCT02581943|564270775|FG001|Overall Study|Death|2|||
156320394|NCT02581943|564270774|FG000|Overall Study|Disease Progression|12|||
156320395|NCT02581943|564270775|FG001|Overall Study|Disease Progression|15|||
156320396|NCT02581943|564270774|FG000|Overall Study|Withdrawal by Subject|1|||
156320397|NCT02581943|564270775|FG001|Overall Study|Withdrawal by Subject|2|||
156320398|NCT03783702|564270776|FG000|Overall Study|Lost to Follow-up|6|||
156320399|NCT03783702|564270777|FG001|Overall Study|Lost to Follow-up|8|||
156320400|NCT03783702|564270776|FG000|Overall Study|Protocol Violation|1|||
156320401|NCT03783702|564270777|FG001|Overall Study|Protocol Violation|3|||
156320402|NCT01163032|564270783|FG000|Randomization Phase|Withdrawal by Subject|2|||
156320403|NCT01163032|564270784|FG001|Randomization Phase|Withdrawal by Subject|3|||
156320404|NCT01163032|564270785|FG002|Randomization Phase|Withdrawal by Subject|0|||
156422304|NCT00748969|564639039|FG000|Overall Study|Withdrawal by Subject|1|||
156422305|NCT00748969|564639040|FG001|Overall Study|Withdrawal by Subject|0|||
156422306|NCT00748969|564639039|FG000|Overall Study|Withdrawal by Subject|0|||
156422307|NCT00748969|564639040|FG001|Overall Study|Withdrawal by Subject|1|||
156422308|NCT00945477|564639044|FG000|Overall Study|Adverse Event|3|||
156320405|NCT01163032|564270783|FG000|Randomization Phase|Adverse Event|3|||
156320406|NCT01163032|564270784|FG001|Randomization Phase|Adverse Event|3|||
156320407|NCT01163032|564270785|FG002|Randomization Phase|Adverse Event|0|||
156320408|NCT01163032|564270783|FG000|Randomization Phase|Protocol Violation|0|||
156320409|NCT01163032|564270784|FG001|Randomization Phase|Protocol Violation|1|||
156320410|NCT01163032|564270785|FG002|Randomization Phase|Protocol Violation|0|||
156320411|NCT01163032|564270783|FG000|Randomization Phase|Various*|5|||
156422309|NCT00945477|564639044|FG000|Overall Study|Lack of Efficacy|2|||
156422310|NCT00945477|564639044|FG000|Overall Study|Withdrawal by Subject|1|||
156422311|NCT01072929|564639045|FG000|Overall Study|Adverse Event|8|||
156422312|NCT01072929|564639046|FG001|Overall Study|Adverse Event|11|||
156422313|NCT01072929|564639047|FG002|Overall Study|Adverse Event|2|||
156422314|NCT01072929|564639045|FG000|Overall Study|Lack of Efficacy|7|||
156422315|NCT01072929|564639046|FG001|Overall Study|Lack of Efficacy|4|||
156422316|NCT01072929|564639047|FG002|Overall Study|Lack of Efficacy|0|||
156422317|NCT01072929|564639045|FG000|Overall Study|Withdrawal by Subject|7|||
156422318|NCT01072929|564639046|FG001|Overall Study|Withdrawal by Subject|15|||
156422319|NCT01072929|564639047|FG002|Overall Study|Withdrawal by Subject|3|||
156320412|NCT01163032|564270784|FG001|Randomization Phase|Various*|4|||
156320413|NCT01163032|564270785|FG002|Randomization Phase|Various*|0|||
156320414|NCT01163032|564270783|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
156320415|NCT01163032|564270784|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
156320416|NCT01163032|564270785|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
156320417|NCT01163032|564270783|FG000|Open Label Extension Phase|Adverse Event|0|||
156320418|NCT01163032|564270784|FG001|Open Label Extension Phase|Adverse Event|0|||
156320419|NCT01163032|564270785|FG002|Open Label Extension Phase|Adverse Event|3|||
156320420|NCT01163032|564270783|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
156320421|NCT01163032|564270784|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
156320422|NCT01163032|564270785|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
156320423|NCT01163032|564270783|FG000|Open Label Extension Phase|Protocol Violation|0|||
156320424|NCT01163032|564270784|FG001|Open Label Extension Phase|Protocol Violation|0|||
156320425|NCT01163032|564270785|FG002|Open Label Extension Phase|Protocol Violation|1|||
156320426|NCT01163032|564270783|FG000|Open Label Extension Phase|Study Termination|0|||
156320427|NCT01163032|564270784|FG001|Open Label Extension Phase|Study Termination|0|||
156320428|NCT01163032|564270785|FG002|Open Label Extension Phase|Study Termination|7|||
156320429|NCT01163032|564270783|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
156320430|NCT01163032|564270784|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
156320431|NCT01163032|564270785|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
156320432|NCT02751931|564270786|FG000|Overall Study|Adverse Event|3|||
156320433|NCT02751931|564270787|FG001|Overall Study|Adverse Event|0|||
156320434|NCT02751931|564270786|FG000|Overall Study|Other: Miscelleneous|10|||
156320435|NCT02751931|564270787|FG001|Overall Study|Other: Miscelleneous|8|||
156320436|NCT03326206|564270789|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
156320437|NCT03326206|564270790|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
156320438|NCT03326206|564270789|FG000|Overall Study - 24 months|Death|8|||
156320439|NCT03326206|564270790|FG001|Overall Study - 24 months|Death|92|||
156320440|NCT03326206|564270789|FG000|Overall Study - 24 months|Observational data not available|43|||
156320441|NCT03326206|564270790|FG001|Overall Study - 24 months|Observational data not available|2879|||
156320442|NCT03326206|564270789|FG000|12 months|Unable to match cases with controls|17|||
156320443|NCT03326206|564270790|FG001|12 months|Unable to match cases with controls|22721|||
156320444|NCT03326206|564270789|FG000|12 months|Death|2|||
156320445|NCT03326206|564270790|FG001|12 months|Death|50|||
156320446|NCT03326206|564270789|FG000|12 months|Observational data not available|49|||
156320447|NCT03326206|564270790|FG001|12 months|Observational data not available|2921|||
156320448|NCT03764033|564270795|FG000|Treatment Phase|Withdrawal by Subject|8|||
156320449|NCT03764033|564270796|FG001|Treatment Phase|Withdrawal by Subject|3|||
156320450|NCT03764033|564270795|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
156320451|NCT03764033|564270796|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
156320452|NCT03764033|564270795|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
156320453|NCT03764033|564270796|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
156320454|NCT02477696|564270797|FG000|Overall Study|Death|89|||
156320455|NCT02477696|564270798|FG001|Overall Study|Death|106|||
156320456|NCT02477696|564270797|FG000|Overall Study|Lost to Follow-up|7|||
156320457|NCT02477696|564270798|FG001|Overall Study|Lost to Follow-up|5|||
156320458|NCT02477696|564270797|FG000|Overall Study|Withdrawal by Subject|37|||
156320459|NCT02477696|564270798|FG001|Overall Study|Withdrawal by Subject|34|||
156320460|NCT02477696|564270797|FG000|Overall Study|Physician Decision|7|||
156320461|NCT02477696|564270798|FG001|Overall Study|Physician Decision|9|||
156320462|NCT02477696|564270797|FG000|Overall Study|Study terminated by sponsor|103|||
156320463|NCT02477696|564270798|FG001|Overall Study|Study terminated by sponsor|99|||
156320464|NCT02477696|564270797|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
156320465|NCT02477696|564270798|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
156320466|NCT02477696|564270797|FG000|Overall Study|Missing/Unknown|2|||
156422320|NCT01072929|564639045|FG000|Overall Study|Protocol Violation|13|||
156422321|NCT01072929|564639046|FG001|Overall Study|Protocol Violation|11|||
156422322|NCT01072929|564639047|FG002|Overall Study|Protocol Violation|2|||
156320467|NCT02477696|564270798|FG001|Overall Study|Missing/Unknown|0|||
156320468|NCT03587727|564270799|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
156422323|NCT01072929|564639045|FG000|Overall Study|Lost to Follow-up|8|||
156422324|NCT01072929|564639046|FG001|Overall Study|Lost to Follow-up|4|||
156320469|NCT03587727|564270799|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
156320470|NCT02003365|564271584|FG000|Overall Study|Lost to Follow-up|0|||
156320471|NCT02003365|564271585|FG001|Overall Study|Lost to Follow-up|0|||
156320472|NCT02003365|564271586|FG002|Overall Study|Lost to Follow-up|1|||
156320473|NCT05710185|564271590|FG000|Overall Study|Adverse Event|1|||
156320474|NCT05710185|564271590|FG000|Overall Study|Lack of Efficacy|1|||
156320475|NCT04617795|564271593|FG000|Main Study|Lost to Follow-up|1|||
156320476|NCT04617795|564271594|FG001|Main Study|Lost to Follow-up|0|||
156320477|NCT00472459|564271595|FG000|Overall Study|Adverse Event|13|||
156320478|NCT00472459|564271596|FG001|Overall Study|Adverse Event|13|||
156320479|NCT00472459|564271595|FG000|Overall Study|Withdrawal by Subject|5|||
156320480|NCT00472459|564271596|FG001|Overall Study|Withdrawal by Subject|5|||
156320481|NCT00472459|564271595|FG000|Overall Study|Protocol Violation|3|||
156320482|NCT00472459|564271596|FG001|Overall Study|Protocol Violation|3|||
156320483|NCT00472459|564271595|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
156320484|NCT00472459|564271596|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
156320485|NCT00472459|564271595|FG000|Overall Study|Lost to Follow-up|1|||
156320486|NCT00472459|564271596|FG001|Overall Study|Lost to Follow-up|1|||
156320487|NCT04850313|564271597|FG000|Overall Study|Withdrawal by Subject|0|||
156320488|NCT04850313|564271598|FG001|Overall Study|Withdrawal by Subject|1|||
156320489|NCT05313009|564271599|FG000|Overall Study|Death|1|||
156320490|NCT05313009|564271600|FG001|Overall Study|Death|0|||
156320491|NCT03505671|564271603|FG000|Overall Study|Withdrawal by Subject|2|||
156320492|NCT03505671|564271604|FG001|Overall Study|Withdrawal by Subject|1|||
156320493|NCT03505671|564271603|FG000|Overall Study|Lost to Follow-up|1|||
156320494|NCT03505671|564271604|FG001|Overall Study|Lost to Follow-up|0|||
156320495|NCT02038829|564271605|FG000|Washout Period 1|Death|0|||
156320496|NCT02038829|564271606|FG001|Washout Period 1|Death|0|||
156320497|NCT02038829|564271607|FG002|Washout Period 1|Death|0|||
156320498|NCT02038829|564271608|FG003|Washout Period 1|Death|0|||
156320499|NCT02038829|564271609|FG004|Washout Period 1|Death|1|||
156320500|NCT02038829|564271610|FG005|Washout Period 1|Death|0|||
156320501|NCT02038829|564271611|FG006|Washout Period 1|Death|0|||
156320502|NCT02038829|564271612|FG007|Washout Period 1|Death|0|||
156320503|NCT02038829|564271613|FG008|Washout Period 1|Death|0|||
156320504|NCT02038829|564271614|FG009|Washout Period 1|Death|0|||
156320505|NCT02038829|564271615|FG010|Washout Period 1|Death|0|||
156320506|NCT02038829|564271616|FG011|Washout Period 1|Death|0|||
156320507|NCT02038829|564271605|FG000|Treatment Period 2|Adverse Event|0|||
156320508|NCT02038829|564271606|FG001|Treatment Period 2|Adverse Event|0|||
156320509|NCT02038829|564271607|FG002|Treatment Period 2|Adverse Event|0|||
156320510|NCT02038829|564271608|FG003|Treatment Period 2|Adverse Event|0|||
156320511|NCT02038829|564271609|FG004|Treatment Period 2|Adverse Event|0|||
156320512|NCT02038829|564271610|FG005|Treatment Period 2|Adverse Event|0|||
156320513|NCT02038829|564271611|FG006|Treatment Period 2|Adverse Event|0|||
156320514|NCT02038829|564271612|FG007|Treatment Period 2|Adverse Event|0|||
156320515|NCT02038829|564271613|FG008|Treatment Period 2|Adverse Event|0|||
156320516|NCT02038829|564271614|FG009|Treatment Period 2|Adverse Event|0|||
156320517|NCT02038829|564271615|FG010|Treatment Period 2|Adverse Event|1|||
156320518|NCT02038829|564271616|FG011|Treatment Period 2|Adverse Event|0|||
156320519|NCT02038829|564271605|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156320520|NCT02038829|564271606|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156422325|NCT01072929|564639047|FG002|Overall Study|Lost to Follow-up|1|||
156422326|NCT01072929|564639045|FG000|Overall Study|Noncompliance with study medication|0|||
156422327|NCT01072929|564639046|FG001|Overall Study|Noncompliance with study medication|3|||
156422328|NCT01072929|564639047|FG002|Overall Study|Noncompliance with study medication|0|||
156422329|NCT01072929|564639045|FG000|Overall Study|Noncompliance with study procedures|1|||
156422330|NCT01072929|564639046|FG001|Overall Study|Noncompliance with study procedures|0|||
156422331|NCT01072929|564639047|FG002|Overall Study|Noncompliance with study procedures|1|||
156422332|NCT01072929|564639045|FG000|Overall Study|Other|0|||
156422333|NCT01072929|564639046|FG001|Overall Study|Other|3|||
156422334|NCT01072929|564639047|FG002|Overall Study|Other|0|||
156422335|NCT02806336|564639048|FG000|Overall Study|Physician Decision|1|||
156422336|NCT02806336|564639049|FG001|Overall Study|Physician Decision|0|||
156422337|NCT02806336|564639048|FG000|Overall Study|Withdrawal by Subject|2|||
156422338|NCT02806336|564639049|FG001|Overall Study|Withdrawal by Subject|4|||
156422339|NCT02806336|564639048|FG000|Overall Study|COVID-19 research shut down|3|||
156422340|NCT02806336|564639049|FG001|Overall Study|COVID-19 research shut down|4|||
156422341|NCT02806336|564639048|FG000|Overall Study|Lack of Efficacy|0|||
156422342|NCT02806336|564639049|FG001|Overall Study|Lack of Efficacy|1|||
156422343|NCT03682536|564639050|FG000|Randomization|Withdrawal by Subject|0|||
156320521|NCT02038829|564271607|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156320522|NCT02038829|564271608|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156320523|NCT02038829|564271609|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156320524|NCT02038829|564271610|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156320525|NCT02038829|564271611|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156320526|NCT02038829|564271612|FG007|Treatment Period 2|Withdrawal by Subject|0|||
156320527|NCT02038829|564271613|FG008|Treatment Period 2|Withdrawal by Subject|0|||
156422344|NCT03682536|564639051|FG001|Randomization|Withdrawal by Subject|2|||
156422345|NCT03682536|564639050|FG000|Treatment|Other Reasons|8|||
156422346|NCT03682536|564639051|FG001|Treatment|Other Reasons|7|||
156422347|NCT03682536|564639050|FG000|Treatment|Physician Decision|5|||
156422348|NCT03682536|564639051|FG001|Treatment|Physician Decision|5|||
156422349|NCT03682536|564639050|FG000|Treatment|Protocol Violation|1|||
156422350|NCT03682536|564639051|FG001|Treatment|Protocol Violation|0|||
156422351|NCT03682536|564639050|FG000|Treatment|Study Terminated by Sponsor|1|||
156422352|NCT03682536|564639051|FG001|Treatment|Study Terminated by Sponsor|2|||
156422353|NCT03682536|564639050|FG000|Treatment|Lost to Follow-up|0|||
156422354|NCT03682536|564639051|FG001|Treatment|Lost to Follow-up|1|||
156422355|NCT03682536|564639050|FG000|Treatment|Withdrawal by Subject|16|||
156422356|NCT03682536|564639051|FG001|Treatment|Withdrawal by Subject|18|||
156422357|NCT03682536|564639050|FG000|Treatment|Lack of Efficacy|41|||
156422358|NCT03682536|564639051|FG001|Treatment|Lack of Efficacy|68|||
156422359|NCT03682536|564639050|FG000|Treatment|Disease Progression|9|||
156422360|NCT03682536|564639051|FG001|Treatment|Disease Progression|7|||
156422361|NCT03682536|564639050|FG000|Treatment|Adverse Event|9|||
156422362|NCT03682536|564639051|FG001|Treatment|Adverse Event|5|||
156422363|NCT03682536|564639050|FG000|Treatment|Death|14|||
156422364|NCT03682536|564639051|FG001|Treatment|Death|13|||
156422365|NCT02487446|564639055|FG000|Period 1|Physician Decision|0|||
156422366|NCT02487446|564639056|FG001|Period 1|Physician Decision|1|||
156422367|NCT02487446|564639055|FG000|Period 1|Lack of Efficacy|1|||
156422368|NCT02487446|564639056|FG001|Period 1|Lack of Efficacy|0|||
156422369|NCT02487446|564639055|FG000|Period 1|Protocol deviation|3|||
156422370|NCT02487446|564639056|FG001|Period 1|Protocol deviation|2|||
156422371|NCT02487446|564639055|FG000|Period 1|Lost to Follow-up|2|||
156422372|NCT02487446|564639056|FG001|Period 1|Lost to Follow-up|0|||
156422373|NCT02487446|564639055|FG000|Period 1|Withdrawal by Subject|2|||
156422374|NCT02487446|564639056|FG001|Period 1|Withdrawal by Subject|0|||
156422375|NCT02487446|564639055|FG000|Period 1|Adverse Event|5|||
156422376|NCT02487446|564639056|FG001|Period 1|Adverse Event|5|||
156422377|NCT02487446|564639055|FG000|Washout|Lost to Follow-up|0|||
156422378|NCT02487446|564639056|FG001|Washout|Lost to Follow-up|2|||
156422379|NCT02487446|564639055|FG000|Washout|Withdrawal by Subject|1|||
156422380|NCT02487446|564639056|FG001|Washout|Withdrawal by Subject|4|||
156422381|NCT02487446|564639055|FG000|Washout|Adverse Event|2|||
156422382|NCT02487446|564639056|FG001|Washout|Adverse Event|2|||
156422383|NCT02487446|564639055|FG000|Period 2|Protocol deviation|0|||
156422384|NCT02487446|564639056|FG001|Period 2|Protocol deviation|1|||
156422385|NCT02487446|564639055|FG000|Period 2|Lost to Follow-up|1|||
156422386|NCT02487446|564639056|FG001|Period 2|Lost to Follow-up|1|||
156422387|NCT02487446|564639055|FG000|Period 2|Withdrawal by Subject|1|||
156422388|NCT02487446|564639056|FG001|Period 2|Withdrawal by Subject|1|||
156422389|NCT02487446|564639055|FG000|Period 2|Adverse Event|6|||
156422390|NCT02487446|564639056|FG001|Period 2|Adverse Event|2|||
156422391|NCT02234310|564639057|FG000|Overall Study|Physician Decision|1|||
156422392|NCT02234310|564639057|FG000|Overall Study|Adverse Event|1|||
156422393|NCT02234310|564639057|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
156422394|NCT02234310|564639057|FG000|Overall Study|Withdrawal by Subject|2|||
156422395|NCT03289455|564639058|FG000|Overall Study|Death|1|||
156422396|NCT03289455|564639059|FG001|Overall Study|Death|0|||
156422397|NCT03289455|564639060|FG002|Overall Study|Death|0|||
156422398|NCT03289455|564639058|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
156422399|NCT03289455|564639059|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
156422400|NCT03289455|564639060|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
156422401|NCT03289455|564639058|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
156422402|NCT03289455|564639059|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
156422403|NCT03289455|564639060|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
156422404|NCT03289455|564639058|FG000|Overall Study|Progressive disease|3|||
156422405|NCT03289455|564639059|FG001|Overall Study|Progressive disease|4|||
156422406|NCT03289455|564639060|FG002|Overall Study|Progressive disease|5|||
156422407|NCT01822821|564639061|FG000|Overall Study|Eligible surgery cancelled|1|||
156422408|NCT01822821|564639062|FG001|Overall Study|Eligible surgery cancelled|1|||
156422409|NCT01822821|564639061|FG000|Overall Study|Other reasons|1|||
156422410|NCT01822821|564639062|FG001|Overall Study|Other reasons|0|||
156422411|NCT00333788|564639063|FG000|Overall Study|Adverse Event|44|||
156422412|NCT00333788|564639063|FG000|Overall Study|Lack of Efficacy|80|||
156422413|NCT00333788|564639063|FG000|Overall Study|Lost to Follow-up|2|||
156422414|NCT00333788|564639063|FG000|Overall Study|Withdrawal by Subject|24|||
156422415|NCT00333788|564639063|FG000|Overall Study|Other: Non-compliance|2|||
156422416|NCT00333788|564639063|FG000|Overall Study|Other: Moved|2|||
156422417|NCT00333788|564639063|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
156422418|NCT00333788|564639063|FG000|Overall Study|Other: Investigator decision|1|||
156422419|NCT00333788|564639063|FG000|Overall Study|Other: Quality of life concern|1|||
156422420|NCT00333788|564639063|FG000|Overall Study|Other: Sponsor decision|1|||
156422421|NCT00333788|564639063|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
156422422|NCT00333788|564639063|FG000|Overall Study|Other: Medical monitor decision|1|||
156422423|NCT00333788|564639063|FG000|Overall Study|Other: Physician decision|1|||
156422424|NCT00333788|564639063|FG000|Overall Study|Other: Signed consent for another study|1|||
156422425|NCT03251378|564639064|FG000|Overall Study|Death|3|||
156422426|NCT03251378|564639065|FG001|Overall Study|Death|2|||
156422427|NCT03251378|564639066|FG002|Overall Study|Death|3|||
156422428|NCT03251378|564639067|FG003|Overall Study|Death|30|||
156422429|NCT03251378|564639068|FG004|Overall Study|Death|24|||
156422430|NCT03251378|564639069|FG005|Overall Study|Death|12|||
156422431|NCT03251378|564639070|FG006|Overall Study|Death|12|||
156422432|NCT03251378|564639064|FG000|Overall Study|Lost to Follow-up|0|||
156422433|NCT03251378|564639065|FG001|Overall Study|Lost to Follow-up|0|||
156422434|NCT03251378|564639066|FG002|Overall Study|Lost to Follow-up|1|||
156422435|NCT03251378|564639067|FG003|Overall Study|Lost to Follow-up|3|||
156422436|NCT03251378|564639068|FG004|Overall Study|Lost to Follow-up|0|||
156422437|NCT03251378|564639069|FG005|Overall Study|Lost to Follow-up|0|||
156422438|NCT03251378|564639070|FG006|Overall Study|Lost to Follow-up|0|||
156422439|NCT03251378|564639064|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
156422440|NCT03251378|564639065|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
156422441|NCT03251378|564639066|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
156320528|NCT02038829|564271614|FG009|Treatment Period 2|Withdrawal by Subject|0|||
156320529|NCT02038829|564271615|FG010|Treatment Period 2|Withdrawal by Subject|0|||
156320530|NCT02038829|564271616|FG011|Treatment Period 2|Withdrawal by Subject|0|||
156320531|NCT02038829|564271605|FG000|Washout Period 2|Adverse Event|0|||
156320532|NCT02038829|564271606|FG001|Washout Period 2|Adverse Event|0|||
156320533|NCT02038829|564271607|FG002|Washout Period 2|Adverse Event|0|||
156320534|NCT02038829|564271608|FG003|Washout Period 2|Adverse Event|0|||
156320535|NCT02038829|564271609|FG004|Washout Period 2|Adverse Event|0|||
156320536|NCT02038829|564271610|FG005|Washout Period 2|Adverse Event|0|||
156320537|NCT02038829|564271611|FG006|Washout Period 2|Adverse Event|0|||
156320538|NCT02038829|564271612|FG007|Washout Period 2|Adverse Event|0|||
156320539|NCT02038829|564271613|FG008|Washout Period 2|Adverse Event|1|||
156320540|NCT02038829|564271614|FG009|Washout Period 2|Adverse Event|0|||
156320541|NCT02038829|564271615|FG010|Washout Period 2|Adverse Event|0|||
156320542|NCT02038829|564271616|FG011|Washout Period 2|Adverse Event|0|||
156320543|NCT02038829|564271605|FG000|Washout Period 2|Withdrawal by Subject|0|||
156320544|NCT02038829|564271606|FG001|Washout Period 2|Withdrawal by Subject|0|||
156320545|NCT02038829|564271607|FG002|Washout Period 2|Withdrawal by Subject|0|||
156320546|NCT02038829|564271608|FG003|Washout Period 2|Withdrawal by Subject|0|||
156320547|NCT02038829|564271609|FG004|Washout Period 2|Withdrawal by Subject|0|||
156320548|NCT02038829|564271610|FG005|Washout Period 2|Withdrawal by Subject|1|||
156320549|NCT02038829|564271611|FG006|Washout Period 2|Withdrawal by Subject|0|||
156320550|NCT02038829|564271612|FG007|Washout Period 2|Withdrawal by Subject|0|||
156320551|NCT02038829|564271613|FG008|Washout Period 2|Withdrawal by Subject|0|||
156320552|NCT02038829|564271614|FG009|Washout Period 2|Withdrawal by Subject|0|||
156320553|NCT02038829|564271615|FG010|Washout Period 2|Withdrawal by Subject|0|||
156320554|NCT02038829|564271616|FG011|Washout Period 2|Withdrawal by Subject|0|||
156320555|NCT02038829|564271605|FG000|Treatment Period 4|Adverse Event|0|||
156320556|NCT02038829|564271606|FG001|Treatment Period 4|Adverse Event|1|||
156320557|NCT02038829|564271607|FG002|Treatment Period 4|Adverse Event|0|||
156320558|NCT02038829|564271608|FG003|Treatment Period 4|Adverse Event|0|||
156320559|NCT02038829|564271609|FG004|Treatment Period 4|Adverse Event|0|||
156320560|NCT02038829|564271610|FG005|Treatment Period 4|Adverse Event|0|||
156320561|NCT02038829|564271611|FG006|Treatment Period 4|Adverse Event|0|||
156320562|NCT02038829|564271612|FG007|Treatment Period 4|Adverse Event|0|||
156320563|NCT02038829|564271613|FG008|Treatment Period 4|Adverse Event|0|||
156320564|NCT02038829|564271614|FG009|Treatment Period 4|Adverse Event|0|||
156320565|NCT02038829|564271615|FG010|Treatment Period 4|Adverse Event|0|||
156320566|NCT02038829|564271616|FG011|Treatment Period 4|Adverse Event|0|||
156320567|NCT02038829|564271605|FG000|Washout Period 4|Adverse Event|0|||
156320568|NCT02038829|564271606|FG001|Washout Period 4|Adverse Event|0|||
156320569|NCT02038829|564271607|FG002|Washout Period 4|Adverse Event|0|||
156320570|NCT02038829|564271608|FG003|Washout Period 4|Adverse Event|0|||
156320571|NCT02038829|564271609|FG004|Washout Period 4|Adverse Event|0|||
156422442|NCT03251378|564639067|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
156422443|NCT03251378|564639068|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
156422444|NCT03251378|564639069|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
156654831|NCT01215942|565482599|FG000|Treatment Period|Lack of Efficacy|23|||
156320572|NCT02038829|564271610|FG005|Washout Period 4|Adverse Event|0|||
156320573|NCT02038829|564271611|FG006|Washout Period 4|Adverse Event|1|||
156320574|NCT02038829|564271612|FG007|Washout Period 4|Adverse Event|0|||
156320575|NCT02038829|564271613|FG008|Washout Period 4|Adverse Event|0|||
156320576|NCT02038829|564271614|FG009|Washout Period 4|Adverse Event|0|||
156320577|NCT02038829|564271615|FG010|Washout Period 4|Adverse Event|0|||
156320578|NCT02038829|564271616|FG011|Washout Period 4|Adverse Event|0|||
156320579|NCT02038829|564271605|FG000|Treatment Period 6|Adverse Event|0|||
156320580|NCT02038829|564271606|FG001|Treatment Period 6|Adverse Event|0|||
156320581|NCT02038829|564271607|FG002|Treatment Period 6|Adverse Event|1|||
156422445|NCT03251378|564639070|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
156422446|NCT03251378|564639064|FG000|Overall Study|Progressive disease|2|||
156422447|NCT03251378|564639065|FG001|Overall Study|Progressive disease|0|||
156422448|NCT03251378|564639066|FG002|Overall Study|Progressive disease|0|||
156422449|NCT03251378|564639067|FG003|Overall Study|Progressive disease|1|||
156422450|NCT03251378|564639068|FG004|Overall Study|Progressive disease|0|||
156422451|NCT03251378|564639069|FG005|Overall Study|Progressive disease|0|||
156422452|NCT03251378|564639070|FG006|Overall Study|Progressive disease|0|||
156422453|NCT03251378|564639064|FG000|Overall Study|Physician Decision|0|||
156422454|NCT03251378|564639065|FG001|Overall Study|Physician Decision|2|||
156422455|NCT03251378|564639066|FG002|Overall Study|Physician Decision|0|||
156422456|NCT03251378|564639067|FG003|Overall Study|Physician Decision|0|||
156422457|NCT03251378|564639068|FG004|Overall Study|Physician Decision|0|||
156422458|NCT03251378|564639069|FG005|Overall Study|Physician Decision|0|||
156422459|NCT03251378|564639070|FG006|Overall Study|Physician Decision|0|||
156422460|NCT03251378|564639064|FG000|Overall Study|Other|2|||
156422461|NCT03251378|564639065|FG001|Overall Study|Other|3|||
156422462|NCT03251378|564639066|FG002|Overall Study|Other|2|||
156422463|NCT03251378|564639067|FG003|Overall Study|Other|0|||
156422464|NCT03251378|564639068|FG004|Overall Study|Other|1|||
156422465|NCT03251378|564639069|FG005|Overall Study|Other|1|||
156422466|NCT03251378|564639070|FG006|Overall Study|Other|1|||
156422467|NCT03251378|564639064|FG000|Overall Study|Other|0|||
156422468|NCT03251378|564639065|FG001|Overall Study|Other|0|||
156422469|NCT03251378|564639066|FG002|Overall Study|Other|0|||
156422470|NCT03251378|564639067|FG003|Overall Study|Other|4|||
156422471|NCT03251378|564639068|FG004|Overall Study|Other|13|||
156422472|NCT03251378|564639069|FG005|Overall Study|Other|0|||
156422473|NCT03251378|564639070|FG006|Overall Study|Other|0|||
156422474|NCT02956967|564639075|FG000|Overall Study|Adverse Event|3|||
156422475|NCT02956967|564639075|FG000|Overall Study|Reason non-related to neutropenia|10|||
156422476|NCT02956967|564639075|FG000|Overall Study|Lost to Follow-up|5|||
156422477|NCT02956967|564639075|FG000|Overall Study|Missing|1|||
156422478|NCT02956967|564639075|FG000|Overall Study|Termination of Nivestim administration|29|||
156422479|NCT02322775|564639076|FG000|Overall Study|Adverse Event|1|||
156422480|NCT02322775|564639077|FG001|Overall Study|Adverse Event|0|||
156422481|NCT02322775|564639076|FG000|Overall Study|Lost to Follow-up|0|||
156422482|NCT02322775|564639077|FG001|Overall Study|Lost to Follow-up|1|||
156422483|NCT02322775|564639076|FG000|Overall Study|Protocol Violation|1|||
156422484|NCT02322775|564639077|FG001|Overall Study|Protocol Violation|0|||
156422485|NCT02322775|564639076|FG000|Overall Study|Withdrawal by Subject|3|||
156422486|NCT02322775|564639077|FG001|Overall Study|Withdrawal by Subject|4|||
156422487|NCT02322775|564639076|FG000|Overall Study|Not willing to perform all FU visits|0|||
156422488|NCT02322775|564639077|FG001|Overall Study|Not willing to perform all FU visits|1|||
156422489|NCT04739423|564639078|FG000|Overall Study|Protocol Violation|0|||
156422490|NCT04739423|564639079|FG001|Overall Study|Protocol Violation|1|||
156422491|NCT04739423|564639080|FG002|Overall Study|Protocol Violation|0|||
156422492|NCT04739423|564639081|FG003|Overall Study|Protocol Violation|0|||
156422493|NCT04739423|564639082|FG004|Overall Study|Protocol Violation|0|||
156422494|NCT04739423|564639083|FG005|Overall Study|Protocol Violation|0|||
156422495|NCT04739423|564639078|FG000|Overall Study|Adverse Event|0|||
156422496|NCT04739423|564639079|FG001|Overall Study|Adverse Event|0|||
156422497|NCT04739423|564639080|FG002|Overall Study|Adverse Event|1|||
156422498|NCT04739423|564639081|FG003|Overall Study|Adverse Event|0|||
156422499|NCT04739423|564639082|FG004|Overall Study|Adverse Event|1|||
156422500|NCT04739423|564639083|FG005|Overall Study|Adverse Event|0|||
156422501|NCT04739423|564639078|FG000|Overall Study|Withdrawal by Subject|0|||
156422502|NCT04739423|564639079|FG001|Overall Study|Withdrawal by Subject|0|||
156422503|NCT04739423|564639080|FG002|Overall Study|Withdrawal by Subject|0|||
156654832|NCT01215942|565482600|FG001|Treatment Period|Lack of Efficacy|62|||
156422504|NCT04739423|564639081|FG003|Overall Study|Withdrawal by Subject|0|||
156422505|NCT04739423|564639082|FG004|Overall Study|Withdrawal by Subject|0|||
156422506|NCT04739423|564639083|FG005|Overall Study|Withdrawal by Subject|1|||
156422507|NCT01007552|564639084|FG000|Overall Study|Withdrawal by Subject|1|||
156422508|NCT00764868|564639089|FG000|Overall Study|Adverse Event|18|||
156422509|NCT00764868|564639089|FG000|Overall Study|Withdrawal by Subject|31|||
156422510|NCT00764868|564639089|FG000|Overall Study|Non-compliance|16|||
156422511|NCT00764868|564639089|FG000|Overall Study|Lost to Follow-up|25|||
156422512|NCT00764868|564639089|FG000|Overall Study|Lack of Efficacy|5|||
156654833|NCT01215942|565482599|FG000|Treatment Period|Lost to Follow-up|3|||
156422513|NCT00764868|564639089|FG000|Overall Study|Subject moved|7|||
156422514|NCT00764868|564639089|FG000|Overall Study|Pregnancy|3|||
156422515|NCT00764868|564639089|FG000|Overall Study|Prohibited medication|1|||
156422516|NCT00764868|564639089|FG000|Overall Study|Out of town|1|||
156422517|NCT00764868|564639089|FG000|Overall Study|Misuse and compliance of study drug|1|||
156422518|NCT00764868|564639089|FG000|Overall Study|Subject sent to boarding school|1|||
156422519|NCT00764868|564639089|FG000|Overall Study|Met an exclusion criteria|1|||
156422520|NCT00764868|564639089|FG000|Overall Study|Positive drug screen|2|||
156422521|NCT00764868|564639089|FG000|Overall Study|Sponsor requested withdrawal|1|||
156422522|NCT00783692|564639098|FG000|Induction Phase|Adverse Event|7|||
156422523|NCT00783692|564639099|FG001|Induction Phase|Adverse Event|9|||
156422524|NCT00783692|564639100|FG002|Induction Phase|Adverse Event|24|||
156422525|NCT00783692|564639101|FG003|Induction Phase|Adverse Event|0|||
156422526|NCT00783692|564639102|FG004|Induction Phase|Adverse Event|0|||
156422527|NCT00783692|564639103|FG005|Induction Phase|Adverse Event|0|||
156422528|NCT00783692|564639104|FG006|Induction Phase|Adverse Event|0|||
156422529|NCT00783692|564639098|FG000|Induction Phase|Protocol Violation|0|||
156422530|NCT00783692|564639099|FG001|Induction Phase|Protocol Violation|0|||
156422531|NCT00783692|564639100|FG002|Induction Phase|Protocol Violation|1|||
156422532|NCT00783692|564639101|FG003|Induction Phase|Protocol Violation|0|||
156422533|NCT00783692|564639102|FG004|Induction Phase|Protocol Violation|0|||
156422534|NCT00783692|564639103|FG005|Induction Phase|Protocol Violation|0|||
156422535|NCT00783692|564639104|FG006|Induction Phase|Protocol Violation|0|||
156422536|NCT00783692|564639098|FG000|Induction Phase|Lack of Efficacy|1|||
156422537|NCT00783692|564639099|FG001|Induction Phase|Lack of Efficacy|3|||
156422538|NCT00783692|564639100|FG002|Induction Phase|Lack of Efficacy|28|||
156422539|NCT00783692|564639101|FG003|Induction Phase|Lack of Efficacy|0|||
156422540|NCT00783692|564639102|FG004|Induction Phase|Lack of Efficacy|0|||
156422541|NCT00783692|564639103|FG005|Induction Phase|Lack of Efficacy|0|||
156422542|NCT00783692|564639104|FG006|Induction Phase|Lack of Efficacy|0|||
156422543|NCT00783692|564639098|FG000|Induction Phase|Withdrawal by Subject|3|||
156422544|NCT00783692|564639099|FG001|Induction Phase|Withdrawal by Subject|9|||
156422545|NCT00783692|564639100|FG002|Induction Phase|Withdrawal by Subject|16|||
156422546|NCT00783692|564639101|FG003|Induction Phase|Withdrawal by Subject|0|||
156422547|NCT00783692|564639102|FG004|Induction Phase|Withdrawal by Subject|0|||
156422548|NCT00783692|564639103|FG005|Induction Phase|Withdrawal by Subject|0|||
156422549|NCT00783692|564639104|FG006|Induction Phase|Withdrawal by Subject|0|||
156422550|NCT00783692|564639098|FG000|Induction Phase|Lost to Follow-up|0|||
156422551|NCT00783692|564639099|FG001|Induction Phase|Lost to Follow-up|0|||
156422552|NCT00783692|564639100|FG002|Induction Phase|Lost to Follow-up|3|||
156422553|NCT00783692|564639101|FG003|Induction Phase|Lost to Follow-up|0|||
156422554|NCT00783692|564639102|FG004|Induction Phase|Lost to Follow-up|0|||
156422555|NCT00783692|564639103|FG005|Induction Phase|Lost to Follow-up|0|||
156422556|NCT00783692|564639104|FG006|Induction Phase|Lost to Follow-up|0|||
156422557|NCT00783692|564639098|FG000|Induction Phase|Other|0|||
156422558|NCT00783692|564639099|FG001|Induction Phase|Other|0|||
156422559|NCT00783692|564639100|FG002|Induction Phase|Other|2|||
156422560|NCT00783692|564639101|FG003|Induction Phase|Other|0|||
156422561|NCT00783692|564639102|FG004|Induction Phase|Other|0|||
156422562|NCT00783692|564639103|FG005|Induction Phase|Other|0|||
156422563|NCT00783692|564639104|FG006|Induction Phase|Other|0|||
156422564|NCT00783692|564639098|FG000|Maintenance Phase|Adverse Event|7|||
156422565|NCT00783692|564639099|FG001|Maintenance Phase|Adverse Event|0|||
156422566|NCT00783692|564639100|FG002|Maintenance Phase|Adverse Event|0|||
156422567|NCT00783692|564639101|FG003|Maintenance Phase|Adverse Event|15|||
156422568|NCT00783692|564639102|FG004|Maintenance Phase|Adverse Event|12|||
156422569|NCT00783692|564639103|FG005|Maintenance Phase|Adverse Event|9|||
156422570|NCT00783692|564639104|FG006|Maintenance Phase|Adverse Event|38|||
156422571|NCT00783692|564639098|FG000|Maintenance Phase|Protocol Violation|0|||
156422572|NCT00783692|564639099|FG001|Maintenance Phase|Protocol Violation|0|||
156422573|NCT00783692|564639100|FG002|Maintenance Phase|Protocol Violation|0|||
156422574|NCT00783692|564639101|FG003|Maintenance Phase|Protocol Violation|1|||
156422575|NCT00783692|564639102|FG004|Maintenance Phase|Protocol Violation|2|||
156422576|NCT00783692|564639103|FG005|Maintenance Phase|Protocol Violation|3|||
156422577|NCT00783692|564639104|FG006|Maintenance Phase|Protocol Violation|4|||
156422578|NCT00783692|564639098|FG000|Maintenance Phase|Lack of Efficacy|79|||
156422579|NCT00783692|564639099|FG001|Maintenance Phase|Lack of Efficacy|0|||
156422580|NCT00783692|564639100|FG002|Maintenance Phase|Lack of Efficacy|0|||
156422581|NCT00783692|564639101|FG003|Maintenance Phase|Lack of Efficacy|64|||
156422582|NCT00783692|564639102|FG004|Maintenance Phase|Lack of Efficacy|58|||
156422583|NCT00783692|564639103|FG005|Maintenance Phase|Lack of Efficacy|48|||
156422584|NCT00783692|564639104|FG006|Maintenance Phase|Lack of Efficacy|177|||
156422585|NCT00783692|564639098|FG000|Maintenance Phase|Withdrawal by Subject|7|||
156422586|NCT00783692|564639099|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156422587|NCT00783692|564639100|FG002|Maintenance Phase|Withdrawal by Subject|0|||
156422588|NCT00783692|564639101|FG003|Maintenance Phase|Withdrawal by Subject|7|||
156422589|NCT00783692|564639102|FG004|Maintenance Phase|Withdrawal by Subject|6|||
156422590|NCT00783692|564639103|FG005|Maintenance Phase|Withdrawal by Subject|9|||
156422591|NCT00783692|564639104|FG006|Maintenance Phase|Withdrawal by Subject|24|||
156422592|NCT00783692|564639098|FG000|Maintenance Phase|Lost to Follow-up|2|||
156422593|NCT00783692|564639099|FG001|Maintenance Phase|Lost to Follow-up|0|||
156422594|NCT00783692|564639100|FG002|Maintenance Phase|Lost to Follow-up|0|||
156422595|NCT00783692|564639101|FG003|Maintenance Phase|Lost to Follow-up|1|||
156422596|NCT00783692|564639102|FG004|Maintenance Phase|Lost to Follow-up|3|||
156422597|NCT00783692|564639103|FG005|Maintenance Phase|Lost to Follow-up|2|||
156422598|NCT00783692|564639104|FG006|Maintenance Phase|Lost to Follow-up|5|||
156422599|NCT00783692|564639098|FG000|Maintenance Phase|Other|0|||
156422600|NCT00783692|564639099|FG001|Maintenance Phase|Other|0|||
156320582|NCT02038829|564271608|FG003|Treatment Period 6|Adverse Event|0|||
156320583|NCT02038829|564271609|FG004|Treatment Period 6|Adverse Event|0|||
156320584|NCT02038829|564271610|FG005|Treatment Period 6|Adverse Event|0|||
156320585|NCT02038829|564271611|FG006|Treatment Period 6|Adverse Event|0|||
156320586|NCT02038829|564271612|FG007|Treatment Period 6|Adverse Event|0|||
156320587|NCT02038829|564271613|FG008|Treatment Period 6|Adverse Event|0|||
156320588|NCT02038829|564271614|FG009|Treatment Period 6|Adverse Event|0|||
156320589|NCT02038829|564271615|FG010|Treatment Period 6|Adverse Event|0|||
156320590|NCT02038829|564271616|FG011|Treatment Period 6|Adverse Event|0|||
156320591|NCT05128929|564271620|FG000|Overall Study|Adverse Event|0|||
156320592|NCT05128929|564271621|FG001|Overall Study|Adverse Event|1|||
156320593|NCT02987660|564271624|FG000|Overall Study|Study terminated by sponsor|10|||
156320594|NCT02987660|564271625|FG001|Overall Study|Study terminated by sponsor|10|||
156320595|NCT03707184|564271626|FG000|Overall Study|Withdrawal by Subject|2|||
156320596|NCT04704154|564271627|FG000|Overall Study|Adverse Event|3|||
156320597|NCT04704154|564271628|FG001|Overall Study|Adverse Event|2|||
156320598|NCT04704154|564271629|FG002|Overall Study|Adverse Event|4|||
156320599|NCT04704154|564271630|FG003|Overall Study|Adverse Event|2|||
156320600|NCT04704154|564271631|FG004|Overall Study|Adverse Event|3|||
156320601|NCT04704154|564271632|FG005|Overall Study|Adverse Event|0|||
156320602|NCT04704154|564271627|FG000|Overall Study|Death|3|||
156320603|NCT04704154|564271628|FG001|Overall Study|Death|0|||
156320604|NCT04704154|564271629|FG002|Overall Study|Death|0|||
156320605|NCT04704154|564271630|FG003|Overall Study|Death|0|||
156320606|NCT04704154|564271631|FG004|Overall Study|Death|3|||
156320607|NCT04704154|564271632|FG005|Overall Study|Death|0|||
156320608|NCT04704154|564271627|FG000|Overall Study|Physician Decision|1|||
156320609|NCT04704154|564271628|FG001|Overall Study|Physician Decision|0|||
156320610|NCT04704154|564271629|FG002|Overall Study|Physician Decision|1|||
156320611|NCT04704154|564271630|FG003|Overall Study|Physician Decision|0|||
156320612|NCT04704154|564271631|FG004|Overall Study|Physician Decision|2|||
156320613|NCT04704154|564271632|FG005|Overall Study|Physician Decision|0|||
156320614|NCT04704154|564271627|FG000|Overall Study|Participant Decision|1|||
156320615|NCT04704154|564271628|FG001|Overall Study|Participant Decision|1|||
156320616|NCT04704154|564271629|FG002|Overall Study|Participant Decision|0|||
156320617|NCT04704154|564271630|FG003|Overall Study|Participant Decision|0|||
156320618|NCT04704154|564271631|FG004|Overall Study|Participant Decision|0|||
156320619|NCT04704154|564271632|FG005|Overall Study|Participant Decision|0|||
156320620|NCT04704154|564271627|FG000|Overall Study|Progressive Disease|19|||
156320621|NCT04704154|564271628|FG001|Overall Study|Progressive Disease|17|||
156320622|NCT04704154|564271629|FG002|Overall Study|Progressive Disease|20|||
156320623|NCT04704154|564271630|FG003|Overall Study|Progressive Disease|18|||
156320624|NCT04704154|564271631|FG004|Overall Study|Progressive Disease|36|||
156320625|NCT04704154|564271632|FG005|Overall Study|Progressive Disease|30|||
156320626|NCT04704154|564271627|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
156320627|NCT04704154|564271628|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
156320628|NCT04704154|564271629|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
156320629|NCT04704154|564271630|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
156320630|NCT04704154|564271631|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
156320631|NCT04704154|564271632|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
156320632|NCT04704154|564271627|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
156320633|NCT04704154|564271628|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
156320634|NCT04704154|564271629|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
156320635|NCT04704154|564271630|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
156320636|NCT04704154|564271631|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
156320637|NCT04704154|564271632|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
156320638|NCT04950608|564271633|FG000|Overall Study|Withdrawal by Subject|2|||
156320639|NCT04950608|564271633|FG000|Overall Study|Physician Decision|3|||
156320640|NCT03553836|564271634|FG000|Overall Study|Ongoing in Study|460|||
156320641|NCT03553836|564271635|FG001|Overall Study|Ongoing in Study|459|||
156320642|NCT03553836|564271634|FG000|Overall Study|Withdrawal by Subject|9|||
156320643|NCT03553836|564271635|FG001|Overall Study|Withdrawal by Subject|10|||
156422601|NCT00783692|564639100|FG002|Maintenance Phase|Other|0|||
156320644|NCT03553836|564271634|FG000|Overall Study|Lost to Follow-up|1|||
156320645|NCT03553836|564271635|FG001|Overall Study|Lost to Follow-up|3|||
156422602|NCT00783692|564639101|FG003|Maintenance Phase|Other|1|||
156422603|NCT00783692|564639102|FG004|Maintenance Phase|Other|0|||
156422604|NCT00783692|564639103|FG005|Maintenance Phase|Other|1|||
156422605|NCT00783692|564639104|FG006|Maintenance Phase|Other|1|||
156422606|NCT00333138|564639107|FG000|Core Study (6 Months)|Adverse Event|4|||
156422607|NCT00333138|564639108|FG001|Core Study (6 Months)|Adverse Event|5|||
156422608|NCT00333138|564639109|FG002|Core Study (6 Months)|Adverse Event|8|||
156422609|NCT00333138|564639107|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
156422610|NCT00333138|564639108|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
156422611|NCT00333138|564639109|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
156422612|NCT00333138|564639107|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
156320646|NCT03553836|564271634|FG000|Overall Study|Death|17|||
156320647|NCT03553836|564271635|FG001|Overall Study|Death|17|||
156320648|NCT03220438|564271636|FG000|Overall Study|Lost to Follow-up|0|||
156320649|NCT03220438|564271637|FG001|Overall Study|Lost to Follow-up|0|||
156320650|NCT03220438|564271638|FG002|Overall Study|Lost to Follow-up|1|||
156320651|NCT03220438|564271639|FG003|Overall Study|Lost to Follow-up|0|||
156320652|NCT04190680|564271640|FG000|Overall Study|Not meeting criteria for data analysis|1|||
156320653|NCT04190680|564271641|FG001|Overall Study|Not meeting criteria for data analysis|15|||
156320654|NCT04190680|564271640|FG000|Overall Study|Administrative error|0|||
156320655|NCT04190680|564271641|FG001|Overall Study|Administrative error|18|||
156320656|NCT05660850|564271643|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
156320657|NCT05660850|564271644|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
156320658|NCT05660850|564271645|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
156320659|NCT05660850|564271646|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
156320660|NCT04973137|564271653|FG000|Double Blind Phase|Adverse Event|4|||
156320661|NCT04973137|564271654|FG001|Double Blind Phase|Adverse Event|0|||
156320662|NCT04973137|564271653|FG000|Double Blind Phase|Death|25|||
156320663|NCT04973137|564271654|FG001|Double Blind Phase|Death|15|||
156320664|NCT04973137|564271653|FG000|Double Blind Phase|Physician Decision|5|||
156320665|NCT04973137|564271654|FG001|Double Blind Phase|Physician Decision|1|||
156320666|NCT04973137|564271653|FG000|Double Blind Phase|Withdrawal by Subject|6|||
156320667|NCT04973137|564271654|FG001|Double Blind Phase|Withdrawal by Subject|1|||
156320668|NCT04973137|564271653|FG000|Double Blind Phase|Other|2|||
156320669|NCT04973137|564271654|FG001|Double Blind Phase|Other|2|||
156320670|NCT04973137|564271653|FG000|Open Label Extension Phase|Death|3|||
156320671|NCT04973137|564271654|FG001|Open Label Extension Phase|Death|0|||
156320672|NCT04973137|564271653|FG000|Open Label Extension Phase|Physician Decision|0|||
156320673|NCT04973137|564271654|FG001|Open Label Extension Phase|Physician Decision|1|||
156320674|NCT04973137|564271653|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
156320675|NCT04973137|564271654|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
156320676|NCT04973137|564271653|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
156320677|NCT04973137|564271654|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
156320678|NCT04973137|564271653|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
156320679|NCT04973137|564271654|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
156320680|NCT02274038|564271656|FG000|Overall Study|Death|1|||
156320681|NCT00745615|564271657|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
156320682|NCT00745615|564271658|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
156320683|NCT00745615|564271659|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
156320684|NCT00745615|564271660|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
156320685|NCT00745615|564271661|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
156320686|NCT00745615|564271662|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
156320687|NCT00745615|564271657|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156320688|NCT00745615|564271658|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
156320689|NCT00745615|564271659|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156320690|NCT00745615|564271660|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156320691|NCT00745615|564271661|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156320692|NCT00745615|564271662|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156320693|NCT00745615|564271657|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
156320694|NCT00745615|564271658|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
156320695|NCT00745615|564271659|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
156320696|NCT00745615|564271660|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
156320697|NCT00745615|564271661|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
156320698|NCT00745615|564271662|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
156320699|NCT00745615|564271657|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156320700|NCT00745615|564271658|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
156320701|NCT00745615|564271659|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156320702|NCT00745615|564271660|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156320703|NCT00745615|564271661|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156320704|NCT00745615|564271662|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156320705|NCT00745615|564271657|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156320706|NCT00745615|564271658|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
156320707|NCT00745615|564271659|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156320708|NCT00745615|564271660|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156320709|NCT00745615|564271661|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156320710|NCT00745615|564271662|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156320711|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
156320712|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
156320713|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
156320714|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
156422613|NCT00333138|564639108|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
156422614|NCT00333138|564639109|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
156422615|NCT00333138|564639107|FG000|Core Study (6 Months)|Protocol Violation|1|||
156422616|NCT00333138|564639108|FG001|Core Study (6 Months)|Protocol Violation|0|||
156422617|NCT00333138|564639109|FG002|Core Study (6 Months)|Protocol Violation|1|||
156422618|NCT00333138|564639107|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
156422619|NCT00333138|564639108|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
156422620|NCT00333138|564639109|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
156422621|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
156422622|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
156422623|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
156422624|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
156422625|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
156422626|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
156422627|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
156422628|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
156422629|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
156422630|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
156422631|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
156422632|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
156422633|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
156422634|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
156422635|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
156422636|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
156422637|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
156422638|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
156422639|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
156422640|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
156422641|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
156422642|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
156422643|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
156422644|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
156422645|NCT00333138|564639107|FG000|Extension Study (Month6 to End of Study)|Death|0|||
156422646|NCT00333138|564639108|FG001|Extension Study (Month6 to End of Study)|Death|1|||
156422647|NCT00333138|564639109|FG002|Extension Study (Month6 to End of Study)|Death|0|||
156422648|NCT03005288|564639111|FG000|Overall Study|Withdrawal by Subject|7|||
156422649|NCT03005288|564639112|FG001|Overall Study|Withdrawal by Subject|5|||
156422650|NCT03005288|564639111|FG000|Overall Study|Lost to Follow-up|0|||
156422651|NCT03005288|564639112|FG001|Overall Study|Lost to Follow-up|1|||
156422652|NCT03005288|564639111|FG000|Overall Study|Adverse Event|5|||
156422653|NCT03005288|564639112|FG001|Overall Study|Adverse Event|0|||
156422654|NCT03005288|564639111|FG000|Overall Study|Protocol deviation|0|||
156422655|NCT03005288|564639112|FG001|Overall Study|Protocol deviation|1|||
156422656|NCT03005288|564639111|FG000|Overall Study|Physician Decision|0|||
156422657|NCT03005288|564639112|FG001|Overall Study|Physician Decision|1|||
156422658|NCT00819234|564639117|FG000|Overall Study|Withdrawal by Subject|8|||
156422659|NCT00819234|564639118|FG001|Overall Study|Withdrawal by Subject|13|||
156422660|NCT00819234|564639119|FG002|Overall Study|Withdrawal by Subject|6|||
156422661|NCT00819234|564639120|FG003|Overall Study|Withdrawal by Subject|3|||
156422662|NCT00819234|564639121|FG004|Overall Study|Withdrawal by Subject|0|||
156422663|NCT00819234|564639122|FG005|Overall Study|Withdrawal by Subject|4|||
156422664|NCT00819234|564639123|FG006|Overall Study|Withdrawal by Subject|4|||
156422665|NCT00819234|564639124|FG007|Overall Study|Withdrawal by Subject|8|||
156422666|NCT00819234|564639125|FG008|Overall Study|Withdrawal by Subject|5|||
156422667|NCT00819234|564639126|FG009|Overall Study|Withdrawal by Subject|3|||
156422668|NCT00819234|564639117|FG000|Overall Study|Adverse Event|0|||
156422669|NCT00819234|564639118|FG001|Overall Study|Adverse Event|0|||
156422670|NCT00819234|564639119|FG002|Overall Study|Adverse Event|1|||
156422671|NCT00819234|564639120|FG003|Overall Study|Adverse Event|0|||
156422672|NCT00819234|564639121|FG004|Overall Study|Adverse Event|0|||
156422673|NCT00819234|564639122|FG005|Overall Study|Adverse Event|2|||
156422674|NCT00819234|564639123|FG006|Overall Study|Adverse Event|0|||
156422675|NCT00819234|564639124|FG007|Overall Study|Adverse Event|0|||
156422676|NCT00819234|564639125|FG008|Overall Study|Adverse Event|0|||
156422677|NCT00819234|564639126|FG009|Overall Study|Adverse Event|0|||
156422678|NCT00819234|564639117|FG000|Overall Study|Physician Decision|0|||
156422679|NCT00819234|564639118|FG001|Overall Study|Physician Decision|0|||
156422680|NCT00819234|564639119|FG002|Overall Study|Physician Decision|0|||
156422681|NCT00819234|564639120|FG003|Overall Study|Physician Decision|1|||
156422682|NCT00819234|564639121|FG004|Overall Study|Physician Decision|0|||
156422683|NCT00819234|564639122|FG005|Overall Study|Physician Decision|0|||
156422684|NCT00819234|564639123|FG006|Overall Study|Physician Decision|0|||
156422685|NCT00819234|564639124|FG007|Overall Study|Physician Decision|0|||
156422686|NCT00819234|564639125|FG008|Overall Study|Physician Decision|0|||
156422687|NCT00819234|564639126|FG009|Overall Study|Physician Decision|2|||
156422688|NCT00819234|564639117|FG000|Overall Study|Protocol Violation|0|||
156422689|NCT00819234|564639118|FG001|Overall Study|Protocol Violation|0|||
156422690|NCT00819234|564639119|FG002|Overall Study|Protocol Violation|1|||
156422691|NCT00819234|564639120|FG003|Overall Study|Protocol Violation|0|||
156422692|NCT00819234|564639121|FG004|Overall Study|Protocol Violation|0|||
156422693|NCT00819234|564639122|FG005|Overall Study|Protocol Violation|0|||
156422694|NCT00819234|564639123|FG006|Overall Study|Protocol Violation|0|||
156422695|NCT00819234|564639124|FG007|Overall Study|Protocol Violation|0|||
156422696|NCT00819234|564639125|FG008|Overall Study|Protocol Violation|0|||
156422697|NCT00819234|564639126|FG009|Overall Study|Protocol Violation|0|||
156422698|NCT00819234|564639117|FG000|Overall Study|Lost to Follow-up|2|||
156422699|NCT00819234|564639118|FG001|Overall Study|Lost to Follow-up|2|||
156422700|NCT00819234|564639119|FG002|Overall Study|Lost to Follow-up|0|||
156422701|NCT00819234|564639120|FG003|Overall Study|Lost to Follow-up|2|||
156422702|NCT00819234|564639121|FG004|Overall Study|Lost to Follow-up|1|||
156422703|NCT00819234|564639122|FG005|Overall Study|Lost to Follow-up|1|||
156422704|NCT00819234|564639123|FG006|Overall Study|Lost to Follow-up|1|||
156422705|NCT00819234|564639124|FG007|Overall Study|Lost to Follow-up|1|||
156422706|NCT00819234|564639125|FG008|Overall Study|Lost to Follow-up|1|||
156422707|NCT00819234|564639126|FG009|Overall Study|Lost to Follow-up|2|||
156422708|NCT04438785|564639127|FG000|Overall Study|change of weight, give up intervention|2|||
156422709|NCT04438785|564639128|FG001|Overall Study|change of weight, give up intervention|10|||
156422710|NCT04011033|564639129|FG000|Overall Study|Physician Decision|2|||
156422711|NCT04011033|564639130|FG001|Overall Study|Physician Decision|3|||
156422712|NCT04011033|564639129|FG000|Overall Study|Withdrawal by Subject|1|||
156422713|NCT04011033|564639130|FG001|Overall Study|Withdrawal by Subject|0|||
156422714|NCT01823341|564639131|FG000|Overall Study|Failed run-in|7|||
156422715|NCT01823341|564639131|FG000|Overall Study|Withdrawal by Subject|7|||
156422716|NCT01823341|564639131|FG000|Overall Study|Adverse Event|1|||
156422717|NCT02027935|564639132|FG000|Overall Study|Death|1|||
156422718|NCT02027935|564639132|FG000|Overall Study|Lack of Efficacy|5|||
156422719|NCT02027935|564639132|FG000|Overall Study|Study Closure|1|||
156422720|NCT00689104|564639133|FG000|Overall Study|Eligibility criterion not met|5|||
156422721|NCT00689104|564639134|FG001|Overall Study|Eligibility criterion not met|8|||
156422722|NCT00689104|564639135|FG002|Overall Study|Eligibility criterion not met|0|||
156422723|NCT00689104|564639136|FG003|Overall Study|Eligibility criterion not met|4|||
156422724|NCT00689104|564639133|FG000|Overall Study|Adverse Event|13|||
156422725|NCT00689104|564639134|FG001|Overall Study|Adverse Event|25|||
156422726|NCT00689104|564639135|FG002|Overall Study|Adverse Event|16|||
156422727|NCT00689104|564639136|FG003|Overall Study|Adverse Event|24|||
156422728|NCT00689104|564639133|FG000|Overall Study|Lack of Efficacy|5|||
156422729|NCT00689104|564639134|FG001|Overall Study|Lack of Efficacy|6|||
156422730|NCT00689104|564639135|FG002|Overall Study|Lack of Efficacy|2|||
156422731|NCT00689104|564639136|FG003|Overall Study|Lack of Efficacy|3|||
156422732|NCT00689104|564639133|FG000|Overall Study|Withdrawal by Subject|12|||
156422733|NCT00689104|564639134|FG001|Overall Study|Withdrawal by Subject|11|||
156422734|NCT00689104|564639135|FG002|Overall Study|Withdrawal by Subject|18|||
156422735|NCT00689104|564639136|FG003|Overall Study|Withdrawal by Subject|11|||
156422736|NCT00689104|564639133|FG000|Overall Study|Lost to Follow-up|4|||
156422737|NCT00689104|564639134|FG001|Overall Study|Lost to Follow-up|3|||
156422738|NCT00689104|564639135|FG002|Overall Study|Lost to Follow-up|2|||
156422739|NCT00689104|564639136|FG003|Overall Study|Lost to Follow-up|5|||
156422740|NCT00689104|564639133|FG000|Overall Study|Protocol Violation|2|||
156422741|NCT00689104|564639134|FG001|Overall Study|Protocol Violation|3|||
156422742|NCT00689104|564639135|FG002|Overall Study|Protocol Violation|5|||
156422743|NCT00689104|564639136|FG003|Overall Study|Protocol Violation|3|||
156422744|NCT00689104|564639133|FG000|Overall Study|Randomized but never received study drug|2|||
156422745|NCT00689104|564639134|FG001|Overall Study|Randomized but never received study drug|1|||
156422746|NCT00689104|564639135|FG002|Overall Study|Randomized but never received study drug|1|||
156422747|NCT00689104|564639136|FG003|Overall Study|Randomized but never received study drug|0|||
156422748|NCT00689104|564639133|FG000|Overall Study|Physician Decision|1|||
156422749|NCT00689104|564639134|FG001|Overall Study|Physician Decision|0|||
156422750|NCT00689104|564639135|FG002|Overall Study|Physician Decision|0|||
156422751|NCT00689104|564639136|FG003|Overall Study|Physician Decision|0|||
156422752|NCT00689104|564639133|FG000|Overall Study|Non-compliance with study procedures|0|||
156422753|NCT00689104|564639134|FG001|Overall Study|Non-compliance with study procedures|0|||
156422754|NCT00689104|564639135|FG002|Overall Study|Non-compliance with study procedures|1|||
156422755|NCT00689104|564639136|FG003|Overall Study|Non-compliance with study procedures|0|||
156422756|NCT04873817|564639137|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
156422757|NCT04873817|564639137|FG000|Overall Study|Lost to Follow-up|4|||
156422758|NCT04873817|564639137|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
156422759|NCT04873817|564639137|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
156422760|NCT04873817|564639137|FG000|Overall Study|Other Reasons|3|||
156422761|NCT00663962|564639143|FG000|Overall Study|somnolence|1|||
156422762|NCT00663962|564639144|FG001|Overall Study|somnolence|0|||
156422763|NCT00062868|564639161|FG000|Dose Level 1|Death|2|||
156422764|NCT00062868|564639162|FG001|Dose Level 1|Death|0|||
156422765|NCT00062868|564639163|FG002|Dose Level 1|Death|0|||
156422766|NCT00062868|564639164|FG003|Dose Level 1|Death|2|||
156422767|NCT00062868|564639165|FG004|Dose Level 1|Death|0|||
156422768|NCT00062868|564639166|FG005|Dose Level 1|Death|0|||
156422769|NCT00062868|564639167|FG006|Dose Level 1|Death|3|||
156422770|NCT00062868|564639168|FG007|Dose Level 1|Death|0|||
156422771|NCT00062868|564639169|FG008|Dose Level 1|Death|0|||
156422772|NCT00062868|564639170|FG009|Dose Level 1|Death|0|||
156422773|NCT00062868|564639171|FG010|Dose Level 1|Death|0|||
156422774|NCT00062868|564639172|FG011|Dose Level 1|Death|0|||
156422775|NCT00062868|564639173|FG012|Dose Level 1|Death|0|||
156422776|NCT00062868|564639174|FG013|Dose Level 1|Death|0|||
156422777|NCT00062868|564639175|FG014|Dose Level 1|Death|0|||
156422778|NCT00062868|564639176|FG015|Dose Level 1|Death|0|||
156422779|NCT00062868|564639177|FG016|Dose Level 1|Death|0|||
156422780|NCT00062868|564639178|FG017|Dose Level 1|Death|0|||
156422781|NCT00062868|564639179|FG018|Dose Level 1|Death|7|||
156422782|NCT00062868|564639180|FG019|Dose Level 1|Death|0|||
156422783|NCT00062868|564639181|FG020|Dose Level 1|Death|1|||
156422784|NCT00062868|564639161|FG000|Dose Level 1|Lost to Follow-up|0|||
156422785|NCT00062868|564639162|FG001|Dose Level 1|Lost to Follow-up|0|||
156422786|NCT00062868|564639163|FG002|Dose Level 1|Lost to Follow-up|0|||
156422787|NCT00062868|564639164|FG003|Dose Level 1|Lost to Follow-up|0|||
156422788|NCT00062868|564639165|FG004|Dose Level 1|Lost to Follow-up|0|||
156422789|NCT00062868|564639166|FG005|Dose Level 1|Lost to Follow-up|0|||
156422790|NCT00062868|564639167|FG006|Dose Level 1|Lost to Follow-up|0|||
156422791|NCT00062868|564639168|FG007|Dose Level 1|Lost to Follow-up|0|||
156422792|NCT00062868|564639169|FG008|Dose Level 1|Lost to Follow-up|0|||
156422793|NCT00062868|564639170|FG009|Dose Level 1|Lost to Follow-up|0|||
156422794|NCT00062868|564639171|FG010|Dose Level 1|Lost to Follow-up|0|||
156422795|NCT00062868|564639172|FG011|Dose Level 1|Lost to Follow-up|0|||
156422796|NCT00062868|564639173|FG012|Dose Level 1|Lost to Follow-up|1|||
156422797|NCT00062868|564639174|FG013|Dose Level 1|Lost to Follow-up|0|||
156422798|NCT00062868|564639175|FG014|Dose Level 1|Lost to Follow-up|0|||
156422799|NCT00062868|564639176|FG015|Dose Level 1|Lost to Follow-up|0|||
156422800|NCT00062868|564639177|FG016|Dose Level 1|Lost to Follow-up|0|||
156422801|NCT00062868|564639178|FG017|Dose Level 1|Lost to Follow-up|0|||
156422802|NCT00062868|564639179|FG018|Dose Level 1|Lost to Follow-up|2|||
156422803|NCT00062868|564639180|FG019|Dose Level 1|Lost to Follow-up|0|||
156422804|NCT00062868|564639181|FG020|Dose Level 1|Lost to Follow-up|1|||
156422805|NCT00062868|564639161|FG000|Dose Level 2|Death|0|||
156422806|NCT00062868|564639162|FG001|Dose Level 2|Death|3|||
156422807|NCT00062868|564639163|FG002|Dose Level 2|Death|0|||
156422808|NCT00062868|564639164|FG003|Dose Level 2|Death|0|||
156422809|NCT00062868|564639165|FG004|Dose Level 2|Death|2|||
156422810|NCT00062868|564639166|FG005|Dose Level 2|Death|0|||
156422811|NCT00062868|564639167|FG006|Dose Level 2|Death|0|||
156422812|NCT00062868|564639168|FG007|Dose Level 2|Death|0|||
156422813|NCT00062868|564639169|FG008|Dose Level 2|Death|0|||
156422814|NCT00062868|564639170|FG009|Dose Level 2|Death|0|||
156422815|NCT00062868|564639171|FG010|Dose Level 2|Death|1|||
156422816|NCT00062868|564639172|FG011|Dose Level 2|Death|0|||
156422817|NCT00062868|564639173|FG012|Dose Level 2|Death|0|||
156422818|NCT00062868|564639174|FG013|Dose Level 2|Death|0|||
156422819|NCT00062868|564639175|FG014|Dose Level 2|Death|0|||
156422820|NCT00062868|564639176|FG015|Dose Level 2|Death|0|||
156422821|NCT00062868|564639177|FG016|Dose Level 2|Death|2|||
156422822|NCT00062868|564639178|FG017|Dose Level 2|Death|0|||
156422823|NCT00062868|564639179|FG018|Dose Level 2|Death|0|||
156422824|NCT00062868|564639180|FG019|Dose Level 2|Death|0|||
156422825|NCT00062868|564639181|FG020|Dose Level 2|Death|0|||
156422826|NCT00062868|564639161|FG000|Dose Level 2|Lost to Follow-up|0|||
156422827|NCT00062868|564639162|FG001|Dose Level 2|Lost to Follow-up|0|||
156422828|NCT00062868|564639163|FG002|Dose Level 2|Lost to Follow-up|0|||
156422829|NCT00062868|564639164|FG003|Dose Level 2|Lost to Follow-up|0|||
156422830|NCT00062868|564639165|FG004|Dose Level 2|Lost to Follow-up|0|||
156422831|NCT00062868|564639166|FG005|Dose Level 2|Lost to Follow-up|0|||
156422832|NCT00062868|564639167|FG006|Dose Level 2|Lost to Follow-up|0|||
156422833|NCT00062868|564639168|FG007|Dose Level 2|Lost to Follow-up|0|||
156422834|NCT00062868|564639169|FG008|Dose Level 2|Lost to Follow-up|0|||
156422835|NCT00062868|564639170|FG009|Dose Level 2|Lost to Follow-up|0|||
156422836|NCT00062868|564639171|FG010|Dose Level 2|Lost to Follow-up|0|||
156422837|NCT00062868|564639172|FG011|Dose Level 2|Lost to Follow-up|0|||
156422838|NCT00062868|564639173|FG012|Dose Level 2|Lost to Follow-up|0|||
156422839|NCT00062868|564639174|FG013|Dose Level 2|Lost to Follow-up|1|||
156422840|NCT00062868|564639175|FG014|Dose Level 2|Lost to Follow-up|0|||
156422841|NCT00062868|564639176|FG015|Dose Level 2|Lost to Follow-up|0|||
156422842|NCT00062868|564639177|FG016|Dose Level 2|Lost to Follow-up|1|||
156422843|NCT00062868|564639178|FG017|Dose Level 2|Lost to Follow-up|0|||
156422844|NCT00062868|564639179|FG018|Dose Level 2|Lost to Follow-up|0|||
156422845|NCT00062868|564639180|FG019|Dose Level 2|Lost to Follow-up|0|||
156422846|NCT00062868|564639181|FG020|Dose Level 2|Lost to Follow-up|0|||
156422847|NCT00062868|564639161|FG000|Dose Level 3|Death|0|||
156422848|NCT00062868|564639162|FG001|Dose Level 3|Death|0|||
156422849|NCT00062868|564639163|FG002|Dose Level 3|Death|0|||
156422850|NCT00062868|564639164|FG003|Dose Level 3|Death|0|||
156422851|NCT00062868|564639165|FG004|Dose Level 3|Death|0|||
156422852|NCT00062868|564639166|FG005|Dose Level 3|Death|0|||
156422853|NCT00062868|564639167|FG006|Dose Level 3|Death|0|||
156422854|NCT00062868|564639168|FG007|Dose Level 3|Death|0|||
156422855|NCT00062868|564639169|FG008|Dose Level 3|Death|0|||
156422856|NCT00062868|564639170|FG009|Dose Level 3|Death|0|||
156422857|NCT00062868|564639171|FG010|Dose Level 3|Death|0|||
156422858|NCT00062868|564639172|FG011|Dose Level 3|Death|1|||
156422859|NCT00062868|564639173|FG012|Dose Level 3|Death|0|||
156422860|NCT00062868|564639174|FG013|Dose Level 3|Death|0|||
156422861|NCT00062868|564639175|FG014|Dose Level 3|Death|0|||
156422862|NCT00062868|564639176|FG015|Dose Level 3|Death|0|||
156422863|NCT00062868|564639177|FG016|Dose Level 3|Death|0|||
156422864|NCT00062868|564639178|FG017|Dose Level 3|Death|1|||
156422865|NCT00062868|564639179|FG018|Dose Level 3|Death|0|||
156422866|NCT00062868|564639180|FG019|Dose Level 3|Death|0|||
156422867|NCT00062868|564639181|FG020|Dose Level 3|Death|0|||
156422868|NCT00062868|564639161|FG000|Dose Level 3|Lost to Follow-up|0|||
156422869|NCT00062868|564639162|FG001|Dose Level 3|Lost to Follow-up|0|||
156422870|NCT00062868|564639163|FG002|Dose Level 3|Lost to Follow-up|0|||
156422871|NCT00062868|564639164|FG003|Dose Level 3|Lost to Follow-up|0|||
156422872|NCT00062868|564639165|FG004|Dose Level 3|Lost to Follow-up|0|||
156422873|NCT00062868|564639166|FG005|Dose Level 3|Lost to Follow-up|0|||
156422874|NCT00062868|564639167|FG006|Dose Level 3|Lost to Follow-up|0|||
156422875|NCT00062868|564639168|FG007|Dose Level 3|Lost to Follow-up|0|||
156422876|NCT00062868|564639169|FG008|Dose Level 3|Lost to Follow-up|0|||
156422877|NCT00062868|564639170|FG009|Dose Level 3|Lost to Follow-up|0|||
156422878|NCT00062868|564639171|FG010|Dose Level 3|Lost to Follow-up|0|||
156422879|NCT00062868|564639172|FG011|Dose Level 3|Lost to Follow-up|0|||
156422880|NCT00062868|564639173|FG012|Dose Level 3|Lost to Follow-up|0|||
156422881|NCT00062868|564639174|FG013|Dose Level 3|Lost to Follow-up|0|||
156422882|NCT00062868|564639175|FG014|Dose Level 3|Lost to Follow-up|1|||
156422883|NCT00062868|564639176|FG015|Dose Level 3|Lost to Follow-up|0|||
156422884|NCT00062868|564639177|FG016|Dose Level 3|Lost to Follow-up|0|||
156422885|NCT00062868|564639178|FG017|Dose Level 3|Lost to Follow-up|0|||
156422886|NCT00062868|564639179|FG018|Dose Level 3|Lost to Follow-up|0|||
156422887|NCT00062868|564639180|FG019|Dose Level 3|Lost to Follow-up|0|||
156422888|NCT00062868|564639181|FG020|Dose Level 3|Lost to Follow-up|0|||
156422889|NCT00062868|564639161|FG000|Dose Level 3|Withdrew|0|||
156422890|NCT00062868|564639162|FG001|Dose Level 3|Withdrew|0|||
156422891|NCT00062868|564639163|FG002|Dose Level 3|Withdrew|2|||
156422892|NCT00062868|564639164|FG003|Dose Level 3|Withdrew|0|||
156422893|NCT00062868|564639165|FG004|Dose Level 3|Withdrew|0|||
156422894|NCT00062868|564639166|FG005|Dose Level 3|Withdrew|0|||
156422895|NCT00062868|564639167|FG006|Dose Level 3|Withdrew|0|||
156422896|NCT00062868|564639168|FG007|Dose Level 3|Withdrew|0|||
156422897|NCT00062868|564639169|FG008|Dose Level 3|Withdrew|0|||
156422898|NCT00062868|564639170|FG009|Dose Level 3|Withdrew|0|||
156422899|NCT00062868|564639171|FG010|Dose Level 3|Withdrew|0|||
156422900|NCT00062868|564639172|FG011|Dose Level 3|Withdrew|0|||
156422901|NCT00062868|564639173|FG012|Dose Level 3|Withdrew|0|||
156422902|NCT00062868|564639174|FG013|Dose Level 3|Withdrew|0|||
156422903|NCT00062868|564639175|FG014|Dose Level 3|Withdrew|0|||
156422904|NCT00062868|564639176|FG015|Dose Level 3|Withdrew|0|||
156422905|NCT00062868|564639177|FG016|Dose Level 3|Withdrew|0|||
156422906|NCT00062868|564639178|FG017|Dose Level 3|Withdrew|0|||
156422907|NCT00062868|564639179|FG018|Dose Level 3|Withdrew|0|||
156422908|NCT00062868|564639180|FG019|Dose Level 3|Withdrew|0|||
156422909|NCT00062868|564639181|FG020|Dose Level 3|Withdrew|0|||
156422910|NCT01641861|564639182|FG000|Overall Study|Lost to Follow-up|21|||
156422911|NCT01641861|564639183|FG001|Overall Study|Lost to Follow-up|16|||
156422912|NCT01641861|564639182|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
156422913|NCT01641861|564639183|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
156422914|NCT01641861|564639182|FG000|Overall Study|Died due to drowning|0|||
156422915|NCT01641861|564639183|FG001|Overall Study|Died due to drowning|1|||
156422916|NCT01712685|564639184|FG000|Overall Study|pt declined to participate before trmt|1|||
156422917|NCT01515319|564639185|FG000|Overall Study|Withdrawal by Subject|0|||
156422918|NCT01515319|564639186|FG001|Overall Study|Withdrawal by Subject|0|||
156422919|NCT01515319|564639187|FG002|Overall Study|Withdrawal by Subject|0|||
156422920|NCT01515319|564639188|FG003|Overall Study|Withdrawal by Subject|0|||
156422921|NCT01515319|564639189|FG004|Overall Study|Withdrawal by Subject|0|||
156422922|NCT01515319|564639190|FG005|Overall Study|Withdrawal by Subject|0|||
156422923|NCT01515319|564639191|FG006|Overall Study|Withdrawal by Subject|1|||
156422924|NCT01515319|564639192|FG007|Overall Study|Withdrawal by Subject|0|||
156422925|NCT01515319|564639193|FG008|Overall Study|Withdrawal by Subject|0|||
156422926|NCT01515319|564639194|FG009|Overall Study|Withdrawal by Subject|0|||
156422927|NCT01515319|564639185|FG000|Overall Study|Adverse Event|0|||
156422928|NCT01515319|564639186|FG001|Overall Study|Adverse Event|0|||
156422929|NCT01515319|564639187|FG002|Overall Study|Adverse Event|0|||
156422930|NCT01515319|564639188|FG003|Overall Study|Adverse Event|0|||
156422931|NCT01515319|564639189|FG004|Overall Study|Adverse Event|0|||
156422932|NCT01515319|564639190|FG005|Overall Study|Adverse Event|0|||
156422933|NCT01515319|564639191|FG006|Overall Study|Adverse Event|0|||
156422934|NCT01515319|564639192|FG007|Overall Study|Adverse Event|0|||
156422935|NCT01515319|564639193|FG008|Overall Study|Adverse Event|3|||
156422936|NCT01515319|564639194|FG009|Overall Study|Adverse Event|0|||
156422937|NCT01515319|564639185|FG000|Overall Study|Protocol Violation|0|||
156422938|NCT01515319|564639186|FG001|Overall Study|Protocol Violation|0|||
156422939|NCT01515319|564639187|FG002|Overall Study|Protocol Violation|0|||
156422940|NCT01515319|564639188|FG003|Overall Study|Protocol Violation|0|||
156422941|NCT01515319|564639189|FG004|Overall Study|Protocol Violation|0|||
156422942|NCT01515319|564639190|FG005|Overall Study|Protocol Violation|0|||
156422943|NCT01515319|564639191|FG006|Overall Study|Protocol Violation|0|||
156422944|NCT01515319|564639192|FG007|Overall Study|Protocol Violation|0|||
156422945|NCT01515319|564639193|FG008|Overall Study|Protocol Violation|2|||
156422946|NCT01515319|564639194|FG009|Overall Study|Protocol Violation|0|||
156422947|NCT01449929|564639195|FG000|Randomization Phase 96 Week|Adverse Event|5|||
156422948|NCT01449929|564639196|FG001|Randomization Phase 96 Week|Adverse Event|13|||
156422949|NCT01449929|564639197|FG002|Randomization Phase 96 Week|Adverse Event|0|||
156422950|NCT01449929|564639195|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
156422951|NCT01449929|564639196|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
156422952|NCT01449929|564639197|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
156422953|NCT01449929|564639195|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
156422954|NCT01449929|564639196|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
156422955|NCT01449929|564639197|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
156422956|NCT01449929|564639195|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
156422957|NCT01449929|564639196|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
156422958|NCT01449929|564639197|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
156422959|NCT01449929|564639195|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
156422960|NCT01449929|564639196|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
156422961|NCT01449929|564639197|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
156422962|NCT01449929|564639195|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
156422963|NCT01449929|564639196|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
156422964|NCT01449929|564639197|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
156422965|NCT01449929|564639195|FG000|Randomization Phase 96 Week|Physician Decision|2|||
156422966|NCT01449929|564639196|FG001|Randomization Phase 96 Week|Physician Decision|3|||
156422967|NCT01449929|564639197|FG002|Randomization Phase 96 Week|Physician Decision|0|||
156422968|NCT01449929|564639195|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
156422969|NCT01449929|564639196|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
156422970|NCT01449929|564639197|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
156422971|NCT01449929|564639195|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
156422972|NCT01449929|564639196|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
156422973|NCT01449929|564639197|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
156422974|NCT01449929|564639195|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
156422975|NCT01449929|564639196|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
156422976|NCT01449929|564639197|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
156422977|NCT01449929|564639195|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
156422978|NCT01449929|564639196|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
156422979|NCT01449929|564639197|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
156422980|NCT01919619|564639198|FG000|Overall Study|Physician Decision|1|||
156422981|NCT01919619|564639199|FG001|Overall Study|Physician Decision|1|||
156422982|NCT04091672|564641297|FG000|Overall Study|Death|6|||
156422983|NCT04091672|564641298|FG001|Overall Study|Death|6|||
156422984|NCT04091672|564641297|FG000|Overall Study|Lost to Follow-up|7|||
156422985|NCT04091672|564641298|FG001|Overall Study|Lost to Follow-up|7|||
156422986|NCT04091672|564641297|FG000|Overall Study|Withdrawal by Subject|3|||
156422987|NCT04091672|564641298|FG001|Overall Study|Withdrawal by Subject|3|||
156422988|NCT04091672|564641297|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
156422989|NCT04091672|564641298|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
156422990|NCT00359619|564641299|FG000|Overall Study|Adverse Event|0|||
156422991|NCT00359619|564641300|FG001|Overall Study|Adverse Event|0|||
156422992|NCT00359619|564641301|FG002|Overall Study|Adverse Event|1|||
156422993|NCT00359619|564641302|FG003|Overall Study|Adverse Event|0|||
156422994|NCT00359619|564641303|FG004|Overall Study|Adverse Event|0|||
156422995|NCT00359619|564641304|FG005|Overall Study|Adverse Event|0|||
156422996|NCT00359619|564641305|FG006|Overall Study|Adverse Event|1|||
156422997|NCT00359619|564641299|FG000|Overall Study|Withdrawal by Subject|3|||
156422998|NCT00359619|564641300|FG001|Overall Study|Withdrawal by Subject|1|||
156422999|NCT00359619|564641301|FG002|Overall Study|Withdrawal by Subject|4|||
156423000|NCT00359619|564641302|FG003|Overall Study|Withdrawal by Subject|2|||
156423001|NCT00359619|564641303|FG004|Overall Study|Withdrawal by Subject|2|||
156423002|NCT00359619|564641304|FG005|Overall Study|Withdrawal by Subject|0|||
156320715|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
156320716|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
156320717|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
156320718|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
156320719|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
156320720|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
156320721|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
156320722|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
156320723|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
156320724|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
156320725|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
156320726|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
156320727|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
156320728|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
156320729|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
156320730|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
156320731|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
156320732|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
156320733|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
156320734|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
156320735|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
156320736|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
156320737|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
156320738|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
156320739|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
156320740|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
156320741|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
156320742|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
156320743|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
156320744|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
156320745|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
156320746|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
156320747|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156320748|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156320749|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156320750|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156320751|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156320752|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
156320753|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
156320754|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
156320755|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
156320756|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
156320757|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
156320758|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
156320759|NCT00745615|564271657|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
156320760|NCT00745615|564271658|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
156320761|NCT00745615|564271659|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
156320762|NCT00745615|564271660|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
156320763|NCT00745615|564271661|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
156320764|NCT00745615|564271662|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
156320765|NCT00570232|564271663|FG000|Overall Study|Adverse Event|10|||
156320766|NCT00570232|564271663|FG000|Overall Study|discontinued due to medical condition|3|||
156320767|NCT00570232|564271663|FG000|Overall Study|discontinued due to recurrence|8|||
156320768|NCT00570232|564271663|FG000|Overall Study|discontinued due to noncompliance|2|||
156320769|NCT01076075|564271664|FG000|Overall Study|Adverse Event|3|||
156320770|NCT01076075|564271665|FG001|Overall Study|Adverse Event|9|||
156320771|NCT01076075|564271664|FG000|Overall Study|Lack of Efficacy|5|||
156320772|NCT01076075|564271665|FG001|Overall Study|Lack of Efficacy|4|||
156320773|NCT01076075|564271664|FG000|Overall Study|Lost to Follow-up|6|||
156320774|NCT01076075|564271665|FG001|Overall Study|Lost to Follow-up|5|||
156320775|NCT01076075|564271664|FG000|Overall Study|other|19|||
156320776|NCT01076075|564271665|FG001|Overall Study|other|9|||
156654834|NCT01215942|565482600|FG001|Treatment Period|Lost to Follow-up|4|||
156320777|NCT01076075|564271664|FG000|Overall Study|Protocol Violation|0|||
156320778|NCT01076075|564271665|FG001|Overall Study|Protocol Violation|1|||
156320779|NCT01076075|564271664|FG000|Overall Study|Withdrawal by Subject|8|||
156320780|NCT01076075|564271665|FG001|Overall Study|Withdrawal by Subject|19|||
156320781|NCT01615029|564271669|FG000|Overall Study|Adverse Event|1|||
156320782|NCT01615029|564271670|FG001|Overall Study|Adverse Event|0|||
156423003|NCT00359619|564641305|FG006|Overall Study|Withdrawal by Subject|3|||
156423004|NCT00359619|564641299|FG000|Overall Study|Other|1|||
156423005|NCT00359619|564641300|FG001|Overall Study|Other|0|||
156423006|NCT00359619|564641301|FG002|Overall Study|Other|0|||
156423007|NCT00359619|564641302|FG003|Overall Study|Other|0|||
156423008|NCT00359619|564641303|FG004|Overall Study|Other|0|||
156423009|NCT00359619|564641304|FG005|Overall Study|Other|0|||
156423010|NCT00359619|564641305|FG006|Overall Study|Other|0|||
156423011|NCT00359619|564641299|FG000|Overall Study|Lost to Follow-up|4|||
156423012|NCT00359619|564641300|FG001|Overall Study|Lost to Follow-up|4|||
156423013|NCT00359619|564641301|FG002|Overall Study|Lost to Follow-up|2|||
156423014|NCT00359619|564641302|FG003|Overall Study|Lost to Follow-up|1|||
156423015|NCT00359619|564641303|FG004|Overall Study|Lost to Follow-up|1|||
156423016|NCT00359619|564641304|FG005|Overall Study|Lost to Follow-up|5|||
156423017|NCT00359619|564641305|FG006|Overall Study|Lost to Follow-up|0|||
156423018|NCT04978363|564641311|FG000|Overall Study|Other medical issues unrelated to the study|0|||
156423019|NCT04978363|564641312|FG001|Overall Study|Other medical issues unrelated to the study|0|||
156423020|NCT04978363|564641313|FG002|Overall Study|Other medical issues unrelated to the study|0|||
156423021|NCT04978363|564641314|FG003|Overall Study|Other medical issues unrelated to the study|0|||
156423022|NCT04978363|564641315|FG004|Overall Study|Other medical issues unrelated to the study|1|||
156423023|NCT04978363|564641316|FG005|Overall Study|Other medical issues unrelated to the study|0|||
156423024|NCT04978363|564641317|FG006|Overall Study|Other medical issues unrelated to the study|0|||
156423025|NCT04978363|564641318|FG007|Overall Study|Other medical issues unrelated to the study|0|||
156423026|NCT04978363|564641319|FG008|Overall Study|Other medical issues unrelated to the study|0|||
156423027|NCT04978363|564641320|FG009|Overall Study|Other medical issues unrelated to the study|0|||
156423028|NCT04978363|564641321|FG010|Overall Study|Other medical issues unrelated to the study|0|||
156423029|NCT04978363|564641311|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
156423030|NCT04978363|564641312|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
156423031|NCT04978363|564641313|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
156423032|NCT04978363|564641314|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
156423033|NCT04978363|564641315|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
156423034|NCT04978363|564641316|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
156423035|NCT04978363|564641317|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
156423036|NCT04978363|564641318|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
156423037|NCT04978363|564641319|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
156423038|NCT04978363|564641320|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
156423039|NCT04978363|564641321|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
156423040|NCT04978363|564641311|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423041|NCT04978363|564641312|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
156423042|NCT04978363|564641313|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423043|NCT04978363|564641314|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423044|NCT04978363|564641315|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423045|NCT04978363|564641316|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423046|NCT04978363|564641317|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423047|NCT04978363|564641318|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423048|NCT04978363|564641319|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423049|NCT04978363|564641320|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423050|NCT04978363|564641321|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156423051|NCT01251614|564641322|FG000|Overall Study|Adverse Event|1|||
156423052|NCT01251614|564641323|FG001|Overall Study|Adverse Event|0|||
156423053|NCT01251614|564641324|FG002|Overall Study|Adverse Event|1|||
156423054|NCT01251614|564641322|FG000|Overall Study|Lack of Efficacy|1|||
156423055|NCT01251614|564641323|FG001|Overall Study|Lack of Efficacy|9|||
156423056|NCT01251614|564641324|FG002|Overall Study|Lack of Efficacy|4|||
156423057|NCT01251614|564641322|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
156423058|NCT01251614|564641323|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
156423059|NCT01251614|564641324|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
156423060|NCT01251614|564641322|FG000|Overall Study|Pregnancy|0|||
156423061|NCT01251614|564641323|FG001|Overall Study|Pregnancy|0|||
156423062|NCT01251614|564641324|FG002|Overall Study|Pregnancy|2|||
156423063|NCT01251614|564641322|FG000|Overall Study|Loss of Disease Control|0|||
156423064|NCT01251614|564641323|FG001|Overall Study|Loss of Disease Control|1|||
156423065|NCT01251614|564641324|FG002|Overall Study|Loss of Disease Control|0|||
156423066|NCT01251614|564641322|FG000|Overall Study|Withdrawal by Subject|0|||
156423067|NCT01251614|564641323|FG001|Overall Study|Withdrawal by Subject|2|||
156423068|NCT01251614|564641324|FG002|Overall Study|Withdrawal by Subject|1|||
156423069|NCT01251614|564641322|FG000|Overall Study|Lost to Follow-up|0|||
156423070|NCT01251614|564641323|FG001|Overall Study|Lost to Follow-up|1|||
156423071|NCT01251614|564641324|FG002|Overall Study|Lost to Follow-up|0|||
156423072|NCT00723294|564641330|FG000|Overall Study|Lobular histology|2|||
156423073|NCT00723294|564641330|FG000|Overall Study|>25% intraductal component|1|||
156423074|NCT00723294|564641330|FG000|Overall Study|No MRI tumor enhancement|1|||
156423075|NCT00723294|564641330|FG000|Overall Study|1.0-Tesla MRI|1|||
156423076|NCT00723294|564641330|FG000|Overall Study|No cryoabalation|2|||
156423077|NCT00723294|564641330|FG000|Overall Study|Did not undergo surgery|1|||
156423078|NCT00723294|564641330|FG000|Overall Study|Treated prior to registration|1|||
156423079|NCT00723294|564641330|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
156423080|NCT00723294|564641330|FG000|Overall Study|Benign lesion|1|||
156423081|NCT00723294|564641330|FG000|Overall Study|Withdrawal by Subject|1|||
156423082|NCT00723294|564641330|FG000|Overall Study|No treatment due to probe failure|1|||
156423083|NCT01211665|564641331|FG000|Overall Study|Withdrawal by Subject|1|||
156423084|NCT01211665|564641332|FG001|Overall Study|Withdrawal by Subject|0|||
156423085|NCT01211665|564641331|FG000|Overall Study|Death|1|||
156423086|NCT01211665|564641332|FG001|Overall Study|Death|0|||
156423087|NCT00498186|564641335|FG000|Overall Study|Protocol Violation|10|||
156423088|NCT00498186|564641335|FG000|Overall Study|Lack of Efficacy|31|||
156423089|NCT00498186|564641335|FG000|Overall Study|Adverse Event|89|||
156423090|NCT00498186|564641335|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
156423091|NCT00498186|564641335|FG000|Overall Study|Withdrawal by Subject|18|||
156423092|NCT00498186|564641335|FG000|Overall Study|Lost to Follow-up|3|||
156423093|NCT00498186|564641335|FG000|Overall Study|Other|10|||
156423094|NCT04454567|564641336|FG000|Overall Study|Study Terminated by Sponsor|1|||
156423095|NCT04454567|564641337|FG001|Overall Study|Study Terminated by Sponsor|1|||
156423096|NCT02757885|564641338|FG000|Overall Study|Screen Failures|4|||
156423097|NCT01456780|564641339|FG000|Overall Study|Lost to Follow-up|3|||
156423098|NCT01456780|564641340|FG001|Overall Study|Lost to Follow-up|3|||
156423099|NCT01456780|564641341|FG002|Overall Study|Lost to Follow-up|0|||
156423100|NCT02688621|564641346|FG000|Overall Study|Pregnancy|1|||
156423101|NCT02688621|564641347|FG001|Overall Study|Pregnancy|3|||
156423102|NCT02688621|564641346|FG000|Overall Study|Lost to Follow-up|38|||
156423103|NCT02688621|564641347|FG001|Overall Study|Lost to Follow-up|15|||
156423104|NCT02688621|564641346|FG000|Overall Study|Withdrawal by Subject|1|||
156423105|NCT02688621|564641347|FG001|Overall Study|Withdrawal by Subject|0|||
156423106|NCT04565249|564641352|FG000|Overall Study|Death|0|||
156423107|NCT04565249|564641353|FG001|Overall Study|Death|0|||
156423108|NCT04565249|564641354|FG002|Overall Study|Death|0|||
156423109|NCT04565249|564641355|FG003|Overall Study|Death|1|||
156423110|NCT05349864|564641360|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
156423111|NCT05349864|564641361|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
156423112|NCT02333630|564641362|FG000|Overall Study|Lost to Follow-up|5|||
156423113|NCT02333630|564641363|FG001|Overall Study|Lost to Follow-up|2|||
156423114|NCT00984282|564641364|FG000|Double Blind Treatment|Adverse Event|40|||
156423115|NCT00984282|564641365|FG001|Double Blind Treatment|Adverse Event|6|||
156423116|NCT00984282|564641364|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
156423117|NCT00984282|564641365|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
156423118|NCT00984282|564641364|FG000|Double Blind Treatment|Physician Decision|1|||
156423119|NCT00984282|564641365|FG001|Double Blind Treatment|Physician Decision|2|||
156423120|NCT00984282|564641364|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
156423121|NCT00984282|564641365|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
156423122|NCT00984282|564641364|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
156423123|NCT00984282|564641365|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
156423124|NCT00984282|564641364|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
156423125|NCT00984282|564641365|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
156423126|NCT00984282|564641364|FG000|Double Blind Treatment|Lost to Follow-up|3|||
156423127|NCT00984282|564641365|FG001|Double Blind Treatment|Lost to Follow-up|0|||
156423128|NCT00984282|564641364|FG000|Double Blind Treatment|Death|8|||
156423129|NCT00984282|564641365|FG001|Double Blind Treatment|Death|4|||
156423130|NCT00984282|564641364|FG000|Double Blind Treatment|Not treated|0|||
156423131|NCT00984282|564641365|FG001|Double Blind Treatment|Not treated|1|||
156423132|NCT00984282|564641364|FG000|Double Blind Treatment|Switched to commercial drug|6|||
156423133|NCT00984282|564641365|FG001|Double Blind Treatment|Switched to commercial drug|1|||
156423134|NCT00984282|564641364|FG000|Double Blind Treatment|protocol driven decision point|1|||
156423135|NCT00984282|564641365|FG001|Double Blind Treatment|protocol driven decision point|1|||
156423136|NCT00984282|564641364|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
156423137|NCT00984282|564641365|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
156423138|NCT00984282|564641364|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
156423139|NCT00984282|564641365|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
156423140|NCT00984282|564641364|FG000|Open-label Treatment|Adverse Event|20|||
156423141|NCT00984282|564641365|FG001|Open-label Treatment|Adverse Event|30|||
156423142|NCT00984282|564641364|FG000|Open-label Treatment|Withdrawal by Subject|6|||
156423143|NCT00984282|564641365|FG001|Open-label Treatment|Withdrawal by Subject|21|||
156423144|NCT00984282|564641364|FG000|Open-label Treatment|Death|7|||
156423145|NCT00984282|564641365|FG001|Open-label Treatment|Death|15|||
156423146|NCT00984282|564641364|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
156423147|NCT00984282|564641365|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
156423148|NCT00984282|564641364|FG000|Open-label Treatment|Lost to Follow-up|1|||
156423149|NCT00984282|564641365|FG001|Open-label Treatment|Lost to Follow-up|1|||
156423150|NCT00984282|564641364|FG000|Open-label Treatment|Patient convenience|1|||
156423151|NCT00984282|564641365|FG001|Open-label Treatment|Patient convenience|0|||
156423152|NCT00984282|564641364|FG000|Open-label Treatment|Non-compliant with study medication|1|||
156423153|NCT00984282|564641365|FG001|Open-label Treatment|Non-compliant with study medication|0|||
156423154|NCT00984282|564641364|FG000|Open-label Treatment|Target lesion removed|0|||
156423155|NCT00984282|564641365|FG001|Open-label Treatment|Target lesion removed|1|||
156423156|NCT00984282|564641364|FG000|Open-label Treatment|Protocol driven decision point|1|||
156423157|NCT00984282|564641365|FG001|Open-label Treatment|Protocol driven decision point|1|||
156423158|NCT00984282|564641364|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
156423159|NCT00984282|564641365|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
156423160|NCT00984282|564641364|FG000|Open-label Treatment|Switched to commercial drug|6|||
156423161|NCT00984282|564641365|FG001|Open-label Treatment|Switched to commercial drug|7|||
156423162|NCT00984282|564641364|FG000|Open-label Treatment|Physician Decision|1|||
156423163|NCT00984282|564641365|FG001|Open-label Treatment|Physician Decision|0|||
156423164|NCT00984282|564641364|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
156423165|NCT00984282|564641365|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
156423166|NCT00984282|564641364|FG000|Long Term Follow-up|Death|27|||
156423167|NCT00984282|564641365|FG001|Long Term Follow-up|Death|68|||
156423168|NCT00984282|564641364|FG000|Long Term Follow-up|Lost to Follow-up|3|||
156423169|NCT00984282|564641365|FG001|Long Term Follow-up|Lost to Follow-up|6|||
156423170|NCT00984282|564641364|FG000|Long Term Follow-up|Protocol driven decision point|25|||
156423171|NCT00984282|564641365|FG001|Long Term Follow-up|Protocol driven decision point|26|||
156423172|NCT00984282|564641364|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
156423173|NCT00984282|564641365|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
156423174|NCT00984282|564641364|FG000|Long Term Follow-up|Switched to commercial drug|4|||
156423175|NCT00984282|564641365|FG001|Long Term Follow-up|Switched to commercial drug|2|||
156423176|NCT00984282|564641364|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
156423177|NCT00984282|564641365|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
156423178|NCT02223793|564641366|FG000|Overall Study|Lost to Follow-up|10|||
156423179|NCT02223793|564641367|FG001|Overall Study|Lost to Follow-up|1|||
156423180|NCT02223793|564641368|FG002|Overall Study|Lost to Follow-up|2|||
156423181|NCT02223793|564641366|FG000|Overall Study|Withdrawal by Subject|3|||
156423182|NCT02223793|564641367|FG001|Overall Study|Withdrawal by Subject|2|||
156423183|NCT02223793|564641368|FG002|Overall Study|Withdrawal by Subject|3|||
156423184|NCT02223793|564641366|FG000|Overall Study|Moved/studycenter unable to participate|4|||
156423185|NCT02223793|564641367|FG001|Overall Study|Moved/studycenter unable to participate|6|||
156423186|NCT02223793|564641368|FG002|Overall Study|Moved/studycenter unable to participate|8|||
156423187|NCT00315055|564641369|FG000|Overall Study|Protocol Violation|2|||
156423188|NCT00315055|564641370|FG001|Overall Study|Protocol Violation|4|||
156423189|NCT00315055|564641369|FG000|Overall Study|Lost to Follow-up|1|||
156423190|NCT00315055|564641370|FG001|Overall Study|Lost to Follow-up|1|||
156423191|NCT02321540|564641371|FG000|Overall Study|Death|0|||
156423192|NCT02321540|564641372|FG001|Overall Study|Death|1|||
156423193|NCT02321540|564641371|FG000|Overall Study|Progression|3|||
156423194|NCT02321540|564641372|FG001|Overall Study|Progression|9|||
156423195|NCT03606460|564641374|FG000|Overall Study|Lost to Follow-up|1|||
156423196|NCT03606460|564641375|FG001|Overall Study|Lost to Follow-up|8|||
156423197|NCT00303303|564641376|FG000|Overall Study|Withdrawal by Subject|0|||
156423198|NCT00303303|564641377|FG001|Overall Study|Withdrawal by Subject|0|||
156423199|NCT00303303|564641378|FG002|Overall Study|Withdrawal by Subject|1|||
156423200|NCT02390557|564641379|FG000|Wave 2|Survey non-respondent|72|||
156423201|NCT02390557|564641380|FG001|Wave 2|Survey non-respondent|41|||
156423202|NCT02390557|564641381|FG002|Wave 2|Survey non-respondent|23|||
156423203|NCT04337489|564641382|FG000|Overall Study|Withdrawal by Subject|1|||
156423204|NCT05349084|564641383|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
156423205|NCT03283553|564641384|FG000|Patient Participant Flow|Death|5|||
156423206|NCT03283553|564641385|FG001|Patient Participant Flow|Death|10|||
156423207|NCT03283553|564641384|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
156423208|NCT03283553|564641385|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
156423209|NCT03283553|564641384|FG000|Patient Participant Flow|Lost to Follow-up|1|||
156423210|NCT03283553|564641385|FG001|Patient Participant Flow|Lost to Follow-up|1|||
156423211|NCT03283553|564641384|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
156423212|NCT03283553|564641385|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
156423213|NCT03283553|564641384|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
156423214|NCT03283553|564641385|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
156423215|NCT03283553|564641384|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
156423216|NCT03283553|564641385|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
156423217|NCT03686683|564641386|FG000|Overall Study|Withdrawal by Subject|52|||
156423218|NCT03686683|564641387|FG001|Overall Study|Withdrawal by Subject|32|||
156423219|NCT03686683|564641386|FG000|Overall Study|Lost to Follow-up|23|||
156423220|NCT03686683|564641387|FG001|Overall Study|Lost to Follow-up|19|||
156423221|NCT03686683|564641386|FG000|Overall Study|Adverse Event|1|||
156423222|NCT03686683|564641387|FG001|Overall Study|Adverse Event|0|||
156423223|NCT03686683|564641386|FG000|Overall Study|Death|10|||
156423224|NCT03686683|564641387|FG001|Overall Study|Death|5|||
156423225|NCT03686683|564641386|FG000|Overall Study|Progressive Disease|1|||
156423226|NCT03686683|564641387|FG001|Overall Study|Progressive Disease|1|||
156423227|NCT03686683|564641386|FG000|Overall Study|Noncompliance|1|||
156423228|NCT03686683|564641387|FG001|Overall Study|Noncompliance|0|||
156423229|NCT03686683|564641386|FG000|Overall Study|Physician Decision|1|||
156423230|NCT03686683|564641387|FG001|Overall Study|Physician Decision|1|||
156423231|NCT03686683|564641386|FG000|Overall Study|Screen fail post-randomization|1|||
156423232|NCT03686683|564641387|FG001|Overall Study|Screen fail post-randomization|0|||
156423233|NCT03686683|564641386|FG000|Overall Study|Protocol Violation|3|||
156423234|NCT03686683|564641387|FG001|Overall Study|Protocol Violation|0|||
156423235|NCT03686683|564641386|FG000|Overall Study|No data available|1|||
156423236|NCT03686683|564641387|FG001|Overall Study|No data available|0|||
156423237|NCT03255941|564641388|FG000|Overall Study|Not eligible or refused injection|37|||
156423238|NCT03255941|564641389|FG001|Overall Study|Not eligible or refused injection|44|||
156423239|NCT03255941|564641390|FG002|Overall Study|Not eligible or refused injection|5|||
156423240|NCT03255941|564641391|FG003|Overall Study|Not eligible or refused injection|6|||
156423241|NCT03255941|564641388|FG000|Overall Study|Did not complete exit interview|1|||
156423242|NCT03255941|564641389|FG001|Overall Study|Did not complete exit interview|2|||
156423243|NCT03255941|564641390|FG002|Overall Study|Did not complete exit interview|0|||
156423244|NCT03255941|564641391|FG003|Overall Study|Did not complete exit interview|0|||
156423245|NCT01579578|564641392|FG000|Overall Study|Death|4|||
156423246|NCT01579578|564641393|FG001|Overall Study|Death|1|||
156423247|NCT01579578|564641392|FG000|Overall Study|Lost to Follow-up|1|||
156423248|NCT01579578|564641393|FG001|Overall Study|Lost to Follow-up|1|||
156423249|NCT01579578|564641392|FG000|Overall Study|Withdrawal by Subject|2|||
156423250|NCT01579578|564641393|FG001|Overall Study|Withdrawal by Subject|1|||
156423251|NCT01579578|564641392|FG000|Overall Study|Eligibility criteria|3|||
156423252|NCT01579578|564641393|FG001|Overall Study|Eligibility criteria|9|||
156423253|NCT01579578|564641392|FG000|Overall Study|Ongoing|3|||
156423254|NCT01579578|564641393|FG001|Overall Study|Ongoing|0|||
156423255|NCT00335153|564641394|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
156423256|NCT00335153|564641394|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
156423257|NCT00335153|564641394|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
156423258|NCT00335153|564641394|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
156423259|NCT00335153|564641394|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
156423260|NCT00335153|564641394|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
156423261|NCT00335153|564641394|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
156423262|NCT00335153|564641394|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
156423263|NCT00335153|564641394|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
156423264|NCT00335153|564641394|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
156423265|NCT01770860|564641399|FG000|Overall Study|Withdrawal by Subject|4|||
156423266|NCT01770860|564641399|FG000|Overall Study|Lost to Follow-up|1|||
156423267|NCT01770860|564641399|FG000|Overall Study|Administrative decision made by the PI|1|||
156423268|NCT05124899|564641401|FG000|Overall Study|Lost to Follow-up|3|||
156423269|NCT03432533|564641408|FG000|Overall Study|Lost to Follow-up|1|||
156423270|NCT03432533|564641409|FG001|Overall Study|Lost to Follow-up|2|||
156423271|NCT03432533|564641408|FG000|Overall Study|Withdrawal by Subject|14|||
156423272|NCT03432533|564641409|FG001|Overall Study|Withdrawal by Subject|9|||
156423273|NCT01648283|564641410|FG000|Overall Study|Withdrawal by Subject|14|||
156423274|NCT00821236|564641414|FG000|Overall Study|Lost to Follow-up|3|||
156423275|NCT01582243|564641418|FG000|Overall Study|Withdrawal by Subject|1|||
156423276|NCT01582243|564641418|FG000|Overall Study|Adverse Event|1|||
156423277|NCT01582243|564641418|FG000|Overall Study|Lost to Follow-up|1|||
156423278|NCT03382821|564641419|FG000|Overall Study|Did not receive allocated intervention.|0|||
156423279|NCT03382821|564641420|FG001|Overall Study|Did not receive allocated intervention.|3|||
156423280|NCT00797225|564641422|FG000|Weeks 1 to 12|Adverse Event|0|||
156423281|NCT00797225|564641423|FG001|Weeks 1 to 12|Adverse Event|0|||
156423282|NCT00797225|564641424|FG002|Weeks 1 to 12|Adverse Event|1|||
156423283|NCT00797225|564641425|FG003|Weeks 1 to 12|Adverse Event|0|||
156423284|NCT00797225|564641426|FG004|Weeks 1 to 12|Adverse Event|0|||
156423285|NCT00797225|564641427|FG005|Weeks 1 to 12|Adverse Event|0|||
156423286|NCT00797225|564641428|FG006|Weeks 1 to 12|Adverse Event|0|||
156423287|NCT00797225|564641429|FG007|Weeks 1 to 12|Adverse Event|0|||
156423288|NCT00797225|564641422|FG000|Weeks 1 to 12|Non-compliance|0|||
156423289|NCT00797225|564641423|FG001|Weeks 1 to 12|Non-compliance|1|||
156423290|NCT00797225|564641424|FG002|Weeks 1 to 12|Non-compliance|0|||
156423291|NCT00797225|564641425|FG003|Weeks 1 to 12|Non-compliance|0|||
156423292|NCT00797225|564641426|FG004|Weeks 1 to 12|Non-compliance|0|||
156423293|NCT00797225|564641427|FG005|Weeks 1 to 12|Non-compliance|0|||
156423294|NCT00797225|564641428|FG006|Weeks 1 to 12|Non-compliance|0|||
156423295|NCT00797225|564641429|FG007|Weeks 1 to 12|Non-compliance|0|||
156423296|NCT00797225|564641422|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
156423297|NCT00797225|564641423|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
156423298|NCT00797225|564641424|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
156423299|NCT00797225|564641425|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
156423300|NCT00797225|564641426|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
156423301|NCT00797225|564641427|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
156423302|NCT00797225|564641428|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
156423303|NCT00797225|564641429|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
156423304|NCT00797225|564641422|FG000|Weeks 1 to 12|Sponsor Decision|1|||
156423305|NCT00797225|564641423|FG001|Weeks 1 to 12|Sponsor Decision|0|||
156423306|NCT00797225|564641424|FG002|Weeks 1 to 12|Sponsor Decision|0|||
156423307|NCT00797225|564641425|FG003|Weeks 1 to 12|Sponsor Decision|0|||
156423308|NCT00797225|564641426|FG004|Weeks 1 to 12|Sponsor Decision|0|||
156423309|NCT00797225|564641427|FG005|Weeks 1 to 12|Sponsor Decision|0|||
156423310|NCT00797225|564641428|FG006|Weeks 1 to 12|Sponsor Decision|0|||
156423311|NCT00797225|564641429|FG007|Weeks 1 to 12|Sponsor Decision|0|||
156423312|NCT00797225|564641422|FG000|Weeks 13 to 24|Non-compliance|0|||
156423313|NCT00797225|564641423|FG001|Weeks 13 to 24|Non-compliance|2|||
156423314|NCT00797225|564641424|FG002|Weeks 13 to 24|Non-compliance|0|||
156423315|NCT00797225|564641425|FG003|Weeks 13 to 24|Non-compliance|0|||
156423316|NCT00797225|564641426|FG004|Weeks 13 to 24|Non-compliance|0|||
156423317|NCT00797225|564641427|FG005|Weeks 13 to 24|Non-compliance|0|||
156423318|NCT00797225|564641428|FG006|Weeks 13 to 24|Non-compliance|0|||
156423319|NCT00797225|564641429|FG007|Weeks 13 to 24|Non-compliance|0|||
156423320|NCT00797225|564641422|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
156423321|NCT00797225|564641423|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
156423322|NCT00797225|564641424|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
156423323|NCT00797225|564641425|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
156423324|NCT00797225|564641426|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
156423325|NCT00797225|564641427|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
156423326|NCT00797225|564641428|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
156423327|NCT00797225|564641429|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
156423328|NCT00797225|564641422|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
156423329|NCT00797225|564641423|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
156423330|NCT00797225|564641424|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
156423331|NCT00797225|564641425|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
156423332|NCT00797225|564641426|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
156423333|NCT00797225|564641427|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
156423334|NCT00797225|564641428|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
156423335|NCT00797225|564641429|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
156423336|NCT00797225|564641422|FG000|Weeks 13 to 24|Adverse Event|0|||
156423337|NCT00797225|564641423|FG001|Weeks 13 to 24|Adverse Event|1|||
156423338|NCT00797225|564641424|FG002|Weeks 13 to 24|Adverse Event|0|||
156423339|NCT00797225|564641425|FG003|Weeks 13 to 24|Adverse Event|0|||
156423340|NCT00797225|564641426|FG004|Weeks 13 to 24|Adverse Event|0|||
156423341|NCT00797225|564641427|FG005|Weeks 13 to 24|Adverse Event|0|||
156423342|NCT00797225|564641428|FG006|Weeks 13 to 24|Adverse Event|1|||
156423343|NCT00797225|564641429|FG007|Weeks 13 to 24|Adverse Event|0|||
156423344|NCT00797225|564641422|FG000|Weeks 13 to 24|Sponsor Decision|0|||
156423345|NCT00797225|564641423|FG001|Weeks 13 to 24|Sponsor Decision|0|||
156423346|NCT00797225|564641424|FG002|Weeks 13 to 24|Sponsor Decision|0|||
156423347|NCT00797225|564641425|FG003|Weeks 13 to 24|Sponsor Decision|0|||
156423348|NCT00797225|564641426|FG004|Weeks 13 to 24|Sponsor Decision|0|||
156423349|NCT00797225|564641427|FG005|Weeks 13 to 24|Sponsor Decision|0|||
156423350|NCT00797225|564641428|FG006|Weeks 13 to 24|Sponsor Decision|1|||
156423351|NCT00797225|564641429|FG007|Weeks 13 to 24|Sponsor Decision|0|||
156423352|NCT02096003|564641432|FG000|Overall Study|Protocol Violation|0|||
156423353|NCT02096003|564641433|FG001|Overall Study|Protocol Violation|2|||
156423354|NCT02096003|564641432|FG000|Overall Study|additional surgery|2|||
156423355|NCT02096003|564641433|FG001|Overall Study|additional surgery|1|||
156423356|NCT01008748|564641436|FG000|Overall Study|Lost to Follow-up|80|||
156423357|NCT01008748|564641436|FG000|Overall Study|Other|1|||
156423358|NCT04833855|564641437|FG000|Overall Study|Decision by sponsor|0|||
156423359|NCT04833855|564641438|FG001|Overall Study|Decision by sponsor|1|||
156423360|NCT04833855|564641439|FG002|Overall Study|Decision by sponsor|0|||
156423361|NCT04833855|564641440|FG003|Overall Study|Decision by sponsor|0|||
156423362|NCT04833855|564641437|FG000|Overall Study|Withdrawal by Subject|4|||
156423363|NCT04833855|564641438|FG001|Overall Study|Withdrawal by Subject|1|||
156423364|NCT04833855|564641439|FG002|Overall Study|Withdrawal by Subject|3|||
156423365|NCT04833855|564641440|FG003|Overall Study|Withdrawal by Subject|1|||
156423366|NCT04833855|564641437|FG000|Overall Study|Lost to Follow-up|1|||
156423367|NCT04833855|564641438|FG001|Overall Study|Lost to Follow-up|0|||
156423368|NCT04833855|564641439|FG002|Overall Study|Lost to Follow-up|2|||
156423369|NCT04833855|564641440|FG003|Overall Study|Lost to Follow-up|2|||
156423370|NCT04833855|564641437|FG000|Overall Study|Protocol specified criteria|0|||
156423371|NCT04833855|564641438|FG001|Overall Study|Protocol specified criteria|0|||
156423372|NCT04833855|564641439|FG002|Overall Study|Protocol specified criteria|2|||
156423373|NCT04833855|564641440|FG003|Overall Study|Protocol specified criteria|1|||
156423374|NCT04824131|564641442|FG000|CAB LA Oral Phase|Adverse Event|1|||
156761962|NCT05616013|565879949|FG005|Overall Study|Non-compliance with study requirements|2|||
156761963|NCT05616013|565879950|FG006|Overall Study|Non-compliance with study requirements|1|||
156320783|NCT01615029|564271671|FG002|Overall Study|Adverse Event|3|||
156320784|NCT01615029|564271672|FG003|Overall Study|Adverse Event|0|||
156320785|NCT01615029|564271673|FG004|Overall Study|Adverse Event|4|||
156320786|NCT01615029|564271669|FG000|Overall Study|Progressive disease|1|||
156320787|NCT01615029|564271670|FG001|Overall Study|Progressive disease|1|||
156320788|NCT01615029|564271671|FG002|Overall Study|Progressive disease|1|||
156320789|NCT01615029|564271672|FG003|Overall Study|Progressive disease|1|||
156320790|NCT01615029|564271673|FG004|Overall Study|Progressive disease|10|||
156320791|NCT01615029|564271669|FG000|Overall Study|Physician Decision|0|||
156320792|NCT01615029|564271670|FG001|Overall Study|Physician Decision|0|||
156320793|NCT01615029|564271671|FG002|Overall Study|Physician Decision|0|||
156320794|NCT01615029|564271672|FG003|Overall Study|Physician Decision|0|||
156320795|NCT01615029|564271673|FG004|Overall Study|Physician Decision|2|||
156320796|NCT01163318|564271675|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
156320797|NCT01163318|564271675|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
156320798|NCT01163318|564271675|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
156320799|NCT01163318|564271675|FG000|Overall Study|Participants Without Case Report Form|7|||
156320800|NCT01163318|564271675|FG000|Overall Study|Multiple Reasons Per Participant|224|||
156320801|NCT01892722|564271676|FG000|Overall Study|Protocol deviation|0|||
156320802|NCT01892722|564271677|FG001|Overall Study|Protocol deviation|1|||
156320803|NCT01892722|564271676|FG000|Overall Study|Administrative problems|0|||
156320804|NCT01892722|564271677|FG001|Overall Study|Administrative problems|1|||
156320805|NCT01892722|564271676|FG000|Overall Study|Patient/guardian decision|0|||
156320806|NCT01892722|564271677|FG001|Overall Study|Patient/guardian decision|2|||
156320807|NCT01892722|564271676|FG000|Overall Study|Physician Decision|1|||
156320808|NCT01892722|564271677|FG001|Overall Study|Physician Decision|2|||
156320809|NCT01892722|564271676|FG000|Overall Study|Adverse Event|3|||
156320810|NCT01892722|564271677|FG001|Overall Study|Adverse Event|2|||
156320811|NCT01892722|564271676|FG000|Overall Study|Lack of Efficacy|0|||
156320812|NCT01892722|564271677|FG001|Overall Study|Lack of Efficacy|7|||
156320813|NCT01892722|564271676|FG000|Overall Study|Withdrawal by Subject|3|||
156320814|NCT01892722|564271677|FG001|Overall Study|Withdrawal by Subject|5|||
156320815|NCT02604017|564272463|FG000|Overall Study|Withdrew Consent|0|||
156320816|NCT02604017|564272464|FG001|Overall Study|Withdrew Consent|2|||
156320817|NCT02604017|564272463|FG000|Overall Study|Lost to Follow-up|5|||
156320818|NCT02604017|564272464|FG001|Overall Study|Lost to Follow-up|6|||
156320819|NCT02604017|564272463|FG000|Overall Study|Other|1|||
156320820|NCT02604017|564272464|FG001|Overall Study|Other|0|||
156320821|NCT04104438|564272467|FG000|Overall Study|Death|2|||
156320822|NCT04104438|564272468|FG001|Overall Study|Death|1|||
156320823|NCT04104438|564272469|FG002|Overall Study|Death|2|||
156320824|NCT04104438|564272467|FG000|Overall Study|Adverse Event|0|||
156320825|NCT04104438|564272468|FG001|Overall Study|Adverse Event|3|||
156320826|NCT04104438|564272469|FG002|Overall Study|Adverse Event|0|||
156320827|NCT04104438|564272467|FG000|Overall Study|Withdrawal by Subject|0|||
156320828|NCT04104438|564272468|FG001|Overall Study|Withdrawal by Subject|1|||
156320829|NCT04104438|564272469|FG002|Overall Study|Withdrawal by Subject|0|||
156320830|NCT04104438|564272467|FG000|Overall Study|Disenrolled due to noncompliance|0|||
156320831|NCT04104438|564272468|FG001|Overall Study|Disenrolled due to noncompliance|1|||
156320832|NCT04104438|564272469|FG002|Overall Study|Disenrolled due to noncompliance|0|||
156320833|NCT04104438|564272467|FG000|Overall Study|stopped due to possible operation|0|||
156320834|NCT04104438|564272468|FG001|Overall Study|stopped due to possible operation|1|||
156320835|NCT04104438|564272469|FG002|Overall Study|stopped due to possible operation|0|||
156320836|NCT04104438|564272467|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
156320837|NCT04104438|564272468|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
156320838|NCT04104438|564272469|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
156320839|NCT01315236|564272470|FG000|Double-blind Phase|Death|1|||
156320840|NCT01315236|564272471|FG001|Double-blind Phase|Death|0|||
156320841|NCT01315236|564272470|FG000|Double-blind Phase|Adverse Event|1|||
156320842|NCT01315236|564272471|FG001|Double-blind Phase|Adverse Event|0|||
156320843|NCT01315236|564272470|FG000|Double-blind Phase|Withdrawal of Consent|1|||
156320844|NCT01315236|564272471|FG001|Double-blind Phase|Withdrawal of Consent|0|||
156320845|NCT01315236|564272470|FG000|Double-blind Phase|Lost to Follow-up|1|||
156320846|NCT01315236|564272471|FG001|Double-blind Phase|Lost to Follow-up|0|||
156320847|NCT01315236|564272470|FG000|Open-label Phase|Death|1|||
156320848|NCT01315236|564272471|FG001|Open-label Phase|Death|0|||
156320849|NCT01315236|564272470|FG000|Open-label Phase|Adverse Event|0|||
156320850|NCT01315236|564272471|FG001|Open-label Phase|Adverse Event|1|||
156320851|NCT01315236|564272470|FG000|Open-label Phase|Other|0|||
156320852|NCT01315236|564272471|FG001|Open-label Phase|Other|1|||
156320853|NCT01315236|564272470|FG000|12-Month Follow-up Period|Death|0|||
156320854|NCT01315236|564272471|FG001|12-Month Follow-up Period|Death|1|||
156320855|NCT01315236|564272470|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
156320856|NCT01315236|564272471|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
156320857|NCT03116347|564272472|FG000|Overall Study|Withdrawal by Subject|1|||
156320858|NCT03116347|564272473|FG001|Overall Study|Withdrawal by Subject|2|||
156320859|NCT04193410|564272474|FG000|Overall Study|Lost to Follow-up|7|||
156320860|NCT04193410|564272475|FG001|Overall Study|Lost to Follow-up|6|||
156320861|NCT01293799|564272476|FG000|Overall Study|Kidney transplantation|109|||
156320862|NCT01293799|564272477|FG001|Overall Study|Kidney transplantation|96|||
156320863|NCT01293799|564272476|FG000|Overall Study|Transfer to hemodialysis|70|||
156320864|NCT01293799|564272477|FG001|Overall Study|Transfer to hemodialysis|90|||
156320865|NCT01293799|564272476|FG000|Overall Study|Death|27|||
156320866|NCT01293799|564272477|FG001|Overall Study|Death|29|||
156320867|NCT01293799|564272476|FG000|Overall Study|Transfer to assisted PD|24|||
156320868|NCT01293799|564272477|FG001|Overall Study|Transfer to assisted PD|18|||
156320869|NCT01293799|564272476|FG000|Overall Study|Withdrawal by Subject|26|||
156320870|NCT01293799|564272477|FG001|Overall Study|Withdrawal by Subject|0|||
156320871|NCT01293799|564272476|FG000|Overall Study|Investigator decision|5|||
156320872|NCT01293799|564272477|FG001|Overall Study|Investigator decision|2|||
156320873|NCT01293799|564272476|FG000|Overall Study|Kidney function improved|6|||
156320874|NCT01293799|564272477|FG001|Overall Study|Kidney function improved|7|||
156320875|NCT01293799|564272476|FG000|Overall Study|Other causes|6|||
156320876|NCT01293799|564272477|FG001|Overall Study|Other causes|3|||
156320877|NCT01302834|564272486|FG000|Overall Study|Protocol Violation|17|||
156320878|NCT01302834|564272487|FG001|Overall Study|Protocol Violation|23|||
156320879|NCT01302834|564272486|FG000|Overall Study|HIV positive|1|||
156320880|NCT01302834|564272487|FG001|Overall Study|HIV positive|3|||
156320881|NCT04779216|564272488|FG000|Overall Study|Lost to Follow-up|1|||
156320882|NCT04779216|564272489|FG001|Overall Study|Lost to Follow-up|0|||
156320883|NCT04779216|564272488|FG000|Overall Study|Withdrawal by Subject|1|||
156320884|NCT04779216|564272489|FG001|Overall Study|Withdrawal by Subject|0|||
156320885|NCT02674854|564272490|FG000|Overall Study|Adverse Event|17|||
156320886|NCT02674854|564272491|FG001|Overall Study|Adverse Event|15|||
156320887|NCT02674854|564272492|FG002|Overall Study|Adverse Event|5|||
156320888|NCT02674854|564272490|FG000|Overall Study|Withdrawal by Subject|1|||
156320889|NCT02674854|564272491|FG001|Overall Study|Withdrawal by Subject|5|||
156320890|NCT02674854|564272492|FG002|Overall Study|Withdrawal by Subject|4|||
156320891|NCT02674854|564272490|FG000|Overall Study|No-compliant subject|1|||
156320892|NCT02674854|564272491|FG001|Overall Study|No-compliant subject|0|||
156320893|NCT02674854|564272492|FG002|Overall Study|No-compliant subject|1|||
156320894|NCT02674854|564272490|FG000|Overall Study|Lost to Follow-up|1|||
156320895|NCT02674854|564272491|FG001|Overall Study|Lost to Follow-up|0|||
156320896|NCT02674854|564272492|FG002|Overall Study|Lost to Follow-up|2|||
156320897|NCT02674854|564272490|FG000|Overall Study|Lack of Efficacy|0|||
156320898|NCT02674854|564272491|FG001|Overall Study|Lack of Efficacy|3|||
156320899|NCT02674854|564272492|FG002|Overall Study|Lack of Efficacy|0|||
156320900|NCT02674854|564272490|FG000|Overall Study|Disallowed Concurrent Medication|2|||
156320901|NCT02674854|564272491|FG001|Overall Study|Disallowed Concurrent Medication|2|||
156320902|NCT02674854|564272492|FG002|Overall Study|Disallowed Concurrent Medication|0|||
156320903|NCT02674854|564272490|FG000|Overall Study|Protocol Violation|1|||
156320904|NCT02674854|564272491|FG001|Overall Study|Protocol Violation|1|||
156320905|NCT02674854|564272492|FG002|Overall Study|Protocol Violation|2|||
156320906|NCT02674854|564272490|FG000|Overall Study|Death|0|||
156320907|NCT02674854|564272491|FG001|Overall Study|Death|1|||
156320908|NCT02674854|564272492|FG002|Overall Study|Death|0|||
156320909|NCT02674854|564272490|FG000|Overall Study|Subject missed V6.2|1|||
156320910|NCT02674854|564272491|FG001|Overall Study|Subject missed V6.2|0|||
156320911|NCT02674854|564272492|FG002|Overall Study|Subject missed V6.2|0|||
156320912|NCT04594369|564272497|FG000|Overall Study|Adverse Event|10|||
156320913|NCT04594369|564272498|FG001|Overall Study|Adverse Event|10|||
156320914|NCT04594369|564272499|FG002|Overall Study|Adverse Event|9|||
156423375|NCT04824131|564641442|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
156423376|NCT04824131|564641442|FG000|Step 3|Withdrawal by Subject|2|||
156423377|NCT03686384|564641443|FG000|Overall Study|Lack of Efficacy|4|||
156423378|NCT03686384|564641444|FG001|Overall Study|Lack of Efficacy|13|||
156423379|NCT03686384|564641443|FG000|Overall Study|Lost to Follow-up|3|||
156423380|NCT03686384|564641444|FG001|Overall Study|Lost to Follow-up|0|||
156423381|NCT03686384|564641443|FG000|Overall Study|Physician Decision|0|||
156423382|NCT03686384|564641444|FG001|Overall Study|Physician Decision|1|||
156423383|NCT03686384|564641443|FG000|Overall Study|Took prohibited medication|0|||
156423384|NCT03686384|564641444|FG001|Overall Study|Took prohibited medication|1|||
156423385|NCT05174065|564641451|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
156423386|NCT05174065|564641452|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
156423387|NCT05174065|564641453|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
156320915|NCT04594369|564272497|FG000|Overall Study|Death|2|||
156320916|NCT04594369|564272498|FG001|Overall Study|Death|4|||
156320917|NCT04594369|564272499|FG002|Overall Study|Death|8|||
156423388|NCT05174065|564641451|FG000|Placebo-controlled Period|Other|0|||
156423389|NCT05174065|564641452|FG001|Placebo-controlled Period|Other|1|||
156320918|NCT04594369|564272497|FG000|Overall Study|Lost to Follow-up|10|||
156320919|NCT04594369|564272498|FG001|Overall Study|Lost to Follow-up|2|||
156320920|NCT04594369|564272499|FG002|Overall Study|Lost to Follow-up|4|||
156423390|NCT05174065|564641453|FG002|Placebo-controlled Period|Other|0|||
156320921|NCT04594369|564272497|FG000|Overall Study|Physician Decision|2|||
156320922|NCT04594369|564272498|FG001|Overall Study|Physician Decision|2|||
156320923|NCT04594369|564272499|FG002|Overall Study|Physician Decision|3|||
156320924|NCT04594369|564272497|FG000|Overall Study|Protocol deviation|1|||
156320925|NCT04594369|564272498|FG001|Overall Study|Protocol deviation|3|||
156320926|NCT04594369|564272499|FG002|Overall Study|Protocol deviation|2|||
156320927|NCT04594369|564272497|FG000|Overall Study|Withdrawal by Subject|40|||
156320928|NCT04594369|564272498|FG001|Overall Study|Withdrawal by Subject|32|||
156320929|NCT04594369|564272499|FG002|Overall Study|Withdrawal by Subject|37|||
156320930|NCT04594369|564272497|FG000|Overall Study|Reason not specified|60|||
156320931|NCT04594369|564272498|FG001|Overall Study|Reason not specified|56|||
156320932|NCT04594369|564272499|FG002|Overall Study|Reason not specified|43|||
156320933|NCT01602666|564272500|FG000|Induction Chemotherapy|Death|2|||
156320934|NCT01602666|564272501|FG001|Induction Chemotherapy|Death|1|||
156320935|NCT01602666|564272500|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
156320936|NCT01602666|564272501|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
156320937|NCT01602666|564272500|FG000|Induction Chemotherapy|Physician Decision|12|||
156320938|NCT01602666|564272501|FG001|Induction Chemotherapy|Physician Decision|5|||
156320939|NCT01602666|564272500|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
156320940|NCT01602666|564272501|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
156320941|NCT01602666|564272500|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
156320942|NCT01602666|564272501|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
156320943|NCT01602666|564272500|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
156320944|NCT01602666|564272501|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
156320945|NCT01602666|564272500|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
156320946|NCT01602666|564272501|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
156320947|NCT01602666|564272500|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
156320948|NCT01602666|564272501|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
156320949|NCT01602666|564272500|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
156320950|NCT01602666|564272501|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
156320951|NCT01602666|564272500|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
156320952|NCT01602666|564272501|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
156320953|NCT01602666|564272500|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
156320954|NCT01602666|564272501|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
156320955|NCT05458648|564272502|FG000|Overall Study|Physician Decision|1|||
156320956|NCT05458648|564272502|FG000|Overall Study|Patient presented in atrial flutter|1|||
156320957|NCT03610555|564272506|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
156320958|NCT03610555|564272507|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
156320959|NCT03610555|564272508|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
156320960|NCT03610555|564272509|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
156320961|NCT02275910|564272510|FG000|Overall Study|Subject Choice|0|||
156320962|NCT02275910|564272511|FG001|Overall Study|Subject Choice|0|||
156320963|NCT02275910|564272512|FG002|Overall Study|Subject Choice|0|||
156320964|NCT02275910|564272513|FG003|Overall Study|Subject Choice|0|||
156320965|NCT02275910|564272514|FG004|Overall Study|Subject Choice|0|||
156320966|NCT02275910|564272515|FG005|Overall Study|Subject Choice|0|||
156320967|NCT02275910|564272516|FG006|Overall Study|Subject Choice|0|||
156320968|NCT02275910|564272517|FG007|Overall Study|Subject Choice|0|||
156320969|NCT02275910|564272518|FG008|Overall Study|Subject Choice|1|||
156320970|NCT02275910|564272519|FG009|Overall Study|Subject Choice|0|||
156320971|NCT02275910|564272520|FG010|Overall Study|Subject Choice|0|||
156320972|NCT02275910|564272521|FG011|Overall Study|Subject Choice|0|||
156320973|NCT02275910|564272510|FG000|Overall Study|Radiological Disease Progression|0|||
156320974|NCT02275910|564272511|FG001|Overall Study|Radiological Disease Progression|0|||
156320975|NCT02275910|564272512|FG002|Overall Study|Radiological Disease Progression|0|||
156320976|NCT02275910|564272513|FG003|Overall Study|Radiological Disease Progression|0|||
156320977|NCT02275910|564272514|FG004|Overall Study|Radiological Disease Progression|0|||
156320978|NCT02275910|564272515|FG005|Overall Study|Radiological Disease Progression|0|||
156320979|NCT02275910|564272516|FG006|Overall Study|Radiological Disease Progression|1|||
156320980|NCT02275910|564272517|FG007|Overall Study|Radiological Disease Progression|1|||
156320981|NCT02275910|564272518|FG008|Overall Study|Radiological Disease Progression|0|||
156320982|NCT02275910|564272519|FG009|Overall Study|Radiological Disease Progression|1|||
156320983|NCT02275910|564272520|FG010|Overall Study|Radiological Disease Progression|0|||
156320984|NCT02275910|564272521|FG011|Overall Study|Radiological Disease Progression|0|||
156320985|NCT04285580|564273608|FG000|Overall Study|Protocol Violation|0|||
156320986|NCT04285580|564273609|FG001|Overall Study|Protocol Violation|1|||
156320987|NCT02582255|564273610|FG000|Overall Study|Protocol Violation|0|||
156320988|NCT02582255|564273611|FG001|Overall Study|Protocol Violation|3|||
156320989|NCT01709578|564273613|FG000|Overall Study|Rescued and entered in long term safety|63|||
156320990|NCT01709578|564273614|FG001|Overall Study|Rescued and entered in long term safety|25|||
156320991|NCT01709578|564273615|FG002|Overall Study|Rescued and entered in long term safety|26|||
156320992|NCT01709578|564273613|FG000|Overall Study|Adverse Event|9|||
156320993|NCT01709578|564273614|FG001|Overall Study|Adverse Event|18|||
156320994|NCT01709578|564273615|FG002|Overall Study|Adverse Event|17|||
156320995|NCT01709578|564273613|FG000|Overall Study|Lack of Efficacy|5|||
156320996|NCT01709578|564273614|FG001|Overall Study|Lack of Efficacy|4|||
156320997|NCT01709578|564273615|FG002|Overall Study|Lack of Efficacy|2|||
156320998|NCT01709578|564273613|FG000|Overall Study|Poor compliance to protocol|1|||
156320999|NCT01709578|564273614|FG001|Overall Study|Poor compliance to protocol|2|||
156321000|NCT01709578|564273615|FG002|Overall Study|Poor compliance to protocol|1|||
156321001|NCT01709578|564273613|FG000|Overall Study|Other, not related to safety or efficacy|2|||
156321002|NCT01709578|564273614|FG001|Overall Study|Other, not related to safety or efficacy|7|||
156321003|NCT01709578|564273615|FG002|Overall Study|Other, not related to safety or efficacy|5|||
156321004|NCT04050371|564273616|FG000|Overall Study|Withdrawal by Subject|1|||
156321005|NCT04050371|564273617|FG001|Overall Study|Withdrawal by Subject|0|||
156321006|NCT01107418|564273618|FG000|Overall Study|Disease Progression|45|||
156321007|NCT01107418|564273618|FG000|Overall Study|Adverse Event|3|||
156321008|NCT01107418|564273618|FG000|Overall Study|Withdrawal by Subject|1|||
156321009|NCT01107418|564273618|FG000|Overall Study|Study Closing|1|||
156321010|NCT01107418|564273618|FG000|Overall Study|Started Other Therapy|1|||
156321011|NCT01107418|564273618|FG000|Overall Study|Entered Extension Study|1|||
156321012|NCT00597701|564273619|FG000|Overall Study|Withdrawal by Subject|5|||
156321013|NCT00597701|564273620|FG001|Overall Study|Withdrawal by Subject|5|||
156321014|NCT00597701|564273619|FG000|Overall Study|Death|0|||
156321015|NCT00597701|564273620|FG001|Overall Study|Death|1|||
156321016|NCT00597701|564273619|FG000|Overall Study|Physician Decision|2|||
156321017|NCT00597701|564273620|FG001|Overall Study|Physician Decision|0|||
156321018|NCT00597701|564273619|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
156321019|NCT00597701|564273620|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
156321020|NCT01741012|564273622|FG000|Overall Study|Lost to Follow-up|1|||
156321021|NCT01741012|564273622|FG000|Overall Study|Withdrawal by Subject|2|||
156321022|NCT04626310|564273637|FG000|Overall Study|4-miss from treatment|6|||
156321023|NCT04626310|564273638|FG001|Overall Study|4-miss from treatment|5|||
156321024|NCT04626310|564273639|FG002|Overall Study|4-miss from treatment|5|||
156321025|NCT04626310|564273637|FG000|Overall Study|Withdrawal by Subject|1|||
156321026|NCT04626310|564273638|FG001|Overall Study|Withdrawal by Subject|0|||
156321027|NCT04626310|564273639|FG002|Overall Study|Withdrawal by Subject|3|||
156321028|NCT01282203|564273642|FG000|Overall Study|Adverse Event|1|||
156321029|NCT00518973|564273643|FG000|Overall Study|Withdrawal by Subject|3|||
156321030|NCT00518973|564273644|FG001|Overall Study|Withdrawal by Subject|2|||
156321031|NCT03452527|564273645|FG000|Overall Study|Withdrawal by Subject|1|||
156321032|NCT03452527|564273646|FG001|Overall Study|Withdrawal by Subject|1|||
156321033|NCT03452527|564273645|FG000|Overall Study|Study Terminated|2|||
156321034|NCT03452527|564273646|FG001|Overall Study|Study Terminated|3|||
156321035|NCT00582816|564273647|FG000|Overall Study|Engraftment Failure|3|||
156321036|NCT01565499|564273650|FG000|Overall Study|Physician Decision|1|||
156321037|NCT01565499|564273650|FG000|Overall Study|Adverse Event|5|||
156321038|NCT01565499|564273650|FG000|Overall Study|Withdrawal by Subject|2|||
156321039|NCT01923168|564273651|FG000|Overall Study|Protocol Violation|1|||
156321040|NCT01923168|564273652|FG001|Overall Study|Protocol Violation|1|||
156321041|NCT01923168|564273653|FG002|Overall Study|Protocol Violation|0|||
156321042|NCT01923168|564273651|FG000|Overall Study|Subject/guardian decision|14|||
156321043|NCT01923168|564273652|FG001|Overall Study|Subject/guardian decision|14|||
156321044|NCT01923168|564273653|FG002|Overall Study|Subject/guardian decision|4|||
156321045|NCT01923168|564273651|FG000|Overall Study|Adverse Event|12|||
156321046|NCT01923168|564273652|FG001|Overall Study|Adverse Event|12|||
156321047|NCT01923168|564273653|FG002|Overall Study|Adverse Event|0|||
156321048|NCT01923168|564273651|FG000|Overall Study|Physician Decision|6|||
156321049|NCT01923168|564273652|FG001|Overall Study|Physician Decision|9|||
156321050|NCT01923168|564273653|FG002|Overall Study|Physician Decision|5|||
156321051|NCT01923168|564273651|FG000|Overall Study|Progressive disease|4|||
156321052|NCT01923168|564273652|FG001|Overall Study|Progressive disease|3|||
156321053|NCT01923168|564273653|FG002|Overall Study|Progressive disease|7|||
156321054|NCT01923168|564273651|FG000|Overall Study|Death|0|||
156321055|NCT01923168|564273652|FG001|Overall Study|Death|0|||
156321056|NCT01923168|564273653|FG002|Overall Study|Death|1|||
156321057|NCT01255787|564273654|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
156321058|NCT01255787|564273655|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
156321059|NCT01255787|564273656|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
156321060|NCT01255787|564273657|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
156321061|NCT01255787|564273654|FG000|Overall Study|Major Protocol Deviation|1|||
156321062|NCT01255787|564273655|FG001|Overall Study|Major Protocol Deviation|1|||
156321063|NCT01255787|564273656|FG002|Overall Study|Major Protocol Deviation|0|||
156321064|NCT01255787|564273657|FG003|Overall Study|Major Protocol Deviation|4|||
156321065|NCT01255787|564273654|FG000|Overall Study|Lost to Follow-up|1|||
156321066|NCT01255787|564273655|FG001|Overall Study|Lost to Follow-up|2|||
156321067|NCT01255787|564273656|FG002|Overall Study|Lost to Follow-up|4|||
156321068|NCT01255787|564273657|FG003|Overall Study|Lost to Follow-up|2|||
156423391|NCT05174065|564641451|FG000|Placebo-controlled Period|Adverse Event|1|||
156423392|NCT05174065|564641452|FG001|Placebo-controlled Period|Adverse Event|1|||
156423393|NCT05174065|564641453|FG002|Placebo-controlled Period|Adverse Event|0|||
156423394|NCT05174065|564641451|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
156423395|NCT05174065|564641452|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
156423396|NCT05174065|564641453|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
156423397|NCT05174065|564641451|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
156423398|NCT05174065|564641452|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
156423399|NCT05174065|564641453|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
156423400|NCT05174065|564641451|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
156423401|NCT05174065|564641452|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
156423402|NCT05174065|564641453|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
156423403|NCT00924560|564641455|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
156423404|NCT00924560|564641456|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
156423405|NCT00924560|564641457|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
156423406|NCT00924560|564641455|FG000|Overall Study|Non Compliance with the Protocol|20|||
156423407|NCT00924560|564641456|FG001|Overall Study|Non Compliance with the Protocol|15|||
156423408|NCT00924560|564641457|FG002|Overall Study|Non Compliance with the Protocol|4|||
156423409|NCT00924560|564641455|FG000|Overall Study|Physician Decision|2|||
156423410|NCT00924560|564641456|FG001|Overall Study|Physician Decision|3|||
156423411|NCT00924560|564641457|FG002|Overall Study|Physician Decision|4|||
156423412|NCT00924560|564641455|FG000|Overall Study|Withdrawal by Subject|50|||
156423413|NCT00924560|564641456|FG001|Overall Study|Withdrawal by Subject|44|||
156423414|NCT00924560|564641457|FG002|Overall Study|Withdrawal by Subject|18|||
156423415|NCT00924560|564641455|FG000|Overall Study|Adverse Event|39|||
156423416|NCT00924560|564641456|FG001|Overall Study|Adverse Event|33|||
156423417|NCT00924560|564641457|FG002|Overall Study|Adverse Event|0|||
156423418|NCT00924560|564641455|FG000|Overall Study|Pregnancy|5|||
156423419|NCT00924560|564641456|FG001|Overall Study|Pregnancy|7|||
156423420|NCT00924560|564641457|FG002|Overall Study|Pregnancy|1|||
156423421|NCT00924560|564641455|FG000|Overall Study|Lost to Follow-up|78|||
156423422|NCT00924560|564641456|FG001|Overall Study|Lost to Follow-up|94|||
156423423|NCT00924560|564641457|FG002|Overall Study|Lost to Follow-up|45|||
156423424|NCT00924560|564641455|FG000|Overall Study|Miscellaneous Reasons|13|||
156423425|NCT00924560|564641456|FG001|Overall Study|Miscellaneous Reasons|10|||
156423426|NCT00924560|564641457|FG002|Overall Study|Miscellaneous Reasons|10|||
156423427|NCT00209274|564641460|FG000|Overall Study|Missed visit|3|||
156423428|NCT00209274|564641461|FG001|Overall Study|Missed visit|2|||
156423429|NCT00209274|564641460|FG000|Overall Study|Death|32|||
156423430|NCT00209274|564641461|FG001|Overall Study|Death|15|||
156423431|NCT00209274|564641460|FG000|Overall Study|Withdrawal by Subject|30|||
156423432|NCT00209274|564641461|FG001|Overall Study|Withdrawal by Subject|15|||
156423433|NCT00209274|564641460|FG000|Overall Study|Randomized not treated (RNT)|6|||
156423434|NCT00209274|564641461|FG001|Overall Study|Randomized not treated (RNT)|15|||
156423435|NCT00604786|564641465|FG000|Overall Study|Lost to Follow-up|2|||
156423436|NCT00604786|564641466|FG001|Overall Study|Lost to Follow-up|0|||
156423437|NCT02268396|564642970|FG000|Overall Study|Adverse Event|3|||
156423438|NCT02268396|564642970|FG000|Overall Study|Administrative|2|||
156423439|NCT02268396|564642970|FG000|Overall Study|Withdrawal by Subject|1|||
156423440|NCT02268396|564642970|FG000|Overall Study|Lost to Follow-up|2|||
156423441|NCT02268396|564642970|FG000|Overall Study|Protocol-Specified Criteria|2|||
156423442|NCT02268396|564642970|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
156423443|NCT01304706|564642973|FG000|Overall Study|Adverse Event|2|||
156423444|NCT01304706|564642973|FG000|Overall Study|Lack of Efficacy|1|||
156423445|NCT01304706|564642973|FG000|Overall Study|Death|3|||
156423446|NCT01304706|564642973|FG000|Overall Study|Withdrawal by Subject|3|||
156423447|NCT01304706|564642973|FG000|Overall Study|Lost to Follow-up|7|||
156423448|NCT01304706|564642973|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
156423449|NCT01419717|564642974|FG000|Overall Study|Protocol-specified Criteria|62|||
156423450|NCT01419717|564642974|FG000|Overall Study|Adverse Event|19|||
156423451|NCT01419717|564642974|FG000|Overall Study|Death|17|||
156423452|NCT01419717|564642974|FG000|Overall Study|Withdrawal by Subject|10|||
156423453|NCT01419717|564642974|FG000|Overall Study|Disease Progression|9|||
156423454|NCT01419717|564642974|FG000|Overall Study|Other|4|||
156423455|NCT01419717|564642974|FG000|Overall Study|Lost to Follow-up|2|||
156423456|NCT01419717|564642974|FG000|Overall Study|Administrative Decision|1|||
156423457|NCT01419717|564642974|FG000|Overall Study|Noncompliance|1|||
156423458|NCT00797862|564642975|FG000|Overall Study|Adverse Event|86|||
156423459|NCT00797862|564642976|FG001|Overall Study|Adverse Event|44|||
156423460|NCT00797862|564642977|FG002|Overall Study|Adverse Event|58|||
156423461|NCT00797862|564642975|FG000|Overall Study|Abnormal Test Procedure Result|0|||
156423462|NCT00797862|564642976|FG001|Overall Study|Abnormal Test Procedure Result|1|||
156423463|NCT00797862|564642977|FG002|Overall Study|Abnormal Test Procedure Result|1|||
156423464|NCT00797862|564642975|FG000|Overall Study|Lack of Efficacy|1|||
156423465|NCT00797862|564642976|FG001|Overall Study|Lack of Efficacy|7|||
156423466|NCT00797862|564642977|FG002|Overall Study|Lack of Efficacy|6|||
156423467|NCT00797862|564642975|FG000|Overall Study|No longer required study medication|1|||
156423468|NCT00797862|564642976|FG001|Overall Study|No longer required study medication|0|||
156423469|NCT00797862|564642977|FG002|Overall Study|No longer required study medication|0|||
156423470|NCT00797862|564642975|FG000|Overall Study|Withdrawal by Subject|14|||
156423471|NCT00797862|564642976|FG001|Overall Study|Withdrawal by Subject|7|||
156423472|NCT00797862|564642977|FG002|Overall Study|Withdrawal by Subject|7|||
156423473|NCT00797862|564642975|FG000|Overall Study|Lost to Follow-up|11|||
156423474|NCT00797862|564642976|FG001|Overall Study|Lost to Follow-up|0|||
156423475|NCT00797862|564642977|FG002|Overall Study|Lost to Follow-up|5|||
156423476|NCT00797862|564642975|FG000|Overall Study|Administrative Problem|4|||
156423477|NCT00797862|564642976|FG001|Overall Study|Administrative Problem|0|||
156423478|NCT00797862|564642977|FG002|Overall Study|Administrative Problem|0|||
156423479|NCT00797862|564642975|FG000|Overall Study|Protocol Violation|4|||
156423480|NCT00797862|564642976|FG001|Overall Study|Protocol Violation|6|||
156423481|NCT00797862|564642977|FG002|Overall Study|Protocol Violation|8|||
156423482|NCT00797862|564642975|FG000|Overall Study|Mis-randomized|3|||
156423483|NCT00797862|564642976|FG001|Overall Study|Mis-randomized|3|||
156423484|NCT00797862|564642977|FG002|Overall Study|Mis-randomized|1|||
156423485|NCT02359435|564642978|FG000|Overall Study|Lost to Follow-up|4|||
156423486|NCT02359435|564642979|FG001|Overall Study|Lost to Follow-up|4|||
156423487|NCT04541186|564642983|FG000|Main Study|Adverse Event|0|||
156423488|NCT04541186|564642984|FG001|Main Study|Adverse Event|0|||
156423489|NCT04541186|564642985|FG002|Main Study|Adverse Event|4|||
156423490|NCT04541186|564642986|FG003|Main Study|Adverse Event|0|||
156423491|NCT04541186|564642987|FG004|Main Study|Adverse Event|0|||
156423492|NCT04541186|564642983|FG000|Main Study|Investigator Decision|0|||
156423493|NCT04541186|564642984|FG001|Main Study|Investigator Decision|0|||
156423494|NCT04541186|564642985|FG002|Main Study|Investigator Decision|1|||
156423495|NCT04541186|564642986|FG003|Main Study|Investigator Decision|1|||
156423496|NCT04541186|564642987|FG004|Main Study|Investigator Decision|0|||
156423497|NCT04541186|564642983|FG000|Main Study|Withdrawal by Subject|1|||
156423498|NCT04541186|564642984|FG001|Main Study|Withdrawal by Subject|1|||
156423499|NCT04541186|564642985|FG002|Main Study|Withdrawal by Subject|0|||
156423500|NCT04541186|564642986|FG003|Main Study|Withdrawal by Subject|0|||
156423501|NCT04541186|564642987|FG004|Main Study|Withdrawal by Subject|0|||
156423502|NCT04541186|564642983|FG000|Main Study|COVID-19-related Dose Interruption|0|||
156423503|NCT04541186|564642984|FG001|Main Study|COVID-19-related Dose Interruption|0|||
156423504|NCT04541186|564642985|FG002|Main Study|COVID-19-related Dose Interruption|0|||
156423505|NCT04541186|564642986|FG003|Main Study|COVID-19-related Dose Interruption|0|||
156423506|NCT04541186|564642987|FG004|Main Study|COVID-19-related Dose Interruption|1|||
156423507|NCT04541186|564642983|FG000|Main Study|Randomized in Error Not Treated|0|||
156423508|NCT04541186|564642984|FG001|Main Study|Randomized in Error Not Treated|0|||
156423509|NCT04541186|564642985|FG002|Main Study|Randomized in Error Not Treated|1|||
156423510|NCT04541186|564642986|FG003|Main Study|Randomized in Error Not Treated|0|||
156423511|NCT04541186|564642987|FG004|Main Study|Randomized in Error Not Treated|0|||
156423512|NCT04541186|564642983|FG000|Fibrate Expansion Study|Other than Specified|0|||
156423513|NCT04541186|564642984|FG001|Fibrate Expansion Study|Other than Specified|0|||
156423514|NCT04541186|564642985|FG002|Fibrate Expansion Study|Other than Specified|0|||
156423515|NCT04541186|564642986|FG003|Fibrate Expansion Study|Other than Specified|0|||
156423516|NCT04541186|564642987|FG004|Fibrate Expansion Study|Other than Specified|1|||
156423517|NCT02347943|564642988|FG000|Overall Study|Study was cancelled|140|||
156423518|NCT02347943|564642989|FG001|Overall Study|Study was cancelled|67|||
156423519|NCT02347943|564642990|FG002|Overall Study|Study was cancelled|45|||
156423520|NCT00058058|564642992|FG000|Overall Study|Withdrawal by Subject|4|||
156423521|NCT00058058|564642992|FG000|Overall Study|Ineligible|20|||
156423522|NCT00058058|564642992|FG000|Overall Study|Claustrophobic|5|||
156423523|NCT00058058|564642992|FG000|Overall Study|technical issues|6|||
156423524|NCT00058058|564642992|FG000|Overall Study|Poor positioning, illness,pain|3|||
156423525|NCT03085017|564642993|FG000|Overall Study|Death|0|||
156423526|NCT03085017|564642994|FG001|Overall Study|Death|3|||
156423527|NCT02680756|564642995|FG000|Overall Study|Adverse Event|10|||
156423528|NCT02680756|564642996|FG001|Overall Study|Adverse Event|2|||
156423529|NCT02680756|564642995|FG000|Overall Study|Lost to Follow-up|7|||
156423530|NCT02680756|564642996|FG001|Overall Study|Lost to Follow-up|6|||
156423531|NCT02680756|564642995|FG000|Overall Study|Withdrawal by Subject|5|||
156423532|NCT02680756|564642996|FG001|Overall Study|Withdrawal by Subject|5|||
156423533|NCT02680756|564642995|FG000|Overall Study|Physician Decision|4|||
156423534|NCT02680756|564642996|FG001|Overall Study|Physician Decision|1|||
156423535|NCT02680756|564642995|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
156423536|NCT02680756|564642996|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
156423537|NCT02680756|564642995|FG000|Overall Study|Blood transfusion for any reason|0|||
156423538|NCT02680756|564642996|FG001|Overall Study|Blood transfusion for any reason|1|||
156423539|NCT02680756|564642995|FG000|Overall Study|Death|1|||
156423540|NCT02680756|564642996|FG001|Overall Study|Death|0|||
156423541|NCT02680756|564642995|FG000|Overall Study|Protocol Violation|1|||
156423542|NCT02680756|564642996|FG001|Overall Study|Protocol Violation|0|||
156423543|NCT02680756|564642995|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
156423544|NCT02680756|564642996|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
156423545|NCT02680756|564642995|FG000|Overall Study|None of above or not recorded|3|||
156423546|NCT02680756|564642996|FG001|Overall Study|None of above or not recorded|2|||
156423547|NCT03302156|564642997|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
156423548|NCT03302156|564642998|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
156423549|NCT03302156|564642999|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
156423550|NCT03635112|564643001|FG000|Overall Study|Adverse Event|5|||
156423551|NCT03635112|564643002|FG001|Overall Study|Adverse Event|9|||
156423552|NCT03635112|564643003|FG002|Overall Study|Adverse Event|14|||
156423553|NCT03635112|564643001|FG000|Overall Study|Lost to Follow-up|1|||
156423554|NCT03635112|564643002|FG001|Overall Study|Lost to Follow-up|0|||
156423555|NCT03635112|564643003|FG002|Overall Study|Lost to Follow-up|1|||
156423556|NCT03635112|564643001|FG000|Overall Study|Physician Decision|5|||
156423557|NCT03635112|564643002|FG001|Overall Study|Physician Decision|7|||
156423558|NCT03635112|564643003|FG002|Overall Study|Physician Decision|5|||
156423559|NCT03635112|564643001|FG000|Overall Study|Protocol Violation|0|||
156423560|NCT03635112|564643002|FG001|Overall Study|Protocol Violation|0|||
156423561|NCT03635112|564643003|FG002|Overall Study|Protocol Violation|1|||
156423562|NCT03635112|564643001|FG000|Overall Study|Study Terminated by Sponsor|11|||
156423563|NCT03635112|564643002|FG001|Overall Study|Study Terminated by Sponsor|17|||
156423564|NCT03635112|564643003|FG002|Overall Study|Study Terminated by Sponsor|21|||
156423565|NCT03635112|564643001|FG000|Overall Study|Withdrawal by Subject|4|||
156423566|NCT03635112|564643002|FG001|Overall Study|Withdrawal by Subject|9|||
156423567|NCT03635112|564643003|FG002|Overall Study|Withdrawal by Subject|7|||
156423568|NCT03635112|564643001|FG000|Overall Study|Miscellaneous|0|||
156321069|NCT01255787|564273654|FG000|Overall Study|Withdrawal of Consent|3|||
156321070|NCT01255787|564273655|FG001|Overall Study|Withdrawal of Consent|9|||
156321071|NCT01255787|564273656|FG002|Overall Study|Withdrawal of Consent|3|||
156321072|NCT01255787|564273657|FG003|Overall Study|Withdrawal of Consent|4|||
156321073|NCT01255787|564273654|FG000|Overall Study|Pregnancy|0|||
156321074|NCT01255787|564273655|FG001|Overall Study|Pregnancy|0|||
156321075|NCT01255787|564273656|FG002|Overall Study|Pregnancy|0|||
156321076|NCT01255787|564273657|FG003|Overall Study|Pregnancy|1|||
156321077|NCT01255787|564273654|FG000|Overall Study|Lack of Efficacy|2|||
156321078|NCT01255787|564273655|FG001|Overall Study|Lack of Efficacy|2|||
156321079|NCT01255787|564273656|FG002|Overall Study|Lack of Efficacy|2|||
156321080|NCT01255787|564273657|FG003|Overall Study|Lack of Efficacy|2|||
156321081|NCT01255787|564273654|FG000|Overall Study|Noncompliance with Study Drug|3|||
156321082|NCT01255787|564273655|FG001|Overall Study|Noncompliance with Study Drug|1|||
156321083|NCT01255787|564273656|FG002|Overall Study|Noncompliance with Study Drug|0|||
156321084|NCT01255787|564273657|FG003|Overall Study|Noncompliance with Study Drug|0|||
156321085|NCT00476047|564273658|FG000|Overall Study|Lost to Follow-up|1|||
156321086|NCT00768469|564273659|FG000|Overall Study|Adverse Event|0|||
156321087|NCT00768469|564273660|FG001|Overall Study|Adverse Event|2|||
156321088|NCT00768469|564273659|FG000|Overall Study|Disease Progression|3|||
156321089|NCT00768469|564273660|FG001|Overall Study|Disease Progression|4|||
156321090|NCT00768469|564273659|FG000|Overall Study|Withdrawal by Subject|0|||
156321091|NCT00768469|564273660|FG001|Overall Study|Withdrawal by Subject|1|||
156321092|NCT04966741|564273661|FG000|Overall Study|Lost to Follow-up|1|||
156321093|NCT04966741|564273662|FG001|Overall Study|Lost to Follow-up|0|||
156321094|NCT02241889|564273665|FG000|Overall Study|device issues|0|||
156321095|NCT02241889|564273666|FG001|Overall Study|device issues|0|||
156321096|NCT02241889|564273667|FG002|Overall Study|device issues|1|||
156321097|NCT02241889|564273668|FG003|Overall Study|device issues|0|||
156321098|NCT02241889|564273669|FG004|Overall Study|device issues|0|||
156321099|NCT02241889|564273670|FG005|Overall Study|device issues|0|||
156321100|NCT02241889|564273665|FG000|Overall Study|Withdrawal by Subject|0|||
156321101|NCT02241889|564273666|FG001|Overall Study|Withdrawal by Subject|0|||
156321102|NCT02241889|564273667|FG002|Overall Study|Withdrawal by Subject|0|||
156321103|NCT02241889|564273668|FG003|Overall Study|Withdrawal by Subject|0|||
156321104|NCT02241889|564273669|FG004|Overall Study|Withdrawal by Subject|0|||
156321105|NCT02241889|564273670|FG005|Overall Study|Withdrawal by Subject|1|||
156423569|NCT03635112|564643002|FG001|Overall Study|Miscellaneous|0|||
156423570|NCT03635112|564643003|FG002|Overall Study|Miscellaneous|1|||
156423571|NCT00463151|564643008|FG000|Overall Study|Adverse Event|0|||
156321106|NCT00773838|564273671|FG000|Overall Study|Adverse Event|29|||
156321107|NCT00773838|564273671|FG000|Overall Study|Lost to Follow-up|1|||
156321108|NCT00773838|564273671|FG000|Overall Study|Physician Decision|8|||
156321109|NCT00773838|564273671|FG000|Overall Study|Progressive Disease|82|||
156321110|NCT00773838|564273671|FG000|Overall Study|Protocol Violation|2|||
156321111|NCT00773838|564273671|FG000|Overall Study|Withdrawal by Subject|21|||
156321112|NCT00459056|564273673|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
156423572|NCT00463151|564643009|FG001|Overall Study|Adverse Event|0|||
156423573|NCT00463151|564643010|FG002|Overall Study|Adverse Event|1|||
156321113|NCT00459056|564273674|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
156321114|NCT01658813|564273675|FG000|Overall Study|Disease progression|3|||
156423574|NCT00463151|564643011|FG003|Overall Study|Adverse Event|0|||
156321115|NCT04473482|564273676|FG000|Overall Study|Death|0|||
156321116|NCT04473482|564273677|FG001|Overall Study|Death|3|||
156321117|NCT04473482|564273676|FG000|Overall Study|Lost to Follow-up|9|||
156321118|NCT04473482|564273677|FG001|Overall Study|Lost to Follow-up|7|||
156321119|NCT04473482|564273676|FG000|Overall Study|Withdrawal by Subject|2|||
156321120|NCT04473482|564273677|FG001|Overall Study|Withdrawal by Subject|1|||
156321121|NCT05217927|564273685|FG000|DBT Phase|Adverse Event|7|||
156321122|NCT05217927|564273686|FG001|DBT Phase|Adverse Event|2|||
156321123|NCT05217927|564273687|FG002|DBT Phase|Adverse Event|5|||
156321124|NCT05217927|564273685|FG000|DBT Phase|Lack of Efficacy|1|||
156321125|NCT05217927|564273686|FG001|DBT Phase|Lack of Efficacy|0|||
156321126|NCT05217927|564273687|FG002|DBT Phase|Lack of Efficacy|0|||
156321127|NCT05217927|564273685|FG000|DBT Phase|Lost to Follow-up|0|||
156321128|NCT05217927|564273686|FG001|DBT Phase|Lost to Follow-up|2|||
156321129|NCT05217927|564273687|FG002|DBT Phase|Lost to Follow-up|0|||
156321130|NCT05217927|564273685|FG000|DBT Phase|Non-compliance|1|||
156321131|NCT05217927|564273686|FG001|DBT Phase|Non-compliance|0|||
156321132|NCT05217927|564273687|FG002|DBT Phase|Non-compliance|0|||
156321133|NCT05217927|564273685|FG000|DBT Phase|Pregnancy|0|||
156321134|NCT05217927|564273686|FG001|DBT Phase|Pregnancy|0|||
156321135|NCT05217927|564273687|FG002|DBT Phase|Pregnancy|1|||
156321136|NCT05217927|564273685|FG000|DBT Phase|Protocol Violation|0|||
156321137|NCT05217927|564273686|FG001|DBT Phase|Protocol Violation|2|||
156321138|NCT05217927|564273687|FG002|DBT Phase|Protocol Violation|1|||
156321139|NCT05217927|564273685|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
156321140|NCT05217927|564273686|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
156321141|NCT05217927|564273687|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
156321142|NCT05217927|564273685|FG000|DBT Phase|Withdrawal of consent|8|||
156321143|NCT05217927|564273686|FG001|DBT Phase|Withdrawal of consent|5|||
156321144|NCT05217927|564273687|FG002|DBT Phase|Withdrawal of consent|7|||
156321145|NCT05217927|564273685|FG000|DBT Phase|Other|7|||
156321146|NCT05217927|564273686|FG001|DBT Phase|Other|3|||
156321147|NCT05217927|564273687|FG002|DBT Phase|Other|4|||
156321148|NCT05217927|564273685|FG000|DBT Phase|Randomized, not treated|2|||
156321149|NCT05217927|564273686|FG001|DBT Phase|Randomized, not treated|3|||
156321150|NCT05217927|564273687|FG002|DBT Phase|Randomized, not treated|2|||
156321151|NCT05217927|564273685|FG000|OLE Phase|Adverse Event|4|||
156321152|NCT05217927|564273686|FG001|OLE Phase|Adverse Event|1|||
156321153|NCT05217927|564273687|FG002|OLE Phase|Adverse Event|1|||
156321154|NCT05217927|564273685|FG000|OLE Phase|Extension phase eligibility failure|1|||
156321155|NCT05217927|564273686|FG001|OLE Phase|Extension phase eligibility failure|0|||
156321156|NCT05217927|564273687|FG002|OLE Phase|Extension phase eligibility failure|0|||
156321157|NCT05217927|564273685|FG000|OLE Phase|Lost to Follow-up|1|||
156321158|NCT05217927|564273686|FG001|OLE Phase|Lost to Follow-up|2|||
156321159|NCT05217927|564273687|FG002|OLE Phase|Lost to Follow-up|1|||
156321160|NCT05217927|564273685|FG000|OLE Phase|Non-compliance|0|||
156321161|NCT05217927|564273686|FG001|OLE Phase|Non-compliance|0|||
156321162|NCT05217927|564273687|FG002|OLE Phase|Non-compliance|1|||
156321163|NCT05217927|564273685|FG000|OLE Phase|Other|3|||
156321164|NCT05217927|564273686|FG001|OLE Phase|Other|5|||
156321165|NCT05217927|564273687|FG002|OLE Phase|Other|4|||
156321166|NCT05217927|564273685|FG000|OLE Phase|Withdrawal of consent|3|||
156321167|NCT05217927|564273686|FG001|OLE Phase|Withdrawal of consent|1|||
156321168|NCT05217927|564273687|FG002|OLE Phase|Withdrawal of consent|5|||
156321169|NCT06785857|564273690|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
156321170|NCT06785857|564273691|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
156321171|NCT03576274|564273693|FG000|Overall Study|Lost to Follow-up|3|||
156321172|NCT03576274|564273694|FG001|Overall Study|Lost to Follow-up|2|||
156321173|NCT03576274|564273695|FG002|Overall Study|Lost to Follow-up|3|||
156321174|NCT03576274|564273696|FG003|Overall Study|Lost to Follow-up|1|||
156321175|NCT03576274|564273697|FG004|Overall Study|Lost to Follow-up|3|||
156321176|NCT03576274|564273693|FG000|Overall Study|Withdrawal by Subject|5|||
156321177|NCT03576274|564273694|FG001|Overall Study|Withdrawal by Subject|3|||
156321178|NCT03576274|564273695|FG002|Overall Study|Withdrawal by Subject|2|||
156321179|NCT03576274|564273696|FG003|Overall Study|Withdrawal by Subject|8|||
156321180|NCT03576274|564273697|FG004|Overall Study|Withdrawal by Subject|6|||
156321181|NCT05952401|564273706|FG000|Overall Study|Lost to Follow-up|4|||
156321182|NCT05952401|564273707|FG001|Overall Study|Lost to Follow-up|1|||
156321183|NCT00076024|564274964|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
156321184|NCT00076024|564274965|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
156321185|NCT00076024|564274966|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
156321186|NCT00076024|564274967|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
156321187|NCT00076024|564274964|FG000|Phase 1, Lead-in|Adverse Event|1|||
156321188|NCT00076024|564274965|FG001|Phase 1, Lead-in|Adverse Event|0|||
156423575|NCT00463151|564643008|FG000|Overall Study|Lack of Efficacy|2|||
156321189|NCT00076024|564274966|FG002|Phase 1, Lead-in|Adverse Event|0|||
156321190|NCT00076024|564274967|FG003|Phase 1, Lead-in|Adverse Event|0|||
156321191|NCT00076024|564274964|FG000|Phase 1, Lead-in|Clinical progression|1|||
156321192|NCT00076024|564274965|FG001|Phase 1, Lead-in|Clinical progression|0|||
156321193|NCT00076024|564274966|FG002|Phase 1, Lead-in|Clinical progression|0|||
156423576|NCT00463151|564643009|FG001|Overall Study|Lack of Efficacy|5|||
156321194|NCT00076024|564274967|FG003|Phase 1, Lead-in|Clinical progression|0|||
156321195|NCT00076024|564274964|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
156423577|NCT00463151|564643010|FG002|Overall Study|Lack of Efficacy|2|||
156423578|NCT00463151|564643011|FG003|Overall Study|Lack of Efficacy|5|||
156423579|NCT00463151|564643008|FG000|Overall Study|Protocol Violation|0|||
156423580|NCT00463151|564643009|FG001|Overall Study|Protocol Violation|0|||
156423581|NCT00463151|564643010|FG002|Overall Study|Protocol Violation|0|||
156423582|NCT00463151|564643011|FG003|Overall Study|Protocol Violation|1|||
156423583|NCT00463151|564643008|FG000|Overall Study|Withdrawal by Subject|0|||
156423584|NCT00463151|564643009|FG001|Overall Study|Withdrawal by Subject|0|||
156423585|NCT00463151|564643010|FG002|Overall Study|Withdrawal by Subject|0|||
156423586|NCT00463151|564643011|FG003|Overall Study|Withdrawal by Subject|1|||
156423587|NCT00972543|564643012|FG000|Overall Study|Adverse Event|1|||
156423588|NCT00972543|564643013|FG001|Overall Study|Adverse Event|0|||
156423589|NCT00972543|564643012|FG000|Overall Study|Early study termination by sponsor|4|||
156423590|NCT00972543|564643013|FG001|Overall Study|Early study termination by sponsor|1|||
156423591|NCT00688688|564643014|FG000|Overall Study|Eligibility criterion not met|7|||
156423592|NCT00688688|564643015|FG001|Overall Study|Eligibility criterion not met|7|||
156423593|NCT00688688|564643016|FG002|Overall Study|Eligibility criterion not met|10|||
156423594|NCT00688688|564643014|FG000|Overall Study|Adverse Event|52|||
156423595|NCT00688688|564643015|FG001|Overall Study|Adverse Event|51|||
156423596|NCT00688688|564643016|FG002|Overall Study|Adverse Event|50|||
156423597|NCT00688688|564643014|FG000|Overall Study|Lack of Efficacy|34|||
156423598|NCT00688688|564643015|FG001|Overall Study|Lack of Efficacy|25|||
156423599|NCT00688688|564643016|FG002|Overall Study|Lack of Efficacy|45|||
156423600|NCT00688688|564643014|FG000|Overall Study|Withdrawal by Subject|66|||
156423601|NCT00688688|564643015|FG001|Overall Study|Withdrawal by Subject|75|||
156423602|NCT00688688|564643016|FG002|Overall Study|Withdrawal by Subject|65|||
156321196|NCT00076024|564274965|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
156321197|NCT00076024|564274966|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
156321198|NCT00076024|564274967|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
156321199|NCT00076024|564274964|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
156321200|NCT00076024|564274965|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
156321201|NCT00076024|564274966|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
156321202|NCT00076024|564274967|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
156321203|NCT00076024|564274964|FG000|Phase 2, Double-blind|Adverse Event|0|||
156321204|NCT00076024|564274965|FG001|Phase 2, Double-blind|Adverse Event|25|||
156321205|NCT00076024|564274966|FG002|Phase 2, Double-blind|Adverse Event|6|||
156321206|NCT00076024|564274967|FG003|Phase 2, Double-blind|Adverse Event|0|||
156321207|NCT00076024|564274964|FG000|Phase 2, Double-blind|Un-specified|0|||
156321208|NCT00076024|564274965|FG001|Phase 2, Double-blind|Un-specified|14|||
156321209|NCT00076024|564274966|FG002|Phase 2, Double-blind|Un-specified|6|||
156321210|NCT00076024|564274967|FG003|Phase 2, Double-blind|Un-specified|0|||
156321211|NCT00076024|564274964|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
156321212|NCT00076024|564274965|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
156321213|NCT00076024|564274966|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
156321214|NCT00076024|564274967|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
156321215|NCT00076024|564274964|FG000|Phase 2, Open-label|Adverse Event|0|||
156321216|NCT00076024|564274965|FG001|Phase 2, Open-label|Adverse Event|0|||
156321217|NCT00076024|564274966|FG002|Phase 2, Open-label|Adverse Event|0|||
156321218|NCT00076024|564274967|FG003|Phase 2, Open-label|Adverse Event|2|||
156321219|NCT00076024|564274964|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
156321220|NCT00076024|564274965|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
156321221|NCT00076024|564274966|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
156321222|NCT00076024|564274967|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
156321223|NCT00076024|564274964|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
156321224|NCT00076024|564274965|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
156321225|NCT00076024|564274966|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
156321226|NCT00076024|564274967|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
156321227|NCT00076024|564274964|FG000|Phase 2, Open-label|Other|0|||
156321228|NCT00076024|564274965|FG001|Phase 2, Open-label|Other|0|||
156321229|NCT00076024|564274966|FG002|Phase 2, Open-label|Other|0|||
156321230|NCT00076024|564274967|FG003|Phase 2, Open-label|Other|2|||
156321231|NCT01155219|564274974|FG000|Overall Study|Adverse Event|3|||
156321232|NCT01155219|564274975|FG001|Overall Study|Adverse Event|1|||
156321233|NCT01155219|564274974|FG000|Overall Study|non-medical reason|1|||
156423603|NCT00688688|564643014|FG000|Overall Study|Lost to Follow-up|14|||
156423604|NCT00688688|564643015|FG001|Overall Study|Lost to Follow-up|7|||
156423605|NCT00688688|564643016|FG002|Overall Study|Lost to Follow-up|7|||
156423606|NCT00688688|564643014|FG000|Overall Study|Protocol Violation|6|||
156423607|NCT00688688|564643015|FG001|Overall Study|Protocol Violation|9|||
156423608|NCT00688688|564643016|FG002|Overall Study|Protocol Violation|11|||
156761964|NCT05616013|565879951|FG007|Overall Study|Non-compliance with study requirements|1|||
156321234|NCT01155219|564274975|FG001|Overall Study|non-medical reason|2|||
156321235|NCT03052764|564274977|FG000|Double-Blind Treatment Period|Adverse Event|2|||
156423609|NCT00688688|564643014|FG000|Overall Study|Randomized but never received study drug|1|||
156423610|NCT00688688|564643015|FG001|Overall Study|Randomized but never received study drug|0|||
156423611|NCT00688688|564643016|FG002|Overall Study|Randomized but never received study drug|0|||
156423612|NCT00688688|564643014|FG000|Overall Study|Non-compliance with study procedures|5|||
156423613|NCT00688688|564643015|FG001|Overall Study|Non-compliance with study procedures|3|||
156423614|NCT00688688|564643016|FG002|Overall Study|Non-compliance with study procedures|4|||
156423615|NCT00688688|564643014|FG000|Overall Study|Taking exclusionary medications|1|||
156423616|NCT00688688|564643015|FG001|Overall Study|Taking exclusionary medications|0|||
156423617|NCT00688688|564643016|FG002|Overall Study|Taking exclusionary medications|0|||
156423618|NCT00688688|564643014|FG000|Overall Study|Site closure|0|||
156423619|NCT00688688|564643015|FG001|Overall Study|Site closure|1|||
156423620|NCT00688688|564643016|FG002|Overall Study|Site closure|0|||
156423621|NCT00688688|564643014|FG000|Overall Study|Violation of exclusion criterion|0|||
156423622|NCT00688688|564643015|FG001|Overall Study|Violation of exclusion criterion|1|||
156423623|NCT00688688|564643016|FG002|Overall Study|Violation of exclusion criterion|0|||
156423624|NCT04296942|564643020|FG000|Overall Study|Study closure by sponsor|1|||
156423625|NCT04296942|564643021|FG001|Overall Study|Study closure by sponsor|0|||
156423626|NCT04296942|564643022|FG002|Overall Study|Study closure by sponsor|0|||
156423627|NCT01528709|564643034|FG000|Overall Study|Death|2|||
156423628|NCT01528709|564643035|FG001|Overall Study|Death|0|||
156423629|NCT01528709|564643034|FG000|Overall Study|Withdrawal by Subject|10|||
156423630|NCT01528709|564643035|FG001|Overall Study|Withdrawal by Subject|15|||
156423631|NCT01528709|564643034|FG000|Overall Study|allergy|1|||
156423632|NCT01528709|564643035|FG001|Overall Study|allergy|0|||
156423633|NCT01982760|564643036|FG000|Overall Study|Physician Decision|1|||
156423634|NCT01982760|564643037|FG001|Overall Study|Physician Decision|0|||
156423635|NCT00530777|564643039|FG000|Overall Study|Lost to Follow-up|0|||
156423636|NCT00530777|564643040|FG001|Overall Study|Lost to Follow-up|1|||
156423637|NCT00530777|564643039|FG000|Overall Study|Death|1|||
156423638|NCT00530777|564643040|FG001|Overall Study|Death|2|||
156423639|NCT00530777|564643039|FG000|Overall Study|Physician Decision|1|||
156423640|NCT00530777|564643040|FG001|Overall Study|Physician Decision|0|||
156423641|NCT00530777|564643039|FG000|Overall Study|Withdrawal by Subject|0|||
156423642|NCT00530777|564643040|FG001|Overall Study|Withdrawal by Subject|1|||
156423643|NCT00530777|564643039|FG000|Overall Study|Unable to adhere to visit schedule|5|||
156423644|NCT00530777|564643040|FG001|Overall Study|Unable to adhere to visit schedule|1|||
156423645|NCT02954055|564643045|FG000|Overall Study|Did not initiate therapy|6|||
156423646|NCT02954055|564643046|FG001|Overall Study|Did not initiate therapy|1|||
156423647|NCT01119703|564643051|FG000|Overall Study|Adverse Event|0|||
156423648|NCT01119703|564643052|FG001|Overall Study|Adverse Event|1|||
156761965|NCT05616013|565879952|FG008|Overall Study|Non-compliance with study requirements|4|||
156321236|NCT03052764|564274978|FG001|Double-Blind Treatment Period|Adverse Event|0|||
156321237|NCT03052764|564274977|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
156423649|NCT01511250|564643053|FG000|Overall Study|Withdrawal of Consent|1|||
156423650|NCT01511250|564643054|FG001|Overall Study|Withdrawal of Consent|0|||
156423651|NCT01511250|564643055|FG002|Overall Study|Withdrawal of Consent|0|||
156321238|NCT03052764|564274978|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
156321239|NCT03052764|564274977|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
156321240|NCT03052764|564274978|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
156321241|NCT03052764|564274977|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
156321242|NCT03052764|564274978|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156321243|NCT03052764|564274977|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
156321244|NCT03052764|564274978|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
156321245|NCT01314911|564274979|FG000|Overall Study|Lost to Follow-up|3|||
156321246|NCT01314911|564274980|FG001|Overall Study|Lost to Follow-up|2|||
156321247|NCT01314911|564274979|FG000|Overall Study|Withdrawal by Subject|1|||
156321248|NCT01314911|564274980|FG001|Overall Study|Withdrawal by Subject|3|||
156321249|NCT01314911|564274979|FG000|Overall Study|Received Non-randomized Study Drug|0|||
156321250|NCT01314911|564274980|FG001|Overall Study|Received Non-randomized Study Drug|1|||
156321251|NCT01314911|564274979|FG000|Overall Study|Never Started Treatment|1|||
156321252|NCT01314911|564274980|FG001|Overall Study|Never Started Treatment|0|||
156321253|NCT03150485|564274984|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
156321254|NCT03150485|564274985|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
156321255|NCT03150485|564274986|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
156321256|NCT03150485|564274987|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
156423652|NCT01511250|564643056|FG003|Overall Study|Withdrawal of Consent|0|||
156423653|NCT01511250|564643057|FG004|Overall Study|Withdrawal of Consent|0|||
156423654|NCT01511250|564643058|FG005|Overall Study|Withdrawal of Consent|0|||
156423655|NCT01511250|564643059|FG006|Overall Study|Withdrawal of Consent|0|||
156423656|NCT01511250|564643060|FG007|Overall Study|Withdrawal of Consent|1|||
156423657|NCT01511250|564643061|FG008|Overall Study|Withdrawal of Consent|1|||
156423658|NCT01511250|564643062|FG009|Overall Study|Withdrawal of Consent|0|||
156423659|NCT01511250|564643053|FG000|Overall Study|Sponsor/Investigator Decision|1|||
156423660|NCT01511250|564643054|FG001|Overall Study|Sponsor/Investigator Decision|0|||
156321257|NCT03150485|564274988|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
156321258|NCT03150485|564274989|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
156321259|NCT01394718|564274991|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
156321260|NCT01394718|564274992|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
156321261|NCT00096954|564274995|FG000|Overall Study|Adverse Event|3|||
156321262|NCT00096954|564274996|FG001|Overall Study|Adverse Event|1|||
156321263|NCT00096954|564274995|FG000|Overall Study|Withdrawal by Subject|9|||
156321264|NCT00096954|564274996|FG001|Overall Study|Withdrawal by Subject|8|||
156321265|NCT00096954|564274995|FG000|Overall Study|Physician Decision|1|||
156321266|NCT00096954|564274996|FG001|Overall Study|Physician Decision|1|||
156321267|NCT00096954|564274995|FG000|Overall Study|Sponsors Decision|1|||
156321268|NCT00096954|564274996|FG001|Overall Study|Sponsors Decision|1|||
156321269|NCT00096954|564274995|FG000|Overall Study|Pregnancy|1|||
156321270|NCT00096954|564274996|FG001|Overall Study|Pregnancy|1|||
156321271|NCT00096954|564274995|FG000|Overall Study|Initiation of immunotherapy|1|||
156321272|NCT00096954|564274996|FG001|Overall Study|Initiation of immunotherapy|0|||
156321273|NCT00096954|564274995|FG000|Overall Study|Non-compliance|0|||
156321274|NCT00096954|564274996|FG001|Overall Study|Non-compliance|3|||
156321275|NCT00096954|564274995|FG000|Overall Study|Lost to Follow-up|8|||
156321276|NCT00096954|564274996|FG001|Overall Study|Lost to Follow-up|5|||
156321277|NCT04478123|564274997|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
156321278|NCT04478123|564274997|FG000|Overall Study|NE|1|||
156321279|NCT02395016|564274998|FG000|Overall Study|Adverse Event|4|||
156321280|NCT02395016|564274999|FG001|Overall Study|Adverse Event|3|||
156321281|NCT02395016|564274998|FG000|Overall Study|Withdrawal by Subject|9|||
156321282|NCT02395016|564274999|FG001|Overall Study|Withdrawal by Subject|6|||
156321283|NCT02395016|564274998|FG000|Overall Study|Protocol Violation|2|||
156321284|NCT02395016|564274999|FG001|Overall Study|Protocol Violation|3|||
156321285|NCT01547780|564275000|FG000|Baseline PET Scan|Physician Decision|1|||
156321286|NCT01547780|564275001|FG001|Baseline PET Scan|Physician Decision|0|||
156321287|NCT01547780|564275002|FG002|Baseline PET Scan|Physician Decision|1|||
156321288|NCT01547780|564275003|FG003|Baseline PET Scan|Physician Decision|0|||
156321289|NCT01547780|564275000|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
156321290|NCT01547780|564275001|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
156321291|NCT01547780|564275002|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
156321292|NCT01547780|564275003|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
156321293|NCT00814879|564275005|FG000|By Week 24|Cancer Diagnosis|1|||
156321294|NCT00814879|564275006|FG001|By Week 24|Cancer Diagnosis|0|||
156321295|NCT00814879|564275005|FG000|By Week 24|Incarceration|0|||
156321296|NCT00814879|564275006|FG001|By Week 24|Incarceration|1|||
156321297|NCT00814879|564275005|FG000|By Week 48|Lost to Follow-up|2|||
156321298|NCT00814879|564275006|FG001|By Week 48|Lost to Follow-up|2|||
156321299|NCT00814879|564275005|FG000|By Week 48|Death|0|||
156321300|NCT00814879|564275006|FG001|By Week 48|Death|1|||
156321301|NCT00588952|564275007|FG000|Overall Study|Adverse Event|0|||
156321302|NCT00588952|564275008|FG001|Overall Study|Adverse Event|2|||
156321303|NCT00588952|564275007|FG000|Overall Study|Withdrawal by Subject|3|||
156321304|NCT00588952|564275008|FG001|Overall Study|Withdrawal by Subject|5|||
156321305|NCT01461057|564275009|FG000|Overall Study|Death|10|||
156321306|NCT01461057|564275010|FG001|Overall Study|Death|9|||
156321307|NCT01461057|564275009|FG000|Overall Study|Withdrawal by Subject|2|||
156321308|NCT01461057|564275010|FG001|Overall Study|Withdrawal by Subject|3|||
156321309|NCT01461057|564275009|FG000|Overall Study|Physician Decision|0|||
156321310|NCT01461057|564275010|FG001|Overall Study|Physician Decision|2|||
156321311|NCT01461057|564275009|FG000|Overall Study|Adverse Event|0|||
156321312|NCT01461057|564275010|FG001|Overall Study|Adverse Event|1|||
156321313|NCT01461057|564275009|FG000|Overall Study|Progression of Disease|1|||
156321314|NCT01461057|564275010|FG001|Overall Study|Progression of Disease|0|||
156321315|NCT01461057|564275009|FG000|Overall Study|Study Terminated by Sponsor|2|||
156321316|NCT01461057|564275010|FG001|Overall Study|Study Terminated by Sponsor|0|||
156321317|NCT01288976|564275011|FG000|Overall Study|Withdrawal by Subject|58|||
156321318|NCT01288976|564275012|FG001|Overall Study|Withdrawal by Subject|12|||
156321319|NCT01288976|564275013|FG002|Overall Study|Withdrawal by Subject|9|||
156321320|NCT01288976|564275011|FG000|Overall Study|Death|98|||
156321321|NCT01288976|564275012|FG001|Overall Study|Death|6|||
156321322|NCT01288976|564275013|FG002|Overall Study|Death|4|||
156321323|NCT01288976|564275011|FG000|Overall Study|Data unavailable|22|||
156321324|NCT01288976|564275012|FG001|Overall Study|Data unavailable|9|||
156321325|NCT01288976|564275013|FG002|Overall Study|Data unavailable|7|||
156321326|NCT04533880|564275014|FG000|Overall Study|Lost to Follow-up|0|||
156321327|NCT04533880|564275015|FG001|Overall Study|Lost to Follow-up|1|||
156321328|NCT04533880|564275016|FG002|Overall Study|Lost to Follow-up|1|||
156321329|NCT02284178|564275017|FG000|Overall Study|Met exclusion criteria|49|||
156321330|NCT02284178|564275018|FG001|Overall Study|Met exclusion criteria|54|||
156321331|NCT04123665|564275019|FG000|Overall Study|Withdrawal by Subject|7|||
156321332|NCT04123665|564275020|FG001|Overall Study|Withdrawal by Subject|0|||
156321333|NCT04123665|564275019|FG000|Overall Study|Lost to Follow-up|1|||
156321334|NCT04123665|564275020|FG001|Overall Study|Lost to Follow-up|0|||
156321335|NCT01466179|564275021|FG000|Overall Study|Ongoing in core study|2|||
156321336|NCT01466179|564275021|FG000|Overall Study|Physician Decision|46|||
156423661|NCT01511250|564643055|FG002|Overall Study|Sponsor/Investigator Decision|0|||
156423662|NCT01511250|564643056|FG003|Overall Study|Sponsor/Investigator Decision|0|||
156423663|NCT01511250|564643057|FG004|Overall Study|Sponsor/Investigator Decision|0|||
156423664|NCT01511250|564643058|FG005|Overall Study|Sponsor/Investigator Decision|0|||
156423665|NCT01511250|564643059|FG006|Overall Study|Sponsor/Investigator Decision|0|||
156423666|NCT01511250|564643060|FG007|Overall Study|Sponsor/Investigator Decision|0|||
156423667|NCT01511250|564643061|FG008|Overall Study|Sponsor/Investigator Decision|0|||
156423668|NCT01511250|564643062|FG009|Overall Study|Sponsor/Investigator Decision|0|||
156423669|NCT01511250|564643053|FG000|Overall Study|Lost to Follow-up|7|||
156423670|NCT01511250|564643054|FG001|Overall Study|Lost to Follow-up|3|||
156423671|NCT01511250|564643055|FG002|Overall Study|Lost to Follow-up|3|||
156423672|NCT01511250|564643056|FG003|Overall Study|Lost to Follow-up|3|||
156423673|NCT01511250|564643057|FG004|Overall Study|Lost to Follow-up|0|||
156423674|NCT01511250|564643058|FG005|Overall Study|Lost to Follow-up|0|||
156423675|NCT01511250|564643059|FG006|Overall Study|Lost to Follow-up|2|||
156423676|NCT01511250|564643060|FG007|Overall Study|Lost to Follow-up|3|||
156423677|NCT01511250|564643061|FG008|Overall Study|Lost to Follow-up|13|||
156423678|NCT01511250|564643062|FG009|Overall Study|Lost to Follow-up|5|||
156423679|NCT01511250|564643053|FG000|Overall Study|Protocol Violation|0|||
156423680|NCT01511250|564643054|FG001|Overall Study|Protocol Violation|2|||
156423681|NCT01511250|564643055|FG002|Overall Study|Protocol Violation|1|||
156423682|NCT01511250|564643056|FG003|Overall Study|Protocol Violation|0|||
156423683|NCT01511250|564643057|FG004|Overall Study|Protocol Violation|0|||
156423684|NCT01511250|564643058|FG005|Overall Study|Protocol Violation|0|||
156423685|NCT01511250|564643059|FG006|Overall Study|Protocol Violation|0|||
156423686|NCT01511250|564643060|FG007|Overall Study|Protocol Violation|0|||
156423687|NCT01511250|564643061|FG008|Overall Study|Protocol Violation|0|||
156423688|NCT01511250|564643062|FG009|Overall Study|Protocol Violation|0|||
156423689|NCT01763047|564643063|FG000|Period 1|Test Article Not Available|4|||
156423690|NCT01763047|564643064|FG001|Period 1|Test Article Not Available|1|||
156423691|NCT01763047|564643063|FG000|Period 1|Protocol Violation|4|||
156423692|NCT01763047|564643064|FG001|Period 1|Protocol Violation|4|||
156423693|NCT01763047|564643063|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
156423694|NCT01763047|564643064|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
156423695|NCT01763047|564643063|FG000|Period 1|Adverse Event|0|||
156423696|NCT01763047|564643064|FG001|Period 1|Adverse Event|1|||
156423697|NCT01763047|564643063|FG000|Period 1|Unsatisfactory Visual Response|0|||
156423698|NCT01763047|564643064|FG001|Period 1|Unsatisfactory Visual Response|3|||
156423699|NCT01763047|564643063|FG000|Period 1|Lens Power Not Available|0|||
156423700|NCT01763047|564643064|FG001|Period 1|Lens Power Not Available|1|||
156423701|NCT01763047|564643063|FG000|Period 1|Study Site office Closed|0|||
156423702|NCT01763047|564643064|FG001|Period 1|Study Site office Closed|1|||
156423703|NCT01763047|564643063|FG000|Period 2|Lens Discomfort|1|||
156423704|NCT01763047|564643064|FG001|Period 2|Lens Discomfort|0|||
156423705|NCT01763047|564643063|FG000|Period 2|No longer meets Eligibility Criteria|1|||
156423706|NCT01763047|564643064|FG001|Period 2|No longer meets Eligibility Criteria|0|||
156423707|NCT01763047|564643063|FG000|Period 2|Study Site office Closed|1|||
156423708|NCT01763047|564643064|FG001|Period 2|Study Site office Closed|1|||
156423709|NCT01763047|564643063|FG000|Period 2|Unsatisfactory Visual Response|1|||
156423710|NCT01763047|564643064|FG001|Period 2|Unsatisfactory Visual Response|1|||
156423711|NCT01763047|564643063|FG000|Period 2|Protocol Violation|0|||
156423712|NCT01763047|564643064|FG001|Period 2|Protocol Violation|2|||
156423713|NCT01763047|564643063|FG000|Period 2|Unsatisfactory lens Fitting|0|||
156423714|NCT01763047|564643064|FG001|Period 2|Unsatisfactory lens Fitting|1|||
156423715|NCT01941316|564643070|FG000|Overall Study|Adverse Event|0|||
156423716|NCT01941316|564643071|FG001|Overall Study|Adverse Event|1|||
156423717|NCT01941316|564643072|FG002|Overall Study|Adverse Event|0|||
156423718|NCT01941316|564643073|FG003|Overall Study|Adverse Event|7|||
156423719|NCT01941316|564643070|FG000|Overall Study|Progressive Disease|3|||
156423720|NCT01941316|564643071|FG001|Overall Study|Progressive Disease|6|||
156423721|NCT01941316|564643072|FG002|Overall Study|Progressive Disease|2|||
156423722|NCT01941316|564643073|FG003|Overall Study|Progressive Disease|29|||
156423723|NCT01941316|564643070|FG000|Overall Study|Withdrawal by Subject|0|||
156423724|NCT01941316|564643071|FG001|Overall Study|Withdrawal by Subject|2|||
156423725|NCT01941316|564643072|FG002|Overall Study|Withdrawal by Subject|1|||
156423726|NCT01941316|564643073|FG003|Overall Study|Withdrawal by Subject|8|||
156423727|NCT01941316|564643070|FG000|Overall Study|Death|0|||
156423728|NCT01941316|564643071|FG001|Overall Study|Death|0|||
156423729|NCT01941316|564643072|FG002|Overall Study|Death|0|||
156423730|NCT01941316|564643073|FG003|Overall Study|Death|3|||
156423731|NCT01941316|564643070|FG000|Overall Study|Physician Decision|0|||
156423732|NCT01941316|564643071|FG001|Overall Study|Physician Decision|0|||
156423733|NCT01941316|564643072|FG002|Overall Study|Physician Decision|0|||
156423734|NCT01941316|564643073|FG003|Overall Study|Physician Decision|3|||
156423735|NCT01941316|564643070|FG000|Overall Study|Protocol Violation|0|||
156423736|NCT01941316|564643071|FG001|Overall Study|Protocol Violation|0|||
156423737|NCT01941316|564643072|FG002|Overall Study|Protocol Violation|0|||
156423738|NCT01941316|564643073|FG003|Overall Study|Protocol Violation|3|||
156423739|NCT01941316|564643070|FG000|Overall Study|Intercurrent illness|0|||
156423740|NCT01941316|564643071|FG001|Overall Study|Intercurrent illness|0|||
156423741|NCT01941316|564643072|FG002|Overall Study|Intercurrent illness|0|||
156423742|NCT01941316|564643073|FG003|Overall Study|Intercurrent illness|1|||
156423743|NCT01941316|564643070|FG000|Overall Study|Other, not specified|0|||
156423744|NCT01941316|564643071|FG001|Overall Study|Other, not specified|0|||
156423745|NCT01941316|564643072|FG002|Overall Study|Other, not specified|0|||
156423746|NCT01941316|564643073|FG003|Overall Study|Other, not specified|1|||
156423747|NCT02775435|564643074|FG000|Overall Study|Adverse Event|32|||
156423748|NCT02775435|564643075|FG001|Overall Study|Adverse Event|27|||
156423749|NCT02775435|564643074|FG000|Overall Study|Lost to Follow-up|2|||
156423750|NCT02775435|564643075|FG001|Overall Study|Lost to Follow-up|2|||
156423751|NCT02775435|564643074|FG000|Overall Study|Sponsor decision|44|||
156423752|NCT02775435|564643075|FG001|Overall Study|Sponsor decision|19|||
156423753|NCT02775435|564643074|FG000|Overall Study|Withdrawal by Subject|4|||
156423754|NCT02775435|564643075|FG001|Overall Study|Withdrawal by Subject|9|||
156423755|NCT02775435|564643074|FG000|Overall Study|Death|196|||
156423756|NCT02775435|564643075|FG001|Overall Study|Death|224|||
156423757|NCT02282527|564643076|FG000|Overall Study|Lost to Follow-up|0|||
156423758|NCT02282527|564643077|FG001|Overall Study|Lost to Follow-up|1|||
156423759|NCT02282527|564643076|FG000|Overall Study|Lack of home health aid|1|||
156423760|NCT02282527|564643077|FG001|Overall Study|Lack of home health aid|0|||
156423761|NCT00941031|564643078|FG000|Induction Period|Lack of Efficacy|2|||
156423762|NCT00941031|564643079|FG001|Induction Period|Lack of Efficacy|1|||
156423763|NCT00941031|564643080|FG002|Induction Period|Lack of Efficacy|0|||
156423764|NCT00941031|564643081|FG003|Induction Period|Lack of Efficacy|5|||
156423765|NCT00941031|564643082|FG004|Induction Period|Lack of Efficacy|0|||
156423766|NCT00941031|564643083|FG005|Induction Period|Lack of Efficacy|0|||
156423767|NCT00941031|564643084|FG006|Induction Period|Lack of Efficacy|0|||
156423768|NCT00941031|564643078|FG000|Induction Period|Withdrawal by Subject|1|||
156423769|NCT00941031|564643079|FG001|Induction Period|Withdrawal by Subject|2|||
156423770|NCT00941031|564643080|FG002|Induction Period|Withdrawal by Subject|2|||
156423771|NCT00941031|564643081|FG003|Induction Period|Withdrawal by Subject|2|||
156423772|NCT00941031|564643082|FG004|Induction Period|Withdrawal by Subject|0|||
156423773|NCT00941031|564643083|FG005|Induction Period|Withdrawal by Subject|0|||
156423774|NCT00941031|564643084|FG006|Induction Period|Withdrawal by Subject|0|||
156423775|NCT00941031|564643078|FG000|Induction Period|Adminstative Problems|1|||
156423776|NCT00941031|564643079|FG001|Induction Period|Adminstative Problems|1|||
156423777|NCT00941031|564643080|FG002|Induction Period|Adminstative Problems|1|||
156423778|NCT00941031|564643081|FG003|Induction Period|Adminstative Problems|0|||
156423779|NCT00941031|564643082|FG004|Induction Period|Adminstative Problems|0|||
156423780|NCT00941031|564643083|FG005|Induction Period|Adminstative Problems|0|||
156423781|NCT00941031|564643084|FG006|Induction Period|Adminstative Problems|0|||
156423782|NCT00941031|564643078|FG000|Induction Period|Adverse Event|1|||
156423783|NCT00941031|564643079|FG001|Induction Period|Adverse Event|0|||
156423784|NCT00941031|564643080|FG002|Induction Period|Adverse Event|3|||
156423785|NCT00941031|564643081|FG003|Induction Period|Adverse Event|2|||
156423786|NCT00941031|564643082|FG004|Induction Period|Adverse Event|0|||
156423787|NCT00941031|564643083|FG005|Induction Period|Adverse Event|0|||
156423788|NCT00941031|564643084|FG006|Induction Period|Adverse Event|0|||
156423789|NCT00941031|564643078|FG000|Maintenance Period|Withdrawal by Subject|0|||
156423790|NCT00941031|564643079|FG001|Maintenance Period|Withdrawal by Subject|0|||
156423791|NCT00941031|564643080|FG002|Maintenance Period|Withdrawal by Subject|0|||
156423792|NCT00941031|564643081|FG003|Maintenance Period|Withdrawal by Subject|0|||
156423793|NCT00941031|564643082|FG004|Maintenance Period|Withdrawal by Subject|6|||
156423794|NCT00941031|564643083|FG005|Maintenance Period|Withdrawal by Subject|2|||
156423795|NCT00941031|564643084|FG006|Maintenance Period|Withdrawal by Subject|13|||
156423796|NCT00941031|564643078|FG000|Maintenance Period|Administrative Problems|0|||
156423797|NCT00941031|564643079|FG001|Maintenance Period|Administrative Problems|0|||
156423798|NCT00941031|564643080|FG002|Maintenance Period|Administrative Problems|0|||
156423799|NCT00941031|564643081|FG003|Maintenance Period|Administrative Problems|0|||
156423800|NCT00941031|564643082|FG004|Maintenance Period|Administrative Problems|1|||
156423801|NCT00941031|564643083|FG005|Maintenance Period|Administrative Problems|0|||
156423802|NCT00941031|564643084|FG006|Maintenance Period|Administrative Problems|1|||
156423803|NCT00941031|564643078|FG000|Maintenance Period|Protocol Violation|0|||
156423804|NCT00941031|564643079|FG001|Maintenance Period|Protocol Violation|0|||
156423805|NCT00941031|564643080|FG002|Maintenance Period|Protocol Violation|0|||
156423806|NCT00941031|564643081|FG003|Maintenance Period|Protocol Violation|0|||
156423807|NCT00941031|564643082|FG004|Maintenance Period|Protocol Violation|0|||
156423808|NCT00941031|564643083|FG005|Maintenance Period|Protocol Violation|0|||
156423809|NCT00941031|564643084|FG006|Maintenance Period|Protocol Violation|1|||
156423810|NCT00941031|564643078|FG000|Maintenance Period|Adverse Event|0|||
156423811|NCT00941031|564643079|FG001|Maintenance Period|Adverse Event|0|||
156423812|NCT00941031|564643080|FG002|Maintenance Period|Adverse Event|0|||
156423813|NCT00941031|564643081|FG003|Maintenance Period|Adverse Event|0|||
156423814|NCT00941031|564643082|FG004|Maintenance Period|Adverse Event|0|||
156423815|NCT00941031|564643083|FG005|Maintenance Period|Adverse Event|2|||
156423816|NCT00941031|564643084|FG006|Maintenance Period|Adverse Event|8|||
156423817|NCT00941031|564643078|FG000|Maintenance Period|Lost to Follow-up|0|||
156423818|NCT00941031|564643079|FG001|Maintenance Period|Lost to Follow-up|0|||
156423819|NCT00941031|564643080|FG002|Maintenance Period|Lost to Follow-up|0|||
156423820|NCT00941031|564643081|FG003|Maintenance Period|Lost to Follow-up|0|||
156423821|NCT00941031|564643082|FG004|Maintenance Period|Lost to Follow-up|2|||
156423822|NCT00941031|564643083|FG005|Maintenance Period|Lost to Follow-up|2|||
156423823|NCT00941031|564643084|FG006|Maintenance Period|Lost to Follow-up|7|||
156423824|NCT00941031|564643078|FG000|Maintenance Period|Lack of Efficacy|0|||
156423825|NCT00941031|564643079|FG001|Maintenance Period|Lack of Efficacy|0|||
156423826|NCT00941031|564643080|FG002|Maintenance Period|Lack of Efficacy|0|||
156423827|NCT00941031|564643081|FG003|Maintenance Period|Lack of Efficacy|0|||
156423828|NCT00941031|564643082|FG004|Maintenance Period|Lack of Efficacy|0|||
156423829|NCT00941031|564643083|FG005|Maintenance Period|Lack of Efficacy|0|||
156423830|NCT00941031|564643084|FG006|Maintenance Period|Lack of Efficacy|13|||
156423831|NCT04555044|564643087|FG000|Overall Study|Adverse Event|0|||
156423832|NCT04555044|564643088|FG001|Overall Study|Adverse Event|1|||
156423833|NCT00631917|564643090|FG000|Overall Study|Adverse Event|34|||
156423834|NCT00631917|564643091|FG001|Overall Study|Adverse Event|45|||
156423835|NCT00631917|564643090|FG000|Overall Study|Abnormal laboratory value(s)|2|||
156423836|NCT00631917|564643091|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156423837|NCT00631917|564643090|FG000|Overall Study|Abnormal test procedure result(s)|3|||
156423838|NCT00631917|564643091|FG001|Overall Study|Abnormal test procedure result(s)|2|||
156423839|NCT00631917|564643090|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
156423840|NCT00631917|564643091|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
156423841|NCT00631917|564643090|FG000|Overall Study|No longer required study drug|0|||
156423842|NCT00631917|564643091|FG001|Overall Study|No longer required study drug|1|||
156423843|NCT00631917|564643090|FG000|Overall Study|Protocol deviation|6|||
156423844|NCT00631917|564643091|FG001|Overall Study|Protocol deviation|5|||
156423845|NCT00631917|564643090|FG000|Overall Study|Subject withdrew consent|25|||
156423846|NCT00631917|564643091|FG001|Overall Study|Subject withdrew consent|33|||
156423847|NCT00631917|564643090|FG000|Overall Study|Lost to Follow-up|7|||
156423848|NCT00631917|564643091|FG001|Overall Study|Lost to Follow-up|7|||
156423849|NCT00631917|564643090|FG000|Overall Study|Administrative problems|2|||
156423850|NCT00631917|564643091|FG001|Overall Study|Administrative problems|0|||
156423851|NCT00631917|564643090|FG000|Overall Study|Death|1|||
156423852|NCT00631917|564643091|FG001|Overall Study|Death|0|||
156423853|NCT01767909|564643094|FG000|Overall Study|Withdrawal by Subject|4|||
156423854|NCT01767909|564643095|FG001|Overall Study|Withdrawal by Subject|7|||
156423855|NCT01767909|564643094|FG000|Overall Study|Adverse Event|3|||
156423856|NCT01767909|564643095|FG001|Overall Study|Adverse Event|1|||
156423857|NCT01767909|564643094|FG000|Overall Study|Withdrawal by Study Partner|3|||
156423858|NCT01767909|564643095|FG001|Overall Study|Withdrawal by Study Partner|1|||
156423859|NCT01767909|564643094|FG000|Overall Study|Non-Compliance|2|||
156423860|NCT01767909|564643095|FG001|Overall Study|Non-Compliance|0|||
156423861|NCT01767909|564643094|FG000|Overall Study|Perceived Lack of Efficacy|1|||
156423862|NCT01767909|564643095|FG001|Overall Study|Perceived Lack of Efficacy|0|||
156423863|NCT01767909|564643094|FG000|Overall Study|Investigator Recommendation|0|||
156423864|NCT01767909|564643095|FG001|Overall Study|Investigator Recommendation|1|||
156423865|NCT01767909|564643094|FG000|Overall Study|Lost to Follow-up|0|||
156423866|NCT01767909|564643095|FG001|Overall Study|Lost to Follow-up|1|||
156423867|NCT01767909|564643094|FG000|Overall Study|LP uncessessful|0|||
156423868|NCT01767909|564643095|FG001|Overall Study|LP uncessessful|1|||
156423869|NCT02431533|564643102|FG000|Overall Study|Withdrawal by Subject|1|||
156423870|NCT02431533|564643103|FG001|Overall Study|Withdrawal by Subject|3|||
156423871|NCT02431533|564643102|FG000|Overall Study|Developed Exclusionary criteria|1|||
156423872|NCT02431533|564643103|FG001|Overall Study|Developed Exclusionary criteria|0|||
156423873|NCT02320253|564643104|FG000|Overall Study|Withdrawal by Subject|3|||
156423874|NCT02320253|564643105|FG001|Overall Study|Withdrawal by Subject|0|||
156423875|NCT02320253|564643106|FG002|Overall Study|Withdrawal by Subject|0|||
156423876|NCT02320253|564643104|FG000|Overall Study|Lost to Follow-up|2|||
156423877|NCT02320253|564643105|FG001|Overall Study|Lost to Follow-up|2|||
156423878|NCT02320253|564643106|FG002|Overall Study|Lost to Follow-up|1|||
156423879|NCT02320253|564643104|FG000|Overall Study|Death|1|||
156423880|NCT02320253|564643105|FG001|Overall Study|Death|0|||
156423881|NCT02320253|564643106|FG002|Overall Study|Death|1|||
156423882|NCT05780047|564643107|FG000|Overall Study|Did not submit baseline urine test kit|226|||
156423883|NCT05780047|564643107|FG000|Overall Study|Lost to Follow-up|34|||
156423884|NCT05780047|564643107|FG000|Overall Study|Did not submit second urine test kit|124|||
156423885|NCT03115346|564643116|FG000|Overall Study|Did not have AAA surgery|28|||
156423886|NCT03115346|564643117|FG001|Overall Study|Did not have AAA surgery|15|||
156423887|NCT03115346|564643116|FG000|Overall Study|Death|3|||
156423888|NCT03115346|564643117|FG001|Overall Study|Death|1|||
156423889|NCT03115346|564643116|FG000|Overall Study|Withdrawal by Subject|0|||
156423890|NCT03115346|564643117|FG001|Overall Study|Withdrawal by Subject|3|||
156423891|NCT03115346|564643116|FG000|Overall Study|Lost to Follow-up|0|||
156423892|NCT03115346|564643117|FG001|Overall Study|Lost to Follow-up|3|||
156423893|NCT01737268|564643119|FG000|Overall Study|Adverse Event|6|||
156321337|NCT01466179|564275021|FG000|Overall Study|Progressive disease|43|||
156321338|NCT01466179|564275021|FG000|Overall Study|Adverse Event|32|||
156321339|NCT01466179|564275021|FG000|Overall Study|Disease relapse|23|||
156321340|NCT01466179|564275021|FG000|Overall Study|Lack of Efficacy|14|||
156321341|NCT01466179|564275021|FG000|Overall Study|Death|7|||
156321342|NCT01466179|564275021|FG000|Overall Study|Withdrawal by Subject|7|||
156321343|NCT01466179|564275021|FG000|Overall Study|Protocol Violation|2|||
156321344|NCT01466179|564275021|FG000|Overall Study|Other|3|||
156321345|NCT00930982|564275022|FG000|Overall Study|Adverse Event|19|||
156321346|NCT00930982|564275023|FG001|Overall Study|Adverse Event|23|||
156321347|NCT00930982|564275022|FG000|Overall Study|Protocol Violation|1|||
156321348|NCT00930982|564275023|FG001|Overall Study|Protocol Violation|5|||
156321349|NCT00930982|564275022|FG000|Overall Study|Withdrawal by Subject|1|||
156321350|NCT00930982|564275023|FG001|Overall Study|Withdrawal by Subject|1|||
156321351|NCT00991952|564275024|FG000|Overall Study|Adverse Event|0|||
156321352|NCT00991952|564275025|FG001|Overall Study|Adverse Event|1|||
156321353|NCT02522871|564275026|FG000|Overall Study|Protocol Violation|1|||
156321354|NCT02522871|564275027|FG001|Overall Study|Protocol Violation|4|||
156321355|NCT02522871|564275026|FG000|Overall Study|Treated without randomization|1|||
156321356|NCT02522871|564275027|FG001|Overall Study|Treated without randomization|0|||
156321357|NCT02522871|564275026|FG000|Overall Study|Death|9|||
156321358|NCT02522871|564275027|FG001|Overall Study|Death|9|||
156321359|NCT02522871|564275026|FG000|Overall Study|Died in operating room prior to transplant|0|||
156321360|NCT02522871|564275027|FG001|Overall Study|Died in operating room prior to transplant|1|||
156321361|NCT00509262|564275028|FG000|Overall Study|Adverse Event|16|||
156321362|NCT00509262|564275029|FG001|Overall Study|Adverse Event|18|||
156321363|NCT00509262|564275028|FG000|Overall Study|Other|2|||
156321364|NCT00509262|564275029|FG001|Overall Study|Other|2|||
156321365|NCT00509262|564275028|FG000|Overall Study|Lack of Efficacy|1|||
156321366|NCT00509262|564275029|FG001|Overall Study|Lack of Efficacy|0|||
156321367|NCT00509262|564275028|FG000|Overall Study|Lost to Follow-up|1|||
156321368|NCT00509262|564275029|FG001|Overall Study|Lost to Follow-up|6|||
156321369|NCT00509262|564275028|FG000|Overall Study|Physician Decision|1|||
156321370|NCT00509262|564275029|FG001|Overall Study|Physician Decision|3|||
156321371|NCT00509262|564275028|FG000|Overall Study|Protocol Violation|2|||
156321372|NCT00509262|564275029|FG001|Overall Study|Protocol Violation|2|||
156321373|NCT00509262|564275028|FG000|Overall Study|Withdrawal by Subject|24|||
156321374|NCT00509262|564275029|FG001|Overall Study|Withdrawal by Subject|11|||
156321375|NCT00725842|564275030|FG000|Overall Study|Lost to Follow-up|19|||
156321376|NCT00725842|564275030|FG000|Overall Study|Death|1|||
156321377|NCT00725842|564275030|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
156321378|NCT00725842|564275030|FG000|Overall Study|Consent date prior to study start date|5|||
156321379|NCT00725842|564275030|FG000|Overall Study|Inclusion criterion not met|1|||
156321380|NCT00725842|564275030|FG000|Overall Study|No Visit 1 data|1|||
156321381|NCT01853618|564275031|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
156321382|NCT01853618|564275032|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
156321383|NCT01853618|564275033|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
156321384|NCT01853618|564275034|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
156321385|NCT01853618|564275035|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
156321386|NCT01853618|564275031|FG000|Overall Study|Progressive disease|1|||
156321387|NCT01853618|564275032|FG001|Overall Study|Progressive disease|1|||
156321388|NCT01853618|564275033|FG002|Overall Study|Progressive disease|1|||
156321389|NCT01853618|564275034|FG003|Overall Study|Progressive disease|1|||
156321390|NCT01853618|564275035|FG004|Overall Study|Progressive disease|2|||
156321391|NCT01853618|564275031|FG000|Overall Study|Physician Decision|0|||
156321392|NCT01853618|564275032|FG001|Overall Study|Physician Decision|1|||
156321393|NCT01853618|564275033|FG002|Overall Study|Physician Decision|1|||
156321394|NCT01853618|564275034|FG003|Overall Study|Physician Decision|0|||
156321395|NCT01853618|564275035|FG004|Overall Study|Physician Decision|0|||
156321396|NCT01853618|564275031|FG000|Overall Study|Refused further treatment|0|||
156321397|NCT01853618|564275032|FG001|Overall Study|Refused further treatment|0|||
156321398|NCT01853618|564275033|FG002|Overall Study|Refused further treatment|0|||
156321399|NCT01853618|564275034|FG003|Overall Study|Refused further treatment|0|||
156321400|NCT01853618|564275035|FG004|Overall Study|Refused further treatment|1|||
156321401|NCT02398227|564275042|FG000|Overall Study|Lost to Follow-up|21|||
156321402|NCT02398227|564275043|FG001|Overall Study|Lost to Follow-up|12|||
156321403|NCT02398227|564275042|FG000|Overall Study|Withdrawal by Subject|5|||
156321404|NCT02398227|564275043|FG001|Overall Study|Withdrawal by Subject|6|||
156321405|NCT02398227|564275042|FG000|Overall Study|Removed from treatment and dropped out|1|||
156321406|NCT02398227|564275043|FG001|Overall Study|Removed from treatment and dropped out|0|||
156321407|NCT01715129|564275045|FG000|Overall Study|Adverse Event, fatal|1|||
156321408|NCT01715129|564275045|FG000|Overall Study|Lack of Efficacy|3|||
156321409|NCT01715129|564275045|FG000|Overall Study|Protocol Violation|1|||
156321410|NCT01715129|564275045|FG000|Overall Study|Consent Withdrawn|2|||
156321411|NCT01715129|564275045|FG000|Overall Study|Lost to Follow-up|1|||
156321412|NCT01715129|564275045|FG000|Overall Study|Other|1|||
156321413|NCT02009384|564275046|FG000|Overall Study|Death|2|||
156321414|NCT01146860|564275047|FG000|Overall Study|Withdrawal by Subject|0|||
156423894|NCT01737268|564643119|FG000|Overall Study|Worsening of Target Disease|2|||
156423895|NCT01737268|564643119|FG000|Overall Study|In consideration of the patient's safety|1|||
156423896|NCT02753530|564643120|FG000|Overall Study|Adverse Event|7|||
156423897|NCT02753530|564643121|FG001|Overall Study|Adverse Event|1|||
156423898|NCT02753530|564643120|FG000|Overall Study|Death|0|||
156423899|NCT02753530|564643121|FG001|Overall Study|Death|1|||
156423900|NCT02753530|564643120|FG000|Overall Study|Physician Decision|0|||
156423901|NCT02753530|564643121|FG001|Overall Study|Physician Decision|1|||
156423902|NCT02753530|564643120|FG000|Overall Study|Protocol Violation|1|||
156423903|NCT02753530|564643121|FG001|Overall Study|Protocol Violation|0|||
156423904|NCT02753530|564643120|FG000|Overall Study|Withdrawal by Subject|4|||
156423905|NCT02753530|564643121|FG001|Overall Study|Withdrawal by Subject|3|||
156423906|NCT01221181|564643122|FG000|Overall Study|Lost to Follow-up|1|||
156423907|NCT03369951|564643123|FG000|Overall Study|Withdrawal by Subject|3|||
156423908|NCT03369951|564643123|FG000|Overall Study|Death|1|||
156423909|NCT03369951|564643123|FG000|Overall Study|Lost to Follow-up|1|||
156423910|NCT03369951|564643123|FG000|Overall Study|Protocol Violation|1|||
156423911|NCT01311648|564644826|FG000|Main Study|Protocol Violation|0|||
156423912|NCT01311648|564644827|FG001|Main Study|Protocol Violation|1|||
156423913|NCT01311648|564644826|FG000|Main Study|Adverse Event|0|||
156423914|NCT01311648|564644827|FG001|Main Study|Adverse Event|1|||
156423915|NCT01311648|564644826|FG000|Main Study|Inhibitor management|0|||
156423916|NCT01311648|564644827|FG001|Main Study|Inhibitor management|17|||
156423917|NCT01311648|564644826|FG000|Main Study|Withdrawal by Subject|0|||
156423918|NCT01311648|564644827|FG001|Main Study|Withdrawal by Subject|2|||
156423919|NCT01311648|564644826|FG000|Extension Study|Physician Decision|0|||
156423920|NCT01311648|564644827|FG001|Extension Study|Physician Decision|1|||
156423921|NCT01311648|564644826|FG000|Extension Study|ITI therapy with marketed product|0|||
156423922|NCT01311648|564644827|FG001|Extension Study|ITI therapy with marketed product|1|||
156423923|NCT01311648|564644826|FG000|Extension Study|Incorrect visit planning|0|||
156423924|NCT01311648|564644827|FG001|Extension Study|Incorrect visit planning|1|||
156423925|NCT01311648|564644826|FG000|Extension Study|Family's decision|0|||
156423926|NCT01311648|564644827|FG001|Extension Study|Family's decision|1|||
156423927|NCT01311648|564644826|FG000|Extension Study|Failure of ITI therapy|0|||
156423928|NCT01311648|564644827|FG001|Extension Study|Failure of ITI therapy|3|||
156423929|NCT01311648|564644826|FG000|Extension Study|Long travel|0|||
156423930|NCT01311648|564644827|FG001|Extension Study|Long travel|1|||
156423931|NCT01311648|564644826|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
156423932|NCT01311648|564644827|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
156423933|NCT01311648|564644826|FG000|Extension Study|Withdrawal by Subject|0|||
156423934|NCT01311648|564644827|FG001|Extension Study|Withdrawal by Subject|1|||
156423935|NCT01311648|564644826|FG000|Extension Study|Inhibitor management|0|||
156423936|NCT01311648|564644827|FG001|Extension Study|Inhibitor management|2|||
156423937|NCT01645111|564644828|FG000|Overall Study|Did not require Clevidipine|15|||
156423938|NCT05526911|564644829|FG000|Overall Study|Adverse Event|2|||
156423939|NCT05025449|564644830|FG000|Overall Study|Withdrawal by Subject|1|||
156423940|NCT05025449|564644830|FG000|Overall Study|Patient emergently taken to operating room|1|||
156423941|NCT00587288|564644832|FG000|Overall Study|Adverse Event|0|||
156423942|NCT00587288|564644833|FG001|Overall Study|Adverse Event|1|||
156423943|NCT00587288|564644832|FG000|Overall Study|Lack of Efficacy|2|||
156423944|NCT00587288|564644833|FG001|Overall Study|Lack of Efficacy|8|||
156423945|NCT00587288|564644832|FG000|Overall Study|Protocol Violation|1|||
156423946|NCT00587288|564644833|FG001|Overall Study|Protocol Violation|0|||
156423947|NCT00762463|564644834|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
156423948|NCT00762463|564644835|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
156423949|NCT00762463|564644836|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
156423950|NCT00762463|564644837|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
156423951|NCT00762463|564644834|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
156423952|NCT00762463|564644835|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
156423953|NCT00762463|564644836|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
156423954|NCT00762463|564644837|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
156423955|NCT00762463|564644834|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
156423956|NCT00762463|564644835|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
156423957|NCT00762463|564644836|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
156423958|NCT00762463|564644837|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
156423959|NCT00762463|564644834|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
156423960|NCT00762463|564644835|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
156423961|NCT00762463|564644836|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
156423962|NCT00762463|564644837|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
156423963|NCT00762463|564644834|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
156423964|NCT00762463|564644835|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
156423965|NCT00762463|564644836|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
156423966|NCT00762463|564644837|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
156423967|NCT00762463|564644834|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
156423968|NCT00762463|564644835|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
156423969|NCT00762463|564644836|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
156423970|NCT00762463|564644837|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
156423971|NCT00762463|564644834|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
156423972|NCT00762463|564644835|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
156423973|NCT00762463|564644836|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
156423974|NCT00762463|564644837|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
156423975|NCT00762463|564644834|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
156423976|NCT00762463|564644835|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
156423977|NCT00762463|564644836|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
156423978|NCT00762463|564644837|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
156423979|NCT05074498|564644840|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156423980|NCT05074498|564644841|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156423981|NCT05074498|564644842|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156423982|NCT05074498|564644843|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
156423983|NCT05074498|564644844|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156423984|NCT05074498|564644845|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156423985|NCT05074498|564644840|FG000|Part 1 (Upto Day 104)|Other|1|||
156423986|NCT05074498|564644841|FG001|Part 1 (Upto Day 104)|Other|0|||
156423987|NCT05074498|564644842|FG002|Part 1 (Upto Day 104)|Other|0|||
156423988|NCT05074498|564644843|FG003|Part 1 (Upto Day 104)|Other|0|||
156423989|NCT05074498|564644844|FG004|Part 1 (Upto Day 104)|Other|0|||
156423990|NCT05074498|564644845|FG005|Part 1 (Upto Day 104)|Other|0|||
156423991|NCT05074498|564644840|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156423992|NCT05074498|564644841|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156423993|NCT05074498|564644842|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156423994|NCT05074498|564644843|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156423995|NCT05074498|564644844|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
156423996|NCT05074498|564644845|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156423997|NCT05074498|564644840|FG000|Part 2 (Upto Day 104)|Death|0|||
156423998|NCT05074498|564644841|FG001|Part 2 (Upto Day 104)|Death|0|||
156423999|NCT05074498|564644842|FG002|Part 2 (Upto Day 104)|Death|0|||
156424000|NCT05074498|564644843|FG003|Part 2 (Upto Day 104)|Death|0|||
156424001|NCT05074498|564644844|FG004|Part 2 (Upto Day 104)|Death|1|||
156424002|NCT05074498|564644845|FG005|Part 2 (Upto Day 104)|Death|0|||
156424003|NCT05074498|564644840|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
156424004|NCT05074498|564644841|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
156424005|NCT05074498|564644842|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
156424006|NCT05074498|564644843|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
156424007|NCT05074498|564644844|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
156424008|NCT05074498|564644845|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
156424009|NCT05074498|564644840|FG000|Part 2 (Upto Day 104)|Other|0|||
156424010|NCT05074498|564644841|FG001|Part 2 (Upto Day 104)|Other|0|||
156424011|NCT05074498|564644842|FG002|Part 2 (Upto Day 104)|Other|0|||
156424012|NCT05074498|564644843|FG003|Part 2 (Upto Day 104)|Other|0|||
156424013|NCT05074498|564644844|FG004|Part 2 (Upto Day 104)|Other|1|||
156424014|NCT05074498|564644845|FG005|Part 2 (Upto Day 104)|Other|0|||
156424015|NCT01257503|564644847|FG000|Overall Study|Lost to Follow-up|7|||
156424016|NCT01257503|564644848|FG001|Overall Study|Lost to Follow-up|10|||
156424017|NCT01257503|564644847|FG000|Overall Study|Over 5 years old at enrollment|0|||
156424018|NCT01257503|564644848|FG001|Overall Study|Over 5 years old at enrollment|1|||
156424019|NCT01257503|564644847|FG000|Overall Study|strep culture positive at enrollment|1|||
156424020|NCT01257503|564644848|FG001|Overall Study|strep culture positive at enrollment|0|||
156424021|NCT00088465|564644849|FG000|Overall Study|Withdrawal by Subject|290|||
156424022|NCT00088465|564644849|FG000|Overall Study|Adverse Event|77|||
156424023|NCT00088465|564644849|FG000|Overall Study|Lost to Follow-up|57|||
156424024|NCT00088465|564644849|FG000|Overall Study|Physician Decision|45|||
156424025|NCT00088465|564644849|FG000|Overall Study|Sponsor Decision|37|||
156424026|NCT00088465|564644849|FG000|Overall Study|Lack of Efficacy|27|||
156424027|NCT00088465|564644849|FG000|Overall Study|Protocol Violation|17|||
156424028|NCT00088465|564644849|FG000|Overall Study|Death|11|||
156424029|NCT01390857|564644850|FG000|Overall Study|Protocol Violation|2|||
156424030|NCT01390857|564644850|FG000|Overall Study|Lost to Follow-up|1|||
156424031|NCT01390857|564644850|FG000|Overall Study|No Visit after the First Visit|7|||
156424032|NCT01474538|564644852|FG000|Treatment Period 1|Death|1|||
156424033|NCT01474538|564644853|FG001|Treatment Period 1|Death|0|||
156424034|NCT01474538|564644852|FG000|Treatment Period 1|Physician Decision|1|||
156424035|NCT01474538|564644853|FG001|Treatment Period 1|Physician Decision|0|||
156424036|NCT01474538|564644852|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156424037|NCT01474538|564644853|FG001|Treatment Period 1|Withdrawal by Subject|3|||
156424038|NCT01474538|564644852|FG000|Treatment Period 1|Protocol Violation|0|||
156424039|NCT01474538|564644853|FG001|Treatment Period 1|Protocol Violation|1|||
156424040|NCT01474538|564644852|FG000|Treatment Period 2|Death|1|||
156424041|NCT01474538|564644853|FG001|Treatment Period 2|Death|0|||
156424042|NCT01474538|564644852|FG000|Treatment Period 2|Adverse Event|1|||
156424043|NCT01474538|564644853|FG001|Treatment Period 2|Adverse Event|1|||
156424044|NCT01474538|564644852|FG000|Treatment Period 2|Withdrawal by Subject|2|||
156424045|NCT01474538|564644853|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156424046|NCT01474538|564644852|FG000|Treatment Period 2|Sponsor decision|1|||
156424047|NCT01474538|564644853|FG001|Treatment Period 2|Sponsor decision|0|||
156424048|NCT01474538|564644852|FG000|Treatment Period 2|Physician Decision|0|||
156424049|NCT01474538|564644853|FG001|Treatment Period 2|Physician Decision|1|||
156424050|NCT01474538|564644852|FG000|Treatment Period 2|Protocol Violation|1|||
156424051|NCT01474538|564644853|FG001|Treatment Period 2|Protocol Violation|0|||
156424052|NCT00367237|564644854|FG000|Overall Study|Adverse Event|7|||
156424053|NCT00367237|564644855|FG001|Overall Study|Adverse Event|2|||
156424054|NCT00367237|564644854|FG000|Overall Study|Lost to Follow-up|1|||
156424055|NCT00367237|564644855|FG001|Overall Study|Lost to Follow-up|0|||
156424056|NCT00367237|564644854|FG000|Overall Study|Withdrawal by Subject|0|||
156424057|NCT00367237|564644855|FG001|Overall Study|Withdrawal by Subject|4|||
156424058|NCT00367237|564644854|FG000|Overall Study|Protocol Violation|2|||
156424059|NCT00367237|564644855|FG001|Overall Study|Protocol Violation|5|||
156424060|NCT02501629|564644856|FG000|Overall Study|Death|0|||
156424061|NCT02501629|564644857|FG001|Overall Study|Death|1|||
156424062|NCT02501629|564644856|FG000|Overall Study|Withdrawn from study by sponsor|1|||
156424063|NCT02501629|564644857|FG001|Overall Study|Withdrawn from study by sponsor|0|||
156424064|NCT02501629|564644856|FG000|Overall Study|Early termination by sponsor|1|||
156424065|NCT02501629|564644857|FG001|Overall Study|Early termination by sponsor|0|||
156424066|NCT02501629|564644856|FG000|Overall Study|Withdrawal by Subject|3|||
156424067|NCT02501629|564644857|FG001|Overall Study|Withdrawal by Subject|5|||
156424068|NCT02501629|564644856|FG000|Overall Study|Subject did not return to site|0|||
156424069|NCT02501629|564644857|FG001|Overall Study|Subject did not return to site|1|||
156424070|NCT03120676|564644860|FG000|Overall Study|Not treated|1|||
156424071|NCT00886613|564644865|FG000|Overall Study|Protocol deviation (Part B)|1|||
156424072|NCT00886613|564644866|FG001|Overall Study|Protocol deviation (Part B)|0|||
156424073|NCT00886613|564644867|FG002|Overall Study|Protocol deviation (Part B)|0|||
156424074|NCT00886613|564644865|FG000|Overall Study|Lost to follow-up (Part B)|1|||
156424075|NCT00886613|564644866|FG001|Overall Study|Lost to follow-up (Part B)|0|||
156424076|NCT00886613|564644867|FG002|Overall Study|Lost to follow-up (Part B)|1|||
156424077|NCT00886613|564644865|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
156424078|NCT00886613|564644866|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
156424079|NCT00886613|564644867|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
156424080|NCT01289119|564644871|FG000|Overall Study|Adverse Event|2|||
156424081|NCT01289119|564644872|FG001|Overall Study|Adverse Event|1|||
156424082|NCT01289119|564644873|FG002|Overall Study|Adverse Event|0|||
156424083|NCT01289119|564644874|FG003|Overall Study|Adverse Event|2|||
156424084|NCT01289119|564644875|FG004|Overall Study|Adverse Event|1|||
156424085|NCT01289119|564644876|FG005|Overall Study|Adverse Event|0|||
156424086|NCT01289119|564644871|FG000|Overall Study|Major Protocol Deviation|2|||
156424087|NCT01289119|564644872|FG001|Overall Study|Major Protocol Deviation|1|||
156424088|NCT01289119|564644873|FG002|Overall Study|Major Protocol Deviation|3|||
156424089|NCT01289119|564644874|FG003|Overall Study|Major Protocol Deviation|0|||
156424090|NCT01289119|564644875|FG004|Overall Study|Major Protocol Deviation|2|||
156424091|NCT01289119|564644876|FG005|Overall Study|Major Protocol Deviation|1|||
156424092|NCT01289119|564644871|FG000|Overall Study|Lost to Follow-up|0|||
156424093|NCT01289119|564644872|FG001|Overall Study|Lost to Follow-up|3|||
156424094|NCT01289119|564644873|FG002|Overall Study|Lost to Follow-up|0|||
156424095|NCT01289119|564644874|FG003|Overall Study|Lost to Follow-up|0|||
156424096|NCT01289119|564644875|FG004|Overall Study|Lost to Follow-up|0|||
156424097|NCT01289119|564644876|FG005|Overall Study|Lost to Follow-up|1|||
156424098|NCT01289119|564644871|FG000|Overall Study|Withdrawal by Subject|4|||
156424099|NCT01289119|564644872|FG001|Overall Study|Withdrawal by Subject|2|||
156424100|NCT01289119|564644873|FG002|Overall Study|Withdrawal by Subject|4|||
156424101|NCT01289119|564644874|FG003|Overall Study|Withdrawal by Subject|3|||
156424102|NCT01289119|564644875|FG004|Overall Study|Withdrawal by Subject|1|||
156424103|NCT01289119|564644876|FG005|Overall Study|Withdrawal by Subject|1|||
156424104|NCT01289119|564644871|FG000|Overall Study|Pregnancy|0|||
156424105|NCT01289119|564644872|FG001|Overall Study|Pregnancy|1|||
156424106|NCT01289119|564644873|FG002|Overall Study|Pregnancy|0|||
156424107|NCT01289119|564644874|FG003|Overall Study|Pregnancy|0|||
156424108|NCT01289119|564644875|FG004|Overall Study|Pregnancy|0|||
156424109|NCT01289119|564644876|FG005|Overall Study|Pregnancy|0|||
156424110|NCT01289119|564644871|FG000|Overall Study|Lack of Efficacy|0|||
156424111|NCT01289119|564644872|FG001|Overall Study|Lack of Efficacy|1|||
156424112|NCT01289119|564644873|FG002|Overall Study|Lack of Efficacy|1|||
156424113|NCT01289119|564644874|FG003|Overall Study|Lack of Efficacy|1|||
156424114|NCT01289119|564644875|FG004|Overall Study|Lack of Efficacy|1|||
156424115|NCT01289119|564644876|FG005|Overall Study|Lack of Efficacy|1|||
156424116|NCT01289119|564644871|FG000|Overall Study|Other|1|||
156424117|NCT01289119|564644872|FG001|Overall Study|Other|0|||
156424118|NCT01289119|564644873|FG002|Overall Study|Other|1|||
156424119|NCT01289119|564644874|FG003|Overall Study|Other|0|||
156424120|NCT01289119|564644875|FG004|Overall Study|Other|0|||
156424121|NCT01289119|564644876|FG005|Overall Study|Other|0|||
156424122|NCT01704846|564644877|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156424123|NCT01704846|564644878|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156424124|NCT00530335|564644881|FG000|Overall Study|Adverse Event|3|||
156424125|NCT00530335|564644881|FG000|Overall Study|Protocol Violation|1|||
156424126|NCT00530335|564644881|FG000|Overall Study|Withdrawal by Subject|1|||
156424127|NCT00530335|564644881|FG000|Overall Study|Physician Decision|1|||
156424128|NCT01244984|564644883|FG000|Overall Study|Adverse Event|2|||
156424129|NCT01244984|564644884|FG001|Overall Study|Adverse Event|11|||
156424130|NCT01244984|564644885|FG002|Overall Study|Adverse Event|2|||
156424131|NCT01244984|564644883|FG000|Overall Study|Protocol Violation|1|||
156424132|NCT01244984|564644884|FG001|Overall Study|Protocol Violation|0|||
156424133|NCT01244984|564644885|FG002|Overall Study|Protocol Violation|0|||
156424134|NCT01244984|564644883|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
156424135|NCT01244984|564644884|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
156424136|NCT01244984|564644885|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
156424137|NCT01244984|564644883|FG000|Overall Study|Withdrawal by Subject|1|||
156424138|NCT01244984|564644884|FG001|Overall Study|Withdrawal by Subject|2|||
156424139|NCT01244984|564644885|FG002|Overall Study|Withdrawal by Subject|2|||
156424140|NCT04577183|564644886|FG000|Overall Study|Death|1|||
156424141|NCT04577183|564644886|FG000|Overall Study|Withdrawal by Subject|3|||
156424142|NCT04577183|564644886|FG000|Overall Study|Early termination|2|||
156424143|NCT00672256|564644892|FG000|Overall Study|PI dropped, bad data|44|||
156424144|NCT00691028|564644893|FG000|Open-label Period|Adverse Event|0|||
156424145|NCT00691028|564644894|FG001|Open-label Period|Adverse Event|0|||
156424146|NCT00691028|564644895|FG002|Open-label Period|Adverse Event|0|||
156424147|NCT00691028|564644896|FG003|Open-label Period|Adverse Event|16|||
156424148|NCT00691028|564644893|FG000|Open-label Period|Withdrawal by Subject|0|||
156424149|NCT00691028|564644894|FG001|Open-label Period|Withdrawal by Subject|0|||
156424150|NCT00691028|564644895|FG002|Open-label Period|Withdrawal by Subject|0|||
156424151|NCT00691028|564644896|FG003|Open-label Period|Withdrawal by Subject|3|||
156424152|NCT00691028|564644893|FG000|Open-label Period|not come to a hospital|0|||
156424153|NCT00691028|564644894|FG001|Open-label Period|not come to a hospital|0|||
156424154|NCT00691028|564644895|FG002|Open-label Period|not come to a hospital|0|||
156424155|NCT00691028|564644896|FG003|Open-label Period|not come to a hospital|1|||
156424156|NCT00691028|564644893|FG000|Double-blind Period|Adverse Event|8|||
156424157|NCT00691028|564644894|FG001|Double-blind Period|Adverse Event|9|||
156424158|NCT00691028|564644895|FG002|Double-blind Period|Adverse Event|6|||
156424159|NCT00691028|564644896|FG003|Double-blind Period|Adverse Event|0|||
156424160|NCT00691028|564644893|FG000|Double-blind Period|Lack of Efficacy|4|||
156424161|NCT00691028|564644894|FG001|Double-blind Period|Lack of Efficacy|3|||
156424162|NCT00691028|564644895|FG002|Double-blind Period|Lack of Efficacy|2|||
156424163|NCT00691028|564644896|FG003|Double-blind Period|Lack of Efficacy|0|||
156424164|NCT00691028|564644893|FG000|Double-blind Period|Withdrawal by Subject|1|||
156424165|NCT00691028|564644894|FG001|Double-blind Period|Withdrawal by Subject|0|||
156424166|NCT00691028|564644895|FG002|Double-blind Period|Withdrawal by Subject|1|||
156424167|NCT00691028|564644896|FG003|Double-blind Period|Withdrawal by Subject|0|||
156424168|NCT00691028|564644893|FG000|Double-blind Period|not come to a hospital.|0|||
156424169|NCT00691028|564644894|FG001|Double-blind Period|not come to a hospital.|1|||
156424170|NCT00691028|564644895|FG002|Double-blind Period|not come to a hospital.|0|||
156424171|NCT00691028|564644896|FG003|Double-blind Period|not come to a hospital.|0|||
156424172|NCT03681691|564644905|FG000|Overall Study|COVID|1|||
156424173|NCT03681691|564644906|FG001|Overall Study|COVID|0|||
156424174|NCT03681691|564644905|FG000|Overall Study|prolonged bleeding|1|||
156424175|NCT03681691|564644906|FG001|Overall Study|prolonged bleeding|0|||
156424176|NCT03681691|564644905|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
156424177|NCT03681691|564644906|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
156424178|NCT02334306|564644907|FG000|Double-blind Period|Adverse Event|0|||
156424179|NCT02334306|564644908|FG001|Double-blind Period|Adverse Event|1|||
156424180|NCT02334306|564644907|FG000|Double-blind Period|Withdrawal by Subject|1|||
156424181|NCT02334306|564644908|FG001|Double-blind Period|Withdrawal by Subject|1|||
156424182|NCT01687270|564644909|FG000|Overall Study|Lack of Efficacy|11|||
156424183|NCT01687270|564644909|FG000|Overall Study|Lost to Follow-up|1|||
156424184|NCT00465985|564644910|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
156424185|NCT00465985|564644911|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
156424186|NCT00465985|564644910|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
156424187|NCT00465985|564644911|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
156424188|NCT00465985|564644910|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
156424189|NCT00465985|564644911|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
156424190|NCT00465985|564644910|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
156424191|NCT00465985|564644911|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
156424192|NCT03006341|564644912|FG000|Overall Study|Not linked in the EMR|25069|||
156424193|NCT03006341|564644913|FG001|Overall Study|Not linked in the EMR|67505|||
156424194|NCT03006341|564644914|FG002|Overall Study|Not linked in the EMR|30993|||
156424195|NCT03006341|564644915|FG003|Overall Study|Not linked in the EMR|10685|||
156424196|NCT02950545|564644916|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156424197|NCT02950545|564644917|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156424198|NCT02950545|564644918|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156424199|NCT02950545|564644919|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156424200|NCT02950545|564644920|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156424201|NCT02950545|564644921|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
156424202|NCT02950545|564644916|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
156424203|NCT02950545|564644917|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
156424204|NCT02950545|564644918|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
156424205|NCT02950545|564644919|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
156424206|NCT02950545|564644920|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
156424207|NCT02950545|564644921|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
156424208|NCT02950545|564644916|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156424209|NCT02950545|564644917|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156424210|NCT02950545|564644918|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156424211|NCT02950545|564644919|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156424212|NCT02950545|564644920|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
156424213|NCT02950545|564644921|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156424214|NCT02950545|564644916|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
156424215|NCT02950545|564644917|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156424216|NCT02950545|564644918|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156424217|NCT02950545|564644919|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156424218|NCT02950545|564644920|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156424219|NCT02950545|564644921|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156424220|NCT02950545|564644916|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156424221|NCT02950545|564644917|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156424222|NCT02950545|564644918|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156424223|NCT02950545|564644919|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156424224|NCT02950545|564644920|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156424225|NCT02950545|564644921|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
156424226|NCT01004263|564644922|FG000|Overall Study|Adverse Event|15|||
156424227|NCT01004263|564644922|FG000|Overall Study|Withdrawal by Subject|58|||
156424228|NCT01004263|564644922|FG000|Overall Study|Protocol Violation|10|||
156424229|NCT01004263|564644922|FG000|Overall Study|Lost to Follow-up|64|||
156424230|NCT01004263|564644922|FG000|Overall Study|Lack of Efficacy|13|||
156424231|NCT01004263|564644922|FG000|Overall Study|Pregnancy|2|||
156424232|NCT01004263|564644922|FG000|Overall Study|Physician Decision|15|||
156424233|NCT01004263|564644922|FG000|Overall Study|Lack of Qualifying Event|2|||
156424234|NCT01237678|564644923|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
156424235|NCT01237678|564644924|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
156424236|NCT01237678|564644925|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
156424237|NCT01237678|564644923|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
156424238|NCT01237678|564644924|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
156424239|NCT01237678|564644925|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
156424240|NCT01237678|564644923|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
156424241|NCT01237678|564644924|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
156424242|NCT01237678|564644925|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
156424243|NCT01237678|564644923|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
156424244|NCT01237678|564644924|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
156424245|NCT01237678|564644925|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
156424246|NCT01237678|564644923|FG000|Phase II|Adverse Event|0|||
156424247|NCT01237678|564644924|FG001|Phase II|Adverse Event|39|||
156424248|NCT01237678|564644925|FG002|Phase II|Adverse Event|9|||
156424249|NCT01237678|564644923|FG000|Phase II|Death|0|||
156424250|NCT01237678|564644924|FG001|Phase II|Death|0|||
156424251|NCT01237678|564644925|FG002|Phase II|Death|2|||
156424252|NCT01237678|564644923|FG000|Phase II|Lack of Efficacy|0|||
156424253|NCT01237678|564644924|FG001|Phase II|Lack of Efficacy|25|||
156424254|NCT01237678|564644925|FG002|Phase II|Lack of Efficacy|3|||
156424255|NCT01237678|564644923|FG000|Phase II|Withdrawal by Subject|0|||
156424256|NCT01237678|564644924|FG001|Phase II|Withdrawal by Subject|1|||
156424257|NCT01237678|564644925|FG002|Phase II|Withdrawal by Subject|5|||
156424258|NCT01237678|564644923|FG000|Phase II|Completed Cycles 4-6|0|||
156424259|NCT01237678|564644924|FG001|Phase II|Completed Cycles 4-6|11|||
156424260|NCT01237678|564644925|FG002|Phase II|Completed Cycles 4-6|21|||
156424261|NCT01237678|564644923|FG000|Phase II|Sponsor Decision/Study Closed|0|||
156424262|NCT01237678|564644924|FG001|Phase II|Sponsor Decision/Study Closed|18|||
156424263|NCT01237678|564644925|FG002|Phase II|Sponsor Decision/Study Closed|7|||
156424264|NCT01237678|564644923|FG000|Phase II|Randomized but were not treated|0|||
156424265|NCT01237678|564644924|FG001|Phase II|Randomized but were not treated|4|||
156424266|NCT01237678|564644925|FG002|Phase II|Randomized but were not treated|3|||
156424267|NCT03398356|564644926|FG000|Before Treatment|Lost to Follow-up|1|||
156424268|NCT03398356|564644927|FG001|Before Treatment|Lost to Follow-up|2|||
156424269|NCT03398356|564644928|FG002|Before Treatment|Lost to Follow-up|0|||
156424270|NCT03398356|564644926|FG000|Before Treatment|drug intolerance|2|||
156424271|NCT03398356|564644927|FG001|Before Treatment|drug intolerance|1|||
156424272|NCT03398356|564644928|FG002|Before Treatment|drug intolerance|0|||
156424273|NCT03398356|564644926|FG000|Before Treatment|Withdrawal by Subject|0|||
156424274|NCT03398356|564644927|FG001|Before Treatment|Withdrawal by Subject|5|||
156424275|NCT03398356|564644928|FG002|Before Treatment|Withdrawal by Subject|0|||
156424276|NCT03398356|564644926|FG000|Before Treatment|Physician Decision|0|||
156424277|NCT03398356|564644927|FG001|Before Treatment|Physician Decision|0|||
156424278|NCT03398356|564644928|FG002|Before Treatment|Physician Decision|11|||
156424279|NCT03398356|564644926|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
156424280|NCT03398356|564644927|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
156424281|NCT03398356|564644928|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
156424282|NCT00282438|564644929|FG000|Overall Study|Lack of Efficacy|1|||
156424283|NCT00282438|564644930|FG001|Overall Study|Lack of Efficacy|0|||
156761966|NCT05616013|565879944|FG000|Overall Study|Withdrawal by Subject|11|||
156761967|NCT05616013|565879945|FG001|Overall Study|Withdrawal by Subject|9|||
156761968|NCT05616013|565879946|FG002|Overall Study|Withdrawal by Subject|8|||
156424284|NCT00282438|564644929|FG000|Overall Study|Death|0|||
156424285|NCT00282438|564644930|FG001|Overall Study|Death|1|||
156424286|NCT02397889|564644931|FG000|Overall Study|Physician Decision|1|||
156424287|NCT02397889|564644932|FG001|Overall Study|Physician Decision|0|||
156424288|NCT02696785|564644938|FG000|Blinded Treatment Period|Adverse Event|0|||
156424289|NCT02696785|564644939|FG001|Blinded Treatment Period|Adverse Event|1|||
156424290|NCT02696785|564644940|FG002|Blinded Treatment Period|Adverse Event|3|||
156424291|NCT02696785|564644941|FG003|Blinded Treatment Period|Adverse Event|0|||
156424292|NCT02696785|564644938|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
156424293|NCT02696785|564644939|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
156424294|NCT02696785|564644940|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
156424295|NCT02696785|564644941|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
156424296|NCT02696785|564644938|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
156424297|NCT02696785|564644939|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
156424298|NCT02696785|564644940|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
156424299|NCT02696785|564644941|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
156424300|NCT02696785|564644938|FG000|Blinded Treatment Period|Screen Failure|1|||
156424301|NCT02696785|564644939|FG001|Blinded Treatment Period|Screen Failure|0|||
156424302|NCT02696785|564644940|FG002|Blinded Treatment Period|Screen Failure|0|||
156424303|NCT02696785|564644941|FG003|Blinded Treatment Period|Screen Failure|0|||
156424304|NCT02696785|564644938|FG000|Washout Period|Withdrawal by Subject|0|||
156424305|NCT02696785|564644939|FG001|Washout Period|Withdrawal by Subject|1|||
156424306|NCT02696785|564644940|FG002|Washout Period|Withdrawal by Subject|0|||
156424307|NCT02696785|564644941|FG003|Washout Period|Withdrawal by Subject|0|||
156424308|NCT02696785|564644938|FG000|Washout Period|Lack of Efficacy|0|||
156424309|NCT02696785|564644939|FG001|Washout Period|Lack of Efficacy|1|||
156424310|NCT02696785|564644940|FG002|Washout Period|Lack of Efficacy|0|||
156424311|NCT02696785|564644941|FG003|Washout Period|Lack of Efficacy|0|||
156424312|NCT02696785|564644938|FG000|Extended Treatment Period|Adverse Event|2|||
156424313|NCT02696785|564644939|FG001|Extended Treatment Period|Adverse Event|3|||
156424314|NCT02696785|564644940|FG002|Extended Treatment Period|Adverse Event|2|||
156424315|NCT02696785|564644941|FG003|Extended Treatment Period|Adverse Event|1|||
156424316|NCT02696785|564644938|FG000|Extended Treatment Period|Lack of Efficacy|0|||
156424317|NCT02696785|564644939|FG001|Extended Treatment Period|Lack of Efficacy|1|||
156424318|NCT02696785|564644940|FG002|Extended Treatment Period|Lack of Efficacy|0|||
156424319|NCT02696785|564644941|FG003|Extended Treatment Period|Lack of Efficacy|0|||
156424320|NCT02696785|564644938|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
156424321|NCT02696785|564644939|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
156424322|NCT02696785|564644940|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
156424323|NCT02696785|564644941|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
156424324|NCT02696785|564644938|FG000|Follow-up Period|Adverse Event|0|||
156424325|NCT02696785|564644939|FG001|Follow-up Period|Adverse Event|0|||
156424326|NCT02696785|564644940|FG002|Follow-up Period|Adverse Event|8|||
156424327|NCT02696785|564644941|FG003|Follow-up Period|Adverse Event|2|||
156424328|NCT02696785|564644938|FG000|Follow-up Period|Lost to Follow-up|0|||
156424329|NCT02696785|564644939|FG001|Follow-up Period|Lost to Follow-up|0|||
156424330|NCT02696785|564644940|FG002|Follow-up Period|Lost to Follow-up|0|||
156424331|NCT02696785|564644941|FG003|Follow-up Period|Lost to Follow-up|1|||
156424332|NCT02696785|564644938|FG000|Follow-up Period|Lack of Efficacy|0|||
156424333|NCT02696785|564644939|FG001|Follow-up Period|Lack of Efficacy|0|||
156424334|NCT02696785|564644940|FG002|Follow-up Period|Lack of Efficacy|0|||
156424335|NCT02696785|564644941|FG003|Follow-up Period|Lack of Efficacy|1|||
156424336|NCT02696785|564644938|FG000|Follow-up Period|Withdrawal by Subject|1|||
156761969|NCT05616013|565879947|FG003|Overall Study|Withdrawal by Subject|6|||
156761970|NCT05616013|565879948|FG004|Overall Study|Withdrawal by Subject|3|||
156761971|NCT05616013|565879949|FG005|Overall Study|Withdrawal by Subject|4|||
156761972|NCT05616013|565879950|FG006|Overall Study|Withdrawal by Subject|6|||
156761973|NCT05616013|565879951|FG007|Overall Study|Withdrawal by Subject|5|||
156761974|NCT05616013|565879952|FG008|Overall Study|Withdrawal by Subject|4|||
156761975|NCT05616013|565879944|FG000|Overall Study|Physician Decision|0|||
156761976|NCT05616013|565879945|FG001|Overall Study|Physician Decision|0|||
156761977|NCT05616013|565879946|FG002|Overall Study|Physician Decision|1|||
156761978|NCT05616013|565879947|FG003|Overall Study|Physician Decision|0|||
156761979|NCT05616013|565879948|FG004|Overall Study|Physician Decision|0|||
156424337|NCT02696785|564644939|FG001|Follow-up Period|Withdrawal by Subject|0|||
156424338|NCT02696785|564644940|FG002|Follow-up Period|Withdrawal by Subject|5|||
156424339|NCT02696785|564644941|FG003|Follow-up Period|Withdrawal by Subject|4|||
156424340|NCT04863898|564644945|FG000|Overall Study|Away from study clinic during intervention training period|2|||
156424341|NCT04863898|564644945|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
156424342|NCT04863898|564644945|FG000|Overall Study|Lost to Follow-up|3|||
156424343|NCT04863898|564644945|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
156424344|NCT04863898|564644945|FG000|Overall Study|No longer employed at clinic|3|||
156424345|NCT00614744|564644946|FG000|Overall Study|Lost to Follow-up|5|||
156424346|NCT00614744|564644947|FG001|Overall Study|Lost to Follow-up|4|||
156424347|NCT00614744|564644946|FG000|Overall Study|Incomplete for Behavior Issues|0|||
156424348|NCT00614744|564644947|FG001|Overall Study|Incomplete for Behavior Issues|2|||
156424349|NCT01516892|564644949|FG000|Overall Study|Adverse Event|25|||
156424350|NCT01516892|564644949|FG000|Overall Study|Lack of Efficacy|35|||
156424351|NCT01516892|564644949|FG000|Overall Study|Pregnancy|5|||
156424352|NCT01516892|564644949|FG000|Overall Study|Lost to Follow-up|82|||
156424353|NCT01516892|564644949|FG000|Overall Study|Subject Withdrew Consent|92|||
156424354|NCT01516892|564644949|FG000|Overall Study|Protocol Violation|60|||
156424355|NCT01516892|564644949|FG000|Overall Study|Other Miscellaneous Reasons|43|||
156424356|NCT01516892|564644949|FG000|Overall Study|Missing|1|||
156424357|NCT01096056|564644950|FG000|Overall Study|Lost to Follow-up|0|||
156424358|NCT01096056|564644951|FG001|Overall Study|Lost to Follow-up|1|||
156424359|NCT04831775|564644952|FG000|Overall Study|Lost to Follow-up|11|||
156424360|NCT04831775|564644953|FG001|Overall Study|Lost to Follow-up|13|||
156424361|NCT00337818|564644954|FG000|Overall Study|Lost to Follow-up|289|||
156424362|NCT00337818|564644955|FG001|Overall Study|Lost to Follow-up|91|||
156424363|NCT00337818|564644956|FG002|Overall Study|Lost to Follow-up|107|||
156424364|NCT03590743|564644957|FG000|Overall Study|Withdrawal by Subject|0|||
156424365|NCT03590743|564644958|FG001|Overall Study|Withdrawal by Subject|1|||
156424366|NCT01190176|564644959|FG000|Overall Study|Withdrawal by Subject|1|||
156424367|NCT01190176|564644959|FG000|Overall Study|Lost to Follow-up|1|||
156424368|NCT02696226|564644960|FG000|Overall Study|Study terminated - lack of enrollment|1|||
156424369|NCT02696226|564644961|FG001|Overall Study|Study terminated - lack of enrollment|0|||
156424370|NCT02696226|564644962|FG002|Overall Study|Study terminated - lack of enrollment|2|||
156424371|NCT02696226|564644963|FG003|Overall Study|Study terminated - lack of enrollment|0|||
156424372|NCT02414828|564644966|FG000|Overall Study|Lost to Follow-up|0|||
156424373|NCT02414828|564644967|FG001|Overall Study|Lost to Follow-up|1|||
156424374|NCT02414828|564644968|FG002|Overall Study|Lost to Follow-up|1|||
156424375|NCT02414828|564644969|FG003|Overall Study|Lost to Follow-up|2|||
156424376|NCT04580407|564644972|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
156424377|NCT04949399|564644973|FG000|Overall Study|Lost to Follow-up|11|||
156424378|NCT04949399|564644974|FG001|Overall Study|Lost to Follow-up|6|||
156424379|NCT04949399|564644973|FG000|Overall Study|Withdrawal by Subject|2|||
156424380|NCT04949399|564644974|FG001|Overall Study|Withdrawal by Subject|3|||
156424381|NCT00670540|564644975|FG000|Overall Study|ineligible|17|||
156424382|NCT00670540|564644975|FG000|Overall Study|not living in France|348|||
156424383|NCT00670540|564644975|FG000|Overall Study|refused to participate|189|||
156424384|NCT00670540|564644975|FG000|Overall Study|controls randomised for no follow up|2770|||
156424385|NCT00670540|564644975|FG000|Overall Study|missing information inclusion criteria|1|||
156424386|NCT01866917|564644976|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
156424387|NCT01866917|564644977|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
156424388|NCT00531479|564647032|FG000|Overall Study|Death|68|||
156424389|NCT00531479|564647033|FG001|Overall Study|Death|71|||
156424390|NCT00531479|564647032|FG000|Overall Study|Lost to Follow-up|0|||
156424391|NCT00531479|564647033|FG001|Overall Study|Lost to Follow-up|2|||
156424392|NCT00531479|564647032|FG000|Overall Study|Other|0|||
156424393|NCT00531479|564647033|FG001|Overall Study|Other|1|||
156424394|NCT00531479|564647032|FG000|Overall Study|Withdrawal by Subject|6|||
156424395|NCT00531479|564647033|FG001|Overall Study|Withdrawal by Subject|6|||
156424396|NCT00531479|564647032|FG000|Overall Study|Did not receive treatment|2|||
156424397|NCT00531479|564647033|FG001|Overall Study|Did not receive treatment|3|||
156424398|NCT01240356|564647034|FG000|Overall Study|Withdrawal by Subject|2|||
156424399|NCT01240356|564647035|FG001|Overall Study|Withdrawal by Subject|0|||
156761980|NCT05616013|565879949|FG005|Overall Study|Physician Decision|1|||
156761981|NCT05616013|565879950|FG006|Overall Study|Physician Decision|3|||
156761982|NCT05616013|565879951|FG007|Overall Study|Physician Decision|0|||
156424400|NCT01240356|564647034|FG000|Overall Study|MRI contraindication|1|||
156424401|NCT01240356|564647035|FG001|Overall Study|MRI contraindication|0|||
156424402|NCT01677936|564647036|FG000|Overall Study|Lost to Follow-up|4|||
156424403|NCT01677936|564647037|FG001|Overall Study|Lost to Follow-up|1|||
156424404|NCT01677936|564647036|FG000|Overall Study|Protocol Violation|3|||
156761983|NCT05616013|565879952|FG008|Overall Study|Physician Decision|0|||
156761984|NCT05616013|565879944|FG000|Overall Study|Protocol Violation|0|||
156424405|NCT01677936|564647037|FG001|Overall Study|Protocol Violation|0|||
156424406|NCT01677936|564647036|FG000|Overall Study|Adverse Event|1|||
156424407|NCT01677936|564647037|FG001|Overall Study|Adverse Event|0|||
156424408|NCT01677936|564647036|FG000|Overall Study|Lost to Follow-up|1|||
156424409|NCT01677936|564647037|FG001|Overall Study|Lost to Follow-up|0|||
156424410|NCT01677936|564647036|FG000|Overall Study|Protocol Violation|0|||
156424411|NCT01677936|564647037|FG001|Overall Study|Protocol Violation|4|||
156424412|NCT03837028|564647040|FG000|Overall Study|Lost to Follow-up|4|||
156424413|NCT03837028|564647041|FG001|Overall Study|Lost to Follow-up|0|||
156424414|NCT03837028|564647042|FG002|Overall Study|Lost to Follow-up|2|||
156424415|NCT03837028|564647043|FG003|Overall Study|Lost to Follow-up|0|||
156424416|NCT03837028|564647040|FG000|Overall Study|Withdrawal by Subject|12|||
156424417|NCT03837028|564647041|FG001|Overall Study|Withdrawal by Subject|11|||
156424418|NCT03837028|564647042|FG002|Overall Study|Withdrawal by Subject|11|||
156424419|NCT03837028|564647043|FG003|Overall Study|Withdrawal by Subject|7|||
156424420|NCT00157014|564647044|FG000|Overall Study|Death|4|||
156424421|NCT00157014|564647045|FG001|Overall Study|Death|2|||
156424422|NCT00157014|564647046|FG002|Overall Study|Death|1|||
156424423|NCT00157014|564647047|FG003|Overall Study|Death|1|||
156424424|NCT00157014|564647044|FG000|Overall Study|Physician Decision|0|||
156424425|NCT00157014|564647045|FG001|Overall Study|Physician Decision|1|||
156424426|NCT00157014|564647046|FG002|Overall Study|Physician Decision|0|||
156424427|NCT00157014|564647047|FG003|Overall Study|Physician Decision|0|||
156424428|NCT00157014|564647044|FG000|Overall Study|Medications withdrawn on family request|0|||
156424429|NCT00157014|564647045|FG001|Overall Study|Medications withdrawn on family request|1|||
156424430|NCT00157014|564647046|FG002|Overall Study|Medications withdrawn on family request|0|||
156424431|NCT00157014|564647047|FG003|Overall Study|Medications withdrawn on family request|0|||
156424432|NCT00157014|564647044|FG000|Overall Study|Patient withdrawn by investigator|1|||
156424433|NCT00157014|564647045|FG001|Overall Study|Patient withdrawn by investigator|0|||
156424434|NCT00157014|564647046|FG002|Overall Study|Patient withdrawn by investigator|0|||
156424435|NCT00157014|564647047|FG003|Overall Study|Patient withdrawn by investigator|0|||
156424436|NCT00157014|564647044|FG000|Overall Study|Patient unable to return in nursing home|1|||
156424437|NCT00157014|564647045|FG001|Overall Study|Patient unable to return in nursing home|0|||
156424438|NCT00157014|564647046|FG002|Overall Study|Patient unable to return in nursing home|0|||
156424439|NCT00157014|564647047|FG003|Overall Study|Patient unable to return in nursing home|0|||
156424440|NCT00157014|564647044|FG000|Overall Study|Patient would not receive transplant|0|||
156424441|NCT00157014|564647045|FG001|Overall Study|Patient would not receive transplant|1|||
156424442|NCT00157014|564647046|FG002|Overall Study|Patient would not receive transplant|0|||
156424443|NCT00157014|564647047|FG003|Overall Study|Patient would not receive transplant|0|||
156424444|NCT00157014|564647044|FG000|Overall Study|Withdrawal by Subject|1|||
156424445|NCT00157014|564647045|FG001|Overall Study|Withdrawal by Subject|0|||
156424446|NCT00157014|564647046|FG002|Overall Study|Withdrawal by Subject|0|||
156424447|NCT00157014|564647047|FG003|Overall Study|Withdrawal by Subject|0|||
156424448|NCT01362491|564647048|FG000|Overall Study|Ineligible|1|||
156424449|NCT01362491|564647049|FG001|Overall Study|Ineligible|0|||
156424450|NCT01362491|564647050|FG002|Overall Study|Ineligible|0|||
156424451|NCT04867902|564647051|FG000|Overall Study|Lost to Follow-up|1|||
156424452|NCT04867902|564647051|FG000|Overall Study|Withdrawal by Subject|2|||
156424453|NCT04867902|564647051|FG000|Overall Study|Protocol Violation|1|||
156424454|NCT00448864|564647054|FG000|Overall Study|Death|1|||
156424455|NCT00448864|564647055|FG001|Overall Study|Death|0|||
156424456|NCT00448864|564647056|FG002|Overall Study|Death|0|||
156424457|NCT00448864|564647054|FG000|Overall Study|Lost to Follow-up|3|||
156424458|NCT00448864|564647055|FG001|Overall Study|Lost to Follow-up|1|||
156424459|NCT00448864|564647056|FG002|Overall Study|Lost to Follow-up|0|||
156424460|NCT00448864|564647054|FG000|Overall Study|Physician Decision|1|||
156424461|NCT00448864|564647055|FG001|Overall Study|Physician Decision|0|||
156424462|NCT00448864|564647056|FG002|Overall Study|Physician Decision|1|||
156424463|NCT00448864|564647054|FG000|Overall Study|Withdrawal by Subject|0|||
156424464|NCT00448864|564647055|FG001|Overall Study|Withdrawal by Subject|2|||
156424465|NCT00448864|564647056|FG002|Overall Study|Withdrawal by Subject|0|||
156424466|NCT00448864|564647054|FG000|Overall Study|Protocol Violation|0|||
156424467|NCT00448864|564647055|FG001|Overall Study|Protocol Violation|2|||
156424468|NCT00448864|564647056|FG002|Overall Study|Protocol Violation|0|||
156424469|NCT01124162|564647057|FG000|First Intervention|Adverse Event|2|||
156424470|NCT01124162|564647058|FG001|First Intervention|Adverse Event|0|||
156424471|NCT01124162|564647057|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156424472|NCT01124162|564647058|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156424473|NCT02534896|564647064|FG000|Overall Study|Adverse Event|2|||
156424474|NCT02534896|564647065|FG001|Overall Study|Adverse Event|1|||
156424475|NCT02534896|564647066|FG002|Overall Study|Adverse Event|1|||
156424476|NCT02534896|564647064|FG000|Overall Study|Insufficient therapeutic response|2|||
156424477|NCT02534896|564647065|FG001|Overall Study|Insufficient therapeutic response|0|||
156424478|NCT02534896|564647066|FG002|Overall Study|Insufficient therapeutic response|0|||
156424479|NCT00711646|564647067|FG000|Overall Study|Adverse Event|6|||
156424480|NCT00711646|564647068|FG001|Overall Study|Adverse Event|1|||
156424481|NCT00711646|564647067|FG000|Overall Study|Withdrawal by Subject|4|||
156424482|NCT00711646|564647068|FG001|Overall Study|Withdrawal by Subject|0|||
156424483|NCT00711646|564647067|FG000|Overall Study|Protocol Violation|0|||
156424484|NCT00711646|564647068|FG001|Overall Study|Protocol Violation|1|||
156424485|NCT00711646|564647067|FG000|Overall Study|Lost to Follow-up|1|||
156424486|NCT00711646|564647068|FG001|Overall Study|Lost to Follow-up|0|||
156424487|NCT00711646|564647067|FG000|Overall Study|administrative decision|0|||
156424488|NCT00711646|564647068|FG001|Overall Study|administrative decision|1|||
156424489|NCT00711646|564647067|FG000|Overall Study|patient non-compliance|1|||
156424490|NCT00711646|564647068|FG001|Overall Study|patient non-compliance|0|||
156424491|NCT00269399|564647069|FG000|Overall Study|Lack of Efficacy|27|||
156424492|NCT00269399|564647070|FG001|Overall Study|Lack of Efficacy|10|||
156424493|NCT00269399|564647069|FG000|Overall Study|Adverse Event|10|||
156424494|NCT00269399|564647070|FG001|Overall Study|Adverse Event|4|||
156424495|NCT00269399|564647069|FG000|Overall Study|Withdrawal by Subject|2|||
156424496|NCT00269399|564647070|FG001|Overall Study|Withdrawal by Subject|5|||
156424497|NCT00269399|564647069|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
156424498|NCT00269399|564647070|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
156761985|NCT05616013|565879945|FG001|Overall Study|Protocol Violation|0|||
156761986|NCT05616013|565879946|FG002|Overall Study|Protocol Violation|0|||
156761987|NCT05616013|565879947|FG003|Overall Study|Protocol Violation|0|||
156424499|NCT00269399|564647069|FG000|Overall Study|Other|0|||
156424500|NCT00269399|564647070|FG001|Overall Study|Other|4|||
156424501|NCT00269399|564647069|FG000|Overall Study|Development of exclusion criteria|0|||
156424502|NCT00269399|564647070|FG001|Overall Study|Development of exclusion criteria|1|||
156424503|NCT03441360|564647071|FG000|Overall Study|Radiological disease progression|5|||
156424504|NCT03441360|564647072|FG001|Overall Study|Radiological disease progression|6|||
156424505|NCT03441360|564647073|FG002|Overall Study|Radiological disease progression|4|||
156424506|NCT03441360|564647071|FG000|Overall Study|Clinical disease progression|2|||
156424507|NCT03441360|564647072|FG001|Overall Study|Clinical disease progression|2|||
156424508|NCT03441360|564647073|FG002|Overall Study|Clinical disease progression|0|||
156424509|NCT03441360|564647071|FG000|Overall Study|Adverse Event|1|||
156424510|NCT03441360|564647072|FG001|Overall Study|Adverse Event|0|||
156424511|NCT03441360|564647073|FG002|Overall Study|Adverse Event|1|||
156424512|NCT03439124|564647074|FG000|Overall Study|Adverse Event|2|||
156424513|NCT03439124|564647075|FG001|Overall Study|Adverse Event|0|||
156424514|NCT03439124|564647074|FG000|Overall Study|Lost to Follow-up|1|||
156424515|NCT03439124|564647075|FG001|Overall Study|Lost to Follow-up|0|||
156424516|NCT03439124|564647074|FG000|Overall Study|Other reasons|1|||
156424517|NCT03439124|564647075|FG001|Overall Study|Other reasons|0|||
156424518|NCT01360840|564647077|FG000|Overall Study|Ongoing at data cut-off|10|||
156424519|NCT01360840|564647078|FG001|Overall Study|Ongoing at data cut-off|10|||
156424520|NCT01360840|564647079|FG002|Overall Study|Ongoing at data cut-off|9|||
156424521|NCT00920686|564647081|FG000|Overall Study|Lost to Follow-up|2|||
156424522|NCT00920686|564647082|FG001|Overall Study|Lost to Follow-up|3|||
156424523|NCT00920686|564647083|FG002|Overall Study|Lost to Follow-up|1|||
156424524|NCT00920686|564647081|FG000|Overall Study|Study drug dosing criteria not met|17|||
156424525|NCT00920686|564647082|FG001|Overall Study|Study drug dosing criteria not met|19|||
156424526|NCT00920686|564647083|FG002|Overall Study|Study drug dosing criteria not met|12|||
156424527|NCT00293462|564647084|FG000|Overall Study|Withdrawal by Subject|4|||
156424528|NCT00293462|564647085|FG001|Overall Study|Withdrawal by Subject|3|||
156424529|NCT00293462|564647086|FG002|Overall Study|Withdrawal by Subject|8|||
156424530|NCT00293462|564647084|FG000|Overall Study|Death|1|||
156424531|NCT00293462|564647085|FG001|Overall Study|Death|0|||
156761988|NCT05616013|565879948|FG004|Overall Study|Protocol Violation|0|||
156761989|NCT05616013|565879949|FG005|Overall Study|Protocol Violation|0|||
156761990|NCT05616013|565879950|FG006|Overall Study|Protocol Violation|1|||
156424532|NCT00293462|564647086|FG002|Overall Study|Death|0|||
156424533|NCT00293462|564647084|FG000|Overall Study|Lost to Follow-up|0|||
156424534|NCT00293462|564647085|FG001|Overall Study|Lost to Follow-up|1|||
156424535|NCT00293462|564647086|FG002|Overall Study|Lost to Follow-up|0|||
156424536|NCT00293462|564647084|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
156761991|NCT05616013|565879951|FG007|Overall Study|Protocol Violation|0|||
156761992|NCT05616013|565879952|FG008|Overall Study|Protocol Violation|2|||
156424537|NCT00293462|564647085|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
156424538|NCT00293462|564647086|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
156424539|NCT00293462|564647084|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
156424540|NCT00293462|564647085|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
156424541|NCT00293462|564647086|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
156424542|NCT00293462|564647084|FG000|Overall Study|Refuse Radiation Treatment|1|||
156321415|NCT01146860|564275048|FG001|Overall Study|Withdrawal by Subject|1|||
156321416|NCT00722371|564275049|FG000|Overall Study|Adverse Event|6|||
156321417|NCT00722371|564275050|FG001|Overall Study|Adverse Event|13|||
156321418|NCT00722371|564275051|FG002|Overall Study|Adverse Event|9|||
156321419|NCT00722371|564275052|FG003|Overall Study|Adverse Event|10|||
156321420|NCT00722371|564275053|FG004|Overall Study|Adverse Event|6|||
156321421|NCT00722371|564275054|FG005|Overall Study|Adverse Event|8|||
156321422|NCT00722371|564275055|FG006|Overall Study|Adverse Event|4|||
156321423|NCT00722371|564275049|FG000|Overall Study|Contraindication|0|||
156321424|NCT00722371|564275050|FG001|Overall Study|Contraindication|0|||
156321425|NCT00722371|564275051|FG002|Overall Study|Contraindication|1|||
156321426|NCT00722371|564275052|FG003|Overall Study|Contraindication|0|||
156321427|NCT00722371|564275053|FG004|Overall Study|Contraindication|0|||
156321428|NCT00722371|564275054|FG005|Overall Study|Contraindication|0|||
156321429|NCT00722371|564275055|FG006|Overall Study|Contraindication|0|||
156321430|NCT00722371|564275049|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
156321431|NCT00722371|564275050|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
156321432|NCT00722371|564275051|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
156321433|NCT00722371|564275052|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
156321434|NCT00722371|564275053|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
156321435|NCT00722371|564275054|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
156321436|NCT00722371|564275055|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
156321437|NCT00722371|564275049|FG000|Overall Study|Excluded medication|0|||
156321438|NCT00722371|564275050|FG001|Overall Study|Excluded medication|1|||
156321439|NCT00722371|564275051|FG002|Overall Study|Excluded medication|1|||
156321440|NCT00722371|564275052|FG003|Overall Study|Excluded medication|0|||
156321441|NCT00722371|564275053|FG004|Overall Study|Excluded medication|0|||
156321442|NCT00722371|564275054|FG005|Overall Study|Excluded medication|0|||
156321443|NCT00722371|564275055|FG006|Overall Study|Excluded medication|1|||
156321444|NCT00722371|564275049|FG000|Overall Study|Hyperglycemia|2|||
156321445|NCT00722371|564275050|FG001|Overall Study|Hyperglycemia|6|||
156321446|NCT00722371|564275051|FG002|Overall Study|Hyperglycemia|4|||
156321447|NCT00722371|564275052|FG003|Overall Study|Hyperglycemia|2|||
156321448|NCT00722371|564275053|FG004|Overall Study|Hyperglycemia|5|||
156321449|NCT00722371|564275054|FG005|Overall Study|Hyperglycemia|1|||
156321450|NCT00722371|564275055|FG006|Overall Study|Hyperglycemia|1|||
156321451|NCT00722371|564275049|FG000|Overall Study|Hypoglycemia|1|||
156321452|NCT00722371|564275050|FG001|Overall Study|Hypoglycemia|0|||
156321453|NCT00722371|564275051|FG002|Overall Study|Hypoglycemia|0|||
156321454|NCT00722371|564275052|FG003|Overall Study|Hypoglycemia|0|||
156321455|NCT00722371|564275053|FG004|Overall Study|Hypoglycemia|0|||
156321456|NCT00722371|564275054|FG005|Overall Study|Hypoglycemia|0|||
156321457|NCT00722371|564275055|FG006|Overall Study|Hypoglycemia|0|||
156321458|NCT00722371|564275049|FG000|Overall Study|Lack of Efficacy|4|||
156321459|NCT00722371|564275050|FG001|Overall Study|Lack of Efficacy|6|||
156321460|NCT00722371|564275051|FG002|Overall Study|Lack of Efficacy|6|||
156321461|NCT00722371|564275052|FG003|Overall Study|Lack of Efficacy|6|||
156321462|NCT00722371|564275053|FG004|Overall Study|Lack of Efficacy|2|||
156321463|NCT00722371|564275054|FG005|Overall Study|Lack of Efficacy|3|||
156321464|NCT00722371|564275055|FG006|Overall Study|Lack of Efficacy|0|||
156321465|NCT00722371|564275049|FG000|Overall Study|Lost to Follow-up|11|||
156321466|NCT00722371|564275050|FG001|Overall Study|Lost to Follow-up|14|||
156321467|NCT00722371|564275051|FG002|Overall Study|Lost to Follow-up|21|||
156321468|NCT00722371|564275052|FG003|Overall Study|Lost to Follow-up|13|||
156321469|NCT00722371|564275053|FG004|Overall Study|Lost to Follow-up|8|||
156321470|NCT00722371|564275054|FG005|Overall Study|Lost to Follow-up|16|||
156321471|NCT00722371|564275055|FG006|Overall Study|Lost to Follow-up|13|||
156321472|NCT00722371|564275049|FG000|Overall Study|Physician Decision|5|||
156321473|NCT00722371|564275050|FG001|Overall Study|Physician Decision|2|||
156321474|NCT00722371|564275051|FG002|Overall Study|Physician Decision|2|||
156321475|NCT00722371|564275052|FG003|Overall Study|Physician Decision|5|||
156321476|NCT00722371|564275053|FG004|Overall Study|Physician Decision|2|||
156321477|NCT00722371|564275054|FG005|Overall Study|Physician Decision|3|||
156321478|NCT00722371|564275055|FG006|Overall Study|Physician Decision|4|||
156321479|NCT00722371|564275049|FG000|Overall Study|Pregnancy|1|||
156321480|NCT00722371|564275050|FG001|Overall Study|Pregnancy|1|||
156321481|NCT00722371|564275051|FG002|Overall Study|Pregnancy|0|||
156321482|NCT00722371|564275052|FG003|Overall Study|Pregnancy|0|||
156321483|NCT00722371|564275053|FG004|Overall Study|Pregnancy|0|||
156321484|NCT00722371|564275054|FG005|Overall Study|Pregnancy|1|||
156321485|NCT00722371|564275055|FG006|Overall Study|Pregnancy|0|||
156321486|NCT00722371|564275049|FG000|Overall Study|Protocol Violation|6|||
156321487|NCT00722371|564275050|FG001|Overall Study|Protocol Violation|1|||
156321488|NCT00722371|564275051|FG002|Overall Study|Protocol Violation|0|||
156321489|NCT00722371|564275052|FG003|Overall Study|Protocol Violation|1|||
156321490|NCT00722371|564275053|FG004|Overall Study|Protocol Violation|4|||
156321491|NCT00722371|564275054|FG005|Overall Study|Protocol Violation|2|||
156321492|NCT00722371|564275055|FG006|Overall Study|Protocol Violation|1|||
156321493|NCT00722371|564275049|FG000|Overall Study|Withdrawal by Subject|18|||
156321494|NCT00722371|564275050|FG001|Overall Study|Withdrawal by Subject|27|||
156321495|NCT00722371|564275051|FG002|Overall Study|Withdrawal by Subject|19|||
156321496|NCT00722371|564275052|FG003|Overall Study|Withdrawal by Subject|23|||
156321497|NCT00722371|564275053|FG004|Overall Study|Withdrawal by Subject|19|||
156321498|NCT00722371|564275054|FG005|Overall Study|Withdrawal by Subject|18|||
156321499|NCT00722371|564275055|FG006|Overall Study|Withdrawal by Subject|26|||
156321500|NCT01092832|564275056|FG000|Overall Study|Other|1|||
156424543|NCT00293462|564647085|FG001|Overall Study|Refuse Radiation Treatment|0|||
156424544|NCT00293462|564647086|FG002|Overall Study|Refuse Radiation Treatment|0|||
156424545|NCT00293462|564647084|FG000|Overall Study|No Show|0|||
156424546|NCT00293462|564647085|FG001|Overall Study|No Show|0|||
156424547|NCT00293462|564647086|FG002|Overall Study|No Show|1|||
156424548|NCT00293462|564647084|FG000|Overall Study|Went back to his home country|0|||
156321501|NCT01092832|564275057|FG001|Overall Study|Other|0|||
156321502|NCT01075191|564275058|FG000|Overall Study|Death|1|||
156321503|NCT01075191|564275058|FG000|Overall Study|Intensification|3|||
156321504|NCT01075191|564275058|FG000|Overall Study|Co-morbidities|1|||
156321505|NCT01075191|564275058|FG000|Overall Study|Adverse Event|4|||
156321506|NCT01075191|564275058|FG000|Overall Study|Noncompliance|3|||
156321507|NCT01075191|564275058|FG000|Overall Study|Therapy Break|3|||
156321508|NCT01075191|564275058|FG000|Overall Study|Patient's Wish|2|||
156321509|NCT01075191|564275058|FG000|Overall Study|Unknown Reasons|1|||
156321510|NCT00718237|564275063|FG000|Overall Study|Adverse Event|1|||
156321511|NCT00718237|564275064|FG001|Overall Study|Adverse Event|3|||
156321512|NCT00718237|564275063|FG000|Overall Study|Lost to Follow-up|2|||
156321513|NCT00718237|564275064|FG001|Overall Study|Lost to Follow-up|2|||
156321514|NCT00718237|564275063|FG000|Overall Study|Physician Decision|1|||
156321515|NCT00718237|564275064|FG001|Overall Study|Physician Decision|0|||
156321516|NCT00718237|564275063|FG000|Overall Study|Withdrawal by Subject|9|||
156321517|NCT00718237|564275064|FG001|Overall Study|Withdrawal by Subject|10|||
156321518|NCT02635646|564275065|FG000|Overall Study|Lost to Follow-up|24|||
156321519|NCT02635646|564275066|FG001|Overall Study|Lost to Follow-up|25|||
156321520|NCT02635646|564275065|FG000|Overall Study|Pregnancy|1|||
156321521|NCT02635646|564275066|FG001|Overall Study|Pregnancy|1|||
156321522|NCT03149848|564275069|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
156321523|NCT03149848|564275069|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
156321524|NCT04738318|564275072|FG000|Overall Study|Protocol Violation|1|||
156321525|NCT04738318|564275073|FG001|Overall Study|Protocol Violation|0|||
156321526|NCT01226121|564275074|FG000|Overall Study|Lost to Follow-up|2|||
156321527|NCT01226121|564275075|FG001|Overall Study|Lost to Follow-up|0|||
156321528|NCT01226121|564275076|FG002|Overall Study|Lost to Follow-up|1|||
156321529|NCT00378079|564275077|FG000|Overall Study|Lost to Follow-up|6|||
156321530|NCT00378079|564275078|FG001|Overall Study|Lost to Follow-up|1|||
156321531|NCT00378079|564275079|FG002|Overall Study|Lost to Follow-up|0|||
156321532|NCT00586664|564275087|FG000|Overall Study|Withdrawal by Subject|3|||
156321533|NCT00586664|564275088|FG001|Overall Study|Withdrawal by Subject|7|||
156321534|NCT00586664|564275089|FG002|Overall Study|Withdrawal by Subject|1|||
156321535|NCT00586664|564275087|FG000|Overall Study|Exclusion criteria met|2|||
156321536|NCT00586664|564275088|FG001|Overall Study|Exclusion criteria met|0|||
156321537|NCT00586664|564275089|FG002|Overall Study|Exclusion criteria met|0|||
156321538|NCT00686998|564275093|FG000|Overall Study|Adverse Event|3|||
156321539|NCT00686998|564275094|FG001|Overall Study|Adverse Event|2|||
156321540|NCT00686998|564275095|FG002|Overall Study|Adverse Event|1|||
156321541|NCT00686998|564275093|FG000|Overall Study|Withdrawal by Subject|2|||
156321542|NCT00686998|564275094|FG001|Overall Study|Withdrawal by Subject|1|||
156321543|NCT00686998|564275095|FG002|Overall Study|Withdrawal by Subject|2|||
156321544|NCT00686998|564275093|FG000|Overall Study|Lack of Efficacy|7|||
156321545|NCT00686998|564275094|FG001|Overall Study|Lack of Efficacy|5|||
156321546|NCT00686998|564275095|FG002|Overall Study|Lack of Efficacy|0|||
156321547|NCT00686998|564275093|FG000|Overall Study|Other|0|||
156321548|NCT00686998|564275094|FG001|Overall Study|Other|0|||
156321549|NCT00686998|564275095|FG002|Overall Study|Other|1|||
156321550|NCT00686998|564275093|FG000|Overall Study|Safety Reasons|1|||
156321551|NCT00686998|564275094|FG001|Overall Study|Safety Reasons|0|||
156424549|NCT00293462|564647085|FG001|Overall Study|Went back to his home country|0|||
156654835|NCT01215942|565482599|FG000|Treatment Period|Withdrawal by Subject|17|||
156424550|NCT00293462|564647086|FG002|Overall Study|Went back to his home country|1|||
156654836|NCT01215942|565482600|FG001|Treatment Period|Withdrawal by Subject|40|||
156654837|NCT01215942|565482599|FG000|Treatment Period|Physician Decision|5|||
156654838|NCT01215942|565482600|FG001|Treatment Period|Physician Decision|5|||
156654839|NCT01215942|565482599|FG000|Treatment Period|Protocol Violation|0|||
156654840|NCT01215942|565482600|FG001|Treatment Period|Protocol Violation|1|||
156654841|NCT01215942|565482599|FG000|Treatment Period|Sponsor Decision|349|||
156654842|NCT01215942|565482600|FG001|Treatment Period|Sponsor Decision|530|||
156321552|NCT00686998|564275095|FG002|Overall Study|Safety Reasons|0|||
156321553|NCT02361346|564275096|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
156321554|NCT02361346|564275097|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
156321555|NCT02361346|564275098|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
156321556|NCT02361346|564275099|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
156424551|NCT00293462|564647084|FG000|Overall Study|Blood clot after chemotherapy|0|||
156424552|NCT00293462|564647085|FG001|Overall Study|Blood clot after chemotherapy|0|||
156424553|NCT00293462|564647086|FG002|Overall Study|Blood clot after chemotherapy|1|||
156424554|NCT00293462|564647084|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
156424555|NCT00293462|564647085|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
156424556|NCT00293462|564647086|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
156424557|NCT00293462|564647084|FG000|Overall Study|Possible Tracheostomy leakage|0|||
156424558|NCT00293462|564647085|FG001|Overall Study|Possible Tracheostomy leakage|1|||
156424559|NCT00293462|564647086|FG002|Overall Study|Possible Tracheostomy leakage|0|||
156424560|NCT00293462|564647084|FG000|Overall Study|Low radiation dose in oral cavity|0|||
156424561|NCT00293462|564647085|FG001|Overall Study|Low radiation dose in oral cavity|1|||
156424562|NCT00293462|564647086|FG002|Overall Study|Low radiation dose in oral cavity|0|||
156424563|NCT00293462|564647084|FG000|Overall Study|Physician Decision|0|||
156424564|NCT00293462|564647085|FG001|Overall Study|Physician Decision|1|||
156424565|NCT00293462|564647086|FG002|Overall Study|Physician Decision|0|||
156424566|NCT00372060|564647087|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
156424567|NCT00372060|564647088|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
156424568|NCT00372060|564647087|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
156424569|NCT00372060|564647088|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
156424570|NCT00372060|564647087|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
156424571|NCT00372060|564647088|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
156424572|NCT00372060|564647087|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
156424573|NCT00372060|564647088|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
156424574|NCT00372060|564647087|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
156424575|NCT00372060|564647088|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
156424576|NCT00372060|564647087|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
156424577|NCT00372060|564647088|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
156424578|NCT00647348|564647091|FG000|Overall Study|Lost to Follow-up|3|||
156424579|NCT00647348|564647092|FG001|Overall Study|Lost to Follow-up|6|||
156424580|NCT03178201|564647093|FG000|Overall Study|Off study|5|||
156424581|NCT04668144|564647094|FG000|Overall Study|Protocol Violation|0|||
156424582|NCT04668144|564647095|FG001|Overall Study|Protocol Violation|1|||
156424583|NCT04668144|564647096|FG002|Overall Study|Protocol Violation|2|||
156424584|NCT02095158|564647100|FG000|Overall Study|Adverse Event|14|||
156424585|NCT02095158|564647100|FG000|Overall Study|Lack of Efficacy|3|||
156424586|NCT02095158|564647100|FG000|Overall Study|Pregnancy|1|||
156424587|NCT02095158|564647100|FG000|Overall Study|Lost to Follow-up|20|||
156424588|NCT02095158|564647100|FG000|Overall Study|Personal Reasons|35|||
156424589|NCT02095158|564647100|FG000|Overall Study|Protocol Violation|1|||
156424590|NCT02095158|564647100|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156424591|NCT00320489|564647101|FG000|Overall Study|Adverse Event|26|||
156424592|NCT00320489|564647102|FG001|Overall Study|Adverse Event|25|||
156424593|NCT00320489|564647101|FG000|Overall Study|Clinical Relapse|26|||
156424594|NCT00320489|564647102|FG001|Overall Study|Clinical Relapse|20|||
156424595|NCT00320489|564647101|FG000|Overall Study|Death|0|||
156424596|NCT00320489|564647102|FG001|Overall Study|Death|2|||
156424597|NCT00320489|564647101|FG000|Overall Study|Entry Criteria Exclusion|2|||
156424598|NCT00320489|564647102|FG001|Overall Study|Entry Criteria Exclusion|4|||
156424599|NCT00320489|564647101|FG000|Overall Study|Lack of Efficacy|16|||
156424600|NCT00320489|564647102|FG001|Overall Study|Lack of Efficacy|7|||
156424601|NCT00320489|564647101|FG000|Overall Study|Lost to Follow-up|21|||
156424602|NCT00320489|564647102|FG001|Overall Study|Lost to Follow-up|22|||
156424603|NCT00320489|564647101|FG000|Overall Study|Physician Decision|8|||
156424604|NCT00320489|564647102|FG001|Overall Study|Physician Decision|8|||
156424605|NCT00320489|564647101|FG000|Overall Study|Protocol Violation|4|||
156424606|NCT00320489|564647102|FG001|Overall Study|Protocol Violation|4|||
156424607|NCT00320489|564647101|FG000|Overall Study|Sponsor Decision|3|||
156424608|NCT00320489|564647102|FG001|Overall Study|Sponsor Decision|3|||
156424609|NCT00320489|564647101|FG000|Overall Study|Withdrawal by Subject|39|||
156424610|NCT00320489|564647102|FG001|Overall Study|Withdrawal by Subject|41|||
156424611|NCT01872611|564647103|FG000|Overall Study|Adverse Event|3|||
156424612|NCT01872611|564647104|FG001|Overall Study|Adverse Event|1|||
156424613|NCT01872611|564647103|FG000|Overall Study|Adverse Event, prior to treatment|0|||
156424614|NCT01872611|564647104|FG001|Overall Study|Adverse Event, prior to treatment|1|||
156424615|NCT01872611|564647103|FG000|Overall Study|Death|0|||
156424616|NCT01872611|564647104|FG001|Overall Study|Death|1|||
156424617|NCT01872611|564647103|FG000|Overall Study|Death, prior to treatment|0|||
156424618|NCT01872611|564647104|FG001|Overall Study|Death, prior to treatment|1|||
156424619|NCT01872611|564647103|FG000|Overall Study|Lost to Follow-up|8|||
156424620|NCT01872611|564647104|FG001|Overall Study|Lost to Follow-up|1|||
156424621|NCT01872611|564647103|FG000|Overall Study|Physician Decision|1|||
156424622|NCT01872611|564647104|FG001|Overall Study|Physician Decision|0|||
156424623|NCT01872611|564647103|FG000|Overall Study|Withdrawal by Subject|6|||
156424624|NCT01872611|564647104|FG001|Overall Study|Withdrawal by Subject|1|||
156424625|NCT01872611|564647103|FG000|Overall Study|Reason not provided|6|||
156424626|NCT01872611|564647104|FG001|Overall Study|Reason not provided|6|||
156424627|NCT03441984|564647105|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424628|NCT03441984|564647106|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424629|NCT03441984|564647107|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
156424630|NCT03441984|564647108|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424631|NCT03441984|564647109|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424632|NCT03441984|564647110|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156761993|NCT05616013|565879944|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
156761994|NCT05616013|565879945|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
156424633|NCT03441984|564647111|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424634|NCT03441984|564647112|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424635|NCT03441984|564647113|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424636|NCT03441984|564647114|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424637|NCT03441984|564647115|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424638|NCT03441984|564647116|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156424639|NCT03537651|564647122|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
156424640|NCT03537651|564647122|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
156424641|NCT03537651|564647122|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
156424642|NCT03537651|564647122|FG000|Part A (Up to 96 Weeks)|Other|1|||
156424643|NCT03537651|564647122|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
156321557|NCT02361346|564275100|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
156321558|NCT02361346|564275101|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
156321559|NCT02361346|564275102|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
156321560|NCT02361346|564275103|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
156321561|NCT02361346|564275104|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
156321562|NCT02361346|564275096|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156321563|NCT02361346|564275097|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156321564|NCT02361346|564275098|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156321565|NCT02361346|564275099|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156321566|NCT02361346|564275100|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
156321567|NCT02361346|564275101|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156321568|NCT02361346|564275102|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156321569|NCT02361346|564275103|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156321570|NCT02361346|564275104|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156321571|NCT02361346|564275096|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
156321572|NCT02361346|564275097|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
156321573|NCT02361346|564275098|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
156321574|NCT02361346|564275099|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
156321575|NCT02361346|564275100|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
156321576|NCT02361346|564275101|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
156321577|NCT02361346|564275102|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
156321578|NCT02361346|564275103|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
156321579|NCT02361346|564275104|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
156321580|NCT02361346|564275096|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156321581|NCT02361346|564275097|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156321582|NCT02361346|564275098|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156321583|NCT02361346|564275099|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156321584|NCT02361346|564275100|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156321585|NCT02361346|564275101|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156321586|NCT02361346|564275102|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156321587|NCT02361346|564275103|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
156321588|NCT02361346|564275104|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156321589|NCT02361346|564275096|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156321590|NCT02361346|564275097|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156321591|NCT02361346|564275098|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156321592|NCT02361346|564275099|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156321593|NCT02361346|564275100|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156321594|NCT02361346|564275101|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156321595|NCT02361346|564275102|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156321596|NCT02361346|564275103|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
156321597|NCT02361346|564275104|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156321598|NCT02361346|564275096|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156321599|NCT02361346|564275097|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156321600|NCT02361346|564275098|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156321601|NCT02361346|564275099|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156321602|NCT02361346|564275100|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156321603|NCT02361346|564275101|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156424644|NCT03537651|564647122|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
156424645|NCT03537651|564647122|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
156424646|NCT03537651|564647122|FG000|Part B (Up to 192 Weeks)|Other|1|||
156424647|NCT01835899|564647123|FG000|Overall Study|Adverse Event|0|||
156424648|NCT01835899|564647124|FG001|Overall Study|Adverse Event|0|||
156424649|NCT01835899|564647125|FG002|Overall Study|Adverse Event|1|||
156424650|NCT01835899|564647123|FG000|Overall Study|Other than stated above|0|||
156424651|NCT01835899|564647124|FG001|Overall Study|Other than stated above|1|||
156424652|NCT01835899|564647125|FG002|Overall Study|Other than stated above|0|||
156424653|NCT04939428|564647128|FG000|Overall Study|Death|0|||
156424654|NCT04939428|564647129|FG001|Overall Study|Death|1|||
156424655|NCT04939428|564647130|FG002|Overall Study|Death|0|||
156424656|NCT04939428|564647128|FG000|Overall Study|Lost to Follow-up|0|||
156761995|NCT05616013|565879946|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
156761996|NCT05616013|565879947|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
156761997|NCT05616013|565879948|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
156761998|NCT05616013|565879949|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
156761999|NCT05616013|565879950|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
156762000|NCT05616013|565879951|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
156762001|NCT05616013|565879952|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
156762002|NCT05616013|565879944|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
156424657|NCT04939428|564647129|FG001|Overall Study|Lost to Follow-up|5|||
156424658|NCT04939428|564647130|FG002|Overall Study|Lost to Follow-up|0|||
156424659|NCT04939428|564647128|FG000|Overall Study|Physician Decision|1|||
156424660|NCT04939428|564647129|FG001|Overall Study|Physician Decision|0|||
156424661|NCT04939428|564647130|FG002|Overall Study|Physician Decision|0|||
156424662|NCT04939428|564647128|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156424663|NCT04939428|564647129|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156424664|NCT04939428|564647130|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156424665|NCT04939428|564647128|FG000|Overall Study|Withdrawal by Subject|10|||
156424666|NCT04939428|564647129|FG001|Overall Study|Withdrawal by Subject|11|||
156424667|NCT04939428|564647130|FG002|Overall Study|Withdrawal by Subject|0|||
156424668|NCT04939428|564647128|FG000|Overall Study|Unkown|6|||
156424669|NCT04939428|564647129|FG001|Overall Study|Unkown|3|||
156424670|NCT04939428|564647130|FG002|Overall Study|Unkown|0|||
156424671|NCT04939428|564647128|FG000|Overall Study|Discotinued per protocol|0|||
156424672|NCT04939428|564647129|FG001|Overall Study|Discotinued per protocol|0|||
156424673|NCT04939428|564647130|FG002|Overall Study|Discotinued per protocol|902|||
156424674|NCT04319094|564647131|FG000|Baseline|Lost to Follow-up|4|||
156424675|NCT04319094|564647132|FG001|Baseline|Lost to Follow-up|5|||
156424676|NCT04319094|564647131|FG000|Baseline|Protocol Violation|0|||
156424677|NCT04319094|564647132|FG001|Baseline|Protocol Violation|3|||
156424678|NCT04319094|564647131|FG000|Baseline|Withdrawal by Subject|2|||
156424679|NCT04319094|564647132|FG001|Baseline|Withdrawal by Subject|1|||
156424680|NCT04319094|564647131|FG000|Post-Intervention|Death|0|||
156424681|NCT04319094|564647132|FG001|Post-Intervention|Death|1|||
156424682|NCT04319094|564647131|FG000|Post-Intervention|Lost to Follow-up|4|||
156424683|NCT04319094|564647132|FG001|Post-Intervention|Lost to Follow-up|4|||
156424684|NCT04319094|564647131|FG000|Post-Intervention|Withdrawal by Subject|8|||
156424685|NCT04319094|564647132|FG001|Post-Intervention|Withdrawal by Subject|5|||
156424686|NCT04319094|564647131|FG000|Post-Intervention|Incomplete Data Collection|1|||
156424687|NCT04319094|564647132|FG001|Post-Intervention|Incomplete Data Collection|3|||
156424688|NCT04319094|564647131|FG000|3-month|Death|1|||
156424689|NCT04319094|564647132|FG001|3-month|Death|0|||
156424690|NCT04319094|564647131|FG000|3-month|Lost to Follow-up|2|||
156424691|NCT04319094|564647132|FG001|3-month|Lost to Follow-up|2|||
156424692|NCT04319094|564647131|FG000|3-month|Withdrawal by Subject|0|||
156424693|NCT04319094|564647132|FG001|3-month|Withdrawal by Subject|3|||
156424694|NCT04319094|564647131|FG000|3-month|Incomplete data collection|9|||
156424695|NCT04319094|564647132|FG001|3-month|Incomplete data collection|7|||
156424696|NCT04319094|564647131|FG000|6-month|Lost to Follow-up|1|||
156424697|NCT04319094|564647132|FG001|6-month|Lost to Follow-up|1|||
156424698|NCT04319094|564647131|FG000|6-month|Withdrawal by Subject|0|||
156424699|NCT04319094|564647132|FG001|6-month|Withdrawal by Subject|3|||
156424700|NCT04319094|564647131|FG000|6-month|Incomplete data collection|14|||
156424701|NCT04319094|564647132|FG001|6-month|Incomplete data collection|9|||
156424702|NCT04319094|564647131|FG000|9-month|Lost to Follow-up|8|||
156424703|NCT04319094|564647132|FG001|9-month|Lost to Follow-up|4|||
156424704|NCT04319094|564647131|FG000|9-month|Withdrawal by Subject|0|||
156424705|NCT04319094|564647132|FG001|9-month|Withdrawal by Subject|1|||
156424706|NCT04319094|564647131|FG000|9-month|Incomplete data collection|8|||
156424707|NCT04319094|564647132|FG001|9-month|Incomplete data collection|5|||
156424708|NCT04319094|564647131|FG000|12-month|Lost to Follow-up|11|||
156424709|NCT04319094|564647132|FG001|12-month|Lost to Follow-up|8|||
156424710|NCT00877851|564647133|FG000|Overall Study|Lost to Follow-up|5|||
156424711|NCT00877851|564647134|FG001|Overall Study|Lost to Follow-up|5|||
156424712|NCT00877851|564647133|FG000|Overall Study|computer problem|3|||
156424713|NCT00877851|564647134|FG001|Overall Study|computer problem|0|||
156424714|NCT00877851|564647133|FG000|Overall Study|no longer interested in participating|1|||
156424715|NCT00877851|564647134|FG001|Overall Study|no longer interested in participating|0|||
156424716|NCT03285711|564647135|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
156321604|NCT02361346|564275102|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156321605|NCT02361346|564275103|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
156321606|NCT02361346|564275104|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156338116|NCT01847274|564336532|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156338117|NCT01847274|564336522|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156338118|NCT01847274|564336523|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156338119|NCT01847274|564336524|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156338120|NCT01847274|564336525|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156338121|NCT01847274|564336526|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156338122|NCT01847274|564336527|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156338123|NCT01847274|564336528|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156338124|NCT01847274|564336529|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
156338125|NCT01847274|564336530|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156338126|NCT01847274|564336531|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
156338127|NCT01847274|564336532|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
156338128|NCT01847274|564336522|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338129|NCT01847274|564336523|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338130|NCT01847274|564336524|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338131|NCT01847274|564336525|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338132|NCT01847274|564336526|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338133|NCT01847274|564336527|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338134|NCT01847274|564336528|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338135|NCT01847274|564336529|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338136|NCT01847274|564336530|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338137|NCT01847274|564336531|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
156338138|NCT01847274|564336532|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156338139|NCT00261807|564336533|FG000|Overall Study|Lost to Follow-up|2|||
156338140|NCT00261807|564336533|FG000|Overall Study|Adverse Event|2|||
156338141|NCT00261807|564336533|FG000|Overall Study|Death|1|||
156338142|NCT00261807|564336533|FG000|Overall Study|Protocol Violation|2|||
156338143|NCT01706146|564336534|FG000|Overall Study|Withdrawal by Subject|1|||
156338144|NCT01706146|564336534|FG000|Overall Study|Adverse Event|3|||
156338145|NCT01706146|564336534|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
156338146|NCT02582983|564336535|FG000|Overall Study|Death|3|||
156338147|NCT02582983|564336535|FG000|Overall Study|Withdrawal by Subject|2|||
156338148|NCT02582983|564336535|FG000|Overall Study|Adverse Event|1|||
156338149|NCT02021331|564336536|FG000|Overall Study|Adverse Event|0|||
156338150|NCT02021331|564336537|FG001|Overall Study|Adverse Event|2|||
156338151|NCT01619423|564336547|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
156338152|NCT01619423|564336548|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
156338153|NCT01619423|564336549|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
156338154|NCT01619423|564336550|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
156338155|NCT02590003|564336558|FG000|Overall Study|Death|1|||
156338156|NCT02590003|564336559|FG001|Overall Study|Death|2|||
156338157|NCT02589405|564336563|FG000|Overall Study|Adverse Event|3|||
156338158|NCT02589405|564336563|FG000|Overall Study|Withdrawal by Subject|1|||
156338159|NCT03330288|564336566|FG000|Overall Study|Other reason|1|||
156338160|NCT03330288|564336567|FG001|Overall Study|Other reason|1|||
156338161|NCT03330288|564336566|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
156338162|NCT03330288|564336567|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
156338163|NCT03330288|564336566|FG000|Overall Study|Adverse Event|1|||
156338164|NCT03330288|564336567|FG001|Overall Study|Adverse Event|0|||
156338165|NCT03330288|564336566|FG000|Overall Study|Withdrawal by Subject|1|||
156338166|NCT03330288|564336567|FG001|Overall Study|Withdrawal by Subject|0|||
156338167|NCT03330288|564336566|FG000|Overall Study|Lost to Follow-up|26|||
156338168|NCT03330288|564336567|FG001|Overall Study|Lost to Follow-up|7|||
156338169|NCT02264639|564336569|FG000|Overall Study|Death (after completing single-dose phase)|1|||
156338170|NCT02264639|564336570|FG001|Overall Study|Death (after completing single-dose phase)|0|||
156338171|NCT02264639|564336571|FG002|Overall Study|Death (after completing single-dose phase)|0|||
156338172|NCT02264639|564336572|FG003|Overall Study|Death (after completing single-dose phase)|0|||
156338173|NCT02264639|564336573|FG004|Overall Study|Death (after completing single-dose phase)|0|||
156338174|NCT02264639|564336569|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
156338175|NCT02264639|564336570|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
156338176|NCT02264639|564336571|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
156338177|NCT02264639|564336572|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
156424717|NCT03285711|564647136|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
156424718|NCT03285711|564647137|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
156424719|NCT03285711|564647138|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
156424720|NCT03285711|564647135|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
156424721|NCT03285711|564647136|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
156424722|NCT03285711|564647137|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
156424723|NCT03285711|564647138|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
156424724|NCT03285711|564647135|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
156424725|NCT03285711|564647136|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
156424726|NCT03285711|564647137|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
156424727|NCT03285711|564647138|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
156424728|NCT03285711|564647135|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
156424729|NCT03285711|564647136|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
156424730|NCT03285711|564647137|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
156424731|NCT03285711|564647138|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
156424732|NCT03424239|564647148|FG000|Overall Study|Withdrawal by Subject|2|||
156424733|NCT00770211|564647149|FG000|Overall Study|Lost to Follow-up|1|||
156424734|NCT00770211|564647150|FG001|Overall Study|Lost to Follow-up|0|||
156424735|NCT00770211|564647149|FG000|Overall Study|Withdrawal by Subject|0|||
156424736|NCT00770211|564647150|FG001|Overall Study|Withdrawal by Subject|2|||
156424737|NCT00235495|564647151|FG000|Overall Study|Death|52|||
156424738|NCT00235495|564647152|FG001|Overall Study|Death|42|||
156424739|NCT00235495|564647151|FG000|Overall Study|Withdrawal by Subject|5|||
156424740|NCT00235495|564647152|FG001|Overall Study|Withdrawal by Subject|3|||
156424741|NCT00235495|564647151|FG000|Overall Study|Lost to Follow-up|11|||
156424742|NCT00235495|564647152|FG001|Overall Study|Lost to Follow-up|13|||
156424743|NCT00235495|564647151|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
156424744|NCT00235495|564647152|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
156424745|NCT00318656|564647154|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
156424746|NCT00318656|564647155|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
156424747|NCT00318656|564647154|FG000|Overall Study|Did not receive any treatment|0|||
156424748|NCT00318656|564647155|FG001|Overall Study|Did not receive any treatment|1|||
156424749|NCT01446003|564647156|FG000|Period 1|Protocol Violation|2|||
156424750|NCT01446003|564647157|FG001|Period 1|Protocol Violation|0|||
156424751|NCT01446003|564647156|FG000|Period 2|Adverse Event|1|||
156424752|NCT01446003|564647157|FG001|Period 2|Adverse Event|0|||
156424753|NCT03905135|564647158|FG000|Dose Escalation|Adverse Event|1|||
156424754|NCT03905135|564647159|FG001|Dose Escalation|Adverse Event|1|||
156424755|NCT03905135|564647158|FG000|Dose Escalation|Progressive disease|3|||
156424756|NCT03905135|564647159|FG001|Dose Escalation|Progressive disease|1|||
156424757|NCT03905135|564647158|FG000|Dose Escalation|Intercurrent illness|1|||
156424758|NCT03905135|564647159|FG001|Dose Escalation|Intercurrent illness|0|||
156424759|NCT01740557|564647160|FG000|Overall Study|Ineligible|1|||
156424760|NCT01740557|564647160|FG000|Overall Study|Screen failure|1|||
156424761|NCT00490555|564647161|FG000|Overall Study|noncompliant with drug administration|0|||
156424762|NCT00490555|564647162|FG001|Overall Study|noncompliant with drug administration|0|||
156424763|NCT00490555|564647163|FG002|Overall Study|noncompliant with drug administration|2|||
156424764|NCT00490555|564647164|FG003|Overall Study|noncompliant with drug administration|0|||
156424765|NCT01007149|564647167|FG000|Overall Study|Administrative problems|0|||
156424766|NCT01007149|564647168|FG001|Overall Study|Administrative problems|1|||
156424767|NCT03568162|564647169|FG000|Overall Study|Adverse Event|0|||
156424768|NCT03568162|564647170|FG001|Overall Study|Adverse Event|1|||
156424769|NCT03568162|564647171|FG002|Overall Study|Adverse Event|2|||
156424770|NCT03568162|564647172|FG003|Overall Study|Adverse Event|0|||
156424771|NCT03568162|564647173|FG004|Overall Study|Adverse Event|0|||
156424772|NCT03568162|564647174|FG005|Overall Study|Adverse Event|1|||
156424773|NCT03568162|564647169|FG000|Overall Study|Death|0|||
156424774|NCT03568162|564647170|FG001|Overall Study|Death|0|||
156424775|NCT03568162|564647171|FG002|Overall Study|Death|0|||
156424776|NCT03568162|564647172|FG003|Overall Study|Death|0|||
156424777|NCT03568162|564647173|FG004|Overall Study|Death|1|||
156424778|NCT03568162|564647174|FG005|Overall Study|Death|0|||
156424779|NCT03568162|564647169|FG000|Overall Study|Lost to Follow-up|3|||
156424780|NCT03568162|564647170|FG001|Overall Study|Lost to Follow-up|2|||
156424781|NCT03568162|564647171|FG002|Overall Study|Lost to Follow-up|4|||
156424782|NCT03568162|564647172|FG003|Overall Study|Lost to Follow-up|2|||
156424783|NCT03568162|564647173|FG004|Overall Study|Lost to Follow-up|3|||
156424784|NCT03568162|564647174|FG005|Overall Study|Lost to Follow-up|2|||
156424785|NCT03568162|564647169|FG000|Overall Study|Physician Decision|0|||
156424786|NCT03568162|564647170|FG001|Overall Study|Physician Decision|1|||
156424787|NCT03568162|564647171|FG002|Overall Study|Physician Decision|1|||
156424788|NCT03568162|564647172|FG003|Overall Study|Physician Decision|0|||
156424789|NCT03568162|564647173|FG004|Overall Study|Physician Decision|1|||
156424790|NCT03568162|564647174|FG005|Overall Study|Physician Decision|0|||
156424791|NCT03568162|564647169|FG000|Overall Study|Pregnancy|0|||
156424792|NCT03568162|564647170|FG001|Overall Study|Pregnancy|0|||
156424793|NCT03568162|564647171|FG002|Overall Study|Pregnancy|0|||
156424794|NCT03568162|564647172|FG003|Overall Study|Pregnancy|1|||
156424795|NCT03568162|564647173|FG004|Overall Study|Pregnancy|0|||
156424796|NCT03568162|564647174|FG005|Overall Study|Pregnancy|0|||
156424797|NCT03568162|564647169|FG000|Overall Study|Protocol Violation|1|||
156424798|NCT03568162|564647170|FG001|Overall Study|Protocol Violation|0|||
156424799|NCT03568162|564647171|FG002|Overall Study|Protocol Violation|1|||
156424800|NCT03568162|564647172|FG003|Overall Study|Protocol Violation|1|||
156424801|NCT03568162|564647173|FG004|Overall Study|Protocol Violation|1|||
156424802|NCT03568162|564647174|FG005|Overall Study|Protocol Violation|1|||
156424803|NCT03568162|564647169|FG000|Overall Study|Withdrawal by Subject|15|||
156424804|NCT03568162|564647170|FG001|Overall Study|Withdrawal by Subject|15|||
156424805|NCT03568162|564647171|FG002|Overall Study|Withdrawal by Subject|26|||
156424806|NCT03568162|564647172|FG003|Overall Study|Withdrawal by Subject|22|||
156424807|NCT03568162|564647173|FG004|Overall Study|Withdrawal by Subject|6|||
156424808|NCT03568162|564647174|FG005|Overall Study|Withdrawal by Subject|9|||
156424809|NCT03568162|564647169|FG000|Overall Study|Others|3|||
156424810|NCT03568162|564647170|FG001|Overall Study|Others|4|||
156424811|NCT03568162|564647171|FG002|Overall Study|Others|1|||
156424812|NCT03568162|564647172|FG003|Overall Study|Others|4|||
156424813|NCT03568162|564647173|FG004|Overall Study|Others|2|||
156424814|NCT03568162|564647174|FG005|Overall Study|Others|1|||
156424815|NCT00938340|564647175|FG000|Overall Study|Withdrawal by Subject|3|||
156424816|NCT00938340|564647175|FG000|Overall Study|Protocol Violation|1|||
156424817|NCT00938340|564647175|FG000|Overall Study|Adverse Event|1|||
156424818|NCT02909101|564647176|FG000|Overall Study|Lost to Follow-up|1|||
156424819|NCT02909101|564647177|FG001|Overall Study|Lost to Follow-up|1|||
156424820|NCT02189863|564647178|FG000|First 2 Weeks|Motion Sickness|4|||
156424821|NCT02189863|564647179|FG001|First 2 Weeks|Motion Sickness|2|||
156424822|NCT03697460|564647180|FG000|Overall Study|Withdrawal by Subject|3|||
156424823|NCT01080131|564647182|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
156424824|NCT01080131|564647183|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
156424825|NCT01080131|564647182|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
156762003|NCT05616013|565879945|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762004|NCT05616013|565879946|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156424826|NCT01080131|564647183|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
156424827|NCT01080131|564647182|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
156424828|NCT01080131|564647183|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
156424829|NCT01080131|564647182|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
156424830|NCT01080131|564647183|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
156321607|NCT04369053|564276797|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
156321608|NCT04369053|564276797|FG000|Overall Study|Withdrawal by Subject|773|||
156321609|NCT04369053|564276797|FG000|Overall Study|Lost to Follow-up|182|||
156321610|NCT04369053|564276797|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
156321611|NCT01695005|564276798|FG000|Overall Study|Lost to Follow-up|0|||
156321612|NCT01695005|564276799|FG001|Overall Study|Lost to Follow-up|1|||
156321613|NCT01695005|564276800|FG002|Overall Study|Lost to Follow-up|1|||
156321614|NCT01695005|564276801|FG003|Overall Study|Lost to Follow-up|0|||
156321615|NCT01695005|564276802|FG004|Overall Study|Lost to Follow-up|0|||
156321616|NCT01695005|564276803|FG005|Overall Study|Lost to Follow-up|1|||
156321617|NCT01695005|564276804|FG006|Overall Study|Lost to Follow-up|1|||
156321618|NCT01695005|564276805|FG007|Overall Study|Lost to Follow-up|1|||
156321619|NCT01695005|564276806|FG008|Overall Study|Lost to Follow-up|3|||
156321620|NCT01695005|564276807|FG009|Overall Study|Lost to Follow-up|3|||
156321621|NCT01695005|564276808|FG010|Overall Study|Lost to Follow-up|8|||
156321622|NCT01695005|564276809|FG011|Overall Study|Lost to Follow-up|5|||
156321623|NCT01695005|564276810|FG012|Overall Study|Lost to Follow-up|2|||
156321624|NCT01695005|564276811|FG013|Overall Study|Lost to Follow-up|5|||
156321625|NCT01695005|564276812|FG014|Overall Study|Lost to Follow-up|0|||
156321626|NCT01695005|564276813|FG015|Overall Study|Lost to Follow-up|4|||
156321627|NCT01695005|564276814|FG016|Overall Study|Lost to Follow-up|0|||
156321628|NCT01695005|564276815|FG017|Overall Study|Lost to Follow-up|0|||
156321629|NCT01695005|564276816|FG018|Overall Study|Lost to Follow-up|0|||
156321630|NCT01695005|564276817|FG019|Overall Study|Lost to Follow-up|1|||
156321631|NCT01695005|564276818|FG020|Overall Study|Lost to Follow-up|1|||
156321632|NCT01695005|564276819|FG021|Overall Study|Lost to Follow-up|0|||
156321633|NCT01695005|564276820|FG022|Overall Study|Lost to Follow-up|2|||
156321634|NCT01695005|564276821|FG023|Overall Study|Lost to Follow-up|4|||
156321635|NCT01695005|564276822|FG024|Overall Study|Lost to Follow-up|2|||
156321636|NCT01695005|564276823|FG025|Overall Study|Lost to Follow-up|0|||
156424831|NCT01080131|564647182|FG000|Core Study (0- 12 Weeks)|Death|1|||
156424832|NCT01080131|564647183|FG001|Core Study (0- 12 Weeks)|Death|0|||
156424833|NCT01080131|564647182|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
156424834|NCT01080131|564647183|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
156321637|NCT01695005|564276824|FG026|Overall Study|Lost to Follow-up|0|||
156321638|NCT01695005|564276825|FG027|Overall Study|Lost to Follow-up|0|||
156321639|NCT01695005|564276826|FG028|Overall Study|Lost to Follow-up|1|||
156321640|NCT01695005|564276798|FG000|Overall Study|Withdrawal by Subject|0|||
156321641|NCT01695005|564276799|FG001|Overall Study|Withdrawal by Subject|0|||
156424835|NCT01080131|564647182|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
156424836|NCT01080131|564647183|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
156424837|NCT01080131|564647182|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
156424838|NCT01080131|564647183|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
156424839|NCT01080131|564647182|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
156424840|NCT01080131|564647183|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
156424841|NCT01080131|564647182|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
156424842|NCT01080131|564647183|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
156424843|NCT01080131|564647182|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
156424844|NCT01080131|564647183|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
156424845|NCT01080131|564647182|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
156424846|NCT01080131|564647183|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
156424847|NCT01080131|564647182|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
156424848|NCT01080131|564647183|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
156424849|NCT00299702|564647184|FG000|Overall Study|Death|1|||
156424850|NCT00299702|564647185|FG001|Overall Study|Death|0|||
156424851|NCT00299702|564647184|FG000|Overall Study|Adverse Event|0|||
156424852|NCT00299702|564647185|FG001|Overall Study|Adverse Event|4|||
156424853|NCT00299702|564647184|FG000|Overall Study|Lost to Follow-up|18|||
156424854|NCT00299702|564647185|FG001|Overall Study|Lost to Follow-up|10|||
156424855|NCT00299702|564647184|FG000|Overall Study|Withdrawal by Subject|25|||
156424856|NCT00299702|564647185|FG001|Overall Study|Withdrawal by Subject|23|||
156424857|NCT00299702|564647184|FG000|Overall Study|Pregnancy|0|||
156424858|NCT00299702|564647185|FG001|Overall Study|Pregnancy|1|||
156424859|NCT00299702|564647184|FG000|Overall Study|Insufficient Response|4|||
156424860|NCT00299702|564647185|FG001|Overall Study|Insufficient Response|3|||
156424861|NCT00299702|564647184|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
156424862|NCT00299702|564647185|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
156424863|NCT01560949|564647186|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
156424864|NCT01560949|564647186|FG000|Surgery Phase|Physician Decision|3|||
156424865|NCT01140347|564647190|FG000|Overall Study|Lost to Follow-up|5|||
156424866|NCT01140347|564647191|FG001|Overall Study|Lost to Follow-up|6|||
156424867|NCT01140347|564647190|FG000|Overall Study|Withdrawal by Subject|13|||
156424868|NCT01140347|564647191|FG001|Overall Study|Withdrawal by Subject|8|||
156424869|NCT01959880|564647193|FG000|Overall Study|Withdrawal by Subject|11|||
156424870|NCT01959880|564647194|FG001|Overall Study|Withdrawal by Subject|13|||
156424871|NCT01959880|564647195|FG002|Overall Study|Withdrawal by Subject|8|||
156424872|NCT01959880|564647196|FG003|Overall Study|Withdrawal by Subject|7|||
156424873|NCT01959880|564647193|FG000|Overall Study|Death|1|||
156424874|NCT01959880|564647194|FG001|Overall Study|Death|10|||
156424875|NCT01959880|564647195|FG002|Overall Study|Death|1|||
156424876|NCT01959880|564647196|FG003|Overall Study|Death|2|||
156424877|NCT01959880|564647193|FG000|Overall Study|Lost to Follow-up|95|||
156424878|NCT01959880|564647194|FG001|Overall Study|Lost to Follow-up|18|||
156424879|NCT01959880|564647195|FG002|Overall Study|Lost to Follow-up|15|||
156424880|NCT01959880|564647196|FG003|Overall Study|Lost to Follow-up|8|||
156424881|NCT01959880|564647193|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
156424882|NCT01959880|564647194|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
156424883|NCT01959880|564647195|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
156424884|NCT01959880|564647196|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
156424885|NCT01959880|564647193|FG000|Overall Study|Study completed early-FDA approved|1003|||
156424886|NCT01959880|564647194|FG001|Overall Study|Study completed early-FDA approved|311|||
156424887|NCT01959880|564647195|FG002|Overall Study|Study completed early-FDA approved|179|||
156424888|NCT01959880|564647196|FG003|Overall Study|Study completed early-FDA approved|152|||
156424889|NCT02738840|564648965|FG000|Overall Study|MRI Scan not Performed|5|||
156424890|NCT02738840|564648965|FG000|Overall Study|Lost to Follow-up|1|||
156424891|NCT02738840|564648965|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
156424892|NCT02738840|564648965|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
156424893|NCT00256308|564648971|FG000|Overall Study|Death|2|||
156424894|NCT01537133|564648972|FG000|Overall Study|Withdrawal by Subject|2|||
156424895|NCT01537133|564648973|FG001|Overall Study|Withdrawal by Subject|0|||
156424896|NCT01537133|564648974|FG002|Overall Study|Withdrawal by Subject|0|||
156424897|NCT01537133|564648975|FG003|Overall Study|Withdrawal by Subject|0|||
156424898|NCT01537133|564648972|FG000|Overall Study|Lost to Follow-up|1|||
156424899|NCT01537133|564648973|FG001|Overall Study|Lost to Follow-up|0|||
156424900|NCT01537133|564648974|FG002|Overall Study|Lost to Follow-up|0|||
156424901|NCT01537133|564648975|FG003|Overall Study|Lost to Follow-up|0|||
156424902|NCT02466516|564648978|FG000|Overall Study|Adverse Event|1|||
156424903|NCT02466516|564648979|FG001|Overall Study|Adverse Event|1|||
156424904|NCT02466516|564648980|FG002|Overall Study|Adverse Event|0|||
156424905|NCT02466516|564648981|FG003|Overall Study|Adverse Event|0|||
156424906|NCT02466516|564648982|FG004|Overall Study|Adverse Event|0|||
156424907|NCT02466516|564648978|FG000|Overall Study|Withdrew Consent|1|||
156424908|NCT02466516|564648979|FG001|Overall Study|Withdrew Consent|0|||
156424909|NCT02466516|564648980|FG002|Overall Study|Withdrew Consent|0|||
156424910|NCT02466516|564648981|FG003|Overall Study|Withdrew Consent|0|||
156762005|NCT05616013|565879947|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762006|NCT05616013|565879948|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762007|NCT05616013|565879949|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762008|NCT05616013|565879950|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762009|NCT05616013|565879951|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156321642|NCT01695005|564276800|FG002|Overall Study|Withdrawal by Subject|0|||
156321643|NCT01695005|564276801|FG003|Overall Study|Withdrawal by Subject|2|||
156321644|NCT01695005|564276802|FG004|Overall Study|Withdrawal by Subject|0|||
156321645|NCT01695005|564276803|FG005|Overall Study|Withdrawal by Subject|1|||
156321646|NCT01695005|564276804|FG006|Overall Study|Withdrawal by Subject|0|||
156321647|NCT01695005|564276805|FG007|Overall Study|Withdrawal by Subject|1|||
156321648|NCT01695005|564276806|FG008|Overall Study|Withdrawal by Subject|0|||
156321649|NCT01695005|564276807|FG009|Overall Study|Withdrawal by Subject|1|||
156321650|NCT01695005|564276808|FG010|Overall Study|Withdrawal by Subject|2|||
156321651|NCT01695005|564276809|FG011|Overall Study|Withdrawal by Subject|1|||
156321652|NCT01695005|564276810|FG012|Overall Study|Withdrawal by Subject|1|||
156321653|NCT01695005|564276811|FG013|Overall Study|Withdrawal by Subject|0|||
156321654|NCT01695005|564276812|FG014|Overall Study|Withdrawal by Subject|0|||
156321655|NCT01695005|564276813|FG015|Overall Study|Withdrawal by Subject|0|||
156321656|NCT01695005|564276814|FG016|Overall Study|Withdrawal by Subject|0|||
156321657|NCT01695005|564276815|FG017|Overall Study|Withdrawal by Subject|0|||
156321658|NCT01695005|564276816|FG018|Overall Study|Withdrawal by Subject|2|||
156321659|NCT01695005|564276817|FG019|Overall Study|Withdrawal by Subject|0|||
156321660|NCT01695005|564276818|FG020|Overall Study|Withdrawal by Subject|1|||
156321661|NCT01695005|564276819|FG021|Overall Study|Withdrawal by Subject|0|||
156321662|NCT01695005|564276820|FG022|Overall Study|Withdrawal by Subject|0|||
156321663|NCT01695005|564276821|FG023|Overall Study|Withdrawal by Subject|0|||
156321664|NCT01695005|564276822|FG024|Overall Study|Withdrawal by Subject|1|||
156321665|NCT01695005|564276823|FG025|Overall Study|Withdrawal by Subject|0|||
156321666|NCT01695005|564276824|FG026|Overall Study|Withdrawal by Subject|0|||
156321667|NCT01695005|564276825|FG027|Overall Study|Withdrawal by Subject|1|||
156321668|NCT01695005|564276826|FG028|Overall Study|Withdrawal by Subject|0|||
156321669|NCT03560739|564276828|FG000|Overall Study|Adverse Event|0|||
156321670|NCT03560739|564276829|FG001|Overall Study|Adverse Event|1|||
156321671|NCT03560739|564276830|FG002|Overall Study|Adverse Event|0|||
156321672|NCT03560739|564276831|FG003|Overall Study|Adverse Event|0|||
156321673|NCT01362595|564276832|FG000|Overall Study|Screen failure|10|||
156321674|NCT01362595|564276832|FG000|Overall Study|Withdrawal by Subject|2|||
156321675|NCT00959374|564276833|FG000|Overall Study|Withdrawal by Subject|2|||
156321676|NCT00959374|564276833|FG000|Overall Study|Lost to Follow-up|14|||
156321677|NCT00959374|564276833|FG000|Overall Study|Death|1|||
156321678|NCT00959374|564276833|FG000|Overall Study|Protocol Violation|1|||
156321679|NCT00959374|564276833|FG000|Overall Study|Implant Removed/Not Replaced|4|||
156321680|NCT00959374|564276833|FG000|Overall Study|Physician Decision|1|||
156321681|NCT02448680|564276834|FG000|Overall Study|Physician Decision|1|||
156321682|NCT02448680|564276835|FG001|Overall Study|Physician Decision|1|||
156321683|NCT02448680|564276834|FG000|Overall Study|Withdrawal by Subject|0|||
156321684|NCT02448680|564276835|FG001|Overall Study|Withdrawal by Subject|2|||
156321685|NCT01739400|564276836|FG000|Overall Study|Physician Decision|3|||
156321686|NCT01739400|564276837|FG001|Overall Study|Physician Decision|0|||
156321687|NCT01739400|564276836|FG000|Overall Study|Lost to Follow-up|2|||
156321688|NCT01739400|564276837|FG001|Overall Study|Lost to Follow-up|0|||
156321689|NCT01739400|564276836|FG000|Overall Study|Death|5|||
156321690|NCT01739400|564276837|FG001|Overall Study|Death|2|||
156321691|NCT01739400|564276836|FG000|Overall Study|Withdrawal by Subject|7|||
156321692|NCT01739400|564276837|FG001|Overall Study|Withdrawal by Subject|7|||
156321693|NCT01736657|564276838|FG000|Overall Study|insufficient vascular access|1|||
156321694|NCT03350984|564276839|FG000|Overall Study|Death|1|||
156321695|NCT03350984|564276840|FG001|Overall Study|Death|0|||
156321696|NCT03350984|564276839|FG000|Overall Study|Lost to Follow-up|5|||
156321697|NCT03350984|564276840|FG001|Overall Study|Lost to Follow-up|6|||
156321698|NCT03350984|564276839|FG000|Overall Study|Protocol Violation|1|||
156321699|NCT03350984|564276840|FG001|Overall Study|Protocol Violation|2|||
156321700|NCT03350984|564276839|FG000|Overall Study|Physician Decision|1|||
156321701|NCT03350984|564276840|FG001|Overall Study|Physician Decision|0|||
156321702|NCT00642473|564276849|FG000|Overall Study|Withdrawal by Subject|0|||
156321703|NCT00642473|564276850|FG001|Overall Study|Withdrawal by Subject|5|||
156321704|NCT00642473|564276849|FG000|Overall Study|Progression or death|2|||
156321705|NCT00642473|564276850|FG001|Overall Study|Progression or death|4|||
156321706|NCT00642473|564276849|FG000|Overall Study|Other|2|||
156321707|NCT00642473|564276850|FG001|Overall Study|Other|2|||
156321708|NCT01711879|564276853|FG000|Overall Study|Death|1|||
156321709|NCT01711879|564276854|FG001|Overall Study|Death|0|||
156321710|NCT00958789|564276858|FG000|Overall Study|Death|5|||
156321711|NCT00958789|564276858|FG000|Overall Study|Lost to Follow-up|14|||
156762010|NCT05616013|565879952|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762011|NCT05616013|565879944|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
156762012|NCT05616013|565879945|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762013|NCT05616013|565879946|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762014|NCT05616013|565879947|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762015|NCT05616013|565879948|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156321712|NCT00958789|564276858|FG000|Overall Study|Withdrawal by Subject|17|||
156321713|NCT00958789|564276858|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
156321714|NCT00958789|564276858|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
156321715|NCT00958789|564276858|FG000|Overall Study|Subject terminated|2|||
156321716|NCT00958789|564276858|FG000|Overall Study|Revision|7|||
156321717|NCT00478881|564276861|FG000|Overall Study|Adverse Event|31|||
156321718|NCT00478881|564276862|FG001|Overall Study|Adverse Event|12|||
156321719|NCT00478881|564276861|FG000|Overall Study|Lack of Efficacy|0|||
156321720|NCT00478881|564276862|FG001|Overall Study|Lack of Efficacy|3|||
156321721|NCT00478881|564276861|FG000|Overall Study|Lost to Follow-up|0|||
156321722|NCT00478881|564276862|FG001|Overall Study|Lost to Follow-up|1|||
156321723|NCT00478881|564276861|FG000|Overall Study|Protocol Violation|2|||
156321724|NCT00478881|564276862|FG001|Overall Study|Protocol Violation|2|||
156321725|NCT00478881|564276861|FG000|Overall Study|Withdrawal by Subject|6|||
156321726|NCT00478881|564276862|FG001|Overall Study|Withdrawal by Subject|2|||
156321727|NCT00478881|564276861|FG000|Overall Study|Non-Compliance with Study Medication|0|||
156321728|NCT00478881|564276862|FG001|Overall Study|Non-Compliance with Study Medication|2|||
156321729|NCT01083173|564276865|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
156321730|NCT01083173|564276866|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
156321731|NCT01083173|564276865|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
156321732|NCT01083173|564276866|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
156321733|NCT01083173|564276865|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
156321734|NCT01083173|564276866|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
156321735|NCT01083173|564276865|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
156321736|NCT01083173|564276866|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
156321737|NCT01083173|564276865|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
156321738|NCT01083173|564276866|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
156321739|NCT01083173|564276865|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
156321740|NCT01083173|564276866|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
156321741|NCT01083173|564276865|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
156321742|NCT01083173|564276866|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
156321743|NCT01083173|564276865|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
156321744|NCT01083173|564276866|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
156321745|NCT01083173|564276865|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
156321746|NCT01083173|564276866|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
156321747|NCT01083173|564276865|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
156321748|NCT01083173|564276866|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
156321749|NCT01083173|564276865|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
156321750|NCT01083173|564276866|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
156321751|NCT03410823|564276867|FG000|Overall Study|Death|1|||
156321752|NCT03410823|564276867|FG000|Overall Study|Withdrawal by Subject|2|||
156321753|NCT03410823|564276867|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
156321754|NCT04148911|564276869|FG000|Overall Study|Death|104|||
156321755|NCT04148911|564276869|FG000|Overall Study|Lost to Follow-up|5|||
156321756|NCT04148911|564276869|FG000|Overall Study|Withdrawal by Subject|17|||
156321757|NCT04148911|564276869|FG000|Overall Study|Study Ended by Sponsor|56|||
156321758|NCT04062123|564276870|FG000|Overall Study|Withdrawal by Subject|0|||
156321759|NCT04062123|564276871|FG001|Overall Study|Withdrawal by Subject|1|||
156321760|NCT04062123|564276872|FG002|Overall Study|Withdrawal by Subject|0|||
156321761|NCT00740246|564276877|FG000|Overall Study|Received Blood Transfusion|0|||
156321762|NCT00740246|564276878|FG001|Overall Study|Received Blood Transfusion|1|||
156321763|NCT00740246|564276877|FG000|Overall Study|Adverse Event|1|||
156321764|NCT00740246|564276878|FG001|Overall Study|Adverse Event|2|||
156321765|NCT00740246|564276877|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
156321766|NCT00740246|564276878|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
156321767|NCT00740246|564276877|FG000|Overall Study|Lost to Follow-up|2|||
156321768|NCT00740246|564276878|FG001|Overall Study|Lost to Follow-up|2|||
156321769|NCT00740246|564276877|FG000|Overall Study|Withdrawal by Subject|4|||
156321770|NCT00740246|564276878|FG001|Overall Study|Withdrawal by Subject|3|||
156321771|NCT00740246|564276877|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
156321772|NCT00740246|564276878|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
156762016|NCT05616013|565879949|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762017|NCT05616013|565879950|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762018|NCT05616013|565879951|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762019|NCT05616013|565879952|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762020|NCT05616013|565879944|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156321773|NCT00740246|564276877|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
156321774|NCT00740246|564276878|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
156321775|NCT00740246|564276877|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
156321776|NCT00740246|564276878|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
156321777|NCT00740246|564276877|FG000|Overall Study|Unable To Comply With Study Visits|2|||
156321778|NCT00740246|564276878|FG001|Overall Study|Unable To Comply With Study Visits|0|||
156321779|NCT00740246|564276877|FG000|Overall Study|Unable to Access Vein|0|||
156321780|NCT00740246|564276878|FG001|Overall Study|Unable to Access Vein|2|||
156321781|NCT00740246|564276877|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
156321782|NCT00740246|564276878|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
156321783|NCT01041495|564276879|FG000|Overall Study|Withdrawal by Subject|2|||
156321784|NCT01041495|564276880|FG001|Overall Study|Withdrawal by Subject|5|||
156321785|NCT01041495|564276879|FG000|Overall Study|Adverse Event|2|||
156321786|NCT01041495|564276880|FG001|Overall Study|Adverse Event|1|||
156321787|NCT01041495|564276879|FG000|Overall Study|Lost to Follow-up|0|||
156321788|NCT01041495|564276880|FG001|Overall Study|Lost to Follow-up|1|||
156321789|NCT03584373|564276881|FG000|Overall Study|Lost to Follow-up|7|||
156321790|NCT03584373|564276882|FG001|Overall Study|Lost to Follow-up|8|||
156321791|NCT03780400|564276884|FG000|Overall Study|Lost to Follow-up|5|||
156321792|NCT03780400|564276884|FG000|Overall Study|Withdrawal by Subject|2|||
156321793|NCT01850602|564276885|FG000|Overall Study|Adverse Event|7|||
156321794|NCT01850602|564276886|FG001|Overall Study|Adverse Event|10|||
156321795|NCT01850602|564276885|FG000|Overall Study|Physician Decision|2|||
156321796|NCT01850602|564276886|FG001|Overall Study|Physician Decision|1|||
156321797|NCT01850602|564276885|FG000|Overall Study|Withdrawal by Subject|2|||
156321798|NCT01850602|564276886|FG001|Overall Study|Withdrawal by Subject|4|||
156321799|NCT01850602|564276885|FG000|Overall Study|Decrease in serum calcium|2|||
156321800|NCT01850602|564276886|FG001|Overall Study|Decrease in serum calcium|3|||
156321801|NCT01850602|564276885|FG000|Overall Study|Increase in serum ferritin|1|||
156321802|NCT01850602|564276886|FG001|Overall Study|Increase in serum ferritin|0|||
156321803|NCT00366340|564276887|FG000|Infant Series|Protocol Violation|3|||
156321804|NCT00366340|564276888|FG001|Infant Series|Protocol Violation|4|||
156321805|NCT00366340|564276887|FG000|Infant Series|Withdrawal by Subject|3|||
156321806|NCT00366340|564276888|FG001|Infant Series|Withdrawal by Subject|3|||
156321807|NCT00366340|564276887|FG000|Infant Series|Adverse Event|0|||
156321808|NCT00366340|564276888|FG001|Infant Series|Adverse Event|2|||
156321809|NCT00366340|564276887|FG000|Infant Series|Lost to Follow-up|1|||
156321810|NCT00366340|564276888|FG001|Infant Series|Lost to Follow-up|1|||
156321811|NCT00366340|564276887|FG000|Infant Series|Failure to return|1|||
156321812|NCT00366340|564276888|FG001|Infant Series|Failure to return|0|||
156321813|NCT00366340|564276887|FG000|After the Infant Series|Parent/legal guardian request|1|||
156321814|NCT00366340|564276888|FG001|After the Infant Series|Parent/legal guardian request|1|||
156321815|NCT00366340|564276887|FG000|After the Infant Series|Failed to return|0|||
156321816|NCT00366340|564276888|FG001|After the Infant Series|Failed to return|1|||
156321817|NCT00366340|564276887|FG000|After the Infant Series|Protocol Violation|2|||
156321818|NCT00366340|564276888|FG001|After the Infant Series|Protocol Violation|2|||
156321819|NCT00366340|564276887|FG000|After the Infant Series|Adverse Event|0|||
156321820|NCT00366340|564276888|FG001|After the Infant Series|Adverse Event|1|||
156321821|NCT00366340|564276887|FG000|After the Infant Series|Lost to Follow-up|0|||
156321822|NCT00366340|564276888|FG001|After the Infant Series|Lost to Follow-up|1|||
156321823|NCT00366340|564276887|FG000|Toddler Dose|Failed to return|1|||
156321824|NCT00366340|564276888|FG001|Toddler Dose|Failed to return|0|||
156321825|NCT00366340|564276887|FG000|Toddler Dose|Parent/legal guardian request|0|||
156321826|NCT00366340|564276888|FG001|Toddler Dose|Parent/legal guardian request|1|||
156321827|NCT00367770|564276889|FG000|Overall Study|Adverse Event|1|||
156321828|NCT00367770|564276889|FG000|Overall Study|Withdrawal by Subject|1|||
156321829|NCT03282565|564276894|FG000|Overall Study|COVID-19 Research Shutdown|0|||
156321830|NCT03282565|564276895|FG001|Overall Study|COVID-19 Research Shutdown|2|||
156321831|NCT03282565|564276896|FG002|Overall Study|COVID-19 Research Shutdown|2|||
156321832|NCT00740051|564276897|FG000|Overall Study|Lack of Efficacy|2|||
156321833|NCT00740051|564276898|FG001|Overall Study|Lack of Efficacy|5|||
156321834|NCT00740051|564276897|FG000|Overall Study|Adverse Event|1|||
156321835|NCT00740051|564276898|FG001|Overall Study|Adverse Event|4|||
156321836|NCT00740051|564276897|FG000|Overall Study|Protocol Violation|2|||
156321837|NCT00740051|564276898|FG001|Overall Study|Protocol Violation|6|||
156321838|NCT00740051|564276897|FG000|Overall Study|Lost to Follow-up|3|||
156321839|NCT00740051|564276898|FG001|Overall Study|Lost to Follow-up|8|||
156424911|NCT02466516|564648982|FG004|Overall Study|Withdrew Consent|0|||
156424912|NCT02466516|564648978|FG000|Overall Study|Lost to Follow-up|2|||
156424913|NCT02466516|564648979|FG001|Overall Study|Lost to Follow-up|0|||
156424914|NCT02466516|564648980|FG002|Overall Study|Lost to Follow-up|1|||
156424915|NCT02466516|564648981|FG003|Overall Study|Lost to Follow-up|0|||
156424916|NCT02466516|564648982|FG004|Overall Study|Lost to Follow-up|0|||
156424917|NCT04358549|564648983|FG000|Overall Study|Adverse Event|0|||
156424918|NCT04358549|564648984|FG001|Overall Study|Adverse Event|1|||
156424919|NCT04358549|564648983|FG000|Overall Study|Death|1|||
156424920|NCT04358549|564648984|FG001|Overall Study|Death|0|||
156424921|NCT04358549|564648983|FG000|Overall Study|Lost to Follow-up|2|||
156424922|NCT04358549|564648984|FG001|Overall Study|Lost to Follow-up|1|||
156424923|NCT04358549|564648983|FG000|Overall Study|Withdrawal by Subject|6|||
156424924|NCT04358549|564648984|FG001|Overall Study|Withdrawal by Subject|6|||
156424925|NCT04358549|564648983|FG000|Overall Study|Start remdesivir|1|||
156424926|NCT04358549|564648984|FG001|Overall Study|Start remdesivir|0|||
156424927|NCT03712930|564648985|FG000|Overall Study|Death|7|||
156424928|NCT03712930|564648985|FG000|Overall Study|Physician Decision|1|||
156424929|NCT03712930|564648985|FG000|Overall Study|Study Terminated by Sponsor|3|||
156424930|NCT03712930|564648985|FG000|Overall Study|Progressive Disease|2|||
156424931|NCT01062126|564648989|FG000|Overall Study|Death|209|||
156424932|NCT01062126|564648989|FG000|Overall Study|All Withdrawals|324|||
156424933|NCT00646451|564648990|FG000|Overall Study|Adverse Event|3|||
156762021|NCT05616013|565879945|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
156762022|NCT05616013|565879946|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762023|NCT05616013|565879947|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762024|NCT05616013|565879948|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762025|NCT05616013|565879949|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762026|NCT05616013|565879950|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762027|NCT05616013|565879951|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762028|NCT05616013|565879952|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156424934|NCT00646451|564648991|FG001|Overall Study|Adverse Event|0|||
156424935|NCT00646451|564648990|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
156424936|NCT00646451|564648991|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
156424937|NCT03784963|564648992|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
156424938|NCT03784963|564648993|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
156424939|NCT03784963|564648994|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
156424940|NCT03784963|564648995|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
156424941|NCT05355116|564648996|FG000|Overall Study|Withdrawal by Subject|2|||
156424942|NCT00868231|564648997|FG000|Treatment Period 1|Adverse Event|0|||
156424943|NCT00868231|564648998|FG001|Treatment Period 1|Adverse Event|0|||
156762029|NCT05616013|565879944|FG000|Overall Study|Participant Decision, Time Constraints|0|||
156762030|NCT05616013|565879945|FG001|Overall Study|Participant Decision, Time Constraints|1|||
156762031|NCT05616013|565879946|FG002|Overall Study|Participant Decision, Time Constraints|0|||
156762032|NCT05616013|565879947|FG003|Overall Study|Participant Decision, Time Constraints|0|||
156762033|NCT05616013|565879948|FG004|Overall Study|Participant Decision, Time Constraints|0|||
156762034|NCT05616013|565879949|FG005|Overall Study|Participant Decision, Time Constraints|0|||
156762035|NCT05616013|565879950|FG006|Overall Study|Participant Decision, Time Constraints|0|||
156424944|NCT00868231|564648999|FG002|Treatment Period 1|Adverse Event|0|||
156424945|NCT00868231|564649000|FG003|Treatment Period 1|Adverse Event|0|||
156424946|NCT00868231|564649001|FG004|Treatment Period 1|Adverse Event|1|||
156424947|NCT00868231|564649002|FG005|Treatment Period 1|Adverse Event|0|||
156424948|NCT00868231|564648997|FG000|Treatment Period 2|Adverse Event|1|||
156424949|NCT00868231|564648998|FG001|Treatment Period 2|Adverse Event|0|||
156424950|NCT00868231|564648999|FG002|Treatment Period 2|Adverse Event|0|||
156424951|NCT00868231|564649000|FG003|Treatment Period 2|Adverse Event|0|||
156424952|NCT00868231|564649001|FG004|Treatment Period 2|Adverse Event|0|||
156424953|NCT00868231|564649002|FG005|Treatment Period 2|Adverse Event|0|||
156424954|NCT00868231|564648997|FG000|Treatment Period 3|Adverse Event|0|||
156424955|NCT00868231|564648998|FG001|Treatment Period 3|Adverse Event|0|||
156424956|NCT00868231|564648999|FG002|Treatment Period 3|Adverse Event|1|||
156424957|NCT00868231|564649000|FG003|Treatment Period 3|Adverse Event|0|||
156424958|NCT00868231|564649001|FG004|Treatment Period 3|Adverse Event|0|||
156424959|NCT00868231|564649002|FG005|Treatment Period 3|Adverse Event|0|||
156424960|NCT01168401|564649003|FG000|Overall Study|Lost to Follow-up|1|||
156424961|NCT01168401|564649004|FG001|Overall Study|Lost to Follow-up|1|||
156424962|NCT01168401|564649005|FG002|Overall Study|Lost to Follow-up|2|||
156424963|NCT01168401|564649006|FG003|Overall Study|Lost to Follow-up|1|||
156424964|NCT01168401|564649007|FG004|Overall Study|Lost to Follow-up|0|||
156424965|NCT01168401|564649008|FG005|Overall Study|Lost to Follow-up|0|||
156424966|NCT01168401|564649009|FG006|Overall Study|Lost to Follow-up|0|||
156424967|NCT01168401|564649010|FG007|Overall Study|Lost to Follow-up|0|||
156424968|NCT01168401|564649011|FG008|Overall Study|Lost to Follow-up|0|||
156424969|NCT01168401|564649012|FG009|Overall Study|Lost to Follow-up|0|||
156424970|NCT01168401|564649013|FG010|Overall Study|Lost to Follow-up|0|||
156424971|NCT01168401|564649003|FG000|Overall Study|Withdrawal by Subject|0|||
156424972|NCT01168401|564649004|FG001|Overall Study|Withdrawal by Subject|0|||
156424973|NCT01168401|564649005|FG002|Overall Study|Withdrawal by Subject|0|||
156424974|NCT01168401|564649006|FG003|Overall Study|Withdrawal by Subject|1|||
156424975|NCT01168401|564649007|FG004|Overall Study|Withdrawal by Subject|0|||
156424976|NCT01168401|564649008|FG005|Overall Study|Withdrawal by Subject|0|||
156321840|NCT00740051|564276897|FG000|Overall Study|Withdrawal by Subject|6|||
156424977|NCT01168401|564649009|FG006|Overall Study|Withdrawal by Subject|0|||
156424978|NCT01168401|564649010|FG007|Overall Study|Withdrawal by Subject|0|||
156424979|NCT01168401|564649011|FG008|Overall Study|Withdrawal by Subject|0|||
156424980|NCT01168401|564649012|FG009|Overall Study|Withdrawal by Subject|0|||
156424981|NCT01168401|564649013|FG010|Overall Study|Withdrawal by Subject|0|||
156424982|NCT01801930|564649019|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
156424983|NCT01801930|564649020|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
156424984|NCT01801930|564649021|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
156424985|NCT01801930|564649022|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
156424986|NCT01801930|564649019|FG000|Overall Study|DLT occurs|0|||
156424987|NCT01801930|564649020|FG001|Overall Study|DLT occurs|1|||
156424988|NCT01801930|564649021|FG002|Overall Study|DLT occurs|0|||
156424989|NCT01801930|564649022|FG003|Overall Study|DLT occurs|0|||
156424990|NCT02072226|564649023|FG000|Overall Study|Lost to Follow-up|11|||
156424991|NCT02072226|564649024|FG001|Overall Study|Lost to Follow-up|7|||
156424992|NCT02072226|564649023|FG000|Overall Study|Patient Non-compliance|2|||
156424993|NCT02072226|564649024|FG001|Overall Study|Patient Non-compliance|3|||
156424994|NCT02072226|564649023|FG000|Overall Study|Death|1|||
156424995|NCT02072226|564649024|FG001|Overall Study|Death|0|||
156424996|NCT02072226|564649023|FG000|Overall Study|Patient Withdrawal of Consent|1|||
156424997|NCT02072226|564649024|FG001|Overall Study|Patient Withdrawal of Consent|0|||
156424998|NCT03255018|564649026|FG000|Overall Study|Death on study|0|||
156321841|NCT00740051|564276898|FG001|Overall Study|Withdrawal by Subject|8|||
156321842|NCT00740051|564276897|FG000|Overall Study|Other reason (not specified)|4|||
156321843|NCT00740051|564276898|FG001|Overall Study|Other reason (not specified)|1|||
156321844|NCT02011893|564276899|FG000|Enrollment to Randomization|Adverse Event|2|||
156321845|NCT02011893|564276900|FG001|Enrollment to Randomization|Adverse Event|0|||
156321846|NCT02011893|564276901|FG002|Enrollment to Randomization|Adverse Event|0|||
156321847|NCT02011893|564276899|FG000|Enrollment to Randomization|Physician Decision|10|||
156321848|NCT02011893|564276900|FG001|Enrollment to Randomization|Physician Decision|0|||
156321849|NCT02011893|564276901|FG002|Enrollment to Randomization|Physician Decision|0|||
156321850|NCT02011893|564276899|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
156321851|NCT02011893|564276900|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
156321852|NCT02011893|564276901|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
156321853|NCT02011893|564276899|FG000|Enrollment to Randomization|Screening Failure|29|||
156321854|NCT02011893|564276900|FG001|Enrollment to Randomization|Screening Failure|0|||
156321855|NCT02011893|564276901|FG002|Enrollment to Randomization|Screening Failure|0|||
156321856|NCT02011893|564276899|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
156321857|NCT02011893|564276900|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
156321858|NCT02011893|564276901|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
156321859|NCT02011893|564276899|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
156321860|NCT02011893|564276900|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
156321861|NCT02011893|564276901|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
156321862|NCT02011893|564276899|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
156321863|NCT02011893|564276900|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
156321864|NCT02011893|564276901|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
156321865|NCT02011893|564276899|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
156321866|NCT02011893|564276900|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
156321867|NCT02011893|564276901|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
156321868|NCT02011893|564276899|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
156321869|NCT02011893|564276900|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
156321870|NCT02011893|564276901|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
156321871|NCT01001299|564276903|FG000|Overall Study|Insufficient Therapeutic Response|20|||
156321872|NCT01001299|564276903|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
156321873|NCT01001299|564276903|FG000|Overall Study|Death|1|||
156321874|NCT01001299|564276903|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
156321875|NCT01001299|564276903|FG000|Overall Study|Withdrew Consent|1|||
156321876|NCT05101317|564276904|FG000|Week1-13|Adverse Event|0|||
156424999|NCT03255018|564649027|FG001|Overall Study|Death on study|5|||
156425000|NCT03255018|564649026|FG000|Overall Study|Withdrawal by Subject|0|||
156425001|NCT03255018|564649027|FG001|Overall Study|Withdrawal by Subject|2|||
156425002|NCT01720043|564649029|FG000|Overall Study|Withdrawal by Subject|1|||
156425003|NCT01688973|564649030|FG000|Overall Study|Ineligible|2|||
156425004|NCT01688973|564649031|FG001|Overall Study|Ineligible|3|||
156425005|NCT03613129|564649035|FG000|Pre-treatment Assessment|Protocol Violation|2|||
156425006|NCT03613129|564649036|FG001|Pre-treatment Assessment|Protocol Violation|0|||
156425007|NCT03613129|564649037|FG002|Pre-treatment Assessment|Protocol Violation|0|||
156425008|NCT03613129|564649038|FG003|Pre-treatment Assessment|Protocol Violation|0|||
156425009|NCT03613129|564649039|FG004|Pre-treatment Assessment|Protocol Violation|0|||
156425010|NCT03613129|564649035|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
156425011|NCT03613129|564649036|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
156425012|NCT03613129|564649037|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
156425013|NCT03613129|564649038|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
156425014|NCT03613129|564649039|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
156425015|NCT03396835|564649042|FG000|Overall Study|Withdrawn prior to completion|1|||
156425016|NCT03396835|564649042|FG000|Overall Study|Did not meet criteria for data analysis|1|||
156425017|NCT01451814|564649043|FG000|Overall Study|Withdrawal by Subject|1|||
156425018|NCT01451814|564649044|FG001|Overall Study|Withdrawal by Subject|1|||
156425019|NCT01451814|564649043|FG000|Overall Study|Lost to Follow-up|5|||
156425020|NCT01451814|564649044|FG001|Overall Study|Lost to Follow-up|4|||
156425021|NCT02049866|564649045|FG000|Overall Study|Withdrawal by Subject|1|||
156762036|NCT05616013|565879951|FG007|Overall Study|Participant Decision, Time Constraints|0|||
156762037|NCT05616013|565879952|FG008|Overall Study|Participant Decision, Time Constraints|0|||
156762038|NCT05616013|565879944|FG000|Overall Study|Prohibited Concomitant Medication|0|||
156762039|NCT05616013|565879945|FG001|Overall Study|Prohibited Concomitant Medication|0|||
156425022|NCT04353037|564649047|FG000|Overall Study|Lost to Follow-up|0|||
156425023|NCT04353037|564649048|FG001|Overall Study|Lost to Follow-up|1|||
156425024|NCT04353037|564649049|FG002|Overall Study|Lost to Follow-up|2|||
156425025|NCT04353037|564649050|FG003|Overall Study|Lost to Follow-up|3|||
156425026|NCT04353037|564649047|FG000|Overall Study|Withdrawal by Subject|0|||
156425027|NCT04353037|564649048|FG001|Overall Study|Withdrawal by Subject|2|||
156425028|NCT04353037|564649049|FG002|Overall Study|Withdrawal by Subject|3|||
156425029|NCT04353037|564649050|FG003|Overall Study|Withdrawal by Subject|5|||
156425030|NCT04353037|564649047|FG000|Overall Study|Adverse Event|0|||
156425031|NCT04353037|564649048|FG001|Overall Study|Adverse Event|0|||
156425032|NCT04353037|564649049|FG002|Overall Study|Adverse Event|2|||
156425033|NCT04353037|564649050|FG003|Overall Study|Adverse Event|0|||
156425034|NCT04353037|564649047|FG000|Overall Study|Exposure Change|0|||
156425035|NCT04353037|564649048|FG001|Overall Study|Exposure Change|0|||
156425036|NCT04353037|564649049|FG002|Overall Study|Exposure Change|0|||
156425037|NCT04353037|564649050|FG003|Overall Study|Exposure Change|2|||
156425038|NCT03101592|564649051|FG000|Overall Study|participant files could not be located|111|||
156425039|NCT03101592|564649052|FG001|Overall Study|participant files could not be located|170|||
156425040|NCT03101592|564649053|FG002|Overall Study|participant files could not be located|118|||
156425041|NCT02219490|564649056|FG000|Overall Study|Adverse Event|24|||
156425042|NCT02219490|564649056|FG000|Overall Study|Withdrew consent|96|||
156425043|NCT02219490|564649056|FG000|Overall Study|Lost to Follow-up|126|||
156425044|NCT02219490|564649056|FG000|Overall Study|COVID-19 infection|2|||
156425045|NCT02219490|564649056|FG000|Overall Study|COVID-19 logistical restrictions|33|||
156425046|NCT02219490|564649056|FG000|Overall Study|Other, not specified|57|||
156425047|NCT01352507|564649060|FG000|Treatment Period 1|Adverse Event|3|||
156425048|NCT01352507|564649061|FG001|Treatment Period 1|Adverse Event|0|||
156425049|NCT01352507|564649060|FG000|Treatment Period 1|Lost to Follow-up|3|||
156762040|NCT05616013|565879946|FG002|Overall Study|Prohibited Concomitant Medication|1|||
156762041|NCT05616013|565879947|FG003|Overall Study|Prohibited Concomitant Medication|0|||
156762042|NCT05616013|565879948|FG004|Overall Study|Prohibited Concomitant Medication|0|||
156425050|NCT01352507|564649061|FG001|Treatment Period 1|Lost to Follow-up|4|||
156425051|NCT01352507|564649060|FG000|Treatment Period 1|Withdrawal by Subject|7|||
156425052|NCT01352507|564649061|FG001|Treatment Period 1|Withdrawal by Subject|5|||
156425053|NCT01352507|564649060|FG000|Treatment Period 1|Physician Decision|1|||
156425054|NCT01352507|564649061|FG001|Treatment Period 1|Physician Decision|0|||
156425055|NCT01352507|564649060|FG000|Washout Period|Withdrawal by Subject|0|||
156425056|NCT01352507|564649061|FG001|Washout Period|Withdrawal by Subject|1|||
156425057|NCT01352507|564649060|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
156425058|NCT01352507|564649061|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
156425059|NCT01352507|564649060|FG000|Treatment Period 2|Withdrawal by Subject|4|||
156425060|NCT01352507|564649061|FG001|Treatment Period 2|Withdrawal by Subject|3|||
156425061|NCT01352507|564649060|FG000|Treatment Period 2|Lack of Efficacy|1|||
156425062|NCT01352507|564649061|FG001|Treatment Period 2|Lack of Efficacy|0|||
156425063|NCT02524288|564649062|FG000|Overall Study|Adverse Event|115|||
156425064|NCT02524288|564649062|FG000|Overall Study|Lost to Follow-up|216|||
156425065|NCT02524288|564649062|FG000|Overall Study|Non-Compliance With Protocol|32|||
156425066|NCT02524288|564649062|FG000|Overall Study|Non-Compliance With Study Drug|14|||
156425067|NCT02524288|564649062|FG000|Overall Study|Pregnancy Wish|6|||
156425068|NCT02524288|564649062|FG000|Overall Study|Protocol Violation|6|||
156425069|NCT02524288|564649062|FG000|Overall Study|Screen Failure|2|||
156425070|NCT02524288|564649062|FG000|Overall Study|Site Discontinued Study Participation|1|||
156425071|NCT02524288|564649062|FG000|Overall Study|Study Terminated By Sponsor|1417|||
156425072|NCT02524288|564649062|FG000|Overall Study|Subject Moved|32|||
156425073|NCT02524288|564649062|FG000|Overall Study|Withdrawal by Subject|76|||
156425074|NCT02524288|564649062|FG000|Overall Study|Pregnancy|22|||
156425075|NCT02524288|564649062|FG000|Overall Study|Physician Decision|2|||
156425076|NCT02616263|564649064|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
156425077|NCT02616263|564649065|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
156425078|NCT02616263|564649064|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
156425079|NCT02616263|564649065|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
156425080|NCT02616263|564649064|FG000|6 Month to 1.5 Year|Death|1|||
156425081|NCT02616263|564649065|FG001|6 Month to 1.5 Year|Death|0|||
156425082|NCT02616263|564649064|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
156425083|NCT02616263|564649065|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
156425084|NCT02616263|564649064|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
156425085|NCT02616263|564649065|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
156425086|NCT02616263|564649064|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
156425087|NCT02616263|564649065|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
156425088|NCT02939183|564649068|FG000|Overall Study|Death|0|||
156425089|NCT02939183|564649069|FG001|Overall Study|Death|0|||
156425090|NCT02939183|564649070|FG002|Overall Study|Death|1|||
156425091|NCT02939183|564649071|FG003|Overall Study|Death|0|||
156425092|NCT02939183|564649072|FG004|Overall Study|Death|0|||
156425093|NCT02939183|564649073|FG005|Overall Study|Death|2|||
156425094|NCT02939183|564649074|FG006|Overall Study|Death|1|||
156425095|NCT02939183|564649075|FG007|Overall Study|Death|0|||
156425096|NCT02939183|564649076|FG008|Overall Study|Death|0|||
156425097|NCT02939183|564649068|FG000|Overall Study|Sponsor decision|0|||
156425098|NCT02939183|564649069|FG001|Overall Study|Sponsor decision|1|||
156425099|NCT02939183|564649070|FG002|Overall Study|Sponsor decision|0|||
156425100|NCT02939183|564649071|FG003|Overall Study|Sponsor decision|1|||
156425101|NCT02939183|564649072|FG004|Overall Study|Sponsor decision|2|||
156425102|NCT02939183|564649073|FG005|Overall Study|Sponsor decision|0|||
156425103|NCT02939183|564649074|FG006|Overall Study|Sponsor decision|3|||
156425104|NCT02939183|564649075|FG007|Overall Study|Sponsor decision|1|||
156425105|NCT02939183|564649076|FG008|Overall Study|Sponsor decision|4|||
156425106|NCT02939183|564649068|FG000|Overall Study|Withdrawal by Subject|0|||
156425107|NCT02939183|564649069|FG001|Overall Study|Withdrawal by Subject|2|||
156425108|NCT02939183|564649070|FG002|Overall Study|Withdrawal by Subject|0|||
156425109|NCT02939183|564649071|FG003|Overall Study|Withdrawal by Subject|1|||
156425110|NCT02939183|564649072|FG004|Overall Study|Withdrawal by Subject|0|||
156425111|NCT02939183|564649073|FG005|Overall Study|Withdrawal by Subject|0|||
156425112|NCT02939183|564649074|FG006|Overall Study|Withdrawal by Subject|2|||
156425113|NCT02939183|564649075|FG007|Overall Study|Withdrawal by Subject|2|||
156425114|NCT02939183|564649076|FG008|Overall Study|Withdrawal by Subject|2|||
156425115|NCT02939183|564649068|FG000|Overall Study|Not treated due to adverse event|0|||
156425116|NCT02939183|564649069|FG001|Overall Study|Not treated due to adverse event|0|||
156425117|NCT02939183|564649070|FG002|Overall Study|Not treated due to adverse event|0|||
156425118|NCT02939183|564649071|FG003|Overall Study|Not treated due to adverse event|1|||
156425119|NCT02939183|564649072|FG004|Overall Study|Not treated due to adverse event|0|||
156425120|NCT02939183|564649073|FG005|Overall Study|Not treated due to adverse event|0|||
156425121|NCT02939183|564649074|FG006|Overall Study|Not treated due to adverse event|1|||
156425122|NCT02939183|564649075|FG007|Overall Study|Not treated due to adverse event|0|||
156425123|NCT02939183|564649076|FG008|Overall Study|Not treated due to adverse event|0|||
156425124|NCT05015478|564649077|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
156425125|NCT05015478|564649078|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
156425126|NCT05015478|564649079|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
156425127|NCT05015478|564649080|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
156425128|NCT02042443|564649083|FG000|Overall Study|Adverse Event|2|||
156425129|NCT02042443|564649084|FG001|Overall Study|Adverse Event|1|||
156762043|NCT05616013|565879949|FG005|Overall Study|Prohibited Concomitant Medication|0|||
156762044|NCT05616013|565879950|FG006|Overall Study|Prohibited Concomitant Medication|0|||
156762045|NCT05616013|565879951|FG007|Overall Study|Prohibited Concomitant Medication|0|||
156425130|NCT02042443|564649083|FG000|Overall Study|Withdrawal by Subject|0|||
156425131|NCT02042443|564649084|FG001|Overall Study|Withdrawal by Subject|1|||
156425132|NCT02042443|564649083|FG000|Overall Study|Progression|21|||
156425133|NCT02042443|564649084|FG001|Overall Study|Progression|17|||
156425134|NCT02042443|564649083|FG000|Overall Study|not protocol specified|1|||
156425135|NCT02042443|564649084|FG001|Overall Study|not protocol specified|1|||
156425136|NCT02042443|564649083|FG000|Overall Study|Not eligible/not analyzable|3|||
156425137|NCT02042443|564649084|FG001|Overall Study|Not eligible/not analyzable|6|||
156425138|NCT01913340|564649085|FG000|Overall Study|Death|2|||
156425139|NCT01913340|564649086|FG001|Overall Study|Death|5|||
156425140|NCT01913340|564649085|FG000|Overall Study|Lost to Follow-up|1|||
156425141|NCT01913340|564649086|FG001|Overall Study|Lost to Follow-up|1|||
156425142|NCT02784704|564649087|FG000|Overall Study|Adverse Event|4|||
156425143|NCT02784704|564649088|FG001|Overall Study|Adverse Event|2|||
156425144|NCT02784704|564649087|FG000|Overall Study|Lost to Follow-up|6|||
156425145|NCT02784704|564649088|FG001|Overall Study|Lost to Follow-up|4|||
156425146|NCT02784704|564649087|FG000|Overall Study|Withdrawal by Subject|1|||
156425147|NCT02784704|564649088|FG001|Overall Study|Withdrawal by Subject|3|||
156425148|NCT02784704|564649087|FG000|Overall Study|Subject Non Compliance|2|||
156425149|NCT02784704|564649088|FG001|Overall Study|Subject Non Compliance|0|||
156425150|NCT00603538|564649089|FG000|Overall Study|Adverse Event|0|||
156425151|NCT00603538|564649090|FG001|Overall Study|Adverse Event|4|||
156425152|NCT00603538|564649091|FG002|Overall Study|Adverse Event|2|||
156425153|NCT00603538|564649089|FG000|Overall Study|Objective progression or relapse|3|||
156425154|NCT00603538|564649090|FG001|Overall Study|Objective progression or relapse|0|||
156425155|NCT00603538|564649091|FG002|Overall Study|Objective progression or relapse|0|||
156425156|NCT05750745|564649093|FG000|Overall Study|Adverse Event|1|||
156425157|NCT05750745|564649094|FG001|Overall Study|Adverse Event|0|||
156425158|NCT05750745|564649095|FG002|Overall Study|Adverse Event|0|||
156425159|NCT05750745|564649093|FG000|Overall Study|Protocol Violation|1|||
156425160|NCT05750745|564649094|FG001|Overall Study|Protocol Violation|0|||
156321877|NCT05101317|564276905|FG001|Week1-13|Adverse Event|1|||
156321878|NCT05101317|564276906|FG002|Week1-13|Adverse Event|0|||
156321879|NCT05101317|564276907|FG003|Week1-13|Adverse Event|0|||
156321880|NCT05101317|564276904|FG000|Week1-13|Withdrawal by Subject|0|||
156321881|NCT05101317|564276905|FG001|Week1-13|Withdrawal by Subject|2|||
156321882|NCT05101317|564276906|FG002|Week1-13|Withdrawal by Subject|0|||
156321883|NCT05101317|564276907|FG003|Week1-13|Withdrawal by Subject|0|||
156321884|NCT05101317|564276904|FG000|Week1-13|Early Withdrawl|0|||
156321885|NCT05101317|564276905|FG001|Week1-13|Early Withdrawl|0|||
156321886|NCT05101317|564276906|FG002|Week1-13|Early Withdrawl|0|||
156321887|NCT05101317|564276907|FG003|Week1-13|Early Withdrawl|1|||
156321888|NCT05101317|564276904|FG000|Week 13-25|Lost to Follow-up|0|||
156321889|NCT05101317|564276905|FG001|Week 13-25|Lost to Follow-up|0|||
156321890|NCT05101317|564276906|FG002|Week 13-25|Lost to Follow-up|1|||
156321891|NCT05101317|564276907|FG003|Week 13-25|Lost to Follow-up|0|||
156321892|NCT05101317|564276904|FG000|Week 13-25|Withdrawal by Subject|1|||
156321893|NCT05101317|564276905|FG001|Week 13-25|Withdrawal by Subject|1|||
156321894|NCT05101317|564276906|FG002|Week 13-25|Withdrawal by Subject|0|||
156321895|NCT05101317|564276907|FG003|Week 13-25|Withdrawal by Subject|0|||
156321896|NCT05101317|564276904|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
156321897|NCT05101317|564276905|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
156321898|NCT05101317|564276906|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
156321899|NCT05101317|564276907|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
156321900|NCT05764265|564276908|FG000|Overall Study|Adverse Event|1|||
156321901|NCT05764265|564276909|FG001|Overall Study|Adverse Event|0|||
156321902|NCT05764265|564276908|FG000|Overall Study|Physician Decision|1|||
156321903|NCT05764265|564276909|FG001|Overall Study|Physician Decision|8|||
156321904|NCT05764265|564276908|FG000|Overall Study|Study Terminated By Sponsor|20|||
156321905|NCT05764265|564276909|FG001|Overall Study|Study Terminated By Sponsor|0|||
156321906|NCT05764265|564276908|FG000|Overall Study|Participant Decision|1|||
156321907|NCT05764265|564276909|FG001|Overall Study|Participant Decision|0|||
156321908|NCT02793622|564276912|FG000|Overall Study|Lost to Follow-up|31|||
156321909|NCT02793622|564276913|FG001|Overall Study|Lost to Follow-up|19|||
156321910|NCT02793622|564276912|FG000|Overall Study|Withdrawal by Subject|21|||
156321911|NCT02793622|564276913|FG001|Overall Study|Withdrawal by Subject|17|||
156321912|NCT02793622|564276912|FG000|Overall Study|Adverse Event|0|||
156321913|NCT02793622|564276913|FG001|Overall Study|Adverse Event|1|||
156321914|NCT02793622|564276912|FG000|Overall Study|Protocol Violation|1|||
156321915|NCT02793622|564276913|FG001|Overall Study|Protocol Violation|5|||
156321916|NCT01244490|564276914|FG000|Overall Study|Lack of Efficacy|14|||
156321917|NCT01244490|564276915|FG001|Overall Study|Lack of Efficacy|5|||
156321918|NCT01244490|564276916|FG002|Overall Study|Lack of Efficacy|5|||
156321919|NCT01244490|564276914|FG000|Overall Study|Withdrawal by Subject|4|||
156321920|NCT01244490|564276915|FG001|Overall Study|Withdrawal by Subject|4|||
156321921|NCT01244490|564276916|FG002|Overall Study|Withdrawal by Subject|9|||
156321922|NCT01244490|564276914|FG000|Overall Study|Adverse Event|1|||
156321923|NCT01244490|564276915|FG001|Overall Study|Adverse Event|9|||
156321924|NCT01244490|564276916|FG002|Overall Study|Adverse Event|5|||
156321925|NCT01244490|564276914|FG000|Overall Study|Lost to Follow-up|0|||
156321926|NCT01244490|564276915|FG001|Overall Study|Lost to Follow-up|6|||
156321927|NCT01244490|564276916|FG002|Overall Study|Lost to Follow-up|3|||
156321928|NCT01244490|564276914|FG000|Overall Study|Other|0|||
156321929|NCT01244490|564276915|FG001|Overall Study|Other|0|||
156321930|NCT01244490|564276916|FG002|Overall Study|Other|1|||
156321931|NCT00400153|564276919|FG000|Overall Study|AE due to study disease worsening|14|||
156321932|NCT00400153|564276920|FG001|Overall Study|AE due to study disease worsening|19|||
156321933|NCT00400153|564276921|FG002|Overall Study|AE due to study disease worsening|20|||
156321934|NCT00400153|564276919|FG000|Overall Study|AE due to other disease worsening|2|||
156321935|NCT00400153|564276920|FG001|Overall Study|AE due to other disease worsening|1|||
156425161|NCT05750745|564649095|FG002|Overall Study|Protocol Violation|0|||
156425162|NCT05750745|564649093|FG000|Overall Study|Withdrawal by Subject|0|||
156425163|NCT05750745|564649094|FG001|Overall Study|Withdrawal by Subject|1|||
156425164|NCT05750745|564649095|FG002|Overall Study|Withdrawal by Subject|0|||
156425165|NCT04794179|564649097|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
156425166|NCT04794179|564649098|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
156425167|NCT00768066|564649100|FG000|Overall Study|Did not receive study product injection.|3|||
156425168|NCT00768066|564649101|FG001|Overall Study|Did not receive study product injection.|3|||
156425169|NCT00768066|564649102|FG002|Overall Study|Did not receive study product injection.|0|||
156425170|NCT00429793|564649103|FG000|Overall Study|Improper pre-protocol treatment|3|||
156425171|NCT00429793|564649103|FG000|Overall Study|Required test not done|1|||
156425172|NCT00429793|564649103|FG000|Overall Study|Never treated|1|||
156425173|NCT00429793|564649103|FG000|Overall Study|Non-measurable|1|||
156425174|NCT03677375|564649108|FG000|Overall Study|Incomplete procedure|8|||
156425175|NCT03677375|564649108|FG000|Overall Study|Adverse Event|3|||
156425176|NCT03677375|564649108|FG000|Overall Study|Physician Decision|1|||
156425177|NCT00725010|564649109|FG000|Overall Study|Toxicity|9|||
156425178|NCT00725010|564649109|FG000|Overall Study|Tumor Progression|7|||
156425179|NCT00725010|564649109|FG000|Overall Study|Withdrawal by Subject|2|||
156425180|NCT00725010|564649109|FG000|Overall Study|Death|1|||
156425181|NCT00725010|564649109|FG000|Overall Study|Lost to Follow-up|1|||
156425182|NCT00725010|564649109|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
156425183|NCT00725010|564649109|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
156425184|NCT00725010|564649109|FG000|Overall Study|No further documentation|1|||
156425185|NCT00725010|564649109|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
156425186|NCT00445692|564649110|FG000|Overall Study|Adverse Event|11|||
156425187|NCT00445692|564649110|FG000|Overall Study|Lack of Efficacy|5|||
156425188|NCT00389519|564649116|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
156425189|NCT00389519|564649117|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
156425190|NCT00389519|564649118|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
156425191|NCT00389519|564649119|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
156425192|NCT00389519|564649116|FG000|Placebo Run-In|Withdrawal by Subject|19|||
156425193|NCT00389519|564649117|FG001|Placebo Run-In|Withdrawal by Subject|0|||
156425194|NCT00389519|564649118|FG002|Placebo Run-In|Withdrawal by Subject|0|||
156425195|NCT00389519|564649119|FG003|Placebo Run-In|Withdrawal by Subject|0|||
156425196|NCT00389519|564649116|FG000|Placebo Run-In|Reason not specified|40|||
156425197|NCT00389519|564649117|FG001|Placebo Run-In|Reason not specified|0|||
156425198|NCT00389519|564649118|FG002|Placebo Run-In|Reason not specified|0|||
156425199|NCT00389519|564649119|FG003|Placebo Run-In|Reason not specified|0|||
156425200|NCT00389519|564649116|FG000|Randomized|Did not receive study drug|2|||
156425201|NCT00389519|564649117|FG001|Randomized|Did not receive study drug|0|||
156425202|NCT00389519|564649118|FG002|Randomized|Did not receive study drug|0|||
156425203|NCT00389519|564649119|FG003|Randomized|Did not receive study drug|0|||
156425204|NCT00389519|564649116|FG000|Treated|Adverse Event|1|||
156425205|NCT00389519|564649117|FG001|Treated|Adverse Event|0|||
156425206|NCT00389519|564649118|FG002|Treated|Adverse Event|0|||
156425207|NCT00389519|564649119|FG003|Treated|Adverse Event|2|||
156425208|NCT00389519|564649116|FG000|Treated|Reason not specified|1|||
156425209|NCT00389519|564649117|FG001|Treated|Reason not specified|1|||
156425210|NCT00389519|564649118|FG002|Treated|Reason not specified|0|||
156425211|NCT00389519|564649119|FG003|Treated|Reason not specified|2|||
156425212|NCT03425539|564649120|FG000|Overall Study|Randomized but not treated|0|||
156425213|NCT03425539|564649121|FG001|Overall Study|Randomized but not treated|1|||
156425214|NCT03425539|564649120|FG000|Overall Study|Adverse Event|2|||
156425215|NCT03425539|564649121|FG001|Overall Study|Adverse Event|2|||
156425216|NCT03425539|564649120|FG000|Overall Study|Withdrawal by Subject|3|||
156425217|NCT03425539|564649121|FG001|Overall Study|Withdrawal by Subject|0|||
156321936|NCT00400153|564276921|FG002|Overall Study|AE due to other disease worsening|0|||
156321937|NCT00400153|564276919|FG000|Overall Study|AE due to other condition|3|||
156321938|NCT00400153|564276920|FG001|Overall Study|AE due to other condition|14|||
156321939|NCT00400153|564276921|FG002|Overall Study|AE due to other condition|15|||
156321940|NCT00400153|564276919|FG000|Overall Study|Protocol Violation|7|||
156321941|NCT00400153|564276920|FG001|Overall Study|Protocol Violation|4|||
156321942|NCT00400153|564276921|FG002|Overall Study|Protocol Violation|9|||
156321943|NCT00400153|564276919|FG000|Overall Study|Lost to Follow-up|2|||
156321944|NCT00400153|564276920|FG001|Overall Study|Lost to Follow-up|1|||
156321945|NCT00400153|564276921|FG002|Overall Study|Lost to Follow-up|4|||
156321946|NCT00400153|564276919|FG000|Overall Study|Withdrawal by Subject|12|||
156425218|NCT03425539|564649120|FG000|Overall Study|Lost to Follow-up|0|||
156321947|NCT00400153|564276920|FG001|Overall Study|Withdrawal by Subject|11|||
156321948|NCT00400153|564276921|FG002|Overall Study|Withdrawal by Subject|10|||
156321949|NCT00400153|564276919|FG000|Overall Study|Other reasons - not mentioned above|8|||
156425219|NCT03425539|564649121|FG001|Overall Study|Lost to Follow-up|1|||
156425220|NCT00751036|564649122|FG000|Overall Study|Disease Progression|28|||
156425221|NCT00751036|564649123|FG001|Overall Study|Disease Progression|29|||
156425222|NCT00751036|564649122|FG000|Overall Study|Adverse Event|6|||
156654843|NCT01215942|565482599|FG000|Post-Treatment Follow-Up Period|Death|0|||
156654844|NCT01215942|565482600|FG001|Post-Treatment Follow-Up Period|Death|1|||
156654845|NCT01215942|565482599|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
156654846|NCT01215942|565482600|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
156654847|NCT01215942|565482599|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
156654848|NCT01215942|565482600|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
156654849|NCT01215942|565482599|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
156654850|NCT01215942|565482600|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
156654851|NCT01215942|565482599|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
156654852|NCT01215942|565482600|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
156654853|NCT03305055|565482601|FG000|Overall Study|Withdrawal by Subject|0|||
156654854|NCT03305055|565482602|FG001|Overall Study|Withdrawal by Subject|1|||
156654855|NCT03305055|565482601|FG000|Overall Study|Adverse Event|1|||
156654856|NCT03305055|565482602|FG001|Overall Study|Adverse Event|1|||
156654857|NCT00113490|565482603|FG000|Overall Study|Withdrawal by Subject|1|||
156654858|NCT00113490|565482604|FG001|Overall Study|Withdrawal by Subject|3|||
156654859|NCT00113490|565482603|FG000|Overall Study|Lost to Follow-up|1|||
156654860|NCT00113490|565482604|FG001|Overall Study|Lost to Follow-up|0|||
156654861|NCT00819247|565482605|FG000|Overall Study|Adverse Event|0|||
156654862|NCT00819247|565482606|FG001|Overall Study|Adverse Event|5|||
156654863|NCT00819247|565482607|FG002|Overall Study|Adverse Event|3|||
156654864|NCT00819247|565482605|FG000|Overall Study|Insufficient testosterone response|5|||
156654865|NCT00819247|565482606|FG001|Overall Study|Insufficient testosterone response|8|||
156654866|NCT00819247|565482607|FG002|Overall Study|Insufficient testosterone response|10|||
156425223|NCT00751036|564649123|FG001|Overall Study|Adverse Event|4|||
156654867|NCT00819247|565482605|FG000|Overall Study|Withdrawal by Subject|1|||
156654868|NCT00819247|565482606|FG001|Overall Study|Withdrawal by Subject|0|||
156654869|NCT00819247|565482607|FG002|Overall Study|Withdrawal by Subject|0|||
156654870|NCT00819247|565482605|FG000|Overall Study|Protocol Violation|1|||
156654871|NCT00819247|565482606|FG001|Overall Study|Protocol Violation|0|||
156654872|NCT00819247|565482607|FG002|Overall Study|Protocol Violation|1|||
156654873|NCT00819247|565482605|FG000|Overall Study|Mistakenly withdrawn|0|||
156654874|NCT00819247|565482606|FG001|Overall Study|Mistakenly withdrawn|1|||
156654875|NCT00819247|565482607|FG002|Overall Study|Mistakenly withdrawn|0|||
156654876|NCT00819247|565482605|FG000|Overall Study|Bad prostate-specific antigen response|3|||
156654877|NCT00819247|565482606|FG001|Overall Study|Bad prostate-specific antigen response|2|||
156654878|NCT00819247|565482607|FG002|Overall Study|Bad prostate-specific antigen response|0|||
156654879|NCT00819247|565482605|FG000|Overall Study|Other|1|||
156654880|NCT00819247|565482606|FG001|Overall Study|Other|0|||
156654881|NCT00819247|565482607|FG002|Overall Study|Other|0|||
156654882|NCT03500484|565482608|FG000|Overall Study|Adverse Event|2|||
156654883|NCT03500484|565482609|FG001|Overall Study|Adverse Event|0|||
156654884|NCT03500484|565482608|FG000|Overall Study|Physician Decision|1|||
156654885|NCT03500484|565482609|FG001|Overall Study|Physician Decision|0|||
156654886|NCT03500484|565482608|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
156654887|NCT03500484|565482609|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
156654888|NCT02795104|565482610|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
156425224|NCT00751036|564649122|FG000|Overall Study|Administrative Problems|3|||
156425225|NCT00751036|564649123|FG001|Overall Study|Administrative Problems|4|||
156425226|NCT00751036|564649122|FG000|Overall Study|Withdrawal by Subject|5|||
156425227|NCT00751036|564649123|FG001|Overall Study|Withdrawal by Subject|2|||
156425228|NCT00751036|564649122|FG000|Overall Study|Death|3|||
156425229|NCT00751036|564649123|FG001|Overall Study|Death|3|||
156425230|NCT00751036|564649122|FG000|Overall Study|Lost to Follow-up|0|||
156425231|NCT00751036|564649123|FG001|Overall Study|Lost to Follow-up|1|||
156425232|NCT00751036|564649122|FG000|Overall Study|Protocol Violation|1|||
156425233|NCT00751036|564649123|FG001|Overall Study|Protocol Violation|0|||
156425234|NCT00751036|564649122|FG000|Overall Study|Missing end of Treatment Page|2|||
156425235|NCT00751036|564649123|FG001|Overall Study|Missing end of Treatment Page|3|||
156425236|NCT05460663|564649124|FG000|Overall Study|Withdrawal by Subject|2|||
156425237|NCT05460663|564649125|FG001|Overall Study|Withdrawal by Subject|5|||
156425238|NCT02068885|564649126|FG000|Overall Study|Withdrew|3|||
156425239|NCT02068885|564649127|FG001|Overall Study|Withdrew|5|||
156425240|NCT02068885|564649128|FG002|Overall Study|Withdrew|8|||
156425241|NCT01562743|564649137|FG000|Overall Study|Adverse Event|29|||
156425242|NCT01562743|564649137|FG000|Overall Study|Lack of Efficacy|3|||
156425243|NCT01562743|564649137|FG000|Overall Study|Withdrawal by Subject|13|||
156425244|NCT01562743|564649137|FG000|Overall Study|Protocol Violation|1|||
156425245|NCT01562743|564649137|FG000|Overall Study|Discontinuation criteria|2|||
156425246|NCT01562743|564649137|FG000|Overall Study|Lost to Follow-up|2|||
156425247|NCT01562743|564649137|FG000|Overall Study|Physician Decision|2|||
156425248|NCT05567159|564649138|FG000|Overall Study|Adverse Event|4|||
156425249|NCT05567159|564649138|FG000|Overall Study|Physician Decision|3|||
156425250|NCT05567159|564649138|FG000|Overall Study|Protocol deviation|1|||
156425251|NCT04155424|564649139|FG000|Overall Study|Other than specified|3|||
156425252|NCT04155424|564649139|FG000|Overall Study|Withdrawal by Subject|1|||
156425253|NCT04155424|564649139|FG000|Overall Study|Adverse Event|1|||
156425254|NCT00349908|564651062|FG000|Overall Study|Withdrawal by Subject|0|||
156425255|NCT00349908|564651063|FG001|Overall Study|Withdrawal by Subject|4|||
156425256|NCT03467724|564651070|FG000|Overall Study|Lost to Follow-up|5|||
156425257|NCT03467724|564651070|FG000|Overall Study|Withdrawal by Subject|1|||
156425258|NCT03467724|564651070|FG000|Overall Study|Protocol Violation|1|||
156425259|NCT03467724|564651070|FG000|Overall Study|Adverse Event|1|||
156425260|NCT03710564|564651072|FG000|Overall Study|Study Terminated by Sponsor|104|||
156425261|NCT03710564|564651073|FG001|Overall Study|Study Terminated by Sponsor|55|||
156425262|NCT03710564|564651072|FG000|Overall Study|Withdrawal by Subject|57|||
156425263|NCT03710564|564651073|FG001|Overall Study|Withdrawal by Subject|25|||
156425264|NCT03710564|564651072|FG000|Overall Study|Death|10|||
156425265|NCT03710564|564651073|FG001|Overall Study|Death|4|||
156425266|NCT03710564|564651072|FG000|Overall Study|Lost to Follow-up|5|||
156425267|NCT03710564|564651073|FG001|Overall Study|Lost to Follow-up|4|||
156425268|NCT03710564|564651072|FG000|Overall Study|Protocol Violation|3|||
156425269|NCT03710564|564651073|FG001|Overall Study|Protocol Violation|2|||
156425270|NCT03710564|564651072|FG000|Overall Study|Adverse Event|3|||
156425271|NCT03710564|564651073|FG001|Overall Study|Adverse Event|0|||
156425272|NCT03710564|564651072|FG000|Overall Study|Physician Decision|2|||
156425273|NCT03710564|564651073|FG001|Overall Study|Physician Decision|3|||
156425274|NCT02993471|564651074|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
156425275|NCT02993471|564651074|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
156425276|NCT00742274|564651077|FG000|Overall Study|Death|1|||
156425277|NCT00742274|564651078|FG001|Overall Study|Death|0|||
156425278|NCT00742274|564651077|FG000|Overall Study|Withdrawal by Subject|1|||
156425279|NCT00742274|564651078|FG001|Overall Study|Withdrawal by Subject|2|||
156425280|NCT00742274|564651077|FG000|Overall Study|Removed for medical reasons|1|||
156425281|NCT00742274|564651078|FG001|Overall Study|Removed for medical reasons|1|||
156425282|NCT00619151|564651079|FG000|Overall Study|Study terminated prior to followup|1|||
156425283|NCT00619151|564651080|FG001|Overall Study|Study terminated prior to followup|0|||
156425284|NCT01928940|564651088|FG000|Overall Study|Adverse Event|0|||
156425285|NCT01928940|564651089|FG001|Overall Study|Adverse Event|1|||
156425286|NCT04088188|564651092|FG000|Overall Study|Withdrawal by Subject|2|||
156425287|NCT04088188|564651093|FG001|Overall Study|Withdrawal by Subject|0|||
156425288|NCT04088188|564651092|FG000|Overall Study|Adverse Event|2|||
156425289|NCT04088188|564651093|FG001|Overall Study|Adverse Event|0|||
156425290|NCT03124108|564651094|FG000|Overall Study|Adverse Event|0|||
156425291|NCT03124108|564651095|FG001|Overall Study|Adverse Event|1|||
156425292|NCT03124108|564651096|FG002|Overall Study|Adverse Event|0|||
156425293|NCT00197236|564651099|FG000|Overall Study|Adverse Event|1|||
156425294|NCT00197236|564651100|FG001|Overall Study|Adverse Event|0|||
156425295|NCT00197236|564651101|FG002|Overall Study|Adverse Event|1|||
156425296|NCT00197236|564651099|FG000|Overall Study|Lost to Follow-up|5|||
156425297|NCT00197236|564651100|FG001|Overall Study|Lost to Follow-up|14|||
156425298|NCT00197236|564651101|FG002|Overall Study|Lost to Follow-up|6|||
156425299|NCT00197236|564651099|FG000|Overall Study|Protocol Violation|0|||
156425300|NCT00197236|564651100|FG001|Overall Study|Protocol Violation|0|||
156425301|NCT00197236|564651101|FG002|Overall Study|Protocol Violation|1|||
156425302|NCT00197236|564651099|FG000|Overall Study|Withdrawal by Subject|7|||
156425303|NCT00197236|564651100|FG001|Overall Study|Withdrawal by Subject|3|||
156425304|NCT00197236|564651101|FG002|Overall Study|Withdrawal by Subject|11|||
156425305|NCT00197236|564651099|FG000|Overall Study|Study drug/medication expiration|1|||
156425306|NCT00197236|564651100|FG001|Overall Study|Study drug/medication expiration|0|||
156425307|NCT00197236|564651101|FG002|Overall Study|Study drug/medication expiration|3|||
156425308|NCT00197236|564651099|FG000|Overall Study|Returned out of specified time window|0|||
156425309|NCT00197236|564651100|FG001|Overall Study|Returned out of specified time window|0|||
156425310|NCT00197236|564651101|FG002|Overall Study|Returned out of specified time window|1|||
156425311|NCT00746330|564651102|FG000|Period 1|Abnormal test procedure result|0|||
156425312|NCT00746330|564651103|FG001|Period 1|Abnormal test procedure result|0|||
156425313|NCT00746330|564651104|FG002|Period 1|Abnormal test procedure result|1|||
156425314|NCT00746330|564651105|FG003|Period 1|Abnormal test procedure result|0|||
156425315|NCT00517933|564651106|FG000|Period 1|Death|2|||
156425316|NCT00517933|564651107|FG001|Period 1|Death|1|||
156425317|NCT00517933|564651106|FG000|Period 1|Adverse Event|4|||
156425318|NCT00517933|564651107|FG001|Period 1|Adverse Event|4|||
156425319|NCT00517933|564651106|FG000|Period 1|Lost to Follow-up|2|||
156425320|NCT00517933|564651107|FG001|Period 1|Lost to Follow-up|0|||
156425321|NCT00517933|564651106|FG000|Period 1|Underwent lung transplant|0|||
156425322|NCT00517933|564651107|FG001|Period 1|Underwent lung transplant|1|||
156425323|NCT00517933|564651106|FG000|Period 2|Death|2|||
156425324|NCT00517933|564651107|FG001|Period 2|Death|4|||
156425325|NCT00517933|564651106|FG000|Period 2|Adverse Event|2|||
156425326|NCT00517933|564651107|FG001|Period 2|Adverse Event|4|||
156425327|NCT00517933|564651106|FG000|Period 2|Physician Decision|1|||
156425328|NCT00517933|564651107|FG001|Period 2|Physician Decision|0|||
156425329|NCT00517933|564651106|FG000|Period 2|Withdrawal by Subject|1|||
156425330|NCT00517933|564651107|FG001|Period 2|Withdrawal by Subject|3|||
156425331|NCT00517933|564651106|FG000|Period 2|Underwent lung transplant|0|||
156425332|NCT00517933|564651107|FG001|Period 2|Underwent lung transplant|2|||
156425333|NCT00654238|564651109|FG000|Overall Study|Screen Failures|4|||
156425334|NCT04523181|564651110|FG000|Overall Study|Withdrawal by Subject|4|||
156425335|NCT04523181|564651111|FG001|Overall Study|Withdrawal by Subject|5|||
156425336|NCT04523181|564651110|FG000|Overall Study|Lost to Follow-up|2|||
156425337|NCT04523181|564651111|FG001|Overall Study|Lost to Follow-up|3|||
156425338|NCT04523181|564651110|FG000|Overall Study|Physician Decision|1|||
156425339|NCT04523181|564651111|FG001|Overall Study|Physician Decision|0|||
156425340|NCT04523181|564651110|FG000|Overall Study|Transferred to external facility.|1|||
156425341|NCT04523181|564651111|FG001|Overall Study|Transferred to external facility.|1|||
156425342|NCT04927975|564651114|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
156425343|NCT04927975|564651115|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
156425344|NCT04927975|564651116|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
156425345|NCT04927975|564651117|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
156425346|NCT04927975|564651118|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
156425347|NCT04927975|564651119|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
156425348|NCT04927975|564651114|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
156425349|NCT04927975|564651115|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
156425350|NCT04927975|564651116|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
156425351|NCT04927975|564651117|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
156425352|NCT04927975|564651118|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
156425353|NCT04927975|564651119|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
156425354|NCT04927975|564651114|FG000|Period 1 (Baseline-Week 24)|Death|0|||
156425355|NCT04927975|564651115|FG001|Period 1 (Baseline-Week 24)|Death|0|||
156425356|NCT04927975|564651116|FG002|Period 1 (Baseline-Week 24)|Death|0|||
156425357|NCT04927975|564651117|FG003|Period 1 (Baseline-Week 24)|Death|0|||
156425358|NCT04927975|564651118|FG004|Period 1 (Baseline-Week 24)|Death|0|||
156425359|NCT04927975|564651119|FG005|Period 1 (Baseline-Week 24)|Death|1|||
156425360|NCT04927975|564651114|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
156425361|NCT04927975|564651115|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
156425362|NCT04927975|564651116|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
156425363|NCT04927975|564651117|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
156425364|NCT04927975|564651118|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
156425365|NCT04927975|564651119|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
156425366|NCT04927975|564651114|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
156425367|NCT04927975|564651115|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
156425368|NCT04927975|564651116|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
156425369|NCT04927975|564651117|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
156425370|NCT04927975|564651118|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
156425371|NCT04927975|564651119|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
156425372|NCT03781804|564651120|FG000|Overall Study|Adverse Event|2|||
156425373|NCT03781804|564651121|FG001|Overall Study|Adverse Event|2|||
156425374|NCT03781804|564651122|FG002|Overall Study|Adverse Event|3|||
156425375|NCT03781804|564651120|FG000|Overall Study|Lost to Follow-up|1|||
156425376|NCT03781804|564651121|FG001|Overall Study|Lost to Follow-up|1|||
156425377|NCT03781804|564651122|FG002|Overall Study|Lost to Follow-up|2|||
156425378|NCT03781804|564651120|FG000|Overall Study|Lack of Efficacy|4|||
156425379|NCT03781804|564651121|FG001|Overall Study|Lack of Efficacy|2|||
156425380|NCT03781804|564651122|FG002|Overall Study|Lack of Efficacy|9|||
156425381|NCT03781804|564651120|FG000|Overall Study|Protocol Violation|0|||
156425382|NCT03781804|564651121|FG001|Overall Study|Protocol Violation|0|||
156425383|NCT03781804|564651122|FG002|Overall Study|Protocol Violation|1|||
156425384|NCT03781804|564651120|FG000|Overall Study|Withdrawal by Subject|0|||
156425385|NCT03781804|564651121|FG001|Overall Study|Withdrawal by Subject|1|||
156425386|NCT03781804|564651122|FG002|Overall Study|Withdrawal by Subject|1|||
156425387|NCT03781804|564651120|FG000|Overall Study|Reason not provided|2|||
156425388|NCT03781804|564651121|FG001|Overall Study|Reason not provided|2|||
156425389|NCT03781804|564651122|FG002|Overall Study|Reason not provided|0|||
156425390|NCT03717194|564651123|FG000|Overall Study|Withdrawal by Subject|2|||
156425391|NCT03717194|564651124|FG001|Overall Study|Withdrawal by Subject|4|||
156425392|NCT03717194|564651123|FG000|Overall Study|Adverse Event|1|||
156425393|NCT03717194|564651124|FG001|Overall Study|Adverse Event|1|||
156425394|NCT03499600|564651127|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
156425395|NCT03499600|564651128|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
156425396|NCT00561574|564651129|FG000|Overall Study|Adverse Event|21|||
156425397|NCT00561574|564651130|FG001|Overall Study|Adverse Event|24|||
156425398|NCT00561574|564651129|FG000|Overall Study|Lack of Efficacy|11|||
156425399|NCT00561574|564651130|FG001|Overall Study|Lack of Efficacy|21|||
156425400|NCT00561574|564651129|FG000|Overall Study|Withdrawal by Subject|4|||
156425401|NCT00561574|564651130|FG001|Overall Study|Withdrawal by Subject|4|||
156425402|NCT00561574|564651129|FG000|Overall Study|Reason Unrelated to Trial|6|||
156425403|NCT00561574|564651130|FG001|Overall Study|Reason Unrelated to Trial|2|||
156425404|NCT00561574|564651129|FG000|Overall Study|Lost to Follow-up|1|||
156425405|NCT00561574|564651130|FG001|Overall Study|Lost to Follow-up|0|||
156425406|NCT00561574|564651129|FG000|Overall Study|Other|5|||
156425407|NCT00561574|564651130|FG001|Overall Study|Other|7|||
156425408|NCT03971357|564651131|FG000|Overall Study|Lack of Efficacy|0|||
156425409|NCT03971357|564651132|FG001|Overall Study|Lack of Efficacy|1|||
156425410|NCT01143077|564651133|FG000|Overall Study|Lack of Efficacy|0|||
156425411|NCT01143077|564651134|FG001|Overall Study|Lack of Efficacy|2|||
156425412|NCT01143077|564651135|FG002|Overall Study|Lack of Efficacy|1|||
156425413|NCT01143077|564651133|FG000|Overall Study|Adverse Event|5|||
156425414|NCT01143077|564651134|FG001|Overall Study|Adverse Event|6|||
156425415|NCT01143077|564651135|FG002|Overall Study|Adverse Event|5|||
156425416|NCT01143077|564651133|FG000|Overall Study|Lost to Follow-up|2|||
156425417|NCT01143077|564651134|FG001|Overall Study|Lost to Follow-up|3|||
156425418|NCT01143077|564651135|FG002|Overall Study|Lost to Follow-up|4|||
156425419|NCT01143077|564651133|FG000|Overall Study|Protocol Violation|2|||
156425420|NCT01143077|564651134|FG001|Overall Study|Protocol Violation|0|||
156425421|NCT01143077|564651135|FG002|Overall Study|Protocol Violation|0|||
156425422|NCT01143077|564651133|FG000|Overall Study|Withdrawal by Subject|4|||
156425423|NCT01143077|564651134|FG001|Overall Study|Withdrawal by Subject|3|||
156425424|NCT01143077|564651135|FG002|Overall Study|Withdrawal by Subject|3|||
156425425|NCT01143077|564651133|FG000|Overall Study|Non-compliance with study drug|0|||
156425426|NCT01143077|564651134|FG001|Overall Study|Non-compliance with study drug|1|||
156425427|NCT01143077|564651135|FG002|Overall Study|Non-compliance with study drug|1|||
156425428|NCT01143077|564651133|FG000|Overall Study|Administrative|1|||
156425429|NCT01143077|564651134|FG001|Overall Study|Administrative|0|||
156425430|NCT01143077|564651135|FG002|Overall Study|Administrative|0|||
156425431|NCT01143077|564651133|FG000|Overall Study|Principal Investigator Decision|2|||
156425432|NCT01143077|564651134|FG001|Overall Study|Principal Investigator Decision|0|||
156425433|NCT01143077|564651135|FG002|Overall Study|Principal Investigator Decision|1|||
156425434|NCT00630864|564651141|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
156425435|NCT00630864|564651141|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
156425436|NCT00430677|564651142|FG000|Short-term Period|Death|1|||
156425437|NCT00430677|564651143|FG001|Short-term Period|Death|1|||
156425438|NCT00430677|564651144|FG002|Short-term Period|Death|5|||
156425439|NCT00430677|564651142|FG000|Short-term Period|Adverse Event|15|||
156425440|NCT00430677|564651143|FG001|Short-term Period|Adverse Event|13|||
156425441|NCT00430677|564651144|FG002|Short-term Period|Adverse Event|9|||
156425442|NCT00430677|564651142|FG000|Short-term Period|Lack of Efficacy|5|||
156425443|NCT00430677|564651143|FG001|Short-term Period|Lack of Efficacy|6|||
156425444|NCT00430677|564651144|FG002|Short-term Period|Lack of Efficacy|4|||
156425445|NCT00430677|564651142|FG000|Short-term Period|Withdrawal by Subject|1|||
156425446|NCT00430677|564651143|FG001|Short-term Period|Withdrawal by Subject|1|||
156425447|NCT00430677|564651144|FG002|Short-term Period|Withdrawal by Subject|2|||
156425448|NCT00430677|564651142|FG000|Short-term Period|Participant no longer met study criteria|1|||
156425449|NCT00430677|564651143|FG001|Short-term Period|Participant no longer met study criteria|1|||
156425450|NCT00430677|564651144|FG002|Short-term Period|Participant no longer met study criteria|2|||
156425451|NCT00430677|564651142|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
156425452|NCT00430677|564651143|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
156425453|NCT00430677|564651144|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
156425454|NCT00430677|564651142|FG000|Short-term Period|Pregnancy|0|||
156425455|NCT00430677|564651143|FG001|Short-term Period|Pregnancy|2|||
156425456|NCT00430677|564651144|FG002|Short-term Period|Pregnancy|0|||
156425457|NCT00430677|564651142|FG000|Long-term Extension Period|Death|1|||
156425458|NCT00430677|564651143|FG001|Long-term Extension Period|Death|0|||
156425459|NCT00430677|564651144|FG002|Long-term Extension Period|Death|0|||
156425460|NCT00430677|564651142|FG000|Long-term Extension Period|Adverse Event|3|||
156425461|NCT00430677|564651143|FG001|Long-term Extension Period|Adverse Event|2|||
156425462|NCT00430677|564651144|FG002|Long-term Extension Period|Adverse Event|5|||
156425463|NCT00430677|564651142|FG000|Long-term Extension Period|Lack of Efficacy|5|||
156425464|NCT00430677|564651143|FG001|Long-term Extension Period|Lack of Efficacy|3|||
156425465|NCT00430677|564651144|FG002|Long-term Extension Period|Lack of Efficacy|8|||
156425466|NCT00430677|564651142|FG000|Long-term Extension Period|Lost to Follow-up|1|||
156425467|NCT00430677|564651143|FG001|Long-term Extension Period|Lost to Follow-up|1|||
156425468|NCT00430677|564651144|FG002|Long-term Extension Period|Lost to Follow-up|1|||
156425469|NCT00430677|564651142|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
156425470|NCT00430677|564651143|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
156425471|NCT00430677|564651144|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
156425472|NCT00430677|564651142|FG000|Long-term Extension Period|Pregnancy|1|||
156425473|NCT00430677|564651143|FG001|Long-term Extension Period|Pregnancy|1|||
156425474|NCT00430677|564651144|FG002|Long-term Extension Period|Pregnancy|0|||
156425475|NCT00430677|564651142|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
156425476|NCT00430677|564651143|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
156425477|NCT00430677|564651144|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
156425478|NCT00430677|564651142|FG000|Long-term Extension Period|Other|2|||
156425479|NCT00430677|564651143|FG001|Long-term Extension Period|Other|1|||
156425480|NCT00430677|564651144|FG002|Long-term Extension Period|Other|1|||
156425481|NCT00430677|564651142|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
156425482|NCT00430677|564651143|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
156425483|NCT00430677|564651144|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
156425484|NCT01555762|564651145|FG000|Overall Study|No information on Bevacizumab intake|11|||
156425485|NCT01555762|564651145|FG000|Overall Study|Missing start date of infusion|8|||
156425486|NCT01555762|564651145|FG000|Overall Study|75 years old or more ticked No|1|||
156762046|NCT05616013|565879952|FG008|Overall Study|Prohibited Concomitant Medication|0|||
156762047|NCT05616013|565879944|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762048|NCT05616013|565879945|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762049|NCT05616013|565879946|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
156762050|NCT05616013|565879947|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762051|NCT05616013|565879948|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762052|NCT05616013|565879949|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762053|NCT05616013|565879950|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762054|NCT05616013|565879951|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
156808567|NCT01070979|566052716|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
156425487|NCT01555762|564651145|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
156425488|NCT01555762|564651145|FG000|Overall Study|Death linked to progression of disease|165|||
156425489|NCT01555762|564651145|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
156425490|NCT01555762|564651145|FG000|Overall Study|Investigator's decision|10|||
156425491|NCT01555762|564651145|FG000|Overall Study|Participant not wishing to continue|5|||
156425492|NCT01555762|564651145|FG000|Overall Study|Missing data|1|||
156425493|NCT01555762|564651145|FG000|Overall Study|Death linked to an adverse event|14|||
156425494|NCT00819910|564651146|FG000|Overall Study|Adverse Event|0|||
156425495|NCT00819910|564651147|FG001|Overall Study|Adverse Event|0|||
156425496|NCT00819910|564651148|FG002|Overall Study|Adverse Event|2|||
156425497|NCT00819910|564651149|FG003|Overall Study|Adverse Event|1|||
156425498|NCT00819910|564651146|FG000|Overall Study|Withdrawal by Subject|1|||
156425499|NCT00819910|564651147|FG001|Overall Study|Withdrawal by Subject|1|||
156425500|NCT00819910|564651148|FG002|Overall Study|Withdrawal by Subject|1|||
156425501|NCT00819910|564651149|FG003|Overall Study|Withdrawal by Subject|0|||
156425502|NCT00819910|564651146|FG000|Overall Study|Lost to Follow-up|1|||
156425503|NCT00819910|564651147|FG001|Overall Study|Lost to Follow-up|0|||
156425504|NCT00819910|564651148|FG002|Overall Study|Lost to Follow-up|0|||
156425505|NCT00819910|564651149|FG003|Overall Study|Lost to Follow-up|0|||
156425506|NCT00836810|564651150|FG000|Overall Study|New diagnosis|1|||
156425507|NCT00836810|564651151|FG001|Overall Study|New diagnosis|0|||
156425508|NCT01772719|564651159|FG000|Overall Study|Withdrawal by Subject|3|||
156425509|NCT01772719|564651159|FG000|Overall Study|Adverse Event|2|||
156425510|NCT01772719|564651159|FG000|Overall Study|Protocol Violation|1|||
156425511|NCT01772719|564651159|FG000|Overall Study|Lost to Follow-up|1|||
156425512|NCT02040844|564651160|FG000|Overall Study|Adverse Event|0|||
156425513|NCT02040844|564651161|FG001|Overall Study|Adverse Event|0|||
156425514|NCT02040844|564651162|FG002|Overall Study|Adverse Event|1|||
156425515|NCT02040844|564651160|FG000|Overall Study|Withdrawal by Subject|16|||
156425516|NCT02040844|564651161|FG001|Overall Study|Withdrawal by Subject|22|||
156425517|NCT02040844|564651162|FG002|Overall Study|Withdrawal by Subject|25|||
156425518|NCT02040844|564651160|FG000|Overall Study|Lost to Follow-up|12|||
156425519|NCT02040844|564651161|FG001|Overall Study|Lost to Follow-up|9|||
156425520|NCT02040844|564651162|FG002|Overall Study|Lost to Follow-up|13|||
156425521|NCT02040844|564651160|FG000|Overall Study|Missing|13|||
156425522|NCT02040844|564651161|FG001|Overall Study|Missing|3|||
156425523|NCT02040844|564651162|FG002|Overall Study|Missing|2|||
156425524|NCT02040844|564651160|FG000|Overall Study|Non-specified|8|||
156425525|NCT02040844|564651161|FG001|Overall Study|Non-specified|2|||
156425526|NCT02040844|564651162|FG002|Overall Study|Non-specified|5|||
156425527|NCT02040844|564651160|FG000|Overall Study|Concomitant medication|1|||
156425528|NCT02040844|564651161|FG001|Overall Study|Concomitant medication|3|||
156425529|NCT02040844|564651162|FG002|Overall Study|Concomitant medication|1|||
156425530|NCT00946192|564651163|FG000|Overall Study|Lost to Follow-up|6|||
156425531|NCT00946192|564651164|FG001|Overall Study|Lost to Follow-up|11|||
156425532|NCT00946192|564651165|FG002|Overall Study|Lost to Follow-up|9|||
156425533|NCT00946192|564651163|FG000|Overall Study|Withdrawal by Subject|10|||
156425534|NCT00946192|564651164|FG001|Overall Study|Withdrawal by Subject|7|||
156425535|NCT00946192|564651165|FG002|Overall Study|Withdrawal by Subject|3|||
156425536|NCT00946192|564651163|FG000|Overall Study|Did not start medication|2|||
156425537|NCT00946192|564651164|FG001|Overall Study|Did not start medication|0|||
156425538|NCT00946192|564651165|FG002|Overall Study|Did not start medication|0|||
156425539|NCT02014558|564651166|FG000|Overall Study|Never Received Study Drug|0|||
156425540|NCT02014558|564651167|FG001|Overall Study|Never Received Study Drug|0|||
156425541|NCT02014558|564651168|FG002|Overall Study|Never Received Study Drug|0|||
156425542|NCT02014558|564651169|FG003|Overall Study|Never Received Study Drug|0|||
156425543|NCT02014558|564651170|FG004|Overall Study|Never Received Study Drug|1|||
156425544|NCT02014558|564651171|FG005|Overall Study|Never Received Study Drug|0|||
156425545|NCT02014558|564651172|FG006|Overall Study|Never Received Study Drug|1|||
156425546|NCT02014558|564651173|FG007|Overall Study|Never Received Study Drug|0|||
156425547|NCT02014558|564651174|FG008|Overall Study|Never Received Study Drug|2|||
156425548|NCT02014558|564651175|FG009|Overall Study|Never Received Study Drug|0|||
156425549|NCT02014558|564651176|FG010|Overall Study|Never Received Study Drug|2|||
156425550|NCT02014558|564651177|FG011|Overall Study|Never Received Study Drug|2|||
156425551|NCT02014558|564651178|FG012|Overall Study|Never Received Study Drug|0|||
156425552|NCT02014558|564651166|FG000|Overall Study|Adverse Event|0|||
156425553|NCT02014558|564651167|FG001|Overall Study|Adverse Event|0|||
156425554|NCT02014558|564651168|FG002|Overall Study|Adverse Event|0|||
156425555|NCT02014558|564651169|FG003|Overall Study|Adverse Event|0|||
156425556|NCT02014558|564651170|FG004|Overall Study|Adverse Event|1|||
156425557|NCT02014558|564651171|FG005|Overall Study|Adverse Event|0|||
156425558|NCT02014558|564651172|FG006|Overall Study|Adverse Event|0|||
156425559|NCT02014558|564651173|FG007|Overall Study|Adverse Event|0|||
156425560|NCT02014558|564651174|FG008|Overall Study|Adverse Event|2|||
156425561|NCT02014558|564651175|FG009|Overall Study|Adverse Event|2|||
156425562|NCT02014558|564651176|FG010|Overall Study|Adverse Event|5|||
156425563|NCT02014558|564651177|FG011|Overall Study|Adverse Event|21|||
156425564|NCT02014558|564651178|FG012|Overall Study|Adverse Event|3|||
156425565|NCT02014558|564651166|FG000|Overall Study|Death|1|||
156425566|NCT02014558|564651167|FG001|Overall Study|Death|0|||
156425567|NCT02014558|564651168|FG002|Overall Study|Death|0|||
156425568|NCT02014558|564651169|FG003|Overall Study|Death|0|||
156425569|NCT02014558|564651170|FG004|Overall Study|Death|0|||
156425570|NCT02014558|564651171|FG005|Overall Study|Death|0|||
156425571|NCT02014558|564651172|FG006|Overall Study|Death|1|||
156425572|NCT02014558|564651173|FG007|Overall Study|Death|1|||
156425573|NCT02014558|564651174|FG008|Overall Study|Death|2|||
156425574|NCT02014558|564651175|FG009|Overall Study|Death|5|||
156425575|NCT02014558|564651176|FG010|Overall Study|Death|5|||
156425576|NCT02014558|564651177|FG011|Overall Study|Death|19|||
156425577|NCT02014558|564651178|FG012|Overall Study|Death|2|||
156425578|NCT02014558|564651166|FG000|Overall Study|Lack of Efficacy|1|||
156425579|NCT02014558|564651167|FG001|Overall Study|Lack of Efficacy|2|||
156425580|NCT02014558|564651168|FG002|Overall Study|Lack of Efficacy|1|||
156425581|NCT02014558|564651169|FG003|Overall Study|Lack of Efficacy|1|||
156425582|NCT02014558|564651170|FG004|Overall Study|Lack of Efficacy|0|||
156425583|NCT02014558|564651171|FG005|Overall Study|Lack of Efficacy|0|||
156425584|NCT02014558|564651172|FG006|Overall Study|Lack of Efficacy|1|||
156425585|NCT02014558|564651173|FG007|Overall Study|Lack of Efficacy|3|||
156425586|NCT02014558|564651174|FG008|Overall Study|Lack of Efficacy|3|||
156425587|NCT02014558|564651175|FG009|Overall Study|Lack of Efficacy|3|||
156425588|NCT02014558|564651176|FG010|Overall Study|Lack of Efficacy|16|||
156425589|NCT02014558|564651177|FG011|Overall Study|Lack of Efficacy|8|||
156425590|NCT02014558|564651178|FG012|Overall Study|Lack of Efficacy|5|||
156425591|NCT02014558|564651166|FG000|Overall Study|Lost to Follow-up|0|||
156425592|NCT02014558|564651167|FG001|Overall Study|Lost to Follow-up|0|||
156425593|NCT02014558|564651168|FG002|Overall Study|Lost to Follow-up|0|||
156425594|NCT02014558|564651169|FG003|Overall Study|Lost to Follow-up|0|||
156425595|NCT02014558|564651170|FG004|Overall Study|Lost to Follow-up|0|||
156425596|NCT02014558|564651171|FG005|Overall Study|Lost to Follow-up|0|||
156425597|NCT02014558|564651172|FG006|Overall Study|Lost to Follow-up|0|||
156425598|NCT02014558|564651173|FG007|Overall Study|Lost to Follow-up|0|||
156425599|NCT02014558|564651174|FG008|Overall Study|Lost to Follow-up|0|||
156425600|NCT02014558|564651175|FG009|Overall Study|Lost to Follow-up|0|||
156425601|NCT02014558|564651176|FG010|Overall Study|Lost to Follow-up|1|||
156425602|NCT02014558|564651177|FG011|Overall Study|Lost to Follow-up|0|||
156425603|NCT02014558|564651178|FG012|Overall Study|Lost to Follow-up|0|||
156425604|NCT02014558|564651166|FG000|Overall Study|Progressive Disease|1|||
156425605|NCT02014558|564651167|FG001|Overall Study|Progressive Disease|0|||
156425606|NCT02014558|564651168|FG002|Overall Study|Progressive Disease|1|||
156425607|NCT02014558|564651169|FG003|Overall Study|Progressive Disease|1|||
156425608|NCT02014558|564651170|FG004|Overall Study|Progressive Disease|1|||
156425609|NCT02014558|564651171|FG005|Overall Study|Progressive Disease|2|||
156425610|NCT02014558|564651172|FG006|Overall Study|Progressive Disease|1|||
156425611|NCT02014558|564651173|FG007|Overall Study|Progressive Disease|6|||
156425612|NCT02014558|564651174|FG008|Overall Study|Progressive Disease|5|||
156425613|NCT02014558|564651175|FG009|Overall Study|Progressive Disease|6|||
156425614|NCT02014558|564651176|FG010|Overall Study|Progressive Disease|22|||
156425615|NCT02014558|564651177|FG011|Overall Study|Progressive Disease|31|||
156425616|NCT02014558|564651178|FG012|Overall Study|Progressive Disease|6|||
156425617|NCT02014558|564651166|FG000|Overall Study|Withdrawal by Subject|0|||
156425618|NCT02014558|564651167|FG001|Overall Study|Withdrawal by Subject|0|||
156425619|NCT02014558|564651168|FG002|Overall Study|Withdrawal by Subject|0|||
156425620|NCT02014558|564651169|FG003|Overall Study|Withdrawal by Subject|0|||
156425621|NCT02014558|564651170|FG004|Overall Study|Withdrawal by Subject|1|||
156654889|NCT02795104|565482611|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
156425622|NCT02014558|564651171|FG005|Overall Study|Withdrawal by Subject|0|||
156425623|NCT02014558|564651172|FG006|Overall Study|Withdrawal by Subject|0|||
156425624|NCT02014558|564651173|FG007|Overall Study|Withdrawal by Subject|0|||
156425625|NCT02014558|564651174|FG008|Overall Study|Withdrawal by Subject|0|||
156425626|NCT02014558|564651175|FG009|Overall Study|Withdrawal by Subject|2|||
156425627|NCT02014558|564651176|FG010|Overall Study|Withdrawal by Subject|6|||
156425628|NCT02014558|564651177|FG011|Overall Study|Withdrawal by Subject|10|||
156425629|NCT02014558|564651178|FG012|Overall Study|Withdrawal by Subject|0|||
156425630|NCT02014558|564651166|FG000|Overall Study|Miscellaneous|2|||
156425631|NCT02014558|564651167|FG001|Overall Study|Miscellaneous|1|||
156425632|NCT02014558|564651168|FG002|Overall Study|Miscellaneous|1|||
156425633|NCT02014558|564651169|FG003|Overall Study|Miscellaneous|1|||
156425634|NCT02014558|564651170|FG004|Overall Study|Miscellaneous|0|||
156425635|NCT02014558|564651171|FG005|Overall Study|Miscellaneous|1|||
156425636|NCT02014558|564651172|FG006|Overall Study|Miscellaneous|0|||
156762055|NCT05616013|565879952|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762056|NCT05616013|565879944|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762057|NCT05616013|565879945|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762058|NCT05616013|565879946|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762059|NCT05616013|565879947|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
156762060|NCT05616013|565879948|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762061|NCT05616013|565879949|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762062|NCT05616013|565879950|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762063|NCT05616013|565879951|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762064|NCT05616013|565879952|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762065|NCT05616013|565879944|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762066|NCT05616013|565879945|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762067|NCT05616013|565879946|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762068|NCT05616013|565879947|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762069|NCT05616013|565879948|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762070|NCT05616013|565879949|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762071|NCT05616013|565879950|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
156762072|NCT05616013|565879951|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762073|NCT05616013|565879952|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762074|NCT05616013|565879944|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762075|NCT05616013|565879945|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762076|NCT05616013|565879946|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762077|NCT05616013|565879947|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762078|NCT05616013|565879948|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762079|NCT05616013|565879949|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762080|NCT05616013|565879950|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762081|NCT05616013|565879951|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762082|NCT05616013|565879952|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
156762083|NCT05616013|565879944|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762084|NCT05616013|565879945|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762085|NCT05616013|565879946|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762086|NCT05616013|565879947|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762087|NCT05616013|565879948|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762088|NCT05616013|565879949|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762089|NCT05616013|565879950|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762090|NCT05616013|565879951|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762091|NCT05616013|565879952|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
156762092|NCT04391842|565879953|FG000|Overall Study|Withdrawal by Subject|2|||
156762093|NCT00810199|565879954|FG000|Overall Study|Adverse Event|24|||
156762094|NCT00810199|565879955|FG001|Overall Study|Adverse Event|26|||
156762095|NCT00810199|565879954|FG000|Overall Study|Death|4|||
156762096|NCT00810199|565879955|FG001|Overall Study|Death|6|||
156762097|NCT00810199|565879954|FG000|Overall Study|Withdrew consent|9|||
156762098|NCT00810199|565879955|FG001|Overall Study|Withdrew consent|12|||
156762099|NCT00810199|565879954|FG000|Overall Study|Insufficient therapeutic response|5|||
156762100|NCT00810199|565879955|FG001|Overall Study|Insufficient therapeutic response|14|||
156762101|NCT00810199|565879954|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
156425637|NCT02014558|564651173|FG007|Overall Study|Miscellaneous|1|||
156425638|NCT02014558|564651174|FG008|Overall Study|Miscellaneous|1|||
156425639|NCT02014558|564651175|FG009|Overall Study|Miscellaneous|3|||
156425640|NCT02014558|564651176|FG010|Overall Study|Miscellaneous|12|||
156425641|NCT02014558|564651177|FG011|Overall Study|Miscellaneous|11|||
156762102|NCT00810199|565879955|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
156762103|NCT00810199|565879954|FG000|Overall Study|Administrative/Other|5|||
156762104|NCT00810199|565879955|FG001|Overall Study|Administrative/Other|6|||
156762105|NCT00810199|565879954|FG000|Overall Study|Protocol Violation|2|||
156762106|NCT00810199|565879955|FG001|Overall Study|Protocol Violation|6|||
156762107|NCT00810199|565879954|FG000|Overall Study|Failure to return|1|||
156762108|NCT00810199|565879955|FG001|Overall Study|Failure to return|4|||
156762109|NCT00810199|565879954|FG000|Overall Study|Did not receive study drug|2|||
156762110|NCT00810199|565879955|FG001|Overall Study|Did not receive study drug|1|||
156762111|NCT00992017|565879957|FG000|Overall Study|Lost to Follow-up|2|||
156762112|NCT00992017|565879957|FG000|Overall Study|Withdrawal by Subject|2|||
156762113|NCT00992017|565879957|FG000|Overall Study|Unable to get to clinic|5|||
156762114|NCT00992017|565879957|FG000|Overall Study|Not adhere to study requirements|1|||
156425642|NCT02014558|564651178|FG012|Overall Study|Miscellaneous|1|||
156425643|NCT02931396|564651181|FG000|Overall Study|Lost to Follow-up|3|||
156425644|NCT02931396|564651182|FG001|Overall Study|Lost to Follow-up|0|||
156762115|NCT02864407|565879958|FG000|Overall Study|Protocol Violation|3|||
156762116|NCT02864407|565879958|FG000|Overall Study|Lost to Follow-up|115|||
156425645|NCT02931396|564651181|FG000|Overall Study|Withdrawal by Subject|2|||
156425646|NCT02931396|564651182|FG001|Overall Study|Withdrawal by Subject|0|||
156425647|NCT00681811|564651185|FG000|Overall Study|Adverse Event|1|||
156425648|NCT00681811|564651186|FG001|Overall Study|Adverse Event|1|||
156425649|NCT00681811|564651185|FG000|Overall Study|Withdrawal by Subject|2|||
156425650|NCT00681811|564651186|FG001|Overall Study|Withdrawal by Subject|2|||
156425651|NCT00681811|564651185|FG000|Overall Study|Non-compliance|0|||
156425652|NCT00681811|564651186|FG001|Overall Study|Non-compliance|1|||
156425653|NCT05273801|564651187|FG000|Overall Study|Physician Decision|1|||
156762117|NCT02864407|565879958|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
156762118|NCT02864407|565879958|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
156762119|NCT02864407|565879958|FG000|Overall Study|Consent prior to the contract date|1|||
156762120|NCT02686164|565879966|FG000|Overall Study|Adverse Event|1|||
156762121|NCT02686164|565879966|FG000|Overall Study|Withdrawal of consent|1|||
156762122|NCT02686164|565879966|FG000|Overall Study|Clinical progression|1|||
156762123|NCT01691378|565879967|FG000|Overall Study|Withdrawal by Subject|2|||
156762124|NCT01691378|565879968|FG001|Overall Study|Withdrawal by Subject|0|||
156762125|NCT01691378|565879967|FG000|Overall Study|Lost to Follow-up|5|||
156762126|NCT01691378|565879968|FG001|Overall Study|Lost to Follow-up|2|||
156762127|NCT01827592|565879971|FG000|Overall Study|Adverse Event|11|||
156762128|NCT01827592|565879972|FG001|Overall Study|Adverse Event|9|||
156762129|NCT01827592|565879973|FG002|Overall Study|Adverse Event|2|||
156762130|NCT01827592|565879971|FG000|Overall Study|Physician Decision|0|||
156762131|NCT01827592|565879972|FG001|Overall Study|Physician Decision|2|||
156762132|NCT01827592|565879973|FG002|Overall Study|Physician Decision|1|||
156425654|NCT00828919|564651188|FG000|Overall Study|Death|0|||
156425655|NCT00828919|564651189|FG001|Overall Study|Death|1|||
156425656|NCT00828919|564651190|FG002|Overall Study|Death|2|||
156425657|NCT00828919|564651191|FG003|Overall Study|Death|0|||
156425658|NCT00828919|564651192|FG004|Overall Study|Death|0|||
156425659|NCT00828919|564651188|FG000|Overall Study|Adverse Event|2|||
156425660|NCT00828919|564651189|FG001|Overall Study|Adverse Event|2|||
156425661|NCT00828919|564651190|FG002|Overall Study|Adverse Event|2|||
156425662|NCT00828919|564651191|FG003|Overall Study|Adverse Event|1|||
156425663|NCT00828919|564651192|FG004|Overall Study|Adverse Event|3|||
156425664|NCT00828919|564651188|FG000|Overall Study|Objective progression or relapse|4|||
156425665|NCT00828919|564651189|FG001|Overall Study|Objective progression or relapse|4|||
156425666|NCT00828919|564651190|FG002|Overall Study|Objective progression or relapse|11|||
156425667|NCT00828919|564651191|FG003|Overall Study|Objective progression or relapse|0|||
156425668|NCT00828919|564651192|FG004|Overall Study|Objective progression or relapse|5|||
156425669|NCT00828919|564651188|FG000|Overall Study|No longer willing to participate in study|0|||
156425670|NCT00828919|564651189|FG001|Overall Study|No longer willing to participate in study|0|||
156425671|NCT00828919|564651190|FG002|Overall Study|No longer willing to participate in study|2|||
156425672|NCT00828919|564651191|FG003|Overall Study|No longer willing to participate in study|0|||
156425673|NCT00828919|564651192|FG004|Overall Study|No longer willing to participate in study|0|||
156425674|NCT00828919|564651188|FG000|Overall Study|Insufficient Clinical Response|0|||
156425675|NCT00828919|564651189|FG001|Overall Study|Insufficient Clinical Response|1|||
156425676|NCT00828919|564651190|FG002|Overall Study|Insufficient Clinical Response|2|||
156425677|NCT00828919|564651191|FG003|Overall Study|Insufficient Clinical Response|0|||
156425678|NCT00828919|564651192|FG004|Overall Study|Insufficient Clinical Response|0|||
156762133|NCT01827592|565879971|FG000|Overall Study|Protocol Violation|2|||
156762134|NCT01827592|565879972|FG001|Overall Study|Protocol Violation|1|||
156425679|NCT00828919|564651188|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
156425680|NCT00828919|564651189|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
156425681|NCT00828919|564651190|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
156425682|NCT00828919|564651191|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
156425683|NCT00828919|564651192|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
156425684|NCT00828919|564651188|FG000|Overall Study|Other|1|||
156425685|NCT00828919|564651189|FG001|Overall Study|Other|0|||
156425686|NCT00828919|564651190|FG002|Overall Study|Other|1|||
156425687|NCT00828919|564651191|FG003|Overall Study|Other|1|||
156425688|NCT00828919|564651192|FG004|Overall Study|Other|0|||
156425689|NCT00828919|564651188|FG000|Overall Study|Lost to Follow-up|0|||
156425690|NCT00828919|564651189|FG001|Overall Study|Lost to Follow-up|1|||
156425691|NCT00828919|564651190|FG002|Overall Study|Lost to Follow-up|0|||
156425692|NCT00828919|564651191|FG003|Overall Study|Lost to Follow-up|0|||
156425693|NCT00828919|564651192|FG004|Overall Study|Lost to Follow-up|0|||
156425694|NCT04159506|564651195|FG000|Overall Study|Lost to Follow-up|2|||
156425695|NCT04159506|564651196|FG001|Overall Study|Lost to Follow-up|5|||
156425696|NCT02449044|564651197|FG000|Overall Study|Lost to Follow-up|2|||
156425697|NCT02449044|564651197|FG000|Overall Study|Withdrawal by Subject|13|||
156425698|NCT02449044|564651197|FG000|Overall Study|Adverse Event|30|||
156425699|NCT02449044|564651197|FG000|Overall Study|Met Withdrawal Criteria|7|||
156425700|NCT02449044|564651197|FG000|Overall Study|Physician Decision|9|||
156425701|NCT02449044|564651197|FG000|Overall Study|Sponsor Discontinued Trial|3|||
156425702|NCT03227757|564652759|FG000|Overall Study|Death|25|||
156425703|NCT03227757|564652759|FG000|Overall Study|Withdrawal|10|||
156425704|NCT03227757|564652759|FG000|Overall Study|Missed visits|1|||
156425705|NCT03227757|564652759|FG000|Overall Study|Lost to Follow-up|2|||
156425706|NCT01144468|564652760|FG000|Overall Study|Lost to Follow-up|4|||
156425707|NCT01144468|564652761|FG001|Overall Study|Lost to Follow-up|7|||
156425708|NCT01144468|564652760|FG000|Overall Study|Adverse Event|3|||
156425709|NCT01144468|564652761|FG001|Overall Study|Adverse Event|2|||
156762135|NCT01827592|565879973|FG002|Overall Study|Protocol Violation|0|||
156425710|NCT01144468|564652760|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
156425711|NCT01144468|564652761|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
156425712|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
156425713|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
156425714|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
156425715|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
156425716|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Adverse Event|198|||
156425717|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Adverse Event|0|||
156425718|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Adverse Event|0|||
156425719|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Adverse Event|0|||
156425720|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Death|62|||
156425721|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Death|0|||
156425722|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Death|0|||
156425723|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Death|0|||
156425724|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
156762136|NCT01827592|565879971|FG000|Overall Study|Lost to Follow-up|1|||
156762137|NCT01827592|565879972|FG001|Overall Study|Lost to Follow-up|2|||
156762138|NCT01827592|565879973|FG002|Overall Study|Lost to Follow-up|2|||
156762139|NCT01827592|565879971|FG000|Overall Study|Withdrawal by Subject|12|||
156762140|NCT01827592|565879972|FG001|Overall Study|Withdrawal by Subject|11|||
156762141|NCT01827592|565879973|FG002|Overall Study|Withdrawal by Subject|11|||
156762142|NCT01827592|565879971|FG000|Overall Study|Patient's substantial non-compliance|1|||
156762143|NCT01827592|565879972|FG001|Overall Study|Patient's substantial non-compliance|1|||
156762144|NCT01827592|565879973|FG002|Overall Study|Patient's substantial non-compliance|6|||
156762145|NCT01827592|565879971|FG000|Overall Study|Trial terminated by Sponsor|47|||
156762146|NCT01827592|565879972|FG001|Overall Study|Trial terminated by Sponsor|53|||
156762147|NCT01827592|565879973|FG002|Overall Study|Trial terminated by Sponsor|51|||
156762148|NCT01827592|565879971|FG000|Overall Study|Others|0|||
156762149|NCT01827592|565879972|FG001|Overall Study|Others|1|||
156762150|NCT01827592|565879973|FG002|Overall Study|Others|3|||
156762151|NCT04888494|565879979|FG000|Overall Study|Lost to Follow-up|2|||
156762152|NCT04888494|565879980|FG001|Overall Study|Lost to Follow-up|3|||
156762153|NCT04888494|565879979|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
156762154|NCT04888494|565879980|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
156762155|NCT02357459|565882412|FG000|Overall Study|Adverse Event|0|||
156762156|NCT02357459|565882413|FG001|Overall Study|Adverse Event|1|||
156762157|NCT02357459|565882414|FG002|Overall Study|Adverse Event|1|||
156762158|NCT02357459|565882412|FG000|Overall Study|Withdrawal by Subject|5|||
156425725|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
156425726|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
156425727|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
156425728|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Complicating disease|13|||
156425729|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Complicating disease|0|||
156425730|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Complicating disease|0|||
156425731|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Complicating disease|0|||
156425732|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
156425733|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
156762159|NCT02357459|565882413|FG001|Overall Study|Withdrawal by Subject|3|||
156762160|NCT02357459|565882414|FG002|Overall Study|Withdrawal by Subject|3|||
156762161|NCT02357459|565882412|FG000|Overall Study|Physician Decision|0|||
156762162|NCT02357459|565882413|FG001|Overall Study|Physician Decision|2|||
156762163|NCT02357459|565882414|FG002|Overall Study|Physician Decision|0|||
156762164|NCT02357459|565882412|FG000|Overall Study|Protocol Violation|1|||
156762165|NCT02357459|565882413|FG001|Overall Study|Protocol Violation|1|||
156762166|NCT02357459|565882414|FG002|Overall Study|Protocol Violation|0|||
156762167|NCT02357459|565882412|FG000|Overall Study|Lost to Follow-up|1|||
156762168|NCT02357459|565882413|FG001|Overall Study|Lost to Follow-up|3|||
156762169|NCT02357459|565882414|FG002|Overall Study|Lost to Follow-up|0|||
156762170|NCT02357459|565882412|FG000|Overall Study|Lack of Efficacy|7|||
156762171|NCT02357459|565882413|FG001|Overall Study|Lack of Efficacy|4|||
156762172|NCT02357459|565882414|FG002|Overall Study|Lack of Efficacy|4|||
156762173|NCT02357459|565882412|FG000|Overall Study|Patient Relocated|2|||
156762174|NCT02357459|565882413|FG001|Overall Study|Patient Relocated|0|||
156762175|NCT02357459|565882414|FG002|Overall Study|Patient Relocated|0|||
156762176|NCT02357459|565882412|FG000|Overall Study|Instruction from PCP|1|||
156762177|NCT02357459|565882413|FG001|Overall Study|Instruction from PCP|0|||
156762178|NCT02357459|565882414|FG002|Overall Study|Instruction from PCP|0|||
156762179|NCT02357459|565882412|FG000|Overall Study|Incarceration|0|||
156762180|NCT02357459|565882413|FG001|Overall Study|Incarceration|0|||
156762181|NCT02357459|565882414|FG002|Overall Study|Incarceration|1|||
156762182|NCT02357459|565882412|FG000|Overall Study|Pre-planned Knee surgery|0|||
156762183|NCT02357459|565882413|FG001|Overall Study|Pre-planned Knee surgery|0|||
156762184|NCT02357459|565882414|FG002|Overall Study|Pre-planned Knee surgery|2|||
156762185|NCT02357459|565882412|FG000|Overall Study|Job Commitments|0|||
156762186|NCT02357459|565882413|FG001|Overall Study|Job Commitments|0|||
156762187|NCT02357459|565882414|FG002|Overall Study|Job Commitments|1|||
156762188|NCT03246347|565882415|FG000|Overall Study|On Study|23|||
156762189|NCT02188160|565882416|FG000|Overall Study|Adverse Event|1|||
156762190|NCT02188160|565882417|FG001|Overall Study|Adverse Event|0|||
156762191|NCT02188160|565882416|FG000|Overall Study|Use of an excluded medication|0|||
156762192|NCT02188160|565882417|FG001|Overall Study|Use of an excluded medication|1|||
156762193|NCT04113694|565882418|FG000|Overall Study|Adverse Event|2|||
156762194|NCT04113694|565882418|FG000|Overall Study|Lost to Follow-up|2|||
156762195|NCT04113694|565882418|FG000|Overall Study|Withdrawal by Subject|6|||
156762196|NCT04113694|565882418|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
156762197|NCT05630196|565882421|FG000|Overall Study|Adverse Event|2|||
156762198|NCT05630196|565882422|FG001|Overall Study|Adverse Event|1|||
156762199|NCT05630196|565882421|FG000|Overall Study|Lost to Follow-up|1|||
156762200|NCT05630196|565882422|FG001|Overall Study|Lost to Follow-up|1|||
156762201|NCT05630196|565882421|FG000|Overall Study|Protocol Violation|2|||
156762202|NCT05630196|565882422|FG001|Overall Study|Protocol Violation|3|||
156762203|NCT05630196|565882421|FG000|Overall Study|Physician Decision|1|||
156762204|NCT05630196|565882422|FG001|Overall Study|Physician Decision|0|||
156762205|NCT05630196|565882421|FG000|Overall Study|Withdrawal by Subject|3|||
156762206|NCT05630196|565882422|FG001|Overall Study|Withdrawal by Subject|4|||
156762207|NCT00916578|565882423|FG000|Overall Study|Physician Decision|2|||
156762208|NCT00916578|565882423|FG000|Overall Study|Withdrawal by Subject|3|||
156762209|NCT00916578|565882423|FG000|Overall Study|Insurance Denial|2|||
156762210|NCT01022203|565882429|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
156762211|NCT01022203|565882430|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
156762212|NCT01022203|565882429|FG000|Post Treatment Assessment|Physician Decision|2|||
156762213|NCT01022203|565882430|FG001|Post Treatment Assessment|Physician Decision|0|||
156762214|NCT01022203|565882429|FG000|Post Treatment Assessment|Adverse Event|0|||
156762215|NCT01022203|565882430|FG001|Post Treatment Assessment|Adverse Event|2|||
156762216|NCT01022203|565882429|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
156762217|NCT01022203|565882430|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
156762218|NCT03163446|565882433|FG000|Overall Study|Unable to return for Day 180 visit|2|||
156762219|NCT03163446|565882434|FG001|Overall Study|Unable to return for Day 180 visit|0|||
156762220|NCT03163446|565882433|FG000|Overall Study|Withdrawal by Subject|2|||
156762221|NCT03163446|565882434|FG001|Overall Study|Withdrawal by Subject|6|||
156762222|NCT03163446|565882433|FG000|Overall Study|Death|16|||
156762223|NCT03163446|565882434|FG001|Overall Study|Death|5|||
156762224|NCT03163446|565882433|FG000|Overall Study|Lost to Follow-up|6|||
156762225|NCT03163446|565882434|FG001|Overall Study|Lost to Follow-up|5|||
156762226|NCT03163446|565882433|FG000|Overall Study|Physician Decision|1|||
156762227|NCT03163446|565882434|FG001|Overall Study|Physician Decision|1|||
156762228|NCT03163446|565882433|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
156762229|NCT03163446|565882434|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
156762230|NCT00903201|565882435|FG000|Overall Study|Adverse Event|1|||
156762231|NCT00903201|565882436|FG001|Overall Study|Adverse Event|4|||
156762232|NCT00903201|565882437|FG002|Overall Study|Adverse Event|0|||
156762233|NCT00903201|565882435|FG000|Overall Study|Protocol Violation|2|||
156762234|NCT00903201|565882436|FG001|Overall Study|Protocol Violation|1|||
156762235|NCT00903201|565882437|FG002|Overall Study|Protocol Violation|0|||
156762236|NCT00903201|565882435|FG000|Overall Study|Lost to Follow-up|0|||
156762237|NCT00903201|565882436|FG001|Overall Study|Lost to Follow-up|1|||
156762238|NCT00903201|565882437|FG002|Overall Study|Lost to Follow-up|0|||
156762239|NCT00903201|565882435|FG000|Overall Study|Physician Decision|1|||
156762240|NCT00903201|565882436|FG001|Overall Study|Physician Decision|0|||
156762241|NCT00903201|565882437|FG002|Overall Study|Physician Decision|1|||
156762242|NCT00903201|565882435|FG000|Overall Study|Withdrawal by Subject|1|||
156762243|NCT00903201|565882436|FG001|Overall Study|Withdrawal by Subject|0|||
156762244|NCT00903201|565882437|FG002|Overall Study|Withdrawal by Subject|1|||
156762245|NCT01094288|565882440|FG000|Overall Study|Adverse Event|0|||
156762246|NCT01094288|565882441|FG001|Overall Study|Adverse Event|3|||
156762247|NCT01094288|565882442|FG002|Overall Study|Adverse Event|1|||
156762248|NCT01094288|565882443|FG003|Overall Study|Adverse Event|1|||
156762249|NCT01094288|565882444|FG004|Overall Study|Adverse Event|0|||
156762250|NCT01094288|565882445|FG005|Overall Study|Adverse Event|0|||
156762251|NCT01094288|565882446|FG006|Overall Study|Adverse Event|0|||
156762252|NCT01094288|565882447|FG007|Overall Study|Adverse Event|0|||
156762253|NCT01094288|565882440|FG000|Overall Study|Withdrawal by Subject|0|||
156762254|NCT01094288|565882441|FG001|Overall Study|Withdrawal by Subject|1|||
156762255|NCT01094288|565882442|FG002|Overall Study|Withdrawal by Subject|2|||
156762256|NCT01094288|565882443|FG003|Overall Study|Withdrawal by Subject|0|||
156762257|NCT01094288|565882444|FG004|Overall Study|Withdrawal by Subject|0|||
156762258|NCT01094288|565882445|FG005|Overall Study|Withdrawal by Subject|0|||
156762259|NCT01094288|565882446|FG006|Overall Study|Withdrawal by Subject|0|||
156762260|NCT01094288|565882447|FG007|Overall Study|Withdrawal by Subject|2|||
156762261|NCT01094288|565882440|FG000|Overall Study|Initiation of Alternative Therapy|0|||
156762262|NCT01094288|565882441|FG001|Overall Study|Initiation of Alternative Therapy|0|||
156762263|NCT01094288|565882442|FG002|Overall Study|Initiation of Alternative Therapy|1|||
156762264|NCT01094288|565882443|FG003|Overall Study|Initiation of Alternative Therapy|0|||
156762265|NCT01094288|565882444|FG004|Overall Study|Initiation of Alternative Therapy|0|||
156762266|NCT01094288|565882445|FG005|Overall Study|Initiation of Alternative Therapy|0|||
156762267|NCT01094288|565882446|FG006|Overall Study|Initiation of Alternative Therapy|0|||
156762268|NCT01094288|565882447|FG007|Overall Study|Initiation of Alternative Therapy|0|||
156762269|NCT01094288|565882440|FG000|Overall Study|Reason not Specified|2|||
156762270|NCT01094288|565882441|FG001|Overall Study|Reason not Specified|3|||
156762271|NCT01094288|565882442|FG002|Overall Study|Reason not Specified|0|||
156762272|NCT01094288|565882443|FG003|Overall Study|Reason not Specified|1|||
156762273|NCT01094288|565882444|FG004|Overall Study|Reason not Specified|0|||
156762274|NCT01094288|565882445|FG005|Overall Study|Reason not Specified|0|||
156762275|NCT01094288|565882446|FG006|Overall Study|Reason not Specified|0|||
156762276|NCT01094288|565882447|FG007|Overall Study|Reason not Specified|0|||
156762277|NCT01094288|565882440|FG000|Overall Study|Ongoing Participants|0|||
156762278|NCT01094288|565882441|FG001|Overall Study|Ongoing Participants|3|||
156762279|NCT01094288|565882442|FG002|Overall Study|Ongoing Participants|0|||
156762280|NCT01094288|565882443|FG003|Overall Study|Ongoing Participants|0|||
156762281|NCT01094288|565882444|FG004|Overall Study|Ongoing Participants|0|||
156762282|NCT01094288|565882445|FG005|Overall Study|Ongoing Participants|0|||
156762283|NCT01094288|565882446|FG006|Overall Study|Ongoing Participants|0|||
156762284|NCT01094288|565882447|FG007|Overall Study|Ongoing Participants|0|||
156762285|NCT02611882|565882448|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
156762286|NCT02611882|565882449|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
156762287|NCT02611882|565882450|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
156762288|NCT01228591|565882451|FG000|Baseline|Lack of Efficacy|1|||
156762289|NCT01228591|565882452|FG001|Baseline|Lack of Efficacy|2|||
156762290|NCT01389232|565882453|FG000|Overall Study|Had scaffold removed|15|||
156762291|NCT01389232|565882453|FG000|Overall Study|Personal reasons|2|||
156762292|NCT01389232|565882453|FG000|Overall Study|Adverse Event|1|||
156762293|NCT01389232|565882453|FG000|Overall Study|Death|1|||
156762294|NCT01317940|565882454|FG000|Overall Study|Death|1|||
156762295|NCT01317940|565882455|FG001|Overall Study|Death|0|||
156762296|NCT01317940|565882456|FG002|Overall Study|Death|1|||
156762297|NCT01317940|565882457|FG003|Overall Study|Death|0|||
156762298|NCT01317940|565882458|FG004|Overall Study|Death|0|||
156762299|NCT01317940|565882459|FG005|Overall Study|Death|0|||
156762300|NCT01317940|565882454|FG000|Overall Study|Lost to Follow-up|0|||
156762301|NCT01317940|565882455|FG001|Overall Study|Lost to Follow-up|0|||
156762302|NCT01317940|565882456|FG002|Overall Study|Lost to Follow-up|1|||
156762303|NCT01317940|565882457|FG003|Overall Study|Lost to Follow-up|1|||
156762304|NCT01317940|565882458|FG004|Overall Study|Lost to Follow-up|1|||
156762305|NCT01317940|565882459|FG005|Overall Study|Lost to Follow-up|0|||
156762306|NCT01317940|565882454|FG000|Overall Study|Change in therapy plan|0|||
156762307|NCT01317940|565882455|FG001|Overall Study|Change in therapy plan|0|||
156762308|NCT01317940|565882456|FG002|Overall Study|Change in therapy plan|3|||
156762309|NCT01317940|565882457|FG003|Overall Study|Change in therapy plan|0|||
156762310|NCT01317940|565882458|FG004|Overall Study|Change in therapy plan|0|||
156762311|NCT01317940|565882459|FG005|Overall Study|Change in therapy plan|0|||
156654890|NCT02795104|565482612|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
156654891|NCT02795104|565482610|FG000|Overall Study|Withdrawal by Subject|0|||
156654892|NCT02795104|565482611|FG001|Overall Study|Withdrawal by Subject|2|||
156654893|NCT02795104|565482612|FG002|Overall Study|Withdrawal by Subject|0|||
156654894|NCT02795104|565482610|FG000|Overall Study|Lost to Follow-up|0|||
156654895|NCT02795104|565482611|FG001|Overall Study|Lost to Follow-up|0|||
156654896|NCT02795104|565482612|FG002|Overall Study|Lost to Follow-up|1|||
156654897|NCT00948675|565482613|FG000|Overall Study|Lost to Follow-up|1|||
156654898|NCT00948675|565482614|FG001|Overall Study|Lost to Follow-up|0|||
156654899|NCT01654380|565482618|FG000|Part B, Period 1|Physician Decision|0|||
156654900|NCT01654380|565482619|FG001|Part B, Period 1|Physician Decision|0|||
156654901|NCT01654380|565482620|FG002|Part B, Period 1|Physician Decision|1|||
156654902|NCT01654380|565482621|FG003|Part B, Period 1|Physician Decision|0|||
156654903|NCT02978326|565482626|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
156654904|NCT02978326|565482627|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
156654905|NCT02978326|565482628|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
156654906|NCT02978326|565482626|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
156654907|NCT02978326|565482627|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
156654908|NCT02978326|565482628|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
156654909|NCT02978326|565482626|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
156654910|NCT02978326|565482627|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
156654911|NCT02978326|565482628|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
156654912|NCT02978326|565482626|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
156654913|NCT02978326|565482627|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
156654914|NCT02978326|565482628|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
156654915|NCT00601354|565482631|FG000|Overall Study|Lost to Follow-up|4|||
156654916|NCT00601354|565482632|FG001|Overall Study|Lost to Follow-up|5|||
156654917|NCT03462719|565482633|FG000|Overall Study|Withdrawal by Subject|4|||
156654918|NCT03462719|565482634|FG001|Overall Study|Withdrawal by Subject|3|||
156654919|NCT03462719|565482633|FG000|Overall Study|Ongoing|87|||
156654920|NCT03462719|565482634|FG001|Overall Study|Ongoing|72|||
156654921|NCT02829918|565482635|FG000|Overall Study|Death|2|||
156654922|NCT02829918|565482635|FG000|Overall Study|Withdrawal by Subject|4|||
156654923|NCT02829918|565482635|FG000|Overall Study|Adverse Event|1|||
156654924|NCT02829918|565482635|FG000|Overall Study|Progression|1|||
156654925|NCT02257736|565482636|FG000|Overall Study|Progressive disease|365|||
156654926|NCT02257736|565482637|FG001|Overall Study|Progressive disease|327|||
156654927|NCT02257736|565482636|FG000|Overall Study|Adverse Event|45|||
156654928|NCT02257736|565482637|FG001|Overall Study|Adverse Event|56|||
156654929|NCT02257736|565482636|FG000|Overall Study|Withdrawal by Subject|21|||
156654930|NCT02257736|565482637|FG001|Overall Study|Withdrawal by Subject|38|||
156654931|NCT02257736|565482636|FG000|Overall Study|Death|11|||
156654932|NCT02257736|565482637|FG001|Overall Study|Death|6|||
156654933|NCT02257736|565482636|FG000|Overall Study|Physician Decision|5|||
156654934|NCT02257736|565482637|FG001|Overall Study|Physician Decision|9|||
156654935|NCT02257736|565482636|FG000|Overall Study|Non-Compliance with study drug|1|||
156654936|NCT02257736|565482637|FG001|Overall Study|Non-Compliance with study drug|2|||
156654937|NCT02257736|565482636|FG000|Overall Study|Protocol Violation|1|||
156654938|NCT02257736|565482637|FG001|Overall Study|Protocol Violation|0|||
156654939|NCT02257736|565482636|FG000|Overall Study|Other|1|||
156654940|NCT02257736|565482637|FG001|Overall Study|Other|7|||
156654941|NCT02257736|565482636|FG000|Overall Study|Randomized, not treated|1|||
156654942|NCT02257736|565482637|FG001|Overall Study|Randomized, not treated|2|||
156654943|NCT02779855|565482645|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
156654944|NCT02779855|565482646|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
156654945|NCT02779855|565482647|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
156654946|NCT05328375|565483816|FG000|Overall Study|Withdrawal by Subject|0|||
156654947|NCT05328375|565483817|FG001|Overall Study|Withdrawal by Subject|1|||
156654948|NCT05514119|565483822|FG000|Overall Study|Ineligible due to disease progression|1|||
156654949|NCT02178709|565483823|FG000|Overall Study|Adverse Event|5|||
156654950|NCT02178709|565483823|FG000|Overall Study|Death|2|||
156654951|NCT02178709|565483823|FG000|Overall Study|Withdrawal by Subject|2|||
156654952|NCT02178709|565483823|FG000|Overall Study|Physician Decision|2|||
156654953|NCT02178709|565483823|FG000|Overall Study|Disease Progression|5|||
156654954|NCT02946385|565483824|FG000|Overall Study|Lost to Follow-up|0|||
156654955|NCT02946385|565483825|FG001|Overall Study|Lost to Follow-up|0|||
156654956|NCT02946385|565483826|FG002|Overall Study|Lost to Follow-up|3|||
156654957|NCT02946385|565483827|FG003|Overall Study|Lost to Follow-up|0|||
156654958|NCT02946385|565483828|FG004|Overall Study|Lost to Follow-up|2|||
156654959|NCT02946385|565483829|FG005|Overall Study|Lost to Follow-up|1|||
156654960|NCT04849988|565483832|FG000|Overall Study|Lack of Efficacy|3|||
156654961|NCT04849988|565483833|FG001|Overall Study|Lack of Efficacy|4|||
156654962|NCT04849988|565483834|FG002|Overall Study|Lack of Efficacy|1|||
156654963|NCT04849988|565483835|FG003|Overall Study|Lack of Efficacy|4|||
156654964|NCT04849988|565483832|FG000|Overall Study|Other reasons|1|||
156654965|NCT04849988|565483833|FG001|Overall Study|Other reasons|2|||
156654966|NCT04849988|565483834|FG002|Overall Study|Other reasons|2|||
156654967|NCT04849988|565483835|FG003|Overall Study|Other reasons|1|||
156425734|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
156425735|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
156425736|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
156425737|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
156425738|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
156425739|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
156425740|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Non-compliance|4|||
156425741|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Non-compliance|0|||
156425742|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Non-compliance|0|||
156425743|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Non-compliance|0|||
156425744|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Pain|4|||
156425745|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Pain|0|||
156425746|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Pain|0|||
156425747|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Pain|0|||
156425748|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
156425749|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
156425750|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
156425751|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
156425752|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Hospice care|1|||
156425753|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Hospice care|0|||
156425754|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Hospice care|0|||
156425755|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Hospice care|0|||
156425756|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Physician Decision|1|||
156425757|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Physician Decision|0|||
156425758|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Physician Decision|0|||
156425759|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Physician Decision|0|||
156425760|NCT01107626|564652765|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
156425761|NCT01107626|564652766|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
156425762|NCT01107626|564652767|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
156425763|NCT01107626|564652768|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
156425764|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
156425765|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
156425766|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
156425767|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
156425768|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
156425769|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
156425770|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
156425771|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
156425772|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Death|0|||
156425773|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Death|8|||
156425774|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Death|2|||
156425775|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Death|13|||
156425776|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
156425777|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
156425778|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
156425779|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
156425780|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
156425781|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
156425782|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
156425783|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
156425784|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
156425785|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
156425786|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
156321950|NCT00400153|564276920|FG001|Overall Study|Other reasons - not mentioned above|5|||
156321951|NCT00400153|564276921|FG002|Overall Study|Other reasons - not mentioned above|3|||
156321952|NCT01423604|564276923|FG000|Safety Run-In|Adverse Event|3|||
156321953|NCT01423604|564276924|FG001|Safety Run-In|Adverse Event|0|||
156321954|NCT01423604|564276923|FG000|Safety Run-In|Death|1|||
156321955|NCT01423604|564276924|FG001|Safety Run-In|Death|0|||
156321956|NCT01423604|564276923|FG000|Safety Run-In|Physician Decision|1|||
156321957|NCT01423604|564276924|FG001|Safety Run-In|Physician Decision|0|||
156321958|NCT01423604|564276923|FG000|Safety Run-In|Disease progression|3|||
156321959|NCT01423604|564276924|FG001|Safety Run-In|Disease progression|0|||
156425787|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
156425788|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
156425789|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
156425790|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
156425791|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
156425792|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
156654968|NCT01027143|565483842|FG000|Overall Study|Lost to Follow-up|9|||
156321960|NCT01423604|564276923|FG000|Safety Run-In|Patient decision|1|||
156321961|NCT01423604|564276924|FG001|Safety Run-In|Patient decision|0|||
156425793|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
156425794|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
156425795|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
156425796|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
156762312|NCT00945243|565882461|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
156762313|NCT03256578|565882462|FG000|Overall Study|Excluded Post Randomization|66|||
156762314|NCT03256578|565882463|FG001|Overall Study|Excluded Post Randomization|56|||
156762315|NCT02371616|565882464|FG000|Overall Study|Protocol Violation|2|||
156762316|NCT02371616|565882465|FG001|Overall Study|Protocol Violation|1|||
156762317|NCT02371616|565882464|FG000|Overall Study|Adverse Event|0|||
156762318|NCT02371616|565882465|FG001|Overall Study|Adverse Event|1|||
156762319|NCT02371616|565882464|FG000|Overall Study|Withdrawal of Consent|1|||
156762320|NCT02371616|565882465|FG001|Overall Study|Withdrawal of Consent|0|||
156762321|NCT02371616|565882464|FG000|Overall Study|Other (Not specified)|1|||
156425797|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
156425798|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
156425799|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
156425800|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
156425801|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
156425802|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
156425803|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
156425804|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
156425805|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
156425806|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
156425807|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
156425808|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
156425809|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
156425810|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
156425811|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
156425812|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
156425813|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
156425814|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
156425815|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
156425816|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Pain|0|||
156425817|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Pain|0|||
156425818|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Pain|0|||
156425819|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Pain|1|||
156425820|NCT01107626|564652765|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
156425821|NCT01107626|564652766|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
156425822|NCT01107626|564652767|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
156425823|NCT01107626|564652768|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
156425824|NCT04381494|564652769|FG000|Overall Study|Early termination of trial|19|||
156425825|NCT04381494|564652769|FG000|Overall Study|Investigator's discretion|1|||
156425826|NCT04381494|564652769|FG000|Overall Study|Withdrawal by Subject|9|||
156425827|NCT04381494|564652769|FG000|Overall Study|NSCLC disease progression|4|||
156425828|NCT04381494|564652769|FG000|Overall Study|Device-Related Adverse Event|2|||
156425829|NCT04310579|564652770|FG000|Overall Study|Adverse Event|0|||
156425830|NCT04310579|564652771|FG001|Overall Study|Adverse Event|0|||
156425831|NCT04310579|564652772|FG002|Overall Study|Adverse Event|0|||
156425832|NCT04310579|564652773|FG003|Overall Study|Adverse Event|0|||
156425833|NCT04310579|564652774|FG004|Overall Study|Adverse Event|0|||
156425834|NCT04310579|564652775|FG005|Overall Study|Adverse Event|0|||
156425835|NCT04310579|564652776|FG006|Overall Study|Adverse Event|2|||
156425836|NCT04310579|564652777|FG007|Overall Study|Adverse Event|0|||
156425837|NCT04310579|564652778|FG008|Overall Study|Adverse Event|1|||
156425838|NCT04310579|564652779|FG009|Overall Study|Adverse Event|1|||
156425839|NCT04310579|564652780|FG010|Overall Study|Adverse Event|0|||
156425840|NCT04310579|564652770|FG000|Overall Study|Withdrawal by Subject|0|||
156762322|NCT02371616|565882465|FG001|Overall Study|Other (Not specified)|5|||
156762323|NCT02699996|565882468|FG000|Overall Study|Withdrawal by Subject|5|||
156762324|NCT02699996|565882469|FG001|Overall Study|Withdrawal by Subject|2|||
156425841|NCT04310579|564652771|FG001|Overall Study|Withdrawal by Subject|0|||
156425842|NCT04310579|564652772|FG002|Overall Study|Withdrawal by Subject|0|||
156425843|NCT04310579|564652773|FG003|Overall Study|Withdrawal by Subject|0|||
156425844|NCT04310579|564652774|FG004|Overall Study|Withdrawal by Subject|0|||
156425845|NCT04310579|564652775|FG005|Overall Study|Withdrawal by Subject|1|||
156762325|NCT03205150|565882470|FG000|Overall Study|Protocol deviation|1|||
156425846|NCT04310579|564652776|FG006|Overall Study|Withdrawal by Subject|0|||
156425847|NCT04310579|564652777|FG007|Overall Study|Withdrawal by Subject|0|||
156425848|NCT04310579|564652778|FG008|Overall Study|Withdrawal by Subject|0|||
156762326|NCT03205150|565882471|FG001|Overall Study|Protocol deviation|3|||
156762327|NCT03205150|565882472|FG002|Overall Study|Protocol deviation|0|||
156762328|NCT03205150|565882470|FG000|Overall Study|Patient/guardian decision|0|||
156762329|NCT03205150|565882471|FG001|Overall Study|Patient/guardian decision|3|||
156321962|NCT01423604|564276923|FG000|Randomized|Adverse Event|4|||
156321963|NCT01423604|564276924|FG001|Randomized|Adverse Event|10|||
156321964|NCT01423604|564276923|FG000|Randomized|Death|1|||
156321965|NCT01423604|564276924|FG001|Randomized|Death|0|||
156321966|NCT01423604|564276923|FG000|Randomized|Physician Decision|16|||
156321967|NCT01423604|564276924|FG001|Randomized|Physician Decision|13|||
156321968|NCT01423604|564276923|FG000|Randomized|Other - unspecified|37|||
156321969|NCT01423604|564276924|FG001|Randomized|Other - unspecified|31|||
156321970|NCT01423604|564276923|FG000|Randomized|Patient decision|5|||
156321971|NCT01423604|564276924|FG001|Randomized|Patient decision|9|||
156321972|NCT02414139|564276928|FG000|Treatment Period|Adverse Event|11|||
156321973|NCT02414139|564276929|FG001|Treatment Period|Adverse Event|6|||
156321974|NCT02414139|564276930|FG002|Treatment Period|Adverse Event|8|||
156321975|NCT02414139|564276931|FG003|Treatment Period|Adverse Event|5|||
156321976|NCT02414139|564276932|FG004|Treatment Period|Adverse Event|14|||
156321977|NCT02414139|564276933|FG005|Treatment Period|Adverse Event|3|||
156321978|NCT02414139|564276934|FG006|Treatment Period|Adverse Event|6|||
156321979|NCT02414139|564276935|FG007|Treatment Period|Adverse Event|1|||
156321980|NCT02414139|564276936|FG008|Treatment Period|Adverse Event|6|||
156321981|NCT02414139|564276937|FG009|Treatment Period|Adverse Event|8|||
156321982|NCT02414139|564276928|FG000|Treatment Period|Death|0|||
156321983|NCT02414139|564276929|FG001|Treatment Period|Death|0|||
156321984|NCT02414139|564276930|FG002|Treatment Period|Death|1|||
156321985|NCT02414139|564276931|FG003|Treatment Period|Death|1|||
156321986|NCT02414139|564276932|FG004|Treatment Period|Death|0|||
156321987|NCT02414139|564276933|FG005|Treatment Period|Death|0|||
156321988|NCT02414139|564276934|FG006|Treatment Period|Death|0|||
156321989|NCT02414139|564276935|FG007|Treatment Period|Death|0|||
156321990|NCT02414139|564276936|FG008|Treatment Period|Death|0|||
156321991|NCT02414139|564276937|FG009|Treatment Period|Death|1|||
156321992|NCT02414139|564276928|FG000|Treatment Period|Physician Decision|5|||
156321993|NCT02414139|564276929|FG001|Treatment Period|Physician Decision|4|||
156321994|NCT02414139|564276930|FG002|Treatment Period|Physician Decision|6|||
156321995|NCT02414139|564276931|FG003|Treatment Period|Physician Decision|1|||
156321996|NCT02414139|564276932|FG004|Treatment Period|Physician Decision|4|||
156321997|NCT02414139|564276933|FG005|Treatment Period|Physician Decision|0|||
156321998|NCT02414139|564276934|FG006|Treatment Period|Physician Decision|2|||
156321999|NCT02414139|564276935|FG007|Treatment Period|Physician Decision|0|||
156322000|NCT02414139|564276936|FG008|Treatment Period|Physician Decision|1|||
156322001|NCT02414139|564276937|FG009|Treatment Period|Physician Decision|4|||
156322002|NCT02414139|564276928|FG000|Treatment Period|Progressive disease|48|||
156322003|NCT02414139|564276929|FG001|Treatment Period|Progressive disease|31|||
156322004|NCT02414139|564276930|FG002|Treatment Period|Progressive disease|37|||
156322005|NCT02414139|564276931|FG003|Treatment Period|Progressive disease|21|||
156322006|NCT02414139|564276932|FG004|Treatment Period|Progressive disease|43|||
156322007|NCT02414139|564276933|FG005|Treatment Period|Progressive disease|12|||
156322008|NCT02414139|564276934|FG006|Treatment Period|Progressive disease|16|||
156322009|NCT02414139|564276935|FG007|Treatment Period|Progressive disease|2|||
156322010|NCT02414139|564276936|FG008|Treatment Period|Progressive disease|20|||
156322011|NCT02414139|564276937|FG009|Treatment Period|Progressive disease|14|||
156322012|NCT02414139|564276928|FG000|Treatment Period|Protocol deviation|0|||
156762330|NCT03205150|565882472|FG002|Overall Study|Patient/guardian decision|0|||
156762331|NCT03205150|565882470|FG000|Overall Study|Adverse Event|1|||
156762332|NCT03205150|565882471|FG001|Overall Study|Adverse Event|1|||
156762333|NCT03205150|565882472|FG002|Overall Study|Adverse Event|1|||
156762334|NCT03205150|565882470|FG000|Overall Study|Lost to Follow-up|0|||
156762335|NCT03205150|565882471|FG001|Overall Study|Lost to Follow-up|0|||
156762336|NCT03205150|565882472|FG002|Overall Study|Lost to Follow-up|1|||
156762337|NCT01095835|565882473|FG000|Overall Study|Adverse Event|8|||
156762338|NCT01095835|565882474|FG001|Overall Study|Adverse Event|6|||
156762339|NCT01095835|565882475|FG002|Overall Study|Adverse Event|6|||
156762340|NCT01095835|565882473|FG000|Overall Study|Lack of Efficacy|0|||
156762341|NCT01095835|565882474|FG001|Overall Study|Lack of Efficacy|1|||
156762342|NCT01095835|565882475|FG002|Overall Study|Lack of Efficacy|0|||
156762343|NCT01095835|565882473|FG000|Overall Study|Physician Decision|0|||
156762344|NCT01095835|565882474|FG001|Overall Study|Physician Decision|0|||
156762345|NCT01095835|565882475|FG002|Overall Study|Physician Decision|1|||
156762346|NCT01095835|565882473|FG000|Overall Study|Withdrawal by Subject|1|||
156322013|NCT02414139|564276929|FG001|Treatment Period|Protocol deviation|0|||
156322014|NCT02414139|564276930|FG002|Treatment Period|Protocol deviation|1|||
156322015|NCT02414139|564276931|FG003|Treatment Period|Protocol deviation|0|||
156322016|NCT02414139|564276932|FG004|Treatment Period|Protocol deviation|0|||
156322017|NCT02414139|564276933|FG005|Treatment Period|Protocol deviation|0|||
156322018|NCT02414139|564276934|FG006|Treatment Period|Protocol deviation|0|||
156322019|NCT02414139|564276935|FG007|Treatment Period|Protocol deviation|0|||
156322020|NCT02414139|564276936|FG008|Treatment Period|Protocol deviation|0|||
156322021|NCT02414139|564276937|FG009|Treatment Period|Protocol deviation|0|||
156322022|NCT02414139|564276928|FG000|Treatment Period|Subject/Guardian decision|5|||
156762347|NCT01095835|565882474|FG001|Overall Study|Withdrawal by Subject|3|||
156322023|NCT02414139|564276929|FG001|Treatment Period|Subject/Guardian decision|1|||
156322024|NCT02414139|564276930|FG002|Treatment Period|Subject/Guardian decision|1|||
156322025|NCT02414139|564276931|FG003|Treatment Period|Subject/Guardian decision|2|||
156322026|NCT02414139|564276932|FG004|Treatment Period|Subject/Guardian decision|5|||
156322027|NCT02414139|564276933|FG005|Treatment Period|Subject/Guardian decision|0|||
156322028|NCT02414139|564276934|FG006|Treatment Period|Subject/Guardian decision|2|||
156322029|NCT02414139|564276935|FG007|Treatment Period|Subject/Guardian decision|0|||
156322030|NCT02414139|564276936|FG008|Treatment Period|Subject/Guardian decision|1|||
156425849|NCT04310579|564652779|FG009|Overall Study|Withdrawal by Subject|0|||
156654969|NCT01027143|565483843|FG001|Overall Study|Lost to Follow-up|4|||
156654970|NCT02228382|565483846|FG000|Overall Study|Death|5|||
156654971|NCT02228382|565483847|FG001|Overall Study|Death|7|||
156654972|NCT02228382|565483848|FG002|Overall Study|Death|5|||
156654973|NCT02228382|565483849|FG003|Overall Study|Death|0|||
156654974|NCT02228382|565483850|FG004|Overall Study|Death|2|||
156654975|NCT02228382|565483846|FG000|Overall Study|Participant refused further follow-up|0|||
156654976|NCT02228382|565483847|FG001|Overall Study|Participant refused further follow-up|0|||
156654977|NCT02228382|565483848|FG002|Overall Study|Participant refused further follow-up|1|||
156654978|NCT02228382|565483849|FG003|Overall Study|Participant refused further follow-up|0|||
156654979|NCT02228382|565483850|FG004|Overall Study|Participant refused further follow-up|0|||
156654980|NCT02228382|565483846|FG000|Overall Study|Study terminated by sponsor|3|||
156654981|NCT02228382|565483847|FG001|Overall Study|Study terminated by sponsor|5|||
156654982|NCT02228382|565483848|FG002|Overall Study|Study terminated by sponsor|7|||
156654983|NCT02228382|565483849|FG003|Overall Study|Study terminated by sponsor|0|||
156654984|NCT02228382|565483850|FG004|Overall Study|Study terminated by sponsor|0|||
156654985|NCT02228382|565483846|FG000|Overall Study|Lost to Follow-up|0|||
156654986|NCT02228382|565483847|FG001|Overall Study|Lost to Follow-up|0|||
156654987|NCT02228382|565483848|FG002|Overall Study|Lost to Follow-up|3|||
156654988|NCT02228382|565483849|FG003|Overall Study|Lost to Follow-up|1|||
156654989|NCT02228382|565483850|FG004|Overall Study|Lost to Follow-up|0|||
156654990|NCT02228382|565483846|FG000|Overall Study|Withdrawal by Subject|0|||
156654991|NCT02228382|565483847|FG001|Overall Study|Withdrawal by Subject|3|||
156654992|NCT02228382|565483848|FG002|Overall Study|Withdrawal by Subject|2|||
156654993|NCT02228382|565483849|FG003|Overall Study|Withdrawal by Subject|1|||
156654994|NCT02228382|565483850|FG004|Overall Study|Withdrawal by Subject|0|||
156654995|NCT02228382|565483846|FG000|Overall Study|Other|2|||
156654996|NCT02228382|565483847|FG001|Overall Study|Other|3|||
156654997|NCT02228382|565483848|FG002|Overall Study|Other|3|||
156654998|NCT02228382|565483849|FG003|Overall Study|Other|0|||
156654999|NCT02228382|565483850|FG004|Overall Study|Other|0|||
156655000|NCT02396381|565483852|FG000|Overall Study|Adverse Event|3|||
156655001|NCT02396381|565483853|FG001|Overall Study|Adverse Event|2|||
156655002|NCT02396381|565483852|FG000|Overall Study|Withdrawal by Subject|33|||
156655003|NCT02396381|565483853|FG001|Overall Study|Withdrawal by Subject|24|||
156655004|NCT02396381|565483852|FG000|Overall Study|Lost to Follow-up|49|||
156655005|NCT02396381|565483853|FG001|Overall Study|Lost to Follow-up|31|||
156655006|NCT02396381|565483852|FG000|Overall Study|Protocol Violation|1|||
156655007|NCT02396381|565483853|FG001|Overall Study|Protocol Violation|0|||
156655008|NCT02396381|565483852|FG000|Overall Study|Site terminated by sponsor|7|||
156655009|NCT02396381|565483853|FG001|Overall Study|Site terminated by sponsor|8|||
156655010|NCT02396381|565483852|FG000|Overall Study|Physician Decision|5|||
156655011|NCT02396381|565483853|FG001|Overall Study|Physician Decision|5|||
156655012|NCT02396381|565483852|FG000|Overall Study|Pregnancy|2|||
156655013|NCT02396381|565483853|FG001|Overall Study|Pregnancy|0|||
156655014|NCT02396381|565483852|FG000|Overall Study|Non-compliance with study procedures|1|||
156655015|NCT02396381|565483853|FG001|Overall Study|Non-compliance with study procedures|0|||
156655016|NCT02396381|565483852|FG000|Overall Study|Moved out of town/state|1|||
156655017|NCT02396381|565483853|FG001|Overall Study|Moved out of town/state|3|||
156655018|NCT02396381|565483852|FG000|Overall Study|Could not complete visit|1|||
156655019|NCT02396381|565483853|FG001|Overall Study|Could not complete visit|0|||
156655020|NCT02396381|565483852|FG000|Overall Study|Possible conflict of interest|1|||
156655021|NCT02396381|565483853|FG001|Overall Study|Possible conflict of interest|0|||
156655022|NCT02396381|565483852|FG000|Overall Study|Randomization/Screening Error|3|||
156655023|NCT02396381|565483853|FG001|Overall Study|Randomization/Screening Error|1|||
156655024|NCT00275002|565483854|FG000|Overall Study|Death|1|||
156655025|NCT00275002|565483855|FG001|Overall Study|Death|0|||
156655026|NCT00275002|565483854|FG000|Overall Study|Disease progression|21|||
156655027|NCT00275002|565483855|FG001|Overall Study|Disease progression|15|||
156655028|NCT00275002|565483854|FG000|Overall Study|Adverse Event|0|||
156655029|NCT00275002|565483855|FG001|Overall Study|Adverse Event|1|||
156655030|NCT02918162|565483857|FG000|Overall Study|Withdrawal by Subject|1|||
156655031|NCT02918162|565483857|FG000|Overall Study|Omental Disease|1|||
156655032|NCT00395226|565483858|FG000|Overall Study|Adverse Event|4|||
156655033|NCT00395226|565483859|FG001|Overall Study|Adverse Event|3|||
156655034|NCT00395226|565483858|FG000|Overall Study|Withdrawal by Subject|0|||
156655035|NCT00395226|565483859|FG001|Overall Study|Withdrawal by Subject|1|||
156655036|NCT00395226|565483858|FG000|Overall Study|Lost to Follow-up|0|||
156425850|NCT04310579|564652780|FG010|Overall Study|Withdrawal by Subject|0|||
156425851|NCT04310579|564652770|FG000|Overall Study|Positive COVID-19 test|0|||
156425852|NCT04310579|564652771|FG001|Overall Study|Positive COVID-19 test|0|||
156425853|NCT04310579|564652772|FG002|Overall Study|Positive COVID-19 test|0|||
156425854|NCT04310579|564652773|FG003|Overall Study|Positive COVID-19 test|0|||
156425855|NCT04310579|564652774|FG004|Overall Study|Positive COVID-19 test|0|||
156425856|NCT04310579|564652775|FG005|Overall Study|Positive COVID-19 test|0|||
156425857|NCT04310579|564652776|FG006|Overall Study|Positive COVID-19 test|0|||
156425858|NCT04310579|564652777|FG007|Overall Study|Positive COVID-19 test|0|||
156425859|NCT04310579|564652778|FG008|Overall Study|Positive COVID-19 test|0|||
156425860|NCT04310579|564652779|FG009|Overall Study|Positive COVID-19 test|0|||
156425861|NCT04310579|564652780|FG010|Overall Study|Positive COVID-19 test|1|||
156425862|NCT02236559|564652784|FG000|Overall Study|Met Exclusion|3|||
156425863|NCT02236559|564652785|FG001|Overall Study|Met Exclusion|6|||
156425864|NCT02236559|564652784|FG000|Overall Study|Did not Meet Inclusion|3|||
156425865|NCT02236559|564652785|FG001|Overall Study|Did not Meet Inclusion|3|||
156425866|NCT02236559|564652784|FG000|Overall Study|Subject Did Not Consent|4|||
156762348|NCT01095835|565882475|FG002|Overall Study|Withdrawal by Subject|0|||
156762349|NCT01095835|565882473|FG000|Overall Study|Non study compliance|0|||
156762350|NCT01095835|565882474|FG001|Overall Study|Non study compliance|0|||
156762351|NCT01095835|565882475|FG002|Overall Study|Non study compliance|1|||
156762352|NCT01095835|565882473|FG000|Overall Study|Protocol Violation|1|||
156762353|NCT01095835|565882474|FG001|Overall Study|Protocol Violation|2|||
156762354|NCT01095835|565882475|FG002|Overall Study|Protocol Violation|0|||
156762355|NCT03028142|565882478|FG000|Overall Study|Adverse Event|1|||
156762356|NCT03028142|565882479|FG001|Overall Study|Adverse Event|1|||
156762357|NCT03028142|565882480|FG002|Overall Study|Adverse Event|0|||
156762358|NCT03028142|565882481|FG003|Overall Study|Adverse Event|0|||
156762359|NCT03028142|565882482|FG004|Overall Study|Adverse Event|0|||
156762360|NCT03028142|565882483|FG005|Overall Study|Adverse Event|1|||
156762361|NCT03028142|565882478|FG000|Overall Study|Withdrawal by Subject|0|||
156762362|NCT03028142|565882479|FG001|Overall Study|Withdrawal by Subject|0|||
156762363|NCT03028142|565882480|FG002|Overall Study|Withdrawal by Subject|0|||
156762364|NCT03028142|565882481|FG003|Overall Study|Withdrawal by Subject|0|||
156762365|NCT03028142|565882482|FG004|Overall Study|Withdrawal by Subject|1|||
156762366|NCT03028142|565882483|FG005|Overall Study|Withdrawal by Subject|0|||
156762367|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
156762368|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
156762369|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
156762370|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
156762371|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
156762372|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
156762373|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
156762374|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
156762375|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
156762376|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
156762377|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
156762378|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
156762379|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
156762380|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
156762381|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
156762382|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
156762383|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
156762384|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
156762385|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
156762386|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
156762387|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
156762388|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
156762389|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
156762390|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
156762391|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
156762392|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
156762393|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
156762394|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
156762395|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
156425867|NCT02236559|564652785|FG001|Overall Study|Subject Did Not Consent|2|||
156425868|NCT02236559|564652784|FG000|Overall Study|Physician Decision|1|||
156425869|NCT02236559|564652785|FG001|Overall Study|Physician Decision|1|||
156762396|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
156762397|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
156762398|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
156762399|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
156762400|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
156762401|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
156762402|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
156762403|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
156762404|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
156762405|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
156762406|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
156762407|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
156762408|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
156762409|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
156762410|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
156762411|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
156762412|NCT02812186|565882493|FG000|Period 1|Post randomization screen failure|5|||
156762413|NCT02812186|565882494|FG001|Period 1|Post randomization screen failure|9|||
156762414|NCT02812186|565882493|FG000|Period 1|nonevaluable data sets|6|||
156762415|NCT02812186|565882494|FG001|Period 1|nonevaluable data sets|6|||
156762416|NCT01162343|565882495|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
156762417|NCT01162343|565882495|FG000|Overall Study|Refused psychiatrist assessment|12|||
156425870|NCT02236559|564652784|FG000|Overall Study|Withdrawal by Subject|1|||
156425871|NCT02236559|564652785|FG001|Overall Study|Withdrawal by Subject|0|||
156425872|NCT03721016|564652786|FG000|Overall Study|Adverse Event|0|||
156425873|NCT03721016|564652787|FG001|Overall Study|Adverse Event|1|||
156425874|NCT03721016|564652788|FG002|Overall Study|Adverse Event|1|||
156425875|NCT03721016|564652786|FG000|Overall Study|Withdrawal by Subject|8|||
156425876|NCT03721016|564652787|FG001|Overall Study|Withdrawal by Subject|16|||
156425877|NCT03721016|564652788|FG002|Overall Study|Withdrawal by Subject|13|||
156425878|NCT03721016|564652786|FG000|Overall Study|Lost to Follow-up|4|||
156425879|NCT03721016|564652787|FG001|Overall Study|Lost to Follow-up|6|||
156425880|NCT03721016|564652788|FG002|Overall Study|Lost to Follow-up|5|||
156425881|NCT03721016|564652786|FG000|Overall Study|Physician Decision|0|||
156425882|NCT03721016|564652787|FG001|Overall Study|Physician Decision|1|||
156425883|NCT03721016|564652788|FG002|Overall Study|Physician Decision|2|||
156425884|NCT03721016|564652786|FG000|Overall Study|Protocol Violation|0|||
156425885|NCT03721016|564652787|FG001|Overall Study|Protocol Violation|1|||
156425886|NCT03721016|564652788|FG002|Overall Study|Protocol Violation|0|||
156425887|NCT03721016|564652786|FG000|Overall Study|Site terminated by sponsor|3|||
156762418|NCT01130272|565882496|FG000|Overall Study|Adverse Event|2|||
156762419|NCT01130272|565882497|FG001|Overall Study|Adverse Event|5|||
156762420|NCT01130272|565882498|FG002|Overall Study|Adverse Event|6|||
156762421|NCT01130272|565882499|FG003|Overall Study|Adverse Event|22|||
156762422|NCT01130272|565882500|FG004|Overall Study|Adverse Event|7|||
156762423|NCT01130272|565882496|FG000|Overall Study|IVRS-confirmed constipation|0|||
156762424|NCT01130272|565882497|FG001|Overall Study|IVRS-confirmed constipation|1|||
156762425|NCT01130272|565882498|FG002|Overall Study|IVRS-confirmed constipation|1|||
156762426|NCT01130272|565882499|FG003|Overall Study|IVRS-confirmed constipation|2|||
156762427|NCT01130272|565882500|FG004|Overall Study|IVRS-confirmed constipation|0|||
156762428|NCT01130272|565882496|FG000|Overall Study|Rescue medications due to diarrhea|3|||
156762429|NCT01130272|565882497|FG001|Overall Study|Rescue medications due to diarrhea|5|||
156762430|NCT01130272|565882498|FG002|Overall Study|Rescue medications due to diarrhea|8|||
156425888|NCT03721016|564652787|FG001|Overall Study|Site terminated by sponsor|7|||
156425889|NCT03721016|564652788|FG002|Overall Study|Site terminated by sponsor|6|||
156425890|NCT03721016|564652786|FG000|Overall Study|Subject exited early due to COVID-19|1|||
156425891|NCT03721016|564652787|FG001|Overall Study|Subject exited early due to COVID-19|0|||
156425892|NCT03721016|564652788|FG002|Overall Study|Subject exited early due to COVID-19|0|||
156425893|NCT01149681|564652791|FG000|Overall Study|Withdrawal by Subject|7|||
156762431|NCT01130272|565882499|FG003|Overall Study|Rescue medications due to diarrhea|8|||
156762432|NCT01130272|565882500|FG004|Overall Study|Rescue medications due to diarrhea|6|||
156762433|NCT01130272|565882496|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
156762434|NCT01130272|565882497|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
156762435|NCT01130272|565882498|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
156762436|NCT01130272|565882499|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
156762437|NCT01130272|565882500|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
156425894|NCT01149681|564652791|FG000|Overall Study|Progressive disease|1|||
156425895|NCT01149681|564652791|FG000|Overall Study|Physician Decision|2|||
156425896|NCT01149681|564652791|FG000|Overall Study|adverse events nonrelated study drug|2|||
156425897|NCT00817635|564652792|FG000|Overall Study|Adverse Event|1|||
156425898|NCT00817635|564652793|FG001|Overall Study|Adverse Event|0|||
156425899|NCT00817635|564652794|FG002|Overall Study|Adverse Event|0|||
156425900|NCT00817635|564652795|FG003|Overall Study|Adverse Event|1|||
156425901|NCT00817635|564652796|FG004|Overall Study|Adverse Event|1|||
156425902|NCT00817635|564652792|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
156425903|NCT00817635|564652793|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
156762438|NCT01130272|565882496|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
156762439|NCT01130272|565882497|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
156425904|NCT00817635|564652794|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
156425905|NCT00817635|564652795|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
156762440|NCT01130272|565882498|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
156762441|NCT01130272|565882499|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
156762442|NCT01130272|565882500|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
156762443|NCT01130272|565882496|FG000|Overall Study|Protocol Violation|0|||
156762444|NCT01130272|565882497|FG001|Overall Study|Protocol Violation|0|||
156762445|NCT01130272|565882498|FG002|Overall Study|Protocol Violation|3|||
156762446|NCT01130272|565882499|FG003|Overall Study|Protocol Violation|5|||
156762447|NCT01130272|565882500|FG004|Overall Study|Protocol Violation|5|||
156762448|NCT01130272|565882496|FG000|Overall Study|Lost to Follow-up|4|||
156762449|NCT01130272|565882497|FG001|Overall Study|Lost to Follow-up|3|||
156762450|NCT01130272|565882498|FG002|Overall Study|Lost to Follow-up|4|||
156762451|NCT01130272|565882499|FG003|Overall Study|Lost to Follow-up|7|||
156762452|NCT01130272|565882500|FG004|Overall Study|Lost to Follow-up|6|||
156762453|NCT01130272|565882496|FG000|Overall Study|Withdrawal by Subject|4|||
156762454|NCT01130272|565882497|FG001|Overall Study|Withdrawal by Subject|11|||
156762455|NCT01130272|565882498|FG002|Overall Study|Withdrawal by Subject|10|||
156762456|NCT01130272|565882499|FG003|Overall Study|Withdrawal by Subject|9|||
156762457|NCT01130272|565882500|FG004|Overall Study|Withdrawal by Subject|8|||
156762458|NCT01130272|565882496|FG000|Overall Study|Physician Decision|1|||
156762459|NCT01130272|565882497|FG001|Overall Study|Physician Decision|1|||
156762460|NCT01130272|565882498|FG002|Overall Study|Physician Decision|0|||
156762461|NCT01130272|565882499|FG003|Overall Study|Physician Decision|1|||
156762462|NCT01130272|565882500|FG004|Overall Study|Physician Decision|2|||
156762463|NCT01130272|565882496|FG000|Overall Study|Sponsor decision|6|||
156762464|NCT01130272|565882497|FG001|Overall Study|Sponsor decision|15|||
156762465|NCT01130272|565882498|FG002|Overall Study|Sponsor decision|16|||
156762466|NCT01130272|565882499|FG003|Overall Study|Sponsor decision|13|||
156762467|NCT01130272|565882500|FG004|Overall Study|Sponsor decision|16|||
156762468|NCT01130272|565882496|FG000|Overall Study|Study arm discontinued|38|||
156762469|NCT01130272|565882497|FG001|Overall Study|Study arm discontinued|0|||
156762470|NCT01130272|565882498|FG002|Overall Study|Study arm discontinued|0|||
156762471|NCT01130272|565882499|FG003|Overall Study|Study arm discontinued|0|||
156762472|NCT01130272|565882500|FG004|Overall Study|Study arm discontinued|0|||
156762473|NCT01405560|565882505|FG000|Overall Study|Physician Decision|1|||
156762474|NCT01699750|565882508|FG000|Overall Study|Withdrew Consent|0|||
156425906|NCT00817635|564652796|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
156425907|NCT00817635|564652792|FG000|Overall Study|Withdrawal by Subject|2|||
156425908|NCT00817635|564652793|FG001|Overall Study|Withdrawal by Subject|1|||
156425909|NCT00817635|564652794|FG002|Overall Study|Withdrawal by Subject|0|||
156425910|NCT00817635|564652795|FG003|Overall Study|Withdrawal by Subject|1|||
156425911|NCT00817635|564652796|FG004|Overall Study|Withdrawal by Subject|2|||
156425912|NCT00817635|564652792|FG000|Overall Study|Lost to Follow-up|0|||
156425913|NCT00817635|564652793|FG001|Overall Study|Lost to Follow-up|1|||
156425914|NCT00817635|564652794|FG002|Overall Study|Lost to Follow-up|0|||
156425915|NCT00817635|564652795|FG003|Overall Study|Lost to Follow-up|1|||
156425916|NCT00817635|564652796|FG004|Overall Study|Lost to Follow-up|0|||
156425917|NCT00817635|564652792|FG000|Overall Study|Administrative Problems|0|||
156425918|NCT00817635|564652793|FG001|Overall Study|Administrative Problems|0|||
156425919|NCT00817635|564652794|FG002|Overall Study|Administrative Problems|0|||
156425920|NCT00817635|564652795|FG003|Overall Study|Administrative Problems|0|||
156425921|NCT00817635|564652796|FG004|Overall Study|Administrative Problems|1|||
156425922|NCT00817635|564652792|FG000|Overall Study|Protocol Violation|5|||
156425923|NCT00817635|564652793|FG001|Overall Study|Protocol Violation|1|||
156425924|NCT00817635|564652794|FG002|Overall Study|Protocol Violation|3|||
156425925|NCT00817635|564652795|FG003|Overall Study|Protocol Violation|2|||
156425926|NCT00817635|564652796|FG004|Overall Study|Protocol Violation|3|||
156425927|NCT00918957|564652797|FG000|Overall Study|Adverse Event|2|||
156425928|NCT00918957|564652798|FG001|Overall Study|Adverse Event|0|||
156425929|NCT00918957|564652797|FG000|Overall Study|Withdrawal by Subject|1|||
156425930|NCT00918957|564652798|FG001|Overall Study|Withdrawal by Subject|0|||
156425931|NCT03107611|564652799|FG000|Overall Study|Adverse Event|1|||
156762475|NCT01699750|565882509|FG001|Overall Study|Withdrew Consent|1|||
156762476|NCT01699750|565882508|FG000|Overall Study|Other|0|||
156762477|NCT01699750|565882509|FG001|Overall Study|Other|2|||
156762478|NCT01484951|565882510|FG000|Overall Study|Adverse Event|3|||
156762479|NCT01484951|565882510|FG000|Overall Study|Personal Reasons|1|||
156762480|NCT01484951|565882510|FG000|Overall Study|Non-Compliance|1|||
156762481|NCT02452047|565882512|FG000|Overall Study|Adverse Event|0|||
156762482|NCT02452047|565882513|FG001|Overall Study|Adverse Event|1|||
156762483|NCT02452047|565882514|FG002|Overall Study|Adverse Event|1|||
156425932|NCT03107611|564652800|FG001|Overall Study|Adverse Event|0|||
156425933|NCT03107611|564652801|FG002|Overall Study|Adverse Event|2|||
156425934|NCT03107611|564652799|FG000|Overall Study|Lost to Follow-up|3|||
156425935|NCT03107611|564652800|FG001|Overall Study|Lost to Follow-up|3|||
156762484|NCT02452047|565882512|FG000|Overall Study|Death|1|||
156762485|NCT02452047|565882513|FG001|Overall Study|Death|3|||
156762486|NCT02452047|565882514|FG002|Overall Study|Death|1|||
156762487|NCT02452047|565882512|FG000|Overall Study|Physician Decision|1|||
156762488|NCT02452047|565882513|FG001|Overall Study|Physician Decision|0|||
156762489|NCT02452047|565882514|FG002|Overall Study|Physician Decision|0|||
156762490|NCT02452047|565882512|FG000|Overall Study|Lost to Follow-up|1|||
156762491|NCT02452047|565882513|FG001|Overall Study|Lost to Follow-up|1|||
156762492|NCT02452047|565882514|FG002|Overall Study|Lost to Follow-up|0|||
156762493|NCT02452047|565882512|FG000|Overall Study|Withdrawal by Subject|1|||
156762494|NCT02452047|565882513|FG001|Overall Study|Withdrawal by Subject|0|||
156762495|NCT02452047|565882514|FG002|Overall Study|Withdrawal by Subject|0|||
156762496|NCT02169505|565882515|FG000|Overall Study|Withdrawal by Subject|1|||
156322031|NCT02414139|564276937|FG009|Treatment Period|Subject/Guardian decision|1|||
156322032|NCT02414139|564276928|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156322033|NCT02414139|564276929|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156322034|NCT02414139|564276930|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156322035|NCT02414139|564276931|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156322036|NCT02414139|564276932|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
156322037|NCT02414139|564276933|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156322038|NCT02414139|564276934|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
156322039|NCT02414139|564276935|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156322040|NCT02414139|564276936|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
156322041|NCT02414139|564276937|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
156322042|NCT02414139|564276928|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
156322043|NCT02414139|564276929|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156322044|NCT02414139|564276930|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156322045|NCT02414139|564276931|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156322046|NCT02414139|564276932|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
156322047|NCT02414139|564276933|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156322048|NCT02414139|564276934|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156322049|NCT02414139|564276935|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156322050|NCT02414139|564276936|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156322051|NCT02414139|564276937|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156322052|NCT02414139|564276928|FG000|Post-treatment Efficacy Follow-up|Death|0|||
156322053|NCT02414139|564276929|FG001|Post-treatment Efficacy Follow-up|Death|1|||
156322054|NCT02414139|564276930|FG002|Post-treatment Efficacy Follow-up|Death|0|||
156322055|NCT02414139|564276931|FG003|Post-treatment Efficacy Follow-up|Death|0|||
156322056|NCT02414139|564276932|FG004|Post-treatment Efficacy Follow-up|Death|1|||
156322057|NCT02414139|564276933|FG005|Post-treatment Efficacy Follow-up|Death|0|||
156322058|NCT02414139|564276934|FG006|Post-treatment Efficacy Follow-up|Death|0|||
156322059|NCT02414139|564276935|FG007|Post-treatment Efficacy Follow-up|Death|0|||
156322060|NCT02414139|564276936|FG008|Post-treatment Efficacy Follow-up|Death|0|||
156322061|NCT02414139|564276937|FG009|Post-treatment Efficacy Follow-up|Death|1|||
156322062|NCT02414139|564276928|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
156322063|NCT02414139|564276929|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322064|NCT02414139|564276930|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322065|NCT02414139|564276931|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322066|NCT02414139|564276932|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322067|NCT02414139|564276933|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322068|NCT02414139|564276934|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322069|NCT02414139|564276935|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322070|NCT02414139|564276936|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322071|NCT02414139|564276937|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156322072|NCT02414139|564276928|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
156322073|NCT02414139|564276929|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156322074|NCT02414139|564276930|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
156322075|NCT02414139|564276931|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156322076|NCT02414139|564276932|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
156322077|NCT02414139|564276933|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156322078|NCT02414139|564276934|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156322079|NCT02414139|564276935|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156322080|NCT02414139|564276936|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156322081|NCT02414139|564276937|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156322082|NCT02414139|564276928|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
156322083|NCT02414139|564276929|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
156322084|NCT02414139|564276930|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
156322085|NCT02414139|564276931|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
156322086|NCT02414139|564276932|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
156322087|NCT02414139|564276933|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
156762497|NCT00917124|565882519|FG000|Overall Study|Protocol Violation|4|||
156762498|NCT00917124|565882520|FG001|Overall Study|Protocol Violation|6|||
156762499|NCT01783743|565882521|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
156762500|NCT01783743|565882522|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
156762501|NCT01783743|565882521|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
156762502|NCT01783743|565882522|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
156762503|NCT01783743|565882521|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
156762504|NCT01783743|565882522|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
156762505|NCT02631941|565882538|FG000|Overall Study|Physician Decision|0|||
156762506|NCT02631941|565882539|FG001|Overall Study|Physician Decision|1|||
156762507|NCT02631941|565882540|FG002|Overall Study|Physician Decision|0|||
156762508|NCT02631941|565882541|FG003|Overall Study|Physician Decision|0|||
156762509|NCT02631941|565882542|FG004|Overall Study|Physician Decision|0|||
156762510|NCT02631941|565882543|FG005|Overall Study|Physician Decision|0|||
156762511|NCT02631941|565882544|FG006|Overall Study|Physician Decision|0|||
156762512|NCT02631941|565882545|FG007|Overall Study|Physician Decision|0|||
156762513|NCT02631941|565882546|FG008|Overall Study|Physician Decision|0|||
156762514|NCT02631941|565882547|FG009|Overall Study|Physician Decision|0|||
156762515|NCT02631941|565882538|FG000|Overall Study|Adverse Event|0|||
156762516|NCT02631941|565882539|FG001|Overall Study|Adverse Event|1|||
156762517|NCT02631941|565882540|FG002|Overall Study|Adverse Event|0|||
156762518|NCT02631941|565882541|FG003|Overall Study|Adverse Event|0|||
156762519|NCT02631941|565882542|FG004|Overall Study|Adverse Event|0|||
156425936|NCT03107611|564652801|FG002|Overall Study|Lost to Follow-up|3|||
156425937|NCT03107611|564652799|FG000|Overall Study|Protocol Violation|0|||
156762520|NCT02631941|565882543|FG005|Overall Study|Adverse Event|0|||
156762521|NCT02631941|565882544|FG006|Overall Study|Adverse Event|0|||
156762522|NCT02631941|565882545|FG007|Overall Study|Adverse Event|0|||
156762523|NCT02631941|565882546|FG008|Overall Study|Adverse Event|0|||
156762524|NCT02631941|565882547|FG009|Overall Study|Adverse Event|0|||
156762525|NCT02631941|565882538|FG000|Overall Study|Withdrawal by Subject|0|||
156762526|NCT02631941|565882539|FG001|Overall Study|Withdrawal by Subject|0|||
156762527|NCT02631941|565882540|FG002|Overall Study|Withdrawal by Subject|0|||
156762528|NCT02631941|565882541|FG003|Overall Study|Withdrawal by Subject|0|||
156762529|NCT02631941|565882542|FG004|Overall Study|Withdrawal by Subject|1|||
156762530|NCT02631941|565882543|FG005|Overall Study|Withdrawal by Subject|0|||
156762531|NCT02631941|565882544|FG006|Overall Study|Withdrawal by Subject|0|||
156762532|NCT02631941|565882545|FG007|Overall Study|Withdrawal by Subject|1|||
156762533|NCT02631941|565882546|FG008|Overall Study|Withdrawal by Subject|0|||
156762534|NCT02631941|565882547|FG009|Overall Study|Withdrawal by Subject|0|||
156762535|NCT02631941|565882538|FG000|Overall Study|Lost to Follow-up|0|||
156762536|NCT02631941|565882539|FG001|Overall Study|Lost to Follow-up|0|||
156762537|NCT02631941|565882540|FG002|Overall Study|Lost to Follow-up|0|||
156762538|NCT02631941|565882541|FG003|Overall Study|Lost to Follow-up|0|||
156762539|NCT02631941|565882542|FG004|Overall Study|Lost to Follow-up|0|||
156762540|NCT02631941|565882543|FG005|Overall Study|Lost to Follow-up|0|||
156762541|NCT02631941|565882544|FG006|Overall Study|Lost to Follow-up|0|||
156762542|NCT02631941|565882545|FG007|Overall Study|Lost to Follow-up|0|||
156762543|NCT02631941|565882546|FG008|Overall Study|Lost to Follow-up|1|||
156762544|NCT02631941|565882547|FG009|Overall Study|Lost to Follow-up|0|||
156762545|NCT03933449|565882548|FG000|Overall Study|Adverse Event|6|||
156762546|NCT03933449|565882549|FG001|Overall Study|Adverse Event|4|||
156762547|NCT03933449|565882548|FG000|Overall Study|Death|55|||
156762548|NCT03933449|565882549|FG001|Overall Study|Death|57|||
156762549|NCT03933449|565882548|FG000|Overall Study|Sponsor Decision|1|||
156762550|NCT03933449|565882549|FG001|Overall Study|Sponsor Decision|0|||
156425938|NCT03107611|564652800|FG001|Overall Study|Protocol Violation|0|||
156425939|NCT03107611|564652801|FG002|Overall Study|Protocol Violation|1|||
156425940|NCT03107611|564652799|FG000|Overall Study|Withdrawal by Subject|1|||
156655037|NCT00395226|565483859|FG001|Overall Study|Lost to Follow-up|1|||
156655038|NCT02655237|565483862|FG000|Overall Study|Adverse Event|10|||
156655039|NCT02655237|565483863|FG001|Overall Study|Adverse Event|7|||
156655040|NCT02655237|565483862|FG000|Overall Study|Protocol Deviation|2|||
156655041|NCT02655237|565483863|FG001|Overall Study|Protocol Deviation|0|||
156655042|NCT02655237|565483862|FG000|Overall Study|Withdrawal by Participant|1|||
156655043|NCT02655237|565483863|FG001|Overall Study|Withdrawal by Participant|2|||
156655044|NCT02655237|565483862|FG000|Overall Study|Lack of Efficacy|0|||
156655045|NCT02655237|565483863|FG001|Overall Study|Lack of Efficacy|1|||
156655046|NCT02655237|565483862|FG000|Overall Study|Recovery Leading to Surgery|2|||
156762551|NCT02087774|565882552|FG000|Overall Study|Were absent day of data collection|8|||
156762552|NCT02087774|565882553|FG001|Overall Study|Were absent day of data collection|20|||
156425941|NCT03107611|564652800|FG001|Overall Study|Withdrawal by Subject|0|||
156655047|NCT02655237|565483863|FG001|Overall Study|Recovery Leading to Surgery|1|||
156762553|NCT00719901|565882554|FG000|Overall Study|Adverse Event|5|||
156762554|NCT00719901|565882554|FG000|Overall Study|Withdrawal by Subject|1|||
156762555|NCT00719901|565882554|FG000|Overall Study|Alternate Treatment|1|||
156762556|NCT00719901|565882554|FG000|Overall Study|Disease Progression|3|||
156762557|NCT00719901|565882554|FG000|Overall Study|Availability of Study Drug|1|||
156425942|NCT03107611|564652801|FG002|Overall Study|Withdrawal by Subject|1|||
156425943|NCT03107611|564652799|FG000|Overall Study|Worsening signs/symptoms|2|||
156425944|NCT03107611|564652800|FG001|Overall Study|Worsening signs/symptoms|1|||
156425945|NCT03107611|564652801|FG002|Overall Study|Worsening signs/symptoms|2|||
156425946|NCT01720446|564652804|FG000|Overall Study|Lost to Follow-up|12|||
156762558|NCT04456686|565882555|FG000|Overall Study|Adverse Event|2|||
156762559|NCT04456686|565882556|FG001|Overall Study|Adverse Event|1|||
156655048|NCT02655237|565483862|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
156655049|NCT02655237|565483863|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
156655050|NCT02655237|565483862|FG000|Overall Study|Randomized but Not Treated|1|||
156655051|NCT02655237|565483863|FG001|Overall Study|Randomized but Not Treated|0|||
156655052|NCT03679741|565483864|FG000|Period 1|No longer meet eligibility criteria|1|||
156762560|NCT04456686|565882555|FG000|Overall Study|Lack of Efficacy|3|||
156762561|NCT04456686|565882556|FG001|Overall Study|Lack of Efficacy|1|||
156762562|NCT04456686|565882555|FG000|Overall Study|Withdrew consent|3|||
156762563|NCT04456686|565882556|FG001|Overall Study|Withdrew consent|1|||
156762564|NCT04456686|565882555|FG000|Overall Study|Physician Decision|2|||
156762565|NCT04456686|565882556|FG001|Overall Study|Physician Decision|2|||
156762566|NCT04456686|565882555|FG000|Overall Study|Withdrawal by Subject|5|||
156762567|NCT04456686|565882556|FG001|Overall Study|Withdrawal by Subject|1|||
156762568|NCT04456686|565882555|FG000|Overall Study|Protocol Violation|0|||
156762569|NCT04456686|565882556|FG001|Overall Study|Protocol Violation|1|||
156762570|NCT02858401|565882561|FG000|Overall Study|Withdrew Consent|0|||
156762571|NCT02858401|565882562|FG001|Overall Study|Withdrew Consent|0|||
156762572|NCT02858401|565882563|FG002|Overall Study|Withdrew Consent|0|||
156762573|NCT02858401|565882564|FG003|Overall Study|Withdrew Consent|0|||
156762574|NCT02858401|565882565|FG004|Overall Study|Withdrew Consent|0|||
156762575|NCT02858401|565882566|FG005|Overall Study|Withdrew Consent|1|||
156762576|NCT02858401|565882567|FG006|Overall Study|Withdrew Consent|0|||
156762577|NCT02858401|565882561|FG000|Overall Study|Lost to Follow-up|0|||
156762578|NCT02858401|565882562|FG001|Overall Study|Lost to Follow-up|1|||
156762579|NCT02858401|565882563|FG002|Overall Study|Lost to Follow-up|0|||
156762580|NCT02858401|565882564|FG003|Overall Study|Lost to Follow-up|0|||
156762581|NCT02858401|565882565|FG004|Overall Study|Lost to Follow-up|0|||
156762582|NCT02858401|565882566|FG005|Overall Study|Lost to Follow-up|0|||
156762583|NCT02858401|565882567|FG006|Overall Study|Lost to Follow-up|0|||
156762584|NCT02869789|565882573|FG000|Overall Study|Disease progression|184|||
156762585|NCT02869789|565882574|FG001|Overall Study|Disease progression|109|||
156762586|NCT02869789|565882575|FG002|Overall Study|Disease progression|260|||
156762587|NCT02869789|565882576|FG003|Overall Study|Disease progression|19|||
156762588|NCT02869789|565882573|FG000|Overall Study|Study drug toxicity|90|||
156762589|NCT02869789|565882574|FG001|Overall Study|Study drug toxicity|32|||
156762590|NCT02869789|565882575|FG002|Overall Study|Study drug toxicity|55|||
156762591|NCT02869789|565882576|FG003|Overall Study|Study drug toxicity|14|||
156762592|NCT02869789|565882573|FG000|Overall Study|Death|7|||
156762593|NCT02869789|565882574|FG001|Overall Study|Death|3|||
156762594|NCT02869789|565882575|FG002|Overall Study|Death|5|||
156762595|NCT02869789|565882576|FG003|Overall Study|Death|1|||
156762596|NCT02869789|565882573|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
156762597|NCT02869789|565882574|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
156762598|NCT02869789|565882575|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
156762599|NCT02869789|565882576|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
156762600|NCT02869789|565882573|FG000|Overall Study|Participant request to discontinue study treatment|10|||
156762601|NCT02869789|565882574|FG001|Overall Study|Participant request to discontinue study treatment|5|||
156762602|NCT02869789|565882575|FG002|Overall Study|Participant request to discontinue study treatment|5|||
156762603|NCT02869789|565882576|FG003|Overall Study|Participant request to discontinue study treatment|3|||
156762604|NCT02869789|565882573|FG000|Overall Study|Withdrawal by Subject|5|||
156425947|NCT01720446|564652805|FG001|Overall Study|Lost to Follow-up|6|||
156425948|NCT01720446|564652806|FG002|Overall Study|Lost to Follow-up|16|||
156425949|NCT01720446|564652807|FG003|Overall Study|Lost to Follow-up|16|||
156655053|NCT03679741|565483865|FG001|Period 1|No longer meet eligibility criteria|0|||
156655054|NCT03679741|565483864|FG000|Period 1|Lost to Follow-up|0|||
156655055|NCT03679741|565483865|FG001|Period 1|Lost to Follow-up|1|||
156655056|NCT03679741|565483864|FG000|Period 1|Adverse Event|1|||
156655057|NCT03679741|565483865|FG001|Period 1|Adverse Event|1|||
156655058|NCT03679741|565483864|FG000|Period 1|Withdrawal by Subject|0|||
156655059|NCT03679741|565483865|FG001|Period 1|Withdrawal by Subject|1|||
156655060|NCT03679741|565483864|FG000|Period 2|Adverse Event|2|||
156762605|NCT02869789|565882574|FG001|Overall Study|Withdrawal by Subject|2|||
156762606|NCT02869789|565882575|FG002|Overall Study|Withdrawal by Subject|7|||
156762607|NCT02869789|565882576|FG003|Overall Study|Withdrawal by Subject|2|||
156762608|NCT02869789|565882573|FG000|Overall Study|Lost to Follow-up|0|||
156762609|NCT02869789|565882574|FG001|Overall Study|Lost to Follow-up|0|||
156762610|NCT02869789|565882575|FG002|Overall Study|Lost to Follow-up|2|||
156762611|NCT02869789|565882576|FG003|Overall Study|Lost to Follow-up|0|||
156762612|NCT02869789|565882573|FG000|Overall Study|Maximum clinical benefit|5|||
156762613|NCT02869789|565882574|FG001|Overall Study|Maximum clinical benefit|2|||
156425950|NCT01720446|564652804|FG000|Overall Study|Withdrawal by Subject|2|||
156762614|NCT02869789|565882575|FG002|Overall Study|Maximum clinical benefit|1|||
156762615|NCT02869789|565882576|FG003|Overall Study|Maximum clinical benefit|0|||
156762616|NCT02869789|565882573|FG000|Overall Study|Poor/Non-compliance|0|||
156762617|NCT02869789|565882574|FG001|Overall Study|Poor/Non-compliance|2|||
156762618|NCT02869789|565882575|FG002|Overall Study|Poor/Non-compliance|1|||
156762619|NCT02869789|565882576|FG003|Overall Study|Poor/Non-compliance|0|||
156762620|NCT02869789|565882573|FG000|Overall Study|Participant no longer meets study criteria|0|||
156762621|NCT02869789|565882574|FG001|Overall Study|Participant no longer meets study criteria|1|||
156762622|NCT02869789|565882575|FG002|Overall Study|Participant no longer meets study criteria|1|||
156762623|NCT02869789|565882576|FG003|Overall Study|Participant no longer meets study criteria|0|||
156762624|NCT02869789|565882573|FG000|Overall Study|Administrative reason by sponsor|0|||
156762625|NCT02869789|565882574|FG001|Overall Study|Administrative reason by sponsor|0|||
156762626|NCT02869789|565882575|FG002|Overall Study|Administrative reason by sponsor|1|||
156425951|NCT01720446|564652805|FG001|Overall Study|Withdrawal by Subject|5|||
156425952|NCT01720446|564652806|FG002|Overall Study|Withdrawal by Subject|4|||
156425953|NCT01720446|564652807|FG003|Overall Study|Withdrawal by Subject|4|||
156425954|NCT01020838|564652808|FG000|Overall Study|Death|90|||
156425955|NCT01020838|564652808|FG000|Overall Study|Adverse Event|1|||
156425956|NCT01020838|564652808|FG000|Overall Study|Withdrawal by Subject|9|||
156425957|NCT01020838|564652808|FG000|Overall Study|Lost to Follow-up|6|||
156425958|NCT01020838|564652808|FG000|Overall Study|Most common: Study ended by sponsor|77|||
156425959|NCT01167426|564652809|FG000|Overall Study|Lost to Follow-up|6|||
156425960|NCT01167426|564652809|FG000|Overall Study|Protocol Violation|1|||
156425961|NCT01167426|564652809|FG000|Overall Study|Withdrawal by Subject|2|||
156425962|NCT01167426|564652809|FG000|Overall Study|Sponsor Decision|1|||
156425963|NCT01908634|564652810|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
156425964|NCT01908634|564652810|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
156425965|NCT04176458|564652812|FG000|Overall Study|Covid 19|4|||
156425966|NCT02131324|564652813|FG000|Overall Study|Withdrawal by Subject|1|||
156425967|NCT02131324|564652814|FG001|Overall Study|Withdrawal by Subject|2|||
156425968|NCT02131324|564652813|FG000|Overall Study|Lost to Follow-up|1|||
156425969|NCT02131324|564652814|FG001|Overall Study|Lost to Follow-up|1|||
156425970|NCT00891618|564652815|FG000|Overall Study|Withdrawal by Subject|1|||
156425971|NCT04582877|564652818|FG000|Overall Study|Did not use device measurement|5|||
156425972|NCT04582877|564652818|FG000|Overall Study|No fractional flow reserve test results|2|||
156425973|NCT04582877|564652818|FG000|Overall Study|Protocol Violation|1|||
156425974|NCT00003656|564652819|FG000|Overall Study|Adverse Event|0|||
156425975|NCT00003656|564652820|FG001|Overall Study|Adverse Event|1|||
156425976|NCT00763282|564652823|FG000|Overall Study|Withdrawal by Subject|6|||
156425977|NCT00763282|564652824|FG001|Overall Study|Withdrawal by Subject|5|||
156425978|NCT00763282|564652823|FG000|Overall Study|Death|4|||
156425979|NCT00763282|564652824|FG001|Overall Study|Death|3|||
156425980|NCT00763282|564652823|FG000|Overall Study|Lost to Follow-up|22|||
156425981|NCT00763282|564652824|FG001|Overall Study|Lost to Follow-up|26|||
156425982|NCT00335556|564652828|FG000|Overall Study|Death|0|||
156425983|NCT00335556|564652829|FG001|Overall Study|Death|5|||
156425984|NCT00335556|564652830|FG002|Overall Study|Death|0|||
156425985|NCT00335556|564652831|FG003|Overall Study|Death|0|||
156425986|NCT00335556|564652832|FG004|Overall Study|Death|1|||
156425987|NCT00335556|564652833|FG005|Overall Study|Death|0|||
156425988|NCT00335556|564652828|FG000|Overall Study|Lack of Efficacy|0|||
156425989|NCT00335556|564652829|FG001|Overall Study|Lack of Efficacy|19|||
156425990|NCT00335556|564652830|FG002|Overall Study|Lack of Efficacy|3|||
156425991|NCT00335556|564652831|FG003|Overall Study|Lack of Efficacy|3|||
156425992|NCT00335556|564652832|FG004|Overall Study|Lack of Efficacy|0|||
156425993|NCT00335556|564652833|FG005|Overall Study|Lack of Efficacy|1|||
156425994|NCT00335556|564652828|FG000|Overall Study|Physician Decision|0|||
156425995|NCT00335556|564652829|FG001|Overall Study|Physician Decision|6|||
156425996|NCT00335556|564652830|FG002|Overall Study|Physician Decision|2|||
156762627|NCT02869789|565882576|FG003|Overall Study|Administrative reason by sponsor|0|||
156762628|NCT02869789|565882573|FG000|Overall Study|Other reasons|4|||
156762629|NCT02869789|565882574|FG001|Overall Study|Other reasons|8|||
156425997|NCT00335556|564652831|FG003|Overall Study|Physician Decision|1|||
156425998|NCT00335556|564652832|FG004|Overall Study|Physician Decision|0|||
156762630|NCT02869789|565882575|FG002|Overall Study|Other reasons|6|||
156425999|NCT00335556|564652833|FG005|Overall Study|Physician Decision|0|||
156426000|NCT00335556|564652828|FG000|Overall Study|Ineligible|2|||
156426001|NCT00335556|564652829|FG001|Overall Study|Ineligible|0|||
156426002|NCT00335556|564652830|FG002|Overall Study|Ineligible|0|||
156426003|NCT00335556|564652831|FG003|Overall Study|Ineligible|0|||
156762631|NCT02869789|565882576|FG003|Overall Study|Other reasons|0|||
156762632|NCT00297648|565882578|FG000|Overall Study|Adverse Event|13|||
156426004|NCT00335556|564652832|FG004|Overall Study|Ineligible|0|||
156426005|NCT00335556|564652833|FG005|Overall Study|Ineligible|0|||
156762633|NCT00297648|565882578|FG000|Overall Study|Lack of Efficacy|18|||
156762634|NCT00297648|565882578|FG000|Overall Study|Lost to Follow-up|1|||
156762635|NCT00297648|565882578|FG000|Overall Study|Withdrawal by Subject|3|||
156426006|NCT00335556|564652828|FG000|Overall Study|Refusal of further protocol therapy|0|||
156426007|NCT00335556|564652829|FG001|Overall Study|Refusal of further protocol therapy|4|||
156426008|NCT00335556|564652830|FG002|Overall Study|Refusal of further protocol therapy|0|||
156426009|NCT00335556|564652831|FG003|Overall Study|Refusal of further protocol therapy|1|||
156426010|NCT00335556|564652832|FG004|Overall Study|Refusal of further protocol therapy|0|||
156426011|NCT00335556|564652833|FG005|Overall Study|Refusal of further protocol therapy|0|||
156426012|NCT02365298|564652834|FG000|Period 2|incorrect Rx dispensed|1|||
156426013|NCT02365298|564652835|FG001|Period 2|incorrect Rx dispensed|0|||
156426014|NCT02365298|564652834|FG000|Period 2|Discontinued at request of Sponsor|1|||
156426015|NCT02365298|564652835|FG001|Period 2|Discontinued at request of Sponsor|0|||
156426016|NCT02365298|564652834|FG000|Period 2|Test Article longer available|0|||
156426017|NCT02365298|564652835|FG001|Period 2|Test Article longer available|1|||
156426018|NCT02365298|564652834|FG000|Period 2|Protocol Violation|0|||
156426019|NCT02365298|564652835|FG001|Period 2|Protocol Violation|1|||
156426020|NCT01670019|564652838|FG000|Overall Study|Adverse Event|3|||
156426021|NCT01670019|564652839|FG001|Overall Study|Adverse Event|0|||
156426022|NCT01670019|564652838|FG000|Overall Study|Withdrawal by Subject|6|||
156426023|NCT01670019|564652839|FG001|Overall Study|Withdrawal by Subject|0|||
156426024|NCT05487703|564652840|FG000|Overall Study|Other|19|||
156426025|NCT05487703|564652840|FG000|Overall Study|Participant not well|5|||
156426026|NCT05487703|564652840|FG000|Overall Study|Insurance Reasons|6|||
156426027|NCT05487703|564652840|FG000|Overall Study|Physician Decision|19|||
156426028|NCT05487703|564652840|FG000|Overall Study|Lack of Efficacy|60|||
156426029|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
156426030|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
156426031|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
156426032|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Death|3|||
156426033|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Death|0|||
156426034|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Death|0|||
156426035|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
156426036|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
156426037|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
156426038|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
156426039|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
156322088|NCT02414139|564276934|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
156322089|NCT02414139|564276935|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
156322090|NCT02414139|564276936|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
156322091|NCT02414139|564276937|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
156322092|NCT02414139|564276928|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156322093|NCT02414139|564276929|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
156322094|NCT02414139|564276930|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156322095|NCT02414139|564276931|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156322096|NCT02414139|564276932|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156322097|NCT02414139|564276933|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156322098|NCT02414139|564276934|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156322099|NCT02414139|564276935|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156322100|NCT02414139|564276936|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156322101|NCT02414139|564276937|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
156322102|NCT02414139|564276928|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
156322103|NCT02414139|564276929|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156322104|NCT02414139|564276930|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
156322105|NCT02414139|564276931|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
156322106|NCT02414139|564276932|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
156322107|NCT02414139|564276933|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
156322108|NCT02414139|564276934|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
156322109|NCT02414139|564276935|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
156322110|NCT02414139|564276936|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
156322111|NCT02414139|564276937|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156322112|NCT02290431|564276938|FG000|Overall Study|Adverse Event|20|||
156322113|NCT02290431|564276938|FG000|Overall Study|Progressive disease|4|||
156322114|NCT02290431|564276938|FG000|Overall Study|Study terminated by Sponsor|1|||
156322115|NCT02290431|564276938|FG000|Overall Study|Physician Decision|2|||
156322116|NCT03324581|564276940|FG000|Overall Study|Adverse Event|18|||
156322117|NCT03324581|564276941|FG001|Overall Study|Adverse Event|11|||
156322118|NCT03324581|564276942|FG002|Overall Study|Adverse Event|7|||
156322119|NCT03324581|564276940|FG000|Overall Study|Lack of Efficacy|0|||
156322120|NCT03324581|564276941|FG001|Overall Study|Lack of Efficacy|1|||
156322121|NCT03324581|564276942|FG002|Overall Study|Lack of Efficacy|0|||
156322122|NCT03324581|564276940|FG000|Overall Study|Lost to Follow-up|5|||
156426040|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
156322123|NCT03324581|564276941|FG001|Overall Study|Lost to Follow-up|3|||
156762636|NCT00297648|565882578|FG000|Overall Study|Other: Incompliance|1|||
156762637|NCT02048722|565882579|FG000|2 Cycles of Treatment|Adverse Event|2|||
156762638|NCT02048722|565882579|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
156762639|NCT02048722|565882579|FG000|2 Cycles of Treatment|Progressive Disease|2|||
156762640|NCT02048722|565882579|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
156762641|NCT02048722|565882579|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
156762642|NCT02048722|565882579|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
156762643|NCT01529606|565882581|FG000|Overall Study|Lost to Follow-up|21|||
156762644|NCT01529606|565882582|FG001|Overall Study|Lost to Follow-up|18|||
156655061|NCT03679741|565483865|FG001|Period 2|Adverse Event|1|||
156762645|NCT01746862|565882583|FG000|Overall Study|Withdrawal by Subject|1|||
156762646|NCT01746862|565882584|FG001|Overall Study|Withdrawal by Subject|1|||
156762647|NCT01746862|565882583|FG000|Overall Study|Protocol Violation|1|||
156762648|NCT01746862|565882584|FG001|Overall Study|Protocol Violation|0|||
156762649|NCT01746862|565882583|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
156762650|NCT01746862|565882584|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
156762651|NCT01746862|565882583|FG000|Overall Study|Entered puberty during the study|1|||
156762652|NCT01746862|565882584|FG001|Overall Study|Entered puberty during the study|0|||
156762653|NCT05209880|565882589|FG000|1-Month Follow-up|Spoke with Doctor|5|||
156762654|NCT05209880|565882590|FG001|1-Month Follow-up|Spoke with Doctor|5|||
156426041|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
156426042|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
156426043|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
156426044|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
156426045|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
156426046|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
156426047|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
156426048|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
156426049|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
156426050|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Other|1|||
156426051|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Other|0|||
156426052|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Other|0|||
156426053|NCT02403323|564652841|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
156426054|NCT02403323|564652842|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
156426055|NCT02403323|564652843|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
156426056|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
156426057|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
156426058|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
156655062|NCT03679741|565483864|FG000|Period 2|Withdrawal by Subject|1|||
156655063|NCT03679741|565483865|FG001|Period 2|Withdrawal by Subject|1|||
156655064|NCT04652453|565483870|FG000|Overall Study|Death|8|||
156655065|NCT04652453|565483871|FG001|Overall Study|Death|2|||
156655066|NCT04652453|565483872|FG002|Overall Study|Death|0|||
156655067|NCT04652453|565483870|FG000|Overall Study|Hospice|5|||
156655068|NCT04652453|565483871|FG001|Overall Study|Hospice|5|||
156655069|NCT04652453|565483872|FG002|Overall Study|Hospice|0|||
156655070|NCT04652453|565483870|FG000|Overall Study|Withdrawal by Subject|2|||
156655071|NCT04652453|565483871|FG001|Overall Study|Withdrawal by Subject|0|||
156655072|NCT04652453|565483872|FG002|Overall Study|Withdrawal by Subject|0|||
156655073|NCT04543136|565483873|FG000|Overall Study|Withdrawal by Subject|0|||
156655074|NCT04543136|565483874|FG001|Overall Study|Withdrawal by Subject|1|||
156655075|NCT04543136|565483875|FG002|Overall Study|Withdrawal by Subject|0|||
156655076|NCT04543136|565483876|FG003|Overall Study|Withdrawal by Subject|1|||
156655077|NCT04543136|565483877|FG004|Overall Study|Withdrawal by Subject|0|||
156655078|NCT04543136|565483878|FG005|Overall Study|Withdrawal by Subject|0|||
156655079|NCT06331156|565483884|FG000|Overall Study|Adverse Event|1|||
156655080|NCT06331156|565483885|FG001|Overall Study|Adverse Event|0|||
156655081|NCT06331156|565483884|FG000|Overall Study|Lost to Follow-up|1|||
156655082|NCT06331156|565483885|FG001|Overall Study|Lost to Follow-up|0|||
156655083|NCT06331156|565483884|FG000|Overall Study|Migrated / Moved from the study area|4|||
156655084|NCT06331156|565483885|FG001|Overall Study|Migrated / Moved from the study area|3|||
156655085|NCT06331156|565483884|FG000|Overall Study|Other|7|||
156655086|NCT06331156|565483885|FG001|Overall Study|Other|0|||
156655087|NCT06331156|565483884|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
156655088|NCT06331156|565483885|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
156655089|NCT04799158|565483887|FG000|Run-In Period|Adverse Event|6|||
156655090|NCT04799158|565483888|FG001|Run-In Period|Adverse Event|0|||
156655091|NCT04799158|565483889|FG002|Run-In Period|Adverse Event|0|||
156655092|NCT04799158|565483890|FG003|Run-In Period|Adverse Event|0|||
156762655|NCT05209880|565882589|FG000|1-Month Follow-up|Lost to Follow-up|7|||
156426059|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
156762656|NCT05209880|565882590|FG001|1-Month Follow-up|Lost to Follow-up|9|||
156655093|NCT04799158|565483891|FG004|Run-In Period|Adverse Event|0|||
156655094|NCT04799158|565483887|FG000|Run-In Period|Lost to Follow-up|4|||
156426060|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
156426061|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
156762657|NCT05209880|565882589|FG000|1-Month Follow-up|Discontinued|0|||
156762658|NCT05209880|565882590|FG001|1-Month Follow-up|Discontinued|1|||
156426062|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
156426063|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
156426064|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
156762659|NCT05209880|565882589|FG000|3-Month Follow-up|Spoke with Doctor|17|||
156762660|NCT05209880|565882590|FG001|3-Month Follow-up|Spoke with Doctor|7|||
156762661|NCT05209880|565882589|FG000|3-Month Follow-up|Lost to Follow-up|8|||
156762662|NCT05209880|565882590|FG001|3-Month Follow-up|Lost to Follow-up|10|||
156762663|NCT05209880|565882589|FG000|3-Month Follow-up|Discontinued|1|||
156762664|NCT05209880|565882590|FG001|3-Month Follow-up|Discontinued|3|||
156762665|NCT05209880|565882589|FG000|6-Month Follow-up|Spoke with Doctor|25|||
156762666|NCT05209880|565882590|FG001|6-Month Follow-up|Spoke with Doctor|14|||
156762667|NCT05209880|565882589|FG000|6-Month Follow-up|Lost to Follow-up|9|||
156762668|NCT05209880|565882590|FG001|6-Month Follow-up|Lost to Follow-up|14|||
156762669|NCT05209880|565882589|FG000|6-Month Follow-up|Discontinued|1|||
156762670|NCT05209880|565882590|FG001|6-Month Follow-up|Discontinued|3|||
156762671|NCT03143101|565882598|FG000|Overall Study|Withdrawal by Subject|0|||
156762672|NCT03143101|565882599|FG001|Overall Study|Withdrawal by Subject|1|||
156762673|NCT03143101|565882600|FG002|Overall Study|Withdrawal by Subject|0|||
156762674|NCT03143101|565882598|FG000|Overall Study|Lost to Follow-up|2|||
156762675|NCT03143101|565882599|FG001|Overall Study|Lost to Follow-up|2|||
156762676|NCT03143101|565882600|FG002|Overall Study|Lost to Follow-up|0|||
156762677|NCT03973996|565884599|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156762678|NCT03973996|565884600|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156762679|NCT03973996|565884601|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156762680|NCT03973996|565884602|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
156762681|NCT02026141|565884603|FG000|Overall Study|Protocol Violation|0|||
156762682|NCT02026141|565884604|FG001|Overall Study|Protocol Violation|1|||
156762683|NCT02735980|565884605|FG000|Overall Study|Adverse Event|0|||
156762684|NCT02735980|565884606|FG001|Overall Study|Adverse Event|4|||
156762685|NCT02735980|565884607|FG002|Overall Study|Adverse Event|1|||
156762686|NCT02735980|565884605|FG000|Overall Study|Death|5|||
156762687|NCT02735980|565884606|FG001|Overall Study|Death|4|||
156426065|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
156426066|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
156426067|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
156426068|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
156426069|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
156426070|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
156426071|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
156426072|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
156426073|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
156426074|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
156426075|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
156426076|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
156426077|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
156426078|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
156426079|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
156426080|NCT02403323|564652841|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
156426081|NCT02403323|564652842|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
156426082|NCT02403323|564652843|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
156426083|NCT03885596|564652847|FG000|Overall Study|Withdrawal by Subject|2|||
156426084|NCT03885596|564652848|FG001|Overall Study|Withdrawal by Subject|1|||
156426085|NCT03885596|564652849|FG002|Overall Study|Withdrawal by Subject|0|||
156426086|NCT03885596|564652850|FG003|Overall Study|Withdrawal by Subject|0|||
156426087|NCT01076335|564652851|FG000|Overall Study|Withdrawal by Subject|3|||
156655095|NCT04799158|565483888|FG001|Run-In Period|Lost to Follow-up|0|||
156655096|NCT04799158|565483889|FG002|Run-In Period|Lost to Follow-up|0|||
156655097|NCT04799158|565483890|FG003|Run-In Period|Lost to Follow-up|0|||
156655098|NCT04799158|565483891|FG004|Run-In Period|Lost to Follow-up|0|||
156655099|NCT04799158|565483887|FG000|Run-In Period|Significant Protocol Deviation|1|||
156655100|NCT04799158|565483888|FG001|Run-In Period|Significant Protocol Deviation|0|||
156655101|NCT04799158|565483889|FG002|Run-In Period|Significant Protocol Deviation|0|||
156655102|NCT04799158|565483890|FG003|Run-In Period|Significant Protocol Deviation|0|||
156655103|NCT04799158|565483891|FG004|Run-In Period|Significant Protocol Deviation|0|||
156655104|NCT04799158|565483887|FG000|Run-In Period|Withdrawal by Subject|11|||
156655105|NCT04799158|565483888|FG001|Run-In Period|Withdrawal by Subject|0|||
156655106|NCT04799158|565483889|FG002|Run-In Period|Withdrawal by Subject|0|||
156655107|NCT04799158|565483890|FG003|Run-In Period|Withdrawal by Subject|0|||
156762688|NCT02735980|565884607|FG002|Overall Study|Death|0|||
156426088|NCT01076335|564652851|FG000|Overall Study|Withdrawal without treatment|1|||
156426089|NCT04639947|564652855|FG000|Overall Study|Screen fail|1|||
156762689|NCT02735980|565884605|FG000|Overall Study|Physician Decision|3|||
156426090|NCT01018511|564652856|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
156426091|NCT01018511|564652857|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
156426092|NCT01018511|564652858|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
156426093|NCT01018511|564652859|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
156426094|NCT01018511|564652856|FG000|Overall Study|Adverse Event|5|||
156426095|NCT01018511|564652857|FG001|Overall Study|Adverse Event|9|||
156426096|NCT01018511|564652858|FG002|Overall Study|Adverse Event|13|||
156426097|NCT01018511|564652859|FG003|Overall Study|Adverse Event|10|||
156426098|NCT01018511|564652856|FG000|Overall Study|Lack of Efficacy|4|||
156426099|NCT01018511|564652857|FG001|Overall Study|Lack of Efficacy|1|||
156426100|NCT01018511|564652858|FG002|Overall Study|Lack of Efficacy|1|||
156426101|NCT01018511|564652859|FG003|Overall Study|Lack of Efficacy|2|||
156426102|NCT01018511|564652856|FG000|Overall Study|Withdrawal by Subject|6|||
156426103|NCT01018511|564652857|FG001|Overall Study|Withdrawal by Subject|5|||
156426104|NCT01018511|564652858|FG002|Overall Study|Withdrawal by Subject|11|||
156426105|NCT01018511|564652859|FG003|Overall Study|Withdrawal by Subject|9|||
156426106|NCT01018511|564652856|FG000|Overall Study|Lost to Follow-up|0|||
156426107|NCT01018511|564652857|FG001|Overall Study|Lost to Follow-up|0|||
156426108|NCT01018511|564652858|FG002|Overall Study|Lost to Follow-up|1|||
156426109|NCT01018511|564652859|FG003|Overall Study|Lost to Follow-up|0|||
156426110|NCT01018511|564652856|FG000|Overall Study|Protocol Violation|5|||
156426111|NCT01018511|564652857|FG001|Overall Study|Protocol Violation|8|||
156426112|NCT01018511|564652858|FG002|Overall Study|Protocol Violation|7|||
156426113|NCT01018511|564652859|FG003|Overall Study|Protocol Violation|9|||
156426114|NCT01018511|564652856|FG000|Overall Study|Miscellaneous|0|||
156426115|NCT01018511|564652857|FG001|Overall Study|Miscellaneous|2|||
156426116|NCT01018511|564652858|FG002|Overall Study|Miscellaneous|0|||
156762690|NCT02735980|565884606|FG001|Overall Study|Physician Decision|1|||
156762691|NCT02735980|565884607|FG002|Overall Study|Physician Decision|0|||
156762692|NCT02735980|565884605|FG000|Overall Study|Screen failure|1|||
156762693|NCT02735980|565884606|FG001|Overall Study|Screen failure|0|||
156762694|NCT02735980|565884607|FG002|Overall Study|Screen failure|0|||
156762695|NCT02735980|565884605|FG000|Overall Study|Withdrawal by Subject|1|||
156762696|NCT02735980|565884606|FG001|Overall Study|Withdrawal by Subject|2|||
156426117|NCT01018511|564652859|FG003|Overall Study|Miscellaneous|0|||
156426118|NCT01268566|564652865|FG000|Overall Study|Lost to Follow-up|1|||
156426119|NCT01268566|564652865|FG000|Overall Study|Withdrawal by Subject|12|||
156426120|NCT01268566|564652865|FG000|Overall Study|Death|30|||
156426121|NCT01649427|564652870|FG000|Overall Study|Adverse Event|1|||
156426122|NCT01649427|564652871|FG001|Overall Study|Adverse Event|1|||
156426123|NCT01649427|564652870|FG000|Overall Study|Withdrawal by Subject|8|||
156426124|NCT01649427|564652871|FG001|Overall Study|Withdrawal by Subject|7|||
156426125|NCT01649427|564652870|FG000|Overall Study|Lost to Follow-up|0|||
156426126|NCT01649427|564652871|FG001|Overall Study|Lost to Follow-up|1|||
156426127|NCT01649427|564652870|FG000|Overall Study|Graft loss|0|||
156426128|NCT01649427|564652871|FG001|Overall Study|Graft loss|1|||
156426129|NCT01649427|564652870|FG000|Overall Study|Surgical problems during nephrectomy|2|||
156426130|NCT01649427|564652871|FG001|Overall Study|Surgical problems during nephrectomy|2|||
156426131|NCT02138916|564652872|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
156426132|NCT02138916|564652873|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
156426133|NCT02138916|564652874|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
156426134|NCT02138916|564652872|FG000|Overall Study|Death|14|||
156426135|NCT02138916|564652873|FG001|Overall Study|Death|11|||
156426136|NCT02138916|564652874|FG002|Overall Study|Death|12|||
156426137|NCT02138916|564652872|FG000|Overall Study|Withdrawal by Subject|27|||
156426138|NCT02138916|564652873|FG001|Overall Study|Withdrawal by Subject|31|||
156426139|NCT02138916|564652874|FG002|Overall Study|Withdrawal by Subject|32|||
156426140|NCT02138916|564652872|FG000|Overall Study|Study specific withdrawal criteria|0|||
156426141|NCT02138916|564652873|FG001|Overall Study|Study specific withdrawal criteria|0|||
156426142|NCT02138916|564652874|FG002|Overall Study|Study specific withdrawal criteria|1|||
156762697|NCT02735980|565884607|FG002|Overall Study|Withdrawal by Subject|0|||
156426143|NCT02138916|564652872|FG000|Overall Study|incorrect enrolment|1|||
156426144|NCT02138916|564652873|FG001|Overall Study|incorrect enrolment|1|||
156762698|NCT00126594|565884608|FG000|Overall Study|Ineligible|2|||
156762699|NCT00126594|565884609|FG001|Overall Study|Ineligible|0|||
156426145|NCT02138916|564652874|FG002|Overall Study|incorrect enrolment|0|||
156426146|NCT02138916|564652872|FG000|Overall Study|Severe non-compliance|1|||
156426147|NCT02138916|564652873|FG001|Overall Study|Severe non-compliance|2|||
156426148|NCT02138916|564652874|FG002|Overall Study|Severe non-compliance|1|||
156426149|NCT02138916|564652872|FG000|Overall Study|Lost to Follow-up|4|||
156426150|NCT02138916|564652873|FG001|Overall Study|Lost to Follow-up|2|||
156426151|NCT02138916|564652874|FG002|Overall Study|Lost to Follow-up|3|||
156762700|NCT00126594|565884608|FG000|Overall Study|Withdrawal by Subject|0|||
156762701|NCT00126594|565884609|FG001|Overall Study|Withdrawal by Subject|4|||
156322124|NCT03324581|564276942|FG002|Overall Study|Lost to Follow-up|6|||
156322125|NCT03324581|564276940|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
156322126|NCT03324581|564276941|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
156322127|NCT03324581|564276942|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
156322128|NCT03324581|564276940|FG000|Overall Study|Physician Decision|0|||
156322129|NCT03324581|564276941|FG001|Overall Study|Physician Decision|1|||
156322130|NCT03324581|564276942|FG002|Overall Study|Physician Decision|2|||
156322131|NCT03324581|564276940|FG000|Overall Study|Protocol Deviation|8|||
156322132|NCT03324581|564276941|FG001|Overall Study|Protocol Deviation|9|||
156322133|NCT03324581|564276942|FG002|Overall Study|Protocol Deviation|4|||
156322134|NCT03324581|564276940|FG000|Overall Study|Withdrawal by Subject|6|||
156322135|NCT03324581|564276941|FG001|Overall Study|Withdrawal by Subject|8|||
156322136|NCT03324581|564276942|FG002|Overall Study|Withdrawal by Subject|6|||
156322137|NCT03324581|564276940|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
156322138|NCT03324581|564276941|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
156322139|NCT03324581|564276942|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
156322140|NCT00321893|564276943|FG000|Overall Study|Non-Compliance/Refusal|16|||
156322141|NCT00321893|564276944|FG001|Overall Study|Non-Compliance/Refusal|10|||
156322142|NCT00321893|564276943|FG000|Overall Study|Lost to Follow-up|2|||
156322143|NCT00321893|564276944|FG001|Overall Study|Lost to Follow-up|1|||
156322144|NCT00321893|564276943|FG000|Overall Study|Adverse Event|6|||
156322145|NCT00321893|564276944|FG001|Overall Study|Adverse Event|3|||
156322146|NCT03455764|564276945|FG000|Overall Study|Adverse Event|1|||
156322147|NCT03455764|564276946|FG001|Overall Study|Adverse Event|0|||
156322148|NCT03455764|564276947|FG002|Overall Study|Adverse Event|0|||
156426152|NCT02138916|564652872|FG000|Overall Study|Adverse Event|4|||
156655108|NCT04799158|565483891|FG004|Run-In Period|Withdrawal by Subject|0|||
156322149|NCT03455764|564276948|FG003|Overall Study|Adverse Event|0|||
156322150|NCT03455764|564276949|FG004|Overall Study|Adverse Event|0|||
156322151|NCT03455764|564276945|FG000|Overall Study|Disease Progression|4|||
156322152|NCT03455764|564276946|FG001|Overall Study|Disease Progression|0|||
156322153|NCT03455764|564276947|FG002|Overall Study|Disease Progression|0|||
156322154|NCT03455764|564276948|FG003|Overall Study|Disease Progression|0|||
156322155|NCT03455764|564276949|FG004|Overall Study|Disease Progression|0|||
156322156|NCT03455764|564276945|FG000|Overall Study|On Treatment|1|||
156322157|NCT03455764|564276946|FG001|Overall Study|On Treatment|0|||
156322158|NCT03455764|564276947|FG002|Overall Study|On Treatment|0|||
156322159|NCT03455764|564276948|FG003|Overall Study|On Treatment|0|||
156322160|NCT03455764|564276949|FG004|Overall Study|On Treatment|0|||
156322161|NCT01585584|564276950|FG000|Overall Study|Lack of Efficacy|1|||
156322162|NCT01585584|564276950|FG000|Overall Study|Withdrawal by Subject|1|||
156322163|NCT01585584|564276950|FG000|Overall Study|Physician Decision|2|||
156322164|NCT04777331|564277274|FG000|DBT Period|Death|2|||
156322165|NCT04777331|564277275|FG001|DBT Period|Death|1|||
156322166|NCT04777331|564277276|FG002|DBT Period|Death|0|||
156322167|NCT04777331|564277274|FG000|DBT Period|Reason not Specified|1|||
156322168|NCT04777331|564277275|FG001|DBT Period|Reason not Specified|1|||
156322169|NCT04777331|564277276|FG002|DBT Period|Reason not Specified|0|||
156322170|NCT04777331|564277274|FG000|DBT Period|Physician Decision|4|||
156322171|NCT04777331|564277275|FG001|DBT Period|Physician Decision|0|||
156322172|NCT04777331|564277276|FG002|DBT Period|Physician Decision|0|||
156322173|NCT04777331|564277274|FG000|DBT Period|Withdrawal by Subject|12|||
156426153|NCT02138916|564652873|FG001|Overall Study|Adverse Event|4|||
156655109|NCT04799158|565483887|FG000|Run-In Period|Miscellaneous|3|||
156655110|NCT04799158|565483888|FG001|Run-In Period|Miscellaneous|0|||
156655111|NCT04799158|565483889|FG002|Run-In Period|Miscellaneous|0|||
156655112|NCT04799158|565483890|FG003|Run-In Period|Miscellaneous|0|||
156655113|NCT04799158|565483891|FG004|Run-In Period|Miscellaneous|0|||
156655114|NCT04799158|565483887|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
156655115|NCT04799158|565483888|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
156655116|NCT04799158|565483889|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
156655117|NCT04799158|565483890|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
156655118|NCT04799158|565483891|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
156655119|NCT04799158|565483887|FG000|On-Demand Treatment Period|Adverse Event|0|||
156655120|NCT04799158|565483888|FG001|On-Demand Treatment Period|Adverse Event|1|||
156655121|NCT04799158|565483889|FG002|On-Demand Treatment Period|Adverse Event|0|||
156655122|NCT04799158|565483890|FG003|On-Demand Treatment Period|Adverse Event|0|||
156655123|NCT04799158|565483891|FG004|On-Demand Treatment Period|Adverse Event|1|||
156655124|NCT04799158|565483887|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
156655125|NCT04799158|565483888|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
156655126|NCT04799158|565483889|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
156655127|NCT04799158|565483890|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
156655128|NCT04799158|565483891|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
156655129|NCT04799158|565483887|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
156655130|NCT04799158|565483888|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
156655131|NCT04799158|565483889|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
156426154|NCT02138916|564652874|FG002|Overall Study|Adverse Event|3|||
156426155|NCT05096884|564652876|FG000|Overall Study|Excluded based on negative tilt table test|4|||
156426156|NCT02482233|564652881|FG000|Overall Study|Lost to Follow-up|1|||
156322174|NCT04777331|564277275|FG001|DBT Period|Withdrawal by Subject|11|||
156322175|NCT04777331|564277276|FG002|DBT Period|Withdrawal by Subject|0|||
156322176|NCT04777331|564277274|FG000|DBT Period|Randomized but not Treated|1|||
156322177|NCT04777331|564277275|FG001|DBT Period|Randomized but not Treated|3|||
156322178|NCT04777331|564277276|FG002|DBT Period|Randomized but not Treated|0|||
156322179|NCT04777331|564277274|FG000|OLE Period|Ongoing in OLE|0|||
156322180|NCT04777331|564277275|FG001|OLE Period|Ongoing in OLE|0|||
156322181|NCT04777331|564277276|FG002|OLE Period|Ongoing in OLE|534|||
156322182|NCT03993379|564277277|FG000|Overall Study|The study was terminated early due to business decision.|0|||
156322183|NCT03993379|564277278|FG001|Overall Study|The study was terminated early due to business decision.|2|||
156322184|NCT03993379|564277279|FG002|Overall Study|The study was terminated early due to business decision.|0|||
156322185|NCT03993379|564277280|FG003|Overall Study|The study was terminated early due to business decision.|0|||
156322186|NCT03993379|564277277|FG000|Overall Study|Withdrawal by Subject|0|||
156322187|NCT03993379|564277278|FG001|Overall Study|Withdrawal by Subject|1|||
156322188|NCT03993379|564277279|FG002|Overall Study|Withdrawal by Subject|0|||
156322189|NCT03993379|564277280|FG003|Overall Study|Withdrawal by Subject|0|||
156322190|NCT06374394|564277281|FG000|Overall Study|Adverse Event|0|||
156322191|NCT06374394|564277282|FG001|Overall Study|Adverse Event|2|||
156322192|NCT06374394|564277281|FG000|Overall Study|Lost to Follow-up|6|||
156322193|NCT06374394|564277282|FG001|Overall Study|Lost to Follow-up|9|||
156322194|NCT06374394|564277281|FG000|Overall Study|Withdrawal by Subject|1|||
156322195|NCT06374394|564277282|FG001|Overall Study|Withdrawal by Subject|7|||
156322196|NCT06374394|564277281|FG000|Overall Study|Other|1|||
156322197|NCT06374394|564277282|FG001|Overall Study|Other|0|||
156322198|NCT03954041|564278013|FG000|Overall Study|Lost to Follow-up|3|||
156322199|NCT03954041|564278014|FG001|Overall Study|Lost to Follow-up|3|||
156322200|NCT03954041|564278015|FG002|Overall Study|Lost to Follow-up|6|||
156322201|NCT03954041|564278013|FG000|Overall Study|Death|4|||
156322202|NCT03954041|564278014|FG001|Overall Study|Death|0|||
156322203|NCT03954041|564278015|FG002|Overall Study|Death|1|||
156426157|NCT02482233|564652882|FG001|Overall Study|Lost to Follow-up|1|||
156762702|NCT00126594|565884608|FG000|Overall Study|Physician Decision|1|||
156762703|NCT00126594|565884609|FG001|Overall Study|Physician Decision|3|||
156762704|NCT00126594|565884608|FG000|Overall Study|Adverse Event|7|||
156762705|NCT00126594|565884609|FG001|Overall Study|Adverse Event|5|||
156762706|NCT00126594|565884608|FG000|Overall Study|Non-compliance|0|||
156762707|NCT00126594|565884609|FG001|Overall Study|Non-compliance|1|||
156762708|NCT00126594|565884608|FG000|Overall Study|Disease Progression|29|||
156762709|NCT00126594|565884609|FG001|Overall Study|Disease Progression|24|||
156762710|NCT01232790|565884612|FG000|Randomization|Withdrawal by Subject|2|||
156762711|NCT01232790|565884613|FG001|Randomization|Withdrawal by Subject|0|||
156762712|NCT01232790|565884612|FG000|Randomization|Protocol Violation|0|||
156762713|NCT01232790|565884613|FG001|Randomization|Protocol Violation|1|||
156762714|NCT01232790|565884612|FG000|Randomization|Physician Decision|0|||
156762715|NCT01232790|565884613|FG001|Randomization|Physician Decision|1|||
156762716|NCT01232790|565884612|FG000|Initial Assessment|Withdrawal by Subject|0|||
156762717|NCT01232790|565884613|FG001|Initial Assessment|Withdrawal by Subject|1|||
156762718|NCT01232790|565884612|FG000|First Crossover|Withdrawal by Subject|1|||
156762719|NCT01232790|565884613|FG001|First Crossover|Withdrawal by Subject|0|||
156762720|NCT01232790|565884612|FG000|Second Crossover|Withdrawal by Subject|1|||
156762721|NCT01232790|565884613|FG001|Second Crossover|Withdrawal by Subject|2|||
156762722|NCT01239797|565884616|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
156762723|NCT01239797|565884617|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
156762724|NCT01239797|565884616|FG000|Randomized Participants|Participant withdrew consent|1|||
156762725|NCT01239797|565884617|FG001|Randomized Participants|Participant withdrew consent|7|||
156762726|NCT01239797|565884616|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
156762727|NCT01239797|565884617|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
156762728|NCT01239797|565884616|FG000|Treated Participants|Disease progression|185|||
156762729|NCT01239797|565884617|FG001|Treated Participants|Disease progression|185|||
156762730|NCT01239797|565884616|FG000|Treated Participants|Study drug toxicity|39|||
156762731|NCT01239797|565884617|FG001|Treated Participants|Study drug toxicity|45|||
156762732|NCT01239797|565884616|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
156762733|NCT01239797|565884617|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
156322204|NCT03954041|564278013|FG000|Overall Study|Death by neurologic criteria|0|||
156426158|NCT04888585|564652883|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
156762734|NCT01239797|565884616|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
156762735|NCT01239797|565884617|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
156762736|NCT01239797|565884616|FG000|Treated Participants|Administrative reason by sponsor|13|||
156426159|NCT04888585|564652884|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
156322205|NCT03954041|564278014|FG001|Overall Study|Death by neurologic criteria|0|||
156322206|NCT03954041|564278015|FG002|Overall Study|Death by neurologic criteria|1|||
156762737|NCT01239797|565884617|FG001|Treated Participants|Administrative reason by sponsor|4|||
156762738|NCT01239797|565884616|FG000|Treated Participants|Other reasons|14|||
156762739|NCT01239797|565884617|FG001|Treated Participants|Other reasons|14|||
156762740|NCT01239797|565884616|FG000|Treated Participants|Participant withdrew consent|6|||
156762741|NCT01239797|565884617|FG001|Treated Participants|Participant withdrew consent|11|||
156762742|NCT01239797|565884616|FG000|Treated Participants|Death|1|||
156762743|NCT01239797|565884617|FG001|Treated Participants|Death|1|||
156762744|NCT01239797|565884616|FG000|Treated Participants|Participant no longer meets study criteria|1|||
156762745|NCT01239797|565884617|FG001|Treated Participants|Participant no longer meets study criteria|1|||
156762746|NCT01239797|565884616|FG000|Treated Participants|Poor/non-compliance|0|||
156762747|NCT01239797|565884617|FG001|Treated Participants|Poor/non-compliance|1|||
156762748|NCT00853762|565884618|FG000|Overall Study|Premature Termination|16|||
156762749|NCT00853762|565884619|FG001|Overall Study|Premature Termination|15|||
156762750|NCT00853762|565884620|FG002|Overall Study|Premature Termination|14|||
156762751|NCT00853762|565884621|FG003|Overall Study|Premature Termination|21|||
156762752|NCT00853762|565884618|FG000|Overall Study|Protocol Violation|0|||
156762753|NCT00853762|565884619|FG001|Overall Study|Protocol Violation|0|||
156762754|NCT00853762|565884620|FG002|Overall Study|Protocol Violation|0|||
156762755|NCT00853762|565884621|FG003|Overall Study|Protocol Violation|1|||
156762756|NCT00853762|565884618|FG000|Overall Study|Withdrawal by Subject|0|||
156762757|NCT00853762|565884619|FG001|Overall Study|Withdrawal by Subject|0|||
156762758|NCT00853762|565884620|FG002|Overall Study|Withdrawal by Subject|1|||
156762759|NCT00853762|565884621|FG003|Overall Study|Withdrawal by Subject|0|||
156762760|NCT00853762|565884618|FG000|Overall Study|Other|0|||
156762761|NCT00853762|565884619|FG001|Overall Study|Other|2|||
156762762|NCT00853762|565884620|FG002|Overall Study|Other|0|||
156762763|NCT00853762|565884621|FG003|Overall Study|Other|0|||
156762764|NCT00853762|565884618|FG000|Overall Study|Randomised but not Treated|0|||
156762765|NCT00853762|565884619|FG001|Overall Study|Randomised but not Treated|2|||
156762766|NCT00853762|565884620|FG002|Overall Study|Randomised but not Treated|2|||
156762767|NCT00853762|565884621|FG003|Overall Study|Randomised but not Treated|0|||
156762768|NCT02059239|565884628|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
156762769|NCT02059239|565884629|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
156762770|NCT02059239|565884628|FG000|Overall Study|Physician Decision|1|||
156762771|NCT02059239|565884629|FG001|Overall Study|Physician Decision|0|||
156762772|NCT01408706|565884631|FG000|Overall Study|Physician Decision|1|||
156762773|NCT01408706|565884632|FG001|Overall Study|Physician Decision|0|||
156762774|NCT01222104|565884633|FG000|Overall Study|Lost to Follow-up|37|||
156762775|NCT01222104|565884633|FG000|Overall Study|Death|10|||
156762776|NCT00888654|565884635|FG000|Overall Study|Problems swallowing oral meds.|1|||
156762777|NCT00888654|565884635|FG000|Overall Study|Not enough oral meds before surgery|3|||
156762778|NCT00888654|565884635|FG000|Overall Study|Surgery aborted|2|||
156762779|NCT00888654|565884635|FG000|Overall Study|Withdrawal by Subject|1|||
156762780|NCT00888654|565884635|FG000|Overall Study|Inelig. due to contraindication of med|1|||
156762781|NCT00888654|565884635|FG000|Overall Study|Change in surg date|1|||
156655132|NCT04799158|565483890|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
156655133|NCT04799158|565483891|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
156655134|NCT04799158|565483887|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
156655135|NCT04799158|565483888|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
156655136|NCT04799158|565483889|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
156655137|NCT04799158|565483890|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
156655138|NCT04799158|565483891|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
156655139|NCT04799158|565483887|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
156655140|NCT04799158|565483888|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
156655141|NCT04799158|565483889|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
156655142|NCT04799158|565483890|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
156655143|NCT04799158|565483891|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
156655144|NCT04799158|565483887|FG000|On-Demand Treatment Period|Miscellaneous|0|||
156655145|NCT04799158|565483888|FG001|On-Demand Treatment Period|Miscellaneous|0|||
156655146|NCT04799158|565483889|FG002|On-Demand Treatment Period|Miscellaneous|0|||
156655147|NCT04799158|565483890|FG003|On-Demand Treatment Period|Miscellaneous|0|||
156655148|NCT04799158|565483891|FG004|On-Demand Treatment Period|Miscellaneous|1|||
156655149|NCT00936975|565483892|FG000|Overall Study|Withdrawal by Subject|1|||
156655150|NCT00936975|565483892|FG000|Overall Study|Disease progression|3|||
156655151|NCT00936975|565483892|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
156655152|NCT00679783|565483900|FG000|Overall Study|Adverse Event|0|||
156762782|NCT00888654|565884635|FG000|Overall Study|Stopped meds due to headaches|1|||
156322207|NCT03954041|564278013|FG000|Overall Study|Reason not specified|7|||
156655153|NCT00679783|565483901|FG001|Overall Study|Adverse Event|0|||
156655154|NCT00679783|565483902|FG002|Overall Study|Adverse Event|0|||
156655155|NCT00679783|565483903|FG003|Overall Study|Adverse Event|3|||
156655156|NCT00679783|565483904|FG004|Overall Study|Adverse Event|0|||
156762783|NCT01418339|565884636|FG000|Overall Study|Adverse Event|5|||
156762784|NCT01418339|565884637|FG001|Overall Study|Adverse Event|2|||
156762785|NCT01418339|565884636|FG000|Overall Study|Subject Withdrew Consent|1|||
156426160|NCT04888585|564652885|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
156426161|NCT04888585|564652886|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
156426162|NCT04888585|564652887|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
156426163|NCT04888585|564652888|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156426164|NCT04888585|564652889|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156426165|NCT04888585|564652890|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156426166|NCT04888585|564652891|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156426167|NCT04888585|564652892|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156426168|NCT04888585|564652893|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156426169|NCT04888585|564652883|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156426170|NCT04888585|564652884|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
156426171|NCT04888585|564652885|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
156426172|NCT04888585|564652886|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
156426173|NCT04888585|564652887|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
156426174|NCT04888585|564652888|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156426175|NCT04888585|564652889|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156426176|NCT04888585|564652890|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156426177|NCT04888585|564652891|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156426178|NCT04888585|564652892|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156426179|NCT04888585|564652893|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156426180|NCT04888585|564652883|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426181|NCT04888585|564652884|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426182|NCT04888585|564652885|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
156426183|NCT04888585|564652886|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426184|NCT04888585|564652887|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
156426185|NCT04888585|564652888|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426186|NCT04888585|564652889|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426187|NCT04888585|564652890|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426188|NCT04888585|564652891|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426189|NCT04888585|564652892|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426190|NCT04888585|564652893|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156426191|NCT04888585|564652883|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426192|NCT04888585|564652884|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426193|NCT04888585|564652885|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426194|NCT04888585|564652886|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426195|NCT04888585|564652887|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426196|NCT04888585|564652888|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426197|NCT04888585|564652889|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426198|NCT04888585|564652890|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
156426199|NCT04888585|564652891|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426200|NCT04888585|564652892|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
156426201|NCT04888585|564652893|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
156426202|NCT04888585|564652883|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156655157|NCT00679783|565483905|FG005|Overall Study|Adverse Event|0|||
156655158|NCT00679783|565483906|FG006|Overall Study|Adverse Event|1|||
156655159|NCT00679783|565483900|FG000|Overall Study|Lack of Efficacy|0|||
156655160|NCT00679783|565483901|FG001|Overall Study|Lack of Efficacy|1|||
156655161|NCT00679783|565483902|FG002|Overall Study|Lack of Efficacy|0|||
156655162|NCT00679783|565483903|FG003|Overall Study|Lack of Efficacy|2|||
156655163|NCT00679783|565483904|FG004|Overall Study|Lack of Efficacy|0|||
156655164|NCT00679783|565483905|FG005|Overall Study|Lack of Efficacy|0|||
156655165|NCT00679783|565483906|FG006|Overall Study|Lack of Efficacy|0|||
156655166|NCT00679783|565483900|FG000|Overall Study|Withdrawal by Subject|0|||
156655167|NCT00679783|565483901|FG001|Overall Study|Withdrawal by Subject|0|||
156655168|NCT00679783|565483902|FG002|Overall Study|Withdrawal by Subject|1|||
156655169|NCT00679783|565483903|FG003|Overall Study|Withdrawal by Subject|1|||
156655170|NCT00679783|565483904|FG004|Overall Study|Withdrawal by Subject|0|||
156655171|NCT00679783|565483905|FG005|Overall Study|Withdrawal by Subject|0|||
156655172|NCT00679783|565483906|FG006|Overall Study|Withdrawal by Subject|0|||
156655173|NCT00679783|565483900|FG000|Overall Study|Not Captured|0|||
156655174|NCT00679783|565483901|FG001|Overall Study|Not Captured|0|||
156655175|NCT00679783|565483902|FG002|Overall Study|Not Captured|0|||
156655176|NCT00679783|565483903|FG003|Overall Study|Not Captured|5|||
156655177|NCT00679783|565483904|FG004|Overall Study|Not Captured|0|||
156655178|NCT00679783|565483905|FG005|Overall Study|Not Captured|0|||
156655179|NCT00679783|565483906|FG006|Overall Study|Not Captured|0|||
156655180|NCT00679783|565483900|FG000|Overall Study|Ongoing at data cut-off|2|||
156655181|NCT00679783|565483901|FG001|Overall Study|Ongoing at data cut-off|2|||
156655182|NCT00679783|565483902|FG002|Overall Study|Ongoing at data cut-off|0|||
156655183|NCT00679783|565483903|FG003|Overall Study|Ongoing at data cut-off|9|||
156655184|NCT00679783|565483904|FG004|Overall Study|Ongoing at data cut-off|1|||
156762786|NCT01418339|565884637|FG001|Overall Study|Subject Withdrew Consent|2|||
156762787|NCT01418339|565884636|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
156762788|NCT01418339|565884637|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
156762789|NCT02204917|565884640|FG000|Overall Study|Protocol Violation|1|||
156762790|NCT02219685|565884641|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
156762791|NCT02219685|565884642|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
156762792|NCT02219685|565884641|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
156762793|NCT02219685|565884642|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
156762794|NCT00698815|565884643|FG000|Overall Study|Death|1|||
156762795|NCT00698815|565884644|FG001|Overall Study|Death|2|||
156762796|NCT00698815|565884645|FG002|Overall Study|Death|4|||
156762797|NCT00698815|565884643|FG000|Overall Study|Withdrawal by Subject|6|||
156762798|NCT00698815|565884644|FG001|Overall Study|Withdrawal by Subject|3|||
156762799|NCT00698815|565884645|FG002|Overall Study|Withdrawal by Subject|2|||
156762800|NCT00698815|565884643|FG000|Overall Study|MD discretion|2|||
156762801|NCT00698815|565884644|FG001|Overall Study|MD discretion|7|||
156762802|NCT00698815|565884645|FG002|Overall Study|MD discretion|2|||
156762803|NCT00698815|565884643|FG000|Overall Study|Did not receive protocol treatment|1|||
156322208|NCT03954041|564278014|FG001|Overall Study|Reason not specified|4|||
156322209|NCT03954041|564278015|FG002|Overall Study|Reason not specified|2|||
156322210|NCT03954041|564278013|FG000|Overall Study|Withdrew prior to dosing|4|||
156322211|NCT03954041|564278014|FG001|Overall Study|Withdrew prior to dosing|2|||
156322212|NCT03954041|564278015|FG002|Overall Study|Withdrew prior to dosing|0|||
156322213|NCT04565236|564278018|FG000|Overall Study|Patient/Guardian Decision|0|||
156322214|NCT04565236|564278019|FG001|Overall Study|Patient/Guardian Decision|0|||
156322215|NCT04565236|564278020|FG002|Overall Study|Patient/Guardian Decision|1|||
156322216|NCT04565236|564278021|FG003|Overall Study|Patient/Guardian Decision|0|||
156322217|NCT00662532|564278022|FG000|Overall Study|Adverse Event|0|||
156322218|NCT00662532|564278023|FG001|Overall Study|Adverse Event|1|||
156322219|NCT00662532|564278022|FG000|Overall Study|Lost to Follow-up|0|||
156322220|NCT00662532|564278023|FG001|Overall Study|Lost to Follow-up|1|||
156322221|NCT00442468|564278027|FG000|Overall Study|Adverse Event|4|||
156322222|NCT00442468|564278027|FG000|Overall Study|Withdrawal by Subject|91|||
156322223|NCT00442468|564278027|FG000|Overall Study|Did not complete all study procedures|88|||
156322224|NCT00589784|564278028|FG000|Overall Study|Withdrawal by Subject|0|||
156322225|NCT00589784|564278029|FG001|Overall Study|Withdrawal by Subject|6|||
156322226|NCT00589784|564278028|FG000|Overall Study|Patient inevaluable|1|||
156322227|NCT00589784|564278029|FG001|Overall Study|Patient inevaluable|0|||
156322228|NCT00589784|564278028|FG000|Overall Study|Adverse Event|0|||
156322229|NCT00589784|564278029|FG001|Overall Study|Adverse Event|4|||
156322230|NCT00287079|564278031|FG000|Overall Study|Qualifying relapse|12|||
156322231|NCT00287079|564278032|FG001|Overall Study|Qualifying relapse|1|||
156322232|NCT00287079|564278031|FG000|Overall Study|Non-qualifying relapse|1|||
156322233|NCT00287079|564278032|FG001|Overall Study|Non-qualifying relapse|0|||
156322234|NCT00287079|564278031|FG000|Overall Study|Adverse Event|5|||
156322235|NCT00287079|564278032|FG001|Overall Study|Adverse Event|0|||
156322236|NCT00287079|564278031|FG000|Overall Study|Protocol Violation|1|||
156322237|NCT00287079|564278032|FG001|Overall Study|Protocol Violation|0|||
156322238|NCT00287079|564278031|FG000|Overall Study|Other|3|||
156322239|NCT00287079|564278032|FG001|Overall Study|Other|0|||
156322240|NCT00470184|564278033|FG000|Overall Study|Not Treated(became ineligible)|4|||
156322241|NCT00470184|564278033|FG000|Overall Study|Not treated (other)|1|||
156322242|NCT00470184|564278033|FG000|Overall Study|disease Progression|4|||
156322243|NCT00470184|564278033|FG000|Overall Study|Adverse Event|3|||
156322244|NCT00470184|564278033|FG000|Overall Study|Withdrawal by Subject|4|||
156322245|NCT00470184|564278033|FG000|Overall Study|other|5|||
156322246|NCT00470184|564278033|FG000|Overall Study|recurrence|1|||
156322247|NCT03882008|564278034|FG000|Overall Study|Withdrawal by Subject|1|||
156322248|NCT03882008|564278034|FG000|Overall Study|Lost to Follow-up|1|||
156322249|NCT01185834|564278035|FG000|Overall Study|Lost to Follow-up|2|||
156322250|NCT01185834|564278035|FG000|Overall Study|Discomfort|4|||
156322251|NCT01185834|564278035|FG000|Overall Study|Biomicroscopy|4|||
156322252|NCT01185834|564278035|FG000|Overall Study|Time/Job Conflict|2|||
156322253|NCT01185834|564278035|FG000|Overall Study|Early exit - Site error|2|||
156322254|NCT01401959|564278036|FG000|Enrolled|Withdrawal by Subject|1|||
156322255|NCT01401959|564278037|FG001|Enrolled|Withdrawal by Subject|0|||
156322256|NCT01401959|564278038|FG002|Enrolled|Withdrawal by Subject|0|||
156322257|NCT01401959|564278036|FG000|Treated|Disease Progression|2|||
156322258|NCT01401959|564278037|FG001|Treated|Disease Progression|2|||
156322259|NCT01401959|564278038|FG002|Treated|Disease Progression|1|||
156322260|NCT01401959|564278036|FG000|Treated|Adverse Event|4|||
156322261|NCT01401959|564278037|FG001|Treated|Adverse Event|3|||
156322262|NCT01401959|564278038|FG002|Treated|Adverse Event|2|||
156322263|NCT01401959|564278036|FG000|Treated|Withdrawal by Subject|1|||
156322264|NCT01401959|564278037|FG001|Treated|Withdrawal by Subject|2|||
156322265|NCT01401959|564278038|FG002|Treated|Withdrawal by Subject|2|||
156762804|NCT00698815|565884644|FG001|Overall Study|Did not receive protocol treatment|2|||
156762805|NCT00698815|565884645|FG002|Overall Study|Did not receive protocol treatment|2|||
156762806|NCT00731822|565884653|FG000|Overall Study|Adverse Event|2|||
156762807|NCT00731822|565884654|FG001|Overall Study|Adverse Event|1|||
156762808|NCT00731822|565884653|FG000|Overall Study|Protocol Violation|1|||
156762809|NCT00731822|565884654|FG001|Overall Study|Protocol Violation|0|||
156762810|NCT00731822|565884653|FG000|Overall Study|Lost to Follow-up|1|||
156762811|NCT00731822|565884654|FG001|Overall Study|Lost to Follow-up|0|||
156762812|NCT02127658|565884658|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
156762813|NCT02127658|565884659|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
156762814|NCT02127658|565884658|FG000|Overall Study|Withdrawal by Subject|0|||
156762815|NCT02127658|565884659|FG001|Overall Study|Withdrawal by Subject|2|||
156762816|NCT02127658|565884658|FG000|Overall Study|Physician Decision|0|||
156762817|NCT02127658|565884659|FG001|Overall Study|Physician Decision|1|||
156762818|NCT03834493|565884660|FG000|Overall Study|Participants Ongoing|311|||
156762819|NCT03834493|565884661|FG001|Overall Study|Participants Ongoing|324|||
156762820|NCT03834493|565884660|FG000|Overall Study|Withdrawal by Subject|20|||
156762821|NCT03834493|565884661|FG001|Overall Study|Withdrawal by Subject|17|||
156762822|NCT03834493|565884660|FG000|Overall Study|Physician Decision|1|||
156762823|NCT03834493|565884661|FG001|Overall Study|Physician Decision|0|||
156762824|NCT03834493|565884660|FG000|Overall Study|Death|289|||
156762825|NCT03834493|565884661|FG001|Overall Study|Death|282|||
156762826|NCT04003103|565884662|FG000|Overall Study|Death|1|||
156762827|NCT04003103|565884663|FG001|Overall Study|Death|0|||
156762828|NCT04003103|565884664|FG002|Overall Study|Death|0|||
156762829|NCT04003103|565884662|FG000|Overall Study|Lost to Follow-up|4|||
156762830|NCT04003103|565884663|FG001|Overall Study|Lost to Follow-up|3|||
156762831|NCT04003103|565884664|FG002|Overall Study|Lost to Follow-up|2|||
156762832|NCT04003103|565884662|FG000|Overall Study|Withdrawal by Subject|10|||
156762833|NCT04003103|565884663|FG001|Overall Study|Withdrawal by Subject|1|||
156762834|NCT04003103|565884664|FG002|Overall Study|Withdrawal by Subject|1|||
156762835|NCT04003103|565884662|FG000|Overall Study|Status not recorded|0|||
156762836|NCT04003103|565884663|FG001|Overall Study|Status not recorded|2|||
156762837|NCT04003103|565884664|FG002|Overall Study|Status not recorded|0|||
156762838|NCT04144322|565884668|FG000|Overall Study|Lack of Efficacy|2|||
156762839|NCT04144322|565884669|FG001|Overall Study|Lack of Efficacy|2|||
156762840|NCT02277028|565884670|FG000|Overall Study|Lost to Follow-up|1|||
156762841|NCT02277028|565884671|FG001|Overall Study|Lost to Follow-up|0|||
156762842|NCT02277028|565884670|FG000|Overall Study|Withdrawal by Subject|0|||
156762843|NCT02277028|565884671|FG001|Overall Study|Withdrawal by Subject|1|||
156762844|NCT02718911|565884672|FG000|Overall Study|Adverse Event|0|||
156762845|NCT02718911|565884673|FG001|Overall Study|Adverse Event|0|||
156762846|NCT02718911|565884674|FG002|Overall Study|Adverse Event|0|||
156762847|NCT02718911|565884675|FG003|Overall Study|Adverse Event|0|||
156762848|NCT02718911|565884676|FG004|Overall Study|Adverse Event|0|||
156762849|NCT02718911|565884677|FG005|Overall Study|Adverse Event|0|||
156762850|NCT02718911|565884678|FG006|Overall Study|Adverse Event|0|||
156762851|NCT02718911|565884679|FG007|Overall Study|Adverse Event|0|||
156762852|NCT02718911|565884680|FG008|Overall Study|Adverse Event|0|||
156762853|NCT02718911|565884681|FG009|Overall Study|Adverse Event|2|||
156762854|NCT02718911|565884672|FG000|Overall Study|Death|2|||
156762855|NCT02718911|565884673|FG001|Overall Study|Death|3|||
156762856|NCT02718911|565884674|FG002|Overall Study|Death|1|||
156762857|NCT02718911|565884675|FG003|Overall Study|Death|0|||
156762858|NCT02718911|565884676|FG004|Overall Study|Death|1|||
156762859|NCT02718911|565884677|FG005|Overall Study|Death|3|||
156762860|NCT02718911|565884678|FG006|Overall Study|Death|1|||
156762861|NCT02718911|565884679|FG007|Overall Study|Death|1|||
156762862|NCT02718911|565884680|FG008|Overall Study|Death|4|||
156762863|NCT02718911|565884681|FG009|Overall Study|Death|3|||
156762864|NCT02718911|565884672|FG000|Overall Study|Lost to Follow-up|0|||
156762865|NCT02718911|565884673|FG001|Overall Study|Lost to Follow-up|0|||
156762866|NCT02718911|565884674|FG002|Overall Study|Lost to Follow-up|0|||
156762867|NCT02718911|565884675|FG003|Overall Study|Lost to Follow-up|0|||
156762868|NCT02718911|565884676|FG004|Overall Study|Lost to Follow-up|0|||
156762869|NCT02718911|565884677|FG005|Overall Study|Lost to Follow-up|0|||
156762870|NCT02718911|565884678|FG006|Overall Study|Lost to Follow-up|0|||
156762871|NCT02718911|565884679|FG007|Overall Study|Lost to Follow-up|0|||
156762872|NCT02718911|565884680|FG008|Overall Study|Lost to Follow-up|1|||
156762873|NCT02718911|565884681|FG009|Overall Study|Lost to Follow-up|0|||
156762874|NCT02718911|565884672|FG000|Overall Study|Physician Decision|2|||
156762875|NCT02718911|565884673|FG001|Overall Study|Physician Decision|0|||
156762876|NCT02718911|565884674|FG002|Overall Study|Physician Decision|1|||
156762877|NCT02718911|565884675|FG003|Overall Study|Physician Decision|1|||
156762878|NCT02718911|565884676|FG004|Overall Study|Physician Decision|0|||
156762879|NCT02718911|565884677|FG005|Overall Study|Physician Decision|0|||
156762880|NCT02718911|565884678|FG006|Overall Study|Physician Decision|0|||
156762881|NCT02718911|565884679|FG007|Overall Study|Physician Decision|1|||
156762882|NCT02718911|565884680|FG008|Overall Study|Physician Decision|2|||
156762883|NCT02718911|565884681|FG009|Overall Study|Physician Decision|1|||
156762884|NCT02718911|565884672|FG000|Overall Study|Withdrawal by Subject|0|||
156762885|NCT02718911|565884673|FG001|Overall Study|Withdrawal by Subject|0|||
156762886|NCT02718911|565884674|FG002|Overall Study|Withdrawal by Subject|0|||
156762887|NCT02718911|565884675|FG003|Overall Study|Withdrawal by Subject|0|||
156426203|NCT04888585|564652884|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156655185|NCT00679783|565483905|FG005|Overall Study|Ongoing at data cut-off|0|||
156655186|NCT00679783|565483906|FG006|Overall Study|Ongoing at data cut-off|0|||
156655187|NCT01485536|565483909|FG000|Overall Study|Withdrawal by Subject|3|||
156426204|NCT04888585|564652885|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156655188|NCT01485536|565483909|FG000|Overall Study|Adverse Event|1|||
156655189|NCT02626949|565483910|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
156655190|NCT02626949|565483911|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
156655191|NCT02626949|565483910|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
156655192|NCT02626949|565483911|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
156655193|NCT02626949|565483910|FG000|Enrolled|Lost to Follow-up|7|||
156655194|NCT02626949|565483911|FG001|Enrolled|Lost to Follow-up|6|||
156655195|NCT02626949|565483910|FG000|Enrolled|Withdrawal by Subject|3|||
156655196|NCT02626949|565483911|FG001|Enrolled|Withdrawal by Subject|2|||
156655197|NCT00673790|565483912|FG000|Overall Study|Adverse Event|23|||
156655198|NCT00673790|565483913|FG001|Overall Study|Adverse Event|14|||
156655199|NCT00673790|565483914|FG002|Overall Study|Adverse Event|2|||
156655200|NCT00673790|565483912|FG000|Overall Study|Lack of Efficacy|2|||
156655201|NCT00673790|565483913|FG001|Overall Study|Lack of Efficacy|2|||
156655202|NCT00673790|565483914|FG002|Overall Study|Lack of Efficacy|2|||
156655203|NCT00673790|565483912|FG000|Overall Study|Protocol Violation|6|||
156655204|NCT00673790|565483913|FG001|Overall Study|Protocol Violation|9|||
156655205|NCT00673790|565483914|FG002|Overall Study|Protocol Violation|1|||
156655206|NCT00673790|565483912|FG000|Overall Study|Withdrawal by Subject|7|||
156655207|NCT00673790|565483913|FG001|Overall Study|Withdrawal by Subject|4|||
156655208|NCT00673790|565483914|FG002|Overall Study|Withdrawal by Subject|1|||
156655209|NCT00673790|565483912|FG000|Overall Study|Lost to Follow-up|6|||
156655210|NCT00673790|565483913|FG001|Overall Study|Lost to Follow-up|6|||
156655211|NCT00673790|565483914|FG002|Overall Study|Lost to Follow-up|5|||
156655212|NCT00673790|565483912|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
156655213|NCT00673790|565483913|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
156655214|NCT00673790|565483914|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
156655215|NCT00673790|565483912|FG000|Overall Study|Poor compliance|1|||
156655216|NCT00673790|565483913|FG001|Overall Study|Poor compliance|0|||
156655217|NCT00673790|565483914|FG002|Overall Study|Poor compliance|0|||
156655218|NCT00673790|565483912|FG000|Overall Study|Participated in two Nebivolol studies|0|||
156655219|NCT00673790|565483913|FG001|Overall Study|Participated in two Nebivolol studies|0|||
156655220|NCT00673790|565483914|FG002|Overall Study|Participated in two Nebivolol studies|1|||
156655221|NCT00673790|565483912|FG000|Overall Study|Unconfirmed pregnancy|0|||
156655222|NCT00673790|565483913|FG001|Overall Study|Unconfirmed pregnancy|1|||
156655223|NCT00673790|565483914|FG002|Overall Study|Unconfirmed pregnancy|0|||
156655224|NCT00673790|565483912|FG000|Overall Study|Randomization criteria not met|0|||
156655225|NCT00673790|565483913|FG001|Overall Study|Randomization criteria not met|1|||
156655226|NCT00673790|565483914|FG002|Overall Study|Randomization criteria not met|0|||
156655227|NCT00306384|565483915|FG000|Overall Study|Adverse Event|103|||
156655228|NCT00306384|565483916|FG001|Overall Study|Adverse Event|87|||
156655229|NCT00306384|565483917|FG002|Overall Study|Adverse Event|40|||
156655230|NCT00306384|565483915|FG000|Overall Study|Major protocol deviation|43|||
156655231|NCT00306384|565483916|FG001|Overall Study|Major protocol deviation|51|||
156655232|NCT00306384|565483917|FG002|Overall Study|Major protocol deviation|18|||
156655233|NCT00306384|565483915|FG000|Overall Study|Lost to Follow-up|57|||
156655234|NCT00306384|565483916|FG001|Overall Study|Lost to Follow-up|41|||
156655235|NCT00306384|565483917|FG002|Overall Study|Lost to Follow-up|35|||
156655236|NCT00306384|565483915|FG000|Overall Study|Voluntary withdrawal|199|||
156655237|NCT00306384|565483916|FG001|Overall Study|Voluntary withdrawal|187|||
156655238|NCT00306384|565483917|FG002|Overall Study|Voluntary withdrawal|91|||
156655239|NCT00306384|565483915|FG000|Overall Study|Study termination|1|||
156655240|NCT00306384|565483916|FG001|Overall Study|Study termination|0|||
156655241|NCT00306384|565483917|FG002|Overall Study|Study termination|1|||
156655242|NCT00306384|565483915|FG000|Overall Study|Pregnancy|3|||
156655243|NCT00306384|565483916|FG001|Overall Study|Pregnancy|1|||
156655244|NCT00306384|565483917|FG002|Overall Study|Pregnancy|1|||
156655245|NCT00306384|565483915|FG000|Overall Study|Lack of Efficacy|26|||
156655246|NCT00306384|565483916|FG001|Overall Study|Lack of Efficacy|40|||
156655247|NCT00306384|565483917|FG002|Overall Study|Lack of Efficacy|38|||
156655248|NCT00306384|565483915|FG000|Overall Study|Investigator discretion|28|||
156655249|NCT00306384|565483916|FG001|Overall Study|Investigator discretion|31|||
156655250|NCT00306384|565483917|FG002|Overall Study|Investigator discretion|21|||
156655251|NCT00306384|565483915|FG000|Overall Study|Other|80|||
156655252|NCT00306384|565483916|FG001|Overall Study|Other|70|||
156655253|NCT00306384|565483917|FG002|Overall Study|Other|32|||
156655254|NCT00306384|565483915|FG000|Overall Study|Site closure|2|||
156655255|NCT00306384|565483916|FG001|Overall Study|Site closure|0|||
156655256|NCT00306384|565483917|FG002|Overall Study|Site closure|0|||
156655257|NCT00601484|565483918|FG000|Overall Study|Adverse Event|0|||
156655258|NCT00601484|565483919|FG001|Overall Study|Adverse Event|1|||
156762888|NCT02718911|565884676|FG004|Overall Study|Withdrawal by Subject|1|||
156762889|NCT02718911|565884677|FG005|Overall Study|Withdrawal by Subject|0|||
156762890|NCT02718911|565884678|FG006|Overall Study|Withdrawal by Subject|0|||
156762891|NCT02718911|565884679|FG007|Overall Study|Withdrawal by Subject|0|||
156762892|NCT02718911|565884680|FG008|Overall Study|Withdrawal by Subject|1|||
156762893|NCT02718911|565884681|FG009|Overall Study|Withdrawal by Subject|4|||
156762894|NCT02718911|565884672|FG000|Overall Study|Reason Not Collected|0|||
156762895|NCT02718911|565884673|FG001|Overall Study|Reason Not Collected|0|||
156762896|NCT02718911|565884674|FG002|Overall Study|Reason Not Collected|1|||
156762897|NCT02718911|565884675|FG003|Overall Study|Reason Not Collected|0|||
156762898|NCT02718911|565884676|FG004|Overall Study|Reason Not Collected|0|||
156762899|NCT02718911|565884677|FG005|Overall Study|Reason Not Collected|0|||
156762900|NCT02718911|565884678|FG006|Overall Study|Reason Not Collected|2|||
156762901|NCT02718911|565884679|FG007|Overall Study|Reason Not Collected|1|||
156762902|NCT02718911|565884680|FG008|Overall Study|Reason Not Collected|4|||
156762903|NCT02718911|565884681|FG009|Overall Study|Reason Not Collected|9|||
156762904|NCT04817332|565884682|FG000|Overall Study|Lost to Follow-up|3|||
156762905|NCT04817332|565884683|FG001|Overall Study|Lost to Follow-up|3|||
156762906|NCT04817332|565884682|FG000|Overall Study|Protocol Violation|2|||
156762907|NCT04817332|565884683|FG001|Overall Study|Protocol Violation|0|||
156762908|NCT01867008|565884684|FG000|Overall Study|Withdrawal by Subject|1|||
156762909|NCT00983372|565884685|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
156762910|NCT00983372|565884685|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
156762911|NCT00983372|565884685|FG000|Diltiazem ER Alone|Adverse Event|1|||
156762912|NCT05635045|565884686|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
156762913|NCT05635045|565884687|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
156762914|NCT05635045|565884688|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
156762915|NCT05635045|565884689|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
156762916|NCT00570401|565884704|FG000|Overall Study|Adverse Event|2|||
156762917|NCT00871234|565884705|FG000|Overall Study|Adverse Event|2|||
156762918|NCT00871234|565884705|FG000|Overall Study|Lost to Follow-up|3|||
156762919|NCT00427908|565884706|FG000|Primary Phase|Lost to Follow-up|4|||
156762920|NCT00427908|565884707|FG001|Primary Phase|Lost to Follow-up|0|||
156762921|NCT00427908|565884708|FG002|Primary Phase|Lost to Follow-up|2|||
156762922|NCT00427908|565884709|FG003|Primary Phase|Lost to Follow-up|0|||
156762923|NCT00427908|565884706|FG000|Primary Phase|Withdrawal by Subject|1|||
156762924|NCT00427908|565884707|FG001|Primary Phase|Withdrawal by Subject|2|||
156762925|NCT00427908|565884708|FG002|Primary Phase|Withdrawal by Subject|1|||
156762926|NCT00427908|565884709|FG003|Primary Phase|Withdrawal by Subject|0|||
156762927|NCT00427908|565884706|FG000|Primary Phase|Adverse Event|0|||
156762928|NCT00427908|565884707|FG001|Primary Phase|Adverse Event|1|||
156762929|NCT00427908|565884708|FG002|Primary Phase|Adverse Event|0|||
156762930|NCT00427908|565884709|FG003|Primary Phase|Adverse Event|0|||
156762931|NCT01710020|565884710|FG000|Period 1|Protocol Violation|1|||
156762932|NCT01764841|565884711|FG000|Overall Study|Logistical Difficulties|0|||
156762933|NCT01764841|565884712|FG001|Overall Study|Logistical Difficulties|1|||
156762934|NCT01764841|565884713|FG002|Overall Study|Logistical Difficulties|0|||
156762935|NCT01764841|565884714|FG003|Overall Study|Logistical Difficulties|0|||
156762936|NCT01764841|565884711|FG000|Overall Study|Death|3|||
156762937|NCT01764841|565884712|FG001|Overall Study|Death|0|||
156762938|NCT01764841|565884713|FG002|Overall Study|Death|1|||
156762939|NCT01764841|565884714|FG003|Overall Study|Death|4|||
156762940|NCT01764841|565884711|FG000|Overall Study|No Follow Up|1|||
156762941|NCT01764841|565884712|FG001|Overall Study|No Follow Up|0|||
156762942|NCT01764841|565884713|FG002|Overall Study|No Follow Up|1|||
156762943|NCT01764841|565884714|FG003|Overall Study|No Follow Up|0|||
156762944|NCT01764841|565884711|FG000|Overall Study|Protocol Violation|0|||
156322266|NCT01401959|564278036|FG000|Treated|Protocol Violation|0|||
156322267|NCT01401959|564278037|FG001|Treated|Protocol Violation|1|||
156322268|NCT01401959|564278038|FG002|Treated|Protocol Violation|0|||
156322269|NCT02694718|564278043|FG000|Overall Study|Death|1|||
156322270|NCT02694718|564278043|FG000|Overall Study|Withdrawal by Subject|1|||
156322271|NCT00322153|564278044|FG000|Overall Study|Adverse Event|21|||
156322272|NCT00322153|564278045|FG001|Overall Study|Adverse Event|34|||
156322273|NCT00322153|564278044|FG000|Overall Study|Protocol Violation|6|||
156322274|NCT00322153|564278045|FG001|Overall Study|Protocol Violation|14|||
156322275|NCT00322153|564278044|FG000|Overall Study|Withdrawal by Subject|18|||
156762945|NCT01764841|565884712|FG001|Overall Study|Protocol Violation|1|||
156762946|NCT01764841|565884713|FG002|Overall Study|Protocol Violation|0|||
156762947|NCT01764841|565884714|FG003|Overall Study|Protocol Violation|0|||
156762948|NCT01764841|565884711|FG000|Overall Study|Withdrawal by Subject|16|||
156762949|NCT01764841|565884712|FG001|Overall Study|Withdrawal by Subject|24|||
156762950|NCT01764841|565884713|FG002|Overall Study|Withdrawal by Subject|11|||
156762951|NCT01764841|565884714|FG003|Overall Study|Withdrawal by Subject|15|||
156762952|NCT01764841|565884711|FG000|Overall Study|Lost to Follow-up|3|||
156762953|NCT01764841|565884712|FG001|Overall Study|Lost to Follow-up|0|||
156762954|NCT01764841|565884713|FG002|Overall Study|Lost to Follow-up|1|||
156762955|NCT01764841|565884714|FG003|Overall Study|Lost to Follow-up|0|||
156762956|NCT02573259|565884720|FG000|Overall Study|Death|1|||
156762957|NCT02573259|565884721|FG001|Overall Study|Death|6|||
156762958|NCT02573259|565884722|FG002|Overall Study|Death|5|||
156762959|NCT02573259|565884723|FG003|Overall Study|Death|6|||
156762960|NCT02573259|565884724|FG004|Overall Study|Death|9|||
156762961|NCT02573259|565884725|FG005|Overall Study|Death|32|||
156762962|NCT02573259|565884726|FG006|Overall Study|Death|21|||
156762963|NCT02573259|565884720|FG000|Overall Study|Lost to Follow-up|0|||
156762964|NCT02573259|565884721|FG001|Overall Study|Lost to Follow-up|0|||
156762965|NCT02573259|565884722|FG002|Overall Study|Lost to Follow-up|0|||
156762966|NCT02573259|565884723|FG003|Overall Study|Lost to Follow-up|0|||
156762967|NCT02573259|565884724|FG004|Overall Study|Lost to Follow-up|0|||
156762968|NCT02573259|565884725|FG005|Overall Study|Lost to Follow-up|2|||
156762969|NCT02573259|565884726|FG006|Overall Study|Lost to Follow-up|1|||
156762970|NCT02573259|565884720|FG000|Overall Study|Participant refused further follow-up|0|||
156762971|NCT02573259|565884721|FG001|Overall Study|Participant refused further follow-up|2|||
156762972|NCT02573259|565884722|FG002|Overall Study|Participant refused further follow-up|1|||
156762973|NCT02573259|565884723|FG003|Overall Study|Participant refused further follow-up|0|||
156762974|NCT02573259|565884724|FG004|Overall Study|Participant refused further follow-up|3|||
156762975|NCT02573259|565884725|FG005|Overall Study|Participant refused further follow-up|20|||
156762976|NCT02573259|565884726|FG006|Overall Study|Participant refused further follow-up|7|||
156762977|NCT02573259|565884720|FG000|Overall Study|Other|0|||
156762978|NCT02573259|565884721|FG001|Overall Study|Other|0|||
156762979|NCT02573259|565884722|FG002|Overall Study|Other|0|||
156762980|NCT02573259|565884723|FG003|Overall Study|Other|0|||
156762981|NCT02573259|565884724|FG004|Overall Study|Other|1|||
156762982|NCT02573259|565884725|FG005|Overall Study|Other|4|||
156762983|NCT02573259|565884726|FG006|Overall Study|Other|5|||
156762984|NCT00751140|565884730|FG000|Overall Study|benign angioma excluded from analysis|1|||
156762985|NCT03160716|565884731|FG000|Overall Study|Lost to Follow-up|1|||
156762986|NCT01628848|565884732|FG000|Overall Study|Adverse Event|9|||
156762987|NCT01628848|565884733|FG001|Overall Study|Adverse Event|7|||
156762988|NCT01628848|565884732|FG000|Overall Study|Lack of Efficacy|0|||
156762989|NCT01628848|565884733|FG001|Overall Study|Lack of Efficacy|4|||
156762990|NCT01628848|565884732|FG000|Overall Study|Withdrawal by Subject|0|||
156762991|NCT01628848|565884733|FG001|Overall Study|Withdrawal by Subject|2|||
156762992|NCT01628848|565884732|FG000|Overall Study|Physician Decision|3|||
156762993|NCT01628848|565884733|FG001|Overall Study|Physician Decision|1|||
156762994|NCT00689338|565884735|FG000|Overall Study|Death|65|||
156762995|NCT00689338|565884735|FG000|Overall Study|Adverse Event|13|||
156762996|NCT00689338|565884735|FG000|Overall Study|Insufficient Clinical Response|1|||
156762997|NCT00689338|565884735|FG000|Overall Study|Lack of Efficacy|6|||
156762998|NCT00689338|565884735|FG000|Overall Study|Other|8|||
156762999|NCT00689338|565884735|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
156763000|NCT00689338|565884735|FG000|Overall Study|Lost to Follow-up|5|||
156763001|NCT00689338|565884735|FG000|Overall Study|Withdrawal by Subject|3|||
156763002|NCT00689338|565884735|FG000|Overall Study|Protocol Violation|15|||
156763003|NCT00808067|565884736|FG000|Overall Study|Major/minor bleed|30|||
156763004|NCT00808067|565884737|FG001|Overall Study|Major/minor bleed|44|||
156763005|NCT00808067|565884736|FG000|Overall Study|Outcome event - other|33|||
156763006|NCT00808067|565884737|FG001|Overall Study|Outcome event - other|25|||
156763007|NCT00808067|565884736|FG000|Overall Study|Adverse Event|111|||
156763008|NCT00808067|565884737|FG001|Overall Study|Adverse Event|121|||
156763009|NCT00808067|565884736|FG000|Overall Study|Hospitalization (not including surgery)|18|||
156763010|NCT00808067|565884737|FG001|Overall Study|Hospitalization (not including surgery)|17|||
156763011|NCT00808067|565884736|FG000|Overall Study|Hospitalization due to surgery|37|||
156763012|NCT00808067|565884737|FG001|Overall Study|Hospitalization due to surgery|40|||
156763013|NCT00808067|565884736|FG000|Overall Study|Reduced creatinine clearance|53|||
156763014|NCT00808067|565884737|FG001|Overall Study|Reduced creatinine clearance|55|||
156763015|NCT00808067|565884736|FG000|Overall Study|Elevated LFT results|7|||
156763016|NCT00808067|565884737|FG001|Overall Study|Elevated LFT results|3|||
156763017|NCT00808067|565884736|FG000|Overall Study|Patient refused to take study medication|65|||
156763018|NCT00808067|565884737|FG001|Overall Study|Patient refused to take study medication|76|||
156763019|NCT00808067|565884736|FG000|Overall Study|Missing|1|||
156763020|NCT00808067|565884737|FG001|Overall Study|Missing|0|||
156763021|NCT00808067|565884736|FG000|Overall Study|Death|1|||
156763022|NCT00808067|565884737|FG001|Overall Study|Death|1|||
156763023|NCT00808067|565884736|FG000|Overall Study|Procedure|6|||
156763024|NCT00808067|565884737|FG001|Overall Study|Procedure|7|||
156763025|NCT00808067|565884736|FG000|Overall Study|Withdrawal by Subject|21|||
156763026|NCT00808067|565884737|FG001|Overall Study|Withdrawal by Subject|25|||
156763027|NCT00808067|565884736|FG000|Overall Study|Site closed|4|||
156763028|NCT00808067|565884737|FG001|Overall Study|Site closed|3|||
156763029|NCT00808067|565884736|FG000|Overall Study|Physician Decision|47|||
156763030|NCT00808067|565884737|FG001|Overall Study|Physician Decision|38|||
156763031|NCT00808067|565884736|FG000|Overall Study|Protocol Violation|3|||
156763032|NCT00808067|565884737|FG001|Overall Study|Protocol Violation|11|||
156763033|NCT00808067|565884736|FG000|Overall Study|Patient elected|7|||
156763034|NCT00808067|565884737|FG001|Overall Study|Patient elected|9|||
156763035|NCT00808067|565884736|FG000|Overall Study|Site closed for cause|19|||
156763036|NCT00808067|565884737|FG001|Overall Study|Site closed for cause|19|||
156763037|NCT00808067|565884736|FG000|Overall Study|Other reason not defined above|5|||
156763038|NCT00808067|565884737|FG001|Overall Study|Other reason not defined above|5|||
156763039|NCT00808067|565884736|FG000|Overall Study|Excluded from analysis|13|||
156763040|NCT00808067|565884737|FG001|Overall Study|Excluded from analysis|19|||
156763041|NCT01939314|565884738|FG000|Overall Study|Withdrawal by Subject|3|||
156763042|NCT01939314|565884739|FG001|Overall Study|Withdrawal by Subject|1|||
156763043|NCT01939314|565884738|FG000|Overall Study|Protocol Violation|1|||
156763044|NCT01939314|565884739|FG001|Overall Study|Protocol Violation|0|||
156763045|NCT01939314|565884738|FG000|Overall Study|Pregnancy|0|||
156763046|NCT01939314|565884739|FG001|Overall Study|Pregnancy|1|||
156763047|NCT01939314|565884738|FG000|Overall Study|Lost to Follow-up|5|||
156763048|NCT01939314|565884739|FG001|Overall Study|Lost to Follow-up|6|||
156763049|NCT02104895|565884742|FG000|Overall Study|Withdrawal by Subject|0|||
156763050|NCT02104895|565884743|FG001|Overall Study|Withdrawal by Subject|14|||
156763051|NCT00969228|565884744|FG000|Overall Study|Adverse Event|1|||
156763052|NCT00969228|565884745|FG001|Overall Study|Adverse Event|0|||
156763053|NCT00969228|565884744|FG000|Overall Study|Withdrawal by Subject|4|||
156763054|NCT00969228|565884745|FG001|Overall Study|Withdrawal by Subject|0|||
156763055|NCT00969228|565884744|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
156763056|NCT00969228|565884745|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
156763057|NCT03311945|565884754|FG000|Overall Study|Adverse Event|2|||
156763058|NCT03311945|565884754|FG000|Overall Study|Lack of Efficacy|1|||
156763059|NCT01107925|565884755|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
156763060|NCT01107925|565884756|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
156763061|NCT01107925|565884757|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
156763062|NCT01107925|565884758|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
156763063|NCT01107925|565884759|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
156763064|NCT01107925|565884760|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
156763065|NCT01107925|565884755|FG000|Period 2|Withdrawal by Subject|0|||
156763066|NCT01107925|565884756|FG001|Period 2|Withdrawal by Subject|1|||
156763067|NCT01107925|565884757|FG002|Period 2|Withdrawal by Subject|0|||
156763068|NCT01107925|565884758|FG003|Period 2|Withdrawal by Subject|0|||
156763069|NCT01107925|565884759|FG004|Period 2|Withdrawal by Subject|0|||
156763070|NCT01107925|565884760|FG005|Period 2|Withdrawal by Subject|1|||
156763071|NCT04877990|565884761|FG000|Treatment|Other reasons|3|||
156763072|NCT04877990|565884762|FG001|Treatment|Other reasons|1|||
156763073|NCT04877990|565884761|FG000|Treatment|Administrative reasons by sponsor|17|||
156763074|NCT04877990|565884762|FG001|Treatment|Administrative reasons by sponsor|33|||
156763075|NCT04877990|565884761|FG000|Treatment|Withdrawal by Subject|2|||
156763076|NCT04877990|565884762|FG001|Treatment|Withdrawal by Subject|6|||
156763077|NCT04877990|565884761|FG000|Treatment|Adverse Event|2|||
156763078|NCT04877990|565884762|FG001|Treatment|Adverse Event|1|||
156763079|NCT04235504|565884763|FG000|Study Phase|Withdrawal by Subject|5|||
156763080|NCT04235504|565884764|FG001|Study Phase|Withdrawal by Subject|2|||
156763081|NCT04235504|565884765|FG002|Study Phase|Withdrawal by Subject|0|||
156763082|NCT04235504|565884766|FG003|Study Phase|Withdrawal by Subject|0|||
156763083|NCT04235504|565884763|FG000|Continuation Phase|Withdrawal by Subject|0|||
156763084|NCT04235504|565884764|FG001|Continuation Phase|Withdrawal by Subject|4|||
156763085|NCT04235504|565884765|FG002|Continuation Phase|Withdrawal by Subject|0|||
156763086|NCT04235504|565884766|FG003|Continuation Phase|Withdrawal by Subject|0|||
156763087|NCT04235504|565884763|FG000|Continuation Phase|Adverse Event|0|||
156763088|NCT04235504|565884764|FG001|Continuation Phase|Adverse Event|1|||
156763089|NCT04235504|565884765|FG002|Continuation Phase|Adverse Event|0|||
156763090|NCT04235504|565884766|FG003|Continuation Phase|Adverse Event|0|||
156763091|NCT04235504|565884763|FG000|Continuation Phase|Physician Decision|1|||
156763092|NCT04235504|565884764|FG001|Continuation Phase|Physician Decision|2|||
156763093|NCT04235504|565884765|FG002|Continuation Phase|Physician Decision|1|||
156763094|NCT04235504|565884766|FG003|Continuation Phase|Physician Decision|0|||
156763095|NCT02532283|565884770|FG000|Overall Study|Adverse Event|0|||
156763096|NCT02532283|565884771|FG001|Overall Study|Adverse Event|1|||
156763097|NCT02532283|565884770|FG000|Overall Study|Death|1|||
156763098|NCT02532283|565884771|FG001|Overall Study|Death|0|||
156763099|NCT02532283|565884770|FG000|Overall Study|Lost to Follow-up|0|||
156763100|NCT02532283|565884771|FG001|Overall Study|Lost to Follow-up|1|||
156763101|NCT02532283|565884770|FG000|Overall Study|Withdrawal by Subject|8|||
156763102|NCT02532283|565884771|FG001|Overall Study|Withdrawal by Subject|3|||
156763103|NCT01945944|565884772|FG000|Overall Study|Adverse Event|0|||
156763104|NCT01945944|565884773|FG001|Overall Study|Adverse Event|2|||
156763105|NCT01945944|565884772|FG000|Overall Study|Physician Decision|1|||
156763106|NCT01945944|565884773|FG001|Overall Study|Physician Decision|0|||
156763107|NCT01945944|565884772|FG000|Overall Study|Withdrawal by Subject|0|||
156763108|NCT01945944|565884773|FG001|Overall Study|Withdrawal by Subject|1|||
156763109|NCT01817075|565884774|FG000|Overall Study|Adverse Event|7|||
156763110|NCT01817075|565884775|FG001|Overall Study|Adverse Event|5|||
156763111|NCT01817075|565884774|FG000|Overall Study|Physician Decision|9|||
156763112|NCT01817075|565884775|FG001|Overall Study|Physician Decision|12|||
156763113|NCT01817075|565884774|FG000|Overall Study|Withdrawal by Subject|31|||
156763114|NCT01817075|565884775|FG001|Overall Study|Withdrawal by Subject|15|||
156763115|NCT01817075|565884774|FG000|Overall Study|Received Sorafenib after enrollment|0|||
156763116|NCT01817075|565884775|FG001|Overall Study|Received Sorafenib after enrollment|1|||
156763117|NCT01817075|565884774|FG000|Overall Study|Ineligible|0|||
156763118|NCT01817075|565884775|FG001|Overall Study|Ineligible|2|||
156763119|NCT04376515|565884778|FG000|Overall Study|Found to have been vaccinated before study start|6|||
156763120|NCT04376515|565884779|FG001|Overall Study|Found to have been vaccinated before study start|6|||
156763121|NCT03811821|565884780|FG000|Overall Study|Adverse Event|1|||
156763122|NCT03811821|565884781|FG001|Overall Study|Adverse Event|1|||
156763123|NCT03811821|565884780|FG000|Overall Study|Withdrawal by Subject|5|||
156763124|NCT03811821|565884781|FG001|Overall Study|Withdrawal by Subject|4|||
156763125|NCT03811821|565884780|FG000|Overall Study|Lost to Follow-up|2|||
156763126|NCT03811821|565884781|FG001|Overall Study|Lost to Follow-up|2|||
156763127|NCT03811821|565884780|FG000|Overall Study|Contraindication for treatment|0|||
156763128|NCT03811821|565884781|FG001|Overall Study|Contraindication for treatment|1|||
156763129|NCT03811821|565884780|FG000|Overall Study|Tolerability|0|||
156763130|NCT03811821|565884781|FG001|Overall Study|Tolerability|3|||
156763131|NCT03811821|565884780|FG000|Overall Study|Comorbidities|0|||
156763132|NCT03811821|565884781|FG001|Overall Study|Comorbidities|2|||
156763133|NCT01395810|565884784|FG000|Overall Study|Adverse Event|0|||
156763134|NCT01395810|565884785|FG001|Overall Study|Adverse Event|1|||
156763135|NCT01395810|565884786|FG002|Overall Study|Adverse Event|0|||
156763136|NCT01395810|565884787|FG003|Overall Study|Adverse Event|0|||
156763137|NCT01395810|565884784|FG000|Overall Study|Lack of Efficacy|0|||
156763138|NCT01395810|565884785|FG001|Overall Study|Lack of Efficacy|1|||
156763139|NCT01395810|565884786|FG002|Overall Study|Lack of Efficacy|0|||
156763140|NCT01395810|565884787|FG003|Overall Study|Lack of Efficacy|0|||
156763141|NCT01395810|565884784|FG000|Overall Study|Withdrawal criteria|0|||
156763142|NCT01395810|565884785|FG001|Overall Study|Withdrawal criteria|2|||
156763143|NCT01395810|565884786|FG002|Overall Study|Withdrawal criteria|0|||
156763144|NCT01395810|565884787|FG003|Overall Study|Withdrawal criteria|0|||
156763145|NCT01395810|565884784|FG000|Overall Study|Unclassified|2|||
156763146|NCT01395810|565884785|FG001|Overall Study|Unclassified|0|||
156763147|NCT01395810|565884786|FG002|Overall Study|Unclassified|0|||
156763148|NCT01395810|565884787|FG003|Overall Study|Unclassified|0|||
156763149|NCT01496976|565886291|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
156763150|NCT04579380|565886292|FG000|Overall Study|Death|9|||
156763151|NCT04579380|565886293|FG001|Overall Study|Death|22|||
156763152|NCT04579380|565886294|FG002|Overall Study|Death|22|||
156763153|NCT04579380|565886295|FG003|Overall Study|Death|17|||
156763154|NCT04579380|565886296|FG004|Overall Study|Death|6|||
156763155|NCT04579380|565886297|FG005|Overall Study|Death|21|||
156763156|NCT04579380|565886298|FG006|Overall Study|Death|10|||
156763157|NCT04579380|565886299|FG007|Overall Study|Death|11|||
156763158|NCT04579380|565886300|FG008|Overall Study|Death|25|||
156763159|NCT04579380|565886292|FG000|Overall Study|Withdrawal by Subject|0|||
156763160|NCT04579380|565886293|FG001|Overall Study|Withdrawal by Subject|3|||
156763161|NCT04579380|565886294|FG002|Overall Study|Withdrawal by Subject|4|||
156763162|NCT04579380|565886295|FG003|Overall Study|Withdrawal by Subject|0|||
156763163|NCT04579380|565886296|FG004|Overall Study|Withdrawal by Subject|1|||
156763164|NCT04579380|565886297|FG005|Overall Study|Withdrawal by Subject|2|||
156763165|NCT04579380|565886298|FG006|Overall Study|Withdrawal by Subject|0|||
156763166|NCT04579380|565886299|FG007|Overall Study|Withdrawal by Subject|1|||
156763167|NCT04579380|565886300|FG008|Overall Study|Withdrawal by Subject|2|||
156763168|NCT04579380|565886292|FG000|Overall Study|Ongoing|2|||
156763169|NCT04579380|565886293|FG001|Overall Study|Ongoing|6|||
156763170|NCT04579380|565886294|FG002|Overall Study|Ongoing|4|||
156763171|NCT04579380|565886295|FG003|Overall Study|Ongoing|8|||
156763172|NCT04579380|565886296|FG004|Overall Study|Ongoing|5|||
156763173|NCT04579380|565886297|FG005|Overall Study|Ongoing|8|||
156763174|NCT04579380|565886298|FG006|Overall Study|Ongoing|3|||
156763175|NCT04579380|565886299|FG007|Overall Study|Ongoing|19|||
156763176|NCT04579380|565886300|FG008|Overall Study|Ongoing|6|||
156763177|NCT04070989|565886302|FG000|Overall Study|Death|1|||
156763178|NCT04070989|565886303|FG001|Overall Study|Death|0|||
156763179|NCT04070989|565886304|FG002|Overall Study|Death|0|||
156763180|NCT04070989|565886302|FG000|Overall Study|Study Terminated by Sponsor|7|||
156763181|NCT04070989|565886303|FG001|Overall Study|Study Terminated by Sponsor|8|||
156763182|NCT04070989|565886304|FG002|Overall Study|Study Terminated by Sponsor|23|||
156763183|NCT04070989|565886302|FG000|Overall Study|Withdrawal by Subject|0|||
156763184|NCT04070989|565886303|FG001|Overall Study|Withdrawal by Subject|1|||
156763185|NCT04070989|565886304|FG002|Overall Study|Withdrawal by Subject|0|||
156763186|NCT04070989|565886302|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
156763187|NCT04070989|565886303|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
156763188|NCT04070989|565886304|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
156763189|NCT04070989|565886302|FG000|Overall Study|Other|1|||
156655259|NCT00601484|565483918|FG000|Overall Study|Lost to Follow-up|4|||
156655260|NCT00601484|565483919|FG001|Overall Study|Lost to Follow-up|3|||
156655261|NCT00601484|565483918|FG000|Overall Study|Lack of Efficacy|0|||
156655262|NCT00601484|565483919|FG001|Overall Study|Lack of Efficacy|2|||
156655263|NCT00601484|565483918|FG000|Overall Study|Withdrawal by Subject|1|||
156655264|NCT00601484|565483919|FG001|Overall Study|Withdrawal by Subject|1|||
156655265|NCT00601484|565483918|FG000|Overall Study|Randomized, but not treated|0|||
156655266|NCT00601484|565483919|FG001|Overall Study|Randomized, but not treated|1|||
156655267|NCT04471428|565483920|FG000|Overall Study|Withdrawal by Subject|29|||
156655268|NCT04471428|565483921|FG001|Overall Study|Withdrawal by Subject|4|||
156655269|NCT04471428|565483920|FG000|Overall Study|Physician Decision|0|||
156655270|NCT04471428|565483921|FG001|Overall Study|Physician Decision|1|||
156655271|NCT04471428|565483920|FG000|Overall Study|Reason Not Specified|0|||
156655272|NCT04471428|565483921|FG001|Overall Study|Reason Not Specified|2|||
156655273|NCT04471428|565483920|FG000|Overall Study|Death|131|||
156655274|NCT04471428|565483921|FG001|Overall Study|Death|147|||
156655275|NCT04471428|565483920|FG000|Overall Study|Lost to Follow-up|0|||
156655276|NCT04471428|565483921|FG001|Overall Study|Lost to Follow-up|3|||
156655277|NCT04471428|565483920|FG000|Overall Study|Study Terminated by Sponsor|20|||
156655278|NCT04471428|565483921|FG001|Overall Study|Study Terminated by Sponsor|29|||
156655279|NCT03504852|565483922|FG000|Overall Study|Withdrawal of informed consent|2|||
156655280|NCT03504852|565483923|FG001|Overall Study|Withdrawal of informed consent|1|||
156655281|NCT03504852|565483924|FG002|Overall Study|Withdrawal of informed consent|0|||
156655282|NCT03504852|565483922|FG000|Overall Study|Withdrawal by Subject|5|||
156655283|NCT03504852|565483923|FG001|Overall Study|Withdrawal by Subject|5|||
156655284|NCT03504852|565483924|FG002|Overall Study|Withdrawal by Subject|1|||
156655285|NCT03504852|565483922|FG000|Overall Study|Lost to Follow-up|4|||
156655286|NCT03504852|565483923|FG001|Overall Study|Lost to Follow-up|1|||
156655287|NCT03504852|565483924|FG002|Overall Study|Lost to Follow-up|0|||
156655288|NCT03504852|565483922|FG000|Overall Study|New therapy for study indication|1|||
156655289|NCT03504852|565483923|FG001|Overall Study|New therapy for study indication|0|||
156655290|NCT03504852|565483924|FG002|Overall Study|New therapy for study indication|0|||
156655291|NCT03504852|565483922|FG000|Overall Study|Lack of Efficacy|1|||
156655292|NCT03504852|565483923|FG001|Overall Study|Lack of Efficacy|2|||
156655293|NCT03504852|565483924|FG002|Overall Study|Lack of Efficacy|0|||
156655294|NCT03504852|565483922|FG000|Overall Study|Death|0|||
156655295|NCT03504852|565483923|FG001|Overall Study|Death|1|||
156655296|NCT03504852|565483924|FG002|Overall Study|Death|0|||
156655297|NCT03504852|565483922|FG000|Overall Study|Adverse Event|4|||
156655298|NCT03504852|565483923|FG001|Overall Study|Adverse Event|8|||
156655299|NCT03504852|565483924|FG002|Overall Study|Adverse Event|2|||
156655300|NCT03290079|565483925|FG000|Overall Study|Death|2|||
156655301|NCT03390504|565483926|FG000|Overall Study|Lost to Follow-up|2|||
156655302|NCT03390504|565483927|FG001|Overall Study|Lost to Follow-up|4|||
156655303|NCT03390504|565483928|FG002|Overall Study|Lost to Follow-up|0|||
156655304|NCT03390504|565483929|FG003|Overall Study|Lost to Follow-up|1|||
156655305|NCT03390504|565483926|FG000|Overall Study|Withdrawal by Subject|3|||
156655306|NCT03390504|565483927|FG001|Overall Study|Withdrawal by Subject|15|||
156655307|NCT03390504|565483928|FG002|Overall Study|Withdrawal by Subject|5|||
156655308|NCT03390504|565483929|FG003|Overall Study|Withdrawal by Subject|2|||
156655309|NCT03390504|565483926|FG000|Overall Study|Other|1|||
156655310|NCT03390504|565483927|FG001|Overall Study|Other|2|||
156655311|NCT03390504|565483928|FG002|Overall Study|Other|2|||
156655312|NCT03390504|565483929|FG003|Overall Study|Other|6|||
156655313|NCT00969332|565483930|FG000|Overall Study|Physician Decision|8|||
156655314|NCT00969332|565483930|FG000|Overall Study|Withdrawal by Subject|3|||
156655315|NCT00576199|565483931|FG000|Overall Study|Adverse Event|12|||
156655316|NCT00576199|565483931|FG000|Overall Study|Insufficient Therapeutic Response|14|||
156655317|NCT00576199|565483931|FG000|Overall Study|Refused Treatment|2|||
156655318|NCT00576199|565483931|FG000|Overall Study|Reason Unspecified|2|||
156655319|NCT00663871|565483932|FG000|Overall Study|Lost to Follow-up|5|||
156655320|NCT00663871|565483933|FG001|Overall Study|Lost to Follow-up|5|||
156655321|NCT00663871|565483932|FG000|Overall Study|Withdrawal by Subject|5|||
156655322|NCT00663871|565483933|FG001|Overall Study|Withdrawal by Subject|2|||
156655323|NCT00582309|565483934|FG000|Overall Study|Protocol Violation|0|||
156655324|NCT00582309|565483935|FG001|Overall Study|Protocol Violation|0|||
156655325|NCT00582309|565483936|FG002|Overall Study|Protocol Violation|2|||
156655326|NCT03922477|565483937|FG000|Overall Study|Death|9|||
156655327|NCT03922477|565483937|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
156655328|NCT03922477|565483937|FG000|Overall Study|Physician Decision|1|||
156655329|NCT03922477|565483937|FG000|Overall Study|Withdrawal by Subject|2|||
156655330|NCT01893905|565485690|FG000|Overall Study|Withdrawal by Subject|1|||
156655331|NCT01893905|565485691|FG001|Overall Study|Withdrawal by Subject|0|||
156655332|NCT01893905|565485690|FG000|Overall Study|Adverse Event|9|||
156655333|NCT01893905|565485691|FG001|Overall Study|Adverse Event|3|||
156655334|NCT01893905|565485690|FG000|Overall Study|Lack of Efficacy|5|||
156655335|NCT01893905|565485691|FG001|Overall Study|Lack of Efficacy|7|||
156655336|NCT01893905|565485690|FG000|Overall Study|Lost to Follow-up|1|||
156655337|NCT01893905|565485691|FG001|Overall Study|Lost to Follow-up|0|||
156763190|NCT04070989|565886303|FG001|Overall Study|Other|1|||
156763191|NCT04070989|565886304|FG002|Overall Study|Other|0|||
156763192|NCT06088784|565886305|FG000|Overall Study|Adverse Event|0|||
156763193|NCT06088784|565886306|FG001|Overall Study|Adverse Event|0|||
156763194|NCT06088784|565886307|FG002|Overall Study|Adverse Event|0|||
156763195|NCT06088784|565886308|FG003|Overall Study|Adverse Event|0|||
156763196|NCT06088784|565886309|FG004|Overall Study|Adverse Event|0|||
156763197|NCT06088784|565886310|FG005|Overall Study|Adverse Event|0|||
156763198|NCT06088784|565886311|FG006|Overall Study|Adverse Event|3|||
156763199|NCT06088784|565886312|FG007|Overall Study|Adverse Event|0|||
156763200|NCT06088784|565886313|FG008|Overall Study|Adverse Event|0|||
156763201|NCT06088784|565886314|FG009|Overall Study|Adverse Event|0|||
156763202|NCT06088784|565886315|FG010|Overall Study|Adverse Event|0|||
156763203|NCT06088784|565886316|FG011|Overall Study|Adverse Event|0|||
156763204|NCT06088784|565886305|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763205|NCT06088784|565886306|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763206|NCT06088784|565886307|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763207|NCT06088784|565886308|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763208|NCT06088784|565886309|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763209|NCT06088784|565886310|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763210|NCT06088784|565886311|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
156763211|NCT06088784|565886312|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763212|NCT06088784|565886313|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763213|NCT06088784|565886314|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763214|NCT06088784|565886315|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763215|NCT06088784|565886316|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763216|NCT05556616|565886319|FG000|Overall Study|Withdrawal by Subject|1|||
156763217|NCT05556616|565886320|FG001|Overall Study|Withdrawal by Subject|0|||
156763218|NCT05556616|565886321|FG002|Overall Study|Withdrawal by Subject|0|||
156763219|NCT05556616|565886322|FG003|Overall Study|Withdrawal by Subject|0|||
156763220|NCT05556616|565886323|FG004|Overall Study|Withdrawal by Subject|0|||
156763221|NCT05556616|565886324|FG005|Overall Study|Withdrawal by Subject|0|||
156763222|NCT05556616|565886325|FG006|Overall Study|Withdrawal by Subject|0|||
156763223|NCT05556616|565886319|FG000|Overall Study|Death|0|||
156763224|NCT05556616|565886320|FG001|Overall Study|Death|0|||
156763225|NCT05556616|565886321|FG002|Overall Study|Death|2|||
156763226|NCT05556616|565886322|FG003|Overall Study|Death|1|||
156763227|NCT05556616|565886323|FG004|Overall Study|Death|0|||
156763228|NCT05556616|565886324|FG005|Overall Study|Death|0|||
156763229|NCT05556616|565886325|FG006|Overall Study|Death|0|||
156763230|NCT05556616|565886319|FG000|Overall Study|Study Terminated by Sponsor|0|||
156763231|NCT05556616|565886320|FG001|Overall Study|Study Terminated by Sponsor|3|||
156763232|NCT05556616|565886321|FG002|Overall Study|Study Terminated by Sponsor|0|||
156763233|NCT05556616|565886322|FG003|Overall Study|Study Terminated by Sponsor|0|||
156763234|NCT05556616|565886323|FG004|Overall Study|Study Terminated by Sponsor|0|||
156763235|NCT05556616|565886324|FG005|Overall Study|Study Terminated by Sponsor|0|||
156763236|NCT05556616|565886325|FG006|Overall Study|Study Terminated by Sponsor|0|||
156763237|NCT05428436|565886326|FG000|Period 1 - 2 washout|Adverse Event|1|||
156763238|NCT05428436|565886327|FG001|Period 1 - 2 washout|Adverse Event|0|||
156763239|NCT05428436|565886328|FG002|Period 1 - 2 washout|Adverse Event|0|||
156763240|NCT03964207|565886329|FG000|First Treatment|Withdrawal by Subject|1|||
156763241|NCT03964207|565886330|FG001|First Treatment|Withdrawal by Subject|2|||
156763242|NCT03964207|565886329|FG000|First Treatment|Protocol Violation|1|||
156322276|NCT00322153|564278045|FG001|Overall Study|Withdrawal by Subject|10|||
156322277|NCT00322153|564278044|FG000|Overall Study|Lack of Efficacy|8|||
156322278|NCT00322153|564278045|FG001|Overall Study|Lack of Efficacy|3|||
156322279|NCT00322153|564278044|FG000|Overall Study|Lost to Follow-up|5|||
156322280|NCT00322153|564278045|FG001|Overall Study|Lost to Follow-up|4|||
156322281|NCT00322153|564278044|FG000|Overall Study|Withdrawn for other reasons|5|||
156322282|NCT00322153|564278045|FG001|Overall Study|Withdrawn for other reasons|4|||
156322283|NCT03523000|564278047|FG000|Overall Study|Withdrawal by Subject|3|||
156322284|NCT03523000|564278048|FG001|Overall Study|Withdrawal by Subject|0|||
156322285|NCT03523000|564278047|FG000|Overall Study|Unsuccessful trial|2|||
156322286|NCT03523000|564278048|FG001|Overall Study|Unsuccessful trial|0|||
156322287|NCT00772070|564278049|FG000|Overall Study|Lost to Follow-up|0|||
156322288|NCT00772070|564278050|FG001|Overall Study|Lost to Follow-up|8|||
156322289|NCT00772070|564278049|FG000|Overall Study|Withdrawal by Subject|0|||
156322290|NCT00772070|564278050|FG001|Overall Study|Withdrawal by Subject|2|||
156322291|NCT00772070|564278049|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
156322292|NCT00772070|564278050|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
156322293|NCT01309308|564278051|FG000|Overall Study|Lost to Follow-up|6|||
156763243|NCT03964207|565886330|FG001|First Treatment|Protocol Violation|0|||
156763244|NCT03964207|565886329|FG000|First Treatment|Lost to Follow-up|1|||
156763245|NCT03964207|565886330|FG001|First Treatment|Lost to Follow-up|0|||
156763246|NCT03964207|565886329|FG000|Second Treatment|Lost to Follow-up|0|||
156763247|NCT03964207|565886330|FG001|Second Treatment|Lost to Follow-up|1|||
156763248|NCT03964207|565886329|FG000|Second Treatment|Adverse Event|1|||
156763249|NCT03964207|565886330|FG001|Second Treatment|Adverse Event|2|||
156763250|NCT00830219|565886333|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156763251|NCT00830219|565886334|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
156763252|NCT00641056|565886335|FG000|Overall Study|Adverse Event|12|||
156763253|NCT00641056|565886336|FG001|Overall Study|Adverse Event|2|||
156763254|NCT00641056|565886335|FG000|Overall Study|Lost to Follow-up|2|||
156763255|NCT00641056|565886336|FG001|Overall Study|Lost to Follow-up|1|||
156763256|NCT00641056|565886335|FG000|Overall Study|Physician Decision|3|||
156763257|NCT00641056|565886336|FG001|Overall Study|Physician Decision|1|||
156763258|NCT00641056|565886335|FG000|Overall Study|Protocol Violation|2|||
156763259|NCT00641056|565886336|FG001|Overall Study|Protocol Violation|0|||
156763260|NCT00641056|565886335|FG000|Overall Study|Entry Criteria Not Met|3|||
156763261|NCT00641056|565886336|FG001|Overall Study|Entry Criteria Not Met|0|||
156763262|NCT00641056|565886335|FG000|Overall Study|Subject Decision|6|||
156763263|NCT00641056|565886336|FG001|Overall Study|Subject Decision|19|||
156763264|NCT00641056|565886335|FG000|Overall Study|Sponsor Decision|1|||
156763265|NCT00641056|565886336|FG001|Overall Study|Sponsor Decision|2|||
156763266|NCT00239720|565886338|FG000|Overall Study|Adverse Event|1|||
156763267|NCT00239720|565886339|FG001|Overall Study|Adverse Event|0|||
156763268|NCT00239720|565886338|FG000|Overall Study|Lost to Follow-up|0|||
156763269|NCT00239720|565886339|FG001|Overall Study|Lost to Follow-up|1|||
156763270|NCT01811732|565886342|FG000|Overall Study|Lost to Follow-up|24|||
156763271|NCT01811732|565886343|FG001|Overall Study|Lost to Follow-up|30|||
156763272|NCT01811732|565886342|FG000|Overall Study|Withdrawal by Subject|16|||
156763273|NCT01811732|565886343|FG001|Overall Study|Withdrawal by Subject|10|||
156763274|NCT01811732|565886342|FG000|Overall Study|Adverse Event|3|||
156763275|NCT01811732|565886343|FG001|Overall Study|Adverse Event|9|||
156763276|NCT01811732|565886342|FG000|Overall Study|Lack of Efficacy|3|||
156763277|NCT01811732|565886343|FG001|Overall Study|Lack of Efficacy|1|||
156763278|NCT01811732|565886342|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
156763279|NCT01811732|565886343|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
156763280|NCT01811732|565886342|FG000|Overall Study|Physician Decision|2|||
156763281|NCT01811732|565886343|FG001|Overall Study|Physician Decision|0|||
156763282|NCT01811732|565886342|FG000|Overall Study|Death|1|||
156763283|NCT01811732|565886343|FG001|Overall Study|Death|1|||
156763284|NCT01811732|565886342|FG000|Overall Study|Insufficient venous access|0|||
156763285|NCT01811732|565886343|FG001|Overall Study|Insufficient venous access|1|||
156763286|NCT01811732|565886342|FG000|Overall Study|Protocol Violation|0|||
156763287|NCT01811732|565886343|FG001|Overall Study|Protocol Violation|1|||
156763288|NCT01811732|565886342|FG000|Overall Study|Subject incarcerated|1|||
156763289|NCT01811732|565886343|FG001|Overall Study|Subject incarcerated|2|||
156763290|NCT01811732|565886342|FG000|Overall Study|Admitted to another facility|1|||
156763291|NCT01811732|565886343|FG001|Overall Study|Admitted to another facility|0|||
156763292|NCT01811732|565886342|FG000|Overall Study|Correct study drug not available on site|1|||
156763293|NCT01811732|565886343|FG001|Overall Study|Correct study drug not available on site|0|||
156763294|NCT00896493|565886344|FG000|Overall Study|Early disease relapse|3|||
156763295|NCT01868646|565886347|FG000|Overall Study|Do not meet inclusion criteria|3|||
156763296|NCT01868646|565886348|FG001|Overall Study|Do not meet inclusion criteria|5|||
156763297|NCT01831427|565886349|FG000|Overall Study|Adverse Event|0|||
156763298|NCT01831427|565886350|FG001|Overall Study|Adverse Event|1|||
156763299|NCT01831427|565886351|FG002|Overall Study|Adverse Event|0|||
156763300|NCT01831427|565886352|FG003|Overall Study|Adverse Event|0|||
156763301|NCT01831427|565886353|FG004|Overall Study|Adverse Event|0|||
156763302|NCT01831427|565886354|FG005|Overall Study|Adverse Event|1|||
156763303|NCT01831427|565886355|FG006|Overall Study|Adverse Event|0|||
156322294|NCT01309308|564278052|FG001|Overall Study|Lost to Follow-up|4|||
156322295|NCT01307020|564278055|FG000|Overall Study|Lost to Follow-up|0|||
156322296|NCT01307020|564278056|FG001|Overall Study|Lost to Follow-up|0|||
156322297|NCT01307020|564278057|FG002|Overall Study|Lost to Follow-up|1|||
156322298|NCT01307020|564278058|FG003|Overall Study|Lost to Follow-up|1|||
156322299|NCT01307020|564278059|FG004|Overall Study|Lost to Follow-up|0|||
156322300|NCT01307020|564278060|FG005|Overall Study|Lost to Follow-up|0|||
156322301|NCT01307020|564278061|FG006|Overall Study|Lost to Follow-up|1|||
156322302|NCT01307020|564278062|FG007|Overall Study|Lost to Follow-up|0|||
156322303|NCT01307020|564278063|FG008|Overall Study|Lost to Follow-up|0|||
156322304|NCT01307020|564278064|FG009|Overall Study|Lost to Follow-up|0|||
156322305|NCT01307020|564278055|FG000|Overall Study|Electronic data capture failure|0|||
156763304|NCT01831427|565886356|FG007|Overall Study|Adverse Event|1|||
156763305|NCT01831427|565886357|FG008|Overall Study|Adverse Event|0|||
156763306|NCT01831427|565886358|FG009|Overall Study|Adverse Event|0|||
156763307|NCT01831427|565886359|FG010|Overall Study|Adverse Event|2|||
156763308|NCT01831427|565886349|FG000|Overall Study|Investigator's Discretion|0|||
156763309|NCT01831427|565886350|FG001|Overall Study|Investigator's Discretion|0|||
156763310|NCT01831427|565886351|FG002|Overall Study|Investigator's Discretion|0|||
156763311|NCT01831427|565886352|FG003|Overall Study|Investigator's Discretion|1|||
156763312|NCT01831427|565886353|FG004|Overall Study|Investigator's Discretion|0|||
156763313|NCT01831427|565886354|FG005|Overall Study|Investigator's Discretion|0|||
156763314|NCT01831427|565886355|FG006|Overall Study|Investigator's Discretion|0|||
156426205|NCT04888585|564652886|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156426206|NCT04888585|564652887|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156426207|NCT04888585|564652888|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
156426208|NCT04888585|564652889|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
156426209|NCT04888585|564652890|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
156426210|NCT04888585|564652891|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
156426211|NCT04888585|564652892|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
156426212|NCT04888585|564652893|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
156426213|NCT04888585|564652883|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156763315|NCT01831427|565886356|FG007|Overall Study|Investigator's Discretion|0|||
156763316|NCT01831427|565886357|FG008|Overall Study|Investigator's Discretion|0|||
156763317|NCT01831427|565886358|FG009|Overall Study|Investigator's Discretion|0|||
156763318|NCT01831427|565886359|FG010|Overall Study|Investigator's Discretion|0|||
156763319|NCT01831427|565886349|FG000|Overall Study|Withdrew Consent|0|||
156763320|NCT01831427|565886350|FG001|Overall Study|Withdrew Consent|0|||
156763321|NCT01831427|565886351|FG002|Overall Study|Withdrew Consent|0|||
156763322|NCT01831427|565886352|FG003|Overall Study|Withdrew Consent|0|||
156763323|NCT01831427|565886353|FG004|Overall Study|Withdrew Consent|0|||
156763324|NCT01831427|565886354|FG005|Overall Study|Withdrew Consent|0|||
156763325|NCT01831427|565886355|FG006|Overall Study|Withdrew Consent|2|||
156763326|NCT01831427|565886356|FG007|Overall Study|Withdrew Consent|0|||
156763327|NCT01831427|565886357|FG008|Overall Study|Withdrew Consent|0|||
156763328|NCT01831427|565886358|FG009|Overall Study|Withdrew Consent|1|||
156763329|NCT01831427|565886359|FG010|Overall Study|Withdrew Consent|1|||
156763330|NCT01249417|565886362|FG000|Randomised Population|Study treatment not received|0|||
156763331|NCT01249417|565886363|FG001|Randomised Population|Study treatment not received|0|||
156763332|NCT01249417|565886364|FG002|Randomised Population|Study treatment not received|2|||
156763333|NCT01249417|565886362|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
156763334|NCT01249417|565886363|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
156763335|NCT01249417|565886364|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
156763336|NCT01249417|565886362|FG000|Treatment Phase - ITT Population|Other|0|||
156763337|NCT01249417|565886363|FG001|Treatment Phase - ITT Population|Other|0|||
156763338|NCT01249417|565886364|FG002|Treatment Phase - ITT Population|Other|1|||
156763339|NCT01249417|565886362|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
156763340|NCT01249417|565886363|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
156763341|NCT01249417|565886364|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
156763342|NCT01249417|565886362|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
156763343|NCT01249417|565886363|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
156763344|NCT01249417|565886364|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
156763345|NCT01249417|565886362|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
156763346|NCT01249417|565886363|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
156763347|NCT01249417|565886364|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
156763348|NCT01248455|565886365|FG000|Overall Study|switched to alternate treatment|1|||
156763349|NCT02035553|565886366|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
156763350|NCT02035553|565886367|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
156763351|NCT02035553|565886366|FG000|Overall Study|Adverse Event|10|||
156763352|NCT02035553|565886367|FG001|Overall Study|Adverse Event|6|||
156763353|NCT02035553|565886366|FG000|Overall Study|Physician Decision|3|||
156763354|NCT02035553|565886367|FG001|Overall Study|Physician Decision|2|||
156763355|NCT02035553|565886366|FG000|Overall Study|Lack of Efficacy|1|||
156763356|NCT02035553|565886367|FG001|Overall Study|Lack of Efficacy|1|||
156763357|NCT02035553|565886366|FG000|Overall Study|Withdrawal by Subject|4|||
156763358|NCT02035553|565886367|FG001|Overall Study|Withdrawal by Subject|7|||
156763359|NCT02035553|565886366|FG000|Overall Study|Non-compliance with Study Drug|0|||
156763360|NCT02035553|565886367|FG001|Overall Study|Non-compliance with Study Drug|1|||
156763361|NCT02035553|565886366|FG000|Overall Study|Lost to Follow-up|0|||
156763362|NCT02035553|565886367|FG001|Overall Study|Lost to Follow-up|1|||
156763363|NCT02035553|565886366|FG000|Overall Study|Other Reason|0|||
156763364|NCT02035553|565886367|FG001|Overall Study|Other Reason|4|||
156763365|NCT04539964|565886368|FG000|Overall Study|device malfunction|1|||
156763366|NCT04539964|565886369|FG001|Overall Study|device malfunction|0|||
156763367|NCT04539964|565886368|FG000|Overall Study|Withdrawal by Subject|1|||
156763368|NCT04539964|565886369|FG001|Overall Study|Withdrawal by Subject|2|||
156763369|NCT04539964|565886368|FG000|Overall Study|Adverse Event|0|||
156763370|NCT04539964|565886369|FG001|Overall Study|Adverse Event|2|||
156763371|NCT01854697|565886370|FG000|Overall Study|Adverse Event|1|||
156426214|NCT04888585|564652884|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156763372|NCT01854697|565886371|FG001|Overall Study|Adverse Event|0|||
156763373|NCT01854697|565886372|FG002|Overall Study|Adverse Event|0|||
156763374|NCT01854697|565886373|FG003|Overall Study|Adverse Event|0|||
156763375|NCT01854697|565886374|FG004|Overall Study|Adverse Event|1|||
156763376|NCT01854697|565886370|FG000|Overall Study|Lost to Follow-up|4|||
156763377|NCT01854697|565886371|FG001|Overall Study|Lost to Follow-up|1|||
156763378|NCT01854697|565886372|FG002|Overall Study|Lost to Follow-up|1|||
156763379|NCT01854697|565886373|FG003|Overall Study|Lost to Follow-up|2|||
156763380|NCT01854697|565886374|FG004|Overall Study|Lost to Follow-up|0|||
156763381|NCT01854697|565886370|FG000|Overall Study|To enter another AbbVie study|1|||
156763382|NCT01854697|565886371|FG001|Overall Study|To enter another AbbVie study|0|||
156763383|NCT01854697|565886372|FG002|Overall Study|To enter another AbbVie study|0|||
156763384|NCT01854697|565886373|FG003|Overall Study|To enter another AbbVie study|0|||
156763385|NCT01854697|565886374|FG004|Overall Study|To enter another AbbVie study|1|||
156763386|NCT01854697|565886370|FG000|Overall Study|Withdrew Consent|0|||
156763387|NCT01854697|565886371|FG001|Overall Study|Withdrew Consent|1|||
156763388|NCT01854697|565886372|FG002|Overall Study|Withdrew Consent|0|||
156763389|NCT01854697|565886373|FG003|Overall Study|Withdrew Consent|1|||
156763390|NCT01854697|565886374|FG004|Overall Study|Withdrew Consent|0|||
156763391|NCT01854697|565886370|FG000|Overall Study|Other|0|||
156763392|NCT01854697|565886371|FG001|Overall Study|Other|1|||
156763393|NCT01854697|565886372|FG002|Overall Study|Other|1|||
156763394|NCT01854697|565886373|FG003|Overall Study|Other|0|||
156763395|NCT01854697|565886374|FG004|Overall Study|Other|0|||
156763396|NCT02771275|565886379|FG000|Overall Study|Reoperation|3|||
156763397|NCT02771275|565886379|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
156763398|NCT05556148|565886380|FG000|Overall Study|Early Termination|29|||
156763399|NCT05556148|565886380|FG000|Overall Study|Baseline Tasks Expired|4|||
156763400|NCT05556148|565886380|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
156763401|NCT05556148|565886380|FG000|Overall Study|No Longer Wished to Participate|1|||
156763402|NCT05556148|565886380|FG000|Overall Study|Bacterial Conjunctivitis|1|||
156763403|NCT01171898|565886381|FG000|Overall Study|Death|0|||
156763404|NCT01171898|565886382|FG001|Overall Study|Death|0|||
156763405|NCT01171898|565886383|FG002|Overall Study|Death|2|||
156763406|NCT01171898|565886384|FG003|Overall Study|Death|0|||
156763407|NCT01171898|565886381|FG000|Overall Study|Lost to Follow-up|0|||
156763408|NCT01171898|565886382|FG001|Overall Study|Lost to Follow-up|1|||
156763409|NCT01171898|565886383|FG002|Overall Study|Lost to Follow-up|1|||
156763410|NCT01171898|565886384|FG003|Overall Study|Lost to Follow-up|1|||
156763411|NCT01171898|565886381|FG000|Overall Study|Withdrawal by Subject|1|||
156763412|NCT01171898|565886382|FG001|Overall Study|Withdrawal by Subject|4|||
156763413|NCT01171898|565886383|FG002|Overall Study|Withdrawal by Subject|6|||
156763414|NCT01171898|565886384|FG003|Overall Study|Withdrawal by Subject|3|||
156763415|NCT01171898|565886381|FG000|Overall Study|Terminated by Sponsor|1|||
156763416|NCT01171898|565886382|FG001|Overall Study|Terminated by Sponsor|0|||
156763417|NCT01171898|565886383|FG002|Overall Study|Terminated by Sponsor|0|||
156763418|NCT01171898|565886384|FG003|Overall Study|Terminated by Sponsor|0|||
156763419|NCT01171898|565886381|FG000|Overall Study|Ongoing|1|||
156763420|NCT01171898|565886382|FG001|Overall Study|Ongoing|9|||
156763421|NCT01171898|565886383|FG002|Overall Study|Ongoing|3|||
156763422|NCT01171898|565886384|FG003|Overall Study|Ongoing|0|||
156763423|NCT01171898|565886381|FG000|Overall Study|Other|1|||
156763424|NCT01171898|565886382|FG001|Overall Study|Other|5|||
156763425|NCT01171898|565886383|FG002|Overall Study|Other|0|||
156763426|NCT01171898|565886384|FG003|Overall Study|Other|2|||
156763427|NCT03191799|565886385|FG000|Overall Study|Withdrawal by Subject|4|||
156763428|NCT03191799|565886385|FG000|Overall Study|Physician Decision|2|||
156763429|NCT03191799|565886385|FG000|Overall Study|Lost to Follow-up|1|||
156763430|NCT03191799|565886385|FG000|Overall Study|Death|2|||
156763431|NCT00902577|565886389|FG000|Overall Study|Withdrawal by Subject|6|||
156763432|NCT00902577|565886389|FG000|Overall Study|FMISO production failure|2|||
156763433|NCT00468585|565886390|FG000|Overall Study|Patient not treated|1|||
156763434|NCT00468585|565886391|FG001|Overall Study|Patient not treated|0|||
156763435|NCT00468585|565886392|FG002|Overall Study|Patient not treated|1|||
156763436|NCT00468585|565886393|FG003|Overall Study|Patient not treated|0|||
156763437|NCT00468585|565886390|FG000|Overall Study|Patient found to be ineligible|0|||
156763438|NCT00468585|565886391|FG001|Overall Study|Patient found to be ineligible|0|||
156763439|NCT00468585|565886392|FG002|Overall Study|Patient found to be ineligible|1|||
156763440|NCT00468585|565886393|FG003|Overall Study|Patient found to be ineligible|0|||
156763441|NCT00468585|565886390|FG000|Overall Study|Adverse Event|0|||
156763442|NCT00468585|565886391|FG001|Overall Study|Adverse Event|0|||
156322306|NCT01307020|564278056|FG001|Overall Study|Electronic data capture failure|1|||
156322307|NCT01307020|564278057|FG002|Overall Study|Electronic data capture failure|0|||
156322308|NCT01307020|564278058|FG003|Overall Study|Electronic data capture failure|0|||
156322309|NCT01307020|564278059|FG004|Overall Study|Electronic data capture failure|0|||
156322310|NCT01307020|564278060|FG005|Overall Study|Electronic data capture failure|0|||
156322311|NCT01307020|564278061|FG006|Overall Study|Electronic data capture failure|0|||
156322312|NCT01307020|564278062|FG007|Overall Study|Electronic data capture failure|0|||
156763443|NCT00468585|565886392|FG002|Overall Study|Adverse Event|1|||
156763444|NCT00468585|565886393|FG003|Overall Study|Adverse Event|0|||
156763445|NCT00468585|565886390|FG000|Overall Study|Withdrawal by Subject|0|||
156763446|NCT00468585|565886391|FG001|Overall Study|Withdrawal by Subject|0|||
156763447|NCT00468585|565886392|FG002|Overall Study|Withdrawal by Subject|2|||
156763448|NCT00468585|565886393|FG003|Overall Study|Withdrawal by Subject|1|||
156763449|NCT03769649|565886394|FG000|Overall Study|Lost to Follow-up|4|||
156763450|NCT03322293|565886395|FG000|Overall Study|Lost to Follow-up|0|||
156763451|NCT03322293|565886396|FG001|Overall Study|Lost to Follow-up|0|||
156763452|NCT03322293|565886397|FG002|Overall Study|Lost to Follow-up|1|||
156763453|NCT00083915|565886398|FG000|Overall Study|Death|6|||
156763454|NCT00083915|565886399|FG001|Overall Study|Death|3|||
156763455|NCT00083915|565886398|FG000|Overall Study|Physician Decision|11|||
156763456|NCT00083915|565886399|FG001|Overall Study|Physician Decision|6|||
156763457|NCT00083915|565886398|FG000|Overall Study|Withdrawal by Subject|8|||
156763458|NCT00083915|565886399|FG001|Overall Study|Withdrawal by Subject|3|||
156763459|NCT00083915|565886398|FG000|Overall Study|disease progression|18|||
156763460|NCT00083915|565886399|FG001|Overall Study|disease progression|23|||
156763461|NCT00083915|565886398|FG000|Overall Study|Failure to collect|3|||
156763462|NCT00083915|565886399|FG001|Overall Study|Failure to collect|0|||
156763463|NCT00083915|565886398|FG000|Overall Study|No response|3|||
156763464|NCT00083915|565886399|FG001|Overall Study|No response|1|||
156763465|NCT00083915|565886398|FG000|Overall Study|Insurance issues|1|||
156763466|NCT00083915|565886399|FG001|Overall Study|Insurance issues|1|||
156763467|NCT02000921|565886401|FG000|Overall Study|Withdrawal by Subject|3|||
156763468|NCT02000921|565886402|FG001|Overall Study|Withdrawal by Subject|10|||
156763469|NCT02000921|565886403|FG002|Overall Study|Withdrawal by Subject|5|||
156763470|NCT02000921|565886401|FG000|Overall Study|Lost to Follow-up|2|||
156763471|NCT02000921|565886402|FG001|Overall Study|Lost to Follow-up|4|||
156763472|NCT02000921|565886403|FG002|Overall Study|Lost to Follow-up|5|||
156763473|NCT02000921|565886401|FG000|Overall Study|Physician Decision|0|||
156763474|NCT02000921|565886402|FG001|Overall Study|Physician Decision|2|||
156763475|NCT02000921|565886403|FG002|Overall Study|Physician Decision|0|||
156763476|NCT01290718|565886404|FG000|Overall Study|Early termination of the study|4|||
156763477|NCT03722576|565886408|FG000|Overall Study|Withdrawal by Subject|3|||
156763478|NCT03722576|565886408|FG000|Overall Study|Adverse Event|2|||
156763479|NCT03722576|565886408|FG000|Overall Study|Physician Decision|1|||
156763480|NCT03722576|565886408|FG000|Overall Study|Lost to Follow-up|1|||
156763481|NCT01240382|565886409|FG000|Overall Study|Adverse Event|2|||
156763482|NCT01240382|565886410|FG001|Overall Study|Adverse Event|1|||
156763483|NCT01240382|565886409|FG000|Overall Study|Lack of Efficacy|0|||
156763484|NCT01240382|565886410|FG001|Overall Study|Lack of Efficacy|2|||
156763485|NCT01240382|565886409|FG000|Overall Study|Fear of adverse events|0|||
156763486|NCT01240382|565886410|FG001|Overall Study|Fear of adverse events|1|||
156763487|NCT02643693|565886411|FG000|Overall Study|Physician Decision|0|||
156763488|NCT02643693|565886412|FG001|Overall Study|Physician Decision|1|||
156763489|NCT02643693|565886413|FG002|Overall Study|Physician Decision|0|||
156763490|NCT02643693|565886414|FG003|Overall Study|Physician Decision|0|||
156763491|NCT02643693|565886415|FG004|Overall Study|Physician Decision|0|||
156763492|NCT02643693|565886416|FG005|Overall Study|Physician Decision|0|||
156763493|NCT02643693|565886411|FG000|Overall Study|Withdrawal by Subject|0|||
156763494|NCT02643693|565886412|FG001|Overall Study|Withdrawal by Subject|1|||
156763495|NCT02643693|565886413|FG002|Overall Study|Withdrawal by Subject|0|||
156763496|NCT02643693|565886414|FG003|Overall Study|Withdrawal by Subject|0|||
156763497|NCT02643693|565886415|FG004|Overall Study|Withdrawal by Subject|0|||
156763498|NCT02643693|565886416|FG005|Overall Study|Withdrawal by Subject|0|||
156763499|NCT02643693|565886411|FG000|Overall Study|Protocol Adherence Issues|2|||
156763500|NCT02643693|565886412|FG001|Overall Study|Protocol Adherence Issues|0|||
156763501|NCT02643693|565886413|FG002|Overall Study|Protocol Adherence Issues|1|||
156763502|NCT02643693|565886414|FG003|Overall Study|Protocol Adherence Issues|0|||
156763503|NCT02643693|565886415|FG004|Overall Study|Protocol Adherence Issues|0|||
156763504|NCT02643693|565886416|FG005|Overall Study|Protocol Adherence Issues|1|||
156426215|NCT04888585|564652885|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156426216|NCT04888585|564652886|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156426217|NCT04888585|564652887|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156763505|NCT01319565|565886417|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
156763506|NCT01319565|565886418|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
156763507|NCT01319565|565886419|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
156763508|NCT01268267|565886420|FG000|Overall Study|Protocol Violation|1|||
156763509|NCT02131064|565886422|FG000|Overall Study|Death|5|||
156763510|NCT02131064|565886423|FG001|Overall Study|Death|6|||
156763511|NCT02131064|565886422|FG000|Overall Study|Lost to Follow-up|4|||
156763512|NCT02131064|565886423|FG001|Overall Study|Lost to Follow-up|8|||
156763513|NCT02131064|565886422|FG000|Overall Study|Withdrawal by Subject|14|||
156763514|NCT02131064|565886423|FG001|Overall Study|Withdrawal by Subject|18|||
156763515|NCT02131064|565886422|FG000|Overall Study|Other|2|||
156763516|NCT02131064|565886423|FG001|Overall Study|Other|2|||
156763517|NCT04831138|565886426|FG000|Overall Study|Lost to Follow-up|2|||
156763518|NCT04831138|565886427|FG001|Overall Study|Lost to Follow-up|0|||
156763519|NCT00593918|565886428|FG000|Overall Study|Withdrawal by Subject|5|||
156763520|NCT00593918|565886429|FG001|Overall Study|Withdrawal by Subject|24|||
156763521|NCT04414787|565886437|FG000|Overall Study|Patient Death|18|||
156763522|NCT04414787|565886438|FG001|Overall Study|Patient Death|18|||
156763523|NCT04414787|565886439|FG002|Overall Study|Patient Death|15|||
156763524|NCT04414787|565886440|FG003|Overall Study|Patient Death|15|||
156763525|NCT04414787|565886437|FG000|Overall Study|Patient Hospitalization|1|||
156763526|NCT04414787|565886438|FG001|Overall Study|Patient Hospitalization|1|||
156763527|NCT04414787|565886439|FG002|Overall Study|Patient Hospitalization|2|||
156763528|NCT04414787|565886440|FG003|Overall Study|Patient Hospitalization|2|||
156763529|NCT04414787|565886437|FG000|Overall Study|Lost to Follow-up|7|||
156763530|NCT04414787|565886438|FG001|Overall Study|Lost to Follow-up|7|||
156763531|NCT04414787|565886439|FG002|Overall Study|Lost to Follow-up|5|||
156763532|NCT04414787|565886440|FG003|Overall Study|Lost to Follow-up|5|||
156763533|NCT04414787|565886437|FG000|Overall Study|Residence in post-acute care facility|3|||
156763534|NCT04414787|565886438|FG001|Overall Study|Residence in post-acute care facility|3|||
156763535|NCT04414787|565886439|FG002|Overall Study|Residence in post-acute care facility|5|||
156763536|NCT04414787|565886440|FG003|Overall Study|Residence in post-acute care facility|5|||
156763537|NCT00536510|565887912|FG000|Overall Study|Adverse Event|27|||
156763538|NCT00536510|565887913|FG001|Overall Study|Adverse Event|4|||
156763539|NCT00536510|565887912|FG000|Overall Study|Lost to Follow-up|11|||
156763540|NCT00536510|565887913|FG001|Overall Study|Lost to Follow-up|8|||
156763541|NCT00536510|565887912|FG000|Overall Study|Protocol Violation|4|||
156763542|NCT00536510|565887913|FG001|Overall Study|Protocol Violation|5|||
156763543|NCT00536510|565887912|FG000|Overall Study|Withdrawal by Subject|16|||
156763544|NCT00536510|565887913|FG001|Overall Study|Withdrawal by Subject|9|||
156763545|NCT00536510|565887912|FG000|Overall Study|Flushing with Product|20|||
156763546|NCT00536510|565887913|FG001|Overall Study|Flushing with Product|0|||
156763547|NCT00536510|565887912|FG000|Overall Study|Laboratory Adverse Event|2|||
156763548|NCT00536510|565887913|FG001|Overall Study|Laboratory Adverse Event|1|||
156763549|NCT00536510|565887912|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
156763550|NCT00536510|565887913|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
156763551|NCT02062437|565887914|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
156763552|NCT02062437|565887914|FG000|Overall Study|Patient not available for the 2y visit|18|||
156763553|NCT02062437|565887914|FG000|Overall Study|Death|2|||
156763554|NCT02062437|565887914|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
156763555|NCT01674725|565887915|FG000|Overall Study|Adverse Event|1|||
156763556|NCT01674725|565887916|FG001|Overall Study|Adverse Event|0|||
156763557|NCT01674725|565887915|FG000|Overall Study|Did not receive study drug|1|||
156763558|NCT01674725|565887916|FG001|Overall Study|Did not receive study drug|0|||
156763559|NCT01674725|565887915|FG000|Overall Study|Withdrawal by Subject|1|||
156763560|NCT01674725|565887916|FG001|Overall Study|Withdrawal by Subject|0|||
156763561|NCT01674725|565887915|FG000|Overall Study|Lost to Follow-up|0|||
156763562|NCT01674725|565887916|FG001|Overall Study|Lost to Follow-up|1|||
156763563|NCT03102762|565887917|FG000|Overall Study|Lost to Follow-up|1|||
156763564|NCT03102762|565887918|FG001|Overall Study|Lost to Follow-up|0|||
156763565|NCT03074695|565887923|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
156763566|NCT03074695|565887924|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
156763567|NCT03074695|565887923|FG000|Overall Study|Research staff not available|1|||
156763568|NCT03074695|565887924|FG001|Overall Study|Research staff not available|2|||
156763569|NCT03074695|565887923|FG000|Overall Study|Did not receive neuraxial block|2|||
156763570|NCT03074695|565887924|FG001|Overall Study|Did not receive neuraxial block|2|||
156763571|NCT04464707|565887926|FG000|Overall Study|Adverse Event|1|||
156763572|NCT04464707|565887927|FG001|Overall Study|Adverse Event|0|||
156763573|NCT04464707|565887928|FG002|Overall Study|Adverse Event|0|||
156763574|NCT04464707|565887926|FG000|Overall Study|Withdrawal by Subject|0|||
156763575|NCT04464707|565887927|FG001|Overall Study|Withdrawal by Subject|0|||
156763576|NCT04464707|565887928|FG002|Overall Study|Withdrawal by Subject|2|||
156763577|NCT04464707|565887926|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156763578|NCT04464707|565887927|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156763579|NCT04464707|565887928|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156763580|NCT04464707|565887926|FG000|Overall Study|Protocol Deviation|1|||
156763581|NCT04464707|565887927|FG001|Overall Study|Protocol Deviation|0|||
156763582|NCT04464707|565887928|FG002|Overall Study|Protocol Deviation|0|||
156763583|NCT04464707|565887926|FG000|Overall Study|Lost to Follow-up|2|||
156763584|NCT04464707|565887927|FG001|Overall Study|Lost to Follow-up|0|||
156763585|NCT04464707|565887928|FG002|Overall Study|Lost to Follow-up|1|||
156763586|NCT04202497|565887933|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
156763587|NCT04202497|565887934|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
156763588|NCT04202497|565887935|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
156763589|NCT04202497|565887936|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
156322313|NCT01307020|564278063|FG008|Overall Study|Electronic data capture failure|0|||
156322314|NCT01307020|564278064|FG009|Overall Study|Electronic data capture failure|0|||
156322315|NCT02380690|564278065|FG000|Overall Study|Lost to Follow-up|14|||
156322316|NCT02380690|564278066|FG001|Overall Study|Lost to Follow-up|4|||
156763590|NCT04344301|565887937|FG000|Overall Study|Withdrawal by Subject|1|||
156763591|NCT04344301|565887938|FG001|Overall Study|Withdrawal by Subject|0|||
156763592|NCT04344301|565887937|FG000|Overall Study|Death|0|||
156763593|NCT04344301|565887938|FG001|Overall Study|Death|1|||
156763594|NCT00072410|565887939|FG000|Overall Study|Progressive disease|0|||
156763595|NCT00072410|565887940|FG001|Overall Study|Progressive disease|3|||
156763596|NCT05590377|565887943|FG000|Overall Study|Death|1|||
156763597|NCT05590377|565887944|FG001|Overall Study|Death|1|||
156763598|NCT05590377|565887945|FG002|Overall Study|Death|2|||
156763599|NCT05590377|565887946|FG003|Overall Study|Death|0|||
156763600|NCT05590377|565887947|FG004|Overall Study|Death|0|||
156763601|NCT05590377|565887943|FG000|Overall Study|Study Terminated by Sponsor|1|||
156763602|NCT05590377|565887944|FG001|Overall Study|Study Terminated by Sponsor|5|||
156763603|NCT05590377|565887945|FG002|Overall Study|Study Terminated by Sponsor|4|||
156763604|NCT05590377|565887946|FG003|Overall Study|Study Terminated by Sponsor|0|||
156763605|NCT05590377|565887947|FG004|Overall Study|Study Terminated by Sponsor|0|||
156763606|NCT05590377|565887943|FG000|Overall Study|Withdrawal by Subject|1|||
156763607|NCT05590377|565887944|FG001|Overall Study|Withdrawal by Subject|0|||
156763608|NCT05590377|565887945|FG002|Overall Study|Withdrawal by Subject|0|||
156763609|NCT05590377|565887946|FG003|Overall Study|Withdrawal by Subject|0|||
156763610|NCT05590377|565887947|FG004|Overall Study|Withdrawal by Subject|0|||
156763611|NCT03389620|565887948|FG000|Overall Study|Lost to Follow-up|5|||
156763612|NCT03389620|565887949|FG001|Overall Study|Lost to Follow-up|1|||
156763613|NCT00549549|565887950|FG000|Overall Study|Adverse Event|5|||
156763614|NCT00549549|565887951|FG001|Overall Study|Adverse Event|3|||
156763615|NCT00549549|565887952|FG002|Overall Study|Adverse Event|1|||
156763616|NCT00549549|565887953|FG003|Overall Study|Adverse Event|9|||
156763617|NCT00549549|565887950|FG000|Overall Study|Lack of Efficacy|9|||
156763618|NCT00549549|565887951|FG001|Overall Study|Lack of Efficacy|6|||
156763619|NCT00549549|565887952|FG002|Overall Study|Lack of Efficacy|4|||
156763620|NCT00549549|565887953|FG003|Overall Study|Lack of Efficacy|2|||
156763621|NCT00549549|565887950|FG000|Overall Study|Lost to Follow-up|1|||
156763622|NCT00549549|565887951|FG001|Overall Study|Lost to Follow-up|0|||
156763623|NCT00549549|565887952|FG002|Overall Study|Lost to Follow-up|1|||
156763624|NCT00549549|565887953|FG003|Overall Study|Lost to Follow-up|2|||
156763625|NCT00549549|565887950|FG000|Overall Study|Withdrawal by Subject|0|||
156763626|NCT00549549|565887951|FG001|Overall Study|Withdrawal by Subject|4|||
156763627|NCT00549549|565887952|FG002|Overall Study|Withdrawal by Subject|1|||
156763628|NCT00549549|565887953|FG003|Overall Study|Withdrawal by Subject|0|||
156763629|NCT00549549|565887950|FG000|Overall Study|Other|9|||
156763630|NCT00549549|565887951|FG001|Overall Study|Other|9|||
156763631|NCT00549549|565887952|FG002|Overall Study|Other|9|||
156763632|NCT00549549|565887953|FG003|Overall Study|Other|11|||
156763633|NCT00549549|565887950|FG000|Overall Study|Randomized but not treated|0|||
156763634|NCT00549549|565887951|FG001|Overall Study|Randomized but not treated|0|||
156763635|NCT00549549|565887952|FG002|Overall Study|Randomized but not treated|1|||
156763636|NCT00549549|565887953|FG003|Overall Study|Randomized but not treated|1|||
156763637|NCT02155699|565887954|FG000|Overall Study|Withdrawal by Subject|0|||
156763638|NCT02155699|565887955|FG001|Overall Study|Withdrawal by Subject|3|||
156763639|NCT02155699|565887956|FG002|Overall Study|Withdrawal by Subject|6|||
156763640|NCT02155699|565887957|FG003|Overall Study|Withdrawal by Subject|1|||
156763641|NCT02155699|565887954|FG000|Overall Study|Lost to Follow-up|0|||
156763642|NCT02155699|565887955|FG001|Overall Study|Lost to Follow-up|0|||
156763643|NCT02155699|565887956|FG002|Overall Study|Lost to Follow-up|0|||
156763644|NCT02155699|565887957|FG003|Overall Study|Lost to Follow-up|3|||
156763645|NCT02155699|565887954|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
156763646|NCT02155699|565887955|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
156763647|NCT02155699|565887956|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
156763648|NCT02155699|565887957|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
156763649|NCT05547386|565887958|FG000|Overall Study|Withdrawal by Subject|7|||
156763650|NCT05852353|565887959|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
156763651|NCT05852353|565887959|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
156763652|NCT05852353|565887959|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
156763653|NCT05852353|565887959|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
156763654|NCT03509467|565887960|FG000|Overall Study|Withdrawal by Subject|5|||
156763655|NCT03509467|565887961|FG001|Overall Study|Withdrawal by Subject|1|||
156763656|NCT03509467|565887962|FG002|Overall Study|Withdrawal by Subject|6|||
156763657|NCT03509467|565887963|FG003|Overall Study|Withdrawal by Subject|7|||
156763658|NCT03509467|565887964|FG004|Overall Study|Withdrawal by Subject|10|||
156763659|NCT03509467|565887965|FG005|Overall Study|Withdrawal by Subject|10|||
156763660|NCT03509467|565887966|FG006|Overall Study|Withdrawal by Subject|10|||
156763661|NCT03509467|565887967|FG007|Overall Study|Withdrawal by Subject|10|||
156763662|NCT03509467|565887960|FG000|Overall Study|Death|0|||
156763663|NCT03509467|565887961|FG001|Overall Study|Death|0|||
156763664|NCT03509467|565887962|FG002|Overall Study|Death|2|||
156763665|NCT03509467|565887963|FG003|Overall Study|Death|2|||
156763666|NCT03509467|565887964|FG004|Overall Study|Death|1|||
156763667|NCT03509467|565887965|FG005|Overall Study|Death|0|||
156763668|NCT03509467|565887966|FG006|Overall Study|Death|1|||
156322317|NCT02380690|564278065|FG000|Overall Study|Withdrawal by Subject|20|||
156322318|NCT02380690|564278066|FG001|Overall Study|Withdrawal by Subject|8|||
156322319|NCT00266864|564278067|FG000|Overall Study|Lost to Follow-up|4|||
156322320|NCT00266864|564278068|FG001|Overall Study|Lost to Follow-up|1|||
156322321|NCT00266864|564278067|FG000|Overall Study|Withdrawal by Subject|1|||
156322322|NCT00266864|564278068|FG001|Overall Study|Withdrawal by Subject|1|||
156322323|NCT00727532|564278069|FG000|Overall Study|Adverse Event|1|||
156322324|NCT00727532|564278069|FG000|Overall Study|Withdrawal by Subject|1|||
156322325|NCT00829933|564278070|FG000|Overall Study|Adverse Event|2|||
156655338|NCT01893905|565485690|FG000|Overall Study|Protocol Violation|6|||
156655339|NCT01893905|565485691|FG001|Overall Study|Protocol Violation|1|||
156655340|NCT01893905|565485690|FG000|Overall Study|Lack of adherence to treatment|2|||
156655341|NCT01893905|565485691|FG001|Overall Study|Lack of adherence to treatment|0|||
156655342|NCT01893905|565485690|FG000|Overall Study|Other reason|1|||
156655343|NCT01893905|565485691|FG001|Overall Study|Other reason|3|||
156655344|NCT01768858|565485692|FG000|Overall Study|Lost to Follow-up|9|||
156655345|NCT01768858|565485692|FG000|Overall Study|Lack of Efficacy|8|||
156655346|NCT01768858|565485692|FG000|Overall Study|Serious Adverse Event|1|||
156655347|NCT01768858|565485692|FG000|Overall Study|Participant moved to Germany|1|||
156655348|NCT01768858|565485692|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
156655349|NCT01768858|565485692|FG000|Overall Study|Exanthema|1|||
156655350|NCT01768858|565485692|FG000|Overall Study|Withdrawal by Subject|1|||
156655351|NCT02742090|565485694|FG000|Overall Study|Adverse Event|10|||
156655352|NCT02742090|565485694|FG000|Overall Study|Death|3|||
156655353|NCT02742090|565485694|FG000|Overall Study|Disease Progression|25|||
156655354|NCT02742090|565485694|FG000|Overall Study|Investigator's Decision|1|||
156655355|NCT02742090|565485694|FG000|Overall Study|Lost to Follow-up|1|||
156655356|NCT02742090|565485694|FG000|Overall Study|Non-compliance with Study|1|||
156655357|NCT02742090|565485694|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
156655358|NCT02742090|565485694|FG000|Overall Study|Withdrawal by Subject|4|||
156655359|NCT02742090|565485694|FG000|Overall Study|Reason Not Specified|1|||
156655360|NCT02192905|565485701|FG000|Overall Study|Lost to Follow-up|1|||
156655361|NCT01691859|565485707|FG000|Overall Study|Adverse Event|19|||
156655362|NCT01691859|565485707|FG000|Overall Study|Lack of Efficacy|11|||
156655363|NCT01691859|565485707|FG000|Overall Study|Protocol Violation|4|||
156655364|NCT01691859|565485707|FG000|Overall Study|Product commercially available|221|||
156655365|NCT01691859|565485707|FG000|Overall Study|Study closed/terminated|50|||
156655366|NCT01691859|565485707|FG000|Overall Study|Lost to Follow-up|5|||
156655367|NCT01691859|565485707|FG000|Overall Study|Physician Decision|6|||
156655368|NCT01691859|565485707|FG000|Overall Study|Withdrawal by Subject|31|||
156655369|NCT00862979|565485710|FG000|Overall Study|Adverse Event|6|||
156655370|NCT00862979|565485711|FG001|Overall Study|Adverse Event|3|||
156655371|NCT00862979|565485710|FG000|Overall Study|Protocol Violation|0|||
156655372|NCT00862979|565485711|FG001|Overall Study|Protocol Violation|1|||
156655373|NCT00862979|565485710|FG000|Overall Study|Patient withdrew consent|2|||
156655374|NCT00862979|565485711|FG001|Overall Study|Patient withdrew consent|1|||
156655375|NCT00862979|565485710|FG000|Overall Study|Administrative problems|0|||
156655376|NCT00862979|565485711|FG001|Overall Study|Administrative problems|1|||
156655377|NCT00862979|565485710|FG000|Overall Study|Death|0|||
156655378|NCT00862979|565485711|FG001|Overall Study|Death|1|||
156655379|NCT02688400|565485713|FG000|Overall Study|Protocol Violation|2|||
156655380|NCT02688400|565485714|FG001|Overall Study|Protocol Violation|5|||
156655381|NCT02688400|565485713|FG000|Overall Study|Lack of Efficacy|7|||
156655382|NCT02688400|565485714|FG001|Overall Study|Lack of Efficacy|7|||
156655383|NCT02688400|565485713|FG000|Overall Study|Adverse Event|21|||
156655384|NCT02688400|565485714|FG001|Overall Study|Adverse Event|12|||
156655385|NCT02688400|565485713|FG000|Overall Study|Withdrawal by Subject|15|||
156655386|NCT02688400|565485714|FG001|Overall Study|Withdrawal by Subject|13|||
156655387|NCT02688400|565485713|FG000|Overall Study|No study medication intake|1|||
156655388|NCT02688400|565485714|FG001|Overall Study|No study medication intake|4|||
156655389|NCT02688400|565485713|FG000|Overall Study|Lost to Follow-up|0|||
156655390|NCT02688400|565485714|FG001|Overall Study|Lost to Follow-up|3|||
156655391|NCT00992407|565485715|FG000|Overall Study|Protocol Violation|2|||
156655392|NCT00992407|565485716|FG001|Overall Study|Protocol Violation|1|||
156655393|NCT00992407|565485715|FG000|Overall Study|Lost to Follow-up|3|||
156655394|NCT00992407|565485716|FG001|Overall Study|Lost to Follow-up|3|||
156655395|NCT00992407|565485715|FG000|Overall Study|Adverse Event|3|||
156655396|NCT00992407|565485716|FG001|Overall Study|Adverse Event|2|||
156655397|NCT00992407|565485715|FG000|Overall Study|protocol Violation & Adverse events|2|||
156655398|NCT00992407|565485716|FG001|Overall Study|protocol Violation & Adverse events|4|||
156655399|NCT00992407|565485715|FG000|Overall Study|Other|2|||
156655400|NCT00992407|565485716|FG001|Overall Study|Other|0|||
156655401|NCT00992407|565485715|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
156655402|NCT00992407|565485716|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
156655403|NCT00992407|565485715|FG000|Overall Study|Study medication not administered|17|||
156763669|NCT03509467|565887967|FG007|Overall Study|Death|0|||
156763670|NCT03509467|565887960|FG000|Overall Study|Proxy Withdrawal|0|||
156763671|NCT03509467|565887961|FG001|Overall Study|Proxy Withdrawal|0|||
156763672|NCT03509467|565887962|FG002|Overall Study|Proxy Withdrawal|0|||
156763673|NCT03509467|565887963|FG003|Overall Study|Proxy Withdrawal|0|||
156763674|NCT03509467|565887964|FG004|Overall Study|Proxy Withdrawal|0|||
156763675|NCT03509467|565887965|FG005|Overall Study|Proxy Withdrawal|0|||
156763676|NCT03509467|565887966|FG006|Overall Study|Proxy Withdrawal|0|||
156763677|NCT03509467|565887967|FG007|Overall Study|Proxy Withdrawal|1|||
156763678|NCT01005745|565887968|FG000|Overall Study|No TIL growth|1|||
156763679|NCT01005745|565887968|FG000|Overall Study|Disease progressed during TIL growth|3|||
156763680|NCT01005745|565887968|FG000|Overall Study|Death prior to treatment|1|||
156763681|NCT01005745|565887968|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
156763682|NCT03834506|565887969|FG000|Overall Study|Death|336|||
156763683|NCT03834506|565887970|FG001|Overall Study|Death|326|||
156763684|NCT03834506|565887969|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156763685|NCT03834506|565887970|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156763686|NCT03834506|565887969|FG000|Overall Study|Withdrawal by Subject|10|||
156763687|NCT03834506|565887970|FG001|Overall Study|Withdrawal by Subject|8|||
156763688|NCT03834506|565887969|FG000|Overall Study|Sponsor decision|165|||
156763689|NCT03834506|565887970|FG001|Overall Study|Sponsor decision|178|||
156763690|NCT03834506|565887969|FG000|Overall Study|Physician Decision|3|||
156763691|NCT03834506|565887970|FG001|Overall Study|Physician Decision|1|||
156763692|NCT03834506|565887969|FG000|Overall Study|Lost to Follow-up|0|||
156763693|NCT03834506|565887970|FG001|Overall Study|Lost to Follow-up|1|||
156763694|NCT02287038|565887973|FG000|Overall Study|Stopped attending appointments|3|||
156763695|NCT02287038|565887974|FG001|Overall Study|Stopped attending appointments|2|||
156763696|NCT02287038|565887973|FG000|Overall Study|Anxiety after starting medication|0|||
156763697|NCT02287038|565887974|FG001|Overall Study|Anxiety after starting medication|1|||
156763698|NCT02287038|565887973|FG000|Overall Study|Nausea after starting medication|1|||
156763699|NCT02287038|565887974|FG001|Overall Study|Nausea after starting medication|0|||
156763700|NCT02287038|565887973|FG000|Overall Study|Abnormal ECG after starting medication|1|||
156763701|NCT02287038|565887974|FG001|Overall Study|Abnormal ECG after starting medication|0|||
156763702|NCT05502302|565887980|FG000|Overall Study|Lost to Follow-up|6|||
156763703|NCT05502302|565887980|FG000|Overall Study|Death|2|||
156763704|NCT02998151|565887981|FG000|Overall Study|Withdrawal by Subject|3|||
156763705|NCT02998151|565887981|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
156763706|NCT02998151|565887981|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
156763707|NCT02667301|565887982|FG000|Overall Study|Adverse Event|1|||
156763708|NCT02667301|565887982|FG000|Overall Study|Lack of Efficacy|1|||
156763709|NCT01619878|565887984|FG000|6 Week Follow-up Phase|Adverse Event|1|||
156763710|NCT01619878|565887984|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
156763711|NCT01619878|565887984|FG000|Follow-up at 12 Months of Age|Death|2|||
156763712|NCT02895295|565887985|FG000|Overall Study|Survey Non-response|71|||
156763713|NCT02895295|565887986|FG001|Overall Study|Survey Non-response|94|||
156763714|NCT02895295|565887987|FG002|Overall Study|Survey Non-response|92|||
156763715|NCT05093933|565887988|FG000|Overall Study|Death|372|||
156763716|NCT05093933|565887989|FG001|Overall Study|Death|434|||
156763717|NCT05093933|565887988|FG000|Overall Study|Lost to Follow-up|13|||
156763718|NCT05093933|565887989|FG001|Overall Study|Lost to Follow-up|16|||
156763719|NCT05093933|565887988|FG000|Overall Study|Physician Decision|0|||
156763720|NCT05093933|565887989|FG001|Overall Study|Physician Decision|2|||
156763721|NCT05093933|565887988|FG000|Overall Study|Sponsor Decision|1|||
156763722|NCT05093933|565887989|FG001|Overall Study|Sponsor Decision|3|||
156763723|NCT05093933|565887988|FG000|Overall Study|Withdrawal by Guardian|1|||
156763724|NCT05093933|565887989|FG001|Overall Study|Withdrawal by Guardian|1|||
156322326|NCT00829933|564278071|FG001|Overall Study|Adverse Event|3|||
156322327|NCT00829933|564278072|FG002|Overall Study|Adverse Event|2|||
156322328|NCT00829933|564278073|FG003|Overall Study|Adverse Event|1|||
156322329|NCT00829933|564278070|FG000|Overall Study|Death|0|||
156322330|NCT00829933|564278071|FG001|Overall Study|Death|0|||
156322331|NCT00829933|564278072|FG002|Overall Study|Death|1|||
156322332|NCT00829933|564278073|FG003|Overall Study|Death|1|||
156322333|NCT00829933|564278070|FG000|Overall Study|Lack of Efficacy|0|||
156322334|NCT00829933|564278071|FG001|Overall Study|Lack of Efficacy|1|||
156322335|NCT00829933|564278072|FG002|Overall Study|Lack of Efficacy|0|||
156322336|NCT00829933|564278073|FG003|Overall Study|Lack of Efficacy|0|||
156322337|NCT00829933|564278070|FG000|Overall Study|Physician Decision|5|||
156322338|NCT00829933|564278071|FG001|Overall Study|Physician Decision|7|||
156322339|NCT00829933|564278072|FG002|Overall Study|Physician Decision|8|||
156322340|NCT00829933|564278073|FG003|Overall Study|Physician Decision|1|||
156322341|NCT00829933|564278070|FG000|Overall Study|Pregnancy|0|||
156322342|NCT00829933|564278071|FG001|Overall Study|Pregnancy|0|||
156322343|NCT00829933|564278072|FG002|Overall Study|Pregnancy|0|||
156322344|NCT00829933|564278073|FG003|Overall Study|Pregnancy|2|||
156763725|NCT05093933|565887988|FG000|Overall Study|Withdrawal by Subject|18|||
156763726|NCT05093933|565887989|FG001|Overall Study|Withdrawal by Subject|25|||
156763727|NCT04037358|565887990|FG000|Overall Study|Patient withdrew before intervention|1|||
156763728|NCT04037358|565887991|FG001|Overall Study|Patient withdrew before intervention|0|||
156763729|NCT04157517|565887994|FG000|Overall Study|Death|1|||
156763730|NCT04157517|565887995|FG001|Overall Study|Death|2|||
156763731|NCT04157517|565887996|FG002|Overall Study|Death|2|||
156763732|NCT04157517|565887997|FG003|Overall Study|Death|3|||
156763733|NCT04157517|565887998|FG004|Overall Study|Death|3|||
156763734|NCT04157517|565887999|FG005|Overall Study|Death|4|||
156763735|NCT04157517|565888000|FG006|Overall Study|Death|1|||
156322345|NCT00829933|564278070|FG000|Overall Study|Protocol Violation|2|||
156322346|NCT00829933|564278071|FG001|Overall Study|Protocol Violation|1|||
156322347|NCT00829933|564278072|FG002|Overall Study|Protocol Violation|0|||
156322348|NCT00829933|564278073|FG003|Overall Study|Protocol Violation|0|||
156322349|NCT00829933|564278070|FG000|Overall Study|withdrew before treatment started|5|||
156322350|NCT00829933|564278071|FG001|Overall Study|withdrew before treatment started|1|||
156322351|NCT00829933|564278072|FG002|Overall Study|withdrew before treatment started|2|||
156322352|NCT00829933|564278073|FG003|Overall Study|withdrew before treatment started|9|||
156322353|NCT03687970|564278077|FG000|Overall Study|visit scheduling conflicts|2|||
156322354|NCT03687970|564278078|FG001|Overall Study|visit scheduling conflicts|0|||
156322355|NCT05985980|564278085|FG000|Overall Study|Withdrawal by Subject|1|||
156322356|NCT05985980|564278085|FG000|Overall Study|Withdrawal by Subject|1|||
156322357|NCT05985980|564278085|FG000|Overall Study|Withdrawal by Subject|1|||
156322358|NCT05985980|564278085|FG000|Overall Study|Withdrawal by Subject|1|||
156322359|NCT00523367|564278086|FG000|Overall Study|19 screen failures|19|||
156322360|NCT00523367|564278086|FG000|Overall Study|4 Withdrawn by PI|4|||
156322361|NCT00356122|564278090|FG000|TREATMENT|Lack of Efficacy|26|||
156322362|NCT00356122|564278090|FG000|TREATMENT|Adverse Event|10|||
156322363|NCT00356122|564278090|FG000|TREATMENT|Subject's request|4|||
156322364|NCT00356122|564278090|FG000|TREATMENT|Other|4|||
156322365|NCT00356122|564278090|FG000|TREATMENT|Did not receive study medication|1|||
156322366|NCT00356122|564278090|FG000|FOLLOW-UP|Death|37|||
156322367|NCT00356122|564278090|FG000|FOLLOW-UP|Lost to Follow-up|2|||
156322368|NCT00356122|564278090|FG000|FOLLOW-UP|Other|2|||
156322369|NCT02483429|564278094|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
156322370|NCT02483429|564278095|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
156322371|NCT04090957|564278096|FG000|Overall Study|Lost to Follow-up|22|||
156322372|NCT04090957|564278097|FG001|Overall Study|Lost to Follow-up|25|||
156322373|NCT04090957|564278098|FG002|Overall Study|Lost to Follow-up|25|||
156322374|NCT04090957|564278099|FG003|Overall Study|Lost to Follow-up|36|||
156322375|NCT04090957|564278096|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
156322376|NCT04090957|564278097|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
156322377|NCT04090957|564278098|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
156322378|NCT04090957|564278099|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
156322379|NCT04090957|564278096|FG000|Overall Study|Adverse Event|19|||
156322380|NCT04090957|564278097|FG001|Overall Study|Adverse Event|25|||
156322381|NCT04090957|564278098|FG002|Overall Study|Adverse Event|8|||
156322382|NCT04090957|564278099|FG003|Overall Study|Adverse Event|104|||
156322383|NCT04090957|564278096|FG000|Overall Study|Other|10|||
156322384|NCT04090957|564278097|FG001|Overall Study|Other|6|||
156322385|NCT04090957|564278098|FG002|Overall Study|Other|5|||
156322386|NCT04090957|564278099|FG003|Overall Study|Other|12|||
156322387|NCT04090957|564278096|FG000|Overall Study|Serious Adverse Event|7|||
156322388|NCT04090957|564278097|FG001|Overall Study|Serious Adverse Event|11|||
156322389|NCT04090957|564278098|FG002|Overall Study|Serious Adverse Event|1|||
156322390|NCT04090957|564278099|FG003|Overall Study|Serious Adverse Event|32|||
156322391|NCT04090957|564278096|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
156322392|NCT04090957|564278097|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
156322393|NCT04090957|564278098|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
156322394|NCT04090957|564278099|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
156322395|NCT04090957|564278096|FG000|Overall Study|Lack of Efficacy|1|||
156322396|NCT04090957|564278097|FG001|Overall Study|Lack of Efficacy|1|||
156322397|NCT04090957|564278098|FG002|Overall Study|Lack of Efficacy|9|||
156322398|NCT04090957|564278099|FG003|Overall Study|Lack of Efficacy|0|||
156322399|NCT04090957|564278096|FG000|Overall Study|Protocol Violation|3|||
156322400|NCT04090957|564278097|FG001|Overall Study|Protocol Violation|5|||
156322401|NCT04090957|564278098|FG002|Overall Study|Protocol Violation|2|||
156322402|NCT04090957|564278099|FG003|Overall Study|Protocol Violation|1|||
156322403|NCT04090957|564278096|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
156322404|NCT04090957|564278097|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
156322405|NCT04090957|564278098|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
156322406|NCT04090957|564278099|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
156322407|NCT04090957|564278096|FG000|Overall Study|COVID-19|2|||
156322408|NCT04090957|564278097|FG001|Overall Study|COVID-19|2|||
156322409|NCT04090957|564278098|FG002|Overall Study|COVID-19|3|||
156763736|NCT04157517|565888001|FG007|Overall Study|Death|2|||
156763737|NCT04157517|565888002|FG008|Overall Study|Death|4|||
156763738|NCT04157517|565888003|FG009|Overall Study|Death|0|||
156763739|NCT04157517|565887994|FG000|Overall Study|Withdrawal by Subject|1|||
156322410|NCT04090957|564278099|FG003|Overall Study|COVID-19|7|||
156322411|NCT04090957|564278096|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
156322412|NCT04090957|564278097|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
156322413|NCT04090957|564278098|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
156322414|NCT04090957|564278099|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
156322415|NCT04090957|564278096|FG000|Overall Study|Physician Decision|2|||
156322416|NCT04090957|564278097|FG001|Overall Study|Physician Decision|1|||
156322417|NCT04090957|564278098|FG002|Overall Study|Physician Decision|1|||
156322418|NCT04090957|564278099|FG003|Overall Study|Physician Decision|5|||
156322419|NCT04090957|564278096|FG000|Overall Study|Sponsor Decision|1|||
156322420|NCT04090957|564278097|FG001|Overall Study|Sponsor Decision|1|||
156322421|NCT04090957|564278098|FG002|Overall Study|Sponsor Decision|1|||
156322422|NCT04090957|564278099|FG003|Overall Study|Sponsor Decision|3|||
156322423|NCT04090957|564278096|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
156322424|NCT04090957|564278097|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
156322425|NCT04090957|564278098|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
156322426|NCT04090957|564278099|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
156322427|NCT04090957|564278096|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
156322428|NCT04090957|564278097|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
156322429|NCT04090957|564278098|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
156322430|NCT04090957|564278099|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
156322431|NCT04090957|564278096|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
156322432|NCT04090957|564278097|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
156322433|NCT04090957|564278098|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
156322434|NCT04090957|564278099|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
156322435|NCT04090957|564278096|FG000|Overall Study|Death|1|||
156322436|NCT04090957|564278097|FG001|Overall Study|Death|0|||
156322437|NCT04090957|564278098|FG002|Overall Study|Death|0|||
156322438|NCT04090957|564278099|FG003|Overall Study|Death|0|||
156322439|NCT04090957|564278096|FG000|Overall Study|No Treatment Administered|2|||
156322440|NCT04090957|564278097|FG001|Overall Study|No Treatment Administered|1|||
156322441|NCT04090957|564278098|FG002|Overall Study|No Treatment Administered|2|||
156322442|NCT04090957|564278099|FG003|Overall Study|No Treatment Administered|1|||
156322443|NCT01683019|564280139|FG000|Overall Study|Withdrawal by Subject|2|||
156322444|NCT01683019|564280140|FG001|Overall Study|Withdrawal by Subject|1|||
156322445|NCT01683019|564280141|FG002|Overall Study|Withdrawal by Subject|4|||
156322446|NCT00543855|564280142|FG000|Overall Study|Adverse Event|3|||
156322447|NCT00543855|564280143|FG001|Overall Study|Adverse Event|1|||
156322448|NCT00543855|564280144|FG002|Overall Study|Adverse Event|3|||
156322449|NCT00543855|564280145|FG003|Overall Study|Adverse Event|4|||
156322450|NCT00543855|564280142|FG000|Overall Study|Lost to Follow-up|0|||
156322451|NCT00543855|564280143|FG001|Overall Study|Lost to Follow-up|0|||
156322452|NCT00543855|564280144|FG002|Overall Study|Lost to Follow-up|1|||
156322453|NCT00543855|564280145|FG003|Overall Study|Lost to Follow-up|0|||
156655404|NCT00992407|565485716|FG001|Overall Study|Study medication not administered|13|||
156655405|NCT03738332|565485717|FG000|Overall Study|Withdrawal by Subject|1|||
156655406|NCT01521559|565485718|FG000|Overall Study|Adverse Event|0|||
156655407|NCT01521559|565485719|FG001|Overall Study|Adverse Event|4|||
156655408|NCT01521559|565485718|FG000|Overall Study|Death|1|||
156655409|NCT01521559|565485719|FG001|Overall Study|Death|0|||
156655410|NCT01521559|565485718|FG000|Overall Study|Withdrawal by Subject|9|||
156655411|NCT01521559|565485719|FG001|Overall Study|Withdrawal by Subject|11|||
156655412|NCT01521559|565485718|FG000|Overall Study|Lost to Follow-up|3|||
156655413|NCT01521559|565485719|FG001|Overall Study|Lost to Follow-up|1|||
156655414|NCT01521559|565485718|FG000|Overall Study|Protocol Violation|1|||
156655415|NCT01521559|565485719|FG001|Overall Study|Protocol Violation|0|||
156655416|NCT01521559|565485718|FG000|Overall Study|Other|1|||
156655417|NCT01521559|565485719|FG001|Overall Study|Other|2|||
156655418|NCT02336737|565485720|FG000|Overall Study|Withdrawal by Subject|5|||
156655419|NCT02336737|565485720|FG000|Overall Study|Physician Decision|8|||
156655420|NCT00576381|565485727|FG000|Overall Study|Reoperation|3|||
156655421|NCT00576381|565485727|FG000|Overall Study|Adverse Event|4|||
156655422|NCT02518113|565485728|FG000|Overall Study|Adverse Event|1|||
156655423|NCT02518113|565485729|FG001|Overall Study|Adverse Event|0|||
156655424|NCT02518113|565485730|FG002|Overall Study|Adverse Event|1|||
156655425|NCT02518113|565485731|FG003|Overall Study|Adverse Event|0|||
156655426|NCT02518113|565485728|FG000|Overall Study|Death|1|||
156655427|NCT02518113|565485729|FG001|Overall Study|Death|2|||
156655428|NCT02518113|565485730|FG002|Overall Study|Death|0|||
156655429|NCT02518113|565485731|FG003|Overall Study|Death|0|||
156655430|NCT02518113|565485728|FG000|Overall Study|Physician Decision|0|||
156655431|NCT02518113|565485729|FG001|Overall Study|Physician Decision|1|||
156655432|NCT02518113|565485730|FG002|Overall Study|Physician Decision|0|||
156655433|NCT02518113|565485731|FG003|Overall Study|Physician Decision|0|||
156655434|NCT02518113|565485728|FG000|Overall Study|Progressive Disease|1|||
156655435|NCT02518113|565485729|FG001|Overall Study|Progressive Disease|2|||
156763740|NCT04157517|565887995|FG001|Overall Study|Withdrawal by Subject|1|||
156763741|NCT04157517|565887996|FG002|Overall Study|Withdrawal by Subject|1|||
156763742|NCT04157517|565887997|FG003|Overall Study|Withdrawal by Subject|0|||
156763743|NCT04157517|565887998|FG004|Overall Study|Withdrawal by Subject|0|||
156763744|NCT04157517|565887999|FG005|Overall Study|Withdrawal by Subject|1|||
156763745|NCT04157517|565888000|FG006|Overall Study|Withdrawal by Subject|0|||
156763746|NCT04157517|565888001|FG007|Overall Study|Withdrawal by Subject|0|||
156763747|NCT04157517|565888002|FG008|Overall Study|Withdrawal by Subject|1|||
156763748|NCT04157517|565888003|FG009|Overall Study|Withdrawal by Subject|0|||
156763749|NCT04157517|565887994|FG000|Overall Study|Other|1|||
156763750|NCT04157517|565887995|FG001|Overall Study|Other|0|||
156763751|NCT04157517|565887996|FG002|Overall Study|Other|0|||
156763752|NCT04157517|565887997|FG003|Overall Study|Other|0|||
156763753|NCT04157517|565887998|FG004|Overall Study|Other|0|||
156763754|NCT04157517|565887999|FG005|Overall Study|Other|1|||
156763755|NCT04157517|565888000|FG006|Overall Study|Other|2|||
156763756|NCT04157517|565888001|FG007|Overall Study|Other|7|||
156763757|NCT04157517|565888002|FG008|Overall Study|Other|7|||
156763758|NCT04157517|565888003|FG009|Overall Study|Other|0|||
156763759|NCT03433898|565888006|FG000|Overall Study|Progressive disease|6|||
156763760|NCT03433898|565888007|FG001|Overall Study|Progressive disease|3|||
156763761|NCT03433898|565888008|FG002|Overall Study|Progressive disease|3|||
156763762|NCT03433898|565888009|FG003|Overall Study|Progressive disease|2|||
156763763|NCT03433898|565888010|FG004|Overall Study|Progressive disease|30|||
156763764|NCT03433898|565888011|FG005|Overall Study|Progressive disease|29|||
156763765|NCT03433898|565888012|FG006|Overall Study|Progressive disease|17|||
156763766|NCT03433898|565888013|FG007|Overall Study|Progressive disease|30|||
156763767|NCT03433898|565888006|FG000|Overall Study|Not treated|1|||
156763768|NCT03433898|565888007|FG001|Overall Study|Not treated|0|||
156763769|NCT03433898|565888008|FG002|Overall Study|Not treated|0|||
156763770|NCT03433898|565888009|FG003|Overall Study|Not treated|0|||
156763771|NCT03433898|565888010|FG004|Overall Study|Not treated|1|||
156763772|NCT03433898|565888011|FG005|Overall Study|Not treated|0|||
156763773|NCT03433898|565888012|FG006|Overall Study|Not treated|0|||
156763774|NCT03433898|565888013|FG007|Overall Study|Not treated|0|||
156763775|NCT03433898|565888006|FG000|Overall Study|Death|0|||
156763776|NCT03433898|565888007|FG001|Overall Study|Death|0|||
156763777|NCT03433898|565888008|FG002|Overall Study|Death|0|||
156763778|NCT03433898|565888009|FG003|Overall Study|Death|0|||
156763779|NCT03433898|565888010|FG004|Overall Study|Death|0|||
156763780|NCT03433898|565888011|FG005|Overall Study|Death|0|||
156763781|NCT03433898|565888012|FG006|Overall Study|Death|1|||
156322454|NCT00543855|564280142|FG000|Overall Study|Withdrawal by Subject|0|||
156322455|NCT00543855|564280143|FG001|Overall Study|Withdrawal by Subject|1|||
156322456|NCT00543855|564280144|FG002|Overall Study|Withdrawal by Subject|2|||
156322457|NCT00543855|564280145|FG003|Overall Study|Withdrawal by Subject|0|||
156322458|NCT00543855|564280142|FG000|Overall Study|Protocol Violation|1|||
156322459|NCT00543855|564280143|FG001|Overall Study|Protocol Violation|0|||
156322460|NCT00543855|564280144|FG002|Overall Study|Protocol Violation|0|||
156322461|NCT00543855|564280145|FG003|Overall Study|Protocol Violation|0|||
156322462|NCT04854642|564280146|FG000|Overall Study|Adverse Event|1|||
156322463|NCT04854642|564280147|FG001|Overall Study|Adverse Event|2|||
156322464|NCT04854642|564280146|FG000|Overall Study|Withdrawal by Subject|0|||
156322465|NCT04854642|564280147|FG001|Overall Study|Withdrawal by Subject|1|||
156322466|NCT00301821|564280152|FG000|Overall Study|Ineligible|25|||
156322467|NCT00301821|564280152|FG000|Overall Study|Cancel|1|||
156322468|NCT02294773|564280153|FG000|Overall Study|Withdrawal by Subject|0|||
156322469|NCT02294773|564280154|FG001|Overall Study|Withdrawal by Subject|2|||
156322470|NCT01865084|564280155|FG000|Double Blind Period (DB)|Adverse Event|2|||
156322471|NCT01865084|564280156|FG001|Double Blind Period (DB)|Adverse Event|2|||
156322472|NCT01865084|564280157|FG002|Double Blind Period (DB)|Adverse Event|1|||
156322473|NCT01865084|564280155|FG000|Double Blind Period (DB)|Protocol Violation|0|||
156655436|NCT02518113|565485730|FG002|Overall Study|Progressive Disease|3|||
156655437|NCT02518113|565485731|FG003|Overall Study|Progressive Disease|0|||
156655438|NCT00797108|565485732|FG000|Overall Study|Adverse Event|1|||
156655439|NCT00797108|565485733|FG001|Overall Study|Adverse Event|0|||
156655440|NCT00797108|565485734|FG002|Overall Study|Adverse Event|3|||
156655441|NCT00797108|565485732|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
156655442|NCT00797108|565485733|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
156655443|NCT00797108|565485734|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
156655444|NCT00797108|565485732|FG000|Overall Study|Global Deterioration of Health Status|0|||
156655445|NCT00797108|565485733|FG001|Overall Study|Global Deterioration of Health Status|1|||
156655446|NCT00797108|565485734|FG002|Overall Study|Global Deterioration of Health Status|0|||
156655447|NCT00797108|565485732|FG000|Overall Study|Lack of Efficacy|1|||
156655448|NCT00797108|565485733|FG001|Overall Study|Lack of Efficacy|0|||
156655449|NCT00797108|565485734|FG002|Overall Study|Lack of Efficacy|1|||
156763782|NCT03433898|565888013|FG007|Overall Study|Death|1|||
156655450|NCT00797108|565485732|FG000|Overall Study|Other|0|||
156763783|NCT03433898|565888006|FG000|Overall Study|Withdrawal by Subject|0|||
156763784|NCT03433898|565888007|FG001|Overall Study|Withdrawal by Subject|0|||
156763785|NCT03433898|565888008|FG002|Overall Study|Withdrawal by Subject|0|||
156763786|NCT03433898|565888009|FG003|Overall Study|Withdrawal by Subject|0|||
156763787|NCT03433898|565888010|FG004|Overall Study|Withdrawal by Subject|2|||
156763788|NCT03433898|565888011|FG005|Overall Study|Withdrawal by Subject|0|||
156763789|NCT03433898|565888012|FG006|Overall Study|Withdrawal by Subject|0|||
156763790|NCT03433898|565888013|FG007|Overall Study|Withdrawal by Subject|0|||
156763791|NCT03433898|565888006|FG000|Overall Study|Adverse Event|0|||
156763792|NCT03433898|565888007|FG001|Overall Study|Adverse Event|0|||
156763793|NCT03433898|565888008|FG002|Overall Study|Adverse Event|0|||
156763794|NCT03433898|565888009|FG003|Overall Study|Adverse Event|0|||
156763795|NCT03433898|565888010|FG004|Overall Study|Adverse Event|0|||
156763796|NCT03433898|565888011|FG005|Overall Study|Adverse Event|5|||
156763797|NCT03433898|565888012|FG006|Overall Study|Adverse Event|2|||
156763798|NCT03433898|565888013|FG007|Overall Study|Adverse Event|2|||
156763799|NCT03433898|565888006|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763800|NCT03433898|565888007|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763801|NCT03433898|565888008|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763802|NCT03433898|565888009|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763803|NCT03433898|565888010|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
156763804|NCT03433898|565888011|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763805|NCT03433898|565888012|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763806|NCT03433898|565888013|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763807|NCT05027815|565888016|FG000|Overall Study|Death|2|||
156763808|NCT05027815|565888017|FG001|Overall Study|Death|1|||
156763809|NCT05069259|565888021|FG000|Overall Study|Withdrawal by Subject|1|||
156763810|NCT05069259|565888021|FG000|Overall Study|Sponsor decision|1|||
156763811|NCT00447902|565888023|FG000|Overall Study|Adverse Event|0|||
156763812|NCT00447902|565888024|FG001|Overall Study|Adverse Event|3|||
156763813|NCT00447902|565888023|FG000|Overall Study|Protocol Violation|1|||
156763814|NCT00447902|565888024|FG001|Overall Study|Protocol Violation|0|||
156763815|NCT00447902|565888023|FG000|Overall Study|Withdrawal by Subject|0|||
156763816|NCT00447902|565888024|FG001|Overall Study|Withdrawal by Subject|1|||
156763817|NCT00447902|565888023|FG000|Overall Study|included patients who discontinued|1|||
156763818|NCT00447902|565888024|FG001|Overall Study|included patients who discontinued|1|||
156763819|NCT00447902|565888023|FG000|Overall Study|Lack of Efficacy|2|||
156763820|NCT00447902|565888024|FG001|Overall Study|Lack of Efficacy|1|||
156763821|NCT00870727|565889503|FG000|Overall Study|Lost to Follow-up|0|||
156763822|NCT00870727|565889504|FG001|Overall Study|Lost to Follow-up|1|||
156763823|NCT00870727|565889503|FG000|Overall Study|Lack of Efficacy|1|||
156763824|NCT00870727|565889504|FG001|Overall Study|Lack of Efficacy|3|||
156763825|NCT00870727|565889503|FG000|Overall Study|Adverse Event|0|||
156763826|NCT00870727|565889504|FG001|Overall Study|Adverse Event|1|||
156763827|NCT01712516|565889505|FG000|Overall Study|Technical problems|0|||
156763828|NCT01712516|565889506|FG001|Overall Study|Technical problems|0|||
156763829|NCT01712516|565889507|FG002|Overall Study|Technical problems|0|||
156763830|NCT01712516|565889508|FG003|Overall Study|Technical problems|2|||
156763831|NCT01712516|565889505|FG000|Overall Study|Lost to Follow-up|0|||
156763832|NCT01712516|565889506|FG001|Overall Study|Lost to Follow-up|0|||
156763833|NCT01712516|565889507|FG002|Overall Study|Lost to Follow-up|2|||
156763834|NCT01712516|565889508|FG003|Overall Study|Lost to Follow-up|1|||
156763835|NCT01712516|565889505|FG000|Overall Study|Death|0|||
156763836|NCT01712516|565889506|FG001|Overall Study|Death|1|||
156763837|NCT01712516|565889507|FG002|Overall Study|Death|0|||
156763838|NCT01712516|565889508|FG003|Overall Study|Death|0|||
156763839|NCT01712516|565889505|FG000|Overall Study|Protocol deviation|1|||
156763840|NCT01712516|565889506|FG001|Overall Study|Protocol deviation|0|||
156763841|NCT01712516|565889507|FG002|Overall Study|Protocol deviation|1|||
156763842|NCT01712516|565889508|FG003|Overall Study|Protocol deviation|0|||
156763843|NCT01712516|565889505|FG000|Overall Study|Physician Decision|2|||
156763844|NCT01712516|565889506|FG001|Overall Study|Physician Decision|0|||
156763845|NCT01712516|565889507|FG002|Overall Study|Physician Decision|0|||
156763846|NCT01712516|565889508|FG003|Overall Study|Physician Decision|1|||
156763847|NCT01712516|565889505|FG000|Overall Study|Withdrawal by Subject|3|||
156763848|NCT01712516|565889506|FG001|Overall Study|Withdrawal by Subject|9|||
156763849|NCT01712516|565889507|FG002|Overall Study|Withdrawal by Subject|3|||
156763850|NCT01712516|565889508|FG003|Overall Study|Withdrawal by Subject|9|||
156763851|NCT01251952|565889509|FG000|Overall Study|Adverse Event|1|||
156763852|NCT00496769|565889510|FG000|Double Blind|>=1 reason assigned per patient|558|||
156763853|NCT00496769|565889511|FG001|Double Blind|>=1 reason assigned per patient|649|||
156763854|NCT00496769|565889512|FG002|Double Blind|>=1 reason assigned per patient|0|||
156763855|NCT00496769|565889510|FG000|Open Label|>=1 reason assigned per patient|0|||
156763856|NCT00496769|565889511|FG001|Open Label|>=1 reason assigned per patient|0|||
156763857|NCT00496769|565889512|FG002|Open Label|>=1 reason assigned per patient|1011|||
156763858|NCT02224625|565889518|FG000|Irritation|Adverse Event|6|||
156763859|NCT02224625|565889518|FG000|Sensitization|Adverse Event|55|||
156763860|NCT01433159|565889522|FG000|Overall Study|Adverse Event|1|||
156763861|NCT01433159|565889523|FG001|Overall Study|Adverse Event|0|||
156763862|NCT01433159|565889522|FG000|Overall Study|Physician Decision|1|||
156426218|NCT04888585|564652888|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
156426219|NCT04888585|564652889|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
156426220|NCT04888585|564652890|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
156426221|NCT04888585|564652891|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
156426222|NCT04888585|564652892|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
156426223|NCT04888585|564652893|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
156655451|NCT00797108|565485733|FG001|Overall Study|Other|0|||
156322474|NCT01865084|564280156|FG001|Double Blind Period (DB)|Protocol Violation|0|||
156322475|NCT01865084|564280157|FG002|Double Blind Period (DB)|Protocol Violation|1|||
156322476|NCT01865084|564280155|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
156322477|NCT01865084|564280156|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
156322478|NCT01865084|564280157|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
156322479|NCT01865084|564280155|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
156322480|NCT01865084|564280156|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
156322481|NCT01865084|564280157|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
156322482|NCT01865084|564280155|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
156322483|NCT01865084|564280156|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
156322484|NCT01865084|564280157|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
156322485|NCT01865084|564280155|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
156322486|NCT01865084|564280156|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
156322487|NCT01865084|564280157|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
156322488|NCT01865084|564280155|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
156322489|NCT01865084|564280156|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
156322490|NCT01865084|564280157|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
156322491|NCT01865084|564280155|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
156322492|NCT01865084|564280156|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
156322493|NCT01865084|564280157|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
156322494|NCT01865084|564280155|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
156322495|NCT01865084|564280156|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
156322496|NCT01865084|564280157|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
156322497|NCT03332771|564280158|FG000|Overall Study|Adverse Event|6|||
156322498|NCT03332771|564280159|FG001|Overall Study|Adverse Event|4|||
156322499|NCT03332771|564280160|FG002|Overall Study|Adverse Event|1|||
156322500|NCT03332771|564280161|FG003|Overall Study|Adverse Event|3|||
156322501|NCT03332771|564280158|FG000|Overall Study|Poor Compliance to Protocol|0|||
156322502|NCT03332771|564280159|FG001|Overall Study|Poor Compliance to Protocol|1|||
156322503|NCT03332771|564280160|FG002|Overall Study|Poor Compliance to Protocol|0|||
156322504|NCT03332771|564280161|FG003|Overall Study|Poor Compliance to Protocol|1|||
156322505|NCT03332771|564280158|FG000|Overall Study|Lost to Follow-up|2|||
156322506|NCT03332771|564280159|FG001|Overall Study|Lost to Follow-up|2|||
156322507|NCT03332771|564280160|FG002|Overall Study|Lost to Follow-up|1|||
156322508|NCT03332771|564280161|FG003|Overall Study|Lost to Follow-up|2|||
156322509|NCT03332771|564280158|FG000|Overall Study|At the Participant's own request|20|||
156322510|NCT03332771|564280159|FG001|Overall Study|At the Participant's own request|26|||
156322511|NCT03332771|564280160|FG002|Overall Study|At the Participant's own request|14|||
156322512|NCT03332771|564280161|FG003|Overall Study|At the Participant's own request|23|||
156322513|NCT03332771|564280158|FG000|Overall Study|Reason Not Specified|6|||
156322514|NCT03332771|564280159|FG001|Overall Study|Reason Not Specified|18|||
156322515|NCT03332771|564280160|FG002|Overall Study|Reason Not Specified|16|||
156322516|NCT03332771|564280161|FG003|Overall Study|Reason Not Specified|19|||
156322517|NCT01277042|564280162|FG000|Overall Study|Adverse Event|4|||
156655452|NCT00797108|565485734|FG002|Overall Study|Other|2|||
156322518|NCT01277042|564280163|FG001|Overall Study|Adverse Event|3|||
156655453|NCT00797108|565485732|FG000|Overall Study|Randomized but not Treated|2|||
156655454|NCT00797108|565485733|FG001|Overall Study|Randomized but not Treated|0|||
156655455|NCT00797108|565485734|FG002|Overall Study|Randomized but not Treated|0|||
156655456|NCT00287118|565485735|FG000|Overall Study|Adverse Event|30|||
156655457|NCT00287118|565485735|FG000|Overall Study|Death|1|||
156655458|NCT00287118|565485735|FG000|Overall Study|Lack of Efficacy|11|||
156655459|NCT00287118|565485735|FG000|Overall Study|Lost to Follow-up|1|||
156655460|NCT00287118|565485735|FG000|Overall Study|Protocol Violation|2|||
156655461|NCT00287118|565485735|FG000|Overall Study|Other|7|||
156655462|NCT02324465|565485736|FG000|Overall Study|device failure|0|||
156655463|NCT02324465|565485737|FG001|Overall Study|device failure|1|||
156655464|NCT01631864|565485738|FG000|Overall Study|Withdrawal by Subject|0|||
156655465|NCT01631864|565485739|FG001|Overall Study|Withdrawal by Subject|1|||
156655466|NCT01631864|565485738|FG000|Overall Study|Adverse Event|2|||
156655467|NCT01631864|565485739|FG001|Overall Study|Adverse Event|3|||
156655468|NCT01031537|565485740|FG000|Overall Study|medical reasons not related to study|3|||
156655469|NCT01031537|565485740|FG000|Overall Study|Lack of Efficacy|1|||
156655470|NCT01031537|565485740|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
156763863|NCT01433159|565889523|FG001|Overall Study|Physician Decision|0|||
156763864|NCT01433159|565889522|FG000|Overall Study|Protocol Violation|0|||
156763865|NCT01433159|565889523|FG001|Overall Study|Protocol Violation|1|||
156763866|NCT01100853|565889524|FG000|Overall Study|Lost to Follow-up|11|||
156763867|NCT01100853|565889525|FG001|Overall Study|Lost to Follow-up|6|||
156763868|NCT01100853|565889524|FG000|Overall Study|Received <4 study injections|10|||
156763869|NCT01100853|565889525|FG001|Overall Study|Received <4 study injections|13|||
156763870|NCT01100853|565889524|FG000|Overall Study|Withdrawal by Subject|6|||
156763871|NCT01100853|565889525|FG001|Overall Study|Withdrawal by Subject|4|||
156763872|NCT01384877|565889526|FG000|Treatment 2|Lost to Follow-up|2|||
156763873|NCT01384877|565889527|FG001|Treatment 2|Lost to Follow-up|2|||
156763874|NCT01548404|565889528|FG000|Overall Study|Adverse Event|3|||
156763875|NCT01548404|565889529|FG001|Overall Study|Adverse Event|1|||
156763876|NCT01548404|565889528|FG000|Overall Study|Physician Decision|2|||
156322519|NCT01277042|564280162|FG000|Overall Study|Lost to Follow-up|2|||
156322520|NCT01277042|564280163|FG001|Overall Study|Lost to Follow-up|2|||
156763877|NCT01548404|565889529|FG001|Overall Study|Physician Decision|1|||
156763878|NCT01548404|565889528|FG000|Overall Study|Inadequate response to study treatment|23|||
156763879|NCT01548404|565889529|FG001|Overall Study|Inadequate response to study treatment|7|||
156763880|NCT01548404|565889528|FG000|Overall Study|Lost to Follow-up|2|||
156763881|NCT01548404|565889529|FG001|Overall Study|Lost to Follow-up|0|||
156763882|NCT01548404|565889528|FG000|Overall Study|Withdrawal by Subject|0|||
156763883|NCT01548404|565889529|FG001|Overall Study|Withdrawal by Subject|3|||
156763884|NCT01548404|565889528|FG000|Overall Study|Other than specified above|0|||
156763885|NCT01548404|565889529|FG001|Overall Study|Other than specified above|2|||
156763886|NCT00426270|565889530|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
156763887|NCT00426270|565889530|FG000|Overall Study|Adverse Event|5|||
156763888|NCT01117870|565889531|FG000|Overall Study|Inability to place needle|1|||
156763889|NCT01117870|565889532|FG001|Overall Study|Inability to place needle|0|||
156763890|NCT01774981|565889535|FG000|Overall Study|Adverse Event|0|||
156763891|NCT01774981|565889536|FG001|Overall Study|Adverse Event|0|||
156763892|NCT01774981|565889537|FG002|Overall Study|Adverse Event|0|||
156763893|NCT01774981|565889538|FG003|Overall Study|Adverse Event|0|||
156763894|NCT01774981|565889539|FG004|Overall Study|Adverse Event|0|||
156763895|NCT01774981|565889540|FG005|Overall Study|Adverse Event|1|||
156763896|NCT01774981|565889541|FG006|Overall Study|Adverse Event|0|||
156763897|NCT01774981|565889542|FG007|Overall Study|Adverse Event|0|||
156763898|NCT01774981|565889535|FG000|Overall Study|Withdrawal by Subject|0|||
156763899|NCT01774981|565889536|FG001|Overall Study|Withdrawal by Subject|0|||
156763900|NCT01774981|565889537|FG002|Overall Study|Withdrawal by Subject|0|||
156763901|NCT01774981|565889538|FG003|Overall Study|Withdrawal by Subject|0|||
156763902|NCT01774981|565889539|FG004|Overall Study|Withdrawal by Subject|0|||
156763903|NCT01774981|565889540|FG005|Overall Study|Withdrawal by Subject|0|||
156763904|NCT01774981|565889541|FG006|Overall Study|Withdrawal by Subject|0|||
156763905|NCT01774981|565889542|FG007|Overall Study|Withdrawal by Subject|1|||
156763906|NCT01774981|565889535|FG000|Overall Study|Death|0|||
156763907|NCT01774981|565889536|FG001|Overall Study|Death|0|||
156763908|NCT01774981|565889537|FG002|Overall Study|Death|0|||
156763909|NCT01774981|565889538|FG003|Overall Study|Death|0|||
156763910|NCT01774981|565889539|FG004|Overall Study|Death|1|||
156763911|NCT01774981|565889540|FG005|Overall Study|Death|0|||
156322521|NCT01277042|564280162|FG000|Overall Study|Withdrawal by Subject|2|||
156763912|NCT01774981|565889541|FG006|Overall Study|Death|0|||
156763913|NCT01774981|565889542|FG007|Overall Study|Death|0|||
156763914|NCT00960193|565889543|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
156763915|NCT01324102|565889546|FG000|Overall Study|illness|1|||
156763916|NCT01324102|565889547|FG001|Overall Study|illness|6|||
156763917|NCT00728494|565889548|FG000|Overall Study|Adverse Event|7|||
156763918|NCT00728494|565889549|FG001|Overall Study|Adverse Event|0|||
156763919|NCT00728494|565889548|FG000|Overall Study|Withdrawal by Subject|0|||
156763920|NCT00728494|565889549|FG001|Overall Study|Withdrawal by Subject|2|||
156763921|NCT00728494|565889548|FG000|Overall Study|Lack of Efficacy|2|||
156763922|NCT00728494|565889549|FG001|Overall Study|Lack of Efficacy|4|||
156763923|NCT00728494|565889548|FG000|Overall Study|No data available|0|||
156763924|NCT00728494|565889549|FG001|Overall Study|No data available|1|||
156763925|NCT00001566|565889550|FG000|Overall Study|patients' choice to discontinue protocol|3|||
156763926|NCT00001566|565889550|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
156763927|NCT00001566|565889550|FG000|Overall Study|Death|13|||
156763928|NCT00001566|565889550|FG000|Overall Study|Lost to Follow-up|1|||
156322522|NCT01277042|564280163|FG001|Overall Study|Withdrawal by Subject|0|||
156763929|NCT00001566|565889550|FG000|Overall Study|unable to complete initial apheresis|1|||
156763930|NCT00433836|565889551|FG000|Overall Study|Adverse Event|7|||
156763931|NCT00433836|565889552|FG001|Overall Study|Adverse Event|0|||
156763932|NCT00433836|565889551|FG000|Overall Study|Lost to Follow-up|3|||
156763933|NCT00433836|565889552|FG001|Overall Study|Lost to Follow-up|0|||
156322523|NCT03034200|564280164|FG000|Overall Study|Disease progression|8|||
156763934|NCT00433836|565889551|FG000|Overall Study|Withdrawal by Subject|2|||
156763935|NCT00433836|565889552|FG001|Overall Study|Withdrawal by Subject|1|||
156763936|NCT00433836|565889551|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156763937|NCT00433836|565889552|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156763938|NCT00433836|565889551|FG000|Overall Study|Protocol Violation|0|||
156763939|NCT00433836|565889552|FG001|Overall Study|Protocol Violation|2|||
156763940|NCT00433836|565889551|FG000|Overall Study|Condition no longer requires study drug|0|||
156763941|NCT00433836|565889552|FG001|Overall Study|Condition no longer requires study drug|1|||
156763942|NCT00433836|565889551|FG000|Overall Study|Abnormal laboratory values|0|||
156763943|NCT00433836|565889552|FG001|Overall Study|Abnormal laboratory values|1|||
156763944|NCT00748241|565889553|FG000|Overall Study|Implant failure|1|||
156763945|NCT00748241|565889553|FG000|Overall Study|Lost to Follow-up|5|||
156763946|NCT00748241|565889553|FG000|Overall Study|Death|2|||
156763947|NCT02456727|565889554|FG000|Overall Study|Lost to Follow-up|63|||
156763948|NCT02456727|565889555|FG001|Overall Study|Lost to Follow-up|65|||
156763949|NCT02456727|565889554|FG000|Overall Study|Death|2|||
156763950|NCT02456727|565889555|FG001|Overall Study|Death|1|||
156763951|NCT02456727|565889554|FG000|Overall Study|Withdrawal by Subject|1|||
156763952|NCT02456727|565889555|FG001|Overall Study|Withdrawal by Subject|10|||
156763953|NCT02456727|565889554|FG000|Overall Study|Never Initiated Treatment|43|||
156763954|NCT02456727|565889555|FG001|Overall Study|Never Initiated Treatment|30|||
156655471|NCT01031537|565485740|FG000|Overall Study|moved, met exclusion criteria|10|||
156655472|NCT01031537|565485740|FG000|Overall Study|Withdrawal by Subject|5|||
156655473|NCT01031537|565485740|FG000|Overall Study|PI removal, no longer met eligibility|12|||
156655474|NCT01506947|565485764|FG000|Overall Study|Lost to Follow-up|7|||
156655475|NCT01506947|565485764|FG000|Overall Study|Adverse Event|5|||
156655476|NCT01506947|565485764|FG000|Overall Study|Death|1|||
156655477|NCT01506947|565485764|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
156655478|NCT00290745|565485766|FG000|Overall Study|Withdrawal by Subject|4|||
156655479|NCT00290745|565485766|FG000|Overall Study|Physician Decision|2|||
156655480|NCT00290745|565485766|FG000|Overall Study|Surgery after 3 months for progression|3|||
156655481|NCT00290745|565485766|FG000|Overall Study|Baseline MRI not available|3|||
156655482|NCT01802879|565485771|FG000|Overall Study|Administrative problems|2|||
156655483|NCT01802879|565485771|FG000|Overall Study|Disease progression|6|||
156655484|NCT00266409|565485772|FG000|Overall Study|Lack of Efficacy|2|||
156655485|NCT00266409|565485773|FG001|Overall Study|Lack of Efficacy|6|||
156655486|NCT00266409|565485774|FG002|Overall Study|Lack of Efficacy|1|||
156655487|NCT00266409|565485775|FG003|Overall Study|Lack of Efficacy|2|||
156655488|NCT00266409|565485772|FG000|Overall Study|Adverse Event|7|||
156655489|NCT00266409|565485773|FG001|Overall Study|Adverse Event|2|||
156655490|NCT00266409|565485774|FG002|Overall Study|Adverse Event|1|||
156655491|NCT00266409|565485775|FG003|Overall Study|Adverse Event|1|||
156655492|NCT00266409|565485772|FG000|Overall Study|Lost to Follow-up|18|||
156655493|NCT00266409|565485773|FG001|Overall Study|Lost to Follow-up|21|||
156655494|NCT00266409|565485774|FG002|Overall Study|Lost to Follow-up|6|||
156655495|NCT00266409|565485775|FG003|Overall Study|Lost to Follow-up|8|||
156655496|NCT00266409|565485772|FG000|Overall Study|Withdrawal by Subject|6|||
156655497|NCT00266409|565485773|FG001|Overall Study|Withdrawal by Subject|10|||
156655498|NCT00266409|565485774|FG002|Overall Study|Withdrawal by Subject|3|||
156655499|NCT00266409|565485775|FG003|Overall Study|Withdrawal by Subject|9|||
156655500|NCT00266409|565485772|FG000|Overall Study|Protocol Violation|5|||
156655501|NCT00266409|565485773|FG001|Overall Study|Protocol Violation|3|||
156655502|NCT00266409|565485774|FG002|Overall Study|Protocol Violation|4|||
156655503|NCT00266409|565485775|FG003|Overall Study|Protocol Violation|2|||
156655504|NCT00266409|565485772|FG000|Overall Study|Other|7|||
156655505|NCT00266409|565485773|FG001|Overall Study|Other|4|||
156655506|NCT00266409|565485774|FG002|Overall Study|Other|2|||
156655507|NCT00266409|565485775|FG003|Overall Study|Other|0|||
156655508|NCT00108732|565485778|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
156655509|NCT00108732|565485778|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
156655510|NCT00108732|565485778|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
156655511|NCT00108732|565485778|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
156655512|NCT00108732|565485778|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
156655513|NCT00108732|565485778|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
156655514|NCT00108732|565485778|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
156763955|NCT00492297|565889556|FG000|Treatment|Death|2|||
156763956|NCT00492297|565889556|FG000|Treatment|Study terminated by sponsor|3|||
156763957|NCT00492297|565889556|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
156655515|NCT02187042|565485779|FG000|Overall Study|Death|1|||
156655516|NCT02187042|565485780|FG001|Overall Study|Death|1|||
156655517|NCT02187042|565485779|FG000|Overall Study|Toxicity|6|||
156655518|NCT02187042|565485780|FG001|Overall Study|Toxicity|5|||
156655519|NCT02187042|565485779|FG000|Overall Study|Participant choice|1|||
156655520|NCT02187042|565485780|FG001|Overall Study|Participant choice|0|||
156655521|NCT02187042|565485779|FG000|Overall Study|Doctor choice|1|||
156655522|NCT02187042|565485780|FG001|Overall Study|Doctor choice|0|||
156655523|NCT02187042|565485779|FG000|Overall Study|Progressive disease|4|||
156763958|NCT00492297|565889556|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
156763959|NCT00492297|565889556|FG000|Survival Only Follow-up|Death|46|||
156763960|NCT00492297|565889556|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
156655524|NCT02187042|565485780|FG001|Overall Study|Progressive disease|8|||
156655525|NCT01766921|565485784|FG000|Overall Study|Administrative Reason|5|||
156655526|NCT01766921|565485785|FG001|Overall Study|Administrative Reason|5|||
156655527|NCT01766921|565485784|FG000|Overall Study|Death|1|||
156655528|NCT01766921|565485785|FG001|Overall Study|Death|1|||
156655529|NCT01766921|565485784|FG000|Overall Study|Lost to Follow-up|1|||
156655530|NCT01766921|565485785|FG001|Overall Study|Lost to Follow-up|3|||
156655531|NCT01766921|565485784|FG000|Overall Study|Unclassified|2|||
156655532|NCT01766921|565485785|FG001|Overall Study|Unclassified|2|||
156655533|NCT01766921|565485784|FG000|Overall Study|Protocol Violation|1|||
156655534|NCT01766921|565485785|FG001|Overall Study|Protocol Violation|1|||
156655535|NCT01766921|565485784|FG000|Overall Study|Withdrawal by Subject|14|||
156655536|NCT01766921|565485785|FG001|Overall Study|Withdrawal by Subject|5|||
156655537|NCT01901055|565485788|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
156655538|NCT01901055|565485789|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
156655539|NCT01901055|565485788|FG000|Randomization But Not Titrated|Physician Decision|0|||
156655540|NCT01901055|565485789|FG001|Randomization But Not Titrated|Physician Decision|1|||
156655541|NCT01901055|565485788|FG000|Started Protocol to Week 6|Physician Decision|2|||
156655542|NCT01901055|565485789|FG001|Started Protocol to Week 6|Physician Decision|1|||
156655543|NCT01901055|565485788|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
156655544|NCT01901055|565485789|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
156655545|NCT01901055|565485788|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
156655546|NCT01901055|565485789|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
156655547|NCT01901055|565485788|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
156655548|NCT01901055|565485789|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
156655549|NCT01901055|565485788|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
156655550|NCT01901055|565485789|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
156655551|NCT01901055|565485788|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
156655552|NCT01901055|565485789|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
156655553|NCT01901055|565485788|FG000|Week 24|Withdrawal by Subject|13|||
156655554|NCT01901055|565485789|FG001|Week 24|Withdrawal by Subject|19|||
156655555|NCT01901055|565485788|FG000|Week 24|Physician Decision|1|||
156655556|NCT01901055|565485789|FG001|Week 24|Physician Decision|0|||
156655557|NCT01901055|565485788|FG000|Week 36|Withdrawal by Subject|0|||
156655558|NCT01901055|565485789|FG001|Week 36|Withdrawal by Subject|5|||
156655559|NCT03019965|565485792|FG000|Overall Study|Withdrawal by Subject|1|||
156655560|NCT03019965|565485793|FG001|Overall Study|Withdrawal by Subject|0|||
156655561|NCT03019965|565485792|FG000|Overall Study|Protocol Violation|1|||
156655562|NCT03019965|565485793|FG001|Overall Study|Protocol Violation|3|||
156655563|NCT03019965|565485792|FG000|Overall Study|viral or fungal infection|3|||
156655564|NCT03019965|565485793|FG001|Overall Study|viral or fungal infection|4|||
156655565|NCT03019965|565485792|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
156655566|NCT03019965|565485793|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
156655567|NCT03019965|565485792|FG000|Overall Study|Physician Decision|1|||
156655568|NCT03019965|565485793|FG001|Overall Study|Physician Decision|1|||
156655569|NCT00635154|565485794|FG000|Overall Study|Alternative Treatment|8|||
156655570|NCT00635154|565485794|FG000|Overall Study|Other|4|||
156655571|NCT00635154|565485794|FG000|Overall Study|Still on treatment|21|||
156655572|NCT01513148|565485795|FG000|Overall Study|Protocol Violation|2|||
156655573|NCT01513148|565485796|FG001|Overall Study|Protocol Violation|2|||
156655574|NCT03552757|565485797|FG000|Overall Study|Withdrawal by Subject|10|||
156655575|NCT03552757|565485798|FG001|Overall Study|Withdrawal by Subject|5|||
156655576|NCT03552757|565485799|FG002|Overall Study|Withdrawal by Subject|12|||
156655577|NCT03552757|565485797|FG000|Overall Study|Lost to Follow-up|2|||
156655578|NCT03552757|565485798|FG001|Overall Study|Lost to Follow-up|7|||
156655579|NCT03552757|565485799|FG002|Overall Study|Lost to Follow-up|7|||
156655580|NCT03552757|565485797|FG000|Overall Study|Death|1|||
156655581|NCT03552757|565485798|FG001|Overall Study|Death|1|||
156655582|NCT03552757|565485799|FG002|Overall Study|Death|1|||
156655583|NCT01862328|565485808|FG000|Overall Study|Progressive Disease|3|||
156655584|NCT01862328|565485809|FG001|Overall Study|Progressive Disease|11|||
156655585|NCT01862328|565485810|FG002|Overall Study|Progressive Disease|5|||
156655586|NCT01862328|565485811|FG003|Overall Study|Progressive Disease|6|||
156655587|NCT01862328|565485812|FG004|Overall Study|Progressive Disease|7|||
156763961|NCT00492297|565889556|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
156655588|NCT01862328|565485813|FG005|Overall Study|Progressive Disease|4|||
156655589|NCT01862328|565485814|FG006|Overall Study|Progressive Disease|3|||
156655590|NCT01862328|565485808|FG000|Overall Study|Adverse Event|0|||
156655591|NCT01862328|565485809|FG001|Overall Study|Adverse Event|4|||
156655592|NCT01862328|565485810|FG002|Overall Study|Adverse Event|0|||
156655593|NCT01862328|565485811|FG003|Overall Study|Adverse Event|1|||
156655594|NCT01862328|565485812|FG004|Overall Study|Adverse Event|0|||
156655595|NCT01862328|565485813|FG005|Overall Study|Adverse Event|2|||
156655596|NCT01862328|565485814|FG006|Overall Study|Adverse Event|4|||
156655597|NCT01862328|565485808|FG000|Overall Study|Other|0|||
156763962|NCT00113607|565889557|FG000|Overall Study|Adverse Event|40|||
156763963|NCT00113607|565889558|FG001|Overall Study|Adverse Event|71|||
156763964|NCT00113607|565889557|FG000|Overall Study|Death|8|||
156763965|NCT00113607|565889558|FG001|Overall Study|Death|8|||
156763966|NCT00113607|565889557|FG000|Overall Study|Withdrawal by Subject|50|||
156763967|NCT00113607|565889558|FG001|Overall Study|Withdrawal by Subject|58|||
156763968|NCT00113607|565889557|FG000|Overall Study|Lost to Follow-up|0|||
156763969|NCT00113607|565889558|FG001|Overall Study|Lost to Follow-up|2|||
156763970|NCT00113607|565889557|FG000|Overall Study|Disease Progression|180|||
156763971|NCT00113607|565889558|FG001|Overall Study|Disease Progression|142|||
156763972|NCT00113607|565889557|FG000|Overall Study|Complete Response (Confirmed)|14|||
156763973|NCT00113607|565889558|FG001|Overall Study|Complete Response (Confirmed)|24|||
156763974|NCT00113607|565889557|FG000|Overall Study|Other|43|||
156763975|NCT00113607|565889558|FG001|Overall Study|Other|32|||
156763976|NCT03669549|565889559|FG000|Overall Study|Adverse Event|4|||
156763977|NCT03669549|565889559|FG000|Overall Study|Withdrawal by Subject|1|||
156763978|NCT03669549|565889559|FG000|Overall Study|Study terminated by the Sponsor|1|||
156763979|NCT00909844|565889560|FG000|Overall Study|Adverse Event|1|||
156763980|NCT00909844|565889560|FG000|Overall Study|Withdrawal by Subject|1|||
156763981|NCT00909844|565889560|FG000|Overall Study|Lost to Follow-up|2|||
156763982|NCT02974868|565889562|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
156763983|NCT02974868|565889563|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
156763984|NCT02974868|565889564|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
156763985|NCT02974868|565889565|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
156763986|NCT02974868|565889562|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
156763987|NCT02974868|565889563|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
156763988|NCT02974868|565889564|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
156763989|NCT02974868|565889565|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
156763990|NCT02974868|565889562|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
156763991|NCT02974868|565889563|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
156763992|NCT02974868|565889564|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
156763993|NCT02974868|565889565|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
156763994|NCT02974868|565889562|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
156763995|NCT02974868|565889563|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
156763996|NCT02974868|565889564|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
156763997|NCT02974868|565889565|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
156763998|NCT00706004|565889566|FG000|Overall Study|Did not meet eligibility criteria|2|||
156763999|NCT02674516|565889567|FG000|Overall Study|Lost to Follow-up|3|||
156764000|NCT02674516|565889568|FG001|Overall Study|Lost to Follow-up|0|||
156764001|NCT02674516|565889567|FG000|Overall Study|Protocol Violation|0|||
156764002|NCT02674516|565889568|FG001|Overall Study|Protocol Violation|4|||
156764003|NCT02674516|565889567|FG000|Overall Study|Knowledge of study hypothesis|1|||
156764004|NCT02674516|565889568|FG001|Overall Study|Knowledge of study hypothesis|0|||
156764005|NCT01064479|565889569|FG000|Overall Study|Death|10|||
156764006|NCT01064479|565889570|FG001|Overall Study|Death|11|||
156764007|NCT01064479|565889569|FG000|Overall Study|Withdrawal by Subject|2|||
156764008|NCT01064479|565889570|FG001|Overall Study|Withdrawal by Subject|2|||
156322524|NCT03034200|564280165|FG001|Overall Study|Disease progression|10|||
156322525|NCT03034200|564280166|FG002|Overall Study|Disease progression|4|||
156322526|NCT03034200|564280164|FG000|Overall Study|Physician Decision|2|||
156322527|NCT03034200|564280165|FG001|Overall Study|Physician Decision|0|||
156322528|NCT03034200|564280166|FG002|Overall Study|Physician Decision|3|||
156322529|NCT03034200|564280164|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
156322530|NCT03034200|564280165|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
156322531|NCT03034200|564280166|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
156322532|NCT03034200|564280164|FG000|Overall Study|Adjuvant Therapy|0|||
156322533|NCT03034200|564280165|FG001|Overall Study|Adjuvant Therapy|0|||
156322534|NCT03034200|564280166|FG002|Overall Study|Adjuvant Therapy|1|||
156322535|NCT02469038|564280167|FG000|Overall Study|Physician Decision|4|||
156322536|NCT02469038|564280168|FG001|Overall Study|Physician Decision|5|||
156322537|NCT03435640|564280169|FG000|Overall Study|Withdrawal by Subject|0|||
156322538|NCT03435640|564280170|FG001|Overall Study|Withdrawal by Subject|1|||
156426224|NCT04888585|564652883|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
156764009|NCT01064479|565889569|FG000|Overall Study|Disease progression|1|||
156764010|NCT01064479|565889570|FG001|Overall Study|Disease progression|1|||
156764011|NCT01064479|565889569|FG000|Overall Study|Toxicity|1|||
156322539|NCT03435640|564280171|FG002|Overall Study|Withdrawal by Subject|0|||
156322540|NCT03435640|564280172|FG003|Overall Study|Withdrawal by Subject|2|||
156764012|NCT01064479|565889570|FG001|Overall Study|Toxicity|1|||
156764013|NCT01064479|565889569|FG000|Overall Study|Other|1|||
156764014|NCT01064479|565889570|FG001|Overall Study|Other|2|||
156764015|NCT00749398|565889571|FG000|Overall Study|Lack of Efficacy|7|||
156764016|NCT00749398|565889571|FG000|Overall Study|Adverse Event|4|||
156764017|NCT00749398|565889571|FG000|Overall Study|Serious adverse event|11|||
156764018|NCT00749398|565889571|FG000|Overall Study|Withdrawal by Subject|17|||
156764019|NCT00749398|565889571|FG000|Overall Study|Lost to Follow-up|11|||
156764020|NCT00749398|565889571|FG000|Overall Study|Reason not specified|2|||
156764021|NCT00749398|565889571|FG000|Overall Study|Unknown reason|1|||
156764022|NCT01663402|565889577|FG000|Overall Study|Randomized but not treated|19|||
156764023|NCT01663402|565889578|FG001|Overall Study|Randomized but not treated|11|||
156764024|NCT01663402|565889577|FG000|Overall Study|Adverse Event|347|||
156764025|NCT01663402|565889578|FG001|Overall Study|Adverse Event|362|||
156764026|NCT01663402|565889577|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
156764027|NCT01663402|565889578|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
156764028|NCT01663402|565889577|FG000|Overall Study|Poor compliance to protocol|529|||
156764029|NCT01663402|565889578|FG001|Overall Study|Poor compliance to protocol|454|||
156764030|NCT01663402|565889577|FG000|Overall Study|Physician Decision|77|||
156764031|NCT01663402|565889578|FG001|Overall Study|Physician Decision|62|||
156764032|NCT01663402|565889577|FG000|Overall Study|Site terminated by sponsor|1|||
156764033|NCT01663402|565889578|FG001|Overall Study|Site terminated by sponsor|3|||
156764034|NCT01663402|565889577|FG000|Overall Study|Participant moved|139|||
156764035|NCT01663402|565889578|FG001|Overall Study|Participant moved|104|||
156764036|NCT01663402|565889577|FG000|Overall Study|Withdrawal by Subject|118|||
156764037|NCT01663402|565889578|FG001|Overall Study|Withdrawal by Subject|91|||
156764038|NCT01663402|565889577|FG000|Overall Study|Related to study drug administration|96|||
156764039|NCT01663402|565889578|FG001|Overall Study|Related to study drug administration|105|||
156764040|NCT01663402|565889577|FG000|Overall Study|Lost to Follow-up|17|||
156764041|NCT01663402|565889578|FG001|Overall Study|Lost to Follow-up|15|||
156764042|NCT01663402|565889577|FG000|Overall Study|Other than specified above|172|||
156764043|NCT01663402|565889578|FG001|Overall Study|Other than specified above|147|||
156764044|NCT03575702|565889581|FG000|Overall Study|Withdrawal by Subject|1|||
156764045|NCT03575702|565889582|FG001|Overall Study|Withdrawal by Subject|1|||
156764046|NCT03575702|565889581|FG000|Overall Study|Lost to Follow-up|1|||
156764047|NCT03575702|565889582|FG001|Overall Study|Lost to Follow-up|2|||
156764048|NCT03575702|565889581|FG000|Overall Study|Protocol Violation|0|||
156764049|NCT03575702|565889582|FG001|Overall Study|Protocol Violation|1|||
156764050|NCT03575702|565889581|FG000|Overall Study|Patient non compliance|4|||
156764051|NCT03575702|565889582|FG001|Overall Study|Patient non compliance|0|||
156764052|NCT01900444|565889583|FG000|Overall Study|Protocol Violation|2|||
156764053|NCT01900444|565889583|FG000|Overall Study|Lost to Follow-up|1|||
156764054|NCT00072384|565889584|FG000|Overall Study|Physician Decision|1|||
156764055|NCT00072384|565889584|FG000|Overall Study|Ineligible|8|||
156764056|NCT01825200|565889589|FG000|Overall Study|Lost to Follow-up|5|||
156764057|NCT01825200|565889590|FG001|Overall Study|Lost to Follow-up|6|||
156764058|NCT01825200|565889589|FG000|Overall Study|Withdrawal by Subject|0|||
156764059|NCT01825200|565889590|FG001|Overall Study|Withdrawal by Subject|1|||
156764060|NCT00490035|565889591|FG000|Overall Study|AE, non-serious non-fatal|3|||
156764061|NCT00490035|565889592|FG001|Overall Study|AE, non-serious non-fatal|4|||
156764062|NCT00490035|565889593|FG002|Overall Study|AE, non-serious non-fatal|4|||
156764063|NCT00490035|565889594|FG003|Overall Study|AE, non-serious non-fatal|5|||
156764064|NCT00490035|565889591|FG000|Overall Study|Lost to Follow-up|2|||
156764065|NCT00490035|565889592|FG001|Overall Study|Lost to Follow-up|0|||
156764066|NCT00490035|565889593|FG002|Overall Study|Lost to Follow-up|1|||
156655598|NCT01862328|565485809|FG001|Overall Study|Other|2|||
156655599|NCT01862328|565485810|FG002|Overall Study|Other|1|||
156655600|NCT01862328|565485811|FG003|Overall Study|Other|0|||
156655601|NCT01862328|565485812|FG004|Overall Study|Other|4|||
156655602|NCT01862328|565485813|FG005|Overall Study|Other|0|||
156655603|NCT01862328|565485814|FG006|Overall Study|Other|1|||
156655604|NCT01862328|565485808|FG000|Overall Study|Withdrawal by Subject|1|||
156655605|NCT01862328|565485809|FG001|Overall Study|Withdrawal by Subject|1|||
156655606|NCT01862328|565485810|FG002|Overall Study|Withdrawal by Subject|0|||
156655607|NCT01862328|565485811|FG003|Overall Study|Withdrawal by Subject|0|||
156655608|NCT01862328|565485812|FG004|Overall Study|Withdrawal by Subject|1|||
156655609|NCT01862328|565485813|FG005|Overall Study|Withdrawal by Subject|1|||
156655610|NCT01862328|565485814|FG006|Overall Study|Withdrawal by Subject|1|||
156655611|NCT01862328|565485808|FG000|Overall Study|Symptomatic Deterioration|0|||
156655612|NCT01862328|565485809|FG001|Overall Study|Symptomatic Deterioration|0|||
156655613|NCT01862328|565485810|FG002|Overall Study|Symptomatic Deterioration|0|||
156655614|NCT01862328|565485811|FG003|Overall Study|Symptomatic Deterioration|0|||
156764067|NCT00490035|565889594|FG003|Overall Study|Lost to Follow-up|0|||
156764068|NCT00490035|565889591|FG000|Overall Study|Withdrawal by Subject|2|||
156764069|NCT00490035|565889592|FG001|Overall Study|Withdrawal by Subject|1|||
156764070|NCT00490035|565889593|FG002|Overall Study|Withdrawal by Subject|1|||
156764071|NCT00490035|565889594|FG003|Overall Study|Withdrawal by Subject|0|||
156764072|NCT00490035|565889591|FG000|Overall Study|Other reason|0|||
156764073|NCT00490035|565889592|FG001|Overall Study|Other reason|1|||
156655615|NCT01862328|565485812|FG004|Overall Study|Symptomatic Deterioration|0|||
156655616|NCT01862328|565485813|FG005|Overall Study|Symptomatic Deterioration|0|||
156655617|NCT01862328|565485814|FG006|Overall Study|Symptomatic Deterioration|1|||
156764074|NCT00490035|565889593|FG002|Overall Study|Other reason|3|||
156764075|NCT00490035|565889594|FG003|Overall Study|Other reason|1|||
156764076|NCT00490035|565889591|FG000|Overall Study|AE, serious fatal|1|||
156764077|NCT00490035|565889592|FG001|Overall Study|AE, serious fatal|0|||
156764078|NCT00490035|565889593|FG002|Overall Study|AE, serious fatal|0|||
156764079|NCT00490035|565889594|FG003|Overall Study|AE, serious fatal|0|||
156764080|NCT00490035|565889591|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
156764081|NCT00490035|565889592|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
156764082|NCT00490035|565889593|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
156764083|NCT00490035|565889594|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
156764084|NCT00490035|565889591|FG000|Overall Study|AE of unknown type|0|||
156764085|NCT00490035|565889592|FG001|Overall Study|AE of unknown type|0|||
156764086|NCT00490035|565889593|FG002|Overall Study|AE of unknown type|2|||
156764087|NCT00490035|565889594|FG003|Overall Study|AE of unknown type|0|||
156764088|NCT06058390|565889595|FG000|Overall Study|Lost to Follow-up|0|||
156764089|NCT06058390|565889596|FG001|Overall Study|Lost to Follow-up|0|||
156764090|NCT06058390|565889597|FG002|Overall Study|Lost to Follow-up|2|||
156764091|NCT06058390|565889598|FG003|Overall Study|Lost to Follow-up|1|||
156764092|NCT06058390|565889595|FG000|Overall Study|Physician Decision|0|||
156764093|NCT06058390|565889596|FG001|Overall Study|Physician Decision|0|||
156764094|NCT06058390|565889597|FG002|Overall Study|Physician Decision|0|||
156764095|NCT06058390|565889598|FG003|Overall Study|Physician Decision|1|||
156764096|NCT06058390|565889595|FG000|Overall Study|Participants did not receive any study intervention|0|||
156764097|NCT06058390|565889596|FG001|Overall Study|Participants did not receive any study intervention|0|||
156764098|NCT06058390|565889597|FG002|Overall Study|Participants did not receive any study intervention|0|||
156764099|NCT06058390|565889598|FG003|Overall Study|Participants did not receive any study intervention|1|||
156764100|NCT03585270|565889601|FG000|Overall Study|Withdrawal by Subject|2|||
156764101|NCT03585270|565889602|FG001|Overall Study|Withdrawal by Subject|6|||
156764102|NCT03585270|565889601|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
156764103|NCT03585270|565889602|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
156764104|NCT03585270|565889601|FG000|Overall Study|Adverse Event|5|||
156764105|NCT03585270|565889602|FG001|Overall Study|Adverse Event|2|||
156764106|NCT03585270|565889601|FG000|Overall Study|Lost to Follow-up|1|||
156764107|NCT03585270|565889602|FG001|Overall Study|Lost to Follow-up|4|||
156764108|NCT03585270|565889601|FG000|Overall Study|Death|5|||
156764109|NCT03585270|565889602|FG001|Overall Study|Death|3|||
156764110|NCT03585270|565889601|FG000|Overall Study|Other reasons|2|||
156764111|NCT03585270|565889602|FG001|Overall Study|Other reasons|2|||
156764112|NCT05953363|565889603|FG000|Overall Study|Screen Failure|2|||
156764113|NCT05953363|565889603|FG000|Overall Study|Withdrawal by Subject|3|||
156764114|NCT05953363|565889603|FG000|Overall Study|Surgery cancelled|2|||
156764115|NCT05953363|565889603|FG000|Overall Study|Adverse Event|1|||
156764116|NCT05559905|565889604|FG000|Overall Study|Withdrawal by Subject|1|||
156764117|NCT05559905|565889605|FG001|Overall Study|Withdrawal by Subject|0|||
156764118|NCT05559905|565889606|FG002|Overall Study|Withdrawal by Subject|0|||
156764119|NCT05559905|565889604|FG000|Overall Study|Not Reported|1|||
156764120|NCT05559905|565889605|FG001|Overall Study|Not Reported|0|||
156764121|NCT05559905|565889606|FG002|Overall Study|Not Reported|0|||
156764122|NCT01701674|565889607|FG000|Overall Study|Unable to safely complete treatment|1|||
156764123|NCT05696392|565889609|FG000|Overall Study|Lost to Follow-up|3|||
156764124|NCT05696392|565889609|FG000|Overall Study|Protocol Violation|1|||
156764125|NCT05696392|565889609|FG000|Overall Study|Withdrawal by Subject|1|||
156764126|NCT05276973|565889610|FG000|Overall Study|Treated and DLT unevaluable|1|||
156764127|NCT05276973|565889611|FG001|Overall Study|Treated and DLT unevaluable|1|||
156764128|NCT05276973|565889612|FG002|Overall Study|Treated and DLT unevaluable|0|||
156764129|NCT03904693|565889613|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764130|NCT03904693|565889614|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764131|NCT03904693|565889615|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
156764132|NCT03904693|565889616|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764133|NCT03904693|565889617|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764134|NCT03904693|565889618|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764135|NCT03904693|565889613|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764136|NCT03904693|565889614|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764137|NCT03904693|565889615|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
156764138|NCT03904693|565889616|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764139|NCT03904693|565889617|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764140|NCT03904693|565889618|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764141|NCT03904693|565889613|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156764142|NCT03904693|565889614|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
156764143|NCT03904693|565889615|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
156764144|NCT03904693|565889616|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156764145|NCT03904693|565889617|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156764146|NCT03904693|565889618|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156764147|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
156764148|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
156764149|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
156764150|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
156764151|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
156764152|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
156764153|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764154|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764155|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764156|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764157|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764158|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
156764159|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764160|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764161|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764162|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
156764163|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764164|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764165|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764166|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764167|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764168|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
156764169|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764170|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764171|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764172|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764173|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764174|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764175|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764176|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
156764177|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764178|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764179|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764180|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764181|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
156764182|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764183|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764184|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764185|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764186|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764187|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764188|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
156764189|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764190|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764191|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764192|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764193|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764194|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
156322541|NCT03435640|564280173|FG004|Overall Study|Withdrawal by Subject|0|||
156322542|NCT03435640|564280174|FG005|Overall Study|Withdrawal by Subject|0|||
156322543|NCT03435640|564280175|FG006|Overall Study|Withdrawal by Subject|3|||
156322544|NCT03435640|564280176|FG007|Overall Study|Withdrawal by Subject|0|||
156322545|NCT03435640|564280177|FG008|Overall Study|Withdrawal by Subject|0|||
156322546|NCT03435640|564280178|FG009|Overall Study|Withdrawal by Subject|2|||
156322547|NCT03435640|564280179|FG010|Overall Study|Withdrawal by Subject|3|||
156322548|NCT03435640|564280169|FG000|Overall Study|Lost to Follow-up|0|||
156322549|NCT03435640|564280170|FG001|Overall Study|Lost to Follow-up|0|||
156322550|NCT03435640|564280171|FG002|Overall Study|Lost to Follow-up|1|||
156322551|NCT03435640|564280172|FG003|Overall Study|Lost to Follow-up|0|||
156322552|NCT03435640|564280173|FG004|Overall Study|Lost to Follow-up|0|||
156322553|NCT03435640|564280174|FG005|Overall Study|Lost to Follow-up|0|||
156322554|NCT03435640|564280175|FG006|Overall Study|Lost to Follow-up|0|||
156322555|NCT03435640|564280176|FG007|Overall Study|Lost to Follow-up|0|||
156426225|NCT04888585|564652884|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
156322556|NCT03435640|564280177|FG008|Overall Study|Lost to Follow-up|0|||
156322557|NCT03435640|564280178|FG009|Overall Study|Lost to Follow-up|0|||
156322558|NCT03435640|564280179|FG010|Overall Study|Lost to Follow-up|0|||
156426226|NCT04888585|564652885|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
156764195|NCT03180736|565889619|FG000|Overall Study|Adverse Event|3|||
156764196|NCT03180736|565889620|FG001|Overall Study|Adverse Event|4|||
156764197|NCT03180736|565889619|FG000|Overall Study|Death|10|||
156764198|NCT03180736|565889620|FG001|Overall Study|Death|7|||
156322559|NCT00510874|564280180|FG000|Overall Study|Withdrawal by Subject|1|||
156322560|NCT00510874|564280181|FG001|Overall Study|Withdrawal by Subject|1|||
156322561|NCT00510874|564280182|FG002|Overall Study|Withdrawal by Subject|0|||
156322562|NCT00510874|564280183|FG003|Overall Study|Withdrawal by Subject|0|||
156322563|NCT00510874|564280184|FG004|Overall Study|Withdrawal by Subject|3|||
156322564|NCT00510874|564280185|FG005|Overall Study|Withdrawal by Subject|0|||
156322565|NCT00510874|564280186|FG006|Overall Study|Withdrawal by Subject|0|||
156322566|NCT00510874|564280180|FG000|Overall Study|Lost to Follow-up|2|||
156322567|NCT00510874|564280181|FG001|Overall Study|Lost to Follow-up|3|||
156322568|NCT00510874|564280182|FG002|Overall Study|Lost to Follow-up|1|||
156322569|NCT00510874|564280183|FG003|Overall Study|Lost to Follow-up|3|||
156322570|NCT00510874|564280184|FG004|Overall Study|Lost to Follow-up|4|||
156322571|NCT00510874|564280185|FG005|Overall Study|Lost to Follow-up|0|||
156322572|NCT00510874|564280186|FG006|Overall Study|Lost to Follow-up|1|||
156322573|NCT00636987|564280187|FG000|Overall Study|Death|44|||
156322574|NCT00636987|564280187|FG000|Overall Study|Explanted|13|||
156322575|NCT00636987|564280187|FG000|Overall Study|Lost to Follow-up|63|||
156322576|NCT00636987|564280187|FG000|Overall Study|5 year visit window not complete|69|||
156322577|NCT01347307|564280188|FG000|Overall Study|Death|0|||
156322578|NCT01347307|564280189|FG001|Overall Study|Death|4|||
156322579|NCT01347307|564280188|FG000|Overall Study|Physician Decision|0|||
156322580|NCT01347307|564280189|FG001|Overall Study|Physician Decision|1|||
156322581|NCT03183778|564280191|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
156322582|NCT00737464|564280192|FG000|Overall Study|Adverse Event|1|||
156322583|NCT00737464|564280192|FG000|Overall Study|Death|6|||
156322584|NCT00737464|564280192|FG000|Overall Study|Other - Failure to Return|1|||
156322585|NCT00737464|564280192|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
156322586|NCT00737464|564280192|FG000|Overall Study|Other reasons|4|||
156322587|NCT03228420|564280198|FG000|Overall Study|Lost to Follow-up|5|||
156322588|NCT03228420|564280199|FG001|Overall Study|Lost to Follow-up|3|||
156322589|NCT03228420|564280198|FG000|Overall Study|Withdrawal by Subject|10|||
156322590|NCT03228420|564280199|FG001|Overall Study|Withdrawal by Subject|0|||
156322591|NCT03228420|564280198|FG000|Overall Study|Adverse Event|5|||
156322592|NCT03228420|564280199|FG001|Overall Study|Adverse Event|2|||
156322593|NCT03868124|564280200|FG000|Overall Study|Withdrawal by Subject|4|||
156322594|NCT03868124|564280201|FG001|Overall Study|Withdrawal by Subject|0|||
156322595|NCT03868124|564280202|FG002|Overall Study|Withdrawal by Subject|1|||
156322596|NCT03868124|564280200|FG000|Overall Study|Physician Decision|1|||
156322597|NCT03868124|564280201|FG001|Overall Study|Physician Decision|0|||
156322598|NCT03868124|564280202|FG002|Overall Study|Physician Decision|1|||
156322599|NCT03868124|564280200|FG000|Overall Study|Lost to Follow-up|1|||
156322600|NCT03868124|564280201|FG001|Overall Study|Lost to Follow-up|1|||
156322601|NCT03868124|564280202|FG002|Overall Study|Lost to Follow-up|2|||
156322602|NCT03868124|564280200|FG000|Overall Study|Death|1|||
156322603|NCT03868124|564280201|FG001|Overall Study|Death|1|||
156322604|NCT03868124|564280202|FG002|Overall Study|Death|2|||
156322605|NCT03868124|564280200|FG000|Overall Study|Adverse Event|0|||
156322606|NCT03868124|564280201|FG001|Overall Study|Adverse Event|0|||
156322607|NCT03868124|564280202|FG002|Overall Study|Adverse Event|3|||
156322608|NCT03868124|564280200|FG000|Overall Study|Explanted|2|||
156322609|NCT03868124|564280201|FG001|Overall Study|Explanted|1|||
156322610|NCT03868124|564280202|FG002|Overall Study|Explanted|0|||
156322611|NCT03868124|564280200|FG000|Overall Study|Ongoing in study|176|||
156322612|NCT03868124|564280201|FG001|Overall Study|Ongoing in study|180|||
156322613|NCT03868124|564280202|FG002|Overall Study|Ongoing in study|183|||
156322614|NCT04177355|564280203|FG000|Overall Study|Lost to Follow-up|0|||
156322615|NCT04177355|564280204|FG001|Overall Study|Lost to Follow-up|2|||
156426227|NCT04888585|564652886|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
156426228|NCT04888585|564652887|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
156322616|NCT04177355|564280205|FG002|Overall Study|Lost to Follow-up|0|||
156322617|NCT04177355|564280206|FG003|Overall Study|Lost to Follow-up|1|||
156322618|NCT04177355|564280207|FG004|Overall Study|Lost to Follow-up|2|||
156322619|NCT04177355|564280208|FG005|Overall Study|Lost to Follow-up|0|||
156322620|NCT04177355|564280209|FG006|Overall Study|Lost to Follow-up|1|||
156322621|NCT04177355|564280210|FG007|Overall Study|Lost to Follow-up|0|||
156322622|NCT04177355|564280211|FG008|Overall Study|Lost to Follow-up|0|||
156322623|NCT04177355|564280212|FG009|Overall Study|Lost to Follow-up|0|||
156322624|NCT04177355|564280213|FG010|Overall Study|Lost to Follow-up|0|||
156322625|NCT04177355|564280203|FG000|Overall Study|Withdrawal by Subject|0|||
156322626|NCT04177355|564280204|FG001|Overall Study|Withdrawal by Subject|0|||
156322627|NCT04177355|564280205|FG002|Overall Study|Withdrawal by Subject|0|||
156322628|NCT04177355|564280206|FG003|Overall Study|Withdrawal by Subject|1|||
156322629|NCT04177355|564280207|FG004|Overall Study|Withdrawal by Subject|1|||
156322630|NCT04177355|564280208|FG005|Overall Study|Withdrawal by Subject|0|||
156322631|NCT04177355|564280209|FG006|Overall Study|Withdrawal by Subject|0|||
156764199|NCT03180736|565889619|FG000|Overall Study|Withdrawal by Subject|5|||
156764200|NCT03180736|565889620|FG001|Overall Study|Withdrawal by Subject|12|||
156764201|NCT03180736|565889619|FG000|Overall Study|Lost to Follow-up|1|||
156764202|NCT03180736|565889620|FG001|Overall Study|Lost to Follow-up|0|||
156764203|NCT03180736|565889619|FG000|Overall Study|Lack of Efficacy|66|||
156764204|NCT03180736|565889620|FG001|Overall Study|Lack of Efficacy|87|||
156764205|NCT03180736|565889619|FG000|Overall Study|Physician Decision|4|||
156764206|NCT03180736|565889620|FG001|Overall Study|Physician Decision|7|||
156764207|NCT03180736|565889619|FG000|Overall Study|randomized but not treated|2|||
156764208|NCT03180736|565889620|FG001|Overall Study|randomized but not treated|3|||
156764209|NCT03258593|565889621|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
156764210|NCT03258593|565889622|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
156764211|NCT03258593|565889623|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
156764212|NCT03258593|565889624|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
156764213|NCT03258593|565889621|FG000|Run-In Maintenance Phase|Disease progression|3|||
156764214|NCT03258593|565889622|FG001|Run-In Maintenance Phase|Disease progression|0|||
156764215|NCT03258593|565889623|FG002|Run-In Maintenance Phase|Disease progression|0|||
156764216|NCT03258593|565889624|FG003|Run-In Maintenance Phase|Disease progression|0|||
156764217|NCT03258593|565889621|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
156764218|NCT03258593|565889622|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
156764219|NCT03258593|565889623|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
156764220|NCT03258593|565889624|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
156764221|NCT03258593|565889621|FG000|Expansion Maintenance Phase|Physician Decision|0|||
156764222|NCT03258593|565889622|FG001|Expansion Maintenance Phase|Physician Decision|1|||
156764223|NCT03258593|565889623|FG002|Expansion Maintenance Phase|Physician Decision|0|||
156764224|NCT03258593|565889624|FG003|Expansion Maintenance Phase|Physician Decision|0|||
156764225|NCT05457257|565889629|FG000|Overall Study|Withdrawal by Subject|0|||
156764226|NCT05457257|565889630|FG001|Overall Study|Withdrawal by Subject|2|||
156764227|NCT05457257|565889629|FG000|Overall Study|Death|10|||
156764228|NCT05457257|565889630|FG001|Overall Study|Death|3|||
156764229|NCT05457257|565889629|FG000|Overall Study|Ongoing|19|||
156764230|NCT05457257|565889630|FG001|Overall Study|Ongoing|9|||
156764231|NCT06077773|565889635|FG000|Overall Study|Withdrawal by Subject|1|||
156764232|NCT06077773|565889636|FG001|Overall Study|Withdrawal by Subject|0|||
156764233|NCT06077773|565889637|FG002|Overall Study|Withdrawal by Subject|1|||
156764234|NCT06077773|565889635|FG000|Overall Study|Lost to Follow-up|0|||
156764235|NCT06077773|565889636|FG001|Overall Study|Lost to Follow-up|1|||
156764236|NCT06077773|565889637|FG002|Overall Study|Lost to Follow-up|0|||
156764237|NCT06077773|565889635|FG000|Overall Study|Adverse Event|0|||
156764238|NCT06077773|565889636|FG001|Overall Study|Adverse Event|0|||
156764239|NCT06077773|565889637|FG002|Overall Study|Adverse Event|2|||
156764240|NCT04275973|565889638|FG000|Overall Study|Withdrawal by Subject|2|||
156764241|NCT04275973|565889639|FG001|Overall Study|Withdrawal by Subject|1|||
156764242|NCT02499146|565889642|FG000|Overall Study|Global deterioration of health status|1|||
156764243|NCT02499146|565889642|FG000|Overall Study|Objective progression or relapse|20|||
156764244|NCT02499146|565889642|FG000|Overall Study|Other|2|||
156764245|NCT02499146|565889642|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
156764246|NCT04325828|565889643|FG000|Overall Study|Ongoing|26|||
156764247|NCT05115630|565889644|FG000|Overall Study|Due to COVID19|1|||
156764248|NCT05115630|565889644|FG000|Overall Study|Due to Bacteremia|1|||
156764249|NCT05115630|565889644|FG000|Overall Study|Due to viral infection|1|||
156764250|NCT01655901|565890828|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
156764251|NCT01655901|565890829|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
156764252|NCT01655901|565890830|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
156764253|NCT01655901|565890831|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
156764254|NCT01655901|565890832|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
156764255|NCT01655901|565890833|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
156764256|NCT00352118|565890834|FG000|Overall Study|Physician Decision|4|||
156764257|NCT02997163|565890835|FG000|Overall Study|Adverse Event|1|||
156764258|NCT02997163|565890836|FG001|Overall Study|Adverse Event|0|||
156764259|NCT02997163|565890837|FG002|Overall Study|Adverse Event|0|||
156322632|NCT04177355|564280210|FG007|Overall Study|Withdrawal by Subject|0|||
156764260|NCT02997163|565890838|FG003|Overall Study|Adverse Event|1|||
156764261|NCT00922636|565890839|FG000|Overall Study|Adverse Event|3|||
156764262|NCT00922636|565890840|FG001|Overall Study|Adverse Event|3|||
156764263|NCT00922636|565890841|FG002|Overall Study|Adverse Event|2|||
156322633|NCT04177355|564280211|FG008|Overall Study|Withdrawal by Subject|1|||
156322634|NCT04177355|564280212|FG009|Overall Study|Withdrawal by Subject|0|||
156764264|NCT00922636|565890842|FG003|Overall Study|Adverse Event|3|||
156764265|NCT00922636|565890843|FG004|Overall Study|Adverse Event|2|||
156764266|NCT00922636|565890839|FG000|Overall Study|Lack of Efficacy|1|||
156764267|NCT00922636|565890840|FG001|Overall Study|Lack of Efficacy|7|||
156764268|NCT00922636|565890841|FG002|Overall Study|Lack of Efficacy|3|||
156764269|NCT00922636|565890842|FG003|Overall Study|Lack of Efficacy|2|||
156764270|NCT00922636|565890843|FG004|Overall Study|Lack of Efficacy|4|||
156322635|NCT04177355|564280213|FG010|Overall Study|Withdrawal by Subject|0|||
156764271|NCT00922636|565890839|FG000|Overall Study|Sponsor Decision|0|||
156764272|NCT00922636|565890840|FG001|Overall Study|Sponsor Decision|0|||
156764273|NCT00922636|565890841|FG002|Overall Study|Sponsor Decision|2|||
156764274|NCT00922636|565890842|FG003|Overall Study|Sponsor Decision|0|||
156764275|NCT00922636|565890843|FG004|Overall Study|Sponsor Decision|0|||
156764276|NCT00922636|565890839|FG000|Overall Study|Withdrawal by Subject|0|||
156764277|NCT00922636|565890840|FG001|Overall Study|Withdrawal by Subject|0|||
156764278|NCT00922636|565890841|FG002|Overall Study|Withdrawal by Subject|5|||
156764279|NCT00922636|565890842|FG003|Overall Study|Withdrawal by Subject|2|||
156764280|NCT00922636|565890843|FG004|Overall Study|Withdrawal by Subject|4|||
156764281|NCT00922636|565890839|FG000|Overall Study|Protocol Violation|0|||
156764282|NCT00922636|565890840|FG001|Overall Study|Protocol Violation|0|||
156426229|NCT04888585|564652888|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
156426230|NCT04888585|564652889|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
156426231|NCT04888585|564652890|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
156426232|NCT04888585|564652891|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
156764283|NCT00922636|565890841|FG002|Overall Study|Protocol Violation|2|||
156764284|NCT00922636|565890842|FG003|Overall Study|Protocol Violation|2|||
156764285|NCT00922636|565890843|FG004|Overall Study|Protocol Violation|0|||
156764286|NCT00922636|565890839|FG000|Overall Study|Entry Criteria Not Met|0|||
156764287|NCT00922636|565890840|FG001|Overall Study|Entry Criteria Not Met|0|||
156764288|NCT00922636|565890841|FG002|Overall Study|Entry Criteria Not Met|1|||
156764289|NCT00922636|565890842|FG003|Overall Study|Entry Criteria Not Met|1|||
156764290|NCT00922636|565890843|FG004|Overall Study|Entry Criteria Not Met|0|||
156764291|NCT00922636|565890839|FG000|Overall Study|Parent/Caregiver Decision|2|||
156764292|NCT00922636|565890840|FG001|Overall Study|Parent/Caregiver Decision|4|||
156764293|NCT00922636|565890841|FG002|Overall Study|Parent/Caregiver Decision|3|||
156764294|NCT00922636|565890842|FG003|Overall Study|Parent/Caregiver Decision|5|||
156764295|NCT00922636|565890843|FG004|Overall Study|Parent/Caregiver Decision|2|||
156764296|NCT00922636|565890839|FG000|Overall Study|Lost to Follow-up|1|||
156764297|NCT00922636|565890840|FG001|Overall Study|Lost to Follow-up|2|||
156764298|NCT00922636|565890841|FG002|Overall Study|Lost to Follow-up|2|||
156764299|NCT00922636|565890842|FG003|Overall Study|Lost to Follow-up|2|||
156764300|NCT00922636|565890843|FG004|Overall Study|Lost to Follow-up|4|||
156764301|NCT02308046|565890844|FG000|Overall Study|Negative yeast culture at Baseline|32|||
156764302|NCT02308046|565890845|FG001|Overall Study|Negative yeast culture at Baseline|33|||
156764303|NCT02308046|565890844|FG000|Overall Study|Positive for STD at Baseline|1|||
156764304|NCT02308046|565890845|FG001|Overall Study|Positive for STD at Baseline|2|||
156764305|NCT02308046|565890844|FG000|Overall Study|Lost to Follow-up|1|||
156764306|NCT02308046|565890845|FG001|Overall Study|Lost to Follow-up|3|||
156764307|NCT01181167|565890846|FG000|Overall Study|Adverse Event|11|||
156764308|NCT01181167|565890847|FG001|Overall Study|Adverse Event|21|||
156764309|NCT01181167|565890846|FG000|Overall Study|Lost to Follow-up|1|||
156764310|NCT01181167|565890847|FG001|Overall Study|Lost to Follow-up|0|||
156764311|NCT01181167|565890846|FG000|Overall Study|Physician Decision|2|||
156764312|NCT01181167|565890847|FG001|Overall Study|Physician Decision|3|||
156764313|NCT01181167|565890846|FG000|Overall Study|Protocol Violation|3|||
156764314|NCT01181167|565890847|FG001|Overall Study|Protocol Violation|0|||
156764315|NCT01181167|565890846|FG000|Overall Study|Withdrawal by Subject|6|||
156764316|NCT01181167|565890847|FG001|Overall Study|Withdrawal by Subject|8|||
156764317|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
156764318|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
156764319|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
156764320|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
156764321|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
156764322|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
156764323|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
156764324|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
156764325|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
156764326|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
156764327|NCT01573000|565890848|FG000|Crossover Phase|Lack of Efficacy|0|||
156764328|NCT01573000|565890849|FG001|Crossover Phase|Lack of Efficacy|13|||
156764329|NCT01573000|565890848|FG000|Crossover Phase|Lost to Follow-up|0|||
156764330|NCT01573000|565890849|FG001|Crossover Phase|Lost to Follow-up|2|||
156764331|NCT01573000|565890848|FG000|Crossover Phase|Death|0|||
156764332|NCT01573000|565890849|FG001|Crossover Phase|Death|3|||
156764333|NCT01573000|565890848|FG000|Long-Term Follow-Up|Death|3|||
156764334|NCT01573000|565890849|FG001|Long-Term Follow-Up|Death|0|||
156764335|NCT01573000|565890848|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
156764336|NCT01573000|565890849|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
156764337|NCT03885908|565890855|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
156426233|NCT04888585|564652892|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
156764338|NCT03885908|565890856|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
156764339|NCT03885908|565890855|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
156764340|NCT03885908|565890856|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
156764341|NCT03885908|565890855|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
156764342|NCT03885908|565890856|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
156764343|NCT03885908|565890855|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
156764344|NCT03885908|565890856|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
156764345|NCT03903172|565890861|FG000|Overall Study|screen fail|4|||
156764346|NCT03903172|565890862|FG001|Overall Study|screen fail|1|||
156764347|NCT01545388|565890863|FG000|Overall Study|Adverse Event|2|||
156764348|NCT01545388|565890864|FG001|Overall Study|Adverse Event|4|||
156764349|NCT01545388|565890865|FG002|Overall Study|Adverse Event|1|||
156764350|NCT01545388|565890863|FG000|Overall Study|Lack of Efficacy|3|||
156764351|NCT01545388|565890864|FG001|Overall Study|Lack of Efficacy|2|||
156764352|NCT01545388|565890865|FG002|Overall Study|Lack of Efficacy|5|||
156764353|NCT01545388|565890863|FG000|Overall Study|Participant moved or relocated|1|||
156764354|NCT01545388|565890864|FG001|Overall Study|Participant moved or relocated|0|||
156764355|NCT01545388|565890865|FG002|Overall Study|Participant moved or relocated|0|||
156764356|NCT01545388|565890863|FG000|Overall Study|Withdrawal by Subject|1|||
156764357|NCT01545388|565890864|FG001|Overall Study|Withdrawal by Subject|4|||
156764358|NCT01545388|565890865|FG002|Overall Study|Withdrawal by Subject|2|||
156764359|NCT01545388|565890863|FG000|Overall Study|Other|1|||
156764360|NCT01545388|565890864|FG001|Overall Study|Other|1|||
156764361|NCT01545388|565890865|FG002|Overall Study|Other|0|||
156764362|NCT05002972|565890867|FG000|Overall Study|Withdrawal by Subject|2|||
156764363|NCT01664091|565890868|FG000|Overall Study|Death|1|||
156764364|NCT01664091|565890868|FG000|Overall Study|Disease Progression|2|||
156764365|NCT01664091|565890868|FG000|Overall Study|Lost to Follow-up|2|||
156764366|NCT01664091|565890868|FG000|Overall Study|Withdrawal by Subject|1|||
156764367|NCT01946204|565890880|FG000|Overall Study|Death|38|||
156764368|NCT01946204|565890881|FG001|Overall Study|Death|59|||
156764369|NCT01946204|565890880|FG000|Overall Study|Withdrawal by Subject|37|||
156764370|NCT01946204|565890881|FG001|Overall Study|Withdrawal by Subject|50|||
156764371|NCT01946204|565890880|FG000|Overall Study|Lost to Follow-up|3|||
156764372|NCT01946204|565890881|FG001|Overall Study|Lost to Follow-up|7|||
156764373|NCT01946204|565890880|FG000|Overall Study|Ongoing|316|||
156764374|NCT01946204|565890881|FG001|Overall Study|Ongoing|687|||
156764375|NCT01946204|565890880|FG000|Overall Study|Other|7|||
156764376|NCT01946204|565890881|FG001|Overall Study|Other|3|||
156764377|NCT04782180|565890882|FG000|Overall Study|Withdrawal by Subject|2|||
156764378|NCT04782180|565890882|FG000|Overall Study|Lost to Follow-up|2|||
156764379|NCT00249834|565890883|FG000|Overall Study|Ovarian stimulation failed|1|||
156764380|NCT00249834|565890884|FG001|Overall Study|Ovarian stimulation failed|0|||
156764381|NCT00249834|565890885|FG002|Overall Study|Ovarian stimulation failed|0|||
156764382|NCT00249834|565890886|FG003|Overall Study|Ovarian stimulation failed|0|||
156764383|NCT00249834|565890887|FG004|Overall Study|Ovarian stimulation failed|0|||
156764384|NCT00249834|565890888|FG005|Overall Study|Ovarian stimulation failed|0|||
156764385|NCT00249834|565890889|FG006|Overall Study|Ovarian stimulation failed|0|||
156764386|NCT00249834|565890890|FG007|Overall Study|Ovarian stimulation failed|0|||
156764387|NCT00249834|565890883|FG000|Overall Study|Failure of down-regulation|0|||
156764388|NCT00249834|565890884|FG001|Overall Study|Failure of down-regulation|0|||
156764389|NCT00249834|565890885|FG002|Overall Study|Failure of down-regulation|0|||
156764390|NCT00249834|565890886|FG003|Overall Study|Failure of down-regulation|0|||
156764391|NCT00249834|565890887|FG004|Overall Study|Failure of down-regulation|0|||
156764392|NCT00249834|565890888|FG005|Overall Study|Failure of down-regulation|0|||
156764393|NCT00249834|565890889|FG006|Overall Study|Failure of down-regulation|1|||
156764394|NCT00249834|565890890|FG007|Overall Study|Failure of down-regulation|0|||
156764395|NCT00249834|565890883|FG000|Overall Study|Protocol Violation|0|||
156764396|NCT00249834|565890884|FG001|Overall Study|Protocol Violation|19|||
156764397|NCT00249834|565890885|FG002|Overall Study|Protocol Violation|14|||
156764398|NCT00249834|565890886|FG003|Overall Study|Protocol Violation|8|||
156764399|NCT00249834|565890887|FG004|Overall Study|Protocol Violation|5|||
156764400|NCT00249834|565890888|FG005|Overall Study|Protocol Violation|2|||
156764401|NCT00249834|565890889|FG006|Overall Study|Protocol Violation|0|||
156764402|NCT00249834|565890890|FG007|Overall Study|Protocol Violation|0|||
156764403|NCT06110754|565890891|FG000|Overall Study|Withdrawal by Subject|0|||
156764404|NCT06110754|565890892|FG001|Overall Study|Withdrawal by Subject|0|||
156764405|NCT06110754|565890893|FG002|Overall Study|Withdrawal by Subject|1|||
156764406|NCT06110754|565890894|FG003|Overall Study|Withdrawal by Subject|0|||
156764407|NCT00846586|565890900|FG000|Overall Study|Adverse Event|20|||
156764408|NCT00846586|565890901|FG001|Overall Study|Adverse Event|10|||
156764409|NCT00846586|565890900|FG000|Overall Study|Subject withdrew consent|8|||
156764410|NCT00846586|565890901|FG001|Overall Study|Subject withdrew consent|10|||
156764411|NCT00846586|565890900|FG000|Overall Study|Administrative problems|5|||
156764412|NCT00846586|565890901|FG001|Overall Study|Administrative problems|4|||
156764413|NCT00846586|565890900|FG000|Overall Study|Death|2|||
156764414|NCT00846586|565890901|FG001|Overall Study|Death|0|||
156764415|NCT00846586|565890900|FG000|Overall Study|Protocol deviation|2|||
156764416|NCT00846586|565890901|FG001|Overall Study|Protocol deviation|6|||
156764417|NCT00846586|565890900|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156764418|NCT00846586|565890901|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156764419|NCT00846586|565890900|FG000|Overall Study|Lost to Follow-up|1|||
156764420|NCT00846586|565890901|FG001|Overall Study|Lost to Follow-up|4|||
156764421|NCT00846586|565890900|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156764422|NCT00846586|565890901|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156764423|NCT01949142|565890914|FG000|Overall Study|Withdrawal of consent|1|||
156764424|NCT01949142|565890915|FG001|Overall Study|Withdrawal of consent|0|||
156764425|NCT01949142|565890914|FG000|Overall Study|Lost to Follow-up|1|||
156764426|NCT01949142|565890915|FG001|Overall Study|Lost to Follow-up|1|||
156764427|NCT01949142|565890914|FG000|Overall Study|Parent changed their mind|1|||
156764428|NCT01949142|565890915|FG001|Overall Study|Parent changed their mind|0|||
156764429|NCT04802161|565890916|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
156764430|NCT04802161|565890917|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
156764431|NCT04802161|565890918|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
156764432|NCT04802161|565890919|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
156764433|NCT04802161|565890916|FG000|Overall Study|Clinical Instability|0|||
156764434|NCT04802161|565890917|FG001|Overall Study|Clinical Instability|0|||
156764435|NCT04802161|565890918|FG002|Overall Study|Clinical Instability|1|||
156764436|NCT04802161|565890919|FG003|Overall Study|Clinical Instability|0|||
156764437|NCT04802161|565890916|FG000|Overall Study|Adverse Event|0|||
156764438|NCT04802161|565890917|FG001|Overall Study|Adverse Event|0|||
156764439|NCT04802161|565890918|FG002|Overall Study|Adverse Event|1|||
156764440|NCT04802161|565890919|FG003|Overall Study|Adverse Event|0|||
156764441|NCT04802161|565890916|FG000|Overall Study|Death|0|||
156764442|NCT04802161|565890917|FG001|Overall Study|Death|0|||
156764443|NCT04802161|565890918|FG002|Overall Study|Death|1|||
156764444|NCT04802161|565890919|FG003|Overall Study|Death|0|||
156764445|NCT01249131|565892904|FG000|Washout Period of 10 Days|Adverse Event|0|||
156764446|NCT01249131|565892905|FG001|Washout Period of 10 Days|Adverse Event|0|||
156764447|NCT01249131|565892906|FG002|Washout Period of 10 Days|Adverse Event|0|||
156764448|NCT01249131|565892907|FG003|Washout Period of 10 Days|Adverse Event|0|||
156764449|NCT01249131|565892908|FG004|Washout Period of 10 Days|Adverse Event|1|||
156764450|NCT01249131|565892909|FG005|Washout Period of 10 Days|Adverse Event|0|||
156764451|NCT02915835|565892910|FG000|Overall Study|Physician Decision|1|||
156764452|NCT02915835|565892911|FG001|Overall Study|Physician Decision|0|||
156764453|NCT02915835|565892910|FG000|Overall Study|Withdrawal by Subject|0|||
156764454|NCT02915835|565892911|FG001|Overall Study|Withdrawal by Subject|1|||
156764455|NCT03426345|565892912|FG000|Overall Study|Adverse Event|4|||
156764456|NCT03426345|565892913|FG001|Overall Study|Adverse Event|4|||
156764457|NCT03426345|565892912|FG000|Overall Study|Lack of Efficacy|1|||
156764458|NCT03426345|565892913|FG001|Overall Study|Lack of Efficacy|0|||
156764459|NCT03426345|565892912|FG000|Overall Study|Withdrawal by Subject|5|||
156764460|NCT03426345|565892913|FG001|Overall Study|Withdrawal by Subject|6|||
156764461|NCT03426345|565892912|FG000|Overall Study|Lost to Follow-up|3|||
156764462|NCT03426345|565892913|FG001|Overall Study|Lost to Follow-up|1|||
156764463|NCT03426345|565892912|FG000|Overall Study|Protocol Deviation|3|||
156764464|NCT03426345|565892913|FG001|Overall Study|Protocol Deviation|4|||
156764465|NCT03426345|565892912|FG000|Overall Study|Reason Not Specified|1|||
156764466|NCT03426345|565892913|FG001|Overall Study|Reason Not Specified|2|||
156764467|NCT03426345|565892912|FG000|Overall Study|Missing Completion Status|1|||
156764468|NCT03426345|565892913|FG001|Overall Study|Missing Completion Status|0|||
156764469|NCT02446691|565892920|FG000|Overall Study|Withdrawal by Subject|2|||
156764470|NCT02446691|565892920|FG000|Overall Study|Lost to Follow-up|8|||
156764471|NCT02446691|565892920|FG000|Overall Study|Protocol Violation|1|||
156764472|NCT00192114|565892921|FG000|Overall Study|Objective Tumor Progression|19|||
156764473|NCT00192114|565892921|FG000|Overall Study|Adverse Event|2|||
156764474|NCT00192114|565892921|FG000|Overall Study|Clinical Progression|2|||
156764475|NCT00192114|565892921|FG000|Overall Study|Death|1|||
156764476|NCT01172873|565892925|FG000|Overall Study|Withdrawal by Subject|3|||
156764477|NCT01172873|565892926|FG001|Overall Study|Withdrawal by Subject|2|||
156764478|NCT05518539|565892930|FG000|Overall Study|Lost to Follow-up|6|||
156764479|NCT02053493|565892931|FG000|Overall Study|Withdrawal by Subject|1|||
156764480|NCT02053493|565892932|FG001|Overall Study|Withdrawal by Subject|1|||
156764481|NCT01909804|565892933|FG000|Overall Study|Randomized but Never Treated|0|||
156764482|NCT01909804|565892934|FG001|Overall Study|Randomized but Never Treated|0|||
156764483|NCT01909804|565892935|FG002|Overall Study|Randomized but Never Treated|0|||
156764484|NCT01909804|565892936|FG003|Overall Study|Randomized but Never Treated|0|||
156764485|NCT01909804|565892937|FG004|Overall Study|Randomized but Never Treated|0|||
156764486|NCT01909804|565892938|FG005|Overall Study|Randomized but Never Treated|0|||
156764487|NCT01909804|565892939|FG006|Overall Study|Randomized but Never Treated|1|||
156764488|NCT01909804|565892940|FG007|Overall Study|Randomized but Never Treated|0|||
156764489|NCT01909804|565892941|FG008|Overall Study|Randomized but Never Treated|0|||
156764490|NCT01909804|565892942|FG009|Overall Study|Randomized but Never Treated|0|||
156764491|NCT01909804|565892943|FG010|Overall Study|Randomized but Never Treated|0|||
156764492|NCT01909804|565892944|FG011|Overall Study|Randomized but Never Treated|1|||
156764493|NCT01909804|565892933|FG000|Overall Study|Death|0|||
156764494|NCT01909804|565892934|FG001|Overall Study|Death|0|||
156764495|NCT01909804|565892935|FG002|Overall Study|Death|0|||
156764496|NCT01909804|565892936|FG003|Overall Study|Death|0|||
156764497|NCT01909804|565892937|FG004|Overall Study|Death|0|||
156764498|NCT01909804|565892938|FG005|Overall Study|Death|0|||
156764499|NCT01909804|565892939|FG006|Overall Study|Death|0|||
156764500|NCT01909804|565892940|FG007|Overall Study|Death|0|||
156764501|NCT01909804|565892941|FG008|Overall Study|Death|0|||
156764502|NCT01909804|565892942|FG009|Overall Study|Death|0|||
156764503|NCT01909804|565892943|FG010|Overall Study|Death|1|||
156764504|NCT01909804|565892944|FG011|Overall Study|Death|0|||
156764505|NCT01909804|565892933|FG000|Overall Study|Lack of Efficacy|4|||
156764506|NCT01909804|565892934|FG001|Overall Study|Lack of Efficacy|1|||
156764507|NCT01909804|565892935|FG002|Overall Study|Lack of Efficacy|0|||
156764508|NCT01909804|565892936|FG003|Overall Study|Lack of Efficacy|0|||
156764509|NCT01909804|565892937|FG004|Overall Study|Lack of Efficacy|7|||
156764510|NCT01909804|565892938|FG005|Overall Study|Lack of Efficacy|3|||
156764511|NCT01909804|565892939|FG006|Overall Study|Lack of Efficacy|1|||
156764512|NCT01909804|565892940|FG007|Overall Study|Lack of Efficacy|1|||
156764513|NCT01909804|565892941|FG008|Overall Study|Lack of Efficacy|0|||
156764514|NCT01909804|565892942|FG009|Overall Study|Lack of Efficacy|1|||
156764515|NCT01909804|565892943|FG010|Overall Study|Lack of Efficacy|0|||
156764516|NCT01909804|565892944|FG011|Overall Study|Lack of Efficacy|1|||
156764517|NCT01909804|565892933|FG000|Overall Study|Withdrew Consent|0|||
156764518|NCT01909804|565892934|FG001|Overall Study|Withdrew Consent|0|||
156764519|NCT01909804|565892935|FG002|Overall Study|Withdrew Consent|0|||
156764520|NCT01909804|565892936|FG003|Overall Study|Withdrew Consent|0|||
156764521|NCT01909804|565892937|FG004|Overall Study|Withdrew Consent|1|||
156764522|NCT01909804|565892938|FG005|Overall Study|Withdrew Consent|1|||
156764523|NCT01909804|565892939|FG006|Overall Study|Withdrew Consent|0|||
156764524|NCT01909804|565892940|FG007|Overall Study|Withdrew Consent|0|||
156764525|NCT01909804|565892941|FG008|Overall Study|Withdrew Consent|0|||
156764526|NCT01909804|565892942|FG009|Overall Study|Withdrew Consent|0|||
156764527|NCT01909804|565892943|FG010|Overall Study|Withdrew Consent|0|||
156764528|NCT01909804|565892944|FG011|Overall Study|Withdrew Consent|0|||
156764529|NCT01909804|565892933|FG000|Overall Study|Protocol Violation|0|||
156764530|NCT01909804|565892934|FG001|Overall Study|Protocol Violation|0|||
156764531|NCT01909804|565892935|FG002|Overall Study|Protocol Violation|0|||
156764532|NCT01909804|565892936|FG003|Overall Study|Protocol Violation|0|||
156764533|NCT01909804|565892937|FG004|Overall Study|Protocol Violation|0|||
156764534|NCT01909804|565892938|FG005|Overall Study|Protocol Violation|0|||
156764535|NCT01909804|565892939|FG006|Overall Study|Protocol Violation|0|||
156764536|NCT01909804|565892940|FG007|Overall Study|Protocol Violation|0|||
156764537|NCT01909804|565892941|FG008|Overall Study|Protocol Violation|0|||
156764538|NCT01909804|565892942|FG009|Overall Study|Protocol Violation|0|||
156764539|NCT01909804|565892943|FG010|Overall Study|Protocol Violation|0|||
156764540|NCT01909804|565892944|FG011|Overall Study|Protocol Violation|1|||
156764541|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
156764542|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
156764543|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
156764544|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Adverse Event|2|||
156764545|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Adverse Event|0|||
156764546|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Adverse Event|1|||
156764547|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
156764548|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
156764549|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
156764550|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
156764551|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
156322636|NCT00054717|564280215|FG000|Overall Study|Randomized but not treated|2|||
156322637|NCT00054717|564280216|FG001|Overall Study|Randomized but not treated|8|||
156322638|NCT00054717|564280215|FG000|Overall Study|Adverse Event|70|||
156322639|NCT00054717|564280216|FG001|Overall Study|Adverse Event|22|||
156322640|NCT00054717|564280215|FG000|Overall Study|Protocol Violation|18|||
156322641|NCT00054717|564280216|FG001|Overall Study|Protocol Violation|19|||
156322642|NCT00054717|564280215|FG000|Overall Study|Lost to Follow-up|23|||
156322643|NCT00054717|564280216|FG001|Overall Study|Lost to Follow-up|13|||
156322644|NCT00054717|564280215|FG000|Overall Study|Withdrawal by Subject|32|||
156322645|NCT00054717|564280216|FG001|Overall Study|Withdrawal by Subject|20|||
156764552|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
156322646|NCT00054717|564280215|FG000|Overall Study|Other reason not defined above|117|||
156322647|NCT00054717|564280216|FG001|Overall Study|Other reason not defined above|217|||
156322648|NCT05007717|564280217|FG000|Overall Study|Death|3|||
156764553|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Other Reasons|2|||
156764554|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Other Reasons|0|||
156764555|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Other Reasons|0|||
156764556|NCT04613518|565892947|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
156426234|NCT04888585|564652893|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
156426235|NCT04888585|564652883|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156655618|NCT01656889|565485815|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
156655619|NCT01656889|565485816|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
156655620|NCT01656889|565485815|FG000|Treatment Period, 12 Weeks|Death|0|||
156655621|NCT01656889|565485816|FG001|Treatment Period, 12 Weeks|Death|1|||
156655622|NCT01656889|565485815|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
156655623|NCT01656889|565485816|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
156655624|NCT01656889|565485815|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
156655625|NCT01656889|565485816|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
156655626|NCT01656889|565485815|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
156655627|NCT01656889|565485816|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
156655628|NCT01656889|565485815|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
156655629|NCT01656889|565485816|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
156655630|NCT01656889|565485815|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
156655631|NCT01656889|565485816|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
156655632|NCT01656889|565485815|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
156655633|NCT01656889|565485816|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
156655634|NCT01656889|565485815|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
156655635|NCT01656889|565485816|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
156655636|NCT01656889|565485815|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
156655637|NCT01656889|565485816|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
156655638|NCT02486796|565485817|FG000|Overall Study|Withdrawal by Subject|1|||
156655639|NCT02486796|565485818|FG001|Overall Study|Withdrawal by Subject|1|||
156655640|NCT02486796|565485817|FG000|Overall Study|Physician Decision|1|||
156655641|NCT02486796|565485818|FG001|Overall Study|Physician Decision|0|||
156655642|NCT03276975|565485819|FG000|Overall Study|Withdrawal by Subject|1|||
156655643|NCT03276975|565485820|FG001|Overall Study|Withdrawal by Subject|0|||
156655644|NCT02928848|565485821|FG000|Arm 2|Withdrawal by Subject|1|||
156655645|NCT02928848|565485822|FG001|Arm 2|Withdrawal by Subject|0|||
156655646|NCT01463683|565485825|FG000|Overall Study|Adverse Event|2|||
156655647|NCT01463683|565485826|FG001|Overall Study|Adverse Event|0|||
156655648|NCT01463683|565485827|FG002|Overall Study|Adverse Event|0|||
156655649|NCT01463683|565485825|FG000|Overall Study|Lost to Follow-up|10|||
156655650|NCT01463683|565485826|FG001|Overall Study|Lost to Follow-up|9|||
156655651|NCT01463683|565485827|FG002|Overall Study|Lost to Follow-up|7|||
156655652|NCT01463683|565485825|FG000|Overall Study|Physician Decision|0|||
156655653|NCT01463683|565485826|FG001|Overall Study|Physician Decision|3|||
156655654|NCT01463683|565485827|FG002|Overall Study|Physician Decision|1|||
156655655|NCT01463683|565485825|FG000|Overall Study|Pregnancy|2|||
156655656|NCT01463683|565485826|FG001|Overall Study|Pregnancy|2|||
156655657|NCT01463683|565485827|FG002|Overall Study|Pregnancy|1|||
156655658|NCT01463683|565485825|FG000|Overall Study|Withdrawal by Subject|5|||
156655659|NCT01463683|565485826|FG001|Overall Study|Withdrawal by Subject|17|||
156655660|NCT01463683|565485827|FG002|Overall Study|Withdrawal by Subject|2|||
156655661|NCT03111147|565485828|FG000|Overall Study|Lost to Follow-up|2|||
156655662|NCT03111147|565485829|FG001|Overall Study|Lost to Follow-up|5|||
156655663|NCT03111147|565485828|FG000|Overall Study|Withdrawal by Subject|4|||
156655664|NCT03111147|565485829|FG001|Overall Study|Withdrawal by Subject|3|||
156655665|NCT03111147|565485828|FG000|Overall Study|Protocol Violation|2|||
156655666|NCT03111147|565485829|FG001|Overall Study|Protocol Violation|1|||
156655667|NCT03111147|565485828|FG000|Overall Study|Death|1|||
156655668|NCT03111147|565485829|FG001|Overall Study|Death|1|||
156655669|NCT03384745|565485830|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
156655670|NCT03384745|565485831|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
156655671|NCT03384745|565485832|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
156655672|NCT03384745|565485833|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
156655673|NCT03384745|565485834|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
156655674|NCT03384745|565485835|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
156655675|NCT03384745|565485830|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
156655676|NCT03384745|565485831|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
156655677|NCT03384745|565485832|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
156655678|NCT03384745|565485833|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
156655679|NCT03384745|565485834|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
156655680|NCT03384745|565485835|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
156655681|NCT03384745|565485830|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
156655682|NCT03384745|565485831|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
156655683|NCT03384745|565485832|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
156655684|NCT03384745|565485833|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
156655685|NCT03384745|565485834|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
156655686|NCT03384745|565485835|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
156655687|NCT03384745|565485830|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
156764557|NCT04613518|565892948|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
156764558|NCT04613518|565892949|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
156764559|NCT04613518|565892947|FG000|Open-Label Treatment Period|Adverse Event|1|||
156764560|NCT04613518|565892948|FG001|Open-Label Treatment Period|Adverse Event|0|||
156764561|NCT04613518|565892949|FG002|Open-Label Treatment Period|Adverse Event|3|||
156764562|NCT04613518|565892947|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
156764563|NCT04613518|565892948|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
156764564|NCT04613518|565892949|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
156764565|NCT04613518|565892947|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
156764566|NCT04613518|565892948|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
156764567|NCT04613518|565892949|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
156764568|NCT04613518|565892947|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
156764569|NCT04613518|565892948|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
156764570|NCT04613518|565892949|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
156764571|NCT04613518|565892947|FG000|Open-Label Treatment Period|Other reasons|1|||
156764572|NCT04613518|565892948|FG001|Open-Label Treatment Period|Other reasons|0|||
156764573|NCT04613518|565892949|FG002|Open-Label Treatment Period|Other reasons|0|||
156764574|NCT03589807|565892950|FG000|Overall Study|Lost to Follow-up|0|||
156764575|NCT03589807|565892951|FG001|Overall Study|Lost to Follow-up|2|||
156764576|NCT03589807|565892952|FG002|Overall Study|Lost to Follow-up|2|||
156764577|NCT03589807|565892953|FG003|Overall Study|Lost to Follow-up|3|||
156764578|NCT03589807|565892954|FG004|Overall Study|Lost to Follow-up|1|||
156764579|NCT03589807|565892955|FG005|Overall Study|Lost to Follow-up|1|||
156764580|NCT03589807|565892950|FG000|Overall Study|Withdrawal by Subject|0|||
156764581|NCT03589807|565892951|FG001|Overall Study|Withdrawal by Subject|5|||
156764582|NCT03589807|565892952|FG002|Overall Study|Withdrawal by Subject|0|||
156764583|NCT03589807|565892953|FG003|Overall Study|Withdrawal by Subject|0|||
156764584|NCT03589807|565892954|FG004|Overall Study|Withdrawal by Subject|0|||
156764585|NCT03589807|565892955|FG005|Overall Study|Withdrawal by Subject|0|||
156764586|NCT03589807|565892950|FG000|Overall Study|Protocol Violation|0|||
156764587|NCT03589807|565892951|FG001|Overall Study|Protocol Violation|0|||
156764588|NCT03589807|565892952|FG002|Overall Study|Protocol Violation|0|||
156764589|NCT03589807|565892953|FG003|Overall Study|Protocol Violation|1|||
156764590|NCT03589807|565892954|FG004|Overall Study|Protocol Violation|0|||
156764591|NCT03589807|565892955|FG005|Overall Study|Protocol Violation|0|||
156764592|NCT03589807|565892950|FG000|Overall Study|Enrolled but treatment not administered|0|||
156764593|NCT03589807|565892951|FG001|Overall Study|Enrolled but treatment not administered|0|||
156764594|NCT03589807|565892952|FG002|Overall Study|Enrolled but treatment not administered|0|||
156764595|NCT03589807|565892953|FG003|Overall Study|Enrolled but treatment not administered|0|||
156764596|NCT03589807|565892954|FG004|Overall Study|Enrolled but treatment not administered|1|||
156764597|NCT03589807|565892955|FG005|Overall Study|Enrolled but treatment not administered|0|||
156764598|NCT01076543|565892957|FG000|Overall Study|Withdrawal by Subject|2|||
156764599|NCT01076543|565892958|FG001|Overall Study|Withdrawal by Subject|0|||
156764600|NCT01076543|565892959|FG002|Overall Study|Withdrawal by Subject|0|||
156764601|NCT01076543|565892960|FG003|Overall Study|Withdrawal by Subject|0|||
156764602|NCT01076543|565892961|FG004|Overall Study|Withdrawal by Subject|0|||
156764603|NCT01076543|565892962|FG005|Overall Study|Withdrawal by Subject|0|||
156764604|NCT00338741|565892963|FG000|Overall Study|Lost to Follow-up|2|||
156764605|NCT00338741|565892964|FG001|Overall Study|Lost to Follow-up|0|||
156764606|NCT01534273|565892965|FG000|Period 1|Physician Decision|0|||
156764607|NCT01534273|565892966|FG001|Period 1|Physician Decision|0|||
156764608|NCT01534273|565892967|FG002|Period 1|Physician Decision|0|||
156764609|NCT01534273|565892968|FG003|Period 1|Physician Decision|1|||
156764610|NCT01534273|565892969|FG004|Period 1|Physician Decision|0|||
156764611|NCT01534273|565892970|FG005|Period 1|Physician Decision|0|||
156764612|NCT01534273|565892971|FG006|Period 1|Physician Decision|0|||
156764613|NCT01619865|565892972|FG000|Overall Study|Adverse Event|1|||
156764614|NCT01619865|565892972|FG000|Overall Study|Death|2|||
156764615|NCT01619865|565892972|FG000|Overall Study|subject not able to comply|1|||
156764616|NCT03586050|565892973|FG000|Overall Study|Death|3|||
156764617|NCT03586050|565892973|FG000|Overall Study|Withdrawal by Subject|2|||
156764618|NCT01494818|565892974|FG000|Overall Study|Relocation|1|||
156764619|NCT01494818|565892975|FG001|Overall Study|Relocation|2|||
156764620|NCT01494818|565892974|FG000|Overall Study|Lost to Follow-up|1|||
156764621|NCT01494818|565892975|FG001|Overall Study|Lost to Follow-up|0|||
156764622|NCT01211145|565892976|FG000|Overall Study|Reason not specified|3|||
156764623|NCT01211145|565892977|FG001|Overall Study|Reason not specified|2|||
156764624|NCT01211145|565892978|FG002|Overall Study|Reason not specified|2|||
156764625|NCT01211145|565892979|FG003|Overall Study|Reason not specified|1|||
156764626|NCT01211145|565892976|FG000|Overall Study|Lost to Follow-up|3|||
156764627|NCT01211145|565892977|FG001|Overall Study|Lost to Follow-up|2|||
156764628|NCT01211145|565892978|FG002|Overall Study|Lost to Follow-up|1|||
156764629|NCT01211145|565892979|FG003|Overall Study|Lost to Follow-up|2|||
156764630|NCT01211145|565892976|FG000|Overall Study|Study-specific withdrawal criteria|1|||
156764631|NCT01211145|565892977|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156764632|NCT01211145|565892978|FG002|Overall Study|Study-specific withdrawal criteria|0|||
156764633|NCT01211145|565892979|FG003|Overall Study|Study-specific withdrawal criteria|0|||
156764634|NCT01211145|565892976|FG000|Overall Study|Severe noncompliance to protocol|1|||
156764635|NCT01211145|565892977|FG001|Overall Study|Severe noncompliance to protocol|0|||
156764636|NCT01211145|565892978|FG002|Overall Study|Severe noncompliance to protocol|0|||
156764637|NCT01211145|565892979|FG003|Overall Study|Severe noncompliance to protocol|0|||
156764638|NCT01211145|565892976|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
156764639|NCT01211145|565892977|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
156764640|NCT01211145|565892978|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
156764641|NCT01211145|565892979|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
156764642|NCT01211145|565892976|FG000|Overall Study|Patient decision|2|||
156764643|NCT01211145|565892977|FG001|Overall Study|Patient decision|1|||
156764644|NCT01211145|565892978|FG002|Overall Study|Patient decision|0|||
156764645|NCT01211145|565892979|FG003|Overall Study|Patient decision|2|||
156764646|NCT00791999|565892980|FG000|Overall Study|Protocol planed withdrawal|14|||
156764647|NCT00791999|565892981|FG001|Overall Study|Protocol planed withdrawal|11|||
156764648|NCT00791999|565892982|FG002|Overall Study|Protocol planed withdrawal|11|||
156764649|NCT00791999|565892983|FG003|Overall Study|Protocol planed withdrawal|45|||
156764650|NCT00791999|565892980|FG000|Overall Study|Withdrawal by Subject|0|||
156764651|NCT00791999|565892981|FG001|Overall Study|Withdrawal by Subject|1|||
156764652|NCT00791999|565892982|FG002|Overall Study|Withdrawal by Subject|0|||
156764653|NCT00791999|565892983|FG003|Overall Study|Withdrawal by Subject|2|||
156764654|NCT00791999|565892980|FG000|Overall Study|Protocol Violation|3|||
156764655|NCT00791999|565892981|FG001|Overall Study|Protocol Violation|0|||
156764656|NCT00791999|565892982|FG002|Overall Study|Protocol Violation|1|||
156764657|NCT00791999|565892983|FG003|Overall Study|Protocol Violation|0|||
156764658|NCT00791999|565892980|FG000|Overall Study|Adverse Event|3|||
156764659|NCT00791999|565892981|FG001|Overall Study|Adverse Event|3|||
156764660|NCT00791999|565892982|FG002|Overall Study|Adverse Event|7|||
156764661|NCT00791999|565892983|FG003|Overall Study|Adverse Event|3|||
156764662|NCT00791999|565892980|FG000|Overall Study|Lack of Efficacy|0|||
156764663|NCT00791999|565892981|FG001|Overall Study|Lack of Efficacy|1|||
156764664|NCT00791999|565892982|FG002|Overall Study|Lack of Efficacy|0|||
156764665|NCT00791999|565892983|FG003|Overall Study|Lack of Efficacy|2|||
156764666|NCT00791999|565892980|FG000|Overall Study|Reason other than those above|1|||
156764667|NCT00791999|565892981|FG001|Overall Study|Reason other than those above|0|||
156764668|NCT00791999|565892982|FG002|Overall Study|Reason other than those above|1|||
156764669|NCT00791999|565892983|FG003|Overall Study|Reason other than those above|0|||
156764670|NCT00617357|565892986|FG000|Overall Study|Lost to Follow-up|7|||
156764671|NCT00617357|565892986|FG000|Overall Study|Death|5|||
156764672|NCT00617357|565892986|FG000|Overall Study|insurance concerns|2|||
156764673|NCT00617357|565892986|FG000|Overall Study|Withdrawal by Subject|1|||
156764674|NCT00617357|565892986|FG000|Overall Study|Physician Decision|1|||
156764675|NCT01791985|565892991|FG000|Overall Study|Adverse Event|7|||
156764676|NCT01791985|565892991|FG000|Overall Study|Withdrawal by Subject|1|||
156764677|NCT00485069|565892996|FG000|Overall Study|Adverse Event|10|||
156764678|NCT00485069|565892997|FG001|Overall Study|Adverse Event|4|||
156764679|NCT00485069|565892996|FG000|Overall Study|Lack of Efficacy|2|||
156764680|NCT00485069|565892997|FG001|Overall Study|Lack of Efficacy|1|||
156764681|NCT00485069|565892996|FG000|Overall Study|Protocol Violation|0|||
156764682|NCT00485069|565892997|FG001|Overall Study|Protocol Violation|1|||
156764683|NCT00485069|565892996|FG000|Overall Study|Withdrawal by Subject|6|||
156764684|NCT00485069|565892997|FG001|Overall Study|Withdrawal by Subject|6|||
156764685|NCT00086190|565892998|FG000|Overall Study|Adverse Event|6|||
156764686|NCT00086190|565892999|FG001|Overall Study|Adverse Event|2|||
156764687|NCT00086190|565893000|FG002|Overall Study|Adverse Event|2|||
156764688|NCT00086190|565892998|FG000|Overall Study|Withdrawal by Subject|0|||
156764689|NCT00086190|565892999|FG001|Overall Study|Withdrawal by Subject|2|||
156764690|NCT00086190|565893000|FG002|Overall Study|Withdrawal by Subject|2|||
156764691|NCT00086190|565892998|FG000|Overall Study|Protocol Violation|1|||
156764692|NCT00086190|565892999|FG001|Overall Study|Protocol Violation|0|||
156764693|NCT00086190|565893000|FG002|Overall Study|Protocol Violation|0|||
156764694|NCT00086190|565892998|FG000|Overall Study|Moved|1|||
156764695|NCT00086190|565892999|FG001|Overall Study|Moved|0|||
156764696|NCT00086190|565893000|FG002|Overall Study|Moved|0|||
156764697|NCT00086190|565892998|FG000|Overall Study|Worsening depression|0|||
156322649|NCT05007717|564280218|FG001|Overall Study|Death|2|||
156322650|NCT00427960|564280220|FG000|Overall Study|Adverse Event|2|||
156322651|NCT00427960|564280221|FG001|Overall Study|Adverse Event|0|||
156764698|NCT00086190|565892999|FG001|Overall Study|Worsening depression|0|||
156764699|NCT00086190|565893000|FG002|Overall Study|Worsening depression|2|||
156764700|NCT02688933|565893003|FG000|Overall Study|Adverse Event|3|||
156764701|NCT02688933|565893004|FG001|Overall Study|Adverse Event|1|||
156764702|NCT02688933|565893003|FG000|Overall Study|Lack of Efficacy|2|||
156764703|NCT02688933|565893004|FG001|Overall Study|Lack of Efficacy|2|||
156764704|NCT02688933|565893003|FG000|Overall Study|Poor compliance to protocol|7|||
156322652|NCT00427960|564280220|FG000|Overall Study|Withdrawal by Subject|0|||
156764705|NCT02688933|565893004|FG001|Overall Study|Poor compliance to protocol|4|||
156764706|NCT02688933|565893003|FG000|Overall Study|Hypoglycemia|2|||
156764707|NCT02688933|565893004|FG001|Overall Study|Hypoglycemia|0|||
156764708|NCT02688933|565893003|FG000|Overall Study|Other than Specified|14|||
156764709|NCT02688933|565893004|FG001|Overall Study|Other than Specified|25|||
156764710|NCT02688933|565893003|FG000|Overall Study|Lost to Follow-up|1|||
156764711|NCT02688933|565893004|FG001|Overall Study|Lost to Follow-up|5|||
156764712|NCT03902613|565893005|FG000|Overall Study|Physician Decision|1|||
156764713|NCT04622969|565893009|FG000|Overall Study|Withdrawal by Subject|2|||
156764714|NCT04622969|565893010|FG001|Overall Study|Withdrawal by Subject|3|||
156764715|NCT04467515|565893011|FG000|Overall Study|Lost to Follow-up|1|||
156764716|NCT04467515|565893012|FG001|Overall Study|Lost to Follow-up|0|||
156764717|NCT04467515|565893013|FG002|Overall Study|Lost to Follow-up|0|||
156764718|NCT04467515|565893011|FG000|Overall Study|Withdrawal by Subject|1|||
156764719|NCT04467515|565893012|FG001|Overall Study|Withdrawal by Subject|0|||
156764720|NCT04467515|565893013|FG002|Overall Study|Withdrawal by Subject|1|||
156764721|NCT04467515|565893011|FG000|Overall Study|Progressive Disease|0|||
156764722|NCT04467515|565893012|FG001|Overall Study|Progressive Disease|1|||
156764723|NCT04467515|565893013|FG002|Overall Study|Progressive Disease|3|||
156764724|NCT04467515|565893011|FG000|Overall Study|Death|0|||
156764725|NCT04467515|565893012|FG001|Overall Study|Death|1|||
156764726|NCT04467515|565893013|FG002|Overall Study|Death|0|||
156764727|NCT01091246|565893016|FG000|Overall Study|Lost to Follow-up|23|||
156764728|NCT01091246|565893017|FG001|Overall Study|Lost to Follow-up|11|||
156764729|NCT01091246|565893018|FG002|Overall Study|Lost to Follow-up|7|||
156764730|NCT01091246|565893016|FG000|Overall Study|Adverse Event|1|||
156764731|NCT01091246|565893017|FG001|Overall Study|Adverse Event|0|||
156764732|NCT01091246|565893018|FG002|Overall Study|Adverse Event|1|||
156764733|NCT01091246|565893016|FG000|Overall Study|Withdrawal by Subject|9|||
156764734|NCT01091246|565893017|FG001|Overall Study|Withdrawal by Subject|5|||
156764735|NCT01091246|565893018|FG002|Overall Study|Withdrawal by Subject|4|||
156764736|NCT01091246|565893016|FG000|Overall Study|Subject not dosed|2|||
156764737|NCT01091246|565893017|FG001|Overall Study|Subject not dosed|0|||
156764738|NCT01091246|565893018|FG002|Overall Study|Subject not dosed|1|||
156764739|NCT04577794|565893019|FG000|Overall Study|Adverse Event|1|||
156764740|NCT04577794|565893020|FG001|Overall Study|Adverse Event|1|||
156764741|NCT01676012|565893021|FG000|Overall Study|Adverse Event|2|||
156764742|NCT01676012|565893021|FG000|Overall Study|incomplete set of videos|1|||
156764743|NCT02155985|565893031|FG000|Overall Study|Withdrawal by Subject|0|||
156764744|NCT02155985|565893032|FG001|Overall Study|Withdrawal by Subject|0|||
156764745|NCT02155985|565893033|FG002|Overall Study|Withdrawal by Subject|1|||
156764746|NCT02155985|565893031|FG000|Overall Study|Lost to Follow-up|1|||
156764747|NCT02155985|565893032|FG001|Overall Study|Lost to Follow-up|0|||
156764748|NCT02155985|565893033|FG002|Overall Study|Lost to Follow-up|0|||
156764749|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Early discharge|5|||
156764750|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Early discharge|5|||
156764751|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
156764752|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
156764753|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
156764754|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
156764755|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
156764756|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
156764757|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
156764758|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
156764759|NCT04460326|565893038|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
156764760|NCT04460326|565893039|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
156764761|NCT03372798|565893040|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
156764762|NCT03372798|565893041|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
156764763|NCT03372798|565893040|FG000|Overall Study|Failure of imaging probe|0|||
156764764|NCT03372798|565893041|FG001|Overall Study|Failure of imaging probe|1|||
156764765|NCT04794751|565893043|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
156764766|NCT04794751|565893044|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
156764767|NCT04794751|565893043|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
156764768|NCT04794751|565893044|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
156764769|NCT04794751|565893043|FG000|Period 1|Protocol Violation|0|||
156764770|NCT04794751|565893044|FG001|Period 1|Protocol Violation|2|||
156764771|NCT04794751|565893043|FG000|Period 1|Withdrawal by Subject|0|||
156764772|NCT04794751|565893044|FG001|Period 1|Withdrawal by Subject|1|||
156764773|NCT04794751|565893043|FG000|Period 2|Withdrawal by Subject|0|||
156764774|NCT04794751|565893044|FG001|Period 2|Withdrawal by Subject|1|||
156764775|NCT04794751|565893043|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
156764776|NCT04794751|565893044|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
156764777|NCT04794751|565893043|FG000|Period 2|Protocol Violation|1|||
156764778|NCT04794751|565893044|FG001|Period 2|Protocol Violation|0|||
156764779|NCT01405898|565893045|FG000|Overall Study|Withdrawal by Subject|2|||
156764780|NCT01405898|565893046|FG001|Overall Study|Withdrawal by Subject|2|||
156764781|NCT01687218|565893047|FG000|Overall Study|Withdrawal by Subject|2|||
156764782|NCT01687218|565893048|FG001|Overall Study|Withdrawal by Subject|3|||
156764783|NCT01687218|565893049|FG002|Overall Study|Withdrawal by Subject|0|||
156764784|NCT01687218|565893050|FG003|Overall Study|Withdrawal by Subject|1|||
156764785|NCT01687218|565893051|FG004|Overall Study|Withdrawal by Subject|1|||
156764786|NCT01687218|565893052|FG005|Overall Study|Withdrawal by Subject|0|||
156764787|NCT01687218|565893047|FG000|Overall Study|Relocated, no follow-up planned|1|||
156764788|NCT01687218|565893048|FG001|Overall Study|Relocated, no follow-up planned|0|||
156764789|NCT01687218|565893049|FG002|Overall Study|Relocated, no follow-up planned|1|||
156764790|NCT01687218|565893050|FG003|Overall Study|Relocated, no follow-up planned|1|||
156764791|NCT01687218|565893051|FG004|Overall Study|Relocated, no follow-up planned|0|||
156764792|NCT01687218|565893052|FG005|Overall Study|Relocated, no follow-up planned|0|||
156764793|NCT03528551|565893057|FG000|Overall Study|Lost to Follow-up|0|||
156764794|NCT03528551|565893058|FG001|Overall Study|Lost to Follow-up|1|||
156764795|NCT03528551|565893059|FG002|Overall Study|Lost to Follow-up|0|||
156764796|NCT03528551|565893057|FG000|Overall Study|Transferred to other arm/group|2|||
156764797|NCT03528551|565893058|FG001|Overall Study|Transferred to other arm/group|3|||
156764798|NCT03528551|565893059|FG002|Overall Study|Transferred to other arm/group|0|||
156764799|NCT03528551|565893057|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156764800|NCT03528551|565893058|FG001|Overall Study|Withdrawal by parent/guardian|5|||
156764801|NCT03528551|565893059|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156764802|NCT03528551|565893057|FG000|Overall Study|Protocol Violation|0|||
156764803|NCT03528551|565893058|FG001|Overall Study|Protocol Violation|3|||
156764804|NCT03528551|565893059|FG002|Overall Study|Protocol Violation|0|||
156764805|NCT03528551|565893057|FG000|Overall Study|Withdrawal by Subject|0|||
156764806|NCT03528551|565893058|FG001|Overall Study|Withdrawal by Subject|7|||
156764807|NCT03528551|565893059|FG002|Overall Study|Withdrawal by Subject|0|||
156764808|NCT01789047|565893060|FG000|Overall Study|Adverse Event|3|||
156764809|NCT01789047|565893061|FG001|Overall Study|Adverse Event|2|||
156764810|NCT01789047|565893060|FG000|Overall Study|Withdrawal by Subject|1|||
156764811|NCT01789047|565893061|FG001|Overall Study|Withdrawal by Subject|2|||
156764812|NCT03644017|565893062|FG000|Overall Study|Access Abandonment|5|||
156764813|NCT03644017|565893062|FG000|Overall Study|Kidney Transplant|2|||
156764814|NCT01204671|565893063|FG000|Overall Study|Adverse Event|4|||
156764815|NCT01204671|565893064|FG001|Overall Study|Adverse Event|3|||
156764816|NCT01204671|565893065|FG002|Overall Study|Adverse Event|3|||
156764817|NCT01204671|565893066|FG003|Overall Study|Adverse Event|3|||
156764818|NCT01204671|565893067|FG004|Overall Study|Adverse Event|1|||
156764819|NCT01204671|565893063|FG000|Overall Study|Withdrawal by Subject|2|||
156764820|NCT01204671|565893064|FG001|Overall Study|Withdrawal by Subject|3|||
156764821|NCT01204671|565893065|FG002|Overall Study|Withdrawal by Subject|4|||
156764822|NCT01204671|565893066|FG003|Overall Study|Withdrawal by Subject|5|||
156764823|NCT01204671|565893067|FG004|Overall Study|Withdrawal by Subject|3|||
156764824|NCT01204671|565893063|FG000|Overall Study|Lost to Follow-up|7|||
156764825|NCT01204671|565893064|FG001|Overall Study|Lost to Follow-up|8|||
156764826|NCT01204671|565893065|FG002|Overall Study|Lost to Follow-up|6|||
156764827|NCT01204671|565893066|FG003|Overall Study|Lost to Follow-up|4|||
156764828|NCT01204671|565893067|FG004|Overall Study|Lost to Follow-up|0|||
156764829|NCT01204671|565893063|FG000|Overall Study|Unknown Completion Status|1|||
156764830|NCT01204671|565893064|FG001|Overall Study|Unknown Completion Status|1|||
156764831|NCT01204671|565893065|FG002|Overall Study|Unknown Completion Status|0|||
156764832|NCT01204671|565893066|FG003|Overall Study|Unknown Completion Status|0|||
156764833|NCT01204671|565893067|FG004|Overall Study|Unknown Completion Status|0|||
156764834|NCT01204671|565893063|FG000|Overall Study|Physician Decision|0|||
156764835|NCT01204671|565893064|FG001|Overall Study|Physician Decision|0|||
156764836|NCT01204671|565893065|FG002|Overall Study|Physician Decision|0|||
156764837|NCT01204671|565893066|FG003|Overall Study|Physician Decision|1|||
156764838|NCT01204671|565893067|FG004|Overall Study|Physician Decision|0|||
156764839|NCT02700048|565893068|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
156764840|NCT02700048|565893069|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
156322653|NCT00427960|564280221|FG001|Overall Study|Withdrawal by Subject|3|||
156322654|NCT00427960|564280220|FG000|Overall Study|Other|0|||
156322655|NCT00427960|564280221|FG001|Overall Study|Other|1|||
156322656|NCT03823378|564280222|FG000|Overall Study|Adverse Event|2|||
156322657|NCT03823378|564280223|FG001|Overall Study|Adverse Event|2|||
156426236|NCT04888585|564652884|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156764841|NCT02175225|565893070|FG000|Overall Study|Withdrawal by Subject|1|||
156764842|NCT02175225|565893071|FG001|Overall Study|Withdrawal by Subject|2|||
156764843|NCT02175225|565893070|FG000|Overall Study|Lost to Follow-up|6|||
156764844|NCT02175225|565893071|FG001|Overall Study|Lost to Follow-up|7|||
156764845|NCT02175225|565893070|FG000|Overall Study|Study drug not administered|1|||
156764846|NCT02175225|565893071|FG001|Overall Study|Study drug not administered|2|||
156322658|NCT03823378|564280224|FG002|Overall Study|Adverse Event|0|||
156322659|NCT03823378|564280225|FG003|Overall Study|Adverse Event|0|||
156322660|NCT03823378|564280226|FG004|Overall Study|Adverse Event|0|||
156322661|NCT03823378|564280227|FG005|Overall Study|Adverse Event|0|||
156764847|NCT02340000|565893072|FG000|Time Period 1|Withdrawal by Subject|6|||
156764848|NCT02340000|565893073|FG001|Time Period 1|Withdrawal by Subject|8|||
156764849|NCT02340000|565893072|FG000|Time Period 1|Lost to Follow-up|6|||
156764850|NCT02340000|565893073|FG001|Time Period 1|Lost to Follow-up|7|||
156764851|NCT02340000|565893072|FG000|Time Period 2|Withdrawal by Subject|9|||
156764852|NCT02340000|565893073|FG001|Time Period 2|Withdrawal by Subject|7|||
156764853|NCT02340000|565893072|FG000|Time Period 2|Lost to Follow-up|10|||
156764854|NCT02340000|565893073|FG001|Time Period 2|Lost to Follow-up|8|||
156764855|NCT02668640|565893074|FG000|Overall Study|Lost to Follow-up|13|||
156764856|NCT02668640|565893074|FG000|Overall Study|Other, not specified|1|||
156764857|NCT01883895|565893076|FG000|Overall Study|Lost to Follow-up|2|||
156764858|NCT07116759|565893084|FG000|Overall Study|Incompatibility with the RHMC device|2|||
156764859|NCT03342001|565894435|FG000|Overall Study|Adverse Event|1|||
156764860|NCT03342001|565894435|FG000|Overall Study|Lost to Follow-up|1|||
156764861|NCT01930539|565894450|FG000|Overall Study|Withdrawal by Subject|2|||
156764862|NCT01930539|565894451|FG001|Overall Study|Withdrawal by Subject|2|||
156764863|NCT00883181|565894452|FG000|Overall Study|Hematological Adverse Event|26|||
156764864|NCT00883181|565894452|FG000|Overall Study|Non-hematological Adverse Event|55|||
156764865|NCT00883181|565894452|FG000|Overall Study|Disease Progression|94|||
156764866|NCT00883181|565894452|FG000|Overall Study|Administrative Reason|24|||
156764867|NCT00883181|565894452|FG000|Overall Study|Withdrawal by Subject|4|||
156764868|NCT00883181|565894452|FG000|Overall Study|Death|31|||
156764869|NCT00883181|565894452|FG000|Overall Study|Other|38|||
156764870|NCT00883181|565894452|FG000|Overall Study|Protocol Deviation|3|||
156764871|NCT00883181|565894452|FG000|Overall Study|Noncompliance|3|||
156764872|NCT04040439|565894453|FG000|Overall Study|Invalid registration|11|||
156764873|NCT04040439|565894453|FG000|Overall Study|No IC* on publication of study results|2|||
156764874|NCT01450813|565894458|FG000|Overall Study|Physician Decision|1|||
156764875|NCT01450813|565894459|FG001|Overall Study|Physician Decision|1|||
156764876|NCT01450813|565894460|FG002|Overall Study|Physician Decision|0|||
156764877|NCT01450813|565894461|FG003|Overall Study|Physician Decision|3|||
156764878|NCT01309386|565894462|FG000|Overall Study|Other|2|||
156764879|NCT01309386|565894463|FG001|Overall Study|Other|0|||
156764880|NCT01309386|565894462|FG000|Overall Study|Withdrawal by Subject|2|||
156764881|NCT01309386|565894463|FG001|Overall Study|Withdrawal by Subject|0|||
156764882|NCT01309386|565894462|FG000|Overall Study|Progressive disease|9|||
156764883|NCT01309386|565894463|FG001|Overall Study|Progressive disease|11|||
156764884|NCT01309386|565894462|FG000|Overall Study|Physician Decision|1|||
156764885|NCT01309386|565894463|FG001|Overall Study|Physician Decision|1|||
156764886|NCT01309386|565894462|FG000|Overall Study|Lack of Efficacy|3|||
156764887|NCT01309386|565894463|FG001|Overall Study|Lack of Efficacy|1|||
156764888|NCT01309386|565894462|FG000|Overall Study|Adverse Event|5|||
156764889|NCT01309386|565894463|FG001|Overall Study|Adverse Event|8|||
156764890|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
156764891|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
156764892|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
156764893|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
156764894|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
156764895|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
156764896|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
156764897|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
156764898|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
156764899|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
156764900|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
156764901|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
156764902|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
156764903|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
156764904|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
156764905|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
156764906|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
156764907|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
156764908|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
156764909|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
156764910|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
156764911|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
156764912|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
156764913|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
156764914|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
156764915|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
156764916|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
156764917|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
156322662|NCT03823378|564280222|FG000|Overall Study|Lost to Follow-up|0|||
156764918|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
156764919|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
156764920|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
156764921|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
156764922|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
156764923|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
156764924|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
156764925|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
156764926|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
156764927|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
156764928|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
156764929|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
156764930|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
156764931|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
156764932|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
156764933|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
156764934|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
156764935|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
156764936|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
156764937|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
156764938|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
156764939|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
156764940|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
156764941|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
156764942|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
156764943|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
156764944|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
156764945|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
156764946|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
156764947|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
156764948|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
156764949|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
156764950|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
156764951|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
156764952|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
156764953|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
156764954|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
156764955|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
156764956|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
156764957|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
156764958|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
156764959|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
156764960|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
156764961|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
156764962|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
156764963|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
156764964|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
156764965|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
156764966|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
156764967|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
156764968|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
156764969|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
156764970|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
156764971|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
156764972|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
156764973|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
156764974|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
156764975|NCT00752089|565894469|FG000|Overall Study|Adverse Event|1|||
156764976|NCT00752089|565894469|FG000|Overall Study|Protocol Deviation|2|||
156764977|NCT00752089|565894469|FG000|Overall Study|Could not attend visit 9|1|||
156764978|NCT00752089|565894469|FG000|Overall Study|Not capable of wearing partial denture|1|||
156764979|NCT00752089|565894469|FG000|Overall Study|Cannot continue the study|1|||
156764980|NCT02089347|565894470|FG000|Overall Study|Protocol Violation|1|||
156764981|NCT02089347|565894471|FG001|Overall Study|Protocol Violation|0|||
156764982|NCT02914834|565894475|FG000|Overall Study|Study halted due to COVID|1|||
156764983|NCT02914834|565894476|FG001|Overall Study|Study halted due to COVID|1|||
156764984|NCT02914834|565894475|FG000|Overall Study|1 subject withdrew|0|||
156764985|NCT02914834|565894476|FG001|Overall Study|1 subject withdrew|1|||
156764986|NCT00975416|565894483|FG000|Overall Study|early discharge from tx|3|||
156764987|NCT00975416|565894484|FG001|Overall Study|early discharge from tx|5|||
156764988|NCT01245101|565894485|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
156764989|NCT01245101|565894486|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
156764990|NCT01245101|565894485|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
156764991|NCT01245101|565894486|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
156764992|NCT01245101|565894485|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
156764993|NCT01245101|565894486|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
156764994|NCT01225549|565894487|FG000|Period 4 - Washout|Disallowed medication|0|||
156764995|NCT01225549|565894488|FG001|Period 4 - Washout|Disallowed medication|1|||
156764996|NCT01225549|565894489|FG002|Period 4 - Washout|Disallowed medication|0|||
156764997|NCT01225549|565894490|FG003|Period 4 - Washout|Disallowed medication|0|||
156764998|NCT01225549|565894491|FG004|Period 4 - Washout|Disallowed medication|0|||
156764999|NCT01225549|565894492|FG005|Period 4 - Washout|Disallowed medication|0|||
156765000|NCT01225549|565894493|FG006|Period 4 - Washout|Disallowed medication|0|||
156765001|NCT01225549|565894494|FG007|Period 4 - Washout|Disallowed medication|0|||
156765002|NCT01225549|565894495|FG008|Period 4 - Washout|Disallowed medication|0|||
156765003|NCT01225549|565894496|FG009|Period 4 - Washout|Disallowed medication|0|||
156765004|NCT01225549|565894487|FG000|Period 6 - Washout|Disallowed medication|0|||
156765005|NCT01225549|565894488|FG001|Period 6 - Washout|Disallowed medication|0|||
156765006|NCT01225549|565894489|FG002|Period 6 - Washout|Disallowed medication|0|||
156765007|NCT01225549|565894490|FG003|Period 6 - Washout|Disallowed medication|1|||
156765008|NCT01225549|565894491|FG004|Period 6 - Washout|Disallowed medication|0|||
156765009|NCT01225549|565894492|FG005|Period 6 - Washout|Disallowed medication|0|||
156765010|NCT01225549|565894493|FG006|Period 6 - Washout|Disallowed medication|0|||
156765011|NCT01225549|565894494|FG007|Period 6 - Washout|Disallowed medication|0|||
156765012|NCT01225549|565894495|FG008|Period 6 - Washout|Disallowed medication|0|||
156765013|NCT01225549|565894496|FG009|Period 6 - Washout|Disallowed medication|0|||
156765014|NCT00473083|565894499|FG000|Overall Study|Adverse Event|1|||
156765015|NCT00473083|565894500|FG001|Overall Study|Adverse Event|0|||
156765016|NCT00473083|565894501|FG002|Overall Study|Adverse Event|0|||
156765017|NCT01184872|565894502|FG000|Overall Study|Adverse Event|3|||
156765018|NCT01184872|565894503|FG001|Overall Study|Adverse Event|4|||
156765019|NCT01184872|565894502|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156765020|NCT01184872|565894503|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156765021|NCT01184872|565894502|FG000|Overall Study|Withdrawal by Subject|2|||
156765022|NCT01184872|565894503|FG001|Overall Study|Withdrawal by Subject|0|||
156765023|NCT01184872|565894502|FG000|Overall Study|Lost to Follow-up|0|||
156765024|NCT01184872|565894503|FG001|Overall Study|Lost to Follow-up|1|||
156765025|NCT01184872|565894502|FG000|Overall Study|Administrative problems|1|||
156765026|NCT01184872|565894503|FG001|Overall Study|Administrative problems|1|||
156765027|NCT01184872|565894502|FG000|Overall Study|Protocol deviation|1|||
156765028|NCT01184872|565894503|FG001|Overall Study|Protocol deviation|0|||
156765029|NCT02283658|565894507|FG000|Overall Study|Withdrawal by Subject|1|||
156765030|NCT03608826|565894509|FG000|Overall Study|Death|3|||
156765031|NCT03608826|565894509|FG000|Overall Study|Heart Transplant|3|||
156765032|NCT03608826|565894509|FG000|Overall Study|Physician Decision|4|||
156765033|NCT00875810|565894510|FG000|Overall Study|Withdrawal by Subject|1|||
156765034|NCT00875810|565894510|FG000|Overall Study|Physician Decision|3|||
156765035|NCT00875810|565894510|FG000|Overall Study|Lost to Follow-up|39|||
156765036|NCT00875810|565894510|FG000|Overall Study|Patient enroled but not implanted|2|||
156765037|NCT00875810|565894510|FG000|Overall Study|Device explanted|1|||
156765038|NCT00780975|565894511|FG000|Overall Study|Progressive disease|3|||
156765039|NCT00780975|565894511|FG000|Overall Study|Toxicity|5|||
156765040|NCT01061606|565894512|FG000|Overall Study|Adverse Event|1|||
156765041|NCT01061606|565894512|FG000|Overall Study|Death|1|||
156765042|NCT01061606|565894512|FG000|Overall Study|Disease Progression|4|||
156765043|NCT01061606|565894512|FG000|Overall Study|alternative therapy|2|||
156765044|NCT01305564|565894513|FG000|Overall Study|Death|21|||
156765045|NCT01305564|565894513|FG000|Overall Study|Lost to Follow-up|12|||
156765046|NCT01305564|565894513|FG000|Overall Study|Withdrawal by Subject|1|||
156765047|NCT01305564|565894513|FG000|Overall Study|Physician Decision|3|||
156765048|NCT02322749|565894515|FG000|Period 2|Adverse Event|0|||
156765049|NCT02322749|565894516|FG001|Period 2|Adverse Event|0|||
156765050|NCT02322749|565894517|FG002|Period 2|Adverse Event|0|||
156765051|NCT02322749|565894518|FG003|Period 2|Adverse Event|1|||
156765052|NCT02322749|565894519|FG004|Period 2|Adverse Event|0|||
156765053|NCT02322749|565894520|FG005|Period 2|Adverse Event|0|||
156765054|NCT02322749|565894515|FG000|Period 2|Withdrawal by Subject|0|||
156765055|NCT02322749|565894516|FG001|Period 2|Withdrawal by Subject|0|||
156765056|NCT02322749|565894517|FG002|Period 2|Withdrawal by Subject|0|||
156765057|NCT02322749|565894518|FG003|Period 2|Withdrawal by Subject|1|||
156765058|NCT02322749|565894519|FG004|Period 2|Withdrawal by Subject|0|||
156765059|NCT02322749|565894520|FG005|Period 2|Withdrawal by Subject|0|||
156765060|NCT02322749|565894515|FG000|Period 3|Withdrawal by Subject|0|||
156765061|NCT02322749|565894516|FG001|Period 3|Withdrawal by Subject|0|||
156765062|NCT02322749|565894517|FG002|Period 3|Withdrawal by Subject|1|||
156765063|NCT02322749|565894518|FG003|Period 3|Withdrawal by Subject|0|||
156765064|NCT02322749|565894519|FG004|Period 3|Withdrawal by Subject|0|||
156765065|NCT02322749|565894520|FG005|Period 3|Withdrawal by Subject|0|||
156765066|NCT00073918|565894525|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
156765067|NCT00073918|565894525|FG000|Overall Study|Rapid disease progression|2|||
156765068|NCT00073918|565894525|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
156765069|NCT01190813|565894528|FG000|Overall Study|Lost to Follow-up|1|||
156765070|NCT01190813|565894529|FG001|Overall Study|Lost to Follow-up|2|||
156765071|NCT01190813|565894528|FG000|Overall Study|Withdrawal by Subject|2|||
156765072|NCT01190813|565894529|FG001|Overall Study|Withdrawal by Subject|1|||
156765073|NCT01190813|565894528|FG000|Overall Study|Refused study treatment after randomized|1|||
156765074|NCT01190813|565894529|FG001|Overall Study|Refused study treatment after randomized|0|||
156765075|NCT01190813|565894528|FG000|Overall Study|Adverse Event|0|||
156765076|NCT01190813|565894529|FG001|Overall Study|Adverse Event|1|||
156765077|NCT02033759|565894531|FG000|Overall Study|Withdrawal by Subject|2|||
156765078|NCT02033759|565894532|FG001|Overall Study|Withdrawal by Subject|1|||
156765079|NCT02033759|565894531|FG000|Overall Study|Protocol Violation|1|||
156765080|NCT02033759|565894532|FG001|Overall Study|Protocol Violation|1|||
156765081|NCT00807365|565894536|FG000|Overall Study|Study Terminated|5|||
156765082|NCT04821830|565894539|FG000|Overall Study|Withdrawal by Subject|1|||
156765083|NCT04821830|565894540|FG001|Overall Study|Withdrawal by Subject|0|||
156765084|NCT00919633|565894542|FG000|Overall Study|Adverse Event|1|||
156765085|NCT00919633|565894543|FG001|Overall Study|Adverse Event|9|||
156765086|NCT00919633|565894544|FG002|Overall Study|Adverse Event|12|||
156765087|NCT00919633|565894545|FG003|Overall Study|Adverse Event|10|||
156765088|NCT00919633|565894542|FG000|Overall Study|Death|0|||
156765089|NCT00919633|565894543|FG001|Overall Study|Death|0|||
156765090|NCT00919633|565894544|FG002|Overall Study|Death|2|||
156765091|NCT00919633|565894545|FG003|Overall Study|Death|0|||
156765092|NCT00919633|565894542|FG000|Overall Study|Lack of Efficacy|17|||
156765093|NCT00919633|565894543|FG001|Overall Study|Lack of Efficacy|3|||
156765094|NCT00919633|565894544|FG002|Overall Study|Lack of Efficacy|2|||
156765095|NCT00919633|565894545|FG003|Overall Study|Lack of Efficacy|3|||
156765096|NCT00919633|565894542|FG000|Overall Study|Withdrawal by Subject|1|||
156765097|NCT00919633|565894543|FG001|Overall Study|Withdrawal by Subject|2|||
156765098|NCT00919633|565894544|FG002|Overall Study|Withdrawal by Subject|4|||
156765099|NCT00919633|565894545|FG003|Overall Study|Withdrawal by Subject|3|||
156765100|NCT00919633|565894542|FG000|Overall Study|Lost to Follow-up|3|||
156765101|NCT00919633|565894543|FG001|Overall Study|Lost to Follow-up|1|||
156765102|NCT00919633|565894544|FG002|Overall Study|Lost to Follow-up|0|||
156765103|NCT00919633|565894545|FG003|Overall Study|Lost to Follow-up|2|||
156765104|NCT00919633|565894542|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
156765105|NCT00919633|565894543|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
156765106|NCT00919633|565894544|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
156765107|NCT00919633|565894545|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
156765108|NCT00919633|565894542|FG000|Overall Study|Protocol Violation|0|||
156765109|NCT00919633|565894543|FG001|Overall Study|Protocol Violation|0|||
156765110|NCT00919633|565894544|FG002|Overall Study|Protocol Violation|0|||
156765111|NCT00919633|565894545|FG003|Overall Study|Protocol Violation|1|||
156765112|NCT00919633|565894542|FG000|Overall Study|Physician Decision|0|||
156765113|NCT00919633|565894543|FG001|Overall Study|Physician Decision|0|||
156765114|NCT00919633|565894544|FG002|Overall Study|Physician Decision|0|||
156765115|NCT00919633|565894545|FG003|Overall Study|Physician Decision|1|||
156765116|NCT00919633|565894542|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
156765117|NCT00919633|565894543|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
156765118|NCT00919633|565894544|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
156765119|NCT00919633|565894545|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
156765120|NCT00919633|565894542|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
156426237|NCT04888585|564652885|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156426238|NCT04888585|564652886|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156426239|NCT04888585|564652887|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156426240|NCT04888585|564652888|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156426241|NCT04888585|564652889|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
156426242|NCT04888585|564652890|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
156426243|NCT04888585|564652891|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
156426244|NCT04888585|564652892|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
156765121|NCT00919633|565894543|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
156765122|NCT00919633|565894544|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
156765123|NCT00919633|565894545|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
156765124|NCT01526785|565894546|FG000|Overall Study|Study Terminated by Sponsor|8|||
156765125|NCT01526785|565894546|FG000|Overall Study|Death|2|||
156426245|NCT04888585|564652893|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156426246|NCT04678830|564652900|FG000|Overall Study|Lack of Efficacy|2|||
156426247|NCT04678830|564652901|FG001|Overall Study|Lack of Efficacy|0|||
156765126|NCT01526785|565894546|FG000|Overall Study|Physician Decision|1|||
156426248|NCT04678830|564652900|FG000|Overall Study|Withdrawal by Subject|0|||
156426249|NCT04678830|564652901|FG001|Overall Study|Withdrawal by Subject|1|||
156426250|NCT05550337|564652902|FG000|Overall Study|Lack of Efficacy|0|||
156426251|NCT05550337|564652903|FG001|Overall Study|Lack of Efficacy|0|||
156426252|NCT05550337|564652904|FG002|Overall Study|Lack of Efficacy|1|||
156426253|NCT05550337|564652902|FG000|Overall Study|Adverse Event|1|||
156426254|NCT05550337|564652903|FG001|Overall Study|Adverse Event|5|||
156426255|NCT05550337|564652904|FG002|Overall Study|Adverse Event|0|||
156426256|NCT05550337|564652902|FG000|Overall Study|Withdrawal by Subject|8|||
156426257|NCT05550337|564652903|FG001|Overall Study|Withdrawal by Subject|14|||
156426258|NCT05550337|564652904|FG002|Overall Study|Withdrawal by Subject|10|||
156426259|NCT05550337|564652902|FG000|Overall Study|Pregnancy|0|||
156426260|NCT05550337|564652903|FG001|Overall Study|Pregnancy|0|||
156426261|NCT05550337|564652904|FG002|Overall Study|Pregnancy|1|||
156426262|NCT05550337|564652902|FG000|Overall Study|Protocol Violation|1|||
156426263|NCT05550337|564652903|FG001|Overall Study|Protocol Violation|3|||
156765127|NCT01526785|565894546|FG000|Overall Study|Withdrawal by Subject|2|||
156765128|NCT01121263|565894549|FG000|Overall Study|Death|3|||
156765129|NCT01121263|565894550|FG001|Overall Study|Death|2|||
156765130|NCT01121263|565894549|FG000|Overall Study|Lost to Follow-up|22|||
156765131|NCT01121263|565894550|FG001|Overall Study|Lost to Follow-up|12|||
156765132|NCT01121263|565894549|FG000|Overall Study|Withdrawal by Subject|0|||
156765133|NCT01121263|565894550|FG001|Overall Study|Withdrawal by Subject|1|||
156765134|NCT02007720|565894551|FG000|Overall Study|Withdrawal by Subject|9|||
156765135|NCT02007720|565894552|FG001|Overall Study|Withdrawal by Subject|11|||
156765136|NCT02007720|565894551|FG000|Overall Study|study terminated by sponsor|58|||
156765137|NCT02007720|565894552|FG001|Overall Study|study terminated by sponsor|54|||
156765138|NCT02007720|565894551|FG000|Overall Study|technical problem|4|||
156765139|NCT02007720|565894552|FG001|Overall Study|technical problem|2|||
156765140|NCT02007720|565894551|FG000|Overall Study|patient followd less than 165 days|11|||
156765141|NCT02007720|565894552|FG001|Overall Study|patient followd less than 165 days|5|||
156765142|NCT03810456|565894554|FG000|Treatment|Urgent Family Matters|3|||
156765143|NCT03810456|565894555|FG001|Treatment|Urgent Family Matters|0|||
156765144|NCT03810456|565894556|FG002|Treatment|Urgent Family Matters|0|||
156765145|NCT03810456|565894554|FG000|Treatment|Scheduling Conflicts|0|||
156765146|NCT03810456|565894555|FG001|Treatment|Scheduling Conflicts|11|||
156765147|NCT03810456|565894556|FG002|Treatment|Scheduling Conflicts|0|||
156765148|NCT03810456|565894554|FG000|Treatment|No Longer Interested|0|||
156765149|NCT03810456|565894555|FG001|Treatment|No Longer Interested|12|||
156765150|NCT03810456|565894556|FG002|Treatment|No Longer Interested|0|||
156765151|NCT03810456|565894554|FG000|Treatment|Transportation Issues|0|||
156765152|NCT03810456|565894555|FG001|Treatment|Transportation Issues|1|||
156765153|NCT03810456|565894556|FG002|Treatment|Transportation Issues|0|||
156765154|NCT03810456|565894554|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
156765155|NCT03810456|565894555|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
156765156|NCT03810456|565894556|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
156426264|NCT05550337|564652904|FG002|Overall Study|Protocol Violation|4|||
156426265|NCT05550337|564652902|FG000|Overall Study|Physician Decision|2|||
156426266|NCT05550337|564652903|FG001|Overall Study|Physician Decision|1|||
156426267|NCT05550337|564652904|FG002|Overall Study|Physician Decision|1|||
156426268|NCT05550337|564652902|FG000|Overall Study|Lost to Follow-up|16|||
156426269|NCT05550337|564652903|FG001|Overall Study|Lost to Follow-up|11|||
156426270|NCT05550337|564652904|FG002|Overall Study|Lost to Follow-up|11|||
156426271|NCT01836458|564652907|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156426272|NCT01836458|564652908|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156426273|NCT01836458|564652909|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
156426274|NCT01836458|564652910|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
156765157|NCT03810456|565894554|FG000|1 Month Follow-Up|Relocated to Different State|1|||
156765158|NCT03810456|565894555|FG001|1 Month Follow-Up|Relocated to Different State|0|||
156765159|NCT03810456|565894556|FG002|1 Month Follow-Up|Relocated to Different State|1|||
156426275|NCT04257058|564654595|FG000|Overall Study|Lost to Follow-up|31|||
156426276|NCT02960659|564654597|FG000|Overall Study|Withdrawal by Subject|1|||
156426277|NCT02960659|564654598|FG001|Overall Study|Withdrawal by Subject|0|||
156426278|NCT02960659|564654597|FG000|Overall Study|Poor compliance|0|||
156765160|NCT03810456|565894554|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
156765161|NCT03810456|565894555|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
156765162|NCT03810456|565894556|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
156765163|NCT03810456|565894554|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
156765164|NCT03810456|565894555|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
156426279|NCT02960659|564654598|FG001|Overall Study|Poor compliance|1|||
156426280|NCT04199728|564654602|FG000|Overall Study|Adverse Event|1|||
156426281|NCT04199728|564654603|FG001|Overall Study|Adverse Event|0|||
156765165|NCT03810456|565894556|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
156765166|NCT03810456|565894554|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
156426282|NCT04199728|564654602|FG000|Overall Study|Withdrawal by Subject|8|||
156426283|NCT04199728|564654603|FG001|Overall Study|Withdrawal by Subject|3|||
156426284|NCT04199728|564654602|FG000|Overall Study|Screen fail after consent|0|||
156426285|NCT04199728|564654603|FG001|Overall Study|Screen fail after consent|1|||
156426286|NCT04199728|564654602|FG000|Overall Study|Early withdraw criteria met|0|||
156426287|NCT04199728|564654603|FG001|Overall Study|Early withdraw criteria met|1|||
156426288|NCT04199728|564654602|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
156426289|NCT04199728|564654603|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
156426290|NCT04057196|564654605|FG000|Overall Study|Withdrawal by Subject|3|||
156426291|NCT04057196|564654605|FG000|Overall Study|Death|3|||
156426292|NCT03068468|564654606|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
156426293|NCT03068468|564654607|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
156426294|NCT03068468|564654608|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
156426295|NCT03068468|564654609|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
156426296|NCT03068468|564654606|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
156426297|NCT03068468|564654607|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
156426298|NCT03068468|564654608|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
156426299|NCT03068468|564654609|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
156426300|NCT03068468|564654606|FG000|Placebo-Controlled Period|Adverse Event|16|||
156426301|NCT03068468|564654607|FG001|Placebo-Controlled Period|Adverse Event|21|||
156426302|NCT03068468|564654608|FG002|Placebo-Controlled Period|Adverse Event|0|||
156426303|NCT03068468|564654609|FG003|Placebo-Controlled Period|Adverse Event|0|||
156426304|NCT03068468|564654606|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
156426305|NCT03068468|564654607|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
156426306|NCT03068468|564654608|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
156426307|NCT03068468|564654609|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
156426308|NCT03068468|564654606|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
156426309|NCT03068468|564654607|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
156426310|NCT03068468|564654608|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156426311|NCT03068468|564654609|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156426312|NCT03068468|564654606|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
156426313|NCT03068468|564654607|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
156426314|NCT03068468|564654608|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
156426315|NCT03068468|564654609|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
156426316|NCT03068468|564654606|FG000|Placebo-Controlled Period|Death|0|||
156426317|NCT03068468|564654607|FG001|Placebo-Controlled Period|Death|1|||
156426318|NCT03068468|564654608|FG002|Placebo-Controlled Period|Death|0|||
156426319|NCT03068468|564654609|FG003|Placebo-Controlled Period|Death|0|||
156426320|NCT03068468|564654606|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
156426321|NCT03068468|564654607|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
156426322|NCT03068468|564654608|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
156426323|NCT03068468|564654609|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
156426324|NCT03068468|564654606|FG000|Open-Label Extension Period|Adverse Event|0|||
156426325|NCT03068468|564654607|FG001|Open-Label Extension Period|Adverse Event|0|||
156426326|NCT03068468|564654608|FG002|Open-Label Extension Period|Adverse Event|13|||
156426327|NCT03068468|564654609|FG003|Open-Label Extension Period|Adverse Event|17|||
156426328|NCT03068468|564654606|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
156426329|NCT03068468|564654607|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
156426330|NCT03068468|564654608|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
156426331|NCT03068468|564654609|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
156426332|NCT03068468|564654606|FG000|Open-Label Extension Period|Death|0|||
156426333|NCT03068468|564654607|FG001|Open-Label Extension Period|Death|0|||
156426334|NCT03068468|564654608|FG002|Open-Label Extension Period|Death|0|||
156426335|NCT03068468|564654609|FG003|Open-Label Extension Period|Death|1|||
156426336|NCT03068468|564654606|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
156322663|NCT03823378|564280223|FG001|Overall Study|Lost to Follow-up|1|||
156426337|NCT03068468|564654607|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
156426338|NCT03068468|564654608|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
156426339|NCT03068468|564654609|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
156322664|NCT03823378|564280224|FG002|Overall Study|Lost to Follow-up|0|||
156322665|NCT03823378|564280225|FG003|Overall Study|Lost to Follow-up|0|||
156322666|NCT03823378|564280226|FG004|Overall Study|Lost to Follow-up|1|||
156322667|NCT03823378|564280227|FG005|Overall Study|Lost to Follow-up|0|||
156322668|NCT03823378|564280222|FG000|Overall Study|Withdrawal by Subject|0|||
156322669|NCT03823378|564280223|FG001|Overall Study|Withdrawal by Subject|1|||
156322670|NCT03823378|564280224|FG002|Overall Study|Withdrawal by Subject|4|||
156322671|NCT03823378|564280225|FG003|Overall Study|Withdrawal by Subject|2|||
156322672|NCT03823378|564280226|FG004|Overall Study|Withdrawal by Subject|0|||
156322673|NCT03823378|564280227|FG005|Overall Study|Withdrawal by Subject|1|||
156322674|NCT03823378|564280222|FG000|Overall Study|Other, not specified|19|||
156322675|NCT03823378|564280223|FG001|Overall Study|Other, not specified|12|||
156322676|NCT03823378|564280224|FG002|Overall Study|Other, not specified|6|||
156426340|NCT03068468|564654606|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
156426341|NCT03068468|564654607|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
156426342|NCT03068468|564654608|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
156426343|NCT03068468|564654609|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
156426344|NCT03068468|564654606|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
156426345|NCT03068468|564654607|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
156426346|NCT03068468|564654608|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
156426347|NCT03068468|564654609|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
156426348|NCT03068468|564654606|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
156426349|NCT03068468|564654607|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
156426350|NCT03068468|564654608|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
156426351|NCT03068468|564654609|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
156655688|NCT03384745|565485831|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
156655689|NCT03384745|565485832|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
156655690|NCT03384745|565485833|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
156655691|NCT03384745|565485834|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
156655692|NCT03384745|565485835|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
156655693|NCT03384745|565485830|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
156655694|NCT03384745|565485831|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
156655695|NCT03384745|565485832|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
156655696|NCT03384745|565485833|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
156655697|NCT03384745|565485834|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
156655698|NCT03384745|565485835|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
156655699|NCT03384745|565485830|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
156655700|NCT03384745|565485831|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
156655701|NCT03384745|565485832|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
156655702|NCT03384745|565485833|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
156655703|NCT03384745|565485834|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
156655704|NCT03384745|565485835|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
156655705|NCT03384745|565485830|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
156655706|NCT03384745|565485831|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
156655707|NCT03384745|565485832|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
156655708|NCT03384745|565485833|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
156655709|NCT03384745|565485834|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
156655710|NCT03384745|565485835|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
156655711|NCT03384745|565485830|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
156655712|NCT03384745|565485831|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
156655713|NCT03384745|565485832|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
156655714|NCT03384745|565485833|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
156655715|NCT03384745|565485834|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
156655716|NCT03384745|565485835|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
156655717|NCT03384745|565485830|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
156655718|NCT03384745|565485831|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
156655719|NCT03384745|565485832|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
156655720|NCT03384745|565485833|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
156655721|NCT03384745|565485834|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
156655722|NCT03384745|565485835|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
156655723|NCT03384745|565485830|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
156655724|NCT03384745|565485831|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
156655725|NCT03384745|565485832|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
156655726|NCT03384745|565485833|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
156655727|NCT03384745|565485834|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
156655728|NCT03384745|565485835|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
156655729|NCT03384745|565485830|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
156655730|NCT03384745|565485831|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
156655731|NCT03384745|565485832|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
156655732|NCT03384745|565485833|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
156655733|NCT03384745|565485834|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
156655734|NCT03384745|565485835|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
156655735|NCT01058421|565485838|FG000|1 Month Outcomes|Death|10|||
156655736|NCT01058421|565485839|FG001|1 Month Outcomes|Death|6|||
156655737|NCT01058421|565485838|FG000|1 Month Outcomes|Lost to Follow-up|8|||
156655738|NCT01058421|565485839|FG001|1 Month Outcomes|Lost to Follow-up|7|||
156655739|NCT01058421|565485838|FG000|1 Month Outcomes|Remained in Hospital|5|||
156655740|NCT01058421|565485839|FG001|1 Month Outcomes|Remained in Hospital|12|||
156655741|NCT01058421|565485838|FG000|1 Month Outcomes|Remained in Other Facility|16|||
156655742|NCT01058421|565485839|FG001|1 Month Outcomes|Remained in Other Facility|17|||
156655743|NCT01058421|565485838|FG000|3 Month Outcomes|Death|3|||
156765167|NCT03810456|565894555|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
156765168|NCT03810456|565894556|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
156765169|NCT03810456|565894554|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
156765170|NCT03810456|565894555|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
156765171|NCT03810456|565894556|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
156765172|NCT03810456|565894554|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
156765173|NCT03810456|565894555|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
156765174|NCT03810456|565894556|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
156765175|NCT00490919|565894559|FG000|Open-label Run-in Period|Adverse Event|239|||
156765176|NCT00490919|565894560|FG001|Open-label Run-in Period|Adverse Event|0|||
156765177|NCT00490919|565894561|FG002|Open-label Run-in Period|Adverse Event|0|||
156765178|NCT00490919|565894559|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
156765179|NCT00490919|565894560|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
156765180|NCT00490919|565894561|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
156765181|NCT00490919|565894559|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
156765182|NCT00490919|565894560|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
156765183|NCT00490919|565894561|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
156765184|NCT00490919|565894559|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
156765185|NCT00490919|565894560|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
156765186|NCT00490919|565894561|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
156765187|NCT00490919|565894559|FG000|Open-label Run-in Period|Administrative|40|||
156765188|NCT00490919|565894560|FG001|Open-label Run-in Period|Administrative|0|||
156765189|NCT00490919|565894561|FG002|Open-label Run-in Period|Administrative|0|||
156765190|NCT00490919|565894559|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
156765191|NCT00490919|565894560|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
156765192|NCT00490919|565894561|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
156765193|NCT00490919|565894559|FG000|Double-blind Phase|Adverse Event|0|||
156765194|NCT00490919|565894560|FG001|Double-blind Phase|Adverse Event|40|||
156765195|NCT00490919|565894561|FG002|Double-blind Phase|Adverse Event|20|||
156765196|NCT00490919|565894559|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156765197|NCT00490919|565894560|FG001|Double-blind Phase|Withdrawal by Subject|10|||
156765198|NCT00490919|565894561|FG002|Double-blind Phase|Withdrawal by Subject|11|||
156765199|NCT00490919|565894559|FG000|Double-blind Phase|Lost to Follow-up|0|||
156765200|NCT00490919|565894560|FG001|Double-blind Phase|Lost to Follow-up|8|||
156765201|NCT00490919|565894561|FG002|Double-blind Phase|Lost to Follow-up|11|||
156765202|NCT00490919|565894559|FG000|Double-blind Phase|Lack of Efficacy|0|||
156765203|NCT00490919|565894560|FG001|Double-blind Phase|Lack of Efficacy|22|||
156765204|NCT00490919|565894561|FG002|Double-blind Phase|Lack of Efficacy|36|||
156765205|NCT00490919|565894559|FG000|Double-blind Phase|Administrative|0|||
156765206|NCT00490919|565894560|FG001|Double-blind Phase|Administrative|6|||
156765207|NCT00490919|565894561|FG002|Double-blind Phase|Administrative|6|||
156765208|NCT02100124|565894568|FG000|Overall Study|Lost to Follow-up|5|||
156765209|NCT02100124|565894569|FG001|Overall Study|Lost to Follow-up|11|||
156765210|NCT02100124|565894570|FG002|Overall Study|Lost to Follow-up|3|||
156765211|NCT02100124|565894568|FG000|Overall Study|Withdrawal by Subject|1|||
156765212|NCT02100124|565894569|FG001|Overall Study|Withdrawal by Subject|0|||
156765213|NCT02100124|565894570|FG002|Overall Study|Withdrawal by Subject|0|||
156765214|NCT04350827|565894571|FG000|Overall Study|Lost to Follow-up|1|||
156765215|NCT04350827|565894572|FG001|Overall Study|Lost to Follow-up|2|||
156765216|NCT04265261|565894573|FG000|Overall Study|Adverse Event|2|||
156765217|NCT04265261|565894574|FG001|Overall Study|Adverse Event|0|||
156765218|NCT04265261|565894575|FG002|Overall Study|Adverse Event|0|||
156765219|NCT04265261|565894573|FG000|Overall Study|Death|1|||
156765220|NCT04265261|565894574|FG001|Overall Study|Death|0|||
156765221|NCT04265261|565894575|FG002|Overall Study|Death|0|||
156765222|NCT04265261|565894573|FG000|Overall Study|Lost to Follow-up|4|||
156765223|NCT04265261|565894574|FG001|Overall Study|Lost to Follow-up|1|||
156765224|NCT04265261|565894575|FG002|Overall Study|Lost to Follow-up|3|||
156765225|NCT04265261|565894573|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156765226|NCT04265261|565894574|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156765227|NCT04265261|565894575|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156765228|NCT04265261|565894573|FG000|Overall Study|Physician Decision|0|||
156765229|NCT04265261|565894574|FG001|Overall Study|Physician Decision|0|||
156765230|NCT04265261|565894575|FG002|Overall Study|Physician Decision|1|||
156765231|NCT04265261|565894573|FG000|Overall Study|Protocol Deviation|0|||
156765232|NCT04265261|565894574|FG001|Overall Study|Protocol Deviation|2|||
156765233|NCT04265261|565894575|FG002|Overall Study|Protocol Deviation|0|||
156765234|NCT04265261|565894573|FG000|Overall Study|Withdrawal by Subject|2|||
156765235|NCT04265261|565894574|FG001|Overall Study|Withdrawal by Subject|1|||
156765236|NCT04265261|565894575|FG002|Overall Study|Withdrawal by Subject|4|||
156765237|NCT02337764|565896475|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
156765238|NCT02337764|565896475|FG000|Overall Study|Voluntary Withdrawal|12|||
156765239|NCT02337764|565896475|FG000|Overall Study|Lack of Efficacy|2|||
156765240|NCT02990000|565896476|FG000|Overall Study|Failed to provide data beyond baseline|36|||
156765241|NCT02990000|565896477|FG001|Overall Study|Failed to provide data beyond baseline|34|||
156765242|NCT00557466|565896481|FG000|Overall Study|Adverse Event|3|||
156765243|NCT00557466|565896482|FG001|Overall Study|Adverse Event|1|||
156765244|NCT00557466|565896483|FG002|Overall Study|Adverse Event|4|||
156765245|NCT00557466|565896484|FG003|Overall Study|Adverse Event|1|||
156765246|NCT00557466|565896485|FG004|Overall Study|Adverse Event|2|||
156765247|NCT00557466|565896486|FG005|Overall Study|Adverse Event|4|||
156765248|NCT00557466|565896481|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156765249|NCT00557466|565896482|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156765250|NCT00557466|565896483|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156765251|NCT00557466|565896484|FG003|Overall Study|Abnormal laboratory value(s)|0|||
156765252|NCT00557466|565896485|FG004|Overall Study|Abnormal laboratory value(s)|0|||
156765253|NCT00557466|565896486|FG005|Overall Study|Abnormal laboratory value(s)|0|||
156765254|NCT00557466|565896481|FG000|Overall Study|Protocol deviation|0|||
156765255|NCT00557466|565896482|FG001|Overall Study|Protocol deviation|1|||
156765256|NCT00557466|565896483|FG002|Overall Study|Protocol deviation|0|||
156765257|NCT00557466|565896484|FG003|Overall Study|Protocol deviation|2|||
156765258|NCT00557466|565896485|FG004|Overall Study|Protocol deviation|0|||
156765259|NCT00557466|565896486|FG005|Overall Study|Protocol deviation|0|||
156765260|NCT00557466|565896481|FG000|Overall Study|Subject withdrew consent|0|||
156765261|NCT00557466|565896482|FG001|Overall Study|Subject withdrew consent|0|||
156765262|NCT00557466|565896483|FG002|Overall Study|Subject withdrew consent|0|||
156765263|NCT00557466|565896484|FG003|Overall Study|Subject withdrew consent|0|||
156765264|NCT00557466|565896485|FG004|Overall Study|Subject withdrew consent|1|||
156765265|NCT00557466|565896486|FG005|Overall Study|Subject withdrew consent|2|||
156765266|NCT00557466|565896481|FG000|Overall Study|Administrative problems|0|||
156765267|NCT00557466|565896482|FG001|Overall Study|Administrative problems|1|||
156765268|NCT00557466|565896483|FG002|Overall Study|Administrative problems|1|||
156765269|NCT00557466|565896484|FG003|Overall Study|Administrative problems|0|||
156765270|NCT00557466|565896485|FG004|Overall Study|Administrative problems|0|||
156765271|NCT00557466|565896486|FG005|Overall Study|Administrative problems|0|||
156765272|NCT00557466|565896481|FG000|Overall Study|Abnormal test procedure results|0|||
156765273|NCT00557466|565896482|FG001|Overall Study|Abnormal test procedure results|0|||
156765274|NCT00557466|565896483|FG002|Overall Study|Abnormal test procedure results|1|||
156765275|NCT00557466|565896484|FG003|Overall Study|Abnormal test procedure results|0|||
156765276|NCT00557466|565896485|FG004|Overall Study|Abnormal test procedure results|0|||
156765277|NCT00557466|565896486|FG005|Overall Study|Abnormal test procedure results|0|||
156765278|NCT00557466|565896481|FG000|Overall Study|Lost to Follow-up|0|||
156765279|NCT00557466|565896482|FG001|Overall Study|Lost to Follow-up|0|||
156765280|NCT00557466|565896483|FG002|Overall Study|Lost to Follow-up|0|||
156765281|NCT00557466|565896484|FG003|Overall Study|Lost to Follow-up|1|||
156765282|NCT00557466|565896485|FG004|Overall Study|Lost to Follow-up|0|||
156765283|NCT00557466|565896486|FG005|Overall Study|Lost to Follow-up|0|||
156765284|NCT02810418|565896497|FG000|Arm A Dose Escalation|Adverse Event|2|||
156765285|NCT02810418|565896498|FG001|Arm A Dose Escalation|Adverse Event|1|||
156765286|NCT02810418|565896499|FG002|Arm A Dose Escalation|Adverse Event|0|||
156765287|NCT02810418|565896500|FG003|Arm A Dose Escalation|Adverse Event|0|||
156765288|NCT02810418|565896501|FG004|Arm A Dose Escalation|Adverse Event|0|||
156765289|NCT02810418|565896502|FG005|Arm A Dose Escalation|Adverse Event|0|||
156765290|NCT02810418|565896503|FG006|Arm A Dose Escalation|Adverse Event|0|||
156765291|NCT02810418|565896497|FG000|Dose Expansion|Adverse Event|0|||
156765292|NCT02810418|565896498|FG001|Dose Expansion|Adverse Event|1|||
156765293|NCT02810418|565896499|FG002|Dose Expansion|Adverse Event|1|||
156765294|NCT02810418|565896500|FG003|Dose Expansion|Adverse Event|0|||
156765295|NCT02810418|565896501|FG004|Dose Expansion|Adverse Event|0|||
156765296|NCT02810418|565896502|FG005|Dose Expansion|Adverse Event|0|||
156765297|NCT02810418|565896503|FG006|Dose Expansion|Adverse Event|0|||
156765298|NCT02810418|565896497|FG000|Dose Expansion|Physician Decision|0|||
156765299|NCT02810418|565896498|FG001|Dose Expansion|Physician Decision|0|||
156765300|NCT02810418|565896499|FG002|Dose Expansion|Physician Decision|2|||
156765301|NCT02810418|565896500|FG003|Dose Expansion|Physician Decision|0|||
156765302|NCT02810418|565896501|FG004|Dose Expansion|Physician Decision|0|||
156765303|NCT02810418|565896502|FG005|Dose Expansion|Physician Decision|0|||
156765304|NCT02810418|565896503|FG006|Dose Expansion|Physician Decision|0|||
156765305|NCT02810418|565896497|FG000|Arm B Dose Escalation|Adverse Event|0|||
156765306|NCT02810418|565896498|FG001|Arm B Dose Escalation|Adverse Event|0|||
156765307|NCT02810418|565896499|FG002|Arm B Dose Escalation|Adverse Event|0|||
156765308|NCT02810418|565896500|FG003|Arm B Dose Escalation|Adverse Event|0|||
156765309|NCT02810418|565896501|FG004|Arm B Dose Escalation|Adverse Event|1|||
156765310|NCT02810418|565896502|FG005|Arm B Dose Escalation|Adverse Event|2|||
156765311|NCT02810418|565896503|FG006|Arm B Dose Escalation|Adverse Event|0|||
156765312|NCT04161391|565896504|FG000|Overall Study|Adverse Event|0|||
156765313|NCT04161391|565896505|FG001|Overall Study|Adverse Event|1|||
156765314|NCT04161391|565896506|FG002|Overall Study|Adverse Event|0|||
156765315|NCT04161391|565896507|FG003|Overall Study|Adverse Event|1|||
156765316|NCT04161391|565896508|FG004|Overall Study|Adverse Event|0|||
156765317|NCT04161391|565896509|FG005|Overall Study|Adverse Event|0|||
156765318|NCT04161391|565896510|FG006|Overall Study|Adverse Event|0|||
156765319|NCT04161391|565896511|FG007|Overall Study|Adverse Event|3|||
156765320|NCT04161391|565896512|FG008|Overall Study|Adverse Event|0|||
156765321|NCT04161391|565896504|FG000|Overall Study|Death|0|||
156765322|NCT04161391|565896505|FG001|Overall Study|Death|0|||
156765323|NCT04161391|565896506|FG002|Overall Study|Death|0|||
156765324|NCT04161391|565896507|FG003|Overall Study|Death|0|||
156765325|NCT04161391|565896508|FG004|Overall Study|Death|0|||
156765326|NCT04161391|565896509|FG005|Overall Study|Death|0|||
156765327|NCT04161391|565896510|FG006|Overall Study|Death|0|||
156765328|NCT04161391|565896511|FG007|Overall Study|Death|1|||
156765329|NCT04161391|565896512|FG008|Overall Study|Death|0|||
156765330|NCT04161391|565896504|FG000|Overall Study|Physician Decision|0|||
156765331|NCT04161391|565896505|FG001|Overall Study|Physician Decision|0|||
156765332|NCT04161391|565896506|FG002|Overall Study|Physician Decision|1|||
156765333|NCT04161391|565896507|FG003|Overall Study|Physician Decision|2|||
156765334|NCT04161391|565896508|FG004|Overall Study|Physician Decision|0|||
156765335|NCT04161391|565896509|FG005|Overall Study|Physician Decision|0|||
156765336|NCT04161391|565896510|FG006|Overall Study|Physician Decision|2|||
156765337|NCT04161391|565896511|FG007|Overall Study|Physician Decision|0|||
156765338|NCT04161391|565896512|FG008|Overall Study|Physician Decision|0|||
156765339|NCT04161391|565896504|FG000|Overall Study|Progressive Disease|4|||
156765340|NCT04161391|565896505|FG001|Overall Study|Progressive Disease|3|||
156765341|NCT04161391|565896506|FG002|Overall Study|Progressive Disease|3|||
156765342|NCT04161391|565896507|FG003|Overall Study|Progressive Disease|5|||
156765343|NCT04161391|565896508|FG004|Overall Study|Progressive Disease|3|||
156765344|NCT04161391|565896509|FG005|Overall Study|Progressive Disease|3|||
156765345|NCT04161391|565896510|FG006|Overall Study|Progressive Disease|5|||
156765346|NCT04161391|565896511|FG007|Overall Study|Progressive Disease|2|||
156765347|NCT04161391|565896512|FG008|Overall Study|Progressive Disease|2|||
156765348|NCT02579629|565896516|FG000|Overall Study|Withdrawal by Subject|0|||
156765349|NCT02579629|565896517|FG001|Overall Study|Withdrawal by Subject|1|||
156765350|NCT02579629|565896518|FG002|Overall Study|Withdrawal by Subject|0|||
156765351|NCT02579629|565896516|FG000|Overall Study|Screen Failure|2|||
156765352|NCT02579629|565896517|FG001|Overall Study|Screen Failure|0|||
156765353|NCT02579629|565896518|FG002|Overall Study|Screen Failure|2|||
156765354|NCT02666222|565896525|FG000|Overall Study|Death|2|||
156765355|NCT01474486|565896526|FG000|Overall Study|Death|2|||
156765356|NCT01474486|565896526|FG000|Overall Study|Withdrawal by Subject|4|||
156765357|NCT01474486|565896526|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
156765358|NCT01255163|565896527|FG000|Overall Study|Withdrawal by Subject|1|||
156765359|NCT01255163|565896528|FG001|Overall Study|Withdrawal by Subject|0|||
156765360|NCT01255163|565896527|FG000|Overall Study|Lost to Follow-up|2|||
156765361|NCT01255163|565896528|FG001|Overall Study|Lost to Follow-up|0|||
156765362|NCT01255163|565896527|FG000|Overall Study|Adverse Event|0|||
156765363|NCT01255163|565896528|FG001|Overall Study|Adverse Event|2|||
156765364|NCT01255163|565896527|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
156765365|NCT01255163|565896528|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
156765366|NCT03504917|565896532|FG000|Blinded Treatment Period|Protocol Violation|1|||
156765367|NCT03504917|565896533|FG001|Blinded Treatment Period|Protocol Violation|0|||
156765368|NCT03504917|565896532|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
156765369|NCT03504917|565896533|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
156765370|NCT03504917|565896532|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
156765371|NCT03504917|565896533|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
156765372|NCT03504917|565896532|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
156765373|NCT03504917|565896533|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
156765374|NCT03504917|565896532|FG000|Blinded Treatment Period|Adverse Event|4|||
156765375|NCT03504917|565896533|FG001|Blinded Treatment Period|Adverse Event|4|||
156765376|NCT03504917|565896532|FG000|Blinded Treatment Period|Physician Decision|1|||
156765377|NCT03504917|565896533|FG001|Blinded Treatment Period|Physician Decision|0|||
156765378|NCT03504917|565896532|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
156765379|NCT03504917|565896533|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
156765380|NCT03504917|565896532|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
156765381|NCT03504917|565896533|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
156765382|NCT03504917|565896532|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
156765383|NCT03504917|565896533|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
156765384|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
156765385|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
156765386|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
156765387|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
156765388|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
156765389|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
156765390|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
156765391|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
156765392|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
156765393|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
156765394|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
156765395|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
156765396|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
156765397|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
156765398|NCT04219189|565896534|FG000|Overall Study|Withdrawal by Subject|1|||
156765399|NCT04219189|565896535|FG001|Overall Study|Withdrawal by Subject|2|||
156765400|NCT04219189|565896534|FG000|Overall Study|Protocol Violation|0|||
156765401|NCT04219189|565896535|FG001|Overall Study|Protocol Violation|1|||
156765402|NCT04219189|565896534|FG000|Overall Study|Lost to Follow-up|0|||
156765403|NCT04219189|565896535|FG001|Overall Study|Lost to Follow-up|1|||
156765404|NCT04219189|565896534|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
156765405|NCT04219189|565896535|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
156765406|NCT03863353|565896536|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
156765407|NCT03863353|565896537|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
156426352|NCT03068468|564654606|FG000|Open-Label Extension Period|Reason not Specified|0|||
156426353|NCT03068468|564654607|FG001|Open-Label Extension Period|Reason not Specified|0|||
156426354|NCT03068468|564654608|FG002|Open-Label Extension Period|Reason not Specified|1|||
156426355|NCT03068468|564654609|FG003|Open-Label Extension Period|Reason not Specified|4|||
156426356|NCT03895034|564654611|FG000|Overall Study|Lost to Follow-up|2|||
156426357|NCT01118377|564654616|FG000|Overall Study|Did Not Receive Study Medication|1|||
156426358|NCT01118377|564654616|FG000|Overall Study|Death|38|||
156426359|NCT01118377|564654616|FG000|Overall Study|Failure to Return|3|||
156426360|NCT00739102|564654617|FG000|Overall Study|Death|5|||
156426361|NCT00739102|564654617|FG000|Overall Study|Withdrawal by Subject|10|||
156426362|NCT01331824|564654621|FG000|Overall Study|Adverse Event|2|||
156426363|NCT01331824|564654621|FG000|Overall Study|Death|1|||
156426364|NCT01331824|564654621|FG000|Overall Study|Disease Progression|9|||
156426365|NCT01331824|564654621|FG000|Overall Study|Withdrawal by Subject|1|||
156426366|NCT01091454|564654622|FG000|Overall Study|Ineligible|1|||
156426367|NCT01510912|564654623|FG000|Overall Study|Adverse Event|99|||
156426368|NCT01510912|564654623|FG000|Overall Study|Lack of Efficacy|12|||
156426369|NCT01510912|564654623|FG000|Overall Study|Non-compliance with trial drug|23|||
156426370|NCT01510912|564654623|FG000|Overall Study|Withdrawal by Subject|49|||
156426371|NCT01510912|564654623|FG000|Overall Study|Physician Decision|1|||
156426372|NCT01510912|564654623|FG000|Overall Study|Protocol Violation|27|||
156426373|NCT01510912|564654623|FG000|Overall Study|Lost to Follow-up|26|||
156426374|NCT01510912|564654623|FG000|Overall Study|Other, including joint replacement|5|||
156426375|NCT03181958|564654624|FG000|Overall Study|Lost to Follow-up|17|||
156426376|NCT03181958|564654625|FG001|Overall Study|Lost to Follow-up|21|||
156426377|NCT03181958|564654626|FG002|Overall Study|Lost to Follow-up|15|||
156426378|NCT00991276|564654628|FG000|First Intervention Period|Adverse Event|0|||
156426379|NCT00991276|564654629|FG001|First Intervention Period|Adverse Event|1|||
156426380|NCT00991276|564654630|FG002|First Intervention Period|Adverse Event|0|||
156426381|NCT00991276|564654631|FG003|First Intervention Period|Adverse Event|1|||
156426382|NCT00991276|564654632|FG004|First Intervention Period|Adverse Event|0|||
156426383|NCT00991276|564654633|FG005|First Intervention Period|Adverse Event|0|||
156426384|NCT00991276|564654628|FG000|First Intervention Period|Protocol Violation|0|||
156426385|NCT00991276|564654629|FG001|First Intervention Period|Protocol Violation|0|||
156426386|NCT00991276|564654630|FG002|First Intervention Period|Protocol Violation|0|||
156426387|NCT00991276|564654631|FG003|First Intervention Period|Protocol Violation|0|||
156426388|NCT00991276|564654632|FG004|First Intervention Period|Protocol Violation|2|||
156426389|NCT00991276|564654633|FG005|First Intervention Period|Protocol Violation|0|||
156426390|NCT00991276|564654628|FG000|First Intervention Period|Insufficient clinical response|0|||
156426391|NCT00991276|564654629|FG001|First Intervention Period|Insufficient clinical response|0|||
156426392|NCT00991276|564654630|FG002|First Intervention Period|Insufficient clinical response|0|||
156426393|NCT00991276|564654631|FG003|First Intervention Period|Insufficient clinical response|0|||
156426394|NCT00991276|564654632|FG004|First Intervention Period|Insufficient clinical response|1|||
156426395|NCT00991276|564654633|FG005|First Intervention Period|Insufficient clinical response|0|||
156426396|NCT00991276|564654628|FG000|First Intervention Period|Other|0|||
156426397|NCT00991276|564654629|FG001|First Intervention Period|Other|0|||
156426398|NCT00991276|564654630|FG002|First Intervention Period|Other|0|||
156426399|NCT00991276|564654631|FG003|First Intervention Period|Other|1|||
156426400|NCT00991276|564654632|FG004|First Intervention Period|Other|1|||
156426401|NCT00991276|564654633|FG005|First Intervention Period|Other|0|||
156426402|NCT00991276|564654628|FG000|First Intervention Period|Withdrawal by Subject|0|||
156426403|NCT00991276|564654629|FG001|First Intervention Period|Withdrawal by Subject|1|||
156426404|NCT00991276|564654630|FG002|First Intervention Period|Withdrawal by Subject|0|||
156426405|NCT00991276|564654631|FG003|First Intervention Period|Withdrawal by Subject|1|||
156426406|NCT00991276|564654632|FG004|First Intervention Period|Withdrawal by Subject|0|||
156426407|NCT00991276|564654633|FG005|First Intervention Period|Withdrawal by Subject|1|||
156426408|NCT00991276|564654628|FG000|First Intervention Period|Lost to Follow-up|0|||
156765408|NCT02495389|565896538|FG000|Overall Study|Withdrawal by Subject|40|||
156765409|NCT04079790|565896542|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
156765410|NCT04079790|565896543|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
156765411|NCT04079790|565896544|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
156765412|NCT04079790|565896545|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
156765413|NCT04079790|565896542|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
156765414|NCT04079790|565896543|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
156765415|NCT04079790|565896544|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
156765416|NCT04079790|565896545|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
156765417|NCT04079790|565896542|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
156765418|NCT04079790|565896543|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
156765419|NCT04079790|565896544|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
156765420|NCT04079790|565896545|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
156765421|NCT01924533|565896547|FG000|Overall Study|Death|181|||
156765422|NCT01924533|565896548|FG001|Overall Study|Death|200|||
156765423|NCT01924533|565896547|FG000|Overall Study|Lost to Follow-up|0|||
156765424|NCT01924533|565896548|FG001|Overall Study|Lost to Follow-up|1|||
156765425|NCT01924533|565896547|FG000|Overall Study|Withdrawal by Subject|7|||
156765426|NCT01924533|565896548|FG001|Overall Study|Withdrawal by Subject|3|||
156765427|NCT01924533|565896547|FG000|Overall Study|Other Eligibility criteria|1|||
156765428|NCT01924533|565896548|FG001|Overall Study|Other Eligibility criteria|1|||
156765429|NCT05817669|565896549|FG000|Overall Study|Prohibited medication used|1|||
156765430|NCT05817669|565896550|FG001|Overall Study|Prohibited medication used|2|||
156765431|NCT05817669|565896549|FG000|Overall Study|Adverse Event|1|||
156765432|NCT05817669|565896550|FG001|Overall Study|Adverse Event|0|||
156765433|NCT05817669|565896549|FG000|Overall Study|Withdrawal by Subject|1|||
156765434|NCT05817669|565896550|FG001|Overall Study|Withdrawal by Subject|2|||
156765435|NCT04233879|565896551|FG000|Overall Study|Death|2|||
156765436|NCT04233879|565896552|FG001|Overall Study|Death|0|||
156765437|NCT04233879|565896551|FG000|Overall Study|Lost to Follow-up|3|||
156765438|NCT04233879|565896552|FG001|Overall Study|Lost to Follow-up|8|||
156765439|NCT04233879|565896551|FG000|Overall Study|Physician Decision|4|||
156765440|NCT04233879|565896552|FG001|Overall Study|Physician Decision|4|||
156765441|NCT04233879|565896551|FG000|Overall Study|Withdrawal by Subject|7|||
156765442|NCT04233879|565896552|FG001|Overall Study|Withdrawal by Subject|10|||
156765443|NCT04233879|565896551|FG000|Overall Study|Other|281|||
156765444|NCT04233879|565896552|FG001|Overall Study|Other|279|||
156765445|NCT03292016|565896555|FG000|Second Washout|Adverse Event|0|||
156765446|NCT03292016|565896556|FG001|Second Washout|Adverse Event|1|||
156765447|NCT03292016|565896557|FG002|Second Washout|Adverse Event|0|||
156765448|NCT03292016|565896558|FG003|Second Washout|Adverse Event|0|||
156765449|NCT03292016|565896559|FG004|Second Washout|Adverse Event|0|||
156765450|NCT03292016|565896560|FG005|Second Washout|Adverse Event|0|||
156765451|NCT01802385|565896562|FG000|Overall Study|Death|106|||
156765452|NCT01802385|565896563|FG001|Overall Study|Death|120|||
156765453|NCT03810183|565896564|FG000|Overall Study|Study terminated by Sponsor|2|||
156765454|NCT03810183|565896565|FG001|Overall Study|Study terminated by Sponsor|1|||
156765455|NCT00323063|565896567|FG000|Overall Study|Adverse Event|1|||
156765456|NCT00323063|565896568|FG001|Overall Study|Adverse Event|0|||
156765457|NCT00323063|565896567|FG000|Overall Study|brain mets discovered prior to treatment|1|||
156765458|NCT00323063|565896568|FG001|Overall Study|brain mets discovered prior to treatment|0|||
156765459|NCT04275336|565896571|FG000|Overall Study|First venipuncture failed|4|||
156765460|NCT04275336|565896572|FG001|Overall Study|First venipuncture failed|6|||
156765461|NCT04275336|565896573|FG002|Overall Study|First venipuncture failed|5|||
156765462|NCT04275336|565896571|FG000|Overall Study|Unscheduled venipuncture|9|||
156765463|NCT04275336|565896572|FG001|Overall Study|Unscheduled venipuncture|13|||
156426409|NCT00991276|564654629|FG001|First Intervention Period|Lost to Follow-up|1|||
156765464|NCT04275336|565896573|FG002|Overall Study|Unscheduled venipuncture|7|||
156765465|NCT04275336|565896571|FG000|Overall Study|Failed specimen of saliva|4|||
156765466|NCT04275336|565896572|FG001|Overall Study|Failed specimen of saliva|3|||
156765467|NCT04275336|565896573|FG002|Overall Study|Failed specimen of saliva|4|||
156765468|NCT03055936|565896574|FG000|Overall Study|Adverse Event|0|||
156765469|NCT03055936|565896575|FG001|Overall Study|Adverse Event|1|||
156765470|NCT03055936|565896576|FG002|Overall Study|Adverse Event|1|||
156765471|NCT03055936|565896577|FG003|Overall Study|Adverse Event|1|||
156765472|NCT03055936|565896574|FG000|Overall Study|Personal reason|2|||
156426410|NCT00991276|564654630|FG002|First Intervention Period|Lost to Follow-up|0|||
156426411|NCT00991276|564654631|FG003|First Intervention Period|Lost to Follow-up|1|||
156426412|NCT00991276|564654632|FG004|First Intervention Period|Lost to Follow-up|0|||
156426413|NCT00991276|564654633|FG005|First Intervention Period|Lost to Follow-up|0|||
156765473|NCT03055936|565896575|FG001|Overall Study|Personal reason|0|||
156765474|NCT03055936|565896576|FG002|Overall Study|Personal reason|1|||
156765475|NCT03055936|565896577|FG003|Overall Study|Personal reason|0|||
156765476|NCT05222880|565896583|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
156765477|NCT05222880|565896583|FG000|Overall Study|Withdrew Consent during Study|1|||
156765478|NCT05222880|565896583|FG000|Overall Study|COVID-19 Related|1|||
156765479|NCT01077323|565896586|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
156765480|NCT01077323|565896587|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
156765481|NCT01077323|565896588|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
156765482|NCT01077323|565896586|FG000|Overall Study|Dispensing of drug in baseline period|0|||
156765483|NCT01077323|565896587|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
156765484|NCT01077323|565896588|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
156765485|NCT01077323|565896586|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
156765486|NCT01077323|565896587|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
156765487|NCT01077323|565896588|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
156765488|NCT02153918|565896589|FG000|Overall Study|Refused further treatment|1|||
156765489|NCT02144701|565896590|FG000|Overall Study|development of relapse, GVHD or death|9|||
156765490|NCT02144701|565896591|FG001|Overall Study|development of relapse, GVHD or death|3|||
156765491|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765492|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
156765493|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765494|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
156765495|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765496|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
156765497|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|Refused|0|||
156765498|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|Refused|0|||
156765499|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|Refused|0|||
156765500|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|Refused|0|||
156765501|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|Refused|1|||
156765502|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|Refused|0|||
156765503|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765504|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
156765505|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765506|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765507|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765508|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765509|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|Death|0|||
156765510|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|Death|0|||
156765511|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|Death|0|||
156765512|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|Death|0|||
156765513|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|Death|1|||
156765514|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|Death|0|||
156765515|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765516|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765517|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765518|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765519|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765520|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
156765521|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765522|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765523|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
156765524|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765525|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765526|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765527|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
156765528|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
156765529|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
156765530|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
156765531|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
156765532|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
156765533|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
156765534|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156765535|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156765536|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156322677|NCT03823378|564280225|FG003|Overall Study|Other, not specified|8|||
156322678|NCT03823378|564280226|FG004|Overall Study|Other, not specified|17|||
156322679|NCT03823378|564280227|FG005|Overall Study|Other, not specified|7|||
156322680|NCT01606254|564280228|FG000|Overall Study|Withdrawal by Subject|1|||
156322681|NCT01606254|564280229|FG001|Overall Study|Withdrawal by Subject|3|||
156322682|NCT01606254|564280230|FG002|Overall Study|Withdrawal by Subject|0|||
156322683|NCT01606254|564280231|FG003|Overall Study|Withdrawal by Subject|2|||
156322684|NCT01606254|564280228|FG000|Overall Study|Adverse Event|1|||
156322685|NCT01606254|564280229|FG001|Overall Study|Adverse Event|1|||
156322686|NCT01606254|564280230|FG002|Overall Study|Adverse Event|0|||
156322687|NCT01606254|564280231|FG003|Overall Study|Adverse Event|1|||
156322688|NCT02131532|564280232|FG000|Overall Study|Withdrawal by Subject|1|||
156322689|NCT02131532|564280232|FG000|Overall Study|Physician Decision|1|||
156322690|NCT02131532|564280232|FG000|Overall Study|Other health conditions|2|||
156322691|NCT02093026|564280233|FG000|Overall Study|Adverse Event|26|||
156322692|NCT02093026|564280233|FG000|Overall Study|Death|10|||
156322693|NCT02093026|564280233|FG000|Overall Study|Other|157|||
156322694|NCT02195011|564280239|FG000|Overall Study|Adverse Event|4|||
156322695|NCT02195011|564280240|FG001|Overall Study|Adverse Event|0|||
156322696|NCT02195011|564280239|FG000|Overall Study|Progressive Disease|18|||
156322697|NCT02195011|564280240|FG001|Overall Study|Progressive Disease|1|||
156322698|NCT02195011|564280239|FG000|Overall Study|Withdrawal by Subject|3|||
156322699|NCT02195011|564280240|FG001|Overall Study|Withdrawal by Subject|0|||
156322700|NCT00174291|564280242|FG000|Overall Study|Lost to Follow-up|1|||
156322701|NCT00174291|564280243|FG001|Overall Study|Lost to Follow-up|1|||
156322702|NCT00174291|564280242|FG000|Overall Study|Protocol Violation|0|||
156322703|NCT00174291|564280243|FG001|Overall Study|Protocol Violation|2|||
156322704|NCT00174291|564280242|FG000|Overall Study|Study terminated by sponsor|1|||
156322705|NCT00174291|564280243|FG001|Overall Study|Study terminated by sponsor|0|||
156322706|NCT00174291|564280242|FG000|Overall Study|Withdrawal by Subject|3|||
156322707|NCT00174291|564280243|FG001|Overall Study|Withdrawal by Subject|3|||
156322708|NCT00450112|564280244|FG000|Overall Study|Other Treatment Required|5|||
156322709|NCT00450112|564280245|FG001|Overall Study|Other Treatment Required|1|||
156322710|NCT00450112|564280244|FG000|Overall Study|Withdrawal by Subject|4|||
156322711|NCT00450112|564280245|FG001|Overall Study|Withdrawal by Subject|1|||
156322712|NCT00450112|564280244|FG000|Overall Study|Lost to Follow-up|2|||
156322713|NCT00450112|564280245|FG001|Overall Study|Lost to Follow-up|1|||
156322714|NCT00450112|564280244|FG000|Overall Study|Others|2|||
156322715|NCT00450112|564280245|FG001|Overall Study|Others|3|||
156322716|NCT03418571|564280246|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
156322717|NCT03418571|564280247|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
156322718|NCT03170232|564280248|FG000|Overall Study|Adverse Event|0|||
156322719|NCT03170232|564280249|FG001|Overall Study|Adverse Event|1|||
156322720|NCT03170232|564280248|FG000|Overall Study|Protocol Violation|0|||
156322721|NCT03170232|564280249|FG001|Overall Study|Protocol Violation|1|||
156322722|NCT03170232|564280248|FG000|Overall Study|Lack of Efficacy|0|||
156322723|NCT03170232|564280249|FG001|Overall Study|Lack of Efficacy|1|||
156322724|NCT03170232|564280248|FG000|Overall Study|Study closed/terminated|26|||
156322725|NCT03170232|564280249|FG001|Overall Study|Study closed/terminated|23|||
156322726|NCT03170232|564280248|FG000|Overall Study|Lost to Follow-up|1|||
156322727|NCT03170232|564280249|FG001|Overall Study|Lost to Follow-up|0|||
156322728|NCT03170232|564280248|FG000|Overall Study|Withdrawal by Subject|0|||
156322729|NCT03170232|564280249|FG001|Overall Study|Withdrawal by Subject|1|||
156322730|NCT01056380|564280250|FG000|Overall Study|Lost to Follow-up|2|||
156322731|NCT01056380|564280251|FG001|Overall Study|Lost to Follow-up|3|||
156322732|NCT03595774|564280252|FG000|Overall Study|Adverse Event|1|||
156322733|NCT03595774|564280253|FG001|Overall Study|Adverse Event|0|||
156322734|NCT03595774|564280254|FG002|Overall Study|Adverse Event|1|||
156322735|NCT03595774|564280255|FG003|Overall Study|Adverse Event|0|||
156426414|NCT00991276|564654628|FG000|Second Intervention Period|Adverse Event|0|||
156426415|NCT00991276|564654629|FG001|Second Intervention Period|Adverse Event|2|||
156322736|NCT03595774|564280252|FG000|Overall Study|screen failure|0|||
156322737|NCT03595774|564280253|FG001|Overall Study|screen failure|1|||
156322738|NCT03595774|564280254|FG002|Overall Study|screen failure|0|||
156322739|NCT03595774|564280255|FG003|Overall Study|screen failure|1|||
156322740|NCT01582854|564280261|FG000|Overall Study|Death|8|||
156322741|NCT01582854|564280262|FG001|Overall Study|Death|5|||
156322742|NCT01582854|564280261|FG000|Overall Study|Adverse Event|2|||
156322743|NCT01582854|564280262|FG001|Overall Study|Adverse Event|3|||
156322744|NCT01582854|564280261|FG000|Overall Study|Withdrawal by Participant|8|||
156322745|NCT01582854|564280262|FG001|Overall Study|Withdrawal by Participant|11|||
156322746|NCT01582854|564280261|FG000|Overall Study|Lost to Follow-up|1|||
156322747|NCT01582854|564280262|FG001|Overall Study|Lost to Follow-up|2|||
156322748|NCT01582854|564280261|FG000|Overall Study|Physician Decision|0|||
156322749|NCT01582854|564280262|FG001|Overall Study|Physician Decision|1|||
156322750|NCT01582854|564280261|FG000|Overall Study|Recurrent Stroke|13|||
156322751|NCT01582854|564280262|FG001|Overall Study|Recurrent Stroke|8|||
156322752|NCT01582854|564280261|FG000|Overall Study|Disallowed Concomitant Medication|3|||
156322753|NCT01582854|564280262|FG001|Overall Study|Disallowed Concomitant Medication|2|||
156426416|NCT00991276|564654630|FG002|Second Intervention Period|Adverse Event|0|||
156426417|NCT00991276|564654631|FG003|Second Intervention Period|Adverse Event|1|||
156426418|NCT00991276|564654632|FG004|Second Intervention Period|Adverse Event|1|||
156426419|NCT00991276|564654633|FG005|Second Intervention Period|Adverse Event|0|||
156426420|NCT00991276|564654628|FG000|Second Intervention Period|Protocol Violation|1|||
156426421|NCT00991276|564654629|FG001|Second Intervention Period|Protocol Violation|0|||
156426422|NCT00991276|564654630|FG002|Second Intervention Period|Protocol Violation|0|||
156426423|NCT00991276|564654631|FG003|Second Intervention Period|Protocol Violation|0|||
156426424|NCT00991276|564654632|FG004|Second Intervention Period|Protocol Violation|0|||
156426425|NCT00991276|564654633|FG005|Second Intervention Period|Protocol Violation|0|||
156426426|NCT00991276|564654628|FG000|Second Intervention Period|Other|0|||
156426427|NCT00991276|564654629|FG001|Second Intervention Period|Other|0|||
156426428|NCT00991276|564654630|FG002|Second Intervention Period|Other|0|||
156426429|NCT00991276|564654631|FG003|Second Intervention Period|Other|1|||
156426430|NCT00991276|564654632|FG004|Second Intervention Period|Other|0|||
156426431|NCT00991276|564654633|FG005|Second Intervention Period|Other|1|||
156426432|NCT00991276|564654628|FG000|Third Intervention Period|Protocol Violation|1|||
156426433|NCT00991276|564654629|FG001|Third Intervention Period|Protocol Violation|0|||
156426434|NCT00991276|564654630|FG002|Third Intervention Period|Protocol Violation|0|||
156426435|NCT00991276|564654631|FG003|Third Intervention Period|Protocol Violation|0|||
156426436|NCT00991276|564654632|FG004|Third Intervention Period|Protocol Violation|0|||
156426437|NCT00991276|564654633|FG005|Third Intervention Period|Protocol Violation|0|||
156426438|NCT00991276|564654628|FG000|Third Intervention Period|Other|0|||
156426439|NCT00991276|564654629|FG001|Third Intervention Period|Other|0|||
156426440|NCT00991276|564654630|FG002|Third Intervention Period|Other|0|||
156426441|NCT00991276|564654631|FG003|Third Intervention Period|Other|0|||
156426442|NCT00991276|564654632|FG004|Third Intervention Period|Other|0|||
156426443|NCT00991276|564654633|FG005|Third Intervention Period|Other|1|||
156426444|NCT00991276|564654628|FG000|Third Intervention Period|Adverse Event|0|||
156426445|NCT00991276|564654629|FG001|Third Intervention Period|Adverse Event|0|||
156426446|NCT00991276|564654630|FG002|Third Intervention Period|Adverse Event|1|||
156426447|NCT00991276|564654631|FG003|Third Intervention Period|Adverse Event|0|||
156426448|NCT00991276|564654632|FG004|Third Intervention Period|Adverse Event|0|||
156426449|NCT00991276|564654633|FG005|Third Intervention Period|Adverse Event|0|||
156426450|NCT00991276|564654628|FG000|Third Intervention Period|Withdrawal by Subject|0|||
156426451|NCT00991276|564654629|FG001|Third Intervention Period|Withdrawal by Subject|0|||
156426452|NCT00991276|564654630|FG002|Third Intervention Period|Withdrawal by Subject|0|||
156426453|NCT00991276|564654631|FG003|Third Intervention Period|Withdrawal by Subject|1|||
156426454|NCT00991276|564654632|FG004|Third Intervention Period|Withdrawal by Subject|0|||
156426455|NCT00991276|564654633|FG005|Third Intervention Period|Withdrawal by Subject|0|||
156426456|NCT01268891|564654635|FG000|Overall Study|Adverse Event|3|||
156426457|NCT01268891|564654636|FG001|Overall Study|Adverse Event|7|||
156426458|NCT01268891|564654635|FG000|Overall Study|Lack of Efficacy|1|||
156426459|NCT01268891|564654636|FG001|Overall Study|Lack of Efficacy|0|||
156426460|NCT01268891|564654635|FG000|Overall Study|Withdrawal of Consent|3|||
156426461|NCT01268891|564654636|FG001|Overall Study|Withdrawal of Consent|1|||
156426462|NCT01268891|564654635|FG000|Overall Study|Administrative or other reason(s)|1|||
156655744|NCT01058421|565485839|FG001|3 Month Outcomes|Death|5|||
156655745|NCT01058421|565485838|FG000|3 Month Outcomes|Lost to Follow-up|12|||
156655746|NCT01058421|565485839|FG001|3 Month Outcomes|Lost to Follow-up|11|||
156655747|NCT01058421|565485838|FG000|3 Month Outcomes|Remained in Hospital|0|||
156655748|NCT01058421|565485839|FG001|3 Month Outcomes|Remained in Hospital|2|||
156655749|NCT01058421|565485838|FG000|3 Month Outcomes|Remained in Other Facility|5|||
156655750|NCT01058421|565485839|FG001|3 Month Outcomes|Remained in Other Facility|8|||
156655751|NCT01058421|565485838|FG000|6 Month Outcomes|Death|2|||
156655752|NCT01058421|565485839|FG001|6 Month Outcomes|Death|2|||
156655753|NCT01058421|565485838|FG000|6 Month Outcomes|Lost to Follow-up|16|||
156655754|NCT01058421|565485839|FG001|6 Month Outcomes|Lost to Follow-up|21|||
156655755|NCT01058421|565485838|FG000|6 Month Outcomes|Remained in Other Facility|1|||
156655756|NCT01058421|565485839|FG001|6 Month Outcomes|Remained in Other Facility|3|||
156655757|NCT02984683|565485840|FG000|Overall Study|Adverse Event|3|||
156655758|NCT02984683|565485841|FG001|Overall Study|Adverse Event|3|||
156655759|NCT02984683|565485840|FG000|Overall Study|Withdrawal by Subject|1|||
156655760|NCT02984683|565485841|FG001|Overall Study|Withdrawal by Subject|0|||
156655761|NCT02984683|565485840|FG000|Overall Study|Disease progression|7|||
156655762|NCT02984683|565485841|FG001|Overall Study|Disease progression|9|||
156655763|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
156655764|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
156655765|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
156655766|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
156655767|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
156655768|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
156655769|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
156426463|NCT01268891|564654636|FG001|Overall Study|Administrative or other reason(s)|0|||
156426464|NCT01063036|564654639|FG000|Participants Treated With Study Drug|Adverse Event|1|||
156426465|NCT01063036|564654639|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
156426466|NCT01063036|564654639|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
156426467|NCT01063036|564654639|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
156426468|NCT01063036|564654639|FG000|Participants Treated With Study Drug|Pregnancy|1|||
156426469|NCT01063036|564654639|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
156426470|NCT01063036|564654639|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
156426471|NCT01063036|564654639|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
156426472|NCT01977612|564654640|FG000|Overall Study|Lost to Follow-up|1|||
156426473|NCT01977612|564654641|FG001|Overall Study|Lost to Follow-up|1|||
156426474|NCT01280591|564654642|FG000|Overall Study|Withdrawal by Subject|0|||
156426475|NCT01280591|564654643|FG001|Overall Study|Withdrawal by Subject|0|||
156426476|NCT01280591|564654644|FG002|Overall Study|Withdrawal by Subject|0|||
156426477|NCT01280591|564654645|FG003|Overall Study|Withdrawal by Subject|2|||
156426478|NCT01280591|564654642|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
156426479|NCT01280591|564654643|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
156426480|NCT01280591|564654644|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
156426481|NCT01280591|564654645|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
156426482|NCT02955069|564654646|FG000|Overall Study|Adverse Event|7|||
156426483|NCT02955069|564654647|FG001|Overall Study|Adverse Event|2|||
156426484|NCT02955069|564654646|FG000|Overall Study|Death|7|||
156426485|NCT02955069|564654647|FG001|Overall Study|Death|3|||
156426486|NCT02955069|564654646|FG000|Overall Study|Physician Decision|10|||
156426487|NCT02955069|564654647|FG001|Overall Study|Physician Decision|2|||
156426488|NCT02955069|564654646|FG000|Overall Study|Progressive disease|64|||
156426489|NCT02955069|564654647|FG001|Overall Study|Progressive disease|13|||
156426490|NCT02955069|564654646|FG000|Overall Study|Study terminated by sponsor|4|||
156426491|NCT02955069|564654647|FG001|Overall Study|Study terminated by sponsor|0|||
156426492|NCT02955069|564654646|FG000|Overall Study|Subject/Guardian decision|3|||
156426493|NCT02955069|564654647|FG001|Overall Study|Subject/Guardian decision|1|||
156426494|NCT00464672|564654648|FG000|Overall Study|withdrawal of consent|0|||
156426495|NCT00464672|564654649|FG001|Overall Study|withdrawal of consent|0|||
156426496|NCT00464672|564654650|FG002|Overall Study|withdrawal of consent|0|||
156426497|NCT00464672|564654651|FG003|Overall Study|withdrawal of consent|1|||
156426498|NCT00464672|564654652|FG004|Overall Study|withdrawal of consent|9|||
156426499|NCT00464672|564654653|FG005|Overall Study|withdrawal of consent|4|||
156426500|NCT00464672|564654648|FG000|Overall Study|Lost to Follow-up|25|||
156426501|NCT00464672|564654649|FG001|Overall Study|Lost to Follow-up|10|||
156765537|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156765538|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156765539|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|Death|1|||
156765540|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|Death|0|||
156765541|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|Death|1|||
156765542|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|Death|1|||
156765543|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|Death|1|||
156765544|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|Death|0|||
156765545|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765546|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765547|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765548|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765549|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765550|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
156765551|NCT03327324|565896592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
156426502|NCT00464672|564654650|FG002|Overall Study|Lost to Follow-up|0|||
156426503|NCT00464672|564654651|FG003|Overall Study|Lost to Follow-up|0|||
156426504|NCT00464672|564654652|FG004|Overall Study|Lost to Follow-up|1|||
156426505|NCT00464672|564654653|FG005|Overall Study|Lost to Follow-up|0|||
156426506|NCT03055767|564654654|FG000|Open-Label Period|Lost to Follow-up|0|||
156426507|NCT03055767|564654655|FG001|Open-Label Period|Lost to Follow-up|0|||
156426508|NCT03055767|564654656|FG002|Open-Label Period|Lost to Follow-up|2|||
156426509|NCT03055767|564654657|FG003|Open-Label Period|Lost to Follow-up|0|||
156426510|NCT03055767|564654654|FG000|Open-Label Period|Withdrawal by Subject|0|||
156426511|NCT03055767|564654655|FG001|Open-Label Period|Withdrawal by Subject|0|||
156426512|NCT03055767|564654656|FG002|Open-Label Period|Withdrawal by Subject|0|||
156426513|NCT03055767|564654657|FG003|Open-Label Period|Withdrawal by Subject|1|||
156426514|NCT02759731|564654658|FG000|Overall Study|Did not complete treatment.|8|||
156426515|NCT01101165|564654659|FG000|Period 1|Adverse Event|1|||
156765552|NCT03327324|565896593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765553|NCT03327324|565896594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765554|NCT03327324|565896595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765555|NCT03327324|565896596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765556|NCT03327324|565896597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765557|NCT03327324|565896592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
156765558|NCT03327324|565896593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
156765559|NCT03327324|565896594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
156765560|NCT03327324|565896595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
156765561|NCT03327324|565896596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
156765562|NCT03327324|565896597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
156426516|NCT01101165|564654660|FG001|Period 1|Adverse Event|2|||
156426517|NCT01101165|564654659|FG000|Period 1|Withdrawal by Subject|0|||
156426518|NCT01101165|564654660|FG001|Period 1|Withdrawal by Subject|2|||
156426519|NCT01101165|564654659|FG000|Period 1|Positive Drug Screen|0|||
156426520|NCT01101165|564654660|FG001|Period 1|Positive Drug Screen|1|||
156426521|NCT01101165|564654659|FG000|Period 1|Lost to Follow-up|1|||
156426522|NCT01101165|564654660|FG001|Period 1|Lost to Follow-up|0|||
156426523|NCT01101165|564654659|FG000|Period 2|Withdrawal by Subject|3|||
156426524|NCT01101165|564654660|FG001|Period 2|Withdrawal by Subject|1|||
156765563|NCT03327324|565896592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
156426525|NCT01101165|564654659|FG000|Period 2|Adverse Event|1|||
156426526|NCT01101165|564654660|FG001|Period 2|Adverse Event|0|||
156426527|NCT03095508|564654662|FG000|Overall Study|Adverse Event|0|||
156426528|NCT03095508|564654663|FG001|Overall Study|Adverse Event|1|||
156426529|NCT01599325|564654664|FG000|Primary Parent Phase|Adverse Event|5|||
156426530|NCT01599325|564654664|FG000|Primary Parent Phase|Disease Progression|7|||
156426531|NCT01599325|564654664|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
156426532|NCT01599325|564654664|FG000|Primary Parent Phase|Death|13|||
156426533|NCT01599325|564654664|FG000|Primary Parent Phase|Protocol Violation|1|||
156426534|NCT01599325|564654664|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
156426535|NCT01599325|564654664|FG000|Primary Parent Phase|Other|2|||
156426536|NCT01599325|564654664|FG000|Extension Phase|Study Closure|1|||
156426537|NCT01599325|564654664|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
156426538|NCT01599325|564654664|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
156426539|NCT01599325|564654664|FG000|Extension Phase|Disease Progression|1|||
156426540|NCT01599325|564654664|FG000|Extension Phase|Withdrawal by Subject|8|||
156426541|NCT01710514|564654666|FG000|Overall Study|Adverse Event|6|||
156426542|NCT01710514|564654667|FG001|Overall Study|Adverse Event|7|||
156426543|NCT01710514|564654666|FG000|Overall Study|Withdrawal by Subject|1|||
156426544|NCT01710514|564654667|FG001|Overall Study|Withdrawal by Subject|0|||
156426545|NCT03404843|564654670|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
156426546|NCT03404843|564654671|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
156426547|NCT04044664|564654672|FG000|Stage 1|Adverse Event|3|||
156426548|NCT04044664|564654673|FG001|Stage 1|Adverse Event|3|||
156426549|NCT04044664|564654674|FG002|Stage 1|Adverse Event|1|||
156426550|NCT04044664|564654672|FG000|Stage 1|Lost to Follow-up|3|||
156426551|NCT04044664|564654673|FG001|Stage 1|Lost to Follow-up|2|||
156426552|NCT04044664|564654674|FG002|Stage 1|Lost to Follow-up|2|||
156426553|NCT04044664|564654672|FG000|Stage 1|Withdrawal by Subject|9|||
156426554|NCT04044664|564654673|FG001|Stage 1|Withdrawal by Subject|1|||
156426555|NCT04044664|564654674|FG002|Stage 1|Withdrawal by Subject|0|||
156426556|NCT04044664|564654672|FG000|Stage 1|noncompliance, personal reason|2|||
156426557|NCT04044664|564654673|FG001|Stage 1|noncompliance, personal reason|0|||
156426558|NCT04044664|564654674|FG002|Stage 1|noncompliance, personal reason|0|||
156765564|NCT03327324|565896593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
156765565|NCT03327324|565896594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
156765566|NCT03327324|565896595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
156765567|NCT03327324|565896596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
156765568|NCT03327324|565896597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
156765569|NCT03327324|565896592|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156426559|NCT04044664|564654672|FG000|Stage 1|randomization error|0|||
156426560|NCT04044664|564654673|FG001|Stage 1|randomization error|1|||
156426561|NCT04044664|564654674|FG002|Stage 1|randomization error|0|||
156426562|NCT04044664|564654672|FG000|Stage 2|Adverse Event|2|||
156426563|NCT04044664|564654673|FG001|Stage 2|Adverse Event|0|||
156426564|NCT04044664|564654674|FG002|Stage 2|Adverse Event|0|||
156426565|NCT04044664|564654672|FG000|Stage 2|Lost to Follow-up|3|||
156426566|NCT04044664|564654673|FG001|Stage 2|Lost to Follow-up|2|||
156426567|NCT04044664|564654674|FG002|Stage 2|Lost to Follow-up|1|||
156426568|NCT04044664|564654672|FG000|Stage 2|Withdrawal by Subject|3|||
156426569|NCT04044664|564654673|FG001|Stage 2|Withdrawal by Subject|0|||
156765570|NCT03327324|565896593|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765571|NCT03327324|565896594|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765572|NCT03327324|565896595|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
156765573|NCT03327324|565896596|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
156765574|NCT03327324|565896597|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765575|NCT03327324|565896592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
156765576|NCT03327324|565896593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765577|NCT03327324|565896594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765578|NCT03327324|565896595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765579|NCT03327324|565896596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765580|NCT03327324|565896597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765581|NCT03327324|565896592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
156765582|NCT03327324|565896593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765583|NCT03327324|565896594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765584|NCT03327324|565896595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765585|NCT03327324|565896596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765586|NCT03327324|565896597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765587|NCT03886272|565896599|FG000|Period 1|Withdrawal by Subject|0|||
156765588|NCT03886272|565896600|FG001|Period 1|Withdrawal by Subject|0|||
156765589|NCT03886272|565896601|FG002|Period 1|Withdrawal by Subject|0|||
156765590|NCT03886272|565896602|FG003|Period 1|Withdrawal by Subject|0|||
156765591|NCT03886272|565896603|FG004|Period 1|Withdrawal by Subject|0|||
156765592|NCT03886272|565896604|FG005|Period 1|Withdrawal by Subject|1|||
156765593|NCT03886272|565896605|FG006|Period 1|Withdrawal by Subject|0|||
156765594|NCT03014206|565896606|FG000|Overall Study|Registration Violation|12|||
156765595|NCT02895347|565896609|FG000|Overall Study|Withdrawal by Subject|3|||
156765596|NCT02895347|565896610|FG001|Overall Study|Withdrawal by Subject|1|||
156765597|NCT01673178|565896614|FG000|Overall Study|Lost to Follow-up|0|||
156765598|NCT01673178|565896615|FG001|Overall Study|Lost to Follow-up|1|||
156765599|NCT01673178|565896616|FG002|Overall Study|Lost to Follow-up|0|||
156765600|NCT01673178|565896617|FG003|Overall Study|Lost to Follow-up|0|||
156765601|NCT01673178|565896618|FG004|Overall Study|Lost to Follow-up|0|||
156765602|NCT01673178|565896614|FG000|Overall Study|Withdrawal by Subject|0|||
156765603|NCT01673178|565896615|FG001|Overall Study|Withdrawal by Subject|0|||
156765604|NCT01673178|565896616|FG002|Overall Study|Withdrawal by Subject|1|||
156765605|NCT01673178|565896617|FG003|Overall Study|Withdrawal by Subject|4|||
156765606|NCT01673178|565896618|FG004|Overall Study|Withdrawal by Subject|2|||
156765607|NCT01673178|565896614|FG000|Overall Study|Protocol Violation|1|||
156765608|NCT01673178|565896615|FG001|Overall Study|Protocol Violation|1|||
156765609|NCT01673178|565896616|FG002|Overall Study|Protocol Violation|0|||
156765610|NCT01673178|565896617|FG003|Overall Study|Protocol Violation|1|||
156765611|NCT01673178|565896618|FG004|Overall Study|Protocol Violation|0|||
156765612|NCT01673178|565896614|FG000|Overall Study|Adverse Event|1|||
156765613|NCT01673178|565896615|FG001|Overall Study|Adverse Event|0|||
156765614|NCT01673178|565896616|FG002|Overall Study|Adverse Event|0|||
156765615|NCT01673178|565896617|FG003|Overall Study|Adverse Event|2|||
156765616|NCT01673178|565896618|FG004|Overall Study|Adverse Event|0|||
156765617|NCT01673178|565896614|FG000|Overall Study|Other|1|||
156765618|NCT01673178|565896615|FG001|Overall Study|Other|0|||
156765619|NCT01673178|565896616|FG002|Overall Study|Other|2|||
156765620|NCT01673178|565896617|FG003|Overall Study|Other|1|||
156765621|NCT01673178|565896618|FG004|Overall Study|Other|0|||
156765622|NCT03177148|565896619|FG000|Overall Study|Lost to Follow-up|50|||
156765623|NCT03177148|565896620|FG001|Overall Study|Lost to Follow-up|1|||
156765624|NCT03177148|565896619|FG000|Overall Study|Death|1|||
156765625|NCT03177148|565896620|FG001|Overall Study|Death|0|||
156765626|NCT02848664|565896624|FG000|Overall Study|Withdrawal by Subject|2|||
156426570|NCT04044664|564654674|FG002|Stage 2|Withdrawal by Subject|0|||
156426571|NCT04044664|564654672|FG000|Stage 2|protocol deviation|1|||
156426572|NCT04044664|564654673|FG001|Stage 2|protocol deviation|0|||
156426573|NCT04044664|564654674|FG002|Stage 2|protocol deviation|0|||
156426574|NCT03822351|564654686|FG000|Overall Study|Death|27|||
156426575|NCT03822351|564654687|FG001|Overall Study|Death|23|||
156765627|NCT02848664|565896624|FG000|Overall Study|Adverse Event|1|||
156426576|NCT03822351|564654688|FG002|Overall Study|Death|24|||
156426577|NCT03822351|564654686|FG000|Overall Study|Lost to Follow-up|6|||
156426578|NCT03822351|564654687|FG001|Overall Study|Lost to Follow-up|2|||
156765628|NCT02848664|565896624|FG000|Overall Study|no assistance for device training|1|||
156765629|NCT01819727|565896627|FG000|Overall Study|Adverse Event|8|||
156765630|NCT01819727|565896628|FG001|Overall Study|Adverse Event|9|||
156765631|NCT01819727|565896627|FG000|Overall Study|Death|1|||
156426579|NCT03822351|564654688|FG002|Overall Study|Lost to Follow-up|1|||
156426580|NCT03822351|564654686|FG000|Overall Study|Withdrawal by Subject|10|||
156426581|NCT03822351|564654687|FG001|Overall Study|Withdrawal by Subject|4|||
156765632|NCT01819727|565896628|FG001|Overall Study|Death|0|||
156765633|NCT01819727|565896627|FG000|Overall Study|Lost to Follow-up|1|||
156765634|NCT01819727|565896628|FG001|Overall Study|Lost to Follow-up|1|||
156765635|NCT01819727|565896627|FG000|Overall Study|Physician Decision|3|||
156765636|NCT01819727|565896628|FG001|Overall Study|Physician Decision|2|||
156765637|NCT01819727|565896627|FG000|Overall Study|Pregnancy|1|||
156765638|NCT01819727|565896628|FG001|Overall Study|Pregnancy|0|||
156765639|NCT01819727|565896627|FG000|Overall Study|Protocol Violation|0|||
156765640|NCT01819727|565896628|FG001|Overall Study|Protocol Violation|2|||
156765641|NCT01819727|565896627|FG000|Overall Study|Study Terminated by Sponsor|0|||
156765642|NCT01819727|565896628|FG001|Overall Study|Study Terminated by Sponsor|1|||
156765643|NCT01819727|565896627|FG000|Overall Study|Withdrawal by Subject|6|||
156765644|NCT01819727|565896628|FG001|Overall Study|Withdrawal by Subject|11|||
156765645|NCT01819727|565896627|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
156765646|NCT01819727|565896628|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
156765647|NCT01819727|565896627|FG000|Overall Study|Quit due to lack of health benifits|0|||
156765648|NCT01819727|565896628|FG001|Overall Study|Quit due to lack of health benifits|1|||
156765649|NCT00402727|565896631|FG000|Overall Study|Adverse Event|10|||
156765650|NCT00402727|565896632|FG001|Overall Study|Adverse Event|6|||
156765651|NCT00402727|565896631|FG000|Overall Study|Death|1|||
156765652|NCT00402727|565896632|FG001|Overall Study|Death|0|||
156765653|NCT00402727|565896631|FG000|Overall Study|Lack of Efficacy|1|||
156765654|NCT00402727|565896632|FG001|Overall Study|Lack of Efficacy|3|||
156765655|NCT00402727|565896631|FG000|Overall Study|Lost to Follow-up|24|||
156765656|NCT00402727|565896632|FG001|Overall Study|Lost to Follow-up|11|||
156765657|NCT00402727|565896631|FG000|Overall Study|Physician Decision|1|||
156426582|NCT03822351|564654688|FG002|Overall Study|Withdrawal by Subject|6|||
156426583|NCT03822351|564654686|FG000|Overall Study|Progressive Disease|2|||
156426584|NCT03822351|564654687|FG001|Overall Study|Progressive Disease|1|||
156426585|NCT03822351|564654688|FG002|Overall Study|Progressive Disease|0|||
156426586|NCT03822351|564654686|FG000|Overall Study|Not Treated|1|||
156426587|NCT03822351|564654687|FG001|Overall Study|Not Treated|1|||
156426588|NCT03822351|564654688|FG002|Overall Study|Not Treated|1|||
156426589|NCT02081391|564654689|FG000|12-hour Treatment|Withdrawal by Subject|3|||
156426590|NCT02081391|564654690|FG001|12-hour Treatment|Withdrawal by Subject|2|||
156426591|NCT02081391|564654691|FG002|12-hour Treatment|Withdrawal by Subject|0|||
156426592|NCT02081391|564654692|FG003|12-hour Treatment|Withdrawal by Subject|0|||
156426593|NCT02081391|564654689|FG000|12-hour Treatment|Physician Decision|4|||
156426594|NCT02081391|564654690|FG001|12-hour Treatment|Physician Decision|1|||
156426595|NCT02081391|564654691|FG002|12-hour Treatment|Physician Decision|0|||
156426596|NCT02081391|564654692|FG003|12-hour Treatment|Physician Decision|0|||
156426597|NCT02081391|564654689|FG000|12-hour Treatment|Lack of Efficacy|3|||
156426598|NCT02081391|564654690|FG001|12-hour Treatment|Lack of Efficacy|0|||
156426599|NCT02081391|564654691|FG002|12-hour Treatment|Lack of Efficacy|0|||
156426600|NCT02081391|564654692|FG003|12-hour Treatment|Lack of Efficacy|0|||
156426601|NCT02081391|564654689|FG000|12-hour Treatment|Adverse Event|4|||
156426602|NCT02081391|564654690|FG001|12-hour Treatment|Adverse Event|2|||
156426603|NCT02081391|564654691|FG002|12-hour Treatment|Adverse Event|0|||
156426604|NCT02081391|564654692|FG003|12-hour Treatment|Adverse Event|0|||
156426605|NCT02081391|564654689|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
156426606|NCT02081391|564654690|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
156426607|NCT02081391|564654691|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
156426608|NCT02081391|564654692|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
156426609|NCT02081391|564654689|FG000|12-hour Treatment|Further reasons|2|||
156426610|NCT02081391|564654690|FG001|12-hour Treatment|Further reasons|1|||
156426611|NCT02081391|564654691|FG002|12-hour Treatment|Further reasons|0|||
156426612|NCT02081391|564654692|FG003|12-hour Treatment|Further reasons|0|||
156426613|NCT02081391|564654689|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
156426614|NCT02081391|564654690|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
156426615|NCT02081391|564654691|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
156426616|NCT02081391|564654692|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
156426617|NCT02081391|564654689|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
156426618|NCT02081391|564654690|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
156426619|NCT02081391|564654691|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
156426620|NCT02081391|564654692|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
156765658|NCT00402727|565896632|FG001|Overall Study|Physician Decision|1|||
156765659|NCT00402727|565896631|FG000|Overall Study|Protocol Violation|0|||
156765660|NCT00402727|565896632|FG001|Overall Study|Protocol Violation|4|||
156765661|NCT00402727|565896631|FG000|Overall Study|Withdrawal by Subject|3|||
156765662|NCT00402727|565896632|FG001|Overall Study|Withdrawal by Subject|7|||
156765663|NCT00402727|565896631|FG000|Overall Study|supply problems|2|||
156765664|NCT00402727|565896632|FG001|Overall Study|supply problems|1|||
156765665|NCT00402727|565896631|FG000|Overall Study|non-compliance|0|||
156426621|NCT02081391|564654689|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
156426622|NCT02081391|564654690|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
156426623|NCT02081391|564654691|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
156765666|NCT00402727|565896632|FG001|Overall Study|non-compliance|1|||
156765667|NCT00732069|565896633|FG000|Washout After First Study Drug|Adverse Event|1|||
156765668|NCT00732069|565896634|FG001|Washout After First Study Drug|Adverse Event|0|||
156765669|NCT00732069|565896635|FG002|Washout After First Study Drug|Adverse Event|0|||
156765670|NCT00732069|565896636|FG003|Washout After First Study Drug|Adverse Event|0|||
156765671|NCT00732069|565896637|FG004|Washout After First Study Drug|Adverse Event|0|||
156765672|NCT00732069|565896638|FG005|Washout After First Study Drug|Adverse Event|0|||
156765673|NCT00577317|565896639|FG000|Overall Study|Study Terminated|0|||
156426624|NCT02081391|564654692|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
156426625|NCT02081391|564654689|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
156426626|NCT02081391|564654690|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
156426627|NCT02081391|564654691|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
156426628|NCT02081391|564654692|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
156426629|NCT02081391|564654689|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
156426630|NCT02081391|564654690|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
156426631|NCT02081391|564654691|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
156426632|NCT02081391|564654692|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
156426633|NCT02081391|564654689|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
156426634|NCT02081391|564654690|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
156426635|NCT02081391|564654691|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
156426636|NCT02081391|564654692|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
156426637|NCT01458275|564654693|FG000|Overall Study|Adverse Event|3|||
156765674|NCT00577317|565896640|FG001|Overall Study|Study Terminated|2|||
156765675|NCT03106077|565896660|FG000|Overall Study|Screen Failure|94|||
156765676|NCT03106077|565896661|FG001|Overall Study|Screen Failure|0|||
156765677|NCT00606307|565896662|FG000|Overall Study|Adverse Event|2|||
156765678|NCT00606307|565896662|FG000|Overall Study|Withdrawal by Subject|2|||
156765679|NCT00606307|565896662|FG000|Overall Study|Disease progression|6|||
156765680|NCT00606307|565896662|FG000|Overall Study|QTc prolongation|1|||
156765681|NCT01274533|565896663|FG000|Overall Study|Withdrawal by Subject|1|||
156765682|NCT01274533|565896663|FG000|Overall Study|Non-compliance|1|||
156765683|NCT01274533|565896663|FG000|Overall Study|Disease progression|2|||
156765684|NCT02563899|565896664|FG000|Overall Study|Protocol Violation|1|||
156765685|NCT02563899|565896665|FG001|Overall Study|Protocol Violation|0|||
156765686|NCT02563899|565896666|FG002|Overall Study|Protocol Violation|0|||
156765687|NCT02563899|565896667|FG003|Overall Study|Protocol Violation|0|||
156765688|NCT02563899|565896664|FG000|Overall Study|Withdrawal by Subject|0|||
156765689|NCT02563899|565896665|FG001|Overall Study|Withdrawal by Subject|0|||
156765690|NCT02563899|565896666|FG002|Overall Study|Withdrawal by Subject|1|||
156765691|NCT02563899|565896667|FG003|Overall Study|Withdrawal by Subject|0|||
156765692|NCT03669588|565896669|FG000|Overall Study|Adverse Event|1|||
156765693|NCT03669588|565896670|FG001|Overall Study|Adverse Event|0|||
156765694|NCT03669588|565896669|FG000|Overall Study|Physician Decision|0|||
156765695|NCT03669588|565896670|FG001|Overall Study|Physician Decision|1|||
156765696|NCT03669588|565896669|FG000|Overall Study|Protocol Violation|1|||
156765697|NCT03669588|565896670|FG001|Overall Study|Protocol Violation|0|||
156765698|NCT03669588|565896669|FG000|Overall Study|Sponsor Decision|1|||
156765699|NCT03669588|565896670|FG001|Overall Study|Sponsor Decision|1|||
156765700|NCT03669588|565896669|FG000|Overall Study|Withdrawal by Subject|1|||
156765701|NCT03669588|565896670|FG001|Overall Study|Withdrawal by Subject|4|||
156765702|NCT03669588|565896669|FG000|Overall Study|Rescue Therapy Needed|0|||
156765703|NCT03669588|565896670|FG001|Overall Study|Rescue Therapy Needed|1|||
156765704|NCT02008526|565896671|FG000|Overall Study|Death|0|||
156765705|NCT02008526|565896672|FG001|Overall Study|Death|2|||
156765706|NCT02008526|565896673|FG002|Overall Study|Death|1|||
156765707|NCT02008526|565896671|FG000|Overall Study|Withdrawal by Subject|3|||
156765708|NCT02008526|565896672|FG001|Overall Study|Withdrawal by Subject|3|||
156765709|NCT02008526|565896673|FG002|Overall Study|Withdrawal by Subject|2|||
156765710|NCT02008526|565896671|FG000|Overall Study|Lost to Follow-up|5|||
156765711|NCT02008526|565896672|FG001|Overall Study|Lost to Follow-up|9|||
156765712|NCT02008526|565896673|FG002|Overall Study|Lost to Follow-up|6|||
156765713|NCT00161213|565898493|FG000|Overall Study|Withdrawal by Subject|1|||
156765714|NCT00161213|565898493|FG000|Overall Study|Evaluable for toxicity but not response|1|||
156765715|NCT03103503|565898494|FG000|Overall Study|Death|64|||
156765716|NCT03103503|565898494|FG000|Overall Study|Physician Decision|57|||
156765717|NCT03103503|565898494|FG000|Overall Study|Withdrawal by Subject|10|||
156765718|NCT03103503|565898494|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
156765719|NCT03103503|565898494|FG000|Overall Study|Lost to Follow-up|3|||
156426638|NCT01458275|564654694|FG001|Overall Study|Adverse Event|4|||
156426639|NCT01458275|564654695|FG002|Overall Study|Adverse Event|1|||
156765720|NCT03103503|565898494|FG000|Overall Study|Study Closure|757|||
156765721|NCT00737048|565898501|FG000|Overall Study|Physician Decision|0|||
156765722|NCT00737048|565898502|FG001|Overall Study|Physician Decision|0|||
156765723|NCT00737048|565898503|FG002|Overall Study|Physician Decision|1|||
156765724|NCT00737048|565898501|FG000|Overall Study|Adverse Event|0|||
156426640|NCT01458275|564654693|FG000|Overall Study|Lost to Follow-up|3|||
156426641|NCT01458275|564654694|FG001|Overall Study|Lost to Follow-up|2|||
156426642|NCT01458275|564654695|FG002|Overall Study|Lost to Follow-up|5|||
156426643|NCT01458275|564654693|FG000|Overall Study|Protocol Violation|5|||
156426644|NCT01458275|564654694|FG001|Overall Study|Protocol Violation|5|||
156765725|NCT00737048|565898502|FG001|Overall Study|Adverse Event|1|||
156765726|NCT00737048|565898503|FG002|Overall Study|Adverse Event|0|||
156765727|NCT00737048|565898501|FG000|Overall Study|Worsening of the symptoms|3|||
156765728|NCT00737048|565898502|FG001|Overall Study|Worsening of the symptoms|5|||
156765729|NCT00737048|565898503|FG002|Overall Study|Worsening of the symptoms|3|||
156765730|NCT00301834|565898504|FG000|Overall Study|Death|1|||
156765731|NCT02737358|565898505|FG000|Overall Study|Withdrawal by Subject|7|||
156765732|NCT02737358|565898506|FG001|Overall Study|Withdrawal by Subject|12|||
156765733|NCT02737358|565898505|FG000|Overall Study|Lost to Follow-up|2|||
156765734|NCT02737358|565898506|FG001|Overall Study|Lost to Follow-up|3|||
156765735|NCT02870868|565898507|FG000|Overall Study|Withdrawal by Subject|2|||
156765736|NCT02870868|565898508|FG001|Overall Study|Withdrawal by Subject|1|||
156765737|NCT00744939|565898509|FG000|Overall Study|Withdrawal by Subject|9|||
156765738|NCT00744939|565898509|FG000|Overall Study|Protocol Violation|13|||
156322754|NCT01582854|564280261|FG000|Overall Study|Carotid or Neurosurgery|0|||
156322755|NCT01582854|564280262|FG001|Overall Study|Carotid or Neurosurgery|1|||
156322756|NCT01582854|564280261|FG000|Overall Study|General Anaesthesia|0|||
156322757|NCT01582854|564280262|FG001|Overall Study|General Anaesthesia|1|||
156322758|NCT01582854|564280261|FG000|Overall Study|Other Miscellaneous Reason|1|||
156322759|NCT01582854|564280262|FG001|Overall Study|Other Miscellaneous Reason|0|||
156322760|NCT03101267|564280263|FG000|Primary Study Period|Withdrawal by Subject|1|||
156322761|NCT03101267|564280264|FG001|Primary Study Period|Withdrawal by Subject|2|||
156322762|NCT03101267|564280265|FG002|Primary Study Period|Withdrawal by Subject|3|||
156322763|NCT03101267|564280263|FG000|Primary Study Period|Miscellaneous|2|||
156322764|NCT03101267|564280264|FG001|Primary Study Period|Miscellaneous|0|||
156322765|NCT03101267|564280265|FG002|Primary Study Period|Miscellaneous|0|||
156322766|NCT04068896|564280266|FG000|Overall Study|Adverse Event|2|||
156322767|NCT04068896|564280267|FG001|Overall Study|Adverse Event|0|||
156322768|NCT04068896|564280268|FG002|Overall Study|Adverse Event|1|||
156322769|NCT04068896|564280269|FG003|Overall Study|Adverse Event|0|||
156322770|NCT04068896|564280270|FG004|Overall Study|Adverse Event|0|||
156322771|NCT04068896|564280271|FG005|Overall Study|Adverse Event|0|||
156322772|NCT04068896|564280266|FG000|Overall Study|Death|3|||
156322773|NCT04068896|564280267|FG001|Overall Study|Death|1|||
156322774|NCT04068896|564280268|FG002|Overall Study|Death|3|||
156322775|NCT04068896|564280269|FG003|Overall Study|Death|19|||
156322776|NCT04068896|564280270|FG004|Overall Study|Death|17|||
156322777|NCT04068896|564280271|FG005|Overall Study|Death|0|||
156322778|NCT04068896|564280266|FG000|Overall Study|Physician Decision|0|||
156322779|NCT04068896|564280267|FG001|Overall Study|Physician Decision|0|||
156322780|NCT04068896|564280268|FG002|Overall Study|Physician Decision|0|||
156322781|NCT04068896|564280269|FG003|Overall Study|Physician Decision|1|||
156322782|NCT04068896|564280270|FG004|Overall Study|Physician Decision|0|||
156322783|NCT04068896|564280271|FG005|Overall Study|Physician Decision|0|||
156426645|NCT01458275|564654695|FG002|Overall Study|Protocol Violation|2|||
156426646|NCT01458275|564654693|FG000|Overall Study|Withdrawal by Subject|3|||
156426647|NCT01458275|564654694|FG001|Overall Study|Withdrawal by Subject|2|||
156426648|NCT01458275|564654695|FG002|Overall Study|Withdrawal by Subject|1|||
156426649|NCT00813488|564654697|FG000|Titration Period 1|Adverse Event|6|||
156426650|NCT00813488|564654698|FG001|Titration Period 1|Adverse Event|1|||
156426651|NCT00813488|564654697|FG000|Titration Period 1|Lack of Efficacy|9|||
156426652|NCT00813488|564654698|FG001|Titration Period 1|Lack of Efficacy|7|||
156426653|NCT00813488|564654697|FG000|Titration Period 1|Withdrawal by Subject|2|||
156426654|NCT00813488|564654698|FG001|Titration Period 1|Withdrawal by Subject|2|||
156426655|NCT00813488|564654697|FG000|Titration Period 1|Protocol Violation|4|||
156426656|NCT00813488|564654698|FG001|Titration Period 1|Protocol Violation|3|||
156426657|NCT00813488|564654697|FG000|Titration Period 1|Non-compliance to study medication|4|||
156426658|NCT00813488|564654698|FG001|Titration Period 1|Non-compliance to study medication|1|||
156426659|NCT00813488|564654697|FG000|Titration Period 1|Non-compliance to study procedures|2|||
156426660|NCT00813488|564654698|FG001|Titration Period 1|Non-compliance to study procedures|2|||
156426661|NCT00813488|564654697|FG000|Titration Period 1|Technical Difficulties|0|||
156426662|NCT00813488|564654698|FG001|Titration Period 1|Technical Difficulties|1|||
156426663|NCT00813488|564654697|FG000|Titration Period 2|Adverse Event|2|||
156426664|NCT00813488|564654698|FG001|Titration Period 2|Adverse Event|3|||
156426665|NCT00813488|564654697|FG000|Titration Period 2|Lack of Efficacy|8|||
156426666|NCT00813488|564654698|FG001|Titration Period 2|Lack of Efficacy|4|||
156426667|NCT00813488|564654697|FG000|Titration Period 2|Protocol Violation|3|||
156426668|NCT00813488|564654698|FG001|Titration Period 2|Protocol Violation|2|||
156426669|NCT00813488|564654697|FG000|Titration Period 2|Lost to Follow-up|1|||
156426670|NCT00813488|564654698|FG001|Titration Period 2|Lost to Follow-up|0|||
156426671|NCT00813488|564654697|FG000|Titration Period 2|Non-compliance with study procedures|2|||
156426672|NCT00813488|564654698|FG001|Titration Period 2|Non-compliance with study procedures|1|||
156322784|NCT04068896|564280266|FG000|Overall Study|progressive disease|3|||
156322785|NCT04068896|564280267|FG001|Overall Study|progressive disease|5|||
156322786|NCT04068896|564280268|FG002|Overall Study|progressive disease|3|||
156322787|NCT04068896|564280269|FG003|Overall Study|progressive disease|2|||
156322788|NCT04068896|564280270|FG004|Overall Study|progressive disease|1|||
156322789|NCT04068896|564280271|FG005|Overall Study|progressive disease|2|||
156322790|NCT04068896|564280266|FG000|Overall Study|Study terminated by sponsor|0|||
156322791|NCT04068896|564280267|FG001|Overall Study|Study terminated by sponsor|0|||
156322792|NCT04068896|564280268|FG002|Overall Study|Study terminated by sponsor|1|||
156322793|NCT04068896|564280269|FG003|Overall Study|Study terminated by sponsor|2|||
156322794|NCT04068896|564280270|FG004|Overall Study|Study terminated by sponsor|1|||
156322795|NCT04068896|564280271|FG005|Overall Study|Study terminated by sponsor|4|||
156322796|NCT04068896|564280266|FG000|Overall Study|Protocol Violation|0|||
156322797|NCT04068896|564280267|FG001|Overall Study|Protocol Violation|0|||
156322798|NCT04068896|564280268|FG002|Overall Study|Protocol Violation|0|||
156322799|NCT04068896|564280269|FG003|Overall Study|Protocol Violation|1|||
156322800|NCT04068896|564280270|FG004|Overall Study|Protocol Violation|0|||
156322801|NCT04068896|564280271|FG005|Overall Study|Protocol Violation|0|||
156322802|NCT04068896|564280266|FG000|Overall Study|Withdrawal by Subject|0|||
156322803|NCT04068896|564280267|FG001|Overall Study|Withdrawal by Subject|3|||
156322804|NCT04068896|564280268|FG002|Overall Study|Withdrawal by Subject|0|||
156322805|NCT04068896|564280269|FG003|Overall Study|Withdrawal by Subject|2|||
156322806|NCT04068896|564280270|FG004|Overall Study|Withdrawal by Subject|1|||
156322807|NCT04068896|564280271|FG005|Overall Study|Withdrawal by Subject|0|||
156322808|NCT04068896|564280266|FG000|Overall Study|Symptomatic deterioration|2|||
156322809|NCT04068896|564280267|FG001|Overall Study|Symptomatic deterioration|0|||
156322810|NCT04068896|564280268|FG002|Overall Study|Symptomatic deterioration|0|||
156322811|NCT04068896|564280269|FG003|Overall Study|Symptomatic deterioration|0|||
156322812|NCT04068896|564280270|FG004|Overall Study|Symptomatic deterioration|0|||
156322813|NCT04068896|564280271|FG005|Overall Study|Symptomatic deterioration|0|||
156322814|NCT02953509|564280272|FG000|Overall Study|Death|1|||
156322815|NCT02953509|564280273|FG001|Overall Study|Death|3|||
156322816|NCT02953509|564280274|FG002|Overall Study|Death|3|||
156322817|NCT02953509|564280275|FG003|Overall Study|Death|4|||
156322818|NCT02953509|564280276|FG004|Overall Study|Death|12|||
156322819|NCT02953509|564280277|FG005|Overall Study|Death|3|||
156322820|NCT02953509|564280278|FG006|Overall Study|Death|25|||
156322821|NCT02953509|564280279|FG007|Overall Study|Death|10|||
156322822|NCT02953509|564280280|FG008|Overall Study|Death|21|||
156322823|NCT02953509|564280281|FG009|Overall Study|Death|20|||
156322824|NCT02953509|564280272|FG000|Overall Study|Reason Not Specified|0|||
156322825|NCT02953509|564280273|FG001|Overall Study|Reason Not Specified|2|||
156322826|NCT02953509|564280274|FG002|Overall Study|Reason Not Specified|8|||
156322827|NCT02953509|564280275|FG003|Overall Study|Reason Not Specified|2|||
156322828|NCT02953509|564280276|FG004|Overall Study|Reason Not Specified|11|||
156322829|NCT02953509|564280277|FG005|Overall Study|Reason Not Specified|4|||
156322830|NCT02953509|564280278|FG006|Overall Study|Reason Not Specified|12|||
156322831|NCT02953509|564280279|FG007|Overall Study|Reason Not Specified|2|||
156322832|NCT02953509|564280280|FG008|Overall Study|Reason Not Specified|7|||
156322833|NCT02953509|564280281|FG009|Overall Study|Reason Not Specified|2|||
156322834|NCT02953509|564280272|FG000|Overall Study|Consent Withdrawn|1|||
156322835|NCT02953509|564280273|FG001|Overall Study|Consent Withdrawn|1|||
156322836|NCT02953509|564280274|FG002|Overall Study|Consent Withdrawn|2|||
156322837|NCT02953509|564280275|FG003|Overall Study|Consent Withdrawn|1|||
156322838|NCT02953509|564280276|FG004|Overall Study|Consent Withdrawn|3|||
156322839|NCT02953509|564280277|FG005|Overall Study|Consent Withdrawn|0|||
156322840|NCT02953509|564280278|FG006|Overall Study|Consent Withdrawn|4|||
156322841|NCT02953509|564280279|FG007|Overall Study|Consent Withdrawn|1|||
156322842|NCT02953509|564280280|FG008|Overall Study|Consent Withdrawn|1|||
156322843|NCT02953509|564280281|FG009|Overall Study|Consent Withdrawn|4|||
156322844|NCT02953509|564280272|FG000|Overall Study|Lost to Follow-up|0|||
156322845|NCT02953509|564280273|FG001|Overall Study|Lost to Follow-up|0|||
156322846|NCT02953509|564280274|FG002|Overall Study|Lost to Follow-up|0|||
156322847|NCT02953509|564280275|FG003|Overall Study|Lost to Follow-up|0|||
156322848|NCT02953509|564280276|FG004|Overall Study|Lost to Follow-up|0|||
156322849|NCT02953509|564280277|FG005|Overall Study|Lost to Follow-up|0|||
156322850|NCT02953509|564280278|FG006|Overall Study|Lost to Follow-up|1|||
156322851|NCT02953509|564280279|FG007|Overall Study|Lost to Follow-up|1|||
156322852|NCT02953509|564280280|FG008|Overall Study|Lost to Follow-up|1|||
156322853|NCT02953509|564280281|FG009|Overall Study|Lost to Follow-up|1|||
156322854|NCT02953509|564280272|FG000|Overall Study|Study terminated by sponsor|1|||
156322855|NCT02953509|564280273|FG001|Overall Study|Study terminated by sponsor|0|||
156322856|NCT02953509|564280274|FG002|Overall Study|Study terminated by sponsor|0|||
156322857|NCT02953509|564280275|FG003|Overall Study|Study terminated by sponsor|0|||
156322858|NCT02953509|564280276|FG004|Overall Study|Study terminated by sponsor|0|||
156322859|NCT02953509|564280277|FG005|Overall Study|Study terminated by sponsor|0|||
156322860|NCT02953509|564280278|FG006|Overall Study|Study terminated by sponsor|1|||
156322861|NCT02953509|564280279|FG007|Overall Study|Study terminated by sponsor|0|||
156322862|NCT02953509|564280280|FG008|Overall Study|Study terminated by sponsor|1|||
156765739|NCT00744939|565898509|FG000|Overall Study|Death|24|||
156765740|NCT00744939|565898509|FG000|Overall Study|distance|4|||
156765741|NCT00744939|565898509|FG000|Overall Study|Lost to Follow-up|12|||
156765742|NCT00744939|565898509|FG000|Overall Study|Medical history exclusionary|1|||
156765743|NCT00744939|565898509|FG000|Overall Study|Did not receive Magnevist|7|||
156765744|NCT00744939|565898509|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
156765745|NCT00744939|565898509|FG000|Overall Study|coma|1|||
156765746|NCT00744939|565898509|FG000|Overall Study|incorrect race|1|||
156765747|NCT01739335|565898510|FG000|Overall Study|Lost to Follow-up|7|||
156765748|NCT01739335|565898511|FG001|Overall Study|Lost to Follow-up|4|||
156765749|NCT01739335|565898510|FG000|Overall Study|Ineligible patient randomized|0|||
156765750|NCT01739335|565898511|FG001|Overall Study|Ineligible patient randomized|1|||
156765751|NCT00288912|565898512|FG000|Overall Study|Developed exclusion criterion|4|||
156765752|NCT00288912|565898513|FG001|Overall Study|Developed exclusion criterion|6|||
156765753|NCT00288912|565898514|FG002|Overall Study|Developed exclusion criterion|7|||
156765754|NCT00288912|565898512|FG000|Overall Study|Lost to Follow-up|9|||
156765755|NCT00288912|565898513|FG001|Overall Study|Lost to Follow-up|6|||
156765756|NCT00288912|565898514|FG002|Overall Study|Lost to Follow-up|9|||
156765757|NCT00288912|565898512|FG000|Overall Study|Withdrawal by Subject|4|||
156765758|NCT00288912|565898513|FG001|Overall Study|Withdrawal by Subject|5|||
156765759|NCT00288912|565898514|FG002|Overall Study|Withdrawal by Subject|12|||
156765760|NCT00183430|565898517|FG000|Overall Study|Adverse Event|1|||
156765761|NCT00183430|565898518|FG001|Overall Study|Adverse Event|0|||
156765762|NCT00183430|565898517|FG000|Overall Study|Lost to Follow-up|3|||
156765763|NCT00183430|565898518|FG001|Overall Study|Lost to Follow-up|0|||
156765764|NCT00183430|565898517|FG000|Overall Study|did not meet inclusion criteria|1|||
156765765|NCT00183430|565898518|FG001|Overall Study|did not meet inclusion criteria|0|||
156765766|NCT00183430|565898517|FG000|Overall Study|Withdrawal by Subject|1|||
156765767|NCT00183430|565898518|FG001|Overall Study|Withdrawal by Subject|0|||
156765768|NCT01863771|565898527|FG000|Induction Phase|Adverse Event|9|||
156765769|NCT01863771|565898528|FG001|Induction Phase|Adverse Event|0|||
156765770|NCT01863771|565898529|FG002|Induction Phase|Adverse Event|0|||
156765771|NCT01863771|565898530|FG003|Induction Phase|Adverse Event|0|||
156765772|NCT01863771|565898527|FG000|Induction Phase|Lack of Efficacy|10|||
156765773|NCT01863771|565898528|FG001|Induction Phase|Lack of Efficacy|0|||
156765774|NCT01863771|565898529|FG002|Induction Phase|Lack of Efficacy|0|||
156765775|NCT01863771|565898530|FG003|Induction Phase|Lack of Efficacy|0|||
156765776|NCT01863771|565898527|FG000|Induction Phase|Withdrawal by Subject|2|||
156765777|NCT01863771|565898528|FG001|Induction Phase|Withdrawal by Subject|0|||
156765778|NCT01863771|565898529|FG002|Induction Phase|Withdrawal by Subject|0|||
156765779|NCT01863771|565898530|FG003|Induction Phase|Withdrawal by Subject|0|||
156765780|NCT01863771|565898527|FG000|Maintenance Phase|Adverse Event|0|||
156765781|NCT01863771|565898528|FG001|Maintenance Phase|Adverse Event|0|||
156765782|NCT01863771|565898529|FG002|Maintenance Phase|Adverse Event|1|||
156765783|NCT01863771|565898530|FG003|Maintenance Phase|Adverse Event|1|||
156765784|NCT01863771|565898527|FG000|Maintenance Phase|Lack of Efficacy|0|||
156765785|NCT01863771|565898528|FG001|Maintenance Phase|Lack of Efficacy|3|||
156765786|NCT01863771|565898529|FG002|Maintenance Phase|Lack of Efficacy|7|||
156765787|NCT01863771|565898530|FG003|Maintenance Phase|Lack of Efficacy|38|||
156765788|NCT01863771|565898527|FG000|Maintenance Phase|Physician Decision|0|||
156765789|NCT01863771|565898528|FG001|Maintenance Phase|Physician Decision|0|||
156765790|NCT01863771|565898529|FG002|Maintenance Phase|Physician Decision|2|||
156765791|NCT01863771|565898530|FG003|Maintenance Phase|Physician Decision|1|||
156765792|NCT01863771|565898527|FG000|Maintenance Phase|Pregnancy|0|||
156765793|NCT01863771|565898528|FG001|Maintenance Phase|Pregnancy|1|||
156765794|NCT01863771|565898529|FG002|Maintenance Phase|Pregnancy|0|||
156765795|NCT01863771|565898530|FG003|Maintenance Phase|Pregnancy|0|||
156765796|NCT01863771|565898527|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156765797|NCT01863771|565898528|FG001|Maintenance Phase|Withdrawal by Subject|1|||
156765798|NCT01863771|565898529|FG002|Maintenance Phase|Withdrawal by Subject|2|||
156765799|NCT01863771|565898530|FG003|Maintenance Phase|Withdrawal by Subject|3|||
156765800|NCT03636256|565898531|FG000|Overall Study|Lost to Follow-up|3|||
156765801|NCT03636256|565898532|FG001|Overall Study|Lost to Follow-up|0|||
156765802|NCT03636256|565898533|FG002|Overall Study|Lost to Follow-up|2|||
156765803|NCT03636256|565898534|FG003|Overall Study|Lost to Follow-up|1|||
156765804|NCT03636256|565898535|FG004|Overall Study|Lost to Follow-up|0|||
156765805|NCT03636256|565898536|FG005|Overall Study|Lost to Follow-up|4|||
156765806|NCT03636256|565898537|FG006|Overall Study|Lost to Follow-up|2|||
156765807|NCT03636256|565898538|FG007|Overall Study|Lost to Follow-up|0|||
156765808|NCT03636256|565898539|FG008|Overall Study|Lost to Follow-up|4|||
156765809|NCT03636256|565898531|FG000|Overall Study|Withdrawal by Subject|0|||
156765810|NCT03636256|565898532|FG001|Overall Study|Withdrawal by Subject|0|||
156765811|NCT03636256|565898533|FG002|Overall Study|Withdrawal by Subject|0|||
156765812|NCT03636256|565898534|FG003|Overall Study|Withdrawal by Subject|0|||
156765813|NCT03636256|565898535|FG004|Overall Study|Withdrawal by Subject|0|||
156765814|NCT03636256|565898536|FG005|Overall Study|Withdrawal by Subject|0|||
156765815|NCT03636256|565898537|FG006|Overall Study|Withdrawal by Subject|0|||
156765816|NCT03636256|565898538|FG007|Overall Study|Withdrawal by Subject|0|||
156765817|NCT03636256|565898539|FG008|Overall Study|Withdrawal by Subject|1|||
156765818|NCT01218308|565898540|FG000|Overall Study|Adverse Event|1|||
156765819|NCT01218308|565898541|FG001|Overall Study|Adverse Event|2|||
156765820|NCT01218308|565898540|FG000|Overall Study|Protocol Violation|0|||
156765821|NCT01218308|565898541|FG001|Overall Study|Protocol Violation|2|||
156765822|NCT01218308|565898540|FG000|Overall Study|Withdrawal by Subject|61|||
156765823|NCT01218308|565898541|FG001|Overall Study|Withdrawal by Subject|64|||
156765824|NCT01218308|565898540|FG000|Overall Study|Lost to Follow-up|27|||
156765825|NCT01218308|565898541|FG001|Overall Study|Lost to Follow-up|31|||
156765826|NCT01218308|565898540|FG000|Overall Study|Other|14|||
156765827|NCT01218308|565898541|FG001|Overall Study|Other|21|||
156765828|NCT00723229|565898542|FG000|First Intervention|Lost to Follow-up|7|||
156765829|NCT00723229|565898543|FG001|First Intervention|Lost to Follow-up|3|||
156765830|NCT02900352|565898544|FG000|Overall Study|Lost to Follow-up|28|||
156765831|NCT02900352|565898545|FG001|Overall Study|Lost to Follow-up|17|||
156765832|NCT00386334|565898548|FG000|Double Blind Period|Adverse Event|9|||
156765833|NCT00386334|565898549|FG001|Double Blind Period|Adverse Event|14|||
156765834|NCT00386334|565898548|FG000|Double Blind Period|Protocol Violation|1|||
156765835|NCT00386334|565898549|FG001|Double Blind Period|Protocol Violation|1|||
156765836|NCT00386334|565898548|FG000|Double Blind Period|Withdrawal by Subject|9|||
156765837|NCT00386334|565898549|FG001|Double Blind Period|Withdrawal by Subject|13|||
156765838|NCT00386334|565898548|FG000|Double Blind Period|Lack of Efficacy|20|||
156765839|NCT00386334|565898549|FG001|Double Blind Period|Lack of Efficacy|11|||
156765840|NCT00386334|565898548|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
156765841|NCT00386334|565898549|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
156765842|NCT00386334|565898548|FG000|Double Blind Period|Other|3|||
156765843|NCT00386334|565898549|FG001|Double Blind Period|Other|3|||
156765844|NCT00386334|565898548|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
156765845|NCT00386334|565898549|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
156765846|NCT00785356|565898550|FG000|Overall Study|Study prematurely terminated|8|||
156765847|NCT03238417|565898551|FG000|Overall|non-response|955|||
156765848|NCT03238417|565898552|FG001|Overall|non-response|1920|||
156765849|NCT03238417|565898551|FG000|Overall|partial completion|48|||
156765850|NCT03238417|565898552|FG001|Overall|partial completion|68|||
156765851|NCT03238417|565898551|FG000|Baseline|Partial completion|17|||
156765852|NCT03238417|565898552|FG001|Baseline|Partial completion|48|||
156765853|NCT03238417|565898551|FG000|Baseline|non-response|372|||
156765854|NCT03238417|565898552|FG001|Baseline|non-response|669|||
156765855|NCT03238417|565898551|FG000|12-month|non-response|296|||
156765856|NCT03238417|565898552|FG001|12-month|non-response|669|||
156765857|NCT03238417|565898551|FG000|12-month|partial completion|23|||
156765858|NCT03238417|565898552|FG001|12-month|partial completion|37|||
156765859|NCT03238417|565898551|FG000|24-month|non-response|287|||
156765860|NCT03238417|565898552|FG001|24-month|non-response|594|||
156765861|NCT03238417|565898551|FG000|24-month|partial completion|8|||
156765862|NCT03238417|565898552|FG001|24-month|partial completion|31|||
156765863|NCT00106002|565898553|FG000|Overall Study|Did not take any study drug|1|||
156765864|NCT00106002|565898553|FG000|Overall Study|Ineligible after Registration|1|||
156765865|NCT01122173|565898558|FG000|Overall Study|Lost to Follow-up|3|||
156765866|NCT01122173|565898558|FG000|Overall Study|Withdrawal by Subject|3|||
156765867|NCT01122173|565898558|FG000|Overall Study|Left study for other reasons|3|||
156765868|NCT04210986|565898560|FG000|Overall Study|Lost to Follow-up|5|||
156765869|NCT04210986|565898561|FG001|Overall Study|Lost to Follow-up|2|||
156765870|NCT04210986|565898560|FG000|Overall Study|Withdrawal by Subject|3|||
156765871|NCT04210986|565898561|FG001|Overall Study|Withdrawal by Subject|1|||
156765872|NCT04210986|565898560|FG000|Overall Study|Protocol Violation|1|||
156765873|NCT04210986|565898561|FG001|Overall Study|Protocol Violation|1|||
156765874|NCT04210986|565898560|FG000|Overall Study|Physician Decision|0|||
156765875|NCT04210986|565898561|FG001|Overall Study|Physician Decision|1|||
156765876|NCT02378662|565898562|FG000|Overall Study|Early Discontinuation|2|||
156765877|NCT02378662|565898563|FG001|Overall Study|Early Discontinuation|0|||
156765878|NCT02295644|565898564|FG000|Overall Study|Did not meet inclusion criterion|0|||
156765879|NCT02295644|565898565|FG001|Overall Study|Did not meet inclusion criterion|0|||
156765880|NCT02295644|565898566|FG002|Overall Study|Did not meet inclusion criterion|1|||
156765881|NCT02295644|565898567|FG003|Overall Study|Did not meet inclusion criterion|2|||
156765882|NCT03101020|565898568|FG000|Overall Study|Lack of time to participate|1|||
156765883|NCT03101020|565898569|FG001|Overall Study|Lack of time to participate|0|||
156765884|NCT03101020|565898568|FG000|Overall Study|Ran over by a car|0|||
156765885|NCT03101020|565898569|FG001|Overall Study|Ran over by a car|1|||
156765886|NCT03101020|565898568|FG000|Overall Study|Withdrawal by Subject|0|||
156765887|NCT03101020|565898569|FG001|Overall Study|Withdrawal by Subject|2|||
156765888|NCT02616783|565898570|FG000|Overall Study|Randomized but Not Treated|1|||
156765889|NCT02616783|565898571|FG001|Overall Study|Randomized but Not Treated|0|||
156765890|NCT02616783|565898570|FG000|Overall Study|Adverse Event|1|||
156765891|NCT02616783|565898571|FG001|Overall Study|Adverse Event|0|||
156765892|NCT02616783|565898570|FG000|Overall Study|Death|1|||
156765893|NCT02616783|565898571|FG001|Overall Study|Death|0|||
156765894|NCT02616783|565898570|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156765895|NCT02616783|565898571|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156765896|NCT02616783|565898570|FG000|Overall Study|Protocol Violation|1|||
156765897|NCT02616783|565898571|FG001|Overall Study|Protocol Violation|1|||
156765898|NCT02616783|565898570|FG000|Overall Study|Withdrew Consent|1|||
156765899|NCT02616783|565898571|FG001|Overall Study|Withdrew Consent|1|||
156765900|NCT01103323|565898572|FG000|Without/Before Drug Switch|Adverse Event|50|||
156765901|NCT01103323|565898573|FG001|Without/Before Drug Switch|Adverse Event|7|||
156765902|NCT01103323|565898572|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
156765903|NCT01103323|565898573|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
156765904|NCT01103323|565898572|FG000|Without/Before Drug Switch|Protocol Violation|2|||
156765905|NCT01103323|565898573|FG001|Without/Before Drug Switch|Protocol Violation|0|||
156765906|NCT01103323|565898572|FG000|Without/Before Drug Switch|Physician Decision|2|||
156765907|NCT01103323|565898573|FG001|Without/Before Drug Switch|Physician Decision|0|||
156765908|NCT01103323|565898572|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
156765909|NCT01103323|565898573|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
156765910|NCT01103323|565898572|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
156765911|NCT01103323|565898573|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
156765912|NCT01103323|565898572|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
156765913|NCT01103323|565898573|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
156765914|NCT00372424|565898574|FG000|Overall Study|Adverse Event|2|||
156765915|NCT00372424|565898574|FG000|Overall Study|Withdrawal by Subject|1|||
156765916|NCT00372424|565898574|FG000|Overall Study|Death|1|||
156765917|NCT00372424|565898574|FG000|Overall Study|Objective Progression or Relapse|14|||
156765918|NCT00372424|565898574|FG000|Overall Study|Other|7|||
156765919|NCT00372424|565898574|FG000|Overall Study|Enrolled, Not Treated|1|||
156765920|NCT05214118|565898583|FG000|Overall Study|Lost to Follow-up|0|||
156765921|NCT05214118|565898584|FG001|Overall Study|Lost to Follow-up|2|||
156765922|NCT05214118|565898583|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
156765923|NCT05214118|565898584|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
156765924|NCT05214118|565898583|FG000|Overall Study|moved|1|||
156765925|NCT05214118|565898584|FG001|Overall Study|moved|0|||
156765926|NCT03797898|565898587|FG000|Overall Study|Lost to Follow-up|60|||
156765927|NCT03797898|565898588|FG001|Overall Study|Lost to Follow-up|69|||
156765928|NCT03797898|565898587|FG000|Overall Study|Withdrawal by Subject|9|||
156765929|NCT03797898|565898588|FG001|Overall Study|Withdrawal by Subject|7|||
156765930|NCT03797898|565898587|FG000|Overall Study|Became ineligible|5|||
156765931|NCT03797898|565898588|FG001|Overall Study|Became ineligible|2|||
156765932|NCT02314728|565898589|FG000|Overall Study|Protocol Violation|1|||
156765933|NCT02314728|565898590|FG001|Overall Study|Protocol Violation|0|||
156765934|NCT02314728|565898589|FG000|Overall Study|Lost to Follow-up|0|||
156765935|NCT02314728|565898590|FG001|Overall Study|Lost to Follow-up|1|||
156765936|NCT03080935|565898591|FG000|Overall Study|Death|34|||
156765937|NCT03080935|565898592|FG001|Overall Study|Death|50|||
156765938|NCT03080935|565898591|FG000|Overall Study|Lost to Follow-up|5|||
156765939|NCT03080935|565898592|FG001|Overall Study|Lost to Follow-up|4|||
156765940|NCT03080935|565898591|FG000|Overall Study|Withdrawal by Subject|11|||
156765941|NCT03080935|565898592|FG001|Overall Study|Withdrawal by Subject|15|||
156765942|NCT03118934|565898593|FG000|Overall Study|Adverse Event|0|||
156765943|NCT03118934|565898594|FG001|Overall Study|Adverse Event|0|||
156765944|NCT03118934|565898595|FG002|Overall Study|Adverse Event|0|||
156765945|NCT03118934|565898596|FG003|Overall Study|Adverse Event|0|||
156765946|NCT03118934|565898597|FG004|Overall Study|Adverse Event|0|||
156765947|NCT03118934|565898598|FG005|Overall Study|Adverse Event|1|||
156765948|NCT03118934|565898593|FG000|Overall Study|Physician Decision|0|||
156765949|NCT03118934|565898594|FG001|Overall Study|Physician Decision|0|||
156765950|NCT03118934|565898595|FG002|Overall Study|Physician Decision|0|||
156765951|NCT03118934|565898596|FG003|Overall Study|Physician Decision|0|||
156765952|NCT03118934|565898597|FG004|Overall Study|Physician Decision|0|||
156765953|NCT03118934|565898598|FG005|Overall Study|Physician Decision|1|||
156765954|NCT03118934|565898593|FG000|Overall Study|Discontinued prior to exposure|0|||
156765955|NCT03118934|565898594|FG001|Overall Study|Discontinued prior to exposure|1|||
156765956|NCT03118934|565898595|FG002|Overall Study|Discontinued prior to exposure|1|||
156765957|NCT03118934|565898596|FG003|Overall Study|Discontinued prior to exposure|1|||
156765958|NCT03118934|565898597|FG004|Overall Study|Discontinued prior to exposure|2|||
156765959|NCT03118934|565898598|FG005|Overall Study|Discontinued prior to exposure|0|||
156765960|NCT01614470|565898599|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
156765961|NCT01614470|565898600|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156765962|NCT01614470|565898601|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156765963|NCT01614470|565898599|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
156765964|NCT01614470|565898600|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
156765965|NCT01614470|565898601|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
156765966|NCT03217591|565898602|FG000|Overall Study|Adverse Event|1|||
156765967|NCT03217591|565898603|FG001|Overall Study|Adverse Event|2|||
156765968|NCT03217591|565898604|FG002|Overall Study|Adverse Event|6|||
156765969|NCT03217591|565898602|FG000|Overall Study|Withdrawal by Subject|0|||
156765970|NCT03217591|565898603|FG001|Overall Study|Withdrawal by Subject|1|||
156765971|NCT03217591|565898604|FG002|Overall Study|Withdrawal by Subject|3|||
156765972|NCT03217591|565898602|FG000|Overall Study|Lost to Follow-up|1|||
156765973|NCT03217591|565898603|FG001|Overall Study|Lost to Follow-up|0|||
156765974|NCT03217591|565898604|FG002|Overall Study|Lost to Follow-up|0|||
156765975|NCT03217591|565898602|FG000|Overall Study|Protocol Violation|1|||
156765976|NCT03217591|565898603|FG001|Overall Study|Protocol Violation|0|||
156765977|NCT03217591|565898604|FG002|Overall Study|Protocol Violation|1|||
156765978|NCT00069264|565898619|FG000|Overall Study|Adverse Event|3|||
156765979|NCT00069264|565898619|FG000|Overall Study|Progressive Disease|23|||
156765980|NCT00069264|565898619|FG000|Overall Study|Withdrawal by Subject|3|||
156765981|NCT00069264|565898619|FG000|Overall Study|Discon Therapy|3|||
156765982|NCT04249427|565898622|FG000|Overall Study|Adverse Event|3|||
156765983|NCT04249427|565898623|FG001|Overall Study|Adverse Event|1|||
156765984|NCT04249427|565898622|FG000|Overall Study|Lack of Efficacy|0|||
156765985|NCT04249427|565898623|FG001|Overall Study|Lack of Efficacy|1|||
156765986|NCT04249427|565898622|FG000|Overall Study|Withdrawal by Subject|1|||
156765987|NCT04249427|565898623|FG001|Overall Study|Withdrawal by Subject|2|||
156765988|NCT02557399|565898624|FG000|Overall Study|Adverse Event|6|||
156765989|NCT02557399|565898625|FG001|Overall Study|Adverse Event|5|||
156765990|NCT02557399|565898624|FG000|Overall Study|Protocol Violation|0|||
156765991|NCT02557399|565898625|FG001|Overall Study|Protocol Violation|1|||
156426673|NCT00813488|564654697|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
156426674|NCT00813488|564654698|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
156426675|NCT00813488|564654697|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
156426676|NCT00813488|564654698|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
156426677|NCT00813488|564654697|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
156426678|NCT00813488|564654698|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
156426679|NCT00813488|564654697|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
156426680|NCT00813488|564654698|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
156426681|NCT00813488|564654697|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
156426682|NCT00813488|564654698|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
156426683|NCT00813488|564654697|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
156426684|NCT00813488|564654698|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
156426685|NCT00813488|564654697|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
156426686|NCT00813488|564654698|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
156426687|NCT00813488|564654697|FG000|Double-blind Treatment Period 2|Other|1|||
156426688|NCT00813488|564654698|FG001|Double-blind Treatment Period 2|Other|0|||
156426689|NCT00813488|564654697|FG000|Open-label Extension|Adverse Event|1|||
156426690|NCT00813488|564654698|FG001|Open-label Extension|Adverse Event|2|||
156426691|NCT00813488|564654697|FG000|Open-label Extension|Lack of Efficacy|3|||
156426692|NCT00813488|564654698|FG001|Open-label Extension|Lack of Efficacy|0|||
156426693|NCT00813488|564654697|FG000|Open-label Extension|Withdrawal by Subject|0|||
156426694|NCT00813488|564654698|FG001|Open-label Extension|Withdrawal by Subject|2|||
156426695|NCT00813488|564654697|FG000|Open-label Extension|Protocol Violation|1|||
156426696|NCT00813488|564654698|FG001|Open-label Extension|Protocol Violation|2|||
156426697|NCT00813488|564654697|FG000|Open-label Extension|Non-compliance study medication|4|||
156426698|NCT00813488|564654698|FG001|Open-label Extension|Non-compliance study medication|0|||
156426699|NCT00813488|564654697|FG000|Open-label Extension|Non-compliance study procedures|2|||
156426700|NCT00813488|564654698|FG001|Open-label Extension|Non-compliance study procedures|1|||
156426701|NCT00813488|564654697|FG000|Open-label Extension|Other|1|||
156426702|NCT00813488|564654698|FG001|Open-label Extension|Other|0|||
156426703|NCT02926937|564654699|FG000|Overall Study|Adverse Event|0|||
156426704|NCT02926937|564654700|FG001|Overall Study|Adverse Event|1|||
156426705|NCT02926937|564654701|FG002|Overall Study|Adverse Event|1|||
156426706|NCT02926937|564654699|FG000|Overall Study|Poor Compliance to Protocol|1|||
156426707|NCT02926937|564654700|FG001|Overall Study|Poor Compliance to Protocol|0|||
156322863|NCT02953509|564280281|FG009|Overall Study|Study terminated by sponsor|1|||
156322864|NCT01222403|564280284|FG000|Overall Study|Inappropriate enrollment|0|||
156322865|NCT01222403|564280285|FG001|Overall Study|Inappropriate enrollment|2|||
156322866|NCT02068768|564280287|FG000|Overall Study|Lost to Follow-up|5|||
156322867|NCT02068768|564280287|FG000|Overall Study|Early Termination by Sponsor|2|||
156322868|NCT01262352|564280288|FG000|Period 1|Illness after randomization|1|||
156426708|NCT02926937|564654701|FG002|Overall Study|Poor Compliance to Protocol|0|||
156765992|NCT02557399|565898624|FG000|Overall Study|Protocol-defined stopping criteria|0|||
156765993|NCT02557399|565898625|FG001|Overall Study|Protocol-defined stopping criteria|1|||
156765994|NCT02557399|565898624|FG000|Overall Study|Withdrawal by Subject|1|||
156765995|NCT02557399|565898625|FG001|Overall Study|Withdrawal by Subject|1|||
156765996|NCT02849080|565898627|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
156765997|NCT02849080|565898628|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
156322869|NCT01262352|564280289|FG001|Period 1|Illness after randomization|0|||
156322870|NCT01262352|564280288|FG000|Washout|Adverse Event|1|||
156322871|NCT01262352|564280289|FG001|Washout|Adverse Event|1|||
156426709|NCT02926937|564654699|FG000|Overall Study|Lost to Follow-up|4|||
156426710|NCT02926937|564654700|FG001|Overall Study|Lost to Follow-up|5|||
156426711|NCT02926937|564654701|FG002|Overall Study|Lost to Follow-up|0|||
156426712|NCT02926937|564654699|FG000|Overall Study|At the Participant's own Request|11|||
156765998|NCT02849080|565898629|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
156765999|NCT02849080|565898630|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
156766000|NCT02849080|565898627|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
156766001|NCT02849080|565898628|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
156766002|NCT02849080|565898629|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
156766003|NCT02849080|565898630|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
156426713|NCT02926937|564654700|FG001|Overall Study|At the Participant's own Request|5|||
156426714|NCT02926937|564654701|FG002|Overall Study|At the Participant's own Request|8|||
156426715|NCT02926937|564654699|FG000|Overall Study|Reason not Specified|3|||
156426716|NCT02926937|564654700|FG001|Overall Study|Reason not Specified|4|||
156426717|NCT02926937|564654701|FG002|Overall Study|Reason not Specified|2|||
156426718|NCT01559090|564654702|FG000|Stage I|Withdrawal by Subject|2|||
156426719|NCT01559090|564654703|FG001|Stage I|Withdrawal by Subject|2|||
156426720|NCT01559090|564654704|FG002|Stage I|Withdrawal by Subject|3|||
156426721|NCT01559090|564654702|FG000|Stage II|Withdrawal by Subject|1|||
156426722|NCT01559090|564654703|FG001|Stage II|Withdrawal by Subject|0|||
156426723|NCT01559090|564654704|FG002|Stage II|Withdrawal by Subject|0|||
156426724|NCT01729871|564654708|FG000|Overall Study|Adverse Event|7|||
156426725|NCT01729871|564654709|FG001|Overall Study|Adverse Event|7|||
156426726|NCT01729871|564654708|FG000|Overall Study|Death|0|||
156426727|NCT01729871|564654709|FG001|Overall Study|Death|1|||
156426728|NCT01729871|564654708|FG000|Overall Study|Lack of Efficacy|0|||
156426729|NCT01729871|564654709|FG001|Overall Study|Lack of Efficacy|1|||
156426730|NCT01729871|564654708|FG000|Overall Study|Physician Decision|0|||
156426731|NCT01729871|564654709|FG001|Overall Study|Physician Decision|2|||
156426732|NCT01729871|564654708|FG000|Overall Study|Protocol Violation|1|||
156426733|NCT01729871|564654709|FG001|Overall Study|Protocol Violation|0|||
156426734|NCT01729871|564654708|FG000|Overall Study|Withdrawal by Subject|0|||
156426735|NCT01729871|564654709|FG001|Overall Study|Withdrawal by Subject|3|||
156426736|NCT01729871|564654708|FG000|Overall Study|Other|4|||
156426737|NCT01729871|564654709|FG001|Overall Study|Other|9|||
156426738|NCT01333514|564654710|FG000|Overall Study|Withdrawal by Subject|1|||
156426739|NCT01333514|564654711|FG001|Overall Study|Withdrawal by Subject|0|||
156426740|NCT00871429|564654712|FG000|Overall Study|Lost to Follow-up|6|||
156426741|NCT00871429|564654712|FG000|Overall Study|Withdrawal by Subject|17|||
156766004|NCT02849080|565898627|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
156766005|NCT02849080|565898628|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
156426742|NCT00871429|564654712|FG000|Overall Study|Questionnaire not completed|1|||
156426743|NCT03102242|564654713|FG000|Overall Study|Adverse Event|2|||
156426744|NCT00477412|564654714|FG000|Overall Study|Death|0|||
156426745|NCT00477412|564654715|FG001|Overall Study|Death|0|||
156426746|NCT00477412|564654716|FG002|Overall Study|Death|0|||
156426747|NCT00477412|564654717|FG003|Overall Study|Death|4|||
156426748|NCT00477412|564654714|FG000|Overall Study|Lost to Follow-up|0|||
156426749|NCT00477412|564654715|FG001|Overall Study|Lost to Follow-up|0|||
156766006|NCT02849080|565898629|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
156766007|NCT02849080|565898630|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
156766008|NCT02849080|565898627|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
156766009|NCT02849080|565898628|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
156766010|NCT02849080|565898629|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
156766011|NCT02849080|565898630|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
156766012|NCT02849080|565898627|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
156766013|NCT02849080|565898628|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
156766014|NCT02849080|565898629|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
156766015|NCT02849080|565898630|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
156766016|NCT02849080|565898627|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
156766017|NCT02849080|565898628|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
156766018|NCT02849080|565898629|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
156766019|NCT02849080|565898630|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
156766020|NCT00449163|565898633|FG000|Overall Study|Physician Decision|3|||
156426750|NCT00477412|564654716|FG002|Overall Study|Lost to Follow-up|0|||
156426751|NCT00477412|564654717|FG003|Overall Study|Lost to Follow-up|1|||
156766021|NCT03368807|565898646|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
156766022|NCT03368807|565898646|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
156426752|NCT00477412|564654714|FG000|Overall Study|Withdrawal by Subject|0|||
156426753|NCT00477412|564654715|FG001|Overall Study|Withdrawal by Subject|0|||
156766023|NCT03368807|565898646|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
156766024|NCT03368807|565898646|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
156426754|NCT00477412|564654716|FG002|Overall Study|Withdrawal by Subject|0|||
156426755|NCT00477412|564654717|FG003|Overall Study|Withdrawal by Subject|2|||
156426756|NCT00477412|564654714|FG000|Overall Study|Second Malignancy|0|||
156426757|NCT00477412|564654715|FG001|Overall Study|Second Malignancy|0|||
156426758|NCT00477412|564654716|FG002|Overall Study|Second Malignancy|0|||
156426759|NCT00477412|564654717|FG003|Overall Study|Second Malignancy|1|||
156766025|NCT00369343|565898661|FG000|Double-blind Phase|Adverse Event|19|||
156766026|NCT00369343|565898662|FG001|Double-blind Phase|Adverse Event|4|||
156766027|NCT00369343|565898661|FG000|Double-blind Phase|Failed to return|2|||
156766028|NCT00369343|565898662|FG001|Double-blind Phase|Failed to return|0|||
156766029|NCT00369343|565898661|FG000|Double-blind Phase|Lost to Follow-up|9|||
156766030|NCT00369343|565898662|FG001|Double-blind Phase|Lost to Follow-up|2|||
156766031|NCT00369343|565898661|FG000|Double-blind Phase|Protocol Violation|2|||
156766032|NCT00369343|565898662|FG001|Double-blind Phase|Protocol Violation|0|||
156766033|NCT00369343|565898661|FG000|Double-blind Phase|Withdrawal by Subject|8|||
156766034|NCT00369343|565898662|FG001|Double-blind Phase|Withdrawal by Subject|6|||
156766035|NCT00369343|565898661|FG000|Double-blind Phase|Lack of Efficacy|0|||
156766036|NCT00369343|565898662|FG001|Double-blind Phase|Lack of Efficacy|4|||
156766037|NCT00369343|565898661|FG000|Double-blind Phase|Protocol deviation|4|||
156766038|NCT00369343|565898662|FG001|Double-blind Phase|Protocol deviation|0|||
156766039|NCT00369343|565898661|FG000|Open-label Phase|Adverse Event|19|||
156766040|NCT00369343|565898662|FG001|Open-label Phase|Adverse Event|7|||
156766041|NCT00369343|565898661|FG000|Open-label Phase|Failed to return|4|||
156766042|NCT00369343|565898662|FG001|Open-label Phase|Failed to return|0|||
156766043|NCT00369343|565898661|FG000|Open-label Phase|Physician Decision|2|||
156766044|NCT00369343|565898662|FG001|Open-label Phase|Physician Decision|0|||
156766045|NCT00369343|565898661|FG000|Open-label Phase|Lost to Follow-up|5|||
156766046|NCT00369343|565898662|FG001|Open-label Phase|Lost to Follow-up|3|||
156766047|NCT00369343|565898661|FG000|Open-label Phase|inadvertently reported study completers|3|||
156766048|NCT00369343|565898662|FG001|Open-label Phase|inadvertently reported study completers|2|||
156766049|NCT00369343|565898661|FG000|Open-label Phase|Protocol Violation|1|||
156766050|NCT00369343|565898662|FG001|Open-label Phase|Protocol Violation|3|||
156766051|NCT00369343|565898661|FG000|Open-label Phase|Withdrawal by Subject|15|||
156766052|NCT00369343|565898662|FG001|Open-label Phase|Withdrawal by Subject|6|||
156766053|NCT00369343|565898661|FG000|Open-label Phase|Lack of Efficacy|4|||
156766054|NCT00369343|565898662|FG001|Open-label Phase|Lack of Efficacy|3|||
156766055|NCT00369343|565898661|FG000|Open-label Phase|Lack of continuance tolerability|3|||
156655770|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
156655771|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
156655772|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
156655773|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
156426760|NCT00477412|564654714|FG000|Overall Study|Adverse Event|1|||
156426761|NCT00477412|564654715|FG001|Overall Study|Adverse Event|0|||
156426762|NCT00477412|564654716|FG002|Overall Study|Adverse Event|1|||
156426763|NCT00477412|564654717|FG003|Overall Study|Adverse Event|0|||
156426764|NCT02501811|564654719|FG000|Overall Study|Death|1|||
156426765|NCT02501811|564654720|FG001|Overall Study|Death|3|||
156426766|NCT02501811|564654721|FG002|Overall Study|Death|2|||
156426767|NCT02501811|564654722|FG003|Overall Study|Death|3|||
156655774|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
156655775|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
156766056|NCT00369343|565898662|FG001|Open-label Phase|Lack of continuance tolerability|4|||
156766057|NCT00369343|565898661|FG000|Open-label Phase|did not take study drug|1|||
156655776|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
156655777|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
156655778|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
156655779|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
156655780|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
156655781|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
156655782|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
156655783|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
156655784|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
156655785|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
156655786|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
156655787|NCT00455533|565485844|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
156655788|NCT00455533|565485845|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
156766058|NCT00369343|565898662|FG001|Open-label Phase|did not take study drug|2|||
156766059|NCT02949947|565898663|FG000|Overall Study|Non Compliance|0|||
156766060|NCT02949947|565898664|FG001|Overall Study|Non Compliance|1|||
156766061|NCT02949947|565898663|FG000|Overall Study|Insurance change|1|||
156766062|NCT02949947|565898664|FG001|Overall Study|Insurance change|0|||
156766063|NCT01973218|565898667|FG000|Overall Study|Adverse Event|1|||
156766064|NCT01973218|565898668|FG001|Overall Study|Adverse Event|0|||
156766065|NCT01973218|565898667|FG000|Overall Study|Withdrawal by Subject|1|||
156766066|NCT01973218|565898668|FG001|Overall Study|Withdrawal by Subject|0|||
156766067|NCT02247466|565898669|FG000|Overall Study|Procedure changed to open surgery|0|||
156766068|NCT02247466|565898670|FG001|Overall Study|Procedure changed to open surgery|3|||
156426768|NCT02501811|564654719|FG000|Overall Study|Withdrawal by Subject|3|||
156426769|NCT02501811|564654720|FG001|Overall Study|Withdrawal by Subject|3|||
156426770|NCT02501811|564654721|FG002|Overall Study|Withdrawal by Subject|2|||
156655789|NCT00455533|565485846|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
156655790|NCT00455533|565485844|FG000|Period Two: Randomized Period|Death|0|||
156655791|NCT00455533|565485845|FG001|Period Two: Randomized Period|Death|0|||
156655792|NCT00455533|565485846|FG002|Period Two: Randomized Period|Death|3|||
156655793|NCT00455533|565485844|FG000|Period Two: Randomized Period|Disease Progression|0|||
156655794|NCT00455533|565485845|FG001|Period Two: Randomized Period|Disease Progression|1|||
156655795|NCT00455533|565485846|FG002|Period Two: Randomized Period|Disease Progression|1|||
156655796|NCT00455533|565485844|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
156655797|NCT00455533|565485845|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
156655798|NCT00455533|565485846|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
156655799|NCT00455533|565485844|FG000|Period Two: Randomized Period|Other - need reasons|0|||
156655800|NCT00455533|565485845|FG001|Period Two: Randomized Period|Other - need reasons|1|||
156655801|NCT00455533|565485846|FG002|Period Two: Randomized Period|Other - need reasons|0|||
156655802|NCT00455533|565485844|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
156655803|NCT00455533|565485845|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
156655804|NCT00455533|565485846|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
156655805|NCT00455533|565485844|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
156655806|NCT00455533|565485845|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
156655807|NCT00455533|565485846|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
156655808|NCT04634409|565485849|FG000|Overall Study|Death|0|||
156655809|NCT04634409|565485850|FG001|Overall Study|Death|0|||
156655810|NCT04634409|565485851|FG002|Overall Study|Death|0|||
156655811|NCT04634409|565485852|FG003|Overall Study|Death|0|||
156655812|NCT04634409|565485853|FG004|Overall Study|Death|0|||
156655813|NCT04634409|565485854|FG005|Overall Study|Death|0|||
156655814|NCT04634409|565485855|FG006|Overall Study|Death|0|||
156655815|NCT04634409|565485856|FG007|Overall Study|Death|0|||
156655816|NCT04634409|565485857|FG008|Overall Study|Death|0|||
156655817|NCT04634409|565485858|FG009|Overall Study|Death|0|||
156655818|NCT04634409|565485859|FG010|Overall Study|Death|1|||
156655819|NCT04634409|565485860|FG011|Overall Study|Death|0|||
156655820|NCT04634409|565485861|FG012|Overall Study|Death|1|||
156655821|NCT04634409|565485862|FG013|Overall Study|Death|0|||
156655822|NCT04634409|565485863|FG014|Overall Study|Death|0|||
156655823|NCT04634409|565485864|FG015|Overall Study|Death|0|||
156655824|NCT04634409|565485865|FG016|Overall Study|Death|0|||
156655825|NCT04634409|565485866|FG017|Overall Study|Death|0|||
156655826|NCT04634409|565485867|FG018|Overall Study|Death|0|||
156655827|NCT04634409|565485868|FG019|Overall Study|Death|0|||
156655828|NCT04634409|565485869|FG020|Overall Study|Death|0|||
156655829|NCT04634409|565485870|FG021|Overall Study|Death|0|||
156655830|NCT04634409|565485871|FG022|Overall Study|Death|0|||
156655831|NCT04634409|565485872|FG023|Overall Study|Death|0|||
156655832|NCT04634409|565485873|FG024|Overall Study|Death|0|||
156655833|NCT04634409|565485874|FG025|Overall Study|Death|0|||
156655834|NCT04634409|565485875|FG026|Overall Study|Death|0|||
156655835|NCT04634409|565485849|FG000|Overall Study|Adverse Event|0|||
156655836|NCT04634409|565485850|FG001|Overall Study|Adverse Event|0|||
156655837|NCT04634409|565485851|FG002|Overall Study|Adverse Event|1|||
156655838|NCT04634409|565485852|FG003|Overall Study|Adverse Event|0|||
156655839|NCT04634409|565485853|FG004|Overall Study|Adverse Event|0|||
156655840|NCT04634409|565485854|FG005|Overall Study|Adverse Event|1|||
156655841|NCT04634409|565485855|FG006|Overall Study|Adverse Event|0|||
156655842|NCT04634409|565485856|FG007|Overall Study|Adverse Event|0|||
156655843|NCT04634409|565485857|FG008|Overall Study|Adverse Event|0|||
156655844|NCT04634409|565485858|FG009|Overall Study|Adverse Event|0|||
156655845|NCT04634409|565485859|FG010|Overall Study|Adverse Event|0|||
156655846|NCT04634409|565485860|FG011|Overall Study|Adverse Event|0|||
156655847|NCT04634409|565485861|FG012|Overall Study|Adverse Event|0|||
156655848|NCT04634409|565485862|FG013|Overall Study|Adverse Event|0|||
156655849|NCT04634409|565485863|FG014|Overall Study|Adverse Event|0|||
156655850|NCT04634409|565485864|FG015|Overall Study|Adverse Event|0|||
156655851|NCT04634409|565485865|FG016|Overall Study|Adverse Event|0|||
156655852|NCT04634409|565485866|FG017|Overall Study|Adverse Event|0|||
156655853|NCT04634409|565485867|FG018|Overall Study|Adverse Event|0|||
156655854|NCT04634409|565485868|FG019|Overall Study|Adverse Event|0|||
156655855|NCT04634409|565485869|FG020|Overall Study|Adverse Event|0|||
156655856|NCT04634409|565485870|FG021|Overall Study|Adverse Event|0|||
156655857|NCT04634409|565485871|FG022|Overall Study|Adverse Event|0|||
156655858|NCT04634409|565485872|FG023|Overall Study|Adverse Event|0|||
156655859|NCT04634409|565485873|FG024|Overall Study|Adverse Event|0|||
156655860|NCT04634409|565485874|FG025|Overall Study|Adverse Event|0|||
156655861|NCT04634409|565485875|FG026|Overall Study|Adverse Event|0|||
156655862|NCT04634409|565485849|FG000|Overall Study|Lost to Follow-up|3|||
156655863|NCT04634409|565485850|FG001|Overall Study|Lost to Follow-up|1|||
156655864|NCT04634409|565485851|FG002|Overall Study|Lost to Follow-up|1|||
156655865|NCT04634409|565485852|FG003|Overall Study|Lost to Follow-up|3|||
156655866|NCT04634409|565485853|FG004|Overall Study|Lost to Follow-up|1|||
156655867|NCT04634409|565485854|FG005|Overall Study|Lost to Follow-up|1|||
156766069|NCT00492726|565898671|FG000|Overall Study|Adverse Event|10|||
156766070|NCT00492726|565898672|FG001|Overall Study|Adverse Event|6|||
156766071|NCT00492726|565898671|FG000|Overall Study|Death|7|||
156766072|NCT00492726|565898672|FG001|Overall Study|Death|2|||
156766073|NCT00492726|565898671|FG000|Overall Study|Lack of Efficacy|0|||
156766074|NCT00492726|565898672|FG001|Overall Study|Lack of Efficacy|2|||
156766075|NCT00492726|565898671|FG000|Overall Study|Lost to Follow-up|27|||
156766076|NCT00492726|565898672|FG001|Overall Study|Lost to Follow-up|19|||
156766077|NCT00492726|565898671|FG000|Overall Study|Physician Decision|0|||
156766078|NCT00492726|565898672|FG001|Overall Study|Physician Decision|1|||
156766079|NCT00492726|565898671|FG000|Overall Study|Withdrawal by Subject|6|||
156766080|NCT00492726|565898672|FG001|Overall Study|Withdrawal by Subject|3|||
156766081|NCT00492726|565898671|FG000|Overall Study|Non compliant with study medication|0|||
156766082|NCT00492726|565898672|FG001|Overall Study|Non compliant with study medication|3|||
156766083|NCT04386902|565898673|FG000|Overall Study|Withdrawal by Subject|5|||
156766084|NCT04386902|565898673|FG000|Overall Study|Technical problems in the recording|5|||
156766085|NCT01100502|565898674|FG000|Overall Study|Withdrawal by Subject|18|||
156766086|NCT01100502|565898675|FG001|Overall Study|Withdrawal by Subject|25|||
156766087|NCT01100502|565898674|FG000|Overall Study|Lost to Follow-up|13|||
156766088|NCT01100502|565898675|FG001|Overall Study|Lost to Follow-up|28|||
156766089|NCT01100502|565898674|FG000|Overall Study|Site request to end participation in study|0|||
156766090|NCT01100502|565898675|FG001|Overall Study|Site request to end participation in study|1|||
156766091|NCT01100502|565898674|FG000|Overall Study|Death|45|||
156766092|NCT01100502|565898675|FG001|Overall Study|Death|40|||
156766093|NCT04356937|565898678|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
156766094|NCT04356937|565898679|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
156766095|NCT00960804|565898680|FG000|Overall Study|Adverse Event|1|||
156766096|NCT00960804|565898681|FG001|Overall Study|Adverse Event|0|||
156766097|NCT00960804|565898682|FG002|Overall Study|Adverse Event|0|||
156766098|NCT00960804|565898680|FG000|Overall Study|Withdrawal by Subject|1|||
156766099|NCT00960804|565898681|FG001|Overall Study|Withdrawal by Subject|0|||
156766100|NCT00960804|565898682|FG002|Overall Study|Withdrawal by Subject|0|||
156766101|NCT00960804|565898680|FG000|Overall Study|Study terminated by the sponsor|5|||
156426771|NCT02501811|564654722|FG003|Overall Study|Withdrawal by Subject|3|||
156426772|NCT02501811|564654719|FG000|Overall Study|Lost to Follow-up|0|||
156426773|NCT02501811|564654720|FG001|Overall Study|Lost to Follow-up|0|||
156426774|NCT02501811|564654721|FG002|Overall Study|Lost to Follow-up|2|||
156426775|NCT02501811|564654722|FG003|Overall Study|Lost to Follow-up|1|||
156426776|NCT00662909|564654723|FG000|Overall Study|Adverse Event|17|||
156426777|NCT00662909|564654724|FG001|Overall Study|Adverse Event|18|||
156426778|NCT00662909|564654725|FG002|Overall Study|Adverse Event|19|||
156766102|NCT00960804|565898681|FG001|Overall Study|Study terminated by the sponsor|4|||
156426779|NCT00662909|564654723|FG000|Overall Study|Lack of Efficacy|9|||
156426780|NCT00662909|564654724|FG001|Overall Study|Lack of Efficacy|1|||
156426781|NCT00662909|564654725|FG002|Overall Study|Lack of Efficacy|5|||
156426782|NCT00662909|564654723|FG000|Overall Study|Withdrawal by Subject|29|||
156426783|NCT00662909|564654724|FG001|Overall Study|Withdrawal by Subject|22|||
156426784|NCT00662909|564654725|FG002|Overall Study|Withdrawal by Subject|16|||
156426785|NCT00662909|564654723|FG000|Overall Study|Lost to Follow-up|2|||
156426786|NCT00662909|564654724|FG001|Overall Study|Lost to Follow-up|9|||
156426787|NCT00662909|564654725|FG002|Overall Study|Lost to Follow-up|3|||
156426788|NCT00662909|564654723|FG000|Overall Study|Protocol Violation|7|||
156426789|NCT00662909|564654724|FG001|Overall Study|Protocol Violation|4|||
156426790|NCT00662909|564654725|FG002|Overall Study|Protocol Violation|5|||
156766103|NCT00960804|565898682|FG002|Overall Study|Study terminated by the sponsor|10|||
156766104|NCT01190891|565900382|FG000|Overall Study|Protocol Violation|1|||
156766105|NCT01190891|565900383|FG001|Overall Study|Protocol Violation|0|||
156766106|NCT01190891|565900382|FG000|Overall Study|Withdrawal by Subject|5|||
156766107|NCT01190891|565900383|FG001|Overall Study|Withdrawal by Subject|0|||
156766108|NCT01926028|565900384|FG000|Overall Study|Lost to Follow-up|7|||
156322872|NCT01262352|564280288|FG000|Washout|Extended Washout|0|||
156322873|NCT01262352|564280289|FG001|Washout|Extended Washout|1|||
156322874|NCT00913692|564280291|FG000|Screening (4 Months)|Physician Decision|3|||
156322875|NCT00913692|564280291|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
156322876|NCT00913692|564280291|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
156322877|NCT02925793|564280292|FG000|Overall Study|Adverse Event|3|||
156322878|NCT02925793|564280293|FG001|Overall Study|Adverse Event|3|||
156426791|NCT00662909|564654723|FG000|Overall Study|Randomized- never received study drug|1|||
156426792|NCT00662909|564654724|FG001|Overall Study|Randomized- never received study drug|0|||
156766109|NCT01926028|565900385|FG001|Overall Study|Lost to Follow-up|6|||
156766110|NCT01926028|565900386|FG002|Overall Study|Lost to Follow-up|0|||
156766111|NCT01926028|565900384|FG000|Overall Study|Physician Decision|1|||
156766112|NCT01926028|565900385|FG001|Overall Study|Physician Decision|5|||
156322879|NCT02925793|564280294|FG002|Overall Study|Adverse Event|6|||
156322880|NCT02925793|564280292|FG000|Overall Study|Withdrawal by Subject|16|||
156322881|NCT02925793|564280293|FG001|Overall Study|Withdrawal by Subject|15|||
156322882|NCT02925793|564280294|FG002|Overall Study|Withdrawal by Subject|13|||
156766113|NCT01926028|565900386|FG002|Overall Study|Physician Decision|0|||
156766114|NCT01926028|565900384|FG000|Overall Study|Withdrawal by Subject|9|||
156766115|NCT01926028|565900385|FG001|Overall Study|Withdrawal by Subject|9|||
156766116|NCT01926028|565900386|FG002|Overall Study|Withdrawal by Subject|2|||
156766117|NCT01926028|565900384|FG000|Overall Study|Non compliance or other reasons|4|||
156766118|NCT01926028|565900385|FG001|Overall Study|Non compliance or other reasons|2|||
156426793|NCT00662909|564654725|FG002|Overall Study|Randomized- never received study drug|0|||
156426794|NCT00662909|564654723|FG000|Overall Study|Non-compliance with study procedures|3|||
156426795|NCT00662909|564654724|FG001|Overall Study|Non-compliance with study procedures|3|||
156426796|NCT00662909|564654725|FG002|Overall Study|Non-compliance with study procedures|2|||
156426797|NCT00662909|564654723|FG000|Overall Study|Physician Decision|1|||
156426798|NCT00662909|564654724|FG001|Overall Study|Physician Decision|1|||
156426799|NCT00662909|564654725|FG002|Overall Study|Physician Decision|2|||
156426800|NCT00662909|564654723|FG000|Overall Study|Eligibility criterion not met|0|||
156426801|NCT00662909|564654724|FG001|Overall Study|Eligibility criterion not met|1|||
156426802|NCT00662909|564654725|FG002|Overall Study|Eligibility criterion not met|1|||
156426803|NCT01875250|564656427|FG000|Overall Study|Adverse Event|2|||
156426804|NCT01875250|564656428|FG001|Overall Study|Adverse Event|0|||
156426805|NCT00661778|564656429|FG000|Overall Study|Disease Progression|23|||
156426806|NCT00661778|564656429|FG000|Overall Study|Adverse Event|18|||
156426807|NCT00661778|564656429|FG000|Overall Study|Reason not Specified|6|||
156426808|NCT00661778|564656429|FG000|Overall Study|Protocol Violation|2|||
156426809|NCT00661778|564656429|FG000|Overall Study|Withdrawal of Consent|1|||
156426810|NCT05298111|564656434|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
156426811|NCT05298111|564656435|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
156426812|NCT02001623|564656445|FG000|Overall Study|Disease Progression|2|||
156426813|NCT02001623|564656446|FG001|Overall Study|Disease Progression|2|||
156426814|NCT02001623|564656447|FG002|Overall Study|Disease Progression|3|||
156426815|NCT02001623|564656448|FG003|Overall Study|Disease Progression|2|||
156426816|NCT02001623|564656449|FG004|Overall Study|Disease Progression|3|||
156426817|NCT02001623|564656450|FG005|Overall Study|Disease Progression|2|||
156426818|NCT02001623|564656451|FG006|Overall Study|Disease Progression|3|||
156426819|NCT02001623|564656452|FG007|Overall Study|Disease Progression|3|||
156766119|NCT01926028|565900386|FG002|Overall Study|Non compliance or other reasons|0|||
156766120|NCT04635839|565900387|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
156766121|NCT04635839|565900388|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
156766122|NCT02669849|565900394|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
156766123|NCT02669849|565900395|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
156766124|NCT02669849|565900396|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
156426820|NCT02001623|564656453|FG008|Overall Study|Disease Progression|7|||
156426821|NCT02001623|564656454|FG009|Overall Study|Disease Progression|40|||
156426822|NCT02001623|564656455|FG010|Overall Study|Disease Progression|5|||
156426823|NCT02001623|564656456|FG011|Overall Study|Disease Progression|9|||
156426824|NCT02001623|564656457|FG012|Overall Study|Disease Progression|9|||
156426825|NCT02001623|564656458|FG013|Overall Study|Disease Progression|20|||
156426826|NCT02001623|564656459|FG014|Overall Study|Disease Progression|9|||
156426827|NCT02001623|564656445|FG000|Overall Study|Physician Decision|0|||
156426828|NCT02001623|564656446|FG001|Overall Study|Physician Decision|0|||
156426829|NCT02001623|564656447|FG002|Overall Study|Physician Decision|0|||
156426830|NCT02001623|564656448|FG003|Overall Study|Physician Decision|0|||
156426831|NCT02001623|564656449|FG004|Overall Study|Physician Decision|0|||
156426832|NCT02001623|564656450|FG005|Overall Study|Physician Decision|0|||
156426833|NCT02001623|564656451|FG006|Overall Study|Physician Decision|0|||
156426834|NCT02001623|564656452|FG007|Overall Study|Physician Decision|0|||
156426835|NCT02001623|564656453|FG008|Overall Study|Physician Decision|3|||
156426836|NCT02001623|564656454|FG009|Overall Study|Physician Decision|2|||
156426837|NCT02001623|564656455|FG010|Overall Study|Physician Decision|3|||
156426838|NCT02001623|564656456|FG011|Overall Study|Physician Decision|3|||
156426839|NCT02001623|564656457|FG012|Overall Study|Physician Decision|1|||
156426840|NCT02001623|564656458|FG013|Overall Study|Physician Decision|2|||
156426841|NCT02001623|564656459|FG014|Overall Study|Physician Decision|1|||
156426842|NCT02001623|564656445|FG000|Overall Study|Death|0|||
156426843|NCT02001623|564656446|FG001|Overall Study|Death|1|||
156426844|NCT02001623|564656447|FG002|Overall Study|Death|0|||
156426845|NCT02001623|564656448|FG003|Overall Study|Death|0|||
156426846|NCT02001623|564656449|FG004|Overall Study|Death|0|||
156426847|NCT02001623|564656450|FG005|Overall Study|Death|0|||
156426848|NCT02001623|564656451|FG006|Overall Study|Death|0|||
156426849|NCT02001623|564656452|FG007|Overall Study|Death|0|||
156426850|NCT02001623|564656453|FG008|Overall Study|Death|0|||
156426851|NCT02001623|564656454|FG009|Overall Study|Death|0|||
156766125|NCT02669849|565900394|FG000|Overall Study|Lost to Follow-up|1|||
156426852|NCT02001623|564656455|FG010|Overall Study|Death|0|||
156426853|NCT02001623|564656456|FG011|Overall Study|Death|0|||
156426854|NCT02001623|564656457|FG012|Overall Study|Death|0|||
156426855|NCT02001623|564656458|FG013|Overall Study|Death|0|||
156426856|NCT02001623|564656459|FG014|Overall Study|Death|0|||
156426857|NCT02001623|564656445|FG000|Overall Study|Adverse Event|0|||
156426858|NCT02001623|564656446|FG001|Overall Study|Adverse Event|0|||
156766126|NCT02669849|565900395|FG001|Overall Study|Lost to Follow-up|0|||
156766127|NCT02669849|565900396|FG002|Overall Study|Lost to Follow-up|3|||
156766128|NCT02669849|565900394|FG000|Overall Study|Death|1|||
156766129|NCT02669849|565900395|FG001|Overall Study|Death|1|||
156766130|NCT02669849|565900396|FG002|Overall Study|Death|2|||
156766131|NCT02669849|565900394|FG000|Overall Study|Study terminated by sponsor|16|||
156766132|NCT02669849|565900395|FG001|Overall Study|Study terminated by sponsor|1|||
156766133|NCT02669849|565900396|FG002|Overall Study|Study terminated by sponsor|14|||
156766134|NCT02669849|565900394|FG000|Overall Study|Other|0|||
156766135|NCT02669849|565900395|FG001|Overall Study|Other|0|||
156766136|NCT02669849|565900396|FG002|Overall Study|Other|2|||
156766137|NCT03408899|565900397|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
156766138|NCT00606008|565900398|FG000|Overall Study|Adverse Event|1|||
156766139|NCT00606008|565900398|FG000|Overall Study|Withdrawal by Subject|4|||
156766140|NCT04745351|565900399|FG000|Overall Study|Death|51|||
156766141|NCT04745351|565900400|FG001|Overall Study|Death|25|||
156766142|NCT04745351|565900399|FG000|Overall Study|Lost to Follow-up|9|||
156766143|NCT04745351|565900400|FG001|Overall Study|Lost to Follow-up|3|||
156766144|NCT04745351|565900399|FG000|Overall Study|Randomized but Never Treated|3|||
156766145|NCT04745351|565900400|FG001|Overall Study|Randomized but Never Treated|3|||
156766146|NCT04745351|565900399|FG000|Overall Study|Adverse Event|4|||
156766147|NCT04745351|565900400|FG001|Overall Study|Adverse Event|0|||
156766148|NCT04745351|565900399|FG000|Overall Study|Withdrew Consent|1|||
156766149|NCT04745351|565900400|FG001|Overall Study|Withdrew Consent|2|||
156766150|NCT04745351|565900399|FG000|Overall Study|Investigator's Discretion|2|||
156766151|NCT04745351|565900400|FG001|Overall Study|Investigator's Discretion|0|||
156766152|NCT04745351|565900399|FG000|Overall Study|Protocol Violation|1|||
156766153|NCT04745351|565900400|FG001|Overall Study|Protocol Violation|0|||
156766154|NCT02426684|565900401|FG000|Overall Study|Physician Decision|1|||
156766155|NCT01587885|565900404|FG000|Treatment Period 1|Failure to Return|0|||
156766156|NCT01587885|565900405|FG001|Treatment Period 1|Failure to Return|1|||
156766157|NCT01587885|565900404|FG000|Treatment Period 1|Protocol Violation|0|||
156766158|NCT01587885|565900405|FG001|Treatment Period 1|Protocol Violation|2|||
156766159|NCT00977197|565900406|FG000|Overall Study|Withdrawal by Subject|3|||
156766160|NCT00977197|565900407|FG001|Overall Study|Withdrawal by Subject|4|||
156766161|NCT00977197|565900406|FG000|Overall Study|Adverse Event|3|||
156766162|NCT00977197|565900407|FG001|Overall Study|Adverse Event|1|||
156766163|NCT00977197|565900406|FG000|Overall Study|Lack of Efficacy|1|||
156766164|NCT00977197|565900407|FG001|Overall Study|Lack of Efficacy|0|||
156766165|NCT00977197|565900406|FG000|Overall Study|Lost to Follow-up|1|||
156766166|NCT00977197|565900407|FG001|Overall Study|Lost to Follow-up|3|||
156766167|NCT00977197|565900406|FG000|Overall Study|Nonadherence|1|||
156766168|NCT00977197|565900407|FG001|Overall Study|Nonadherence|1|||
156766169|NCT02265510|565900408|FG000|Overall Study|Withdrawal by Subject|1|||
156766170|NCT02265510|565900409|FG001|Overall Study|Withdrawal by Subject|1|||
156766171|NCT02265510|565900410|FG002|Overall Study|Withdrawal by Subject|2|||
156766172|NCT02265510|565900411|FG003|Overall Study|Withdrawal by Subject|1|||
156766173|NCT02265510|565900412|FG004|Overall Study|Withdrawal by Subject|0|||
156766174|NCT02265510|565900413|FG005|Overall Study|Withdrawal by Subject|2|||
156766175|NCT02265510|565900414|FG006|Overall Study|Withdrawal by Subject|0|||
156766176|NCT02265510|565900415|FG007|Overall Study|Withdrawal by Subject|2|||
156766177|NCT02265510|565900416|FG008|Overall Study|Withdrawal by Subject|0|||
156766178|NCT02265510|565900417|FG009|Overall Study|Withdrawal by Subject|0|||
156426859|NCT02001623|564656447|FG002|Overall Study|Adverse Event|0|||
156766179|NCT02265510|565900418|FG010|Overall Study|Withdrawal by Subject|0|||
156766180|NCT02265510|565900419|FG011|Overall Study|Withdrawal by Subject|0|||
156766181|NCT02265510|565900420|FG012|Overall Study|Withdrawal by Subject|1|||
156766182|NCT02265510|565900421|FG013|Overall Study|Withdrawal by Subject|0|||
156766183|NCT02265510|565900408|FG000|Overall Study|Disease Progression|0|||
156766184|NCT02265510|565900409|FG001|Overall Study|Disease Progression|1|||
156766185|NCT02265510|565900410|FG002|Overall Study|Disease Progression|2|||
156426860|NCT02001623|564656448|FG003|Overall Study|Adverse Event|0|||
156766186|NCT02265510|565900411|FG003|Overall Study|Disease Progression|1|||
156766187|NCT02265510|565900412|FG004|Overall Study|Disease Progression|1|||
156766188|NCT02265510|565900413|FG005|Overall Study|Disease Progression|0|||
156766189|NCT02265510|565900414|FG006|Overall Study|Disease Progression|0|||
156766190|NCT02265510|565900415|FG007|Overall Study|Disease Progression|0|||
156766191|NCT02265510|565900416|FG008|Overall Study|Disease Progression|0|||
156766192|NCT02265510|565900417|FG009|Overall Study|Disease Progression|0|||
156766193|NCT02265510|565900418|FG010|Overall Study|Disease Progression|0|||
156766194|NCT02265510|565900419|FG011|Overall Study|Disease Progression|0|||
156766195|NCT02265510|565900420|FG012|Overall Study|Disease Progression|0|||
156766196|NCT02265510|565900421|FG013|Overall Study|Disease Progression|0|||
156766197|NCT02265510|565900408|FG000|Overall Study|Death|2|||
156766198|NCT02265510|565900409|FG001|Overall Study|Death|0|||
156766199|NCT02265510|565900410|FG002|Overall Study|Death|2|||
156766200|NCT02265510|565900411|FG003|Overall Study|Death|2|||
156766201|NCT02265510|565900412|FG004|Overall Study|Death|1|||
156766202|NCT02265510|565900413|FG005|Overall Study|Death|3|||
156766203|NCT02265510|565900414|FG006|Overall Study|Death|2|||
156766204|NCT02265510|565900415|FG007|Overall Study|Death|1|||
156766205|NCT02265510|565900416|FG008|Overall Study|Death|3|||
156766206|NCT02265510|565900417|FG009|Overall Study|Death|3|||
156766207|NCT02265510|565900418|FG010|Overall Study|Death|4|||
156766208|NCT02265510|565900419|FG011|Overall Study|Death|12|||
156766209|NCT02265510|565900420|FG012|Overall Study|Death|7|||
156426861|NCT02001623|564656449|FG004|Overall Study|Adverse Event|0|||
156426862|NCT02001623|564656450|FG005|Overall Study|Adverse Event|1|||
156426863|NCT02001623|564656451|FG006|Overall Study|Adverse Event|0|||
156426864|NCT02001623|564656452|FG007|Overall Study|Adverse Event|3|||
156426865|NCT02001623|564656453|FG008|Overall Study|Adverse Event|4|||
156426866|NCT02001623|564656454|FG009|Overall Study|Adverse Event|6|||
156426867|NCT02001623|564656455|FG010|Overall Study|Adverse Event|4|||
156426868|NCT02001623|564656456|FG011|Overall Study|Adverse Event|0|||
156426869|NCT02001623|564656457|FG012|Overall Study|Adverse Event|3|||
156426870|NCT02001623|564656458|FG013|Overall Study|Adverse Event|5|||
156426871|NCT02001623|564656459|FG014|Overall Study|Adverse Event|6|||
156426872|NCT02001623|564656445|FG000|Overall Study|Other - Miscellaneous|0|||
156426873|NCT02001623|564656446|FG001|Overall Study|Other - Miscellaneous|0|||
156426874|NCT02001623|564656447|FG002|Overall Study|Other - Miscellaneous|0|||
156426875|NCT02001623|564656448|FG003|Overall Study|Other - Miscellaneous|0|||
156426876|NCT02001623|564656449|FG004|Overall Study|Other - Miscellaneous|0|||
156426877|NCT02001623|564656450|FG005|Overall Study|Other - Miscellaneous|0|||
156426878|NCT02001623|564656451|FG006|Overall Study|Other - Miscellaneous|0|||
156426879|NCT02001623|564656452|FG007|Overall Study|Other - Miscellaneous|0|||
156426880|NCT02001623|564656453|FG008|Overall Study|Other - Miscellaneous|0|||
156426881|NCT02001623|564656454|FG009|Overall Study|Other - Miscellaneous|1|||
156426882|NCT02001623|564656455|FG010|Overall Study|Other - Miscellaneous|0|||
156426883|NCT02001623|564656456|FG011|Overall Study|Other - Miscellaneous|0|||
156426884|NCT02001623|564656457|FG012|Overall Study|Other - Miscellaneous|0|||
156426885|NCT02001623|564656458|FG013|Overall Study|Other - Miscellaneous|1|||
156426886|NCT02001623|564656459|FG014|Overall Study|Other - Miscellaneous|0|||
156426887|NCT02001623|564656445|FG000|Overall Study|Withdrawal by Subject|1|||
156426888|NCT02001623|564656446|FG001|Overall Study|Withdrawal by Subject|0|||
156426889|NCT02001623|564656447|FG002|Overall Study|Withdrawal by Subject|0|||
156426890|NCT02001623|564656448|FG003|Overall Study|Withdrawal by Subject|0|||
156426891|NCT02001623|564656449|FG004|Overall Study|Withdrawal by Subject|0|||
156426892|NCT02001623|564656450|FG005|Overall Study|Withdrawal by Subject|0|||
156426893|NCT02001623|564656451|FG006|Overall Study|Withdrawal by Subject|0|||
156426894|NCT02001623|564656452|FG007|Overall Study|Withdrawal by Subject|0|||
156426895|NCT02001623|564656453|FG008|Overall Study|Withdrawal by Subject|1|||
156426896|NCT02001623|564656454|FG009|Overall Study|Withdrawal by Subject|3|||
156426897|NCT02001623|564656455|FG010|Overall Study|Withdrawal by Subject|2|||
156426898|NCT02001623|564656456|FG011|Overall Study|Withdrawal by Subject|2|||
156426899|NCT02001623|564656457|FG012|Overall Study|Withdrawal by Subject|1|||
156426900|NCT02001623|564656458|FG013|Overall Study|Withdrawal by Subject|5|||
156426901|NCT02001623|564656459|FG014|Overall Study|Withdrawal by Subject|2|||
156426902|NCT02001623|564656445|FG000|Overall Study|Lost to Follow-up|0|||
156426903|NCT02001623|564656446|FG001|Overall Study|Lost to Follow-up|0|||
156426904|NCT02001623|564656447|FG002|Overall Study|Lost to Follow-up|0|||
156426905|NCT02001623|564656448|FG003|Overall Study|Lost to Follow-up|0|||
156426906|NCT02001623|564656449|FG004|Overall Study|Lost to Follow-up|0|||
156426907|NCT02001623|564656450|FG005|Overall Study|Lost to Follow-up|0|||
156426908|NCT02001623|564656451|FG006|Overall Study|Lost to Follow-up|0|||
156426909|NCT02001623|564656452|FG007|Overall Study|Lost to Follow-up|0|||
156426910|NCT02001623|564656453|FG008|Overall Study|Lost to Follow-up|0|||
156426911|NCT02001623|564656454|FG009|Overall Study|Lost to Follow-up|1|||
156426912|NCT02001623|564656455|FG010|Overall Study|Lost to Follow-up|0|||
156426913|NCT02001623|564656456|FG011|Overall Study|Lost to Follow-up|0|||
156426914|NCT02001623|564656457|FG012|Overall Study|Lost to Follow-up|0|||
156426915|NCT02001623|564656458|FG013|Overall Study|Lost to Follow-up|0|||
156426916|NCT02001623|564656459|FG014|Overall Study|Lost to Follow-up|0|||
156426917|NCT02001623|564656445|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
156426918|NCT02001623|564656446|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
156426919|NCT02001623|564656447|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
156426920|NCT02001623|564656448|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
156766210|NCT02265510|565900421|FG013|Overall Study|Death|6|||
156766211|NCT02265510|565900408|FG000|Overall Study|Lost to Follow-up|0|||
156766212|NCT02265510|565900409|FG001|Overall Study|Lost to Follow-up|0|||
156766213|NCT02265510|565900410|FG002|Overall Study|Lost to Follow-up|0|||
156426921|NCT02001623|564656449|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
156766214|NCT02265510|565900411|FG003|Overall Study|Lost to Follow-up|0|||
156766215|NCT02265510|565900412|FG004|Overall Study|Lost to Follow-up|1|||
156766216|NCT02265510|565900413|FG005|Overall Study|Lost to Follow-up|0|||
156426922|NCT02001623|564656450|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
156426923|NCT02001623|564656451|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
156426924|NCT02001623|564656452|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
156766217|NCT02265510|565900414|FG006|Overall Study|Lost to Follow-up|0|||
156766218|NCT02265510|565900415|FG007|Overall Study|Lost to Follow-up|0|||
156766219|NCT02265510|565900416|FG008|Overall Study|Lost to Follow-up|0|||
156766220|NCT02265510|565900417|FG009|Overall Study|Lost to Follow-up|2|||
156766221|NCT02265510|565900418|FG010|Overall Study|Lost to Follow-up|0|||
156766222|NCT02265510|565900419|FG011|Overall Study|Lost to Follow-up|0|||
156766223|NCT02265510|565900420|FG012|Overall Study|Lost to Follow-up|0|||
156766224|NCT02265510|565900421|FG013|Overall Study|Lost to Follow-up|2|||
156766225|NCT02265510|565900408|FG000|Overall Study|Other|0|||
156766226|NCT02265510|565900409|FG001|Overall Study|Other|1|||
156766227|NCT02265510|565900410|FG002|Overall Study|Other|0|||
156766228|NCT02265510|565900411|FG003|Overall Study|Other|0|||
156766229|NCT02265510|565900412|FG004|Overall Study|Other|0|||
156766230|NCT02265510|565900413|FG005|Overall Study|Other|0|||
156766231|NCT02265510|565900414|FG006|Overall Study|Other|0|||
156766232|NCT02265510|565900415|FG007|Overall Study|Other|0|||
156766233|NCT02265510|565900416|FG008|Overall Study|Other|0|||
156766234|NCT02265510|565900417|FG009|Overall Study|Other|0|||
156766235|NCT02265510|565900418|FG010|Overall Study|Other|0|||
156766236|NCT02265510|565900419|FG011|Overall Study|Other|0|||
156766237|NCT02265510|565900420|FG012|Overall Study|Other|0|||
156766238|NCT02265510|565900421|FG013|Overall Study|Other|0|||
156766239|NCT02265510|565900408|FG000|Overall Study|Study Terminated by Sponsor|0|||
156766240|NCT02265510|565900409|FG001|Overall Study|Study Terminated by Sponsor|0|||
156766241|NCT02265510|565900410|FG002|Overall Study|Study Terminated by Sponsor|0|||
156766242|NCT02265510|565900411|FG003|Overall Study|Study Terminated by Sponsor|0|||
156766243|NCT02265510|565900412|FG004|Overall Study|Study Terminated by Sponsor|0|||
156766244|NCT02265510|565900413|FG005|Overall Study|Study Terminated by Sponsor|1|||
156766245|NCT02265510|565900414|FG006|Overall Study|Study Terminated by Sponsor|1|||
156766246|NCT02265510|565900415|FG007|Overall Study|Study Terminated by Sponsor|1|||
156766247|NCT02265510|565900416|FG008|Overall Study|Study Terminated by Sponsor|1|||
156766248|NCT02265510|565900417|FG009|Overall Study|Study Terminated by Sponsor|2|||
156766249|NCT02265510|565900418|FG010|Overall Study|Study Terminated by Sponsor|1|||
156766250|NCT02265510|565900419|FG011|Overall Study|Study Terminated by Sponsor|4|||
156766251|NCT02265510|565900420|FG012|Overall Study|Study Terminated by Sponsor|1|||
156766252|NCT02265510|565900421|FG013|Overall Study|Study Terminated by Sponsor|2|||
156766253|NCT02530385|565900422|FG000|Overall Study|Withdrawal by Subject|0|||
156766254|NCT02530385|565900423|FG001|Overall Study|Withdrawal by Subject|1|||
156766255|NCT00116142|565900424|FG000|Overall Study|Adverse Event|8|||
156766256|NCT00116142|565900425|FG001|Overall Study|Adverse Event|7|||
156766257|NCT00116142|565900424|FG000|Overall Study|Protocol Violation|2|||
156766258|NCT00116142|565900425|FG001|Overall Study|Protocol Violation|1|||
156655868|NCT04634409|565485855|FG006|Overall Study|Lost to Follow-up|1|||
156655869|NCT04634409|565485856|FG007|Overall Study|Lost to Follow-up|3|||
156655870|NCT04634409|565485857|FG008|Overall Study|Lost to Follow-up|3|||
156655871|NCT04634409|565485858|FG009|Overall Study|Lost to Follow-up|11|||
156655872|NCT04634409|565485859|FG010|Overall Study|Lost to Follow-up|8|||
156655873|NCT04634409|565485860|FG011|Overall Study|Lost to Follow-up|15|||
156655874|NCT04634409|565485861|FG012|Overall Study|Lost to Follow-up|3|||
156655875|NCT04634409|565485862|FG013|Overall Study|Lost to Follow-up|2|||
156655876|NCT04634409|565485863|FG014|Overall Study|Lost to Follow-up|7|||
156655877|NCT04634409|565485864|FG015|Overall Study|Lost to Follow-up|0|||
156655878|NCT04634409|565485865|FG016|Overall Study|Lost to Follow-up|0|||
156655879|NCT04634409|565485866|FG017|Overall Study|Lost to Follow-up|0|||
156655880|NCT04634409|565485867|FG018|Overall Study|Lost to Follow-up|0|||
156655881|NCT04634409|565485868|FG019|Overall Study|Lost to Follow-up|0|||
156655882|NCT04634409|565485869|FG020|Overall Study|Lost to Follow-up|0|||
156655883|NCT04634409|565485870|FG021|Overall Study|Lost to Follow-up|0|||
156655884|NCT04634409|565485871|FG022|Overall Study|Lost to Follow-up|0|||
156655885|NCT04634409|565485872|FG023|Overall Study|Lost to Follow-up|0|||
156655886|NCT04634409|565485873|FG024|Overall Study|Lost to Follow-up|0|||
156655887|NCT04634409|565485874|FG025|Overall Study|Lost to Follow-up|0|||
156655888|NCT04634409|565485875|FG026|Overall Study|Lost to Follow-up|0|||
156655889|NCT04634409|565485849|FG000|Overall Study|Withdrawal by Subject|3|||
156655890|NCT04634409|565485850|FG001|Overall Study|Withdrawal by Subject|1|||
156655891|NCT04634409|565485851|FG002|Overall Study|Withdrawal by Subject|6|||
156655892|NCT04634409|565485852|FG003|Overall Study|Withdrawal by Subject|4|||
156655893|NCT04634409|565485853|FG004|Overall Study|Withdrawal by Subject|2|||
156766259|NCT00116142|565900424|FG000|Overall Study|Withdrawal by Subject|5|||
156766260|NCT00116142|565900425|FG001|Overall Study|Withdrawal by Subject|5|||
156766261|NCT00116142|565900424|FG000|Overall Study|Physician Decision|3|||
156766262|NCT00116142|565900425|FG001|Overall Study|Physician Decision|1|||
156766263|NCT00116142|565900424|FG000|Overall Study|Delayed Radiation Therapy|1|||
156655894|NCT04634409|565485854|FG005|Overall Study|Withdrawal by Subject|0|||
156655895|NCT04634409|565485855|FG006|Overall Study|Withdrawal by Subject|0|||
156655896|NCT04634409|565485856|FG007|Overall Study|Withdrawal by Subject|2|||
156655897|NCT04634409|565485857|FG008|Overall Study|Withdrawal by Subject|3|||
156766264|NCT00116142|565900425|FG001|Overall Study|Delayed Radiation Therapy|0|||
156766265|NCT00116142|565900424|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
156766266|NCT00116142|565900425|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
156766267|NCT00116142|565900424|FG000|Overall Study|Patient stopped due to depression|0|||
156766268|NCT00116142|565900425|FG001|Overall Study|Patient stopped due to depression|1|||
156766269|NCT00116142|565900424|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
156766270|NCT00116142|565900425|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
156766271|NCT00116142|565900424|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
156766272|NCT00116142|565900425|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
156766273|NCT00116142|565900424|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
156766274|NCT00116142|565900425|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
156766275|NCT02133508|565900426|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
156766276|NCT02133508|565900426|FG000|Overall Study|Death|12|||
156766277|NCT02133508|565900426|FG000|Overall Study|Lost to Follow-up|2|||
156766278|NCT01026493|565900427|FG000|Overall Study|Protocol Violation|0|||
156766279|NCT01026493|565900428|FG001|Overall Study|Protocol Violation|1|||
156426925|NCT02001623|564656453|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
156426926|NCT02001623|564656454|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
156426927|NCT02001623|564656455|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
156426928|NCT02001623|564656456|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
156426929|NCT02001623|564656457|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
156426930|NCT02001623|564656458|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
156426931|NCT02001623|564656459|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
156426932|NCT02001623|564656445|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
156426933|NCT02001623|564656446|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
156426934|NCT02001623|564656447|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
156426935|NCT02001623|564656448|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
156426936|NCT02001623|564656449|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
156426937|NCT02001623|564656450|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
156426938|NCT02001623|564656451|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
156426939|NCT02001623|564656452|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
156426940|NCT02001623|564656453|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
156426941|NCT02001623|564656454|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
156426942|NCT02001623|564656455|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
156426943|NCT02001623|564656456|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
156426944|NCT02001623|564656457|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
156426945|NCT02001623|564656458|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
156426946|NCT02001623|564656459|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
156426947|NCT00109967|564656464|FG000|Overall Study|Cancel Prior to Treatment|2|||
156426948|NCT00109967|564656465|FG001|Overall Study|Cancel Prior to Treatment|0|||
156426949|NCT00109967|564656464|FG000|Overall Study|Adverse Event|12|||
156426950|NCT00109967|564656465|FG001|Overall Study|Adverse Event|1|||
156426951|NCT00109967|564656464|FG000|Overall Study|Withdrawal by Subject|5|||
156426952|NCT00109967|564656465|FG001|Overall Study|Withdrawal by Subject|0|||
156426953|NCT00109967|564656464|FG000|Overall Study|Physician Decision|1|||
156426954|NCT00109967|564656465|FG001|Overall Study|Physician Decision|3|||
156426955|NCT00109967|564656464|FG000|Overall Study|Death|0|||
156426956|NCT00109967|564656465|FG001|Overall Study|Death|2|||
156426957|NCT02715258|564656473|FG000|Overall Study|Withdrawal by Subject|6|||
156426958|NCT02715258|564656474|FG001|Overall Study|Withdrawal by Subject|1|||
156426959|NCT02715258|564656473|FG000|Overall Study|Lost to Follow-up|7|||
156426960|NCT02715258|564656474|FG001|Overall Study|Lost to Follow-up|1|||
156426961|NCT02715258|564656473|FG000|Overall Study|Terminated by Sponsor|0|||
156426962|NCT02715258|564656474|FG001|Overall Study|Terminated by Sponsor|1|||
156426963|NCT02715258|564656473|FG000|Overall Study|Death|0|||
156426964|NCT02715258|564656474|FG001|Overall Study|Death|1|||
156426965|NCT02715258|564656473|FG000|Overall Study|Subject non-compliant|1|||
156426966|NCT02715258|564656474|FG001|Overall Study|Subject non-compliant|1|||
156426967|NCT02715258|564656473|FG000|Overall Study|GCP violation|2|||
156426968|NCT02715258|564656474|FG001|Overall Study|GCP violation|1|||
156426969|NCT01117480|564656481|FG000|Overall Study|Protocol Violation|8|||
156426970|NCT01117480|564656481|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
156426971|NCT02263508|564656483|FG000|Overall Study|Withdrawal by Subject|1|||
156426972|NCT02263508|564656484|FG001|Overall Study|Withdrawal by Subject|23|||
156426973|NCT02263508|564656485|FG002|Overall Study|Withdrawal by Subject|17|||
156426974|NCT02263508|564656483|FG000|Overall Study|Sponsor Decision|12|||
156426975|NCT02263508|564656484|FG001|Overall Study|Sponsor Decision|165|||
156426976|NCT02263508|564656485|FG002|Overall Study|Sponsor Decision|182|||
156426977|NCT02263508|564656483|FG000|Overall Study|Lost to Follow-up|2|||
156426978|NCT02263508|564656484|FG001|Overall Study|Lost to Follow-up|7|||
156426979|NCT02263508|564656485|FG002|Overall Study|Lost to Follow-up|7|||
156766280|NCT01026493|565900429|FG002|Overall Study|Protocol Violation|0|||
156766281|NCT01026493|565900430|FG003|Overall Study|Protocol Violation|0|||
156426980|NCT02263508|564656483|FG000|Overall Study|Death|6|||
156426981|NCT02263508|564656484|FG001|Overall Study|Death|151|||
156426982|NCT02263508|564656485|FG002|Overall Study|Death|140|||
156426983|NCT00943605|564656486|FG000|Overall Study|Study termination|30|||
156426984|NCT00943605|564656487|FG001|Overall Study|Study termination|30|||
156426985|NCT04148937|564656488|FG000|Overall Study|Withdrawal by Subject|0|||
156426986|NCT04148937|564656489|FG001|Overall Study|Withdrawal by Subject|0|||
156426987|NCT04148937|564656490|FG002|Overall Study|Withdrawal by Subject|0|||
156426988|NCT04148937|564656491|FG003|Overall Study|Withdrawal by Subject|1|||
156426989|NCT04148937|564656492|FG004|Overall Study|Withdrawal by Subject|0|||
156426990|NCT04148937|564656493|FG005|Overall Study|Withdrawal by Subject|1|||
156426991|NCT04148937|564656494|FG006|Overall Study|Withdrawal by Subject|1|||
156426992|NCT04148937|564656495|FG007|Overall Study|Withdrawal by Subject|0|||
156426993|NCT04148937|564656488|FG000|Overall Study|Lost to Follow-up|0|||
156426994|NCT04148937|564656489|FG001|Overall Study|Lost to Follow-up|0|||
156426995|NCT04148937|564656490|FG002|Overall Study|Lost to Follow-up|1|||
156426996|NCT04148937|564656491|FG003|Overall Study|Lost to Follow-up|0|||
156426997|NCT04148937|564656492|FG004|Overall Study|Lost to Follow-up|0|||
156426998|NCT04148937|564656493|FG005|Overall Study|Lost to Follow-up|2|||
156426999|NCT04148937|564656494|FG006|Overall Study|Lost to Follow-up|0|||
156427000|NCT04148937|564656495|FG007|Overall Study|Lost to Follow-up|0|||
156427001|NCT02232178|564656496|FG000|Overall Study|Lost to Follow-up|0|||
156427002|NCT02232178|564656497|FG001|Overall Study|Lost to Follow-up|1|||
156427003|NCT02232178|564656498|FG002|Overall Study|Lost to Follow-up|0|||
156427004|NCT02232178|564656496|FG000|Overall Study|ineligibility|0|||
156427005|NCT02232178|564656497|FG001|Overall Study|ineligibility|0|||
156427006|NCT02232178|564656498|FG002|Overall Study|ineligibility|1|||
156427007|NCT02232178|564656496|FG000|Overall Study|surgical complication|1|||
156427008|NCT02232178|564656497|FG001|Overall Study|surgical complication|0|||
156427009|NCT02232178|564656498|FG002|Overall Study|surgical complication|0|||
156427010|NCT01259102|564656499|FG000|Overall Study|Adverse Event|1|||
156427011|NCT01259102|564656500|FG001|Overall Study|Adverse Event|0|||
156427012|NCT01259102|564656501|FG002|Overall Study|Adverse Event|1|||
156427013|NCT01259102|564656502|FG003|Overall Study|Adverse Event|1|||
156427014|NCT01259102|564656503|FG004|Overall Study|Adverse Event|0|||
156427015|NCT01259102|564656499|FG000|Overall Study|Other|0|||
156427016|NCT01259102|564656500|FG001|Overall Study|Other|0|||
156427017|NCT01259102|564656501|FG002|Overall Study|Other|1|||
156427018|NCT01259102|564656502|FG003|Overall Study|Other|1|||
156427019|NCT01259102|564656503|FG004|Overall Study|Other|1|||
156427020|NCT00686517|564656505|FG000|Treatment|Serious Adverse Event|1|||
156427021|NCT00686517|564656506|FG001|Treatment|Serious Adverse Event|2|||
156427022|NCT00686517|564656507|FG002|Treatment|Serious Adverse Event|1|||
156427023|NCT00686517|564656505|FG000|Treatment|Adverse Event|2|||
156427024|NCT00686517|564656506|FG001|Treatment|Adverse Event|0|||
156427025|NCT00686517|564656507|FG002|Treatment|Adverse Event|0|||
156427026|NCT00686517|564656505|FG000|Treatment|Poor Protocol Compliance|1|||
156427027|NCT00686517|564656506|FG001|Treatment|Poor Protocol Compliance|0|||
156427028|NCT00686517|564656507|FG002|Treatment|Poor Protocol Compliance|0|||
156427029|NCT00686517|564656505|FG000|Treatment|Protocol Violation|2|||
156427030|NCT00686517|564656506|FG001|Treatment|Protocol Violation|1|||
156427031|NCT00686517|564656507|FG002|Treatment|Protocol Violation|0|||
156427032|NCT01803646|564656508|FG000|Overall Study|Protocol Violation|1|||
156427033|NCT01803646|564656509|FG001|Overall Study|Protocol Violation|0|||
156427034|NCT01803646|564656508|FG000|Overall Study|Adverse Event|1|||
156427035|NCT01803646|564656509|FG001|Overall Study|Adverse Event|1|||
156427036|NCT01803646|564656508|FG000|Overall Study|Withdrawal by Subject|9|||
156427037|NCT01803646|564656509|FG001|Overall Study|Withdrawal by Subject|6|||
156427038|NCT01803646|564656508|FG000|Overall Study|Randomization error|1|||
156322883|NCT02925793|564280292|FG000|Overall Study|Investigator Discretion|0|||
156322884|NCT02925793|564280293|FG001|Overall Study|Investigator Discretion|1|||
156322885|NCT02925793|564280294|FG002|Overall Study|Investigator Discretion|1|||
156322886|NCT02925793|564280292|FG000|Overall Study|Lost to Follow-up|2|||
156322887|NCT02925793|564280293|FG001|Overall Study|Lost to Follow-up|3|||
156322888|NCT02925793|564280294|FG002|Overall Study|Lost to Follow-up|1|||
156322889|NCT02925793|564280292|FG000|Overall Study|Lack of Efficacy|2|||
156322890|NCT02925793|564280293|FG001|Overall Study|Lack of Efficacy|6|||
156322891|NCT02925793|564280294|FG002|Overall Study|Lack of Efficacy|4|||
156427039|NCT01803646|564656509|FG001|Overall Study|Randomization error|2|||
156427040|NCT01803646|564656508|FG000|Overall Study|Lost to Follow-up|5|||
156427041|NCT01803646|564656509|FG001|Overall Study|Lost to Follow-up|1|||
156427042|NCT01072357|564656512|FG000|Overall Study|Lost to Follow-up|0|||
156427043|NCT01072357|564656513|FG001|Overall Study|Lost to Follow-up|1|||
156427044|NCT01876511|564656514|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
156427045|NCT01876511|564656515|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
156427046|NCT01876511|564656516|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
156427047|NCT01876511|564656514|FG000|Overall Study|Death (unrelated)|3|||
156427048|NCT01876511|564656515|FG001|Overall Study|Death (unrelated)|0|||
156427049|NCT01876511|564656516|FG002|Overall Study|Death (unrelated)|2|||
156427050|NCT01876511|564656514|FG000|Overall Study|Drug-related Toxicity|5|||
156427051|NCT01876511|564656515|FG001|Overall Study|Drug-related Toxicity|1|||
156427052|NCT01876511|564656516|FG002|Overall Study|Drug-related Toxicity|6|||
156427053|NCT01876511|564656514|FG000|Overall Study|Patient Decision|3|||
156427054|NCT01876511|564656515|FG001|Overall Study|Patient Decision|0|||
156427055|NCT01876511|564656516|FG002|Overall Study|Patient Decision|6|||
156766282|NCT01026493|565900431|FG004|Overall Study|Protocol Violation|2|||
156766283|NCT01026493|565900432|FG005|Overall Study|Protocol Violation|3|||
156766284|NCT01026493|565900433|FG006|Overall Study|Protocol Violation|4|||
156427056|NCT01876511|564656514|FG000|Overall Study|Physician Decision|1|||
156427057|NCT01876511|564656515|FG001|Overall Study|Physician Decision|0|||
156427058|NCT01876511|564656516|FG002|Overall Study|Physician Decision|1|||
156427059|NCT01048788|564656517|FG000|Overall Study|Adverse Event|5|||
156427060|NCT01048788|564656518|FG001|Overall Study|Adverse Event|1|||
156427061|NCT01048788|564656519|FG002|Overall Study|Adverse Event|1|||
156427062|NCT01048788|564656517|FG000|Overall Study|Lack of Efficacy|0|||
156427063|NCT01048788|564656518|FG001|Overall Study|Lack of Efficacy|0|||
156427064|NCT01048788|564656519|FG002|Overall Study|Lack of Efficacy|1|||
156427065|NCT01048788|564656517|FG000|Overall Study|Withdrawal by Subject|0|||
156427066|NCT01048788|564656518|FG001|Overall Study|Withdrawal by Subject|1|||
156427067|NCT01048788|564656519|FG002|Overall Study|Withdrawal by Subject|0|||
156427068|NCT02145182|564656520|FG000|Overall Study|Adverse Event|4|||
156427069|NCT02145182|564656521|FG001|Overall Study|Adverse Event|1|||
156427070|NCT02145182|564656520|FG000|Overall Study|Death|7|||
156427071|NCT02145182|564656521|FG001|Overall Study|Death|7|||
156427072|NCT02145182|564656520|FG000|Overall Study|Lost to Follow-up|2|||
156427073|NCT02145182|564656521|FG001|Overall Study|Lost to Follow-up|2|||
156427074|NCT02145182|564656520|FG000|Overall Study|Pre-transplant Withdrawal|0|||
156427075|NCT02145182|564656521|FG001|Overall Study|Pre-transplant Withdrawal|2|||
156427076|NCT02145182|564656520|FG000|Overall Study|Withdrawal by Subject|5|||
156427077|NCT02145182|564656521|FG001|Overall Study|Withdrawal by Subject|4|||
156427078|NCT01196988|564656522|FG000|Overall Study|Adverse Event|1|||
156427079|NCT01196988|564656523|FG001|Overall Study|Adverse Event|2|||
156427080|NCT01196988|564656524|FG002|Overall Study|Adverse Event|0|||
156427081|NCT01196988|564656525|FG003|Overall Study|Adverse Event|0|||
156427082|NCT01196988|564656522|FG000|Overall Study|Withdrawal by Subject|5|||
156427083|NCT01196988|564656523|FG001|Overall Study|Withdrawal by Subject|1|||
156427084|NCT01196988|564656524|FG002|Overall Study|Withdrawal by Subject|4|||
156427085|NCT01196988|564656525|FG003|Overall Study|Withdrawal by Subject|0|||
156427086|NCT01196988|564656522|FG000|Overall Study|Lost to Follow-up|16|||
156427087|NCT01196988|564656523|FG001|Overall Study|Lost to Follow-up|29|||
156427088|NCT01196988|564656524|FG002|Overall Study|Lost to Follow-up|21|||
156427089|NCT01196988|564656525|FG003|Overall Study|Lost to Follow-up|1|||
156427090|NCT01196988|564656522|FG000|Overall Study|Other|2|||
156427091|NCT01196988|564656523|FG001|Overall Study|Other|0|||
156427092|NCT01196988|564656524|FG002|Overall Study|Other|0|||
156427093|NCT01196988|564656525|FG003|Overall Study|Other|0|||
156427094|NCT01233050|564656526|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
156427095|NCT01233050|564656527|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
156427096|NCT03999554|564656530|FG000|Overall Study|Lost to Follow-up|4|||
156427097|NCT03999554|564656531|FG001|Overall Study|Lost to Follow-up|5|||
156427098|NCT03999554|564656532|FG002|Overall Study|Lost to Follow-up|4|||
156427099|NCT03999554|564656533|FG003|Overall Study|Lost to Follow-up|5|||
156427100|NCT03999554|564656534|FG004|Overall Study|Lost to Follow-up|8|||
156427101|NCT03999554|564656530|FG000|Overall Study|Protocol Violation|0|||
156427102|NCT03999554|564656531|FG001|Overall Study|Protocol Violation|0|||
156427103|NCT03999554|564656532|FG002|Overall Study|Protocol Violation|5|||
156427104|NCT03999554|564656533|FG003|Overall Study|Protocol Violation|0|||
156427105|NCT03999554|564656534|FG004|Overall Study|Protocol Violation|0|||
156427106|NCT03999554|564656530|FG000|Overall Study|Pregnancy|0|||
156427107|NCT03999554|564656531|FG001|Overall Study|Pregnancy|0|||
156427108|NCT03999554|564656532|FG002|Overall Study|Pregnancy|1|||
156427109|NCT03999554|564656533|FG003|Overall Study|Pregnancy|0|||
156427110|NCT03999554|564656534|FG004|Overall Study|Pregnancy|0|||
156427111|NCT03999554|564656530|FG000|Overall Study|Withdrawal by Subject|2|||
156427112|NCT03999554|564656531|FG001|Overall Study|Withdrawal by Subject|2|||
156427113|NCT03999554|564656532|FG002|Overall Study|Withdrawal by Subject|2|||
156766285|NCT01026493|565900434|FG007|Overall Study|Protocol Violation|1|||
156766286|NCT03093181|565900435|FG000|Overall Study|Withdrawal by Subject|2|||
156766287|NCT03093181|565900436|FG001|Overall Study|Withdrawal by Subject|1|||
156766288|NCT03093181|565900437|FG002|Overall Study|Withdrawal by Subject|2|||
156427114|NCT03999554|564656533|FG003|Overall Study|Withdrawal by Subject|1|||
156427115|NCT03999554|564656534|FG004|Overall Study|Withdrawal by Subject|1|||
156427116|NCT03999554|564656530|FG000|Overall Study|failure to comply with protocol requirements|0|||
156427117|NCT03999554|564656531|FG001|Overall Study|failure to comply with protocol requirements|0|||
156427118|NCT03999554|564656532|FG002|Overall Study|failure to comply with protocol requirements|0|||
156766289|NCT03093181|565900435|FG000|Overall Study|Other (Not specified)|1|||
156766290|NCT03093181|565900436|FG001|Overall Study|Other (Not specified)|0|||
156766291|NCT03093181|565900437|FG002|Overall Study|Other (Not specified)|0|||
156766292|NCT03093181|565900435|FG000|Overall Study|Adverse Event|0|||
156427119|NCT03999554|564656533|FG003|Overall Study|failure to comply with protocol requirements|1|||
156427120|NCT03999554|564656534|FG004|Overall Study|failure to comply with protocol requirements|0|||
156427121|NCT02082158|564656535|FG000|Overall Study|Withdrawal by Subject|0|||
156427122|NCT02082158|564656536|FG001|Overall Study|Withdrawal by Subject|0|||
156766293|NCT03093181|565900436|FG001|Overall Study|Adverse Event|1|||
156766294|NCT03093181|565900437|FG002|Overall Study|Adverse Event|0|||
156766295|NCT03093181|565900435|FG000|Overall Study|Other (Protocol violation)|0|||
156766296|NCT03093181|565900436|FG001|Overall Study|Other (Protocol violation)|0|||
156766297|NCT03093181|565900437|FG002|Overall Study|Other (Protocol violation)|1|||
156766298|NCT04076917|565900440|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
156766299|NCT04076917|565900440|FG000|Overall Study|Study closure|13|||
156766300|NCT04076917|565900440|FG000|Overall Study|Physician Decision|3|||
156766301|NCT04076917|565900440|FG000|Overall Study|Death|1|||
156766302|NCT04076917|565900440|FG000|Overall Study|Lost to Follow-up|1|||
156766303|NCT04076917|565900440|FG000|Overall Study|Withdrawal by Subject|1|||
156766304|NCT04076917|565900440|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
156766305|NCT01774591|565900443|FG000|Overall Study|Physician Decision|1|||
156766306|NCT01774591|565900444|FG001|Overall Study|Physician Decision|1|||
156766307|NCT01774591|565900443|FG000|Overall Study|Withdrawal by Subject|0|||
156766308|NCT01774591|565900444|FG001|Overall Study|Withdrawal by Subject|1|||
156766309|NCT01774591|565900443|FG000|Overall Study|Adverse Event|0|||
156766310|NCT01774591|565900444|FG001|Overall Study|Adverse Event|2|||
156766311|NCT01701245|565900445|FG000|Overall Study|Protocol Violation|1|||
156766312|NCT01701245|565900446|FG001|Overall Study|Protocol Violation|3|||
156766313|NCT01701245|565900445|FG000|Overall Study|Did not complete the open label period|11|||
156766314|NCT01701245|565900446|FG001|Overall Study|Did not complete the open label period|12|||
156766315|NCT01159574|565900447|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
156766316|NCT01159574|565900447|FG000|Treatment Phase|Adverse Event|3|||
156766317|NCT01159574|565900447|FG000|Treatment Phase|Death|6|||
156766318|NCT01159574|565900447|FG000|Treatment Phase|Physician Decision|2|||
156766319|NCT01159574|565900447|FG000|Treatment Phase|Withdrawal by Subject|7|||
156766320|NCT01159574|565900447|FG000|Treatment Phase|still on treatment|2|||
156766321|NCT01159574|565900447|FG000|Follow Up Phase|Lost to Follow-up|2|||
156766322|NCT01159574|565900447|FG000|Follow Up Phase|still being followed for overall surviva|18|||
156766323|NCT01787552|565900450|FG000|Overall Study|Withdrawal by Subject|2|||
156766324|NCT01787552|565900451|FG001|Overall Study|Withdrawal by Subject|0|||
156766325|NCT01787552|565900452|FG002|Overall Study|Withdrawal by Subject|0|||
156766326|NCT01787552|565900453|FG003|Overall Study|Withdrawal by Subject|4|||
156766327|NCT01787552|565900450|FG000|Overall Study|Physician Decision|2|||
156766328|NCT01787552|565900451|FG001|Overall Study|Physician Decision|2|||
156766329|NCT01787552|565900452|FG002|Overall Study|Physician Decision|1|||
156766330|NCT01787552|565900453|FG003|Overall Study|Physician Decision|2|||
156766331|NCT01787552|565900450|FG000|Overall Study|Death|0|||
156766332|NCT01787552|565900451|FG001|Overall Study|Death|0|||
156766333|NCT01787552|565900452|FG002|Overall Study|Death|0|||
156766334|NCT01787552|565900453|FG003|Overall Study|Death|1|||
156766335|NCT01787552|565900450|FG000|Overall Study|Adverse Event|2|||
156766336|NCT01787552|565900451|FG001|Overall Study|Adverse Event|5|||
156766337|NCT01787552|565900452|FG002|Overall Study|Adverse Event|2|||
156766338|NCT01787552|565900453|FG003|Overall Study|Adverse Event|16|||
156766339|NCT01787552|565900450|FG000|Overall Study|Study terminated by Sponsor|0|||
156766340|NCT01787552|565900451|FG001|Overall Study|Study terminated by Sponsor|0|||
156766341|NCT01787552|565900452|FG002|Overall Study|Study terminated by Sponsor|1|||
156766342|NCT01787552|565900453|FG003|Overall Study|Study terminated by Sponsor|3|||
156766343|NCT01787552|565900450|FG000|Overall Study|Progressive Disease|2|||
156766344|NCT01787552|565900451|FG001|Overall Study|Progressive Disease|2|||
156766345|NCT01787552|565900452|FG002|Overall Study|Progressive Disease|1|||
156766346|NCT01787552|565900453|FG003|Overall Study|Progressive Disease|1|||
156766347|NCT00630916|565900454|FG000|Overall Study|Death|110|||
156766348|NCT00630916|565900454|FG000|Overall Study|Explant|8|||
156766349|NCT00630916|565900454|FG000|Overall Study|Lost to Follow-up|5|||
156766350|NCT00630916|565900454|FG000|Overall Study|Withdrawal by Subject|30|||
156766351|NCT00630916|565900454|FG000|Overall Study|Protocol Violation|7|||
156766352|NCT00630916|565900454|FG000|Overall Study|Physician Decision|47|||
156766353|NCT00630916|565900454|FG000|Overall Study|Lack of Efficacy|3|||
156766354|NCT02147626|565900458|FG000|Overall Study|Lost to Follow-up|4|||
156766355|NCT02147626|565900459|FG001|Overall Study|Lost to Follow-up|4|||
156766356|NCT02147626|565900458|FG000|Overall Study|Pregnancy|1|||
156766357|NCT02147626|565900459|FG001|Overall Study|Pregnancy|2|||
156766358|NCT02147626|565900458|FG000|Overall Study|Withdrawal by Subject|0|||
156766359|NCT02147626|565900459|FG001|Overall Study|Withdrawal by Subject|1|||
156766360|NCT03167242|565900462|FG000|Overall Study|Patient/Guardian Decision|0|||
156766361|NCT03167242|565900463|FG001|Overall Study|Patient/Guardian Decision|1|||
156766362|NCT03167242|565900464|FG002|Overall Study|Patient/Guardian Decision|2|||
156766363|NCT03167242|565900465|FG003|Overall Study|Patient/Guardian Decision|1|||
156766364|NCT03167242|565900466|FG004|Overall Study|Patient/Guardian Decision|1|||
156427123|NCT02082158|564656537|FG002|Overall Study|Withdrawal by Subject|0|||
156766365|NCT03167242|565900467|FG005|Overall Study|Patient/Guardian Decision|1|||
156766366|NCT03167242|565900468|FG006|Overall Study|Patient/Guardian Decision|0|||
156766367|NCT03167242|565900469|FG007|Overall Study|Patient/Guardian Decision|0|||
156766368|NCT03167242|565900470|FG008|Overall Study|Patient/Guardian Decision|0|||
156766369|NCT03167242|565900471|FG009|Overall Study|Patient/Guardian Decision|0|||
156427124|NCT02082158|564656538|FG003|Overall Study|Withdrawal by Subject|0|||
156427125|NCT02082158|564656539|FG004|Overall Study|Withdrawal by Subject|1|||
156655898|NCT04634409|565485858|FG009|Overall Study|Withdrawal by Subject|2|||
156655899|NCT04634409|565485859|FG010|Overall Study|Withdrawal by Subject|3|||
156655900|NCT04634409|565485860|FG011|Overall Study|Withdrawal by Subject|2|||
156655901|NCT04634409|565485861|FG012|Overall Study|Withdrawal by Subject|2|||
156427126|NCT02082158|564656540|FG005|Overall Study|Withdrawal by Subject|0|||
156427127|NCT02082158|564656535|FG000|Overall Study|Failed Fit-testing|8|||
156427128|NCT02082158|564656536|FG001|Overall Study|Failed Fit-testing|8|||
156427129|NCT02082158|564656537|FG002|Overall Study|Failed Fit-testing|14|||
156427130|NCT02082158|564656538|FG003|Overall Study|Failed Fit-testing|4|||
156427131|NCT02082158|564656539|FG004|Overall Study|Failed Fit-testing|3|||
156427132|NCT02082158|564656540|FG005|Overall Study|Failed Fit-testing|7|||
156427133|NCT04012853|564656541|FG000|Overall Study|Withdrawal by Subject|1|||
156427134|NCT04012853|564656542|FG001|Overall Study|Withdrawal by Subject|1|||
156427135|NCT04012853|564656541|FG000|Overall Study|Protocol Violation|1|||
156427136|NCT04012853|564656542|FG001|Overall Study|Protocol Violation|0|||
156427137|NCT04012853|564656541|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
156427138|NCT04012853|564656542|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
156427139|NCT04304534|564656543|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
156427140|NCT04304534|564656544|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
156427141|NCT04304534|564656545|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
156427142|NCT04304534|564656546|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
156427143|NCT04304534|564656543|FG000|Overall Study|Non-Compliance with study drug|0|||
156427144|NCT04304534|564656544|FG001|Overall Study|Non-Compliance with study drug|1|||
156427145|NCT04304534|564656545|FG002|Overall Study|Non-Compliance with study drug|1|||
156427146|NCT04304534|564656546|FG003|Overall Study|Non-Compliance with study drug|1|||
156427147|NCT04304534|564656543|FG000|Overall Study|Lost to Follow-up|0|||
156427148|NCT04304534|564656544|FG001|Overall Study|Lost to Follow-up|1|||
156427149|NCT04304534|564656545|FG002|Overall Study|Lost to Follow-up|2|||
156427150|NCT04304534|564656546|FG003|Overall Study|Lost to Follow-up|3|||
156427151|NCT04304534|564656543|FG000|Overall Study|Unspecific|4|||
156427152|NCT04304534|564656544|FG001|Overall Study|Unspecific|2|||
156427153|NCT04304534|564656545|FG002|Overall Study|Unspecific|2|||
156427154|NCT04304534|564656546|FG003|Overall Study|Unspecific|2|||
156427155|NCT04304534|564656543|FG000|Overall Study|Technical Problems|2|||
156427156|NCT04304534|564656544|FG001|Overall Study|Technical Problems|2|||
156427157|NCT04304534|564656545|FG002|Overall Study|Technical Problems|3|||
156427158|NCT04304534|564656546|FG003|Overall Study|Technical Problems|4|||
156427159|NCT04304534|564656543|FG000|Overall Study|Death|7|||
156427160|NCT04304534|564656544|FG001|Overall Study|Death|2|||
156427161|NCT04304534|564656545|FG002|Overall Study|Death|4|||
156427162|NCT04304534|564656546|FG003|Overall Study|Death|3|||
156427163|NCT04304534|564656543|FG000|Overall Study|Withdrawal by Subject|7|||
156427164|NCT04304534|564656544|FG001|Overall Study|Withdrawal by Subject|2|||
156427165|NCT04304534|564656545|FG002|Overall Study|Withdrawal by Subject|7|||
156427166|NCT04304534|564656546|FG003|Overall Study|Withdrawal by Subject|4|||
156427167|NCT04304534|564656543|FG000|Overall Study|Physician Decision|4|||
156427168|NCT04304534|564656544|FG001|Overall Study|Physician Decision|9|||
156427169|NCT04304534|564656545|FG002|Overall Study|Physician Decision|9|||
156427170|NCT04304534|564656546|FG003|Overall Study|Physician Decision|5|||
156427171|NCT04304534|564656543|FG000|Overall Study|Subject Decision|34|||
156427172|NCT04304534|564656544|FG001|Overall Study|Subject Decision|25|||
156655902|NCT04634409|565485862|FG013|Overall Study|Withdrawal by Subject|1|||
156655903|NCT04634409|565485863|FG014|Overall Study|Withdrawal by Subject|5|||
156655904|NCT04634409|565485864|FG015|Overall Study|Withdrawal by Subject|0|||
156655905|NCT04634409|565485865|FG016|Overall Study|Withdrawal by Subject|0|||
156655906|NCT04634409|565485866|FG017|Overall Study|Withdrawal by Subject|1|||
156655907|NCT04634409|565485867|FG018|Overall Study|Withdrawal by Subject|0|||
156655908|NCT04634409|565485868|FG019|Overall Study|Withdrawal by Subject|0|||
156655909|NCT04634409|565485869|FG020|Overall Study|Withdrawal by Subject|0|||
156655910|NCT04634409|565485870|FG021|Overall Study|Withdrawal by Subject|0|||
156655911|NCT04634409|565485871|FG022|Overall Study|Withdrawal by Subject|0|||
156655912|NCT04634409|565485872|FG023|Overall Study|Withdrawal by Subject|1|||
156655913|NCT04634409|565485873|FG024|Overall Study|Withdrawal by Subject|0|||
156655914|NCT04634409|565485874|FG025|Overall Study|Withdrawal by Subject|0|||
156655915|NCT04634409|565485875|FG026|Overall Study|Withdrawal by Subject|0|||
156655916|NCT04634409|565485849|FG000|Overall Study|Other - As reported by Investigator|1|||
156655917|NCT04634409|565485850|FG001|Overall Study|Other - As reported by Investigator|0|||
156655918|NCT04634409|565485851|FG002|Overall Study|Other - As reported by Investigator|0|||
156655919|NCT04634409|565485852|FG003|Overall Study|Other - As reported by Investigator|0|||
156655920|NCT04634409|565485853|FG004|Overall Study|Other - As reported by Investigator|0|||
156655921|NCT04634409|565485854|FG005|Overall Study|Other - As reported by Investigator|0|||
156655922|NCT04634409|565485855|FG006|Overall Study|Other - As reported by Investigator|0|||
156655923|NCT04634409|565485856|FG007|Overall Study|Other - As reported by Investigator|6|||
156655924|NCT04634409|565485857|FG008|Overall Study|Other - As reported by Investigator|4|||
156766370|NCT03167242|565900472|FG010|Overall Study|Patient/Guardian Decision|1|||
156766371|NCT03167242|565900473|FG011|Overall Study|Patient/Guardian Decision|0|||
156766372|NCT03167242|565900462|FG000|Overall Study|Lost to Follow-up|0|||
156766373|NCT03167242|565900463|FG001|Overall Study|Lost to Follow-up|0|||
156766374|NCT03167242|565900464|FG002|Overall Study|Lost to Follow-up|1|||
156766375|NCT03167242|565900465|FG003|Overall Study|Lost to Follow-up|0|||
156766376|NCT03167242|565900466|FG004|Overall Study|Lost to Follow-up|0|||
156766377|NCT03167242|565900467|FG005|Overall Study|Lost to Follow-up|1|||
156766378|NCT03167242|565900468|FG006|Overall Study|Lost to Follow-up|2|||
156766379|NCT03167242|565900469|FG007|Overall Study|Lost to Follow-up|1|||
156766380|NCT03167242|565900470|FG008|Overall Study|Lost to Follow-up|0|||
156766381|NCT03167242|565900471|FG009|Overall Study|Lost to Follow-up|0|||
156766382|NCT03167242|565900472|FG010|Overall Study|Lost to Follow-up|1|||
156766383|NCT03167242|565900473|FG011|Overall Study|Lost to Follow-up|1|||
156766384|NCT03167242|565900462|FG000|Overall Study|Reason not provided|0|||
156766385|NCT03167242|565900463|FG001|Overall Study|Reason not provided|0|||
156427173|NCT04304534|564656545|FG002|Overall Study|Subject Decision|25|||
156427174|NCT04304534|564656546|FG003|Overall Study|Subject Decision|26|||
156427175|NCT04304534|564656543|FG000|Overall Study|Adverse Event|35|||
156427176|NCT04304534|564656544|FG001|Overall Study|Adverse Event|40|||
156427177|NCT04304534|564656545|FG002|Overall Study|Adverse Event|39|||
156427178|NCT04304534|564656546|FG003|Overall Study|Adverse Event|44|||
156427179|NCT01695317|564656547|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
156427180|NCT01695317|564656548|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
156427181|NCT01695317|564656547|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
156427182|NCT01695317|564656548|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
156427183|NCT01466881|564656549|FG000|Overall Study|Ineligible|5|||
156427184|NCT01466881|564656549|FG000|Overall Study|Adverse Event|6|||
156427185|NCT01466881|564656549|FG000|Overall Study|Progression/relapse|20|||
156427186|NCT01466881|564656549|FG000|Overall Study|Death|4|||
156427187|NCT01466881|564656549|FG000|Overall Study|Other reason not protocol specified|5|||
156427188|NCT00957229|564656550|FG000|Study Start|Adverse Event|0|||
156427189|NCT00957229|564656551|FG001|Study Start|Adverse Event|3|||
156427190|NCT00957229|564656550|FG000|Study Start|Disease Progression|1|||
156427191|NCT00957229|564656551|FG001|Study Start|Disease Progression|0|||
156427192|NCT00957229|564656550|FG000|Reallocated to or Continued Vismodegib|Death|1|||
156427193|NCT00957229|564656551|FG001|Reallocated to or Continued Vismodegib|Death|1|||
156427194|NCT00957229|564656550|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
156427195|NCT00957229|564656551|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
156427196|NCT00606580|564656552|FG000|Overall Study|Lost to Follow-up|1|||
156427197|NCT00606580|564656553|FG001|Overall Study|Lost to Follow-up|1|||
156427198|NCT00606580|564656554|FG002|Overall Study|Lost to Follow-up|4|||
156427199|NCT00606580|564656552|FG000|Overall Study|Clinical failures|1|||
156427200|NCT00606580|564656553|FG001|Overall Study|Clinical failures|0|||
156427201|NCT00606580|564656554|FG002|Overall Study|Clinical failures|12|||
156427202|NCT00606580|564656552|FG000|Overall Study|Withdrawal by investigator|0|||
156427203|NCT00606580|564656553|FG001|Overall Study|Withdrawal by investigator|1|||
156427204|NCT00606580|564656554|FG002|Overall Study|Withdrawal by investigator|6|||
156427205|NCT00606580|564656552|FG000|Overall Study|Withdrawal by Subject|0|||
156766386|NCT03167242|565900464|FG002|Overall Study|Reason not provided|0|||
156766387|NCT03167242|565900465|FG003|Overall Study|Reason not provided|0|||
156427206|NCT00606580|564656553|FG001|Overall Study|Withdrawal by Subject|1|||
156427207|NCT00606580|564656554|FG002|Overall Study|Withdrawal by Subject|0|||
156427208|NCT04580303|564656555|FG000|Overall Study|Adverse Event|0|||
156427209|NCT04580303|564656556|FG001|Overall Study|Adverse Event|1|||
156427210|NCT04580303|564656557|FG002|Overall Study|Adverse Event|0|||
156427211|NCT04580303|564656558|FG003|Overall Study|Adverse Event|0|||
156766388|NCT03167242|565900466|FG004|Overall Study|Reason not provided|0|||
156766389|NCT03167242|565900467|FG005|Overall Study|Reason not provided|0|||
156766390|NCT03167242|565900468|FG006|Overall Study|Reason not provided|0|||
156766391|NCT03167242|565900469|FG007|Overall Study|Reason not provided|0|||
156766392|NCT03167242|565900470|FG008|Overall Study|Reason not provided|1|||
156766393|NCT03167242|565900471|FG009|Overall Study|Reason not provided|0|||
156427212|NCT04580303|564656555|FG000|Overall Study|Withdrawal by Subject|0|||
156427213|NCT04580303|564656556|FG001|Overall Study|Withdrawal by Subject|0|||
156427214|NCT04580303|564656557|FG002|Overall Study|Withdrawal by Subject|1|||
156427215|NCT04580303|564656558|FG003|Overall Study|Withdrawal by Subject|0|||
156427216|NCT01833065|564656559|FG000|Overall Study|Adverse Event|6|||
156427217|NCT01833065|564656560|FG001|Overall Study|Adverse Event|1|||
156427218|NCT01833065|564656561|FG002|Overall Study|Adverse Event|0|||
156427219|NCT01833065|564656562|FG003|Overall Study|Adverse Event|2|||
156427220|NCT01833065|564656563|FG004|Overall Study|Adverse Event|3|||
156427221|NCT01833065|564656559|FG000|Overall Study|Protocol Violation|1|||
156766394|NCT03167242|565900472|FG010|Overall Study|Reason not provided|0|||
156766395|NCT03167242|565900473|FG011|Overall Study|Reason not provided|0|||
156766396|NCT03786380|565900474|FG000|Overall Study|Adverse Event|1|||
156766397|NCT03786380|565900475|FG001|Overall Study|Adverse Event|0|||
156766398|NCT03786380|565900476|FG002|Overall Study|Adverse Event|0|||
156427222|NCT01833065|564656560|FG001|Overall Study|Protocol Violation|0|||
156766399|NCT03786380|565900477|FG003|Overall Study|Adverse Event|3|||
156766400|NCT03786380|565900478|FG004|Overall Study|Adverse Event|1|||
156766401|NCT03786380|565900474|FG000|Overall Study|Lack of Efficacy|0|||
156766402|NCT03786380|565900475|FG001|Overall Study|Lack of Efficacy|0|||
156766403|NCT03786380|565900476|FG002|Overall Study|Lack of Efficacy|0|||
156766404|NCT03786380|565900477|FG003|Overall Study|Lack of Efficacy|0|||
156766405|NCT03786380|565900478|FG004|Overall Study|Lack of Efficacy|1|||
156766406|NCT03786380|565900474|FG000|Overall Study|Withdrawal by Subject|1|||
156766407|NCT03786380|565900475|FG001|Overall Study|Withdrawal by Subject|2|||
156766408|NCT03786380|565900476|FG002|Overall Study|Withdrawal by Subject|2|||
156766409|NCT03786380|565900477|FG003|Overall Study|Withdrawal by Subject|1|||
156766410|NCT03786380|565900478|FG004|Overall Study|Withdrawal by Subject|2|||
156766411|NCT03786380|565900474|FG000|Overall Study|Lost to Follow-up|3|||
156766412|NCT03786380|565900475|FG001|Overall Study|Lost to Follow-up|0|||
156766413|NCT03786380|565900476|FG002|Overall Study|Lost to Follow-up|1|||
156766414|NCT03786380|565900477|FG003|Overall Study|Lost to Follow-up|2|||
156766415|NCT03786380|565900478|FG004|Overall Study|Lost to Follow-up|0|||
156766416|NCT03786380|565900474|FG000|Overall Study|Physician Decision|0|||
156766417|NCT03786380|565900475|FG001|Overall Study|Physician Decision|0|||
156766418|NCT03786380|565900476|FG002|Overall Study|Physician Decision|1|||
156766419|NCT03786380|565900477|FG003|Overall Study|Physician Decision|0|||
156766420|NCT03786380|565900478|FG004|Overall Study|Physician Decision|0|||
156766421|NCT03786380|565900474|FG000|Overall Study|Study Terminated by the Sponsor|30|||
156766422|NCT03786380|565900475|FG001|Overall Study|Study Terminated by the Sponsor|20|||
156766423|NCT03786380|565900476|FG002|Overall Study|Study Terminated by the Sponsor|50|||
156766424|NCT03786380|565900477|FG003|Overall Study|Study Terminated by the Sponsor|57|||
156766425|NCT03786380|565900478|FG004|Overall Study|Study Terminated by the Sponsor|23|||
156766426|NCT03786380|565900474|FG000|Overall Study|Reason Not Specified|0|||
156766427|NCT03786380|565900475|FG001|Overall Study|Reason Not Specified|0|||
156766428|NCT03786380|565900476|FG002|Overall Study|Reason Not Specified|0|||
156766429|NCT03786380|565900477|FG003|Overall Study|Reason Not Specified|0|||
156766430|NCT03786380|565900478|FG004|Overall Study|Reason Not Specified|1|||
156766431|NCT01038687|565900481|FG000|Overall Study|Adverse Event|0|||
156766432|NCT01038687|565900482|FG001|Overall Study|Adverse Event|2|||
156766433|NCT01038687|565900483|FG002|Overall Study|Adverse Event|1|||
156766434|NCT05401565|565900484|FG000|Overall Study|Lost to Follow-up|1|||
156766435|NCT05401565|565900485|FG001|Overall Study|Lost to Follow-up|0|||
156766436|NCT05401565|565900484|FG000|Overall Study|Adverse Event|2|||
156766437|NCT05401565|565900485|FG001|Overall Study|Adverse Event|0|||
156766438|NCT02984982|565900486|FG000|Overall Study|Adverse Event|2|||
156766439|NCT02984982|565900487|FG001|Overall Study|Adverse Event|5|||
156766440|NCT02984982|565900486|FG000|Overall Study|Poor Compliance to Protocol|4|||
156766441|NCT02984982|565900487|FG001|Overall Study|Poor Compliance to Protocol|4|||
156766442|NCT02984982|565900486|FG000|Overall Study|Withdrawal by Subject|2|||
156766443|NCT02984982|565900487|FG001|Overall Study|Withdrawal by Subject|0|||
156427223|NCT01833065|564656561|FG002|Overall Study|Protocol Violation|0|||
156427224|NCT01833065|564656562|FG003|Overall Study|Protocol Violation|0|||
156427225|NCT01833065|564656563|FG004|Overall Study|Protocol Violation|2|||
156427226|NCT01833065|564656559|FG000|Overall Study|Lost to Follow-up|1|||
156427227|NCT01833065|564656560|FG001|Overall Study|Lost to Follow-up|0|||
156427228|NCT01833065|564656561|FG002|Overall Study|Lost to Follow-up|0|||
156427229|NCT01833065|564656562|FG003|Overall Study|Lost to Follow-up|0|||
156427230|NCT01833065|564656563|FG004|Overall Study|Lost to Follow-up|3|||
156427231|NCT01833065|564656559|FG000|Overall Study|Withdrawal by Subject|6|||
156427232|NCT01833065|564656560|FG001|Overall Study|Withdrawal by Subject|2|||
156427233|NCT01833065|564656561|FG002|Overall Study|Withdrawal by Subject|4|||
156427234|NCT01833065|564656562|FG003|Overall Study|Withdrawal by Subject|3|||
156427235|NCT01833065|564656563|FG004|Overall Study|Withdrawal by Subject|11|||
156427236|NCT01833065|564656559|FG000|Overall Study|Subject's substantial non-compliance|0|||
156427237|NCT01833065|564656560|FG001|Overall Study|Subject's substantial non-compliance|1|||
156427238|NCT01833065|564656561|FG002|Overall Study|Subject's substantial non-compliance|0|||
156427239|NCT01833065|564656562|FG003|Overall Study|Subject's substantial non-compliance|0|||
156427240|NCT01833065|564656563|FG004|Overall Study|Subject's substantial non-compliance|0|||
156766444|NCT02984982|565900486|FG000|Overall Study|Randomized but not treated|0|||
156766445|NCT02984982|565900487|FG001|Overall Study|Randomized but not treated|1|||
156766446|NCT02175121|565900489|FG000|Overall Study|Lack of Efficacy|1|||
156427241|NCT01833065|564656559|FG000|Overall Study|Trial terminated by sponsor|8|||
156766447|NCT02175121|565900490|FG001|Overall Study|Lack of Efficacy|0|||
156766448|NCT02175121|565900491|FG002|Overall Study|Lack of Efficacy|0|||
156766449|NCT02175121|565900492|FG003|Overall Study|Lack of Efficacy|0|||
156766450|NCT02175121|565900493|FG004|Overall Study|Lack of Efficacy|0|||
156427242|NCT01833065|564656560|FG001|Overall Study|Trial terminated by sponsor|8|||
156427243|NCT01833065|564656561|FG002|Overall Study|Trial terminated by sponsor|7|||
156427244|NCT01833065|564656562|FG003|Overall Study|Trial terminated by sponsor|3|||
156766451|NCT02175121|565900489|FG000|Overall Study|Lost to Follow-up|0|||
156766452|NCT02175121|565900490|FG001|Overall Study|Lost to Follow-up|1|||
156766453|NCT02175121|565900491|FG002|Overall Study|Lost to Follow-up|0|||
156766454|NCT02175121|565900492|FG003|Overall Study|Lost to Follow-up|1|||
156766455|NCT02175121|565900493|FG004|Overall Study|Lost to Follow-up|0|||
156766456|NCT02175121|565900489|FG000|Overall Study|Personal emergency|0|||
156766457|NCT02175121|565900490|FG001|Overall Study|Personal emergency|0|||
156766458|NCT02175121|565900491|FG002|Overall Study|Personal emergency|0|||
156766459|NCT02175121|565900492|FG003|Overall Study|Personal emergency|0|||
156766460|NCT02175121|565900493|FG004|Overall Study|Personal emergency|1|||
156766461|NCT02175121|565900489|FG000|Overall Study|Schedule conflict|0|||
156766462|NCT02175121|565900490|FG001|Overall Study|Schedule conflict|0|||
156766463|NCT02175121|565900491|FG002|Overall Study|Schedule conflict|1|||
156766464|NCT02175121|565900492|FG003|Overall Study|Schedule conflict|0|||
156766465|NCT02175121|565900493|FG004|Overall Study|Schedule conflict|0|||
156766466|NCT02175121|565900489|FG000|Overall Study|Time issues|0|||
156766467|NCT02175121|565900490|FG001|Overall Study|Time issues|0|||
156766468|NCT02175121|565900491|FG002|Overall Study|Time issues|1|||
156766469|NCT02175121|565900492|FG003|Overall Study|Time issues|0|||
156766470|NCT02175121|565900493|FG004|Overall Study|Time issues|0|||
156766471|NCT00931632|565900498|FG000|Overall Study|Withdrawal by Subject|2|||
156766472|NCT00931632|565900499|FG001|Overall Study|Withdrawal by Subject|3|||
156766473|NCT00931632|565900498|FG000|Overall Study|Adverse Event|19|||
156766474|NCT00931632|565900499|FG001|Overall Study|Adverse Event|15|||
156766475|NCT01419314|565900500|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
156766476|NCT01419314|565900501|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
156766477|NCT01419314|565900500|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
156427245|NCT01833065|564656563|FG004|Overall Study|Trial terminated by sponsor|13|||
156427246|NCT01833065|564656559|FG000|Overall Study|Others|2|||
156766478|NCT01419314|565900501|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
156766479|NCT01419314|565900500|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
156766480|NCT01419314|565900501|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
156766481|NCT03139552|565900510|FG000|Overall Study|unable to attend tasting due to schedule|3|||
156766482|NCT00887484|565900519|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
156766483|NCT00887484|565900519|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
156766484|NCT00887484|565900519|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
156766485|NCT03122171|565900521|FG000|Overall Study|Withdrawal by Subject|1|||
156766486|NCT03044314|565900522|FG000|Overall Study|Physician Decision|2|||
156766487|NCT03044314|565900522|FG000|Overall Study|Withdrawal by Subject|1|||
156766488|NCT03044314|565900522|FG000|Overall Study|Connector tubing not available|1|||
156766489|NCT01316224|565900523|FG000|Overall Study|Protocol Violation|3|||
156766490|NCT01316224|565900523|FG000|Overall Study|Adverse Event|3|||
156766491|NCT01316224|565900523|FG000|Overall Study|Lack of Efficacy|1|||
156766492|NCT01316224|565900523|FG000|Overall Study|Withdrawal by Subject|1|||
156766493|NCT01316224|565900523|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
156766494|NCT01316224|565900523|FG000|Overall Study|Other|1|||
156766495|NCT00264147|565900524|FG000|Treatment I Period|Adverse Event|3|||
156766496|NCT00264147|565900525|FG001|Treatment I Period|Adverse Event|6|||
156766497|NCT00264147|565900526|FG002|Treatment I Period|Adverse Event|3|||
156766498|NCT00264147|565900527|FG003|Treatment I Period|Adverse Event|5|||
156766499|NCT00264147|565900528|FG004|Treatment I Period|Adverse Event|7|||
156766500|NCT00264147|565900529|FG005|Treatment I Period|Adverse Event|0|||
156766501|NCT00264147|565900524|FG000|Treatment I Period|Laboratory Adverse Event|0|||
156766502|NCT00264147|565900525|FG001|Treatment I Period|Laboratory Adverse Event|0|||
156766503|NCT00264147|565900526|FG002|Treatment I Period|Laboratory Adverse Event|0|||
156766504|NCT00264147|565900527|FG003|Treatment I Period|Laboratory Adverse Event|1|||
156766505|NCT00264147|565900528|FG004|Treatment I Period|Laboratory Adverse Event|0|||
156766506|NCT00264147|565900529|FG005|Treatment I Period|Laboratory Adverse Event|0|||
156766507|NCT00264147|565900524|FG000|Treatment I Period|Lack of Efficacy|6|||
156766508|NCT00264147|565900525|FG001|Treatment I Period|Lack of Efficacy|2|||
156766509|NCT00264147|565900526|FG002|Treatment I Period|Lack of Efficacy|8|||
156766510|NCT00264147|565900527|FG003|Treatment I Period|Lack of Efficacy|0|||
156766511|NCT00264147|565900528|FG004|Treatment I Period|Lack of Efficacy|1|||
156766512|NCT00264147|565900529|FG005|Treatment I Period|Lack of Efficacy|0|||
156766513|NCT00264147|565900524|FG000|Treatment I Period|Lost to Follow-up|1|||
156766514|NCT00264147|565900525|FG001|Treatment I Period|Lost to Follow-up|0|||
156766515|NCT00264147|565900526|FG002|Treatment I Period|Lost to Follow-up|0|||
156766516|NCT00264147|565900527|FG003|Treatment I Period|Lost to Follow-up|1|||
156766517|NCT00264147|565900528|FG004|Treatment I Period|Lost to Follow-up|1|||
156766518|NCT00264147|565900529|FG005|Treatment I Period|Lost to Follow-up|0|||
156766519|NCT00264147|565900524|FG000|Treatment I Period|Protocol Violation|2|||
156766520|NCT00264147|565900525|FG001|Treatment I Period|Protocol Violation|2|||
156766521|NCT00264147|565900526|FG002|Treatment I Period|Protocol Violation|0|||
156766522|NCT00264147|565900527|FG003|Treatment I Period|Protocol Violation|0|||
156427247|NCT01833065|564656560|FG001|Overall Study|Others|1|||
156766523|NCT00264147|565900528|FG004|Treatment I Period|Protocol Violation|0|||
156766524|NCT00264147|565900529|FG005|Treatment I Period|Protocol Violation|0|||
156766525|NCT00264147|565900524|FG000|Treatment I Period|Withdrawal by Subject|2|||
156427248|NCT01833065|564656561|FG002|Overall Study|Others|1|||
156766526|NCT00264147|565900525|FG001|Treatment I Period|Withdrawal by Subject|0|||
156766527|NCT00264147|565900526|FG002|Treatment I Period|Withdrawal by Subject|0|||
156766528|NCT00264147|565900527|FG003|Treatment I Period|Withdrawal by Subject|2|||
156766529|NCT00264147|565900528|FG004|Treatment I Period|Withdrawal by Subject|2|||
156766530|NCT00264147|565900529|FG005|Treatment I Period|Withdrawal by Subject|0|||
156766531|NCT00264147|565900524|FG000|Treatment I Period|Patient out of town for an extended time|0|||
156766532|NCT00264147|565900525|FG001|Treatment I Period|Patient out of town for an extended time|1|||
156766533|NCT00264147|565900526|FG002|Treatment I Period|Patient out of town for an extended time|0|||
156766534|NCT00264147|565900527|FG003|Treatment I Period|Patient out of town for an extended time|0|||
156766535|NCT00264147|565900528|FG004|Treatment I Period|Patient out of town for an extended time|0|||
156766536|NCT00264147|565900529|FG005|Treatment I Period|Patient out of town for an extended time|0|||
156766537|NCT00264147|565900524|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766538|NCT00264147|565900525|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766539|NCT00264147|565900526|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
156766540|NCT00264147|565900527|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766541|NCT00264147|565900528|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766542|NCT00264147|565900529|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766543|NCT00264147|565900524|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
156766544|NCT00264147|565900525|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
156766545|NCT00264147|565900526|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
156766546|NCT00264147|565900527|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
156766547|NCT00264147|565900528|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
156766548|NCT00264147|565900529|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
156766549|NCT00264147|565900524|FG000|Treatment II Period|Adverse Event|0|||
156766550|NCT00264147|565900525|FG001|Treatment II Period|Adverse Event|0|||
156766551|NCT00264147|565900526|FG002|Treatment II Period|Adverse Event|0|||
156766552|NCT00264147|565900527|FG003|Treatment II Period|Adverse Event|0|||
156766553|NCT00264147|565900528|FG004|Treatment II Period|Adverse Event|9|||
156766554|NCT00264147|565900529|FG005|Treatment II Period|Adverse Event|9|||
156766555|NCT00264147|565900524|FG000|Treatment II Period|Laboratory Adverse Event|0|||
156766556|NCT00264147|565900525|FG001|Treatment II Period|Laboratory Adverse Event|0|||
156766557|NCT00264147|565900526|FG002|Treatment II Period|Laboratory Adverse Event|0|||
156766558|NCT00264147|565900527|FG003|Treatment II Period|Laboratory Adverse Event|0|||
156766559|NCT00264147|565900528|FG004|Treatment II Period|Laboratory Adverse Event|0|||
156766560|NCT00264147|565900529|FG005|Treatment II Period|Laboratory Adverse Event|1|||
156766561|NCT00264147|565900524|FG000|Treatment II Period|Lack of Efficacy|0|||
156766562|NCT00264147|565900525|FG001|Treatment II Period|Lack of Efficacy|0|||
156766563|NCT00264147|565900526|FG002|Treatment II Period|Lack of Efficacy|0|||
156766564|NCT00264147|565900527|FG003|Treatment II Period|Lack of Efficacy|0|||
156766565|NCT00264147|565900528|FG004|Treatment II Period|Lack of Efficacy|20|||
156766566|NCT00264147|565900529|FG005|Treatment II Period|Lack of Efficacy|19|||
156766567|NCT00264147|565900524|FG000|Treatment II Period|Lost to Follow-up|0|||
156766568|NCT00264147|565900525|FG001|Treatment II Period|Lost to Follow-up|0|||
156766569|NCT00264147|565900526|FG002|Treatment II Period|Lost to Follow-up|0|||
156766570|NCT00264147|565900527|FG003|Treatment II Period|Lost to Follow-up|0|||
156766571|NCT00264147|565900528|FG004|Treatment II Period|Lost to Follow-up|1|||
156766572|NCT00264147|565900529|FG005|Treatment II Period|Lost to Follow-up|1|||
156766573|NCT00264147|565900524|FG000|Treatment II Period|Withdrawal by Subject|0|||
156766574|NCT00264147|565900525|FG001|Treatment II Period|Withdrawal by Subject|0|||
156766575|NCT00264147|565900526|FG002|Treatment II Period|Withdrawal by Subject|0|||
156766576|NCT00264147|565900527|FG003|Treatment II Period|Withdrawal by Subject|0|||
156766577|NCT00264147|565900528|FG004|Treatment II Period|Withdrawal by Subject|3|||
156766578|NCT00264147|565900529|FG005|Treatment II Period|Withdrawal by Subject|2|||
156766579|NCT00264147|565900524|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766580|NCT00264147|565900525|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766581|NCT00264147|565900526|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766582|NCT00264147|565900527|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766583|NCT00264147|565900528|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766584|NCT00264147|565900529|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
156766585|NCT03234465|565900530|FG000|Overall Study|Adverse Event|4|||
156766586|NCT03234465|565900531|FG001|Overall Study|Adverse Event|2|||
156766587|NCT03234465|565900530|FG000|Overall Study|Death|0|||
156766588|NCT03234465|565900531|FG001|Overall Study|Death|1|||
156766589|NCT03234465|565900530|FG000|Overall Study|Lost to Follow-up|1|||
156766590|NCT03234465|565900531|FG001|Overall Study|Lost to Follow-up|1|||
156766591|NCT03234465|565900530|FG000|Overall Study|Withdrawal by Subject|12|||
156766592|NCT03234465|565900531|FG001|Overall Study|Withdrawal by Subject|27|||
156766593|NCT03234465|565900530|FG000|Overall Study|Symptomatic deterioration|0|||
156766594|NCT03234465|565900531|FG001|Overall Study|Symptomatic deterioration|1|||
156766595|NCT03234465|565900530|FG000|Overall Study|Non-compliance|2|||
156766596|NCT03234465|565900531|FG001|Overall Study|Non-compliance|0|||
156766597|NCT03234465|565900530|FG000|Overall Study|Other|14|||
156766598|NCT03234465|565900531|FG001|Overall Study|Other|8|||
156766599|NCT00720499|565900532|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
156766600|NCT00720499|565900533|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156766601|NCT00720499|565900532|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
156766602|NCT00720499|565900533|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
156766603|NCT00720499|565900532|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
156766604|NCT00720499|565900533|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
156766605|NCT00721799|565900538|FG000|Overall Study|Withdrawal by Subject|7|||
156766606|NCT00721799|565900538|FG000|Overall Study|withdraw by subject after scan 1|1|||
156766607|NCT01441973|565900539|FG000|Overall Study|Disease progression|8|||
156766608|NCT01441973|565900540|FG001|Overall Study|Disease progression|6|||
156766609|NCT01441973|565900539|FG000|Overall Study|Adverse event unrelated to study drug|3|||
156766610|NCT01441973|565900540|FG001|Overall Study|Adverse event unrelated to study drug|2|||
156766611|NCT01441973|565900539|FG000|Overall Study|Participant request to discontinue|1|||
156766612|NCT01441973|565900540|FG001|Overall Study|Participant request to discontinue|1|||
156766613|NCT01441973|565900539|FG000|Overall Study|Poor compliance/noncompliance|0|||
156766614|NCT01441973|565900540|FG001|Overall Study|Poor compliance/noncompliance|1|||
156766615|NCT01441973|565900539|FG000|Overall Study|Administrative reason by sponsor|3|||
156766616|NCT01441973|565900540|FG001|Overall Study|Administrative reason by sponsor|5|||
156766617|NCT01441973|565900539|FG000|Overall Study|Participant withdrew consent|0|||
156766618|NCT01441973|565900540|FG001|Overall Study|Participant withdrew consent|1|||
156766619|NCT00617279|565900541|FG000|Overall Study|Study terminated by Sponsor|10|||
156766620|NCT00617279|565900542|FG001|Overall Study|Study terminated by Sponsor|15|||
156766621|NCT00617279|565900541|FG000|Overall Study|Graft abandonment|2|||
156766622|NCT00617279|565900542|FG001|Overall Study|Graft abandonment|0|||
156766623|NCT00617279|565900541|FG000|Overall Study|Lost to Follow-up|1|||
156766624|NCT00617279|565900542|FG001|Overall Study|Lost to Follow-up|0|||
156766625|NCT00617279|565900541|FG000|Overall Study|Death|1|||
156766626|NCT00617279|565900542|FG001|Overall Study|Death|2|||
156766627|NCT02351934|565903013|FG000|Allocation|POD weight<pre-op weight|3|||
156766628|NCT02351934|565903014|FG001|Allocation|POD weight<pre-op weight|0|||
156766629|NCT02351934|565903013|FG000|Allocation|Hypotension preventing administration|2|||
156766630|NCT02351934|565903014|FG001|Allocation|Hypotension preventing administration|0|||
156766631|NCT02351934|565903013|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
156766632|NCT02351934|565903014|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
156766633|NCT02351934|565903013|FG000|Follow-Up|POD weight<pre-op weight|3|||
156766634|NCT02351934|565903014|FG001|Follow-Up|POD weight<pre-op weight|0|||
156766635|NCT02351934|565903013|FG000|Follow-Up|Acute Kidney Injury|1|||
156766636|NCT02351934|565903014|FG001|Follow-Up|Acute Kidney Injury|0|||
156766637|NCT02351934|565903013|FG000|Follow-Up|Early dismissal|3|||
156766638|NCT02351934|565903014|FG001|Follow-Up|Early dismissal|0|||
156766639|NCT02351934|565903013|FG000|Follow-Up|Hypotension|3|||
156766640|NCT02351934|565903014|FG001|Follow-Up|Hypotension|0|||
156766641|NCT02351934|565903013|FG000|Follow-Up|No documentation|2|||
156766642|NCT02351934|565903014|FG001|Follow-Up|No documentation|0|||
156766643|NCT02351934|565903013|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
156766644|NCT02351934|565903014|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
156766645|NCT02351934|565903013|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
156766646|NCT02351934|565903014|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
156766647|NCT02014272|565903018|FG000|Intervention Period 1|Withdrawal by Subject|1|||
156766648|NCT02014272|565903019|FG001|Intervention Period 1|Withdrawal by Subject|0|||
156766649|NCT02014272|565903018|FG000|Intervention Period 1|Adverse Event|0|||
156766650|NCT02014272|565903019|FG001|Intervention Period 1|Adverse Event|1|||
156766651|NCT03499795|565903020|FG000|Overall Study|Adverse Event|1|||
156766652|NCT03499795|565903020|FG000|Overall Study|Lost to Follow-up|1|||
156766653|NCT00547339|565903021|FG000|Overall Study|Physician Decision|0|||
156766654|NCT00547339|565903022|FG001|Overall Study|Physician Decision|0|||
156766655|NCT00547339|565903023|FG002|Overall Study|Physician Decision|1|||
156766656|NCT00547339|565903024|FG003|Overall Study|Physician Decision|0|||
156766657|NCT03736967|565903025|FG000|Overall Study|Withdrawal by Subject|26|||
156766658|NCT03736967|565903026|FG001|Overall Study|Withdrawal by Subject|25|||
156766659|NCT03736967|565903027|FG002|Overall Study|Withdrawal by Subject|23|||
156766660|NCT03736967|565903028|FG003|Overall Study|Withdrawal by Subject|26|||
156427249|NCT01833065|564656562|FG003|Overall Study|Others|1|||
156427250|NCT01833065|564656563|FG004|Overall Study|Others|4|||
156766661|NCT03736967|565903025|FG000|Overall Study|Lost to Follow-up|3|||
156766662|NCT03736967|565903026|FG001|Overall Study|Lost to Follow-up|2|||
156766663|NCT03736967|565903027|FG002|Overall Study|Lost to Follow-up|1|||
156766664|NCT03736967|565903028|FG003|Overall Study|Lost to Follow-up|1|||
156766665|NCT03736967|565903025|FG000|Overall Study|Physician Decision|1|||
156766666|NCT03736967|565903026|FG001|Overall Study|Physician Decision|0|||
156766667|NCT03736967|565903027|FG002|Overall Study|Physician Decision|0|||
156766668|NCT03736967|565903028|FG003|Overall Study|Physician Decision|1|||
156766669|NCT03736967|565903025|FG000|Overall Study|Adverse Event|0|||
156766670|NCT03736967|565903026|FG001|Overall Study|Adverse Event|1|||
156427251|NCT00927823|564656567|FG000|Continuous Dosing Period|Death|0|||
156766671|NCT03736967|565903027|FG002|Overall Study|Adverse Event|0|||
156766672|NCT03736967|565903028|FG003|Overall Study|Adverse Event|1|||
156766673|NCT03736967|565903025|FG000|Overall Study|Death|0|||
156766674|NCT03736967|565903026|FG001|Overall Study|Death|0|||
156766675|NCT03736967|565903027|FG002|Overall Study|Death|0|||
156766676|NCT03736967|565903028|FG003|Overall Study|Death|1|||
156766677|NCT03736967|565903025|FG000|Overall Study|Randomized but never treated|1|||
156766678|NCT03736967|565903026|FG001|Overall Study|Randomized but never treated|0|||
156766679|NCT03736967|565903027|FG002|Overall Study|Randomized but never treated|0|||
156766680|NCT03736967|565903028|FG003|Overall Study|Randomized but never treated|0|||
156766681|NCT02369653|565903029|FG000|Overall Study|Lost to Follow-up|0|||
156766682|NCT02369653|565903030|FG001|Overall Study|Lost to Follow-up|1|||
156766683|NCT02369653|565903029|FG000|Overall Study|Administrative reason by sponsor|0|||
156766684|NCT02369653|565903030|FG001|Overall Study|Administrative reason by sponsor|1|||
156766685|NCT02369653|565903029|FG000|Overall Study|Death|1|||
156766686|NCT02369653|565903030|FG001|Overall Study|Death|2|||
156766687|NCT02369653|565903029|FG000|Overall Study|Participant withdrew consent|13|||
156766688|NCT02369653|565903030|FG001|Overall Study|Participant withdrew consent|3|||
156766689|NCT03587636|565903031|FG000|Overall Study|Lost to Follow-up|2|||
156766690|NCT03587636|565903032|FG001|Overall Study|Lost to Follow-up|5|||
156766691|NCT01458587|565903033|FG000|Overall Study|Withdrawal by Subject|1|||
156766692|NCT01458587|565903034|FG001|Overall Study|Withdrawal by Subject|0|||
156766693|NCT01603602|565903035|FG000|Overall Study|Adverse Event|1|||
156766694|NCT01603602|565903036|FG001|Overall Study|Adverse Event|0|||
156766695|NCT01603602|565903037|FG002|Overall Study|Adverse Event|0|||
156766696|NCT01603602|565903035|FG000|Overall Study|Personal Reasons|1|||
156655925|NCT04634409|565485858|FG009|Overall Study|Other - As reported by Investigator|0|||
156655926|NCT04634409|565485859|FG010|Overall Study|Other - As reported by Investigator|1|||
156655927|NCT04634409|565485860|FG011|Overall Study|Other - As reported by Investigator|2|||
156655928|NCT04634409|565485861|FG012|Overall Study|Other - As reported by Investigator|2|||
156655929|NCT04634409|565485862|FG013|Overall Study|Other - As reported by Investigator|1|||
156655930|NCT04634409|565485863|FG014|Overall Study|Other - As reported by Investigator|0|||
156655931|NCT04634409|565485864|FG015|Overall Study|Other - As reported by Investigator|0|||
156655932|NCT04634409|565485865|FG016|Overall Study|Other - As reported by Investigator|0|||
156655933|NCT04634409|565485866|FG017|Overall Study|Other - As reported by Investigator|0|||
156655934|NCT04634409|565485867|FG018|Overall Study|Other - As reported by Investigator|0|||
156766697|NCT01603602|565903036|FG001|Overall Study|Personal Reasons|0|||
156766698|NCT01603602|565903037|FG002|Overall Study|Personal Reasons|1|||
156766699|NCT04748718|565903041|FG000|Overall Study|Lost to Follow-up|50|||
156766700|NCT00316004|565903042|FG000|Overall Study|Subject was not given study fluid.|14|||
156766701|NCT00316004|565903043|FG001|Overall Study|Subject was not given study fluid.|14|||
156766702|NCT00316004|565903044|FG002|Overall Study|Subject was not given study fluid.|21|||
156766703|NCT01118299|565903046|FG000|Overall Study|Death|7|||
156766704|NCT01118299|565903047|FG001|Overall Study|Death|5|||
156655935|NCT04634409|565485868|FG019|Overall Study|Other - As reported by Investigator|0|||
156655936|NCT04634409|565485869|FG020|Overall Study|Other - As reported by Investigator|0|||
156766705|NCT01118299|565903046|FG000|Overall Study|Withdrawal by Subject|8|||
156427252|NCT00927823|564656568|FG001|Continuous Dosing Period|Death|0|||
156427253|NCT00927823|564656569|FG002|Continuous Dosing Period|Death|6|||
156766706|NCT01118299|565903047|FG001|Overall Study|Withdrawal by Subject|8|||
156766707|NCT01118299|565903046|FG000|Overall Study|Lost to Follow-up|2|||
156766708|NCT01118299|565903047|FG001|Overall Study|Lost to Follow-up|1|||
156766709|NCT01118299|565903046|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
156766710|NCT01118299|565903047|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
156766711|NCT01935089|565903048|FG000|Overall Study|Adverse Event|2|||
156766712|NCT01935089|565903048|FG000|Overall Study|Withdrawal by Subject|1|||
156766713|NCT02932943|565903049|FG000|Overall Study|Lost to Follow-up|0|||
156766714|NCT02932943|565903050|FG001|Overall Study|Lost to Follow-up|2|||
156766715|NCT02932943|565903049|FG000|Overall Study|Adverse Event|2|||
156766716|NCT02932943|565903050|FG001|Overall Study|Adverse Event|2|||
156766717|NCT02932943|565903049|FG000|Overall Study|Withdrawal by Subject|3|||
156766718|NCT02932943|565903050|FG001|Overall Study|Withdrawal by Subject|3|||
156427254|NCT00927823|564656570|FG003|Continuous Dosing Period|Death|0|||
156655937|NCT04634409|565485870|FG021|Overall Study|Other - As reported by Investigator|0|||
156655938|NCT04634409|565485871|FG022|Overall Study|Other - As reported by Investigator|0|||
156655939|NCT04634409|565485872|FG023|Overall Study|Other - As reported by Investigator|0|||
156766719|NCT02665117|565903053|FG000|Overall Study|Physician Decision|1|||
156766720|NCT02665117|565903054|FG001|Overall Study|Physician Decision|0|||
156766721|NCT02337491|565903057|FG000|Overall Study|Death|1|||
156766722|NCT02337491|565903058|FG001|Overall Study|Death|1|||
156766723|NCT02337491|565903057|FG000|Overall Study|Adverse Event|0|||
156766724|NCT02337491|565903058|FG001|Overall Study|Adverse Event|1|||
156766725|NCT02337491|565903057|FG000|Overall Study|Withdrawal by Subject|3|||
156766726|NCT02337491|565903058|FG001|Overall Study|Withdrawal by Subject|0|||
156766727|NCT02337491|565903057|FG000|Overall Study|Progressive Disease|44|||
156427255|NCT00927823|564656567|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
156766728|NCT02337491|565903058|FG001|Overall Study|Progressive Disease|28|||
156766729|NCT02337491|565903057|FG000|Overall Study|On Treatment|2|||
156766730|NCT02337491|565903058|FG001|Overall Study|On Treatment|0|||
156766731|NCT01432951|565903059|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
156766732|NCT03712280|565903069|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
156766733|NCT03712280|565903070|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
156766734|NCT03712280|565903071|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
156766735|NCT03712280|565903072|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
156766736|NCT03712280|565903069|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
156766737|NCT03712280|565903070|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
156766738|NCT03712280|565903071|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
156766739|NCT03712280|565903072|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
156766740|NCT03712280|565903069|FG000|Overall Study|Adverse Event|0|||
156766741|NCT03712280|565903070|FG001|Overall Study|Adverse Event|0|||
156766742|NCT03712280|565903071|FG002|Overall Study|Adverse Event|1|||
156766743|NCT03712280|565903072|FG003|Overall Study|Adverse Event|0|||
156766744|NCT00551369|565903073|FG000|Overall Study|Protocol Violation|5|||
156766745|NCT00551369|565903073|FG000|Overall Study|Withdrawal by Subject|1|||
156766746|NCT00551369|565903073|FG000|Overall Study|Not treated per protocol and re|1|||
156766747|NCT03439137|565903076|FG000|Overall Study|Adverse Event|16|||
156766748|NCT03439137|565903077|FG001|Overall Study|Adverse Event|12|||
156766749|NCT03439137|565903076|FG000|Overall Study|Physician Decision|0|||
156766750|NCT03439137|565903077|FG001|Overall Study|Physician Decision|5|||
156766751|NCT03439137|565903076|FG000|Overall Study|Withdrawal by Subject|14|||
156766752|NCT03439137|565903077|FG001|Overall Study|Withdrawal by Subject|4|||
156766753|NCT03439137|565903076|FG000|Overall Study|Conducting rescue therapy|2|||
156766754|NCT03439137|565903077|FG001|Overall Study|Conducting rescue therapy|1|||
156766755|NCT03439137|565903076|FG000|Overall Study|Difficult to control Hb|10|||
156766756|NCT03439137|565903077|FG001|Overall Study|Difficult to control Hb|2|||
156766757|NCT03439137|565903076|FG000|Overall Study|Initiation of a renal transplant|0|||
156766758|NCT03439137|565903077|FG001|Overall Study|Initiation of a renal transplant|2|||
156766759|NCT01569022|565903081|FG000|First Intervention|Lost to Follow-up|2|||
156766760|NCT01569022|565903082|FG001|First Intervention|Lost to Follow-up|1|||
156766761|NCT01569022|565903081|FG000|Second Intervention|Lost to Follow-up|2|||
156766762|NCT01569022|565903082|FG001|Second Intervention|Lost to Follow-up|2|||
156766763|NCT00644059|565903087|FG000|Overall Study|Lost to Follow-up|37|||
156766764|NCT00644059|565903088|FG001|Overall Study|Lost to Follow-up|34|||
156766765|NCT00644059|565903089|FG002|Overall Study|Lost to Follow-up|16|||
156766766|NCT00644059|565903087|FG000|Overall Study|Withdrawal by Subject|52|||
156766767|NCT00644059|565903088|FG001|Overall Study|Withdrawal by Subject|60|||
156766768|NCT00644059|565903089|FG002|Overall Study|Withdrawal by Subject|30|||
156766769|NCT00644059|565903087|FG000|Overall Study|Adverse Event|8|||
156766770|NCT00644059|565903088|FG001|Overall Study|Adverse Event|5|||
156766771|NCT00644059|565903089|FG002|Overall Study|Adverse Event|1|||
156766772|NCT00644059|565903087|FG000|Overall Study|Inappropriate Enrollment|1|||
156766773|NCT00644059|565903088|FG001|Overall Study|Inappropriate Enrollment|3|||
156766774|NCT00644059|565903089|FG002|Overall Study|Inappropriate Enrollment|0|||
156766775|NCT00644059|565903087|FG000|Overall Study|Protocol Deviation/violation|20|||
156766776|NCT00644059|565903088|FG001|Overall Study|Protocol Deviation/violation|19|||
156766777|NCT00644059|565903089|FG002|Overall Study|Protocol Deviation/violation|15|||
156766778|NCT00644059|565903087|FG000|Overall Study|Unable to classify|6|||
156766779|NCT00644059|565903088|FG001|Overall Study|Unable to classify|2|||
156766780|NCT00644059|565903089|FG002|Overall Study|Unable to classify|3|||
156766781|NCT01302899|565903090|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
156766782|NCT01302899|565903091|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
156766783|NCT01302899|565903090|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
156766784|NCT01302899|565903091|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
156766785|NCT02834975|565903092|FG000|Overall Study|Physician Decision|2|||
156766786|NCT02834975|565903092|FG000|Overall Study|Adverse Event|1|||
156766787|NCT02834975|565903092|FG000|Overall Study|Withdrawal by Subject|1|||
156766788|NCT02834975|565903092|FG000|Overall Study|Lack of Efficacy|1|||
156766789|NCT03482024|565903094|FG000|Overall Study|Physician Decision|1|||
156766790|NCT03482024|565903095|FG001|Overall Study|Physician Decision|0|||
156766791|NCT03482024|565903096|FG002|Overall Study|Physician Decision|0|||
156766792|NCT03482024|565903097|FG003|Overall Study|Physician Decision|0|||
156766793|NCT03482024|565903098|FG004|Overall Study|Physician Decision|0|||
156766794|NCT00472420|565903099|FG000|Induction Treatment Period|Physician Decision|9|||
156766795|NCT00472420|565903099|FG000|Induction Treatment Period|Adverse Event|3|||
156766796|NCT00472420|565903099|FG000|Induction Treatment Period|Non-compliance|1|||
156766797|NCT00472420|565903099|FG000|Induction Treatment Period|Death|3|||
156766798|NCT00472420|565903099|FG000|Follow-up Period|Death|5|||
156766799|NCT00472420|565903099|FG000|Follow-up Period|Physician Decision|9|||
156766800|NCT00472420|565903099|FG000|Follow-up Period|Lost to Follow-up|2|||
156766801|NCT00472420|565903099|FG000|Follow-up Period|Protocol Violation|1|||
156322892|NCT02925793|564280292|FG000|Overall Study|Other:|2|||
156766802|NCT00686972|565903101|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
156766803|NCT02065557|565903102|FG000|Induction Period|Withdrawal by Subject|2|||
156766804|NCT02065557|565903103|FG001|Induction Period|Withdrawal by Subject|1|||
156766805|NCT02065557|565903104|FG002|Induction Period|Withdrawal by Subject|0|||
156766806|NCT02065557|565903105|FG003|Induction Period|Withdrawal by Subject|0|||
156766807|NCT02065557|565903106|FG004|Induction Period|Withdrawal by Subject|0|||
156766808|NCT02065557|565903107|FG005|Induction Period|Withdrawal by Subject|0|||
156766809|NCT02065557|565903102|FG000|Induction Period|Lack of Efficacy|2|||
156766810|NCT02065557|565903103|FG001|Induction Period|Lack of Efficacy|1|||
156766811|NCT02065557|565903104|FG002|Induction Period|Lack of Efficacy|1|||
156766812|NCT02065557|565903105|FG003|Induction Period|Lack of Efficacy|0|||
156766813|NCT02065557|565903106|FG004|Induction Period|Lack of Efficacy|0|||
156766814|NCT02065557|565903107|FG005|Induction Period|Lack of Efficacy|0|||
156766815|NCT02065557|565903102|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
156766816|NCT02065557|565903103|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
156766817|NCT02065557|565903104|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
156766818|NCT02065557|565903105|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
156766819|NCT02065557|565903106|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
156766820|NCT02065557|565903107|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
156766821|NCT02065557|565903102|FG000|Induction Period|Non-Responder at Week 8|4|||
156766822|NCT02065557|565903103|FG001|Induction Period|Non-Responder at Week 8|4|||
156766823|NCT02065557|565903104|FG002|Induction Period|Non-Responder at Week 8|0|||
156766824|NCT02065557|565903105|FG003|Induction Period|Non-Responder at Week 8|0|||
156766825|NCT02065557|565903106|FG004|Induction Period|Non-Responder at Week 8|0|||
156766826|NCT02065557|565903107|FG005|Induction Period|Non-Responder at Week 8|0|||
156766827|NCT02065557|565903102|FG000|Induction Period|Adverse Event|1|||
156766828|NCT02065557|565903103|FG001|Induction Period|Adverse Event|1|||
156766829|NCT02065557|565903104|FG002|Induction Period|Adverse Event|0|||
156766830|NCT02065557|565903105|FG003|Induction Period|Adverse Event|0|||
156766831|NCT02065557|565903106|FG004|Induction Period|Adverse Event|0|||
156766832|NCT02065557|565903107|FG005|Induction Period|Adverse Event|0|||
156766833|NCT02065557|565903102|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
156766834|NCT02065557|565903103|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
156766835|NCT02065557|565903104|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
156766836|NCT02065557|565903105|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
156766837|NCT02065557|565903106|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
156766838|NCT02065557|565903107|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
156766839|NCT02065557|565903102|FG000|Maintenance Period|Withdrawal by Subject|0|||
156766840|NCT02065557|565903103|FG001|Maintenance Period|Withdrawal by Subject|0|||
156766841|NCT02065557|565903104|FG002|Maintenance Period|Withdrawal by Subject|0|||
156766842|NCT02065557|565903105|FG003|Maintenance Period|Withdrawal by Subject|0|||
156766843|NCT02065557|565903106|FG004|Maintenance Period|Withdrawal by Subject|2|||
156766844|NCT02065557|565903107|FG005|Maintenance Period|Withdrawal by Subject|1|||
156766845|NCT02065557|565903102|FG000|Maintenance Period|Lack of Efficacy|0|||
156766846|NCT02065557|565903103|FG001|Maintenance Period|Lack of Efficacy|0|||
156766847|NCT02065557|565903104|FG002|Maintenance Period|Lack of Efficacy|0|||
156766848|NCT02065557|565903105|FG003|Maintenance Period|Lack of Efficacy|0|||
156766849|NCT02065557|565903106|FG004|Maintenance Period|Lack of Efficacy|5|||
156766850|NCT02065557|565903107|FG005|Maintenance Period|Lack of Efficacy|2|||
156766851|NCT02065557|565903102|FG000|Maintenance Period|Subject Non-Compliance|0|||
156766852|NCT02065557|565903103|FG001|Maintenance Period|Subject Non-Compliance|0|||
156766853|NCT02065557|565903104|FG002|Maintenance Period|Subject Non-Compliance|0|||
156427256|NCT00927823|564656568|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
156427257|NCT00927823|564656569|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
156427258|NCT00927823|564656570|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
156427259|NCT00927823|564656567|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
156427260|NCT00927823|564656568|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
156427261|NCT00927823|564656569|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
156427262|NCT00927823|564656570|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
156427263|NCT00927823|564656567|FG000|Continuous Dosing Period|Other|1|||
156427264|NCT00927823|564656568|FG001|Continuous Dosing Period|Other|2|||
156427265|NCT00927823|564656569|FG002|Continuous Dosing Period|Other|9|||
156766854|NCT02065557|565903105|FG003|Maintenance Period|Subject Non-Compliance|0|||
156766855|NCT02065557|565903106|FG004|Maintenance Period|Subject Non-Compliance|0|||
156766856|NCT02065557|565903107|FG005|Maintenance Period|Subject Non-Compliance|1|||
156766857|NCT01462942|565903111|FG000|Overall Study|Adverse Event|7|||
156766858|NCT01462942|565903112|FG001|Overall Study|Adverse Event|12|||
156766859|NCT01462942|565903113|FG002|Overall Study|Adverse Event|10|||
156766860|NCT01462942|565903114|FG003|Overall Study|Adverse Event|11|||
156766861|NCT01462942|565903115|FG004|Overall Study|Adverse Event|11|||
156766862|NCT01462942|565903111|FG000|Overall Study|Other, including COPD exacerbation|3|||
156766863|NCT01462942|565903112|FG001|Overall Study|Other, including COPD exacerbation|5|||
156766864|NCT01462942|565903113|FG002|Overall Study|Other, including COPD exacerbation|2|||
156322893|NCT02925793|564280293|FG001|Overall Study|Other:|1|||
156322894|NCT02925793|564280294|FG002|Overall Study|Other:|3|||
156322895|NCT00393042|564280297|FG000|First Intervention|Withdrawal by Subject|1|||
156322896|NCT00393042|564280298|FG001|First Intervention|Withdrawal by Subject|2|||
156322897|NCT00393042|564280297|FG000|First Intervention|Lost to Follow-up|3|||
156322898|NCT00393042|564280298|FG001|First Intervention|Lost to Follow-up|3|||
156322899|NCT00393042|564280297|FG000|First Intervention|Protocol Violation|1|||
156322900|NCT00393042|564280298|FG001|First Intervention|Protocol Violation|0|||
156322901|NCT00393042|564280297|FG000|First Intervention|Adverse Event|0|||
156322902|NCT00393042|564280298|FG001|First Intervention|Adverse Event|1|||
156427266|NCT00927823|564656570|FG003|Continuous Dosing Period|Other|3|||
156427267|NCT00828672|564656571|FG000|Study Treatment|Lost to Follow-up|1|||
156427268|NCT00828672|564656572|FG001|Study Treatment|Lost to Follow-up|0|||
156522529|NCT03184870|565007743|FG013|Initial Treatment|Withdrawal by Subject|0|||
156522530|NCT03184870|565007744|FG014|Initial Treatment|Withdrawal by Subject|1|||
156522531|NCT03184870|565007745|FG015|Initial Treatment|Withdrawal by Subject|5|||
156522532|NCT03184870|565007746|FG016|Initial Treatment|Withdrawal by Subject|2|||
156522533|NCT03184870|565007747|FG017|Initial Treatment|Withdrawal by Subject|2|||
156655940|NCT04634409|565485873|FG024|Overall Study|Other - As reported by Investigator|0|||
156427269|NCT00828672|564656571|FG000|Study Treatment|Adverse Event|0|||
156427270|NCT00828672|564656572|FG001|Study Treatment|Adverse Event|1|||
156427271|NCT00828672|564656571|FG000|Study Treatment|Complete response, no surgery|1|||
156427272|NCT00828672|564656572|FG001|Study Treatment|Complete response, no surgery|1|||
156427273|NCT00828672|564656571|FG000|Post-surgery (<30 Days)|No central review materials|0|||
156427274|NCT00828672|564656572|FG001|Post-surgery (<30 Days)|No central review materials|1|||
156427275|NCT00601640|564656573|FG000|Overall Study|Withdrawal by Subject|3|||
156322903|NCT00393042|564280297|FG000|Second Intervetion|Adverse Event|0|||
156322904|NCT00393042|564280298|FG001|Second Intervetion|Adverse Event|3|||
156322905|NCT00393042|564280297|FG000|Second Intervetion|Withdrawal by Subject|0|||
156322906|NCT00393042|564280298|FG001|Second Intervetion|Withdrawal by Subject|2|||
156322907|NCT00393042|564280297|FG000|Second Intervetion|Lack of Efficacy|1|||
156322908|NCT00393042|564280298|FG001|Second Intervetion|Lack of Efficacy|0|||
156322909|NCT00393042|564280297|FG000|Second Intervetion|Lost to Follow-up|0|||
156322910|NCT00393042|564280298|FG001|Second Intervetion|Lost to Follow-up|2|||
156322911|NCT00393042|564280297|FG000|Second Intervetion|Protocol Violation|1|||
156322912|NCT00393042|564280298|FG001|Second Intervetion|Protocol Violation|1|||
156427276|NCT00601640|564656574|FG001|Overall Study|Withdrawal by Subject|0|||
156427277|NCT00601640|564656575|FG002|Overall Study|Withdrawal by Subject|7|||
156427278|NCT00601640|564656573|FG000|Overall Study|Death|1|||
156427279|NCT00601640|564656574|FG001|Overall Study|Death|0|||
156427280|NCT00601640|564656575|FG002|Overall Study|Death|0|||
156655941|NCT04634409|565485874|FG025|Overall Study|Other - As reported by Investigator|0|||
156655942|NCT04634409|565485875|FG026|Overall Study|Other - As reported by Investigator|0|||
156655943|NCT02683187|565485876|FG000|Overall Study|Failed IV access|3|||
156322913|NCT02045303|564280302|FG000|Overall Study|Protocol Violation|2|||
156322914|NCT02045303|564280303|FG001|Overall Study|Protocol Violation|1|||
156322915|NCT02045303|564280304|FG002|Overall Study|Protocol Violation|0|||
156322916|NCT02045303|564280302|FG000|Overall Study|Withdrawal by Subject|0|||
156655944|NCT02683187|565485876|FG000|Overall Study|Withdrawal by Subject|5|||
156655945|NCT03471078|565487377|FG000|Overall Study|Withdrawal by Subject|9|||
156655946|NCT03471078|565487378|FG001|Overall Study|Withdrawal by Subject|1|||
156655947|NCT03471078|565487377|FG000|Overall Study|Adverse Event|4|||
156655948|NCT03471078|565487378|FG001|Overall Study|Adverse Event|1|||
156655949|NCT03471078|565487377|FG000|Overall Study|Physician Decision|3|||
156655950|NCT03471078|565487378|FG001|Overall Study|Physician Decision|2|||
156655951|NCT03471078|565487377|FG000|Overall Study|Death|2|||
156655952|NCT03471078|565487378|FG001|Overall Study|Death|0|||
156655953|NCT03471078|565487377|FG000|Overall Study|Other|3|||
156655954|NCT03471078|565487378|FG001|Overall Study|Other|2|||
156655955|NCT00278200|565487379|FG000|Overall Study|Death|1|||
156655956|NCT00278200|565487380|FG001|Overall Study|Death|3|||
156655957|NCT00278200|565487379|FG000|Overall Study|Physician Decision|0|||
156655958|NCT00278200|565487380|FG001|Overall Study|Physician Decision|1|||
156655959|NCT05568225|565487388|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
156655960|NCT05568225|565487389|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
156655961|NCT05568225|565487390|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
156655962|NCT05568225|565487388|FG000|Primary Treatment Period|Physician Decision|0|||
156655963|NCT05568225|565487389|FG001|Primary Treatment Period|Physician Decision|1|||
156655964|NCT05568225|565487390|FG002|Primary Treatment Period|Physician Decision|0|||
156655965|NCT05568225|565487388|FG000|Primary Treatment Period|Disease progression|0|||
156655966|NCT05568225|565487389|FG001|Primary Treatment Period|Disease progression|1|||
156655967|NCT05568225|565487390|FG002|Primary Treatment Period|Disease progression|0|||
156655968|NCT05568225|565487388|FG000|Primary Treatment Period|Lack of Efficacy|0|||
156655969|NCT05568225|565487389|FG001|Primary Treatment Period|Lack of Efficacy|1|||
156655970|NCT05568225|565487390|FG002|Primary Treatment Period|Lack of Efficacy|0|||
156655971|NCT05568225|565487388|FG000|Primary Treatment Period|Withdrawal of conset|1|||
156427281|NCT00601640|564656573|FG000|Overall Study|Adverse Event|0|||
156427282|NCT00601640|564656574|FG001|Overall Study|Adverse Event|4|||
156427283|NCT00601640|564656575|FG002|Overall Study|Adverse Event|2|||
156427284|NCT00601640|564656573|FG000|Overall Study|intercurrent illness|1|||
156427285|NCT00601640|564656574|FG001|Overall Study|intercurrent illness|0|||
156427286|NCT00601640|564656575|FG002|Overall Study|intercurrent illness|0|||
156427287|NCT00601640|564656573|FG000|Overall Study|change in eligibility status|0|||
156427288|NCT00601640|564656574|FG001|Overall Study|change in eligibility status|1|||
156427289|NCT00601640|564656575|FG002|Overall Study|change in eligibility status|1|||
156427290|NCT00015457|564656582|FG000|First Intervention|Adverse Event|0|||
156427291|NCT00015457|564656583|FG001|First Intervention|Adverse Event|2|||
156427292|NCT00015457|564656582|FG000|First Intervention|Lack of Efficacy|0|||
156427293|NCT00015457|564656583|FG001|First Intervention|Lack of Efficacy|1|||
156427294|NCT00015457|564656582|FG000|Second Intervention|Withdrawal by Subject|1|||
156427295|NCT00015457|564656583|FG001|Second Intervention|Withdrawal by Subject|0|||
156427296|NCT01456936|564656588|FG000|Overall Study|Other reason|41|||
156427297|NCT01456936|564656589|FG001|Overall Study|Other reason|30|||
156427298|NCT01456936|564656590|FG002|Overall Study|Other reason|36|||
156427299|NCT01456936|564656591|FG003|Overall Study|Other reason|33|||
156427300|NCT01456936|564656588|FG000|Overall Study|No longer meets eligibility criteria|4|||
156427301|NCT01456936|564656589|FG001|Overall Study|No longer meets eligibility criteria|8|||
156427302|NCT01456936|564656590|FG002|Overall Study|No longer meets eligibility criteria|6|||
156427303|NCT01456936|564656591|FG003|Overall Study|No longer meets eligibility criteria|5|||
156427304|NCT01456936|564656588|FG000|Overall Study|Protocol Violation|4|||
156427305|NCT01456936|564656589|FG001|Overall Study|Protocol Violation|2|||
156427306|NCT01456936|564656590|FG002|Overall Study|Protocol Violation|5|||
156766865|NCT01462942|565903114|FG003|Overall Study|Other, including COPD exacerbation|8|||
156766866|NCT01462942|565903115|FG004|Overall Study|Other, including COPD exacerbation|5|||
156766867|NCT01462942|565903111|FG000|Overall Study|Withdrawal by Subject|14|||
156766868|NCT01462942|565903112|FG001|Overall Study|Withdrawal by Subject|10|||
156766869|NCT01462942|565903113|FG002|Overall Study|Withdrawal by Subject|14|||
156766870|NCT01462942|565903114|FG003|Overall Study|Withdrawal by Subject|16|||
156766871|NCT01462942|565903115|FG004|Overall Study|Withdrawal by Subject|19|||
156766872|NCT01462942|565903111|FG000|Overall Study|Lack of Efficacy|6|||
156766873|NCT01462942|565903112|FG001|Overall Study|Lack of Efficacy|0|||
156766874|NCT01462942|565903113|FG002|Overall Study|Lack of Efficacy|4|||
156766875|NCT01462942|565903114|FG003|Overall Study|Lack of Efficacy|5|||
156766876|NCT01462942|565903115|FG004|Overall Study|Lack of Efficacy|3|||
156766877|NCT01462942|565903111|FG000|Overall Study|Lost to Follow-up|0|||
156766878|NCT01462942|565903112|FG001|Overall Study|Lost to Follow-up|1|||
156766879|NCT01462942|565903113|FG002|Overall Study|Lost to Follow-up|1|||
156766880|NCT01462942|565903114|FG003|Overall Study|Lost to Follow-up|1|||
156766881|NCT01462942|565903115|FG004|Overall Study|Lost to Follow-up|1|||
156766882|NCT01462942|565903111|FG000|Overall Study|Protocol Violation|4|||
156766883|NCT01462942|565903112|FG001|Overall Study|Protocol Violation|6|||
156766884|NCT01462942|565903113|FG002|Overall Study|Protocol Violation|9|||
156766885|NCT01462942|565903114|FG003|Overall Study|Protocol Violation|9|||
156766886|NCT01462942|565903115|FG004|Overall Study|Protocol Violation|6|||
156766887|NCT02737722|565903118|FG000|Overall Study|Physician Decision|0|||
156766888|NCT02737722|565903119|FG001|Overall Study|Physician Decision|0|||
156766889|NCT02737722|565903120|FG002|Overall Study|Physician Decision|1|||
156766890|NCT02737722|565903121|FG003|Overall Study|Physician Decision|0|||
156766891|NCT02662569|565903122|FG000|Overall Study|Withdrawal by Subject|6|||
156766892|NCT02662569|565903123|FG001|Overall Study|Withdrawal by Subject|1|||
156766893|NCT02662569|565903124|FG002|Overall Study|Withdrawal by Subject|6|||
156766894|NCT02662569|565903125|FG003|Overall Study|Withdrawal by Subject|4|||
156766895|NCT02662569|565903122|FG000|Overall Study|Lost to Follow-up|1|||
156766896|NCT02662569|565903123|FG001|Overall Study|Lost to Follow-up|0|||
156766897|NCT02662569|565903124|FG002|Overall Study|Lost to Follow-up|0|||
156766898|NCT02662569|565903125|FG003|Overall Study|Lost to Follow-up|0|||
156766899|NCT03154086|565903126|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766900|NCT03154086|565903127|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766901|NCT03154086|565903128|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766902|NCT03154086|565903129|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
156766903|NCT03154086|565903130|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766904|NCT03154086|565903131|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766905|NCT03154086|565903132|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766906|NCT03154086|565903133|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766907|NCT03154086|565903134|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766908|NCT03154086|565903135|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766909|NCT03154086|565903136|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766910|NCT03154086|565903137|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766911|NCT03154086|565903138|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766912|NCT03154086|565903139|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156427307|NCT01456936|564656591|FG003|Overall Study|Protocol Violation|5|||
156427308|NCT01456936|564656588|FG000|Overall Study|Pregnancy|1|||
156427309|NCT01456936|564656589|FG001|Overall Study|Pregnancy|0|||
156427310|NCT01456936|564656590|FG002|Overall Study|Pregnancy|0|||
156427311|NCT01456936|564656591|FG003|Overall Study|Pregnancy|1|||
156427312|NCT01456936|564656588|FG000|Overall Study|Insufficient clinical response|4|||
156427313|NCT01456936|564656589|FG001|Overall Study|Insufficient clinical response|4|||
156427314|NCT01456936|564656590|FG002|Overall Study|Insufficient clinical response|14|||
156427315|NCT01456936|564656591|FG003|Overall Study|Insufficient clinical response|13|||
156427316|NCT01456936|564656588|FG000|Overall Study|No longer willing to participate|195|||
156427317|NCT01456936|564656589|FG001|Overall Study|No longer willing to participate|218|||
156427318|NCT01456936|564656590|FG002|Overall Study|No longer willing to participate|224|||
156427319|NCT01456936|564656591|FG003|Overall Study|No longer willing to participate|248|||
156655972|NCT05568225|565487389|FG001|Primary Treatment Period|Withdrawal of conset|0|||
156655973|NCT05568225|565487390|FG002|Primary Treatment Period|Withdrawal of conset|4|||
156655974|NCT05568225|565487388|FG000|Primary Treatment Period|Adverse Event|1|||
156655975|NCT05568225|565487389|FG001|Primary Treatment Period|Adverse Event|0|||
156655976|NCT05568225|565487390|FG002|Primary Treatment Period|Adverse Event|0|||
156655977|NCT05568225|565487388|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
156655978|NCT05568225|565487389|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
156655979|NCT05568225|565487390|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
156655980|NCT05568225|565487388|FG000|Extension Treatment Period|Protocol Violation|0|||
156655981|NCT05568225|565487389|FG001|Extension Treatment Period|Protocol Violation|0|||
156655982|NCT05568225|565487390|FG002|Extension Treatment Period|Protocol Violation|1|||
156655983|NCT05568225|565487388|FG000|Extension Treatment Period|Lack of Efficacy|0|||
156655984|NCT05568225|565487389|FG001|Extension Treatment Period|Lack of Efficacy|0|||
156655985|NCT05568225|565487390|FG002|Extension Treatment Period|Lack of Efficacy|1|||
156655986|NCT03519256|565487396|FG000|Overall Study|Disease recurrence|4|||
156655987|NCT03519256|565487397|FG001|Overall Study|Disease recurrence|4|||
156655988|NCT03519256|565487398|FG002|Overall Study|Disease recurrence|5|||
156655989|NCT03519256|565487399|FG003|Overall Study|Disease recurrence|2|||
156655990|NCT03519256|565487396|FG000|Overall Study|Study drug toxicity|0|||
156655991|NCT03519256|565487397|FG001|Overall Study|Study drug toxicity|2|||
156655992|NCT03519256|565487398|FG002|Overall Study|Study drug toxicity|5|||
156655993|NCT03519256|565487399|FG003|Overall Study|Study drug toxicity|2|||
156655994|NCT03519256|565487396|FG000|Overall Study|Adverse event unrelated to study drug|0|||
156655995|NCT03519256|565487397|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156655996|NCT03519256|565487398|FG002|Overall Study|Adverse event unrelated to study drug|1|||
156655997|NCT03519256|565487399|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156655998|NCT03519256|565487396|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156655999|NCT03519256|565487397|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156656000|NCT03519256|565487398|FG002|Overall Study|Participant request to discontinue study treatment|0|||
156656001|NCT03519256|565487399|FG003|Overall Study|Participant request to discontinue study treatment|2|||
156656002|NCT03519256|565487396|FG000|Overall Study|Other reasons|0|||
156656003|NCT03519256|565487397|FG001|Overall Study|Other reasons|0|||
156656004|NCT03519256|565487398|FG002|Overall Study|Other reasons|2|||
156656005|NCT03519256|565487399|FG003|Overall Study|Other reasons|0|||
156656006|NCT03519256|565487396|FG000|Overall Study|Disease progression|6|||
156656007|NCT03519256|565487397|FG001|Overall Study|Disease progression|3|||
156656008|NCT03519256|565487398|FG002|Overall Study|Disease progression|2|||
156656009|NCT03519256|565487399|FG003|Overall Study|Disease progression|1|||
156656010|NCT03519256|565487396|FG000|Overall Study|Lost to Follow-up|0|||
156656011|NCT03519256|565487397|FG001|Overall Study|Lost to Follow-up|1|||
156656012|NCT03519256|565487398|FG002|Overall Study|Lost to Follow-up|0|||
156656013|NCT03519256|565487399|FG003|Overall Study|Lost to Follow-up|0|||
156656014|NCT00421174|565487400|FG000|Overall Study|Withdrawal by Subject|0|||
156656015|NCT00421174|565487401|FG001|Overall Study|Withdrawal by Subject|1|||
156656016|NCT00421174|565487400|FG000|Overall Study|Ineligible due to infection|2|||
156656017|NCT00421174|565487401|FG001|Overall Study|Ineligible due to infection|0|||
156656018|NCT02309099|565487405|FG000|Overall Study|Adverse Event|2|||
156656019|NCT02309099|565487406|FG001|Overall Study|Adverse Event|0|||
156656020|NCT02819362|565487408|FG000|Overall Study|On-site MRI could not be performed|70|||
156656021|NCT05456529|565487409|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
156656022|NCT05456529|565487409|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
156656023|NCT05456529|565487409|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
156656024|NCT05456529|565487409|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
156656025|NCT05456529|565487409|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
156656026|NCT05456529|565487409|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
156656027|NCT05456529|565487409|FG000|44-week Long-term Safety Period|Physician Decision|2|||
156656028|NCT05456529|565487409|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
156656029|NCT05456529|565487409|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
156656030|NCT05456529|565487409|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
156427320|NCT01456936|564656588|FG000|Overall Study|Lost to Follow-up|135|||
156427321|NCT01456936|564656589|FG001|Overall Study|Lost to Follow-up|126|||
156427322|NCT01456936|564656590|FG002|Overall Study|Lost to Follow-up|144|||
156427323|NCT01456936|564656591|FG003|Overall Study|Lost to Follow-up|127|||
156766913|NCT03154086|565903140|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766914|NCT03154086|565903126|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766915|NCT03154086|565903127|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
156766916|NCT03154086|565903128|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766917|NCT03154086|565903129|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766918|NCT03154086|565903130|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766919|NCT03154086|565903131|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766920|NCT03154086|565903132|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766921|NCT03154086|565903133|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766922|NCT03154086|565903134|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766923|NCT03154086|565903135|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766924|NCT03154086|565903136|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766925|NCT03154086|565903137|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766926|NCT03154086|565903138|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156427324|NCT01456936|564656588|FG000|Overall Study|Medication error|0|||
156766927|NCT03154086|565903139|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766928|NCT03154086|565903140|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766929|NCT03154086|565903126|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766930|NCT03154086|565903127|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766931|NCT03154086|565903128|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
156766932|NCT03154086|565903129|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766933|NCT03154086|565903130|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766934|NCT03154086|565903131|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766935|NCT03154086|565903132|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766936|NCT03154086|565903133|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766937|NCT03154086|565903134|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766938|NCT03154086|565903135|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766939|NCT03154086|565903136|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766940|NCT03154086|565903137|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766941|NCT03154086|565903138|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766942|NCT03154086|565903139|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766943|NCT03154086|565903140|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766944|NCT03154086|565903126|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
156766945|NCT03154086|565903127|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766946|NCT03154086|565903128|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766947|NCT03154086|565903129|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766948|NCT03154086|565903130|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766949|NCT03154086|565903131|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766950|NCT03154086|565903132|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766951|NCT03154086|565903133|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766952|NCT03154086|565903134|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766953|NCT03154086|565903135|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766954|NCT03154086|565903136|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766955|NCT03154086|565903137|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766956|NCT03154086|565903138|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766957|NCT03154086|565903139|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766958|NCT03154086|565903140|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766959|NCT03154086|565903126|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766960|NCT03154086|565903127|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766961|NCT03154086|565903128|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766962|NCT03154086|565903129|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766963|NCT03154086|565903130|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766964|NCT03154086|565903131|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766965|NCT03154086|565903132|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766966|NCT03154086|565903133|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766967|NCT03154086|565903134|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
156766968|NCT03154086|565903135|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766969|NCT03154086|565903136|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766970|NCT03154086|565903137|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156322917|NCT02045303|564280303|FG001|Overall Study|Withdrawal by Subject|2|||
156427325|NCT01456936|564656589|FG001|Overall Study|Medication error|1|||
156427326|NCT01456936|564656590|FG002|Overall Study|Medication error|0|||
156766971|NCT03154086|565903138|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766972|NCT03154086|565903139|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766973|NCT03154086|565903140|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766974|NCT03154086|565903126|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766975|NCT03154086|565903127|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766976|NCT03154086|565903128|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766977|NCT03154086|565903129|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766978|NCT03154086|565903130|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766979|NCT03154086|565903131|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766980|NCT03154086|565903132|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766981|NCT03154086|565903133|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
156766982|NCT03154086|565903134|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766983|NCT03154086|565903135|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766984|NCT03154086|565903136|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766985|NCT03154086|565903137|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766986|NCT03154086|565903138|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766987|NCT03154086|565903139|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766988|NCT03154086|565903140|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766989|NCT03154086|565903126|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
156766990|NCT03154086|565903127|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
156766991|NCT03154086|565903128|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
156766992|NCT03154086|565903129|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
156766993|NCT03154086|565903130|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
156766994|NCT03154086|565903131|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
156766995|NCT03154086|565903132|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
156766996|NCT03154086|565903133|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
156766997|NCT03154086|565903134|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
156766998|NCT03154086|565903135|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
156766999|NCT03154086|565903136|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
156767000|NCT03154086|565903137|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
156767001|NCT03154086|565903138|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
156767002|NCT03154086|565903139|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
156767003|NCT03154086|565903140|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
156767004|NCT03555149|565903148|FG000|Overall Study|Death|18|||
156767005|NCT03555149|565903149|FG001|Overall Study|Death|15|||
156767006|NCT03555149|565903150|FG002|Overall Study|Death|15|||
156767007|NCT03555149|565903151|FG003|Overall Study|Death|4|||
156767008|NCT03555149|565903152|FG004|Overall Study|Death|4|||
156767009|NCT03555149|565903153|FG005|Overall Study|Death|11|||
156767010|NCT03555149|565903154|FG006|Overall Study|Death|12|||
156767011|NCT03555149|565903155|FG007|Overall Study|Death|1|||
156767012|NCT03555149|565903148|FG000|Overall Study|Lost to Follow-up|1|||
156767013|NCT03555149|565903149|FG001|Overall Study|Lost to Follow-up|0|||
156767014|NCT03555149|565903150|FG002|Overall Study|Lost to Follow-up|0|||
156767015|NCT03555149|565903151|FG003|Overall Study|Lost to Follow-up|0|||
156767016|NCT03555149|565903152|FG004|Overall Study|Lost to Follow-up|0|||
156767017|NCT03555149|565903153|FG005|Overall Study|Lost to Follow-up|1|||
156767018|NCT03555149|565903154|FG006|Overall Study|Lost to Follow-up|0|||
156767019|NCT03555149|565903155|FG007|Overall Study|Lost to Follow-up|0|||
156767020|NCT03555149|565903148|FG000|Overall Study|Physician Decision|1|||
156767021|NCT03555149|565903149|FG001|Overall Study|Physician Decision|0|||
156767022|NCT03555149|565903150|FG002|Overall Study|Physician Decision|0|||
156767023|NCT03555149|565903151|FG003|Overall Study|Physician Decision|0|||
156767024|NCT03555149|565903152|FG004|Overall Study|Physician Decision|0|||
156767025|NCT03555149|565903153|FG005|Overall Study|Physician Decision|0|||
156767026|NCT03555149|565903154|FG006|Overall Study|Physician Decision|0|||
156767027|NCT03555149|565903155|FG007|Overall Study|Physician Decision|0|||
156767028|NCT03555149|565903148|FG000|Overall Study|Study Terminated By Sponsor|1|||
156427327|NCT01456936|564656591|FG003|Overall Study|Medication error|1|||
156427328|NCT01456936|564656588|FG000|Overall Study|Adverse event (study drug)|25|||
156767029|NCT03555149|565903149|FG001|Overall Study|Study Terminated By Sponsor|0|||
156767030|NCT03555149|565903150|FG002|Overall Study|Study Terminated By Sponsor|0|||
156767031|NCT03555149|565903151|FG003|Overall Study|Study Terminated By Sponsor|0|||
156767032|NCT03555149|565903152|FG004|Overall Study|Study Terminated By Sponsor|0|||
156767033|NCT03555149|565903153|FG005|Overall Study|Study Terminated By Sponsor|2|||
156767034|NCT03555149|565903154|FG006|Overall Study|Study Terminated By Sponsor|3|||
156767035|NCT03555149|565903155|FG007|Overall Study|Study Terminated By Sponsor|1|||
156767036|NCT03555149|565903148|FG000|Overall Study|Withdrawal by Subject|3|||
156767037|NCT03555149|565903149|FG001|Overall Study|Withdrawal by Subject|0|||
156767038|NCT03555149|565903150|FG002|Overall Study|Withdrawal by Subject|0|||
156767039|NCT03555149|565903151|FG003|Overall Study|Withdrawal by Subject|2|||
156767040|NCT03555149|565903152|FG004|Overall Study|Withdrawal by Subject|0|||
156767041|NCT03555149|565903153|FG005|Overall Study|Withdrawal by Subject|1|||
156767042|NCT03555149|565903154|FG006|Overall Study|Withdrawal by Subject|0|||
156767043|NCT03555149|565903155|FG007|Overall Study|Withdrawal by Subject|0|||
156427329|NCT01456936|564656589|FG001|Overall Study|Adverse event (study drug)|21|||
156427330|NCT01456936|564656590|FG002|Overall Study|Adverse event (study drug)|26|||
156427331|NCT01456936|564656591|FG003|Overall Study|Adverse event (study drug)|17|||
156427332|NCT01456936|564656588|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
156427333|NCT01456936|564656589|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
156427334|NCT01456936|564656590|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
156427335|NCT01456936|564656591|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
156656031|NCT05456529|565487409|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
156656032|NCT02750761|565487410|FG000|Overall Study|Lost to Follow-up|0|||
156656033|NCT02750761|565487411|FG001|Overall Study|Lost to Follow-up|0|||
156656034|NCT02750761|565487412|FG002|Overall Study|Lost to Follow-up|1|||
156656035|NCT02750761|565487413|FG003|Overall Study|Lost to Follow-up|0|||
156656036|NCT02750761|565487414|FG004|Overall Study|Lost to Follow-up|0|||
156656037|NCT02750761|565487415|FG005|Overall Study|Lost to Follow-up|0|||
156656038|NCT01860976|565487416|FG000|Blinded Treatment|Adverse Event|1|||
156656039|NCT01860976|565487417|FG001|Blinded Treatment|Adverse Event|3|||
156656040|NCT01860976|565487416|FG000|Blinded Treatment|Lack of Efficacy|5|||
156656041|NCT01860976|565487417|FG001|Blinded Treatment|Lack of Efficacy|12|||
156656042|NCT01860976|565487416|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
156656043|NCT01860976|565487417|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
156656044|NCT01860976|565487416|FG000|Blinded Treatment|Withdrawal by Subject|3|||
156656045|NCT01860976|565487417|FG001|Blinded Treatment|Withdrawal by Subject|5|||
156656046|NCT01860976|565487416|FG000|Blinded Treatment|Subject no longer met criteria|1|||
156656047|NCT01860976|565487417|FG001|Blinded Treatment|Subject no longer met criteria|0|||
156656048|NCT01860976|565487416|FG000|Blinded Treatment|Entered Open-Label in error|0|||
156656049|NCT01860976|565487417|FG001|Blinded Treatment|Entered Open-Label in error|1|||
156656050|NCT01860976|565487416|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
156656051|NCT01860976|565487417|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
156656052|NCT01860976|565487416|FG000|Open-Label|Adverse Event|2|||
156656053|NCT01860976|565487417|FG001|Open-Label|Adverse Event|4|||
156656054|NCT01860976|565487416|FG000|Open-Label|Lack of Efficacy|16|||
156656055|NCT01860976|565487417|FG001|Open-Label|Lack of Efficacy|8|||
156656056|NCT01860976|565487416|FG000|Open-Label|Lost to Follow-up|1|||
156656057|NCT01860976|565487417|FG001|Open-Label|Lost to Follow-up|2|||
156656058|NCT01860976|565487416|FG000|Open-Label|Subject request discontinue treatment|4|||
156656059|NCT01860976|565487417|FG001|Open-Label|Subject request discontinue treatment|3|||
156656060|NCT01860976|565487416|FG000|Open-Label|Withdrawal by Subject|4|||
156656061|NCT01860976|565487417|FG001|Open-Label|Withdrawal by Subject|1|||
156656062|NCT01860976|565487416|FG000|Open-Label|Other Reasons|1|||
156656063|NCT01860976|565487417|FG001|Open-Label|Other Reasons|1|||
156656064|NCT01860976|565487416|FG000|Long Term Extension|Adverse Event|4|||
156656065|NCT01860976|565487417|FG001|Long Term Extension|Adverse Event|0|||
156656066|NCT01860976|565487416|FG000|Long Term Extension|Lack of Efficacy|2|||
156656067|NCT01860976|565487417|FG001|Long Term Extension|Lack of Efficacy|0|||
156656068|NCT01860976|565487416|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
156656069|NCT01860976|565487417|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
156656070|NCT01860976|565487416|FG000|Long Term Extension|Lost to Follow-up|2|||
156322918|NCT02045303|564280304|FG002|Overall Study|Withdrawal by Subject|0|||
156322919|NCT01856023|564280305|FG000|Overall Study|Death|1|||
156322920|NCT01856023|564280306|FG001|Overall Study|Death|2|||
156322921|NCT01856023|564280305|FG000|Overall Study|Adverse Event|2|||
156322922|NCT01856023|564280306|FG001|Overall Study|Adverse Event|1|||
156322923|NCT01856023|564280305|FG000|Overall Study|Lack of Efficacy|5|||
156322924|NCT01856023|564280306|FG001|Overall Study|Lack of Efficacy|5|||
156322925|NCT01856023|564280305|FG000|Overall Study|non compliance, study closure|1|||
156322926|NCT01856023|564280306|FG001|Overall Study|non compliance, study closure|3|||
156322927|NCT01856023|564280305|FG000|Overall Study|Withdrawal by Subject|1|||
156322928|NCT01856023|564280306|FG001|Overall Study|Withdrawal by Subject|1|||
156322929|NCT00829283|564280307|FG000|Overall Study|Lost to Follow-up|7|||
156322930|NCT00829283|564280308|FG001|Overall Study|Lost to Follow-up|25|||
156322931|NCT00256282|564280309|FG000|Overall Study|Disease progression, relapse during acti|12|||
156322932|NCT00256282|564280309|FG000|Overall Study|Adverse Event|3|||
156322933|NCT00256282|564280309|FG000|Overall Study|Physician Decision|1|||
156322934|NCT02431247|564280310|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
156322935|NCT02431247|564280311|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
156322936|NCT02431247|564280312|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
156322937|NCT02431247|564280310|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
156322938|NCT02431247|564280311|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
156322939|NCT02431247|564280312|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
156656071|NCT01860976|565487417|FG001|Long Term Extension|Lost to Follow-up|0|||
156656072|NCT01860976|565487416|FG000|Long Term Extension|subject withdrew consent|7|||
156656073|NCT01860976|565487417|FG001|Long Term Extension|subject withdrew consent|0|||
156656074|NCT00419926|565487418|FG000|Overall Study|Withdrawal by Subject|7|||
156656075|NCT00419926|565487419|FG001|Overall Study|Withdrawal by Subject|3|||
156656076|NCT00419926|565487418|FG000|Overall Study|Administrative Problem|4|||
156656077|NCT00419926|565487419|FG001|Overall Study|Administrative Problem|4|||
156656078|NCT00419926|565487418|FG000|Overall Study|Lost to Follow-up|1|||
156656079|NCT00419926|565487419|FG001|Overall Study|Lost to Follow-up|2|||
156656080|NCT00419926|565487418|FG000|Overall Study|Death|2|||
156656081|NCT00419926|565487419|FG001|Overall Study|Death|1|||
156656082|NCT02204371|565487422|FG000|Overall Study|Adverse Event|1|||
156656083|NCT03594123|565487425|FG000|Overall Study|Lost to Follow-up|0|||
156656084|NCT03594123|565487426|FG001|Overall Study|Lost to Follow-up|1|||
156656085|NCT03594123|565487425|FG000|Overall Study|Adverse Event|8|||
156656086|NCT03594123|565487426|FG001|Overall Study|Adverse Event|5|||
156656087|NCT03594123|565487425|FG000|Overall Study|Site Terminated by Sponsor|4|||
156656088|NCT03594123|565487426|FG001|Overall Study|Site Terminated by Sponsor|1|||
156656089|NCT03594123|565487425|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
156656090|NCT03594123|565487426|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
156656091|NCT03594123|565487425|FG000|Overall Study|Lack of Efficacy|1|||
156656092|NCT03594123|565487426|FG001|Overall Study|Lack of Efficacy|0|||
156656093|NCT03594123|565487425|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
156656094|NCT03594123|565487426|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
156656095|NCT02483975|565487427|FG000|Overall Study|Adverse Event|0|||
156656096|NCT02483975|565487428|FG001|Overall Study|Adverse Event|1|||
156656097|NCT02483975|565487427|FG000|Overall Study|Lost to Follow-up|0|||
156656098|NCT02483975|565487428|FG001|Overall Study|Lost to Follow-up|1|||
156656099|NCT02483975|565487427|FG000|Overall Study|Physician Decision|2|||
156656100|NCT02483975|565487428|FG001|Overall Study|Physician Decision|0|||
156656101|NCT03365375|565487429|FG000|Overall Study|Withdrawal by Subject|0|||
156656102|NCT03365375|565487430|FG001|Overall Study|Withdrawal by Subject|1|||
156656103|NCT03365375|565487429|FG000|Overall Study|Lost to Follow-up|0|||
156656104|NCT03365375|565487430|FG001|Overall Study|Lost to Follow-up|4|||
156656105|NCT00818883|565487431|FG000|Overall Study|Adverse Event|28|||
156656106|NCT00818883|565487432|FG001|Overall Study|Adverse Event|19|||
156656107|NCT00818883|565487431|FG000|Overall Study|Protocol Violation|2|||
156656108|NCT00818883|565487432|FG001|Overall Study|Protocol Violation|2|||
156656109|NCT00818883|565487431|FG000|Overall Study|Lost to Follow-up|3|||
156656110|NCT00818883|565487432|FG001|Overall Study|Lost to Follow-up|2|||
156656111|NCT00818883|565487431|FG000|Overall Study|Withdrawal by Subject|16|||
156656112|NCT00818883|565487432|FG001|Overall Study|Withdrawal by Subject|14|||
156656113|NCT00818883|565487431|FG000|Overall Study|Lack of Efficacy|0|||
156656114|NCT00818883|565487432|FG001|Overall Study|Lack of Efficacy|2|||
156656115|NCT00818883|565487431|FG000|Overall Study|Other|2|||
156656116|NCT00818883|565487432|FG001|Overall Study|Other|7|||
156656117|NCT01659567|565487437|FG000|Overall Study|Lack of Efficacy|22|||
156656118|NCT01659567|565487437|FG000|Overall Study|Switched to Pegferon|6|||
156656119|NCT01659567|565487437|FG000|Overall Study|Adverse Event|12|||
156656120|NCT01659567|565487437|FG000|Overall Study|Good result at early stage of treatment|5|||
156656121|NCT01659567|565487437|FG000|Overall Study|Withdrawal by Subject|64|||
156656122|NCT01659567|565487437|FG000|Overall Study|Progression of the main disease|1|||
156656123|NCT01659567|565487437|FG000|Overall Study|Other|13|||
156656124|NCT01179919|565487438|FG000|Overall Study|Protocol Violation|1|||
156656125|NCT01179919|565487438|FG000|Overall Study|Adverse Event|1|||
156656126|NCT00698685|565487439|FG000|Overall Study|Sister withdrew as donor|1|||
156656127|NCT00698685|565487439|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
156656128|NCT01325207|565487440|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
156656129|NCT01325207|565487441|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
156656130|NCT01325207|565487442|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
156656131|NCT01325207|565487443|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
156656132|NCT01325207|565487444|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
156656133|NCT01325207|565487445|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
156656134|NCT01325207|565487440|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
156656135|NCT01325207|565487441|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
156656136|NCT01325207|565487442|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
156656137|NCT01325207|565487443|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
156656138|NCT01325207|565487444|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
156656139|NCT01325207|565487445|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
156767044|NCT02785939|565903169|FG000|Overall Study|Progression|25|||
156656140|NCT01325207|565487440|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
156656141|NCT01325207|565487441|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
156656142|NCT01325207|565487442|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
156656143|NCT01325207|565487443|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
156656144|NCT01325207|565487444|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
156656145|NCT01325207|565487445|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
156656146|NCT01325207|565487440|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
156427336|NCT01456936|564656588|FG000|Overall Study|Death|0|||
156427337|NCT01456936|564656589|FG001|Overall Study|Death|3|||
156427338|NCT01456936|564656590|FG002|Overall Study|Death|1|||
156427339|NCT01456936|564656591|FG003|Overall Study|Death|3|||
156427340|NCT01456936|564656588|FG000|Overall Study|Randomized but not treated|21|||
156427341|NCT01456936|564656589|FG001|Overall Study|Randomized but not treated|28|||
156427342|NCT01456936|564656590|FG002|Overall Study|Randomized but not treated|16|||
156767045|NCT02785939|565903170|FG001|Overall Study|Progression|8|||
156767046|NCT02785939|565903169|FG000|Overall Study|Adverse Event|3|||
156767047|NCT02785939|565903170|FG001|Overall Study|Adverse Event|1|||
156767048|NCT02785939|565903169|FG000|Overall Study|Death|1|||
156767049|NCT02785939|565903170|FG001|Overall Study|Death|0|||
156767050|NCT02785939|565903169|FG000|Overall Study|Refusal|1|||
156767051|NCT02785939|565903170|FG001|Overall Study|Refusal|0|||
156767052|NCT02785939|565903169|FG000|Overall Study|Deteriorating health|1|||
156767053|NCT02785939|565903170|FG001|Overall Study|Deteriorating health|0|||
156767054|NCT02785939|565903169|FG000|Overall Study|Not protocol specified|0|||
156767055|NCT02785939|565903170|FG001|Overall Study|Not protocol specified|1|||
156767056|NCT04465422|565903171|FG000|Overall Study|Lost to Follow-up|0|||
156767057|NCT04465422|565903172|FG001|Overall Study|Lost to Follow-up|2|||
156767058|NCT00572832|565903178|FG000|Overall Study|Lost to Follow-up|0|||
156767059|NCT00572832|565903179|FG001|Overall Study|Lost to Follow-up|11|||
156427343|NCT01456936|564656591|FG003|Overall Study|Randomized but not treated|21|||
156767060|NCT00572832|565903178|FG000|Overall Study|Pregnancy|0|||
156767061|NCT00572832|565903179|FG001|Overall Study|Pregnancy|1|||
156767062|NCT00324155|565903180|FG000|Enrolled and Randomized|No longer met study criteria|3|||
156767063|NCT00324155|565903181|FG001|Enrolled and Randomized|No longer met study criteria|0|||
156767064|NCT00324155|565903180|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
156767065|NCT00324155|565903181|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
156767066|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
156767067|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
156767068|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
156767069|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
156767070|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Death|8|||
156767071|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Death|15|||
156767072|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
156767073|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
156767074|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
156767075|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
156767076|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
156767077|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
156767078|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
156767079|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
156767080|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
156767081|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
156767082|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
156767083|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
156767084|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
156767085|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
156767086|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
156767087|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
156767088|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
156767089|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
156767090|NCT00324155|565903180|FG000|Follow-up Phase|On-going participants still on drug|11|||
156767091|NCT00324155|565903181|FG001|Follow-up Phase|On-going participants still on drug|6|||
156767092|NCT00390689|565903182|FG000|Overall Study|Adverse Event|2|||
156767093|NCT00390689|565903183|FG001|Overall Study|Adverse Event|5|||
156767094|NCT00390689|565903184|FG002|Overall Study|Adverse Event|2|||
156767095|NCT00390689|565903182|FG000|Overall Study|Lack of Efficacy|0|||
156767096|NCT00390689|565903183|FG001|Overall Study|Lack of Efficacy|0|||
156767097|NCT00390689|565903184|FG002|Overall Study|Lack of Efficacy|1|||
156767098|NCT00390689|565903182|FG000|Overall Study|Protocol Violation|1|||
156767099|NCT00390689|565903183|FG001|Overall Study|Protocol Violation|0|||
156767100|NCT00390689|565903184|FG002|Overall Study|Protocol Violation|0|||
156767101|NCT00390689|565903182|FG000|Overall Study|Investigator's judgement|2|||
156427344|NCT02317705|564656592|FG000|Overall Study|Withdrawal by Subject|3|||
156427345|NCT02317705|564656592|FG000|Overall Study|Physician Decision|1|||
156767102|NCT00390689|565903183|FG001|Overall Study|Investigator's judgement|0|||
156767103|NCT00390689|565903184|FG002|Overall Study|Investigator's judgement|0|||
156767104|NCT01253161|565903185|FG000|Overall Study|Adverse Event|1|||
156427346|NCT02317705|564656592|FG000|Overall Study|Drug not usable|1|||
156427347|NCT01674569|564656593|FG000|Overall Study|Adverse Event|0|||
156767105|NCT05412134|565903187|FG000|Overall Study|Lost to Follow-up|2|||
156427348|NCT01674569|564656594|FG001|Overall Study|Adverse Event|2|||
156656147|NCT01325207|565487441|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
156656148|NCT01325207|565487442|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
156656149|NCT01325207|565487443|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
156656150|NCT01325207|565487444|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
156656151|NCT01325207|565487445|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
156767106|NCT05412134|565903188|FG001|Overall Study|Lost to Follow-up|0|||
156767107|NCT03444584|565903191|FG000|Overall Study|Withdrawal by Subject|0|||
156767108|NCT03444584|565903192|FG001|Overall Study|Withdrawal by Subject|1|||
156767109|NCT03444584|565903191|FG000|Overall Study|Other|0|||
156767110|NCT03444584|565903192|FG001|Overall Study|Other|1|||
156767111|NCT00423046|565903193|FG000|Overall Study|Other|340|||
156767112|NCT00423046|565903194|FG001|Overall Study|Other|345|||
156767113|NCT01604785|565903195|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
156767114|NCT01604785|565903196|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
156767115|NCT02783911|565903197|FG000|Overall Study|Lost to Follow-up|3|||
156767116|NCT02783911|565903198|FG001|Overall Study|Lost to Follow-up|32|||
156767117|NCT00467519|565903199|FG000|Overall Study|Protocol Violation|8|||
156767118|NCT00467519|565903200|FG001|Overall Study|Protocol Violation|4|||
156767119|NCT00467519|565903199|FG000|Overall Study|Lost to Follow-up|2|||
156767120|NCT00467519|565903200|FG001|Overall Study|Lost to Follow-up|9|||
156767121|NCT00467519|565903199|FG000|Overall Study|Withdrawal by Subject|4|||
156767122|NCT00467519|565903200|FG001|Overall Study|Withdrawal by Subject|10|||
156767123|NCT01118052|565903201|FG000|Overall Study|Never treated|2|||
156767124|NCT00843492|565903206|FG000|Overall Study|Adverse Event|0|||
156767125|NCT00843492|565903207|FG001|Overall Study|Adverse Event|3|||
156767126|NCT00843492|565903206|FG000|Overall Study|Lost to Follow-up|4|||
156767127|NCT00843492|565903207|FG001|Overall Study|Lost to Follow-up|4|||
156767128|NCT00843492|565903206|FG000|Overall Study|Withdrawal by Subject|0|||
156767129|NCT00843492|565903207|FG001|Overall Study|Withdrawal by Subject|4|||
156767130|NCT00843492|565903206|FG000|Overall Study|Immobilization Stopped|1|||
156767131|NCT00843492|565903207|FG001|Overall Study|Immobilization Stopped|0|||
156767132|NCT00843492|565903206|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
156427349|NCT01674569|564656595|FG002|Overall Study|Adverse Event|0|||
156427350|NCT01674569|564656596|FG003|Overall Study|Adverse Event|1|||
156656152|NCT01325207|565487440|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
156656153|NCT01325207|565487441|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
156656154|NCT01325207|565487442|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
156656155|NCT01325207|565487443|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
156656156|NCT01325207|565487444|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
156656157|NCT01325207|565487445|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
156656158|NCT01325207|565487440|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
156656159|NCT01325207|565487441|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
156656160|NCT01325207|565487442|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
156656161|NCT01325207|565487443|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
156656162|NCT01325207|565487444|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
156656163|NCT01325207|565487445|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
156656164|NCT01325207|565487440|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
156656165|NCT01325207|565487441|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
156656166|NCT01325207|565487442|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
156656167|NCT01325207|565487443|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
156656168|NCT01325207|565487444|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
156656169|NCT01325207|565487445|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
156656170|NCT00708422|565487446|FG000|Overall Study|Adverse Event|3|||
156656171|NCT00708422|565487447|FG001|Overall Study|Adverse Event|1|||
156656172|NCT00708422|565487446|FG000|Overall Study|Withdrawal by Subject|1|||
156656173|NCT00708422|565487447|FG001|Overall Study|Withdrawal by Subject|0|||
156656174|NCT01254409|565487448|FG000|Overall Study|Adverse Event|0|||
156656175|NCT01254409|565487449|FG001|Overall Study|Adverse Event|1|||
156656176|NCT01254409|565487450|FG002|Overall Study|Adverse Event|0|||
156656177|NCT01254409|565487451|FG003|Overall Study|Adverse Event|0|||
156656178|NCT00337571|565487454|FG000|Overall Study|Lack of Efficacy|3|||
156656179|NCT00337571|565487455|FG001|Overall Study|Lack of Efficacy|0|||
156656180|NCT00337571|565487456|FG002|Overall Study|Lack of Efficacy|0|||
156656181|NCT00337571|565487457|FG003|Overall Study|Lack of Efficacy|0|||
156656182|NCT00337571|565487454|FG000|Overall Study|Adverse Event|4|||
156656183|NCT00337571|565487455|FG001|Overall Study|Adverse Event|5|||
156656184|NCT00337571|565487456|FG002|Overall Study|Adverse Event|8|||
156656185|NCT00337571|565487457|FG003|Overall Study|Adverse Event|4|||
156656186|NCT00337571|565487454|FG000|Overall Study|Withdrawal by Subject|2|||
156656187|NCT00337571|565487455|FG001|Overall Study|Withdrawal by Subject|2|||
156656188|NCT00337571|565487456|FG002|Overall Study|Withdrawal by Subject|1|||
156656189|NCT00337571|565487457|FG003|Overall Study|Withdrawal by Subject|0|||
156767133|NCT00843492|565903207|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
156767134|NCT00843492|565903206|FG000|Overall Study|Orthopedic Surgery|0|||
156767135|NCT00843492|565903207|FG001|Overall Study|Orthopedic Surgery|2|||
156767136|NCT00843492|565903206|FG000|Overall Study|Visit Not Performed|1|||
156767137|NCT00843492|565903207|FG001|Overall Study|Visit Not Performed|0|||
156767138|NCT00843492|565903206|FG000|Overall Study|Deep-vein Thrombosis|1|||
156767139|NCT00843492|565903207|FG001|Overall Study|Deep-vein Thrombosis|0|||
156767140|NCT00794664|565903208|FG000|Treatment Period|Withdrawal by Subject|0|||
156767141|NCT00794664|565903209|FG001|Treatment Period|Withdrawal by Subject|2|||
156767142|NCT00794664|565903208|FG000|Treatment Period|Protocol non-compliance|0|||
156767143|NCT00794664|565903209|FG001|Treatment Period|Protocol non-compliance|1|||
156767144|NCT00794664|565903208|FG000|Treatment Period|Other|0|||
156767145|NCT00794664|565903209|FG001|Treatment Period|Other|1|||
156767146|NCT00794664|565903208|FG000|Treatment Period|Adverse Event|1|||
156767147|NCT00794664|565903209|FG001|Treatment Period|Adverse Event|8|||
156767148|NCT00794664|565903208|FG000|Follow-up Period|Other|1|||
156767149|NCT00794664|565903209|FG001|Follow-up Period|Other|2|||
156767150|NCT00794664|565903208|FG000|Follow-up Period|Withdrawal by Subject|0|||
156767151|NCT00794664|565903209|FG001|Follow-up Period|Withdrawal by Subject|2|||
156767152|NCT00794664|565903208|FG000|Follow-up Period|Protocol non-compliance|0|||
156767153|NCT00794664|565903209|FG001|Follow-up Period|Protocol non-compliance|1|||
156767154|NCT01677741|565903210|FG000|Overall Study|Death|0|||
156767155|NCT01677741|565903211|FG001|Overall Study|Death|0|||
156767156|NCT01677741|565903212|FG002|Overall Study|Death|0|||
156767157|NCT01677741|565903213|FG003|Overall Study|Death|1|||
156767158|NCT01677741|565903214|FG004|Overall Study|Death|0|||
156767159|NCT01677741|565903215|FG005|Overall Study|Death|1|||
156767160|NCT01677741|565903216|FG006|Overall Study|Death|0|||
156767161|NCT01677741|565903217|FG007|Overall Study|Death|0|||
156767162|NCT01677741|565903210|FG000|Overall Study|Withdrawal by Subject|2|||
156767163|NCT01677741|565903211|FG001|Overall Study|Withdrawal by Subject|7|||
156767164|NCT01677741|565903212|FG002|Overall Study|Withdrawal by Subject|5|||
156767165|NCT01677741|565903213|FG003|Overall Study|Withdrawal by Subject|4|||
156767166|NCT01677741|565903214|FG004|Overall Study|Withdrawal by Subject|11|||
156767167|NCT01677741|565903215|FG005|Overall Study|Withdrawal by Subject|20|||
156767168|NCT01677741|565903216|FG006|Overall Study|Withdrawal by Subject|4|||
156767169|NCT01677741|565903217|FG007|Overall Study|Withdrawal by Subject|2|||
156767170|NCT01677741|565903210|FG000|Overall Study|Enrolled in a rollover study|0|||
156767171|NCT01677741|565903211|FG001|Overall Study|Enrolled in a rollover study|3|||
156767172|NCT01677741|565903212|FG002|Overall Study|Enrolled in a rollover study|2|||
156767173|NCT01677741|565903213|FG003|Overall Study|Enrolled in a rollover study|1|||
156767174|NCT01677741|565903214|FG004|Overall Study|Enrolled in a rollover study|6|||
156767175|NCT01677741|565903215|FG005|Overall Study|Enrolled in a rollover study|6|||
156767176|NCT01677741|565903216|FG006|Overall Study|Enrolled in a rollover study|7|||
156767177|NCT01677741|565903217|FG007|Overall Study|Enrolled in a rollover study|0|||
156767178|NCT01677741|565903210|FG000|Overall Study|Progressive disease|1|||
156767179|NCT01677741|565903211|FG001|Overall Study|Progressive disease|0|||
156767180|NCT01677741|565903212|FG002|Overall Study|Progressive disease|1|||
156767181|NCT01677741|565903213|FG003|Overall Study|Progressive disease|0|||
156322940|NCT02431247|564280310|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
156322941|NCT02431247|564280311|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
156322942|NCT02431247|564280312|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
156322943|NCT02431247|564280310|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
156322944|NCT02431247|564280311|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
156322945|NCT02431247|564280312|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
156322946|NCT02431247|564280310|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
156322947|NCT02431247|564280311|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
156322948|NCT02431247|564280312|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
156322949|NCT02431247|564280310|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
156322950|NCT02431247|564280311|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
156322951|NCT02431247|564280312|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
156322952|NCT02431247|564280310|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
156322953|NCT02431247|564280311|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
156322954|NCT02431247|564280312|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
156767182|NCT01677741|565903214|FG004|Overall Study|Progressive disease|0|||
156767183|NCT01677741|565903215|FG005|Overall Study|Progressive disease|1|||
156767184|NCT01677741|565903216|FG006|Overall Study|Progressive disease|0|||
156767185|NCT01677741|565903217|FG007|Overall Study|Progressive disease|0|||
156767186|NCT02873689|565904599|FG000|Overall Study|Lack of Efficacy|1|||
156767187|NCT02873689|565904600|FG001|Overall Study|Lack of Efficacy|0|||
156322955|NCT02431247|564280310|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
156767188|NCT02873689|565904599|FG000|Overall Study|Withdrawal by Subject|2|||
156767189|NCT02873689|565904600|FG001|Overall Study|Withdrawal by Subject|2|||
156427351|NCT01674569|564656597|FG004|Overall Study|Adverse Event|2|||
156427352|NCT01674569|564656598|FG005|Overall Study|Adverse Event|2|||
156656190|NCT00337571|565487454|FG000|Overall Study|Lost to Follow-up|3|||
156656191|NCT00337571|565487455|FG001|Overall Study|Lost to Follow-up|1|||
156322956|NCT02431247|564280311|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
156322957|NCT02431247|564280312|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
156322958|NCT02431247|564280310|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
156322959|NCT02431247|564280311|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
156322960|NCT02431247|564280312|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
156322961|NCT02431247|564280310|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
156322962|NCT02431247|564280311|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
156322963|NCT02431247|564280312|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
156322964|NCT02431247|564280310|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
156322965|NCT02431247|564280311|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
156322966|NCT02431247|564280312|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
156322967|NCT02431247|564280310|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
156322968|NCT02431247|564280311|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
156322969|NCT02431247|564280312|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
156322970|NCT02431247|564280310|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
156322971|NCT02431247|564280311|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
156322972|NCT02431247|564280312|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
156322973|NCT02431247|564280310|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
156322974|NCT02431247|564280311|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
156322975|NCT02431247|564280312|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
156322976|NCT00667446|564280313|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
156322977|NCT00667446|564280314|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
156322978|NCT00667446|564280313|FG000|Treatment Period (36 Months)|Other|2|||
156322979|NCT00667446|564280314|FG001|Treatment Period (36 Months)|Other|2|||
156322980|NCT00667446|564280313|FG000|Treatment Period (36 Months)|Personal reasons|2|||
156322981|NCT00667446|564280314|FG001|Treatment Period (36 Months)|Personal reasons|2|||
156322982|NCT00667446|564280313|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
156322983|NCT00667446|564280314|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
156322984|NCT00667446|564280313|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
156322985|NCT00667446|564280314|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
156322986|NCT00667446|564280313|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
156322987|NCT00667446|564280314|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
156322988|NCT00667446|564280313|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
156322989|NCT00667446|564280314|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
156322990|NCT00667446|564280313|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
156322991|NCT00667446|564280314|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
156322992|NCT00667446|564280313|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
156322993|NCT00667446|564280314|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
156322994|NCT00591578|564280315|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
156322995|NCT00591578|564280316|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
156322996|NCT00591578|564280317|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
156322997|NCT00591578|564280315|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
156322998|NCT00591578|564280316|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
156322999|NCT00591578|564280317|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
156323000|NCT00591578|564280315|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
156323001|NCT00591578|564280316|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
156323002|NCT00591578|564280317|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
156323003|NCT00591578|564280315|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
156323004|NCT00591578|564280316|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
156323005|NCT00591578|564280317|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
156323006|NCT00591578|564280315|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
156323007|NCT00591578|564280316|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
156323008|NCT00591578|564280317|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
156323009|NCT00591578|564280315|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
156323010|NCT00591578|564280316|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
156323011|NCT00591578|564280317|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
156323012|NCT00591578|564280315|FG000|Double-Blind Treatment Phase|Other|4|||
156323013|NCT00591578|564280316|FG001|Double-Blind Treatment Phase|Other|9|||
156323014|NCT00591578|564280317|FG002|Double-Blind Treatment Phase|Other|4|||
156323015|NCT00591578|564280315|FG000|Open-Label Extension Phase|Adverse Event|3|||
156323016|NCT00591578|564280316|FG001|Open-Label Extension Phase|Adverse Event|5|||
156323017|NCT00591578|564280317|FG002|Open-Label Extension Phase|Adverse Event|0|||
156323018|NCT00591578|564280315|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
156323019|NCT00591578|564280316|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
156323020|NCT00591578|564280317|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
156323021|NCT00591578|564280315|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
156323022|NCT00591578|564280316|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
156427353|NCT01674569|564656593|FG000|Overall Study|Protocol Violation|0|||
156656192|NCT00337571|565487456|FG002|Overall Study|Lost to Follow-up|0|||
156656193|NCT00337571|565487457|FG003|Overall Study|Lost to Follow-up|1|||
156656194|NCT00337571|565487454|FG000|Overall Study|Poor/noncompliance|1|||
156656195|NCT00337571|565487455|FG001|Overall Study|Poor/noncompliance|1|||
156656196|NCT00337571|565487456|FG002|Overall Study|Poor/noncompliance|1|||
156656197|NCT00337571|565487457|FG003|Overall Study|Poor/noncompliance|1|||
156656198|NCT00337571|565487454|FG000|Overall Study|No longer met study criteria|1|||
156656199|NCT00337571|565487455|FG001|Overall Study|No longer met study criteria|0|||
156656200|NCT00337571|565487456|FG002|Overall Study|No longer met study criteria|0|||
156656201|NCT00337571|565487457|FG003|Overall Study|No longer met study criteria|0|||
156656202|NCT00337571|565487454|FG000|Overall Study|High Potassium level|0|||
156656203|NCT00337571|565487455|FG001|Overall Study|High Potassium level|0|||
156656204|NCT00337571|565487456|FG002|Overall Study|High Potassium level|0|||
156656205|NCT00337571|565487457|FG003|Overall Study|High Potassium level|1|||
156656206|NCT01974895|565487463|FG000|Overall Study|Protocol Violation|1|||
156656207|NCT01974895|565487464|FG001|Overall Study|Protocol Violation|0|||
156656208|NCT01974895|565487463|FG000|Overall Study|Lost to Follow-up|4|||
156656209|NCT01974895|565487464|FG001|Overall Study|Lost to Follow-up|6|||
156656210|NCT01974895|565487463|FG000|Overall Study|Withdrawal by Subject|0|||
156656211|NCT01974895|565487464|FG001|Overall Study|Withdrawal by Subject|1|||
156656212|NCT01974895|565487463|FG000|Overall Study|Other (Missed Visit)|1|||
156656213|NCT01974895|565487464|FG001|Overall Study|Other (Missed Visit)|0|||
156656214|NCT01974895|565487463|FG000|Overall Study|Other (Reason unknown)|9|||
156656215|NCT01974895|565487464|FG001|Overall Study|Other (Reason unknown)|8|||
156656216|NCT02192099|565487465|FG000|Overall Study|Adverse Event|1|||
156656217|NCT02192099|565487465|FG000|Overall Study|Lost to Follow-up|2|||
156656218|NCT02192099|565487465|FG000|Overall Study|Physician Decision|1|||
156656219|NCT02192099|565487465|FG000|Overall Study|Pregnancy|1|||
156656220|NCT02192099|565487465|FG000|Overall Study|Protocol Violation|8|||
156656221|NCT02192099|565487465|FG000|Overall Study|Study Terminated by Sponsor|32|||
156656222|NCT02192099|565487465|FG000|Overall Study|Withdrawal by Subject|11|||
156656223|NCT02192099|565487465|FG000|Overall Study|Miscellaneous Reasons|5|||
156656224|NCT00386009|565487466|FG000|Overall Study|Adverse Event|0|||
156656225|NCT00386009|565487467|FG001|Overall Study|Adverse Event|2|||
156656226|NCT00386009|565487466|FG000|Overall Study|Death|1|||
156656227|NCT00386009|565487467|FG001|Overall Study|Death|0|||
156656228|NCT00386009|565487466|FG000|Overall Study|Entry Criteria Not Met|0|||
156656229|NCT00386009|565487467|FG001|Overall Study|Entry Criteria Not Met|2|||
156656230|NCT00386009|565487466|FG000|Overall Study|Lost to Follow-up|1|||
156656231|NCT00386009|565487467|FG001|Overall Study|Lost to Follow-up|1|||
156656232|NCT00386009|565487466|FG000|Overall Study|Protocol Violation|1|||
156656233|NCT00386009|565487467|FG001|Overall Study|Protocol Violation|0|||
156656234|NCT00386009|565487466|FG000|Overall Study|Sponsor Decision|1|||
156656235|NCT00386009|565487467|FG001|Overall Study|Sponsor Decision|1|||
156656236|NCT00386009|565487466|FG000|Overall Study|Withdrawal by Subject|5|||
156656237|NCT00386009|565487467|FG001|Overall Study|Withdrawal by Subject|4|||
156656238|NCT00319449|565487479|FG000|Overall Study|Subject did not wish to continue|1|||
156656239|NCT00319449|565487480|FG001|Overall Study|Subject did not wish to continue|0|||
156656240|NCT00319449|565487479|FG000|Overall Study|Noncompliance with the protocol|1|||
156656241|NCT00319449|565487480|FG001|Overall Study|Noncompliance with the protocol|0|||
156656242|NCT02415959|565487481|FG000|Overall Study|Adverse Event|0|||
156323023|NCT00591578|564280317|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
156323024|NCT00591578|564280315|FG000|Open-Label Extension Phase|Other|1|||
156323025|NCT00591578|564280316|FG001|Open-Label Extension Phase|Other|0|||
156323026|NCT00591578|564280317|FG002|Open-Label Extension Phase|Other|0|||
156323027|NCT03631355|564280318|FG000|Overall Study|Lost to Follow-up|1|||
156323028|NCT03631355|564280319|FG001|Overall Study|Lost to Follow-up|2|||
156323029|NCT00782795|564280322|FG000|Overall Study|Withdrawal by Subject|1|||
156323030|NCT00782795|564280323|FG001|Overall Study|Withdrawal by Subject|2|||
156323031|NCT04480424|564280324|FG000|Overall Study|Withdrawal by Subject|0|||
156323032|NCT04480424|564280325|FG001|Overall Study|Withdrawal by Subject|2|||
156656243|NCT02415959|565487482|FG001|Overall Study|Adverse Event|1|||
156767190|NCT02873689|565904599|FG000|Overall Study|Protocol Violation|1|||
156767191|NCT02873689|565904600|FG001|Overall Study|Protocol Violation|0|||
156656244|NCT02415959|565487483|FG002|Overall Study|Adverse Event|0|||
156656245|NCT02415959|565487484|FG003|Overall Study|Adverse Event|0|||
156656246|NCT02415959|565487485|FG004|Overall Study|Adverse Event|0|||
156767192|NCT02873689|565904599|FG000|Overall Study|Adverse Event|2|||
156767193|NCT02873689|565904600|FG001|Overall Study|Adverse Event|2|||
156767194|NCT02873689|565904599|FG000|Overall Study|Randomized but not Treated|1|||
156767195|NCT02873689|565904600|FG001|Overall Study|Randomized but not Treated|1|||
156656247|NCT02415959|565487481|FG000|Overall Study|Protocol Violation|0|||
156656248|NCT02415959|565487482|FG001|Overall Study|Protocol Violation|0|||
156656249|NCT02415959|565487483|FG002|Overall Study|Protocol Violation|0|||
156767196|NCT00350545|565904601|FG000|Overall Study|Withdrawal by Subject|2|||
156767197|NCT00434252|565904602|FG000|Overall Study|Lack of Efficacy|50|||
156767198|NCT00434252|565904603|FG001|Overall Study|Lack of Efficacy|100|||
156656250|NCT02415959|565487484|FG003|Overall Study|Protocol Violation|1|||
156427354|NCT01674569|564656594|FG001|Overall Study|Protocol Violation|1|||
156427355|NCT01674569|564656595|FG002|Overall Study|Protocol Violation|1|||
156767199|NCT00434252|565904602|FG000|Overall Study|Adverse Event|6|||
156767200|NCT00434252|565904603|FG001|Overall Study|Adverse Event|13|||
156767201|NCT00434252|565904602|FG000|Overall Study|Death|1|||
156767202|NCT00434252|565904603|FG001|Overall Study|Death|2|||
156767203|NCT00434252|565904602|FG000|Overall Study|Lost to Follow-up|0|||
156767204|NCT00434252|565904603|FG001|Overall Study|Lost to Follow-up|1|||
156767205|NCT00434252|565904602|FG000|Overall Study|Physician Decision|4|||
156767206|NCT00434252|565904603|FG001|Overall Study|Physician Decision|8|||
156767207|NCT00434252|565904602|FG000|Overall Study|Withdrawal by Subject|3|||
156767208|NCT00434252|565904603|FG001|Overall Study|Withdrawal by Subject|7|||
156767209|NCT00750269|565904622|FG000|Overall Study|Protocol Violation|0|||
156767210|NCT00750269|565904623|FG001|Overall Study|Protocol Violation|1|||
156767211|NCT00750269|565904624|FG002|Overall Study|Protocol Violation|1|||
156767212|NCT00750269|565904625|FG003|Overall Study|Protocol Violation|2|||
156767213|NCT00750269|565904626|FG004|Overall Study|Protocol Violation|4|||
156767214|NCT00750269|565904622|FG000|Overall Study|Withdrawal by Subject|0|||
156767215|NCT00750269|565904623|FG001|Overall Study|Withdrawal by Subject|0|||
156767216|NCT00750269|565904624|FG002|Overall Study|Withdrawal by Subject|2|||
156767217|NCT00750269|565904625|FG003|Overall Study|Withdrawal by Subject|2|||
156767218|NCT00750269|565904626|FG004|Overall Study|Withdrawal by Subject|2|||
156767219|NCT00750269|565904622|FG000|Overall Study|Physician Decision|0|||
156767220|NCT00750269|565904623|FG001|Overall Study|Physician Decision|0|||
156767221|NCT00750269|565904624|FG002|Overall Study|Physician Decision|0|||
156767222|NCT00750269|565904625|FG003|Overall Study|Physician Decision|0|||
156767223|NCT00750269|565904626|FG004|Overall Study|Physician Decision|2|||
156767224|NCT00750269|565904622|FG000|Overall Study|Patient too large for positioning|0|||
156767225|NCT00750269|565904623|FG001|Overall Study|Patient too large for positioning|0|||
156767226|NCT00750269|565904624|FG002|Overall Study|Patient too large for positioning|1|||
156767227|NCT00750269|565904625|FG003|Overall Study|Patient too large for positioning|0|||
156767228|NCT00750269|565904626|FG004|Overall Study|Patient too large for positioning|0|||
156767229|NCT00750269|565904622|FG000|Overall Study|Site error|0|||
156767230|NCT00750269|565904623|FG001|Overall Study|Site error|0|||
156767231|NCT00750269|565904624|FG002|Overall Study|Site error|0|||
156767232|NCT00750269|565904625|FG003|Overall Study|Site error|1|||
156767233|NCT00750269|565904626|FG004|Overall Study|Site error|0|||
156767234|NCT00750269|565904622|FG000|Overall Study|SBRT plan could not be drawn|0|||
156767235|NCT00750269|565904623|FG001|Overall Study|SBRT plan could not be drawn|0|||
156767236|NCT00750269|565904624|FG002|Overall Study|SBRT plan could not be drawn|0|||
156767237|NCT00750269|565904625|FG003|Overall Study|SBRT plan could not be drawn|0|||
156767238|NCT00750269|565904626|FG004|Overall Study|SBRT plan could not be drawn|1|||
156767239|NCT00750269|565904622|FG000|Overall Study|Fiducials could not be placed|0|||
156767240|NCT00750269|565904623|FG001|Overall Study|Fiducials could not be placed|0|||
156767241|NCT00750269|565904624|FG002|Overall Study|Fiducials could not be placed|0|||
156767242|NCT00750269|565904625|FG003|Overall Study|Fiducials could not be placed|0|||
156767243|NCT00750269|565904626|FG004|Overall Study|Fiducials could not be placed|1|||
156767244|NCT01898078|565904627|FG000|Overall Study|Progressive Disease|1|||
156767245|NCT01898078|565904628|FG001|Overall Study|Progressive Disease|5|||
156767246|NCT01898078|565904627|FG000|Overall Study|Adverse Event|2|||
156767247|NCT01898078|565904628|FG001|Overall Study|Adverse Event|1|||
156767248|NCT01898078|565904627|FG000|Overall Study|Withdrawal by Subject|1|||
156767249|NCT01898078|565904628|FG001|Overall Study|Withdrawal by Subject|1|||
156767250|NCT01898078|565904627|FG000|Overall Study|Symptomatic Deterioration|2|||
156767251|NCT01898078|565904628|FG001|Overall Study|Symptomatic Deterioration|0|||
156767252|NCT01898078|565904627|FG000|Overall Study|Reason not Specified|0|||
156767253|NCT01898078|565904628|FG001|Overall Study|Reason not Specified|1|||
156767254|NCT00720278|565904635|FG000|Overall Study|Adverse Event|5|||
156767255|NCT00720278|565904636|FG001|Overall Study|Adverse Event|3|||
156767256|NCT00720278|565904637|FG002|Overall Study|Adverse Event|4|||
156767257|NCT00720278|565904635|FG000|Overall Study|Withdrawal by Subject|0|||
156767258|NCT00720278|565904636|FG001|Overall Study|Withdrawal by Subject|1|||
156767259|NCT00720278|565904637|FG002|Overall Study|Withdrawal by Subject|0|||
156767260|NCT00720278|565904635|FG000|Overall Study|Lost to Follow-up|0|||
156767261|NCT00720278|565904636|FG001|Overall Study|Lost to Follow-up|0|||
156427356|NCT01674569|564656596|FG003|Overall Study|Protocol Violation|0|||
156427357|NCT01674569|564656597|FG004|Overall Study|Protocol Violation|0|||
156427358|NCT01674569|564656598|FG005|Overall Study|Protocol Violation|0|||
156427359|NCT01674569|564656593|FG000|Overall Study|Withdrawal by Subject|0|||
156427360|NCT01674569|564656594|FG001|Overall Study|Withdrawal by Subject|0|||
156427361|NCT01674569|564656595|FG002|Overall Study|Withdrawal by Subject|1|||
156427362|NCT01674569|564656596|FG003|Overall Study|Withdrawal by Subject|0|||
156427363|NCT01674569|564656597|FG004|Overall Study|Withdrawal by Subject|0|||
156427364|NCT01674569|564656598|FG005|Overall Study|Withdrawal by Subject|0|||
156427365|NCT01878890|564656599|FG000|Overall Study|Protocol Violation|0|||
156427366|NCT01878890|564656600|FG001|Overall Study|Protocol Violation|1|||
156427367|NCT01878890|564656601|FG002|Overall Study|Protocol Violation|0|||
156767262|NCT00720278|565904637|FG002|Overall Study|Lost to Follow-up|1|||
156767263|NCT00720278|565904635|FG000|Overall Study|Non-compliance|1|||
156767264|NCT00720278|565904636|FG001|Overall Study|Non-compliance|0|||
156767265|NCT00720278|565904637|FG002|Overall Study|Non-compliance|0|||
156767266|NCT00720278|565904635|FG000|Overall Study|eligibility criteria violation|1|||
156767267|NCT00720278|565904636|FG001|Overall Study|eligibility criteria violation|0|||
156767268|NCT00720278|565904637|FG002|Overall Study|eligibility criteria violation|1|||
156767269|NCT03630393|565904639|FG000|Overall Study|Death|1|||
156767270|NCT03630393|565904640|FG001|Overall Study|Death|0|||
156767271|NCT00408499|565904641|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
156767272|NCT00408499|565904642|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
156767273|NCT00408499|565904643|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
156767274|NCT00408499|565904644|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
156767275|NCT00408499|565904645|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
156767276|NCT00408499|565904641|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
156767277|NCT00408499|565904642|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
156767278|NCT00408499|565904643|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
156767279|NCT00408499|565904644|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
156767280|NCT00408499|565904645|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
156767281|NCT00408499|565904641|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
156767282|NCT00408499|565904642|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
156767283|NCT00408499|565904643|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
156767284|NCT00408499|565904644|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
156767285|NCT00408499|565904645|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
156767286|NCT00408499|565904641|FG000|Phase II- MTD Expansion|Adverse Event|0|||
156767287|NCT00408499|565904642|FG001|Phase II- MTD Expansion|Adverse Event|0|||
156767288|NCT00408499|565904643|FG002|Phase II- MTD Expansion|Adverse Event|0|||
156767289|NCT00408499|565904644|FG003|Phase II- MTD Expansion|Adverse Event|0|||
156767290|NCT00408499|565904645|FG004|Phase II- MTD Expansion|Adverse Event|9|||
156767291|NCT00408499|565904641|FG000|Phase II- MTD Expansion|Death|0|||
156767292|NCT00408499|565904642|FG001|Phase II- MTD Expansion|Death|0|||
156767293|NCT00408499|565904643|FG002|Phase II- MTD Expansion|Death|0|||
156767294|NCT00408499|565904644|FG003|Phase II- MTD Expansion|Death|0|||
156656251|NCT02415959|565487485|FG004|Overall Study|Protocol Violation|0|||
156656252|NCT02260492|565487486|FG000|Overall Study|Adverse Event|6|||
156656253|NCT02260492|565487487|FG001|Overall Study|Adverse Event|1|||
156767295|NCT00408499|565904645|FG004|Phase II- MTD Expansion|Death|2|||
156767296|NCT00408499|565904641|FG000|Phase II- MTD Expansion|Physician Decision|0|||
156767297|NCT00408499|565904642|FG001|Phase II- MTD Expansion|Physician Decision|0|||
156767298|NCT00408499|565904643|FG002|Phase II- MTD Expansion|Physician Decision|0|||
156767299|NCT00408499|565904644|FG003|Phase II- MTD Expansion|Physician Decision|0|||
156767300|NCT00408499|565904645|FG004|Phase II- MTD Expansion|Physician Decision|1|||
156767301|NCT00408499|565904641|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
156767302|NCT00408499|565904642|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
156767303|NCT00408499|565904643|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
156656254|NCT02260492|565487488|FG002|Overall Study|Adverse Event|2|||
156656255|NCT02260492|565487486|FG000|Overall Study|Death|0|||
156656256|NCT02260492|565487487|FG001|Overall Study|Death|1|||
156656257|NCT02260492|565487488|FG002|Overall Study|Death|0|||
156656258|NCT02260492|565487486|FG000|Overall Study|Lost to Follow-up|12|||
156656259|NCT02260492|565487487|FG001|Overall Study|Lost to Follow-up|9|||
156656260|NCT02260492|565487488|FG002|Overall Study|Lost to Follow-up|0|||
156656261|NCT02260492|565487486|FG000|Overall Study|Physician Decision|2|||
156656262|NCT02260492|565487487|FG001|Overall Study|Physician Decision|0|||
156656263|NCT02260492|565487488|FG002|Overall Study|Physician Decision|1|||
156656264|NCT02260492|565487486|FG000|Overall Study|Withdrawal by Subject|3|||
156656265|NCT02260492|565487487|FG001|Overall Study|Withdrawal by Subject|2|||
156656266|NCT02260492|565487488|FG002|Overall Study|Withdrawal by Subject|2|||
156656267|NCT03131999|565487489|FG000|Overall Study|Withdrawal by Subject|0|||
156656268|NCT03131999|565487490|FG001|Overall Study|Withdrawal by Subject|1|||
156656269|NCT00996736|565487491|FG000|Overall Study|Death|1|||
156656270|NCT00996736|565487492|FG001|Overall Study|Death|1|||
156656271|NCT00996736|565487491|FG000|Overall Study|Lost to Follow-up|15|||
156656272|NCT00996736|565487492|FG001|Overall Study|Lost to Follow-up|14|||
156656273|NCT00996736|565487491|FG000|Overall Study|Visit not within 3-month window|5|||
156656274|NCT00996736|565487492|FG001|Overall Study|Visit not within 3-month window|3|||
156656275|NCT02346201|565487494|FG000|Overall Study|Adverse Event|3|||
156656276|NCT02346201|565487495|FG001|Overall Study|Adverse Event|2|||
156656277|NCT02346201|565487494|FG000|Overall Study|Lost to Follow-up|1|||
156656278|NCT02346201|565487495|FG001|Overall Study|Lost to Follow-up|0|||
156656279|NCT02346201|565487494|FG000|Overall Study|Withdrawal by Subject|6|||
156656280|NCT02346201|565487495|FG001|Overall Study|Withdrawal by Subject|3|||
156656281|NCT02346201|565487494|FG000|Overall Study|Unavailable for future follow-up|0|||
156656282|NCT02346201|565487495|FG001|Overall Study|Unavailable for future follow-up|1|||
156656283|NCT02346201|565487494|FG000|Overall Study|Physician Decision|0|||
156656284|NCT02346201|565487495|FG001|Overall Study|Physician Decision|1|||
156656285|NCT02346201|565487494|FG000|Overall Study|Missed final visit|0|||
156656286|NCT02346201|565487495|FG001|Overall Study|Missed final visit|2|||
156656287|NCT01497938|565487496|FG000|Overall Study|Adverse Event|0|||
156656288|NCT01497938|565487497|FG001|Overall Study|Adverse Event|1|||
156656289|NCT01497938|565487496|FG000|Overall Study|Physician Decision|0|||
156656290|NCT01497938|565487497|FG001|Overall Study|Physician Decision|1|||
156656291|NCT01497938|565487496|FG000|Overall Study|Withdrawal by Subject|4|||
156656292|NCT01497938|565487497|FG001|Overall Study|Withdrawal by Subject|0|||
156656293|NCT01497938|565487496|FG000|Overall Study|Device Violation|1|||
156656294|NCT01497938|565487497|FG001|Overall Study|Device Violation|0|||
156656295|NCT03708211|565487498|FG000|Overall Study|Progressive Disease|10|||
156656296|NCT03708211|565487499|FG001|Overall Study|Progressive Disease|7|||
156656297|NCT03708211|565487498|FG000|Overall Study|Withdrawal by Subject|0|||
156656298|NCT03708211|565487499|FG001|Overall Study|Withdrawal by Subject|1|||
156656299|NCT03708211|565487498|FG000|Overall Study|Other|2|||
156656300|NCT03708211|565487499|FG001|Overall Study|Other|0|||
156656301|NCT00365352|565487500|FG000|Overall Study|Adverse Event|6|||
156656302|NCT00365352|565487501|FG001|Overall Study|Adverse Event|7|||
156522534|NCT03184870|565007730|FG000|Initial Treatment|Moved to crossover treatment|0|||
156767304|NCT00408499|565904644|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
156767305|NCT00408499|565904645|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
156767306|NCT00408499|565904641|FG000|Phase II- MTD Expansion|treatment delay|0|||
156767307|NCT00408499|565904642|FG001|Phase II- MTD Expansion|treatment delay|0|||
156767308|NCT00408499|565904643|FG002|Phase II- MTD Expansion|treatment delay|0|||
156767309|NCT00408499|565904644|FG003|Phase II- MTD Expansion|treatment delay|0|||
156767310|NCT00408499|565904645|FG004|Phase II- MTD Expansion|treatment delay|3|||
156767311|NCT00997334|565904647|FG000|Overall Study|still on therapy|12|||
156767312|NCT00997334|565904647|FG000|Overall Study|Adverse Event|3|||
156767313|NCT00997334|565904647|FG000|Overall Study|Patient non-compliance|1|||
156767314|NCT00997334|565904647|FG000|Overall Study|Withdrawal by Subject|3|||
156767315|NCT00997334|565904647|FG000|Overall Study|Death|2|||
156767316|NCT00997334|565904647|FG000|Overall Study|Urgent Palliative Care|2|||
156767317|NCT00997334|565904647|FG000|Overall Study|No lesion amenable|1|||
156767318|NCT00997334|565904647|FG000|Overall Study|Ineligible|1|||
156767319|NCT01586195|565904648|FG000|Overall Study|Death|11|||
156767320|NCT01586195|565904648|FG000|Overall Study|Withdrawal of Consent|5|||
156767321|NCT01586195|565904648|FG000|Overall Study|Started new anti-melanoma therapy|1|||
156767322|NCT01586195|565904648|FG000|Overall Study|Reason not specified|9|||
156767323|NCT01855958|565904649|FG000|Overall Study|Withdrawal by Subject|1|||
156767324|NCT01855958|565904650|FG001|Overall Study|Withdrawal by Subject|0|||
156767325|NCT00266708|565904656|FG000|Overall Study|No renal function|1|||
156767326|NCT00266708|565904657|FG001|Overall Study|No renal function|1|||
156767327|NCT00266708|565904656|FG000|Overall Study|Refused biopsy|3|||
156767328|NCT00266708|565904657|FG001|Overall Study|Refused biopsy|6|||
156767329|NCT00266708|565904656|FG000|Overall Study|Asthma|0|||
156767330|NCT00266708|565904657|FG001|Overall Study|Asthma|2|||
156767331|NCT02791269|565904658|FG000|Overall Study|Lost to Follow-up|0|||
156767332|NCT02791269|565904659|FG001|Overall Study|Lost to Follow-up|1|||
156767333|NCT02683109|565904660|FG000|Overall Study|Adverse Event|1|||
156767334|NCT02683109|565904661|FG001|Overall Study|Adverse Event|0|||
156767335|NCT00368251|565904662|FG000|Overall Study|SAE, non-fatal|1|||
156767336|NCT00368251|565904663|FG001|Overall Study|SAE, non-fatal|0|||
156767337|NCT00368251|565904664|FG002|Overall Study|SAE, non-fatal|0|||
156767338|NCT00368251|565904662|FG000|Overall Study|AE, non-serious non-fatal|0|||
156767339|NCT00368251|565904663|FG001|Overall Study|AE, non-serious non-fatal|0|||
156767340|NCT00368251|565904664|FG002|Overall Study|AE, non-serious non-fatal|1|||
156767341|NCT00499122|565904666|FG000|Overall Study|Withdrawal by Subject|2|||
156767342|NCT03312738|565904667|FG000|Overall Study|Progressive disease|58|||
156767343|NCT03312738|565904668|FG001|Overall Study|Progressive disease|67|||
156767344|NCT03312738|565904667|FG000|Overall Study|Patient/guardian decision|13|||
156767345|NCT03312738|565904668|FG001|Overall Study|Patient/guardian decision|5|||
156767346|NCT03312738|565904667|FG000|Overall Study|Adverse Event|5|||
156522535|NCT03184870|565007731|FG001|Initial Treatment|Moved to crossover treatment|0|||
156656303|NCT00365352|565487502|FG002|Overall Study|Adverse Event|8|||
156656304|NCT00365352|565487500|FG000|Overall Study|Participant Withdrew Consent|8|||
156656305|NCT00365352|565487501|FG001|Overall Study|Participant Withdrew Consent|3|||
156767347|NCT03312738|565904668|FG001|Overall Study|Adverse Event|3|||
156767348|NCT03312738|565904667|FG000|Overall Study|Protocol deviation|2|||
156767349|NCT03312738|565904668|FG001|Overall Study|Protocol deviation|0|||
156767350|NCT03312738|565904667|FG000|Overall Study|Technical problems|0|||
156767351|NCT03312738|565904668|FG001|Overall Study|Technical problems|1|||
156656306|NCT00365352|565487502|FG002|Overall Study|Participant Withdrew Consent|4|||
156656307|NCT00365352|565487500|FG000|Overall Study|Lack of Efficacy|3|||
156656308|NCT00365352|565487501|FG001|Overall Study|Lack of Efficacy|0|||
156656309|NCT00365352|565487502|FG002|Overall Study|Lack of Efficacy|0|||
156656310|NCT00365352|565487500|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
156656311|NCT00365352|565487501|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
156656312|NCT00365352|565487502|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
156656313|NCT00365352|565487500|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
156656314|NCT00365352|565487501|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
156656315|NCT00365352|565487502|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
156656316|NCT00365352|565487500|FG000|Overall Study|Lost to Follow-up|1|||
156656317|NCT00365352|565487501|FG001|Overall Study|Lost to Follow-up|1|||
156656318|NCT00365352|565487502|FG002|Overall Study|Lost to Follow-up|0|||
156656319|NCT00365352|565487500|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
156656320|NCT00365352|565487501|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
156656321|NCT00365352|565487502|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
156656322|NCT00462982|565487507|FG000|Overall Study|Adverse Event|1|||
156656323|NCT00462982|565487507|FG000|Overall Study|Patient Not Treated|2|||
156656324|NCT05200858|565487510|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
156656325|NCT05200858|565487511|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
156656326|NCT05200858|565487512|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
156656327|NCT05200858|565487513|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
156656328|NCT00770315|565487514|FG000|Overall Study|Adverse Event|11|||
156656329|NCT00770315|565487515|FG001|Overall Study|Adverse Event|17|||
156656330|NCT00770315|565487516|FG002|Overall Study|Adverse Event|16|||
156656331|NCT00770315|565487517|FG003|Overall Study|Adverse Event|6|||
156656332|NCT00770315|565487514|FG000|Overall Study|Lost to Follow-up|9|||
156656333|NCT00770315|565487515|FG001|Overall Study|Lost to Follow-up|5|||
156656334|NCT00770315|565487516|FG002|Overall Study|Lost to Follow-up|10|||
156656335|NCT00770315|565487517|FG003|Overall Study|Lost to Follow-up|3|||
156656336|NCT00770315|565487514|FG000|Overall Study|Withdrawal by Subject|13|||
156656337|NCT00770315|565487515|FG001|Overall Study|Withdrawal by Subject|17|||
156656338|NCT00770315|565487516|FG002|Overall Study|Withdrawal by Subject|24|||
156656339|NCT00770315|565487517|FG003|Overall Study|Withdrawal by Subject|20|||
156656340|NCT00770315|565487514|FG000|Overall Study|Noncompliance with Protocol|7|||
156656341|NCT00770315|565487515|FG001|Overall Study|Noncompliance with Protocol|4|||
156656342|NCT00770315|565487516|FG002|Overall Study|Noncompliance with Protocol|7|||
156656343|NCT00770315|565487517|FG003|Overall Study|Noncompliance with Protocol|9|||
156656344|NCT04256421|565487520|FG000|Overall Study|Death|171|||
156656345|NCT04256421|565487521|FG001|Overall Study|Death|180|||
156656346|NCT04256421|565487520|FG000|Overall Study|Lost to Follow-up|1|||
156656347|NCT04256421|565487521|FG001|Overall Study|Lost to Follow-up|1|||
156656348|NCT04256421|565487520|FG000|Overall Study|Withdrawal by Subject|9|||
156656349|NCT04256421|565487521|FG001|Overall Study|Withdrawal by Subject|10|||
156656350|NCT04256421|565487520|FG000|Overall Study|Ongoing in Study|66|||
156656351|NCT04256421|565487521|FG001|Overall Study|Ongoing in Study|52|||
156656352|NCT01402908|565489350|FG000|Overall Study|Withdrawal by Subject|30|||
156656353|NCT01402908|565489351|FG001|Overall Study|Withdrawal by Subject|17|||
156656354|NCT01402908|565489350|FG000|Overall Study|Lost to Follow-up|3|||
156656355|NCT01402908|565489351|FG001|Overall Study|Lost to Follow-up|1|||
156656356|NCT01402908|565489350|FG000|Overall Study|Physician Decision|1|||
156656357|NCT01402908|565489351|FG001|Overall Study|Physician Decision|0|||
156656358|NCT01739790|565489352|FG000|Overall Study|Early Trial Termination|2|||
156656359|NCT01739790|565489353|FG001|Overall Study|Early Trial Termination|4|||
156656360|NCT02581345|565489354|FG000|Part 1: up to Week 16|Adverse Event|3|||
156656361|NCT02581345|565489355|FG001|Part 1: up to Week 16|Adverse Event|8|||
156656362|NCT02581345|565489356|FG002|Part 1: up to Week 16|Adverse Event|0|||
156656363|NCT02581345|565489357|FG003|Part 1: up to Week 16|Adverse Event|0|||
156656364|NCT02581345|565489354|FG000|Part 1: up to Week 16|Physician Decision|2|||
156656365|NCT02581345|565489355|FG001|Part 1: up to Week 16|Physician Decision|4|||
156656366|NCT02581345|565489356|FG002|Part 1: up to Week 16|Physician Decision|0|||
156656367|NCT02581345|565489357|FG003|Part 1: up to Week 16|Physician Decision|0|||
156656368|NCT02581345|565489354|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
156656369|NCT02581345|565489355|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
156656370|NCT02581345|565489356|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
156656371|NCT02581345|565489357|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
156656372|NCT02581345|565489354|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
156656373|NCT02581345|565489355|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
156656374|NCT02581345|565489356|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
156656375|NCT02581345|565489357|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
156656376|NCT02581345|565489354|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
156656377|NCT02581345|565489355|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
156656378|NCT02581345|565489356|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
156656379|NCT02581345|565489357|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
156656380|NCT02581345|565489354|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
156656381|NCT02581345|565489355|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
156656382|NCT02581345|565489356|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
156656383|NCT02581345|565489357|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
156656384|NCT02581345|565489354|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
156656385|NCT02581345|565489355|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
156656386|NCT02581345|565489356|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
156656387|NCT02581345|565489357|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
156656388|NCT02581345|565489354|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
156656389|NCT02581345|565489355|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
156656390|NCT02581345|565489356|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
156656391|NCT02581345|565489357|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
156656392|NCT02581345|565489354|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
156656393|NCT02581345|565489355|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
156656394|NCT02581345|565489356|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
156656395|NCT02581345|565489357|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
156656396|NCT02581345|565489354|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
156656397|NCT02581345|565489355|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
156656398|NCT02581345|565489356|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
156656399|NCT02581345|565489357|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
156656400|NCT02581345|565489354|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
156656401|NCT02581345|565489355|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
156656402|NCT02581345|565489356|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
156656403|NCT02581345|565489357|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
156656404|NCT02581345|565489354|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
156656405|NCT02581345|565489355|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
156656406|NCT02581345|565489356|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
156656407|NCT02581345|565489357|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
156656408|NCT02207231|565489364|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
156656409|NCT02207231|565489365|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
156656410|NCT02207231|565489366|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
156656411|NCT02207231|565489367|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
156656412|NCT02207231|565489364|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
156767352|NCT03312738|565904667|FG000|Overall Study|Physician Decision|2|||
156767353|NCT03312738|565904668|FG001|Overall Study|Physician Decision|3|||
156767354|NCT02466399|565904677|FG000|Overall Study|Adverse Event|1|||
156767355|NCT02466399|565904678|FG001|Overall Study|Adverse Event|0|||
156767356|NCT02466399|565904677|FG000|Overall Study|Early exit due to family emergency|1|||
156767357|NCT02466399|565904678|FG001|Overall Study|Early exit due to family emergency|0|||
156767358|NCT04539275|565904679|FG000|Overall Study|Death|2|||
156767359|NCT04539275|565904680|FG001|Overall Study|Death|4|||
156767360|NCT04539275|565904679|FG000|Overall Study|Lost to Follow-up|1|||
156767361|NCT04539275|565904680|FG001|Overall Study|Lost to Follow-up|1|||
156767362|NCT04539275|565904679|FG000|Overall Study|Withdrawal by Subject|3|||
156767363|NCT04539275|565904680|FG001|Overall Study|Withdrawal by Subject|0|||
156767364|NCT01715831|565904683|FG000|Overall Study|Adverse Event|1|||
156767365|NCT00900562|565904684|FG000|Overall Study|Progressive disease|9|||
156767366|NCT00900562|565904685|FG001|Overall Study|Progressive disease|5|||
156767367|NCT00900562|565904684|FG000|Overall Study|Toxicity|1|||
156767368|NCT00900562|565904685|FG001|Overall Study|Toxicity|0|||
156767369|NCT00900562|565904684|FG000|Overall Study|Death|1|||
156767370|NCT00900562|565904685|FG001|Overall Study|Death|1|||
156767371|NCT00900562|565904684|FG000|Overall Study|Withdrawal by Subject|0|||
156767372|NCT00900562|565904685|FG001|Overall Study|Withdrawal by Subject|1|||
156767373|NCT00900562|565904684|FG000|Overall Study|Unrelated adverse event|1|||
156767374|NCT00900562|565904685|FG001|Overall Study|Unrelated adverse event|0|||
156767375|NCT01516216|565904688|FG000|Overall Study|Adverse Event|2|||
156767376|NCT01516216|565904689|FG001|Overall Study|Adverse Event|4|||
156767377|NCT01516216|565904688|FG000|Overall Study|Disease Progression|38|||
156767378|NCT01516216|565904689|FG001|Overall Study|Disease Progression|34|||
156767379|NCT01516216|565904688|FG000|Overall Study|Withdrawal by Subject|9|||
156767380|NCT01516216|565904689|FG001|Overall Study|Withdrawal by Subject|11|||
156767381|NCT01516216|565904688|FG000|Overall Study|Potentially Curative Resection|6|||
156767382|NCT01516216|565904689|FG001|Overall Study|Potentially Curative Resection|12|||
156767383|NCT01516216|565904688|FG000|Overall Study|Nonadherence|2|||
156767384|NCT01516216|565904689|FG001|Overall Study|Nonadherence|3|||
156767385|NCT01516216|565904688|FG000|Overall Study|Physician Decision|6|||
156767386|NCT01516216|565904689|FG001|Overall Study|Physician Decision|3|||
156767387|NCT01516216|565904688|FG000|Overall Study|Prolonged Treatment Delay|5|||
156767388|NCT01516216|565904689|FG001|Overall Study|Prolonged Treatment Delay|1|||
156767389|NCT01516216|565904688|FG000|Overall Study|Intercurrent Illness|1|||
156767390|NCT01516216|565904689|FG001|Overall Study|Intercurrent Illness|0|||
156767391|NCT01516216|565904688|FG000|Overall Study|Death|1|||
156767392|NCT01516216|565904689|FG001|Overall Study|Death|1|||
156767393|NCT03098979|565904690|FG000|Overall Study|Adverse Event|1|||
156767394|NCT03098979|565904691|FG001|Overall Study|Adverse Event|0|||
156767395|NCT03098979|565904692|FG002|Overall Study|Adverse Event|1|||
156767396|NCT03098979|565904693|FG003|Overall Study|Adverse Event|4|||
156767397|NCT03098979|565904694|FG004|Overall Study|Adverse Event|6|||
156767398|NCT03098979|565904695|FG005|Overall Study|Adverse Event|1|||
156767399|NCT03098979|565904690|FG000|Overall Study|Withdrawal by Subject|2|||
156656413|NCT02207231|565489365|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
156767400|NCT03098979|565904691|FG001|Overall Study|Withdrawal by Subject|1|||
156767401|NCT03098979|565904692|FG002|Overall Study|Withdrawal by Subject|1|||
156767402|NCT03098979|565904693|FG003|Overall Study|Withdrawal by Subject|1|||
156767403|NCT03098979|565904694|FG004|Overall Study|Withdrawal by Subject|2|||
156767404|NCT03098979|565904695|FG005|Overall Study|Withdrawal by Subject|1|||
156767405|NCT03098979|565904690|FG000|Overall Study|Death|1|||
156767406|NCT03098979|565904691|FG001|Overall Study|Death|0|||
156767407|NCT03098979|565904692|FG002|Overall Study|Death|2|||
156767408|NCT03098979|565904693|FG003|Overall Study|Death|0|||
156767409|NCT03098979|565904694|FG004|Overall Study|Death|1|||
156767410|NCT03098979|565904695|FG005|Overall Study|Death|0|||
156767411|NCT03098979|565904690|FG000|Overall Study|Physician Decision|2|||
156767412|NCT03098979|565904691|FG001|Overall Study|Physician Decision|1|||
156767413|NCT03098979|565904692|FG002|Overall Study|Physician Decision|0|||
156767414|NCT03098979|565904693|FG003|Overall Study|Physician Decision|0|||
156767415|NCT03098979|565904694|FG004|Overall Study|Physician Decision|0|||
156767416|NCT03098979|565904695|FG005|Overall Study|Physician Decision|0|||
156767417|NCT03098979|565904690|FG000|Overall Study|Non-compliance|0|||
156767418|NCT03098979|565904691|FG001|Overall Study|Non-compliance|0|||
156767419|NCT03098979|565904692|FG002|Overall Study|Non-compliance|0|||
156767420|NCT03098979|565904693|FG003|Overall Study|Non-compliance|0|||
156767421|NCT03098979|565904694|FG004|Overall Study|Non-compliance|0|||
156767422|NCT03098979|565904695|FG005|Overall Study|Non-compliance|1|||
156767423|NCT03098979|565904690|FG000|Overall Study|Protocol Violation|0|||
156767424|NCT03098979|565904691|FG001|Overall Study|Protocol Violation|0|||
156767425|NCT03098979|565904692|FG002|Overall Study|Protocol Violation|0|||
156767426|NCT03098979|565904693|FG003|Overall Study|Protocol Violation|0|||
156767427|NCT03098979|565904694|FG004|Overall Study|Protocol Violation|0|||
156767428|NCT03098979|565904695|FG005|Overall Study|Protocol Violation|1|||
156767429|NCT01483118|565904699|FG000|Overall Study|Lost to Follow-up|12|||
156767430|NCT01483118|565904700|FG001|Overall Study|Lost to Follow-up|16|||
156767431|NCT01079780|565904701|FG000|Overall Study|Disease progression|43|||
156767432|NCT01079780|565904702|FG001|Overall Study|Disease progression|7|||
156767433|NCT01079780|565904703|FG002|Overall Study|Disease progression|31|||
156767434|NCT01079780|565904701|FG000|Overall Study|Adverse Event|13|||
156767435|NCT01079780|565904702|FG001|Overall Study|Adverse Event|5|||
156767436|NCT01079780|565904703|FG002|Overall Study|Adverse Event|7|||
156767437|NCT01079780|565904701|FG000|Overall Study|Death|2|||
156767438|NCT01079780|565904702|FG001|Overall Study|Death|0|||
156767439|NCT01079780|565904703|FG002|Overall Study|Death|2|||
156767440|NCT01079780|565904701|FG000|Overall Study|Withdrawal by Subject|6|||
156767441|NCT01079780|565904702|FG001|Overall Study|Withdrawal by Subject|4|||
156767442|NCT01079780|565904703|FG002|Overall Study|Withdrawal by Subject|4|||
156767443|NCT01079780|565904701|FG000|Overall Study|Alternative therapy|2|||
156767444|NCT01079780|565904702|FG001|Overall Study|Alternative therapy|0|||
156767445|NCT01079780|565904703|FG002|Overall Study|Alternative therapy|2|||
156767446|NCT01079780|565904701|FG000|Overall Study|Physician Decision|1|||
156767447|NCT01079780|565904702|FG001|Overall Study|Physician Decision|0|||
156767448|NCT01079780|565904703|FG002|Overall Study|Physician Decision|1|||
156767449|NCT01079780|565904701|FG000|Overall Study|Error made in lesion measurement|1|||
156767450|NCT01079780|565904702|FG001|Overall Study|Error made in lesion measurement|0|||
156767451|NCT01079780|565904703|FG002|Overall Study|Error made in lesion measurement|0|||
156767452|NCT01079780|565904701|FG000|Overall Study|Patient had surgery|1|||
156767453|NCT01079780|565904702|FG001|Overall Study|Patient had surgery|0|||
156767454|NCT01079780|565904703|FG002|Overall Study|Patient had surgery|0|||
156767455|NCT01079780|565904701|FG000|Overall Study|Treatment cycle delay|0|||
156767456|NCT01079780|565904702|FG001|Overall Study|Treatment cycle delay|0|||
156767457|NCT01079780|565904703|FG002|Overall Study|Treatment cycle delay|1|||
156767458|NCT01079780|565904701|FG000|Overall Study|Never started treatment|1|||
156767459|NCT01079780|565904702|FG001|Overall Study|Never started treatment|0|||
156767460|NCT01079780|565904703|FG002|Overall Study|Never started treatment|2|||
156767461|NCT01178294|565904704|FG000|Overall Study|Adverse Event|4|||
156767462|NCT01178294|565904704|FG000|Overall Study|Lost to Follow-up|2|||
156767463|NCT01178294|565904704|FG000|Overall Study|Lack of Efficacy|1|||
156767464|NCT01178294|565904704|FG000|Overall Study|Death|1|||
156767465|NCT01178294|565904704|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
156767466|NCT01178294|565904704|FG000|Overall Study|Subject status is terminal|1|||
156767467|NCT01178294|565904704|FG000|Overall Study|Completion status could not be verified|1|||
156767468|NCT02783066|565904705|FG000|Overall Study|Withdrawal by Subject|13|||
156767469|NCT05379920|565904706|FG000|Overall Study|Lost to Follow-up|0|||
156767470|NCT05379920|565904707|FG001|Overall Study|Lost to Follow-up|5|||
156767471|NCT05379920|565904708|FG002|Overall Study|Lost to Follow-up|0|||
156767472|NCT05379920|565904709|FG003|Overall Study|Lost to Follow-up|0|||
156767473|NCT03530293|565904712|FG000|Pre-randomization|Adverse Event|12|||
156767474|NCT03530293|565904713|FG001|Pre-randomization|Adverse Event|0|||
156767475|NCT03530293|565904714|FG002|Pre-randomization|Adverse Event|0|||
156767476|NCT03530293|565904712|FG000|Pre-randomization|Protocol Violation|2|||
156767477|NCT03530293|565904713|FG001|Pre-randomization|Protocol Violation|0|||
156767478|NCT03530293|565904714|FG002|Pre-randomization|Protocol Violation|0|||
156656414|NCT02207231|565489366|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
156656415|NCT02207231|565489367|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
156656416|NCT02207231|565489364|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
156656417|NCT02207231|565489365|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
156656418|NCT02207231|565489366|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
156656419|NCT02207231|565489367|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
156656420|NCT02207231|565489364|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
156656421|NCT02207231|565489365|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
156656422|NCT02207231|565489366|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
156656423|NCT02207231|565489367|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
156656424|NCT02207231|565489364|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
156656425|NCT02207231|565489365|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
156656426|NCT02207231|565489366|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
156656427|NCT02207231|565489367|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
156656428|NCT02207231|565489364|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
156656429|NCT02207231|565489365|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
156656430|NCT02207231|565489366|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
156656431|NCT02207231|565489367|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
156656432|NCT02207231|565489364|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
156656433|NCT02207231|565489365|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
156656434|NCT02207231|565489366|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
156656435|NCT02207231|565489367|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
156767479|NCT03530293|565904712|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
156767480|NCT03530293|565904713|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
156767481|NCT03530293|565904714|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
156767482|NCT03530293|565904712|FG000|Pre-randomization|Withdrawal by Subject|5|||
156323033|NCT04480424|564280324|FG000|Overall Study|Lost to Follow-up|3|||
156767483|NCT03530293|565904713|FG001|Pre-randomization|Withdrawal by Subject|0|||
156767484|NCT03530293|565904714|FG002|Pre-randomization|Withdrawal by Subject|0|||
156323034|NCT04480424|564280325|FG001|Overall Study|Lost to Follow-up|3|||
156323035|NCT04480424|564280324|FG000|Overall Study|Death|14|||
156323036|NCT04480424|564280325|FG001|Overall Study|Death|16|||
156323037|NCT04480424|564280324|FG000|Overall Study|Reason not Specified|5|||
156323038|NCT04480424|564280325|FG001|Overall Study|Reason not Specified|5|||
156323039|NCT03437512|564282294|FG000|Randomized|Withdrawal by Subject|0|||
156323040|NCT03437512|564282295|FG001|Randomized|Withdrawal by Subject|2|||
156323041|NCT03437512|564282294|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
156323042|NCT03437512|564282295|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
156323043|NCT05828095|564282296|FG000|Overall Study|Lost to Follow-up|1|||
156323044|NCT05828095|564282297|FG001|Overall Study|Lost to Follow-up|0|||
156323045|NCT05828095|564282296|FG000|Overall Study|Reactogenicity symptom|0|||
156323046|NCT05828095|564282297|FG001|Overall Study|Reactogenicity symptom|1|||
156323047|NCT01994590|564282300|FG000|Overall Study|Adverse Event|1|||
156323048|NCT01994590|564282300|FG000|Overall Study|Trial Terminated|1|||
156323049|NCT03206073|564282301|FG000|Overall Study|Participant Noncompliance|0|||
156323050|NCT03206073|564282302|FG001|Overall Study|Participant Noncompliance|1|||
156323051|NCT03206073|564282303|FG002|Overall Study|Participant Noncompliance|0|||
156323052|NCT03206073|564282304|FG003|Overall Study|Participant Noncompliance|0|||
156323053|NCT03206073|564282301|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
156323054|NCT03206073|564282302|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
156323055|NCT03206073|564282303|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
156323056|NCT03206073|564282304|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
156323057|NCT03206073|564282301|FG000|Overall Study|Death|0|||
156323058|NCT03206073|564282302|FG001|Overall Study|Death|0|||
156323059|NCT03206073|564282303|FG002|Overall Study|Death|1|||
156323060|NCT03206073|564282304|FG003|Overall Study|Death|0|||
156323061|NCT03206073|564282301|FG000|Overall Study|Taken off active treatment|0|||
156323062|NCT03206073|564282302|FG001|Overall Study|Taken off active treatment|0|||
156323063|NCT03206073|564282303|FG002|Overall Study|Taken off active treatment|3|||
156323064|NCT03206073|564282304|FG003|Overall Study|Taken off active treatment|0|||
156323065|NCT03442764|564282306|FG000|Overall Study|Adverse Event|1|||
156323066|NCT03442764|564282307|FG001|Overall Study|Adverse Event|0|||
156323067|NCT03442764|564282308|FG002|Overall Study|Adverse Event|0|||
156323068|NCT01801072|564282309|FG000|Overall Study|Lost to Follow-up|17|||
156323069|NCT01801072|564282310|FG001|Overall Study|Lost to Follow-up|14|||
156323070|NCT01801072|564282309|FG000|Overall Study|Physician Decision|2|||
156323071|NCT01801072|564282310|FG001|Overall Study|Physician Decision|3|||
156323072|NCT01801072|564282309|FG000|Overall Study|Withdrawal by Subject|1|||
156323073|NCT01801072|564282310|FG001|Overall Study|Withdrawal by Subject|0|||
156656436|NCT02207231|565489364|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
156656437|NCT02207231|565489365|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
156656438|NCT02207231|565489366|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
156656439|NCT02207231|565489367|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
156656440|NCT02207231|565489364|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
156656441|NCT02207231|565489365|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
156656442|NCT02207231|565489366|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
156656443|NCT02207231|565489367|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
156656444|NCT02207231|565489364|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
156656445|NCT02207231|565489365|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
156656446|NCT02207231|565489366|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
156656447|NCT02207231|565489367|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
156656448|NCT02207231|565489364|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
156656449|NCT02207231|565489365|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
156656450|NCT02207231|565489366|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
156656451|NCT02207231|565489367|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
156656452|NCT02207231|565489364|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
156656453|NCT02207231|565489365|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
156656454|NCT02207231|565489366|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
156656455|NCT02207231|565489367|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
156656456|NCT02207231|565489364|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
156656457|NCT02207231|565489365|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
156656458|NCT02207231|565489366|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
156656459|NCT02207231|565489367|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
156656460|NCT02207231|565489364|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
156656461|NCT02207231|565489365|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
156656462|NCT02207231|565489366|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
156656463|NCT02207231|565489367|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
156656464|NCT02207231|565489364|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
156656465|NCT02207231|565489365|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
156656466|NCT02207231|565489366|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
156656467|NCT02207231|565489367|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
156656468|NCT02207231|565489364|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
156656469|NCT02207231|565489365|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
156656470|NCT02207231|565489366|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
156656471|NCT02207231|565489367|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
156656472|NCT02207231|565489364|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
156656473|NCT02207231|565489365|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
156656474|NCT02207231|565489366|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
156656475|NCT02207231|565489367|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
156656476|NCT02207231|565489364|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
156656477|NCT02207231|565489365|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
156656478|NCT02207231|565489366|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
156656479|NCT02207231|565489367|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
156656480|NCT02207231|565489364|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
156656481|NCT02207231|565489365|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
156656482|NCT02207231|565489366|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
156656483|NCT02207231|565489367|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
156656484|NCT02207231|565489364|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
156656485|NCT02207231|565489365|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
156656486|NCT02207231|565489366|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
156656487|NCT02207231|565489367|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
156656488|NCT02207231|565489364|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
156656489|NCT02207231|565489365|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
156656490|NCT02207231|565489366|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
156656491|NCT02207231|565489367|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
156656492|NCT01290263|565489370|FG000|Overall Study|Adverse Event|0|||
156323074|NCT01801072|564282309|FG000|Overall Study|Protocol Violation|2|||
156323075|NCT01801072|564282310|FG001|Overall Study|Protocol Violation|0|||
156323076|NCT01801072|564282309|FG000|Overall Study|Death|7|||
156323077|NCT01801072|564282310|FG001|Overall Study|Death|8|||
156323078|NCT00719264|564282311|FG000|Overall Study|Adverse Event|41|||
156323079|NCT00719264|564282312|FG001|Overall Study|Adverse Event|49|||
156323080|NCT00719264|564282311|FG000|Overall Study|Death|13|||
156323081|NCT00719264|564282312|FG001|Overall Study|Death|10|||
156323082|NCT00719264|564282311|FG000|Overall Study|Administrative Problems|6|||
156323083|NCT00719264|564282312|FG001|Overall Study|Administrative Problems|4|||
156323084|NCT00719264|564282311|FG000|Overall Study|Lost to Follow-up|1|||
156323085|NCT00719264|564282312|FG001|Overall Study|Lost to Follow-up|1|||
156323086|NCT00719264|564282311|FG000|Overall Study|Withdrawal by Subject|12|||
156656493|NCT01290263|565489371|FG001|Overall Study|Adverse Event|0|||
156656494|NCT01290263|565489372|FG002|Overall Study|Adverse Event|0|||
156656495|NCT01290263|565489373|FG003|Overall Study|Adverse Event|1|||
156656496|NCT01290263|565489374|FG004|Overall Study|Adverse Event|1|||
156656497|NCT01290263|565489370|FG000|Overall Study|Lack of Efficacy|8|||
156656498|NCT01290263|565489371|FG001|Overall Study|Lack of Efficacy|2|||
156656499|NCT01290263|565489372|FG002|Overall Study|Lack of Efficacy|7|||
156656500|NCT01290263|565489373|FG003|Overall Study|Lack of Efficacy|24|||
156656501|NCT01290263|565489374|FG004|Overall Study|Lack of Efficacy|33|||
156427368|NCT01878890|564656602|FG003|Overall Study|Protocol Violation|0|||
156427369|NCT03140176|564658712|FG000|Overall Study|Reason missing|23|||
156427370|NCT03140176|564658712|FG000|Overall Study|Death|33|||
156427371|NCT03140176|564658712|FG000|Overall Study|Disease progression|1|||
156427372|NCT03140176|564658712|FG000|Overall Study|Physician Decision|1|||
156427373|NCT03140176|564658712|FG000|Overall Study|Withdrawal by Subject|1|||
156427374|NCT03140176|564658712|FG000|Overall Study|Lost to Follow-up|15|||
156427375|NCT03179787|564658718|FG000|Overall Study|Lost to Follow-up|15|||
156656502|NCT01290263|565489370|FG000|Overall Study|Withdrawal by Subject|3|||
156656503|NCT01290263|565489371|FG001|Overall Study|Withdrawal by Subject|1|||
156656504|NCT01290263|565489372|FG002|Overall Study|Withdrawal by Subject|0|||
156656505|NCT01290263|565489373|FG003|Overall Study|Withdrawal by Subject|1|||
156656506|NCT01290263|565489374|FG004|Overall Study|Withdrawal by Subject|2|||
156656507|NCT01290263|565489370|FG000|Overall Study|Participant Non-Compliance|0|||
156656508|NCT01290263|565489371|FG001|Overall Study|Participant Non-Compliance|0|||
156656509|NCT01290263|565489372|FG002|Overall Study|Participant Non-Compliance|0|||
156656510|NCT01290263|565489373|FG003|Overall Study|Participant Non-Compliance|1|||
156656511|NCT01290263|565489374|FG004|Overall Study|Participant Non-Compliance|1|||
156656512|NCT00502775|565489375|FG000|Overall Study|Adverse Event|1|||
156656513|NCT00502775|565489376|FG001|Overall Study|Adverse Event|2|||
156656514|NCT00502775|565489377|FG002|Overall Study|Adverse Event|1|||
156656515|NCT00502775|565489375|FG000|Overall Study|Protocol Violation|1|||
156656516|NCT00502775|565489376|FG001|Overall Study|Protocol Violation|5|||
156656517|NCT00502775|565489377|FG002|Overall Study|Protocol Violation|2|||
156656518|NCT00502775|565489375|FG000|Overall Study|Withdrawal by Subject|1|||
156656519|NCT00502775|565489376|FG001|Overall Study|Withdrawal by Subject|1|||
156656520|NCT00502775|565489377|FG002|Overall Study|Withdrawal by Subject|2|||
156656521|NCT00502775|565489375|FG000|Overall Study|Sponsor Terminated Study|1|||
156656522|NCT00502775|565489376|FG001|Overall Study|Sponsor Terminated Study|0|||
156656523|NCT00502775|565489377|FG002|Overall Study|Sponsor Terminated Study|1|||
156656524|NCT00502775|565489375|FG000|Overall Study|Non-compliance with eDiary|4|||
156656525|NCT00502775|565489376|FG001|Overall Study|Non-compliance with eDiary|1|||
156656526|NCT00502775|565489377|FG002|Overall Study|Non-compliance with eDiary|1|||
156656527|NCT00502775|565489375|FG000|Overall Study|Subject unable to swallow capsule|1|||
156656528|NCT00502775|565489376|FG001|Overall Study|Subject unable to swallow capsule|0|||
156656529|NCT00502775|565489377|FG002|Overall Study|Subject unable to swallow capsule|1|||
156656530|NCT00502775|565489375|FG000|Overall Study|Logpad compliance <80%|1|||
156656531|NCT00502775|565489376|FG001|Overall Study|Logpad compliance <80%|0|||
156656532|NCT00502775|565489377|FG002|Overall Study|Logpad compliance <80%|0|||
156656533|NCT00502775|565489375|FG000|Overall Study|Randomized in error|0|||
156656534|NCT00502775|565489376|FG001|Overall Study|Randomized in error|1|||
156656535|NCT00502775|565489377|FG002|Overall Study|Randomized in error|1|||
156656536|NCT00502775|565489375|FG000|Overall Study|Non-compliance|0|||
156656537|NCT00502775|565489376|FG001|Overall Study|Non-compliance|2|||
156656538|NCT00502775|565489377|FG002|Overall Study|Non-compliance|2|||
156656539|NCT00502775|565489375|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
156656540|NCT00502775|565489376|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
156656541|NCT00502775|565489377|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
156656542|NCT00502775|565489375|FG000|Overall Study|Declining pollen counts|0|||
156656543|NCT00502775|565489376|FG001|Overall Study|Declining pollen counts|1|||
156656544|NCT00502775|565489377|FG002|Overall Study|Declining pollen counts|1|||
156656545|NCT00502775|565489375|FG000|Overall Study|Subject in jail|0|||
156656546|NCT00502775|565489376|FG001|Overall Study|Subject in jail|1|||
156656547|NCT00502775|565489377|FG002|Overall Study|Subject in jail|0|||
156656548|NCT00502775|565489375|FG000|Overall Study|Subject took disallowed drug|0|||
156656549|NCT00502775|565489376|FG001|Overall Study|Subject took disallowed drug|0|||
156656550|NCT00502775|565489377|FG002|Overall Study|Subject took disallowed drug|1|||
156656551|NCT01545076|565489379|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
156656552|NCT01545076|565489380|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
156656553|NCT01545076|565489381|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
156656554|NCT01545076|565489382|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
156656555|NCT01545076|565489383|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
156656556|NCT01545076|565489379|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
156656557|NCT01545076|565489380|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
156656558|NCT01545076|565489381|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
156656559|NCT01545076|565489382|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
156656560|NCT01545076|565489383|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
156656561|NCT01545076|565489379|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
156767485|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
156323087|NCT00719264|564282312|FG001|Overall Study|Withdrawal by Subject|7|||
156323088|NCT00719264|564282311|FG000|Overall Study|Protocol Deviation|1|||
156323089|NCT00719264|564282312|FG001|Overall Study|Protocol Deviation|3|||
156323090|NCT00719264|564282311|FG000|Overall Study|New Cancer Therapy|4|||
156323091|NCT00719264|564282312|FG001|Overall Study|New Cancer Therapy|2|||
156323092|NCT00719264|564282311|FG000|Overall Study|Disease Progression|104|||
156323093|NCT00719264|564282312|FG001|Overall Study|Disease Progression|107|||
156323094|NCT03581786|564282319|FG000|Overall Study|Death|67|||
156323095|NCT03581786|564282320|FG001|Overall Study|Death|47|||
156323096|NCT03581786|564282319|FG000|Overall Study|Withdrawal by Subject|2|||
156323097|NCT03581786|564282320|FG001|Overall Study|Withdrawal by Subject|5|||
156323098|NCT03581786|564282319|FG000|Overall Study|Lost to Follow-up|7|||
156323099|NCT03581786|564282320|FG001|Overall Study|Lost to Follow-up|4|||
156323100|NCT03581786|564282319|FG000|Overall Study|reason other than specified above|0|||
156323101|NCT03581786|564282320|FG001|Overall Study|reason other than specified above|1|||
156323102|NCT01251146|564282321|FG000|Overall Study|Lost to Follow-up|3|||
156323103|NCT01251146|564282322|FG001|Overall Study|Lost to Follow-up|10|||
156323104|NCT01483690|564282325|FG000|Overall Study|Adverse Event|1|||
156323105|NCT01483690|564282326|FG001|Overall Study|Adverse Event|2|||
156323106|NCT01483690|564282325|FG000|Overall Study|clinical deterioration|1|||
156323107|NCT01483690|564282326|FG001|Overall Study|clinical deterioration|0|||
156323108|NCT01483690|564282325|FG000|Overall Study|Physician Decision|0|||
156323109|NCT01483690|564282326|FG001|Overall Study|Physician Decision|2|||
156323110|NCT01483690|564282325|FG000|Overall Study|exclusionary procedure|0|||
156323111|NCT01483690|564282326|FG001|Overall Study|exclusionary procedure|1|||
156323112|NCT02239224|564282327|FG000|Overall Study|Administrative|0|||
156323113|NCT02239224|564282328|FG001|Overall Study|Administrative|0|||
156323114|NCT02239224|564282329|FG002|Overall Study|Administrative|3|||
156323115|NCT02239224|564282330|FG003|Overall Study|Administrative|1|||
156323116|NCT03981822|564282335|FG000|Overall Study|Lost to Follow-up|0|||
156323117|NCT03981822|564282336|FG001|Overall Study|Lost to Follow-up|1|||
156323118|NCT03981822|564282337|FG002|Overall Study|Lost to Follow-up|1|||
156323119|NCT03981822|564282338|FG003|Overall Study|Lost to Follow-up|0|||
156323120|NCT03981822|564282339|FG004|Overall Study|Lost to Follow-up|6|||
156323121|NCT03981822|564282340|FG005|Overall Study|Lost to Follow-up|4|||
156323122|NCT03981822|564282341|FG006|Overall Study|Lost to Follow-up|4|||
156323123|NCT03981822|564282342|FG007|Overall Study|Lost to Follow-up|2|||
156323124|NCT03981822|564282335|FG000|Overall Study|Withdrawal by Subject|0|||
156323125|NCT03981822|564282336|FG001|Overall Study|Withdrawal by Subject|1|||
156323126|NCT03981822|564282337|FG002|Overall Study|Withdrawal by Subject|0|||
156323127|NCT03981822|564282338|FG003|Overall Study|Withdrawal by Subject|0|||
156323128|NCT03981822|564282339|FG004|Overall Study|Withdrawal by Subject|0|||
156323129|NCT03981822|564282340|FG005|Overall Study|Withdrawal by Subject|1|||
156323130|NCT03981822|564282341|FG006|Overall Study|Withdrawal by Subject|0|||
156323131|NCT03981822|564282342|FG007|Overall Study|Withdrawal by Subject|2|||
156323132|NCT03981822|564282335|FG000|Overall Study|COVID-19 Related|0|||
156323133|NCT03981822|564282336|FG001|Overall Study|COVID-19 Related|0|||
156323134|NCT03981822|564282337|FG002|Overall Study|COVID-19 Related|0|||
156323135|NCT03981822|564282338|FG003|Overall Study|COVID-19 Related|0|||
156323136|NCT03981822|564282339|FG004|Overall Study|COVID-19 Related|2|||
156323137|NCT03981822|564282340|FG005|Overall Study|COVID-19 Related|1|||
156323138|NCT03981822|564282341|FG006|Overall Study|COVID-19 Related|2|||
156323139|NCT03981822|564282342|FG007|Overall Study|COVID-19 Related|1|||
156323140|NCT02742246|564282343|FG000|Overall Study|Never initiated treatment|5|||
156323141|NCT02742246|564282344|FG001|Overall Study|Never initiated treatment|3|||
156323142|NCT02742246|564282345|FG002|Overall Study|Never initiated treatment|1|||
156323143|NCT02742246|564282343|FG000|Overall Study|dropped out during treatment|7|||
156323144|NCT02742246|564282344|FG001|Overall Study|dropped out during treatment|13|||
156767486|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
156767487|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
156767488|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
156767489|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
156323145|NCT02742246|564282345|FG002|Overall Study|dropped out during treatment|10|||
156323146|NCT02742246|564282343|FG000|Overall Study|Death|1|||
156767490|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
156767491|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
156767492|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
156767493|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
156767494|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
156767495|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
156767496|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
156767497|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
156767498|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
156767499|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
156656562|NCT01545076|565489380|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
156656563|NCT01545076|565489381|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
156656564|NCT01545076|565489382|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
156656565|NCT01545076|565489383|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
156656566|NCT01545076|565489379|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
156656567|NCT01545076|565489380|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
156656568|NCT01545076|565489381|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
156767500|NCT01663623|565904715|FG000|Overall Study|Adverse Event|3|||
156767501|NCT01663623|565904716|FG001|Overall Study|Adverse Event|7|||
156767502|NCT01663623|565904715|FG000|Overall Study|Lack of Efficacy|5|||
156767503|NCT01663623|565904716|FG001|Overall Study|Lack of Efficacy|6|||
156767504|NCT01663623|565904715|FG000|Overall Study|Protocol Violation|0|||
156767505|NCT01663623|565904716|FG001|Overall Study|Protocol Violation|1|||
156767506|NCT01663623|565904715|FG000|Overall Study|Other-Study closed/terminated|1|||
156767507|NCT01663623|565904716|FG001|Overall Study|Other-Study closed/terminated|1|||
156767508|NCT01663623|565904715|FG000|Overall Study|Physician Decision|1|||
156767509|NCT01663623|565904716|FG001|Overall Study|Physician Decision|4|||
156767510|NCT01663623|565904715|FG000|Overall Study|Withdrawal by Subject|2|||
156767511|NCT01663623|565904716|FG001|Overall Study|Withdrawal by Subject|1|||
156767512|NCT02251275|565904717|FG000|Overall Study|Adverse Event|23|||
156656569|NCT01545076|565489382|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
156656570|NCT01545076|565489383|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
156656571|NCT01545076|565489379|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
156656572|NCT01545076|565489380|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
156656573|NCT01545076|565489381|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
156656574|NCT01545076|565489382|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
156656575|NCT01545076|565489383|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
156656576|NCT01545076|565489379|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
156656577|NCT01545076|565489380|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
156656578|NCT01545076|565489381|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
156656579|NCT01545076|565489382|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
156656580|NCT01545076|565489383|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
156656581|NCT01545076|565489379|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
156656582|NCT01545076|565489380|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
156656583|NCT01545076|565489381|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
156656584|NCT01545076|565489382|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
156656585|NCT01545076|565489383|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
156656586|NCT01545076|565489379|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
156656587|NCT01545076|565489380|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
156656588|NCT01545076|565489381|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
156656589|NCT01545076|565489382|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
156656590|NCT01545076|565489383|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
156656591|NCT01545076|565489379|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
156767513|NCT02251275|565904718|FG001|Overall Study|Adverse Event|60|||
156767514|NCT02251275|565904719|FG002|Overall Study|Adverse Event|28|||
156323147|NCT02742246|564282344|FG001|Overall Study|Death|0|||
156323148|NCT02742246|564282345|FG002|Overall Study|Death|0|||
156323149|NCT01117051|564282354|FG000|Overall Study|Withdrawal by Subject|5|||
156323150|NCT01117051|564282355|FG001|Overall Study|Withdrawal by Subject|3|||
156323151|NCT01117051|564282354|FG000|Overall Study|Adverse Event|4|||
156323152|NCT01117051|564282355|FG001|Overall Study|Adverse Event|3|||
156323153|NCT01117051|564282354|FG000|Overall Study|Lost to Follow-up|0|||
156323154|NCT01117051|564282355|FG001|Overall Study|Lost to Follow-up|1|||
156323155|NCT01117051|564282354|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
156323156|NCT01117051|564282355|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
156323157|NCT01117051|564282354|FG000|Overall Study|Sponsor's decision|3|||
156323158|NCT01117051|564282355|FG001|Overall Study|Sponsor's decision|1|||
156323159|NCT01117051|564282354|FG000|Overall Study|Surgical procedure|0|||
156323160|NCT01117051|564282355|FG001|Overall Study|Surgical procedure|1|||
156323161|NCT01117051|564282354|FG000|Overall Study|Randomized by mistake|0|||
156323162|NCT01117051|564282355|FG001|Overall Study|Randomized by mistake|1|||
156323163|NCT01117051|564282354|FG000|Overall Study|Convenience issue|1|||
156323164|NCT01117051|564282355|FG001|Overall Study|Convenience issue|0|||
156323165|NCT01142128|564282356|FG000|Overall Study|Physician Decision|1|||
156323166|NCT01142128|564282356|FG000|Overall Study|Lost to Follow-up|1|||
156323167|NCT01142128|564282356|FG000|Overall Study|Withdrawal by Subject|2|||
156323168|NCT03355664|564282357|FG000|Overall Study|Adverse Event|1|||
156767515|NCT02251275|565904720|FG003|Overall Study|Adverse Event|0|||
156323169|NCT03355664|564282358|FG001|Overall Study|Adverse Event|2|||
156323170|NCT03355664|564282357|FG000|Overall Study|Lost to Follow-up|11|||
156522536|NCT03184870|565007732|FG002|Initial Treatment|Moved to crossover treatment|0|||
156323171|NCT03355664|564282358|FG001|Overall Study|Lost to Follow-up|7|||
156656592|NCT01545076|565489380|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
156656593|NCT01545076|565489381|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
156656594|NCT01545076|565489382|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
156656595|NCT01545076|565489383|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
156656596|NCT02710123|565489384|FG000|Overall Study|Lost to Follow-up|3|||
156656597|NCT02710123|565489385|FG001|Overall Study|Lost to Follow-up|4|||
156656598|NCT02710123|565489384|FG000|Overall Study|Withdrawal by Subject|1|||
156656599|NCT02710123|565489385|FG001|Overall Study|Withdrawal by Subject|1|||
156656600|NCT02710123|565489384|FG000|Overall Study|Illness unrelated to study intervention|1|||
156656601|NCT02710123|565489385|FG001|Overall Study|Illness unrelated to study intervention|0|||
156656602|NCT02153398|565489386|FG000|Overall Study|Withdrawal by Subject|1|||
156656603|NCT02153398|565489387|FG001|Overall Study|Withdrawal by Subject|0|||
156656604|NCT02153398|565489388|FG002|Overall Study|Withdrawal by Subject|0|||
156656605|NCT02153398|565489389|FG003|Overall Study|Withdrawal by Subject|0|||
156427376|NCT03179787|564658718|FG000|Overall Study|Case report failures|2|||
156323172|NCT03355664|564282357|FG000|Overall Study|Protocol Violation|1|||
156656606|NCT02153398|565489390|FG004|Overall Study|Withdrawal by Subject|0|||
156323173|NCT03355664|564282358|FG001|Overall Study|Protocol Violation|2|||
156323174|NCT03355664|564282357|FG000|Overall Study|Withdrawal by Subject|2|||
156323175|NCT03355664|564282358|FG001|Overall Study|Withdrawal by Subject|1|||
156323176|NCT04163718|564282362|FG000|Overall Study|Study terminated|12|||
156323177|NCT04543409|564282368|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156323178|NCT04543409|564282369|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156323179|NCT04543409|564282368|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
156323180|NCT04543409|564282369|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
156323181|NCT04543409|564282368|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
156323182|NCT04543409|564282369|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
156427377|NCT03179787|564658718|FG000|Overall Study|Treatment not administered|1|||
156427378|NCT02030028|564658719|FG000|Overall Study|Withdrawal by Subject|4|||
156427379|NCT02030028|564658719|FG000|Overall Study|lack of transportation|1|||
156427380|NCT00149630|564658720|FG000|Overall Study|Incarceration|2|||
156427381|NCT00149630|564658721|FG001|Overall Study|Incarceration|0|||
156427382|NCT00149630|564658720|FG000|Overall Study|Treatment Programs|4|||
156427383|NCT00149630|564658721|FG001|Overall Study|Treatment Programs|5|||
156427384|NCT00149630|564658720|FG000|Overall Study|Adverse Event|2|||
156427385|NCT00149630|564658721|FG001|Overall Study|Adverse Event|0|||
156427386|NCT03357341|564658730|FG000|Overall Study|Withdrawal by Subject|3|||
156427387|NCT03357341|564658731|FG001|Overall Study|Withdrawal by Subject|6|||
156427388|NCT03357341|564658730|FG000|Overall Study|Lost to Follow-up|4|||
156427389|NCT03357341|564658731|FG001|Overall Study|Lost to Follow-up|5|||
156427390|NCT03357341|564658730|FG000|Overall Study|Death|0|||
156427391|NCT03357341|564658731|FG001|Overall Study|Death|1|||
156427392|NCT01956669|564658734|FG000|Overall Study|Disease Progression|12|||
156427393|NCT01956669|564658735|FG001|Overall Study|Disease Progression|7|||
156427394|NCT01956669|564658736|FG002|Overall Study|Disease Progression|7|||
156656607|NCT02153398|565489386|FG000|Overall Study|Adverse Event|0|||
156656608|NCT02153398|565489387|FG001|Overall Study|Adverse Event|0|||
156656609|NCT02153398|565489388|FG002|Overall Study|Adverse Event|1|||
156656610|NCT02153398|565489389|FG003|Overall Study|Adverse Event|1|||
156656611|NCT02153398|565489390|FG004|Overall Study|Adverse Event|0|||
156656612|NCT02374918|565489391|FG000|Overall Study|Protocol Violation|2|||
156656613|NCT02374918|565489392|FG001|Overall Study|Protocol Violation|0|||
156656614|NCT02374918|565489393|FG002|Overall Study|Protocol Violation|2|||
156656615|NCT02374918|565489394|FG003|Overall Study|Protocol Violation|1|||
156656616|NCT02374918|565489391|FG000|Overall Study|Withdrawal by Subject|1|||
156656617|NCT02374918|565489392|FG001|Overall Study|Withdrawal by Subject|1|||
156656618|NCT02374918|565489393|FG002|Overall Study|Withdrawal by Subject|1|||
156656619|NCT02374918|565489394|FG003|Overall Study|Withdrawal by Subject|0|||
156656620|NCT02374918|565489391|FG000|Overall Study|Lack of Efficacy|0|||
156656621|NCT02374918|565489392|FG001|Overall Study|Lack of Efficacy|0|||
156656622|NCT02374918|565489393|FG002|Overall Study|Lack of Efficacy|1|||
156656623|NCT02374918|565489394|FG003|Overall Study|Lack of Efficacy|1|||
156656624|NCT01505530|565489395|FG000|Overall Study|Progressive Disease|19|||
156656625|NCT01505530|565489396|FG001|Overall Study|Progressive Disease|17|||
156656626|NCT01505530|565489397|FG002|Overall Study|Progressive Disease|18|||
156656627|NCT01505530|565489395|FG000|Overall Study|Adverse Event|1|||
156656628|NCT01505530|565489396|FG001|Overall Study|Adverse Event|1|||
156656629|NCT01505530|565489397|FG002|Overall Study|Adverse Event|0|||
156656630|NCT01505530|565489395|FG000|Overall Study|Withdrawal by Subject|7|||
156656631|NCT01505530|565489396|FG001|Overall Study|Withdrawal by Subject|8|||
156656632|NCT01505530|565489397|FG002|Overall Study|Withdrawal by Subject|6|||
156656633|NCT01505530|565489395|FG000|Overall Study|Physician Decision|6|||
156656634|NCT01505530|565489396|FG001|Overall Study|Physician Decision|2|||
156656635|NCT01505530|565489397|FG002|Overall Study|Physician Decision|5|||
156656636|NCT01505530|565489395|FG000|Overall Study|Sponsor Decision|1|||
156656637|NCT01505530|565489396|FG001|Overall Study|Sponsor Decision|8|||
156656638|NCT01505530|565489397|FG002|Overall Study|Sponsor Decision|7|||
156656639|NCT01505530|565489395|FG000|Overall Study|Death|7|||
156656640|NCT01505530|565489396|FG001|Overall Study|Death|6|||
156656641|NCT01505530|565489397|FG002|Overall Study|Death|5|||
156656642|NCT01505530|565489395|FG000|Overall Study|entry criteria not met|0|||
156656643|NCT01505530|565489396|FG001|Overall Study|entry criteria not met|1|||
156656644|NCT01505530|565489397|FG002|Overall Study|entry criteria not met|0|||
156656645|NCT01153984|565489398|FG000|Overall Study|Withdrawal by Subject|1|||
156656646|NCT01153984|565489398|FG000|Overall Study|Adverse Event|1|||
156656647|NCT00973700|565489399|FG000|Overall Study|Withdrawal by Subject|2|||
156656648|NCT00973700|565489400|FG001|Overall Study|Withdrawal by Subject|2|||
156656649|NCT00973700|565489401|FG002|Overall Study|Withdrawal by Subject|8|||
156656650|NCT00973700|565489402|FG003|Overall Study|Withdrawal by Subject|4|||
156656651|NCT00973700|565489403|FG004|Overall Study|Withdrawal by Subject|4|||
156656652|NCT00973700|565489399|FG000|Overall Study|Lost to Follow-up|5|||
156656653|NCT00973700|565489400|FG001|Overall Study|Lost to Follow-up|0|||
156656654|NCT00973700|565489401|FG002|Overall Study|Lost to Follow-up|1|||
156656655|NCT00973700|565489402|FG003|Overall Study|Lost to Follow-up|8|||
156656656|NCT00973700|565489403|FG004|Overall Study|Lost to Follow-up|5|||
156656657|NCT00973700|565489399|FG000|Overall Study|Inappropriate enrolment|0|||
156767516|NCT02251275|565904721|FG004|Overall Study|Adverse Event|0|||
156767517|NCT02251275|565904717|FG000|Overall Study|Lost to Follow-up|5|||
156767518|NCT02251275|565904718|FG001|Overall Study|Lost to Follow-up|6|||
156767519|NCT02251275|565904719|FG002|Overall Study|Lost to Follow-up|4|||
156767520|NCT02251275|565904720|FG003|Overall Study|Lost to Follow-up|0|||
156767521|NCT02251275|565904721|FG004|Overall Study|Lost to Follow-up|0|||
156767522|NCT02251275|565904717|FG000|Overall Study|Physician Decision|19|||
156767523|NCT02251275|565904718|FG001|Overall Study|Physician Decision|30|||
156767524|NCT02251275|565904719|FG002|Overall Study|Physician Decision|26|||
156767525|NCT02251275|565904720|FG003|Overall Study|Physician Decision|0|||
156767526|NCT02251275|565904721|FG004|Overall Study|Physician Decision|1|||
156767527|NCT02251275|565904717|FG000|Overall Study|Protocol Deviation|0|||
156767528|NCT02251275|565904718|FG001|Overall Study|Protocol Deviation|0|||
156767529|NCT02251275|565904719|FG002|Overall Study|Protocol Deviation|1|||
156656658|NCT00973700|565489400|FG001|Overall Study|Inappropriate enrolment|0|||
156656659|NCT00973700|565489401|FG002|Overall Study|Inappropriate enrolment|0|||
156656660|NCT00973700|565489402|FG003|Overall Study|Inappropriate enrolment|4|||
156656661|NCT00973700|565489403|FG004|Overall Study|Inappropriate enrolment|0|||
156656662|NCT00973700|565489399|FG000|Overall Study|Unable to Classify|0|||
156656663|NCT00973700|565489400|FG001|Overall Study|Unable to Classify|0|||
156656664|NCT00973700|565489401|FG002|Overall Study|Unable to Classify|1|||
156656665|NCT00973700|565489402|FG003|Overall Study|Unable to Classify|2|||
156656666|NCT00973700|565489403|FG004|Overall Study|Unable to Classify|1|||
156656667|NCT01618266|565489412|FG000|Overall Study|Lost to Follow-up|9|||
156656668|NCT01618266|565489412|FG000|Overall Study|Treatment satisfaction|10|||
156656669|NCT01618266|565489412|FG000|Overall Study|Other reasons|11|||
156656670|NCT01618266|565489412|FG000|Overall Study|Lack of Efficacy|23|||
156656671|NCT01618266|565489412|FG000|Overall Study|Protocol Violation|43|||
156656672|NCT00626925|565489413|FG000|Overall Study|Lost to Follow-up|1|||
156656673|NCT00626925|565489414|FG001|Overall Study|Lost to Follow-up|2|||
156656674|NCT00626925|565489413|FG000|Overall Study|relapse|1|||
156656675|NCT00626925|565489414|FG001|Overall Study|relapse|0|||
156656676|NCT00626925|565489413|FG000|Overall Study|Adverse effect|6|||
156767530|NCT02251275|565904720|FG003|Overall Study|Protocol Deviation|0|||
156767531|NCT02251275|565904721|FG004|Overall Study|Protocol Deviation|0|||
156767532|NCT02251275|565904717|FG000|Overall Study|Withdrawal by Subject|25|||
156656677|NCT00626925|565489414|FG001|Overall Study|Adverse effect|2|||
156656678|NCT00626925|565489413|FG000|Overall Study|Lack of Efficacy|1|||
156656679|NCT00626925|565489414|FG001|Overall Study|Lack of Efficacy|4|||
156656680|NCT00626925|565489413|FG000|Overall Study|Time constraints|3|||
156656681|NCT00626925|565489414|FG001|Overall Study|Time constraints|1|||
156656682|NCT01966042|565489415|FG000|Overall Study|Death|2|||
156767533|NCT02251275|565904718|FG001|Overall Study|Withdrawal by Subject|51|||
156427395|NCT01956669|564658737|FG003|Overall Study|Disease Progression|8|||
156656683|NCT00625807|565489416|FG000|Overall Study|schedule conflict|2|||
156656684|NCT00625807|565489417|FG001|Overall Study|schedule conflict|8|||
156656685|NCT01946165|565489418|FG000|Overall Study|Physician Decision|2|||
156656686|NCT01946165|565489419|FG001|Overall Study|Physician Decision|0|||
156656687|NCT01946165|565489418|FG000|Overall Study|Withdrawal by Subject|0|||
156656688|NCT01946165|565489419|FG001|Overall Study|Withdrawal by Subject|2|||
156656689|NCT01915732|565489432|FG000|Overall Study|Withdrawal by Subject|18|||
156656690|NCT01915732|565489433|FG001|Overall Study|Withdrawal by Subject|18|||
156767534|NCT02251275|565904719|FG002|Overall Study|Withdrawal by Subject|35|||
156767535|NCT02251275|565904720|FG003|Overall Study|Withdrawal by Subject|1|||
156767536|NCT02251275|565904721|FG004|Overall Study|Withdrawal by Subject|0|||
156767537|NCT01004614|565904723|FG000|Washout|Withdrawal by Subject|0|||
156767538|NCT01004614|565904724|FG001|Washout|Withdrawal by Subject|1|||
156767539|NCT01004614|565904725|FG002|Washout|Withdrawal by Subject|0|||
156427396|NCT01956669|564658738|FG004|Overall Study|Disease Progression|4|||
156427397|NCT01956669|564658739|FG005|Overall Study|Disease Progression|3|||
156427398|NCT01956669|564658740|FG006|Overall Study|Disease Progression|5|||
156767540|NCT01004614|565904726|FG003|Washout|Withdrawal by Subject|0|||
156427399|NCT01956669|564658734|FG000|Overall Study|Adverse Event|0|||
156427400|NCT01956669|564658735|FG001|Overall Study|Adverse Event|2|||
156427401|NCT01956669|564658736|FG002|Overall Study|Adverse Event|2|||
156427402|NCT01956669|564658737|FG003|Overall Study|Adverse Event|1|||
156427403|NCT01956669|564658738|FG004|Overall Study|Adverse Event|0|||
156427404|NCT01956669|564658739|FG005|Overall Study|Adverse Event|0|||
156767541|NCT02111083|565904728|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
156767542|NCT02111083|565904729|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
156767543|NCT02152007|565904730|FG000|Overall Study|Withdrawal by Subject|1|||
156767544|NCT02497469|565904735|FG000|Overall Study|Randomized but not Treated|0|||
156767545|NCT02497469|565904736|FG001|Overall Study|Randomized but not Treated|2|||
156767546|NCT02497469|565904735|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
156323183|NCT04543409|564282368|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
156427405|NCT01956669|564658740|FG006|Overall Study|Adverse Event|0|||
156427406|NCT01956669|564658734|FG000|Overall Study|Physician Decision|0|||
156427407|NCT01956669|564658735|FG001|Overall Study|Physician Decision|2|||
156427408|NCT01956669|564658736|FG002|Overall Study|Physician Decision|0|||
156427409|NCT01956669|564658737|FG003|Overall Study|Physician Decision|0|||
156427410|NCT01956669|564658738|FG004|Overall Study|Physician Decision|0|||
156427411|NCT01956669|564658739|FG005|Overall Study|Physician Decision|1|||
156427412|NCT01956669|564658740|FG006|Overall Study|Physician Decision|0|||
156427413|NCT01956669|564658734|FG000|Overall Study|Withdrawal by Subject|0|||
156427414|NCT01956669|564658735|FG001|Overall Study|Withdrawal by Subject|0|||
156427415|NCT01956669|564658736|FG002|Overall Study|Withdrawal by Subject|1|||
156427416|NCT01956669|564658737|FG003|Overall Study|Withdrawal by Subject|1|||
156427417|NCT01956669|564658738|FG004|Overall Study|Withdrawal by Subject|0|||
156427418|NCT01956669|564658739|FG005|Overall Study|Withdrawal by Subject|0|||
156427419|NCT01956669|564658740|FG006|Overall Study|Withdrawal by Subject|1|||
156427420|NCT00930813|564658741|FG000|Overall Study|Death|4|||
156427421|NCT00930813|564658742|FG001|Overall Study|Death|5|||
156427422|NCT00930813|564658741|FG000|Overall Study|Withdrawal by Subject|2|||
156427423|NCT00930813|564658742|FG001|Overall Study|Withdrawal by Subject|5|||
156427424|NCT00930813|564658741|FG000|Overall Study|Lost to Follow-up|2|||
156427425|NCT00930813|564658742|FG001|Overall Study|Lost to Follow-up|4|||
156427426|NCT01570751|564658743|FG000|Period A (16 Weeks)|Protocol Violation|1|||
156427427|NCT01570751|564658744|FG001|Period A (16 Weeks)|Protocol Violation|1|||
156427428|NCT01570751|564658743|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
156427429|NCT01570751|564658744|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
156427430|NCT01570751|564658743|FG000|Period A (16 Weeks)|Unclassified|2|||
156427431|NCT01570751|564658744|FG001|Period A (16 Weeks)|Unclassified|3|||
156427432|NCT01570751|564658743|FG000|Period B (16 Weeks)|Adverse Event|1|||
156427433|NCT01570751|564658744|FG001|Period B (16 Weeks)|Adverse Event|0|||
156522537|NCT03184870|565007733|FG003|Initial Treatment|Moved to crossover treatment|0|||
156522538|NCT03184870|565007734|FG004|Initial Treatment|Moved to crossover treatment|0|||
156522539|NCT03184870|565007735|FG005|Initial Treatment|Moved to crossover treatment|0|||
156522540|NCT03184870|565007736|FG006|Initial Treatment|Moved to crossover treatment|0|||
156427434|NCT01570751|564658743|FG000|Period B (16 Weeks)|Protocol Violation|0|||
156427435|NCT01570751|564658744|FG001|Period B (16 Weeks)|Protocol Violation|1|||
156427436|NCT05790408|564658749|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
156427437|NCT01693614|564658750|FG000|Overall Study|Adverse Event|7|||
156427438|NCT01693614|564658751|FG001|Overall Study|Adverse Event|11|||
156427439|NCT01693614|564658752|FG002|Overall Study|Adverse Event|5|||
156427440|NCT01693614|564658750|FG000|Overall Study|Disease progression|11|||
156427441|NCT01693614|564658751|FG001|Overall Study|Disease progression|8|||
156427442|NCT01693614|564658752|FG002|Overall Study|Disease progression|7|||
156427443|NCT01693614|564658750|FG000|Overall Study|Protocol Violation|5|||
156427444|NCT01693614|564658751|FG001|Overall Study|Protocol Violation|2|||
156427445|NCT01693614|564658752|FG002|Overall Study|Protocol Violation|1|||
156427446|NCT01693614|564658750|FG000|Overall Study|Death|1|||
156427447|NCT01693614|564658751|FG001|Overall Study|Death|0|||
156427448|NCT01693614|564658752|FG002|Overall Study|Death|0|||
156427449|NCT01693614|564658750|FG000|Overall Study|Physician Decision|1|||
156427450|NCT01693614|564658751|FG001|Overall Study|Physician Decision|1|||
156522541|NCT03184870|565007737|FG007|Initial Treatment|Moved to crossover treatment|0|||
156522542|NCT03184870|565007738|FG008|Initial Treatment|Moved to crossover treatment|0|||
156522543|NCT03184870|565007739|FG009|Initial Treatment|Moved to crossover treatment|0|||
156522544|NCT03184870|565007740|FG010|Initial Treatment|Moved to crossover treatment|0|||
156522545|NCT03184870|565007741|FG011|Initial Treatment|Moved to crossover treatment|0|||
156522546|NCT03184870|565007742|FG012|Initial Treatment|Moved to crossover treatment|9|||
156522547|NCT03184870|565007743|FG013|Initial Treatment|Moved to crossover treatment|0|||
156522548|NCT03184870|565007744|FG014|Initial Treatment|Moved to crossover treatment|0|||
156767547|NCT02497469|565904736|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
156767548|NCT02497469|565904735|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
156767549|NCT02497469|565904736|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
156767550|NCT02497469|565904735|FG000|Overall Study|Significant Protocol Deviation|4|||
156767551|NCT02497469|565904736|FG001|Overall Study|Significant Protocol Deviation|5|||
156767552|NCT02497469|565904735|FG000|Overall Study|Lost to Follow-up|14|||
156767553|NCT02497469|565904736|FG001|Overall Study|Lost to Follow-up|4|||
156767554|NCT02497469|565904735|FG000|Overall Study|Voluntary Withdrawal|39|||
156767555|NCT02497469|565904736|FG001|Overall Study|Voluntary Withdrawal|41|||
156767556|NCT02497469|565904735|FG000|Overall Study|Pregnancy|1|||
156767557|NCT02497469|565904736|FG001|Overall Study|Pregnancy|1|||
156767558|NCT02497469|565904735|FG000|Overall Study|Lack of Efficacy|86|||
156767559|NCT02497469|565904736|FG001|Overall Study|Lack of Efficacy|40|||
156767560|NCT02497469|565904735|FG000|Overall Study|Reason not Specified|6|||
156767561|NCT02497469|565904736|FG001|Overall Study|Reason not Specified|6|||
156767562|NCT03558516|565904737|FG000|Overall Study|Protocol Violation|2|||
156767563|NCT03558516|565904738|FG001|Overall Study|Protocol Violation|2|||
156767564|NCT02714153|565904739|FG000|Overall Study|Death|1|||
156767565|NCT01901185|565904740|FG000|Overall Study|Withdrawal by Subject|2|||
156767566|NCT00828711|565904743|FG000|Overall Study|Lost to Follow-up|1|||
156767567|NCT00828711|565904744|FG001|Overall Study|Lost to Follow-up|0|||
156767568|NCT00828711|565904745|FG002|Overall Study|Lost to Follow-up|0|||
156767569|NCT01618968|565904746|FG000|Overall Study|Adverse Event|1|||
156767570|NCT01618968|565904747|FG001|Overall Study|Adverse Event|0|||
156767571|NCT01618968|565904748|FG002|Overall Study|Adverse Event|0|||
156767572|NCT01618968|565904749|FG003|Overall Study|Adverse Event|0|||
156767573|NCT01618968|565904746|FG000|Overall Study|Death|0|||
156767574|NCT01618968|565904747|FG001|Overall Study|Death|0|||
156767575|NCT01618968|565904748|FG002|Overall Study|Death|0|||
156767576|NCT01618968|565904749|FG003|Overall Study|Death|1|||
156767577|NCT03087058|565904752|FG000|Overall Study|Withdrawal by Subject|2|||
156767578|NCT03087058|565904753|FG001|Overall Study|Withdrawal by Subject|0|||
156767579|NCT03087058|565904754|FG002|Overall Study|Withdrawal by Subject|0|||
156767580|NCT05158140|565904755|FG000|Overall Study|Death|0|||
156767581|NCT05158140|565904756|FG001|Overall Study|Death|0|||
156767582|NCT05158140|565904757|FG002|Overall Study|Death|0|||
156767583|NCT05158140|565904758|FG003|Overall Study|Death|1|||
156767584|NCT05158140|565904755|FG000|Overall Study|Lost to Follow-up|3|||
156767585|NCT05158140|565904756|FG001|Overall Study|Lost to Follow-up|6|||
156767586|NCT05158140|565904757|FG002|Overall Study|Lost to Follow-up|4|||
156767587|NCT05158140|565904758|FG003|Overall Study|Lost to Follow-up|3|||
156767588|NCT05158140|565904755|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156767589|NCT05158140|565904756|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156767590|NCT05158140|565904757|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
156767591|NCT05158140|565904758|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156767592|NCT05158140|565904755|FG000|Overall Study|Withdrawal by Subject|3|||
156767593|NCT05158140|565904756|FG001|Overall Study|Withdrawal by Subject|7|||
156767594|NCT05158140|565904757|FG002|Overall Study|Withdrawal by Subject|3|||
156767595|NCT05158140|565904758|FG003|Overall Study|Withdrawal by Subject|7|||
156767596|NCT01113749|565906313|FG000|Overall Study|Lost to Follow-up|1|||
156767597|NCT01113749|565906314|FG001|Overall Study|Lost to Follow-up|2|||
156767598|NCT02034006|565906315|FG000|Overall Study|Withdrawal by Subject|7|||
156767599|NCT02034006|565906315|FG000|Overall Study|Lost to Follow-up|5|||
156767600|NCT02034006|565906315|FG000|Overall Study|Death|1|||
156767601|NCT02034006|565906315|FG000|Overall Study|Pregnancy|1|||
156767602|NCT02934178|565906316|FG000|Received Vaccination 2|Death|0|||
156767603|NCT02934178|565906317|FG001|Received Vaccination 2|Death|1|||
156767604|NCT02934178|565906316|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
156767605|NCT02934178|565906317|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
156767606|NCT03944616|565906318|FG000|Overall Study|Lost to Follow-up|0|||
156767607|NCT03944616|565906319|FG001|Overall Study|Lost to Follow-up|2|||
156767608|NCT01373164|565906320|FG000|Overall Study|Lost to Follow-up|0|||
156767609|NCT01373164|565906321|FG001|Overall Study|Lost to Follow-up|0|||
156767610|NCT01373164|565906322|FG002|Overall Study|Lost to Follow-up|1|||
156767611|NCT01373164|565906323|FG003|Overall Study|Lost to Follow-up|2|||
156767612|NCT01373164|565906324|FG004|Overall Study|Lost to Follow-up|0|||
156767613|NCT01373164|565906320|FG000|Overall Study|Withdrawal by Subject|0|||
156767614|NCT01373164|565906321|FG001|Overall Study|Withdrawal by Subject|1|||
156767615|NCT01373164|565906322|FG002|Overall Study|Withdrawal by Subject|0|||
156767616|NCT01373164|565906323|FG003|Overall Study|Withdrawal by Subject|10|||
156767617|NCT01373164|565906324|FG004|Overall Study|Withdrawal by Subject|2|||
156767618|NCT00607893|565906325|FG000|Overall Study|Lost to Follow-up|4|||
156767619|NCT00607893|565906326|FG001|Overall Study|Lost to Follow-up|0|||
156767620|NCT00607893|565906325|FG000|Overall Study|withdrew due to loss of interest|0|||
156767621|NCT00607893|565906326|FG001|Overall Study|withdrew due to loss of interest|1|||
156767622|NCT00607893|565906325|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
156767623|NCT00607893|565906326|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
156767624|NCT00607893|565906325|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
156767625|NCT00607893|565906326|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
156767626|NCT00607893|565906325|FG000|Overall Study|Declined to be treated|1|||
156656691|NCT01915732|565489432|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
156656692|NCT01915732|565489433|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
156656693|NCT01915732|565489432|FG000|Overall Study|Adverse Event|12|||
156656694|NCT01915732|565489433|FG001|Overall Study|Adverse Event|4|||
156656695|NCT01915732|565489432|FG000|Overall Study|Protocol Violation|5|||
156656696|NCT01915732|565489433|FG001|Overall Study|Protocol Violation|5|||
156656697|NCT01915732|565489432|FG000|Overall Study|Lack of Efficacy|6|||
156656698|NCT01915732|565489433|FG001|Overall Study|Lack of Efficacy|11|||
156656699|NCT01915732|565489432|FG000|Overall Study|Lost to Follow-up|22|||
156656700|NCT01915732|565489433|FG001|Overall Study|Lost to Follow-up|26|||
156656701|NCT01915732|565489432|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
156656702|NCT01915732|565489433|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
156656703|NCT01915732|565489432|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
156656704|NCT01915732|565489433|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
156656705|NCT01915732|565489432|FG000|Overall Study|Drug Release Error|1|||
156656706|NCT01915732|565489433|FG001|Overall Study|Drug Release Error|0|||
156656707|NCT01915732|565489432|FG000|Overall Study|Recovered|1|||
156656708|NCT01915732|565489433|FG001|Overall Study|Recovered|0|||
156522549|NCT03184870|565007745|FG015|Initial Treatment|Moved to crossover treatment|0|||
156522550|NCT03184870|565007746|FG016|Initial Treatment|Moved to crossover treatment|0|||
156522551|NCT03184870|565007747|FG017|Initial Treatment|Moved to crossover treatment|0|||
156522552|NCT03184870|565007730|FG000|Crossover Treatment|Other reasons|0|||
156522553|NCT03184870|565007731|FG001|Crossover Treatment|Other reasons|0|||
156522554|NCT03184870|565007732|FG002|Crossover Treatment|Other reasons|0|||
156522555|NCT03184870|565007733|FG003|Crossover Treatment|Other reasons|0|||
156522556|NCT03184870|565007734|FG004|Crossover Treatment|Other reasons|0|||
156522557|NCT03184870|565007735|FG005|Crossover Treatment|Other reasons|0|||
156522558|NCT03184870|565007736|FG006|Crossover Treatment|Other reasons|0|||
156522559|NCT03184870|565007737|FG007|Crossover Treatment|Other reasons|0|||
156522560|NCT03184870|565007738|FG008|Crossover Treatment|Other reasons|0|||
156522561|NCT03184870|565007739|FG009|Crossover Treatment|Other reasons|0|||
156522562|NCT03184870|565007740|FG010|Crossover Treatment|Other reasons|0|||
156522563|NCT03184870|565007741|FG011|Crossover Treatment|Other reasons|0|||
156323184|NCT04543409|564282369|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
156323185|NCT04543409|564282368|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
156323186|NCT04543409|564282369|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
156323187|NCT04543409|564282368|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
156323188|NCT04543409|564282369|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
156323189|NCT04543409|564282368|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
156323190|NCT04543409|564282369|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
156323191|NCT04543409|564282368|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
156323192|NCT04543409|564282369|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
156323193|NCT04543409|564282368|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
156323194|NCT04543409|564282369|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
156522564|NCT03184870|565007742|FG012|Crossover Treatment|Other reasons|0|||
156522565|NCT03184870|565007743|FG013|Crossover Treatment|Other reasons|0|||
156767627|NCT00607893|565906326|FG001|Overall Study|Declined to be treated|0|||
156767628|NCT00607893|565906325|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
156767629|NCT00607893|565906326|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
156767630|NCT01799941|565906327|FG000|Overall Study|Adverse Event|34|||
156656709|NCT01915732|565489432|FG000|Overall Study|Pregnancy|1|||
156767631|NCT01799941|565906327|FG000|Overall Study|Withdrawal by Subject|21|||
156767632|NCT01799941|565906327|FG000|Overall Study|Death|2|||
156767633|NCT01799941|565906327|FG000|Overall Study|Investigator Decision|4|||
156767634|NCT01799941|565906327|FG000|Overall Study|Lack of Efficacy|3|||
156767635|NCT01799941|565906327|FG000|Overall Study|Lost to Follow-up|17|||
156767636|NCT01799941|565906327|FG000|Overall Study|Other|15|||
156767637|NCT03176771|565906345|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
156767638|NCT03176771|565906346|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
156767639|NCT03176771|565906347|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
156767640|NCT03176771|565906348|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
156767641|NCT03176771|565906349|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
156767642|NCT03176771|565906345|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
156767643|NCT03176771|565906346|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
156767644|NCT03176771|565906347|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
156767645|NCT03176771|565906348|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
156767646|NCT03176771|565906349|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
156767647|NCT03176771|565906345|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
156522566|NCT03184870|565007744|FG014|Crossover Treatment|Other reasons|0|||
156522567|NCT03184870|565007745|FG015|Crossover Treatment|Other reasons|0|||
156522568|NCT03184870|565007746|FG016|Crossover Treatment|Other reasons|0|||
156656710|NCT01915732|565489433|FG001|Overall Study|Pregnancy|0|||
156767648|NCT03176771|565906346|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
156767649|NCT03176771|565906347|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
156767650|NCT03176771|565906348|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
156767651|NCT03176771|565906349|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
156767652|NCT03176771|565906345|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
156767653|NCT03176771|565906346|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
156767654|NCT03176771|565906347|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
156767655|NCT03176771|565906348|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
156767656|NCT03176771|565906349|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
156767657|NCT03176771|565906345|FG000|Double-Blind Extension Period|Adverse Event|0|||
156767658|NCT03176771|565906346|FG001|Double-Blind Extension Period|Adverse Event|0|||
156767659|NCT03176771|565906347|FG002|Double-Blind Extension Period|Adverse Event|0|||
156767660|NCT03176771|565906348|FG003|Double-Blind Extension Period|Adverse Event|15|||
156767661|NCT03176771|565906349|FG004|Double-Blind Extension Period|Adverse Event|18|||
156767662|NCT03176771|565906345|FG000|Double-Blind Extension Period|Death|0|||
156767663|NCT03176771|565906346|FG001|Double-Blind Extension Period|Death|0|||
156767664|NCT03176771|565906347|FG002|Double-Blind Extension Period|Death|0|||
156767665|NCT03176771|565906348|FG003|Double-Blind Extension Period|Death|3|||
156767666|NCT03176771|565906349|FG004|Double-Blind Extension Period|Death|4|||
156767667|NCT03176771|565906345|FG000|Double-Blind Extension Period|Physician Decision|0|||
156767668|NCT03176771|565906346|FG001|Double-Blind Extension Period|Physician Decision|0|||
156767669|NCT03176771|565906347|FG002|Double-Blind Extension Period|Physician Decision|0|||
156767670|NCT03176771|565906348|FG003|Double-Blind Extension Period|Physician Decision|3|||
156767671|NCT03176771|565906349|FG004|Double-Blind Extension Period|Physician Decision|1|||
156767672|NCT03176771|565906345|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
156767673|NCT03176771|565906346|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
156767674|NCT03176771|565906347|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
156767675|NCT03176771|565906348|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
156767676|NCT03176771|565906349|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
156767677|NCT03363906|565906350|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
156767678|NCT03363906|565906351|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
156767679|NCT03363906|565906350|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
156767680|NCT03363906|565906351|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
156767681|NCT03363906|565906350|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
156767682|NCT03363906|565906351|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
156767683|NCT03363906|565906350|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
156767684|NCT03363906|565906351|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
156767685|NCT00676143|565906352|FG000|Overall Study|Adverse Event|34|||
156767686|NCT00676143|565906353|FG001|Overall Study|Adverse Event|60|||
156767687|NCT00676143|565906352|FG000|Overall Study|Death|4|||
156767688|NCT00676143|565906353|FG001|Overall Study|Death|4|||
156767689|NCT00676143|565906352|FG000|Overall Study|Lack of Efficacy|0|||
156767690|NCT00676143|565906353|FG001|Overall Study|Lack of Efficacy|6|||
156767691|NCT00676143|565906352|FG000|Overall Study|Lost to Follow-up|0|||
156767692|NCT00676143|565906353|FG001|Overall Study|Lost to Follow-up|13|||
156767693|NCT00676143|565906352|FG000|Overall Study|Physician Decision|5|||
156767694|NCT00676143|565906353|FG001|Overall Study|Physician Decision|8|||
156767695|NCT00676143|565906352|FG000|Overall Study|Protocol Violation|4|||
156767696|NCT00676143|565906353|FG001|Overall Study|Protocol Violation|8|||
156767697|NCT00676143|565906352|FG000|Overall Study|Withdrawal by Subject|24|||
156767698|NCT00676143|565906353|FG001|Overall Study|Withdrawal by Subject|42|||
156656711|NCT01915732|565489432|FG000|Overall Study|Poor Perceived Efficacy|1|||
156656712|NCT01915732|565489433|FG001|Overall Study|Poor Perceived Efficacy|0|||
156656713|NCT01915732|565489432|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
156656714|NCT01915732|565489433|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
156656715|NCT01915732|565489432|FG000|Overall Study|Got Well|0|||
156656716|NCT01915732|565489433|FG001|Overall Study|Got Well|1|||
156656717|NCT01915732|565489432|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
156767699|NCT00676143|565906352|FG000|Overall Study|Discontinuation of study by sponsor|65|||
156767700|NCT00676143|565906353|FG001|Overall Study|Discontinuation of study by sponsor|88|||
156767701|NCT00676143|565906352|FG000|Overall Study|Failed to return|2|||
156767702|NCT00676143|565906353|FG001|Overall Study|Failed to return|1|||
156767703|NCT00676143|565906352|FG000|Overall Study|Loss of caregiver|5|||
156767704|NCT00676143|565906353|FG001|Overall Study|Loss of caregiver|3|||
156767705|NCT00676143|565906352|FG000|Overall Study|Other|11|||
156767706|NCT00676143|565906353|FG001|Overall Study|Other|20|||
156767707|NCT00676143|565906352|FG000|Overall Study|Participant participation unknown|1|||
156767708|NCT00676143|565906353|FG001|Overall Study|Participant participation unknown|4|||
156767709|NCT00676143|565906352|FG000|Overall Study|Vasogenic edema recurrence|1|||
156767710|NCT00676143|565906353|FG001|Overall Study|Vasogenic edema recurrence|3|||
156522569|NCT03184870|565007747|FG017|Crossover Treatment|Other reasons|2|||
156767711|NCT00929669|565906354|FG000|Overall Study|elevated glucose levels|1|||
156656718|NCT01915732|565489433|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
156656719|NCT01915732|565489432|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
156656720|NCT01915732|565489433|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
156656721|NCT01915732|565489432|FG000|Overall Study|Job Transfer|0|||
156656722|NCT01915732|565489433|FG001|Overall Study|Job Transfer|1|||
156656723|NCT01915732|565489432|FG000|Overall Study|Improper Facial Procedure|0|||
156656724|NCT01915732|565489433|FG001|Overall Study|Improper Facial Procedure|1|||
156656725|NCT01915732|565489432|FG000|Overall Study|Poor Conscious Effect|0|||
156656726|NCT01915732|565489433|FG001|Overall Study|Poor Conscious Effect|1|||
156656727|NCT02114697|565489439|FG000|Overall Study|Study terminated|5|||
156656728|NCT02114697|565489440|FG001|Overall Study|Study terminated|4|||
156656729|NCT00424489|565489441|FG000|Overall Study|Death|3|||
156656730|NCT01984242|565489442|FG000|Overall Study|Death|52|||
156656731|NCT01984242|565489443|FG001|Overall Study|Death|50|||
156656732|NCT01984242|565489444|FG002|Overall Study|Death|52|||
156656733|NCT01984242|565489442|FG000|Overall Study|Withdrawal by Subject|5|||
156656734|NCT01984242|565489443|FG001|Overall Study|Withdrawal by Subject|3|||
156656735|NCT01984242|565489444|FG002|Overall Study|Withdrawal by Subject|10|||
156656736|NCT01984242|565489442|FG000|Overall Study|Physician Decision|0|||
156656737|NCT01984242|565489443|FG001|Overall Study|Physician Decision|0|||
156656738|NCT01984242|565489444|FG002|Overall Study|Physician Decision|1|||
156656739|NCT01984242|565489442|FG000|Overall Study|Lost to Follow-up|4|||
156656740|NCT01984242|565489443|FG001|Overall Study|Lost to Follow-up|0|||
156656741|NCT01984242|565489444|FG002|Overall Study|Lost to Follow-up|3|||
156656742|NCT01984242|565489442|FG000|Overall Study|Sponsor Decision|1|||
156656743|NCT01984242|565489443|FG001|Overall Study|Sponsor Decision|0|||
156656744|NCT01984242|565489444|FG002|Overall Study|Sponsor Decision|0|||
156656745|NCT01984242|565489442|FG000|Overall Study|Non-Compliance|1|||
156656746|NCT01984242|565489443|FG001|Overall Study|Non-Compliance|0|||
156656747|NCT01984242|565489444|FG002|Overall Study|Non-Compliance|0|||
156656748|NCT01984242|565489442|FG000|Overall Study|Study terminated by Sponsor|38|||
156767712|NCT00250588|565906355|FG000|Overall Study|Withdrawal by Subject|3|||
156767713|NCT00250588|565906356|FG001|Overall Study|Withdrawal by Subject|6|||
156767714|NCT00250588|565906357|FG002|Overall Study|Withdrawal by Subject|0|||
156767715|NCT00250588|565906355|FG000|Overall Study|Lost to Follow-up|6|||
156656749|NCT01984242|565489443|FG001|Overall Study|Study terminated by Sponsor|50|||
156656750|NCT01984242|565489444|FG002|Overall Study|Study terminated by Sponsor|34|||
156656751|NCT01984242|565489442|FG000|Overall Study|Disease Progression|0|||
156656752|NCT01984242|565489443|FG001|Overall Study|Disease Progression|0|||
156656753|NCT01984242|565489444|FG002|Overall Study|Disease Progression|1|||
156656754|NCT00449150|565489445|FG000|Overall Study|Adverse Event|11|||
156656755|NCT00449150|565489446|FG001|Overall Study|Adverse Event|18|||
156767716|NCT00250588|565906356|FG001|Overall Study|Lost to Follow-up|13|||
156323195|NCT04543409|564282368|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
156323196|NCT04543409|564282369|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
156767717|NCT00250588|565906357|FG002|Overall Study|Lost to Follow-up|13|||
156323197|NCT04543409|564282368|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
156323198|NCT04543409|564282369|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
156323199|NCT01289782|564282370|FG000|Overall Study|Lost to Follow-up|14|||
156323200|NCT01289782|564282371|FG001|Overall Study|Lost to Follow-up|7|||
156323201|NCT01289782|564282370|FG000|Overall Study|Protocol Violation|1|||
156323202|NCT01289782|564282371|FG001|Overall Study|Protocol Violation|1|||
156323203|NCT01289782|564282370|FG000|Overall Study|Withdrawal by Subject|8|||
156656756|NCT00449150|565489447|FG002|Overall Study|Adverse Event|9|||
156656757|NCT00449150|565489445|FG000|Overall Study|Lack of Efficacy|1|||
156767718|NCT00706797|565906358|FG000|Overall Study|Lack of Efficacy|3|||
156323204|NCT01289782|564282371|FG001|Overall Study|Withdrawal by Subject|2|||
156323205|NCT01289782|564282370|FG000|Overall Study|Sponsor's Decision|1|||
156323206|NCT01289782|564282371|FG001|Overall Study|Sponsor's Decision|0|||
156323207|NCT01289782|564282370|FG000|Overall Study|Reason not specified|1|||
156323208|NCT01289782|564282371|FG001|Overall Study|Reason not specified|2|||
156323209|NCT00586326|564282385|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
156656758|NCT00449150|565489446|FG001|Overall Study|Lack of Efficacy|2|||
156656759|NCT00449150|565489447|FG002|Overall Study|Lack of Efficacy|2|||
156656760|NCT00449150|565489445|FG000|Overall Study|Other|16|||
156656761|NCT00449150|565489446|FG001|Overall Study|Other|13|||
156656762|NCT00449150|565489447|FG002|Overall Study|Other|14|||
156767719|NCT00706797|565906359|FG001|Overall Study|Lack of Efficacy|0|||
156767720|NCT00706797|565906358|FG000|Overall Study|Adverse Event|0|||
156767721|NCT00706797|565906359|FG001|Overall Study|Adverse Event|3|||
156767722|NCT00706797|565906358|FG000|Overall Study|Withdrawal by Subject|8|||
156767723|NCT00706797|565906359|FG001|Overall Study|Withdrawal by Subject|1|||
156767724|NCT00706797|565906358|FG000|Overall Study|Death|1|||
156767725|NCT00706797|565906359|FG001|Overall Study|Death|0|||
156767726|NCT00706797|565906358|FG000|Overall Study|Discontinuation of study by sponsor|52|||
156767727|NCT00706797|565906359|FG001|Overall Study|Discontinuation of study by sponsor|63|||
156767728|NCT00706797|565906358|FG000|Overall Study|Protocol Violation|3|||
156767729|NCT00706797|565906359|FG001|Overall Study|Protocol Violation|2|||
156767730|NCT00706797|565906358|FG000|Overall Study|Lost to Follow-up|1|||
156767731|NCT00706797|565906359|FG001|Overall Study|Lost to Follow-up|2|||
156767732|NCT00706797|565906358|FG000|Overall Study|Other|1|||
156767733|NCT00706797|565906359|FG001|Overall Study|Other|0|||
156767734|NCT03502798|565906362|FG000|Overall Study|equipment failure|0|||
156767735|NCT03502798|565906363|FG001|Overall Study|equipment failure|7|||
156767736|NCT01603277|565906367|FG000|Overall Study|Adverse Event|1|||
156767737|NCT01603277|565906368|FG001|Overall Study|Adverse Event|2|||
156767738|NCT01603277|565906367|FG000|Overall Study|Physician Decision|0|||
156767739|NCT01603277|565906368|FG001|Overall Study|Physician Decision|1|||
156767740|NCT01603277|565906367|FG000|Overall Study|Protocol Violation|6|||
156767741|NCT01603277|565906368|FG001|Overall Study|Protocol Violation|10|||
156767742|NCT01603277|565906367|FG000|Overall Study|Withdrawal by Subject|5|||
156767743|NCT01603277|565906368|FG001|Overall Study|Withdrawal by Subject|4|||
156767744|NCT01603277|565906367|FG000|Overall Study|Non-Compliance|2|||
156767745|NCT01603277|565906368|FG001|Overall Study|Non-Compliance|1|||
156767746|NCT00087178|565906369|FG000|Overall Study|No follow up data|5|||
156767747|NCT00087178|565906370|FG001|Overall Study|No follow up data|15|||
156767748|NCT00087178|565906369|FG000|Overall Study|No clinical assessment|1|||
156767749|NCT00087178|565906370|FG001|Overall Study|No clinical assessment|2|||
156767750|NCT00087178|565906369|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
156767751|NCT00087178|565906370|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
156767752|NCT01692119|565906373|FG000|Overall Study|Protocol Violation|3|||
156767753|NCT01692119|565906374|FG001|Overall Study|Protocol Violation|1|||
156767754|NCT01692119|565906373|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
156767755|NCT01692119|565906374|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
156767756|NCT01299584|565906381|FG000|Overall Study|Protocol Violation|9|||
156767757|NCT05063448|565906394|FG000|Overall Study|Withdrawal by Subject|1|||
156767758|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
156767759|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767760|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767761|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767762|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767763|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767764|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767765|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
156767766|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767767|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767768|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767769|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767770|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767771|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767772|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767773|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
156767774|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767775|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767776|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767777|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767778|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767779|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767780|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767781|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
156767782|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767783|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767784|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767785|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767786|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767787|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767788|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
156767789|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767790|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767791|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767792|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767793|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156767794|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156767795|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
156767796|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156767797|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156767798|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156656763|NCT00449150|565489445|FG000|Overall Study|Withdrawal by Subject|17|||
156656764|NCT00449150|565489446|FG001|Overall Study|Withdrawal by Subject|18|||
156656765|NCT00449150|565489447|FG002|Overall Study|Withdrawal by Subject|21|||
156656766|NCT00449150|565489445|FG000|Overall Study|Protocol Violation|1|||
156656767|NCT00449150|565489446|FG001|Overall Study|Protocol Violation|2|||
156656768|NCT00449150|565489447|FG002|Overall Study|Protocol Violation|1|||
156656769|NCT02246478|565489448|FG000|Multiple-dose Phase|Protocol Violation|1|||
156656770|NCT02246478|565489449|FG001|Multiple-dose Phase|Protocol Violation|0|||
156656771|NCT02246478|565489450|FG002|Multiple-dose Phase|Protocol Violation|0|||
156323210|NCT00586326|564282385|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
156323211|NCT00586326|564282385|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
156323212|NCT00586326|564282385|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
156323213|NCT00586326|564282385|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
156323214|NCT00586326|564282385|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
156323215|NCT00586326|564282385|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
156323216|NCT00586326|564282385|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
156323217|NCT00586326|564282385|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
156656772|NCT02246478|565489451|FG003|Multiple-dose Phase|Protocol Violation|1|||
156656773|NCT00536575|565489452|FG000|Overall Study|Withdrawal by Subject|1|||
156656774|NCT00536575|565489452|FG000|Overall Study|Death|1|||
156656775|NCT00865709|565489462|FG000|Treatment|Adverse Event|9|||
156323218|NCT00586326|564282385|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
156323219|NCT00586326|564282385|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
156323220|NCT00586326|564282385|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
156323221|NCT00586326|564282385|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
156323222|NCT00586326|564282385|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
156656776|NCT00865709|565489463|FG001|Treatment|Adverse Event|6|||
156656777|NCT00865709|565489462|FG000|Treatment|Withdrawal by Subject|10|||
156656778|NCT00865709|565489463|FG001|Treatment|Withdrawal by Subject|7|||
156656779|NCT00865709|565489462|FG000|Treatment|Physician Decision|3|||
156656780|NCT00865709|565489463|FG001|Treatment|Physician Decision|2|||
156656781|NCT00865709|565489462|FG000|Treatment|Surgery|8|||
156656782|NCT00865709|565489463|FG001|Treatment|Surgery|3|||
156656783|NCT00429923|565489464|FG000|Overall Study|Adverse Event|0|||
156656784|NCT00429923|565489465|FG001|Overall Study|Adverse Event|2|||
156656785|NCT00429923|565489466|FG002|Overall Study|Adverse Event|3|||
156656786|NCT00429923|565489464|FG000|Overall Study|Lack of Efficacy|4|||
156656787|NCT00429923|565489465|FG001|Overall Study|Lack of Efficacy|1|||
156656788|NCT00429923|565489466|FG002|Overall Study|Lack of Efficacy|33|||
156656789|NCT00429923|565489464|FG000|Overall Study|Lost to Follow-up|0|||
156656790|NCT00429923|565489465|FG001|Overall Study|Lost to Follow-up|0|||
156656791|NCT00429923|565489466|FG002|Overall Study|Lost to Follow-up|2|||
156656792|NCT00429923|565489464|FG000|Overall Study|Withdrew Consent|1|||
156656793|NCT00429923|565489465|FG001|Overall Study|Withdrew Consent|0|||
156656794|NCT00429923|565489466|FG002|Overall Study|Withdrew Consent|1|||
156656795|NCT00429923|565489464|FG000|Overall Study|Early Termination|0|||
156656796|NCT00429923|565489465|FG001|Overall Study|Early Termination|1|||
156656797|NCT00429923|565489466|FG002|Overall Study|Early Termination|0|||
156656798|NCT01265784|565489467|FG000|Overall Study|Lost to Follow-up|5|||
156656799|NCT01265784|565489468|FG001|Overall Study|Lost to Follow-up|3|||
156656800|NCT01265784|565489469|FG002|Overall Study|Lost to Follow-up|2|||
156656801|NCT01265784|565489467|FG000|Overall Study|Withdrawal by Subject|0|||
156656802|NCT01265784|565489468|FG001|Overall Study|Withdrawal by Subject|5|||
156656803|NCT01265784|565489469|FG002|Overall Study|Withdrawal by Subject|0|||
156656804|NCT01265784|565489467|FG000|Overall Study|Physician Decision|1|||
156656805|NCT01265784|565489468|FG001|Overall Study|Physician Decision|0|||
156656806|NCT01265784|565489469|FG002|Overall Study|Physician Decision|1|||
156656807|NCT01265784|565489467|FG000|Overall Study|Adverse Event|1|||
156656808|NCT01265784|565489468|FG001|Overall Study|Adverse Event|0|||
156656809|NCT01265784|565489469|FG002|Overall Study|Adverse Event|0|||
156656810|NCT01265784|565489467|FG000|Overall Study|Death|3|||
156656811|NCT01265784|565489468|FG001|Overall Study|Death|0|||
156656812|NCT01265784|565489469|FG002|Overall Study|Death|0|||
156656813|NCT01265784|565489467|FG000|Overall Study|Protocol Violation|2|||
156656814|NCT01265784|565489468|FG001|Overall Study|Protocol Violation|0|||
156656815|NCT01265784|565489469|FG002|Overall Study|Protocol Violation|0|||
156656816|NCT01265784|565489467|FG000|Overall Study|Incorrectly Randomized|0|||
156656817|NCT01265784|565489468|FG001|Overall Study|Incorrectly Randomized|0|||
156656818|NCT01265784|565489469|FG002|Overall Study|Incorrectly Randomized|1|||
156656819|NCT04333095|565489472|FG000|Overall Study|Protocol Violation|4|||
156656820|NCT04333095|565489473|FG001|Overall Study|Protocol Violation|0|||
156656821|NCT04333095|565489472|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
156767799|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156656822|NCT04333095|565489473|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
156656823|NCT04333095|565489472|FG000|Overall Study|Mini Sternotomy|4|||
156656824|NCT04333095|565489473|FG001|Overall Study|Mini Sternotomy|5|||
156656825|NCT00984295|565489474|FG000|Overall Study|Lost to Follow-up|31|||
156767800|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767801|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767802|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767803|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
156767804|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767805|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767806|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767807|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767808|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767809|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767810|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
156767811|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767812|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767813|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767814|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156323223|NCT00586326|564282385|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
156323224|NCT00586326|564282385|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
156323225|NCT00586326|564282385|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
156323226|NCT02325791|564282389|FG000|Overall Study|Adverse Event|0|||
156323227|NCT02325791|564282390|FG001|Overall Study|Adverse Event|1|||
156323228|NCT02325791|564282391|FG002|Overall Study|Adverse Event|1|||
156323229|NCT02325791|564282392|FG003|Overall Study|Adverse Event|0|||
156323230|NCT02325791|564282389|FG000|Overall Study|Death|0|||
156323231|NCT02325791|564282390|FG001|Overall Study|Death|3|||
156323232|NCT02325791|564282391|FG002|Overall Study|Death|0|||
156323233|NCT02325791|564282392|FG003|Overall Study|Death|1|||
156323234|NCT02325791|564282389|FG000|Overall Study|Lost to Follow-up|0|||
156323235|NCT02325791|564282390|FG001|Overall Study|Lost to Follow-up|15|||
156323236|NCT02325791|564282391|FG002|Overall Study|Lost to Follow-up|14|||
156323237|NCT02325791|564282392|FG003|Overall Study|Lost to Follow-up|9|||
156323238|NCT02325791|564282389|FG000|Overall Study|Physician Decision|0|||
156323239|NCT02325791|564282390|FG001|Overall Study|Physician Decision|1|||
156323240|NCT02325791|564282391|FG002|Overall Study|Physician Decision|1|||
156323241|NCT02325791|564282392|FG003|Overall Study|Physician Decision|0|||
156323242|NCT02325791|564282389|FG000|Overall Study|Protocol Violation|0|||
156323243|NCT02325791|564282390|FG001|Overall Study|Protocol Violation|0|||
156323244|NCT02325791|564282391|FG002|Overall Study|Protocol Violation|1|||
156323245|NCT02325791|564282392|FG003|Overall Study|Protocol Violation|0|||
156323246|NCT02325791|564282389|FG000|Overall Study|Withdrawal by Subject|0|||
156323247|NCT02325791|564282390|FG001|Overall Study|Withdrawal by Subject|5|||
156323248|NCT02325791|564282391|FG002|Overall Study|Withdrawal by Subject|8|||
156323249|NCT02325791|564282392|FG003|Overall Study|Withdrawal by Subject|16|||
156323250|NCT00555425|564282393|FG000|Overall Study|Missed Medication > 1 wk|34|||
156323251|NCT00555425|564282394|FG001|Overall Study|Missed Medication > 1 wk|15|||
156323252|NCT00555425|564282393|FG000|Overall Study|Missed 3 physician management visits|1|||
156323253|NCT00555425|564282394|FG001|Overall Study|Missed 3 physician management visits|0|||
156323254|NCT00555425|564282393|FG000|Overall Study|Met criteria for protective transfer|16|||
156323255|NCT00555425|564282394|FG001|Overall Study|Met criteria for protective transfer|3|||
156323256|NCT00555425|564282393|FG000|Overall Study|Became pregnant and transferred care|0|||
156323257|NCT00555425|564282394|FG001|Overall Study|Became pregnant and transferred care|1|||
156323258|NCT01975831|564282395|FG000|Overall Study|Adverse Event|1|||
156323259|NCT01975831|564282396|FG001|Overall Study|Adverse Event|2|||
156323260|NCT01975831|564282397|FG002|Overall Study|Adverse Event|2|||
156323261|NCT01975831|564282398|FG003|Overall Study|Adverse Event|0|||
156323262|NCT01975831|564282399|FG004|Overall Study|Adverse Event|1|||
156323263|NCT01975831|564282400|FG005|Overall Study|Adverse Event|1|||
156323264|NCT01975831|564282401|FG006|Overall Study|Adverse Event|3|||
156323265|NCT01975831|564282402|FG007|Overall Study|Adverse Event|4|||
156323266|NCT01975831|564282403|FG008|Overall Study|Adverse Event|1|||
156323267|NCT01975831|564282395|FG000|Overall Study|Death|1|||
156323268|NCT01975831|564282396|FG001|Overall Study|Death|1|||
156323269|NCT01975831|564282397|FG002|Overall Study|Death|0|||
156323270|NCT01975831|564282398|FG003|Overall Study|Death|0|||
156323271|NCT01975831|564282399|FG004|Overall Study|Death|1|||
156323272|NCT01975831|564282400|FG005|Overall Study|Death|0|||
156323273|NCT01975831|564282401|FG006|Overall Study|Death|1|||
156767815|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156427451|NCT01693614|564658752|FG002|Overall Study|Physician Decision|4|||
156323274|NCT01975831|564282402|FG007|Overall Study|Death|0|||
156323275|NCT01975831|564282403|FG008|Overall Study|Death|0|||
156323276|NCT01975831|564282395|FG000|Overall Study|Progressive Disease|1|||
156323277|NCT01975831|564282396|FG001|Overall Study|Progressive Disease|3|||
156323278|NCT01975831|564282397|FG002|Overall Study|Progressive Disease|2|||
156323279|NCT01975831|564282398|FG003|Overall Study|Progressive Disease|4|||
156427452|NCT01693614|564658750|FG000|Overall Study|Withdrawal by subject/guardian|0|||
156656826|NCT00984295|565489475|FG001|Overall Study|Lost to Follow-up|12|||
156656827|NCT00984295|565489476|FG002|Overall Study|Lost to Follow-up|13|||
156656828|NCT00984295|565489474|FG000|Overall Study|Protocol Violation|2|||
156656829|NCT00984295|565489475|FG001|Overall Study|Protocol Violation|1|||
156656830|NCT00984295|565489476|FG002|Overall Study|Protocol Violation|4|||
156656831|NCT00984295|565489474|FG000|Overall Study|Withdrawal by Subject|18|||
156656832|NCT00984295|565489475|FG001|Overall Study|Withdrawal by Subject|9|||
156656833|NCT00984295|565489476|FG002|Overall Study|Withdrawal by Subject|12|||
156656834|NCT00984295|565489474|FG000|Overall Study|CAE - discontinued test vaccine|0|||
156656835|NCT00984295|565489475|FG001|Overall Study|CAE - discontinued test vaccine|1|||
156656836|NCT00984295|565489476|FG002|Overall Study|CAE - discontinued test vaccine|3|||
156656837|NCT00984295|565489474|FG000|Overall Study|Missed one or more blood samplings|3|||
156656838|NCT00984295|565489475|FG001|Overall Study|Missed one or more blood samplings|7|||
156767816|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156767817|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156767818|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
156767819|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156767820|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156767821|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767822|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767823|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767824|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767825|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
156767826|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767827|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767828|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767829|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767830|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767831|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767832|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
156767833|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767834|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767835|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767836|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767837|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156656839|NCT00984295|565489476|FG002|Overall Study|Missed one or more blood samplings|2|||
156656840|NCT00984295|565489474|FG000|Overall Study|Incomplete safety follow-up|11|||
156656841|NCT00984295|565489475|FG001|Overall Study|Incomplete safety follow-up|2|||
156656842|NCT00984295|565489476|FG002|Overall Study|Incomplete safety follow-up|3|||
156656843|NCT03740165|565489477|FG000|Overall Study|Death|232|||
156656844|NCT03740165|565489478|FG001|Overall Study|Death|242|||
156656845|NCT03740165|565489479|FG002|Overall Study|Death|229|||
156656846|NCT03740165|565489477|FG000|Overall Study|Lost to Follow-up|0|||
156656847|NCT03740165|565489478|FG001|Overall Study|Lost to Follow-up|0|||
156656848|NCT03740165|565489479|FG002|Overall Study|Lost to Follow-up|1|||
156656849|NCT03740165|565489477|FG000|Overall Study|Withdrawal by Subject|7|||
156656850|NCT03740165|565489478|FG001|Overall Study|Withdrawal by Subject|4|||
156656851|NCT03740165|565489479|FG002|Overall Study|Withdrawal by Subject|3|||
156656852|NCT03740165|565489477|FG000|Overall Study|Ongoing in Study|216|||
156656853|NCT03740165|565489478|FG001|Overall Study|Ongoing in Study|212|||
156656854|NCT03740165|565489479|FG002|Overall Study|Ongoing in Study|221|||
156656855|NCT03049618|565489480|FG000|Overall Study|Death|1|||
156656856|NCT03049618|565489481|FG001|Overall Study|Death|0|||
156656857|NCT03049618|565489480|FG000|Overall Study|Lack of Efficacy|1|||
156656858|NCT03049618|565489481|FG001|Overall Study|Lack of Efficacy|2|||
156656859|NCT00662129|565489485|FG000|Overall Study|Protocol Violation|1|||
156656860|NCT00662129|565489485|FG000|Overall Study|Cancel prior to beginning treatment|1|||
156656861|NCT00662129|565489485|FG000|Overall Study|Ineligible|1|||
156656862|NCT00329602|565489487|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
156656863|NCT00329602|565489488|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
156656864|NCT00329602|565489489|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
156656865|NCT00329602|565489487|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
156767838|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156656866|NCT00329602|565489488|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
156656867|NCT00329602|565489489|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
156656868|NCT00329602|565489487|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
156656869|NCT00329602|565489488|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
156656870|NCT00329602|565489489|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
156656871|NCT00329602|565489487|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
156656872|NCT00329602|565489488|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
156767839|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
156767840|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767841|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767842|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767843|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767844|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767845|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767846|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767847|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
156767848|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767849|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767850|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767851|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767852|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767853|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767854|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
156767855|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767856|NCT01791595|565906398|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767857|NCT01791595|565906399|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767858|NCT01791595|565906400|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767859|NCT01791595|565906401|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767860|NCT01791595|565906402|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767861|NCT01791595|565906403|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767862|NCT01791595|565906404|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
156767863|NCT01791595|565906398|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767864|NCT01791595|565906399|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767865|NCT01791595|565906400|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767866|NCT01791595|565906401|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767867|NCT01791595|565906402|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767868|NCT01791595|565906403|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767869|NCT01791595|565906404|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
156767870|NCT01791595|565906398|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767871|NCT01791595|565906399|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767872|NCT01791595|565906400|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767873|NCT01791595|565906401|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767874|NCT01791595|565906402|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767875|NCT01791595|565906403|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767876|NCT01791595|565906404|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
156767877|NCT01791595|565906398|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767878|NCT01791595|565906399|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767879|NCT01791595|565906400|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767880|NCT01791595|565906401|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767881|NCT01791595|565906402|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767882|NCT01791595|565906403|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767883|NCT01791595|565906404|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
156522570|NCT03184870|565007730|FG000|Crossover Treatment|Death|0|||
156767884|NCT01776554|565906405|FG000|Overall Study|Adverse Event|1|||
156767885|NCT01776554|565906406|FG001|Overall Study|Adverse Event|0|||
156767886|NCT01776554|565906405|FG000|Overall Study|Withdrawal by Subject|3|||
156767887|NCT01776554|565906406|FG001|Overall Study|Withdrawal by Subject|8|||
156767888|NCT01776554|565906405|FG000|Overall Study|Lost to Follow-up|6|||
156767889|NCT01776554|565906406|FG001|Overall Study|Lost to Follow-up|9|||
156767890|NCT01776554|565906405|FG000|Overall Study|Administrative Reason|2|||
156767891|NCT01776554|565906406|FG001|Overall Study|Administrative Reason|5|||
156767892|NCT01776554|565906405|FG000|Overall Study|Protocol Violation|1|||
156767893|NCT01776554|565906406|FG001|Overall Study|Protocol Violation|0|||
156767894|NCT01776554|565906405|FG000|Overall Study|Unclassified|4|||
156767895|NCT01776554|565906406|FG001|Overall Study|Unclassified|1|||
156767896|NCT01041859|565906407|FG000|Open-Label Titration|Adverse Event|69|||
156767897|NCT01041859|565906408|FG001|Open-Label Titration|Adverse Event|0|||
156767898|NCT01041859|565906409|FG002|Open-Label Titration|Adverse Event|0|||
156767899|NCT01041859|565906407|FG000|Open-Label Titration|Lack of Efficacy|3|||
156767900|NCT01041859|565906408|FG001|Open-Label Titration|Lack of Efficacy|0|||
156767901|NCT01041859|565906409|FG002|Open-Label Titration|Lack of Efficacy|0|||
156767902|NCT01041859|565906407|FG000|Open-Label Titration|Lost to Follow-up|1|||
156767903|NCT01041859|565906408|FG001|Open-Label Titration|Lost to Follow-up|0|||
156767904|NCT01041859|565906409|FG002|Open-Label Titration|Lost to Follow-up|0|||
156767905|NCT01041859|565906407|FG000|Open-Label Titration|Physician Decision|1|||
156767906|NCT01041859|565906408|FG001|Open-Label Titration|Physician Decision|0|||
156767907|NCT01041859|565906409|FG002|Open-Label Titration|Physician Decision|0|||
156767908|NCT01041859|565906407|FG000|Open-Label Titration|Protocol Violation|1|||
156767909|NCT01041859|565906408|FG001|Open-Label Titration|Protocol Violation|0|||
156767910|NCT01041859|565906409|FG002|Open-Label Titration|Protocol Violation|0|||
156767911|NCT01041859|565906407|FG000|Open-Label Titration|Other|7|||
156767912|NCT01041859|565906408|FG001|Open-Label Titration|Other|0|||
156767913|NCT01041859|565906409|FG002|Open-Label Titration|Other|0|||
156767914|NCT01041859|565906407|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
156767915|NCT01041859|565906408|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
156767916|NCT01041859|565906409|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
156767917|NCT01041859|565906407|FG000|Open-Label Titration|Withdrawal by Subject|11|||
156767918|NCT01041859|565906408|FG001|Open-Label Titration|Withdrawal by Subject|0|||
156323280|NCT01975831|564282399|FG004|Overall Study|Progressive Disease|13|||
156323281|NCT01975831|564282400|FG005|Overall Study|Progressive Disease|9|||
156323282|NCT01975831|564282401|FG006|Overall Study|Progressive Disease|10|||
156323283|NCT01975831|564282402|FG007|Overall Study|Progressive Disease|8|||
156323284|NCT01975831|564282403|FG008|Overall Study|Progressive Disease|10|||
156323285|NCT01975831|564282395|FG000|Overall Study|Withdrawal by Subject|0|||
156323286|NCT01975831|564282396|FG001|Overall Study|Withdrawal by Subject|3|||
156323287|NCT01975831|564282397|FG002|Overall Study|Withdrawal by Subject|0|||
156323288|NCT01975831|564282398|FG003|Overall Study|Withdrawal by Subject|0|||
156323289|NCT01975831|564282399|FG004|Overall Study|Withdrawal by Subject|3|||
156323290|NCT01975831|564282400|FG005|Overall Study|Withdrawal by Subject|1|||
156323291|NCT01975831|564282401|FG006|Overall Study|Withdrawal by Subject|1|||
156323292|NCT01975831|564282402|FG007|Overall Study|Withdrawal by Subject|0|||
156323293|NCT01975831|564282403|FG008|Overall Study|Withdrawal by Subject|0|||
156323294|NCT01975831|564282395|FG000|Overall Study|Physician Decision|0|||
156323295|NCT01975831|564282396|FG001|Overall Study|Physician Decision|0|||
156323296|NCT01975831|564282397|FG002|Overall Study|Physician Decision|0|||
156323297|NCT01975831|564282398|FG003|Overall Study|Physician Decision|0|||
156323298|NCT01975831|564282399|FG004|Overall Study|Physician Decision|0|||
156323299|NCT01975831|564282400|FG005|Overall Study|Physician Decision|1|||
156323300|NCT01975831|564282401|FG006|Overall Study|Physician Decision|0|||
156323301|NCT01975831|564282402|FG007|Overall Study|Physician Decision|1|||
156323302|NCT01975831|564282403|FG008|Overall Study|Physician Decision|0|||
156323303|NCT01975831|564282395|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
156323304|NCT01975831|564282396|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
156323305|NCT01975831|564282397|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
156323306|NCT01975831|564282398|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
156323307|NCT01975831|564282399|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
156323308|NCT01975831|564282400|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
156323309|NCT01975831|564282401|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
156323310|NCT01975831|564282402|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
156323311|NCT01975831|564282403|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
156323312|NCT01975831|564282395|FG000|Overall Study|Entered Hospice|0|||
156323313|NCT01975831|564282396|FG001|Overall Study|Entered Hospice|0|||
156323314|NCT01975831|564282397|FG002|Overall Study|Entered Hospice|0|||
156323315|NCT01975831|564282398|FG003|Overall Study|Entered Hospice|0|||
156323316|NCT01975831|564282399|FG004|Overall Study|Entered Hospice|0|||
156323317|NCT01975831|564282400|FG005|Overall Study|Entered Hospice|1|||
156323318|NCT01975831|564282401|FG006|Overall Study|Entered Hospice|0|||
156323319|NCT01975831|564282402|FG007|Overall Study|Entered Hospice|0|||
156323320|NCT01975831|564282403|FG008|Overall Study|Entered Hospice|0|||
156323321|NCT01975831|564282395|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
156323322|NCT01975831|564282396|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
156323323|NCT01975831|564282397|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
156323324|NCT01975831|564282398|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
156323325|NCT01975831|564282399|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
156323326|NCT01975831|564282400|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
156323327|NCT01975831|564282401|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
156323328|NCT01975831|564282402|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
156323329|NCT01975831|564282403|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
156323330|NCT01642407|564282404|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
156323331|NCT01642407|564282404|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
156323332|NCT01642407|564282404|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
156323333|NCT00424255|564282405|FG000|Overall Study|Death|115|||
156323334|NCT00424255|564282406|FG001|Overall Study|Death|111|||
156323335|NCT00424255|564282405|FG000|Overall Study|Lost to Follow-up|26|||
156323336|NCT00424255|564282406|FG001|Overall Study|Lost to Follow-up|20|||
156323337|NCT00424255|564282405|FG000|Overall Study|Protocol Violation|0|||
156522571|NCT03184870|565007731|FG001|Crossover Treatment|Death|0|||
156767919|NCT01041859|565906409|FG002|Open-Label Titration|Withdrawal by Subject|0|||
156767920|NCT01041859|565906407|FG000|Double-Blind Maintenance|Adverse Event|0|||
156767921|NCT01041859|565906408|FG001|Double-Blind Maintenance|Adverse Event|23|||
156767922|NCT01041859|565906409|FG002|Double-Blind Maintenance|Adverse Event|13|||
156767923|NCT01041859|565906407|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
156767924|NCT01041859|565906408|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
156767925|NCT01041859|565906409|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
156767926|NCT01041859|565906407|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
156767927|NCT01041859|565906408|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
156767928|NCT01041859|565906409|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
156767929|NCT01041859|565906407|FG000|Double-Blind Maintenance|Physician Decision|0|||
156767930|NCT01041859|565906408|FG001|Double-Blind Maintenance|Physician Decision|2|||
156767931|NCT01041859|565906409|FG002|Double-Blind Maintenance|Physician Decision|1|||
156767932|NCT01041859|565906407|FG000|Double-Blind Maintenance|Protocol Violation|0|||
156767933|NCT01041859|565906408|FG001|Double-Blind Maintenance|Protocol Violation|1|||
156767934|NCT01041859|565906409|FG002|Double-Blind Maintenance|Protocol Violation|3|||
156767935|NCT01041859|565906407|FG000|Double-Blind Maintenance|Other|0|||
156767936|NCT01041859|565906408|FG001|Double-Blind Maintenance|Other|6|||
156767937|NCT01041859|565906409|FG002|Double-Blind Maintenance|Other|2|||
156767938|NCT01041859|565906407|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
156767939|NCT01041859|565906408|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
156767940|NCT01041859|565906409|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
156767941|NCT01041859|565906407|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
156767942|NCT01041859|565906408|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
156767943|NCT01041859|565906409|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
156767944|NCT03329885|565906410|FG000|Overall Study|Sponsor discontinued the study early|0|||
156767945|NCT03329885|565906411|FG001|Overall Study|Sponsor discontinued the study early|0|||
156767946|NCT03329885|565906412|FG002|Overall Study|Sponsor discontinued the study early|0|||
156767947|NCT03329885|565906413|FG003|Overall Study|Sponsor discontinued the study early|0|||
156767948|NCT03329885|565906414|FG004|Overall Study|Sponsor discontinued the study early|0|||
156767949|NCT03329885|565906415|FG005|Overall Study|Sponsor discontinued the study early|0|||
156767950|NCT03329885|565906416|FG006|Overall Study|Sponsor discontinued the study early|1|||
156767951|NCT03329885|565906417|FG007|Overall Study|Sponsor discontinued the study early|1|||
156767952|NCT03329885|565906418|FG008|Overall Study|Sponsor discontinued the study early|0|||
156767953|NCT01991795|565906419|FG000|Overall Study|Lost to Follow-up|6|||
156767954|NCT01991795|565906420|FG001|Overall Study|Lost to Follow-up|4|||
156767955|NCT01991795|565906419|FG000|Overall Study|Withdrawal by Subject|117|||
156767956|NCT01991795|565906420|FG001|Overall Study|Withdrawal by Subject|94|||
156767957|NCT01991795|565906419|FG000|Overall Study|Site prematurely closed by sponsor|26|||
156767958|NCT01991795|565906420|FG001|Overall Study|Site prematurely closed by sponsor|25|||
156767959|NCT02027025|565906421|FG000|Overall Study|Adverse Event|0|||
156767960|NCT02027025|565906422|FG001|Overall Study|Adverse Event|1|||
156767961|NCT02027025|565906423|FG002|Overall Study|Adverse Event|1|||
156767962|NCT02027025|565906421|FG000|Overall Study|Protocol Violation|1|||
156767963|NCT02027025|565906422|FG001|Overall Study|Protocol Violation|0|||
156767964|NCT02027025|565906423|FG002|Overall Study|Protocol Violation|0|||
156767965|NCT02027025|565906421|FG000|Overall Study|Lost to Follow-up|0|||
156767966|NCT02027025|565906422|FG001|Overall Study|Lost to Follow-up|2|||
156767967|NCT02027025|565906423|FG002|Overall Study|Lost to Follow-up|0|||
156767968|NCT02027025|565906421|FG000|Overall Study|Withdrawal by Subject|0|||
156767969|NCT02027025|565906422|FG001|Overall Study|Withdrawal by Subject|1|||
156767970|NCT02027025|565906423|FG002|Overall Study|Withdrawal by Subject|0|||
156767971|NCT02027025|565906421|FG000|Overall Study|Sponsor's decision|0|||
156767972|NCT02027025|565906422|FG001|Overall Study|Sponsor's decision|1|||
156767973|NCT02027025|565906423|FG002|Overall Study|Sponsor's decision|0|||
156767974|NCT03883386|565906426|FG000|First Assignment|Lost to Follow-up|1|||
156767975|NCT03883386|565906427|FG001|First Assignment|Lost to Follow-up|0|||
156767976|NCT03883386|565906426|FG000|First Assignment|Withdrawal by Subject|1|||
156767977|NCT03883386|565906427|FG001|First Assignment|Withdrawal by Subject|1|||
156767978|NCT01326871|565906428|FG000|Overall Study|Major surgery|0|||
156767979|NCT01326871|565906429|FG001|Overall Study|Major surgery|1|||
156767980|NCT01326871|565906430|FG002|Overall Study|Major surgery|0|||
156767981|NCT01326871|565906428|FG000|Overall Study|SAE and death|0|||
156767982|NCT01326871|565906429|FG001|Overall Study|SAE and death|2|||
156767983|NCT01326871|565906430|FG002|Overall Study|SAE and death|0|||
156767984|NCT01326871|565906428|FG000|Overall Study|Physician decision and decreased performance status|0|||
156767985|NCT01326871|565906429|FG001|Overall Study|Physician decision and decreased performance status|1|||
156767986|NCT01326871|565906430|FG002|Overall Study|Physician decision and decreased performance status|0|||
156767987|NCT01326871|565906428|FG000|Overall Study|Disease progression|0|||
156767988|NCT01326871|565906429|FG001|Overall Study|Disease progression|11|||
156767989|NCT01326871|565906430|FG002|Overall Study|Disease progression|5|||
156767990|NCT01326871|565906428|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
156522572|NCT03184870|565007732|FG002|Crossover Treatment|Death|0|||
156522573|NCT03184870|565007733|FG003|Crossover Treatment|Death|0|||
156767991|NCT01326871|565906429|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
156656873|NCT00329602|565489489|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
156656874|NCT00329602|565489487|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
156656875|NCT00329602|565489488|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
156656876|NCT00329602|565489489|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
156656877|NCT00329602|565489487|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
156656878|NCT00329602|565489488|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
156656879|NCT00329602|565489489|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
156656880|NCT02275364|565489490|FG000|Period 1|Withdrawal by Subject|1|||
156656881|NCT02275364|565489491|FG001|Period 1|Withdrawal by Subject|0|||
156656882|NCT02275364|565489490|FG000|Period 1|Other reason|1|||
156656883|NCT02275364|565489491|FG001|Period 1|Other reason|0|||
156656884|NCT02579096|565489492|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
156656885|NCT02579096|565489493|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
156656886|NCT02579096|565489492|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
156656887|NCT02579096|565489493|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
156656888|NCT02579096|565489492|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
156656889|NCT02579096|565489493|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
156656890|NCT02579096|565489492|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
156656891|NCT02579096|565489493|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
156656892|NCT02579096|565489492|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
156656893|NCT02579096|565489493|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
156656894|NCT02579096|565489492|FG000|Phase 2, Weeks 25 - 48|Death|2|||
156656895|NCT02579096|565489493|FG001|Phase 2, Weeks 25 - 48|Death|4|||
156656896|NCT02579096|565489492|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
156656897|NCT02579096|565489493|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
156656898|NCT02579096|565489492|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
156767992|NCT01326871|565906430|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
156323338|NCT00424255|564282406|FG001|Overall Study|Protocol Violation|1|||
156323339|NCT00424255|564282405|FG000|Overall Study|Withdrawal by Subject|34|||
156323340|NCT00424255|564282406|FG001|Overall Study|Withdrawal by Subject|38|||
156323341|NCT00424255|564282405|FG000|Overall Study|Physician Decision|3|||
156323342|NCT00424255|564282406|FG001|Overall Study|Physician Decision|7|||
156323343|NCT00424255|564282405|FG000|Overall Study|Cognitive Disturbance|1|||
156323344|NCT00424255|564282406|FG001|Overall Study|Cognitive Disturbance|0|||
156323345|NCT00424255|564282405|FG000|Overall Study|Non-compliance by Participants|1|||
156323346|NCT00424255|564282406|FG001|Overall Study|Non-compliance by Participants|0|||
156323347|NCT00424255|564282405|FG000|Overall Study|Fatigue|1|||
156323348|NCT00424255|564282406|FG001|Overall Study|Fatigue|0|||
156323349|NCT00424255|564282405|FG000|Overall Study|Disease Progression|0|||
156323350|NCT00424255|564282406|FG001|Overall Study|Disease Progression|2|||
156323351|NCT00424255|564282405|FG000|Overall Study|Sponsor Terminated Study|161|||
156323352|NCT00424255|564282406|FG001|Overall Study|Sponsor Terminated Study|167|||
156323353|NCT02810340|564282408|FG000|Overall Study|Withdrawal by Subject|1|||
156323354|NCT02810340|564282409|FG001|Overall Study|Withdrawal by Subject|0|||
156323355|NCT02810340|564282410|FG002|Overall Study|Withdrawal by Subject|0|||
156323356|NCT02810340|564282408|FG000|Overall Study|Incarceration|0|||
156323357|NCT02810340|564282409|FG001|Overall Study|Incarceration|1|||
156323358|NCT02810340|564282410|FG002|Overall Study|Incarceration|0|||
156323359|NCT02810340|564282408|FG000|Overall Study|Lost to Follow-up|0|||
156323360|NCT02810340|564282409|FG001|Overall Study|Lost to Follow-up|0|||
156323361|NCT02810340|564282410|FG002|Overall Study|Lost to Follow-up|1|||
156323362|NCT00870233|564282416|FG000|Overall Study|Withdrawal by Subject|18|||
156323363|NCT00870233|564282416|FG000|Overall Study|Did not undergo laparotomy|3|||
156323364|NCT00870233|564282416|FG000|Overall Study|Incompatible internet browser|2|||
156323365|NCT00870233|564282416|FG000|Overall Study|Death|1|||
156323366|NCT00769483|564282419|FG000|Overall Study|Withdrawal by Subject|0|||
156323367|NCT00769483|564282420|FG001|Overall Study|Withdrawal by Subject|1|||
156323368|NCT00769483|564282421|FG002|Overall Study|Withdrawal by Subject|0|||
156323369|NCT00769483|564282422|FG003|Overall Study|Withdrawal by Subject|0|||
156323370|NCT00769483|564282423|FG004|Overall Study|Withdrawal by Subject|1|||
156323371|NCT00769483|564282424|FG005|Overall Study|Withdrawal by Subject|0|||
156323372|NCT01306877|564282425|FG000|Overall Study|Lost to Follow-up|3|||
156323373|NCT01306877|564282426|FG001|Overall Study|Lost to Follow-up|3|||
156323374|NCT01306877|564282425|FG000|Overall Study|Physician Decision|0|||
156323375|NCT01306877|564282426|FG001|Overall Study|Physician Decision|1|||
156323376|NCT00999921|564282443|FG000|Overall Study|Lost to Follow-up|10|||
156323377|NCT00999921|564282444|FG001|Overall Study|Lost to Follow-up|19|||
156323378|NCT00473746|564282452|FG000|Period 1 (Phase 1)|Adverse Event|1|||
156323379|NCT00473746|564282453|FG001|Period 1 (Phase 1)|Adverse Event|0|||
156323380|NCT00473746|564282454|FG002|Period 1 (Phase 1)|Adverse Event|0|||
156323381|NCT00473746|564282455|FG003|Period 1 (Phase 1)|Adverse Event|0|||
156323382|NCT00473746|564282456|FG004|Period 1 (Phase 1)|Adverse Event|0|||
156323383|NCT00473746|564282452|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
156323384|NCT00473746|564282453|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
156323385|NCT00473746|564282454|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
156656899|NCT02579096|565489493|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
156656900|NCT02579096|565489492|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
156656901|NCT02579096|565489493|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
156656902|NCT02579096|565489492|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
156656903|NCT02579096|565489493|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
156656904|NCT02579096|565489492|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
156656905|NCT02579096|565489493|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
156656906|NCT02579096|565489492|FG000|Phase 3, Weeks 49 - 72|Death|3|||
156656907|NCT02579096|565489493|FG001|Phase 3, Weeks 49 - 72|Death|2|||
156656908|NCT02579096|565489492|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
156656909|NCT02579096|565489493|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
156656910|NCT02579096|565489492|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
156656911|NCT02579096|565489493|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
156656912|NCT02579096|565489492|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
156656913|NCT02579096|565489493|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
156656914|NCT02579096|565489492|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
156656915|NCT02579096|565489493|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
156656916|NCT02579096|565489492|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
156656917|NCT02579096|565489493|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
156656918|NCT02579096|565489492|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
156656919|NCT02579096|565489493|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
156656920|NCT00510510|565489494|FG000|Overall Study|Adverse Event|4|||
156656921|NCT00510510|565489495|FG001|Overall Study|Adverse Event|3|||
156656922|NCT00510510|565489496|FG002|Overall Study|Adverse Event|6|||
156656923|NCT00510510|565489494|FG000|Overall Study|Lack of Efficacy|0|||
156767993|NCT01326871|565906428|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
156767994|NCT01326871|565906429|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
156767995|NCT01326871|565906430|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
156767996|NCT01326871|565906428|FG000|Overall Study|Withdrawal by Subject|0|||
156767997|NCT01326871|565906429|FG001|Overall Study|Withdrawal by Subject|1|||
156767998|NCT01326871|565906430|FG002|Overall Study|Withdrawal by Subject|0|||
156767999|NCT01326871|565906428|FG000|Overall Study|DLT|0|||
156768000|NCT01326871|565906429|FG001|Overall Study|DLT|2|||
156323386|NCT00473746|564282455|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
156323387|NCT00473746|564282456|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
156323388|NCT00473746|564282452|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
156323389|NCT00473746|564282453|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
156323390|NCT00473746|564282454|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
156323391|NCT00473746|564282455|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
156323392|NCT00473746|564282456|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
156323393|NCT00473746|564282452|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
156323394|NCT00473746|564282453|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
156323395|NCT00473746|564282454|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
156323396|NCT00473746|564282455|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
156323397|NCT00473746|564282456|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
156323398|NCT00473746|564282452|FG000|Period 1 (Phase 1)|Reason not specified|0|||
156323399|NCT00473746|564282453|FG001|Period 1 (Phase 1)|Reason not specified|1|||
156323400|NCT00473746|564282454|FG002|Period 1 (Phase 1)|Reason not specified|0|||
156323401|NCT00473746|564282455|FG003|Period 1 (Phase 1)|Reason not specified|0|||
156323402|NCT00473746|564282456|FG004|Period 1 (Phase 1)|Reason not specified|0|||
156323403|NCT00473746|564282452|FG000|Period 2 (Phase 2)|Adverse Event|0|||
156323404|NCT00473746|564282453|FG001|Period 2 (Phase 2)|Adverse Event|0|||
156323405|NCT00473746|564282454|FG002|Period 2 (Phase 2)|Adverse Event|0|||
156323406|NCT00473746|564282455|FG003|Period 2 (Phase 2)|Adverse Event|0|||
156323407|NCT00473746|564282456|FG004|Period 2 (Phase 2)|Adverse Event|3|||
156323408|NCT00473746|564282452|FG000|Period 2 (Phase 2)|Death|0|||
156323409|NCT00473746|564282453|FG001|Period 2 (Phase 2)|Death|0|||
156323410|NCT00473746|564282454|FG002|Period 2 (Phase 2)|Death|0|||
156323411|NCT00473746|564282455|FG003|Period 2 (Phase 2)|Death|0|||
156323412|NCT00473746|564282456|FG004|Period 2 (Phase 2)|Death|1|||
156323413|NCT00473746|564282452|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
156323414|NCT00473746|564282453|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
156323415|NCT00473746|564282454|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
156323416|NCT00473746|564282455|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
156323417|NCT00473746|564282456|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
156323418|NCT00473746|564282452|FG000|Period 2 (Phase 2)|Reason not specified|0|||
156323419|NCT00473746|564282453|FG001|Period 2 (Phase 2)|Reason not specified|0|||
156323420|NCT00473746|564282454|FG002|Period 2 (Phase 2)|Reason not specified|0|||
156656924|NCT00510510|565489495|FG001|Overall Study|Lack of Efficacy|1|||
156768001|NCT01326871|565906430|FG002|Overall Study|DLT|0|||
156323421|NCT00473746|564282455|FG003|Period 2 (Phase 2)|Reason not specified|0|||
156323422|NCT00473746|564282456|FG004|Period 2 (Phase 2)|Reason not specified|3|||
156323423|NCT00495131|564282457|FG000|Overall Study|Adverse Event|6|||
156323424|NCT00495131|564282458|FG001|Overall Study|Adverse Event|2|||
156768002|NCT01326871|565906428|FG000|Overall Study|SAE, disease progression and subject decision|0|||
156768003|NCT01326871|565906429|FG001|Overall Study|SAE, disease progression and subject decision|1|||
156768004|NCT01326871|565906430|FG002|Overall Study|SAE, disease progression and subject decision|0|||
156768005|NCT01326871|565906428|FG000|Overall Study|Death|0|||
156768006|NCT01326871|565906429|FG001|Overall Study|Death|1|||
156768007|NCT01326871|565906430|FG002|Overall Study|Death|0|||
156768008|NCT01326871|565906428|FG000|Overall Study|Other|0|||
156768009|NCT01326871|565906429|FG001|Overall Study|Other|3|||
156768010|NCT01326871|565906430|FG002|Overall Study|Other|0|||
156768011|NCT01326871|565906428|FG000|Overall Study|SAE and disease progression|0|||
156768012|NCT01326871|565906429|FG001|Overall Study|SAE and disease progression|0|||
156768013|NCT01326871|565906430|FG002|Overall Study|SAE and disease progression|1|||
156768014|NCT01326871|565906428|FG000|Overall Study|SAE and physician decision|0|||
156768015|NCT01326871|565906429|FG001|Overall Study|SAE and physician decision|0|||
156768016|NCT01326871|565906430|FG002|Overall Study|SAE and physician decision|1|||
156768017|NCT01326871|565906428|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
156768018|NCT01326871|565906429|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
156768019|NCT01326871|565906430|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
156768020|NCT01326871|565906428|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
156768021|NCT01326871|565906429|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
156768022|NCT01326871|565906430|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
156768023|NCT01326871|565906428|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
156768024|NCT01326871|565906429|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
156768025|NCT01326871|565906430|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
156768026|NCT01326871|565906428|FG000|Overall Study|Physician Decision|0|||
156768027|NCT01326871|565906429|FG001|Overall Study|Physician Decision|0|||
156768028|NCT01326871|565906430|FG002|Overall Study|Physician Decision|1|||
156768029|NCT01326871|565906428|FG000|Overall Study|SAE|0|||
156768030|NCT01326871|565906429|FG001|Overall Study|SAE|0|||
156768031|NCT01326871|565906430|FG002|Overall Study|SAE|1|||
156768032|NCT01326871|565906428|FG000|Overall Study|Disease progression and death|0|||
156768033|NCT01326871|565906429|FG001|Overall Study|Disease progression and death|0|||
156768034|NCT01326871|565906430|FG002|Overall Study|Disease progression and death|1|||
156768035|NCT01326871|565906428|FG000|Overall Study|Subject decision|0|||
156768036|NCT01326871|565906429|FG001|Overall Study|Subject decision|0|||
156768037|NCT01326871|565906430|FG002|Overall Study|Subject decision|1|||
156768038|NCT01387269|565906434|FG000|Overall Study|Death|38|||
156768039|NCT01387269|565906435|FG001|Overall Study|Death|20|||
156768040|NCT01387269|565906434|FG000|Overall Study|Other|8|||
156768041|NCT01387269|565906435|FG001|Overall Study|Other|7|||
156768042|NCT01387269|565906434|FG000|Overall Study|Unrelated AE|12|||
156768043|NCT01387269|565906435|FG001|Overall Study|Unrelated AE|3|||
156768044|NCT01387269|565906434|FG000|Overall Study|Withdrawal by patient|32|||
156768045|NCT01387269|565906435|FG001|Overall Study|Withdrawal by patient|10|||
156768046|NCT01387269|565906434|FG000|Overall Study|Study drug-related AE|1|||
156768047|NCT01387269|565906435|FG001|Overall Study|Study drug-related AE|0|||
156768048|NCT01387269|565906434|FG000|Overall Study|Lost to Follow-up|1|||
156768049|NCT01387269|565906435|FG001|Overall Study|Lost to Follow-up|0|||
156323425|NCT00495131|564282457|FG000|Overall Study|Lack of Efficacy|0|||
156323426|NCT00495131|564282458|FG001|Overall Study|Lack of Efficacy|2|||
156323427|NCT00495131|564282457|FG000|Overall Study|Lost to Follow-up|0|||
156323428|NCT00495131|564282458|FG001|Overall Study|Lost to Follow-up|2|||
156323429|NCT00495131|564282457|FG000|Overall Study|Withdrawal by Subject|1|||
156323430|NCT00495131|564282458|FG001|Overall Study|Withdrawal by Subject|0|||
156323431|NCT01280955|564282459|FG000|Overall Study|Death|2|||
156323432|NCT01280955|564282459|FG000|Overall Study|Withdrawal by Subject|1|||
156323433|NCT00976573|564282466|FG000|Overall Study|Ineligible|0|||
156323434|NCT00976573|564282467|FG001|Overall Study|Ineligible|1|||
156323435|NCT00976573|564282466|FG000|Overall Study|Cancel prior to receiving treatment|4|||
156323436|NCT00976573|564282467|FG001|Overall Study|Cancel prior to receiving treatment|2|||
156323437|NCT02117427|564282468|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
156323438|NCT02117427|564282469|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
156323439|NCT02117427|564282470|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
156323440|NCT02117427|564282468|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
156522574|NCT03184870|565007734|FG004|Crossover Treatment|Death|0|||
156522575|NCT03184870|565007735|FG005|Crossover Treatment|Death|0|||
156768050|NCT01200329|565906436|FG000|Overall Study|Lack of financial coverage|2|||
156768051|NCT01200329|565906436|FG000|Overall Study|Progressive disease|1|||
156768052|NCT02230891|565906441|FG000|Baseline|Did not meet inclusion|0|||
156768053|NCT02230891|565906442|FG001|Baseline|Did not meet inclusion|1|||
156768054|NCT02230891|565906443|FG002|Baseline|Did not meet inclusion|1|||
156768055|NCT02230891|565906441|FG000|2 Week|Withdrawal by Subject|2|||
156768056|NCT02230891|565906442|FG001|2 Week|Withdrawal by Subject|2|||
156768057|NCT02230891|565906443|FG002|2 Week|Withdrawal by Subject|0|||
156768058|NCT02230891|565906441|FG000|2 Week|Consent withdrawn|1|||
156768059|NCT02230891|565906442|FG001|2 Week|Consent withdrawn|0|||
156768060|NCT02230891|565906443|FG002|2 Week|Consent withdrawn|0|||
156768061|NCT02230891|565906441|FG000|6 Month|Withdrawal by Subject|1|||
156768062|NCT02230891|565906442|FG001|6 Month|Withdrawal by Subject|1|||
156768063|NCT02230891|565906443|FG002|6 Month|Withdrawal by Subject|1|||
156768064|NCT02230891|565906441|FG000|6 Month|Physician Decision|0|||
156768065|NCT02230891|565906442|FG001|6 Month|Physician Decision|2|||
156768066|NCT02230891|565906443|FG002|6 Month|Physician Decision|0|||
156768067|NCT02230891|565906441|FG000|12 Month|Death|1|||
156768068|NCT02230891|565906442|FG001|12 Month|Death|0|||
156768069|NCT02230891|565906443|FG002|12 Month|Death|0|||
156768070|NCT02230891|565906441|FG000|12 Month|Lost to Follow-up|0|||
156768071|NCT02230891|565906442|FG001|12 Month|Lost to Follow-up|1|||
156768072|NCT02230891|565906443|FG002|12 Month|Lost to Follow-up|0|||
156768073|NCT02230891|565906441|FG000|12 Month|Withdrawal by Subject|0|||
156768074|NCT02230891|565906442|FG001|12 Month|Withdrawal by Subject|2|||
156768075|NCT02230891|565906443|FG002|12 Month|Withdrawal by Subject|0|||
156768076|NCT02230891|565906441|FG000|18 Month End of Study|Death|0|||
156768077|NCT02230891|565906442|FG001|18 Month End of Study|Death|0|||
156768078|NCT02230891|565906443|FG002|18 Month End of Study|Death|1|||
156768079|NCT02230891|565906441|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
156768080|NCT02230891|565906442|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
156768081|NCT02230891|565906443|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
156768082|NCT00921024|565906448|FG000|Overall Study|Lost to Follow-up|2|||
156768083|NCT00921024|565906449|FG001|Overall Study|Lost to Follow-up|0|||
156768084|NCT00921024|565906448|FG000|Overall Study|Received concomittant therapy|2|||
156768085|NCT00921024|565906449|FG001|Overall Study|Received concomittant therapy|0|||
156768086|NCT00921024|565906448|FG000|Overall Study|Withdrawal by Subject|0|||
156768087|NCT00921024|565906449|FG001|Overall Study|Withdrawal by Subject|3|||
156768088|NCT04158219|565906454|FG000|Overall Study|Lost to Follow-up|1|||
156768089|NCT01814007|565906455|FG000|Overall Study|Withdrawal by Subject|1|||
156768090|NCT01324947|565906457|FG000|Overall Study|Adverse Event|7|||
156768091|NCT01324947|565906457|FG000|Overall Study|Death|10|||
156768092|NCT01324947|565906457|FG000|Overall Study|Other|3|||
156768093|NCT01324947|565906457|FG000|Overall Study|Progressive Disease|50|||
156768094|NCT01324947|565906457|FG000|Overall Study|Withdrawal by Subject|3|||
156522576|NCT03184870|565007736|FG006|Crossover Treatment|Death|0|||
156768095|NCT01324947|565906457|FG000|Overall Study|1 discontinued before starting drug|1|||
156768096|NCT01274351|565906458|FG000|Overall Study|Lost to Follow-up|1|||
156768097|NCT01274351|565906458|FG000|Overall Study|patient not compliant with the protocol|1|||
156768098|NCT01274351|565906458|FG000|Overall Study|Pregnancy|1|||
156768099|NCT01274351|565906458|FG000|Overall Study|Death|2|||
156768100|NCT01274351|565906458|FG000|Overall Study|Withdrawal by Subject|3|||
156768101|NCT01274351|565906458|FG000|Overall Study|Adverse Event|8|||
156768102|NCT01274351|565906458|FG000|Overall Study|progression of disease|3|||
156768103|NCT01274351|565906458|FG000|Overall Study|hospitalization|1|||
156768104|NCT01296412|565906461|FG000|Overall Study|Adverse Event|8|||
156768105|NCT01296412|565906462|FG001|Overall Study|Adverse Event|29|||
156768106|NCT01296412|565906461|FG000|Overall Study|Lack of Efficacy|1|||
156768107|NCT01296412|565906462|FG001|Overall Study|Lack of Efficacy|0|||
156768108|NCT01296412|565906461|FG000|Overall Study|Lost to Follow-up|10|||
156768109|NCT01296412|565906462|FG001|Overall Study|Lost to Follow-up|7|||
156768110|NCT01296412|565906461|FG000|Overall Study|Non-compliance with study drug|1|||
156768111|NCT01296412|565906462|FG001|Overall Study|Non-compliance with study drug|2|||
156768112|NCT01296412|565906461|FG000|Overall Study|Other reason not specified|20|||
156768113|NCT01296412|565906462|FG001|Overall Study|Other reason not specified|15|||
156768114|NCT01296412|565906461|FG000|Overall Study|Physician Decision|1|||
156768115|NCT01296412|565906462|FG001|Overall Study|Physician Decision|3|||
156768116|NCT01296412|565906461|FG000|Overall Study|Pregnancy|0|||
156768117|NCT01296412|565906462|FG001|Overall Study|Pregnancy|1|||
156768118|NCT01296412|565906461|FG000|Overall Study|Withdrawal by Subject|10|||
156768119|NCT01296412|565906462|FG001|Overall Study|Withdrawal by Subject|13|||
156768120|NCT02160626|565906463|FG000|Overall Study|Adverse Event|1|||
156768121|NCT02160626|565906464|FG001|Overall Study|Adverse Event|0|||
156768122|NCT02160626|565906465|FG002|Overall Study|Adverse Event|0|||
156768123|NCT02160626|565906463|FG000|Overall Study|Schedule not conducive to study visits|0|||
156768124|NCT02160626|565906464|FG001|Overall Study|Schedule not conducive to study visits|0|||
156768125|NCT02160626|565906465|FG002|Overall Study|Schedule not conducive to study visits|1|||
156768126|NCT02160626|565906463|FG000|Overall Study|Withdrawal by Subject|0|||
156768127|NCT02160626|565906464|FG001|Overall Study|Withdrawal by Subject|1|||
156768128|NCT02160626|565906465|FG002|Overall Study|Withdrawal by Subject|0|||
156768129|NCT04194814|565906469|FG000|Overall Study|Physician Decision|3|||
156768130|NCT04194814|565906470|FG001|Overall Study|Physician Decision|0|||
156768131|NCT04194814|565906469|FG000|Overall Study|Withdrawal by Subject|0|||
156522577|NCT03184870|565007737|FG007|Crossover Treatment|Death|0|||
156768132|NCT04194814|565906470|FG001|Overall Study|Withdrawal by Subject|2|||
156768133|NCT00959751|565908376|FG000|Overall Study|Lost to Follow-up|2|||
156768134|NCT00959751|565908377|FG001|Overall Study|Lost to Follow-up|3|||
156768135|NCT00959751|565908376|FG000|Overall Study|Consent Withdrawn|0|||
156768136|NCT00959751|565908377|FG001|Overall Study|Consent Withdrawn|1|||
156768137|NCT00959751|565908376|FG000|Overall Study|Non-compliance to Study Procedures|0|||
156768138|NCT00959751|565908377|FG001|Overall Study|Non-compliance to Study Procedures|1|||
156768139|NCT00959751|565908376|FG000|Overall Study|No migraine headache without aura|7|||
156768140|NCT00959751|565908377|FG001|Overall Study|No migraine headache without aura|7|||
156768141|NCT03737994|565908378|FG000|Overall Study|Withdrawal by Subject|0|||
156768142|NCT03737994|565908379|FG001|Overall Study|Withdrawal by Subject|0|||
156768143|NCT03737994|565908380|FG002|Overall Study|Withdrawal by Subject|0|||
156768144|NCT03737994|565908381|FG003|Overall Study|Withdrawal by Subject|0|||
156768145|NCT03737994|565908382|FG004|Overall Study|Withdrawal by Subject|0|||
156768146|NCT03737994|565908383|FG005|Overall Study|Withdrawal by Subject|0|||
156768147|NCT03737994|565908384|FG006|Overall Study|Withdrawal by Subject|1|||
156768148|NCT03861039|565908387|FG000|Overall Study|Adverse Event|2|||
156768149|NCT03861039|565908388|FG001|Overall Study|Adverse Event|5|||
156768150|NCT03861039|565908389|FG002|Overall Study|Adverse Event|11|||
156768151|NCT03861039|565908387|FG000|Overall Study|Withdrawal by Subject|1|||
156768152|NCT03861039|565908388|FG001|Overall Study|Withdrawal by Subject|3|||
156768153|NCT03861039|565908389|FG002|Overall Study|Withdrawal by Subject|4|||
156768154|NCT03427892|565908390|FG000|Overall Study|Lost to Follow-up|2|||
156768155|NCT03255187|565908391|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
156768156|NCT03255187|565908392|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
156768157|NCT03255187|565908391|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
156768158|NCT03255187|565908392|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
156768159|NCT03617588|565908399|FG000|Overall Study|Withdrawal by Subject|1|||
156768160|NCT03617588|565908400|FG001|Overall Study|Withdrawal by Subject|0|||
156768161|NCT02419807|565908401|FG000|Overall Study|Withdrawal by Subject|4|||
156768162|NCT02419807|565908401|FG000|Overall Study|Physician Decision|1|||
156768163|NCT02419807|565908401|FG000|Overall Study|Protocol Violation|5|||
156768164|NCT01006629|565908402|FG000|Overall Study|Adverse Event|1|||
156768165|NCT01006629|565908402|FG000|Overall Study|Parent refused to continue participation|1|||
156768166|NCT01006629|565908402|FG000|Overall Study|Parent unable to perform site visit|4|||
156768167|NCT01499511|565908403|FG000|Overall Study|Death|1|||
156768168|NCT01499511|565908404|FG001|Overall Study|Death|0|||
156768169|NCT01065818|565908406|FG000|Overall Study|Withdrawal by Subject|1|||
156768170|NCT01065818|565908406|FG000|Overall Study|Not a candidate for surgery|1|||
156768171|NCT04459338|565908409|FG000|Overall Study|Loss of IV during study|1|||
156768172|NCT04459338|565908410|FG001|Overall Study|Loss of IV during study|0|||
156768173|NCT03157089|565908411|FG000|Overall Study|Treated only with pembrolizumab|1|||
156768174|NCT03157089|565908412|FG001|Overall Study|Treated only with pembrolizumab|0|||
156768175|NCT03157089|565908411|FG000|Overall Study|Adverse Event|5|||
156768176|NCT03157089|565908412|FG001|Overall Study|Adverse Event|4|||
156768177|NCT03157089|565908411|FG000|Overall Study|Progressive disease|6|||
156768178|NCT03157089|565908412|FG001|Overall Study|Progressive disease|8|||
156768179|NCT00784875|565908413|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
156768180|NCT00784875|565908414|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
156768181|NCT00784875|565908415|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
156768182|NCT00784875|565908416|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
156768183|NCT00784875|565908413|FG000|Period A - Baseline|Adverse Event|0|||
156768184|NCT00784875|565908414|FG001|Period A - Baseline|Adverse Event|0|||
156768185|NCT00784875|565908415|FG002|Period A - Baseline|Adverse Event|0|||
156768186|NCT00784875|565908416|FG003|Period A - Baseline|Adverse Event|8|||
156768187|NCT00784875|565908413|FG000|Period A - Baseline|Protocol Violation|0|||
156768188|NCT00784875|565908414|FG001|Period A - Baseline|Protocol Violation|0|||
156768189|NCT00784875|565908415|FG002|Period A - Baseline|Protocol Violation|0|||
156768190|NCT00784875|565908416|FG003|Period A - Baseline|Protocol Violation|25|||
156768191|NCT00784875|565908413|FG000|Period A - Baseline|Withdrawal by Subject|0|||
156768192|NCT00784875|565908414|FG001|Period A - Baseline|Withdrawal by Subject|0|||
156768193|NCT00784875|565908415|FG002|Period A - Baseline|Withdrawal by Subject|0|||
156768194|NCT00784875|565908416|FG003|Period A - Baseline|Withdrawal by Subject|27|||
156768195|NCT00784875|565908413|FG000|Period A - Baseline|Physician Decision|0|||
156768196|NCT00784875|565908414|FG001|Period A - Baseline|Physician Decision|0|||
156768197|NCT00784875|565908415|FG002|Period A - Baseline|Physician Decision|0|||
156768198|NCT00784875|565908416|FG003|Period A - Baseline|Physician Decision|2|||
156768199|NCT00784875|565908413|FG000|Period A - Baseline|Sponsor Decision|0|||
156768200|NCT00784875|565908414|FG001|Period A - Baseline|Sponsor Decision|0|||
156768201|NCT00784875|565908415|FG002|Period A - Baseline|Sponsor Decision|0|||
156768202|NCT00784875|565908416|FG003|Period A - Baseline|Sponsor Decision|113|||
156768203|NCT00784875|565908413|FG000|Period A - Baseline|Lost to Follow-up|0|||
156768204|NCT00784875|565908414|FG001|Period A - Baseline|Lost to Follow-up|0|||
156427453|NCT01693614|564658751|FG001|Overall Study|Withdrawal by subject/guardian|0|||
156768205|NCT00784875|565908415|FG002|Period A - Baseline|Lost to Follow-up|0|||
156768206|NCT00784875|565908416|FG003|Period A - Baseline|Lost to Follow-up|2|||
156768207|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
156768208|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
156768209|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
156768210|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
156768211|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
156768212|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
156768213|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
156768214|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
156768215|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
156768216|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
156768217|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
156323441|NCT02117427|564282469|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
156323442|NCT02117427|564282470|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
156323443|NCT02117427|564282468|FG000|Overall Study|Physician Decision|0|||
156323444|NCT02117427|564282469|FG001|Overall Study|Physician Decision|2|||
156323445|NCT02117427|564282470|FG002|Overall Study|Physician Decision|0|||
156323446|NCT02117427|564282468|FG000|Overall Study|No longer meets inclusion criteria|0|||
156323447|NCT02117427|564282469|FG001|Overall Study|No longer meets inclusion criteria|1|||
156323448|NCT02117427|564282470|FG002|Overall Study|No longer meets inclusion criteria|0|||
156323449|NCT02117427|564282468|FG000|Overall Study|Death|0|||
156323450|NCT02117427|564282469|FG001|Overall Study|Death|1|||
156323451|NCT02117427|564282470|FG002|Overall Study|Death|0|||
156323452|NCT02730208|564282471|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156323453|NCT02730208|564282472|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
156323454|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
156323455|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
156323456|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
156323457|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
156323458|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
156323459|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
156323460|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
156323461|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
156323462|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
156323463|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
156323464|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
156323465|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
156323466|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
156323467|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
156323468|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
156323469|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
156323470|NCT00491556|564282490|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
156323471|NCT00491556|564282491|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
156323472|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
156323473|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
156323474|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
156323475|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
156323476|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
156323477|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
156323478|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
156323479|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
156323480|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
156323481|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
156323482|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
156323483|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
156323484|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
156323485|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
156323486|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
156323487|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
156323488|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
156323489|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
156323490|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
156323491|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
156323492|NCT00491556|564282490|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
156323493|NCT00491556|564282491|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
156323494|NCT02418156|564282492|FG000|Overall Study|Lost to Follow-up|12|||
156323495|NCT02418156|564282492|FG000|Overall Study|Death|2|||
156323496|NCT02418156|564282492|FG000|Overall Study|Physician Decision|1|||
156768218|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
156768219|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
156323497|NCT02418156|564282492|FG000|Overall Study|Withdrawal by Subject|1|||
156323498|NCT02418156|564282492|FG000|Overall Study|Subject refused to return|1|||
156323499|NCT01909453|564282493|FG000|Overall Study|Ongoing|118|||
156323500|NCT01909453|564282494|FG001|Overall Study|Ongoing|103|||
156323501|NCT01909453|564282495|FG002|Overall Study|Ongoing|83|||
156323502|NCT01909453|564282496|FG003|Overall Study|Ongoing|164|||
156323503|NCT01909453|564282497|FG004|Overall Study|Ongoing|50|||
156323504|NCT01909453|564282493|FG000|Overall Study|Death|69|||
156323505|NCT01909453|564282494|FG001|Overall Study|Death|74|||
156323506|NCT01909453|564282495|FG002|Overall Study|Death|88|||
156323507|NCT01909453|564282496|FG003|Overall Study|Death|86|||
156323508|NCT01909453|564282497|FG004|Overall Study|Death|29|||
156323509|NCT01909453|564282493|FG000|Overall Study|Lost to Follow-up|3|||
156323510|NCT01909453|564282494|FG001|Overall Study|Lost to Follow-up|4|||
156323511|NCT01909453|564282495|FG002|Overall Study|Lost to Follow-up|4|||
156323512|NCT01909453|564282496|FG003|Overall Study|Lost to Follow-up|3|||
156323513|NCT01909453|564282497|FG004|Overall Study|Lost to Follow-up|3|||
156323514|NCT01909453|564282493|FG000|Overall Study|Withdrawal by Subject|2|||
156323515|NCT01909453|564282494|FG001|Overall Study|Withdrawal by Subject|13|||
156323516|NCT01909453|564282495|FG002|Overall Study|Withdrawal by Subject|16|||
156323517|NCT01909453|564282496|FG003|Overall Study|Withdrawal by Subject|5|||
156323518|NCT01909453|564282497|FG004|Overall Study|Withdrawal by Subject|4|||
156323519|NCT03693170|564284186|FG000|Overall Study|Disease Progression|48|||
156323520|NCT03693170|564284186|FG000|Overall Study|Adverse Event|16|||
156323521|NCT03693170|564284186|FG000|Overall Study|Physician Decision|6|||
156323522|NCT03693170|564284186|FG000|Overall Study|Protocol Violation|2|||
156323523|NCT03693170|564284186|FG000|Overall Study|Death|1|||
156323524|NCT03693170|564284186|FG000|Overall Study|Non compliance with study drug|1|||
156323525|NCT03693170|564284186|FG000|Overall Study|Withdrawal by Subject|1|||
156323526|NCT04444895|564284187|FG000|Overall Study|Adverse Event|2|||
156323527|NCT04444895|564284187|FG000|Overall Study|Lost to Follow-up|2|||
156323528|NCT04444895|564284187|FG000|Overall Study|Withdrawal by Subject|5|||
156323529|NCT05523323|564284188|FG000|Overall Study|Death|26|||
156323530|NCT05523323|564284189|FG001|Overall Study|Death|21|||
156323531|NCT05523323|564284188|FG000|Overall Study|Ongoing participants|35|||
156323532|NCT05523323|564284189|FG001|Overall Study|Ongoing participants|30|||
156323533|NCT00920829|564284190|FG000|Allocation|No post randomization data|3|||
156323534|NCT00920829|564284191|FG001|Allocation|No post randomization data|1|||
156323535|NCT00920829|564284192|FG002|Allocation|No post randomization data|0|||
156323536|NCT00920829|564284193|FG003|Allocation|No post randomization data|2|||
156323537|NCT00920829|564284190|FG000|Available for Analysis|Withdrawal by Subject|6|||
156323538|NCT00920829|564284191|FG001|Available for Analysis|Withdrawal by Subject|6|||
156323539|NCT00920829|564284192|FG002|Available for Analysis|Withdrawal by Subject|6|||
156323540|NCT00920829|564284193|FG003|Available for Analysis|Withdrawal by Subject|10|||
156323541|NCT00920829|564284190|FG000|Available for Analysis|Required Medical Treatment|0|||
156323542|NCT00920829|564284191|FG001|Available for Analysis|Required Medical Treatment|1|||
156323543|NCT00920829|564284192|FG002|Available for Analysis|Required Medical Treatment|2|||
156323544|NCT00920829|564284193|FG003|Available for Analysis|Required Medical Treatment|0|||
156323545|NCT00920829|564284190|FG000|Available for Analysis|Adverse Event|1|||
156323546|NCT00920829|564284191|FG001|Available for Analysis|Adverse Event|2|||
156323547|NCT00920829|564284192|FG002|Available for Analysis|Adverse Event|1|||
156323548|NCT00920829|564284193|FG003|Available for Analysis|Adverse Event|0|||
156323549|NCT00920829|564284190|FG000|Available for Analysis|Death|1|||
156323550|NCT00920829|564284191|FG001|Available for Analysis|Death|0|||
156323551|NCT00920829|564284192|FG002|Available for Analysis|Death|0|||
156323552|NCT00920829|564284193|FG003|Available for Analysis|Death|0|||
156323553|NCT00920829|564284190|FG000|Available for Analysis|Protocol Violation|0|||
156323554|NCT00920829|564284191|FG001|Available for Analysis|Protocol Violation|0|||
156323555|NCT00920829|564284192|FG002|Available for Analysis|Protocol Violation|1|||
156323556|NCT00920829|564284193|FG003|Available for Analysis|Protocol Violation|0|||
156323557|NCT00920829|564284190|FG000|Available for Analysis|Required more treatment|0|||
156323558|NCT00920829|564284191|FG001|Available for Analysis|Required more treatment|2|||
156323559|NCT00920829|564284192|FG002|Available for Analysis|Required more treatment|0|||
156323560|NCT00920829|564284193|FG003|Available for Analysis|Required more treatment|1|||
156323561|NCT00053365|564284196|FG000|Overall Study|Incorrect cell type|1|||
156323562|NCT00053365|564284196|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
156323563|NCT00053365|564284196|FG000|Overall Study|Never treated|4|||
156323564|NCT02423109|564284205|FG000|Lens 1|Adverse Event|1|||
156323565|NCT02423109|564284206|FG001|Lens 1|Adverse Event|0|||
156323566|NCT03347188|564284207|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
156323567|NCT03347188|564284208|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
156323568|NCT03347188|564284207|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
156323569|NCT03347188|564284208|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
156323570|NCT03347188|564284207|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
156323571|NCT03347188|564284208|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
156323572|NCT03347188|564284207|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
156323573|NCT03347188|564284208|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
156323574|NCT03347188|564284207|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
156768220|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
156768221|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
156768222|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
156768223|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
156768224|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
156768225|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
156768226|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
156768227|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
156768228|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
156768229|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
156768230|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
156768231|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
156768232|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
156768233|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
156768234|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
156768235|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
156768236|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
156768237|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
156768238|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
156768239|NCT00784875|565908413|FG000|Period C|Adverse Event|1|||
156768240|NCT00784875|565908414|FG001|Period C|Adverse Event|0|||
156768241|NCT00784875|565908415|FG002|Period C|Adverse Event|4|||
156768242|NCT00784875|565908416|FG003|Period C|Adverse Event|2|||
156768243|NCT00784875|565908413|FG000|Period C|Protocol Violation|0|||
156768244|NCT00784875|565908414|FG001|Period C|Protocol Violation|0|||
156768245|NCT00784875|565908415|FG002|Period C|Protocol Violation|1|||
156768246|NCT00784875|565908416|FG003|Period C|Protocol Violation|2|||
156768247|NCT00784875|565908413|FG000|Period C|Lack of Efficacy|0|||
156768248|NCT00784875|565908414|FG001|Period C|Lack of Efficacy|0|||
156768249|NCT00784875|565908415|FG002|Period C|Lack of Efficacy|1|||
156768250|NCT00784875|565908416|FG003|Period C|Lack of Efficacy|0|||
156768251|NCT00784875|565908413|FG000|Period C|Withdrawal by Subject|1|||
156768252|NCT00784875|565908414|FG001|Period C|Withdrawal by Subject|1|||
156768253|NCT00784875|565908415|FG002|Period C|Withdrawal by Subject|2|||
156768254|NCT00784875|565908416|FG003|Period C|Withdrawal by Subject|0|||
156768255|NCT00784875|565908413|FG000|Period C|Physician Decision|0|||
156768256|NCT00784875|565908414|FG001|Period C|Physician Decision|0|||
156768257|NCT00784875|565908415|FG002|Period C|Physician Decision|1|||
156768258|NCT00784875|565908416|FG003|Period C|Physician Decision|1|||
156768259|NCT00784875|565908413|FG000|Period C|Sponsor Decision|5|||
156768260|NCT00784875|565908414|FG001|Period C|Sponsor Decision|5|||
156768261|NCT00784875|565908415|FG002|Period C|Sponsor Decision|4|||
156768262|NCT00784875|565908416|FG003|Period C|Sponsor Decision|2|||
156768263|NCT00784875|565908413|FG000|Period D|Adverse Event|0|||
156768264|NCT00784875|565908414|FG001|Period D|Adverse Event|2|||
156768265|NCT00784875|565908415|FG002|Period D|Adverse Event|2|||
156768266|NCT00784875|565908416|FG003|Period D|Adverse Event|0|||
156768267|NCT00784875|565908413|FG000|Period D|Protocol Violation|1|||
156768268|NCT00784875|565908414|FG001|Period D|Protocol Violation|0|||
156768269|NCT00784875|565908415|FG002|Period D|Protocol Violation|0|||
156768270|NCT00784875|565908416|FG003|Period D|Protocol Violation|0|||
156323575|NCT03347188|564284208|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
156323576|NCT03347188|564284207|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
156323577|NCT03347188|564284208|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
156323578|NCT03347188|564284207|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
156323579|NCT03347188|564284208|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
156323580|NCT03347188|564284207|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
156323581|NCT03347188|564284208|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
156323582|NCT03489551|564284209|FG000|Overall Study|Withdrawal by Subject|2|||
156323583|NCT03139604|564284210|FG000|Overall Study|Other|7|||
156323584|NCT03139604|564284211|FG001|Overall Study|Other|3|||
156768271|NCT00784875|565908413|FG000|Period D|Withdrawal by Subject|2|||
156768272|NCT00784875|565908414|FG001|Period D|Withdrawal by Subject|0|||
156768273|NCT00784875|565908415|FG002|Period D|Withdrawal by Subject|2|||
156768274|NCT00784875|565908416|FG003|Period D|Withdrawal by Subject|0|||
156768275|NCT00784875|565908413|FG000|Period D|Physician Decision|0|||
156768276|NCT00784875|565908414|FG001|Period D|Physician Decision|1|||
156768277|NCT00784875|565908415|FG002|Period D|Physician Decision|0|||
156768278|NCT00784875|565908416|FG003|Period D|Physician Decision|0|||
156768279|NCT00784875|565908413|FG000|Period D|Sponsor Decision|1|||
156768280|NCT00784875|565908414|FG001|Period D|Sponsor Decision|1|||
156768281|NCT00784875|565908415|FG002|Period D|Sponsor Decision|1|||
156768282|NCT00784875|565908416|FG003|Period D|Sponsor Decision|0|||
156768283|NCT00784875|565908413|FG000|Period D|Lost to Follow-up|1|||
156768284|NCT00784875|565908414|FG001|Period D|Lost to Follow-up|0|||
156768285|NCT00784875|565908415|FG002|Period D|Lost to Follow-up|1|||
156768286|NCT00784875|565908416|FG003|Period D|Lost to Follow-up|1|||
156768287|NCT00958074|565908417|FG000|Overall Study|Withdrawal by Subject|0|||
156768288|NCT00958074|565908418|FG001|Overall Study|Withdrawal by Subject|1|||
156768289|NCT00853385|565908419|FG000|Overall Study|Death|0|||
156768290|NCT00853385|565908420|FG001|Overall Study|Death|0|||
156768291|NCT00853385|565908421|FG002|Overall Study|Death|0|||
156768292|NCT00853385|565908422|FG003|Overall Study|Death|0|||
156768293|NCT00853385|565908423|FG004|Overall Study|Death|1|||
156768294|NCT00853385|565908419|FG000|Overall Study|Adverse Event|24|||
156768295|NCT00853385|565908420|FG001|Overall Study|Adverse Event|24|||
156768296|NCT00853385|565908421|FG002|Overall Study|Adverse Event|2|||
156768297|NCT00853385|565908422|FG003|Overall Study|Adverse Event|5|||
156768298|NCT00853385|565908423|FG004|Overall Study|Adverse Event|22|||
156768299|NCT00853385|565908419|FG000|Overall Study|Lack of Efficacy|6|||
156768300|NCT00853385|565908420|FG001|Overall Study|Lack of Efficacy|7|||
156768301|NCT00853385|565908421|FG002|Overall Study|Lack of Efficacy|3|||
156768302|NCT00853385|565908422|FG003|Overall Study|Lack of Efficacy|3|||
156768303|NCT00853385|565908423|FG004|Overall Study|Lack of Efficacy|6|||
156768304|NCT00853385|565908419|FG000|Overall Study|Lost to Follow-up|2|||
156768305|NCT00853385|565908420|FG001|Overall Study|Lost to Follow-up|1|||
156768306|NCT00853385|565908421|FG002|Overall Study|Lost to Follow-up|0|||
156768307|NCT00853385|565908422|FG003|Overall Study|Lost to Follow-up|0|||
156768308|NCT00853385|565908423|FG004|Overall Study|Lost to Follow-up|0|||
156768309|NCT00853385|565908419|FG000|Overall Study|Withdrawal by Subject|4|||
156768310|NCT00853385|565908420|FG001|Overall Study|Withdrawal by Subject|2|||
156768311|NCT00853385|565908421|FG002|Overall Study|Withdrawal by Subject|0|||
156768312|NCT00853385|565908422|FG003|Overall Study|Withdrawal by Subject|1|||
156768313|NCT00853385|565908423|FG004|Overall Study|Withdrawal by Subject|1|||
156768314|NCT00853385|565908419|FG000|Overall Study|Other|18|||
156768315|NCT00853385|565908420|FG001|Overall Study|Other|9|||
156768316|NCT00853385|565908421|FG002|Overall Study|Other|4|||
156768317|NCT00853385|565908422|FG003|Overall Study|Other|4|||
156768318|NCT00853385|565908423|FG004|Overall Study|Other|12|||
156768319|NCT00941928|565908424|FG000|Overall Study|Withdrawal by Subject|1|||
156768320|NCT00941928|565908424|FG000|Overall Study|Disease Progression|1|||
156768321|NCT02300610|565908429|FG000|Overall Study|Withdrawal by Subject|1|||
156768322|NCT02300610|565908430|FG001|Overall Study|Withdrawal by Subject|0|||
156768323|NCT02300610|565908431|FG002|Overall Study|Withdrawal by Subject|1|||
156768324|NCT00095979|565908432|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
156768325|NCT01829347|565908433|FG000|VTI-210|Death|5|||
156768326|NCT01829347|565908434|FG001|VTI-210|Death|3|||
156768327|NCT01829347|565908433|FG000|VTI-210|Withdrawal by Subject|1|||
156768328|NCT01829347|565908434|FG001|VTI-210|Withdrawal by Subject|0|||
156768329|NCT01829347|565908433|FG000|VTI-210E|Death|2|||
156768330|NCT01829347|565908434|FG001|VTI-210E|Death|1|||
156768331|NCT01829347|565908433|FG000|VTI-210E|Study terminated prematurely|1|||
156768332|NCT01829347|565908434|FG001|VTI-210E|Study terminated prematurely|5|||
156768333|NCT02051296|565908437|FG000|Overall Study|Lost to Follow-up|1|||
156768334|NCT02051296|565908438|FG001|Overall Study|Lost to Follow-up|2|||
156768335|NCT02051296|565908437|FG000|Overall Study|withdraw prior to treatment|7|||
156768336|NCT02051296|565908438|FG001|Overall Study|withdraw prior to treatment|7|||
156768337|NCT02515227|565908439|FG000|Overall Study|Adverse Event|0|||
156768338|NCT02515227|565908440|FG001|Overall Study|Adverse Event|2|||
156768339|NCT02515227|565908439|FG000|Overall Study|Progressive disease|2|||
156768340|NCT02515227|565908440|FG001|Overall Study|Progressive disease|9|||
156768341|NCT03451071|565908447|FG000|First Vaccine|Withdrawal by Subject|1|||
156768342|NCT03451071|565908447|FG000|Second Vaccine|Lost to Follow-up|19|||
156768343|NCT03451071|565908447|FG000|Third Vaccine|Lost to Follow-up|22|||
156768344|NCT03451071|565908447|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
156768345|NCT01027845|565908452|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
156768346|NCT01027845|565908453|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
156768347|NCT01027845|565908454|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
156768348|NCT01027845|565908455|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
156768349|NCT01027845|565908452|FG000|Primary Vaccination Phase|Adverse Event|1|||
156768350|NCT01027845|565908453|FG001|Primary Vaccination Phase|Adverse Event|0|||
156768351|NCT01027845|565908454|FG002|Primary Vaccination Phase|Adverse Event|0|||
156768352|NCT01027845|565908455|FG003|Primary Vaccination Phase|Adverse Event|0|||
156768353|NCT01027845|565908452|FG000|Primary Vaccination Phase|Protocol Violation|1|||
156768354|NCT01027845|565908453|FG001|Primary Vaccination Phase|Protocol Violation|0|||
156768355|NCT01027845|565908454|FG002|Primary Vaccination Phase|Protocol Violation|0|||
156768356|NCT01027845|565908455|FG003|Primary Vaccination Phase|Protocol Violation|0|||
156768357|NCT01027845|565908452|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
156768358|NCT01027845|565908453|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
156768359|NCT01027845|565908454|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
156768360|NCT01027845|565908455|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
156768361|NCT01027845|565908452|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
156768362|NCT01027845|565908453|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
156768363|NCT01027845|565908454|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
156768364|NCT01027845|565908455|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
156768365|NCT01027845|565908452|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
156768366|NCT01027845|565908453|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
156768367|NCT01027845|565908454|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
156768368|NCT01027845|565908455|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
156768369|NCT01670292|565908456|FG000|Overall Study|Lost to Follow-up|14|||
156768370|NCT04142242|565908458|FG000|Stage I|Non-compliance with the protocol|1|||
156768371|NCT04142242|565908459|FG001|Stage I|Non-compliance with the protocol|0|||
156768372|NCT04142242|565908460|FG002|Stage I|Non-compliance with the protocol|0|||
156768373|NCT04142242|565908461|FG003|Stage I|Non-compliance with the protocol|0|||
156768374|NCT04142242|565908462|FG004|Stage I|Non-compliance with the protocol|0|||
156768375|NCT04142242|565908463|FG005|Stage I|Non-compliance with the protocol|1|||
156768376|NCT04142242|565908458|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768377|NCT04142242|565908459|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
156768378|NCT04142242|565908460|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768379|NCT04142242|565908461|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768380|NCT04142242|565908462|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768381|NCT04142242|565908463|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768382|NCT04142242|565908458|FG000|Stage II|Non-compliance with the protocol|0|||
156768383|NCT04142242|565908459|FG001|Stage II|Non-compliance with the protocol|0|||
156768384|NCT04142242|565908460|FG002|Stage II|Non-compliance with the protocol|0|||
156768385|NCT04142242|565908461|FG003|Stage II|Non-compliance with the protocol|2|||
156768386|NCT04142242|565908462|FG004|Stage II|Non-compliance with the protocol|0|||
156768387|NCT04142242|565908463|FG005|Stage II|Non-compliance with the protocol|0|||
156768388|NCT04142242|565908458|FG000|Stage II|Lost to Follow-up|0|||
156768389|NCT04142242|565908459|FG001|Stage II|Lost to Follow-up|0|||
156768390|NCT04142242|565908460|FG002|Stage II|Lost to Follow-up|1|||
156768391|NCT04142242|565908461|FG003|Stage II|Lost to Follow-up|2|||
156768392|NCT04142242|565908462|FG004|Stage II|Lost to Follow-up|0|||
156768393|NCT04142242|565908463|FG005|Stage II|Lost to Follow-up|0|||
156768394|NCT04142242|565908458|FG000|Stage II|Withdrawal by Subject|0|||
156768395|NCT04142242|565908459|FG001|Stage II|Withdrawal by Subject|0|||
156768396|NCT04142242|565908460|FG002|Stage II|Withdrawal by Subject|5|||
156768397|NCT04142242|565908461|FG003|Stage II|Withdrawal by Subject|9|||
156768398|NCT04142242|565908462|FG004|Stage II|Withdrawal by Subject|0|||
156768399|NCT04142242|565908463|FG005|Stage II|Withdrawal by Subject|0|||
156768400|NCT00846053|565908466|FG000|Overall Study|Physician Decision|3|||
156768401|NCT00846053|565908467|FG001|Overall Study|Physician Decision|0|||
156768402|NCT02475369|565908474|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
156768403|NCT02475369|565908475|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
156768404|NCT04798027|565908484|FG000|Overall Study|Protocol Violation|0|||
156768405|NCT04798027|565908485|FG001|Overall Study|Protocol Violation|0|||
156768406|NCT04798027|565908486|FG002|Overall Study|Protocol Violation|0|||
156768407|NCT04798027|565908487|FG003|Overall Study|Protocol Violation|0|||
156768408|NCT04798027|565908488|FG004|Overall Study|Protocol Violation|1|||
156768409|NCT04798027|565908489|FG005|Overall Study|Protocol Violation|0|||
156768410|NCT04798027|565908490|FG006|Overall Study|Protocol Violation|0|||
156768411|NCT04798027|565908491|FG007|Overall Study|Protocol Violation|1|||
156768412|NCT04798027|565908492|FG008|Overall Study|Protocol Violation|0|||
156768413|NCT04798027|565908484|FG000|Overall Study|Withdrawal by Subject|1|||
156768414|NCT04798027|565908485|FG001|Overall Study|Withdrawal by Subject|0|||
156768415|NCT04798027|565908486|FG002|Overall Study|Withdrawal by Subject|1|||
156768416|NCT04798027|565908487|FG003|Overall Study|Withdrawal by Subject|1|||
156768417|NCT04798027|565908488|FG004|Overall Study|Withdrawal by Subject|1|||
156768418|NCT04798027|565908489|FG005|Overall Study|Withdrawal by Subject|1|||
156768419|NCT04798027|565908490|FG006|Overall Study|Withdrawal by Subject|3|||
156768420|NCT04798027|565908491|FG007|Overall Study|Withdrawal by Subject|2|||
156768421|NCT04798027|565908492|FG008|Overall Study|Withdrawal by Subject|2|||
156768422|NCT04798027|565908484|FG000|Overall Study|Lost to Follow-up|1|||
156768423|NCT04798027|565908485|FG001|Overall Study|Lost to Follow-up|3|||
156768424|NCT04798027|565908486|FG002|Overall Study|Lost to Follow-up|0|||
156768425|NCT04798027|565908487|FG003|Overall Study|Lost to Follow-up|0|||
156768426|NCT04798027|565908488|FG004|Overall Study|Lost to Follow-up|0|||
156768427|NCT04798027|565908489|FG005|Overall Study|Lost to Follow-up|1|||
156768428|NCT04798027|565908490|FG006|Overall Study|Lost to Follow-up|0|||
156768429|NCT04798027|565908491|FG007|Overall Study|Lost to Follow-up|0|||
156768430|NCT04798027|565908492|FG008|Overall Study|Lost to Follow-up|1|||
156768431|NCT04798027|565908484|FG000|Overall Study|Withdrawal by Sponsor|8|||
156768432|NCT04798027|565908485|FG001|Overall Study|Withdrawal by Sponsor|22|||
156768433|NCT04798027|565908486|FG002|Overall Study|Withdrawal by Sponsor|9|||
156768434|NCT04798027|565908487|FG003|Overall Study|Withdrawal by Sponsor|26|||
156768435|NCT04798027|565908488|FG004|Overall Study|Withdrawal by Sponsor|24|||
156323585|NCT03139604|564284210|FG000|Overall Study|Withdrawal by Subject|16|||
156323586|NCT03139604|564284211|FG001|Overall Study|Withdrawal by Subject|17|||
156768436|NCT04798027|565908489|FG005|Overall Study|Withdrawal by Sponsor|11|||
156768437|NCT04798027|565908490|FG006|Overall Study|Withdrawal by Sponsor|25|||
156768438|NCT04798027|565908491|FG007|Overall Study|Withdrawal by Sponsor|26|||
156768439|NCT04798027|565908492|FG008|Overall Study|Withdrawal by Sponsor|11|||
156768440|NCT03210714|565908493|FG000|Overall Study|Adverse Event|6|||
156768441|NCT03210714|565908493|FG000|Overall Study|Physician Decision|1|||
156768442|NCT03210714|565908493|FG000|Overall Study|Progressive disease|11|||
156768443|NCT03210714|565908493|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
156768444|NCT00803179|565908494|FG000|Overall Study|Lost to Follow-up|3|||
156768445|NCT04158648|565908495|FG000|Overall Study|Ongoing in the Study|69|||
156768446|NCT04158648|565908495|FG000|Overall Study|Withdrawal by Subject|4|||
156768447|NCT02121210|565908496|FG000|Overall Study|Adverse Event|5|||
156768448|NCT02121210|565908497|FG001|Overall Study|Adverse Event|7|||
156768449|NCT02121210|565908496|FG000|Overall Study|Lack of Efficacy|2|||
156768450|NCT02121210|565908497|FG001|Overall Study|Lack of Efficacy|0|||
156768451|NCT02121210|565908496|FG000|Overall Study|Other than specified above|0|||
156768452|NCT02121210|565908497|FG001|Overall Study|Other than specified above|2|||
156768453|NCT04609514|565908498|FG000|Overall Study|Lost to Follow-up|5|||
156768454|NCT04609514|565908499|FG001|Overall Study|Lost to Follow-up|4|||
156768455|NCT04609514|565908498|FG000|Overall Study|Withdrawal by PI|0|||
156768456|NCT04609514|565908499|FG001|Overall Study|Withdrawal by PI|2|||
156768457|NCT00885118|565908500|FG000|Overall Study|Adverse Event|1|||
156768458|NCT00885118|565908501|FG001|Overall Study|Adverse Event|0|||
156768459|NCT00885118|565908502|FG002|Overall Study|Adverse Event|0|||
156768460|NCT00885118|565908503|FG003|Overall Study|Adverse Event|0|||
156768461|NCT00885118|565908504|FG004|Overall Study|Adverse Event|0|||
156768462|NCT00885118|565908500|FG000|Overall Study|Withdrawal by Subject|0|||
156768463|NCT00885118|565908501|FG001|Overall Study|Withdrawal by Subject|0|||
156768464|NCT00885118|565908502|FG002|Overall Study|Withdrawal by Subject|0|||
156768465|NCT00885118|565908503|FG003|Overall Study|Withdrawal by Subject|0|||
156768466|NCT00885118|565908504|FG004|Overall Study|Withdrawal by Subject|1|||
156768467|NCT00885118|565908500|FG000|Overall Study|Other reason not defined above|0|||
156768468|NCT00885118|565908501|FG001|Overall Study|Other reason not defined above|0|||
156768469|NCT00885118|565908502|FG002|Overall Study|Other reason not defined above|1|||
156768470|NCT00885118|565908503|FG003|Overall Study|Other reason not defined above|0|||
156768471|NCT00885118|565908504|FG004|Overall Study|Other reason not defined above|0|||
156768472|NCT03642990|565908511|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
156768473|NCT03642990|565908511|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
156768474|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
156768475|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
156768476|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
156768477|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
156768478|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
156768479|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
156768480|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
156768481|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156768482|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156768483|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156768484|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
156768485|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
156768486|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
156768487|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
156768488|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
156768489|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
156768490|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
156768491|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156768492|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156768493|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156768494|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
156768495|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
156768496|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156768497|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156768498|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156768499|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
156768500|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
156768501|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
156768502|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
156768503|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
156768504|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
156768505|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
156768506|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
156768507|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
156768508|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
156768509|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
156768510|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
156768511|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
156768512|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
156768513|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
156768514|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
156768515|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
156768516|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
156768517|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
156768518|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
156768519|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
156768520|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
156768521|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
156768522|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
156768523|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
156768524|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
156768525|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
156768526|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
156768527|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
156768528|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
156768529|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
156768530|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
156768531|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
156768532|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
156427454|NCT01693614|564658752|FG002|Overall Study|Withdrawal by subject/guardian|2|||
156427455|NCT01693614|564658750|FG000|Overall Study|Withdrawal by Subject|1|||
156427456|NCT01693614|564658751|FG001|Overall Study|Withdrawal by Subject|0|||
156427457|NCT01693614|564658752|FG002|Overall Study|Withdrawal by Subject|5|||
156427458|NCT01131494|564658753|FG000|Overall Study|Withdrawal by Subject|2|||
156427459|NCT05419557|564658754|FG000|Overall Study|Lost to Follow-up|11|||
156427460|NCT05419557|564658755|FG001|Overall Study|Lost to Follow-up|4|||
156427461|NCT00588666|564658757|FG000|Overall Study|Adverse Event|4|||
156768533|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
156768534|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
156768535|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
156768536|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
156768537|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
156768538|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
156768539|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
156768540|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
156768541|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
156768542|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
156768543|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
156768544|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
156768545|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
156768546|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
156768547|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
156768548|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
156768549|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
156768550|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
156768551|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
156427462|NCT02281318|564658758|FG000|Overall Study|Adverse Event|2|||
156427463|NCT02281318|564658759|FG001|Overall Study|Adverse Event|2|||
156427464|NCT02281318|564658758|FG000|Overall Study|Lack of Efficacy|2|||
156427465|NCT02281318|564658759|FG001|Overall Study|Lack of Efficacy|0|||
156427466|NCT02281318|564658758|FG000|Overall Study|Lost to Follow-up|2|||
156427467|NCT02281318|564658759|FG001|Overall Study|Lost to Follow-up|1|||
156427468|NCT02281318|564658758|FG000|Overall Study|Physician Decision|2|||
156427469|NCT02281318|564658759|FG001|Overall Study|Physician Decision|0|||
156427470|NCT02281318|564658758|FG000|Overall Study|Withdrawal by Subject|6|||
156427471|NCT02281318|564658759|FG001|Overall Study|Withdrawal by Subject|2|||
156427472|NCT05257798|564658760|FG000|Follow-up Phase|Lost to Follow-up|1|||
156427473|NCT05257798|564658761|FG001|Follow-up Phase|Lost to Follow-up|0|||
156427474|NCT00703911|564658764|FG000|Overall Study|Death|1|||
156427475|NCT00703911|564658764|FG000|Overall Study|Physician Decision|6|||
156427476|NCT00703911|564658764|FG000|Overall Study|Lost to Follow-up|1|||
156427477|NCT00703911|564658764|FG000|Overall Study|Withdrawal by Subject|2|||
156427478|NCT01064817|564658765|FG000|Study Completion|Physician Decision|1|||
156427479|NCT01064817|564658766|FG001|Study Completion|Physician Decision|0|||
156427480|NCT01064817|564658765|FG000|Study Completion|Withdrawal by Subject|1|||
156427481|NCT01064817|564658766|FG001|Study Completion|Withdrawal by Subject|0|||
156427482|NCT01368406|564658767|FG000|Overall Study|Lost to Follow-up|8|||
156427483|NCT01368406|564658768|FG001|Overall Study|Lost to Follow-up|4|||
156427484|NCT01368406|564658767|FG000|Overall Study|Withdrawal by Subject|8|||
156427485|NCT01368406|564658768|FG001|Overall Study|Withdrawal by Subject|4|||
156427486|NCT01368406|564658767|FG000|Overall Study|relapse of the disease|3|||
156427487|NCT01368406|564658768|FG001|Overall Study|relapse of the disease|2|||
156427488|NCT01368406|564658767|FG000|Overall Study|started working|2|||
156427489|NCT01368406|564658768|FG001|Overall Study|started working|3|||
156427490|NCT00543725|564658771|FG000|Overall Study|Adverse Event|18|||
156427491|NCT00543725|564658772|FG001|Overall Study|Adverse Event|27|||
156427492|NCT00543725|564658771|FG000|Overall Study|Sponsor's Decision|0|||
156427493|NCT00543725|564658772|FG001|Overall Study|Sponsor's Decision|1|||
156427494|NCT00543725|564658771|FG000|Overall Study|Subject Non-Compliant|4|||
156427495|NCT00543725|564658772|FG001|Overall Study|Subject Non-Compliant|4|||
156427496|NCT00543725|564658771|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
156427497|NCT00543725|564658772|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
156427498|NCT00543725|564658771|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
156427499|NCT00543725|564658772|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
156427500|NCT00543725|564658771|FG000|Overall Study|Protocol Violation|0|||
156427501|NCT00543725|564658772|FG001|Overall Study|Protocol Violation|1|||
156427502|NCT00543725|564658771|FG000|Overall Study|Withdrawal by Subject|4|||
156427503|NCT00543725|564658772|FG001|Overall Study|Withdrawal by Subject|13|||
156427504|NCT00543725|564658771|FG000|Overall Study|Lost to Follow-up|15|||
156427505|NCT00543725|564658772|FG001|Overall Study|Lost to Follow-up|11|||
156427506|NCT00543725|564658771|FG000|Overall Study|Other|3|||
156427507|NCT00543725|564658772|FG001|Overall Study|Other|3|||
156427508|NCT01250002|564658773|FG000|Overall Study|Change to open surgical procedure|4|||
156427509|NCT01250002|564658774|FG001|Overall Study|Change to open surgical procedure|3|||
156427510|NCT00831792|564658785|FG000|Overall Study|Not Eligible|3|||
156427511|NCT00831792|564658785|FG000|Overall Study|Adverse Event|1|||
156427512|NCT00831792|564658785|FG000|Overall Study|Death|1|||
156427513|NCT00831792|564658785|FG000|Overall Study|Lack of Efficacy|1|||
156427514|NCT03736785|564658787|FG000|Overall Study|Adverse Event|1|||
156427515|NCT03736785|564658788|FG001|Overall Study|Adverse Event|1|||
156427516|NCT03736785|564658789|FG002|Overall Study|Adverse Event|1|||
156427517|NCT03736785|564658787|FG000|Overall Study|Death|1|||
156427518|NCT03736785|564658788|FG001|Overall Study|Death|0|||
156427519|NCT03736785|564658789|FG002|Overall Study|Death|1|||
156427520|NCT03736785|564658787|FG000|Overall Study|Lost to Follow-up|0|||
156427521|NCT03736785|564658788|FG001|Overall Study|Lost to Follow-up|2|||
156427522|NCT03736785|564658789|FG002|Overall Study|Lost to Follow-up|3|||
156427523|NCT03736785|564658787|FG000|Overall Study|Non compliance with study drug|1|||
156427524|NCT03736785|564658788|FG001|Overall Study|Non compliance with study drug|1|||
156427525|NCT03736785|564658789|FG002|Overall Study|Non compliance with study drug|0|||
156427526|NCT03736785|564658787|FG000|Overall Study|Physician Decision|0|||
156427527|NCT03736785|564658788|FG001|Overall Study|Physician Decision|1|||
156427528|NCT03736785|564658789|FG002|Overall Study|Physician Decision|1|||
156427529|NCT03736785|564658787|FG000|Overall Study|Protocol Violation|1|||
156427530|NCT03736785|564658788|FG001|Overall Study|Protocol Violation|4|||
156427531|NCT03736785|564658789|FG002|Overall Study|Protocol Violation|3|||
156427532|NCT03736785|564658787|FG000|Overall Study|Sponsor Decision|1|||
156427533|NCT03736785|564658788|FG001|Overall Study|Sponsor Decision|0|||
156427534|NCT03736785|564658789|FG002|Overall Study|Sponsor Decision|0|||
156427535|NCT03736785|564658787|FG000|Overall Study|Unknown/Missing data|3|||
156427536|NCT03736785|564658788|FG001|Overall Study|Unknown/Missing data|2|||
156427537|NCT03736785|564658789|FG002|Overall Study|Unknown/Missing data|1|||
156427538|NCT03736785|564658787|FG000|Overall Study|Withdrawal by Subject|9|||
156427539|NCT03736785|564658788|FG001|Overall Study|Withdrawal by Subject|6|||
156427540|NCT03736785|564658789|FG002|Overall Study|Withdrawal by Subject|4|||
156427541|NCT02974010|564658790|FG000|Overall Study|Lost to Follow-up|3|||
156427542|NCT02974010|564658791|FG001|Overall Study|Lost to Follow-up|1|||
156427543|NCT02974010|564658792|FG002|Overall Study|Lost to Follow-up|0|||
156427544|NCT02974010|564658793|FG003|Overall Study|Lost to Follow-up|0|||
156427545|NCT02974010|564658790|FG000|Overall Study|Withdrawal by Subject|2|||
156427546|NCT02974010|564658791|FG001|Overall Study|Withdrawal by Subject|1|||
156808568|NCT01070979|566052717|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
156427547|NCT02974010|564658792|FG002|Overall Study|Withdrawal by Subject|0|||
156427548|NCT02974010|564658793|FG003|Overall Study|Withdrawal by Subject|0|||
156768552|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
156768553|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
156768554|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
156768555|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
156768556|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
156768557|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
156768558|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
156768559|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
156768560|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
156768561|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
156768562|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
156768563|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
156768564|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
156768565|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
156768566|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
156768567|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
156768568|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
156768569|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
156768570|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
156768571|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
156768572|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
156768573|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
156768574|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
156768575|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
156768576|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
156768577|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
156768578|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
156768579|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
156768580|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
156768581|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
156768582|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
156768583|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
156768584|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
156768585|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
156768586|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
156768587|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
156768588|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
156768589|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
156768590|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
156768591|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
156768592|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
156768593|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
156768594|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
156768595|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
156768596|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
156768597|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
156768598|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
156768599|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
156768600|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
156768601|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
156768602|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
156768603|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
156768604|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156768605|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156427549|NCT02974010|564658790|FG000|Overall Study|Adverse Event|0|||
156323587|NCT03139604|564284210|FG000|Overall Study|Physician Decision|1|||
156323588|NCT03139604|564284211|FG001|Overall Study|Physician Decision|2|||
156323589|NCT03139604|564284210|FG000|Overall Study|Lost to Follow-up|3|||
156323590|NCT03139604|564284211|FG001|Overall Study|Lost to Follow-up|1|||
156323591|NCT03139604|564284210|FG000|Overall Study|Death|65|||
156323592|NCT03139604|564284211|FG001|Overall Study|Death|67|||
156323593|NCT03139604|564284210|FG000|Overall Study|Study Terminated by Sponsor|122|||
156323594|NCT03139604|564284211|FG001|Overall Study|Study Terminated by Sponsor|127|||
156323595|NCT03139604|564284210|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
156427550|NCT02974010|564658791|FG001|Overall Study|Adverse Event|1|||
156427551|NCT02974010|564658792|FG002|Overall Study|Adverse Event|0|||
156427552|NCT02974010|564658793|FG003|Overall Study|Adverse Event|0|||
156427553|NCT02974010|564658790|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
156427554|NCT02974010|564658791|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
156427555|NCT02974010|564658792|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
156427556|NCT02974010|564658793|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
156427557|NCT02974010|564658790|FG000|Overall Study|Lack of Efficacy|0|||
156427558|NCT02974010|564658791|FG001|Overall Study|Lack of Efficacy|0|||
156427559|NCT02974010|564658792|FG002|Overall Study|Lack of Efficacy|1|||
156427560|NCT02974010|564658793|FG003|Overall Study|Lack of Efficacy|0|||
156427561|NCT02595398|564658804|FG000|Overall Study|Non-compliance|1|||
156427562|NCT02595398|564658805|FG001|Overall Study|Non-compliance|0|||
156427563|NCT02595398|564658804|FG000|Overall Study|Withdrawal by Subject|2|||
156427564|NCT02595398|564658805|FG001|Overall Study|Withdrawal by Subject|1|||
156427565|NCT02595398|564658804|FG000|Overall Study|Lost to Follow-up|1|||
156427566|NCT02595398|564658805|FG001|Overall Study|Lost to Follow-up|0|||
156427567|NCT00502593|564658806|FG000|Overall Study|Withdrawn unspecified reason|1|||
156427568|NCT00502593|564658807|FG001|Overall Study|Withdrawn unspecified reason|1|||
156427569|NCT00502593|564658808|FG002|Overall Study|Withdrawn unspecified reason|3|||
156427570|NCT00502593|564658809|FG003|Overall Study|Withdrawn unspecified reason|1|||
156427571|NCT00502593|564658810|FG004|Overall Study|Withdrawn unspecified reason|2|||
156427572|NCT00502593|564658811|FG005|Overall Study|Withdrawn unspecified reason|0|||
156427573|NCT00502593|564658812|FG006|Overall Study|Withdrawn unspecified reason|2|||
156427574|NCT00502593|564658813|FG007|Overall Study|Withdrawn unspecified reason|0|||
156427575|NCT00502593|564658814|FG008|Overall Study|Withdrawn unspecified reason|0|||
156427576|NCT00502593|564658815|FG009|Overall Study|Withdrawn unspecified reason|0|||
156427577|NCT00502593|564658816|FG010|Overall Study|Withdrawn unspecified reason|0|||
156427578|NCT00502593|564658817|FG011|Overall Study|Withdrawn unspecified reason|0|||
156427579|NCT00502593|564658806|FG000|Overall Study|Withdrawal by Subject|0|||
156427580|NCT00502593|564658807|FG001|Overall Study|Withdrawal by Subject|0|||
156427581|NCT00502593|564658808|FG002|Overall Study|Withdrawal by Subject|6|||
156427582|NCT00502593|564658809|FG003|Overall Study|Withdrawal by Subject|2|||
156427583|NCT00502593|564658810|FG004|Overall Study|Withdrawal by Subject|2|||
156427584|NCT00502593|564658811|FG005|Overall Study|Withdrawal by Subject|0|||
156427585|NCT00502593|564658812|FG006|Overall Study|Withdrawal by Subject|3|||
156427586|NCT00502593|564658813|FG007|Overall Study|Withdrawal by Subject|0|||
156768606|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
156768607|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
156768608|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
156427587|NCT00502593|564658814|FG008|Overall Study|Withdrawal by Subject|3|||
156427588|NCT00502593|564658815|FG009|Overall Study|Withdrawal by Subject|0|||
156427589|NCT00502593|564658816|FG010|Overall Study|Withdrawal by Subject|1|||
156427590|NCT00502593|564658817|FG011|Overall Study|Withdrawal by Subject|0|||
156427591|NCT00502593|564658806|FG000|Overall Study|Lost to Follow-up|2|||
156427592|NCT00502593|564658807|FG001|Overall Study|Lost to Follow-up|1|||
156427593|NCT00502593|564658808|FG002|Overall Study|Lost to Follow-up|1|||
156427594|NCT00502593|564658809|FG003|Overall Study|Lost to Follow-up|1|||
156427595|NCT00502593|564658810|FG004|Overall Study|Lost to Follow-up|0|||
156427596|NCT00502593|564658811|FG005|Overall Study|Lost to Follow-up|0|||
156427597|NCT00502593|564658812|FG006|Overall Study|Lost to Follow-up|0|||
156427598|NCT00502593|564658813|FG007|Overall Study|Lost to Follow-up|0|||
156427599|NCT00502593|564658814|FG008|Overall Study|Lost to Follow-up|3|||
156427600|NCT00502593|564658815|FG009|Overall Study|Lost to Follow-up|0|||
156427601|NCT00502593|564658816|FG010|Overall Study|Lost to Follow-up|1|||
156427602|NCT00502593|564658817|FG011|Overall Study|Lost to Follow-up|0|||
156427603|NCT00880906|564658818|FG000|Overall Study|Lost to Follow-up|0|||
156427604|NCT00880906|564658819|FG001|Overall Study|Lost to Follow-up|1|||
156427605|NCT00880906|564658818|FG000|Overall Study|Did not meet criteria following patholog|12|||
156427606|NCT00880906|564658819|FG001|Overall Study|Did not meet criteria following patholog|6|||
156427607|NCT00544440|564658820|FG000|Overall Study|Other|1|||
156427608|NCT00544440|564658820|FG000|Overall Study|Adverse Event|1|||
156427609|NCT00544440|564658820|FG000|Overall Study|Withdrawal by Subject|2|||
156427610|NCT00544440|564658820|FG000|Overall Study|Subject Non-compliance|1|||
156427611|NCT00544440|564658820|FG000|Overall Study|Progressive Disease|47|||
156427612|NCT00544440|564658820|FG000|Overall Study|Other|5|||
156427613|NCT01664104|564658821|FG000|Overall Study|Adverse Event|6|||
156768609|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
156427614|NCT01664104|564658821|FG000|Overall Study|Lack of Efficacy|2|||
156427615|NCT01664104|564658821|FG000|Overall Study|Withdrawal by Subject|1|||
156427616|NCT01664104|564658821|FG000|Overall Study|Lost to Follow-up|4|||
156427617|NCT01664104|564658821|FG000|Overall Study|Other|1|||
156427618|NCT01664104|564658821|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
156427619|NCT01460342|564658824|FG000|Overall Study|Adverse Event|5|||
156427620|NCT01460342|564658825|FG001|Overall Study|Adverse Event|4|||
156768610|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
156768611|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
156768612|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
156768613|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
156768614|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
156768615|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
156768616|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
156768617|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
156768618|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
156768619|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
156768620|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
156768621|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
156768622|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
156768623|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
156768624|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
156768625|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
156768626|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
156768627|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
156768628|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
156768629|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
156768630|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
156768631|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
156768632|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
156768633|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
156768634|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
156768635|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
156768636|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
156768637|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
156768638|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
156768639|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
156768640|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
156323596|NCT03139604|564284211|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
156323597|NCT00206076|564284213|FG000|Overall Study|Physician Decision|2|||
156323598|NCT00206076|564284214|FG001|Overall Study|Physician Decision|0|||
156323599|NCT00206076|564284213|FG000|Overall Study|Withdrawal by Subject|1|||
156323600|NCT00206076|564284214|FG001|Overall Study|Withdrawal by Subject|1|||
156323601|NCT00521001|564284218|FG000|Overall Study|Ineligible|1|||
156323602|NCT02821910|564284219|FG000|Overall Study|Withdrawal by Subject|0|||
156323603|NCT02821910|564284220|FG001|Overall Study|Withdrawal by Subject|0|||
156323604|NCT02821910|564284221|FG002|Overall Study|Withdrawal by Subject|1|||
156323605|NCT02821910|564284222|FG003|Overall Study|Withdrawal by Subject|0|||
156323606|NCT02821910|564284223|FG004|Overall Study|Withdrawal by Subject|0|||
156323607|NCT02821910|564284224|FG005|Overall Study|Withdrawal by Subject|1|||
156323608|NCT02821910|564284219|FG000|Overall Study|Other than specified|1|||
156323609|NCT02821910|564284220|FG001|Overall Study|Other than specified|0|||
156323610|NCT02821910|564284221|FG002|Overall Study|Other than specified|1|||
156323611|NCT02821910|564284222|FG003|Overall Study|Other than specified|0|||
156323612|NCT02821910|564284223|FG004|Overall Study|Other than specified|0|||
156323613|NCT02821910|564284224|FG005|Overall Study|Other than specified|0|||
156323614|NCT00423670|564284225|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
156323615|NCT00423670|564284226|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
156323616|NCT00423670|564284227|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
156323617|NCT00423670|564284228|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
156323618|NCT00423670|564284229|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
156323619|NCT00423670|564284230|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
156323620|NCT00423670|564284231|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
156323621|NCT00423670|564284232|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
156323622|NCT00423670|564284225|FG000|Treatment Period|Adverse Event|8|||
156323623|NCT00423670|564284226|FG001|Treatment Period|Adverse Event|12|||
156323624|NCT00423670|564284227|FG002|Treatment Period|Adverse Event|15|||
156323625|NCT00423670|564284228|FG003|Treatment Period|Adverse Event|20|||
156323626|NCT00423670|564284229|FG004|Treatment Period|Adverse Event|9|||
156323627|NCT00423670|564284230|FG005|Treatment Period|Adverse Event|4|||
156323628|NCT00423670|564284231|FG006|Treatment Period|Adverse Event|7|||
156323629|NCT00423670|564284232|FG007|Treatment Period|Adverse Event|2|||
156323630|NCT00423670|564284225|FG000|Treatment Period|Protocol-defined clinical event|0|||
156323631|NCT00423670|564284226|FG001|Treatment Period|Protocol-defined clinical event|7|||
156323632|NCT00423670|564284227|FG002|Treatment Period|Protocol-defined clinical event|4|||
156427621|NCT01460342|564658824|FG000|Overall Study|Lost to Follow-up|1|||
156427622|NCT01460342|564658825|FG001|Overall Study|Lost to Follow-up|2|||
156427623|NCT01460342|564658824|FG000|Overall Study|Protocol Violation|0|||
156427624|NCT01460342|564658825|FG001|Overall Study|Protocol Violation|1|||
156427625|NCT01460342|564658824|FG000|Overall Study|Withdrawal by Subject|3|||
156427626|NCT01460342|564658825|FG001|Overall Study|Withdrawal by Subject|4|||
156427627|NCT01460342|564658824|FG000|Overall Study|Physician Decision|1|||
156427628|NCT01460342|564658825|FG001|Overall Study|Physician Decision|3|||
156427629|NCT01460342|564658824|FG000|Overall Study|Lack of Efficacy|1|||
156427630|NCT01460342|564658825|FG001|Overall Study|Lack of Efficacy|0|||
156427631|NCT03586167|564658827|FG000|Overall Study|Other|1|||
156427632|NCT03586167|564658828|FG001|Overall Study|Other|0|||
156427633|NCT00591838|564658829|FG000|Overall Study|Withdrawal by Subject|0|||
156427634|NCT00591838|564658830|FG001|Overall Study|Withdrawal by Subject|0|||
156427635|NCT00591838|564658831|FG002|Overall Study|Withdrawal by Subject|0|||
156427636|NCT00591838|564658832|FG003|Overall Study|Withdrawal by Subject|1|||
156427637|NCT00591838|564658833|FG004|Overall Study|Withdrawal by Subject|0|||
156427638|NCT00559949|564658836|FG000|Overall Study|Progressive Disease during cycle 1|1|||
156427639|NCT00559949|564658836|FG000|Overall Study|Adverse Event|1|||
156427640|NCT00559949|564658836|FG000|Overall Study|Withdrawal by Subject|4|||
156427641|NCT00559949|564658836|FG000|Overall Study|No disease evaluation per protocol|1|||
156427642|NCT04163458|564658839|FG000|Overall Study|Protocol Deviation|7|||
156427643|NCT04163458|564658840|FG001|Overall Study|Protocol Deviation|13|||
156427644|NCT04163458|564658839|FG000|Overall Study|Adverse Event|5|||
156427645|NCT04163458|564658840|FG001|Overall Study|Adverse Event|8|||
156427646|NCT04163458|564658839|FG000|Overall Study|Due to COVID-19 pandemic|4|||
156427647|NCT04163458|564658840|FG001|Overall Study|Due to COVID-19 pandemic|2|||
156427648|NCT04163458|564658839|FG000|Overall Study|Participant withdrew consent|2|||
156427649|NCT04163458|564658840|FG001|Overall Study|Participant withdrew consent|3|||
156427650|NCT04163458|564658839|FG000|Overall Study|Randomization failure|2|||
156427651|NCT04163458|564658840|FG001|Overall Study|Randomization failure|2|||
156427652|NCT04163458|564658839|FG000|Overall Study|Other|4|||
156427653|NCT04163458|564658840|FG001|Overall Study|Other|2|||
156427654|NCT03852433|564658846|FG000|Overall Study|Withdrawal of consent|5|||
156427655|NCT03852433|564658847|FG001|Overall Study|Withdrawal of consent|8|||
156427656|NCT03852433|564658848|FG002|Overall Study|Withdrawal of consent|1|||
156427657|NCT03852433|564658849|FG003|Overall Study|Withdrawal of consent|1|||
156427658|NCT03852433|564658846|FG000|Overall Study|Adverse Event|1|||
156427659|NCT03852433|564658847|FG001|Overall Study|Adverse Event|1|||
156427660|NCT03852433|564658848|FG002|Overall Study|Adverse Event|1|||
156427661|NCT03852433|564658849|FG003|Overall Study|Adverse Event|1|||
156427662|NCT03852433|564658846|FG000|Overall Study|Lost to Follow-up|0|||
156427663|NCT03852433|564658847|FG001|Overall Study|Lost to Follow-up|1|||
156427664|NCT03852433|564658848|FG002|Overall Study|Lost to Follow-up|0|||
156427665|NCT03852433|564658849|FG003|Overall Study|Lost to Follow-up|1|||
156427666|NCT03852433|564658846|FG000|Overall Study|Pregnancy|0|||
156427667|NCT03852433|564658847|FG001|Overall Study|Pregnancy|1|||
156427668|NCT03852433|564658848|FG002|Overall Study|Pregnancy|1|||
156427669|NCT03852433|564658849|FG003|Overall Study|Pregnancy|0|||
156427670|NCT03852433|564658846|FG000|Overall Study|Protocol Violation|0|||
156427671|NCT03852433|564658847|FG001|Overall Study|Protocol Violation|0|||
156427672|NCT03852433|564658848|FG002|Overall Study|Protocol Violation|1|||
156427673|NCT03852433|564658849|FG003|Overall Study|Protocol Violation|1|||
156427674|NCT03852433|564658846|FG000|Overall Study|Death|0|||
156427675|NCT03852433|564658847|FG001|Overall Study|Death|0|||
156427676|NCT03852433|564658848|FG002|Overall Study|Death|1|||
156427677|NCT03852433|564658849|FG003|Overall Study|Death|0|||
156427678|NCT03852433|564658846|FG000|Overall Study|Lack of Efficacy|0|||
156427679|NCT03852433|564658847|FG001|Overall Study|Lack of Efficacy|1|||
156427680|NCT03852433|564658848|FG002|Overall Study|Lack of Efficacy|0|||
156427681|NCT03852433|564658849|FG003|Overall Study|Lack of Efficacy|0|||
156427682|NCT03852433|564658846|FG000|Overall Study|Non-compliance with study drug|0|||
156768641|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
156768642|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
156768643|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
156427683|NCT03852433|564658847|FG001|Overall Study|Non-compliance with study drug|0|||
156427684|NCT03852433|564658848|FG002|Overall Study|Non-compliance with study drug|0|||
156427685|NCT03852433|564658849|FG003|Overall Study|Non-compliance with study drug|1|||
156427686|NCT03852433|564658846|FG000|Overall Study|Physician Decision|1|||
156427687|NCT03852433|564658847|FG001|Overall Study|Physician Decision|0|||
156427688|NCT03852433|564658848|FG002|Overall Study|Physician Decision|0|||
156427689|NCT03852433|564658849|FG003|Overall Study|Physician Decision|0|||
156427690|NCT03852433|564658846|FG000|Overall Study|Randomized but never treated|1|||
156427691|NCT03852433|564658847|FG001|Overall Study|Randomized but never treated|0|||
156427692|NCT03852433|564658848|FG002|Overall Study|Randomized but never treated|0|||
156427693|NCT03852433|564658849|FG003|Overall Study|Randomized but never treated|0|||
156427694|NCT01467700|564658850|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
156427695|NCT01467700|564658851|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
156768644|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
156768645|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
156768646|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
156768647|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
156768648|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
156768649|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
156768650|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
156768651|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
156768652|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
156768653|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
156768654|NCT02577029|565908519|FG000|Overall Study|Adverse Event|1|||
156768655|NCT02577029|565908520|FG001|Overall Study|Adverse Event|0|||
156768656|NCT02577029|565908521|FG002|Overall Study|Adverse Event|2|||
156768657|NCT02577029|565908522|FG003|Overall Study|Adverse Event|0|||
156768658|NCT02577029|565908523|FG004|Overall Study|Adverse Event|1|||
156768659|NCT02577029|565908524|FG005|Overall Study|Adverse Event|0|||
156768660|NCT02577029|565908525|FG006|Overall Study|Adverse Event|0|||
156768661|NCT02577029|565908526|FG007|Overall Study|Adverse Event|0|||
156768662|NCT02577029|565908519|FG000|Overall Study|Withdrawal by Subject|0|||
156768663|NCT02577029|565908520|FG001|Overall Study|Withdrawal by Subject|0|||
156768664|NCT02577029|565908521|FG002|Overall Study|Withdrawal by Subject|0|||
156768665|NCT02577029|565908522|FG003|Overall Study|Withdrawal by Subject|0|||
156768666|NCT02577029|565908523|FG004|Overall Study|Withdrawal by Subject|0|||
156768667|NCT02577029|565908524|FG005|Overall Study|Withdrawal by Subject|1|||
156768668|NCT02577029|565908525|FG006|Overall Study|Withdrawal by Subject|0|||
156768669|NCT02577029|565908526|FG007|Overall Study|Withdrawal by Subject|0|||
156768670|NCT02577029|565908519|FG000|Overall Study|Sponsor Termination of the Study|9|||
156768671|NCT02577029|565908520|FG001|Overall Study|Sponsor Termination of the Study|2|||
156768672|NCT02577029|565908521|FG002|Overall Study|Sponsor Termination of the Study|5|||
156768673|NCT02577029|565908522|FG003|Overall Study|Sponsor Termination of the Study|12|||
156768674|NCT02577029|565908523|FG004|Overall Study|Sponsor Termination of the Study|10|||
156768675|NCT02577029|565908524|FG005|Overall Study|Sponsor Termination of the Study|12|||
156768676|NCT02577029|565908525|FG006|Overall Study|Sponsor Termination of the Study|12|||
156768677|NCT02577029|565908526|FG007|Overall Study|Sponsor Termination of the Study|12|||
156768678|NCT02078817|565908527|FG000|Overall Study|Withdrawal by Subject|1|||
156768679|NCT00769561|565908528|FG000|Overall Study|Withdrawal by Subject|2|||
156768680|NCT00769561|565908529|FG001|Overall Study|Withdrawal by Subject|2|||
156768681|NCT00769561|565908528|FG000|Overall Study|Lost to Follow-up|1|||
156768682|NCT00769561|565908529|FG001|Overall Study|Lost to Follow-up|3|||
156768683|NCT02370511|565908537|FG000|Overall Study|Death|10|||
156768684|NCT02370511|565908538|FG001|Overall Study|Death|7|||
156768685|NCT02370511|565908539|FG002|Overall Study|Death|1|||
156323633|NCT00423670|564284228|FG003|Treatment Period|Protocol-defined clinical event|12|||
156323634|NCT00423670|564284229|FG004|Treatment Period|Protocol-defined clinical event|5|||
156323635|NCT00423670|564284230|FG005|Treatment Period|Protocol-defined clinical event|4|||
156323636|NCT00423670|564284231|FG006|Treatment Period|Protocol-defined clinical event|16|||
156323637|NCT00423670|564284232|FG007|Treatment Period|Protocol-defined clinical event|15|||
156323638|NCT00423670|564284225|FG000|Treatment Period|Lost to Follow-up|2|||
156323639|NCT00423670|564284226|FG001|Treatment Period|Lost to Follow-up|1|||
156323640|NCT00423670|564284227|FG002|Treatment Period|Lost to Follow-up|3|||
156323641|NCT00423670|564284228|FG003|Treatment Period|Lost to Follow-up|1|||
156323642|NCT00423670|564284229|FG004|Treatment Period|Lost to Follow-up|6|||
156323643|NCT00423670|564284230|FG005|Treatment Period|Lost to Follow-up|0|||
156323644|NCT00423670|564284231|FG006|Treatment Period|Lost to Follow-up|3|||
156323645|NCT00423670|564284232|FG007|Treatment Period|Lost to Follow-up|1|||
156323646|NCT00423670|564284225|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
156323647|NCT00423670|564284226|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
156323648|NCT00423670|564284227|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
156323649|NCT00423670|564284228|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
156323650|NCT00423670|564284229|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
156323651|NCT00423670|564284230|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
156323652|NCT00423670|564284231|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
156323653|NCT00423670|564284232|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
156323654|NCT00423670|564284225|FG000|Treatment Period|Investigator decision|0|||
156323655|NCT00423670|564284226|FG001|Treatment Period|Investigator decision|0|||
156323656|NCT00423670|564284227|FG002|Treatment Period|Investigator decision|0|||
156427696|NCT01467700|564658852|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
156768686|NCT02370511|565908537|FG000|Overall Study|Withdrawal by Subject|2|||
156768687|NCT02370511|565908538|FG001|Overall Study|Withdrawal by Subject|0|||
156768688|NCT02370511|565908539|FG002|Overall Study|Withdrawal by Subject|0|||
156768689|NCT02370511|565908537|FG000|Overall Study|Lost to Follow-up|0|||
156768690|NCT02370511|565908538|FG001|Overall Study|Lost to Follow-up|4|||
156656925|NCT00510510|565489496|FG002|Overall Study|Lack of Efficacy|1|||
156323657|NCT00423670|564284228|FG003|Treatment Period|Investigator decision|0|||
156323658|NCT00423670|564284229|FG004|Treatment Period|Investigator decision|0|||
156323659|NCT00423670|564284230|FG005|Treatment Period|Investigator decision|0|||
156323660|NCT00423670|564284231|FG006|Treatment Period|Investigator decision|0|||
156323661|NCT00423670|564284232|FG007|Treatment Period|Investigator decision|1|||
156323662|NCT00423670|564284225|FG000|Treatment Period|Non-compliance with protocol|3|||
156323663|NCT00423670|564284226|FG001|Treatment Period|Non-compliance with protocol|1|||
156323664|NCT00423670|564284227|FG002|Treatment Period|Non-compliance with protocol|1|||
156323665|NCT00423670|564284228|FG003|Treatment Period|Non-compliance with protocol|3|||
156323666|NCT00423670|564284229|FG004|Treatment Period|Non-compliance with protocol|2|||
156323667|NCT00423670|564284230|FG005|Treatment Period|Non-compliance with protocol|0|||
156323668|NCT00423670|564284231|FG006|Treatment Period|Non-compliance with protocol|2|||
156323669|NCT00423670|564284232|FG007|Treatment Period|Non-compliance with protocol|2|||
156323670|NCT00423670|564284225|FG000|Follow-up Period|Lost to Follow-up|0|||
156323671|NCT00423670|564284226|FG001|Follow-up Period|Lost to Follow-up|12|||
156323672|NCT00423670|564284227|FG002|Follow-up Period|Lost to Follow-up|8|||
156323673|NCT00423670|564284228|FG003|Follow-up Period|Lost to Follow-up|3|||
156323674|NCT00423670|564284229|FG004|Follow-up Period|Lost to Follow-up|1|||
156323675|NCT00423670|564284230|FG005|Follow-up Period|Lost to Follow-up|0|||
156323676|NCT00423670|564284231|FG006|Follow-up Period|Lost to Follow-up|5|||
156323677|NCT00423670|564284232|FG007|Follow-up Period|Lost to Follow-up|0|||
156323678|NCT00423670|564284225|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
156323679|NCT00423670|564284226|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
156323680|NCT00423670|564284227|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
156323681|NCT00423670|564284228|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
156323682|NCT00423670|564284229|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
156323683|NCT00423670|564284230|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
156323684|NCT00423670|564284231|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
156323685|NCT00423670|564284232|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
156323686|NCT00423670|564284225|FG000|Follow-up Period|Non-compliance with protocol|2|||
156323687|NCT00423670|564284226|FG001|Follow-up Period|Non-compliance with protocol|0|||
156323688|NCT00423670|564284227|FG002|Follow-up Period|Non-compliance with protocol|1|||
156323689|NCT00423670|564284228|FG003|Follow-up Period|Non-compliance with protocol|1|||
156323690|NCT00423670|564284229|FG004|Follow-up Period|Non-compliance with protocol|0|||
156323691|NCT00423670|564284230|FG005|Follow-up Period|Non-compliance with protocol|0|||
156323692|NCT00423670|564284231|FG006|Follow-up Period|Non-compliance with protocol|3|||
156323693|NCT00423670|564284232|FG007|Follow-up Period|Non-compliance with protocol|2|||
156323694|NCT00900601|564284233|FG000|Overall Study|Physician Decision|1|||
156323695|NCT01082640|564284235|FG000|Overall Study|Adverse Event|9|||
156323696|NCT01082640|564284236|FG001|Overall Study|Adverse Event|5|||
156323697|NCT01082640|564284237|FG002|Overall Study|Adverse Event|3|||
156323698|NCT01082640|564284235|FG000|Overall Study|Withdrawal by Subject|3|||
156656926|NCT00510510|565489494|FG000|Overall Study|Subjects no longer requires study drug|0|||
156323699|NCT01082640|564284236|FG001|Overall Study|Withdrawal by Subject|3|||
156323700|NCT01082640|564284237|FG002|Overall Study|Withdrawal by Subject|2|||
156323701|NCT01082640|564284235|FG000|Overall Study|Major protocol deviation|3|||
156323702|NCT01082640|564284236|FG001|Overall Study|Major protocol deviation|3|||
156323703|NCT01082640|564284237|FG002|Overall Study|Major protocol deviation|0|||
156323704|NCT01082640|564284235|FG000|Overall Study|Lost to Follow-up|0|||
156323705|NCT01082640|564284236|FG001|Overall Study|Lost to Follow-up|3|||
156323706|NCT01082640|564284237|FG002|Overall Study|Lost to Follow-up|0|||
156656927|NCT00510510|565489495|FG001|Overall Study|Subjects no longer requires study drug|0|||
156656928|NCT00510510|565489496|FG002|Overall Study|Subjects no longer requires study drug|2|||
156656929|NCT00510510|565489494|FG000|Overall Study|Withdrawal by Subject|1|||
156656930|NCT00510510|565489495|FG001|Overall Study|Withdrawal by Subject|2|||
156656931|NCT00510510|565489496|FG002|Overall Study|Withdrawal by Subject|3|||
156656932|NCT00510510|565489494|FG000|Overall Study|Lost to Follow-up|0|||
156656933|NCT00510510|565489495|FG001|Overall Study|Lost to Follow-up|0|||
156656934|NCT00510510|565489496|FG002|Overall Study|Lost to Follow-up|1|||
156656935|NCT00510510|565489494|FG000|Overall Study|Protocol Violation|0|||
156656936|NCT00510510|565489495|FG001|Overall Study|Protocol Violation|3|||
156656937|NCT00510510|565489496|FG002|Overall Study|Protocol Violation|4|||
156656938|NCT01200394|565489497|FG000|Overall Study|Adverse Event|0|||
156656939|NCT01200394|565489498|FG001|Overall Study|Adverse Event|14|||
156656940|NCT01200394|565489497|FG000|Overall Study|Death|1|||
156656941|NCT01200394|565489498|FG001|Overall Study|Death|0|||
156656942|NCT01200394|565489497|FG000|Overall Study|Lost to Follow-up|0|||
156656943|NCT01200394|565489498|FG001|Overall Study|Lost to Follow-up|1|||
156656944|NCT01200394|565489497|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
156656945|NCT01200394|565489498|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
156656946|NCT01200394|565489497|FG000|Overall Study|Protocol Violation|0|||
156656947|NCT01200394|565489498|FG001|Overall Study|Protocol Violation|3|||
156427697|NCT01467700|564658853|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
156427698|NCT01467700|564658850|FG000|Overall Study|Major Protocol Deviation|3|||
156427699|NCT01467700|564658851|FG001|Overall Study|Major Protocol Deviation|3|||
156427700|NCT01467700|564658852|FG002|Overall Study|Major Protocol Deviation|2|||
156427701|NCT01467700|564658853|FG003|Overall Study|Major Protocol Deviation|3|||
156427702|NCT01467700|564658850|FG000|Overall Study|Lost to Follow-up|6|||
156427703|NCT01467700|564658851|FG001|Overall Study|Lost to Follow-up|5|||
156427704|NCT01467700|564658852|FG002|Overall Study|Lost to Follow-up|2|||
156427705|NCT01467700|564658853|FG003|Overall Study|Lost to Follow-up|3|||
156427706|NCT01467700|564658850|FG000|Overall Study|Voluntary Withdrawal|5|||
156427707|NCT01467700|564658851|FG001|Overall Study|Voluntary Withdrawal|7|||
156427708|NCT01467700|564658852|FG002|Overall Study|Voluntary Withdrawal|6|||
156427709|NCT01467700|564658853|FG003|Overall Study|Voluntary Withdrawal|2|||
156427710|NCT01467700|564658850|FG000|Overall Study|Study Termination|6|||
156427711|NCT01467700|564658851|FG001|Overall Study|Study Termination|5|||
156427712|NCT01467700|564658852|FG002|Overall Study|Study Termination|10|||
156427713|NCT01467700|564658853|FG003|Overall Study|Study Termination|7|||
156427714|NCT01467700|564658850|FG000|Overall Study|Pregnancy|0|||
156427715|NCT01467700|564658851|FG001|Overall Study|Pregnancy|1|||
156427716|NCT01467700|564658852|FG002|Overall Study|Pregnancy|1|||
156427717|NCT01467700|564658853|FG003|Overall Study|Pregnancy|0|||
156427718|NCT01467700|564658850|FG000|Overall Study|Lack of Efficacy|2|||
156427719|NCT01467700|564658851|FG001|Overall Study|Lack of Efficacy|0|||
156427720|NCT01467700|564658852|FG002|Overall Study|Lack of Efficacy|2|||
156427721|NCT01467700|564658853|FG003|Overall Study|Lack of Efficacy|1|||
156427722|NCT01467700|564658850|FG000|Overall Study|Reason not Specified|1|||
156427723|NCT01467700|564658851|FG001|Overall Study|Reason not Specified|3|||
156427724|NCT01467700|564658852|FG002|Overall Study|Reason not Specified|2|||
156427725|NCT01467700|564658853|FG003|Overall Study|Reason not Specified|8|||
156427726|NCT00121199|564658861|FG000|Overall Study|Adverse Event|11|||
156427727|NCT00121199|564658861|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156427728|NCT00121199|564658861|FG000|Overall Study|Progression/Relapse|1|||
156427729|NCT00121199|564658861|FG000|Overall Study|Death|3|||
156522578|NCT03184870|565007738|FG008|Crossover Treatment|Death|0|||
156768691|NCT02370511|565908539|FG002|Overall Study|Lost to Follow-up|0|||
156768692|NCT03092752|565908540|FG000|Overall Study|Aged <40 years|14209|||
156768693|NCT03092752|565908540|FG000|Overall Study|At least one claim with T2DM|61299|||
156768694|NCT03092752|565908540|FG000|Overall Study|Having no claim of study drugs|29282|||
156768695|NCT03092752|565908540|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
156768696|NCT03092752|565908540|FG000|Overall Study|<6 month history|245900|||
156768697|NCT03882918|565908543|FG000|Overall Study|Study terminated by sponsor|98|||
156768698|NCT03882918|565908543|FG000|Overall Study|Protocol Violation|1|||
156768699|NCT03882918|565908543|FG000|Overall Study|Other|9|||
156768700|NCT03882918|565908543|FG000|Overall Study|Lack of Efficacy|14|||
156768701|NCT03882918|565908543|FG000|Overall Study|Adverse Event|13|||
156768702|NCT03882918|565908543|FG000|Overall Study|Withdrawal by Subject|5|||
156768703|NCT01075048|565909979|FG000|Overall Study|Death|4|||
156768704|NCT01075048|565909980|FG001|Overall Study|Death|17|||
156768705|NCT01075048|565909981|FG002|Overall Study|Death|12|||
156768706|NCT01075048|565909979|FG000|Overall Study|Start of other or new therapy|4|||
156768707|NCT01075048|565909980|FG001|Overall Study|Start of other or new therapy|36|||
156768708|NCT01075048|565909981|FG002|Overall Study|Start of other or new therapy|46|||
156768709|NCT01075048|565909979|FG000|Overall Study|Withdrawal by Subject|1|||
156768710|NCT01075048|565909980|FG001|Overall Study|Withdrawal by Subject|6|||
156768711|NCT01075048|565909981|FG002|Overall Study|Withdrawal by Subject|3|||
156768712|NCT01075048|565909979|FG000|Overall Study|Lost to Follow-up|0|||
156768713|NCT01075048|565909980|FG001|Overall Study|Lost to Follow-up|1|||
156768714|NCT01075048|565909981|FG002|Overall Study|Lost to Follow-up|1|||
156768715|NCT01287936|565909986|FG000|Overall Study|Lost to Follow-up|0|||
156427730|NCT00121199|564658861|FG000|Overall Study|Other - Not Protocol Specified|3|||
156427731|NCT00121199|564658861|FG000|Overall Study|Ineligible|9|||
156427732|NCT03168438|564658862|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
156427733|NCT03168438|564658863|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
156427734|NCT04109118|564658866|FG000|Overall Study|Lost to Follow-up|3|||
156427735|NCT03235349|564658869|FG000|Overall Study|Adverse Event|1|||
156522579|NCT03184870|565007739|FG009|Crossover Treatment|Death|0|||
156768716|NCT01287936|565909987|FG001|Overall Study|Lost to Follow-up|1|||
156768717|NCT01287936|565909988|FG002|Overall Study|Lost to Follow-up|1|||
156427736|NCT03235349|564658869|FG000|Overall Study|Other|1|||
156427737|NCT03394027|564658870|FG000|Overall Study|Ineligible|3|||
156427738|NCT03394027|564658871|FG001|Overall Study|Ineligible|1|||
156427739|NCT03394027|564658872|FG002|Overall Study|Ineligible|3|||
156522580|NCT03184870|565007740|FG010|Crossover Treatment|Death|0|||
156768718|NCT00296244|565909989|FG000|Overall Study|Underwent retransplant|0|||
156768719|NCT00296244|565909990|FG001|Overall Study|Underwent retransplant|1|||
156768720|NCT00427934|565909991|FG000|Overall Study|Adverse Event|1|||
156768721|NCT00427934|565909992|FG001|Overall Study|Adverse Event|0|||
156768722|NCT00427934|565909993|FG002|Overall Study|Adverse Event|5|||
156768723|NCT00427934|565909994|FG003|Overall Study|Adverse Event|4|||
156427740|NCT03394027|564658870|FG000|Overall Study|Participant declined to participate before treatment started|0|||
156427741|NCT03394027|564658871|FG001|Overall Study|Participant declined to participate before treatment started|0|||
156427742|NCT03394027|564658872|FG002|Overall Study|Participant declined to participate before treatment started|1|||
156427743|NCT04305912|564658877|FG000|First Intervention|COVID-19 Suspension|2|||
156427744|NCT04305912|564658878|FG001|First Intervention|COVID-19 Suspension|0|||
156427745|NCT04305912|564658877|FG000|First Intervention|Withdrawal by Subject|0|||
156427746|NCT04305912|564658878|FG001|First Intervention|Withdrawal by Subject|1|||
156427747|NCT04305912|564658877|FG000|Second Intervention|Adverse Event|0|||
156427748|NCT04305912|564658878|FG001|Second Intervention|Adverse Event|1|||
156427749|NCT01348087|564658879|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
156427750|NCT01348087|564658879|FG000|Overall Study|Administrative problems|79|||
156427751|NCT01348087|564658879|FG000|Overall Study|protocol deviation|1|||
156427752|NCT01348087|564658879|FG000|Overall Study|Lost to Follow-up|1|||
156427753|NCT01348087|564658879|FG000|Overall Study|Subject withdrew consent|7|||
156427754|NCT01348087|564658879|FG000|Overall Study|Adverse Event|25|||
156427755|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
156427756|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
156768724|NCT00427934|565909991|FG000|Overall Study|Lack of Efficacy|0|||
156768725|NCT00427934|565909992|FG001|Overall Study|Lack of Efficacy|0|||
156768726|NCT00427934|565909993|FG002|Overall Study|Lack of Efficacy|5|||
156768727|NCT00427934|565909994|FG003|Overall Study|Lack of Efficacy|2|||
156768728|NCT00427934|565909991|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
156768729|NCT00427934|565909992|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
156768730|NCT00427934|565909993|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
156768731|NCT00427934|565909994|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
156768732|NCT00427934|565909991|FG000|Overall Study|Other|0|||
156768733|NCT00427934|565909992|FG001|Overall Study|Other|0|||
156768734|NCT00427934|565909993|FG002|Overall Study|Other|11|||
156768735|NCT00427934|565909994|FG003|Overall Study|Other|5|||
156768736|NCT00427934|565909991|FG000|Overall Study|Withdrawal by Subject|0|||
156427757|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
156427758|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
156427759|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
156427760|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
156427761|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
156427762|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
156427763|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
156427764|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
156427765|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
156427766|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
156427767|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156427768|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156427769|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156427770|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
156427771|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156427772|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156427773|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
156427774|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
156427775|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
156427776|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156427777|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156427778|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156427779|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156427780|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156427781|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156427782|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
156427783|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
156427784|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
156427785|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156427786|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156427787|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156427788|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156427789|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156768737|NCT00427934|565909992|FG001|Overall Study|Withdrawal by Subject|0|||
156768738|NCT00427934|565909993|FG002|Overall Study|Withdrawal by Subject|1|||
156768739|NCT00427934|565909994|FG003|Overall Study|Withdrawal by Subject|3|||
156768740|NCT00761319|565909995|FG000|Overall Study|Protocol Violation|21|||
156768741|NCT00761319|565909996|FG001|Overall Study|Protocol Violation|14|||
156768742|NCT00761319|565909995|FG000|Overall Study|Adverse Event|11|||
156768743|NCT00761319|565909996|FG001|Overall Study|Adverse Event|7|||
156768744|NCT00761319|565909995|FG000|Overall Study|Withdrawal by Subject|8|||
156768745|NCT00761319|565909996|FG001|Overall Study|Withdrawal by Subject|7|||
156768746|NCT00761319|565909995|FG000|Overall Study|Noncompliance|4|||
156768747|NCT00761319|565909996|FG001|Overall Study|Noncompliance|3|||
156768748|NCT00761319|565909995|FG000|Overall Study|Lost to Follow-up|1|||
156768749|NCT00761319|565909996|FG001|Overall Study|Lost to Follow-up|1|||
156768750|NCT00761319|565909995|FG000|Overall Study|Nonspecified|2|||
156768751|NCT00761319|565909996|FG001|Overall Study|Nonspecified|2|||
156768752|NCT00761319|565909995|FG000|Overall Study|Missing|1|||
156768753|NCT00761319|565909996|FG001|Overall Study|Missing|0|||
156768754|NCT03261401|565909999|FG000|Overall Study|Withdrawal by Subject|0|||
156768755|NCT03261401|565910000|FG001|Overall Study|Withdrawal by Subject|0|||
156768756|NCT03261401|565910001|FG002|Overall Study|Withdrawal by Subject|0|||
156768757|NCT03261401|565910002|FG003|Overall Study|Withdrawal by Subject|0|||
156768758|NCT03261401|565910003|FG004|Overall Study|Withdrawal by Subject|0|||
156768759|NCT03261401|565910004|FG005|Overall Study|Withdrawal by Subject|1|||
156768760|NCT03261401|565910005|FG006|Overall Study|Withdrawal by Subject|0|||
156768761|NCT03261401|565910006|FG007|Overall Study|Withdrawal by Subject|0|||
156768762|NCT03261401|565910007|FG008|Overall Study|Withdrawal by Subject|0|||
156768763|NCT03261401|565910008|FG009|Overall Study|Withdrawal by Subject|0|||
156768764|NCT03261401|565910009|FG010|Overall Study|Withdrawal by Subject|0|||
156768765|NCT03261401|565910010|FG011|Overall Study|Withdrawal by Subject|0|||
156768766|NCT03261401|565910011|FG012|Overall Study|Withdrawal by Subject|0|||
156768767|NCT03261401|565909999|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
156768768|NCT03261401|565910000|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
156768769|NCT03261401|565910001|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
156768770|NCT03261401|565910002|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
156768771|NCT03261401|565910003|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
156768772|NCT03261401|565910004|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
156768773|NCT03261401|565910005|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
156768774|NCT03261401|565910006|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
156768775|NCT03261401|565910007|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
156768776|NCT03261401|565910008|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
156768777|NCT03261401|565910009|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
156768778|NCT03261401|565910010|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
156768779|NCT03261401|565910011|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
156768780|NCT00915525|565910015|FG000|Overall Study|Protocol Violation|9|||
156768781|NCT00915525|565910016|FG001|Overall Study|Protocol Violation|4|||
156768782|NCT00915525|565910015|FG000|Overall Study|Withdrawal by Subject|59|||
156768783|NCT00915525|565910016|FG001|Overall Study|Withdrawal by Subject|21|||
156768784|NCT00915525|565910015|FG000|Overall Study|Lost to Follow-up|27|||
156768785|NCT00915525|565910016|FG001|Overall Study|Lost to Follow-up|16|||
156768786|NCT00915525|565910015|FG000|Overall Study|Pregnancy|2|||
156768787|NCT00915525|565910016|FG001|Overall Study|Pregnancy|0|||
156768788|NCT00915525|565910015|FG000|Overall Study|Lack of Efficacy|15|||
156768789|NCT00915525|565910016|FG001|Overall Study|Lack of Efficacy|32|||
156768790|NCT00915525|565910015|FG000|Overall Study|Adverse Event|29|||
156768791|NCT00915525|565910016|FG001|Overall Study|Adverse Event|13|||
156768792|NCT00915525|565910015|FG000|Overall Study|Missing|12|||
156768793|NCT00915525|565910016|FG001|Overall Study|Missing|1|||
156427790|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156768794|NCT00915525|565910015|FG000|Overall Study|Other Reason|35|||
156768795|NCT00915525|565910016|FG001|Overall Study|Other Reason|12|||
156768796|NCT00915525|565910015|FG000|Overall Study|Site Closed|27|||
156768797|NCT00915525|565910016|FG001|Overall Study|Site Closed|9|||
156427791|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
156427792|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
156427793|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
156427794|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156427795|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156427796|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156427797|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
156427798|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156427799|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156427800|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
156768798|NCT00915525|565910015|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
156768799|NCT00915525|565910016|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
156768800|NCT00915525|565910015|FG000|Overall Study|Study Burden|28|||
156768801|NCT00915525|565910016|FG001|Overall Study|Study Burden|12|||
156768802|NCT00915525|565910015|FG000|Overall Study|Non-Compliance|3|||
156768803|NCT00915525|565910016|FG001|Overall Study|Non-Compliance|1|||
156768804|NCT00915525|565910015|FG000|Overall Study|Patient Moved|15|||
156768805|NCT00915525|565910016|FG001|Overall Study|Patient Moved|9|||
156768806|NCT00577408|565910017|FG000|Overall Study|Stopped attending study visits|9|||
156768807|NCT00577408|565910018|FG001|Overall Study|Stopped attending study visits|11|||
156768808|NCT00577408|565910017|FG000|Overall Study|Continued opioid use|3|||
156768809|NCT00577408|565910018|FG001|Overall Study|Continued opioid use|2|||
156768810|NCT00577408|565910017|FG000|Overall Study|Non-compliance with study meds|0|||
156768811|NCT00577408|565910018|FG001|Overall Study|Non-compliance with study meds|3|||
156768812|NCT00577408|565910017|FG000|Overall Study|Refused Oral Naltrexone|0|||
156768813|NCT00577408|565910018|FG001|Overall Study|Refused Oral Naltrexone|1|||
156768814|NCT00577408|565910017|FG000|Overall Study|Moved out of state|0|||
156768815|NCT00577408|565910018|FG001|Overall Study|Moved out of state|1|||
156768816|NCT00577408|565910017|FG000|Overall Study|Scheduling Issues|0|||
156768817|NCT00577408|565910018|FG001|Overall Study|Scheduling Issues|3|||
156768818|NCT00577408|565910017|FG000|Overall Study|Death|0|||
156768819|NCT00577408|565910018|FG001|Overall Study|Death|1|||
156768820|NCT00577408|565910017|FG000|Overall Study|Psychiatric hospitalization|0|||
156768821|NCT00577408|565910018|FG001|Overall Study|Psychiatric hospitalization|1|||
156768822|NCT02765035|565910024|FG000|First Intervention (90 Days)|Adverse Event|1|||
156768823|NCT02765035|565910025|FG001|First Intervention (90 Days)|Adverse Event|1|||
156768824|NCT02765035|565910024|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
156323707|NCT01082640|564284235|FG000|Overall Study|Other|2|||
156323708|NCT01082640|564284236|FG001|Overall Study|Other|1|||
156323709|NCT01082640|564284237|FG002|Overall Study|Other|3|||
156323710|NCT03190369|564284242|FG000|Overall Study|Poor compliance to protocol|0|||
156323711|NCT03190369|564284243|FG001|Overall Study|Poor compliance to protocol|1|||
156323712|NCT03190369|564284242|FG000|Overall Study|Withdraw before treatment|1|||
156323713|NCT03190369|564284243|FG001|Overall Study|Withdraw before treatment|5|||
156323714|NCT03190369|564284242|FG000|Overall Study|Randomized but not treated|0|||
156323715|NCT03190369|564284243|FG001|Overall Study|Randomized but not treated|2|||
156323716|NCT01052844|564284246|FG000|Overall Study|Adverse Event|0|||
156323717|NCT01052844|564284247|FG001|Overall Study|Adverse Event|1|||
156323718|NCT00559754|564284251|FG000|Overall Study|Disease progression|1|||
156323719|NCT00559754|564284251|FG000|Overall Study|Adverse Event|5|||
156323720|NCT00559754|564284251|FG000|Overall Study|Protocol Violation|1|||
156323721|NCT00559754|564284251|FG000|Overall Study|Investigator criteria|2|||
156323722|NCT00559754|564284251|FG000|Overall Study|Withdrawal by Subject|2|||
156323723|NCT01264016|564284252|FG000|Overall Study|Withdrawal by Subject|1|||
156323724|NCT01264016|564284252|FG000|Overall Study|Felt faint at sight of blood|1|||
156323725|NCT01629706|564284253|FG000|Phase 1 PureVision|Screen Failure|4|||
156323726|NCT01629706|564284253|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
156323727|NCT01629706|564284253|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
156323728|NCT01629706|564284253|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
156323729|NCT01629706|564284253|FG000|Phase 2 Habitual|Screen Failure|6|||
156323730|NCT01629706|564284253|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
156323731|NCT01629706|564284253|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
156323732|NCT01629706|564284253|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
156323733|NCT01629706|564284253|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
156323734|NCT01439347|564284254|FG000|Overall Study|Death|10|||
156323735|NCT01439347|564284255|FG001|Overall Study|Death|9|||
156323736|NCT01439347|564284254|FG000|Overall Study|Withdrawal by Subject|0|||
156323737|NCT01439347|564284255|FG001|Overall Study|Withdrawal by Subject|1|||
156323738|NCT01439347|564284254|FG000|Overall Study|Physician Decision|1|||
156323739|NCT01439347|564284255|FG001|Overall Study|Physician Decision|0|||
156323740|NCT01439347|564284254|FG000|Overall Study|Sponsor Terminated Study|2|||
156323741|NCT01439347|564284255|FG001|Overall Study|Sponsor Terminated Study|3|||
156323742|NCT03519386|564284257|FG000|Overall Study|Withdrawal by Subject|4|||
156323743|NCT03519386|564284258|FG001|Overall Study|Withdrawal by Subject|1|||
156323744|NCT03519386|564284259|FG002|Overall Study|Withdrawal by Subject|2|||
156323745|NCT03519386|564284257|FG000|Overall Study|Physician Decision|1|||
156323746|NCT03519386|564284258|FG001|Overall Study|Physician Decision|1|||
156323747|NCT03519386|564284259|FG002|Overall Study|Physician Decision|1|||
156323748|NCT03519386|564284257|FG000|Overall Study|Lost to Follow-up|0|||
156323749|NCT03519386|564284258|FG001|Overall Study|Lost to Follow-up|1|||
156323750|NCT03519386|564284259|FG002|Overall Study|Lost to Follow-up|1|||
156323751|NCT03519386|564284257|FG000|Overall Study|Death|1|||
156323752|NCT03519386|564284258|FG001|Overall Study|Death|0|||
156323753|NCT03519386|564284259|FG002|Overall Study|Death|4|||
156323754|NCT03519386|564284257|FG000|Overall Study|Adverse Event|2|||
156323755|NCT03519386|564284258|FG001|Overall Study|Adverse Event|1|||
156323756|NCT03519386|564284259|FG002|Overall Study|Adverse Event|2|||
156323757|NCT03519386|564284257|FG000|Overall Study|Explanted|2|||
156323758|NCT03519386|564284258|FG001|Overall Study|Explanted|1|||
156427801|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156323759|NCT03519386|564284259|FG002|Overall Study|Explanted|0|||
156427802|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156768825|NCT02765035|565910025|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
156768826|NCT02732639|565910031|FG000|Overall Study|Lost to Follow-up|1|||
156768827|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
156768828|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
156768829|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
156768830|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
156768831|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
156768832|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
156768833|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
156768834|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
156768835|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
156768836|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
156768837|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
156768838|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
156768839|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
156768840|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
156768841|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
156768842|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
156768843|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
156768844|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
156768845|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
156768846|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
156768847|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
156768848|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
156768849|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
156768850|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
156768851|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
156768852|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
156768853|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
156768854|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
156768855|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
156768856|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
156768857|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
156768858|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
156768859|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
156768860|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
156768861|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
156768862|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
156768863|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
156768864|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
156768865|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
156768866|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
156768867|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
156768868|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
156768869|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
156768870|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
156768871|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
156768872|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
156768873|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
156768874|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
156768875|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
156768876|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
156768877|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
156768878|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
156768879|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
156768880|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
156768881|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
156768882|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
156768883|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
156768884|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
156768885|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
156768886|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
156768887|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
156768888|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
156323760|NCT03519386|564284257|FG000|Overall Study|Ongoing in study|190|||
156323761|NCT03519386|564284258|FG001|Overall Study|Ongoing in study|192|||
156323762|NCT03519386|564284259|FG002|Overall Study|Ongoing in study|183|||
156323763|NCT00484185|564284260|FG000|Overall Study|Lost to Follow-up|44|||
156768889|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
156323764|NCT00484185|564284260|FG000|Overall Study|Other|20|||
156323765|NCT00484185|564284260|FG000|Overall Study|Randomized but not treated|5|||
156768890|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
156768891|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
156768892|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
156768893|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
156768894|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
156768895|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
156768896|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
156768897|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
156768898|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
156768899|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
156768900|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
156768901|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
156768902|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
156768903|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
156768904|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
156768905|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
156768906|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
156427803|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156427804|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156427805|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156768907|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
156768908|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
156768909|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
156768910|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
156768911|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
156768912|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
156768913|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
156768914|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
156768915|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
156768916|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
156768917|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
156768918|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
156768919|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
156768920|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
156768921|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
156768922|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
156768923|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
156768924|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
156768925|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
156768926|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
156768927|NCT00827567|565910036|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
156768928|NCT01259245|565910039|FG000|Overall Study|Withdrawal by Subject|27|||
156768929|NCT01259245|565910040|FG001|Overall Study|Withdrawal by Subject|24|||
156768930|NCT01259245|565910039|FG000|Overall Study|Death|1|||
156768931|NCT01259245|565910040|FG001|Overall Study|Death|2|||
156768932|NCT00296335|565910048|FG000|Overall Study|Recurrence|3|||
156768933|NCT00296335|565910049|FG001|Overall Study|Recurrence|51|||
156768934|NCT00296335|565910048|FG000|Overall Study|Adverse Event|17|||
156768935|NCT00296335|565910049|FG001|Overall Study|Adverse Event|27|||
156768936|NCT00296335|565910048|FG000|Overall Study|Lost to Follow-up|7|||
156768937|NCT00296335|565910049|FG001|Overall Study|Lost to Follow-up|33|||
156768938|NCT00296335|565910048|FG000|Overall Study|Physician Decision|3|||
156768939|NCT00296335|565910049|FG001|Overall Study|Physician Decision|11|||
156768940|NCT03895086|565910056|FG000|Overall Study|Early termination study|1|||
156768941|NCT03895086|565910057|FG001|Overall Study|Early termination study|0|||
156768942|NCT04656652|565910058|FG000|Overall Study|Lost to Follow-up|2|||
156427806|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156427807|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156427808|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156427809|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156522581|NCT03184870|565007741|FG011|Crossover Treatment|Death|0|||
156768943|NCT04656652|565910059|FG001|Overall Study|Lost to Follow-up|2|||
156768944|NCT04656652|565910058|FG000|Overall Study|Death|213|||
156427810|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
156768945|NCT04656652|565910059|FG001|Overall Study|Death|212|||
156768946|NCT04656652|565910058|FG000|Overall Study|Other|1|||
156768947|NCT04656652|565910059|FG001|Overall Study|Other|0|||
156427811|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156768948|NCT04656652|565910058|FG000|Overall Study|Withdrawal by Subject|15|||
156768949|NCT04656652|565910059|FG001|Overall Study|Withdrawal by Subject|29|||
156768950|NCT01192815|565910060|FG000|Overall Study|Withdrawal by Subject|1|||
156323766|NCT00484185|564284260|FG000|Overall Study|Death|2|||
156323767|NCT01298193|564284261|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
156323768|NCT01298193|564284261|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
156323769|NCT01298193|564284261|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
156323770|NCT01298193|564284261|FG000|Efficacy Phase (Second Cycle)|Death|1|||
156323771|NCT03189381|564284262|FG000|Overall Study|Death|1|||
156323772|NCT03189381|564284263|FG001|Overall Study|Death|0|||
156323773|NCT00107952|564284264|FG000|Overall Study|Death|75|||
156323774|NCT00107952|564284265|FG001|Overall Study|Death|61|||
156323775|NCT00107952|564284264|FG000|Overall Study|Lost to Follow-up|0|||
156323776|NCT00107952|564284265|FG001|Overall Study|Lost to Follow-up|3|||
156323777|NCT00107952|564284264|FG000|Overall Study|Withdrawal by Subject|9|||
156323778|NCT00107952|564284265|FG001|Overall Study|Withdrawal by Subject|6|||
156323779|NCT00107952|564284264|FG000|Overall Study|Other|2|||
156323780|NCT00107952|564284265|FG001|Overall Study|Other|5|||
156323781|NCT00107952|564284264|FG000|Overall Study|Never received study treatment|9|||
156323782|NCT00107952|564284265|FG001|Overall Study|Never received study treatment|6|||
156323783|NCT00251004|564284266|FG000|Overall Study|Withdrawal by Subject|23|||
156323784|NCT00251004|564284267|FG001|Overall Study|Withdrawal by Subject|16|||
156323785|NCT00251004|564284268|FG002|Overall Study|Withdrawal by Subject|14|||
156323786|NCT00251004|564284266|FG000|Overall Study|Death|9|||
156323787|NCT00251004|564284267|FG001|Overall Study|Death|10|||
156323788|NCT00251004|564284268|FG002|Overall Study|Death|8|||
156323789|NCT00251004|564284266|FG000|Overall Study|Lost to Follow-up|1|||
156323790|NCT00251004|564284267|FG001|Overall Study|Lost to Follow-up|2|||
156323791|NCT00251004|564284268|FG002|Overall Study|Lost to Follow-up|1|||
156323792|NCT00251004|564284266|FG000|Overall Study|Graft Loss|12|||
156323793|NCT00251004|564284267|FG001|Overall Study|Graft Loss|13|||
156323794|NCT00251004|564284268|FG002|Overall Study|Graft Loss|8|||
156323795|NCT03475875|564284269|FG000|Period 1|Lost to Follow-up|1|||
156323796|NCT03475875|564284270|FG001|Period 1|Lost to Follow-up|0|||
156323797|NCT03475875|564284269|FG000|Period 1|Adverse Event|2|||
156323798|NCT03475875|564284270|FG001|Period 1|Adverse Event|1|||
156323799|NCT03475875|564284269|FG000|Period 2|Adverse Event|3|||
156323800|NCT03475875|564284270|FG001|Period 2|Adverse Event|0|||
156323801|NCT03475875|564284269|FG000|Period 2|Protocol Violation|0|||
156323802|NCT03475875|564284270|FG001|Period 2|Protocol Violation|1|||
156323803|NCT02632838|564284273|FG000|Overall Study|Withdrawal by Subject|3|||
156323804|NCT02632838|564284274|FG001|Overall Study|Withdrawal by Subject|0|||
156323805|NCT02632838|564284273|FG000|Overall Study|Lost to Follow-up|0|||
156323806|NCT02632838|564284274|FG001|Overall Study|Lost to Follow-up|2|||
156323807|NCT03945175|564284275|FG000|Overall Study|Did not meet inclusion criteria|31|||
156323808|NCT03945175|564284275|FG000|Overall Study|Withdrew consent|2|||
156323809|NCT03945175|564284275|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
156323810|NCT03945175|564284275|FG000|Overall Study|Early termination during Mydayis treatment|1|||
156323811|NCT01369485|564284276|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
156323812|NCT01369485|564284277|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
156323813|NCT01369485|564284276|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
156323814|NCT01369485|564284277|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
156323815|NCT01369485|564284276|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
156323816|NCT01369485|564284277|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
156323817|NCT01369485|564284276|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
156323818|NCT01369485|564284277|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
156323819|NCT01369485|564284276|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
156323820|NCT01369485|564284277|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
156323821|NCT01369485|564284276|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
156323822|NCT01369485|564284277|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
156323823|NCT01369485|564284276|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
156323824|NCT01369485|564284277|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
156323825|NCT01369485|564284276|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
156323826|NCT01369485|564284277|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
156323827|NCT01369485|564284276|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
156323828|NCT01369485|564284277|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
156427812|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156323829|NCT01369485|564284276|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
156323830|NCT01369485|564284277|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
156323831|NCT02942576|564284278|FG000|Overall Study|Adverse Event|28|||
156323832|NCT02942576|564284279|FG001|Overall Study|Adverse Event|6|||
156323833|NCT02942576|564284278|FG000|Overall Study|Withdrawal by Subject|7|||
156768951|NCT01192815|565910060|FG000|Overall Study|Lack of Efficacy|1|||
156768952|NCT03451045|565910061|FG000|Overall Study|Lack of Efficacy|3|||
156768953|NCT03451045|565910062|FG001|Overall Study|Lack of Efficacy|2|||
156768954|NCT03451045|565910063|FG002|Overall Study|Lack of Efficacy|2|||
156768955|NCT03451045|565910061|FG000|Overall Study|Physician Decision|1|||
156768956|NCT03451045|565910062|FG001|Overall Study|Physician Decision|1|||
156768957|NCT03451045|565910063|FG002|Overall Study|Physician Decision|1|||
156768958|NCT03451045|565910061|FG000|Overall Study|Withdrawal by Subject|4|||
156768959|NCT03451045|565910062|FG001|Overall Study|Withdrawal by Subject|0|||
156768960|NCT03451045|565910063|FG002|Overall Study|Withdrawal by Subject|5|||
156768961|NCT03451045|565910061|FG000|Overall Study|Pregnancy|0|||
156768962|NCT03451045|565910062|FG001|Overall Study|Pregnancy|0|||
156768963|NCT03451045|565910063|FG002|Overall Study|Pregnancy|2|||
156768964|NCT03451045|565910061|FG000|Overall Study|Adverse Event|7|||
156768965|NCT03451045|565910062|FG001|Overall Study|Adverse Event|1|||
156768966|NCT03451045|565910063|FG002|Overall Study|Adverse Event|3|||
156768967|NCT03451045|565910061|FG000|Overall Study|Non-compliance with study|2|||
156768968|NCT03451045|565910062|FG001|Overall Study|Non-compliance with study|0|||
156768969|NCT03451045|565910063|FG002|Overall Study|Non-compliance with study|1|||
156768970|NCT03451045|565910061|FG000|Overall Study|any other reason|10|||
156768971|NCT03451045|565910062|FG001|Overall Study|any other reason|2|||
156768972|NCT03451045|565910063|FG002|Overall Study|any other reason|13|||
156768973|NCT01142336|565910064|FG000|Overall Study|Adverse Event|1|||
156768974|NCT01142336|565910065|FG001|Overall Study|Adverse Event|1|||
156768975|NCT01142336|565910064|FG000|Overall Study|Lost to Follow-up|0|||
156768976|NCT01142336|565910065|FG001|Overall Study|Lost to Follow-up|1|||
156768977|NCT02722967|565910066|FG000|Overall Study|Adverse Event|1|||
156768978|NCT02722967|565910067|FG001|Overall Study|Adverse Event|0|||
156768979|NCT02722967|565910068|FG002|Overall Study|Adverse Event|0|||
156768980|NCT02722967|565910066|FG000|Overall Study|Lost to Follow-up|0|||
156768981|NCT02722967|565910067|FG001|Overall Study|Lost to Follow-up|1|||
156768982|NCT02722967|565910068|FG002|Overall Study|Lost to Follow-up|0|||
156768983|NCT02722967|565910066|FG000|Overall Study|Non-compliance with patch wearing|2|||
156768984|NCT02722967|565910067|FG001|Overall Study|Non-compliance with patch wearing|1|||
156768985|NCT02722967|565910068|FG002|Overall Study|Non-compliance with patch wearing|1|||
156768986|NCT02722967|565910066|FG000|Overall Study|Withdrawal by Subject|1|||
156768987|NCT02722967|565910067|FG001|Overall Study|Withdrawal by Subject|0|||
156768988|NCT02722967|565910068|FG002|Overall Study|Withdrawal by Subject|1|||
156768989|NCT02722967|565910066|FG000|Overall Study|Physician Decision|1|||
156768990|NCT02722967|565910067|FG001|Overall Study|Physician Decision|0|||
156768991|NCT02722967|565910068|FG002|Overall Study|Physician Decision|0|||
156768992|NCT02722967|565910066|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
156768993|NCT02722967|565910067|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
156768994|NCT02722967|565910068|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
156768995|NCT01123655|565910071|FG000|Overall Study|Medication for RA had to be changed|1|||
156768996|NCT01123655|565910072|FG001|Overall Study|Medication for RA had to be changed|0|||
156768997|NCT01123655|565910073|FG002|Overall Study|Medication for RA had to be changed|0|||
156768998|NCT01123655|565910071|FG000|Overall Study|new illness|0|||
156768999|NCT01123655|565910072|FG001|Overall Study|new illness|1|||
156769000|NCT01123655|565910073|FG002|Overall Study|new illness|0|||
156769001|NCT01123655|565910071|FG000|Overall Study|began prohibitive drug|0|||
156769002|NCT01123655|565910072|FG001|Overall Study|began prohibitive drug|0|||
156769003|NCT01123655|565910073|FG002|Overall Study|began prohibitive drug|1|||
156769004|NCT00062166|565910074|FG000|Overall Study|Withdrawal by Subject|6|||
156769005|NCT06996301|565910076|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
156769006|NCT06996301|565910077|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
156769007|NCT06996301|565910076|FG000|Overall Study|Patients with discordant diagnostic results|107|||
156769008|NCT06996301|565910077|FG001|Overall Study|Patients with discordant diagnostic results|90|||
156769009|NCT06996301|565910076|FG000|Overall Study|Lost to Follow-up|31|||
156769010|NCT06996301|565910077|FG001|Overall Study|Lost to Follow-up|56|||
156769011|NCT06996301|565910076|FG000|Overall Study|Withdrawal by Subject|12|||
156769012|NCT06996301|565910077|FG001|Overall Study|Withdrawal by Subject|7|||
156769013|NCT04030598|565910078|FG000|Overall Study|Voluntary Withdrawal|0|||
156769014|NCT04030598|565910079|FG001|Overall Study|Voluntary Withdrawal|1|||
156427813|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156769015|NCT04030598|565910080|FG002|Overall Study|Voluntary Withdrawal|0|||
156769016|NCT05117060|565910083|FG000|Overall Study|Adverse Event|3|||
156769017|NCT05117060|565910084|FG001|Overall Study|Adverse Event|5|||
156769018|NCT05117060|565910085|FG002|Overall Study|Adverse Event|6|||
156769019|NCT05117060|565910086|FG003|Overall Study|Adverse Event|1|||
156769020|NCT05117060|565910083|FG000|Overall Study|Lost to Follow-up|0|||
156769021|NCT05117060|565910084|FG001|Overall Study|Lost to Follow-up|0|||
156769022|NCT05117060|565910085|FG002|Overall Study|Lost to Follow-up|0|||
156769023|NCT05117060|565910086|FG003|Overall Study|Lost to Follow-up|1|||
156769024|NCT05117060|565910083|FG000|Overall Study|Lack of Efficacy|4|||
156769025|NCT05117060|565910084|FG001|Overall Study|Lack of Efficacy|5|||
156769026|NCT05117060|565910085|FG002|Overall Study|Lack of Efficacy|2|||
156769027|NCT05117060|565910086|FG003|Overall Study|Lack of Efficacy|6|||
156769028|NCT05117060|565910083|FG000|Overall Study|Withdrawal by Subject|8|||
156769029|NCT05117060|565910084|FG001|Overall Study|Withdrawal by Subject|5|||
156769030|NCT05117060|565910085|FG002|Overall Study|Withdrawal by Subject|5|||
156769031|NCT05117060|565910086|FG003|Overall Study|Withdrawal by Subject|6|||
156427814|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427815|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427816|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427817|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427818|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156427819|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156427820|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
156427821|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156427822|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156427823|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156427824|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156427825|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156427826|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156427827|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
156427828|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156427829|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156427830|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156427831|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156427832|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156427833|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156427834|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156427835|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156427836|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
156427837|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156427838|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156427839|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156427840|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156427841|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156427842|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156427843|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156427844|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156427845|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
156427846|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156427847|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156427848|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156427849|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156427850|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156427851|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156427852|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156427853|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156427854|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427855|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
156427856|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
156427857|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427858|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427859|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427860|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427861|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427862|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156427863|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
156427864|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
156427865|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156427866|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156427867|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156427868|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156427869|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156427870|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156769032|NCT05117060|565910083|FG000|Overall Study|Other|2|||
156769033|NCT05117060|565910084|FG001|Overall Study|Other|1|||
156427871|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156427872|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156427873|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
156769034|NCT05117060|565910085|FG002|Overall Study|Other|3|||
156769035|NCT05117060|565910086|FG003|Overall Study|Other|1|||
156769036|NCT03141359|565910087|FG000|Overall Study|Death|32|||
156769037|NCT03141359|565910087|FG000|Overall Study|Still On Study (in follow up)|29|||
156769038|NCT05079321|565910088|FG000|Overall Study|Withdrawal by Subject|2|||
156769039|NCT05079321|565910089|FG001|Overall Study|Withdrawal by Subject|2|||
156769040|NCT05079321|565910088|FG000|Overall Study|Lost to Follow-up|0|||
156769041|NCT05079321|565910089|FG001|Overall Study|Lost to Follow-up|1|||
156769042|NCT02097823|565910090|FG000|Overall Study|Withdrawal by Subject|1|||
156769043|NCT02097823|565910091|FG001|Overall Study|Withdrawal by Subject|1|||
156769044|NCT01081626|565910092|FG000|Overall Study|Dosing error|1|||
156769045|NCT01081626|565910093|FG001|Overall Study|Dosing error|1|||
156769046|NCT01081626|565910092|FG000|Overall Study|Missing Estradiol|25|||
156769047|NCT01081626|565910093|FG001|Overall Study|Missing Estradiol|28|||
156769048|NCT01081626|565910092|FG000|Overall Study|Low antral follicle count|1|||
156769049|NCT01081626|565910093|FG001|Overall Study|Low antral follicle count|0|||
156769050|NCT01081626|565910092|FG000|Overall Study|Overstimulation|0|||
156769051|NCT01081626|565910093|FG001|Overall Study|Overstimulation|1|||
156769052|NCT01081626|565910092|FG000|Overall Study|Lost to Follow-up|0|||
156769053|NCT01081626|565910093|FG001|Overall Study|Lost to Follow-up|1|||
156769054|NCT01081626|565910092|FG000|Overall Study|Other|33|||
156769055|NCT01081626|565910093|FG001|Overall Study|Other|30|||
156769056|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Other than specified|2|||
156769057|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Other than specified|4|||
156769058|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
156769059|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
156769060|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Pregnancy|0|||
156769061|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Pregnancy|2|||
156769062|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Physician Decision|1|||
156769063|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Physician Decision|1|||
156769064|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
156769065|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
156769066|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Adverse Event|2|||
156769067|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Adverse Event|1|||
156769068|NCT01419535|565910097|FG000|Overall Study|could not maintain iv line|1|||
156769069|NCT01419535|565910098|FG001|Overall Study|could not maintain iv line|1|||
156769070|NCT01419535|565910097|FG000|Overall Study|Withdrawal by Subject|0|||
156769071|NCT01419535|565910098|FG001|Overall Study|Withdrawal by Subject|1|||
156769072|NCT04239924|565910103|FG000|Overall Study|Lost to Follow-up|2|||
156769073|NCT03759379|565911728|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
156769074|NCT03759379|565911729|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
156769075|NCT03759379|565911728|FG000|Treatment Period|Death|2|||
156769076|NCT03759379|565911729|FG001|Treatment Period|Death|3|||
156769077|NCT03759379|565911728|FG000|Treatment Period|Lost to Follow-up|1|||
156769078|NCT03759379|565911729|FG001|Treatment Period|Lost to Follow-up|0|||
156769079|NCT03759379|565911728|FG000|Treatment Period|Physician Decision|0|||
156769080|NCT03759379|565911729|FG001|Treatment Period|Physician Decision|1|||
156427874|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156427875|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156427876|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156427877|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156427878|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156427879|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156427880|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156769081|NCT05399680|565911730|FG000|Overall Study|Lost to Follow-up|1|||
156427881|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156769082|NCT05399680|565911731|FG001|Overall Study|Lost to Follow-up|0|||
156769083|NCT05399680|565911730|FG000|Overall Study|Death|0|||
156769084|NCT05399680|565911731|FG001|Overall Study|Death|1|||
156427882|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
156769085|NCT02659865|565911732|FG000|Period 1|Withdrawal by Subject|1|||
156769086|NCT02659865|565911733|FG001|Period 1|Withdrawal by Subject|0|||
156769087|NCT02659865|565911734|FG002|Period 1|Withdrawal by Subject|0|||
156427883|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156769088|NCT02659865|565911735|FG003|Period 1|Withdrawal by Subject|0|||
156427884|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156769089|NCT02659865|565911736|FG004|Period 1|Withdrawal by Subject|0|||
156769090|NCT02659865|565911732|FG000|Period 1|Adverse Event|0|||
156769091|NCT02659865|565911733|FG001|Period 1|Adverse Event|0|||
156769092|NCT02659865|565911734|FG002|Period 1|Adverse Event|0|||
156769093|NCT02659865|565911735|FG003|Period 1|Adverse Event|0|||
156427885|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156427886|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156427887|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156427888|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156427889|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156427890|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156427891|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156427892|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
156427893|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156427894|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156427895|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156427896|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156427897|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156427898|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156427899|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156427900|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156427901|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
156427902|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156427903|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156427904|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156427905|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156427906|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156427907|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156427908|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156427909|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156427910|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
156427911|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156427912|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156427913|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156427914|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156427915|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156427916|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156427917|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156427918|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156427919|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156427920|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156427921|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156427922|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156427923|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
156427924|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156427925|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156427926|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
156427927|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
156427928|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156427929|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156427930|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156427931|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156427932|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156427933|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156427934|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156522582|NCT03184870|565007742|FG012|Crossover Treatment|Death|0|||
156656948|NCT01200394|565489497|FG000|Overall Study|Withdrawal by Subject|0|||
156656949|NCT01200394|565489498|FG001|Overall Study|Withdrawal by Subject|5|||
156656950|NCT01200394|565489497|FG000|Overall Study|Other|0|||
156656951|NCT01200394|565489498|FG001|Overall Study|Other|1|||
156656952|NCT02729896|565489501|FG000|Overall Study|Death|0|||
156656953|NCT02729896|565489502|FG001|Overall Study|Death|2|||
156656954|NCT02729896|565489503|FG002|Overall Study|Death|13|||
156656955|NCT02729896|565489501|FG000|Overall Study|Lost to Follow-up|0|||
156427935|NCT03598790|564660749|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156427936|NCT03598790|564660750|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156427937|NCT03598790|564660751|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
156427938|NCT03598790|564660752|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156427939|NCT03598790|564660753|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156427940|NCT03598790|564660754|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156427941|NCT03598790|564660755|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156427942|NCT03598790|564660756|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156427943|NCT03598790|564660757|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156427944|NCT03598790|564660749|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156427945|NCT03598790|564660750|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156427946|NCT03598790|564660751|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156427947|NCT03598790|564660752|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
156427948|NCT03598790|564660753|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
156427949|NCT03598790|564660754|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
156427950|NCT03598790|564660755|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156427951|NCT03598790|564660756|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156427952|NCT03598790|564660757|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156427953|NCT03598790|564660749|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156427954|NCT03598790|564660750|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156427955|NCT03598790|564660751|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156427956|NCT03598790|564660752|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
156427957|NCT03598790|564660753|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156427958|NCT03598790|564660754|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156427959|NCT03598790|564660755|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156427960|NCT03598790|564660756|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156427961|NCT03598790|564660757|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156427962|NCT03598790|564660749|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156427963|NCT03598790|564660750|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156427964|NCT03598790|564660751|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156427965|NCT03598790|564660752|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
156427966|NCT03598790|564660753|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156427967|NCT03598790|564660754|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156427968|NCT03598790|564660755|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156427969|NCT03598790|564660756|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156427970|NCT03598790|564660757|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156427971|NCT03598790|564660749|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156427972|NCT03598790|564660750|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156427973|NCT03598790|564660751|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156427974|NCT03598790|564660752|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
156427975|NCT03598790|564660753|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
156427976|NCT03598790|564660754|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156427977|NCT03598790|564660755|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156427978|NCT03598790|564660756|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156427979|NCT03598790|564660757|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156427980|NCT03598790|564660749|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156427981|NCT03598790|564660750|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156427982|NCT03598790|564660751|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156427983|NCT03598790|564660752|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
156427984|NCT03598790|564660753|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156427985|NCT03598790|564660754|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156427986|NCT03598790|564660755|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156427987|NCT03598790|564660756|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156427988|NCT03598790|564660757|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156427989|NCT05570006|564660758|FG000|Overall Study|Lost to Follow-up|2|||
156427990|NCT05570006|564660758|FG000|Overall Study|Withdrawal by Subject|5|||
156427991|NCT05570006|564660758|FG000|Overall Study|Other than Specified|5|||
156427992|NCT03410992|564660766|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156427993|NCT03410992|564660767|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
156427994|NCT03410992|564660768|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156427995|NCT03410992|564660769|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156769094|NCT02659865|565911736|FG004|Period 1|Adverse Event|1|||
156769095|NCT03675308|565911737|FG000|Overall Study|Adverse Event|3|||
156656956|NCT02729896|565489502|FG001|Overall Study|Lost to Follow-up|2|||
156323834|NCT02942576|564284279|FG001|Overall Study|Withdrawal by Subject|5|||
156323835|NCT02942576|564284278|FG000|Overall Study|Physician Decision|1|||
156323836|NCT02942576|564284279|FG001|Overall Study|Physician Decision|4|||
156323837|NCT02942576|564284278|FG000|Overall Study|Other|10|||
156323838|NCT02942576|564284279|FG001|Overall Study|Other|8|||
156323839|NCT00006389|564284280|FG000|Overall Study|Adverse Event|1|||
156323840|NCT01017575|564284288|FG000|Overall Study|Lack of Efficacy|0|||
156323841|NCT01017575|564284289|FG001|Overall Study|Lack of Efficacy|1|||
156323842|NCT01017575|564284290|FG002|Overall Study|Lack of Efficacy|0|||
156323843|NCT01017575|564284291|FG003|Overall Study|Lack of Efficacy|1|||
156323844|NCT01017575|564284292|FG004|Overall Study|Lack of Efficacy|1|||
156323845|NCT01017575|564284288|FG000|Overall Study|Adverse Event|0|||
156323846|NCT01017575|564284289|FG001|Overall Study|Adverse Event|1|||
156323847|NCT01017575|564284290|FG002|Overall Study|Adverse Event|0|||
156323848|NCT01017575|564284291|FG003|Overall Study|Adverse Event|0|||
156323849|NCT01017575|564284292|FG004|Overall Study|Adverse Event|2|||
156323850|NCT01017575|564284288|FG000|Overall Study|Withdrawal by Subject|1|||
156323851|NCT01017575|564284289|FG001|Overall Study|Withdrawal by Subject|0|||
156323852|NCT01017575|564284290|FG002|Overall Study|Withdrawal by Subject|0|||
156323853|NCT01017575|564284291|FG003|Overall Study|Withdrawal by Subject|0|||
156323854|NCT01017575|564284292|FG004|Overall Study|Withdrawal by Subject|0|||
156323855|NCT01962922|564284295|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
156323856|NCT01962922|564284296|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
156323857|NCT01962922|564284295|FG000|PK Portion Day 7|non-compliance|1|||
156323858|NCT01962922|564284296|FG001|PK Portion Day 7|non-compliance|0|||
156656957|NCT02729896|565489503|FG002|Overall Study|Lost to Follow-up|3|||
156656958|NCT02729896|565489501|FG000|Overall Study|Other|0|||
156656959|NCT02729896|565489502|FG001|Overall Study|Other|2|||
156656960|NCT02729896|565489503|FG002|Overall Study|Other|0|||
156656961|NCT02729896|565489501|FG000|Overall Study|Physician Decision|1|||
156656962|NCT02729896|565489502|FG001|Overall Study|Physician Decision|2|||
156656963|NCT02729896|565489503|FG002|Overall Study|Physician Decision|3|||
156656964|NCT02729896|565489501|FG000|Overall Study|Progressive Disease|0|||
156656965|NCT02729896|565489502|FG001|Overall Study|Progressive Disease|1|||
156656966|NCT02729896|565489503|FG002|Overall Study|Progressive Disease|0|||
156656967|NCT02729896|565489501|FG000|Overall Study|Withdrawal by Subject|1|||
156656968|NCT02729896|565489502|FG001|Overall Study|Withdrawal by Subject|0|||
156656969|NCT02729896|565489503|FG002|Overall Study|Withdrawal by Subject|3|||
156656970|NCT01592370|565489507|FG000|Overall Study|Disease Progression|62|||
156656971|NCT01592370|565489508|FG001|Overall Study|Disease Progression|16|||
156656972|NCT01592370|565489509|FG002|Overall Study|Disease Progression|52|||
156656973|NCT01592370|565489510|FG003|Overall Study|Disease Progression|3|||
156656974|NCT01592370|565489511|FG004|Overall Study|Disease Progression|3|||
156656975|NCT01592370|565489512|FG005|Overall Study|Disease Progression|31|||
156656976|NCT01592370|565489513|FG006|Overall Study|Disease Progression|14|||
156656977|NCT01592370|565489507|FG000|Overall Study|Study Drug Toxicity|14|||
156656978|NCT01592370|565489508|FG001|Overall Study|Study Drug Toxicity|3|||
156656979|NCT01592370|565489509|FG002|Overall Study|Study Drug Toxicity|0|||
156656980|NCT01592370|565489510|FG003|Overall Study|Study Drug Toxicity|0|||
156656981|NCT01592370|565489511|FG004|Overall Study|Study Drug Toxicity|0|||
156656982|NCT01592370|565489512|FG005|Overall Study|Study Drug Toxicity|0|||
156656983|NCT01592370|565489513|FG006|Overall Study|Study Drug Toxicity|1|||
156656984|NCT01592370|565489507|FG000|Overall Study|AE unrelated to study drug|4|||
156656985|NCT01592370|565489508|FG001|Overall Study|AE unrelated to study drug|3|||
156656986|NCT01592370|565489509|FG002|Overall Study|AE unrelated to study drug|0|||
156656987|NCT01592370|565489510|FG003|Overall Study|AE unrelated to study drug|0|||
156656988|NCT01592370|565489511|FG004|Overall Study|AE unrelated to study drug|0|||
156656989|NCT01592370|565489512|FG005|Overall Study|AE unrelated to study drug|0|||
156656990|NCT01592370|565489513|FG006|Overall Study|AE unrelated to study drug|1|||
156656991|NCT01592370|565489507|FG000|Overall Study|Request to discontinue study treatment|5|||
156656992|NCT01592370|565489508|FG001|Overall Study|Request to discontinue study treatment|0|||
156656993|NCT01592370|565489509|FG002|Overall Study|Request to discontinue study treatment|2|||
156656994|NCT01592370|565489510|FG003|Overall Study|Request to discontinue study treatment|0|||
156656995|NCT01592370|565489511|FG004|Overall Study|Request to discontinue study treatment|1|||
156656996|NCT01592370|565489512|FG005|Overall Study|Request to discontinue study treatment|2|||
156656997|NCT01592370|565489513|FG006|Overall Study|Request to discontinue study treatment|0|||
156656998|NCT01592370|565489507|FG000|Overall Study|Withdrew consent|1|||
156656999|NCT01592370|565489508|FG001|Overall Study|Withdrew consent|2|||
156657000|NCT01592370|565489509|FG002|Overall Study|Withdrew consent|1|||
156657001|NCT01592370|565489510|FG003|Overall Study|Withdrew consent|1|||
156657002|NCT01592370|565489511|FG004|Overall Study|Withdrew consent|0|||
156657003|NCT01592370|565489512|FG005|Overall Study|Withdrew consent|0|||
156657004|NCT01592370|565489513|FG006|Overall Study|Withdrew consent|0|||
156657005|NCT01592370|565489507|FG000|Overall Study|Maximum clinical benefit|11|||
156657006|NCT01592370|565489508|FG001|Overall Study|Maximum clinical benefit|1|||
156427996|NCT03410992|564660770|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156427997|NCT03410992|564660771|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156427998|NCT03410992|564660772|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156769096|NCT03675308|565911738|FG001|Overall Study|Adverse Event|2|||
156769097|NCT03675308|565911737|FG000|Overall Study|Withdrawal by Subject|6|||
156769098|NCT03675308|565911738|FG001|Overall Study|Withdrawal by Subject|4|||
156769099|NCT03675308|565911737|FG000|Overall Study|Lost to Follow-up|3|||
156769100|NCT03675308|565911738|FG001|Overall Study|Lost to Follow-up|0|||
156769101|NCT03675308|565911737|FG000|Overall Study|Lack of Efficacy|1|||
156769102|NCT03675308|565911738|FG001|Overall Study|Lack of Efficacy|1|||
156769103|NCT03675308|565911737|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
156769104|NCT03675308|565911738|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
156769105|NCT03675308|565911737|FG000|Overall Study|Other|0|||
156769106|NCT03675308|565911738|FG001|Overall Study|Other|1|||
156769107|NCT02325414|565911739|FG000|Overall Study|Withdrawal by Subject|3|||
156769108|NCT02325414|565911740|FG001|Overall Study|Withdrawal by Subject|1|||
156769109|NCT02325414|565911739|FG000|Overall Study|Lost to Follow-up|5|||
156769110|NCT02325414|565911740|FG001|Overall Study|Lost to Follow-up|5|||
156769111|NCT05722522|565911741|FG000|Overall Study|Adverse Event|0|||
156769112|NCT05722522|565911742|FG001|Overall Study|Adverse Event|1|||
156769113|NCT02775851|565911746|FG000|Overall Study|Adverse Event|1|||
156769114|NCT02775851|565911747|FG001|Overall Study|Adverse Event|10|||
156769115|NCT02775851|565911746|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
156769116|NCT02775851|565911747|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
156769117|NCT02775851|565911746|FG000|Overall Study|Progression/Relapse|0|||
156769118|NCT02775851|565911747|FG001|Overall Study|Progression/Relapse|4|||
156769119|NCT02775851|565911746|FG000|Overall Study|Other - Not Protocol Specified|0|||
156769120|NCT02775851|565911747|FG001|Overall Study|Other - Not Protocol Specified|7|||
156769121|NCT02775851|565911746|FG000|Overall Study|Withdrawal by Subject|1|||
156769122|NCT02775851|565911747|FG001|Overall Study|Withdrawal by Subject|0|||
156769123|NCT00703534|565911748|FG000|Overall Study|Adverse Event|14|||
156769124|NCT00703534|565911749|FG001|Overall Study|Adverse Event|3|||
156769125|NCT00703534|565911748|FG000|Overall Study|Withdrawal by Subject|8|||
156769126|NCT00703534|565911749|FG001|Overall Study|Withdrawal by Subject|7|||
156769127|NCT00703534|565911748|FG000|Overall Study|Incorrect Enrollment|6|||
156769128|NCT00703534|565911749|FG001|Overall Study|Incorrect Enrollment|6|||
156769129|NCT00703534|565911748|FG000|Overall Study|Lost to Follow-up|1|||
156769130|NCT00703534|565911749|FG001|Overall Study|Lost to Follow-up|4|||
156769131|NCT00703534|565911748|FG000|Overall Study|Severe Non Compliance|1|||
156769132|NCT00703534|565911749|FG001|Overall Study|Severe Non Compliance|5|||
156769133|NCT02194465|565911750|FG000|Overall Study|Adverse Event|6|||
156769134|NCT02194465|565911751|FG001|Overall Study|Adverse Event|1|||
156769135|NCT02194465|565911752|FG002|Overall Study|Adverse Event|4|||
156769136|NCT02194465|565911753|FG003|Overall Study|Adverse Event|4|||
156769137|NCT02194465|565911754|FG004|Overall Study|Adverse Event|4|||
156769138|NCT02194465|565911755|FG005|Overall Study|Adverse Event|2|||
156769139|NCT02194465|565911756|FG006|Overall Study|Adverse Event|0|||
156769140|NCT02194465|565911750|FG000|Overall Study|Lost to Follow-up|0|||
156769141|NCT02194465|565911751|FG001|Overall Study|Lost to Follow-up|0|||
156769142|NCT02194465|565911752|FG002|Overall Study|Lost to Follow-up|0|||
156769143|NCT02194465|565911753|FG003|Overall Study|Lost to Follow-up|1|||
156769144|NCT02194465|565911754|FG004|Overall Study|Lost to Follow-up|0|||
156769145|NCT02194465|565911755|FG005|Overall Study|Lost to Follow-up|1|||
156769146|NCT02194465|565911756|FG006|Overall Study|Lost to Follow-up|0|||
156769147|NCT02194465|565911750|FG000|Overall Study|Physician Decision|1|||
156769148|NCT02194465|565911751|FG001|Overall Study|Physician Decision|0|||
156769149|NCT02194465|565911752|FG002|Overall Study|Physician Decision|0|||
156769150|NCT02194465|565911753|FG003|Overall Study|Physician Decision|0|||
156769151|NCT02194465|565911754|FG004|Overall Study|Physician Decision|0|||
156769152|NCT02194465|565911755|FG005|Overall Study|Physician Decision|0|||
156769153|NCT02194465|565911756|FG006|Overall Study|Physician Decision|0|||
156769154|NCT02194465|565911750|FG000|Overall Study|Protocol Violation|1|||
156769155|NCT02194465|565911751|FG001|Overall Study|Protocol Violation|1|||
156769156|NCT02194465|565911752|FG002|Overall Study|Protocol Violation|2|||
156769157|NCT02194465|565911753|FG003|Overall Study|Protocol Violation|1|||
156769158|NCT02194465|565911754|FG004|Overall Study|Protocol Violation|1|||
156769159|NCT02194465|565911755|FG005|Overall Study|Protocol Violation|0|||
156769160|NCT02194465|565911756|FG006|Overall Study|Protocol Violation|0|||
156769161|NCT02194465|565911750|FG000|Overall Study|Withdrawal by Subject|1|||
156769162|NCT02194465|565911751|FG001|Overall Study|Withdrawal by Subject|3|||
156769163|NCT02194465|565911752|FG002|Overall Study|Withdrawal by Subject|1|||
156769164|NCT02194465|565911753|FG003|Overall Study|Withdrawal by Subject|2|||
156769165|NCT02194465|565911754|FG004|Overall Study|Withdrawal by Subject|2|||
156769166|NCT02194465|565911755|FG005|Overall Study|Withdrawal by Subject|1|||
156769167|NCT02194465|565911756|FG006|Overall Study|Withdrawal by Subject|2|||
156769168|NCT02194465|565911750|FG000|Overall Study|Discontinued follow-up period|0|||
156769169|NCT02194465|565911751|FG001|Overall Study|Discontinued follow-up period|2|||
156769170|NCT02194465|565911752|FG002|Overall Study|Discontinued follow-up period|1|||
156769171|NCT02194465|565911753|FG003|Overall Study|Discontinued follow-up period|0|||
156769172|NCT02194465|565911754|FG004|Overall Study|Discontinued follow-up period|2|||
156769173|NCT02194465|565911755|FG005|Overall Study|Discontinued follow-up period|0|||
156769174|NCT02194465|565911756|FG006|Overall Study|Discontinued follow-up period|0|||
156769175|NCT01125930|565911757|FG000|Overall Study|Adverse Event|0|||
156769176|NCT01125930|565911758|FG001|Overall Study|Adverse Event|1|||
156769177|NCT01125930|565911757|FG000|Overall Study|Withdrawal by Subject|1|||
156769178|NCT01125930|565911758|FG001|Overall Study|Withdrawal by Subject|6|||
156769179|NCT01125930|565911757|FG000|Overall Study|Protocol Violation|0|||
156769180|NCT01125930|565911758|FG001|Overall Study|Protocol Violation|1|||
156769181|NCT01125930|565911757|FG000|Overall Study|Lost to Follow-up|0|||
156769182|NCT01125930|565911758|FG001|Overall Study|Lost to Follow-up|2|||
156769183|NCT01715298|565911759|FG000|Overall Study|Lost to Follow-up|0|||
156769184|NCT01715298|565911760|FG001|Overall Study|Lost to Follow-up|2|||
156769185|NCT01715298|565911759|FG000|Overall Study|Patient/guardian decision|7|||
156769186|NCT01715298|565911760|FG001|Overall Study|Patient/guardian decision|9|||
156769187|NCT02058095|565911761|FG000|Overall Study|Adverse Event|1|||
156769188|NCT02058095|565911762|FG001|Overall Study|Adverse Event|0|||
156769189|NCT00998946|565911765|FG000|Overall Study|Lost to Follow-up|1|||
156769190|NCT00998946|565911765|FG000|Overall Study|Withdrawal by Subject|1|||
156769191|NCT00998946|565911765|FG000|Overall Study|Death|2|||
156769192|NCT00998946|565911765|FG000|Overall Study|Reason Unspecified|3|||
156769193|NCT00998946|565911765|FG000|Overall Study|Enrolled but not Dosed|2|||
156769194|NCT01454284|565911768|FG000|Overall Study|Adverse Event|20|||
156769195|NCT01454284|565911769|FG001|Overall Study|Adverse Event|7|||
156769196|NCT01454284|565911768|FG000|Overall Study|Death|0|||
156769197|NCT01454284|565911769|FG001|Overall Study|Death|3|||
156769198|NCT01454284|565911768|FG000|Overall Study|Lost to Follow-up|13|||
156769199|NCT01454284|565911769|FG001|Overall Study|Lost to Follow-up|8|||
156769200|NCT01454284|565911768|FG000|Overall Study|Protocol Violation|9|||
156769201|NCT01454284|565911769|FG001|Overall Study|Protocol Violation|6|||
156769202|NCT01454284|565911768|FG000|Overall Study|Withdrawal by Subject|58|||
156769203|NCT01454284|565911769|FG001|Overall Study|Withdrawal by Subject|36|||
156769204|NCT01454284|565911768|FG000|Overall Study|Physician Decision|16|||
156769205|NCT01454284|565911769|FG001|Overall Study|Physician Decision|11|||
156769206|NCT01454284|565911768|FG000|Overall Study|Sponsor Decision|0|||
156769207|NCT01454284|565911769|FG001|Overall Study|Sponsor Decision|2|||
156769208|NCT02842866|565911770|FG000|Overall Study|Serious Adverse Event|0|||
156769209|NCT02842866|565911771|FG001|Overall Study|Serious Adverse Event|1|||
156769210|NCT02842866|565911770|FG000|Overall Study|Protocol Violation|4|||
156769211|NCT02842866|565911771|FG001|Overall Study|Protocol Violation|2|||
156769212|NCT02842866|565911770|FG000|Overall Study|Lost to Follow-up|2|||
156769213|NCT02842866|565911771|FG001|Overall Study|Lost to Follow-up|0|||
156769214|NCT02842866|565911770|FG000|Overall Study|Withdrawal by Subject|1|||
156769215|NCT02842866|565911771|FG001|Overall Study|Withdrawal by Subject|0|||
156769216|NCT01432327|565911772|FG000|Posttest 3 Months|depression|3|||
156769217|NCT01432327|565911773|FG001|Posttest 3 Months|depression|0|||
156769218|NCT01432327|565911774|FG002|Posttest 3 Months|depression|0|||
156769219|NCT01432327|565911775|FG003|Posttest 3 Months|depression|0|||
156769220|NCT01432327|565911772|FG000|Posttest 3 Months|Lost to Follow-up|1|||
156769221|NCT01432327|565911773|FG001|Posttest 3 Months|Lost to Follow-up|0|||
156769222|NCT01432327|565911774|FG002|Posttest 3 Months|Lost to Follow-up|2|||
156769223|NCT01432327|565911775|FG003|Posttest 3 Months|Lost to Follow-up|1|||
156769224|NCT01432327|565911772|FG000|Posttest 3 Months|Allergic reaction|0|||
156769225|NCT01432327|565911773|FG001|Posttest 3 Months|Allergic reaction|2|||
156769226|NCT01432327|565911774|FG002|Posttest 3 Months|Allergic reaction|0|||
156769227|NCT01432327|565911775|FG003|Posttest 3 Months|Allergic reaction|0|||
156769228|NCT01432327|565911772|FG000|Posttest 6 Months|Lost to Follow-up|0|||
156769229|NCT01432327|565911773|FG001|Posttest 6 Months|Lost to Follow-up|0|||
156769230|NCT01432327|565911774|FG002|Posttest 6 Months|Lost to Follow-up|3|||
156769231|NCT01432327|565911775|FG003|Posttest 6 Months|Lost to Follow-up|2|||
156769232|NCT01432327|565911772|FG000|Posttest 6 Months|Allergic reaction|0|||
156769233|NCT01432327|565911773|FG001|Posttest 6 Months|Allergic reaction|0|||
156769234|NCT01432327|565911774|FG002|Posttest 6 Months|Allergic reaction|1|||
156769235|NCT01432327|565911775|FG003|Posttest 6 Months|Allergic reaction|0|||
156769236|NCT01432327|565911772|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
156769237|NCT01432327|565911773|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
156769238|NCT01432327|565911774|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
156769239|NCT01432327|565911775|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
156769240|NCT01432327|565911772|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
156769241|NCT01432327|565911773|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
156769242|NCT01432327|565911774|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
156769243|NCT01432327|565911775|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
156769244|NCT01432327|565911772|FG000|Posttest 1 Year|Lost to Follow-up|0|||
156769245|NCT01432327|565911773|FG001|Posttest 1 Year|Lost to Follow-up|0|||
156522583|NCT03184870|565007743|FG013|Crossover Treatment|Death|0|||
156769246|NCT01432327|565911774|FG002|Posttest 1 Year|Lost to Follow-up|4|||
156769247|NCT01432327|565911775|FG003|Posttest 1 Year|Lost to Follow-up|2|||
156769248|NCT01432327|565911772|FG000|Posttest 1 Year|Allergic reaction|0|||
156769249|NCT01432327|565911773|FG001|Posttest 1 Year|Allergic reaction|0|||
156769250|NCT01432327|565911774|FG002|Posttest 1 Year|Allergic reaction|1|||
156769251|NCT01432327|565911775|FG003|Posttest 1 Year|Allergic reaction|1|||
156769252|NCT03248037|565911776|FG000|Overall Study|Withdrawal by Subject|6|||
156769253|NCT03248037|565911777|FG001|Overall Study|Withdrawal by Subject|9|||
156769254|NCT03248037|565911776|FG000|Overall Study|Adverse Event|15|||
156769255|NCT03248037|565911777|FG001|Overall Study|Adverse Event|0|||
156769256|NCT03055013|565911779|FG000|Overall Study|Adverse Event|78|||
156769257|NCT03055013|565911780|FG001|Overall Study|Adverse Event|0|||
156769258|NCT03055013|565911779|FG000|Overall Study|Death|6|||
156769259|NCT03055013|565911780|FG001|Overall Study|Death|0|||
156769260|NCT03055013|565911779|FG000|Overall Study|Disease relapse|33|||
156769261|NCT03055013|565911780|FG001|Overall Study|Disease relapse|0|||
156769262|NCT03055013|565911779|FG000|Overall Study|Withdrawal by Subject|28|||
156769263|NCT03055013|565911780|FG001|Overall Study|Withdrawal by Subject|0|||
156769264|NCT03055013|565911779|FG000|Overall Study|Other complicating disease|5|||
156769265|NCT03055013|565911780|FG001|Overall Study|Other complicating disease|0|||
156769266|NCT03055013|565911779|FG000|Overall Study|Physician Decision|1|||
156769267|NCT03055013|565911780|FG001|Overall Study|Physician Decision|0|||
156769268|NCT03055013|565911779|FG000|Overall Study|Benign mass/non-RCC|4|||
156769269|NCT03055013|565911780|FG001|Overall Study|Benign mass/non-RCC|0|||
156769270|NCT03055013|565911779|FG000|Overall Study|Enrolled in another trial|1|||
156769271|NCT03055013|565911780|FG001|Overall Study|Enrolled in another trial|0|||
156769272|NCT03055013|565911779|FG000|Overall Study|Non-protocol therapy|1|||
156769273|NCT03055013|565911780|FG001|Overall Study|Non-protocol therapy|0|||
156769274|NCT03055013|565911779|FG000|Overall Study|Incompliance|1|||
156769275|NCT03055013|565911780|FG001|Overall Study|Incompliance|0|||
156769276|NCT03055013|565911779|FG000|Overall Study|Insurance issues|1|||
156769277|NCT03055013|565911780|FG001|Overall Study|Insurance issues|0|||
156769278|NCT03055013|565911779|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
156769279|NCT03055013|565911780|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
156769280|NCT03055013|565911779|FG000|Overall Study|Did not receive nivolumab|10|||
156769281|NCT03055013|565911780|FG001|Overall Study|Did not receive nivolumab|0|||
156769282|NCT03055013|565911779|FG000|Overall Study|Did not receive surgery|0|||
156769283|NCT03055013|565911780|FG001|Overall Study|Did not receive surgery|28|||
156769284|NCT03435055|565911781|FG000|Screening|Physician Decision|2|||
156769285|NCT03435055|565911781|FG000|Received Intervention|Did not complete nitrous administration|3|||
156769286|NCT03817528|565911782|FG000|Overall Study|Withdrawal by Subject|1|||
156769287|NCT03817528|565911782|FG000|Overall Study|Adverse Event|2|||
156769288|NCT00671749|565911788|FG000|Overall Study|Adverse Event|2|||
156769289|NCT00671749|565911788|FG000|Overall Study|Withdrawal by Subject|4|||
156769290|NCT00671749|565911788|FG000|Overall Study|Protocol Violation|1|||
156769291|NCT00671749|565911788|FG000|Overall Study|Lost to Follow-up|1|||
156769292|NCT03937778|565911794|FG000|Overall Study|Withdrawal by Subject|1|||
156769293|NCT03937778|565911794|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
156769294|NCT01200355|565911795|FG000|Overall Study|Death|7|||
156769295|NCT01200355|565911796|FG001|Overall Study|Death|2|||
156769296|NCT00485303|565911797|FG000|Overall Study|Adverse Event|5|||
156769297|NCT00485303|565911797|FG000|Overall Study|Progressive Disease|44|||
156769298|NCT00485303|565911797|FG000|Overall Study|Other|3|||
156769299|NCT00485303|565911797|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
156769300|NCT00485303|565911797|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
156769301|NCT03307174|565911798|FG000|Overall Study|Unplanned ICU Administrion|5|||
156769302|NCT03307174|565911799|FG001|Overall Study|Unplanned ICU Administrion|3|||
156769303|NCT03307174|565911798|FG000|Overall Study|Aborted Surgery|1|||
156769304|NCT03307174|565911799|FG001|Overall Study|Aborted Surgery|2|||
156769305|NCT03307174|565911798|FG000|Overall Study|Hypotension|6|||
156769306|NCT03307174|565911799|FG001|Overall Study|Hypotension|0|||
156769307|NCT03307174|565911798|FG000|Overall Study|Nonfunctional epidural|1|||
156427999|NCT03410992|564660773|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156769308|NCT03307174|565911799|FG001|Overall Study|Nonfunctional epidural|1|||
156769309|NCT03307174|565911798|FG000|Overall Study|Planned epidural removal|1|||
156769310|NCT03307174|565911799|FG001|Overall Study|Planned epidural removal|0|||
156769311|NCT03307174|565911798|FG000|Overall Study|Intrathecal catheter placement|0|||
156769312|NCT03307174|565911799|FG001|Overall Study|Intrathecal catheter placement|1|||
156769313|NCT00863707|565911800|FG000|Overall Study|Randomized, but drug not received|4|||
156769314|NCT00863707|565911801|FG001|Overall Study|Randomized, but drug not received|3|||
156769315|NCT01704261|565911802|FG000|Overall Study|Withdrawal by Subject|12|||
156769316|NCT01704261|565911803|FG001|Overall Study|Withdrawal by Subject|15|||
156769317|NCT01704261|565911802|FG000|Overall Study|Lost to Follow-up|1|||
156769318|NCT01704261|565911803|FG001|Overall Study|Lost to Follow-up|0|||
156769319|NCT02391337|565911804|FG000|6 Months Follow-up|Death|5|||
156769320|NCT02391337|565911805|FG001|6 Months Follow-up|Death|4|||
156769321|NCT02391337|565911804|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
156769322|NCT02391337|565911805|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
156769323|NCT02391337|565911804|FG000|12 Months Follow-up|Death|2|||
156769324|NCT02391337|565911805|FG001|12 Months Follow-up|Death|0|||
156769325|NCT02391337|565911804|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
156769326|NCT02391337|565911805|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
156769327|NCT02391337|565911804|FG000|12 Months Follow-up|Lost to Follow-up|0|||
156769328|NCT02391337|565911805|FG001|12 Months Follow-up|Lost to Follow-up|2|||
156769329|NCT03704064|565911809|FG000|Overall Study|Lost to Follow-up|8|||
156769330|NCT03704064|565911810|FG001|Overall Study|Lost to Follow-up|4|||
156769331|NCT03704064|565911809|FG000|Overall Study|Withdrawal by Subject|1|||
156769332|NCT03704064|565911810|FG001|Overall Study|Withdrawal by Subject|1|||
156769333|NCT03704064|565911809|FG000|Overall Study|No longer available for study visits|0|||
156769334|NCT03704064|565911810|FG001|Overall Study|No longer available for study visits|1|||
156769335|NCT03704064|565911809|FG000|Overall Study|Censoring event|1|||
156769336|NCT03704064|565911810|FG001|Overall Study|Censoring event|0|||
156769337|NCT01286129|565911811|FG000|Overall Study|Withdrawal by Subject|4|||
156769338|NCT01286129|565911812|FG001|Overall Study|Withdrawal by Subject|1|||
156769339|NCT01286129|565911811|FG000|Overall Study|Could not comply with study requirements|4|||
156769340|NCT01286129|565911812|FG001|Overall Study|Could not comply with study requirements|4|||
156769341|NCT00830128|565911813|FG000|Overall Study|Adverse Event|5|||
156769342|NCT00830128|565911813|FG000|Overall Study|Lack of Efficacy|7|||
156769343|NCT00830128|565911813|FG000|Overall Study|Protocol Violation|1|||
156769344|NCT00830128|565911813|FG000|Overall Study|Withdrawal by Subject|2|||
156769345|NCT00830128|565911813|FG000|Overall Study|Family obligation|1|||
156769346|NCT00830128|565911813|FG000|Overall Study|Relocation|1|||
156769347|NCT00830128|565911813|FG000|Overall Study|Work obligation|1|||
156769348|NCT00830128|565911813|FG000|Overall Study|Operating a vehicle|1|||
156769349|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
156769350|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
156769351|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
156769352|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
156769353|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
156769354|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
156769355|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
156769356|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
156769357|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
156769358|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
156769359|NCT03025035|565911822|FG000|Overall Study|Death|2|||
156769360|NCT03025035|565911822|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
156769361|NCT01218802|565911823|FG000|Overall Study|Lost to Follow-up|5|||
156769362|NCT01218802|565911824|FG001|Overall Study|Lost to Follow-up|6|||
156769363|NCT01218802|565911823|FG000|Overall Study|Withdrawal by Subject|3|||
156769364|NCT01218802|565911824|FG001|Overall Study|Withdrawal by Subject|10|||
156769365|NCT01218802|565911823|FG000|Overall Study|Adverse Event|0|||
156769366|NCT01218802|565911824|FG001|Overall Study|Adverse Event|2|||
156769367|NCT01218802|565911823|FG000|Overall Study|Incarcerated|2|||
156769368|NCT01218802|565911824|FG001|Overall Study|Incarcerated|0|||
156769369|NCT03104374|565911827|FG000|Period 1|Adverse Event|7|||
156769370|NCT03104374|565911828|FG001|Period 1|Adverse Event|7|||
156769371|NCT03104374|565911829|FG002|Period 1|Adverse Event|12|||
156769372|NCT03104374|565911830|FG003|Period 1|Adverse Event|14|||
156769373|NCT03104374|565911827|FG000|Period 1|Withdrawal by Subject|18|||
156769374|NCT03104374|565911828|FG001|Period 1|Withdrawal by Subject|9|||
156769375|NCT03104374|565911829|FG002|Period 1|Withdrawal by Subject|10|||
156323859|NCT01962922|564284295|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
156323860|NCT01962922|564284296|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
156323861|NCT01962922|564284295|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
156323862|NCT01962922|564284296|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
156323863|NCT03224546|564284300|FG000|Overall Study|Lost to Follow-up|9|||
156323864|NCT03224546|564284301|FG001|Overall Study|Lost to Follow-up|8|||
156323865|NCT03224546|564284302|FG002|Overall Study|Lost to Follow-up|3|||
156323866|NCT03224546|564284300|FG000|Overall Study|Withdrawal by Subject|7|||
156323867|NCT03224546|564284301|FG001|Overall Study|Withdrawal by Subject|14|||
156323868|NCT03224546|564284302|FG002|Overall Study|Withdrawal by Subject|12|||
156522584|NCT03184870|565007744|FG014|Crossover Treatment|Death|0|||
156522585|NCT03184870|565007745|FG015|Crossover Treatment|Death|0|||
156522586|NCT03184870|565007746|FG016|Crossover Treatment|Death|0|||
156769376|NCT03104374|565911830|FG003|Period 1|Withdrawal by Subject|17|||
156769377|NCT03104374|565911827|FG000|Period 1|Lost to Follow-up|4|||
156769378|NCT03104374|565911828|FG001|Period 1|Lost to Follow-up|4|||
156769379|NCT03104374|565911829|FG002|Period 1|Lost to Follow-up|6|||
156769380|NCT03104374|565911830|FG003|Period 1|Lost to Follow-up|8|||
156522587|NCT03184870|565007747|FG017|Crossover Treatment|Death|7|||
156769381|NCT03104374|565911827|FG000|Period 1|Lack of Efficacy|6|||
156769382|NCT03104374|565911828|FG001|Period 1|Lack of Efficacy|7|||
156769383|NCT03104374|565911829|FG002|Period 1|Lack of Efficacy|12|||
156769384|NCT03104374|565911830|FG003|Period 1|Lack of Efficacy|6|||
156769385|NCT03104374|565911827|FG000|Period 1|Other|2|||
156769386|NCT03104374|565911828|FG001|Period 1|Other|2|||
156769387|NCT03104374|565911829|FG002|Period 1|Other|4|||
156769388|NCT03104374|565911830|FG003|Period 1|Other|7|||
156769389|NCT03104374|565911827|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
156769390|NCT03104374|565911828|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
156769391|NCT03104374|565911829|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
156769392|NCT03104374|565911830|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
156769393|NCT03104374|565911827|FG000|Period 2|Adverse Event|4|||
156769394|NCT03104374|565911828|FG001|Period 2|Adverse Event|7|||
156769395|NCT03104374|565911829|FG002|Period 2|Adverse Event|10|||
156769396|NCT03104374|565911830|FG003|Period 2|Adverse Event|10|||
156769397|NCT03104374|565911827|FG000|Period 2|Withdrawal by Subject|3|||
156769398|NCT03104374|565911828|FG001|Period 2|Withdrawal by Subject|7|||
156769399|NCT03104374|565911829|FG002|Period 2|Withdrawal by Subject|13|||
156769400|NCT03104374|565911830|FG003|Period 2|Withdrawal by Subject|16|||
156769401|NCT03104374|565911827|FG000|Period 2|Lost to Follow-up|2|||
156769402|NCT03104374|565911828|FG001|Period 2|Lost to Follow-up|2|||
156769403|NCT03104374|565911829|FG002|Period 2|Lost to Follow-up|3|||
156769404|NCT03104374|565911830|FG003|Period 2|Lost to Follow-up|5|||
156769405|NCT03104374|565911827|FG000|Period 2|Lack of Efficacy|2|||
156769406|NCT03104374|565911828|FG001|Period 2|Lack of Efficacy|4|||
156769407|NCT03104374|565911829|FG002|Period 2|Lack of Efficacy|7|||
156769408|NCT03104374|565911830|FG003|Period 2|Lack of Efficacy|4|||
156769409|NCT03104374|565911827|FG000|Period 2|COVID-19 Infection|0|||
156769410|NCT03104374|565911828|FG001|Period 2|COVID-19 Infection|0|||
156769411|NCT03104374|565911829|FG002|Period 2|COVID-19 Infection|1|||
156769412|NCT03104374|565911830|FG003|Period 2|COVID-19 Infection|0|||
156769413|NCT03104374|565911827|FG000|Period 2|Other|3|||
156769414|NCT03104374|565911828|FG001|Period 2|Other|2|||
156769415|NCT03104374|565911829|FG002|Period 2|Other|2|||
156769416|NCT03104374|565911830|FG003|Period 2|Other|4|||
156769417|NCT00251758|565911832|FG000|Overall Study|Adverse Event|7|||
156769418|NCT00251758|565911833|FG001|Overall Study|Adverse Event|9|||
156769419|NCT00251758|565911834|FG002|Overall Study|Adverse Event|11|||
156769420|NCT00251758|565911832|FG000|Overall Study|Lost to Follow-up|4|||
156769421|NCT00251758|565911833|FG001|Overall Study|Lost to Follow-up|2|||
156769422|NCT00251758|565911834|FG002|Overall Study|Lost to Follow-up|5|||
156769423|NCT00251758|565911832|FG000|Overall Study|Withdrawal by Subject|13|||
156769424|NCT00251758|565911833|FG001|Overall Study|Withdrawal by Subject|7|||
156769425|NCT00251758|565911834|FG002|Overall Study|Withdrawal by Subject|3|||
156769426|NCT00251758|565911832|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
156769427|NCT00251758|565911833|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
156769428|NCT00251758|565911834|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
156769429|NCT00251758|565911832|FG000|Overall Study|Lack of Efficacy|3|||
156769430|NCT00251758|565911833|FG001|Overall Study|Lack of Efficacy|0|||
156769431|NCT00251758|565911834|FG002|Overall Study|Lack of Efficacy|0|||
156769432|NCT00251758|565911832|FG000|Overall Study|Noncompliant|0|||
156769433|NCT00251758|565911833|FG001|Overall Study|Noncompliant|2|||
156769434|NCT00251758|565911834|FG002|Overall Study|Noncompliant|2|||
156769435|NCT00251758|565911832|FG000|Overall Study|Pregnancy|0|||
156323869|NCT00744471|564284303|FG000|Overall Study|Randomized but not treated|1|||
156323870|NCT00744471|564284304|FG001|Overall Study|Randomized but not treated|1|||
156323871|NCT00744471|564284305|FG002|Overall Study|Randomized but not treated|4|||
156323872|NCT00744471|564284306|FG003|Overall Study|Randomized but not treated|0|||
156323873|NCT00744471|564284303|FG000|Overall Study|Death|0|||
156323874|NCT00744471|564284304|FG001|Overall Study|Death|0|||
156323875|NCT00744471|564284305|FG002|Overall Study|Death|0|||
156323876|NCT00744471|564284306|FG003|Overall Study|Death|1|||
156323877|NCT00744471|564284303|FG000|Overall Study|Adverse Event|6|||
156323878|NCT00744471|564284304|FG001|Overall Study|Adverse Event|7|||
156522588|NCT05081388|565007748|FG000|Overall Study|Adverse Event|1|||
156522589|NCT05081388|565007749|FG001|Overall Study|Adverse Event|0|||
156769436|NCT00251758|565911833|FG001|Overall Study|Pregnancy|1|||
156769437|NCT00251758|565911834|FG002|Overall Study|Pregnancy|0|||
156769438|NCT00251758|565911832|FG000|Overall Study|Per Subject Request|0|||
156769439|NCT00251758|565911833|FG001|Overall Study|Per Subject Request|0|||
156769440|NCT00251758|565911834|FG002|Overall Study|Per Subject Request|1|||
156769441|NCT00251758|565911832|FG000|Overall Study|Per Investigator Request|1|||
156769442|NCT00251758|565911833|FG001|Overall Study|Per Investigator Request|0|||
156769443|NCT00251758|565911834|FG002|Overall Study|Per Investigator Request|0|||
156769444|NCT01981616|565911837|FG000|Overall Study|Adverse Event|0|||
156769445|NCT01981616|565911838|FG001|Overall Study|Adverse Event|1|||
156769446|NCT01981616|565911837|FG000|Overall Study|Protocol Violation|1|||
156323879|NCT00744471|564284305|FG002|Overall Study|Adverse Event|5|||
156769447|NCT01981616|565911838|FG001|Overall Study|Protocol Violation|0|||
156769448|NCT02404545|565911839|FG000|Overall Study|Sponsor Termination|6|||
156769449|NCT02404545|565911840|FG001|Overall Study|Sponsor Termination|6|||
156769450|NCT03641508|565911841|FG000|First Injection|Lost to Follow-up|2|||
156769451|NCT03641508|565911842|FG001|First Injection|Lost to Follow-up|0|||
156769452|NCT00094445|565911843|FG000|Overall Study|Withdrawal by Subject|3|||
156769453|NCT00094445|565911843|FG000|Overall Study|Lost to Follow-up|1|||
156769454|NCT00094445|565911843|FG000|Overall Study|Progressive Disease|2|||
156769455|NCT00855218|565911844|FG000|Overall Study|Adverse Event|43|||
156769456|NCT00855218|565911845|FG001|Overall Study|Adverse Event|27|||
156769457|NCT00855218|565911844|FG000|Overall Study|Withdrawal by Subject|10|||
156769458|NCT00855218|565911845|FG001|Overall Study|Withdrawal by Subject|6|||
156769459|NCT00855218|565911844|FG000|Overall Study|Physician Decision|18|||
156769460|NCT00855218|565911845|FG001|Overall Study|Physician Decision|11|||
156769461|NCT00855218|565911844|FG000|Overall Study|Lost to Follow-up|0|||
156769462|NCT00855218|565911845|FG001|Overall Study|Lost to Follow-up|1|||
156769463|NCT00855218|565911844|FG000|Overall Study|Protocol Violation|5|||
156769464|NCT00855218|565911845|FG001|Overall Study|Protocol Violation|9|||
156769465|NCT00855218|565911844|FG000|Overall Study|non-compliant with study drug|3|||
156769466|NCT00855218|565911845|FG001|Overall Study|non-compliant with study drug|1|||
156769467|NCT00855218|565911844|FG000|Overall Study|patient convenience|2|||
156769468|NCT00855218|565911845|FG001|Overall Study|patient convenience|0|||
156769469|NCT00855218|565911844|FG000|Overall Study|technical problems|2|||
156769470|NCT00855218|565911845|FG001|Overall Study|technical problems|1|||
156769471|NCT00855218|565911844|FG000|Overall Study|Still treated with study medication|0|||
156769472|NCT00855218|565911845|FG001|Overall Study|Still treated with study medication|1|||
156769473|NCT00855218|565911844|FG000|Overall Study|Untreatable disease progression|54|||
156769474|NCT00855218|565911845|FG001|Overall Study|Untreatable disease progression|67|||
156769475|NCT00855218|565911844|FG000|Overall Study|Second malignancy|0|||
156769476|NCT00855218|565911845|FG001|Overall Study|Second malignancy|1|||
156769477|NCT00855218|565911844|FG000|Overall Study|Progression measurement proven|7|||
156769478|NCT00855218|565911845|FG001|Overall Study|Progression measurement proven|15|||
156769479|NCT00855218|565911844|FG000|Overall Study|Clinical endpoint reached|10|||
156769480|NCT00855218|565911845|FG001|Overall Study|Clinical endpoint reached|13|||
156769481|NCT03191552|565911853|FG000|Overall Study|Lost to Follow-up|1|||
156769482|NCT03191552|565911854|FG001|Overall Study|Lost to Follow-up|0|||
156769483|NCT03191552|565911855|FG002|Overall Study|Lost to Follow-up|0|||
156769484|NCT03191552|565911853|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
156769485|NCT03191552|565911854|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
156769486|NCT03191552|565911855|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
156769487|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
156769488|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
156769489|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
156769490|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
156769491|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
156769492|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
156769493|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
156769494|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
156769495|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
156769496|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
156769497|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
156769498|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
156769499|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
156769500|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
156769501|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
156769502|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
156769503|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
156769504|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
156769505|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
156769506|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
156769507|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
156769508|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
156769509|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
156769510|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
156769511|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
156428000|NCT03410992|564660774|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156428001|NCT03410992|564660775|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156769512|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
156769513|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
156769514|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
156428002|NCT03410992|564660776|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156428003|NCT03410992|564660766|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
156522590|NCT05081388|565007750|FG002|Overall Study|Adverse Event|0|||
156769515|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
156769516|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
156769517|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
156769518|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
156769519|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
156769520|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
156769521|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
156769522|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
156323880|NCT00744471|564284306|FG003|Overall Study|Adverse Event|9|||
156323881|NCT00744471|564284303|FG000|Overall Study|Withdrawal by Subject|9|||
156323882|NCT00744471|564284304|FG001|Overall Study|Withdrawal by Subject|9|||
156323883|NCT00744471|564284305|FG002|Overall Study|Withdrawal by Subject|15|||
156323884|NCT00744471|564284306|FG003|Overall Study|Withdrawal by Subject|12|||
156323885|NCT00744471|564284303|FG000|Overall Study|Protocol Violation|1|||
156323886|NCT00744471|564284304|FG001|Overall Study|Protocol Violation|4|||
156323887|NCT00744471|564284305|FG002|Overall Study|Protocol Violation|1|||
156323888|NCT00744471|564284306|FG003|Overall Study|Protocol Violation|2|||
156323889|NCT00744471|564284303|FG000|Overall Study|Entered extension study|41|||
156323890|NCT00744471|564284304|FG001|Overall Study|Entered extension study|84|||
156323891|NCT00744471|564284305|FG002|Overall Study|Entered extension study|100|||
156323892|NCT00744471|564284306|FG003|Overall Study|Entered extension study|91|||
156323893|NCT00744471|564284303|FG000|Overall Study|Other|2|||
156323894|NCT00744471|564284304|FG001|Overall Study|Other|3|||
156323895|NCT00744471|564284305|FG002|Overall Study|Other|6|||
156323896|NCT00744471|564284306|FG003|Overall Study|Other|2|||
156323897|NCT00744471|564284303|FG000|Overall Study|Lack of Efficacy|83|||
156323898|NCT00744471|564284304|FG001|Overall Study|Lack of Efficacy|37|||
156323899|NCT00744471|564284305|FG002|Overall Study|Lack of Efficacy|19|||
156323900|NCT00744471|564284306|FG003|Overall Study|Lack of Efficacy|31|||
156323901|NCT00744471|564284303|FG000|Overall Study|Lost to Follow-up|0|||
156323902|NCT00744471|564284304|FG001|Overall Study|Lost to Follow-up|0|||
156323903|NCT00744471|564284305|FG002|Overall Study|Lost to Follow-up|2|||
156323904|NCT00744471|564284306|FG003|Overall Study|Lost to Follow-up|0|||
156323905|NCT00596362|564284307|FG000|Overall Study|Progressive Disease|1|||
156323906|NCT00055471|564284308|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
156323907|NCT00055471|564284309|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
156323908|NCT00055471|564284310|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
156323909|NCT00055471|564284308|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
156323910|NCT00055471|564284309|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
156323911|NCT00055471|564284310|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
156323912|NCT00055471|564284308|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
156323913|NCT00055471|564284309|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
156323914|NCT00055471|564284310|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
156323915|NCT01854944|564284311|FG000|Overall Study|Withdrawal by Subject|0|||
156323916|NCT01854944|564284312|FG001|Overall Study|Withdrawal by Subject|0|||
156323917|NCT01854944|564284313|FG002|Overall Study|Withdrawal by Subject|1|||
156323918|NCT00282347|564284316|FG000|Treatment Period|Death|2|||
156323919|NCT00282347|564284317|FG001|Treatment Period|Death|0|||
156323920|NCT00282347|564284316|FG000|Treatment Period|Lost to Follow-up|2|||
156323921|NCT00282347|564284317|FG001|Treatment Period|Lost to Follow-up|5|||
156323922|NCT00282347|564284316|FG000|Treatment Period|Withdrawal by Subject|1|||
156323923|NCT00282347|564284317|FG001|Treatment Period|Withdrawal by Subject|3|||
156323924|NCT00282347|564284316|FG000|Treatment Period|Physician Decision|0|||
156323925|NCT00282347|564284317|FG001|Treatment Period|Physician Decision|1|||
156323926|NCT00282347|564284316|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
156323927|NCT00282347|564284317|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
156323928|NCT00282347|564284316|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
156323929|NCT00282347|564284317|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
156323930|NCT00282347|564284316|FG000|Safety Follow-up Period|Physician Decision|1|||
156323931|NCT00282347|564284317|FG001|Safety Follow-up Period|Physician Decision|1|||
156323932|NCT00282347|564284316|FG000|Safety Follow-up Period|Protocol Deviation|0|||
156323933|NCT00282347|564284317|FG001|Safety Follow-up Period|Protocol Deviation|2|||
156323934|NCT00282347|564284316|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
156323935|NCT00282347|564284317|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
156323936|NCT00282347|564284316|FG000|B Cell Follow-up Period|Physician Decision|1|||
156323937|NCT00282347|564284317|FG001|B Cell Follow-up Period|Physician Decision|0|||
156323938|NCT00282347|564284316|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
156323939|NCT00282347|564284317|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
156323940|NCT02782923|564284320|FG000|Overall Study|Lost to Follow-up|15|||
156323941|NCT00993044|564284323|FG000|Irinotecan 50 mg|Physician Decision|1|||
156323942|NCT05063318|564284328|FG000|Overall Study|Progressive disease|2|||
156323943|NCT05063318|564284329|FG001|Overall Study|Progressive disease|0|||
156323944|NCT05063318|564284330|FG002|Overall Study|Progressive disease|3|||
156428004|NCT03410992|564660767|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
156428005|NCT03410992|564660768|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156428006|NCT03410992|564660769|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156428007|NCT03410992|564660770|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156769523|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
156769524|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
156769525|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
156769526|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
156769527|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
156769528|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
156769529|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
156769530|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
156769531|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
156769532|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
156769533|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
156769534|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
156769535|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
156769536|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
156769537|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
156769538|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
156769539|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
156769540|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
156769541|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
156769542|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
156769543|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
156769544|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
156769545|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
156769546|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
156769547|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
156769548|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
156769549|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
156769550|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
156769551|NCT01265498|565911862|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
156769552|NCT01265498|565911863|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
156769553|NCT01884597|565911864|FG000|Overall Study|Adverse Event|0|||
156769554|NCT01884597|565911865|FG001|Overall Study|Adverse Event|0|||
156769555|NCT01884597|565911866|FG002|Overall Study|Adverse Event|1|||
156769556|NCT01884597|565911864|FG000|Overall Study|Lack of Efficacy|1|||
156769557|NCT01884597|565911865|FG001|Overall Study|Lack of Efficacy|0|||
156769558|NCT01884597|565911866|FG002|Overall Study|Lack of Efficacy|0|||
156769559|NCT01884597|565911864|FG000|Overall Study|Death|0|||
156769560|NCT01884597|565911865|FG001|Overall Study|Death|1|||
156769561|NCT01884597|565911866|FG002|Overall Study|Death|0|||
156769562|NCT05965752|565911869|FG000|Overall Study|Adverse Event|0|||
156769563|NCT05965752|565911870|FG001|Overall Study|Adverse Event|1|||
156769564|NCT05965752|565911871|FG002|Overall Study|Adverse Event|0|||
156769565|NCT05965752|565911872|FG003|Overall Study|Adverse Event|1|||
156769566|NCT05965752|565911873|FG004|Overall Study|Adverse Event|3|||
156769567|NCT05965752|565911869|FG000|Overall Study|Lost to Follow-up|2|||
156769568|NCT05965752|565911870|FG001|Overall Study|Lost to Follow-up|0|||
156769569|NCT05965752|565911871|FG002|Overall Study|Lost to Follow-up|1|||
156769570|NCT05965752|565911872|FG003|Overall Study|Lost to Follow-up|1|||
156769571|NCT05965752|565911873|FG004|Overall Study|Lost to Follow-up|1|||
156769572|NCT05965752|565911869|FG000|Overall Study|Withdrawal by Subject|2|||
156769573|NCT05965752|565911870|FG001|Overall Study|Withdrawal by Subject|2|||
156769574|NCT05965752|565911871|FG002|Overall Study|Withdrawal by Subject|1|||
156769575|NCT05965752|565911872|FG003|Overall Study|Withdrawal by Subject|5|||
156769576|NCT05965752|565911873|FG004|Overall Study|Withdrawal by Subject|0|||
156769577|NCT05965752|565911869|FG000|Overall Study|Disease Relapse|1|||
156769578|NCT05965752|565911870|FG001|Overall Study|Disease Relapse|0|||
156428008|NCT03410992|564660771|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156428009|NCT03410992|564660772|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156428010|NCT03410992|564660773|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156769579|NCT05965752|565911871|FG002|Overall Study|Disease Relapse|1|||
156769580|NCT05965752|565911872|FG003|Overall Study|Disease Relapse|0|||
156769581|NCT05965752|565911873|FG004|Overall Study|Disease Relapse|0|||
156769582|NCT05965752|565911869|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
156769583|NCT05965752|565911870|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
156769584|NCT05965752|565911871|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
156769585|NCT05965752|565911872|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
156769586|NCT05965752|565911873|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
156769587|NCT05965752|565911869|FG000|Overall Study|Unable to Return for Study Visits|0|||
156769588|NCT05965752|565911870|FG001|Overall Study|Unable to Return for Study Visits|1|||
156769589|NCT05965752|565911871|FG002|Overall Study|Unable to Return for Study Visits|0|||
156769590|NCT05965752|565911872|FG003|Overall Study|Unable to Return for Study Visits|3|||
156769591|NCT05965752|565911873|FG004|Overall Study|Unable to Return for Study Visits|1|||
156769592|NCT05965752|565911869|FG000|Overall Study|Early Termination|0|||
156769593|NCT05965752|565911870|FG001|Overall Study|Early Termination|0|||
156769594|NCT05965752|565911871|FG002|Overall Study|Early Termination|1|||
156769595|NCT05965752|565911872|FG003|Overall Study|Early Termination|0|||
156769596|NCT05965752|565911873|FG004|Overall Study|Early Termination|0|||
156769597|NCT05965752|565911869|FG000|Overall Study|Reported Unwanted Symptoms|0|||
156428011|NCT03410992|564660774|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156428012|NCT03410992|564660775|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156428013|NCT03410992|564660776|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156428014|NCT03410992|564660766|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
156769598|NCT05965752|565911870|FG001|Overall Study|Reported Unwanted Symptoms|0|||
156769599|NCT05965752|565911871|FG002|Overall Study|Reported Unwanted Symptoms|0|||
156769600|NCT05965752|565911872|FG003|Overall Study|Reported Unwanted Symptoms|0|||
156769601|NCT05965752|565911873|FG004|Overall Study|Reported Unwanted Symptoms|1|||
156769602|NCT05965752|565911869|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
156769603|NCT05965752|565911870|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
156769604|NCT05965752|565911871|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
156769605|NCT05965752|565911872|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
156769606|NCT05965752|565911873|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
156769607|NCT02074514|565911875|FG000|Overall Study|Lack of Efficacy|3|||
156769608|NCT02074514|565911876|FG001|Overall Study|Lack of Efficacy|2|||
156769609|NCT02074514|565911875|FG000|Overall Study|Lost to Follow-up|0|||
156769610|NCT02074514|565911876|FG001|Overall Study|Lost to Follow-up|1|||
156769611|NCT02074514|565911875|FG000|Overall Study|Withdrew Consent|0|||
156769612|NCT02074514|565911876|FG001|Overall Study|Withdrew Consent|1|||
156769613|NCT00666237|565911879|FG000|Overall Study|Death|5|||
156769614|NCT00666237|565911880|FG001|Overall Study|Death|5|||
156769615|NCT00666237|565911879|FG000|Overall Study|Lost to Follow-up|29|||
156769616|NCT00666237|565911880|FG001|Overall Study|Lost to Follow-up|25|||
156769617|NCT02839707|565911882|FG000|Phase I|Not eligible for analysis|9|||
156769618|NCT02839707|565911883|FG001|Phase I|Not eligible for analysis|0|||
156769619|NCT02839707|565911884|FG002|Phase I|Not eligible for analysis|0|||
156769620|NCT02839707|565911882|FG000|Phase II|Not treated according to protocol|4|||
156769621|NCT02839707|565911883|FG001|Phase II|Not treated according to protocol|0|||
156769622|NCT02839707|565911884|FG002|Phase II|Not treated according to protocol|2|||
156769623|NCT02839707|565911882|FG000|Phase III|Not treated according to protocol|0|||
156769624|NCT02839707|565911883|FG001|Phase III|Not treated according to protocol|0|||
156769625|NCT02839707|565911884|FG002|Phase III|Not treated according to protocol|4|||
156769626|NCT03834961|565913004|FG000|Overall Study|Lack of Efficacy|1|||
156769627|NCT03834961|565913005|FG001|Overall Study|Lack of Efficacy|1|||
156769628|NCT03834961|565913006|FG002|Overall Study|Lack of Efficacy|0|||
156769629|NCT03834961|565913004|FG000|Overall Study|Physician Decision|0|||
156769630|NCT03834961|565913005|FG001|Overall Study|Physician Decision|1|||
156769631|NCT03834961|565913006|FG002|Overall Study|Physician Decision|0|||
156769632|NCT03370172|565913007|FG000|Overall Study|Withdrawal by Subject|0|||
156769633|NCT03370172|565913008|FG001|Overall Study|Withdrawal by Subject|1|||
156769634|NCT05610605|565913009|FG000|6-month Assessment|Death|1|||
156769635|NCT05610605|565913010|FG001|6-month Assessment|Death|1|||
156769636|NCT05610605|565913009|FG000|6-month Assessment|Lost to Follow-up|20|||
156769637|NCT05610605|565913010|FG001|6-month Assessment|Lost to Follow-up|0|||
156769638|NCT05610605|565913009|FG000|6-month Assessment|Institutionalized|1|||
156769639|NCT05610605|565913010|FG001|6-month Assessment|Institutionalized|2|||
156769640|NCT05610605|565913009|FG000|12-month Assessment|Death|2|||
156769641|NCT05610605|565913010|FG001|12-month Assessment|Death|1|||
156769642|NCT05610605|565913009|FG000|12-month Assessment|Lost to Follow-up|1|||
156769643|NCT05610605|565913010|FG001|12-month Assessment|Lost to Follow-up|4|||
156769644|NCT05610605|565913009|FG000|12-month Assessment|Institutionalized|2|||
156769645|NCT05610605|565913010|FG001|12-month Assessment|Institutionalized|1|||
156769646|NCT00753519|565913011|FG000|Overall Study|Withdrawal by Subject|0|||
156769647|NCT00753519|565913012|FG001|Overall Study|Withdrawal by Subject|2|||
156769648|NCT01171534|565913013|FG000|Overall Study|Lost to Follow-up|0|||
156769649|NCT01171534|565913014|FG001|Overall Study|Lost to Follow-up|2|||
156769650|NCT01171534|565913013|FG000|Overall Study|screen failure|0|||
156769651|NCT01171534|565913014|FG001|Overall Study|screen failure|1|||
156769652|NCT00548327|565913015|FG000|Overall Study|Adverse Event|0|||
156769653|NCT00548327|565913016|FG001|Overall Study|Adverse Event|1|||
156428015|NCT03410992|564660767|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
156428016|NCT03410992|564660768|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156769654|NCT02100631|565913017|FG000|Overall Study|Withdrawal by Subject|1|||
156769655|NCT02100631|565913018|FG001|Overall Study|Withdrawal by Subject|0|||
156428017|NCT03410992|564660769|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156428018|NCT03410992|564660770|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156428019|NCT03410992|564660771|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156428020|NCT03410992|564660772|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156428021|NCT03410992|564660773|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156428022|NCT03410992|564660774|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156428023|NCT03410992|564660775|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156428024|NCT03410992|564660776|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156428025|NCT03410992|564660766|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
156428026|NCT03410992|564660767|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428027|NCT03410992|564660768|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428028|NCT03410992|564660769|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428029|NCT03410992|564660770|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428030|NCT03410992|564660771|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428031|NCT03410992|564660772|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428032|NCT03410992|564660773|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428033|NCT03410992|564660774|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428034|NCT03410992|564660775|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428035|NCT03410992|564660776|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156428036|NCT03410992|564660766|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
156428037|NCT03410992|564660767|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
156428038|NCT03410992|564660768|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428039|NCT03410992|564660769|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428040|NCT03410992|564660770|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428041|NCT03410992|564660771|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428042|NCT03410992|564660772|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428043|NCT03410992|564660773|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428044|NCT03410992|564660774|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428045|NCT03410992|564660775|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428046|NCT03410992|564660776|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156428047|NCT03410992|564660766|FG000|Week 16 Assessment|Incorrect escapers|0|||
156428048|NCT03410992|564660767|FG001|Week 16 Assessment|Incorrect escapers|6|||
156428049|NCT03410992|564660768|FG002|Week 16 Assessment|Incorrect escapers|0|||
156428050|NCT03410992|564660769|FG003|Week 16 Assessment|Incorrect escapers|0|||
156428051|NCT03410992|564660770|FG004|Week 16 Assessment|Incorrect escapers|0|||
156428052|NCT03410992|564660771|FG005|Week 16 Assessment|Incorrect escapers|0|||
156769656|NCT02100631|565913019|FG002|Overall Study|Withdrawal by Subject|0|||
156769657|NCT02100631|565913017|FG000|Overall Study|Lost to Follow-up|3|||
156769658|NCT02100631|565913018|FG001|Overall Study|Lost to Follow-up|4|||
156769659|NCT02100631|565913019|FG002|Overall Study|Lost to Follow-up|0|||
156769660|NCT02100631|565913017|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
156769661|NCT02100631|565913018|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
156769662|NCT02100631|565913019|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
156769663|NCT01316614|565913020|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
156769664|NCT01316614|565913020|FG000|Overall Study|Cytology slides not available for review|4|||
156769665|NCT01316614|565913020|FG000|Overall Study|Cystic lesion|5|||
156769666|NCT01316614|565913020|FG000|Overall Study|Inadequate number of passes|2|||
156769667|NCT01316614|565913020|FG000|Overall Study|Medically unstable|1|||
156769668|NCT00089648|565913021|FG000|Overall Study|Adverse Event|7|||
156769669|NCT00089648|565913021|FG000|Overall Study|Withdrawal by Subject|1|||
156769670|NCT00089648|565913021|FG000|Overall Study|Lack of Efficacy|33|||
156769671|NCT00420745|565913022|FG000|Overall Study|Adverse Event|2|||
156769672|NCT00420745|565913023|FG001|Overall Study|Adverse Event|2|||
156769673|NCT00420745|565913022|FG000|Overall Study|Lost to Follow-up|10|||
156769674|NCT00420745|565913023|FG001|Overall Study|Lost to Follow-up|2|||
156769675|NCT00420745|565913022|FG000|Overall Study|Protocol Violation|1|||
156769676|NCT00420745|565913023|FG001|Overall Study|Protocol Violation|0|||
156769677|NCT00420745|565913022|FG000|Overall Study|Physician Decision|1|||
156769678|NCT00420745|565913023|FG001|Overall Study|Physician Decision|1|||
156428053|NCT03410992|564660772|FG006|Week 16 Assessment|Incorrect escapers|0|||
156428054|NCT03410992|564660773|FG007|Week 16 Assessment|Incorrect escapers|0|||
156428055|NCT03410992|564660774|FG008|Week 16 Assessment|Incorrect escapers|0|||
156428056|NCT03410992|564660775|FG009|Week 16 Assessment|Incorrect escapers|0|||
156522591|NCT05081388|565007751|FG003|Overall Study|Adverse Event|0|||
156522592|NCT05081388|565007752|FG004|Overall Study|Adverse Event|0|||
156769679|NCT00420745|565913022|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
156769680|NCT00420745|565913023|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
156769681|NCT00420745|565913022|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
156769682|NCT00420745|565913023|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
156769683|NCT00423605|565913024|FG000|Overall Study|Adverse Event|129|||
156428057|NCT03410992|564660776|FG010|Week 16 Assessment|Incorrect escapers|0|||
156657007|NCT01592370|565489509|FG002|Overall Study|Maximum clinical benefit|7|||
156769684|NCT00423605|565913024|FG000|Overall Study|Withdrawal by Subject|36|||
156769685|NCT00423605|565913024|FG000|Overall Study|Lost to Follow-up|15|||
156657008|NCT01592370|565489510|FG003|Overall Study|Maximum clinical benefit|1|||
156657009|NCT01592370|565489511|FG004|Overall Study|Maximum clinical benefit|0|||
156657010|NCT01592370|565489512|FG005|Overall Study|Maximum clinical benefit|0|||
156657011|NCT01592370|565489513|FG006|Overall Study|Maximum clinical benefit|0|||
156657012|NCT01592370|565489507|FG000|Overall Study|No longer meets study criteria|1|||
156657013|NCT01592370|565489508|FG001|Overall Study|No longer meets study criteria|0|||
156657014|NCT01592370|565489509|FG002|Overall Study|No longer meets study criteria|0|||
156657015|NCT01592370|565489510|FG003|Overall Study|No longer meets study criteria|0|||
156657016|NCT01592370|565489511|FG004|Overall Study|No longer meets study criteria|0|||
156657017|NCT01592370|565489512|FG005|Overall Study|No longer meets study criteria|0|||
156657018|NCT01592370|565489513|FG006|Overall Study|No longer meets study criteria|0|||
156657019|NCT01592370|565489507|FG000|Overall Study|Other Reasons|6|||
156657020|NCT01592370|565489508|FG001|Overall Study|Other Reasons|0|||
156657021|NCT01592370|565489509|FG002|Overall Study|Other Reasons|10|||
156657022|NCT01592370|565489510|FG003|Overall Study|Other Reasons|0|||
156657023|NCT01592370|565489511|FG004|Overall Study|Other Reasons|0|||
156657024|NCT01592370|565489512|FG005|Overall Study|Other Reasons|1|||
156657025|NCT01592370|565489513|FG006|Overall Study|Other Reasons|0|||
156657026|NCT01592370|565489507|FG000|Overall Study|Not Treated|0|||
156657027|NCT01592370|565489508|FG001|Overall Study|Not Treated|0|||
156657028|NCT01592370|565489509|FG002|Overall Study|Not Treated|0|||
156657029|NCT01592370|565489510|FG003|Overall Study|Not Treated|0|||
156657030|NCT01592370|565489511|FG004|Overall Study|Not Treated|2|||
156657031|NCT01592370|565489512|FG005|Overall Study|Not Treated|2|||
156657032|NCT01592370|565489513|FG006|Overall Study|Not Treated|0|||
156657033|NCT01048333|565489518|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
156657034|NCT01048333|565489519|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
156657035|NCT01048333|565489520|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
156657036|NCT01048333|565489521|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
156657037|NCT01048333|565489522|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
156657038|NCT01048333|565489523|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
156657039|NCT01052116|565491712|FG000|Overall Study|Lost to Follow-up|11|||
156657040|NCT01052116|565491713|FG001|Overall Study|Lost to Follow-up|17|||
156657041|NCT01052116|565491712|FG000|Overall Study|Withdrawal by Subject|3|||
156657042|NCT01052116|565491713|FG001|Overall Study|Withdrawal by Subject|6|||
156657043|NCT01052116|565491712|FG000|Overall Study|Spirometry not performed|0|||
156657044|NCT01052116|565491713|FG001|Overall Study|Spirometry not performed|4|||
156657045|NCT05301751|565491714|FG000|Overall Study|Withdrawal by Subject|0|||
156657046|NCT05301751|565491715|FG001|Overall Study|Withdrawal by Subject|0|||
156657047|NCT05301751|565491716|FG002|Overall Study|Withdrawal by Subject|1|||
156657048|NCT05301751|565491717|FG003|Overall Study|Withdrawal by Subject|0|||
156657049|NCT06165744|565491720|FG000|Overall Study|Non device-related adverse event|1|||
156657050|NCT01546987|565491721|FG000|Overall Study|Protocol Violation|3|||
156657051|NCT01546987|565491722|FG001|Overall Study|Protocol Violation|4|||
156657052|NCT02270736|565491723|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
156657053|NCT02270736|565491724|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
156657054|NCT02270736|565491725|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
156657055|NCT02270736|565491726|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
156657056|NCT02270736|565491727|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
156657057|NCT02270736|565491723|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
156657058|NCT02270736|565491724|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
156657059|NCT02270736|565491725|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
156657060|NCT02270736|565491726|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
156657061|NCT02270736|565491727|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
156657062|NCT02270736|565491723|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
156657063|NCT02270736|565491724|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
156657064|NCT02270736|565491725|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
156657065|NCT02270736|565491726|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
156657066|NCT02270736|565491727|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
156657067|NCT02270736|565491723|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
156657068|NCT02270736|565491724|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
156657069|NCT02270736|565491725|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
156657070|NCT02270736|565491726|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
156657071|NCT02270736|565491727|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
156657072|NCT02270736|565491723|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
156657073|NCT02270736|565491724|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
156657074|NCT02270736|565491725|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
156769686|NCT00423605|565913024|FG000|Overall Study|Lack of Efficacy|38|||
156769687|NCT00423605|565913024|FG000|Overall Study|Sponsor Decision|3|||
156769688|NCT00423605|565913024|FG000|Overall Study|Physician Decision|8|||
156769689|NCT00423605|565913024|FG000|Overall Study|Protocol Violation|7|||
156769690|NCT00423605|565913024|FG000|Overall Study|Not one of the pre-specified options|5|||
156769691|NCT00726453|565913026|FG000|Primary Enrollment Group|Death|18|||
156769692|NCT00726453|565913027|FG001|Primary Enrollment Group|Death|0|||
156769693|NCT00726453|565913026|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
156769694|NCT00726453|565913027|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
156769695|NCT00726453|565913026|FG000|38 mm Length Group|Death|0|||
156769696|NCT00726453|565913027|FG001|38 mm Length Group|Death|3|||
156769697|NCT01588509|565913029|FG000|Overall Study|Lost to Follow-up|1|||
156769698|NCT01588509|565913030|FG001|Overall Study|Lost to Follow-up|0|||
156769699|NCT02897349|565913034|FG000|Overall Study|Lost to Follow-up|2|||
156769700|NCT02897349|565913035|FG001|Overall Study|Lost to Follow-up|2|||
156769701|NCT02897349|565913034|FG000|Overall Study|Adverse Event|3|||
156769702|NCT02897349|565913035|FG001|Overall Study|Adverse Event|3|||
156769703|NCT02897349|565913034|FG000|Overall Study|Other than listed above|0|||
156769704|NCT02897349|565913035|FG001|Overall Study|Other than listed above|1|||
156769705|NCT01281306|565913043|FG000|Overall Study|Lack of Efficacy|0|||
156769706|NCT01281306|565913044|FG001|Overall Study|Lack of Efficacy|1|||
156769707|NCT01281306|565913045|FG002|Overall Study|Lack of Efficacy|3|||
156769708|NCT01281306|565913046|FG003|Overall Study|Lack of Efficacy|0|||
156769709|NCT01281306|565913047|FG004|Overall Study|Lack of Efficacy|2|||
156769710|NCT01281306|565913048|FG005|Overall Study|Lack of Efficacy|0|||
156769711|NCT01281306|565913049|FG006|Overall Study|Lack of Efficacy|1|||
156769712|NCT01281306|565913043|FG000|Overall Study|Withdrawal by Subject|1|||
156769713|NCT01281306|565913044|FG001|Overall Study|Withdrawal by Subject|0|||
156769714|NCT01281306|565913045|FG002|Overall Study|Withdrawal by Subject|2|||
156769715|NCT01281306|565913046|FG003|Overall Study|Withdrawal by Subject|4|||
156769716|NCT01281306|565913047|FG004|Overall Study|Withdrawal by Subject|1|||
156769717|NCT01281306|565913048|FG005|Overall Study|Withdrawal by Subject|3|||
156769718|NCT01281306|565913049|FG006|Overall Study|Withdrawal by Subject|1|||
156769719|NCT01281306|565913043|FG000|Overall Study|Protocol deviation|0|||
156769720|NCT01281306|565913044|FG001|Overall Study|Protocol deviation|1|||
156769721|NCT01281306|565913045|FG002|Overall Study|Protocol deviation|1|||
156769722|NCT01281306|565913046|FG003|Overall Study|Protocol deviation|1|||
156769723|NCT01281306|565913047|FG004|Overall Study|Protocol deviation|1|||
156769724|NCT01281306|565913048|FG005|Overall Study|Protocol deviation|0|||
156769725|NCT01281306|565913049|FG006|Overall Study|Protocol deviation|0|||
156769726|NCT01281306|565913043|FG000|Overall Study|Condition no longer requires study drug|1|||
156769727|NCT01281306|565913044|FG001|Overall Study|Condition no longer requires study drug|0|||
156769728|NCT01281306|565913045|FG002|Overall Study|Condition no longer requires study drug|0|||
156769729|NCT01281306|565913046|FG003|Overall Study|Condition no longer requires study drug|0|||
156769730|NCT01281306|565913047|FG004|Overall Study|Condition no longer requires study drug|0|||
156769731|NCT01281306|565913048|FG005|Overall Study|Condition no longer requires study drug|1|||
156769732|NCT01281306|565913049|FG006|Overall Study|Condition no longer requires study drug|1|||
156769733|NCT01281306|565913043|FG000|Overall Study|Lost to Follow-up|1|||
156769734|NCT01281306|565913044|FG001|Overall Study|Lost to Follow-up|0|||
156769735|NCT01281306|565913045|FG002|Overall Study|Lost to Follow-up|0|||
156769736|NCT01281306|565913046|FG003|Overall Study|Lost to Follow-up|2|||
156769737|NCT01281306|565913047|FG004|Overall Study|Lost to Follow-up|0|||
156769738|NCT01281306|565913048|FG005|Overall Study|Lost to Follow-up|0|||
156769739|NCT01281306|565913049|FG006|Overall Study|Lost to Follow-up|1|||
156769740|NCT01281306|565913043|FG000|Overall Study|Death|1|||
156769741|NCT01281306|565913044|FG001|Overall Study|Death|0|||
156769742|NCT01281306|565913045|FG002|Overall Study|Death|0|||
156769743|NCT01281306|565913046|FG003|Overall Study|Death|0|||
156769744|NCT01281306|565913047|FG004|Overall Study|Death|0|||
156769745|NCT01281306|565913048|FG005|Overall Study|Death|0|||
156769746|NCT01281306|565913049|FG006|Overall Study|Death|0|||
156769747|NCT01281306|565913043|FG000|Overall Study|Adverse Event|3|||
156769748|NCT01281306|565913044|FG001|Overall Study|Adverse Event|2|||
156769749|NCT01281306|565913045|FG002|Overall Study|Adverse Event|2|||
156769750|NCT01281306|565913046|FG003|Overall Study|Adverse Event|3|||
156769751|NCT01281306|565913047|FG004|Overall Study|Adverse Event|5|||
156769752|NCT01281306|565913048|FG005|Overall Study|Adverse Event|3|||
156769753|NCT01281306|565913049|FG006|Overall Study|Adverse Event|3|||
156769754|NCT01281306|565913043|FG000|Overall Study|Randomized in error|1|||
156769755|NCT01281306|565913044|FG001|Overall Study|Randomized in error|0|||
156769756|NCT01281306|565913045|FG002|Overall Study|Randomized in error|0|||
156769757|NCT01281306|565913046|FG003|Overall Study|Randomized in error|1|||
156769758|NCT01281306|565913047|FG004|Overall Study|Randomized in error|0|||
156769759|NCT01281306|565913048|FG005|Overall Study|Randomized in error|0|||
156769760|NCT01281306|565913049|FG006|Overall Study|Randomized in error|0|||
156769761|NCT00368550|565913050|FG000|Overall Study|Adverse Event|7|||
156769762|NCT00368550|565913051|FG001|Overall Study|Adverse Event|4|||
156769763|NCT00368550|565913050|FG000|Overall Study|Lack of Efficacy|4|||
156769764|NCT00368550|565913051|FG001|Overall Study|Lack of Efficacy|9|||
156769765|NCT00368550|565913050|FG000|Overall Study|Withdrawal by Subject|17|||
156769766|NCT00368550|565913051|FG001|Overall Study|Withdrawal by Subject|10|||
156769767|NCT01401322|565913052|FG000|Overall Study|Withdrawal by Subject|1|||
156769768|NCT01401322|565913052|FG000|Overall Study|Physician Decision|1|||
156769769|NCT02410629|565913054|FG000|Overall Study|Family cannot commit to the study|2|||
156769770|NCT02410629|565913055|FG001|Overall Study|Family cannot commit to the study|1|||
156769771|NCT02410629|565913054|FG000|Overall Study|Subject returned to work|1|||
156769772|NCT02410629|565913055|FG001|Overall Study|Subject returned to work|0|||
156769773|NCT02410629|565913054|FG000|Overall Study|Subject moved back to home country|0|||
156769774|NCT02410629|565913055|FG001|Overall Study|Subject moved back to home country|1|||
156769775|NCT02410629|565913054|FG000|Overall Study|Subject underwent heart surgery|0|||
156769776|NCT02410629|565913055|FG001|Overall Study|Subject underwent heart surgery|1|||
156769777|NCT01206764|565913056|FG000|Overall Study|Adverse Event|20|||
156769778|NCT01206764|565913056|FG000|Overall Study|Abnormal laboratory value|2|||
156769779|NCT01206764|565913056|FG000|Overall Study|Abnormal test procedure result|1|||
156769780|NCT01206764|565913056|FG000|Overall Study|Patient withdrew consent|5|||
156769781|NCT01206764|565913056|FG000|Overall Study|Lost to Follow-up|6|||
156769782|NCT01206764|565913056|FG000|Overall Study|Death|11|||
156769783|NCT01206764|565913056|FG000|Overall Study|New cancer therapy|2|||
156769784|NCT01206764|565913056|FG000|Overall Study|Disease progression|88|||
156769785|NCT01206764|565913056|FG000|Overall Study|Protocol deviation|3|||
156769786|NCT04494646|565913057|FG000|Overall Study|Adverse Event|0|||
156769787|NCT04494646|565913058|FG001|Overall Study|Adverse Event|1|||
156769788|NCT04494646|565913057|FG000|Overall Study|Withdrawal by Subject|0|||
156769789|NCT04494646|565913058|FG001|Overall Study|Withdrawal by Subject|1|||
156769790|NCT05282823|565913061|FG000|Overall Study|Withdrawal by Subject|9|||
156769791|NCT05282823|565913061|FG000|Overall Study|Adverse Event|1|||
156769792|NCT05282823|565913061|FG000|Overall Study|did not meet protocol criteria|2|||
156769793|NCT05282823|565913061|FG000|Overall Study|Withdrawal by Subject|7|||
156769794|NCT00997893|565913062|FG000|Overall Study|Adverse Event|1|||
156769795|NCT00997893|565913063|FG001|Overall Study|Adverse Event|0|||
156769796|NCT00997893|565913064|FG002|Overall Study|Adverse Event|0|||
156769797|NCT00997893|565913062|FG000|Overall Study|Unable to meet study timelines|1|||
156769798|NCT00997893|565913063|FG001|Overall Study|Unable to meet study timelines|0|||
156769799|NCT00997893|565913064|FG002|Overall Study|Unable to meet study timelines|0|||
156769800|NCT00997893|565913062|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
156769801|NCT00997893|565913063|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
156769802|NCT00997893|565913064|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
156769803|NCT05569174|565913065|FG000|Overall Study|Adverse Event|0|||
156769804|NCT05569174|565913066|FG001|Overall Study|Adverse Event|1|||
156769805|NCT05569174|565913065|FG000|Overall Study|Lack of compliance|0|||
156769806|NCT05569174|565913066|FG001|Overall Study|Lack of compliance|1|||
156769807|NCT05569174|565913065|FG000|Overall Study|Withdrawal of consent|0|||
156769808|NCT05569174|565913066|FG001|Overall Study|Withdrawal of consent|1|||
156769809|NCT05569174|565913065|FG000|Overall Study|Participant wish|0|||
156769810|NCT05569174|565913066|FG001|Overall Study|Participant wish|1|||
156769811|NCT05569174|565913065|FG000|Overall Study|Lost to Follow-up|0|||
156769812|NCT05569174|565913066|FG001|Overall Study|Lost to Follow-up|1|||
156769813|NCT00112957|565913067|FG000|Overall Study|Progressive disease|18|||
156769814|NCT00112957|565913067|FG000|Overall Study|Physician Decision|1|||
156769815|NCT00961415|565913068|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
156769816|NCT00961415|565913069|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
156769817|NCT00961415|565913070|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
156769818|NCT00961415|565913068|FG000|Induction Treatment Phase|Death|77|||
156769819|NCT00961415|565913069|FG001|Induction Treatment Phase|Death|0|||
156769820|NCT00961415|565913070|FG002|Induction Treatment Phase|Death|0|||
156769821|NCT00961415|565913068|FG000|Induction Treatment Phase|Protocol Violation|1|||
156769822|NCT00961415|565913069|FG001|Induction Treatment Phase|Protocol Violation|0|||
156769823|NCT00961415|565913070|FG002|Induction Treatment Phase|Protocol Violation|0|||
156769824|NCT00961415|565913068|FG000|Induction Treatment Phase|Physician Decision|2|||
156769825|NCT00961415|565913069|FG001|Induction Treatment Phase|Physician Decision|0|||
156769826|NCT00961415|565913070|FG002|Induction Treatment Phase|Physician Decision|0|||
156769827|NCT00961415|565913068|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
156769828|NCT00961415|565913069|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
156769829|NCT00961415|565913070|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
156769830|NCT00961415|565913068|FG000|Induction Treatment Phase|Other Reason|5|||
156769831|NCT00961415|565913069|FG001|Induction Treatment Phase|Other Reason|0|||
156769832|NCT00961415|565913070|FG002|Induction Treatment Phase|Other Reason|0|||
156769833|NCT00961415|565913068|FG000|Maintenance Treatment Phase|Death|0|||
156769834|NCT00961415|565913069|FG001|Maintenance Treatment Phase|Death|42|||
156769835|NCT00961415|565913070|FG002|Maintenance Treatment Phase|Death|34|||
156769836|NCT00961415|565913068|FG000|Maintenance Treatment Phase|Investigators decision|0|||
156769837|NCT00961415|565913069|FG001|Maintenance Treatment Phase|Investigators decision|2|||
156769838|NCT00961415|565913070|FG002|Maintenance Treatment Phase|Investigators decision|0|||
156657075|NCT02270736|565491726|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
156769839|NCT00961415|565913068|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156769840|NCT00961415|565913069|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
156769841|NCT00961415|565913070|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
156769842|NCT00961415|565913068|FG000|Maintenance Treatment Phase|Other reason|0|||
156769843|NCT00961415|565913069|FG001|Maintenance Treatment Phase|Other reason|1|||
156769844|NCT00961415|565913070|FG002|Maintenance Treatment Phase|Other reason|3|||
156769845|NCT02309359|565913071|FG000|Overall Study|Adverse Event|4|||
156769846|NCT02309359|565913072|FG001|Overall Study|Adverse Event|5|||
156769847|NCT02309359|565913073|FG002|Overall Study|Adverse Event|5|||
156769848|NCT02309359|565913074|FG003|Overall Study|Adverse Event|4|||
156769849|NCT02309359|565913075|FG004|Overall Study|Adverse Event|4|||
156769850|NCT02309359|565913071|FG000|Overall Study|Death|1|||
156769851|NCT02309359|565913072|FG001|Overall Study|Death|0|||
156769852|NCT02309359|565913073|FG002|Overall Study|Death|0|||
156769853|NCT02309359|565913074|FG003|Overall Study|Death|0|||
156769854|NCT02309359|565913075|FG004|Overall Study|Death|0|||
156769855|NCT02309359|565913071|FG000|Overall Study|Withdrawal by Subject|2|||
156769856|NCT02309359|565913072|FG001|Overall Study|Withdrawal by Subject|2|||
156769857|NCT02309359|565913073|FG002|Overall Study|Withdrawal by Subject|4|||
156769858|NCT02309359|565913074|FG003|Overall Study|Withdrawal by Subject|4|||
156769859|NCT02309359|565913075|FG004|Overall Study|Withdrawal by Subject|0|||
156769860|NCT02309359|565913071|FG000|Overall Study|Lack of Efficacy|3|||
156769861|NCT02309359|565913072|FG001|Overall Study|Lack of Efficacy|1|||
156769862|NCT02309359|565913073|FG002|Overall Study|Lack of Efficacy|0|||
156769863|NCT02309359|565913074|FG003|Overall Study|Lack of Efficacy|0|||
156769864|NCT02309359|565913075|FG004|Overall Study|Lack of Efficacy|3|||
156769865|NCT02309359|565913071|FG000|Overall Study|Lost to Follow-up|0|||
156769866|NCT02309359|565913072|FG001|Overall Study|Lost to Follow-up|0|||
156769867|NCT02309359|565913073|FG002|Overall Study|Lost to Follow-up|0|||
156657076|NCT02270736|565491727|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
156657077|NCT02270736|565491723|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
156657078|NCT02270736|565491724|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
156657079|NCT02270736|565491725|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
156657080|NCT02270736|565491726|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
156657081|NCT02270736|565491727|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
156657082|NCT02270736|565491723|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
156657083|NCT02270736|565491724|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
156657084|NCT02270736|565491725|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
156657085|NCT02270736|565491726|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
156657086|NCT02270736|565491727|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
156657087|NCT02270736|565491723|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
156657088|NCT02270736|565491724|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
156657089|NCT02270736|565491725|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
156657090|NCT02270736|565491726|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
156657091|NCT02270736|565491727|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
156657092|NCT02270736|565491723|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
156657093|NCT02270736|565491724|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
156657094|NCT02270736|565491725|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
156657095|NCT02270736|565491726|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
156657096|NCT02270736|565491727|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
156657097|NCT00262600|565491728|FG000|Overall Study|Lost to Follow-up|17|||
156657098|NCT00262600|565491729|FG001|Overall Study|Lost to Follow-up|31|||
156657099|NCT00262600|565491730|FG002|Overall Study|Lost to Follow-up|41|||
156657100|NCT00262600|565491728|FG000|Overall Study|Withdrawal by Subject|128|||
156657101|NCT00262600|565491729|FG001|Overall Study|Withdrawal by Subject|145|||
156657102|NCT00262600|565491730|FG002|Overall Study|Withdrawal by Subject|139|||
156657103|NCT00262600|565491728|FG000|Overall Study|Not Treated|32|||
156657104|NCT00262600|565491729|FG001|Overall Study|Not Treated|17|||
156657105|NCT00262600|565491730|FG002|Overall Study|Not Treated|24|||
156657106|NCT00262600|565491728|FG000|Overall Study|Other|58|||
156657107|NCT00262600|565491729|FG001|Overall Study|Other|59|||
156657108|NCT00262600|565491730|FG002|Overall Study|Other|62|||
156657109|NCT05381948|565491735|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
156657110|NCT05381948|565491736|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
156657111|NCT05381948|565491737|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
156657112|NCT05381948|565491735|FG000|Overall Study|Adverse Event: Non-ocular|0|||
156657113|NCT05381948|565491736|FG001|Overall Study|Adverse Event: Non-ocular|1|||
156657114|NCT05381948|565491737|FG002|Overall Study|Adverse Event: Non-ocular|0|||
156657115|NCT05381948|565491735|FG000|Overall Study|Lost to Follow-up|1|||
156657116|NCT05381948|565491736|FG001|Overall Study|Lost to Follow-up|0|||
156657117|NCT05381948|565491737|FG002|Overall Study|Lost to Follow-up|0|||
156657118|NCT05381948|565491735|FG000|Overall Study|Protocol Deviation|0|||
156657119|NCT05381948|565491736|FG001|Overall Study|Protocol Deviation|2|||
156769868|NCT02309359|565913074|FG003|Overall Study|Lost to Follow-up|1|||
156769869|NCT02309359|565913075|FG004|Overall Study|Lost to Follow-up|0|||
156769870|NCT02309359|565913071|FG000|Overall Study|Other|2|||
156769871|NCT02309359|565913072|FG001|Overall Study|Other|0|||
156769872|NCT02309359|565913073|FG002|Overall Study|Other|2|||
156769873|NCT02309359|565913074|FG003|Overall Study|Other|3|||
156769874|NCT02309359|565913075|FG004|Overall Study|Other|2|||
156769875|NCT06129149|565913078|FG000|Overall Study|Death|1|||
156769876|NCT04649359|565913079|FG000|Overall Study|Withdrawal by Subject|7|||
156769877|NCT04649359|565913080|FG001|Overall Study|Withdrawal by Subject|7|||
156769878|NCT04649359|565913079|FG000|Overall Study|Death|41|||
156769879|NCT04649359|565913080|FG001|Overall Study|Death|26|||
156769880|NCT04649359|565913079|FG000|Overall Study|Ongoing in the study|75|||
156769881|NCT04649359|565913080|FG001|Overall Study|Ongoing in the study|31|||
156769882|NCT05595369|565913081|FG000|Overall Study|Adverse Event|2|||
156769883|NCT05595369|565913082|FG001|Overall Study|Adverse Event|0|||
156769884|NCT05595369|565913083|FG002|Overall Study|Adverse Event|0|||
156769885|NCT05595369|565913081|FG000|Overall Study|Lost to Follow-up|11|||
156769886|NCT05595369|565913082|FG001|Overall Study|Lost to Follow-up|10|||
156769887|NCT05595369|565913083|FG002|Overall Study|Lost to Follow-up|10|||
156769888|NCT05595369|565913081|FG000|Overall Study|Physician Decision|1|||
156769889|NCT05595369|565913082|FG001|Overall Study|Physician Decision|0|||
156769890|NCT05595369|565913083|FG002|Overall Study|Physician Decision|0|||
156769891|NCT05595369|565913081|FG000|Overall Study|Withdrawal by Subject|5|||
156769892|NCT05595369|565913082|FG001|Overall Study|Withdrawal by Subject|7|||
156769893|NCT05595369|565913083|FG002|Overall Study|Withdrawal by Subject|6|||
156769894|NCT05595369|565913081|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156769895|NCT05595369|565913082|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
156769896|NCT05595369|565913083|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
156769897|NCT05595369|565913081|FG000|Overall Study|Study Drug Non-compliance|0|||
156769898|NCT05595369|565913082|FG001|Overall Study|Study Drug Non-compliance|1|||
156769899|NCT05595369|565913083|FG002|Overall Study|Study Drug Non-compliance|0|||
156769900|NCT05595369|565913081|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
156769901|NCT05595369|565913082|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
156769902|NCT05595369|565913083|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
156769903|NCT06494761|565913084|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
156769904|NCT06494761|565913084|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
156769905|NCT04865289|565913086|FG000|Overall Study|Death|34|||
156769906|NCT04865289|565913087|FG001|Overall Study|Death|25|||
156769907|NCT04865289|565913086|FG000|Overall Study|Physician Decision|27|||
156769908|NCT04865289|565913087|FG001|Overall Study|Physician Decision|27|||
156769909|NCT04865289|565913086|FG000|Overall Study|Sponsor Decision|11|||
156769910|NCT04865289|565913087|FG001|Overall Study|Sponsor Decision|1|||
156769911|NCT04865289|565913086|FG000|Overall Study|Withdrawal by Subject|2|||
156769912|NCT04865289|565913087|FG001|Overall Study|Withdrawal by Subject|3|||
156769913|NCT02867592|565913088|FG000|Overall Study|Adverse Event|3|||
156769914|NCT02867592|565913089|FG001|Overall Study|Adverse Event|0|||
156769915|NCT02867592|565913090|FG002|Overall Study|Adverse Event|2|||
156769916|NCT02867592|565913091|FG003|Overall Study|Adverse Event|1|||
156769917|NCT02867592|565913092|FG004|Overall Study|Adverse Event|1|||
156769918|NCT02867592|565913093|FG005|Overall Study|Adverse Event|5|||
156769919|NCT02867592|565913088|FG000|Overall Study|Death|0|||
156769920|NCT02867592|565913089|FG001|Overall Study|Death|0|||
156769921|NCT02867592|565913090|FG002|Overall Study|Death|0|||
156769922|NCT02867592|565913091|FG003|Overall Study|Death|1|||
156769923|NCT02867592|565913092|FG004|Overall Study|Death|0|||
156769924|NCT02867592|565913093|FG005|Overall Study|Death|1|||
156769925|NCT02867592|565913088|FG000|Overall Study|Lack of Efficacy|8|||
156769926|NCT02867592|565913089|FG001|Overall Study|Lack of Efficacy|10|||
156769927|NCT02867592|565913090|FG002|Overall Study|Lack of Efficacy|8|||
156769928|NCT02867592|565913091|FG003|Overall Study|Lack of Efficacy|8|||
156769929|NCT02867592|565913092|FG004|Overall Study|Lack of Efficacy|12|||
156769930|NCT02867592|565913093|FG005|Overall Study|Lack of Efficacy|17|||
156769931|NCT02867592|565913088|FG000|Overall Study|Physician Decision|1|||
156769932|NCT02867592|565913089|FG001|Overall Study|Physician Decision|2|||
156769933|NCT02867592|565913090|FG002|Overall Study|Physician Decision|2|||
156769934|NCT02867592|565913091|FG003|Overall Study|Physician Decision|0|||
156769935|NCT02867592|565913092|FG004|Overall Study|Physician Decision|5|||
156769936|NCT02867592|565913093|FG005|Overall Study|Physician Decision|1|||
156769937|NCT02867592|565913088|FG000|Overall Study|Protocol Violation|0|||
156769938|NCT02867592|565913089|FG001|Overall Study|Protocol Violation|0|||
156769939|NCT02867592|565913090|FG002|Overall Study|Protocol Violation|0|||
156769940|NCT02867592|565913091|FG003|Overall Study|Protocol Violation|0|||
156769941|NCT02867592|565913092|FG004|Overall Study|Protocol Violation|1|||
156769942|NCT02867592|565913093|FG005|Overall Study|Protocol Violation|1|||
156769943|NCT02867592|565913088|FG000|Overall Study|Withdrawal by Subject|0|||
156769944|NCT02867592|565913089|FG001|Overall Study|Withdrawal by Subject|1|||
156769945|NCT02867592|565913090|FG002|Overall Study|Withdrawal by Subject|0|||
156769946|NCT02867592|565913091|FG003|Overall Study|Withdrawal by Subject|1|||
156769947|NCT02867592|565913092|FG004|Overall Study|Withdrawal by Subject|3|||
156769948|NCT02867592|565913093|FG005|Overall Study|Withdrawal by Subject|3|||
156769949|NCT02867592|565913088|FG000|Overall Study|Ineligible|1|||
156769950|NCT02867592|565913089|FG001|Overall Study|Ineligible|1|||
156769951|NCT02867592|565913090|FG002|Overall Study|Ineligible|0|||
156769952|NCT02867592|565913091|FG003|Overall Study|Ineligible|0|||
156769953|NCT02867592|565913092|FG004|Overall Study|Ineligible|2|||
156769954|NCT02867592|565913093|FG005|Overall Study|Ineligible|0|||
156769955|NCT02867592|565913088|FG000|Overall Study|No Treatment|1|||
156769956|NCT02867592|565913089|FG001|Overall Study|No Treatment|0|||
156769957|NCT02867592|565913090|FG002|Overall Study|No Treatment|0|||
156769958|NCT02867592|565913091|FG003|Overall Study|No Treatment|0|||
156769959|NCT02867592|565913092|FG004|Overall Study|No Treatment|0|||
156769960|NCT02867592|565913093|FG005|Overall Study|No Treatment|0|||
156769961|NCT02867592|565913088|FG000|Overall Study|Still on Therapy|0|||
156769962|NCT02867592|565913089|FG001|Overall Study|Still on Therapy|0|||
156769963|NCT02867592|565913090|FG002|Overall Study|Still on Therapy|0|||
156769964|NCT02867592|565913091|FG003|Overall Study|Still on Therapy|0|||
156769965|NCT02867592|565913092|FG004|Overall Study|Still on Therapy|1|||
156769966|NCT02867592|565913093|FG005|Overall Study|Still on Therapy|0|||
156769967|NCT02867592|565913088|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769968|NCT02867592|565913089|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769969|NCT02867592|565913090|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769970|NCT02867592|565913091|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769971|NCT02867592|565913092|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769972|NCT02867592|565913093|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
156769973|NCT02867592|565913088|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
156769974|NCT02867592|565913089|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
156769975|NCT02867592|565913090|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
156769976|NCT02867592|565913091|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
156769977|NCT02867592|565913092|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
156769978|NCT02867592|565913093|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
156769979|NCT00909870|565913094|FG000|Overall Study|Adverse Event|13|||
156769980|NCT00909870|565913095|FG001|Overall Study|Adverse Event|7|||
156769981|NCT00909870|565913094|FG000|Overall Study|Protocol Violation|1|||
156769982|NCT00909870|565913095|FG001|Overall Study|Protocol Violation|2|||
156769983|NCT00909870|565913094|FG000|Overall Study|Withdrawal by Subject|5|||
156769984|NCT00909870|565913095|FG001|Overall Study|Withdrawal by Subject|8|||
156769985|NCT00909870|565913094|FG000|Overall Study|Lost to Follow-up|3|||
156769986|NCT00909870|565913095|FG001|Overall Study|Lost to Follow-up|3|||
156769987|NCT00909870|565913094|FG000|Overall Study|Physician Decision|0|||
156769988|NCT00909870|565913095|FG001|Overall Study|Physician Decision|2|||
156769989|NCT00909870|565913094|FG000|Overall Study|Other|1|||
156769990|NCT00909870|565913095|FG001|Overall Study|Other|5|||
156769991|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
156769992|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
156769993|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769994|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769995|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769996|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769997|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769998|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769999|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156770000|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156770001|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
156770002|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
156770003|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770004|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770005|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770006|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770007|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770008|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770009|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770010|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770011|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
156770012|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770013|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156323945|NCT05063318|564284328|FG000|Overall Study|Compassionate use|1|||
156323946|NCT05063318|564284329|FG001|Overall Study|Compassionate use|3|||
156770014|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770015|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770016|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770017|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770018|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770019|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770020|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770021|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
156770022|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
156770023|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770024|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770025|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770026|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156657120|NCT05381948|565491737|FG002|Overall Study|Protocol Deviation|0|||
156770027|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770028|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770029|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156323947|NCT05063318|564284330|FG002|Overall Study|Compassionate use|3|||
156657121|NCT05381948|565491735|FG000|Overall Study|Withdrawal by Subject|1|||
156657122|NCT05381948|565491736|FG001|Overall Study|Withdrawal by Subject|0|||
156657123|NCT05381948|565491737|FG002|Overall Study|Withdrawal by Subject|1|||
156657124|NCT05381948|565491735|FG000|Overall Study|Death|0|||
156657125|NCT05381948|565491736|FG001|Overall Study|Death|2|||
156657126|NCT05381948|565491737|FG002|Overall Study|Death|0|||
156657127|NCT05381948|565491735|FG000|Overall Study|Discontinued study without receiving study drug|0|||
156657128|NCT05381948|565491736|FG001|Overall Study|Discontinued study without receiving study drug|0|||
156657129|NCT05381948|565491737|FG002|Overall Study|Discontinued study without receiving study drug|1|||
156657130|NCT04471207|565491738|FG000|Overall Study|Lost to Follow-up|4|||
156657131|NCT04471207|565491739|FG001|Overall Study|Lost to Follow-up|1|||
156657132|NCT04471207|565491738|FG000|Overall Study|Medication Contraindication|0|||
156657133|NCT04471207|565491739|FG001|Overall Study|Medication Contraindication|1|||
156657134|NCT04471207|565491738|FG000|Overall Study|Loss of Interest|2|||
156657135|NCT04471207|565491739|FG001|Overall Study|Loss of Interest|1|||
156657136|NCT04471207|565491738|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
156657137|NCT04471207|565491739|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
156657138|NCT04471207|565491738|FG000|Overall Study|Scheduling Conflicts|3|||
156657139|NCT04471207|565491739|FG001|Overall Study|Scheduling Conflicts|1|||
156657140|NCT04471207|565491738|FG000|Overall Study|Physician Decision|1|||
156657141|NCT04471207|565491739|FG001|Overall Study|Physician Decision|0|||
156657142|NCT04471207|565491738|FG000|Overall Study|Unwilling to Use System|0|||
156657143|NCT04471207|565491739|FG001|Overall Study|Unwilling to Use System|1|||
156657144|NCT02132247|565491744|FG000|Overall Study|Protocol Violation|1|||
156657145|NCT02132247|565491745|FG001|Overall Study|Protocol Violation|0|||
156657146|NCT00561730|565491746|FG000|Overall Study|Adverse Event|2|||
156657147|NCT00561730|565491746|FG000|Overall Study|Handling of the drug|1|||
156657148|NCT00561730|565491746|FG000|Overall Study|Lost to Follow-up|5|||
156657149|NCT00561730|565491746|FG000|Overall Study|Not specified reasons|1|||
156657150|NCT00520741|565491753|FG000|Overall Study|Adverse Event|16|||
156657151|NCT00520741|565491754|FG001|Overall Study|Adverse Event|56|||
156657152|NCT00520741|565491753|FG000|Overall Study|Lack of Efficacy|11|||
156657153|NCT00520741|565491754|FG001|Overall Study|Lack of Efficacy|30|||
156657154|NCT00520741|565491753|FG000|Overall Study|Withdrawal by Subject|0|||
156657155|NCT00520741|565491754|FG001|Overall Study|Withdrawal by Subject|11|||
156657156|NCT00520741|565491753|FG000|Overall Study|Protocol Violation|2|||
156657157|NCT00520741|565491754|FG001|Overall Study|Protocol Violation|15|||
156657158|NCT00520741|565491753|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
156657159|NCT00520741|565491754|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
156657160|NCT00520741|565491753|FG000|Overall Study|Lost to Follow-up|4|||
156657161|NCT00520741|565491754|FG001|Overall Study|Lost to Follow-up|4|||
156657162|NCT00520741|565491753|FG000|Overall Study|Other reasons for premature termination|0|||
156657163|NCT00520741|565491754|FG001|Overall Study|Other reasons for premature termination|6|||
156323948|NCT05063318|564284328|FG000|Overall Study|Adverse Event|0|||
156323949|NCT05063318|564284329|FG001|Overall Study|Adverse Event|1|||
156657164|NCT04373434|565491755|FG000|Overall Study|Lost to Follow-up|37|||
156657165|NCT04373434|565491756|FG001|Overall Study|Lost to Follow-up|32|||
156657166|NCT04373434|565491755|FG000|Overall Study|Refused at 9 months|1|||
156657167|NCT04373434|565491756|FG001|Overall Study|Refused at 9 months|2|||
156657168|NCT04373434|565491755|FG000|Overall Study|Refused at 4 months|7|||
156323950|NCT05063318|564284330|FG002|Overall Study|Adverse Event|0|||
156657169|NCT04373434|565491756|FG001|Overall Study|Refused at 4 months|3|||
156657170|NCT04373434|565491755|FG000|Overall Study|Excluded|2|||
156657171|NCT04373434|565491756|FG001|Overall Study|Excluded|0|||
156323951|NCT05063318|564284328|FG000|Overall Study|Withdrawal by Subject|0|||
156323952|NCT05063318|564284329|FG001|Overall Study|Withdrawal by Subject|1|||
156657172|NCT03702621|565491757|FG000|Overall Study|Physician Decision|6|||
156657173|NCT03702621|565491758|FG001|Overall Study|Physician Decision|6|||
156657174|NCT00527423|565491759|FG000|Overall Study|Protocol Violation|1|||
156657175|NCT00527423|565491759|FG000|Overall Study|Adverse Event|5|||
156657176|NCT00527423|565491759|FG000|Overall Study|Physician Decision|4|||
156657177|NCT00527423|565491759|FG000|Overall Study|Withdrawal by Subject|10|||
156657178|NCT00527423|565491759|FG000|Overall Study|Lost to Follow-up|4|||
156657179|NCT00527423|565491759|FG000|Overall Study|OTHER|4|||
156657180|NCT00527423|565491759|FG000|Overall Study|Death|9|||
156657181|NCT03194464|565491760|FG000|Overall Study|data not usable|2|||
156657182|NCT02446132|565491761|FG000|Overall Study|Adverse Event|10|||
156657183|NCT02446132|565491762|FG001|Overall Study|Adverse Event|27|||
156657184|NCT02446132|565491763|FG002|Overall Study|Adverse Event|27|||
156657185|NCT02446132|565491761|FG000|Overall Study|Death|2|||
156657186|NCT02446132|565491762|FG001|Overall Study|Death|13|||
156657187|NCT02446132|565491763|FG002|Overall Study|Death|10|||
156657188|NCT02446132|565491761|FG000|Overall Study|Lack of Efficacy|1|||
156657189|NCT02446132|565491762|FG001|Overall Study|Lack of Efficacy|10|||
156657190|NCT02446132|565491763|FG002|Overall Study|Lack of Efficacy|6|||
156657191|NCT02446132|565491761|FG000|Overall Study|Lost to Follow-up|2|||
156657192|NCT02446132|565491762|FG001|Overall Study|Lost to Follow-up|4|||
156657193|NCT02446132|565491763|FG002|Overall Study|Lost to Follow-up|5|||
156657194|NCT02446132|565491761|FG000|Overall Study|Non-compliance With Study Drug|2|||
156657195|NCT02446132|565491762|FG001|Overall Study|Non-compliance With Study Drug|2|||
156657196|NCT02446132|565491763|FG002|Overall Study|Non-compliance With Study Drug|3|||
156657197|NCT02446132|565491761|FG000|Overall Study|Physician Decision|1|||
156657198|NCT02446132|565491762|FG001|Overall Study|Physician Decision|8|||
156657199|NCT02446132|565491763|FG002|Overall Study|Physician Decision|13|||
156657200|NCT02446132|565491761|FG000|Overall Study|Protocol Deviation|0|||
156657201|NCT02446132|565491762|FG001|Overall Study|Protocol Deviation|0|||
156657202|NCT02446132|565491763|FG002|Overall Study|Protocol Deviation|1|||
156657203|NCT02446132|565491761|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
156657204|NCT02446132|565491762|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
156657205|NCT02446132|565491763|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
156657206|NCT02446132|565491761|FG000|Overall Study|Study Terminated by Sponsor|4|||
156657207|NCT02446132|565491762|FG001|Overall Study|Study Terminated by Sponsor|35|||
156657208|NCT02446132|565491763|FG002|Overall Study|Study Terminated by Sponsor|58|||
156657209|NCT02446132|565491761|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
156657210|NCT02446132|565491762|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
156657211|NCT02446132|565491763|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
156657212|NCT02446132|565491761|FG000|Overall Study|Withdrawal by Subject|11|||
156657213|NCT02446132|565491762|FG001|Overall Study|Withdrawal by Subject|29|||
156657214|NCT02446132|565491763|FG002|Overall Study|Withdrawal by Subject|25|||
156657215|NCT02446132|565491761|FG000|Overall Study|Reason not Specified|4|||
156657216|NCT02446132|565491762|FG001|Overall Study|Reason not Specified|16|||
156657217|NCT02446132|565491763|FG002|Overall Study|Reason not Specified|10|||
156657218|NCT02446132|565491761|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
156657219|NCT02446132|565491762|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
156657220|NCT02446132|565491763|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
156657221|NCT03444038|565491764|FG000|Overall Study|Adverse Event|12|||
156657222|NCT03444038|565491764|FG000|Overall Study|Withdrawal by Subject|7|||
156657223|NCT03444038|565491764|FG000|Overall Study|Lost to Follow-up|1|||
156657224|NCT03444038|565491764|FG000|Overall Study|Physician Decision|2|||
156657225|NCT03444038|565491764|FG000|Overall Study|Lack of Efficacy|7|||
156657226|NCT02354586|565491765|FG000|Overall Study|Death|230|||
156657227|NCT02354586|565491765|FG000|Overall Study|Withdrawal by Subject|59|||
156657228|NCT02354586|565491765|FG000|Overall Study|Lost to Follow-up|11|||
156657229|NCT02354586|565491765|FG000|Overall Study|Sponsor decision|51|||
156657230|NCT02354586|565491765|FG000|Overall Study|Site closure|2|||
156657231|NCT02354586|565491765|FG000|Overall Study|Intercurrent illness|1|||
156657232|NCT02354586|565491765|FG000|Overall Study|Protocol Violation|3|||
156657233|NCT02354586|565491765|FG000|Overall Study|Physician Decision|13|||
156657234|NCT02354586|565491765|FG000|Overall Study|Lack of Efficacy|86|||
156657235|NCT02354586|565491765|FG000|Overall Study|Adverse Event|7|||
156657236|NCT00721409|565491766|FG000|Overall Study|Global deterioration of health status|2|||
156657237|NCT00721409|565491767|FG001|Overall Study|Global deterioration of health status|6|||
156657238|NCT00721409|565491768|FG002|Overall Study|Global deterioration of health status|3|||
156657239|NCT00721409|565491766|FG000|Overall Study|Death|0|||
156657240|NCT00721409|565491767|FG001|Overall Study|Death|1|||
156657241|NCT00721409|565491768|FG002|Overall Study|Death|0|||
156657242|NCT00721409|565491766|FG000|Overall Study|Randomized not Treated|0|||
156657243|NCT00721409|565491767|FG001|Overall Study|Randomized not Treated|1|||
156657244|NCT00721409|565491768|FG002|Overall Study|Randomized not Treated|4|||
156770030|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770031|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
156770032|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
156770033|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770034|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770035|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770036|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770037|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770038|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770039|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770040|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770041|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
156770042|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
156770043|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770044|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770045|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770046|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770047|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770048|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770049|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770050|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770051|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
156770052|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
156770053|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770054|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770055|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770056|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770057|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770058|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770059|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770060|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770061|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770062|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770063|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
156770064|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
156770065|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770066|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770067|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770068|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770069|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770070|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770071|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770072|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770073|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
156770074|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
156770075|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770076|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770077|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770078|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770079|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770080|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770081|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770082|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770083|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
156770084|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770085|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770086|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770087|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770088|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770089|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770090|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770091|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770092|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770093|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
156770094|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
156770095|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770096|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770097|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770098|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770099|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770100|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770101|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770102|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770103|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
156770104|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
156770105|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770106|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770107|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770108|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770109|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770110|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770111|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
156770112|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
156770113|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
156770114|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
156770115|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
156770116|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
156770117|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
156770118|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
156770119|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
156770120|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
156770121|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770122|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770123|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770124|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770125|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
156770126|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
156770127|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770128|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
156770129|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770130|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770131|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770132|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770133|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770134|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770135|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
156770136|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770137|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
156770138|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
156770139|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770140|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770141|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770142|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770143|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770144|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770145|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
156770146|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
156770147|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
156770148|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
156770149|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770150|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770151|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770152|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770153|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770154|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770155|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
156770156|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770157|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770158|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770159|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770160|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770161|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770162|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770163|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770164|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770165|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
156770166|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770167|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
156770168|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
156770169|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770170|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770171|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770172|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770173|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770174|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770175|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770176|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770177|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770178|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
156770179|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770180|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770181|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770182|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770183|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770184|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770185|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770186|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
156770187|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770188|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770189|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770190|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770191|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770192|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770193|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770194|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770195|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770196|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770197|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770198|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770199|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
156770200|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
156770201|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770202|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156657245|NCT00721409|565491766|FG000|Overall Study|Reason not specified|1|||
156657246|NCT00721409|565491767|FG001|Overall Study|Reason not specified|0|||
156657247|NCT00721409|565491768|FG002|Overall Study|Reason not specified|2|||
156657248|NCT00721409|565491766|FG000|Overall Study|Adverse Event|0|||
156657249|NCT00721409|565491767|FG001|Overall Study|Adverse Event|13|||
156657250|NCT00721409|565491768|FG002|Overall Study|Adverse Event|2|||
156657251|NCT00721409|565491766|FG000|Overall Study|Lost to Follow-up|0|||
156657252|NCT00721409|565491767|FG001|Overall Study|Lost to Follow-up|0|||
156657253|NCT00721409|565491768|FG002|Overall Study|Lost to Follow-up|1|||
156657254|NCT00721409|565491766|FG000|Overall Study|Withdrawal by Subject|1|||
156657255|NCT00721409|565491767|FG001|Overall Study|Withdrawal by Subject|6|||
156657256|NCT00721409|565491768|FG002|Overall Study|Withdrawal by Subject|5|||
156657257|NCT00721409|565491766|FG000|Overall Study|Objective progression or relapse|8|||
156657258|NCT00721409|565491767|FG001|Overall Study|Objective progression or relapse|55|||
156657259|NCT00721409|565491768|FG002|Overall Study|Objective progression or relapse|62|||
156657260|NCT01957488|565491769|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
156657261|NCT01957488|565491770|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
156657262|NCT01957488|565491771|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
156657263|NCT01957488|565491772|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
156657264|NCT01957488|565491773|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
156657265|NCT01957488|565491774|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
156657266|NCT01957488|565491769|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
156657267|NCT01957488|565491770|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
156657268|NCT01957488|565491771|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
156657269|NCT01957488|565491772|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
156657270|NCT01957488|565491773|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
156657271|NCT01957488|565491774|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
156657272|NCT01957488|565491769|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
156770203|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770204|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770205|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770206|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770207|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770208|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770209|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
156770210|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
156770211|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770212|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770213|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770214|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770215|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770216|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770217|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770218|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770219|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
156770220|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
156770221|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770222|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770223|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770224|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770225|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770226|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770227|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770228|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770229|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
156770230|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
156770231|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770232|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770233|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770234|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770235|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770236|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770237|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770238|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770239|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
156770240|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
156770241|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770242|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770243|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770244|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770245|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770246|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156428058|NCT03410992|564660766|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156770247|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770248|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770249|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
156770250|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770251|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770252|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770253|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770254|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770255|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770256|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770257|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770258|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770259|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
156770260|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770261|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770262|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770263|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156428059|NCT03410992|564660767|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156428060|NCT03410992|564660768|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156770264|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770265|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770266|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770267|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770268|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770269|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
156657273|NCT01957488|565491770|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
156657274|NCT01957488|565491771|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
156657275|NCT01957488|565491772|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
156657276|NCT01957488|565491773|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
156657277|NCT01957488|565491774|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
156770270|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
156770271|NCT03824561|565913108|FG000|Overall Study|Protocol Violation|19|||
156770272|NCT01773928|565913110|FG000|Overall Study|Adverse Event|0|||
156770273|NCT01773928|565913111|FG001|Overall Study|Adverse Event|0|||
156770274|NCT01773928|565913112|FG002|Overall Study|Adverse Event|0|||
156770275|NCT01773928|565913113|FG003|Overall Study|Adverse Event|0|||
156770276|NCT01773928|565913114|FG004|Overall Study|Adverse Event|0|||
156770277|NCT01773928|565913115|FG005|Overall Study|Adverse Event|0|||
156770278|NCT01773928|565913116|FG006|Overall Study|Adverse Event|0|||
156770279|NCT01773928|565913117|FG007|Overall Study|Adverse Event|1|||
156770280|NCT01773928|565913118|FG008|Overall Study|Adverse Event|0|||
156770281|NCT01773928|565913110|FG000|Overall Study|Physician Decision|0|||
156770282|NCT01773928|565913111|FG001|Overall Study|Physician Decision|0|||
156770283|NCT01773928|565913112|FG002|Overall Study|Physician Decision|0|||
156770284|NCT01773928|565913113|FG003|Overall Study|Physician Decision|1|||
156770285|NCT01773928|565913114|FG004|Overall Study|Physician Decision|0|||
156770286|NCT01773928|565913115|FG005|Overall Study|Physician Decision|0|||
156770287|NCT01773928|565913116|FG006|Overall Study|Physician Decision|0|||
156770288|NCT01773928|565913117|FG007|Overall Study|Physician Decision|0|||
156770289|NCT01773928|565913118|FG008|Overall Study|Physician Decision|0|||
156770290|NCT01773928|565913110|FG000|Overall Study|Withdrawal by Subject|5|||
156770291|NCT01773928|565913111|FG001|Overall Study|Withdrawal by Subject|4|||
156770292|NCT01773928|565913112|FG002|Overall Study|Withdrawal by Subject|4|||
156770293|NCT01773928|565913113|FG003|Overall Study|Withdrawal by Subject|4|||
156770294|NCT01773928|565913114|FG004|Overall Study|Withdrawal by Subject|7|||
156770295|NCT01773928|565913115|FG005|Overall Study|Withdrawal by Subject|1|||
156770296|NCT01773928|565913116|FG006|Overall Study|Withdrawal by Subject|0|||
156770297|NCT01773928|565913117|FG007|Overall Study|Withdrawal by Subject|0|||
156770298|NCT01773928|565913118|FG008|Overall Study|Withdrawal by Subject|1|||
156770299|NCT01773928|565913110|FG000|Overall Study|Lost to Follow-up|0|||
156770300|NCT01773928|565913111|FG001|Overall Study|Lost to Follow-up|0|||
156323953|NCT05063318|564284330|FG002|Overall Study|Withdrawal by Subject|0|||
156522593|NCT05081388|565007748|FG000|Overall Study|Lost to Follow-up|0|||
156522594|NCT05081388|565007749|FG001|Overall Study|Lost to Follow-up|1|||
156522595|NCT05081388|565007750|FG002|Overall Study|Lost to Follow-up|0|||
156522596|NCT05081388|565007751|FG003|Overall Study|Lost to Follow-up|0|||
156522597|NCT05081388|565007752|FG004|Overall Study|Lost to Follow-up|0|||
156522598|NCT05081388|565007748|FG000|Overall Study|Subject decision|0|||
156522599|NCT05081388|565007749|FG001|Overall Study|Subject decision|0|||
156522600|NCT05081388|565007750|FG002|Overall Study|Subject decision|0|||
156522601|NCT05081388|565007751|FG003|Overall Study|Subject decision|1|||
156522602|NCT05081388|565007752|FG004|Overall Study|Subject decision|0|||
156522603|NCT03786783|565007753|FG000|Overall Study|Death|1|||
156522604|NCT03786783|565007753|FG000|Overall Study|Physician Decision|6|||
156522605|NCT03786783|565007753|FG000|Overall Study|Withdrawal by Subject|2|||
156522606|NCT03786783|565007753|FG000|Overall Study|Disease Progression|7|||
156522607|NCT03786783|565007753|FG000|Overall Study|Patient/Parent Refusal|4|||
156522608|NCT01776541|565007754|FG000|Overall Study|Administrative Reason|6|||
156657278|NCT01957488|565491769|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156522609|NCT01776541|565007755|FG001|Overall Study|Administrative Reason|2|||
156522610|NCT01776541|565007754|FG000|Overall Study|Death|4|||
156522611|NCT01776541|565007755|FG001|Overall Study|Death|0|||
156522612|NCT01776541|565007754|FG000|Overall Study|Lost to Follow-up|27|||
156657279|NCT01957488|565491770|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156657280|NCT01957488|565491771|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156657281|NCT01957488|565491772|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
156657282|NCT01957488|565491773|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
156657283|NCT01957488|565491774|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
156657284|NCT01957488|565491769|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
156657285|NCT01957488|565491770|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
156657286|NCT01957488|565491771|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
156657287|NCT01957488|565491772|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
156657288|NCT01957488|565491773|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
156657289|NCT01957488|565491774|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
156522613|NCT01776541|565007755|FG001|Overall Study|Lost to Follow-up|48|||
156522614|NCT01776541|565007754|FG000|Overall Study|Unclassified|5|||
156522615|NCT01776541|565007755|FG001|Overall Study|Unclassified|4|||
156522616|NCT01776541|565007754|FG000|Overall Study|Protocol Violation|2|||
156522617|NCT01776541|565007755|FG001|Overall Study|Protocol Violation|1|||
156522618|NCT01776541|565007754|FG000|Overall Study|Withdrawal by Subject|12|||
156522619|NCT01776541|565007755|FG001|Overall Study|Withdrawal by Subject|20|||
156522620|NCT04279392|565007758|FG000|Overall Study|Physician Decision|1|||
156522621|NCT04279392|565007759|FG001|Overall Study|Physician Decision|0|||
156522622|NCT01171807|565007760|FG000|Overall Study|Treatment failure|2|||
156522623|NCT01171807|565007761|FG001|Overall Study|Treatment failure|4|||
156522624|NCT01171807|565007760|FG000|Overall Study|Non compliance|1|||
156522625|NCT01171807|565007761|FG001|Overall Study|Non compliance|0|||
156522626|NCT01171807|565007760|FG000|Overall Study|Lost to Follow-up|3|||
156522627|NCT01171807|565007761|FG001|Overall Study|Lost to Follow-up|0|||
156522628|NCT01901341|565007762|FG000|Overall Study|Adverse Event|4|||
156522629|NCT01901341|565007763|FG001|Overall Study|Adverse Event|2|||
156522630|NCT01901341|565007762|FG000|Overall Study|Lack of Efficacy|0|||
156522631|NCT01901341|565007763|FG001|Overall Study|Lack of Efficacy|2|||
156522632|NCT01901341|565007762|FG000|Overall Study|Lost to Follow-up|0|||
156522633|NCT01901341|565007763|FG001|Overall Study|Lost to Follow-up|1|||
156522634|NCT01901341|565007762|FG000|Overall Study|Protocol Violation|2|||
156522635|NCT01901341|565007763|FG001|Overall Study|Protocol Violation|0|||
156522636|NCT01901341|565007762|FG000|Overall Study|Study Terminated by Sponsor|13|||
156522637|NCT01901341|565007763|FG001|Overall Study|Study Terminated by Sponsor|15|||
156522638|NCT01901341|565007762|FG000|Overall Study|Withdrawal by Subject|1|||
156522639|NCT01901341|565007763|FG001|Overall Study|Withdrawal by Subject|1|||
156522640|NCT04964388|565007764|FG000|Overall Study|Lost to Follow-up|3|||
156522641|NCT04964388|565007765|FG001|Overall Study|Lost to Follow-up|2|||
156522642|NCT00757588|565007766|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
156522643|NCT00757588|565007767|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
156522644|NCT00757588|565007766|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
156522645|NCT00757588|565007767|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
156522646|NCT00757588|565007766|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
156522647|NCT00757588|565007767|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
156522648|NCT00757588|565007766|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
156522649|NCT00757588|565007767|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
156522650|NCT00757588|565007766|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
156522651|NCT00757588|565007767|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
156522652|NCT00757588|565007766|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
156522653|NCT00757588|565007767|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
156522654|NCT00757588|565007766|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
156522655|NCT00757588|565007767|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
156522656|NCT00757588|565007766|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
156522657|NCT00757588|565007767|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
156522658|NCT00757588|565007766|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
156522659|NCT00757588|565007767|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
156522660|NCT00757588|565007766|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
156522661|NCT00757588|565007767|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
156522662|NCT00757588|565007766|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
156522663|NCT00757588|565007767|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
156522664|NCT00757588|565007766|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
156522665|NCT00757588|565007767|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
156522666|NCT00757588|565007766|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
156522667|NCT00757588|565007767|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
156522668|NCT00757588|565007766|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
156522669|NCT00757588|565007767|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
156323954|NCT00323869|564284333|FG000|Overall Study|Death|1|||
156522670|NCT00757588|565007766|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
156522671|NCT00757588|565007767|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
156522672|NCT00757588|565007766|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
156770301|NCT01773928|565913112|FG002|Overall Study|Lost to Follow-up|0|||
156323955|NCT03172910|564286004|FG000|Overall Study|Adverse Event|0|||
156522673|NCT00757588|565007767|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
156522674|NCT00666679|565007768|FG000|First Intervention|Lost to Follow-up|1|||
156522675|NCT00666679|565007769|FG001|First Intervention|Lost to Follow-up|0|||
156522676|NCT00666679|565007768|FG000|First Intervention|Protocol Violation|1|||
156522677|NCT00666679|565007769|FG001|First Intervention|Protocol Violation|0|||
156522678|NCT00666679|565007768|FG000|First Intervention|Withdrawal by Subject|1|||
156522679|NCT00666679|565007769|FG001|First Intervention|Withdrawal by Subject|0|||
156522680|NCT00666679|565007768|FG000|First Intervention|Randomized did not start treatment|1|||
156522681|NCT00666679|565007769|FG001|First Intervention|Randomized did not start treatment|1|||
156522682|NCT00666679|565007768|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
156522683|NCT00666679|565007769|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
156522684|NCT00666679|565007768|FG000|Washout Period of 1 Week|Protocol Violation|0|||
156522685|NCT00666679|565007769|FG001|Washout Period of 1 Week|Protocol Violation|1|||
156522686|NCT00666679|565007768|FG000|Second Intervention|Adverse Event|1|||
156522687|NCT00666679|565007769|FG001|Second Intervention|Adverse Event|0|||
156522688|NCT00666679|565007768|FG000|Second Intervention|Death|0|||
156522689|NCT00666679|565007769|FG001|Second Intervention|Death|1|||
156522690|NCT03405792|565007770|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
156522691|NCT03405792|565007771|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
156522692|NCT03405792|565007770|FG000|Overall Study|o Did not receive pembrolizumab|1|||
156522693|NCT03405792|565007771|FG001|Overall Study|o Did not receive pembrolizumab|0|||
156522694|NCT00918580|565007772|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
156522695|NCT00918580|565007772|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
156522696|NCT00918580|565007772|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
156522697|NCT00918580|565007772|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
156522698|NCT00918580|565007772|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
156522699|NCT00918580|565007772|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
156522700|NCT00918580|565007772|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
156522701|NCT04882995|565007773|FG000|Overall Study|Withdrawal by Subject|1|||
156522702|NCT04882995|565007774|FG001|Overall Study|Withdrawal by Subject|2|||
156522703|NCT04882995|565007773|FG000|Overall Study|Protocol Violation|4|||
156522704|NCT04882995|565007774|FG001|Overall Study|Protocol Violation|4|||
156522705|NCT04882995|565007773|FG000|Overall Study|Surgery postponed due to COVID|1|||
156522706|NCT04882995|565007774|FG001|Overall Study|Surgery postponed due to COVID|1|||
156522707|NCT04371198|565007775|FG000|Overall Study|inadequate sample|4|||
156522708|NCT01347762|565007776|FG000|Overall Study|Lost to Follow-up|0|||
156522709|NCT01347762|565007777|FG001|Overall Study|Lost to Follow-up|1|||
156522710|NCT01347762|565007778|FG002|Overall Study|Lost to Follow-up|6|||
156522711|NCT01347762|565007779|FG003|Overall Study|Lost to Follow-up|5|||
156522712|NCT01347762|565007776|FG000|Overall Study|Withdrawal by Subject|4|||
156522713|NCT01347762|565007777|FG001|Overall Study|Withdrawal by Subject|1|||
156522714|NCT01347762|565007778|FG002|Overall Study|Withdrawal by Subject|3|||
156522715|NCT01347762|565007779|FG003|Overall Study|Withdrawal by Subject|3|||
156522716|NCT03235284|565007780|FG000|Overall Study|Adverse Event|1|||
156522717|NCT03235284|565007781|FG001|Overall Study|Adverse Event|2|||
156522718|NCT03235284|565007782|FG002|Overall Study|Adverse Event|1|||
156522719|NCT05478499|565007783|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
156522720|NCT05478499|565007784|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
156522721|NCT05478499|565007783|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
156522722|NCT05478499|565007784|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
156522723|NCT05478499|565007783|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
156522724|NCT05478499|565007784|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
156522725|NCT05478499|565007783|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
156522726|NCT05478499|565007784|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
156522727|NCT05478499|565007783|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
156522728|NCT05478499|565007784|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
156522729|NCT05478499|565007783|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
156522730|NCT05478499|565007784|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
156522731|NCT05478499|565007783|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
156522732|NCT05478499|565007784|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
156522733|NCT05478499|565007783|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
156522734|NCT05478499|565007784|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
156522735|NCT05478499|565007783|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
156522736|NCT05478499|565007784|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
156522737|NCT05478499|565007783|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
156522738|NCT05478499|565007784|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
156522739|NCT05478499|565007783|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
156522740|NCT05478499|565007784|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
156323956|NCT03172910|564286005|FG001|Overall Study|Adverse Event|0|||
156323957|NCT03172910|564286006|FG002|Overall Study|Adverse Event|0|||
156522741|NCT00069108|565007785|FG000|Overall Study|Withdrawal by Subject|5|||
156522742|NCT00069108|565007786|FG001|Overall Study|Withdrawal by Subject|9|||
156522743|NCT00069108|565007785|FG000|Overall Study|Adverse Event|64|||
156522744|NCT00069108|565007786|FG001|Overall Study|Adverse Event|42|||
156522745|NCT00069108|565007785|FG000|Overall Study|Death|6|||
156522746|NCT00069108|565007786|FG001|Overall Study|Death|6|||
156522747|NCT00069108|565007785|FG000|Overall Study|Administration|15|||
156522748|NCT00069108|565007786|FG001|Overall Study|Administration|4|||
156522749|NCT00069108|565007785|FG000|Overall Study|Insufficient therapy|117|||
156522750|NCT00069108|565007786|FG001|Overall Study|Insufficient therapy|144|||
156522751|NCT00069108|565007785|FG000|Overall Study|Violation criteria|1|||
156522752|NCT00069108|565007786|FG001|Overall Study|Violation criteria|4|||
156428061|NCT03410992|564660769|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
156428062|NCT03410992|564660770|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
156428063|NCT03410992|564660771|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156428064|NCT03410992|564660772|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156428065|NCT03410992|564660773|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156428066|NCT03410992|564660774|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156428067|NCT03410992|564660775|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156428068|NCT03410992|564660776|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156428069|NCT03410992|564660766|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156428070|NCT03410992|564660767|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156428071|NCT03410992|564660768|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156428072|NCT03410992|564660769|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
156428073|NCT03410992|564660770|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
156428074|NCT03410992|564660771|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
156428075|NCT03410992|564660772|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156428076|NCT03410992|564660773|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156428077|NCT03410992|564660774|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156428078|NCT03410992|564660775|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156428079|NCT03410992|564660776|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156428080|NCT03410992|564660766|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428081|NCT03410992|564660767|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428082|NCT03410992|564660768|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428083|NCT03410992|564660769|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428084|NCT03410992|564660770|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428085|NCT03410992|564660771|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
156428086|NCT03410992|564660772|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428087|NCT03410992|564660773|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428088|NCT03410992|564660774|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428089|NCT03410992|564660775|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428090|NCT03410992|564660776|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156428091|NCT03410992|564660766|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156428092|NCT03410992|564660767|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156428093|NCT03410992|564660768|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156428094|NCT03410992|564660769|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
156428095|NCT03410992|564660770|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
156428096|NCT03410992|564660771|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
156428097|NCT03410992|564660772|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156428098|NCT03410992|564660773|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156428099|NCT03410992|564660774|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156428100|NCT03410992|564660775|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156428101|NCT03410992|564660776|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156428102|NCT03410992|564660766|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428103|NCT03410992|564660767|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428104|NCT03410992|564660768|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428105|NCT03410992|564660769|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428106|NCT03410992|564660770|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428107|NCT03410992|564660771|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428108|NCT03410992|564660772|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428109|NCT03410992|564660773|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
156428110|NCT03410992|564660774|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428111|NCT03410992|564660775|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428112|NCT03410992|564660776|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
156428113|NCT03410992|564660766|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428114|NCT03410992|564660767|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428115|NCT03410992|564660768|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428116|NCT03410992|564660769|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428117|NCT03410992|564660770|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428118|NCT03410992|564660771|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428119|NCT03410992|564660772|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428120|NCT03410992|564660773|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428121|NCT03410992|564660774|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
156428122|NCT03410992|564660775|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156522753|NCT00069108|565007785|FG000|Overall Study|Refused treatment|5|||
156522754|NCT00069108|565007786|FG001|Overall Study|Refused treatment|10|||
156522755|NCT02476279|565007787|FG000|Overall Study|Lost to Follow-up|1|||
156522756|NCT02476279|565007788|FG001|Overall Study|Lost to Follow-up|1|||
156522757|NCT02208999|565007789|FG000|Overall Study|Lost to Follow-up|1|||
156522758|NCT00319839|565007790|FG000|Overall Study|Adverse Event|5|||
156522759|NCT00319839|565007790|FG000|Overall Study|Withdrawal by Subject|1|||
156522760|NCT04494256|565007791|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
156522761|NCT04494256|565007792|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
156522762|NCT04494256|565007793|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
156522763|NCT04494256|565007794|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
156522764|NCT04494256|565007795|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
156522765|NCT04494256|565007796|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
156522766|NCT04494256|565007797|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
156522767|NCT04494256|565007791|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
156522768|NCT04494256|565007792|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
156522769|NCT04494256|565007793|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
156522770|NCT04494256|565007794|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
156522771|NCT04494256|565007795|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
156522772|NCT04494256|565007796|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
156522773|NCT04494256|565007797|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
156522774|NCT04494256|565007791|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
156522775|NCT04494256|565007792|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
156522776|NCT04494256|565007793|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
156522777|NCT04494256|565007794|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
156522778|NCT04494256|565007795|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
156770302|NCT01773928|565913113|FG003|Overall Study|Lost to Follow-up|0|||
156770303|NCT01773928|565913114|FG004|Overall Study|Lost to Follow-up|0|||
156770304|NCT01773928|565913115|FG005|Overall Study|Lost to Follow-up|1|||
156522779|NCT04494256|565007796|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
156522780|NCT04494256|565007797|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
156522781|NCT04494256|565007791|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522782|NCT04494256|565007792|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522783|NCT04494256|565007793|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522784|NCT04494256|565007794|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
156522785|NCT04494256|565007795|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
156522786|NCT04494256|565007796|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522787|NCT04494256|565007797|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522788|NCT04494256|565007791|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
156522789|NCT04494256|565007792|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
156522790|NCT04494256|565007793|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
156522791|NCT04494256|565007794|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
156522792|NCT04494256|565007795|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
156522793|NCT04494256|565007796|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
156522794|NCT04494256|565007797|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
156522795|NCT04494256|565007791|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
156522796|NCT04494256|565007792|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
156522797|NCT04494256|565007793|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
156522798|NCT04494256|565007794|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
156522799|NCT04494256|565007795|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
156522800|NCT04494256|565007796|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
156522801|NCT04494256|565007797|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
156522802|NCT04494256|565007791|FG000|Part 2: Open Label Period|Death|0|||
156522803|NCT04494256|565007792|FG001|Part 2: Open Label Period|Death|0|||
156522804|NCT04494256|565007793|FG002|Part 2: Open Label Period|Death|0|||
156522805|NCT04494256|565007794|FG003|Part 2: Open Label Period|Death|0|||
156522806|NCT04494256|565007795|FG004|Part 2: Open Label Period|Death|0|||
156522807|NCT04494256|565007796|FG005|Part 2: Open Label Period|Death|4|||
156522808|NCT04494256|565007797|FG006|Part 2: Open Label Period|Death|2|||
156522809|NCT04494256|565007791|FG000|Part 2: Open Label Period|Adverse Event|0|||
156522810|NCT04494256|565007792|FG001|Part 2: Open Label Period|Adverse Event|0|||
156522811|NCT04494256|565007793|FG002|Part 2: Open Label Period|Adverse Event|0|||
156522812|NCT04494256|565007794|FG003|Part 2: Open Label Period|Adverse Event|0|||
156770305|NCT01773928|565913116|FG006|Overall Study|Lost to Follow-up|0|||
156770306|NCT01773928|565913117|FG007|Overall Study|Lost to Follow-up|0|||
156770307|NCT01773928|565913118|FG008|Overall Study|Lost to Follow-up|0|||
156770308|NCT01773928|565913110|FG000|Overall Study|Subject misrepresented age|0|||
156770309|NCT01773928|565913111|FG001|Overall Study|Subject misrepresented age|1|||
156522813|NCT04494256|565007795|FG004|Part 2: Open Label Period|Adverse Event|0|||
156522814|NCT04494256|565007796|FG005|Part 2: Open Label Period|Adverse Event|0|||
156522815|NCT04494256|565007797|FG006|Part 2: Open Label Period|Adverse Event|2|||
156522816|NCT04494256|565007791|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
156522817|NCT04494256|565007792|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
156522818|NCT04494256|565007793|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
156522819|NCT04494256|565007794|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
156522820|NCT04494256|565007795|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
156522821|NCT04494256|565007796|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
156522822|NCT04494256|565007797|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
156522823|NCT04494256|565007791|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
156522824|NCT04494256|565007792|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
156522825|NCT04494256|565007793|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
156522826|NCT04494256|565007794|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
156522827|NCT04494256|565007795|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
156522828|NCT04494256|565007796|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
156522829|NCT04494256|565007797|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
156522830|NCT04494256|565007791|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
156522831|NCT04494256|565007792|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
156522832|NCT04494256|565007793|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
156522833|NCT04494256|565007794|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
156522834|NCT04494256|565007795|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
156522835|NCT04494256|565007796|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
156522836|NCT04494256|565007797|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
156522837|NCT04494256|565007791|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522838|NCT04494256|565007792|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522839|NCT04494256|565007793|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522840|NCT04494256|565007794|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522841|NCT04494256|565007795|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
156522842|NCT04494256|565007796|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
156522843|NCT04494256|565007797|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
156522844|NCT04494256|565007791|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
156522845|NCT04494256|565007792|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
156522846|NCT04494256|565007793|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
156522847|NCT04494256|565007794|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
156522848|NCT04494256|565007795|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
156522849|NCT04494256|565007796|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
156522850|NCT04494256|565007797|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
156522851|NCT00903630|565007798|FG000|Phase 2|Adverse Event|0|||
156522852|NCT00903630|565007799|FG001|Phase 2|Adverse Event|0|||
156522853|NCT00903630|565007800|FG002|Phase 2|Adverse Event|1|||
156522854|NCT01249274|565007804|FG000|Overall Study|Lost to Follow-up|3|||
156522855|NCT01249274|565007805|FG001|Overall Study|Lost to Follow-up|4|||
156522856|NCT01249274|565007804|FG000|Overall Study|Received inpatient substance treatment|1|||
156522857|NCT01249274|565007805|FG001|Overall Study|Received inpatient substance treatment|2|||
156522858|NCT03451162|565007806|FG000|Overall Study|Lost to Follow-up|1|||
156522859|NCT03451162|565007807|FG001|Overall Study|Lost to Follow-up|0|||
156522860|NCT03451162|565007808|FG002|Overall Study|Lost to Follow-up|0|||
156522861|NCT03451162|565007809|FG003|Overall Study|Lost to Follow-up|0|||
156522862|NCT03451162|565007810|FG004|Overall Study|Lost to Follow-up|0|||
156522863|NCT03451162|565007806|FG000|Overall Study|Physician Decision|0|||
156522864|NCT03451162|565007807|FG001|Overall Study|Physician Decision|1|||
156522865|NCT03451162|565007808|FG002|Overall Study|Physician Decision|0|||
156522866|NCT03451162|565007809|FG003|Overall Study|Physician Decision|0|||
156522867|NCT03451162|565007810|FG004|Overall Study|Physician Decision|0|||
156522868|NCT03451162|565007806|FG000|Overall Study|Withdrawal by Subject|1|||
156522869|NCT03451162|565007807|FG001|Overall Study|Withdrawal by Subject|1|||
156522870|NCT03451162|565007808|FG002|Overall Study|Withdrawal by Subject|0|||
156522871|NCT03451162|565007809|FG003|Overall Study|Withdrawal by Subject|0|||
156522872|NCT03451162|565007810|FG004|Overall Study|Withdrawal by Subject|0|||
156522873|NCT03658668|565007811|FG000|Overall Study|Time Commitment|1|||
156522874|NCT03658668|565007812|FG001|Overall Study|Time Commitment|1|||
156522875|NCT04634825|565007813|FG000|Overall Study|Death|10|||
156522876|NCT04634825|565007814|FG001|Overall Study|Death|3|||
156522877|NCT04634825|565007813|FG000|Overall Study|Lost to Follow-up|1|||
156522878|NCT04634825|565007814|FG001|Overall Study|Lost to Follow-up|0|||
156522879|NCT04634825|565007813|FG000|Overall Study|Study terminated by sponsor|35|||
156522880|NCT04634825|565007814|FG001|Overall Study|Study terminated by sponsor|11|||
156522881|NCT04634825|565007813|FG000|Overall Study|Withdrawal by Subject|2|||
156522882|NCT04634825|565007814|FG001|Overall Study|Withdrawal by Subject|0|||
156522883|NCT00402597|565007817|FG000|Overall Study|Death|15|||
156522884|NCT00402597|565007818|FG001|Overall Study|Death|7|||
156522885|NCT00402597|565007819|FG002|Overall Study|Death|6|||
156522886|NCT00402597|565007820|FG003|Overall Study|Death|4|||
156522887|NCT00402597|565007821|FG004|Overall Study|Death|6|||
156522888|NCT00402597|565007817|FG000|Overall Study|Adverse Event|81|||
156522889|NCT00402597|565007818|FG001|Overall Study|Adverse Event|18|||
156522890|NCT00402597|565007819|FG002|Overall Study|Adverse Event|106|||
156522891|NCT00402597|565007820|FG003|Overall Study|Adverse Event|39|||
156522892|NCT00402597|565007821|FG004|Overall Study|Adverse Event|71|||
156522893|NCT00402597|565007817|FG000|Overall Study|Lost to Follow-up|8|||
156522894|NCT00402597|565007818|FG001|Overall Study|Lost to Follow-up|1|||
156522895|NCT00402597|565007819|FG002|Overall Study|Lost to Follow-up|8|||
156522896|NCT00402597|565007820|FG003|Overall Study|Lost to Follow-up|2|||
156522897|NCT00402597|565007821|FG004|Overall Study|Lost to Follow-up|3|||
156522898|NCT00402597|565007817|FG000|Overall Study|Withdrawal by Subject|57|||
156522899|NCT00402597|565007818|FG001|Overall Study|Withdrawal by Subject|16|||
156522900|NCT00402597|565007819|FG002|Overall Study|Withdrawal by Subject|65|||
156522901|NCT00402597|565007820|FG003|Overall Study|Withdrawal by Subject|15|||
156522902|NCT00402597|565007821|FG004|Overall Study|Withdrawal by Subject|24|||
156522903|NCT00402597|565007817|FG000|Overall Study|reason not specified|30|||
156522904|NCT00402597|565007818|FG001|Overall Study|reason not specified|4|||
156522905|NCT00402597|565007819|FG002|Overall Study|reason not specified|27|||
156522906|NCT00402597|565007820|FG003|Overall Study|reason not specified|14|||
156522907|NCT00402597|565007821|FG004|Overall Study|reason not specified|20|||
156522908|NCT01100034|565007822|FG000|Overall Study|Lost to Follow-up|11|||
156522909|NCT01100034|565007822|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
156522910|NCT01100034|565007822|FG000|Overall Study|Withdrawal by Subject|4|||
156522911|NCT01100034|565007822|FG000|Overall Study|Sponsor decision|21|||
156522912|NCT01100034|565007822|FG000|Overall Study|Participated in another clinical trial|1|||
156522913|NCT01100034|565007822|FG000|Overall Study|Participants moved to another hospital|4|||
156522914|NCT01100034|565007822|FG000|Overall Study|Site closed due to non-responsiveness|1|||
156522915|NCT01831856|565007823|FG000|Overall Study|Adverse Event|5|||
156522916|NCT01831856|565007824|FG001|Overall Study|Adverse Event|8|||
156522917|NCT01831856|565007823|FG000|Overall Study|Lack of Efficacy|13|||
156522918|NCT01831856|565007824|FG001|Overall Study|Lack of Efficacy|11|||
156522919|NCT01831856|565007823|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
156522920|NCT01831856|565007824|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
156522921|NCT00836095|565007828|FG000|Overall Study|Physician Decision|0|||
156522922|NCT00836095|565007829|FG001|Overall Study|Physician Decision|3|||
156522923|NCT04964414|565007830|FG000|Overall Study|Lost to Follow-up|10|||
156522924|NCT04964414|565007831|FG001|Overall Study|Lost to Follow-up|8|||
156522925|NCT04964414|565007830|FG000|Overall Study|Withdrawal by Subject|1|||
156522926|NCT04964414|565007831|FG001|Overall Study|Withdrawal by Subject|1|||
156522927|NCT00609765|565007834|FG000|Overall Study|Study ended prior to 12 months|1|||
156522928|NCT01272804|565007835|FG000|Overall Study|Adverse Event|1|||
156522929|NCT01272804|565007836|FG001|Overall Study|Adverse Event|0|||
156522930|NCT01272804|565007837|FG002|Overall Study|Adverse Event|0|||
156522931|NCT01272804|565007838|FG003|Overall Study|Adverse Event|0|||
156522932|NCT01272804|565007839|FG004|Overall Study|Adverse Event|2|||
156522933|NCT01272804|565007840|FG005|Overall Study|Adverse Event|1|||
156522934|NCT02003573|565007844|FG000|Overall Study|Progressive disease|2|||
156522935|NCT02003573|565007845|FG001|Overall Study|Progressive disease|0|||
156522936|NCT02003573|565007846|FG002|Overall Study|Progressive disease|1|||
156522937|NCT02003573|565007844|FG000|Overall Study|Other Adverse event|0|||
156522938|NCT02003573|565007845|FG001|Overall Study|Other Adverse event|1|||
156522939|NCT02003573|565007846|FG002|Overall Study|Other Adverse event|1|||
156522940|NCT02003573|565007844|FG000|Overall Study|Refuse to take trial medication|0|||
156522941|NCT02003573|565007845|FG001|Overall Study|Refuse to take trial medication|1|||
156522942|NCT02003573|565007846|FG002|Overall Study|Refuse to take trial medication|1|||
156522943|NCT02003573|565007844|FG000|Overall Study|Other than specified|1|||
156522944|NCT02003573|565007845|FG001|Overall Study|Other than specified|2|||
156522945|NCT02003573|565007846|FG002|Overall Study|Other than specified|3|||
156522946|NCT05026710|565007847|FG000|Overall Study|No longer met eligibility criteria|3|||
156522947|NCT05026710|565007848|FG001|Overall Study|No longer met eligibility criteria|1|||
156522948|NCT03218397|565007849|FG000|Overall Study|Prior positive blood culture|8|||
156522949|NCT03218397|565007850|FG001|Overall Study|Prior positive blood culture|13|||
156522950|NCT03218397|565007849|FG000|Overall Study|Comfort care|8|||
156522951|NCT03218397|565007850|FG001|Overall Study|Comfort care|5|||
156522952|NCT03218397|565007849|FG000|Overall Study|Comfort care and positive blood culture|1|||
156770310|NCT01773928|565913112|FG002|Overall Study|Subject misrepresented age|0|||
156522953|NCT03218397|565007850|FG001|Overall Study|Comfort care and positive blood culture|0|||
156770311|NCT01773928|565913113|FG003|Overall Study|Subject misrepresented age|0|||
156522954|NCT03218397|565007849|FG000|Overall Study|Comfort care and mixed culture|0|||
156522955|NCT03218397|565007850|FG001|Overall Study|Comfort care and mixed culture|1|||
156522956|NCT03218397|565007849|FG000|Overall Study|Mixed culture|2|||
156522957|NCT03218397|565007850|FG001|Overall Study|Mixed culture|2|||
156522958|NCT03218397|565007849|FG000|Overall Study|Inaccessible hospital records|2|||
156522959|NCT03218397|565007850|FG001|Overall Study|Inaccessible hospital records|5|||
156522960|NCT03218397|565007849|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
156522961|NCT03218397|565007850|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
156522962|NCT03218397|565007849|FG000|Overall Study|Randomized during laboratory off hours|2|||
156522963|NCT03218397|565007850|FG001|Overall Study|Randomized during laboratory off hours|1|||
156522964|NCT01796548|565007851|FG000|Overall Study|Lost to Follow-up|1|||
156522965|NCT01796548|565007851|FG000|Overall Study|Other|2|||
156522966|NCT00126503|565007854|FG000|Overall Study|disease progression|23|||
156522967|NCT00126503|565007855|FG001|Overall Study|disease progression|14|||
156522968|NCT00126503|565007854|FG000|Overall Study|Withdrawal by Subject|0|||
156522969|NCT00126503|565007855|FG001|Overall Study|Withdrawal by Subject|1|||
156522970|NCT00126503|565007854|FG000|Overall Study|alternative therapy|1|||
156522971|NCT00126503|565007855|FG001|Overall Study|alternative therapy|1|||
156522972|NCT00126503|565007854|FG000|Overall Study|other complicating disease|4|||
156522973|NCT00126503|565007855|FG001|Overall Study|other complicating disease|1|||
156522974|NCT00126503|565007854|FG000|Overall Study|Death|3|||
156522975|NCT00126503|565007855|FG001|Overall Study|Death|0|||
156522976|NCT00126503|565007854|FG000|Overall Study|Adverse Event|13|||
156522977|NCT00126503|565007855|FG001|Overall Study|Adverse Event|3|||
156522978|NCT00126503|565007854|FG000|Overall Study|non-compliant|1|||
156522979|NCT00126503|565007855|FG001|Overall Study|non-compliant|0|||
156522980|NCT00126503|565007854|FG000|Overall Study|Physician Decision|2|||
156522981|NCT00126503|565007855|FG001|Overall Study|Physician Decision|1|||
156522982|NCT02495792|565007856|FG000|Overall Study|Lost to Follow-up|5|||
156522983|NCT02495792|565007857|FG001|Overall Study|Lost to Follow-up|9|||
156522984|NCT02495792|565007856|FG000|Overall Study|Protocol Violation|32|||
156522985|NCT02495792|565007857|FG001|Overall Study|Protocol Violation|31|||
156522986|NCT04134845|565007862|FG000|Overall Study|withdrawl by PI|12|||
156522987|NCT04134845|565007863|FG001|Overall Study|withdrawl by PI|5|||
156522988|NCT00409773|565009473|FG000|Overall Study|Adverse Event|3|||
156522989|NCT00409773|565009474|FG001|Overall Study|Adverse Event|4|||
156522990|NCT00409773|565009475|FG002|Overall Study|Adverse Event|4|||
156522991|NCT00409773|565009476|FG003|Overall Study|Adverse Event|2|||
156522992|NCT00409773|565009477|FG004|Overall Study|Adverse Event|6|||
156522993|NCT00409773|565009473|FG000|Overall Study|Lost to Follow-up|6|||
156522994|NCT00409773|565009474|FG001|Overall Study|Lost to Follow-up|1|||
156522995|NCT00409773|565009475|FG002|Overall Study|Lost to Follow-up|2|||
156522996|NCT00409773|565009476|FG003|Overall Study|Lost to Follow-up|3|||
156522997|NCT00409773|565009477|FG004|Overall Study|Lost to Follow-up|1|||
156522998|NCT00409773|565009473|FG000|Overall Study|Physician Decision|0|||
156522999|NCT00409773|565009474|FG001|Overall Study|Physician Decision|0|||
156523000|NCT00409773|565009475|FG002|Overall Study|Physician Decision|0|||
156523001|NCT00409773|565009476|FG003|Overall Study|Physician Decision|2|||
156523002|NCT00409773|565009477|FG004|Overall Study|Physician Decision|0|||
156523003|NCT00409773|565009473|FG000|Overall Study|Protocol Violation|0|||
156523004|NCT00409773|565009474|FG001|Overall Study|Protocol Violation|2|||
156523005|NCT00409773|565009475|FG002|Overall Study|Protocol Violation|3|||
156523006|NCT00409773|565009476|FG003|Overall Study|Protocol Violation|3|||
156523007|NCT00409773|565009477|FG004|Overall Study|Protocol Violation|1|||
156523008|NCT00409773|565009473|FG000|Overall Study|Withdrawal by Subject|0|||
156523009|NCT00409773|565009474|FG001|Overall Study|Withdrawal by Subject|0|||
156523010|NCT00409773|565009475|FG002|Overall Study|Withdrawal by Subject|0|||
156523011|NCT00409773|565009476|FG003|Overall Study|Withdrawal by Subject|2|||
156523012|NCT00409773|565009477|FG004|Overall Study|Withdrawal by Subject|1|||
156523013|NCT00409773|565009473|FG000|Overall Study|Lack of Eligibility|0|||
156523014|NCT00409773|565009474|FG001|Overall Study|Lack of Eligibility|0|||
156523015|NCT00409773|565009475|FG002|Overall Study|Lack of Eligibility|0|||
156523016|NCT00409773|565009476|FG003|Overall Study|Lack of Eligibility|0|||
156523017|NCT00409773|565009477|FG004|Overall Study|Lack of Eligibility|1|||
156523018|NCT01201343|565009478|FG000|Overall Study|Adverse Event|6|||
156523019|NCT01201343|565009478|FG000|Overall Study|Withdrawal by Subject|5|||
156523020|NCT01201343|565009478|FG000|Overall Study|Lost to Follow-up|2|||
156523021|NCT01201343|565009478|FG000|Overall Study|Lack of Efficacy|2|||
156523022|NCT01201343|565009478|FG000|Overall Study|Participant wrongly included in trial|1|||
156523023|NCT01201343|565009478|FG000|Overall Study|Randomized, not treated|3|||
156523024|NCT01919814|565009479|FG000|Overall Study|Adverse Event|1|||
156523025|NCT01919814|565009480|FG001|Overall Study|Adverse Event|0|||
156523026|NCT01919814|565009479|FG000|Overall Study|Protocol Violation|1|||
156523027|NCT01919814|565009480|FG001|Overall Study|Protocol Violation|0|||
156523028|NCT01919814|565009479|FG000|Overall Study|Withdrawal by Subject|1|||
156523029|NCT01919814|565009480|FG001|Overall Study|Withdrawal by Subject|0|||
156523030|NCT01440374|565009481|FG000|Part 1: Open-label Phase|Adverse Event|5|||
156523031|NCT01440374|565009482|FG001|Part 1: Open-label Phase|Adverse Event|0|||
156523032|NCT01440374|565009483|FG002|Part 1: Open-label Phase|Adverse Event|0|||
156523033|NCT01440374|565009484|FG003|Part 1: Open-label Phase|Adverse Event|0|||
156657290|NCT01957488|565491769|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
156657291|NCT01957488|565491770|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
156657292|NCT01957488|565491771|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
156657293|NCT01957488|565491772|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
156657294|NCT01957488|565491773|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
156657295|NCT01957488|565491774|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
156657296|NCT01957488|565491769|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
156657297|NCT01957488|565491770|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
156657298|NCT01957488|565491771|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
156657299|NCT01957488|565491772|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
156657300|NCT01957488|565491773|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
156657301|NCT01957488|565491774|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
156657302|NCT01957488|565491769|FG000|Test Period 2 (2 Weeks)|Other|1|||
156657303|NCT01957488|565491770|FG001|Test Period 2 (2 Weeks)|Other|0|||
156657304|NCT01957488|565491771|FG002|Test Period 2 (2 Weeks)|Other|0|||
156657305|NCT01957488|565491772|FG003|Test Period 2 (2 Weeks)|Other|0|||
156657306|NCT01957488|565491773|FG004|Test Period 2 (2 Weeks)|Other|0|||
156657307|NCT01957488|565491774|FG005|Test Period 2 (2 Weeks)|Other|0|||
156657308|NCT01957488|565491769|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
156657309|NCT01957488|565491770|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
156657310|NCT01957488|565491771|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
156428123|NCT03410992|564660776|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156428124|NCT04804605|564660777|FG000|Overall Study|Withdrawal by Subject|46|||
156428125|NCT04804605|564660778|FG001|Overall Study|Withdrawal by Subject|26|||
156428126|NCT04804605|564660779|FG002|Overall Study|Withdrawal by Subject|37|||
156428127|NCT04804605|564660780|FG003|Overall Study|Withdrawal by Subject|21|||
156428128|NCT04804605|564660777|FG000|Overall Study|Lost to Follow-up|47|||
156428129|NCT04804605|564660778|FG001|Overall Study|Lost to Follow-up|21|||
156428130|NCT04804605|564660779|FG002|Overall Study|Lost to Follow-up|30|||
156428131|NCT04804605|564660780|FG003|Overall Study|Lost to Follow-up|17|||
156428132|NCT04804605|564660777|FG000|Overall Study|Lack of Efficacy|28|||
156428133|NCT04804605|564660778|FG001|Overall Study|Lack of Efficacy|11|||
156428134|NCT04804605|564660779|FG002|Overall Study|Lack of Efficacy|37|||
156428135|NCT04804605|564660780|FG003|Overall Study|Lack of Efficacy|8|||
156428136|NCT04804605|564660777|FG000|Overall Study|Adverse Event|10|||
156428137|NCT04804605|564660778|FG001|Overall Study|Adverse Event|10|||
156428138|NCT04804605|564660779|FG002|Overall Study|Adverse Event|10|||
156428139|NCT04804605|564660780|FG003|Overall Study|Adverse Event|7|||
156428140|NCT04804605|564660777|FG000|Overall Study|Non-compliance|8|||
156428141|NCT04804605|564660778|FG001|Overall Study|Non-compliance|3|||
156428142|NCT04804605|564660779|FG002|Overall Study|Non-compliance|5|||
156428143|NCT04804605|564660780|FG003|Overall Study|Non-compliance|1|||
156428144|NCT04804605|564660777|FG000|Overall Study|Physician Decision|3|||
156428145|NCT04804605|564660778|FG001|Overall Study|Physician Decision|0|||
156428146|NCT04804605|564660779|FG002|Overall Study|Physician Decision|5|||
156428147|NCT04804605|564660780|FG003|Overall Study|Physician Decision|0|||
156428148|NCT04804605|564660777|FG000|Overall Study|Protocol Violation|1|||
156428149|NCT04804605|564660778|FG001|Overall Study|Protocol Violation|0|||
156428150|NCT04804605|564660779|FG002|Overall Study|Protocol Violation|0|||
156428151|NCT04804605|564660780|FG003|Overall Study|Protocol Violation|1|||
156428152|NCT04804605|564660777|FG000|Overall Study|Miscellaneous|7|||
156428153|NCT04804605|564660778|FG001|Overall Study|Miscellaneous|3|||
156428154|NCT04804605|564660779|FG002|Overall Study|Miscellaneous|4|||
156428155|NCT04804605|564660780|FG003|Overall Study|Miscellaneous|2|||
156428156|NCT04018066|564660783|FG000|Overall Study|participants started taking medications during the study period|3|||
156428157|NCT04018066|564660783|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
156428158|NCT03568318|564660784|FG000|Overall Study|Adverse Event|3|||
156428159|NCT03568318|564660785|FG001|Overall Study|Adverse Event|1|||
156428160|NCT03568318|564660786|FG002|Overall Study|Adverse Event|1|||
156428161|NCT03568318|564660787|FG003|Overall Study|Adverse Event|0|||
156428162|NCT03568318|564660788|FG004|Overall Study|Adverse Event|1|||
156428163|NCT03568318|564660789|FG005|Overall Study|Adverse Event|0|||
156428164|NCT03568318|564660784|FG000|Overall Study|Withdrawal by Subject|6|||
156428165|NCT03568318|564660785|FG001|Overall Study|Withdrawal by Subject|5|||
156428166|NCT03568318|564660786|FG002|Overall Study|Withdrawal by Subject|2|||
156428167|NCT03568318|564660787|FG003|Overall Study|Withdrawal by Subject|1|||
156428168|NCT03568318|564660788|FG004|Overall Study|Withdrawal by Subject|0|||
156428169|NCT03568318|564660789|FG005|Overall Study|Withdrawal by Subject|0|||
156428170|NCT03568318|564660784|FG000|Overall Study|Lost to Follow-up|3|||
156428171|NCT03568318|564660785|FG001|Overall Study|Lost to Follow-up|2|||
156428172|NCT03568318|564660786|FG002|Overall Study|Lost to Follow-up|2|||
156428173|NCT03568318|564660787|FG003|Overall Study|Lost to Follow-up|2|||
156428174|NCT03568318|564660788|FG004|Overall Study|Lost to Follow-up|1|||
156428175|NCT03568318|564660789|FG005|Overall Study|Lost to Follow-up|0|||
156428176|NCT03568318|564660784|FG000|Overall Study|Other|3|||
156428177|NCT03568318|564660785|FG001|Overall Study|Other|1|||
156428178|NCT03568318|564660786|FG002|Overall Study|Other|3|||
156657311|NCT01957488|565491772|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
156523034|NCT01440374|565009481|FG000|Part 1: Open-label Phase|Physician Decision|1|||
156523035|NCT01440374|565009482|FG001|Part 1: Open-label Phase|Physician Decision|0|||
156523036|NCT01440374|565009483|FG002|Part 1: Open-label Phase|Physician Decision|0|||
156523037|NCT01440374|565009484|FG003|Part 1: Open-label Phase|Physician Decision|0|||
156523038|NCT01440374|565009481|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
156523039|NCT01440374|565009482|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
156428179|NCT03568318|564660787|FG003|Overall Study|Other|0|||
156523040|NCT01440374|565009483|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
156523041|NCT01440374|565009484|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
156428180|NCT03568318|564660788|FG004|Overall Study|Other|0|||
156428181|NCT03568318|564660789|FG005|Overall Study|Other|0|||
156428182|NCT03568318|564660784|FG000|Overall Study|Ongoing at Time of Analysis|5|||
156428183|NCT03568318|564660785|FG001|Overall Study|Ongoing at Time of Analysis|3|||
156428184|NCT03568318|564660786|FG002|Overall Study|Ongoing at Time of Analysis|2|||
156428185|NCT03568318|564660787|FG003|Overall Study|Ongoing at Time of Analysis|1|||
156428186|NCT03568318|564660788|FG004|Overall Study|Ongoing at Time of Analysis|0|||
156428187|NCT03568318|564660789|FG005|Overall Study|Ongoing at Time of Analysis|0|||
156428188|NCT04988295|564660790|FG000|Overall Study|Withdrawal by Subject|9|||
156428189|NCT04988295|564660791|FG001|Overall Study|Withdrawal by Subject|29|||
156428190|NCT04988295|564660792|FG002|Overall Study|Withdrawal by Subject|6|||
156428191|NCT04988295|564660793|FG003|Overall Study|Withdrawal by Subject|0|||
156428192|NCT04988295|564660790|FG000|Overall Study|Lost to Follow-up|1|||
156428193|NCT04988295|564660791|FG001|Overall Study|Lost to Follow-up|0|||
156428194|NCT04988295|564660792|FG002|Overall Study|Lost to Follow-up|0|||
156428195|NCT04988295|564660793|FG003|Overall Study|Lost to Follow-up|0|||
156428196|NCT04988295|564660790|FG000|Overall Study|Study participation ongoing|186|||
156428197|NCT04988295|564660791|FG001|Overall Study|Study participation ongoing|169|||
156428198|NCT04988295|564660792|FG002|Overall Study|Study participation ongoing|99|||
156428199|NCT04988295|564660793|FG003|Overall Study|Study participation ongoing|119|||
156428200|NCT04083976|564660794|FG000|Overall Study|Lost to Follow-up|3|||
156428201|NCT04083976|564660795|FG001|Overall Study|Lost to Follow-up|0|||
156428202|NCT04083976|564660796|FG002|Overall Study|Lost to Follow-up|0|||
156428203|NCT04083976|564660797|FG003|Overall Study|Lost to Follow-up|1|||
156428204|NCT04083976|564660794|FG000|Overall Study|Withdrawal by Subject|16|||
156428205|NCT04083976|564660795|FG001|Overall Study|Withdrawal by Subject|1|||
156428206|NCT04083976|564660796|FG002|Overall Study|Withdrawal by Subject|9|||
156428207|NCT04083976|564660797|FG003|Overall Study|Withdrawal by Subject|0|||
156428208|NCT04083976|564660794|FG000|Overall Study|Sponsor Decision|14|||
156428209|NCT04083976|564660795|FG001|Overall Study|Sponsor Decision|0|||
156428210|NCT04083976|564660796|FG002|Overall Study|Sponsor Decision|0|||
156428211|NCT04083976|564660797|FG003|Overall Study|Sponsor Decision|7|||
156428212|NCT04083976|564660794|FG000|Overall Study|Other|1|||
156428213|NCT04083976|564660795|FG001|Overall Study|Other|0|||
156428214|NCT04083976|564660796|FG002|Overall Study|Other|1|||
156428215|NCT04083976|564660797|FG003|Overall Study|Other|0|||
156428216|NCT03102710|564660798|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
156428217|NCT03102710|564660799|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
156428218|NCT03102710|564660800|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
156428219|NCT03102710|564660798|FG000|Overall Study|Technical issues during final MRI scan|0|||
156428220|NCT03102710|564660799|FG001|Overall Study|Technical issues during final MRI scan|1|||
156428221|NCT03102710|564660800|FG002|Overall Study|Technical issues during final MRI scan|0|||
156428222|NCT03102710|564660798|FG000|Overall Study|Nausea during MRI scan|0|||
156428223|NCT03102710|564660799|FG001|Overall Study|Nausea during MRI scan|1|||
156428224|NCT03102710|564660800|FG002|Overall Study|Nausea during MRI scan|0|||
156428225|NCT03102710|564660798|FG000|Overall Study|Subject unable to attend final session|0|||
156428226|NCT03102710|564660799|FG001|Overall Study|Subject unable to attend final session|1|||
156428227|NCT03102710|564660800|FG002|Overall Study|Subject unable to attend final session|0|||
156428228|NCT01313182|564660801|FG000|Overall Study|Protocol Violation|66|||
156428229|NCT01313182|564660802|FG001|Overall Study|Protocol Violation|92|||
156428230|NCT05197049|564660806|FG000|Overall Study|Death|0|||
156523042|NCT01440374|565009481|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
156428231|NCT05197049|564660807|FG001|Overall Study|Death|1|||
156523043|NCT01440374|565009482|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
156523044|NCT01440374|565009483|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
156428232|NCT05197049|564660808|FG002|Overall Study|Death|0|||
156428233|NCT05197049|564660806|FG000|Overall Study|Lost to Follow-up|3|||
156770312|NCT01773928|565913114|FG004|Overall Study|Subject misrepresented age|0|||
156428234|NCT05197049|564660807|FG001|Overall Study|Lost to Follow-up|1|||
156428235|NCT05197049|564660808|FG002|Overall Study|Lost to Follow-up|0|||
156428236|NCT05197049|564660806|FG000|Overall Study|Withdrawal by Subject|15|||
156428237|NCT05197049|564660807|FG001|Overall Study|Withdrawal by Subject|3|||
156428238|NCT05197049|564660808|FG002|Overall Study|Withdrawal by Subject|1|||
156770313|NCT01773928|565913115|FG005|Overall Study|Subject misrepresented age|0|||
156428239|NCT05197049|564660806|FG000|Overall Study|GCP non-compliance|1|||
156523045|NCT01440374|565009484|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
156523046|NCT01440374|565009481|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
156428240|NCT05197049|564660807|FG001|Overall Study|GCP non-compliance|2|||
156428241|NCT05197049|564660808|FG002|Overall Study|GCP non-compliance|0|||
156428242|NCT02299635|564660809|FG000|Overall Study|Adverse Event|2|||
156428243|NCT02299635|564660809|FG000|Overall Study|Death|1|||
156428244|NCT02299635|564660809|FG000|Overall Study|Global deterioration of health status|1|||
156428245|NCT02299635|564660809|FG000|Overall Study|Objective progression or relapse|10|||
156428246|NCT02299635|564660809|FG000|Overall Study|Withdrawal by Subject|2|||
156428247|NCT02299635|564660809|FG000|Overall Study|Other|3|||
156428248|NCT04889118|564660810|FG000|Overall Study|Death|49|||
156428249|NCT04889118|564660811|FG001|Overall Study|Death|47|||
156428250|NCT04889118|564660810|FG000|Overall Study|Sponsor Decision|15|||
156428251|NCT04889118|564660811|FG001|Overall Study|Sponsor Decision|20|||
156428252|NCT00906698|564660812|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
156428253|NCT00906698|564660813|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
156428254|NCT00906698|564660814|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
156428255|NCT00906698|564660815|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
156428256|NCT00906698|564660816|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
156428257|NCT00906698|564660817|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
156428258|NCT00906698|564660812|FG000|Overall Study|Adverse Event|0|||
156428259|NCT00906698|564660813|FG001|Overall Study|Adverse Event|0|||
156428260|NCT00906698|564660814|FG002|Overall Study|Adverse Event|2|||
156428261|NCT00906698|564660815|FG003|Overall Study|Adverse Event|0|||
156428262|NCT00906698|564660816|FG004|Overall Study|Adverse Event|4|||
156428263|NCT00906698|564660817|FG005|Overall Study|Adverse Event|1|||
156428264|NCT00906698|564660812|FG000|Overall Study|Disease progression|3|||
156428265|NCT00906698|564660813|FG001|Overall Study|Disease progression|12|||
156428266|NCT00906698|564660814|FG002|Overall Study|Disease progression|4|||
156428267|NCT00906698|564660815|FG003|Overall Study|Disease progression|4|||
156428268|NCT00906698|564660816|FG004|Overall Study|Disease progression|12|||
156428269|NCT00906698|564660817|FG005|Overall Study|Disease progression|4|||
156428270|NCT00906698|564660812|FG000|Overall Study|Withdrawal by Subject|0|||
156428271|NCT00906698|564660813|FG001|Overall Study|Withdrawal by Subject|0|||
156428272|NCT00906698|564660814|FG002|Overall Study|Withdrawal by Subject|0|||
156428273|NCT00906698|564660815|FG003|Overall Study|Withdrawal by Subject|0|||
156428274|NCT00906698|564660816|FG004|Overall Study|Withdrawal by Subject|1|||
156428275|NCT00906698|564660817|FG005|Overall Study|Withdrawal by Subject|0|||
156428276|NCT00906698|564660812|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
156428277|NCT00906698|564660813|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
156428278|NCT00906698|564660814|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
156428279|NCT00906698|564660815|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
156428280|NCT00906698|564660816|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
156428281|NCT00906698|564660817|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
156428282|NCT02846415|564660821|FG000|Overall Study|Lost to Follow-up|2|||
156428283|NCT02846415|564660822|FG001|Overall Study|Lost to Follow-up|0|||
156428284|NCT02846415|564660821|FG000|Overall Study|Withdrawal by Subject|1|||
156428285|NCT02846415|564660822|FG001|Overall Study|Withdrawal by Subject|1|||
156428286|NCT00567164|564660823|FG000|Overall Study|Withdrawal by Subject|171|||
156428287|NCT00567164|564660824|FG001|Overall Study|Withdrawal by Subject|21|||
156428288|NCT00567164|564660825|FG002|Overall Study|Withdrawal by Subject|17|||
156428289|NCT00567164|564660823|FG000|Overall Study|Protocol Violation|23|||
156428290|NCT00567164|564660824|FG001|Overall Study|Protocol Violation|4|||
156428291|NCT00567164|564660825|FG002|Overall Study|Protocol Violation|2|||
156428292|NCT00567164|564660823|FG000|Overall Study|Adverse Event|92|||
156428293|NCT00567164|564660824|FG001|Overall Study|Adverse Event|13|||
156428294|NCT00567164|564660825|FG002|Overall Study|Adverse Event|9|||
156428295|NCT00567164|564660823|FG000|Overall Study|Death|0|||
156428296|NCT00567164|564660824|FG001|Overall Study|Death|0|||
156428297|NCT00567164|564660825|FG002|Overall Study|Death|1|||
156428298|NCT00567164|564660823|FG000|Overall Study|Lost to Follow-up|202|||
156428299|NCT00567164|564660824|FG001|Overall Study|Lost to Follow-up|23|||
156428300|NCT00567164|564660825|FG002|Overall Study|Lost to Follow-up|21|||
156428301|NCT00567164|564660823|FG000|Overall Study|Pregnancy|20|||
156428302|NCT00567164|564660824|FG001|Overall Study|Pregnancy|4|||
156428303|NCT00567164|564660825|FG002|Overall Study|Pregnancy|6|||
156428304|NCT00567164|564660823|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
156428305|NCT00567164|564660824|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
156428306|NCT00567164|564660825|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
156428307|NCT00567164|564660823|FG000|Overall Study|Missing|1|||
156428308|NCT00567164|564660824|FG001|Overall Study|Missing|0|||
156428309|NCT00567164|564660825|FG002|Overall Study|Missing|0|||
156428310|NCT00001575|564660826|FG000|Overall Study|Screening failures-Ph I portion|22|||
156428311|NCT00001575|564660826|FG000|Overall Study|Withdrawn/deaths|23|||
156428312|NCT03256344|564660827|FG000|Overall Study|Death|6|||
156428313|NCT03256344|564660828|FG001|Overall Study|Death|22|||
156428314|NCT03256344|564660827|FG000|Overall Study|Withdrawal by Subject|3|||
156428315|NCT03256344|564660828|FG001|Overall Study|Withdrawal by Subject|3|||
156428316|NCT03256344|564660827|FG000|Overall Study|Sponsor Decision|1|||
156428317|NCT03256344|564660828|FG001|Overall Study|Sponsor Decision|0|||
156523047|NCT01440374|565009482|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
156523048|NCT01440374|565009483|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
156523049|NCT01440374|565009484|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
156523050|NCT01440374|565009481|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
156523051|NCT01440374|565009482|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
156523052|NCT01440374|565009483|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
156523053|NCT01440374|565009484|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
156523054|NCT01440374|565009481|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
156523055|NCT01440374|565009482|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
156523056|NCT01440374|565009483|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
156523057|NCT01440374|565009484|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
156523058|NCT01440374|565009481|FG000|Part 2; Double-blind Phase|Not treated|0|||
156523059|NCT01440374|565009482|FG001|Part 2; Double-blind Phase|Not treated|0|||
156523060|NCT01440374|565009483|FG002|Part 2; Double-blind Phase|Not treated|1|||
156523061|NCT01440374|565009484|FG003|Part 2; Double-blind Phase|Not treated|0|||
156523062|NCT01440374|565009481|FG000|Part 3: Extension|Withdrawal by Subject|0|||
156523063|NCT01440374|565009482|FG001|Part 3: Extension|Withdrawal by Subject|0|||
156523064|NCT01440374|565009483|FG002|Part 3: Extension|Withdrawal by Subject|0|||
156523065|NCT01440374|565009484|FG003|Part 3: Extension|Withdrawal by Subject|5|||
156523066|NCT01440374|565009481|FG000|Part 3: Extension|Adverse Event|0|||
156523067|NCT01440374|565009482|FG001|Part 3: Extension|Adverse Event|0|||
156523068|NCT01440374|565009483|FG002|Part 3: Extension|Adverse Event|0|||
156523069|NCT01440374|565009484|FG003|Part 3: Extension|Adverse Event|13|||
156523070|NCT01440374|565009481|FG000|Part 3: Extension|Physician Decision|0|||
156523071|NCT01440374|565009482|FG001|Part 3: Extension|Physician Decision|0|||
156523072|NCT01440374|565009483|FG002|Part 3: Extension|Physician Decision|0|||
156523073|NCT01440374|565009484|FG003|Part 3: Extension|Physician Decision|14|||
156523074|NCT04812548|565009486|FG000|Overall Study|Adverse Event|2|||
156523075|NCT04812548|565009487|FG001|Overall Study|Adverse Event|7|||
156523076|NCT04812548|565009486|FG000|Overall Study|HSCT Planned|2|||
156523077|NCT04812548|565009487|FG001|Overall Study|HSCT Planned|3|||
156523078|NCT04812548|565009486|FG000|Overall Study|Progressive Disease|0|||
156523079|NCT04812548|565009487|FG001|Overall Study|Progressive Disease|2|||
156523080|NCT04812548|565009486|FG000|Overall Study|Death|0|||
156523081|NCT04812548|565009487|FG001|Overall Study|Death|1|||
156523082|NCT04812548|565009486|FG000|Overall Study|Post Study Access to Treatment|0|||
156523083|NCT04812548|565009487|FG001|Overall Study|Post Study Access to Treatment|1|||
156523084|NCT04812548|565009486|FG000|Overall Study|Withdrawal by Subject|0|||
156523085|NCT04812548|565009487|FG001|Overall Study|Withdrawal by Subject|1|||
156523086|NCT04812548|565009486|FG000|Overall Study|Physician Decision|1|||
156523087|NCT04812548|565009487|FG001|Overall Study|Physician Decision|0|||
156523088|NCT02141984|565009489|FG000|Overall Study|Lack of Efficacy|2|||
156523089|NCT02079610|565009490|FG000|Overall Study|Withdrawal by Subject|1|||
156523090|NCT02079610|565009491|FG001|Overall Study|Withdrawal by Subject|1|||
156523091|NCT01716117|565009494|FG000|Overall Study|Death|5|||
156523092|NCT01716117|565009495|FG001|Overall Study|Death|2|||
156523093|NCT01716117|565009494|FG000|Overall Study|Withdrawal by Subject|2|||
156523094|NCT01716117|565009495|FG001|Overall Study|Withdrawal by Subject|0|||
156523095|NCT01557283|565009496|FG000|Overall Study|Lost to Follow-up|7|||
156523096|NCT01557283|565009496|FG000|Overall Study|Non-responder|19|||
156523097|NCT01557283|565009496|FG000|Overall Study|Adverse Event|7|||
156523098|NCT01557283|565009496|FG000|Overall Study|Lack of Efficacy|1|||
156523099|NCT01557283|565009496|FG000|Overall Study|Non-compliance|1|||
156523100|NCT01557283|565009496|FG000|Overall Study|Withdrawal by Subject|1|||
156523101|NCT01557283|565009496|FG000|Overall Study|Participant's weight too high for dose|1|||
156323958|NCT03172910|564286007|FG003|Overall Study|Adverse Event|0|||
156323959|NCT03172910|564286008|FG004|Overall Study|Adverse Event|1|||
156323960|NCT01659658|564286009|FG000|Overall Study|Withdrawal by Patient|18|||
156323961|NCT01659658|564286010|FG001|Overall Study|Withdrawal by Patient|4|||
156323962|NCT01659658|564286011|FG002|Overall Study|Withdrawal by Patient|2|||
156323963|NCT01659658|564286012|FG003|Overall Study|Withdrawal by Patient|0|||
156323964|NCT01659658|564286013|FG004|Overall Study|Withdrawal by Patient|11|||
156323965|NCT01659658|564286009|FG000|Overall Study|Study Terminated by Sponsor|9|||
156323966|NCT01659658|564286010|FG001|Overall Study|Study Terminated by Sponsor|7|||
156323967|NCT01659658|564286011|FG002|Overall Study|Study Terminated by Sponsor|0|||
156323968|NCT01659658|564286012|FG003|Overall Study|Study Terminated by Sponsor|1|||
156523102|NCT01557283|565009496|FG000|Overall Study|Worsening of psoriasis|1|||
156323969|NCT01659658|564286013|FG004|Overall Study|Study Terminated by Sponsor|4|||
156323970|NCT01659658|564286009|FG000|Overall Study|Reason not Specified|61|||
156523103|NCT01557283|565009496|FG000|Overall Study|Other|6|||
156323971|NCT01659658|564286010|FG001|Overall Study|Reason not Specified|15|||
156323972|NCT01659658|564286011|FG002|Overall Study|Reason not Specified|8|||
156323973|NCT01659658|564286012|FG003|Overall Study|Reason not Specified|1|||
156523104|NCT01765192|565009497|FG000|Treatment Period 1|Adverse Event|0|||
156523105|NCT01765192|565009498|FG001|Treatment Period 1|Adverse Event|1|||
156523106|NCT01765192|565009497|FG000|Washout Period|Voluntary Withdrawal|1|||
156523107|NCT01765192|565009498|FG001|Washout Period|Voluntary Withdrawal|1|||
156523108|NCT01765192|565009497|FG000|Washout Period|Reason not specified|1|||
156523109|NCT01765192|565009498|FG001|Washout Period|Reason not specified|0|||
156523110|NCT01765192|565009497|FG000|Treatment Period 2|Reason not specified|0|||
156523111|NCT01765192|565009498|FG001|Treatment Period 2|Reason not specified|2|||
156523112|NCT01765192|565009497|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
156523113|NCT01765192|565009498|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
156523114|NCT03645057|565009502|FG000|Randomization to Baseline|Lost to Follow-up|1|||
156523115|NCT03645057|565009503|FG001|Randomization to Baseline|Lost to Follow-up|0|||
156523116|NCT03645057|565009504|FG002|Randomization to Baseline|Lost to Follow-up|1|||
156523117|NCT03645057|565009505|FG003|Randomization to Baseline|Lost to Follow-up|0|||
156523118|NCT03645057|565009502|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
156523119|NCT03645057|565009503|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
156523120|NCT03645057|565009504|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
156523121|NCT03645057|565009505|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
156523122|NCT03645057|565009502|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
156523123|NCT03645057|565009503|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
156523124|NCT03645057|565009504|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
156523125|NCT03645057|565009505|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
156523126|NCT03645057|565009502|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
156523127|NCT03645057|565009503|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
156523128|NCT03645057|565009504|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
156657312|NCT01957488|565491773|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
156523129|NCT03645057|565009505|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
156523130|NCT00250679|565009506|FG000|Overall Study|Adverse Event|12|||
156523131|NCT00250679|565009507|FG001|Overall Study|Adverse Event|15|||
156657313|NCT01957488|565491774|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
156657314|NCT01957488|565491769|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
156657315|NCT01957488|565491770|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
156657316|NCT01957488|565491771|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
156657317|NCT01957488|565491772|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
156657318|NCT01957488|565491773|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
156657319|NCT01957488|565491774|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
156657320|NCT01957488|565491769|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
156657321|NCT01957488|565491770|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
156657322|NCT01957488|565491771|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
156657323|NCT01957488|565491772|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
156657324|NCT01957488|565491773|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
156657325|NCT01957488|565491774|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
156657326|NCT01957488|565491769|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
156657327|NCT01957488|565491770|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
156657328|NCT01957488|565491771|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
156657329|NCT01957488|565491772|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
156657330|NCT01957488|565491773|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
156657331|NCT01957488|565491774|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
156657332|NCT01957488|565491769|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
156657333|NCT01957488|565491770|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
156657334|NCT01957488|565491771|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
156657335|NCT01957488|565491772|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
156657336|NCT01957488|565491773|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
156657337|NCT01957488|565491774|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
156657338|NCT02402166|565491775|FG000|Overall Study|Adverse Event|2|||
156657339|NCT02402166|565491775|FG000|Overall Study|Withdrawal by Subject|2|||
156657340|NCT02402166|565491775|FG000|Overall Study|Lost to Follow-up|1|||
156657341|NCT00810368|565491777|FG000|Overall Study|Lost to Follow-up|4|||
156657342|NCT00810368|565491778|FG001|Overall Study|Lost to Follow-up|2|||
156657343|NCT00810368|565491777|FG000|Overall Study|Lack of Efficacy|2|||
156657344|NCT00810368|565491778|FG001|Overall Study|Lack of Efficacy|0|||
156657345|NCT00623103|565491779|FG000|Overall Study|Adverse Event|70|||
156657346|NCT00623103|565491780|FG001|Overall Study|Adverse Event|60|||
156657347|NCT00623103|565491779|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156657348|NCT00623103|565491780|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
156657349|NCT00623103|565491779|FG000|Overall Study|Withdrawal by Subject|18|||
156657350|NCT00623103|565491780|FG001|Overall Study|Withdrawal by Subject|24|||
156657351|NCT00623103|565491779|FG000|Overall Study|Lost to Follow-up|4|||
156657352|NCT00623103|565491780|FG001|Overall Study|Lost to Follow-up|1|||
156657353|NCT00623103|565491779|FG000|Overall Study|Administrative problems|2|||
156657354|NCT00623103|565491780|FG001|Overall Study|Administrative problems|4|||
156657355|NCT00623103|565491779|FG000|Overall Study|Death|11|||
156657356|NCT00623103|565491780|FG001|Overall Study|Death|11|||
156523132|NCT00250679|565009508|FG002|Overall Study|Adverse Event|16|||
156523133|NCT00250679|565009506|FG000|Overall Study|Protocol Violation|2|||
156657357|NCT00623103|565491779|FG000|Overall Study|Protocol deviation|2|||
156523134|NCT00250679|565009507|FG001|Overall Study|Protocol Violation|4|||
156523135|NCT00250679|565009508|FG002|Overall Study|Protocol Violation|3|||
156523136|NCT00250679|565009506|FG000|Overall Study|Withdrawal by Subject|15|||
156523137|NCT00250679|565009507|FG001|Overall Study|Withdrawal by Subject|18|||
156523138|NCT00250679|565009508|FG002|Overall Study|Withdrawal by Subject|15|||
156523139|NCT00250679|565009506|FG000|Overall Study|Lost to Follow-up|3|||
156523140|NCT00250679|565009507|FG001|Overall Study|Lost to Follow-up|4|||
156523141|NCT00250679|565009508|FG002|Overall Study|Lost to Follow-up|2|||
156523142|NCT00250679|565009506|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
156523143|NCT00250679|565009507|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
156523144|NCT00250679|565009508|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
156523145|NCT00250679|565009506|FG000|Overall Study|Lack of Efficacy|0|||
156523146|NCT00250679|565009507|FG001|Overall Study|Lack of Efficacy|1|||
156523147|NCT00250679|565009508|FG002|Overall Study|Lack of Efficacy|3|||
156523148|NCT00250679|565009506|FG000|Overall Study|Technical Holter issues|1|||
156523149|NCT00250679|565009507|FG001|Overall Study|Technical Holter issues|0|||
156523150|NCT00250679|565009508|FG002|Overall Study|Technical Holter issues|2|||
156523151|NCT00250679|565009506|FG000|Overall Study|Moved|1|||
156523152|NCT00250679|565009507|FG001|Overall Study|Moved|1|||
156523153|NCT00250679|565009508|FG002|Overall Study|Moved|0|||
156523154|NCT00250679|565009506|FG000|Overall Study|Non-compliance|1|||
156523155|NCT00250679|565009507|FG001|Overall Study|Non-compliance|1|||
156523156|NCT00250679|565009508|FG002|Overall Study|Non-compliance|0|||
156523157|NCT00250679|565009506|FG000|Overall Study|various single events: hip surgery,diary|3|||
156523158|NCT00250679|565009507|FG001|Overall Study|various single events: hip surgery,diary|1|||
156523159|NCT00250679|565009508|FG002|Overall Study|various single events: hip surgery,diary|1|||
156523160|NCT00448279|565009510|FG000|Overall Study|Lost to Follow-up|2|||
156523161|NCT00448279|565009511|FG001|Overall Study|Lost to Follow-up|2|||
156523162|NCT00448279|565009510|FG000|Overall Study|Adverse Event|1|||
156523163|NCT00448279|565009511|FG001|Overall Study|Adverse Event|1|||
156523164|NCT00448279|565009510|FG000|Overall Study|Disease progression|16|||
156523165|NCT00448279|565009511|FG001|Overall Study|Disease progression|18|||
156523166|NCT00448279|565009510|FG000|Overall Study|Withdrawal by Subject|4|||
156523167|NCT00448279|565009511|FG001|Overall Study|Withdrawal by Subject|3|||
156523168|NCT00448279|565009510|FG000|Overall Study|Other|6|||
156523169|NCT00448279|565009511|FG001|Overall Study|Other|4|||
156523170|NCT00448279|565009510|FG000|Overall Study|Protocol Violation|0|||
156770314|NCT01773928|565913116|FG006|Overall Study|Subject misrepresented age|0|||
156770315|NCT01773928|565913117|FG007|Overall Study|Subject misrepresented age|0|||
156770316|NCT01773928|565913118|FG008|Overall Study|Subject misrepresented age|0|||
156770317|NCT01773928|565913110|FG000|Overall Study|Subject met exclusion criteria|0|||
156770318|NCT01773928|565913111|FG001|Overall Study|Subject met exclusion criteria|0|||
156770319|NCT01773928|565913112|FG002|Overall Study|Subject met exclusion criteria|0|||
156770320|NCT01773928|565913113|FG003|Overall Study|Subject met exclusion criteria|0|||
156770321|NCT01773928|565913114|FG004|Overall Study|Subject met exclusion criteria|0|||
156770322|NCT01773928|565913115|FG005|Overall Study|Subject met exclusion criteria|0|||
156770323|NCT01773928|565913116|FG006|Overall Study|Subject met exclusion criteria|0|||
156770324|NCT01773928|565913117|FG007|Overall Study|Subject met exclusion criteria|0|||
156770325|NCT01773928|565913118|FG008|Overall Study|Subject met exclusion criteria|1|||
156770326|NCT01773928|565913110|FG000|Overall Study|Randomized, had to leave, never returned|0|||
156770327|NCT01773928|565913111|FG001|Overall Study|Randomized, had to leave, never returned|0|||
156770328|NCT01773928|565913112|FG002|Overall Study|Randomized, had to leave, never returned|0|||
156770329|NCT01773928|565913113|FG003|Overall Study|Randomized, had to leave, never returned|1|||
156770330|NCT01773928|565913114|FG004|Overall Study|Randomized, had to leave, never returned|0|||
156770331|NCT01773928|565913115|FG005|Overall Study|Randomized, had to leave, never returned|0|||
156770332|NCT01773928|565913116|FG006|Overall Study|Randomized, had to leave, never returned|0|||
156770333|NCT01773928|565913117|FG007|Overall Study|Randomized, had to leave, never returned|0|||
156770334|NCT01773928|565913118|FG008|Overall Study|Randomized, had to leave, never returned|0|||
156770335|NCT01773928|565913110|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
156770336|NCT01773928|565913111|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
156770337|NCT01773928|565913112|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
156770338|NCT01773928|565913113|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
156770339|NCT01773928|565913114|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
156770340|NCT01773928|565913115|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
156770341|NCT01773928|565913116|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
156770342|NCT01773928|565913117|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
156323974|NCT01659658|564286013|FG004|Overall Study|Reason not Specified|34|||
156323975|NCT01659658|564286009|FG000|Overall Study|Lost to Follow-up|2|||
156523171|NCT00448279|565009511|FG001|Overall Study|Protocol Violation|1|||
156523172|NCT03907410|565009512|FG000|Overall Study|Lost to Follow-up|4|||
156523173|NCT03907410|565009513|FG001|Overall Study|Lost to Follow-up|1|||
156523174|NCT03907410|565009514|FG002|Overall Study|Lost to Follow-up|1|||
156523175|NCT03907410|565009512|FG000|Overall Study|Lost to follow-up and research burden|0|||
156523176|NCT03907410|565009513|FG001|Overall Study|Lost to follow-up and research burden|0|||
156770343|NCT01773928|565913118|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
156770344|NCT06125964|565914573|FG000|Overall Study|Lost to Follow-up|0|||
156770345|NCT06125964|565914574|FG001|Overall Study|Lost to Follow-up|1|||
156523177|NCT03907410|565009514|FG002|Overall Study|Lost to follow-up and research burden|1|||
156523178|NCT01981473|565009515|FG000|Overall Study|Incorrect diagnosis of RA|0|||
156523179|NCT01981473|565009516|FG001|Overall Study|Incorrect diagnosis of RA|0|||
156657358|NCT00623103|565491780|FG001|Overall Study|Protocol deviation|1|||
156323976|NCT01659658|564286010|FG001|Overall Study|Lost to Follow-up|0|||
156323977|NCT01659658|564286011|FG002|Overall Study|Lost to Follow-up|0|||
156323978|NCT01659658|564286012|FG003|Overall Study|Lost to Follow-up|0|||
156657359|NCT03803943|565491789|FG000|Overall Study|Withdrawal by Subject|2|||
156657360|NCT03803943|565491790|FG001|Overall Study|Withdrawal by Subject|2|||
156657361|NCT03803943|565491791|FG002|Overall Study|Withdrawal by Subject|2|||
156657362|NCT03803943|565491792|FG003|Overall Study|Withdrawal by Subject|2|||
156657363|NCT01424722|565491793|FG000|Overall Study|Sponsor terminated investigation|2258|||
156657364|NCT01781286|565491794|FG000|Overall Study|Lost to Follow-up|0|||
156657365|NCT01781286|565491795|FG001|Overall Study|Lost to Follow-up|0|||
156657366|NCT01781286|565491796|FG002|Overall Study|Lost to Follow-up|0|||
156657367|NCT01781286|565491797|FG003|Overall Study|Lost to Follow-up|0|||
156657368|NCT01781286|565491798|FG004|Overall Study|Lost to Follow-up|0|||
156657369|NCT01781286|565491799|FG005|Overall Study|Lost to Follow-up|1|||
156657370|NCT01781286|565491794|FG000|Overall Study|Time Constraints|2|||
156657371|NCT01781286|565491795|FG001|Overall Study|Time Constraints|0|||
156657372|NCT01781286|565491796|FG002|Overall Study|Time Constraints|2|||
156657373|NCT01781286|565491797|FG003|Overall Study|Time Constraints|0|||
156657374|NCT01781286|565491798|FG004|Overall Study|Time Constraints|0|||
156657375|NCT01781286|565491799|FG005|Overall Study|Time Constraints|0|||
156657376|NCT01781286|565491794|FG000|Overall Study|Noncompliance|0|||
156657377|NCT01781286|565491795|FG001|Overall Study|Noncompliance|0|||
156657378|NCT01781286|565491796|FG002|Overall Study|Noncompliance|0|||
156657379|NCT01781286|565491797|FG003|Overall Study|Noncompliance|1|||
156657380|NCT01781286|565491798|FG004|Overall Study|Noncompliance|0|||
156657381|NCT01781286|565491799|FG005|Overall Study|Noncompliance|0|||
156657382|NCT00995410|565491800|FG000|Overall Study|Adverse Event|51|||
156657383|NCT00995410|565491800|FG000|Overall Study|Withdrawal by Subject|7|||
156657384|NCT00995410|565491800|FG000|Overall Study|Lost to Follow-up|2|||
156657385|NCT00995410|565491800|FG000|Overall Study|Misc|28|||
156657386|NCT02166697|565491801|FG000|Overall Study|Protocol Violation|347|||
156657387|NCT02684578|565491804|FG000|Overall Study|Withdrawal by Subject|10|||
156657388|NCT02684578|565491805|FG001|Overall Study|Withdrawal by Subject|7|||
156657389|NCT02684578|565491804|FG000|Overall Study|Lost to Follow-up|0|||
156657390|NCT02684578|565491805|FG001|Overall Study|Lost to Follow-up|3|||
156657391|NCT02684578|565491804|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
156657392|NCT02684578|565491805|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
156657393|NCT02684578|565491804|FG000|Overall Study|Missing follow-up data|0|||
156657394|NCT02684578|565491805|FG001|Overall Study|Missing follow-up data|1|||
156657395|NCT03267264|565491808|FG000|Overall Study|Withdrawal by Subject|1|||
156657396|NCT03267264|565491809|FG001|Overall Study|Withdrawal by Subject|0|||
156657397|NCT03267264|565491810|FG002|Overall Study|Withdrawal by Subject|2|||
156657398|NCT03267264|565491811|FG003|Overall Study|Withdrawal by Subject|4|||
156657399|NCT02224391|565491812|FG000|Overall Study|Lost to Follow-up|26|||
156657400|NCT02224391|565491813|FG001|Overall Study|Lost to Follow-up|19|||
156657401|NCT02224391|565491812|FG000|Overall Study|Withdrawal by Subject|6|||
156657402|NCT02224391|565491813|FG001|Overall Study|Withdrawal by Subject|5|||
156657403|NCT02492958|565491814|FG000|Overall Study|Withdrawal by Subject|0|||
156657404|NCT02492958|565491815|FG001|Overall Study|Withdrawal by Subject|0|||
156657405|NCT02492958|565491816|FG002|Overall Study|Withdrawal by Subject|1|||
156657406|NCT02492958|565491817|FG003|Overall Study|Withdrawal by Subject|0|||
156657407|NCT02492958|565491814|FG000|Overall Study|Adverse Event|1|||
156657408|NCT02492958|565491815|FG001|Overall Study|Adverse Event|0|||
156657409|NCT02492958|565491816|FG002|Overall Study|Adverse Event|1|||
156657410|NCT02492958|565491817|FG003|Overall Study|Adverse Event|0|||
156657411|NCT03522948|565491818|FG000|Overall Study|Lost to Follow-up|1|||
156657412|NCT00084084|565491820|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
156657413|NCT00084084|565491820|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
156657414|NCT02236130|565491828|FG000|Overall Study|Lost to Follow-up|7|||
156657415|NCT02236130|565491829|FG001|Overall Study|Lost to Follow-up|12|||
156657416|NCT00712010|565491830|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
156657417|NCT02660242|565491837|FG000|Glucose Tabs|Lost to Follow-up|1|||
156657418|NCT02660242|565491837|FG000|Glucagon Injection|Lost to Follow-up|1|||
156657419|NCT00770510|565491839|FG000|Overall Study|Lost to Follow-up|2|||
156657420|NCT00770510|565491839|FG000|Overall Study|Pregnancy|1|||
156657421|NCT00770510|565491839|FG000|Overall Study|Withdrawal by Subject|2|||
156657422|NCT01089647|565491841|FG000|Overall Study|Lost to Follow-up|2|||
156657423|NCT01089647|565491842|FG001|Overall Study|Lost to Follow-up|2|||
156657424|NCT01089647|565491841|FG000|Overall Study|Withdrawal by Subject|2|||
156657425|NCT01089647|565491842|FG001|Overall Study|Withdrawal by Subject|1|||
156770346|NCT06125964|565914575|FG002|Overall Study|Lost to Follow-up|0|||
156770347|NCT06125964|565914576|FG003|Overall Study|Lost to Follow-up|0|||
156770348|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
156770349|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
156770350|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
156770351|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Death|1|||
156770352|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Death|1|||
156770353|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Death|0|||
156770354|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
156770355|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
156770356|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
156770357|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
156770358|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
156770359|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
156770360|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
156770361|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
156770362|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
156770363|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
156770364|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
156770365|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
156770366|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
156770367|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
156770368|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
156770369|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
156770370|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
156770371|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
156770372|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
156770373|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
156770374|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
156770375|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
156770376|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
156770377|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
156770378|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Other|10|||
156770379|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Other|4|||
156770380|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Other|0|||
156770381|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
156770382|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
156770383|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
156770384|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
156770385|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
156770386|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
156770387|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
156770388|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
156770389|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
156770390|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
156770391|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
156770392|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
156770393|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
156770394|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
156770395|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
156770396|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
156770397|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
156770398|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
156770399|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Other|2|||
156770400|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Other|3|||
156770401|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Other|0|||
156770402|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
156770403|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
156770404|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
156770405|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Ongoing|86|||
156770406|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Ongoing|96|||
156770407|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Ongoing|0|||
156770408|NCT04006457|565914577|FG000|Main Study Observation Period|Adverse Event|1|||
156770409|NCT04006457|565914578|FG001|Main Study Observation Period|Adverse Event|1|||
156770410|NCT04006457|565914579|FG002|Main Study Observation Period|Adverse Event|0|||
156770411|NCT04006457|565914577|FG000|Main Study Observation Period|Lost to Follow-up|0|||
156770412|NCT04006457|565914578|FG001|Main Study Observation Period|Lost to Follow-up|1|||
156770413|NCT04006457|565914579|FG002|Main Study Observation Period|Lost to Follow-up|0|||
156770414|NCT04006457|565914577|FG000|Main Study Observation Period|Pregnancy|1|||
156770415|NCT04006457|565914578|FG001|Main Study Observation Period|Pregnancy|0|||
156770416|NCT04006457|565914579|FG002|Main Study Observation Period|Pregnancy|0|||
156770417|NCT04006457|565914577|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
156770418|NCT04006457|565914578|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
156523180|NCT01981473|565009517|FG002|Overall Study|Incorrect diagnosis of RA|1|||
156523181|NCT01981473|565009515|FG000|Overall Study|Received treatment for < 6 months|0|||
156770419|NCT04006457|565914579|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
156770420|NCT04006457|565914577|FG000|Main Study Observation Period|Other|8|||
156770421|NCT04006457|565914578|FG001|Main Study Observation Period|Other|16|||
156770422|NCT04006457|565914579|FG002|Main Study Observation Period|Other|0|||
156770423|NCT04006457|565914577|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
156770424|NCT04006457|565914578|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
156770425|NCT04006457|565914579|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
156770426|NCT04006457|565914577|FG000|Main Study Observation Period|Ongoing|2|||
156770427|NCT04006457|565914578|FG001|Main Study Observation Period|Ongoing|1|||
156770428|NCT04006457|565914579|FG002|Main Study Observation Period|Ongoing|0|||
156770429|NCT04006457|565914577|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
156770430|NCT04006457|565914578|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
156770431|NCT04006457|565914579|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
156770432|NCT05918055|565914580|FG000|Phase I - Dose Level 1|Ineligible|0|||
156770433|NCT05918055|565914581|FG001|Phase I - Dose Level 1|Ineligible|0|||
156770434|NCT05918055|565914582|FG002|Phase I - Dose Level 1|Ineligible|1|||
156770435|NCT05918055|565914580|FG000|Phase I - Dose Level -1|Physician Decision|1|||
156770436|NCT05918055|565914581|FG001|Phase I - Dose Level -1|Physician Decision|0|||
156770437|NCT05918055|565914582|FG002|Phase I - Dose Level -1|Physician Decision|0|||
156770438|NCT00109343|565914585|FG000|Overall Study|Adverse Event|1|||
156770439|NCT00109343|565914586|FG001|Overall Study|Adverse Event|0|||
156770440|NCT00109343|565914587|FG002|Overall Study|Adverse Event|2|||
156770441|NCT00109343|565914585|FG000|Overall Study|Lack of Efficacy|1|||
156770442|NCT00109343|565914586|FG001|Overall Study|Lack of Efficacy|0|||
156770443|NCT00109343|565914587|FG002|Overall Study|Lack of Efficacy|0|||
156770444|NCT00109343|565914585|FG000|Overall Study|Lost to Follow-up|35|||
156770445|NCT00109343|565914586|FG001|Overall Study|Lost to Follow-up|20|||
156770446|NCT00109343|565914587|FG002|Overall Study|Lost to Follow-up|14|||
156770447|NCT00109343|565914585|FG000|Overall Study|Protocol Violation|1|||
156770448|NCT00109343|565914586|FG001|Overall Study|Protocol Violation|2|||
156770449|NCT00109343|565914587|FG002|Overall Study|Protocol Violation|2|||
156770450|NCT00109343|565914585|FG000|Overall Study|Withdrawal by Subject|15|||
156657426|NCT01089647|565491841|FG000|Overall Study|Adverse Event|0|||
156770451|NCT00109343|565914586|FG001|Overall Study|Withdrawal by Subject|11|||
156770452|NCT00109343|565914587|FG002|Overall Study|Withdrawal by Subject|10|||
156770453|NCT00109343|565914585|FG000|Overall Study|Subject Moved|6|||
156657427|NCT01089647|565491842|FG001|Overall Study|Adverse Event|1|||
156657428|NCT01531205|565491843|FG000|Overall Study|Did not proceed to surgery|1|||
156657429|NCT00995553|565491844|FG000|Overall Study|Withdrawal by Subject|2|||
156657430|NCT00995553|565491845|FG001|Overall Study|Withdrawal by Subject|6|||
156657431|NCT00198029|565491848|FG000|Overall Study|Withdrawal by Subject|4|||
156657432|NCT02465567|565491849|FG000|Overall Study|Adverse Event|118|||
156657433|NCT02465567|565491850|FG001|Overall Study|Adverse Event|113|||
156657434|NCT02465567|565491851|FG002|Overall Study|Adverse Event|147|||
156657435|NCT02465567|565491852|FG003|Overall Study|Adverse Event|138|||
156657436|NCT02465567|565491849|FG000|Overall Study|Lack of Efficacy|103|||
156657437|NCT02465567|565491850|FG001|Overall Study|Lack of Efficacy|102|||
156657438|NCT02465567|565491851|FG002|Overall Study|Lack of Efficacy|171|||
156657439|NCT02465567|565491852|FG003|Overall Study|Lack of Efficacy|135|||
156657440|NCT02465567|565491849|FG000|Overall Study|Withdrawal by Subject|104|||
156657441|NCT02465567|565491850|FG001|Overall Study|Withdrawal by Subject|94|||
156657442|NCT02465567|565491851|FG002|Overall Study|Withdrawal by Subject|123|||
156657443|NCT02465567|565491852|FG003|Overall Study|Withdrawal by Subject|130|||
156657444|NCT02465567|565491849|FG000|Overall Study|Physician Decision|23|||
156657445|NCT02465567|565491850|FG001|Overall Study|Physician Decision|33|||
156657446|NCT02465567|565491851|FG002|Overall Study|Physician Decision|38|||
156770454|NCT00109343|565914586|FG001|Overall Study|Subject Moved|2|||
156770455|NCT00109343|565914587|FG002|Overall Study|Subject Moved|1|||
156657447|NCT02465567|565491852|FG003|Overall Study|Physician Decision|28|||
156770456|NCT00109343|565914585|FG000|Overall Study|Other|5|||
156770457|NCT00109343|565914586|FG001|Overall Study|Other|2|||
156770458|NCT00109343|565914587|FG002|Overall Study|Other|1|||
156323979|NCT01659658|564286013|FG004|Overall Study|Lost to Follow-up|0|||
156657448|NCT02465567|565491849|FG000|Overall Study|Major Protocol Deviation|24|||
156657449|NCT02465567|565491850|FG001|Overall Study|Major Protocol Deviation|26|||
156657450|NCT02465567|565491851|FG002|Overall Study|Major Protocol Deviation|22|||
156523182|NCT01981473|565009516|FG001|Overall Study|Received treatment for < 6 months|0|||
156657451|NCT02465567|565491852|FG003|Overall Study|Major Protocol Deviation|25|||
156657452|NCT02465567|565491849|FG000|Overall Study|Lost to Follow-up|25|||
156523183|NCT01981473|565009517|FG002|Overall Study|Received treatment for < 6 months|1|||
156523184|NCT01981473|565009515|FG000|Overall Study|Received treatment for >24 months|2|||
156523185|NCT01981473|565009516|FG001|Overall Study|Received treatment for >24 months|0|||
156770459|NCT01721798|565914590|FG000|Overall Study|Death|0|||
156770460|NCT01721798|565914591|FG001|Overall Study|Death|0|||
156770461|NCT01721798|565914592|FG002|Overall Study|Death|1|||
156770462|NCT01721798|565914593|FG003|Overall Study|Death|1|||
156770463|NCT01721798|565914590|FG000|Overall Study|Lost to Follow-up|2|||
156770464|NCT01721798|565914591|FG001|Overall Study|Lost to Follow-up|2|||
156770465|NCT01721798|565914592|FG002|Overall Study|Lost to Follow-up|9|||
156770466|NCT01721798|565914593|FG003|Overall Study|Lost to Follow-up|9|||
156770467|NCT01721798|565914590|FG000|Overall Study|Pregnancy|0|||
156770468|NCT01721798|565914591|FG001|Overall Study|Pregnancy|0|||
156770469|NCT01721798|565914592|FG002|Overall Study|Pregnancy|1|||
156770470|NCT01721798|565914593|FG003|Overall Study|Pregnancy|1|||
156770471|NCT01721798|565914590|FG000|Overall Study|Withdrawal by Subject|1|||
156770472|NCT01721798|565914591|FG001|Overall Study|Withdrawal by Subject|0|||
156770473|NCT01721798|565914592|FG002|Overall Study|Withdrawal by Subject|2|||
156770474|NCT01721798|565914593|FG003|Overall Study|Withdrawal by Subject|1|||
156770475|NCT01721798|565914590|FG000|Overall Study|Not eligible for 24 month visit|1|||
156770476|NCT01721798|565914591|FG001|Overall Study|Not eligible for 24 month visit|0|||
156770477|NCT01721798|565914592|FG002|Overall Study|Not eligible for 24 month visit|8|||
156770478|NCT01721798|565914593|FG003|Overall Study|Not eligible for 24 month visit|7|||
156770479|NCT01983930|565914597|FG000|Overall Study|Withdrawal by Subject|9|||
156323980|NCT01897714|564286015|FG000|Phase I (Dose Escalation)|Disease progression|3|||
156523186|NCT01981473|565009517|FG002|Overall Study|Received treatment for >24 months|6|||
156523187|NCT04776148|565009518|FG000|Overall Study|Death|249|||
156523188|NCT04776148|565009519|FG001|Overall Study|Death|260|||
156323981|NCT01897714|564286016|FG001|Phase I (Dose Escalation)|Disease progression|5|||
156323982|NCT01897714|564286017|FG002|Phase I (Dose Escalation)|Disease progression|1|||
156523189|NCT04776148|565009518|FG000|Overall Study|Lost to Follow-up|0|||
156657453|NCT02465567|565491850|FG001|Overall Study|Lost to Follow-up|21|||
156657454|NCT02465567|565491851|FG002|Overall Study|Lost to Follow-up|19|||
156657455|NCT02465567|565491852|FG003|Overall Study|Lost to Follow-up|15|||
156657456|NCT02465567|565491849|FG000|Overall Study|Protocol Specified Criteria|20|||
156657457|NCT02465567|565491850|FG001|Overall Study|Protocol Specified Criteria|10|||
156657458|NCT02465567|565491851|FG002|Overall Study|Protocol Specified Criteria|9|||
156657459|NCT02465567|565491852|FG003|Overall Study|Protocol Specified Criteria|12|||
156657460|NCT02465567|565491849|FG000|Overall Study|Administrative Reasons|12|||
156657461|NCT02465567|565491850|FG001|Overall Study|Administrative Reasons|9|||
156657462|NCT02465567|565491851|FG002|Overall Study|Administrative Reasons|11|||
156657463|NCT02465567|565491852|FG003|Overall Study|Administrative Reasons|5|||
156657464|NCT02465567|565491849|FG000|Overall Study|Randomized but not treated|1|||
156657465|NCT02465567|565491850|FG001|Overall Study|Randomized but not treated|5|||
156657466|NCT02465567|565491851|FG002|Overall Study|Randomized but not treated|4|||
156657467|NCT02465567|565491852|FG003|Overall Study|Randomized but not treated|5|||
156657468|NCT02465567|565491849|FG000|Overall Study|enrolled in >1 studies|18|||
156657469|NCT02465567|565491850|FG001|Overall Study|enrolled in >1 studies|11|||
156657470|NCT02465567|565491851|FG002|Overall Study|enrolled in >1 studies|19|||
156657471|NCT02465567|565491852|FG003|Overall Study|enrolled in >1 studies|15|||
156657472|NCT02465567|565491849|FG000|Overall Study|missing PI Signature|1|||
156657473|NCT02465567|565491850|FG001|Overall Study|missing PI Signature|0|||
156657474|NCT02465567|565491851|FG002|Overall Study|missing PI Signature|0|||
156657475|NCT02465567|565491852|FG003|Overall Study|missing PI Signature|0|||
156657476|NCT02001558|565491853|FG000|Overall Study|Lost to Follow-up|8|||
156657477|NCT02001558|565491854|FG001|Overall Study|Lost to Follow-up|14|||
156657478|NCT04117607|565491855|FG000|Overall Study|Early Termination|0|||
156657479|NCT04117607|565491856|FG001|Overall Study|Early Termination|1|||
156657480|NCT04117607|565491857|FG002|Overall Study|Early Termination|0|||
156657481|NCT04117607|565491858|FG003|Overall Study|Early Termination|0|||
156657482|NCT04117607|565491859|FG004|Overall Study|Early Termination|0|||
156657483|NCT04117607|565491860|FG005|Overall Study|Early Termination|0|||
156657484|NCT04117607|565491861|FG006|Overall Study|Early Termination|1|||
156657485|NCT04117607|565491862|FG007|Overall Study|Early Termination|0|||
156657486|NCT04117607|565491863|FG008|Overall Study|Early Termination|0|||
156657487|NCT04117607|565491864|FG009|Overall Study|Early Termination|0|||
156523190|NCT04776148|565009519|FG001|Overall Study|Lost to Follow-up|1|||
156523191|NCT04776148|565009518|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156523192|NCT04776148|565009519|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156523193|NCT04776148|565009518|FG000|Overall Study|Withdrawal by Subject|3|||
156523194|NCT04776148|565009519|FG001|Overall Study|Withdrawal by Subject|4|||
156523195|NCT04776148|565009518|FG000|Overall Study|Sponsor Decision|30|||
156657488|NCT04117607|565491865|FG010|Overall Study|Early Termination|0|||
156657489|NCT04117607|565491866|FG011|Overall Study|Early Termination|0|||
156770480|NCT01983930|565914598|FG001|Overall Study|Withdrawal by Subject|8|||
156770481|NCT01983930|565914597|FG000|Overall Study|Adverse Event|0|||
156523196|NCT04776148|565009519|FG001|Overall Study|Sponsor Decision|15|||
156323983|NCT01897714|564286018|FG003|Phase I (Dose Escalation)|Disease progression|3|||
156523197|NCT00738582|565009520|FG000|Combination Therapy|Completed Combination Therapy|1|||
156523198|NCT00738582|565009521|FG001|Combination Therapy|Completed Combination Therapy|0|||
156523199|NCT00738582|565009520|FG000|Combination Therapy|Physician Decision|1|||
156323984|NCT01897714|564286019|FG004|Phase I (Dose Escalation)|Disease progression|0|||
156523200|NCT00738582|565009521|FG001|Combination Therapy|Physician Decision|0|||
156523201|NCT00738582|565009520|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
156523202|NCT00738582|565009521|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
156523203|NCT00738582|565009520|FG000|Combination Therapy|Other|5|||
156523204|NCT00738582|565009521|FG001|Combination Therapy|Other|0|||
156523205|NCT00738582|565009520|FG000|Combination Therapy|Adverse Event|16|||
156523206|NCT00738582|565009521|FG001|Combination Therapy|Adverse Event|0|||
156523207|NCT00738582|565009520|FG000|Combination Therapy|Progressive Disease|9|||
156523208|NCT00738582|565009521|FG001|Combination Therapy|Progressive Disease|0|||
156523209|NCT00738582|565009520|FG000|Maintenance Therapy|Other|0|||
156523210|NCT00738582|565009521|FG001|Maintenance Therapy|Other|2|||
156523211|NCT00738582|565009520|FG000|Maintenance Therapy|Adverse Event|0|||
156523212|NCT00738582|565009521|FG001|Maintenance Therapy|Adverse Event|6|||
156523213|NCT00738582|565009520|FG000|Maintenance Therapy|Progressive Disease|0|||
156523214|NCT00738582|565009521|FG001|Maintenance Therapy|Progressive Disease|47|||
156523215|NCT00738582|565009520|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
156770482|NCT01983930|565914598|FG001|Overall Study|Adverse Event|1|||
156770483|NCT00486044|565914599|FG000|Overall Study|Withdrawal by Subject|2|||
156770484|NCT00486044|565914600|FG001|Overall Study|Withdrawal by Subject|1|||
156770485|NCT00486044|565914599|FG000|Overall Study|Adverse Event|0|||
156770486|NCT00486044|565914600|FG001|Overall Study|Adverse Event|1|||
156770487|NCT00486044|565914599|FG000|Overall Study|Lost to Follow-up|0|||
156770488|NCT00486044|565914600|FG001|Overall Study|Lost to Follow-up|1|||
156770489|NCT03466346|565914603|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
156770490|NCT03466346|565914604|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
156770491|NCT03466346|565914605|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
156770492|NCT03466346|565914606|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
156770493|NCT03466346|565914607|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
156770494|NCT03466346|565914603|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
156770495|NCT03466346|565914604|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
156770496|NCT03466346|565914605|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
156770497|NCT03466346|565914606|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
156770498|NCT03466346|565914607|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
156770499|NCT03466346|565914603|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
156770500|NCT03466346|565914604|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
156770501|NCT03466346|565914605|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
156770502|NCT03466346|565914606|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
156770503|NCT03466346|565914607|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
156770504|NCT03466346|565914603|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
156770505|NCT03466346|565914604|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
156770506|NCT03466346|565914605|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
156770507|NCT03466346|565914606|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
156770508|NCT03466346|565914607|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
156770509|NCT03466346|565914603|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
156770510|NCT03466346|565914604|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
156770511|NCT03466346|565914605|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
156770512|NCT03466346|565914606|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
156770513|NCT03466346|565914607|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
156770514|NCT03466346|565914603|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
156770515|NCT03466346|565914604|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
156770516|NCT03466346|565914605|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
156770517|NCT03466346|565914606|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
156770518|NCT03466346|565914607|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
156770519|NCT03466346|565914603|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
156770520|NCT03466346|565914604|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
156770521|NCT03466346|565914605|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
156770522|NCT03466346|565914606|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
156770523|NCT03466346|565914607|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
156770524|NCT02701634|565914612|FG000|Overall Study|Adverse Event|2|||
156323985|NCT01897714|564286020|FG005|Phase I (Dose Escalation)|Disease progression|0|||
156523216|NCT00738582|565009521|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
156523217|NCT02563522|565009522|FG000|Overall Study|Adverse Event|2|||
156523218|NCT02563522|565009523|FG001|Overall Study|Adverse Event|3|||
156523219|NCT02563522|565009522|FG000|Overall Study|Lost to Follow-up|1|||
156770525|NCT02701634|565914613|FG001|Overall Study|Adverse Event|3|||
156770526|NCT02701634|565914612|FG000|Overall Study|Death|1|||
156770527|NCT02701634|565914613|FG001|Overall Study|Death|0|||
156770528|NCT02701634|565914612|FG000|Overall Study|Investigator's Discretion|7|||
156770529|NCT02701634|565914613|FG001|Overall Study|Investigator's Discretion|4|||
156770530|NCT02701634|565914612|FG000|Overall Study|Study terminated by Sponsor|15|||
156770531|NCT02701634|565914613|FG001|Overall Study|Study terminated by Sponsor|17|||
156770532|NCT02701634|565914612|FG000|Overall Study|Withdrew Consent|6|||
156770533|NCT02701634|565914613|FG001|Overall Study|Withdrew Consent|7|||
156770534|NCT02701634|565914612|FG000|Overall Study|Randomized but not treated|1|||
156770535|NCT02701634|565914613|FG001|Overall Study|Randomized but not treated|0|||
156770536|NCT00537277|565914614|FG000|Overall Study|Adverse Event|1|||
156770537|NCT00537277|565914614|FG000|Overall Study|Lack of Efficacy|2|||
156770538|NCT00537277|565914614|FG000|Overall Study|Lost to Follow-up|12|||
156770539|NCT00537277|565914614|FG000|Overall Study|Protocol Violation|11|||
156770540|NCT00537277|565914614|FG000|Overall Study|Unclassified|4|||
156770541|NCT00537277|565914614|FG000|Overall Study|Inability to tolerate trial medication|4|||
156770542|NCT00537277|565914614|FG000|Overall Study|Non-compliance with trial procedures|15|||
156770543|NCT05911841|565914615|FG000|Induction Period|Study Terminated by Sponsor|2|||
156770544|NCT05911841|565914616|FG001|Induction Period|Study Terminated by Sponsor|0|||
156770545|NCT05911841|565914617|FG002|Induction Period|Study Terminated by Sponsor|14|||
156770546|NCT05911841|565914618|FG003|Induction Period|Study Terminated by Sponsor|6|||
156770547|NCT05911841|565914619|FG004|Induction Period|Study Terminated by Sponsor|0|||
156770548|NCT05911841|565914620|FG005|Induction Period|Study Terminated by Sponsor|0|||
156770549|NCT05911841|565914621|FG006|Induction Period|Study Terminated by Sponsor|0|||
156770550|NCT05911841|565914622|FG007|Induction Period|Study Terminated by Sponsor|0|||
156770551|NCT05911841|565914623|FG008|Induction Period|Study Terminated by Sponsor|0|||
156770552|NCT05911841|565914624|FG009|Induction Period|Study Terminated by Sponsor|0|||
156770553|NCT05911841|565914615|FG000|Induction Period|Withdrawal by Subject|4|||
156770554|NCT05911841|565914616|FG001|Induction Period|Withdrawal by Subject|3|||
156770555|NCT05911841|565914617|FG002|Induction Period|Withdrawal by Subject|4|||
156770556|NCT05911841|565914618|FG003|Induction Period|Withdrawal by Subject|6|||
156770557|NCT05911841|565914619|FG004|Induction Period|Withdrawal by Subject|0|||
156770558|NCT05911841|565914620|FG005|Induction Period|Withdrawal by Subject|0|||
156770559|NCT05911841|565914621|FG006|Induction Period|Withdrawal by Subject|0|||
156770560|NCT05911841|565914622|FG007|Induction Period|Withdrawal by Subject|0|||
156770561|NCT05911841|565914623|FG008|Induction Period|Withdrawal by Subject|0|||
156770562|NCT05911841|565914624|FG009|Induction Period|Withdrawal by Subject|0|||
156770563|NCT05911841|565914615|FG000|Induction Period|Lack of Efficacy|3|||
156770564|NCT05911841|565914616|FG001|Induction Period|Lack of Efficacy|0|||
156770565|NCT05911841|565914617|FG002|Induction Period|Lack of Efficacy|3|||
156770566|NCT05911841|565914618|FG003|Induction Period|Lack of Efficacy|3|||
156770567|NCT05911841|565914619|FG004|Induction Period|Lack of Efficacy|0|||
156770568|NCT05911841|565914620|FG005|Induction Period|Lack of Efficacy|0|||
156770569|NCT05911841|565914621|FG006|Induction Period|Lack of Efficacy|0|||
156770570|NCT05911841|565914622|FG007|Induction Period|Lack of Efficacy|0|||
156770571|NCT05911841|565914623|FG008|Induction Period|Lack of Efficacy|0|||
156770572|NCT05911841|565914624|FG009|Induction Period|Lack of Efficacy|0|||
156770573|NCT05911841|565914615|FG000|Induction Period|Adverse Event|3|||
156770574|NCT05911841|565914616|FG001|Induction Period|Adverse Event|1|||
156770575|NCT05911841|565914617|FG002|Induction Period|Adverse Event|2|||
156770576|NCT05911841|565914618|FG003|Induction Period|Adverse Event|0|||
156770577|NCT05911841|565914619|FG004|Induction Period|Adverse Event|0|||
156770578|NCT05911841|565914620|FG005|Induction Period|Adverse Event|0|||
156770579|NCT05911841|565914621|FG006|Induction Period|Adverse Event|0|||
156770580|NCT05911841|565914622|FG007|Induction Period|Adverse Event|0|||
156770581|NCT05911841|565914623|FG008|Induction Period|Adverse Event|0|||
156770582|NCT05911841|565914624|FG009|Induction Period|Adverse Event|0|||
156770583|NCT05911841|565914615|FG000|Induction Period|Assigned Treatment by Mistake|0|||
156323986|NCT01897714|564286015|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
156323987|NCT01897714|564286016|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
156323988|NCT01897714|564286017|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
156523220|NCT02563522|565009523|FG001|Overall Study|Lost to Follow-up|0|||
156770584|NCT05911841|565914616|FG001|Induction Period|Assigned Treatment by Mistake|1|||
156770585|NCT05911841|565914617|FG002|Induction Period|Assigned Treatment by Mistake|0|||
156770586|NCT05911841|565914618|FG003|Induction Period|Assigned Treatment by Mistake|1|||
156770587|NCT05911841|565914619|FG004|Induction Period|Assigned Treatment by Mistake|0|||
156770588|NCT05911841|565914620|FG005|Induction Period|Assigned Treatment by Mistake|0|||
156770589|NCT05911841|565914621|FG006|Induction Period|Assigned Treatment by Mistake|0|||
156770590|NCT05911841|565914622|FG007|Induction Period|Assigned Treatment by Mistake|0|||
156770591|NCT05911841|565914623|FG008|Induction Period|Assigned Treatment by Mistake|0|||
156770592|NCT05911841|565914624|FG009|Induction Period|Assigned Treatment by Mistake|0|||
156770593|NCT05911841|565914615|FG000|Induction Period|Lost to Follow-up|0|||
156770594|NCT05911841|565914616|FG001|Induction Period|Lost to Follow-up|0|||
156770595|NCT05911841|565914617|FG002|Induction Period|Lost to Follow-up|1|||
156770596|NCT05911841|565914618|FG003|Induction Period|Lost to Follow-up|1|||
156770597|NCT05911841|565914619|FG004|Induction Period|Lost to Follow-up|0|||
156770598|NCT05911841|565914620|FG005|Induction Period|Lost to Follow-up|0|||
156770599|NCT05911841|565914621|FG006|Induction Period|Lost to Follow-up|0|||
156770600|NCT05911841|565914622|FG007|Induction Period|Lost to Follow-up|0|||
156770601|NCT05911841|565914623|FG008|Induction Period|Lost to Follow-up|0|||
156770602|NCT05911841|565914624|FG009|Induction Period|Lost to Follow-up|0|||
156770603|NCT05911841|565914615|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
156770604|NCT05911841|565914616|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
156770605|NCT05911841|565914617|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
156770606|NCT05911841|565914618|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
156770607|NCT05911841|565914619|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
156770608|NCT05911841|565914620|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
156770609|NCT05911841|565914621|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
156770610|NCT05911841|565914622|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
156770611|NCT05911841|565914623|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
156770612|NCT05911841|565914624|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
156770613|NCT05911841|565914615|FG000|Maintenance Period|Lack of Efficacy|0|||
156770614|NCT05911841|565914616|FG001|Maintenance Period|Lack of Efficacy|0|||
156770615|NCT05911841|565914617|FG002|Maintenance Period|Lack of Efficacy|0|||
156770616|NCT05911841|565914618|FG003|Maintenance Period|Lack of Efficacy|0|||
156770617|NCT05911841|565914619|FG004|Maintenance Period|Lack of Efficacy|1|||
156770618|NCT05911841|565914620|FG005|Maintenance Period|Lack of Efficacy|0|||
156770619|NCT05911841|565914621|FG006|Maintenance Period|Lack of Efficacy|1|||
156770620|NCT05911841|565914622|FG007|Maintenance Period|Lack of Efficacy|0|||
156770621|NCT05911841|565914623|FG008|Maintenance Period|Lack of Efficacy|0|||
156770622|NCT05911841|565914624|FG009|Maintenance Period|Lack of Efficacy|0|||
156770623|NCT05911841|565914615|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
156770624|NCT05911841|565914616|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
156770625|NCT05911841|565914617|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
156770626|NCT05911841|565914618|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
156770627|NCT05911841|565914619|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
156770628|NCT05911841|565914620|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
156770629|NCT05911841|565914621|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
156770630|NCT05911841|565914622|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
156770631|NCT05911841|565914623|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
156770632|NCT05911841|565914624|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
156770633|NCT05911841|565914615|FG000|Maintenance Period|Withdrawal by Subject|0|||
156770634|NCT05911841|565914616|FG001|Maintenance Period|Withdrawal by Subject|0|||
156770635|NCT05911841|565914617|FG002|Maintenance Period|Withdrawal by Subject|0|||
156770636|NCT05911841|565914618|FG003|Maintenance Period|Withdrawal by Subject|0|||
156770637|NCT05911841|565914619|FG004|Maintenance Period|Withdrawal by Subject|0|||
156770638|NCT05911841|565914620|FG005|Maintenance Period|Withdrawal by Subject|1|||
156770639|NCT05911841|565914621|FG006|Maintenance Period|Withdrawal by Subject|0|||
156770640|NCT05911841|565914622|FG007|Maintenance Period|Withdrawal by Subject|1|||
156770641|NCT05911841|565914623|FG008|Maintenance Period|Withdrawal by Subject|0|||
156770642|NCT05911841|565914624|FG009|Maintenance Period|Withdrawal by Subject|0|||
156770643|NCT05911841|565914615|FG000|Maintenance Period|Adverse Event|0|||
156770644|NCT05911841|565914616|FG001|Maintenance Period|Adverse Event|0|||
156770645|NCT05911841|565914617|FG002|Maintenance Period|Adverse Event|0|||
156770646|NCT05911841|565914618|FG003|Maintenance Period|Adverse Event|0|||
156770647|NCT05911841|565914619|FG004|Maintenance Period|Adverse Event|0|||
156770648|NCT05911841|565914620|FG005|Maintenance Period|Adverse Event|0|||
156770649|NCT05911841|565914621|FG006|Maintenance Period|Adverse Event|0|||
156770650|NCT05911841|565914622|FG007|Maintenance Period|Adverse Event|1|||
156770651|NCT05911841|565914623|FG008|Maintenance Period|Adverse Event|0|||
156770652|NCT05911841|565914624|FG009|Maintenance Period|Adverse Event|0|||
156770653|NCT05911841|565914615|FG000|Escape Period|Adverse Event|0|||
156770654|NCT05911841|565914616|FG001|Escape Period|Adverse Event|0|||
156770655|NCT05911841|565914617|FG002|Escape Period|Adverse Event|0|||
156770656|NCT05911841|565914618|FG003|Escape Period|Adverse Event|0|||
156770657|NCT05911841|565914619|FG004|Escape Period|Adverse Event|0|||
156770658|NCT05911841|565914620|FG005|Escape Period|Adverse Event|0|||
156770659|NCT05911841|565914621|FG006|Escape Period|Adverse Event|0|||
156323989|NCT01897714|564286018|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
156323990|NCT01897714|564286019|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
156323991|NCT01897714|564286020|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
156770660|NCT05911841|565914622|FG007|Escape Period|Adverse Event|0|||
156770661|NCT05911841|565914623|FG008|Escape Period|Adverse Event|0|||
156770662|NCT05911841|565914624|FG009|Escape Period|Adverse Event|1|||
156770663|NCT05911841|565914615|FG000|Escape Period|Lack of Efficacy|0|||
156770664|NCT05911841|565914616|FG001|Escape Period|Lack of Efficacy|0|||
156770665|NCT05911841|565914617|FG002|Escape Period|Lack of Efficacy|0|||
156770666|NCT05911841|565914618|FG003|Escape Period|Lack of Efficacy|0|||
156770667|NCT05911841|565914619|FG004|Escape Period|Lack of Efficacy|0|||
156770668|NCT05911841|565914620|FG005|Escape Period|Lack of Efficacy|0|||
156770669|NCT05911841|565914621|FG006|Escape Period|Lack of Efficacy|0|||
156770670|NCT05911841|565914622|FG007|Escape Period|Lack of Efficacy|0|||
156770671|NCT05911841|565914623|FG008|Escape Period|Lack of Efficacy|0|||
156770672|NCT05911841|565914624|FG009|Escape Period|Lack of Efficacy|31|||
156770673|NCT05911841|565914615|FG000|Escape Period|Lost to Follow-up|0|||
156770674|NCT05911841|565914616|FG001|Escape Period|Lost to Follow-up|0|||
156770675|NCT05911841|565914617|FG002|Escape Period|Lost to Follow-up|0|||
156770676|NCT05911841|565914618|FG003|Escape Period|Lost to Follow-up|0|||
156770677|NCT05911841|565914619|FG004|Escape Period|Lost to Follow-up|0|||
156770678|NCT05911841|565914620|FG005|Escape Period|Lost to Follow-up|0|||
156770679|NCT05911841|565914621|FG006|Escape Period|Lost to Follow-up|0|||
156770680|NCT05911841|565914622|FG007|Escape Period|Lost to Follow-up|0|||
156770681|NCT05911841|565914623|FG008|Escape Period|Lost to Follow-up|0|||
156770682|NCT05911841|565914624|FG009|Escape Period|Lost to Follow-up|1|||
156770683|NCT05911841|565914615|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770684|NCT05911841|565914616|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156523221|NCT02563522|565009522|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
156523222|NCT02563522|565009523|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
156523223|NCT01052103|565009524|FG000|Overall Study|Adverse Event|10|||
156523224|NCT01052103|565009525|FG001|Overall Study|Adverse Event|6|||
156523225|NCT01052103|565009524|FG000|Overall Study|Entry Criteria Not Met|3|||
156523226|NCT01052103|565009525|FG001|Overall Study|Entry Criteria Not Met|1|||
156523227|NCT01052103|565009524|FG000|Overall Study|Lost to Follow-up|3|||
156523228|NCT01052103|565009525|FG001|Overall Study|Lost to Follow-up|5|||
156523229|NCT01052103|565009524|FG000|Overall Study|Protocol Violation|10|||
156523230|NCT01052103|565009525|FG001|Overall Study|Protocol Violation|4|||
156523231|NCT01052103|565009524|FG000|Overall Study|Scheduling conflict|2|||
156523232|NCT01052103|565009525|FG001|Overall Study|Scheduling conflict|1|||
156523233|NCT01052103|565009524|FG000|Overall Study|Sponsor Decision|2|||
156523234|NCT01052103|565009525|FG001|Overall Study|Sponsor Decision|0|||
156523235|NCT01052103|565009524|FG000|Overall Study|Withdrawal by Subject|3|||
156523236|NCT01052103|565009525|FG001|Overall Study|Withdrawal by Subject|6|||
156523237|NCT01052103|565009524|FG000|Overall Study|Perceived Lack of Efficacy|1|||
156523238|NCT01052103|565009525|FG001|Overall Study|Perceived Lack of Efficacy|0|||
156523239|NCT00799513|565009526|FG000|Overall Study|Physician Decision|1|||
156523240|NCT00799513|565009526|FG000|Overall Study|Adverse Event|1|||
156523241|NCT00903006|565009532|FG000|Overall Study|Withdrawal by Subject|2|||
156523242|NCT00903006|565009533|FG001|Overall Study|Withdrawal by Subject|0|||
156523243|NCT00903006|565009534|FG002|Overall Study|Withdrawal by Subject|0|||
156523244|NCT00903006|565009535|FG003|Overall Study|Withdrawal by Subject|0|||
156523245|NCT00903006|565009532|FG000|Overall Study|Progressive Disease|0|||
156523246|NCT00903006|565009533|FG001|Overall Study|Progressive Disease|3|||
156523247|NCT00903006|565009534|FG002|Overall Study|Progressive Disease|1|||
156523248|NCT00903006|565009535|FG003|Overall Study|Progressive Disease|0|||
156523249|NCT00372229|565009536|FG000|Study Phase|Graft loss|0|||
156523250|NCT00372229|565009537|FG001|Study Phase|Graft loss|3|||
156523251|NCT00372229|565009536|FG000|Study Phase|Protocol Violation|3|||
156523252|NCT00372229|565009537|FG001|Study Phase|Protocol Violation|4|||
156523253|NCT00372229|565009536|FG000|Study Phase|Consent withdrawn|16|||
156770685|NCT05911841|565914617|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770686|NCT05911841|565914618|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770687|NCT05911841|565914619|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770688|NCT05911841|565914620|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770689|NCT05911841|565914621|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770690|NCT05911841|565914622|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770691|NCT05911841|565914623|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770692|NCT05911841|565914624|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
156770693|NCT05911841|565914615|FG000|Escape Period|Site Terminated by Sponsor|0|||
156770694|NCT05911841|565914616|FG001|Escape Period|Site Terminated by Sponsor|0|||
156770695|NCT05911841|565914617|FG002|Escape Period|Site Terminated by Sponsor|0|||
156770696|NCT05911841|565914618|FG003|Escape Period|Site Terminated by Sponsor|0|||
156770697|NCT05911841|565914619|FG004|Escape Period|Site Terminated by Sponsor|0|||
156770698|NCT05911841|565914620|FG005|Escape Period|Site Terminated by Sponsor|0|||
156770699|NCT05911841|565914621|FG006|Escape Period|Site Terminated by Sponsor|0|||
156770700|NCT05911841|565914622|FG007|Escape Period|Site Terminated by Sponsor|0|||
156770701|NCT05911841|565914623|FG008|Escape Period|Site Terminated by Sponsor|0|||
156770702|NCT05911841|565914624|FG009|Escape Period|Site Terminated by Sponsor|1|||
156770703|NCT05911841|565914615|FG000|Escape Period|Study Terminated by Sponsor|0|||
156523254|NCT00372229|565009537|FG001|Study Phase|Consent withdrawn|14|||
156523255|NCT00372229|565009536|FG000|Study Phase|Refused treatment/did not cooperate|3|||
156523256|NCT00372229|565009537|FG001|Study Phase|Refused treatment/did not cooperate|1|||
156523257|NCT00372229|565009536|FG000|Study Phase|Death|3|||
156523258|NCT00372229|565009537|FG001|Study Phase|Death|2|||
156523259|NCT00372229|565009536|FG000|Study Phase|Reason not specified|3|||
156523260|NCT00372229|565009537|FG001|Study Phase|Reason not specified|2|||
156770704|NCT05911841|565914616|FG001|Escape Period|Study Terminated by Sponsor|0|||
156770705|NCT05911841|565914617|FG002|Escape Period|Study Terminated by Sponsor|0|||
156770706|NCT05911841|565914618|FG003|Escape Period|Study Terminated by Sponsor|0|||
156770707|NCT05911841|565914619|FG004|Escape Period|Study Terminated by Sponsor|0|||
156770708|NCT05911841|565914620|FG005|Escape Period|Study Terminated by Sponsor|0|||
156770709|NCT05911841|565914621|FG006|Escape Period|Study Terminated by Sponsor|0|||
156770710|NCT05911841|565914622|FG007|Escape Period|Study Terminated by Sponsor|0|||
156770711|NCT05911841|565914623|FG008|Escape Period|Study Terminated by Sponsor|0|||
156770712|NCT05911841|565914624|FG009|Escape Period|Study Terminated by Sponsor|34|||
156770713|NCT05911841|565914615|FG000|Escape Period|Withdrawal by Subject|0|||
156770714|NCT05911841|565914616|FG001|Escape Period|Withdrawal by Subject|0|||
156770715|NCT05911841|565914617|FG002|Escape Period|Withdrawal by Subject|0|||
156770716|NCT05911841|565914618|FG003|Escape Period|Withdrawal by Subject|0|||
156770717|NCT05911841|565914619|FG004|Escape Period|Withdrawal by Subject|0|||
156770718|NCT05911841|565914620|FG005|Escape Period|Withdrawal by Subject|0|||
156770719|NCT05911841|565914621|FG006|Escape Period|Withdrawal by Subject|0|||
156770720|NCT05911841|565914622|FG007|Escape Period|Withdrawal by Subject|0|||
156770721|NCT05911841|565914623|FG008|Escape Period|Withdrawal by Subject|0|||
156770722|NCT05911841|565914624|FG009|Escape Period|Withdrawal by Subject|10|||
156323992|NCT01897714|564286015|FG000|Phase I (Dose Escalation)|Other|0|||
156770723|NCT00111761|565914631|FG000|Part 1|Physician Decision|0|||
156770724|NCT00111761|565914632|FG001|Part 1|Physician Decision|1|||
156770725|NCT00111761|565914631|FG000|Part 1|Death|0|||
156770726|NCT00111761|565914632|FG001|Part 1|Death|2|||
156770727|NCT00111761|565914631|FG000|Part 1|Other|0|||
156770728|NCT00111761|565914632|FG001|Part 1|Other|1|||
156770729|NCT00111761|565914631|FG000|Part 1|Withdrawal by Subject|0|||
156770730|NCT00111761|565914632|FG001|Part 1|Withdrawal by Subject|1|||
156770731|NCT00111761|565914631|FG000|Part 2|Adverse Event|1|||
156770732|NCT00111761|565914632|FG001|Part 2|Adverse Event|0|||
156770733|NCT00111761|565914631|FG000|Part 2|Physician Decision|1|||
156770734|NCT00111761|565914632|FG001|Part 2|Physician Decision|0|||
156770735|NCT00111761|565914631|FG000|Part 2|Death|1|||
156770736|NCT00111761|565914632|FG001|Part 2|Death|0|||
156770737|NCT00111761|565914631|FG000|Part 2|Disease progression|3|||
156770738|NCT00111761|565914632|FG001|Part 2|Disease progression|0|||
156770739|NCT00111761|565914631|FG000|Part 2|Protocol-specified criteria|1|||
156770740|NCT00111761|565914632|FG001|Part 2|Protocol-specified criteria|0|||
156770741|NCT00111761|565914631|FG000|Part 2|Other|1|||
156770742|NCT00111761|565914632|FG001|Part 2|Other|0|||
156770743|NCT04108468|565914636|FG000|Overall Study|Physician Decision|0|||
156770744|NCT04108468|565914637|FG001|Overall Study|Physician Decision|1|||
156770745|NCT04108468|565914636|FG000|Overall Study|Lost to Follow-up|0|||
156770746|NCT04108468|565914637|FG001|Overall Study|Lost to Follow-up|1|||
156770747|NCT04108468|565914636|FG000|Overall Study|Non-compliance|1|||
156770748|NCT04108468|565914637|FG001|Overall Study|Non-compliance|1|||
156770749|NCT04108468|565914636|FG000|Overall Study|Unable to attend final visit|2|||
156770750|NCT04108468|565914637|FG001|Overall Study|Unable to attend final visit|0|||
156770751|NCT04108468|565914636|FG000|Overall Study|Missed study medication|0|||
156770752|NCT04108468|565914637|FG001|Overall Study|Missed study medication|1|||
156770753|NCT00471497|565914638|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
156770754|NCT00471497|565914639|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
156770755|NCT00471497|565914640|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
156770756|NCT00471497|565914638|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
156770757|NCT00471497|565914639|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
156770758|NCT00471497|565914640|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
156770759|NCT00471497|565914638|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
156770760|NCT00471497|565914639|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
156770761|NCT00471497|565914640|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
156770762|NCT00471497|565914638|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
156770763|NCT00471497|565914639|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
156770764|NCT00471497|565914640|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
156770765|NCT00471497|565914638|FG000|Core Treatment Phase|Lost to Follow-up|6|||
156770766|NCT00471497|565914639|FG001|Core Treatment Phase|Lost to Follow-up|6|||
156770767|NCT00471497|565914640|FG002|Core Treatment Phase|Lost to Follow-up|3|||
156770768|NCT00471497|565914638|FG000|Core Treatment Phase|Death|3|||
156770769|NCT00471497|565914639|FG001|Core Treatment Phase|Death|9|||
156770770|NCT00471497|565914640|FG002|Core Treatment Phase|Death|3|||
156770771|NCT00471497|565914638|FG000|Core Treatment Phase|Disease Progression|10|||
156323993|NCT01897714|564286016|FG001|Phase I (Dose Escalation)|Other|1|||
156323994|NCT01897714|564286017|FG002|Phase I (Dose Escalation)|Other|0|||
156770772|NCT00471497|565914639|FG001|Core Treatment Phase|Disease Progression|2|||
156770773|NCT00471497|565914640|FG002|Core Treatment Phase|Disease Progression|4|||
156770774|NCT00471497|565914638|FG000|Core Treatment Phase|Protocol Violation|6|||
156770775|NCT00471497|565914639|FG001|Core Treatment Phase|Protocol Violation|15|||
156770776|NCT00471497|565914640|FG002|Core Treatment Phase|Protocol Violation|11|||
156323995|NCT01897714|564286018|FG003|Phase I (Dose Escalation)|Other|0|||
156323996|NCT01897714|564286019|FG004|Phase I (Dose Escalation)|Other|0|||
156657490|NCT04117607|565491867|FG012|Overall Study|Early Termination|0|||
156657491|NCT04117607|565491868|FG013|Overall Study|Early Termination|0|||
156657492|NCT04582539|565491870|FG000|Overall Study|Death|1|||
156657493|NCT04582539|565491871|FG001|Overall Study|Death|1|||
156657494|NCT04582539|565491872|FG002|Overall Study|Death|0|||
156657495|NCT04582539|565491873|FG003|Overall Study|Death|1|||
156657496|NCT04582539|565491874|FG004|Overall Study|Death|0|||
156657497|NCT04582539|565491870|FG000|Overall Study|Lost to Follow-up|1|||
156657498|NCT04582539|565491871|FG001|Overall Study|Lost to Follow-up|0|||
156657499|NCT04582539|565491872|FG002|Overall Study|Lost to Follow-up|0|||
156657500|NCT04582539|565491873|FG003|Overall Study|Lost to Follow-up|0|||
156657501|NCT04582539|565491874|FG004|Overall Study|Lost to Follow-up|0|||
156657502|NCT04582539|565491870|FG000|Overall Study|Study Terminated by Sponsor|1|||
156657503|NCT04582539|565491871|FG001|Overall Study|Study Terminated by Sponsor|3|||
156657504|NCT04582539|565491872|FG002|Overall Study|Study Terminated by Sponsor|2|||
156657505|NCT04582539|565491873|FG003|Overall Study|Study Terminated by Sponsor|2|||
156657506|NCT04582539|565491874|FG004|Overall Study|Study Terminated by Sponsor|3|||
156657507|NCT04582539|565491870|FG000|Overall Study|Physician Decision|0|||
156657508|NCT04582539|565491871|FG001|Overall Study|Physician Decision|1|||
156657509|NCT04582539|565491872|FG002|Overall Study|Physician Decision|0|||
156657510|NCT04582539|565491873|FG003|Overall Study|Physician Decision|0|||
156657511|NCT04582539|565491874|FG004|Overall Study|Physician Decision|0|||
156657512|NCT04582539|565491870|FG000|Overall Study|Withdrawal by Subject|1|||
156657513|NCT04582539|565491871|FG001|Overall Study|Withdrawal by Subject|0|||
156657514|NCT04582539|565491872|FG002|Overall Study|Withdrawal by Subject|2|||
156657515|NCT04582539|565491873|FG003|Overall Study|Withdrawal by Subject|1|||
156657516|NCT04582539|565491874|FG004|Overall Study|Withdrawal by Subject|0|||
156657517|NCT04582539|565491870|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
156657518|NCT04582539|565491871|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
156657519|NCT04582539|565491872|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
156657520|NCT04582539|565491873|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
156657521|NCT04582539|565491874|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
156657522|NCT00788957|565491875|FG000|Part 1|Death|8|||
156657523|NCT00788957|565491876|FG001|Part 1|Death|0|||
156657524|NCT00788957|565491877|FG002|Part 1|Death|0|||
156657525|NCT00788957|565491878|FG003|Part 1|Death|0|||
156657526|NCT00788957|565491879|FG004|Part 1|Death|0|||
156657527|NCT00788957|565491880|FG005|Part 1|Death|0|||
156657528|NCT00788957|565491875|FG000|Part 1|Lost to Follow-up|1|||
156657529|NCT00788957|565491876|FG001|Part 1|Lost to Follow-up|0|||
156657530|NCT00788957|565491877|FG002|Part 1|Lost to Follow-up|0|||
156657531|NCT00788957|565491878|FG003|Part 1|Lost to Follow-up|0|||
156657532|NCT00788957|565491879|FG004|Part 1|Lost to Follow-up|0|||
156657533|NCT00788957|565491880|FG005|Part 1|Lost to Follow-up|0|||
156657534|NCT00788957|565491875|FG000|Part 2|Withdrawal by Subject|0|||
156657535|NCT00788957|565491876|FG001|Part 2|Withdrawal by Subject|9|||
156657536|NCT00788957|565491877|FG002|Part 2|Withdrawal by Subject|5|||
156657537|NCT00788957|565491878|FG003|Part 2|Withdrawal by Subject|3|||
156657538|NCT00788957|565491879|FG004|Part 2|Withdrawal by Subject|0|||
156657539|NCT00788957|565491880|FG005|Part 2|Withdrawal by Subject|0|||
156657540|NCT00788957|565491875|FG000|Part 2|Death|0|||
156657541|NCT00788957|565491876|FG001|Part 2|Death|32|||
156657542|NCT00788957|565491877|FG002|Part 2|Death|35|||
156657543|NCT00788957|565491878|FG003|Part 2|Death|37|||
156657544|NCT00788957|565491879|FG004|Part 2|Death|0|||
156657545|NCT00788957|565491880|FG005|Part 2|Death|0|||
156657546|NCT00788957|565491875|FG000|Part 2|Lost to Follow-up|0|||
156657547|NCT00788957|565491876|FG001|Part 2|Lost to Follow-up|0|||
156657548|NCT00788957|565491877|FG002|Part 2|Lost to Follow-up|3|||
156657549|NCT00788957|565491878|FG003|Part 2|Lost to Follow-up|0|||
156657550|NCT00788957|565491879|FG004|Part 2|Lost to Follow-up|0|||
156657551|NCT00788957|565491880|FG005|Part 2|Lost to Follow-up|0|||
156657552|NCT00788957|565491875|FG000|Part 2|On-study at time of data cut-off|0|||
156657553|NCT00788957|565491876|FG001|Part 2|On-study at time of data cut-off|1|||
156657554|NCT00788957|565491877|FG002|Part 2|On-study at time of data cut-off|1|||
156657555|NCT00788957|565491878|FG003|Part 2|On-study at time of data cut-off|1|||
156657556|NCT00788957|565491879|FG004|Part 2|On-study at time of data cut-off|0|||
156657557|NCT00788957|565491880|FG005|Part 2|On-study at time of data cut-off|0|||
156657558|NCT00788957|565491875|FG000|Part 3|Withdrawal by Subject|0|||
156657559|NCT00788957|565491876|FG001|Part 3|Withdrawal by Subject|0|||
156657560|NCT00788957|565491877|FG002|Part 3|Withdrawal by Subject|0|||
156657561|NCT00788957|565491878|FG003|Part 3|Withdrawal by Subject|0|||
156657562|NCT00788957|565491879|FG004|Part 3|Withdrawal by Subject|0|||
156657563|NCT00788957|565491880|FG005|Part 3|Withdrawal by Subject|2|||
156657564|NCT00788957|565491875|FG000|Part 3|Death|0|||
156657565|NCT00788957|565491876|FG001|Part 3|Death|0|||
156657566|NCT00788957|565491877|FG002|Part 3|Death|0|||
156657567|NCT00788957|565491878|FG003|Part 3|Death|0|||
156657568|NCT00788957|565491879|FG004|Part 3|Death|8|||
156657569|NCT00788957|565491880|FG005|Part 3|Death|8|||
156323997|NCT01897714|564286020|FG005|Phase I (Dose Escalation)|Other|0|||
156323998|NCT01897714|564286015|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
156323999|NCT01897714|564286016|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
156324000|NCT01897714|564286017|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
156324001|NCT01897714|564286018|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
156324002|NCT01897714|564286019|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
156324003|NCT01897714|564286020|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
156324004|NCT01897714|564286015|FG000|Phase II (MTD)|Lost to Follow-up|0|||
156324005|NCT01897714|564286016|FG001|Phase II (MTD)|Lost to Follow-up|0|||
156324006|NCT01897714|564286017|FG002|Phase II (MTD)|Lost to Follow-up|0|||
156324007|NCT01897714|564286018|FG003|Phase II (MTD)|Lost to Follow-up|0|||
156324008|NCT01897714|564286019|FG004|Phase II (MTD)|Lost to Follow-up|1|||
156324009|NCT01897714|564286020|FG005|Phase II (MTD)|Lost to Follow-up|0|||
156324010|NCT01897714|564286015|FG000|Phase II (MTD)|Death|0|||
156324011|NCT01897714|564286016|FG001|Phase II (MTD)|Death|0|||
156324012|NCT01897714|564286017|FG002|Phase II (MTD)|Death|0|||
156324013|NCT01897714|564286018|FG003|Phase II (MTD)|Death|0|||
156324014|NCT01897714|564286019|FG004|Phase II (MTD)|Death|25|||
156324015|NCT01897714|564286020|FG005|Phase II (MTD)|Death|10|||
156324016|NCT01897714|564286015|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
156324017|NCT01897714|564286016|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
156324018|NCT01897714|564286017|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
156324019|NCT01897714|564286018|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
156324020|NCT01897714|564286019|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
156324021|NCT01897714|564286020|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
156324022|NCT01897714|564286015|FG000|Phase II (MTD)|Other|0|||
156324023|NCT01897714|564286016|FG001|Phase II (MTD)|Other|0|||
156324024|NCT01897714|564286017|FG002|Phase II (MTD)|Other|0|||
156324025|NCT01897714|564286018|FG003|Phase II (MTD)|Other|0|||
156324026|NCT01897714|564286019|FG004|Phase II (MTD)|Other|3|||
156324027|NCT01897714|564286020|FG005|Phase II (MTD)|Other|0|||
156324028|NCT03875118|564286035|FG000|Overall Study|Withdrawal by Subject|4|||
156324029|NCT03875118|564286036|FG001|Overall Study|Withdrawal by Subject|4|||
156324030|NCT02237911|564286037|FG000|Overall Study|Withdrawal by Subject|4|||
156324031|NCT02237911|564286038|FG001|Overall Study|Withdrawal by Subject|7|||
156324032|NCT02237911|564286039|FG002|Overall Study|Withdrawal by Subject|2|||
156324033|NCT02237911|564286037|FG000|Overall Study|Lost to Follow-up|3|||
156324034|NCT02237911|564286038|FG001|Overall Study|Lost to Follow-up|1|||
156324035|NCT02237911|564286039|FG002|Overall Study|Lost to Follow-up|1|||
156324036|NCT00721123|564286040|FG000|Overall Study|Adverse Event|96|||
156324037|NCT00721123|564286040|FG000|Overall Study|Death|10|||
156324038|NCT00721123|564286040|FG000|Overall Study|Insufficient Therapeutic Response|21|||
156324039|NCT00721123|564286040|FG000|Overall Study|Protocol Violation|1|||
156324040|NCT00721123|564286040|FG000|Overall Study|Refused Treatment|41|||
156324041|NCT00721123|564286040|FG000|Overall Study|Failure to Return|9|||
156324042|NCT00721123|564286040|FG000|Overall Study|Withdrawal by Subject|5|||
156324043|NCT02428608|564286043|FG000|Overall Study|Pregnancy|2|||
156523261|NCT00372229|565009536|FG000|Study Phase|Lost to Follow-up|3|||
156523262|NCT00372229|565009537|FG001|Study Phase|Lost to Follow-up|3|||
156523263|NCT00372229|565009536|FG000|Follow-Up Phase|Graft loss|8|||
156523264|NCT00372229|565009537|FG001|Follow-Up Phase|Graft loss|7|||
156523265|NCT00372229|565009536|FG000|Follow-Up Phase|Consent withdrawn|13|||
156523266|NCT00372229|565009537|FG001|Follow-Up Phase|Consent withdrawn|19|||
156523267|NCT00372229|565009536|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
156657570|NCT00788957|565491875|FG000|Part 3|On-study at time of data cut-off|0|||
156657571|NCT00788957|565491876|FG001|Part 3|On-study at time of data cut-off|0|||
156657572|NCT00788957|565491877|FG002|Part 3|On-study at time of data cut-off|0|||
156324044|NCT02428608|564286043|FG000|Overall Study|Lost to Follow-up|37|||
156324045|NCT02428608|564286043|FG000|Overall Study|Withdrawal by Subject|2|||
156657573|NCT00788957|565491878|FG003|Part 3|On-study at time of data cut-off|0|||
156657574|NCT00788957|565491879|FG004|Part 3|On-study at time of data cut-off|1|||
156657575|NCT00788957|565491880|FG005|Part 3|On-study at time of data cut-off|0|||
156657576|NCT05030753|565491881|FG000|9-week|Lost to Follow-up|10|||
156657577|NCT05030753|565491882|FG001|9-week|Lost to Follow-up|7|||
156657578|NCT05030753|565491881|FG000|9-week|Withdrawal by Subject|1|||
156657579|NCT05030753|565491882|FG001|9-week|Withdrawal by Subject|0|||
156657580|NCT05030753|565491881|FG000|9-week|Excluded from analysis due to missing covariates|2|||
156657581|NCT05030753|565491882|FG001|9-week|Excluded from analysis due to missing covariates|1|||
156657582|NCT05030753|565491881|FG000|6-month post intervention|Lost to Follow-up|5|||
156657583|NCT05030753|565491882|FG001|6-month post intervention|Lost to Follow-up|4|||
156657584|NCT05030753|565491881|FG000|6-month post intervention|Withdrawal by Subject|4|||
156657585|NCT05030753|565491882|FG001|6-month post intervention|Withdrawal by Subject|0|||
156657586|NCT05030753|565491881|FG000|18-month post intervention|Lost to Follow-up|3|||
156657587|NCT05030753|565491882|FG001|18-month post intervention|Lost to Follow-up|1|||
156657588|NCT03072459|565491883|FG000|Overall Study|Device revised/removed|1|||
156657589|NCT03072459|565491883|FG000|Overall Study|Subject not able to return|1|||
156523268|NCT00372229|565009537|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
156523269|NCT00372229|565009536|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
156770777|NCT00471497|565914638|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
156770778|NCT00471497|565914639|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
156770779|NCT00471497|565914640|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
156770780|NCT00471497|565914638|FG000|Core Treatment Phase|Administrative problems|14|||
156770781|NCT00471497|565914639|FG001|Core Treatment Phase|Administrative problems|14|||
156770782|NCT00471497|565914640|FG002|Core Treatment Phase|Administrative problems|12|||
156770783|NCT00471497|565914638|FG000|Core Treatment Phase|Adverse Event|43|||
156770784|NCT00471497|565914639|FG001|Core Treatment Phase|Adverse Event|53|||
156770785|NCT00471497|565914640|FG002|Core Treatment Phase|Adverse Event|89|||
156770786|NCT00471497|565914638|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
156770787|NCT00471497|565914639|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
156770788|NCT00471497|565914640|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
156770789|NCT00471497|565914638|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
156770790|NCT00471497|565914639|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
156770791|NCT00471497|565914640|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
156770792|NCT00471497|565914638|FG000|Extension Phase|Adverse Event|9|||
156770793|NCT00471497|565914639|FG001|Extension Phase|Adverse Event|5|||
156770794|NCT00471497|565914640|FG002|Extension Phase|Adverse Event|1|||
156770795|NCT00471497|565914638|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
156770796|NCT00471497|565914639|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
156770797|NCT00471497|565914640|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
156770798|NCT00471497|565914638|FG000|Extension Phase|Withdrawal by Subject|3|||
156770799|NCT00471497|565914639|FG001|Extension Phase|Withdrawal by Subject|1|||
156770800|NCT00471497|565914640|FG002|Extension Phase|Withdrawal by Subject|0|||
156770801|NCT00471497|565914638|FG000|Extension Phase|Lost to Follow-up|2|||
156770802|NCT00471497|565914639|FG001|Extension Phase|Lost to Follow-up|0|||
156770803|NCT00471497|565914640|FG002|Extension Phase|Lost to Follow-up|0|||
156770804|NCT00471497|565914638|FG000|Extension Phase|Death|1|||
156770805|NCT00471497|565914639|FG001|Extension Phase|Death|0|||
156770806|NCT00471497|565914640|FG002|Extension Phase|Death|0|||
156770807|NCT00471497|565914638|FG000|Extension Phase|Disease progression|2|||
156770808|NCT00471497|565914639|FG001|Extension Phase|Disease progression|0|||
156770809|NCT00471497|565914640|FG002|Extension Phase|Disease progression|0|||
156770810|NCT00471497|565914638|FG000|Extension Phase|Protocol Violation|2|||
156770811|NCT00471497|565914639|FG001|Extension Phase|Protocol Violation|2|||
156770812|NCT00471497|565914640|FG002|Extension Phase|Protocol Violation|0|||
156770813|NCT04004000|565914644|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
156770814|NCT06121609|565914645|FG000|Overall Study|Lack of Efficacy|0|||
156770815|NCT06121609|565914646|FG001|Overall Study|Lack of Efficacy|0|||
156770816|NCT06121609|565914647|FG002|Overall Study|Lack of Efficacy|45|||
156770817|NCT00848497|565914648|FG000|Overall Study|Screen failure|2|||
156770818|NCT00848497|565914649|FG001|Overall Study|Screen failure|0|||
156770819|NCT00848497|565914648|FG000|Overall Study|Withdrawal by Subject|0|||
156770820|NCT00848497|565914649|FG001|Overall Study|Withdrawal by Subject|1|||
156770821|NCT01420536|565914659|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
156770822|NCT01420536|565914660|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
156770823|NCT04711005|565914661|FG000|Overall Study|Withdrawal by Subject|0|||
156770824|NCT04711005|565914662|FG001|Overall Study|Withdrawal by Subject|0|||
156770825|NCT04711005|565914663|FG002|Overall Study|Withdrawal by Subject|0|||
156770826|NCT04711005|565914664|FG003|Overall Study|Withdrawal by Subject|0|||
156770827|NCT04711005|565914665|FG004|Overall Study|Withdrawal by Subject|0|||
156770828|NCT04711005|565914666|FG005|Overall Study|Withdrawal by Subject|0|||
156770829|NCT04711005|565914667|FG006|Overall Study|Withdrawal by Subject|0|||
156770830|NCT04711005|565914668|FG007|Overall Study|Withdrawal by Subject|1|||
156770831|NCT04711005|565914669|FG008|Overall Study|Withdrawal by Subject|0|||
156770832|NCT04711005|565914670|FG009|Overall Study|Withdrawal by Subject|0|||
156770833|NCT04711005|565914661|FG000|Overall Study|Physician Decision|0|||
156770834|NCT04711005|565914662|FG001|Overall Study|Physician Decision|0|||
156770835|NCT04711005|565914663|FG002|Overall Study|Physician Decision|0|||
156770836|NCT04711005|565914664|FG003|Overall Study|Physician Decision|0|||
156770837|NCT04711005|565914665|FG004|Overall Study|Physician Decision|0|||
156770838|NCT04711005|565914666|FG005|Overall Study|Physician Decision|0|||
156770839|NCT04711005|565914667|FG006|Overall Study|Physician Decision|0|||
156770840|NCT04711005|565914668|FG007|Overall Study|Physician Decision|2|||
156770841|NCT04711005|565914669|FG008|Overall Study|Physician Decision|1|||
156770842|NCT04711005|565914670|FG009|Overall Study|Physician Decision|0|||
156770843|NCT04935879|565914671|FG000|Overall Study|Adverse Event|2|||
156770844|NCT04935879|565914672|FG001|Overall Study|Adverse Event|1|||
156523270|NCT00372229|565009537|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
156770845|NCT04935879|565914671|FG000|Overall Study|Lost to Follow-up|1|||
156770846|NCT04935879|565914672|FG001|Overall Study|Lost to Follow-up|1|||
156770847|NCT04935879|565914671|FG000|Overall Study|Pregnancy|2|||
156770848|NCT04935879|565914672|FG001|Overall Study|Pregnancy|3|||
156770849|NCT04935879|565914671|FG000|Overall Study|Withdrawal by Subject|8|||
156770850|NCT04935879|565914672|FG001|Overall Study|Withdrawal by Subject|6|||
156770851|NCT04935879|565914671|FG000|Overall Study|Other|3|||
156770852|NCT04935879|565914672|FG001|Overall Study|Other|3|||
156770853|NCT03054428|565914673|FG000|Overall Study|Physician Decision|0|||
156770854|NCT03054428|565914674|FG001|Overall Study|Physician Decision|1|||
156770855|NCT03054428|565914675|FG002|Overall Study|Physician Decision|1|||
156770856|NCT03054428|565914673|FG000|Overall Study|Lack of Efficacy|3|||
156770857|NCT03054428|565914674|FG001|Overall Study|Lack of Efficacy|1|||
156523271|NCT00372229|565009536|FG000|Follow-Up Phase|Death|9|||
156523272|NCT00372229|565009537|FG001|Follow-Up Phase|Death|12|||
156523273|NCT00372229|565009536|FG000|Follow-Up Phase|Administrative|1|||
156523274|NCT00372229|565009537|FG001|Follow-Up Phase|Administrative|0|||
156523275|NCT00372229|565009536|FG000|Follow-Up Phase|Reason not specified|2|||
156523276|NCT00372229|565009537|FG001|Follow-Up Phase|Reason not specified|3|||
156523277|NCT00372229|565009536|FG000|Follow-Up Phase|Lost to Follow-up|12|||
156523278|NCT00372229|565009537|FG001|Follow-Up Phase|Lost to Follow-up|10|||
156523279|NCT00701220|565009538|FG000|Overall Study|Withdrawal by Subject|0|||
156523280|NCT00701220|565009539|FG001|Overall Study|Withdrawal by Subject|2|||
156523281|NCT00701220|565009538|FG000|Overall Study|Protocol Violation|2|||
156523282|NCT00701220|565009539|FG001|Overall Study|Protocol Violation|0|||
156523283|NCT00211185|565009540|FG000|Overall Study|Death|2|||
156523284|NCT00211185|565009540|FG000|Overall Study|Disease progression|7|||
156523285|NCT00211185|565009540|FG000|Overall Study|Withdrawal by Subject|6|||
156523286|NCT00211185|565009540|FG000|Overall Study|Physician Decision|5|||
156523287|NCT00249002|565009541|FG000|Overall Study|Adverse Event|2|||
156523288|NCT00249002|565009541|FG000|Overall Study|Study cancellation|3|||
156523289|NCT00249002|565009541|FG000|Overall Study|Other|2|||
156523290|NCT00986674|565009542|FG000|Overall Study|Lack of Efficacy|28|||
156523291|NCT00986674|565009543|FG001|Overall Study|Lack of Efficacy|25|||
156523292|NCT00986674|565009544|FG002|Overall Study|Lack of Efficacy|23|||
156523293|NCT00986674|565009542|FG000|Overall Study|Adverse Event|4|||
156523294|NCT00986674|565009543|FG001|Overall Study|Adverse Event|8|||
156523295|NCT00986674|565009544|FG002|Overall Study|Adverse Event|9|||
156523296|NCT00986674|565009542|FG000|Overall Study|Death|5|||
156523297|NCT00986674|565009543|FG001|Overall Study|Death|0|||
156523298|NCT00986674|565009544|FG002|Overall Study|Death|4|||
156523299|NCT00986674|565009542|FG000|Overall Study|Withdrawal by Subject|6|||
156523300|NCT00986674|565009543|FG001|Overall Study|Withdrawal by Subject|2|||
156523301|NCT00986674|565009544|FG002|Overall Study|Withdrawal by Subject|1|||
156523302|NCT00986674|565009542|FG000|Overall Study|alternative therapy|0|||
156523303|NCT00986674|565009543|FG001|Overall Study|alternative therapy|0|||
156523304|NCT00986674|565009544|FG002|Overall Study|alternative therapy|1|||
156523305|NCT00986674|565009542|FG000|Overall Study|not start protocol therapy|4|||
156523306|NCT00986674|565009543|FG001|Overall Study|not start protocol therapy|3|||
156523307|NCT00986674|565009544|FG002|Overall Study|not start protocol therapy|1|||
156523308|NCT00986674|565009542|FG000|Overall Study|unknown/not specify|0|||
156770858|NCT03054428|565914675|FG002|Overall Study|Lack of Efficacy|0|||
156770859|NCT03054428|565914673|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
156770860|NCT03054428|565914674|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
156770861|NCT03054428|565914675|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
156770862|NCT03054428|565914673|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
156770863|NCT03054428|565914674|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
156770864|NCT03054428|565914675|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
156770865|NCT03054428|565914673|FG000|Overall Study|Transitioned to OLE study|76|||
156770866|NCT03054428|565914674|FG001|Overall Study|Transitioned to OLE study|76|||
156770867|NCT03054428|565914675|FG002|Overall Study|Transitioned to OLE study|73|||
156770868|NCT03054428|565914673|FG000|Overall Study|Withdrawal by Subject|3|||
156770869|NCT03054428|565914674|FG001|Overall Study|Withdrawal by Subject|2|||
156770870|NCT03054428|565914675|FG002|Overall Study|Withdrawal by Subject|3|||
156770871|NCT03054428|565914673|FG000|Overall Study|Lost to Follow-up|0|||
156770872|NCT03054428|565914674|FG001|Overall Study|Lost to Follow-up|0|||
156770873|NCT03054428|565914675|FG002|Overall Study|Lost to Follow-up|1|||
156770874|NCT01652690|565914676|FG000|Overall Study|Withdrawal by Subject|16|||
156770875|NCT01652690|565914677|FG001|Overall Study|Withdrawal by Subject|4|||
156770876|NCT01652690|565914676|FG000|Overall Study|Other|8|||
156770877|NCT01652690|565914677|FG001|Overall Study|Other|9|||
156770878|NCT01652690|565914676|FG000|Overall Study|Lost to Follow-up|6|||
156770879|NCT01652690|565914677|FG001|Overall Study|Lost to Follow-up|6|||
156770880|NCT01652690|565914676|FG000|Overall Study|Death|5|||
156770881|NCT01652690|565914677|FG001|Overall Study|Death|2|||
156770882|NCT03533751|565914678|FG000|Overall Study|Withdrawal by Subject|12|||
156770883|NCT03533751|565914679|FG001|Overall Study|Withdrawal by Subject|6|||
156523309|NCT00986674|565009543|FG001|Overall Study|unknown/not specify|7|||
156523310|NCT00986674|565009544|FG002|Overall Study|unknown/not specify|9|||
156523311|NCT00690820|565009545|FG000|Period 1|Withdrawal by Subject|0|||
156523312|NCT00690820|565009546|FG001|Period 1|Withdrawal by Subject|1|||
156770884|NCT03533751|565914680|FG002|Overall Study|Withdrawal by Subject|11|||
156770885|NCT03533751|565914681|FG003|Overall Study|Withdrawal by Subject|9|||
156770886|NCT03533751|565914682|FG004|Overall Study|Withdrawal by Subject|10|||
156770887|NCT03533751|565914678|FG000|Overall Study|Adverse Event|4|||
156770888|NCT03533751|565914679|FG001|Overall Study|Adverse Event|7|||
156770889|NCT03533751|565914680|FG002|Overall Study|Adverse Event|2|||
156770890|NCT03533751|565914681|FG003|Overall Study|Adverse Event|4|||
156770891|NCT03533751|565914682|FG004|Overall Study|Adverse Event|5|||
156770892|NCT03533751|565914678|FG000|Overall Study|Physician Decision|0|||
156523313|NCT01411215|565009547|FG000|Overall Study|Adverse Event|1|||
156523314|NCT01411215|565009548|FG001|Overall Study|Adverse Event|2|||
156523315|NCT01411215|565009547|FG000|Overall Study|Lack of Efficacy|2|||
156523316|NCT01411215|565009548|FG001|Overall Study|Lack of Efficacy|4|||
156523317|NCT01411215|565009547|FG000|Overall Study|Lost to Follow-up|12|||
156523318|NCT01411215|565009548|FG001|Overall Study|Lost to Follow-up|18|||
156523319|NCT01411215|565009547|FG000|Overall Study|Did not meet entrance criteria|0|||
156523320|NCT01411215|565009548|FG001|Overall Study|Did not meet entrance criteria|1|||
156523321|NCT01411215|565009547|FG000|Overall Study|Study terminated by sponsor|2|||
156523322|NCT01411215|565009548|FG001|Overall Study|Study terminated by sponsor|15|||
156523323|NCT01411215|565009547|FG000|Overall Study|Protocol Violation|3|||
156523324|NCT01411215|565009548|FG001|Overall Study|Protocol Violation|5|||
156523325|NCT01411215|565009547|FG000|Overall Study|Withdrawal by Subject|34|||
156523326|NCT01411215|565009548|FG001|Overall Study|Withdrawal by Subject|21|||
156523327|NCT01411215|565009547|FG000|Overall Study|Other|12|||
156523328|NCT01411215|565009548|FG001|Overall Study|Other|17|||
156523329|NCT01411215|565009547|FG000|Overall Study|Screen failure|0|||
156523330|NCT01411215|565009548|FG001|Overall Study|Screen failure|1|||
156770893|NCT03533751|565914679|FG001|Overall Study|Physician Decision|2|||
156770894|NCT03533751|565914680|FG002|Overall Study|Physician Decision|1|||
156770895|NCT03533751|565914681|FG003|Overall Study|Physician Decision|2|||
156770896|NCT03533751|565914682|FG004|Overall Study|Physician Decision|1|||
156770897|NCT03533751|565914678|FG000|Overall Study|Sponsor Decision|0|||
156770898|NCT03533751|565914679|FG001|Overall Study|Sponsor Decision|0|||
156770899|NCT03533751|565914680|FG002|Overall Study|Sponsor Decision|1|||
156770900|NCT03533751|565914681|FG003|Overall Study|Sponsor Decision|1|||
156770901|NCT03533751|565914682|FG004|Overall Study|Sponsor Decision|0|||
156770902|NCT03533751|565914678|FG000|Overall Study|Lost to Follow-up|3|||
156770903|NCT03533751|565914679|FG001|Overall Study|Lost to Follow-up|7|||
156770904|NCT03533751|565914680|FG002|Overall Study|Lost to Follow-up|6|||
156770905|NCT03533751|565914681|FG003|Overall Study|Lost to Follow-up|4|||
156770906|NCT03533751|565914682|FG004|Overall Study|Lost to Follow-up|3|||
156770907|NCT03533751|565914678|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
156770908|NCT03533751|565914679|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
156770909|NCT03533751|565914680|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
156770910|NCT03533751|565914681|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
156770911|NCT03533751|565914682|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
156770912|NCT03533751|565914678|FG000|Overall Study|Other|0|||
156770913|NCT03533751|565914679|FG001|Overall Study|Other|2|||
156770914|NCT03533751|565914680|FG002|Overall Study|Other|1|||
156770915|NCT03533751|565914681|FG003|Overall Study|Other|0|||
156770916|NCT03533751|565914682|FG004|Overall Study|Other|3|||
156770917|NCT03225287|565914683|FG000|Overall Study|Adverse Event|0|||
156770918|NCT03225287|565914684|FG001|Overall Study|Adverse Event|0|||
156770919|NCT03225287|565914685|FG002|Overall Study|Adverse Event|1|||
156770920|NCT03225287|565914683|FG000|Overall Study|Protocol non-compliance|0|||
156770921|NCT03225287|565914684|FG001|Overall Study|Protocol non-compliance|0|||
156770922|NCT03225287|565914685|FG002|Overall Study|Protocol non-compliance|1|||
156770923|NCT03225287|565914683|FG000|Overall Study|Subject withdraws consent|3|||
156770924|NCT03225287|565914684|FG001|Overall Study|Subject withdraws consent|0|||
156770925|NCT03225287|565914685|FG002|Overall Study|Subject withdraws consent|0|||
156770926|NCT03225287|565914683|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
156770927|NCT03225287|565914684|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
156770928|NCT03225287|565914685|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
156523331|NCT04025580|565009549|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
156523332|NCT04025580|565009550|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
156523333|NCT04025580|565009551|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
156523334|NCT03305731|565009553|FG000|Overall Study|Protocol Violation|1|||
156523335|NCT01952054|565009554|FG000|Overall Study|Physician Decision|1|||
156523336|NCT05208866|565009555|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
156523337|NCT03881553|565009556|FG000|Overall Study|Discharged prior to participation|1|||
156523338|NCT03881553|565009557|FG001|Overall Study|Discharged prior to participation|1|||
156523339|NCT03881553|565009558|FG002|Overall Study|Discharged prior to participation|0|||
156523340|NCT03881553|565009556|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
156523341|NCT03881553|565009557|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
156770929|NCT03225287|565914683|FG000|Overall Study|Trial drug not effective|0|||
156523342|NCT03881553|565009558|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
156523343|NCT01718353|565009559|FG000|Overall Study|Lost to Follow-up|0|||
156523344|NCT01718353|565009560|FG001|Overall Study|Lost to Follow-up|1|||
156523345|NCT01718353|565009559|FG000|Overall Study|Principal Investigator's Decision|10|||
156523346|NCT01718353|565009560|FG001|Overall Study|Principal Investigator's Decision|4|||
156523347|NCT01718353|565009559|FG000|Overall Study|Randomized but not treated|2|||
156523348|NCT01718353|565009560|FG001|Overall Study|Randomized but not treated|0|||
156523349|NCT01959516|565009561|FG000|Epoch 1|Adverse Event|4|||
156523350|NCT01959516|565009562|FG001|Epoch 1|Adverse Event|1|||
156523351|NCT01959516|565009561|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
156523352|NCT01959516|565009562|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
156523353|NCT01959516|565009561|FG000|Epoch 1|Subject withdrew consent|3|||
156523354|NCT01959516|565009562|FG001|Epoch 1|Subject withdrew consent|2|||
156657590|NCT02097121|565491888|FG000|Overall Study|Other, not specified|4|||
156523355|NCT01959516|565009561|FG000|Epoch 1|Administrative problems|1|||
156523356|NCT01959516|565009562|FG001|Epoch 1|Administrative problems|0|||
156523357|NCT01959516|565009561|FG000|Epoch 1|Use of prohibited treatment|1|||
156523358|NCT01959516|565009562|FG001|Epoch 1|Use of prohibited treatment|0|||
156523359|NCT01959516|565009561|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
156523360|NCT01959516|565009562|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
156523361|NCT01959516|565009561|FG000|Epoch 1|Protocol deviation|0|||
156523362|NCT01959516|565009562|FG001|Epoch 1|Protocol deviation|1|||
156523363|NCT01959516|565009561|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
156523364|NCT01959516|565009562|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
156523365|NCT01959516|565009561|FG000|Epoch 2|Subject withdrew consent|1|||
156523366|NCT01959516|565009562|FG001|Epoch 2|Subject withdrew consent|0|||
156523367|NCT01959516|565009561|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
156523368|NCT01959516|565009562|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
156523369|NCT00455325|565009563|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
156523370|NCT00455325|565009564|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
156523371|NCT00455325|565009565|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
156523372|NCT00455325|565009566|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
156523373|NCT00455325|565009563|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
156523374|NCT00455325|565009564|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
156523375|NCT00455325|565009565|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
156523376|NCT00455325|565009566|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
156523377|NCT00455325|565009563|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
156523378|NCT00455325|565009564|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
156523379|NCT00455325|565009565|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
156523380|NCT00455325|565009566|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
156523381|NCT00455325|565009563|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
156523382|NCT00455325|565009564|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
156523383|NCT00455325|565009565|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
156523384|NCT00455325|565009566|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
156523385|NCT00455325|565009563|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
156657591|NCT02097121|565491889|FG001|Overall Study|Other, not specified|2|||
156770930|NCT03225287|565914684|FG001|Overall Study|Trial drug not effective|1|||
156770931|NCT03225287|565914685|FG002|Overall Study|Trial drug not effective|0|||
156770932|NCT03225287|565914683|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
156770933|NCT03225287|565914684|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
156770934|NCT03225287|565914685|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
156770935|NCT03225287|565914683|FG000|Overall Study|Stem cell transplantation|0|||
156770936|NCT03225287|565914684|FG001|Overall Study|Stem cell transplantation|1|||
156770937|NCT03225287|565914685|FG002|Overall Study|Stem cell transplantation|0|||
156770938|NCT06070610|565914690|FG000|Washout period|Adverse Event|1|||
156770939|NCT06070610|565914690|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
156770940|NCT01499810|565914691|FG000|Overall Study|Lost to Follow-up|10|||
156770941|NCT01499810|565914691|FG000|Overall Study|Protocol Violation|1|||
156770942|NCT01499810|565914691|FG000|Overall Study|Withdrawal by Subject|1|||
156770943|NCT04530630|565916132|FG000|Overall Study|Physician Decision|1|||
156770944|NCT04736199|565916135|FG000|Overall Study|Adverse Event|28|||
156523386|NCT00455325|565009564|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
156657592|NCT02097121|565491890|FG002|Overall Study|Other, not specified|3|||
156657593|NCT02097121|565491888|FG000|Overall Study|Lack of Efficacy|2|||
156657594|NCT02097121|565491889|FG001|Overall Study|Lack of Efficacy|1|||
156657595|NCT02097121|565491890|FG002|Overall Study|Lack of Efficacy|3|||
156657596|NCT02097121|565491888|FG000|Overall Study|Withdrawal by Subject|0|||
156657597|NCT02097121|565491889|FG001|Overall Study|Withdrawal by Subject|1|||
156657598|NCT02097121|565491890|FG002|Overall Study|Withdrawal by Subject|2|||
156657599|NCT02097121|565491888|FG000|Overall Study|Adverse Event|0|||
156657600|NCT02097121|565491889|FG001|Overall Study|Adverse Event|1|||
156657601|NCT02097121|565491890|FG002|Overall Study|Adverse Event|0|||
156657602|NCT02097121|565491888|FG000|Overall Study|Lost to Follow-up|1|||
156657603|NCT02097121|565491889|FG001|Overall Study|Lost to Follow-up|1|||
156657604|NCT02097121|565491890|FG002|Overall Study|Lost to Follow-up|2|||
156657605|NCT03595657|565491891|FG000|Overall Study|Adverse Event|14|||
156770945|NCT04736199|565916136|FG001|Overall Study|Adverse Event|22|||
156770946|NCT04736199|565916135|FG000|Overall Study|Death|9|||
156770947|NCT04736199|565916136|FG001|Overall Study|Death|3|||
156770948|NCT04736199|565916135|FG000|Overall Study|Lost to Follow-up|4|||
156770949|NCT04736199|565916136|FG001|Overall Study|Lost to Follow-up|1|||
156770950|NCT04736199|565916135|FG000|Overall Study|Physician Decision|5|||
156770951|NCT04736199|565916136|FG001|Overall Study|Physician Decision|9|||
156770952|NCT04736199|565916135|FG000|Overall Study|Withdrawal by Subject|21|||
156770953|NCT04736199|565916136|FG001|Overall Study|Withdrawal by Subject|9|||
156770954|NCT04736199|565916135|FG000|Overall Study|Progressive disease|120|||
156770955|NCT04736199|565916136|FG001|Overall Study|Progressive disease|101|||
156770956|NCT04736199|565916135|FG000|Overall Study|Subject decision|13|||
156770957|NCT04736199|565916136|FG001|Overall Study|Subject decision|13|||
156770958|NCT04736199|565916135|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
156770959|NCT04736199|565916136|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
156770960|NCT04736199|565916135|FG000|Overall Study|Additional primary malignancy|1|||
156770961|NCT04736199|565916136|FG001|Overall Study|Additional primary malignancy|0|||
156770962|NCT04736199|565916135|FG000|Overall Study|Non-compliance with study drug|0|||
156770963|NCT04736199|565916136|FG001|Overall Study|Non-compliance with study drug|1|||
156770964|NCT04736199|565916135|FG000|Overall Study|Other reason|0|||
156770965|NCT04736199|565916136|FG001|Overall Study|Other reason|1|||
156770966|NCT04736199|565916135|FG000|Overall Study|Ongoing with study drug|240|||
156770967|NCT04736199|565916136|FG001|Overall Study|Ongoing with study drug|63|||
156770968|NCT04736199|565916135|FG000|Overall Study|Study drug never administered|3|||
156770969|NCT04736199|565916136|FG001|Overall Study|Study drug never administered|0|||
156770970|NCT05172609|565916137|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
156770971|NCT05172609|565916138|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
156770972|NCT05172609|565916137|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
156770973|NCT05172609|565916138|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
156770974|NCT05172609|565916137|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
156770975|NCT05172609|565916138|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
156770976|NCT00336544|565916144|FG000|Overall Study|Lack of Efficacy|8|||
156523387|NCT00455325|565009565|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
156523388|NCT00455325|565009566|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
156523389|NCT00455325|565009563|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
156523390|NCT00455325|565009564|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
156523391|NCT00455325|565009565|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
156523392|NCT00455325|565009566|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
156523393|NCT00455325|565009563|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
156523394|NCT00455325|565009564|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
156770977|NCT00336544|565916145|FG001|Overall Study|Lack of Efficacy|5|||
156770978|NCT00336544|565916144|FG000|Overall Study|Adverse Event|4|||
156770979|NCT00336544|565916145|FG001|Overall Study|Adverse Event|9|||
156770980|NCT00336544|565916144|FG000|Overall Study|Withdrawal by Subject|4|||
156770981|NCT00336544|565916145|FG001|Overall Study|Withdrawal by Subject|3|||
156770982|NCT00336544|565916144|FG000|Overall Study|Other|3|||
156770983|NCT00336544|565916145|FG001|Overall Study|Other|5|||
156770984|NCT00961064|565916146|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
156523395|NCT00455325|565009565|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
156523396|NCT00455325|565009566|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
156523397|NCT01759368|565009573|FG000|Overall Study|Lost to Follow-up|1|||
156523398|NCT01759368|565009574|FG001|Overall Study|Lost to Follow-up|0|||
156523399|NCT02951767|565009575|FG000|Overall Study|Study Terminated By Sponsor|9|||
156523400|NCT02951767|565009575|FG000|Overall Study|Withdrawal by Subject|11|||
156523401|NCT02951767|565009575|FG000|Overall Study|Death|96|||
156523402|NCT02951767|565009575|FG000|Overall Study|Lost to Follow-up|2|||
156523403|NCT02951767|565009575|FG000|Overall Study|Physician Decision|1|||
156523404|NCT03426605|565009576|FG000|Overall Study|AML relapse or progression|2|||
156523405|NCT03426605|565009577|FG001|Overall Study|AML relapse or progression|1|||
156523406|NCT03426605|565009578|FG002|Overall Study|AML relapse or progression|2|||
156523407|NCT03426605|565009579|FG003|Overall Study|AML relapse or progression|2|||
156523408|NCT03426605|565009576|FG000|Overall Study|Treatment failure|3|||
156523409|NCT03426605|565009577|FG001|Overall Study|Treatment failure|2|||
156523410|NCT03426605|565009578|FG002|Overall Study|Treatment failure|0|||
156523411|NCT03426605|565009579|FG003|Overall Study|Treatment failure|0|||
156523412|NCT03426605|565009576|FG000|Overall Study|Adverse Event|1|||
156770985|NCT00961064|565916146|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
156523413|NCT03426605|565009577|FG001|Overall Study|Adverse Event|0|||
156770986|NCT00961064|565916146|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
156770987|NCT00961064|565916146|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
156770988|NCT00961064|565916146|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
156770989|NCT00961064|565916146|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
156770990|NCT00961064|565916146|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
156770991|NCT00961064|565916146|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
156770992|NCT01408641|565916147|FG000|Overall Study|Physician Decision|1|||
156770993|NCT01408641|565916148|FG001|Overall Study|Physician Decision|0|||
156770994|NCT00576758|565916149|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
156770995|NCT00576758|565916150|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
156770996|NCT00576758|565916149|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
156770997|NCT00576758|565916150|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
156770998|NCT00576758|565916149|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
156770999|NCT00576758|565916150|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
156428318|NCT00404079|564660829|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
156428319|NCT00404079|564660830|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
156428320|NCT00853827|564660831|FG000|Single Blind Period (1 Week)|Other|4|||
156428321|NCT00853827|564660832|FG001|Single Blind Period (1 Week)|Other|0|||
156428322|NCT00853827|564660831|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
156428323|NCT00853827|564660832|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
156428324|NCT00853827|564660831|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
156428325|NCT00853827|564660832|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
156428326|NCT00853827|564660831|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
156428327|NCT00853827|564660832|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
156428328|NCT00853827|564660831|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
156428329|NCT00853827|564660832|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
156428330|NCT00853827|564660831|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
156428331|NCT00853827|564660832|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
156428332|NCT00853827|564660831|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
156428333|NCT00853827|564660832|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
156428334|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
156428335|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
156428336|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
156428337|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
156428338|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
156428339|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
156428340|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
156428341|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
156428342|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
156428343|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
156428344|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
156428345|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
156428346|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
156428347|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
156428348|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
156428349|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
156428350|NCT00853827|564660831|FG000|Double Blind Period (103 Weeks)|Death|1|||
156428351|NCT00853827|564660832|FG001|Double Blind Period (103 Weeks)|Death|6|||
156428352|NCT00580801|564660843|FG000|Overall Study|Physician Decision|1|||
156428353|NCT00580801|564660844|FG001|Overall Study|Physician Decision|0|||
156428354|NCT00580801|564660845|FG002|Overall Study|Physician Decision|0|||
156428355|NCT00580801|564660843|FG000|Overall Study|Adverse Event|2|||
156428356|NCT00580801|564660844|FG001|Overall Study|Adverse Event|0|||
156428357|NCT00580801|564660845|FG002|Overall Study|Adverse Event|0|||
156428358|NCT00580801|564660843|FG000|Overall Study|Lost to Follow-up|2|||
156428359|NCT00580801|564660844|FG001|Overall Study|Lost to Follow-up|0|||
156428360|NCT00580801|564660845|FG002|Overall Study|Lost to Follow-up|0|||
156428361|NCT00580801|564660843|FG000|Overall Study|Reached a virologic endpoint|0|||
156428362|NCT00580801|564660844|FG001|Overall Study|Reached a virologic endpoint|1|||
156428363|NCT00580801|564660845|FG002|Overall Study|Reached a virologic endpoint|2|||
156428364|NCT00580801|564660843|FG000|Overall Study|Participant non-compliant|0|||
156428365|NCT00580801|564660844|FG001|Overall Study|Participant non-compliant|0|||
156428366|NCT00580801|564660845|FG002|Overall Study|Participant non-compliant|1|||
156428367|NCT00580801|564660843|FG000|Overall Study|Travel|1|||
156428368|NCT00580801|564660844|FG001|Overall Study|Travel|0|||
156428369|NCT00580801|564660845|FG002|Overall Study|Travel|0|||
156428370|NCT05576051|564660846|FG000|Overall Study|Lack of Efficacy|543|||
156428371|NCT05576051|564660847|FG001|Overall Study|Lack of Efficacy|343|||
156428372|NCT05576051|564660848|FG002|Overall Study|Lack of Efficacy|108|||
156428373|NCT05576051|564660849|FG003|Overall Study|Lack of Efficacy|72|||
156428374|NCT05576051|564660850|FG004|Overall Study|Lack of Efficacy|28|||
156428375|NCT05576051|564660851|FG005|Overall Study|Lack of Efficacy|50|||
156428376|NCT05576051|564660846|FG000|Overall Study|Safety|78|||
156428377|NCT05576051|564660847|FG001|Overall Study|Safety|74|||
156428378|NCT05576051|564660848|FG002|Overall Study|Safety|16|||
156428379|NCT05576051|564660849|FG003|Overall Study|Safety|14|||
156523414|NCT03426605|565009578|FG002|Overall Study|Adverse Event|1|||
156771000|NCT00576758|565916149|FG000|Induction Treatment Period|Death|1|||
156771001|NCT00576758|565916150|FG001|Induction Treatment Period|Death|0|||
156771002|NCT00576758|565916149|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
156771003|NCT00576758|565916150|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
156771004|NCT00576758|565916149|FG000|Induction Treatment Period|Withdrew consent|1|||
156771005|NCT00576758|565916150|FG001|Induction Treatment Period|Withdrew consent|0|||
156771006|NCT00576758|565916149|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
156771007|NCT00576758|565916150|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
156771008|NCT00576758|565916149|FG000|Extension Treatment Period|Death|1|||
156771009|NCT00576758|565916150|FG001|Extension Treatment Period|Death|1|||
156771010|NCT00576758|565916149|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
156771011|NCT00576758|565916150|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
156771012|NCT00576758|565916149|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
156771013|NCT00576758|565916150|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
156771014|NCT00576758|565916149|FG000|Extension Treatment Period|Administrative/Other|3|||
156771015|NCT00576758|565916150|FG001|Extension Treatment Period|Administrative/Other|1|||
156771016|NCT00576758|565916149|FG000|Follow-up Period|Administrative/Other|6|||
156771017|NCT00576758|565916150|FG001|Follow-up Period|Administrative/Other|8|||
156771018|NCT00576758|565916149|FG000|Follow-up Period|Death|3|||
156771019|NCT00576758|565916150|FG001|Follow-up Period|Death|3|||
156771020|NCT00576758|565916149|FG000|Follow-up Period|Insufficient therapeutic response|16|||
156771021|NCT00576758|565916150|FG001|Follow-up Period|Insufficient therapeutic response|5|||
156771022|NCT00576758|565916149|FG000|Follow-up Period|Withdrew consent|2|||
156771023|NCT00576758|565916150|FG001|Follow-up Period|Withdrew consent|1|||
156771024|NCT00715208|565916151|FG000|Overall Study|Withdrawal by Subject|1|||
156771025|NCT00715208|565916152|FG001|Overall Study|Withdrawal by Subject|1|||
156771026|NCT00715208|565916151|FG000|Overall Study|Adverse Event|0|||
156771027|NCT00715208|565916152|FG001|Overall Study|Adverse Event|6|||
156771028|NCT00715208|565916151|FG000|Overall Study|Lack of Efficacy|0|||
156771029|NCT00715208|565916152|FG001|Overall Study|Lack of Efficacy|2|||
156771030|NCT00076570|565916153|FG000|Overall Study|Drug intolerance|8|||
156771031|NCT00076570|565916154|FG001|Overall Study|Drug intolerance|8|||
156771032|NCT03427411|565916155|FG000|Overall Study|Screen failure - platelets too low|0|||
156771033|NCT03427411|565916156|FG001|Overall Study|Screen failure - platelets too low|1|||
156771034|NCT00903968|565916157|FG000|Overall Study|Adverse Event|0|||
156771035|NCT00903968|565916158|FG001|Overall Study|Adverse Event|0|||
156771036|NCT00903968|565916159|FG002|Overall Study|Adverse Event|0|||
156771037|NCT00903968|565916160|FG003|Overall Study|Adverse Event|0|||
156771038|NCT00903968|565916161|FG004|Overall Study|Adverse Event|0|||
156771039|NCT00903968|565916162|FG005|Overall Study|Adverse Event|0|||
156771040|NCT00903968|565916163|FG006|Overall Study|Adverse Event|1|||
156771041|NCT00903968|565916164|FG007|Overall Study|Adverse Event|8|||
156771042|NCT00903968|565916157|FG000|Overall Study|DLT|0|||
156771043|NCT00903968|565916158|FG001|Overall Study|DLT|0|||
156771044|NCT00903968|565916159|FG002|Overall Study|DLT|0|||
156771045|NCT00903968|565916160|FG003|Overall Study|DLT|0|||
156771046|NCT00903968|565916161|FG004|Overall Study|DLT|0|||
156771047|NCT00903968|565916162|FG005|Overall Study|DLT|0|||
156771048|NCT00903968|565916163|FG006|Overall Study|DLT|2|||
156771049|NCT00903968|565916164|FG007|Overall Study|DLT|0|||
156771050|NCT00903968|565916157|FG000|Overall Study|Withdrawal by Subject|1|||
156771051|NCT00903968|565916158|FG001|Overall Study|Withdrawal by Subject|0|||
156771052|NCT00903968|565916159|FG002|Overall Study|Withdrawal by Subject|1|||
156771053|NCT00903968|565916160|FG003|Overall Study|Withdrawal by Subject|0|||
156771054|NCT00903968|565916161|FG004|Overall Study|Withdrawal by Subject|1|||
156771055|NCT00903968|565916162|FG005|Overall Study|Withdrawal by Subject|1|||
156771056|NCT00903968|565916163|FG006|Overall Study|Withdrawal by Subject|0|||
156771057|NCT00903968|565916164|FG007|Overall Study|Withdrawal by Subject|4|||
156771058|NCT00903968|565916157|FG000|Overall Study|Non-Compliance|0|||
156771059|NCT00903968|565916158|FG001|Overall Study|Non-Compliance|0|||
156771060|NCT00903968|565916159|FG002|Overall Study|Non-Compliance|0|||
156771061|NCT00903968|565916160|FG003|Overall Study|Non-Compliance|0|||
156771062|NCT00903968|565916161|FG004|Overall Study|Non-Compliance|0|||
156771063|NCT00903968|565916162|FG005|Overall Study|Non-Compliance|1|||
156771064|NCT00903968|565916163|FG006|Overall Study|Non-Compliance|0|||
156771065|NCT00903968|565916164|FG007|Overall Study|Non-Compliance|0|||
156771066|NCT00903968|565916157|FG000|Overall Study|Physician Decision|0|||
156771067|NCT00903968|565916158|FG001|Overall Study|Physician Decision|0|||
156771068|NCT00903968|565916159|FG002|Overall Study|Physician Decision|0|||
156771069|NCT00903968|565916160|FG003|Overall Study|Physician Decision|0|||
156771070|NCT00903968|565916161|FG004|Overall Study|Physician Decision|0|||
156523415|NCT03426605|565009579|FG003|Overall Study|Adverse Event|1|||
156771071|NCT00903968|565916162|FG005|Overall Study|Physician Decision|1|||
156771072|NCT00903968|565916163|FG006|Overall Study|Physician Decision|0|||
156771073|NCT00903968|565916164|FG007|Overall Study|Physician Decision|0|||
156771074|NCT00903968|565916157|FG000|Overall Study|Progressive Disease|2|||
156771075|NCT00903968|565916158|FG001|Overall Study|Progressive Disease|3|||
156771076|NCT00903968|565916159|FG002|Overall Study|Progressive Disease|2|||
156771077|NCT00903968|565916160|FG003|Overall Study|Progressive Disease|3|||
156771078|NCT00903968|565916161|FG004|Overall Study|Progressive Disease|3|||
156771079|NCT00903968|565916162|FG005|Overall Study|Progressive Disease|3|||
156771080|NCT00903968|565916163|FG006|Overall Study|Progressive Disease|0|||
156771081|NCT00903968|565916164|FG007|Overall Study|Progressive Disease|18|||
156771082|NCT00903968|565916157|FG000|Overall Study|Lack of Efficacy|0|||
156771083|NCT00903968|565916158|FG001|Overall Study|Lack of Efficacy|0|||
156523416|NCT03426605|565009576|FG000|Overall Study|Withdrawal by Subject|0|||
156523417|NCT03426605|565009577|FG001|Overall Study|Withdrawal by Subject|0|||
156523418|NCT03426605|565009578|FG002|Overall Study|Withdrawal by Subject|1|||
156523419|NCT03426605|565009579|FG003|Overall Study|Withdrawal by Subject|1|||
156523420|NCT02054520|565009580|FG000|Overall Study|Adverse Event|1|||
156523421|NCT02054520|565009581|FG001|Overall Study|Adverse Event|4|||
156523422|NCT02054520|565009582|FG002|Overall Study|Adverse Event|2|||
156523423|NCT02054520|565009583|FG003|Overall Study|Adverse Event|1|||
156523424|NCT02054520|565009584|FG004|Overall Study|Adverse Event|1|||
156523425|NCT02054520|565009585|FG005|Overall Study|Adverse Event|0|||
156523426|NCT02054520|565009580|FG000|Overall Study|Lack of Efficacy|7|||
156523427|NCT02054520|565009581|FG001|Overall Study|Lack of Efficacy|0|||
156523428|NCT02054520|565009582|FG002|Overall Study|Lack of Efficacy|2|||
156523429|NCT02054520|565009583|FG003|Overall Study|Lack of Efficacy|1|||
156523430|NCT02054520|565009584|FG004|Overall Study|Lack of Efficacy|3|||
156523431|NCT02054520|565009585|FG005|Overall Study|Lack of Efficacy|2|||
156523432|NCT02054520|565009580|FG000|Overall Study|Withdrawal by Subject|1|||
156523433|NCT02054520|565009581|FG001|Overall Study|Withdrawal by Subject|0|||
156523434|NCT02054520|565009582|FG002|Overall Study|Withdrawal by Subject|0|||
156523435|NCT02054520|565009583|FG003|Overall Study|Withdrawal by Subject|2|||
156523436|NCT02054520|565009584|FG004|Overall Study|Withdrawal by Subject|1|||
156523437|NCT02054520|565009585|FG005|Overall Study|Withdrawal by Subject|0|||
156523438|NCT02054520|565009580|FG000|Overall Study|Physician Decision|0|||
156771084|NCT00903968|565916159|FG002|Overall Study|Lack of Efficacy|0|||
156771085|NCT00903968|565916160|FG003|Overall Study|Lack of Efficacy|0|||
156771086|NCT00903968|565916161|FG004|Overall Study|Lack of Efficacy|0|||
156771087|NCT00903968|565916162|FG005|Overall Study|Lack of Efficacy|0|||
156771088|NCT00903968|565916163|FG006|Overall Study|Lack of Efficacy|0|||
156771089|NCT00903968|565916164|FG007|Overall Study|Lack of Efficacy|3|||
156771090|NCT01294046|565916165|FG000|Overall Study|Infection and surgical explant|1|||
156771091|NCT01294046|565916165|FG000|Overall Study|Eligibility criteria expanded|1|||
156771092|NCT01294046|565916165|FG000|Overall Study|Stimulation response inadqequate|1|||
156771093|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
156771094|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
156771095|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
156771096|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
156771097|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
156771098|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
156771099|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
156771100|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
156771101|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
156771102|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
156771103|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
156771104|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
156771105|NCT03979313|565916166|FG000|All Subjects|Any Other Reason|16|||
156771106|NCT03979313|565916167|FG001|All Subjects|Any Other Reason|23|||
156771107|NCT03979313|565916166|FG000|All Subjects|Covid-19|1|||
156771108|NCT03979313|565916167|FG001|All Subjects|Covid-19|3|||
156771109|NCT03979313|565916166|FG000|All Subjects|Withdrawal by Subject|35|||
156771110|NCT03979313|565916167|FG001|All Subjects|Withdrawal by Subject|44|||
156771111|NCT03979313|565916166|FG000|All Subjects|Death|0|||
156771112|NCT03979313|565916167|FG001|All Subjects|Death|5|||
156771113|NCT03979313|565916166|FG000|All Subjects|Lost to Follow-up|28|||
156324046|NCT02428608|564286043|FG000|Overall Study|scheduling conflicts|15|||
156324047|NCT02428608|564286043|FG000|Overall Study|moved away|10|||
156771114|NCT03979313|565916167|FG001|All Subjects|Lost to Follow-up|61|||
156771115|NCT03183908|565916168|FG000|Overall Study|Missing Symptom Diary Data|0|||
156771116|NCT03183908|565916169|FG001|Overall Study|Missing Symptom Diary Data|2|||
156771117|NCT00393367|565916174|FG000|Overall Study|Protocol Violation|2|||
156771118|NCT00393367|565916175|FG001|Overall Study|Protocol Violation|5|||
156771119|NCT00393367|565916174|FG000|Overall Study|Withdrawal by Subject|0|||
156771120|NCT00393367|565916175|FG001|Overall Study|Withdrawal by Subject|2|||
156771121|NCT01027949|565916176|FG000|Overall Study|Death|174|||
156771122|NCT01027949|565916176|FG000|Overall Study|Progressive Disease|163|||
156324048|NCT02428608|564286043|FG000|Overall Study|Death|1|||
156771123|NCT01027949|565916176|FG000|Overall Study|Adverse Event|172|||
156771124|NCT01027949|565916176|FG000|Overall Study|Withdrawal by Subject|113|||
156771125|NCT01027949|565916176|FG000|Overall Study|Lost to Follow-up|17|||
156771126|NCT01027949|565916176|FG000|Overall Study|Protocol Violation|13|||
156771127|NCT01027949|565916176|FG000|Overall Study|PI Decision|8|||
156771128|NCT01027949|565916176|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
156771129|NCT01027949|565916176|FG000|Overall Study|Non-compliance with Study Procedures|7|||
156771130|NCT01027949|565916176|FG000|Overall Study|Lung Transplant|5|||
156771131|NCT01027949|565916176|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
156771132|NCT01027949|565916176|FG000|Overall Study|Use of Excluded Medication|2|||
156771133|NCT01027949|565916176|FG000|Overall Study|Patient Self-discontinuation|1|||
156771134|NCT01027949|565916176|FG000|Overall Study|Pregnancy|1|||
156771135|NCT01027949|565916176|FG000|Overall Study|Surgery|1|||
156771136|NCT00091819|565916181|FG000|Overall Study|Adverse Event|1|||
156771137|NCT00091819|565916182|FG001|Overall Study|Adverse Event|1|||
156771138|NCT00091819|565916181|FG000|Overall Study|Death|4|||
156771139|NCT00091819|565916182|FG001|Overall Study|Death|5|||
156771140|NCT00091819|565916181|FG000|Overall Study|Lost to Follow-up|26|||
156771141|NCT00091819|565916182|FG001|Overall Study|Lost to Follow-up|23|||
156771142|NCT00091819|565916181|FG000|Overall Study|Withdrawal by Subject|5|||
156771143|NCT00091819|565916182|FG001|Overall Study|Withdrawal by Subject|8|||
156771144|NCT00091819|565916181|FG000|Overall Study|Protocol Violation|1|||
156771145|NCT00091819|565916182|FG001|Overall Study|Protocol Violation|2|||
156771146|NCT00091819|565916181|FG000|Overall Study|Other|2|||
156771147|NCT00091819|565916182|FG001|Overall Study|Other|3|||
156771148|NCT00091819|565916181|FG000|Overall Study|Never received study treatment|3|||
156771149|NCT00091819|565916182|FG001|Overall Study|Never received study treatment|4|||
156771150|NCT00856180|565916183|FG000|Overall Study|Adverse Event|4|||
156771151|NCT00856180|565916183|FG000|Overall Study|Progressive Disease|16|||
156771152|NCT00481676|565916184|FG000|Overall Study|Adverse Event|0|||
156771153|NCT00481676|565916185|FG001|Overall Study|Adverse Event|1|||
156771154|NCT00481676|565916184|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156771155|NCT00481676|565916185|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156771156|NCT00481676|565916184|FG000|Overall Study|Administrative problem|1|||
156771157|NCT00481676|565916185|FG001|Overall Study|Administrative problem|0|||
156771158|NCT02911116|565916186|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156771159|NCT02911116|565916187|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156771160|NCT02911116|565916186|FG000|Overall Study|Lost to Follow-up|0|||
156771161|NCT02911116|565916187|FG001|Overall Study|Lost to Follow-up|1|||
156771162|NCT04796415|565916188|FG000|Overall Study|not interested|12|||
156771163|NCT04796415|565916188|FG000|Overall Study|health issue|8|||
156771164|NCT04796415|565916188|FG000|Overall Study|Other|4|||
156771165|NCT04796415|565916188|FG000|Overall Study|discharged from home health service|3|||
156771166|NCT04796415|565916188|FG000|Overall Study|re-hospitalization|2|||
156771167|NCT04796415|565916188|FG000|Overall Study|moving to nursing home|1|||
156771168|NCT04796415|565916188|FG000|Overall Study|lost contact|1|||
156771169|NCT01513590|565916189|FG000|Overall Study|Adverse Event|2|||
156771170|NCT01513590|565916190|FG001|Overall Study|Adverse Event|3|||
156771171|NCT01513590|565916189|FG000|Overall Study|Withdrawal Criteria|3|||
156771172|NCT01513590|565916190|FG001|Overall Study|Withdrawal Criteria|0|||
156771173|NCT01513590|565916189|FG000|Overall Study|Unclassified|5|||
156771174|NCT01513590|565916190|FG001|Overall Study|Unclassified|10|||
156771175|NCT04810962|565916191|FG000|Overall Study|Adverse Event|0|||
156771176|NCT04810962|565916192|FG001|Overall Study|Adverse Event|1|||
156771177|NCT04810962|565916191|FG000|Overall Study|Lost to Follow-up|2|||
156771178|NCT04810962|565916192|FG001|Overall Study|Lost to Follow-up|1|||
156771179|NCT04810962|565916191|FG000|Overall Study|Physician Decision|1|||
156771180|NCT04810962|565916192|FG001|Overall Study|Physician Decision|0|||
156771181|NCT04810962|565916191|FG000|Overall Study|Withdrawal by Subject|1|||
156771182|NCT04810962|565916192|FG001|Overall Study|Withdrawal by Subject|3|||
156771183|NCT04810962|565916191|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
156771184|NCT04810962|565916192|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
156771185|NCT03620162|565916193|FG000|Overall Study|Physician Decision|4|||
156771186|NCT03620162|565916194|FG001|Overall Study|Physician Decision|0|||
156771187|NCT03620162|565916195|FG002|Overall Study|Physician Decision|1|||
156771188|NCT03620162|565916196|FG003|Overall Study|Physician Decision|0|||
156771189|NCT03620162|565916197|FG004|Overall Study|Physician Decision|2|||
156771190|NCT03620162|565916193|FG000|Overall Study|Lost to Follow-up|2|||
156771191|NCT03620162|565916194|FG001|Overall Study|Lost to Follow-up|6|||
156771192|NCT03620162|565916195|FG002|Overall Study|Lost to Follow-up|7|||
156771193|NCT03620162|565916196|FG003|Overall Study|Lost to Follow-up|3|||
156771194|NCT03620162|565916197|FG004|Overall Study|Lost to Follow-up|2|||
156771195|NCT03620162|565916193|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
156771196|NCT03620162|565916194|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
156771197|NCT03620162|565916195|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
156771198|NCT03620162|565916196|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
156771199|NCT03620162|565916197|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
156771200|NCT04009837|565916201|FG000|Overall Study|Withdrawal by Subject|5|||
156771201|NCT04009837|565916202|FG001|Overall Study|Withdrawal by Subject|4|||
156771202|NCT04009837|565916201|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
156771203|NCT04009837|565916202|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
156771204|NCT05352815|565916204|FG000|Overall Study|Withdrawal by Subject|28|||
156771205|NCT05352815|565916205|FG001|Overall Study|Withdrawal by Subject|24|||
156771206|NCT05352815|565916204|FG000|Overall Study|Lost to Follow-up|4|||
156771207|NCT05352815|565916205|FG001|Overall Study|Lost to Follow-up|7|||
156771208|NCT05352815|565916204|FG000|Overall Study|Death|2|||
156771209|NCT05352815|565916205|FG001|Overall Study|Death|3|||
156771210|NCT05352815|565916204|FG000|Overall Study|Site closure|1|||
156771211|NCT05352815|565916205|FG001|Overall Study|Site closure|0|||
156771212|NCT00226655|565916206|FG000|Overall Study|Death|13|||
156771213|NCT00226655|565916206|FG000|Overall Study|Withdrawal by Subject|15|||
156771214|NCT00226655|565916206|FG000|Overall Study|Adverse Event|35|||
156771215|NCT00226655|565916206|FG000|Overall Study|Physician Decision|6|||
156771216|NCT00226655|565916206|FG000|Overall Study|Clinical deterioration|10|||
156771217|NCT05144945|565916207|FG000|Overall Study|Withdrawal by Subject|1|||
156771218|NCT05144945|565916208|FG001|Overall Study|Withdrawal by Subject|0|||
156771219|NCT04530552|565916212|FG000|Overall Study|Physician Decision|0|||
156771220|NCT04530552|565916213|FG001|Overall Study|Physician Decision|1|||
156771221|NCT04530552|565916212|FG000|Overall Study|Withdrawal by Subject|0|||
156771222|NCT04530552|565916213|FG001|Overall Study|Withdrawal by Subject|1|||
156771223|NCT04530552|565916212|FG000|Overall Study|Adverse Event|0|||
156771224|NCT04530552|565916213|FG001|Overall Study|Adverse Event|1|||
156771225|NCT04530552|565916212|FG000|Overall Study|No surgery|0|||
156771226|NCT04530552|565916213|FG001|Overall Study|No surgery|1|||
156771227|NCT02855268|565916214|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
156771228|NCT02855268|565916215|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
156771229|NCT02855268|565916214|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
156771230|NCT02855268|565916215|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
156771231|NCT02855268|565916214|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
156771232|NCT02855268|565916215|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
156771233|NCT02855268|565916214|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
156771234|NCT02855268|565916215|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
156771235|NCT02855268|565916214|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
156771236|NCT02855268|565916215|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
156771237|NCT02855268|565916214|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
156771238|NCT02855268|565916215|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
156771239|NCT00465517|565916216|FG000|Overall Study|Adverse Event|7|||
156771240|NCT00465517|565916217|FG001|Overall Study|Adverse Event|3|||
156771241|NCT00465517|565916216|FG000|Overall Study|Lost to Follow-up|1|||
156771242|NCT00465517|565916217|FG001|Overall Study|Lost to Follow-up|0|||
156771243|NCT00465517|565916216|FG000|Overall Study|Withdrawal by Subject|4|||
156771244|NCT00465517|565916217|FG001|Overall Study|Withdrawal by Subject|1|||
156771245|NCT00726609|565916228|FG000|Overall Study|Adverse Event|10|||
156771246|NCT00726609|565916228|FG000|Overall Study|Withdrawal by Subject|2|||
156771247|NCT00726609|565916228|FG000|Overall Study|Lack of Efficacy|25|||
156771248|NCT00726609|565916228|FG000|Overall Study|Other|16|||
156771249|NCT00726609|565916228|FG000|Overall Study|Missing|42|||
156771250|NCT00726609|565916228|FG000|Overall Study|Other|3|||
156771251|NCT02029417|565916231|FG000|Overall Study|Death|1|||
156771252|NCT02029417|565916231|FG000|Overall Study|Adverse Event|1|||
156771253|NCT00071981|565916232|FG000|Overall Study|Lack of Efficacy|37|||
156771254|NCT00071981|565916233|FG001|Overall Study|Lack of Efficacy|29|||
156771255|NCT00071981|565916234|FG002|Overall Study|Lack of Efficacy|30|||
156771256|NCT00071981|565916235|FG003|Overall Study|Lack of Efficacy|43|||
156771257|NCT00071981|565916232|FG000|Overall Study|Adverse Event|4|||
156771258|NCT00071981|565916233|FG001|Overall Study|Adverse Event|4|||
156771259|NCT00071981|565916234|FG002|Overall Study|Adverse Event|3|||
156771260|NCT00071981|565916235|FG003|Overall Study|Adverse Event|1|||
156771261|NCT00071981|565916232|FG000|Overall Study|Death|0|||
156771262|NCT00071981|565916233|FG001|Overall Study|Death|0|||
156771263|NCT00071981|565916234|FG002|Overall Study|Death|1|||
156771264|NCT00071981|565916235|FG003|Overall Study|Death|1|||
156771265|NCT00071981|565916232|FG000|Overall Study|Withdrawal by Subject|3|||
156771266|NCT00071981|565916233|FG001|Overall Study|Withdrawal by Subject|1|||
156771267|NCT00071981|565916234|FG002|Overall Study|Withdrawal by Subject|0|||
156771268|NCT00071981|565916235|FG003|Overall Study|Withdrawal by Subject|0|||
156771269|NCT00071981|565916232|FG000|Overall Study|No protocol therapy|2|||
156771270|NCT00071981|565916233|FG001|Overall Study|No protocol therapy|5|||
156771271|NCT00071981|565916234|FG002|Overall Study|No protocol therapy|1|||
156771272|NCT00071981|565916235|FG003|Overall Study|No protocol therapy|0|||
156771273|NCT00071981|565916232|FG000|Overall Study|others (not specified in the study)|0|||
156771274|NCT00071981|565916233|FG001|Overall Study|others (not specified in the study)|2|||
156771275|NCT00071981|565916234|FG002|Overall Study|others (not specified in the study)|2|||
156771276|NCT00071981|565916235|FG003|Overall Study|others (not specified in the study)|0|||
156771277|NCT00465179|565916238|FG000|Overall Study|Adverse Event|4|||
156771278|NCT00465179|565916238|FG000|Overall Study|Withdrawal by Subject|2|||
156771279|NCT00465179|565916238|FG000|Overall Study|Progression of Disease|47|||
156771280|NCT00833755|565916242|FG000|Overall Study|Physician Decision|4|||
156771281|NCT00833755|565916243|FG001|Overall Study|Physician Decision|4|||
156771282|NCT00833755|565916244|FG002|Overall Study|Physician Decision|2|||
156771283|NCT00833755|565916245|FG003|Overall Study|Physician Decision|6|||
156771284|NCT00833755|565916242|FG000|Overall Study|Subject had scheduling issues|0|||
156771285|NCT00833755|565916243|FG001|Overall Study|Subject had scheduling issues|1|||
156771286|NCT00833755|565916244|FG002|Overall Study|Subject had scheduling issues|0|||
156771287|NCT00833755|565916245|FG003|Overall Study|Subject had scheduling issues|0|||
156771288|NCT00262925|565916246|FG000|Overall Study|Lack of Efficacy|3|||
156771289|NCT00262925|565916246|FG000|Overall Study|Adverse Event|4|||
156771290|NCT00262925|565916246|FG000|Overall Study|Death|2|||
156771291|NCT00262925|565916246|FG000|Overall Study|alternative therapy|1|||
156771292|NCT00262925|565916246|FG000|Overall Study|Other|1|||
156771293|NCT00560404|565916248|FG000|Overall Study|Adverse Event|2|||
156771294|NCT00560404|565916249|FG001|Overall Study|Adverse Event|3|||
156771295|NCT00560404|565916248|FG000|Overall Study|Death|3|||
156771296|NCT00560404|565916249|FG001|Overall Study|Death|3|||
156771297|NCT00560404|565916248|FG000|Overall Study|Protocol Violation|12|||
156771298|NCT00560404|565916249|FG001|Overall Study|Protocol Violation|7|||
156771299|NCT00560404|565916248|FG000|Overall Study|Administrative Reasons|1|||
156771300|NCT00560404|565916249|FG001|Overall Study|Administrative Reasons|1|||
156771301|NCT00560404|565916248|FG000|Overall Study|Withdrew Consent|4|||
156771302|NCT00560404|565916249|FG001|Overall Study|Withdrew Consent|0|||
156771303|NCT00560404|565916248|FG000|Overall Study|Failure to return|1|||
156771304|NCT00560404|565916249|FG001|Overall Study|Failure to return|2|||
156771305|NCT00560404|565916248|FG000|Overall Study|Other withdrawal reason|13|||
156771306|NCT00560404|565916249|FG001|Overall Study|Other withdrawal reason|5|||
156771307|NCT02642042|565916250|FG000|Overall Study|Adverse Event|22|||
156771308|NCT02642042|565916250|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156771309|NCT02642042|565916250|FG000|Overall Study|Progression/Relapse|28|||
156771310|NCT02642042|565916250|FG000|Overall Study|Death|1|||
156771311|NCT02642042|565916250|FG000|Overall Study|Not Protocol Specified|2|||
156771312|NCT03260023|565916251|FG000|Overall Study|Adverse Event|0|||
156771313|NCT03260023|565916252|FG001|Overall Study|Adverse Event|0|||
156771314|NCT03260023|565916253|FG002|Overall Study|Adverse Event|4|||
156771315|NCT03260023|565916254|FG003|Overall Study|Adverse Event|4|||
156771316|NCT03260023|565916255|FG004|Overall Study|Adverse Event|4|||
156771317|NCT03260023|565916256|FG005|Overall Study|Adverse Event|1|||
156771318|NCT03260023|565916257|FG006|Overall Study|Adverse Event|2|||
156771319|NCT03260023|565916251|FG000|Overall Study|Clinical Progression|0|||
156771320|NCT03260023|565916252|FG001|Overall Study|Clinical Progression|1|||
156771321|NCT03260023|565916253|FG002|Overall Study|Clinical Progression|3|||
156771322|NCT03260023|565916254|FG003|Overall Study|Clinical Progression|1|||
156771323|NCT03260023|565916255|FG004|Overall Study|Clinical Progression|0|||
156771324|NCT03260023|565916256|FG005|Overall Study|Clinical Progression|0|||
156771325|NCT03260023|565916257|FG006|Overall Study|Clinical Progression|0|||
156771326|NCT03260023|565916251|FG000|Overall Study|Physician Decision|0|||
156771327|NCT03260023|565916252|FG001|Overall Study|Physician Decision|0|||
156771328|NCT03260023|565916253|FG002|Overall Study|Physician Decision|0|||
156771329|NCT03260023|565916254|FG003|Overall Study|Physician Decision|1|||
156771330|NCT03260023|565916255|FG004|Overall Study|Physician Decision|1|||
156771331|NCT03260023|565916256|FG005|Overall Study|Physician Decision|0|||
156771332|NCT03260023|565916257|FG006|Overall Study|Physician Decision|0|||
156771333|NCT03260023|565916251|FG000|Overall Study|Withdrawal by Subject|0|||
156771334|NCT03260023|565916252|FG001|Overall Study|Withdrawal by Subject|0|||
156771335|NCT03260023|565916253|FG002|Overall Study|Withdrawal by Subject|0|||
156771336|NCT03260023|565916254|FG003|Overall Study|Withdrawal by Subject|0|||
156771337|NCT03260023|565916255|FG004|Overall Study|Withdrawal by Subject|3|||
156771338|NCT03260023|565916256|FG005|Overall Study|Withdrawal by Subject|0|||
156771339|NCT03260023|565916257|FG006|Overall Study|Withdrawal by Subject|0|||
156771340|NCT03260023|565916251|FG000|Overall Study|Under trial intervention|0|||
156771341|NCT03260023|565916252|FG001|Overall Study|Under trial intervention|0|||
156771342|NCT03260023|565916253|FG002|Overall Study|Under trial intervention|2|||
156771343|NCT03260023|565916254|FG003|Overall Study|Under trial intervention|5|||
156771344|NCT03260023|565916255|FG004|Overall Study|Under trial intervention|3|||
156771345|NCT03260023|565916256|FG005|Overall Study|Under trial intervention|0|||
156771346|NCT03260023|565916257|FG006|Overall Study|Under trial intervention|0|||
156771347|NCT05035407|565916260|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
156771348|NCT05035407|565916261|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771349|NCT05035407|565916262|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771350|NCT05035407|565916263|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771351|NCT05035407|565916264|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771352|NCT05035407|565916265|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771353|NCT04220021|565916266|FG000|Overall Study|Withdrawal by Subject|11|||
156771354|NCT04220021|565916266|FG000|Overall Study|Physician Decision|2|||
156771355|NCT04220021|565916266|FG000|Overall Study|Non-study related illness|5|||
156771356|NCT04513366|565916267|FG000|Treatment Phase|Withdrawal by Subject|6|||
156771357|NCT04513366|565916268|FG001|Treatment Phase|Withdrawal by Subject|8|||
156771358|NCT04513366|565916269|FG002|Treatment Phase|Withdrawal by Subject|3|||
156771359|NCT04513366|565916267|FG000|Treatment Phase|Lost to Follow-up|1|||
156771360|NCT04513366|565916268|FG001|Treatment Phase|Lost to Follow-up|2|||
156771361|NCT04513366|565916269|FG002|Treatment Phase|Lost to Follow-up|5|||
156771362|NCT04513366|565916267|FG000|Treatment Phase|Other than Specified|1|||
156771363|NCT04513366|565916268|FG001|Treatment Phase|Other than Specified|0|||
156771364|NCT04513366|565916269|FG002|Treatment Phase|Other than Specified|2|||
156771365|NCT04513366|565916267|FG000|Treatment Phase|Physician Decision|2|||
156771366|NCT04513366|565916268|FG001|Treatment Phase|Physician Decision|0|||
156771367|NCT04513366|565916269|FG002|Treatment Phase|Physician Decision|0|||
156771368|NCT04513366|565916267|FG000|Treatment Phase|Adverse Event|0|||
156771369|NCT04513366|565916268|FG001|Treatment Phase|Adverse Event|1|||
156771370|NCT04513366|565916269|FG002|Treatment Phase|Adverse Event|1|||
156771371|NCT04513366|565916267|FG000|Extension Phase|Withdrawal by Subject|3|||
156771372|NCT04513366|565916268|FG001|Extension Phase|Withdrawal by Subject|1|||
156771373|NCT04513366|565916269|FG002|Extension Phase|Withdrawal by Subject|1|||
156771374|NCT04513366|565916267|FG000|Extension Phase|Other than Specified|4|||
156771375|NCT04513366|565916268|FG001|Extension Phase|Other than Specified|0|||
156771376|NCT04513366|565916269|FG002|Extension Phase|Other than Specified|1|||
156771377|NCT04513366|565916267|FG000|Extension Phase|Lost to Follow-up|1|||
156771378|NCT04513366|565916268|FG001|Extension Phase|Lost to Follow-up|1|||
156771379|NCT04513366|565916269|FG002|Extension Phase|Lost to Follow-up|1|||
156771380|NCT04513366|565916267|FG000|Extension Phase|Sponsor Decision|0|||
156771381|NCT04513366|565916268|FG001|Extension Phase|Sponsor Decision|1|||
156771382|NCT04513366|565916269|FG002|Extension Phase|Sponsor Decision|0|||
156771383|NCT04513366|565916267|FG000|Extension Phase|Death|0|||
156771384|NCT04513366|565916268|FG001|Extension Phase|Death|1|||
156771385|NCT04513366|565916269|FG002|Extension Phase|Death|0|||
156771386|NCT04513366|565916267|FG000|Extension Phase|Adverse Event|0|||
156771387|NCT04513366|565916268|FG001|Extension Phase|Adverse Event|0|||
156771388|NCT04513366|565916269|FG002|Extension Phase|Adverse Event|1|||
156771389|NCT02187783|565916270|FG000|Overall Study|Adverse Event|8|||
156771390|NCT02187783|565916270|FG000|Overall Study|Death|3|||
156771391|NCT02187783|565916270|FG000|Overall Study|Progressive disease|80|||
156771392|NCT02187783|565916270|FG000|Overall Study|Protocol Violation|3|||
156771393|NCT02187783|565916270|FG000|Overall Study|Physician Decision|2|||
156771394|NCT02187783|565916270|FG000|Overall Study|Withdrawal by Subject|9|||
156771395|NCT02187783|565916270|FG000|Overall Study|Study terminated by sponsor|1|||
156771396|NCT00171249|565916271|FG000|Overall Study|Withdrawal by Subject|2|||
156771397|NCT00171249|565916272|FG001|Overall Study|Withdrawal by Subject|0|||
156771398|NCT00171249|565916273|FG002|Overall Study|Withdrawal by Subject|0|||
156771399|NCT00171249|565916274|FG003|Overall Study|Withdrawal by Subject|6|||
156771400|NCT00171249|565916275|FG004|Overall Study|Withdrawal by Subject|0|||
156771401|NCT00171249|565916276|FG005|Overall Study|Withdrawal by Subject|0|||
156771402|NCT00171249|565916277|FG006|Overall Study|Withdrawal by Subject|0|||
156771403|NCT00171249|565916271|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
156771404|NCT00171249|565916272|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156771405|NCT00171249|565916273|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
156771406|NCT00171249|565916274|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
156771407|NCT00171249|565916275|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156771408|NCT00171249|565916276|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
156771409|NCT00171249|565916277|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
156771410|NCT00171249|565916271|FG000|Overall Study|Death|7|||
156771411|NCT00171249|565916272|FG001|Overall Study|Death|1|||
156771412|NCT00171249|565916273|FG002|Overall Study|Death|0|||
156771413|NCT00171249|565916274|FG003|Overall Study|Death|4|||
156771414|NCT00171249|565916275|FG004|Overall Study|Death|0|||
156771415|NCT00171249|565916276|FG005|Overall Study|Death|3|||
156771416|NCT00171249|565916277|FG006|Overall Study|Death|1|||
156523439|NCT02054520|565009581|FG001|Overall Study|Physician Decision|1|||
156771417|NCT00171249|565916271|FG000|Overall Study|Other|10|||
156771418|NCT00171249|565916272|FG001|Overall Study|Other|0|||
156771419|NCT00171249|565916273|FG002|Overall Study|Other|0|||
156771420|NCT00171249|565916274|FG003|Overall Study|Other|43|||
156771421|NCT00171249|565916275|FG004|Overall Study|Other|0|||
156771422|NCT00171249|565916276|FG005|Overall Study|Other|2|||
156771423|NCT00171249|565916277|FG006|Overall Study|Other|0|||
156771424|NCT00171249|565916271|FG000|Overall Study|No Longer Requires Study Drug|4|||
156771425|NCT00171249|565916272|FG001|Overall Study|No Longer Requires Study Drug|0|||
156771426|NCT00171249|565916273|FG002|Overall Study|No Longer Requires Study Drug|0|||
156771427|NCT00171249|565916274|FG003|Overall Study|No Longer Requires Study Drug|3|||
156771428|NCT00171249|565916275|FG004|Overall Study|No Longer Requires Study Drug|0|||
156771429|NCT00171249|565916276|FG005|Overall Study|No Longer Requires Study Drug|5|||
156771430|NCT00171249|565916277|FG006|Overall Study|No Longer Requires Study Drug|0|||
156771431|NCT00171249|565916271|FG000|Overall Study|Administrative Problems|1|||
156771432|NCT00171249|565916272|FG001|Overall Study|Administrative Problems|0|||
156771433|NCT00171249|565916273|FG002|Overall Study|Administrative Problems|0|||
156771434|NCT00171249|565916274|FG003|Overall Study|Administrative Problems|2|||
156771435|NCT00171249|565916275|FG004|Overall Study|Administrative Problems|0|||
156771436|NCT00171249|565916276|FG005|Overall Study|Administrative Problems|0|||
156771437|NCT00171249|565916277|FG006|Overall Study|Administrative Problems|0|||
156771438|NCT00171249|565916271|FG000|Overall Study|Adverse Event|3|||
156771439|NCT00171249|565916272|FG001|Overall Study|Adverse Event|1|||
156771440|NCT00171249|565916273|FG002|Overall Study|Adverse Event|0|||
156771441|NCT00171249|565916274|FG003|Overall Study|Adverse Event|15|||
156771442|NCT00171249|565916275|FG004|Overall Study|Adverse Event|0|||
156771443|NCT00171249|565916276|FG005|Overall Study|Adverse Event|2|||
156771444|NCT00171249|565916277|FG006|Overall Study|Adverse Event|0|||
156771445|NCT00171249|565916271|FG000|Overall Study|Lost to Follow-up|5|||
156771446|NCT00171249|565916272|FG001|Overall Study|Lost to Follow-up|0|||
156771447|NCT00171249|565916273|FG002|Overall Study|Lost to Follow-up|0|||
156771448|NCT00171249|565916274|FG003|Overall Study|Lost to Follow-up|9|||
156771449|NCT00171249|565916275|FG004|Overall Study|Lost to Follow-up|0|||
156771450|NCT00171249|565916276|FG005|Overall Study|Lost to Follow-up|0|||
156771451|NCT00171249|565916277|FG006|Overall Study|Lost to Follow-up|0|||
156771452|NCT02908347|565916278|FG000|Overall Study|Adverse Event|0|||
156771453|NCT02908347|565916279|FG001|Overall Study|Adverse Event|1|||
156771454|NCT02908347|565916278|FG000|Overall Study|Lost to Follow-up|1|||
156771455|NCT02908347|565916279|FG001|Overall Study|Lost to Follow-up|0|||
156771456|NCT03344757|565916280|FG000|Overall Study|Withdrawal by Subject|18|||
156771457|NCT03344757|565916281|FG001|Overall Study|Withdrawal by Subject|16|||
156771458|NCT03344757|565916280|FG000|Overall Study|Lost to Follow-up|0|||
156771459|NCT03344757|565916281|FG001|Overall Study|Lost to Follow-up|2|||
156771460|NCT01832766|565916282|FG000|Washout|Lost to Follow-up|0|||
156771461|NCT01832766|565916283|FG001|Washout|Lost to Follow-up|1|||
156771462|NCT00764790|565916286|FG000|Overall Study|Protocol Violation|0|||
156771463|NCT00764790|565916287|FG001|Overall Study|Protocol Violation|0|||
156771464|NCT00764790|565916288|FG002|Overall Study|Protocol Violation|1|||
156771465|NCT00764790|565916286|FG000|Overall Study|Withdrawal by Subject|10|||
156771466|NCT00764790|565916287|FG001|Overall Study|Withdrawal by Subject|12|||
156771467|NCT00764790|565916288|FG002|Overall Study|Withdrawal by Subject|6|||
156771468|NCT00764790|565916286|FG000|Overall Study|Lost to Follow-up|28|||
156771469|NCT00764790|565916287|FG001|Overall Study|Lost to Follow-up|29|||
156771470|NCT00764790|565916288|FG002|Overall Study|Lost to Follow-up|23|||
156771471|NCT02634710|565916293|FG000|Overall Study|Death|4|||
156771472|NCT04780659|565918095|FG000|Overall Study|Adverse event, serious fatal|3|||
156771473|NCT04780659|565918096|FG001|Overall Study|Adverse event, serious fatal|0|||
156771474|NCT04780659|565918095|FG000|Overall Study|Withdrawal by Subject|3|||
156771475|NCT04780659|565918096|FG001|Overall Study|Withdrawal by Subject|0|||
156771476|NCT04780659|565918095|FG000|Overall Study|Physician Decision|1|||
156771477|NCT04780659|565918096|FG001|Overall Study|Physician Decision|0|||
156771478|NCT04780659|565918095|FG000|Overall Study|Died in original disease|2|||
156771479|NCT04780659|565918096|FG001|Overall Study|Died in original disease|0|||
156771480|NCT04780659|565918095|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
156771481|NCT04780659|565918096|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
156771482|NCT05507437|565918097|FG000|Overall Study|Withdrawal by Subject|1|||
156771483|NCT05507437|565918098|FG001|Overall Study|Withdrawal by Subject|1|||
156771484|NCT05507437|565918097|FG000|Overall Study|Death|3|||
156771485|NCT05507437|565918098|FG001|Overall Study|Death|0|||
156771486|NCT06583096|565918099|FG000|Overall Study|Lost to Follow-up|4|||
156771487|NCT06583096|565918100|FG001|Overall Study|Lost to Follow-up|10|||
156771488|NCT06583096|565918099|FG000|Overall Study|Withdrawal by Subject|0|||
156771489|NCT06583096|565918100|FG001|Overall Study|Withdrawal by Subject|2|||
156771490|NCT03729362|565918101|FG000|Overall Study|Withdrawal by Subject|2|||
156771491|NCT03729362|565918102|FG001|Overall Study|Withdrawal by Subject|0|||
156771492|NCT03729362|565918101|FG000|Overall Study|Physician Decision|1|||
156523440|NCT02054520|565009582|FG002|Overall Study|Physician Decision|0|||
156771493|NCT03729362|565918102|FG001|Overall Study|Physician Decision|0|||
156771494|NCT03729362|565918101|FG000|Overall Study|COVID-19 Pandemic|1|||
156771495|NCT03729362|565918102|FG001|Overall Study|COVID-19 Pandemic|0|||
156771496|NCT03729362|565918101|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
156771497|NCT03729362|565918102|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
156771498|NCT03729362|565918101|FG000|Overall Study|Adverse Event|0|||
156771499|NCT03729362|565918102|FG001|Overall Study|Adverse Event|1|||
156771500|NCT03729362|565918101|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
156771501|NCT03729362|565918102|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
156771502|NCT03405870|565918103|FG000|Overall Study|Withdrawal|1|||
156771503|NCT03405870|565918104|FG001|Overall Study|Withdrawal|0|||
156771504|NCT03405870|565918105|FG002|Overall Study|Withdrawal|1|||
156771505|NCT03405870|565918106|FG003|Overall Study|Withdrawal|0|||
156771506|NCT03405870|565918107|FG004|Overall Study|Withdrawal|0|||
156771507|NCT03405870|565918108|FG005|Overall Study|Withdrawal|0|||
156771508|NCT03405870|565918109|FG006|Overall Study|Withdrawal|1|||
156771509|NCT03405870|565918110|FG007|Overall Study|Withdrawal|0|||
156771510|NCT00042289|565918111|FG000|Overall Study|Lost to Follow-up|3|||
156771511|NCT00042289|565918112|FG001|Overall Study|Lost to Follow-up|0|||
156771512|NCT00042289|565918113|FG002|Overall Study|Lost to Follow-up|0|||
156771513|NCT00042289|565918114|FG003|Overall Study|Lost to Follow-up|1|||
156771514|NCT00042289|565918115|FG004|Overall Study|Lost to Follow-up|3|||
156771515|NCT00042289|565918116|FG005|Overall Study|Lost to Follow-up|3|||
156771516|NCT00042289|565918117|FG006|Overall Study|Lost to Follow-up|6|||
156771517|NCT00042289|565918118|FG007|Overall Study|Lost to Follow-up|1|||
156771518|NCT00042289|565918119|FG008|Overall Study|Lost to Follow-up|1|||
156771519|NCT00042289|565918120|FG009|Overall Study|Lost to Follow-up|0|||
156771520|NCT00042289|565918121|FG010|Overall Study|Lost to Follow-up|0|||
156771521|NCT00042289|565918122|FG011|Overall Study|Lost to Follow-up|0|||
156771522|NCT00042289|565918123|FG012|Overall Study|Lost to Follow-up|0|||
156771523|NCT00042289|565918124|FG013|Overall Study|Lost to Follow-up|0|||
156771524|NCT00042289|565918125|FG014|Overall Study|Lost to Follow-up|0|||
156771525|NCT00042289|565918126|FG015|Overall Study|Lost to Follow-up|1|||
156771526|NCT00042289|565918127|FG016|Overall Study|Lost to Follow-up|1|||
156771527|NCT00042289|565918128|FG017|Overall Study|Lost to Follow-up|0|||
156771528|NCT00042289|565918129|FG018|Overall Study|Lost to Follow-up|3|||
156771529|NCT00042289|565918130|FG019|Overall Study|Lost to Follow-up|2|||
156771530|NCT00042289|565918131|FG020|Overall Study|Lost to Follow-up|0|||
156771531|NCT00042289|565918132|FG021|Overall Study|Lost to Follow-up|0|||
156771532|NCT00042289|565918133|FG022|Overall Study|Lost to Follow-up|0|||
156771533|NCT00042289|565918134|FG023|Overall Study|Lost to Follow-up|0|||
156771534|NCT00042289|565918135|FG024|Overall Study|Lost to Follow-up|0|||
156771535|NCT00042289|565918136|FG025|Overall Study|Lost to Follow-up|0|||
156771536|NCT00042289|565918137|FG026|Overall Study|Lost to Follow-up|2|||
156771537|NCT00042289|565918138|FG027|Overall Study|Lost to Follow-up|2|||
156771538|NCT00042289|565918139|FG028|Overall Study|Lost to Follow-up|2|||
156771539|NCT00042289|565918140|FG029|Overall Study|Lost to Follow-up|0|||
156771540|NCT00042289|565918141|FG030|Overall Study|Lost to Follow-up|0|||
156771541|NCT00042289|565918142|FG031|Overall Study|Lost to Follow-up|2|||
156771542|NCT00042289|565918143|FG032|Overall Study|Lost to Follow-up|1|||
156771543|NCT00042289|565918144|FG033|Overall Study|Lost to Follow-up|1|||
156771544|NCT00042289|565918145|FG034|Overall Study|Lost to Follow-up|1|||
156771545|NCT00042289|565918146|FG035|Overall Study|Lost to Follow-up|2|||
156771546|NCT00042289|565918147|FG036|Overall Study|Lost to Follow-up|1|||
156771547|NCT00042289|565918148|FG037|Overall Study|Lost to Follow-up|1|||
156771548|NCT00042289|565918149|FG038|Overall Study|Lost to Follow-up|0|||
156771549|NCT00042289|565918150|FG039|Overall Study|Lost to Follow-up|5|||
156771550|NCT00042289|565918151|FG040|Overall Study|Lost to Follow-up|0|||
156771551|NCT00042289|565918152|FG041|Overall Study|Lost to Follow-up|2|||
156771552|NCT00042289|565918153|FG042|Overall Study|Lost to Follow-up|2|||
156771553|NCT00042289|565918154|FG043|Overall Study|Lost to Follow-up|0|||
156771554|NCT00042289|565918155|FG044|Overall Study|Lost to Follow-up|0|||
156771555|NCT00042289|565918156|FG045|Overall Study|Lost to Follow-up|1|||
156771556|NCT00042289|565918157|FG046|Overall Study|Lost to Follow-up|0|||
156771557|NCT00042289|565918111|FG000|Overall Study|Other reason|0|||
156771558|NCT00042289|565918112|FG001|Overall Study|Other reason|0|||
156771559|NCT00042289|565918113|FG002|Overall Study|Other reason|0|||
156771560|NCT00042289|565918114|FG003|Overall Study|Other reason|2|||
156771561|NCT00042289|565918115|FG004|Overall Study|Other reason|0|||
156771562|NCT00042289|565918116|FG005|Overall Study|Other reason|0|||
156771563|NCT00042289|565918117|FG006|Overall Study|Other reason|0|||
156771564|NCT00042289|565918118|FG007|Overall Study|Other reason|0|||
156771565|NCT00042289|565918119|FG008|Overall Study|Other reason|0|||
156771566|NCT00042289|565918120|FG009|Overall Study|Other reason|0|||
156771567|NCT00042289|565918121|FG010|Overall Study|Other reason|0|||
156771568|NCT00042289|565918122|FG011|Overall Study|Other reason|0|||
156771569|NCT00042289|565918123|FG012|Overall Study|Other reason|0|||
156771570|NCT00042289|565918124|FG013|Overall Study|Other reason|0|||
156771571|NCT00042289|565918125|FG014|Overall Study|Other reason|0|||
156771572|NCT00042289|565918126|FG015|Overall Study|Other reason|0|||
156771573|NCT00042289|565918127|FG016|Overall Study|Other reason|0|||
156771574|NCT00042289|565918128|FG017|Overall Study|Other reason|0|||
156771575|NCT00042289|565918129|FG018|Overall Study|Other reason|1|||
156771576|NCT00042289|565918130|FG019|Overall Study|Other reason|0|||
156771577|NCT00042289|565918131|FG020|Overall Study|Other reason|0|||
156771578|NCT00042289|565918132|FG021|Overall Study|Other reason|0|||
156771579|NCT00042289|565918133|FG022|Overall Study|Other reason|0|||
156771580|NCT00042289|565918134|FG023|Overall Study|Other reason|1|||
156523441|NCT02054520|565009583|FG003|Overall Study|Physician Decision|1|||
156771581|NCT00042289|565918135|FG024|Overall Study|Other reason|0|||
156771582|NCT00042289|565918136|FG025|Overall Study|Other reason|0|||
156771583|NCT00042289|565918137|FG026|Overall Study|Other reason|1|||
156771584|NCT00042289|565918138|FG027|Overall Study|Other reason|0|||
156771585|NCT00042289|565918139|FG028|Overall Study|Other reason|3|||
156771586|NCT00042289|565918140|FG029|Overall Study|Other reason|0|||
156771587|NCT00042289|565918141|FG030|Overall Study|Other reason|0|||
156771588|NCT00042289|565918142|FG031|Overall Study|Other reason|1|||
156523442|NCT02054520|565009584|FG004|Overall Study|Physician Decision|0|||
156523443|NCT02054520|565009585|FG005|Overall Study|Physician Decision|1|||
156523444|NCT02054520|565009580|FG000|Overall Study|Study terminated by Sponsor|0|||
156523445|NCT02054520|565009581|FG001|Overall Study|Study terminated by Sponsor|0|||
156523446|NCT02054520|565009582|FG002|Overall Study|Study terminated by Sponsor|2|||
156771589|NCT00042289|565918143|FG032|Overall Study|Other reason|0|||
156771590|NCT00042289|565918144|FG033|Overall Study|Other reason|1|||
156771591|NCT00042289|565918145|FG034|Overall Study|Other reason|0|||
156771592|NCT00042289|565918146|FG035|Overall Study|Other reason|2|||
156771593|NCT00042289|565918147|FG036|Overall Study|Other reason|0|||
156771594|NCT00042289|565918148|FG037|Overall Study|Other reason|0|||
156771595|NCT00042289|565918149|FG038|Overall Study|Other reason|0|||
156771596|NCT00042289|565918150|FG039|Overall Study|Other reason|0|||
156771597|NCT00042289|565918151|FG040|Overall Study|Other reason|0|||
156771598|NCT00042289|565918152|FG041|Overall Study|Other reason|0|||
156771599|NCT00042289|565918153|FG042|Overall Study|Other reason|0|||
156771600|NCT00042289|565918154|FG043|Overall Study|Other reason|1|||
156771601|NCT00042289|565918155|FG044|Overall Study|Other reason|0|||
156771602|NCT00042289|565918156|FG045|Overall Study|Other reason|0|||
156771603|NCT00042289|565918157|FG046|Overall Study|Other reason|0|||
156771604|NCT00042289|565918111|FG000|Overall Study|Severe debilitation, unable to continue|0|||
156771605|NCT00042289|565918112|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156771606|NCT00042289|565918113|FG002|Overall Study|Severe debilitation, unable to continue|0|||
156771607|NCT00042289|565918114|FG003|Overall Study|Severe debilitation, unable to continue|0|||
156771608|NCT00042289|565918115|FG004|Overall Study|Severe debilitation, unable to continue|0|||
156771609|NCT00042289|565918116|FG005|Overall Study|Severe debilitation, unable to continue|0|||
156771610|NCT00042289|565918117|FG006|Overall Study|Severe debilitation, unable to continue|0|||
156771611|NCT00042289|565918118|FG007|Overall Study|Severe debilitation, unable to continue|0|||
156771612|NCT00042289|565918119|FG008|Overall Study|Severe debilitation, unable to continue|0|||
156771613|NCT00042289|565918120|FG009|Overall Study|Severe debilitation, unable to continue|0|||
156771614|NCT00042289|565918121|FG010|Overall Study|Severe debilitation, unable to continue|0|||
156771615|NCT00042289|565918122|FG011|Overall Study|Severe debilitation, unable to continue|0|||
156771616|NCT00042289|565918123|FG012|Overall Study|Severe debilitation, unable to continue|0|||
156771617|NCT00042289|565918124|FG013|Overall Study|Severe debilitation, unable to continue|0|||
156771618|NCT00042289|565918125|FG014|Overall Study|Severe debilitation, unable to continue|0|||
156771619|NCT00042289|565918126|FG015|Overall Study|Severe debilitation, unable to continue|0|||
156771620|NCT00042289|565918127|FG016|Overall Study|Severe debilitation, unable to continue|0|||
156771621|NCT00042289|565918128|FG017|Overall Study|Severe debilitation, unable to continue|0|||
156771622|NCT00042289|565918129|FG018|Overall Study|Severe debilitation, unable to continue|0|||
156771623|NCT00042289|565918130|FG019|Overall Study|Severe debilitation, unable to continue|0|||
156771624|NCT00042289|565918131|FG020|Overall Study|Severe debilitation, unable to continue|0|||
156771625|NCT00042289|565918132|FG021|Overall Study|Severe debilitation, unable to continue|1|||
156771626|NCT00042289|565918133|FG022|Overall Study|Severe debilitation, unable to continue|0|||
156771627|NCT00042289|565918134|FG023|Overall Study|Severe debilitation, unable to continue|1|||
156771628|NCT00042289|565918135|FG024|Overall Study|Severe debilitation, unable to continue|0|||
156771629|NCT00042289|565918136|FG025|Overall Study|Severe debilitation, unable to continue|0|||
156771630|NCT00042289|565918137|FG026|Overall Study|Severe debilitation, unable to continue|0|||
156771631|NCT00042289|565918138|FG027|Overall Study|Severe debilitation, unable to continue|1|||
156771632|NCT00042289|565918139|FG028|Overall Study|Severe debilitation, unable to continue|0|||
156771633|NCT00042289|565918140|FG029|Overall Study|Severe debilitation, unable to continue|0|||
156771634|NCT00042289|565918141|FG030|Overall Study|Severe debilitation, unable to continue|0|||
156771635|NCT00042289|565918142|FG031|Overall Study|Severe debilitation, unable to continue|1|||
156771636|NCT00042289|565918143|FG032|Overall Study|Severe debilitation, unable to continue|1|||
156771637|NCT00042289|565918144|FG033|Overall Study|Severe debilitation, unable to continue|0|||
156771638|NCT00042289|565918145|FG034|Overall Study|Severe debilitation, unable to continue|0|||
156771639|NCT00042289|565918146|FG035|Overall Study|Severe debilitation, unable to continue|0|||
156771640|NCT00042289|565918147|FG036|Overall Study|Severe debilitation, unable to continue|0|||
156771641|NCT00042289|565918148|FG037|Overall Study|Severe debilitation, unable to continue|0|||
156771642|NCT00042289|565918149|FG038|Overall Study|Severe debilitation, unable to continue|0|||
156771643|NCT00042289|565918150|FG039|Overall Study|Severe debilitation, unable to continue|0|||
156771644|NCT00042289|565918151|FG040|Overall Study|Severe debilitation, unable to continue|0|||
156771645|NCT00042289|565918152|FG041|Overall Study|Severe debilitation, unable to continue|0|||
156771646|NCT00042289|565918153|FG042|Overall Study|Severe debilitation, unable to continue|0|||
156771647|NCT00042289|565918154|FG043|Overall Study|Severe debilitation, unable to continue|0|||
156771648|NCT00042289|565918155|FG044|Overall Study|Severe debilitation, unable to continue|0|||
156771649|NCT00042289|565918156|FG045|Overall Study|Severe debilitation, unable to continue|0|||
156771650|NCT00042289|565918157|FG046|Overall Study|Severe debilitation, unable to continue|0|||
156771651|NCT00042289|565918111|FG000|Overall Study|Site closed|0|||
156771652|NCT00042289|565918112|FG001|Overall Study|Site closed|0|||
156771653|NCT00042289|565918113|FG002|Overall Study|Site closed|0|||
156771654|NCT00042289|565918114|FG003|Overall Study|Site closed|0|||
156771655|NCT00042289|565918115|FG004|Overall Study|Site closed|0|||
156771656|NCT00042289|565918116|FG005|Overall Study|Site closed|0|||
156771657|NCT00042289|565918117|FG006|Overall Study|Site closed|0|||
156771658|NCT00042289|565918118|FG007|Overall Study|Site closed|0|||
156771659|NCT00042289|565918119|FG008|Overall Study|Site closed|0|||
156771660|NCT00042289|565918120|FG009|Overall Study|Site closed|0|||
156771661|NCT00042289|565918121|FG010|Overall Study|Site closed|0|||
156771662|NCT00042289|565918122|FG011|Overall Study|Site closed|0|||
156771663|NCT00042289|565918123|FG012|Overall Study|Site closed|0|||
156771664|NCT00042289|565918124|FG013|Overall Study|Site closed|0|||
156771665|NCT00042289|565918125|FG014|Overall Study|Site closed|0|||
156771666|NCT00042289|565918126|FG015|Overall Study|Site closed|0|||
156771667|NCT00042289|565918127|FG016|Overall Study|Site closed|0|||
156771668|NCT00042289|565918128|FG017|Overall Study|Site closed|0|||
156771669|NCT00042289|565918129|FG018|Overall Study|Site closed|0|||
156771670|NCT00042289|565918130|FG019|Overall Study|Site closed|0|||
156771671|NCT00042289|565918131|FG020|Overall Study|Site closed|0|||
156771672|NCT00042289|565918132|FG021|Overall Study|Site closed|0|||
156771673|NCT00042289|565918133|FG022|Overall Study|Site closed|0|||
156771674|NCT00042289|565918134|FG023|Overall Study|Site closed|0|||
156771675|NCT00042289|565918135|FG024|Overall Study|Site closed|0|||
156771676|NCT00042289|565918136|FG025|Overall Study|Site closed|0|||
156771677|NCT00042289|565918137|FG026|Overall Study|Site closed|0|||
156771678|NCT00042289|565918138|FG027|Overall Study|Site closed|0|||
156771679|NCT00042289|565918139|FG028|Overall Study|Site closed|0|||
156771680|NCT00042289|565918140|FG029|Overall Study|Site closed|0|||
156771681|NCT00042289|565918141|FG030|Overall Study|Site closed|0|||
156771682|NCT00042289|565918142|FG031|Overall Study|Site closed|3|||
156771683|NCT00042289|565918143|FG032|Overall Study|Site closed|0|||
156771684|NCT00042289|565918144|FG033|Overall Study|Site closed|0|||
156771685|NCT00042289|565918145|FG034|Overall Study|Site closed|0|||
156523447|NCT02054520|565009583|FG003|Overall Study|Study terminated by Sponsor|1|||
156523448|NCT02054520|565009584|FG004|Overall Study|Study terminated by Sponsor|0|||
156771686|NCT00042289|565918146|FG035|Overall Study|Site closed|0|||
156771687|NCT00042289|565918147|FG036|Overall Study|Site closed|1|||
156771688|NCT00042289|565918148|FG037|Overall Study|Site closed|0|||
156771689|NCT00042289|565918149|FG038|Overall Study|Site closed|0|||
156771690|NCT00042289|565918150|FG039|Overall Study|Site closed|0|||
156771691|NCT00042289|565918151|FG040|Overall Study|Site closed|0|||
156771692|NCT00042289|565918152|FG041|Overall Study|Site closed|0|||
156771693|NCT00042289|565918153|FG042|Overall Study|Site closed|1|||
156771694|NCT00042289|565918154|FG043|Overall Study|Site closed|0|||
156771695|NCT00042289|565918155|FG044|Overall Study|Site closed|0|||
156771696|NCT00042289|565918156|FG045|Overall Study|Site closed|0|||
156771697|NCT00042289|565918157|FG046|Overall Study|Site closed|0|||
156523449|NCT02054520|565009585|FG005|Overall Study|Study terminated by Sponsor|0|||
156523450|NCT02232243|565009586|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
156523451|NCT02232243|565009587|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
156523452|NCT02232243|565009588|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
156523453|NCT00490724|565009589|FG000|Period I|Physician Decision|0|||
156523454|NCT00490724|565009590|FG001|Period I|Physician Decision|0|||
156523455|NCT00490724|565009591|FG002|Period I|Physician Decision|1|||
156523456|NCT00490724|565009589|FG000|Period II|Treatment Discontinuation|3|||
156523457|NCT00490724|565009590|FG001|Period II|Treatment Discontinuation|1|||
156523458|NCT00490724|565009591|FG002|Period II|Treatment Discontinuation|3|||
156523459|NCT02457559|565009592|FG000|Overall Study|Progressive Disease|1|||
156523460|NCT02457559|565009593|FG001|Overall Study|Progressive Disease|2|||
156523461|NCT02457559|565009594|FG002|Overall Study|Progressive Disease|3|||
156523462|NCT02457559|565009595|FG003|Overall Study|Progressive Disease|0|||
156523463|NCT02457559|565009596|FG004|Overall Study|Progressive Disease|0|||
156523464|NCT02457559|565009597|FG005|Overall Study|Progressive Disease|2|||
156523465|NCT02457559|565009598|FG006|Overall Study|Progressive Disease|1|||
156523466|NCT02457559|565009599|FG007|Overall Study|Progressive Disease|0|||
156523467|NCT02457559|565009600|FG008|Overall Study|Progressive Disease|1|||
156523468|NCT02457559|565009601|FG009|Overall Study|Progressive Disease|1|||
156523469|NCT02457559|565009602|FG010|Overall Study|Progressive Disease|1|||
156523470|NCT02457559|565009592|FG000|Overall Study|Investigator's Discretion|0|||
156523471|NCT02457559|565009593|FG001|Overall Study|Investigator's Discretion|0|||
156523472|NCT02457559|565009594|FG002|Overall Study|Investigator's Discretion|2|||
156771698|NCT00042289|565918111|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
156771699|NCT00042289|565918112|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
156771700|NCT00042289|565918113|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
156771701|NCT00042289|565918114|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
156771702|NCT00042289|565918115|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
156771703|NCT00042289|565918116|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
156771704|NCT00042289|565918117|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
156771705|NCT00042289|565918118|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
156771706|NCT00042289|565918119|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
156771707|NCT00042289|565918120|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
156523473|NCT02457559|565009595|FG003|Overall Study|Investigator's Discretion|0|||
156523474|NCT02457559|565009596|FG004|Overall Study|Investigator's Discretion|1|||
156523475|NCT02457559|565009597|FG005|Overall Study|Investigator's Discretion|0|||
156523476|NCT02457559|565009598|FG006|Overall Study|Investigator's Discretion|1|||
156523477|NCT02457559|565009599|FG007|Overall Study|Investigator's Discretion|0|||
156523478|NCT02457559|565009600|FG008|Overall Study|Investigator's Discretion|1|||
156523479|NCT02457559|565009601|FG009|Overall Study|Investigator's Discretion|0|||
156523480|NCT02457559|565009602|FG010|Overall Study|Investigator's Discretion|1|||
156523481|NCT02457559|565009592|FG000|Overall Study|Adverse Event|0|||
156523482|NCT02457559|565009593|FG001|Overall Study|Adverse Event|1|||
156523483|NCT02457559|565009594|FG002|Overall Study|Adverse Event|2|||
156523484|NCT02457559|565009595|FG003|Overall Study|Adverse Event|0|||
156523485|NCT02457559|565009596|FG004|Overall Study|Adverse Event|0|||
156523486|NCT02457559|565009597|FG005|Overall Study|Adverse Event|0|||
156523487|NCT02457559|565009598|FG006|Overall Study|Adverse Event|0|||
156523488|NCT02457559|565009599|FG007|Overall Study|Adverse Event|0|||
156523489|NCT02457559|565009600|FG008|Overall Study|Adverse Event|0|||
156523490|NCT02457559|565009601|FG009|Overall Study|Adverse Event|0|||
156523491|NCT02457559|565009602|FG010|Overall Study|Adverse Event|0|||
156523492|NCT02457559|565009592|FG000|Overall Study|Reason not Specified|1|||
156523493|NCT02457559|565009593|FG001|Overall Study|Reason not Specified|0|||
156523494|NCT02457559|565009594|FG002|Overall Study|Reason not Specified|0|||
156523495|NCT02457559|565009595|FG003|Overall Study|Reason not Specified|0|||
156523496|NCT02457559|565009596|FG004|Overall Study|Reason not Specified|0|||
156523497|NCT02457559|565009597|FG005|Overall Study|Reason not Specified|0|||
156523498|NCT02457559|565009598|FG006|Overall Study|Reason not Specified|0|||
156523499|NCT02457559|565009599|FG007|Overall Study|Reason not Specified|0|||
156523500|NCT02457559|565009600|FG008|Overall Study|Reason not Specified|0|||
156523501|NCT02457559|565009601|FG009|Overall Study|Reason not Specified|2|||
156523502|NCT02457559|565009602|FG010|Overall Study|Reason not Specified|0|||
156523503|NCT02457559|565009592|FG000|Overall Study|Death|0|||
156523504|NCT02457559|565009593|FG001|Overall Study|Death|0|||
156523505|NCT02457559|565009594|FG002|Overall Study|Death|0|||
156523506|NCT02457559|565009595|FG003|Overall Study|Death|0|||
156523507|NCT02457559|565009596|FG004|Overall Study|Death|0|||
156523508|NCT02457559|565009597|FG005|Overall Study|Death|0|||
156523509|NCT02457559|565009598|FG006|Overall Study|Death|0|||
156523510|NCT02457559|565009599|FG007|Overall Study|Death|0|||
156523511|NCT02457559|565009600|FG008|Overall Study|Death|1|||
156523512|NCT02457559|565009601|FG009|Overall Study|Death|1|||
156523513|NCT02457559|565009602|FG010|Overall Study|Death|0|||
156523514|NCT03866473|565009607|FG000|Phase 1|Death|1|||
156523515|NCT03866473|565009608|FG001|Phase 1|Death|0|||
156523516|NCT03866473|565009607|FG000|Phase 2|Death|0|||
156523517|NCT03866473|565009608|FG001|Phase 2|Death|2|||
156523518|NCT03866473|565009607|FG000|Phase 2|Dropped|1|||
156523519|NCT03866473|565009608|FG001|Phase 2|Dropped|1|||
156523520|NCT03866473|565009607|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
156523521|NCT03866473|565009608|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
156523522|NCT05590884|565009609|FG000|Overall Study|Withdrawal by Subject|1|||
156523523|NCT05590884|565009610|FG001|Overall Study|Withdrawal by Subject|0|||
156523524|NCT05590884|565009611|FG002|Overall Study|Withdrawal by Subject|0|||
156523525|NCT04443153|565009616|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
156523526|NCT04443153|565009617|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
156523527|NCT04443153|565009616|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
156523528|NCT04443153|565009617|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
156523529|NCT04443153|565009616|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
156523530|NCT04443153|565009617|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
156523531|NCT04443153|565009616|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
156523532|NCT04443153|565009617|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
156771708|NCT00042289|565918121|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
156771709|NCT00042289|565918122|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
156771710|NCT00042289|565918123|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
156771711|NCT00042289|565918124|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
156771712|NCT00042289|565918125|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
156324049|NCT02428608|564286043|FG000|Overall Study|various|16|||
156324050|NCT00397943|564286044|FG000|Overall Study|Unspecified reasons|12|||
156324051|NCT00397943|564286045|FG001|Overall Study|Unspecified reasons|9|||
156324052|NCT00397943|564286046|FG002|Overall Study|Unspecified reasons|0|||
156324053|NCT00397943|564286047|FG003|Overall Study|Unspecified reasons|0|||
156523533|NCT03110224|565009621|FG000|Overall Study|Death|3|||
156523534|NCT03110224|565009621|FG000|Overall Study|Lost to Follow-up|132|||
156523535|NCT03110224|565009621|FG000|Overall Study|Physician Decision|2|||
156523536|NCT03110224|565009621|FG000|Overall Study|Site Closed by Physician|35|||
156523537|NCT03110224|565009621|FG000|Overall Study|Site Closed by Sponsor|202|||
156523538|NCT03110224|565009621|FG000|Overall Study|Withdrawal by Subject|9|||
156324054|NCT00397943|564286048|FG004|Overall Study|Unspecified reasons|0|||
156771713|NCT00042289|565918126|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
156771714|NCT00042289|565918127|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
156771715|NCT00042289|565918128|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
156771716|NCT00042289|565918129|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
156771717|NCT00042289|565918130|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
156771718|NCT00042289|565918131|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
156771719|NCT00042289|565918132|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
156771720|NCT00042289|565918133|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
156771721|NCT00042289|565918134|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
156771722|NCT00042289|565918135|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
156771723|NCT00042289|565918136|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
156771724|NCT00042289|565918137|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
156771725|NCT00042289|565918138|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
156771726|NCT00042289|565918139|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
156771727|NCT00042289|565918140|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
156771728|NCT00042289|565918141|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
156771729|NCT00042289|565918142|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
156771730|NCT00042289|565918143|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
156771731|NCT00042289|565918144|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
156771732|NCT00042289|565918145|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
156771733|NCT00042289|565918146|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
156771734|NCT00042289|565918147|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
156771735|NCT00042289|565918148|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
156771736|NCT00042289|565918149|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
156771737|NCT00042289|565918150|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
156771738|NCT00042289|565918151|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
156771739|NCT00042289|565918152|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
156771740|NCT00042289|565918153|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
156771741|NCT00042289|565918154|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
156771742|NCT00042289|565918155|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
156771743|NCT00042289|565918156|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
156771744|NCT00042289|565918157|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
156771745|NCT00042289|565918111|FG000|Overall Study|Protocol Violation|0|||
156771746|NCT00042289|565918112|FG001|Overall Study|Protocol Violation|0|||
156771747|NCT00042289|565918113|FG002|Overall Study|Protocol Violation|0|||
156771748|NCT00042289|565918114|FG003|Overall Study|Protocol Violation|0|||
156771749|NCT00042289|565918115|FG004|Overall Study|Protocol Violation|0|||
156771750|NCT00042289|565918116|FG005|Overall Study|Protocol Violation|1|||
156771751|NCT00042289|565918117|FG006|Overall Study|Protocol Violation|0|||
156771752|NCT00042289|565918118|FG007|Overall Study|Protocol Violation|1|||
156771753|NCT00042289|565918119|FG008|Overall Study|Protocol Violation|0|||
156324055|NCT04209426|564286049|FG000|Overall Study|Lost to Follow-up|3|||
156324056|NCT04209426|564286050|FG001|Overall Study|Lost to Follow-up|2|||
156324057|NCT01751802|564286060|FG000|Overall Study|Adverse Event|4|||
156324058|NCT01751802|564286061|FG001|Overall Study|Adverse Event|2|||
156324059|NCT01143207|564286062|FG000|Overall Study|Lost to Follow-up|2|||
156324060|NCT01466595|564286063|FG000|Overall Study|Withdrawal by Subject|0|||
156324061|NCT01466595|564286064|FG001|Overall Study|Withdrawal by Subject|1|||
156324062|NCT02376829|564286065|FG000|Overall Study|Withdrawal by Subject|27|||
156324063|NCT02376829|564286066|FG001|Overall Study|Withdrawal by Subject|44|||
156324064|NCT02117414|564286067|FG000|Overall Study|Death|5|||
156324065|NCT02117414|564286068|FG001|Overall Study|Death|2|||
156324066|NCT02117414|564286067|FG000|Overall Study|Withdrawal by Subject|10|||
156324067|NCT02117414|564286068|FG001|Overall Study|Withdrawal by Subject|4|||
156324068|NCT02663687|564286069|FG000|Overall Study|Adverse Event|1|||
156324069|NCT02663687|564286070|FG001|Overall Study|Adverse Event|0|||
156324070|NCT02663687|564286071|FG002|Overall Study|Adverse Event|0|||
156324071|NCT02663687|564286072|FG003|Overall Study|Adverse Event|0|||
156324072|NCT02663687|564286073|FG004|Overall Study|Adverse Event|0|||
156324073|NCT02663687|564286069|FG000|Overall Study|Other|1|||
156324074|NCT02663687|564286070|FG001|Overall Study|Other|0|||
156771754|NCT00042289|565918120|FG009|Overall Study|Protocol Violation|0|||
156771755|NCT00042289|565918121|FG010|Overall Study|Protocol Violation|0|||
156771756|NCT00042289|565918122|FG011|Overall Study|Protocol Violation|0|||
156771757|NCT00042289|565918123|FG012|Overall Study|Protocol Violation|0|||
156771758|NCT00042289|565918124|FG013|Overall Study|Protocol Violation|0|||
156324075|NCT02663687|564286071|FG002|Overall Study|Other|1|||
156324076|NCT02663687|564286072|FG003|Overall Study|Other|0|||
156324077|NCT02663687|564286073|FG004|Overall Study|Other|0|||
156324078|NCT00417482|564286074|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
156324079|NCT00417482|564286075|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
156771759|NCT00042289|565918125|FG014|Overall Study|Protocol Violation|0|||
156771760|NCT00042289|565918126|FG015|Overall Study|Protocol Violation|0|||
156771761|NCT00042289|565918127|FG016|Overall Study|Protocol Violation|0|||
156771762|NCT00042289|565918128|FG017|Overall Study|Protocol Violation|0|||
156771763|NCT00042289|565918129|FG018|Overall Study|Protocol Violation|0|||
156771764|NCT00042289|565918130|FG019|Overall Study|Protocol Violation|0|||
156771765|NCT00042289|565918131|FG020|Overall Study|Protocol Violation|0|||
156771766|NCT00042289|565918132|FG021|Overall Study|Protocol Violation|0|||
156771767|NCT00042289|565918133|FG022|Overall Study|Protocol Violation|0|||
156771768|NCT00042289|565918134|FG023|Overall Study|Protocol Violation|1|||
156771769|NCT00042289|565918135|FG024|Overall Study|Protocol Violation|1|||
156771770|NCT00042289|565918136|FG025|Overall Study|Protocol Violation|0|||
156771771|NCT00042289|565918137|FG026|Overall Study|Protocol Violation|2|||
156771772|NCT00042289|565918138|FG027|Overall Study|Protocol Violation|0|||
156771773|NCT00042289|565918139|FG028|Overall Study|Protocol Violation|0|||
156771774|NCT00042289|565918140|FG029|Overall Study|Protocol Violation|0|||
156771775|NCT00042289|565918141|FG030|Overall Study|Protocol Violation|1|||
156771776|NCT00042289|565918142|FG031|Overall Study|Protocol Violation|0|||
156771777|NCT00042289|565918143|FG032|Overall Study|Protocol Violation|0|||
156771778|NCT00042289|565918144|FG033|Overall Study|Protocol Violation|0|||
156771779|NCT00042289|565918145|FG034|Overall Study|Protocol Violation|0|||
156771780|NCT00042289|565918146|FG035|Overall Study|Protocol Violation|0|||
156771781|NCT00042289|565918147|FG036|Overall Study|Protocol Violation|0|||
156771782|NCT00042289|565918148|FG037|Overall Study|Protocol Violation|0|||
156771783|NCT00042289|565918149|FG038|Overall Study|Protocol Violation|0|||
156771784|NCT00042289|565918150|FG039|Overall Study|Protocol Violation|0|||
156771785|NCT00042289|565918151|FG040|Overall Study|Protocol Violation|0|||
156771786|NCT00042289|565918152|FG041|Overall Study|Protocol Violation|1|||
156771787|NCT00042289|565918153|FG042|Overall Study|Protocol Violation|1|||
156771788|NCT00042289|565918154|FG043|Overall Study|Protocol Violation|1|||
156771789|NCT00042289|565918155|FG044|Overall Study|Protocol Violation|0|||
156771790|NCT00042289|565918156|FG045|Overall Study|Protocol Violation|0|||
156771791|NCT00042289|565918157|FG046|Overall Study|Protocol Violation|0|||
156771792|NCT00042289|565918111|FG000|Overall Study|Withdrawal by Subject|4|||
156771793|NCT00042289|565918112|FG001|Overall Study|Withdrawal by Subject|1|||
156771794|NCT00042289|565918113|FG002|Overall Study|Withdrawal by Subject|0|||
156771795|NCT00042289|565918114|FG003|Overall Study|Withdrawal by Subject|2|||
156771796|NCT00042289|565918115|FG004|Overall Study|Withdrawal by Subject|0|||
156771797|NCT00042289|565918116|FG005|Overall Study|Withdrawal by Subject|2|||
156771798|NCT00042289|565918117|FG006|Overall Study|Withdrawal by Subject|0|||
156771799|NCT00042289|565918118|FG007|Overall Study|Withdrawal by Subject|0|||
156771800|NCT00042289|565918119|FG008|Overall Study|Withdrawal by Subject|0|||
156771801|NCT00042289|565918120|FG009|Overall Study|Withdrawal by Subject|1|||
156771802|NCT00042289|565918121|FG010|Overall Study|Withdrawal by Subject|0|||
156771803|NCT00042289|565918122|FG011|Overall Study|Withdrawal by Subject|0|||
156771804|NCT00042289|565918123|FG012|Overall Study|Withdrawal by Subject|2|||
156771805|NCT00042289|565918124|FG013|Overall Study|Withdrawal by Subject|0|||
156771806|NCT00042289|565918125|FG014|Overall Study|Withdrawal by Subject|0|||
156428380|NCT05576051|564660850|FG004|Overall Study|Safety|4|||
156771807|NCT00042289|565918126|FG015|Overall Study|Withdrawal by Subject|0|||
156771808|NCT00042289|565918127|FG016|Overall Study|Withdrawal by Subject|0|||
156771809|NCT00042289|565918128|FG017|Overall Study|Withdrawal by Subject|0|||
156771810|NCT00042289|565918129|FG018|Overall Study|Withdrawal by Subject|0|||
156771811|NCT00042289|565918130|FG019|Overall Study|Withdrawal by Subject|0|||
156771812|NCT00042289|565918131|FG020|Overall Study|Withdrawal by Subject|0|||
156771813|NCT00042289|565918132|FG021|Overall Study|Withdrawal by Subject|1|||
156771814|NCT00042289|565918133|FG022|Overall Study|Withdrawal by Subject|1|||
156771815|NCT00042289|565918134|FG023|Overall Study|Withdrawal by Subject|1|||
156771816|NCT00042289|565918135|FG024|Overall Study|Withdrawal by Subject|0|||
156771817|NCT00042289|565918136|FG025|Overall Study|Withdrawal by Subject|0|||
156771818|NCT00042289|565918137|FG026|Overall Study|Withdrawal by Subject|1|||
156771819|NCT00042289|565918138|FG027|Overall Study|Withdrawal by Subject|0|||
156771820|NCT00042289|565918139|FG028|Overall Study|Withdrawal by Subject|2|||
156771821|NCT00042289|565918140|FG029|Overall Study|Withdrawal by Subject|0|||
156428381|NCT05576051|564660851|FG005|Overall Study|Safety|5|||
156771822|NCT00042289|565918141|FG030|Overall Study|Withdrawal by Subject|0|||
156771823|NCT00042289|565918142|FG031|Overall Study|Withdrawal by Subject|1|||
156657606|NCT03595657|565491891|FG000|Overall Study|Death|1|||
156771824|NCT00042289|565918143|FG032|Overall Study|Withdrawal by Subject|2|||
156771825|NCT00042289|565918144|FG033|Overall Study|Withdrawal by Subject|1|||
156771826|NCT00042289|565918145|FG034|Overall Study|Withdrawal by Subject|0|||
156771827|NCT00042289|565918146|FG035|Overall Study|Withdrawal by Subject|0|||
156771828|NCT00042289|565918147|FG036|Overall Study|Withdrawal by Subject|0|||
156771829|NCT00042289|565918148|FG037|Overall Study|Withdrawal by Subject|1|||
156771830|NCT00042289|565918149|FG038|Overall Study|Withdrawal by Subject|0|||
156771831|NCT00042289|565918150|FG039|Overall Study|Withdrawal by Subject|0|||
156771832|NCT00042289|565918151|FG040|Overall Study|Withdrawal by Subject|0|||
156428382|NCT05576051|564660846|FG000|Overall Study|Efficacy + Safety|10|||
156771833|NCT00042289|565918152|FG041|Overall Study|Withdrawal by Subject|0|||
156771834|NCT00042289|565918153|FG042|Overall Study|Withdrawal by Subject|1|||
156771835|NCT00042289|565918154|FG043|Overall Study|Withdrawal by Subject|0|||
156771836|NCT00042289|565918155|FG044|Overall Study|Withdrawal by Subject|0|||
156771837|NCT00042289|565918156|FG045|Overall Study|Withdrawal by Subject|0|||
156771838|NCT00042289|565918157|FG046|Overall Study|Withdrawal by Subject|0|||
156771839|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
156771840|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
156771841|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
156771842|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
156771843|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
156771844|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
156771845|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
156771846|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
156771847|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
156771848|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
156771849|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
156771850|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
156771851|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
156771852|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
156771853|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
156771854|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
156771855|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
156771856|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
156771857|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
156771858|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
156771859|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
156771860|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
156771861|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
156771862|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
156771863|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
156771864|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
156771865|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
156771866|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
156771867|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
156771868|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
156771869|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
156771870|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
156771871|NCT04588259|565918161|FG000|Run-in period|Run-in failure|0|||
156771872|NCT04588259|565918162|FG001|Run-in period|Run-in failure|23|||
156771873|NCT04588259|565918161|FG000|Run-in period|Withdrawn before randomisation|0|||
156771874|NCT04588259|565918162|FG001|Run-in period|Withdrawn before randomisation|8|||
156771875|NCT04588259|565918161|FG000|Treatment period|Withdrawal by Subject|6|||
156771876|NCT04588259|565918162|FG001|Treatment period|Withdrawal by Subject|6|||
156771877|NCT01673386|565918163|FG000|Overall Study|Study terminated by sponsor|16|||
156771878|NCT01673386|565918164|FG001|Overall Study|Study terminated by sponsor|22|||
156771879|NCT01673386|565918163|FG000|Overall Study|Adverse Event|5|||
156771880|NCT01673386|565918164|FG001|Overall Study|Adverse Event|2|||
156771881|NCT01673386|565918163|FG000|Overall Study|Progressive disease|4|||
156771882|NCT01673386|565918164|FG001|Overall Study|Progressive disease|1|||
156771883|NCT01673386|565918163|FG000|Overall Study|Withdrawal by Subject|0|||
156771884|NCT01673386|565918164|FG001|Overall Study|Withdrawal by Subject|2|||
156771885|NCT00274456|565918165|FG000|Overall Study|Still on treatment|2|||
156771886|NCT00274456|565918166|FG001|Overall Study|Still on treatment|3|||
156771887|NCT00274456|565918167|FG002|Overall Study|Still on treatment|5|||
156771888|NCT00274456|565918168|FG003|Overall Study|Still on treatment|1|||
156771889|NCT00274456|565918165|FG000|Overall Study|Unacceptable toxicity|10|||
156771890|NCT00274456|565918166|FG001|Overall Study|Unacceptable toxicity|5|||
156771891|NCT00274456|565918167|FG002|Overall Study|Unacceptable toxicity|12|||
156771892|NCT00274456|565918168|FG003|Overall Study|Unacceptable toxicity|16|||
156771893|NCT00274456|565918165|FG000|Overall Study|Adverse Event|0|||
156771894|NCT00274456|565918166|FG001|Overall Study|Adverse Event|1|||
156771895|NCT00274456|565918167|FG002|Overall Study|Adverse Event|2|||
156771896|NCT00274456|565918168|FG003|Overall Study|Adverse Event|2|||
156771897|NCT00274456|565918165|FG000|Overall Study|Physician Decision|7|||
156771898|NCT00274456|565918166|FG001|Overall Study|Physician Decision|5|||
156771899|NCT00274456|565918167|FG002|Overall Study|Physician Decision|6|||
156771900|NCT00274456|565918168|FG003|Overall Study|Physician Decision|13|||
156771901|NCT00274456|565918165|FG000|Overall Study|Lost to Follow-up|0|||
156771902|NCT00274456|565918166|FG001|Overall Study|Lost to Follow-up|0|||
156771903|NCT00274456|565918167|FG002|Overall Study|Lost to Follow-up|1|||
156771904|NCT00274456|565918168|FG003|Overall Study|Lost to Follow-up|0|||
156771905|NCT00274456|565918165|FG000|Overall Study|Withdrawal by Subject|18|||
156771906|NCT00274456|565918166|FG001|Overall Study|Withdrawal by Subject|13|||
156771907|NCT00274456|565918167|FG002|Overall Study|Withdrawal by Subject|9|||
156771908|NCT00274456|565918168|FG003|Overall Study|Withdrawal by Subject|13|||
156771909|NCT03738696|565918175|FG000|Overall Study|Withdrawal by Subject|0|||
156771910|NCT03738696|565918176|FG001|Overall Study|Withdrawal by Subject|1|||
156771911|NCT03738696|565918175|FG000|Overall Study|Lost to Follow-up|8|||
156771912|NCT03738696|565918176|FG001|Overall Study|Lost to Follow-up|14|||
156771913|NCT02030600|565918177|FG000|Treatment Period 1|Adverse Event|5|||
156771914|NCT02030600|565918178|FG001|Treatment Period 1|Adverse Event|7|||
156771915|NCT02030600|565918177|FG000|Treatment Period 1|Lack of Efficacy|0|||
156771916|NCT02030600|565918178|FG001|Treatment Period 1|Lack of Efficacy|1|||
156771917|NCT02030600|565918177|FG000|Treatment Period 1|Lost to Follow-up|11|||
156771918|NCT02030600|565918178|FG001|Treatment Period 1|Lost to Follow-up|3|||
156771919|NCT02030600|565918177|FG000|Treatment Period 1|Protocol Violation|22|||
156771920|NCT02030600|565918178|FG001|Treatment Period 1|Protocol Violation|17|||
156771921|NCT02030600|565918177|FG000|Treatment Period 1|Withdrawal by Subject|13|||
156771922|NCT02030600|565918178|FG001|Treatment Period 1|Withdrawal by Subject|17|||
156771923|NCT02030600|565918177|FG000|Treatment Period 1|Casebook Unsigned|1|||
156771924|NCT02030600|565918178|FG001|Treatment Period 1|Casebook Unsigned|0|||
156771925|NCT02030600|565918177|FG000|Treatment Period 1|Unclassified|1|||
156771926|NCT02030600|565918178|FG001|Treatment Period 1|Unclassified|0|||
156771927|NCT02030600|565918177|FG000|Treatment Period 2|Adverse Event|4|||
156771928|NCT02030600|565918178|FG001|Treatment Period 2|Adverse Event|4|||
156771929|NCT02030600|565918177|FG000|Treatment Period 2|Lack of Efficacy|2|||
156771930|NCT02030600|565918178|FG001|Treatment Period 2|Lack of Efficacy|1|||
156771931|NCT02030600|565918177|FG000|Treatment Period 2|Lost to Follow-up|4|||
156771932|NCT02030600|565918178|FG001|Treatment Period 2|Lost to Follow-up|2|||
156771933|NCT02030600|565918177|FG000|Treatment Period 2|Protocol Violation|1|||
156771934|NCT02030600|565918178|FG001|Treatment Period 2|Protocol Violation|2|||
156771935|NCT02030600|565918177|FG000|Treatment Period 2|Withdrawal by Subject|13|||
156771936|NCT02030600|565918178|FG001|Treatment Period 2|Withdrawal by Subject|9|||
156771937|NCT02030600|565918177|FG000|Treatment Period 2|Unclassified|1|||
156771938|NCT02030600|565918178|FG001|Treatment Period 2|Unclassified|0|||
156771939|NCT01712178|565918179|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
156771940|NCT01712178|565918180|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
156771941|NCT01712178|565918179|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
156771942|NCT01712178|565918180|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
156771943|NCT01712178|565918179|FG000|Overall Study|Lost to Follow-up|0|||
156771944|NCT01712178|565918180|FG001|Overall Study|Lost to Follow-up|1|||
156771945|NCT05001620|565918181|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
156771946|NCT05001620|565918182|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
156771947|NCT00819039|565918183|FG000|Overall Study|Physician Decision|1|||
156771948|NCT00819039|565918184|FG001|Overall Study|Physician Decision|0|||
156771949|NCT00819039|565918185|FG002|Overall Study|Physician Decision|1|||
156771950|NCT00819039|565918183|FG000|Overall Study|Protocol Violation|1|||
156771951|NCT00819039|565918184|FG001|Overall Study|Protocol Violation|0|||
156771952|NCT00819039|565918185|FG002|Overall Study|Protocol Violation|0|||
156771953|NCT01240694|565918186|FG000|Overall Study|Adverse Event|9|||
156771954|NCT01240694|565918186|FG000|Overall Study|Lack of Efficacy|6|||
156771955|NCT01240694|565918186|FG000|Overall Study|Withdrawal by Subject|6|||
156771956|NCT01240694|565918186|FG000|Overall Study|Protocol Violation|2|||
156771957|NCT01240694|565918186|FG000|Overall Study|Lost to Follow-up|2|||
156771958|NCT01240694|565918186|FG000|Overall Study|Other than specified|3|||
156771959|NCT01240694|565918186|FG000|Overall Study|Withdrawn due to early study termination|107|||
156771960|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
156771961|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
156771962|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
156771963|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
156771964|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
156771965|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
156523539|NCT05328167|565009622|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
156771966|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
156324080|NCT00417482|564286076|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
156324081|NCT00417482|564286074|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
156523540|NCT05328167|565009622|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
156771967|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
156771968|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
156771969|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
156324082|NCT00417482|564286075|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
156771970|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Death|3|||
156771971|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Death|1|||
156771972|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
156771973|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
156771974|NCT01056276|565918187|FG000|Maintenance Therapy|Toxicity|0|||
156771975|NCT01056276|565918188|FG001|Maintenance Therapy|Toxicity|2|||
156771976|NCT01056276|565918187|FG000|Maintenance Therapy|Progressive Disease|0|||
156771977|NCT01056276|565918188|FG001|Maintenance Therapy|Progressive Disease|9|||
156771978|NCT01056276|565918187|FG000|Maintenance Therapy|Physician Decision|0|||
156771979|NCT01056276|565918188|FG001|Maintenance Therapy|Physician Decision|1|||
156771980|NCT01056276|565918187|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
156771981|NCT01056276|565918188|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
156771982|NCT01056276|565918187|FG000|Maintenance Therapy|Intercurrent Illness|0|||
156771983|NCT01056276|565918188|FG001|Maintenance Therapy|Intercurrent Illness|1|||
156771984|NCT01056276|565918187|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
156771985|NCT01056276|565918188|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
156771986|NCT01881425|565918189|FG000|Overall Study|Death|5|||
156771987|NCT01881425|565918190|FG001|Overall Study|Death|1|||
156771988|NCT01881425|565918189|FG000|Overall Study|Withdrawal by Subject|8|||
156771989|NCT01881425|565918190|FG001|Overall Study|Withdrawal by Subject|3|||
156771990|NCT01881425|565918189|FG000|Overall Study|Physician Decision|2|||
156771991|NCT01881425|565918190|FG001|Overall Study|Physician Decision|1|||
156771992|NCT01881425|565918189|FG000|Overall Study|Adverse Event|3|||
156771993|NCT01881425|565918190|FG001|Overall Study|Adverse Event|0|||
156771994|NCT01881425|565918189|FG000|Overall Study|General Anesthesia panic attack|0|||
156771995|NCT01881425|565918190|FG001|Overall Study|General Anesthesia panic attack|1|||
156771996|NCT01881425|565918189|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
156771997|NCT01881425|565918190|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
156771998|NCT01881425|565918189|FG000|Overall Study|Lost to Follow-up|7|||
156771999|NCT01881425|565918190|FG001|Overall Study|Lost to Follow-up|2|||
156772000|NCT04154956|565918195|FG000|Overall Study|Death|109|||
156772001|NCT04154956|565918196|FG001|Overall Study|Death|110|||
156772002|NCT04154956|565918195|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
156772003|NCT04154956|565918196|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
156772004|NCT04154956|565918195|FG000|Overall Study|Withdrawal by Subject|1|||
156772005|NCT04154956|565918196|FG001|Overall Study|Withdrawal by Subject|7|||
156772006|NCT04154956|565918195|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
156772007|NCT04154956|565918196|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
156772008|NCT00147238|565918197|FG000|Overall Study|Inevaluable|8|||
156772009|NCT04424901|565918198|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
156772010|NCT04424901|565918199|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
156772011|NCT01348269|565918200|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
156772012|NCT01348269|565918201|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
156772013|NCT01348269|565918200|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
156772014|NCT01348269|565918201|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
156772015|NCT01348269|565918200|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
156772016|NCT01348269|565918201|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
156772017|NCT00805532|565918202|FG000|Overall Study|invalid data|0|||
156772018|NCT00805532|565918203|FG001|Overall Study|invalid data|1|||
156772019|NCT01859741|565918204|FG000|Overall Study|Death|3|||
156772020|NCT01859741|565918205|FG001|Overall Study|Death|2|||
156772021|NCT01859741|565918206|FG002|Overall Study|Death|4|||
156772022|NCT01859741|565918207|FG003|Overall Study|Death|3|||
156772023|NCT01859741|565918208|FG004|Overall Study|Death|5|||
156772024|NCT01859741|565918209|FG005|Overall Study|Death|4|||
156772025|NCT01859741|565918210|FG006|Overall Study|Death|51|||
156772026|NCT01859741|565918211|FG007|Overall Study|Death|51|||
156772027|NCT01859741|565918204|FG000|Overall Study|Lost to Follow-up|0|||
156772028|NCT01859741|565918205|FG001|Overall Study|Lost to Follow-up|0|||
156772029|NCT01859741|565918206|FG002|Overall Study|Lost to Follow-up|0|||
156772030|NCT01859741|565918207|FG003|Overall Study|Lost to Follow-up|0|||
156772031|NCT01859741|565918208|FG004|Overall Study|Lost to Follow-up|0|||
156772032|NCT01859741|565918209|FG005|Overall Study|Lost to Follow-up|1|||
156772033|NCT01859741|565918210|FG006|Overall Study|Lost to Follow-up|0|||
156772034|NCT01859741|565918211|FG007|Overall Study|Lost to Follow-up|4|||
156772035|NCT01859741|565918204|FG000|Overall Study|Withdrawal by Subject|0|||
156772036|NCT01859741|565918205|FG001|Overall Study|Withdrawal by Subject|1|||
156772037|NCT01859741|565918206|FG002|Overall Study|Withdrawal by Subject|2|||
156772038|NCT01859741|565918207|FG003|Overall Study|Withdrawal by Subject|0|||
156772039|NCT01859741|565918208|FG004|Overall Study|Withdrawal by Subject|0|||
156428383|NCT05576051|564660847|FG001|Overall Study|Efficacy + Safety|7|||
156772040|NCT01859741|565918209|FG005|Overall Study|Withdrawal by Subject|1|||
156772041|NCT01859741|565918210|FG006|Overall Study|Withdrawal by Subject|1|||
156772042|NCT01859741|565918211|FG007|Overall Study|Withdrawal by Subject|1|||
156772043|NCT01859741|565918204|FG000|Overall Study|Study Terminated by Sponsor|0|||
156772044|NCT01859741|565918205|FG001|Overall Study|Study Terminated by Sponsor|0|||
156772045|NCT01859741|565918206|FG002|Overall Study|Study Terminated by Sponsor|0|||
156772046|NCT01859741|565918207|FG003|Overall Study|Study Terminated by Sponsor|0|||
156428384|NCT05576051|564660848|FG002|Overall Study|Efficacy + Safety|3|||
156772047|NCT01859741|565918208|FG004|Overall Study|Study Terminated by Sponsor|1|||
156772048|NCT01859741|565918209|FG005|Overall Study|Study Terminated by Sponsor|0|||
156772049|NCT01859741|565918210|FG006|Overall Study|Study Terminated by Sponsor|16|||
156772050|NCT01859741|565918211|FG007|Overall Study|Study Terminated by Sponsor|14|||
156772051|NCT01859741|565918204|FG000|Overall Study|Other|0|||
156772052|NCT01859741|565918205|FG001|Overall Study|Other|0|||
156772053|NCT01859741|565918206|FG002|Overall Study|Other|0|||
156772054|NCT01859741|565918207|FG003|Overall Study|Other|0|||
156772055|NCT01859741|565918208|FG004|Overall Study|Other|0|||
156772056|NCT01859741|565918209|FG005|Overall Study|Other|0|||
156772057|NCT01859741|565918210|FG006|Overall Study|Other|2|||
156772058|NCT01859741|565918211|FG007|Overall Study|Other|0|||
156772059|NCT02412657|565918212|FG000|Overall Study|Lost to Follow-up|1|||
156772060|NCT02412657|565918213|FG001|Overall Study|Lost to Follow-up|0|||
156772061|NCT02412657|565918214|FG002|Overall Study|Lost to Follow-up|0|||
156772062|NCT02412657|565918212|FG000|Overall Study|Protocol Violation|0|||
156772063|NCT02412657|565918213|FG001|Overall Study|Protocol Violation|2|||
156772064|NCT02412657|565918214|FG002|Overall Study|Protocol Violation|3|||
156772065|NCT03185208|565918218|FG000|Overall Study|Did not start study medication|0|||
156772066|NCT03185208|565918219|FG001|Overall Study|Did not start study medication|3|||
156772067|NCT03834350|565918220|FG000|Overall Study|Withdrawal by Subject|1|||
156772068|NCT00701363|565918221|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
156772069|NCT00701363|565918222|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
156772070|NCT00701363|565918223|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
156772071|NCT00701363|565918224|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
156772072|NCT00701363|565918221|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
156772073|NCT00701363|565918222|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
156772074|NCT00701363|565918223|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
156772075|NCT00701363|565918224|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
156772076|NCT00701363|565918221|FG000|Treatment Phase 1|Adverse Event|7|||
156772077|NCT00701363|565918222|FG001|Treatment Phase 1|Adverse Event|0|||
156772078|NCT00701363|565918223|FG002|Treatment Phase 1|Adverse Event|0|||
156772079|NCT00701363|565918224|FG003|Treatment Phase 1|Adverse Event|0|||
156772080|NCT00701363|565918221|FG000|Treatment Phase 1|Protocol Violation|1|||
156772081|NCT00701363|565918222|FG001|Treatment Phase 1|Protocol Violation|0|||
156772082|NCT00701363|565918223|FG002|Treatment Phase 1|Protocol Violation|0|||
156772083|NCT00701363|565918224|FG003|Treatment Phase 1|Protocol Violation|0|||
156772084|NCT00701363|565918221|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
156772085|NCT00701363|565918222|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
156772086|NCT00701363|565918223|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
156772087|NCT00701363|565918224|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
156772088|NCT00701363|565918221|FG000|Treatment Phase 1|Lack of Efficacy|1|||
156772089|NCT00701363|565918222|FG001|Treatment Phase 1|Lack of Efficacy|0|||
156772090|NCT00701363|565918223|FG002|Treatment Phase 1|Lack of Efficacy|0|||
156772091|NCT00701363|565918224|FG003|Treatment Phase 1|Lack of Efficacy|0|||
156772092|NCT00701363|565918221|FG000|Treatment Phase 2|Adverse Event|0|||
156772093|NCT00701363|565918222|FG001|Treatment Phase 2|Adverse Event|0|||
156772094|NCT00701363|565918223|FG002|Treatment Phase 2|Adverse Event|1|||
156772095|NCT00701363|565918224|FG003|Treatment Phase 2|Adverse Event|0|||
156772096|NCT00701363|565918221|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
156772097|NCT00701363|565918222|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
156772098|NCT00701363|565918223|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
156772099|NCT00701363|565918224|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
156772100|NCT04759131|565918225|FG000|Overall Study|Investigator's discretion|1|||
156772101|NCT04759131|565918226|FG001|Overall Study|Investigator's discretion|0|||
156772102|NCT04759131|565918225|FG000|Overall Study|Subject withdrawal|1|||
156772103|NCT04759131|565918226|FG001|Overall Study|Subject withdrawal|0|||
156772104|NCT02592824|565918231|FG000|Overall Study|Protocol Violation|5|||
156772105|NCT02592824|565918232|FG001|Overall Study|Protocol Violation|3|||
156772106|NCT02592824|565918231|FG000|Overall Study|Lost to Follow-up|2|||
156772107|NCT02592824|565918232|FG001|Overall Study|Lost to Follow-up|1|||
156772108|NCT00289276|565918233|FG000|Second Part of FAST Study (Expansion)|Death|0|||
156772109|NCT00289276|565918234|FG001|Second Part of FAST Study (Expansion)|Death|2|||
156772110|NCT00289276|565918233|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
156772111|NCT00289276|565918234|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
156772112|NCT04458922|565918237|FG000|Overall Study|Withdrawal by Subject|1|||
156772113|NCT04458922|565918238|FG001|Overall Study|Withdrawal by Subject|0|||
156772114|NCT04458922|565918239|FG002|Overall Study|Withdrawal by Subject|2|||
156772115|NCT04458922|565918237|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
156772116|NCT04458922|565918238|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
156772117|NCT04458922|565918239|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
156772118|NCT04458922|565918237|FG000|Overall Study|Adverse Event|1|||
156772119|NCT04458922|565918238|FG001|Overall Study|Adverse Event|0|||
156772120|NCT04458922|565918239|FG002|Overall Study|Adverse Event|0|||
156772121|NCT04458922|565918237|FG000|Overall Study|Started new study|0|||
156772122|NCT04458922|565918238|FG001|Overall Study|Started new study|0|||
156772123|NCT04458922|565918239|FG002|Overall Study|Started new study|1|||
156772124|NCT04458922|565918237|FG000|Overall Study|Progressive disease|6|||
156772125|NCT04458922|565918238|FG001|Overall Study|Progressive disease|8|||
156772126|NCT04458922|565918239|FG002|Overall Study|Progressive disease|2|||
156772127|NCT04458922|565918237|FG000|Overall Study|Death|1|||
156772128|NCT04458922|565918238|FG001|Overall Study|Death|0|||
156772129|NCT04458922|565918239|FG002|Overall Study|Death|2|||
156772130|NCT04458922|565918237|FG000|Overall Study|Participant started chemotherapy|0|||
156772131|NCT04458922|565918238|FG001|Overall Study|Participant started chemotherapy|1|||
156772132|NCT04458922|565918239|FG002|Overall Study|Participant started chemotherapy|0|||
156772133|NCT04682301|565918240|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
156772134|NCT04682301|565918240|FG000|Overall Study|Death|2|||
156772135|NCT05219162|565918241|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
156772136|NCT05219162|565918241|FG000|Overall Study|Withdrawal by Subject|23|||
156772137|NCT00392223|565918248|FG000|Overall Study|Adverse Event|5|||
156772138|NCT00392223|565918249|FG001|Overall Study|Adverse Event|4|||
156772139|NCT00392223|565918248|FG000|Overall Study|Lost to Follow-up|1|||
156772140|NCT00392223|565918249|FG001|Overall Study|Lost to Follow-up|4|||
156772141|NCT00392223|565918248|FG000|Overall Study|Protocol Violation|0|||
156772142|NCT00392223|565918249|FG001|Overall Study|Protocol Violation|3|||
156772143|NCT00392223|565918248|FG000|Overall Study|Withdrawal by Subject|3|||
156772144|NCT00392223|565918249|FG001|Overall Study|Withdrawal by Subject|2|||
156772145|NCT00269152|565918250|FG000|Overall Study|Adverse Event|9|||
156772146|NCT00269152|565918251|FG001|Overall Study|Adverse Event|3|||
156772147|NCT00269152|565918250|FG000|Overall Study|Withdrawal by Subject|7|||
156772148|NCT00269152|565918251|FG001|Overall Study|Withdrawal by Subject|3|||
156772149|NCT00269152|565918250|FG000|Overall Study|Physician Decision|2|||
156772150|NCT00269152|565918251|FG001|Overall Study|Physician Decision|3|||
156772151|NCT00269152|565918250|FG000|Overall Study|Protocol Violation|0|||
156772152|NCT00269152|565918251|FG001|Overall Study|Protocol Violation|1|||
156772153|NCT05516758|565918252|FG000|Overall Study|Adverse Event|5|||
156772154|NCT05516758|565918253|FG001|Overall Study|Adverse Event|1|||
156428385|NCT05576051|564660849|FG003|Overall Study|Efficacy + Safety|0|||
156428386|NCT05576051|564660850|FG004|Overall Study|Efficacy + Safety|0|||
156428387|NCT05576051|564660851|FG005|Overall Study|Efficacy + Safety|0|||
156428388|NCT05576051|564660846|FG000|Overall Study|Other|231|||
156428389|NCT05576051|564660847|FG001|Overall Study|Other|127|||
156428390|NCT05576051|564660848|FG002|Overall Study|Other|35|||
156428391|NCT05576051|564660849|FG003|Overall Study|Other|14|||
156428392|NCT05576051|564660850|FG004|Overall Study|Other|6|||
156428393|NCT05576051|564660851|FG005|Overall Study|Other|0|||
156428394|NCT03601507|564660852|FG000|Overall Study|Adverse Event|1|||
156428395|NCT05650333|564660853|FG000|Treatment Period (7 Days)|Adverse Event|1|||
156428396|NCT02107014|564660854|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
156428397|NCT03761784|564660855|FG000|Overall Study|Adverse Event|4|||
156428398|NCT03761784|564660856|FG001|Overall Study|Adverse Event|0|||
156428399|NCT03761784|564660855|FG000|Overall Study|Lost to Follow-up|10|||
156428400|NCT03761784|564660856|FG001|Overall Study|Lost to Follow-up|7|||
156428401|NCT03761784|564660855|FG000|Overall Study|Pregnancy|1|||
156428402|NCT03761784|564660856|FG001|Overall Study|Pregnancy|0|||
156428403|NCT03761784|564660855|FG000|Overall Study|Protocol Violation|2|||
156428404|NCT03761784|564660856|FG001|Overall Study|Protocol Violation|0|||
156428405|NCT03761784|564660855|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
156772155|NCT05516758|565918254|FG002|Overall Study|Adverse Event|3|||
156772156|NCT05516758|565918255|FG003|Overall Study|Adverse Event|0|||
156772157|NCT05516758|565918256|FG004|Overall Study|Adverse Event|1|||
156772158|NCT05516758|565918257|FG005|Overall Study|Adverse Event|3|||
156772159|NCT05516758|565918258|FG006|Overall Study|Adverse Event|5|||
156772160|NCT05516758|565918252|FG000|Overall Study|Assigned treatment by mistake|1|||
156772161|NCT05516758|565918253|FG001|Overall Study|Assigned treatment by mistake|0|||
156772162|NCT05516758|565918254|FG002|Overall Study|Assigned treatment by mistake|0|||
156772163|NCT05516758|565918255|FG003|Overall Study|Assigned treatment by mistake|0|||
156772164|NCT05516758|565918256|FG004|Overall Study|Assigned treatment by mistake|1|||
156772165|NCT05516758|565918257|FG005|Overall Study|Assigned treatment by mistake|0|||
156523541|NCT01873495|565011748|FG000|Overall Study|Withdrawal by Subject|1|||
156523542|NCT01873495|565011748|FG000|Overall Study|Physician Decision|3|||
156523543|NCT01873495|565011748|FG000|Overall Study|Adverse Event|1|||
156772166|NCT05516758|565918258|FG006|Overall Study|Assigned treatment by mistake|0|||
156772167|NCT05516758|565918252|FG000|Overall Study|Lack of Efficacy|6|||
156772168|NCT05516758|565918253|FG001|Overall Study|Lack of Efficacy|0|||
156772169|NCT05516758|565918254|FG002|Overall Study|Lack of Efficacy|2|||
156772170|NCT05516758|565918255|FG003|Overall Study|Lack of Efficacy|0|||
156772171|NCT05516758|565918256|FG004|Overall Study|Lack of Efficacy|3|||
156772172|NCT05516758|565918257|FG005|Overall Study|Lack of Efficacy|6|||
156772173|NCT05516758|565918258|FG006|Overall Study|Lack of Efficacy|3|||
156428406|NCT03761784|564660856|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
156428407|NCT03761784|564660855|FG000|Overall Study|Withdrawal by Subject|9|||
156428408|NCT03761784|564660856|FG001|Overall Study|Withdrawal by Subject|4|||
156428409|NCT03761784|564660855|FG000|Overall Study|Physician Decision|1|||
156772174|NCT05516758|565918252|FG000|Overall Study|Lost to Follow-up|2|||
156772175|NCT05516758|565918253|FG001|Overall Study|Lost to Follow-up|0|||
156772176|NCT05516758|565918254|FG002|Overall Study|Lost to Follow-up|2|||
156772177|NCT05516758|565918255|FG003|Overall Study|Lost to Follow-up|0|||
156772178|NCT05516758|565918256|FG004|Overall Study|Lost to Follow-up|3|||
156772179|NCT05516758|565918257|FG005|Overall Study|Lost to Follow-up|2|||
156772180|NCT05516758|565918258|FG006|Overall Study|Lost to Follow-up|1|||
156772181|NCT05516758|565918252|FG000|Overall Study|Other- As reported by the site|2|||
156772182|NCT05516758|565918253|FG001|Overall Study|Other- As reported by the site|1|||
156772183|NCT05516758|565918254|FG002|Overall Study|Other- As reported by the site|8|||
156772184|NCT05516758|565918255|FG003|Overall Study|Other- As reported by the site|1|||
156772185|NCT05516758|565918256|FG004|Overall Study|Other- As reported by the site|2|||
156772186|NCT05516758|565918257|FG005|Overall Study|Other- As reported by the site|3|||
156772187|NCT05516758|565918258|FG006|Overall Study|Other- As reported by the site|8|||
156772188|NCT05516758|565918252|FG000|Overall Study|Physician Decision|1|||
156772189|NCT05516758|565918253|FG001|Overall Study|Physician Decision|0|||
156772190|NCT05516758|565918254|FG002|Overall Study|Physician Decision|7|||
156772191|NCT05516758|565918255|FG003|Overall Study|Physician Decision|0|||
156772192|NCT05516758|565918256|FG004|Overall Study|Physician Decision|1|||
156772193|NCT05516758|565918257|FG005|Overall Study|Physician Decision|1|||
156772194|NCT05516758|565918258|FG006|Overall Study|Physician Decision|2|||
156772195|NCT05516758|565918252|FG000|Overall Study|Protocol Deviation|1|||
156772196|NCT05516758|565918253|FG001|Overall Study|Protocol Deviation|0|||
156772197|NCT05516758|565918254|FG002|Overall Study|Protocol Deviation|0|||
156772198|NCT05516758|565918255|FG003|Overall Study|Protocol Deviation|0|||
156772199|NCT05516758|565918256|FG004|Overall Study|Protocol Deviation|0|||
156772200|NCT05516758|565918257|FG005|Overall Study|Protocol Deviation|1|||
156772201|NCT05516758|565918258|FG006|Overall Study|Protocol Deviation|5|||
156772202|NCT05516758|565918252|FG000|Overall Study|Withdrawal by Subject|11|||
156772203|NCT05516758|565918253|FG001|Overall Study|Withdrawal by Subject|1|||
156772204|NCT05516758|565918254|FG002|Overall Study|Withdrawal by Subject|15|||
156772205|NCT05516758|565918255|FG003|Overall Study|Withdrawal by Subject|2|||
156772206|NCT05516758|565918256|FG004|Overall Study|Withdrawal by Subject|7|||
156772207|NCT05516758|565918257|FG005|Overall Study|Withdrawal by Subject|7|||
156772208|NCT05516758|565918258|FG006|Overall Study|Withdrawal by Subject|6|||
156772209|NCT05516758|565918252|FG000|Overall Study|Death|1|||
156772210|NCT05516758|565918253|FG001|Overall Study|Death|0|||
156772211|NCT05516758|565918254|FG002|Overall Study|Death|0|||
156772212|NCT05516758|565918255|FG003|Overall Study|Death|0|||
156772213|NCT05516758|565918256|FG004|Overall Study|Death|0|||
156772214|NCT05516758|565918257|FG005|Overall Study|Death|0|||
156772215|NCT05516758|565918258|FG006|Overall Study|Death|0|||
156772216|NCT05516758|565918252|FG000|Overall Study|Non-compliance With Study Drug|0|||
156772217|NCT05516758|565918253|FG001|Overall Study|Non-compliance With Study Drug|0|||
156772218|NCT05516758|565918254|FG002|Overall Study|Non-compliance With Study Drug|1|||
156772219|NCT05516758|565918255|FG003|Overall Study|Non-compliance With Study Drug|0|||
156772220|NCT05516758|565918256|FG004|Overall Study|Non-compliance With Study Drug|0|||
156772221|NCT05516758|565918257|FG005|Overall Study|Non-compliance With Study Drug|0|||
156772222|NCT05516758|565918258|FG006|Overall Study|Non-compliance With Study Drug|0|||
156772223|NCT05516758|565918252|FG000|Overall Study|Site Terminated by Sponsor|2|||
156772224|NCT05516758|565918253|FG001|Overall Study|Site Terminated by Sponsor|0|||
156772225|NCT05516758|565918254|FG002|Overall Study|Site Terminated by Sponsor|0|||
156772226|NCT05516758|565918255|FG003|Overall Study|Site Terminated by Sponsor|0|||
156772227|NCT05516758|565918256|FG004|Overall Study|Site Terminated by Sponsor|0|||
156772228|NCT05516758|565918257|FG005|Overall Study|Site Terminated by Sponsor|0|||
156772229|NCT05516758|565918258|FG006|Overall Study|Site Terminated by Sponsor|0|||
156772230|NCT05516758|565918252|FG000|Overall Study|Study Terminated by Sponsor|4|||
156772231|NCT05516758|565918253|FG001|Overall Study|Study Terminated by Sponsor|0|||
156772232|NCT05516758|565918254|FG002|Overall Study|Study Terminated by Sponsor|3|||
156772233|NCT05516758|565918255|FG003|Overall Study|Study Terminated by Sponsor|0|||
156772234|NCT05516758|565918256|FG004|Overall Study|Study Terminated by Sponsor|2|||
156772235|NCT05516758|565918257|FG005|Overall Study|Study Terminated by Sponsor|3|||
156772236|NCT05516758|565918258|FG006|Overall Study|Study Terminated by Sponsor|0|||
156772237|NCT05516758|565918252|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
156772238|NCT05516758|565918253|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
156324083|NCT00417482|564286076|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
156772239|NCT05516758|565918254|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
156324084|NCT00417482|564286074|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
156772240|NCT05516758|565918255|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
156324085|NCT00417482|564286075|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
156324086|NCT00417482|564286076|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
156772241|NCT05516758|565918256|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
156772242|NCT05516758|565918257|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
156772243|NCT05516758|565918258|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
156324087|NCT00417482|564286074|FG000|Phase B 1st 16 Weeks|Death|1|||
156772244|NCT05516758|565918252|FG000|Overall Study|Other|0|||
156772245|NCT05516758|565918253|FG001|Overall Study|Other|0|||
156772246|NCT05516758|565918254|FG002|Overall Study|Other|0|||
156772247|NCT05516758|565918255|FG003|Overall Study|Other|0|||
156772248|NCT05516758|565918256|FG004|Overall Study|Other|0|||
156772249|NCT05516758|565918257|FG005|Overall Study|Other|0|||
156772250|NCT05516758|565918258|FG006|Overall Study|Other|1|||
156772251|NCT01316575|565918259|FG000|Overall Study|Withdrawal by Subject|2|||
156772252|NCT01316575|565918260|FG001|Overall Study|Withdrawal by Subject|0|||
156772253|NCT01316575|565918259|FG000|Overall Study|Required alternate treatment|0|||
156772254|NCT01316575|565918260|FG001|Overall Study|Required alternate treatment|1|||
156772255|NCT00402831|565918261|FG000|Overall Study|Lost to Follow-up|1|||
156772256|NCT00402831|565918262|FG001|Overall Study|Lost to Follow-up|2|||
156772257|NCT00402831|565918261|FG000|Overall Study|Non-compliance with protocol|0|||
156772258|NCT00402831|565918262|FG001|Overall Study|Non-compliance with protocol|1|||
156772259|NCT02792504|565918265|FG000|Overall Study|Lost to Follow-up|24|||
156772260|NCT02792504|565918265|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
156772261|NCT02814526|565918272|FG000|Overall Study|Adverse Event|4|||
156772262|NCT02814526|565918273|FG001|Overall Study|Adverse Event|3|||
156772263|NCT02814526|565918272|FG000|Overall Study|Death|1|||
156772264|NCT02814526|565918273|FG001|Overall Study|Death|1|||
156772265|NCT02814526|565918272|FG000|Overall Study|Lost to Follow-up|3|||
156772266|NCT02814526|565918273|FG001|Overall Study|Lost to Follow-up|4|||
156772267|NCT02814526|565918272|FG000|Overall Study|non site physician decision|1|||
156772268|NCT02814526|565918273|FG001|Overall Study|non site physician decision|0|||
156772269|NCT02814526|565918272|FG000|Overall Study|participant noncompliance|1|||
156772270|NCT02814526|565918273|FG001|Overall Study|participant noncompliance|1|||
156772271|NCT02814526|565918272|FG000|Overall Study|Withdrawal by Subject|20|||
156772272|NCT02814526|565918273|FG001|Overall Study|Withdrawal by Subject|14|||
156772273|NCT02814526|565918272|FG000|Overall Study|safety risk|2|||
156772274|NCT02814526|565918273|FG001|Overall Study|safety risk|1|||
156772275|NCT02814526|565918272|FG000|Overall Study|early termination-study terminated|1|||
156772276|NCT02814526|565918273|FG001|Overall Study|early termination-study terminated|2|||
156772277|NCT02814526|565918272|FG000|Overall Study|Other|0|||
156772278|NCT02814526|565918273|FG001|Overall Study|Other|4|||
156772279|NCT04585893|565918274|FG000|Overall Study|Death|1|||
156772280|NCT04585893|565918275|FG001|Overall Study|Death|0|||
156772281|NCT06178991|565918280|FG000|Overall Study|Withdrawal by Subject|2|||
156772282|NCT06178991|565918281|FG001|Overall Study|Withdrawal by Subject|6|||
156772283|NCT06178991|565918282|FG002|Overall Study|Withdrawal by Subject|44|||
156772284|NCT06178991|565918283|FG003|Overall Study|Withdrawal by Subject|23|||
156772285|NCT06178991|565918284|FG004|Overall Study|Withdrawal by Subject|7|||
156772286|NCT06178991|565918285|FG005|Overall Study|Withdrawal by Subject|7|||
156772287|NCT06178991|565918286|FG006|Overall Study|Withdrawal by Subject|7|||
156772288|NCT06178991|565918287|FG007|Overall Study|Withdrawal by Subject|5|||
156772289|NCT06178991|565918280|FG000|Overall Study|Lost to Follow-up|2|||
156772290|NCT06178991|565918281|FG001|Overall Study|Lost to Follow-up|4|||
156772291|NCT06178991|565918282|FG002|Overall Study|Lost to Follow-up|133|||
156772292|NCT06178991|565918283|FG003|Overall Study|Lost to Follow-up|65|||
156772293|NCT06178991|565918284|FG004|Overall Study|Lost to Follow-up|68|||
156772294|NCT06178991|565918285|FG005|Overall Study|Lost to Follow-up|57|||
156772295|NCT06178991|565918286|FG006|Overall Study|Lost to Follow-up|25|||
156772296|NCT06178991|565918287|FG007|Overall Study|Lost to Follow-up|18|||
156772297|NCT06178991|565918280|FG000|Overall Study|Death|1|||
156772298|NCT06178991|565918281|FG001|Overall Study|Death|0|||
156772299|NCT06178991|565918282|FG002|Overall Study|Death|2|||
156772300|NCT06178991|565918283|FG003|Overall Study|Death|1|||
156772301|NCT06178991|565918284|FG004|Overall Study|Death|1|||
156772302|NCT06178991|565918285|FG005|Overall Study|Death|0|||
156772303|NCT06178991|565918286|FG006|Overall Study|Death|1|||
156772304|NCT06178991|565918287|FG007|Overall Study|Death|1|||
156772305|NCT06178991|565918280|FG000|Overall Study|Randomized but not Vaccinated|4|||
156772306|NCT06178991|565918281|FG001|Overall Study|Randomized but not Vaccinated|1|||
156772307|NCT06178991|565918282|FG002|Overall Study|Randomized but not Vaccinated|15|||
156772308|NCT06178991|565918283|FG003|Overall Study|Randomized but not Vaccinated|9|||
156772309|NCT06178991|565918284|FG004|Overall Study|Randomized but not Vaccinated|8|||
156772310|NCT06178991|565918285|FG005|Overall Study|Randomized but not Vaccinated|4|||
156772311|NCT06178991|565918286|FG006|Overall Study|Randomized but not Vaccinated|2|||
156772312|NCT06178991|565918287|FG007|Overall Study|Randomized but not Vaccinated|2|||
156772313|NCT06178991|565918280|FG000|Overall Study|Other: Unspecified|0|||
156772314|NCT06178991|565918281|FG001|Overall Study|Other: Unspecified|1|||
156772315|NCT06178991|565918282|FG002|Overall Study|Other: Unspecified|7|||
156772316|NCT06178991|565918283|FG003|Overall Study|Other: Unspecified|6|||
156772317|NCT06178991|565918284|FG004|Overall Study|Other: Unspecified|1|||
156772318|NCT06178991|565918285|FG005|Overall Study|Other: Unspecified|1|||
156772319|NCT06178991|565918286|FG006|Overall Study|Other: Unspecified|1|||
156772320|NCT06178991|565918287|FG007|Overall Study|Other: Unspecified|0|||
156772321|NCT06178991|565918280|FG000|Overall Study|Physician Decision|0|||
156772322|NCT06178991|565918281|FG001|Overall Study|Physician Decision|0|||
156772323|NCT06178991|565918282|FG002|Overall Study|Physician Decision|2|||
156772324|NCT06178991|565918283|FG003|Overall Study|Physician Decision|0|||
156772325|NCT06178991|565918284|FG004|Overall Study|Physician Decision|2|||
156772326|NCT06178991|565918285|FG005|Overall Study|Physician Decision|1|||
156772327|NCT06178991|565918286|FG006|Overall Study|Physician Decision|0|||
156772328|NCT06178991|565918287|FG007|Overall Study|Physician Decision|0|||
156772329|NCT06178991|565918280|FG000|Overall Study|Protocol Violation|0|||
156772330|NCT06178991|565918281|FG001|Overall Study|Protocol Violation|0|||
156772331|NCT06178991|565918282|FG002|Overall Study|Protocol Violation|1|||
156772332|NCT06178991|565918283|FG003|Overall Study|Protocol Violation|0|||
156772333|NCT06178991|565918284|FG004|Overall Study|Protocol Violation|0|||
156772334|NCT06178991|565918285|FG005|Overall Study|Protocol Violation|0|||
156772335|NCT06178991|565918286|FG006|Overall Study|Protocol Violation|0|||
156772336|NCT06178991|565918287|FG007|Overall Study|Protocol Violation|0|||
156772337|NCT02485860|565918291|FG000|Overall Study|Lost to Follow-up|4|||
156772338|NCT02485860|565918292|FG001|Overall Study|Lost to Follow-up|1|||
156772339|NCT02485860|565918291|FG000|Overall Study|Physician Decision|1|||
156772340|NCT02485860|565918292|FG001|Overall Study|Physician Decision|2|||
156772341|NCT02485860|565918291|FG000|Overall Study|Health context (COVID-19)|1|||
156772342|NCT02485860|565918292|FG001|Overall Study|Health context (COVID-19)|0|||
156772343|NCT01366092|565918293|FG000|Overall Study|Progressive cGVHD|2|||
156772344|NCT01366092|565918293|FG000|Overall Study|Physician Decision|1|||
156772345|NCT01366092|565918293|FG000|Overall Study|Withdrawal by Subject|1|||
156772346|NCT03082729|565918297|FG000|Overall Study|Lost to Follow-up|7|||
156772347|NCT03082729|565918297|FG000|Overall Study|Physician Decision|2|||
156772348|NCT03082729|565918297|FG000|Overall Study|Withdrawal by Subject|1|||
156772349|NCT03082729|565918297|FG000|Overall Study|Lack of Efficacy|9|||
156772350|NCT03082729|565918297|FG000|Overall Study|Adverse Event|4|||
156772351|NCT03082729|565918297|FG000|Overall Study|Protocol Violation|6|||
156772352|NCT03082729|565918297|FG000|Overall Study|Fear of study procedure|1|||
156772353|NCT03082729|565918297|FG000|Overall Study|Scheduling conflict|1|||
156772354|NCT03608163|565918302|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
156772355|NCT03608163|565918303|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
156772356|NCT03454555|565919838|FG000|Overall Study|Death|6|||
156772357|NCT03454555|565919839|FG001|Overall Study|Death|6|||
156772358|NCT03454555|565919838|FG000|Overall Study|Lost to Follow-up|31|||
156772359|NCT03454555|565919839|FG001|Overall Study|Lost to Follow-up|12|||
156772360|NCT03454555|565919838|FG000|Overall Study|Physician Decision|2|||
156772361|NCT03454555|565919839|FG001|Overall Study|Physician Decision|6|||
156772362|NCT03454555|565919838|FG000|Overall Study|Withdrawal by Subject|34|||
156772363|NCT03454555|565919839|FG001|Overall Study|Withdrawal by Subject|5|||
156772364|NCT03454555|565919838|FG000|Overall Study|Ineligible|1|||
156772365|NCT03454555|565919839|FG001|Overall Study|Ineligible|5|||
156772366|NCT04770753|565919846|FG000|Overall Study|Randomized, never treated|1|||
156772367|NCT04770753|565919847|FG001|Overall Study|Randomized, never treated|1|||
156772368|NCT04770753|565919846|FG000|Overall Study|Withdrawal by Subject|3|||
156772369|NCT04770753|565919847|FG001|Overall Study|Withdrawal by Subject|1|||
156772370|NCT04770753|565919846|FG000|Overall Study|Adverse Event|2|||
156772371|NCT04770753|565919847|FG001|Overall Study|Adverse Event|0|||
156772372|NCT04770753|565919846|FG000|Overall Study|Pregnancy|1|||
156772373|NCT04770753|565919847|FG001|Overall Study|Pregnancy|0|||
156772374|NCT04770753|565919846|FG000|Overall Study|Other un-specified|1|||
156772375|NCT04770753|565919847|FG001|Overall Study|Other un-specified|0|||
156772376|NCT00788671|565919848|FG000|Overall Study|Death|2|||
156772377|NCT00788671|565919848|FG000|Overall Study|Unable to biopsy|1|||
156772378|NCT00788671|565919848|FG000|Overall Study|Withdrawal by Subject|4|||
156772379|NCT00788671|565919848|FG000|Overall Study|IUD expulsed|1|||
156772380|NCT00788671|565919848|FG000|Overall Study|Lost to follow up|2|||
156772381|NCT00375752|565919851|FG000|Overall Study|Lack of Efficacy|4|||
156772382|NCT00375752|565919852|FG001|Overall Study|Lack of Efficacy|4|||
156772383|NCT00375752|565919851|FG000|Overall Study|Adverse Event|1|||
156772384|NCT00375752|565919852|FG001|Overall Study|Adverse Event|6|||
156772385|NCT00375752|565919851|FG000|Overall Study|Withdrawal by Subject|6|||
156772386|NCT00375752|565919852|FG001|Overall Study|Withdrawal by Subject|1|||
156772387|NCT00375752|565919851|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
156772388|NCT00375752|565919852|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
156772389|NCT00375752|565919851|FG000|Overall Study|Protocol Violation|0|||
156772390|NCT00375752|565919852|FG001|Overall Study|Protocol Violation|2|||
156772391|NCT00375752|565919851|FG000|Overall Study|Administrative Problems|0|||
156772392|NCT00375752|565919852|FG001|Overall Study|Administrative Problems|1|||
156324088|NCT00417482|564286075|FG001|Phase B 1st 16 Weeks|Death|0|||
156772393|NCT04460885|565919854|FG000|Overall Study|Withdrawal by Subject|6|||
156772394|NCT04460885|565919855|FG001|Overall Study|Withdrawal by Subject|8|||
156772395|NCT04460885|565919854|FG000|Overall Study|Site closure|1|||
156772396|NCT04460885|565919855|FG001|Overall Study|Site closure|0|||
156772397|NCT04460885|565919854|FG000|Overall Study|Death|5|||
156772398|NCT04460885|565919855|FG001|Overall Study|Death|4|||
156772399|NCT04460885|565919854|FG000|Overall Study|Physician Decision|2|||
156772400|NCT04460885|565919855|FG001|Overall Study|Physician Decision|1|||
156772401|NCT04460885|565919854|FG000|Overall Study|Lost to Follow-up|4|||
156772402|NCT04460885|565919855|FG001|Overall Study|Lost to Follow-up|4|||
156772403|NCT01140906|565919859|FG000|Overall Study|Adverse Event|7|||
156772404|NCT01140906|565919860|FG001|Overall Study|Adverse Event|10|||
156772405|NCT01140906|565919861|FG002|Overall Study|Adverse Event|17|||
156772406|NCT01140906|565919862|FG003|Overall Study|Adverse Event|7|||
156772407|NCT01140906|565919859|FG000|Overall Study|Lack of Efficacy|6|||
156772408|NCT01140906|565919860|FG001|Overall Study|Lack of Efficacy|8|||
156772409|NCT01140906|565919861|FG002|Overall Study|Lack of Efficacy|2|||
156772410|NCT01140906|565919862|FG003|Overall Study|Lack of Efficacy|1|||
156772411|NCT01140906|565919859|FG000|Overall Study|Non-compliance|0|||
156772412|NCT01140906|565919860|FG001|Overall Study|Non-compliance|1|||
156772413|NCT01140906|565919861|FG002|Overall Study|Non-compliance|0|||
156772414|NCT01140906|565919862|FG003|Overall Study|Non-compliance|1|||
156772415|NCT01140906|565919859|FG000|Overall Study|Protocol Violation|5|||
156772416|NCT01140906|565919860|FG001|Overall Study|Protocol Violation|3|||
156772417|NCT01140906|565919861|FG002|Overall Study|Protocol Violation|2|||
156772418|NCT01140906|565919862|FG003|Overall Study|Protocol Violation|1|||
156772419|NCT01140906|565919859|FG000|Overall Study|Withdrawal of consent|6|||
156772420|NCT01140906|565919860|FG001|Overall Study|Withdrawal of consent|6|||
156772421|NCT01140906|565919861|FG002|Overall Study|Withdrawal of consent|2|||
156772422|NCT01140906|565919862|FG003|Overall Study|Withdrawal of consent|2|||
156772423|NCT01140906|565919859|FG000|Overall Study|Lost to Follow-up|1|||
156772424|NCT01140906|565919860|FG001|Overall Study|Lost to Follow-up|1|||
156772425|NCT01140906|565919861|FG002|Overall Study|Lost to Follow-up|0|||
156772426|NCT01140906|565919862|FG003|Overall Study|Lost to Follow-up|2|||
156772427|NCT01140906|565919859|FG000|Overall Study|Administrative or other reason|0|||
156772428|NCT01140906|565919860|FG001|Overall Study|Administrative or other reason|5|||
156772429|NCT01140906|565919861|FG002|Overall Study|Administrative or other reason|3|||
156772430|NCT01140906|565919862|FG003|Overall Study|Administrative or other reason|2|||
156772431|NCT01649765|565919863|FG000|Overall Study|Adverse Event|5|||
156772432|NCT01649765|565919864|FG001|Overall Study|Adverse Event|3|||
156772433|NCT01649765|565919863|FG000|Overall Study|Lack of Efficacy|1|||
156772434|NCT01649765|565919864|FG001|Overall Study|Lack of Efficacy|1|||
156772435|NCT01649765|565919863|FG000|Overall Study|Physician Decision|0|||
156772436|NCT01649765|565919864|FG001|Overall Study|Physician Decision|3|||
156772437|NCT01649765|565919863|FG000|Overall Study|Protocol Violation|1|||
156772438|NCT01649765|565919864|FG001|Overall Study|Protocol Violation|0|||
156772439|NCT01649765|565919863|FG000|Overall Study|Withdrawal by Subject|2|||
156772440|NCT01649765|565919864|FG001|Overall Study|Withdrawal by Subject|1|||
156772441|NCT02469233|565919865|FG000|Overall Study|Death|1|||
156772442|NCT02469233|565919866|FG001|Overall Study|Death|1|||
156772443|NCT02469233|565919865|FG000|Overall Study|Lost to post or 6 month follow up|7|||
156772444|NCT02469233|565919866|FG001|Overall Study|Lost to post or 6 month follow up|2|||
156772445|NCT01648764|565919867|FG000|Overall Study|Progressive Disease|0|||
156772446|NCT01648764|565919868|FG001|Overall Study|Progressive Disease|1|||
156772447|NCT01648764|565919869|FG002|Overall Study|Progressive Disease|0|||
156772448|NCT01648764|565919870|FG003|Overall Study|Progressive Disease|0|||
156772449|NCT01648764|565919871|FG004|Overall Study|Progressive Disease|0|||
156772450|NCT01648764|565919872|FG005|Overall Study|Progressive Disease|1|||
156772451|NCT01648764|565919873|FG006|Overall Study|Progressive Disease|1|||
156772452|NCT01648764|565919874|FG007|Overall Study|Progressive Disease|0|||
156772453|NCT01648764|565919875|FG008|Overall Study|Progressive Disease|0|||
156772454|NCT01648764|565919876|FG009|Overall Study|Progressive Disease|2|||
156772455|NCT01648764|565919877|FG010|Overall Study|Progressive Disease|0|||
156772456|NCT01648764|565919878|FG011|Overall Study|Progressive Disease|1|||
156772457|NCT01648764|565919879|FG012|Overall Study|Progressive Disease|2|||
156772458|NCT01648764|565919880|FG013|Overall Study|Progressive Disease|1|||
156772459|NCT01648764|565919867|FG000|Overall Study|Adverse Event|0|||
156772460|NCT01648764|565919868|FG001|Overall Study|Adverse Event|0|||
156772461|NCT01648764|565919869|FG002|Overall Study|Adverse Event|0|||
156772462|NCT01648764|565919870|FG003|Overall Study|Adverse Event|0|||
156772463|NCT01648764|565919871|FG004|Overall Study|Adverse Event|0|||
156772464|NCT01648764|565919872|FG005|Overall Study|Adverse Event|1|||
156772465|NCT01648764|565919873|FG006|Overall Study|Adverse Event|0|||
156772466|NCT01648764|565919874|FG007|Overall Study|Adverse Event|0|||
156772467|NCT01648764|565919875|FG008|Overall Study|Adverse Event|0|||
156772468|NCT01648764|565919876|FG009|Overall Study|Adverse Event|1|||
156772469|NCT01648764|565919877|FG010|Overall Study|Adverse Event|0|||
156772470|NCT01648764|565919878|FG011|Overall Study|Adverse Event|3|||
156772471|NCT01648764|565919879|FG012|Overall Study|Adverse Event|1|||
156772472|NCT01648764|565919880|FG013|Overall Study|Adverse Event|1|||
156772473|NCT01648764|565919867|FG000|Overall Study|Death|0|||
156772474|NCT01648764|565919868|FG001|Overall Study|Death|0|||
156772475|NCT01648764|565919869|FG002|Overall Study|Death|0|||
156772476|NCT01648764|565919870|FG003|Overall Study|Death|0|||
156772477|NCT01648764|565919871|FG004|Overall Study|Death|0|||
156772478|NCT01648764|565919872|FG005|Overall Study|Death|0|||
156772479|NCT01648764|565919873|FG006|Overall Study|Death|1|||
156772480|NCT01648764|565919874|FG007|Overall Study|Death|0|||
156772481|NCT01648764|565919875|FG008|Overall Study|Death|0|||
156772482|NCT01648764|565919876|FG009|Overall Study|Death|0|||
156772483|NCT01648764|565919877|FG010|Overall Study|Death|0|||
156772484|NCT01648764|565919878|FG011|Overall Study|Death|0|||
156772485|NCT01648764|565919879|FG012|Overall Study|Death|0|||
156772486|NCT01648764|565919880|FG013|Overall Study|Death|1|||
156772487|NCT01648764|565919867|FG000|Overall Study|Withdrawal by Subject|0|||
156772488|NCT01648764|565919868|FG001|Overall Study|Withdrawal by Subject|0|||
156772489|NCT01648764|565919869|FG002|Overall Study|Withdrawal by Subject|0|||
156772490|NCT01648764|565919870|FG003|Overall Study|Withdrawal by Subject|0|||
156772491|NCT01648764|565919871|FG004|Overall Study|Withdrawal by Subject|0|||
156772492|NCT01648764|565919872|FG005|Overall Study|Withdrawal by Subject|0|||
156772493|NCT01648764|565919873|FG006|Overall Study|Withdrawal by Subject|2|||
156772494|NCT01648764|565919874|FG007|Overall Study|Withdrawal by Subject|0|||
156772495|NCT01648764|565919875|FG008|Overall Study|Withdrawal by Subject|0|||
156772496|NCT01648764|565919876|FG009|Overall Study|Withdrawal by Subject|0|||
156772497|NCT01648764|565919877|FG010|Overall Study|Withdrawal by Subject|0|||
156772498|NCT01648764|565919878|FG011|Overall Study|Withdrawal by Subject|0|||
156772499|NCT01648764|565919879|FG012|Overall Study|Withdrawal by Subject|1|||
156772500|NCT01648764|565919880|FG013|Overall Study|Withdrawal by Subject|0|||
156772501|NCT01648764|565919867|FG000|Overall Study|Investigator Decision|0|||
156772502|NCT01648764|565919868|FG001|Overall Study|Investigator Decision|0|||
156772503|NCT01648764|565919869|FG002|Overall Study|Investigator Decision|0|||
156772504|NCT01648764|565919870|FG003|Overall Study|Investigator Decision|0|||
156772505|NCT01648764|565919871|FG004|Overall Study|Investigator Decision|0|||
156772506|NCT01648764|565919872|FG005|Overall Study|Investigator Decision|0|||
156772507|NCT01648764|565919873|FG006|Overall Study|Investigator Decision|1|||
156772508|NCT01648764|565919874|FG007|Overall Study|Investigator Decision|0|||
156772509|NCT01648764|565919875|FG008|Overall Study|Investigator Decision|0|||
156772510|NCT01648764|565919876|FG009|Overall Study|Investigator Decision|0|||
156772511|NCT01648764|565919877|FG010|Overall Study|Investigator Decision|0|||
156772512|NCT01648764|565919878|FG011|Overall Study|Investigator Decision|1|||
156772513|NCT01648764|565919879|FG012|Overall Study|Investigator Decision|0|||
156772514|NCT01648764|565919880|FG013|Overall Study|Investigator Decision|0|||
156772515|NCT04889040|565919883|FG000|Overall Study|Withdrawal by Subject|3|||
156772516|NCT04889040|565919884|FG001|Overall Study|Withdrawal by Subject|3|||
156772517|NCT04889040|565919883|FG000|Overall Study|Lost to Follow-up|0|||
156772518|NCT04889040|565919884|FG001|Overall Study|Lost to Follow-up|1|||
156772519|NCT04889040|565919883|FG000|Overall Study|Adverse Event|2|||
156772520|NCT04889040|565919884|FG001|Overall Study|Adverse Event|1|||
156772521|NCT03801252|565919887|FG000|Overall Study|Protocol Violation|1|||
156772522|NCT03801252|565919888|FG001|Overall Study|Protocol Violation|2|||
156772523|NCT02690727|565919889|FG000|Overall Study|Adverse Event|2|||
156772524|NCT02690727|565919890|FG001|Overall Study|Adverse Event|2|||
156772525|NCT00855582|565919893|FG000|Overall Study|Adverse Event|2|||
156772526|NCT00855582|565919894|FG001|Overall Study|Adverse Event|6|||
156772527|NCT00855582|565919895|FG002|Overall Study|Adverse Event|3|||
156772528|NCT00855582|565919893|FG000|Overall Study|Death|1|||
156772529|NCT00855582|565919894|FG001|Overall Study|Death|0|||
156772530|NCT00855582|565919895|FG002|Overall Study|Death|0|||
156772531|NCT00855582|565919893|FG000|Overall Study|Lack of Efficacy|1|||
156772532|NCT00855582|565919894|FG001|Overall Study|Lack of Efficacy|3|||
156772533|NCT00855582|565919895|FG002|Overall Study|Lack of Efficacy|8|||
156772534|NCT00855582|565919893|FG000|Overall Study|Lost to Follow-up|1|||
156772535|NCT00855582|565919894|FG001|Overall Study|Lost to Follow-up|3|||
156772536|NCT00855582|565919895|FG002|Overall Study|Lost to Follow-up|1|||
156772537|NCT00855582|565919893|FG000|Overall Study|Physician Decision|0|||
156772538|NCT00855582|565919894|FG001|Overall Study|Physician Decision|0|||
156772539|NCT00855582|565919895|FG002|Overall Study|Physician Decision|1|||
156772540|NCT00855582|565919893|FG000|Overall Study|Protocol Violation|6|||
156772541|NCT00855582|565919894|FG001|Overall Study|Protocol Violation|2|||
156772542|NCT00855582|565919895|FG002|Overall Study|Protocol Violation|6|||
156772543|NCT00855582|565919893|FG000|Overall Study|Entry Criteria Not Met|8|||
156772544|NCT00855582|565919894|FG001|Overall Study|Entry Criteria Not Met|6|||
156772545|NCT00855582|565919895|FG002|Overall Study|Entry Criteria Not Met|3|||
156772546|NCT00855582|565919893|FG000|Overall Study|Withdrawal by Subject|7|||
156324089|NCT00417482|564286076|FG002|Phase B 1st 16 Weeks|Death|0|||
156772547|NCT00855582|565919894|FG001|Overall Study|Withdrawal by Subject|4|||
156772548|NCT00855582|565919895|FG002|Overall Study|Withdrawal by Subject|8|||
156772549|NCT04757636|565919899|FG000|Overall Study|Adverse Event|25|||
156772550|NCT04757636|565919900|FG001|Overall Study|Adverse Event|8|||
156772551|NCT04757636|565919901|FG002|Overall Study|Adverse Event|11|||
156772552|NCT04757636|565919899|FG000|Overall Study|Death|9|||
156772553|NCT04757636|565919900|FG001|Overall Study|Death|12|||
156772554|NCT04757636|565919901|FG002|Overall Study|Death|6|||
156772555|NCT04757636|565919899|FG000|Overall Study|Lack of Efficacy|2|||
156772556|NCT04757636|565919900|FG001|Overall Study|Lack of Efficacy|0|||
156772557|NCT04757636|565919901|FG002|Overall Study|Lack of Efficacy|0|||
156772558|NCT04757636|565919899|FG000|Overall Study|Lost to Follow-up|1|||
156772559|NCT04757636|565919900|FG001|Overall Study|Lost to Follow-up|6|||
156772560|NCT04757636|565919901|FG002|Overall Study|Lost to Follow-up|7|||
156657607|NCT03595657|565491891|FG000|Overall Study|Lack of Efficacy|40|||
156657608|NCT03595657|565491891|FG000|Overall Study|Withdrawal by Subject|10|||
156657609|NCT03595657|565491891|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
156657610|NCT03595657|565491891|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
156657611|NCT01066052|565491892|FG000|Overall Study|Enrolled But Not Treated|3|||
156772561|NCT04757636|565919899|FG000|Overall Study|Physician Decision|1|||
156772562|NCT04757636|565919900|FG001|Overall Study|Physician Decision|3|||
156772563|NCT04757636|565919901|FG002|Overall Study|Physician Decision|4|||
156772564|NCT04757636|565919899|FG000|Overall Study|Withdrawal by Subject|20|||
156772565|NCT04757636|565919900|FG001|Overall Study|Withdrawal by Subject|23|||
156772566|NCT04757636|565919901|FG002|Overall Study|Withdrawal by Subject|18|||
156772567|NCT04757636|565919899|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
156772568|NCT04757636|565919900|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
156772569|NCT04757636|565919901|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
156772570|NCT04757636|565919899|FG000|Overall Study|Study Terminated by Sponsor|103|||
156772571|NCT04757636|565919900|FG001|Overall Study|Study Terminated by Sponsor|104|||
156772572|NCT04757636|565919901|FG002|Overall Study|Study Terminated by Sponsor|114|||
156772573|NCT04757636|565919899|FG000|Overall Study|Sponsor Decision|0|||
156772574|NCT04757636|565919900|FG001|Overall Study|Sponsor Decision|0|||
156772575|NCT04757636|565919901|FG002|Overall Study|Sponsor Decision|1|||
156772576|NCT04757636|565919899|FG000|Overall Study|Randomized in Error|0|||
156772577|NCT04757636|565919900|FG001|Overall Study|Randomized in Error|0|||
156772578|NCT04757636|565919901|FG002|Overall Study|Randomized in Error|2|||
156772579|NCT01732692|565919905|FG000|Overall Study|Adverse Event|0|||
156772580|NCT01732692|565919906|FG001|Overall Study|Adverse Event|1|||
156772581|NCT00656617|565919907|FG000|Overall Study|Adverse Event|1|||
156772582|NCT00656617|565919907|FG000|Overall Study|Death|2|||
156772583|NCT00656617|565919907|FG000|Overall Study|Insurance Issues|2|||
156772584|NCT00656617|565919907|FG000|Overall Study|Move to different clinical trial|2|||
156772585|NCT01155323|565919914|FG000|First Intervention|exclusion criteria|1|||
156772586|NCT01155323|565919915|FG001|First Intervention|exclusion criteria|1|||
156772587|NCT01155323|565919914|FG000|Second Intervention|Lost to Follow-up|1|||
156772588|NCT01155323|565919915|FG001|Second Intervention|Lost to Follow-up|1|||
156772589|NCT01208051|565919916|FG000|Total Enrollment|Withdrawal by Subject|0|||
156772590|NCT01208051|565919917|FG001|Total Enrollment|Withdrawal by Subject|1|||
156772591|NCT01208051|565919918|FG002|Total Enrollment|Withdrawal by Subject|0|||
156772592|NCT01208051|565919919|FG003|Total Enrollment|Withdrawal by Subject|0|||
156772593|NCT01208051|565919920|FG004|Total Enrollment|Withdrawal by Subject|2|||
156772594|NCT01208051|565919916|FG000|Total Enrollment|Brain metastases|0|||
156772595|NCT01208051|565919917|FG001|Total Enrollment|Brain metastases|0|||
156772596|NCT01208051|565919918|FG002|Total Enrollment|Brain metastases|1|||
156772597|NCT01208051|565919919|FG003|Total Enrollment|Brain metastases|0|||
156772598|NCT01208051|565919920|FG004|Total Enrollment|Brain metastases|0|||
156772599|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
156772600|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
156772601|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
156772602|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
156772603|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
156772604|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
156772605|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
156772606|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
156772607|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
156772608|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
156772609|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
156772610|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
156772611|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
156772612|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
156772613|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
156772614|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
156772615|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
156772616|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
156772617|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
156772618|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
156772619|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
156772620|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
156772621|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
156772622|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
156772623|NCT02471339|565919923|FG000|Overall Study|Did not provide follow-up data|2|||
156772624|NCT02471339|565919924|FG001|Overall Study|Did not provide follow-up data|0|||
156772625|NCT06057064|565919925|FG000|Overall Study|Death|2|||
156772626|NCT06057064|565919926|FG001|Overall Study|Death|0|||
156772627|NCT06057064|565919925|FG000|Overall Study|Physician Decision|1|||
156772628|NCT06057064|565919926|FG001|Overall Study|Physician Decision|0|||
156772629|NCT06057064|565919925|FG000|Overall Study|Withdrawal by Subject|1|||
156772630|NCT06057064|565919926|FG001|Overall Study|Withdrawal by Subject|1|||
156772631|NCT00851591|565919928|FG000|Overall Study|Withdrawal by Subject|2|||
156772632|NCT00851591|565919929|FG001|Overall Study|Withdrawal by Subject|0|||
156772633|NCT00746551|565919939|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
156772634|NCT00746551|565919940|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
156772635|NCT00746551|565919939|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
156772636|NCT00746551|565919940|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
156772637|NCT00746551|565919939|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
156772638|NCT00746551|565919940|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
156772639|NCT01114724|565919945|FG000|Overall Study|Death|8|||
156772640|NCT01114724|565919945|FG000|Overall Study|Lost to Follow-up|1|||
156772641|NCT01114724|565919945|FG000|Overall Study|Withdrawal by Subject|1|||
156772642|NCT02273167|565919948|FG000|Overall Study|Adverse Event|1|||
156772643|NCT02273167|565919949|FG001|Overall Study|Adverse Event|0|||
156772644|NCT02273167|565919950|FG002|Overall Study|Adverse Event|0|||
156772645|NCT02273167|565919948|FG000|Overall Study|Protocol Violation|3|||
156772646|NCT02273167|565919949|FG001|Overall Study|Protocol Violation|1|||
156772647|NCT02273167|565919950|FG002|Overall Study|Protocol Violation|1|||
156772648|NCT02273167|565919948|FG000|Overall Study|Lost to Follow-up|0|||
156772649|NCT02273167|565919949|FG001|Overall Study|Lost to Follow-up|1|||
156772650|NCT02273167|565919950|FG002|Overall Study|Lost to Follow-up|1|||
156772651|NCT02273167|565919948|FG000|Overall Study|Withdrawal by Subject|10|||
156772652|NCT02273167|565919949|FG001|Overall Study|Withdrawal by Subject|12|||
156772653|NCT02273167|565919950|FG002|Overall Study|Withdrawal by Subject|11|||
156772654|NCT02273167|565919948|FG000|Overall Study|Various|10|||
156772655|NCT02273167|565919949|FG001|Overall Study|Various|9|||
156772656|NCT02273167|565919950|FG002|Overall Study|Various|8|||
156772657|NCT00834041|565919954|FG000|Overall Study|Withdrawal by Subject|1|||
156772658|NCT00834041|565919955|FG001|Overall Study|Withdrawal by Subject|0|||
156772659|NCT00834041|565919954|FG000|Overall Study|Lost to Follow-up|0|||
156772660|NCT00834041|565919955|FG001|Overall Study|Lost to Follow-up|1|||
156772661|NCT03074500|565919956|FG000|Overall Study|Lost to Follow-up|1|||
156772662|NCT03074500|565919957|FG001|Overall Study|Lost to Follow-up|0|||
156772663|NCT03074500|565919958|FG002|Overall Study|Lost to Follow-up|0|||
156772664|NCT03074500|565919956|FG000|Overall Study|Lack of Efficacy|0|||
156772665|NCT03074500|565919957|FG001|Overall Study|Lack of Efficacy|1|||
156772666|NCT03074500|565919958|FG002|Overall Study|Lack of Efficacy|0|||
156772667|NCT03074500|565919956|FG000|Overall Study|Adverse Event|0|||
156772668|NCT03074500|565919957|FG001|Overall Study|Adverse Event|0|||
156772669|NCT03074500|565919958|FG002|Overall Study|Adverse Event|1|||
156772670|NCT01416571|565919959|FG000|Overall Study|Lost to Follow-up|2|||
156772671|NCT03353220|565919965|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
156772672|NCT03353220|565919966|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
156772673|NCT03586479|565919967|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
156772674|NCT03586479|565919968|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
156772675|NCT03586479|565919969|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
156772676|NCT03586479|565919967|FG000|Overall Study|Protocol Violation|2|||
156772677|NCT03586479|565919968|FG001|Overall Study|Protocol Violation|0|||
156772678|NCT03586479|565919969|FG002|Overall Study|Protocol Violation|0|||
156772679|NCT03586479|565919967|FG000|Overall Study|Lost to Follow-up|1|||
156772680|NCT03586479|565919968|FG001|Overall Study|Lost to Follow-up|1|||
156772681|NCT03586479|565919969|FG002|Overall Study|Lost to Follow-up|2|||
156772682|NCT03586479|565919967|FG000|Overall Study|Behavioral Issues|1|||
156772683|NCT03586479|565919968|FG001|Overall Study|Behavioral Issues|0|||
156772684|NCT03586479|565919969|FG002|Overall Study|Behavioral Issues|0|||
156772685|NCT01288430|565921118|FG000|Part 1|Progressive disease|2|||
156772686|NCT01288430|565921119|FG001|Part 1|Progressive disease|1|||
156772687|NCT01288430|565921120|FG002|Part 1|Progressive disease|1|||
156772688|NCT01288430|565921121|FG003|Part 1|Progressive disease|6|||
156772689|NCT01288430|565921122|FG004|Part 1|Progressive disease|2|||
156772690|NCT01288430|565921123|FG005|Part 1|Progressive disease|4|||
156772691|NCT01288430|565921124|FG006|Part 1|Progressive disease|2|||
156772692|NCT01288430|565921125|FG007|Part 1|Progressive disease|0|||
156772693|NCT01288430|565921126|FG008|Part 1|Progressive disease|0|||
156772694|NCT01288430|565921127|FG009|Part 1|Progressive disease|0|||
156772695|NCT01288430|565921118|FG000|Part 1|Clinical disease progression|0|||
156772696|NCT01288430|565921119|FG001|Part 1|Clinical disease progression|0|||
156772697|NCT01288430|565921120|FG002|Part 1|Clinical disease progression|1|||
156772698|NCT01288430|565921121|FG003|Part 1|Clinical disease progression|0|||
156772699|NCT01288430|565921122|FG004|Part 1|Clinical disease progression|0|||
156772700|NCT01288430|565921123|FG005|Part 1|Clinical disease progression|2|||
156772701|NCT01288430|565921124|FG006|Part 1|Clinical disease progression|2|||
156428410|NCT03761784|564660856|FG001|Overall Study|Physician Decision|0|||
156772702|NCT01288430|565921125|FG007|Part 1|Clinical disease progression|0|||
156772703|NCT01288430|565921126|FG008|Part 1|Clinical disease progression|0|||
156772704|NCT01288430|565921127|FG009|Part 1|Clinical disease progression|0|||
156772705|NCT01288430|565921118|FG000|Part 1|Death due to disease progression|0|||
156772706|NCT01288430|565921119|FG001|Part 1|Death due to disease progression|0|||
156772707|NCT01288430|565921120|FG002|Part 1|Death due to disease progression|0|||
156772708|NCT01288430|565921121|FG003|Part 1|Death due to disease progression|0|||
156772709|NCT01288430|565921122|FG004|Part 1|Death due to disease progression|1|||
156772710|NCT01288430|565921123|FG005|Part 1|Death due to disease progression|0|||
156772711|NCT01288430|565921124|FG006|Part 1|Death due to disease progression|0|||
156772712|NCT01288430|565921125|FG007|Part 1|Death due to disease progression|0|||
156772713|NCT01288430|565921126|FG008|Part 1|Death due to disease progression|0|||
156772714|NCT01288430|565921127|FG009|Part 1|Death due to disease progression|0|||
156772715|NCT01288430|565921118|FG000|Part 1|Adverse Event|0|||
156772716|NCT01288430|565921119|FG001|Part 1|Adverse Event|0|||
156772717|NCT01288430|565921120|FG002|Part 1|Adverse Event|3|||
156772718|NCT01288430|565921121|FG003|Part 1|Adverse Event|1|||
156772719|NCT01288430|565921122|FG004|Part 1|Adverse Event|0|||
156772720|NCT01288430|565921123|FG005|Part 1|Adverse Event|0|||
156772721|NCT01288430|565921124|FG006|Part 1|Adverse Event|2|||
156772722|NCT01288430|565921125|FG007|Part 1|Adverse Event|0|||
156772723|NCT01288430|565921126|FG008|Part 1|Adverse Event|0|||
156772724|NCT01288430|565921127|FG009|Part 1|Adverse Event|0|||
156772725|NCT01288430|565921118|FG000|Part 1|Other|0|||
156772726|NCT01288430|565921119|FG001|Part 1|Other|2|||
156772727|NCT01288430|565921120|FG002|Part 1|Other|0|||
156772728|NCT01288430|565921121|FG003|Part 1|Other|0|||
156772729|NCT01288430|565921122|FG004|Part 1|Other|0|||
156772730|NCT01288430|565921123|FG005|Part 1|Other|0|||
156772731|NCT01288430|565921124|FG006|Part 1|Other|1|||
156772732|NCT01288430|565921125|FG007|Part 1|Other|0|||
156772733|NCT01288430|565921126|FG008|Part 1|Other|0|||
156772734|NCT01288430|565921127|FG009|Part 1|Other|0|||
156772735|NCT01288430|565921118|FG000|Part 2|Progressive disease|0|||
156772736|NCT01288430|565921119|FG001|Part 2|Progressive disease|0|||
156772737|NCT01288430|565921120|FG002|Part 2|Progressive disease|0|||
156772738|NCT01288430|565921121|FG003|Part 2|Progressive disease|0|||
156772739|NCT01288430|565921122|FG004|Part 2|Progressive disease|0|||
156772740|NCT01288430|565921123|FG005|Part 2|Progressive disease|0|||
156772741|NCT01288430|565921124|FG006|Part 2|Progressive disease|0|||
156772742|NCT01288430|565921125|FG007|Part 2|Progressive disease|8|||
156772743|NCT01288430|565921126|FG008|Part 2|Progressive disease|7|||
156772744|NCT01288430|565921127|FG009|Part 2|Progressive disease|2|||
156772745|NCT01288430|565921118|FG000|Part 2|Clinical disease progression|0|||
156772746|NCT01288430|565921119|FG001|Part 2|Clinical disease progression|0|||
156772747|NCT01288430|565921120|FG002|Part 2|Clinical disease progression|0|||
156772748|NCT01288430|565921121|FG003|Part 2|Clinical disease progression|0|||
156772749|NCT01288430|565921122|FG004|Part 2|Clinical disease progression|0|||
156772750|NCT01288430|565921123|FG005|Part 2|Clinical disease progression|0|||
156772751|NCT01288430|565921124|FG006|Part 2|Clinical disease progression|0|||
156772752|NCT01288430|565921125|FG007|Part 2|Clinical disease progression|2|||
156772753|NCT01288430|565921126|FG008|Part 2|Clinical disease progression|0|||
156772754|NCT01288430|565921127|FG009|Part 2|Clinical disease progression|0|||
156772755|NCT01288430|565921118|FG000|Part 2|Withdrawal by Subject|0|||
156772756|NCT01288430|565921119|FG001|Part 2|Withdrawal by Subject|0|||
156772757|NCT01288430|565921120|FG002|Part 2|Withdrawal by Subject|0|||
156772758|NCT01288430|565921121|FG003|Part 2|Withdrawal by Subject|0|||
156772759|NCT01288430|565921122|FG004|Part 2|Withdrawal by Subject|0|||
156772760|NCT01288430|565921123|FG005|Part 2|Withdrawal by Subject|0|||
156428411|NCT03761784|564660855|FG000|Overall Study|Other Than Specified|1|||
156772761|NCT01288430|565921124|FG006|Part 2|Withdrawal by Subject|0|||
156772762|NCT01288430|565921125|FG007|Part 2|Withdrawal by Subject|1|||
156772763|NCT01288430|565921126|FG008|Part 2|Withdrawal by Subject|4|||
156772764|NCT01288430|565921127|FG009|Part 2|Withdrawal by Subject|0|||
156772765|NCT01288430|565921118|FG000|Part 2|Adverse Event|0|||
156772766|NCT01288430|565921119|FG001|Part 2|Adverse Event|0|||
156772767|NCT01288430|565921120|FG002|Part 2|Adverse Event|0|||
156772768|NCT01288430|565921121|FG003|Part 2|Adverse Event|0|||
156772769|NCT01288430|565921122|FG004|Part 2|Adverse Event|0|||
156772770|NCT01288430|565921123|FG005|Part 2|Adverse Event|0|||
156772771|NCT01288430|565921124|FG006|Part 2|Adverse Event|0|||
156772772|NCT01288430|565921125|FG007|Part 2|Adverse Event|1|||
156428412|NCT03761784|564660856|FG001|Overall Study|Other Than Specified|0|||
156428413|NCT00586339|564660857|FG000|Overall Study|Withdrawal by Subject|1|||
156772773|NCT01288430|565921126|FG008|Part 2|Adverse Event|1|||
156772774|NCT01288430|565921127|FG009|Part 2|Adverse Event|0|||
156772775|NCT01288430|565921118|FG000|Part 2|Other|0|||
156772776|NCT01288430|565921119|FG001|Part 2|Other|0|||
156772777|NCT01288430|565921120|FG002|Part 2|Other|0|||
156772778|NCT01288430|565921121|FG003|Part 2|Other|0|||
156772779|NCT01288430|565921122|FG004|Part 2|Other|0|||
156772780|NCT01288430|565921123|FG005|Part 2|Other|0|||
156772781|NCT01288430|565921124|FG006|Part 2|Other|0|||
156772782|NCT01288430|565921125|FG007|Part 2|Other|0|||
156772783|NCT01288430|565921126|FG008|Part 2|Other|0|||
156772784|NCT01288430|565921127|FG009|Part 2|Other|1|||
156772785|NCT05493111|565921128|FG000|Overall Study|Adverse Event|3|||
156772786|NCT05493111|565921129|FG001|Overall Study|Adverse Event|4|||
156772787|NCT05493111|565921128|FG000|Overall Study|Withdrawal of Consent|19|||
156772788|NCT05493111|565921129|FG001|Overall Study|Withdrawal of Consent|10|||
156772789|NCT05493111|565921128|FG000|Overall Study|Non-compliance|1|||
156772790|NCT05493111|565921129|FG001|Overall Study|Non-compliance|1|||
156772791|NCT05493111|565921128|FG000|Overall Study|Lost to Follow-up|8|||
156772792|NCT05493111|565921129|FG001|Overall Study|Lost to Follow-up|1|||
156772793|NCT05493111|565921128|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
156772794|NCT05493111|565921129|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
156772795|NCT05493111|565921128|FG000|Overall Study|Withdrawal by Subject|1|||
156772796|NCT05493111|565921129|FG001|Overall Study|Withdrawal by Subject|1|||
156772797|NCT03836053|565921132|FG000|Overall Study|Protocol-specified criteria|0|||
156324090|NCT00417482|564286074|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
156772798|NCT03836053|565921133|FG001|Overall Study|Protocol-specified criteria|2|||
156772799|NCT03836053|565921134|FG002|Overall Study|Protocol-specified criteria|1|||
156772800|NCT03836053|565921132|FG000|Overall Study|Death|1|||
156772801|NCT03836053|565921133|FG001|Overall Study|Death|6|||
156772802|NCT03836053|565921134|FG002|Overall Study|Death|4|||
156772803|NCT03836053|565921132|FG000|Overall Study|Withdrawal of consent from study|0|||
156772804|NCT03836053|565921133|FG001|Overall Study|Withdrawal of consent from study|0|||
156772805|NCT03836053|565921134|FG002|Overall Study|Withdrawal of consent from study|1|||
156772806|NCT03836053|565921132|FG000|Overall Study|Decision by sponsor|0|||
156772807|NCT03836053|565921133|FG001|Overall Study|Decision by sponsor|2|||
156772808|NCT03836053|565921134|FG002|Overall Study|Decision by sponsor|4|||
156772809|NCT04486716|565921135|FG000|Core Phase|Subject decision|6|||
156772810|NCT04486716|565921135|FG000|Core Phase|Adverse Event|5|||
156772811|NCT04486716|565921135|FG000|Core Phase|Lost to Follow-up|1|||
156772812|NCT04486716|565921135|FG000|Core Phase|Physician Decision|1|||
156772813|NCT04486716|565921135|FG000|Core Phase|Enrolled subjects not treated|9|||
156772814|NCT02807259|565921136|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
156772815|NCT02807259|565921137|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
156772816|NCT02807259|565921136|FG000|Midline (3 Months)|migration, refusal, not available|30|||
156772817|NCT02807259|565921137|FG001|Midline (3 Months)|migration, refusal, not available|34|||
156772818|NCT02807259|565921136|FG000|Endline (3 Months)|migration, refusal, not available|35|||
156772819|NCT02807259|565921137|FG001|Endline (3 Months)|migration, refusal, not available|87|||
156772820|NCT04761822|565921140|FG000|Overall Study|Adverse Event|3|||
156772821|NCT04761822|565921141|FG001|Overall Study|Adverse Event|1|||
156772822|NCT04761822|565921142|FG002|Overall Study|Adverse Event|1|||
156772823|NCT04761822|565921143|FG003|Overall Study|Adverse Event|3|||
156772824|NCT04761822|565921140|FG000|Overall Study|Lost to Follow-up|1|||
156772825|NCT04761822|565921141|FG001|Overall Study|Lost to Follow-up|0|||
156772826|NCT04761822|565921142|FG002|Overall Study|Lost to Follow-up|2|||
156772827|NCT04761822|565921143|FG003|Overall Study|Lost to Follow-up|3|||
156772828|NCT04761822|565921140|FG000|Overall Study|Physician Decision|0|||
156772829|NCT04761822|565921141|FG001|Overall Study|Physician Decision|1|||
156772830|NCT04761822|565921142|FG002|Overall Study|Physician Decision|0|||
156772831|NCT04761822|565921143|FG003|Overall Study|Physician Decision|0|||
156772832|NCT04761822|565921140|FG000|Overall Study|Withdrawal by Subject|3|||
156772833|NCT04761822|565921141|FG001|Overall Study|Withdrawal by Subject|8|||
156772834|NCT04761822|565921142|FG002|Overall Study|Withdrawal by Subject|1|||
156772835|NCT04761822|565921143|FG003|Overall Study|Withdrawal by Subject|11|||
156772836|NCT04761822|565921140|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
156772837|NCT04761822|565921141|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
156772838|NCT04761822|565921142|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
156772839|NCT04761822|565921143|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
156772840|NCT04761822|565921140|FG000|Overall Study|Participant requested unblinding|0|||
156772841|NCT04761822|565921141|FG001|Overall Study|Participant requested unblinding|0|||
156772842|NCT04761822|565921142|FG002|Overall Study|Participant requested unblinding|0|||
156772843|NCT04761822|565921143|FG003|Overall Study|Participant requested unblinding|1|||
156772844|NCT02233413|565921144|FG000|Overall Study|Lost to Follow-up|7|||
156772845|NCT02233413|565921145|FG001|Overall Study|Lost to Follow-up|9|||
156772846|NCT02233413|565921144|FG000|Overall Study|Withdrawal by Subject|4|||
156772847|NCT02233413|565921145|FG001|Overall Study|Withdrawal by Subject|5|||
156324091|NCT00417482|564286075|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
156772848|NCT04476043|565921150|FG000|Overall Study|Withdrawal by Subject|1|||
156772849|NCT04476043|565921151|FG001|Overall Study|Withdrawal by Subject|3|||
156772850|NCT04476043|565921152|FG002|Overall Study|Withdrawal by Subject|4|||
156772851|NCT04476043|565921153|FG003|Overall Study|Withdrawal by Subject|1|||
156324092|NCT00417482|564286076|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
156324093|NCT00417482|564286074|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
156772852|NCT04476043|565921150|FG000|Overall Study|Lost to Follow-up|1|||
156772853|NCT04476043|565921151|FG001|Overall Study|Lost to Follow-up|1|||
156772854|NCT04476043|565921152|FG002|Overall Study|Lost to Follow-up|2|||
156772855|NCT04476043|565921153|FG003|Overall Study|Lost to Follow-up|1|||
156772856|NCT04476043|565921150|FG000|Overall Study|Adverse Event|2|||
156772857|NCT04476043|565921151|FG001|Overall Study|Adverse Event|0|||
156772858|NCT04476043|565921152|FG002|Overall Study|Adverse Event|1|||
156772859|NCT04476043|565921153|FG003|Overall Study|Adverse Event|0|||
156772860|NCT04476043|565921150|FG000|Overall Study|Protocol Violation|0|||
156772861|NCT04476043|565921151|FG001|Overall Study|Protocol Violation|1|||
156772862|NCT04476043|565921152|FG002|Overall Study|Protocol Violation|0|||
156772863|NCT04476043|565921153|FG003|Overall Study|Protocol Violation|0|||
156772864|NCT02349386|565921154|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
156772865|NCT02349386|565921155|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
156772866|NCT02349386|565921156|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
156772867|NCT02349386|565921157|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
156772868|NCT02349386|565921154|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
156772869|NCT02349386|565921155|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
156772870|NCT02349386|565921156|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
156772871|NCT02349386|565921157|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
156772872|NCT02349386|565921154|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
156772873|NCT02349386|565921155|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
156772874|NCT02349386|565921156|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
156772875|NCT02349386|565921157|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
156772876|NCT02349386|565921154|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
156772877|NCT02349386|565921155|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
156772878|NCT02349386|565921156|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
156772879|NCT02349386|565921157|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
156772880|NCT02349386|565921154|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
156772881|NCT02349386|565921155|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
156772882|NCT02349386|565921156|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
156772883|NCT02349386|565921157|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
156772884|NCT02349386|565921154|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
156772885|NCT02349386|565921155|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
156772886|NCT02349386|565921156|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
156772887|NCT02349386|565921157|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
156772888|NCT02736617|565921158|FG000|Treatment|Adverse Event|1|||
156772889|NCT02736617|565921158|FG000|Treatment|Lack of Efficacy|1|||
156772890|NCT02736617|565921158|FG000|Treatment|Withdrawal by Subject|1|||
156772891|NCT02736617|565921158|FG000|Maintenance|Lack of Efficacy|4|||
156772892|NCT02736617|565921158|FG000|Maintenance|Physician Decision|1|||
156772893|NCT02110693|565921159|FG000|Overall Study|Withdrawal by Subject|6|||
156772894|NCT02110693|565921160|FG001|Overall Study|Withdrawal by Subject|7|||
156772895|NCT02110693|565921159|FG000|Overall Study|skipped assessment|15|||
156772896|NCT02110693|565921160|FG001|Overall Study|skipped assessment|18|||
156772897|NCT02110693|565921159|FG000|Overall Study|technical difficulties|6|||
156772898|NCT02110693|565921160|FG001|Overall Study|technical difficulties|4|||
156772899|NCT02110693|565921159|FG000|Overall Study|Other|1|||
156772900|NCT02110693|565921160|FG001|Overall Study|Other|0|||
156772901|NCT00920816|565921161|FG000|Overall Study|Death|116|||
156772902|NCT00920816|565921162|FG001|Overall Study|Death|63|||
156772903|NCT00920816|565921163|FG002|Overall Study|Death|8|||
156772904|NCT00920816|565921164|FG003|Overall Study|Death|3|||
156772905|NCT00920816|565921161|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
156772906|NCT00920816|565921162|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
156772907|NCT00920816|565921163|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
156772908|NCT00920816|565921164|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
156772909|NCT00920816|565921161|FG000|Overall Study|Global deterioration of health status|2|||
156772910|NCT00920816|565921162|FG001|Overall Study|Global deterioration of health status|0|||
156772911|NCT00920816|565921163|FG002|Overall Study|Global deterioration of health status|0|||
156772912|NCT00920816|565921164|FG003|Overall Study|Global deterioration of health status|0|||
156772913|NCT00920816|565921161|FG000|Overall Study|Objective progression or relapse|6|||
156772914|NCT00920816|565921162|FG001|Overall Study|Objective progression or relapse|2|||
156772915|NCT00920816|565921163|FG002|Overall Study|Objective progression or relapse|0|||
156772916|NCT00920816|565921164|FG003|Overall Study|Objective progression or relapse|0|||
156772917|NCT00920816|565921161|FG000|Overall Study|Other|26|||
156772918|NCT00920816|565921162|FG001|Overall Study|Other|15|||
156772919|NCT00920816|565921163|FG002|Overall Study|Other|1|||
156772920|NCT00920816|565921164|FG003|Overall Study|Other|2|||
156772921|NCT00920816|565921161|FG000|Overall Study|Lost to Follow-up|11|||
156772922|NCT00920816|565921162|FG001|Overall Study|Lost to Follow-up|2|||
156772923|NCT00920816|565921163|FG002|Overall Study|Lost to Follow-up|0|||
156772924|NCT00920816|565921164|FG003|Overall Study|Lost to Follow-up|0|||
156772925|NCT00920816|565921161|FG000|Overall Study|Adverse Event|1|||
156657612|NCT01066052|565491893|FG001|Overall Study|Enrolled But Not Treated|0|||
156657613|NCT01835145|565491894|FG000|Overall Study|Ineligible prior to treatment|1|||
156657614|NCT01835145|565491895|FG001|Overall Study|Ineligible prior to treatment|0|||
156657615|NCT04094870|565491896|FG000|Overall Study|Lost to Follow-up|1|||
156657616|NCT04094870|565491897|FG001|Overall Study|Lost to Follow-up|1|||
156657617|NCT02708277|565491898|FG000|Overall Study|Lost to Follow-up|7|||
156657618|NCT02708277|565491899|FG001|Overall Study|Lost to Follow-up|4|||
156657619|NCT02742181|565491900|FG000|Overall Study|Physician Decision|1|||
156657620|NCT02742181|565491901|FG001|Overall Study|Physician Decision|0|||
156657621|NCT02739984|565491902|FG000|Overall Study|Sponsor Decision|1|||
156657622|NCT02739984|565491903|FG001|Overall Study|Sponsor Decision|0|||
156657623|NCT02739984|565491902|FG000|Overall Study|Withdrawal by Subject|1|||
156657624|NCT02739984|565491903|FG001|Overall Study|Withdrawal by Subject|1|||
156657625|NCT02739984|565491902|FG000|Overall Study|Death|0|||
156657626|NCT02739984|565491903|FG001|Overall Study|Death|1|||
156657627|NCT02739984|565491902|FG000|Overall Study|Lost to Follow-up|3|||
156657628|NCT02739984|565491903|FG001|Overall Study|Lost to Follow-up|0|||
156657629|NCT00409578|565491906|FG000|Overall Study|Adverse Event|27|||
156657630|NCT00409578|565491907|FG001|Overall Study|Adverse Event|37|||
156657631|NCT00409578|565491908|FG002|Overall Study|Adverse Event|25|||
156657632|NCT00409578|565491909|FG003|Overall Study|Adverse Event|33|||
156657633|NCT00409578|565491906|FG000|Overall Study|Abnormal laboratory value(s)|2|||
156657634|NCT00409578|565491907|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156657635|NCT00409578|565491908|FG002|Overall Study|Abnormal laboratory value(s)|2|||
156657636|NCT00409578|565491909|FG003|Overall Study|Abnormal laboratory value(s)|4|||
156657637|NCT00409578|565491906|FG000|Overall Study|Lack of Efficacy|0|||
156657638|NCT00409578|565491907|FG001|Overall Study|Lack of Efficacy|0|||
156657639|NCT00409578|565491908|FG002|Overall Study|Lack of Efficacy|0|||
156657640|NCT00409578|565491909|FG003|Overall Study|Lack of Efficacy|2|||
156657641|NCT00409578|565491906|FG000|Overall Study|Subject no longer requires study drug|0|||
156657642|NCT00409578|565491907|FG001|Overall Study|Subject no longer requires study drug|0|||
156657643|NCT00409578|565491908|FG002|Overall Study|Subject no longer requires study drug|0|||
156657644|NCT00409578|565491909|FG003|Overall Study|Subject no longer requires study drug|1|||
156657645|NCT00409578|565491906|FG000|Overall Study|Withdrawal by Subject|8|||
156657646|NCT00409578|565491907|FG001|Overall Study|Withdrawal by Subject|15|||
156657647|NCT00409578|565491908|FG002|Overall Study|Withdrawal by Subject|16|||
156657648|NCT00409578|565491909|FG003|Overall Study|Withdrawal by Subject|17|||
156657649|NCT00409578|565491906|FG000|Overall Study|Lost to Follow-up|2|||
156657650|NCT00409578|565491907|FG001|Overall Study|Lost to Follow-up|0|||
156657651|NCT00409578|565491908|FG002|Overall Study|Lost to Follow-up|2|||
156657652|NCT00409578|565491909|FG003|Overall Study|Lost to Follow-up|2|||
156657653|NCT00409578|565491906|FG000|Overall Study|Administrative problems|8|||
156657654|NCT00409578|565491907|FG001|Overall Study|Administrative problems|9|||
156657655|NCT00409578|565491908|FG002|Overall Study|Administrative problems|2|||
156657656|NCT00409578|565491909|FG003|Overall Study|Administrative problems|4|||
156657657|NCT00409578|565491906|FG000|Overall Study|Death|2|||
156657658|NCT00409578|565491907|FG001|Overall Study|Death|4|||
156657659|NCT00409578|565491908|FG002|Overall Study|Death|4|||
156657660|NCT00409578|565491909|FG003|Overall Study|Death|2|||
156657661|NCT00409578|565491906|FG000|Overall Study|Protocol Violation|3|||
156657662|NCT00409578|565491907|FG001|Overall Study|Protocol Violation|2|||
156657663|NCT00409578|565491908|FG002|Overall Study|Protocol Violation|3|||
156657664|NCT00409578|565491909|FG003|Overall Study|Protocol Violation|1|||
156657665|NCT00409578|565491906|FG000|Overall Study|Missing|0|||
156657666|NCT00409578|565491907|FG001|Overall Study|Missing|1|||
156657667|NCT00409578|565491908|FG002|Overall Study|Missing|0|||
156657668|NCT00409578|565491909|FG003|Overall Study|Missing|1|||
156657669|NCT02109133|565491910|FG000|Overall Study|Lost to Follow-up|1|||
156657670|NCT02109133|565491911|FG001|Overall Study|Lost to Follow-up|0|||
156657671|NCT02448771|565491912|FG000|Overall Study|Disease Progression|30|||
156657672|NCT02448771|565491912|FG000|Overall Study|Unacceptable Toxicity|1|||
156657673|NCT02448771|565491912|FG000|Overall Study|Physician Decision|3|||
156657674|NCT02448771|565491912|FG000|Overall Study|Started new therapy|2|||
156657675|NCT03968224|565491913|FG000|Overall Study|Lost to Follow-up|11|||
156657676|NCT03968224|565491914|FG001|Overall Study|Lost to Follow-up|18|||
156657677|NCT05665595|565493619|FG000|Overall Study|Ongoing|692|||
156657678|NCT05665595|565493620|FG001|Overall Study|Ongoing|698|||
156657679|NCT05665595|565493619|FG000|Overall Study|Withdrawal by Subject|2|||
156657680|NCT05665595|565493620|FG001|Overall Study|Withdrawal by Subject|2|||
156657681|NCT05665595|565493619|FG000|Overall Study|Lost to Follow-up|1|||
156657682|NCT05665595|565493620|FG001|Overall Study|Lost to Follow-up|0|||
156657683|NCT05665595|565493619|FG000|Overall Study|Death|6|||
156657684|NCT05665595|565493620|FG001|Overall Study|Death|1|||
156657685|NCT02785913|565493621|FG000|Overall Study|Adverse Event|5|||
156657686|NCT02785913|565493621|FG000|Overall Study|Death|2|||
156657687|NCT02785913|565493621|FG000|Overall Study|Progression|18|||
156657688|NCT02785913|565493621|FG000|Overall Study|Not protocol specified|1|||
156657689|NCT02016300|565493628|FG000|Overall Study|Lost to Follow-up|0|||
156657690|NCT02016300|565493629|FG001|Overall Study|Lost to Follow-up|3|||
156772926|NCT00920816|565921162|FG001|Overall Study|Adverse Event|1|||
156772927|NCT00920816|565921163|FG002|Overall Study|Adverse Event|1|||
156772928|NCT00920816|565921164|FG003|Overall Study|Adverse Event|0|||
156772929|NCT00920816|565921161|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
156772930|NCT00920816|565921162|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
156772931|NCT00920816|565921163|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
156772932|NCT00920816|565921164|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
156772933|NCT00920816|565921161|FG000|Overall Study|Randomized but not treated|3|||
156772934|NCT00920816|565921162|FG001|Overall Study|Randomized but not treated|0|||
156772935|NCT00920816|565921163|FG002|Overall Study|Randomized but not treated|0|||
156772936|NCT00920816|565921164|FG003|Overall Study|Randomized but not treated|0|||
156772937|NCT01180777|565921165|FG000|Overall Study|Protocol Violation|6|||
156772938|NCT01180777|565921165|FG000|Overall Study|Poor lens fit|4|||
156772939|NCT01180777|565921165|FG000|Overall Study|Lost to Follow-up|1|||
156772940|NCT01180777|565921165|FG000|Overall Study|Adverse Event|1|||
156772941|NCT02606253|565921166|FG000|Overall Study|Adverse Event|2|||
156772942|NCT02606253|565921167|FG001|Overall Study|Adverse Event|0|||
156772943|NCT02606253|565921168|FG002|Overall Study|Adverse Event|0|||
156772944|NCT02606253|565921166|FG000|Overall Study|Protocol Violation|2|||
156772945|NCT02606253|565921167|FG001|Overall Study|Protocol Violation|1|||
156772946|NCT02606253|565921168|FG002|Overall Study|Protocol Violation|0|||
156772947|NCT02606253|565921166|FG000|Overall Study|Physician Decision|1|||
156772948|NCT02606253|565921167|FG001|Overall Study|Physician Decision|1|||
156772949|NCT02606253|565921168|FG002|Overall Study|Physician Decision|0|||
156772950|NCT01311661|565921169|FG000|Overall Study|Adverse Event|2|||
156772951|NCT01311661|565921169|FG000|Overall Study|Protocol Violation|3|||
156772952|NCT01311661|565921169|FG000|Overall Study|Withdrawal by Subject|2|||
156772953|NCT00284856|565921170|FG000|Overall Study|Adverse Event|3|||
156772954|NCT00284856|565921171|FG001|Overall Study|Adverse Event|3|||
156772955|NCT00284856|565921172|FG002|Overall Study|Adverse Event|3|||
156772956|NCT00284856|565921170|FG000|Overall Study|Lack of Efficacy|2|||
156772957|NCT00284856|565921171|FG001|Overall Study|Lack of Efficacy|1|||
156772958|NCT00284856|565921172|FG002|Overall Study|Lack of Efficacy|8|||
156772959|NCT00284856|565921170|FG000|Overall Study|Lost to Follow-up|25|||
156772960|NCT00284856|565921171|FG001|Overall Study|Lost to Follow-up|21|||
156772961|NCT00284856|565921172|FG002|Overall Study|Lost to Follow-up|22|||
156772962|NCT00284856|565921170|FG000|Overall Study|Protocol Violation|5|||
156772963|NCT00284856|565921171|FG001|Overall Study|Protocol Violation|4|||
156772964|NCT00284856|565921172|FG002|Overall Study|Protocol Violation|5|||
156772965|NCT00284856|565921170|FG000|Overall Study|Withdrawal by Subject|12|||
156772966|NCT00284856|565921171|FG001|Overall Study|Withdrawal by Subject|16|||
156772967|NCT00284856|565921172|FG002|Overall Study|Withdrawal by Subject|18|||
156772968|NCT00284856|565921170|FG000|Overall Study|Other|4|||
156772969|NCT00284856|565921171|FG001|Overall Study|Other|5|||
156772970|NCT00284856|565921172|FG002|Overall Study|Other|4|||
156772971|NCT03426878|565921173|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
156772972|NCT03426878|565921173|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
156772973|NCT03426878|565921173|FG000|Overall Study|Declined to receive results|3|||
156772974|NCT03426878|565921173|FG000|Overall Study|Received negative results by mailed letter|65|||
156772975|NCT03426878|565921173|FG000|Overall Study|Lost to Follow-up|177|||
156772976|NCT05082025|565921175|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
156772977|NCT00869960|565921176|FG000|Overall Study|Lost to Follow-up|2|||
156772978|NCT04428151|565921177|FG000|Overall Study|Death|100|||
156772979|NCT04428151|565921178|FG001|Overall Study|Death|86|||
156772980|NCT04428151|565921179|FG002|Overall Study|Death|57|||
156772981|NCT04428151|565921177|FG000|Overall Study|Lost to Follow-up|1|||
156772982|NCT04428151|565921178|FG001|Overall Study|Lost to Follow-up|1|||
156772983|NCT04428151|565921179|FG002|Overall Study|Lost to Follow-up|0|||
156772984|NCT04428151|565921177|FG000|Overall Study|Withdrawal by Subject|2|||
156772985|NCT04428151|565921178|FG001|Overall Study|Withdrawal by Subject|2|||
156772986|NCT04428151|565921179|FG002|Overall Study|Withdrawal by Subject|3|||
156772987|NCT04428151|565921177|FG000|Overall Study|Participant Ongoing in Study|41|||
156772988|NCT04428151|565921178|FG001|Overall Study|Participant Ongoing in Study|53|||
156772989|NCT04428151|565921179|FG002|Overall Study|Participant Ongoing in Study|28|||
156772990|NCT00671788|565921180|FG000|Overall Study|Adverse Event|8|||
156772991|NCT00671788|565921180|FG000|Overall Study|Refused further treatment|3|||
156772992|NCT00671788|565921180|FG000|Overall Study|Ineligible|1|||
156772993|NCT00671788|565921180|FG000|Overall Study|MD Decision|1|||
156772994|NCT00671788|565921180|FG000|Overall Study|Other|1|||
156772995|NCT04739800|565921181|FG000|Overall Study|Adverse Event|2|||
156772996|NCT04739800|565921182|FG001|Overall Study|Adverse Event|1|||
156772997|NCT04739800|565921183|FG002|Overall Study|Adverse Event|4|||
156772998|NCT04739800|565921184|FG003|Overall Study|Adverse Event|5|||
156772999|NCT04739800|565921181|FG000|Overall Study|Never Treated|2|||
156523544|NCT01873495|565011748|FG000|Overall Study|Removed for Transplantation|1|||
156773000|NCT04739800|565921182|FG001|Overall Study|Never Treated|0|||
156773001|NCT04739800|565921183|FG002|Overall Study|Never Treated|1|||
156773002|NCT04739800|565921184|FG003|Overall Study|Never Treated|1|||
156773003|NCT04739800|565921181|FG000|Overall Study|On Treatment|5|||
156773004|NCT04739800|565921182|FG001|Overall Study|On Treatment|9|||
156773005|NCT04739800|565921183|FG002|Overall Study|On Treatment|9|||
156773006|NCT04739800|565921184|FG003|Overall Study|On Treatment|9|||
156773007|NCT04739800|565921181|FG000|Overall Study|Symptomatic Deterioration|1|||
156773008|NCT04739800|565921182|FG001|Overall Study|Symptomatic Deterioration|1|||
156773009|NCT04739800|565921183|FG002|Overall Study|Symptomatic Deterioration|3|||
156773010|NCT04739800|565921184|FG003|Overall Study|Symptomatic Deterioration|0|||
156773011|NCT04739800|565921181|FG000|Overall Study|Withdrawal by Subject|1|||
156773012|NCT04739800|565921182|FG001|Overall Study|Withdrawal by Subject|2|||
156773013|NCT04739800|565921183|FG002|Overall Study|Withdrawal by Subject|1|||
156773014|NCT04739800|565921184|FG003|Overall Study|Withdrawal by Subject|3|||
156773015|NCT04739800|565921181|FG000|Overall Study|Other Reason|1|||
156773016|NCT04739800|565921182|FG001|Overall Study|Other Reason|3|||
156773017|NCT04739800|565921183|FG002|Overall Study|Other Reason|5|||
156773018|NCT04739800|565921184|FG003|Overall Study|Other Reason|4|||
156773019|NCT03415178|565921185|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
156773020|NCT03415178|565921186|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
156773021|NCT03415178|565921185|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
156773022|NCT03415178|565921186|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
156773023|NCT04880850|565921187|FG000|Overall Study|Death|2|||
156773024|NCT04880850|565921188|FG001|Overall Study|Death|1|||
156773025|NCT04880850|565921187|FG000|Overall Study|Lost to Follow-up|3|||
156773026|NCT04880850|565921188|FG001|Overall Study|Lost to Follow-up|6|||
156773027|NCT04880850|565921187|FG000|Overall Study|Physician Decision|2|||
156773028|NCT04880850|565921188|FG001|Overall Study|Physician Decision|1|||
156773029|NCT04880850|565921187|FG000|Overall Study|Withdrawal by Subject|9|||
156773030|NCT04880850|565921188|FG001|Overall Study|Withdrawal by Subject|10|||
156773031|NCT03907488|565921189|FG000|Overall Study|Adverse Event|20|||
156773032|NCT03907488|565921190|FG001|Overall Study|Adverse Event|20|||
156773033|NCT03907488|565921189|FG000|Overall Study|Withdrawal by Subject|9|||
156773034|NCT03907488|565921190|FG001|Overall Study|Withdrawal by Subject|13|||
156773035|NCT03907488|565921189|FG000|Overall Study|Lack of Efficacy|0|||
156773036|NCT03907488|565921190|FG001|Overall Study|Lack of Efficacy|9|||
156773037|NCT03907488|565921189|FG000|Overall Study|Death|3|||
156773038|NCT03907488|565921190|FG001|Overall Study|Death|8|||
156773039|NCT03907488|565921189|FG000|Overall Study|not protocol specified|5|||
156773040|NCT03907488|565921190|FG001|Overall Study|not protocol specified|8|||
156773041|NCT03907488|565921189|FG000|Overall Study|Ineligible|9|||
156773042|NCT03907488|565921190|FG001|Overall Study|Ineligible|15|||
156773043|NCT01093846|565921192|FG000|Overall Study|Adverse Event|0|||
156773044|NCT01093846|565921193|FG001|Overall Study|Adverse Event|0|||
156773045|NCT01093846|565921194|FG002|Overall Study|Adverse Event|1|||
156773046|NCT01093846|565921192|FG000|Overall Study|Lack of Efficacy|0|||
156773047|NCT01093846|565921193|FG001|Overall Study|Lack of Efficacy|0|||
156773048|NCT01093846|565921194|FG002|Overall Study|Lack of Efficacy|4|||
156773049|NCT01093846|565921192|FG000|Overall Study|Condition no longer required study drug|1|||
156773050|NCT01093846|565921193|FG001|Overall Study|Condition no longer required study drug|1|||
156773051|NCT01093846|565921194|FG002|Overall Study|Condition no longer required study drug|1|||
156773052|NCT01093846|565921192|FG000|Overall Study|Administrative Problems|18|||
156773053|NCT01093846|565921193|FG001|Overall Study|Administrative Problems|17|||
156773054|NCT01093846|565921194|FG002|Overall Study|Administrative Problems|15|||
156773055|NCT03321721|565921195|FG000|Overall Study|Lost to Follow-up|4|||
156773056|NCT03321721|565921196|FG001|Overall Study|Lost to Follow-up|8|||
156773057|NCT03321721|565921197|FG002|Overall Study|Lost to Follow-up|11|||
156773058|NCT00661388|565921201|FG000|Overall Study|Adverse Event|14|||
156773059|NCT00661388|565921201|FG000|Overall Study|Protocol Violation|7|||
156773060|NCT00661388|565921201|FG000|Overall Study|Renal transplantation|1|||
156773061|NCT00661388|565921201|FG000|Overall Study|Dialysis initiation|1|||
156773062|NCT00661388|565921201|FG000|Overall Study|Administrative reasons|1|||
156773063|NCT02332707|565922650|FG000|Overall Study|Adverse Event|0|||
156773064|NCT02332707|565922651|FG001|Overall Study|Adverse Event|0|||
156773065|NCT02332707|565922652|FG002|Overall Study|Adverse Event|0|||
156773066|NCT02332707|565922653|FG003|Overall Study|Adverse Event|0|||
156773067|NCT02332707|565922654|FG004|Overall Study|Adverse Event|0|||
156773068|NCT02332707|565922655|FG005|Overall Study|Adverse Event|0|||
156773069|NCT02332707|565922656|FG006|Overall Study|Adverse Event|0|||
156773070|NCT02332707|565922657|FG007|Overall Study|Adverse Event|0|||
156773071|NCT02332707|565922658|FG008|Overall Study|Adverse Event|0|||
156773072|NCT02332707|565922659|FG009|Overall Study|Adverse Event|0|||
156773073|NCT02332707|565922660|FG010|Overall Study|Adverse Event|0|||
156773074|NCT02332707|565922661|FG011|Overall Study|Adverse Event|0|||
156773075|NCT02332707|565922662|FG012|Overall Study|Adverse Event|1|||
156773076|NCT02332707|565922663|FG013|Overall Study|Adverse Event|0|||
156773077|NCT02332707|565922664|FG014|Overall Study|Adverse Event|0|||
156773078|NCT02332707|565922665|FG015|Overall Study|Adverse Event|0|||
156773079|NCT02332707|565922666|FG016|Overall Study|Adverse Event|0|||
156773080|NCT02332707|565922667|FG017|Overall Study|Adverse Event|0|||
156773081|NCT02332707|565922650|FG000|Overall Study|Lost to Follow-up|0|||
156773082|NCT02332707|565922651|FG001|Overall Study|Lost to Follow-up|0|||
156773083|NCT02332707|565922652|FG002|Overall Study|Lost to Follow-up|0|||
156773084|NCT02332707|565922653|FG003|Overall Study|Lost to Follow-up|0|||
156773085|NCT02332707|565922654|FG004|Overall Study|Lost to Follow-up|0|||
156773086|NCT02332707|565922655|FG005|Overall Study|Lost to Follow-up|1|||
156773087|NCT02332707|565922656|FG006|Overall Study|Lost to Follow-up|0|||
156773088|NCT02332707|565922657|FG007|Overall Study|Lost to Follow-up|0|||
156773089|NCT02332707|565922658|FG008|Overall Study|Lost to Follow-up|0|||
156773090|NCT02332707|565922659|FG009|Overall Study|Lost to Follow-up|0|||
156773091|NCT02332707|565922660|FG010|Overall Study|Lost to Follow-up|2|||
156773092|NCT02332707|565922661|FG011|Overall Study|Lost to Follow-up|0|||
156773093|NCT02332707|565922662|FG012|Overall Study|Lost to Follow-up|3|||
156773094|NCT02332707|565922663|FG013|Overall Study|Lost to Follow-up|0|||
156773095|NCT02332707|565922664|FG014|Overall Study|Lost to Follow-up|0|||
156773096|NCT02332707|565922665|FG015|Overall Study|Lost to Follow-up|0|||
156773097|NCT02332707|565922666|FG016|Overall Study|Lost to Follow-up|0|||
156773098|NCT02332707|565922667|FG017|Overall Study|Lost to Follow-up|0|||
156773099|NCT02332707|565922650|FG000|Overall Study|Physician Decision|0|||
156773100|NCT02332707|565922651|FG001|Overall Study|Physician Decision|0|||
156773101|NCT02332707|565922652|FG002|Overall Study|Physician Decision|0|||
156773102|NCT02332707|565922653|FG003|Overall Study|Physician Decision|1|||
156773103|NCT02332707|565922654|FG004|Overall Study|Physician Decision|0|||
156773104|NCT02332707|565922655|FG005|Overall Study|Physician Decision|0|||
156773105|NCT02332707|565922656|FG006|Overall Study|Physician Decision|0|||
156773106|NCT02332707|565922657|FG007|Overall Study|Physician Decision|0|||
156773107|NCT02332707|565922658|FG008|Overall Study|Physician Decision|0|||
156773108|NCT02332707|565922659|FG009|Overall Study|Physician Decision|0|||
156773109|NCT02332707|565922660|FG010|Overall Study|Physician Decision|0|||
156773110|NCT02332707|565922661|FG011|Overall Study|Physician Decision|0|||
156773111|NCT02332707|565922662|FG012|Overall Study|Physician Decision|1|||
156773112|NCT02332707|565922663|FG013|Overall Study|Physician Decision|0|||
156773113|NCT02332707|565922664|FG014|Overall Study|Physician Decision|0|||
156773114|NCT02332707|565922665|FG015|Overall Study|Physician Decision|0|||
156773115|NCT02332707|565922666|FG016|Overall Study|Physician Decision|0|||
156773116|NCT02332707|565922667|FG017|Overall Study|Physician Decision|0|||
156773117|NCT02332707|565922650|FG000|Overall Study|Withdrawal by Subject|0|||
156773118|NCT02332707|565922651|FG001|Overall Study|Withdrawal by Subject|0|||
156773119|NCT02332707|565922652|FG002|Overall Study|Withdrawal by Subject|1|||
156773120|NCT02332707|565922653|FG003|Overall Study|Withdrawal by Subject|0|||
156773121|NCT02332707|565922654|FG004|Overall Study|Withdrawal by Subject|0|||
156773122|NCT02332707|565922655|FG005|Overall Study|Withdrawal by Subject|0|||
156773123|NCT02332707|565922656|FG006|Overall Study|Withdrawal by Subject|0|||
156773124|NCT02332707|565922657|FG007|Overall Study|Withdrawal by Subject|0|||
156773125|NCT02332707|565922658|FG008|Overall Study|Withdrawal by Subject|0|||
156773126|NCT02332707|565922659|FG009|Overall Study|Withdrawal by Subject|3|||
156773127|NCT02332707|565922660|FG010|Overall Study|Withdrawal by Subject|0|||
156773128|NCT02332707|565922661|FG011|Overall Study|Withdrawal by Subject|0|||
156773129|NCT02332707|565922662|FG012|Overall Study|Withdrawal by Subject|0|||
156773130|NCT02332707|565922663|FG013|Overall Study|Withdrawal by Subject|0|||
156773131|NCT02332707|565922664|FG014|Overall Study|Withdrawal by Subject|0|||
156773132|NCT02332707|565922665|FG015|Overall Study|Withdrawal by Subject|0|||
156773133|NCT02332707|565922666|FG016|Overall Study|Withdrawal by Subject|0|||
156773134|NCT02332707|565922667|FG017|Overall Study|Withdrawal by Subject|0|||
156773135|NCT01473134|565922668|FG000|Overall Study|Lost to Follow-up|21|||
156773136|NCT01473134|565922669|FG001|Overall Study|Lost to Follow-up|13|||
156773137|NCT01473134|565922668|FG000|Overall Study|Protocol Violation|32|||
156773138|NCT01473134|565922669|FG001|Overall Study|Protocol Violation|19|||
156773139|NCT01473134|565922668|FG000|Overall Study|Withdrawal by Subject|1|||
156773140|NCT01473134|565922669|FG001|Overall Study|Withdrawal by Subject|2|||
156773141|NCT01473134|565922668|FG000|Overall Study|Death|0|||
156773142|NCT01473134|565922669|FG001|Overall Study|Death|1|||
156773143|NCT01473134|565922668|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
156773144|NCT01473134|565922669|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
156773145|NCT03286504|565922673|FG000|Overall Study|Lost to Follow-up|19|||
156773146|NCT03286504|565922674|FG001|Overall Study|Lost to Follow-up|16|||
156773147|NCT02832037|565922676|FG000|Overall Study|Administrative reasons|0|||
156773148|NCT02832037|565922677|FG001|Overall Study|Administrative reasons|0|||
156773149|NCT02832037|565922678|FG002|Overall Study|Administrative reasons|1|||
156773150|NCT02832037|565922679|FG003|Overall Study|Administrative reasons|0|||
156773151|NCT02832037|565922680|FG004|Overall Study|Administrative reasons|0|||
156773152|NCT02832037|565922676|FG000|Overall Study|Protocol Violation|3|||
156773153|NCT02832037|565922677|FG001|Overall Study|Protocol Violation|0|||
156773154|NCT02832037|565922678|FG002|Overall Study|Protocol Violation|4|||
156773155|NCT02832037|565922679|FG003|Overall Study|Protocol Violation|1|||
156773156|NCT02832037|565922680|FG004|Overall Study|Protocol Violation|2|||
156773157|NCT02832037|565922676|FG000|Overall Study|Lost to Follow-up|2|||
156773158|NCT02832037|565922677|FG001|Overall Study|Lost to Follow-up|0|||
156773159|NCT02832037|565922678|FG002|Overall Study|Lost to Follow-up|3|||
156773160|NCT02832037|565922679|FG003|Overall Study|Lost to Follow-up|0|||
156773161|NCT02832037|565922680|FG004|Overall Study|Lost to Follow-up|5|||
156773162|NCT02832037|565922676|FG000|Overall Study|Withdrawal by Subject|9|||
156773163|NCT02832037|565922677|FG001|Overall Study|Withdrawal by Subject|8|||
156773164|NCT02832037|565922678|FG002|Overall Study|Withdrawal by Subject|0|||
156773165|NCT02832037|565922679|FG003|Overall Study|Withdrawal by Subject|4|||
156773166|NCT02832037|565922680|FG004|Overall Study|Withdrawal by Subject|8|||
156773167|NCT02832037|565922676|FG000|Overall Study|Adverse Event|5|||
156773168|NCT02832037|565922677|FG001|Overall Study|Adverse Event|4|||
156773169|NCT02832037|565922678|FG002|Overall Study|Adverse Event|0|||
156773170|NCT02832037|565922679|FG003|Overall Study|Adverse Event|2|||
156773171|NCT02832037|565922680|FG004|Overall Study|Adverse Event|4|||
156773172|NCT04167462|565922689|FG000|Overall Study|Other reasons|3|||
156773173|NCT04167462|565922690|FG001|Overall Study|Other reasons|2|||
156773174|NCT04167462|565922689|FG000|Overall Study|Withdrawal by Subject|6|||
156773175|NCT04167462|565922690|FG001|Overall Study|Withdrawal by Subject|7|||
156773176|NCT04167462|565922689|FG000|Overall Study|Adverse Event|4|||
156773177|NCT04167462|565922690|FG001|Overall Study|Adverse Event|0|||
156773178|NCT04167462|565922689|FG000|Overall Study|Pregnancy|1|||
156773179|NCT04167462|565922690|FG001|Overall Study|Pregnancy|0|||
156773180|NCT04167462|565922689|FG000|Overall Study|Lack of Efficacy|0|||
156773181|NCT04167462|565922690|FG001|Overall Study|Lack of Efficacy|1|||
156773182|NCT02765165|565922691|FG000|Treatment Period|Progressive disease|3|||
156773183|NCT02765165|565922692|FG001|Treatment Period|Progressive disease|2|||
156773184|NCT02765165|565922693|FG002|Treatment Period|Progressive disease|3|||
156773185|NCT02765165|565922694|FG003|Treatment Period|Progressive disease|3|||
156773186|NCT02765165|565922695|FG004|Treatment Period|Progressive disease|4|||
156773187|NCT02765165|565922696|FG005|Treatment Period|Progressive disease|2|||
156773188|NCT02765165|565922697|FG006|Treatment Period|Progressive disease|2|||
156773189|NCT02765165|565922691|FG000|Treatment Period|Physician Decision|0|||
156773190|NCT02765165|565922692|FG001|Treatment Period|Physician Decision|1|||
156773191|NCT02765165|565922693|FG002|Treatment Period|Physician Decision|0|||
156773192|NCT02765165|565922694|FG003|Treatment Period|Physician Decision|0|||
156773193|NCT02765165|565922695|FG004|Treatment Period|Physician Decision|0|||
156773194|NCT02765165|565922696|FG005|Treatment Period|Physician Decision|0|||
156773195|NCT02765165|565922697|FG006|Treatment Period|Physician Decision|0|||
156773196|NCT02765165|565922691|FG000|Treatment Period|Adverse Event|0|||
156773197|NCT02765165|565922692|FG001|Treatment Period|Adverse Event|1|||
156773198|NCT02765165|565922693|FG002|Treatment Period|Adverse Event|0|||
156773199|NCT02765165|565922694|FG003|Treatment Period|Adverse Event|0|||
156773200|NCT02765165|565922695|FG004|Treatment Period|Adverse Event|0|||
156773201|NCT02765165|565922696|FG005|Treatment Period|Adverse Event|0|||
156773202|NCT02765165|565922697|FG006|Treatment Period|Adverse Event|0|||
156773203|NCT02765165|565922691|FG000|Treatment Period|Withdrawal by Subject|0|||
156773204|NCT02765165|565922692|FG001|Treatment Period|Withdrawal by Subject|0|||
156773205|NCT02765165|565922693|FG002|Treatment Period|Withdrawal by Subject|0|||
156773206|NCT02765165|565922694|FG003|Treatment Period|Withdrawal by Subject|0|||
156773207|NCT02765165|565922695|FG004|Treatment Period|Withdrawal by Subject|2|||
156773208|NCT02765165|565922696|FG005|Treatment Period|Withdrawal by Subject|0|||
156773209|NCT02765165|565922697|FG006|Treatment Period|Withdrawal by Subject|0|||
156773210|NCT02765165|565922691|FG000|Treatment Period|Study terminated|0|||
156773211|NCT02765165|565922692|FG001|Treatment Period|Study terminated|0|||
156773212|NCT02765165|565922693|FG002|Treatment Period|Study terminated|0|||
156773213|NCT02765165|565922694|FG003|Treatment Period|Study terminated|0|||
156773214|NCT02765165|565922695|FG004|Treatment Period|Study terminated|0|||
156773215|NCT02765165|565922696|FG005|Treatment Period|Study terminated|1|||
156773216|NCT02765165|565922697|FG006|Treatment Period|Study terminated|2|||
156773217|NCT02765165|565922691|FG000|Post-treatment Follow-up|Death|1|||
156773218|NCT02765165|565922692|FG001|Post-treatment Follow-up|Death|2|||
156773219|NCT02765165|565922693|FG002|Post-treatment Follow-up|Death|1|||
156773220|NCT02765165|565922694|FG003|Post-treatment Follow-up|Death|1|||
156773221|NCT02765165|565922695|FG004|Post-treatment Follow-up|Death|1|||
156773222|NCT02765165|565922696|FG005|Post-treatment Follow-up|Death|1|||
156773223|NCT02765165|565922697|FG006|Post-treatment Follow-up|Death|0|||
156657691|NCT00436007|565493637|FG000|Overall Study|Withdrawal by Subject|5|||
156773224|NCT02765165|565922691|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
156773225|NCT02765165|565922692|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
156773226|NCT02765165|565922693|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
156773227|NCT02765165|565922694|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
156773228|NCT02765165|565922695|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
156773229|NCT02765165|565922696|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
156773230|NCT02765165|565922697|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
156773231|NCT02765165|565922691|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773232|NCT02765165|565922692|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773233|NCT02765165|565922693|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
156773234|NCT02765165|565922694|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773235|NCT02765165|565922695|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773236|NCT02765165|565922696|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773237|NCT02765165|565922697|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773238|NCT02765165|565922691|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773239|NCT02765165|565922692|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773240|NCT02765165|565922693|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
156773241|NCT02765165|565922694|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
156773242|NCT02765165|565922695|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773243|NCT02765165|565922696|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773244|NCT02765165|565922697|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773245|NCT02765165|565922691|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773246|NCT02765165|565922692|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
156773247|NCT02765165|565922693|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773248|NCT02765165|565922694|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773249|NCT02765165|565922695|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773250|NCT02765165|565922696|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773251|NCT02765165|565922697|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773252|NCT02765165|565922691|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
156773253|NCT02765165|565922692|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
156773254|NCT02765165|565922693|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
156773255|NCT02765165|565922694|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
156773256|NCT02765165|565922695|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
156773257|NCT02765165|565922696|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
156773258|NCT02765165|565922697|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
156773259|NCT02382939|565922700|FG000|Overall Study|Adverse Event|1|||
156773260|NCT02382939|565922701|FG001|Overall Study|Adverse Event|1|||
156773261|NCT02382939|565922700|FG000|Overall Study|Withdrawal by Subject|2|||
156773262|NCT02382939|565922701|FG001|Overall Study|Withdrawal by Subject|2|||
156773263|NCT00142415|565922702|FG000|Overall Study|Physician Decision|0|||
156773264|NCT00142415|565922703|FG001|Overall Study|Physician Decision|0|||
156773265|NCT00142415|565922704|FG002|Overall Study|Physician Decision|0|||
156773266|NCT00142415|565922705|FG003|Overall Study|Physician Decision|0|||
156773267|NCT00142415|565922706|FG004|Overall Study|Physician Decision|1|||
156773268|NCT00142415|565922707|FG005|Overall Study|Physician Decision|2|||
156773269|NCT01189266|565922712|FG000|Overall Study|Adverse Event|1|||
156773270|NCT01189266|565922713|FG001|Overall Study|Adverse Event|0|||
156773271|NCT01189266|565922714|FG002|Overall Study|Adverse Event|5|||
156773272|NCT01189266|565922712|FG000|Overall Study|Death|0|||
156773273|NCT01189266|565922713|FG001|Overall Study|Death|0|||
156773274|NCT01189266|565922714|FG002|Overall Study|Death|5|||
156773275|NCT01189266|565922712|FG000|Overall Study|Lack of Efficacy|4|||
156773276|NCT01189266|565922713|FG001|Overall Study|Lack of Efficacy|5|||
156773277|NCT01189266|565922714|FG002|Overall Study|Lack of Efficacy|44|||
156773278|NCT01189266|565922712|FG000|Overall Study|Physician Decision|0|||
156773279|NCT01189266|565922713|FG001|Overall Study|Physician Decision|0|||
156773280|NCT01189266|565922714|FG002|Overall Study|Physician Decision|1|||
156773281|NCT01189266|565922712|FG000|Overall Study|Protocol Violation|0|||
156773282|NCT01189266|565922713|FG001|Overall Study|Protocol Violation|1|||
156773283|NCT01189266|565922714|FG002|Overall Study|Protocol Violation|1|||
156773284|NCT01189266|565922712|FG000|Overall Study|Withdrawal by Subject|0|||
156773285|NCT01189266|565922713|FG001|Overall Study|Withdrawal by Subject|0|||
156773286|NCT01189266|565922714|FG002|Overall Study|Withdrawal by Subject|1|||
156773287|NCT01189266|565922712|FG000|Overall Study|Patient refuses further therapy|1|||
156773288|NCT01189266|565922713|FG001|Overall Study|Patient refuses further therapy|0|||
156773289|NCT01189266|565922714|FG002|Overall Study|Patient refuses further therapy|7|||
156773290|NCT01189266|565922712|FG000|Overall Study|No treatment|0|||
156773291|NCT01189266|565922713|FG001|Overall Study|No treatment|0|||
156773292|NCT01189266|565922714|FG002|Overall Study|No treatment|1|||
156773293|NCT00321763|565922715|FG000|Overall Study|Adverse Event|1|||
156773294|NCT00321763|565922716|FG001|Overall Study|Adverse Event|1|||
156773295|NCT00321763|565922717|FG002|Overall Study|Adverse Event|0|||
156773296|NCT00321763|565922718|FG003|Overall Study|Adverse Event|1|||
156773297|NCT00321763|565922715|FG000|Overall Study|Withdrawal by Subject|2|||
156773298|NCT00321763|565922716|FG001|Overall Study|Withdrawal by Subject|0|||
156773299|NCT00321763|565922717|FG002|Overall Study|Withdrawal by Subject|1|||
156773300|NCT00321763|565922718|FG003|Overall Study|Withdrawal by Subject|0|||
156773301|NCT00321763|565922715|FG000|Overall Study|Lost to Follow-up|3|||
156773302|NCT00321763|565922716|FG001|Overall Study|Lost to Follow-up|1|||
156773303|NCT00321763|565922717|FG002|Overall Study|Lost to Follow-up|5|||
156773304|NCT00321763|565922718|FG003|Overall Study|Lost to Follow-up|4|||
156773305|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
156773306|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
156773307|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
156773308|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
156773309|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
156773310|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
156773311|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
156773312|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
156773313|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
156773314|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
156773315|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
156773316|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
156773317|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
156773318|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
156773319|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
156773320|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
156773321|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
156773322|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
156773323|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
156773324|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
156773325|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
156428414|NCT00586339|564660858|FG001|Overall Study|Withdrawal by Subject|3|||
156773326|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
156773327|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
156773328|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
156773329|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
156773330|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
156773331|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
156773332|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
156773333|NCT01572792|565922723|FG000|Lead-in Study|Lost to Follow-up|5|||
156773334|NCT01572792|565922724|FG001|Lead-in Study|Lost to Follow-up|9|||
156773335|NCT01572792|565922725|FG002|Lead-in Study|Lost to Follow-up|4|||
156773336|NCT01572792|565922726|FG003|Lead-in Study|Lost to Follow-up|2|||
156773337|NCT01572792|565922727|FG004|Lead-in Study|Lost to Follow-up|4|||
156773338|NCT01572792|565922723|FG000|Lead-in Study|Withdrawal by Subject|22|||
156773339|NCT01572792|565922724|FG001|Lead-in Study|Withdrawal by Subject|11|||
156773340|NCT01572792|565922725|FG002|Lead-in Study|Withdrawal by Subject|12|||
156773341|NCT01572792|565922726|FG003|Lead-in Study|Withdrawal by Subject|24|||
156773342|NCT01572792|565922727|FG004|Lead-in Study|Withdrawal by Subject|11|||
156773343|NCT01572792|565922723|FG000|Lead-in Study|Protocol Violation|19|||
156773344|NCT01572792|565922724|FG001|Lead-in Study|Protocol Violation|10|||
156773345|NCT01572792|565922725|FG002|Lead-in Study|Protocol Violation|12|||
156773346|NCT01572792|565922726|FG003|Lead-in Study|Protocol Violation|13|||
156773347|NCT01572792|565922727|FG004|Lead-in Study|Protocol Violation|21|||
156773348|NCT01572792|565922723|FG000|Lead-in Study|Lack of Efficacy|20|||
156773349|NCT01572792|565922724|FG001|Lead-in Study|Lack of Efficacy|5|||
156773350|NCT01572792|565922725|FG002|Lead-in Study|Lack of Efficacy|4|||
156773351|NCT01572792|565922726|FG003|Lead-in Study|Lack of Efficacy|8|||
156773352|NCT01572792|565922727|FG004|Lead-in Study|Lack of Efficacy|10|||
156773353|NCT01572792|565922723|FG000|Lead-in Study|Adverse Event|21|||
156773354|NCT01572792|565922724|FG001|Lead-in Study|Adverse Event|21|||
156773355|NCT01572792|565922725|FG002|Lead-in Study|Adverse Event|22|||
156773356|NCT01572792|565922726|FG003|Lead-in Study|Adverse Event|16|||
156773357|NCT01572792|565922727|FG004|Lead-in Study|Adverse Event|14|||
156773358|NCT01572792|565922723|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
156773359|NCT01572792|565922724|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
156773360|NCT01572792|565922725|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
156773361|NCT01572792|565922726|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
156773362|NCT01572792|565922727|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
156773363|NCT01572792|565922723|FG000|Extension Study|Lost to Follow-up|6|||
156773364|NCT01572792|565922724|FG001|Extension Study|Lost to Follow-up|2|||
156773365|NCT01572792|565922725|FG002|Extension Study|Lost to Follow-up|0|||
156773366|NCT01572792|565922726|FG003|Extension Study|Lost to Follow-up|3|||
156428415|NCT00586339|564660859|FG002|Overall Study|Withdrawal by Subject|1|||
156428416|NCT00586339|564660857|FG000|Overall Study|Migrated/moved from study area|3|||
156773367|NCT01572792|565922727|FG004|Extension Study|Lost to Follow-up|3|||
156773368|NCT01572792|565922723|FG000|Extension Study|Withdrawal by Subject|7|||
156773369|NCT01572792|565922724|FG001|Extension Study|Withdrawal by Subject|6|||
156428417|NCT00586339|564660858|FG001|Overall Study|Migrated/moved from study area|2|||
156428418|NCT00586339|564660859|FG002|Overall Study|Migrated/moved from study area|4|||
156773370|NCT01572792|565922725|FG002|Extension Study|Withdrawal by Subject|11|||
156773371|NCT01572792|565922726|FG003|Extension Study|Withdrawal by Subject|8|||
156773372|NCT01572792|565922727|FG004|Extension Study|Withdrawal by Subject|14|||
156773373|NCT01572792|565922723|FG000|Extension Study|Protocol Violation|0|||
156773374|NCT01572792|565922724|FG001|Extension Study|Protocol Violation|4|||
156773375|NCT01572792|565922725|FG002|Extension Study|Protocol Violation|3|||
156773376|NCT01572792|565922726|FG003|Extension Study|Protocol Violation|4|||
156773377|NCT01572792|565922727|FG004|Extension Study|Protocol Violation|3|||
156773378|NCT01572792|565922723|FG000|Extension Study|Lack of Efficacy|2|||
156773379|NCT01572792|565922724|FG001|Extension Study|Lack of Efficacy|3|||
156773380|NCT01572792|565922725|FG002|Extension Study|Lack of Efficacy|3|||
156773381|NCT01572792|565922726|FG003|Extension Study|Lack of Efficacy|2|||
156773382|NCT01572792|565922727|FG004|Extension Study|Lack of Efficacy|2|||
156773383|NCT01572792|565922723|FG000|Extension Study|Adverse Event|7|||
156773384|NCT01572792|565922724|FG001|Extension Study|Adverse Event|6|||
156773385|NCT01572792|565922725|FG002|Extension Study|Adverse Event|5|||
156773386|NCT01572792|565922726|FG003|Extension Study|Adverse Event|6|||
156773387|NCT01572792|565922727|FG004|Extension Study|Adverse Event|4|||
156773388|NCT01572792|565922723|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
156773389|NCT01572792|565922724|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
156773390|NCT01572792|565922725|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
156773391|NCT01572792|565922726|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
156773392|NCT01572792|565922727|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
156773393|NCT03530696|565922730|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
156773394|NCT03530696|565922731|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
156773395|NCT01129128|565922732|FG000|Overall Study|Lost to Follow-up|2|||
156773396|NCT01129128|565922733|FG001|Overall Study|Lost to Follow-up|2|||
156773397|NCT01129128|565922734|FG002|Overall Study|Lost to Follow-up|1|||
156773398|NCT01129128|565922732|FG000|Overall Study|Protocol Violation|0|||
156773399|NCT01129128|565922733|FG001|Overall Study|Protocol Violation|1|||
156773400|NCT01129128|565922734|FG002|Overall Study|Protocol Violation|0|||
156773401|NCT01129128|565922732|FG000|Overall Study|Withdrawal by Subject|0|||
156773402|NCT01129128|565922733|FG001|Overall Study|Withdrawal by Subject|1|||
156773403|NCT01129128|565922734|FG002|Overall Study|Withdrawal by Subject|3|||
156773404|NCT01129128|565922732|FG000|Overall Study|Physician Decision|1|||
156773405|NCT01129128|565922733|FG001|Overall Study|Physician Decision|0|||
156773406|NCT01129128|565922734|FG002|Overall Study|Physician Decision|0|||
156773407|NCT01900314|565922737|FG000|Overall Study|Lost to Follow-up|1|||
156773408|NCT01900314|565922738|FG001|Overall Study|Lost to Follow-up|0|||
156773409|NCT01900314|565922737|FG000|Overall Study|Protocol Violation|0|||
156773410|NCT01900314|565922738|FG001|Overall Study|Protocol Violation|1|||
156773411|NCT01900314|565922737|FG000|Overall Study|Withdrawal by Subject|3|||
156773412|NCT01900314|565922738|FG001|Overall Study|Withdrawal by Subject|3|||
156773413|NCT05452239|565922740|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
156773414|NCT05452239|565922741|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
156773415|NCT05452239|565922740|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
156773416|NCT05452239|565922741|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
156773417|NCT05452239|565922740|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
156773418|NCT05452239|565922741|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
156773419|NCT05452239|565922740|FG000|Placebo-controlled Period|Randomized but not treated|2|||
156773420|NCT05452239|565922741|FG001|Placebo-controlled Period|Randomized but not treated|2|||
156773421|NCT05452239|565922740|FG000|Placebo-controlled Period|Other than specified|1|||
156773422|NCT05452239|565922741|FG001|Placebo-controlled Period|Other than specified|1|||
156773423|NCT05452239|565922740|FG000|Open-label Period|Withdrawal by Subject|2|||
156773424|NCT05452239|565922741|FG001|Open-label Period|Withdrawal by Subject|1|||
156773425|NCT05452239|565922740|FG000|Open-label Period|Lost to Follow-up|3|||
156773426|NCT05452239|565922741|FG001|Open-label Period|Lost to Follow-up|0|||
156773427|NCT05452239|565922740|FG000|Open-label Period|Other than specified|1|||
156773428|NCT05452239|565922741|FG001|Open-label Period|Other than specified|2|||
156773429|NCT01385176|565922742|FG000|Randomization Phase|Death|1|||
156773430|NCT01385176|565922743|FG001|Randomization Phase|Death|2|||
156773431|NCT01385176|565922742|FG000|6-18 Month All VNS Active|Death|1|||
156773432|NCT01385176|565922743|FG001|6-18 Month All VNS Active|Death|2|||
156773433|NCT01385176|565922742|FG000|6-18 Month All VNS Active|Physician Decision|0|||
156773434|NCT01385176|565922743|FG001|6-18 Month All VNS Active|Physician Decision|1|||
156773435|NCT01385176|565922742|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
156773436|NCT01385176|565922743|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
156773437|NCT01385176|565922742|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
156773438|NCT01385176|565922743|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
156773439|NCT01056536|565922744|FG000|Overall Study|Lost to Follow-up|202|||
156773440|NCT01056536|565922745|FG001|Overall Study|Lost to Follow-up|116|||
156773441|NCT01056536|565922746|FG002|Overall Study|Lost to Follow-up|248|||
156428419|NCT00586339|564660857|FG000|Overall Study|Lost to Follow-up|3|||
156773442|NCT05853120|565922747|FG000|Overall Study|Lost to Follow-up|4|||
156773443|NCT05853120|565922748|FG001|Overall Study|Lost to Follow-up|4|||
156773444|NCT05853120|565922747|FG000|Overall Study|Physician Decision|3|||
156773445|NCT05853120|565922748|FG001|Overall Study|Physician Decision|0|||
156773446|NCT05853120|565922747|FG000|Overall Study|Withdrawal by Subject|5|||
156773447|NCT05853120|565922748|FG001|Overall Study|Withdrawal by Subject|2|||
156773448|NCT03692949|565922753|FG000|Overall Study|Lost to Follow-up|0|||
156773449|NCT03692949|565922754|FG001|Overall Study|Lost to Follow-up|0|||
156773450|NCT03692949|565922755|FG002|Overall Study|Lost to Follow-up|0|||
156773451|NCT03692949|565922756|FG003|Overall Study|Lost to Follow-up|0|||
156773452|NCT03692949|565922757|FG004|Overall Study|Lost to Follow-up|0|||
156773453|NCT03692949|565922758|FG005|Overall Study|Lost to Follow-up|0|||
156773454|NCT03692949|565922759|FG006|Overall Study|Lost to Follow-up|0|||
156773455|NCT03692949|565922760|FG007|Overall Study|Lost to Follow-up|1|||
156773456|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Adverse Event|6|||
156773457|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Adverse Event|15|||
156773458|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Adverse Event|0|||
156773459|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Death|0|||
156773460|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Death|2|||
156773461|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Death|0|||
156773462|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
156773463|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
156773464|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
156773465|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
156773466|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
156773467|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
156773468|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Physician Decision|1|||
156773469|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Physician Decision|1|||
156773470|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Physician Decision|0|||
156773471|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
156773472|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
156773473|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
156773474|NCT02921256|565922766|FG000|Arm Ib v Arm III|Adverse Event|9|||
156773475|NCT02921256|565922767|FG001|Arm Ib v Arm III|Adverse Event|0|||
156773476|NCT02921256|565922768|FG002|Arm Ib v Arm III|Adverse Event|4|||
156773477|NCT02921256|565922766|FG000|Arm Ib v Arm III|Death|1|||
156773478|NCT02921256|565922767|FG001|Arm Ib v Arm III|Death|0|||
156773479|NCT02921256|565922768|FG002|Arm Ib v Arm III|Death|1|||
156773480|NCT02921256|565922766|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
156773481|NCT02921256|565922767|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
156773482|NCT02921256|565922768|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
156773483|NCT02921256|565922766|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
156773484|NCT02921256|565922767|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
156773485|NCT02921256|565922768|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
156773486|NCT02921256|565922766|FG000|Arm Ib v Arm III|Physician Decision|4|||
156773487|NCT02921256|565922767|FG001|Arm Ib v Arm III|Physician Decision|0|||
156773488|NCT02921256|565922768|FG002|Arm Ib v Arm III|Physician Decision|1|||
156773489|NCT02921256|565922766|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
156773490|NCT02921256|565922767|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
156773491|NCT02921256|565922768|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
156773492|NCT04848480|565922769|FG000|Main Phase (26 Weeks)|Death|1|||
156773493|NCT04848480|565922770|FG001|Main Phase (26 Weeks)|Death|0|||
156773494|NCT04848480|565922769|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
156773495|NCT04848480|565922770|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
156773496|NCT04848480|565922769|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
156773497|NCT04848480|565922770|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
156773498|NCT04848480|565922769|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
156773499|NCT04848480|565922770|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
156773500|NCT04848480|565922769|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
156773501|NCT04848480|565922770|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
156773502|NCT04848480|565922769|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
156773503|NCT04848480|565922770|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
156773504|NCT02783690|565922773|FG000|Overall Study|Withdrawal by Subject|3|||
156773505|NCT02783690|565922774|FG001|Overall Study|Withdrawal by Subject|3|||
156773506|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
156773507|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
156773508|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
156773509|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
156773510|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Death|38|||
156773511|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Death|10|||
156773512|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
156428420|NCT00586339|564660858|FG001|Overall Study|Lost to Follow-up|2|||
156773513|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
156773514|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
156773515|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
156773516|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
156773517|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
156773518|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
156773519|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
156773520|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
156773521|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
156428421|NCT00586339|564660859|FG002|Overall Study|Lost to Follow-up|1|||
156428422|NCT02512042|564660860|FG000|Overall Study|Adverse Event|0|||
156428423|NCT02512042|564660861|FG001|Overall Study|Adverse Event|4|||
156428424|NCT02512042|564660860|FG000|Overall Study|Withdrawal by Subject|6|||
156428425|NCT02512042|564660861|FG001|Overall Study|Withdrawal by Subject|6|||
156428426|NCT02512042|564660860|FG000|Overall Study|Non-compliance with study drug|1|||
156428427|NCT02512042|564660861|FG001|Overall Study|Non-compliance with study drug|2|||
156428428|NCT02512042|564660860|FG000|Overall Study|Lost to Follow-up|5|||
156428429|NCT02512042|564660861|FG001|Overall Study|Lost to Follow-up|2|||
156428430|NCT02512042|564660860|FG000|Overall Study|Other|11|||
156428431|NCT02512042|564660861|FG001|Overall Study|Other|11|||
156428432|NCT01194258|564660863|FG000|Titration Period|Withdrawal by Subject|6|||
156428433|NCT01194258|564660864|FG001|Titration Period|Withdrawal by Subject|0|||
156428434|NCT01194258|564660865|FG002|Titration Period|Withdrawal by Subject|0|||
156428435|NCT01194258|564660866|FG003|Titration Period|Withdrawal by Subject|0|||
156428436|NCT01194258|564660867|FG004|Titration Period|Withdrawal by Subject|0|||
156428437|NCT01194258|564660863|FG000|Titration Period|Lost to Follow-up|2|||
156428438|NCT01194258|564660864|FG001|Titration Period|Lost to Follow-up|0|||
156428439|NCT01194258|564660865|FG002|Titration Period|Lost to Follow-up|0|||
156428440|NCT01194258|564660866|FG003|Titration Period|Lost to Follow-up|0|||
156428441|NCT01194258|564660867|FG004|Titration Period|Lost to Follow-up|0|||
156428442|NCT01194258|564660863|FG000|Titration Period|Titration failure|3|||
156428443|NCT01194258|564660864|FG001|Titration Period|Titration failure|0|||
156428444|NCT01194258|564660865|FG002|Titration Period|Titration failure|0|||
156428445|NCT01194258|564660866|FG003|Titration Period|Titration failure|0|||
156428446|NCT01194258|564660867|FG004|Titration Period|Titration failure|0|||
156428447|NCT01194258|564660863|FG000|Period 1 (12 Weeks)|Death|0|||
156428448|NCT01194258|564660864|FG001|Period 1 (12 Weeks)|Death|0|||
156428449|NCT01194258|564660865|FG002|Period 1 (12 Weeks)|Death|0|||
156428450|NCT01194258|564660866|FG003|Period 1 (12 Weeks)|Death|0|||
156428451|NCT01194258|564660867|FG004|Period 1 (12 Weeks)|Death|1|||
156428452|NCT01194258|564660863|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156428453|NCT01194258|564660864|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156428454|NCT01194258|564660865|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156428455|NCT01194258|564660866|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156428456|NCT01194258|564660867|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
156428457|NCT01194258|564660863|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
156428458|NCT01194258|564660864|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
156428459|NCT01194258|564660865|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
156428460|NCT01194258|564660866|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
156428461|NCT01194258|564660867|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
156428462|NCT01194258|564660863|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156428463|NCT01194258|564660864|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156428464|NCT01194258|564660865|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156428465|NCT01194258|564660866|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156428466|NCT01194258|564660867|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156773522|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
156773523|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
156773524|NCT02421939|565922775|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
156428467|NCT01981850|564660868|FG000|Main Phase Stage 1|Death|2|||
156428468|NCT01981850|564660869|FG001|Main Phase Stage 1|Death|0|||
156428469|NCT01981850|564660870|FG002|Main Phase Stage 1|Death|0|||
156428470|NCT01981850|564660871|FG003|Main Phase Stage 1|Death|0|||
156428471|NCT01981850|564660872|FG004|Main Phase Stage 1|Death|0|||
156428472|NCT01981850|564660873|FG005|Main Phase Stage 1|Death|0|||
156428473|NCT01981850|564660874|FG006|Main Phase Stage 1|Death|0|||
156428474|NCT01981850|564660875|FG007|Main Phase Stage 1|Death|0|||
156428475|NCT01981850|564660876|FG008|Main Phase Stage 1|Death|0|||
156428476|NCT01981850|564660877|FG009|Main Phase Stage 1|Death|0|||
156428477|NCT01981850|564660868|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
156428478|NCT01981850|564660869|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156428479|NCT01981850|564660870|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156428480|NCT01981850|564660871|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156773525|NCT02421939|565922776|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
156773526|NCT02421939|565922775|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
156428481|NCT01981850|564660872|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156428482|NCT01981850|564660873|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156773527|NCT02421939|565922776|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
156428483|NCT01981850|564660874|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156428484|NCT01981850|564660875|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156428485|NCT01981850|564660876|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156428486|NCT01981850|564660877|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156428487|NCT01981850|564660868|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
156428488|NCT01981850|564660869|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
156428489|NCT01981850|564660870|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
156428490|NCT01981850|564660871|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
156773528|NCT02421939|565922775|FG000|Long Term Follow up: up to 3 Years|Death|118|||
156428491|NCT01981850|564660872|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
156428492|NCT01981850|564660873|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
156428493|NCT01981850|564660874|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
156428494|NCT01981850|564660875|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
156428495|NCT01981850|564660876|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
156428496|NCT01981850|564660877|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
156428497|NCT01981850|564660868|FG000|Main Phase Stage 1|Various reasons|0|||
156428498|NCT01981850|564660869|FG001|Main Phase Stage 1|Various reasons|0|||
156428499|NCT01981850|564660870|FG002|Main Phase Stage 1|Various reasons|2|||
156773529|NCT02421939|565922776|FG001|Long Term Follow up: up to 3 Years|Death|65|||
156773530|NCT02421939|565922775|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
156428500|NCT01981850|564660871|FG003|Main Phase Stage 1|Various reasons|0|||
156428501|NCT01981850|564660872|FG004|Main Phase Stage 1|Various reasons|0|||
156428502|NCT01981850|564660873|FG005|Main Phase Stage 1|Various reasons|0|||
156428503|NCT01981850|564660874|FG006|Main Phase Stage 1|Various reasons|0|||
156428504|NCT01981850|564660875|FG007|Main Phase Stage 1|Various reasons|0|||
156428505|NCT01981850|564660876|FG008|Main Phase Stage 1|Various reasons|0|||
156428506|NCT01981850|564660877|FG009|Main Phase Stage 1|Various reasons|0|||
156428507|NCT01981850|564660868|FG000|Main Phase Stage 2|Adverse Event|0|||
156428508|NCT01981850|564660869|FG001|Main Phase Stage 2|Adverse Event|0|||
156428509|NCT01981850|564660870|FG002|Main Phase Stage 2|Adverse Event|0|||
156428510|NCT01981850|564660871|FG003|Main Phase Stage 2|Adverse Event|0|||
156428511|NCT01981850|564660872|FG004|Main Phase Stage 2|Adverse Event|6|||
156428512|NCT01981850|564660873|FG005|Main Phase Stage 2|Adverse Event|5|||
156428513|NCT01981850|564660874|FG006|Main Phase Stage 2|Adverse Event|7|||
156428514|NCT01981850|564660875|FG007|Main Phase Stage 2|Adverse Event|0|||
156428515|NCT01981850|564660876|FG008|Main Phase Stage 2|Adverse Event|0|||
156773531|NCT02421939|565922776|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
156773532|NCT01035138|565922780|FG000|Overall Study|Adverse Event|4|||
156773533|NCT01035138|565922781|FG001|Overall Study|Adverse Event|0|||
156773534|NCT01035138|565922782|FG002|Overall Study|Adverse Event|2|||
156773535|NCT01035138|565922780|FG000|Overall Study|Caregiver Decision|2|||
156773536|NCT01035138|565922781|FG001|Overall Study|Caregiver Decision|0|||
156773537|NCT01035138|565922782|FG002|Overall Study|Caregiver Decision|1|||
156773538|NCT01035138|565922780|FG000|Overall Study|Withdrawal by Subject|1|||
156773539|NCT01035138|565922781|FG001|Overall Study|Withdrawal by Subject|0|||
156324094|NCT00417482|564286075|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
156428516|NCT01981850|564660877|FG009|Main Phase Stage 2|Adverse Event|0|||
156428517|NCT01981850|564660868|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156428518|NCT01981850|564660869|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156324095|NCT00417482|564286076|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
156324096|NCT00417482|564286074|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
156324097|NCT00417482|564286075|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
156324098|NCT00417482|564286076|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
156324099|NCT00417482|564286074|FG000|Phase B 2nd 16 Weeks|Death|1|||
156324100|NCT00417482|564286075|FG001|Phase B 2nd 16 Weeks|Death|1|||
156324101|NCT00417482|564286076|FG002|Phase B 2nd 16 Weeks|Death|0|||
156324102|NCT03343067|564286079|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
156324103|NCT03343067|564286080|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
156324104|NCT03343067|564286081|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
156324105|NCT00116168|564286082|FG000|Overall Study|Lost to Follow-up|6|||
156324106|NCT00116168|564286083|FG001|Overall Study|Lost to Follow-up|5|||
156324107|NCT00116168|564286084|FG002|Overall Study|Lost to Follow-up|0|||
156324108|NCT00116168|564286085|FG003|Overall Study|Lost to Follow-up|0|||
156324109|NCT00048061|564286086|FG000|Overall Study|Adverse Event|41|||
156324110|NCT00048061|564286087|FG001|Overall Study|Adverse Event|32|||
156324111|NCT00048061|564286088|FG002|Overall Study|Adverse Event|44|||
156324112|NCT00048061|564286089|FG003|Overall Study|Adverse Event|37|||
156324113|NCT00048061|564286086|FG000|Overall Study|Lost to Follow-up|3|||
156324114|NCT00048061|564286087|FG001|Overall Study|Lost to Follow-up|2|||
156324115|NCT00048061|564286088|FG002|Overall Study|Lost to Follow-up|4|||
156324116|NCT00048061|564286089|FG003|Overall Study|Lost to Follow-up|5|||
156324117|NCT00048061|564286086|FG000|Overall Study|Withdrawal by Subject|20|||
156324118|NCT00048061|564286087|FG001|Overall Study|Withdrawal by Subject|29|||
156324119|NCT00048061|564286088|FG002|Overall Study|Withdrawal by Subject|29|||
156324120|NCT00048061|564286089|FG003|Overall Study|Withdrawal by Subject|32|||
156324121|NCT00048061|564286086|FG000|Overall Study|Did not follow-up|5|||
156324122|NCT00048061|564286087|FG001|Overall Study|Did not follow-up|5|||
156324123|NCT00048061|564286088|FG002|Overall Study|Did not follow-up|4|||
156324124|NCT00048061|564286089|FG003|Overall Study|Did not follow-up|5|||
156324125|NCT00048061|564286086|FG000|Overall Study|Early improvement|6|||
156428519|NCT01981850|564660870|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156773540|NCT01035138|565922782|FG002|Overall Study|Withdrawal by Subject|0|||
156324126|NCT00048061|564286087|FG001|Overall Study|Early improvement|5|||
156773541|NCT01035138|565922780|FG000|Overall Study|Physician Decision|0|||
156773542|NCT01035138|565922781|FG001|Overall Study|Physician Decision|0|||
156773543|NCT01035138|565922782|FG002|Overall Study|Physician Decision|1|||
156773544|NCT01035138|565922780|FG000|Overall Study|Sponsor Decision|66|||
156324127|NCT00048061|564286088|FG002|Overall Study|Early improvement|3|||
156324128|NCT00048061|564286089|FG003|Overall Study|Early improvement|0|||
156324129|NCT03583073|564286090|FG000|Overall Study|Lost to Follow-up|8|||
156324130|NCT03583073|564286091|FG001|Overall Study|Lost to Follow-up|12|||
156324131|NCT04718103|564286098|FG000|Overall Study|Adverse Event|1|||
156324132|NCT04718103|564286099|FG001|Overall Study|Adverse Event|1|||
156324133|NCT04718103|564286098|FG000|Overall Study|Lack of Efficacy|4|||
156324134|NCT04718103|564286099|FG001|Overall Study|Lack of Efficacy|1|||
156324135|NCT04718103|564286098|FG000|Overall Study|Lost to Follow-up|2|||
156324136|NCT04718103|564286099|FG001|Overall Study|Lost to Follow-up|2|||
156324137|NCT04718103|564286098|FG000|Overall Study|Physician Decision|2|||
156324138|NCT04718103|564286099|FG001|Overall Study|Physician Decision|0|||
156324139|NCT04718103|564286098|FG000|Overall Study|Pregnancy|0|||
156324140|NCT04718103|564286099|FG001|Overall Study|Pregnancy|1|||
156324141|NCT04718103|564286098|FG000|Overall Study|Withdrawal by Subject|10|||
156324142|NCT04718103|564286099|FG001|Overall Study|Withdrawal by Subject|6|||
156324143|NCT04718103|564286098|FG000|Overall Study|Randomized, not treated|4|||
156324144|NCT04718103|564286099|FG001|Overall Study|Randomized, not treated|1|||
156324145|NCT04718103|564286098|FG000|Overall Study|GCP violations|7|||
156324146|NCT04718103|564286099|FG001|Overall Study|GCP violations|5|||
156324147|NCT04706416|564286100|FG000|Overall Study|Lost to Follow-up|2|||
156324148|NCT04706416|564286101|FG001|Overall Study|Lost to Follow-up|0|||
156324149|NCT01484054|564286105|FG000|Period 1|Withdrawal by Subject|0|||
156324150|NCT01484054|564286106|FG001|Period 1|Withdrawal by Subject|1|||
156324151|NCT05281601|564286107|FG000|Overall Study|Physician Decision|2|||
156324152|NCT05281601|564286108|FG001|Overall Study|Physician Decision|0|||
156324153|NCT05281601|564286107|FG000|Overall Study|Lost to Follow-up|2|||
156324154|NCT05281601|564286108|FG001|Overall Study|Lost to Follow-up|0|||
156324155|NCT05281601|564286107|FG000|Overall Study|Death|1|||
156324156|NCT05281601|564286108|FG001|Overall Study|Death|0|||
156324157|NCT05281601|564286107|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156324158|NCT05281601|564286108|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156324159|NCT00995865|564286115|FG000|Overall Study|Protocol Violation|2|||
156324160|NCT00995865|564286116|FG001|Overall Study|Protocol Violation|0|||
156324161|NCT00995865|564286117|FG002|Overall Study|Protocol Violation|0|||
156324162|NCT00995865|564286115|FG000|Overall Study|Lost to Follow-up|0|||
156324163|NCT00995865|564286116|FG001|Overall Study|Lost to Follow-up|0|||
156324164|NCT00995865|564286117|FG002|Overall Study|Lost to Follow-up|1|||
156324165|NCT02021656|564286125|FG000|Overall Study|Adverse Event|1|||
156324166|NCT02021656|564286125|FG000|Overall Study|Lack of Efficacy|2|||
156324167|NCT02021656|564286125|FG000|Overall Study|Lost to Follow-up|1|||
156324168|NCT02021656|564286125|FG000|Overall Study|Withdrew Consent|2|||
156324169|NCT00510952|564286126|FG000|Overall Study|Adverse Event|1|||
156324170|NCT00510952|564286127|FG001|Overall Study|Adverse Event|0|||
156324171|NCT00510952|564286126|FG000|Overall Study|Entry Criteria Not Met|3|||
156324172|NCT00510952|564286127|FG001|Overall Study|Entry Criteria Not Met|1|||
156324173|NCT00510952|564286126|FG000|Overall Study|Lost to Follow-up|5|||
156324174|NCT00510952|564286127|FG001|Overall Study|Lost to Follow-up|3|||
156324175|NCT00510952|564286126|FG000|Overall Study|Physician Decision|1|||
156324176|NCT00510952|564286127|FG001|Overall Study|Physician Decision|1|||
156324177|NCT00510952|564286126|FG000|Overall Study|Protocol Violation|7|||
156324178|NCT00510952|564286127|FG001|Overall Study|Protocol Violation|4|||
156324179|NCT00510952|564286126|FG000|Overall Study|Sponsor Decision|1|||
156324180|NCT00510952|564286127|FG001|Overall Study|Sponsor Decision|0|||
156324181|NCT00510952|564286126|FG000|Overall Study|Withdrawal by Subject|6|||
156324182|NCT00510952|564286127|FG001|Overall Study|Withdrawal by Subject|7|||
156324183|NCT00510952|564286126|FG000|Overall Study|Did Not Receive Study Drug|2|||
156324184|NCT00510952|564286127|FG001|Overall Study|Did Not Receive Study Drug|0|||
156324185|NCT03119701|564286129|FG000|6-day Dosing|Death|4|||
156324186|NCT03119701|564286130|FG001|6-day Dosing|Death|1|||
156324187|NCT03119701|564286129|FG000|6-day Dosing|Adverse Event|3|||
156324188|NCT03119701|564286130|FG001|6-day Dosing|Adverse Event|0|||
156324189|NCT03119701|564286129|FG000|6-day Dosing|Physician Decision|0|||
156324190|NCT03119701|564286130|FG001|6-day Dosing|Physician Decision|1|||
156324191|NCT03119701|564286129|FG000|6-day Dosing|Withdrawal by Subject|0|||
156324192|NCT03119701|564286130|FG001|6-day Dosing|Withdrawal by Subject|1|||
156324193|NCT03119701|564286129|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
156324194|NCT03119701|564286130|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
156324195|NCT00817479|564286132|FG000|Overall Study|Physician Decision|1|||
156324196|NCT00817479|564286133|FG001|Overall Study|Physician Decision|1|||
156324197|NCT02793128|564286136|FG000|Overall Study|Death|4|||
156324198|NCT02793128|564286136|FG000|Overall Study|Withdrawal by Subject|2|||
156324199|NCT02793128|564286136|FG000|Overall Study|Physician Decision|1|||
156324200|NCT02793128|564286136|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
156324201|NCT02793128|564286136|FG000|Overall Study|Patient elected nephroureterectomy|1|||
156324202|NCT02359851|564286137|FG000|Overall Study|Death|1|||
156657692|NCT00436007|565493638|FG001|Overall Study|Withdrawal by Subject|3|||
156657693|NCT00436007|565493639|FG002|Overall Study|Withdrawal by Subject|4|||
156657694|NCT00436007|565493637|FG000|Overall Study|Lost to Follow-up|14|||
156657695|NCT00436007|565493638|FG001|Overall Study|Lost to Follow-up|10|||
156657696|NCT00436007|565493639|FG002|Overall Study|Lost to Follow-up|13|||
156657697|NCT00436007|565493637|FG000|Overall Study|Physician Decision|0|||
156657698|NCT00436007|565493638|FG001|Overall Study|Physician Decision|0|||
156657699|NCT00436007|565493639|FG002|Overall Study|Physician Decision|2|||
156657700|NCT00436007|565493637|FG000|Overall Study|Death|0|||
156657701|NCT00436007|565493638|FG001|Overall Study|Death|1|||
156657702|NCT00436007|565493639|FG002|Overall Study|Death|3|||
156657703|NCT00436007|565493637|FG000|Overall Study|Other|0|||
156657704|NCT00436007|565493638|FG001|Overall Study|Other|0|||
156657705|NCT00436007|565493639|FG002|Overall Study|Other|1|||
156657706|NCT03331042|565493641|FG000|Overall Study|Protocol Violation|1|||
156773545|NCT01035138|565922781|FG001|Overall Study|Sponsor Decision|60|||
156773546|NCT01035138|565922782|FG002|Overall Study|Sponsor Decision|42|||
156773547|NCT01035138|565922780|FG000|Overall Study|Lost to Follow-up|0|||
156773548|NCT01035138|565922781|FG001|Overall Study|Lost to Follow-up|0|||
156773549|NCT01035138|565922782|FG002|Overall Study|Lost to Follow-up|1|||
156428520|NCT01981850|564660871|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156428521|NCT01981850|564660872|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
156428522|NCT01981850|564660873|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
156773550|NCT02966834|565922783|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773551|NCT02966834|565922784|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773552|NCT02966834|565922785|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773553|NCT02966834|565922786|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773554|NCT02966834|565922787|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
156773555|NCT02966834|565922788|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773556|NCT02966834|565922783|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
156773557|NCT02966834|565922784|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773558|NCT02966834|565922785|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773559|NCT02966834|565922786|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773560|NCT02966834|565922787|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773561|NCT02966834|565922788|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773562|NCT02966834|565922783|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
156773563|NCT02966834|565922784|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
156773564|NCT02966834|565922785|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
156773565|NCT02966834|565922786|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
156773566|NCT02966834|565922787|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
156773567|NCT02966834|565922788|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
156773568|NCT02966834|565922783|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
156773569|NCT02966834|565922784|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
156773570|NCT02966834|565922785|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
156773571|NCT02966834|565922786|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
156773572|NCT02966834|565922787|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
156773573|NCT02966834|565922788|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
156773574|NCT02966834|565922783|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773575|NCT02966834|565922784|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773576|NCT02966834|565922785|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773577|NCT02966834|565922786|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
156773578|NCT02966834|565922787|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773579|NCT02966834|565922788|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773580|NCT02966834|565922783|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773581|NCT02966834|565922784|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773582|NCT02966834|565922785|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773583|NCT02966834|565922786|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
156773584|NCT02966834|565922787|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773585|NCT02966834|565922788|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773586|NCT00655889|565922789|FG000|Overall Study|Inadequate cell growth|1|||
156773587|NCT00655889|565922789|FG000|Overall Study|Protocol Violation|1|||
156773588|NCT03573297|565922792|FG000|Open Label Treatment Period|Adverse Event|67|||
156773589|NCT03573297|565922793|FG001|Open Label Treatment Period|Adverse Event|0|||
156773590|NCT03573297|565922794|FG002|Open Label Treatment Period|Adverse Event|0|||
156773591|NCT03573297|565922795|FG003|Open Label Treatment Period|Adverse Event|0|||
156773592|NCT03573297|565922792|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
156657707|NCT03331042|565493642|FG001|Overall Study|Protocol Violation|0|||
156657708|NCT03331042|565493643|FG002|Overall Study|Protocol Violation|0|||
156657709|NCT03331042|565493644|FG003|Overall Study|Protocol Violation|0|||
156657710|NCT03331042|565493641|FG000|Overall Study|Physician Decision|0|||
156657711|NCT03331042|565493642|FG001|Overall Study|Physician Decision|0|||
156657712|NCT03331042|565493643|FG002|Overall Study|Physician Decision|1|||
156657713|NCT03331042|565493644|FG003|Overall Study|Physician Decision|0|||
156657714|NCT03331042|565493641|FG000|Overall Study|Lost to Follow-up|0|||
156657715|NCT03331042|565493642|FG001|Overall Study|Lost to Follow-up|0|||
156773593|NCT03573297|565922793|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
156773594|NCT03573297|565922794|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
156773595|NCT03573297|565922795|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
156773596|NCT03573297|565922792|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
156773597|NCT03573297|565922793|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
156773598|NCT03573297|565922794|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
156773599|NCT03573297|565922795|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
156773600|NCT03573297|565922792|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
156773601|NCT03573297|565922793|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
156773602|NCT03573297|565922794|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
156773603|NCT03573297|565922795|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
156773604|NCT03573297|565922792|FG000|Open Label Treatment Period|Pregnancy|1|||
156773605|NCT03573297|565922793|FG001|Open Label Treatment Period|Pregnancy|0|||
156773606|NCT03573297|565922794|FG002|Open Label Treatment Period|Pregnancy|0|||
156773607|NCT03573297|565922795|FG003|Open Label Treatment Period|Pregnancy|0|||
156773608|NCT03573297|565922792|FG000|Open Label Treatment Period|Protocol Violation|17|||
156773609|NCT03573297|565922793|FG001|Open Label Treatment Period|Protocol Violation|0|||
156773610|NCT03573297|565922794|FG002|Open Label Treatment Period|Protocol Violation|0|||
156773611|NCT03573297|565922795|FG003|Open Label Treatment Period|Protocol Violation|0|||
156773612|NCT03573297|565922792|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
156773613|NCT03573297|565922793|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
156773614|NCT03573297|565922794|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
156773615|NCT03573297|565922795|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
156773616|NCT03573297|565922792|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
156773617|NCT03573297|565922793|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
156773618|NCT03573297|565922794|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
156773619|NCT03573297|565922795|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
156773620|NCT03573297|565922792|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
156773621|NCT03573297|565922793|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
156773622|NCT03573297|565922794|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
156773623|NCT03573297|565922795|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
156773624|NCT03573297|565922792|FG000|Open Label Treatment Period|Other, Not Specified|7|||
156773625|NCT03573297|565922793|FG001|Open Label Treatment Period|Other, Not Specified|0|||
156773626|NCT03573297|565922794|FG002|Open Label Treatment Period|Other, Not Specified|0|||
156773627|NCT03573297|565922795|FG003|Open Label Treatment Period|Other, Not Specified|0|||
156773628|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
156773629|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
156773630|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
156773631|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
156773632|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156773633|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156773634|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Adverse Event|5|||
156773635|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Adverse Event|1|||
156773636|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156773637|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
156773638|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
156773639|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
156773640|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156773641|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
156773642|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
156773643|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
156773644|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156773645|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
156773646|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
156523545|NCT01873495|565011748|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
156523546|NCT04874415|565011752|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156523547|NCT04874415|565011753|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156523548|NCT04874415|565011754|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156523549|NCT04874415|565011755|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156657716|NCT03331042|565493643|FG002|Overall Study|Lost to Follow-up|0|||
156657717|NCT03331042|565493644|FG003|Overall Study|Lost to Follow-up|1|||
156773647|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
156657718|NCT02433678|565493648|FG000|Overall Study|Lost to Follow-up|1|||
156657719|NCT02433678|565493649|FG001|Overall Study|Lost to Follow-up|2|||
156523550|NCT04874415|565011756|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156523551|NCT04874415|565011757|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156523552|NCT04874415|565011758|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
156523553|NCT04874415|565011759|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156523554|NCT04874415|565011760|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
156523555|NCT04874415|565011761|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
156523556|NCT04874415|565011762|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156523557|NCT04874415|565011763|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
156523558|NCT04874415|565011764|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
156523559|NCT04874415|565011765|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
156773648|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156773649|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
156773650|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
156773651|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
156773652|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
156773653|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
156773654|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
156773655|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
156773656|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
156773657|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
156324203|NCT02359851|564286137|FG000|Overall Study|Disease progression|1|||
156324204|NCT02101112|564286138|FG000|Overall Study|Adverse Event|0|||
156324205|NCT02101112|564286139|FG001|Overall Study|Adverse Event|0|||
156324206|NCT02101112|564286140|FG002|Overall Study|Adverse Event|1|||
156324207|NCT02101112|564286141|FG003|Overall Study|Adverse Event|0|||
156324208|NCT02101112|564286142|FG004|Overall Study|Adverse Event|0|||
156324209|NCT02101112|564286143|FG005|Overall Study|Adverse Event|0|||
156324210|NCT02101112|564286138|FG000|Overall Study|Withdrawal by Subject|0|||
156324211|NCT02101112|564286139|FG001|Overall Study|Withdrawal by Subject|0|||
156324212|NCT02101112|564286140|FG002|Overall Study|Withdrawal by Subject|0|||
156324213|NCT02101112|564286141|FG003|Overall Study|Withdrawal by Subject|0|||
156324214|NCT02101112|564286142|FG004|Overall Study|Withdrawal by Subject|1|||
156324215|NCT02101112|564286143|FG005|Overall Study|Withdrawal by Subject|0|||
156324216|NCT02125604|564286144|FG000|Overall Study|Other|4|||
156324217|NCT02125604|564286144|FG000|Overall Study|Investigator Decision|1|||
156324218|NCT02125604|564286144|FG000|Overall Study|Lost to Follow-up|2|||
156324219|NCT02125604|564286144|FG000|Overall Study|Consent Withdrawn|4|||
156324220|NCT02125604|564286144|FG000|Overall Study|Adverse Event|20|||
156324221|NCT04340063|564286145|FG000|Overall Study|Withdrawal by Subject|1|||
156324222|NCT04340063|564286146|FG001|Overall Study|Withdrawal by Subject|2|||
156324223|NCT04340063|564286145|FG000|Overall Study|Lost to Follow-up|3|||
156324224|NCT04340063|564286146|FG001|Overall Study|Lost to Follow-up|1|||
156324225|NCT04340063|564286145|FG000|Overall Study|Protocol Violation|0|||
156324226|NCT04340063|564286146|FG001|Overall Study|Protocol Violation|1|||
156324227|NCT00734747|564286147|FG000|SRS Procedure|No staples placed|3|||
156324228|NCT00734747|564286147|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
156324229|NCT03287635|564286150|FG000|Overall Study|Lost to Follow-up|5|||
156324230|NCT03287635|564286150|FG000|Overall Study|Withdrawal by Subject|1|||
156324231|NCT03287635|564286150|FG000|Overall Study|Physician Decision|1|||
156324232|NCT03468985|564287581|FG000|Overall Study|Adverse Event|0|||
156324233|NCT03468985|564287582|FG001|Overall Study|Adverse Event|2|||
156324234|NCT03468985|564287583|FG002|Overall Study|Adverse Event|0|||
156324235|NCT03468985|564287584|FG003|Overall Study|Adverse Event|0|||
156324236|NCT03468985|564287581|FG000|Overall Study|Withdrawal by Subject|0|||
156324237|NCT03468985|564287582|FG001|Overall Study|Withdrawal by Subject|0|||
156324238|NCT03468985|564287583|FG002|Overall Study|Withdrawal by Subject|0|||
156324239|NCT03468985|564287584|FG003|Overall Study|Withdrawal by Subject|1|||
156324240|NCT02806973|564287585|FG000|Period 1|Withdrawal by Subject|0|||
156523560|NCT04874415|565011766|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
156324241|NCT02806973|564287586|FG001|Period 1|Withdrawal by Subject|2|||
156324242|NCT02806973|564287587|FG002|Period 1|Withdrawal by Subject|1|||
156324243|NCT02806973|564287588|FG003|Period 1|Withdrawal by Subject|1|||
156324244|NCT02806973|564287585|FG000|Period 1|Adverse Event|0|||
156324245|NCT02806973|564287586|FG001|Period 1|Adverse Event|0|||
156324246|NCT02806973|564287587|FG002|Period 1|Adverse Event|0|||
156324247|NCT02806973|564287588|FG003|Period 1|Adverse Event|1|||
156324248|NCT02806973|564287585|FG000|Period 3|Withdrawal by Subject|0|||
156324249|NCT02806973|564287586|FG001|Period 3|Withdrawal by Subject|0|||
156324250|NCT02806973|564287587|FG002|Period 3|Withdrawal by Subject|0|||
156324251|NCT02806973|564287588|FG003|Period 3|Withdrawal by Subject|3|||
156324252|NCT02806973|564287585|FG000|Period 3|Adverse Event|0|||
156324253|NCT02806973|564287586|FG001|Period 3|Adverse Event|0|||
156324254|NCT02806973|564287587|FG002|Period 3|Adverse Event|1|||
156324255|NCT02806973|564287588|FG003|Period 3|Adverse Event|0|||
156324256|NCT04060862|564287591|FG000|Overall Study|Symptomatic Deterioration|1|||
156773658|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
156773659|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
156773660|NCT02781324|565922797|FG000|Overall Study|Withdrawal by Subject|1|||
156773661|NCT02781324|565922798|FG001|Overall Study|Withdrawal by Subject|0|||
156773662|NCT02781324|565922797|FG000|Overall Study|Physician Decision|1|||
156773663|NCT02781324|565922798|FG001|Overall Study|Physician Decision|2|||
156773664|NCT03846479|565924688|FG000|Overall Study|Death|8|||
156773665|NCT03846479|565924688|FG000|Overall Study|Lost to Follow-up|1|||
156773666|NCT00300053|565924693|FG000|Overall Study|Patient/Caregiver Preference|2|||
156773667|NCT00300053|565924694|FG001|Overall Study|Patient/Caregiver Preference|2|||
156773668|NCT00300053|565924695|FG002|Overall Study|Patient/Caregiver Preference|3|||
156773669|NCT00300053|565924693|FG000|Overall Study|Death|0|||
156773670|NCT00300053|565924694|FG001|Overall Study|Death|0|||
156773671|NCT00300053|565924695|FG002|Overall Study|Death|3|||
156773672|NCT00300053|565924693|FG000|Overall Study|Lost to Follow-up|0|||
156773673|NCT00300053|565924694|FG001|Overall Study|Lost to Follow-up|1|||
156773674|NCT00300053|565924695|FG002|Overall Study|Lost to Follow-up|0|||
156773675|NCT03095287|565924699|FG000|Overall Study|Treatment Failure|1|||
156773676|NCT03095287|565924699|FG000|Overall Study|Adverse Event|1|||
156773677|NCT01294514|565924702|FG000|Overall Study|Excluded due to Arrhythmia|1|||
156773678|NCT01963611|565924703|FG000|Overall Study|Adverse Event|1|||
156773679|NCT01963611|565924704|FG001|Overall Study|Adverse Event|1|||
156773680|NCT01963611|565924705|FG002|Overall Study|Adverse Event|3|||
156773681|NCT01963611|565924706|FG003|Overall Study|Adverse Event|4|||
156773682|NCT01963611|565924707|FG004|Overall Study|Adverse Event|3|||
156773683|NCT01963611|565924703|FG000|Overall Study|Protocol Violation|0|||
156773684|NCT01963611|565924704|FG001|Overall Study|Protocol Violation|0|||
156773685|NCT01963611|565924705|FG002|Overall Study|Protocol Violation|0|||
156773686|NCT01963611|565924706|FG003|Overall Study|Protocol Violation|1|||
156773687|NCT01963611|565924707|FG004|Overall Study|Protocol Violation|0|||
156773688|NCT01963611|565924703|FG000|Overall Study|Lack of Efficacy|0|||
156773689|NCT01963611|565924704|FG001|Overall Study|Lack of Efficacy|0|||
156773690|NCT01963611|565924705|FG002|Overall Study|Lack of Efficacy|0|||
156773691|NCT01963611|565924706|FG003|Overall Study|Lack of Efficacy|1|||
156773692|NCT01963611|565924707|FG004|Overall Study|Lack of Efficacy|0|||
156773693|NCT01963611|565924703|FG000|Overall Study|Withdrawal by Subject|3|||
156773694|NCT01963611|565924704|FG001|Overall Study|Withdrawal by Subject|2|||
156773695|NCT01963611|565924705|FG002|Overall Study|Withdrawal by Subject|1|||
156773696|NCT01963611|565924706|FG003|Overall Study|Withdrawal by Subject|1|||
156773697|NCT01963611|565924707|FG004|Overall Study|Withdrawal by Subject|3|||
156773698|NCT01963611|565924703|FG000|Overall Study|Other|47|||
156773699|NCT01963611|565924704|FG001|Overall Study|Other|46|||
156773700|NCT01963611|565924705|FG002|Overall Study|Other|48|||
156773701|NCT01963611|565924706|FG003|Overall Study|Other|45|||
156773702|NCT01963611|565924707|FG004|Overall Study|Other|45|||
156773703|NCT01126424|565924709|FG000|Overall Study|Adverse Event|0|||
156773704|NCT01126424|565924710|FG001|Overall Study|Adverse Event|0|||
156324257|NCT04060862|564287591|FG000|Overall Study|Un-specified|6|||
156324258|NCT04060862|564287591|FG000|Overall Study|Progressive disease|12|||
156324259|NCT04060862|564287591|FG000|Overall Study|Physician Decision|1|||
156324260|NCT01229397|564287592|FG000|Overall Study|Withdrawal by Subject|3|||
156324261|NCT01229397|564287593|FG001|Overall Study|Withdrawal by Subject|3|||
156324262|NCT01229397|564287592|FG000|Overall Study|Lost to Follow-up|7|||
156324263|NCT01229397|564287593|FG001|Overall Study|Lost to Follow-up|6|||
156324264|NCT01229397|564287592|FG000|Overall Study|Migrated/moved from study area|1|||
156324265|NCT01229397|564287593|FG001|Overall Study|Migrated/moved from study area|0|||
156324266|NCT01869725|564287595|FG000|Overall Study|ineligible after registration|1|||
156324267|NCT01869725|564287595|FG000|Overall Study|Death|1|||
156324268|NCT01869725|564287595|FG000|Overall Study|Lost to Follow-up|2|||
156324269|NCT03416374|564287596|FG000|Between Treatment Period I and II|Other|0|||
156324270|NCT03416374|564287597|FG001|Between Treatment Period I and II|Other|9|||
156324271|NCT03416374|564287596|FG000|Treatment Period II|Lack of Efficacy|3|||
156324272|NCT03416374|564287597|FG001|Treatment Period II|Lack of Efficacy|11|||
156773705|NCT01126424|565924711|FG002|Overall Study|Adverse Event|0|||
156773706|NCT01126424|565924712|FG003|Overall Study|Adverse Event|0|||
156773707|NCT01126424|565924713|FG004|Overall Study|Adverse Event|1|||
156773708|NCT01126424|565924714|FG005|Overall Study|Adverse Event|0|||
156773709|NCT01126424|565924709|FG000|Overall Study|Withdrawal by Subject|0|||
156773710|NCT01126424|565924710|FG001|Overall Study|Withdrawal by Subject|0|||
156773711|NCT01126424|565924711|FG002|Overall Study|Withdrawal by Subject|1|||
156324273|NCT03416374|564287596|FG000|Treatment Period II|Adverse Event|1|||
156324274|NCT03416374|564287597|FG001|Treatment Period II|Adverse Event|4|||
156324275|NCT03416374|564287596|FG000|Treatment Period II|Death|0|||
156324276|NCT03416374|564287597|FG001|Treatment Period II|Death|1|||
156324277|NCT03416374|564287596|FG000|Treatment Period II|Other|0|||
156324278|NCT03416374|564287597|FG001|Treatment Period II|Other|2|||
156324279|NCT03463031|564287600|FG000|Overall Study|Withdrawal by Subject|4|||
156324280|NCT03463031|564287601|FG001|Overall Study|Withdrawal by Subject|2|||
156324281|NCT03463031|564287600|FG000|Overall Study|Investigator/Sponsor Decision|0|||
156657720|NCT02720510|565493650|FG000|Overall Study|Study Terminated by the sponsor|2|||
156657721|NCT02720510|565493651|FG001|Overall Study|Study Terminated by the sponsor|0|||
156657722|NCT02720510|565493650|FG000|Overall Study|Adverse Event|0|||
156657723|NCT02720510|565493651|FG001|Overall Study|Adverse Event|1|||
156657724|NCT02720510|565493650|FG000|Overall Study|Physician Decision|1|||
156657725|NCT02720510|565493651|FG001|Overall Study|Physician Decision|2|||
156657726|NCT03499964|565493652|FG000|Overall Study|Lack of Efficacy|6|||
156657727|NCT03499964|565493653|FG001|Overall Study|Lack of Efficacy|26|||
156657728|NCT03499964|565493652|FG000|Overall Study|Adverse Event|1|||
156657729|NCT03499964|565493653|FG001|Overall Study|Adverse Event|0|||
156657730|NCT03499964|565493652|FG000|Overall Study|Death|1|||
156657731|NCT03499964|565493653|FG001|Overall Study|Death|0|||
156657732|NCT03499964|565493652|FG000|Overall Study|Withdrawal by Subject|2|||
156657733|NCT03499964|565493653|FG001|Overall Study|Withdrawal by Subject|1|||
156657734|NCT03499964|565493652|FG000|Overall Study|Lost to Follow-up|1|||
156657735|NCT03499964|565493653|FG001|Overall Study|Lost to Follow-up|0|||
156657736|NCT01047345|565493654|FG000|Base Study|Adverse Event|3|||
156657737|NCT01047345|565493655|FG001|Base Study|Adverse Event|0|||
156657738|NCT01047345|565493656|FG002|Base Study|Adverse Event|0|||
156657739|NCT01047345|565493654|FG000|Base Study|Lost to Follow-up|4|||
156657740|NCT01047345|565493655|FG001|Base Study|Lost to Follow-up|1|||
156657741|NCT01047345|565493656|FG002|Base Study|Lost to Follow-up|0|||
156657742|NCT01047345|565493654|FG000|Base Study|Protocol Violation|3|||
156657743|NCT01047345|565493655|FG001|Base Study|Protocol Violation|1|||
156657744|NCT01047345|565493656|FG002|Base Study|Protocol Violation|0|||
156657745|NCT01047345|565493654|FG000|Base Study|Withdrawal by Subject|12|||
156657746|NCT01047345|565493655|FG001|Base Study|Withdrawal by Subject|4|||
156657747|NCT01047345|565493656|FG002|Base Study|Withdrawal by Subject|0|||
156657748|NCT01047345|565493654|FG000|Extension|Withdrawal by Subject|0|||
156657749|NCT01047345|565493655|FG001|Extension|Withdrawal by Subject|0|||
156657750|NCT01047345|565493656|FG002|Extension|Withdrawal by Subject|1|||
156657751|NCT01047345|565493654|FG000|Extension|Lost to Follow-up|0|||
156657752|NCT01047345|565493655|FG001|Extension|Lost to Follow-up|0|||
156657753|NCT01047345|565493656|FG002|Extension|Lost to Follow-up|5|||
156657754|NCT00454636|565493657|FG000|Overall Study|Adverse Event|10|||
156657755|NCT00454636|565493658|FG001|Overall Study|Adverse Event|6|||
156657756|NCT00454636|565493659|FG002|Overall Study|Adverse Event|9|||
156657757|NCT00454636|565493660|FG003|Overall Study|Adverse Event|15|||
156657758|NCT00454636|565493657|FG000|Overall Study|Disease Progression|11|||
156657759|NCT00454636|565493658|FG001|Overall Study|Disease Progression|12|||
156657760|NCT00454636|565493659|FG002|Overall Study|Disease Progression|4|||
156657761|NCT00454636|565493660|FG003|Overall Study|Disease Progression|11|||
156657762|NCT00454636|565493657|FG000|Overall Study|Protocol Violation|3|||
156657763|NCT00454636|565493658|FG001|Overall Study|Protocol Violation|2|||
156657764|NCT00454636|565493659|FG002|Overall Study|Protocol Violation|3|||
156428523|NCT01981850|564660874|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
156428524|NCT01981850|564660875|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156428525|NCT01981850|564660876|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156428526|NCT01981850|564660877|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156428527|NCT01981850|564660868|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
156428528|NCT01981850|564660869|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
156428529|NCT01981850|564660870|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
156428530|NCT01981850|564660871|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
156428531|NCT01981850|564660872|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
156428532|NCT01981850|564660873|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
156428533|NCT01981850|564660874|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
156428534|NCT01981850|564660875|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
156428535|NCT01981850|564660876|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
156428536|NCT01981850|564660877|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
156428537|NCT01981850|564660868|FG000|Main Phase Stage 2|Various reasons|0|||
156773712|NCT01126424|565924712|FG003|Overall Study|Withdrawal by Subject|3|||
156773713|NCT01126424|565924713|FG004|Overall Study|Withdrawal by Subject|1|||
156428538|NCT01981850|564660869|FG001|Main Phase Stage 2|Various reasons|0|||
156428539|NCT01981850|564660870|FG002|Main Phase Stage 2|Various reasons|0|||
156428540|NCT01981850|564660871|FG003|Main Phase Stage 2|Various reasons|0|||
156428541|NCT01981850|564660872|FG004|Main Phase Stage 2|Various reasons|2|||
156428542|NCT01981850|564660873|FG005|Main Phase Stage 2|Various reasons|0|||
156428543|NCT01981850|564660874|FG006|Main Phase Stage 2|Various reasons|1|||
156428544|NCT01981850|564660875|FG007|Main Phase Stage 2|Various reasons|0|||
156657765|NCT00454636|565493660|FG003|Overall Study|Protocol Violation|3|||
156657766|NCT00454636|565493657|FG000|Overall Study|Death|6|||
156657767|NCT00454636|565493658|FG001|Overall Study|Death|1|||
156657768|NCT00454636|565493659|FG002|Overall Study|Death|1|||
156657769|NCT00454636|565493660|FG003|Overall Study|Death|1|||
156657770|NCT00454636|565493657|FG000|Overall Study|Patient refusal|1|||
156657771|NCT00454636|565493658|FG001|Overall Study|Patient refusal|1|||
156773714|NCT01126424|565924714|FG005|Overall Study|Withdrawal by Subject|0|||
156657772|NCT00454636|565493659|FG002|Overall Study|Patient refusal|3|||
156657773|NCT00454636|565493660|FG003|Overall Study|Patient refusal|2|||
156657774|NCT00454636|565493657|FG000|Overall Study|Lost to Follow-up|0|||
156657775|NCT00454636|565493658|FG001|Overall Study|Lost to Follow-up|1|||
156657776|NCT00454636|565493659|FG002|Overall Study|Lost to Follow-up|0|||
156657777|NCT00454636|565493660|FG003|Overall Study|Lost to Follow-up|0|||
156657778|NCT01400113|565493661|FG000|Overall Study|Withdrawal by Subject|1|||
156657779|NCT01400113|565493662|FG001|Overall Study|Withdrawal by Subject|1|||
156657780|NCT00282256|565493663|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
156657781|NCT00282256|565493663|FG000|Extension Treatment Period|Adverse Event|2|||
156657782|NCT00806156|565493664|FG000|Overall Study|Death|35|||
156657783|NCT00806156|565493665|FG001|Overall Study|Death|95|||
156657784|NCT00806156|565493664|FG000|Overall Study|Did not meet eligibility criteria|1|||
156657785|NCT00806156|565493665|FG001|Overall Study|Did not meet eligibility criteria|0|||
156657786|NCT00806156|565493664|FG000|Overall Study|Study terminated by Sponsor|2|||
156657787|NCT00806156|565493665|FG001|Overall Study|Study terminated by Sponsor|40|||
156657788|NCT00806156|565493664|FG000|Overall Study|Consent withdrawn by subject|1|||
156657789|NCT00806156|565493665|FG001|Overall Study|Consent withdrawn by subject|3|||
156657790|NCT00806156|565493664|FG000|Overall Study|Lost to Follow-up|0|||
156657791|NCT00806156|565493665|FG001|Overall Study|Lost to Follow-up|1|||
156657792|NCT01025037|565493673|FG000|Overall Study|Adverse Event|3|||
156657793|NCT01025037|565493673|FG000|Overall Study|Lost to Follow-up|7|||
156657794|NCT01025037|565493673|FG000|Overall Study|Withdrawal by Subject|1|||
156657795|NCT01890915|565493674|FG000|Overall Study|Adverse Event|1|||
156657796|NCT01890915|565493675|FG001|Overall Study|Adverse Event|0|||
156657797|NCT01890915|565493674|FG000|Overall Study|Protocol Violation|2|||
156657798|NCT01890915|565493675|FG001|Overall Study|Protocol Violation|0|||
156657799|NCT01890915|565493674|FG000|Overall Study|Equipment Malfunction|0|||
156657800|NCT01890915|565493675|FG001|Overall Study|Equipment Malfunction|1|||
156657801|NCT02796664|565493681|FG000|Overall Study|Withdrawal by Subject|0|||
156657802|NCT02796664|565493682|FG001|Overall Study|Withdrawal by Subject|3|||
156657803|NCT02796664|565493681|FG000|Overall Study|Noncompliance|1|||
156657804|NCT02796664|565493682|FG001|Overall Study|Noncompliance|1|||
156657805|NCT02796664|565493681|FG000|Overall Study|Death|0|||
156657806|NCT02796664|565493682|FG001|Overall Study|Death|1|||
156657807|NCT00927810|565493685|FG000|Overall Study|Withdrawal by Subject|0|||
156657808|NCT00927810|565493686|FG001|Overall Study|Withdrawal by Subject|3|||
156428545|NCT01981850|564660876|FG008|Main Phase Stage 2|Various reasons|0|||
156428546|NCT01981850|564660877|FG009|Main Phase Stage 2|Various reasons|0|||
156428547|NCT01981850|564660868|FG000|Main Phase Stage 2|Progressive Disease|0|||
156428548|NCT01981850|564660869|FG001|Main Phase Stage 2|Progressive Disease|0|||
156428549|NCT01981850|564660870|FG002|Main Phase Stage 2|Progressive Disease|0|||
156428550|NCT01981850|564660871|FG003|Main Phase Stage 2|Progressive Disease|0|||
156428551|NCT01981850|564660872|FG004|Main Phase Stage 2|Progressive Disease|0|||
156428552|NCT01981850|564660873|FG005|Main Phase Stage 2|Progressive Disease|6|||
156428553|NCT01981850|564660874|FG006|Main Phase Stage 2|Progressive Disease|6|||
156428554|NCT01981850|564660875|FG007|Main Phase Stage 2|Progressive Disease|0|||
156428555|NCT01981850|564660876|FG008|Main Phase Stage 2|Progressive Disease|0|||
156428556|NCT01981850|564660877|FG009|Main Phase Stage 2|Progressive Disease|0|||
156428557|NCT01981850|564660868|FG000|Open Label Extension (OLE)|Adverse Event|0|||
156428558|NCT01981850|564660869|FG001|Open Label Extension (OLE)|Adverse Event|0|||
156428559|NCT01981850|564660870|FG002|Open Label Extension (OLE)|Adverse Event|0|||
156428560|NCT01981850|564660871|FG003|Open Label Extension (OLE)|Adverse Event|0|||
156428561|NCT01981850|564660872|FG004|Open Label Extension (OLE)|Adverse Event|0|||
156428562|NCT01981850|564660873|FG005|Open Label Extension (OLE)|Adverse Event|0|||
156428563|NCT01981850|564660874|FG006|Open Label Extension (OLE)|Adverse Event|0|||
156428564|NCT01981850|564660875|FG007|Open Label Extension (OLE)|Adverse Event|2|||
156428565|NCT01981850|564660876|FG008|Open Label Extension (OLE)|Adverse Event|1|||
156428566|NCT01981850|564660877|FG009|Open Label Extension (OLE)|Adverse Event|8|||
156428567|NCT01981850|564660868|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
156428568|NCT01981850|564660869|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
156428569|NCT01981850|564660870|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
156428570|NCT01981850|564660871|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
156428571|NCT01981850|564660872|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
156428572|NCT01981850|564660873|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
156428573|NCT01981850|564660874|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
156428574|NCT01981850|564660875|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
156523561|NCT04874415|565011767|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
156657809|NCT00927810|565493687|FG002|Overall Study|Withdrawal by Subject|0|||
156657810|NCT00927810|565493688|FG003|Overall Study|Withdrawal by Subject|1|||
156657811|NCT00927810|565493685|FG000|Overall Study|Lost to Follow-up|0|||
156657812|NCT00927810|565493686|FG001|Overall Study|Lost to Follow-up|2|||
156657813|NCT00927810|565493687|FG002|Overall Study|Lost to Follow-up|1|||
156657814|NCT00927810|565493688|FG003|Overall Study|Lost to Follow-up|1|||
156773715|NCT02127671|565924715|FG000|Overall Study|Death|2|||
156428575|NCT01981850|564660876|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
156657815|NCT00927810|565493685|FG000|Overall Study|Death|0|||
156657816|NCT00927810|565493686|FG001|Overall Study|Death|2|||
156523562|NCT04874415|565011752|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
156523563|NCT04874415|565011753|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
156523564|NCT04874415|565011754|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
156523565|NCT04874415|565011755|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
156523566|NCT04874415|565011756|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
156523567|NCT04874415|565011757|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
156523568|NCT04874415|565011758|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
156523569|NCT04874415|565011759|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
156523570|NCT04874415|565011760|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
156523571|NCT04874415|565011761|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
156523572|NCT04874415|565011762|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
156523573|NCT04874415|565011763|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
156523574|NCT04874415|565011764|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
156523575|NCT04874415|565011765|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
156523576|NCT04874415|565011766|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
156523577|NCT04874415|565011767|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
156523578|NCT04874415|565011752|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156657817|NCT00927810|565493687|FG002|Overall Study|Death|0|||
156773716|NCT02127671|565924716|FG001|Overall Study|Death|2|||
156773717|NCT02127671|565924715|FG000|Overall Study|Lost to Follow-up|4|||
156773718|NCT02127671|565924716|FG001|Overall Study|Lost to Follow-up|2|||
156773719|NCT02127671|565924715|FG000|Overall Study|Physician Decision|1|||
156428576|NCT01981850|564660877|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
156428577|NCT01981850|564660868|FG000|Open Label Extension (OLE)|Various reasons|0|||
156428578|NCT01981850|564660869|FG001|Open Label Extension (OLE)|Various reasons|0|||
156428579|NCT01981850|564660870|FG002|Open Label Extension (OLE)|Various reasons|0|||
156428580|NCT01981850|564660871|FG003|Open Label Extension (OLE)|Various reasons|0|||
156428581|NCT01981850|564660872|FG004|Open Label Extension (OLE)|Various reasons|0|||
156428582|NCT01981850|564660873|FG005|Open Label Extension (OLE)|Various reasons|0|||
156428583|NCT01981850|564660874|FG006|Open Label Extension (OLE)|Various reasons|0|||
156428584|NCT01981850|564660875|FG007|Open Label Extension (OLE)|Various reasons|3|||
156428585|NCT01981850|564660876|FG008|Open Label Extension (OLE)|Various reasons|1|||
156428586|NCT01981850|564660877|FG009|Open Label Extension (OLE)|Various reasons|3|||
156428587|NCT01981850|564660868|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
156428588|NCT01981850|564660869|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
156428589|NCT01981850|564660870|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
156428590|NCT01981850|564660871|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
156428591|NCT01981850|564660872|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
156428592|NCT01981850|564660873|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
156428593|NCT01981850|564660874|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
156428594|NCT01981850|564660875|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
156428595|NCT01981850|564660876|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
156428596|NCT01981850|564660877|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
156428597|NCT01981850|564660868|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428598|NCT01981850|564660869|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428599|NCT01981850|564660870|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428600|NCT01981850|564660871|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428601|NCT01981850|564660872|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428602|NCT01981850|564660873|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428603|NCT01981850|564660874|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428604|NCT01981850|564660875|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428605|NCT01981850|564660876|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156428606|NCT01981850|564660877|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
156428607|NCT01981850|564660868|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428608|NCT01981850|564660869|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428609|NCT01981850|564660870|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428610|NCT01981850|564660871|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428611|NCT01981850|564660872|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428612|NCT01981850|564660873|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428613|NCT01981850|564660874|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428614|NCT01981850|564660875|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428615|NCT01981850|564660876|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
156428616|NCT01981850|564660877|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
156657818|NCT00927810|565493688|FG003|Overall Study|Death|0|||
156773720|NCT02127671|565924716|FG001|Overall Study|Physician Decision|0|||
156428617|NCT03381274|564660880|FG000|Overall Study|Death|2|||
156428618|NCT03381274|564660881|FG001|Overall Study|Death|9|||
156428619|NCT03381274|564660882|FG002|Overall Study|Death|3|||
156523579|NCT04874415|565011753|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156773721|NCT02127671|565924715|FG000|Overall Study|incarceration|0|||
156428620|NCT03381274|564660883|FG003|Overall Study|Death|2|||
156428621|NCT03381274|564660884|FG004|Overall Study|Death|3|||
156428622|NCT03381274|564660880|FG000|Overall Study|Lost to Follow-up|0|||
156428623|NCT03381274|564660881|FG001|Overall Study|Lost to Follow-up|0|||
156428624|NCT03381274|564660882|FG002|Overall Study|Lost to Follow-up|0|||
156428625|NCT03381274|564660883|FG003|Overall Study|Lost to Follow-up|1|||
156428626|NCT03381274|564660884|FG004|Overall Study|Lost to Follow-up|0|||
156428627|NCT03381274|564660880|FG000|Overall Study|Withdrawal by Subject|2|||
156657819|NCT00927810|565493685|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156657820|NCT00927810|565493686|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156657821|NCT00927810|565493687|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156657822|NCT00927810|565493688|FG003|Overall Study|Abnormal laboratory value(s)|0|||
156657823|NCT01626079|565493689|FG000|Overall Study|Death|167|||
156657824|NCT01626079|565493690|FG001|Overall Study|Death|192|||
156657825|NCT01626079|565493691|FG002|Overall Study|Death|39|||
156657826|NCT01626079|565493689|FG000|Overall Study|Withdrawal by Subject|23|||
156657827|NCT01626079|565493690|FG001|Overall Study|Withdrawal by Subject|37|||
156657828|NCT01626079|565493691|FG002|Overall Study|Withdrawal by Subject|5|||
156657829|NCT01626079|565493689|FG000|Overall Study|Lost to Follow-up|7|||
156657830|NCT01626079|565493690|FG001|Overall Study|Lost to Follow-up|4|||
156657831|NCT01626079|565493691|FG002|Overall Study|Lost to Follow-up|2|||
156657832|NCT01626079|565493689|FG000|Overall Study|Missed Visits|1|||
156657833|NCT01626079|565493690|FG001|Overall Study|Missed Visits|4|||
156657834|NCT01626079|565493691|FG002|Overall Study|Missed Visits|6|||
156657835|NCT00950807|565493694|FG000|Treatment Period 1|Lack of Efficacy|1|||
156657836|NCT00950807|565493695|FG001|Treatment Period 1|Lack of Efficacy|0|||
156657837|NCT00950807|565493696|FG002|Treatment Period 1|Lack of Efficacy|0|||
156657838|NCT00950807|565493697|FG003|Treatment Period 1|Lack of Efficacy|0|||
156657839|NCT00950807|565493698|FG004|Treatment Period 1|Lack of Efficacy|0|||
156657840|NCT00950807|565493699|FG005|Treatment Period 1|Lack of Efficacy|1|||
156657841|NCT00950807|565493700|FG006|Treatment Period 1|Lack of Efficacy|0|||
156657842|NCT00950807|565493701|FG007|Treatment Period 1|Lack of Efficacy|0|||
156657843|NCT00950807|565493702|FG008|Treatment Period 1|Lack of Efficacy|0|||
156657844|NCT00950807|565493703|FG009|Treatment Period 1|Lack of Efficacy|0|||
156657845|NCT00950807|565493694|FG000|Treatment Period 1|Protocol Violation|1|||
156657846|NCT00950807|565493695|FG001|Treatment Period 1|Protocol Violation|0|||
156657847|NCT00950807|565493696|FG002|Treatment Period 1|Protocol Violation|0|||
156657848|NCT00950807|565493697|FG003|Treatment Period 1|Protocol Violation|0|||
156657849|NCT00950807|565493698|FG004|Treatment Period 1|Protocol Violation|0|||
156657850|NCT00950807|565493699|FG005|Treatment Period 1|Protocol Violation|0|||
156657851|NCT00950807|565493700|FG006|Treatment Period 1|Protocol Violation|0|||
156657852|NCT00950807|565493701|FG007|Treatment Period 1|Protocol Violation|0|||
156657853|NCT00950807|565493702|FG008|Treatment Period 1|Protocol Violation|0|||
156657854|NCT00950807|565493703|FG009|Treatment Period 1|Protocol Violation|0|||
156657855|NCT00950807|565493694|FG000|Treatment Period 1|Lost to Follow-up|0|||
156657856|NCT00950807|565493695|FG001|Treatment Period 1|Lost to Follow-up|0|||
156657857|NCT00950807|565493696|FG002|Treatment Period 1|Lost to Follow-up|1|||
156657858|NCT00950807|565493697|FG003|Treatment Period 1|Lost to Follow-up|0|||
156657859|NCT00950807|565493698|FG004|Treatment Period 1|Lost to Follow-up|0|||
156657860|NCT00950807|565493699|FG005|Treatment Period 1|Lost to Follow-up|0|||
156657861|NCT00950807|565493700|FG006|Treatment Period 1|Lost to Follow-up|0|||
156657862|NCT00950807|565493701|FG007|Treatment Period 1|Lost to Follow-up|0|||
156657863|NCT00950807|565493702|FG008|Treatment Period 1|Lost to Follow-up|0|||
156657864|NCT00950807|565493703|FG009|Treatment Period 1|Lost to Follow-up|0|||
156657865|NCT00950807|565493694|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156657866|NCT00950807|565493695|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156657867|NCT00950807|565493696|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156657868|NCT00950807|565493697|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156657869|NCT00950807|565493698|FG004|Treatment Period 1|Withdrawal by Subject|1|||
156657870|NCT00950807|565493699|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156657871|NCT00950807|565493700|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156657872|NCT00950807|565493701|FG007|Treatment Period 1|Withdrawal by Subject|0|||
156657873|NCT00950807|565493702|FG008|Treatment Period 1|Withdrawal by Subject|1|||
156657874|NCT00950807|565493703|FG009|Treatment Period 1|Withdrawal by Subject|0|||
156657875|NCT00950807|565493694|FG000|Treatment Period 1|Adverse Event|0|||
156657876|NCT00950807|565493695|FG001|Treatment Period 1|Adverse Event|0|||
156657877|NCT00950807|565493696|FG002|Treatment Period 1|Adverse Event|0|||
156657878|NCT00950807|565493697|FG003|Treatment Period 1|Adverse Event|0|||
156657879|NCT00950807|565493698|FG004|Treatment Period 1|Adverse Event|0|||
156657880|NCT00950807|565493699|FG005|Treatment Period 1|Adverse Event|1|||
156657881|NCT00950807|565493700|FG006|Treatment Period 1|Adverse Event|0|||
156657882|NCT00950807|565493701|FG007|Treatment Period 1|Adverse Event|0|||
156657883|NCT00950807|565493702|FG008|Treatment Period 1|Adverse Event|0|||
156657884|NCT00950807|565493703|FG009|Treatment Period 1|Adverse Event|0|||
156657885|NCT00950807|565493694|FG000|Washout Period 1|Lack of Efficacy|0|||
156428628|NCT03381274|564660881|FG001|Overall Study|Withdrawal by Subject|1|||
156428629|NCT03381274|564660882|FG002|Overall Study|Withdrawal by Subject|3|||
156657886|NCT00950807|565493695|FG001|Washout Period 1|Lack of Efficacy|0|||
156657887|NCT00950807|565493696|FG002|Washout Period 1|Lack of Efficacy|0|||
156657888|NCT00950807|565493697|FG003|Washout Period 1|Lack of Efficacy|0|||
156657889|NCT00950807|565493698|FG004|Washout Period 1|Lack of Efficacy|0|||
156773722|NCT02127671|565924716|FG001|Overall Study|incarceration|1|||
156773723|NCT02127671|565924715|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
156773724|NCT02127671|565924716|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
156773725|NCT02394275|565924717|FG000|Overall Study|Adverse Event|22|||
156773726|NCT02394275|565924717|FG000|Overall Study|Lost to Follow-up|7|||
156773727|NCT00782067|565924719|FG000|Overall Study|Adverse Event|35|||
156324282|NCT03463031|564287601|FG001|Overall Study|Investigator/Sponsor Decision|1|||
156324283|NCT03463031|564287600|FG000|Overall Study|Lost to Follow-up|1|||
156324284|NCT03463031|564287601|FG001|Overall Study|Lost to Follow-up|1|||
156324285|NCT03463031|564287600|FG000|Overall Study|Adverse Event|4|||
156773728|NCT00782067|565924719|FG000|Overall Study|Subject withdrew consent|11|||
156324286|NCT03463031|564287601|FG001|Overall Study|Adverse Event|1|||
156324287|NCT03463031|564287600|FG000|Overall Study|Use of prohibited medication by subject|1|||
156324288|NCT03463031|564287601|FG001|Overall Study|Use of prohibited medication by subject|0|||
156324289|NCT01241240|564287602|FG000|Overall Study|Adverse Event|5|||
156324290|NCT01241240|564287603|FG001|Overall Study|Adverse Event|4|||
156324291|NCT01241240|564287602|FG000|Overall Study|Lost to Follow-up|2|||
156324292|NCT01241240|564287603|FG001|Overall Study|Lost to Follow-up|4|||
156324293|NCT01241240|564287602|FG000|Overall Study|Personal Reasons|1|||
156324294|NCT01241240|564287603|FG001|Overall Study|Personal Reasons|1|||
156324295|NCT01025154|564287604|FG000|Overall Study|Lost to Follow-up|1|||
156324296|NCT01025154|564287604|FG000|Overall Study|Withdrawal by Subject|1|||
156324297|NCT01810432|564287605|FG000|Washout|Protocol Violation|0|||
156324298|NCT01810432|564287606|FG001|Washout|Protocol Violation|1|||
156324299|NCT01810432|564287605|FG000|Washout|Adverse Event|1|||
156324300|NCT01810432|564287606|FG001|Washout|Adverse Event|0|||
156324301|NCT01810432|564287605|FG000|Period 2|Withdrawal by Subject|2|||
156324302|NCT01810432|564287606|FG001|Period 2|Withdrawal by Subject|1|||
156324303|NCT01810432|564287605|FG000|Period 2|Physician Decision|1|||
156324304|NCT01810432|564287606|FG001|Period 2|Physician Decision|0|||
156324305|NCT01810432|564287605|FG000|Period 2|Lost to Follow-up|1|||
156324306|NCT01810432|564287606|FG001|Period 2|Lost to Follow-up|1|||
156324307|NCT00057954|564287607|FG000|Overall Study|Death|1|||
156324308|NCT00057954|564287607|FG000|Overall Study|Disease progression|1|||
156324309|NCT01251744|564287608|FG000|Overall Study|Lost to Follow-up|1|||
156324310|NCT01251744|564287609|FG001|Overall Study|Lost to Follow-up|0|||
156324311|NCT02147184|564287610|FG000|Overall Study|Lost to Follow-up|28|||
156324312|NCT02147184|564287611|FG001|Overall Study|Lost to Follow-up|15|||
156324313|NCT02147184|564287610|FG000|Overall Study|Study Burden|11|||
156324314|NCT02147184|564287611|FG001|Overall Study|Study Burden|7|||
156324315|NCT02147184|564287610|FG000|Overall Study|Pregnancy|6|||
156324316|NCT02147184|564287611|FG001|Overall Study|Pregnancy|0|||
156324317|NCT02147184|564287610|FG000|Overall Study|Moved out of state|3|||
156324318|NCT02147184|564287611|FG001|Overall Study|Moved out of state|3|||
156324319|NCT02147184|564287610|FG000|Overall Study|Physician Decision|0|||
156324320|NCT02147184|564287611|FG001|Overall Study|Physician Decision|2|||
156324321|NCT02147184|564287610|FG000|Overall Study|Other|1|||
156324322|NCT02147184|564287611|FG001|Overall Study|Other|0|||
156324323|NCT02537574|564287613|FG000|Overall Study|Adverse Event|1|||
156324324|NCT02537574|564287614|FG001|Overall Study|Adverse Event|3|||
156324325|NCT02537574|564287615|FG002|Overall Study|Adverse Event|2|||
156324326|NCT02537574|564287613|FG000|Overall Study|Lost to Follow-up|40|||
156324327|NCT02537574|564287614|FG001|Overall Study|Lost to Follow-up|51|||
156324328|NCT02537574|564287615|FG002|Overall Study|Lost to Follow-up|55|||
156324329|NCT02537574|564287613|FG000|Overall Study|Noncompliance with study drug|0|||
156324330|NCT02537574|564287614|FG001|Overall Study|Noncompliance with study drug|1|||
156324331|NCT02537574|564287615|FG002|Overall Study|Noncompliance with study drug|1|||
156324332|NCT02537574|564287613|FG000|Overall Study|Physician Decision|2|||
156324333|NCT02537574|564287614|FG001|Overall Study|Physician Decision|0|||
156324334|NCT02537574|564287615|FG002|Overall Study|Physician Decision|0|||
156324335|NCT02537574|564287613|FG000|Overall Study|Protocol Violation|4|||
156324336|NCT02537574|564287614|FG001|Overall Study|Protocol Violation|2|||
156324337|NCT02537574|564287615|FG002|Overall Study|Protocol Violation|3|||
156324338|NCT02537574|564287613|FG000|Overall Study|Withdrawal by Subject|37|||
156324339|NCT02537574|564287614|FG001|Overall Study|Withdrawal by Subject|27|||
156324340|NCT02537574|564287615|FG002|Overall Study|Withdrawal by Subject|29|||
156324341|NCT02537574|564287613|FG000|Overall Study|Lack of Efficacy|14|||
156324342|NCT02537574|564287614|FG001|Overall Study|Lack of Efficacy|16|||
156773729|NCT00782067|565924719|FG000|Overall Study|Lost to Follow-up|2|||
156324343|NCT02537574|564287615|FG002|Overall Study|Lack of Efficacy|15|||
156324344|NCT02537574|564287613|FG000|Overall Study|Duplicate Patient|1|||
156324345|NCT02537574|564287614|FG001|Overall Study|Duplicate Patient|0|||
156324346|NCT02537574|564287615|FG002|Overall Study|Duplicate Patient|0|||
156324347|NCT02537574|564287613|FG000|Overall Study|Patient not Stable|0|||
156324348|NCT02537574|564287614|FG001|Overall Study|Patient not Stable|1|||
156324349|NCT02537574|564287615|FG002|Overall Study|Patient not Stable|0|||
156657890|NCT00950807|565493699|FG005|Washout Period 1|Lack of Efficacy|0|||
156657891|NCT00950807|565493700|FG006|Washout Period 1|Lack of Efficacy|1|||
156657892|NCT00950807|565493701|FG007|Washout Period 1|Lack of Efficacy|0|||
156657893|NCT00950807|565493702|FG008|Washout Period 1|Lack of Efficacy|0|||
156657894|NCT00950807|565493703|FG009|Washout Period 1|Lack of Efficacy|0|||
156657895|NCT00950807|565493694|FG000|Washout Period 1|Withdrawal by Subject|0|||
156657896|NCT00950807|565493695|FG001|Washout Period 1|Withdrawal by Subject|0|||
156657897|NCT00950807|565493696|FG002|Washout Period 1|Withdrawal by Subject|0|||
156657898|NCT00950807|565493697|FG003|Washout Period 1|Withdrawal by Subject|0|||
156657899|NCT00950807|565493698|FG004|Washout Period 1|Withdrawal by Subject|0|||
156657900|NCT00950807|565493699|FG005|Washout Period 1|Withdrawal by Subject|0|||
156657901|NCT00950807|565493700|FG006|Washout Period 1|Withdrawal by Subject|0|||
156657902|NCT00950807|565493701|FG007|Washout Period 1|Withdrawal by Subject|0|||
156657903|NCT00950807|565493702|FG008|Washout Period 1|Withdrawal by Subject|1|||
156657904|NCT00950807|565493703|FG009|Washout Period 1|Withdrawal by Subject|0|||
156523580|NCT04874415|565011754|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523581|NCT04874415|565011755|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523582|NCT04874415|565011756|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
156523583|NCT04874415|565011757|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523584|NCT04874415|565011758|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156657905|NCT00950807|565493694|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
156657906|NCT00950807|565493695|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156657907|NCT00950807|565493696|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156657908|NCT00950807|565493697|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156657909|NCT00950807|565493698|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156657910|NCT00950807|565493699|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156657911|NCT00950807|565493700|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
156657912|NCT00950807|565493701|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
156657913|NCT00950807|565493702|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156657914|NCT00950807|565493703|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156657915|NCT00950807|565493694|FG000|Washout Period 1|Adverse Event|2|||
156657916|NCT00950807|565493695|FG001|Washout Period 1|Adverse Event|0|||
156657917|NCT00950807|565493696|FG002|Washout Period 1|Adverse Event|0|||
156657918|NCT00950807|565493697|FG003|Washout Period 1|Adverse Event|1|||
156657919|NCT00950807|565493698|FG004|Washout Period 1|Adverse Event|1|||
156657920|NCT00950807|565493699|FG005|Washout Period 1|Adverse Event|0|||
156657921|NCT00950807|565493700|FG006|Washout Period 1|Adverse Event|0|||
156657922|NCT00950807|565493701|FG007|Washout Period 1|Adverse Event|0|||
156657923|NCT00950807|565493702|FG008|Washout Period 1|Adverse Event|0|||
156657924|NCT00950807|565493703|FG009|Washout Period 1|Adverse Event|0|||
156657925|NCT00950807|565493694|FG000|Treatment Period 2|Lack of Efficacy|1|||
156657926|NCT00950807|565493695|FG001|Treatment Period 2|Lack of Efficacy|0|||
156657927|NCT00950807|565493696|FG002|Treatment Period 2|Lack of Efficacy|0|||
156657928|NCT00950807|565493697|FG003|Treatment Period 2|Lack of Efficacy|0|||
156657929|NCT00950807|565493698|FG004|Treatment Period 2|Lack of Efficacy|0|||
156657930|NCT00950807|565493699|FG005|Treatment Period 2|Lack of Efficacy|0|||
156657931|NCT00950807|565493700|FG006|Treatment Period 2|Lack of Efficacy|0|||
156324350|NCT02537574|564287613|FG000|Overall Study|Incarceration|0|||
156324351|NCT02537574|564287614|FG001|Overall Study|Incarceration|1|||
156324352|NCT02537574|564287615|FG002|Overall Study|Incarceration|0|||
156324353|NCT02537574|564287613|FG000|Overall Study|Failed Naloxone Challenge|0|||
156324354|NCT02537574|564287614|FG001|Overall Study|Failed Naloxone Challenge|1|||
156324355|NCT02537574|564287615|FG002|Overall Study|Failed Naloxone Challenge|0|||
156324356|NCT02537574|564287613|FG000|Overall Study|Transportation Issues|0|||
156324357|NCT02537574|564287614|FG001|Overall Study|Transportation Issues|0|||
156324358|NCT02537574|564287615|FG002|Overall Study|Transportation Issues|1|||
156324359|NCT02537574|564287613|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
156324360|NCT02537574|564287614|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
156324361|NCT02537574|564287615|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
156324362|NCT02537574|564287613|FG000|Overall Study|Noncompliance with Protocol|0|||
156324363|NCT02537574|564287614|FG001|Overall Study|Noncompliance with Protocol|0|||
156324364|NCT02537574|564287615|FG002|Overall Study|Noncompliance with Protocol|1|||
156324365|NCT01151098|564287616|FG000|Overall Study|Adverse Event|82|||
156324366|NCT01151098|564287616|FG000|Overall Study|Lost to Follow-up|6|||
156324367|NCT01151098|564287616|FG000|Overall Study|Lack of Efficacy|15|||
156324368|NCT01151098|564287616|FG000|Overall Study|Protocol Violation|1|||
156324369|NCT01151098|564287616|FG000|Overall Study|Miscellaneous|13|||
156324370|NCT00542451|564287617|FG000|Overall Study|Adverse Event|31|||
156324371|NCT00542451|564287617|FG000|Overall Study|Withdrawal by Subject|30|||
156324372|NCT00542451|564287617|FG000|Overall Study|Physician Decision|4|||
156324373|NCT00542451|564287617|FG000|Overall Study|Recurrent disease|1|||
156324374|NCT00542451|564287617|FG000|Overall Study|unknown reason|1|||
156324375|NCT00542451|564287617|FG000|Overall Study|Death|2|||
156657932|NCT00950807|565493701|FG007|Treatment Period 2|Lack of Efficacy|0|||
156428630|NCT03381274|564660883|FG003|Overall Study|Withdrawal by Subject|1|||
156428631|NCT03381274|564660884|FG004|Overall Study|Withdrawal by Subject|0|||
156428632|NCT03381274|564660880|FG000|Overall Study|Other|1|||
156428633|NCT03381274|564660881|FG001|Overall Study|Other|11|||
156428634|NCT03381274|564660882|FG002|Overall Study|Other|0|||
156428635|NCT03381274|564660883|FG003|Overall Study|Other|2|||
156428636|NCT03381274|564660884|FG004|Overall Study|Other|2|||
156428637|NCT04982575|564660885|FG000|Overall Study|Withdrawal by Subject|2|||
156428638|NCT04982575|564660886|FG001|Overall Study|Withdrawal by Subject|0|||
156428639|NCT04982575|564660887|FG002|Overall Study|Withdrawal by Subject|2|||
156428640|NCT04948333|564660890|FG000|Overall Study|Adverse Event|6|||
156428641|NCT04948333|564660891|FG001|Overall Study|Adverse Event|4|||
156428642|NCT04948333|564660892|FG002|Overall Study|Adverse Event|0|||
156428643|NCT04948333|564660893|FG003|Overall Study|Adverse Event|2|||
156428644|NCT04948333|564660890|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
156428645|NCT04948333|564660891|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156428646|NCT04948333|564660892|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156428647|NCT04948333|564660893|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156428648|NCT04948333|564660890|FG000|Overall Study|Progressive Disease|1|||
156428649|NCT04948333|564660891|FG001|Overall Study|Progressive Disease|5|||
156428650|NCT04948333|564660892|FG002|Overall Study|Progressive Disease|0|||
156428651|NCT04948333|564660893|FG003|Overall Study|Progressive Disease|0|||
156428652|NCT04948333|564660890|FG000|Overall Study|Physician Decision|2|||
156428653|NCT04948333|564660891|FG001|Overall Study|Physician Decision|2|||
156428654|NCT04948333|564660892|FG002|Overall Study|Physician Decision|0|||
156428655|NCT04948333|564660893|FG003|Overall Study|Physician Decision|0|||
156428656|NCT04948333|564660890|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
156428657|NCT04948333|564660891|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
156428658|NCT04948333|564660892|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
156428659|NCT04948333|564660893|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
156428660|NCT04948333|564660890|FG000|Overall Study|Withdrawal by Subject|2|||
156428661|NCT04948333|564660891|FG001|Overall Study|Withdrawal by Subject|0|||
156773730|NCT00782067|565924719|FG000|Overall Study|Administrative problems|14|||
156324376|NCT00542451|564287617|FG000|Overall Study|Lost to Follow-up|10|||
156324377|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
156324378|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
156324379|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
156324380|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
156324381|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156324382|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
156324383|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156324384|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
156324385|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
156324386|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
156324387|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
156324388|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
156324389|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
156324390|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
156324391|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
156324392|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
156324393|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Program Termination|3|||
156324394|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Program Termination|0|||
156324395|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Program Termination|1|||
156324396|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Program Termination|1|||
156324397|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
156324398|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
156324399|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
156324400|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
156324401|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
156324402|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
156324403|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
156324404|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
156324405|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
156324406|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
156324407|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
156324408|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
156324409|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
156324410|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
156428662|NCT04948333|564660892|FG002|Overall Study|Withdrawal by Subject|0|||
156428663|NCT04948333|564660893|FG003|Overall Study|Withdrawal by Subject|1|||
156773731|NCT00782067|565924719|FG000|Overall Study|Death|9|||
156773732|NCT00782067|565924719|FG000|Overall Study|Disease progression|43|||
156773733|NCT00782067|565924719|FG000|Overall Study|Protocol deviation|2|||
156773734|NCT02471183|565924720|FG000|Main Treatment Period|Adverse Event|1|||
156773735|NCT02471183|565924720|FG000|Main Treatment Period|Withdrawal by Subject|1|||
156773736|NCT02471183|565924720|FG000|Extended Treatment Period|Lack of Efficacy|1|||
156773737|NCT02328105|565924722|FG000|Overall Study|Death|6|||
156773738|NCT02328105|565924722|FG000|Overall Study|Withdrawal by Subject|1|||
156657933|NCT00950807|565493702|FG008|Treatment Period 2|Lack of Efficacy|0|||
156773739|NCT02328105|565924722|FG000|Overall Study|Still On Study in Follow-Up|4|||
156773740|NCT00614393|565924723|FG000|Overall Study|Adverse Event|20|||
156773741|NCT00614393|565924724|FG001|Overall Study|Adverse Event|2|||
156773742|NCT00614393|565924725|FG002|Overall Study|Adverse Event|3|||
156773743|NCT00614393|565924726|FG003|Overall Study|Adverse Event|13|||
156773744|NCT00614393|565924727|FG004|Overall Study|Adverse Event|21|||
156773745|NCT00614393|565924723|FG000|Overall Study|Lost to Follow-up|0|||
156773746|NCT00614393|565924724|FG001|Overall Study|Lost to Follow-up|0|||
156773747|NCT00614393|565924725|FG002|Overall Study|Lost to Follow-up|0|||
156773748|NCT00614393|565924726|FG003|Overall Study|Lost to Follow-up|1|||
156324411|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
156657934|NCT00950807|565493703|FG009|Treatment Period 2|Lack of Efficacy|0|||
156773749|NCT00614393|565924727|FG004|Overall Study|Lost to Follow-up|2|||
156324412|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
156324413|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
156324414|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
156324415|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
156324416|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
156324417|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
156324418|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
156324419|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
156324420|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
156324421|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
156324422|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
156324423|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
156324424|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
156324425|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
156324426|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
156324427|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
156324428|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
156324429|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
156324430|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
156324431|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
156324432|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
156324433|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
156324434|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
156324435|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
156324436|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
156324437|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
156324438|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
156324439|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
156324440|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
156324441|NCT03739840|564287618|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
156324442|NCT03739840|564287619|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
156324443|NCT03739840|564287620|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
156324444|NCT03739840|564287621|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
156324445|NCT03739840|564287618|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
156324446|NCT03739840|564287619|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
156324447|NCT03739840|564287620|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
156324448|NCT03739840|564287621|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
156324449|NCT03739840|564287618|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
156324450|NCT03739840|564287619|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
156324451|NCT03739840|564287620|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
156324452|NCT03739840|564287621|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
156324453|NCT03739840|564287618|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
156324454|NCT03739840|564287619|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
156324455|NCT03739840|564287620|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
156428664|NCT04948333|564660890|FG000|Overall Study|Protocol Violation|0|||
156773750|NCT00614393|565924723|FG000|Overall Study|Physician Decision|17|||
156773751|NCT00614393|565924724|FG001|Overall Study|Physician Decision|0|||
156773752|NCT00614393|565924725|FG002|Overall Study|Physician Decision|1|||
156773753|NCT00614393|565924726|FG003|Overall Study|Physician Decision|8|||
156773754|NCT00614393|565924727|FG004|Overall Study|Physician Decision|9|||
156773755|NCT00614393|565924723|FG000|Overall Study|Progressive Disease|118|||
156657935|NCT00950807|565493694|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156657936|NCT00950807|565493695|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156657937|NCT00950807|565493696|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156657938|NCT00950807|565493697|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156657939|NCT00950807|565493698|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156657940|NCT00950807|565493699|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156657941|NCT00950807|565493700|FG006|Treatment Period 2|Withdrawal by Subject|1|||
156657942|NCT00950807|565493701|FG007|Treatment Period 2|Withdrawal by Subject|2|||
156657943|NCT00950807|565493702|FG008|Treatment Period 2|Withdrawal by Subject|0|||
156657944|NCT00950807|565493703|FG009|Treatment Period 2|Withdrawal by Subject|0|||
156657945|NCT00950807|565493694|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
156657946|NCT00950807|565493695|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657947|NCT00950807|565493696|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657948|NCT00950807|565493697|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657949|NCT00950807|565493698|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657950|NCT00950807|565493699|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657951|NCT00950807|565493700|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657952|NCT00950807|565493701|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657953|NCT00950807|565493702|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657954|NCT00950807|565493703|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156657955|NCT00950807|565493694|FG000|Treatment Period 2|Adverse Event|0|||
156657956|NCT00950807|565493695|FG001|Treatment Period 2|Adverse Event|1|||
156657957|NCT00950807|565493696|FG002|Treatment Period 2|Adverse Event|0|||
156657958|NCT00950807|565493697|FG003|Treatment Period 2|Adverse Event|1|||
156657959|NCT00950807|565493698|FG004|Treatment Period 2|Adverse Event|0|||
156657960|NCT00950807|565493699|FG005|Treatment Period 2|Adverse Event|1|||
156657961|NCT00950807|565493700|FG006|Treatment Period 2|Adverse Event|0|||
156657962|NCT00950807|565493701|FG007|Treatment Period 2|Adverse Event|1|||
156657963|NCT00950807|565493702|FG008|Treatment Period 2|Adverse Event|0|||
156657964|NCT00950807|565493703|FG009|Treatment Period 2|Adverse Event|0|||
156657965|NCT00950807|565493694|FG000|Washout Period 2|Lack of Efficacy|1|||
156657966|NCT00950807|565493695|FG001|Washout Period 2|Lack of Efficacy|0|||
156657967|NCT00950807|565493696|FG002|Washout Period 2|Lack of Efficacy|0|||
156657968|NCT00950807|565493697|FG003|Washout Period 2|Lack of Efficacy|0|||
156657969|NCT00950807|565493698|FG004|Washout Period 2|Lack of Efficacy|0|||
156657970|NCT00950807|565493699|FG005|Washout Period 2|Lack of Efficacy|0|||
156657971|NCT00950807|565493700|FG006|Washout Period 2|Lack of Efficacy|0|||
156657972|NCT00950807|565493701|FG007|Washout Period 2|Lack of Efficacy|0|||
156657973|NCT00950807|565493702|FG008|Washout Period 2|Lack of Efficacy|0|||
156657974|NCT00950807|565493703|FG009|Washout Period 2|Lack of Efficacy|0|||
156657975|NCT00950807|565493694|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
156657976|NCT00950807|565493695|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
156657977|NCT00950807|565493696|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
156657978|NCT00950807|565493697|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
156657979|NCT00950807|565493698|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
156657980|NCT00950807|565493699|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
156657981|NCT00950807|565493700|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
156657982|NCT00950807|565493701|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
156657983|NCT00950807|565493702|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
156657984|NCT00950807|565493703|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
156657985|NCT00950807|565493694|FG000|Washout Period 2|Adverse Event|3|||
156773756|NCT00614393|565924724|FG001|Overall Study|Progressive Disease|5|||
156773757|NCT00614393|565924725|FG002|Overall Study|Progressive Disease|5|||
156324456|NCT03739840|564287621|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
156324457|NCT03739840|564287618|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
156324458|NCT03739840|564287619|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
156324459|NCT03739840|564287620|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
156324460|NCT03739840|564287621|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
156324461|NCT03739840|564287618|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
156657986|NCT00950807|565493695|FG001|Washout Period 2|Adverse Event|0|||
156657987|NCT00950807|565493696|FG002|Washout Period 2|Adverse Event|0|||
156657988|NCT00950807|565493697|FG003|Washout Period 2|Adverse Event|1|||
156657989|NCT00950807|565493698|FG004|Washout Period 2|Adverse Event|0|||
156657990|NCT00950807|565493699|FG005|Washout Period 2|Adverse Event|0|||
156657991|NCT00950807|565493700|FG006|Washout Period 2|Adverse Event|0|||
156657992|NCT00950807|565493701|FG007|Washout Period 2|Adverse Event|0|||
156657993|NCT00950807|565493702|FG008|Washout Period 2|Adverse Event|0|||
156657994|NCT00950807|565493703|FG009|Washout Period 2|Adverse Event|0|||
156657995|NCT00950807|565493694|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156657996|NCT00950807|565493695|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156657997|NCT00950807|565493696|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156657998|NCT00950807|565493697|FG003|Treatment Period 3|Withdrawal by Subject|0|||
156657999|NCT00950807|565493698|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156658000|NCT00950807|565493699|FG005|Treatment Period 3|Withdrawal by Subject|0|||
156658001|NCT00950807|565493700|FG006|Treatment Period 3|Withdrawal by Subject|0|||
156658002|NCT00950807|565493701|FG007|Treatment Period 3|Withdrawal by Subject|0|||
156658003|NCT00950807|565493702|FG008|Treatment Period 3|Withdrawal by Subject|0|||
156658004|NCT00950807|565493703|FG009|Treatment Period 3|Withdrawal by Subject|1|||
156658005|NCT00950807|565493694|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
156658006|NCT00950807|565493695|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156658007|NCT00950807|565493696|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156658008|NCT00950807|565493697|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156658009|NCT00950807|565493698|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156658010|NCT00950807|565493699|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156658011|NCT00950807|565493700|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156658012|NCT00950807|565493701|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
156658013|NCT00950807|565493702|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156658014|NCT00950807|565493703|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156658015|NCT00950807|565493694|FG000|Treatment Period 3|Adverse Event|0|||
156658016|NCT00950807|565493695|FG001|Treatment Period 3|Adverse Event|0|||
156658017|NCT00950807|565493696|FG002|Treatment Period 3|Adverse Event|0|||
156658018|NCT00950807|565493697|FG003|Treatment Period 3|Adverse Event|0|||
156658019|NCT00950807|565493698|FG004|Treatment Period 3|Adverse Event|0|||
156658020|NCT00950807|565493699|FG005|Treatment Period 3|Adverse Event|0|||
156658021|NCT00950807|565493700|FG006|Treatment Period 3|Adverse Event|1|||
156658022|NCT00950807|565493701|FG007|Treatment Period 3|Adverse Event|0|||
156658023|NCT00950807|565493702|FG008|Treatment Period 3|Adverse Event|0|||
156658024|NCT00950807|565493703|FG009|Treatment Period 3|Adverse Event|0|||
156658025|NCT00337077|565493704|FG000|Overall Study|Progressive disease|25|||
156658026|NCT00337077|565493705|FG001|Overall Study|Progressive disease|37|||
156658027|NCT00337077|565493706|FG002|Overall Study|Progressive disease|19|||
156658028|NCT00337077|565493704|FG000|Overall Study|Adverse Event|7|||
156658029|NCT00337077|565493705|FG001|Overall Study|Adverse Event|7|||
156658030|NCT00337077|565493706|FG002|Overall Study|Adverse Event|1|||
156658031|NCT00337077|565493704|FG000|Overall Study|Death|0|||
156658032|NCT00337077|565493705|FG001|Overall Study|Death|1|||
156658033|NCT00337077|565493706|FG002|Overall Study|Death|0|||
156658034|NCT00337077|565493704|FG000|Overall Study|Withdrawal by Subject|7|||
156658035|NCT00337077|565493705|FG001|Overall Study|Withdrawal by Subject|2|||
156658036|NCT00337077|565493706|FG002|Overall Study|Withdrawal by Subject|2|||
156658037|NCT00337077|565493704|FG000|Overall Study|Alternative therapy|1|||
156658038|NCT00337077|565493705|FG001|Overall Study|Alternative therapy|0|||
156658039|NCT00337077|565493706|FG002|Overall Study|Alternative therapy|0|||
156658040|NCT00337077|565493704|FG000|Overall Study|Physician Decision|1|||
156658041|NCT00337077|565493705|FG001|Overall Study|Physician Decision|4|||
156658042|NCT00337077|565493706|FG002|Overall Study|Physician Decision|2|||
156658043|NCT00337077|565493704|FG000|Overall Study|Never started treatment|1|||
156658044|NCT00337077|565493705|FG001|Overall Study|Never started treatment|1|||
156658045|NCT00337077|565493706|FG002|Overall Study|Never started treatment|0|||
156658046|NCT00337077|565493704|FG000|Overall Study|Ineligible|1|||
156658047|NCT00337077|565493705|FG001|Overall Study|Ineligible|1|||
156658048|NCT00337077|565493706|FG002|Overall Study|Ineligible|1|||
156658049|NCT01492400|565493711|FG000|Overall Study|Miscellaneous Reasons|2|||
156658050|NCT01492400|565493712|FG001|Overall Study|Miscellaneous Reasons|3|||
156658051|NCT01492400|565493711|FG000|Overall Study|Personal Reasons|0|||
156658052|NCT01492400|565493712|FG001|Overall Study|Personal Reasons|5|||
156658053|NCT01492400|565493711|FG000|Overall Study|Lost to Follow-up|3|||
156658054|NCT01492400|565493712|FG001|Overall Study|Lost to Follow-up|1|||
156658055|NCT01492400|565493711|FG000|Overall Study|Pregnancy|0|||
156658056|NCT01492400|565493712|FG001|Overall Study|Pregnancy|1|||
156658057|NCT01492400|565493711|FG000|Overall Study|Lack of Efficacy|1|||
156658058|NCT01492400|565493712|FG001|Overall Study|Lack of Efficacy|1|||
156658059|NCT01492400|565493711|FG000|Overall Study|Adverse Event|10|||
156658060|NCT01492400|565493712|FG001|Overall Study|Adverse Event|5|||
156658061|NCT00659607|565493713|FG000|Overall Study|No blood pressure recorded|147|||
156658062|NCT00659607|565493713|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
156773758|NCT00614393|565924726|FG003|Overall Study|Progressive Disease|138|||
156773759|NCT00614393|565924727|FG004|Overall Study|Progressive Disease|130|||
156773760|NCT00614393|565924723|FG000|Overall Study|Protocol Violation|1|||
156773761|NCT00614393|565924724|FG001|Overall Study|Protocol Violation|0|||
156773762|NCT00614393|565924725|FG002|Overall Study|Protocol Violation|0|||
156773763|NCT00614393|565924726|FG003|Overall Study|Protocol Violation|0|||
156773764|NCT00614393|565924727|FG004|Overall Study|Protocol Violation|0|||
156658063|NCT00659607|565493713|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
156658064|NCT00659607|565493713|FG000|Overall Study|No recorded efficacy data|15|||
156658065|NCT00659607|565493713|FG000|Overall Study|Inconsistent BP measuring date|2|||
156658066|NCT01457053|565493714|FG000|Overall Study|Unable to undergo selected treatment|1|||
156773765|NCT00614393|565924723|FG000|Overall Study|Terminated by Sponsor|0|||
156773766|NCT00614393|565924724|FG001|Overall Study|Terminated by Sponsor|0|||
156773767|NCT00614393|565924725|FG002|Overall Study|Terminated by Sponsor|0|||
156658067|NCT01457053|565493715|FG001|Overall Study|Unable to undergo selected treatment|1|||
156658068|NCT02073643|565493717|FG000|Overall Study|Lost to Follow-up|24|||
156658069|NCT02430870|565493718|FG000|Part 2|Voluntary Withdrawal|0|||
156658070|NCT02430870|565493719|FG001|Part 2|Voluntary Withdrawal|0|||
156658071|NCT02430870|565493720|FG002|Part 2|Voluntary Withdrawal|0|||
156658072|NCT02430870|565493721|FG003|Part 2|Voluntary Withdrawal|0|||
156658073|NCT02430870|565493722|FG004|Part 2|Voluntary Withdrawal|0|||
156658074|NCT02430870|565493723|FG005|Part 2|Voluntary Withdrawal|0|||
156658075|NCT02430870|565493724|FG006|Part 2|Voluntary Withdrawal|1|||
156658076|NCT02430870|565493725|FG007|Part 2|Voluntary Withdrawal|0|||
156658077|NCT02430870|565493718|FG000|Part 2|Other Reason Not Specified|0|||
156658078|NCT02430870|565493719|FG001|Part 2|Other Reason Not Specified|0|||
156658079|NCT02430870|565493720|FG002|Part 2|Other Reason Not Specified|0|||
156658080|NCT02430870|565493721|FG003|Part 2|Other Reason Not Specified|0|||
156658081|NCT02430870|565493722|FG004|Part 2|Other Reason Not Specified|0|||
156658082|NCT02430870|565493723|FG005|Part 2|Other Reason Not Specified|0|||
156658083|NCT02430870|565493724|FG006|Part 2|Other Reason Not Specified|0|||
156658084|NCT02430870|565493725|FG007|Part 2|Other Reason Not Specified|1|||
156658085|NCT02364557|565493729|FG000|Overall Study|Protocol Violation|3|||
156658086|NCT02364557|565493730|FG001|Overall Study|Protocol Violation|1|||
156658087|NCT04347239|565493731|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
156658088|NCT04347239|565493732|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
156658089|NCT04347239|565493733|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
156658090|NCT04347239|565493731|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
156658091|NCT04347239|565493732|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
156658092|NCT04347239|565493733|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
156658093|NCT02153736|565493738|FG000|Overall Study|Lost to Follow-up|1|||
156658094|NCT02153736|565493739|FG001|Overall Study|Lost to Follow-up|0|||
156658095|NCT02153736|565493738|FG000|Overall Study|Medical status change made ineligible|1|||
156658096|NCT02153736|565493739|FG001|Overall Study|Medical status change made ineligible|0|||
156658097|NCT02153736|565493738|FG000|Overall Study|Death|0|||
156658098|NCT02153736|565493739|FG001|Overall Study|Death|1|||
156658099|NCT02153736|565493738|FG000|Overall Study|Withdrawal by Subject|0|||
156658100|NCT02153736|565493739|FG001|Overall Study|Withdrawal by Subject|1|||
156658101|NCT02568384|565493744|FG000|Overall Study|Mobile devices incompatible with App|2|||
156658102|NCT00796510|565493749|FG000|Overall Study|Death|1|||
156658103|NCT00796510|565493750|FG001|Overall Study|Death|0|||
156658104|NCT00796510|565493749|FG000|Overall Study|Study Terminated|2|||
156658105|NCT00796510|565493750|FG001|Overall Study|Study Terminated|0|||
156658106|NCT00720122|565493759|FG000|Overall Study|Lost to Follow-up|1|||
156658107|NCT00720122|565493759|FG000|Overall Study|Physician Decision|1|||
156658108|NCT00720122|565493759|FG000|Overall Study|Withdrawal by Subject|7|||
156658109|NCT04025229|565494999|FG000|Overall Study|Adverse Event|1|||
156658110|NCT04025229|565495000|FG001|Overall Study|Adverse Event|0|||
156658111|NCT04025229|565494999|FG000|Overall Study|Withdrawal by Subject|0|||
156658112|NCT04025229|565495000|FG001|Overall Study|Withdrawal by Subject|2|||
156658113|NCT04025229|565494999|FG000|Overall Study|Death|0|||
156658114|NCT04025229|565495000|FG001|Overall Study|Death|1|||
156658115|NCT04025229|565494999|FG000|Overall Study|Physician Decision|0|||
156658116|NCT04025229|565495000|FG001|Overall Study|Physician Decision|1|||
156658117|NCT03815942|565495001|FG000|Overall Study|Withdrawal by Subject|0|||
156658118|NCT03815942|565495002|FG001|Overall Study|Withdrawal by Subject|17|||
156658119|NCT03717064|565495003|FG000|Period 2|Adverse Event|1|||
156658120|NCT01298570|565495004|FG000|Overall Study|Disease progression, relapse during acti|64|||
156658121|NCT01298570|565495005|FG001|Overall Study|Disease progression, relapse during acti|40|||
156658122|NCT01298570|565495004|FG000|Overall Study|Adverse Event|20|||
156658123|NCT01298570|565495005|FG001|Overall Study|Adverse Event|2|||
156428665|NCT04948333|564660891|FG001|Overall Study|Protocol Violation|1|||
156428666|NCT04948333|564660892|FG002|Overall Study|Protocol Violation|0|||
156428667|NCT04948333|564660893|FG003|Overall Study|Protocol Violation|0|||
156428668|NCT04948333|564660890|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
156428669|NCT04948333|564660891|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
156428670|NCT04948333|564660892|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
156428671|NCT04948333|564660893|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
156428672|NCT03887936|564660894|FG000|Overall Study|Relocation|2|||
156428673|NCT03887936|564660895|FG001|Overall Study|Relocation|2|||
156428674|NCT03887936|564660894|FG000|Overall Study|Physician Decision|0|||
156658124|NCT01298570|565495004|FG000|Overall Study|Withdrawal by Subject|21|||
156658125|NCT01298570|565495005|FG001|Overall Study|Withdrawal by Subject|6|||
156658126|NCT01298570|565495004|FG000|Overall Study|Treatment delay > 4 weeks|4|||
156658127|NCT01298570|565495005|FG001|Overall Study|Treatment delay > 4 weeks|5|||
156658128|NCT01298570|565495004|FG000|Overall Study|Physician Decision|4|||
156658129|NCT01298570|565495005|FG001|Overall Study|Physician Decision|2|||
156658130|NCT01298570|565495004|FG000|Overall Study|Other complicating disease|2|||
156658131|NCT01298570|565495005|FG001|Overall Study|Other complicating disease|1|||
156658132|NCT01298570|565495004|FG000|Overall Study|Surgery|2|||
156658133|NCT01298570|565495005|FG001|Overall Study|Surgery|1|||
156658134|NCT01298570|565495004|FG000|Overall Study|Symptomatic progression/deterioration|3|||
156658135|NCT01298570|565495005|FG001|Overall Study|Symptomatic progression/deterioration|2|||
156658136|NCT01298570|565495004|FG000|Overall Study|Death|0|||
156658137|NCT01298570|565495005|FG001|Overall Study|Death|1|||
156658138|NCT01298570|565495004|FG000|Overall Study|Ineligibility|0|||
156658139|NCT01298570|565495005|FG001|Overall Study|Ineligibility|1|||
156658140|NCT02841709|565495006|FG000|5th Intervention|Adverse Event|2|||
156658141|NCT02841709|565495007|FG001|5th Intervention|Adverse Event|0|||
156658142|NCT02841709|565495008|FG002|5th Intervention|Adverse Event|0|||
156658143|NCT02841709|565495009|FG003|5th Intervention|Adverse Event|0|||
156658144|NCT02841709|565495010|FG004|5th Intervention|Adverse Event|2|||
156658145|NCT01929109|565495011|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
156658146|NCT01929109|565495012|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
156658147|NCT01929109|565495013|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
156658148|NCT01929109|565495014|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
156658149|NCT01929109|565495015|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
156658150|NCT00076102|565495016|FG000|Overall Study|Clinical progression|1|||
156658151|NCT00076102|565495016|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
156658152|NCT00076102|565495016|FG000|Overall Study|plexiform neurofibroma surgery|1|||
156658153|NCT00076102|565495016|FG000|Overall Study|refusal of further therapy|2|||
156658154|NCT00788125|565495017|FG000|Overall Study|Death|6|||
156658155|NCT02180711|565495019|FG000|Overall Study|Death|0|||
156658156|NCT02180711|565495020|FG001|Overall Study|Death|1|||
156658157|NCT02180711|565495021|FG002|Overall Study|Death|0|||
156658158|NCT02180711|565495022|FG003|Overall Study|Death|0|||
156658159|NCT02180711|565495023|FG004|Overall Study|Death|7|||
156658160|NCT02180711|565495024|FG005|Overall Study|Death|0|||
156658161|NCT02180711|565495025|FG006|Overall Study|Death|1|||
156658162|NCT02180711|565495026|FG007|Overall Study|Death|3|||
156658163|NCT02180711|565495019|FG000|Overall Study|Lost to Follow-up|0|||
156658164|NCT02180711|565495020|FG001|Overall Study|Lost to Follow-up|1|||
156658165|NCT02180711|565495021|FG002|Overall Study|Lost to Follow-up|0|||
156658166|NCT02180711|565495022|FG003|Overall Study|Lost to Follow-up|0|||
156658167|NCT02180711|565495023|FG004|Overall Study|Lost to Follow-up|1|||
156658168|NCT02180711|565495024|FG005|Overall Study|Lost to Follow-up|1|||
156658169|NCT02180711|565495025|FG006|Overall Study|Lost to Follow-up|0|||
156658170|NCT02180711|565495026|FG007|Overall Study|Lost to Follow-up|3|||
156658171|NCT02180711|565495019|FG000|Overall Study|Withdrawal by Subject|2|||
156658172|NCT02180711|565495020|FG001|Overall Study|Withdrawal by Subject|1|||
156658173|NCT02180711|565495021|FG002|Overall Study|Withdrawal by Subject|0|||
156658174|NCT02180711|565495022|FG003|Overall Study|Withdrawal by Subject|4|||
156658175|NCT02180711|565495023|FG004|Overall Study|Withdrawal by Subject|3|||
156658176|NCT02180711|565495024|FG005|Overall Study|Withdrawal by Subject|0|||
156658177|NCT02180711|565495025|FG006|Overall Study|Withdrawal by Subject|3|||
156658178|NCT02180711|565495026|FG007|Overall Study|Withdrawal by Subject|2|||
156658179|NCT02180711|565495019|FG000|Overall Study|- Disease Progression|0|||
156658180|NCT02180711|565495020|FG001|Overall Study|- Disease Progression|1|||
156658181|NCT02180711|565495021|FG002|Overall Study|- Disease Progression|0|||
156324462|NCT03739840|564287619|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
156324463|NCT03739840|564287620|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
156324464|NCT03739840|564287621|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
156324465|NCT03739840|564287618|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
156324466|NCT03739840|564287619|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
156324467|NCT03739840|564287620|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
156324468|NCT03739840|564287621|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
156324469|NCT03739840|564287618|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
156324470|NCT03739840|564287619|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
156324471|NCT03739840|564287620|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
156324472|NCT03739840|564287621|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
156324473|NCT03739840|564287618|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
156324474|NCT03739840|564287619|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
156658182|NCT02180711|565495022|FG003|Overall Study|- Disease Progression|0|||
156658183|NCT02180711|565495023|FG004|Overall Study|- Disease Progression|0|||
156658184|NCT02180711|565495024|FG005|Overall Study|- Disease Progression|0|||
156658185|NCT02180711|565495025|FG006|Overall Study|- Disease Progression|0|||
156658186|NCT02180711|565495026|FG007|Overall Study|- Disease Progression|0|||
156658187|NCT02180711|565495019|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
156658188|NCT02180711|565495020|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
156658189|NCT02180711|565495021|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
156658190|NCT02180711|565495022|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
156658191|NCT02180711|565495023|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
156658192|NCT02180711|565495024|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
156658193|NCT02180711|565495025|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
156658194|NCT02180711|565495026|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
156658195|NCT02180711|565495019|FG000|Overall Study|- Study Terminated by Sponsor|2|||
156658196|NCT02180711|565495020|FG001|Overall Study|- Study Terminated by Sponsor|3|||
156658197|NCT02180711|565495021|FG002|Overall Study|- Study Terminated by Sponsor|0|||
156658198|NCT02180711|565495022|FG003|Overall Study|- Study Terminated by Sponsor|5|||
156658199|NCT02180711|565495023|FG004|Overall Study|- Study Terminated by Sponsor|32|||
156658200|NCT02180711|565495024|FG005|Overall Study|- Study Terminated by Sponsor|0|||
156658201|NCT02180711|565495025|FG006|Overall Study|- Study Terminated by Sponsor|4|||
156658202|NCT02180711|565495026|FG007|Overall Study|- Study Terminated by Sponsor|13|||
156658203|NCT02180711|565495019|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
156658204|NCT02180711|565495020|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
156658205|NCT02180711|565495021|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
156658206|NCT02180711|565495022|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
156658207|NCT02180711|565495023|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
156658208|NCT02180711|565495024|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
156658209|NCT02180711|565495025|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
156658210|NCT02180711|565495026|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
156658211|NCT02180711|565495019|FG000|Overall Study|- Other|1|||
156658212|NCT02180711|565495020|FG001|Overall Study|- Other|0|||
156658213|NCT02180711|565495021|FG002|Overall Study|- Other|0|||
156658214|NCT02180711|565495022|FG003|Overall Study|- Other|1|||
156658215|NCT02180711|565495023|FG004|Overall Study|- Other|0|||
156658216|NCT02180711|565495024|FG005|Overall Study|- Other|0|||
156658217|NCT02180711|565495025|FG006|Overall Study|- Other|0|||
156658218|NCT02180711|565495026|FG007|Overall Study|- Other|0|||
156658219|NCT00444145|565495034|FG000|Overall Study|Withdrawal by Subject|2|||
156658220|NCT00444145|565495034|FG000|Overall Study|Lost to Follow-up|1|||
156658221|NCT00444145|565495034|FG000|Overall Study|non-compliant|11|||
156658222|NCT00444145|565495034|FG000|Overall Study|Screen Failures|5|||
156658223|NCT01619800|565495035|FG000|Overall Study|study terminated|2|||
156658224|NCT01619800|565495036|FG001|Overall Study|study terminated|0|||
156658225|NCT00414466|565495038|FG000|Overall Study|Adverse Event|0|||
156658226|NCT00414466|565495039|FG001|Overall Study|Adverse Event|0|||
156658227|NCT00414466|565495040|FG002|Overall Study|Adverse Event|1|||
156658228|NCT00414466|565495041|FG003|Overall Study|Adverse Event|1|||
156658229|NCT00414466|565495038|FG000|Overall Study|Lack of Efficacy|1|||
156658230|NCT00414466|565495039|FG001|Overall Study|Lack of Efficacy|0|||
156658231|NCT00414466|565495040|FG002|Overall Study|Lack of Efficacy|0|||
156658232|NCT00414466|565495041|FG003|Overall Study|Lack of Efficacy|0|||
156658233|NCT00414466|565495038|FG000|Overall Study|Withdrawn by Sponsor|1|||
156658234|NCT00414466|565495039|FG001|Overall Study|Withdrawn by Sponsor|0|||
156658235|NCT00414466|565495040|FG002|Overall Study|Withdrawn by Sponsor|0|||
156658236|NCT00414466|565495041|FG003|Overall Study|Withdrawn by Sponsor|0|||
156658237|NCT04526210|565495042|FG000|Overall Study|Sponsor decision|7|||
156658238|NCT04526210|565495043|FG001|Overall Study|Sponsor decision|5|||
156658239|NCT04526210|565495042|FG000|Overall Study|Withdrawal by Subject|3|||
156658240|NCT04526210|565495043|FG001|Overall Study|Withdrawal by Subject|2|||
156658241|NCT02637232|565495044|FG000|Overall Study|Lost to Follow-up|42|||
156658242|NCT02637232|565495044|FG000|Overall Study|Adverse Event|11|||
156658243|NCT02637232|565495044|FG000|Overall Study|patient 's decision|2|||
156658244|NCT01781637|565495045|FG000|Overall Study|Adverse Event|1|||
156658245|NCT01781637|565495046|FG001|Overall Study|Adverse Event|0|||
156658246|NCT01781637|565495045|FG000|Overall Study|Lack of Efficacy|2|||
156658247|NCT01781637|565495046|FG001|Overall Study|Lack of Efficacy|6|||
156658248|NCT01781637|565495045|FG000|Overall Study|Withdrawal by Subject|1|||
156658249|NCT01781637|565495046|FG001|Overall Study|Withdrawal by Subject|0|||
156658250|NCT02999178|565495047|FG000|Overall Study|Adverse Event|85|||
156658251|NCT02999178|565495048|FG001|Overall Study|Adverse Event|62|||
156658252|NCT02999178|565495047|FG000|Overall Study|Protocol Violation|1|||
156658253|NCT02999178|565495048|FG001|Overall Study|Protocol Violation|2|||
156658254|NCT02999178|565495047|FG000|Overall Study|Lost to Follow-up|0|||
156658255|NCT02999178|565495048|FG001|Overall Study|Lost to Follow-up|2|||
156658256|NCT02999178|565495047|FG000|Overall Study|Withdrawal by Subject|21|||
156658257|NCT02999178|565495048|FG001|Overall Study|Withdrawal by Subject|21|||
156658258|NCT02999178|565495047|FG000|Overall Study|Other reason not defined above|7|||
156428675|NCT03887936|564660895|FG001|Overall Study|Physician Decision|1|||
156658259|NCT02999178|565495048|FG001|Overall Study|Other reason not defined above|13|||
156658260|NCT00090857|565495050|FG000|Overall Study|Lost to Follow-up|0|||
156658261|NCT00090857|565495051|FG001|Overall Study|Lost to Follow-up|1|||
156658262|NCT00090857|565495050|FG000|Overall Study|Withdrawal by Subject|2|||
156658263|NCT00090857|565495051|FG001|Overall Study|Withdrawal by Subject|0|||
156658264|NCT00090857|565495050|FG000|Overall Study|Adverse Event|2|||
156658265|NCT00090857|565495051|FG001|Overall Study|Adverse Event|2|||
156658266|NCT05097326|565495052|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
156658267|NCT05097326|565495053|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
156658268|NCT03480425|565495055|FG000|Overall Study|Force transducer technical failure|1|||
156658269|NCT01244126|565495056|FG000|Overall Study|Protocol Violation|3|||
156658270|NCT01244126|565495057|FG001|Overall Study|Protocol Violation|3|||
156658271|NCT01244126|565495058|FG002|Overall Study|Protocol Violation|9|||
156658272|NCT00863746|565495062|FG000|Treatment|Not treated|4|||
156658273|NCT00863746|565495063|FG001|Treatment|Not treated|2|||
156658274|NCT00863746|565495062|FG000|Treatment|Adverse Event|41|||
156658275|NCT00863746|565495063|FG001|Treatment|Adverse Event|16|||
156658276|NCT00863746|565495062|FG000|Treatment|non-compliant with study medication|4|||
156658277|NCT00863746|565495063|FG001|Treatment|non-compliant with study medication|0|||
156658278|NCT00863746|565495062|FG000|Treatment|Consent withdrawn|15|||
156658279|NCT00863746|565495063|FG001|Treatment|Consent withdrawn|14|||
156658280|NCT00863746|565495062|FG000|Treatment|Lost to Follow-up|1|||
156658281|NCT00863746|565495063|FG001|Treatment|Lost to Follow-up|0|||
156658282|NCT00863746|565495062|FG000|Treatment|Protocol Violation|5|||
156658283|NCT00863746|565495063|FG001|Treatment|Protocol Violation|3|||
156658284|NCT00863746|565495062|FG000|Treatment|Other|1|||
156658285|NCT00863746|565495063|FG001|Treatment|Other|0|||
156658286|NCT00863746|565495062|FG000|Survival Follow up|Death|244|||
156658287|NCT00863746|565495063|FG001|Survival Follow up|Death|271|||
156658288|NCT00863746|565495062|FG000|Survival Follow up|Lost to Follow-up|2|||
156658289|NCT00863746|565495063|FG001|Survival Follow up|Lost to Follow-up|1|||
156658290|NCT00863746|565495062|FG000|Survival Follow up|Consent Withdrawn|7|||
156658291|NCT00863746|565495063|FG001|Survival Follow up|Consent Withdrawn|8|||
156658292|NCT02395822|565495064|FG000|Overall Study|Withdrawal by Subject|1|||
156658293|NCT02395822|565495064|FG000|Overall Study|Death|1|||
156658294|NCT03292653|565495065|FG000|Overall Study|Adverse Event|0|||
156658295|NCT03292653|565495066|FG001|Overall Study|Adverse Event|0|||
156658296|NCT03292653|565495067|FG002|Overall Study|Adverse Event|1|||
156658297|NCT03292653|565495065|FG000|Overall Study|Did not Receive Treatment|1|||
156658298|NCT03292653|565495066|FG001|Overall Study|Did not Receive Treatment|0|||
156658299|NCT03292653|565495067|FG002|Overall Study|Did not Receive Treatment|0|||
156658300|NCT04720664|565495068|FG000|Overall Study|Adverse Event|2|||
156658301|NCT04720664|565495068|FG000|Overall Study|Lack of Efficacy|9|||
156658302|NCT03311646|565495073|FG000|Overall Study|Physician Decision|1|||
156658303|NCT03311646|565495073|FG000|Overall Study|Withdrawal by Subject|5|||
156658304|NCT03311646|565495073|FG000|Overall Study|Lost to Follow-up|5|||
156658305|NCT03311646|565495073|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
156658306|NCT03103100|565495074|FG000|Overall Study|Adverse Event|1|||
156658307|NCT03103100|565495075|FG001|Overall Study|Adverse Event|0|||
156658308|NCT03103100|565495076|FG002|Overall Study|Adverse Event|0|||
156658309|NCT03103100|565495074|FG000|Overall Study|Physician Decision|1|||
156658310|NCT03103100|565495075|FG001|Overall Study|Physician Decision|0|||
156658311|NCT03103100|565495076|FG002|Overall Study|Physician Decision|2|||
156658312|NCT00531206|565495077|FG000|Overall Study|Adverse Event related|5|||
156658313|NCT00531206|565495077|FG000|Overall Study|Lack of Efficacy|2|||
156658314|NCT00531206|565495077|FG000|Overall Study|Lost to Follow-up|5|||
156658315|NCT00531206|565495077|FG000|Overall Study|including non-related adverse events|8|||
156658316|NCT02899338|565495085|FG000|Overall Study|Adverse Event|1|||
156658317|NCT02899338|565495086|FG001|Overall Study|Adverse Event|2|||
156658318|NCT02899338|565495085|FG000|Overall Study|Withdrawal by Subject|2|||
156658319|NCT02899338|565495086|FG001|Overall Study|Withdrawal by Subject|0|||
156658320|NCT06179108|565495087|FG000|Overall Study|Withdrawal by Subject|16|||
156658321|NCT06179108|565495088|FG001|Overall Study|Withdrawal by Subject|19|||
156658322|NCT06179108|565495089|FG002|Overall Study|Withdrawal by Subject|10|||
156658323|NCT06179108|565495090|FG003|Overall Study|Withdrawal by Subject|11|||
156658324|NCT06179108|565495087|FG000|Overall Study|Lost to Follow-up|12|||
156658325|NCT06179108|565495088|FG001|Overall Study|Lost to Follow-up|4|||
156658326|NCT06179108|565495089|FG002|Overall Study|Lost to Follow-up|1|||
156773768|NCT00614393|565924726|FG003|Overall Study|Terminated by Sponsor|0|||
156773769|NCT00614393|565924727|FG004|Overall Study|Terminated by Sponsor|1|||
156324475|NCT03739840|564287620|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
156523585|NCT04874415|565011759|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156658327|NCT06179108|565495090|FG003|Overall Study|Lost to Follow-up|9|||
156658328|NCT06179108|565495087|FG000|Overall Study|Adverse Event|2|||
156658329|NCT06179108|565495088|FG001|Overall Study|Adverse Event|3|||
156658330|NCT06179108|565495089|FG002|Overall Study|Adverse Event|3|||
156658331|NCT06179108|565495090|FG003|Overall Study|Adverse Event|2|||
156658332|NCT06179108|565495087|FG000|Overall Study|Protocol Violation|0|||
156658333|NCT06179108|565495088|FG001|Overall Study|Protocol Violation|1|||
156658334|NCT06179108|565495089|FG002|Overall Study|Protocol Violation|0|||
156658335|NCT06179108|565495090|FG003|Overall Study|Protocol Violation|1|||
156658336|NCT06179108|565495087|FG000|Overall Study|Physician Decision|1|||
156658337|NCT06179108|565495088|FG001|Overall Study|Physician Decision|1|||
156658338|NCT06179108|565495089|FG002|Overall Study|Physician Decision|0|||
156658339|NCT06179108|565495090|FG003|Overall Study|Physician Decision|0|||
156658340|NCT06179108|565495087|FG000|Overall Study|Lack of Efficacy|0|||
156658341|NCT06179108|565495088|FG001|Overall Study|Lack of Efficacy|0|||
156773770|NCT00614393|565924723|FG000|Overall Study|Withdrawal by Subject|20|||
156658342|NCT06179108|565495089|FG002|Overall Study|Lack of Efficacy|0|||
156658343|NCT06179108|565495090|FG003|Overall Study|Lack of Efficacy|1|||
156658344|NCT06179108|565495087|FG000|Overall Study|Death|0|||
156658345|NCT06179108|565495088|FG001|Overall Study|Death|0|||
156658346|NCT06179108|565495089|FG002|Overall Study|Death|0|||
156658347|NCT06179108|565495090|FG003|Overall Study|Death|1|||
156658348|NCT00814463|565495091|FG000|Overall Study|Lost to Follow-up|1|||
156658349|NCT02353169|565495092|FG000|Overall Study|QTc > 450 msec|1|||
156658350|NCT02353169|565495093|FG001|Overall Study|QTc > 450 msec|1|||
156658351|NCT02353169|565495094|FG002|Overall Study|QTc > 450 msec|1|||
156658352|NCT02353169|565495095|FG003|Overall Study|QTc > 450 msec|1|||
156658353|NCT02353169|565495092|FG000|Overall Study|OR team declined|2|||
156658354|NCT02353169|565495093|FG001|Overall Study|OR team declined|0|||
156658355|NCT02353169|565495094|FG002|Overall Study|OR team declined|0|||
156658356|NCT02353169|565495095|FG003|Overall Study|OR team declined|0|||
156658357|NCT02353169|565495092|FG000|Overall Study|Inhalational induction|0|||
156658358|NCT02353169|565495093|FG001|Overall Study|Inhalational induction|2|||
156658359|NCT02353169|565495094|FG002|Overall Study|Inhalational induction|0|||
156658360|NCT02353169|565495095|FG003|Overall Study|Inhalational induction|0|||
156658361|NCT02353169|565495092|FG000|Overall Study|ECG data error|0|||
156658362|NCT02353169|565495093|FG001|Overall Study|ECG data error|3|||
156658363|NCT02353169|565495094|FG002|Overall Study|ECG data error|2|||
156658364|NCT02353169|565495095|FG003|Overall Study|ECG data error|2|||
156658365|NCT02353169|565495092|FG000|Overall Study|Pre-op medication|0|||
156658366|NCT02353169|565495093|FG001|Overall Study|Pre-op medication|0|||
156658367|NCT02353169|565495094|FG002|Overall Study|Pre-op medication|1|||
156658368|NCT02353169|565495095|FG003|Overall Study|Pre-op medication|0|||
156658369|NCT00414765|565495096|FG000|Overall Study|Adverse Event|5|||
156658370|NCT00414765|565495097|FG001|Overall Study|Adverse Event|9|||
156658371|NCT00414765|565495096|FG000|Overall Study|Withdrawal by Subject|1|||
156658372|NCT00414765|565495097|FG001|Overall Study|Withdrawal by Subject|1|||
156658373|NCT00414765|565495096|FG000|Overall Study|Disease Progression|0|||
156658374|NCT00414765|565495097|FG001|Overall Study|Disease Progression|1|||
156658375|NCT05694013|565495098|FG000|Overall Study|Death|6|||
156658376|NCT05694013|565495099|FG001|Overall Study|Death|2|||
156658377|NCT05694013|565495098|FG000|Overall Study|Participant Decision|0|||
156658378|NCT05694013|565495099|FG001|Overall Study|Participant Decision|1|||
156658379|NCT05694013|565495098|FG000|Overall Study|Physician Decision|1|||
156658380|NCT05694013|565495099|FG001|Overall Study|Physician Decision|0|||
156658381|NCT05694013|565495098|FG000|Overall Study|Progressive Disease|0|||
156658382|NCT05694013|565495099|FG001|Overall Study|Progressive Disease|1|||
156658383|NCT05694013|565495098|FG000|Overall Study|Study Terminated by Sponsor|12|||
156658384|NCT05694013|565495099|FG001|Overall Study|Study Terminated by Sponsor|17|||
156658385|NCT05694013|565495098|FG000|Overall Study|Withdrawal by Subject|3|||
156658386|NCT05694013|565495099|FG001|Overall Study|Withdrawal by Subject|0|||
156658387|NCT04817891|565495100|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
156658388|NCT04817891|565495100|FG000|Overall Study|Adverse Event|1|||
156658389|NCT04817891|565495100|FG000|Overall Study|Withdrawal by Subject|1|||
156658390|NCT03982433|565495101|FG000|Overall Study|Lost to Follow-up|1|||
156658391|NCT04981912|565495102|FG000|Overall Study|Physician Decision|2|||
156658392|NCT01734772|565495113|FG000|Overall Study|Adverse Event|1|||
156658393|NCT01734772|565495114|FG001|Overall Study|Adverse Event|2|||
156658394|NCT01734772|565495113|FG000|Overall Study|Withdrawal by Subject|0|||
156658395|NCT01734772|565495114|FG001|Overall Study|Withdrawal by Subject|1|||
156658396|NCT01139164|565495115|FG000|Overall Study|Withdrawn prior to study start|0|||
156658397|NCT01139164|565495116|FG001|Overall Study|Withdrawn prior to study start|2|||
156658398|NCT01139164|565495117|FG002|Overall Study|Withdrawn prior to study start|0|||
156324476|NCT03739840|564287621|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
156658399|NCT01790568|565495118|FG000|Overall Study|Progression prior to transplant|0|||
156324477|NCT01058265|564287624|FG000|Overall Study|Lost to Follow-up|11|||
156324478|NCT01058265|564287625|FG001|Overall Study|Lost to Follow-up|12|||
156324479|NCT01243671|564287626|FG000|Overall Study|Adverse Event|3|||
156324480|NCT01243671|564287626|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
156324481|NCT01243671|564287626|FG000|Overall Study|Other|1|||
156324482|NCT02869438|564287627|FG000|Overall Study|Lost to Follow-up|1|||
156324483|NCT02869438|564287628|FG001|Overall Study|Lost to Follow-up|0|||
156324484|NCT02869438|564287627|FG000|Overall Study|Adverse Event|1|||
156324485|NCT02869438|564287628|FG001|Overall Study|Adverse Event|0|||
156324486|NCT02869438|564287627|FG000|Overall Study|Withdrawal by Subject|1|||
156324487|NCT02869438|564287628|FG001|Overall Study|Withdrawal by Subject|2|||
156324488|NCT02962765|564287629|FG000|Overall Study|Protocol Violation|9|||
156324489|NCT02962765|564287629|FG000|Overall Study|Withdrawal by Subject|3|||
156658400|NCT01790568|565495119|FG001|Overall Study|Progression prior to transplant|1|||
156658401|NCT03184441|565495120|FG000|Overall Study|Withdrawal by Subject|1|||
156658402|NCT02994056|565495121|FG000|Overall Study|Death|8|||
156773771|NCT00614393|565924724|FG001|Overall Study|Withdrawal by Subject|1|||
156658403|NCT02994056|565495121|FG000|Overall Study|Withdrew Consent|1|||
156658404|NCT00979628|565495122|FG000|Overall Study|received regimen < 24 hours|7|||
156523586|NCT04874415|565011760|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523587|NCT04874415|565011761|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523588|NCT04874415|565011762|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523589|NCT04874415|565011763|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523590|NCT04874415|565011764|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523591|NCT04874415|565011765|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523592|NCT04874415|565011766|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523593|NCT04874415|565011767|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
156523594|NCT05062759|565011770|FG000|Overall Study|Death|0|||
156523595|NCT05062759|565011771|FG001|Overall Study|Death|1|||
156523596|NCT05062759|565011770|FG000|Overall Study|Lost to Follow-up|1|||
156523597|NCT05062759|565011771|FG001|Overall Study|Lost to Follow-up|0|||
156523598|NCT04981366|565011772|FG000|Overall Study|Withdrawal by Subject|5|||
156523599|NCT04981366|565011773|FG001|Overall Study|Withdrawal by Subject|4|||
156523600|NCT04981366|565011774|FG002|Overall Study|Withdrawal by Subject|8|||
156523601|NCT04981366|565011772|FG000|Overall Study|Health issues unrelated to the trial|1|||
156523602|NCT04981366|565011773|FG001|Overall Study|Health issues unrelated to the trial|2|||
156523603|NCT04981366|565011774|FG002|Overall Study|Health issues unrelated to the trial|0|||
156523604|NCT03214094|565011775|FG000|Overall Study|Case Report Forms Uncollected|14|||
156523605|NCT03214094|565011775|FG000|Overall Study|Protocol Deviation|46|||
156523606|NCT00310037|565011776|FG000|Overall Study|Adverse Event|7|||
156523607|NCT00310037|565011777|FG001|Overall Study|Adverse Event|14|||
156523608|NCT00310037|565011776|FG000|Overall Study|Withdrawal by Subject|4|||
156523609|NCT00310037|565011777|FG001|Overall Study|Withdrawal by Subject|3|||
156523610|NCT00310037|565011776|FG000|Overall Study|Progression|6|||
156523611|NCT00310037|565011777|FG001|Overall Study|Progression|0|||
156523612|NCT00310037|565011776|FG000|Overall Study|Non-protocol treatment|1|||
156523613|NCT00310037|565011777|FG001|Overall Study|Non-protocol treatment|0|||
156523614|NCT00440999|565011788|FG000|Overall Study|Adverse Event|0|||
156523615|NCT00440999|565011789|FG001|Overall Study|Adverse Event|2|||
156523616|NCT00440999|565011788|FG000|Overall Study|Lack of Efficacy|6|||
156523617|NCT00440999|565011789|FG001|Overall Study|Lack of Efficacy|7|||
156523618|NCT00440999|565011788|FG000|Overall Study|Lost to Follow-up|19|||
156523619|NCT00440999|565011789|FG001|Overall Study|Lost to Follow-up|12|||
156523620|NCT00440999|565011788|FG000|Overall Study|Protocol Violation|1|||
156523621|NCT00440999|565011789|FG001|Overall Study|Protocol Violation|0|||
156523622|NCT00440999|565011788|FG000|Overall Study|Withdrawal by Subject|2|||
156523623|NCT00440999|565011789|FG001|Overall Study|Withdrawal by Subject|5|||
156523624|NCT00440999|565011788|FG000|Overall Study|Subjets missed the visit|1|||
156523625|NCT00440999|565011789|FG001|Overall Study|Subjets missed the visit|0|||
156523626|NCT00440999|565011788|FG000|Overall Study|Mixed infection at entry|1|||
156523627|NCT00440999|565011789|FG001|Overall Study|Mixed infection at entry|0|||
156523628|NCT00440999|565011788|FG000|Overall Study|P. falciparum malaria|5|||
156523629|NCT00440999|565011789|FG001|Overall Study|P. falciparum malaria|14|||
156523630|NCT00440999|565011788|FG000|Overall Study|Subj left hosp without inform staff|0|||
156523631|NCT00440999|565011789|FG001|Overall Study|Subj left hosp without inform staff|1|||
156523632|NCT05559099|565011792|FG000|Overall Study|Death|5|||
156523633|NCT05559099|565011793|FG001|Overall Study|Death|4|||
156523634|NCT05559099|565011792|FG000|Overall Study|Lost to Follow-up|0|||
156523635|NCT05559099|565011793|FG001|Overall Study|Lost to Follow-up|2|||
156523636|NCT05559099|565011792|FG000|Overall Study|Adverse Event|1|||
156523637|NCT05559099|565011793|FG001|Overall Study|Adverse Event|1|||
156523638|NCT04018092|565011794|FG000|Overall Study|Withdrawal by Subject|1|||
156523639|NCT04018092|565011795|FG001|Overall Study|Withdrawal by Subject|1|||
156523640|NCT04018092|565011794|FG000|Overall Study|Withdrawal by Subject|1|||
156523641|NCT04018092|565011795|FG001|Overall Study|Withdrawal by Subject|1|||
156523642|NCT06469242|565011796|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
156523643|NCT06469242|565011797|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
156523644|NCT06469242|565011796|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
156523645|NCT06469242|565011797|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
156523646|NCT05041101|565011798|FG000|Overall Study|Adverse Event|1|||
156523647|NCT05041101|565011799|FG001|Overall Study|Adverse Event|0|||
156523648|NCT05041101|565011800|FG002|Overall Study|Adverse Event|0|||
156523649|NCT05041101|565011798|FG000|Overall Study|Diease Progression|5|||
156523650|NCT05041101|565011799|FG001|Overall Study|Diease Progression|0|||
156523651|NCT05041101|565011800|FG002|Overall Study|Diease Progression|0|||
156523652|NCT01205152|565011801|FG000|Overall Study|Death|1|||
156523653|NCT00842985|565011802|FG000|Screening|Did not meet entrance requirements|27|||
156523654|NCT00842985|565011802|FG000|First Intervention|Withdrawal by Subject|3|||
156523655|NCT00842985|565011802|FG000|First Intervention|Protocol Violation|3|||
156523656|NCT00842985|565011802|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
156523657|NCT00842985|565011802|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
156523658|NCT01037244|565011803|FG000|Overall Study|Adverse Event|3|||
156523659|NCT01037244|565011804|FG001|Overall Study|Adverse Event|2|||
156658405|NCT00979628|565495123|FG001|Overall Study|received regimen < 24 hours|6|||
156658406|NCT00979628|565495124|FG002|Overall Study|received regimen < 24 hours|5|||
156658407|NCT00979628|565495122|FG000|Overall Study|received steroids|1|||
156658408|NCT00979628|565495123|FG001|Overall Study|received steroids|1|||
156658409|NCT00979628|565495124|FG002|Overall Study|received steroids|0|||
156658410|NCT00979628|565495122|FG000|Overall Study|transferred to ICU|1|||
156658411|NCT00979628|565495123|FG001|Overall Study|transferred to ICU|2|||
156658412|NCT00979628|565495124|FG002|Overall Study|transferred to ICU|1|||
156658413|NCT00911859|565495125|FG000|Treatment Period|Adverse Event|3|||
156658414|NCT00911859|565495126|FG001|Treatment Period|Adverse Event|3|||
156658415|NCT00911859|565495127|FG002|Treatment Period|Adverse Event|7|||
156658416|NCT00911859|565495125|FG000|Treatment Period|Death|1|||
156658417|NCT00911859|565495126|FG001|Treatment Period|Death|3|||
156658418|NCT00911859|565495127|FG002|Treatment Period|Death|5|||
156658419|NCT00911859|565495125|FG000|Treatment Period|Lack of Efficacy|1|||
156658420|NCT00911859|565495126|FG001|Treatment Period|Lack of Efficacy|7|||
156658421|NCT00911859|565495127|FG002|Treatment Period|Lack of Efficacy|5|||
156658422|NCT00911859|565495125|FG000|Treatment Period|Physician Decision|3|||
156658423|NCT00911859|565495126|FG001|Treatment Period|Physician Decision|3|||
156658424|NCT00911859|565495127|FG002|Treatment Period|Physician Decision|3|||
156658425|NCT00911859|565495125|FG000|Treatment Period|Withdrawal by Subject|0|||
156658426|NCT00911859|565495126|FG001|Treatment Period|Withdrawal by Subject|4|||
156658427|NCT00911859|565495127|FG002|Treatment Period|Withdrawal by Subject|5|||
156658428|NCT00911859|565495125|FG000|Treatment Period|Did not receive study treatment|0|||
156658429|NCT00911859|565495126|FG001|Treatment Period|Did not receive study treatment|1|||
156658430|NCT00911859|565495127|FG002|Treatment Period|Did not receive study treatment|0|||
156658431|NCT00911859|565495125|FG000|Maintainance Period|Lack of Efficacy|0|||
156658432|NCT00911859|565495126|FG001|Maintainance Period|Lack of Efficacy|0|||
156658433|NCT00911859|565495127|FG002|Maintainance Period|Lack of Efficacy|9|||
156658434|NCT00911859|565495125|FG000|Maintainance Period|Physician Decision|0|||
156658435|NCT00911859|565495126|FG001|Maintainance Period|Physician Decision|0|||
156658436|NCT00911859|565495127|FG002|Maintainance Period|Physician Decision|9|||
156658437|NCT00911859|565495125|FG000|Maintainance Period|Withdrawal by Subject|0|||
156658438|NCT00911859|565495126|FG001|Maintainance Period|Withdrawal by Subject|0|||
156658439|NCT00911859|565495127|FG002|Maintainance Period|Withdrawal by Subject|3|||
156658440|NCT00911859|565495125|FG000|Follow-up Period|Death|5|||
156658441|NCT00911859|565495126|FG001|Follow-up Period|Death|8|||
156658442|NCT00911859|565495127|FG002|Follow-up Period|Death|10|||
156658443|NCT00911859|565495125|FG000|Follow-up Period|Lost to Follow-up|1|||
156658444|NCT00911859|565495126|FG001|Follow-up Period|Lost to Follow-up|1|||
156658445|NCT00911859|565495127|FG002|Follow-up Period|Lost to Follow-up|0|||
156658446|NCT00911859|565495125|FG000|Follow-up Period|Withdrawal by Subject|0|||
156658447|NCT00911859|565495126|FG001|Follow-up Period|Withdrawal by Subject|4|||
156658448|NCT00911859|565495127|FG002|Follow-up Period|Withdrawal by Subject|4|||
156658449|NCT00911859|565495125|FG000|Follow-up Period|Study terminated by sponsor|5|||
156658450|NCT00911859|565495126|FG001|Follow-up Period|Study terminated by sponsor|33|||
156658451|NCT00911859|565495127|FG002|Follow-up Period|Study terminated by sponsor|27|||
156658452|NCT03008460|565495130|FG000|Overall Study|Protocol deviation|0|||
156658453|NCT03008460|565495131|FG001|Overall Study|Protocol deviation|2|||
156658454|NCT03008460|565495130|FG000|Overall Study|Study drug not dispensed|0|||
156658455|NCT03008460|565495131|FG001|Overall Study|Study drug not dispensed|1|||
156658456|NCT03008460|565495130|FG000|Overall Study|Adverse Event|0|||
156658457|NCT03008460|565495131|FG001|Overall Study|Adverse Event|1|||
156658458|NCT03008460|565495130|FG000|Overall Study|Withdrawal by Subject|5|||
156428676|NCT03887936|564660894|FG000|Overall Study|Withdrawal by Subject|0|||
156428677|NCT03887936|564660895|FG001|Overall Study|Withdrawal by Subject|1|||
156428678|NCT02824432|564660897|FG000|Overall Study|Major Protocol Deviation|1|||
156428679|NCT02824432|564660898|FG001|Overall Study|Major Protocol Deviation|0|||
156428680|NCT00117988|564660902|FG000|Overall Study|Death|3|||
156658459|NCT03008460|565495131|FG001|Overall Study|Withdrawal by Subject|6|||
156658460|NCT03008460|565495130|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
156658461|NCT03008460|565495131|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
156658462|NCT03008460|565495130|FG000|Overall Study|End of study visit outside permitted time window|0|||
156658463|NCT03008460|565495131|FG001|Overall Study|End of study visit outside permitted time window|1|||
156658464|NCT03008460|565495130|FG000|Overall Study|Lost to Follow-up|1|||
156658465|NCT03008460|565495131|FG001|Overall Study|Lost to Follow-up|3|||
156658466|NCT00767325|565495135|FG000|Overall Study|Lack of Efficacy|2|||
156658467|NCT00767325|565495135|FG000|Overall Study|Adverse Event|7|||
156658468|NCT00767325|565495135|FG000|Overall Study|Lost to Follow-up|3|||
156658469|NCT00767325|565495135|FG000|Overall Study|No longer met study criteria|2|||
156658470|NCT00767325|565495135|FG000|Overall Study|Missed visit due to family reasons|1|||
156658471|NCT03538756|565495136|FG000|Long-Term Follow-up|Adverse Event|0|||
156658472|NCT03538756|565495137|FG001|Long-Term Follow-up|Adverse Event|0|||
156658473|NCT03538756|565495138|FG002|Long-Term Follow-up|Adverse Event|6|||
156658474|NCT03538756|565495136|FG000|Long-Term Follow-up|Death|0|||
156658475|NCT03538756|565495137|FG001|Long-Term Follow-up|Death|0|||
156658476|NCT03538756|565495138|FG002|Long-Term Follow-up|Death|1|||
156658477|NCT03538756|565495136|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
156658478|NCT03538756|565495137|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
156658479|NCT03538756|565495138|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
156658480|NCT03538756|565495136|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
156658481|NCT03538756|565495137|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
156658482|NCT03538756|565495138|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
156658483|NCT03538756|565495136|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
156658484|NCT03538756|565495137|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
156523660|NCT01037244|565011805|FG002|Overall Study|Adverse Event|6|||
156523661|NCT01037244|565011806|FG003|Overall Study|Adverse Event|3|||
156523662|NCT01037244|565011803|FG000|Overall Study|Lack of Efficacy|1|||
156523663|NCT01037244|565011804|FG001|Overall Study|Lack of Efficacy|1|||
156523664|NCT01037244|565011805|FG002|Overall Study|Lack of Efficacy|0|||
156523665|NCT01037244|565011806|FG003|Overall Study|Lack of Efficacy|1|||
156523666|NCT01037244|565011803|FG000|Overall Study|Lost to Follow-up|3|||
156523667|NCT01037244|565011804|FG001|Overall Study|Lost to Follow-up|3|||
156523668|NCT01037244|565011805|FG002|Overall Study|Lost to Follow-up|4|||
156523669|NCT01037244|565011806|FG003|Overall Study|Lost to Follow-up|4|||
156523670|NCT01037244|565011803|FG000|Overall Study|Withdrawal by Subject|1|||
156523671|NCT01037244|565011804|FG001|Overall Study|Withdrawal by Subject|5|||
156523672|NCT01037244|565011805|FG002|Overall Study|Withdrawal by Subject|3|||
156523673|NCT01037244|565011806|FG003|Overall Study|Withdrawal by Subject|5|||
156523674|NCT01037244|565011803|FG000|Overall Study|Partner Withdrew Consent|2|||
156523675|NCT01037244|565011804|FG001|Overall Study|Partner Withdrew Consent|1|||
156523676|NCT01037244|565011805|FG002|Overall Study|Partner Withdrew Consent|0|||
156523677|NCT01037244|565011806|FG003|Overall Study|Partner Withdrew Consent|0|||
156523678|NCT01037244|565011803|FG000|Overall Study|Various|3|||
156523679|NCT01037244|565011804|FG001|Overall Study|Various|2|||
156523680|NCT01037244|565011805|FG002|Overall Study|Various|1|||
156523681|NCT01037244|565011806|FG003|Overall Study|Various|1|||
156523682|NCT01127139|565011807|FG000|Overall Study|Adverse Event|40|||
156523683|NCT01127139|565011807|FG000|Overall Study|Incompliance|12|||
156523684|NCT01127139|565011807|FG000|Overall Study|Lack of Efficacy|4|||
156523685|NCT01127139|565011807|FG000|Overall Study|Reason not specified|1|||
156523686|NCT01136772|565011808|FG000|Overall Study|Adverse Event|15|||
156523687|NCT01136772|565011809|FG001|Overall Study|Adverse Event|14|||
156523688|NCT01136772|565011808|FG000|Overall Study|Lack of Efficacy|42|||
156523689|NCT01136772|565011809|FG001|Overall Study|Lack of Efficacy|39|||
156523690|NCT01136772|565011808|FG000|Overall Study|Administrative|14|||
156523691|NCT01136772|565011809|FG001|Overall Study|Administrative|12|||
156523692|NCT01136772|565011808|FG000|Overall Study|Withdrawal by Subject|33|||
156523693|NCT01136772|565011809|FG001|Overall Study|Withdrawal by Subject|36|||
156523694|NCT01136772|565011808|FG000|Overall Study|Did not receive injection|10|||
156523695|NCT01136772|565011809|FG001|Overall Study|Did not receive injection|7|||
156523696|NCT01136772|565011808|FG000|Overall Study|Did not follow up after first injection|2|||
156523697|NCT01136772|565011809|FG001|Overall Study|Did not follow up after first injection|2|||
156523698|NCT01498653|565011810|FG000|Overall Study|Adverse Event|2|||
156523699|NCT01498653|565011811|FG001|Overall Study|Adverse Event|2|||
156523700|NCT01498653|565011810|FG000|Overall Study|Lack of Efficacy|12|||
156523701|NCT01498653|565011811|FG001|Overall Study|Lack of Efficacy|26|||
156658485|NCT03538756|565495138|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
156658486|NCT00752856|565495139|FG000|Overall Study|randomized but did not do viral kinetics|0|||
156658487|NCT00752856|565495140|FG001|Overall Study|randomized but did not do viral kinetics|1|||
156773772|NCT00614393|565924725|FG002|Overall Study|Withdrawal by Subject|1|||
156324490|NCT02962765|564287629|FG000|Overall Study|Lost to Follow-up|1|||
156523702|NCT01498653|565011810|FG000|Overall Study|Protocol Violation|0|||
156523703|NCT01498653|565011811|FG001|Overall Study|Protocol Violation|4|||
156523704|NCT01498653|565011810|FG000|Overall Study|Lost to Follow-up|1|||
156523705|NCT01498653|565011811|FG001|Overall Study|Lost to Follow-up|0|||
156523706|NCT01498653|565011810|FG000|Overall Study|Physician Decision|2|||
156523707|NCT01498653|565011811|FG001|Overall Study|Physician Decision|0|||
156523708|NCT01498653|565011810|FG000|Overall Study|Withdrawal by Subject|2|||
156523709|NCT01498653|565011811|FG001|Overall Study|Withdrawal by Subject|3|||
156523710|NCT03421431|565011817|FG000|Overall Study|Adverse Event|2|||
156523711|NCT03421431|565011818|FG001|Overall Study|Adverse Event|1|||
156523712|NCT03421431|565011819|FG002|Overall Study|Adverse Event|12|||
156523713|NCT03421431|565011817|FG000|Overall Study|Lost to Follow-up|1|||
156658488|NCT02688608|565495141|FG000|Overall Study|Lost to Follow-up|1|||
156523714|NCT03421431|565011818|FG001|Overall Study|Lost to Follow-up|1|||
156523715|NCT03421431|565011819|FG002|Overall Study|Lost to Follow-up|1|||
156523716|NCT03421431|565011817|FG000|Overall Study|Withdrawal by Subject|3|||
156523717|NCT03421431|565011818|FG001|Overall Study|Withdrawal by Subject|2|||
156523718|NCT03421431|565011819|FG002|Overall Study|Withdrawal by Subject|1|||
156523719|NCT03421431|565011817|FG000|Overall Study|Protocol Violation|0|||
156523720|NCT03421431|565011818|FG001|Overall Study|Protocol Violation|1|||
156523721|NCT03421431|565011819|FG002|Overall Study|Protocol Violation|0|||
156523722|NCT03421431|565011817|FG000|Overall Study|Participant met Stopping Rules|0|||
156773773|NCT00614393|565924726|FG003|Overall Study|Withdrawal by Subject|16|||
156773774|NCT00614393|565924727|FG004|Overall Study|Withdrawal by Subject|13|||
156773775|NCT00614393|565924723|FG000|Overall Study|Other|4|||
156773776|NCT00614393|565924724|FG001|Overall Study|Other|0|||
156773777|NCT00614393|565924725|FG002|Overall Study|Other|0|||
156773778|NCT00614393|565924726|FG003|Overall Study|Other|4|||
156773779|NCT00614393|565924727|FG004|Overall Study|Other|2|||
156773780|NCT00614393|565924723|FG000|Overall Study|Not Treated|0|||
156773781|NCT00614393|565924724|FG001|Overall Study|Not Treated|0|||
156773782|NCT00614393|565924725|FG002|Overall Study|Not Treated|0|||
156773783|NCT00614393|565924726|FG003|Overall Study|Not Treated|0|||
156773784|NCT00614393|565924727|FG004|Overall Study|Not Treated|2|||
156773785|NCT05350423|565924731|FG000|Overall Study|Lost to Follow-up|3|||
156773786|NCT05350423|565924732|FG001|Overall Study|Lost to Follow-up|3|||
156773787|NCT05350423|565924731|FG000|Overall Study|screen failure|5|||
156773788|NCT05350423|565924732|FG001|Overall Study|screen failure|6|||
156773789|NCT02097277|565924734|FG000|Overall Study|Subject no longer meets study criteria|0|||
156773790|NCT02097277|565924735|FG001|Overall Study|Subject no longer meets study criteria|1|||
156773791|NCT02097277|565924736|FG002|Overall Study|Subject no longer meets study criteria|0|||
156773792|NCT02097277|565924737|FG003|Overall Study|Subject no longer meets study criteria|1|||
156773793|NCT02097277|565924738|FG004|Overall Study|Subject no longer meets study criteria|0|||
156773794|NCT02097277|565924734|FG000|Overall Study|Subject request to discontinue treatment|0|||
156773795|NCT02097277|565924735|FG001|Overall Study|Subject request to discontinue treatment|0|||
156773796|NCT02097277|565924736|FG002|Overall Study|Subject request to discontinue treatment|0|||
156773797|NCT02097277|565924737|FG003|Overall Study|Subject request to discontinue treatment|0|||
156773798|NCT02097277|565924738|FG004|Overall Study|Subject request to discontinue treatment|1|||
156773799|NCT02097277|565924734|FG000|Overall Study|Lost to Follow-up|0|||
156773800|NCT02097277|565924735|FG001|Overall Study|Lost to Follow-up|1|||
156773801|NCT02097277|565924736|FG002|Overall Study|Lost to Follow-up|1|||
156773802|NCT02097277|565924737|FG003|Overall Study|Lost to Follow-up|0|||
156773803|NCT02097277|565924738|FG004|Overall Study|Lost to Follow-up|0|||
156773804|NCT02097277|565924734|FG000|Overall Study|Withdrawal by Subject|2|||
156773805|NCT02097277|565924735|FG001|Overall Study|Withdrawal by Subject|1|||
156773806|NCT02097277|565924736|FG002|Overall Study|Withdrawal by Subject|0|||
156773807|NCT02097277|565924737|FG003|Overall Study|Withdrawal by Subject|1|||
156773808|NCT02097277|565924738|FG004|Overall Study|Withdrawal by Subject|0|||
156773809|NCT02097277|565924734|FG000|Overall Study|Adverse Event|0|||
156773810|NCT02097277|565924735|FG001|Overall Study|Adverse Event|0|||
156773811|NCT02097277|565924736|FG002|Overall Study|Adverse Event|1|||
156773812|NCT02097277|565924737|FG003|Overall Study|Adverse Event|2|||
156773813|NCT02097277|565924738|FG004|Overall Study|Adverse Event|0|||
156773814|NCT00141921|565924740|FG000|Overall Study|Remain on Study|28|||
156773815|NCT00141921|565924740|FG000|Overall Study|Withdrawal by Subject|42|||
156773816|NCT00141921|565924740|FG000|Overall Study|Lost to Follow-up|19|||
156773817|NCT00141921|565924740|FG000|Overall Study|Noncompliance|17|||
156773818|NCT00141921|565924740|FG000|Overall Study|Disease Progression|7|||
156773819|NCT00141921|565924740|FG000|Overall Study|Protocol Deviation|7|||
156773820|NCT00141921|565924740|FG000|Overall Study|Adverse Event|5|||
156773821|NCT00141921|565924740|FG000|Overall Study|Administrative Decision|2|||
156773822|NCT00141921|565924740|FG000|Overall Study|Pregnancy|4|||
156773823|NCT00141921|565924740|FG000|Overall Study|Ineligibility Determined|2|||
156773824|NCT00141921|565924740|FG000|Overall Study|Other|8|||
156773825|NCT03320369|565924741|FG000|Overall Study|Adverse Event|1|||
156773826|NCT03320369|565924741|FG000|Overall Study|Withdrawal by Subject|2|||
156773827|NCT03813654|565924744|FG000|Overall Study|Protocol Violation|0|||
156324491|NCT02962765|564287629|FG000|Overall Study|Death|1|||
156324492|NCT02962765|564287629|FG000|Overall Study|Limited access to study medication|3|||
156324493|NCT02169284|564287632|FG000|Overall Study|Physician Decision|0|||
156324494|NCT02169284|564287633|FG001|Overall Study|Physician Decision|1|||
156324495|NCT01569464|564287637|FG000|Overall Study|Adverse Event|4|||
156324496|NCT01569464|564287638|FG001|Overall Study|Adverse Event|0|||
156324497|NCT01569464|564287637|FG000|Overall Study|Lack of Efficacy|1|||
156324498|NCT01569464|564287638|FG001|Overall Study|Lack of Efficacy|0|||
156324499|NCT01569464|564287637|FG000|Overall Study|Protocol Violation|1|||
156324500|NCT01569464|564287638|FG001|Overall Study|Protocol Violation|0|||
156324501|NCT01569464|564287637|FG000|Overall Study|Lost to Follow-up|2|||
156428681|NCT00117988|564660902|FG000|Overall Study|Adverse Event|1|||
156773828|NCT03813654|565924745|FG001|Overall Study|Protocol Violation|1|||
156773829|NCT03813654|565924746|FG002|Overall Study|Protocol Violation|2|||
156773830|NCT03813654|565924744|FG000|Overall Study|Withdrawal by Subject|1|||
156773831|NCT03813654|565924745|FG001|Overall Study|Withdrawal by Subject|0|||
156773832|NCT03813654|565924746|FG002|Overall Study|Withdrawal by Subject|0|||
156773833|NCT03473197|565924770|FG000|Overall Study|Adverse Event|4|||
156773834|NCT03473197|565924770|FG000|Overall Study|Lost to Follow-up|1|||
156773835|NCT03473197|565924770|FG000|Overall Study|Withdrawal by Subject|5|||
156773836|NCT02326883|565924771|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
156773837|NCT02326883|565924772|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
156808569|NCT01070979|566052715|FG000|Overall Study|Withdrawal by Subject|3|||
156773838|NCT02326883|565924773|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
156773839|NCT00435942|565924777|FG000|Overall Study|Death|17|||
156773840|NCT00435942|565924778|FG001|Overall Study|Death|10|||
156773841|NCT00435942|565924777|FG000|Overall Study|Withdrawal by Subject|2|||
156773842|NCT00435942|565924778|FG001|Overall Study|Withdrawal by Subject|0|||
156773843|NCT00435942|565924777|FG000|Overall Study|Lost to Follow-up|0|||
156773844|NCT00435942|565924778|FG001|Overall Study|Lost to Follow-up|16|||
156428682|NCT02912260|564660903|FG000|Main Study|Lost to Follow-up|5|||
156428683|NCT02912260|564660904|FG001|Main Study|Lost to Follow-up|4|||
156428684|NCT02912260|564660903|FG000|Main Study|Withdrawal by Subject|2|||
156428685|NCT02912260|564660904|FG001|Main Study|Withdrawal by Subject|2|||
156428686|NCT02912260|564660903|FG000|Main Study|Adverse Event|3|||
156428687|NCT02912260|564660904|FG001|Main Study|Adverse Event|0|||
156428688|NCT02912260|564660903|FG000|Main Study|Physician Decision|0|||
156428689|NCT02912260|564660904|FG001|Main Study|Physician Decision|1|||
156428690|NCT02912260|564660903|FG000|Extension Study|Withdrawal by Subject|1|||
156428691|NCT02912260|564660904|FG001|Extension Study|Withdrawal by Subject|1|||
156428692|NCT00124982|564660906|FG000|Short-term Period|Death|1|||
156428693|NCT00124982|564660907|FG001|Short-term Period|Death|1|||
156428694|NCT00124982|564660908|FG002|Short-term Period|Death|0|||
156428695|NCT00124982|564660906|FG000|Short-term Period|Adverse Event|17|||
156428696|NCT00124982|564660907|FG001|Short-term Period|Adverse Event|22|||
156428697|NCT00124982|564660908|FG002|Short-term Period|Adverse Event|0|||
156428698|NCT00124982|564660906|FG000|Short-term Period|Lack of Efficacy|32|||
156428699|NCT00124982|564660907|FG001|Short-term Period|Lack of Efficacy|73|||
156428700|NCT00124982|564660908|FG002|Short-term Period|Lack of Efficacy|0|||
156428701|NCT00124982|564660906|FG000|Short-term Period|Lost to Follow-up|8|||
156428702|NCT00124982|564660907|FG001|Short-term Period|Lost to Follow-up|5|||
156428703|NCT00124982|564660908|FG002|Short-term Period|Lost to Follow-up|0|||
156428704|NCT00124982|564660906|FG000|Short-term Period|Withdrawal of Consent|7|||
156428705|NCT00124982|564660907|FG001|Short-term Period|Withdrawal of Consent|9|||
156428706|NCT00124982|564660908|FG002|Short-term Period|Withdrawal of Consent|0|||
156428707|NCT00124982|564660906|FG000|Short-term Period|Poor/Non-compliance|3|||
156428708|NCT00124982|564660907|FG001|Short-term Period|Poor/Non-compliance|1|||
156428709|NCT00124982|564660908|FG002|Short-term Period|Poor/Non-compliance|0|||
156428710|NCT00124982|564660906|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
156428711|NCT00124982|564660907|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
156428712|NCT00124982|564660908|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
156428713|NCT00124982|564660906|FG000|Short-term Period|Participant Decision|1|||
156773845|NCT00435942|565924777|FG000|Overall Study|Conversion to Open Repair|1|||
156773846|NCT00435942|565924778|FG001|Overall Study|Conversion to Open Repair|0|||
156773847|NCT00435942|565924777|FG000|Overall Study|Technical Failure|3|||
156773848|NCT00435942|565924778|FG001|Overall Study|Technical Failure|0|||
156773849|NCT00435942|565924777|FG000|Overall Study|Other|0|||
156773850|NCT00435942|565924778|FG001|Overall Study|Other|1|||
156773851|NCT00297167|565924780|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
156773852|NCT00297167|565924781|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
156773853|NCT00297167|565924782|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
156773854|NCT00297167|565924780|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
156773855|NCT00297167|565924781|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
156773856|NCT00297167|565924782|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
156773857|NCT02320396|565924783|FG000|Overall Study|Adverse Event|2|||
156773858|NCT02320396|565924784|FG001|Overall Study|Adverse Event|2|||
156428714|NCT00124982|564660907|FG001|Short-term Period|Participant Decision|0|||
156428715|NCT00124982|564660908|FG002|Short-term Period|Participant Decision|0|||
156428716|NCT00124982|564660906|FG000|Short-term Period|Participant Chose Own Doctor|0|||
156773859|NCT02320396|565924783|FG000|Overall Study|Pregnancy|0|||
156428717|NCT00124982|564660907|FG001|Short-term Period|Participant Chose Own Doctor|1|||
156428718|NCT00124982|564660908|FG002|Short-term Period|Participant Chose Own Doctor|0|||
156428719|NCT00124982|564660906|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
156428720|NCT00124982|564660907|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
156428721|NCT00124982|564660908|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
156428722|NCT00124982|564660906|FG000|Short-term Period|Participant Had Lymphopenia|1|||
156428723|NCT00124982|564660907|FG001|Short-term Period|Participant Had Lymphopenia|0|||
156428724|NCT00124982|564660908|FG002|Short-term Period|Participant Had Lymphopenia|0|||
156428725|NCT00124982|564660906|FG000|Long-term Period|Death|0|||
156428726|NCT00124982|564660907|FG001|Long-term Period|Death|0|||
156428727|NCT00124982|564660908|FG002|Long-term Period|Death|1|||
156428728|NCT00124982|564660906|FG000|Long-term Period|Adverse Event|0|||
156428729|NCT00124982|564660907|FG001|Long-term Period|Adverse Event|0|||
156428730|NCT00124982|564660908|FG002|Long-term Period|Adverse Event|17|||
156428731|NCT00124982|564660906|FG000|Long-term Period|Lack of Efficacy|0|||
156773860|NCT02320396|565924784|FG001|Overall Study|Pregnancy|1|||
156773861|NCT02320396|565924783|FG000|Overall Study|Protocol Violation|0|||
156773862|NCT02320396|565924784|FG001|Overall Study|Protocol Violation|1|||
156773863|NCT02320396|565924783|FG000|Overall Study|Withdrawal by Subject|2|||
156658489|NCT04529109|565495143|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
156658490|NCT04529109|565495144|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
156658491|NCT01508936|565495146|FG000|Overall Study|Adverse Event|11|||
156658492|NCT01508936|565495147|FG001|Overall Study|Adverse Event|32|||
156658493|NCT01508936|565495146|FG000|Overall Study|Lack of Efficacy|0|||
156658494|NCT01508936|565495147|FG001|Overall Study|Lack of Efficacy|1|||
156658495|NCT01508936|565495146|FG000|Overall Study|Withdrawal by Subject|4|||
156658496|NCT01508936|565495147|FG001|Overall Study|Withdrawal by Subject|18|||
156658497|NCT01508936|565495146|FG000|Overall Study|Protocol Violation|2|||
156658498|NCT01508936|565495147|FG001|Overall Study|Protocol Violation|3|||
156658499|NCT01508936|565495146|FG000|Overall Study|Lost to Follow-up|2|||
156773864|NCT02320396|565924784|FG001|Overall Study|Withdrawal by Subject|0|||
156658500|NCT01508936|565495147|FG001|Overall Study|Lost to Follow-up|9|||
156658501|NCT01508936|565495146|FG000|Overall Study|Other|0|||
156658502|NCT01508936|565495147|FG001|Overall Study|Other|5|||
156658503|NCT01508936|565495146|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
156658504|NCT01508936|565495147|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
156658505|NCT00679367|565495148|FG000|Overall Study|Adverse Event|7|||
156658506|NCT00679367|565495148|FG000|Overall Study|inability to swallow oral drugs|1|||
156658507|NCT00679367|565495148|FG000|Overall Study|Lack of Efficacy|3|||
156658508|NCT00679367|565495148|FG000|Overall Study|Withdrawal by Subject|1|||
156658509|NCT03365947|565495149|FG000|Overall Study|Lost to Follow-up|0|||
156658510|NCT03365947|565495150|FG001|Overall Study|Lost to Follow-up|0|||
156658511|NCT03365947|565495151|FG002|Overall Study|Lost to Follow-up|0|||
156658512|NCT03365947|565495152|FG003|Overall Study|Lost to Follow-up|0|||
156658513|NCT03365947|565495153|FG004|Overall Study|Lost to Follow-up|0|||
156658514|NCT03365947|565495154|FG005|Overall Study|Lost to Follow-up|1|||
156658515|NCT03365947|565495155|FG006|Overall Study|Lost to Follow-up|0|||
156658516|NCT03365947|565495156|FG007|Overall Study|Lost to Follow-up|0|||
156658517|NCT03365947|565495157|FG008|Overall Study|Lost to Follow-up|0|||
156658518|NCT03365947|565495158|FG009|Overall Study|Lost to Follow-up|0|||
156658519|NCT03365947|565495159|FG010|Overall Study|Lost to Follow-up|0|||
156658520|NCT03365947|565495160|FG011|Overall Study|Lost to Follow-up|0|||
156658521|NCT03365947|565495161|FG012|Overall Study|Lost to Follow-up|0|||
156658522|NCT03365947|565495162|FG013|Overall Study|Lost to Follow-up|0|||
156658523|NCT03365947|565495163|FG014|Overall Study|Lost to Follow-up|0|||
156658524|NCT03365947|565495164|FG015|Overall Study|Lost to Follow-up|0|||
156658525|NCT03365947|565495165|FG016|Overall Study|Lost to Follow-up|0|||
156658526|NCT03365947|565495166|FG017|Overall Study|Lost to Follow-up|0|||
156658527|NCT03365947|565495167|FG018|Overall Study|Lost to Follow-up|0|||
156658528|NCT01611090|565495168|FG000|Randomized Period|Lost to Follow-up|8|||
156658529|NCT01611090|565495169|FG001|Randomized Period|Lost to Follow-up|3|||
156658530|NCT01611090|565495170|FG002|Randomized Period|Lost to Follow-up|0|||
156658531|NCT01611090|565495168|FG000|Randomized Period|Withdrawal by Subject|22|||
156658532|NCT01611090|565495169|FG001|Randomized Period|Withdrawal by Subject|26|||
156658533|NCT01611090|565495170|FG002|Randomized Period|Withdrawal by Subject|0|||
156658534|NCT01611090|565495168|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
156658535|NCT01611090|565495169|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
156658536|NCT01611090|565495170|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
156658537|NCT01611090|565495168|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
156658538|NCT01611090|565495169|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
156658539|NCT01611090|565495170|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
156658540|NCT02473640|565496831|FG000|Treatment Period 1|Adverse Event|1|||
156658541|NCT00977106|565496834|FG000|Overall Study|Adverse Event|5|||
156658542|NCT00977106|565496835|FG001|Overall Study|Adverse Event|6|||
156658543|NCT00977106|565496834|FG000|Overall Study|Withdrawal by Subject|2|||
156658544|NCT00977106|565496835|FG001|Overall Study|Withdrawal by Subject|2|||
156658545|NCT00977106|565496834|FG000|Overall Study|Lack of Efficacy|2|||
156658546|NCT00977106|565496835|FG001|Overall Study|Lack of Efficacy|2|||
156658547|NCT00977106|565496834|FG000|Overall Study|Protocol Violation|0|||
156658548|NCT00977106|565496835|FG001|Overall Study|Protocol Violation|1|||
156658549|NCT00977106|565496834|FG000|Overall Study|Other|1|||
156658550|NCT00977106|565496835|FG001|Overall Study|Other|0|||
156658551|NCT01439165|565496842|FG000|Overall Study|Protocol Violation|3|||
156658552|NCT01439165|565496843|FG001|Overall Study|Protocol Violation|0|||
156658553|NCT01439165|565496842|FG000|Overall Study|Lost to Follow-up|11|||
156658554|NCT01439165|565496843|FG001|Overall Study|Lost to Follow-up|1|||
156773865|NCT02441283|565924785|FG000|Overall Study|Withdrew consent|15|||
156658555|NCT01439165|565496842|FG000|Overall Study|Withdrawal by Subject|7|||
156658556|NCT01439165|565496843|FG001|Overall Study|Withdrawal by Subject|1|||
156658557|NCT02419313|565496844|FG000|First Intervention|Lost to Follow-up|2|||
156658558|NCT02419313|565496845|FG001|First Intervention|Lost to Follow-up|0|||
156658559|NCT02419313|565496844|FG000|Second Intervention|Lost to Follow-up|1|||
156658560|NCT02419313|565496845|FG001|Second Intervention|Lost to Follow-up|0|||
156658561|NCT04557124|565496847|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
156658562|NCT04557124|565496848|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
156773866|NCT02441283|565924785|FG000|Overall Study|Lost to Follow-up|42|||
156658563|NCT04557124|565496847|FG000|Mid-point (1 Month)|Missed testing|5|||
156658564|NCT04557124|565496848|FG001|Mid-point (1 Month)|Missed testing|4|||
156658565|NCT04557124|565496847|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
156658566|NCT04557124|565496848|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
156658567|NCT04557124|565496847|FG000|Post-testing (2 Months)|Missed testing|1|||
156658568|NCT04557124|565496848|FG001|Post-testing (2 Months)|Missed testing|5|||
156658569|NCT04557124|565496847|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
156658570|NCT04557124|565496848|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
156658571|NCT04557124|565496847|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
156658572|NCT04557124|565496848|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
156658573|NCT00001849|565496849|FG000|Overall Study|Death|4|||
156658574|NCT00001849|565496849|FG000|Overall Study|Lost to Follow-up|2|||
156658575|NCT00001849|565496849|FG000|Overall Study|Withdrawal by Subject|2|||
156658576|NCT00001849|565496849|FG000|Overall Study|tumor remained occult|6|||
156658577|NCT00442936|565496850|FG000|Overall Study|Protocol Violation|1|||
156658578|NCT00442936|565496851|FG001|Overall Study|Protocol Violation|0|||
156658579|NCT00442936|565496852|FG002|Overall Study|Protocol Violation|1|||
156658580|NCT00442936|565496853|FG003|Overall Study|Protocol Violation|1|||
156658581|NCT02428699|565496855|FG000|Washout Period 1|Screen Failure|1|||
156658582|NCT02428699|565496856|FG001|Washout Period 1|Screen Failure|2|||
156658583|NCT02460159|565496857|FG000|Overall Study|Adverse Event|4|||
156658584|NCT02460159|565496858|FG001|Overall Study|Adverse Event|1|||
156658585|NCT02460159|565496857|FG000|Overall Study|Withdrawal by Subject|2|||
156658586|NCT02460159|565496858|FG001|Overall Study|Withdrawal by Subject|0|||
156658587|NCT00243932|565496859|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
156658588|NCT00243932|565496860|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
156658589|NCT00243932|565496861|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
156658590|NCT05518487|565496862|FG000|Overall Study|Withdrawal by Subject|3|||
156658591|NCT01370408|565496863|FG000|Overall Study|treatment failure|9|||
156658592|NCT02780687|565496865|FG000|Overall Study|Adverse Event|1|||
156773867|NCT02441283|565924785|FG000|Overall Study|Death|1|||
156773868|NCT02441283|565924785|FG000|Overall Study|Other, not specified|32|||
156773869|NCT06438601|565924786|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
156773870|NCT06438601|565924787|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
156773871|NCT06438601|565924786|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
156773872|NCT06438601|565924787|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
156773873|NCT03282097|565924788|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
156773874|NCT03282097|565924789|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
156773875|NCT03282097|565924788|FG000|Intervention Visit Complete|Patient Death|13|||
156773876|NCT03282097|565924789|FG001|Intervention Visit Complete|Patient Death|15|||
156773877|NCT03282097|565924788|FG000|Intervention Visit Complete|Caregiver Death|0|||
156773878|NCT03282097|565924789|FG001|Intervention Visit Complete|Caregiver Death|3|||
156773879|NCT03282097|565924788|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
156773880|NCT03282097|565924789|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
156773881|NCT03282097|565924788|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
156773882|NCT03282097|565924789|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
156773883|NCT03282097|565924788|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
156773884|NCT03282097|565924789|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
156773885|NCT03282097|565924788|FG000|Primary Outcome Data Collection Complete|Missing|2|||
156773886|NCT03282097|565924789|FG001|Primary Outcome Data Collection Complete|Missing|3|||
156773887|NCT03282097|565924788|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
156773888|NCT03282097|565924789|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
156773889|NCT03282097|565924788|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
156773890|NCT03282097|565924789|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
156773891|NCT03282097|565924788|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
156773892|NCT03282097|565924789|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
156773893|NCT03034967|565924792|FG000|Overall Study|Withdrawal by Subject|9|||
156658593|NCT02780687|565496866|FG001|Overall Study|Adverse Event|1|||
156658594|NCT02780687|565496865|FG000|Overall Study|Withdrawal by Subject|2|||
156658595|NCT02780687|565496866|FG001|Overall Study|Withdrawal by Subject|1|||
156658596|NCT02780687|565496865|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
156658597|NCT02780687|565496866|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
156658598|NCT02780687|565496865|FG000|Overall Study|progressive disease|29|||
156773894|NCT03034967|565924793|FG001|Overall Study|Withdrawal by Subject|2|||
156773895|NCT03034967|565924794|FG002|Overall Study|Withdrawal by Subject|6|||
156773896|NCT03034967|565924795|FG003|Overall Study|Withdrawal by Subject|6|||
156773897|NCT03034967|565924796|FG004|Overall Study|Withdrawal by Subject|9|||
156773898|NCT03034967|565924797|FG005|Overall Study|Withdrawal by Subject|2|||
156658599|NCT02780687|565496866|FG001|Overall Study|progressive disease|6|||
156658600|NCT05014412|565496867|FG000|Overall Study|Death|11|||
156773899|NCT03034967|565924792|FG000|Overall Study|Physician Decision|1|||
156773900|NCT03034967|565924793|FG001|Overall Study|Physician Decision|0|||
156773901|NCT03034967|565924794|FG002|Overall Study|Physician Decision|1|||
156658601|NCT05014412|565496868|FG001|Overall Study|Death|7|||
156658602|NCT05014412|565496869|FG002|Overall Study|Death|4|||
156658603|NCT05014412|565496870|FG003|Overall Study|Death|7|||
156658604|NCT05014412|565496867|FG000|Overall Study|Withdrawal by Subject|1|||
156658605|NCT05014412|565496868|FG001|Overall Study|Withdrawal by Subject|1|||
156658606|NCT05014412|565496869|FG002|Overall Study|Withdrawal by Subject|1|||
156658607|NCT05014412|565496870|FG003|Overall Study|Withdrawal by Subject|2|||
156658608|NCT05014412|565496867|FG000|Overall Study|Ongoing|21|||
156658609|NCT05014412|565496868|FG001|Overall Study|Ongoing|4|||
156658610|NCT05014412|565496869|FG002|Overall Study|Ongoing|6|||
156658611|NCT05014412|565496870|FG003|Overall Study|Ongoing|20|||
156658612|NCT05295953|565496872|FG000|Overall Study|Withdrawal by Subject|0|||
156658613|NCT05295953|565496873|FG001|Overall Study|Withdrawal by Subject|1|||
156658614|NCT01199861|565496875|FG000|Overall Study|Administrative problems|1|||
156658615|NCT01199861|565496876|FG001|Overall Study|Administrative problems|0|||
156658616|NCT01199861|565496875|FG000|Overall Study|Adverse Event|1|||
156658617|NCT01199861|565496876|FG001|Overall Study|Adverse Event|0|||
156658618|NCT04257929|565496877|FG000|Overall Study|Adverse Event|1|||
156658619|NCT04257929|565496878|FG001|Overall Study|Adverse Event|0|||
156658620|NCT04257929|565496879|FG002|Overall Study|Adverse Event|1|||
156658621|NCT04257929|565496877|FG000|Overall Study|Withdrawal by Subject|1|||
156658622|NCT04257929|565496878|FG001|Overall Study|Withdrawal by Subject|0|||
156658623|NCT04257929|565496879|FG002|Overall Study|Withdrawal by Subject|0|||
156658624|NCT04257929|565496877|FG000|Overall Study|COVID-19|0|||
156658625|NCT04257929|565496878|FG001|Overall Study|COVID-19|1|||
156658626|NCT04257929|565496879|FG002|Overall Study|COVID-19|1|||
156658627|NCT04257929|565496877|FG000|Overall Study|Lost to Follow-up|0|||
156658628|NCT04257929|565496878|FG001|Overall Study|Lost to Follow-up|0|||
156658629|NCT04257929|565496879|FG002|Overall Study|Lost to Follow-up|1|||
156658630|NCT05630547|565496880|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
156658631|NCT05630547|565496881|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
156658632|NCT05630547|565496882|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
156658633|NCT05630547|565496883|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
156658634|NCT05630547|565496880|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
156658635|NCT05630547|565496881|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
156658636|NCT05630547|565496882|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
156658637|NCT05630547|565496883|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
156658638|NCT05630547|565496880|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
156658639|NCT05630547|565496881|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
156658640|NCT05630547|565496882|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
156658641|NCT05630547|565496883|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
156658642|NCT05630547|565496880|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
156658643|NCT05630547|565496881|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
156658644|NCT05630547|565496882|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
156658645|NCT05630547|565496883|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
156773902|NCT03034967|565924795|FG003|Overall Study|Physician Decision|1|||
156773903|NCT03034967|565924796|FG004|Overall Study|Physician Decision|1|||
156324502|NCT01569464|564287638|FG001|Overall Study|Lost to Follow-up|3|||
156324503|NCT01569464|564287637|FG000|Overall Study|Withdrawal by Subject|1|||
156324504|NCT01569464|564287638|FG001|Overall Study|Withdrawal by Subject|1|||
156324505|NCT01569464|564287637|FG000|Overall Study|Other|1|||
156324506|NCT01569464|564287638|FG001|Overall Study|Other|1|||
156324507|NCT03063203|564287639|FG000|Overall Study|Chose alternative therapy|3|||
156324508|NCT03063203|564287639|FG000|Overall Study|Death|2|||
156324509|NCT03063203|564287639|FG000|Overall Study|Disease progression|4|||
156324510|NCT03063203|564287639|FG000|Overall Study|Physician Decision|5|||
156324511|NCT04025710|564287640|FG000|Overall Study|Death|3|||
156324512|NCT04025710|564287640|FG000|Overall Study|Lost to Follow-up|5|||
156324513|NCT04025710|564287640|FG000|Overall Study|Withdrawal by Subject|1|||
156324514|NCT04025710|564287640|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
156324515|NCT04025710|564287640|FG000|Overall Study|Drop-out according to protocol|34|||
156324516|NCT00245583|564287641|FG000|Overall Study|Lost to Follow-up|1|||
156324517|NCT00245583|564287642|FG001|Overall Study|Lost to Follow-up|5|||
156324518|NCT00245583|564287641|FG000|Overall Study|Adverse Event|2|||
156324519|NCT00245583|564287642|FG001|Overall Study|Adverse Event|1|||
156324520|NCT00245583|564287641|FG000|Overall Study|Lack of Efficacy|1|||
156324521|NCT00245583|564287642|FG001|Overall Study|Lack of Efficacy|0|||
156324522|NCT00245583|564287641|FG000|Overall Study|Withdrawal by Subject|2|||
156324523|NCT00245583|564287642|FG001|Overall Study|Withdrawal by Subject|3|||
156324524|NCT01309893|564287643|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
156658646|NCT05630547|565496880|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
156773904|NCT03034967|565924797|FG005|Overall Study|Physician Decision|0|||
156773905|NCT03034967|565924792|FG000|Overall Study|Lost to Follow-up|0|||
156773906|NCT03034967|565924793|FG001|Overall Study|Lost to Follow-up|0|||
156324525|NCT01309893|564287644|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
156428732|NCT00124982|564660907|FG001|Long-term Period|Lack of Efficacy|0|||
156658647|NCT05630547|565496881|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
156658648|NCT05630547|565496882|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
156658649|NCT05630547|565496883|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
156658650|NCT05630547|565496880|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
156658651|NCT05630547|565496881|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
156658652|NCT05630547|565496882|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
156658653|NCT05630547|565496883|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
156658654|NCT05630547|565496880|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
156658655|NCT05630547|565496881|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
156658656|NCT05630547|565496882|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
156658657|NCT05630547|565496883|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
156658658|NCT05630547|565496880|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
156658659|NCT05630547|565496881|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
156658660|NCT05630547|565496882|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
156658661|NCT05630547|565496883|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
156658662|NCT05630547|565496880|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
156658663|NCT05630547|565496881|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
156658664|NCT05630547|565496882|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
156658665|NCT05630547|565496883|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
156658666|NCT05630547|565496880|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
156658667|NCT05630547|565496881|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
156658668|NCT05630547|565496882|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
156658669|NCT05630547|565496883|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
156658670|NCT05049460|565496884|FG000|Overall Study|Withdrawal by Subject|2|||
156658671|NCT05049460|565496885|FG001|Overall Study|Withdrawal by Subject|2|||
156658672|NCT05049460|565496884|FG000|Overall Study|Lost to Follow-up|2|||
156658673|NCT05049460|565496885|FG001|Overall Study|Lost to Follow-up|2|||
156658674|NCT00918567|565496886|FG000|Overall Study|Lack of Efficacy|3|||
156658675|NCT00918567|565496887|FG001|Overall Study|Lack of Efficacy|1|||
156658676|NCT00918567|565496886|FG000|Overall Study|Withdrawal by Subject|1|||
156658677|NCT00918567|565496887|FG001|Overall Study|Withdrawal by Subject|1|||
156658678|NCT00918567|565496886|FG000|Overall Study|Adverse Event|1|||
156658679|NCT00918567|565496887|FG001|Overall Study|Adverse Event|0|||
156658680|NCT05275998|565496888|FG000|Overall Study|Adverse Event|0|||
156658681|NCT05275998|565496889|FG001|Overall Study|Adverse Event|0|||
156658682|NCT05275998|565496890|FG002|Overall Study|Adverse Event|0|||
156658683|NCT05275998|565496891|FG003|Overall Study|Adverse Event|1|||
156658684|NCT05275998|565496888|FG000|Overall Study|Withdrawal by Subject|0|||
156658685|NCT05275998|565496889|FG001|Overall Study|Withdrawal by Subject|0|||
156658686|NCT05275998|565496890|FG002|Overall Study|Withdrawal by Subject|0|||
156658687|NCT05275998|565496891|FG003|Overall Study|Withdrawal by Subject|1|||
156658688|NCT05275998|565496888|FG000|Overall Study|Physician Decision|0|||
156658689|NCT05275998|565496889|FG001|Overall Study|Physician Decision|0|||
156658690|NCT05275998|565496890|FG002|Overall Study|Physician Decision|0|||
156658691|NCT05275998|565496891|FG003|Overall Study|Physician Decision|1|||
156658692|NCT05275998|565496888|FG000|Overall Study|Protocol Violation|0|||
156658693|NCT05275998|565496889|FG001|Overall Study|Protocol Violation|0|||
156658694|NCT05275998|565496890|FG002|Overall Study|Protocol Violation|1|||
156658695|NCT05275998|565496891|FG003|Overall Study|Protocol Violation|0|||
156658696|NCT01867242|565496894|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
156658697|NCT01867242|565496895|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
156658698|NCT01867242|565496896|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
156658699|NCT03066999|565496897|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
156658700|NCT03066999|565496898|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
156658701|NCT00661999|565496899|FG000|Overall Study|Adverse Event|11|||
156658702|NCT00661999|565496900|FG001|Overall Study|Adverse Event|5|||
156658703|NCT00661999|565496901|FG002|Overall Study|Adverse Event|8|||
156658704|NCT00661999|565496899|FG000|Overall Study|Death|8|||
156658705|NCT00661999|565496900|FG001|Overall Study|Death|6|||
156658706|NCT00661999|565496901|FG002|Overall Study|Death|3|||
156658707|NCT00661999|565496899|FG000|Overall Study|Other Reasons|5|||
156658708|NCT00661999|565496900|FG001|Overall Study|Other Reasons|12|||
156658709|NCT00661999|565496901|FG002|Overall Study|Other Reasons|23|||
156658710|NCT00661999|565496899|FG000|Overall Study|Withdrawal by Subject|30|||
156658711|NCT00661999|565496900|FG001|Overall Study|Withdrawal by Subject|23|||
156658712|NCT00661999|565496901|FG002|Overall Study|Withdrawal by Subject|14|||
156658713|NCT00661999|565496899|FG000|Overall Study|Alternative Treatment|1|||
156658714|NCT00661999|565496900|FG001|Overall Study|Alternative Treatment|0|||
156658715|NCT00661999|565496901|FG002|Overall Study|Alternative Treatment|0|||
156658716|NCT00661999|565496899|FG000|Overall Study|Other Medical Problems|4|||
156658717|NCT00661999|565496900|FG001|Overall Study|Other Medical Problems|4|||
156658718|NCT00661999|565496901|FG002|Overall Study|Other Medical Problems|9|||
156658719|NCT01361126|565496904|FG000|Overall Study|Sponsor decision|0|||
156658720|NCT01361126|565496905|FG001|Overall Study|Sponsor decision|2|||
156658721|NCT00264810|565496906|FG000|Baseline|Withdrawal by Subject|10|||
156658722|NCT00264810|565496907|FG001|Baseline|Withdrawal by Subject|10|||
156658723|NCT00264810|565496906|FG000|Baseline|Physician Decision|7|||
156658724|NCT00264810|565496907|FG001|Baseline|Physician Decision|8|||
156658725|NCT00264810|565496906|FG000|Baseline|Subject Compliance Failure|3|||
156658726|NCT00264810|565496907|FG001|Baseline|Subject Compliance Failure|3|||
156658727|NCT00264810|565496906|FG000|Baseline|Insufficient Seizure Frequency|2|||
156658728|NCT00264810|565496907|FG001|Baseline|Insufficient Seizure Frequency|2|||
156658729|NCT00264810|565496906|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
156658730|NCT00264810|565496907|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
156658731|NCT00264810|565496906|FG000|Baseline|Other|0|||
156658732|NCT00264810|565496907|FG001|Baseline|Other|1|||
156658733|NCT00264810|565496906|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
156658734|NCT00264810|565496907|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
156658735|NCT00264810|565496906|FG000|Stimulation Optimization Period|Death|0|||
156658736|NCT00264810|565496907|FG001|Stimulation Optimization Period|Death|1|||
156658737|NCT00264810|565496906|FG000|Blinded Evaluation Period|Explant due to infection|1|||
156658738|NCT00264810|565496907|FG001|Blinded Evaluation Period|Explant due to infection|1|||
156658739|NCT00264810|565496906|FG000|Open Label Evaluation Period|Explant due to infection|1|||
156658740|NCT00264810|565496907|FG001|Open Label Evaluation Period|Explant due to infection|1|||
156658741|NCT00264810|565496906|FG000|Open Label Evaluation Period|Death|3|||
156658742|NCT00264810|565496907|FG001|Open Label Evaluation Period|Death|2|||
156658743|NCT00264810|565496906|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
156658744|NCT00264810|565496907|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
156658745|NCT02879643|565496911|FG000|Overall Study|Adverse Event|0|||
156658746|NCT02879643|565496912|FG001|Overall Study|Adverse Event|0|||
156523723|NCT03421431|565011818|FG001|Overall Study|Participant met Stopping Rules|1|||
156523724|NCT03421431|565011819|FG002|Overall Study|Participant met Stopping Rules|0|||
156523725|NCT02216357|565011821|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
156523726|NCT02216357|565011822|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
156523727|NCT00141726|565011823|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
156523728|NCT00235326|565011831|FG000|Overall Study|Lost to Follow-up|746|||
156523729|NCT00235326|565011832|FG001|Overall Study|Lost to Follow-up|1400|||
156523730|NCT01477333|565011835|FG000|Overall Study|Adverse Event|1|||
156523731|NCT01477333|565011835|FG000|Overall Study|Withdrawal by Subject|1|||
156523732|NCT01477333|565011835|FG000|Overall Study|Clinical Deterioration|1|||
156523733|NCT01178671|565011836|FG000|Overall Study|Adverse Event|4|||
156523734|NCT01178671|565011837|FG001|Overall Study|Adverse Event|6|||
156523735|NCT01178671|565011836|FG000|Overall Study|Protocol Violation|1|||
156523736|NCT01178671|565011837|FG001|Overall Study|Protocol Violation|1|||
156523737|NCT01178671|565011836|FG000|Overall Study|Lack of Efficacy|0|||
156523738|NCT01178671|565011837|FG001|Overall Study|Lack of Efficacy|1|||
156523739|NCT01178671|565011836|FG000|Overall Study|Lost to Follow-up|3|||
156523740|NCT01178671|565011837|FG001|Overall Study|Lost to Follow-up|1|||
156523741|NCT01178671|565011836|FG000|Overall Study|Physician Decision|4|||
156523742|NCT01178671|565011837|FG001|Overall Study|Physician Decision|6|||
156523743|NCT02435966|565011838|FG000|Overall Study|Withdrawal by Subject|0|||
156523744|NCT02435966|565011839|FG001|Overall Study|Withdrawal by Subject|1|||
156523745|NCT02435966|565011840|FG002|Overall Study|Withdrawal by Subject|0|||
156523746|NCT01078675|565011841|FG000|Overall Study|Withdrawal by Subject|7|||
156523747|NCT01078675|565011842|FG001|Overall Study|Withdrawal by Subject|3|||
156523748|NCT01078675|565011841|FG000|Overall Study|Protocol Violation|56|||
156523749|NCT01078675|565011842|FG001|Overall Study|Protocol Violation|0|||
156523750|NCT01078675|565011841|FG000|Overall Study|Provided in CRF for specific reasons|2|||
156658747|NCT02879643|565496913|FG002|Overall Study|Adverse Event|1|||
156658748|NCT02879643|565496914|FG003|Overall Study|Adverse Event|1|||
156658749|NCT02879643|565496915|FG004|Overall Study|Adverse Event|0|||
156658750|NCT00182091|565496916|FG000|Overall Study|Withdrawal by Subject|1|||
156658751|NCT00182091|565496917|FG001|Overall Study|Withdrawal by Subject|0|||
156658752|NCT00182091|565496918|FG002|Overall Study|Withdrawal by Subject|0|||
156658753|NCT00182091|565496919|FG003|Overall Study|Withdrawal by Subject|0|||
156773907|NCT03034967|565924794|FG002|Overall Study|Lost to Follow-up|0|||
156523751|NCT01078675|565011842|FG001|Overall Study|Provided in CRF for specific reasons|3|||
156523752|NCT01078675|565011841|FG000|Overall Study|Adverse Event|3|||
156523753|NCT01078675|565011842|FG001|Overall Study|Adverse Event|0|||
156523754|NCT00928746|565011845|FG000|Overall Study|Adverse Event|2|||
156523755|NCT00928746|565011845|FG000|Overall Study|Protocol Violation|1|||
156523756|NCT00928746|565011845|FG000|Overall Study|Withdrawal by Subject|1|||
156523757|NCT00928746|565011845|FG000|Overall Study|Other|2|||
156658754|NCT02199509|565496920|FG000|Overall Study|Suicidal Ideation|0|||
156658755|NCT02199509|565496921|FG001|Overall Study|Suicidal Ideation|1|||
156523758|NCT02745392|565011847|FG000|Overall Study|Lost to Follow-up|0|||
156523759|NCT02745392|565011848|FG001|Overall Study|Lost to Follow-up|1|||
156523760|NCT02745392|565011849|FG002|Overall Study|Lost to Follow-up|0|||
156658756|NCT02199509|565496920|FG000|Overall Study|Misunderstood titration schedule|1|||
156658757|NCT02199509|565496921|FG001|Overall Study|Misunderstood titration schedule|0|||
156658758|NCT01658943|565496923|FG000|Overall Study|Adverse Event|6|||
156658759|NCT01658943|565496924|FG001|Overall Study|Adverse Event|13|||
156658760|NCT01658943|565496923|FG000|Overall Study|Withdrawal by Subject|9|||
156658761|NCT01658943|565496924|FG001|Overall Study|Withdrawal by Subject|2|||
156658762|NCT01658943|565496923|FG000|Overall Study|Progression/Relapse|39|||
156658763|NCT01658943|565496924|FG001|Overall Study|Progression/Relapse|40|||
156658764|NCT01658943|565496923|FG000|Overall Study|Death|4|||
156658765|NCT01658943|565496924|FG001|Overall Study|Death|2|||
156658766|NCT01658943|565496923|FG000|Overall Study|not protocol specified|4|||
156658767|NCT01658943|565496924|FG001|Overall Study|not protocol specified|1|||
156658768|NCT01658943|565496923|FG000|Overall Study|Not eligible|7|||
156658769|NCT01658943|565496924|FG001|Overall Study|Not eligible|9|||
156658770|NCT01658943|565496923|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
156658771|NCT01658943|565496924|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
156658772|NCT01346410|565496926|FG000|Overall Study|Death|1|||
156658773|NCT02576990|565496927|FG000|Overall Study|Death|29|||
156658774|NCT02576990|565496928|FG001|Overall Study|Death|18|||
156658775|NCT02576990|565496927|FG000|Overall Study|Physician Decision|1|||
156658776|NCT02576990|565496928|FG001|Overall Study|Physician Decision|0|||
156658777|NCT02576990|565496927|FG000|Overall Study|Screen failure|2|||
156658778|NCT02576990|565496928|FG001|Overall Study|Screen failure|0|||
156658779|NCT02576990|565496927|FG000|Overall Study|Sponsor's decision|24|||
156658780|NCT02576990|565496928|FG001|Overall Study|Sponsor's decision|4|||
156658781|NCT02576990|565496927|FG000|Overall Study|Withdrawal by Subject|0|||
156658782|NCT02576990|565496928|FG001|Overall Study|Withdrawal by Subject|2|||
156658783|NCT00936390|565496929|FG000|Overall Study|Protocol Violation|21|||
156658784|NCT00936390|565496930|FG001|Overall Study|Protocol Violation|25|||
156658785|NCT05905783|565496931|FG000|Overall Study|Lost to Follow-up|12|||
156658786|NCT05905783|565496932|FG001|Overall Study|Lost to Follow-up|18|||
156658787|NCT05905783|565496931|FG000|Overall Study|Withdrawal by Subject|29|||
156658788|NCT05905783|565496932|FG001|Overall Study|Withdrawal by Subject|37|||
156658789|NCT05905783|565496931|FG000|Overall Study|Decision by sponsor|69|||
156658790|NCT05905783|565496932|FG001|Overall Study|Decision by sponsor|65|||
156658791|NCT02093689|565496933|FG000|Overall Study|Physician Decision|4|||
156658792|NCT02093689|565496934|FG001|Overall Study|Physician Decision|0|||
156658793|NCT02093689|565496935|FG002|Overall Study|Physician Decision|0|||
156658794|NCT04947579|565496940|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
156658795|NCT04947579|565496941|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
156658796|NCT04947579|565496942|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
156658797|NCT04947579|565496943|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
156658798|NCT04947579|565496944|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
156658799|NCT04947579|565496945|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
156658800|NCT04947579|565496940|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
156658801|NCT04947579|565496941|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
156658802|NCT04947579|565496942|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
156658803|NCT04947579|565496943|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
156658804|NCT04947579|565496944|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
156658805|NCT04947579|565496945|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
156658806|NCT04947579|565496940|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
156658807|NCT04947579|565496941|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
156658808|NCT04947579|565496942|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
156658809|NCT04947579|565496943|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
156324526|NCT01309893|564287643|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
156324527|NCT01309893|564287644|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
156324528|NCT01343901|564287645|FG000|Overall Study|Death|85|||
156324529|NCT01343901|564287645|FG000|Overall Study|Physician Decision|4|||
156324530|NCT01343901|564287645|FG000|Overall Study|Lost to Follow-up|12|||
156324531|NCT01343901|564287645|FG000|Overall Study|Management by another medical team|11|||
156324532|NCT01343901|564287645|FG000|Overall Study|Participant decision|1|||
156324533|NCT02764190|564287646|FG000|Overall Study|Lost to Follow-up|17|||
156324534|NCT02764190|564287647|FG001|Overall Study|Lost to Follow-up|13|||
156324535|NCT01484938|564287652|FG000|Overall Study|Adverse Event|2|||
156324536|NCT01484938|564287652|FG000|Overall Study|Lost to Follow-up|1|||
156324537|NCT01484938|564287652|FG000|Overall Study|Noncompliance|1|||
156324538|NCT02140775|564287654|FG000|Overall Study|Withdrawal by Subject|30|||
156324539|NCT02140775|564287655|FG001|Overall Study|Withdrawal by Subject|7|||
156324540|NCT00938964|564287659|FG000|Overall Study|Death|3|||
156324541|NCT00938964|564287660|FG001|Overall Study|Death|3|||
156658810|NCT04947579|565496944|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
156658811|NCT04947579|565496945|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
156658812|NCT04947579|565496940|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
156324542|NCT00938964|564287659|FG000|Overall Study|Lost to Follow-up|2|||
156658813|NCT04947579|565496941|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
156658814|NCT04947579|565496942|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
156658815|NCT04947579|565496943|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
156773908|NCT03034967|565924795|FG003|Overall Study|Lost to Follow-up|1|||
156428733|NCT00124982|564660908|FG002|Long-term Period|Lack of Efficacy|46|||
156428734|NCT00124982|564660906|FG000|Long-term Period|Lost to Follow-up|0|||
156428735|NCT00124982|564660907|FG001|Long-term Period|Lost to Follow-up|0|||
156428736|NCT00124982|564660908|FG002|Long-term Period|Lost to Follow-up|4|||
156428737|NCT00124982|564660906|FG000|Long-term Period|Withdrawal by Subject|0|||
156428738|NCT00124982|564660907|FG001|Long-term Period|Withdrawal by Subject|0|||
156428739|NCT00124982|564660908|FG002|Long-term Period|Withdrawal by Subject|16|||
156428740|NCT00124982|564660906|FG000|Long-term Period|Pregnancy|0|||
156428741|NCT00124982|564660907|FG001|Long-term Period|Pregnancy|0|||
156428742|NCT00124982|564660908|FG002|Long-term Period|Pregnancy|1|||
156428743|NCT00124982|564660906|FG000|Long-term Period|Poor/Non-compliance|0|||
156428744|NCT00124982|564660907|FG001|Long-term Period|Poor/Non-compliance|0|||
156428745|NCT00124982|564660908|FG002|Long-term Period|Poor/Non-compliance|2|||
156428746|NCT00124982|564660906|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
156428747|NCT00124982|564660907|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
156428748|NCT00124982|564660908|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
156428749|NCT00124982|564660906|FG000|Long-term Period|Neurologist Recommendation|0|||
156428750|NCT00124982|564660907|FG001|Long-term Period|Neurologist Recommendation|0|||
156428751|NCT00124982|564660908|FG002|Long-term Period|Neurologist Recommendation|1|||
156428752|NCT01137292|564660909|FG000|Overall Study|Death|30|||
156428753|NCT01137292|564660909|FG000|Overall Study|Adverse Event|3|||
156428754|NCT01137292|564660909|FG000|Overall Study|Lack of Efficacy|13|||
156428755|NCT01137292|564660909|FG000|Overall Study|Lost to Follow-up|1|||
156523761|NCT02745392|565011850|FG003|Overall Study|Lost to Follow-up|0|||
156523762|NCT02513303|565011851|FG000|Overall Study|Withdrawal by Subject|9|||
156523763|NCT02513303|565011852|FG001|Overall Study|Withdrawal by Subject|7|||
156523764|NCT02513303|565011853|FG002|Overall Study|Withdrawal by Subject|2|||
156523765|NCT02513303|565011851|FG000|Overall Study|Lost to Follow-up|2|||
156523766|NCT02513303|565011852|FG001|Overall Study|Lost to Follow-up|4|||
156523767|NCT02513303|565011853|FG002|Overall Study|Lost to Follow-up|0|||
156523768|NCT02513303|565011851|FG000|Overall Study|Adverse Event|0|||
156523769|NCT02513303|565011852|FG001|Overall Study|Adverse Event|1|||
156523770|NCT02513303|565011853|FG002|Overall Study|Adverse Event|0|||
156523771|NCT02513303|565011851|FG000|Overall Study|Physician Decision|1|||
156523772|NCT02513303|565011852|FG001|Overall Study|Physician Decision|1|||
156523773|NCT02513303|565011853|FG002|Overall Study|Physician Decision|0|||
156523774|NCT02513303|565011851|FG000|Overall Study|Death|8|||
156523775|NCT02513303|565011852|FG001|Overall Study|Death|4|||
156523776|NCT02513303|565011853|FG002|Overall Study|Death|2|||
156523777|NCT02004353|565011858|FG000|Overall Study|Voluntary participation|1334|||
156523778|NCT01691768|565011859|FG000|Overall Study|Death|0|||
156523779|NCT01691768|565011860|FG001|Overall Study|Death|2|||
156523780|NCT01691768|565011859|FG000|Overall Study|Lost to Follow-up|4|||
156523781|NCT01691768|565011860|FG001|Overall Study|Lost to Follow-up|3|||
156523782|NCT01691768|565011859|FG000|Overall Study|Withdrawal by Subject|10|||
156523783|NCT01691768|565011860|FG001|Overall Study|Withdrawal by Subject|9|||
156523784|NCT01691768|565011859|FG000|Overall Study|Relocated|0|||
156523785|NCT01691768|565011860|FG001|Overall Study|Relocated|1|||
156523786|NCT01691768|565011859|FG000|Overall Study|Investigator decision|1|||
156523787|NCT01691768|565011860|FG001|Overall Study|Investigator decision|1|||
156523788|NCT02581631|565011861|FG000|Overall Study|Disease progression|29|||
156523789|NCT02581631|565011862|FG001|Overall Study|Disease progression|19|||
156523790|NCT02581631|565011863|FG002|Overall Study|Disease progression|13|||
156523791|NCT02581631|565011864|FG003|Overall Study|Disease progression|5|||
156523792|NCT02581631|565011865|FG004|Overall Study|Disease progression|8|||
156523793|NCT02581631|565011861|FG000|Overall Study|Study drug toxicity|4|||
156523794|NCT02581631|565011862|FG001|Overall Study|Study drug toxicity|6|||
156523795|NCT02581631|565011863|FG002|Overall Study|Study drug toxicity|7|||
156523796|NCT02581631|565011864|FG003|Overall Study|Study drug toxicity|0|||
156523797|NCT02581631|565011865|FG004|Overall Study|Study drug toxicity|3|||
156773909|NCT03034967|565924796|FG004|Overall Study|Lost to Follow-up|0|||
156428756|NCT01137292|564660909|FG000|Overall Study|Other|7|||
156428757|NCT01311713|564660910|FG000|Overall Study|Death|0|||
156428758|NCT01311713|564660911|FG001|Overall Study|Death|0|||
156523798|NCT02581631|565011861|FG000|Overall Study|AE unrelated to study drug|3|||
156523799|NCT02581631|565011862|FG001|Overall Study|AE unrelated to study drug|1|||
156523800|NCT02581631|565011863|FG002|Overall Study|AE unrelated to study drug|1|||
156428759|NCT01311713|564660912|FG002|Overall Study|Death|1|||
156428760|NCT01311713|564660913|FG003|Overall Study|Death|1|||
156523801|NCT02581631|565011864|FG003|Overall Study|AE unrelated to study drug|0|||
156523802|NCT02581631|565011865|FG004|Overall Study|AE unrelated to study drug|2|||
156523803|NCT02581631|565011861|FG000|Overall Study|Request to discontinue|1|||
156523804|NCT02581631|565011862|FG001|Overall Study|Request to discontinue|0|||
156523805|NCT02581631|565011863|FG002|Overall Study|Request to discontinue|3|||
156773910|NCT03034967|565924797|FG005|Overall Study|Lost to Follow-up|2|||
156773911|NCT03034967|565924792|FG000|Overall Study|Liver function test abnormality|0|||
156773912|NCT03034967|565924793|FG001|Overall Study|Liver function test abnormality|0|||
156773913|NCT03034967|565924794|FG002|Overall Study|Liver function test abnormality|1|||
156773914|NCT03034967|565924795|FG003|Overall Study|Liver function test abnormality|0|||
156773915|NCT03034967|565924796|FG004|Overall Study|Liver function test abnormality|0|||
156773916|NCT03034967|565924797|FG005|Overall Study|Liver function test abnormality|0|||
156773917|NCT03034967|565924792|FG000|Overall Study|Protocol Violation|1|||
156658816|NCT04947579|565496944|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
156658817|NCT04947579|565496945|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
156658818|NCT04947579|565496940|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
156658819|NCT04947579|565496941|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
156658820|NCT04947579|565496942|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
156658821|NCT04947579|565496943|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
156658822|NCT04947579|565496944|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
156658823|NCT04947579|565496945|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
156658824|NCT04947579|565496940|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
156658825|NCT04947579|565496941|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
156658826|NCT04947579|565496942|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
156658827|NCT04947579|565496943|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
156658828|NCT04947579|565496944|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
156658829|NCT04947579|565496945|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
156658830|NCT04947579|565496940|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
156658831|NCT04947579|565496941|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
156658832|NCT04947579|565496942|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
156658833|NCT04947579|565496943|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
156658834|NCT04947579|565496944|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
156658835|NCT04947579|565496945|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
156658836|NCT04947579|565496940|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
156658837|NCT04947579|565496941|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
156658838|NCT04947579|565496942|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
156658839|NCT04947579|565496943|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
156658840|NCT04947579|565496944|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
156658841|NCT04947579|565496945|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
156658842|NCT04947579|565496940|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
156658843|NCT04947579|565496941|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
156658844|NCT04947579|565496942|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
156658845|NCT04947579|565496943|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
156658846|NCT04947579|565496944|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
156658847|NCT04947579|565496945|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
156658848|NCT04947579|565496940|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
156658849|NCT04947579|565496941|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
156658850|NCT04947579|565496942|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
156658851|NCT04947579|565496943|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
156658852|NCT04947579|565496944|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
156658853|NCT04947579|565496945|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
156658854|NCT04947579|565496940|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
156658855|NCT04947579|565496941|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
156658856|NCT04947579|565496942|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
156658857|NCT04947579|565496943|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
156658858|NCT04947579|565496944|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
156658859|NCT04947579|565496945|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
156658860|NCT00634179|565496946|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
156658861|NCT04272801|565496947|FG000|Overall Study|Withdrawal by Subject|4|||
156658862|NCT04272801|565496947|FG000|Overall Study|Lost to Follow-up|4|||
156658863|NCT04272801|565496947|FG000|Overall Study|Ineligible|1|||
156773918|NCT03034967|565924793|FG001|Overall Study|Protocol Violation|0|||
156324543|NCT00938964|564287660|FG001|Overall Study|Lost to Follow-up|3|||
156324544|NCT00938964|564287659|FG000|Overall Study|Withdrawal by Subject|22|||
156324545|NCT00938964|564287660|FG001|Overall Study|Withdrawal by Subject|18|||
156324546|NCT00938964|564287659|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
156324547|NCT00938964|564287660|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
156324548|NCT01858636|564287661|FG000|Overall Study|No Device Deployment Attempted|24|||
156324549|NCT01858636|564287661|FG000|Overall Study|Physician Decision|1|||
156324550|NCT01858636|564287661|FG000|Overall Study|Death|1|||
156324551|NCT01858636|564287661|FG000|Overall Study|Lost to Follow-up|1|||
156324552|NCT01858636|564287661|FG000|Overall Study|Withdrawal by Subject|1|||
156658864|NCT00475020|565496948|FG000|Overall Study|Physician Decision|3|||
156658865|NCT00475020|565496948|FG000|Overall Study|Insurance Denial|1|||
156658866|NCT00475020|565496948|FG000|Overall Study|Donor not able to donate the last minute|1|||
156658867|NCT01575054|565496949|FG000|Overall Study|Other Reasons|5|||
156658868|NCT01575054|565496950|FG001|Overall Study|Other Reasons|3|||
156658869|NCT01575054|565496949|FG000|Overall Study|Protocol Violation|2|||
156658870|NCT01575054|565496950|FG001|Overall Study|Protocol Violation|1|||
156658871|NCT01575054|565496949|FG000|Overall Study|Personal Reasons|10|||
156658872|NCT01575054|565496950|FG001|Overall Study|Personal Reasons|11|||
156658873|NCT01575054|565496949|FG000|Overall Study|Lost to Follow-up|3|||
156658874|NCT01575054|565496950|FG001|Overall Study|Lost to Follow-up|3|||
156658875|NCT01575054|565496949|FG000|Overall Study|Adverse Event|9|||
156658876|NCT01575054|565496950|FG001|Overall Study|Adverse Event|8|||
156658877|NCT03481309|565496951|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
156658878|NCT03481309|565496952|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
156658879|NCT03481309|565496953|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
156658880|NCT03481309|565496954|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
156658881|NCT03481309|565496955|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
156658882|NCT03481309|565496956|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
156658883|NCT02768298|565496959|FG000|Overall Study|Adverse Event|1|||
156658884|NCT02768298|565496960|FG001|Overall Study|Adverse Event|4|||
156658885|NCT02768298|565496959|FG000|Overall Study|Death|2|||
156658886|NCT02768298|565496960|FG001|Overall Study|Death|1|||
156658887|NCT02768298|565496959|FG000|Overall Study|Non-compliance with study treatment|0|||
156658888|NCT02768298|565496960|FG001|Overall Study|Non-compliance with study treatment|1|||
156658889|NCT02768298|565496959|FG000|Overall Study|Subject/guardian decision|1|||
156658890|NCT02768298|565496960|FG001|Overall Study|Subject/guardian decision|0|||
156658891|NCT02768298|565496959|FG000|Overall Study|Withdrawal of informed consent|0|||
156658892|NCT02768298|565496960|FG001|Overall Study|Withdrawal of informed consent|1|||
156658893|NCT02130466|565496961|FG000|Overall Study|Death|4|||
156658894|NCT02130466|565496962|FG001|Overall Study|Death|1|||
156658895|NCT02130466|565496963|FG002|Overall Study|Death|1|||
156658896|NCT02130466|565496964|FG003|Overall Study|Death|3|||
156658897|NCT02130466|565496965|FG004|Overall Study|Death|2|||
156658898|NCT02130466|565496966|FG005|Overall Study|Death|30|||
156523806|NCT02581631|565011864|FG003|Overall Study|Request to discontinue|0|||
156523807|NCT02581631|565011865|FG004|Overall Study|Request to discontinue|1|||
156523808|NCT02581631|565011861|FG000|Overall Study|participant withdrew consent|3|||
156523809|NCT02581631|565011862|FG001|Overall Study|participant withdrew consent|0|||
156523810|NCT02581631|565011863|FG002|Overall Study|participant withdrew consent|1|||
156523811|NCT02581631|565011864|FG003|Overall Study|participant withdrew consent|0|||
156523812|NCT02581631|565011865|FG004|Overall Study|participant withdrew consent|0|||
156523813|NCT02581631|565011861|FG000|Overall Study|Maximum clinical benefit|1|||
156523814|NCT02581631|565011862|FG001|Overall Study|Maximum clinical benefit|7|||
156523815|NCT02581631|565011863|FG002|Overall Study|Maximum clinical benefit|1|||
156523816|NCT02581631|565011864|FG003|Overall Study|Maximum clinical benefit|3|||
156523817|NCT02581631|565011865|FG004|Overall Study|Maximum clinical benefit|13|||
156523818|NCT02581631|565011861|FG000|Overall Study|Other Reasons|1|||
156523819|NCT02581631|565011862|FG001|Overall Study|Other Reasons|0|||
156523820|NCT02581631|565011863|FG002|Overall Study|Other Reasons|2|||
156523821|NCT02581631|565011864|FG003|Overall Study|Other Reasons|2|||
156523822|NCT02581631|565011865|FG004|Overall Study|Other Reasons|3|||
156523823|NCT02581631|565011861|FG000|Overall Study|Poor/Non-Compliance|0|||
156523824|NCT02581631|565011862|FG001|Overall Study|Poor/Non-Compliance|0|||
156523825|NCT02581631|565011863|FG002|Overall Study|Poor/Non-Compliance|1|||
156523826|NCT02581631|565011864|FG003|Overall Study|Poor/Non-Compliance|0|||
156523827|NCT02581631|565011865|FG004|Overall Study|Poor/Non-Compliance|0|||
156523828|NCT01191268|565011875|FG000|Overall Study|Withdrawal by Subject|19|||
156523829|NCT01191268|565011876|FG001|Overall Study|Withdrawal by Subject|25|||
156523830|NCT01191268|565011877|FG002|Overall Study|Withdrawal by Subject|21|||
156523831|NCT01191268|565011875|FG000|Overall Study|Adverse Event|21|||
156523832|NCT01191268|565011876|FG001|Overall Study|Adverse Event|13|||
156523833|NCT01191268|565011877|FG002|Overall Study|Adverse Event|8|||
156523834|NCT01191268|565011875|FG000|Overall Study|Physician Decision|6|||
156523835|NCT01191268|565011876|FG001|Overall Study|Physician Decision|8|||
156523836|NCT01191268|565011877|FG002|Overall Study|Physician Decision|9|||
156523837|NCT01191268|565011875|FG000|Overall Study|Lost to Follow-up|8|||
156523838|NCT01191268|565011876|FG001|Overall Study|Lost to Follow-up|5|||
156523839|NCT01191268|565011877|FG002|Overall Study|Lost to Follow-up|9|||
156523840|NCT01191268|565011875|FG000|Overall Study|Entry Criteria Not Met|3|||
156523841|NCT01191268|565011876|FG001|Overall Study|Entry Criteria Not Met|1|||
156658899|NCT02130466|565496967|FG006|Overall Study|Death|45|||
156523842|NCT01191268|565011877|FG002|Overall Study|Entry Criteria Not Met|1|||
156523843|NCT01191268|565011875|FG000|Overall Study|Death|0|||
156658900|NCT02130466|565496968|FG007|Overall Study|Death|2|||
156658901|NCT02130466|565496969|FG008|Overall Study|Death|3|||
156658902|NCT02130466|565496970|FG009|Overall Study|Death|4|||
156658903|NCT02130466|565496971|FG010|Overall Study|Death|5|||
156658904|NCT02130466|565496972|FG011|Overall Study|Death|3|||
156658905|NCT02130466|565496973|FG012|Overall Study|Death|11|||
156658906|NCT02130466|565496974|FG013|Overall Study|Death|7|||
156658907|NCT02130466|565496961|FG000|Overall Study|Lost to Follow-up|1|||
156658908|NCT02130466|565496962|FG001|Overall Study|Lost to Follow-up|0|||
156658909|NCT02130466|565496963|FG002|Overall Study|Lost to Follow-up|0|||
156658910|NCT02130466|565496964|FG003|Overall Study|Lost to Follow-up|0|||
156658911|NCT02130466|565496965|FG004|Overall Study|Lost to Follow-up|0|||
156658912|NCT02130466|565496966|FG005|Overall Study|Lost to Follow-up|1|||
156658913|NCT02130466|565496967|FG006|Overall Study|Lost to Follow-up|0|||
156658914|NCT02130466|565496968|FG007|Overall Study|Lost to Follow-up|0|||
156658915|NCT02130466|565496969|FG008|Overall Study|Lost to Follow-up|0|||
156658916|NCT02130466|565496970|FG009|Overall Study|Lost to Follow-up|0|||
156658917|NCT02130466|565496971|FG010|Overall Study|Lost to Follow-up|0|||
156658918|NCT02130466|565496972|FG011|Overall Study|Lost to Follow-up|0|||
156658919|NCT02130466|565496973|FG012|Overall Study|Lost to Follow-up|1|||
156658920|NCT02130466|565496974|FG013|Overall Study|Lost to Follow-up|0|||
156658921|NCT02130466|565496961|FG000|Overall Study|Physician Decision|0|||
156658922|NCT02130466|565496962|FG001|Overall Study|Physician Decision|0|||
156658923|NCT02130466|565496963|FG002|Overall Study|Physician Decision|0|||
156658924|NCT02130466|565496964|FG003|Overall Study|Physician Decision|0|||
156658925|NCT02130466|565496965|FG004|Overall Study|Physician Decision|0|||
156658926|NCT02130466|565496966|FG005|Overall Study|Physician Decision|1|||
156658927|NCT02130466|565496967|FG006|Overall Study|Physician Decision|1|||
156658928|NCT02130466|565496968|FG007|Overall Study|Physician Decision|0|||
156658929|NCT02130466|565496969|FG008|Overall Study|Physician Decision|0|||
156658930|NCT02130466|565496970|FG009|Overall Study|Physician Decision|0|||
156658931|NCT02130466|565496971|FG010|Overall Study|Physician Decision|0|||
156658932|NCT02130466|565496972|FG011|Overall Study|Physician Decision|0|||
156658933|NCT02130466|565496973|FG012|Overall Study|Physician Decision|0|||
156658934|NCT02130466|565496974|FG013|Overall Study|Physician Decision|0|||
156658935|NCT02130466|565496961|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
156658936|NCT02130466|565496962|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
156658937|NCT02130466|565496963|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
156658938|NCT02130466|565496964|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
156658939|NCT02130466|565496965|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
156658940|NCT02130466|565496966|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
156658941|NCT02130466|565496967|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
156658942|NCT02130466|565496968|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
156658943|NCT02130466|565496969|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
156658944|NCT02130466|565496970|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
156658945|NCT02130466|565496971|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
156658946|NCT02130466|565496972|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
156658947|NCT02130466|565496973|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
156658948|NCT02130466|565496974|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
156658949|NCT02130466|565496961|FG000|Overall Study|Withdrawal by Subject|1|||
156658950|NCT02130466|565496962|FG001|Overall Study|Withdrawal by Subject|0|||
156658951|NCT02130466|565496963|FG002|Overall Study|Withdrawal by Subject|0|||
156658952|NCT02130466|565496964|FG003|Overall Study|Withdrawal by Subject|0|||
156324553|NCT01172275|564287664|FG000|Overall Study|Lost to Follow-up|1|||
156324554|NCT01172275|564287665|FG001|Overall Study|Lost to Follow-up|0|||
156324555|NCT01172275|564287664|FG000|Overall Study|Protocol Violation|1|||
156324556|NCT01172275|564287665|FG001|Overall Study|Protocol Violation|0|||
156324557|NCT01227564|564287673|FG000|Overall Study|No Longer Willing to Participate|4|||
156324558|NCT01227564|564287674|FG001|Overall Study|No Longer Willing to Participate|2|||
156324559|NCT01227564|564287675|FG002|Overall Study|No Longer Willing to Participate|5|||
156324560|NCT01227564|564287673|FG000|Overall Study|Participant moved to another town|0|||
156324561|NCT01227564|564287674|FG001|Overall Study|Participant moved to another town|0|||
156324562|NCT01227564|564287675|FG002|Overall Study|Participant moved to another town|1|||
156324563|NCT04650854|564287678|FG000|Overall Study|Adverse Event|1|||
156324564|NCT04650854|564287679|FG001|Overall Study|Adverse Event|12|||
156324565|NCT04650854|564287680|FG002|Overall Study|Adverse Event|14|||
156324566|NCT04650854|564287678|FG000|Overall Study|Lack of Efficacy|1|||
156324567|NCT04650854|564287679|FG001|Overall Study|Lack of Efficacy|3|||
156658953|NCT02130466|565496965|FG004|Overall Study|Withdrawal by Subject|0|||
156324568|NCT04650854|564287680|FG002|Overall Study|Lack of Efficacy|6|||
156324569|NCT04650854|564287678|FG000|Overall Study|Lost to Follow-up|1|||
156324570|NCT04650854|564287679|FG001|Overall Study|Lost to Follow-up|1|||
156324571|NCT04650854|564287680|FG002|Overall Study|Lost to Follow-up|0|||
156324572|NCT04650854|564287678|FG000|Overall Study|Withdrawal by Subject|2|||
156324573|NCT04650854|564287679|FG001|Overall Study|Withdrawal by Subject|17|||
156324574|NCT04650854|564287680|FG002|Overall Study|Withdrawal by Subject|9|||
156658954|NCT02130466|565496966|FG005|Overall Study|Withdrawal by Subject|1|||
156658955|NCT02130466|565496967|FG006|Overall Study|Withdrawal by Subject|0|||
156324575|NCT04650854|564287678|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
156324576|NCT04650854|564287679|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
156523844|NCT01191268|565011876|FG001|Overall Study|Death|1|||
156523845|NCT01191268|565011877|FG002|Overall Study|Death|3|||
156523846|NCT01191268|565011875|FG000|Overall Study|Protocol Violation|1|||
156773919|NCT03034967|565924794|FG002|Overall Study|Protocol Violation|0|||
156773920|NCT03034967|565924795|FG003|Overall Study|Protocol Violation|0|||
156773921|NCT03034967|565924796|FG004|Overall Study|Protocol Violation|0|||
156773922|NCT03034967|565924797|FG005|Overall Study|Protocol Violation|2|||
156773923|NCT03034967|565924792|FG000|Overall Study|Lack of Efficacy|0|||
156773924|NCT03034967|565924793|FG001|Overall Study|Lack of Efficacy|1|||
156523847|NCT01191268|565011876|FG001|Overall Study|Protocol Violation|0|||
156523848|NCT01191268|565011877|FG002|Overall Study|Protocol Violation|1|||
156523849|NCT01191268|565011875|FG000|Overall Study|Sponsor Decision|0|||
156523850|NCT01191268|565011876|FG001|Overall Study|Sponsor Decision|2|||
156523851|NCT01191268|565011877|FG002|Overall Study|Sponsor Decision|0|||
156523852|NCT00336895|565011878|FG000|Overall Study|diarrhea|1|||
156523853|NCT00336895|565011878|FG000|Overall Study|nausea and upset stomach|1|||
156523854|NCT00336895|565011878|FG000|Overall Study|Physician Decision|1|||
156523855|NCT00336895|565011878|FG000|Overall Study|screen failed|1|||
156523856|NCT01959334|565011879|FG000|Second Dose|Adverse Event|1|||
156523857|NCT01959334|565011880|FG001|Second Dose|Adverse Event|0|||
156523858|NCT01959334|565011879|FG000|Third Dose|Adverse Event|0|||
156523859|NCT01959334|565011880|FG001|Third Dose|Adverse Event|1|||
156523860|NCT01313689|565011881|FG000|24-Week Randomization 1|Adverse Event|10|||
156523861|NCT01313689|565011882|FG001|24-Week Randomization 1|Adverse Event|5|||
156523862|NCT01313689|565011883|FG002|24-Week Randomization 1|Adverse Event|0|||
156523863|NCT01313689|565011884|FG003|24-Week Randomization 1|Adverse Event|0|||
156523864|NCT01313689|565011885|FG004|24-Week Randomization 1|Adverse Event|0|||
156523865|NCT01313689|565011881|FG000|24-Week Randomization 1|Physician Decision|4|||
156523866|NCT01313689|565011882|FG001|24-Week Randomization 1|Physician Decision|5|||
156523867|NCT01313689|565011883|FG002|24-Week Randomization 1|Physician Decision|0|||
156523868|NCT01313689|565011884|FG003|24-Week Randomization 1|Physician Decision|0|||
156523869|NCT01313689|565011885|FG004|24-Week Randomization 1|Physician Decision|0|||
156523870|NCT01313689|565011881|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
156523871|NCT01313689|565011882|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
156523872|NCT01313689|565011883|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
156523873|NCT01313689|565011884|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
156523874|NCT01313689|565011885|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
156773925|NCT03034967|565924794|FG002|Overall Study|Lack of Efficacy|2|||
156523875|NCT01313689|565011881|FG000|24-Week Randomization 2|Adverse Event|0|||
156523876|NCT01313689|565011882|FG001|24-Week Randomization 2|Adverse Event|0|||
156523877|NCT01313689|565011883|FG002|24-Week Randomization 2|Adverse Event|2|||
156523878|NCT01313689|565011884|FG003|24-Week Randomization 2|Adverse Event|0|||
156523879|NCT01313689|565011885|FG004|24-Week Randomization 2|Adverse Event|8|||
156523880|NCT01313689|565011881|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
156523881|NCT01313689|565011882|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
156523882|NCT01313689|565011883|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
156523883|NCT01313689|565011884|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
156523884|NCT01313689|565011885|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
156523885|NCT01313689|565011881|FG000|24-Week Randomization 2|Physician Decision|0|||
156523886|NCT01313689|565011882|FG001|24-Week Randomization 2|Physician Decision|0|||
156523887|NCT01313689|565011883|FG002|24-Week Randomization 2|Physician Decision|0|||
156523888|NCT01313689|565011884|FG003|24-Week Randomization 2|Physician Decision|0|||
156523889|NCT01313689|565011885|FG004|24-Week Randomization 2|Physician Decision|4|||
156523890|NCT01768637|565011887|FG000|Overall Study|Lost to Follow-up|2|||
156523891|NCT01768637|565011888|FG001|Overall Study|Lost to Follow-up|7|||
156523892|NCT01768637|565011887|FG000|Overall Study|Difficult blood draw|1|||
156523893|NCT01768637|565011888|FG001|Overall Study|Difficult blood draw|0|||
156523894|NCT01007448|565011889|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
156523895|NCT01007448|565011890|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
156523896|NCT01007448|565011889|FG000|Overall Study|Staph Skin Infection Flare|1|||
156523897|NCT01007448|565011890|FG001|Overall Study|Staph Skin Infection Flare|0|||
156773926|NCT03034967|565924795|FG003|Overall Study|Lack of Efficacy|1|||
156523898|NCT01007448|565011889|FG000|Overall Study|Participant Leaving the Country|1|||
156523899|NCT01007448|565011890|FG001|Overall Study|Participant Leaving the Country|0|||
156523900|NCT01007448|565011889|FG000|Overall Study|Participant Given Prohibited Medication|1|||
156523901|NCT01007448|565011890|FG001|Overall Study|Participant Given Prohibited Medication|0|||
156523902|NCT01007448|565011889|FG000|Overall Study|Progressive Disease|1|||
156523903|NCT01007448|565011890|FG001|Overall Study|Progressive Disease|2|||
156523904|NCT01007448|565011889|FG000|Overall Study|Lack of Efficacy|2|||
156523905|NCT01007448|565011890|FG001|Overall Study|Lack of Efficacy|0|||
156523906|NCT01007448|565011889|FG000|Overall Study|Withdrawal by Subject|2|||
156523907|NCT01007448|565011890|FG001|Overall Study|Withdrawal by Subject|3|||
156523908|NCT01007448|565011889|FG000|Overall Study|Adverse Event|1|||
156523909|NCT01007448|565011890|FG001|Overall Study|Adverse Event|4|||
156773927|NCT03034967|565924796|FG004|Overall Study|Lack of Efficacy|1|||
156773928|NCT03034967|565924797|FG005|Overall Study|Lack of Efficacy|0|||
156658956|NCT02130466|565496968|FG007|Overall Study|Withdrawal by Subject|0|||
156658957|NCT02130466|565496969|FG008|Overall Study|Withdrawal by Subject|1|||
156658958|NCT02130466|565496970|FG009|Overall Study|Withdrawal by Subject|0|||
156658959|NCT02130466|565496971|FG010|Overall Study|Withdrawal by Subject|0|||
156658960|NCT02130466|565496972|FG011|Overall Study|Withdrawal by Subject|0|||
156658961|NCT02130466|565496973|FG012|Overall Study|Withdrawal by Subject|0|||
156658962|NCT02130466|565496974|FG013|Overall Study|Withdrawal by Subject|0|||
156658963|NCT02518685|565496975|FG000|Overall Study|Adverse Event|29|||
156658964|NCT02518685|565496976|FG001|Overall Study|Adverse Event|1|||
156658965|NCT02518685|565496975|FG000|Overall Study|Withdrawal by Subject|10|||
156658966|NCT02518685|565496976|FG001|Overall Study|Withdrawal by Subject|3|||
156658967|NCT02518685|565496975|FG000|Overall Study|relocation, study fatigue|7|||
156428761|NCT01311713|564660914|FG004|Overall Study|Death|0|||
156428762|NCT01311713|564660915|FG005|Overall Study|Death|1|||
156428763|NCT01311713|564660916|FG006|Overall Study|Death|0|||
156428764|NCT01311713|564660910|FG000|Overall Study|Adverse Event|0|||
156428765|NCT01311713|564660911|FG001|Overall Study|Adverse Event|1|||
156428766|NCT01311713|564660912|FG002|Overall Study|Adverse Event|0|||
156428767|NCT01311713|564660913|FG003|Overall Study|Adverse Event|2|||
156428768|NCT01311713|564660914|FG004|Overall Study|Adverse Event|0|||
156428769|NCT01311713|564660915|FG005|Overall Study|Adverse Event|0|||
156428770|NCT01311713|564660916|FG006|Overall Study|Adverse Event|2|||
156428771|NCT01311713|564660910|FG000|Overall Study|Withdrawal by Subject|0|||
156428772|NCT01311713|564660911|FG001|Overall Study|Withdrawal by Subject|1|||
156428773|NCT01311713|564660912|FG002|Overall Study|Withdrawal by Subject|1|||
156428774|NCT01311713|564660913|FG003|Overall Study|Withdrawal by Subject|0|||
156428775|NCT01311713|564660914|FG004|Overall Study|Withdrawal by Subject|0|||
156428776|NCT01311713|564660915|FG005|Overall Study|Withdrawal by Subject|1|||
156428777|NCT01311713|564660916|FG006|Overall Study|Withdrawal by Subject|2|||
156428778|NCT01311713|564660910|FG000|Overall Study|Disease progression|3|||
156428779|NCT01311713|564660911|FG001|Overall Study|Disease progression|4|||
156428780|NCT01311713|564660912|FG002|Overall Study|Disease progression|3|||
156428781|NCT01311713|564660913|FG003|Overall Study|Disease progression|2|||
156428782|NCT01311713|564660914|FG004|Overall Study|Disease progression|4|||
156428783|NCT01311713|564660915|FG005|Overall Study|Disease progression|4|||
156428784|NCT01311713|564660916|FG006|Overall Study|Disease progression|5|||
156428785|NCT01311713|564660910|FG000|Overall Study|Lost to Follow-up|0|||
156428786|NCT01311713|564660911|FG001|Overall Study|Lost to Follow-up|0|||
156428787|NCT01311713|564660912|FG002|Overall Study|Lost to Follow-up|1|||
156428788|NCT01311713|564660913|FG003|Overall Study|Lost to Follow-up|0|||
156428789|NCT01311713|564660914|FG004|Overall Study|Lost to Follow-up|0|||
156428790|NCT01311713|564660915|FG005|Overall Study|Lost to Follow-up|0|||
156428791|NCT01311713|564660916|FG006|Overall Study|Lost to Follow-up|0|||
156428792|NCT01311713|564660910|FG000|Overall Study|Stopped taking study medication|0|||
156428793|NCT01311713|564660911|FG001|Overall Study|Stopped taking study medication|0|||
156428794|NCT01311713|564660912|FG002|Overall Study|Stopped taking study medication|0|||
156428795|NCT01311713|564660913|FG003|Overall Study|Stopped taking study medication|1|||
156428796|NCT01311713|564660914|FG004|Overall Study|Stopped taking study medication|1|||
156428797|NCT01311713|564660915|FG005|Overall Study|Stopped taking study medication|0|||
156428798|NCT01311713|564660916|FG006|Overall Study|Stopped taking study medication|0|||
156428799|NCT01311713|564660910|FG000|Overall Study|Enrolled but not treated|0|||
156428800|NCT01311713|564660911|FG001|Overall Study|Enrolled but not treated|0|||
156428801|NCT01311713|564660912|FG002|Overall Study|Enrolled but not treated|1|||
156428802|NCT01311713|564660913|FG003|Overall Study|Enrolled but not treated|0|||
156428803|NCT01311713|564660914|FG004|Overall Study|Enrolled but not treated|0|||
156658968|NCT02518685|565496976|FG001|Overall Study|relocation, study fatigue|2|||
156658969|NCT02518685|565496975|FG000|Overall Study|Pregnancy|1|||
156658970|NCT02518685|565496976|FG001|Overall Study|Pregnancy|0|||
156428804|NCT01311713|564660915|FG005|Overall Study|Enrolled but not treated|0|||
156428805|NCT01311713|564660916|FG006|Overall Study|Enrolled but not treated|0|||
156428806|NCT01311713|564660910|FG000|Overall Study|Other than specified|0|||
156428807|NCT01311713|564660911|FG001|Overall Study|Other than specified|1|||
156428808|NCT01311713|564660912|FG002|Overall Study|Other than specified|2|||
156428809|NCT01311713|564660913|FG003|Overall Study|Other than specified|0|||
156428810|NCT01311713|564660914|FG004|Overall Study|Other than specified|0|||
156428811|NCT01311713|564660915|FG005|Overall Study|Other than specified|0|||
156428812|NCT01311713|564660916|FG006|Overall Study|Other than specified|0|||
156428813|NCT00980538|564660919|FG000|Overall Study|Lost to Follow-up|20|||
156428814|NCT00980538|564660919|FG000|Overall Study|Sponsor's Decision|4|||
156428815|NCT00980538|564660919|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
156428816|NCT00980538|564660919|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
156428817|NCT00980538|564660919|FG000|Overall Study|Switch to Commercially Available Medication|25|||
156428818|NCT00980538|564660919|FG000|Overall Study|Participant Non-Compliant|9|||
156428819|NCT00980538|564660919|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
156523910|NCT01054170|565011891|FG000|Overall Study|Protocol Violation|1|||
156658971|NCT02518685|565496975|FG000|Overall Study|Physician Decision|1|||
156658972|NCT02518685|565496976|FG001|Overall Study|Physician Decision|0|||
156658973|NCT02518685|565496975|FG000|Overall Study|Lost to Follow-up|1|||
156658974|NCT02518685|565496976|FG001|Overall Study|Lost to Follow-up|4|||
156658975|NCT00922779|565496977|FG000|Overall Study|Adverse Event|67|||
156658976|NCT00922779|565496977|FG000|Overall Study|Pregnancy|7|||
156658977|NCT00922779|565496977|FG000|Overall Study|Withdrawal by Subject|308|||
156658978|NCT00922779|565496977|FG000|Overall Study|Lost to Follow-up|44|||
156658979|NCT00922779|565496977|FG000|Overall Study|Other|27|||
156658980|NCT00922779|565496977|FG000|Overall Study|Missing|1874|||
156658981|NCT01922349|565496978|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
156658982|NCT01922349|565496979|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
156658983|NCT01922349|565496980|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
156658984|NCT01922349|565496981|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
156658985|NCT05109234|565496982|FG000|Overall Study|Adverse Event|2|||
156658986|NCT05109234|565496983|FG001|Overall Study|Adverse Event|2|||
156658987|NCT05109234|565496982|FG000|Overall Study|Lack of Efficacy|5|||
156658988|NCT05109234|565496983|FG001|Overall Study|Lack of Efficacy|0|||
156658989|NCT05109234|565496982|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
156658990|NCT05109234|565496983|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
156658991|NCT05109234|565496982|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
156658992|NCT05109234|565496983|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
156658993|NCT05109234|565496982|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
156658994|NCT05109234|565496983|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
156658995|NCT05109234|565496982|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
156658996|NCT05109234|565496983|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
156658997|NCT00993616|565496984|FG000|Overall Study|No tumor at entry|1|||
156658998|NCT00993616|565496984|FG000|Overall Study|Never treated|1|||
156658999|NCT00336024|565496986|FG000|Overall Study|Death|2|||
156659000|NCT00336024|565496987|FG001|Overall Study|Death|1|||
156659001|NCT00336024|565496986|FG000|Overall Study|Physician Decision|4|||
156659002|NCT00336024|565496987|FG001|Overall Study|Physician Decision|1|||
156659003|NCT00336024|565496986|FG000|Overall Study|Protocol Violation|1|||
156659004|NCT00336024|565496987|FG001|Overall Study|Protocol Violation|0|||
156659005|NCT00336024|565496986|FG000|Overall Study|Withdrawal by Subject|1|||
156659006|NCT00336024|565496987|FG001|Overall Study|Withdrawal by Subject|2|||
156659007|NCT00336024|565496986|FG000|Overall Study|Failure to fulfill consolidation|1|||
156659008|NCT00336024|565496987|FG001|Overall Study|Failure to fulfill consolidation|1|||
156659009|NCT00336024|565496986|FG000|Overall Study|Progressive Disease|4|||
156659010|NCT00336024|565496987|FG001|Overall Study|Progressive Disease|7|||
156659011|NCT00336024|565496986|FG000|Overall Study|Ineligible|7|||
156659012|NCT00336024|565496987|FG001|Overall Study|Ineligible|7|||
156659013|NCT05067504|565496988|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
156659014|NCT05067504|565496989|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
156659015|NCT05067504|565496988|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
156659016|NCT05067504|565496989|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
156659017|NCT05067504|565496988|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
156659018|NCT05067504|565496989|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
156659019|NCT05771428|565499128|FG000|Overall Study|Adverse Event|0|||
156659020|NCT05771428|565499129|FG001|Overall Study|Adverse Event|1|||
156659021|NCT05771428|565499130|FG002|Overall Study|Adverse Event|1|||
156659022|NCT05771428|565499131|FG003|Overall Study|Adverse Event|1|||
156659023|NCT05771428|565499128|FG000|Overall Study|Withdrawal by Subject|3|||
156659024|NCT05771428|565499129|FG001|Overall Study|Withdrawal by Subject|2|||
156659025|NCT05771428|565499130|FG002|Overall Study|Withdrawal by Subject|1|||
156659026|NCT05771428|565499131|FG003|Overall Study|Withdrawal by Subject|4|||
156659027|NCT05771428|565499128|FG000|Overall Study|Other|0|||
156659028|NCT05771428|565499129|FG001|Overall Study|Other|1|||
156659029|NCT05771428|565499130|FG002|Overall Study|Other|2|||
156324577|NCT04650854|564287680|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
156659030|NCT05771428|565499131|FG003|Overall Study|Other|1|||
156324578|NCT04650854|564287678|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
156324579|NCT04650854|564287679|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
156324580|NCT04650854|564287680|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
156324581|NCT04650854|564287678|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
156523911|NCT01054170|565011892|FG001|Overall Study|Protocol Violation|0|||
156659031|NCT05771428|565499128|FG000|Overall Study|Randomized but Not Treated|0|||
156659032|NCT05771428|565499129|FG001|Overall Study|Randomized but Not Treated|0|||
156659033|NCT05771428|565499130|FG002|Overall Study|Randomized but Not Treated|1|||
156659034|NCT05771428|565499131|FG003|Overall Study|Randomized but Not Treated|0|||
156659035|NCT01210001|565499132|FG000|Overall Study|Not treated|1|||
156659036|NCT01210001|565499133|FG001|Overall Study|Not treated|0|||
156659037|NCT01210001|565499134|FG002|Overall Study|Not treated|0|||
156659038|NCT01210001|565499132|FG000|Overall Study|Adverse Event|4|||
156659039|NCT01210001|565499133|FG001|Overall Study|Adverse Event|2|||
156659040|NCT01210001|565499134|FG002|Overall Study|Adverse Event|5|||
156659041|NCT01210001|565499132|FG000|Overall Study|Non compliant with protocol|2|||
156659042|NCT01210001|565499133|FG001|Overall Study|Non compliant with protocol|2|||
156659043|NCT01210001|565499134|FG002|Overall Study|Non compliant with protocol|3|||
156659044|NCT01210001|565499132|FG000|Overall Study|Lost to Follow-up|4|||
156659045|NCT01210001|565499133|FG001|Overall Study|Lost to Follow-up|3|||
156659046|NCT01210001|565499134|FG002|Overall Study|Lost to Follow-up|2|||
156659047|NCT01210001|565499132|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
156659048|NCT01210001|565499133|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
156659049|NCT01210001|565499134|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
156659050|NCT01210001|565499132|FG000|Overall Study|Other reason not defined above|2|||
156659051|NCT01210001|565499133|FG001|Overall Study|Other reason not defined above|2|||
156659052|NCT01210001|565499134|FG002|Overall Study|Other reason not defined above|1|||
156659053|NCT02684344|565499137|FG000|Overall Study|Withdrawal by Subject|0|||
156659054|NCT02684344|565499138|FG001|Overall Study|Withdrawal by Subject|1|||
156659055|NCT01451762|565499139|FG000|Overall Study|Lost to Follow-up|3|||
156659056|NCT01451762|565499140|FG001|Overall Study|Lost to Follow-up|6|||
156659057|NCT01451762|565499141|FG002|Overall Study|Lost to Follow-up|6|||
156523912|NCT01054170|565011891|FG000|Overall Study|Withdrawal by Subject|3|||
156523913|NCT01054170|565011892|FG001|Overall Study|Withdrawal by Subject|2|||
156523914|NCT01054170|565011891|FG000|Overall Study|Adverse Event|0|||
156523915|NCT01054170|565011892|FG001|Overall Study|Adverse Event|4|||
156523916|NCT02751320|565011893|FG000|Overall Study|Adverse Event|2|||
156523917|NCT02751320|565011893|FG000|Overall Study|Withdrawal by Subject|1|||
156523918|NCT01337115|565011897|FG000|Overall Study|Protocol Violation|2|||
156523919|NCT01337115|565011898|FG001|Overall Study|Protocol Violation|0|||
156523920|NCT03426267|565011905|FG000|Overall Study|Physician Decision|1|||
156523921|NCT03426267|565011906|FG001|Overall Study|Physician Decision|4|||
156523922|NCT03426267|565011905|FG000|Overall Study|Lost to Follow-up|1|||
156523923|NCT03426267|565011906|FG001|Overall Study|Lost to Follow-up|0|||
156523924|NCT03426267|565011905|FG000|Overall Study|Withdrawal by Subject|4|||
156523925|NCT03426267|565011906|FG001|Overall Study|Withdrawal by Subject|10|||
156523926|NCT03426267|565011905|FG000|Overall Study|Protocol Violation|1|||
156523927|NCT03426267|565011906|FG001|Overall Study|Protocol Violation|3|||
156523928|NCT03426267|565011905|FG000|Overall Study|Adverse Event|9|||
156523929|NCT03426267|565011906|FG001|Overall Study|Adverse Event|27|||
156523930|NCT03426267|565011905|FG000|Overall Study|Prohibited Treatment Intake|2|||
156523931|NCT03426267|565011906|FG001|Overall Study|Prohibited Treatment Intake|3|||
156523932|NCT03426267|565011905|FG000|Overall Study|Lack of Efficacy|0|||
156523933|NCT03426267|565011906|FG001|Overall Study|Lack of Efficacy|25|||
156523934|NCT03426267|565011905|FG000|Overall Study|other|3|||
156523935|NCT03426267|565011906|FG001|Overall Study|other|0|||
156523936|NCT03801915|565011912|FG000|Overall Study|Screen failure|0|||
156523937|NCT03801915|565011913|FG001|Overall Study|Screen failure|0|||
156523938|NCT03801915|565011914|FG002|Overall Study|Screen failure|1|||
156523939|NCT03801915|565011912|FG000|Overall Study|Ineligible|1|||
156523940|NCT03801915|565011913|FG001|Overall Study|Ineligible|0|||
156523941|NCT03801915|565011914|FG002|Overall Study|Ineligible|0|||
156523942|NCT03801915|565011912|FG000|Overall Study|Physician Decision|2|||
156523943|NCT03801915|565011913|FG001|Overall Study|Physician Decision|1|||
156523944|NCT03801915|565011914|FG002|Overall Study|Physician Decision|0|||
156523945|NCT02308020|565011915|FG000|Overall Study|Lost to Follow-up|1|||
156523946|NCT02308020|565011916|FG001|Overall Study|Lost to Follow-up|7|||
156523947|NCT02308020|565011917|FG002|Overall Study|Lost to Follow-up|0|||
156523948|NCT02308020|565011918|FG003|Overall Study|Lost to Follow-up|0|||
156523949|NCT02308020|565011919|FG004|Overall Study|Lost to Follow-up|1|||
156523950|NCT02308020|565011920|FG005|Overall Study|Lost to Follow-up|2|||
156523951|NCT02308020|565011915|FG000|Overall Study|Sponsor Decision|0|||
156523952|NCT02308020|565011916|FG001|Overall Study|Sponsor Decision|8|||
156659058|NCT00630305|565499142|FG000|Overall Study|Withdrawal by Subject|1|||
156659059|NCT00630305|565499142|FG000|Overall Study|Inability to insert contact lens|1|||
156659060|NCT01085045|565499143|FG000|Part A|Withdrawal by Subject|4|||
156659061|NCT01085045|565499143|FG000|Part A|Adverse Event|6|||
156659062|NCT01085045|565499143|FG000|Part A|Protocol Violation|1|||
156659063|NCT01085045|565499143|FG000|Part A|Protocol Specified Criteria|7|||
156659064|NCT01085045|565499143|FG000|Part B|Withdrawal by Subject|2|||
156659065|NCT01085045|565499143|FG000|Part B|Protocol Specified Criteria|6|||
156523953|NCT02308020|565011917|FG002|Overall Study|Sponsor Decision|0|||
156523954|NCT02308020|565011918|FG003|Overall Study|Sponsor Decision|2|||
156523955|NCT02308020|565011919|FG004|Overall Study|Sponsor Decision|2|||
156523956|NCT02308020|565011920|FG005|Overall Study|Sponsor Decision|1|||
156523957|NCT02308020|565011915|FG000|Overall Study|Withdrawal by Subject|3|||
156659066|NCT01085045|565499143|FG000|Part B|Lost to Follow-up|1|||
156659067|NCT01085045|565499143|FG000|Part B|Adverse Event|6|||
156659068|NCT01494506|565499144|FG000|Overall Study|Lack of Efficacy|77|||
156523958|NCT02308020|565011916|FG001|Overall Study|Withdrawal by Subject|5|||
156523959|NCT02308020|565011917|FG002|Overall Study|Withdrawal by Subject|3|||
156523960|NCT02308020|565011918|FG003|Overall Study|Withdrawal by Subject|2|||
156659069|NCT01494506|565499145|FG001|Overall Study|Lack of Efficacy|83|||
156659070|NCT01494506|565499146|FG002|Overall Study|Lack of Efficacy|57|||
156659071|NCT01494506|565499144|FG000|Overall Study|Adverse Event|17|||
156773929|NCT03034967|565924792|FG000|Overall Study|Adverse Event, non-fatal|3|||
156773930|NCT03034967|565924793|FG001|Overall Study|Adverse Event, non-fatal|1|||
156659072|NCT01494506|565499145|FG001|Overall Study|Adverse Event|10|||
156773931|NCT03034967|565924794|FG002|Overall Study|Adverse Event, non-fatal|2|||
156773932|NCT03034967|565924795|FG003|Overall Study|Adverse Event, non-fatal|0|||
156773933|NCT03034967|565924796|FG004|Overall Study|Adverse Event, non-fatal|2|||
156773934|NCT03034967|565924797|FG005|Overall Study|Adverse Event, non-fatal|8|||
156773935|NCT03034967|565924792|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
156773936|NCT03034967|565924793|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
156773937|NCT03034967|565924794|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
156773938|NCT03034967|565924795|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
156773939|NCT03034967|565924796|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
156773940|NCT03034967|565924797|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
156773941|NCT03806296|565924798|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
156773942|NCT03806296|565924799|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
156773943|NCT03806296|565924800|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
156773944|NCT03806296|565924798|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
156773945|NCT03806296|565924799|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
156773946|NCT03806296|565924800|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
156773947|NCT03806296|565924798|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
156773948|NCT03806296|565924799|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
156773949|NCT03806296|565924800|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
156773950|NCT00879658|565924803|FG000|Overall Study|Abnormal laboratory value(s)|3|||
156773951|NCT00879658|565924804|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156773952|NCT00879658|565924805|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156773953|NCT00879658|565924806|FG003|Overall Study|Abnormal laboratory value(s)|1|||
156773954|NCT00879658|565924807|FG004|Overall Study|Abnormal laboratory value(s)|0|||
156773955|NCT00879658|565924808|FG005|Overall Study|Abnormal laboratory value(s)|0|||
156773956|NCT00879658|565924809|FG006|Overall Study|Abnormal laboratory value(s)|0|||
156773957|NCT00879658|565924803|FG000|Overall Study|Administrative problems|2|||
156773958|NCT00879658|565924804|FG001|Overall Study|Administrative problems|1|||
156773959|NCT00879658|565924805|FG002|Overall Study|Administrative problems|0|||
156773960|NCT00879658|565924806|FG003|Overall Study|Administrative problems|1|||
156773961|NCT00879658|565924807|FG004|Overall Study|Administrative problems|0|||
156773962|NCT00879658|565924808|FG005|Overall Study|Administrative problems|0|||
156773963|NCT00879658|565924809|FG006|Overall Study|Administrative problems|0|||
156773964|NCT00879658|565924803|FG000|Overall Study|Adverse Event|6|||
156773965|NCT00879658|565924804|FG001|Overall Study|Adverse Event|4|||
156773966|NCT00879658|565924805|FG002|Overall Study|Adverse Event|3|||
156773967|NCT00879658|565924806|FG003|Overall Study|Adverse Event|1|||
156773968|NCT00879658|565924807|FG004|Overall Study|Adverse Event|2|||
156773969|NCT00879658|565924808|FG005|Overall Study|Adverse Event|0|||
156773970|NCT00879658|565924809|FG006|Overall Study|Adverse Event|0|||
156773971|NCT00879658|565924803|FG000|Overall Study|Protocol Violation|1|||
156773972|NCT00879658|565924804|FG001|Overall Study|Protocol Violation|0|||
156773973|NCT00879658|565924805|FG002|Overall Study|Protocol Violation|0|||
156773974|NCT00879658|565924806|FG003|Overall Study|Protocol Violation|0|||
156773975|NCT00879658|565924807|FG004|Overall Study|Protocol Violation|0|||
156324582|NCT04650854|564287679|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
156324583|NCT04650854|564287680|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
156324584|NCT04650854|564287678|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
156324585|NCT04650854|564287679|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
156324586|NCT04650854|564287680|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
156324587|NCT04650854|564287678|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
156324588|NCT04650854|564287679|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
156659073|NCT01494506|565499146|FG002|Overall Study|Adverse Event|11|||
156659074|NCT01494506|565499144|FG000|Overall Study|Death|9|||
156659075|NCT01494506|565499145|FG001|Overall Study|Death|5|||
156659076|NCT01494506|565499146|FG002|Overall Study|Death|2|||
156659077|NCT01494506|565499144|FG000|Overall Study|Physician Decision|7|||
156659078|NCT01494506|565499145|FG001|Overall Study|Physician Decision|5|||
156324589|NCT04650854|564287680|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
156428820|NCT00980538|564660919|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
156659079|NCT01494506|565499146|FG002|Overall Study|Physician Decision|4|||
156773976|NCT00879658|565924808|FG005|Overall Study|Protocol Violation|0|||
156773977|NCT00879658|565924809|FG006|Overall Study|Protocol Violation|0|||
156773978|NCT00879658|565924803|FG000|Overall Study|Withdrawal by Subject|3|||
156773979|NCT00879658|565924804|FG001|Overall Study|Withdrawal by Subject|0|||
156773980|NCT00879658|565924805|FG002|Overall Study|Withdrawal by Subject|2|||
156773981|NCT00879658|565924806|FG003|Overall Study|Withdrawal by Subject|0|||
156773982|NCT00879658|565924807|FG004|Overall Study|Withdrawal by Subject|0|||
156773983|NCT00879658|565924808|FG005|Overall Study|Withdrawal by Subject|1|||
156659080|NCT01494506|565499144|FG000|Overall Study|Withdrawal by Subject|17|||
156659081|NCT01494506|565499145|FG001|Overall Study|Withdrawal by Subject|20|||
156659082|NCT01494506|565499146|FG002|Overall Study|Withdrawal by Subject|14|||
156659083|NCT01494506|565499144|FG000|Overall Study|Clinical Deterioration|21|||
156659084|NCT01494506|565499145|FG001|Overall Study|Clinical Deterioration|17|||
156659085|NCT01494506|565499146|FG002|Overall Study|Clinical Deterioration|13|||
156659086|NCT01494506|565499144|FG000|Overall Study|Sponsor Decision|0|||
156659087|NCT01494506|565499145|FG001|Overall Study|Sponsor Decision|0|||
156659088|NCT01494506|565499146|FG002|Overall Study|Sponsor Decision|1|||
156659089|NCT01494506|565499144|FG000|Overall Study|Other|0|||
156659090|NCT01494506|565499145|FG001|Overall Study|Other|3|||
156659091|NCT01494506|565499146|FG002|Overall Study|Other|1|||
156659092|NCT02924038|565499147|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
156659093|NCT02924038|565499148|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
156659094|NCT02777528|565499152|FG000|Overall Study|Still in study|24|||
156659095|NCT02777528|565499153|FG001|Overall Study|Still in study|10|||
156659096|NCT02777528|565499154|FG002|Overall Study|Still in study|1|||
156659097|NCT02777528|565499152|FG000|Overall Study|Study Device Explanted|1|||
156659098|NCT02777528|565499153|FG001|Overall Study|Study Device Explanted|0|||
156659099|NCT02777528|565499154|FG002|Overall Study|Study Device Explanted|0|||
156659100|NCT02777528|565499152|FG000|Overall Study|Death|14|||
156659101|NCT02777528|565499153|FG001|Overall Study|Death|7|||
156659102|NCT02777528|565499154|FG002|Overall Study|Death|1|||
156659103|NCT02777528|565499152|FG000|Overall Study|Withdrawal by Subject|2|||
156659104|NCT02777528|565499153|FG001|Overall Study|Withdrawal by Subject|2|||
156659105|NCT02777528|565499154|FG002|Overall Study|Withdrawal by Subject|1|||
156659106|NCT02777528|565499152|FG000|Overall Study|Physician Decision|2|||
156659107|NCT02777528|565499153|FG001|Overall Study|Physician Decision|1|||
156659108|NCT02777528|565499154|FG002|Overall Study|Physician Decision|0|||
156773984|NCT00879658|565924809|FG006|Overall Study|Withdrawal by Subject|0|||
156773985|NCT00879658|565924803|FG000|Overall Study|Lack of Efficacy|0|||
156659109|NCT02777528|565499152|FG000|Overall Study|Lost to Follow-up|2|||
156659110|NCT02777528|565499153|FG001|Overall Study|Lost to Follow-up|0|||
156659111|NCT02777528|565499154|FG002|Overall Study|Lost to Follow-up|0|||
156659112|NCT02777528|565499152|FG000|Overall Study|Discontinued due to Other|1|||
156659113|NCT02777528|565499153|FG001|Overall Study|Discontinued due to Other|0|||
156659114|NCT02777528|565499154|FG002|Overall Study|Discontinued due to Other|0|||
156659115|NCT00453362|565499155|FG000|Overall Study|Adverse Event|5|||
156659116|NCT00453362|565499155|FG000|Overall Study|Death|7|||
156659117|NCT00453362|565499155|FG000|Overall Study|Physician Decision|2|||
156659118|NCT00453362|565499155|FG000|Overall Study|Withdrawal by Subject|3|||
156659119|NCT00453362|565499155|FG000|Overall Study|Progression of disease|56|||
156659120|NCT00453362|565499155|FG000|Overall Study|Screening Failure|14|||
156659121|NCT02127281|565499156|FG000|Overall Study|Lost to Follow-up|1|||
156659122|NCT02127281|565499157|FG001|Overall Study|Lost to Follow-up|0|||
156659123|NCT04885296|565499158|FG000|Period 1|Covid-19 Related|1|||
156659124|NCT04885296|565499159|FG001|Period 1|Covid-19 Related|0|||
156659125|NCT04885296|565499158|FG000|Period 1|Adverse Event|0|||
156659126|NCT04885296|565499159|FG001|Period 1|Adverse Event|1|||
156659127|NCT04885296|565499158|FG000|Period 1|Withdrawal by Subject|1|||
156659128|NCT04885296|565499159|FG001|Period 1|Withdrawal by Subject|1|||
156659129|NCT04885296|565499158|FG000|Period 1|Test Article No Longer Available|1|||
156659130|NCT04885296|565499159|FG001|Period 1|Test Article No Longer Available|0|||
156659131|NCT04885296|565499158|FG000|Period 1|Dispensed Study lens in Error|1|||
156659132|NCT04885296|565499159|FG001|Period 1|Dispensed Study lens in Error|0|||
156659133|NCT04885296|565499158|FG000|Period 1|Lost to Follow-up|1|||
156659134|NCT04885296|565499159|FG001|Period 1|Lost to Follow-up|0|||
156659135|NCT04885296|565499158|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
156659136|NCT04885296|565499159|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
156659137|NCT00433147|565499160|FG000|Overall Study|Adverse Event|0|||
156659138|NCT00433147|565499161|FG001|Overall Study|Adverse Event|1|||
156659139|NCT00433147|565499162|FG002|Overall Study|Adverse Event|0|||
156659140|NCT00433147|565499163|FG003|Overall Study|Adverse Event|0|||
156659141|NCT01882647|565499164|FG000|Overall Study|Lost to Follow-up|2|||
156659142|NCT01882647|565499165|FG001|Overall Study|Lost to Follow-up|2|||
156659143|NCT01882647|565499164|FG000|Overall Study|Withdrawal by Subject|0|||
156659144|NCT01882647|565499165|FG001|Overall Study|Withdrawal by Subject|4|||
156659145|NCT03601637|565499166|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
156659146|NCT03601637|565499167|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
156659147|NCT03601637|565499166|FG000|Overall Study|Adverse Event|1|||
156659148|NCT03601637|565499167|FG001|Overall Study|Adverse Event|1|||
156659149|NCT03601637|565499166|FG000|Overall Study|Other|0|||
156773986|NCT00879658|565924804|FG001|Overall Study|Lack of Efficacy|0|||
156428821|NCT00980538|564660919|FG000|Overall Study|Other|60|||
156428822|NCT00980538|564660919|FG000|Overall Study|Other|1|||
156428823|NCT03878446|564660920|FG000|Overall Study|Withdrawn by parent or guardian|1|||
156428824|NCT03878446|564660921|FG001|Overall Study|Withdrawn by parent or guardian|0|||
156428825|NCT03878446|564660922|FG002|Overall Study|Withdrawn by parent or guardian|0|||
156659150|NCT03601637|565499167|FG001|Overall Study|Other|1|||
156659151|NCT00376220|565499171|FG000|Overall Study|Lost to Follow-up|7|||
156659152|NCT00376220|565499172|FG001|Overall Study|Lost to Follow-up|10|||
156659153|NCT00376220|565499171|FG000|Overall Study|Withdrawal by Subject|3|||
156659154|NCT00376220|565499172|FG001|Overall Study|Withdrawal by Subject|2|||
156659155|NCT02564263|565499173|FG000|Overall Study|Adverse Event|31|||
156659156|NCT02564263|565499174|FG001|Overall Study|Adverse Event|29|||
156659157|NCT02564263|565499173|FG000|Overall Study|Death|270|||
156659158|NCT02564263|565499174|FG001|Overall Study|Death|262|||
156659159|NCT02564263|565499173|FG000|Overall Study|Withdrawal by Subject|4|||
156659160|NCT02564263|565499174|FG001|Overall Study|Withdrawal by Subject|19|||
156659161|NCT02564263|565499173|FG000|Overall Study|Sponsor's decision|9|||
156659162|NCT02564263|565499174|FG001|Overall Study|Sponsor's decision|4|||
156659163|NCT02906709|565499175|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
156659164|NCT02906709|565499176|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
156659165|NCT02906709|565499175|FG000|Phase A (Week 0 to Week 16)|Death|0|||
156659166|NCT02906709|565499176|FG001|Phase A (Week 0 to Week 16)|Death|1|||
156659167|NCT02906709|565499175|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
156659168|NCT02906709|565499176|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
156659169|NCT02906709|565499175|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
156659170|NCT02906709|565499176|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
156659171|NCT00920140|565499177|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
156659172|NCT00920140|565499178|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
156659173|NCT00920140|565499179|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
156659174|NCT00920140|565499180|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
156659175|NCT00920140|565499181|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
156659176|NCT00920140|565499177|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
156659177|NCT00920140|565499178|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
156659178|NCT00920140|565499179|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
156659179|NCT00920140|565499180|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
156659180|NCT00920140|565499181|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
156659181|NCT00920140|565499177|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156659182|NCT00920140|565499178|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
156659183|NCT00920140|565499179|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156659184|NCT00920140|565499180|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156659185|NCT00920140|565499181|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156659186|NCT00920140|565499177|FG000|Phase 2|Adverse Event|0|||
156659187|NCT00920140|565499178|FG001|Phase 2|Adverse Event|0|||
156659188|NCT00920140|565499179|FG002|Phase 2|Adverse Event|14|||
156659189|NCT00920140|565499180|FG003|Phase 2|Adverse Event|2|||
156659190|NCT00920140|565499181|FG004|Phase 2|Adverse Event|3|||
156659191|NCT00920140|565499177|FG000|Phase 2|Lack of Efficacy|0|||
156659192|NCT00920140|565499178|FG001|Phase 2|Lack of Efficacy|0|||
156659193|NCT00920140|565499179|FG002|Phase 2|Lack of Efficacy|29|||
156659194|NCT00920140|565499180|FG003|Phase 2|Lack of Efficacy|14|||
156659195|NCT00920140|565499181|FG004|Phase 2|Lack of Efficacy|5|||
156659196|NCT00920140|565499177|FG000|Phase 2|Lost to Follow-up|0|||
156659197|NCT00920140|565499178|FG001|Phase 2|Lost to Follow-up|0|||
156659198|NCT00920140|565499179|FG002|Phase 2|Lost to Follow-up|0|||
156659199|NCT00920140|565499180|FG003|Phase 2|Lost to Follow-up|1|||
156659200|NCT00920140|565499181|FG004|Phase 2|Lost to Follow-up|0|||
156659201|NCT00920140|565499177|FG000|Phase 2|Physician Decision|0|||
156659202|NCT00920140|565499178|FG001|Phase 2|Physician Decision|0|||
156659203|NCT00920140|565499179|FG002|Phase 2|Physician Decision|3|||
156659204|NCT00920140|565499180|FG003|Phase 2|Physician Decision|3|||
156659205|NCT00920140|565499181|FG004|Phase 2|Physician Decision|2|||
156659206|NCT00920140|565499177|FG000|Phase 2|Withdrawal by Subject|0|||
156659207|NCT00920140|565499178|FG001|Phase 2|Withdrawal by Subject|0|||
156659208|NCT00920140|565499179|FG002|Phase 2|Withdrawal by Subject|4|||
156659209|NCT00920140|565499180|FG003|Phase 2|Withdrawal by Subject|2|||
156659210|NCT00920140|565499181|FG004|Phase 2|Withdrawal by Subject|1|||
156428826|NCT03878446|564660923|FG003|Overall Study|Withdrawn by parent or guardian|0|||
156428827|NCT03878446|564660924|FG004|Overall Study|Withdrawn by parent or guardian|0|||
156428828|NCT04618471|564661834|FG000|Overall Study|Screen Failure|62|||
156428829|NCT04618471|564661834|FG000|Overall Study|Withdrawal by Subject|6|||
156659211|NCT01124149|565499182|FG000|Acute Phase|Withdrawal by Subject|22|||
156659212|NCT01124149|565499182|FG000|Acute Phase|Adverse Event|21|||
156659213|NCT01124149|565499182|FG000|Acute Phase|Lack of Efficacy|17|||
156659214|NCT01124149|565499182|FG000|Acute Phase|Protocol Violation|14|||
156659215|NCT01124149|565499182|FG000|Acute Phase|Lost to Follow-up|2|||
156659216|NCT01124149|565499182|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
156659217|NCT01124149|565499182|FG000|Acute Phase|Sponsor request|1|||
156659218|NCT01124149|565499182|FG000|Acute Phase|UC symptoms not ameliorated|1|||
156659219|NCT01124149|565499182|FG000|Acute Phase|Non-compliance|1|||
156659220|NCT01124149|565499182|FG000|Acute Phase|Low hemoglobin|1|||
156659221|NCT01124149|565499182|FG000|Acute Phase|Travelling to another country|1|||
156659222|NCT01124149|565499182|FG000|Acute Phase|Sponsor decision|1|||
156428830|NCT04618471|564661834|FG000|Overall Study|Physician Decision|2|||
156428831|NCT04618471|564661834|FG000|Overall Study|Lost to Follow-up|1|||
156773987|NCT00879658|565924805|FG002|Overall Study|Lack of Efficacy|2|||
156773988|NCT00879658|565924806|FG003|Overall Study|Lack of Efficacy|0|||
156773989|NCT00879658|565924807|FG004|Overall Study|Lack of Efficacy|0|||
156324590|NCT04650854|564287678|FG000|Overall Study|Use of Rescue Medication|0|||
156324591|NCT04650854|564287679|FG001|Overall Study|Use of Rescue Medication|0|||
156324592|NCT04650854|564287680|FG002|Overall Study|Use of Rescue Medication|1|||
156324593|NCT04650854|564287678|FG000|Overall Study|Last Treatment Per Sponsor|0|||
156324594|NCT04650854|564287679|FG001|Overall Study|Last Treatment Per Sponsor|0|||
156324595|NCT04650854|564287680|FG002|Overall Study|Last Treatment Per Sponsor|2|||
156324596|NCT04650854|564287678|FG000|Overall Study|Rescue Medication|0|||
156324597|NCT04650854|564287679|FG001|Overall Study|Rescue Medication|0|||
156324598|NCT04650854|564287680|FG002|Overall Study|Rescue Medication|1|||
156324599|NCT04650854|564287678|FG000|Overall Study|Participant Want to Start a Family|0|||
156523961|NCT02308020|565011919|FG004|Overall Study|Withdrawal by Subject|1|||
156523962|NCT02308020|565011920|FG005|Overall Study|Withdrawal by Subject|2|||
156523963|NCT01211288|565011921|FG000|Overall Study|Lost to Follow-up|1|||
156523964|NCT01211288|565011922|FG001|Overall Study|Lost to Follow-up|1|||
156523965|NCT01270971|565011923|FG000|Overall Study|Withdrawal by Subject|24|||
156523966|NCT01270971|565011924|FG001|Overall Study|Withdrawal by Subject|11|||
156523967|NCT01270971|565011923|FG000|Overall Study|Lost to Follow-up|18|||
156523968|NCT01270971|565011924|FG001|Overall Study|Lost to Follow-up|5|||
156523969|NCT01270971|565011923|FG000|Overall Study|Adverse Event|1|||
156523970|NCT01270971|565011924|FG001|Overall Study|Adverse Event|2|||
156523971|NCT01270971|565011923|FG000|Overall Study|Non compliance|2|||
156523972|NCT01270971|565011924|FG001|Overall Study|Non compliance|2|||
156523973|NCT01270971|565011923|FG000|Overall Study|Non-specific|7|||
156523974|NCT01270971|565011924|FG001|Overall Study|Non-specific|3|||
156523975|NCT03333837|565011926|FG000|Overall Study|Adverse Event|2|||
156523976|NCT03333837|565011927|FG001|Overall Study|Adverse Event|1|||
156523977|NCT03333837|565011928|FG002|Overall Study|Adverse Event|1|||
156523978|NCT03333837|565011929|FG003|Overall Study|Adverse Event|1|||
156523979|NCT03333837|565011930|FG004|Overall Study|Adverse Event|0|||
156523980|NCT03333837|565011926|FG000|Overall Study|Caregiver withdrew|0|||
156523981|NCT03333837|565011927|FG001|Overall Study|Caregiver withdrew|2|||
156523982|NCT03333837|565011928|FG002|Overall Study|Caregiver withdrew|1|||
156523983|NCT03333837|565011929|FG003|Overall Study|Caregiver withdrew|0|||
156523984|NCT03333837|565011930|FG004|Overall Study|Caregiver withdrew|0|||
156523985|NCT03333837|565011926|FG000|Overall Study|Withdrawal by Subject|0|||
156523986|NCT03333837|565011927|FG001|Overall Study|Withdrawal by Subject|0|||
156523987|NCT03333837|565011928|FG002|Overall Study|Withdrawal by Subject|1|||
156523988|NCT03333837|565011929|FG003|Overall Study|Withdrawal by Subject|1|||
156523989|NCT03333837|565011930|FG004|Overall Study|Withdrawal by Subject|3|||
156523990|NCT03333837|565011926|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
156523991|NCT03333837|565011927|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
156523992|NCT03333837|565011928|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
156523993|NCT03333837|565011929|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
156523994|NCT03333837|565011930|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
156523995|NCT01551212|565011931|FG000|Overall Study|Graft loss/Retransplantation|0|||
156523996|NCT01551212|565011932|FG001|Overall Study|Graft loss/Retransplantation|1|||
156523997|NCT01551212|565011931|FG000|Overall Study|Administrative problems|1|||
156523998|NCT01551212|565011932|FG001|Overall Study|Administrative problems|2|||
156523999|NCT01551212|565011931|FG000|Overall Study|Lost to Follow-up|0|||
156524000|NCT01551212|565011932|FG001|Overall Study|Lost to Follow-up|1|||
156524001|NCT01551212|565011931|FG000|Overall Study|Protocol Violation|0|||
156524002|NCT01551212|565011932|FG001|Overall Study|Protocol Violation|1|||
156524003|NCT01551212|565011931|FG000|Overall Study|Withdrawal by Subject|0|||
156524004|NCT01551212|565011932|FG001|Overall Study|Withdrawal by Subject|7|||
156524005|NCT01551212|565011931|FG000|Overall Study|Death|2|||
156524006|NCT01551212|565011932|FG001|Overall Study|Death|4|||
156524007|NCT01551212|565011931|FG000|Overall Study|Never Received Study Treatment|2|||
156524008|NCT01551212|565011932|FG001|Overall Study|Never Received Study Treatment|4|||
156524009|NCT04217590|565011933|FG000|Overall Study|Other|1|||
156524010|NCT04217590|565011934|FG001|Overall Study|Other|1|||
156524011|NCT04217590|565011933|FG000|Overall Study|Withdrawal by Subject|3|||
156524012|NCT04217590|565011934|FG001|Overall Study|Withdrawal by Subject|1|||
156524013|NCT04217590|565011933|FG000|Overall Study|Death|0|||
156524014|NCT04217590|565011934|FG001|Overall Study|Death|1|||
156524015|NCT01013285|565011935|FG000|Overall Study|Death|48|||
156773990|NCT00879658|565924808|FG005|Overall Study|Lack of Efficacy|0|||
156324600|NCT04650854|564287679|FG001|Overall Study|Participant Want to Start a Family|0|||
156324601|NCT04650854|564287680|FG002|Overall Study|Participant Want to Start a Family|1|||
156324602|NCT04650854|564287678|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
156524016|NCT01013285|565011936|FG001|Overall Study|Death|89|||
156524017|NCT00704405|565011937|FG000|Overall Study (NC Population)|Adverse Event|1|||
156524018|NCT00704405|565011938|FG001|Overall Study (NC Population)|Adverse Event|0|||
156524019|NCT00704405|565011939|FG002|Overall Study (NC Population)|Adverse Event|0|||
156659223|NCT01124149|565499182|FG000|Maintenance Phase|Lack of Efficacy|40|||
156659224|NCT01124149|565499182|FG000|Maintenance Phase|Adverse Event|24|||
156659225|NCT01124149|565499182|FG000|Maintenance Phase|Lost to Follow-up|15|||
156659226|NCT01124149|565499182|FG000|Maintenance Phase|Withdrawal by Subject|10|||
156659227|NCT01124149|565499182|FG000|Maintenance Phase|Protocol Violation|5|||
156659228|NCT01124149|565499182|FG000|Maintenance Phase|Coordinator error|1|||
156659229|NCT01124149|565499182|FG000|Maintenance Phase|Non-compliance|1|||
156659230|NCT01644500|565499183|FG000|Overall Study|Adverse Event|6|||
156659231|NCT01644500|565499184|FG001|Overall Study|Adverse Event|1|||
156659232|NCT01644500|565499185|FG002|Overall Study|Adverse Event|2|||
156659233|NCT01644500|565499183|FG000|Overall Study|Death|0|||
156659234|NCT01644500|565499184|FG001|Overall Study|Death|1|||
156659235|NCT01644500|565499185|FG002|Overall Study|Death|0|||
156659236|NCT01644500|565499183|FG000|Overall Study|Lost to Follow-up|3|||
156659237|NCT01644500|565499184|FG001|Overall Study|Lost to Follow-up|8|||
156659238|NCT01644500|565499185|FG002|Overall Study|Lost to Follow-up|0|||
156659239|NCT01644500|565499183|FG000|Overall Study|Protocol Violation|1|||
156659240|NCT01644500|565499184|FG001|Overall Study|Protocol Violation|1|||
156659241|NCT01644500|565499185|FG002|Overall Study|Protocol Violation|0|||
156659242|NCT01644500|565499183|FG000|Overall Study|Withdrawal by Subject|11|||
156659243|NCT01644500|565499184|FG001|Overall Study|Withdrawal by Subject|12|||
156659244|NCT01644500|565499185|FG002|Overall Study|Withdrawal by Subject|12|||
156659245|NCT01644500|565499183|FG000|Overall Study|Physician Decision|1|||
156659246|NCT01644500|565499184|FG001|Overall Study|Physician Decision|1|||
156659247|NCT01644500|565499185|FG002|Overall Study|Physician Decision|1|||
156659248|NCT00322491|565499189|FG000|Overall Study|Adverse Event|1|||
156659249|NCT00322491|565499190|FG001|Overall Study|Adverse Event|0|||
156659250|NCT00322491|565499189|FG000|Overall Study|Death|1|||
156659251|NCT00322491|565499190|FG001|Overall Study|Death|2|||
156659252|NCT01400425|565499191|FG000|Overall Study|Withdrawal by Subject|10|||
156659253|NCT00688064|565499192|FG000|Overall Study|Protocol Violation|0|||
156659254|NCT00688064|565499193|FG001|Overall Study|Protocol Violation|1|||
156659255|NCT00688064|565499192|FG000|Overall Study|Adverse Event|2|||
156659256|NCT00688064|565499193|FG001|Overall Study|Adverse Event|4|||
156659257|NCT00688064|565499192|FG000|Overall Study|Withdrawal by Subject|7|||
156659258|NCT00688064|565499193|FG001|Overall Study|Withdrawal by Subject|7|||
156659259|NCT00688064|565499192|FG000|Overall Study|Lost to Follow-up|10|||
156659260|NCT00688064|565499193|FG001|Overall Study|Lost to Follow-up|10|||
156659261|NCT00688064|565499192|FG000|Overall Study|Lack of Efficacy|0|||
156659262|NCT00688064|565499193|FG001|Overall Study|Lack of Efficacy|1|||
156659263|NCT00688064|565499192|FG000|Overall Study|Pregnancy|1|||
156659264|NCT00688064|565499193|FG001|Overall Study|Pregnancy|0|||
156659265|NCT00688064|565499192|FG000|Overall Study|Any other reasons|1|||
156659266|NCT00688064|565499193|FG001|Overall Study|Any other reasons|3|||
156659267|NCT00720096|565499196|FG000|Overall Study|Withdrawal by Subject|0|||
156659268|NCT00720096|565499197|FG001|Overall Study|Withdrawal by Subject|2|||
156659269|NCT00524459|565499201|FG000|Overall Study|Withdrawal by Subject|1|||
156659270|NCT00524459|565499201|FG000|Overall Study|Other|1|||
156659271|NCT03127137|565499202|FG000|Overall Study|Requested sedation after consent|1|||
156659272|NCT03127137|565499203|FG001|Overall Study|Requested sedation after consent|0|||
156659273|NCT03127137|565499202|FG000|Overall Study|Malfunction in electronic data collection|1|||
156659274|NCT03127137|565499203|FG001|Overall Study|Malfunction in electronic data collection|0|||
156659275|NCT03127137|565499202|FG000|Overall Study|Post procedure testing could not be obtained|0|||
156659276|NCT03127137|565499203|FG001|Overall Study|Post procedure testing could not be obtained|1|||
156659277|NCT04424407|565499204|FG000|Overall Study|Withdrawal by Subject|2|||
156659278|NCT04424407|565499204|FG000|Overall Study|Lost to Follow-up|1|||
156659279|NCT01574248|565499207|FG000|Overall Study|Withdrawal by Subject|2|||
156659280|NCT01574248|565499208|FG001|Overall Study|Withdrawal by Subject|0|||
156659281|NCT01574248|565499207|FG000|Overall Study|Missing primary endpoint data|1|||
156659282|NCT01574248|565499208|FG001|Overall Study|Missing primary endpoint data|0|||
156659283|NCT01458405|565499212|FG000|Phase 1 (up to 12 Months)|Other|0|||
156659284|NCT01458405|565499213|FG001|Phase 1 (up to 12 Months)|Other|1|||
156659285|NCT01458405|565499214|FG002|Phase 1 (up to 12 Months)|Other|0|||
156659286|NCT01458405|565499215|FG003|Phase 1 (up to 12 Months)|Other|0|||
156659287|NCT01458405|565499212|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
156659288|NCT01458405|565499213|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
156659289|NCT01458405|565499214|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
156659290|NCT01458405|565499215|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
156659291|NCT01458405|565499212|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
156659292|NCT01458405|565499213|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
156659293|NCT01458405|565499214|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
156659294|NCT01458405|565499215|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
156659295|NCT01458405|565499212|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
156659296|NCT01458405|565499213|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
156659297|NCT01458405|565499214|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
156659298|NCT01458405|565499215|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
156428832|NCT04618471|564661834|FG000|Overall Study|Various other reasons|2|||
156773991|NCT00879658|565924809|FG006|Overall Study|Lack of Efficacy|0|||
156773992|NCT00879658|565924803|FG000|Overall Study|misrandomized (never received study med)|0|||
156428833|NCT04618471|564661834|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
156428834|NCT04154943|564661835|FG000|Overall Study|Study Ongoing|68|||
156428835|NCT04154943|564661835|FG000|Overall Study|Lost to Follow-up|1|||
156428836|NCT04154943|564661835|FG000|Overall Study|Decision by the Investigator|1|||
156428837|NCT04154943|564661835|FG000|Overall Study|Death|5|||
156428838|NCT04154943|564661835|FG000|Overall Study|Withdrawal by Subject|4|||
156428839|NCT05916170|564661836|FG000|No Warning Control|Lost to Follow-up|12|||
156428840|NCT05916170|564661836|FG000|No Warning Control|Withdrawal by Subject|15|||
156428841|NCT05916170|564661836|FG000|No Warning Control|Noncompliance with protocol|1|||
156524020|NCT00704405|565011940|FG003|Overall Study (NC Population)|Adverse Event|0|||
156524021|NCT00704405|565011941|FG004|Overall Study (NC Population)|Adverse Event|0|||
156524022|NCT00704405|565011937|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
156773993|NCT00879658|565924804|FG001|Overall Study|misrandomized (never received study med)|0|||
156773994|NCT00879658|565924805|FG002|Overall Study|misrandomized (never received study med)|0|||
156773995|NCT00879658|565924806|FG003|Overall Study|misrandomized (never received study med)|1|||
156773996|NCT00879658|565924807|FG004|Overall Study|misrandomized (never received study med)|0|||
156773997|NCT00879658|565924808|FG005|Overall Study|misrandomized (never received study med)|0|||
156773998|NCT00879658|565924809|FG006|Overall Study|misrandomized (never received study med)|0|||
156773999|NCT01925417|565924819|FG000|Overall Study|Withdrawal by Subject|2|||
156774000|NCT01925417|565924819|FG000|Overall Study|Death|1|||
156774001|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
156774002|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
156774003|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
156774004|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Death|0|||
156774005|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Death|0|||
156774006|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Death|1|||
156774007|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
156774008|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
156774009|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
156524023|NCT00704405|565011938|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
156524024|NCT00704405|565011939|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
156524025|NCT00704405|565011940|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
156524026|NCT00704405|565011941|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
156524027|NCT00704405|565011937|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
156524028|NCT00704405|565011938|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
156524029|NCT00704405|565011939|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
156524030|NCT00704405|565011940|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
156774010|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
156774011|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
156774012|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
156774013|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
156774014|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
156774015|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
156774016|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
156774017|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
156774018|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
156774019|NCT02696798|565924820|FG000|Extended Treatment Period|Adverse Event|1|||
156774020|NCT02696798|565924821|FG001|Extended Treatment Period|Adverse Event|4|||
156774021|NCT02696798|565924822|FG002|Extended Treatment Period|Adverse Event|5|||
156774022|NCT02696798|565924820|FG000|Extended Treatment Period|Lack of Efficacy|7|||
156774023|NCT02696798|565924821|FG001|Extended Treatment Period|Lack of Efficacy|2|||
156774024|NCT02696798|565924822|FG002|Extended Treatment Period|Lack of Efficacy|2|||
156774025|NCT02696798|565924820|FG000|Extended Treatment Period|Lost to Follow-up|1|||
156774026|NCT02696798|565924821|FG001|Extended Treatment Period|Lost to Follow-up|0|||
156774027|NCT02696798|565924822|FG002|Extended Treatment Period|Lost to Follow-up|0|||
156774028|NCT02696798|565924820|FG000|Extended Treatment Period|Physician Decision|0|||
156774029|NCT02696798|565924821|FG001|Extended Treatment Period|Physician Decision|1|||
156774030|NCT02696798|565924822|FG002|Extended Treatment Period|Physician Decision|0|||
156774031|NCT02696798|565924820|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
156774032|NCT02696798|565924821|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
156774033|NCT02696798|565924822|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
156774034|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
156774035|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
156774036|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
156774037|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
156428842|NCT05916170|564661836|FG000|Health Warning Intervention|Lost to Follow-up|15|||
156428843|NCT05916170|564661836|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
156774038|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
156774039|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
156774040|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
156774041|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
156428844|NCT05916170|564661836|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
156428845|NCT04075266|564661837|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
156428846|NCT04075266|564661838|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
156428847|NCT04075266|564661837|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
156428848|NCT04075266|564661838|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
156428849|NCT03038022|564661845|FG000|Overall Study|Withdrawal by Subject|2|||
156428850|NCT03038022|564661846|FG001|Overall Study|Withdrawal by Subject|0|||
156428851|NCT03038022|564661845|FG000|Overall Study|Adverse Event|4|||
156428852|NCT03038022|564661846|FG001|Overall Study|Adverse Event|2|||
156428853|NCT01467427|564661847|FG000|Overall Study|Withdrawal by Subject|1|||
156428854|NCT01467427|564661848|FG001|Overall Study|Withdrawal by Subject|0|||
156428855|NCT01467427|564661847|FG000|Overall Study|Not continuing in extension phase|0|||
156428856|NCT01467427|564661848|FG001|Overall Study|Not continuing in extension phase|2|||
156428857|NCT01467427|564661847|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
156428858|NCT01467427|564661848|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
156428859|NCT01467427|564661847|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
156428860|NCT01467427|564661848|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
156428861|NCT01467427|564661847|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
156428862|NCT01467427|564661848|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
156428863|NCT01467427|564661847|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
156428864|NCT01467427|564661848|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
156428865|NCT04181827|564661849|FG000|Overall Study|Ongoing|124|||
156428866|NCT04181827|564661850|FG001|Overall Study|Ongoing|157|||
156428867|NCT04181827|564661849|FG000|Overall Study|Death|82|||
156428868|NCT04181827|564661850|FG001|Overall Study|Death|50|||
156428869|NCT04181827|564661849|FG000|Overall Study|Lost to Follow-up|0|||
156659299|NCT02497781|565499218|FG000|Overall Study|Withdrawal by Subject|2|||
156324603|NCT04650854|564287679|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
156324604|NCT04650854|564287680|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
156324605|NCT04650854|564287678|FG000|Overall Study|Participant Screened For MG0020|0|||
156324606|NCT04650854|564287679|FG001|Overall Study|Participant Screened For MG0020|2|||
156324607|NCT04650854|564287680|FG002|Overall Study|Participant Screened For MG0020|3|||
156324608|NCT04650854|564287678|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
156324609|NCT04650854|564287679|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
156324610|NCT04650854|564287680|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
156324611|NCT04650854|564287678|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
156324612|NCT04650854|564287679|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
156324613|NCT04650854|564287680|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
156324614|NCT04650854|564287678|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
156324615|NCT04650854|564287679|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
156324616|NCT04650854|564287680|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
156324617|NCT04650854|564287678|FG000|Overall Study|End Of Study|0|||
156324618|NCT04650854|564287679|FG001|Overall Study|End Of Study|2|||
156324619|NCT04650854|564287680|FG002|Overall Study|End Of Study|1|||
156324620|NCT04650854|564287678|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
156324621|NCT04650854|564287679|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
156324622|NCT04650854|564287680|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
156324623|NCT04650854|564287678|FG000|Overall Study|Participant Received Rescue Medication|0|||
156324624|NCT04650854|564287679|FG001|Overall Study|Participant Received Rescue Medication|1|||
156324625|NCT04650854|564287680|FG002|Overall Study|Participant Received Rescue Medication|0|||
156324626|NCT04650854|564287678|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
156324627|NCT04650854|564287679|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
156324628|NCT04650854|564287680|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
156324629|NCT04650854|564287678|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
156324630|NCT04650854|564287679|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
156324631|NCT04650854|564287680|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
156324632|NCT04650854|564287678|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
156324633|NCT04650854|564287679|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
156324634|NCT04650854|564287680|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
156324635|NCT04650854|564287678|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
156324636|NCT04650854|564287679|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
156324637|NCT04650854|564287680|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
156324638|NCT04650854|564287678|FG000|Overall Study|Enrollment Cup|0|||
156774042|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
156659300|NCT02497781|565499219|FG001|Overall Study|Withdrawal by Subject|0|||
156659301|NCT02497781|565499218|FG000|Overall Study|Lack of Efficacy|0|||
156659302|NCT02497781|565499219|FG001|Overall Study|Lack of Efficacy|1|||
156659303|NCT02497781|565499218|FG000|Overall Study|Randomised but not treated|1|||
156659304|NCT02497781|565499219|FG001|Overall Study|Randomised but not treated|1|||
156659305|NCT02497781|565499218|FG000|Overall Study|Lost to Follow-up|1|||
156659306|NCT02497781|565499219|FG001|Overall Study|Lost to Follow-up|1|||
156659307|NCT01193608|565499220|FG000|Overall Study|Other|0|||
156659308|NCT01193608|565499221|FG001|Overall Study|Other|1|||
156659309|NCT01193608|565499222|FG002|Overall Study|Other|0|||
156659310|NCT01193608|565499223|FG003|Overall Study|Other|0|||
156659311|NCT01193608|565499224|FG004|Overall Study|Other|0|||
156659312|NCT01193608|565499225|FG005|Overall Study|Other|0|||
156659313|NCT01193608|565499220|FG000|Overall Study|Withdrawal by Subject|0|||
156659314|NCT01193608|565499221|FG001|Overall Study|Withdrawal by Subject|1|||
156659315|NCT01193608|565499222|FG002|Overall Study|Withdrawal by Subject|2|||
156659316|NCT01193608|565499223|FG003|Overall Study|Withdrawal by Subject|3|||
156659317|NCT01193608|565499224|FG004|Overall Study|Withdrawal by Subject|3|||
156659318|NCT01193608|565499225|FG005|Overall Study|Withdrawal by Subject|0|||
156659319|NCT01193608|565499220|FG000|Overall Study|Lost to Follow-up|0|||
156659320|NCT01193608|565499221|FG001|Overall Study|Lost to Follow-up|0|||
156659321|NCT01193608|565499222|FG002|Overall Study|Lost to Follow-up|0|||
156659322|NCT01193608|565499223|FG003|Overall Study|Lost to Follow-up|0|||
156659323|NCT01193608|565499224|FG004|Overall Study|Lost to Follow-up|1|||
156659324|NCT01193608|565499225|FG005|Overall Study|Lost to Follow-up|2|||
156659325|NCT01193608|565499220|FG000|Overall Study|Adverse Event|0|||
156659326|NCT01193608|565499221|FG001|Overall Study|Adverse Event|0|||
156659327|NCT01193608|565499222|FG002|Overall Study|Adverse Event|0|||
156659328|NCT01193608|565499223|FG003|Overall Study|Adverse Event|0|||
156659329|NCT01193608|565499224|FG004|Overall Study|Adverse Event|1|||
156659330|NCT01193608|565499225|FG005|Overall Study|Adverse Event|0|||
156659331|NCT02674334|565499230|FG000|Overall Study|Lost to Follow-up|5|||
156659332|NCT02674334|565499231|FG001|Overall Study|Lost to Follow-up|3|||
156659333|NCT02674334|565499230|FG000|Overall Study|participant difficulty breathing|1|||
156659334|NCT02674334|565499231|FG001|Overall Study|participant difficulty breathing|0|||
156659335|NCT02674334|565499230|FG000|Overall Study|NIRS not recording|1|||
156659336|NCT02674334|565499231|FG001|Overall Study|NIRS not recording|0|||
156659337|NCT00860405|565499236|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
156659338|NCT00860405|565499237|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
156659339|NCT00864097|565499238|FG000|Overall Study|Death|0|||
156659340|NCT00864097|565499239|FG001|Overall Study|Death|1|||
156659341|NCT00864097|565499240|FG002|Overall Study|Death|0|||
156659342|NCT00864097|565499241|FG003|Overall Study|Death|0|||
156659343|NCT00864097|565499238|FG000|Overall Study|Adverse Event|6|||
156659344|NCT00864097|565499239|FG001|Overall Study|Adverse Event|8|||
156659345|NCT00864097|565499240|FG002|Overall Study|Adverse Event|11|||
156659346|NCT00864097|565499241|FG003|Overall Study|Adverse Event|9|||
156659347|NCT00864097|565499238|FG000|Overall Study|Lack of Efficacy|9|||
156659348|NCT00864097|565499239|FG001|Overall Study|Lack of Efficacy|3|||
156659349|NCT00864097|565499240|FG002|Overall Study|Lack of Efficacy|7|||
156659350|NCT00864097|565499241|FG003|Overall Study|Lack of Efficacy|2|||
156659351|NCT00864097|565499238|FG000|Overall Study|Lost to Follow-up|0|||
156659352|NCT00864097|565499239|FG001|Overall Study|Lost to Follow-up|1|||
156659353|NCT00864097|565499240|FG002|Overall Study|Lost to Follow-up|0|||
156659354|NCT00864097|565499241|FG003|Overall Study|Lost to Follow-up|1|||
156659355|NCT00864097|565499238|FG000|Overall Study|Withdrawal by Subject|15|||
156659356|NCT00864097|565499239|FG001|Overall Study|Withdrawal by Subject|11|||
156659357|NCT00864097|565499240|FG002|Overall Study|Withdrawal by Subject|11|||
156659358|NCT00864097|565499241|FG003|Overall Study|Withdrawal by Subject|12|||
156659359|NCT00864097|565499238|FG000|Overall Study|Protocol Violation|2|||
156659360|NCT00864097|565499239|FG001|Overall Study|Protocol Violation|1|||
156659361|NCT00864097|565499240|FG002|Overall Study|Protocol Violation|0|||
156659362|NCT00864097|565499241|FG003|Overall Study|Protocol Violation|1|||
156659363|NCT00864097|565499238|FG000|Overall Study|Terminated by sponsor|105|||
156659364|NCT00864097|565499239|FG001|Overall Study|Terminated by sponsor|112|||
156659365|NCT00864097|565499240|FG002|Overall Study|Terminated by sponsor|102|||
156659366|NCT00864097|565499241|FG003|Overall Study|Terminated by sponsor|99|||
156659367|NCT00864097|565499238|FG000|Overall Study|Randomized but not treated|2|||
156659368|NCT00864097|565499239|FG001|Overall Study|Randomized but not treated|0|||
156659369|NCT00864097|565499240|FG002|Overall Study|Randomized but not treated|1|||
156659370|NCT00864097|565499241|FG003|Overall Study|Randomized but not treated|0|||
156324639|NCT04650854|564287679|FG001|Overall Study|Enrollment Cup|0|||
156324640|NCT04650854|564287680|FG002|Overall Study|Enrollment Cup|1|||
156324641|NCT05308290|564287690|FG000|Overall Study|Death|1|||
156324642|NCT05308290|564287691|FG001|Overall Study|Death|0|||
156324643|NCT05308290|564287690|FG000|Overall Study|Lost to Follow-up|2|||
156324644|NCT05308290|564287691|FG001|Overall Study|Lost to Follow-up|1|||
156324645|NCT05308290|564287690|FG000|Overall Study|still in study followup|0|||
156324646|NCT05308290|564287691|FG001|Overall Study|still in study followup|1|||
156659371|NCT00864097|565499238|FG000|Overall Study|Other|0|||
156659372|NCT00864097|565499239|FG001|Overall Study|Other|0|||
156659373|NCT00864097|565499240|FG002|Overall Study|Other|0|||
156659374|NCT00864097|565499241|FG003|Overall Study|Other|1|||
156659375|NCT00320112|565499243|FG000|Overall Study|Lost to Follow-up|3|||
156659376|NCT00320112|565499244|FG001|Overall Study|Lost to Follow-up|4|||
156659377|NCT00320112|565499243|FG000|Overall Study|Withdrawal by Subject|3|||
156659378|NCT00320112|565499244|FG001|Overall Study|Withdrawal by Subject|0|||
156659379|NCT00320112|565499243|FG000|Overall Study|Death|2|||
156659380|NCT00320112|565499244|FG001|Overall Study|Death|1|||
156659381|NCT00486837|565499248|FG000|Overall Study|Withdrawal by Subject|1|||
156659382|NCT00486837|565499249|FG001|Overall Study|Withdrawal by Subject|0|||
156659383|NCT00486837|565499248|FG000|Overall Study|Adverse Event|1|||
156659384|NCT00486837|565499249|FG001|Overall Study|Adverse Event|1|||
156659385|NCT00486837|565499248|FG000|Overall Study|Protocol Violation|4|||
156659386|NCT00486837|565499249|FG001|Overall Study|Protocol Violation|2|||
156659387|NCT00486837|565499248|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
156659388|NCT00486837|565499249|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
156659389|NCT04534283|565499250|FG000|Overall Study|Physician Decision|2|||
156659390|NCT04534283|565499250|FG000|Overall Study|Withdrawal by Subject|1|||
156659391|NCT04534283|565499250|FG000|Overall Study|Disease Progression|12|||
156659392|NCT04534283|565499250|FG000|Overall Study|Adverse Event|1|||
156659393|NCT00661505|565499251|FG000|Overall Study|Adverse Event|3|||
156659394|NCT00661505|565499251|FG000|Overall Study|Protocol Violation|14|||
156659395|NCT00661505|565499251|FG000|Overall Study|Withdrawal by Subject|8|||
156659396|NCT00661505|565499251|FG000|Overall Study|Lost to Follow-up|3|||
156659397|NCT00661505|565499251|FG000|Overall Study|Other|2|||
156659398|NCT00977470|565499254|FG000|Overall Study|Lack of Efficacy|32|||
156659399|NCT00977470|565499255|FG001|Overall Study|Lack of Efficacy|30|||
156659400|NCT00977470|565499254|FG000|Overall Study|Physician Decision|2|||
156659401|NCT00977470|565499255|FG001|Overall Study|Physician Decision|0|||
156659402|NCT00977470|565499254|FG000|Overall Study|Adverse Event|1|||
156659403|NCT00977470|565499255|FG001|Overall Study|Adverse Event|2|||
156659404|NCT00977470|565499254|FG000|Overall Study|Protocol Violation|1|||
156659405|NCT00977470|565499255|FG001|Overall Study|Protocol Violation|0|||
156659406|NCT00977470|565499254|FG000|Overall Study|Withdrawal by Subject|0|||
156659407|NCT00977470|565499255|FG001|Overall Study|Withdrawal by Subject|2|||
156659408|NCT00977470|565499254|FG000|Overall Study|Death|0|||
156659409|NCT00977470|565499255|FG001|Overall Study|Death|2|||
156659410|NCT00977470|565499254|FG000|Overall Study|clinical decline|0|||
156659411|NCT00977470|565499255|FG001|Overall Study|clinical decline|1|||
156659412|NCT00977470|565499254|FG000|Overall Study|prolonged recovery post-surgery|0|||
156659413|NCT00977470|565499255|FG001|Overall Study|prolonged recovery post-surgery|1|||
156659414|NCT00977470|565499254|FG000|Overall Study|Still on-study|2|||
156659415|NCT00977470|565499255|FG001|Overall Study|Still on-study|0|||
156659416|NCT03257462|565499258|FG000|Cohort A|Lost to Follow-up|1|||
156659417|NCT03257462|565499259|FG001|Cohort A|Lost to Follow-up|0|||
156659418|NCT03257462|565499260|FG002|Cohort A|Lost to Follow-up|0|||
156659419|NCT03257462|565499261|FG003|Cohort A|Lost to Follow-up|0|||
156659420|NCT03257462|565499258|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
156659421|NCT03257462|565499259|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
156659422|NCT03257462|565499260|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
156659423|NCT03257462|565499261|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
156659424|NCT00796822|565499262|FG000|Overall Study|Lost to Follow-up|2|||
156659425|NCT00796822|565499263|FG001|Overall Study|Lost to Follow-up|0|||
156659426|NCT00796822|565499262|FG000|Overall Study|Adverse Event|1|||
156659427|NCT00796822|565499263|FG001|Overall Study|Adverse Event|0|||
156659428|NCT00368277|565499264|FG000|Overall Study|Adverse Event|33|||
156659429|NCT00368277|565499265|FG001|Overall Study|Adverse Event|49|||
156659430|NCT00368277|565499264|FG000|Overall Study|Death|2|||
156659431|NCT00368277|565499265|FG001|Overall Study|Death|1|||
156659432|NCT00368277|565499264|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
156324647|NCT01285960|564287692|FG000|Overall Study|Withdrawal by Subject|2|||
156324648|NCT01285960|564287692|FG000|Overall Study|Lost to Follow-up|2|||
156659433|NCT00368277|565499265|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
156659434|NCT00368277|565499264|FG000|Overall Study|Protocol deviation|7|||
156659435|NCT00368277|565499265|FG001|Overall Study|Protocol deviation|0|||
156324649|NCT01285960|564287692|FG000|Overall Study|2 subjects received less 10 sonications|2|||
156659436|NCT00368277|565499264|FG000|Overall Study|Patient withdrew consent|32|||
156659437|NCT00368277|565499265|FG001|Overall Study|Patient withdrew consent|28|||
156659438|NCT00368277|565499264|FG000|Overall Study|Lost to Follow-up|8|||
156659439|NCT00368277|565499265|FG001|Overall Study|Lost to Follow-up|6|||
156659440|NCT03978624|565499266|FG000|Overall Study|Protocol Violation|1|||
156659441|NCT03978624|565499267|FG001|Overall Study|Protocol Violation|0|||
156659442|NCT05097989|565499268|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
156659443|NCT05097989|565499269|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
156659444|NCT05097989|565499270|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
156659445|NCT05097989|565499271|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
156659446|NCT05097989|565499272|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
156659447|NCT05097989|565499273|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
156659448|NCT05097989|565499274|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
156659449|NCT05097989|565499275|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
156659450|NCT05097989|565499276|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
156659451|NCT05097989|565499268|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
156659452|NCT05097989|565499269|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
156659453|NCT05097989|565499270|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
156659454|NCT05097989|565499271|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
156659455|NCT05097989|565499272|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
156659456|NCT05097989|565499273|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
156659457|NCT05097989|565499274|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
156659458|NCT05097989|565499275|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
156659459|NCT05097989|565499276|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
156659460|NCT05097989|565499268|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
156659461|NCT05097989|565499269|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
156659462|NCT05097989|565499270|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
156659463|NCT05097989|565499271|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
156659464|NCT05097989|565499272|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
156659465|NCT05097989|565499273|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
156659466|NCT05097989|565499274|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
156659467|NCT05097989|565499275|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
156659468|NCT05097989|565499276|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
156659469|NCT05097989|565499268|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
156659470|NCT05097989|565499269|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
156659471|NCT05097989|565499270|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
156659472|NCT05097989|565499271|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
156659473|NCT05097989|565499272|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
156659474|NCT05097989|565499273|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
156659475|NCT05097989|565499274|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
156659476|NCT05097989|565499275|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
156659477|NCT05097989|565499276|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
156659478|NCT05097989|565499268|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
156659479|NCT05097989|565499269|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
156659480|NCT05097989|565499270|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
156659481|NCT05097989|565499271|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
156659482|NCT05097989|565499272|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
156659483|NCT05097989|565499273|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
156659484|NCT05097989|565499274|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
156659485|NCT05097989|565499275|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
156659486|NCT05097989|565499276|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
156659487|NCT05097989|565499268|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
156659488|NCT05097989|565499269|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
156659489|NCT05097989|565499270|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
156659490|NCT05097989|565499271|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
156659491|NCT05097989|565499272|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
156659492|NCT05097989|565499273|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
156659493|NCT05097989|565499274|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
156659494|NCT05097989|565499275|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
156659495|NCT05097989|565499276|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
156659496|NCT05097989|565499268|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156659497|NCT05097989|565499269|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156659498|NCT05097989|565499270|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156659499|NCT05097989|565499271|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156659500|NCT05097989|565499272|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156659501|NCT05097989|565499273|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156774043|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
156774044|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
156774045|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
156659502|NCT05097989|565499274|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156659503|NCT05097989|565499275|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156659504|NCT05097989|565499276|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156659505|NCT05097989|565499268|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
156659506|NCT05097989|565499269|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
156324650|NCT00667420|564287693|FG000|Overall Study|Adverse Event|2|||
156324651|NCT00667420|564287693|FG000|Overall Study|Lack of Efficacy|5|||
156324652|NCT00667420|564287693|FG000|Overall Study|Physician Decision|1|||
156659507|NCT05097989|565499270|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
156659508|NCT05097989|565499271|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
156659509|NCT05097989|565499272|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
156659510|NCT05097989|565499273|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
156659511|NCT05097989|565499274|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
156659512|NCT05097989|565499275|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
156659513|NCT05097989|565499276|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
156659514|NCT05097989|565499268|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156659515|NCT05097989|565499269|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
156659516|NCT05097989|565499270|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156659517|NCT05097989|565499271|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
156659518|NCT05097989|565499272|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156659519|NCT05097989|565499273|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156659520|NCT05097989|565499274|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156659521|NCT05097989|565499275|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156659522|NCT05097989|565499276|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156659523|NCT05097989|565499268|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
156659524|NCT05097989|565499269|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
156659525|NCT05097989|565499270|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
156659526|NCT05097989|565499271|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
156659527|NCT05097989|565499272|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
156659528|NCT05097989|565499273|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
156659529|NCT05097989|565499274|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
156659530|NCT05097989|565499275|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
156659531|NCT05097989|565499276|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
156659532|NCT05097989|565499268|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
156659533|NCT05097989|565499269|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
156659534|NCT05097989|565499270|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
156659535|NCT05097989|565499271|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
156659536|NCT05097989|565499272|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
156659537|NCT05097989|565499273|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
156659538|NCT05097989|565499274|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
156659539|NCT05097989|565499275|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
156659540|NCT05097989|565499276|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
156659541|NCT05097989|565499268|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
156659542|NCT05097989|565499269|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
156659543|NCT05097989|565499270|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
156659544|NCT05097989|565499271|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
156659545|NCT05097989|565499272|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
156659546|NCT05097989|565499273|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
156659547|NCT05097989|565499274|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
156659548|NCT05097989|565499275|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
156659549|NCT05097989|565499276|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
156659550|NCT05097989|565499268|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
156659551|NCT05097989|565499269|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
156659552|NCT05097989|565499270|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
156659553|NCT05097989|565499271|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
156659554|NCT05097989|565499272|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
156659555|NCT05097989|565499273|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
156659556|NCT05097989|565499274|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
156659557|NCT05097989|565499275|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
156659558|NCT05097989|565499276|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
156659559|NCT05097989|565499268|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
156774046|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
156524031|NCT00704405|565011941|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
156524032|NCT00704405|565011937|FG000|Overall Study (NC Population)|Other|0|||
156524033|NCT00704405|565011938|FG001|Overall Study (NC Population)|Other|0|||
156524034|NCT00704405|565011939|FG002|Overall Study (NC Population)|Other|0|||
156524035|NCT00704405|565011940|FG003|Overall Study (NC Population)|Other|0|||
156659560|NCT05097989|565499269|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
156659561|NCT05097989|565499270|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
156659562|NCT05097989|565499271|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
156659563|NCT05097989|565499272|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
156524036|NCT00704405|565011941|FG004|Overall Study (NC Population)|Other|1|||
156659564|NCT05097989|565499273|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
156659565|NCT05097989|565499274|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
156659566|NCT05097989|565499275|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
156659567|NCT05097989|565499276|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
156659568|NCT03283709|565499286|FG000|Overall Study|trial terminated|0|||
156659569|NCT03283709|565499287|FG001|Overall Study|trial terminated|1|||
156659570|NCT00117949|565499288|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
156659571|NCT00117949|565499289|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
156659572|NCT00117949|565499290|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
156659573|NCT00117949|565499291|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
156659574|NCT00117949|565499288|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
156659575|NCT00117949|565499289|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
156659576|NCT00117949|565499290|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
156659577|NCT00117949|565499291|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
156659578|NCT00117949|565499288|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
156659579|NCT00117949|565499289|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
156659580|NCT00117949|565499290|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
156659581|NCT00117949|565499291|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
156659582|NCT00117949|565499288|FG000|Overall Study|PSA increase >=10ng/mL|0|||
156659583|NCT00117949|565499289|FG001|Overall Study|PSA increase >=10ng/mL|1|||
156659584|NCT00117949|565499290|FG002|Overall Study|PSA increase >=10ng/mL|1|||
156659585|NCT00117949|565499291|FG003|Overall Study|PSA increase >=10ng/mL|0|||
156659586|NCT00117949|565499288|FG000|Overall Study|PSA reduction <=50%|0|||
156659587|NCT00117949|565499289|FG001|Overall Study|PSA reduction <=50%|2|||
156659588|NCT00117949|565499290|FG002|Overall Study|PSA reduction <=50%|2|||
156659589|NCT00117949|565499291|FG003|Overall Study|PSA reduction <=50%|4|||
156659590|NCT00117949|565499288|FG000|Overall Study|Hepatic abnormalities|0|||
156659591|NCT00117949|565499289|FG001|Overall Study|Hepatic abnormalities|1|||
156659592|NCT00117949|565499290|FG002|Overall Study|Hepatic abnormalities|0|||
156659593|NCT00117949|565499291|FG003|Overall Study|Hepatic abnormalities|1|||
156659594|NCT01004172|565499294|FG000|Overall Study|Progressive Disease in CNS Only|16|||
156659595|NCT01004172|565499294|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
156659596|NCT01004172|565499294|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
156659597|NCT01004172|565499294|FG000|Overall Study|Adverse Event|1|||
156659598|NCT01004172|565499294|FG000|Overall Study|Physician Decision|1|||
156659599|NCT01004172|565499294|FG000|Overall Study|Symptomatic Deterioration|2|||
156659600|NCT00406848|565499298|FG000|Overall Study|Withdrawal by Subject|27|||
156659601|NCT00406848|565499299|FG001|Overall Study|Withdrawal by Subject|22|||
156659602|NCT00406848|565499298|FG000|Overall Study|Adverse Event|38|||
156659603|NCT00406848|565499299|FG001|Overall Study|Adverse Event|7|||
156659604|NCT00406848|565499298|FG000|Overall Study|Lack of Efficacy|9|||
156659605|NCT00406848|565499299|FG001|Overall Study|Lack of Efficacy|14|||
156659606|NCT00406848|565499298|FG000|Overall Study|Protocol Violation|10|||
156659607|NCT00406848|565499299|FG001|Overall Study|Protocol Violation|6|||
156659608|NCT00406848|565499298|FG000|Overall Study|Lost to Follow-up|6|||
156774047|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
156774048|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
156774049|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
156774050|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
156774051|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
156774052|NCT04091451|565924823|FG000|Overall Study|Adverse Event|15|||
156774053|NCT04091451|565924824|FG001|Overall Study|Adverse Event|10|||
156774054|NCT04091451|565924823|FG000|Overall Study|Lost to Follow-up|8|||
156774055|NCT04091451|565924824|FG001|Overall Study|Lost to Follow-up|8|||
156774056|NCT04091451|565924823|FG000|Overall Study|Protocol Violation|5|||
156774057|NCT04091451|565924824|FG001|Overall Study|Protocol Violation|4|||
156774058|NCT04091451|565924823|FG000|Overall Study|Withdrawal by Subject|21|||
156774059|NCT04091451|565924824|FG001|Overall Study|Withdrawal by Subject|27|||
156774060|NCT04091451|565924823|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
156524037|NCT00704405|565011937|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
156659609|NCT00406848|565499299|FG001|Overall Study|Lost to Follow-up|2|||
156659610|NCT00406848|565499298|FG000|Overall Study|Physician Decision|2|||
156659611|NCT00406848|565499299|FG001|Overall Study|Physician Decision|2|||
156659612|NCT00406848|565499298|FG000|Overall Study|Sponsor Decision|1|||
156659613|NCT00406848|565499299|FG001|Overall Study|Sponsor Decision|1|||
156659614|NCT01355081|565499300|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
156659615|NCT01355081|565499301|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
156659616|NCT01355081|565499302|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
156659617|NCT01355081|565499300|FG000|Overall Study|Major Protocol Deviation|0|||
156659618|NCT01355081|565499301|FG001|Overall Study|Major Protocol Deviation|1|||
156659619|NCT01355081|565499302|FG002|Overall Study|Major Protocol Deviation|0|||
156659620|NCT01355081|565499300|FG000|Overall Study|Lost to Follow-up|0|||
156659621|NCT01355081|565499301|FG001|Overall Study|Lost to Follow-up|0|||
156659622|NCT01355081|565499302|FG002|Overall Study|Lost to Follow-up|1|||
156659623|NCT01355081|565499300|FG000|Overall Study|Withdrawal of Consent|2|||
156659624|NCT01355081|565499301|FG001|Overall Study|Withdrawal of Consent|3|||
156659625|NCT01355081|565499302|FG002|Overall Study|Withdrawal of Consent|3|||
156659626|NCT01355081|565499300|FG000|Overall Study|Lack of Efficacy|2|||
156659627|NCT01355081|565499301|FG001|Overall Study|Lack of Efficacy|1|||
156659628|NCT01355081|565499302|FG002|Overall Study|Lack of Efficacy|1|||
156659629|NCT01355081|565499300|FG000|Overall Study|Non Compliance with Study Medication|0|||
156659630|NCT01355081|565499301|FG001|Overall Study|Non Compliance with Study Medication|1|||
156659631|NCT01355081|565499302|FG002|Overall Study|Non Compliance with Study Medication|0|||
156659632|NCT02719522|565499303|FG000|Overall Study|Implant Failure|4|||
156659633|NCT02719522|565499303|FG000|Overall Study|Death|2|||
156659634|NCT02719522|565499303|FG000|Overall Study|Lost to Follow-up|5|||
156659635|NCT04803357|565499304|FG000|Overall Study|Withdrawal by Subject|31|||
156659636|NCT04803357|565499305|FG001|Overall Study|Withdrawal by Subject|5|||
156659637|NCT02456909|565499307|FG000|Overall Study|Did not receive allocated intervention|24|||
156659638|NCT02456909|565499308|FG001|Overall Study|Did not receive allocated intervention|26|||
156659639|NCT02456909|565499307|FG000|Overall Study|Did not complete the primary outcome|0|||
156659640|NCT02456909|565499308|FG001|Overall Study|Did not complete the primary outcome|1|||
156659641|NCT03309956|565499309|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
156659642|NCT04603937|565499310|FG000|Overall Study|Adverse Event|9|||
156659643|NCT04603937|565499311|FG001|Overall Study|Adverse Event|10|||
156659644|NCT04603937|565499310|FG000|Overall Study|Withdrawal by Subject|7|||
156659645|NCT04603937|565499311|FG001|Overall Study|Withdrawal by Subject|6|||
156659646|NCT04603937|565499310|FG000|Overall Study|Lost to Follow-up|5|||
156659647|NCT04603937|565499311|FG001|Overall Study|Lost to Follow-up|6|||
156659648|NCT04603937|565499310|FG000|Overall Study|Physician Decision|0|||
156659649|NCT04603937|565499311|FG001|Overall Study|Physician Decision|1|||
156659650|NCT04603937|565499310|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
156659651|NCT04603937|565499311|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
156659652|NCT03946449|565499312|FG000|Treatment Extension II|Rolled over to another study|0|||
156659653|NCT03946449|565499313|FG001|Treatment Extension II|Rolled over to another study|0|||
156659654|NCT03946449|565499314|FG002|Treatment Extension II|Rolled over to another study|2|||
156659655|NCT03946449|565499312|FG000|Treatment Extension II|Withdrawal by Subject|0|||
156659656|NCT03946449|565499313|FG001|Treatment Extension II|Withdrawal by Subject|0|||
156659657|NCT03946449|565499314|FG002|Treatment Extension II|Withdrawal by Subject|1|||
156659658|NCT01374919|565500959|FG000|Overall Study|Withdrawal by Subject|2|||
156659659|NCT03805438|565500960|FG000|Overall Study|Lack of Efficacy|1|||
156659660|NCT03805438|565500960|FG000|Overall Study|Protocol Violation|1|||
156659661|NCT00366899|565500961|FG000|Infant Series|Withdrawal by Subject|4|||
156659662|NCT00366899|565500962|FG001|Infant Series|Withdrawal by Subject|7|||
156659663|NCT00366899|565500961|FG000|Infant Series|Protocol Violation|2|||
156659664|NCT00366899|565500962|FG001|Infant Series|Protocol Violation|1|||
156659665|NCT00366899|565500961|FG000|Infant Series|Failed to return|1|||
156659666|NCT00366899|565500962|FG001|Infant Series|Failed to return|1|||
156659667|NCT00366899|565500961|FG000|Infant Series|Lost to Follow-up|0|||
156659668|NCT00366899|565500962|FG001|Infant Series|Lost to Follow-up|2|||
156659669|NCT00366899|565500961|FG000|Infant Series|Adverse Event|0|||
156659670|NCT00366899|565500962|FG001|Infant Series|Adverse Event|1|||
156659671|NCT00366899|565500961|FG000|Infant Series|Physician Decision|1|||
156659672|NCT00366899|565500962|FG001|Infant Series|Physician Decision|0|||
156659673|NCT00366899|565500961|FG000|Infant Series|Randomized but not consented|1|||
156659674|NCT00366899|565500962|FG001|Infant Series|Randomized but not consented|0|||
156659675|NCT00366899|565500961|FG000|After Infant Series|Lost to Follow-up|4|||
156659676|NCT00366899|565500962|FG001|After Infant Series|Lost to Follow-up|3|||
156659677|NCT00366899|565500961|FG000|After Infant Series|Withdrawal by Subject|1|||
156774061|NCT04091451|565924824|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
156774062|NCT04091451|565924823|FG000|Overall Study|Migrated/moved from the study area|3|||
156428870|NCT04181827|564661850|FG001|Overall Study|Lost to Follow-up|1|||
156428871|NCT04181827|564661849|FG000|Overall Study|Withdrawal by Subject|5|||
156428872|NCT04181827|564661850|FG001|Overall Study|Withdrawal by Subject|0|||
156659678|NCT00366899|565500962|FG001|After Infant Series|Withdrawal by Subject|4|||
156659679|NCT00366899|565500961|FG000|After Infant Series|Adverse Event|1|||
156659680|NCT00366899|565500962|FG001|After Infant Series|Adverse Event|2|||
156659681|NCT00366899|565500961|FG000|After Infant Series|Protocol Violation|1|||
156659682|NCT00366899|565500962|FG001|After Infant Series|Protocol Violation|0|||
156659683|NCT00366899|565500961|FG000|Toddler Dose|Withdrawal by Subject|1|||
156659684|NCT00366899|565500962|FG001|Toddler Dose|Withdrawal by Subject|1|||
156659685|NCT00366899|565500961|FG000|Toddler Dose|Protocol Violation|1|||
156659686|NCT00366899|565500962|FG001|Toddler Dose|Protocol Violation|0|||
156659687|NCT00419770|565500966|FG000|Overall Study|Withdrawal by Subject|5|||
156774063|NCT04091451|565924824|FG001|Overall Study|Migrated/moved from the study area|5|||
156659688|NCT00419770|565500967|FG001|Overall Study|Withdrawal by Subject|1|||
156428873|NCT00539591|564661851|FG000|Overall Study|Toxicity|3|||
156659689|NCT02424188|565500976|FG000|Overall Study|Death|2|||
156659690|NCT02424188|565500977|FG001|Overall Study|Death|2|||
156659691|NCT02424188|565500976|FG000|Overall Study|Lost to Follow-up|1|||
156659692|NCT02424188|565500977|FG001|Overall Study|Lost to Follow-up|3|||
156659693|NCT02424188|565500976|FG000|Overall Study|Incarceration|1|||
156659694|NCT02424188|565500977|FG001|Overall Study|Incarceration|0|||
156659695|NCT05037097|565500979|FG000|Overall Study|Withdrawal by Subject|0|||
156659696|NCT05037097|565500980|FG001|Overall Study|Withdrawal by Subject|1|||
156659697|NCT05037097|565500981|FG002|Overall Study|Withdrawal by Subject|0|||
156659698|NCT05037097|565500982|FG003|Overall Study|Withdrawal by Subject|1|||
156659699|NCT05037097|565500983|FG004|Overall Study|Withdrawal by Subject|0|||
156659700|NCT05037097|565500984|FG005|Overall Study|Withdrawal by Subject|2|||
156659701|NCT05037097|565500985|FG006|Overall Study|Withdrawal by Subject|0|||
156659702|NCT05037097|565500986|FG007|Overall Study|Withdrawal by Subject|0|||
156659703|NCT05037097|565500979|FG000|Overall Study|Lost to Follow-up|0|||
156659704|NCT05037097|565500980|FG001|Overall Study|Lost to Follow-up|1|||
156659705|NCT05037097|565500981|FG002|Overall Study|Lost to Follow-up|0|||
156659706|NCT05037097|565500982|FG003|Overall Study|Lost to Follow-up|0|||
156659707|NCT05037097|565500983|FG004|Overall Study|Lost to Follow-up|1|||
156659708|NCT05037097|565500984|FG005|Overall Study|Lost to Follow-up|1|||
156659709|NCT05037097|565500985|FG006|Overall Study|Lost to Follow-up|0|||
156659710|NCT05037097|565500986|FG007|Overall Study|Lost to Follow-up|0|||
156659711|NCT02322047|565500987|FG000|Overall Study|Physician Decision|1|||
156659712|NCT02322047|565500988|FG001|Overall Study|Physician Decision|0|||
156659713|NCT02322047|565500989|FG002|Overall Study|Physician Decision|0|||
156659714|NCT02322047|565500990|FG003|Overall Study|Physician Decision|0|||
156659715|NCT02322047|565500987|FG000|Overall Study|Withdrawal by Subject|1|||
156659716|NCT02322047|565500988|FG001|Overall Study|Withdrawal by Subject|0|||
156659717|NCT02322047|565500989|FG002|Overall Study|Withdrawal by Subject|0|||
156659718|NCT02322047|565500990|FG003|Overall Study|Withdrawal by Subject|1|||
156659719|NCT02322047|565500987|FG000|Overall Study|Adverse Event|0|||
156659720|NCT02322047|565500988|FG001|Overall Study|Adverse Event|1|||
156659721|NCT02322047|565500989|FG002|Overall Study|Adverse Event|0|||
156659722|NCT02322047|565500990|FG003|Overall Study|Adverse Event|0|||
156659723|NCT02322047|565500987|FG000|Overall Study|Lost to Follow-up|0|||
156774064|NCT04091451|565924823|FG000|Overall Study|Suspected HZ episode|1|||
156774065|NCT04091451|565924824|FG001|Overall Study|Suspected HZ episode|0|||
156774066|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
156774067|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
156774068|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Death|1|||
156774069|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Death|3|||
156774070|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
156774071|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
156774072|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
156774073|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
156774074|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
156774075|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
156774076|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
156774077|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
156774078|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
156774079|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
156774080|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
156774081|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
156774082|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
156774083|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
156774084|NCT00362232|565926634|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
156774085|NCT00362232|565926635|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
156774086|NCT00362232|565926634|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
156774087|NCT00362232|565926635|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
156324653|NCT00667420|564287693|FG000|Overall Study|Withdrawal by Subject|2|||
156324654|NCT03500679|564287697|FG000|Overall Study|Lost to Follow-up|6|||
156324655|NCT03500679|564287698|FG001|Overall Study|Lost to Follow-up|3|||
156324656|NCT03500679|564287697|FG000|Overall Study|Withdrawal by Subject|3|||
156324657|NCT03500679|564287698|FG001|Overall Study|Withdrawal by Subject|0|||
156324658|NCT00095628|564287700|FG000|Overall Study|Disease progression prior to treatment|1|||
156324659|NCT04271280|564287701|FG000|Overall Study|Lost to Follow-up|300|||
156324660|NCT04271280|564287701|FG000|Overall Study|Death|153|||
156659724|NCT02322047|565500988|FG001|Overall Study|Lost to Follow-up|0|||
156659725|NCT02322047|565500989|FG002|Overall Study|Lost to Follow-up|1|||
156659726|NCT02322047|565500990|FG003|Overall Study|Lost to Follow-up|1|||
156659727|NCT00088829|565500991|FG000|Overall Study|PI left institution and study was close|22|||
156659728|NCT05818137|565500992|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
156659729|NCT05818137|565500992|FG000|Extension Treatment Period|Ongoing participants|44|||
156659730|NCT01367275|565500993|FG000|Overall Study|Ineligible|1|||
156659731|NCT01367275|565500993|FG000|Overall Study|Disease Progression|2|||
156659732|NCT04510857|565500994|FG000|Overall Study|Withdrawal by Subject|1|||
156659733|NCT04510857|565500995|FG001|Overall Study|Withdrawal by Subject|2|||
156659734|NCT02319148|565500998|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
156659735|NCT02319148|565500999|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
156659736|NCT02319148|565501000|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
156659737|NCT02319148|565501001|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
156659738|NCT02319148|565500998|FG000|Second Intervention Period|No longer willing to participate|0|||
156659739|NCT02319148|565500999|FG001|Second Intervention Period|No longer willing to participate|1|||
156659740|NCT02319148|565501000|FG002|Second Intervention Period|No longer willing to participate|0|||
156659741|NCT02319148|565501001|FG003|Second Intervention Period|No longer willing to participate|0|||
156659742|NCT02319148|565500998|FG000|Second Intervention Period|Other|0|||
156659743|NCT02319148|565500999|FG001|Second Intervention Period|Other|0|||
156659744|NCT02319148|565501000|FG002|Second Intervention Period|Other|0|||
156659745|NCT02319148|565501001|FG003|Second Intervention Period|Other|1|||
156659746|NCT00264797|565501004|FG000|Overall Study|Withdrawal by Subject|11|||
156659747|NCT00264797|565501005|FG001|Overall Study|Withdrawal by Subject|11|||
156659748|NCT00264797|565501004|FG000|Overall Study|Lost to Follow-up|9|||
156659749|NCT00264797|565501005|FG001|Overall Study|Lost to Follow-up|17|||
156659750|NCT00264797|565501004|FG000|Overall Study|Moved from area|3|||
156659751|NCT00264797|565501005|FG001|Overall Study|Moved from area|1|||
156659752|NCT00264797|565501004|FG000|Overall Study|Practical Problems|2|||
156659753|NCT00264797|565501005|FG001|Overall Study|Practical Problems|3|||
156659754|NCT00264797|565501004|FG000|Overall Study|Incarceration|4|||
156659755|NCT00264797|565501005|FG001|Overall Study|Incarceration|5|||
156659756|NCT00264797|565501004|FG000|Overall Study|Pressure/advice from Outsiders|1|||
156659757|NCT00264797|565501005|FG001|Overall Study|Pressure/advice from Outsiders|1|||
156659758|NCT00264797|565501004|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
156659759|NCT00264797|565501005|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
156659760|NCT00264797|565501004|FG000|Overall Study|Other|3|||
156659761|NCT00264797|565501005|FG001|Overall Study|Other|4|||
156659762|NCT00048048|565501006|FG000|Core Treatment|Withdrawal by Subject|0|||
156659763|NCT00048048|565501007|FG001|Core Treatment|Withdrawal by Subject|0|||
156659764|NCT00048048|565501008|FG002|Core Treatment|Withdrawal by Subject|1|||
156659765|NCT00048048|565501009|FG003|Core Treatment|Withdrawal by Subject|0|||
156659766|NCT00048048|565501010|FG004|Core Treatment|Withdrawal by Subject|0|||
156659767|NCT00048048|565501011|FG005|Core Treatment|Withdrawal by Subject|0|||
156659768|NCT00048048|565501012|FG006|Core Treatment|Withdrawal by Subject|0|||
156659769|NCT00048048|565501013|FG007|Core Treatment|Withdrawal by Subject|0|||
156659770|NCT00048048|565501014|FG008|Core Treatment|Withdrawal by Subject|0|||
156659771|NCT00048048|565501015|FG009|Core Treatment|Withdrawal by Subject|0|||
156659772|NCT00048048|565501016|FG010|Core Treatment|Withdrawal by Subject|0|||
156659773|NCT00048048|565501017|FG011|Core Treatment|Withdrawal by Subject|0|||
156659774|NCT00048048|565501006|FG000|Core Treatment|Adverse Event|0|||
156659775|NCT00048048|565501007|FG001|Core Treatment|Adverse Event|0|||
156659776|NCT00048048|565501008|FG002|Core Treatment|Adverse Event|0|||
156659777|NCT00048048|565501009|FG003|Core Treatment|Adverse Event|0|||
156659778|NCT00048048|565501010|FG004|Core Treatment|Adverse Event|0|||
156659779|NCT00048048|565501011|FG005|Core Treatment|Adverse Event|0|||
156659780|NCT00048048|565501012|FG006|Core Treatment|Adverse Event|0|||
156659781|NCT00048048|565501013|FG007|Core Treatment|Adverse Event|1|||
156659782|NCT00048048|565501014|FG008|Core Treatment|Adverse Event|0|||
156659783|NCT00048048|565501015|FG009|Core Treatment|Adverse Event|0|||
156659784|NCT00048048|565501016|FG010|Core Treatment|Adverse Event|0|||
156659785|NCT00048048|565501017|FG011|Core Treatment|Adverse Event|0|||
156659786|NCT00048048|565501006|FG000|Extension Year 1|Early withdrawals|0|||
156659787|NCT00048048|565501007|FG001|Extension Year 1|Early withdrawals|0|||
156659788|NCT00048048|565501008|FG002|Extension Year 1|Early withdrawals|0|||
156659789|NCT00048048|565501009|FG003|Extension Year 1|Early withdrawals|0|||
156659790|NCT00048048|565501010|FG004|Extension Year 1|Early withdrawals|0|||
156659791|NCT00048048|565501011|FG005|Extension Year 1|Early withdrawals|0|||
156659792|NCT00048048|565501012|FG006|Extension Year 1|Early withdrawals|0|||
156774088|NCT00362232|565926634|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
156324661|NCT04271280|564287701|FG000|Overall Study|Withdrawal of consent by patient|59|||
156324662|NCT04271280|564287701|FG000|Overall Study|Other|51|||
156659793|NCT00048048|565501013|FG007|Extension Year 1|Early withdrawals|0|||
156659794|NCT00048048|565501014|FG008|Extension Year 1|Early withdrawals|0|||
156659795|NCT00048048|565501015|FG009|Extension Year 1|Early withdrawals|2|||
156659796|NCT00048048|565501016|FG010|Extension Year 1|Early withdrawals|2|||
156659797|NCT00048048|565501017|FG011|Extension Year 1|Early withdrawals|4|||
156659798|NCT00048048|565501006|FG000|Extension Year 2|Early withdrawals|0|||
156659799|NCT00048048|565501007|FG001|Extension Year 2|Early withdrawals|0|||
156659800|NCT00048048|565501008|FG002|Extension Year 2|Early withdrawals|0|||
156659801|NCT00048048|565501009|FG003|Extension Year 2|Early withdrawals|0|||
156659802|NCT00048048|565501010|FG004|Extension Year 2|Early withdrawals|0|||
156659803|NCT00048048|565501011|FG005|Extension Year 2|Early withdrawals|0|||
156659804|NCT00048048|565501012|FG006|Extension Year 2|Early withdrawals|0|||
156659805|NCT00048048|565501013|FG007|Extension Year 2|Early withdrawals|0|||
156659806|NCT00048048|565501014|FG008|Extension Year 2|Early withdrawals|0|||
156659807|NCT00048048|565501015|FG009|Extension Year 2|Early withdrawals|0|||
156659808|NCT00048048|565501016|FG010|Extension Year 2|Early withdrawals|4|||
156659809|NCT00048048|565501017|FG011|Extension Year 2|Early withdrawals|2|||
156659810|NCT03992196|565501018|FG000|Enrollment|lost to follow-up prior dosing|1|||
156659811|NCT03992196|565501019|FG001|Enrollment|lost to follow-up prior dosing|0|||
156659812|NCT03992196|565501020|FG002|Enrollment|lost to follow-up prior dosing|0|||
156659813|NCT03992196|565501018|FG000|Treatment|Protocol Violation|0|||
156659814|NCT03992196|565501019|FG001|Treatment|Protocol Violation|0|||
156659815|NCT03992196|565501020|FG002|Treatment|Protocol Violation|1|||
156659816|NCT03992196|565501018|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
156659817|NCT03992196|565501019|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
156659818|NCT03992196|565501020|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
156659819|NCT03992196|565501018|FG000|Treatment|Withdrawal due to non-compliance|0|||
156659820|NCT03992196|565501019|FG001|Treatment|Withdrawal due to non-compliance|0|||
156659821|NCT03992196|565501020|FG002|Treatment|Withdrawal due to non-compliance|1|||
156774089|NCT00362232|565926635|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
156774090|NCT00362232|565926634|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
156774091|NCT00362232|565926635|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
156774092|NCT05020015|565926640|FG000|Overall Study|Ongoing on study|1|||
156774093|NCT05020015|565926641|FG001|Overall Study|Ongoing on study|3|||
156774094|NCT05020015|565926642|FG002|Overall Study|Ongoing on study|4|||
156774095|NCT05020015|565926643|FG003|Overall Study|Ongoing on study|7|||
156774096|NCT05020015|565926640|FG000|Overall Study|Death|2|||
156774097|NCT05020015|565926641|FG001|Overall Study|Death|3|||
156774098|NCT05020015|565926642|FG002|Overall Study|Death|4|||
156774099|NCT05020015|565926643|FG003|Overall Study|Death|0|||
156774100|NCT05020015|565926640|FG000|Overall Study|Withdrawal by Subject|0|||
156774101|NCT05020015|565926641|FG001|Overall Study|Withdrawal by Subject|0|||
156774102|NCT05020015|565926642|FG002|Overall Study|Withdrawal by Subject|1|||
156774103|NCT05020015|565926643|FG003|Overall Study|Withdrawal by Subject|0|||
156774104|NCT05020015|565926640|FG000|Overall Study|Reason Not Specified|0|||
156774105|NCT05020015|565926641|FG001|Overall Study|Reason Not Specified|0|||
156774106|NCT05020015|565926642|FG002|Overall Study|Reason Not Specified|2|||
156774107|NCT05020015|565926643|FG003|Overall Study|Reason Not Specified|0|||
156774108|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
156774109|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
156774110|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
156774111|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
156774112|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
156774113|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
156774114|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
156774115|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
156774116|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
156774117|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
156774118|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
156774119|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
156774120|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
156774121|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
156774122|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
156774123|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
156324663|NCT04271280|564287701|FG000|Overall Study|No end of study information|42|||
156659822|NCT03992196|565501018|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
156659823|NCT03992196|565501019|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
156774124|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
156774125|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
156774126|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
156774127|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
156774128|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
156324664|NCT04223232|564287704|FG000|Overall Study|Withdrawal by Subject|1|||
156324665|NCT00586846|564287705|FG000|Overall Study|Physician Decision|1|||
156324666|NCT00586846|564287705|FG000|Overall Study|Death|1|||
156324667|NCT00586846|564287705|FG000|Overall Study|Evaluable for Toxicity Only|4|||
156324668|NCT00410202|564287708|FG000|On-Treatment|Continuing treatment|69|||
156324669|NCT00410202|564287709|FG001|On-Treatment|Continuing treatment|71|||
156659824|NCT03992196|565501020|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
156659825|NCT03992196|565501018|FG000|Treatment|Withdrawal by parent/guardian|0|||
156774129|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
156324670|NCT00410202|564287710|FG002|On-Treatment|Continuing treatment|66|||
156659826|NCT03992196|565501019|FG001|Treatment|Withdrawal by parent/guardian|0|||
156659827|NCT03992196|565501020|FG002|Treatment|Withdrawal by parent/guardian|2|||
156659828|NCT00755196|565501024|FG000|Overall Study|Lost to Follow-up|1|||
156659829|NCT00755196|565501024|FG000|Overall Study|Lack of Efficiency|1|||
156659830|NCT02388763|565501025|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
156659831|NCT02388763|565501026|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
156659832|NCT02388763|565501025|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
156659833|NCT02388763|565501026|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
156659834|NCT01604850|565501027|FG000|Overall Study|Enrolled but never treated|0|||
156659835|NCT01604850|565501028|FG001|Overall Study|Enrolled but never treated|1|||
156659836|NCT01604850|565501027|FG000|Overall Study|Efficacy Failure|50|||
156659837|NCT01604850|565501028|FG001|Overall Study|Efficacy Failure|29|||
156659838|NCT01604850|565501027|FG000|Overall Study|Lost to Follow-up|1|||
156659839|NCT01604850|565501028|FG001|Overall Study|Lost to Follow-up|0|||
156659840|NCT01604850|565501027|FG000|Overall Study|Subject withdrew consent|1|||
156659841|NCT01604850|565501028|FG001|Overall Study|Subject withdrew consent|0|||
156659842|NCT01703832|565501029|FG000|Overall Study|Withdrawal by Subject|1|||
156659843|NCT01703832|565501030|FG001|Overall Study|Withdrawal by Subject|0|||
156659844|NCT00543309|565501031|FG000|Overall Study|Physician Decision|0|||
156659845|NCT00543309|565501032|FG001|Overall Study|Physician Decision|1|||
156659846|NCT00543309|565501033|FG002|Overall Study|Physician Decision|0|||
156659847|NCT02194998|565501038|FG000|On-HCV Treatment|Did not pick up study medication|0|||
156659848|NCT02194998|565501039|FG001|On-HCV Treatment|Did not pick up study medication|1|||
156659849|NCT02194998|565501040|FG002|On-HCV Treatment|Did not pick up study medication|0|||
156659850|NCT02194998|565501041|FG003|On-HCV Treatment|Did not pick up study medication|0|||
156659851|NCT02194998|565501038|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
156659852|NCT02194998|565501039|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
156659853|NCT02194998|565501040|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
156659854|NCT02194998|565501041|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
156659855|NCT01249664|565501042|FG000|Overall Study|Withdrawal by Subject|5|||
156659856|NCT01249664|565501043|FG001|Overall Study|Withdrawal by Subject|0|||
156659857|NCT01249664|565501042|FG000|Overall Study|Adverse Event|1|||
156659858|NCT01249664|565501043|FG001|Overall Study|Adverse Event|0|||
156659859|NCT00525590|565501044|FG000|Overall Study|Adverse Event|3|||
156659860|NCT00525590|565501044|FG000|Overall Study|Physician Decision|3|||
156659861|NCT00525590|565501044|FG000|Overall Study|Withdrawal by Subject|16|||
156659862|NCT00525590|565501044|FG000|Overall Study|Lost to Follow-up|1|||
156659863|NCT00525590|565501044|FG000|Overall Study|Death|9|||
156659864|NCT00525590|565501044|FG000|Overall Study|Other|13|||
156659865|NCT00762086|565501049|FG000|Overall Study|Adverse Event|2|||
156659866|NCT00762086|565501050|FG001|Overall Study|Adverse Event|0|||
156774130|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
156774131|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
156774132|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
156774133|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
156774134|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
156774135|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
156774136|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
156774137|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
156774138|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
156774139|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
156774140|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
156774141|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
156774142|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
156774143|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
156774144|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
156774145|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
156774146|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
156774147|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
156774148|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
156774149|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
156324671|NCT00410202|564287708|FG000|On-Treatment|Adverse Event|1|||
156324672|NCT00410202|564287709|FG001|On-Treatment|Adverse Event|3|||
156659867|NCT00762086|565501049|FG000|Overall Study|Lost to Follow-up|0|||
156659868|NCT00762086|565501050|FG001|Overall Study|Lost to Follow-up|2|||
156324673|NCT00410202|564287710|FG002|On-Treatment|Adverse Event|2|||
156324674|NCT00410202|564287708|FG000|On-Treatment|Death|1|||
156324675|NCT00410202|564287709|FG001|On-Treatment|Death|0|||
156659869|NCT00762086|565501049|FG000|Overall Study|Non compliance|1|||
156659870|NCT00762086|565501050|FG001|Overall Study|Non compliance|0|||
156324676|NCT00410202|564287710|FG002|On-Treatment|Death|0|||
156659871|NCT00762086|565501049|FG000|Overall Study|Withdrawal by Subject|2|||
156659872|NCT00762086|565501050|FG001|Overall Study|Withdrawal by Subject|2|||
156659873|NCT00762086|565501049|FG000|Overall Study|Ineligible to participate in the study|1|||
156659874|NCT00762086|565501050|FG001|Overall Study|Ineligible to participate in the study|0|||
156659875|NCT03661528|565501051|FG000|Overall Study|Death|1|||
156659876|NCT03661528|565501052|FG001|Overall Study|Death|0|||
156659877|NCT03661528|565501051|FG000|Overall Study|Physician Decision|3|||
156659878|NCT03661528|565501052|FG001|Overall Study|Physician Decision|1|||
156659879|NCT03661528|565501051|FG000|Overall Study|Other than Specified|5|||
156659880|NCT03661528|565501052|FG001|Overall Study|Other than Specified|2|||
156659881|NCT03661528|565501051|FG000|Overall Study|Withdrawal by Subject|5|||
156659882|NCT03661528|565501052|FG001|Overall Study|Withdrawal by Subject|3|||
156659883|NCT03661528|565501051|FG000|Overall Study|Disease Progression|8|||
156659884|NCT03661528|565501052|FG001|Overall Study|Disease Progression|13|||
156659885|NCT03661528|565501051|FG000|Overall Study|Adverse Event|61|||
156659886|NCT03661528|565501052|FG001|Overall Study|Adverse Event|55|||
156659887|NCT02468778|565501062|FG000|Overall Study|Death|2|||
156659888|NCT02468778|565501063|FG001|Overall Study|Death|1|||
156659889|NCT02468778|565501064|FG002|Overall Study|Death|0|||
156659890|NCT02468778|565501062|FG000|Overall Study|Lost to Follow-up|1|||
156659891|NCT02468778|565501063|FG001|Overall Study|Lost to Follow-up|2|||
156659892|NCT02468778|565501064|FG002|Overall Study|Lost to Follow-up|2|||
156659893|NCT02468778|565501062|FG000|Overall Study|Withdrawal by Subject|0|||
156659894|NCT02468778|565501063|FG001|Overall Study|Withdrawal by Subject|1|||
156659895|NCT02468778|565501064|FG002|Overall Study|Withdrawal by Subject|1|||
156659896|NCT02458469|565501067|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156659897|NCT02458469|565501068|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156659898|NCT02458469|565501069|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
156659899|NCT02458469|565501070|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156659900|NCT02458469|565501071|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156659901|NCT02458469|565501072|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156659902|NCT02458469|565501067|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
156659903|NCT02458469|565501068|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
156659904|NCT02458469|565501069|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
156659905|NCT02458469|565501070|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
156659906|NCT02458469|565501071|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
156659907|NCT02458469|565501072|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
156659908|NCT02458469|565501067|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156659909|NCT02458469|565501068|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156659910|NCT02458469|565501069|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156659911|NCT02458469|565501070|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156774150|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
156774151|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
156428874|NCT00539591|564661852|FG001|Overall Study|Toxicity|0|||
156428875|NCT00539591|564661853|FG002|Overall Study|Toxicity|0|||
156428876|NCT00539591|564661851|FG000|Overall Study|Disease progression|2|||
156428877|NCT00539591|564661852|FG001|Overall Study|Disease progression|2|||
156428878|NCT00539591|564661853|FG002|Overall Study|Disease progression|3|||
156428879|NCT06269367|564661854|FG000|Phase I|Unable to perform study procedures|0|||
156428880|NCT06269367|564661855|FG001|Phase I|Unable to perform study procedures|1|||
156428881|NCT06269367|564661854|FG000|Phase I|Could not continue study for personal reasons.|1|||
156428882|NCT06269367|564661855|FG001|Phase I|Could not continue study for personal reasons.|0|||
156774152|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
156774153|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
156774154|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
156428883|NCT02137850|564661859|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
156428884|NCT02137850|564661860|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
156428885|NCT02137850|564661861|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
156428886|NCT02137850|564661859|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
156428887|NCT02137850|564661860|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
156428888|NCT02137850|564661861|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
156428889|NCT02137850|564661859|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
156659912|NCT02458469|565501071|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156774155|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
156428890|NCT02137850|564661860|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
156659913|NCT02458469|565501072|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
156659914|NCT03130699|565501073|FG000|Overall Study|Lost to Follow-up|34|||
156659915|NCT03130699|565501074|FG001|Overall Study|Lost to Follow-up|37|||
156659916|NCT03130699|565501075|FG002|Overall Study|Lost to Follow-up|26|||
156659917|NCT03130699|565501073|FG000|Overall Study|Withdrawal by Subject|5|||
156428891|NCT02137850|564661861|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
156428892|NCT02137850|564661859|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
156659918|NCT03130699|565501074|FG001|Overall Study|Withdrawal by Subject|1|||
156774156|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
156774157|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
156774158|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
156774159|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
156774160|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
156774161|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
156774162|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
156774163|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
156774164|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
156774165|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
156774166|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
156774167|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
156774168|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
156774169|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
156774170|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
156774171|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
156774172|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
156774173|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
156774174|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
156774175|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
156774176|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
156774177|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
156774178|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
156774179|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
156774180|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
156774181|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
156774182|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
156774183|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
156774184|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
156774185|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
156774186|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
156774187|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
156774188|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
156774189|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
156774190|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
156774191|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
156774192|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
156774193|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
156774194|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
156774195|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
156774196|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
156774197|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
156774198|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
156774199|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
156774200|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
156774201|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
156774202|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
156774203|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
156774204|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
156774205|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
156774206|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
156774207|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
156774208|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
156774209|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
156774210|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
156774211|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
156774212|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
156774213|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
156428893|NCT02137850|564661860|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
156428894|NCT02137850|564661861|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
156428895|NCT02137850|564661859|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
156428896|NCT02137850|564661860|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
156428897|NCT02137850|564661861|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
156774214|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
156774215|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
156774216|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
156774217|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
156774218|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
156774219|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
156774220|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
156774221|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
156774222|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
156774223|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
156774224|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
156774225|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
156774226|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
156774227|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
156774228|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
156774229|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
156774230|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
156774231|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
156774232|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
156774233|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
156774234|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
156774235|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
156774236|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
156774237|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
156774238|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
156774239|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
156774240|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
156774241|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
156774242|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
156774243|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
156774244|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
156774245|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
156774246|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
156774247|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
156774248|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
156774249|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Death|1|||
156774250|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Death|0|||
156774251|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Death|1|||
156774252|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
156774253|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
156774254|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
156774255|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
156774256|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
156774257|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
156774258|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
156774259|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
156774260|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
156774261|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
156774262|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
156774263|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
156774264|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
156774265|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
156774266|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
156774267|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
156774268|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
156774269|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
156774270|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
156774271|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
156774272|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
156774273|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Depression|0|||
156774274|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Depression|1|||
156774275|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Depression|0|||
156774276|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
156774277|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
156774278|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
156774279|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Jailed|0|||
156774280|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Jailed|1|||
156774281|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Jailed|0|||
156774282|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Other|0|||
156774283|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Other|1|||
156774284|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Other|0|||
156774285|NCT01799889|565926649|FG000|Overall Study|Adverse Event|4|||
156774286|NCT01799889|565926650|FG001|Overall Study|Adverse Event|4|||
156774287|NCT01799889|565926651|FG002|Overall Study|Adverse Event|5|||
156774288|NCT01799889|565926652|FG003|Overall Study|Adverse Event|1|||
156774289|NCT01799889|565926653|FG004|Overall Study|Adverse Event|11|||
156774290|NCT01799889|565926654|FG005|Overall Study|Adverse Event|1|||
156774291|NCT01799889|565926655|FG006|Overall Study|Adverse Event|5|||
156774292|NCT01799889|565926656|FG007|Overall Study|Adverse Event|2|||
156774293|NCT01799889|565926657|FG008|Overall Study|Adverse Event|3|||
156774294|NCT01799889|565926658|FG009|Overall Study|Adverse Event|1|||
156774295|NCT01799889|565926659|FG010|Overall Study|Adverse Event|1|||
156774296|NCT01799889|565926660|FG011|Overall Study|Adverse Event|0|||
156774297|NCT01799889|565926649|FG000|Overall Study|Death|1|||
156774298|NCT01799889|565926650|FG001|Overall Study|Death|0|||
156774299|NCT01799889|565926651|FG002|Overall Study|Death|5|||
156774300|NCT01799889|565926652|FG003|Overall Study|Death|3|||
156774301|NCT01799889|565926653|FG004|Overall Study|Death|1|||
156774302|NCT01799889|565926654|FG005|Overall Study|Death|0|||
156774303|NCT01799889|565926655|FG006|Overall Study|Death|0|||
156774304|NCT01799889|565926656|FG007|Overall Study|Death|0|||
156774305|NCT01799889|565926657|FG008|Overall Study|Death|1|||
156774306|NCT01799889|565926658|FG009|Overall Study|Death|0|||
156774307|NCT01799889|565926659|FG010|Overall Study|Death|1|||
156774308|NCT01799889|565926660|FG011|Overall Study|Death|0|||
156774309|NCT01799889|565926649|FG000|Overall Study|Lack of Efficacy|1|||
156774310|NCT01799889|565926650|FG001|Overall Study|Lack of Efficacy|1|||
156774311|NCT01799889|565926651|FG002|Overall Study|Lack of Efficacy|0|||
156774312|NCT01799889|565926652|FG003|Overall Study|Lack of Efficacy|1|||
156774313|NCT01799889|565926653|FG004|Overall Study|Lack of Efficacy|2|||
156774314|NCT01799889|565926654|FG005|Overall Study|Lack of Efficacy|2|||
156774315|NCT01799889|565926655|FG006|Overall Study|Lack of Efficacy|0|||
156774316|NCT01799889|565926656|FG007|Overall Study|Lack of Efficacy|0|||
156774317|NCT01799889|565926657|FG008|Overall Study|Lack of Efficacy|2|||
156774318|NCT01799889|565926658|FG009|Overall Study|Lack of Efficacy|0|||
156774319|NCT01799889|565926659|FG010|Overall Study|Lack of Efficacy|1|||
156774320|NCT01799889|565926660|FG011|Overall Study|Lack of Efficacy|0|||
156774321|NCT01799889|565926649|FG000|Overall Study|Lost to Follow-up|0|||
156428898|NCT02137850|564661859|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
156774322|NCT01799889|565926650|FG001|Overall Study|Lost to Follow-up|1|||
156774323|NCT01799889|565926651|FG002|Overall Study|Lost to Follow-up|0|||
156774324|NCT01799889|565926652|FG003|Overall Study|Lost to Follow-up|0|||
156428899|NCT02137850|564661860|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
156428900|NCT02137850|564661861|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
156428901|NCT02137850|564661859|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
156428902|NCT02137850|564661860|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
156428903|NCT02137850|564661861|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
156428904|NCT02137850|564661859|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
156428905|NCT02137850|564661860|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
156428906|NCT02137850|564661861|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
156428907|NCT02137850|564661859|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
156428908|NCT02137850|564661860|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
156428909|NCT02137850|564661861|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
156428910|NCT02137850|564661859|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
156428911|NCT02137850|564661860|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
156428912|NCT02137850|564661861|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
156428913|NCT02137850|564661859|FG000|Main Phase: Prophylaxis|Other|0|||
156428914|NCT02137850|564661860|FG001|Main Phase: Prophylaxis|Other|1|||
156428915|NCT02137850|564661861|FG002|Main Phase: Prophylaxis|Other|0|||
156428916|NCT02137850|564661859|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
156428917|NCT02137850|564661860|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
156428918|NCT02137850|564661861|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
156428919|NCT02137850|564661859|FG000|Main Phase: Prophylaxis|Early site closure|0|||
156428920|NCT02137850|564661860|FG001|Main Phase: Prophylaxis|Early site closure|2|||
156428921|NCT02137850|564661861|FG002|Main Phase: Prophylaxis|Early site closure|0|||
156428922|NCT02137850|564661859|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
156774325|NCT01799889|565926653|FG004|Overall Study|Lost to Follow-up|0|||
156774326|NCT01799889|565926654|FG005|Overall Study|Lost to Follow-up|0|||
156774327|NCT01799889|565926655|FG006|Overall Study|Lost to Follow-up|0|||
156774328|NCT01799889|565926656|FG007|Overall Study|Lost to Follow-up|0|||
156774329|NCT01799889|565926657|FG008|Overall Study|Lost to Follow-up|0|||
156774330|NCT01799889|565926658|FG009|Overall Study|Lost to Follow-up|0|||
156774331|NCT01799889|565926659|FG010|Overall Study|Lost to Follow-up|0|||
156774332|NCT01799889|565926660|FG011|Overall Study|Lost to Follow-up|0|||
156774333|NCT01799889|565926649|FG000|Overall Study|Physician Decision|3|||
156774334|NCT01799889|565926650|FG001|Overall Study|Physician Decision|2|||
156774335|NCT01799889|565926651|FG002|Overall Study|Physician Decision|4|||
156774336|NCT01799889|565926652|FG003|Overall Study|Physician Decision|4|||
156774337|NCT01799889|565926653|FG004|Overall Study|Physician Decision|5|||
156774338|NCT01799889|565926654|FG005|Overall Study|Physician Decision|5|||
156774339|NCT01799889|565926655|FG006|Overall Study|Physician Decision|5|||
156774340|NCT01799889|565926656|FG007|Overall Study|Physician Decision|2|||
156774341|NCT01799889|565926657|FG008|Overall Study|Physician Decision|6|||
156774342|NCT01799889|565926658|FG009|Overall Study|Physician Decision|0|||
156774343|NCT01799889|565926659|FG010|Overall Study|Physician Decision|0|||
156774344|NCT01799889|565926660|FG011|Overall Study|Physician Decision|1|||
156774345|NCT01799889|565926649|FG000|Overall Study|Progressive Disease|30|||
156774346|NCT01799889|565926650|FG001|Overall Study|Progressive Disease|26|||
156774347|NCT01799889|565926651|FG002|Overall Study|Progressive Disease|25|||
156774348|NCT01799889|565926652|FG003|Overall Study|Progressive Disease|30|||
156774349|NCT01799889|565926653|FG004|Overall Study|Progressive Disease|23|||
156774350|NCT01799889|565926654|FG005|Overall Study|Progressive Disease|9|||
156774351|NCT01799889|565926655|FG006|Overall Study|Progressive Disease|8|||
156774352|NCT01799889|565926656|FG007|Overall Study|Progressive Disease|13|||
156774353|NCT01799889|565926657|FG008|Overall Study|Progressive Disease|18|||
156774354|NCT01799889|565926658|FG009|Overall Study|Progressive Disease|5|||
156774355|NCT01799889|565926659|FG010|Overall Study|Progressive Disease|3|||
156774356|NCT01799889|565926660|FG011|Overall Study|Progressive Disease|1|||
156774357|NCT01799889|565926649|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
156774358|NCT01799889|565926650|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
156774359|NCT01799889|565926651|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
156774360|NCT01799889|565926652|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
156774361|NCT01799889|565926653|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
156774362|NCT01799889|565926654|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
156774363|NCT01799889|565926655|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
156774364|NCT01799889|565926656|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
156774365|NCT01799889|565926657|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
156774366|NCT01799889|565926658|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
156774367|NCT01799889|565926659|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
156774368|NCT01799889|565926660|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
156774369|NCT01799889|565926649|FG000|Overall Study|Study Terminated By Sponsor|1|||
156774370|NCT01799889|565926650|FG001|Overall Study|Study Terminated By Sponsor|0|||
156774371|NCT01799889|565926651|FG002|Overall Study|Study Terminated By Sponsor|0|||
156774372|NCT01799889|565926652|FG003|Overall Study|Study Terminated By Sponsor|0|||
156774373|NCT01799889|565926653|FG004|Overall Study|Study Terminated By Sponsor|2|||
156774374|NCT01799889|565926654|FG005|Overall Study|Study Terminated By Sponsor|1|||
156774375|NCT01799889|565926655|FG006|Overall Study|Study Terminated By Sponsor|0|||
156774376|NCT01799889|565926656|FG007|Overall Study|Study Terminated By Sponsor|2|||
156774377|NCT01799889|565926657|FG008|Overall Study|Study Terminated By Sponsor|1|||
156774378|NCT01799889|565926658|FG009|Overall Study|Study Terminated By Sponsor|1|||
156774379|NCT01799889|565926659|FG010|Overall Study|Study Terminated By Sponsor|0|||
156774380|NCT01799889|565926660|FG011|Overall Study|Study Terminated By Sponsor|0|||
156774381|NCT01799889|565926649|FG000|Overall Study|Withdrawal by Subject|1|||
156774382|NCT01799889|565926650|FG001|Overall Study|Withdrawal by Subject|6|||
156774383|NCT01799889|565926651|FG002|Overall Study|Withdrawal by Subject|4|||
156774384|NCT01799889|565926652|FG003|Overall Study|Withdrawal by Subject|0|||
156774385|NCT01799889|565926653|FG004|Overall Study|Withdrawal by Subject|5|||
156774386|NCT01799889|565926654|FG005|Overall Study|Withdrawal by Subject|1|||
156774387|NCT01799889|565926655|FG006|Overall Study|Withdrawal by Subject|3|||
156774388|NCT01799889|565926656|FG007|Overall Study|Withdrawal by Subject|1|||
156774389|NCT01799889|565926657|FG008|Overall Study|Withdrawal by Subject|2|||
156774390|NCT01799889|565926658|FG009|Overall Study|Withdrawal by Subject|1|||
156774391|NCT01799889|565926659|FG010|Overall Study|Withdrawal by Subject|1|||
156774392|NCT01799889|565926660|FG011|Overall Study|Withdrawal by Subject|1|||
156774393|NCT01799889|565926649|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156774394|NCT01799889|565926650|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156774395|NCT01799889|565926651|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156774396|NCT01799889|565926652|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156774397|NCT01799889|565926653|FG004|Overall Study|Non-Compliance With Study Drug|0|||
156524038|NCT00704405|565011938|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
156774398|NCT01799889|565926654|FG005|Overall Study|Non-Compliance With Study Drug|1|||
156774399|NCT01799889|565926655|FG006|Overall Study|Non-Compliance With Study Drug|0|||
156774400|NCT01799889|565926656|FG007|Overall Study|Non-Compliance With Study Drug|0|||
156774401|NCT01799889|565926657|FG008|Overall Study|Non-Compliance With Study Drug|0|||
156774402|NCT01799889|565926658|FG009|Overall Study|Non-Compliance With Study Drug|0|||
156774403|NCT01799889|565926659|FG010|Overall Study|Non-Compliance With Study Drug|0|||
156774404|NCT01799889|565926660|FG011|Overall Study|Non-Compliance With Study Drug|0|||
156808570|NCT01070979|566052716|FG001|Overall Study|Withdrawal by Subject|1|||
156774405|NCT06217380|565926661|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
156774406|NCT06217380|565926661|FG000|Overall Study|Physician Decision|1|||
156774407|NCT06217380|565926661|FG000|Overall Study|Withdrawal by Subject|2|||
156774408|NCT06633965|565926662|FG000|Overall Study|Withdrawal by Subject|0|||
156774409|NCT06633965|565926663|FG001|Overall Study|Withdrawal by Subject|1|||
156774410|NCT00947544|565926668|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
156774411|NCT00947544|565926669|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
156774412|NCT02566005|565926670|FG000|Overall Study|vaginal bleeding|0|||
156774413|NCT02566005|565926671|FG001|Overall Study|vaginal bleeding|1|||
156774414|NCT02566005|565926670|FG000|Overall Study|received foley|8|||
156524039|NCT00704405|565011939|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
156524040|NCT00704405|565011940|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
156524041|NCT00704405|565011941|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
156524042|NCT00704405|565011937|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
156524043|NCT00704405|565011938|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
156524044|NCT00704405|565011939|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
156524045|NCT00704405|565011940|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
156524046|NCT00704405|565011941|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
156524047|NCT01395888|565011942|FG000|2-week Run-in Period|Adverse Event|2|||
156524048|NCT01395888|565011943|FG001|2-week Run-in Period|Adverse Event|0|||
156524049|NCT01395888|565011944|FG002|2-week Run-in Period|Adverse Event|0|||
156524050|NCT01395888|565011942|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
156524051|NCT01395888|565011943|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
156524052|NCT01395888|565011944|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
156774415|NCT02566005|565926671|FG001|Overall Study|received foley|0|||
156774416|NCT02566005|565926670|FG000|Overall Study|did not receive foley|0|||
156774417|NCT02566005|565926671|FG001|Overall Study|did not receive foley|1|||
156774418|NCT02566005|565926670|FG000|Overall Study|labor after randomization|0|||
156774419|NCT02566005|565926671|FG001|Overall Study|labor after randomization|4|||
156774420|NCT00984867|565926674|FG000|Overall Study|Adverse Event|3|||
156774421|NCT00984867|565926675|FG001|Overall Study|Adverse Event|7|||
156774422|NCT00984867|565926674|FG000|Overall Study|Death|1|||
156774423|NCT00984867|565926675|FG001|Overall Study|Death|0|||
156774424|NCT00984867|565926674|FG000|Overall Study|Withdrawal by Subject|13|||
156774425|NCT00984867|565926675|FG001|Overall Study|Withdrawal by Subject|4|||
156774426|NCT00984867|565926674|FG000|Overall Study|Lost to Follow-up|3|||
156774427|NCT00984867|565926675|FG001|Overall Study|Lost to Follow-up|4|||
156524053|NCT01395888|565011942|FG000|2-week Run-in Period|Lost to Follow-up|1|||
156524054|NCT01395888|565011943|FG001|2-week Run-in Period|Lost to Follow-up|0|||
156524055|NCT01395888|565011944|FG002|2-week Run-in Period|Lost to Follow-up|0|||
156524056|NCT01395888|565011942|FG000|2-week Run-in Period|Protocol Violation|2|||
156524057|NCT01395888|565011943|FG001|2-week Run-in Period|Protocol Violation|0|||
156524058|NCT01395888|565011944|FG002|2-week Run-in Period|Protocol Violation|0|||
156524059|NCT01395888|565011942|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
156524060|NCT01395888|565011943|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156524061|NCT01395888|565011944|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156524062|NCT01395888|565011942|FG000|Treatment Period (TP)|Adverse Event|0|||
156524063|NCT01395888|565011943|FG001|Treatment Period (TP)|Adverse Event|7|||
156524064|NCT01395888|565011944|FG002|Treatment Period (TP)|Adverse Event|6|||
156524065|NCT01395888|565011942|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
156524066|NCT01395888|565011943|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
156524067|NCT01395888|565011944|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
156774428|NCT00984867|565926674|FG000|Overall Study|Poor/non-compliance|0|||
156774429|NCT00984867|565926675|FG001|Overall Study|Poor/non-compliance|1|||
156774430|NCT00984867|565926674|FG000|Overall Study|Subject no longer meets study criteria|1|||
156774431|NCT00984867|565926675|FG001|Overall Study|Subject no longer meets study criteria|1|||
156774432|NCT00984867|565926674|FG000|Overall Study|site closing|1|||
156774433|NCT00984867|565926675|FG001|Overall Study|site closing|0|||
156774434|NCT00984867|565926674|FG000|Overall Study|lack of efficacy and subject compliance|1|||
156774435|NCT00984867|565926675|FG001|Overall Study|lack of efficacy and subject compliance|0|||
156774436|NCT00671060|565926676|FG000|Overall Study|Protocol Violation|1|||
156774437|NCT00671060|565926677|FG001|Overall Study|Protocol Violation|0|||
156774438|NCT00671060|565926676|FG000|Overall Study|Physician Decision|0|||
156774439|NCT00671060|565926677|FG001|Overall Study|Physician Decision|1|||
156774440|NCT00626639|565926678|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
156774441|NCT00626639|565926679|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
156774442|NCT01461551|565926680|FG000|Overall Study|Physician Decision|2|||
156774443|NCT01461551|565926681|FG001|Overall Study|Physician Decision|1|||
156774444|NCT01461551|565926682|FG002|Overall Study|Physician Decision|2|||
156524068|NCT01395888|565011942|FG000|Treatment Period (TP)|Protocol Violation|0|||
156524069|NCT01395888|565011943|FG001|Treatment Period (TP)|Protocol Violation|1|||
156524070|NCT01395888|565011944|FG002|Treatment Period (TP)|Protocol Violation|5|||
156524071|NCT01395888|565011942|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
156524072|NCT01395888|565011943|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
156524073|NCT01395888|565011944|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
156524074|NCT01395888|565011942|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
156524075|NCT01395888|565011943|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
156524076|NCT01395888|565011944|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
156774445|NCT01155141|565926683|FG000|Overall Study|Withdrawal by Subject|1|||
156774446|NCT01155141|565926683|FG000|Overall Study|Screen Failure|1|||
156774447|NCT00303186|565926684|FG000|Overall Study|Other|52|||
156774448|NCT00785629|565926687|FG000|Overall Study|Adverse Event|2|||
156524077|NCT02641496|565011945|FG000|Overall Study|Lost to Follow-up|13|||
156524078|NCT02641496|565011946|FG001|Overall Study|Lost to Follow-up|12|||
156524079|NCT02641496|565011945|FG000|Overall Study|Withdrawal by Subject|1|||
156524080|NCT02641496|565011946|FG001|Overall Study|Withdrawal by Subject|0|||
156524081|NCT03035201|565011947|FG000|Overall Study|Death|9|||
156524082|NCT03035201|565011948|FG001|Overall Study|Death|12|||
156524083|NCT03035201|565011949|FG002|Overall Study|Death|9|||
156524084|NCT03035201|565011950|FG003|Overall Study|Death|10|||
156524085|NCT03035201|565011947|FG000|Overall Study|Withdrawal by Subject|51|||
156524086|NCT03035201|565011948|FG001|Overall Study|Withdrawal by Subject|49|||
156524087|NCT03035201|565011949|FG002|Overall Study|Withdrawal by Subject|37|||
156524088|NCT03035201|565011950|FG003|Overall Study|Withdrawal by Subject|46|||
156524089|NCT03035201|565011947|FG000|Overall Study|Lost to Follow-up|67|||
156524090|NCT03035201|565011948|FG001|Overall Study|Lost to Follow-up|51|||
156524091|NCT03035201|565011949|FG002|Overall Study|Lost to Follow-up|64|||
156524092|NCT03035201|565011950|FG003|Overall Study|Lost to Follow-up|69|||
156774449|NCT00785629|565926688|FG001|Overall Study|Adverse Event|1|||
156774450|NCT00785629|565926689|FG002|Overall Study|Adverse Event|1|||
156774451|NCT00785629|565926690|FG003|Overall Study|Adverse Event|5|||
156774452|NCT00785629|565926687|FG000|Overall Study|Protocol Violation|1|||
156774453|NCT00785629|565926688|FG001|Overall Study|Protocol Violation|2|||
156774454|NCT00785629|565926689|FG002|Overall Study|Protocol Violation|4|||
156774455|NCT00785629|565926690|FG003|Overall Study|Protocol Violation|5|||
156774456|NCT00785629|565926687|FG000|Overall Study|administrative decision|5|||
156774457|NCT00785629|565926688|FG001|Overall Study|administrative decision|1|||
156774458|NCT00785629|565926689|FG002|Overall Study|administrative decision|3|||
156774459|NCT00785629|565926690|FG003|Overall Study|administrative decision|4|||
156774460|NCT00785629|565926687|FG000|Overall Study|Withdrawal by Subject|0|||
156774461|NCT00785629|565926688|FG001|Overall Study|Withdrawal by Subject|1|||
156774462|NCT00785629|565926689|FG002|Overall Study|Withdrawal by Subject|2|||
156774463|NCT00785629|565926690|FG003|Overall Study|Withdrawal by Subject|2|||
156774464|NCT02020941|565926691|FG000|Overall Study|Adverse Event|1|||
156774465|NCT02020941|565926691|FG000|Overall Study|Physician Decision|2|||
156774466|NCT02020941|565926691|FG000|Overall Study|Withdrawal by Subject|1|||
156774467|NCT02020941|565926691|FG000|Overall Study|Disease Progression|4|||
156774468|NCT02107898|565926693|FG000|Overall Study|Adverse Event|4|||
156774469|NCT02107898|565926694|FG001|Overall Study|Adverse Event|7|||
156774470|NCT02107898|565926693|FG000|Overall Study|Poor compliance to protocol|0|||
156774471|NCT02107898|565926694|FG001|Overall Study|Poor compliance to protocol|1|||
156774472|NCT02107898|565926693|FG000|Overall Study|Participant moved|0|||
156774473|NCT02107898|565926694|FG001|Overall Study|Participant moved|2|||
156774474|NCT02107898|565926693|FG000|Overall Study|Consent withdrawn by participant|2|||
156774475|NCT02107898|565926694|FG001|Overall Study|Consent withdrawn by participant|1|||
156774476|NCT02107898|565926693|FG000|Overall Study|Randomized but not treated|0|||
156774477|NCT02107898|565926694|FG001|Overall Study|Randomized but not treated|1|||
156524093|NCT03727438|565011957|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
156524094|NCT03727438|565011958|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
156524095|NCT03727438|565011957|FG000|Intervention Period|Excluded (health)|1|||
156524096|NCT03727438|565011958|FG001|Intervention Period|Excluded (health)|0|||
156774478|NCT03329989|565926695|FG000|Overall Study|Withdrawal by Subject|9|||
156774479|NCT03329989|565926695|FG000|Overall Study|Lost to Follow-up|8|||
156774480|NCT03329989|565926695|FG000|Overall Study|Adverse Event|5|||
156774481|NCT03329989|565926695|FG000|Overall Study|Protocol Violation|1|||
156774482|NCT00634504|565926696|FG000|Overall Study|Protocol Violation|1|||
156774483|NCT00634504|565926697|FG001|Overall Study|Protocol Violation|0|||
156774484|NCT02469857|565926698|FG000|Overall Study|Death|24|||
156774485|NCT02469857|565926699|FG001|Overall Study|Death|29|||
156774486|NCT02469857|565926698|FG000|Overall Study|Discontinuation|1|||
156774487|NCT02469857|565926699|FG001|Overall Study|Discontinuation|3|||
156524097|NCT03727438|565011957|FG000|Intervention Period|Withdrawal by Subject|3|||
156524098|NCT03727438|565011958|FG001|Intervention Period|Withdrawal by Subject|1|||
156524099|NCT03727438|565011957|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
156524100|NCT03727438|565011958|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
156524101|NCT03727438|565011957|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
156774488|NCT00937950|565926700|FG000|Overall Study|Withdrawal by Subject|23|||
156774489|NCT00937950|565926700|FG000|Overall Study|Migrated/moved from study area|27|||
156774490|NCT00937950|565926700|FG000|Overall Study|Lost to Follow-up|144|||
156774491|NCT00937950|565926700|FG000|Overall Study|Missing confirmed|4|||
156774492|NCT00937950|565926700|FG000|Overall Study|Other|18|||
156774493|NCT01531153|565926703|FG000|Overall Study|Withdrawal by Subject|10|||
156774494|NCT01531153|565926704|FG001|Overall Study|Withdrawal by Subject|9|||
156428923|NCT02137850|564661860|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
156428924|NCT02137850|564661861|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
156428925|NCT02137850|564661859|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
156428926|NCT02137850|564661860|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
156428927|NCT02137850|564661861|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
156428928|NCT02137850|564661859|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
156428929|NCT02137850|564661860|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
156428930|NCT02137850|564661861|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
156428931|NCT02137850|564661859|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
156428932|NCT02137850|564661860|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
156428933|NCT02137850|564661861|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
156428934|NCT02137850|564661859|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
156428935|NCT02137850|564661860|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
156428936|NCT02137850|564661861|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
156428937|NCT02137850|564661859|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
156428938|NCT02137850|564661860|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
156428939|NCT02137850|564661861|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
156428940|NCT02137850|564661859|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
156428941|NCT02137850|564661860|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
156428942|NCT02137850|564661861|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
156428943|NCT02137850|564661859|FG000|Extension Phase: Prophylaxis|Other|0|||
156428944|NCT02137850|564661860|FG001|Extension Phase: Prophylaxis|Other|1|||
156428945|NCT02137850|564661861|FG002|Extension Phase: Prophylaxis|Other|0|||
156428946|NCT02137850|564661859|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
156428947|NCT02137850|564661860|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
156428948|NCT02137850|564661861|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
156428949|NCT03431350|564661862|FG000|Overall Study|ONGOING|0|||
156428950|NCT03431350|564661863|FG001|Overall Study|ONGOING|0|||
156428951|NCT03431350|564661864|FG002|Overall Study|ONGOING|2|||
156428952|NCT03431350|564661865|FG003|Overall Study|ONGOING|0|||
156428953|NCT03431350|564661866|FG004|Overall Study|ONGOING|1|||
156428954|NCT03431350|564661867|FG005|Overall Study|ONGOING|3|||
156428955|NCT03431350|564661868|FG006|Overall Study|ONGOING|0|||
156428956|NCT03431350|564661869|FG007|Overall Study|ONGOING|1|||
156428957|NCT03431350|564661870|FG008|Overall Study|ONGOING|3|||
156428958|NCT03431350|564661871|FG009|Overall Study|ONGOING|4|||
156428959|NCT03431350|564661872|FG010|Overall Study|ONGOING|2|||
156428960|NCT03431350|564661873|FG011|Overall Study|ONGOING|1|||
156428961|NCT03431350|564661862|FG000|Overall Study|Death|6|||
156428962|NCT03431350|564661863|FG001|Overall Study|Death|5|||
156428963|NCT03431350|564661864|FG002|Overall Study|Death|18|||
156428964|NCT03431350|564661865|FG003|Overall Study|Death|7|||
156428965|NCT03431350|564661866|FG004|Overall Study|Death|4|||
156428966|NCT03431350|564661867|FG005|Overall Study|Death|3|||
156428967|NCT03431350|564661868|FG006|Overall Study|Death|2|||
156428968|NCT03431350|564661869|FG007|Overall Study|Death|0|||
156428969|NCT03431350|564661870|FG008|Overall Study|Death|0|||
156428970|NCT03431350|564661871|FG009|Overall Study|Death|0|||
156428971|NCT03431350|564661872|FG010|Overall Study|Death|4|||
156428972|NCT03431350|564661873|FG011|Overall Study|Death|0|||
156428973|NCT03431350|564661862|FG000|Overall Study|Lost to Follow-up|0|||
156428974|NCT03431350|564661863|FG001|Overall Study|Lost to Follow-up|1|||
156428975|NCT03431350|564661864|FG002|Overall Study|Lost to Follow-up|0|||
156428976|NCT03431350|564661865|FG003|Overall Study|Lost to Follow-up|0|||
156428977|NCT03431350|564661866|FG004|Overall Study|Lost to Follow-up|0|||
156428978|NCT03431350|564661867|FG005|Overall Study|Lost to Follow-up|0|||
156428979|NCT03431350|564661868|FG006|Overall Study|Lost to Follow-up|0|||
156428980|NCT03431350|564661869|FG007|Overall Study|Lost to Follow-up|0|||
156428981|NCT03431350|564661870|FG008|Overall Study|Lost to Follow-up|0|||
156428982|NCT03431350|564661871|FG009|Overall Study|Lost to Follow-up|0|||
156428983|NCT03431350|564661872|FG010|Overall Study|Lost to Follow-up|0|||
156428984|NCT03431350|564661873|FG011|Overall Study|Lost to Follow-up|0|||
156428985|NCT03431350|564661862|FG000|Overall Study|Withdrawal by Subject|0|||
156428986|NCT03431350|564661863|FG001|Overall Study|Withdrawal by Subject|0|||
156428987|NCT03431350|564661864|FG002|Overall Study|Withdrawal by Subject|0|||
156428988|NCT03431350|564661865|FG003|Overall Study|Withdrawal by Subject|1|||
156428989|NCT03431350|564661866|FG004|Overall Study|Withdrawal by Subject|1|||
156428990|NCT03431350|564661867|FG005|Overall Study|Withdrawal by Subject|1|||
156428991|NCT03431350|564661868|FG006|Overall Study|Withdrawal by Subject|0|||
156428992|NCT03431350|564661869|FG007|Overall Study|Withdrawal by Subject|0|||
156428993|NCT03431350|564661870|FG008|Overall Study|Withdrawal by Subject|0|||
156428994|NCT03431350|564661871|FG009|Overall Study|Withdrawal by Subject|2|||
156428995|NCT03431350|564661872|FG010|Overall Study|Withdrawal by Subject|0|||
156428996|NCT03431350|564661873|FG011|Overall Study|Withdrawal by Subject|1|||
156428997|NCT03431350|564661862|FG000|Overall Study|Other|0|||
156428998|NCT03431350|564661863|FG001|Overall Study|Other|0|||
156428999|NCT03431350|564661864|FG002|Overall Study|Other|1|||
156429000|NCT03431350|564661865|FG003|Overall Study|Other|3|||
156429001|NCT03431350|564661866|FG004|Overall Study|Other|2|||
156429002|NCT03431350|564661867|FG005|Overall Study|Other|2|||
156429003|NCT03431350|564661868|FG006|Overall Study|Other|4|||
156429004|NCT03431350|564661869|FG007|Overall Study|Other|0|||
156429005|NCT03431350|564661870|FG008|Overall Study|Other|14|||
156429006|NCT03431350|564661871|FG009|Overall Study|Other|11|||
156429007|NCT03431350|564661872|FG010|Overall Study|Other|11|||
156429008|NCT03431350|564661873|FG011|Overall Study|Other|15|||
156429009|NCT03563053|564661874|FG000|Overall Study|Withdrawal by Subject|17|||
156429010|NCT03563053|564661874|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
156429011|NCT03563053|564661874|FG000|Overall Study|Adverse Event|3|||
156429012|NCT03563053|564661874|FG000|Overall Study|Physician Decision|1|||
156429013|NCT03563053|564661874|FG000|Overall Study|study terminated by sponsor|71|||
156524102|NCT03727438|565011958|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
156524103|NCT03727438|565011957|FG000|8 Week Assessment|Withdrawal by Subject|6|||
156524104|NCT03727438|565011958|FG001|8 Week Assessment|Withdrawal by Subject|1|||
156524105|NCT03727438|565011957|FG000|6 mo Assessment|did not complete assessment|10|||
156524106|NCT03727438|565011958|FG001|6 mo Assessment|did not complete assessment|11|||
156524107|NCT06729606|565011959|FG000|Overall Study|Adverse Event|0|||
156524108|NCT06729606|565011960|FG001|Overall Study|Adverse Event|2|||
156524109|NCT06729606|565011959|FG000|Overall Study|Death|1|||
156524110|NCT06729606|565011960|FG001|Overall Study|Death|0|||
156524111|NCT06729606|565011959|FG000|Overall Study|Physician Decision|0|||
156524112|NCT06729606|565011960|FG001|Overall Study|Physician Decision|1|||
156524113|NCT06729606|565011959|FG000|Overall Study|Withdrawal by Subject|2|||
156524114|NCT06729606|565011960|FG001|Overall Study|Withdrawal by Subject|4|||
156524115|NCT03440320|565013774|FG000|Overall Study|Withdrawal by Subject|0|||
156524116|NCT03440320|565013775|FG001|Overall Study|Withdrawal by Subject|1|||
156524117|NCT01912456|565013776|FG000|Period 1|Physician Decision|0|||
156524118|NCT01912456|565013777|FG001|Period 1|Physician Decision|0|||
156524119|NCT01912456|565013778|FG002|Period 1|Physician Decision|1|||
156524120|NCT01912456|565013779|FG003|Period 1|Physician Decision|0|||
156524121|NCT01912456|565013776|FG000|Period 1|non-compliance|1|||
156524122|NCT01912456|565013777|FG001|Period 1|non-compliance|0|||
156524123|NCT01912456|565013778|FG002|Period 1|non-compliance|0|||
156524124|NCT01912456|565013779|FG003|Period 1|non-compliance|1|||
156524125|NCT01912456|565013776|FG000|Period 1|Adverse Event|1|||
156524126|NCT01912456|565013777|FG001|Period 1|Adverse Event|0|||
156524127|NCT01912456|565013778|FG002|Period 1|Adverse Event|0|||
156524128|NCT01912456|565013779|FG003|Period 1|Adverse Event|1|||
156524129|NCT01912456|565013776|FG000|Period 1|Withdrawal by Subject|0|||
156524130|NCT01912456|565013777|FG001|Period 1|Withdrawal by Subject|1|||
156524131|NCT01912456|565013778|FG002|Period 1|Withdrawal by Subject|1|||
156524132|NCT01912456|565013779|FG003|Period 1|Withdrawal by Subject|1|||
156524133|NCT01912456|565013776|FG000|Period 2|Lack of Efficacy|0|||
156524134|NCT01912456|565013777|FG001|Period 2|Lack of Efficacy|2|||
156524135|NCT01912456|565013778|FG002|Period 2|Lack of Efficacy|0|||
156524136|NCT01912456|565013779|FG003|Period 2|Lack of Efficacy|0|||
156524137|NCT01912456|565013776|FG000|Period 2|Adverse Event|0|||
156524138|NCT01912456|565013777|FG001|Period 2|Adverse Event|0|||
156524139|NCT01912456|565013778|FG002|Period 2|Adverse Event|0|||
156524140|NCT01912456|565013779|FG003|Period 2|Adverse Event|1|||
156524141|NCT00001962|565013785|FG000|Overall Study|Lack of Efficacy|18|||
156524142|NCT00001962|565013785|FG000|Overall Study|Lack of Accrual|6|||
156524143|NCT00001962|565013785|FG000|Overall Study|Death|1|||
156524144|NCT00001962|565013785|FG000|Overall Study|Lost to Follow-up|2|||
156524145|NCT00001962|565013785|FG000|Overall Study|Adverse Event|1|||
156524146|NCT00171704|565013786|FG000|Overall Study|Adverse Event|24|||
156429014|NCT05663866|564661876|FG000|Overall Study|Adverse Event|0|||
156524147|NCT00171704|565013787|FG001|Overall Study|Adverse Event|33|||
156524148|NCT00171704|565013786|FG000|Overall Study|Disease Progression|14|||
156524149|NCT00171704|565013787|FG001|Overall Study|Disease Progression|9|||
156524150|NCT00171704|565013786|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
156524151|NCT00171704|565013787|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
156524152|NCT00171704|565013786|FG000|Overall Study|Administrative Problems|2|||
156524153|NCT00171704|565013787|FG001|Overall Study|Administrative Problems|1|||
156429015|NCT05663866|564661877|FG001|Overall Study|Adverse Event|0|||
156429016|NCT05663866|564661878|FG002|Overall Study|Adverse Event|1|||
156524154|NCT00171704|565013786|FG000|Overall Study|Death|2|||
156524155|NCT00171704|565013787|FG001|Overall Study|Death|2|||
156429017|NCT05663866|564661879|FG003|Overall Study|Adverse Event|0|||
156429018|NCT05663866|564661876|FG000|Overall Study|Physician Decision|0|||
156429019|NCT05663866|564661877|FG001|Overall Study|Physician Decision|0|||
156429020|NCT05663866|564661878|FG002|Overall Study|Physician Decision|0|||
156524156|NCT00171704|565013786|FG000|Overall Study|Withdrawal by Subject|1|||
156524157|NCT00171704|565013787|FG001|Overall Study|Withdrawal by Subject|3|||
156774495|NCT01531153|565926705|FG002|Overall Study|Withdrawal by Subject|15|||
156774496|NCT03483103|565926706|FG000|Pre-Treatment Phase|Other reasons|1|||
156774497|NCT03483103|565926706|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
156774498|NCT03483103|565926706|FG000|Pre-Treatment Phase|Disease-related complications|1|||
156774499|NCT03483103|565926706|FG000|Pre-Treatment Phase|Death|5|||
156774500|NCT03483103|565926706|FG000|Treatment Phase|Withdrawal by Subject|7|||
156774501|NCT03483103|565926706|FG000|Treatment Phase|Other reasons|1|||
156774502|NCT03483103|565926706|FG000|Treatment Phase|Death|23|||
156774503|NCT03483103|565926706|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
156774504|NCT03483103|565926706|FG000|Treatment Phase|Received nonconforming product|1|||
156774505|NCT04727749|565926707|FG000|Overall Study|Lost to Follow-up|10|||
156774506|NCT04727749|565926708|FG001|Overall Study|Lost to Follow-up|3|||
156774507|NCT02378181|565926709|FG000|Overall Study|Lost to Follow-up|2|||
156774508|NCT02378181|565926710|FG001|Overall Study|Lost to Follow-up|5|||
156774509|NCT02378181|565926709|FG000|Overall Study|Withdrawal by Subject|1|||
156774510|NCT02378181|565926710|FG001|Overall Study|Withdrawal by Subject|1|||
156774511|NCT02378181|565926709|FG000|Overall Study|Incarcerated|0|||
156774512|NCT02378181|565926710|FG001|Overall Study|Incarcerated|1|||
156774513|NCT02475213|565926713|FG000|Overall Study|Adverse Event|2|||
156774514|NCT02475213|565926714|FG001|Overall Study|Adverse Event|0|||
156774515|NCT02475213|565926715|FG002|Overall Study|Adverse Event|0|||
156774516|NCT02475213|565926716|FG003|Overall Study|Adverse Event|1|||
156774517|NCT02475213|565926717|FG004|Overall Study|Adverse Event|1|||
156774518|NCT02475213|565926718|FG005|Overall Study|Adverse Event|4|||
156774519|NCT02475213|565926719|FG006|Overall Study|Adverse Event|6|||
156774520|NCT02475213|565926720|FG007|Overall Study|Adverse Event|2|||
156774521|NCT02475213|565926713|FG000|Overall Study|Physician Decision|1|||
156774522|NCT02475213|565926714|FG001|Overall Study|Physician Decision|1|||
156774523|NCT02475213|565926715|FG002|Overall Study|Physician Decision|1|||
156774524|NCT02475213|565926716|FG003|Overall Study|Physician Decision|0|||
156774525|NCT02475213|565926717|FG004|Overall Study|Physician Decision|0|||
156774526|NCT02475213|565926718|FG005|Overall Study|Physician Decision|1|||
156774527|NCT02475213|565926719|FG006|Overall Study|Physician Decision|4|||
156774528|NCT02475213|565926720|FG007|Overall Study|Physician Decision|0|||
156774529|NCT02475213|565926713|FG000|Overall Study|Progressive Disease|3|||
156774530|NCT02475213|565926714|FG001|Overall Study|Progressive Disease|2|||
156774531|NCT02475213|565926715|FG002|Overall Study|Progressive Disease|2|||
156774532|NCT02475213|565926716|FG003|Overall Study|Progressive Disease|13|||
156774533|NCT02475213|565926717|FG004|Overall Study|Progressive Disease|15|||
156774534|NCT02475213|565926718|FG005|Overall Study|Progressive Disease|25|||
156774535|NCT02475213|565926719|FG006|Overall Study|Progressive Disease|30|||
156774536|NCT02475213|565926720|FG007|Overall Study|Progressive Disease|10|||
156774537|NCT02475213|565926713|FG000|Overall Study|Death|0|||
156774538|NCT02475213|565926714|FG001|Overall Study|Death|0|||
156774539|NCT02475213|565926715|FG002|Overall Study|Death|0|||
156774540|NCT02475213|565926716|FG003|Overall Study|Death|0|||
156774541|NCT02475213|565926717|FG004|Overall Study|Death|0|||
156774542|NCT02475213|565926718|FG005|Overall Study|Death|4|||
156774543|NCT02475213|565926719|FG006|Overall Study|Death|1|||
156774544|NCT02475213|565926720|FG007|Overall Study|Death|0|||
156774545|NCT02475213|565926713|FG000|Overall Study|Protocol Violation|0|||
156774546|NCT02475213|565926714|FG001|Overall Study|Protocol Violation|0|||
156774547|NCT02475213|565926715|FG002|Overall Study|Protocol Violation|0|||
156774548|NCT02475213|565926716|FG003|Overall Study|Protocol Violation|0|||
156774549|NCT02475213|565926717|FG004|Overall Study|Protocol Violation|1|||
156774550|NCT02475213|565926718|FG005|Overall Study|Protocol Violation|0|||
156774551|NCT02475213|565926719|FG006|Overall Study|Protocol Violation|0|||
156774552|NCT02475213|565926720|FG007|Overall Study|Protocol Violation|0|||
156774553|NCT02475213|565926713|FG000|Overall Study|Withdrawal by Subject|0|||
156774554|NCT02475213|565926714|FG001|Overall Study|Withdrawal by Subject|0|||
156774555|NCT02475213|565926715|FG002|Overall Study|Withdrawal by Subject|0|||
156324677|NCT00410202|564287708|FG000|On-Treatment|Lost to Follow-up|1|||
156774556|NCT02475213|565926716|FG003|Overall Study|Withdrawal by Subject|1|||
156324678|NCT00410202|564287709|FG001|On-Treatment|Lost to Follow-up|0|||
156324679|NCT00410202|564287710|FG002|On-Treatment|Lost to Follow-up|1|||
156324680|NCT00410202|564287708|FG000|On-Treatment|Lack of Efficacy|1|||
156774557|NCT02475213|565926717|FG004|Overall Study|Withdrawal by Subject|0|||
156774558|NCT02475213|565926718|FG005|Overall Study|Withdrawal by Subject|2|||
156774559|NCT02475213|565926719|FG006|Overall Study|Withdrawal by Subject|2|||
156774560|NCT02475213|565926720|FG007|Overall Study|Withdrawal by Subject|0|||
156774561|NCT02475213|565926713|FG000|Overall Study|Other|0|||
156774562|NCT02475213|565926714|FG001|Overall Study|Other|0|||
156774563|NCT02475213|565926715|FG002|Overall Study|Other|0|||
156774564|NCT02475213|565926716|FG003|Overall Study|Other|1|||
156774565|NCT02475213|565926717|FG004|Overall Study|Other|3|||
156324681|NCT00410202|564287709|FG001|On-Treatment|Lack of Efficacy|4|||
156774566|NCT02475213|565926718|FG005|Overall Study|Other|1|||
156774567|NCT02475213|565926719|FG006|Overall Study|Other|0|||
156774568|NCT02475213|565926720|FG007|Overall Study|Other|0|||
156774569|NCT01186770|565926721|FG000|Overall Study|Ineligibility|0|||
156774570|NCT01186770|565926722|FG001|Overall Study|Ineligibility|0|||
156429021|NCT05663866|564661879|FG003|Overall Study|Physician Decision|1|||
156429022|NCT05663866|564661876|FG000|Overall Study|Withdrawal by Subject|0|||
156429023|NCT05663866|564661877|FG001|Overall Study|Withdrawal by Subject|2|||
156429024|NCT05663866|564661878|FG002|Overall Study|Withdrawal by Subject|1|||
156429025|NCT05663866|564661879|FG003|Overall Study|Withdrawal by Subject|2|||
156429026|NCT05663866|564661876|FG000|Overall Study|Progressive disease|4|||
156429027|NCT05663866|564661877|FG001|Overall Study|Progressive disease|8|||
156429028|NCT05663866|564661878|FG002|Overall Study|Progressive disease|5|||
156429029|NCT05663866|564661879|FG003|Overall Study|Progressive disease|2|||
156429030|NCT05663866|564661876|FG000|Overall Study|Other|1|||
156429031|NCT05663866|564661877|FG001|Overall Study|Other|0|||
156429032|NCT05663866|564661878|FG002|Overall Study|Other|0|||
156429033|NCT05663866|564661879|FG003|Overall Study|Other|0|||
156429034|NCT05663866|564661876|FG000|Overall Study|Ongoing|1|||
156429035|NCT05663866|564661877|FG001|Overall Study|Ongoing|27|||
156429036|NCT05663866|564661878|FG002|Overall Study|Ongoing|6|||
156429037|NCT05663866|564661879|FG003|Overall Study|Ongoing|1|||
156429038|NCT04845620|564661880|FG000|Overall Study|Withdrawal by Subject|11|||
156429039|NCT04845620|564661881|FG001|Overall Study|Withdrawal by Subject|10|||
156429040|NCT04845620|564661880|FG000|Overall Study|Adverse Event|5|||
156429041|NCT04845620|564661881|FG001|Overall Study|Adverse Event|4|||
156429042|NCT04845620|564661880|FG000|Overall Study|Lost to Follow-up|5|||
156429043|NCT04845620|564661881|FG001|Overall Study|Lost to Follow-up|4|||
156429044|NCT04845620|564661880|FG000|Overall Study|Lack of Efficacy|4|||
156429045|NCT04845620|564661881|FG001|Overall Study|Lack of Efficacy|4|||
156429046|NCT04845620|564661880|FG000|Overall Study|Physician Decision|2|||
156429047|NCT04845620|564661881|FG001|Overall Study|Physician Decision|1|||
156429048|NCT05803720|564661882|FG000|Overall Study|Lost to Follow-up|3|||
156429049|NCT05803720|564661883|FG001|Overall Study|Lost to Follow-up|4|||
156429050|NCT05803720|564661882|FG000|Overall Study|Family leave/emergency|1|||
156429051|NCT05803720|564661883|FG001|Overall Study|Family leave/emergency|1|||
156429052|NCT03370133|564661884|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
156429053|NCT03370133|564661885|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
156429054|NCT03370133|564661886|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
156429055|NCT03370133|564661887|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
156429056|NCT03370133|564661888|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
156429057|NCT03370133|564661889|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
156429058|NCT03370133|564661884|FG000|Initial Treatment Period (WK 16)|Death|1|||
156429059|NCT03370133|564661885|FG001|Initial Treatment Period (WK 16)|Death|1|||
156429060|NCT03370133|564661886|FG002|Initial Treatment Period (WK 16)|Death|1|||
156429061|NCT03370133|564661887|FG003|Initial Treatment Period (WK 16)|Death|0|||
156429062|NCT03370133|564661888|FG004|Initial Treatment Period (WK 16)|Death|0|||
156429063|NCT03370133|564661889|FG005|Initial Treatment Period (WK 16)|Death|0|||
156429064|NCT03370133|564661884|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
156429065|NCT03370133|564661885|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
156429066|NCT03370133|564661886|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
156429067|NCT03370133|564661887|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
156429068|NCT03370133|564661888|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
156429069|NCT03370133|564661889|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
156429070|NCT03370133|564661884|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156429071|NCT03370133|564661885|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156429072|NCT03370133|564661886|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
156429073|NCT03370133|564661887|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156429074|NCT03370133|564661888|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156429075|NCT03370133|564661889|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156429076|NCT03370133|564661884|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156429077|NCT03370133|564661885|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
156429078|NCT03370133|564661886|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156429079|NCT03370133|564661887|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156429080|NCT03370133|564661888|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156524158|NCT00171704|565013786|FG000|Overall Study|Protocol Violation|0|||
156524159|NCT00171704|565013787|FG001|Overall Study|Protocol Violation|1|||
156524160|NCT00320541|565013790|FG000|Overall Study|Adverse Event|21|||
156524161|NCT00320541|565013791|FG001|Overall Study|Adverse Event|19|||
156429081|NCT03370133|564661889|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156429082|NCT03370133|564661884|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
156429083|NCT03370133|564661885|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
156429084|NCT03370133|564661886|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
156429085|NCT03370133|564661887|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
156429086|NCT03370133|564661888|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
156429087|NCT03370133|564661889|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
156429088|NCT03370133|564661884|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
156429089|NCT03370133|564661885|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
156429090|NCT03370133|564661886|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
156774571|NCT01186770|565926723|FG002|Overall Study|Ineligibility|2|||
156774572|NCT01186770|565926724|FG003|Overall Study|Ineligibility|0|||
156774573|NCT01186770|565926721|FG000|Overall Study|Protocol Violation|7|||
156774574|NCT01186770|565926722|FG001|Overall Study|Protocol Violation|9|||
156774575|NCT01186770|565926723|FG002|Overall Study|Protocol Violation|12|||
156774576|NCT01186770|565926724|FG003|Overall Study|Protocol Violation|14|||
156774577|NCT01186770|565926721|FG000|Overall Study|Adverse Event|2|||
156774578|NCT01186770|565926722|FG001|Overall Study|Adverse Event|9|||
156774579|NCT01186770|565926723|FG002|Overall Study|Adverse Event|7|||
156774580|NCT01186770|565926724|FG003|Overall Study|Adverse Event|9|||
156774581|NCT01186770|565926721|FG000|Overall Study|Withdrawal by Subject|15|||
156429091|NCT03370133|564661887|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
156429092|NCT03370133|564661888|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
156429093|NCT03370133|564661889|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
156429094|NCT03370133|564661884|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
156429095|NCT03370133|564661885|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
156429096|NCT03370133|564661886|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
156774582|NCT01186770|565926722|FG001|Overall Study|Withdrawal by Subject|13|||
156774583|NCT01186770|565926723|FG002|Overall Study|Withdrawal by Subject|11|||
156774584|NCT01186770|565926724|FG003|Overall Study|Withdrawal by Subject|17|||
156774585|NCT01186770|565926721|FG000|Overall Study|Lost to Follow-up|10|||
156774586|NCT01186770|565926722|FG001|Overall Study|Lost to Follow-up|6|||
156774587|NCT01186770|565926723|FG002|Overall Study|Lost to Follow-up|14|||
156774588|NCT01186770|565926724|FG003|Overall Study|Lost to Follow-up|9|||
156774589|NCT01186770|565926721|FG000|Overall Study|Insufficient response to treatment|7|||
156774590|NCT01186770|565926722|FG001|Overall Study|Insufficient response to treatment|8|||
156774591|NCT01186770|565926723|FG002|Overall Study|Insufficient response to treatment|5|||
156774592|NCT01186770|565926724|FG003|Overall Study|Insufficient response to treatment|7|||
156774593|NCT01186770|565926721|FG000|Overall Study|Other than specified|0|||
156774594|NCT01186770|565926722|FG001|Overall Study|Other than specified|1|||
156774595|NCT01186770|565926723|FG002|Overall Study|Other than specified|1|||
156774596|NCT01186770|565926724|FG003|Overall Study|Other than specified|2|||
156774597|NCT00505921|565926725|FG000|Overall Study|Ineligible|1|||
156774598|NCT00505921|565926725|FG000|Overall Study|Failed to Mobilize|8|||
156774599|NCT00630292|565926726|FG000|Overall Study|Withdrawal by Subject|1|||
156774600|NCT00797563|565926728|FG000|Overall Study|Adverse Event|1|||
156774601|NCT03416179|565926729|FG000|Overall Study|Death|90|||
156774602|NCT03416179|565926730|FG001|Overall Study|Death|87|||
156774603|NCT03416179|565926731|FG002|Overall Study|Death|117|||
156774604|NCT03416179|565926732|FG003|Overall Study|Death|113|||
156774605|NCT03416179|565926729|FG000|Overall Study|Withdrawal by Subject|15|||
156774606|NCT03416179|565926730|FG001|Overall Study|Withdrawal by Subject|20|||
156774607|NCT03416179|565926731|FG002|Overall Study|Withdrawal by Subject|6|||
156774608|NCT03416179|565926732|FG003|Overall Study|Withdrawal by Subject|9|||
156774609|NCT03416179|565926729|FG000|Overall Study|Lost to Follow-up|1|||
156774610|NCT03416179|565926730|FG001|Overall Study|Lost to Follow-up|1|||
156774611|NCT03416179|565926731|FG002|Overall Study|Lost to Follow-up|0|||
156774612|NCT03416179|565926732|FG003|Overall Study|Lost to Follow-up|3|||
156774613|NCT03416179|565926729|FG000|Overall Study|Study participation terminated by Sponsor|93|||
156429097|NCT03370133|564661887|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
156429098|NCT03370133|564661888|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
156429099|NCT03370133|564661889|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
156429100|NCT03370133|564661884|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
156429101|NCT03370133|564661885|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
156774614|NCT03416179|565926730|FG001|Overall Study|Study participation terminated by Sponsor|91|||
156774615|NCT03416179|565926731|FG002|Overall Study|Study participation terminated by Sponsor|26|||
156774616|NCT03416179|565926732|FG003|Overall Study|Study participation terminated by Sponsor|31|||
156774617|NCT03416179|565926729|FG000|Overall Study|Other|2|||
156774618|NCT03416179|565926730|FG001|Overall Study|Other|3|||
156774619|NCT03416179|565926731|FG002|Overall Study|Other|1|||
156774620|NCT03416179|565926732|FG003|Overall Study|Other|0|||
156774621|NCT00790036|565926738|FG000|Overall Study|Abnormal lab values|3|||
156774622|NCT00790036|565926739|FG001|Overall Study|Abnormal lab values|2|||
156774623|NCT00790036|565926738|FG000|Overall Study|Administrative problems|5|||
156774624|NCT00790036|565926739|FG001|Overall Study|Administrative problems|9|||
156774625|NCT00790036|565926738|FG000|Overall Study|Adverse Event|113|||
156774626|NCT00790036|565926739|FG001|Overall Study|Adverse Event|44|||
156774627|NCT00790036|565926738|FG000|Overall Study|Death|1|||
156774628|NCT00790036|565926739|FG001|Overall Study|Death|0|||
156774629|NCT00790036|565926738|FG000|Overall Study|Disease progression|24|||
156774630|NCT00790036|565926739|FG001|Overall Study|Disease progression|48|||
156774631|NCT00790036|565926738|FG000|Overall Study|Lost to Follow-up|1|||
156429102|NCT03370133|564661886|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
156774632|NCT00790036|565926739|FG001|Overall Study|Lost to Follow-up|2|||
156774633|NCT00790036|565926738|FG000|Overall Study|Protocol Violation|10|||
156774634|NCT00790036|565926739|FG001|Overall Study|Protocol Violation|2|||
156774635|NCT00790036|565926738|FG000|Overall Study|Withdrawal by Subject|18|||
156774636|NCT00790036|565926739|FG001|Overall Study|Withdrawal by Subject|7|||
156774637|NCT00790036|565926738|FG000|Overall Study|Subject/guardian decision|20|||
156774638|NCT00790036|565926739|FG001|Overall Study|Subject/guardian decision|7|||
156774639|NCT03197129|565926740|FG000|Overall Study|did not answer the VPT: shyness|4|||
156774640|NCT03197129|565926741|FG001|Overall Study|did not answer the VPT: shyness|5|||
156774641|NCT05233761|565926742|FG000|Treatment Period A|Withdrawal by Subject|12|||
156774642|NCT05233761|565926743|FG001|Treatment Period A|Withdrawal by Subject|10|||
156774643|NCT05233761|565926742|FG000|Treatment Period A|Lost to Follow-up|6|||
156774644|NCT05233761|565926743|FG001|Treatment Period A|Lost to Follow-up|12|||
156774645|NCT05233761|565926742|FG000|Treatment Period A|Protocol Violation|8|||
156774646|NCT05233761|565926743|FG001|Treatment Period A|Protocol Violation|15|||
156774647|NCT02442349|565926744|FG000|Overall Study|Death|95|||
156774648|NCT02442349|565926744|FG000|Overall Study|Withdrawal by Subject|27|||
156774649|NCT02442349|565926744|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
156774650|NCT02442349|565926744|FG000|Overall Study|Lost to Follow-up|1|||
156774651|NCT01285518|565926745|FG000|Overall Study|Lost to Follow-up|0|||
156774652|NCT01285518|565926746|FG001|Overall Study|Lost to Follow-up|0|||
156774653|NCT01285518|565926747|FG002|Overall Study|Lost to Follow-up|0|||
156774654|NCT01285518|565926748|FG003|Overall Study|Lost to Follow-up|0|||
156774655|NCT01285518|565926749|FG004|Overall Study|Lost to Follow-up|0|||
156774656|NCT01285518|565926750|FG005|Overall Study|Lost to Follow-up|1|||
156774657|NCT01285518|565926751|FG006|Overall Study|Lost to Follow-up|0|||
156774658|NCT01285518|565926752|FG007|Overall Study|Lost to Follow-up|0|||
156774659|NCT00639509|565926759|FG000|Overall Study|Death|1|||
156774660|NCT01551173|565926760|FG000|Overall Study|Withdrawal by Subject|11|||
156774661|NCT01551173|565926761|FG001|Overall Study|Withdrawal by Subject|16|||
156774662|NCT01551173|565926760|FG000|Overall Study|Adverse Event|7|||
156774663|NCT01551173|565926761|FG001|Overall Study|Adverse Event|6|||
156774664|NCT01551173|565926760|FG000|Overall Study|Lost to Follow-up|5|||
156774665|NCT01551173|565926761|FG001|Overall Study|Lost to Follow-up|7|||
156774666|NCT01551173|565926760|FG000|Overall Study|Other|5|||
156774667|NCT01551173|565926761|FG001|Overall Study|Other|3|||
156774668|NCT01394276|565926762|FG000|Overall Study|Related Adverse event (AEs)|15|||
156774669|NCT01394276|565926762|FG000|Overall Study|Not related AEs|9|||
156774670|NCT01394276|565926762|FG000|Overall Study|Remission of disease|2|||
156774671|NCT01394276|565926762|FG000|Overall Study|Insufficient therapeutic effect|17|||
156774672|NCT01394276|565926762|FG000|Overall Study|Insufficient compliance|9|||
156774673|NCT01394276|565926762|FG000|Overall Study|Lost to Follow-up|5|||
156774674|NCT01394276|565926762|FG000|Overall Study|Participant moved to another site|1|||
156774675|NCT01394276|565926762|FG000|Overall Study|Pregnancy|1|||
156774676|NCT01394276|565926762|FG000|Overall Study|unavailability of drug at the Hospital|2|||
156774677|NCT01394276|565926762|FG000|Overall Study|Symptoms of concurrent diseases|1|||
156774678|NCT03507790|565926763|FG000|Overall Study|Adverse Event|0|||
156774679|NCT03507790|565926764|FG001|Overall Study|Adverse Event|11|||
156774680|NCT03507790|565926765|FG002|Overall Study|Adverse Event|3|||
156774681|NCT03507790|565926763|FG000|Overall Study|Withdrawal by Subject|2|||
156774682|NCT03507790|565926764|FG001|Overall Study|Withdrawal by Subject|0|||
156774683|NCT03507790|565926765|FG002|Overall Study|Withdrawal by Subject|0|||
156774684|NCT03507790|565926763|FG000|Overall Study|Subject moved to another location|1|||
156774685|NCT03507790|565926764|FG001|Overall Study|Subject moved to another location|2|||
156774686|NCT03507790|565926765|FG002|Overall Study|Subject moved to another location|0|||
156774687|NCT03507790|565926763|FG000|Overall Study|Non-compliance with study drug|0|||
156774688|NCT03507790|565926764|FG001|Overall Study|Non-compliance with study drug|0|||
156774689|NCT03507790|565926765|FG002|Overall Study|Non-compliance with study drug|1|||
156774690|NCT03507790|565926763|FG000|Overall Study|COVID 19 Pandemic|0|||
156774691|NCT03507790|565926764|FG001|Overall Study|COVID 19 Pandemic|1|||
156774692|NCT03507790|565926765|FG002|Overall Study|COVID 19 Pandemic|0|||
156324682|NCT00410202|564287710|FG002|On-Treatment|Lack of Efficacy|0|||
156324683|NCT00410202|564287708|FG000|On-Treatment|Withdrawal by Subject|2|||
156324684|NCT00410202|564287709|FG001|On-Treatment|Withdrawal by Subject|1|||
156324685|NCT00410202|564287710|FG002|On-Treatment|Withdrawal by Subject|1|||
156324686|NCT00410202|564287708|FG000|On-Treatment|Other Reason|0|||
156774693|NCT03507790|565926763|FG000|Overall Study|Lost to Follow-up|0|||
156774694|NCT03507790|565926764|FG001|Overall Study|Lost to Follow-up|1|||
156774695|NCT03507790|565926765|FG002|Overall Study|Lost to Follow-up|0|||
156774696|NCT03507790|565926763|FG000|Overall Study|Discontinuation of the trial at the site|1|||
156774697|NCT03507790|565926764|FG001|Overall Study|Discontinuation of the trial at the site|1|||
156774698|NCT03507790|565926765|FG002|Overall Study|Discontinuation of the trial at the site|0|||
156324687|NCT00410202|564287709|FG001|On-Treatment|Other Reason|0|||
156774699|NCT03507790|565926763|FG000|Overall Study|Randomized in error|0|||
156774700|NCT03507790|565926764|FG001|Overall Study|Randomized in error|0|||
156774701|NCT03507790|565926765|FG002|Overall Study|Randomized in error|1|||
156324688|NCT00410202|564287710|FG002|On-Treatment|Other Reason|1|||
156774702|NCT00157755|565926767|FG000|Overall Study|Death|2|||
156774703|NCT00157755|565926768|FG001|Overall Study|Death|3|||
156774704|NCT00157755|565926769|FG002|Overall Study|Death|3|||
156774705|NCT00157755|565926770|FG003|Overall Study|Death|2|||
156774706|NCT00157755|565926771|FG004|Overall Study|Death|0|||
156524162|NCT00320541|565013790|FG000|Overall Study|Protocol Violation|0|||
156524163|NCT00320541|565013791|FG001|Overall Study|Protocol Violation|1|||
156524164|NCT00320541|565013790|FG000|Overall Study|Withdrawal by Subject|12|||
156524165|NCT00320541|565013791|FG001|Overall Study|Withdrawal by Subject|16|||
156524166|NCT00320541|565013790|FG000|Overall Study|Physician Decision|9|||
156524167|NCT00320541|565013791|FG001|Overall Study|Physician Decision|13|||
156524168|NCT00320541|565013790|FG000|Overall Study|Other|3|||
156524169|NCT00320541|565013791|FG001|Overall Study|Other|4|||
156524170|NCT00320541|565013790|FG000|Overall Study|Sponsor Decision|2|||
156524171|NCT00320541|565013791|FG001|Overall Study|Sponsor Decision|1|||
156524172|NCT00320541|565013790|FG000|Overall Study|Death due to Study Disease|1|||
156524173|NCT00320541|565013791|FG001|Overall Study|Death due to Study Disease|3|||
156524174|NCT00320541|565013790|FG000|Overall Study|Death due to Adverse Event(s)|1|||
156524175|NCT00320541|565013791|FG001|Overall Study|Death due to Adverse Event(s)|0|||
156524176|NCT00320541|565013790|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
156524177|NCT00320541|565013791|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
156524178|NCT04363801|565013792|FG000|Overall Study|Death|18|||
156524179|NCT04363801|565013793|FG001|Overall Study|Death|14|||
156524180|NCT04363801|565013794|FG002|Overall Study|Death|16|||
156524181|NCT04363801|565013795|FG003|Overall Study|Death|48|||
156524182|NCT04363801|565013796|FG004|Overall Study|Death|38|||
156524183|NCT04363801|565013792|FG000|Overall Study|Withdrawal by Subject|1|||
156524184|NCT04363801|565013793|FG001|Overall Study|Withdrawal by Subject|6|||
156524185|NCT04363801|565013794|FG002|Overall Study|Withdrawal by Subject|1|||
156524186|NCT04363801|565013795|FG003|Overall Study|Withdrawal by Subject|4|||
156524187|NCT04363801|565013796|FG004|Overall Study|Withdrawal by Subject|14|||
156524188|NCT04363801|565013792|FG000|Overall Study|Sponsor Decision|6|||
156524189|NCT04363801|565013793|FG001|Overall Study|Sponsor Decision|4|||
156524190|NCT04363801|565013794|FG002|Overall Study|Sponsor Decision|10|||
156524191|NCT04363801|565013795|FG003|Overall Study|Sponsor Decision|33|||
156524192|NCT04363801|565013796|FG004|Overall Study|Sponsor Decision|32|||
156524193|NCT04363801|565013792|FG000|Overall Study|Lost to Follow-up|0|||
156524194|NCT04363801|565013793|FG001|Overall Study|Lost to Follow-up|0|||
156524195|NCT04363801|565013794|FG002|Overall Study|Lost to Follow-up|1|||
156524196|NCT04363801|565013795|FG003|Overall Study|Lost to Follow-up|0|||
156524197|NCT04363801|565013796|FG004|Overall Study|Lost to Follow-up|1|||
156524198|NCT01146054|565013797|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
156524199|NCT01146054|565013797|FG000|Overall Study|Rapid tumor progression|2|||
156524200|NCT01146054|565013797|FG000|Overall Study|Other illness precluded treatment|2|||
156524201|NCT01146054|565013797|FG000|Overall Study|Lost to Follow-up|1|||
156524202|NCT01155375|565013798|FG000|Overall Study|Adverse Event|1|||
156524203|NCT01155375|565013799|FG001|Overall Study|Adverse Event|0|||
156524204|NCT04335812|565013800|FG000|Overall Study|Withdrawal by Subject|1|||
156524205|NCT04335812|565013801|FG001|Overall Study|Withdrawal by Subject|3|||
156524206|NCT04335812|565013800|FG000|Overall Study|Lost to Follow-up|12|||
156524207|NCT04335812|565013801|FG001|Overall Study|Lost to Follow-up|12|||
156524208|NCT04335812|565013800|FG000|Overall Study|Did not engage in the intervention|22|||
156524209|NCT04335812|565013801|FG001|Overall Study|Did not engage in the intervention|18|||
156524210|NCT02901041|565013802|FG000|Overall Study|Withdrawal by PI|4|||
156524211|NCT02901041|565013803|FG001|Overall Study|Withdrawal by PI|8|||
156524212|NCT02901041|565013802|FG000|Overall Study|Withdrawal by Subject|7|||
156524213|NCT02901041|565013803|FG001|Overall Study|Withdrawal by Subject|3|||
156524214|NCT03818204|565013807|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524215|NCT03818204|565013808|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524216|NCT03818204|565013809|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524217|NCT03818204|565013810|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524218|NCT03818204|565013811|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
156524219|NCT03818204|565013812|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156774707|NCT00157755|565926772|FG005|Overall Study|Death|0|||
156774708|NCT00157755|565926767|FG000|Overall Study|Lost to Follow-up|0|||
156774709|NCT00157755|565926768|FG001|Overall Study|Lost to Follow-up|0|||
156774710|NCT00157755|565926769|FG002|Overall Study|Lost to Follow-up|1|||
156774711|NCT00157755|565926770|FG003|Overall Study|Lost to Follow-up|0|||
156774712|NCT00157755|565926771|FG004|Overall Study|Lost to Follow-up|0|||
156524220|NCT03818204|565013813|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524221|NCT03818204|565013814|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524222|NCT03818204|565013815|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524223|NCT03818204|565013816|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524224|NCT03818204|565013817|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524225|NCT03818204|565013818|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156774713|NCT00157755|565926772|FG005|Overall Study|Lost to Follow-up|0|||
156524226|NCT03818204|565013819|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524227|NCT03818204|565013820|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
156774714|NCT00157755|565926767|FG000|Overall Study|Withdrawal by Subject|0|||
156774715|NCT00157755|565926768|FG001|Overall Study|Withdrawal by Subject|0|||
156429103|NCT03370133|564661887|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
156659919|NCT03130699|565501075|FG002|Overall Study|Withdrawal by Subject|0|||
156429104|NCT03370133|564661888|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
156429105|NCT03370133|564661889|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
156429106|NCT03370133|564661884|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
156429107|NCT03370133|564661885|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
156429108|NCT03370133|564661886|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
156429109|NCT03370133|564661887|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
156429110|NCT03370133|564661888|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
156429111|NCT03370133|564661889|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
156429112|NCT03370133|564661884|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
156429113|NCT03370133|564661885|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
156429114|NCT03370133|564661886|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
156429115|NCT03370133|564661887|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
156429116|NCT03370133|564661888|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
156429117|NCT03370133|564661889|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
156429118|NCT03370133|564661884|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
156429119|NCT03370133|564661885|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
156429120|NCT03370133|564661886|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
156429121|NCT03370133|564661887|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
156659920|NCT03130699|565501073|FG000|Overall Study|Withdrawal by PI|1|||
156659921|NCT03130699|565501074|FG001|Overall Study|Withdrawal by PI|2|||
156659922|NCT03130699|565501075|FG002|Overall Study|Withdrawal by PI|5|||
156659923|NCT03130699|565501073|FG000|Overall Study|Death|0|||
156659924|NCT03130699|565501074|FG001|Overall Study|Death|0|||
156659925|NCT03130699|565501075|FG002|Overall Study|Death|1|||
156659926|NCT03561883|565501078|FG000|Overall Study|Adverse Event|10|||
156659927|NCT03561883|565501079|FG001|Overall Study|Adverse Event|13|||
156659928|NCT03561883|565501078|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156659929|NCT03561883|565501079|FG001|Overall Study|Non-Compliance With Study Drug|2|||
156659930|NCT03561883|565501078|FG000|Overall Study|Protocol Violation|2|||
156659931|NCT03561883|565501079|FG001|Overall Study|Protocol Violation|3|||
156659932|NCT03561883|565501078|FG000|Overall Study|Withdrawal by Subject|14|||
156659933|NCT03561883|565501079|FG001|Overall Study|Withdrawal by Subject|6|||
156659934|NCT03561883|565501078|FG000|Overall Study|Lost to Follow-up|2|||
156659935|NCT03561883|565501079|FG001|Overall Study|Lost to Follow-up|6|||
156659936|NCT03561883|565501078|FG000|Overall Study|Study Terminated by Sponsor|12|||
156659937|NCT03561883|565501079|FG001|Overall Study|Study Terminated by Sponsor|11|||
156659938|NCT03561883|565501078|FG000|Overall Study|Physician Decision|1|||
156659939|NCT03561883|565501079|FG001|Overall Study|Physician Decision|0|||
156659940|NCT03561883|565501078|FG000|Overall Study|Randomized by Mistake|1|||
156659941|NCT03561883|565501079|FG001|Overall Study|Randomized by Mistake|0|||
156659942|NCT03561883|565501078|FG000|Overall Study|Other, Not Specified|3|||
156659943|NCT03561883|565501079|FG001|Overall Study|Other, Not Specified|2|||
156659944|NCT05956665|565501080|FG000|Overall Study|Death|1|||
156659945|NCT05956665|565501080|FG000|Overall Study|Withdrawal by Subject|1|||
156659946|NCT01606306|565501087|FG000|Overall Study|Lack of Efficacy|2|||
156659947|NCT01606306|565501088|FG001|Overall Study|Lack of Efficacy|1|||
156659948|NCT01606306|565501089|FG002|Overall Study|Lack of Efficacy|4|||
156659949|NCT01606306|565501090|FG003|Overall Study|Lack of Efficacy|4|||
156659950|NCT01606306|565501091|FG004|Overall Study|Lack of Efficacy|1|||
156659951|NCT01606306|565501092|FG005|Overall Study|Lack of Efficacy|2|||
156659952|NCT01606306|565501087|FG000|Overall Study|Adverse Event|1|||
156659953|NCT01606306|565501088|FG001|Overall Study|Adverse Event|0|||
156659954|NCT01606306|565501089|FG002|Overall Study|Adverse Event|1|||
156659955|NCT01606306|565501090|FG003|Overall Study|Adverse Event|1|||
156659956|NCT01606306|565501091|FG004|Overall Study|Adverse Event|2|||
156659957|NCT01606306|565501092|FG005|Overall Study|Adverse Event|0|||
156659958|NCT01606306|565501087|FG000|Overall Study|Lost to Follow-up|7|||
156659959|NCT01606306|565501088|FG001|Overall Study|Lost to Follow-up|4|||
156659960|NCT01606306|565501089|FG002|Overall Study|Lost to Follow-up|5|||
156429122|NCT03370133|564661888|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
156429123|NCT03370133|564661889|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
156429124|NCT03370133|564661884|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
156429125|NCT03370133|564661885|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
156429126|NCT03370133|564661886|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
156659961|NCT01606306|565501090|FG003|Overall Study|Lost to Follow-up|4|||
156659962|NCT01606306|565501091|FG004|Overall Study|Lost to Follow-up|3|||
156659963|NCT01606306|565501092|FG005|Overall Study|Lost to Follow-up|5|||
156659964|NCT01606306|565501087|FG000|Overall Study|Withdrawal by Subject|4|||
156659965|NCT01606306|565501088|FG001|Overall Study|Withdrawal by Subject|3|||
156659966|NCT01606306|565501089|FG002|Overall Study|Withdrawal by Subject|4|||
156659967|NCT01606306|565501090|FG003|Overall Study|Withdrawal by Subject|4|||
156659968|NCT01606306|565501091|FG004|Overall Study|Withdrawal by Subject|5|||
156659969|NCT01606306|565501092|FG005|Overall Study|Withdrawal by Subject|4|||
156659970|NCT01606306|565501087|FG000|Overall Study|Physician Decision|1|||
156659971|NCT01606306|565501088|FG001|Overall Study|Physician Decision|2|||
156659972|NCT01606306|565501089|FG002|Overall Study|Physician Decision|0|||
156659973|NCT01606306|565501090|FG003|Overall Study|Physician Decision|0|||
156659974|NCT01606306|565501091|FG004|Overall Study|Physician Decision|0|||
156659975|NCT01606306|565501092|FG005|Overall Study|Physician Decision|0|||
156659976|NCT02003183|565501095|FG000|Overall Study|Lost to Follow-up|0|||
156774716|NCT00157755|565926769|FG002|Overall Study|Withdrawal by Subject|1|||
156774717|NCT00157755|565926770|FG003|Overall Study|Withdrawal by Subject|1|||
156774718|NCT00157755|565926771|FG004|Overall Study|Withdrawal by Subject|1|||
156774719|NCT00157755|565926772|FG005|Overall Study|Withdrawal by Subject|2|||
156774720|NCT00157755|565926767|FG000|Overall Study|Explant due to infection|0|||
156774721|NCT00157755|565926768|FG001|Overall Study|Explant due to infection|0|||
156774722|NCT00157755|565926769|FG002|Overall Study|Explant due to infection|1|||
156774723|NCT00157755|565926770|FG003|Overall Study|Explant due to infection|0|||
156774724|NCT00157755|565926771|FG004|Overall Study|Explant due to infection|0|||
156774725|NCT00157755|565926772|FG005|Overall Study|Explant due to infection|0|||
156774726|NCT00157755|565926767|FG000|Overall Study|Medical reason|0|||
156774727|NCT00157755|565926768|FG001|Overall Study|Medical reason|0|||
156774728|NCT00157755|565926769|FG002|Overall Study|Medical reason|1|||
156659977|NCT02003183|565501096|FG001|Overall Study|Lost to Follow-up|2|||
156774729|NCT00157755|565926770|FG003|Overall Study|Medical reason|1|||
156774730|NCT00157755|565926771|FG004|Overall Study|Medical reason|0|||
156774731|NCT00157755|565926772|FG005|Overall Study|Medical reason|0|||
156774732|NCT00157755|565926767|FG000|Overall Study|Study site closure|0|||
156324689|NCT00410202|564287708|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
156324690|NCT00410202|564287709|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
156324691|NCT00410202|564287710|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
156324692|NCT00410202|564287708|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
156324693|NCT00410202|564287709|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
156324694|NCT00410202|564287710|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
156324695|NCT00410202|564287708|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
156324696|NCT00410202|564287709|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
156324697|NCT00410202|564287710|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
156324698|NCT00122278|564289364|FG000|Overall Study|Lost to Follow-up|2|||
156324699|NCT00122278|564289365|FG001|Overall Study|Lost to Follow-up|0|||
156324700|NCT01002482|564289366|FG000|Overall Study|Withdrawal by Subject|14|||
156324701|NCT01002482|564289367|FG001|Overall Study|Withdrawal by Subject|21|||
156324702|NCT01002482|564289366|FG000|Overall Study|Included twice|1|||
156324703|NCT01002482|564289367|FG001|Overall Study|Included twice|0|||
156324704|NCT02247531|564289368|FG000|Overall Study|Adverse Event|3|||
156324705|NCT02247531|564289369|FG001|Overall Study|Adverse Event|4|||
156324706|NCT02247531|564289370|FG002|Overall Study|Adverse Event|9|||
156324707|NCT02247531|564289368|FG000|Overall Study|Death|8|||
156324708|NCT02247531|564289369|FG001|Overall Study|Death|9|||
156324709|NCT02247531|564289370|FG002|Overall Study|Death|5|||
156324710|NCT02247531|564289368|FG000|Overall Study|Lost to Follow-up|1|||
156324711|NCT02247531|564289369|FG001|Overall Study|Lost to Follow-up|8|||
156324712|NCT02247531|564289370|FG002|Overall Study|Lost to Follow-up|3|||
156324713|NCT02247531|564289368|FG000|Overall Study|Non-compliance|2|||
156324714|NCT02247531|564289369|FG001|Overall Study|Non-compliance|2|||
156324715|NCT02247531|564289370|FG002|Overall Study|Non-compliance|0|||
156324716|NCT02247531|564289368|FG000|Overall Study|Withdrawal by Subject|26|||
156324717|NCT02247531|564289369|FG001|Overall Study|Withdrawal by Subject|31|||
156324718|NCT02247531|564289370|FG002|Overall Study|Withdrawal by Subject|25|||
156324719|NCT02247531|564289368|FG000|Overall Study|Study Terminated by Sponsor|64|||
156324720|NCT02247531|564289369|FG001|Overall Study|Study Terminated by Sponsor|66|||
156324721|NCT02247531|564289370|FG002|Overall Study|Study Terminated by Sponsor|62|||
156324722|NCT02247531|564289368|FG000|Overall Study|Physician Decision|0|||
156324723|NCT02247531|564289369|FG001|Overall Study|Physician Decision|2|||
156324724|NCT02247531|564289370|FG002|Overall Study|Physician Decision|2|||
156324725|NCT02247531|564289368|FG000|Overall Study|Unspecified Reason|2|||
156324726|NCT02247531|564289369|FG001|Overall Study|Unspecified Reason|3|||
156324727|NCT02247531|564289370|FG002|Overall Study|Unspecified Reason|4|||
156324728|NCT04521777|564289371|FG000|Overall Study|Death|2|||
156324729|NCT04521777|564289371|FG000|Overall Study|Withdrawal by Subject|2|||
156324730|NCT00608543|564289372|FG000|Overall Study|Adverse Event|4|||
156324731|NCT03555435|564289380|FG000|Overall Study|Lost to Follow-up|17|||
156324732|NCT03555435|564289381|FG001|Overall Study|Lost to Follow-up|19|||
156324733|NCT03555435|564289382|FG002|Overall Study|Lost to Follow-up|8|||
156324734|NCT01323946|564289385|FG000|Overall Study|Lost to Follow-up|0|||
156324735|NCT01323946|564289386|FG001|Overall Study|Lost to Follow-up|1|||
156324736|NCT01323946|564289387|FG002|Overall Study|Lost to Follow-up|0|||
156324737|NCT01323946|564289385|FG000|Overall Study|Parents refused the last blood draw|1|||
156324738|NCT01323946|564289386|FG001|Overall Study|Parents refused the last blood draw|0|||
156324739|NCT01323946|564289387|FG002|Overall Study|Parents refused the last blood draw|0|||
156659978|NCT01759290|565501099|FG000|Overall Study|Subjects withdrawn consent|5|||
156774733|NCT00157755|565926768|FG001|Overall Study|Study site closure|1|||
156774734|NCT00157755|565926769|FG002|Overall Study|Study site closure|0|||
156774735|NCT00157755|565926770|FG003|Overall Study|Study site closure|0|||
156774736|NCT00157755|565926771|FG004|Overall Study|Study site closure|0|||
156774737|NCT00157755|565926772|FG005|Overall Study|Study site closure|0|||
156774738|NCT00157755|565926767|FG000|Overall Study|Subject non-compliance|0|||
156774739|NCT00157755|565926768|FG001|Overall Study|Subject non-compliance|0|||
156774740|NCT00157755|565926769|FG002|Overall Study|Subject non-compliance|0|||
156774741|NCT00157755|565926770|FG003|Overall Study|Subject non-compliance|0|||
156774742|NCT00157755|565926771|FG004|Overall Study|Subject non-compliance|0|||
156774743|NCT00157755|565926772|FG005|Overall Study|Subject non-compliance|1|||
156774744|NCT00157755|565926767|FG000|Overall Study|Study completion|0|||
156774745|NCT00157755|565926768|FG001|Overall Study|Study completion|0|||
156774746|NCT00157755|565926769|FG002|Overall Study|Study completion|0|||
156774747|NCT00157755|565926770|FG003|Overall Study|Study completion|0|||
156774748|NCT00157755|565926771|FG004|Overall Study|Study completion|1|||
156774749|NCT00157755|565926772|FG005|Overall Study|Study completion|2|||
156774750|NCT01933594|565926773|FG000|Overall Study|Lost to Follow-up|1|||
156774751|NCT01933594|565926774|FG001|Overall Study|Lost to Follow-up|0|||
156774752|NCT01933594|565926775|FG002|Overall Study|Lost to Follow-up|0|||
156774753|NCT01933594|565926776|FG003|Overall Study|Lost to Follow-up|0|||
156774754|NCT01933594|565926777|FG004|Overall Study|Lost to Follow-up|1|||
156774755|NCT01933594|565926778|FG005|Overall Study|Lost to Follow-up|0|||
156774756|NCT01933594|565926773|FG000|Overall Study|Ineligible for subsequent study step|0|||
156774757|NCT01933594|565926774|FG001|Overall Study|Ineligible for subsequent study step|0|||
156774758|NCT01933594|565926775|FG002|Overall Study|Ineligible for subsequent study step|0|||
156774759|NCT01933594|565926776|FG003|Overall Study|Ineligible for subsequent study step|0|||
156774760|NCT01933594|565926777|FG004|Overall Study|Ineligible for subsequent study step|1|||
156774761|NCT01933594|565926778|FG005|Overall Study|Ineligible for subsequent study step|0|||
156774762|NCT03570892|565926789|FG000|Overall Study|Death|51|||
156774763|NCT03570892|565926790|FG001|Overall Study|Death|45|||
156774764|NCT03570892|565926789|FG000|Overall Study|Subject decision|5|||
156774765|NCT03570892|565926790|FG001|Overall Study|Subject decision|3|||
156774766|NCT03570892|565926789|FG000|Overall Study|Protocol Violation|1|||
156774767|NCT03570892|565926790|FG001|Overall Study|Protocol Violation|4|||
156774768|NCT03570892|565926789|FG000|Overall Study|Physician Decision|0|||
156774769|NCT03570892|565926790|FG001|Overall Study|Physician Decision|2|||
156774770|NCT02472405|565928328|FG000|Overall Study|Lost to Follow-up|9|||
156774771|NCT02472405|565928328|FG000|Overall Study|Adverse Event|1|||
156774772|NCT01431976|565928329|FG000|Overall Study|Adverse Event|6|||
156774773|NCT01431976|565928329|FG000|Overall Study|Lack of Efficacy|2|||
156774774|NCT01431976|565928329|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
156774775|NCT01431976|565928329|FG000|Overall Study|Physician Decision|1|||
156774776|NCT01431976|565928329|FG000|Overall Study|Withdrawal by Subject|1|||
156774777|NCT01134042|565928336|FG000|Overall Study|Adverse Event|3|||
156774778|NCT01134042|565928337|FG001|Overall Study|Adverse Event|7|||
156774779|NCT01134042|565928338|FG002|Overall Study|Adverse Event|2|||
156774780|NCT01134042|565928336|FG000|Overall Study|Lack of Efficacy|21|||
156774781|NCT01134042|565928337|FG001|Overall Study|Lack of Efficacy|6|||
156774782|NCT01134042|565928338|FG002|Overall Study|Lack of Efficacy|18|||
156429127|NCT03370133|564661887|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
156429128|NCT03370133|564661888|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
156429129|NCT03370133|564661889|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
156429130|NCT03370133|564661884|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156429131|NCT03370133|564661885|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156429132|NCT03370133|564661886|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156429133|NCT03370133|564661887|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156429134|NCT03370133|564661888|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
156429135|NCT03370133|564661889|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156429136|NCT03370133|564661884|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156774783|NCT01134042|565928336|FG000|Overall Study|Protocol Violation|5|||
156774784|NCT01134042|565928337|FG001|Overall Study|Protocol Violation|3|||
156774785|NCT01134042|565928338|FG002|Overall Study|Protocol Violation|5|||
156774786|NCT01134042|565928336|FG000|Overall Study|Lost to Follow-up|2|||
156429137|NCT03370133|564661885|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156774787|NCT01134042|565928337|FG001|Overall Study|Lost to Follow-up|0|||
156774788|NCT01134042|565928338|FG002|Overall Study|Lost to Follow-up|1|||
156774789|NCT01134042|565928336|FG000|Overall Study|Physician Decision|4|||
156774790|NCT01134042|565928337|FG001|Overall Study|Physician Decision|8|||
156774791|NCT01134042|565928338|FG002|Overall Study|Physician Decision|1|||
156774792|NCT01134042|565928336|FG000|Overall Study|Withdrawal by Subject|13|||
156774793|NCT01134042|565928337|FG001|Overall Study|Withdrawal by Subject|4|||
156774794|NCT01134042|565928338|FG002|Overall Study|Withdrawal by Subject|7|||
156774795|NCT03345004|565928339|FG000|Overall Study|Physician Decision|1|||
156774796|NCT03345004|565928340|FG001|Overall Study|Physician Decision|0|||
156774797|NCT03345004|565928339|FG000|Overall Study|Withdrawal by Subject|0|||
156774798|NCT03345004|565928340|FG001|Overall Study|Withdrawal by Subject|1|||
156659979|NCT01759290|565501099|FG000|Overall Study|Physician Decision|2|||
156774799|NCT01013753|565928343|FG000|Overall Study|Adverse Event|8|||
156774800|NCT01013753|565928343|FG000|Overall Study|Protocol Violation|3|||
156774801|NCT01013753|565928343|FG000|Overall Study|Lost to Follow-up|1|||
156774802|NCT01013753|565928343|FG000|Overall Study|Withdrawal by Subject|2|||
156774803|NCT01013753|565928343|FG000|Overall Study|Other|2|||
156774804|NCT01091259|565928346|FG000|Overall Study|Adverse Event|3|||
156774805|NCT01091259|565928346|FG000|Overall Study|Lack of Efficacy|2|||
156774806|NCT01541748|565928347|FG000|Overall Study|Lost to Follow-up|17|||
156774807|NCT01541748|565928347|FG000|Overall Study|Moved out of state|1|||
156774808|NCT01541748|565928347|FG000|Overall Study|Withdrawal by Subject|7|||
156774809|NCT01541748|565928347|FG000|Overall Study|Screen failure|5|||
156774810|NCT01541748|565928347|FG000|Overall Study|Did not receive study device|1|||
156774811|NCT01283386|565928348|FG000|Overall Study|Death|2|||
156774812|NCT01283386|565928349|FG001|Overall Study|Death|0|||
156774813|NCT01283386|565928348|FG000|Overall Study|Withdrawal by Subject|2|||
156774814|NCT01283386|565928349|FG001|Overall Study|Withdrawal by Subject|1|||
156774815|NCT01283386|565928348|FG000|Overall Study|Relapse of underlying disease|1|||
156774816|NCT01283386|565928349|FG001|Overall Study|Relapse of underlying disease|3|||
156774817|NCT01283386|565928348|FG000|Overall Study|Progression of underlying disease|2|||
156774818|NCT01283386|565928349|FG001|Overall Study|Progression of underlying disease|7|||
156429138|NCT03370133|564661886|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156429139|NCT03370133|564661887|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156429140|NCT03370133|564661888|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156429141|NCT03370133|564661889|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
156429142|NCT06688370|564661890|FG000|Overall Study|Discontinued the treatment|1|||
156429143|NCT06688370|564661890|FG000|Overall Study|Prohibited treatment taken|4|||
156429144|NCT04540835|564661891|FG000|Week 1|Lost to Follow-up|1|||
156429145|NCT04540835|564661891|FG000|Week 6|Pregnancy|1|||
156429146|NCT04540835|564661891|FG000|Week 6|Lack of Efficacy|1|||
156429147|NCT04487080|564661892|FG000|Overall Study|Withdrawal by Subject|19|||
156429148|NCT04487080|564661893|FG001|Overall Study|Withdrawal by Subject|18|||
156429149|NCT04487080|564661894|FG002|Overall Study|Withdrawal by Subject|13|||
156429150|NCT04487080|564661892|FG000|Overall Study|Lost to Follow-up|3|||
156429151|NCT04487080|564661893|FG001|Overall Study|Lost to Follow-up|1|||
156429152|NCT04487080|564661894|FG002|Overall Study|Lost to Follow-up|0|||
156429153|NCT04487080|564661892|FG000|Overall Study|Ongoing|313|||
156429154|NCT04487080|564661893|FG001|Overall Study|Ongoing|297|||
156429155|NCT04487080|564661894|FG002|Overall Study|Ongoing|149|||
156429156|NCT03105336|564661895|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
156429157|NCT03105336|564661896|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
156429158|NCT03105336|564661895|FG000|Overall Study|Death|40|||
156429159|NCT03105336|564661896|FG001|Overall Study|Death|8|||
156429160|NCT03105336|564661895|FG000|Overall Study|Lost to Follow-up|13|||
156429161|NCT03105336|564661896|FG001|Overall Study|Lost to Follow-up|2|||
156429162|NCT03105336|564661895|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
156429163|NCT03105336|564661896|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
156429164|NCT03105336|564661895|FG000|Overall Study|Reason Not Specified|3|||
156429165|NCT03105336|564661896|FG001|Overall Study|Reason Not Specified|3|||
156429166|NCT03105336|564661895|FG000|Overall Study|Investigator Decision|3|||
156429167|NCT03105336|564661896|FG001|Overall Study|Investigator Decision|0|||
156429168|NCT03944512|564661897|FG000|Overall Study|Death|0|||
156429169|NCT03944512|564661898|FG001|Overall Study|Death|0|||
156429170|NCT03944512|564661899|FG002|Overall Study|Death|1|||
156429171|NCT03944512|564661900|FG003|Overall Study|Death|2|||
156429172|NCT03944512|564661897|FG000|Overall Study|Lost to Follow-up|0|||
156429173|NCT03944512|564661898|FG001|Overall Study|Lost to Follow-up|0|||
156429174|NCT03944512|564661899|FG002|Overall Study|Lost to Follow-up|4|||
156429175|NCT03944512|564661900|FG003|Overall Study|Lost to Follow-up|4|||
156429176|NCT03944512|564661897|FG000|Overall Study|refused follow-up|0|||
156429177|NCT03944512|564661898|FG001|Overall Study|refused follow-up|0|||
156429178|NCT03944512|564661899|FG002|Overall Study|refused follow-up|2|||
156429179|NCT03944512|564661900|FG003|Overall Study|refused follow-up|2|||
156429180|NCT00151996|564663206|FG000|Overall Study|Adverse Event|3|||
156429181|NCT00151996|564663207|FG001|Overall Study|Adverse Event|2|||
156429182|NCT00151996|564663206|FG000|Overall Study|Withdrawal by Subject|1|||
156429183|NCT00151996|564663207|FG001|Overall Study|Withdrawal by Subject|1|||
156429184|NCT00151996|564663206|FG000|Overall Study|Protocol Violation|1|||
156429185|NCT00151996|564663207|FG001|Overall Study|Protocol Violation|2|||
156429186|NCT00151996|564663206|FG000|Overall Study|Sponsor's decision|0|||
156429187|NCT00151996|564663207|FG001|Overall Study|Sponsor's decision|2|||
156774819|NCT01283386|565928348|FG000|Overall Study|Reason not specified|1|||
156774820|NCT01283386|565928349|FG001|Overall Study|Reason not specified|0|||
156774821|NCT01283386|565928348|FG000|Overall Study|Protocol Violation|0|||
156524228|NCT03818204|565013821|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524229|NCT03818204|565013822|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524230|NCT03818204|565013823|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524231|NCT03818204|565013824|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524232|NCT03818204|565013825|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
156524233|NCT03818204|565013807|FG000|Overall Study|Physician Decision|0|||
156524234|NCT03818204|565013808|FG001|Overall Study|Physician Decision|0|||
156524235|NCT03818204|565013809|FG002|Overall Study|Physician Decision|0|||
156524236|NCT03818204|565013810|FG003|Overall Study|Physician Decision|0|||
156524237|NCT03818204|565013811|FG004|Overall Study|Physician Decision|0|||
156524238|NCT03818204|565013812|FG005|Overall Study|Physician Decision|0|||
156524239|NCT03818204|565013813|FG006|Overall Study|Physician Decision|0|||
156524240|NCT03818204|565013814|FG007|Overall Study|Physician Decision|0|||
156524241|NCT03818204|565013815|FG008|Overall Study|Physician Decision|0|||
156524242|NCT03818204|565013816|FG009|Overall Study|Physician Decision|0|||
156524243|NCT03818204|565013817|FG010|Overall Study|Physician Decision|0|||
156524244|NCT03818204|565013818|FG011|Overall Study|Physician Decision|0|||
156524245|NCT03818204|565013819|FG012|Overall Study|Physician Decision|0|||
156524246|NCT03818204|565013820|FG013|Overall Study|Physician Decision|0|||
156524247|NCT03818204|565013821|FG014|Overall Study|Physician Decision|1|||
156524248|NCT03818204|565013822|FG015|Overall Study|Physician Decision|0|||
156524249|NCT03818204|565013823|FG016|Overall Study|Physician Decision|0|||
156524250|NCT03818204|565013824|FG017|Overall Study|Physician Decision|0|||
156524251|NCT03818204|565013825|FG018|Overall Study|Physician Decision|0|||
156524252|NCT00887250|565013826|FG000|Overall Study|Adverse Event|3|||
156524253|NCT00887250|565013827|FG001|Overall Study|Adverse Event|0|||
156524254|NCT00887250|565013828|FG002|Overall Study|Adverse Event|7|||
156524255|NCT00887250|565013826|FG000|Overall Study|Lack of Efficacy|9|||
156524256|NCT00887250|565013827|FG001|Overall Study|Lack of Efficacy|6|||
156524257|NCT00887250|565013828|FG002|Overall Study|Lack of Efficacy|1|||
156524258|NCT00887250|565013826|FG000|Overall Study|Lost to Follow-up|2|||
156524259|NCT00887250|565013827|FG001|Overall Study|Lost to Follow-up|3|||
156524260|NCT00887250|565013828|FG002|Overall Study|Lost to Follow-up|1|||
156524261|NCT00887250|565013826|FG000|Overall Study|Protocol Violation|2|||
156524262|NCT00887250|565013827|FG001|Overall Study|Protocol Violation|2|||
156524263|NCT00887250|565013828|FG002|Overall Study|Protocol Violation|1|||
156524264|NCT00887250|565013826|FG000|Overall Study|Withdrawal by Subject|2|||
156524265|NCT00887250|565013827|FG001|Overall Study|Withdrawal by Subject|1|||
156524266|NCT00887250|565013828|FG002|Overall Study|Withdrawal by Subject|2|||
156524267|NCT00887250|565013826|FG000|Overall Study|Patient uncooperative|0|||
156524268|NCT00887250|565013827|FG001|Overall Study|Patient uncooperative|0|||
156524269|NCT00887250|565013828|FG002|Overall Study|Patient uncooperative|1|||
156524270|NCT05754333|565013829|FG000|Overall Study|Miscellaneous|3|||
156524271|NCT05754333|565013830|FG001|Overall Study|Miscellaneous|0|||
156524272|NCT05754333|565013831|FG002|Overall Study|Miscellaneous|0|||
156524273|NCT05754333|565013832|FG003|Overall Study|Miscellaneous|0|||
156524274|NCT05754333|565013829|FG000|Overall Study|Lost to Follow-up|2|||
156524275|NCT05754333|565013830|FG001|Overall Study|Lost to Follow-up|1|||
156524276|NCT05754333|565013831|FG002|Overall Study|Lost to Follow-up|0|||
156524277|NCT05754333|565013832|FG003|Overall Study|Lost to Follow-up|1|||
156524278|NCT03864146|565013833|FG000|Overall Study|Lost to Follow-up|14|||
156524279|NCT03864146|565013834|FG001|Overall Study|Lost to Follow-up|23|||
156524280|NCT03864146|565013833|FG000|Overall Study|Withdrawal by Subject|3|||
156524281|NCT03864146|565013834|FG001|Overall Study|Withdrawal by Subject|2|||
156524282|NCT01112306|565013840|FG000|Overall Study|Death|175|||
156524283|NCT01112306|565013840|FG000|Overall Study|Lost to Follow-up|9|||
156524284|NCT01112306|565013840|FG000|Overall Study|Withdrawal by Subject|31|||
156524285|NCT01112306|565013840|FG000|Overall Study|Other|70|||
156324740|NCT01323946|564289385|FG000|Overall Study|Withdrawal by Subject|2|||
156324741|NCT01323946|564289386|FG001|Overall Study|Withdrawal by Subject|2|||
156524286|NCT00881608|565013841|FG000|Overall Study|Study prematurely terminated|11|||
156524287|NCT00655486|565013847|FG000|Overall Study|Adverse Event|10|||
156524288|NCT00655486|565013847|FG000|Overall Study|Lack of Efficacy|8|||
156524289|NCT00655486|565013847|FG000|Overall Study|Withdrawal by Subject|4|||
156524290|NCT00655486|565013847|FG000|Overall Study|Protocol Violation|1|||
156524291|NCT00655486|565013847|FG000|Overall Study|Unsatisfactory compliance|2|||
156524292|NCT00655486|565013847|FG000|Overall Study|Other: Pregnancy|1|||
156524293|NCT00655486|565013847|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
156524294|NCT00655486|565013847|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
156524295|NCT04218084|565013848|FG000|Overall Study|Adverse Event|7|||
156524296|NCT04218084|565013849|FG001|Overall Study|Adverse Event|2|||
156524297|NCT04218084|565013848|FG000|Overall Study|Withdrawal of Consent|4|||
156524298|NCT04218084|565013849|FG001|Overall Study|Withdrawal of Consent|5|||
156524299|NCT04218084|565013848|FG000|Overall Study|Physician Decision|1|||
156524300|NCT04218084|565013849|FG001|Overall Study|Physician Decision|1|||
156524301|NCT04218084|565013848|FG000|Overall Study|Lost to Follow-up|1|||
156524302|NCT04218084|565013849|FG001|Overall Study|Lost to Follow-up|1|||
156524303|NCT04218084|565013848|FG000|Overall Study|Non-compliance with study drug|1|||
156774822|NCT01283386|565928349|FG001|Overall Study|Protocol Violation|1|||
156774823|NCT00770367|565928350|FG000|First Intervention|Withdrawal by Subject|0|||
156774824|NCT00770367|565928351|FG001|First Intervention|Withdrawal by Subject|2|||
156774825|NCT00770367|565928350|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
156774826|NCT00770367|565928351|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
156774827|NCT00770367|565928350|FG000|Second Intervention|Lost to Follow-up|2|||
156774828|NCT00770367|565928351|FG001|Second Intervention|Lost to Follow-up|0|||
156774829|NCT01898130|565928352|FG000|Treatment|Withdrawal by Subject|2|||
156774830|NCT01898130|565928352|FG000|Treatment|Progressive Disease|4|||
156774831|NCT01898130|565928352|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
156774832|NCT04115059|565928356|FG000|Overall Study|Withdrawal by Subject|1|||
156774833|NCT04115059|565928356|FG000|Overall Study|Lack of Efficacy|2|||
156774834|NCT04491994|565928357|FG000|Overall Study|Withdrawal by Subject|10|||
156774835|NCT04491994|565928358|FG001|Overall Study|Withdrawal by Subject|5|||
156774836|NCT04491994|565928357|FG000|Overall Study|developed fever > 3 days|4|||
156774837|NCT04491994|565928358|FG001|Overall Study|developed fever > 3 days|1|||
156774838|NCT04491994|565928357|FG000|Overall Study|Protocol Violation|11|||
156774839|NCT04491994|565928358|FG001|Overall Study|Protocol Violation|2|||
156774840|NCT04491994|565928357|FG000|Overall Study|Lost to Follow-up|4|||
156774841|NCT04491994|565928358|FG001|Overall Study|Lost to Follow-up|3|||
156774842|NCT02567188|565928364|FG000|Overall Study|Death|10|||
156774843|NCT02567188|565928364|FG000|Overall Study|Terminated Mircera Treatment|9|||
156774844|NCT02567188|565928364|FG000|Overall Study|Lost to Follow-up|5|||
156774845|NCT02567188|565928364|FG000|Overall Study|Adverse Event|1|||
156774846|NCT02567188|565928364|FG000|Overall Study|Withdrawal by Subject|1|||
156774847|NCT02567188|565928364|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
156774848|NCT02567188|565928364|FG000|Overall Study|Moved and Changed Clinic|1|||
156774849|NCT02567188|565928364|FG000|Overall Study|Started Hemodialysis|2|||
156774850|NCT02567188|565928364|FG000|Overall Study|Protocol Violation|5|||
156774851|NCT01033136|565928365|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
156774852|NCT01033136|565928366|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
156774853|NCT05383209|565928367|FG000|Overall Study|Adverse Event: Non-ocular|0|||
156774854|NCT05383209|565928368|FG001|Overall Study|Adverse Event: Non-ocular|1|||
156774855|NCT05383209|565928369|FG002|Overall Study|Adverse Event: Non-ocular|0|||
156429188|NCT04936035|564663214|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429189|NCT04936035|564663215|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
156429190|NCT04936035|564663216|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429191|NCT04936035|564663217|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429192|NCT04936035|564663218|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429193|NCT04936035|564663219|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429194|NCT04936035|564663220|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429195|NCT04936035|564663221|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429196|NCT04936035|564663222|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429197|NCT04936035|564663223|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429198|NCT04936035|564663224|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429199|NCT04936035|564663225|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429200|NCT04936035|564663226|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156429201|NCT04936035|564663214|FG000|6-Month Placebo-controlled DB Period|Death|0|||
156429202|NCT04936035|564663215|FG001|6-Month Placebo-controlled DB Period|Death|0|||
156429203|NCT04936035|564663216|FG002|6-Month Placebo-controlled DB Period|Death|0|||
156429204|NCT04936035|564663217|FG003|6-Month Placebo-controlled DB Period|Death|1|||
156429205|NCT04936035|564663218|FG004|6-Month Placebo-controlled DB Period|Death|0|||
156429206|NCT04936035|564663219|FG005|6-Month Placebo-controlled DB Period|Death|0|||
156429207|NCT04936035|564663220|FG006|6-Month Placebo-controlled DB Period|Death|0|||
156429208|NCT04936035|564663221|FG007|6-Month Placebo-controlled DB Period|Death|0|||
156429209|NCT04936035|564663222|FG008|6-Month Placebo-controlled DB Period|Death|0|||
156429210|NCT04936035|564663223|FG009|6-Month Placebo-controlled DB Period|Death|0|||
156429211|NCT04936035|564663224|FG010|6-Month Placebo-controlled DB Period|Death|0|||
156429212|NCT04936035|564663225|FG011|6-Month Placebo-controlled DB Period|Death|0|||
156659980|NCT01759290|565501099|FG000|Overall Study|Death|17|||
156774856|NCT05383209|565928367|FG000|Overall Study|Lost to Follow-up|2|||
156774857|NCT05383209|565928368|FG001|Overall Study|Lost to Follow-up|1|||
156774858|NCT05383209|565928369|FG002|Overall Study|Lost to Follow-up|4|||
156774859|NCT05383209|565928367|FG000|Overall Study|Withdrawal by Subject|2|||
156429213|NCT04936035|564663226|FG012|6-Month Placebo-controlled DB Period|Death|0|||
156429214|NCT04936035|564663214|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156429215|NCT04936035|564663215|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
156429216|NCT04936035|564663216|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
156429217|NCT04936035|564663217|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
156429218|NCT04936035|564663218|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
156659981|NCT01759290|565501099|FG000|Overall Study|Lost to Follow-up|53|||
156774860|NCT05383209|565928368|FG001|Overall Study|Withdrawal by Subject|0|||
156774861|NCT05383209|565928369|FG002|Overall Study|Withdrawal by Subject|1|||
156774862|NCT05383209|565928367|FG000|Overall Study|Death|1|||
156774863|NCT05383209|565928368|FG001|Overall Study|Death|0|||
156774864|NCT05383209|565928369|FG002|Overall Study|Death|0|||
156774865|NCT05383209|565928367|FG000|Overall Study|Other|0|||
156774866|NCT05383209|565928368|FG001|Overall Study|Other|1|||
156774867|NCT05383209|565928369|FG002|Overall Study|Other|0|||
156774868|NCT00717886|565928370|FG000|Overall Study|Withdrawal by Subject|3|||
156774869|NCT00717886|565928370|FG000|Overall Study|Treatment Failure|1|||
156774870|NCT01553851|565928371|FG000|Overall Study|Adverse Event|2|||
156774871|NCT01553851|565928371|FG000|Overall Study|constipation|1|||
156774872|NCT02472353|565928374|FG000|Overall Study|Lost to Follow-up|1|||
156774873|NCT02472353|565928375|FG001|Overall Study|Lost to Follow-up|1|||
156774874|NCT02472353|565928374|FG000|Overall Study|Withdrawal by Subject|2|||
156774875|NCT02472353|565928375|FG001|Overall Study|Withdrawal by Subject|1|||
156774876|NCT02472353|565928374|FG000|Overall Study|Study Termination|1|||
156774877|NCT02472353|565928375|FG001|Overall Study|Study Termination|4|||
156774878|NCT02101294|565928376|FG000|Overall Study|Withdrawal by Subject|5|||
156774879|NCT02101294|565928376|FG000|Overall Study|Lost to Follow-up|6|||
156774880|NCT02313155|565928381|FG000|Overall Study|Lost to Follow-up|0|||
156774881|NCT02313155|565928382|FG001|Overall Study|Lost to Follow-up|1|||
156774882|NCT00688597|565928386|FG000|Overall Study|Adverse Event|2|||
156774883|NCT00688597|565928387|FG001|Overall Study|Adverse Event|0|||
156774884|NCT00688597|565928388|FG002|Overall Study|Adverse Event|0|||
156774885|NCT00688597|565928386|FG000|Overall Study|Physician Decision|1|||
156774886|NCT00688597|565928387|FG001|Overall Study|Physician Decision|0|||
156774887|NCT00688597|565928388|FG002|Overall Study|Physician Decision|0|||
156774888|NCT02709369|565928389|FG000|Overall Study|Lost to Follow-up|15|||
156774889|NCT02709369|565928389|FG000|Overall Study|Withdrawal by Subject|10|||
156774890|NCT02709369|565928389|FG000|Overall Study|Did not received intervention|2|||
156774891|NCT02755090|565928390|FG000|Overall Study|equipment malfunction|1|||
156774892|NCT02755090|565928391|FG001|Overall Study|equipment malfunction|0|||
156774893|NCT00207740|565928392|FG000|Overall Study|Adverse Event|4|||
156774894|NCT00207740|565928393|FG001|Overall Study|Adverse Event|14|||
156774895|NCT00207740|565928394|FG002|Overall Study|Adverse Event|14|||
156774896|NCT00207740|565928395|FG003|Overall Study|Adverse Event|11|||
156774897|NCT00207740|565928392|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156774898|NCT00207740|565928393|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156774899|NCT00207740|565928394|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156774900|NCT00207740|565928395|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
156774901|NCT00207740|565928392|FG000|Overall Study|Lost to Follow-up|0|||
156774902|NCT00207740|565928393|FG001|Overall Study|Lost to Follow-up|2|||
156774903|NCT00207740|565928394|FG002|Overall Study|Lost to Follow-up|1|||
156774904|NCT00207740|565928395|FG003|Overall Study|Lost to Follow-up|1|||
156774905|NCT00207740|565928392|FG000|Overall Study|Death|0|||
156774906|NCT00207740|565928393|FG001|Overall Study|Death|0|||
156774907|NCT00207740|565928394|FG002|Overall Study|Death|0|||
156774908|NCT00207740|565928395|FG003|Overall Study|Death|1|||
156774909|NCT00207740|565928392|FG000|Overall Study|Sponsor Directive|22|||
156774910|NCT00207740|565928393|FG001|Overall Study|Sponsor Directive|15|||
156774911|NCT00207740|565928394|FG002|Overall Study|Sponsor Directive|16|||
156774912|NCT00207740|565928395|FG003|Overall Study|Sponsor Directive|21|||
156774913|NCT00207740|565928392|FG000|Overall Study|Other|2|||
156774914|NCT00207740|565928393|FG001|Overall Study|Other|10|||
156774915|NCT00207740|565928394|FG002|Overall Study|Other|7|||
156774916|NCT00207740|565928395|FG003|Overall Study|Other|5|||
156774917|NCT04797169|565928396|FG000|Overall Study|Lost to Follow-up|84|||
156774918|NCT04797169|565928397|FG001|Overall Study|Lost to Follow-up|67|||
156774919|NCT04797169|565928396|FG000|Overall Study|Pregnancy|1|||
156774920|NCT04797169|565928397|FG001|Overall Study|Pregnancy|3|||
156774921|NCT04797169|565928396|FG000|Overall Study|Withdrawal by Subject|27|||
156774922|NCT04797169|565928397|FG001|Overall Study|Withdrawal by Subject|35|||
156324742|NCT01323946|564289387|FG002|Overall Study|Withdrawal by Subject|0|||
156659982|NCT01759290|565501099|FG000|Overall Study|Unknown reason|4|||
156774923|NCT03916926|565928398|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
156774924|NCT03916926|565928399|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
156774925|NCT03916926|565928398|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
156774926|NCT03916926|565928399|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
156774927|NCT03916926|565928398|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
156774928|NCT03916926|565928399|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
156774929|NCT03916926|565928398|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
156774930|NCT03916926|565928399|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
156774931|NCT02763566|565928400|FG000|Overall Study|Lost to Follow-up|1|||
156774932|NCT02763566|565928401|FG001|Overall Study|Lost to Follow-up|4|||
156774933|NCT02763566|565928402|FG002|Overall Study|Lost to Follow-up|0|||
156774934|NCT02763566|565928403|FG003|Overall Study|Lost to Follow-up|1|||
156774935|NCT02763566|565928400|FG000|Overall Study|On study treatment at study conclusion|114|||
156774936|NCT02763566|565928401|FG001|Overall Study|On study treatment at study conclusion|34|||
156659983|NCT00841100|565501100|FG000|Phase 1 (28 Days)|Adverse Event|1|||
156659984|NCT00841100|565501100|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
156659985|NCT03338972|565501103|FG000|Overall Study|Death|1|||
156659986|NCT03338972|565501104|FG001|Overall Study|Death|1|||
156659987|NCT03338972|565501105|FG002|Overall Study|Death|0|||
156659988|NCT03338972|565501106|FG003|Overall Study|Death|0|||
156659989|NCT03338972|565501103|FG000|Overall Study|Withdrawal by Subject|1|||
156659990|NCT03338972|565501104|FG001|Overall Study|Withdrawal by Subject|0|||
156659991|NCT03338972|565501105|FG002|Overall Study|Withdrawal by Subject|0|||
156659992|NCT03338972|565501106|FG003|Overall Study|Withdrawal by Subject|0|||
156659993|NCT06096168|565501109|FG000|Overall Study|Death|30|||
156659994|NCT06096168|565501109|FG000|Overall Study|Revision|2|||
156659995|NCT01868009|565501110|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
156659996|NCT01868009|565501111|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
156659997|NCT01868009|565501110|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
156659998|NCT01868009|565501111|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
156659999|NCT01868009|565501110|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
156660000|NCT01868009|565501111|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
156660001|NCT01046253|565501112|FG000|Second Intervention|Adverse Event|0|||
156660002|NCT01046253|565501113|FG001|Second Intervention|Adverse Event|1|||
156660003|NCT01046253|565501112|FG000|Second Intervention|Protocol Violation|0|||
156660004|NCT01046253|565501113|FG001|Second Intervention|Protocol Violation|1|||
156660005|NCT02339909|565501114|FG000|Overall Study|Became ineligible after randomisation|89|||
156660006|NCT02339909|565501115|FG001|Overall Study|Became ineligible after randomisation|63|||
156660007|NCT02339909|565501116|FG002|Overall Study|Became ineligible after randomisation|71|||
156660008|NCT00860028|565501117|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
156660009|NCT00860028|565501118|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
156660010|NCT02585258|565501119|FG000|Overall Study|Adverse Event|28|||
156660011|NCT02585258|565501120|FG001|Overall Study|Adverse Event|29|||
156660012|NCT02585258|565501119|FG000|Overall Study|Death|3|||
156660013|NCT02585258|565501120|FG001|Overall Study|Death|2|||
156660014|NCT02585258|565501119|FG000|Overall Study|Lack of Efficacy|7|||
156660015|NCT02585258|565501120|FG001|Overall Study|Lack of Efficacy|9|||
156660016|NCT02585258|565501119|FG000|Overall Study|includes covid-related access problems|42|||
156660017|NCT02585258|565501120|FG001|Overall Study|includes covid-related access problems|46|||
156660018|NCT02585258|565501119|FG000|Overall Study|Lost to Follow-up|5|||
156660019|NCT02585258|565501120|FG001|Overall Study|Lost to Follow-up|2|||
156660020|NCT05125952|565501121|FG000|Overall Study|Physician Decision|1|||
156660021|NCT02848326|565502409|FG000|Treatment Period|Adverse Event|5|||
156660022|NCT02848326|565502410|FG001|Treatment Period|Adverse Event|4|||
156660023|NCT02848326|565502411|FG002|Treatment Period|Adverse Event|11|||
156660024|NCT02848326|565502412|FG003|Treatment Period|Adverse Event|6|||
156660025|NCT02848326|565502413|FG004|Treatment Period|Adverse Event|5|||
156660026|NCT02848326|565502414|FG005|Treatment Period|Adverse Event|7|||
156660027|NCT02848326|565502409|FG000|Treatment Period|Withdrawal of Consent|20|||
156660028|NCT02848326|565502410|FG001|Treatment Period|Withdrawal of Consent|6|||
156660029|NCT02848326|565502411|FG002|Treatment Period|Withdrawal of Consent|9|||
156660030|NCT02848326|565502412|FG003|Treatment Period|Withdrawal of Consent|6|||
156660031|NCT02848326|565502413|FG004|Treatment Period|Withdrawal of Consent|9|||
156660032|NCT02848326|565502414|FG005|Treatment Period|Withdrawal of Consent|6|||
156660033|NCT02848326|565502409|FG000|Treatment Period|Lost to Follow-up|5|||
156660034|NCT02848326|565502410|FG001|Treatment Period|Lost to Follow-up|1|||
156660035|NCT02848326|565502411|FG002|Treatment Period|Lost to Follow-up|11|||
156660036|NCT02848326|565502412|FG003|Treatment Period|Lost to Follow-up|7|||
156660037|NCT02848326|565502413|FG004|Treatment Period|Lost to Follow-up|2|||
156660038|NCT02848326|565502414|FG005|Treatment Period|Lost to Follow-up|3|||
156660039|NCT02848326|565502409|FG000|Treatment Period|Pregnancy|0|||
156660040|NCT02848326|565502410|FG001|Treatment Period|Pregnancy|0|||
156660041|NCT02848326|565502411|FG002|Treatment Period|Pregnancy|1|||
156660042|NCT02848326|565502412|FG003|Treatment Period|Pregnancy|1|||
156660043|NCT02848326|565502413|FG004|Treatment Period|Pregnancy|0|||
156660044|NCT02848326|565502414|FG005|Treatment Period|Pregnancy|1|||
156660045|NCT02848326|565502409|FG000|Treatment Period|Protocol Violation|4|||
156774937|NCT02763566|565928402|FG002|Overall Study|On study treatment at study conclusion|54|||
156774938|NCT02763566|565928403|FG003|Overall Study|On study treatment at study conclusion|13|||
156774939|NCT02763566|565928400|FG000|Overall Study|Withdrawal by Subject|3|||
156774940|NCT02763566|565928401|FG001|Overall Study|Withdrawal by Subject|1|||
156774941|NCT02763566|565928402|FG002|Overall Study|Withdrawal by Subject|0|||
156774942|NCT02763566|565928403|FG003|Overall Study|Withdrawal by Subject|0|||
156774943|NCT04530344|565928404|FG000|Overall Study|Lost to Follow-up|3|||
156660046|NCT02848326|565502410|FG001|Treatment Period|Protocol Violation|3|||
156660047|NCT02848326|565502411|FG002|Treatment Period|Protocol Violation|4|||
156660048|NCT02848326|565502412|FG003|Treatment Period|Protocol Violation|2|||
156660049|NCT02848326|565502413|FG004|Treatment Period|Protocol Violation|3|||
156660050|NCT02848326|565502414|FG005|Treatment Period|Protocol Violation|3|||
156660051|NCT02848326|565502409|FG000|Treatment Period|Non-compliance with Study Drug|4|||
156660052|NCT02848326|565502410|FG001|Treatment Period|Non-compliance with Study Drug|0|||
156660053|NCT02848326|565502411|FG002|Treatment Period|Non-compliance with Study Drug|0|||
156660054|NCT02848326|565502412|FG003|Treatment Period|Non-compliance with Study Drug|1|||
156660055|NCT02848326|565502413|FG004|Treatment Period|Non-compliance with Study Drug|0|||
156660056|NCT02848326|565502414|FG005|Treatment Period|Non-compliance with Study Drug|0|||
156660057|NCT02848326|565502409|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
156660058|NCT02848326|565502410|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
156660059|NCT02848326|565502411|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
156660060|NCT02848326|565502412|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
156660061|NCT02848326|565502413|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
156660062|NCT02848326|565502414|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
156660063|NCT02848326|565502409|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
156660064|NCT02848326|565502410|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
156660065|NCT02848326|565502411|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
156660066|NCT02848326|565502412|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
156660067|NCT02848326|565502413|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
156660068|NCT02848326|565502414|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
156660069|NCT02937701|565502424|FG000|Day 1 to Week 22|Adverse Event|11|||
156660070|NCT02937701|565502425|FG001|Day 1 to Week 22|Adverse Event|14|||
156660071|NCT02937701|565502426|FG002|Day 1 to Week 22|Adverse Event|0|||
156660072|NCT02937701|565502427|FG003|Day 1 to Week 22|Adverse Event|0|||
156660073|NCT02937701|565502428|FG004|Day 1 to Week 22|Adverse Event|0|||
156660074|NCT02937701|565502424|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
156660075|NCT02937701|565502425|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
156660076|NCT02937701|565502426|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
156660077|NCT02937701|565502427|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
156660078|NCT02937701|565502428|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
156660079|NCT02937701|565502424|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
156660080|NCT02937701|565502425|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
156660081|NCT02937701|565502426|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
156660082|NCT02937701|565502427|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
156660083|NCT02937701|565502428|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
156660084|NCT02937701|565502424|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
156660085|NCT02937701|565502425|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
156660086|NCT02937701|565502426|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
156660087|NCT02937701|565502427|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
156660088|NCT02937701|565502428|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
156660089|NCT02937701|565502424|FG000|Day 1 to Week 22|Death|1|||
156660090|NCT02937701|565502425|FG001|Day 1 to Week 22|Death|1|||
156660091|NCT02937701|565502426|FG002|Day 1 to Week 22|Death|0|||
156660092|NCT02937701|565502427|FG003|Day 1 to Week 22|Death|0|||
156660093|NCT02937701|565502428|FG004|Day 1 to Week 22|Death|0|||
156660094|NCT02937701|565502424|FG000|Day 1 to Week 22|Protocol Violation|1|||
156660095|NCT02937701|565502425|FG001|Day 1 to Week 22|Protocol Violation|1|||
156660096|NCT02937701|565502426|FG002|Day 1 to Week 22|Protocol Violation|0|||
156660097|NCT02937701|565502427|FG003|Day 1 to Week 22|Protocol Violation|0|||
156660098|NCT02937701|565502428|FG004|Day 1 to Week 22|Protocol Violation|0|||
156660099|NCT02937701|565502424|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
156660100|NCT02937701|565502425|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
156660101|NCT02937701|565502426|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
156660102|NCT02937701|565502427|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
156660103|NCT02937701|565502428|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
156660104|NCT02937701|565502424|FG000|Day 1 to Week 22|Physician Decision|2|||
156660105|NCT02937701|565502425|FG001|Day 1 to Week 22|Physician Decision|0|||
156660106|NCT02937701|565502426|FG002|Day 1 to Week 22|Physician Decision|0|||
156660107|NCT02937701|565502427|FG003|Day 1 to Week 22|Physician Decision|0|||
156660108|NCT02937701|565502428|FG004|Day 1 to Week 22|Physician Decision|0|||
156660109|NCT02937701|565502424|FG000|Day 1 to Week 22|Other|1|||
156660110|NCT02937701|565502425|FG001|Day 1 to Week 22|Other|0|||
156660111|NCT02937701|565502426|FG002|Day 1 to Week 22|Other|0|||
156660112|NCT02937701|565502427|FG003|Day 1 to Week 22|Other|0|||
156660113|NCT02937701|565502428|FG004|Day 1 to Week 22|Other|0|||
156660114|NCT02937701|565502424|FG000|Week 22 to Week 50|Adverse Event|0|||
156660115|NCT02937701|565502425|FG001|Week 22 to Week 50|Adverse Event|0|||
156774944|NCT04530344|565928405|FG001|Overall Study|Lost to Follow-up|3|||
156774945|NCT04530344|565928406|FG002|Overall Study|Lost to Follow-up|3|||
156660116|NCT02937701|565502426|FG002|Week 22 to Week 50|Adverse Event|10|||
156660117|NCT02937701|565502427|FG003|Week 22 to Week 50|Adverse Event|3|||
156660118|NCT02937701|565502428|FG004|Week 22 to Week 50|Adverse Event|3|||
156660119|NCT02937701|565502424|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
156660120|NCT02937701|565502425|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
156660121|NCT02937701|565502426|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
156660122|NCT02937701|565502427|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
156660123|NCT02937701|565502428|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
156774946|NCT04530344|565928407|FG003|Overall Study|Lost to Follow-up|10|||
156660124|NCT02937701|565502424|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
156660125|NCT02937701|565502425|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
156660126|NCT02937701|565502426|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
156660127|NCT02937701|565502427|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
156660128|NCT02937701|565502428|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
156660129|NCT02937701|565502424|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
156660130|NCT02937701|565502425|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
156660131|NCT02937701|565502426|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
156660132|NCT02937701|565502427|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
156660133|NCT02937701|565502428|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
156660134|NCT02937701|565502424|FG000|Week 22 to Week 50|Physician Decision|0|||
156660135|NCT02937701|565502425|FG001|Week 22 to Week 50|Physician Decision|0|||
156660136|NCT02937701|565502426|FG002|Week 22 to Week 50|Physician Decision|2|||
156660137|NCT02937701|565502427|FG003|Week 22 to Week 50|Physician Decision|0|||
156660138|NCT02937701|565502428|FG004|Week 22 to Week 50|Physician Decision|1|||
156660139|NCT02937701|565502424|FG000|Week 22 to Week 50|Other|0|||
156660140|NCT02937701|565502425|FG001|Week 22 to Week 50|Other|0|||
156660141|NCT02937701|565502426|FG002|Week 22 to Week 50|Other|0|||
156660142|NCT02937701|565502427|FG003|Week 22 to Week 50|Other|0|||
156660143|NCT02937701|565502428|FG004|Week 22 to Week 50|Other|1|||
156660144|NCT00416520|565502430|FG000|Open-label Period|Adverse Event|28|||
156660145|NCT00416520|565502431|FG001|Open-label Period|Adverse Event|10|||
156660146|NCT00416520|565502432|FG002|Open-label Period|Adverse Event|0|||
156660147|NCT00416520|565502433|FG003|Open-label Period|Adverse Event|0|||
156660148|NCT00416520|565502430|FG000|Open-label Period|Death|2|||
156660149|NCT00416520|565502431|FG001|Open-label Period|Death|1|||
156774947|NCT04530344|565928404|FG000|Overall Study|Withdrawal by Subject|14|||
156774948|NCT04530344|565928405|FG001|Overall Study|Withdrawal by Subject|5|||
156774949|NCT04530344|565928406|FG002|Overall Study|Withdrawal by Subject|18|||
156774950|NCT04530344|565928407|FG003|Overall Study|Withdrawal by Subject|33|||
156774951|NCT04530344|565928404|FG000|Overall Study|Adverse Event|0|||
156774952|NCT04530344|565928405|FG001|Overall Study|Adverse Event|0|||
156774953|NCT04530344|565928406|FG002|Overall Study|Adverse Event|0|||
156774954|NCT04530344|565928407|FG003|Overall Study|Adverse Event|1|||
156774955|NCT04530344|565928404|FG000|Overall Study|Lack of Efficacy|0|||
156774956|NCT04530344|565928405|FG001|Overall Study|Lack of Efficacy|0|||
156774957|NCT04530344|565928406|FG002|Overall Study|Lack of Efficacy|0|||
156774958|NCT04530344|565928407|FG003|Overall Study|Lack of Efficacy|1|||
156774959|NCT04530344|565928404|FG000|Overall Study|Physician Decision|0|||
156774960|NCT04530344|565928405|FG001|Overall Study|Physician Decision|0|||
156774961|NCT04530344|565928406|FG002|Overall Study|Physician Decision|1|||
156774962|NCT04530344|565928407|FG003|Overall Study|Physician Decision|1|||
156774963|NCT04530344|565928404|FG000|Overall Study|Pregnancy|0|||
156774964|NCT04530344|565928405|FG001|Overall Study|Pregnancy|0|||
156774965|NCT04530344|565928406|FG002|Overall Study|Pregnancy|2|||
156774966|NCT04530344|565928407|FG003|Overall Study|Pregnancy|1|||
156774967|NCT04530344|565928404|FG000|Overall Study|Protocol Violation|0|||
156774968|NCT04530344|565928405|FG001|Overall Study|Protocol Violation|0|||
156774969|NCT04530344|565928406|FG002|Overall Study|Protocol Violation|0|||
156774970|NCT04530344|565928407|FG003|Overall Study|Protocol Violation|1|||
156774971|NCT04530344|565928404|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
156429219|NCT04936035|564663219|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156429220|NCT04936035|564663220|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156429221|NCT04936035|564663221|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156660150|NCT00416520|565502432|FG002|Open-label Period|Death|0|||
156660151|NCT00416520|565502433|FG003|Open-label Period|Death|0|||
156774972|NCT04530344|565928405|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
156660152|NCT00416520|565502430|FG000|Open-label Period|Lack of Efficacy|8|||
156660153|NCT00416520|565502431|FG001|Open-label Period|Lack of Efficacy|1|||
156660154|NCT00416520|565502432|FG002|Open-label Period|Lack of Efficacy|0|||
156774973|NCT04530344|565928406|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
156774974|NCT04530344|565928407|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
156774975|NCT04530344|565928404|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
156774976|NCT04530344|565928405|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
156774977|NCT04530344|565928406|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
156429222|NCT04936035|564663222|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156660155|NCT00416520|565502433|FG003|Open-label Period|Lack of Efficacy|0|||
156660156|NCT00416520|565502430|FG000|Open-label Period|Protocol Violation|3|||
156774978|NCT04530344|565928407|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
156774979|NCT04530344|565928404|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
156774980|NCT04530344|565928405|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
156774981|NCT04530344|565928406|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
156774982|NCT04530344|565928407|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
156660157|NCT00416520|565502431|FG001|Open-label Period|Protocol Violation|3|||
156660158|NCT00416520|565502432|FG002|Open-label Period|Protocol Violation|0|||
156660159|NCT00416520|565502433|FG003|Open-label Period|Protocol Violation|0|||
156660160|NCT00416520|565502430|FG000|Open-label Period|Withdrawal by Subject|16|||
156660161|NCT00416520|565502431|FG001|Open-label Period|Withdrawal by Subject|5|||
156660162|NCT00416520|565502432|FG002|Open-label Period|Withdrawal by Subject|0|||
156660163|NCT00416520|565502433|FG003|Open-label Period|Withdrawal by Subject|0|||
156660164|NCT00416520|565502430|FG000|Open-label Period|Other Reasons|3|||
156660165|NCT00416520|565502431|FG001|Open-label Period|Other Reasons|12|||
156660166|NCT00416520|565502432|FG002|Open-label Period|Other Reasons|0|||
156660167|NCT00416520|565502433|FG003|Open-label Period|Other Reasons|0|||
156660168|NCT00416520|565502430|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
156660169|NCT00416520|565502431|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
156660170|NCT00416520|565502432|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
156660171|NCT00416520|565502433|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
156660172|NCT00416520|565502430|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
156660173|NCT00416520|565502431|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
156660174|NCT00416520|565502432|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
156660175|NCT00416520|565502433|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
156660176|NCT00416520|565502430|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
156660177|NCT00416520|565502431|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
156660178|NCT00416520|565502432|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
156660179|NCT00416520|565502433|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
156660180|NCT01108094|565502437|FG000|Overall Study|Adverse Event|2|||
156660181|NCT01108094|565502438|FG001|Overall Study|Adverse Event|0|||
156660182|NCT01108094|565502439|FG002|Overall Study|Adverse Event|0|||
156660183|NCT01108094|565502440|FG003|Overall Study|Adverse Event|0|||
156660184|NCT01108094|565502437|FG000|Overall Study|Withdrawal by Subject|1|||
156660185|NCT01108094|565502438|FG001|Overall Study|Withdrawal by Subject|0|||
156660186|NCT01108094|565502439|FG002|Overall Study|Withdrawal by Subject|0|||
156660187|NCT01108094|565502440|FG003|Overall Study|Withdrawal by Subject|0|||
156660188|NCT02918877|565502445|FG000|Overall Study|Withdrawal by Subject|2|||
156660189|NCT02918877|565502446|FG001|Overall Study|Withdrawal by Subject|2|||
156660190|NCT02918877|565502445|FG000|Overall Study|Surgery cancelled|1|||
156660191|NCT02918877|565502446|FG001|Overall Study|Surgery cancelled|0|||
156660192|NCT02918877|565502445|FG000|Overall Study|Physician Decision|1|||
156660193|NCT02918877|565502446|FG001|Overall Study|Physician Decision|0|||
156660194|NCT02918877|565502445|FG000|Overall Study|Received intraoperative steroids|1|||
156660195|NCT02918877|565502446|FG001|Overall Study|Received intraoperative steroids|0|||
156660196|NCT02918877|565502445|FG000|Overall Study|Unable to obtain lab samples|1|||
156660197|NCT02918877|565502446|FG001|Overall Study|Unable to obtain lab samples|0|||
156660198|NCT02918877|565502445|FG000|Overall Study|Unsafe to perform BAL|0|||
156660199|NCT02918877|565502446|FG001|Overall Study|Unsafe to perform BAL|1|||
156660200|NCT05346055|565502449|FG000|Overall Study|Withdrawal by Subject|1|||
156660201|NCT05346055|565502449|FG000|Overall Study|Protocol Violation|1|||
156660202|NCT05346055|565502449|FG000|Overall Study|Therapist decision|1|||
156660203|NCT00728949|565502456|FG000|Overall Study|Adverse Event|8|||
156660204|NCT00728949|565502457|FG001|Overall Study|Adverse Event|0|||
156660205|NCT00728949|565502456|FG000|Overall Study|Withdrawal by Subject|2|||
156660206|NCT00728949|565502457|FG001|Overall Study|Withdrawal by Subject|2|||
156660207|NCT00728949|565502456|FG000|Overall Study|Abnormal Lab Results|0|||
156660208|NCT00728949|565502457|FG001|Overall Study|Abnormal Lab Results|2|||
156660209|NCT00728949|565502456|FG000|Overall Study|On treatment at cutoff date|1|||
156660210|NCT00728949|565502457|FG001|Overall Study|On treatment at cutoff date|0|||
156660211|NCT01996033|565502459|FG000|Overall Study|Death|1|||
156660212|NCT01996033|565502459|FG000|Overall Study|Physician Decision|1|||
156660213|NCT01996033|565502459|FG000|Overall Study|Withdrawal by Subject|4|||
156660214|NCT01996033|565502459|FG000|Overall Study|Lost to Follow-up|3|||
156660215|NCT02636907|565502487|FG000|Autoinjector Assessment Period|Adverse Event|2|||
156660216|NCT02636907|565502487|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
156660217|NCT02636907|565502487|FG000|Extension Phase|Adverse Event|2|||
156660218|NCT02636907|565502487|FG000|Extension Phase|Withdrawal by Subject|4|||
156660219|NCT02636907|565502487|FG000|Extension Phase|Physician Decision|1|||
156660220|NCT02636907|565502487|FG000|Extension Phase|Lost to Follow-up|2|||
156660221|NCT02636907|565502487|FG000|Extension Phase|Lack of Efficacy|1|||
156660222|NCT01682083|565502488|FG000|Overall Study|Lost to Follow-up|11|||
156660223|NCT01682083|565502489|FG001|Overall Study|Lost to Follow-up|18|||
156660224|NCT01682083|565502488|FG000|Overall Study|Withdrawal by Subject|31|||
156660225|NCT01682083|565502489|FG001|Overall Study|Withdrawal by Subject|40|||
156660226|NCT01682083|565502488|FG000|Overall Study|Death|60|||
156660227|NCT01682083|565502489|FG001|Overall Study|Death|93|||
156660228|NCT01682083|565502488|FG000|Overall Study|Physician Decision|5|||
156660229|NCT01682083|565502489|FG001|Overall Study|Physician Decision|4|||
156660230|NCT02731157|565502494|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
156660231|NCT00497796|565502497|FG000|Overall Study|Adverse event (not related)|9|||
156660232|NCT00497796|565502498|FG001|Overall Study|Adverse event (not related)|9|||
156660233|NCT00497796|565502497|FG000|Overall Study|Adverse event (related)|5|||
156660234|NCT00497796|565502498|FG001|Overall Study|Adverse event (related)|4|||
156660235|NCT00497796|565502497|FG000|Overall Study|CMV infection or disease treatment|30|||
156774983|NCT04530344|565928404|FG000|Overall Study|Personal Reasons|0|||
156774984|NCT04530344|565928405|FG001|Overall Study|Personal Reasons|0|||
156774985|NCT04530344|565928406|FG002|Overall Study|Personal Reasons|0|||
156774986|NCT04530344|565928407|FG003|Overall Study|Personal Reasons|1|||
156774987|NCT04530344|565928404|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
156774988|NCT04530344|565928405|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
156774989|NCT04530344|565928406|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
156774990|NCT04530344|565928407|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
156774991|NCT01402700|565928408|FG000|Overall Study|Death|3|||
156774992|NCT01402700|565928408|FG000|Overall Study|Withdrawal by Subject|3|||
156774993|NCT01402700|565928408|FG000|Overall Study|Missed Visit|1|||
156774994|NCT05352399|565928420|FG000|Overall Study|Discontinued intervention|6|||
156774995|NCT02657551|565928421|FG000|Overall Study|Adverse Event|2|||
156774996|NCT02657551|565928421|FG000|Overall Study|Withdrawal by Subject|1|||
156774997|NCT02657551|565928421|FG000|Overall Study|Non-Compliance|1|||
156774998|NCT02657551|565928421|FG000|Overall Study|Progression / Relapse|4|||
156774999|NCT04058717|565928422|FG000|Randomization Period|Lost to Follow-up|2|||
156775000|NCT04058717|565928423|FG001|Randomization Period|Lost to Follow-up|3|||
156775001|NCT04058717|565928424|FG002|Randomization Period|Lost to Follow-up|4|||
156775002|NCT04058717|565928425|FG003|Randomization Period|Lost to Follow-up|4|||
156775003|NCT04058717|565928422|FG000|Randomization Period|Withdrawal by Subject|1|||
156775004|NCT04058717|565928423|FG001|Randomization Period|Withdrawal by Subject|3|||
156775005|NCT04058717|565928424|FG002|Randomization Period|Withdrawal by Subject|3|||
156775006|NCT04058717|565928425|FG003|Randomization Period|Withdrawal by Subject|3|||
156775007|NCT04058717|565928422|FG000|Randomization Period|PI decision|0|||
156775008|NCT04058717|565928423|FG001|Randomization Period|PI decision|1|||
156775009|NCT04058717|565928424|FG002|Randomization Period|PI decision|0|||
156775010|NCT04058717|565928425|FG003|Randomization Period|PI decision|0|||
156775011|NCT04770779|565928427|FG000|Overall Study|Randomized, never treated|0|||
156775012|NCT04770779|565928428|FG001|Overall Study|Randomized, never treated|1|||
156775013|NCT04770779|565928427|FG000|Overall Study|Adverse Event|9|||
156775014|NCT04770779|565928428|FG001|Overall Study|Adverse Event|1|||
156775015|NCT04770779|565928427|FG000|Overall Study|Withdrawal by Subject|7|||
156775016|NCT04770779|565928428|FG001|Overall Study|Withdrawal by Subject|1|||
156775017|NCT04770779|565928427|FG000|Overall Study|Pregnancy|0|||
156775018|NCT04770779|565928428|FG001|Overall Study|Pregnancy|1|||
156775019|NCT02799602|565928429|FG000|Overall Study|Protocol Violation|1|||
156775020|NCT02799602|565928430|FG001|Overall Study|Protocol Violation|0|||
156775021|NCT02799602|565928429|FG000|Overall Study|Physician Decision|5|||
156775022|NCT02799602|565928430|FG001|Overall Study|Physician Decision|6|||
156775023|NCT02799602|565928429|FG000|Overall Study|Lost to Follow-up|4|||
156775024|NCT02799602|565928430|FG001|Overall Study|Lost to Follow-up|2|||
156775025|NCT02799602|565928429|FG000|Overall Study|Additional primary malignancy|11|||
156775026|NCT02799602|565928430|FG001|Overall Study|Additional primary malignancy|6|||
156775027|NCT02799602|565928429|FG000|Overall Study|Non-compliance with study drug|14|||
156775028|NCT02799602|565928430|FG001|Overall Study|Non-compliance with study drug|12|||
156775029|NCT02799602|565928429|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
156775030|NCT02799602|565928430|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
156775031|NCT02799602|565928429|FG000|Overall Study|Withdrawal by Subject|26|||
156775032|NCT02799602|565928430|FG001|Overall Study|Withdrawal by Subject|40|||
156775033|NCT02799602|565928429|FG000|Overall Study|Progressive disease - clinical progression|131|||
156775034|NCT02799602|565928430|FG001|Overall Study|Progressive disease - clinical progression|276|||
156775035|NCT02799602|565928429|FG000|Overall Study|Progressive disease - radiological progression|90|||
156775036|NCT02799602|565928430|FG001|Overall Study|Progressive disease - radiological progression|133|||
156775037|NCT02799602|565928429|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
156775038|NCT02799602|565928430|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
156660236|NCT00497796|565502498|FG001|Overall Study|CMV infection or disease treatment|4|||
156660237|NCT00497796|565502497|FG000|Overall Study|Consent withdrawn|10|||
156660238|NCT00497796|565502498|FG001|Overall Study|Consent withdrawn|3|||
156775039|NCT02799602|565928429|FG000|Overall Study|Death|9|||
156775040|NCT02799602|565928430|FG001|Overall Study|Death|5|||
156775041|NCT02799602|565928429|FG000|Overall Study|Other|287|||
156324743|NCT02964507|564289388|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
156660239|NCT00497796|565502497|FG000|Overall Study|Investigator/sponsor discretion|31|||
156660240|NCT00497796|565502498|FG001|Overall Study|Investigator/sponsor discretion|34|||
156660241|NCT00497796|565502497|FG000|Overall Study|Lost to Follow-up|0|||
156775042|NCT02799602|565928430|FG001|Overall Study|Other|118|||
156775043|NCT02799602|565928429|FG000|Overall Study|Study drug never administered|0|||
156775044|NCT02799602|565928430|FG001|Overall Study|Study drug never administered|3|||
156775045|NCT00596635|565928439|FG000|Overall Study|Lost to Follow-up|0|||
156775046|NCT00596635|565928440|FG001|Overall Study|Lost to Follow-up|2|||
156775047|NCT00596635|565928441|FG002|Overall Study|Lost to Follow-up|0|||
156775048|NCT00596635|565928439|FG000|Overall Study|Treatment for symptomatic UTI|4|||
156775049|NCT00596635|565928440|FG001|Overall Study|Treatment for symptomatic UTI|6|||
156660242|NCT00497796|565502498|FG001|Overall Study|Lost to Follow-up|1|||
156660243|NCT00497796|565502497|FG000|Overall Study|Not applicable (randomized not treated)|0|||
156660244|NCT00497796|565502498|FG001|Overall Study|Not applicable (randomized not treated)|4|||
156660245|NCT01074554|565502499|FG000|Overall Study|Adverse Event|3|||
156660246|NCT01074554|565502500|FG001|Overall Study|Adverse Event|3|||
156660247|NCT01074554|565502499|FG000|Overall Study|Lost to Follow-up|0|||
156660248|NCT01074554|565502500|FG001|Overall Study|Lost to Follow-up|1|||
156660249|NCT01856309|565502504|FG000|Overall Study|Death|4|||
156660250|NCT01856309|565502505|FG001|Overall Study|Death|6|||
156660251|NCT01856309|565502506|FG002|Overall Study|Death|11|||
156660252|NCT01856309|565502507|FG003|Overall Study|Death|6|||
156660253|NCT01856309|565502504|FG000|Overall Study|Lost to Follow-up|6|||
156660254|NCT01856309|565502505|FG001|Overall Study|Lost to Follow-up|2|||
156660255|NCT01856309|565502506|FG002|Overall Study|Lost to Follow-up|4|||
156660256|NCT01856309|565502507|FG003|Overall Study|Lost to Follow-up|8|||
156660257|NCT01856309|565502504|FG000|Overall Study|Withdrawal by Subject|11|||
156660258|NCT01856309|565502505|FG001|Overall Study|Withdrawal by Subject|13|||
156660259|NCT01856309|565502506|FG002|Overall Study|Withdrawal by Subject|28|||
156660260|NCT01856309|565502507|FG003|Overall Study|Withdrawal by Subject|26|||
156660261|NCT01856309|565502504|FG000|Overall Study|Other|227|||
156660262|NCT01856309|565502505|FG001|Overall Study|Other|225|||
156660263|NCT01856309|565502506|FG002|Overall Study|Other|447|||
156660264|NCT01856309|565502507|FG003|Overall Study|Other|469|||
156660265|NCT01856309|565502504|FG000|Overall Study|Lack of Efficacy|14|||
156660266|NCT01856309|565502505|FG001|Overall Study|Lack of Efficacy|9|||
156660267|NCT01856309|565502506|FG002|Overall Study|Lack of Efficacy|40|||
156660268|NCT01856309|565502507|FG003|Overall Study|Lack of Efficacy|25|||
156660269|NCT01856309|565502504|FG000|Overall Study|Adverse Event|31|||
156660270|NCT01856309|565502505|FG001|Overall Study|Adverse Event|31|||
156660271|NCT01856309|565502506|FG002|Overall Study|Adverse Event|55|||
156660272|NCT01856309|565502507|FG003|Overall Study|Adverse Event|65|||
156660273|NCT01856309|565502504|FG000|Overall Study|Pregnancy|0|||
156660274|NCT01856309|565502505|FG001|Overall Study|Pregnancy|0|||
156660275|NCT01856309|565502506|FG002|Overall Study|Pregnancy|0|||
156660276|NCT01856309|565502507|FG003|Overall Study|Pregnancy|1|||
156660277|NCT01856309|565502504|FG000|Overall Study|Physician Decision|6|||
156660278|NCT01856309|565502505|FG001|Overall Study|Physician Decision|1|||
156660279|NCT01856309|565502506|FG002|Overall Study|Physician Decision|6|||
156660280|NCT01856309|565502507|FG003|Overall Study|Physician Decision|8|||
156660281|NCT01856309|565502504|FG000|Overall Study|Noncompliance With Study Drug|0|||
156660282|NCT01856309|565502505|FG001|Overall Study|Noncompliance With Study Drug|1|||
156660283|NCT01856309|565502506|FG002|Overall Study|Noncompliance With Study Drug|4|||
156660284|NCT01856309|565502507|FG003|Overall Study|Noncompliance With Study Drug|1|||
156660285|NCT00832377|565502510|FG000|Overall Study|Protocol Violation|1|||
156660286|NCT00220337|565502511|FG000|Overall Study|Adverse Event|70|||
156660287|NCT00220337|565502511|FG000|Overall Study|Lack of Efficacy|17|||
156660288|NCT00220337|565502511|FG000|Overall Study|Withdrawal by Subject|68|||
156660289|NCT00220337|565502511|FG000|Overall Study|Protocol Violation|2|||
156660290|NCT00220337|565502511|FG000|Overall Study|Lost to Follow-up|5|||
156660291|NCT00220337|565502511|FG000|Overall Study|Other|12|||
156660292|NCT00220337|565502511|FG000|Overall Study|Unsatisfactory compliance|5|||
156660293|NCT00944697|565502512|FG000|Overall Study|Withdrawal by Subject|1|||
156660294|NCT00944697|565502513|FG001|Overall Study|Withdrawal by Subject|1|||
156660295|NCT00944697|565502512|FG000|Overall Study|Adverse Event|0|||
156660296|NCT00944697|565502513|FG001|Overall Study|Adverse Event|3|||
156660297|NCT00944697|565502512|FG000|Overall Study|Administrative|1|||
156660298|NCT00944697|565502513|FG001|Overall Study|Administrative|1|||
156660299|NCT01273181|565502514|FG000|Phase I, Dose 1|Study termination|1|||
156660300|NCT01273181|565502515|FG001|Phase I, Dose 1|Study termination|0|||
156660301|NCT01273181|565502516|FG002|Phase I, Dose 1|Study termination|0|||
156660302|NCT01273181|565502517|FG003|Phase I, Dose 1|Study termination|0|||
156660303|NCT01273181|565502514|FG000|Phase I, Dose 2|Death during treatment|0|||
156660304|NCT01273181|565502515|FG001|Phase I, Dose 2|Death during treatment|1|||
156660305|NCT01273181|565502516|FG002|Phase I, Dose 2|Death during treatment|0|||
156660306|NCT01273181|565502517|FG003|Phase I, Dose 2|Death during treatment|0|||
156660307|NCT01273181|565502514|FG000|Phase 2, Dose 1|Study termination|0|||
156660308|NCT01273181|565502515|FG001|Phase 2, Dose 1|Study termination|0|||
156660309|NCT01273181|565502516|FG002|Phase 2, Dose 1|Study termination|1|||
156660310|NCT01273181|565502517|FG003|Phase 2, Dose 1|Study termination|0|||
156660311|NCT01273181|565502514|FG000|Phase 2, Dose 2|Death during treatment|0|||
156660312|NCT01273181|565502515|FG001|Phase 2, Dose 2|Death during treatment|0|||
156660313|NCT01273181|565502516|FG002|Phase 2, Dose 2|Death during treatment|0|||
156660314|NCT01273181|565502517|FG003|Phase 2, Dose 2|Death during treatment|1|||
156660315|NCT04276883|565502518|FG000|Overall Study|Withdrawal by Subject|2|||
156324744|NCT02964507|564289389|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
156660316|NCT04276883|565502519|FG001|Overall Study|Withdrawal by Subject|3|||
156660317|NCT04276883|565502520|FG002|Overall Study|Withdrawal by Subject|6|||
156660318|NCT04276883|565502518|FG000|Overall Study|Lost to Follow-up|1|||
156660319|NCT04276883|565502519|FG001|Overall Study|Lost to Follow-up|3|||
156660320|NCT04276883|565502520|FG002|Overall Study|Lost to Follow-up|0|||
156660321|NCT04276883|565502518|FG000|Overall Study|Adverse Event|0|||
156660322|NCT04276883|565502519|FG001|Overall Study|Adverse Event|1|||
156660323|NCT04276883|565502520|FG002|Overall Study|Adverse Event|0|||
156660324|NCT04276883|565502518|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
156660325|NCT04276883|565502519|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
156660326|NCT04276883|565502520|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
156660327|NCT02732210|565502521|FG000|Overall Study|Site Closed|0|||
156660328|NCT02732210|565502522|FG001|Overall Study|Site Closed|11|||
156660329|NCT02732210|565502521|FG000|Overall Study|Study Ended|13|||
156660330|NCT02732210|565502522|FG001|Overall Study|Study Ended|13|||
156660331|NCT02732210|565502521|FG000|Overall Study|Withdrawal by Subject|28|||
156660332|NCT02732210|565502522|FG001|Overall Study|Withdrawal by Subject|87|||
156660333|NCT02732210|565502521|FG000|Overall Study|Lost to Follow-up|5|||
156660334|NCT02732210|565502522|FG001|Overall Study|Lost to Follow-up|57|||
156660335|NCT02732210|565502521|FG000|Overall Study|Death|4|||
156660336|NCT02732210|565502522|FG001|Overall Study|Death|15|||
156660337|NCT02732210|565502521|FG000|Overall Study|Other|35|||
156660338|NCT02732210|565502522|FG001|Overall Study|Other|103|||
156660339|NCT02732210|565502521|FG000|Overall Study|Missing|0|||
156660340|NCT02732210|565502522|FG001|Overall Study|Missing|8|||
156660341|NCT01876706|565502523|FG000|Overall Study|BPH Intervention|9|||
156660342|NCT01876706|565502523|FG000|Overall Study|Lost to Follow-up|7|||
156660343|NCT01876706|565502523|FG000|Overall Study|Withdrawals|6|||
156660344|NCT01876706|565502523|FG000|Overall Study|Death|3|||
156660345|NCT00604500|565502524|FG000|Overall Study|Adverse Event|2|||
156660346|NCT00604500|565502524|FG000|Overall Study|Protocol Violation|2|||
156660347|NCT00604500|565502524|FG000|Overall Study|Treatment Failure|1|||
156660348|NCT00604500|565502524|FG000|Overall Study|Withdrawal by Subject|4|||
156660349|NCT00604500|565502524|FG000|Overall Study|Administrative|1|||
156660350|NCT00604500|565502524|FG000|Overall Study|Did not meet protocol eligibility|1|||
156660351|NCT06354270|565502528|FG000|Overall Study|Withdrawal by Subject|1|||
156660352|NCT06354270|565502529|FG001|Overall Study|Withdrawal by Subject|0|||
156660353|NCT02603952|565502544|FG000|Overall Study|Withdrawal by Subject|1|||
156660354|NCT02603952|565502545|FG001|Overall Study|Withdrawal by Subject|0|||
156660355|NCT02603952|565502546|FG002|Overall Study|Withdrawal by Subject|0|||
156660356|NCT02603952|565502547|FG003|Overall Study|Withdrawal by Subject|0|||
156660357|NCT02603952|565502544|FG000|Overall Study|Received oseltamivir by error|0|||
156660358|NCT02603952|565502545|FG001|Overall Study|Received oseltamivir by error|0|||
156660359|NCT02603952|565502546|FG002|Overall Study|Received oseltamivir by error|0|||
156660360|NCT02603952|565502547|FG003|Overall Study|Received oseltamivir by error|1|||
156660361|NCT01936948|565502551|FG000|Overall Study|no 30-day follow-up data|0|||
156660362|NCT01936948|565502552|FG001|Overall Study|no 30-day follow-up data|3|||
156660363|NCT01936948|565502553|FG002|Overall Study|no 30-day follow-up data|3|||
156660364|NCT01936948|565502554|FG003|Overall Study|no 30-day follow-up data|3|||
156660365|NCT01395030|565502555|FG000|Overall Study|Did not complete FCH PET/CT|7|||
156660366|NCT01974141|565502559|FG000|Overall Study|Other Reasons|28|||
156660367|NCT01974141|565502560|FG001|Overall Study|Other Reasons|18|||
156660368|NCT01974141|565502559|FG000|Overall Study|Protocol Violation|2|||
156660369|NCT01974141|565502560|FG001|Overall Study|Protocol Violation|6|||
156660370|NCT01974141|565502559|FG000|Overall Study|Personal Reasons|21|||
156660371|NCT01974141|565502560|FG001|Overall Study|Personal Reasons|20|||
156660372|NCT01974141|565502559|FG000|Overall Study|Lost to Follow-up|38|||
156660373|NCT01974141|565502560|FG001|Overall Study|Lost to Follow-up|29|||
156660374|NCT01974141|565502559|FG000|Overall Study|Pregnancy|3|||
156660375|NCT01974141|565502560|FG001|Overall Study|Pregnancy|3|||
156660376|NCT01974141|565502559|FG000|Overall Study|Lack of Efficacy|0|||
156660377|NCT01974141|565502560|FG001|Overall Study|Lack of Efficacy|1|||
156660378|NCT01974141|565502559|FG000|Overall Study|Adverse Event|4|||
156660379|NCT01974141|565502560|FG001|Overall Study|Adverse Event|5|||
156660380|NCT02327130|565502563|FG000|Overall Study|Discharged in less than 5 days|5|||
156660381|NCT02327130|565502563|FG000|Overall Study|Physician Decision|2|||
156660382|NCT02327130|565502563|FG000|Overall Study|Unable to provide breath sample|1|||
156660383|NCT02327130|565502563|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
156660384|NCT02327130|565502563|FG000|Overall Study|Met exclusion criteria|3|||
156660385|NCT04028843|565502564|FG000|Overall Study|Lost to Follow-up|32|||
156660386|NCT04028843|565502565|FG001|Overall Study|Lost to Follow-up|39|||
156660387|NCT04028843|565502564|FG000|Overall Study|Adverse Event|1|||
156660388|NCT04028843|565502565|FG001|Overall Study|Adverse Event|0|||
156660389|NCT04028843|565502564|FG000|Overall Study|Non-viable Pregnancy|0|||
156660390|NCT04028843|565502565|FG001|Overall Study|Non-viable Pregnancy|1|||
156660391|NCT04028843|565502564|FG000|Overall Study|Withdrawal by Subject|4|||
156660392|NCT04028843|565502565|FG001|Overall Study|Withdrawal by Subject|2|||
156660393|NCT00950872|565502569|FG000|Overall Study|Withdrawal by Subject|1|||
156660394|NCT00950872|565502569|FG000|Overall Study|Did not have surgery|2|||
156660395|NCT00441467|565504063|FG000|Overall Study|Adverse Event|6|||
156660396|NCT00441467|565504063|FG000|Overall Study|Withdrawal by Subject|3|||
156660397|NCT00441467|565504063|FG000|Overall Study|Progressive disease|9|||
156660398|NCT02289963|565504064|FG000|Overall Study|Adverse Event|1|||
156660399|NCT02289963|565504065|FG001|Overall Study|Adverse Event|2|||
156660400|NCT02289963|565504064|FG000|Overall Study|Poor compliance to protocol|1|||
156660401|NCT02289963|565504065|FG001|Overall Study|Poor compliance to protocol|0|||
156660402|NCT02289963|565504064|FG000|Overall Study|Withdrawal by Subject|1|||
156660403|NCT02289963|565504065|FG001|Overall Study|Withdrawal by Subject|0|||
156660404|NCT02289963|565504064|FG000|Overall Study|Last injection missed|2|||
156660405|NCT02289963|565504065|FG001|Overall Study|Last injection missed|2|||
156660406|NCT02289963|565504064|FG000|Overall Study|End treatment visit outside visit window|0|||
156660407|NCT02289963|565504065|FG001|Overall Study|End treatment visit outside visit window|4|||
156660408|NCT02289963|565504064|FG000|Overall Study|Other than specified above|0|||
156660409|NCT02289963|565504065|FG001|Overall Study|Other than specified above|2|||
156660410|NCT01042522|565504067|FG000|Overall Study|Adverse Event|1|||
156660411|NCT01042522|565504068|FG001|Overall Study|Adverse Event|2|||
156660412|NCT01042522|565504067|FG000|Overall Study|Disease Progression|5|||
156660413|NCT01042522|565504068|FG001|Overall Study|Disease Progression|0|||
156660414|NCT01042522|565504067|FG000|Overall Study|Death|1|||
156660415|NCT01042522|565504068|FG001|Overall Study|Death|0|||
156660416|NCT01042522|565504067|FG000|Overall Study|Patient Refused|0|||
156660417|NCT01042522|565504068|FG001|Overall Study|Patient Refused|3|||
156660418|NCT01042522|565504067|FG000|Overall Study|Withdrawal by Subject|1|||
156660419|NCT01042522|565504068|FG001|Overall Study|Withdrawal by Subject|1|||
156660420|NCT01941095|565504070|FG000|Overall Study|Insufficient therapeutic response|13|||
156660421|NCT01941095|565504070|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
156660422|NCT01941095|565504070|FG000|Overall Study|Adverse Event|11|||
156660423|NCT01941095|565504070|FG000|Overall Study|Physician Decision|3|||
156660424|NCT01941095|565504070|FG000|Overall Study|Withdrawal by Subject|17|||
156660425|NCT01941095|565504070|FG000|Overall Study|Lost to Follow-up|10|||
156660426|NCT02143102|565504074|FG000|Overall Study|Lost to Follow-up|11|||
156660427|NCT02143102|565504075|FG001|Overall Study|Lost to Follow-up|0|||
156660428|NCT01345019|565504076|FG000|Blinded Treatment Phase|Death|147|||
156660429|NCT01345019|565504077|FG001|Blinded Treatment Phase|Death|137|||
156660430|NCT01345019|565504076|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
156660431|NCT01345019|565504077|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
156660432|NCT01345019|565504076|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
156660433|NCT01345019|565504077|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
156660434|NCT01345019|565504076|FG000|Blinded Treatment Phase|Disease Progression|12|||
156660435|NCT01345019|565504077|FG001|Blinded Treatment Phase|Disease Progression|10|||
156660436|NCT01345019|565504076|FG000|Blinded Treatment Phase|Adverse Event|6|||
156660437|NCT01345019|565504077|FG001|Blinded Treatment Phase|Adverse Event|13|||
156660438|NCT01345019|565504076|FG000|Blinded Treatment Phase|Administrative Decision|10|||
156660439|NCT01345019|565504077|FG001|Blinded Treatment Phase|Administrative Decision|8|||
156660440|NCT01345019|565504076|FG000|Blinded Treatment Phase|Noncompliance|5|||
156660441|NCT01345019|565504077|FG001|Blinded Treatment Phase|Noncompliance|3|||
156660442|NCT01345019|565504076|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
156660443|NCT01345019|565504077|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
156660444|NCT01345019|565504076|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
156660445|NCT01345019|565504077|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
156660446|NCT01345019|565504076|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
156660447|NCT01345019|565504077|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
156660448|NCT01345019|565504076|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
156660449|NCT01345019|565504077|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
156660450|NCT01345019|565504076|FG000|Open Label Treatment Phase|Death|49|||
156660451|NCT01345019|565504077|FG001|Open Label Treatment Phase|Death|48|||
156660452|NCT01345019|565504076|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
156660453|NCT01345019|565504077|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
156660454|NCT01345019|565504076|FG000|Open Label Treatment Phase|Adverse Event|30|||
156660455|NCT01345019|565504077|FG001|Open Label Treatment Phase|Adverse Event|51|||
156660456|NCT01345019|565504076|FG000|Open Label Treatment Phase|Administrative Decision|30|||
156660457|NCT01345019|565504077|FG001|Open Label Treatment Phase|Administrative Decision|15|||
156660458|NCT01345019|565504076|FG000|Open Label Treatment Phase|Disease Progression|17|||
156660459|NCT01345019|565504077|FG001|Open Label Treatment Phase|Disease Progression|18|||
156660460|NCT01345019|565504076|FG000|Open Label Treatment Phase|Noncompliance|5|||
156660461|NCT01345019|565504077|FG001|Open Label Treatment Phase|Noncompliance|4|||
156660462|NCT01345019|565504076|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
156660463|NCT01345019|565504077|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
156660464|NCT01345019|565504076|FG000|Open Label Treatment Phase|Pregnancy|1|||
156775050|NCT00596635|565928441|FG002|Overall Study|Treatment for symptomatic UTI|3|||
156660465|NCT01345019|565504077|FG001|Open Label Treatment Phase|Pregnancy|0|||
156775051|NCT00596635|565928439|FG000|Overall Study|Hip fracture|2|||
156660466|NCT01345019|565504076|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
156660467|NCT01345019|565504077|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
156660468|NCT01345019|565504076|FG000|Open Label Treatment Phase|Protocol Violation|0|||
156660469|NCT01345019|565504077|FG001|Open Label Treatment Phase|Protocol Violation|1|||
156660470|NCT03830164|565504082|FG000|Overall Study|Adverse Event|0|||
156660471|NCT03830164|565504083|FG001|Overall Study|Adverse Event|2|||
156660472|NCT03830164|565504084|FG002|Overall Study|Adverse Event|0|||
156660473|NCT03830164|565504082|FG000|Overall Study|Lack of Efficacy|1|||
156660474|NCT03830164|565504083|FG001|Overall Study|Lack of Efficacy|5|||
156660475|NCT03830164|565504084|FG002|Overall Study|Lack of Efficacy|0|||
156660476|NCT03830164|565504082|FG000|Overall Study|Lost to Follow-up|0|||
156660477|NCT03830164|565504083|FG001|Overall Study|Lost to Follow-up|1|||
156660478|NCT03830164|565504084|FG002|Overall Study|Lost to Follow-up|0|||
156660479|NCT03830164|565504082|FG000|Overall Study|Withdrawal by Subject|1|||
156660480|NCT03830164|565504083|FG001|Overall Study|Withdrawal by Subject|0|||
156660481|NCT03830164|565504084|FG002|Overall Study|Withdrawal by Subject|0|||
156660482|NCT04099888|565504085|FG000|Overall Study|Study terminated by sponsor|9|||
156660483|NCT04099888|565504086|FG001|Overall Study|Study terminated by sponsor|11|||
156660484|NCT04099888|565504085|FG000|Overall Study|Lost to Follow-up|1|||
156660485|NCT04099888|565504086|FG001|Overall Study|Lost to Follow-up|1|||
156660486|NCT04099888|565504085|FG000|Overall Study|Withdrawal by Subject|5|||
156660487|NCT04099888|565504086|FG001|Overall Study|Withdrawal by Subject|6|||
156660488|NCT04099888|565504085|FG000|Overall Study|Death|5|||
156660489|NCT04099888|565504086|FG001|Overall Study|Death|2|||
156660490|NCT04099888|565504085|FG000|Overall Study|Other|1|||
156660491|NCT04099888|565504086|FG001|Overall Study|Other|0|||
156660492|NCT04538170|565504089|FG000|Overall Study|Withdrawal by Subject|104|||
156660493|NCT04538170|565504090|FG001|Overall Study|Withdrawal by Subject|210|||
156660494|NCT02932878|565504094|FG000|Overall Study|Due to Lab Results|2|||
156660495|NCT02932878|565504095|FG001|Overall Study|Due to Lab Results|1|||
156660496|NCT01866319|565504096|FG000|Overall Study|Adverse Event|12|||
156660497|NCT01866319|565504097|FG001|Overall Study|Adverse Event|5|||
156660498|NCT01866319|565504098|FG002|Overall Study|Adverse Event|9|||
156660499|NCT01866319|565504096|FG000|Overall Study|Clinical progression|3|||
156660500|NCT01866319|565504097|FG001|Overall Study|Clinical progression|2|||
156660501|NCT01866319|565504098|FG002|Overall Study|Clinical progression|2|||
156660502|NCT01866319|565504096|FG000|Overall Study|Death|153|||
156660503|NCT01866319|565504097|FG001|Overall Study|Death|154|||
156660504|NCT01866319|565504098|FG002|Overall Study|Death|147|||
156660505|NCT01866319|565504096|FG000|Overall Study|Lost to Follow-up|6|||
156660506|NCT01866319|565504097|FG001|Overall Study|Lost to Follow-up|3|||
156660507|NCT01866319|565504098|FG002|Overall Study|Lost to Follow-up|8|||
156660508|NCT01866319|565504096|FG000|Overall Study|Physician Decision|1|||
156660509|NCT01866319|565504097|FG001|Overall Study|Physician Decision|0|||
156660510|NCT01866319|565504098|FG002|Overall Study|Physician Decision|1|||
156660511|NCT01866319|565504096|FG000|Overall Study|Protocol Violation|0|||
156660512|NCT01866319|565504097|FG001|Overall Study|Protocol Violation|0|||
156660513|NCT01866319|565504098|FG002|Overall Study|Protocol Violation|1|||
156660514|NCT01866319|565504096|FG000|Overall Study|Withdrawal by Subject|32|||
156660515|NCT01866319|565504097|FG001|Overall Study|Withdrawal by Subject|14|||
156660516|NCT01866319|565504098|FG002|Overall Study|Withdrawal by Subject|12|||
156660517|NCT02191891|565504103|FG000|Overall Study|Withdrawal by Subject|0|||
156660518|NCT02191891|565504104|FG001|Overall Study|Withdrawal by Subject|1|||
156660519|NCT02191891|565504105|FG002|Overall Study|Withdrawal by Subject|0|||
156660520|NCT02191891|565504106|FG003|Overall Study|Withdrawal by Subject|0|||
156660521|NCT02191891|565504107|FG004|Overall Study|Withdrawal by Subject|1|||
156660522|NCT02191891|565504103|FG000|Overall Study|Adverse Event|0|||
156660523|NCT02191891|565504104|FG001|Overall Study|Adverse Event|1|||
156660524|NCT02191891|565504105|FG002|Overall Study|Adverse Event|0|||
156660525|NCT02191891|565504106|FG003|Overall Study|Adverse Event|0|||
156660526|NCT02191891|565504107|FG004|Overall Study|Adverse Event|2|||
156660527|NCT02191891|565504103|FG000|Overall Study|Disease Progression|4|||
156660528|NCT02191891|565504104|FG001|Overall Study|Disease Progression|10|||
156660529|NCT02191891|565504105|FG002|Overall Study|Disease Progression|4|||
156660530|NCT02191891|565504106|FG003|Overall Study|Disease Progression|2|||
156660531|NCT02191891|565504107|FG004|Overall Study|Disease Progression|7|||
156660532|NCT01448057|565504111|FG000|Overall Study|Protocol Violation|3|||
156660533|NCT01448057|565504112|FG001|Overall Study|Protocol Violation|2|||
156660534|NCT01448057|565504111|FG000|Overall Study|Lost to Follow-up|3|||
156660535|NCT01448057|565504112|FG001|Overall Study|Lost to Follow-up|0|||
156324745|NCT02964507|564289390|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
156660536|NCT01448057|565504111|FG000|Overall Study|Adverse Event|0|||
156660537|NCT01448057|565504112|FG001|Overall Study|Adverse Event|2|||
156660538|NCT01448057|565504111|FG000|Overall Study|Withdrawal by Subject|2|||
156660539|NCT01448057|565504112|FG001|Overall Study|Withdrawal by Subject|0|||
156660540|NCT00958243|565504115|FG000|Overall Study|Withdrawal by Subject|0|||
156660541|NCT00958243|565504116|FG001|Overall Study|Withdrawal by Subject|1|||
156324746|NCT02964507|564289391|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
156660542|NCT00958243|565504117|FG002|Overall Study|Withdrawal by Subject|3|||
156660543|NCT00958243|565504118|FG003|Overall Study|Withdrawal by Subject|1|||
156660544|NCT00958243|565504119|FG004|Overall Study|Withdrawal by Subject|1|||
156660545|NCT00958243|565504120|FG005|Overall Study|Withdrawal by Subject|5|||
156660546|NCT00958243|565504115|FG000|Overall Study|Lost to Follow-up|2|||
156660547|NCT00958243|565504116|FG001|Overall Study|Lost to Follow-up|5|||
156660548|NCT00958243|565504117|FG002|Overall Study|Lost to Follow-up|11|||
156660549|NCT00958243|565504118|FG003|Overall Study|Lost to Follow-up|2|||
156660550|NCT00958243|565504119|FG004|Overall Study|Lost to Follow-up|8|||
156660551|NCT00958243|565504120|FG005|Overall Study|Lost to Follow-up|5|||
156660552|NCT04646109|565504121|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
156660553|NCT04646109|565504122|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
156660554|NCT06176768|565504123|FG000|Overall Study|Adverse Event|1|||
156660555|NCT06176768|565504124|FG001|Overall Study|Adverse Event|0|||
156660556|NCT06176768|565504123|FG000|Overall Study|Assigned treatment by mistake|1|||
156660557|NCT06176768|565504124|FG001|Overall Study|Assigned treatment by mistake|0|||
156660558|NCT06176768|565504123|FG000|Overall Study|Lost to Follow-up|0|||
156660559|NCT06176768|565504124|FG001|Overall Study|Lost to Follow-up|3|||
156660560|NCT06176768|565504123|FG000|Overall Study|Physician Decision|1|||
156660561|NCT06176768|565504124|FG001|Overall Study|Physician Decision|0|||
156660562|NCT06176768|565504123|FG000|Overall Study|Protocol deviation|3|||
156660563|NCT06176768|565504124|FG001|Overall Study|Protocol deviation|1|||
156660564|NCT06176768|565504123|FG000|Overall Study|Other|1|||
156660565|NCT06176768|565504124|FG001|Overall Study|Other|0|||
156660566|NCT06176768|565504123|FG000|Overall Study|Withdrawal by Subject|6|||
156660567|NCT06176768|565504124|FG001|Overall Study|Withdrawal by Subject|9|||
156660568|NCT01226797|565504125|FG000|Overall Study|Adverse Event|1|||
156660569|NCT01226797|565504126|FG001|Overall Study|Adverse Event|0|||
156660570|NCT01226797|565504125|FG000|Overall Study|No longer willing to participate|1|||
156660571|NCT01226797|565504126|FG001|Overall Study|No longer willing to participate|0|||
156660572|NCT01226797|565504125|FG000|Overall Study|Protocol Violation|0|||
156660573|NCT01226797|565504126|FG001|Overall Study|Protocol Violation|1|||
156660574|NCT00577460|565504127|FG000|Overall Study|Adverse Event|11|||
156660575|NCT00577460|565504128|FG001|Overall Study|Adverse Event|7|||
156660576|NCT00577460|565504129|FG002|Overall Study|Adverse Event|14|||
156660577|NCT00577460|565504127|FG000|Overall Study|Protocol Violation|0|||
156660578|NCT00577460|565504128|FG001|Overall Study|Protocol Violation|1|||
156660579|NCT00577460|565504129|FG002|Overall Study|Protocol Violation|1|||
156660580|NCT00577460|565504127|FG000|Overall Study|Lost to Follow-up|0|||
156660581|NCT00577460|565504128|FG001|Overall Study|Lost to Follow-up|3|||
156660582|NCT00577460|565504129|FG002|Overall Study|Lost to Follow-up|4|||
156660583|NCT00577460|565504127|FG000|Overall Study|Withdrawal by Subject|5|||
156660584|NCT00577460|565504128|FG001|Overall Study|Withdrawal by Subject|5|||
156660585|NCT00577460|565504129|FG002|Overall Study|Withdrawal by Subject|6|||
156660586|NCT00577460|565504127|FG000|Overall Study|Other|0|||
156660587|NCT00577460|565504128|FG001|Overall Study|Other|3|||
156660588|NCT00577460|565504129|FG002|Overall Study|Other|2|||
156660589|NCT00162123|565504130|FG000|Overall Study|Disease progression|27|||
156660590|NCT00162123|565504131|FG001|Overall Study|Disease progression|19|||
156660591|NCT00162123|565504132|FG002|Overall Study|Disease progression|10|||
156660592|NCT00162123|565504133|FG003|Overall Study|Disease progression|4|||
156660593|NCT00162123|565504134|FG004|Overall Study|Disease progression|8|||
156660594|NCT00162123|565504135|FG005|Overall Study|Disease progression|3|||
156660595|NCT00162123|565504136|FG006|Overall Study|Disease progression|1|||
156660596|NCT00162123|565504137|FG007|Overall Study|Disease progression|0|||
156660597|NCT00162123|565504130|FG000|Overall Study|Study drug toxicity|6|||
156660598|NCT00162123|565504131|FG001|Overall Study|Study drug toxicity|1|||
156660599|NCT00162123|565504132|FG002|Overall Study|Study drug toxicity|5|||
156660600|NCT00162123|565504133|FG003|Overall Study|Study drug toxicity|0|||
156660601|NCT00162123|565504134|FG004|Overall Study|Study drug toxicity|4|||
156660602|NCT00162123|565504135|FG005|Overall Study|Study drug toxicity|1|||
156660603|NCT00162123|565504136|FG006|Overall Study|Study drug toxicity|1|||
156660604|NCT00162123|565504137|FG007|Overall Study|Study drug toxicity|0|||
156660605|NCT00162123|565504130|FG000|Overall Study|Death|3|||
156660606|NCT00162123|565504131|FG001|Overall Study|Death|3|||
156660607|NCT00162123|565504132|FG002|Overall Study|Death|1|||
156660608|NCT00162123|565504133|FG003|Overall Study|Death|1|||
156660609|NCT00162123|565504134|FG004|Overall Study|Death|1|||
156660610|NCT00162123|565504135|FG005|Overall Study|Death|1|||
156660611|NCT00162123|565504136|FG006|Overall Study|Death|0|||
156660612|NCT00162123|565504137|FG007|Overall Study|Death|0|||
156660613|NCT00162123|565504130|FG000|Overall Study|Withdrawal by Subject|2|||
156660614|NCT00162123|565504131|FG001|Overall Study|Withdrawal by Subject|0|||
156660615|NCT00162123|565504132|FG002|Overall Study|Withdrawal by Subject|2|||
156660616|NCT00162123|565504133|FG003|Overall Study|Withdrawal by Subject|1|||
156660617|NCT00162123|565504134|FG004|Overall Study|Withdrawal by Subject|1|||
156660618|NCT00162123|565504135|FG005|Overall Study|Withdrawal by Subject|2|||
156660619|NCT00162123|565504136|FG006|Overall Study|Withdrawal by Subject|1|||
156775052|NCT00596635|565928440|FG001|Overall Study|Hip fracture|3|||
156660620|NCT00162123|565504137|FG007|Overall Study|Withdrawal by Subject|0|||
156775053|NCT00596635|565928441|FG002|Overall Study|Hip fracture|3|||
156660621|NCT00162123|565504130|FG000|Overall Study|Deterioration without progression|2|||
156660622|NCT00162123|565504131|FG001|Overall Study|Deterioration without progression|2|||
156660623|NCT00162123|565504132|FG002|Overall Study|Deterioration without progression|3|||
156660624|NCT00162123|565504133|FG003|Overall Study|Deterioration without progression|0|||
156660625|NCT00162123|565504134|FG004|Overall Study|Deterioration without progression|1|||
156660626|NCT00162123|565504135|FG005|Overall Study|Deterioration without progression|0|||
156660627|NCT00162123|565504136|FG006|Overall Study|Deterioration without progression|0|||
156660628|NCT00162123|565504137|FG007|Overall Study|Deterioration without progression|0|||
156660629|NCT00162123|565504130|FG000|Overall Study|Adverse Event|1|||
156660630|NCT00162123|565504131|FG001|Overall Study|Adverse Event|2|||
156660631|NCT00162123|565504132|FG002|Overall Study|Adverse Event|0|||
156660632|NCT00162123|565504133|FG003|Overall Study|Adverse Event|2|||
156660633|NCT00162123|565504134|FG004|Overall Study|Adverse Event|1|||
156660634|NCT00162123|565504135|FG005|Overall Study|Adverse Event|0|||
156660635|NCT00162123|565504136|FG006|Overall Study|Adverse Event|0|||
156660636|NCT00162123|565504137|FG007|Overall Study|Adverse Event|0|||
156660637|NCT00162123|565504130|FG000|Overall Study|Not specified (before treatment)|2|||
156660638|NCT00162123|565504131|FG001|Overall Study|Not specified (before treatment)|0|||
156660639|NCT00162123|565504132|FG002|Overall Study|Not specified (before treatment)|0|||
156660640|NCT00162123|565504133|FG003|Overall Study|Not specified (before treatment)|0|||
156660641|NCT00162123|565504134|FG004|Overall Study|Not specified (before treatment)|12|||
156660642|NCT00162123|565504135|FG005|Overall Study|Not specified (before treatment)|1|||
156660643|NCT00162123|565504136|FG006|Overall Study|Not specified (before treatment)|0|||
156660644|NCT00162123|565504137|FG007|Overall Study|Not specified (before treatment)|0|||
156660645|NCT00162123|565504130|FG000|Overall Study|Not specified (after start of treatment)|0|||
156660646|NCT00162123|565504131|FG001|Overall Study|Not specified (after start of treatment)|0|||
156660647|NCT00162123|565504132|FG002|Overall Study|Not specified (after start of treatment)|0|||
156660648|NCT00162123|565504133|FG003|Overall Study|Not specified (after start of treatment)|0|||
156660649|NCT00162123|565504134|FG004|Overall Study|Not specified (after start of treatment)|3|||
156660650|NCT00162123|565504135|FG005|Overall Study|Not specified (after start of treatment)|0|||
156660651|NCT00162123|565504136|FG006|Overall Study|Not specified (after start of treatment)|0|||
156660652|NCT00162123|565504137|FG007|Overall Study|Not specified (after start of treatment)|0|||
156660653|NCT00162123|565504130|FG000|Overall Study|Physician Decision|1|||
156660654|NCT00162123|565504131|FG001|Overall Study|Physician Decision|2|||
156660655|NCT00162123|565504132|FG002|Overall Study|Physician Decision|0|||
156660656|NCT00162123|565504133|FG003|Overall Study|Physician Decision|0|||
156660657|NCT00162123|565504134|FG004|Overall Study|Physician Decision|0|||
156660658|NCT00162123|565504135|FG005|Overall Study|Physician Decision|1|||
156660659|NCT00162123|565504136|FG006|Overall Study|Physician Decision|1|||
156660660|NCT00162123|565504137|FG007|Overall Study|Physician Decision|0|||
156660661|NCT00162123|565504130|FG000|Overall Study|Tumor assessment only (not treated)|0|||
156660662|NCT00162123|565504131|FG001|Overall Study|Tumor assessment only (not treated)|0|||
156660663|NCT00162123|565504132|FG002|Overall Study|Tumor assessment only (not treated)|0|||
156660664|NCT00162123|565504133|FG003|Overall Study|Tumor assessment only (not treated)|0|||
156660665|NCT00162123|565504134|FG004|Overall Study|Tumor assessment only (not treated)|0|||
156660666|NCT00162123|565504135|FG005|Overall Study|Tumor assessment only (not treated)|0|||
156660667|NCT00162123|565504136|FG006|Overall Study|Tumor assessment only (not treated)|0|||
156660668|NCT00162123|565504137|FG007|Overall Study|Tumor assessment only (not treated)|1|||
156660669|NCT00162123|565504130|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
156660670|NCT00162123|565504131|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
156660671|NCT00162123|565504132|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
156660672|NCT00162123|565504133|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
156660673|NCT00162123|565504134|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
156660674|NCT00162123|565504135|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
156660675|NCT00162123|565504136|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
156660676|NCT00162123|565504137|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
156660677|NCT02016170|565504138|FG000|Overall Study|Adverse Event|1|||
156660678|NCT02016170|565504139|FG001|Overall Study|Adverse Event|1|||
156660679|NCT02016170|565504140|FG002|Overall Study|Adverse Event|0|||
156660680|NCT02016170|565504138|FG000|Overall Study|Protocol Violation|1|||
156660681|NCT02016170|565504139|FG001|Overall Study|Protocol Violation|0|||
156660682|NCT02016170|565504140|FG002|Overall Study|Protocol Violation|0|||
156660683|NCT02365207|565504144|FG000|Overall Study|Withdrawal by Subject|1|||
156660684|NCT02365207|565504144|FG000|Overall Study|Physician Decision|1|||
156660685|NCT01318499|565504147|FG000|Overall Study|Adverse Event|16|||
156660686|NCT01318499|565504148|FG001|Overall Study|Adverse Event|11|||
156660687|NCT01318499|565504149|FG002|Overall Study|Adverse Event|6|||
156660688|NCT01318499|565504147|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
156660689|NCT01318499|565504148|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
156660690|NCT01318499|565504149|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
156660691|NCT01318499|565504147|FG000|Overall Study|Noncompliance|2|||
156660692|NCT01318499|565504148|FG001|Overall Study|Noncompliance|3|||
156660693|NCT01318499|565504149|FG002|Overall Study|Noncompliance|0|||
156660694|NCT01318499|565504147|FG000|Overall Study|Treatment Failure|19|||
156660695|NCT01318499|565504148|FG001|Overall Study|Treatment Failure|19|||
156660696|NCT01318499|565504149|FG002|Overall Study|Treatment Failure|101|||
156775054|NCT00596635|565928439|FG000|Overall Study|Could not provide urine specimen|1|||
156775055|NCT00596635|565928440|FG001|Overall Study|Could not provide urine specimen|2|||
156775056|NCT00596635|565928441|FG002|Overall Study|Could not provide urine specimen|2|||
156775057|NCT01850641|565928444|FG000|Overall Study|Physician Decision|1|||
156775058|NCT01850641|565928444|FG000|Overall Study|Decrease in serum phosphorus|1|||
156775059|NCT01850641|565928444|FG000|Overall Study|Decrease in serum calcium|2|||
156775060|NCT01850641|565928444|FG000|Overall Study|Increase in serum ferritin|1|||
156775061|NCT00846365|565928445|FG000|Overall Study|Adverse Event|20|||
156775062|NCT00846365|565928446|FG001|Overall Study|Adverse Event|30|||
156775063|NCT00846365|565928447|FG002|Overall Study|Adverse Event|11|||
156775064|NCT00846365|565928445|FG000|Overall Study|Protocol Violation|5|||
156775065|NCT00846365|565928446|FG001|Overall Study|Protocol Violation|4|||
156775066|NCT00846365|565928447|FG002|Overall Study|Protocol Violation|0|||
156775067|NCT00846365|565928445|FG000|Overall Study|Lost to Follow-up|8|||
156775068|NCT00846365|565928446|FG001|Overall Study|Lost to Follow-up|2|||
156775069|NCT00846365|565928447|FG002|Overall Study|Lost to Follow-up|5|||
156775070|NCT00846365|565928445|FG000|Overall Study|Withdrawal by Subject|11|||
156775071|NCT00846365|565928446|FG001|Overall Study|Withdrawal by Subject|11|||
156775072|NCT00846365|565928447|FG002|Overall Study|Withdrawal by Subject|9|||
156775073|NCT00846365|565928445|FG000|Overall Study|Pregnancy|1|||
156775074|NCT00846365|565928446|FG001|Overall Study|Pregnancy|0|||
156775075|NCT00846365|565928447|FG002|Overall Study|Pregnancy|0|||
156775076|NCT00846365|565928445|FG000|Overall Study|Lack of Efficacy|1|||
156775077|NCT00846365|565928446|FG001|Overall Study|Lack of Efficacy|1|||
156775078|NCT00846365|565928447|FG002|Overall Study|Lack of Efficacy|2|||
156775079|NCT00846365|565928445|FG000|Overall Study|Other|9|||
156775080|NCT00846365|565928446|FG001|Overall Study|Other|1|||
156775081|NCT00846365|565928447|FG002|Overall Study|Other|6|||
156775082|NCT05032196|565928449|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775083|NCT05032196|565928450|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
156775084|NCT05032196|565928451|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775085|NCT05032196|565928452|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775086|NCT05032196|565928453|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775087|NCT05032196|565928454|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775088|NCT05032196|565928449|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775089|NCT05032196|565928450|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775090|NCT05032196|565928451|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775091|NCT05032196|565928452|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
156775092|NCT05032196|565928453|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775093|NCT05032196|565928454|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775094|NCT05032196|565928449|FG000|Period 2 (Multidose)|Physician Decision|0|||
156775095|NCT05032196|565928450|FG001|Period 2 (Multidose)|Physician Decision|0|||
156775096|NCT05032196|565928451|FG002|Period 2 (Multidose)|Physician Decision|0|||
156775097|NCT05032196|565928452|FG003|Period 2 (Multidose)|Physician Decision|0|||
156775098|NCT05032196|565928453|FG004|Period 2 (Multidose)|Physician Decision|1|||
156775099|NCT05032196|565928454|FG005|Period 2 (Multidose)|Physician Decision|0|||
156775100|NCT05260008|565928455|FG000|Overall Study|Physician Decision|0|||
156775101|NCT05260008|565928456|FG001|Overall Study|Physician Decision|1|||
156775102|NCT05260008|565928457|FG002|Overall Study|Physician Decision|0|||
156775103|NCT05260008|565928458|FG003|Overall Study|Physician Decision|0|||
156775104|NCT04817410|565929820|FG000|Overall Study|Withdrawal by Subject|5|||
156775105|NCT04817410|565929820|FG000|Overall Study|Physician Decision|3|||
156775106|NCT03595748|565929821|FG000|Overall Study|Death|11|||
156775107|NCT03595748|565929822|FG001|Overall Study|Death|12|||
156775108|NCT03595748|565929821|FG000|Overall Study|Withdrawal by Subject|28|||
156775109|NCT03595748|565929822|FG001|Overall Study|Withdrawal by Subject|29|||
156775110|NCT03595748|565929821|FG000|Overall Study|Protocol Violation|0|||
156775111|NCT03595748|565929822|FG001|Overall Study|Protocol Violation|1|||
156775112|NCT04809974|565929823|FG000|Lead-in Phase|Withdrawal by Subject|3|||
156775113|NCT04809974|565929824|FG001|Lead-in Phase|Withdrawal by Subject|0|||
156775114|NCT04809974|565929825|FG002|Lead-in Phase|Withdrawal by Subject|0|||
156775115|NCT04809974|565929823|FG000|Lead-in Phase|No longer eligible|11|||
156775116|NCT04809974|565929824|FG001|Lead-in Phase|No longer eligible|0|||
156775117|NCT04809974|565929825|FG002|Lead-in Phase|No longer eligible|0|||
156775118|NCT04809974|565929823|FG000|Randomized Phase|Lost to Follow-up|0|||
156775119|NCT04809974|565929824|FG001|Randomized Phase|Lost to Follow-up|1|||
156775120|NCT04809974|565929825|FG002|Randomized Phase|Lost to Follow-up|5|||
156775121|NCT04809974|565929823|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
156775122|NCT04809974|565929824|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
156775123|NCT04809974|565929825|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
156775124|NCT04809974|565929823|FG000|Randomized Phase|Adverse Event|0|||
156775125|NCT04809974|565929824|FG001|Randomized Phase|Adverse Event|1|||
156775126|NCT04809974|565929825|FG002|Randomized Phase|Adverse Event|4|||
156775127|NCT04809974|565929823|FG000|Randomized Phase|Withdrawal by Subject|0|||
156660697|NCT01318499|565504147|FG000|Overall Study|Protocol Violation|2|||
156660698|NCT01318499|565504148|FG001|Overall Study|Protocol Violation|4|||
156660699|NCT01318499|565504149|FG002|Overall Study|Protocol Violation|2|||
156660700|NCT01318499|565504147|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
156660701|NCT01318499|565504148|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
156660702|NCT01318499|565504149|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
156660703|NCT01318499|565504147|FG000|Overall Study|Other|7|||
156660704|NCT01318499|565504148|FG001|Overall Study|Other|10|||
156660705|NCT01318499|565504149|FG002|Overall Study|Other|22|||
156660706|NCT01347710|565504153|FG000|Overall Study|Withdrawal by Subject|2|||
156660707|NCT01347710|565504153|FG000|Overall Study|Adverse Event|4|||
156660708|NCT01347710|565504153|FG000|Overall Study|Angio or SPECT not completed|18|||
156660709|NCT01347710|565504153|FG000|Overall Study|issue with vitals prior to dosing|1|||
156660710|NCT01347710|565504153|FG000|Overall Study|Lost to Follow-up|1|||
156660711|NCT01347710|565504153|FG000|Overall Study|Physician Decision|2|||
156660712|NCT01347710|565504153|FG000|Overall Study|Other|3|||
156660713|NCT04591626|565504155|FG000|Overall Study|Adverse Event|4|||
156660714|NCT04591626|565504156|FG001|Overall Study|Adverse Event|0|||
156660715|NCT04591626|565504155|FG000|Overall Study|Withdrawal by Subject|5|||
156660716|NCT04591626|565504156|FG001|Overall Study|Withdrawal by Subject|3|||
156660717|NCT04591626|565504155|FG000|Overall Study|Physician Decision|0|||
156660718|NCT04591626|565504156|FG001|Overall Study|Physician Decision|1|||
156660719|NCT04591626|565504155|FG000|Overall Study|Death|0|||
156660720|NCT04591626|565504156|FG001|Overall Study|Death|1|||
156660721|NCT04591626|565504155|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156660722|NCT04591626|565504156|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156660723|NCT02672553|565504157|FG000|Overall Study|Death|3|||
156660724|NCT02672553|565504158|FG001|Overall Study|Death|5|||
156660725|NCT02672553|565504157|FG000|Overall Study|Valve Explant|1|||
156660726|NCT02672553|565504158|FG001|Overall Study|Valve Explant|0|||
156660727|NCT02672553|565504157|FG000|Overall Study|Conversion to Commercial Valve|3|||
156660728|NCT02672553|565504158|FG001|Overall Study|Conversion to Commercial Valve|0|||
156660729|NCT02672553|565504157|FG000|Overall Study|Withdrawal by Subject|3|||
156660730|NCT02672553|565504158|FG001|Overall Study|Withdrawal by Subject|3|||
156660731|NCT02672553|565504157|FG000|Overall Study|Intraoperative screen failure|2|||
156660732|NCT02672553|565504158|FG001|Overall Study|Intraoperative screen failure|0|||
156660733|NCT00970281|565504159|FG000|Overall Study|Lack of Efficacy|1|||
156660734|NCT00970281|565504160|FG001|Overall Study|Lack of Efficacy|14|||
156660735|NCT00970281|565504159|FG000|Overall Study|Withdrawal by Subject|0|||
156660736|NCT00970281|565504160|FG001|Overall Study|Withdrawal by Subject|1|||
156660737|NCT00970281|565504159|FG000|Overall Study|Physician Decision|1|||
156660738|NCT00970281|565504160|FG001|Overall Study|Physician Decision|1|||
156660739|NCT00878995|565504163|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
156660740|NCT00878995|565504164|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
156660741|NCT02480764|565504165|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
156660742|NCT02480764|565504166|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
156660743|NCT02480764|565504167|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
156660744|NCT02480764|565504165|FG000|Overall Study|Major Protocol Deviation|1|||
156660745|NCT02480764|565504166|FG001|Overall Study|Major Protocol Deviation|4|||
156660746|NCT02480764|565504167|FG002|Overall Study|Major Protocol Deviation|3|||
156660747|NCT02480764|565504165|FG000|Overall Study|Lost to Follow-up|0|||
156660748|NCT02480764|565504166|FG001|Overall Study|Lost to Follow-up|1|||
156660749|NCT02480764|565504167|FG002|Overall Study|Lost to Follow-up|2|||
156660750|NCT02480764|565504165|FG000|Overall Study|Voluntary Withdrawal|6|||
156660751|NCT02480764|565504166|FG001|Overall Study|Voluntary Withdrawal|5|||
156660752|NCT02480764|565504167|FG002|Overall Study|Voluntary Withdrawal|10|||
156660753|NCT02480764|565504165|FG000|Overall Study|Lack of Efficacy|0|||
156660754|NCT02480764|565504166|FG001|Overall Study|Lack of Efficacy|3|||
156660755|NCT02480764|565504167|FG002|Overall Study|Lack of Efficacy|3|||
156660756|NCT02480764|565504165|FG000|Overall Study|Reason not Specified|0|||
156660757|NCT02480764|565504166|FG001|Overall Study|Reason not Specified|1|||
156660758|NCT02480764|565504167|FG002|Overall Study|Reason not Specified|0|||
156660759|NCT03629249|565504168|FG000|Overall Study|Study terminated by sponsor|197|||
156660760|NCT03629249|565504169|FG001|Overall Study|Study terminated by sponsor|197|||
156660761|NCT03629249|565504170|FG002|Overall Study|Study terminated by sponsor|194|||
156660762|NCT03629249|565504168|FG000|Overall Study|Protocol deviation|0|||
156775128|NCT04809974|565929824|FG001|Randomized Phase|Withdrawal by Subject|0|||
156775129|NCT04809974|565929825|FG002|Randomized Phase|Withdrawal by Subject|5|||
156775130|NCT00549055|565929834|FG000|Overall Study|Adverse Event|4|||
156775131|NCT00549055|565929834|FG000|Overall Study|Lack of Efficacy|18|||
156660763|NCT03629249|565504169|FG001|Overall Study|Protocol deviation|2|||
156660764|NCT03629249|565504170|FG002|Overall Study|Protocol deviation|5|||
156660765|NCT03629249|565504168|FG000|Overall Study|Subject decision|1|||
156660766|NCT03629249|565504169|FG001|Overall Study|Subject decision|1|||
156660767|NCT03629249|565504170|FG002|Overall Study|Subject decision|3|||
156660768|NCT03629249|565504168|FG000|Overall Study|Adverse Event|1|||
156775132|NCT00549055|565929834|FG000|Overall Study|Stabilization|5|||
156775133|NCT00549055|565929834|FG000|Overall Study|Progression to fibrosis|2|||
156775134|NCT00549055|565929834|FG000|Overall Study|Decrease of size|1|||
156775135|NCT00549055|565929834|FG000|Overall Study|Active choroidal neovascula increased|1|||
156775136|NCT00549055|565929834|FG000|Overall Study|Vitreous hemorrhage|1|||
156775137|NCT00549055|565929834|FG000|Overall Study|Growth choroidal neovascularisation|1|||
156775138|NCT00549055|565929834|FG000|Overall Study|Choroidal neovascularization|1|||
156775139|NCT00549055|565929834|FG000|Overall Study|Very low visual acuity (VA)|1|||
156775140|NCT01240746|565929835|FG000|Overall Study|Adverse Event|2|||
156775141|NCT01240746|565929836|FG001|Overall Study|Adverse Event|0|||
156775142|NCT01240746|565929837|FG002|Overall Study|Adverse Event|10|||
156775143|NCT01240746|565929835|FG000|Overall Study|Lost to Follow-up|23|||
156775144|NCT01240746|565929836|FG001|Overall Study|Lost to Follow-up|20|||
156775145|NCT01240746|565929837|FG002|Overall Study|Lost to Follow-up|102|||
156775146|NCT01240746|565929835|FG000|Overall Study|Protocol Violation|24|||
156775147|NCT01240746|565929836|FG001|Overall Study|Protocol Violation|15|||
156775148|NCT01240746|565929837|FG002|Overall Study|Protocol Violation|72|||
156775149|NCT01240746|565929835|FG000|Overall Study|Withdrawal by Subject|10|||
156775150|NCT01240746|565929836|FG001|Overall Study|Withdrawal by Subject|13|||
156775151|NCT01240746|565929837|FG002|Overall Study|Withdrawal by Subject|59|||
156775152|NCT00764517|565929842|FG000|Overall Study|Adverse Event|9|||
156775153|NCT00764517|565929843|FG001|Overall Study|Adverse Event|3|||
156775154|NCT00764517|565929842|FG000|Overall Study|Death|3|||
156775155|NCT00764517|565929843|FG001|Overall Study|Death|11|||
156775156|NCT00764517|565929842|FG000|Overall Study|Physician Decision|3|||
156775157|NCT00764517|565929843|FG001|Overall Study|Physician Decision|0|||
156775158|NCT01137786|565929851|FG000|Overall Study|Lost to Follow-up|0|||
156775159|NCT01137786|565929852|FG001|Overall Study|Lost to Follow-up|2|||
156775160|NCT01137786|565929851|FG000|Overall Study|Withdrawal by Subject|1|||
156775161|NCT01137786|565929852|FG001|Overall Study|Withdrawal by Subject|1|||
156775162|NCT03331562|565929853|FG000|Overall Study|Adverse Event|2|||
156775163|NCT03331562|565929854|FG001|Overall Study|Adverse Event|0|||
156775164|NCT03331562|565929853|FG000|Overall Study|Death|1|||
156775165|NCT03331562|565929854|FG001|Overall Study|Death|0|||
156775166|NCT03718000|565929862|FG000|Overall Study|Relocation|2|||
156775167|NCT03718000|565929863|FG001|Overall Study|Relocation|4|||
156775168|NCT03718000|565929862|FG000|Overall Study|Pregnancy|0|||
156775169|NCT03718000|565929863|FG001|Overall Study|Pregnancy|1|||
156775170|NCT03517137|565929864|FG000|Overall Study|Lack of Efficacy|1|||
156775171|NCT03517137|565929864|FG000|Overall Study|Adverse Event|2|||
156775172|NCT03517137|565929864|FG000|Overall Study|Withdrawal by Subject|2|||
156775173|NCT03517137|565929864|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
156775174|NCT03575364|565929865|FG000|Overall Study|Death|45|||
156775175|NCT03575364|565929865|FG000|Overall Study|Lost to Follow-up|114|||
156775176|NCT03575364|565929865|FG000|Overall Study|Withdrawal by Subject|21|||
156775177|NCT03575364|565929865|FG000|Overall Study|Physician Decision|11|||
156775178|NCT03575364|565929865|FG000|Overall Study|Subject Refused Follow-up|13|||
156775179|NCT03575364|565929865|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
156775180|NCT03575364|565929865|FG000|Overall Study|Patient moved out of the state|1|||
156775181|NCT03575364|565929865|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
156775182|NCT03575364|565929865|FG000|Overall Study|Patient is lost to follow up|1|||
156775183|NCT03575364|565929865|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
156775184|NCT00716417|565929866|FG000|Overall Study|Adverse Event|0|||
156775185|NCT00716417|565929867|FG001|Overall Study|Adverse Event|0|||
156775186|NCT00716417|565929868|FG002|Overall Study|Adverse Event|2|||
156775187|NCT00716417|565929869|FG003|Overall Study|Adverse Event|1|||
156775188|NCT00716417|565929870|FG004|Overall Study|Adverse Event|0|||
156775189|NCT00716417|565929871|FG005|Overall Study|Adverse Event|0|||
156775190|NCT00716417|565929872|FG006|Overall Study|Adverse Event|3|||
156775191|NCT00716417|565929873|FG007|Overall Study|Adverse Event|1|||
156775192|NCT00716417|565929874|FG008|Overall Study|Adverse Event|0|||
156775193|NCT00716417|565929875|FG009|Overall Study|Adverse Event|3|||
156660769|NCT03629249|565504169|FG001|Overall Study|Adverse Event|1|||
156775194|NCT00716417|565929866|FG000|Overall Study|Withdrawal by Subject|0|||
156775195|NCT00716417|565929867|FG001|Overall Study|Withdrawal by Subject|1|||
156775196|NCT00716417|565929868|FG002|Overall Study|Withdrawal by Subject|0|||
156775197|NCT00716417|565929869|FG003|Overall Study|Withdrawal by Subject|2|||
156775198|NCT00716417|565929870|FG004|Overall Study|Withdrawal by Subject|0|||
156775199|NCT00716417|565929871|FG005|Overall Study|Withdrawal by Subject|0|||
156775200|NCT00716417|565929872|FG006|Overall Study|Withdrawal by Subject|1|||
156775201|NCT00716417|565929873|FG007|Overall Study|Withdrawal by Subject|0|||
156775202|NCT00716417|565929874|FG008|Overall Study|Withdrawal by Subject|0|||
156324747|NCT02964507|564289392|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
156324748|NCT02964507|564289393|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
156324749|NCT02964507|564289394|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
156775203|NCT00716417|565929875|FG009|Overall Study|Withdrawal by Subject|0|||
156775204|NCT00716417|565929866|FG000|Overall Study|Progressive disease|3|||
156660770|NCT03629249|565504170|FG002|Overall Study|Adverse Event|0|||
156660771|NCT03629249|565504168|FG000|Overall Study|Death|1|||
156660772|NCT03629249|565504169|FG001|Overall Study|Death|0|||
156660773|NCT03629249|565504170|FG002|Overall Study|Death|0|||
156660774|NCT03629249|565504168|FG000|Overall Study|Physician Decision|1|||
156660775|NCT03629249|565504169|FG001|Overall Study|Physician Decision|0|||
156660776|NCT03629249|565504170|FG002|Overall Study|Physician Decision|0|||
156660777|NCT00352690|565504171|FG000|Overall Study|Determined to be ineligible|2|||
156660778|NCT00352690|565504172|FG001|Overall Study|Determined to be ineligible|0|||
156775205|NCT00716417|565929867|FG001|Overall Study|Progressive disease|5|||
156775206|NCT00716417|565929868|FG002|Overall Study|Progressive disease|3|||
156775207|NCT00716417|565929869|FG003|Overall Study|Progressive disease|8|||
156775208|NCT00716417|565929870|FG004|Overall Study|Progressive disease|0|||
156775209|NCT00716417|565929871|FG005|Overall Study|Progressive disease|3|||
156775210|NCT00716417|565929872|FG006|Overall Study|Progressive disease|3|||
156775211|NCT00716417|565929873|FG007|Overall Study|Progressive disease|1|||
156775212|NCT00716417|565929874|FG008|Overall Study|Progressive disease|5|||
156775213|NCT00716417|565929875|FG009|Overall Study|Progressive disease|0|||
156775214|NCT00716417|565929866|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
156775215|NCT00716417|565929867|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
156775216|NCT00716417|565929868|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
156775217|NCT00716417|565929869|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
156775218|NCT00716417|565929870|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
156775219|NCT00716417|565929871|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
156775220|NCT00716417|565929872|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
156775221|NCT00716417|565929873|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
156775222|NCT00716417|565929874|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
156775223|NCT00716417|565929875|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
156775224|NCT00716417|565929866|FG000|Overall Study|On patient request due to toxicities|0|||
156775225|NCT00716417|565929867|FG001|Overall Study|On patient request due to toxicities|0|||
156775226|NCT00716417|565929868|FG002|Overall Study|On patient request due to toxicities|0|||
156775227|NCT00716417|565929869|FG003|Overall Study|On patient request due to toxicities|0|||
156775228|NCT00716417|565929870|FG004|Overall Study|On patient request due to toxicities|0|||
156775229|NCT00716417|565929871|FG005|Overall Study|On patient request due to toxicities|0|||
156775230|NCT00716417|565929872|FG006|Overall Study|On patient request due to toxicities|0|||
156775231|NCT00716417|565929873|FG007|Overall Study|On patient request due to toxicities|1|||
156775232|NCT00716417|565929874|FG008|Overall Study|On patient request due to toxicities|0|||
156775233|NCT00716417|565929875|FG009|Overall Study|On patient request due to toxicities|0|||
156775234|NCT01369433|565929876|FG000|Overall Study|Adverse Event|31|||
156775235|NCT01369433|565929877|FG001|Overall Study|Adverse Event|1|||
156775236|NCT01369433|565929876|FG000|Overall Study|Required significant surgical procedure|1|||
156775237|NCT01369433|565929877|FG001|Overall Study|Required significant surgical procedure|0|||
156775238|NCT01369433|565929876|FG000|Overall Study|Non-compliance|1|||
156775239|NCT01369433|565929877|FG001|Overall Study|Non-compliance|0|||
156775240|NCT01369433|565929876|FG000|Overall Study|Withdrawal by Subject|5|||
156775241|NCT01369433|565929877|FG001|Overall Study|Withdrawal by Subject|2|||
156775242|NCT01369433|565929876|FG000|Overall Study|Study terminated by Sponsor|67|||
156775243|NCT01369433|565929877|FG001|Overall Study|Study terminated by Sponsor|0|||
156775244|NCT01369433|565929876|FG000|Overall Study|Lost to Follow-up|1|||
156775245|NCT01369433|565929877|FG001|Overall Study|Lost to Follow-up|0|||
156775246|NCT01369433|565929876|FG000|Overall Study|Death|5|||
156775247|NCT01369433|565929877|FG001|Overall Study|Death|0|||
156775248|NCT01369433|565929876|FG000|Overall Study|Investigator discretion|6|||
156775249|NCT01369433|565929877|FG001|Overall Study|Investigator discretion|1|||
156775250|NCT01369433|565929876|FG000|Overall Study|Progressive Disease|92|||
156775251|NCT01369433|565929877|FG001|Overall Study|Progressive Disease|12|||
156775252|NCT03822416|565929879|FG000|Overall Study|Lost to Follow-up|1|||
156775253|NCT03822416|565929880|FG001|Overall Study|Lost to Follow-up|0|||
156775254|NCT03822416|565929879|FG000|Overall Study|Withdrawal by Subject|0|||
156775255|NCT03822416|565929880|FG001|Overall Study|Withdrawal by Subject|1|||
156775256|NCT04666298|565929883|FG000|Overall Study|Subject decision|1|||
156660779|NCT03633721|565504175|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
156775257|NCT04666298|565929884|FG001|Overall Study|Subject decision|0|||
156775258|NCT04666298|565929885|FG002|Overall Study|Subject decision|0|||
156775259|NCT04666298|565929886|FG003|Overall Study|Subject decision|2|||
156775260|NCT04666298|565929883|FG000|Overall Study|Death|1|||
156775261|NCT04666298|565929884|FG001|Overall Study|Death|0|||
156775262|NCT04666298|565929885|FG002|Overall Study|Death|0|||
156775263|NCT04666298|565929886|FG003|Overall Study|Death|0|||
156660780|NCT03633721|565504176|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
156775264|NCT04666298|565929883|FG000|Overall Study|Lost to Follow-up|0|||
156775265|NCT04666298|565929884|FG001|Overall Study|Lost to Follow-up|0|||
156775266|NCT04666298|565929885|FG002|Overall Study|Lost to Follow-up|0|||
156775267|NCT04666298|565929886|FG003|Overall Study|Lost to Follow-up|1|||
156775268|NCT04666298|565929883|FG000|Overall Study|Physician Decision|0|||
156660781|NCT03633721|565504177|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
156660782|NCT03633721|565504178|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
156660783|NCT01475474|565504182|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
156660784|NCT01475474|565504182|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
156660785|NCT02343120|565504183|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
156660786|NCT02343120|565504184|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
156660787|NCT02343120|565504185|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
156660788|NCT02343120|565504186|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
156660789|NCT02343120|565504187|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
156660790|NCT02343120|565504183|FG000|Part 1: Dose Escalation|Death|1|||
156660791|NCT02343120|565504184|FG001|Part 1: Dose Escalation|Death|2|||
156660792|NCT02343120|565504185|FG002|Part 1: Dose Escalation|Death|2|||
156660793|NCT02343120|565504186|FG003|Part 1: Dose Escalation|Death|2|||
156660794|NCT02343120|565504187|FG004|Part 1: Dose Escalation|Death|1|||
156660795|NCT02343120|565504183|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
156660796|NCT02343120|565504184|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
156660797|NCT02343120|565504185|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
156660798|NCT02343120|565504186|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
156660799|NCT02343120|565504187|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
156660800|NCT02343120|565504183|FG000|Part 2: Expansion|Sponsor decision|0|||
156660801|NCT02343120|565504184|FG001|Part 2: Expansion|Sponsor decision|0|||
156660802|NCT02343120|565504185|FG002|Part 2: Expansion|Sponsor decision|0|||
156660803|NCT02343120|565504186|FG003|Part 2: Expansion|Sponsor decision|165|||
156660804|NCT02343120|565504187|FG004|Part 2: Expansion|Sponsor decision|67|||
156660805|NCT02343120|565504183|FG000|Part 2: Expansion|Death|0|||
156660806|NCT02343120|565504184|FG001|Part 2: Expansion|Death|0|||
156660807|NCT02343120|565504185|FG002|Part 2: Expansion|Death|0|||
156660808|NCT02343120|565504186|FG003|Part 2: Expansion|Death|74|||
156660809|NCT02343120|565504187|FG004|Part 2: Expansion|Death|17|||
156660810|NCT02343120|565504183|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
156660811|NCT02343120|565504184|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
156660812|NCT02343120|565504185|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
156660813|NCT02343120|565504186|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
156660814|NCT02343120|565504187|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
156660815|NCT02343120|565504183|FG000|Part 2: Expansion|Lost to Follow-up|0|||
156660816|NCT02343120|565504184|FG001|Part 2: Expansion|Lost to Follow-up|0|||
156660817|NCT02343120|565504185|FG002|Part 2: Expansion|Lost to Follow-up|0|||
156660818|NCT02343120|565504186|FG003|Part 2: Expansion|Lost to Follow-up|5|||
156660819|NCT02343120|565504187|FG004|Part 2: Expansion|Lost to Follow-up|2|||
156660820|NCT02343120|565504183|FG000|Part 2: Expansion|Other|0|||
156660821|NCT02343120|565504184|FG001|Part 2: Expansion|Other|0|||
156660822|NCT02343120|565504185|FG002|Part 2: Expansion|Other|0|||
156660823|NCT02343120|565504186|FG003|Part 2: Expansion|Other|1|||
156660824|NCT02343120|565504187|FG004|Part 2: Expansion|Other|5|||
156660825|NCT02343120|565504183|FG000|Part 2: Expansion|Adverse Event|0|||
156660826|NCT02343120|565504184|FG001|Part 2: Expansion|Adverse Event|0|||
156660827|NCT02343120|565504185|FG002|Part 2: Expansion|Adverse Event|0|||
156660828|NCT02343120|565504186|FG003|Part 2: Expansion|Adverse Event|1|||
156660829|NCT02343120|565504187|FG004|Part 2: Expansion|Adverse Event|1|||
156660830|NCT01766778|565504200|FG000|Overall Study|Adverse Event|4|||
156660831|NCT01766778|565504201|FG001|Overall Study|Adverse Event|4|||
156660832|NCT01766778|565504200|FG000|Overall Study|Withdrawal by Subject|1|||
156660833|NCT01766778|565504201|FG001|Overall Study|Withdrawal by Subject|0|||
156660834|NCT01054599|565504202|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
156660835|NCT01054599|565504203|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
156660836|NCT01054599|565504202|FG000|Overall Study|Protocol Violation|1|||
156660837|NCT01054599|565504203|FG001|Overall Study|Protocol Violation|0|||
156660838|NCT01054599|565504202|FG000|Overall Study|Spells/seizure-like episodes|1|||
156660839|NCT01054599|565504203|FG001|Overall Study|Spells/seizure-like episodes|1|||
156660840|NCT01054599|565504202|FG000|Overall Study|Timing/scheduling difficulties|1|||
156660841|NCT01054599|565504203|FG001|Overall Study|Timing/scheduling difficulties|1|||
156660842|NCT01054599|565504202|FG000|Overall Study|Visual impairment, WTAR <80|0|||
156660843|NCT01054599|565504203|FG001|Overall Study|Visual impairment, WTAR <80|1|||
156660844|NCT01054599|565504202|FG000|Overall Study|Lost to Follow-up|0|||
156660845|NCT01054599|565504203|FG001|Overall Study|Lost to Follow-up|2|||
156660846|NCT01054599|565504202|FG000|Overall Study|Adverse Event|0|||
156660847|NCT01054599|565504203|FG001|Overall Study|Adverse Event|1|||
156660848|NCT01054599|565504202|FG000|Overall Study|Withdrawal by Subject|0|||
156660849|NCT01054599|565504203|FG001|Overall Study|Withdrawal by Subject|1|||
156660850|NCT01104662|565504204|FG000|Overall Study|Adverse Event|2|||
156660851|NCT01104662|565504205|FG001|Overall Study|Adverse Event|2|||
156660852|NCT01104662|565504206|FG002|Overall Study|Adverse Event|0|||
156660853|NCT01104662|565504207|FG003|Overall Study|Adverse Event|1|||
156660854|NCT01104662|565504208|FG004|Overall Study|Adverse Event|1|||
156660855|NCT01104662|565504209|FG005|Overall Study|Adverse Event|1|||
156660856|NCT01104662|565504210|FG006|Overall Study|Adverse Event|0|||
156660857|NCT01104662|565504211|FG007|Overall Study|Adverse Event|0|||
156660858|NCT01104662|565504204|FG000|Overall Study|Clinical Failure|1|||
156660859|NCT01104662|565504205|FG001|Overall Study|Clinical Failure|0|||
156775269|NCT04666298|565929884|FG001|Overall Study|Physician Decision|0|||
156775270|NCT04666298|565929885|FG002|Overall Study|Physician Decision|0|||
156775271|NCT04666298|565929886|FG003|Overall Study|Physician Decision|1|||
156775272|NCT04666298|565929883|FG000|Overall Study|Protocol deviation|0|||
156775273|NCT04666298|565929884|FG001|Overall Study|Protocol deviation|0|||
156775274|NCT04666298|565929885|FG002|Overall Study|Protocol deviation|1|||
156775275|NCT04666298|565929886|FG003|Overall Study|Protocol deviation|0|||
156775276|NCT00844519|565929887|FG000|Overall Study|Withdrawal by Subject|1|||
156324750|NCT02964507|564289395|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
156324751|NCT02964507|564289388|FG000|Overall Study|Study terminated by Sponsor|9|||
156660860|NCT01104662|565504206|FG002|Overall Study|Clinical Failure|0|||
156660861|NCT01104662|565504207|FG003|Overall Study|Clinical Failure|0|||
156660862|NCT01104662|565504208|FG004|Overall Study|Clinical Failure|0|||
156660863|NCT01104662|565504209|FG005|Overall Study|Clinical Failure|1|||
156660864|NCT01104662|565504210|FG006|Overall Study|Clinical Failure|0|||
156660865|NCT01104662|565504211|FG007|Overall Study|Clinical Failure|0|||
156660866|NCT01104662|565504204|FG000|Overall Study|Participant left investigator's care|1|||
156660867|NCT01104662|565504205|FG001|Overall Study|Participant left investigator's care|1|||
156660868|NCT01104662|565504206|FG002|Overall Study|Participant left investigator's care|0|||
156660869|NCT01104662|565504207|FG003|Overall Study|Participant left investigator's care|0|||
156660870|NCT01104662|565504208|FG004|Overall Study|Participant left investigator's care|0|||
156660871|NCT01104662|565504209|FG005|Overall Study|Participant left investigator's care|0|||
156660872|NCT01104662|565504210|FG006|Overall Study|Participant left investigator's care|0|||
156660873|NCT01104662|565504211|FG007|Overall Study|Participant left investigator's care|0|||
156660874|NCT01104662|565504204|FG000|Overall Study|Reason not specified|3|||
156660875|NCT01104662|565504205|FG001|Overall Study|Reason not specified|3|||
156660876|NCT01104662|565504206|FG002|Overall Study|Reason not specified|0|||
156660877|NCT01104662|565504207|FG003|Overall Study|Reason not specified|0|||
156660878|NCT01104662|565504208|FG004|Overall Study|Reason not specified|0|||
156660879|NCT01104662|565504209|FG005|Overall Study|Reason not specified|1|||
156660880|NCT01104662|565504210|FG006|Overall Study|Reason not specified|0|||
156660881|NCT01104662|565504211|FG007|Overall Study|Reason not specified|0|||
156660882|NCT01104662|565504204|FG000|Overall Study|Randomized but not treated|3|||
156660883|NCT01104662|565504205|FG001|Overall Study|Randomized but not treated|4|||
156660884|NCT01104662|565504206|FG002|Overall Study|Randomized but not treated|1|||
156660885|NCT01104662|565504207|FG003|Overall Study|Randomized but not treated|0|||
156660886|NCT01104662|565504208|FG004|Overall Study|Randomized but not treated|0|||
156660887|NCT01104662|565504209|FG005|Overall Study|Randomized but not treated|1|||
156660888|NCT01104662|565504210|FG006|Overall Study|Randomized but not treated|0|||
156660889|NCT01104662|565504211|FG007|Overall Study|Randomized but not treated|0|||
156660890|NCT02514174|565504214|FG000|Overall Study|Patient refused to continue medication|1|||
156660891|NCT02514174|565504214|FG000|Overall Study|Adverse Event|2|||
156660892|NCT02514174|565504214|FG000|Overall Study|Study closed by sponsor|9|||
156660893|NCT02514174|565504214|FG000|Overall Study|Progressive disease|11|||
156660894|NCT02514174|565504214|FG000|Overall Study|Treatment change|1|||
156660895|NCT02514174|565504214|FG000|Overall Study|Treated off study with Afatinib.|1|||
156660896|NCT02888171|565504217|FG000|Overall Study|Lost to Follow-up|2|||
156324752|NCT02964507|564289389|FG001|Overall Study|Study terminated by Sponsor|1|||
156324753|NCT02964507|564289390|FG002|Overall Study|Study terminated by Sponsor|9|||
156324754|NCT02964507|564289391|FG003|Overall Study|Study terminated by Sponsor|3|||
156324755|NCT02964507|564289392|FG004|Overall Study|Study terminated by Sponsor|3|||
156660897|NCT02888171|565504218|FG001|Overall Study|Lost to Follow-up|1|||
156660898|NCT02888171|565504217|FG000|Overall Study|Withdrawal by Subject|3|||
156660899|NCT02888171|565504218|FG001|Overall Study|Withdrawal by Subject|2|||
156660900|NCT02888171|565504217|FG000|Overall Study|Adverse Event|0|||
156660901|NCT02888171|565504218|FG001|Overall Study|Adverse Event|1|||
156660902|NCT04349917|565506467|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
156660903|NCT04349917|565506468|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
156660904|NCT04349917|565506467|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
156660905|NCT04349917|565506468|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
156660906|NCT00745420|565506471|FG000|Overall Study|Ineligible|1|||
156660907|NCT04455633|565506481|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
156660908|NCT04455633|565506482|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
156660909|NCT04455633|565506483|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
156660910|NCT04455633|565506481|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
156660911|NCT04455633|565506482|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
156660912|NCT04455633|565506483|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
156660913|NCT04455633|565506481|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
156660914|NCT04455633|565506482|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
156775277|NCT00844519|565929888|FG001|Overall Study|Withdrawal by Subject|1|||
156775278|NCT00844519|565929887|FG000|Overall Study|Adverse Event|1|||
156324756|NCT02964507|564289393|FG005|Overall Study|Study terminated by Sponsor|2|||
156775279|NCT00844519|565929888|FG001|Overall Study|Adverse Event|0|||
156775280|NCT01303419|565929891|FG000|Overall Study|Discontinuation of study|60|||
156775281|NCT01303419|565929891|FG000|Overall Study|Did not complete both imaging methods|5|||
156775282|NCT01303419|565929891|FG000|Overall Study|Did not meet all I/E after screening|31|||
156775283|NCT01995201|565929892|FG000|From Baseline Until Week 24|Adverse Event|4|||
156775284|NCT01995201|565929893|FG001|From Baseline Until Week 24|Adverse Event|15|||
156775285|NCT01995201|565929894|FG002|From Baseline Until Week 24|Adverse Event|0|||
156775286|NCT01995201|565929895|FG003|From Baseline Until Week 24|Adverse Event|0|||
156775287|NCT01995201|565929896|FG004|From Baseline Until Week 24|Adverse Event|0|||
156775288|NCT01995201|565929897|FG005|From Baseline Until Week 24|Adverse Event|0|||
156775289|NCT01995201|565929898|FG006|From Baseline Until Week 24|Adverse Event|0|||
156775290|NCT01995201|565929892|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156524304|NCT04218084|565013849|FG001|Overall Study|Non-compliance with study drug|1|||
156524305|NCT04218084|565013848|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
156524306|NCT04218084|565013849|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
156524307|NCT04218084|565013848|FG000|Overall Study|Other|0|||
156524308|NCT04218084|565013849|FG001|Overall Study|Other|1|||
156524309|NCT04218084|565013848|FG000|Overall Study|Ongoing at data cut-off date|62|||
156524310|NCT04218084|565013849|FG001|Overall Study|Ongoing at data cut-off date|58|||
156524311|NCT02783768|565013850|FG000|Overall Study|Lost to Follow-up|1|||
156524312|NCT02783768|565013851|FG001|Overall Study|Lost to Follow-up|0|||
156524313|NCT01853137|565013852|FG000|Overall Study|Lost to Follow-up|4|||
156524314|NCT01853137|565013853|FG001|Overall Study|Lost to Follow-up|1|||
156524315|NCT03401229|565013854|FG000|Overall Study|Lost to Follow-up|2|||
156524316|NCT03401229|565013855|FG001|Overall Study|Lost to Follow-up|1|||
156524317|NCT03401229|565013854|FG000|Overall Study|Other|1|||
156524318|NCT03401229|565013855|FG001|Overall Study|Other|3|||
156524319|NCT03401229|565013854|FG000|Overall Study|Adverse Event|8|||
156524320|NCT03401229|565013855|FG001|Overall Study|Adverse Event|6|||
156775291|NCT01995201|565929893|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
156775292|NCT01995201|565929894|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775293|NCT01995201|565929895|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775294|NCT01995201|565929896|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775295|NCT01995201|565929897|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775296|NCT01995201|565929898|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775297|NCT01995201|565929892|FG000|From Baseline Until Week 24|Death|0|||
156775298|NCT01995201|565929893|FG001|From Baseline Until Week 24|Death|1|||
156775299|NCT01995201|565929894|FG002|From Baseline Until Week 24|Death|0|||
156775300|NCT01995201|565929895|FG003|From Baseline Until Week 24|Death|0|||
156775301|NCT01995201|565929896|FG004|From Baseline Until Week 24|Death|0|||
156775302|NCT01995201|565929897|FG005|From Baseline Until Week 24|Death|0|||
156775303|NCT01995201|565929898|FG006|From Baseline Until Week 24|Death|0|||
156775304|NCT01995201|565929892|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
156775305|NCT01995201|565929893|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
156775306|NCT01995201|565929894|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
156775307|NCT01995201|565929895|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
156775308|NCT01995201|565929896|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
156775309|NCT01995201|565929897|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
156775310|NCT01995201|565929898|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
156775311|NCT01995201|565929892|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
156775312|NCT01995201|565929893|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
156775313|NCT01995201|565929894|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
156775314|NCT01995201|565929895|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
156775315|NCT01995201|565929896|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
156775316|NCT01995201|565929897|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
156775317|NCT01995201|565929898|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
156775318|NCT01995201|565929892|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
156775319|NCT01995201|565929893|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
156775320|NCT01995201|565929894|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775321|NCT01995201|565929895|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775322|NCT01995201|565929896|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775323|NCT01995201|565929897|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775324|NCT01995201|565929898|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775325|NCT01995201|565929892|FG000|From Baseline Until Week 24|Physician Decision|0|||
156775326|NCT01995201|565929893|FG001|From Baseline Until Week 24|Physician Decision|2|||
156775327|NCT01995201|565929894|FG002|From Baseline Until Week 24|Physician Decision|0|||
156775328|NCT01995201|565929895|FG003|From Baseline Until Week 24|Physician Decision|0|||
156775329|NCT01995201|565929896|FG004|From Baseline Until Week 24|Physician Decision|0|||
156775330|NCT01995201|565929897|FG005|From Baseline Until Week 24|Physician Decision|0|||
156324757|NCT02964507|564289394|FG006|Overall Study|Study terminated by Sponsor|0|||
156524321|NCT03401229|565013854|FG000|Overall Study|Withdrawal by Subject|29|||
156524322|NCT03401229|565013855|FG001|Overall Study|Withdrawal by Subject|26|||
156324758|NCT02964507|564289395|FG007|Overall Study|Study terminated by Sponsor|0|||
156324759|NCT02964507|564289388|FG000|Overall Study|Other|3|||
156324760|NCT02964507|564289389|FG001|Overall Study|Other|0|||
156324761|NCT02964507|564289390|FG002|Overall Study|Other|0|||
156324762|NCT02964507|564289391|FG003|Overall Study|Other|0|||
156324763|NCT02964507|564289392|FG004|Overall Study|Other|1|||
156324764|NCT02964507|564289393|FG005|Overall Study|Other|0|||
156324765|NCT02964507|564289394|FG006|Overall Study|Other|0|||
156324766|NCT02964507|564289395|FG007|Overall Study|Other|0|||
156660915|NCT04455633|565506483|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
156660916|NCT04455633|565506481|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
156660917|NCT04455633|565506482|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
156660918|NCT04455633|565506483|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
156660919|NCT01648166|565506484|FG000|Overall Study|inadequate toenail samples|53|||
156660920|NCT01648166|565506485|FG001|Overall Study|inadequate toenail samples|100|||
156660921|NCT00883090|565506486|FG000|Overall Study|Sponsor's decision|1|||
156660922|NCT00883090|565506486|FG000|Overall Study|Withdrawal by Subject|1|||
156660923|NCT02532764|565506487|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
156660924|NCT02532764|565506488|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
156660925|NCT02532764|565506489|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
156660926|NCT02532764|565506490|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
156660927|NCT02532764|565506491|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
156660928|NCT02532764|565506492|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
156660929|NCT02532764|565506493|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
156660930|NCT02532764|565506494|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
156660931|NCT02532764|565506495|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
156660932|NCT02532764|565506496|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
156660933|NCT03527745|565506497|FG000|Overall Study|Lost to Follow-up|3|||
156660934|NCT03527745|565506498|FG001|Overall Study|Lost to Follow-up|6|||
156660935|NCT03527745|565506499|FG002|Overall Study|Lost to Follow-up|7|||
156660936|NCT03527745|565506500|FG003|Overall Study|Lost to Follow-up|9|||
156660937|NCT03527745|565506501|FG004|Overall Study|Lost to Follow-up|0|||
156660938|NCT03527745|565506502|FG005|Overall Study|Lost to Follow-up|2|||
156660939|NCT03527745|565506503|FG006|Overall Study|Lost to Follow-up|3|||
156660940|NCT03527745|565506504|FG007|Overall Study|Lost to Follow-up|2|||
156660941|NCT03527745|565506505|FG008|Overall Study|Lost to Follow-up|3|||
156660942|NCT03527745|565506506|FG009|Overall Study|Lost to Follow-up|2|||
156660943|NCT03527745|565506507|FG010|Overall Study|Lost to Follow-up|1|||
156660944|NCT03527745|565506508|FG011|Overall Study|Lost to Follow-up|1|||
156660945|NCT03527745|565506509|FG012|Overall Study|Lost to Follow-up|0|||
156660946|NCT03527745|565506510|FG013|Overall Study|Lost to Follow-up|0|||
156660947|NCT03527745|565506511|FG014|Overall Study|Lost to Follow-up|0|||
156660948|NCT03527745|565506512|FG015|Overall Study|Lost to Follow-up|0|||
156660949|NCT03527745|565506513|FG016|Overall Study|Lost to Follow-up|1|||
156660950|NCT03527745|565506514|FG017|Overall Study|Lost to Follow-up|0|||
156660951|NCT03527745|565506515|FG018|Overall Study|Lost to Follow-up|0|||
156660952|NCT03527745|565506516|FG019|Overall Study|Lost to Follow-up|1|||
156660953|NCT03527745|565506517|FG020|Overall Study|Lost to Follow-up|1|||
156660954|NCT03527745|565506518|FG021|Overall Study|Lost to Follow-up|5|||
156660955|NCT03527745|565506519|FG022|Overall Study|Lost to Follow-up|6|||
156660956|NCT03527745|565506520|FG023|Overall Study|Lost to Follow-up|8|||
156660957|NCT03527745|565506521|FG024|Overall Study|Lost to Follow-up|1|||
156660958|NCT03527745|565506522|FG025|Overall Study|Lost to Follow-up|3|||
156660959|NCT01475838|565506526|FG000|Randomized Phase|Randomized but Not Treated|0|||
156660960|NCT01475838|565506527|FG001|Randomized Phase|Randomized but Not Treated|5|||
156660961|NCT01475838|565506526|FG000|Randomized Phase|Adverse Event|6|||
156660962|NCT01475838|565506527|FG001|Randomized Phase|Adverse Event|1|||
156660963|NCT01475838|565506526|FG000|Randomized Phase|Pregnancy|0|||
156660964|NCT01475838|565506527|FG001|Randomized Phase|Pregnancy|1|||
156660965|NCT01475838|565506526|FG000|Randomized Phase|Investigators Discretion|1|||
156660966|NCT01475838|565506527|FG001|Randomized Phase|Investigators Discretion|2|||
156660967|NCT01475838|565506526|FG000|Randomized Phase|Withdrew Consent|10|||
156660968|NCT01475838|565506527|FG001|Randomized Phase|Withdrew Consent|14|||
156660969|NCT01475838|565506526|FG000|Randomized Phase|Lost to Follow-up|3|||
156660970|NCT01475838|565506527|FG001|Randomized Phase|Lost to Follow-up|4|||
156660971|NCT01475838|565506526|FG000|Randomized Phase|Participant Noncompliance|1|||
156660972|NCT01475838|565506527|FG001|Randomized Phase|Participant Noncompliance|5|||
156660973|NCT01475838|565506526|FG000|Randomized Phase|Protocol Violation|9|||
156324767|NCT02964507|564289388|FG000|Overall Study|Death|11|||
156660974|NCT01475838|565506527|FG001|Randomized Phase|Protocol Violation|4|||
156660975|NCT01475838|565506526|FG000|Extension Phase|Participant Noncompliance|1|||
156660976|NCT01475838|565506527|FG001|Extension Phase|Participant Noncompliance|0|||
156324768|NCT02964507|564289389|FG001|Overall Study|Death|9|||
156324769|NCT02964507|564289390|FG002|Overall Study|Death|12|||
156324770|NCT02964507|564289391|FG003|Overall Study|Death|2|||
156660977|NCT00048568|565506533|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
156660978|NCT00048568|565506534|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
156660979|NCT00048568|565506535|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
156660980|NCT00048568|565506533|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
156660981|NCT00048568|565506534|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
156660982|NCT00048568|565506535|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
156660983|NCT00048568|565506533|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
156660984|NCT00048568|565506534|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
156660985|NCT00048568|565506535|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
156660986|NCT00048568|565506533|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
156660987|NCT00048568|565506534|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
156660988|NCT00048568|565506535|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
156660989|NCT00048568|565506533|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
156660990|NCT00048568|565506534|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
156660991|NCT00048568|565506535|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
156660992|NCT00048568|565506533|FG000|Double-Blind Period Days 170 to 365|Death|1|||
156660993|NCT00048568|565506534|FG001|Double-Blind Period Days 170 to 365|Death|1|||
156660994|NCT00048568|565506535|FG002|Double-Blind Period Days 170 to 365|Death|0|||
156660995|NCT00048568|565506533|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
156660996|NCT00048568|565506534|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
156660997|NCT00048568|565506535|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
156660998|NCT00048568|565506533|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
156660999|NCT00048568|565506534|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
156661000|NCT00048568|565506535|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
156661001|NCT00048568|565506533|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
156524323|NCT03401229|565013854|FG000|Overall Study|COVID-19|0|||
156524324|NCT03401229|565013855|FG001|Overall Study|COVID-19|1|||
156524325|NCT05333224|565013856|FG000|Overall Study - Infants|Lost to Follow-up|1|||
156524326|NCT05333224|565013857|FG001|Overall Study - Infants|Lost to Follow-up|1|||
156524327|NCT00848926|565013859|FG000|Treatment Period|Progressive disease|45|||
156524328|NCT00848926|565013859|FG000|Treatment Period|Adverse Event|20|||
156524329|NCT00848926|565013859|FG000|Treatment Period|Physician Decision|12|||
156524330|NCT00848926|565013859|FG000|Treatment Period|Withdrawal by Subject|7|||
156524331|NCT00848926|565013859|FG000|Follow-up Period|Lost to Follow-up|7|||
156524332|NCT00848926|565013859|FG000|Follow-up Period|Withdrawal by Subject|3|||
156524333|NCT00848926|565013859|FG000|Follow-up Period|Other|2|||
156524334|NCT00966277|565013861|FG000|Overall Study|Withdrawal by Subject|3|||
156524335|NCT00966277|565013862|FG001|Overall Study|Withdrawal by Subject|0|||
156524336|NCT00966277|565013861|FG000|Overall Study|Ineligible|1|||
156524337|NCT00966277|565013862|FG001|Overall Study|Ineligible|3|||
156524338|NCT00966277|565013861|FG000|Overall Study|Treatment Plan Changed|0|||
156524339|NCT00966277|565013862|FG001|Overall Study|Treatment Plan Changed|1|||
156524340|NCT04620811|565013864|FG000|Overall Study|Withdrawal by Subject|18|||
156524341|NCT04620811|565013865|FG001|Overall Study|Withdrawal by Subject|15|||
156524342|NCT04620811|565013864|FG000|Overall Study|Adverse Event|6|||
156524343|NCT04620811|565013865|FG001|Overall Study|Adverse Event|11|||
156524344|NCT04620811|565013864|FG000|Overall Study|Lost to Follow-up|4|||
156524345|NCT04620811|565013865|FG001|Overall Study|Lost to Follow-up|8|||
156524346|NCT04620811|565013864|FG000|Overall Study|Physician Decision|1|||
156524347|NCT04620811|565013865|FG001|Overall Study|Physician Decision|4|||
156524348|NCT04620811|565013864|FG000|Overall Study|Sponsor Decision|0|||
156524349|NCT04620811|565013865|FG001|Overall Study|Sponsor Decision|1|||
156524350|NCT04620811|565013864|FG000|Overall Study|Elevation of ALT or AST|1|||
156524351|NCT04620811|565013865|FG001|Overall Study|Elevation of ALT or AST|0|||
156524352|NCT04620811|565013864|FG000|Overall Study|Other|3|||
156524353|NCT04620811|565013865|FG001|Overall Study|Other|5|||
156524354|NCT02481947|565013870|FG000|Overall Study|Withdrawal by Subject|24|||
156524355|NCT02481947|565013871|FG001|Overall Study|Withdrawal by Subject|10|||
156524356|NCT02481947|565013870|FG000|Overall Study|Lost to Follow-up|11|||
156524357|NCT02481947|565013871|FG001|Overall Study|Lost to Follow-up|5|||
156524358|NCT02481947|565013870|FG000|Overall Study|Adverse Event|6|||
156524359|NCT02481947|565013871|FG001|Overall Study|Adverse Event|11|||
156524360|NCT02481947|565013870|FG000|Overall Study|Physician Decision|4|||
156524361|NCT02481947|565013871|FG001|Overall Study|Physician Decision|5|||
156524362|NCT02481947|565013870|FG000|Overall Study|Protocol Violation|1|||
156524363|NCT02481947|565013871|FG001|Overall Study|Protocol Violation|5|||
156524364|NCT00551460|565013872|FG000|Overall Study|Adverse Event|1|||
156524365|NCT00551460|565013872|FG000|Overall Study|Withdrawal by Subject|1|||
156524366|NCT00551460|565013872|FG000|Overall Study|Physician Decision|1|||
156524367|NCT00551460|565013872|FG000|Overall Study|Death|7|||
156524368|NCT00551460|565013872|FG000|Overall Study|Ineligible|4|||
156661002|NCT00048568|565506534|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
156661003|NCT00048568|565506535|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
156524369|NCT00551460|565013872|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
156524370|NCT02027623|565013874|FG000|Overall Study|Lost to Follow-up|3|||
156524371|NCT02027623|565013875|FG001|Overall Study|Lost to Follow-up|3|||
156661004|NCT00048568|565506533|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
156661005|NCT00048568|565506534|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
156775331|NCT01995201|565929898|FG006|From Baseline Until Week 24|Physician Decision|0|||
156775332|NCT01995201|565929892|FG000|From Baseline Until Week 24|Protocol Violation|0|||
156775333|NCT01995201|565929893|FG001|From Baseline Until Week 24|Protocol Violation|9|||
156775334|NCT01995201|565929894|FG002|From Baseline Until Week 24|Protocol Violation|0|||
156775335|NCT01995201|565929895|FG003|From Baseline Until Week 24|Protocol Violation|0|||
156775336|NCT01995201|565929896|FG004|From Baseline Until Week 24|Protocol Violation|0|||
156775337|NCT01995201|565929897|FG005|From Baseline Until Week 24|Protocol Violation|0|||
156775338|NCT01995201|565929898|FG006|From Baseline Until Week 24|Protocol Violation|0|||
156775339|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Adverse Event|0|||
156775340|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Adverse Event|0|||
156775341|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Adverse Event|2|||
156775342|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Adverse Event|1|||
156775343|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Adverse Event|1|||
156775344|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Adverse Event|3|||
156775345|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Adverse Event|1|||
156775346|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Death|0|||
156775347|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Death|0|||
156775348|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Death|0|||
156775349|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Death|0|||
156775350|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Death|0|||
156775351|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Death|2|||
156775352|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Death|0|||
156775353|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
156775354|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
156775355|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
156775356|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
156775357|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
156775358|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
156324771|NCT02964507|564289392|FG004|Overall Study|Death|10|||
156324772|NCT02964507|564289393|FG005|Overall Study|Death|5|||
156661006|NCT00048568|565506535|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
156661007|NCT00048568|565506533|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
156661008|NCT00048568|565506534|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
156661009|NCT00048568|565506535|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
156661010|NCT00048568|565506533|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
156661011|NCT00048568|565506534|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
156661012|NCT00048568|565506535|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
156661013|NCT00048568|565506533|FG000|Open-Label Period|Death|0|||
156661014|NCT00048568|565506534|FG001|Open-Label Period|Death|0|||
156661015|NCT00048568|565506535|FG002|Open-Label Period|Death|13|||
156661016|NCT00048568|565506533|FG000|Open-Label Period|Adverse Event|0|||
156661017|NCT00048568|565506534|FG001|Open-Label Period|Adverse Event|0|||
156661018|NCT00048568|565506535|FG002|Open-Label Period|Adverse Event|49|||
156661019|NCT00048568|565506533|FG000|Open-Label Period|Lack of Efficacy|0|||
156661020|NCT00048568|565506534|FG001|Open-Label Period|Lack of Efficacy|0|||
156661021|NCT00048568|565506535|FG002|Open-Label Period|Lack of Efficacy|32|||
156661022|NCT00048568|565506533|FG000|Open-Label Period|Withdrawal by Subject|0|||
156661023|NCT00048568|565506534|FG001|Open-Label Period|Withdrawal by Subject|0|||
156661024|NCT00048568|565506535|FG002|Open-Label Period|Withdrawal by Subject|26|||
156661025|NCT00048568|565506533|FG000|Open-Label Period|Pregnancy|0|||
156661026|NCT00048568|565506534|FG001|Open-Label Period|Pregnancy|0|||
156661027|NCT00048568|565506535|FG002|Open-Label Period|Pregnancy|5|||
156661028|NCT00048568|565506533|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
156661029|NCT00048568|565506534|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
156661030|NCT00048568|565506535|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
156661031|NCT00048568|565506533|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
156775359|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
156775360|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
156775361|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
156775362|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
156324773|NCT02964507|564289394|FG006|Overall Study|Death|0|||
156324774|NCT02964507|564289395|FG007|Overall Study|Death|0|||
156524372|NCT02027623|565013874|FG000|Overall Study|Withdrawal by Subject|6|||
156524373|NCT02027623|565013875|FG001|Overall Study|Withdrawal by Subject|9|||
156661032|NCT00048568|565506534|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
156661033|NCT00048568|565506535|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
156661034|NCT00048568|565506533|FG000|Open-Label Period|Unknown Reasons|0|||
156661035|NCT00048568|565506534|FG001|Open-Label Period|Unknown Reasons|0|||
156661036|NCT00048568|565506535|FG002|Open-Label Period|Unknown Reasons|25|||
156661037|NCT00048568|565506533|FG000|Open-Label Period|Lost to Follow-up|0|||
156775363|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
156775364|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
156661038|NCT00048568|565506534|FG001|Open-Label Period|Lost to Follow-up|0|||
156661039|NCT00048568|565506535|FG002|Open-Label Period|Lost to Follow-up|7|||
156661040|NCT01717976|565506536|FG000|Overall Study|Protocol Violation|0|||
156661041|NCT01717976|565506537|FG001|Overall Study|Protocol Violation|1|||
156661042|NCT03831048|565506538|FG000|Overall Study|Protocol Violation|9|||
156661043|NCT03831048|565506539|FG001|Overall Study|Protocol Violation|3|||
156661044|NCT03831048|565506538|FG000|Overall Study|Death|4|||
156661045|NCT03831048|565506539|FG001|Overall Study|Death|9|||
156661046|NCT03831048|565506538|FG000|Overall Study|Re-transplant|0|||
156661047|NCT03831048|565506539|FG001|Overall Study|Re-transplant|2|||
156661048|NCT03831048|565506538|FG000|Overall Study|Protocol violation and death|1|||
156661049|NCT03831048|565506539|FG001|Overall Study|Protocol violation and death|1|||
156661050|NCT00560235|565506540|FG000|Phase 1|Discontinued|8|||
156661051|NCT00560235|565506541|FG001|Phase 1|Discontinued|0|||
156661052|NCT00560235|565506542|FG002|Phase 1|Discontinued|0|||
156661053|NCT00560235|565506540|FG000|Phase 1B|Discontinued|0|||
156661054|NCT00560235|565506541|FG001|Phase 1B|Discontinued|19|||
156661055|NCT00560235|565506542|FG002|Phase 1B|Discontinued|0|||
156661056|NCT00560235|565506540|FG000|Phase 2|Discontinued|0|||
156661057|NCT00560235|565506541|FG001|Phase 2|Discontinued|0|||
156661058|NCT00560235|565506542|FG002|Phase 2|Discontinued|96|||
156661059|NCT00560235|565506540|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
156775365|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
156775366|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
156775367|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775368|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775369|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
156775370|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775371|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
156775372|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775373|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775374|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Physician Decision|0|||
156775375|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Physician Decision|0|||
156775376|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Physician Decision|0|||
156775377|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Physician Decision|0|||
156775378|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Physician Decision|1|||
156775379|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Physician Decision|0|||
156775380|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Physician Decision|0|||
156775381|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
156524374|NCT01886378|565013878|FG000|Overall Study|Adverse Event|1|||
156661060|NCT00560235|565506541|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
156661061|NCT00560235|565506542|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
156661062|NCT04015232|565506543|FG000|Overall Study|Withdrawal by Subject|7|||
156661063|NCT04015232|565506544|FG001|Overall Study|Withdrawal by Subject|4|||
156661064|NCT04015232|565506543|FG000|Overall Study|Protocol Violation|1|||
156661065|NCT04015232|565506544|FG001|Overall Study|Protocol Violation|0|||
156661066|NCT04015232|565506543|FG000|Overall Study|Medical Grounds|3|||
156661067|NCT04015232|565506544|FG001|Overall Study|Medical Grounds|3|||
156661068|NCT01087970|565506547|FG000|Overall Study|Protocol Violation|2|||
156661069|NCT03164772|565506548|FG000|Overall Study|Death|4|||
156661070|NCT03164772|565506549|FG001|Overall Study|Death|2|||
156661071|NCT03164772|565506548|FG000|Overall Study|Adverse Event|1|||
156661072|NCT03164772|565506549|FG001|Overall Study|Adverse Event|4|||
156661073|NCT03164772|565506548|FG000|Overall Study|Progressive Disease|11|||
156661074|NCT03164772|565506549|FG001|Overall Study|Progressive Disease|21|||
156661075|NCT03164772|565506548|FG000|Overall Study|Physician Decision|2|||
156661076|NCT03164772|565506549|FG001|Overall Study|Physician Decision|0|||
156661077|NCT03164772|565506548|FG000|Overall Study|Withdrawal by Subject|0|||
156661078|NCT03164772|565506549|FG001|Overall Study|Withdrawal by Subject|4|||
156661079|NCT00849901|565506554|FG000|Acute Treatment Phase|Adverse Event|9|||
156661080|NCT00849901|565506555|FG001|Acute Treatment Phase|Adverse Event|1|||
156661081|NCT00849901|565506556|FG002|Acute Treatment Phase|Adverse Event|3|||
156661082|NCT00849901|565506554|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
156661083|NCT00849901|565506555|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
156661084|NCT00849901|565506556|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
156661085|NCT00849901|565506554|FG000|Acute Treatment Phase|Protocol Violation|0|||
156661086|NCT00849901|565506555|FG001|Acute Treatment Phase|Protocol Violation|2|||
156661087|NCT00849901|565506556|FG002|Acute Treatment Phase|Protocol Violation|1|||
156661088|NCT00849901|565506554|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
156661089|NCT00849901|565506555|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
156661090|NCT00849901|565506556|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
156661091|NCT00849901|565506554|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
156661092|NCT00849901|565506555|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
156661093|NCT00849901|565506556|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
156775382|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
156661094|NCT00849901|565506554|FG000|Acute Treatment Phase|Physician Decision|1|||
156661095|NCT00849901|565506555|FG001|Acute Treatment Phase|Physician Decision|1|||
156661096|NCT00849901|565506556|FG002|Acute Treatment Phase|Physician Decision|1|||
156661097|NCT00849901|565506554|FG000|Acute Treatment Phase|Sponsor Decision|1|||
156661098|NCT00849901|565506555|FG001|Acute Treatment Phase|Sponsor Decision|0|||
156661099|NCT00849901|565506556|FG002|Acute Treatment Phase|Sponsor Decision|0|||
156661100|NCT00849901|565506554|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
156661101|NCT00849901|565506555|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
156661102|NCT00849901|565506556|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
156661103|NCT00849901|565506554|FG000|Extension Phase|Adverse Event|2|||
156661104|NCT00849901|565506555|FG001|Extension Phase|Adverse Event|8|||
156661105|NCT00849901|565506556|FG002|Extension Phase|Adverse Event|4|||
156661106|NCT00849901|565506554|FG000|Extension Phase|Lost to Follow-up|3|||
156661107|NCT00849901|565506555|FG001|Extension Phase|Lost to Follow-up|0|||
156661108|NCT00849901|565506556|FG002|Extension Phase|Lost to Follow-up|1|||
156661109|NCT00849901|565506554|FG000|Extension Phase|Protocol Violation|2|||
156661110|NCT00849901|565506555|FG001|Extension Phase|Protocol Violation|2|||
156661111|NCT00849901|565506556|FG002|Extension Phase|Protocol Violation|4|||
156661112|NCT00849901|565506554|FG000|Extension Phase|Withdrawal by Subject|7|||
156661113|NCT00849901|565506555|FG001|Extension Phase|Withdrawal by Subject|6|||
156661114|NCT00849901|565506556|FG002|Extension Phase|Withdrawal by Subject|3|||
156661115|NCT00849901|565506554|FG000|Extension Phase|Parent or Caregiver Decision|10|||
156661116|NCT00849901|565506555|FG001|Extension Phase|Parent or Caregiver Decision|4|||
156661117|NCT00849901|565506556|FG002|Extension Phase|Parent or Caregiver Decision|4|||
156661118|NCT00849901|565506554|FG000|Extension Phase|Physician Decision|1|||
156661119|NCT00849901|565506555|FG001|Extension Phase|Physician Decision|2|||
156661120|NCT00849901|565506556|FG002|Extension Phase|Physician Decision|0|||
156661121|NCT00849901|565506554|FG000|Extension Phase|Lack of Efficacy|2|||
156661122|NCT00849901|565506555|FG001|Extension Phase|Lack of Efficacy|4|||
156661123|NCT00849901|565506556|FG002|Extension Phase|Lack of Efficacy|1|||
156661124|NCT00262223|565506557|FG000|Treatment Phase|Withdrawal by Subject|3|||
156661125|NCT00262223|565506558|FG001|Treatment Phase|Withdrawal by Subject|6|||
156661126|NCT00262223|565506557|FG000|Treatment Phase|Adverse Event|1|||
156661127|NCT00262223|565506558|FG001|Treatment Phase|Adverse Event|2|||
156661128|NCT00262223|565506557|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
156661129|NCT00262223|565506558|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
156661130|NCT00262223|565506557|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
156661131|NCT00262223|565506558|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
156661132|NCT00262223|565506557|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
156661133|NCT00262223|565506558|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
156661134|NCT00437658|565506561|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
156661135|NCT00437658|565506562|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
156661136|NCT00437658|565506563|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
156661137|NCT00437658|565506561|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
156661138|NCT00437658|565506562|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
156661139|NCT00437658|565506563|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
156661140|NCT00437658|565506561|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
156661141|NCT00437658|565506562|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
156661142|NCT00437658|565506563|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
156661143|NCT00437658|565506561|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
156661144|NCT00437658|565506562|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
156661145|NCT00437658|565506563|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
156661146|NCT00437658|565506561|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
156661147|NCT00437658|565506562|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
156661148|NCT00437658|565506563|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
156661149|NCT00437658|565506561|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
156661150|NCT00437658|565506562|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
156661151|NCT00437658|565506563|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
156661152|NCT00437658|565506561|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
156661153|NCT00437658|565506562|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
156661154|NCT00437658|565506563|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
156661155|NCT00437658|565506561|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
156661156|NCT00437658|565506562|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
156661157|NCT00437658|565506563|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
156661158|NCT00437658|565506561|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
156661159|NCT00437658|565506562|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
156661160|NCT00437658|565506563|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
156661161|NCT00437658|565506561|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
156661162|NCT00437658|565506562|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
156661163|NCT00437658|565506563|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
156661164|NCT00437658|565506561|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
156661165|NCT00437658|565506562|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
156661166|NCT00437658|565506563|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
156661167|NCT00437658|565506561|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
156661168|NCT00437658|565506562|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
156661169|NCT00437658|565506563|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
156661170|NCT03952143|565506564|FG000|Lead-In Period|Adverse Event|2|||
156661171|NCT03952143|565506565|FG001|Lead-In Period|Adverse Event|0|||
156661172|NCT03952143|565506566|FG002|Lead-In Period|Adverse Event|0|||
156661173|NCT03952143|565506564|FG000|Lead-In Period|Lack of Efficacy|2|||
156661174|NCT03952143|565506565|FG001|Lead-In Period|Lack of Efficacy|0|||
156661175|NCT03952143|565506566|FG002|Lead-In Period|Lack of Efficacy|0|||
156661176|NCT03952143|565506564|FG000|Lead-In Period|Physician Decision|5|||
156661177|NCT03952143|565506565|FG001|Lead-In Period|Physician Decision|0|||
156661178|NCT03952143|565506566|FG002|Lead-In Period|Physician Decision|0|||
156661179|NCT03952143|565506564|FG000|Lead-In Period|Protocol Violation|5|||
156661180|NCT03952143|565506565|FG001|Lead-In Period|Protocol Violation|0|||
156661181|NCT03952143|565506566|FG002|Lead-In Period|Protocol Violation|0|||
156661182|NCT03952143|565506564|FG000|Lead-In Period|Withdrawal by Subject|19|||
156661183|NCT03952143|565506565|FG001|Lead-In Period|Withdrawal by Subject|0|||
156661184|NCT03952143|565506566|FG002|Lead-In Period|Withdrawal by Subject|0|||
156661185|NCT03952143|565506564|FG000|Treatment Period|Adverse Event|0|||
156661186|NCT03952143|565506565|FG001|Treatment Period|Adverse Event|0|||
156661187|NCT03952143|565506566|FG002|Treatment Period|Adverse Event|1|||
156661188|NCT03952143|565506564|FG000|Treatment Period|Lost to Follow-up|0|||
156661189|NCT03952143|565506565|FG001|Treatment Period|Lost to Follow-up|2|||
156661190|NCT03952143|565506566|FG002|Treatment Period|Lost to Follow-up|0|||
156661191|NCT03952143|565506564|FG000|Treatment Period|Physician Decision|0|||
156661192|NCT03952143|565506565|FG001|Treatment Period|Physician Decision|0|||
156661193|NCT03952143|565506566|FG002|Treatment Period|Physician Decision|2|||
156661194|NCT03952143|565506564|FG000|Treatment Period|Protocol Violation|0|||
156661195|NCT03952143|565506565|FG001|Treatment Period|Protocol Violation|0|||
156661196|NCT03952143|565506566|FG002|Treatment Period|Protocol Violation|1|||
156661197|NCT03952143|565506564|FG000|Treatment Period|Withdrawal by Subject|0|||
156661198|NCT03952143|565506565|FG001|Treatment Period|Withdrawal by Subject|5|||
156661199|NCT03952143|565506566|FG002|Treatment Period|Withdrawal by Subject|26|||
156661200|NCT03952143|565506564|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
156661201|NCT03952143|565506565|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
156661202|NCT03952143|565506566|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
156661203|NCT03952143|565506564|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
156661204|NCT03952143|565506565|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
156661205|NCT03952143|565506566|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
156661206|NCT02152566|565506567|FG000|Overall Study|Lost to Follow-up|1|||
156661207|NCT02152566|565506567|FG000|Overall Study|Withdrawal by Subject|2|||
156661208|NCT00496964|565506568|FG000|Overall Study|Withdrawal by Subject|0|||
156661209|NCT00496964|565506569|FG001|Overall Study|Withdrawal by Subject|1|||
156661210|NCT02942264|565506570|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
156661211|NCT02942264|565506571|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
156661212|NCT02942264|565506572|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
156661213|NCT02942264|565506573|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
156661214|NCT02942264|565506574|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
156661215|NCT02942264|565506575|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
156661216|NCT02942264|565506576|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
156661217|NCT02942264|565506577|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
156661218|NCT02942264|565506578|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
156661219|NCT02942264|565506570|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
156661220|NCT02942264|565506571|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
156661221|NCT02942264|565506572|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
156661222|NCT02942264|565506573|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
156661223|NCT02942264|565506574|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
156661224|NCT02942264|565506575|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
156324775|NCT02964507|564289388|FG000|Overall Study|Withdrawal by Subject|1|||
156324776|NCT02964507|564289389|FG001|Overall Study|Withdrawal by Subject|0|||
156324777|NCT02964507|564289390|FG002|Overall Study|Withdrawal by Subject|1|||
156324778|NCT02964507|564289391|FG003|Overall Study|Withdrawal by Subject|1|||
156324779|NCT02964507|564289392|FG004|Overall Study|Withdrawal by Subject|0|||
156661225|NCT02942264|565506576|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
156661226|NCT02942264|565506577|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
156661227|NCT02942264|565506578|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
156661228|NCT01328093|565506579|FG000|Double-Blind Phase|Adverse Event|78|||
156661229|NCT01328093|565506580|FG001|Double-Blind Phase|Adverse Event|15|||
156661230|NCT01328093|565506579|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
156661231|NCT01328093|565506580|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
156661232|NCT01328093|565506579|FG000|Double-Blind Phase|Lost to Follow-up|39|||
156661233|NCT01328093|565506580|FG001|Double-Blind Phase|Lost to Follow-up|14|||
156661234|NCT01328093|565506579|FG000|Double-Blind Phase|Protocol Violation|30|||
156775383|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
156775384|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
156775385|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
156775386|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
156775387|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
156775388|NCT01138046|565929899|FG000|Overall Study|Withdrawal due to death|6|||
156775389|NCT02178956|565929900|FG000|Overall Study|Lost to Follow-up|4|||
156775390|NCT02178956|565929901|FG001|Overall Study|Lost to Follow-up|4|||
156775391|NCT02178956|565929900|FG000|Overall Study|Sponsor terminated study|49|||
156775392|NCT02178956|565929901|FG001|Overall Study|Sponsor terminated study|58|||
156775393|NCT02178956|565929900|FG000|Overall Study|Withdrawal by Subject|15|||
156775394|NCT02178956|565929901|FG001|Overall Study|Withdrawal by Subject|11|||
156775395|NCT02178956|565929900|FG000|Overall Study|Various Reasons|3|||
156775396|NCT02178956|565929901|FG001|Overall Study|Various Reasons|5|||
156775397|NCT01341470|565929903|FG000|Overall Study|Sponsor decision|0|||
156775398|NCT01341470|565929904|FG001|Overall Study|Sponsor decision|0|||
156775399|NCT01341470|565929905|FG002|Overall Study|Sponsor decision|1|||
156775400|NCT01341470|565929906|FG003|Overall Study|Sponsor decision|1|||
156775401|NCT01341470|565929907|FG004|Overall Study|Sponsor decision|0|||
156775402|NCT01341470|565929908|FG005|Overall Study|Sponsor decision|1|||
156775403|NCT02337829|565929911|FG000|Overall Study|Death|0|||
156775404|NCT02337829|565929912|FG001|Overall Study|Death|1|||
156775405|NCT02337829|565929913|FG002|Overall Study|Death|0|||
156775406|NCT02337829|565929914|FG003|Overall Study|Death|0|||
156775407|NCT02337829|565929911|FG000|Overall Study|Study terminated by sponsor|12|||
156775408|NCT02337829|565929912|FG001|Overall Study|Study terminated by sponsor|10|||
156775409|NCT02337829|565929913|FG002|Overall Study|Study terminated by sponsor|5|||
156775410|NCT02337829|565929914|FG003|Overall Study|Study terminated by sponsor|6|||
156775411|NCT02337829|565929911|FG000|Overall Study|discontinued for other reasons|6|||
156775412|NCT02337829|565929912|FG001|Overall Study|discontinued for other reasons|3|||
156775413|NCT02337829|565929913|FG002|Overall Study|discontinued for other reasons|1|||
156775414|NCT02337829|565929914|FG003|Overall Study|discontinued for other reasons|4|||
156775415|NCT03188822|565929918|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
156775416|NCT03188822|565929918|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
156775417|NCT01654276|565929927|FG000|Overall Study|Lack of Efficacy|1|||
156775418|NCT01654276|565929927|FG000|Overall Study|Lost to Follow-up|4|||
156775419|NCT01654276|565929927|FG000|Overall Study|Withdrawal by Subject|1|||
156775420|NCT04478266|565929928|FG000|Overall Study|Adverse Event|20|||
156775421|NCT04478266|565929929|FG001|Overall Study|Adverse Event|21|||
156775422|NCT04478266|565929928|FG000|Overall Study|Progressive disease|146|||
156775423|NCT04478266|565929929|FG001|Overall Study|Progressive disease|168|||
156775424|NCT04478266|565929928|FG000|Overall Study|Poor compliance to protocol|1|||
156775425|NCT04478266|565929929|FG001|Overall Study|Poor compliance to protocol|0|||
156775426|NCT04478266|565929928|FG000|Overall Study|Withdrawal by Subject|19|||
156775427|NCT04478266|565929929|FG001|Overall Study|Withdrawal by Subject|16|||
156775428|NCT04478266|565929928|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
156775429|NCT04478266|565929929|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
156775430|NCT04478266|565929928|FG000|Overall Study|Study terminated by sponsor|33|||
156775431|NCT04478266|565929929|FG001|Overall Study|Study terminated by sponsor|35|||
156775432|NCT04478266|565929928|FG000|Overall Study|Other: unspecified|5|||
156775433|NCT04478266|565929929|FG001|Overall Study|Other: unspecified|7|||
156775434|NCT04478266|565929928|FG000|Overall Study|Randomized but not treated|1|||
156775435|NCT04478266|565929929|FG001|Overall Study|Randomized but not treated|1|||
156775436|NCT02340949|565929930|FG000|Overall Study|Adverse Event|4|||
156775437|NCT02340949|565929931|FG001|Overall Study|Adverse Event|2|||
156775438|NCT02340949|565929930|FG000|Overall Study|Withdrawal by Subject|2|||
156775439|NCT02340949|565929931|FG001|Overall Study|Withdrawal by Subject|0|||
156775440|NCT02340949|565929930|FG000|Overall Study|Progression disease|6|||
156775441|NCT02340949|565929931|FG001|Overall Study|Progression disease|2|||
156775442|NCT02340949|565929930|FG000|Overall Study|Death|3|||
156775443|NCT02340949|565929931|FG001|Overall Study|Death|0|||
156775444|NCT02340949|565929930|FG000|Overall Study|Physician Decision|1|||
156775445|NCT02340949|565929931|FG001|Overall Study|Physician Decision|0|||
156775446|NCT01192178|565929932|FG000|Overall Study|Withdrawal by Subject|6|||
156775447|NCT01192178|565929933|FG001|Overall Study|Withdrawal by Subject|10|||
156775448|NCT01192178|565929932|FG000|Overall Study|Protocol Violation|10|||
156775449|NCT01192178|565929933|FG001|Overall Study|Protocol Violation|3|||
156775450|NCT01192178|565929932|FG000|Overall Study|Physician Decision|2|||
156775451|NCT01192178|565929933|FG001|Overall Study|Physician Decision|4|||
156775452|NCT01192178|565929932|FG000|Overall Study|Lost to Follow-up|3|||
156775453|NCT01192178|565929933|FG001|Overall Study|Lost to Follow-up|3|||
156775454|NCT01192178|565929932|FG000|Overall Study|Adverse Event|2|||
156775455|NCT01192178|565929933|FG001|Overall Study|Adverse Event|1|||
156775456|NCT01192178|565929932|FG000|Overall Study|Lack of Efficacy|1|||
156775457|NCT01192178|565929933|FG001|Overall Study|Lack of Efficacy|2|||
156775458|NCT00296517|565929936|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
156661235|NCT01328093|565506580|FG001|Double-Blind Phase|Protocol Violation|10|||
156661236|NCT01328093|565506579|FG000|Double-Blind Phase|Lack of Efficacy|55|||
156661237|NCT01328093|565506580|FG001|Double-Blind Phase|Lack of Efficacy|13|||
156661238|NCT01328093|565506579|FG000|Double-Blind Phase|Sponsor Decision|17|||
156661239|NCT01328093|565506580|FG001|Double-Blind Phase|Sponsor Decision|3|||
156661240|NCT01328093|565506579|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
156661241|NCT01328093|565506580|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
156661242|NCT01328093|565506579|FG000|Double-Blind Phase|Scheduling conflict|8|||
156661243|NCT01328093|565506580|FG001|Double-Blind Phase|Scheduling conflict|3|||
156661244|NCT01328093|565506579|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
156661245|NCT01328093|565506580|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
156661246|NCT01328093|565506579|FG000|Double-Blind Phase|Death|1|||
156661247|NCT01328093|565506580|FG001|Double-Blind Phase|Death|0|||
156661248|NCT01328093|565506579|FG000|Open-Label Phase|Sponsor Decision|98|||
156661249|NCT01328093|565506580|FG001|Open-Label Phase|Sponsor Decision|34|||
156661250|NCT01328093|565506579|FG000|Open-Label Phase|Protocol Violation|8|||
156661251|NCT01328093|565506580|FG001|Open-Label Phase|Protocol Violation|3|||
156661252|NCT01328093|565506579|FG000|Open-Label Phase|Lost to Follow-up|10|||
156661253|NCT01328093|565506580|FG001|Open-Label Phase|Lost to Follow-up|1|||
156661254|NCT01328093|565506579|FG000|Open-Label Phase|Adverse Event|10|||
156661255|NCT01328093|565506580|FG001|Open-Label Phase|Adverse Event|4|||
156661256|NCT01328093|565506579|FG000|Open-Label Phase|Lack of Efficacy|5|||
156661257|NCT01328093|565506580|FG001|Open-Label Phase|Lack of Efficacy|6|||
156661258|NCT01328093|565506579|FG000|Open-Label Phase|Withdrawal by Subject|4|||
156661259|NCT01328093|565506580|FG001|Open-Label Phase|Withdrawal by Subject|1|||
156661260|NCT01328093|565506579|FG000|Open-Label Phase|Scheduling conflict|2|||
156661261|NCT01328093|565506580|FG001|Open-Label Phase|Scheduling conflict|1|||
156661262|NCT01328093|565506579|FG000|Open-Label Phase|Subject is moving or has moved|2|||
156661263|NCT01328093|565506580|FG001|Open-Label Phase|Subject is moving or has moved|0|||
156661264|NCT01328093|565506579|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
156661265|NCT01328093|565506580|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
156661266|NCT03980483|565506583|FG000|Overall Study|Adverse Event|13|||
156661267|NCT03980483|565506584|FG001|Overall Study|Adverse Event|29|||
156661268|NCT03980483|565506585|FG002|Overall Study|Adverse Event|11|||
156661269|NCT03980483|565506586|FG003|Overall Study|Adverse Event|2|||
156661270|NCT03980483|565506587|FG004|Overall Study|Adverse Event|2|||
156661271|NCT03980483|565506588|FG005|Overall Study|Adverse Event|2|||
156661272|NCT03980483|565506583|FG000|Overall Study|Lack of Efficacy|7|||
156661273|NCT03980483|565506584|FG001|Overall Study|Lack of Efficacy|6|||
156661274|NCT03980483|565506585|FG002|Overall Study|Lack of Efficacy|0|||
156661275|NCT03980483|565506586|FG003|Overall Study|Lack of Efficacy|3|||
156661276|NCT03980483|565506587|FG004|Overall Study|Lack of Efficacy|1|||
156661277|NCT03980483|565506588|FG005|Overall Study|Lack of Efficacy|1|||
156661278|NCT03980483|565506583|FG000|Overall Study|Lost to Follow-up|2|||
156661279|NCT03980483|565506584|FG001|Overall Study|Lost to Follow-up|4|||
156661280|NCT03980483|565506585|FG002|Overall Study|Lost to Follow-up|2|||
156661281|NCT03980483|565506586|FG003|Overall Study|Lost to Follow-up|1|||
156661282|NCT03980483|565506587|FG004|Overall Study|Lost to Follow-up|2|||
156661283|NCT03980483|565506588|FG005|Overall Study|Lost to Follow-up|0|||
156661284|NCT03980483|565506583|FG000|Overall Study|Protocol Violation|4|||
156661285|NCT03980483|565506584|FG001|Overall Study|Protocol Violation|2|||
156661286|NCT03980483|565506585|FG002|Overall Study|Protocol Violation|1|||
156775459|NCT00296517|565929937|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
156324780|NCT02964507|564289393|FG005|Overall Study|Withdrawal by Subject|1|||
156324781|NCT02964507|564289394|FG006|Overall Study|Withdrawal by Subject|0|||
156661287|NCT03980483|565506586|FG003|Overall Study|Protocol Violation|1|||
156661288|NCT03980483|565506587|FG004|Overall Study|Protocol Violation|0|||
156661289|NCT03980483|565506588|FG005|Overall Study|Protocol Violation|0|||
156661290|NCT03980483|565506583|FG000|Overall Study|Physician Decision|14|||
156661291|NCT03980483|565506584|FG001|Overall Study|Physician Decision|10|||
156324782|NCT02964507|564289395|FG007|Overall Study|Withdrawal by Subject|0|||
156324783|NCT02964507|564289388|FG000|Overall Study|Physician Decision|2|||
156661292|NCT03980483|565506585|FG002|Overall Study|Physician Decision|7|||
156661293|NCT03980483|565506586|FG003|Overall Study|Physician Decision|4|||
156661294|NCT03980483|565506587|FG004|Overall Study|Physician Decision|4|||
156661295|NCT03980483|565506588|FG005|Overall Study|Physician Decision|2|||
156661296|NCT03980483|565506583|FG000|Overall Study|Withdrawal by Subject|38|||
156661297|NCT03980483|565506584|FG001|Overall Study|Withdrawal by Subject|21|||
156775460|NCT00296517|565929936|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
156661298|NCT03980483|565506585|FG002|Overall Study|Withdrawal by Subject|15|||
156661299|NCT03980483|565506586|FG003|Overall Study|Withdrawal by Subject|5|||
156661300|NCT03980483|565506587|FG004|Overall Study|Withdrawal by Subject|3|||
156661301|NCT03980483|565506588|FG005|Overall Study|Withdrawal by Subject|4|||
156661302|NCT03980483|565506583|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
156661303|NCT03980483|565506584|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156661304|NCT03980483|565506585|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156661305|NCT03980483|565506586|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156661306|NCT03980483|565506587|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156661307|NCT03980483|565506588|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156661308|NCT03980483|565506583|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
156661309|NCT03980483|565506584|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
156661310|NCT03980483|565506585|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
156661311|NCT03980483|565506586|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
156661312|NCT03980483|565506587|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
156661313|NCT03980483|565506588|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
156661314|NCT03980483|565506583|FG000|Overall Study|Other|0|||
156661315|NCT03980483|565506584|FG001|Overall Study|Other|1|||
156661316|NCT03980483|565506585|FG002|Overall Study|Other|0|||
156661317|NCT03980483|565506586|FG003|Overall Study|Other|0|||
156661318|NCT03980483|565506587|FG004|Overall Study|Other|0|||
156661319|NCT03980483|565506588|FG005|Overall Study|Other|0|||
156661320|NCT01225146|565506589|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
156661321|NCT01225146|565506590|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
156661322|NCT05150964|565506591|FG000|Overall Study|Lost to Follow-up|2|||
156661323|NCT00623779|565506592|FG000|Overall Study|Adverse Event|1|||
156661324|NCT00623779|565506593|FG001|Overall Study|Adverse Event|3|||
156661325|NCT00623779|565506594|FG002|Overall Study|Adverse Event|0|||
156661326|NCT00623779|565506592|FG000|Overall Study|Criteria from CSR|2|||
156661327|NCT00623779|565506593|FG001|Overall Study|Criteria from CSR|0|||
156661328|NCT00623779|565506594|FG002|Overall Study|Criteria from CSR|1|||
156661329|NCT00686959|565506595|FG000|Overall Study|Participants censored (no death events)|124|||
156661330|NCT00686959|565506596|FG001|Overall Study|Participants censored (no death events)|117|||
156661331|NCT03883906|565506601|FG000|Overall Study|Withdrawal by Subject|2|||
156661332|NCT03883906|565506601|FG000|Overall Study|Physician Decision|5|||
156661333|NCT03912337|565506607|FG000|Overall Study|Withdrawal of Consent From Study|1|||
156661334|NCT03912337|565506608|FG001|Overall Study|Withdrawal of Consent From Study|0|||
156661335|NCT03912337|565506607|FG000|Overall Study|Lost to Follow-up|1|||
156661336|NCT03912337|565506608|FG001|Overall Study|Lost to Follow-up|1|||
156661337|NCT02545998|565506609|FG000|Overall Study|Lost to Follow-up|12|||
156661338|NCT02545998|565506610|FG001|Overall Study|Lost to Follow-up|3|||
156661339|NCT02545998|565506609|FG000|Overall Study|Withdrawal by Subject|3|||
156661340|NCT02545998|565506610|FG001|Overall Study|Withdrawal by Subject|2|||
156661341|NCT05214560|565506617|FG000|Overall Study|Screening Failure|1|||
156661342|NCT05214560|565506617|FG000|Overall Study|Physician Decision|4|||
156661343|NCT05214560|565506617|FG000|Overall Study|Withdrawal by Subject|1|||
156661344|NCT05214560|565506617|FG000|Overall Study|Lost to Follow-up|2|||
156661345|NCT05214560|565506617|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
156661346|NCT05214560|565506617|FG000|Overall Study|Study physician not available for the anesthesia|3|||
156661347|NCT05214560|565506617|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
156661348|NCT05214560|565506617|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
156661349|NCT05214560|565506617|FG000|Overall Study|Surgery not performed|3|||
156661350|NCT04977336|565506618|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
156661351|NCT04977336|565506619|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
156661352|NCT04977336|565506620|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
156661353|NCT04977336|565506621|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
156661354|NCT04977336|565506622|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
156661355|NCT04977336|565506618|FG000|Overall Study|Lost to Follow-up|0|||
156661356|NCT04977336|565506619|FG001|Overall Study|Lost to Follow-up|0|||
156661357|NCT04977336|565506620|FG002|Overall Study|Lost to Follow-up|1|||
156661358|NCT04977336|565506621|FG003|Overall Study|Lost to Follow-up|0|||
156661359|NCT04977336|565506622|FG004|Overall Study|Lost to Follow-up|0|||
156661360|NCT03298451|565506623|FG000|Overall Study|Death|275|||
156661361|NCT03298451|565506624|FG001|Overall Study|Death|260|||
156661362|NCT03298451|565506625|FG002|Overall Study|Death|122|||
156661363|NCT03298451|565506626|FG003|Overall Study|Death|280|||
156661364|NCT03298451|565506623|FG000|Overall Study|Lost to Follow-up|1|||
156661365|NCT03298451|565506624|FG001|Overall Study|Lost to Follow-up|1|||
156661366|NCT03298451|565506625|FG002|Overall Study|Lost to Follow-up|0|||
156661367|NCT03298451|565506626|FG003|Overall Study|Lost to Follow-up|7|||
156661368|NCT03298451|565506623|FG000|Overall Study|Withdrawal by Subject|9|||
156661369|NCT03298451|565506624|FG001|Overall Study|Withdrawal by Subject|7|||
156661370|NCT03298451|565506625|FG002|Overall Study|Withdrawal by Subject|1|||
156661371|NCT03298451|565506626|FG003|Overall Study|Withdrawal by Subject|20|||
156661372|NCT02534493|565506630|FG000|Overall Study|Lost to Follow-up|1|||
156661373|NCT02534493|565506630|FG000|Overall Study|Withdrawal by Subject|1|||
156661374|NCT01478620|565506634|FG000|Overall Study|Lost to Follow-up|6|||
156661375|NCT00591630|565506638|FG000|Overall Study|Death|0|||
156661376|NCT00591630|565506639|FG001|Overall Study|Death|0|||
156661377|NCT00591630|565506640|FG002|Overall Study|Death|1|||
156661378|NCT00591630|565506641|FG003|Overall Study|Death|0|||
156661379|NCT01691248|565506642|FG000|Overall Study|Protocol Violation|43|||
156661380|NCT01691248|565506643|FG001|Overall Study|Protocol Violation|27|||
156661381|NCT01691248|565506642|FG000|Overall Study|Adverse Event|24|||
156429223|NCT04936035|564663223|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156429224|NCT04936035|564663224|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156429225|NCT04936035|564663225|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156429226|NCT04936035|564663226|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156429227|NCT04936035|564663214|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429228|NCT04936035|564663215|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
156429229|NCT04936035|564663216|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429230|NCT04936035|564663217|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429231|NCT04936035|564663218|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429232|NCT04936035|564663219|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429233|NCT04936035|564663220|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429234|NCT04936035|564663221|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429235|NCT04936035|564663222|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429236|NCT04936035|564663223|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429237|NCT04936035|564663224|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429238|NCT04936035|564663225|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429239|NCT04936035|564663226|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156429240|NCT04936035|564663214|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429241|NCT04936035|564663215|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429242|NCT04936035|564663216|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
156429243|NCT04936035|564663217|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429244|NCT04936035|564663218|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429245|NCT04936035|564663219|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429246|NCT04936035|564663220|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429247|NCT04936035|564663221|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429248|NCT04936035|564663222|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429249|NCT04936035|564663223|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429250|NCT04936035|564663224|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429251|NCT04936035|564663225|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429252|NCT04936035|564663226|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156429253|NCT04936035|564663214|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
156429254|NCT04936035|564663215|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
156429255|NCT04936035|564663216|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
156429256|NCT04936035|564663217|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
156429257|NCT04936035|564663218|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
156429258|NCT04936035|564663219|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156429259|NCT04936035|564663220|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156429260|NCT04936035|564663221|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156429261|NCT04936035|564663222|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156429262|NCT04936035|564663223|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156429263|NCT04936035|564663224|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156429264|NCT04936035|564663225|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156429265|NCT04936035|564663226|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156429266|NCT04936035|564663214|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429267|NCT04936035|564663215|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429268|NCT04936035|564663216|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429269|NCT04936035|564663217|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429270|NCT04936035|564663218|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
156429271|NCT04936035|564663219|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429272|NCT04936035|564663220|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429273|NCT04936035|564663221|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429274|NCT04936035|564663222|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429275|NCT04936035|564663223|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429276|NCT04936035|564663224|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429277|NCT04936035|564663225|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429278|NCT04936035|564663226|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156429279|NCT04936035|564663214|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
156429280|NCT04936035|564663215|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429281|NCT04936035|564663216|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429282|NCT04936035|564663217|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429283|NCT04936035|564663218|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429284|NCT04936035|564663219|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156661382|NCT01691248|565506643|FG001|Overall Study|Adverse Event|22|||
156661383|NCT01691248|565506642|FG000|Overall Study|Withdrawal by Subject|20|||
156661384|NCT01691248|565506643|FG001|Overall Study|Withdrawal by Subject|18|||
156661385|NCT01691248|565506642|FG000|Overall Study|Confirmed CDAD|14|||
156661386|NCT01691248|565506643|FG001|Overall Study|Confirmed CDAD|31|||
156661387|NCT01691248|565506642|FG000|Overall Study|Lost to Follow-up|2|||
156661388|NCT01691248|565506643|FG001|Overall Study|Lost to Follow-up|5|||
156661389|NCT01691248|565506642|FG000|Overall Study|Reason not provided|4|||
156661390|NCT01691248|565506643|FG001|Overall Study|Reason not provided|4|||
156661391|NCT01691248|565506642|FG000|Overall Study|Not Treated|4|||
156661392|NCT01691248|565506643|FG001|Overall Study|Not Treated|7|||
156661393|NCT02863575|565506644|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
156661394|NCT02863575|565506645|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
156661395|NCT02863575|565506646|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
156661396|NCT02863575|565506644|FG000|Overall Study|Withdrawal by Subject|0|||
156661397|NCT02863575|565506645|FG001|Overall Study|Withdrawal by Subject|1|||
156661398|NCT02863575|565506646|FG002|Overall Study|Withdrawal by Subject|1|||
156661399|NCT02863575|565506644|FG000|Overall Study|Adverse Event|0|||
156661400|NCT02863575|565506645|FG001|Overall Study|Adverse Event|1|||
156661401|NCT02863575|565506646|FG002|Overall Study|Adverse Event|0|||
156661402|NCT01507051|565508267|FG000|Overall Study|Withdrawal by Subject|1|||
156661403|NCT01507051|565508268|FG001|Overall Study|Withdrawal by Subject|3|||
156661404|NCT01507051|565508269|FG002|Overall Study|Withdrawal by Subject|1|||
156661405|NCT01507051|565508270|FG003|Overall Study|Withdrawal by Subject|6|||
156661406|NCT01507051|565508267|FG000|Overall Study|Physician Decision|0|||
156661407|NCT01507051|565508268|FG001|Overall Study|Physician Decision|0|||
156661408|NCT01507051|565508269|FG002|Overall Study|Physician Decision|0|||
156661409|NCT01507051|565508270|FG003|Overall Study|Physician Decision|1|||
156661410|NCT01507051|565508267|FG000|Overall Study|Adverse Event|1|||
156661411|NCT01507051|565508268|FG001|Overall Study|Adverse Event|0|||
156661412|NCT01507051|565508269|FG002|Overall Study|Adverse Event|0|||
156661413|NCT01507051|565508270|FG003|Overall Study|Adverse Event|0|||
156661414|NCT01675622|565508271|FG000|Overall Study|Withdrawal by Subject|2|||
156661415|NCT01675622|565508272|FG001|Overall Study|Withdrawal by Subject|2|||
156661416|NCT01675622|565508271|FG000|Overall Study|Adverse Event|12|||
156661417|NCT01675622|565508272|FG001|Overall Study|Adverse Event|10|||
156661418|NCT01675622|565508271|FG000|Overall Study|Protocol Violation|4|||
156661419|NCT01675622|565508272|FG001|Overall Study|Protocol Violation|1|||
156661420|NCT01675622|565508271|FG000|Overall Study|Lack of Efficacy|2|||
156661421|NCT01675622|565508272|FG001|Overall Study|Lack of Efficacy|4|||
156661422|NCT01675622|565508271|FG000|Overall Study|Lost to Follow-up|1|||
156661423|NCT01675622|565508272|FG001|Overall Study|Lost to Follow-up|3|||
156661424|NCT01675622|565508271|FG000|Overall Study|Other|5|||
156661425|NCT01675622|565508272|FG001|Overall Study|Other|4|||
156661426|NCT02311361|565508273|FG000|Overall Study|Did not receive treatment|0|||
156661427|NCT02311361|565508274|FG001|Overall Study|Did not receive treatment|1|||
156661428|NCT02311361|565508275|FG002|Overall Study|Did not receive treatment|0|||
156661429|NCT02311361|565508276|FG003|Overall Study|Did not receive treatment|1|||
156661430|NCT05628675|565508277|FG000|Overall Study|Lost to Follow-up|2|||
156661431|NCT05628675|565508277|FG000|Overall Study|Withdrawal by Subject|1|||
156661432|NCT00365300|565508278|FG000|Open-label Phase|Adverse Event|4|||
156661433|NCT00365300|565508279|FG001|Open-label Phase|Adverse Event|0|||
156661434|NCT00365300|565508278|FG000|Open-label Phase|Failed to Return|1|||
156661435|NCT00365300|565508279|FG001|Open-label Phase|Failed to Return|0|||
156775461|NCT00296517|565929937|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
156775462|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
156775463|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
156775464|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
156775465|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
156775466|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
156661436|NCT00365300|565508278|FG000|Open-label Phase|Physician Decision|1|||
156661437|NCT00365300|565508279|FG001|Open-label Phase|Physician Decision|0|||
156661438|NCT00365300|565508278|FG000|Open-label Phase|Noncompliance|9|||
156661439|NCT00365300|565508279|FG001|Open-label Phase|Noncompliance|0|||
156661440|NCT00365300|565508278|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
156775467|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
156775468|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
156661441|NCT00365300|565508279|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
156661442|NCT00365300|565508278|FG000|Open-label Phase|Protocol Violation|1|||
156661443|NCT00365300|565508279|FG001|Open-label Phase|Protocol Violation|0|||
156661444|NCT00365300|565508278|FG000|Open-label Phase|Lack of Efficacy|1|||
156661445|NCT00365300|565508279|FG001|Open-label Phase|Lack of Efficacy|0|||
156661446|NCT00365300|565508278|FG000|Open-label Phase|Patient skipped open label phase|1|||
156661447|NCT00365300|565508279|FG001|Open-label Phase|Patient skipped open label phase|0|||
156661448|NCT00365300|565508278|FG000|Double-blind Phase|Failed to return|1|||
156661449|NCT00365300|565508279|FG001|Double-blind Phase|Failed to return|0|||
156661450|NCT00365300|565508278|FG000|Double-blind Phase|Noncompliance|1|||
156661451|NCT00365300|565508279|FG001|Double-blind Phase|Noncompliance|1|||
156775469|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
156775470|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
156775471|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
156775472|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
156775473|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
156775474|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
156775475|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
156775476|NCT02164916|565929938|FG000|Overall Study|Adverse Event|3|||
156775477|NCT02164916|565929939|FG001|Overall Study|Adverse Event|8|||
156775478|NCT02164916|565929938|FG000|Overall Study|Death|1|||
156775479|NCT02164916|565929939|FG001|Overall Study|Death|1|||
156775480|NCT02164916|565929938|FG000|Overall Study|Refusal unrelated to adverse event|3|||
156775481|NCT02164916|565929939|FG001|Overall Study|Refusal unrelated to adverse event|7|||
156775482|NCT02164916|565929938|FG000|Overall Study|Progression|37|||
156775483|NCT02164916|565929939|FG001|Overall Study|Progression|26|||
156775484|NCT02164916|565929938|FG000|Overall Study|Not protocol specified|5|||
156775485|NCT02164916|565929939|FG001|Overall Study|Not protocol specified|1|||
156775486|NCT02164916|565929938|FG000|Overall Study|Reason under review|1|||
156775487|NCT02164916|565929939|FG001|Overall Study|Reason under review|6|||
156775488|NCT02164916|565929938|FG000|Overall Study|Not eligible|2|||
156775489|NCT02164916|565929939|FG001|Overall Study|Not eligible|5|||
156775490|NCT00964782|565929942|FG000|Overall Study|Lost to Follow-up|1|||
156775491|NCT00964782|565929943|FG001|Overall Study|Lost to Follow-up|0|||
156775492|NCT01143324|565929944|FG000|Overall Study|Lost to Follow-up|11|||
156775493|NCT01143324|565929944|FG000|Overall Study|Withdrawal by Subject|4|||
156775494|NCT01143324|565929944|FG000|Overall Study|Explant of the device|4|||
156775495|NCT01101178|565929948|FG000|Period 1|Withdrawal by Subject|1|||
156775496|NCT01101178|565929949|FG001|Period 1|Withdrawal by Subject|2|||
156775497|NCT01101178|565929948|FG000|Period 1|Positive drug screen|1|||
156775498|NCT01101178|565929949|FG001|Period 1|Positive drug screen|1|||
156775499|NCT01101178|565929948|FG000|Period 1|Adverse Event|2|||
156775500|NCT01101178|565929949|FG001|Period 1|Adverse Event|1|||
156775501|NCT01101178|565929948|FG000|Period 2|Withdrawal by Subject|0|||
156775502|NCT01101178|565929949|FG001|Period 2|Withdrawal by Subject|1|||
156775503|NCT00141817|565929950|FG000|Overall Study|Protocol Violation|0|||
156775504|NCT00141817|565929951|FG001|Overall Study|Protocol Violation|0|||
156775505|NCT00141817|565929952|FG002|Overall Study|Protocol Violation|1|||
156775506|NCT00141817|565929953|FG003|Overall Study|Protocol Violation|0|||
156775507|NCT00141817|565929950|FG000|Overall Study|Parent request|1|||
156775508|NCT00141817|565929951|FG001|Overall Study|Parent request|0|||
156775509|NCT00141817|565929952|FG002|Overall Study|Parent request|0|||
156775510|NCT00141817|565929953|FG003|Overall Study|Parent request|0|||
156775511|NCT00127803|565929956|FG000|Overall Study|Adverse Event|2|||
156775512|NCT00127803|565929957|FG001|Overall Study|Adverse Event|0|||
156775513|NCT00127803|565929958|FG002|Overall Study|Adverse Event|0|||
156775514|NCT00127803|565929959|FG003|Overall Study|Adverse Event|0|||
156775515|NCT00127803|565929956|FG000|Overall Study|Withdrawal by Subject|1|||
156775516|NCT00127803|565929957|FG001|Overall Study|Withdrawal by Subject|0|||
156775517|NCT00127803|565929958|FG002|Overall Study|Withdrawal by Subject|0|||
156775518|NCT00127803|565929959|FG003|Overall Study|Withdrawal by Subject|0|||
156775519|NCT00127803|565929956|FG000|Overall Study|Lost to Follow-up|0|||
156775520|NCT00127803|565929957|FG001|Overall Study|Lost to Follow-up|0|||
156775521|NCT00127803|565929958|FG002|Overall Study|Lost to Follow-up|0|||
156775522|NCT00127803|565929959|FG003|Overall Study|Lost to Follow-up|1|||
156775523|NCT02318940|565929960|FG000|Overall Study|lost the record|1|||
156775524|NCT02318940|565929961|FG001|Overall Study|lost the record|0|||
156775525|NCT01277861|565929967|FG000|Overall Study|Physician Decision|2|||
156775526|NCT01277861|565929968|FG001|Overall Study|Physician Decision|2|||
156775527|NCT00857389|565929969|FG000|Overall Study|Did not proceed to transplant|2|||
156775528|NCT04584788|565929970|FG000|Overall Study|Physician Decision|8|||
156775529|NCT04584788|565929970|FG000|Overall Study|Withdrawal by Subject|1|||
156775530|NCT04584788|565929970|FG000|Overall Study|Adverse Event|3|||
156775531|NCT04284774|565929972|FG000|Overall Study|Progressive disease|5|||
156775532|NCT03329001|565931298|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775533|NCT03329001|565931299|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775534|NCT03329001|565931300|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
156775535|NCT03329001|565931301|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
156775536|NCT03329001|565931302|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775537|NCT03329001|565931303|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775538|NCT03329001|565931304|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775539|NCT03329001|565931305|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775540|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775541|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775542|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775543|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
156661452|NCT00365300|565508278|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156661453|NCT00365300|565508279|FG001|Double-blind Phase|Withdrawal by Subject|1|||
156661454|NCT00365300|565508278|FG000|Double-blind Phase|Protocol Violation|3|||
156661455|NCT00365300|565508279|FG001|Double-blind Phase|Protocol Violation|1|||
156661456|NCT00365300|565508278|FG000|Double-blind Phase|Lack of Efficacy|6|||
156661457|NCT00365300|565508279|FG001|Double-blind Phase|Lack of Efficacy|6|||
156661458|NCT01991470|565508280|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
156661459|NCT01991470|565508280|FG000|Enlite 1 Period|Adverse Event|1|||
156661460|NCT01991470|565508280|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
156324784|NCT02964507|564289389|FG001|Overall Study|Physician Decision|0|||
156324785|NCT02964507|564289390|FG002|Overall Study|Physician Decision|3|||
156324786|NCT02964507|564289391|FG003|Overall Study|Physician Decision|0|||
156324787|NCT02964507|564289392|FG004|Overall Study|Physician Decision|1|||
156324788|NCT02964507|564289393|FG005|Overall Study|Physician Decision|0|||
156661461|NCT01991470|565508280|FG000|Enlite 3 Period|Lost to Follow-up|1|||
156661462|NCT01991470|565508280|FG000|Enlite 3 Period|Physician Decision|2|||
156661463|NCT01991470|565508280|FG000|Enlite 3 Period|Physician Decision|8|||
156661464|NCT01991470|565508280|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
156661465|NCT02896361|565508281|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
156661466|NCT02896361|565508282|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
156661467|NCT02896361|565508283|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
156661468|NCT02896361|565508281|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
156661469|NCT02896361|565508282|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
156661470|NCT02896361|565508283|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
156661471|NCT01029353|565508284|FG000|Overall Study|Lost to Follow-up|4|||
156661472|NCT01029353|565508285|FG001|Overall Study|Lost to Follow-up|5|||
156661473|NCT01029353|565508286|FG002|Overall Study|Lost to Follow-up|5|||
156661474|NCT01029353|565508287|FG003|Overall Study|Lost to Follow-up|4|||
156661475|NCT01029353|565508284|FG000|Overall Study|Consent Withdrawn|2|||
156661476|NCT01029353|565508285|FG001|Overall Study|Consent Withdrawn|0|||
156661477|NCT01029353|565508286|FG002|Overall Study|Consent Withdrawn|0|||
156661478|NCT01029353|565508287|FG003|Overall Study|Consent Withdrawn|0|||
156661479|NCT01029353|565508284|FG000|Overall Study|Primary Outcome Indeterminate|1|||
156661480|NCT01029353|565508285|FG001|Overall Study|Primary Outcome Indeterminate|3|||
156661481|NCT01029353|565508286|FG002|Overall Study|Primary Outcome Indeterminate|2|||
156661482|NCT01029353|565508287|FG003|Overall Study|Primary Outcome Indeterminate|0|||
156661483|NCT00324168|565508288|FG000|Overall Study|Lost to Follow-up|19|||
156661484|NCT00324168|565508289|FG001|Overall Study|Lost to Follow-up|18|||
156661485|NCT00324168|565508288|FG000|Overall Study|Death|3|||
156661486|NCT00324168|565508289|FG001|Overall Study|Death|3|||
156661487|NCT00324168|565508288|FG000|Overall Study|Patient did not visit in f/u window|6|||
156661488|NCT00324168|565508289|FG001|Overall Study|Patient did not visit in f/u window|9|||
156661489|NCT01203878|565508290|FG000|Overall Study|Withdrawal by Subject|0|||
156661490|NCT01203878|565508291|FG001|Overall Study|Withdrawal by Subject|0|||
156661491|NCT01203878|565508292|FG002|Overall Study|Withdrawal by Subject|1|||
156661492|NCT01203878|565508290|FG000|Overall Study|Adverse Event|0|||
156661493|NCT01203878|565508291|FG001|Overall Study|Adverse Event|0|||
156661494|NCT01203878|565508292|FG002|Overall Study|Adverse Event|2|||
156661495|NCT00528606|565508293|FG000|Overall Study|Withdrew consent|4|||
156661496|NCT00528606|565508294|FG001|Overall Study|Withdrew consent|3|||
156661497|NCT00528606|565508293|FG000|Overall Study|Lost to Follow-up|4|||
156661498|NCT00528606|565508294|FG001|Overall Study|Lost to Follow-up|1|||
156661499|NCT00528606|565508293|FG000|Overall Study|Adverse Event|3|||
156661500|NCT00528606|565508294|FG001|Overall Study|Adverse Event|0|||
156661501|NCT00528606|565508293|FG000|Overall Study|Other|2|||
156661502|NCT00528606|565508294|FG001|Overall Study|Other|0|||
156661503|NCT02475954|565508295|FG000|Overall Study|Withdrawal by Subject|2|||
156661504|NCT02475954|565508296|FG001|Overall Study|Withdrawal by Subject|2|||
156661505|NCT02475954|565508295|FG000|Overall Study|Lost to Follow-up|11|||
156661506|NCT02475954|565508296|FG001|Overall Study|Lost to Follow-up|9|||
156661507|NCT02475954|565508295|FG000|Overall Study|Death|1|||
156661508|NCT02475954|565508296|FG001|Overall Study|Death|1|||
156661509|NCT01918397|565508298|FG000|Overall Study|Never started treatment|2|||
156661510|NCT01918397|565508299|FG001|Overall Study|Never started treatment|1|||
156661511|NCT01918397|565508300|FG002|Overall Study|Never started treatment|0|||
156661512|NCT01918397|565508301|FG003|Overall Study|Never started treatment|0|||
156661513|NCT01918397|565508298|FG000|Overall Study|Adverse Event|1|||
156661514|NCT01918397|565508299|FG001|Overall Study|Adverse Event|1|||
156661515|NCT01918397|565508300|FG002|Overall Study|Adverse Event|1|||
156661516|NCT01918397|565508301|FG003|Overall Study|Adverse Event|0|||
156661517|NCT01918397|565508298|FG000|Overall Study|Lack of compliance|2|||
156661518|NCT01918397|565508299|FG001|Overall Study|Lack of compliance|2|||
156661519|NCT01918397|565508300|FG002|Overall Study|Lack of compliance|3|||
156324789|NCT02964507|564289394|FG006|Overall Study|Physician Decision|0|||
156661520|NCT01918397|565508301|FG003|Overall Study|Lack of compliance|0|||
156661521|NCT01918397|565508298|FG000|Overall Study|Pregnancy|0|||
156661522|NCT01918397|565508299|FG001|Overall Study|Pregnancy|1|||
156661523|NCT01918397|565508300|FG002|Overall Study|Pregnancy|0|||
156524375|NCT01886378|565013878|FG000|Overall Study|Withdrawal by Subject|4|||
156775544|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775545|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775546|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775547|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775548|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775549|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775550|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775551|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
156775552|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775553|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775554|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775555|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775556|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775557|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775558|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775559|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
156775560|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775561|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775562|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775563|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775564|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775565|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775566|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
156775567|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775568|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775569|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775570|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775571|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775572|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775573|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775574|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
156775575|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775576|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775577|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775578|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775579|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775580|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775581|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775582|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
156775583|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775584|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156324790|NCT02964507|564289395|FG007|Overall Study|Physician Decision|0|||
156324791|NCT04341662|564289396|FG000|Overall Study|Did not have source-verified blood loss data|423|||
156324792|NCT04341662|564289397|FG001|Overall Study|Did not have source-verified blood loss data|514|||
156324793|NCT03953183|564289399|FG000|Overall Study|Physician Decision|0|||
156324794|NCT03953183|564289400|FG001|Overall Study|Physician Decision|1|||
156324795|NCT03953183|564289399|FG000|Overall Study|Withdrawal by Subject|0|||
156324796|NCT03953183|564289400|FG001|Overall Study|Withdrawal by Subject|1|||
156324797|NCT01562873|564289401|FG000|Overall Study|Disease Progression per RECIST|10|||
156324798|NCT01562873|564289402|FG001|Overall Study|Disease Progression per RECIST|0|||
156324799|NCT01562873|564289401|FG000|Overall Study|Adverse Event|1|||
156324800|NCT01562873|564289402|FG001|Overall Study|Adverse Event|0|||
156324801|NCT01562873|564289401|FG000|Overall Study|Clinical Disease Progression|9|||
156324802|NCT01562873|564289402|FG001|Overall Study|Clinical Disease Progression|0|||
156324803|NCT01562873|564289401|FG000|Overall Study|Clinical PD and adverse event|1|||
156324804|NCT01562873|564289402|FG001|Overall Study|Clinical PD and adverse event|0|||
156661524|NCT01918397|565508301|FG003|Overall Study|Pregnancy|0|||
156661525|NCT01918397|565508298|FG000|Overall Study|Rifampin susceptible|0|||
156661526|NCT01918397|565508299|FG001|Overall Study|Rifampin susceptible|0|||
156661527|NCT01918397|565508300|FG002|Overall Study|Rifampin susceptible|0|||
156661528|NCT01918397|565508301|FG003|Overall Study|Rifampin susceptible|2|||
156661529|NCT01918397|565508298|FG000|Overall Study|Treatment failure|0|||
156661530|NCT01918397|565508299|FG001|Overall Study|Treatment failure|0|||
156661531|NCT01918397|565508300|FG002|Overall Study|Treatment failure|0|||
156661532|NCT01918397|565508301|FG003|Overall Study|Treatment failure|1|||
156661533|NCT01918397|565508298|FG000|Overall Study|Withdrawal by Subject|3|||
156661534|NCT01918397|565508299|FG001|Overall Study|Withdrawal by Subject|2|||
156661535|NCT01918397|565508300|FG002|Overall Study|Withdrawal by Subject|1|||
156661536|NCT01918397|565508301|FG003|Overall Study|Withdrawal by Subject|1|||
156661537|NCT01918397|565508298|FG000|Overall Study|XDR at baseline|0|||
156661538|NCT01918397|565508299|FG001|Overall Study|XDR at baseline|0|||
156661539|NCT01918397|565508300|FG002|Overall Study|XDR at baseline|1|||
156661540|NCT01918397|565508301|FG003|Overall Study|XDR at baseline|0|||
156661541|NCT01918397|565508298|FG000|Overall Study|Lost to Follow-up|2|||
156661542|NCT01918397|565508299|FG001|Overall Study|Lost to Follow-up|1|||
156661543|NCT01918397|565508300|FG002|Overall Study|Lost to Follow-up|1|||
156661544|NCT01918397|565508301|FG003|Overall Study|Lost to Follow-up|1|||
156661545|NCT01918397|565508298|FG000|Overall Study|Increased QTc|1|||
156661546|NCT01918397|565508299|FG001|Overall Study|Increased QTc|0|||
156661547|NCT01918397|565508300|FG002|Overall Study|Increased QTc|0|||
156661548|NCT01918397|565508301|FG003|Overall Study|Increased QTc|1|||
156661549|NCT01918397|565508298|FG000|Overall Study|Death|0|||
156661550|NCT01918397|565508299|FG001|Overall Study|Death|0|||
156661551|NCT01918397|565508300|FG002|Overall Study|Death|1|||
156661552|NCT01918397|565508301|FG003|Overall Study|Death|0|||
156775585|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775586|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775587|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775588|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775589|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775590|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
156775591|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775592|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775593|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775594|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775595|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775596|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775597|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156661553|NCT01918397|565508298|FG000|Overall Study|Involved in another investigative trial|0|||
156661554|NCT01918397|565508299|FG001|Overall Study|Involved in another investigative trial|0|||
156661555|NCT01918397|565508300|FG002|Overall Study|Involved in another investigative trial|0|||
156661556|NCT01918397|565508301|FG003|Overall Study|Involved in another investigative trial|1|||
156661557|NCT00760266|565508309|FG000|Overall Study|Adverse Event|13|||
156661558|NCT00760266|565508310|FG001|Overall Study|Adverse Event|7|||
156661559|NCT00760266|565508309|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156661560|NCT00760266|565508310|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156661561|NCT00760266|565508309|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156661562|NCT00760266|565508310|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156661563|NCT00760266|565508309|FG000|Overall Study|Lack of Efficacy|2|||
156661564|NCT00760266|565508310|FG001|Overall Study|Lack of Efficacy|2|||
156661565|NCT00760266|565508309|FG000|Overall Study|Protocol deviation|2|||
156661566|NCT00760266|565508310|FG001|Overall Study|Protocol deviation|4|||
156661567|NCT00760266|565508309|FG000|Overall Study|Patient withdrew consent|3|||
156661568|NCT00760266|565508310|FG001|Overall Study|Patient withdrew consent|3|||
156661569|NCT00760266|565508309|FG000|Overall Study|Lost to Follow-up|2|||
156661570|NCT00760266|565508310|FG001|Overall Study|Lost to Follow-up|1|||
156775598|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
156661571|NCT00760266|565508309|FG000|Overall Study|Administrative Problems|0|||
156524376|NCT01740323|565013884|FG000|Overall Study|Adverse Event|1|||
156661572|NCT00760266|565508310|FG001|Overall Study|Administrative Problems|1|||
156661573|NCT01239121|565508311|FG000|Overall Study|Withdrawal by Subject|2|||
156661574|NCT01239121|565508312|FG001|Overall Study|Withdrawal by Subject|4|||
156661575|NCT01239121|565508313|FG002|Overall Study|Withdrawal by Subject|0|||
156524377|NCT01740323|565013885|FG001|Overall Study|Adverse Event|0|||
156661576|NCT03657160|565508314|FG000|Overall Study|Adverse Event|5|||
156661577|NCT03657160|565508315|FG001|Overall Study|Adverse Event|6|||
156661578|NCT03657160|565508314|FG000|Overall Study|Protocol Deviation|3|||
156661579|NCT03657160|565508315|FG001|Overall Study|Protocol Deviation|0|||
156429285|NCT04936035|564663220|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429286|NCT04936035|564663221|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156661580|NCT03657160|565508314|FG000|Overall Study|Withdrawal by Subject|18|||
156661581|NCT03657160|565508315|FG001|Overall Study|Withdrawal by Subject|16|||
156661582|NCT03657160|565508314|FG000|Overall Study|Site Termination|1|||
156661583|NCT03657160|565508315|FG001|Overall Study|Site Termination|0|||
156661584|NCT03657160|565508314|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
156661585|NCT03657160|565508315|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
156661586|NCT03657160|565508314|FG000|Overall Study|Death|33|||
156661587|NCT03657160|565508315|FG001|Overall Study|Death|26|||
156429287|NCT04936035|564663222|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429288|NCT04936035|564663223|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429289|NCT04936035|564663224|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429290|NCT04936035|564663225|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156429291|NCT04936035|564663226|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156661588|NCT03657160|565508314|FG000|Overall Study|Death (COVID-19-Related)|1|||
156661589|NCT03657160|565508315|FG001|Overall Study|Death (COVID-19-Related)|0|||
156661590|NCT03657160|565508314|FG000|Overall Study|Reason Not Specified|5|||
156661591|NCT03657160|565508315|FG001|Overall Study|Reason Not Specified|5|||
156661592|NCT03657160|565508314|FG000|Overall Study|Other (COVID-19-Related)|0|||
156661593|NCT03657160|565508315|FG001|Overall Study|Other (COVID-19-Related)|1|||
156661594|NCT04006171|565508320|FG000|Overall Study|Withdrawal by Subject|8|||
156661595|NCT04006171|565508321|FG001|Overall Study|Withdrawal by Subject|7|||
156661596|NCT04006171|565508320|FG000|Overall Study|missing serum samples|2|||
156661597|NCT04006171|565508321|FG001|Overall Study|missing serum samples|2|||
156661598|NCT04006171|565508320|FG000|Overall Study|insufficient sample volume|2|||
156661599|NCT04006171|565508321|FG001|Overall Study|insufficient sample volume|3|||
156661600|NCT01062256|565508324|FG000|Overall Study|Adverse Event|1|||
156775599|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
156775600|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775601|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775602|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775603|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775604|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775605|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775606|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
156775607|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775608|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775609|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775610|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775611|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775612|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775613|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775614|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
156775615|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
156775616|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775617|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775618|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775619|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775620|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775621|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775622|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
156775623|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
156775624|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775625|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775626|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775627|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775628|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775629|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775630|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
156661601|NCT01062256|565508325|FG001|Overall Study|Adverse Event|0|||
156661602|NCT01062256|565508326|FG002|Overall Study|Adverse Event|0|||
156661603|NCT01062256|565508324|FG000|Overall Study|Withdrawal by Subject|1|||
156661604|NCT01062256|565508325|FG001|Overall Study|Withdrawal by Subject|1|||
156661605|NCT01062256|565508326|FG002|Overall Study|Withdrawal by Subject|1|||
156661606|NCT01062256|565508324|FG000|Overall Study|Ineligible|1|||
156775631|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
156775632|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775633|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775634|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775635|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775636|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775637|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775638|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775639|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
156775640|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775641|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775642|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775643|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775644|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775645|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775646|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775647|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
156775648|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775649|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775650|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775651|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775652|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775653|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775654|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
156775655|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775656|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775657|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775658|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775659|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775660|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775661|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775662|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
156775663|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
156775664|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775665|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775666|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775667|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775668|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775669|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775670|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
156775671|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775672|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775673|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775674|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775675|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775676|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775677|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775678|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
156775679|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775680|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775681|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775682|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775683|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775684|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156661607|NCT01062256|565508325|FG001|Overall Study|Ineligible|4|||
156661608|NCT01062256|565508326|FG002|Overall Study|Ineligible|3|||
156661609|NCT01062256|565508324|FG000|Overall Study|Administrative|0|||
156661610|NCT01062256|565508325|FG001|Overall Study|Administrative|2|||
156661611|NCT01062256|565508326|FG002|Overall Study|Administrative|0|||
156661612|NCT03049488|565508327|FG000|Overall Study|Lost to Follow-up|1|||
156661613|NCT03049488|565508328|FG001|Overall Study|Lost to Follow-up|1|||
156661614|NCT03049488|565508329|FG002|Overall Study|Lost to Follow-up|0|||
156661615|NCT03049488|565508330|FG003|Overall Study|Lost to Follow-up|0|||
156661616|NCT03049488|565508331|FG004|Overall Study|Lost to Follow-up|0|||
156661617|NCT03049488|565508332|FG005|Overall Study|Lost to Follow-up|0|||
156661618|NCT03049488|565508327|FG000|Overall Study|Moved from Area|1|||
156661619|NCT03049488|565508328|FG001|Overall Study|Moved from Area|0|||
156661620|NCT03049488|565508329|FG002|Overall Study|Moved from Area|0|||
156661621|NCT03049488|565508330|FG003|Overall Study|Moved from Area|1|||
156661622|NCT03049488|565508331|FG004|Overall Study|Moved from Area|1|||
156661623|NCT03049488|565508332|FG005|Overall Study|Moved from Area|0|||
156661624|NCT03049488|565508327|FG000|Overall Study|Physician Decision|0|||
156661625|NCT03049488|565508328|FG001|Overall Study|Physician Decision|1|||
156661626|NCT03049488|565508329|FG002|Overall Study|Physician Decision|0|||
156661627|NCT03049488|565508330|FG003|Overall Study|Physician Decision|0|||
156661628|NCT03049488|565508331|FG004|Overall Study|Physician Decision|0|||
156661629|NCT03049488|565508332|FG005|Overall Study|Physician Decision|0|||
156661630|NCT03049488|565508327|FG000|Overall Study|Withdrawal by Subject|0|||
156661631|NCT03049488|565508328|FG001|Overall Study|Withdrawal by Subject|0|||
156661632|NCT03049488|565508329|FG002|Overall Study|Withdrawal by Subject|0|||
156661633|NCT03049488|565508330|FG003|Overall Study|Withdrawal by Subject|1|||
156661634|NCT03049488|565508331|FG004|Overall Study|Withdrawal by Subject|1|||
156661635|NCT03049488|565508332|FG005|Overall Study|Withdrawal by Subject|0|||
156661636|NCT03099538|565508334|FG000|Overall Study|Lack of Efficacy|3|||
156661637|NCT00440557|565508335|FG000|Overall Study|Withdrawal by Subject|10|||
156661638|NCT00440557|565508336|FG001|Overall Study|Withdrawal by Subject|5|||
156661639|NCT00440557|565508337|FG002|Overall Study|Withdrawal by Subject|11|||
156661640|NCT00440557|565508335|FG000|Overall Study|Lost to Follow-up|1|||
156661641|NCT00440557|565508336|FG001|Overall Study|Lost to Follow-up|2|||
156661642|NCT00440557|565508337|FG002|Overall Study|Lost to Follow-up|6|||
156661643|NCT00440557|565508335|FG000|Overall Study|Adverse Event|3|||
156661644|NCT00440557|565508336|FG001|Overall Study|Adverse Event|3|||
156661645|NCT00440557|565508337|FG002|Overall Study|Adverse Event|5|||
156661646|NCT00440557|565508335|FG000|Overall Study|Death|2|||
156661647|NCT00440557|565508336|FG001|Overall Study|Death|6|||
156661648|NCT00440557|565508337|FG002|Overall Study|Death|3|||
156661649|NCT00440557|565508335|FG000|Overall Study|Began Dialysis|4|||
156661650|NCT00440557|565508336|FG001|Overall Study|Began Dialysis|1|||
156661651|NCT00440557|565508337|FG002|Overall Study|Began Dialysis|4|||
156661652|NCT00440557|565508335|FG000|Overall Study|Principal Investigator decision|0|||
156661653|NCT00440557|565508336|FG001|Overall Study|Principal Investigator decision|3|||
156661654|NCT00440557|565508337|FG002|Overall Study|Principal Investigator decision|1|||
156661655|NCT00440557|565508335|FG000|Overall Study|Patient moved|1|||
156661656|NCT00440557|565508336|FG001|Overall Study|Patient moved|2|||
156661657|NCT00440557|565508337|FG002|Overall Study|Patient moved|1|||
156661658|NCT00440557|565508335|FG000|Overall Study|Principal Investigator's office closed|3|||
156661659|NCT00440557|565508336|FG001|Overall Study|Principal Investigator's office closed|6|||
156661660|NCT00440557|565508337|FG002|Overall Study|Principal Investigator's office closed|4|||
156661661|NCT00440557|565508335|FG000|Overall Study|Patient transferred to nursing home|0|||
156661662|NCT00440557|565508336|FG001|Overall Study|Patient transferred to nursing home|1|||
156661663|NCT00440557|565508337|FG002|Overall Study|Patient transferred to nursing home|0|||
156661664|NCT00440557|565508335|FG000|Overall Study|Patient had surgery|1|||
156661665|NCT00440557|565508336|FG001|Overall Study|Patient had surgery|0|||
156661666|NCT00440557|565508337|FG002|Overall Study|Patient had surgery|0|||
156661667|NCT02107092|565508347|FG000|Overall Study|Miscellaneous|3|||
156661668|NCT02107092|565508347|FG000|Overall Study|Subject compliance|3|||
156661669|NCT02107092|565508347|FG000|Overall Study|Hypo-or hyperkalemia|2|||
156661670|NCT02107092|565508347|FG000|Overall Study|Met ECG withdrawal criteria|3|||
156661671|NCT02107092|565508347|FG000|Overall Study|Physician Decision|3|||
156661672|NCT02107092|565508347|FG000|Overall Study|Lost to Follow-up|2|||
156661673|NCT02107092|565508347|FG000|Overall Study|Withdrawal by Subject|9|||
156661674|NCT02107092|565508347|FG000|Overall Study|Adverse Event|7|||
156661675|NCT02107092|565508347|FG000|Overall Study|Expected progression of CKD|12|||
156661676|NCT00537030|565508348|FG000|Overall Study|Physician Decision|2|||
156661677|NCT00537030|565508348|FG000|Overall Study|Withdrawal by Subject|2|||
156661678|NCT00537030|565508348|FG000|Overall Study|≥ Grade 2 allergy|7|||
156661679|NCT00537030|565508348|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
156661680|NCT00537030|565508348|FG000|Overall Study|Ineligible|2|||
156661681|NCT00537030|565508348|FG000|Overall Study|Inevaluable|2|||
156661682|NCT00906347|565508351|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
156661683|NCT00906347|565508352|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
156324805|NCT03370289|564289405|FG000|Overall Study|Screen Failure|1|||
156661684|NCT00906347|565508351|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
156661685|NCT00906347|565508352|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
156661686|NCT00906347|565508351|FG000|Received Study Drug|Refused study drug|1|||
156775685|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775686|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775687|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
156775688|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775689|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775690|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775691|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775692|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775693|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775694|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775695|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775696|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775697|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
156775698|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775699|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775700|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775701|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775702|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775703|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775704|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
156775705|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775706|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775707|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775708|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775709|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775710|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775711|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775712|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
156775713|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
156775714|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775715|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775716|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775717|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775718|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775719|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775720|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
156775721|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775722|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775723|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775724|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775725|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775726|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775727|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775728|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
156775729|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
156775730|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775731|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775732|NCT03329001|565931298|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775733|NCT03329001|565931299|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775734|NCT03329001|565931300|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775735|NCT03329001|565931301|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775736|NCT03329001|565931302|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775737|NCT03329001|565931303|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775738|NCT03329001|565931304|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
156775739|NCT03329001|565931305|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
156775740|NCT03329001|565931298|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775741|NCT03329001|565931299|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775742|NCT03329001|565931300|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775743|NCT03329001|565931301|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775744|NCT03329001|565931302|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775745|NCT03329001|565931303|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156460561|NCT04625725|564781647|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
156661687|NCT00906347|565508352|FG001|Received Study Drug|Refused study drug|0|||
156661688|NCT00906347|565508351|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
156661689|NCT00906347|565508352|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
156661690|NCT01939197|565508358|FG000|Overall Study|Withdrawal by Subject|1|||
156661691|NCT01939197|565508359|FG001|Overall Study|Withdrawal by Subject|0|||
156661692|NCT01939197|565508360|FG002|Overall Study|Withdrawal by Subject|0|||
156661693|NCT01939197|565508361|FG003|Overall Study|Withdrawal by Subject|0|||
156661694|NCT01939197|565508362|FG004|Overall Study|Withdrawal by Subject|1|||
156661695|NCT01939197|565508363|FG005|Overall Study|Withdrawal by Subject|0|||
156661696|NCT01939197|565508364|FG006|Overall Study|Withdrawal by Subject|0|||
156661697|NCT01939197|565508358|FG000|Overall Study|Lost to Follow-up|0|||
156661698|NCT01939197|565508359|FG001|Overall Study|Lost to Follow-up|1|||
156661699|NCT01939197|565508360|FG002|Overall Study|Lost to Follow-up|0|||
156661700|NCT01939197|565508361|FG003|Overall Study|Lost to Follow-up|1|||
156661701|NCT01939197|565508362|FG004|Overall Study|Lost to Follow-up|3|||
156661702|NCT01939197|565508363|FG005|Overall Study|Lost to Follow-up|1|||
156661703|NCT01939197|565508364|FG006|Overall Study|Lost to Follow-up|2|||
156661704|NCT00680121|565508365|FG000|Overall Study|Lost to Follow-up|27|||
156661705|NCT00680121|565508366|FG001|Overall Study|Lost to Follow-up|23|||
156661706|NCT02849652|565508371|FG000|Overall Study|Lost to Follow-up|104|||
156661707|NCT02849652|565508372|FG001|Overall Study|Lost to Follow-up|35|||
156661708|NCT02849652|565508373|FG002|Overall Study|Lost to Follow-up|116|||
156661709|NCT02849652|565508374|FG003|Overall Study|Lost to Follow-up|22|||
156661710|NCT02849652|565508371|FG000|Overall Study|Withdrawal by Subject|10|||
156661711|NCT02849652|565508372|FG001|Overall Study|Withdrawal by Subject|2|||
156661712|NCT02849652|565508373|FG002|Overall Study|Withdrawal by Subject|8|||
156661713|NCT02849652|565508374|FG003|Overall Study|Withdrawal by Subject|4|||
156661714|NCT00472290|565508375|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
156661715|NCT00472290|565508375|FG000|Overall Study|Protocol Specified Criteria|7|||
156661716|NCT00472290|565508375|FG000|Overall Study|Administrative Decision|37|||
156661717|NCT00472290|565508375|FG000|Overall Study|Death|3|||
156661718|NCT00472290|565508375|FG000|Overall Study|Lost to Follow-up|1|||
156661719|NCT00472290|565508375|FG000|Overall Study|Lack of Efficacy|1|||
156661720|NCT00472290|565508375|FG000|Overall Study|Disease Progression|4|||
156661721|NCT00472290|565508375|FG000|Overall Study|Withdrawal by Subject|5|||
156661722|NCT00472290|565508375|FG000|Overall Study|Adverse Event|6|||
156661723|NCT00472290|565508375|FG000|Overall Study|Requirement for alternative therapy|7|||
156661724|NCT00777829|565508377|FG000|Overall Study|Withdrawal by Subject|0|||
156661725|NCT00777829|565508378|FG001|Overall Study|Withdrawal by Subject|2|||
156661726|NCT00745095|565508379|FG000|Overall Study|Declined to participate|1|||
156661727|NCT00745095|565508380|FG001|Overall Study|Declined to participate|0|||
156661728|NCT00745095|565508381|FG002|Overall Study|Declined to participate|0|||
156661729|NCT00745095|565508382|FG003|Overall Study|Declined to participate|0|||
156661730|NCT00745095|565508383|FG004|Overall Study|Declined to participate|92|||
156661731|NCT00745095|565508384|FG005|Overall Study|Declined to participate|95|||
156661732|NCT00745095|565508379|FG000|Overall Study|Ineligible due to GFR criteria|0|||
156661733|NCT00745095|565508380|FG001|Overall Study|Ineligible due to GFR criteria|2|||
156661734|NCT00745095|565508381|FG002|Overall Study|Ineligible due to GFR criteria|3|||
156661735|NCT00745095|565508382|FG003|Overall Study|Ineligible due to GFR criteria|3|||
156661736|NCT00745095|565508383|FG004|Overall Study|Ineligible due to GFR criteria|30|||
156661737|NCT00745095|565508384|FG005|Overall Study|Ineligible due to GFR criteria|28|||
156661738|NCT00408902|565508389|FG000|Overall Study|Lack of Efficacy|7|||
156661739|NCT00408902|565508389|FG000|Overall Study|Adverse Event|3|||
156661740|NCT02457832|565508392|FG000|Training|Lost to Follow-up|10|||
156661741|NCT02457832|565508393|FG001|Training|Lost to Follow-up|6|||
156661742|NCT02457832|565508394|FG002|Training|Lost to Follow-up|3|||
156661743|NCT02457832|565508392|FG000|One Month Washout|Lost to Follow-up|0|||
156661744|NCT02457832|565508393|FG001|One Month Washout|Lost to Follow-up|1|||
156661745|NCT02457832|565508394|FG002|One Month Washout|Lost to Follow-up|1|||
156661746|NCT01030965|565508395|FG000|Overall Study|Lack of Efficacy|3|||
156661747|NCT01030965|565508396|FG001|Overall Study|Lack of Efficacy|2|||
156661748|NCT01030965|565508397|FG002|Overall Study|Lack of Efficacy|0|||
156661749|NCT01030965|565508398|FG003|Overall Study|Lack of Efficacy|3|||
156661750|NCT01030965|565508395|FG000|Overall Study|Protocol Violation|1|||
156661751|NCT01030965|565508396|FG001|Overall Study|Protocol Violation|1|||
156661752|NCT01030965|565508397|FG002|Overall Study|Protocol Violation|1|||
156661753|NCT01030965|565508398|FG003|Overall Study|Protocol Violation|1|||
156661754|NCT01030965|565508395|FG000|Overall Study|Adverse Event|0|||
156661755|NCT01030965|565508396|FG001|Overall Study|Adverse Event|1|||
156661756|NCT01030965|565508397|FG002|Overall Study|Adverse Event|2|||
156429292|NCT04936035|564663214|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156661757|NCT01030965|565508398|FG003|Overall Study|Adverse Event|1|||
156661758|NCT01030965|565508395|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
156661759|NCT01030965|565508396|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
156661760|NCT01030965|565508397|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
156661761|NCT01030965|565508398|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
156661762|NCT01030965|565508395|FG000|Overall Study|Withdrawal by Subject|0|||
156661763|NCT01030965|565508396|FG001|Overall Study|Withdrawal by Subject|1|||
156661764|NCT01030965|565508397|FG002|Overall Study|Withdrawal by Subject|0|||
156661765|NCT01030965|565508398|FG003|Overall Study|Withdrawal by Subject|2|||
156661766|NCT02097290|565508399|FG000|Overall Study|Death|6|||
156661767|NCT02097290|565508399|FG000|Overall Study|Total Withdrawals|3|||
156661768|NCT02097290|565508399|FG000|Overall Study|Attempt|8|||
156661769|NCT05277389|565508400|FG000|Overall Study|Lost to Follow-up|1|||
156661770|NCT05277389|565508401|FG001|Overall Study|Lost to Follow-up|4|||
156661771|NCT03069937|565508402|FG000|Overall Study|Second primary malignancy noted|1|||
156661772|NCT03144687|565508407|FG000|Overall Study|Death|0|||
156661773|NCT03144687|565508408|FG001|Overall Study|Death|2|||
156661774|NCT03144687|565508407|FG000|Overall Study|Lost to Follow-up|0|||
156661775|NCT03144687|565508408|FG001|Overall Study|Lost to Follow-up|1|||
156661776|NCT03144687|565508407|FG000|Overall Study|Physician Decision|0|||
156661777|NCT03144687|565508408|FG001|Overall Study|Physician Decision|1|||
156661778|NCT03144687|565508407|FG000|Overall Study|Withdrawal by Subject|1|||
156661779|NCT03144687|565508408|FG001|Overall Study|Withdrawal by Subject|3|||
156661780|NCT03144687|565508407|FG000|Overall Study|Not Reported|2|||
156661781|NCT03144687|565508408|FG001|Overall Study|Not Reported|0|||
156661782|NCT00683293|565508411|FG000|Overall Study|Withdrawal by Subject|2|||
156661783|NCT00683293|565508412|FG001|Overall Study|Withdrawal by Subject|3|||
156661784|NCT02079532|565508417|FG000|Overall Study|Adverse Event|7|||
156661785|NCT02079532|565508417|FG000|Overall Study|Additional or changed therapy|2|||
156661786|NCT02079532|565508417|FG000|Overall Study|Lack of Efficacy|9|||
156661787|NCT02079532|565508417|FG000|Overall Study|Protocol Violation|3|||
156661788|NCT02079532|565508417|FG000|Overall Study|Withdrawal by Subject|1|||
156661789|NCT02079532|565508417|FG000|Overall Study|Administrative problems|1|||
156661790|NCT02079532|565508417|FG000|Overall Study|Inclusion into ReFIRST|3|||
156661791|NCT02079532|565508417|FG000|Overall Study|Other|3|||
156661792|NCT02920996|565508418|FG000|Overall Study|Adverse Event|8|||
156661793|NCT02920996|565508419|FG001|Overall Study|Adverse Event|0|||
156661794|NCT02920996|565508418|FG000|Overall Study|Physician Decision|1|||
156661795|NCT02920996|565508419|FG001|Overall Study|Physician Decision|0|||
156661796|NCT02920996|565508418|FG000|Overall Study|Death|1|||
156661797|NCT02920996|565508419|FG001|Overall Study|Death|0|||
156661798|NCT02920996|565508418|FG000|Overall Study|Missing|1|||
156661799|NCT02920996|565508419|FG001|Overall Study|Missing|0|||
156661800|NCT02920996|565508418|FG000|Overall Study|Subject Non-Compliance|1|||
156661801|NCT02920996|565508419|FG001|Overall Study|Subject Non-Compliance|0|||
156661802|NCT01387737|565509746|FG000|Overall Study|Adverse Event|20|||
156661803|NCT01387737|565509747|FG001|Overall Study|Adverse Event|30|||
156661804|NCT01387737|565509746|FG000|Overall Study|Lack of Efficacy|1|||
156661805|NCT01387737|565509747|FG001|Overall Study|Lack of Efficacy|0|||
156661806|NCT01387737|565509746|FG000|Overall Study|Physician Decision|3|||
156661807|NCT01387737|565509747|FG001|Overall Study|Physician Decision|10|||
156661808|NCT01387737|565509746|FG000|Overall Study|Withdrawal by Subject|27|||
156661809|NCT01387737|565509747|FG001|Overall Study|Withdrawal by Subject|31|||
156661810|NCT01387737|565509746|FG000|Overall Study|Clearly not eligible for the study|1|||
156661811|NCT01387737|565509747|FG001|Overall Study|Clearly not eligible for the study|3|||
156661812|NCT01248247|565509749|FG000|Overall Study|Adverse Event|2|||
156661813|NCT01248247|565509750|FG001|Overall Study|Adverse Event|4|||
156661814|NCT01248247|565509751|FG002|Overall Study|Adverse Event|4|||
156661815|NCT01248247|565509752|FG003|Overall Study|Adverse Event|2|||
156661816|NCT01248247|565509749|FG000|Overall Study|Death|0|||
156661817|NCT01248247|565509750|FG001|Overall Study|Death|1|||
156661818|NCT01248247|565509751|FG002|Overall Study|Death|4|||
156661819|NCT01248247|565509752|FG003|Overall Study|Death|7|||
156661820|NCT01248247|565509749|FG000|Overall Study|Lost to Follow-up|0|||
156661821|NCT01248247|565509750|FG001|Overall Study|Lost to Follow-up|1|||
156661822|NCT01248247|565509751|FG002|Overall Study|Lost to Follow-up|1|||
156661823|NCT01248247|565509752|FG003|Overall Study|Lost to Follow-up|0|||
156661824|NCT01248247|565509749|FG000|Overall Study|Alternative treatment|0|||
156661825|NCT01248247|565509750|FG001|Overall Study|Alternative treatment|1|||
156661826|NCT01248247|565509751|FG002|Overall Study|Alternative treatment|0|||
156661827|NCT01248247|565509752|FG003|Overall Study|Alternative treatment|0|||
156661828|NCT01248247|565509749|FG000|Overall Study|Other|2|||
156661829|NCT01248247|565509750|FG001|Overall Study|Other|8|||
156661830|NCT01248247|565509751|FG002|Overall Study|Other|8|||
156661831|NCT01248247|565509752|FG003|Overall Study|Other|5|||
156661832|NCT01248247|565509749|FG000|Overall Study|Progression|18|||
156661833|NCT01248247|565509750|FG001|Overall Study|Progression|27|||
156661834|NCT01248247|565509751|FG002|Overall Study|Progression|56|||
156661835|NCT01248247|565509752|FG003|Overall Study|Progression|44|||
156661836|NCT01248247|565509749|FG000|Overall Study|Refuse further treatment|0|||
156661837|NCT01248247|565509750|FG001|Overall Study|Refuse further treatment|0|||
156661838|NCT01248247|565509751|FG002|Overall Study|Refuse further treatment|1|||
156661839|NCT01248247|565509752|FG003|Overall Study|Refuse further treatment|2|||
156661840|NCT01248247|565509749|FG000|Overall Study|Complicating disease|0|||
156661841|NCT01248247|565509750|FG001|Overall Study|Complicating disease|0|||
156661842|NCT01248247|565509751|FG002|Overall Study|Complicating disease|1|||
156661843|NCT01248247|565509752|FG003|Overall Study|Complicating disease|1|||
156661844|NCT02817841|565509753|FG000|Overall Study|Lost to Follow-up|287|||
156661845|NCT02817841|565509753|FG000|Overall Study|Withdrawal by Subject|183|||
156661846|NCT02817841|565509753|FG000|Overall Study|Adverse event not related to bleeding|131|||
156661847|NCT02817841|565509753|FG000|Overall Study|Adverse event related to bleeding|51|||
156661848|NCT02817841|565509753|FG000|Overall Study|Pregnancy|32|||
156661849|NCT02817841|565509753|FG000|Overall Study|Pregnancy wish|17|||
156661850|NCT02817841|565509753|FG000|Overall Study|Other reasons|53|||
156661851|NCT02817841|565509753|FG000|Overall Study|Protocol Violation|94|||
156661852|NCT00705536|565509754|FG000|Start Period 1|Withdrawal by Subject|0|||
156661853|NCT00705536|565509755|FG001|Start Period 1|Withdrawal by Subject|0|||
156661854|NCT00705536|565509756|FG002|Start Period 1|Withdrawal by Subject|0|||
156661855|NCT00705536|565509757|FG003|Start Period 1|Withdrawal by Subject|1|||
156661856|NCT04188106|565509758|FG000|Overall Study|Lost to Follow-up|5|||
156661857|NCT04188106|565509758|FG000|Overall Study|Non-Compliance|1|||
156661858|NCT01746017|565509761|FG000|Period 1|Withdrawal by Subject|0|||
156661859|NCT01746017|565509762|FG001|Period 1|Withdrawal by Subject|0|||
156661860|NCT01746017|565509763|FG002|Period 1|Withdrawal by Subject|0|||
156661861|NCT01746017|565509764|FG003|Period 1|Withdrawal by Subject|0|||
156661862|NCT01746017|565509765|FG004|Period 1|Withdrawal by Subject|0|||
156661863|NCT01746017|565509766|FG005|Period 1|Withdrawal by Subject|0|||
156661864|NCT01746017|565509767|FG006|Period 1|Withdrawal by Subject|1|||
156661865|NCT01746017|565509768|FG007|Period 1|Withdrawal by Subject|0|||
156661866|NCT01746017|565509769|FG008|Period 1|Withdrawal by Subject|0|||
156661867|NCT01746017|565509770|FG009|Period 1|Withdrawal by Subject|0|||
156661868|NCT01746017|565509771|FG010|Period 1|Withdrawal by Subject|0|||
156661869|NCT01746017|565509761|FG000|Period 3|Withdrawal by Subject|0|||
156661870|NCT01746017|565509762|FG001|Period 3|Withdrawal by Subject|0|||
156661871|NCT01746017|565509763|FG002|Period 3|Withdrawal by Subject|0|||
156661872|NCT01746017|565509764|FG003|Period 3|Withdrawal by Subject|0|||
156661873|NCT01746017|565509765|FG004|Period 3|Withdrawal by Subject|0|||
156661874|NCT01746017|565509766|FG005|Period 3|Withdrawal by Subject|1|||
156661875|NCT01746017|565509767|FG006|Period 3|Withdrawal by Subject|0|||
156661876|NCT01746017|565509768|FG007|Period 3|Withdrawal by Subject|0|||
156661877|NCT01746017|565509769|FG008|Period 3|Withdrawal by Subject|0|||
156661878|NCT01746017|565509770|FG009|Period 3|Withdrawal by Subject|0|||
156661879|NCT01746017|565509771|FG010|Period 3|Withdrawal by Subject|0|||
156661880|NCT04032977|565509772|FG000|Overall Study|Withdrawal by Subject|6|||
156661881|NCT04032977|565509773|FG001|Overall Study|Withdrawal by Subject|1|||
156661882|NCT04032977|565509772|FG000|Overall Study|Lost to Follow-up|2|||
156661883|NCT04032977|565509773|FG001|Overall Study|Lost to Follow-up|7|||
156661884|NCT04032977|565509772|FG000|Overall Study|Pregnancy|1|||
156661885|NCT04032977|565509773|FG001|Overall Study|Pregnancy|0|||
156661886|NCT01101022|565509774|FG000|Overall Study|Adverse Event|6|||
156661887|NCT01101022|565509775|FG001|Overall Study|Adverse Event|2|||
156661888|NCT01101022|565509774|FG000|Overall Study|Protocol Violation|4|||
156661889|NCT01101022|565509775|FG001|Overall Study|Protocol Violation|3|||
156661890|NCT01101022|565509774|FG000|Overall Study|Withdrawal by Subject|3|||
156661891|NCT01101022|565509775|FG001|Overall Study|Withdrawal by Subject|8|||
156661892|NCT01101022|565509774|FG000|Overall Study|Lost to Follow-up|1|||
156661893|NCT01101022|565509775|FG001|Overall Study|Lost to Follow-up|4|||
156661894|NCT01101022|565509774|FG000|Overall Study|Lack of Efficacy|0|||
156661895|NCT01101022|565509775|FG001|Overall Study|Lack of Efficacy|7|||
156661896|NCT01101022|565509774|FG000|Overall Study|Sponsor decision|1|||
156661897|NCT01101022|565509775|FG001|Overall Study|Sponsor decision|1|||
156775746|NCT03329001|565931304|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
156429293|NCT04936035|564663215|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156429294|NCT04936035|564663216|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156661898|NCT01101022|565509774|FG000|Overall Study|Non-compliance|1|||
156661899|NCT01101022|565509775|FG001|Overall Study|Non-compliance|0|||
156661900|NCT01101022|565509774|FG000|Overall Study|Work schedule|1|||
156661901|NCT01101022|565509775|FG001|Overall Study|Work schedule|1|||
156661902|NCT01101022|565509774|FG000|Overall Study|Vacation|0|||
156661903|NCT01101022|565509775|FG001|Overall Study|Vacation|1|||
156661904|NCT03075761|565509776|FG000|Overall Study|Lost to Follow-up|1|||
156661905|NCT03075761|565509777|FG001|Overall Study|Lost to Follow-up|6|||
156661906|NCT01519661|565509778|FG000|Overall Study|Protocol deviation|6|||
156661907|NCT01519661|565509778|FG000|Overall Study|Lost to Follow-up|3|||
156661908|NCT01519661|565509778|FG000|Overall Study|Withdrawal by Subject|17|||
156661909|NCT01519661|565509778|FG000|Overall Study|Lack of Efficacy|6|||
156661910|NCT01519661|565509778|FG000|Overall Study|Adverse Event|29|||
156661911|NCT01139047|565509779|FG000|Overall Study|Withdrawal by Subject|1|||
156661912|NCT00420303|565509785|FG000|Overall Study|Serious Adverse Event|1|||
156661913|NCT00420303|565509786|FG001|Overall Study|Serious Adverse Event|0|||
156661914|NCT00420303|565509785|FG000|Overall Study|Lack of Efficacy|0|||
156661915|NCT00420303|565509786|FG001|Overall Study|Lack of Efficacy|3|||
156661916|NCT00420303|565509785|FG000|Overall Study|Physician Decision|0|||
156661917|NCT00420303|565509786|FG001|Overall Study|Physician Decision|1|||
156661918|NCT00840632|565509787|FG000|First Intervention|Withdrawal by Subject|0|||
156661919|NCT00840632|565509788|FG001|First Intervention|Withdrawal by Subject|1|||
156661920|NCT00840632|565509787|FG000|Washout|Withdrawal by Subject|1|||
156661921|NCT00840632|565509788|FG001|Washout|Withdrawal by Subject|1|||
156661922|NCT05017480|565509789|FG000|Stage 1 Study|Withdrawal by Subject|8|||
156661923|NCT05017480|565509790|FG001|Stage 1 Study|Withdrawal by Subject|6|||
156661924|NCT05017480|565509791|FG002|Stage 1 Study|Withdrawal by Subject|0|||
156661925|NCT05017480|565509792|FG003|Stage 1 Study|Withdrawal by Subject|0|||
156661926|NCT05017480|565509793|FG004|Stage 1 Study|Withdrawal by Subject|0|||
156661927|NCT05017480|565509789|FG000|Stage 1 Study|Adverse Event|1|||
156661928|NCT05017480|565509790|FG001|Stage 1 Study|Adverse Event|1|||
156661929|NCT05017480|565509791|FG002|Stage 1 Study|Adverse Event|0|||
156661930|NCT05017480|565509792|FG003|Stage 1 Study|Adverse Event|0|||
156661931|NCT05017480|565509793|FG004|Stage 1 Study|Adverse Event|0|||
156661932|NCT05017480|565509789|FG000|Stage 1 Study|Poor Compliance|1|||
156661933|NCT05017480|565509790|FG001|Stage 1 Study|Poor Compliance|1|||
156661934|NCT05017480|565509791|FG002|Stage 1 Study|Poor Compliance|0|||
156661935|NCT05017480|565509792|FG003|Stage 1 Study|Poor Compliance|0|||
156661936|NCT05017480|565509793|FG004|Stage 1 Study|Poor Compliance|0|||
156661937|NCT05017480|565509789|FG000|Stage 1 Study|Physician Decision|0|||
156661938|NCT05017480|565509790|FG001|Stage 1 Study|Physician Decision|1|||
156661939|NCT05017480|565509791|FG002|Stage 1 Study|Physician Decision|0|||
156661940|NCT05017480|565509792|FG003|Stage 1 Study|Physician Decision|0|||
156661941|NCT05017480|565509793|FG004|Stage 1 Study|Physician Decision|0|||
156661942|NCT05017480|565509789|FG000|Stage 2 Study|Withdrawal by Subject|0|||
156661943|NCT05017480|565509790|FG001|Stage 2 Study|Withdrawal by Subject|0|||
156661944|NCT05017480|565509791|FG002|Stage 2 Study|Withdrawal by Subject|6|||
156661945|NCT05017480|565509792|FG003|Stage 2 Study|Withdrawal by Subject|9|||
156661946|NCT05017480|565509793|FG004|Stage 2 Study|Withdrawal by Subject|11|||
156661947|NCT05017480|565509789|FG000|Stage 2 Study|Lost to Follow-up|0|||
156661948|NCT05017480|565509790|FG001|Stage 2 Study|Lost to Follow-up|0|||
156661949|NCT05017480|565509791|FG002|Stage 2 Study|Lost to Follow-up|0|||
156661950|NCT05017480|565509792|FG003|Stage 2 Study|Lost to Follow-up|2|||
156661951|NCT05017480|565509793|FG004|Stage 2 Study|Lost to Follow-up|1|||
156661952|NCT05017480|565509789|FG000|Stage 2 Study|Adverse Event|0|||
156661953|NCT05017480|565509790|FG001|Stage 2 Study|Adverse Event|0|||
156661954|NCT05017480|565509791|FG002|Stage 2 Study|Adverse Event|0|||
156661955|NCT05017480|565509792|FG003|Stage 2 Study|Adverse Event|1|||
156661956|NCT05017480|565509793|FG004|Stage 2 Study|Adverse Event|0|||
156661957|NCT05017480|565509789|FG000|Stage 2 Study|COVID-19|0|||
156661958|NCT05017480|565509790|FG001|Stage 2 Study|COVID-19|0|||
156661959|NCT05017480|565509791|FG002|Stage 2 Study|COVID-19|0|||
156661960|NCT05017480|565509792|FG003|Stage 2 Study|COVID-19|1|||
156661961|NCT05017480|565509793|FG004|Stage 2 Study|COVID-19|0|||
156661962|NCT05017480|565509789|FG000|Stage 2 Study|Pregnancy|0|||
156661963|NCT05017480|565509790|FG001|Stage 2 Study|Pregnancy|0|||
156661964|NCT05017480|565509791|FG002|Stage 2 Study|Pregnancy|0|||
156661965|NCT05017480|565509792|FG003|Stage 2 Study|Pregnancy|0|||
156661966|NCT05017480|565509793|FG004|Stage 2 Study|Pregnancy|1|||
156661967|NCT00485472|565509794|FG000|Overall Study|Adverse Event|8|||
156661968|NCT00485472|565509795|FG001|Overall Study|Adverse Event|5|||
156661969|NCT00485472|565509794|FG000|Overall Study|Lack of Efficacy|5|||
156661970|NCT00485472|565509795|FG001|Overall Study|Lack of Efficacy|4|||
156661971|NCT00485472|565509794|FG000|Overall Study|Withdrawal by Subject|1|||
156661972|NCT00485472|565509795|FG001|Overall Study|Withdrawal by Subject|0|||
156429295|NCT04936035|564663217|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156429296|NCT04936035|564663218|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156661973|NCT00485472|565509794|FG000|Overall Study|Protocol Violation|0|||
156661974|NCT00485472|565509795|FG001|Overall Study|Protocol Violation|1|||
156661975|NCT00485472|565509794|FG000|Overall Study|Other|2|||
156661976|NCT00485472|565509795|FG001|Overall Study|Other|1|||
156661977|NCT00485472|565509794|FG000|Overall Study|Lost to Follow-up|0|||
156661978|NCT00485472|565509795|FG001|Overall Study|Lost to Follow-up|1|||
156661979|NCT01492361|565509797|FG000|Overall Study|Withdrawal by Subject|281|||
156661980|NCT01492361|565509798|FG001|Overall Study|Withdrawal by Subject|297|||
156661981|NCT01492361|565509797|FG000|Overall Study|Physician Decision|12|||
156661982|NCT01492361|565509798|FG001|Overall Study|Physician Decision|12|||
156661983|NCT01492361|565509797|FG000|Overall Study|Lost to Follow-up|6|||
156661984|NCT01492361|565509798|FG001|Overall Study|Lost to Follow-up|13|||
156661985|NCT01492361|565509797|FG000|Overall Study|Other than specified above|106|||
156661986|NCT01492361|565509798|FG001|Overall Study|Other than specified above|138|||
156661987|NCT03227445|565509803|FG000|Period 1 (28 Days)|Adverse Event|1|||
156661988|NCT03227445|565509804|FG001|Period 1 (28 Days)|Adverse Event|2|||
156661989|NCT03227445|565509805|FG002|Period 1 (28 Days)|Adverse Event|0|||
156661990|NCT03227445|565509806|FG003|Period 1 (28 Days)|Adverse Event|1|||
156661991|NCT03227445|565509803|FG000|Period 1 (28 Days)|Protocol Violation|1|||
156661992|NCT03227445|565509804|FG001|Period 1 (28 Days)|Protocol Violation|0|||
156661993|NCT03227445|565509805|FG002|Period 1 (28 Days)|Protocol Violation|0|||
156661994|NCT03227445|565509806|FG003|Period 1 (28 Days)|Protocol Violation|0|||
156661995|NCT03227445|565509803|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
156661996|NCT03227445|565509804|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
156661997|NCT03227445|565509805|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
156661998|NCT03227445|565509806|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
156661999|NCT03227445|565509803|FG000|Period 2 (28 Days)|Adverse Event|1|||
156662000|NCT03227445|565509804|FG001|Period 2 (28 Days)|Adverse Event|0|||
156662001|NCT03227445|565509805|FG002|Period 2 (28 Days)|Adverse Event|2|||
156662002|NCT03227445|565509806|FG003|Period 2 (28 Days)|Adverse Event|1|||
156662003|NCT03227445|565509803|FG000|Period 2 (28 Days)|Protocol Violation|0|||
156662004|NCT03227445|565509804|FG001|Period 2 (28 Days)|Protocol Violation|0|||
156662005|NCT03227445|565509805|FG002|Period 2 (28 Days)|Protocol Violation|0|||
156662006|NCT03227445|565509806|FG003|Period 2 (28 Days)|Protocol Violation|1|||
156662007|NCT03227445|565509803|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
156662008|NCT03227445|565509804|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
156662009|NCT03227445|565509805|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
156662010|NCT03227445|565509806|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
156662011|NCT01179048|565509809|FG000|Overall Study|Withdrawn - does not allow contact|4|||
156662012|NCT01179048|565509810|FG001|Overall Study|Withdrawn - does not allow contact|8|||
156662013|NCT01179048|565509809|FG000|Overall Study|Lost to Follow-up|8|||
156429297|NCT04936035|564663219|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
156429298|NCT04936035|564663220|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
156429299|NCT04936035|564663221|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156429300|NCT04936035|564663222|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156429301|NCT04936035|564663223|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
156429302|NCT04936035|564663224|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
156429303|NCT04936035|564663225|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
156429304|NCT04936035|564663226|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
156429305|NCT04936035|564663214|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156429306|NCT04936035|564663215|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156429307|NCT04936035|564663216|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156662014|NCT01179048|565509810|FG001|Overall Study|Lost to Follow-up|9|||
156662015|NCT01179048|565509809|FG000|Overall Study|Alive|127|||
156662016|NCT01179048|565509810|FG001|Overall Study|Alive|142|||
156662017|NCT01900730|565509811|FG000|Overall Study|Withdrawal by Subject|1|||
156662018|NCT01900730|565509812|FG001|Overall Study|Withdrawal by Subject|0|||
156662019|NCT01900730|565509811|FG000|Overall Study|Screen Failure|1|||
156775747|NCT03329001|565931305|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775748|NCT03329001|565931298|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775749|NCT03329001|565931299|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775750|NCT03329001|565931300|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156429308|NCT04936035|564663217|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156429309|NCT04936035|564663218|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156429310|NCT04936035|564663219|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
156429311|NCT04936035|564663220|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
156429312|NCT04936035|564663221|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156429313|NCT04936035|564663222|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156429314|NCT04936035|564663223|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
156429315|NCT04936035|564663224|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
156429316|NCT04936035|564663225|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
156429317|NCT04936035|564663226|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
156429318|NCT04936035|564663214|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429319|NCT04936035|564663215|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429320|NCT04936035|564663216|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429321|NCT04936035|564663217|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429322|NCT04936035|564663218|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429323|NCT04936035|564663219|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
156662020|NCT01900730|565509812|FG001|Overall Study|Screen Failure|0|||
156662021|NCT03203447|565509817|FG000|Overall Study|Withdrawal by Subject|2|||
156662022|NCT03203447|565509818|FG001|Overall Study|Withdrawal by Subject|1|||
156662023|NCT03203447|565509817|FG000|Overall Study|Lost to Follow-up|1|||
156662024|NCT03203447|565509818|FG001|Overall Study|Lost to Follow-up|10|||
156662025|NCT03203447|565509817|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
156662026|NCT03203447|565509818|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
156662027|NCT00274937|565509819|FG000|Overall Study|Physician Decision|10|||
156662028|NCT00274937|565509819|FG000|Overall Study|Withdrawal by Subject|6|||
156662029|NCT00274937|565509819|FG000|Overall Study|Progressive Disease|4|||
156662030|NCT00445003|565509820|FG000|Overall Study|Death|1|||
156662031|NCT00445003|565509821|FG001|Overall Study|Death|2|||
156662032|NCT00445003|565509822|FG002|Overall Study|Death|1|||
156662033|NCT00445003|565509820|FG000|Overall Study|Missed Visit|3|||
156662034|NCT00445003|565509821|FG001|Overall Study|Missed Visit|5|||
156662035|NCT00445003|565509822|FG002|Overall Study|Missed Visit|1|||
156662036|NCT00445003|565509820|FG000|Overall Study|Dropped|1|||
156662037|NCT00445003|565509821|FG001|Overall Study|Dropped|3|||
156662038|NCT00445003|565509822|FG002|Overall Study|Dropped|2|||
156662039|NCT00880568|565509826|FG000|Overall Study|Disease progression|3|||
156662040|NCT00880568|565509827|FG001|Overall Study|Disease progression|3|||
156662041|NCT00880568|565509828|FG002|Overall Study|Disease progression|3|||
156662042|NCT00880568|565509829|FG003|Overall Study|Disease progression|1|||
156662043|NCT00880568|565509830|FG004|Overall Study|Disease progression|3|||
156662044|NCT00880568|565509831|FG005|Overall Study|Disease progression|3|||
156662045|NCT00880568|565509832|FG006|Overall Study|Disease progression|5|||
156662046|NCT00880568|565509833|FG007|Overall Study|Disease progression|0|||
156662047|NCT00880568|565509834|FG008|Overall Study|Disease progression|3|||
156662048|NCT00880568|565509826|FG000|Overall Study|Adverse Event|0|||
156662049|NCT00880568|565509827|FG001|Overall Study|Adverse Event|0|||
156662050|NCT00880568|565509828|FG002|Overall Study|Adverse Event|0|||
156662051|NCT00880568|565509829|FG003|Overall Study|Adverse Event|0|||
156662052|NCT00880568|565509830|FG004|Overall Study|Adverse Event|0|||
156662053|NCT00880568|565509831|FG005|Overall Study|Adverse Event|0|||
156662054|NCT00880568|565509832|FG006|Overall Study|Adverse Event|1|||
156662055|NCT00880568|565509833|FG007|Overall Study|Adverse Event|1|||
156662056|NCT00880568|565509834|FG008|Overall Study|Adverse Event|0|||
156662057|NCT00880568|565509826|FG000|Overall Study|Withdrawal by Subject|0|||
156662058|NCT00880568|565509827|FG001|Overall Study|Withdrawal by Subject|0|||
156662059|NCT00880568|565509828|FG002|Overall Study|Withdrawal by Subject|0|||
156662060|NCT00880568|565509829|FG003|Overall Study|Withdrawal by Subject|0|||
156662061|NCT00880568|565509830|FG004|Overall Study|Withdrawal by Subject|0|||
156662062|NCT00880568|565509831|FG005|Overall Study|Withdrawal by Subject|0|||
156662063|NCT00880568|565509832|FG006|Overall Study|Withdrawal by Subject|0|||
156662064|NCT00880568|565509833|FG007|Overall Study|Withdrawal by Subject|1|||
156662065|NCT00880568|565509834|FG008|Overall Study|Withdrawal by Subject|0|||
156662066|NCT00620022|565509835|FG000|Treatment Period 1|Adverse Event|4|||
156662067|NCT00620022|565509836|FG001|Treatment Period 1|Adverse Event|6|||
156662068|NCT00620022|565509835|FG000|Treatment Period 1|Subject withdrew consent|1|||
156662069|NCT00620022|565509836|FG001|Treatment Period 1|Subject withdrew consent|0|||
156662070|NCT00620022|565509835|FG000|Treatment Period 2|Adverse Event|2|||
156662071|NCT00620022|565509836|FG001|Treatment Period 2|Adverse Event|2|||
156662072|NCT00891293|565509837|FG000|Overall Study|Adverse Event|2|||
156662073|NCT00891293|565509837|FG000|Overall Study|Protocol Violation|2|||
156662074|NCT00891293|565509837|FG000|Overall Study|Laboratory abnormality|4|||
156662075|NCT00891293|565509837|FG000|Overall Study|Lost to Follow-up|7|||
156662076|NCT00891293|565509837|FG000|Overall Study|Subject withdrew consent|7|||
156662077|NCT00891293|565509837|FG000|Overall Study|Sponsor termination|62|||
156662078|NCT02178722|565509838|FG000|Overall Study|Withdrawal by Subject|0|||
156662079|NCT02178722|565509839|FG001|Overall Study|Withdrawal by Subject|0|||
156662080|NCT02178722|565509840|FG002|Overall Study|Withdrawal by Subject|0|||
156662081|NCT02178722|565509841|FG003|Overall Study|Withdrawal by Subject|2|||
156662082|NCT02178722|565509842|FG004|Overall Study|Withdrawal by Subject|33|||
156662083|NCT02178722|565509838|FG000|Overall Study|Death|2|||
156662084|NCT02178722|565509839|FG001|Overall Study|Death|13|||
156662085|NCT02178722|565509840|FG002|Overall Study|Death|12|||
156662086|NCT02178722|565509841|FG003|Overall Study|Death|12|||
156662087|NCT02178722|565509842|FG004|Overall Study|Death|205|||
156662088|NCT02178722|565509838|FG000|Overall Study|Lost to Follow-up|0|||
156662089|NCT02178722|565509839|FG001|Overall Study|Lost to Follow-up|0|||
156662090|NCT02178722|565509840|FG002|Overall Study|Lost to Follow-up|0|||
156662091|NCT02178722|565509841|FG003|Overall Study|Lost to Follow-up|2|||
156662092|NCT02178722|565509842|FG004|Overall Study|Lost to Follow-up|11|||
156662093|NCT02178722|565509838|FG000|Overall Study|Study terminated by Sponsor|2|||
156662094|NCT02178722|565509839|FG001|Overall Study|Study terminated by Sponsor|7|||
156662095|NCT02178722|565509840|FG002|Overall Study|Study terminated by Sponsor|6|||
156662096|NCT02178722|565509841|FG003|Overall Study|Study terminated by Sponsor|4|||
156662097|NCT02178722|565509842|FG004|Overall Study|Study terminated by Sponsor|128|||
156662098|NCT02178722|565509838|FG000|Overall Study|Physician Decision|0|||
156662099|NCT02178722|565509839|FG001|Overall Study|Physician Decision|0|||
156662100|NCT02178722|565509840|FG002|Overall Study|Physician Decision|0|||
156662101|NCT02178722|565509841|FG003|Overall Study|Physician Decision|0|||
156662102|NCT02178722|565509842|FG004|Overall Study|Physician Decision|3|||
156662103|NCT02178722|565509838|FG000|Overall Study|Other|0|||
156662104|NCT02178722|565509839|FG001|Overall Study|Other|0|||
156662105|NCT02178722|565509840|FG002|Overall Study|Other|0|||
156662106|NCT02178722|565509841|FG003|Overall Study|Other|0|||
156662107|NCT02178722|565509842|FG004|Overall Study|Other|2|||
156662108|NCT01572948|565509843|FG000|Overall Study|Lost to Follow-up|1|||
156662109|NCT01572948|565509844|FG001|Overall Study|Lost to Follow-up|0|||
156662110|NCT01572948|565509843|FG000|Overall Study|unable to contact|0|||
156662111|NCT01572948|565509844|FG001|Overall Study|unable to contact|1|||
156662112|NCT01126736|565509850|FG000|Overall Study|Death|2|||
156662113|NCT01126736|565509851|FG001|Overall Study|Death|2|||
156662114|NCT01126736|565509852|FG002|Overall Study|Death|1|||
156662115|NCT01126736|565509853|FG003|Overall Study|Death|19|||
156662116|NCT01126736|565509854|FG004|Overall Study|Death|19|||
156662117|NCT01126736|565509850|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
156662118|NCT01126736|565509851|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
156662119|NCT01126736|565509852|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
156662120|NCT01126736|565509853|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
156662121|NCT01126736|565509854|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
156662122|NCT01126736|565509850|FG000|Overall Study|Lost to Follow-up|0|||
156662123|NCT01126736|565509851|FG001|Overall Study|Lost to Follow-up|0|||
156662124|NCT01126736|565509852|FG002|Overall Study|Lost to Follow-up|0|||
156662125|NCT01126736|565509853|FG003|Overall Study|Lost to Follow-up|1|||
156662126|NCT01126736|565509854|FG004|Overall Study|Lost to Follow-up|1|||
156662127|NCT01126736|565509850|FG000|Overall Study|Administrative reasons|0|||
156662128|NCT01126736|565509851|FG001|Overall Study|Administrative reasons|0|||
156662129|NCT01126736|565509852|FG002|Overall Study|Administrative reasons|0|||
156662130|NCT01126736|565509853|FG003|Overall Study|Administrative reasons|0|||
156662131|NCT01126736|565509854|FG004|Overall Study|Administrative reasons|1|||
156662132|NCT01126736|565509850|FG000|Overall Study|Progressive disease|0|||
156662133|NCT01126736|565509851|FG001|Overall Study|Progressive disease|0|||
156662134|NCT01126736|565509852|FG002|Overall Study|Progressive disease|0|||
156662135|NCT01126736|565509853|FG003|Overall Study|Progressive disease|2|||
156662136|NCT01126736|565509854|FG004|Overall Study|Progressive disease|1|||
156662137|NCT01126736|565509850|FG000|Overall Study|Withdrawal by Subject|0|||
156662138|NCT01126736|565509851|FG001|Overall Study|Withdrawal by Subject|0|||
156662139|NCT01126736|565509852|FG002|Overall Study|Withdrawal by Subject|0|||
156662140|NCT01126736|565509853|FG003|Overall Study|Withdrawal by Subject|1|||
156662141|NCT01126736|565509854|FG004|Overall Study|Withdrawal by Subject|1|||
156662142|NCT01126736|565509850|FG000|Overall Study|Other|2|||
156662143|NCT01126736|565509851|FG001|Overall Study|Other|4|||
156662144|NCT01126736|565509852|FG002|Overall Study|Other|4|||
156662145|NCT01126736|565509853|FG003|Overall Study|Other|16|||
156662146|NCT01126736|565509854|FG004|Overall Study|Other|15|||
156662147|NCT00874237|565509855|FG000|Overall Study|Physician Decision|0|||
156662148|NCT00874237|565509856|FG001|Overall Study|Physician Decision|1|||
156662149|NCT00874237|565509857|FG002|Overall Study|Physician Decision|0|||
156662150|NCT00874237|565509858|FG003|Overall Study|Physician Decision|0|||
156662151|NCT00874237|565509859|FG004|Overall Study|Physician Decision|0|||
156662152|NCT00874237|565509860|FG005|Overall Study|Physician Decision|0|||
156662153|NCT00874237|565509855|FG000|Overall Study|Withdrawal by Subject|0|||
156662154|NCT00874237|565509856|FG001|Overall Study|Withdrawal by Subject|0|||
156662155|NCT00874237|565509857|FG002|Overall Study|Withdrawal by Subject|1|||
156662156|NCT00874237|565509858|FG003|Overall Study|Withdrawal by Subject|0|||
156662157|NCT00874237|565509859|FG004|Overall Study|Withdrawal by Subject|0|||
156662158|NCT00874237|565509860|FG005|Overall Study|Withdrawal by Subject|0|||
156662159|NCT01496183|565509862|FG000|Overall Study|Physician Decision|3|||
156662160|NCT01496183|565509863|FG001|Overall Study|Physician Decision|1|||
156662161|NCT01496183|565509862|FG000|Overall Study|Withdrawal by Subject|0|||
156662162|NCT01496183|565509863|FG001|Overall Study|Withdrawal by Subject|1|||
156662163|NCT00669864|565509866|FG000|Overall Study|Lost to Follow-up|2|||
156662164|NCT00669864|565509866|FG000|Overall Study|Protocol Violation|2|||
156662165|NCT00669864|565509866|FG000|Overall Study|Withdrawal by Subject|3|||
156662166|NCT00669864|565509866|FG000|Overall Study|Other|2|||
156662167|NCT01629381|565509867|FG000|Overall Study|Withdrawal by Subject|2|||
156662168|NCT01629381|565509868|FG001|Overall Study|Withdrawal by Subject|5|||
156662169|NCT03991494|565509877|FG000|Overall Study|Progressive Disease|4|||
156662170|NCT00743197|565509881|FG000|Overall Study|Study terminated due to departure of PI.|1|||
156662171|NCT00743197|565509882|FG001|Overall Study|Study terminated due to departure of PI.|2|||
156662172|NCT00824265|565509883|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
156662173|NCT00824265|565509884|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
156662174|NCT00824265|565509883|FG000|Treatment Phase|Protocol Violation|1|||
156662175|NCT00824265|565509884|FG001|Treatment Phase|Protocol Violation|0|||
156662176|NCT00824265|565509883|FG000|Treatment Phase|Lost to Follow-up|1|||
156662177|NCT00824265|565509884|FG001|Treatment Phase|Lost to Follow-up|1|||
156662178|NCT00824265|565509883|FG000|Treatment Phase|Physician Decision|6|||
156662179|NCT00824265|565509884|FG001|Treatment Phase|Physician Decision|12|||
156662180|NCT00824265|565509883|FG000|Treatment Phase|Withdrawal by Subject|6|||
156662181|NCT00824265|565509884|FG001|Treatment Phase|Withdrawal by Subject|15|||
156662182|NCT00824265|565509883|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
156662183|NCT00824265|565509884|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
156662184|NCT00824265|565509883|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
156662185|NCT00824265|565509884|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
156662186|NCT01411332|565509885|FG000|Enrollment|Protocol Violation|0|||
156662187|NCT01411332|565509886|FG001|Enrollment|Protocol Violation|1|||
156662188|NCT01411332|565509885|FG000|Enrollment|Withdrawal by Subject|0|||
156662189|NCT01411332|565509886|FG001|Enrollment|Withdrawal by Subject|1|||
156662190|NCT01411332|565509885|FG000|Treatment|Lost to Follow-up|1|||
156662191|NCT01411332|565509886|FG001|Treatment|Lost to Follow-up|0|||
156662192|NCT02170688|565509887|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
156662193|NCT02170688|565509888|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
156662194|NCT02170688|565509889|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
156662195|NCT02170688|565509890|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
156662196|NCT02170688|565509891|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
156662197|NCT02170688|565509887|FG000|Overall Study|Full dose not received|0|||
156662198|NCT02170688|565509888|FG001|Overall Study|Full dose not received|1|||
156662199|NCT02170688|565509889|FG002|Overall Study|Full dose not received|0|||
156662200|NCT02170688|565509890|FG003|Overall Study|Full dose not received|0|||
156662201|NCT02170688|565509891|FG004|Overall Study|Full dose not received|0|||
156662202|NCT02170688|565509887|FG000|Overall Study|Physician Decision|0|||
156429324|NCT04936035|564663220|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429325|NCT04936035|564663221|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429326|NCT04936035|564663222|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429327|NCT04936035|564663223|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
156429328|NCT04936035|564663224|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
156429329|NCT04936035|564663225|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
156662203|NCT02170688|565509888|FG001|Overall Study|Physician Decision|0|||
156662204|NCT02170688|565509889|FG002|Overall Study|Physician Decision|1|||
156662205|NCT02170688|565509890|FG003|Overall Study|Physician Decision|0|||
156662206|NCT02170688|565509891|FG004|Overall Study|Physician Decision|0|||
156662207|NCT01402947|565509892|FG000|First Intervention|Adverse Event|0|||
156662208|NCT01402947|565509893|FG001|First Intervention|Adverse Event|1|||
156662209|NCT01471522|565509897|FG000|Overall Study|Withdrawal by Subject|28|||
156662210|NCT01471522|565509898|FG001|Overall Study|Withdrawal by Subject|22|||
156662211|NCT01471522|565509897|FG000|Overall Study|Lost to Follow-up|36|||
156662212|NCT01471522|565509898|FG001|Overall Study|Lost to Follow-up|26|||
156662213|NCT01432171|565509900|FG000|Overall Study|Death|1|||
156662214|NCT01432171|565509901|FG001|Overall Study|Death|2|||
156662215|NCT01432171|565509900|FG000|Overall Study|Lost to Follow-up|6|||
156662216|NCT01432171|565509901|FG001|Overall Study|Lost to Follow-up|5|||
156662217|NCT01432171|565509900|FG000|Overall Study|Withdrawal by Subject|3|||
156662218|NCT01432171|565509901|FG001|Overall Study|Withdrawal by Subject|1|||
156662219|NCT01432171|565509900|FG000|Overall Study|Noncompliance|2|||
156662220|NCT01432171|565509901|FG001|Overall Study|Noncompliance|3|||
156662221|NCT01432171|565509900|FG000|Overall Study|Insurance denial trial coverage|1|||
156662222|NCT01432171|565509901|FG001|Overall Study|Insurance denial trial coverage|0|||
156662223|NCT01432171|565509900|FG000|Overall Study|Patient moved to palliative care|1|||
156662224|NCT01432171|565509901|FG001|Overall Study|Patient moved to palliative care|0|||
156662225|NCT01706926|565509902|FG000|Overall Study|Lost to Follow-up|0|||
156662226|NCT01706926|565509903|FG001|Overall Study|Lost to Follow-up|0|||
156662227|NCT01706926|565509904|FG002|Overall Study|Lost to Follow-up|1|||
156662228|NCT01706926|565509905|FG003|Overall Study|Lost to Follow-up|0|||
156662229|NCT01706926|565509902|FG000|Overall Study|Withdrawal by Subject|2|||
156429330|NCT04936035|564663226|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
156662230|NCT01706926|565509903|FG001|Overall Study|Withdrawal by Subject|0|||
156662231|NCT01706926|565509904|FG002|Overall Study|Withdrawal by Subject|1|||
156662232|NCT01706926|565509905|FG003|Overall Study|Withdrawal by Subject|2|||
156662233|NCT01706926|565509902|FG000|Overall Study|Other|4|||
156662234|NCT01706926|565509903|FG001|Overall Study|Other|4|||
156662235|NCT01706926|565509904|FG002|Overall Study|Other|4|||
156662236|NCT01706926|565509905|FG003|Overall Study|Other|3|||
156662237|NCT00549718|565511184|FG000|Overall Study|Insufficient clinical response|20|||
156662238|NCT00549718|565511185|FG001|Overall Study|Insufficient clinical response|7|||
156662239|NCT00549718|565511186|FG002|Overall Study|Insufficient clinical response|18|||
156662240|NCT00549718|565511187|FG003|Overall Study|Insufficient clinical response|32|||
156662241|NCT00549718|565511184|FG000|Overall Study|Adverse Event|6|||
156662242|NCT00549718|565511185|FG001|Overall Study|Adverse Event|8|||
156662243|NCT00549718|565511186|FG002|Overall Study|Adverse Event|7|||
156662244|NCT00549718|565511187|FG003|Overall Study|Adverse Event|3|||
156662245|NCT00549718|565511184|FG000|Overall Study|Lost to Follow-up|4|||
156662246|NCT00549718|565511185|FG001|Overall Study|Lost to Follow-up|2|||
156662247|NCT00549718|565511186|FG002|Overall Study|Lost to Follow-up|0|||
156662248|NCT00549718|565511187|FG003|Overall Study|Lost to Follow-up|6|||
156662249|NCT00549718|565511184|FG000|Overall Study|Withdrawal by Subject|9|||
156662250|NCT00549718|565511185|FG001|Overall Study|Withdrawal by Subject|18|||
156662251|NCT00549718|565511186|FG002|Overall Study|Withdrawal by Subject|12|||
156662252|NCT00549718|565511187|FG003|Overall Study|Withdrawal by Subject|13|||
156662253|NCT00549718|565511184|FG000|Overall Study|Administrative|2|||
156662254|NCT00549718|565511185|FG001|Overall Study|Administrative|2|||
156662255|NCT00549718|565511186|FG002|Overall Study|Administrative|2|||
156662256|NCT00549718|565511187|FG003|Overall Study|Administrative|1|||
156662257|NCT00746798|565511188|FG000|Overall Study|Protocol Violation|0|||
156662258|NCT00746798|565511189|FG001|Overall Study|Protocol Violation|1|||
156662259|NCT00746798|565511190|FG002|Overall Study|Protocol Violation|0|||
156662260|NCT00746798|565511191|FG003|Overall Study|Protocol Violation|0|||
156662261|NCT00746798|565511188|FG000|Overall Study|Withdrawal by Subject|0|||
156662262|NCT00746798|565511189|FG001|Overall Study|Withdrawal by Subject|1|||
156662263|NCT00746798|565511190|FG002|Overall Study|Withdrawal by Subject|1|||
156662264|NCT00746798|565511191|FG003|Overall Study|Withdrawal by Subject|0|||
156662265|NCT00746798|565511188|FG000|Overall Study|Death|0|||
156662266|NCT00746798|565511189|FG001|Overall Study|Death|0|||
156662267|NCT00746798|565511190|FG002|Overall Study|Death|2|||
156662268|NCT00746798|565511191|FG003|Overall Study|Death|0|||
156662269|NCT00746798|565511188|FG000|Overall Study|Participant unable to return for visit|1|||
156662270|NCT00746798|565511189|FG001|Overall Study|Participant unable to return for visit|0|||
156429331|NCT04936035|564663214|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429332|NCT04936035|564663215|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429333|NCT04936035|564663216|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429334|NCT04936035|564663217|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429335|NCT04936035|564663218|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429336|NCT04936035|564663219|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
156429337|NCT04936035|564663220|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429338|NCT04936035|564663221|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
156429339|NCT04936035|564663222|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429340|NCT04936035|564663223|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429341|NCT04936035|564663224|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429342|NCT04936035|564663225|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429343|NCT04936035|564663226|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
156429344|NCT04936035|564663214|FG000|Post-6-Month DB Period (30months)|Death|0|||
156429345|NCT04936035|564663215|FG001|Post-6-Month DB Period (30months)|Death|0|||
156429346|NCT04936035|564663216|FG002|Post-6-Month DB Period (30months)|Death|0|||
156429347|NCT04936035|564663217|FG003|Post-6-Month DB Period (30months)|Death|0|||
156429348|NCT04936035|564663218|FG004|Post-6-Month DB Period (30months)|Death|0|||
156429349|NCT04936035|564663219|FG005|Post-6-Month DB Period (30months)|Death|0|||
156429350|NCT04936035|564663220|FG006|Post-6-Month DB Period (30months)|Death|0|||
156429351|NCT04936035|564663221|FG007|Post-6-Month DB Period (30months)|Death|0|||
156429352|NCT04936035|564663222|FG008|Post-6-Month DB Period (30months)|Death|0|||
156429353|NCT04936035|564663223|FG009|Post-6-Month DB Period (30months)|Death|1|||
156429354|NCT04936035|564663224|FG010|Post-6-Month DB Period (30months)|Death|0|||
156429355|NCT04936035|564663225|FG011|Post-6-Month DB Period (30months)|Death|0|||
156429356|NCT04936035|564663226|FG012|Post-6-Month DB Period (30months)|Death|0|||
156429357|NCT04936035|564663214|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156429358|NCT04936035|564663215|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156429359|NCT04936035|564663216|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156429360|NCT04936035|564663217|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156429361|NCT04936035|564663218|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156429362|NCT04936035|564663219|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
156429363|NCT04936035|564663220|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156429364|NCT04936035|564663221|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156662271|NCT00746798|565511190|FG002|Overall Study|Participant unable to return for visit|0|||
156662272|NCT00746798|565511191|FG003|Overall Study|Participant unable to return for visit|0|||
156662273|NCT00633594|565511194|FG000|Overall Study|Adverse Event|0|||
156662274|NCT00633594|565511195|FG001|Overall Study|Adverse Event|4|||
156662275|NCT00633594|565511196|FG002|Overall Study|Adverse Event|7|||
156662276|NCT00633594|565511194|FG000|Overall Study|Death|0|||
156662277|NCT00633594|565511195|FG001|Overall Study|Death|1|||
156662278|NCT00633594|565511196|FG002|Overall Study|Death|2|||
156429365|NCT04936035|564663222|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156429366|NCT04936035|564663223|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
156429367|NCT04936035|564663224|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
156429368|NCT04936035|564663225|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156662279|NCT00633594|565511194|FG000|Overall Study|Disease Progression|0|||
156662280|NCT00633594|565511195|FG001|Overall Study|Disease Progression|0|||
156662281|NCT00633594|565511196|FG002|Overall Study|Disease Progression|1|||
156662282|NCT02028715|565511197|FG000|Overall Study|Adverse Event|2|||
156662283|NCT02028715|565511198|FG001|Overall Study|Adverse Event|2|||
156662284|NCT02028715|565511197|FG000|Overall Study|Physician Decision|1|||
156662285|NCT02028715|565511198|FG001|Overall Study|Physician Decision|0|||
156662286|NCT02028715|565511197|FG000|Overall Study|Did not complete satisfaction surveys|2|||
156662287|NCT02028715|565511198|FG001|Overall Study|Did not complete satisfaction surveys|2|||
156662288|NCT01315249|565511199|FG000|Overall Study|Adverse Event|22|||
156662289|NCT01315249|565511200|FG001|Overall Study|Adverse Event|26|||
156662290|NCT01315249|565511199|FG000|Overall Study|Withdrawal by Subject|11|||
156662291|NCT01315249|565511200|FG001|Overall Study|Withdrawal by Subject|10|||
156662292|NCT01315249|565511199|FG000|Overall Study|Protocol Violation|8|||
156662293|NCT01315249|565511200|FG001|Overall Study|Protocol Violation|5|||
156662294|NCT01315249|565511199|FG000|Overall Study|Abnormal test results|1|||
156662295|NCT01315249|565511200|FG001|Overall Study|Abnormal test results|2|||
156662296|NCT01315249|565511199|FG000|Overall Study|Administrative problems|1|||
156662297|NCT01315249|565511200|FG001|Overall Study|Administrative problems|0|||
156662298|NCT01315249|565511199|FG000|Overall Study|inability to use device|1|||
156662299|NCT01315249|565511200|FG001|Overall Study|inability to use device|0|||
156662300|NCT01315249|565511199|FG000|Overall Study|Lack of Efficacy|0|||
156662301|NCT01315249|565511200|FG001|Overall Study|Lack of Efficacy|1|||
156662302|NCT01315249|565511199|FG000|Overall Study|Lost to Follow-up|0|||
156662303|NCT01315249|565511200|FG001|Overall Study|Lost to Follow-up|2|||
156662304|NCT01315249|565511199|FG000|Overall Study|Death|0|||
156662305|NCT01315249|565511200|FG001|Overall Study|Death|1|||
156662306|NCT01287013|565511201|FG000|Overall Study|Non-evaluable|3|||
156662307|NCT01287013|565511202|FG001|Overall Study|Non-evaluable|5|||
156662308|NCT01287013|565511203|FG002|Overall Study|Non-evaluable|21|||
156662309|NCT03247556|565511204|FG000|Overall Study|Adverse Event|1|||
156662310|NCT03247556|565511205|FG001|Overall Study|Adverse Event|4|||
156775751|NCT03329001|565931301|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775752|NCT03329001|565931302|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156662311|NCT03247556|565511206|FG002|Overall Study|Adverse Event|5|||
156662312|NCT03247556|565511204|FG000|Overall Study|Lost to Follow-up|5|||
156662313|NCT03247556|565511205|FG001|Overall Study|Lost to Follow-up|5|||
156662314|NCT03247556|565511206|FG002|Overall Study|Lost to Follow-up|4|||
156662315|NCT03247556|565511204|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
156662316|NCT03247556|565511205|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
156662317|NCT03247556|565511206|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
156662318|NCT03247556|565511204|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
156662319|NCT03247556|565511205|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
156662320|NCT03247556|565511206|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
156662321|NCT03247556|565511204|FG000|Overall Study|Protocol Violation|2|||
156662322|NCT03247556|565511205|FG001|Overall Study|Protocol Violation|0|||
156662323|NCT03247556|565511206|FG002|Overall Study|Protocol Violation|1|||
156662324|NCT03247556|565511204|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
156662325|NCT03247556|565511205|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
156662326|NCT03247556|565511206|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
156662327|NCT02109042|565511208|FG000|Overall Study|Sponsor Decision|15|||
156662328|NCT02189941|565511209|FG000|Overall Study|Non-compliance|0|||
156662329|NCT02189941|565511210|FG001|Overall Study|Non-compliance|0|||
156662330|NCT02189941|565511211|FG002|Overall Study|Non-compliance|1|||
156662331|NCT03478397|565511217|FG000|Overall Study|Refused to participate|31|||
156662332|NCT03478397|565511218|FG001|Overall Study|Refused to participate|7|||
156662333|NCT04206332|565511219|FG000|Part A|Lost to Follow-up|0|||
156662334|NCT04206332|565511220|FG001|Part A|Lost to Follow-up|1|||
156662335|NCT04206332|565511221|FG002|Part A|Lost to Follow-up|0|||
156662336|NCT04206332|565511222|FG003|Part A|Lost to Follow-up|0|||
156662337|NCT04206332|565511223|FG004|Part A|Lost to Follow-up|0|||
156662338|NCT04206332|565511224|FG005|Part A|Lost to Follow-up|0|||
156662339|NCT04206332|565511225|FG006|Part A|Lost to Follow-up|0|||
156662340|NCT04206332|565511226|FG007|Part A|Lost to Follow-up|0|||
156662341|NCT04206332|565511227|FG008|Part A|Lost to Follow-up|0|||
156662342|NCT04206332|565511228|FG009|Part A|Lost to Follow-up|0|||
156775753|NCT03329001|565931303|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775754|NCT03329001|565931304|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
156775755|NCT03329001|565931305|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
156775756|NCT03329001|565931298|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775757|NCT03329001|565931299|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156662343|NCT04206332|565511229|FG010|Part A|Lost to Follow-up|0|||
156662344|NCT04206332|565511230|FG011|Part A|Lost to Follow-up|0|||
156662345|NCT04206332|565511231|FG012|Part A|Lost to Follow-up|0|||
156662346|NCT04206332|565511232|FG013|Part A|Lost to Follow-up|0|||
156662347|NCT04206332|565511233|FG014|Part A|Lost to Follow-up|0|||
156775758|NCT03329001|565931300|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775759|NCT03329001|565931301|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775760|NCT03329001|565931302|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775761|NCT03329001|565931303|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775762|NCT03329001|565931304|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
156662348|NCT04206332|565511234|FG015|Part A|Lost to Follow-up|0|||
156662349|NCT04206332|565511235|FG016|Part A|Lost to Follow-up|0|||
156662350|NCT04206332|565511219|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662351|NCT04206332|565511220|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662352|NCT04206332|565511221|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662353|NCT04206332|565511222|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662354|NCT04206332|565511223|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662355|NCT04206332|565511224|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
156662356|NCT04206332|565511225|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662357|NCT04206332|565511226|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662358|NCT04206332|565511227|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662359|NCT04206332|565511228|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662360|NCT04206332|565511229|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662361|NCT04206332|565511230|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662362|NCT04206332|565511231|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662363|NCT04206332|565511232|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662364|NCT04206332|565511233|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662365|NCT04206332|565511234|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662366|NCT04206332|565511235|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
156662367|NCT04206332|565511219|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662368|NCT04206332|565511220|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662369|NCT04206332|565511221|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662370|NCT04206332|565511222|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662371|NCT04206332|565511223|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662372|NCT04206332|565511224|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662373|NCT04206332|565511225|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662374|NCT04206332|565511226|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
156662375|NCT04206332|565511227|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662376|NCT04206332|565511228|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662377|NCT04206332|565511229|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
156662378|NCT04206332|565511230|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662379|NCT04206332|565511231|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662380|NCT04206332|565511232|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662381|NCT04206332|565511233|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662382|NCT04206332|565511234|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662383|NCT04206332|565511235|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662384|NCT04206332|565511219|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662385|NCT04206332|565511220|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662386|NCT04206332|565511221|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662387|NCT04206332|565511222|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662388|NCT04206332|565511223|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662389|NCT04206332|565511224|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662390|NCT04206332|565511225|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662391|NCT04206332|565511226|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662392|NCT04206332|565511227|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662393|NCT04206332|565511228|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662394|NCT04206332|565511229|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662395|NCT04206332|565511230|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662396|NCT04206332|565511231|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156775763|NCT03329001|565931305|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
156775764|NCT00963235|565931311|FG000|Overall Study|Withdrawal by Subject|22|||
156775765|NCT00963235|565931311|FG000|Overall Study|Lost to Follow-up|14|||
156775766|NCT00963235|565931311|FG000|Overall Study|Failed to return|9|||
156324806|NCT03370289|564289405|FG000|Overall Study|Sample Size Sufficient|4|||
156324807|NCT00873860|564289407|FG000|Overall Study|Lost to Follow-up|1|||
156324808|NCT00873860|564289408|FG001|Overall Study|Lost to Follow-up|0|||
156324809|NCT00873860|564289409|FG002|Overall Study|Lost to Follow-up|0|||
156324810|NCT00873860|564289410|FG003|Overall Study|Lost to Follow-up|1|||
156324811|NCT00873860|564289407|FG000|Overall Study|Withdrawal by Subject|1|||
156324812|NCT00873860|564289408|FG001|Overall Study|Withdrawal by Subject|0|||
156662397|NCT04206332|565511232|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662398|NCT04206332|565511233|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662399|NCT04206332|565511234|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
156662400|NCT04206332|565511235|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
156662401|NCT04206332|565511219|FG000|Part C|Withdrawal by Subject|0|||
156662402|NCT04206332|565511220|FG001|Part C|Withdrawal by Subject|0|||
156662403|NCT04206332|565511221|FG002|Part C|Withdrawal by Subject|0|||
156662404|NCT04206332|565511222|FG003|Part C|Withdrawal by Subject|0|||
156662405|NCT04206332|565511223|FG004|Part C|Withdrawal by Subject|0|||
156662406|NCT04206332|565511224|FG005|Part C|Withdrawal by Subject|0|||
156662407|NCT04206332|565511225|FG006|Part C|Withdrawal by Subject|0|||
156662408|NCT04206332|565511226|FG007|Part C|Withdrawal by Subject|0|||
156662409|NCT04206332|565511227|FG008|Part C|Withdrawal by Subject|0|||
156662410|NCT04206332|565511228|FG009|Part C|Withdrawal by Subject|0|||
156662411|NCT04206332|565511229|FG010|Part C|Withdrawal by Subject|0|||
156662412|NCT04206332|565511230|FG011|Part C|Withdrawal by Subject|0|||
156662413|NCT04206332|565511231|FG012|Part C|Withdrawal by Subject|0|||
156662414|NCT04206332|565511232|FG013|Part C|Withdrawal by Subject|0|||
156662415|NCT04206332|565511233|FG014|Part C|Withdrawal by Subject|2|||
156662416|NCT04206332|565511234|FG015|Part C|Withdrawal by Subject|0|||
156662417|NCT04206332|565511235|FG016|Part C|Withdrawal by Subject|0|||
156662418|NCT03988803|565511236|FG000|Period 2|Prematurely discontinued from medication|2|||
156662419|NCT03988803|565511236|FG000|Period 2|Adverse Event|1|||
156662420|NCT01617668|565511237|FG000|Overall Study|Adverse Event|7|||
156662421|NCT01617668|565511238|FG001|Overall Study|Adverse Event|0|||
156662422|NCT01617668|565511239|FG002|Overall Study|Adverse Event|12|||
156775767|NCT00963235|565931311|FG000|Overall Study|Protocol Violation|7|||
156775768|NCT00963235|565931311|FG000|Overall Study|Adverse Event|5|||
156775769|NCT00963235|565931311|FG000|Overall Study|Physician Decision|2|||
156775770|NCT00963235|565931311|FG000|Overall Study|Other|1|||
156775771|NCT01136915|565931313|FG000|Overall Study|Lost to Follow-up|2|||
156775772|NCT01136915|565931314|FG001|Overall Study|Lost to Follow-up|0|||
156775773|NCT01136915|565931313|FG000|Overall Study|Exclusion criterion met|0|||
156775774|NCT01136915|565931314|FG001|Overall Study|Exclusion criterion met|1|||
156775775|NCT03965923|565931319|FG000|Overall Study|Withdrawal by Subject|1|||
156775776|NCT03965923|565931320|FG001|Overall Study|Withdrawal by Subject|2|||
156775777|NCT03965923|565931321|FG002|Overall Study|Withdrawal by Subject|3|||
156775778|NCT03965923|565931322|FG003|Overall Study|Withdrawal by Subject|1|||
156775779|NCT03965923|565931323|FG004|Overall Study|Withdrawal by Subject|2|||
156775780|NCT03965923|565931324|FG005|Overall Study|Withdrawal by Subject|0|||
156775781|NCT03965923|565931325|FG006|Overall Study|Withdrawal by Subject|4|||
156775782|NCT03965923|565931326|FG007|Overall Study|Withdrawal by Subject|3|||
156775783|NCT03965923|565931327|FG008|Overall Study|Withdrawal by Subject|4|||
156775784|NCT03965923|565931328|FG009|Overall Study|Withdrawal by Subject|0|||
156775785|NCT03965923|565931329|FG010|Overall Study|Withdrawal by Subject|2|||
156775786|NCT03965923|565931330|FG011|Overall Study|Withdrawal by Subject|0|||
156775787|NCT03965923|565931319|FG000|Overall Study|Lost to Follow-up|2|||
156775788|NCT03965923|565931320|FG001|Overall Study|Lost to Follow-up|1|||
156775789|NCT03965923|565931321|FG002|Overall Study|Lost to Follow-up|1|||
156775790|NCT03965923|565931322|FG003|Overall Study|Lost to Follow-up|0|||
156775791|NCT03965923|565931323|FG004|Overall Study|Lost to Follow-up|2|||
156775792|NCT03965923|565931324|FG005|Overall Study|Lost to Follow-up|1|||
156775793|NCT03965923|565931325|FG006|Overall Study|Lost to Follow-up|2|||
156775794|NCT03965923|565931326|FG007|Overall Study|Lost to Follow-up|1|||
156775795|NCT03965923|565931327|FG008|Overall Study|Lost to Follow-up|0|||
156775796|NCT03965923|565931328|FG009|Overall Study|Lost to Follow-up|2|||
156775797|NCT03965923|565931329|FG010|Overall Study|Lost to Follow-up|0|||
156775798|NCT03965923|565931330|FG011|Overall Study|Lost to Follow-up|0|||
156775799|NCT03965923|565931319|FG000|Overall Study|Death|0|||
156775800|NCT03965923|565931320|FG001|Overall Study|Death|0|||
156775801|NCT03965923|565931321|FG002|Overall Study|Death|0|||
156775802|NCT03965923|565931322|FG003|Overall Study|Death|0|||
156775803|NCT03965923|565931323|FG004|Overall Study|Death|0|||
156775804|NCT03965923|565931324|FG005|Overall Study|Death|0|||
156775805|NCT03965923|565931325|FG006|Overall Study|Death|0|||
156775806|NCT03965923|565931326|FG007|Overall Study|Death|1|||
156775807|NCT03965923|565931327|FG008|Overall Study|Death|4|||
156775808|NCT03965923|565931328|FG009|Overall Study|Death|0|||
156324813|NCT00873860|564289409|FG002|Overall Study|Withdrawal by Subject|2|||
156324814|NCT00873860|564289410|FG003|Overall Study|Withdrawal by Subject|0|||
156324815|NCT00873860|564289407|FG000|Overall Study|Death|1|||
156662423|NCT01617668|565511240|FG003|Overall Study|Adverse Event|5|||
156662424|NCT01617668|565511237|FG000|Overall Study|Physician Decision|1|||
156662425|NCT01617668|565511238|FG001|Overall Study|Physician Decision|2|||
156662426|NCT01617668|565511239|FG002|Overall Study|Physician Decision|3|||
156662427|NCT01617668|565511240|FG003|Overall Study|Physician Decision|0|||
156662428|NCT01617668|565511237|FG000|Overall Study|Progressive Disease|4|||
156775809|NCT03965923|565931329|FG010|Overall Study|Death|4|||
156662429|NCT01617668|565511238|FG001|Overall Study|Progressive Disease|4|||
156662430|NCT01617668|565511239|FG002|Overall Study|Progressive Disease|6|||
156662431|NCT01617668|565511240|FG003|Overall Study|Progressive Disease|9|||
156662432|NCT01617668|565511237|FG000|Overall Study|Subject/guardian decision|1|||
156662433|NCT01617668|565511238|FG001|Overall Study|Subject/guardian decision|3|||
156662434|NCT01617668|565511239|FG002|Overall Study|Subject/guardian decision|2|||
156662435|NCT01617668|565511240|FG003|Overall Study|Subject/guardian decision|1|||
156662436|NCT02017964|565511241|FG000|Overall Study|Patient deemed ineligible|1|||
156662437|NCT00925769|565511242|FG000|Overall Study|Major toxicity|1|||
156662438|NCT00925769|565511243|FG001|Overall Study|Major toxicity|0|||
156662439|NCT00925769|565511244|FG002|Overall Study|Major toxicity|1|||
156662440|NCT00925769|565511245|FG003|Overall Study|Major toxicity|1|||
156662441|NCT00925769|565511246|FG004|Overall Study|Major toxicity|0|||
156662442|NCT00925769|565511247|FG005|Overall Study|Major toxicity|0|||
156662443|NCT00925769|565511242|FG000|Overall Study|Disease progression|4|||
156662444|NCT00925769|565511243|FG001|Overall Study|Disease progression|5|||
156662445|NCT00925769|565511244|FG002|Overall Study|Disease progression|3|||
156662446|NCT00925769|565511245|FG003|Overall Study|Disease progression|4|||
156662447|NCT00925769|565511246|FG004|Overall Study|Disease progression|2|||
156662448|NCT00925769|565511247|FG005|Overall Study|Disease progression|3|||
156662449|NCT00925769|565511242|FG000|Overall Study|Death|0|||
156662450|NCT00925769|565511243|FG001|Overall Study|Death|0|||
156662451|NCT00925769|565511244|FG002|Overall Study|Death|1|||
156662452|NCT00925769|565511245|FG003|Overall Study|Death|0|||
156662453|NCT00925769|565511246|FG004|Overall Study|Death|0|||
156662454|NCT00925769|565511247|FG005|Overall Study|Death|0|||
156662455|NCT00925769|565511242|FG000|Overall Study|Physician Decision|1|||
156662456|NCT00925769|565511243|FG001|Overall Study|Physician Decision|0|||
156662457|NCT00925769|565511244|FG002|Overall Study|Physician Decision|0|||
156662458|NCT00925769|565511245|FG003|Overall Study|Physician Decision|0|||
156662459|NCT00925769|565511246|FG004|Overall Study|Physician Decision|0|||
156662460|NCT00925769|565511247|FG005|Overall Study|Physician Decision|0|||
156662461|NCT00925769|565511242|FG000|Overall Study|Missing documentation|0|||
156662462|NCT00925769|565511243|FG001|Overall Study|Missing documentation|1|||
156662463|NCT00925769|565511244|FG002|Overall Study|Missing documentation|0|||
156662464|NCT00925769|565511245|FG003|Overall Study|Missing documentation|0|||
156662465|NCT00925769|565511246|FG004|Overall Study|Missing documentation|0|||
156662466|NCT00925769|565511247|FG005|Overall Study|Missing documentation|0|||
156662467|NCT00925769|565511242|FG000|Overall Study|End of study visit not done|0|||
156662468|NCT00925769|565511243|FG001|Overall Study|End of study visit not done|0|||
156662469|NCT00925769|565511244|FG002|Overall Study|End of study visit not done|1|||
156662470|NCT00925769|565511245|FG003|Overall Study|End of study visit not done|0|||
156662471|NCT00925769|565511246|FG004|Overall Study|End of study visit not done|0|||
156662472|NCT00925769|565511247|FG005|Overall Study|End of study visit not done|0|||
156662473|NCT00925769|565511242|FG000|Overall Study|Participant is unable to swallow drug|0|||
156662474|NCT00925769|565511243|FG001|Overall Study|Participant is unable to swallow drug|0|||
156662475|NCT00925769|565511244|FG002|Overall Study|Participant is unable to swallow drug|0|||
156662476|NCT00925769|565511245|FG003|Overall Study|Participant is unable to swallow drug|1|||
156662477|NCT00925769|565511246|FG004|Overall Study|Participant is unable to swallow drug|0|||
156662478|NCT00925769|565511247|FG005|Overall Study|Participant is unable to swallow drug|0|||
156662479|NCT00925769|565511242|FG000|Overall Study|Adverse Event|0|||
156662480|NCT00925769|565511243|FG001|Overall Study|Adverse Event|0|||
156662481|NCT00925769|565511244|FG002|Overall Study|Adverse Event|0|||
156662482|NCT00925769|565511245|FG003|Overall Study|Adverse Event|0|||
156662483|NCT00925769|565511246|FG004|Overall Study|Adverse Event|1|||
156662484|NCT00925769|565511247|FG005|Overall Study|Adverse Event|0|||
156662485|NCT01434693|565511252|FG000|Overall Study|Adverse Event|1|||
156662486|NCT01434693|565511253|FG001|Overall Study|Adverse Event|0|||
156662487|NCT01434693|565511254|FG002|Overall Study|Adverse Event|0|||
156662488|NCT01434693|565511255|FG003|Overall Study|Adverse Event|0|||
156662489|NCT01434693|565511252|FG000|Overall Study|Withdrawal by Subject|1|||
156662490|NCT01434693|565511253|FG001|Overall Study|Withdrawal by Subject|0|||
156662491|NCT01434693|565511254|FG002|Overall Study|Withdrawal by Subject|1|||
156662492|NCT01434693|565511255|FG003|Overall Study|Withdrawal by Subject|1|||
156662493|NCT01434693|565511252|FG000|Overall Study|Lost to Follow-up|1|||
156662494|NCT01434693|565511253|FG001|Overall Study|Lost to Follow-up|0|||
156662495|NCT01434693|565511254|FG002|Overall Study|Lost to Follow-up|0|||
156662496|NCT01434693|565511255|FG003|Overall Study|Lost to Follow-up|0|||
156662497|NCT00912288|565511256|FG000|Overall Study|Death|0|||
156662498|NCT00912288|565511257|FG001|Overall Study|Death|1|||
156662499|NCT00912288|565511256|FG000|Overall Study|Adverse Event|1|||
156662500|NCT00912288|565511257|FG001|Overall Study|Adverse Event|1|||
156662501|NCT00912288|565511256|FG000|Overall Study|Lost to Follow-up|1|||
156662502|NCT00912288|565511257|FG001|Overall Study|Lost to Follow-up|0|||
156662503|NCT00912288|565511256|FG000|Overall Study|Protocol Violation|1|||
156662504|NCT00912288|565511257|FG001|Overall Study|Protocol Violation|0|||
156662505|NCT00912288|565511256|FG000|Overall Study|Withdrawal by Subject|3|||
156662506|NCT00912288|565511257|FG001|Overall Study|Withdrawal by Subject|3|||
156775810|NCT03965923|565931330|FG011|Overall Study|Death|0|||
156662507|NCT00912288|565511256|FG000|Overall Study|Study terminated by sponsor|34|||
156662508|NCT00912288|565511257|FG001|Overall Study|Study terminated by sponsor|35|||
156662509|NCT00912288|565511256|FG000|Overall Study|Other|1|||
156662510|NCT00912288|565511257|FG001|Overall Study|Other|0|||
156662511|NCT02087904|565511259|FG000|Overall Study|Did Not Receive Study Drug|0|||
156662512|NCT02087904|565511260|FG001|Overall Study|Did Not Receive Study Drug|0|||
156662513|NCT02087904|565511261|FG002|Overall Study|Did Not Receive Study Drug|2|||
156662514|NCT02087904|565511262|FG003|Overall Study|Did Not Receive Study Drug|1|||
156662515|NCT02087904|565511259|FG000|Overall Study|Adverse Event|8|||
156662516|NCT02087904|565511260|FG001|Overall Study|Adverse Event|4|||
156662517|NCT02087904|565511261|FG002|Overall Study|Adverse Event|4|||
156662518|NCT02087904|565511262|FG003|Overall Study|Adverse Event|12|||
156662519|NCT02087904|565511259|FG000|Overall Study|Lack of Efficacy|3|||
156662520|NCT02087904|565511260|FG001|Overall Study|Lack of Efficacy|6|||
156662521|NCT02087904|565511261|FG002|Overall Study|Lack of Efficacy|3|||
156662522|NCT02087904|565511262|FG003|Overall Study|Lack of Efficacy|2|||
156662523|NCT02087904|565511259|FG000|Overall Study|Other|6|||
156662524|NCT02087904|565511260|FG001|Overall Study|Other|2|||
156662525|NCT02087904|565511261|FG002|Overall Study|Other|4|||
156662526|NCT02087904|565511262|FG003|Overall Study|Other|4|||
156662527|NCT02087904|565511259|FG000|Overall Study|Withdrawal by Subject|8|||
156662528|NCT02087904|565511260|FG001|Overall Study|Withdrawal by Subject|3|||
156662529|NCT02087904|565511261|FG002|Overall Study|Withdrawal by Subject|7|||
156662530|NCT02087904|565511262|FG003|Overall Study|Withdrawal by Subject|4|||
156662531|NCT02087904|565511259|FG000|Overall Study|Lost to Follow-up|0|||
156662532|NCT02087904|565511260|FG001|Overall Study|Lost to Follow-up|4|||
156662533|NCT02087904|565511261|FG002|Overall Study|Lost to Follow-up|2|||
156662534|NCT02087904|565511262|FG003|Overall Study|Lost to Follow-up|2|||
156662535|NCT01735630|565511263|FG000|Overall Study|Adverse Event|8|||
156775811|NCT03965923|565931319|FG000|Overall Study|Other reason|0|||
156775812|NCT03965923|565931320|FG001|Overall Study|Other reason|0|||
156775813|NCT03965923|565931321|FG002|Overall Study|Other reason|0|||
156775814|NCT03965923|565931322|FG003|Overall Study|Other reason|1|||
156662536|NCT01735630|565511264|FG001|Overall Study|Adverse Event|7|||
156662537|NCT01735630|565511263|FG000|Overall Study|Lost to Follow-up|1|||
156662538|NCT01735630|565511264|FG001|Overall Study|Lost to Follow-up|0|||
156775815|NCT03965923|565931323|FG004|Overall Study|Other reason|0|||
156775816|NCT03965923|565931324|FG005|Overall Study|Other reason|0|||
156775817|NCT03965923|565931325|FG006|Overall Study|Other reason|0|||
156775818|NCT03965923|565931326|FG007|Overall Study|Other reason|0|||
156775819|NCT03965923|565931327|FG008|Overall Study|Other reason|0|||
156775820|NCT03965923|565931328|FG009|Overall Study|Other reason|0|||
156775821|NCT03965923|565931329|FG010|Overall Study|Other reason|2|||
156775822|NCT03965923|565931330|FG011|Overall Study|Other reason|0|||
156775823|NCT02452190|565931331|FG000|Overall Study|Withdrawal by Sponsor|1|||
156775824|NCT02452190|565931332|FG001|Overall Study|Withdrawal by Sponsor|3|||
156775825|NCT02452190|565931331|FG000|Overall Study|Pregnancy|1|||
156775826|NCT02452190|565931332|FG001|Overall Study|Pregnancy|0|||
156775827|NCT02452190|565931331|FG000|Overall Study|Investigator's Decision|2|||
156775828|NCT02452190|565931332|FG001|Overall Study|Investigator's Decision|0|||
156775829|NCT02452190|565931331|FG000|Overall Study|Lack of Efficacy|3|||
156775830|NCT02452190|565931332|FG001|Overall Study|Lack of Efficacy|1|||
156775831|NCT02452190|565931331|FG000|Overall Study|Lost to Follow-up|4|||
156775832|NCT02452190|565931332|FG001|Overall Study|Lost to Follow-up|3|||
156775833|NCT02452190|565931331|FG000|Overall Study|Adverse Event|2|||
156775834|NCT02452190|565931332|FG001|Overall Study|Adverse Event|5|||
156775835|NCT02452190|565931331|FG000|Overall Study|Withdrawal by Subject|20|||
156775836|NCT02452190|565931332|FG001|Overall Study|Withdrawal by Subject|11|||
156775837|NCT02452190|565931331|FG000|Overall Study|Noncompliance with study drug|1|||
156324816|NCT00873860|564289408|FG001|Overall Study|Death|0|||
156324817|NCT00873860|564289409|FG002|Overall Study|Death|0|||
156662539|NCT01735630|565511263|FG000|Overall Study|Physician Decision|0|||
156662540|NCT01735630|565511264|FG001|Overall Study|Physician Decision|1|||
156324818|NCT00873860|564289410|FG003|Overall Study|Death|0|||
156662541|NCT01735630|565511263|FG000|Overall Study|Sponsor Decision|2|||
156662542|NCT01735630|565511264|FG001|Overall Study|Sponsor Decision|1|||
156775838|NCT02452190|565931332|FG001|Overall Study|Noncompliance with study drug|0|||
156775839|NCT02452190|565931331|FG000|Overall Study|Participant traveled abroad|1|||
156775840|NCT02452190|565931332|FG001|Overall Study|Participant traveled abroad|0|||
156775841|NCT02452190|565931331|FG000|Overall Study|Death|0|||
156775842|NCT02452190|565931332|FG001|Overall Study|Death|1|||
156775843|NCT02327078|565931337|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
156775844|NCT02327078|565931338|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
156775845|NCT02327078|565931339|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
156324819|NCT00873860|564289407|FG000|Overall Study|Other|1|||
156662543|NCT01735630|565511263|FG000|Overall Study|Withdrawal by Subject|7|||
156662544|NCT01735630|565511264|FG001|Overall Study|Withdrawal by Subject|9|||
156662545|NCT00877032|565511270|FG000|Overall Study|Did not meet entrance criteria|0|||
156662546|NCT00877032|565511271|FG001|Overall Study|Did not meet entrance criteria|0|||
156775846|NCT02327078|565931340|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
156775847|NCT02327078|565931341|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
156775848|NCT02327078|565931342|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
156775849|NCT02327078|565931343|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
156775850|NCT02327078|565931344|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
156775851|NCT02327078|565931345|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
156775852|NCT02327078|565931337|FG000|Overall Study|Death|2|||
156775853|NCT02327078|565931338|FG001|Overall Study|Death|4|||
156775854|NCT02327078|565931339|FG002|Overall Study|Death|10|||
156775855|NCT02327078|565931340|FG003|Overall Study|Death|6|||
156775856|NCT02327078|565931341|FG004|Overall Study|Death|4|||
156775857|NCT02327078|565931342|FG005|Overall Study|Death|3|||
156775858|NCT02327078|565931343|FG006|Overall Study|Death|2|||
156775859|NCT02327078|565931344|FG007|Overall Study|Death|51|||
156775860|NCT02327078|565931345|FG008|Overall Study|Death|97|||
156775861|NCT02327078|565931337|FG000|Overall Study|Lost to Follow-up|0|||
156775862|NCT02327078|565931338|FG001|Overall Study|Lost to Follow-up|1|||
156775863|NCT02327078|565931339|FG002|Overall Study|Lost to Follow-up|1|||
156775864|NCT02327078|565931340|FG003|Overall Study|Lost to Follow-up|0|||
156775865|NCT02327078|565931341|FG004|Overall Study|Lost to Follow-up|0|||
156775866|NCT02327078|565931342|FG005|Overall Study|Lost to Follow-up|0|||
156775867|NCT02327078|565931343|FG006|Overall Study|Lost to Follow-up|0|||
156775868|NCT02327078|565931344|FG007|Overall Study|Lost to Follow-up|2|||
156775869|NCT02327078|565931345|FG008|Overall Study|Lost to Follow-up|5|||
156775870|NCT02327078|565931337|FG000|Overall Study|Site Terminated by Sponsor|1|||
156775871|NCT02327078|565931338|FG001|Overall Study|Site Terminated by Sponsor|0|||
156775872|NCT02327078|565931339|FG002|Overall Study|Site Terminated by Sponsor|1|||
156775873|NCT02327078|565931340|FG003|Overall Study|Site Terminated by Sponsor|4|||
156775874|NCT02327078|565931341|FG004|Overall Study|Site Terminated by Sponsor|0|||
156775875|NCT02327078|565931342|FG005|Overall Study|Site Terminated by Sponsor|0|||
156775876|NCT02327078|565931343|FG006|Overall Study|Site Terminated by Sponsor|0|||
156775877|NCT02327078|565931344|FG007|Overall Study|Site Terminated by Sponsor|11|||
156775878|NCT02327078|565931345|FG008|Overall Study|Site Terminated by Sponsor|25|||
156775879|NCT02327078|565931337|FG000|Overall Study|Physician Decision|0|||
156775880|NCT02327078|565931338|FG001|Overall Study|Physician Decision|0|||
156775881|NCT02327078|565931339|FG002|Overall Study|Physician Decision|0|||
156775882|NCT02327078|565931340|FG003|Overall Study|Physician Decision|1|||
156775883|NCT02327078|565931341|FG004|Overall Study|Physician Decision|0|||
156775884|NCT02327078|565931342|FG005|Overall Study|Physician Decision|0|||
156775885|NCT02327078|565931343|FG006|Overall Study|Physician Decision|0|||
156775886|NCT02327078|565931344|FG007|Overall Study|Physician Decision|0|||
156775887|NCT02327078|565931345|FG008|Overall Study|Physician Decision|1|||
156775888|NCT02327078|565931337|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
156775889|NCT02327078|565931338|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
156775890|NCT02327078|565931339|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
156775891|NCT02327078|565931340|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
156775892|NCT02327078|565931341|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
156775893|NCT02327078|565931342|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
156775894|NCT02327078|565931343|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
156775895|NCT02327078|565931344|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
156775896|NCT02327078|565931345|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
156775897|NCT02327078|565931337|FG000|Overall Study|Reason not Specified|0|||
156775898|NCT02327078|565931338|FG001|Overall Study|Reason not Specified|0|||
156775899|NCT02327078|565931339|FG002|Overall Study|Reason not Specified|0|||
156775900|NCT02327078|565931340|FG003|Overall Study|Reason not Specified|0|||
156775901|NCT02327078|565931341|FG004|Overall Study|Reason not Specified|0|||
156775902|NCT02327078|565931342|FG005|Overall Study|Reason not Specified|0|||
156775903|NCT02327078|565931343|FG006|Overall Study|Reason not Specified|0|||
156775904|NCT02327078|565931344|FG007|Overall Study|Reason not Specified|5|||
156775905|NCT02327078|565931345|FG008|Overall Study|Reason not Specified|12|||
156775906|NCT06001866|565931350|FG000|Overall Study|Withdrawal by Subject|0|||
156775907|NCT06001866|565931351|FG001|Overall Study|Withdrawal by Subject|2|||
156775908|NCT06001866|565931350|FG000|Overall Study|Protocol Violation|0|||
156775909|NCT06001866|565931351|FG001|Overall Study|Protocol Violation|2|||
156775910|NCT03112603|565931354|FG000|End of Randomization Period|Lost to Follow-up|3|||
156775911|NCT03112603|565931355|FG001|End of Randomization Period|Lost to Follow-up|0|||
156775912|NCT03112603|565931356|FG002|End of Randomization Period|Lost to Follow-up|0|||
156775913|NCT03112603|565931354|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
156775914|NCT03112603|565931355|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
156775915|NCT03112603|565931356|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
156775916|NCT03112603|565931354|FG000|End of Randomization Period|Physician Decision|43|||
156775917|NCT03112603|565931355|FG001|End of Randomization Period|Physician Decision|18|||
156775918|NCT03112603|565931356|FG002|End of Randomization Period|Physician Decision|0|||
156662547|NCT00877032|565511272|FG002|Overall Study|Did not meet entrance criteria|0|||
156662548|NCT00877032|565511273|FG003|Overall Study|Did not meet entrance criteria|1|||
156662549|NCT00877032|565511274|FG004|Overall Study|Did not meet entrance criteria|0|||
156662550|NCT00877032|565511275|FG005|Overall Study|Did not meet entrance criteria|0|||
156662551|NCT00877032|565511276|FG006|Overall Study|Did not meet entrance criteria|2|||
156662552|NCT00813293|565511277|FG000|Overall Study|Intercurrent illness|1|||
156662553|NCT00813293|565511278|FG001|Overall Study|Intercurrent illness|0|||
156662554|NCT00813293|565511277|FG000|Overall Study|Adverse Event|0|||
156662555|NCT00813293|565511278|FG001|Overall Study|Adverse Event|1|||
156662556|NCT00533273|565511279|FG000|Double-blind|Withdrew consent|0|||
156662557|NCT00533273|565511280|FG001|Double-blind|Withdrew consent|2|||
156662558|NCT00533273|565511279|FG000|Open-label|Withdrawal by Subject|6|||
156662559|NCT00533273|565511280|FG001|Open-label|Withdrawal by Subject|0|||
156662560|NCT02794974|565511283|FG000|Overall Study|Physician Decision|0|||
156662561|NCT02794974|565511284|FG001|Overall Study|Physician Decision|1|||
156662562|NCT02202850|565511286|FG000|Overall Study|Other|2|||
156662563|NCT02202850|565511287|FG001|Overall Study|Other|2|||
156662564|NCT02202850|565511286|FG000|Overall Study|Enbrel treatment discontinued|15|||
156662565|NCT02202850|565511287|FG001|Overall Study|Enbrel treatment discontinued|3|||
156662566|NCT02202850|565511286|FG000|Overall Study|Lost to Follow-up|7|||
156662567|NCT02202850|565511287|FG001|Overall Study|Lost to Follow-up|1|||
156662568|NCT00615069|565511288|FG000|Overall Study|Death|10|||
156662569|NCT00615069|565511288|FG000|Overall Study|Physician Decision|2|||
156662570|NCT00615069|565511288|FG000|Overall Study|Withdrawal by Subject|4|||
156662571|NCT00669942|565511289|FG000|Parts 2 and 3|Adverse Event|0|||
156662572|NCT00669942|565511290|FG001|Parts 2 and 3|Adverse Event|0|||
156662573|NCT00669942|565511291|FG002|Parts 2 and 3|Adverse Event|0|||
156662574|NCT00669942|565511292|FG003|Parts 2 and 3|Adverse Event|0|||
156662575|NCT00669942|565511293|FG004|Parts 2 and 3|Adverse Event|0|||
156662576|NCT00669942|565511294|FG005|Parts 2 and 3|Adverse Event|0|||
156662577|NCT00669942|565511295|FG006|Parts 2 and 3|Adverse Event|0|||
156775919|NCT03112603|565931354|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
156775920|NCT03112603|565931355|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
156775921|NCT03112603|565931356|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
156775922|NCT03112603|565931354|FG000|End of Randomization Period|Death|10|||
156775923|NCT03112603|565931355|FG001|End of Randomization Period|Death|7|||
156324820|NCT00873860|564289408|FG001|Overall Study|Other|0|||
156324821|NCT00873860|564289409|FG002|Overall Study|Other|1|||
156324822|NCT00873860|564289410|FG003|Overall Study|Other|0|||
156324823|NCT02862600|564289411|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
156324824|NCT02862600|564289411|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
156324825|NCT02862600|564289411|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
156324826|NCT02862600|564289411|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
156324827|NCT00194675|564289414|FG000|Overall Study|Lost to Follow-up|1|||
156324828|NCT00194675|564289415|FG001|Overall Study|Lost to Follow-up|1|||
156324829|NCT00194675|564289414|FG000|Overall Study|lack of interest|1|||
156324830|NCT00194675|564289415|FG001|Overall Study|lack of interest|1|||
156324831|NCT00194675|564289414|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
156324832|NCT00194675|564289415|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
156324833|NCT00194675|564289414|FG000|Overall Study|Protocol Violation|1|||
156324834|NCT00194675|564289415|FG001|Overall Study|Protocol Violation|0|||
156324835|NCT00194675|564289414|FG000|Overall Study|Death|1|||
156324836|NCT00194675|564289415|FG001|Overall Study|Death|0|||
156324837|NCT00704808|564289416|FG000|Overall Study|Discontinued prior to starting treatment|14|||
156324838|NCT00704808|564289416|FG000|Overall Study|Death|7|||
156324839|NCT00704808|564289416|FG000|Overall Study|Tumor progression|80|||
156324840|NCT00704808|564289416|FG000|Overall Study|Patient's decision|11|||
156324841|NCT00704808|564289416|FG000|Overall Study|Early therapy discontinuation|16|||
156324842|NCT00704808|564289416|FG000|Overall Study|Adverse Event|1|||
156324843|NCT00704808|564289416|FG000|Overall Study|Lost to Follow-up|1|||
156324844|NCT00704808|564289416|FG000|Overall Study|Treatment change|1|||
156324845|NCT04437368|564289420|FG000|Overall Study|Death|3|||
156324846|NCT04437368|564289421|FG001|Overall Study|Death|0|||
156324847|NCT04437368|564289422|FG002|Overall Study|Death|2|||
156324848|NCT04437368|564289420|FG000|Overall Study|Study terminated by sponsor|16|||
156324849|NCT04437368|564289421|FG001|Overall Study|Study terminated by sponsor|1|||
156324850|NCT04437368|564289422|FG002|Overall Study|Study terminated by sponsor|25|||
156324851|NCT04437368|564289420|FG000|Overall Study|Withdrawal by Subject|4|||
156324852|NCT04437368|564289421|FG001|Overall Study|Withdrawal by Subject|0|||
156324853|NCT04437368|564289422|FG002|Overall Study|Withdrawal by Subject|3|||
156324854|NCT04437368|564289420|FG000|Overall Study|Sponsor instructions|23|||
156324855|NCT04437368|564289421|FG001|Overall Study|Sponsor instructions|0|||
156662578|NCT00669942|565511296|FG007|Parts 2 and 3|Adverse Event|2|||
156662579|NCT00669942|565511297|FG008|Parts 2 and 3|Adverse Event|1|||
156662580|NCT00669942|565511298|FG009|Parts 2 and 3|Adverse Event|0|||
156662581|NCT00669942|565511299|FG010|Parts 2 and 3|Adverse Event|0|||
156662582|NCT00669942|565511300|FG011|Parts 2 and 3|Adverse Event|0|||
156662583|NCT00669942|565511289|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
156662584|NCT00669942|565511290|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
156662585|NCT00669942|565511291|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
156662586|NCT00669942|565511292|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
156662587|NCT00669942|565511293|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
156662588|NCT00669942|565511294|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
156662589|NCT00669942|565511295|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
156662590|NCT00669942|565511296|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
156662591|NCT00669942|565511297|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
156662592|NCT00669942|565511298|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
156662593|NCT00669942|565511299|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
156662594|NCT00669942|565511300|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
156662595|NCT00669942|565511289|FG000|Parts 2 and 3|Protocol Violation|0|||
156662596|NCT00669942|565511290|FG001|Parts 2 and 3|Protocol Violation|0|||
156662597|NCT00669942|565511291|FG002|Parts 2 and 3|Protocol Violation|0|||
156662598|NCT00669942|565511292|FG003|Parts 2 and 3|Protocol Violation|0|||
156662599|NCT00669942|565511293|FG004|Parts 2 and 3|Protocol Violation|0|||
156662600|NCT00669942|565511294|FG005|Parts 2 and 3|Protocol Violation|1|||
156662601|NCT00669942|565511295|FG006|Parts 2 and 3|Protocol Violation|0|||
156662602|NCT00669942|565511296|FG007|Parts 2 and 3|Protocol Violation|0|||
156662603|NCT00669942|565511297|FG008|Parts 2 and 3|Protocol Violation|0|||
156662604|NCT00669942|565511298|FG009|Parts 2 and 3|Protocol Violation|0|||
156662605|NCT00669942|565511299|FG010|Parts 2 and 3|Protocol Violation|0|||
156662606|NCT00669942|565511300|FG011|Parts 2 and 3|Protocol Violation|0|||
156662607|NCT03752528|565511301|FG000|Part A|Lost to Follow-up|1|||
156662608|NCT03752528|565511301|FG000|Part A|Protocol Violation|1|||
156662609|NCT03752528|565511301|FG000|Part B|Protocol Violation|1|||
156662610|NCT03752528|565511301|FG000|Part B|Study terminated by sponsor|3|||
156662611|NCT04213326|565511304|FG000|Overall Study|Consent withdrawn|51|||
156662612|NCT04213326|565511305|FG001|Overall Study|Consent withdrawn|241|||
156662613|NCT04213326|565511304|FG000|Overall Study|Lost to Follow-up|50|||
156662614|NCT04213326|565511305|FG001|Overall Study|Lost to Follow-up|902|||
156662615|NCT04213326|565511304|FG000|Overall Study|Protocol Violation|3|||
156662616|NCT04213326|565511305|FG001|Overall Study|Protocol Violation|25|||
156662617|NCT04213326|565511304|FG000|Overall Study|Participant eligibility changed|106|||
156662618|NCT04213326|565511305|FG001|Overall Study|Participant eligibility changed|19|||
156662619|NCT04213326|565511304|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
156662620|NCT04213326|565511305|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
156662621|NCT04213326|565511304|FG000|Overall Study|Incomplete study visit|0|||
156662622|NCT04213326|565511305|FG001|Overall Study|Incomplete study visit|367|||
156662623|NCT00854308|565511312|FG000|Overall Study|Disease progression|42|||
156662624|NCT00854308|565511313|FG001|Overall Study|Disease progression|50|||
156662625|NCT00854308|565511312|FG000|Overall Study|Adverse Event|8|||
156662626|NCT00854308|565511313|FG001|Overall Study|Adverse Event|3|||
156662627|NCT00854308|565511312|FG000|Overall Study|Death|2|||
156662628|NCT00854308|565511313|FG001|Overall Study|Death|5|||
156662629|NCT00854308|565511312|FG000|Overall Study|Physician Decision|6|||
156662630|NCT00854308|565511313|FG001|Overall Study|Physician Decision|6|||
156662631|NCT00854308|565511312|FG000|Overall Study|Withdrawal by Subject|4|||
156662632|NCT00854308|565511313|FG001|Overall Study|Withdrawal by Subject|2|||
156662633|NCT00854308|565511312|FG000|Overall Study|Sponsor's decision to terminate study|0|||
156662634|NCT00854308|565511313|FG001|Overall Study|Sponsor's decision to terminate study|1|||
156662635|NCT02079766|565511316|FG000|Overall Study|Physician Decision|1|||
156662636|NCT02079766|565511317|FG001|Overall Study|Physician Decision|0|||
156662637|NCT02079766|565511316|FG000|Overall Study|Withdrawal by Subject|1|||
156662638|NCT02079766|565511317|FG001|Overall Study|Withdrawal by Subject|0|||
156662639|NCT02781727|565511318|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
156662640|NCT02781727|565511319|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
156662641|NCT02781727|565511318|FG000|Treatment Period|Withdrawal by Subject|1|||
156662642|NCT02781727|565511319|FG001|Treatment Period|Withdrawal by Subject|0|||
156662643|NCT02781727|565511318|FG000|Treatment Period|Lost to Follow-up|0|||
156662644|NCT02781727|565511319|FG001|Treatment Period|Lost to Follow-up|1|||
156662645|NCT01044732|565511321|FG000|Overall Study|Lost to Follow-up|2|||
156662646|NCT01044732|565511322|FG001|Overall Study|Lost to Follow-up|1|||
156662647|NCT01044732|565511321|FG000|Overall Study|Physician Decision|5|||
156662648|NCT01044732|565511322|FG001|Overall Study|Physician Decision|3|||
156662649|NCT01044732|565511321|FG000|Overall Study|Protocol Violation|11|||
156662650|NCT01044732|565511322|FG001|Overall Study|Protocol Violation|12|||
156662651|NCT01044732|565511321|FG000|Overall Study|Withdrawal by Subject|0|||
156662652|NCT01044732|565511322|FG001|Overall Study|Withdrawal by Subject|1|||
156662653|NCT01044732|565511321|FG000|Overall Study|Inadequate bowel preparation|11|||
156662654|NCT01044732|565511322|FG001|Overall Study|Inadequate bowel preparation|17|||
156662655|NCT01044732|565511321|FG000|Overall Study|Inability to reach cecum|5|||
156775924|NCT03112603|565931356|FG002|End of Randomization Period|Death|0|||
156662656|NCT01044732|565511322|FG001|Overall Study|Inability to reach cecum|2|||
156662657|NCT01044732|565511321|FG000|Overall Study|Technical error or malfunction|15|||
156662658|NCT01044732|565511322|FG001|Overall Study|Technical error or malfunction|14|||
156662659|NCT02507375|565511323|FG000|Overall Study|Progressive Disease|4|||
156662660|NCT02507375|565511324|FG001|Overall Study|Progressive Disease|5|||
156662661|NCT02507375|565511323|FG000|Overall Study|Death|0|||
156662662|NCT02507375|565511324|FG001|Overall Study|Death|1|||
156662663|NCT02507375|565511323|FG000|Overall Study|Refused treatment|0|||
156662664|NCT02507375|565511324|FG001|Overall Study|Refused treatment|1|||
156662665|NCT02507375|565511323|FG000|Overall Study|Adverse Event|0|||
156662666|NCT02507375|565511324|FG001|Overall Study|Adverse Event|1|||
156662667|NCT00397488|565512639|FG000|Overall Study|Withdrawal by Subject|3|||
156662668|NCT00397488|565512639|FG000|Overall Study|Adverse Event|3|||
156662669|NCT00397488|565512639|FG000|Overall Study|Death|1|||
156662670|NCT02424097|565512640|FG000|Overall Study|Lost to Follow-up|1|||
156662671|NCT02424097|565512641|FG001|Overall Study|Lost to Follow-up|2|||
156662672|NCT02880761|565512643|FG000|Overall Study|Death|6|||
156662673|NCT02880761|565512644|FG001|Overall Study|Death|8|||
156662674|NCT02880761|565512643|FG000|Overall Study|Withdrawal by Subject|3|||
156662675|NCT02880761|565512644|FG001|Overall Study|Withdrawal by Subject|6|||
156662676|NCT02880761|565512643|FG000|Overall Study|Protocol Violation|4|||
156662677|NCT02880761|565512644|FG001|Overall Study|Protocol Violation|3|||
156662678|NCT02880761|565512643|FG000|Overall Study|Lost to Follow-up|3|||
156662679|NCT02880761|565512644|FG001|Overall Study|Lost to Follow-up|4|||
156662680|NCT03597256|565512645|FG000|Overall Study|Lost to Follow-up|3|||
156662681|NCT03597256|565512646|FG001|Overall Study|Lost to Follow-up|1|||
156662682|NCT03597256|565512645|FG000|Overall Study|Withdrawal by Subject|0|||
156662683|NCT03597256|565512646|FG001|Overall Study|Withdrawal by Subject|1|||
156662684|NCT03597256|565512645|FG000|Overall Study|Could not return for treatment|0|||
156662685|NCT03597256|565512646|FG001|Overall Study|Could not return for treatment|1|||
156662686|NCT03597256|565512645|FG000|Overall Study|Moved from location|0|||
156662687|NCT03597256|565512646|FG001|Overall Study|Moved from location|1|||
156662688|NCT03597256|565512645|FG000|Overall Study|Not accepted the treatment|0|||
156662689|NCT03597256|565512646|FG001|Overall Study|Not accepted the treatment|1|||
156662690|NCT02943447|565512647|FG000|Blinded Study Phase|Withdrew Consent|1|||
156662691|NCT02943447|565512648|FG001|Blinded Study Phase|Withdrew Consent|2|||
156662692|NCT02943447|565512649|FG002|Blinded Study Phase|Withdrew Consent|1|||
156662693|NCT02943447|565512647|FG000|Blinded Study Phase|Adverse Event|3|||
156662694|NCT02943447|565512648|FG001|Blinded Study Phase|Adverse Event|0|||
156662695|NCT02943447|565512649|FG002|Blinded Study Phase|Adverse Event|0|||
156662696|NCT02943447|565512647|FG000|Blinded Study Phase|Investigator's discretion|1|||
156662697|NCT02943447|565512648|FG001|Blinded Study Phase|Investigator's discretion|0|||
156662698|NCT02943447|565512649|FG002|Blinded Study Phase|Investigator's discretion|0|||
156662699|NCT02943447|565512647|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
156662700|NCT02943447|565512648|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
156662701|NCT02943447|565512649|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
156662702|NCT02943447|565512647|FG000|Open-Label Extension Phase|Adverse Event|4|||
156662703|NCT02943447|565512648|FG001|Open-Label Extension Phase|Adverse Event|7|||
156662704|NCT02943447|565512649|FG002|Open-Label Extension Phase|Adverse Event|3|||
156662705|NCT02943447|565512647|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
156662706|NCT02943447|565512648|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
156662707|NCT02943447|565512649|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
156662708|NCT02943447|565512647|FG000|Open-Label Extension Phase|Withdrew consent|1|||
156662709|NCT02943447|565512648|FG001|Open-Label Extension Phase|Withdrew consent|1|||
156662710|NCT02943447|565512649|FG002|Open-Label Extension Phase|Withdrew consent|1|||
156662711|NCT02943447|565512647|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
156662712|NCT02943447|565512648|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
156662713|NCT02943447|565512649|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
156662714|NCT02106156|565512650|FG000|Overall Study|Patient Died|19|||
156662715|NCT02106156|565512651|FG001|Overall Study|Patient Died|0|||
156662716|NCT02106156|565512652|FG002|Overall Study|Patient Died|0|||
156662717|NCT02106156|565512650|FG000|Overall Study|Lack of Tolerability|305|||
156662718|NCT02106156|565512651|FG001|Overall Study|Lack of Tolerability|3|||
156662719|NCT02106156|565512652|FG002|Overall Study|Lack of Tolerability|0|||
156775925|NCT03112603|565931354|FG000|End of Randomization Period|Disease Relapse|12|||
156775926|NCT03112603|565931355|FG001|End of Randomization Period|Disease Relapse|7|||
156662720|NCT02106156|565512650|FG000|Overall Study|Lack of Virological Response|1044|||
156662721|NCT02106156|565512651|FG001|Overall Study|Lack of Virological Response|8|||
156662722|NCT02106156|565512652|FG002|Overall Study|Lack of Virological Response|0|||
156662723|NCT02106156|565512650|FG000|Overall Study|Concomitant Disease|74|||
156662724|NCT02106156|565512651|FG001|Overall Study|Concomitant Disease|2|||
156662725|NCT02106156|565512652|FG002|Overall Study|Concomitant Disease|0|||
156662726|NCT02106156|565512650|FG000|Overall Study|Lack of Compliance|211|||
156662727|NCT02106156|565512651|FG001|Overall Study|Lack of Compliance|7|||
156662728|NCT02106156|565512652|FG002|Overall Study|Lack of Compliance|0|||
156662729|NCT02106156|565512650|FG000|Overall Study|Patients Request|307|||
156662730|NCT02106156|565512651|FG001|Overall Study|Patients Request|9|||
156662731|NCT02106156|565512652|FG002|Overall Study|Patients Request|0|||
156662732|NCT02106156|565512650|FG000|Overall Study|Lost to Follow-up|451|||
156662733|NCT02106156|565512651|FG001|Overall Study|Lost to Follow-up|8|||
156662734|NCT02106156|565512652|FG002|Overall Study|Lost to Follow-up|0|||
156662735|NCT02106156|565512650|FG000|Overall Study|Unplanned Event|82|||
156662736|NCT02106156|565512651|FG001|Overall Study|Unplanned Event|2|||
156662737|NCT02106156|565512652|FG002|Overall Study|Unplanned Event|0|||
156662738|NCT02106156|565512650|FG000|Overall Study|Change of Laboratory Parameter|10|||
156662739|NCT02106156|565512651|FG001|Overall Study|Change of Laboratory Parameter|0|||
156662740|NCT02106156|565512652|FG002|Overall Study|Change of Laboratory Parameter|0|||
156662741|NCT02106156|565512650|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
156662742|NCT02106156|565512651|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
156662743|NCT02106156|565512652|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
156662744|NCT02106156|565512650|FG000|Overall Study|Relocation/Change of Physician|40|||
156662745|NCT02106156|565512651|FG001|Overall Study|Relocation/Change of Physician|1|||
156662746|NCT02106156|565512652|FG002|Overall Study|Relocation/Change of Physician|0|||
156662747|NCT01136382|565512658|FG000|Overall Study|Other|8|||
156662748|NCT01136382|565512659|FG001|Overall Study|Other|3|||
156662749|NCT01136382|565512658|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
156662750|NCT01136382|565512659|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
156662751|NCT01136382|565512658|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
156662752|NCT01136382|565512659|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
156662753|NCT01136382|565512658|FG000|Overall Study|Withdrawal by Subject|4|||
156662754|NCT01136382|565512659|FG001|Overall Study|Withdrawal by Subject|1|||
156662755|NCT01725529|565512669|FG000|Overall Study|Adverse Event|1|||
156662756|NCT01725529|565512670|FG001|Overall Study|Adverse Event|0|||
156662757|NCT01725529|565512671|FG002|Overall Study|Adverse Event|0|||
156662758|NCT01725529|565512669|FG000|Overall Study|Lost to Follow-up|2|||
156662759|NCT01725529|565512670|FG001|Overall Study|Lost to Follow-up|1|||
156662760|NCT01725529|565512671|FG002|Overall Study|Lost to Follow-up|1|||
156662761|NCT01725529|565512669|FG000|Overall Study|Protocol Violation|0|||
156662762|NCT01725529|565512670|FG001|Overall Study|Protocol Violation|1|||
156662763|NCT01725529|565512671|FG002|Overall Study|Protocol Violation|1|||
156662764|NCT01725529|565512669|FG000|Overall Study|Withdrawal by Subject|12|||
156662765|NCT01725529|565512670|FG001|Overall Study|Withdrawal by Subject|14|||
156662766|NCT01725529|565512671|FG002|Overall Study|Withdrawal by Subject|8|||
156662767|NCT02653664|565512677|FG000|Post-Treatment|Withdrawal by Subject|6|||
156662768|NCT02653664|565512678|FG001|Post-Treatment|Withdrawal by Subject|5|||
156662769|NCT02653664|565512679|FG002|Post-Treatment|Withdrawal by Subject|7|||
156662770|NCT02653664|565512677|FG000|Post-Treatment|Lost to Follow-up|8|||
156662771|NCT02653664|565512678|FG001|Post-Treatment|Lost to Follow-up|1|||
156662772|NCT02653664|565512679|FG002|Post-Treatment|Lost to Follow-up|7|||
156662773|NCT02653664|565512677|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
156662774|NCT02653664|565512678|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
156662775|NCT02653664|565512679|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
156662776|NCT02653664|565512677|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
156662777|NCT02653664|565512678|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
156662778|NCT02653664|565512679|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
156662779|NCT02653664|565512677|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
156662780|NCT02653664|565512678|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
156662781|NCT02653664|565512679|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
156662782|NCT02653664|565512677|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
156662783|NCT02653664|565512678|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
156662784|NCT02653664|565512679|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
156662785|NCT02653664|565512677|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
156662786|NCT02653664|565512678|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
156662787|NCT02653664|565512679|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
156662788|NCT02653664|565512677|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
156662789|NCT02653664|565512678|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
156662790|NCT02653664|565512679|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
156662791|NCT02653664|565512677|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
156662792|NCT02653664|565512678|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
156662793|NCT02653664|565512679|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
156775927|NCT03112603|565931356|FG002|End of Randomization Period|Disease Relapse|0|||
156775928|NCT03112603|565931354|FG000|End of Randomization Period|Lack of Efficacy|25|||
156662794|NCT02653664|565512677|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
156662795|NCT02653664|565512678|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
156662796|NCT02653664|565512679|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
156662797|NCT04915755|565512682|FG000|Overall Study|Physician Decision|3|||
156662798|NCT04915755|565512683|FG001|Overall Study|Physician Decision|2|||
156662799|NCT04915755|565512682|FG000|Overall Study|Withdrawal by Subject|1|||
156662800|NCT04915755|565512683|FG001|Overall Study|Withdrawal by Subject|1|||
156662801|NCT04915755|565512682|FG000|Overall Study|Ongoing for PACT|3|||
156662802|NCT04915755|565512683|FG001|Overall Study|Ongoing for PACT|2|||
156662803|NCT04915755|565512682|FG000|Overall Study|Other|7|||
156662804|NCT04915755|565512683|FG001|Overall Study|Other|11|||
156662805|NCT03655106|565512685|FG000|Overall Study|Withdrawal by Subject|3|||
156662806|NCT03655106|565512686|FG001|Overall Study|Withdrawal by Subject|2|||
156662807|NCT03655106|565512685|FG000|Overall Study|Lost to Follow-up|2|||
156662808|NCT03655106|565512686|FG001|Overall Study|Lost to Follow-up|1|||
156662809|NCT03655106|565512685|FG000|Overall Study|Duplicate Enrollment|1|||
156662810|NCT03655106|565512686|FG001|Overall Study|Duplicate Enrollment|1|||
156662811|NCT03655106|565512685|FG000|Overall Study|Protocol Violation|3|||
156662812|NCT03655106|565512686|FG001|Overall Study|Protocol Violation|0|||
156662813|NCT00727571|565512691|FG000|Overall Study|Ineligibility determined|1|||
156662814|NCT00727571|565512692|FG001|Overall Study|Ineligibility determined|1|||
156662815|NCT00727571|565512693|FG002|Overall Study|Ineligibility determined|1|||
156662816|NCT00727571|565512694|FG003|Overall Study|Ineligibility determined|0|||
156662817|NCT00727571|565512691|FG000|Overall Study|Death|0|||
156662818|NCT00727571|565512692|FG001|Overall Study|Death|19|||
156662819|NCT00727571|565512693|FG002|Overall Study|Death|5|||
156662820|NCT00727571|565512694|FG003|Overall Study|Death|1|||
156662821|NCT00727571|565512691|FG000|Overall Study|Physician Decision|0|||
156662822|NCT00727571|565512692|FG001|Overall Study|Physician Decision|5|||
156662823|NCT00727571|565512693|FG002|Overall Study|Physician Decision|0|||
156662824|NCT00727571|565512694|FG003|Overall Study|Physician Decision|0|||
156662825|NCT00727571|565512691|FG000|Overall Study|Withdrawal by Subject|0|||
156662826|NCT00727571|565512692|FG001|Overall Study|Withdrawal by Subject|10|||
156662827|NCT00727571|565512693|FG002|Overall Study|Withdrawal by Subject|11|||
156662828|NCT00727571|565512694|FG003|Overall Study|Withdrawal by Subject|0|||
156662829|NCT00727571|565512691|FG000|Overall Study|Subject Non Compliance|0|||
156662830|NCT00727571|565512692|FG001|Overall Study|Subject Non Compliance|6|||
156662831|NCT00727571|565512693|FG002|Overall Study|Subject Non Compliance|0|||
156662832|NCT00727571|565512694|FG003|Overall Study|Subject Non Compliance|4|||
156662833|NCT00727571|565512691|FG000|Overall Study|Dismissed from nursing home|0|||
156662834|NCT00727571|565512692|FG001|Overall Study|Dismissed from nursing home|9|||
156662835|NCT00727571|565512693|FG002|Overall Study|Dismissed from nursing home|5|||
156662836|NCT00727571|565512694|FG003|Overall Study|Dismissed from nursing home|0|||
156662837|NCT00727571|565512691|FG000|Overall Study|Hospitalization|0|||
156662838|NCT00727571|565512692|FG001|Overall Study|Hospitalization|1|||
156662839|NCT00727571|565512693|FG002|Overall Study|Hospitalization|0|||
156662840|NCT00727571|565512694|FG003|Overall Study|Hospitalization|1|||
156662841|NCT00727571|565512691|FG000|Overall Study|AE not leading to hospitalization|0|||
156662842|NCT00727571|565512692|FG001|Overall Study|AE not leading to hospitalization|0|||
156662843|NCT00727571|565512693|FG002|Overall Study|AE not leading to hospitalization|2|||
156662844|NCT00727571|565512694|FG003|Overall Study|AE not leading to hospitalization|0|||
156662845|NCT00727571|565512691|FG000|Overall Study|Other|0|||
156662846|NCT00727571|565512692|FG001|Overall Study|Other|4|||
156662847|NCT00727571|565512693|FG002|Overall Study|Other|6|||
156662848|NCT00727571|565512694|FG003|Overall Study|Other|0|||
156662849|NCT00051025|565512697|FG000|Overall Study|Progressive Disease|1|||
156662850|NCT00051025|565512698|FG001|Overall Study|Progressive Disease|1|||
156662851|NCT00051025|565512697|FG000|Overall Study|Adverse Event|1|||
156662852|NCT00051025|565512698|FG001|Overall Study|Adverse Event|1|||
156662853|NCT00051025|565512697|FG000|Overall Study|Withdrawal by Subject|0|||
156662854|NCT00051025|565512698|FG001|Overall Study|Withdrawal by Subject|1|||
156662855|NCT00051025|565512697|FG000|Overall Study|Death|0|||
156662856|NCT00051025|565512698|FG001|Overall Study|Death|1|||
156662857|NCT01471093|565512701|FG000|Overall Study|Adverse Event|1|||
156662858|NCT01471093|565512702|FG001|Overall Study|Adverse Event|0|||
156662859|NCT01471093|565512703|FG002|Overall Study|Adverse Event|0|||
156662860|NCT01471093|565512704|FG003|Overall Study|Adverse Event|0|||
156775929|NCT03112603|565931355|FG001|End of Randomization Period|Lack of Efficacy|77|||
156775930|NCT03112603|565931356|FG002|End of Randomization Period|Lack of Efficacy|0|||
156775931|NCT03112603|565931354|FG000|End of Randomization Period|Adverse Event|32|||
156775932|NCT03112603|565931355|FG001|End of Randomization Period|Adverse Event|12|||
156662861|NCT00358449|565512705|FG000|Overall Study|Adverse Event|1|||
156662862|NCT00358449|565512706|FG001|Overall Study|Adverse Event|0|||
156662863|NCT00358449|565512707|FG002|Overall Study|Adverse Event|1|||
156662864|NCT00358449|565512705|FG000|Overall Study|Lost to Follow-up|1|||
156662865|NCT00358449|565512706|FG001|Overall Study|Lost to Follow-up|0|||
156662866|NCT00358449|565512707|FG002|Overall Study|Lost to Follow-up|0|||
156662867|NCT00358449|565512705|FG000|Overall Study|Withdrawal by Subject|2|||
156662868|NCT00358449|565512706|FG001|Overall Study|Withdrawal by Subject|0|||
156662869|NCT00358449|565512707|FG002|Overall Study|Withdrawal by Subject|0|||
156662870|NCT00358449|565512705|FG000|Overall Study|Lack of Efficacy|0|||
156662871|NCT00358449|565512706|FG001|Overall Study|Lack of Efficacy|1|||
156662872|NCT00358449|565512707|FG002|Overall Study|Lack of Efficacy|0|||
156662873|NCT00358449|565512705|FG000|Overall Study|Steriod Inhaler was Increased|0|||
156662874|NCT00358449|565512706|FG001|Overall Study|Steriod Inhaler was Increased|0|||
156662875|NCT00358449|565512707|FG002|Overall Study|Steriod Inhaler was Increased|1|||
156662876|NCT01804270|565512708|FG000|Overall Study|Withdrawal by Subject|1|||
156662877|NCT01804270|565512709|FG001|Overall Study|Withdrawal by Subject|1|||
156662878|NCT01367457|565512713|FG000|Overall Study|Death|2|||
156662879|NCT01367457|565512714|FG001|Overall Study|Death|0|||
156662880|NCT01367457|565512715|FG002|Overall Study|Death|0|||
156662881|NCT01367457|565512713|FG000|Overall Study|Investigator's decision|2|||
156662882|NCT01367457|565512714|FG001|Overall Study|Investigator's decision|0|||
156662883|NCT01367457|565512715|FG002|Overall Study|Investigator's decision|0|||
156662884|NCT01367457|565512713|FG000|Overall Study|Clinical decline (CD)|2|||
156662885|NCT01367457|565512714|FG001|Overall Study|Clinical decline (CD)|0|||
156662886|NCT01367457|565512715|FG002|Overall Study|Clinical decline (CD)|0|||
156662887|NCT01367457|565512713|FG000|Overall Study|Progression and death|8|||
156662888|NCT01367457|565512714|FG001|Overall Study|Progression and death|0|||
156662889|NCT01367457|565512715|FG002|Overall Study|Progression and death|0|||
156662890|NCT01367457|565512713|FG000|Overall Study|Toxicity|16|||
156662891|NCT01367457|565512714|FG001|Overall Study|Toxicity|0|||
156662892|NCT01367457|565512715|FG002|Overall Study|Toxicity|0|||
156662893|NCT01367457|565512713|FG000|Overall Study|Progression|137|||
156662894|NCT01367457|565512714|FG001|Overall Study|Progression|0|||
156662895|NCT01367457|565512715|FG002|Overall Study|Progression|0|||
156662896|NCT01367457|565512713|FG000|Overall Study|Patient asks for rest + slow progression|1|||
156662897|NCT01367457|565512714|FG001|Overall Study|Patient asks for rest + slow progression|0|||
156662898|NCT01367457|565512715|FG002|Overall Study|Patient asks for rest + slow progression|0|||
156662899|NCT01367457|565512713|FG000|Overall Study|Investigator's opinion, stable disease|1|||
156662900|NCT01367457|565512714|FG001|Overall Study|Investigator's opinion, stable disease|0|||
156662901|NCT01367457|565512715|FG002|Overall Study|Investigator's opinion, stable disease|0|||
156662902|NCT01367457|565512713|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
156662903|NCT01367457|565512714|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
156662904|NCT01367457|565512715|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
156662905|NCT01367457|565512713|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
156662906|NCT01367457|565512714|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
156662907|NCT01367457|565512715|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
156662908|NCT01367457|565512713|FG000|Overall Study|low grade toxicities + stable disease|1|||
156662909|NCT01367457|565512714|FG001|Overall Study|low grade toxicities + stable disease|0|||
156662910|NCT01367457|565512715|FG002|Overall Study|low grade toxicities + stable disease|0|||
156662911|NCT01367457|565512713|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
156662912|NCT01367457|565512714|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
156662913|NCT01367457|565512715|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
156662914|NCT01367457|565512713|FG000|Overall Study|Withdrawal by Subject|1|||
156662915|NCT01367457|565512714|FG001|Overall Study|Withdrawal by Subject|0|||
156662916|NCT01367457|565512715|FG002|Overall Study|Withdrawal by Subject|0|||
156662917|NCT01367457|565512713|FG000|Overall Study|CD, associated leukaemia|1|||
156662918|NCT01367457|565512714|FG001|Overall Study|CD, associated leukaemia|0|||
156662919|NCT01367457|565512715|FG002|Overall Study|CD, associated leukaemia|0|||
156662920|NCT01367457|565512713|FG000|Overall Study|Uncontrolled pain|1|||
156662921|NCT01367457|565512714|FG001|Overall Study|Uncontrolled pain|0|||
156662922|NCT01367457|565512715|FG002|Overall Study|Uncontrolled pain|0|||
156662923|NCT01367457|565512713|FG000|Overall Study|Overall status worsens to grade 4|1|||
156662924|NCT01367457|565512714|FG001|Overall Study|Overall status worsens to grade 4|0|||
156662925|NCT01367457|565512715|FG002|Overall Study|Overall status worsens to grade 4|0|||
156662926|NCT01367457|565512713|FG000|Overall Study|Stabilisation + frequent infections|1|||
156662927|NCT01367457|565512714|FG001|Overall Study|Stabilisation + frequent infections|0|||
156662928|NCT01367457|565512715|FG002|Overall Study|Stabilisation + frequent infections|0|||
156662929|NCT01367457|565512713|FG000|Overall Study|No clinical benefit|1|||
156662930|NCT01367457|565512714|FG001|Overall Study|No clinical benefit|0|||
156662931|NCT01367457|565512715|FG002|Overall Study|No clinical benefit|0|||
156662932|NCT01367457|565512713|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
156662933|NCT01367457|565512714|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
156662934|NCT01367457|565512715|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
156662935|NCT01367457|565512713|FG000|Overall Study|Overall decline|1|||
156662936|NCT01367457|565512714|FG001|Overall Study|Overall decline|0|||
156662937|NCT01367457|565512715|FG002|Overall Study|Overall decline|0|||
156662938|NCT01367457|565512713|FG000|Overall Study|Rejection of treatment|1|||
156662939|NCT01367457|565512714|FG001|Overall Study|Rejection of treatment|0|||
156662940|NCT01367457|565512715|FG002|Overall Study|Rejection of treatment|0|||
156662941|NCT01367457|565512713|FG000|Overall Study|Lost to Follow-up|1|||
156662942|NCT01367457|565512714|FG001|Overall Study|Lost to Follow-up|0|||
156662943|NCT01367457|565512715|FG002|Overall Study|Lost to Follow-up|0|||
156662944|NCT01367457|565512713|FG000|Overall Study|Death from septic shock|1|||
156662945|NCT01367457|565512714|FG001|Overall Study|Death from septic shock|0|||
156662946|NCT01367457|565512715|FG002|Overall Study|Death from septic shock|0|||
156662947|NCT01367457|565512713|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
156662948|NCT01367457|565512714|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
156662949|NCT01367457|565512715|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
156662950|NCT01367457|565512713|FG000|Overall Study|Patient's Wish|1|||
156662951|NCT01367457|565512714|FG001|Overall Study|Patient's Wish|0|||
156662952|NCT01367457|565512715|FG002|Overall Study|Patient's Wish|0|||
156662953|NCT01367457|565512713|FG000|Overall Study|Palliative. Overall decline|1|||
156662954|NCT01367457|565512714|FG001|Overall Study|Palliative. Overall decline|0|||
156662955|NCT01367457|565512715|FG002|Overall Study|Palliative. Overall decline|0|||
156662956|NCT01367457|565512713|FG000|Overall Study|Suspected DP/suspected active infection|1|||
156662957|NCT01367457|565512714|FG001|Overall Study|Suspected DP/suspected active infection|0|||
156662958|NCT01367457|565512715|FG002|Overall Study|Suspected DP/suspected active infection|0|||
156662959|NCT02188303|565512716|FG000|Overall Study|Adverse Event|0|||
156662960|NCT02188303|565512717|FG001|Overall Study|Adverse Event|0|||
156662961|NCT02188303|565512718|FG002|Overall Study|Adverse Event|0|||
156662962|NCT02188303|565512719|FG003|Overall Study|Adverse Event|0|||
156662963|NCT02188303|565512720|FG004|Overall Study|Adverse Event|0|||
156662964|NCT02188303|565512721|FG005|Overall Study|Adverse Event|2|||
156662965|NCT02188303|565512722|FG006|Overall Study|Adverse Event|0|||
156662966|NCT02188303|565512723|FG007|Overall Study|Adverse Event|2|||
156662967|NCT02188303|565512716|FG000|Overall Study|Dose Termination Criteria Met|0|||
156662968|NCT02188303|565512717|FG001|Overall Study|Dose Termination Criteria Met|0|||
156662969|NCT02188303|565512718|FG002|Overall Study|Dose Termination Criteria Met|0|||
156662970|NCT02188303|565512719|FG003|Overall Study|Dose Termination Criteria Met|0|||
156662971|NCT02188303|565512720|FG004|Overall Study|Dose Termination Criteria Met|0|||
156662972|NCT02188303|565512721|FG005|Overall Study|Dose Termination Criteria Met|0|||
156662973|NCT02188303|565512722|FG006|Overall Study|Dose Termination Criteria Met|2|||
156662974|NCT02188303|565512723|FG007|Overall Study|Dose Termination Criteria Met|4|||
156662975|NCT02334722|565512725|FG000|Overall Study|Lost to Follow-up|4|||
156662976|NCT02334722|565512726|FG001|Overall Study|Lost to Follow-up|0|||
156662977|NCT02334722|565512725|FG000|Overall Study|6 week questionnaire not completed|2|||
156662978|NCT02334722|565512726|FG001|Overall Study|6 week questionnaire not completed|0|||
156662979|NCT02334722|565512725|FG000|Overall Study|Unable to obtain medication|1|||
156662980|NCT02334722|565512726|FG001|Overall Study|Unable to obtain medication|1|||
156662981|NCT02334722|565512725|FG000|Overall Study|Withdrawal by Subject|0|||
156662982|NCT02334722|565512726|FG001|Overall Study|Withdrawal by Subject|3|||
156662983|NCT02334722|565512725|FG000|Overall Study|Adverse Event|0|||
156662984|NCT02334722|565512726|FG001|Overall Study|Adverse Event|2|||
156662985|NCT02334722|565512725|FG000|Overall Study|Physician Decision|0|||
156662986|NCT02334722|565512726|FG001|Overall Study|Physician Decision|1|||
156662987|NCT04000815|565512734|FG000|Overall Study|Lost to Follow-up|9|||
156662988|NCT04000815|565512735|FG001|Overall Study|Lost to Follow-up|2|||
156662989|NCT04000815|565512736|FG002|Overall Study|Lost to Follow-up|3|||
156662990|NCT04000815|565512734|FG000|Overall Study|Withdrawal by Subject|4|||
156662991|NCT04000815|565512735|FG001|Overall Study|Withdrawal by Subject|3|||
156775933|NCT03112603|565931356|FG002|End of Randomization Period|Adverse Event|0|||
156775934|NCT03112603|565931354|FG000|End of Cross Over Period|Death|0|||
156775935|NCT03112603|565931355|FG001|End of Cross Over Period|Death|0|||
156662992|NCT04000815|565512736|FG002|Overall Study|Withdrawal by Subject|2|||
156662993|NCT04000815|565512734|FG000|Overall Study|Right ovarian cyst occured|1|||
156662994|NCT04000815|565512735|FG001|Overall Study|Right ovarian cyst occured|0|||
156775936|NCT03112603|565931356|FG002|End of Cross Over Period|Death|2|||
156775937|NCT03112603|565931354|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
156775938|NCT03112603|565931355|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
156775939|NCT03112603|565931356|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
156775940|NCT03112603|565931354|FG000|End of Cross Over Period|Physician Decision|0|||
156775941|NCT03112603|565931355|FG001|End of Cross Over Period|Physician Decision|0|||
156775942|NCT03112603|565931356|FG002|End of Cross Over Period|Physician Decision|29|||
156775943|NCT03112603|565931354|FG000|End of Cross Over Period|Lack of Efficacy|0|||
156775944|NCT03112603|565931355|FG001|End of Cross Over Period|Lack of Efficacy|0|||
156775945|NCT03112603|565931356|FG002|End of Cross Over Period|Lack of Efficacy|8|||
156775946|NCT03112603|565931354|FG000|End of Cross Over Period|Adverse Event|0|||
156775947|NCT03112603|565931355|FG001|End of Cross Over Period|Adverse Event|0|||
156775948|NCT03112603|565931356|FG002|End of Cross Over Period|Adverse Event|6|||
156775949|NCT03112603|565931354|FG000|End of Cross Over Period|Disease Relapse|0|||
156775950|NCT03112603|565931355|FG001|End of Cross Over Period|Disease Relapse|0|||
156775951|NCT03112603|565931356|FG002|End of Cross Over Period|Disease Relapse|2|||
156775952|NCT04725188|565931357|FG000|Overall Study|Death|72|||
156775953|NCT04725188|565931358|FG001|Overall Study|Death|69|||
156775954|NCT04725188|565931359|FG002|Overall Study|Death|76|||
156662995|NCT04000815|565512736|FG002|Overall Study|Right ovarian cyst occured|0|||
156662996|NCT04000815|565512734|FG000|Overall Study|Hypertension occured on follow up|0|||
156775955|NCT04725188|565931357|FG000|Overall Study|Lost to Follow-up|1|||
156662997|NCT04000815|565512735|FG001|Overall Study|Hypertension occured on follow up|0|||
156662998|NCT04000815|565512736|FG002|Overall Study|Hypertension occured on follow up|2|||
156662999|NCT00239577|565512737|FG000|Primary Phase|Adverse Event|0|||
156429369|NCT04936035|564663226|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156663000|NCT00239577|565512738|FG001|Primary Phase|Adverse Event|0|||
156663001|NCT00239577|565512739|FG002|Primary Phase|Adverse Event|1|||
156663002|NCT00239577|565512740|FG003|Primary Phase|Adverse Event|0|||
156663003|NCT00239577|565512737|FG000|Primary Phase|Other|5|||
156663004|NCT00239577|565512738|FG001|Primary Phase|Other|3|||
156663005|NCT00239577|565512739|FG002|Primary Phase|Other|2|||
156663006|NCT00239577|565512740|FG003|Primary Phase|Other|0|||
156663007|NCT01391793|565512741|FG000|Overall Study|Ineligible|3|||
156663008|NCT01391793|565512742|FG001|Overall Study|Ineligible|0|||
156324856|NCT04437368|564289422|FG002|Overall Study|Sponsor instructions|0|||
156324857|NCT00364130|564289425|FG000|Intervention Period|Lost to Follow-up|4|||
156324858|NCT00364130|564289426|FG001|Intervention Period|Lost to Follow-up|3|||
156324859|NCT00364130|564289425|FG000|Intervention Period|Pregnancy|1|||
156324860|NCT00364130|564289426|FG001|Intervention Period|Pregnancy|0|||
156324861|NCT00364130|564289425|FG000|Intervention Period|Withdrawal by Subject|4|||
156324862|NCT00364130|564289426|FG001|Intervention Period|Withdrawal by Subject|5|||
156324863|NCT00364130|564289425|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
156324864|NCT00364130|564289426|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
156324865|NCT00901927|564289434|FG000|Overall Study|Lack of Efficacy|1|||
156324866|NCT00901927|564289434|FG000|Overall Study|Protocol Violation|3|||
156324867|NCT00901927|564289434|FG000|Overall Study|Withdrawal by Subject|2|||
156324868|NCT00144027|564289438|FG000|Overall Study|Lost to Follow-up|1|||
156324869|NCT00144027|564289439|FG001|Overall Study|Lost to Follow-up|3|||
156324870|NCT00144027|564289438|FG000|Overall Study|Withdrawal by Subject|2|||
156324871|NCT00144027|564289439|FG001|Overall Study|Withdrawal by Subject|2|||
156324872|NCT00144027|564289438|FG000|Overall Study|did not complete baseline assessment|0|||
156324873|NCT00144027|564289439|FG001|Overall Study|did not complete baseline assessment|6|||
156324874|NCT01178073|564289442|FG000|Overall Study|Adverse Event|34|||
156324875|NCT01178073|564289443|FG001|Overall Study|Adverse Event|27|||
156324876|NCT01178073|564289444|FG002|Overall Study|Adverse Event|24|||
156324877|NCT01178073|564289442|FG000|Overall Study|Protocol Violation|1|||
156324878|NCT01178073|564289443|FG001|Overall Study|Protocol Violation|1|||
156324879|NCT01178073|564289444|FG002|Overall Study|Protocol Violation|1|||
156324880|NCT01178073|564289442|FG000|Overall Study|Lost to Follow-up|2|||
156324881|NCT01178073|564289443|FG001|Overall Study|Lost to Follow-up|0|||
156324882|NCT01178073|564289444|FG002|Overall Study|Lost to Follow-up|3|||
156324883|NCT01178073|564289442|FG000|Overall Study|Physician Decision|14|||
156324884|NCT01178073|564289443|FG001|Overall Study|Physician Decision|10|||
156324885|NCT01178073|564289444|FG002|Overall Study|Physician Decision|10|||
156324886|NCT01178073|564289442|FG000|Overall Study|Withdrawal by Subject|10|||
156324887|NCT01178073|564289443|FG001|Overall Study|Withdrawal by Subject|6|||
156324888|NCT01178073|564289444|FG002|Overall Study|Withdrawal by Subject|8|||
156324889|NCT01178073|564289442|FG000|Overall Study|Missing Completion Status|1|||
156324890|NCT01178073|564289443|FG001|Overall Study|Missing Completion Status|0|||
156324891|NCT01178073|564289444|FG002|Overall Study|Missing Completion Status|0|||
156324892|NCT01674634|564289445|FG000|Overall Study|Withdrawal by Subject|3|||
156663009|NCT01391793|565512741|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
156663010|NCT01391793|565512742|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
156663011|NCT01391793|565512741|FG000|Overall Study|No DMSA|73|||
156663012|NCT01391793|565512742|FG001|Overall Study|No DMSA|57|||
156663013|NCT01666730|565512745|FG000|Overall Study|Adverse Event|16|||
156663014|NCT01666730|565512745|FG000|Overall Study|Death|2|||
156663015|NCT01666730|565512745|FG000|Overall Study|Physician Decision|5|||
156663016|NCT01666730|565512745|FG000|Overall Study|Withdrawal by Subject|9|||
156663017|NCT01666730|565512745|FG000|Overall Study|Disease progression/relapse|18|||
156663018|NCT01449630|565512746|FG000|Period 1|Physician Decision|1|||
156663019|NCT01449630|565512747|FG001|Period 1|Physician Decision|0|||
156663020|NCT01449630|565512748|FG002|Period 1|Physician Decision|0|||
156663021|NCT01449630|565512749|FG003|Period 1|Physician Decision|1|||
156663022|NCT01449630|565512750|FG004|Period 1|Physician Decision|0|||
156663023|NCT01449630|565512751|FG005|Period 1|Physician Decision|0|||
156663024|NCT01449630|565512752|FG006|Period 1|Physician Decision|0|||
156663025|NCT01449630|565512753|FG007|Period 1|Physician Decision|0|||
156663026|NCT01449630|565512754|FG008|Period 1|Physician Decision|0|||
156663027|NCT01449630|565512746|FG000|Period 1|Sponsor Decision|0|||
156663028|NCT01449630|565512747|FG001|Period 1|Sponsor Decision|0|||
156663029|NCT01449630|565512748|FG002|Period 1|Sponsor Decision|0|||
156663030|NCT01449630|565512749|FG003|Period 1|Sponsor Decision|0|||
156663031|NCT01449630|565512750|FG004|Period 1|Sponsor Decision|0|||
156663032|NCT01449630|565512751|FG005|Period 1|Sponsor Decision|1|||
156663033|NCT01449630|565512752|FG006|Period 1|Sponsor Decision|0|||
156663034|NCT01449630|565512753|FG007|Period 1|Sponsor Decision|0|||
156663035|NCT01449630|565512754|FG008|Period 1|Sponsor Decision|0|||
156663036|NCT01449630|565512746|FG000|Period 2|Sponsor Decision|0|||
156663037|NCT01449630|565512747|FG001|Period 2|Sponsor Decision|0|||
156663038|NCT01449630|565512748|FG002|Period 2|Sponsor Decision|0|||
156663039|NCT01449630|565512749|FG003|Period 2|Sponsor Decision|0|||
156663040|NCT01449630|565512750|FG004|Period 2|Sponsor Decision|0|||
156663041|NCT01449630|565512751|FG005|Period 2|Sponsor Decision|0|||
156663042|NCT01449630|565512752|FG006|Period 2|Sponsor Decision|1|||
156663043|NCT01449630|565512753|FG007|Period 2|Sponsor Decision|0|||
156663044|NCT01449630|565512754|FG008|Period 2|Sponsor Decision|0|||
156663045|NCT03340727|565512755|FG000|Overall Study|Death|1|||
156663046|NCT03340727|565512756|FG001|Overall Study|Death|0|||
156663047|NCT03340727|565512755|FG000|Overall Study|Lost to Follow-up|31|||
156663048|NCT03340727|565512756|FG001|Overall Study|Lost to Follow-up|35|||
156663049|NCT03340727|565512755|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
156663050|NCT03340727|565512756|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
156663051|NCT03340727|565512755|FG000|Overall Study|Transferred to another facility|10|||
156663052|NCT03340727|565512756|FG001|Overall Study|Transferred to another facility|7|||
156663053|NCT03340727|565512755|FG000|Overall Study|Withdrawal by Subject|28|||
156663054|NCT03340727|565512756|FG001|Overall Study|Withdrawal by Subject|17|||
156663055|NCT03553823|565512757|FG000|Overall Study|Physician Decision|0|||
156663056|NCT03553823|565512758|FG001|Overall Study|Physician Decision|1|||
156663057|NCT01720264|565512759|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
156663058|NCT01720264|565512759|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
156663059|NCT01720264|565512759|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
156663060|NCT01873586|565512760|FG000|Overall Study|Lost to Follow-up|3|||
156663061|NCT00282048|565512761|FG000|Overall Study|Lack of Efficacy|30|||
156663062|NCT00282048|565512761|FG000|Overall Study|Adverse Event|22|||
156663063|NCT00282048|565512761|FG000|Overall Study|Withdrawal by Subject|1|||
156663064|NCT00282048|565512761|FG000|Overall Study|Other|8|||
156429370|NCT03673124|564663227|FG000|Overall Study|Eligible with no protocol therapy|2|||
156429371|NCT05827926|564663232|FG000|Overall Study|Lost to Follow-up|1|||
156429372|NCT05827926|564663233|FG001|Overall Study|Lost to Follow-up|0|||
156429373|NCT05827926|564663234|FG002|Overall Study|Lost to Follow-up|0|||
156429374|NCT05827926|564663235|FG003|Overall Study|Lost to Follow-up|0|||
156429375|NCT05827926|564663236|FG004|Overall Study|Lost to Follow-up|0|||
156429376|NCT05827926|564663237|FG005|Overall Study|Lost to Follow-up|1|||
156429377|NCT05827926|564663238|FG006|Overall Study|Lost to Follow-up|0|||
156429378|NCT05827926|564663239|FG007|Overall Study|Lost to Follow-up|0|||
156429379|NCT05827926|564663240|FG008|Overall Study|Lost to Follow-up|0|||
156429380|NCT05827926|564663241|FG009|Overall Study|Lost to Follow-up|0|||
156429381|NCT05827926|564663242|FG010|Overall Study|Lost to Follow-up|0|||
156429382|NCT05827926|564663243|FG011|Overall Study|Lost to Follow-up|0|||
156429383|NCT05827926|564663244|FG012|Overall Study|Lost to Follow-up|1|||
156429384|NCT05827926|564663245|FG013|Overall Study|Lost to Follow-up|1|||
156429385|NCT05827926|564663246|FG014|Overall Study|Lost to Follow-up|0|||
156429386|NCT05827926|564663247|FG015|Overall Study|Lost to Follow-up|1|||
156429387|NCT05827926|564663248|FG016|Overall Study|Lost to Follow-up|2|||
156429388|NCT05827926|564663249|FG017|Overall Study|Lost to Follow-up|0|||
156429389|NCT05827926|564663250|FG018|Overall Study|Lost to Follow-up|0|||
156429390|NCT05827926|564663251|FG019|Overall Study|Lost to Follow-up|0|||
156429391|NCT05827926|564663252|FG020|Overall Study|Lost to Follow-up|1|||
156429392|NCT05827926|564663253|FG021|Overall Study|Lost to Follow-up|2|||
156429393|NCT05827926|564663254|FG022|Overall Study|Lost to Follow-up|1|||
156429394|NCT05827926|564663255|FG023|Overall Study|Lost to Follow-up|1|||
156429395|NCT05827926|564663256|FG024|Overall Study|Lost to Follow-up|2|||
156429396|NCT05827926|564663257|FG025|Overall Study|Lost to Follow-up|1|||
156429397|NCT05827926|564663258|FG026|Overall Study|Lost to Follow-up|4|||
156429398|NCT05827926|564663259|FG027|Overall Study|Lost to Follow-up|1|||
156429399|NCT05827926|564663260|FG028|Overall Study|Lost to Follow-up|2|||
156429400|NCT05827926|564663261|FG029|Overall Study|Lost to Follow-up|1|||
156429401|NCT05827926|564663262|FG030|Overall Study|Lost to Follow-up|5|||
156429402|NCT05827926|564663263|FG031|Overall Study|Lost to Follow-up|0|||
156429403|NCT05827926|564663264|FG032|Overall Study|Lost to Follow-up|3|||
156663065|NCT00282048|565512761|FG000|Overall Study|Ongoing|1|||
156663066|NCT03522675|565512763|FG000|Overall Study|Screen fail|1|||
156663067|NCT03522675|565512763|FG000|Overall Study|Non-reactive to histamine|1|||
156663068|NCT02674477|565512764|FG000|Overall Study|Protocol Violation|8|||
156429404|NCT05827926|564663265|FG033|Overall Study|Lost to Follow-up|2|||
156429405|NCT05827926|564663266|FG034|Overall Study|Lost to Follow-up|1|||
156429406|NCT05827926|564663267|FG035|Overall Study|Lost to Follow-up|3|||
156429407|NCT05827926|564663268|FG036|Overall Study|Lost to Follow-up|4|||
156429408|NCT05827926|564663232|FG000|Overall Study|Withdrawal by Subject|1|||
156663069|NCT02674477|565512765|FG001|Overall Study|Protocol Violation|2|||
156663070|NCT02549092|565512769|FG000|Treatment Period|Adverse Event|2|||
156775956|NCT04725188|565931358|FG001|Overall Study|Lost to Follow-up|0|||
156429409|NCT05827926|564663233|FG001|Overall Study|Withdrawal by Subject|0|||
156429410|NCT05827926|564663234|FG002|Overall Study|Withdrawal by Subject|1|||
156429411|NCT05827926|564663235|FG003|Overall Study|Withdrawal by Subject|1|||
156663071|NCT02549092|565512770|FG001|Treatment Period|Adverse Event|2|||
156663072|NCT02549092|565512769|FG000|Treatment Period|Withdrawal by Subject|1|||
156429412|NCT05827926|564663236|FG004|Overall Study|Withdrawal by Subject|0|||
156429413|NCT05827926|564663237|FG005|Overall Study|Withdrawal by Subject|0|||
156429414|NCT05827926|564663238|FG006|Overall Study|Withdrawal by Subject|0|||
156429415|NCT05827926|564663239|FG007|Overall Study|Withdrawal by Subject|0|||
156429416|NCT05827926|564663240|FG008|Overall Study|Withdrawal by Subject|0|||
156429417|NCT05827926|564663241|FG009|Overall Study|Withdrawal by Subject|0|||
156429418|NCT05827926|564663242|FG010|Overall Study|Withdrawal by Subject|0|||
156663073|NCT02549092|565512770|FG001|Treatment Period|Withdrawal by Subject|3|||
156663074|NCT02549092|565512769|FG000|Treatment Period|Lack of Efficacy|0|||
156663075|NCT02549092|565512770|FG001|Treatment Period|Lack of Efficacy|2|||
156663076|NCT02549092|565512769|FG000|Extension/Transition Period|Adverse Event|1|||
156663077|NCT02549092|565512770|FG001|Extension/Transition Period|Adverse Event|1|||
156663078|NCT02549092|565512769|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
156663079|NCT02549092|565512770|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
156663080|NCT02549092|565512769|FG000|Extension/Transition Period|Other, Not Specified|4|||
156663081|NCT02549092|565512770|FG001|Extension/Transition Period|Other, Not Specified|2|||
156663082|NCT03002077|565512777|FG000|Overall Study|Non-compliance with Study Drug|4|||
156663083|NCT03002077|565512777|FG000|Overall Study|Non-compliance w/Background ADT|1|||
156663084|NCT03002077|565512777|FG000|Overall Study|Study Terminated by Sponsor|257|||
156663085|NCT03002077|565512777|FG000|Overall Study|Site Terminated by Sponsor|5|||
156663086|NCT03002077|565512777|FG000|Overall Study|Miscellaneous Reasons|10|||
156663087|NCT03002077|565512777|FG000|Overall Study|Adverse Event|23|||
156663088|NCT03002077|565512777|FG000|Overall Study|Lack of Efficacy|20|||
156663089|NCT03002077|565512777|FG000|Overall Study|Withdrawal by Subject|72|||
156663090|NCT03002077|565512777|FG000|Overall Study|Lost to Follow-up|21|||
156663091|NCT03002077|565512777|FG000|Overall Study|Pregnancy|4|||
156324893|NCT01674634|564289445|FG000|Overall Study|Lost to Follow-up|3|||
156663092|NCT03002077|565512777|FG000|Overall Study|Protocol Violation|21|||
156663093|NCT01173692|565512780|FG000|Overall Study|Adverse Event|1|||
156324894|NCT05080660|564289446|FG000|Overall Study|Adverse Event|4|||
156324895|NCT05080660|564289447|FG001|Overall Study|Adverse Event|0|||
156324896|NCT05080660|564289446|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
156324897|NCT05080660|564289447|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
156324898|NCT05080660|564289446|FG000|Overall Study|Physician Decision|1|||
156324899|NCT05080660|564289447|FG001|Overall Study|Physician Decision|0|||
156324900|NCT05080660|564289446|FG000|Overall Study|Protocol Deviation|2|||
156324901|NCT05080660|564289447|FG001|Overall Study|Protocol Deviation|0|||
156324902|NCT05080660|564289446|FG000|Overall Study|Withdrawal by Subject|5|||
156324903|NCT05080660|564289447|FG001|Overall Study|Withdrawal by Subject|2|||
156324904|NCT00937391|564289448|FG000|Stage 2|Withdrawal by Subject|1|||
156324905|NCT01226043|564289461|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
156324906|NCT01226043|564289462|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
156324907|NCT01226043|564289463|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
156324908|NCT01226043|564289464|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
156324909|NCT01226043|564289461|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
156324910|NCT01226043|564289462|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
156324911|NCT01226043|564289463|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
156324912|NCT01226043|564289464|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
156324913|NCT01226043|564289461|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
156324914|NCT01226043|564289462|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
156324915|NCT01226043|564289463|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
156324916|NCT01226043|564289464|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
156663094|NCT01173692|565512781|FG001|Overall Study|Adverse Event|2|||
156663095|NCT01173692|565512780|FG000|Overall Study|Withdrawal by Subject|1|||
156663096|NCT01173692|565512781|FG001|Overall Study|Withdrawal by Subject|3|||
156663097|NCT04625114|565512784|FG000|Overall Study|Adverse Event|3|||
156663098|NCT04625114|565512785|FG001|Overall Study|Adverse Event|1|||
156663099|NCT04625114|565512784|FG000|Overall Study|Withdrawal by Subject|2|||
156663100|NCT04625114|565512785|FG001|Overall Study|Withdrawal by Subject|0|||
156663101|NCT01390844|565512788|FG000|Treatment Phase|Adverse Event|12|||
156663102|NCT01390844|565512789|FG001|Treatment Phase|Adverse Event|2|||
156663103|NCT01390844|565512790|FG002|Treatment Phase|Adverse Event|3|||
156663104|NCT01390844|565512791|FG003|Treatment Phase|Adverse Event|2|||
156663105|NCT01390844|565512788|FG000|Treatment Phase|Treatment Failure|23|||
156663106|NCT01390844|565512789|FG001|Treatment Phase|Treatment Failure|25|||
156663107|NCT01390844|565512790|FG002|Treatment Phase|Treatment Failure|10|||
156663108|NCT01390844|565512791|FG003|Treatment Phase|Treatment Failure|13|||
156663109|NCT01390844|565512788|FG000|Treatment Phase|Non-Medical Reasons|5|||
156663110|NCT01390844|565512789|FG001|Treatment Phase|Non-Medical Reasons|1|||
156663111|NCT01390844|565512790|FG002|Treatment Phase|Non-Medical Reasons|8|||
156663112|NCT01390844|565512791|FG003|Treatment Phase|Non-Medical Reasons|1|||
156663113|NCT01390844|565512788|FG000|Treatment Phase|Non-GCP Compliant|0|||
156663114|NCT01390844|565512789|FG001|Treatment Phase|Non-GCP Compliant|0|||
156663115|NCT01390844|565512790|FG002|Treatment Phase|Non-GCP Compliant|10|||
156663116|NCT01390844|565512791|FG003|Treatment Phase|Non-GCP Compliant|3|||
156663117|NCT01390844|565512788|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
156663118|NCT01390844|565512789|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
156663119|NCT01390844|565512790|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
156663120|NCT01390844|565512791|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
156663121|NCT03048500|565512794|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
156663122|NCT03048500|565512794|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
156775957|NCT04725188|565931359|FG002|Overall Study|Lost to Follow-up|1|||
156663123|NCT03048500|565512794|FG000|Reached 1st Response/Continued Treatment|Death|1|||
156663124|NCT03048500|565512794|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
156663125|NCT03048500|565512794|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
156663126|NCT03048500|565512794|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
156663127|NCT03048500|565512794|FG000|Follow up for 3 Years|Death|12|||
156663128|NCT01479439|565512797|FG000|Overall Study|Adverse Event|1|||
156663129|NCT01479439|565512798|FG001|Overall Study|Adverse Event|0|||
156663130|NCT01479439|565512799|FG002|Overall Study|Adverse Event|0|||
156663131|NCT01479439|565512797|FG000|Overall Study|Lost to Follow-up|0|||
156663132|NCT01479439|565512798|FG001|Overall Study|Lost to Follow-up|1|||
156663133|NCT01479439|565512799|FG002|Overall Study|Lost to Follow-up|0|||
156663134|NCT01479439|565512797|FG000|Overall Study|Protocol Violation|0|||
156663135|NCT01479439|565512798|FG001|Overall Study|Protocol Violation|0|||
156663136|NCT01479439|565512799|FG002|Overall Study|Protocol Violation|2|||
156663137|NCT03018249|565512801|FG000|Overall Study|Withdrawal by Subject|2|||
156429419|NCT05827926|564663243|FG011|Overall Study|Withdrawal by Subject|0|||
156429420|NCT05827926|564663244|FG012|Overall Study|Withdrawal by Subject|1|||
156429421|NCT05827926|564663245|FG013|Overall Study|Withdrawal by Subject|1|||
156429422|NCT05827926|564663246|FG014|Overall Study|Withdrawal by Subject|1|||
156429423|NCT05827926|564663247|FG015|Overall Study|Withdrawal by Subject|2|||
156429424|NCT05827926|564663248|FG016|Overall Study|Withdrawal by Subject|1|||
156429425|NCT05827926|564663249|FG017|Overall Study|Withdrawal by Subject|1|||
156429426|NCT05827926|564663250|FG018|Overall Study|Withdrawal by Subject|0|||
156429427|NCT05827926|564663251|FG019|Overall Study|Withdrawal by Subject|0|||
156429428|NCT05827926|564663252|FG020|Overall Study|Withdrawal by Subject|1|||
156429429|NCT05827926|564663253|FG021|Overall Study|Withdrawal by Subject|0|||
156429430|NCT05827926|564663254|FG022|Overall Study|Withdrawal by Subject|0|||
156429431|NCT05827926|564663255|FG023|Overall Study|Withdrawal by Subject|2|||
156429432|NCT05827926|564663256|FG024|Overall Study|Withdrawal by Subject|1|||
156429433|NCT05827926|564663257|FG025|Overall Study|Withdrawal by Subject|0|||
156429434|NCT05827926|564663258|FG026|Overall Study|Withdrawal by Subject|0|||
156429435|NCT05827926|564663259|FG027|Overall Study|Withdrawal by Subject|1|||
156429436|NCT05827926|564663260|FG028|Overall Study|Withdrawal by Subject|0|||
156429437|NCT05827926|564663261|FG029|Overall Study|Withdrawal by Subject|0|||
156429438|NCT05827926|564663262|FG030|Overall Study|Withdrawal by Subject|0|||
156429439|NCT05827926|564663263|FG031|Overall Study|Withdrawal by Subject|2|||
156429440|NCT05827926|564663264|FG032|Overall Study|Withdrawal by Subject|0|||
156429441|NCT05827926|564663265|FG033|Overall Study|Withdrawal by Subject|0|||
156429442|NCT05827926|564663266|FG034|Overall Study|Withdrawal by Subject|0|||
156429443|NCT05827926|564663267|FG035|Overall Study|Withdrawal by Subject|0|||
156429444|NCT05827926|564663268|FG036|Overall Study|Withdrawal by Subject|1|||
156429445|NCT05827926|564663232|FG000|Overall Study|Other Than Specified|0|||
156429446|NCT05827926|564663233|FG001|Overall Study|Other Than Specified|0|||
156429447|NCT05827926|564663234|FG002|Overall Study|Other Than Specified|0|||
156429448|NCT05827926|564663235|FG003|Overall Study|Other Than Specified|1|||
156429449|NCT05827926|564663236|FG004|Overall Study|Other Than Specified|0|||
156429450|NCT05827926|564663237|FG005|Overall Study|Other Than Specified|0|||
156429451|NCT05827926|564663238|FG006|Overall Study|Other Than Specified|1|||
156429452|NCT05827926|564663239|FG007|Overall Study|Other Than Specified|0|||
156429453|NCT05827926|564663240|FG008|Overall Study|Other Than Specified|0|||
156429454|NCT05827926|564663241|FG009|Overall Study|Other Than Specified|0|||
156429455|NCT05827926|564663242|FG010|Overall Study|Other Than Specified|0|||
156429456|NCT05827926|564663243|FG011|Overall Study|Other Than Specified|0|||
156429457|NCT05827926|564663244|FG012|Overall Study|Other Than Specified|0|||
156429458|NCT05827926|564663245|FG013|Overall Study|Other Than Specified|1|||
156663138|NCT03018249|565512802|FG001|Overall Study|Withdrawal by Subject|2|||
156429459|NCT05827926|564663246|FG014|Overall Study|Other Than Specified|0|||
156429460|NCT05827926|564663247|FG015|Overall Study|Other Than Specified|1|||
156429461|NCT05827926|564663248|FG016|Overall Study|Other Than Specified|0|||
156429462|NCT05827926|564663249|FG017|Overall Study|Other Than Specified|0|||
156429463|NCT05827926|564663250|FG018|Overall Study|Other Than Specified|0|||
156429464|NCT05827926|564663251|FG019|Overall Study|Other Than Specified|0|||
156429465|NCT05827926|564663252|FG020|Overall Study|Other Than Specified|0|||
156429466|NCT05827926|564663253|FG021|Overall Study|Other Than Specified|1|||
156429467|NCT05827926|564663254|FG022|Overall Study|Other Than Specified|1|||
156429468|NCT05827926|564663255|FG023|Overall Study|Other Than Specified|0|||
156429469|NCT05827926|564663256|FG024|Overall Study|Other Than Specified|0|||
156429470|NCT05827926|564663257|FG025|Overall Study|Other Than Specified|1|||
156663139|NCT02158936|565512805|FG000|Overall Study|Study closed/ terminated|57|||
156429471|NCT05827926|564663258|FG026|Overall Study|Other Than Specified|0|||
156429472|NCT05827926|564663259|FG027|Overall Study|Other Than Specified|0|||
156429473|NCT05827926|564663260|FG028|Overall Study|Other Than Specified|0|||
156663140|NCT02158936|565512806|FG001|Overall Study|Study closed/ terminated|77|||
156663141|NCT02158936|565512805|FG000|Overall Study|Azacitidine tx discontinued|53|||
156663142|NCT02158936|565512806|FG001|Overall Study|Azacitidine tx discontinued|46|||
156663143|NCT02158936|565512805|FG000|Overall Study|Adverse Event|39|||
156663144|NCT02158936|565512806|FG001|Overall Study|Adverse Event|24|||
156663145|NCT02158936|565512805|FG000|Overall Study|Withdrawal by Subject|15|||
156663146|NCT02158936|565512806|FG001|Overall Study|Withdrawal by Subject|16|||
156663147|NCT02158936|565512805|FG000|Overall Study|Physician Decision|15|||
156663148|NCT02158936|565512806|FG001|Overall Study|Physician Decision|13|||
156663149|NCT02158936|565512805|FG000|Overall Study|Lost to Follow-up|0|||
156663150|NCT02158936|565512806|FG001|Overall Study|Lost to Follow-up|1|||
156663151|NCT00522457|565512807|FG000|Overall Study|Due to disease progression|16|||
156663152|NCT00522457|565512807|FG000|Overall Study|Adverse Event|2|||
156663153|NCT01215981|565514843|FG000|Overall Study|Physician Decision|0|||
156663154|NCT01215981|565514844|FG001|Overall Study|Physician Decision|1|||
156663155|NCT01215981|565514843|FG000|Overall Study|Protocol Violation|1|||
156663156|NCT01215981|565514844|FG001|Overall Study|Protocol Violation|0|||
156663157|NCT01215981|565514843|FG000|Overall Study|Withdrawal by Subject|1|||
156663158|NCT01215981|565514844|FG001|Overall Study|Withdrawal by Subject|0|||
156663159|NCT04657770|565514845|FG000|Overall Study|Withdrawal by Subject|3|||
156663160|NCT04657770|565514845|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
156663161|NCT03497897|565514846|FG000|Overall Study|Adverse Event|1|||
156663162|NCT03497897|565514847|FG001|Overall Study|Adverse Event|1|||
156663163|NCT03497897|565514848|FG002|Overall Study|Adverse Event|1|||
156663164|NCT03497897|565514846|FG000|Overall Study|Lost to Follow-up|2|||
156663165|NCT03497897|565514847|FG001|Overall Study|Lost to Follow-up|0|||
156663166|NCT03497897|565514848|FG002|Overall Study|Lost to Follow-up|2|||
156663167|NCT03497897|565514846|FG000|Overall Study|Physician Decision|1|||
156663168|NCT03497897|565514847|FG001|Overall Study|Physician Decision|0|||
156663169|NCT03497897|565514848|FG002|Overall Study|Physician Decision|0|||
156663170|NCT03497897|565514846|FG000|Overall Study|Subject/Guardian Decision|2|||
156663171|NCT03497897|565514847|FG001|Overall Study|Subject/Guardian Decision|1|||
156663172|NCT03497897|565514848|FG002|Overall Study|Subject/Guardian Decision|3|||
156663173|NCT01710657|565514849|FG000|Overall Study|Lost to Follow-up|2|||
156663174|NCT01710657|565514850|FG001|Overall Study|Lost to Follow-up|0|||
156663175|NCT01710657|565514851|FG002|Overall Study|Lost to Follow-up|1|||
156663176|NCT01710657|565514849|FG000|Overall Study|Protocol Violation|2|||
156429474|NCT05827926|564663261|FG029|Overall Study|Other Than Specified|0|||
156429475|NCT05827926|564663262|FG030|Overall Study|Other Than Specified|0|||
156429476|NCT05827926|564663263|FG031|Overall Study|Other Than Specified|1|||
156429477|NCT05827926|564663264|FG032|Overall Study|Other Than Specified|0|||
156429478|NCT05827926|564663265|FG033|Overall Study|Other Than Specified|0|||
156429479|NCT05827926|564663266|FG034|Overall Study|Other Than Specified|0|||
156429480|NCT05827926|564663267|FG035|Overall Study|Other Than Specified|0|||
156429481|NCT05827926|564663268|FG036|Overall Study|Other Than Specified|0|||
156429482|NCT05827926|564663232|FG000|Overall Study|Physician Decision|0|||
156429483|NCT05827926|564663233|FG001|Overall Study|Physician Decision|0|||
156429484|NCT05827926|564663234|FG002|Overall Study|Physician Decision|0|||
156429485|NCT05827926|564663235|FG003|Overall Study|Physician Decision|0|||
156429486|NCT05827926|564663236|FG004|Overall Study|Physician Decision|0|||
156429487|NCT05827926|564663237|FG005|Overall Study|Physician Decision|0|||
156429488|NCT05827926|564663238|FG006|Overall Study|Physician Decision|0|||
156429489|NCT05827926|564663239|FG007|Overall Study|Physician Decision|0|||
156429490|NCT05827926|564663240|FG008|Overall Study|Physician Decision|0|||
156663177|NCT01710657|565514850|FG001|Overall Study|Protocol Violation|2|||
156663178|NCT01710657|565514851|FG002|Overall Study|Protocol Violation|0|||
156663179|NCT01710657|565514849|FG000|Overall Study|Adverse Event|14|||
156663180|NCT01710657|565514850|FG001|Overall Study|Adverse Event|8|||
156663181|NCT01710657|565514851|FG002|Overall Study|Adverse Event|28|||
156663182|NCT01710657|565514849|FG000|Overall Study|Withdrawal by Subject|0|||
156663183|NCT01710657|565514850|FG001|Overall Study|Withdrawal by Subject|1|||
156775958|NCT04725188|565931357|FG000|Overall Study|Withdrawal by Subject|2|||
156775959|NCT04725188|565931358|FG001|Overall Study|Withdrawal by Subject|2|||
156775960|NCT04725188|565931359|FG002|Overall Study|Withdrawal by Subject|1|||
156775961|NCT04725188|565931357|FG000|Overall Study|Sponsor Decision|12|||
156663184|NCT01710657|565514851|FG002|Overall Study|Withdrawal by Subject|2|||
156775962|NCT04725188|565931358|FG001|Overall Study|Sponsor Decision|12|||
156775963|NCT04725188|565931359|FG002|Overall Study|Sponsor Decision|7|||
156429491|NCT05827926|564663241|FG009|Overall Study|Physician Decision|0|||
156429492|NCT05827926|564663242|FG010|Overall Study|Physician Decision|0|||
156663185|NCT01710657|565514849|FG000|Overall Study|Lack of Efficacy|0|||
156429493|NCT05827926|564663243|FG011|Overall Study|Physician Decision|0|||
156663186|NCT01710657|565514850|FG001|Overall Study|Lack of Efficacy|1|||
156663187|NCT01710657|565514851|FG002|Overall Study|Lack of Efficacy|1|||
156429494|NCT05827926|564663244|FG012|Overall Study|Physician Decision|0|||
156429495|NCT05827926|564663245|FG013|Overall Study|Physician Decision|0|||
156429496|NCT05827926|564663246|FG014|Overall Study|Physician Decision|0|||
156429497|NCT05827926|564663247|FG015|Overall Study|Physician Decision|0|||
156663188|NCT02495857|565514858|FG000|Overall Study|Adverse Event|5|||
156663189|NCT02495857|565514859|FG001|Overall Study|Adverse Event|0|||
156775964|NCT00390013|565931361|FG000|Phase 1|tired|0|||
156429498|NCT05827926|564663248|FG016|Overall Study|Physician Decision|0|||
156663190|NCT02495857|565514860|FG002|Overall Study|Adverse Event|1|||
156663191|NCT02495857|565514858|FG000|Overall Study|Withdrawal by Subject|9|||
156663192|NCT02495857|565514859|FG001|Overall Study|Withdrawal by Subject|6|||
156663193|NCT02495857|565514860|FG002|Overall Study|Withdrawal by Subject|10|||
156663194|NCT02495857|565514858|FG000|Overall Study|Physician Decision|0|||
156663195|NCT02495857|565514859|FG001|Overall Study|Physician Decision|1|||
156663196|NCT02495857|565514860|FG002|Overall Study|Physician Decision|0|||
156663197|NCT02495857|565514858|FG000|Overall Study|Protocol Violation|1|||
156663198|NCT02495857|565514859|FG001|Overall Study|Protocol Violation|1|||
156663199|NCT02495857|565514860|FG002|Overall Study|Protocol Violation|2|||
156663200|NCT02495857|565514858|FG000|Overall Study|Lost to Follow-up|4|||
156663201|NCT02495857|565514859|FG001|Overall Study|Lost to Follow-up|5|||
156663202|NCT02495857|565514860|FG002|Overall Study|Lost to Follow-up|3|||
156663203|NCT02495857|565514858|FG000|Overall Study|Other|3|||
156663204|NCT02495857|565514859|FG001|Overall Study|Other|3|||
156663205|NCT02495857|565514860|FG002|Overall Study|Other|2|||
156663206|NCT04407806|565514863|FG000|Overall Study|Withdrawal by Subject|1|||
156663207|NCT04407806|565514864|FG001|Overall Study|Withdrawal by Subject|2|||
156663208|NCT03447262|565514865|FG000|Overall Study|Adverse Event|7|||
156663209|NCT03447262|565514865|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
156663210|NCT03447262|565514865|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
156663211|NCT03447262|565514865|FG000|Overall Study|Death|2|||
156663212|NCT03447262|565514865|FG000|Overall Study|Study Termination by Sponsor|455|||
156663213|NCT03447262|565514865|FG000|Overall Study|Other|4|||
156663214|NCT02058498|565514867|FG000|Overall Study|Withdrawal by Subject|4|||
156663215|NCT05327491|565514868|FG000|Periods 1 & 2|Miscellaneous|0|||
156663216|NCT05327491|565514869|FG001|Periods 1 & 2|Miscellaneous|1|||
156663217|NCT05327491|565514870|FG002|Periods 1 & 2|Miscellaneous|0|||
156663218|NCT05327491|565514871|FG003|Periods 1 & 2|Miscellaneous|0|||
156663219|NCT05327491|565514868|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
156663220|NCT05327491|565514869|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
156663221|NCT05327491|565514870|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
156663222|NCT05327491|565514871|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
156663223|NCT05612724|565514872|FG000|Overall Study|Lost to Follow-up|4|||
156663224|NCT02422264|565514875|FG000|Overall Study|Serious Adverse Event|1|||
156663225|NCT02422264|565514876|FG001|Overall Study|Serious Adverse Event|0|||
156663226|NCT02422264|565514875|FG000|Overall Study|Withdrawal by Subject|1|||
156663227|NCT02422264|565514876|FG001|Overall Study|Withdrawal by Subject|2|||
156663228|NCT02422264|565514875|FG000|Overall Study|Migrated/moved from study area|3|||
156663229|NCT02422264|565514876|FG001|Overall Study|Migrated/moved from study area|1|||
156663230|NCT02422264|565514875|FG000|Overall Study|Subject vaccinated outside of the study|0|||
156663231|NCT02422264|565514876|FG001|Overall Study|Subject vaccinated outside of the study|1|||
156663232|NCT00856388|565514879|FG000|Overall Study|Other|1|||
156663233|NCT01038856|565514883|FG000|Overall Study|Adverse Event|2|||
156429499|NCT05827926|564663249|FG017|Overall Study|Physician Decision|0|||
156663234|NCT02300103|565514884|FG000|Overall Study|Lack of Efficacy|3|||
156663235|NCT02300103|565514884|FG000|Overall Study|Protocol Violation|1|||
156663236|NCT02300103|565514884|FG000|Overall Study|Withdrew Consent|2|||
156663237|NCT04091971|565514885|FG000|Overall Study|Withdrawal by Subject|1|||
156663238|NCT04091971|565514885|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
156663239|NCT04091971|565514885|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
156663240|NCT00150462|565514886|FG000|Overall Study|Disease Progression or Relapse|3|||
156663241|NCT00150462|565514887|FG001|Overall Study|Disease Progression or Relapse|1|||
156663242|NCT00150462|565514888|FG002|Overall Study|Disease Progression or Relapse|2|||
156663243|NCT00150462|565514889|FG003|Overall Study|Disease Progression or Relapse|1|||
156663244|NCT00150462|565514890|FG004|Overall Study|Disease Progression or Relapse|2|||
156663245|NCT00150462|565514891|FG005|Overall Study|Disease Progression or Relapse|2|||
156663246|NCT00150462|565514892|FG006|Overall Study|Disease Progression or Relapse|3|||
156663247|NCT00150462|565514893|FG007|Overall Study|Disease Progression or Relapse|5|||
156663248|NCT00150462|565514894|FG008|Overall Study|Disease Progression or Relapse|5|||
156663249|NCT00150462|565514895|FG009|Overall Study|Disease Progression or Relapse|3|||
156663250|NCT00150462|565514896|FG010|Overall Study|Disease Progression or Relapse|2|||
156663251|NCT00150462|565514886|FG000|Overall Study|Withdrawal by Subject|0|||
156663252|NCT00150462|565514887|FG001|Overall Study|Withdrawal by Subject|1|||
156663253|NCT00150462|565514888|FG002|Overall Study|Withdrawal by Subject|1|||
156663254|NCT00150462|565514889|FG003|Overall Study|Withdrawal by Subject|0|||
156663255|NCT00150462|565514890|FG004|Overall Study|Withdrawal by Subject|1|||
156663256|NCT00150462|565514891|FG005|Overall Study|Withdrawal by Subject|2|||
156429500|NCT05827926|564663250|FG018|Overall Study|Physician Decision|1|||
156663257|NCT00150462|565514892|FG006|Overall Study|Withdrawal by Subject|0|||
156663258|NCT00150462|565514893|FG007|Overall Study|Withdrawal by Subject|1|||
156663259|NCT00150462|565514894|FG008|Overall Study|Withdrawal by Subject|0|||
156663260|NCT00150462|565514895|FG009|Overall Study|Withdrawal by Subject|1|||
156663261|NCT00150462|565514896|FG010|Overall Study|Withdrawal by Subject|0|||
156663262|NCT00150462|565514886|FG000|Overall Study|Death|0|||
156663263|NCT00150462|565514887|FG001|Overall Study|Death|1|||
156663264|NCT00150462|565514888|FG002|Overall Study|Death|0|||
156663265|NCT00150462|565514889|FG003|Overall Study|Death|0|||
156663266|NCT00150462|565514890|FG004|Overall Study|Death|0|||
156663267|NCT00150462|565514891|FG005|Overall Study|Death|0|||
156663268|NCT00150462|565514892|FG006|Overall Study|Death|0|||
156663269|NCT00150462|565514893|FG007|Overall Study|Death|0|||
156663270|NCT00150462|565514894|FG008|Overall Study|Death|1|||
156663271|NCT00150462|565514895|FG009|Overall Study|Death|0|||
156663272|NCT00150462|565514896|FG010|Overall Study|Death|0|||
156663273|NCT00150462|565514886|FG000|Overall Study|Adverse Event|0|||
156663274|NCT00150462|565514887|FG001|Overall Study|Adverse Event|0|||
156663275|NCT00150462|565514888|FG002|Overall Study|Adverse Event|0|||
156663276|NCT00150462|565514889|FG003|Overall Study|Adverse Event|1|||
156663277|NCT00150462|565514890|FG004|Overall Study|Adverse Event|0|||
156663278|NCT00150462|565514891|FG005|Overall Study|Adverse Event|0|||
156663279|NCT00150462|565514892|FG006|Overall Study|Adverse Event|0|||
156663280|NCT00150462|565514893|FG007|Overall Study|Adverse Event|2|||
156663281|NCT00150462|565514894|FG008|Overall Study|Adverse Event|0|||
156663282|NCT00150462|565514895|FG009|Overall Study|Adverse Event|1|||
156663283|NCT00150462|565514896|FG010|Overall Study|Adverse Event|0|||
156663284|NCT00150462|565514886|FG000|Overall Study|Physician Decision|0|||
156663285|NCT00150462|565514887|FG001|Overall Study|Physician Decision|0|||
156663286|NCT00150462|565514888|FG002|Overall Study|Physician Decision|1|||
156663287|NCT00150462|565514889|FG003|Overall Study|Physician Decision|1|||
156663288|NCT00150462|565514890|FG004|Overall Study|Physician Decision|0|||
156663289|NCT00150462|565514891|FG005|Overall Study|Physician Decision|0|||
156663290|NCT00150462|565514892|FG006|Overall Study|Physician Decision|0|||
156663291|NCT00150462|565514893|FG007|Overall Study|Physician Decision|0|||
156663292|NCT00150462|565514894|FG008|Overall Study|Physician Decision|0|||
156663293|NCT00150462|565514895|FG009|Overall Study|Physician Decision|0|||
156663294|NCT00150462|565514896|FG010|Overall Study|Physician Decision|0|||
156663295|NCT00150462|565514886|FG000|Overall Study|Other|0|||
156663296|NCT00150462|565514887|FG001|Overall Study|Other|0|||
156663297|NCT00150462|565514888|FG002|Overall Study|Other|0|||
156663298|NCT00150462|565514889|FG003|Overall Study|Other|0|||
156663299|NCT00150462|565514890|FG004|Overall Study|Other|0|||
156663300|NCT00150462|565514891|FG005|Overall Study|Other|0|||
156663301|NCT00150462|565514892|FG006|Overall Study|Other|0|||
156663302|NCT00150462|565514893|FG007|Overall Study|Other|0|||
156663303|NCT00150462|565514894|FG008|Overall Study|Other|0|||
156663304|NCT00150462|565514895|FG009|Overall Study|Other|1|||
156663305|NCT00150462|565514896|FG010|Overall Study|Other|1|||
156663306|NCT04638153|565514897|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156663307|NCT04638153|565514898|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156663308|NCT04638153|565514899|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156663309|NCT04638153|565514897|FG000|Overall Study|Study terminated by sponsor|4|||
156663310|NCT04638153|565514898|FG001|Overall Study|Study terminated by sponsor|2|||
156663311|NCT04638153|565514899|FG002|Overall Study|Study terminated by sponsor|14|||
156663312|NCT01440283|565514902|FG000|Overall Study|Death|3|||
156663313|NCT01440283|565514902|FG000|Overall Study|Withdrawal by Subject|4|||
156663314|NCT01440283|565514902|FG000|Overall Study|Physician Decision|3|||
156663315|NCT01389102|565514903|FG000|Overall Study|Adverse Event|1|||
156663316|NCT01389102|565514904|FG001|Overall Study|Adverse Event|3|||
156663317|NCT01389102|565514905|FG002|Overall Study|Adverse Event|2|||
156663318|NCT01389102|565514906|FG003|Overall Study|Adverse Event|2|||
156663319|NCT01389102|565514907|FG004|Overall Study|Adverse Event|2|||
156663320|NCT01389102|565514908|FG005|Overall Study|Adverse Event|2|||
156663321|NCT01389102|565514903|FG000|Overall Study|Hurricane Katrina|4|||
156663322|NCT01389102|565514904|FG001|Overall Study|Hurricane Katrina|2|||
156663323|NCT01389102|565514905|FG002|Overall Study|Hurricane Katrina|3|||
156775965|NCT00390013|565931362|FG001|Phase 1|tired|0|||
156775966|NCT00390013|565931363|FG002|Phase 1|tired|0|||
156429501|NCT05827926|564663251|FG019|Overall Study|Physician Decision|0|||
156663324|NCT01389102|565514906|FG003|Overall Study|Hurricane Katrina|0|||
156663325|NCT01389102|565514907|FG004|Overall Study|Hurricane Katrina|3|||
156663326|NCT01389102|565514908|FG005|Overall Study|Hurricane Katrina|1|||
156663327|NCT01389102|565514903|FG000|Overall Study|Lost to Follow-up|4|||
156663328|NCT01389102|565514904|FG001|Overall Study|Lost to Follow-up|1|||
156663329|NCT01389102|565514905|FG002|Overall Study|Lost to Follow-up|1|||
156663330|NCT01389102|565514906|FG003|Overall Study|Lost to Follow-up|2|||
156663331|NCT01389102|565514907|FG004|Overall Study|Lost to Follow-up|4|||
156663332|NCT01389102|565514908|FG005|Overall Study|Lost to Follow-up|1|||
156663333|NCT01389102|565514903|FG000|Overall Study|Protocol Violation|0|||
156663334|NCT01389102|565514904|FG001|Overall Study|Protocol Violation|0|||
156663335|NCT01389102|565514905|FG002|Overall Study|Protocol Violation|3|||
156663336|NCT01389102|565514906|FG003|Overall Study|Protocol Violation|0|||
156663337|NCT01389102|565514907|FG004|Overall Study|Protocol Violation|1|||
156663338|NCT01389102|565514908|FG005|Overall Study|Protocol Violation|1|||
156663339|NCT01389102|565514903|FG000|Overall Study|Withdrawal by Subject|7|||
156663340|NCT01389102|565514904|FG001|Overall Study|Withdrawal by Subject|4|||
156663341|NCT01389102|565514905|FG002|Overall Study|Withdrawal by Subject|9|||
156324917|NCT01226043|564289461|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
156324918|NCT01226043|564289462|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
156324919|NCT01226043|564289463|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
156324920|NCT01226043|564289464|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
156324921|NCT01226043|564289461|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
156429502|NCT05827926|564663252|FG020|Overall Study|Physician Decision|0|||
156429503|NCT05827926|564663253|FG021|Overall Study|Physician Decision|0|||
156429504|NCT05827926|564663254|FG022|Overall Study|Physician Decision|0|||
156429505|NCT05827926|564663255|FG023|Overall Study|Physician Decision|0|||
156429506|NCT05827926|564663256|FG024|Overall Study|Physician Decision|0|||
156429507|NCT05827926|564663257|FG025|Overall Study|Physician Decision|0|||
156429508|NCT05827926|564663258|FG026|Overall Study|Physician Decision|0|||
156429509|NCT05827926|564663259|FG027|Overall Study|Physician Decision|0|||
156429510|NCT05827926|564663260|FG028|Overall Study|Physician Decision|0|||
156429511|NCT05827926|564663261|FG029|Overall Study|Physician Decision|0|||
156429512|NCT05827926|564663262|FG030|Overall Study|Physician Decision|0|||
156429513|NCT05827926|564663263|FG031|Overall Study|Physician Decision|0|||
156429514|NCT05827926|564663264|FG032|Overall Study|Physician Decision|0|||
156429515|NCT05827926|564663265|FG033|Overall Study|Physician Decision|0|||
156429516|NCT05827926|564663266|FG034|Overall Study|Physician Decision|0|||
156429517|NCT05827926|564663267|FG035|Overall Study|Physician Decision|0|||
156429518|NCT05827926|564663268|FG036|Overall Study|Physician Decision|0|||
156429519|NCT01744691|564663275|FG000|Overall Study|Progressive Disease|18|||
156429520|NCT01744691|564663275|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
156429521|NCT01744691|564663275|FG000|Overall Study|Withdrawal of consent for treatment|3|||
156429522|NCT01744691|564663275|FG000|Overall Study|Physician Decision|4|||
156429523|NCT02701361|564663277|FG000|Overall Study|Lost to Follow-up|5|||
156429524|NCT02701361|564663278|FG001|Overall Study|Lost to Follow-up|2|||
156429525|NCT02701361|564663279|FG002|Overall Study|Lost to Follow-up|1|||
156429526|NCT02701361|564663277|FG000|Overall Study|Withdrawal by Subject|4|||
156429527|NCT02701361|564663278|FG001|Overall Study|Withdrawal by Subject|0|||
156429528|NCT02701361|564663279|FG002|Overall Study|Withdrawal by Subject|0|||
156429529|NCT02701361|564663277|FG000|Overall Study|timed out in rehab center|0|||
156429530|NCT02701361|564663278|FG001|Overall Study|timed out in rehab center|1|||
156429531|NCT02701361|564663279|FG002|Overall Study|timed out in rehab center|0|||
156429532|NCT02701361|564663277|FG000|Overall Study|incarceration|0|||
156429533|NCT02701361|564663278|FG001|Overall Study|incarceration|0|||
156429534|NCT02701361|564663279|FG002|Overall Study|incarceration|1|||
156429535|NCT04588480|564663280|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
156429536|NCT04588480|564663281|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
156429537|NCT04588480|564663282|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
156429538|NCT04588480|564663280|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
156429539|NCT04588480|564663281|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
156429540|NCT04588480|564663282|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
156429541|NCT01242085|564663283|FG000|Overall Study|Withdrawal by Subject|4|||
156429542|NCT01242085|564663284|FG001|Overall Study|Withdrawal by Subject|2|||
156429543|NCT01242085|564663285|FG002|Overall Study|Withdrawal by Subject|0|||
156429544|NCT01242085|564663283|FG000|Overall Study|medically unable to have surgery|4|||
156429545|NCT01242085|564663284|FG001|Overall Study|medically unable to have surgery|5|||
156324922|NCT01226043|564289462|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
156324923|NCT01226043|564289463|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
156324924|NCT01226043|564289464|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
156429546|NCT01242085|564663285|FG002|Overall Study|medically unable to have surgery|0|||
156429547|NCT01178762|564663286|FG000|Overall Study|Lost to Follow-up|15|||
156429548|NCT02322216|564663289|FG000|Overall Study|Adverse Event|1|||
156429549|NCT02322216|564663290|FG001|Overall Study|Adverse Event|0|||
156429550|NCT02322216|564663289|FG000|Overall Study|Withdrawal by Subject|1|||
156429551|NCT02322216|564663290|FG001|Overall Study|Withdrawal by Subject|4|||
156429552|NCT02430532|564663292|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
156429553|NCT02430532|564663293|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
156429554|NCT02430532|564663292|FG000|Overall Study|Consent Withdrawn|0|||
156429555|NCT02430532|564663293|FG001|Overall Study|Consent Withdrawn|2|||
156429556|NCT02430532|564663292|FG000|Overall Study|Adverse Event|0|||
156429557|NCT02430532|564663293|FG001|Overall Study|Adverse Event|1|||
156429558|NCT01190150|564663294|FG000|First Treatment|Withdrawal by Subject|1|||
156429559|NCT01190150|564663295|FG001|First Treatment|Withdrawal by Subject|0|||
156429560|NCT01190150|564663294|FG000|Washout|Withdrawal by Subject|0|||
156524378|NCT01740323|565013884|FG000|Overall Study|Randomized but did not take study drug|1|||
156429561|NCT01190150|564663295|FG001|Washout|Withdrawal by Subject|1|||
156429562|NCT01190150|564663294|FG000|Washout|Difficulty in adherence|0|||
156524379|NCT01740323|565013885|FG001|Overall Study|Randomized but did not take study drug|0|||
156429563|NCT01190150|564663295|FG001|Washout|Difficulty in adherence|1|||
156429564|NCT02873754|564663300|FG000|Overall Study|Lost to Follow-up|5|||
156429565|NCT02873754|564663300|FG000|Overall Study|Couldn't complete study procedures|1|||
156524380|NCT02112708|565013891|FG000|Baseline|Physician Decision|16|||
156429566|NCT01081145|564663304|FG000|Open-Label Phase|Lack of Efficacy|56|||
156429567|NCT01081145|564663305|FG001|Open-Label Phase|Lack of Efficacy|0|||
156429568|NCT01081145|564663304|FG000|Open-Label Phase|Response criteria not met|46|||
156429569|NCT01081145|564663305|FG001|Open-Label Phase|Response criteria not met|0|||
156429570|NCT01081145|564663304|FG000|Open-Label Phase|Adverse Event|42|||
156429571|NCT01081145|564663305|FG001|Open-Label Phase|Adverse Event|0|||
156429572|NCT01081145|564663304|FG000|Open-Label Phase|Withdrawal by Subject|41|||
156429573|NCT01081145|564663305|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156429574|NCT01081145|564663304|FG000|Open-Label Phase|Other|12|||
156429575|NCT01081145|564663305|FG001|Open-Label Phase|Other|0|||
156429576|NCT01081145|564663304|FG000|Open-Label Phase|Lost to Follow-up|11|||
156429577|NCT01081145|564663305|FG001|Open-Label Phase|Lost to Follow-up|0|||
156663342|NCT01389102|565514906|FG003|Overall Study|Withdrawal by Subject|2|||
156663343|NCT01389102|565514907|FG004|Overall Study|Withdrawal by Subject|3|||
156663344|NCT01389102|565514908|FG005|Overall Study|Withdrawal by Subject|3|||
156663345|NCT01389102|565514903|FG000|Overall Study|Subject Traveling Out of Country|0|||
156663346|NCT01389102|565514904|FG001|Overall Study|Subject Traveling Out of Country|0|||
156663347|NCT01389102|565514905|FG002|Overall Study|Subject Traveling Out of Country|0|||
156663348|NCT01389102|565514906|FG003|Overall Study|Subject Traveling Out of Country|1|||
156663349|NCT01389102|565514907|FG004|Overall Study|Subject Traveling Out of Country|0|||
156663350|NCT01389102|565514908|FG005|Overall Study|Subject Traveling Out of Country|0|||
156663351|NCT01389102|565514903|FG000|Overall Study|Subject Moved|2|||
156663352|NCT01389102|565514904|FG001|Overall Study|Subject Moved|0|||
156663353|NCT01389102|565514905|FG002|Overall Study|Subject Moved|1|||
156663354|NCT01389102|565514906|FG003|Overall Study|Subject Moved|0|||
156663355|NCT01389102|565514907|FG004|Overall Study|Subject Moved|0|||
156663356|NCT01389102|565514908|FG005|Overall Study|Subject Moved|0|||
156663357|NCT01389102|565514903|FG000|Overall Study|Unavailable due to husband's illness|0|||
156663358|NCT01389102|565514904|FG001|Overall Study|Unavailable due to husband's illness|1|||
156663359|NCT01389102|565514905|FG002|Overall Study|Unavailable due to husband's illness|0|||
156663360|NCT01389102|565514906|FG003|Overall Study|Unavailable due to husband's illness|0|||
156663361|NCT01389102|565514907|FG004|Overall Study|Unavailable due to husband's illness|0|||
156663362|NCT01389102|565514908|FG005|Overall Study|Unavailable due to husband's illness|0|||
156663363|NCT01389102|565514903|FG000|Overall Study|Investigator Judgement|0|||
156663364|NCT01389102|565514904|FG001|Overall Study|Investigator Judgement|1|||
156663365|NCT01389102|565514905|FG002|Overall Study|Investigator Judgement|0|||
156663366|NCT01389102|565514906|FG003|Overall Study|Investigator Judgement|0|||
156663367|NCT01389102|565514907|FG004|Overall Study|Investigator Judgement|0|||
156663368|NCT01389102|565514908|FG005|Overall Study|Investigator Judgement|0|||
156663369|NCT01661686|565514909|FG000|Overall Study|Lost to Follow-up|2|||
156663370|NCT01661686|565514910|FG001|Overall Study|Lost to Follow-up|1|||
156663371|NCT01661686|565514909|FG000|Overall Study|did not receive allocated intervention|0|||
156663372|NCT01661686|565514910|FG001|Overall Study|did not receive allocated intervention|1|||
156663373|NCT04869787|565514915|FG000|Screening|Physician Decision|1|||
156663374|NCT04869787|565514915|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
156663375|NCT00454909|565514916|FG000|Overall Study|Withdrawal by Subject|1|||
156663376|NCT00454909|565514917|FG001|Overall Study|Withdrawal by Subject|0|||
156663377|NCT00454909|565514918|FG002|Overall Study|Withdrawal by Subject|0|||
156663378|NCT00454909|565514916|FG000|Overall Study|Migrated/moved from study area|0|||
156663379|NCT00454909|565514917|FG001|Overall Study|Migrated/moved from study area|0|||
156663380|NCT00454909|565514918|FG002|Overall Study|Migrated/moved from study area|1|||
156663381|NCT00454909|565514916|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
156663382|NCT00454909|565514917|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
156663383|NCT00454909|565514918|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
156663384|NCT00454909|565514916|FG000|Overall Study|Others|1|||
156663385|NCT00454909|565514917|FG001|Overall Study|Others|0|||
156775967|NCT00390013|565931364|FG003|Phase 1|tired|1|||
156775968|NCT00390013|565931361|FG000|Phase 2 First Treatment|tired|1|||
156429578|NCT01081145|564663304|FG000|Open-Label Phase|Protocol Violation|4|||
156429579|NCT01081145|564663305|FG001|Open-Label Phase|Protocol Violation|0|||
156429580|NCT01081145|564663304|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
156429581|NCT01081145|564663305|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
156429582|NCT01081145|564663304|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
156429583|NCT01081145|564663305|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
156524381|NCT02112708|565013892|FG001|Baseline|Physician Decision|11|||
156429584|NCT01081145|564663304|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
156663386|NCT00454909|565514918|FG002|Overall Study|Others|0|||
156663387|NCT02996682|565514919|FG000|Overall Study|Death|0|||
156663388|NCT02996682|565514920|FG001|Overall Study|Death|3|||
156663389|NCT01981720|565514921|FG000|Overall Study|Adverse Event|1|||
156663390|NCT01981720|565514921|FG000|Overall Study|Withdrawal by Subject|3|||
156663391|NCT01981720|565514921|FG000|Overall Study|Pregnancy|1|||
156663392|NCT00259012|565514922|FG000|Overall Study|Adverse Event|0|||
156663393|NCT00259012|565514923|FG001|Overall Study|Adverse Event|1|||
156324925|NCT01226043|564289461|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
156324926|NCT01226043|564289462|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
156324927|NCT01226043|564289463|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
156324928|NCT01226043|564289464|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
156324929|NCT01226043|564289461|FG000|6-week Re-randomization Phase|Adverse Event|0|||
156324930|NCT01226043|564289462|FG001|6-week Re-randomization Phase|Adverse Event|0|||
156663394|NCT00259012|565514922|FG000|Overall Study|Withdrawal by Subject|1|||
156663395|NCT00259012|565514923|FG001|Overall Study|Withdrawal by Subject|0|||
156663396|NCT00259012|565514922|FG000|Overall Study|Physician Decision|0|||
156663397|NCT00259012|565514923|FG001|Overall Study|Physician Decision|1|||
156663398|NCT00259012|565514922|FG000|Overall Study|Lost to Follow-up|0|||
156663399|NCT00259012|565514923|FG001|Overall Study|Lost to Follow-up|1|||
156663400|NCT00259012|565514922|FG000|Overall Study|Protocol Violation|1|||
156663401|NCT00259012|565514923|FG001|Overall Study|Protocol Violation|1|||
156663402|NCT00707161|565514924|FG000|Overall Study|Physician Decision|6|||
156663403|NCT02511782|565514925|FG000|Overall Study|Withdrawal by Subject|1|||
156663404|NCT02511782|565514926|FG001|Overall Study|Withdrawal by Subject|0|||
156663405|NCT02511782|565514927|FG002|Overall Study|Withdrawal by Subject|0|||
156663406|NCT00450190|565514928|FG000|Overall Study|Withdrawal by Subject|2|||
156775969|NCT00390013|565931362|FG001|Phase 2 First Treatment|tired|0|||
156775970|NCT00390013|565931363|FG002|Phase 2 First Treatment|tired|0|||
156775971|NCT00390013|565931364|FG003|Phase 2 First Treatment|tired|0|||
156775972|NCT00390013|565931361|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
156775973|NCT00390013|565931362|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
156775974|NCT00390013|565931363|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
156775975|NCT00390013|565931364|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
156775976|NCT03839641|565931365|FG000|Overall Study|Withdrawal by Subject|1|||
156775977|NCT03839641|565931366|FG001|Overall Study|Withdrawal by Subject|1|||
156775978|NCT04221490|565931370|FG000|At 30 Days Follow-up|Death|7|||
156775979|NCT04221490|565931370|FG000|At 30 Days Follow-up|Missed Visit|4|||
156775980|NCT04221490|565931370|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
156775981|NCT04221490|565931370|FG000|At 6 Months Follow-up|Death|9|||
156775982|NCT04221490|565931370|FG000|At 6 Months Follow-up|Physician Decision|1|||
156775983|NCT04221490|565931370|FG000|At 6 Months Follow-up|Missed Visit|8|||
156775984|NCT04221490|565931370|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
156775985|NCT04896385|565931383|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
156775986|NCT04896385|565931384|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
156775987|NCT04896385|565931385|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
156775988|NCT04896385|565931386|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
156775989|NCT04896385|565931383|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
156775990|NCT04896385|565931384|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
156324931|NCT01226043|564289463|FG002|6-week Re-randomization Phase|Adverse Event|1|||
156324932|NCT01226043|564289464|FG003|6-week Re-randomization Phase|Adverse Event|1|||
156324933|NCT01226043|564289461|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
156324934|NCT01226043|564289462|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
156324935|NCT01226043|564289463|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
156324936|NCT01226043|564289464|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
156324937|NCT01226043|564289461|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
156324938|NCT01226043|564289462|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
156324939|NCT01226043|564289463|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
156324940|NCT01226043|564289464|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
156324941|NCT01226043|564289461|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
156324942|NCT01226043|564289462|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
156324943|NCT01226043|564289463|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
156324944|NCT01226043|564289464|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
156324945|NCT01226043|564289461|FG000|6-week Re-randomization Phase|Physician Decision|0|||
156324946|NCT01226043|564289462|FG001|6-week Re-randomization Phase|Physician Decision|0|||
156324947|NCT01226043|564289463|FG002|6-week Re-randomization Phase|Physician Decision|3|||
156324948|NCT01226043|564289464|FG003|6-week Re-randomization Phase|Physician Decision|2|||
156324949|NCT01226043|564289461|FG000|6-week Re-randomization Phase|completed in error|0|||
156324950|NCT01226043|564289462|FG001|6-week Re-randomization Phase|completed in error|0|||
156324951|NCT01226043|564289463|FG002|6-week Re-randomization Phase|completed in error|0|||
156324952|NCT01226043|564289464|FG003|6-week Re-randomization Phase|completed in error|1|||
156324953|NCT01226043|564289461|FG000|30-week Observational Phase|Adverse Event|0|||
156324954|NCT01226043|564289462|FG001|30-week Observational Phase|Adverse Event|0|||
156324955|NCT01226043|564289463|FG002|30-week Observational Phase|Adverse Event|1|||
156324956|NCT01226043|564289464|FG003|30-week Observational Phase|Adverse Event|1|||
156324957|NCT01226043|564289461|FG000|30-week Observational Phase|Protocol Violation|0|||
156324958|NCT01226043|564289462|FG001|30-week Observational Phase|Protocol Violation|0|||
156663407|NCT01376167|565514929|FG000|Overall Study|Lost to Follow-up|2|||
156663408|NCT01376167|565514930|FG001|Overall Study|Lost to Follow-up|4|||
156663409|NCT01376167|565514931|FG002|Overall Study|Lost to Follow-up|2|||
156663410|NCT01376167|565514929|FG000|Overall Study|Physician Decision|1|||
156663411|NCT01376167|565514930|FG001|Overall Study|Physician Decision|1|||
156663412|NCT01376167|565514931|FG002|Overall Study|Physician Decision|0|||
156663413|NCT01376167|565514929|FG000|Overall Study|Withdrawal by Subject|1|||
156663414|NCT01376167|565514930|FG001|Overall Study|Withdrawal by Subject|5|||
156663415|NCT01376167|565514931|FG002|Overall Study|Withdrawal by Subject|4|||
156663416|NCT02193165|565514932|FG000|4 Week Product Use|Lost to Follow-up|1|||
156663417|NCT02193165|565514933|FG001|4 Week Product Use|Lost to Follow-up|1|||
156663418|NCT02193165|565514934|FG002|4 Week Product Use|Lost to Follow-up|1|||
156663419|NCT02193165|565514932|FG000|6 Week Product Use|Lost to Follow-up|0|||
156663420|NCT02193165|565514933|FG001|6 Week Product Use|Lost to Follow-up|1|||
156663421|NCT02193165|565514934|FG002|6 Week Product Use|Lost to Follow-up|0|||
156663422|NCT00986245|565514941|FG000|First Intervention|Poor compliance|8|||
156663423|NCT00986245|565514942|FG001|First Intervention|Poor compliance|4|||
156663424|NCT00986245|565514941|FG000|First Intervention|Lack of Efficacy|1|||
156663425|NCT00986245|565514942|FG001|First Intervention|Lack of Efficacy|2|||
156663426|NCT00986245|565514941|FG000|First Intervention|Withdrawal by Subject|0|||
156663427|NCT00986245|565514942|FG001|First Intervention|Withdrawal by Subject|1|||
156663428|NCT00986245|565514941|FG000|First Intervention|Protocol Violation|0|||
156663429|NCT00986245|565514942|FG001|First Intervention|Protocol Violation|1|||
156663430|NCT00986245|565514941|FG000|First Intervention|Out of indication|1|||
156663431|NCT00986245|565514942|FG001|First Intervention|Out of indication|0|||
156663432|NCT00986245|565514941|FG000|Second Intervention|Poor compliance|1|||
156663433|NCT00986245|565514942|FG001|Second Intervention|Poor compliance|0|||
156663434|NCT00986245|565514941|FG000|Second Intervention|Lost to Follow-up|1|||
156663435|NCT00986245|565514942|FG001|Second Intervention|Lost to Follow-up|0|||
156663436|NCT00986245|565514941|FG000|Second Intervention|Protocol Violation|0|||
156663437|NCT00986245|565514942|FG001|Second Intervention|Protocol Violation|1|||
156663438|NCT01941030|565514945|FG000|Overall Study|Death|3|||
156663439|NCT01941030|565514946|FG001|Overall Study|Death|2|||
156663440|NCT01941030|565514945|FG000|Overall Study|Lost to Follow-up|6|||
156663441|NCT01941030|565514946|FG001|Overall Study|Lost to Follow-up|5|||
156663442|NCT01941030|565514945|FG000|Overall Study|Withdrawal by Subject|4|||
156663443|NCT01941030|565514946|FG001|Overall Study|Withdrawal by Subject|6|||
156663444|NCT03693430|565514949|FG000|Overall Study|Lost to Follow-up|3|||
156663445|NCT03693430|565514950|FG001|Overall Study|Lost to Follow-up|14|||
156663446|NCT03693430|565514949|FG000|Overall Study|Death|1|||
156663447|NCT03693430|565514950|FG001|Overall Study|Death|0|||
156663448|NCT03693430|565514949|FG000|Overall Study|Withdrawal by Subject|0|||
156663449|NCT03693430|565514950|FG001|Overall Study|Withdrawal by Subject|4|||
156663450|NCT05067647|565514953|FG000|Overall Study|Lost to Follow-up|1|||
156663451|NCT00870870|565514956|FG000|Overall Study|Withdrawal by Subject|0|||
156663452|NCT00870870|565514957|FG001|Overall Study|Withdrawal by Subject|1|||
156663453|NCT00870870|565514958|FG002|Overall Study|Withdrawal by Subject|1|||
156663454|NCT00870870|565514959|FG003|Overall Study|Withdrawal by Subject|3|||
156775991|NCT04896385|565931385|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
156775992|NCT04896385|565931386|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
156775993|NCT04896385|565931383|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
156775994|NCT04896385|565931384|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
156775995|NCT04896385|565931385|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
156775996|NCT04896385|565931386|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
156775997|NCT04896385|565931383|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
156775998|NCT04896385|565931384|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
156775999|NCT04896385|565931385|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
156776000|NCT04896385|565931386|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
156776001|NCT04896385|565931383|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
156776002|NCT04896385|565931384|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
156776003|NCT04896385|565931385|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
156776004|NCT04896385|565931386|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
156663455|NCT00870870|565514956|FG000|Overall Study|Adverse Event|0|||
156663456|NCT00870870|565514957|FG001|Overall Study|Adverse Event|0|||
156663457|NCT00870870|565514958|FG002|Overall Study|Adverse Event|2|||
156663458|NCT00870870|565514959|FG003|Overall Study|Adverse Event|2|||
156429585|NCT01081145|564663305|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
156663459|NCT03639311|565514964|FG000|Maintenance Phase|Lost to Follow-up|1|||
156663460|NCT03639311|565514965|FG001|Maintenance Phase|Lost to Follow-up|0|||
156663461|NCT03639311|565514966|FG002|Maintenance Phase|Lost to Follow-up|0|||
156663462|NCT03639311|565514964|FG000|Maintenance Phase|Adverse Event|1|||
156663463|NCT03639311|565514965|FG001|Maintenance Phase|Adverse Event|0|||
156663464|NCT03639311|565514966|FG002|Maintenance Phase|Adverse Event|0|||
156663465|NCT03639311|565514964|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
156663466|NCT03639311|565514965|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
156663467|NCT03639311|565514966|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
156663468|NCT03639311|565514964|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
156663469|NCT03639311|565514965|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
156663470|NCT03639311|565514966|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
156663471|NCT03639311|565514964|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
156663472|NCT03639311|565514965|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
156663473|NCT03639311|565514966|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
156663474|NCT03639311|565514964|FG000|Maintenance Phase|Lack of Efficacy|1|||
156663475|NCT03639311|565514965|FG001|Maintenance Phase|Lack of Efficacy|0|||
156663476|NCT03639311|565514966|FG002|Maintenance Phase|Lack of Efficacy|0|||
156663477|NCT00855738|565514971|FG000|Overall Study|Lost to Follow-up|2|||
156663478|NCT00855738|565514971|FG000|Overall Study|Adverse Event|1|||
156663479|NCT00855738|565514971|FG000|Overall Study|Subject Defaulted|1|||
156663480|NCT00855738|565514971|FG000|Overall Study|Death|1|||
156663481|NCT00304083|565514977|FG000|Overall Study|Withdrawal by Subject|4|||
156663482|NCT00304083|565514978|FG001|Overall Study|Withdrawal by Subject|2|||
156663483|NCT00304083|565514977|FG000|Overall Study|Physician Decision|8|||
156663484|NCT00304083|565514978|FG001|Overall Study|Physician Decision|3|||
156663485|NCT00304083|565514977|FG000|Overall Study|Disease Progression|5|||
156663486|NCT00304083|565514978|FG001|Overall Study|Disease Progression|1|||
156663487|NCT00304083|565514977|FG000|Overall Study|Other|5|||
156663488|NCT00304083|565514978|FG001|Overall Study|Other|2|||
156663489|NCT03929393|565514979|FG000|Overall Study|Death|1|||
156663490|NCT03929393|565514980|FG001|Overall Study|Death|0|||
156663491|NCT03929393|565514979|FG000|Overall Study|Time Commitment|2|||
156663492|NCT03929393|565514980|FG001|Overall Study|Time Commitment|5|||
156663493|NCT03929393|565514979|FG000|Overall Study|Motor Vehicle Accident|0|||
156663494|NCT03929393|565514980|FG001|Overall Study|Motor Vehicle Accident|1|||
156663495|NCT03929393|565514979|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
156663496|NCT03929393|565514980|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
156663497|NCT03929393|565514979|FG000|Overall Study|Other|1|||
156663498|NCT03929393|565514980|FG001|Overall Study|Other|3|||
156663499|NCT01569152|565514990|FG000|Phase IIa, Period 1|Early Escape|5|||
156663500|NCT01569152|565514991|FG001|Phase IIa, Period 1|Early Escape|22|||
156663501|NCT01569152|565514992|FG002|Phase IIa, Period 1|Early Escape|0|||
156663502|NCT01569152|565514990|FG000|Phase IIa, Period 1|Adverse Event|4|||
156663503|NCT01569152|565514991|FG001|Phase IIa, Period 1|Adverse Event|0|||
156663504|NCT01569152|565514992|FG002|Phase IIa, Period 1|Adverse Event|0|||
156663505|NCT01569152|565514990|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
156663506|NCT01569152|565514991|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
156663507|NCT01569152|565514992|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
156663508|NCT01569152|565514990|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
156663509|NCT01569152|565514991|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
156663510|NCT01569152|565514992|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
156663511|NCT01569152|565514990|FG000|Phase IIa, Period 1|Protocol Violation|0|||
156663512|NCT01569152|565514991|FG001|Phase IIa, Period 1|Protocol Violation|1|||
156663513|NCT01569152|565514992|FG002|Phase IIa, Period 1|Protocol Violation|0|||
156663514|NCT01569152|565514990|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
156663515|NCT01569152|565514991|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
156663516|NCT01569152|565514992|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
156663517|NCT01569152|565514990|FG000|Safety Extension, Period 3|Adverse Event|0|||
156663518|NCT01569152|565514991|FG001|Safety Extension, Period 3|Adverse Event|0|||
156663519|NCT01569152|565514992|FG002|Safety Extension, Period 3|Adverse Event|4|||
156663520|NCT01569152|565514990|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
156663521|NCT01569152|565514991|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
156663522|NCT01569152|565514992|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
156663523|NCT01569152|565514990|FG000|Safety Extension, Period 3|Physician Decision|0|||
156663524|NCT01569152|565514991|FG001|Safety Extension, Period 3|Physician Decision|0|||
156429586|NCT01081145|564663304|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
156663525|NCT01569152|565514992|FG002|Safety Extension, Period 3|Physician Decision|2|||
156663526|NCT01569152|565514990|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
156663527|NCT01569152|565514991|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
156663528|NCT01569152|565514992|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
156663529|NCT03544138|565514993|FG000|Overall Study|Lost to Follow-up|29|||
156663530|NCT04605094|565516925|FG000|Overall Study|Adverse Event|2|||
156663531|NCT04605094|565516926|FG001|Overall Study|Adverse Event|2|||
156663532|NCT04605094|565516925|FG000|Overall Study|Lost to Follow-up|1|||
156663533|NCT04605094|565516926|FG001|Overall Study|Lost to Follow-up|4|||
156663534|NCT04605094|565516925|FG000|Overall Study|Physician Decision|2|||
156663535|NCT04605094|565516926|FG001|Overall Study|Physician Decision|2|||
156663536|NCT04605094|565516925|FG000|Overall Study|Study terminated by Sponsor|31|||
156663537|NCT04605094|565516926|FG001|Overall Study|Study terminated by Sponsor|33|||
156663538|NCT04605094|565516925|FG000|Overall Study|Withdrawal by Subject|22|||
156663539|NCT04605094|565516926|FG001|Overall Study|Withdrawal by Subject|19|||
156663540|NCT04605094|565516925|FG000|Overall Study|Other|1|||
156663541|NCT04605094|565516926|FG001|Overall Study|Other|1|||
156663542|NCT02724462|565516927|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
156663543|NCT02724462|565516928|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
156663544|NCT02724462|565516927|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
156663545|NCT02724462|565516928|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
156663546|NCT02724462|565516927|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
156663547|NCT02724462|565516928|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
156663548|NCT02724462|565516927|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
156663549|NCT02724462|565516928|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
156663550|NCT02724462|565516927|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
156663551|NCT02724462|565516928|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
156663552|NCT02724462|565516927|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
156663553|NCT02724462|565516928|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
156663554|NCT00469417|565516931|FG000|Overall Study|Treatment failure all lesions|18|||
156663555|NCT00469417|565516932|FG001|Overall Study|Treatment failure all lesions|11|||
156663556|NCT00469417|565516931|FG000|Overall Study|Consent withdrawn|1|||
156663557|NCT00469417|565516932|FG001|Overall Study|Consent withdrawn|1|||
156663558|NCT00469417|565516931|FG000|Overall Study|Adverse Event|8|||
156663559|NCT00469417|565516932|FG001|Overall Study|Adverse Event|2|||
156663560|NCT00469417|565516931|FG000|Overall Study|Lost to Follow-up|1|||
156663561|NCT00469417|565516932|FG001|Overall Study|Lost to Follow-up|2|||
156663562|NCT00469417|565516931|FG000|Overall Study|Intercurrent disease|0|||
156663563|NCT00469417|565516932|FG001|Overall Study|Intercurrent disease|1|||
156663564|NCT00469417|565516931|FG000|Overall Study|Randomized but not treated|2|||
156663565|NCT00469417|565516932|FG001|Overall Study|Randomized but not treated|0|||
156663566|NCT03021018|565516936|FG000|Overall Study|Adverse Event|1|||
156429587|NCT01081145|564663305|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
156429588|NCT01081145|564663304|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
156429589|NCT01081145|564663305|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
156429590|NCT01081145|564663304|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
156429591|NCT01081145|564663305|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
156429592|NCT01081145|564663304|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
156429593|NCT01081145|564663305|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
156429594|NCT03412747|564663306|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
156429595|NCT03412747|564663307|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
156429596|NCT03412747|564663308|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
156429597|NCT03412747|564663306|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
156429598|NCT03412747|564663307|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
156429599|NCT03412747|564663308|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
156429600|NCT03412747|564663306|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
156429601|NCT03412747|564663307|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
156429602|NCT03412747|564663308|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
156663567|NCT03021018|565516937|FG001|Overall Study|Adverse Event|0|||
156663568|NCT03021018|565516938|FG002|Overall Study|Adverse Event|0|||
156663569|NCT03021018|565516936|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
156663570|NCT03021018|565516937|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
156663571|NCT03021018|565516938|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
156663572|NCT05038293|565516947|FG000|Overall Study|device was not operating properly for one subject.|1|||
156663573|NCT05038293|565516948|FG001|Overall Study|device was not operating properly for one subject.|0|||
156663574|NCT05038293|565516947|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
156663575|NCT05038293|565516948|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
156663576|NCT01171989|565516950|FG000|Overall Study|Lost to Follow-up|0|||
156663577|NCT01171989|565516951|FG001|Overall Study|Lost to Follow-up|0|||
156663578|NCT01171989|565516952|FG002|Overall Study|Lost to Follow-up|1|||
156663579|NCT01247701|565516954|FG000|Overall Study|Death|2|||
156663580|NCT01247701|565516954|FG000|Overall Study|Relapsed|8|||
156776005|NCT04896385|565931383|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
156429603|NCT03412747|564663306|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
156429604|NCT03412747|564663307|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
156429605|NCT03412747|564663308|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
156524382|NCT02112708|565013891|FG000|Baseline|Lost to Follow-up|12|||
156524383|NCT02112708|565013892|FG001|Baseline|Lost to Follow-up|0|||
156663581|NCT01838941|565516955|FG000|Overall Study|Adverse Event|1|||
156663582|NCT01838941|565516955|FG000|Overall Study|Withdrawal by Subject|1|||
156663583|NCT01034358|565516956|FG000|Overall Study|Withdrawal by Subject|1|||
156663584|NCT01034358|565516956|FG000|Overall Study|Protocol Violation|1|||
156663585|NCT00377260|565516959|FG000|Overall Study|Lost to Follow-up|0|||
156663586|NCT00377260|565516960|FG001|Overall Study|Lost to Follow-up|1|||
156663587|NCT00377260|565516959|FG000|Overall Study|Withdrawal by Subject|2|||
156429606|NCT03412747|564663306|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
156663588|NCT00377260|565516960|FG001|Overall Study|Withdrawal by Subject|4|||
156663589|NCT00829530|565516961|FG000|First Intervention|Adverse Event|0|||
156663590|NCT00829530|565516962|FG001|First Intervention|Adverse Event|1|||
156429607|NCT03412747|564663307|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
156429608|NCT03412747|564663308|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
156429609|NCT03412747|564663306|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
156663591|NCT00829530|565516961|FG000|First Intervention|Intolerance to Venopuncture|0|||
156663592|NCT00829530|565516962|FG001|First Intervention|Intolerance to Venopuncture|1|||
156663593|NCT00829530|565516961|FG000|Second Intervention|Intolerance to Venopuncture|1|||
156663594|NCT00829530|565516962|FG001|Second Intervention|Intolerance to Venopuncture|0|||
156663595|NCT00569374|565516963|FG000|Overall Study|Withdrawal by Subject|4|||
156663596|NCT00105196|565516970|FG000|Overall Study|Lack of Efficacy|2|||
156663597|NCT00105196|565516971|FG001|Overall Study|Lack of Efficacy|3|||
156663598|NCT00105196|565516970|FG000|Overall Study|Adverse Event|11|||
156663599|NCT00105196|565516971|FG001|Overall Study|Adverse Event|3|||
156663600|NCT00105196|565516970|FG000|Overall Study|Withdrawal by Subject|6|||
156663601|NCT00105196|565516971|FG001|Overall Study|Withdrawal by Subject|6|||
156663602|NCT00105196|565516970|FG000|Overall Study|Lost to Follow-up|3|||
156663603|NCT00105196|565516971|FG001|Overall Study|Lost to Follow-up|2|||
156663604|NCT00105196|565516970|FG000|Overall Study|Poor/noncompliance|3|||
156663605|NCT00105196|565516971|FG001|Overall Study|Poor/noncompliance|4|||
156663606|NCT00105196|565516970|FG000|Overall Study|Protocol Violation|5|||
156663607|NCT00105196|565516971|FG001|Overall Study|Protocol Violation|2|||
156663608|NCT00105196|565516970|FG000|Overall Study|pending surgery|0|||
156663609|NCT00105196|565516971|FG001|Overall Study|pending surgery|1|||
156429610|NCT03412747|564663307|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
156429611|NCT03412747|564663308|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
156429612|NCT03412747|564663306|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
156429613|NCT03412747|564663307|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
156429614|NCT03412747|564663308|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
156429615|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
156429616|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
156429617|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
156429618|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
156429619|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
156429620|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
156429621|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
156429622|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
156429623|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
156429624|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
156429625|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
156429626|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
156429627|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
156429628|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
156429629|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
156429630|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
156429631|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
156429632|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
156429633|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
156429634|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
156429635|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
156429636|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
156429637|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
156429638|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
156429639|NCT03412747|564663306|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
156429640|NCT03412747|564663307|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
156429641|NCT03412747|564663308|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
156429642|NCT03643211|564663312|FG000|Overall Study|Contract violation/deficiency|12|||
156429643|NCT03643211|564663312|FG000|Overall Study|Invalid registration|3|||
156663610|NCT00105196|565516970|FG000|Overall Study|marijuana use|0|||
156663611|NCT00105196|565516971|FG001|Overall Study|marijuana use|1|||
156429644|NCT03643211|564663312|FG000|Overall Study|No treatment information|2|||
156429645|NCT03643211|564663312|FG000|Overall Study|No adverse event information - No revisit|4|||
156429646|NCT04858425|564663313|FG000|Overall Study|Adverse Event|2|||
156429647|NCT04858425|564663314|FG001|Overall Study|Adverse Event|2|||
156429648|NCT04858425|564663313|FG000|Overall Study|Withdrawal by Subject|3|||
156429649|NCT04858425|564663314|FG001|Overall Study|Withdrawal by Subject|1|||
156429650|NCT04858425|564663313|FG000|Overall Study|Lost to Follow-up|4|||
156663612|NCT00105196|565516970|FG000|Overall Study|Subject became unblinded|0|||
156663613|NCT00105196|565516971|FG001|Overall Study|Subject became unblinded|1|||
156663614|NCT01196052|565516972|FG000|Overall Study|Adverse Event|9|||
156663615|NCT01196052|565516972|FG000|Overall Study|Lost to Follow-up|1|||
156663616|NCT01196052|565516972|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
156429651|NCT04858425|564663314|FG001|Overall Study|Lost to Follow-up|2|||
156429652|NCT04858425|564663313|FG000|Overall Study|Lost to Follow-up|1|||
156429653|NCT04858425|564663314|FG001|Overall Study|Lost to Follow-up|0|||
156429654|NCT03473743|564663315|FG000|Overall Study|Withdrawal by Subject|0|||
156429655|NCT03473743|564663316|FG001|Overall Study|Withdrawal by Subject|0|||
156429656|NCT03473743|564663317|FG002|Overall Study|Withdrawal by Subject|0|||
156663617|NCT01196052|565516972|FG000|Overall Study|Reason not Specified|5|||
156663618|NCT01196052|565516972|FG000|Overall Study|Withdrawal by Subject|6|||
156663619|NCT03603314|565516973|FG000|Overall Study|Lost to Follow-up|0|||
156663620|NCT03603314|565516974|FG001|Overall Study|Lost to Follow-up|3|||
156663621|NCT03603314|565516975|FG002|Overall Study|Lost to Follow-up|0|||
156663622|NCT03603314|565516973|FG000|Overall Study|Protocol Violation|0|||
156663623|NCT03603314|565516974|FG001|Overall Study|Protocol Violation|1|||
156663624|NCT03603314|565516975|FG002|Overall Study|Protocol Violation|0|||
156663625|NCT03603314|565516973|FG000|Overall Study|Adverse Event|2|||
156663626|NCT03603314|565516974|FG001|Overall Study|Adverse Event|0|||
156663627|NCT03603314|565516975|FG002|Overall Study|Adverse Event|0|||
156663628|NCT03603314|565516973|FG000|Overall Study|Physician Decision|1|||
156663629|NCT03603314|565516974|FG001|Overall Study|Physician Decision|1|||
156663630|NCT03603314|565516975|FG002|Overall Study|Physician Decision|0|||
156663631|NCT03603314|565516973|FG000|Overall Study|Withdrawal by Subject|4|||
156663632|NCT03603314|565516974|FG001|Overall Study|Withdrawal by Subject|5|||
156663633|NCT03603314|565516975|FG002|Overall Study|Withdrawal by Subject|3|||
156663634|NCT03603314|565516973|FG000|Overall Study|Other|0|||
156663635|NCT03603314|565516974|FG001|Overall Study|Other|1|||
156663636|NCT03603314|565516975|FG002|Overall Study|Other|0|||
156663637|NCT00893464|565516976|FG000|Overall Study|Did not complete therapy/experience PD|0|||
156663638|NCT00893464|565516977|FG001|Overall Study|Did not complete therapy/experience PD|0|||
156663639|NCT00893464|565516978|FG002|Overall Study|Did not complete therapy/experience PD|0|||
156663640|NCT00893464|565516979|FG003|Overall Study|Did not complete therapy/experience PD|0|||
156663641|NCT00893464|565516980|FG004|Overall Study|Did not complete therapy/experience PD|0|||
156663642|NCT00893464|565516981|FG005|Overall Study|Did not complete therapy/experience PD|0|||
156663643|NCT00893464|565516982|FG006|Overall Study|Did not complete therapy/experience PD|2|||
156663644|NCT00893464|565516983|FG007|Overall Study|Did not complete therapy/experience PD|2|||
156663645|NCT03450070|565516984|FG000|Overall Study|Withdrawal by Subject|8|||
156663646|NCT00050778|565516985|FG000|Overall Study|Adverse Event|13|||
156663647|NCT00050778|565516986|FG001|Overall Study|Adverse Event|3|||
156663648|NCT00050778|565516987|FG002|Overall Study|Adverse Event|2|||
156663649|NCT00050778|565516985|FG000|Overall Study|Death|0|||
156663650|NCT00050778|565516986|FG001|Overall Study|Death|1|||
156663651|NCT00050778|565516987|FG002|Overall Study|Death|1|||
156663652|NCT00050778|565516985|FG000|Overall Study|Lack of Efficacy|16|||
156663653|NCT00050778|565516986|FG001|Overall Study|Lack of Efficacy|2|||
156663654|NCT00050778|565516987|FG002|Overall Study|Lack of Efficacy|2|||
156663655|NCT00050778|565516985|FG000|Overall Study|Lost to Follow-up|0|||
156663656|NCT00050778|565516986|FG001|Overall Study|Lost to Follow-up|2|||
156663657|NCT00050778|565516987|FG002|Overall Study|Lost to Follow-up|4|||
156663658|NCT00050778|565516985|FG000|Overall Study|Physician Decision|3|||
156663659|NCT00050778|565516986|FG001|Overall Study|Physician Decision|0|||
156663660|NCT00050778|565516987|FG002|Overall Study|Physician Decision|2|||
156663661|NCT00050778|565516985|FG000|Overall Study|Protocol Violation|2|||
156663662|NCT00050778|565516986|FG001|Overall Study|Protocol Violation|0|||
156663663|NCT00050778|565516987|FG002|Overall Study|Protocol Violation|1|||
156663664|NCT00050778|565516985|FG000|Overall Study|Withdrawal by Subject|6|||
156663665|NCT00050778|565516986|FG001|Overall Study|Withdrawal by Subject|8|||
156663666|NCT00050778|565516987|FG002|Overall Study|Withdrawal by Subject|4|||
156663667|NCT00050778|565516985|FG000|Overall Study|Randomized but not treated|4|||
156663668|NCT00050778|565516986|FG001|Overall Study|Randomized but not treated|5|||
156663669|NCT00050778|565516987|FG002|Overall Study|Randomized but not treated|2|||
156663670|NCT00050778|565516985|FG000|Overall Study|Familial and personal reasons|1|||
156663671|NCT00050778|565516986|FG001|Overall Study|Familial and personal reasons|0|||
156663672|NCT00050778|565516987|FG002|Overall Study|Familial and personal reasons|0|||
156663673|NCT02910037|565516988|FG000|Overall Study|Withdrawal by Subject|4|||
156663674|NCT02910037|565516988|FG000|Overall Study|Lost to Follow-up|6|||
156776006|NCT04896385|565931384|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
156776007|NCT04896385|565931385|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
156663675|NCT01035060|565516991|FG000|Overall Study|Lost to Follow-up|0|||
156429657|NCT03473743|564663318|FG003|Overall Study|Withdrawal by Subject|0|||
156429658|NCT03473743|564663319|FG004|Overall Study|Withdrawal by Subject|0|||
156663676|NCT01035060|565516992|FG001|Overall Study|Lost to Follow-up|7|||
156663677|NCT01035060|565516991|FG000|Overall Study|Did not quality after 2nd screening|14|||
156663678|NCT01035060|565516992|FG001|Overall Study|Did not quality after 2nd screening|1|||
156663679|NCT01035060|565516991|FG000|Overall Study|Withdrawal by Subject|8|||
156663680|NCT01035060|565516992|FG001|Overall Study|Withdrawal by Subject|6|||
156663681|NCT01035060|565516991|FG000|Overall Study|Physician Decision|2|||
156663682|NCT01035060|565516992|FG001|Overall Study|Physician Decision|0|||
156663683|NCT00064753|565516993|FG000|Overall Study|Death|251|||
156663684|NCT00064753|565516994|FG001|Overall Study|Death|242|||
156663685|NCT00064753|565516993|FG000|Overall Study|Withdrawal by Subject|198|||
156663686|NCT00064753|565516994|FG001|Overall Study|Withdrawal by Subject|171|||
156663687|NCT00064753|565516993|FG000|Overall Study|Lost to Follow-up|225|||
156663688|NCT00064753|565516994|FG001|Overall Study|Lost to Follow-up|235|||
156663689|NCT02193880|565516997|FG000|Overall Study|patients did not collect enough HPC|3|||
156663690|NCT02914600|565517001|FG000|Overall Study|Adverse Event|298|||
156663691|NCT02914600|565517002|FG001|Overall Study|Adverse Event|35|||
156663692|NCT02914600|565517003|FG002|Overall Study|Adverse Event|25|||
156663693|NCT02914600|565517001|FG000|Overall Study|Sponsors decision|287|||
156663694|NCT02914600|565517002|FG001|Overall Study|Sponsors decision|41|||
156663695|NCT02914600|565517003|FG002|Overall Study|Sponsors decision|12|||
156663696|NCT02914600|565517001|FG000|Overall Study|Withdrawal by Subject|158|||
156663697|NCT02914600|565517002|FG001|Overall Study|Withdrawal by Subject|20|||
156663698|NCT02914600|565517003|FG002|Overall Study|Withdrawal by Subject|18|||
156663699|NCT02914600|565517001|FG000|Overall Study|Investigators discretion|169|||
156663700|NCT02914600|565517002|FG001|Overall Study|Investigators discretion|14|||
156663701|NCT02914600|565517003|FG002|Overall Study|Investigators discretion|13|||
156663702|NCT02914600|565517001|FG000|Overall Study|Lost to Follow-up|10|||
156663703|NCT02914600|565517002|FG001|Overall Study|Lost to Follow-up|4|||
156663704|NCT02914600|565517003|FG002|Overall Study|Lost to Follow-up|0|||
156663705|NCT02914600|565517001|FG000|Overall Study|Pregnancy|8|||
156663706|NCT02914600|565517002|FG001|Overall Study|Pregnancy|0|||
156663707|NCT02914600|565517003|FG002|Overall Study|Pregnancy|0|||
156663708|NCT02914600|565517001|FG000|Overall Study|Protocol Violation|5|||
156663709|NCT02914600|565517002|FG001|Overall Study|Protocol Violation|3|||
156663710|NCT02914600|565517003|FG002|Overall Study|Protocol Violation|0|||
156663711|NCT02914600|565517001|FG000|Overall Study|Non-compliance with study drug|6|||
156663712|NCT02914600|565517002|FG001|Overall Study|Non-compliance with study drug|1|||
156663713|NCT02914600|565517003|FG002|Overall Study|Non-compliance with study drug|0|||
156663714|NCT02914600|565517001|FG000|Overall Study|Death|3|||
156663715|NCT02914600|565517002|FG001|Overall Study|Death|1|||
156663716|NCT02914600|565517003|FG002|Overall Study|Death|1|||
156663717|NCT02914600|565517001|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
156663718|NCT02914600|565517002|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
156663719|NCT02914600|565517003|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
156663720|NCT02914600|565517001|FG000|Overall Study|Enrolled but not treated|1|||
156663721|NCT02914600|565517002|FG001|Overall Study|Enrolled but not treated|0|||
156663722|NCT02914600|565517003|FG002|Overall Study|Enrolled but not treated|0|||
156663723|NCT02457520|565517004|FG000|Active Treatment Phase|Adverse Event|10|||
156663724|NCT02457520|565517004|FG000|Active Treatment Phase|Lost to Follow-up|8|||
156663725|NCT02457520|565517004|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
156663726|NCT02457520|565517004|FG000|Active Treatment Phase|other|4|||
156663727|NCT02457520|565517004|FG000|Active Treatment Phase|Physician Decision|1|||
156663728|NCT02457520|565517004|FG000|Active Treatment Phase|Protocol Violation|1|||
156663729|NCT02457520|565517004|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
156663730|NCT02457520|565517004|FG000|Post-treatment Period|Other: Retreatment Required|7|||
156663731|NCT02457520|565517004|FG000|Post-treatment Period|Lost to Follow-up|23|||
156663732|NCT02457520|565517004|FG000|Post-treatment Period|Other|3|||
156663733|NCT02457520|565517004|FG000|Post-treatment Period|Physician Decision|1|||
156663734|NCT02457520|565517004|FG000|Post-treatment Period|Withdrawal by Subject|14|||
156663735|NCT02336165|565517009|FG000|Overall Study|Death|3|||
156663736|NCT02336165|565517010|FG001|Overall Study|Death|0|||
156663737|NCT02336165|565517011|FG002|Overall Study|Death|0|||
156663738|NCT02336165|565517012|FG003|Overall Study|Death|0|||
156776008|NCT04896385|565931386|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
156776009|NCT05291689|565931390|FG000|Overall Study|Adverse Event|3|||
156776010|NCT05291689|565931390|FG000|Overall Study|Lack of Efficacy|10|||
156776011|NCT05291689|565931390|FG000|Overall Study|Withdrawal by Subject|4|||
156776012|NCT01931098|565931391|FG000|Overall Study|Withdrawal by Subject|0|||
156776013|NCT01931098|565931392|FG001|Overall Study|Withdrawal by Subject|1|||
156776014|NCT01931098|565931391|FG000|Overall Study|Enrolled in different protocol|0|||
156776015|NCT01931098|565931392|FG001|Overall Study|Enrolled in different protocol|1|||
156776016|NCT01931098|565931391|FG000|Overall Study|Unable to begin trmt:active infection|0|||
156776017|NCT01931098|565931392|FG001|Overall Study|Unable to begin trmt:active infection|1|||
156776018|NCT01931098|565931391|FG000|Overall Study|Refused further treatment|0|||
156524384|NCT02112708|565013891|FG000|4 Month|Death|0|||
156524385|NCT02112708|565013892|FG001|4 Month|Death|1|||
156663739|NCT02336165|565517013|FG004|Overall Study|Death|1|||
156663740|NCT02336165|565517009|FG000|Overall Study|Physician Decision|2|||
156663741|NCT02336165|565517010|FG001|Overall Study|Physician Decision|2|||
156663742|NCT02336165|565517011|FG002|Overall Study|Physician Decision|1|||
156663743|NCT02336165|565517012|FG003|Overall Study|Physician Decision|1|||
156663744|NCT02336165|565517013|FG004|Overall Study|Physician Decision|0|||
156663745|NCT02336165|565517009|FG000|Overall Study|Withdrawal by Subject|0|||
156776019|NCT01931098|565931392|FG001|Overall Study|Refused further treatment|1|||
156663746|NCT02336165|565517010|FG001|Overall Study|Withdrawal by Subject|0|||
156663747|NCT02336165|565517011|FG002|Overall Study|Withdrawal by Subject|1|||
156663748|NCT02336165|565517012|FG003|Overall Study|Withdrawal by Subject|0|||
156663749|NCT02336165|565517013|FG004|Overall Study|Withdrawal by Subject|1|||
156663750|NCT02336165|565517009|FG000|Overall Study|Adverse Event|4|||
156663751|NCT02336165|565517010|FG001|Overall Study|Adverse Event|1|||
156663752|NCT02336165|565517011|FG002|Overall Study|Adverse Event|2|||
156663753|NCT02336165|565517012|FG003|Overall Study|Adverse Event|4|||
156663754|NCT02336165|565517013|FG004|Overall Study|Adverse Event|1|||
156663755|NCT02336165|565517009|FG000|Overall Study|Progressive disease|23|||
156663756|NCT02336165|565517010|FG001|Overall Study|Progressive disease|22|||
156663757|NCT02336165|565517011|FG002|Overall Study|Progressive disease|27|||
156663758|NCT02336165|565517012|FG003|Overall Study|Progressive disease|24|||
156663759|NCT02336165|565517013|FG004|Overall Study|Progressive disease|19|||
156663760|NCT02336165|565517009|FG000|Overall Study|Non-compliance|1|||
156663761|NCT02336165|565517010|FG001|Overall Study|Non-compliance|0|||
156663762|NCT02336165|565517011|FG002|Overall Study|Non-compliance|0|||
156663763|NCT02336165|565517012|FG003|Overall Study|Non-compliance|1|||
156663764|NCT02336165|565517013|FG004|Overall Study|Non-compliance|0|||
156663765|NCT02336165|565517009|FG000|Overall Study|Other|1|||
156663766|NCT02336165|565517010|FG001|Overall Study|Other|0|||
156663767|NCT02336165|565517011|FG002|Overall Study|Other|0|||
156663768|NCT02336165|565517012|FG003|Overall Study|Other|1|||
156663769|NCT02336165|565517013|FG004|Overall Study|Other|0|||
156663770|NCT00910663|565517016|FG000|Period 1|Withdrawal by Subject|0|||
156663771|NCT00910663|565517017|FG001|Period 1|Withdrawal by Subject|1|||
156663772|NCT01772537|565517018|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
156663773|NCT01772537|565517019|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
156663774|NCT01772537|565517020|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
156663775|NCT01536574|565517021|FG000|Overall Study|Adverse Event|4|||
156663776|NCT01536574|565517022|FG001|Overall Study|Adverse Event|5|||
156663777|NCT01536574|565517021|FG000|Overall Study|Withdrawal by Subject|1|||
156663778|NCT01536574|565517022|FG001|Overall Study|Withdrawal by Subject|2|||
156663779|NCT01536574|565517021|FG000|Overall Study|Lack of Efficacy|1|||
156663780|NCT01536574|565517022|FG001|Overall Study|Lack of Efficacy|0|||
156663781|NCT00834756|565517023|FG000|First Intervention|Adverse Event|1|||
156663782|NCT00834756|565517024|FG001|First Intervention|Adverse Event|0|||
156663783|NCT00834756|565517023|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
156663784|NCT00834756|565517024|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
156663785|NCT00579670|565517027|FG000|Overall Study|Death|1|||
156663786|NCT00579670|565517028|FG001|Overall Study|Death|0|||
156663787|NCT00579670|565517029|FG002|Overall Study|Death|0|||
156663788|NCT00579670|565517030|FG003|Overall Study|Death|0|||
156663789|NCT00579670|565517031|FG004|Overall Study|Death|0|||
156663790|NCT00579670|565517027|FG000|Overall Study|Adverse Event|1|||
156663791|NCT00579670|565517028|FG001|Overall Study|Adverse Event|0|||
156663792|NCT00579670|565517029|FG002|Overall Study|Adverse Event|1|||
156663793|NCT00579670|565517030|FG003|Overall Study|Adverse Event|2|||
156663794|NCT00579670|565517031|FG004|Overall Study|Adverse Event|0|||
156663795|NCT00579670|565517027|FG000|Overall Study|Lack of Efficacy|0|||
156663796|NCT00579670|565517028|FG001|Overall Study|Lack of Efficacy|0|||
156663797|NCT00579670|565517029|FG002|Overall Study|Lack of Efficacy|1|||
156663798|NCT00579670|565517030|FG003|Overall Study|Lack of Efficacy|14|||
156663799|NCT00579670|565517031|FG004|Overall Study|Lack of Efficacy|0|||
156663800|NCT00579670|565517027|FG000|Overall Study|Lost to Follow-up|0|||
156663801|NCT00579670|565517028|FG001|Overall Study|Lost to Follow-up|1|||
156663802|NCT00579670|565517029|FG002|Overall Study|Lost to Follow-up|0|||
156663803|NCT00579670|565517030|FG003|Overall Study|Lost to Follow-up|4|||
156663804|NCT00579670|565517031|FG004|Overall Study|Lost to Follow-up|0|||
156663805|NCT00579670|565517027|FG000|Overall Study|Other|0|||
156663806|NCT00579670|565517028|FG001|Overall Study|Other|0|||
156663807|NCT00579670|565517029|FG002|Overall Study|Other|1|||
156663808|NCT00579670|565517030|FG003|Overall Study|Other|2|||
156776020|NCT04235374|565931393|FG000|Overall Study|Death|91|||
156776021|NCT04235374|565931394|FG001|Overall Study|Death|91|||
156663809|NCT00579670|565517031|FG004|Overall Study|Other|0|||
156663810|NCT00579670|565517027|FG000|Overall Study|Withdrawal by Subject|0|||
156663811|NCT00579670|565517028|FG001|Overall Study|Withdrawal by Subject|0|||
156663812|NCT00579670|565517029|FG002|Overall Study|Withdrawal by Subject|1|||
156663813|NCT00579670|565517030|FG003|Overall Study|Withdrawal by Subject|0|||
156663814|NCT00579670|565517031|FG004|Overall Study|Withdrawal by Subject|0|||
156663815|NCT00296647|565517035|FG000|Overall Study|Death|4|||
156663816|NCT00296647|565517036|FG001|Overall Study|Death|1|||
156663817|NCT00296647|565517037|FG002|Overall Study|Death|2|||
156663818|NCT00296647|565517038|FG003|Overall Study|Death|1|||
156663819|NCT00296647|565517039|FG004|Overall Study|Death|1|||
156663820|NCT00296647|565517035|FG000|Overall Study|Withdrawal by Subject|28|||
156663821|NCT00296647|565517036|FG001|Overall Study|Withdrawal by Subject|27|||
156663822|NCT00296647|565517037|FG002|Overall Study|Withdrawal by Subject|32|||
156663823|NCT00296647|565517038|FG003|Overall Study|Withdrawal by Subject|16|||
156663824|NCT00296647|565517039|FG004|Overall Study|Withdrawal by Subject|19|||
156663825|NCT01863745|565517040|FG000|Overall Study|Disease Progression|9|||
156663826|NCT01863745|565517040|FG000|Overall Study|Adverse Event|2|||
156663827|NCT01863745|565517040|FG000|Overall Study|Death|1|||
156663828|NCT01863745|565517040|FG000|Overall Study|Withdrawal by Subject|1|||
156663829|NCT00610363|565517042|FG000|Overall Study|Non-compliance with protocol|0|||
156663830|NCT00610363|565517043|FG001|Overall Study|Non-compliance with protocol|1|||
156663831|NCT00610363|565517042|FG000|Overall Study|Adverse Event|3|||
156663832|NCT00610363|565517043|FG001|Overall Study|Adverse Event|1|||
156663833|NCT00610363|565517042|FG000|Overall Study|Lack of Efficacy|2|||
156663834|NCT00610363|565517043|FG001|Overall Study|Lack of Efficacy|0|||
156663835|NCT00610363|565517042|FG000|Overall Study|Lost to Follow-up|4|||
156663836|NCT00610363|565517043|FG001|Overall Study|Lost to Follow-up|0|||
156663837|NCT00610363|565517042|FG000|Overall Study|Withdrawal by Subject|1|||
156663838|NCT00610363|565517043|FG001|Overall Study|Withdrawal by Subject|0|||
156663839|NCT00610363|565517042|FG000|Overall Study|Other than specified above|1|||
156663840|NCT00610363|565517043|FG001|Overall Study|Other than specified above|1|||
156663841|NCT05093205|565517044|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
156663842|NCT05093205|565517045|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
156663843|NCT05093205|565517046|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
156663844|NCT05093205|565517047|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
156663845|NCT05093205|565517048|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
156663846|NCT05093205|565517049|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
156663847|NCT05093205|565517050|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
156663848|NCT05093205|565517051|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
156663849|NCT05093205|565517052|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
156663850|NCT05093205|565517053|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
156663851|NCT05093205|565517054|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
156663852|NCT05093205|565517055|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
156663853|NCT05093205|565517056|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
156663854|NCT05093205|565517044|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663855|NCT05093205|565517045|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663856|NCT05093205|565517046|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
156663857|NCT05093205|565517047|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663858|NCT05093205|565517048|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663859|NCT05093205|565517049|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663860|NCT05093205|565517050|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663861|NCT05093205|565517051|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663862|NCT05093205|565517052|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663863|NCT05093205|565517053|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663864|NCT05093205|565517054|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663865|NCT05093205|565517055|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663866|NCT05093205|565517056|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
156663867|NCT05093205|565517044|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
156663868|NCT05093205|565517045|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
156663869|NCT05093205|565517046|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
156663870|NCT05093205|565517047|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
156663871|NCT05093205|565517048|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
156663872|NCT05093205|565517049|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
156524386|NCT02112708|565013891|FG000|4 Month|Withdrawal by Subject|12|||
156524387|NCT02112708|565013892|FG001|4 Month|Withdrawal by Subject|0|||
156524388|NCT02374671|565013893|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
156524389|NCT02374671|565013894|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
156524390|NCT02374671|565013895|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
156524391|NCT02374671|565013893|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
156524392|NCT02374671|565013894|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
156524393|NCT02374671|565013895|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
156524394|NCT02374671|565013893|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
156524395|NCT02374671|565013894|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
156524396|NCT02374671|565013895|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
156524397|NCT02374671|565013893|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
156663873|NCT05093205|565517050|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
156663874|NCT05093205|565517051|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
156663875|NCT05093205|565517052|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
156663876|NCT05093205|565517053|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
156663877|NCT05093205|565517054|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
156663878|NCT05093205|565517055|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
156663879|NCT05093205|565517056|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
156663880|NCT05093205|565517044|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
156663881|NCT05093205|565517045|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
156663882|NCT05093205|565517046|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
156663883|NCT05093205|565517047|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
156776022|NCT04235374|565931393|FG000|Overall Study|Refused|2|||
156776023|NCT04235374|565931394|FG001|Overall Study|Refused|2|||
156663884|NCT05093205|565517048|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
156663885|NCT05093205|565517049|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
156663886|NCT05093205|565517050|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
156663887|NCT05093205|565517051|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
156663888|NCT05093205|565517052|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
156663889|NCT05093205|565517053|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
156663890|NCT05093205|565517054|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
156663891|NCT05093205|565517055|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
156663892|NCT05093205|565517056|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
156663893|NCT05093205|565517044|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
156663894|NCT05093205|565517045|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
156663895|NCT05093205|565517046|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
156663896|NCT05093205|565517047|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
156663897|NCT05093205|565517048|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
156663898|NCT05093205|565517049|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
156663899|NCT05093205|565517050|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
156663900|NCT05093205|565517051|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
156663901|NCT05093205|565517052|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
156663902|NCT05093205|565517053|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
156663903|NCT05093205|565517054|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
156663904|NCT05093205|565517055|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
156663905|NCT05093205|565517056|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
156663906|NCT05093205|565517044|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
156663907|NCT05093205|565517045|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
156663908|NCT05093205|565517046|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
156663909|NCT05093205|565517047|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
156663910|NCT05093205|565517048|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
156663911|NCT05093205|565517049|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
156663912|NCT05093205|565517050|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
156663913|NCT05093205|565517051|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
156663914|NCT05093205|565517052|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
156663915|NCT05093205|565517053|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
156663916|NCT05093205|565517054|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
156663917|NCT05093205|565517055|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
156663918|NCT05093205|565517056|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
156663919|NCT05093205|565517044|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
156663920|NCT05093205|565517045|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
156663921|NCT05093205|565517046|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
156663922|NCT05093205|565517047|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
156663923|NCT05093205|565517048|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
156663924|NCT05093205|565517049|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
156663925|NCT05093205|565517050|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
156663926|NCT05093205|565517051|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
156663927|NCT05093205|565517052|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
156663928|NCT05093205|565517053|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
156663929|NCT05093205|565517054|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
156663930|NCT05093205|565517055|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
156663931|NCT05093205|565517056|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
156663932|NCT05093205|565517044|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
156663933|NCT05093205|565517045|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
156663934|NCT05093205|565517046|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
156663935|NCT05093205|565517047|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
156663936|NCT05093205|565517048|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
156429659|NCT03473743|564663320|FG005|Overall Study|Withdrawal by Subject|0|||
156429660|NCT03473743|564663321|FG006|Overall Study|Withdrawal by Subject|0|||
156429661|NCT03473743|564663322|FG007|Overall Study|Withdrawal by Subject|3|||
156429662|NCT03473743|564663315|FG000|Overall Study|Other|0|||
156429663|NCT03473743|564663316|FG001|Overall Study|Other|0|||
156663937|NCT05093205|565517049|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
156663938|NCT05093205|565517050|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
156663939|NCT05093205|565517051|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
156663940|NCT05093205|565517052|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
156663941|NCT05093205|565517053|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
156663942|NCT05093205|565517054|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
156663943|NCT05093205|565517055|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
156663944|NCT05093205|565517056|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
156663945|NCT05093205|565517044|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663946|NCT05093205|565517045|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663947|NCT05093205|565517046|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156776024|NCT04235374|565931393|FG000|Overall Study|Unavailable|12|||
156429664|NCT03473743|564663317|FG002|Overall Study|Other|0|||
156663948|NCT05093205|565517047|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663949|NCT05093205|565517048|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663950|NCT05093205|565517049|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156776025|NCT04235374|565931394|FG001|Overall Study|Unavailable|3|||
156776026|NCT04235374|565931393|FG000|Overall Study|Withdrawal by Subject|0|||
156776027|NCT04235374|565931394|FG001|Overall Study|Withdrawal by Subject|1|||
156776028|NCT04235374|565931393|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
156776029|NCT04235374|565931394|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
156776030|NCT00314145|565931395|FG000|Overall Study|Withdrawal by Subject|8|||
156776031|NCT00314145|565931396|FG001|Overall Study|Withdrawal by Subject|10|||
156776032|NCT00314145|565931395|FG000|Overall Study|Lost to Follow-up|5|||
156776033|NCT00314145|565931396|FG001|Overall Study|Lost to Follow-up|12|||
156776034|NCT00314145|565931395|FG000|Overall Study|Physician Decision|3|||
156776035|NCT00314145|565931396|FG001|Overall Study|Physician Decision|4|||
156776036|NCT00314145|565931395|FG000|Overall Study|Adverse Event|0|||
156776037|NCT00314145|565931396|FG001|Overall Study|Adverse Event|3|||
156776038|NCT00314145|565931395|FG000|Overall Study|Protocol Violation|3|||
156776039|NCT00314145|565931396|FG001|Overall Study|Protocol Violation|0|||
156776040|NCT00314145|565931395|FG000|Overall Study|Sponsor Decision|2|||
156776041|NCT00314145|565931396|FG001|Overall Study|Sponsor Decision|0|||
156776042|NCT00294658|565931397|FG000|Overall Study|Death|0|||
156776043|NCT00294658|565931398|FG001|Overall Study|Death|1|||
156776044|NCT00294658|565931397|FG000|Overall Study|Lost to Follow-up|4|||
156776045|NCT00294658|565931398|FG001|Overall Study|Lost to Follow-up|0|||
156776046|NCT00294658|565931397|FG000|Overall Study|Physician Decision|1|||
156776047|NCT00294658|565931398|FG001|Overall Study|Physician Decision|2|||
156776048|NCT00294658|565931397|FG000|Overall Study|Pregnancy|0|||
156776049|NCT00294658|565931398|FG001|Overall Study|Pregnancy|1|||
156776050|NCT00294658|565931397|FG000|Overall Study|Withdrawal by Subject|0|||
156776051|NCT00294658|565931398|FG001|Overall Study|Withdrawal by Subject|4|||
156776052|NCT00294658|565931397|FG000|Overall Study|Found to have invasive thymoma|1|||
156776053|NCT00294658|565931398|FG001|Overall Study|Found to have invasive thymoma|0|||
156776054|NCT00294658|565931397|FG000|Overall Study|Patient and family were not satisfied|0|||
156776055|NCT00294658|565931398|FG001|Overall Study|Patient and family were not satisfied|1|||
156776056|NCT04717557|565931399|FG000|Overall Study|Withdrawal by Subject|2|||
156776057|NCT04717557|565931400|FG001|Overall Study|Withdrawal by Subject|0|||
156776058|NCT04717557|565931399|FG000|Overall Study|Death|1|||
156776059|NCT04717557|565931400|FG001|Overall Study|Death|0|||
156776060|NCT00858988|565931401|FG000|Analysis|Lactulose unable to be detected in urine|2|||
156776061|NCT00858988|565931402|FG001|Analysis|Lactulose unable to be detected in urine|1|||
156776062|NCT01020123|565931407|FG000|Main Period|Withdrawal by Subject|6|||
156776063|NCT01020123|565931408|FG001|Main Period|Withdrawal by Subject|5|||
156776064|NCT01020123|565931409|FG002|Main Period|Withdrawal by Subject|3|||
156776065|NCT01020123|565931410|FG003|Main Period|Withdrawal by Subject|1|||
156776066|NCT01020123|565931411|FG004|Main Period|Withdrawal by Subject|6|||
156776067|NCT01020123|565931412|FG005|Main Period|Withdrawal by Subject|3|||
156776068|NCT01020123|565931413|FG006|Main Period|Withdrawal by Subject|2|||
156776069|NCT01020123|565931407|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
156776070|NCT01020123|565931408|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
156776071|NCT01020123|565931409|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
156776072|NCT01020123|565931410|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
156776073|NCT01020123|565931411|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
156776074|NCT01020123|565931412|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
156776075|NCT01020123|565931413|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
156776076|NCT01020123|565931407|FG000|Main Period|Adverse Event|5|||
156776077|NCT01020123|565931408|FG001|Main Period|Adverse Event|2|||
156776078|NCT01020123|565931409|FG002|Main Period|Adverse Event|2|||
156776079|NCT01020123|565931410|FG003|Main Period|Adverse Event|1|||
156776080|NCT01020123|565931411|FG004|Main Period|Adverse Event|1|||
156324959|NCT01226043|564289463|FG002|30-week Observational Phase|Protocol Violation|0|||
156324960|NCT01226043|564289464|FG003|30-week Observational Phase|Protocol Violation|1|||
156324961|NCT01226043|564289461|FG000|30-week Observational Phase|Lost to Follow-up|0|||
156324962|NCT01226043|564289462|FG001|30-week Observational Phase|Lost to Follow-up|0|||
156324963|NCT01226043|564289463|FG002|30-week Observational Phase|Lost to Follow-up|2|||
156324964|NCT01226043|564289464|FG003|30-week Observational Phase|Lost to Follow-up|2|||
156324965|NCT01226043|564289461|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
156324966|NCT01226043|564289462|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
156324967|NCT01226043|564289463|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
156324968|NCT01226043|564289464|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
156324969|NCT01226043|564289461|FG000|30-week Observational Phase|Physician Decision|0|||
156324970|NCT01226043|564289462|FG001|30-week Observational Phase|Physician Decision|0|||
156324971|NCT01226043|564289463|FG002|30-week Observational Phase|Physician Decision|2|||
156324972|NCT01226043|564289464|FG003|30-week Observational Phase|Physician Decision|2|||
156324973|NCT01702571|564289467|FG000|Overall Study|Death|1067|||
156324974|NCT01702571|564289468|FG001|Overall Study|Death|76|||
156324975|NCT01702571|564289467|FG000|Overall Study|Lost to Follow-up|144|||
156324976|NCT01702571|564289468|FG001|Overall Study|Lost to Follow-up|10|||
156776081|NCT01020123|565931412|FG005|Main Period|Adverse Event|2|||
156776082|NCT01020123|565931413|FG006|Main Period|Adverse Event|1|||
156776083|NCT01020123|565931407|FG000|Main Period|Protocol Violation|4|||
156663951|NCT05093205|565517050|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663952|NCT05093205|565517051|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663953|NCT05093205|565517052|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663954|NCT05093205|565517053|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
156663955|NCT05093205|565517054|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663956|NCT05093205|565517055|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663957|NCT05093205|565517056|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
156663958|NCT05093205|565517044|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
156663959|NCT05093205|565517045|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
156663960|NCT05093205|565517046|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
156663961|NCT05093205|565517047|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
156663962|NCT05093205|565517048|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
156663963|NCT05093205|565517049|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
156663964|NCT05093205|565517050|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
156663965|NCT05093205|565517051|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
156663966|NCT05093205|565517052|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
156663967|NCT05093205|565517053|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
156663968|NCT05093205|565517054|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
156663969|NCT05093205|565517055|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
156663970|NCT05093205|565517056|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
156663971|NCT05093205|565517044|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663972|NCT05093205|565517045|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663973|NCT05093205|565517046|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663974|NCT05093205|565517047|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663975|NCT05093205|565517048|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663976|NCT05093205|565517049|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663977|NCT05093205|565517050|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663978|NCT05093205|565517051|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663979|NCT05093205|565517052|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663980|NCT05093205|565517053|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663981|NCT05093205|565517054|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
156663982|NCT05093205|565517055|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663983|NCT05093205|565517056|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
156663984|NCT05093205|565517044|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663985|NCT05093205|565517045|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663986|NCT05093205|565517046|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663987|NCT05093205|565517047|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663988|NCT05093205|565517048|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663989|NCT05093205|565517049|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663990|NCT05093205|565517050|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663991|NCT05093205|565517051|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663992|NCT05093205|565517052|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663993|NCT05093205|565517053|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663994|NCT05093205|565517054|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663995|NCT05093205|565517055|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
156663996|NCT05093205|565517056|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
156663997|NCT05093205|565517044|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
156663998|NCT05093205|565517045|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
156663999|NCT05093205|565517046|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
156664000|NCT05093205|565517047|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
156664001|NCT05093205|565517048|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
156664002|NCT05093205|565517049|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
156664003|NCT05093205|565517050|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
156664004|NCT05093205|565517051|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
156664005|NCT05093205|565517052|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
156664006|NCT05093205|565517053|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
156664007|NCT05093205|565517054|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
156664008|NCT05093205|565517055|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
156664009|NCT05093205|565517056|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
156664010|NCT05093205|565517044|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664011|NCT05093205|565517045|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664012|NCT05093205|565517046|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664013|NCT05093205|565517047|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664014|NCT05093205|565517048|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664015|NCT05093205|565517049|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664016|NCT05093205|565517050|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664017|NCT05093205|565517051|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664018|NCT05093205|565517052|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664019|NCT05093205|565517053|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664020|NCT05093205|565517054|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664021|NCT05093205|565517055|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
156664022|NCT05093205|565517056|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
156664023|NCT03361228|565517066|FG000|Overall Study|Other|1|||
156664024|NCT03361228|565517067|FG001|Overall Study|Other|1|||
156664025|NCT03361228|565517066|FG000|Overall Study|Death|3|||
156664026|NCT03361228|565517067|FG001|Overall Study|Death|0|||
156664027|NCT02979353|565517072|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
156664028|NCT02979353|565517073|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
156664029|NCT02979353|565517072|FG000|Overall Study|Withdrawal by Subject|16|||
156664030|NCT02979353|565517073|FG001|Overall Study|Withdrawal by Subject|12|||
156664031|NCT02979353|565517072|FG000|Overall Study|Death|10|||
156664032|NCT02979353|565517073|FG001|Overall Study|Death|11|||
156664033|NCT02979353|565517072|FG000|Overall Study|Transfer to Hospice Care|19|||
156664034|NCT02979353|565517073|FG001|Overall Study|Transfer to Hospice Care|14|||
156664035|NCT02979353|565517072|FG000|Overall Study|Lost to Follow-up|1|||
156664036|NCT02979353|565517073|FG001|Overall Study|Lost to Follow-up|5|||
156664037|NCT01722877|565517074|FG000|Overall Study|Death|1|||
156664038|NCT01722877|565517074|FG000|Overall Study|Lost to Follow-up|1|||
156664039|NCT00585689|565517075|FG000|Overall Study|Received different ABI-007 schedule|3|||
156664040|NCT00585689|565517075|FG000|Overall Study|Adverse Event|1|||
156664041|NCT00585689|565517075|FG000|Overall Study|Patient Declined Surgery|1|||
156664042|NCT00585689|565517075|FG000|Overall Study|Patient had unresectable disease|1|||
156664043|NCT00585689|565517075|FG000|Overall Study|Death|1|||
156664044|NCT02930005|565517076|FG000|Overall Study|Lost to Follow-up|1|||
156664045|NCT02930005|565517077|FG001|Overall Study|Lost to Follow-up|5|||
156664046|NCT02373098|565517079|FG000|Overall Study|Lost to Follow-up|1|||
156664047|NCT02373098|565517080|FG001|Overall Study|Lost to Follow-up|0|||
156664048|NCT02373098|565517079|FG000|Overall Study|Protocol Violation|3|||
156664049|NCT02373098|565517080|FG001|Overall Study|Protocol Violation|0|||
156664050|NCT02373098|565517079|FG000|Overall Study|Withdrawal by Subject|5|||
156664051|NCT02373098|565517080|FG001|Overall Study|Withdrawal by Subject|0|||
156664052|NCT02373098|565517079|FG000|Overall Study|Adverse Event|3|||
156664053|NCT02373098|565517080|FG001|Overall Study|Adverse Event|0|||
156664054|NCT00694551|565517084|FG000|Overall Study|Disease Progression|1|||
156664055|NCT00694551|565517085|FG001|Overall Study|Disease Progression|0|||
156664056|NCT00694551|565517086|FG002|Overall Study|Disease Progression|1|||
156664057|NCT01937390|565517089|FG000|Overall Study|Death|2|||
156664058|NCT01937390|565517089|FG000|Overall Study|Lost to Follow-up|7|||
156664059|NCT01937390|565517089|FG000|Overall Study|Withdrawal by Subject|5|||
156664060|NCT01937390|565517089|FG000|Overall Study|Fail to return|21|||
156664061|NCT01706536|565517099|FG000|Overall Study|Withdrawal by Subject|1|||
156664062|NCT01706536|565517100|FG001|Overall Study|Withdrawal by Subject|0|||
156664063|NCT01706536|565517101|FG002|Overall Study|Withdrawal by Subject|1|||
156664064|NCT01706536|565517102|FG003|Overall Study|Withdrawal by Subject|0|||
156664065|NCT01706536|565517103|FG004|Overall Study|Withdrawal by Subject|0|||
156664066|NCT01706536|565517099|FG000|Overall Study|Adverse Event|2|||
156664067|NCT01706536|565517100|FG001|Overall Study|Adverse Event|3|||
156664068|NCT01706536|565517101|FG002|Overall Study|Adverse Event|4|||
156664069|NCT01706536|565517102|FG003|Overall Study|Adverse Event|3|||
156664070|NCT01706536|565517103|FG004|Overall Study|Adverse Event|2|||
156664071|NCT01706536|565517099|FG000|Overall Study|Lack of Efficacy|1|||
156664072|NCT01706536|565517100|FG001|Overall Study|Lack of Efficacy|0|||
156664073|NCT01706536|565517101|FG002|Overall Study|Lack of Efficacy|0|||
156664074|NCT01706536|565517102|FG003|Overall Study|Lack of Efficacy|1|||
156664075|NCT01706536|565517103|FG004|Overall Study|Lack of Efficacy|0|||
156664076|NCT01706536|565517099|FG000|Overall Study|non compliance|0|||
156664077|NCT01706536|565517100|FG001|Overall Study|non compliance|1|||
156664078|NCT01706536|565517101|FG002|Overall Study|non compliance|0|||
156664079|NCT01706536|565517102|FG003|Overall Study|non compliance|0|||
156664080|NCT01706536|565517103|FG004|Overall Study|non compliance|0|||
156664081|NCT03262012|565517104|FG000|Overall Study|Withdrawal by Subject|15|||
156776084|NCT01020123|565931408|FG001|Main Period|Protocol Violation|4|||
156776085|NCT01020123|565931409|FG002|Main Period|Protocol Violation|2|||
156664082|NCT03262012|565517105|FG001|Overall Study|Withdrawal by Subject|13|||
156664083|NCT03262012|565517106|FG002|Overall Study|Withdrawal by Subject|8|||
156664084|NCT03262012|565517107|FG003|Overall Study|Withdrawal by Subject|7|||
156664085|NCT03262012|565517104|FG000|Overall Study|Adverse Event|10|||
156664086|NCT03262012|565517105|FG001|Overall Study|Adverse Event|12|||
156664087|NCT03262012|565517106|FG002|Overall Study|Adverse Event|4|||
156664088|NCT03262012|565517107|FG003|Overall Study|Adverse Event|6|||
156664089|NCT03262012|565517104|FG000|Overall Study|Physician Decision|2|||
156664090|NCT03262012|565517105|FG001|Overall Study|Physician Decision|5|||
156776086|NCT01020123|565931410|FG003|Main Period|Protocol Violation|5|||
156776087|NCT01020123|565931411|FG004|Main Period|Protocol Violation|2|||
156664091|NCT03262012|565517106|FG002|Overall Study|Physician Decision|1|||
156664092|NCT03262012|565517107|FG003|Overall Study|Physician Decision|0|||
156664093|NCT03262012|565517104|FG000|Overall Study|Lack of Efficacy|0|||
156664094|NCT03262012|565517105|FG001|Overall Study|Lack of Efficacy|5|||
156664095|NCT03262012|565517106|FG002|Overall Study|Lack of Efficacy|1|||
156664096|NCT03262012|565517107|FG003|Overall Study|Lack of Efficacy|2|||
156664097|NCT03262012|565517104|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
156664098|NCT03262012|565517105|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
156664099|NCT03262012|565517106|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
156664100|NCT03262012|565517107|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
156664101|NCT04753437|565517110|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156664102|NCT04753437|565517111|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
156664103|NCT04753437|565517110|FG000|Overall Study|Liver Function Test Abnormalities|2|||
156664104|NCT04753437|565517111|FG001|Overall Study|Liver Function Test Abnormalities|4|||
156664105|NCT00385684|565517114|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
156664106|NCT00385684|565517115|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
156664107|NCT00385684|565517114|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
156664108|NCT00385684|565517115|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
156664109|NCT00385684|565517114|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
156664110|NCT00385684|565517115|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
156664111|NCT00154102|565517116|FG000|Overall Study|investigational study phase ongoing|7|||
156664112|NCT00154102|565517117|FG001|Overall Study|investigational study phase ongoing|2|||
156664113|NCT00463606|565517118|FG000|Overall Study|Adverse Event|21|||
156664114|NCT00463606|565517119|FG001|Overall Study|Adverse Event|18|||
156664115|NCT00463606|565517120|FG002|Overall Study|Adverse Event|11|||
156664116|NCT00463606|565517118|FG000|Overall Study|Withdrawal by Subject|11|||
156664117|NCT00463606|565517119|FG001|Overall Study|Withdrawal by Subject|11|||
156664118|NCT00463606|565517120|FG002|Overall Study|Withdrawal by Subject|5|||
156664119|NCT00463606|565517118|FG000|Overall Study|Lost to Follow-up|2|||
156664120|NCT00463606|565517119|FG001|Overall Study|Lost to Follow-up|2|||
156664121|NCT00463606|565517120|FG002|Overall Study|Lost to Follow-up|3|||
156664122|NCT00463606|565517118|FG000|Overall Study|Subject noncompliance|1|||
156664123|NCT00463606|565517119|FG001|Overall Study|Subject noncompliance|1|||
156664124|NCT00463606|565517120|FG002|Overall Study|Subject noncompliance|0|||
156664125|NCT00463606|565517118|FG000|Overall Study|Subject moved out of town|1|||
156664126|NCT00463606|565517119|FG001|Overall Study|Subject moved out of town|0|||
156664127|NCT00463606|565517120|FG002|Overall Study|Subject moved out of town|0|||
156664128|NCT00463606|565517118|FG000|Overall Study|Physician Decision|0|||
156664129|NCT00463606|565517119|FG001|Overall Study|Physician Decision|1|||
156664130|NCT00463606|565517120|FG002|Overall Study|Physician Decision|0|||
156664131|NCT00463606|565517118|FG000|Overall Study|Sponsor request|0|||
156664132|NCT00463606|565517119|FG001|Overall Study|Sponsor request|1|||
156664133|NCT00463606|565517120|FG002|Overall Study|Sponsor request|0|||
156664134|NCT00463606|565517118|FG000|Overall Study|Exclusion criteria violation|2|||
156664135|NCT00463606|565517119|FG001|Overall Study|Exclusion criteria violation|0|||
156664136|NCT00463606|565517120|FG002|Overall Study|Exclusion criteria violation|0|||
156664137|NCT00463606|565517118|FG000|Overall Study|Coordinator error|1|||
156664138|NCT00463606|565517119|FG001|Overall Study|Coordinator error|0|||
156664139|NCT00463606|565517120|FG002|Overall Study|Coordinator error|0|||
156664140|NCT00463606|565517118|FG000|Overall Study|Patient randomized in error|1|||
156664141|NCT00463606|565517119|FG001|Overall Study|Patient randomized in error|0|||
156664142|NCT00463606|565517120|FG002|Overall Study|Patient randomized in error|0|||
156664143|NCT00463606|565517118|FG000|Overall Study|Participation in another ABT-335 trial|1|||
156664144|NCT00463606|565517119|FG001|Overall Study|Participation in another ABT-335 trial|0|||
156664145|NCT00463606|565517120|FG002|Overall Study|Participation in another ABT-335 trial|0|||
156664146|NCT00463606|565517118|FG000|Overall Study|Protocol Violation|0|||
156664147|NCT00463606|565517119|FG001|Overall Study|Protocol Violation|0|||
156664148|NCT00463606|565517120|FG002|Overall Study|Protocol Violation|1|||
156664149|NCT02682602|565517122|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
156664150|NCT02682602|565517123|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
156664151|NCT02682602|565517122|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
156664152|NCT02682602|565517123|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
156664153|NCT03567174|565517124|FG000|Overall Study|Death|24|||
156664154|NCT03567174|565517125|FG001|Overall Study|Death|31|||
156664155|NCT03567174|565517124|FG000|Overall Study|Lost to Follow-up|165|||
156664156|NCT03567174|565517125|FG001|Overall Study|Lost to Follow-up|174|||
156664157|NCT02140060|565517126|FG000|Overall Study|Adverse Event|0|||
156664158|NCT02140060|565517127|FG001|Overall Study|Adverse Event|0|||
156324977|NCT01702571|564289467|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
156324978|NCT01702571|564289468|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
156324979|NCT01702571|564289467|FG000|Overall Study|Investigator Decision|5|||
156324980|NCT01702571|564289468|FG001|Overall Study|Investigator Decision|0|||
156324981|NCT01702571|564289467|FG000|Overall Study|Not Classifiable|1|||
156324982|NCT01702571|564289468|FG001|Overall Study|Not Classifiable|0|||
156324983|NCT01702571|564289467|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
156324984|NCT01702571|564289468|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
156664159|NCT02140060|565517128|FG002|Overall Study|Adverse Event|0|||
156664160|NCT02140060|565517129|FG003|Overall Study|Adverse Event|1|||
156664161|NCT02140060|565517130|FG004|Overall Study|Adverse Event|1|||
156664162|NCT02140060|565517131|FG005|Overall Study|Adverse Event|1|||
156664163|NCT02140060|565517126|FG000|Overall Study|Lack of Efficacy|0|||
156324985|NCT01702571|564289467|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
156776088|NCT01020123|565931412|FG005|Main Period|Protocol Violation|3|||
156776089|NCT01020123|565931413|FG006|Main Period|Protocol Violation|2|||
156776090|NCT01020123|565931407|FG000|Main Period|Lost to Follow-up|0|||
156776091|NCT01020123|565931408|FG001|Main Period|Lost to Follow-up|2|||
156776092|NCT01020123|565931409|FG002|Main Period|Lost to Follow-up|0|||
156524398|NCT02374671|565013894|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
156524399|NCT02374671|565013895|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
156664164|NCT02140060|565517127|FG001|Overall Study|Lack of Efficacy|0|||
156664165|NCT02140060|565517128|FG002|Overall Study|Lack of Efficacy|0|||
156664166|NCT02140060|565517129|FG003|Overall Study|Lack of Efficacy|1|||
156664167|NCT02140060|565517130|FG004|Overall Study|Lack of Efficacy|0|||
156664168|NCT02140060|565517131|FG005|Overall Study|Lack of Efficacy|0|||
156664169|NCT01066143|565518429|FG000|Overall Study|ineligible for the study|8|||
156664170|NCT01294787|565518430|FG000|Period 1|Adverse Event|0|||
156664171|NCT01294787|565518431|FG001|Period 1|Adverse Event|0|||
156664172|NCT01294787|565518432|FG002|Period 1|Adverse Event|0|||
156664173|NCT01294787|565518433|FG003|Period 1|Adverse Event|0|||
156664174|NCT01294787|565518434|FG004|Period 1|Adverse Event|1|||
156664175|NCT01294787|565518435|FG005|Period 1|Adverse Event|0|||
156664176|NCT01294787|565518430|FG000|Period 1|Withdrawal by Subject|0|||
156664177|NCT01294787|565518431|FG001|Period 1|Withdrawal by Subject|0|||
156664178|NCT01294787|565518432|FG002|Period 1|Withdrawal by Subject|0|||
156664179|NCT01294787|565518433|FG003|Period 1|Withdrawal by Subject|1|||
156664180|NCT01294787|565518434|FG004|Period 1|Withdrawal by Subject|1|||
156664181|NCT01294787|565518435|FG005|Period 1|Withdrawal by Subject|1|||
156664182|NCT01294787|565518430|FG000|Period 1|Administrative problem|0|||
156664183|NCT01294787|565518431|FG001|Period 1|Administrative problem|0|||
156664184|NCT01294787|565518432|FG002|Period 1|Administrative problem|1|||
156664185|NCT01294787|565518433|FG003|Period 1|Administrative problem|0|||
156664186|NCT01294787|565518434|FG004|Period 1|Administrative problem|0|||
156664187|NCT01294787|565518435|FG005|Period 1|Administrative problem|1|||
156664188|NCT01294787|565518430|FG000|Period 2|Adverse Event|0|||
156664189|NCT01294787|565518431|FG001|Period 2|Adverse Event|3|||
156664190|NCT01294787|565518432|FG002|Period 2|Adverse Event|0|||
156664191|NCT01294787|565518433|FG003|Period 2|Adverse Event|1|||
156664192|NCT01294787|565518434|FG004|Period 2|Adverse Event|0|||
156664193|NCT01294787|565518435|FG005|Period 2|Adverse Event|0|||
156664194|NCT01294787|565518430|FG000|Period 2|No longer needs study drug|0|||
156664195|NCT01294787|565518431|FG001|Period 2|No longer needs study drug|0|||
156664196|NCT01294787|565518432|FG002|Period 2|No longer needs study drug|0|||
156664197|NCT01294787|565518433|FG003|Period 2|No longer needs study drug|1|||
156664198|NCT01294787|565518434|FG004|Period 2|No longer needs study drug|0|||
156664199|NCT01294787|565518435|FG005|Period 2|No longer needs study drug|0|||
156664200|NCT01294787|565518430|FG000|Period 3|Adverse Event|0|||
156664201|NCT01294787|565518431|FG001|Period 3|Adverse Event|0|||
156664202|NCT01294787|565518432|FG002|Period 3|Adverse Event|0|||
156664203|NCT01294787|565518433|FG003|Period 3|Adverse Event|0|||
156664204|NCT01294787|565518434|FG004|Period 3|Adverse Event|1|||
156664205|NCT01294787|565518435|FG005|Period 3|Adverse Event|0|||
156664206|NCT00723528|565518436|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
156664207|NCT00723528|565518437|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
156664208|NCT00723528|565518438|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
156664209|NCT00723528|565518439|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
156664210|NCT00723528|565518440|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
156664211|NCT00723528|565518441|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
156664212|NCT00723528|565518442|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
156664213|NCT00723528|565518436|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
156664214|NCT00723528|565518437|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
156664215|NCT00723528|565518438|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
156664216|NCT00723528|565518439|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
156664217|NCT00723528|565518440|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
156664218|NCT00723528|565518441|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
156664219|NCT00723528|565518442|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
156664220|NCT00723528|565518436|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
156664221|NCT00723528|565518437|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
156664222|NCT00723528|565518438|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
156664223|NCT00723528|565518439|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
156664224|NCT00723528|565518440|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
156664225|NCT00723528|565518441|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
156664226|NCT00723528|565518442|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
156664227|NCT00723528|565518436|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
156664228|NCT00723528|565518437|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
156664229|NCT00723528|565518438|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
156664230|NCT00723528|565518439|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
156664231|NCT00723528|565518440|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
156664232|NCT00723528|565518441|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
156664233|NCT00723528|565518442|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
156664234|NCT00723528|565518436|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
156664235|NCT00723528|565518437|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
156664236|NCT00723528|565518438|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
156664237|NCT00723528|565518439|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
156664238|NCT00723528|565518440|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
156664239|NCT00723528|565518441|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
156664240|NCT00723528|565518442|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
156664241|NCT00723528|565518436|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
156664242|NCT00723528|565518437|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
156664243|NCT00723528|565518438|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
156664244|NCT00723528|565518439|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
156664245|NCT00723528|565518440|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
156664246|NCT00723528|565518441|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
156664247|NCT00723528|565518442|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
156664248|NCT00723528|565518436|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
156664249|NCT00723528|565518437|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
156664250|NCT00723528|565518438|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
156664251|NCT00723528|565518439|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
156664252|NCT00723528|565518440|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
156664253|NCT00723528|565518441|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
156664254|NCT00723528|565518442|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
156664255|NCT00723528|565518436|FG000|Period 2: After Controlled Period|Other|0|||
156664256|NCT00723528|565518437|FG001|Period 2: After Controlled Period|Other|0|||
156664257|NCT00723528|565518438|FG002|Period 2: After Controlled Period|Other|0|||
156664258|NCT00723528|565518439|FG003|Period 2: After Controlled Period|Other|0|||
156664259|NCT00723528|565518440|FG004|Period 2: After Controlled Period|Other|1|||
156664260|NCT00723528|565518441|FG005|Period 2: After Controlled Period|Other|4|||
156664261|NCT00723528|565518442|FG006|Period 2: After Controlled Period|Other|0|||
156664262|NCT00723528|565518436|FG000|Period 2: After Controlled Period|Adverse Event|0|||
156664263|NCT00723528|565518437|FG001|Period 2: After Controlled Period|Adverse Event|0|||
156664264|NCT00723528|565518438|FG002|Period 2: After Controlled Period|Adverse Event|0|||
156664265|NCT00723528|565518439|FG003|Period 2: After Controlled Period|Adverse Event|0|||
156664266|NCT00723528|565518440|FG004|Period 2: After Controlled Period|Adverse Event|1|||
156664267|NCT00723528|565518441|FG005|Period 2: After Controlled Period|Adverse Event|0|||
156664268|NCT00723528|565518442|FG006|Period 2: After Controlled Period|Adverse Event|1|||
156664269|NCT00723528|565518436|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
156664270|NCT00723528|565518437|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
156664271|NCT00723528|565518438|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
156664272|NCT00723528|565518439|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
156664273|NCT00723528|565518440|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
156664274|NCT00723528|565518441|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
156664275|NCT00723528|565518442|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
156664276|NCT00723528|565518436|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
156664277|NCT00723528|565518437|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
156664278|NCT00723528|565518438|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
156664279|NCT00723528|565518439|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
156664280|NCT00723528|565518440|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
156664281|NCT00723528|565518441|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
156664282|NCT00723528|565518442|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
156664283|NCT00667862|565518444|FG000|Overall Study|Adverse Event|9|||
156664284|NCT00667862|565518444|FG000|Overall Study|Death|1|||
156664285|NCT00667862|565518444|FG000|Overall Study|Disease Progression|22|||
156664286|NCT00667862|565518444|FG000|Overall Study|Withdrawal by Subject|3|||
156664287|NCT00667095|565518448|FG000|Overall Study|Withdrawal by Subject|0|||
156429665|NCT03473743|564663318|FG003|Overall Study|Other|1|||
156664288|NCT00667095|565518449|FG001|Overall Study|Withdrawal by Subject|1|||
156664289|NCT01520909|565518450|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
156664290|NCT01520909|565518451|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
156776093|NCT01020123|565931410|FG003|Main Period|Lost to Follow-up|0|||
156429666|NCT03473743|564663319|FG004|Overall Study|Other|0|||
156429667|NCT03473743|564663320|FG005|Overall Study|Other|0|||
156776094|NCT01020123|565931411|FG004|Main Period|Lost to Follow-up|0|||
156776095|NCT01020123|565931412|FG005|Main Period|Lost to Follow-up|0|||
156776096|NCT01020123|565931413|FG006|Main Period|Lost to Follow-up|0|||
156776097|NCT01020123|565931407|FG000|Main Period|Unclasified|2|||
156776098|NCT01020123|565931408|FG001|Main Period|Unclasified|0|||
156776099|NCT01020123|565931409|FG002|Main Period|Unclasified|1|||
156776100|NCT01020123|565931410|FG003|Main Period|Unclasified|0|||
156776101|NCT01020123|565931411|FG004|Main Period|Unclasified|1|||
156776102|NCT01020123|565931412|FG005|Main Period|Unclasified|3|||
156776103|NCT01020123|565931413|FG006|Main Period|Unclasified|6|||
156776104|NCT01020123|565931407|FG000|Extention Period|Withdrawal by Subject|2|||
156776105|NCT01020123|565931408|FG001|Extention Period|Withdrawal by Subject|1|||
156776106|NCT01020123|565931409|FG002|Extention Period|Withdrawal by Subject|1|||
156776107|NCT01020123|565931410|FG003|Extention Period|Withdrawal by Subject|0|||
156776108|NCT01020123|565931411|FG004|Extention Period|Withdrawal by Subject|0|||
156776109|NCT01020123|565931412|FG005|Extention Period|Withdrawal by Subject|0|||
156776110|NCT01020123|565931413|FG006|Extention Period|Withdrawal by Subject|0|||
156776111|NCT01020123|565931407|FG000|Extention Period|Adverse Event|0|||
156776112|NCT01020123|565931408|FG001|Extention Period|Adverse Event|0|||
156776113|NCT01020123|565931409|FG002|Extention Period|Adverse Event|0|||
156776114|NCT01020123|565931410|FG003|Extention Period|Adverse Event|1|||
156776115|NCT01020123|565931411|FG004|Extention Period|Adverse Event|0|||
156776116|NCT01020123|565931412|FG005|Extention Period|Adverse Event|0|||
156776117|NCT01020123|565931413|FG006|Extention Period|Adverse Event|0|||
156776118|NCT01020123|565931407|FG000|Extention Period|Protocol Violation|1|||
156776119|NCT01020123|565931408|FG001|Extention Period|Protocol Violation|1|||
156776120|NCT01020123|565931409|FG002|Extention Period|Protocol Violation|1|||
156776121|NCT01020123|565931410|FG003|Extention Period|Protocol Violation|0|||
156776122|NCT01020123|565931411|FG004|Extention Period|Protocol Violation|0|||
156524400|NCT02374671|565013893|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
156524401|NCT02374671|565013894|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
156524402|NCT02374671|565013895|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
156524403|NCT00903682|565013896|FG000|Overall Study|Adverse Event|6|||
156524404|NCT00903682|565013897|FG001|Overall Study|Adverse Event|13|||
156524405|NCT00903682|565013896|FG000|Overall Study|Lost to Follow-up|1|||
156524406|NCT00903682|565013897|FG001|Overall Study|Lost to Follow-up|0|||
156524407|NCT00903682|565013896|FG000|Overall Study|Withdrawal by Subject|5|||
156524408|NCT00903682|565013897|FG001|Overall Study|Withdrawal by Subject|0|||
156524409|NCT00903682|565013896|FG000|Overall Study|Pregnancy|0|||
156524410|NCT00903682|565013897|FG001|Overall Study|Pregnancy|1|||
156524411|NCT00903682|565013896|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
156524412|NCT00903682|565013897|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
156524413|NCT00903682|565013896|FG000|Overall Study|Subject Non-Compliant|1|||
156524414|NCT00903682|565013897|FG001|Overall Study|Subject Non-Compliant|0|||
156524415|NCT00903682|565013896|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
156524416|NCT00903682|565013897|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
156524417|NCT00903682|565013896|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
156524418|NCT00903682|565013897|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
156524419|NCT03169101|565013898|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
156524420|NCT03169101|565013899|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
156524421|NCT03169101|565013900|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
156524422|NCT03169101|565013901|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
156524423|NCT00600886|565013904|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
156524424|NCT00600886|565013905|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
156524425|NCT00600886|565013904|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
156524426|NCT00600886|565013905|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
156524427|NCT00600886|565013904|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
156524428|NCT00600886|565013905|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
156524429|NCT00600886|565013904|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
156524430|NCT00600886|565013905|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
156524431|NCT00600886|565013904|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
156524432|NCT00600886|565013905|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
156524433|NCT00600886|565013904|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
156524434|NCT00600886|565013905|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
156776123|NCT01020123|565931412|FG005|Extention Period|Protocol Violation|0|||
156776124|NCT01020123|565931413|FG006|Extention Period|Protocol Violation|1|||
156776125|NCT01020123|565931407|FG000|Extention Period|Lost to Follow-up|0|||
156776126|NCT01020123|565931408|FG001|Extention Period|Lost to Follow-up|0|||
156776127|NCT01020123|565931409|FG002|Extention Period|Lost to Follow-up|0|||
156524435|NCT00600886|565013904|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
156524436|NCT00600886|565013905|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
156776128|NCT01020123|565931410|FG003|Extention Period|Lost to Follow-up|0|||
156776129|NCT01020123|565931411|FG004|Extention Period|Lost to Follow-up|0|||
156324986|NCT01702571|564289468|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
156324987|NCT01702571|564289467|FG000|Overall Study|Progressive Disease|3|||
156324988|NCT01702571|564289468|FG001|Overall Study|Progressive Disease|0|||
156324989|NCT01702571|564289467|FG000|Overall Study|Protocol Violation|2|||
156324990|NCT01702571|564289468|FG001|Overall Study|Protocol Violation|0|||
156324991|NCT01702571|564289467|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
156324992|NCT01702571|564289468|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
156324993|NCT01702571|564289467|FG000|Overall Study|Termination By Sponsor|4|||
156324994|NCT01702571|564289468|FG001|Overall Study|Termination By Sponsor|0|||
156324995|NCT01702571|564289467|FG000|Overall Study|Withdrawal by Subject|177|||
156324996|NCT01702571|564289468|FG001|Overall Study|Withdrawal by Subject|29|||
156324997|NCT01977937|564289471|FG000|Overall Study|Withdrawal by Subject|2|||
156324998|NCT01977937|564289472|FG001|Overall Study|Withdrawal by Subject|1|||
156324999|NCT01977937|564289471|FG000|Overall Study|Adverse Event|1|||
156325000|NCT01977937|564289472|FG001|Overall Study|Adverse Event|0|||
156325001|NCT01977937|564289471|FG000|Overall Study|Physician Decision|0|||
156325002|NCT01977937|564289472|FG001|Overall Study|Physician Decision|1|||
156325003|NCT03004443|564289476|FG000|Overall Study|Pregnancy|0|||
156325004|NCT03004443|564289477|FG001|Overall Study|Pregnancy|1|||
156325005|NCT00828854|564289478|FG000|Overall Study|Disease Progression|17|||
156325006|NCT00828854|564289478|FG000|Overall Study|Adverse Event|9|||
156325007|NCT00828854|564289478|FG000|Overall Study|Reason not Specified|1|||
156325008|NCT04221230|564289479|FG000|Overall Study|Lost to Follow-up|12|||
156325009|NCT04221230|564289480|FG001|Overall Study|Lost to Follow-up|12|||
156325010|NCT04221230|564289479|FG000|Overall Study|Protocol Violation|2|||
156325011|NCT04221230|564289480|FG001|Overall Study|Protocol Violation|2|||
156325012|NCT04221230|564289479|FG000|Overall Study|Adverse Event|0|||
156325013|NCT04221230|564289480|FG001|Overall Study|Adverse Event|8|||
156325014|NCT04221230|564289479|FG000|Overall Study|Physician Decision|1|||
156325015|NCT04221230|564289480|FG001|Overall Study|Physician Decision|0|||
156325016|NCT04221230|564289479|FG000|Overall Study|Withdrawal by Subject|13|||
156325017|NCT04221230|564289480|FG001|Overall Study|Withdrawal by Subject|11|||
156325018|NCT04221230|564289479|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156325019|NCT04221230|564289480|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156325020|NCT04221230|564289479|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156325021|NCT04221230|564289480|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
156325022|NCT04221230|564289479|FG000|Overall Study|Pregnancy|0|||
156524437|NCT00600886|565013904|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
156524438|NCT00600886|565013905|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
156524439|NCT00600886|565013904|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
156524440|NCT00600886|565013905|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
156524441|NCT00600886|565013904|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
156524442|NCT00600886|565013905|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
156524443|NCT00600886|565013904|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
156524444|NCT00600886|565013905|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
156524445|NCT00600886|565013904|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
156524446|NCT00600886|565013905|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
156524447|NCT00600886|565013904|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
156524448|NCT00600886|565013905|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
156524449|NCT00600886|565013904|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
156524450|NCT00600886|565013905|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
156524451|NCT00600886|565013904|FG000|Extension - Same Treatment (FAS)|Death|1|||
156524452|NCT00600886|565013905|FG001|Extension - Same Treatment (FAS)|Death|1|||
156524453|NCT00600886|565013904|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
156524454|NCT00600886|565013905|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
156524455|NCT00600886|565013904|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
156524456|NCT00600886|565013905|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
156524457|NCT00600886|565013904|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
156524458|NCT00600886|565013905|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
156524459|NCT00600886|565013904|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
156524460|NCT00600886|565013905|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
156524461|NCT00600886|565013904|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
156524462|NCT00600886|565013905|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
156524463|NCT00600886|565013904|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
156325023|NCT04221230|564289480|FG001|Overall Study|Pregnancy|1|||
156325024|NCT04221230|564289479|FG000|Overall Study|Other|1|||
156325025|NCT04221230|564289480|FG001|Overall Study|Other|2|||
156325026|NCT00915356|564289481|FG000|Overall Study|Withdrawal by Subject|1|||
156524464|NCT00600886|565013905|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
156524465|NCT00600886|565013904|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
156524466|NCT00600886|565013905|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
156524467|NCT00600886|565013904|FG000|Extension - After Crossover (CAS)|Death|1|||
156325027|NCT00915356|564289482|FG001|Overall Study|Withdrawal by Subject|0|||
156664291|NCT01520909|565518452|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
156664292|NCT01520909|565518450|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
156664293|NCT01520909|565518451|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
156664294|NCT01520909|565518452|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
156664295|NCT01520909|565518450|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
156664296|NCT01520909|565518451|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
156664297|NCT01520909|565518452|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
156664298|NCT01520909|565518450|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
156664299|NCT01520909|565518451|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
156664300|NCT01520909|565518452|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
156664301|NCT01435265|565518453|FG000|Overall Study|Lost to Follow-up|0|||
156664302|NCT01435265|565518454|FG001|Overall Study|Lost to Follow-up|1|||
156664303|NCT02128997|565518455|FG000|Overall Study|Lost to Follow-up|6|||
156664304|NCT02128997|565518456|FG001|Overall Study|Lost to Follow-up|11|||
156664305|NCT04123548|565518457|FG000|Overall Study|Withdrawal by Subject|1|||
156664306|NCT04123548|565518457|FG000|Overall Study|Lost to Follow-up|8|||
156664307|NCT04123548|565518457|FG000|Overall Study|Death|4|||
156664308|NCT04123548|565518457|FG000|Overall Study|Reason Not Specified|1|||
156664309|NCT04166630|565518459|FG000|Overall Study|Withdrawal by Subject|0|||
156664310|NCT04166630|565518460|FG001|Overall Study|Withdrawal by Subject|1|||
156664311|NCT00096447|565518461|FG000|Overall Study|Never treated|1|||
156664312|NCT02822235|565518462|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
156664313|NCT02822235|565518463|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
156664314|NCT02822235|565518462|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
156664315|NCT02822235|565518463|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
156664316|NCT02822235|565518462|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
156664317|NCT02822235|565518463|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
156664318|NCT02822235|565518462|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
156664319|NCT02822235|565518463|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
156664320|NCT02822235|565518462|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
156664321|NCT02822235|565518463|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
156664322|NCT02822235|565518462|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
156664323|NCT02822235|565518463|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
156776130|NCT01020123|565931412|FG005|Extention Period|Lost to Follow-up|2|||
156776131|NCT01020123|565931413|FG006|Extention Period|Lost to Follow-up|0|||
156776132|NCT01349595|565931414|FG000|Overall Study|Lack of funding|2|||
156776133|NCT01349595|565931415|FG001|Overall Study|Lack of funding|2|||
156776134|NCT03479905|565931418|FG000|Overall Study|Other airway method used|4|||
156776135|NCT03479905|565931419|FG001|Overall Study|Other airway method used|5|||
156776136|NCT03479905|565931420|FG002|Overall Study|Other airway method used|5|||
156776137|NCT00862992|565931425|FG000|Overall Study|Adverse Event|2|||
156776138|NCT00862992|565931426|FG001|Overall Study|Adverse Event|1|||
156776139|NCT00862992|565931427|FG002|Overall Study|Adverse Event|1|||
156776140|NCT00862992|565931425|FG000|Overall Study|Physician Decision|1|||
156776141|NCT00862992|565931426|FG001|Overall Study|Physician Decision|0|||
156776142|NCT00862992|565931427|FG002|Overall Study|Physician Decision|0|||
156776143|NCT00862992|565931425|FG000|Overall Study|Withdrawal by Subject|0|||
156776144|NCT00862992|565931426|FG001|Overall Study|Withdrawal by Subject|0|||
156776145|NCT00862992|565931427|FG002|Overall Study|Withdrawal by Subject|2|||
156776146|NCT00720759|565931428|FG000|Overall Study|Lost to Follow-up|0|||
156776147|NCT00720759|565931429|FG001|Overall Study|Lost to Follow-up|1|||
156776148|NCT00720759|565931430|FG002|Overall Study|Lost to Follow-up|1|||
156776149|NCT00720759|565931431|FG003|Overall Study|Lost to Follow-up|0|||
156776150|NCT01706328|565931432|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
156776151|NCT01706328|565931433|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156776152|NCT01706328|565931434|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156776153|NCT01706328|565931432|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
156776154|NCT01706328|565931433|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156776155|NCT01706328|565931434|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156776156|NCT01706328|565931432|FG000|2-week Run-in Period|Physician Decision|4|||
156776157|NCT01706328|565931433|FG001|2-week Run-in Period|Physician Decision|0|||
156776158|NCT01706328|565931434|FG002|2-week Run-in Period|Physician Decision|0|||
156664324|NCT01015625|565518468|FG000|Overall Study|Lost to Follow-up|3|||
156776159|NCT01706328|565931432|FG000|2-week Run-in Period|Adverse Event|4|||
156776160|NCT01706328|565931433|FG001|2-week Run-in Period|Adverse Event|0|||
156776161|NCT01706328|565931434|FG002|2-week Run-in Period|Adverse Event|0|||
156776162|NCT01706328|565931432|FG000|2-week Run-in Period|Lost to Follow-up|2|||
156776163|NCT01706328|565931433|FG001|2-week Run-in Period|Lost to Follow-up|0|||
156325028|NCT00915356|564289483|FG002|Overall Study|Withdrawal by Subject|0|||
156325029|NCT00915356|564289484|FG003|Overall Study|Withdrawal by Subject|0|||
156325030|NCT00915356|564289485|FG004|Overall Study|Withdrawal by Subject|0|||
156325031|NCT00191646|564289488|FG000|Overall Study|Toxicity|26|||
156664325|NCT01015625|565518469|FG001|Overall Study|Lost to Follow-up|1|||
156664326|NCT01015625|565518468|FG000|Overall Study|Withdrawal by Subject|2|||
156664327|NCT01015625|565518469|FG001|Overall Study|Withdrawal by Subject|3|||
156664328|NCT01015625|565518468|FG000|Overall Study|Physician Decision|2|||
156664329|NCT01015625|565518469|FG001|Overall Study|Physician Decision|0|||
156664330|NCT01015625|565518468|FG000|Overall Study|Death|30|||
156664331|NCT01015625|565518469|FG001|Overall Study|Death|22|||
156664332|NCT04112823|565518470|FG000|Overall Study|Lost to Follow-up|2|||
156664333|NCT04112823|565518471|FG001|Overall Study|Lost to Follow-up|3|||
156664334|NCT04466111|565518474|FG000|Prior to Trial Phase|Physician Decision|1|||
156664335|NCT02015390|565518480|FG000|Overall Study|Lost to Follow-up|1|||
156664336|NCT02015390|565518481|FG001|Overall Study|Lost to Follow-up|0|||
156664337|NCT02015390|565518480|FG000|Overall Study|Adverse Event|0|||
156664338|NCT02015390|565518481|FG001|Overall Study|Adverse Event|3|||
156664339|NCT02015390|565518480|FG000|Overall Study|Physician Decision|0|||
156664340|NCT02015390|565518481|FG001|Overall Study|Physician Decision|1|||
156664341|NCT02661295|565518482|FG000|Overall Study|Death|1|||
156664342|NCT02661295|565518482|FG000|Overall Study|Transferred Out|1|||
156664343|NCT02661295|565518482|FG000|Overall Study|Kidney Transplant|1|||
156664344|NCT02661295|565518482|FG000|Overall Study|Withdrawn due to side effects|8|||
156664345|NCT02661295|565518482|FG000|Overall Study|Withdrawn due to access type|1|||
156664346|NCT02661295|565518482|FG000|Overall Study|Withdrawn due to allergies|1|||
156664347|NCT02661295|565518482|FG000|Overall Study|Withdrawn due to non-compliance|1|||
156664348|NCT02661295|565518482|FG000|Overall Study|Withdrawal by Subject|3|||
156664349|NCT02661295|565518482|FG000|Overall Study|Failed screening|2|||
156429668|NCT03473743|564663321|FG006|Overall Study|Other|0|||
156429669|NCT03473743|564663322|FG007|Overall Study|Other|0|||
156664350|NCT02726581|565518483|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
156664351|NCT02726581|565518484|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
156664352|NCT02726581|565518485|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
156664353|NCT02726581|565518483|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
156664354|NCT02726581|565518484|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
156664355|NCT02726581|565518485|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
156664356|NCT02726581|565518483|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156664357|NCT02726581|565518484|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156664358|NCT02726581|565518485|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156664359|NCT02726581|565518483|FG000|Treatment Period|Disease progression|47|||
156664360|NCT02726581|565518484|FG001|Treatment Period|Disease progression|50|||
156664361|NCT02726581|565518485|FG002|Treatment Period|Disease progression|16|||
156664362|NCT02726581|565518483|FG000|Treatment Period|Other reasons|9|||
156664363|NCT02726581|565518484|FG001|Treatment Period|Other reasons|8|||
156664364|NCT02726581|565518485|FG002|Treatment Period|Other reasons|2|||
156664365|NCT02726581|565518483|FG000|Treatment Period|Study drug toxicity|6|||
156664366|NCT02726581|565518484|FG001|Treatment Period|Study drug toxicity|3|||
156664367|NCT02726581|565518485|FG002|Treatment Period|Study drug toxicity|2|||
156664368|NCT02726581|565518483|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
156664369|NCT02726581|565518484|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
156664370|NCT02726581|565518485|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
156664371|NCT02726581|565518483|FG000|Treatment Period|Participant withdrew consent|3|||
156664372|NCT02726581|565518484|FG001|Treatment Period|Participant withdrew consent|1|||
156664373|NCT02726581|565518485|FG002|Treatment Period|Participant withdrew consent|1|||
156664374|NCT02726581|565518483|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
156664375|NCT02726581|565518484|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
156664376|NCT02726581|565518485|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
156664377|NCT02726581|565518483|FG000|Treatment Period|Maximum clinical benefit|0|||
156664378|NCT02726581|565518484|FG001|Treatment Period|Maximum clinical benefit|2|||
156664379|NCT02726581|565518485|FG002|Treatment Period|Maximum clinical benefit|0|||
156664380|NCT02726581|565518483|FG000|Treatment Period|Death|1|||
156664381|NCT02726581|565518484|FG001|Treatment Period|Death|0|||
156664382|NCT02726581|565518485|FG002|Treatment Period|Death|0|||
156776164|NCT01706328|565931434|FG002|2-week Run-in Period|Lost to Follow-up|0|||
156429670|NCT03473743|564663315|FG000|Overall Study|Ongoing|0|||
156664383|NCT02726581|565518483|FG000|Treatment Period|Poor/non-compliance|1|||
156664384|NCT02726581|565518484|FG001|Treatment Period|Poor/non-compliance|0|||
156664385|NCT02726581|565518485|FG002|Treatment Period|Poor/non-compliance|0|||
156664386|NCT02726581|565518483|FG000|Treatment Period|Participant no longer meets study criteria|0|||
156664387|NCT02726581|565518484|FG001|Treatment Period|Participant no longer meets study criteria|1|||
156664388|NCT02726581|565518485|FG002|Treatment Period|Participant no longer meets study criteria|0|||
156776165|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
156429671|NCT03473743|564663316|FG001|Overall Study|Ongoing|0|||
156429672|NCT03473743|564663317|FG002|Overall Study|Ongoing|6|||
156429673|NCT03473743|564663318|FG003|Overall Study|Ongoing|8|||
156429674|NCT03473743|564663319|FG004|Overall Study|Ongoing|1|||
156429675|NCT03473743|564663320|FG005|Overall Study|Ongoing|1|||
156664389|NCT01844375|565518489|FG000|Overall Study|Protocol Violation|1|||
156664390|NCT01844375|565518490|FG001|Overall Study|Protocol Violation|1|||
156664391|NCT00112463|565518491|FG000|Overall Study|Physician Decision|1|||
156664392|NCT00112463|565518491|FG000|Overall Study|Progression|30|||
156664393|NCT00112463|565518491|FG000|Overall Study|Second Primary|1|||
156664394|NCT00112463|565518491|FG000|Overall Study|Toxicity|3|||
156664395|NCT00112463|565518491|FG000|Overall Study|Withdrawal by Subject|2|||
156664396|NCT00112463|565518491|FG000|Overall Study|Never started treatment|2|||
156664397|NCT00678639|565518492|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
156664398|NCT00678639|565518493|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
156664399|NCT01546545|565518496|FG000|Overall Study|Withdrawal by Subject|1|||
156664400|NCT01214850|565518497|FG000|Overall Study|Withdrawal by Subject|38|||
156664401|NCT01214850|565518498|FG001|Overall Study|Withdrawal by Subject|31|||
156664402|NCT01214850|565518499|FG002|Overall Study|Withdrawal by Subject|28|||
156664403|NCT01214850|565518497|FG000|Overall Study|Lost to Follow-up|124|||
156664404|NCT01214850|565518498|FG001|Overall Study|Lost to Follow-up|98|||
156664405|NCT01214850|565518499|FG002|Overall Study|Lost to Follow-up|123|||
156664406|NCT01214850|565518497|FG000|Overall Study|Protocol Violation|5|||
156664407|NCT01214850|565518498|FG001|Overall Study|Protocol Violation|5|||
156664408|NCT01214850|565518499|FG002|Overall Study|Protocol Violation|6|||
156664409|NCT01214850|565518497|FG000|Overall Study|Adverse event or death|11|||
156664410|NCT01214850|565518498|FG001|Overall Study|Adverse event or death|8|||
156664411|NCT01214850|565518499|FG002|Overall Study|Adverse event or death|3|||
156664412|NCT01214850|565518497|FG000|Overall Study|Inappropriate enrollment|2|||
156664413|NCT01214850|565518498|FG001|Overall Study|Inappropriate enrollment|1|||
156664414|NCT01214850|565518499|FG002|Overall Study|Inappropriate enrollment|0|||
156664415|NCT01214850|565518497|FG000|Overall Study|Administrative reason|1|||
156664416|NCT01214850|565518498|FG001|Overall Study|Administrative reason|0|||
156429676|NCT03473743|564663321|FG006|Overall Study|Ongoing|22|||
156429677|NCT03473743|564663322|FG007|Overall Study|Ongoing|24|||
156429678|NCT03473743|564663315|FG000|Overall Study|Randomized but not treated|0|||
156429679|NCT03473743|564663316|FG001|Overall Study|Randomized but not treated|0|||
156429680|NCT03473743|564663317|FG002|Overall Study|Randomized but not treated|0|||
156429681|NCT03473743|564663318|FG003|Overall Study|Randomized but not treated|0|||
156429682|NCT03473743|564663319|FG004|Overall Study|Randomized but not treated|0|||
156429683|NCT03473743|564663320|FG005|Overall Study|Randomized but not treated|0|||
156429684|NCT03473743|564663321|FG006|Overall Study|Randomized but not treated|1|||
156429685|NCT03473743|564663322|FG007|Overall Study|Randomized but not treated|1|||
156429686|NCT02864992|564663323|FG000|Overall Study|still on treatment|15|||
156429687|NCT02864992|564663324|FG001|Overall Study|still on treatment|1|||
156429688|NCT02864992|564663325|FG002|Overall Study|still on treatment|33|||
156429689|NCT04536077|564663327|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
156429690|NCT04536077|564663328|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
156429691|NCT04536077|564663327|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
156429692|NCT04536077|564663328|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
156429693|NCT03805295|564663329|FG000|Overall Study|Lost to Follow-up|17|||
156429694|NCT03805295|564663330|FG001|Overall Study|Lost to Follow-up|43|||
156429695|NCT04925752|564663331|FG000|Overall Study|Still on Study|1826|||
156429696|NCT04925752|564663332|FG001|Overall Study|Still on Study|926|||
156664417|NCT01214850|565518499|FG002|Overall Study|Administrative reason|0|||
156664418|NCT01214850|565518497|FG000|Overall Study|Unable to classify|2|||
156664419|NCT01214850|565518498|FG001|Overall Study|Unable to classify|1|||
156429697|NCT04925752|564663331|FG000|Overall Study|Withdrew Consent|128|||
156429698|NCT04925752|564663332|FG001|Overall Study|Withdrew Consent|59|||
156429699|NCT04925752|564663331|FG000|Overall Study|Lost to Follow-up|73|||
156429700|NCT04925752|564663332|FG001|Overall Study|Lost to Follow-up|47|||
156429701|NCT04925752|564663331|FG000|Overall Study|Randomized but Never Treated|12|||
156429702|NCT04925752|564663332|FG001|Overall Study|Randomized but Never Treated|9|||
156664420|NCT01214850|565518499|FG002|Overall Study|Unable to classify|1|||
156664421|NCT00565448|565518502|FG000|Overall Study|Adverse Event|1|||
156664422|NCT00565448|565518503|FG001|Overall Study|Adverse Event|2|||
156664423|NCT00565448|565518502|FG000|Overall Study|Disease progression|1|||
156664424|NCT00565448|565518503|FG001|Overall Study|Disease progression|0|||
156429703|NCT04925752|564663331|FG000|Overall Study|Hiv-1 Infection|6|||
156664425|NCT00565448|565518502|FG000|Overall Study|Withdrawal by Subject|1|||
156664426|NCT00565448|565518503|FG001|Overall Study|Withdrawal by Subject|0|||
156664427|NCT00193609|565518504|FG000|Overall Study|Lack of Efficacy|2|||
156664428|NCT00193609|565518504|FG000|Overall Study|Adverse Event|2|||
156664429|NCT00735904|565518505|FG000|Overall Study|Adverse Event|3|||
156664430|NCT00735904|565518505|FG000|Overall Study|Death|20|||
156664431|NCT00735904|565518505|FG000|Overall Study|Protocol Violation|1|||
156664432|NCT00735904|565518505|FG000|Overall Study|Withdrawal by Subject|1|||
156429704|NCT04925752|564663332|FG001|Overall Study|Hiv-1 Infection|7|||
156664433|NCT00735904|565518505|FG000|Overall Study|Study Terminated by Sponsor|5|||
156429705|NCT04925752|564663331|FG000|Overall Study|Investigator's discretion|8|||
156664434|NCT00735904|565518505|FG000|Overall Study|Other|8|||
156664435|NCT00822926|565518511|FG000|Second Injection Visit|Lost to Follow-up|1|||
156664436|NCT00822926|565518512|FG001|Second Injection Visit|Lost to Follow-up|0|||
156664437|NCT00822926|565518511|FG000|Second Injection Visit|Withdrawal by Subject|0|||
156664438|NCT00822926|565518512|FG001|Second Injection Visit|Withdrawal by Subject|1|||
156664439|NCT01378975|565518513|FG000|Overall Study|Death|77|||
156664440|NCT01378975|565518514|FG001|Overall Study|Death|46|||
156664441|NCT01378975|565518513|FG000|Overall Study|Investigator Request|1|||
156664442|NCT01378975|565518514|FG001|Overall Study|Investigator Request|0|||
156664443|NCT01378975|565518513|FG000|Overall Study|Lost to Follow-up|4|||
156664444|NCT01378975|565518514|FG001|Overall Study|Lost to Follow-up|1|||
156664445|NCT01378975|565518513|FG000|Overall Study|Withdrew Consent|4|||
156664446|NCT01378975|565518514|FG001|Overall Study|Withdrew Consent|3|||
156664447|NCT00319735|565518517|FG000|Overall Study|Death|2|||
156664448|NCT03125200|565518522|FG000|Overall Study|Study Termination|0|||
156664449|NCT03125200|565518523|FG001|Overall Study|Study Termination|0|||
156664450|NCT03125200|565518524|FG002|Overall Study|Study Termination|0|||
156664451|NCT03125200|565518525|FG003|Overall Study|Study Termination|1|||
156664452|NCT03125200|565518526|FG004|Overall Study|Study Termination|1|||
156664453|NCT03125200|565518527|FG005|Overall Study|Study Termination|2|||
156664454|NCT03125200|565518528|FG006|Overall Study|Study Termination|1|||
156664455|NCT03125200|565518522|FG000|Overall Study|Clinical Progression|0|||
156429706|NCT04925752|564663332|FG001|Overall Study|Investigator's discretion|5|||
156429707|NCT04925752|564663331|FG000|Overall Study|Non-compliance with Study Drug|8|||
156429708|NCT04925752|564663332|FG001|Overall Study|Non-compliance with Study Drug|5|||
156429709|NCT04925752|564663331|FG000|Overall Study|Adverse Event|5|||
156429710|NCT04925752|564663332|FG001|Overall Study|Adverse Event|2|||
156429711|NCT04925752|564663331|FG000|Overall Study|Death|4|||
156429712|NCT04925752|564663332|FG001|Overall Study|Death|2|||
156429713|NCT04925752|564663331|FG000|Overall Study|Protocol Violation|1|||
156429714|NCT04925752|564663332|FG001|Overall Study|Protocol Violation|3|||
156429715|NCT04925752|564663331|FG000|Overall Study|Withdrew Assent|1|||
156429716|NCT04925752|564663332|FG001|Overall Study|Withdrew Assent|0|||
156429717|NCT04269200|564663333|FG000|Global Cohort|Death|72|||
156429718|NCT04269200|564663334|FG001|Global Cohort|Death|54|||
156429719|NCT04269200|564663335|FG002|Global Cohort|Death|49|||
156429720|NCT04269200|564663333|FG000|Global Cohort|Lost to Follow-up|0|||
156429721|NCT04269200|564663334|FG001|Global Cohort|Lost to Follow-up|0|||
156429722|NCT04269200|564663335|FG002|Global Cohort|Lost to Follow-up|2|||
156429723|NCT04269200|564663333|FG000|Global Cohort|Withdrawal by Subject|22|||
156429724|NCT04269200|564663334|FG001|Global Cohort|Withdrawal by Subject|25|||
156429725|NCT04269200|564663335|FG002|Global Cohort|Withdrawal by Subject|18|||
156429726|NCT04269200|564663333|FG000|China Cohort|Death|12|||
156429727|NCT04269200|564663334|FG001|China Cohort|Death|11|||
156429728|NCT04269200|564663335|FG002|China Cohort|Death|13|||
156429729|NCT04269200|564663333|FG000|China Cohort|Lost to Follow-up|0|||
156429730|NCT04269200|564663334|FG001|China Cohort|Lost to Follow-up|1|||
156429731|NCT04269200|564663335|FG002|China Cohort|Lost to Follow-up|1|||
156429732|NCT04269200|564663333|FG000|China Cohort|Withdrawal by Subject|2|||
156429733|NCT04269200|564663334|FG001|China Cohort|Withdrawal by Subject|2|||
156429734|NCT04269200|564663335|FG002|China Cohort|Withdrawal by Subject|4|||
156429735|NCT03331250|564663336|FG000|Overall Study|Withdrawal by Subject|1|||
156429736|NCT04538664|564663337|FG000|Overall Study|Withdrawal by Subject|5|||
156429737|NCT04538664|564663338|FG001|Overall Study|Withdrawal by Subject|9|||
156429738|NCT04538664|564663337|FG000|Overall Study|Lost to Follow-up|2|||
156429739|NCT04538664|564663338|FG001|Overall Study|Lost to Follow-up|1|||
156429740|NCT04538664|564663337|FG000|Overall Study|Ongoing|106|||
156664456|NCT03125200|565518523|FG001|Overall Study|Clinical Progression|0|||
156664457|NCT03125200|565518524|FG002|Overall Study|Clinical Progression|0|||
156664458|NCT03125200|565518525|FG003|Overall Study|Clinical Progression|1|||
156664459|NCT03125200|565518526|FG004|Overall Study|Clinical Progression|0|||
156664460|NCT03125200|565518527|FG005|Overall Study|Clinical Progression|1|||
156664461|NCT03125200|565518528|FG006|Overall Study|Clinical Progression|0|||
156664462|NCT03125200|565518522|FG000|Overall Study|Progressive Disease|2|||
156664463|NCT03125200|565518523|FG001|Overall Study|Progressive Disease|1|||
156664464|NCT03125200|565518524|FG002|Overall Study|Progressive Disease|2|||
156664465|NCT03125200|565518525|FG003|Overall Study|Progressive Disease|1|||
156664466|NCT03125200|565518526|FG004|Overall Study|Progressive Disease|2|||
156664467|NCT03125200|565518527|FG005|Overall Study|Progressive Disease|0|||
156664468|NCT03125200|565518528|FG006|Overall Study|Progressive Disease|1|||
156664469|NCT03125200|565518522|FG000|Overall Study|Lack of Efficacy|0|||
156664470|NCT03125200|565518523|FG001|Overall Study|Lack of Efficacy|0|||
156664471|NCT03125200|565518524|FG002|Overall Study|Lack of Efficacy|0|||
156664472|NCT03125200|565518525|FG003|Overall Study|Lack of Efficacy|1|||
156429741|NCT04538664|564663338|FG001|Overall Study|Ongoing|115|||
156429742|NCT03681678|564663339|FG000|Overall Study|Lost to Follow-up|20|||
156429743|NCT02141074|564663342|FG000|Pre-prophylaxis|Adverse Event|3|||
156429744|NCT02141074|564663343|FG001|Pre-prophylaxis|Adverse Event|0|||
156429745|NCT02141074|564663342|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
156664473|NCT03125200|565518526|FG004|Overall Study|Lack of Efficacy|0|||
156664474|NCT03125200|565518527|FG005|Overall Study|Lack of Efficacy|0|||
156429746|NCT02141074|564663343|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
156429747|NCT02141074|564663342|FG000|Prophylaxis|Adverse Event|0|||
156429748|NCT02141074|564663343|FG001|Prophylaxis|Adverse Event|4|||
156429749|NCT02141074|564663342|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
156429750|NCT02141074|564663343|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
156429751|NCT02141074|564663342|FG000|Prophylaxis|Withdrawal by Subject|0|||
156429752|NCT02141074|564663343|FG001|Prophylaxis|Withdrawal by Subject|1|||
156429753|NCT03536884|564663344|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
156429754|NCT03536884|564663345|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
156429755|NCT03536884|564663346|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429756|NCT03536884|564663347|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429757|NCT03536884|564663348|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429758|NCT03536884|564663349|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429759|NCT03536884|564663350|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429760|NCT03536884|564663351|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429761|NCT03536884|564663352|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429762|NCT03536884|564663353|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429763|NCT03536884|564663354|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429764|NCT03536884|564663355|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
156429765|NCT03536884|564663344|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429766|NCT03536884|564663345|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
156429767|NCT03536884|564663346|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429768|NCT03536884|564663347|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429769|NCT03536884|564663348|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429770|NCT03536884|564663349|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429771|NCT03536884|564663350|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429772|NCT03536884|564663351|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429773|NCT03536884|564663352|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429774|NCT03536884|564663353|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429775|NCT03536884|564663354|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429776|NCT03536884|564663355|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
156429777|NCT03536884|564663344|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
156429778|NCT03536884|564663345|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
156429779|NCT03536884|564663346|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429780|NCT03536884|564663347|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429781|NCT03536884|564663348|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429782|NCT03536884|564663349|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429783|NCT03536884|564663350|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429784|NCT03536884|564663351|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429785|NCT03536884|564663352|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429786|NCT03536884|564663353|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429787|NCT03536884|564663354|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429788|NCT03536884|564663355|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
156429789|NCT03536884|564663344|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429790|NCT03536884|564663345|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
156429791|NCT03536884|564663346|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429792|NCT03536884|564663347|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429793|NCT03536884|564663348|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429794|NCT03536884|564663349|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429795|NCT03536884|564663350|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429796|NCT03536884|564663351|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429797|NCT03536884|564663352|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429798|NCT03536884|564663353|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429799|NCT03536884|564663354|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429800|NCT03536884|564663355|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
156429801|NCT03536884|564663344|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156429802|NCT03536884|564663345|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
156429803|NCT03536884|564663346|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156429804|NCT03536884|564663347|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156429805|NCT03536884|564663348|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156429806|NCT03536884|564663349|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156429807|NCT03536884|564663350|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156664475|NCT03125200|565518528|FG006|Overall Study|Lack of Efficacy|0|||
156429808|NCT03536884|564663351|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156429809|NCT03536884|564663352|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156429810|NCT03536884|564663353|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156664476|NCT03125200|565518522|FG000|Overall Study|Toxicity|0|||
156664477|NCT03125200|565518523|FG001|Overall Study|Toxicity|0|||
156664478|NCT03125200|565518524|FG002|Overall Study|Toxicity|0|||
156664479|NCT03125200|565518525|FG003|Overall Study|Toxicity|1|||
156664480|NCT03125200|565518526|FG004|Overall Study|Toxicity|0|||
156664481|NCT03125200|565518527|FG005|Overall Study|Toxicity|0|||
156664482|NCT03125200|565518528|FG006|Overall Study|Toxicity|0|||
156664483|NCT03125200|565518522|FG000|Overall Study|Consent Withdrawn by Subject|0|||
156664484|NCT03125200|565518523|FG001|Overall Study|Consent Withdrawn by Subject|1|||
156664485|NCT03125200|565518524|FG002|Overall Study|Consent Withdrawn by Subject|0|||
156664486|NCT03125200|565518525|FG003|Overall Study|Consent Withdrawn by Subject|0|||
156664487|NCT03125200|565518526|FG004|Overall Study|Consent Withdrawn by Subject|1|||
156664488|NCT03125200|565518527|FG005|Overall Study|Consent Withdrawn by Subject|0|||
156664489|NCT03125200|565518528|FG006|Overall Study|Consent Withdrawn by Subject|1|||
156664490|NCT00119379|565518529|FG000|Overall Study|Adverse Event|4|||
156664491|NCT00119379|565518530|FG001|Overall Study|Adverse Event|1|||
156664492|NCT02216071|565518539|FG000|Overall Study|Withdrawal by Subject|7|||
156664493|NCT02216071|565518540|FG001|Overall Study|Withdrawal by Subject|2|||
156664494|NCT02216071|565518539|FG000|Overall Study|Lost to Follow-up|3|||
156664495|NCT02216071|565518540|FG001|Overall Study|Lost to Follow-up|3|||
156664496|NCT02216071|565518539|FG000|Overall Study|Protocol Violation|3|||
156664497|NCT02216071|565518540|FG001|Overall Study|Protocol Violation|5|||
156664498|NCT02216071|565518539|FG000|Overall Study|Other|2|||
156664499|NCT02216071|565518540|FG001|Overall Study|Other|2|||
156664500|NCT01900691|565520725|FG000|Overall Study|Death|7|||
156664501|NCT01900691|565520725|FG000|Overall Study|Lost to Follow-up|4|||
156664502|NCT01900691|565520725|FG000|Overall Study|Study Device Not Placed|3|||
156664503|NCT01900691|565520725|FG000|Overall Study|Non study stent placed|2|||
156664504|NCT01900691|565520725|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
156664505|NCT01900691|565520725|FG000|Overall Study|Complete stent migration through digestive tract|1|||
156429811|NCT03536884|564663354|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156664506|NCT01149473|565520726|FG000|First Intervention|Adverse Event|1|||
156664507|NCT01149473|565520727|FG001|First Intervention|Adverse Event|1|||
156664508|NCT01149473|565520726|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156776166|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
156776167|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
156776168|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
156776169|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
156776170|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
156776171|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
156776172|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
156776173|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
156776174|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
156776175|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
156776176|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
156776177|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
156776178|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
156776179|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
156776180|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
156776181|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
156776182|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
156776183|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156776184|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
156776185|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
156776186|NCT06481579|565931443|FG000|Overall Study|Death|1|||
156776187|NCT06481579|565931444|FG001|Overall Study|Death|0|||
156776188|NCT06481579|565931443|FG000|Overall Study|Withdrawal by Subject|3|||
156776189|NCT06481579|565931444|FG001|Overall Study|Withdrawal by Subject|0|||
156429812|NCT03536884|564663355|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
156664509|NCT01149473|565520727|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
156664510|NCT01954394|565520728|FG000|Overall Study|Enrolled but not treated|1|||
156664511|NCT01954394|565520729|FG001|Overall Study|Enrolled but not treated|0|||
156664512|NCT01954394|565520728|FG000|Overall Study|Adverse Event|10|||
156664513|NCT01954394|565520729|FG001|Overall Study|Adverse Event|23|||
156664514|NCT01954394|565520728|FG000|Overall Study|Poor compliance to protocol|7|||
156664515|NCT01954394|565520729|FG001|Overall Study|Poor compliance to protocol|7|||
156664516|NCT01954394|565520728|FG000|Overall Study|Participant Moved|0|||
156664517|NCT01954394|565520729|FG001|Overall Study|Participant Moved|4|||
156524468|NCT00600886|565013905|FG001|Extension - After Crossover (CAS)|Death|0|||
156524469|NCT01028027|565013906|FG000|Overall Study|Lost to Follow-up|4|||
156524470|NCT01028027|565013907|FG001|Overall Study|Lost to Follow-up|1|||
156524471|NCT01028027|565013906|FG000|Overall Study|Withdrawal by Subject|5|||
156524472|NCT01028027|565013907|FG001|Overall Study|Withdrawal by Subject|3|||
156524473|NCT01028027|565013906|FG000|Overall Study|Adverse Event|4|||
156524474|NCT01028027|565013907|FG001|Overall Study|Adverse Event|7|||
156524475|NCT01028027|565013906|FG000|Overall Study|Protocol Violation|3|||
156524476|NCT01028027|565013907|FG001|Overall Study|Protocol Violation|1|||
156524477|NCT01028027|565013906|FG000|Overall Study|Lack of Efficacy|0|||
156524478|NCT01028027|565013907|FG001|Overall Study|Lack of Efficacy|1|||
156524479|NCT02572843|565013917|FG000|Accrual|Brain metastasis retrospectively detected|1|||
156524480|NCT02572843|565013917|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
156524481|NCT02572843|565013917|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
156524482|NCT02572843|565013917|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
156524483|NCT02572843|565013917|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
156524484|NCT02572843|565013917|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
156524485|NCT02572843|565013917|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
156524486|NCT02572843|565013917|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
156524487|NCT02572843|565013917|FG000|Surgery|lost to follow up|7|||
156524488|NCT02572843|565013917|FG000|Surgery|Death|1|||
156524489|NCT01078454|565013921|FG000|Overall Study|Adverse Event|1|||
156524490|NCT01078454|565013922|FG001|Overall Study|Adverse Event|1|||
156524491|NCT01078454|565013921|FG000|Overall Study|Death|0|||
156524492|NCT01078454|565013922|FG001|Overall Study|Death|1|||
156524493|NCT05227703|565013923|FG000|Overall Study|Adverse Event|2|||
156524494|NCT05227703|565013924|FG001|Overall Study|Adverse Event|6|||
156524495|NCT05227703|565013925|FG002|Overall Study|Adverse Event|4|||
156524496|NCT05227703|565013923|FG000|Overall Study|Lack of Efficacy|4|||
156524497|NCT05227703|565013924|FG001|Overall Study|Lack of Efficacy|0|||
156524498|NCT05227703|565013925|FG002|Overall Study|Lack of Efficacy|1|||
156524499|NCT05227703|565013923|FG000|Overall Study|Physician Decision|2|||
156524500|NCT05227703|565013924|FG001|Overall Study|Physician Decision|2|||
156524501|NCT05227703|565013925|FG002|Overall Study|Physician Decision|1|||
156524502|NCT05227703|565013923|FG000|Overall Study|Protocol Violation|2|||
156524503|NCT05227703|565013924|FG001|Overall Study|Protocol Violation|1|||
156524504|NCT05227703|565013925|FG002|Overall Study|Protocol Violation|0|||
156524505|NCT05227703|565013923|FG000|Overall Study|Withdrawal by Subject|17|||
156524506|NCT05227703|565013924|FG001|Overall Study|Withdrawal by Subject|26|||
156524507|NCT05227703|565013925|FG002|Overall Study|Withdrawal by Subject|32|||
156524508|NCT05227703|565013923|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
156524509|NCT05227703|565013924|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
156524510|NCT05227703|565013925|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
156524511|NCT05227703|565013923|FG000|Overall Study|Other|1|||
156524512|NCT05227703|565013924|FG001|Overall Study|Other|1|||
156524513|NCT05227703|565013925|FG002|Overall Study|Other|0|||
156524514|NCT03756129|565013930|FG000|Overall Study|Adverse Event|1|||
156524515|NCT03756129|565013931|FG001|Overall Study|Adverse Event|1|||
156524516|NCT03756129|565013932|FG002|Overall Study|Adverse Event|0|||
156524517|NCT03756129|565013933|FG003|Overall Study|Adverse Event|2|||
156524518|NCT03756129|565013934|FG004|Overall Study|Adverse Event|0|||
156524519|NCT03756129|565013935|FG005|Overall Study|Adverse Event|0|||
156524520|NCT03756129|565013930|FG000|Overall Study|Withdrawal by Subject|2|||
156524521|NCT03756129|565013931|FG001|Overall Study|Withdrawal by Subject|1|||
156524522|NCT03756129|565013932|FG002|Overall Study|Withdrawal by Subject|3|||
156524523|NCT03756129|565013933|FG003|Overall Study|Withdrawal by Subject|1|||
156524524|NCT03756129|565013934|FG004|Overall Study|Withdrawal by Subject|1|||
156524525|NCT03756129|565013935|FG005|Overall Study|Withdrawal by Subject|3|||
156524526|NCT03756129|565013930|FG000|Overall Study|Lost to Follow-up|0|||
156524527|NCT03756129|565013931|FG001|Overall Study|Lost to Follow-up|0|||
156524528|NCT03756129|565013932|FG002|Overall Study|Lost to Follow-up|0|||
156524529|NCT03756129|565013933|FG003|Overall Study|Lost to Follow-up|0|||
156524530|NCT03756129|565013934|FG004|Overall Study|Lost to Follow-up|0|||
156524531|NCT03756129|565013935|FG005|Overall Study|Lost to Follow-up|1|||
156524532|NCT03756129|565013930|FG000|Overall Study|Physician Decision|0|||
156524533|NCT03756129|565013931|FG001|Overall Study|Physician Decision|0|||
156524534|NCT03756129|565013932|FG002|Overall Study|Physician Decision|0|||
156664518|NCT01954394|565520728|FG000|Overall Study|Related to Study Drug administration|2|||
156524535|NCT03756129|565013933|FG003|Overall Study|Physician Decision|0|||
156524536|NCT03756129|565013934|FG004|Overall Study|Physician Decision|0|||
156524537|NCT03756129|565013935|FG005|Overall Study|Physician Decision|1|||
156524538|NCT03170349|565013938|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
156524539|NCT03170349|565013938|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
156524540|NCT03170349|565013938|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
156524541|NCT03170349|565013938|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
156524542|NCT03170349|565013938|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
156664519|NCT01954394|565520729|FG001|Overall Study|Related to Study Drug administration|2|||
156524543|NCT03170349|565013938|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
156524544|NCT03170349|565013938|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
156524545|NCT03170349|565013938|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
156524546|NCT03170349|565013938|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
156524547|NCT03170349|565013938|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
156524548|NCT03170349|565013938|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
156524549|NCT03170349|565013938|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
156524550|NCT03170349|565013938|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
156524551|NCT03170349|565013938|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
156524552|NCT03170349|565013938|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
156524553|NCT03170349|565013938|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
156524554|NCT04281004|565015613|FG000|Overall Study|Physician Decision|1|||
156524555|NCT04281004|565015614|FG001|Overall Study|Physician Decision|0|||
156524556|NCT00701779|565015615|FG000|Overall Study|Adverse Event|6|||
156524557|NCT00701779|565015615|FG000|Overall Study|Lost to Follow-up|1|||
156524558|NCT00701779|565015615|FG000|Overall Study|Withdrawal by Subject|2|||
156524559|NCT02245672|565015616|FG000|Overall Study|Adverse Event|4|||
156524560|NCT02245672|565015617|FG001|Overall Study|Adverse Event|4|||
156524561|NCT02245672|565015618|FG002|Overall Study|Adverse Event|4|||
156524562|NCT02245672|565015616|FG000|Overall Study|Lost to Follow-up|3|||
156524563|NCT02245672|565015617|FG001|Overall Study|Lost to Follow-up|5|||
156524564|NCT02245672|565015618|FG002|Overall Study|Lost to Follow-up|1|||
156524565|NCT02245672|565015616|FG000|Overall Study|Withdrawal by Subject|6|||
156524566|NCT02245672|565015617|FG001|Overall Study|Withdrawal by Subject|3|||
156524567|NCT02245672|565015618|FG002|Overall Study|Withdrawal by Subject|0|||
156524568|NCT02245672|565015616|FG000|Overall Study|Randomized in error (not treated)|0|||
156524569|NCT02245672|565015617|FG001|Overall Study|Randomized in error (not treated)|1|||
156524570|NCT02245672|565015618|FG002|Overall Study|Randomized in error (not treated)|0|||
156524571|NCT00971932|565015621|FG000|Overall Study|Withdrawal by Subject|1|||
156524572|NCT00971932|565015621|FG000|Overall Study|Investigator's decision|2|||
156524573|NCT00971932|565015621|FG000|Overall Study|Ongoing|4|||
156524574|NCT01217957|565015622|FG000|Phase 1|Withdrawal by Patient|1|||
156524575|NCT01217957|565015623|FG001|Phase 1|Withdrawal by Patient|0|||
156524576|NCT01217957|565015624|FG002|Phase 1|Withdrawal by Patient|1|||
156524577|NCT01217957|565015625|FG003|Phase 1|Withdrawal by Patient|1|||
156524578|NCT01217957|565015626|FG004|Phase 1|Withdrawal by Patient|0|||
156524579|NCT01217957|565015622|FG000|Phase 2|Withdrawal by Patient|0|||
156524580|NCT01217957|565015623|FG001|Phase 2|Withdrawal by Patient|0|||
156524581|NCT01217957|565015624|FG002|Phase 2|Withdrawal by Patient|0|||
156524582|NCT01217957|565015625|FG003|Phase 2|Withdrawal by Patient|0|||
156524583|NCT01217957|565015626|FG004|Phase 2|Withdrawal by Patient|1|||
156524584|NCT01640054|565015627|FG000|Overall Study|Study-specific disc criteria|1|||
156524585|NCT01640054|565015627|FG000|Overall Study|Lack of Efficacy|3|||
156524586|NCT01640054|565015627|FG000|Overall Study|Adverse Event|2|||
156524587|NCT01620255|565015631|FG000|Overall Study|Withdrawal by Subject|4|||
156524588|NCT01620255|565015632|FG001|Overall Study|Withdrawal by Subject|1|||
156524589|NCT01620255|565015633|FG002|Overall Study|Withdrawal by Subject|1|||
156524590|NCT01620255|565015634|FG003|Overall Study|Withdrawal by Subject|2|||
156524591|NCT01620255|565015635|FG004|Overall Study|Withdrawal by Subject|4|||
156524592|NCT01620255|565015631|FG000|Overall Study|Participant underwent fecal transplant|0|||
156524593|NCT01620255|565015632|FG001|Overall Study|Participant underwent fecal transplant|0|||
156524594|NCT01620255|565015633|FG002|Overall Study|Participant underwent fecal transplant|1|||
156524595|NCT01620255|565015634|FG003|Overall Study|Participant underwent fecal transplant|0|||
156524596|NCT01620255|565015635|FG004|Overall Study|Participant underwent fecal transplant|0|||
156524597|NCT01620255|565015631|FG000|Overall Study|Non-compliance|0|||
156524598|NCT01620255|565015632|FG001|Overall Study|Non-compliance|1|||
156524599|NCT01620255|565015633|FG002|Overall Study|Non-compliance|0|||
156524600|NCT01620255|565015634|FG003|Overall Study|Non-compliance|0|||
156524601|NCT01620255|565015635|FG004|Overall Study|Non-compliance|0|||
156524602|NCT01620255|565015631|FG000|Overall Study|Adverse Event|0|||
156524603|NCT01620255|565015632|FG001|Overall Study|Adverse Event|4|||
156524604|NCT01620255|565015633|FG002|Overall Study|Adverse Event|0|||
156524605|NCT01620255|565015634|FG003|Overall Study|Adverse Event|1|||
156524606|NCT01620255|565015635|FG004|Overall Study|Adverse Event|1|||
156524607|NCT01620255|565015631|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
156524608|NCT01620255|565015632|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
156524609|NCT01620255|565015633|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
156524610|NCT01620255|565015634|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
156524611|NCT01620255|565015635|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
156524612|NCT01206777|565015641|FG000|Overall Study|Death|1|||
156524613|NCT01206777|565015641|FG000|Overall Study|Adverse Event|1|||
156524614|NCT00975507|565015650|FG000|Overall Study|Adverse Event|1|||
156524615|NCT00975507|565015651|FG001|Overall Study|Adverse Event|0|||
156524616|NCT00975507|565015650|FG000|Overall Study|Lost to Follow-up|7|||
156524617|NCT00975507|565015651|FG001|Overall Study|Lost to Follow-up|1|||
156429813|NCT03536884|564663344|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156429814|NCT03536884|564663345|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
156429815|NCT03536884|564663346|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156664520|NCT01954394|565520728|FG000|Overall Study|Other than specified above|10|||
156664521|NCT01954394|565520729|FG001|Overall Study|Other than specified above|21|||
156664522|NCT03107091|565520732|FG000|Overall Study|Physician Decision|1|||
156664523|NCT03025880|565520737|FG000|Overall Study|Adverse Event|1|||
156664524|NCT03025880|565520738|FG001|Overall Study|Adverse Event|0|||
156664525|NCT03025880|565520737|FG000|Overall Study|Death|1|||
156664526|NCT03025880|565520738|FG001|Overall Study|Death|1|||
156664527|NCT03025880|565520737|FG000|Overall Study|Withdrawal by Subject|0|||
156664528|NCT03025880|565520738|FG001|Overall Study|Withdrawal by Subject|1|||
156664529|NCT03025880|565520737|FG000|Overall Study|Physician Decision|0|||
156664530|NCT03025880|565520738|FG001|Overall Study|Physician Decision|1|||
156664531|NCT03025880|565520737|FG000|Overall Study|Progressive Disease|12|||
156664532|NCT03025880|565520738|FG001|Overall Study|Progressive Disease|19|||
156664533|NCT00436553|565520739|FG000|Overall Study|Adverse Event|4|||
156664534|NCT00436553|565520740|FG001|Overall Study|Adverse Event|3|||
156664535|NCT00436553|565520741|FG002|Overall Study|Adverse Event|4|||
156664536|NCT00436553|565520739|FG000|Overall Study|Death|3|||
156664537|NCT00436553|565520740|FG001|Overall Study|Death|1|||
156664538|NCT00436553|565520741|FG002|Overall Study|Death|3|||
156664539|NCT00436553|565520739|FG000|Overall Study|Lost to Follow-up|0|||
156664540|NCT00436553|565520740|FG001|Overall Study|Lost to Follow-up|2|||
156664541|NCT00436553|565520741|FG002|Overall Study|Lost to Follow-up|0|||
156664542|NCT00436553|565520739|FG000|Overall Study|Protocol Violation|1|||
156664543|NCT00436553|565520740|FG001|Overall Study|Protocol Violation|0|||
156664544|NCT00436553|565520741|FG002|Overall Study|Protocol Violation|0|||
156664545|NCT00436553|565520739|FG000|Overall Study|Withdrawal by Subject|5|||
156664546|NCT00436553|565520740|FG001|Overall Study|Withdrawal by Subject|6|||
156664547|NCT00436553|565520741|FG002|Overall Study|Withdrawal by Subject|3|||
156664548|NCT00625443|565520747|FG000|Overall Study|Adverse Event|1|||
156664549|NCT00625443|565520748|FG001|Overall Study|Adverse Event|4|||
156664550|NCT00625443|565520749|FG002|Overall Study|Adverse Event|0|||
156664551|NCT00625443|565520747|FG000|Overall Study|Non-compliance with protocol|0|||
156664552|NCT00625443|565520748|FG001|Overall Study|Non-compliance with protocol|1|||
156664553|NCT00625443|565520749|FG002|Overall Study|Non-compliance with protocol|0|||
156664554|NCT00625443|565520747|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
156664555|NCT00625443|565520748|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
156664556|NCT00625443|565520749|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
156664557|NCT00625443|565520747|FG000|Overall Study|Withdrawal by Subject|0|||
156664558|NCT00625443|565520748|FG001|Overall Study|Withdrawal by Subject|1|||
156664559|NCT00625443|565520749|FG002|Overall Study|Withdrawal by Subject|2|||
156664560|NCT00625443|565520747|FG000|Overall Study|Physician Decision|0|||
156664561|NCT00625443|565520748|FG001|Overall Study|Physician Decision|4|||
156664562|NCT00625443|565520749|FG002|Overall Study|Physician Decision|2|||
156664563|NCT00625443|565520747|FG000|Overall Study|Other|0|||
156664564|NCT00625443|565520748|FG001|Overall Study|Other|1|||
156664565|NCT00625443|565520749|FG002|Overall Study|Other|1|||
156664566|NCT03136380|565520750|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
156664567|NCT03136380|565520751|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
156664568|NCT03136380|565520752|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
156664569|NCT03136380|565520753|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
156664570|NCT03136380|565520754|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
156664571|NCT02728102|565520755|FG000|Overall Study|Death|3|||
156664572|NCT02728102|565520756|FG001|Overall Study|Death|0|||
156664573|NCT02728102|565520757|FG002|Overall Study|Death|1|||
156664574|NCT02728102|565520755|FG000|Overall Study|Withdrawal by Subject|0|||
156664575|NCT02728102|565520756|FG001|Overall Study|Withdrawal by Subject|2|||
156664576|NCT02728102|565520757|FG002|Overall Study|Withdrawal by Subject|3|||
156664577|NCT02728102|565520755|FG000|Overall Study|Physician Decision|1|||
156664578|NCT02728102|565520756|FG001|Overall Study|Physician Decision|1|||
156664579|NCT02728102|565520757|FG002|Overall Study|Physician Decision|0|||
156664580|NCT02728102|565520755|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
156664581|NCT02728102|565520756|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
156776190|NCT06481579|565931443|FG000|Overall Study|Other|1|||
156429816|NCT03536884|564663347|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156664582|NCT02728102|565520757|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
156776191|NCT06481579|565931444|FG001|Overall Study|Other|1|||
156524618|NCT00975507|565015650|FG000|Overall Study|Protocol Violation|2|||
156664583|NCT02728102|565520755|FG000|Overall Study|Covid|0|||
156664584|NCT02728102|565520756|FG001|Overall Study|Covid|0|||
156664585|NCT02728102|565520757|FG002|Overall Study|Covid|1|||
156664586|NCT02419937|565520761|FG000|Overall Study|Lost to Follow-up|1|||
156664587|NCT02419937|565520762|FG001|Overall Study|Lost to Follow-up|0|||
156664588|NCT00553280|565520764|FG000|Overall Study|Adverse Event|19|||
156776192|NCT01157845|565931445|FG000|Overall Study|Lost to Follow-up|5|||
156664589|NCT00553280|565520764|FG000|Overall Study|Lack of Efficacy|3|||
156664590|NCT00553280|565520764|FG000|Overall Study|Withdrawal by Subject|3|||
156664591|NCT00553280|565520764|FG000|Overall Study|Physician Decision|1|||
156664592|NCT01182415|565520765|FG000|Overall Study|Lost to Follow-up|1|||
156664593|NCT01544127|565520766|FG000|Overall Study|Lost to Follow-up|4|||
156664594|NCT01544127|565520767|FG001|Overall Study|Lost to Follow-up|2|||
156664595|NCT01544127|565520768|FG002|Overall Study|Lost to Follow-up|9|||
156664596|NCT01544127|565520766|FG000|Overall Study|Withdrawal by Subject|2|||
156664597|NCT01544127|565520767|FG001|Overall Study|Withdrawal by Subject|2|||
156664598|NCT01544127|565520768|FG002|Overall Study|Withdrawal by Subject|1|||
156664599|NCT01544127|565520766|FG000|Overall Study|Discharged out of catchment area|1|||
156664600|NCT01544127|565520767|FG001|Overall Study|Discharged out of catchment area|1|||
156664601|NCT01544127|565520768|FG002|Overall Study|Discharged out of catchment area|1|||
156664602|NCT01544127|565520766|FG000|Overall Study|Death|1|||
156664603|NCT01544127|565520767|FG001|Overall Study|Death|0|||
156664604|NCT01544127|565520768|FG002|Overall Study|Death|0|||
156664605|NCT01544127|565520766|FG000|Overall Study|Jail or Prison|1|||
156664606|NCT01544127|565520767|FG001|Overall Study|Jail or Prison|1|||
156664607|NCT01544127|565520768|FG002|Overall Study|Jail or Prison|2|||
156664608|NCT01544127|565520766|FG000|Overall Study|Became Psychotic|1|||
156664609|NCT01544127|565520767|FG001|Overall Study|Became Psychotic|0|||
156664610|NCT01544127|565520768|FG002|Overall Study|Became Psychotic|0|||
156664611|NCT01544127|565520766|FG000|Overall Study|Researcher withdrew|1|||
156664612|NCT01544127|565520767|FG001|Overall Study|Researcher withdrew|0|||
156664613|NCT01544127|565520768|FG002|Overall Study|Researcher withdrew|0|||
156664614|NCT01544127|565520766|FG000|Overall Study|Went active duty|0|||
156664615|NCT01544127|565520767|FG001|Overall Study|Went active duty|0|||
156664616|NCT01544127|565520768|FG002|Overall Study|Went active duty|1|||
156664617|NCT01256684|565520771|FG000|Overall Study|Adverse Event|1|||
156664618|NCT01256684|565520772|FG001|Overall Study|Adverse Event|4|||
156664619|NCT01256684|565520773|FG002|Overall Study|Adverse Event|2|||
156664620|NCT01256684|565520771|FG000|Overall Study|Withdrawal by Subject|4|||
156664621|NCT01256684|565520772|FG001|Overall Study|Withdrawal by Subject|0|||
156664622|NCT01256684|565520773|FG002|Overall Study|Withdrawal by Subject|2|||
156664623|NCT01256684|565520771|FG000|Overall Study|Physician Decision|0|||
156664624|NCT01256684|565520772|FG001|Overall Study|Physician Decision|1|||
156664625|NCT01256684|565520773|FG002|Overall Study|Physician Decision|0|||
156664626|NCT01256684|565520771|FG000|Overall Study|Lack of Efficacy|0|||
156664627|NCT01256684|565520772|FG001|Overall Study|Lack of Efficacy|1|||
156664628|NCT01256684|565520773|FG002|Overall Study|Lack of Efficacy|1|||
156664629|NCT01256684|565520771|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
156664630|NCT01256684|565520772|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
156664631|NCT01256684|565520773|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
156664632|NCT02587962|565520777|FG000|Overall Study|Adverse Event|0|||
156664633|NCT02587962|565520778|FG001|Overall Study|Adverse Event|0|||
156664634|NCT02587962|565520779|FG002|Overall Study|Adverse Event|1|||
156664635|NCT02587962|565520780|FG003|Overall Study|Adverse Event|0|||
156664636|NCT02587962|565520781|FG004|Overall Study|Adverse Event|0|||
156776193|NCT01157845|565931445|FG000|Overall Study|Withdrawal by Subject|12|||
156776194|NCT01157845|565931445|FG000|Overall Study|Physician Decision|3|||
156776195|NCT01157845|565931445|FG000|Overall Study|Protocol Violation|13|||
156776196|NCT01157845|565931445|FG000|Overall Study|Study was ended|1|||
156664637|NCT02587962|565520777|FG000|Overall Study|Withdrawal by Subject|0|||
156776197|NCT01157845|565931445|FG000|Overall Study|Device malfunction|1|||
156776198|NCT03311555|565931446|FG000|Overall Study|Adverse Event|1|||
156776199|NCT04338581|565933390|FG000|Overall Study|Lack of Efficacy|1|||
156776200|NCT04338581|565933391|FG001|Overall Study|Lack of Efficacy|0|||
156776201|NCT04338581|565933390|FG000|Overall Study|Withdrawal by Subject|4|||
156776202|NCT04338581|565933391|FG001|Overall Study|Withdrawal by Subject|4|||
156776203|NCT04338581|565933390|FG000|Overall Study|Prohibited Medication|1|||
156776204|NCT04338581|565933391|FG001|Overall Study|Prohibited Medication|0|||
156664638|NCT02587962|565520778|FG001|Overall Study|Withdrawal by Subject|0|||
156776205|NCT04609553|565933392|FG000|Overall Study|Lost to Follow-up|27|||
156664639|NCT02587962|565520779|FG002|Overall Study|Withdrawal by Subject|1|||
156664640|NCT02587962|565520780|FG003|Overall Study|Withdrawal by Subject|1|||
156664641|NCT02587962|565520781|FG004|Overall Study|Withdrawal by Subject|4|||
156664642|NCT02587962|565520777|FG000|Overall Study|Radiological progression|2|||
156664643|NCT02587962|565520778|FG001|Overall Study|Radiological progression|2|||
156776206|NCT04609553|565933393|FG001|Overall Study|Lost to Follow-up|31|||
156776207|NCT04609553|565933394|FG002|Overall Study|Lost to Follow-up|24|||
156776208|NCT04609553|565933392|FG000|Overall Study|Discontinued|12|||
156776209|NCT04609553|565933393|FG001|Overall Study|Discontinued|10|||
156776210|NCT04609553|565933394|FG002|Overall Study|Discontinued|9|||
156776211|NCT02239328|565933395|FG000|Overall Study|Benign disease noted at time of surgery|6|||
156325032|NCT00191646|564289489|FG001|Overall Study|Toxicity|37|||
156325033|NCT00191646|564289488|FG000|Overall Study|Disease Progression|5|||
156325034|NCT00191646|564289489|FG001|Overall Study|Disease Progression|6|||
156325035|NCT00191646|564289488|FG000|Overall Study|Physician Decision|20|||
156664644|NCT02587962|565520779|FG002|Overall Study|Radiological progression|2|||
156664645|NCT02587962|565520780|FG003|Overall Study|Radiological progression|5|||
156664646|NCT02587962|565520781|FG004|Overall Study|Radiological progression|10|||
156664647|NCT02587962|565520777|FG000|Overall Study|Clinical progression|0|||
156664648|NCT02587962|565520778|FG001|Overall Study|Clinical progression|1|||
156664649|NCT02587962|565520779|FG002|Overall Study|Clinical progression|2|||
156664650|NCT02587962|565520780|FG003|Overall Study|Clinical progression|0|||
156664651|NCT02587962|565520781|FG004|Overall Study|Clinical progression|1|||
156664652|NCT01185548|565520782|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
156664653|NCT00086996|565520783|FG000|Overall Study|Adverse Event|29|||
156664654|NCT00086996|565520783|FG000|Overall Study|Death|4|||
156664655|NCT00086996|565520783|FG000|Overall Study|progression/relapse|7|||
156664656|NCT00086996|565520783|FG000|Overall Study|Withdrawal by Subject|13|||
156664657|NCT00086996|565520783|FG000|Overall Study|Other|6|||
156664658|NCT00086996|565520783|FG000|Overall Study|not eligible|5|||
156664659|NCT01422538|565520785|FG000|Overall Study|Lost to Follow-up|0|||
156664660|NCT01422538|565520786|FG001|Overall Study|Lost to Follow-up|1|||
156664661|NCT01422538|565520787|FG002|Overall Study|Lost to Follow-up|1|||
156664662|NCT01422538|565520785|FG000|Overall Study|Missed visit|0|||
156664663|NCT01422538|565520786|FG001|Overall Study|Missed visit|1|||
156664664|NCT01422538|565520787|FG002|Overall Study|Missed visit|1|||
156664665|NCT00184600|565520788|FG000|Overall Study|Adverse Event|9|||
156664666|NCT00184600|565520789|FG001|Overall Study|Adverse Event|0|||
156664667|NCT00184600|565520790|FG002|Overall Study|Adverse Event|5|||
156664668|NCT00184600|565520788|FG000|Overall Study|Death|3|||
156664669|NCT00184600|565520789|FG001|Overall Study|Death|9|||
156664670|NCT00184600|565520790|FG002|Overall Study|Death|7|||
156664671|NCT00184600|565520788|FG000|Overall Study|Lack of Efficacy|3|||
156664672|NCT00184600|565520789|FG001|Overall Study|Lack of Efficacy|1|||
156664673|NCT00184600|565520790|FG002|Overall Study|Lack of Efficacy|3|||
156664674|NCT00184600|565520788|FG000|Overall Study|Lost to Follow-up|4|||
156664675|NCT00184600|565520789|FG001|Overall Study|Lost to Follow-up|6|||
156664676|NCT00184600|565520790|FG002|Overall Study|Lost to Follow-up|1|||
156664677|NCT00184600|565520788|FG000|Overall Study|Protocol Violation|2|||
156664678|NCT00184600|565520789|FG001|Overall Study|Protocol Violation|2|||
156664679|NCT00184600|565520790|FG002|Overall Study|Protocol Violation|3|||
156776212|NCT02239328|565933395|FG000|Overall Study|Equipment or website malfunction|2|||
156429817|NCT03536884|564663348|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156429818|NCT03536884|564663349|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156664680|NCT00184600|565520788|FG000|Overall Study|Withdrawal by Subject|20|||
156776213|NCT00460798|565933397|FG000|Overall Study|Death|59|||
156776214|NCT00460798|565933397|FG000|Overall Study|Adverse Event|27|||
156776215|NCT00460798|565933397|FG000|Overall Study|Lost to Follow-up|19|||
156429819|NCT03536884|564663350|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156429820|NCT03536884|564663351|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156429821|NCT03536884|564663352|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156429822|NCT03536884|564663353|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156429823|NCT03536884|564663354|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156429824|NCT03536884|564663355|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
156429825|NCT03536884|564663344|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429826|NCT03536884|564663345|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429827|NCT03536884|564663346|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
156429828|NCT03536884|564663347|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429829|NCT03536884|564663348|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
156429830|NCT03536884|564663349|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429831|NCT03536884|564663350|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429832|NCT03536884|564663351|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429833|NCT03536884|564663352|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429834|NCT03536884|564663353|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429835|NCT03536884|564663354|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429836|NCT03536884|564663355|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
156429837|NCT03536884|564663344|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429838|NCT03536884|564663345|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429839|NCT03536884|564663346|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
156664681|NCT00184600|565520789|FG001|Overall Study|Withdrawal by Subject|28|||
156429840|NCT03536884|564663347|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
156664682|NCT00184600|565520790|FG002|Overall Study|Withdrawal by Subject|12|||
156664683|NCT00184600|565520788|FG000|Overall Study|Unclassified|4|||
156664684|NCT00184600|565520789|FG001|Overall Study|Unclassified|5|||
156664685|NCT00184600|565520790|FG002|Overall Study|Unclassified|3|||
156664686|NCT00624065|565520793|FG000|Overall Study|Adverse Event|5|||
156776216|NCT00460798|565933397|FG000|Overall Study|Progressive Disease|99|||
156524619|NCT00975507|565015651|FG001|Overall Study|Protocol Violation|0|||
156664687|NCT00624065|565520794|FG001|Overall Study|Adverse Event|6|||
156664688|NCT00624065|565520793|FG000|Overall Study|Lost to Follow-up|4|||
156664689|NCT00624065|565520794|FG001|Overall Study|Lost to Follow-up|1|||
156664690|NCT00624065|565520793|FG000|Overall Study|Consent withdrawn|6|||
156664691|NCT00624065|565520794|FG001|Overall Study|Consent withdrawn|5|||
156664692|NCT00624065|565520793|FG000|Overall Study|Lack of Efficacy|0|||
156664693|NCT00624065|565520794|FG001|Overall Study|Lack of Efficacy|3|||
156664694|NCT00624065|565520793|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
156664695|NCT00624065|565520794|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
156664696|NCT02770820|565520795|FG000|Overall Study|Death|1|||
156664697|NCT02770820|565520795|FG000|Overall Study|Physician Decision|2|||
156664698|NCT00696020|565520796|FG000|Overall Study|Adverse Event|3|||
156664699|NCT00696020|565520797|FG001|Overall Study|Adverse Event|1|||
156664700|NCT00696020|565520798|FG002|Overall Study|Adverse Event|2|||
156664701|NCT00696020|565520799|FG003|Overall Study|Adverse Event|1|||
156664702|NCT00696020|565520796|FG000|Overall Study|Lack of Efficacy|1|||
156664703|NCT00696020|565520797|FG001|Overall Study|Lack of Efficacy|0|||
156664704|NCT00696020|565520798|FG002|Overall Study|Lack of Efficacy|0|||
156664705|NCT00696020|565520799|FG003|Overall Study|Lack of Efficacy|0|||
156664706|NCT00696020|565520796|FG000|Overall Study|Protocol Violation|0|||
156664707|NCT00696020|565520797|FG001|Overall Study|Protocol Violation|0|||
156664708|NCT00696020|565520798|FG002|Overall Study|Protocol Violation|0|||
156664709|NCT00696020|565520799|FG003|Overall Study|Protocol Violation|1|||
156664710|NCT00696020|565520796|FG000|Overall Study|Withdrawal by Subject|0|||
156664711|NCT00696020|565520797|FG001|Overall Study|Withdrawal by Subject|1|||
156664712|NCT00696020|565520798|FG002|Overall Study|Withdrawal by Subject|0|||
156664713|NCT00696020|565520799|FG003|Overall Study|Withdrawal by Subject|1|||
156664714|NCT00696020|565520796|FG000|Overall Study|Other not stated above|0|||
156664715|NCT00696020|565520797|FG001|Overall Study|Other not stated above|0|||
156664716|NCT00696020|565520798|FG002|Overall Study|Other not stated above|1|||
156664717|NCT00696020|565520799|FG003|Overall Study|Other not stated above|1|||
156664718|NCT01387022|565520800|FG000|Overall Study|Death|1|||
156664719|NCT01387022|565520801|FG001|Overall Study|Death|1|||
156664720|NCT01387022|565520800|FG000|Overall Study|Lost to Follow-up|0|||
156664721|NCT01387022|565520801|FG001|Overall Study|Lost to Follow-up|3|||
156664722|NCT02076022|565520803|FG000|Overall Study|Withdrawal by Subject|2|||
156664723|NCT02076022|565520804|FG001|Overall Study|Withdrawal by Subject|0|||
156664724|NCT03627091|565520807|FG000|Overall Study|Adverse Event|0|||
156664725|NCT03627091|565520808|FG001|Overall Study|Adverse Event|0|||
156664726|NCT03627091|565520809|FG002|Overall Study|Adverse Event|2|||
156664727|NCT03627091|565520807|FG000|Overall Study|Withdrawal by Subject|2|||
156664728|NCT03627091|565520808|FG001|Overall Study|Withdrawal by Subject|0|||
156664729|NCT03627091|565520809|FG002|Overall Study|Withdrawal by Subject|2|||
156664730|NCT03627091|565520807|FG000|Overall Study|Physician Decision|2|||
156664731|NCT03627091|565520808|FG001|Overall Study|Physician Decision|0|||
156664732|NCT03627091|565520809|FG002|Overall Study|Physician Decision|0|||
156664733|NCT03627091|565520807|FG000|Overall Study|Site terminated by sponsor|0|||
156664734|NCT03627091|565520808|FG001|Overall Study|Site terminated by sponsor|1|||
156664735|NCT03627091|565520809|FG002|Overall Study|Site terminated by sponsor|0|||
156664736|NCT03627091|565520807|FG000|Overall Study|Disease relapse|7|||
156664737|NCT03627091|565520808|FG001|Overall Study|Disease relapse|5|||
156664738|NCT03627091|565520809|FG002|Overall Study|Disease relapse|1|||
156664739|NCT03627091|565520807|FG000|Overall Study|Other|1|||
156664740|NCT03627091|565520808|FG001|Overall Study|Other|0|||
156664741|NCT03627091|565520809|FG002|Overall Study|Other|0|||
156664742|NCT00102440|565520810|FG000|Overall Study|Lost to Follow-up|25|||
156664743|NCT00102440|565520811|FG001|Overall Study|Lost to Follow-up|18|||
156776217|NCT00460798|565933397|FG000|Overall Study|Other|27|||
156776218|NCT00460798|565933397|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
156776219|NCT00460798|565933397|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
156776220|NCT00933933|565933400|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
156776221|NCT00933933|565933401|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
156776222|NCT00933933|565933402|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
156776223|NCT00933933|565933400|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
156776224|NCT00933933|565933401|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
156776225|NCT00933933|565933402|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
156776226|NCT01104766|565933403|FG000|Overall Study|Did not meet inc/exc criteria|1|||
156776227|NCT01104766|565933404|FG001|Overall Study|Did not meet inc/exc criteria|0|||
156325036|NCT00191646|564289489|FG001|Overall Study|Physician Decision|11|||
156664744|NCT00102440|565520812|FG002|Overall Study|Lost to Follow-up|21|||
156664745|NCT00102440|565520810|FG000|Overall Study|Adverse Event|16|||
156664746|NCT00102440|565520811|FG001|Overall Study|Adverse Event|23|||
156325037|NCT00191646|564289488|FG000|Overall Study|Withdrawal by Subject|58|||
156664747|NCT00102440|565520812|FG002|Overall Study|Adverse Event|8|||
156664748|NCT00102440|565520810|FG000|Overall Study|Gout Flare|10|||
156664749|NCT00102440|565520811|FG001|Overall Study|Gout Flare|28|||
156664750|NCT00102440|565520812|FG002|Overall Study|Gout Flare|9|||
156664751|NCT00102440|565520810|FG000|Overall Study|Personal Reason(s)|19|||
156664752|NCT00102440|565520811|FG001|Overall Study|Personal Reason(s)|13|||
156664753|NCT00102440|565520812|FG002|Overall Study|Personal Reason(s)|13|||
156664754|NCT00102440|565520810|FG000|Overall Study|Other|11|||
156664755|NCT00102440|565520811|FG001|Overall Study|Other|14|||
156664756|NCT00102440|565520812|FG002|Overall Study|Other|14|||
156664757|NCT00102440|565520810|FG000|Overall Study|Protocol Violation|7|||
156664758|NCT00102440|565520811|FG001|Overall Study|Protocol Violation|2|||
156664759|NCT00102440|565520812|FG002|Overall Study|Protocol Violation|1|||
156664760|NCT04239872|565520813|FG000|Overall Study|Lost to Follow-up|0|||
156664761|NCT04239872|565520814|FG001|Overall Study|Lost to Follow-up|1|||
156664762|NCT01498120|565520818|FG000|Overall Study|Lost to Follow-up|1|||
156664763|NCT01498120|565520818|FG000|Overall Study|Withdrawal by Subject|5|||
156664764|NCT01498120|565520818|FG000|Overall Study|AE, non-serious non-fatal|3|||
156664765|NCT01498120|565520818|FG000|Overall Study|Other|4|||
156664766|NCT01472341|565520819|FG000|Overall Study|Started insulin therapy|55|||
156664767|NCT01472341|565520819|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
156664768|NCT01472341|565520819|FG000|Overall Study|Withdrawal by Subject|39|||
156664769|NCT01472341|565520819|FG000|Overall Study|Lost to Follow-up|52|||
156664770|NCT01472341|565520819|FG000|Overall Study|Laboratory parameters unavailable|25|||
156664771|NCT01472341|565520819|FG000|Overall Study|Death|9|||
156664772|NCT04060147|565520820|FG000|Overall Study|Withdrew consent|1|||
156664773|NCT03204539|565520821|FG000|Overall Study|Loss of funding|0|||
156664774|NCT03204539|565520822|FG001|Overall Study|Loss of funding|1|||
156664775|NCT01171963|565520823|FG000|Overall Study|Adverse Event|10|||
156664776|NCT01171963|565520824|FG001|Overall Study|Adverse Event|15|||
156664777|NCT01171963|565520823|FG000|Overall Study|Lost to Follow-up|23|||
156664778|NCT01171963|565520824|FG001|Overall Study|Lost to Follow-up|24|||
156664779|NCT01171963|565520823|FG000|Overall Study|Other - diarrhoea|1|||
156664780|NCT01171963|565520824|FG001|Overall Study|Other - diarrhoea|0|||
156664781|NCT01171963|565520823|FG000|Overall Study|Withdrawal by Subject|114|||
156664782|NCT01171963|565520824|FG001|Overall Study|Withdrawal by Subject|129|||
156664783|NCT00550537|565520832|FG000|Overall Study|Death|18|||
156664784|NCT00550537|565520832|FG000|Overall Study|Adverse Event|20|||
156664785|NCT00550537|565520832|FG000|Overall Study|Disease progression before|46|||
156664786|NCT00550537|565520832|FG000|Overall Study|Withdrawal by Subject|7|||
156664787|NCT00550537|565520832|FG000|Overall Study|Change in treatment plan|4|||
156664788|NCT00550537|565520832|FG000|Overall Study|Other complicating ilness|3|||
156664789|NCT00550537|565520832|FG000|Overall Study|Declining performance status|2|||
156664790|NCT00550537|565520832|FG000|Overall Study|Treated closer to home|4|||
156664791|NCT02008565|565520833|FG000|Overall Study|Protocol Violation|1|||
156664792|NCT02008565|565520834|FG001|Overall Study|Protocol Violation|1|||
156664793|NCT02008565|565520835|FG002|Overall Study|Protocol Violation|2|||
156664794|NCT02008565|565520836|FG003|Overall Study|Protocol Violation|0|||
156664795|NCT00268905|565520837|FG000|Overall Study|Adverse Event|3|||
156664796|NCT00268905|565520838|FG001|Overall Study|Adverse Event|0|||
156664797|NCT00268905|565520839|FG002|Overall Study|Adverse Event|4|||
156664798|NCT00268905|565520837|FG000|Overall Study|Lost to Follow-up|0|||
156664799|NCT00268905|565520838|FG001|Overall Study|Lost to Follow-up|1|||
156664800|NCT00268905|565520839|FG002|Overall Study|Lost to Follow-up|0|||
156664801|NCT00268905|565520837|FG000|Overall Study|Withdrawal by Subject|0|||
156664802|NCT00268905|565520838|FG001|Overall Study|Withdrawal by Subject|0|||
156325038|NCT00191646|564289489|FG001|Overall Study|Withdrawal by Subject|39|||
156325039|NCT00191646|564289488|FG000|Overall Study|Protocol Violation|5|||
156664803|NCT00268905|565520839|FG002|Overall Study|Withdrawal by Subject|3|||
156664804|NCT00268905|565520837|FG000|Overall Study|Progressive Disease|28|||
156664805|NCT00268905|565520838|FG001|Overall Study|Progressive Disease|4|||
156664806|NCT00268905|565520839|FG002|Overall Study|Progressive Disease|3|||
156664807|NCT00268905|565520837|FG000|Overall Study|Physician Decision|3|||
156664808|NCT00268905|565520838|FG001|Overall Study|Physician Decision|0|||
156325040|NCT00191646|564289489|FG001|Overall Study|Protocol Violation|7|||
156325041|NCT00191646|564289488|FG000|Overall Study|Death|6|||
156325042|NCT00191646|564289489|FG001|Overall Study|Death|8|||
156325043|NCT00191646|564289488|FG000|Overall Study|Other|33|||
156325044|NCT00191646|564289489|FG001|Overall Study|Other|34|||
156325045|NCT00191646|564289488|FG000|Overall Study|Missing Data|18|||
156325046|NCT00191646|564289489|FG001|Overall Study|Missing Data|11|||
156325047|NCT05211284|564289494|FG000|Overall Study|Study Terminated|3|||
156664809|NCT00268905|565520839|FG002|Overall Study|Physician Decision|1|||
156664810|NCT00268905|565520837|FG000|Overall Study|Clinical Progression|9|||
156664811|NCT00268905|565520838|FG001|Overall Study|Clinical Progression|4|||
156664812|NCT00268905|565520839|FG002|Overall Study|Clinical Progression|1|||
156664813|NCT00617305|565520840|FG000|Overall Study|Adverse Event|4|||
156664814|NCT00617305|565520841|FG001|Overall Study|Adverse Event|0|||
156664815|NCT00617305|565520842|FG002|Overall Study|Adverse Event|0|||
156664816|NCT00617305|565520840|FG000|Overall Study|Death|1|||
156664817|NCT00617305|565520841|FG001|Overall Study|Death|0|||
156664818|NCT00617305|565520842|FG002|Overall Study|Death|0|||
156664819|NCT00617305|565520840|FG000|Overall Study|Physician Decision|1|||
156664820|NCT00617305|565520841|FG001|Overall Study|Physician Decision|0|||
156325048|NCT05211284|564289495|FG001|Overall Study|Study Terminated|1|||
156664821|NCT00617305|565520842|FG002|Overall Study|Physician Decision|0|||
156664822|NCT00617305|565520840|FG000|Overall Study|Protocol Violation|1|||
156664823|NCT00617305|565520841|FG001|Overall Study|Protocol Violation|0|||
156664824|NCT00617305|565520842|FG002|Overall Study|Protocol Violation|1|||
156664825|NCT00617305|565520840|FG000|Overall Study|Withdrawal by Subject|1|||
156664826|NCT00617305|565520841|FG001|Overall Study|Withdrawal by Subject|0|||
156664827|NCT00617305|565520842|FG002|Overall Study|Withdrawal by Subject|0|||
156664828|NCT00857623|565520843|FG000|Overall Study|Adverse Event|5|||
156664829|NCT00857623|565520844|FG001|Overall Study|Adverse Event|2|||
156664830|NCT00857623|565520843|FG000|Overall Study|Study-specific discontinuation criteria|5|||
156664831|NCT00857623|565520844|FG001|Overall Study|Study-specific discontinuation criteria|3|||
156664832|NCT00857623|565520843|FG000|Overall Study|Withdrawal by Subject|2|||
156664833|NCT00857623|565520844|FG001|Overall Study|Withdrawal by Subject|1|||
156664834|NCT00857623|565520843|FG000|Overall Study|Lack of Efficacy|1|||
156664835|NCT00857623|565520844|FG001|Overall Study|Lack of Efficacy|1|||
156776228|NCT01104766|565933405|FG002|Overall Study|Did not meet inc/exc criteria|0|||
156325049|NCT00406718|564289496|FG000|Overall Study|Withdrawal by Subject|2|||
156325050|NCT00406718|564289497|FG001|Overall Study|Withdrawal by Subject|9|||
156325051|NCT00406718|564289498|FG002|Overall Study|Withdrawal by Subject|4|||
156325052|NCT00406718|564289496|FG000|Overall Study|Lost to Follow-up|2|||
156325053|NCT00406718|564289497|FG001|Overall Study|Lost to Follow-up|5|||
156325054|NCT00406718|564289498|FG002|Overall Study|Lost to Follow-up|4|||
156325055|NCT01888003|564289501|FG000|Overall Study|Study Terminated|5|||
156325056|NCT01888003|564289502|FG001|Overall Study|Study Terminated|6|||
156325057|NCT01888003|564289503|FG002|Overall Study|Study Terminated|40|||
156325058|NCT03187756|564289504|FG000|Overall Study|Termination of study|4|||
156325059|NCT01442038|564290839|FG000|Overall Study|Death|35|||
156325060|NCT01442038|564290840|FG001|Overall Study|Death|29|||
156325061|NCT01442038|564290839|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
156325062|NCT01442038|564290840|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
156325063|NCT01442038|564290839|FG000|Overall Study|Participant Withdrew Consent|137|||
156325064|NCT01442038|564290840|FG001|Overall Study|Participant Withdrew Consent|102|||
156325065|NCT01442038|564290839|FG000|Overall Study|Lost to Follow-up|37|||
156325066|NCT01442038|564290840|FG001|Overall Study|Lost to Follow-up|51|||
156325067|NCT01442038|564290839|FG000|Overall Study|Adverse Event|26|||
156325068|NCT01442038|564290840|FG001|Overall Study|Adverse Event|15|||
156325069|NCT01442038|564290839|FG000|Overall Study|Protocol Deviation|9|||
156325070|NCT01442038|564290840|FG001|Overall Study|Protocol Deviation|20|||
156325071|NCT01442038|564290839|FG000|Overall Study|Investigator's Discretion|13|||
156325072|NCT01442038|564290840|FG001|Overall Study|Investigator's Discretion|16|||
156325073|NCT01442038|564290839|FG000|Overall Study|Study Terminated By Sponsor|2|||
156325074|NCT01442038|564290840|FG001|Overall Study|Study Terminated By Sponsor|3|||
156325075|NCT04879225|564290841|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
156325076|NCT04879225|564290841|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
156325077|NCT01298531|564290844|FG000|Overall Study|Lack of Efficacy|0|||
156325078|NCT01298531|564290845|FG001|Overall Study|Lack of Efficacy|1|||
156325079|NCT01298531|564290844|FG000|Overall Study|Lost to Follow-up|2|||
156325080|NCT01298531|564290845|FG001|Overall Study|Lost to Follow-up|0|||
156325081|NCT01298531|564290844|FG000|Overall Study|Protocol Violation|1|||
156325082|NCT01298531|564290845|FG001|Overall Study|Protocol Violation|1|||
156325083|NCT01298531|564290844|FG000|Overall Study|Adverse Event|4|||
156325084|NCT01298531|564290845|FG001|Overall Study|Adverse Event|3|||
156325085|NCT01298531|564290844|FG000|Overall Study|Does not meet entrance criteria|0|||
156325086|NCT01298531|564290845|FG001|Overall Study|Does not meet entrance criteria|1|||
156325087|NCT01298531|564290844|FG000|Overall Study|Other|2|||
156325088|NCT01298531|564290845|FG001|Overall Study|Other|1|||
156325089|NCT00736957|564290846|FG000|Overall Study|Adverse Event|43|||
156325090|NCT00736957|564290846|FG000|Overall Study|Withdrawal by Subject|49|||
156325091|NCT00736957|564290846|FG000|Overall Study|violation of eligibility criteria|2|||
156325092|NCT00736957|564290846|FG000|Overall Study|did not attend hospital appointments|1|||
156325093|NCT00736957|564290846|FG000|Overall Study|not eligible for Treatment Period I|22|||
156325094|NCT00736957|564290846|FG000|Overall Study|Physician Decision|5|||
156325095|NCT03646643|564290847|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
156325096|NCT03646643|564290848|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
156325097|NCT03646643|564290847|FG000|Overall Study|Lost to Follow-up|0|||
156325098|NCT03646643|564290848|FG001|Overall Study|Lost to Follow-up|1|||
156325099|NCT05314478|564290849|FG000|Overall Study|Physician Decision|1|||
156325100|NCT03583164|564290852|FG000|Overall Study|Death in Main Phase|35|||
156325101|NCT03583164|564290852|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
156325102|NCT03583164|564290852|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
156325103|NCT03583164|564290852|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
156325104|NCT03583164|564290852|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
156325105|NCT03583164|564290852|FG000|Overall Study|Physician decision in Main Phase|1|||
156325106|NCT03583164|564290852|FG000|Overall Study|Physician decision in Extended Phase|2|||
156664836|NCT00857623|565520843|FG000|Overall Study|Severe non-compliance to protocol|1|||
156776229|NCT01104766|565933406|FG003|Overall Study|Did not meet inc/exc criteria|0|||
156664837|NCT00857623|565520844|FG001|Overall Study|Severe non-compliance to protocol|1|||
156664838|NCT00857623|565520843|FG000|Overall Study|Intake of prohibited medication|0|||
156664839|NCT00857623|565520844|FG001|Overall Study|Intake of prohibited medication|1|||
156664840|NCT00857623|565520843|FG000|Overall Study|Positive for HEP C|0|||
156664841|NCT00857623|565520844|FG001|Overall Study|Positive for HEP C|1|||
156664842|NCT04185909|565520845|FG000|Overall Study|Lost to Follow-up|1|||
156664843|NCT02193178|565520846|FG000|Overall Study|Lost to Follow-up|1|||
156664844|NCT02193178|565520846|FG000|Overall Study|Dry eyes|1|||
156664845|NCT04510285|565520847|FG000|Overall Study|Death|1|||
156664846|NCT00048581|565520848|FG000|Double-Blind Period|Adverse Event|9|||
156664847|NCT00048581|565520849|FG001|Double-Blind Period|Adverse Event|5|||
156664848|NCT00048581|565520850|FG002|Double-Blind Period|Adverse Event|0|||
156664849|NCT00048581|565520848|FG000|Double-Blind Period|Lack of Efficacy|14|||
156664850|NCT00048581|565520849|FG001|Double-Blind Period|Lack of Efficacy|27|||
156664851|NCT00048581|565520850|FG002|Double-Blind Period|Lack of Efficacy|0|||
156664852|NCT00048581|565520848|FG000|Double-Blind Period|Lost to Follow-up|5|||
156664853|NCT00048581|565520849|FG001|Double-Blind Period|Lost to Follow-up|0|||
156664854|NCT00048581|565520850|FG002|Double-Blind Period|Lost to Follow-up|0|||
156664855|NCT00048581|565520848|FG000|Double-Blind Period|Withdrawal by Subject|5|||
156664856|NCT00048581|565520849|FG001|Double-Blind Period|Withdrawal by Subject|2|||
156664857|NCT00048581|565520850|FG002|Double-Blind Period|Withdrawal by Subject|0|||
156664858|NCT00048581|565520848|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
156664859|NCT00048581|565520849|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
156664860|NCT00048581|565520850|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
156664861|NCT00048581|565520848|FG000|Double-Blind Period|Investigator Decision|1|||
156664862|NCT00048581|565520849|FG001|Double-Blind Period|Investigator Decision|0|||
156664863|NCT00048581|565520850|FG002|Double-Blind Period|Investigator Decision|0|||
156664864|NCT00048581|565520848|FG000|Open-Label Period|Death|0|||
156664865|NCT00048581|565520849|FG001|Open-Label Period|Death|0|||
156664866|NCT00048581|565520850|FG002|Open-Label Period|Death|4|||
156664867|NCT00048581|565520848|FG000|Open-Label Period|Adverse Event|0|||
156664868|NCT00048581|565520849|FG001|Open-Label Period|Adverse Event|0|||
156664869|NCT00048581|565520850|FG002|Open-Label Period|Adverse Event|37|||
156664870|NCT00048581|565520848|FG000|Open-Label Period|Lack of Efficacy|0|||
156664871|NCT00048581|565520849|FG001|Open-Label Period|Lack of Efficacy|0|||
156664872|NCT00048581|565520850|FG002|Open-Label Period|Lack of Efficacy|69|||
156664873|NCT00048581|565520848|FG000|Open-Label Period|Lost to Follow-up|0|||
156664874|NCT00048581|565520849|FG001|Open-Label Period|Lost to Follow-up|0|||
156664875|NCT00048581|565520850|FG002|Open-Label Period|Lost to Follow-up|14|||
156664876|NCT00048581|565520848|FG000|Open-Label Period|Withdrawal by Subject|0|||
156664877|NCT00048581|565520849|FG001|Open-Label Period|Withdrawal by Subject|0|||
156664878|NCT00048581|565520850|FG002|Open-Label Period|Withdrawal by Subject|20|||
156664879|NCT00048581|565520848|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
156664880|NCT00048581|565520849|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
156664881|NCT00048581|565520850|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
156664882|NCT00048581|565520848|FG000|Open-Label Period|Poor/Non-compliance|0|||
156664883|NCT00048581|565520849|FG001|Open-Label Period|Poor/Non-compliance|0|||
156664884|NCT00048581|565520850|FG002|Open-Label Period|Poor/Non-compliance|5|||
156664885|NCT00048581|565520848|FG000|Open-Label Period|Pregnancy|0|||
156664886|NCT00048581|565520849|FG001|Open-Label Period|Pregnancy|0|||
156664887|NCT00048581|565520850|FG002|Open-Label Period|Pregnancy|7|||
156664888|NCT00048581|565520848|FG000|Open-Label Period|Study Site Closure|0|||
156776230|NCT01104766|565933403|FG000|Overall Study|Adverse Event|17|||
156776231|NCT01104766|565933404|FG001|Overall Study|Adverse Event|15|||
156776232|NCT01104766|565933405|FG002|Overall Study|Adverse Event|20|||
156776233|NCT01104766|565933406|FG003|Overall Study|Adverse Event|14|||
156776234|NCT01104766|565933403|FG000|Overall Study|Lack of Efficacy|20|||
156776235|NCT01104766|565933404|FG001|Overall Study|Lack of Efficacy|15|||
156776236|NCT01104766|565933405|FG002|Overall Study|Lack of Efficacy|14|||
156776237|NCT01104766|565933406|FG003|Overall Study|Lack of Efficacy|8|||
156776238|NCT01104766|565933403|FG000|Overall Study|Protocol Violation|2|||
156776239|NCT01104766|565933404|FG001|Overall Study|Protocol Violation|0|||
156776240|NCT01104766|565933405|FG002|Overall Study|Protocol Violation|0|||
156776241|NCT01104766|565933406|FG003|Overall Study|Protocol Violation|0|||
156776242|NCT01104766|565933403|FG000|Overall Study|Withdrawal by Subject|17|||
156776243|NCT01104766|565933404|FG001|Overall Study|Withdrawal by Subject|19|||
156325107|NCT03583164|564290852|FG000|Overall Study|Death in Extended Phase|13|||
156325108|NCT03583164|564290852|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
156664889|NCT00048581|565520849|FG001|Open-Label Period|Study Site Closure|0|||
156664890|NCT00048581|565520850|FG002|Open-Label Period|Study Site Closure|2|||
156664891|NCT00048581|565520848|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
156664892|NCT00048581|565520849|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
156664893|NCT00048581|565520850|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
156664894|NCT00048581|565520848|FG000|Open-Label Period|Problem With Transportation To Site|0|||
156776244|NCT01104766|565933405|FG002|Overall Study|Withdrawal by Subject|25|||
156776245|NCT01104766|565933406|FG003|Overall Study|Withdrawal by Subject|15|||
156776246|NCT01104766|565933403|FG000|Overall Study|Lost to Follow-up|1|||
156429841|NCT03536884|564663348|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
156429842|NCT03536884|564663349|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429843|NCT03536884|564663350|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429844|NCT03536884|564663351|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429845|NCT03536884|564663352|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429846|NCT03536884|564663353|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429847|NCT03536884|564663354|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429848|NCT03536884|564663355|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
156429849|NCT03536884|564663344|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429850|NCT03536884|564663345|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429851|NCT03536884|564663346|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429852|NCT03536884|564663347|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
156429853|NCT03536884|564663348|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
156429854|NCT03536884|564663349|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429855|NCT03536884|564663350|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429856|NCT03536884|564663351|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429857|NCT03536884|564663352|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429858|NCT03536884|564663353|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429859|NCT03536884|564663354|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429860|NCT03536884|564663355|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
156429861|NCT03536884|564663344|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156429862|NCT03536884|564663345|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156429863|NCT03536884|564663346|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
156429864|NCT03536884|564663347|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
156429865|NCT03536884|564663348|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
156429866|NCT03536884|564663349|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156429867|NCT03536884|564663350|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156776247|NCT01104766|565933404|FG001|Overall Study|Lost to Follow-up|2|||
156776248|NCT01104766|565933405|FG002|Overall Study|Lost to Follow-up|1|||
156429868|NCT03536884|564663351|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156429869|NCT03536884|564663352|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156429870|NCT03536884|564663353|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156429871|NCT03536884|564663354|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156429872|NCT03536884|564663355|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
156429873|NCT03536884|564663344|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429874|NCT03536884|564663345|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429875|NCT03536884|564663346|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
156429876|NCT03536884|564663347|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
156429877|NCT03536884|564663348|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
156429878|NCT03536884|564663349|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429879|NCT03536884|564663350|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429880|NCT03536884|564663351|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429881|NCT03536884|564663352|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429882|NCT03536884|564663353|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429883|NCT03536884|564663354|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429884|NCT03536884|564663355|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
156429885|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
156429886|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
156429887|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
156429888|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
156429889|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
156429890|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
156429891|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
156429892|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
156429893|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
156776249|NCT01104766|565933406|FG003|Overall Study|Lost to Follow-up|1|||
156776250|NCT01756235|565933407|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
156776251|NCT05376358|565933408|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
156776252|NCT05376358|565933409|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
156776253|NCT05376358|565933408|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
156776254|NCT05376358|565933409|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
156429894|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
156429895|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
156429896|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
156429897|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
156429898|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
156664895|NCT00048581|565520849|FG001|Open-Label Period|Problem With Transportation To Site|0|||
156664896|NCT00048581|565520850|FG002|Open-Label Period|Problem With Transportation To Site|1|||
156664897|NCT00048581|565520848|FG000|Open-Label Period|Primary Investigator Retired|0|||
156664898|NCT00048581|565520849|FG001|Open-Label Period|Primary Investigator Retired|0|||
156664899|NCT00048581|565520850|FG002|Open-Label Period|Primary Investigator Retired|2|||
156664900|NCT00048581|565520848|FG000|Open-Label Period|Study Ended By Sponsor|0|||
156664901|NCT00048581|565520849|FG001|Open-Label Period|Study Ended By Sponsor|0|||
156664902|NCT00048581|565520850|FG002|Open-Label Period|Study Ended By Sponsor|1|||
156664903|NCT03897088|565520851|FG000|Overall Study|Withdrawal by Subject|12|||
156664904|NCT03897088|565520852|FG001|Overall Study|Withdrawal by Subject|12|||
156664905|NCT03897088|565520851|FG000|Overall Study|Lost to Follow-up|7|||
156664906|NCT03897088|565520852|FG001|Overall Study|Lost to Follow-up|15|||
156664907|NCT03897088|565520851|FG000|Overall Study|Sponsor Decision|1|||
156664908|NCT03897088|565520852|FG001|Overall Study|Sponsor Decision|2|||
156664909|NCT03897088|565520851|FG000|Overall Study|COVID-19|2|||
156664910|NCT03897088|565520852|FG001|Overall Study|COVID-19|0|||
156664911|NCT03897088|565520851|FG000|Overall Study|Other|3|||
156664912|NCT03897088|565520852|FG001|Overall Study|Other|0|||
156664913|NCT03897088|565520851|FG000|Overall Study|Non-compliance with Study Drug|1|||
156664914|NCT03897088|565520852|FG001|Overall Study|Non-compliance with Study Drug|1|||
156664915|NCT03897088|565520851|FG000|Overall Study|Pregnancy|0|||
156664916|NCT03897088|565520852|FG001|Overall Study|Pregnancy|1|||
156664917|NCT04320849|565520861|FG000|Overall Study|Withdrawal by Subject|4|||
156664918|NCT04320849|565520861|FG000|Overall Study|Imaging data unavailable|2|||
156664919|NCT04320849|565520861|FG000|Overall Study|Incomplete imaging|2|||
156664920|NCT03555305|565520862|FG000|Period 1|Physician Decision|0|||
156664921|NCT03555305|565520863|FG001|Period 1|Physician Decision|1|||
156664922|NCT03555305|565520862|FG000|Period 1|Adverse Event|0|||
156664923|NCT03555305|565520863|FG001|Period 1|Adverse Event|1|||
156664924|NCT03135834|565520866|FG000|Stage 1|Adverse Event|1|||
156664925|NCT03135834|565520867|FG001|Stage 1|Adverse Event|2|||
156664926|NCT03135834|565520868|FG002|Stage 1|Adverse Event|2|||
156664927|NCT03135834|565520869|FG003|Stage 1|Adverse Event|1|||
156664928|NCT03135834|565520866|FG000|Stage 1|Death|1|||
156664929|NCT03135834|565520867|FG001|Stage 1|Death|0|||
156664930|NCT03135834|565520868|FG002|Stage 1|Death|0|||
156664931|NCT03135834|565520869|FG003|Stage 1|Death|0|||
156664932|NCT03135834|565520866|FG000|Stage 1|Lost to Follow-up|17|||
156664933|NCT03135834|565520867|FG001|Stage 1|Lost to Follow-up|24|||
156664934|NCT03135834|565520868|FG002|Stage 1|Lost to Follow-up|21|||
156664935|NCT03135834|565520869|FG003|Stage 1|Lost to Follow-up|38|||
156664936|NCT03135834|565520866|FG000|Stage 1|No longer met eligibility criteria|1|||
156664937|NCT03135834|565520867|FG001|Stage 1|No longer met eligibility criteria|6|||
156664938|NCT03135834|565520868|FG002|Stage 1|No longer met eligibility criteria|2|||
156664939|NCT03135834|565520869|FG003|Stage 1|No longer met eligibility criteria|5|||
156664940|NCT03135834|565520866|FG000|Stage 1|Other|0|||
156664941|NCT03135834|565520867|FG001|Stage 1|Other|2|||
156664942|NCT03135834|565520868|FG002|Stage 1|Other|1|||
156664943|NCT03135834|565520869|FG003|Stage 1|Other|0|||
156664944|NCT03135834|565520866|FG000|Stage 1|Physician Decision|0|||
156664945|NCT03135834|565520867|FG001|Stage 1|Physician Decision|1|||
156664946|NCT03135834|565520868|FG002|Stage 1|Physician Decision|0|||
156664947|NCT03135834|565520869|FG003|Stage 1|Physician Decision|0|||
156664948|NCT03135834|565520866|FG000|Stage 1|Pregnancy|0|||
156664949|NCT03135834|565520867|FG001|Stage 1|Pregnancy|4|||
156664950|NCT03135834|565520868|FG002|Stage 1|Pregnancy|2|||
156664951|NCT03135834|565520869|FG003|Stage 1|Pregnancy|4|||
156664952|NCT03135834|565520866|FG000|Stage 1|Protocol Violation|1|||
156664953|NCT03135834|565520867|FG001|Stage 1|Protocol Violation|1|||
156664954|NCT03135834|565520868|FG002|Stage 1|Protocol Violation|2|||
156664955|NCT03135834|565520869|FG003|Stage 1|Protocol Violation|1|||
156664956|NCT03135834|565520866|FG000|Stage 1|Withdrawal by parent/guardian|2|||
156664957|NCT03135834|565520867|FG001|Stage 1|Withdrawal by parent/guardian|10|||
156664958|NCT03135834|565520868|FG002|Stage 1|Withdrawal by parent/guardian|2|||
156664959|NCT03135834|565520869|FG003|Stage 1|Withdrawal by parent/guardian|1|||
156664960|NCT03135834|565520866|FG000|Stage 1|Withdrawal by Subject|16|||
156664961|NCT03135834|565520867|FG001|Stage 1|Withdrawal by Subject|22|||
156664962|NCT03135834|565520868|FG002|Stage 1|Withdrawal by Subject|7|||
156664963|NCT03135834|565520869|FG003|Stage 1|Withdrawal by Subject|10|||
156664964|NCT03135834|565520866|FG000|Stage 1|Randomized but not Vaccinated|0|||
156664965|NCT03135834|565520867|FG001|Stage 1|Randomized but not Vaccinated|3|||
156664966|NCT03135834|565520868|FG002|Stage 1|Randomized but not Vaccinated|1|||
156664967|NCT03135834|565520869|FG003|Stage 1|Randomized but not Vaccinated|6|||
156664968|NCT03135834|565520866|FG000|Stage 2|Lost to Follow-up|0|||
156664969|NCT03135834|565520867|FG001|Stage 2|Lost to Follow-up|1|||
156664970|NCT03135834|565520868|FG002|Stage 2|Lost to Follow-up|0|||
156664971|NCT03135834|565520869|FG003|Stage 2|Lost to Follow-up|0|||
156664972|NCT03135834|565520866|FG000|Stage 2|Withdrawal by Subject|0|||
156664973|NCT03135834|565520867|FG001|Stage 2|Withdrawal by Subject|1|||
156664974|NCT03135834|565520868|FG002|Stage 2|Withdrawal by Subject|0|||
156664975|NCT03135834|565520869|FG003|Stage 2|Withdrawal by Subject|0|||
156664976|NCT03135834|565520866|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
156664977|NCT03135834|565520867|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
156664978|NCT03135834|565520868|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
156664979|NCT03135834|565520869|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
156664980|NCT03135834|565520866|FG000|Stage 2|Did not receive Booster Vaccination|1|||
156664981|NCT03135834|565520867|FG001|Stage 2|Did not receive Booster Vaccination|1|||
156664982|NCT03135834|565520868|FG002|Stage 2|Did not receive Booster Vaccination|0|||
156664983|NCT03135834|565520869|FG003|Stage 2|Did not receive Booster Vaccination|0|||
156664984|NCT03966365|565520870|FG000|Overall Study|Protocol Violation|1|||
156664985|NCT03966365|565520871|FG001|Overall Study|Protocol Violation|0|||
156664986|NCT02421952|565520872|FG000|Overall Study|Diary Not Returned|93|||
156664987|NCT02421952|565520872|FG000|Overall Study|Failed seriation task|13|||
156664988|NCT02421952|565520872|FG000|Overall Study|Subject uncooperative for baseline test|2|||
156664989|NCT02421952|565520872|FG000|Overall Study|Surgery cancelled|1|||
156664990|NCT01469546|565520875|FG000|Received 5 mg Dose|Adverse Event|13|||
156664991|NCT01469546|565520875|FG000|Received 5 mg Dose|Death|2|||
156664992|NCT01469546|565520875|FG000|Received 5 mg Dose|Protocol Violation|2|||
156664993|NCT01469546|565520875|FG000|Received 5 mg Dose|Progressive Disease|3|||
156664994|NCT01469546|565520875|FG000|Received 5 mg Dose|Physician Decision|3|||
156664995|NCT02801877|565520876|FG000|Overall Study|Lost to Follow-up|1|||
156664996|NCT02801877|565520877|FG001|Overall Study|Lost to Follow-up|1|||
156664997|NCT02801877|565520878|FG002|Overall Study|Lost to Follow-up|2|||
156664998|NCT02801877|565520879|FG003|Overall Study|Lost to Follow-up|0|||
156664999|NCT02801877|565520876|FG000|Overall Study|Never Started Treatment|2|||
156665000|NCT02801877|565520877|FG001|Overall Study|Never Started Treatment|0|||
156665001|NCT02801877|565520878|FG002|Overall Study|Never Started Treatment|4|||
156665002|NCT02801877|565520879|FG003|Overall Study|Never Started Treatment|0|||
156665003|NCT04934722|565522430|FG000|Overall Study|Death|4|||
156665004|NCT04934722|565522431|FG001|Overall Study|Death|3|||
156665005|NCT04934722|565522430|FG000|Overall Study|Participants Ongoing|88|||
156665006|NCT04934722|565522431|FG001|Overall Study|Participants Ongoing|91|||
156665007|NCT06358820|565522432|FG000|Overall Study|Adverse Event|11|||
156665008|NCT06358820|565522432|FG000|Overall Study|kidney transplantation|3|||
156665009|NCT06358820|565522432|FG000|Overall Study|patient voluntary withdrawal|6|||
156665010|NCT06358820|565522432|FG000|Overall Study|Physician Decision|1|||
156665011|NCT05376319|565522433|FG000|Overall Study|Funding termination|2|||
156665012|NCT05376319|565522434|FG001|Overall Study|Funding termination|4|||
156665013|NCT01124175|565522435|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
156665014|NCT01124175|565522436|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
156665015|NCT00942968|565522437|FG000|Overall Study|Adverse Event|60|||
156665016|NCT00942968|565522437|FG000|Overall Study|Death|76|||
156665017|NCT00942968|565522437|FG000|Overall Study|Protocol Violation|9|||
156665018|NCT00942968|565522437|FG000|Overall Study|Lost to Follow-up|4|||
156665019|NCT00942968|565522437|FG000|Overall Study|Withdrawal by Subject|44|||
156665020|NCT00942968|565522437|FG000|Overall Study|Sponsor request|5|||
156665021|NCT00942968|565522437|FG000|Overall Study|Physician Decision|11|||
156665022|NCT00942968|565522437|FG000|Overall Study|Progression of disease|12|||
156665023|NCT00942968|565522437|FG000|Overall Study|Inferior vena cava filter placement|4|||
156665024|NCT00942968|565522437|FG000|Overall Study|Pulmonary embolism (PE)|1|||
156665025|NCT00942968|565522437|FG000|Overall Study|Participant required pancreatic biopsy|1|||
156665026|NCT00942968|565522437|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
156665027|NCT01948258|565522438|FG000|Overall Study|Pregnancy|41|||
156665028|NCT01948258|565522438|FG000|Overall Study|Did not complete by cut-off date|35|||
156665029|NCT01948258|565522438|FG000|Overall Study|Lost to Follow-up|27|||
156665030|NCT01948258|565522438|FG000|Overall Study|Withdrawal by SPD|8|||
156665031|NCT01948258|565522438|FG000|Overall Study|Withdrawal by Subject|6|||
156665032|NCT01948258|565522438|FG000|Overall Study|Health Care Professional|43|||
156665033|NCT01948258|565522438|FG000|Overall Study|Removed from statistical analysis|2|||
156665034|NCT01340495|565522445|FG000|Overall Study|Withdrawal by Subject|1|||
156665035|NCT01811953|565522446|FG000|Overall Study|Adverse Event|0|||
156665036|NCT01811953|565522447|FG001|Overall Study|Adverse Event|0|||
156665037|NCT01811953|565522448|FG002|Overall Study|Adverse Event|0|||
156665038|NCT01811953|565522449|FG003|Overall Study|Adverse Event|1|||
156665039|NCT01811953|565522450|FG004|Overall Study|Adverse Event|0|||
156665040|NCT01811953|565522451|FG005|Overall Study|Adverse Event|1|||
156665041|NCT01811953|565522446|FG000|Overall Study|Protocol Violation|0|||
156665042|NCT01811953|565522447|FG001|Overall Study|Protocol Violation|0|||
156665043|NCT01811953|565522448|FG002|Overall Study|Protocol Violation|0|||
156665044|NCT01811953|565522449|FG003|Overall Study|Protocol Violation|0|||
156665045|NCT01811953|565522450|FG004|Overall Study|Protocol Violation|1|||
156665046|NCT01811953|565522451|FG005|Overall Study|Protocol Violation|0|||
156665047|NCT00070291|565522453|FG000|Step 1|Withdrawal by Subject|1|||
156665048|NCT00070291|565522453|FG000|Step 1|Adverse Event|1|||
156665049|NCT00070291|565522453|FG000|Step 2|Adverse Event|1|||
156665050|NCT00520130|565522454|FG000|Overall Study|Disease progression on study|4|||
156665051|NCT00520130|565522455|FG001|Overall Study|Disease progression on study|0|||
156665052|NCT00520130|565522454|FG000|Overall Study|Physician Decision|1|||
156665053|NCT00520130|565522455|FG001|Overall Study|Physician Decision|1|||
156665054|NCT02533258|565522458|FG000|Overall Study|Adverse Event|1|||
156665055|NCT02533258|565522458|FG000|Overall Study|Death|2|||
156665056|NCT02533258|565522458|FG000|Overall Study|Other|1|||
156665057|NCT02533258|565522458|FG000|Overall Study|Economic factor|1|||
156665058|NCT02533258|565522458|FG000|Overall Study|Progression of pleural effusion|1|||
156665059|NCT02533258|565522458|FG000|Overall Study|Lack of Efficacy|2|||
156665060|NCT01045096|565522459|FG000|Overall Study|Withdrawal by Subject|2|||
156665061|NCT01045096|565522460|FG001|Overall Study|Withdrawal by Subject|0|||
156665062|NCT01045096|565522461|FG002|Overall Study|Withdrawal by Subject|0|||
156665063|NCT01045096|565522459|FG000|Overall Study|Other|1|||
156665064|NCT01045096|565522460|FG001|Overall Study|Other|0|||
156665065|NCT01045096|565522461|FG002|Overall Study|Other|0|||
156665066|NCT01511939|565522463|FG000|Overall Study|Withdrawal by Subject|2|||
156665067|NCT01511939|565522464|FG001|Overall Study|Withdrawal by Subject|1|||
156665068|NCT01511939|565522465|FG002|Overall Study|Withdrawal by Subject|0|||
156665069|NCT03785548|565522471|FG000|Overall Study|age > 80|1|||
156665070|NCT03785548|565522472|FG001|Overall Study|age > 80|0|||
156665071|NCT03785548|565522471|FG000|Overall Study|no Postop queries|1|||
156665072|NCT03785548|565522472|FG001|Overall Study|no Postop queries|0|||
156665073|NCT01993030|565522473|FG000|Overall Study|Adverse Event|0|||
156665074|NCT01993030|565522474|FG001|Overall Study|Adverse Event|4|||
156665075|NCT00396279|565522476|FG000|Overall Study|Ongoing in study|26|||
156665076|NCT00396279|565522476|FG000|Overall Study|Disease progression|2|||
156665077|NCT00396279|565522476|FG000|Overall Study|Withdrawal by Subject|1|||
156665078|NCT00396279|565522476|FG000|Overall Study|Physician Decision|1|||
156665079|NCT02883452|565522477|FG000|Overall Study|Withdrawal by Subject|1|||
156665080|NCT02883452|565522478|FG001|Overall Study|Withdrawal by Subject|1|||
156665081|NCT02883452|565522479|FG002|Overall Study|Withdrawal by Subject|3|||
156665082|NCT02883452|565522480|FG003|Overall Study|Withdrawal by Subject|0|||
156665083|NCT02883452|565522481|FG004|Overall Study|Withdrawal by Subject|2|||
156665084|NCT02883452|565522482|FG005|Overall Study|Withdrawal by Subject|5|||
156665085|NCT02883452|565522477|FG000|Overall Study|Disease progression|1|||
156665086|NCT02883452|565522478|FG001|Overall Study|Disease progression|0|||
156776255|NCT05376358|565933408|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
156776256|NCT05376358|565933409|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
156776257|NCT05376358|565933408|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
156776258|NCT05376358|565933409|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
156776259|NCT05376358|565933408|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
156776260|NCT05376358|565933409|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
156776261|NCT05376358|565933408|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
156776262|NCT05376358|565933409|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
156776263|NCT04225832|565933410|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
156776264|NCT04225832|565933411|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
156776265|NCT04225832|565933410|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
156776266|NCT04225832|565933411|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
156776267|NCT00311168|565933412|FG000|First Intervention|Withdrawal by Subject|2|||
156776268|NCT00311168|565933413|FG001|First Intervention|Withdrawal by Subject|2|||
156776269|NCT00311168|565933412|FG000|First Intervention|Lost to Follow-up|1|||
156776270|NCT00311168|565933413|FG001|First Intervention|Lost to Follow-up|1|||
156776271|NCT00311168|565933412|FG000|First Intervention|Protocol Violation|1|||
156776272|NCT00311168|565933413|FG001|First Intervention|Protocol Violation|1|||
156776273|NCT00311168|565933412|FG000|First Intervention|Adverse Event|1|||
156776274|NCT00311168|565933413|FG001|First Intervention|Adverse Event|0|||
156429899|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
156429900|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
156776275|NCT00311168|565933412|FG000|First Intervention|Other|2|||
156665087|NCT02883452|565522479|FG002|Overall Study|Disease progression|0|||
156665088|NCT02883452|565522480|FG003|Overall Study|Disease progression|1|||
156665089|NCT02883452|565522481|FG004|Overall Study|Disease progression|4|||
156665090|NCT02883452|565522482|FG005|Overall Study|Disease progression|5|||
156665091|NCT02883452|565522477|FG000|Overall Study|Adverse Event|2|||
156665092|NCT02883452|565522478|FG001|Overall Study|Adverse Event|1|||
156665093|NCT02883452|565522479|FG002|Overall Study|Adverse Event|1|||
156665094|NCT02883452|565522480|FG003|Overall Study|Adverse Event|1|||
156665095|NCT02883452|565522481|FG004|Overall Study|Adverse Event|1|||
156665096|NCT02883452|565522482|FG005|Overall Study|Adverse Event|3|||
156665097|NCT02883452|565522477|FG000|Overall Study|Physician Decision|0|||
156665098|NCT02883452|565522478|FG001|Overall Study|Physician Decision|0|||
156665099|NCT02883452|565522479|FG002|Overall Study|Physician Decision|0|||
156429901|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
156665100|NCT02883452|565522480|FG003|Overall Study|Physician Decision|0|||
156665101|NCT02883452|565522481|FG004|Overall Study|Physician Decision|4|||
156665102|NCT02883452|565522482|FG005|Overall Study|Physician Decision|1|||
156665103|NCT02883452|565522477|FG000|Overall Study|Death|1|||
156665104|NCT02883452|565522478|FG001|Overall Study|Death|0|||
156665105|NCT02883452|565522479|FG002|Overall Study|Death|1|||
156665106|NCT02883452|565522480|FG003|Overall Study|Death|0|||
156665107|NCT02883452|565522481|FG004|Overall Study|Death|0|||
156665108|NCT02883452|565522482|FG005|Overall Study|Death|0|||
156665109|NCT02883452|565522477|FG000|Overall Study|Other|0|||
156665110|NCT02883452|565522478|FG001|Overall Study|Other|0|||
156665111|NCT02883452|565522479|FG002|Overall Study|Other|0|||
156665112|NCT02883452|565522480|FG003|Overall Study|Other|0|||
156665113|NCT02883452|565522481|FG004|Overall Study|Other|0|||
156665114|NCT02883452|565522482|FG005|Overall Study|Other|1|||
156665115|NCT01882257|565522491|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
156665116|NCT01882257|565522492|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
156665117|NCT01882257|565522493|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
156665118|NCT01882257|565522491|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
156665119|NCT01882257|565522492|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
156665120|NCT01882257|565522493|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
156665121|NCT00830206|565522494|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
156665122|NCT00830206|565522495|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
156665123|NCT00905346|565522499|FG000|Period 1|Withdrawal by Subject|1|||
156665124|NCT00905346|565522500|FG001|Period 1|Withdrawal by Subject|0|||
156665125|NCT03351335|565522501|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
156665126|NCT03351335|565522502|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
156665127|NCT03351335|565522503|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
156665128|NCT00909610|565522504|FG000|Period: First Intervention|Adverse Event|0|||
156665129|NCT00909610|565522505|FG001|Period: First Intervention|Adverse Event|1|||
156665130|NCT00909610|565522504|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
156665131|NCT00909610|565522505|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
156665132|NCT00909610|565522504|FG000|Period: Second Intervention|Adverse Event|1|||
156665133|NCT00909610|565522505|FG001|Period: Second Intervention|Adverse Event|0|||
156665134|NCT02736721|565522513|FG000|Overall Study|Adverse Event|8|||
156665135|NCT02736721|565522513|FG000|Overall Study|Lost to Follow-up|3|||
156665136|NCT02736721|565522513|FG000|Overall Study|Other|5|||
156665137|NCT00418184|565522518|FG000|Double-blind Phase|Withdrawal by Subject|22|||
156776276|NCT00311168|565933413|FG001|First Intervention|Other|2|||
156776277|NCT00311168|565933412|FG000|Second Intervention|Lost to Follow-up|9|||
156776278|NCT00311168|565933413|FG001|Second Intervention|Lost to Follow-up|2|||
156776279|NCT00311168|565933412|FG000|Second Intervention|Withdrawal by Subject|0|||
156776280|NCT00311168|565933413|FG001|Second Intervention|Withdrawal by Subject|1|||
156776281|NCT00311168|565933412|FG000|Second Intervention|Other|1|||
156776282|NCT00311168|565933413|FG001|Second Intervention|Other|1|||
156776283|NCT06001021|565933416|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
156776284|NCT06001021|565933417|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
156776285|NCT06001021|565933418|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
156776286|NCT06001021|565933419|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
156776287|NCT06001021|565933420|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
156776288|NCT06001021|565933421|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
156776289|NCT06001021|565933422|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
156776290|NCT06001021|565933416|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
156776291|NCT06001021|565933417|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
156776292|NCT06001021|565933418|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
156776293|NCT06001021|565933419|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
156776294|NCT06001021|565933420|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
156776295|NCT06001021|565933421|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
156776296|NCT06001021|565933422|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
156776297|NCT04703192|565933424|FG000|Overall Study|Withdrawal by Subject|2|||
156776298|NCT04703192|565933425|FG001|Overall Study|Withdrawal by Subject|0|||
156776299|NCT04703192|565933424|FG000|Overall Study|Death|3|||
156665138|NCT00418184|565522519|FG001|Double-blind Phase|Withdrawal by Subject|9|||
156776300|NCT04703192|565933425|FG001|Overall Study|Death|1|||
156776301|NCT04703192|565933424|FG000|Overall Study|Adverse Event|13|||
156665139|NCT00418184|565522518|FG000|Double-blind Phase|Adverse Event|2|||
156665140|NCT00418184|565522519|FG001|Double-blind Phase|Adverse Event|1|||
156665141|NCT00418184|565522518|FG000|Double-blind Phase|Poor compliance|3|||
156665142|NCT00418184|565522519|FG001|Double-blind Phase|Poor compliance|1|||
156665143|NCT00834249|565522520|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
156665144|NCT00834249|565522521|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
156665145|NCT00834249|565522520|FG000|Second Intervention|Adverse Event|1|||
156665146|NCT00834249|565522521|FG001|Second Intervention|Adverse Event|0|||
156665147|NCT00851877|565522522|FG000|Phase I-1|Death|1|||
156776302|NCT04703192|565933425|FG001|Overall Study|Adverse Event|2|||
156776303|NCT04703192|565933424|FG000|Overall Study|Progressive or Relapsed Disease|46|||
156776304|NCT04703192|565933425|FG001|Overall Study|Progressive or Relapsed Disease|7|||
156429902|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
156429903|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
156429904|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
156429905|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
156429906|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
156429907|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
156429908|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
156429909|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429910|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429911|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429912|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429913|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429914|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
156429915|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429916|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
156429917|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156665148|NCT00851877|565522523|FG001|Phase I-1|Death|0|||
156665149|NCT00851877|565522524|FG002|Phase I-1|Death|0|||
156665150|NCT00851877|565522522|FG000|Phase II|Withdrawal by Subject|0|||
156665151|NCT00851877|565522523|FG001|Phase II|Withdrawal by Subject|0|||
156665152|NCT00851877|565522524|FG002|Phase II|Withdrawal by Subject|3|||
156665153|NCT00620074|565522525|FG000|Overall Study|Adverse Event|1|||
156776305|NCT04703192|565933424|FG000|Overall Study|Clinical Progression|19|||
156776306|NCT04703192|565933425|FG001|Overall Study|Clinical Progression|8|||
156776307|NCT04703192|565933424|FG000|Overall Study|Lost to Follow-up|1|||
156776308|NCT04703192|565933425|FG001|Overall Study|Lost to Follow-up|0|||
156665154|NCT00627016|565522526|FG000|Overall Study|Adverse Event|1|||
156665155|NCT00627016|565522527|FG001|Overall Study|Adverse Event|1|||
156665156|NCT00627016|565522526|FG000|Overall Study|Protocol Violation|0|||
156665157|NCT00627016|565522527|FG001|Overall Study|Protocol Violation|2|||
156665158|NCT00627016|565522526|FG000|Overall Study|Lost to Follow-up|0|||
156665159|NCT00627016|565522527|FG001|Overall Study|Lost to Follow-up|1|||
156665160|NCT00627016|565522526|FG000|Overall Study|Withdrawal by Subject|2|||
156665161|NCT00627016|565522527|FG001|Overall Study|Withdrawal by Subject|1|||
156665162|NCT00627016|565522526|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
156665163|NCT00627016|565522527|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
156665164|NCT00627016|565522526|FG000|Overall Study|Lack of Efficacy|1|||
156665165|NCT00627016|565522527|FG001|Overall Study|Lack of Efficacy|0|||
156665166|NCT00627016|565522526|FG000|Overall Study|Placed on Excluded Drugs|1|||
156665167|NCT00627016|565522527|FG001|Overall Study|Placed on Excluded Drugs|0|||
156665168|NCT00627016|565522526|FG000|Overall Study|Pregnancy|1|||
156665169|NCT00627016|565522527|FG001|Overall Study|Pregnancy|0|||
156665170|NCT01534663|565522528|FG000|Overall Study|Lost to Follow-up|0|||
156665171|NCT01534663|565522529|FG001|Overall Study|Lost to Follow-up|2|||
156665172|NCT01534663|565522528|FG000|Overall Study|Adverse Event|2|||
156665173|NCT01534663|565522529|FG001|Overall Study|Adverse Event|1|||
156665174|NCT04088760|565522530|FG000|Overall Study|Physician Decision|1|||
156665175|NCT00286754|565522531|FG000|Overall Study|Adverse Event|2|||
156665176|NCT00286754|565522532|FG001|Overall Study|Adverse Event|2|||
156665177|NCT00286754|565522533|FG002|Overall Study|Adverse Event|3|||
156665178|NCT00286754|565522531|FG000|Overall Study|Withdrawal by Subject|6|||
156665179|NCT00286754|565522532|FG001|Overall Study|Withdrawal by Subject|2|||
156665180|NCT00286754|565522533|FG002|Overall Study|Withdrawal by Subject|0|||
156665181|NCT00286754|565522531|FG000|Overall Study|Lost to Follow-up|12|||
156665182|NCT00286754|565522532|FG001|Overall Study|Lost to Follow-up|14|||
156665183|NCT00286754|565522533|FG002|Overall Study|Lost to Follow-up|6|||
156665184|NCT00286754|565522531|FG000|Overall Study|Moved out of state|0|||
156665185|NCT00286754|565522532|FG001|Overall Study|Moved out of state|0|||
156665186|NCT00286754|565522533|FG002|Overall Study|Moved out of state|1|||
156665187|NCT01536405|565522534|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
156665188|NCT01536405|565522535|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
156776309|NCT04703192|565933424|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
156776310|NCT04703192|565933425|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
156776311|NCT04703192|565933424|FG000|Overall Study|Other|5|||
156665189|NCT01536405|565522534|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
156665190|NCT01536405|565522535|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
156665191|NCT01536405|565522534|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
156665192|NCT01536405|565522535|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
156665193|NCT01536405|565522534|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
156776312|NCT04703192|565933425|FG001|Overall Study|Other|1|||
156665194|NCT01536405|565522535|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
156665195|NCT01536405|565522534|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
156429918|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429919|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429920|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
156429921|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156665196|NCT01536405|565522535|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
156665197|NCT01536405|565522534|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
156665198|NCT01536405|565522535|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
156665199|NCT01536405|565522534|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
156665200|NCT01536405|565522535|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
156665201|NCT01536405|565522534|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
156665202|NCT01536405|565522535|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
156665203|NCT01536405|565522534|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
156665204|NCT01536405|565522535|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
156665205|NCT01536405|565522534|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
156776313|NCT04537299|565933428|FG000|Overall Study|Withdrawal by Subject|2|||
156429922|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156429923|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156429924|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156429925|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156429926|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
156429927|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156429928|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
156429929|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
156429930|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156776314|NCT04537299|565933429|FG001|Overall Study|Withdrawal by Subject|0|||
156776315|NCT04537299|565933428|FG000|Overall Study|Protocol Violation|1|||
156776316|NCT04537299|565933429|FG001|Overall Study|Protocol Violation|1|||
156776317|NCT00876343|565933430|FG000|Overall Study|Adverse Event|7|||
156776318|NCT00876343|565933431|FG001|Overall Study|Adverse Event|8|||
156776319|NCT00876343|565933432|FG002|Overall Study|Adverse Event|2|||
156776320|NCT00876343|565933430|FG000|Overall Study|Withdrawal by Subject|4|||
156776321|NCT00876343|565933431|FG001|Overall Study|Withdrawal by Subject|4|||
156776322|NCT00876343|565933432|FG002|Overall Study|Withdrawal by Subject|3|||
156776323|NCT00876343|565933430|FG000|Overall Study|Lack of Efficacy|0|||
156776324|NCT00876343|565933431|FG001|Overall Study|Lack of Efficacy|0|||
156776325|NCT00876343|565933432|FG002|Overall Study|Lack of Efficacy|1|||
156776326|NCT00876343|565933430|FG000|Overall Study|Protocol Violation|4|||
156776327|NCT00876343|565933431|FG001|Overall Study|Protocol Violation|1|||
156776328|NCT00876343|565933432|FG002|Overall Study|Protocol Violation|1|||
156776329|NCT00876343|565933430|FG000|Overall Study|Physician Decision|0|||
156776330|NCT00876343|565933431|FG001|Overall Study|Physician Decision|1|||
156776331|NCT00876343|565933432|FG002|Overall Study|Physician Decision|1|||
156776332|NCT00876343|565933430|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
156776333|NCT00876343|565933431|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
156776334|NCT00876343|565933432|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
156776335|NCT00876343|565933430|FG000|Overall Study|Change of residence or other commitments|2|||
156776336|NCT00876343|565933431|FG001|Overall Study|Change of residence or other commitments|2|||
156776337|NCT00876343|565933432|FG002|Overall Study|Change of residence or other commitments|3|||
156776338|NCT02802228|565933436|FG000|Overall Study|Withdrawal by Subject|2|||
156776339|NCT02802228|565933437|FG001|Overall Study|Withdrawal by Subject|0|||
156776340|NCT02802228|565933436|FG000|Overall Study|Lost to Follow-up|1|||
156776341|NCT02802228|565933437|FG001|Overall Study|Lost to Follow-up|0|||
156776342|NCT02802228|565933436|FG000|Overall Study|Adverse Event|1|||
156776343|NCT02802228|565933437|FG001|Overall Study|Adverse Event|0|||
156776344|NCT02802228|565933436|FG000|Overall Study|Physician Decision|1|||
156776345|NCT02802228|565933437|FG001|Overall Study|Physician Decision|0|||
156776346|NCT00695019|565933440|FG000|Overall Study|Withdrawal by Subject|8|||
156776347|NCT00695019|565933441|FG001|Overall Study|Withdrawal by Subject|6|||
156776348|NCT00695019|565933442|FG002|Overall Study|Withdrawal by Subject|4|||
156776349|NCT00695019|565933440|FG000|Overall Study|Protocol Violation|1|||
156776350|NCT00695019|565933441|FG001|Overall Study|Protocol Violation|3|||
156776351|NCT00695019|565933442|FG002|Overall Study|Protocol Violation|1|||
156776352|NCT00695019|565933440|FG000|Overall Study|Lack of Efficacy|0|||
156429931|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156429932|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
156429933|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
156429934|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
156776353|NCT00695019|565933441|FG001|Overall Study|Lack of Efficacy|0|||
156776354|NCT00695019|565933442|FG002|Overall Study|Lack of Efficacy|1|||
156776355|NCT00695019|565933440|FG000|Overall Study|Various|4|||
156776356|NCT00695019|565933441|FG001|Overall Study|Various|5|||
156776357|NCT00695019|565933442|FG002|Overall Study|Various|4|||
156665206|NCT01536405|565522535|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
156776358|NCT00924898|565933443|FG000|Overall Study|Withdrawal by Subject|2|||
156776359|NCT02278354|565933447|FG000|Overall Study|Lost to Follow-up|2|||
156776360|NCT02278354|565933448|FG001|Overall Study|Lost to Follow-up|2|||
156429935|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
156429936|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
156429937|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
156665207|NCT01536405|565522534|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
156665208|NCT01536405|565522535|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
156665209|NCT01536405|565522534|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
156665210|NCT01536405|565522535|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
156665211|NCT01536405|565522534|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
156665212|NCT01536405|565522535|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
156665213|NCT04786184|565522537|FG000|Overall Study|Adverse Event|4|||
156665214|NCT04786184|565522538|FG001|Overall Study|Adverse Event|0|||
156665215|NCT04786184|565522537|FG000|Overall Study|Withdrawal by Subject|3|||
156665216|NCT04786184|565522538|FG001|Overall Study|Withdrawal by Subject|1|||
156665217|NCT04786184|565522537|FG000|Overall Study|Lost to Follow-up|4|||
156665218|NCT04786184|565522538|FG001|Overall Study|Lost to Follow-up|2|||
156665219|NCT02514122|565522539|FG000|Overall Study|Withdrawal by Subject|2|||
156665220|NCT02514122|565522540|FG001|Overall Study|Withdrawal by Subject|0|||
156665221|NCT01792635|565522541|FG000|Part B|Adverse Event|0|||
156665222|NCT01792635|565522542|FG001|Part B|Adverse Event|0|||
156665223|NCT01792635|565522543|FG002|Part B|Adverse Event|1|||
156665224|NCT01792635|565522541|FG000|Part B|Study terminated|0|||
156665225|NCT01792635|565522542|FG001|Part B|Study terminated|4|||
156665226|NCT01792635|565522543|FG002|Part B|Study terminated|3|||
156665227|NCT01010542|565522544|FG000|Overall Study|Adverse Event|0|||
156665228|NCT01010542|565522545|FG001|Overall Study|Adverse Event|1|||
156665229|NCT01010542|565522546|FG002|Overall Study|Adverse Event|0|||
156665230|NCT01010542|565522544|FG000|Overall Study|Lost to Follow-up|0|||
156665231|NCT01010542|565522545|FG001|Overall Study|Lost to Follow-up|1|||
156665232|NCT01010542|565522546|FG002|Overall Study|Lost to Follow-up|0|||
156665233|NCT01010542|565522544|FG000|Overall Study|Withdrawal by Subject|0|||
156665234|NCT01010542|565522545|FG001|Overall Study|Withdrawal by Subject|3|||
156665235|NCT01010542|565522546|FG002|Overall Study|Withdrawal by Subject|2|||
156665236|NCT05615935|565522551|FG000|Overall Study|Lost to Follow-up|1|||
156665237|NCT05615935|565522552|FG001|Overall Study|Lost to Follow-up|1|||
156665238|NCT00302952|565522555|FG000|Overall Study|Physician Decision|1|||
156665239|NCT00302952|565522556|FG001|Overall Study|Physician Decision|1|||
156665240|NCT00302952|565522555|FG000|Overall Study|Withdrawal by Subject|2|||
156665241|NCT00302952|565522556|FG001|Overall Study|Withdrawal by Subject|3|||
156665242|NCT00302952|565522555|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
156665243|NCT00302952|565522556|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
156665244|NCT00336479|565522557|FG000|Overall Study|Adverse Event|8|||
156665245|NCT00336479|565522558|FG001|Overall Study|Adverse Event|11|||
156665246|NCT00336479|565522559|FG002|Overall Study|Adverse Event|18|||
156665247|NCT00336479|565522560|FG003|Overall Study|Adverse Event|4|||
156665248|NCT00336479|565522557|FG000|Overall Study|Noncompliant|1|||
156665249|NCT00336479|565522558|FG001|Overall Study|Noncompliant|7|||
156665250|NCT00336479|565522559|FG002|Overall Study|Noncompliant|3|||
156665251|NCT00336479|565522560|FG003|Overall Study|Noncompliant|0|||
156665252|NCT00336479|565522557|FG000|Overall Study|Physician Decision|2|||
156665253|NCT00336479|565522558|FG001|Overall Study|Physician Decision|3|||
156665254|NCT00336479|565522559|FG002|Overall Study|Physician Decision|1|||
156665255|NCT00336479|565522560|FG003|Overall Study|Physician Decision|0|||
156665256|NCT00336479|565522557|FG000|Overall Study|Lost to Follow-up|3|||
156665257|NCT00336479|565522558|FG001|Overall Study|Lost to Follow-up|2|||
156665258|NCT00336479|565522559|FG002|Overall Study|Lost to Follow-up|0|||
156665259|NCT00336479|565522560|FG003|Overall Study|Lost to Follow-up|0|||
156665260|NCT00336479|565522557|FG000|Overall Study|Withdrawal by Subject|3|||
156665261|NCT00336479|565522558|FG001|Overall Study|Withdrawal by Subject|2|||
156665262|NCT00336479|565522559|FG002|Overall Study|Withdrawal by Subject|3|||
156665263|NCT00336479|565522560|FG003|Overall Study|Withdrawal by Subject|0|||
156665264|NCT00336479|565522557|FG000|Overall Study|Other|0|||
156665265|NCT00336479|565522558|FG001|Overall Study|Other|0|||
156665266|NCT00336479|565522559|FG002|Overall Study|Other|1|||
156665267|NCT00336479|565522560|FG003|Overall Study|Other|0|||
156665268|NCT00336479|565522557|FG000|Overall Study|Virologic Stopping Rule|20|||
156665269|NCT00336479|565522558|FG001|Overall Study|Virologic Stopping Rule|0|||
156665270|NCT00336479|565522559|FG002|Overall Study|Virologic Stopping Rule|0|||
156665271|NCT00336479|565522560|FG003|Overall Study|Virologic Stopping Rule|0|||
156665272|NCT03435081|565522563|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
156665273|NCT03435081|565522564|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
156665274|NCT03435081|565522565|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
156665275|NCT03435081|565522563|FG000|Week 0 to Week 16|Adverse Event|2|||
156665276|NCT03435081|565522564|FG001|Week 0 to Week 16|Adverse Event|2|||
156665277|NCT03435081|565522565|FG002|Week 0 to Week 16|Adverse Event|2|||
156665278|NCT03435081|565522563|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
156776361|NCT02278354|565933447|FG000|Overall Study|Withdrawal by Subject|0|||
156776362|NCT02278354|565933448|FG001|Overall Study|Withdrawal by Subject|1|||
156665279|NCT03435081|565522564|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
156665280|NCT03435081|565522565|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
156665281|NCT03435081|565522563|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
156665282|NCT03435081|565522564|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
156665283|NCT03435081|565522565|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
156665284|NCT03435081|565522563|FG000|Week 0 to Week 16|Pregnancy|1|||
156665285|NCT03435081|565522564|FG001|Week 0 to Week 16|Pregnancy|0|||
156665286|NCT03435081|565522565|FG002|Week 0 to Week 16|Pregnancy|0|||
156665287|NCT03435081|565522563|FG000|Week 0 to Week 16|Non-compliance|1|||
156665288|NCT03435081|565522564|FG001|Week 0 to Week 16|Non-compliance|0|||
156665289|NCT03435081|565522565|FG002|Week 0 to Week 16|Non-compliance|2|||
156665290|NCT03435081|565522563|FG000|Week 0 to Week 16|Inadequate Response|0|||
156665291|NCT03435081|565522564|FG001|Week 0 to Week 16|Inadequate Response|1|||
156665292|NCT03435081|565522565|FG002|Week 0 to Week 16|Inadequate Response|0|||
156665293|NCT03435081|565522563|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
156665294|NCT03435081|565522564|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
156665295|NCT03435081|565522565|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
156665296|NCT03435081|565522563|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
156665297|NCT03435081|565522564|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
156665298|NCT03435081|565522565|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
156665299|NCT03435081|565522563|FG000|Week 16 to Week 104|Adverse Event|1|||
156665300|NCT03435081|565522564|FG001|Week 16 to Week 104|Adverse Event|0|||
156665301|NCT03435081|565522565|FG002|Week 16 to Week 104|Adverse Event|2|||
156665302|NCT03435081|565522563|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
156665303|NCT03435081|565522564|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
156665304|NCT03435081|565522565|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
156665305|NCT03435081|565522563|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
156665306|NCT03435081|565522564|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
156665307|NCT03435081|565522565|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
156665308|NCT03435081|565522563|FG000|Week 16 to Week 104|Non--Compliance|0|||
156665309|NCT03435081|565522564|FG001|Week 16 to Week 104|Non--Compliance|0|||
156665310|NCT03435081|565522565|FG002|Week 16 to Week 104|Non--Compliance|1|||
156665311|NCT02601560|565522566|FG000|Overall Study|Other|0|||
156665312|NCT02601560|565522567|FG001|Overall Study|Other|0|||
156665313|NCT02601560|565522568|FG002|Overall Study|Other|0|||
156665314|NCT02601560|565522569|FG003|Overall Study|Other|0|||
156665315|NCT02601560|565522570|FG004|Overall Study|Other|0|||
156665316|NCT02601560|565522571|FG005|Overall Study|Other|0|||
156429938|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
156665317|NCT02601560|565522572|FG006|Overall Study|Other|1|||
156665318|NCT02601560|565522573|FG007|Overall Study|Other|0|||
156665319|NCT00420238|565522574|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
156665320|NCT00420238|565522575|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
156665321|NCT00420238|565522574|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
156665322|NCT00420238|565522575|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
156665323|NCT00420238|565522574|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
156665324|NCT00420238|565522575|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
156665325|NCT00420238|565522574|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
156665326|NCT00420238|565522575|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
156665327|NCT00420238|565522574|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
156665328|NCT00420238|565522575|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
156665329|NCT00420238|565522574|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
156665330|NCT00420238|565522575|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
156665331|NCT01406795|565522576|FG000|Overall Study|Withdrawal by Subject|1|||
156776363|NCT02278354|565933447|FG000|Overall Study|<10 professional fights|2|||
156776364|NCT02278354|565933448|FG001|Overall Study|<10 professional fights|0|||
156776365|NCT01901562|565933453|FG000|Overall Study|Protocol Violation|5|||
156776366|NCT01901562|565933453|FG000|Overall Study|Excluded intraoperatively|4|||
156776367|NCT01925794|565933454|FG000|180 Days|Death|2|||
156776368|NCT01925794|565933454|FG000|180 Days|Withdrawal by Subject|2|||
156776369|NCT01925794|565933454|FG000|270 Days|Death|2|||
156776370|NCT01925794|565933454|FG000|270 Days|Protocol Violation|3|||
156776371|NCT02612155|565933455|FG000|Overall Study|Death|1|||
156776372|NCT02612155|565933456|FG001|Overall Study|Death|1|||
156776373|NCT02612155|565933455|FG000|Overall Study|Lost to Follow-up|2|||
156776374|NCT02612155|565933456|FG001|Overall Study|Lost to Follow-up|2|||
156776375|NCT03126110|565933466|FG000|Phase 1|Death|2|||
156776376|NCT03126110|565933467|FG001|Phase 1|Death|2|||
156776377|NCT03126110|565933468|FG002|Phase 1|Death|4|||
156776378|NCT03126110|565933469|FG003|Phase 1|Death|3|||
156776379|NCT03126110|565933470|FG004|Phase 1|Death|4|||
156776380|NCT03126110|565933471|FG005|Phase 1|Death|4|||
156776381|NCT03126110|565933472|FG006|Phase 1|Death|3|||
156776382|NCT03126110|565933473|FG007|Phase 1|Death|4|||
156776383|NCT03126110|565933474|FG008|Phase 1|Death|5|||
156776384|NCT03126110|565933475|FG009|Phase 1|Death|2|||
156776385|NCT03126110|565933476|FG010|Phase 1|Death|6|||
156776386|NCT03126110|565933477|FG011|Phase 1|Death|0|||
156776387|NCT03126110|565933478|FG012|Phase 1|Death|0|||
156776388|NCT03126110|565933479|FG013|Phase 1|Death|0|||
156776389|NCT03126110|565933480|FG014|Phase 1|Death|0|||
156776390|NCT03126110|565933481|FG015|Phase 1|Death|0|||
156776391|NCT03126110|565933482|FG016|Phase 1|Death|0|||
156776392|NCT03126110|565933466|FG000|Phase 1|Lost to Follow-up|0|||
156776393|NCT03126110|565933467|FG001|Phase 1|Lost to Follow-up|1|||
156776394|NCT03126110|565933468|FG002|Phase 1|Lost to Follow-up|0|||
156776395|NCT03126110|565933469|FG003|Phase 1|Lost to Follow-up|0|||
156776396|NCT03126110|565933470|FG004|Phase 1|Lost to Follow-up|0|||
156776397|NCT03126110|565933471|FG005|Phase 1|Lost to Follow-up|0|||
156776398|NCT03126110|565933472|FG006|Phase 1|Lost to Follow-up|0|||
156776399|NCT03126110|565933473|FG007|Phase 1|Lost to Follow-up|0|||
156776400|NCT03126110|565933474|FG008|Phase 1|Lost to Follow-up|1|||
156776401|NCT03126110|565933475|FG009|Phase 1|Lost to Follow-up|0|||
156776402|NCT03126110|565933476|FG010|Phase 1|Lost to Follow-up|0|||
156776403|NCT03126110|565933477|FG011|Phase 1|Lost to Follow-up|0|||
156776404|NCT03126110|565933478|FG012|Phase 1|Lost to Follow-up|0|||
156776405|NCT03126110|565933479|FG013|Phase 1|Lost to Follow-up|0|||
156776406|NCT03126110|565933480|FG014|Phase 1|Lost to Follow-up|0|||
156776407|NCT03126110|565933481|FG015|Phase 1|Lost to Follow-up|0|||
156776408|NCT03126110|565933482|FG016|Phase 1|Lost to Follow-up|0|||
156776409|NCT03126110|565933466|FG000|Phase 1|Withdrawal by Subject|1|||
156776410|NCT03126110|565933467|FG001|Phase 1|Withdrawal by Subject|0|||
156776411|NCT03126110|565933468|FG002|Phase 1|Withdrawal by Subject|0|||
156776412|NCT03126110|565933469|FG003|Phase 1|Withdrawal by Subject|1|||
156776413|NCT03126110|565933470|FG004|Phase 1|Withdrawal by Subject|1|||
156776414|NCT03126110|565933471|FG005|Phase 1|Withdrawal by Subject|0|||
156776415|NCT03126110|565933472|FG006|Phase 1|Withdrawal by Subject|0|||
156776416|NCT03126110|565933473|FG007|Phase 1|Withdrawal by Subject|0|||
156776417|NCT03126110|565933474|FG008|Phase 1|Withdrawal by Subject|2|||
156776418|NCT03126110|565933475|FG009|Phase 1|Withdrawal by Subject|1|||
156776419|NCT03126110|565933476|FG010|Phase 1|Withdrawal by Subject|0|||
156776420|NCT03126110|565933477|FG011|Phase 1|Withdrawal by Subject|0|||
156776421|NCT03126110|565933478|FG012|Phase 1|Withdrawal by Subject|0|||
156776422|NCT03126110|565933479|FG013|Phase 1|Withdrawal by Subject|0|||
156776423|NCT03126110|565933480|FG014|Phase 1|Withdrawal by Subject|0|||
156776424|NCT03126110|565933481|FG015|Phase 1|Withdrawal by Subject|0|||
156776425|NCT03126110|565933482|FG016|Phase 1|Withdrawal by Subject|0|||
156776426|NCT03126110|565933466|FG000|Phase 1|Safety follow-up no longer necessary|1|||
156776427|NCT03126110|565933467|FG001|Phase 1|Safety follow-up no longer necessary|0|||
156776428|NCT03126110|565933468|FG002|Phase 1|Safety follow-up no longer necessary|0|||
156776429|NCT03126110|565933469|FG003|Phase 1|Safety follow-up no longer necessary|0|||
156776430|NCT03126110|565933470|FG004|Phase 1|Safety follow-up no longer necessary|0|||
156776431|NCT03126110|565933471|FG005|Phase 1|Safety follow-up no longer necessary|0|||
156776432|NCT03126110|565933472|FG006|Phase 1|Safety follow-up no longer necessary|0|||
156776433|NCT03126110|565933473|FG007|Phase 1|Safety follow-up no longer necessary|0|||
156776434|NCT03126110|565933474|FG008|Phase 1|Safety follow-up no longer necessary|0|||
156776435|NCT03126110|565933475|FG009|Phase 1|Safety follow-up no longer necessary|0|||
156776436|NCT03126110|565933476|FG010|Phase 1|Safety follow-up no longer necessary|0|||
156776437|NCT03126110|565933477|FG011|Phase 1|Safety follow-up no longer necessary|0|||
156776438|NCT03126110|565933478|FG012|Phase 1|Safety follow-up no longer necessary|0|||
156776439|NCT03126110|565933479|FG013|Phase 1|Safety follow-up no longer necessary|0|||
156776440|NCT03126110|565933480|FG014|Phase 1|Safety follow-up no longer necessary|0|||
156776441|NCT03126110|565933481|FG015|Phase 1|Safety follow-up no longer necessary|0|||
156776442|NCT03126110|565933482|FG016|Phase 1|Safety follow-up no longer necessary|0|||
156776443|NCT03126110|565933466|FG000|Phase 1|Survival follow-up no longer necessary|0|||
156776444|NCT03126110|565933467|FG001|Phase 1|Survival follow-up no longer necessary|0|||
156776445|NCT03126110|565933468|FG002|Phase 1|Survival follow-up no longer necessary|1|||
156665332|NCT01591785|565524120|FG000|Overall Study|worsening condition|1|||
156665333|NCT01591785|565524121|FG001|Overall Study|worsening condition|2|||
156665334|NCT01591785|565524120|FG000|Overall Study|Protocol Violation|2|||
156665335|NCT01591785|565524121|FG001|Overall Study|Protocol Violation|0|||
156665336|NCT01591785|565524120|FG000|Overall Study|Lost to Follow-up|1|||
156665337|NCT01591785|565524121|FG001|Overall Study|Lost to Follow-up|0|||
156665338|NCT01049334|565524122|FG000|Overall Study|Withdrawal by Subject|5|||
156665339|NCT01049334|565524123|FG001|Overall Study|Withdrawal by Subject|3|||
156665340|NCT01049334|565524122|FG000|Overall Study|Adverse Event|2|||
156665341|NCT01049334|565524123|FG001|Overall Study|Adverse Event|3|||
156665342|NCT01049334|565524122|FG000|Overall Study|Physician Decision|2|||
156665343|NCT01049334|565524123|FG001|Overall Study|Physician Decision|0|||
156665344|NCT01049334|565524122|FG000|Overall Study|Protocol Violation|0|||
156665345|NCT01049334|565524123|FG001|Overall Study|Protocol Violation|1|||
156665346|NCT04089735|565524124|FG000|Overall Study|Adverse Event|1|||
156665347|NCT04089735|565524125|FG001|Overall Study|Adverse Event|0|||
156665348|NCT04089735|565524126|FG002|Overall Study|Adverse Event|1|||
156776446|NCT03126110|565933469|FG003|Phase 1|Survival follow-up no longer necessary|0|||
156776447|NCT03126110|565933470|FG004|Phase 1|Survival follow-up no longer necessary|0|||
156776448|NCT03126110|565933471|FG005|Phase 1|Survival follow-up no longer necessary|0|||
156776449|NCT03126110|565933472|FG006|Phase 1|Survival follow-up no longer necessary|0|||
156776450|NCT03126110|565933473|FG007|Phase 1|Survival follow-up no longer necessary|0|||
156776451|NCT03126110|565933474|FG008|Phase 1|Survival follow-up no longer necessary|0|||
156776452|NCT03126110|565933475|FG009|Phase 1|Survival follow-up no longer necessary|0|||
156665349|NCT04089735|565524127|FG003|Overall Study|Adverse Event|1|||
156776453|NCT03126110|565933476|FG010|Phase 1|Survival follow-up no longer necessary|0|||
156776454|NCT03126110|565933477|FG011|Phase 1|Survival follow-up no longer necessary|0|||
156776455|NCT03126110|565933478|FG012|Phase 1|Survival follow-up no longer necessary|0|||
156776456|NCT03126110|565933479|FG013|Phase 1|Survival follow-up no longer necessary|0|||
156776457|NCT03126110|565933480|FG014|Phase 1|Survival follow-up no longer necessary|0|||
156776458|NCT03126110|565933481|FG015|Phase 1|Survival follow-up no longer necessary|0|||
156776459|NCT03126110|565933482|FG016|Phase 1|Survival follow-up no longer necessary|0|||
156776460|NCT03126110|565933466|FG000|Phase 2|Study terminated by the sponsor|0|||
156776461|NCT03126110|565933467|FG001|Phase 2|Study terminated by the sponsor|0|||
156776462|NCT03126110|565933468|FG002|Phase 2|Study terminated by the sponsor|0|||
156776463|NCT03126110|565933469|FG003|Phase 2|Study terminated by the sponsor|0|||
156776464|NCT03126110|565933470|FG004|Phase 2|Study terminated by the sponsor|0|||
156776465|NCT03126110|565933471|FG005|Phase 2|Study terminated by the sponsor|0|||
156776466|NCT03126110|565933472|FG006|Phase 2|Study terminated by the sponsor|0|||
156665350|NCT04089735|565524128|FG004|Overall Study|Adverse Event|0|||
156665351|NCT04089735|565524129|FG005|Overall Study|Adverse Event|0|||
156665352|NCT04089735|565524124|FG000|Overall Study|Physician Decision|0|||
156665353|NCT04089735|565524125|FG001|Overall Study|Physician Decision|3|||
156665354|NCT04089735|565524126|FG002|Overall Study|Physician Decision|0|||
156665355|NCT04089735|565524127|FG003|Overall Study|Physician Decision|0|||
156665356|NCT04089735|565524128|FG004|Overall Study|Physician Decision|0|||
156665357|NCT04089735|565524129|FG005|Overall Study|Physician Decision|0|||
156665358|NCT04089735|565524124|FG000|Overall Study|Withdrawal by Subject|0|||
156665359|NCT04089735|565524125|FG001|Overall Study|Withdrawal by Subject|0|||
156665360|NCT04089735|565524126|FG002|Overall Study|Withdrawal by Subject|1|||
156665361|NCT04089735|565524127|FG003|Overall Study|Withdrawal by Subject|0|||
156665362|NCT04089735|565524128|FG004|Overall Study|Withdrawal by Subject|0|||
156665363|NCT04089735|565524129|FG005|Overall Study|Withdrawal by Subject|0|||
156665364|NCT04089735|565524124|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
156665365|NCT04089735|565524125|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
156665366|NCT04089735|565524126|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
156665367|NCT04089735|565524127|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
156665368|NCT04089735|565524128|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
156665369|NCT04089735|565524129|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
156665370|NCT00312663|565524135|FG000|Immunization Phase|Adverse Event|0|||
156665371|NCT00312663|565524136|FG001|Immunization Phase|Adverse Event|1|||
156665372|NCT00312663|565524137|FG002|Immunization Phase|Adverse Event|0|||
156665373|NCT00376623|565524138|FG000|Overall Study|Progressive disease|35|||
156665374|NCT00376623|565524139|FG001|Overall Study|Progressive disease|22|||
156665375|NCT00376623|565524140|FG002|Overall Study|Progressive disease|17|||
156665376|NCT00376623|565524138|FG000|Overall Study|Lost to Follow-up|0|||
156665377|NCT00376623|565524139|FG001|Overall Study|Lost to Follow-up|1|||
156665378|NCT00376623|565524140|FG002|Overall Study|Lost to Follow-up|0|||
156665379|NCT00376623|565524138|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
156665380|NCT00376623|565524139|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
156665381|NCT00376623|565524140|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
156665382|NCT00376623|565524138|FG000|Overall Study|Not treated with BI 2536|1|||
156665383|NCT00376623|565524139|FG001|Overall Study|Not treated with BI 2536|0|||
156665384|NCT00376623|565524140|FG002|Overall Study|Not treated with BI 2536|0|||
156665385|NCT00376623|565524138|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
156665386|NCT00376623|565524139|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
156665387|NCT00376623|565524140|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
156665388|NCT00376623|565524138|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
156665389|NCT00376623|565524139|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
156665390|NCT00376623|565524140|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
156665391|NCT00376623|565524138|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
156665392|NCT00376623|565524139|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
156665393|NCT00376623|565524140|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
156665394|NCT00376623|565524138|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
156665395|NCT00376623|565524139|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
156665396|NCT00376623|565524140|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
156665397|NCT00376623|565524138|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
156665398|NCT00376623|565524139|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
156665399|NCT00376623|565524140|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
156665400|NCT00376623|565524138|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
156665401|NCT00376623|565524139|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
156665402|NCT00376623|565524140|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
156665403|NCT00376623|565524138|FG000|Overall Study|Increase of tumour markers|0|||
156665404|NCT00376623|565524139|FG001|Overall Study|Increase of tumour markers|1|||
156665405|NCT00376623|565524140|FG002|Overall Study|Increase of tumour markers|0|||
156665406|NCT00376623|565524138|FG000|Overall Study|Bone metastasis|1|||
156665407|NCT00376623|565524139|FG001|Overall Study|Bone metastasis|0|||
156665408|NCT00376623|565524140|FG002|Overall Study|Bone metastasis|0|||
156665409|NCT00301366|565524143|FG000|Overall Study|Adverse Event|1|||
156665410|NCT01313273|565524146|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
156665411|NCT01313273|565524147|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
156665412|NCT01313273|565524146|FG000|Overall Study|Withdrawal by Subject|1|||
156665413|NCT01313273|565524147|FG001|Overall Study|Withdrawal by Subject|0|||
156665414|NCT01313273|565524146|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
156665415|NCT01313273|565524147|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
156665416|NCT03687736|565524152|FG000|Overall Study|Lost to Follow-up|7|||
156665417|NCT03687736|565524152|FG000|Overall Study|Withdrawal by Subject|3|||
156665418|NCT02098876|565524155|FG000|Overall Study|Withdrawal by Subject|5|||
156665419|NCT02098876|565524156|FG001|Overall Study|Withdrawal by Subject|5|||
156665420|NCT01263704|565524157|FG000|Overall Study|Progressive disease|18|||
156665421|NCT01263704|565524157|FG000|Overall Study|Adverse Event|3|||
156665422|NCT01263704|565524157|FG000|Overall Study|Death|2|||
156665423|NCT01263704|565524157|FG000|Overall Study|Patient withdrew consent|2|||
156665424|NCT01263704|565524157|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
156665425|NCT01263704|565524157|FG000|Overall Study|Lost to Follow-up|1|||
156665426|NCT01263704|565524157|FG000|Overall Study|Colon metastases|1|||
156665427|NCT01263704|565524157|FG000|Overall Study|Principal Investigator (PI) decision|1|||
156665428|NCT03496623|565524160|FG000|Run-In Period (2 Weeks)|Death|1|||
156665429|NCT03496623|565524161|FG001|Run-In Period (2 Weeks)|Death|0|||
156665430|NCT03496623|565524162|FG002|Run-In Period (2 Weeks)|Death|0|||
156776467|NCT03126110|565933473|FG007|Phase 2|Study terminated by the sponsor|0|||
156776468|NCT03126110|565933474|FG008|Phase 2|Study terminated by the sponsor|0|||
156776469|NCT03126110|565933475|FG009|Phase 2|Study terminated by the sponsor|0|||
156776470|NCT03126110|565933476|FG010|Phase 2|Study terminated by the sponsor|0|||
156776471|NCT03126110|565933477|FG011|Phase 2|Study terminated by the sponsor|0|||
156776472|NCT03126110|565933478|FG012|Phase 2|Study terminated by the sponsor|0|||
156776473|NCT03126110|565933479|FG013|Phase 2|Study terminated by the sponsor|4|||
156776474|NCT03126110|565933480|FG014|Phase 2|Study terminated by the sponsor|0|||
156776475|NCT03126110|565933481|FG015|Phase 2|Study terminated by the sponsor|0|||
156776476|NCT03126110|565933482|FG016|Phase 2|Study terminated by the sponsor|0|||
156776477|NCT03126110|565933466|FG000|Phase 2|Withdrawal by Subject|0|||
156776478|NCT03126110|565933467|FG001|Phase 2|Withdrawal by Subject|0|||
156776479|NCT03126110|565933468|FG002|Phase 2|Withdrawal by Subject|0|||
156776480|NCT03126110|565933469|FG003|Phase 2|Withdrawal by Subject|0|||
156776481|NCT03126110|565933470|FG004|Phase 2|Withdrawal by Subject|0|||
156776482|NCT03126110|565933471|FG005|Phase 2|Withdrawal by Subject|0|||
156776483|NCT03126110|565933472|FG006|Phase 2|Withdrawal by Subject|0|||
156776484|NCT03126110|565933473|FG007|Phase 2|Withdrawal by Subject|0|||
156776485|NCT03126110|565933474|FG008|Phase 2|Withdrawal by Subject|0|||
156776486|NCT03126110|565933475|FG009|Phase 2|Withdrawal by Subject|0|||
156776487|NCT03126110|565933476|FG010|Phase 2|Withdrawal by Subject|0|||
156776488|NCT03126110|565933477|FG011|Phase 2|Withdrawal by Subject|1|||
156776489|NCT03126110|565933478|FG012|Phase 2|Withdrawal by Subject|3|||
156776490|NCT03126110|565933479|FG013|Phase 2|Withdrawal by Subject|3|||
156776491|NCT03126110|565933480|FG014|Phase 2|Withdrawal by Subject|2|||
156776492|NCT03126110|565933481|FG015|Phase 2|Withdrawal by Subject|1|||
156776493|NCT03126110|565933482|FG016|Phase 2|Withdrawal by Subject|0|||
156776494|NCT03126110|565933466|FG000|Phase 2|Lost to Follow-up|0|||
156776495|NCT03126110|565933467|FG001|Phase 2|Lost to Follow-up|0|||
156776496|NCT03126110|565933468|FG002|Phase 2|Lost to Follow-up|0|||
156776497|NCT03126110|565933469|FG003|Phase 2|Lost to Follow-up|0|||
156665431|NCT03496623|565524163|FG003|Run-In Period (2 Weeks)|Death|0|||
156776498|NCT03126110|565933470|FG004|Phase 2|Lost to Follow-up|0|||
156776499|NCT03126110|565933471|FG005|Phase 2|Lost to Follow-up|0|||
156776500|NCT03126110|565933472|FG006|Phase 2|Lost to Follow-up|0|||
156776501|NCT03126110|565933473|FG007|Phase 2|Lost to Follow-up|0|||
156665432|NCT03496623|565524164|FG004|Run-In Period (2 Weeks)|Death|0|||
156665433|NCT03496623|565524160|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
156776502|NCT03126110|565933474|FG008|Phase 2|Lost to Follow-up|0|||
156776503|NCT03126110|565933475|FG009|Phase 2|Lost to Follow-up|0|||
156776504|NCT03126110|565933476|FG010|Phase 2|Lost to Follow-up|0|||
156776505|NCT03126110|565933477|FG011|Phase 2|Lost to Follow-up|1|||
156776506|NCT03126110|565933478|FG012|Phase 2|Lost to Follow-up|1|||
156776507|NCT03126110|565933479|FG013|Phase 2|Lost to Follow-up|1|||
156325109|NCT03583164|564290852|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
156325110|NCT03583164|564290852|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
156325111|NCT03583164|564290852|FG000|Overall Study|Treatment failure in Main Phase|2|||
156325112|NCT03583164|564290852|FG000|Overall Study|Treatment failure in Extended Phase|4|||
156325113|NCT03583164|564290852|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
156325114|NCT03583164|564290852|FG000|Overall Study|Other not specified reason in Main Phase|2|||
156325115|NCT01068652|564290853|FG000|Overall Study|Adverse Event|4|||
156325116|NCT01068652|564290854|FG001|Overall Study|Adverse Event|0|||
156325117|NCT01068652|564290853|FG000|Overall Study|Lack of Efficacy|0|||
156325118|NCT01068652|564290854|FG001|Overall Study|Lack of Efficacy|2|||
156325119|NCT01068652|564290853|FG000|Overall Study|Lost to Follow-up|2|||
156325120|NCT01068652|564290854|FG001|Overall Study|Lost to Follow-up|1|||
156325121|NCT01068652|564290853|FG000|Overall Study|Protocol Violation|3|||
156429939|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
156429940|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
156429941|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
156429942|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
156429943|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
156429944|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
156429945|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429946|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429947|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429948|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429949|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429950|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
156429951|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429952|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429953|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429954|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429955|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429956|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
156429957|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429958|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429959|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429960|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429961|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429962|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429963|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
156429964|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429965|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429966|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429967|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429968|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
156429969|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429970|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429971|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429972|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429973|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429974|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429975|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
156429976|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429977|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429978|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429979|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429980|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156429981|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
156429982|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
156429983|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
156429984|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
156325122|NCT01068652|564290854|FG001|Overall Study|Protocol Violation|6|||
156325123|NCT01068652|564290853|FG000|Overall Study|Withdrawal criteria|1|||
156325124|NCT01068652|564290854|FG001|Overall Study|Withdrawal criteria|2|||
156325125|NCT01068652|564290853|FG000|Overall Study|Patient was not eligible|1|||
156325126|NCT01068652|564290854|FG001|Overall Study|Patient was not eligible|0|||
156665434|NCT03496623|565524161|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
156665435|NCT03496623|565524162|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
156665436|NCT03496623|565524163|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
156665437|NCT03496623|565524164|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
156665438|NCT03496623|565524160|FG000|Period 1 (12 Weeks)|Death|0|||
156665439|NCT03496623|565524161|FG001|Period 1 (12 Weeks)|Death|3|||
156665440|NCT03496623|565524162|FG002|Period 1 (12 Weeks)|Death|0|||
156665441|NCT03496623|565524163|FG003|Period 1 (12 Weeks)|Death|0|||
156665442|NCT03496623|565524164|FG004|Period 1 (12 Weeks)|Death|0|||
156665443|NCT03496623|565524160|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
156665444|NCT03496623|565524161|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
156665445|NCT03496623|565524162|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
156665446|NCT03496623|565524163|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
156665447|NCT03496623|565524164|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
156665448|NCT03496623|565524160|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156665449|NCT03496623|565524161|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
156665450|NCT03496623|565524162|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
156665451|NCT03496623|565524163|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156665452|NCT03496623|565524164|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156665453|NCT03496623|565524160|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
156665454|NCT03496623|565524161|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
156665455|NCT03496623|565524162|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
156665456|NCT03496623|565524163|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
156665457|NCT03496623|565524164|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
156665458|NCT03496623|565524160|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156665459|NCT03496623|565524161|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156665460|NCT03496623|565524162|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
156665461|NCT03496623|565524163|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156665462|NCT03496623|565524164|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156665463|NCT03496623|565524160|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
156665464|NCT03496623|565524161|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
156665465|NCT03496623|565524162|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
156665466|NCT03496623|565524163|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
156665467|NCT03496623|565524164|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
156665468|NCT03496623|565524160|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156665469|NCT03496623|565524161|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
156665470|NCT03496623|565524162|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156665471|NCT03496623|565524163|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156665472|NCT03496623|565524164|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156665473|NCT01061866|565524165|FG000|Overall Study|Adverse Event|2|||
156665474|NCT01270503|565524166|FG000|Overall Study|Lost to Follow-up|1|||
156665475|NCT02543203|565524167|FG000|Overall Study|Unpalatable Fragrance|2|||
156665476|NCT02543203|565524168|FG001|Overall Study|Unpalatable Fragrance|2|||
156665477|NCT02543203|565524167|FG000|Overall Study|Lost to Follow-up|1|||
156665478|NCT02543203|565524168|FG001|Overall Study|Lost to Follow-up|0|||
156665479|NCT02543203|565524167|FG000|Overall Study|Increased Irritability|1|||
156665480|NCT02543203|565524168|FG001|Overall Study|Increased Irritability|0|||
156665481|NCT02543203|565524167|FG000|Overall Study|Family|1|||
156665482|NCT02543203|565524168|FG001|Overall Study|Family|2|||
156665483|NCT02543203|565524167|FG000|Overall Study|Negative Behavior|1|||
156665484|NCT02543203|565524168|FG001|Overall Study|Negative Behavior|0|||
156665485|NCT02543203|565524167|FG000|Overall Study|Withdrawal by Subject|0|||
156665486|NCT02543203|565524168|FG001|Overall Study|Withdrawal by Subject|1|||
156665487|NCT02255097|565524169|FG000|Overall Study|Death|151|||
156665488|NCT02255097|565524169|FG000|Overall Study|Lost to Follow-up|5|||
156665489|NCT02255097|565524169|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
156665490|NCT02255097|565524169|FG000|Overall Study|Withdrawal by Subject|7|||
156665491|NCT02255097|565524169|FG000|Overall Study|Allocated but not treated|1|||
156665492|NCT01118312|565524170|FG000|Overall Study|Lost to Follow-up|33|||
156665493|NCT01118312|565524171|FG001|Overall Study|Lost to Follow-up|32|||
156665494|NCT01118312|565524170|FG000|Overall Study|Withdrawal by Subject|1|||
156665495|NCT01118312|565524171|FG001|Overall Study|Withdrawal by Subject|3|||
156665496|NCT03965091|565524172|FG000|Overall Study|Adverse Event|0|||
156665497|NCT03965091|565524173|FG001|Overall Study|Adverse Event|2|||
156665498|NCT03965091|565524174|FG002|Overall Study|Adverse Event|3|||
156325127|NCT01068652|564290853|FG000|Overall Study|Unclassified|7|||
156665499|NCT03965091|565524172|FG000|Overall Study|Withdrawal by Subject|11|||
156665500|NCT03965091|565524173|FG001|Overall Study|Withdrawal by Subject|3|||
156665501|NCT03965091|565524174|FG002|Overall Study|Withdrawal by Subject|5|||
156665502|NCT03965091|565524172|FG000|Overall Study|Non-compliance with study drug|0|||
156665503|NCT03965091|565524173|FG001|Overall Study|Non-compliance with study drug|0|||
156665504|NCT03965091|565524174|FG002|Overall Study|Non-compliance with study drug|1|||
156325128|NCT01068652|564290854|FG001|Overall Study|Unclassified|4|||
156665505|NCT03965091|565524172|FG000|Overall Study|Lost to Follow-up|1|||
156665506|NCT03965091|565524173|FG001|Overall Study|Lost to Follow-up|1|||
156665507|NCT03965091|565524174|FG002|Overall Study|Lost to Follow-up|1|||
156665508|NCT03965091|565524172|FG000|Overall Study|Lack of Efficacy|2|||
156665509|NCT03965091|565524173|FG001|Overall Study|Lack of Efficacy|0|||
156665510|NCT03965091|565524174|FG002|Overall Study|Lack of Efficacy|0|||
156665511|NCT03965091|565524172|FG000|Overall Study|Other than specified|9|||
156665512|NCT03965091|565524173|FG001|Overall Study|Other than specified|11|||
156665513|NCT03965091|565524174|FG002|Overall Study|Other than specified|8|||
156665514|NCT01185821|565524177|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156665515|NCT01185821|565524178|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156776508|NCT03126110|565933480|FG014|Phase 2|Lost to Follow-up|2|||
156776509|NCT03126110|565933481|FG015|Phase 2|Lost to Follow-up|0|||
156776510|NCT03126110|565933482|FG016|Phase 2|Lost to Follow-up|0|||
156776511|NCT03126110|565933466|FG000|Phase 2|Death|0|||
156776512|NCT03126110|565933467|FG001|Phase 2|Death|0|||
156776513|NCT03126110|565933468|FG002|Phase 2|Death|0|||
156776514|NCT03126110|565933469|FG003|Phase 2|Death|0|||
156776515|NCT03126110|565933470|FG004|Phase 2|Death|0|||
156776516|NCT03126110|565933471|FG005|Phase 2|Death|0|||
156776517|NCT03126110|565933472|FG006|Phase 2|Death|0|||
156776518|NCT03126110|565933473|FG007|Phase 2|Death|0|||
156776519|NCT03126110|565933474|FG008|Phase 2|Death|0|||
156776520|NCT03126110|565933475|FG009|Phase 2|Death|0|||
156776521|NCT03126110|565933476|FG010|Phase 2|Death|0|||
156776522|NCT03126110|565933477|FG011|Phase 2|Death|6|||
156776523|NCT03126110|565933478|FG012|Phase 2|Death|12|||
156776524|NCT03126110|565933479|FG013|Phase 2|Death|25|||
156776525|NCT03126110|565933480|FG014|Phase 2|Death|11|||
156776526|NCT03126110|565933481|FG015|Phase 2|Death|3|||
156776527|NCT03126110|565933482|FG016|Phase 2|Death|2|||
156776528|NCT03126110|565933466|FG000|Phase 2|Progressive Disease|0|||
156776529|NCT03126110|565933467|FG001|Phase 2|Progressive Disease|0|||
156776530|NCT03126110|565933468|FG002|Phase 2|Progressive Disease|0|||
156776531|NCT03126110|565933469|FG003|Phase 2|Progressive Disease|0|||
156776532|NCT03126110|565933470|FG004|Phase 2|Progressive Disease|0|||
156776533|NCT03126110|565933471|FG005|Phase 2|Progressive Disease|0|||
156776534|NCT03126110|565933472|FG006|Phase 2|Progressive Disease|0|||
156776535|NCT03126110|565933473|FG007|Phase 2|Progressive Disease|0|||
156776536|NCT03126110|565933474|FG008|Phase 2|Progressive Disease|0|||
156776537|NCT03126110|565933475|FG009|Phase 2|Progressive Disease|0|||
156776538|NCT03126110|565933476|FG010|Phase 2|Progressive Disease|0|||
156776539|NCT03126110|565933477|FG011|Phase 2|Progressive Disease|0|||
156776540|NCT03126110|565933478|FG012|Phase 2|Progressive Disease|0|||
156776541|NCT03126110|565933479|FG013|Phase 2|Progressive Disease|1|||
156776542|NCT03126110|565933480|FG014|Phase 2|Progressive Disease|0|||
156776543|NCT03126110|565933481|FG015|Phase 2|Progressive Disease|0|||
156776544|NCT03126110|565933482|FG016|Phase 2|Progressive Disease|0|||
156776545|NCT03126110|565933466|FG000|Phase 2|Started new treatment|0|||
156776546|NCT03126110|565933467|FG001|Phase 2|Started new treatment|0|||
156776547|NCT03126110|565933468|FG002|Phase 2|Started new treatment|0|||
156776548|NCT03126110|565933469|FG003|Phase 2|Started new treatment|0|||
156776549|NCT03126110|565933470|FG004|Phase 2|Started new treatment|0|||
156776550|NCT03126110|565933471|FG005|Phase 2|Started new treatment|0|||
156776551|NCT03126110|565933472|FG006|Phase 2|Started new treatment|0|||
156776552|NCT03126110|565933473|FG007|Phase 2|Started new treatment|0|||
156776553|NCT03126110|565933474|FG008|Phase 2|Started new treatment|0|||
156776554|NCT03126110|565933475|FG009|Phase 2|Started new treatment|0|||
156776555|NCT03126110|565933476|FG010|Phase 2|Started new treatment|0|||
156776556|NCT03126110|565933477|FG011|Phase 2|Started new treatment|0|||
156325129|NCT00214500|564290855|FG000|Treatment Period|Adverse Event|1|||
156325130|NCT00214500|564290855|FG000|Extension Period|Withdrawal by Subject|2|||
156325131|NCT05153473|564290858|FG000|Overall Study|Death|46|||
156325132|NCT05153473|564290858|FG000|Overall Study|Lost to Follow-up|3|||
156325133|NCT02788474|564290859|FG000|Double Blind Treatment Period|Not treated|1|||
156325134|NCT02788474|564290860|FG001|Double Blind Treatment Period|Not treated|0|||
156776557|NCT03126110|565933478|FG012|Phase 2|Started new treatment|0|||
156776558|NCT03126110|565933479|FG013|Phase 2|Started new treatment|0|||
156776559|NCT03126110|565933480|FG014|Phase 2|Started new treatment|1|||
156776560|NCT03126110|565933481|FG015|Phase 2|Started new treatment|0|||
156776561|NCT03126110|565933482|FG016|Phase 2|Started new treatment|0|||
156776562|NCT04435626|565933486|FG000|Overall Study|Lost to Follow-up|1|||
156776563|NCT04435626|565933487|FG001|Overall Study|Lost to Follow-up|5|||
156776564|NCT04435626|565933486|FG000|Overall Study|Withdrawal by Subject|6|||
156776565|NCT04435626|565933487|FG001|Overall Study|Withdrawal by Subject|7|||
156776566|NCT04435626|565933486|FG000|Overall Study|major GCP violations|8|||
156776567|NCT04435626|565933487|FG001|Overall Study|major GCP violations|7|||
156776568|NCT05049122|565933493|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
156776569|NCT05049122|565933493|FG000|Overall Study|Participant moved|1|||
156776570|NCT05049122|565933493|FG000|Overall Study|At the direction of the doctor|1|||
156776571|NCT03314935|565933494|FG000|Phase 1|Death|4|||
156776572|NCT03314935|565933495|FG001|Phase 1|Death|2|||
156776573|NCT03314935|565933496|FG002|Phase 1|Death|5|||
156776574|NCT03314935|565933497|FG003|Phase 1|Death|4|||
156776575|NCT03314935|565933498|FG004|Phase 1|Death|3|||
156776576|NCT03314935|565933499|FG005|Phase 1|Death|4|||
156776577|NCT03314935|565933500|FG006|Phase 1|Death|5|||
156776578|NCT03314935|565933501|FG007|Phase 1|Death|4|||
156776579|NCT03314935|565933502|FG008|Phase 1|Death|3|||
156776580|NCT03314935|565933503|FG009|Phase 1|Death|0|||
156776581|NCT03314935|565933504|FG010|Phase 1|Death|0|||
156776582|NCT03314935|565933505|FG011|Phase 1|Death|0|||
156776583|NCT03314935|565933506|FG012|Phase 1|Death|0|||
156776584|NCT03314935|565933507|FG013|Phase 1|Death|0|||
156776585|NCT03314935|565933508|FG014|Phase 1|Death|0|||
156776586|NCT03314935|565933494|FG000|Phase 1|Withdrawal by Subject|2|||
156776587|NCT03314935|565933495|FG001|Phase 1|Withdrawal by Subject|1|||
156776588|NCT03314935|565933496|FG002|Phase 1|Withdrawal by Subject|1|||
156776589|NCT03314935|565933497|FG003|Phase 1|Withdrawal by Subject|2|||
156776590|NCT03314935|565933498|FG004|Phase 1|Withdrawal by Subject|1|||
156776591|NCT03314935|565933499|FG005|Phase 1|Withdrawal by Subject|0|||
156776592|NCT03314935|565933500|FG006|Phase 1|Withdrawal by Subject|1|||
156776593|NCT03314935|565933501|FG007|Phase 1|Withdrawal by Subject|0|||
156776594|NCT03314935|565933502|FG008|Phase 1|Withdrawal by Subject|1|||
156776595|NCT03314935|565933503|FG009|Phase 1|Withdrawal by Subject|0|||
156776596|NCT03314935|565933504|FG010|Phase 1|Withdrawal by Subject|0|||
156776597|NCT03314935|565933505|FG011|Phase 1|Withdrawal by Subject|0|||
156776598|NCT03314935|565933506|FG012|Phase 1|Withdrawal by Subject|0|||
156776599|NCT03314935|565933507|FG013|Phase 1|Withdrawal by Subject|0|||
156776600|NCT03314935|565933508|FG014|Phase 1|Withdrawal by Subject|0|||
156776601|NCT03314935|565933494|FG000|Phase 1|Progressive Disease|2|||
156776602|NCT03314935|565933495|FG001|Phase 1|Progressive Disease|0|||
156776603|NCT03314935|565933496|FG002|Phase 1|Progressive Disease|0|||
156776604|NCT03314935|565933497|FG003|Phase 1|Progressive Disease|1|||
156776605|NCT03314935|565933498|FG004|Phase 1|Progressive Disease|0|||
156776606|NCT03314935|565933499|FG005|Phase 1|Progressive Disease|0|||
156776607|NCT03314935|565933500|FG006|Phase 1|Progressive Disease|0|||
156776608|NCT03314935|565933501|FG007|Phase 1|Progressive Disease|0|||
156776609|NCT03314935|565933502|FG008|Phase 1|Progressive Disease|0|||
156776610|NCT03314935|565933503|FG009|Phase 1|Progressive Disease|0|||
156776611|NCT03314935|565933504|FG010|Phase 1|Progressive Disease|0|||
156776612|NCT03314935|565933505|FG011|Phase 1|Progressive Disease|0|||
156776613|NCT03314935|565933506|FG012|Phase 1|Progressive Disease|0|||
156776614|NCT03314935|565933507|FG013|Phase 1|Progressive Disease|0|||
156776615|NCT03314935|565933508|FG014|Phase 1|Progressive Disease|0|||
156776616|NCT03314935|565933494|FG000|Phase 1|Study Terminated by Sponsor|0|||
156776617|NCT03314935|565933495|FG001|Phase 1|Study Terminated by Sponsor|1|||
156776618|NCT03314935|565933496|FG002|Phase 1|Study Terminated by Sponsor|0|||
156776619|NCT03314935|565933497|FG003|Phase 1|Study Terminated by Sponsor|0|||
156776620|NCT03314935|565933498|FG004|Phase 1|Study Terminated by Sponsor|0|||
156776621|NCT03314935|565933499|FG005|Phase 1|Study Terminated by Sponsor|0|||
156776622|NCT03314935|565933500|FG006|Phase 1|Study Terminated by Sponsor|0|||
156776623|NCT03314935|565933501|FG007|Phase 1|Study Terminated by Sponsor|0|||
156776624|NCT03314935|565933502|FG008|Phase 1|Study Terminated by Sponsor|1|||
156776625|NCT03314935|565933503|FG009|Phase 1|Study Terminated by Sponsor|0|||
156776626|NCT03314935|565933504|FG010|Phase 1|Study Terminated by Sponsor|0|||
156776627|NCT03314935|565933505|FG011|Phase 1|Study Terminated by Sponsor|0|||
156776628|NCT03314935|565933506|FG012|Phase 1|Study Terminated by Sponsor|0|||
156776629|NCT03314935|565933507|FG013|Phase 1|Study Terminated by Sponsor|0|||
156776630|NCT03314935|565933508|FG014|Phase 1|Study Terminated by Sponsor|0|||
156776631|NCT03314935|565933494|FG000|Phase 1|"Captured as Other in Database"|0|||
156776632|NCT03314935|565933495|FG001|Phase 1|"Captured as Other in Database"|2|||
156776633|NCT03314935|565933496|FG002|Phase 1|"Captured as Other in Database"|0|||
156776634|NCT03314935|565933497|FG003|Phase 1|"Captured as Other in Database"|0|||
156776635|NCT03314935|565933498|FG004|Phase 1|"Captured as Other in Database"|0|||
156776636|NCT03314935|565933499|FG005|Phase 1|"Captured as Other in Database"|0|||
156776637|NCT03314935|565933500|FG006|Phase 1|"Captured as Other in Database"|1|||
156776638|NCT03314935|565933501|FG007|Phase 1|"Captured as Other in Database"|1|||
156776639|NCT03314935|565933502|FG008|Phase 1|"Captured as Other in Database"|1|||
156776640|NCT03314935|565933503|FG009|Phase 1|"Captured as Other in Database"|0|||
156776641|NCT03314935|565933504|FG010|Phase 1|"Captured as Other in Database"|0|||
156776642|NCT03314935|565933505|FG011|Phase 1|"Captured as Other in Database"|0|||
156776643|NCT03314935|565933506|FG012|Phase 1|"Captured as Other in Database"|0|||
156776644|NCT03314935|565933507|FG013|Phase 1|"Captured as Other in Database"|0|||
156776645|NCT03314935|565933508|FG014|Phase 1|"Captured as Other in Database"|0|||
156776646|NCT03314935|565933494|FG000|Phase 1|Lost to Follow-up|0|||
156776647|NCT03314935|565933495|FG001|Phase 1|Lost to Follow-up|0|||
156776648|NCT03314935|565933496|FG002|Phase 1|Lost to Follow-up|0|||
156776649|NCT03314935|565933497|FG003|Phase 1|Lost to Follow-up|0|||
156776650|NCT03314935|565933498|FG004|Phase 1|Lost to Follow-up|0|||
156776651|NCT03314935|565933499|FG005|Phase 1|Lost to Follow-up|0|||
156776652|NCT03314935|565933500|FG006|Phase 1|Lost to Follow-up|0|||
156776653|NCT03314935|565933501|FG007|Phase 1|Lost to Follow-up|0|||
156776654|NCT03314935|565933502|FG008|Phase 1|Lost to Follow-up|1|||
156776655|NCT03314935|565933503|FG009|Phase 1|Lost to Follow-up|0|||
156776656|NCT03314935|565933504|FG010|Phase 1|Lost to Follow-up|0|||
156776657|NCT03314935|565933505|FG011|Phase 1|Lost to Follow-up|0|||
156429985|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
156776658|NCT03314935|565933506|FG012|Phase 1|Lost to Follow-up|0|||
156776659|NCT03314935|565933507|FG013|Phase 1|Lost to Follow-up|0|||
156776660|NCT03314935|565933508|FG014|Phase 1|Lost to Follow-up|0|||
156429986|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
156429987|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
156429988|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
156429989|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
156429990|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
156429991|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
156776661|NCT03314935|565933494|FG000|Phase 2|Death|0|||
156776662|NCT03314935|565933495|FG001|Phase 2|Death|0|||
156776663|NCT03314935|565933496|FG002|Phase 2|Death|0|||
156776664|NCT03314935|565933497|FG003|Phase 2|Death|0|||
156776665|NCT03314935|565933498|FG004|Phase 2|Death|0|||
156776666|NCT03314935|565933499|FG005|Phase 2|Death|0|||
156776667|NCT03314935|565933500|FG006|Phase 2|Death|0|||
156776668|NCT03314935|565933501|FG007|Phase 2|Death|0|||
156776669|NCT03314935|565933502|FG008|Phase 2|Death|0|||
156776670|NCT03314935|565933503|FG009|Phase 2|Death|5|||
156776671|NCT03314935|565933504|FG010|Phase 2|Death|20|||
156776672|NCT03314935|565933505|FG011|Phase 2|Death|6|||
156776673|NCT03314935|565933506|FG012|Phase 2|Death|7|||
156776674|NCT03314935|565933507|FG013|Phase 2|Death|6|||
156776675|NCT03314935|565933508|FG014|Phase 2|Death|17|||
156776676|NCT03314935|565933494|FG000|Phase 2|Withdrawal by Subject|0|||
156776677|NCT03314935|565933495|FG001|Phase 2|Withdrawal by Subject|0|||
156776678|NCT03314935|565933496|FG002|Phase 2|Withdrawal by Subject|0|||
156776679|NCT03314935|565933497|FG003|Phase 2|Withdrawal by Subject|0|||
156776680|NCT03314935|565933498|FG004|Phase 2|Withdrawal by Subject|0|||
156776681|NCT03314935|565933499|FG005|Phase 2|Withdrawal by Subject|0|||
156776682|NCT03314935|565933500|FG006|Phase 2|Withdrawal by Subject|0|||
156776683|NCT03314935|565933501|FG007|Phase 2|Withdrawal by Subject|0|||
156776684|NCT03314935|565933502|FG008|Phase 2|Withdrawal by Subject|0|||
156776685|NCT03314935|565933503|FG009|Phase 2|Withdrawal by Subject|1|||
156776686|NCT03314935|565933504|FG010|Phase 2|Withdrawal by Subject|4|||
156776687|NCT03314935|565933505|FG011|Phase 2|Withdrawal by Subject|0|||
156776688|NCT03314935|565933506|FG012|Phase 2|Withdrawal by Subject|1|||
156776689|NCT03314935|565933507|FG013|Phase 2|Withdrawal by Subject|0|||
156776690|NCT03314935|565933508|FG014|Phase 2|Withdrawal by Subject|1|||
156776691|NCT03314935|565933494|FG000|Phase 2|Progressive Disease|0|||
156776692|NCT03314935|565933495|FG001|Phase 2|Progressive Disease|0|||
156776693|NCT03314935|565933496|FG002|Phase 2|Progressive Disease|0|||
156776694|NCT03314935|565933497|FG003|Phase 2|Progressive Disease|0|||
156776695|NCT03314935|565933498|FG004|Phase 2|Progressive Disease|0|||
156776696|NCT03314935|565933499|FG005|Phase 2|Progressive Disease|0|||
156776697|NCT03314935|565933500|FG006|Phase 2|Progressive Disease|0|||
156776698|NCT03314935|565933501|FG007|Phase 2|Progressive Disease|0|||
156776699|NCT03314935|565933502|FG008|Phase 2|Progressive Disease|0|||
156776700|NCT03314935|565933503|FG009|Phase 2|Progressive Disease|1|||
156776701|NCT03314935|565933504|FG010|Phase 2|Progressive Disease|1|||
156776702|NCT03314935|565933505|FG011|Phase 2|Progressive Disease|1|||
156776703|NCT03314935|565933506|FG012|Phase 2|Progressive Disease|2|||
156776704|NCT03314935|565933507|FG013|Phase 2|Progressive Disease|0|||
156776705|NCT03314935|565933508|FG014|Phase 2|Progressive Disease|1|||
156776706|NCT03314935|565933494|FG000|Phase 2|Study Terminated by Sponsor|0|||
156776707|NCT03314935|565933495|FG001|Phase 2|Study Terminated by Sponsor|0|||
156776708|NCT03314935|565933496|FG002|Phase 2|Study Terminated by Sponsor|0|||
156776709|NCT03314935|565933497|FG003|Phase 2|Study Terminated by Sponsor|0|||
156776710|NCT03314935|565933498|FG004|Phase 2|Study Terminated by Sponsor|0|||
156776711|NCT03314935|565933499|FG005|Phase 2|Study Terminated by Sponsor|0|||
156776712|NCT03314935|565933500|FG006|Phase 2|Study Terminated by Sponsor|0|||
156776713|NCT03314935|565933501|FG007|Phase 2|Study Terminated by Sponsor|0|||
156776714|NCT03314935|565933502|FG008|Phase 2|Study Terminated by Sponsor|0|||
156776715|NCT03314935|565933503|FG009|Phase 2|Study Terminated by Sponsor|0|||
156776716|NCT03314935|565933504|FG010|Phase 2|Study Terminated by Sponsor|7|||
156776717|NCT03314935|565933505|FG011|Phase 2|Study Terminated by Sponsor|2|||
156776718|NCT03314935|565933506|FG012|Phase 2|Study Terminated by Sponsor|1|||
156776719|NCT03314935|565933507|FG013|Phase 2|Study Terminated by Sponsor|4|||
156776720|NCT03314935|565933508|FG014|Phase 2|Study Terminated by Sponsor|4|||
156776721|NCT03314935|565933494|FG000|Phase 2|Lost to Follow-up|0|||
156776722|NCT03314935|565933495|FG001|Phase 2|Lost to Follow-up|0|||
156776723|NCT03314935|565933496|FG002|Phase 2|Lost to Follow-up|0|||
156776724|NCT03314935|565933497|FG003|Phase 2|Lost to Follow-up|0|||
156776725|NCT03314935|565933498|FG004|Phase 2|Lost to Follow-up|0|||
156776726|NCT03314935|565933499|FG005|Phase 2|Lost to Follow-up|0|||
156776727|NCT03314935|565933500|FG006|Phase 2|Lost to Follow-up|0|||
156776728|NCT03314935|565933501|FG007|Phase 2|Lost to Follow-up|0|||
156776729|NCT03314935|565933502|FG008|Phase 2|Lost to Follow-up|0|||
156776730|NCT03314935|565933503|FG009|Phase 2|Lost to Follow-up|1|||
156776731|NCT03314935|565933504|FG010|Phase 2|Lost to Follow-up|0|||
156776732|NCT03314935|565933505|FG011|Phase 2|Lost to Follow-up|0|||
156776733|NCT03314935|565933506|FG012|Phase 2|Lost to Follow-up|0|||
156776734|NCT03314935|565933507|FG013|Phase 2|Lost to Follow-up|0|||
156776735|NCT03314935|565933508|FG014|Phase 2|Lost to Follow-up|1|||
156776736|NCT03314935|565933494|FG000|Phase 2|Physician Decision|0|||
156776737|NCT03314935|565933495|FG001|Phase 2|Physician Decision|0|||
156776738|NCT03314935|565933496|FG002|Phase 2|Physician Decision|0|||
156776739|NCT03314935|565933497|FG003|Phase 2|Physician Decision|0|||
156776740|NCT03314935|565933498|FG004|Phase 2|Physician Decision|0|||
156776741|NCT03314935|565933499|FG005|Phase 2|Physician Decision|0|||
156776742|NCT03314935|565933500|FG006|Phase 2|Physician Decision|0|||
156776743|NCT03314935|565933501|FG007|Phase 2|Physician Decision|0|||
156776744|NCT03314935|565933502|FG008|Phase 2|Physician Decision|0|||
156776745|NCT03314935|565933503|FG009|Phase 2|Physician Decision|0|||
156776746|NCT03314935|565933504|FG010|Phase 2|Physician Decision|1|||
156776747|NCT03314935|565933505|FG011|Phase 2|Physician Decision|0|||
156776748|NCT03314935|565933506|FG012|Phase 2|Physician Decision|0|||
156776749|NCT03314935|565933507|FG013|Phase 2|Physician Decision|0|||
156776750|NCT03314935|565933508|FG014|Phase 2|Physician Decision|0|||
156776751|NCT05845619|565933509|FG000|Overall Study|duplicate enrollment|2|||
156776752|NCT05845619|565933510|FG001|Overall Study|duplicate enrollment|2|||
156776753|NCT05845619|565933511|FG002|Overall Study|duplicate enrollment|1|||
156776754|NCT05168800|565933512|FG000|Time 1 Survey|Did not start T1 survey|182|||
156776755|NCT05168800|565933513|FG001|Time 1 Survey|Did not start T1 survey|150|||
156776756|NCT05168800|565933514|FG002|Time 1 Survey|Did not start T1 survey|140|||
156776757|NCT05168800|565933512|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
156776758|NCT05168800|565933513|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
156776759|NCT05168800|565933514|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
156776760|NCT05168800|565933512|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
156776761|NCT05168800|565933513|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
156776762|NCT05168800|565933514|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
156776763|NCT05168800|565933512|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
156776764|NCT05168800|565933513|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
156776765|NCT05168800|565933514|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
156776766|NCT05168800|565933512|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
156776767|NCT05168800|565933513|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
156776768|NCT05168800|565933514|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
156776769|NCT05168800|565933512|FG000|Time 1 Survey|Withdrawal by Subject|6|||
156776770|NCT05168800|565933513|FG001|Time 1 Survey|Withdrawal by Subject|3|||
156776771|NCT05168800|565933514|FG002|Time 1 Survey|Withdrawal by Subject|2|||
156776772|NCT05168800|565933512|FG000|Time 2 Survey|Already excluded at Time 1|228|||
156776773|NCT05168800|565933513|FG001|Time 2 Survey|Already excluded at Time 1|202|||
156776774|NCT05168800|565933514|FG002|Time 2 Survey|Already excluded at Time 1|173|||
156776775|NCT05168800|565933512|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
156776776|NCT05168800|565933513|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
156776777|NCT05168800|565933514|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
156776778|NCT05168800|565933512|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
156776779|NCT05168800|565933513|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
156776780|NCT05168800|565933514|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
156776781|NCT05168800|565933512|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
156776782|NCT05168800|565933513|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
156776783|NCT05168800|565933514|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
156776784|NCT05168800|565933512|FG000|Time 2 Survey|Withdrawal by Subject|1|||
156776785|NCT05168800|565933513|FG001|Time 2 Survey|Withdrawal by Subject|0|||
156776786|NCT05168800|565933514|FG002|Time 2 Survey|Withdrawal by Subject|1|||
156776787|NCT05168800|565933512|FG000|Time 3 Survey|Already excluded at Time 1|228|||
156776788|NCT05168800|565933513|FG001|Time 3 Survey|Already excluded at Time 1|200|||
156776789|NCT05168800|565933514|FG002|Time 3 Survey|Already excluded at Time 1|173|||
156776790|NCT05168800|565933512|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
156776791|NCT05168800|565933513|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
156776792|NCT05168800|565933514|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
156776793|NCT05168800|565933512|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
156776794|NCT05168800|565933513|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
156776795|NCT05168800|565933514|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
156776796|NCT05168800|565933512|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
156776797|NCT05168800|565933513|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
156776798|NCT05168800|565933514|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
156776799|NCT05252702|565933515|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
156325135|NCT02788474|564290859|FG000|Double Blind Treatment Period|Patient's refusal|3|||
156776800|NCT05252702|565933515|FG000|Overall Study|Death|16|||
156776801|NCT05252702|565933515|FG000|Overall Study|System explant|5|||
156776802|NCT05252702|565933515|FG000|Overall Study|Lost to Follow-up|1|||
156776803|NCT05252702|565933515|FG000|Overall Study|Withdrawn by investigator|1|||
156325136|NCT02788474|564290860|FG001|Double Blind Treatment Period|Patient's refusal|0|||
156776804|NCT05252702|565933515|FG000|Overall Study|Visit not due|306|||
156665516|NCT01185821|565524179|FG002|Overall Study|Abnormal laboratory value(s)|1|||
156665517|NCT01185821|565524180|FG003|Overall Study|Abnormal laboratory value(s)|0|||
156665518|NCT01185821|565524181|FG004|Overall Study|Abnormal laboratory value(s)|0|||
156665519|NCT01185821|565524177|FG000|Overall Study|Protocol Violation|0|||
156665520|NCT01185821|565524178|FG001|Overall Study|Protocol Violation|0|||
156665521|NCT01185821|565524179|FG002|Overall Study|Protocol Violation|0|||
156665522|NCT01185821|565524180|FG003|Overall Study|Protocol Violation|1|||
156665523|NCT01185821|565524181|FG004|Overall Study|Protocol Violation|1|||
156665524|NCT01185821|565524177|FG000|Overall Study|Abnormal test procedure result|0|||
156665525|NCT01185821|565524178|FG001|Overall Study|Abnormal test procedure result|0|||
156665526|NCT01185821|565524179|FG002|Overall Study|Abnormal test procedure result|0|||
156665527|NCT01185821|565524180|FG003|Overall Study|Abnormal test procedure result|0|||
156665528|NCT01185821|565524181|FG004|Overall Study|Abnormal test procedure result|1|||
156665529|NCT01185821|565524177|FG000|Overall Study|Death|0|||
156665530|NCT01185821|565524178|FG001|Overall Study|Death|1|||
156665531|NCT01185821|565524179|FG002|Overall Study|Death|0|||
156665532|NCT01185821|565524180|FG003|Overall Study|Death|0|||
156665533|NCT01185821|565524181|FG004|Overall Study|Death|0|||
156665534|NCT01185821|565524177|FG000|Overall Study|Condition no longer required study drug|0|||
156665535|NCT01185821|565524178|FG001|Overall Study|Condition no longer required study drug|0|||
156665536|NCT01185821|565524179|FG002|Overall Study|Condition no longer required study drug|0|||
156665537|NCT01185821|565524180|FG003|Overall Study|Condition no longer required study drug|0|||
156665538|NCT01185821|565524181|FG004|Overall Study|Condition no longer required study drug|1|||
156665539|NCT01185821|565524177|FG000|Overall Study|Adverse Event|2|||
156665540|NCT01185821|565524178|FG001|Overall Study|Adverse Event|3|||
156665541|NCT01185821|565524179|FG002|Overall Study|Adverse Event|1|||
156665542|NCT01185821|565524180|FG003|Overall Study|Adverse Event|2|||
156665543|NCT01185821|565524181|FG004|Overall Study|Adverse Event|5|||
156665544|NCT01185821|565524177|FG000|Overall Study|Lack of Efficacy|0|||
156665545|NCT01185821|565524178|FG001|Overall Study|Lack of Efficacy|0|||
156665546|NCT01185821|565524179|FG002|Overall Study|Lack of Efficacy|3|||
156665547|NCT01185821|565524180|FG003|Overall Study|Lack of Efficacy|0|||
156665548|NCT01185821|565524181|FG004|Overall Study|Lack of Efficacy|9|||
156665549|NCT01185821|565524177|FG000|Overall Study|Withdrawal by Subject|3|||
156665550|NCT01185821|565524178|FG001|Overall Study|Withdrawal by Subject|2|||
156665551|NCT01185821|565524179|FG002|Overall Study|Withdrawal by Subject|2|||
156665552|NCT01185821|565524180|FG003|Overall Study|Withdrawal by Subject|1|||
156665553|NCT01185821|565524181|FG004|Overall Study|Withdrawal by Subject|3|||
156665554|NCT01185821|565524177|FG000|Overall Study|Lost to Follow-up|1|||
156665555|NCT01185821|565524178|FG001|Overall Study|Lost to Follow-up|1|||
156665556|NCT01185821|565524179|FG002|Overall Study|Lost to Follow-up|2|||
156665557|NCT01185821|565524180|FG003|Overall Study|Lost to Follow-up|1|||
156665558|NCT01185821|565524181|FG004|Overall Study|Lost to Follow-up|2|||
156665559|NCT01185821|565524177|FG000|Overall Study|Administrative problems|0|||
156665560|NCT01185821|565524178|FG001|Overall Study|Administrative problems|0|||
156665561|NCT01185821|565524179|FG002|Overall Study|Administrative problems|1|||
156665562|NCT01185821|565524180|FG003|Overall Study|Administrative problems|1|||
156665563|NCT01185821|565524181|FG004|Overall Study|Administrative problems|2|||
156665564|NCT01534520|565524183|FG000|Overall Study|Adverse Event|0|||
156665565|NCT01534520|565524184|FG001|Overall Study|Adverse Event|1|||
156665566|NCT00537979|565524188|FG000|Overall Study|Adverse Event|2|||
156665567|NCT00537979|565524189|FG001|Overall Study|Adverse Event|2|||
156665568|NCT00537979|565524188|FG000|Overall Study|Withdrawal by Subject|1|||
156665569|NCT00537979|565524189|FG001|Overall Study|Withdrawal by Subject|4|||
156665570|NCT00537979|565524188|FG000|Overall Study|Lost to Follow-up|1|||
156665571|NCT00537979|565524189|FG001|Overall Study|Lost to Follow-up|4|||
156665572|NCT00537979|565524188|FG000|Overall Study|Lack of Efficacy|0|||
156665573|NCT00537979|565524189|FG001|Overall Study|Lack of Efficacy|1|||
156665574|NCT00537979|565524188|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
156665575|NCT00537979|565524189|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
156665576|NCT00537979|565524188|FG000|Overall Study|Death|0|||
156665577|NCT00537979|565524189|FG001|Overall Study|Death|3|||
156665578|NCT00537979|565524188|FG000|Overall Study|Kidney transplant|0|||
156665579|NCT00537979|565524189|FG001|Overall Study|Kidney transplant|3|||
156665580|NCT00537979|565524188|FG000|Overall Study|Heart failure|0|||
156665581|NCT00537979|565524189|FG001|Overall Study|Heart failure|1|||
156665582|NCT00626548|565524192|FG000|Overall Study|Adverse Event|164|||
156665583|NCT00626548|565524193|FG001|Overall Study|Adverse Event|44|||
156665584|NCT00626548|565524192|FG000|Overall Study|Withdrawal by Subject|42|||
156665585|NCT00626548|565524193|FG001|Overall Study|Withdrawal by Subject|46|||
156665586|NCT00626548|565524192|FG000|Overall Study|Protocol Violation|4|||
156665587|NCT00626548|565524193|FG001|Overall Study|Protocol Violation|11|||
156665588|NCT00626548|565524192|FG000|Overall Study|Lost to Follow-up|2|||
156665589|NCT00626548|565524193|FG001|Overall Study|Lost to Follow-up|2|||
156665590|NCT00626548|565524192|FG000|Overall Study|Other termination reason|493|||
156665591|NCT00626548|565524193|FG001|Overall Study|Other termination reason|613|||
156665592|NCT01059903|565524195|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
156524620|NCT00975507|565015650|FG000|Overall Study|Withdrawal by Subject|10|||
156524621|NCT00975507|565015651|FG001|Overall Study|Withdrawal by Subject|3|||
156776805|NCT05252702|565933515|FG000|Overall Study|Visit within window but not completed|92|||
156776806|NCT05252702|565933515|FG000|Overall Study|Unsuccessful implant|1|||
156776807|NCT04153864|565933516|FG000|Overall Study|Withdrawal by Subject|21|||
156776808|NCT04153864|565933517|FG001|Overall Study|Withdrawal by Subject|7|||
156776809|NCT04153864|565933518|FG002|Overall Study|Withdrawal by Subject|23|||
156776810|NCT04153864|565933519|FG003|Overall Study|Withdrawal by Subject|2|||
156776811|NCT04153864|565933516|FG000|Overall Study|Lost to Follow-up|4|||
156776812|NCT04153864|565933517|FG001|Overall Study|Lost to Follow-up|0|||
156776813|NCT04153864|565933518|FG002|Overall Study|Lost to Follow-up|3|||
156776814|NCT04153864|565933519|FG003|Overall Study|Lost to Follow-up|0|||
156776815|NCT04153864|565933516|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
156776816|NCT04153864|565933517|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
156776817|NCT04153864|565933518|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
156776818|NCT04153864|565933519|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
156776819|NCT04279522|565933521|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
156776820|NCT04279522|565933522|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
156776821|NCT04279522|565933521|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
156776822|NCT04279522|565933522|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
156776823|NCT04279522|565933521|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
156776824|NCT04279522|565933522|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
156776825|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
156776826|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
156776827|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
156776828|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
156776829|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Physician Decision|0|||
156776830|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Physician Decision|3|||
156776831|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Adverse Event|0|||
156776832|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Adverse Event|1|||
156776833|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
156776834|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
156776835|NCT06354257|565933527|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156776836|NCT06354257|565933527|FG000|Treatment Period 2|Adverse Event|1|||
156776837|NCT02685735|565933528|FG000|Overall Study|Surgery Cancelled|4|||
156776838|NCT02685735|565933529|FG001|Overall Study|Surgery Cancelled|9|||
156776839|NCT02685735|565933528|FG000|Overall Study|Adverse Event|10|||
156776840|NCT02685735|565933529|FG001|Overall Study|Adverse Event|3|||
156776841|NCT02685735|565933528|FG000|Overall Study|Preop testing found to be incomplete|2|||
156776842|NCT02685735|565933529|FG001|Overall Study|Preop testing found to be incomplete|2|||
156776843|NCT02685735|565933528|FG000|Overall Study|Withdrawal by Subject|1|||
156776844|NCT02685735|565933529|FG001|Overall Study|Withdrawal by Subject|2|||
156776845|NCT02685735|565933528|FG000|Overall Study|Death|1|||
156776846|NCT02685735|565933529|FG001|Overall Study|Death|0|||
156776847|NCT02401230|565933530|FG000|Overall Study|Adverse Event|3|||
156776848|NCT02401230|565933531|FG001|Overall Study|Adverse Event|2|||
156776849|NCT02401230|565933532|FG002|Overall Study|Adverse Event|0|||
156776850|NCT02401230|565933530|FG000|Overall Study|Withdrawal by Subject|2|||
156776851|NCT02401230|565933531|FG001|Overall Study|Withdrawal by Subject|1|||
156776852|NCT02401230|565933532|FG002|Overall Study|Withdrawal by Subject|1|||
156776853|NCT02401230|565933530|FG000|Overall Study|Lost to Follow-up|1|||
156776854|NCT02401230|565933531|FG001|Overall Study|Lost to Follow-up|3|||
156776855|NCT02401230|565933532|FG002|Overall Study|Lost to Follow-up|3|||
156776856|NCT00831844|565933540|FG000|Overall Study|Adverse Event|2|||
156776857|NCT00831844|565933541|FG001|Overall Study|Adverse Event|0|||
156776858|NCT00831844|565933542|FG002|Overall Study|Adverse Event|0|||
156325137|NCT02788474|564290859|FG000|Double Blind Treatment Period|Adverse Event|6|||
156325138|NCT02788474|564290860|FG001|Double Blind Treatment Period|Adverse Event|4|||
156325139|NCT02788474|564290859|FG000|Open Label Treatment Period|Adverse Event|29|||
156325140|NCT02788474|564290860|FG001|Open Label Treatment Period|Adverse Event|9|||
156325141|NCT02788474|564290859|FG000|Open Label Treatment Period|Other than reason specified|1|||
156325142|NCT02788474|564290860|FG001|Open Label Treatment Period|Other than reason specified|0|||
156325143|NCT02788474|564290859|FG000|Open Label Treatment Period|Patient's refusal|1|||
156325144|NCT02788474|564290860|FG001|Open Label Treatment Period|Patient's refusal|3|||
156325145|NCT02788474|564290859|FG000|Open Label Treatment Period|Non-compliance|1|||
156325146|NCT02788474|564290860|FG001|Open Label Treatment Period|Non-compliance|0|||
156325147|NCT02675231|564290862|FG000|Overall Study|Withdrawal by Subject|2|||
156325148|NCT02675231|564290863|FG001|Overall Study|Withdrawal by Subject|4|||
156325149|NCT02675231|564290864|FG002|Overall Study|Withdrawal by Subject|2|||
156325150|NCT02675231|564290862|FG000|Overall Study|Lost to Follow-up|3|||
156325151|NCT02675231|564290863|FG001|Overall Study|Lost to Follow-up|4|||
156325152|NCT02675231|564290864|FG002|Overall Study|Lost to Follow-up|3|||
156776859|NCT00831844|565933543|FG003|Overall Study|Adverse Event|0|||
156665593|NCT01059903|565524196|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
156665594|NCT04384978|565524199|FG000|Overall Study|Withdrawal by Subject|4|||
156665595|NCT04384978|565524200|FG001|Overall Study|Withdrawal by Subject|0|||
156665596|NCT00385593|565524201|FG000|Overall Study|Adverse Event|3|||
156665597|NCT00385593|565524202|FG001|Overall Study|Adverse Event|2|||
156665598|NCT00385593|565524201|FG000|Overall Study|Withdrawal by Subject|17|||
156665599|NCT00385593|565524202|FG001|Overall Study|Withdrawal by Subject|7|||
156665600|NCT00385593|565524201|FG000|Overall Study|Lost to Follow-up|12|||
156665601|NCT00385593|565524202|FG001|Overall Study|Lost to Follow-up|8|||
156665602|NCT00385593|565524201|FG000|Overall Study|Protocol Violation|7|||
156665603|NCT00385593|565524202|FG001|Overall Study|Protocol Violation|4|||
156665604|NCT00385593|565524201|FG000|Overall Study|Several reasons|17|||
156665605|NCT00385593|565524202|FG001|Overall Study|Several reasons|15|||
156665606|NCT00385593|565524201|FG000|Overall Study|Incorrect inclusion|2|||
156665607|NCT00385593|565524202|FG001|Overall Study|Incorrect inclusion|0|||
156665608|NCT00385593|565524201|FG000|Overall Study|Incorrect randomization|0|||
156665609|NCT00385593|565524202|FG001|Overall Study|Incorrect randomization|1|||
156665610|NCT00858845|565524211|FG000|Overall Study|Patient underwent heart transplant.|0|||
156665611|NCT00858845|565524212|FG001|Overall Study|Patient underwent heart transplant.|1|||
156665612|NCT02100228|565524214|FG000|Overall Study|Other|19|||
156665613|NCT02100228|565524215|FG001|Overall Study|Other|19|||
156665614|NCT02100228|565524214|FG000|Overall Study|Administrative reason|0|||
156665615|NCT02100228|565524215|FG001|Overall Study|Administrative reason|1|||
156665616|NCT02100228|565524214|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
156665617|NCT02100228|565524215|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
156665618|NCT02100228|565524214|FG000|Overall Study|Non-compliance|0|||
156665619|NCT02100228|565524215|FG001|Overall Study|Non-compliance|3|||
156665620|NCT02100228|565524214|FG000|Overall Study|Lost to Follow-up|0|||
156665621|NCT02100228|565524215|FG001|Overall Study|Lost to Follow-up|1|||
156665622|NCT02100228|565524214|FG000|Overall Study|Withdrawal by Subject|27|||
156665623|NCT02100228|565524215|FG001|Overall Study|Withdrawal by Subject|37|||
156665624|NCT02100228|565524214|FG000|Overall Study|Adverse Event|16|||
156665625|NCT02100228|565524215|FG001|Overall Study|Adverse Event|12|||
156665626|NCT02100228|565524214|FG000|Overall Study|Death|1|||
156665627|NCT02100228|565524215|FG001|Overall Study|Death|1|||
156665628|NCT00214422|565524216|FG000|Overall Study|Physician Decision|2|||
156665629|NCT00214422|565524217|FG001|Overall Study|Physician Decision|0|||
156665630|NCT00214422|565524218|FG002|Overall Study|Physician Decision|0|||
156665631|NCT00214422|565524216|FG000|Overall Study|Developed esophageal ca|1|||
156665632|NCT00214422|565524217|FG001|Overall Study|Developed esophageal ca|0|||
156665633|NCT00214422|565524218|FG002|Overall Study|Developed esophageal ca|0|||
156665634|NCT00214422|565524216|FG000|Overall Study|Pt taken off study|1|||
156665635|NCT00214422|565524217|FG001|Overall Study|Pt taken off study|1|||
156665636|NCT00214422|565524218|FG002|Overall Study|Pt taken off study|0|||
156665637|NCT00214422|565524216|FG000|Overall Study|Disease progression on study|1|||
156665638|NCT00214422|565524217|FG001|Overall Study|Disease progression on study|0|||
156665639|NCT00214422|565524218|FG002|Overall Study|Disease progression on study|0|||
156665640|NCT00214422|565524216|FG000|Overall Study|Unable to make a radiation treatment|0|||
156665641|NCT00214422|565524217|FG001|Overall Study|Unable to make a radiation treatment|0|||
156665642|NCT00214422|565524218|FG002|Overall Study|Unable to make a radiation treatment|1|||
156665643|NCT00854100|565524231|FG000|Overall Study|Inability to complete the study visits|0|||
156665644|NCT00854100|565524232|FG001|Overall Study|Inability to complete the study visits|0|||
156665645|NCT00854100|565524233|FG002|Overall Study|Inability to complete the study visits|1|||
156665646|NCT00854100|565524231|FG000|Overall Study|Lost to Follow-up|2|||
156665647|NCT00854100|565524232|FG001|Overall Study|Lost to Follow-up|0|||
156665648|NCT00854100|565524233|FG002|Overall Study|Lost to Follow-up|3|||
156665649|NCT00854100|565524231|FG000|Overall Study|Withdrawal by Subject|3|||
156665650|NCT00854100|565524232|FG001|Overall Study|Withdrawal by Subject|1|||
156665651|NCT00854100|565524233|FG002|Overall Study|Withdrawal by Subject|2|||
156665652|NCT00854100|565524231|FG000|Overall Study|Protocol Violation|2|||
156665653|NCT00854100|565524232|FG001|Overall Study|Protocol Violation|4|||
156665654|NCT00854100|565524233|FG002|Overall Study|Protocol Violation|3|||
156665655|NCT00854100|565524231|FG000|Overall Study|Adverse Event|2|||
156776860|NCT00831844|565933544|FG004|Overall Study|Adverse Event|1|||
156665656|NCT00854100|565524232|FG001|Overall Study|Adverse Event|1|||
156665657|NCT00854100|565524233|FG002|Overall Study|Adverse Event|2|||
156665658|NCT03616106|565524235|FG000|Overall Study|Removed by PI|6|||
156665659|NCT03616106|565524236|FG001|Overall Study|Removed by PI|0|||
156665660|NCT03616106|565524235|FG000|Overall Study|Withdrawal by Subject|1|||
156665661|NCT03616106|565524236|FG001|Overall Study|Withdrawal by Subject|1|||
156665662|NCT03616106|565524235|FG000|Overall Study|Lost to Follow-up|7|||
156665663|NCT03616106|565524236|FG001|Overall Study|Lost to Follow-up|0|||
156665664|NCT01880593|565524239|FG000|Overall Study|Adverse Event|1|||
156776861|NCT00831844|565933545|FG005|Overall Study|Adverse Event|1|||
156776862|NCT00831844|565933546|FG006|Overall Study|Adverse Event|2|||
156776863|NCT00831844|565933547|FG007|Overall Study|Adverse Event|0|||
156776864|NCT00831844|565933548|FG008|Overall Study|Adverse Event|0|||
156776865|NCT00831844|565933549|FG009|Overall Study|Adverse Event|0|||
156776866|NCT00831844|565933540|FG000|Overall Study|Death|0|||
156776867|NCT00831844|565933541|FG001|Overall Study|Death|0|||
156776868|NCT00831844|565933542|FG002|Overall Study|Death|0|||
156776869|NCT00831844|565933543|FG003|Overall Study|Death|1|||
156776870|NCT00831844|565933544|FG004|Overall Study|Death|0|||
156776871|NCT00831844|565933545|FG005|Overall Study|Death|0|||
156776872|NCT00831844|565933546|FG006|Overall Study|Death|0|||
156776873|NCT00831844|565933547|FG007|Overall Study|Death|0|||
156776874|NCT00831844|565933548|FG008|Overall Study|Death|0|||
156776875|NCT00831844|565933549|FG009|Overall Study|Death|0|||
156776876|NCT00831844|565933540|FG000|Overall Study|Lack of Efficacy|8|||
156776877|NCT00831844|565933541|FG001|Overall Study|Lack of Efficacy|10|||
156776878|NCT00831844|565933542|FG002|Overall Study|Lack of Efficacy|15|||
156776879|NCT00831844|565933543|FG003|Overall Study|Lack of Efficacy|8|||
156776880|NCT00831844|565933544|FG004|Overall Study|Lack of Efficacy|11|||
156776881|NCT00831844|565933545|FG005|Overall Study|Lack of Efficacy|17|||
156776882|NCT00831844|565933546|FG006|Overall Study|Lack of Efficacy|8|||
156776883|NCT00831844|565933547|FG007|Overall Study|Lack of Efficacy|9|||
156776884|NCT00831844|565933548|FG008|Overall Study|Lack of Efficacy|7|||
156776885|NCT00831844|565933549|FG009|Overall Study|Lack of Efficacy|0|||
156325153|NCT05323656|564290865|FG000|Overall Study|Still On-Treatment|6|||
156325154|NCT05323656|564290866|FG001|Overall Study|Still On-Treatment|6|||
156325155|NCT05323656|564290865|FG000|Overall Study|Progressive Disease|15|||
156325156|NCT05323656|564290866|FG001|Overall Study|Progressive Disease|14|||
156325157|NCT05323656|564290865|FG000|Overall Study|Adverse Event|2|||
156325158|NCT05323656|564290866|FG001|Overall Study|Adverse Event|3|||
156325159|NCT05323656|564290865|FG000|Overall Study|Death|1|||
156325160|NCT05323656|564290866|FG001|Overall Study|Death|2|||
156325161|NCT05323656|564290865|FG000|Overall Study|Withdrawal by Subject|1|||
156325162|NCT05323656|564290866|FG001|Overall Study|Withdrawal by Subject|0|||
156325163|NCT05323656|564290865|FG000|Overall Study|Clinical disease progression|0|||
156325164|NCT05323656|564290866|FG001|Overall Study|Clinical disease progression|1|||
156325165|NCT05323656|564290865|FG000|Overall Study|Patient and Investigator decision|1|||
156325166|NCT05323656|564290866|FG001|Overall Study|Patient and Investigator decision|0|||
156325167|NCT05323656|564290865|FG000|Overall Study|Physician Decision|0|||
156325168|NCT05323656|564290866|FG001|Overall Study|Physician Decision|1|||
156325169|NCT02495233|564290867|FG000|Overall Study|Miscellaneous|0|||
156325170|NCT02495233|564290868|FG001|Overall Study|Miscellaneous|1|||
156325171|NCT02652767|564290869|FG000|Overall Study|Death|2|||
156325172|NCT02652767|564290869|FG000|Overall Study|Lost to Follow-up|1|||
156325173|NCT02652767|564290869|FG000|Overall Study|Withdrawal by Subject|1|||
156325174|NCT01028378|564290872|FG000|Overall Study|Lost to Follow-up|12|||
156325175|NCT01028378|564290872|FG000|Overall Study|Withdrawal by Subject|1|||
156325176|NCT01028378|564290872|FG000|Overall Study|Adminstrative Reasons|4|||
156325177|NCT00887744|564290884|FG000|Overall Study|Adverse Event|3|||
156325178|NCT00887744|564290884|FG000|Overall Study|Death|1|||
156325179|NCT00887744|564290884|FG000|Overall Study|Lost to Follow-up|3|||
156325180|NCT00887744|564290884|FG000|Overall Study|Withdrawal by Subject|18|||
156325181|NCT00887744|564290884|FG000|Overall Study|Various reasons|9|||
156325182|NCT01115803|564290885|FG000|Overall Study|Withdrawal by Subject|0|||
156325183|NCT01115803|564290886|FG001|Overall Study|Withdrawal by Subject|0|||
156325184|NCT01115803|564290887|FG002|Overall Study|Withdrawal by Subject|0|||
156325185|NCT01115803|564290888|FG003|Overall Study|Withdrawal by Subject|0|||
156325186|NCT01115803|564290889|FG004|Overall Study|Withdrawal by Subject|0|||
156325187|NCT01115803|564290890|FG005|Overall Study|Withdrawal by Subject|0|||
156325188|NCT01115803|564290891|FG006|Overall Study|Withdrawal by Subject|1|||
156325189|NCT01115803|564290885|FG000|Overall Study|Lost to Follow-up|0|||
156325190|NCT01115803|564290886|FG001|Overall Study|Lost to Follow-up|0|||
156325191|NCT01115803|564290887|FG002|Overall Study|Lost to Follow-up|1|||
156325192|NCT01115803|564290888|FG003|Overall Study|Lost to Follow-up|0|||
156325193|NCT01115803|564290889|FG004|Overall Study|Lost to Follow-up|0|||
156325194|NCT01115803|564290890|FG005|Overall Study|Lost to Follow-up|0|||
156325195|NCT01115803|564290891|FG006|Overall Study|Lost to Follow-up|0|||
156325196|NCT01115803|564290885|FG000|Overall Study|Progressive Disease during Cycle1|0|||
156776886|NCT00831844|565933540|FG000|Overall Study|Physician Decision|0|||
156776887|NCT00831844|565933541|FG001|Overall Study|Physician Decision|1|||
156776888|NCT00831844|565933542|FG002|Overall Study|Physician Decision|3|||
156776889|NCT00831844|565933543|FG003|Overall Study|Physician Decision|1|||
156325197|NCT01115803|564290886|FG001|Overall Study|Progressive Disease during Cycle1|0|||
156325198|NCT01115803|564290887|FG002|Overall Study|Progressive Disease during Cycle1|0|||
156325199|NCT01115803|564290888|FG003|Overall Study|Progressive Disease during Cycle1|0|||
156325200|NCT01115803|564290889|FG004|Overall Study|Progressive Disease during Cycle1|0|||
156325201|NCT01115803|564290890|FG005|Overall Study|Progressive Disease during Cycle1|0|||
156325202|NCT01115803|564290891|FG006|Overall Study|Progressive Disease during Cycle1|1|||
156325203|NCT03533686|564290892|FG000|Overall Study|Withdrawal by Subject|1|||
156325204|NCT03533686|564290893|FG001|Overall Study|Withdrawal by Subject|0|||
156776890|NCT00831844|565933544|FG004|Overall Study|Physician Decision|1|||
156776891|NCT00831844|565933545|FG005|Overall Study|Physician Decision|1|||
156665665|NCT01880593|565524240|FG001|Overall Study|Adverse Event|0|||
156665666|NCT01880593|565524239|FG000|Overall Study|Lack of Efficacy|1|||
156665667|NCT01880593|565524240|FG001|Overall Study|Lack of Efficacy|5|||
156665668|NCT01880593|565524239|FG000|Overall Study|Withdrawal by Subject|6|||
156665669|NCT01880593|565524240|FG001|Overall Study|Withdrawal by Subject|1|||
156665670|NCT05275205|565524241|FG000|Overall Study|Adverse Event|1|||
156665671|NCT05275205|565524242|FG001|Overall Study|Adverse Event|2|||
156665672|NCT05275205|565524241|FG000|Overall Study|Physician Decision|1|||
156665673|NCT05275205|565524242|FG001|Overall Study|Physician Decision|1|||
156665674|NCT05275205|565524241|FG000|Overall Study|Withdrawal by Subject|2|||
156665675|NCT05275205|565524242|FG001|Overall Study|Withdrawal by Subject|3|||
156665676|NCT05275205|565524241|FG000|Overall Study|Death|1|||
156665677|NCT05275205|565524242|FG001|Overall Study|Death|0|||
156665678|NCT05275205|565524241|FG000|Overall Study|Patient unable to attend visits|1|||
156665679|NCT05275205|565524242|FG001|Overall Study|Patient unable to attend visits|0|||
156665680|NCT01223365|565524244|FG000|Open-label Titration Period|Enrolled but not treated|1|||
156665681|NCT01223365|565524244|FG000|Open-label Titration Period|Adverse Event|23|||
156665682|NCT01223365|565524244|FG000|Open-label Titration Period|Lack of Efficacy|3|||
156665683|NCT01223365|565524244|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
156665684|NCT01223365|565524244|FG000|Open-label Titration Period|Protocol Violation|1|||
156665685|NCT01223365|565524244|FG000|Open-label Titration Period|Lost to Follow-up|2|||
156665686|NCT01223365|565524244|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
156665687|NCT01223365|565524244|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
156665688|NCT01223365|565524244|FG000|Open-label Titration Period|Starting physical therapy|1|||
156665689|NCT01223365|565524244|FG000|Open-label Treatment Period|Adverse Event|39|||
156665690|NCT01223365|565524244|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
156665691|NCT01223365|565524244|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
156665692|NCT01223365|565524244|FG000|Open-label Treatment Period|Protocol Violation|15|||
156665693|NCT01223365|565524244|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
156665694|NCT01223365|565524244|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
156665695|NCT01223365|565524244|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
156665696|NCT01223365|565524244|FG000|Open-label Treatment Period|Moved out of area|2|||
156665697|NCT01223365|565524244|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
156665698|NCT01223365|565524244|FG000|Open-label Treatment Period|"Out of window"|1|||
156665699|NCT01223365|565524244|FG000|Open-label Treatment Period|Starting physical therapy|1|||
156665700|NCT01223365|565524244|FG000|Open-label Treatment Period|Physician Decision|2|||
156665701|NCT03041025|565524246|FG000|Overall Study|Adverse Event|0|||
156665702|NCT03041025|565524247|FG001|Overall Study|Adverse Event|0|||
156665703|NCT03041025|565524248|FG002|Overall Study|Adverse Event|1|||
156665704|NCT03041025|565524246|FG000|Overall Study|Lost to Follow-up|1|||
156665705|NCT03041025|565524247|FG001|Overall Study|Lost to Follow-up|0|||
156665706|NCT03041025|565524248|FG002|Overall Study|Lost to Follow-up|0|||
156665707|NCT03041025|565524246|FG000|Overall Study|Withdrawal by Subject|0|||
156665708|NCT03041025|565524247|FG001|Overall Study|Withdrawal by Subject|0|||
156665709|NCT03041025|565524248|FG002|Overall Study|Withdrawal by Subject|1|||
156665710|NCT02963259|565524250|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
156665711|NCT02963259|565524250|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
156665712|NCT02963259|565524250|FG000|Overall Study|Death|1|||
156665713|NCT02963259|565524250|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
156665714|NCT03243630|565524252|FG000|Overall Study|Protocol Violation|1|||
156776892|NCT00831844|565933546|FG006|Overall Study|Physician Decision|0|||
156665715|NCT03243630|565524252|FG000|Overall Study|Physician Decision|1|||
156665716|NCT00939003|565524254|FG000|Double-blind Treatment Period|Adverse Event|1|||
156665717|NCT00939003|565524255|FG001|Double-blind Treatment Period|Adverse Event|1|||
156665718|NCT00939003|565524254|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
156665719|NCT00939003|565524255|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
156665720|NCT00939003|565524254|FG000|Double-blind Treatment Period|Pregnancy|0|||
156665721|NCT00939003|565524255|FG001|Double-blind Treatment Period|Pregnancy|1|||
156665722|NCT00939003|565524254|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
156665723|NCT00939003|565524255|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
156665724|NCT00939003|565524254|FG000|Open-label Treatment Period|Adverse Event|4|||
156665725|NCT00939003|565524255|FG001|Open-label Treatment Period|Adverse Event|8|||
156665726|NCT00939003|565524254|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
156665727|NCT00939003|565524255|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
156665728|NCT00939003|565524254|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
156665729|NCT00939003|565524255|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
156665730|NCT00939003|565524254|FG000|Open-label Treatment Period|Pregnancy|1|||
156665731|NCT00939003|565524255|FG001|Open-label Treatment Period|Pregnancy|1|||
156776893|NCT00831844|565933547|FG007|Overall Study|Physician Decision|0|||
156665732|NCT00939003|565524254|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
156665733|NCT00939003|565524255|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
156665734|NCT00939003|565524254|FG000|Open-label Treatment Period|Site Closure|3|||
156776894|NCT00831844|565933548|FG008|Overall Study|Physician Decision|1|||
156665735|NCT00939003|565524255|FG001|Open-label Treatment Period|Site Closure|4|||
156665736|NCT02131129|565524256|FG000|Overall Study|Withdrawal by Subject|1|||
156665737|NCT02131129|565524257|FG001|Overall Study|Withdrawal by Subject|0|||
156665738|NCT03707912|565524258|FG000|Overall Study|Violation of inclusion criteria|1|||
156665739|NCT03707912|565524259|FG001|Overall Study|Violation of inclusion criteria|0|||
156665740|NCT02865122|565524260|FG000|Overall Study|Adverse Event|1|||
156665741|NCT02865122|565524261|FG001|Overall Study|Adverse Event|0|||
156665742|NCT02865122|565524262|FG002|Overall Study|Adverse Event|0|||
156665743|NCT03880266|565524263|FG000|Overall Study|Withdrawal by Subject|0|||
156665744|NCT03880266|565524264|FG001|Overall Study|Withdrawal by Subject|1|||
156665745|NCT03880266|565524265|FG002|Overall Study|Withdrawal by Subject|1|||
156665746|NCT03880266|565524266|FG003|Overall Study|Withdrawal by Subject|0|||
156665747|NCT03880266|565524267|FG004|Overall Study|Withdrawal by Subject|0|||
156665748|NCT03880266|565524268|FG005|Overall Study|Withdrawal by Subject|0|||
156665749|NCT03880266|565524269|FG006|Overall Study|Withdrawal by Subject|0|||
156665750|NCT03880266|565524270|FG007|Overall Study|Withdrawal by Subject|0|||
156665751|NCT05369208|565525829|FG000|Core Phase|Prohibited Medication Required|2|||
156665752|NCT05369208|565525829|FG000|Core Phase|Adverse Event|1|||
156665753|NCT05369208|565525829|FG000|Core Phase|Lack of Efficacy|1|||
156665754|NCT03235739|565525832|FG000|Overall Study|Withdrawal by Subject|2|||
156665755|NCT03235739|565525833|FG001|Overall Study|Withdrawal by Subject|2|||
156665756|NCT03235739|565525832|FG000|Overall Study|Physician Decision|0|||
156665757|NCT03235739|565525833|FG001|Overall Study|Physician Decision|1|||
156665758|NCT00467896|565525834|FG000|Overall Study|Consent Withdrawal|18|||
156665759|NCT00467896|565525834|FG000|Overall Study|Adverse Event|7|||
156665760|NCT00467896|565525834|FG000|Overall Study|Serious Adverse Event|13|||
156665761|NCT00467896|565525834|FG000|Overall Study|Non-compliance|3|||
156665762|NCT00467896|565525834|FG000|Overall Study|Changed therapy|2|||
156665763|NCT00467896|565525834|FG000|Overall Study|Patient received transplant|2|||
156665764|NCT00467896|565525834|FG000|Overall Study|Patient had atrial septostomy|1|||
156665765|NCT00467896|565525834|FG000|Overall Study|Patient weaned off iloprost|1|||
156665766|NCT00467896|565525834|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
156665767|NCT00467896|565525834|FG000|Overall Study|Started intravenous prostacyclin|1|||
156665768|NCT00467896|565525834|FG000|Overall Study|Started inhaled Remodulin|1|||
156665769|NCT00467896|565525834|FG000|Overall Study|Patient had no improvement|1|||
156665770|NCT03818581|565525839|FG000|Overall Study|Adverse Event|1|||
156665771|NCT03818581|565525840|FG001|Overall Study|Adverse Event|0|||
156665772|NCT03818581|565525841|FG002|Overall Study|Adverse Event|0|||
156665773|NCT03818581|565525842|FG003|Overall Study|Adverse Event|0|||
156665774|NCT03818581|565525843|FG004|Overall Study|Adverse Event|0|||
156665775|NCT03818581|565525839|FG000|Overall Study|Covid-19|2|||
156665776|NCT03818581|565525840|FG001|Overall Study|Covid-19|0|||
156665777|NCT03818581|565525841|FG002|Overall Study|Covid-19|0|||
156665778|NCT03818581|565525842|FG003|Overall Study|Covid-19|0|||
156665779|NCT03818581|565525843|FG004|Overall Study|Covid-19|1|||
156665780|NCT03818581|565525839|FG000|Overall Study|Withdrawal by Subject|0|||
156665781|NCT03818581|565525840|FG001|Overall Study|Withdrawal by Subject|0|||
156665782|NCT03818581|565525841|FG002|Overall Study|Withdrawal by Subject|0|||
156665783|NCT03818581|565525842|FG003|Overall Study|Withdrawal by Subject|0|||
156665784|NCT03818581|565525843|FG004|Overall Study|Withdrawal by Subject|1|||
156776895|NCT00831844|565933549|FG009|Overall Study|Physician Decision|0|||
156776896|NCT00831844|565933540|FG000|Overall Study|Withdrawal by Subject|0|||
156776897|NCT00831844|565933541|FG001|Overall Study|Withdrawal by Subject|0|||
156776898|NCT00831844|565933542|FG002|Overall Study|Withdrawal by Subject|1|||
156776899|NCT00831844|565933543|FG003|Overall Study|Withdrawal by Subject|0|||
156776900|NCT00831844|565933544|FG004|Overall Study|Withdrawal by Subject|0|||
156776901|NCT00831844|565933545|FG005|Overall Study|Withdrawal by Subject|0|||
156776902|NCT00831844|565933546|FG006|Overall Study|Withdrawal by Subject|0|||
156776903|NCT00831844|565933547|FG007|Overall Study|Withdrawal by Subject|1|||
156776904|NCT00831844|565933548|FG008|Overall Study|Withdrawal by Subject|1|||
156776905|NCT00831844|565933549|FG009|Overall Study|Withdrawal by Subject|0|||
156776906|NCT00831844|565933540|FG000|Overall Study|Ineligible|0|||
156776907|NCT00831844|565933541|FG001|Overall Study|Ineligible|1|||
156776908|NCT00831844|565933542|FG002|Overall Study|Ineligible|1|||
156325205|NCT03533686|564290894|FG002|Overall Study|Withdrawal by Subject|0|||
156325206|NCT03533686|564290895|FG003|Overall Study|Withdrawal by Subject|3|||
156776909|NCT00831844|565933543|FG003|Overall Study|Ineligible|0|||
156776910|NCT00831844|565933544|FG004|Overall Study|Ineligible|1|||
156665785|NCT03818581|565525839|FG000|Overall Study|No longer met study criteria|0|||
156665786|NCT03818581|565525840|FG001|Overall Study|No longer met study criteria|0|||
156665787|NCT03818581|565525841|FG002|Overall Study|No longer met study criteria|0|||
156665788|NCT03818581|565525842|FG003|Overall Study|No longer met study criteria|0|||
156665789|NCT03818581|565525843|FG004|Overall Study|No longer met study criteria|1|||
156665790|NCT01466166|565525849|FG000|Overall Study|Death|1|||
156665791|NCT01466166|565525849|FG000|Overall Study|Lost to Follow-up|7|||
156665792|NCT01466166|565525849|FG000|Overall Study|Infusion Reaction (IR)|27|||
156776911|NCT00831844|565933545|FG005|Overall Study|Ineligible|0|||
156776912|NCT00831844|565933546|FG006|Overall Study|Ineligible|0|||
156776913|NCT00831844|565933547|FG007|Overall Study|Ineligible|0|||
156776914|NCT00831844|565933548|FG008|Overall Study|Ineligible|0|||
156665793|NCT01466166|565525849|FG000|Overall Study|Adverse Event (Other than IR)|11|||
156665794|NCT01466166|565525849|FG000|Overall Study|Elevated Serum Uric Acid|78|||
156665795|NCT01466166|565525849|FG000|Overall Study|Withdrawal by Subject|13|||
156665796|NCT01466166|565525849|FG000|Overall Study|Sponsor Decision|4|||
156665797|NCT01466166|565525849|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
156665798|NCT01466166|565525849|FG000|Overall Study|Other|20|||
156665799|NCT02262377|565525850|FG000|Overall Study|Lost to Follow-up|5|||
156665800|NCT02262377|565525851|FG001|Overall Study|Lost to Follow-up|6|||
156665801|NCT02262377|565525850|FG000|Overall Study|Found ineligible after enrollment|3|||
156665802|NCT02262377|565525851|FG001|Overall Study|Found ineligible after enrollment|0|||
156665803|NCT02262377|565525850|FG000|Overall Study|Withdrawal by Subject|4|||
156665804|NCT02262377|565525851|FG001|Overall Study|Withdrawal by Subject|0|||
156665805|NCT00371839|565525852|FG000|Overall Study|Death|4|||
156665806|NCT00371839|565525853|FG001|Overall Study|Death|0|||
156665807|NCT00371839|565525854|FG002|Overall Study|Death|0|||
156665808|NCT00371839|565525852|FG000|Overall Study|Withdrawal by Subject|7|||
156665809|NCT00371839|565525853|FG001|Overall Study|Withdrawal by Subject|4|||
156665810|NCT00371839|565525854|FG002|Overall Study|Withdrawal by Subject|0|||
156665811|NCT00371839|565525852|FG000|Overall Study|Lost to Follow-up|6|||
156665812|NCT00371839|565525853|FG001|Overall Study|Lost to Follow-up|3|||
156665813|NCT00371839|565525854|FG002|Overall Study|Lost to Follow-up|2|||
156665814|NCT02096211|565525856|FG000|Overall Study|Death|2|||
156665815|NCT02096211|565525856|FG000|Overall Study|Withdrawal by Subject|8|||
156665816|NCT02096211|565525856|FG000|Overall Study|Revision of implant|7|||
156665817|NCT02096211|565525856|FG000|Overall Study|Lost to Follow-up|43|||
156665818|NCT01439880|565525865|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
156665819|NCT01439880|565525866|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
156665820|NCT01439880|565525865|FG000|SOC-controlled Period (Year 1)|Death|2|||
156665821|NCT01439880|565525866|FG001|SOC-controlled Period (Year 1)|Death|1|||
156665822|NCT01439880|565525865|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
156665823|NCT01439880|565525866|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
156665824|NCT01439880|565525865|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
156665825|NCT01439880|565525866|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
156665826|NCT01439880|565525865|FG000|SOC-controlled Period (Year 1)|Other|8|||
156665827|NCT01439880|565525866|FG001|SOC-controlled Period (Year 1)|Other|13|||
156665828|NCT01439880|565525865|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
156665829|NCT01439880|565525866|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
156665830|NCT01439880|565525865|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
156665831|NCT01439880|565525866|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
156665832|NCT01439880|565525865|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
156665833|NCT01439880|565525866|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
156665834|NCT01439880|565525865|FG000|All-IP Period (Years 2 to 5)|Death|3|||
156665835|NCT01439880|565525866|FG001|All-IP Period (Years 2 to 5)|Death|13|||
156665836|NCT01439880|565525865|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
156776915|NCT00831844|565933549|FG009|Overall Study|Ineligible|0|||
156776916|NCT04133909|565933550|FG000|Overall Study|Death|11|||
156776917|NCT04133909|565933551|FG001|Overall Study|Death|11|||
156776918|NCT04133909|565933550|FG000|Overall Study|Adverse Event|4|||
156665837|NCT01439880|565525866|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
156776919|NCT04133909|565933551|FG001|Overall Study|Adverse Event|5|||
156776920|NCT04133909|565933550|FG000|Overall Study|Lost to Follow-up|3|||
156776921|NCT04133909|565933551|FG001|Overall Study|Lost to Follow-up|5|||
156776922|NCT04133909|565933550|FG000|Overall Study|Physician Decision|4|||
156776923|NCT04133909|565933551|FG001|Overall Study|Physician Decision|7|||
156776924|NCT04133909|565933550|FG000|Overall Study|Withdrawal by Subject|40|||
156776925|NCT04133909|565933551|FG001|Overall Study|Withdrawal by Subject|35|||
156776926|NCT04133909|565933550|FG000|Overall Study|Lack of Efficacy|2|||
156665838|NCT01439880|565525865|FG000|All-IP Period (Years 2 to 5)|Other|14|||
156665839|NCT01439880|565525866|FG001|All-IP Period (Years 2 to 5)|Other|31|||
156665840|NCT01439880|565525865|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
156776927|NCT04133909|565933551|FG001|Overall Study|Lack of Efficacy|7|||
156776928|NCT04133909|565933550|FG000|Overall Study|Randomized in error|1|||
156776929|NCT04133909|565933551|FG001|Overall Study|Randomized in error|1|||
156776930|NCT00315445|565933556|FG000|Overall Study|Adverse Event|7|||
156665841|NCT01439880|565525866|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
156665842|NCT00328926|565525867|FG000|Overall Study|Pregnancy|2|||
156665843|NCT00328926|565525868|FG001|Overall Study|Pregnancy|1|||
156776931|NCT00315445|565933557|FG001|Overall Study|Adverse Event|12|||
156776932|NCT00315445|565933558|FG002|Overall Study|Adverse Event|15|||
156776933|NCT00315445|565933556|FG000|Overall Study|Lack of Efficacy|16|||
156776934|NCT00315445|565933557|FG001|Overall Study|Lack of Efficacy|1|||
156665844|NCT00328926|565525869|FG002|Overall Study|Pregnancy|0|||
156665845|NCT00328926|565525867|FG000|Overall Study|Lost to Follow-up|0|||
156776935|NCT00315445|565933558|FG002|Overall Study|Lack of Efficacy|7|||
156776936|NCT00315445|565933556|FG000|Overall Study|Lost to Follow-up|1|||
156665846|NCT00328926|565525868|FG001|Overall Study|Lost to Follow-up|1|||
156665847|NCT00328926|565525869|FG002|Overall Study|Lost to Follow-up|0|||
156665848|NCT00328926|565525867|FG000|Overall Study|Death|0|||
156665849|NCT00328926|565525868|FG001|Overall Study|Death|0|||
156665850|NCT00328926|565525869|FG002|Overall Study|Death|1|||
156665851|NCT00328926|565525867|FG000|Overall Study|In vitro fertilization treatment|0|||
156665852|NCT00328926|565525868|FG001|Overall Study|In vitro fertilization treatment|0|||
156665853|NCT00328926|565525869|FG002|Overall Study|In vitro fertilization treatment|1|||
156665854|NCT00328926|565525867|FG000|Overall Study|Lack of ovarian response|0|||
156665855|NCT00328926|565525868|FG001|Overall Study|Lack of ovarian response|1|||
156665856|NCT00328926|565525869|FG002|Overall Study|Lack of ovarian response|0|||
156665857|NCT02269657|565525870|FG000|Overall Study|Protocol Violation|3|||
156665858|NCT02956460|565525873|FG000|Lens 1|Lost to Follow-up|1|||
156665859|NCT02956460|565525874|FG001|Lens 1|Lost to Follow-up|0|||
156665860|NCT00829673|565525875|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156665861|NCT00829673|565525876|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156665862|NCT00272779|565525877|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
156665863|NCT00272779|565525878|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
156665864|NCT00272779|565525877|FG000|Baseline Through Week 48|Death before Week 48|4|||
156665865|NCT00272779|565525878|FG001|Baseline Through Week 48|Death before Week 48|4|||
156665866|NCT00272779|565525877|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
156665867|NCT00272779|565525878|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
156665868|NCT00272779|565525877|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
156665869|NCT00272779|565525878|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
156665870|NCT00272779|565525877|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
156665871|NCT00272779|565525878|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
156665872|NCT00272779|565525877|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
156665873|NCT00272779|565525878|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
156665874|NCT00272779|565525877|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
156665875|NCT00272779|565525878|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
156665876|NCT00272779|565525877|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
156665877|NCT00272779|565525878|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
156665878|NCT00272779|565525877|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
156665879|NCT00272779|565525878|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
156665880|NCT00272779|565525877|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
156665881|NCT00272779|565525878|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
156665882|NCT00272779|565525877|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
156665883|NCT00272779|565525878|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
156665884|NCT00272779|565525877|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
156776937|NCT00315445|565933557|FG001|Overall Study|Lost to Follow-up|0|||
156776938|NCT00315445|565933558|FG002|Overall Study|Lost to Follow-up|1|||
156776939|NCT00315445|565933556|FG000|Overall Study|Protocol Violation|2|||
156776940|NCT00315445|565933557|FG001|Overall Study|Protocol Violation|0|||
156776941|NCT00315445|565933558|FG002|Overall Study|Protocol Violation|1|||
156776942|NCT00315445|565933556|FG000|Overall Study|Other|1|||
156776943|NCT00315445|565933557|FG001|Overall Study|Other|3|||
156776944|NCT00315445|565933558|FG002|Overall Study|Other|0|||
156776945|NCT03980223|565933559|FG000|Overall Study|Lost to Follow-up|3|||
156776946|NCT03980223|565933560|FG001|Overall Study|Lost to Follow-up|7|||
156776947|NCT03980223|565933561|FG002|Overall Study|Lost to Follow-up|10|||
156776948|NCT03980223|565933562|FG003|Overall Study|Lost to Follow-up|8|||
156776949|NCT03980223|565933559|FG000|Overall Study|Withdrawal by Subject|0|||
156776950|NCT03980223|565933560|FG001|Overall Study|Withdrawal by Subject|0|||
156776951|NCT03980223|565933561|FG002|Overall Study|Withdrawal by Subject|1|||
156776952|NCT03980223|565933562|FG003|Overall Study|Withdrawal by Subject|2|||
156776953|NCT03980223|565933559|FG000|Overall Study|Physician Decision|0|||
156776954|NCT03980223|565933560|FG001|Overall Study|Physician Decision|0|||
156776955|NCT03980223|565933561|FG002|Overall Study|Physician Decision|1|||
156776956|NCT03980223|565933562|FG003|Overall Study|Physician Decision|0|||
156776957|NCT03980223|565933559|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
156776958|NCT03980223|565933560|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
156776959|NCT03980223|565933561|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
156776960|NCT03980223|565933562|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
156776961|NCT02460289|565933566|FG000|Overall Study|Adverse Event|1|||
156776962|NCT02460289|565933566|FG000|Overall Study|Withdrawal by Subject|8|||
156776963|NCT02460289|565933566|FG000|Overall Study|Lost to Follow-up|1|||
156776964|NCT01977846|565933567|FG000|Total Study - Prospective|Death|0|||
156665885|NCT00272779|565525878|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
156665886|NCT00272779|565525877|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
156665887|NCT00272779|565525878|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
156776965|NCT01977846|565933568|FG001|Total Study - Prospective|Death|1|||
156665888|NCT00272779|565525877|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
156665889|NCT00272779|565525878|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
156665890|NCT00272779|565525877|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
156665891|NCT00272779|565525878|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
156665892|NCT00272779|565525877|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
156665893|NCT00272779|565525878|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
156665894|NCT00272779|565525877|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
156665895|NCT00272779|565525878|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
156665896|NCT00272779|565525877|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
156665897|NCT00272779|565525878|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
156665898|NCT00272779|565525877|FG000|Baseline Through Week 48|Continuing treatment|385|||
156665899|NCT00272779|565525878|FG001|Baseline Through Week 48|Continuing treatment|368|||
156665900|NCT00272779|565525877|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
156665901|NCT00272779|565525878|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
156665902|NCT00272779|565525877|FG000|Baseline Through Week 48|Never treated|2|||
156665903|NCT00272779|565525878|FG001|Baseline Through Week 48|Never treated|3|||
156665904|NCT00272779|565525877|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
156665905|NCT00272779|565525878|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
156665906|NCT00272779|565525877|FG000|Baseline Through Week 96|Death before Week 96|6|||
156665907|NCT00272779|565525878|FG001|Baseline Through Week 96|Death before Week 96|5|||
156665908|NCT00272779|565525877|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
156665909|NCT00272779|565525878|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
156665910|NCT00272779|565525877|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
156665911|NCT00272779|565525878|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
156665912|NCT00272779|565525877|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
156665913|NCT00272779|565525878|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
156665914|NCT00272779|565525877|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
156665915|NCT00272779|565525878|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
156665916|NCT00272779|565525877|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
156665917|NCT00272779|565525878|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
156665918|NCT00272779|565525877|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
156665919|NCT00272779|565525878|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
156665920|NCT00272779|565525877|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
156665921|NCT00272779|565525878|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
156665922|NCT00272779|565525877|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
156665923|NCT00272779|565525878|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
156665924|NCT00272779|565525877|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
156665925|NCT00272779|565525878|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
156665926|NCT00272779|565525877|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
156665927|NCT00272779|565525878|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
156665928|NCT00272779|565525877|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
156665929|NCT00272779|565525878|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
156665930|NCT00272779|565525877|FG000|Baseline Through Week 96|Never treated|2|||
156665931|NCT00272779|565525878|FG001|Baseline Through Week 96|Never treated|3|||
156665932|NCT00272779|565525877|FG000|Baseline Through Week 96|Continuing on treatment|61|||
156665933|NCT00272779|565525878|FG001|Baseline Through Week 96|Continuing on treatment|38|||
156665934|NCT02440711|565525879|FG000|Second Intervention|Lost to Follow-up|1|||
156665935|NCT02440711|565525880|FG001|Second Intervention|Lost to Follow-up|0|||
156665936|NCT03450057|565525885|FG000|Overall Study|Death|17|||
156776966|NCT01977846|565933567|FG000|Total Study - Prospective|Lost to Follow-up|0|||
156776967|NCT01977846|565933568|FG001|Total Study - Prospective|Lost to Follow-up|8|||
156776968|NCT01977846|565933567|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
156776969|NCT01977846|565933568|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
156776970|NCT01977846|565933567|FG000|Total Study - Prospective|Not available at time of visit|0|||
156325207|NCT03533686|564290896|FG004|Overall Study|Withdrawal by Subject|5|||
156325208|NCT03533686|564290897|FG005|Overall Study|Withdrawal by Subject|1|||
156325209|NCT03533686|564290892|FG000|Overall Study|Lost to Follow-up|0|||
156325210|NCT03533686|564290893|FG001|Overall Study|Lost to Follow-up|1|||
156325211|NCT03533686|564290894|FG002|Overall Study|Lost to Follow-up|0|||
156325212|NCT03533686|564290895|FG003|Overall Study|Lost to Follow-up|0|||
156325213|NCT03533686|564290896|FG004|Overall Study|Lost to Follow-up|2|||
156325214|NCT03533686|564290897|FG005|Overall Study|Lost to Follow-up|0|||
156325215|NCT03533686|564290892|FG000|Overall Study|Screen Failure|0|||
156776971|NCT01977846|565933568|FG001|Total Study - Prospective|Not available at time of visit|5|||
156325216|NCT03533686|564290893|FG001|Overall Study|Screen Failure|0|||
156325217|NCT03533686|564290894|FG002|Overall Study|Screen Failure|0|||
156325218|NCT03533686|564290895|FG003|Overall Study|Screen Failure|2|||
156325219|NCT03533686|564290896|FG004|Overall Study|Screen Failure|0|||
156325220|NCT03533686|564290897|FG005|Overall Study|Screen Failure|0|||
156665937|NCT03450057|565525885|FG000|Overall Study|ICF withdrawal|4|||
156665938|NCT03450057|565525885|FG000|Overall Study|Lost to Follow-up|2|||
156665939|NCT04129346|565525886|FG000|Overall Study|Death|1|||
156665940|NCT04129346|565525887|FG001|Overall Study|Death|0|||
156665941|NCT05755282|565525888|FG000|Overall Study|Protocol Violation|0|||
156665942|NCT05755282|565525889|FG001|Overall Study|Protocol Violation|1|||
156665943|NCT00573066|565525890|FG000|Overall Study|Exclusion criteria|18|||
156665944|NCT00573066|565525890|FG000|Overall Study|IV malfunction|1|||
156665945|NCT00573066|565525890|FG000|Overall Study|Postoperative bleeding|1|||
156665946|NCT00829790|565525894|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
156665947|NCT00829790|565525895|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
156665948|NCT02246166|565525896|FG000|Overall Study|Protocol Violation|1|||
156665949|NCT02246166|565525897|FG001|Overall Study|Protocol Violation|0|||
156665950|NCT00834743|565525898|FG000|Second Intervention|Withdrawal by Subject|1|||
156665951|NCT00834743|565525899|FG001|Second Intervention|Withdrawal by Subject|0|||
156665952|NCT01693523|565525902|FG000|Overall Study|Adverse Event|2|||
156665953|NCT01693523|565525903|FG001|Overall Study|Adverse Event|1|||
156665954|NCT01693523|565525904|FG002|Overall Study|Adverse Event|0|||
156665955|NCT01693523|565525902|FG000|Overall Study|Death|0|||
156665956|NCT01693523|565525903|FG001|Overall Study|Death|1|||
156665957|NCT01693523|565525904|FG002|Overall Study|Death|1|||
156665958|NCT01693523|565525902|FG000|Overall Study|Lost to Follow-up|0|||
156665959|NCT01693523|565525903|FG001|Overall Study|Lost to Follow-up|0|||
156665960|NCT01693523|565525904|FG002|Overall Study|Lost to Follow-up|4|||
156665961|NCT01693523|565525902|FG000|Overall Study|Physician Decision|0|||
156665962|NCT01693523|565525903|FG001|Overall Study|Physician Decision|0|||
156665963|NCT01693523|565525904|FG002|Overall Study|Physician Decision|1|||
156665964|NCT01693523|565525902|FG000|Overall Study|Withdrawal by Subject|1|||
156665965|NCT01693523|565525903|FG001|Overall Study|Withdrawal by Subject|2|||
156665966|NCT01693523|565525904|FG002|Overall Study|Withdrawal by Subject|2|||
156665967|NCT01693523|565525902|FG000|Overall Study|Lack of compliance study medication|1|||
156665968|NCT01693523|565525903|FG001|Overall Study|Lack of compliance study medication|2|||
156665969|NCT01693523|565525904|FG002|Overall Study|Lack of compliance study medication|0|||
156665970|NCT01693523|565525902|FG000|Overall Study|Chemotherapy was held|1|||
156665971|NCT01693523|565525903|FG001|Overall Study|Chemotherapy was held|2|||
156665972|NCT01693523|565525904|FG002|Overall Study|Chemotherapy was held|0|||
156665973|NCT02924883|565525907|FG000|Overall Study|Death|39|||
156665974|NCT02924883|565525908|FG001|Overall Study|Death|20|||
156665975|NCT02924883|565525907|FG000|Overall Study|Lost to Follow-up|1|||
156665976|NCT02924883|565525908|FG001|Overall Study|Lost to Follow-up|0|||
156665977|NCT02924883|565525907|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
156665978|NCT02924883|565525908|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
156665979|NCT02924883|565525907|FG000|Overall Study|Protocol Violation|1|||
156776972|NCT01977846|565933567|FG000|Total Study - Prospective|No show|0|||
156325221|NCT02273739|564290898|FG000|Overall Study|Progression of Disease|3|||
156325222|NCT02273739|564290899|FG001|Overall Study|Progression of Disease|4|||
156325223|NCT02273739|564290900|FG002|Overall Study|Progression of Disease|5|||
156325224|NCT02273739|564290901|FG003|Overall Study|Progression of Disease|2|||
156325225|NCT02273739|564290898|FG000|Overall Study|Death|0|||
156325226|NCT02273739|564290899|FG001|Overall Study|Death|0|||
156325227|NCT02273739|564290900|FG002|Overall Study|Death|0|||
156325228|NCT02273739|564290901|FG003|Overall Study|Death|2|||
156325229|NCT02273739|564290898|FG000|Overall Study|Adverse Event|0|||
156325230|NCT02273739|564290899|FG001|Overall Study|Adverse Event|0|||
156325231|NCT02273739|564290900|FG002|Overall Study|Adverse Event|0|||
156325232|NCT02273739|564290901|FG003|Overall Study|Adverse Event|1|||
156325233|NCT02273739|564290898|FG000|Overall Study|Withdrawal by Subject|0|||
156325234|NCT02273739|564290899|FG001|Overall Study|Withdrawal by Subject|0|||
156325235|NCT02273739|564290900|FG002|Overall Study|Withdrawal by Subject|2|||
156325236|NCT02273739|564290901|FG003|Overall Study|Withdrawal by Subject|1|||
156325237|NCT02273739|564290898|FG000|Overall Study|Physician Decision|0|||
156325238|NCT02273739|564290899|FG001|Overall Study|Physician Decision|0|||
156665980|NCT02924883|565525908|FG001|Overall Study|Protocol Violation|0|||
156665981|NCT02924883|565525907|FG000|Overall Study|Withdrawal by Subject|22|||
156665982|NCT02924883|565525908|FG001|Overall Study|Withdrawal by Subject|16|||
156665983|NCT02924883|565525907|FG000|Overall Study|Progressive Disease|1|||
156665984|NCT02924883|565525908|FG001|Overall Study|Progressive Disease|0|||
156665985|NCT02924883|565525907|FG000|Overall Study|Study Terminated by Sponsor|69|||
156325239|NCT02273739|564290900|FG002|Overall Study|Physician Decision|0|||
156325240|NCT02273739|564290901|FG003|Overall Study|Physician Decision|1|||
156325241|NCT02017171|564290903|FG000|Overall Study|Death|10|||
156665986|NCT02924883|565525908|FG001|Overall Study|Study Terminated by Sponsor|32|||
156665987|NCT00004562|565525909|FG000|Overall Study|Lost to Follow-up|102|||
156665988|NCT00004562|565525910|FG001|Overall Study|Lost to Follow-up|91|||
156665989|NCT02331394|565525911|FG000|Overall Study|Disease progression|1|||
156325242|NCT02017171|564290904|FG001|Overall Study|Death|4|||
156325243|NCT02017171|564290903|FG000|Overall Study|Withdrawal by Subject|23|||
156665990|NCT04247282|565525912|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
156776973|NCT01977846|565933568|FG001|Total Study - Prospective|No show|1|||
156524622|NCT00824161|565015652|FG000|Overall Study|Withdrawal by Subject|1|||
156524623|NCT00824161|565015652|FG000|Overall Study|Screen Failure|1|||
156524624|NCT01122862|565015653|FG000|Period 1|Protocol Violation|0|||
156524625|NCT01122862|565015654|FG001|Period 1|Protocol Violation|1|||
156524626|NCT01122862|565015655|FG002|Period 1|Protocol Violation|0|||
156524627|NCT01122862|565015653|FG000|Period 2|Adverse Event|0|||
156524628|NCT01122862|565015654|FG001|Period 2|Adverse Event|0|||
156524629|NCT01122862|565015655|FG002|Period 2|Adverse Event|1|||
156524630|NCT02070588|565015661|FG000|Overall Study|Withdrawal by Subject|29|||
156524631|NCT02070588|565015662|FG001|Overall Study|Withdrawal by Subject|1|||
156524632|NCT02070588|565015663|FG002|Overall Study|Withdrawal by Subject|0|||
156524633|NCT02070588|565015661|FG000|Overall Study|Writhdrawal due to early termination|9|||
156524634|NCT02070588|565015662|FG001|Overall Study|Writhdrawal due to early termination|0|||
156524635|NCT02070588|565015663|FG002|Overall Study|Writhdrawal due to early termination|0|||
156524636|NCT02070588|565015661|FG000|Overall Study|Adverse Event|1|||
156524637|NCT02070588|565015662|FG001|Overall Study|Adverse Event|0|||
156524638|NCT02070588|565015663|FG002|Overall Study|Adverse Event|0|||
156524639|NCT01790126|565015664|FG000|Overall Study|PSA Progression|12|||
156524640|NCT01790126|565015665|FG001|Overall Study|PSA Progression|16|||
156524641|NCT01790126|565015666|FG002|Overall Study|PSA Progression|16|||
156524642|NCT01790126|565015664|FG000|Overall Study|Other|5|||
156524643|NCT01790126|565015665|FG001|Overall Study|Other|4|||
156524644|NCT01790126|565015666|FG002|Overall Study|Other|8|||
156524645|NCT01790126|565015664|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
156524646|NCT01790126|565015665|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
156524647|NCT01790126|565015666|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
156524648|NCT01790126|565015664|FG000|Overall Study|Withdrawal by Physician|1|||
156524649|NCT01790126|565015665|FG001|Overall Study|Withdrawal by Physician|1|||
156524650|NCT01790126|565015666|FG002|Overall Study|Withdrawal by Physician|2|||
156524651|NCT01790126|565015664|FG000|Overall Study|Withdrawal by Subject|3|||
156524652|NCT01790126|565015665|FG001|Overall Study|Withdrawal by Subject|1|||
156524653|NCT01790126|565015666|FG002|Overall Study|Withdrawal by Subject|2|||
156524654|NCT01790126|565015664|FG000|Overall Study|Lost to Follow-up|1|||
156524655|NCT01790126|565015665|FG001|Overall Study|Lost to Follow-up|0|||
156524656|NCT01790126|565015666|FG002|Overall Study|Lost to Follow-up|1|||
156524657|NCT01790126|565015664|FG000|Overall Study|Adverse Event|0|||
156524658|NCT01790126|565015665|FG001|Overall Study|Adverse Event|2|||
156524659|NCT01790126|565015666|FG002|Overall Study|Adverse Event|0|||
156524660|NCT01790126|565015664|FG000|Overall Study|Death|2|||
156524661|NCT01790126|565015665|FG001|Overall Study|Death|0|||
156524662|NCT01790126|565015666|FG002|Overall Study|Death|0|||
156524663|NCT01790126|565015664|FG000|Overall Study|Radiographic Progression|3|||
156524664|NCT01790126|565015665|FG001|Overall Study|Radiographic Progression|1|||
156524665|NCT01790126|565015666|FG002|Overall Study|Radiographic Progression|0|||
156524666|NCT00819390|565015668|FG000|Overall Study|Lost to Follow-up|1|||
156524667|NCT00819390|565015669|FG001|Overall Study|Lost to Follow-up|1|||
156325244|NCT02017171|564290904|FG001|Overall Study|Withdrawal by Subject|17|||
156325245|NCT02017171|564290903|FG000|Overall Study|Lost to Follow-up|21|||
156325246|NCT02017171|564290904|FG001|Overall Study|Lost to Follow-up|20|||
156325247|NCT02017171|564290903|FG000|Overall Study|ESKD|6|||
156325248|NCT02017171|564290904|FG001|Overall Study|ESKD|2|||
156325249|NCT02017171|564290903|FG000|Overall Study|Miscellaneous|2|||
156325250|NCT02017171|564290904|FG001|Overall Study|Miscellaneous|3|||
156325251|NCT03309046|564290905|FG000|Overall Study|Withdrawal by Subject|4|||
156325252|NCT03309046|564290906|FG001|Overall Study|Withdrawal by Subject|17|||
156325253|NCT00237185|564290910|FG000|Core|Adverse Event|3|||
156325254|NCT00237185|564290911|FG001|Core|Adverse Event|4|||
156325255|NCT00237185|564290910|FG000|Core|Abnormal laboratory value|0|||
156325256|NCT00237185|564290911|FG001|Core|Abnormal laboratory value|4|||
156325257|NCT00237185|564290910|FG000|Core|Abnormal test procedure results|1|||
156325258|NCT00237185|564290911|FG001|Core|Abnormal test procedure results|0|||
156325259|NCT00237185|564290910|FG000|Core|Lack of Efficacy|30|||
156325260|NCT00237185|564290911|FG001|Core|Lack of Efficacy|23|||
156325261|NCT00237185|564290910|FG000|Core|Protocol Violation|1|||
156325262|NCT00237185|564290911|FG001|Core|Protocol Violation|1|||
156325263|NCT00237185|564290910|FG000|Core|Withdrawal by Subject|4|||
156325264|NCT00237185|564290911|FG001|Core|Withdrawal by Subject|4|||
156325265|NCT00237185|564290910|FG000|Core|Administrative problems|0|||
156325266|NCT00237185|564290911|FG001|Core|Administrative problems|1|||
156325267|NCT00237185|564290910|FG000|Core|Death|4|||
156325268|NCT00237185|564290911|FG001|Core|Death|0|||
156325269|NCT00237185|564290910|FG000|Core|Determined ineligible post randomization|1|||
156325270|NCT00237185|564290911|FG001|Core|Determined ineligible post randomization|0|||
156325271|NCT00237185|564290910|FG000|Extension|Adverse Event|1|||
156325272|NCT00237185|564290911|FG001|Extension|Adverse Event|0|||
156325273|NCT00237185|564290910|FG000|Extension|Abnormal laboratory value|0|||
156325274|NCT00237185|564290911|FG001|Extension|Abnormal laboratory value|1|||
156325275|NCT00237185|564290910|FG000|Extension|Lack of Efficacy|9|||
156524668|NCT00819390|565015670|FG002|Overall Study|Lost to Follow-up|0|||
156524669|NCT00819390|565015671|FG003|Overall Study|Lost to Follow-up|0|||
156665991|NCT04247282|565525913|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
156665992|NCT04247282|565525914|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
156665993|NCT04247282|565525915|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
156665994|NCT04247282|565525912|FG000|Overall Study|Refused further treatment|0|||
156665995|NCT04247282|565525913|FG001|Overall Study|Refused further treatment|1|||
156665996|NCT04247282|565525914|FG002|Overall Study|Refused further treatment|0|||
156665997|NCT04247282|565525915|FG003|Overall Study|Refused further treatment|0|||
156665998|NCT02865850|565525916|FG000|Overall Study|Death|15|||
156665999|NCT02865850|565525917|FG001|Overall Study|Death|19|||
156666000|NCT02865850|565525916|FG000|Overall Study|Withdrawal by Subject|3|||
156666001|NCT02865850|565525917|FG001|Overall Study|Withdrawal by Subject|2|||
156666002|NCT02865850|565525916|FG000|Overall Study|Lost to Follow-up|3|||
156666003|NCT02865850|565525917|FG001|Overall Study|Lost to Follow-up|2|||
156666004|NCT00552669|565525918|FG000|Overall Study|Death|3|||
156666005|NCT00552669|565525919|FG001|Overall Study|Death|7|||
156666006|NCT03195491|565525921|FG000|Overall Study|Study drug toxicity|25|||
156666007|NCT03195491|565525922|FG001|Overall Study|Study drug toxicity|3|||
156666008|NCT03195491|565525921|FG000|Overall Study|Maximum clinical benefit|5|||
156666009|NCT03195491|565525922|FG001|Overall Study|Maximum clinical benefit|0|||
156666010|NCT03195491|565525921|FG000|Overall Study|Lost to Follow-up|1|||
156666011|NCT03195491|565525922|FG001|Overall Study|Lost to Follow-up|0|||
156666012|NCT03195491|565525921|FG000|Overall Study|Death|3|||
156666013|NCT03195491|565525922|FG001|Overall Study|Death|0|||
156666014|NCT03195491|565525921|FG000|Overall Study|Adverse event unrelated to study drug|19|||
156666015|NCT03195491|565525922|FG001|Overall Study|Adverse event unrelated to study drug|2|||
156666016|NCT03195491|565525921|FG000|Overall Study|Disease progression|266|||
156666017|NCT03195491|565525922|FG001|Overall Study|Disease progression|8|||
156666018|NCT03195491|565525921|FG000|Overall Study|Other reasons|10|||
156666019|NCT03195491|565525922|FG001|Overall Study|Other reasons|0|||
156666020|NCT03195491|565525921|FG000|Overall Study|Participant withdrew consent|8|||
156666021|NCT03195491|565525922|FG001|Overall Study|Participant withdrew consent|1|||
156666022|NCT03195491|565525921|FG000|Overall Study|Participant no longer meets study criteria|0|||
156666023|NCT03195491|565525922|FG001|Overall Study|Participant no longer meets study criteria|1|||
156666024|NCT03195491|565525921|FG000|Overall Study|Participant request to discontinue study treatment|10|||
156666025|NCT03195491|565525922|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156666026|NCT02459951|565525923|FG000|Overall Study|Unable to meet holding requirement|1|||
156666027|NCT00252720|565525926|FG000|Overall Study|Withdrawal by Subject|95|||
156666028|NCT00252720|565525927|FG001|Overall Study|Withdrawal by Subject|97|||
156666029|NCT00252720|565525926|FG000|Overall Study|Death|7|||
156666030|NCT00252720|565525927|FG001|Overall Study|Death|8|||
156666031|NCT00252720|565525926|FG000|Overall Study|Moving|23|||
156666032|NCT00252720|565525927|FG001|Overall Study|Moving|42|||
156666033|NCT00252720|565525926|FG000|Overall Study|Mainly patients lost to follow-up|7|||
156666034|NCT00252720|565525927|FG001|Overall Study|Mainly patients lost to follow-up|18|||
156666035|NCT02481830|565525930|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
156666036|NCT02481830|565525931|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
156666037|NCT02481830|565525930|FG000|Pre-treatment|Withdrawal by Subject|0|||
156666038|NCT02481830|565525931|FG001|Pre-treatment|Withdrawal by Subject|10|||
156666039|NCT02481830|565525930|FG000|Pre-treatment|Disease Progression|1|||
156666040|NCT02481830|565525931|FG001|Pre-treatment|Disease Progression|1|||
156666041|NCT02481830|565525930|FG000|Pre-treatment|Other reasons|0|||
156666042|NCT02481830|565525931|FG001|Pre-treatment|Other reasons|1|||
156666043|NCT02481830|565525930|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
156666044|NCT02481830|565525931|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
156666045|NCT02481830|565525930|FG000|Treatment|Disease Progression|233|||
156666046|NCT02481830|565525931|FG001|Treatment|Disease Progression|171|||
156666047|NCT02481830|565525930|FG000|Treatment|Study drug toxicity|18|||
156666048|NCT02481830|565525931|FG001|Treatment|Study drug toxicity|38|||
156666049|NCT02481830|565525930|FG000|Treatment|Death|1|||
156325276|NCT00237185|564290911|FG001|Extension|Lack of Efficacy|14|||
156325277|NCT00237185|564290910|FG000|Extension|Condition no longer required study drug|0|||
156325278|NCT00237185|564290911|FG001|Extension|Condition no longer required study drug|1|||
156325279|NCT00237185|564290910|FG000|Extension|Withdrawal by Subject|3|||
156325280|NCT00237185|564290911|FG001|Extension|Withdrawal by Subject|2|||
156666050|NCT02481830|565525931|FG001|Treatment|Death|1|||
156666051|NCT02481830|565525930|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
156666052|NCT02481830|565525931|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
156666053|NCT02481830|565525930|FG000|Treatment|Participants request to discontinue Study treatment|6|||
156666054|NCT02481830|565525931|FG001|Treatment|Participants request to discontinue Study treatment|34|||
156666055|NCT02481830|565525930|FG000|Treatment|Withdrawal by Subject|2|||
156666056|NCT02481830|565525931|FG001|Treatment|Withdrawal by Subject|3|||
156325281|NCT00237185|564290910|FG000|Extension|Lost to Follow-up|1|||
156666057|NCT02481830|565525930|FG000|Treatment|Lost to Follow-up|1|||
156666058|NCT02481830|565525931|FG001|Treatment|Lost to Follow-up|0|||
156666059|NCT02481830|565525930|FG000|Treatment|Maximum Clinical Benefit|0|||
156666060|NCT02481830|565525931|FG001|Treatment|Maximum Clinical Benefit|5|||
156666061|NCT02481830|565525930|FG000|Treatment|Administrative reason by sponsor|1|||
156666062|NCT02481830|565525931|FG001|Treatment|Administrative reason by sponsor|1|||
156666063|NCT02481830|565525930|FG000|Treatment|Other reasons|6|||
156666064|NCT02481830|565525931|FG001|Treatment|Other reasons|1|||
156666065|NCT00772941|565525932|FG000|Overall Study|CRFs not available|195|||
156666066|NCT00772941|565525932|FG000|Overall Study|Study not completed|16|||
156666067|NCT00772941|565525932|FG000|Overall Study|Missed Visits|374|||
156666068|NCT00772941|565525932|FG000|Overall Study|Poor Compliance|7|||
156666069|NCT00772941|565525932|FG000|Overall Study|GPSP Violation|90|||
156666070|NCT01745120|565525942|FG000|Overall Study|Investigator decision|1|||
156666071|NCT01745120|565525943|FG001|Overall Study|Investigator decision|0|||
156666072|NCT03956862|565525944|FG000|Overall Study|Lost to Follow-up|1|||
156666073|NCT03956862|565525945|FG001|Overall Study|Lost to Follow-up|1|||
156666074|NCT03956862|565525944|FG000|Overall Study|Withdrawal by Subject|1|||
156666075|NCT03956862|565525945|FG001|Overall Study|Withdrawal by Subject|1|||
156666076|NCT02714062|565525946|FG000|Overall Study|Adverse Event|0|||
156666077|NCT02714062|565525947|FG001|Overall Study|Adverse Event|0|||
156666078|NCT02714062|565525948|FG002|Overall Study|Adverse Event|2|||
156666079|NCT02714062|565525946|FG000|Overall Study|Withdrawal by Subject|1|||
156666080|NCT02714062|565525947|FG001|Overall Study|Withdrawal by Subject|0|||
156666081|NCT02714062|565525948|FG002|Overall Study|Withdrawal by Subject|1|||
156666082|NCT02714062|565525946|FG000|Overall Study|Protocol Violation|0|||
156666083|NCT02714062|565525947|FG001|Overall Study|Protocol Violation|1|||
156666084|NCT02714062|565525948|FG002|Overall Study|Protocol Violation|0|||
156666085|NCT02294604|565525949|FG000|Overall Study|Did not provide samples for culture|0|||
156666086|NCT02294604|565525950|FG001|Overall Study|Did not provide samples for culture|1|||
156666087|NCT02294604|565525951|FG002|Overall Study|Did not provide samples for culture|0|||
156666088|NCT02294604|565525949|FG000|Overall Study|Culture contamination|1|||
156666089|NCT02294604|565525950|FG001|Overall Study|Culture contamination|2|||
156666090|NCT02294604|565525951|FG002|Overall Study|Culture contamination|0|||
156666091|NCT01417078|565525966|FG000|Overall Study|Withdrawal by Subject|1|||
156666092|NCT02392000|565525969|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
156666093|NCT02392000|565525969|FG000|Overall Study|Withdrawal by Subject|1|||
156666094|NCT02392000|565525969|FG000|Overall Study|Lost to Follow-up|8|||
156666095|NCT00389064|565525975|FG000|Overall Study|Adverse Event|11|||
156666096|NCT00389064|565525976|FG001|Overall Study|Adverse Event|3|||
156666097|NCT00389064|565525975|FG000|Overall Study|Lack of Efficacy|3|||
156666098|NCT00389064|565525976|FG001|Overall Study|Lack of Efficacy|14|||
156666099|NCT00389064|565525975|FG000|Overall Study|Withdrawal by Subject|17|||
156666100|NCT00389064|565525976|FG001|Overall Study|Withdrawal by Subject|27|||
156666101|NCT00389064|565525975|FG000|Overall Study|Physician Decision|2|||
156666102|NCT00389064|565525976|FG001|Overall Study|Physician Decision|2|||
156666103|NCT00389064|565525975|FG000|Overall Study|Lost to Follow-up|1|||
156666104|NCT00389064|565525976|FG001|Overall Study|Lost to Follow-up|2|||
156666105|NCT00389064|565525975|FG000|Overall Study|Protocol Violation|2|||
156666106|NCT00389064|565525976|FG001|Overall Study|Protocol Violation|0|||
156666107|NCT00389064|565525975|FG000|Overall Study|Multiple Reasons|9|||
156666108|NCT00389064|565525976|FG001|Overall Study|Multiple Reasons|11|||
156666109|NCT05472038|565527469|FG000|Overall Study|Adverse Event|0|||
156666110|NCT05472038|565527470|FG001|Overall Study|Adverse Event|0|||
156666111|NCT05472038|565527471|FG002|Overall Study|Adverse Event|1|||
156666112|NCT05472038|565527472|FG003|Overall Study|Adverse Event|0|||
156666113|NCT05472038|565527473|FG004|Overall Study|Adverse Event|0|||
156666114|NCT05472038|565527474|FG005|Overall Study|Adverse Event|0|||
156666115|NCT05472038|565527475|FG006|Overall Study|Adverse Event|0|||
156666116|NCT05472038|565527476|FG007|Overall Study|Adverse Event|0|||
156666117|NCT05472038|565527477|FG008|Overall Study|Adverse Event|0|||
156666118|NCT05472038|565527478|FG009|Overall Study|Adverse Event|0|||
156666119|NCT05472038|565527479|FG010|Overall Study|Adverse Event|0|||
156666120|NCT05472038|565527480|FG011|Overall Study|Adverse Event|0|||
156666121|NCT05472038|565527469|FG000|Overall Study|Death|0|||
156666122|NCT05472038|565527470|FG001|Overall Study|Death|0|||
156666123|NCT05472038|565527471|FG002|Overall Study|Death|0|||
156666124|NCT05472038|565527472|FG003|Overall Study|Death|0|||
156666125|NCT05472038|565527473|FG004|Overall Study|Death|0|||
156666126|NCT05472038|565527474|FG005|Overall Study|Death|1|||
156666127|NCT05472038|565527475|FG006|Overall Study|Death|0|||
156776974|NCT01977846|565933567|FG000|Total Study - Prospective|Protocol Violation|0|||
156776975|NCT01977846|565933568|FG001|Total Study - Prospective|Protocol Violation|1|||
156666128|NCT05472038|565527476|FG007|Overall Study|Death|0|||
156666129|NCT05472038|565527477|FG008|Overall Study|Death|0|||
156666130|NCT05472038|565527478|FG009|Overall Study|Death|0|||
156666131|NCT05472038|565527479|FG010|Overall Study|Death|0|||
156666132|NCT05472038|565527480|FG011|Overall Study|Death|0|||
156666133|NCT05472038|565527469|FG000|Overall Study|Lost to Follow-up|1|||
156666134|NCT05472038|565527470|FG001|Overall Study|Lost to Follow-up|3|||
156666135|NCT05472038|565527471|FG002|Overall Study|Lost to Follow-up|3|||
156666136|NCT05472038|565527472|FG003|Overall Study|Lost to Follow-up|9|||
156666137|NCT05472038|565527473|FG004|Overall Study|Lost to Follow-up|2|||
156666138|NCT05472038|565527474|FG005|Overall Study|Lost to Follow-up|2|||
156666139|NCT05472038|565527475|FG006|Overall Study|Lost to Follow-up|1|||
156666140|NCT05472038|565527476|FG007|Overall Study|Lost to Follow-up|0|||
156666141|NCT05472038|565527477|FG008|Overall Study|Lost to Follow-up|1|||
156666142|NCT05472038|565527478|FG009|Overall Study|Lost to Follow-up|0|||
156666143|NCT05472038|565527479|FG010|Overall Study|Lost to Follow-up|2|||
156666144|NCT05472038|565527480|FG011|Overall Study|Lost to Follow-up|1|||
156666145|NCT05472038|565527469|FG000|Overall Study|Physician Decision|0|||
156666146|NCT05472038|565527470|FG001|Overall Study|Physician Decision|0|||
156666147|NCT05472038|565527471|FG002|Overall Study|Physician Decision|0|||
156666148|NCT05472038|565527472|FG003|Overall Study|Physician Decision|0|||
156666149|NCT05472038|565527473|FG004|Overall Study|Physician Decision|1|||
156666150|NCT05472038|565527474|FG005|Overall Study|Physician Decision|0|||
156666151|NCT05472038|565527475|FG006|Overall Study|Physician Decision|0|||
156666152|NCT05472038|565527476|FG007|Overall Study|Physician Decision|0|||
156666153|NCT05472038|565527477|FG008|Overall Study|Physician Decision|0|||
156666154|NCT05472038|565527478|FG009|Overall Study|Physician Decision|0|||
156325282|NCT00237185|564290911|FG001|Extension|Lost to Follow-up|0|||
156325283|NCT00237185|564290910|FG000|Extension|Administrative problems|1|||
156325284|NCT00237185|564290911|FG001|Extension|Administrative problems|0|||
156325285|NCT00237185|564290910|FG000|Extension|Death|1|||
156325286|NCT00237185|564290911|FG001|Extension|Death|1|||
156666155|NCT05472038|565527479|FG010|Overall Study|Physician Decision|0|||
156666156|NCT05472038|565527480|FG011|Overall Study|Physician Decision|0|||
156666157|NCT05472038|565527469|FG000|Overall Study|Withdrawal by Subject|1|||
156666158|NCT05472038|565527470|FG001|Overall Study|Withdrawal by Subject|3|||
156666159|NCT05472038|565527471|FG002|Overall Study|Withdrawal by Subject|1|||
156666160|NCT05472038|565527472|FG003|Overall Study|Withdrawal by Subject|6|||
156666161|NCT05472038|565527473|FG004|Overall Study|Withdrawal by Subject|1|||
156666162|NCT05472038|565527474|FG005|Overall Study|Withdrawal by Subject|3|||
156666163|NCT05472038|565527475|FG006|Overall Study|Withdrawal by Subject|0|||
156666164|NCT05472038|565527476|FG007|Overall Study|Withdrawal by Subject|2|||
156666165|NCT05472038|565527477|FG008|Overall Study|Withdrawal by Subject|3|||
156666166|NCT05472038|565527478|FG009|Overall Study|Withdrawal by Subject|1|||
156666167|NCT05472038|565527479|FG010|Overall Study|Withdrawal by Subject|2|||
156666168|NCT05472038|565527480|FG011|Overall Study|Withdrawal by Subject|2|||
156666169|NCT05472038|565527469|FG000|Overall Study|Protocol Violation|0|||
156666170|NCT05472038|565527470|FG001|Overall Study|Protocol Violation|0|||
156666171|NCT05472038|565527471|FG002|Overall Study|Protocol Violation|0|||
156666172|NCT05472038|565527472|FG003|Overall Study|Protocol Violation|0|||
156666173|NCT05472038|565527473|FG004|Overall Study|Protocol Violation|0|||
156666174|NCT05472038|565527474|FG005|Overall Study|Protocol Violation|0|||
156666175|NCT05472038|565527475|FG006|Overall Study|Protocol Violation|0|||
156666176|NCT05472038|565527476|FG007|Overall Study|Protocol Violation|1|||
156666177|NCT05472038|565527477|FG008|Overall Study|Protocol Violation|1|||
156666178|NCT05472038|565527478|FG009|Overall Study|Protocol Violation|1|||
156666179|NCT05472038|565527479|FG010|Overall Study|Protocol Violation|1|||
156666180|NCT05472038|565527480|FG011|Overall Study|Protocol Violation|1|||
156666181|NCT05472038|565527469|FG000|Overall Study|Not vaccinated|0|||
156666182|NCT05472038|565527470|FG001|Overall Study|Not vaccinated|0|||
156666183|NCT05472038|565527471|FG002|Overall Study|Not vaccinated|0|||
156666184|NCT05472038|565527472|FG003|Overall Study|Not vaccinated|1|||
156666185|NCT05472038|565527473|FG004|Overall Study|Not vaccinated|0|||
156666186|NCT05472038|565527474|FG005|Overall Study|Not vaccinated|0|||
156666187|NCT05472038|565527475|FG006|Overall Study|Not vaccinated|0|||
156666188|NCT05472038|565527476|FG007|Overall Study|Not vaccinated|0|||
156666189|NCT05472038|565527477|FG008|Overall Study|Not vaccinated|0|||
156666190|NCT05472038|565527478|FG009|Overall Study|Not vaccinated|0|||
156666191|NCT05472038|565527479|FG010|Overall Study|Not vaccinated|0|||
156666192|NCT05472038|565527480|FG011|Overall Study|Not vaccinated|0|||
156666193|NCT02378935|565527483|FG000|Overall Study|Lack of Efficacy|10|||
156666194|NCT02378935|565527484|FG001|Overall Study|Lack of Efficacy|0|||
156666195|NCT02378935|565527485|FG002|Overall Study|Lack of Efficacy|2|||
156666196|NCT02378935|565527486|FG003|Overall Study|Lack of Efficacy|6|||
156666197|NCT02378935|565527487|FG004|Overall Study|Lack of Efficacy|0|||
156666198|NCT02378935|565527488|FG005|Overall Study|Lack of Efficacy|0|||
156666199|NCT02378935|565527489|FG006|Overall Study|Lack of Efficacy|0|||
156666200|NCT02378935|565527483|FG000|Overall Study|Death|0|||
156666201|NCT02378935|565527484|FG001|Overall Study|Death|0|||
156666202|NCT02378935|565527485|FG002|Overall Study|Death|1|||
156666203|NCT02378935|565527486|FG003|Overall Study|Death|0|||
156666204|NCT02378935|565527487|FG004|Overall Study|Death|0|||
156666205|NCT02378935|565527488|FG005|Overall Study|Death|0|||
156325287|NCT00910988|564290912|FG000|Overall Study|Lost to Follow-up|2|||
156666206|NCT02378935|565527489|FG006|Overall Study|Death|0|||
156666207|NCT03214952|565527492|FG000|Overall Study|Protocol Deviation|45|||
156666208|NCT03214952|565527492|FG000|Overall Study|Case Report Forms Uncollected|13|||
156666209|NCT03935880|565527493|FG000|Overall Study|Lost to Follow-up|0|||
156666210|NCT03935880|565527494|FG001|Overall Study|Lost to Follow-up|1|||
156666211|NCT02476994|565527495|FG000|Overall Study|Based on feedback from FDA|1|||
156666212|NCT02476994|565527496|FG001|Overall Study|Based on feedback from FDA|0|||
156776976|NCT01155570|565933569|FG000|Overall Study|Adverse Event|39|||
156776977|NCT01155570|565933569|FG000|Overall Study|Lack of Efficacy|46|||
156776978|NCT01155570|565933569|FG000|Overall Study|Participant's Economic Reasons|17|||
156776979|NCT01155570|565933569|FG000|Overall Study|No Hospital Visits|7|||
156776980|NCT01155570|565933569|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
156776981|NCT01155570|565933569|FG000|Overall Study|Adverse Event + Other Reasons|7|||
156776982|NCT01155570|565933569|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
156776983|NCT01155570|565933569|FG000|Overall Study|Other Reasons|23|||
156429992|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
156429993|NCT03536884|564663344|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156776984|NCT02916927|565933570|FG000|Overall Study|Discharged prior to study drug receipt|0|||
156776985|NCT02916927|565933571|FG001|Overall Study|Discharged prior to study drug receipt|2|||
156776986|NCT02916927|565933570|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
156776987|NCT02916927|565933571|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
156776988|NCT02916927|565933570|FG000|Overall Study|Withdrawal before first time point|1|||
156776989|NCT02916927|565933571|FG001|Overall Study|Withdrawal before first time point|0|||
156776990|NCT02774889|565933572|FG000|Overall Study|Lost to Follow-up|2|||
156776991|NCT02774889|565933573|FG001|Overall Study|Lost to Follow-up|1|||
156776992|NCT01047319|565933574|FG000|Overall Study|Teva requested participant withdrawal|3|||
156776993|NCT01047319|565933575|FG001|Overall Study|Teva requested participant withdrawal|0|||
156776994|NCT01047319|565933576|FG002|Overall Study|Teva requested participant withdrawal|1|||
156776995|NCT01047319|565933574|FG000|Overall Study|Protocol Violation|3|||
156776996|NCT01047319|565933575|FG001|Overall Study|Protocol Violation|2|||
156776997|NCT01047319|565933576|FG002|Overall Study|Protocol Violation|4|||
156776998|NCT01047319|565933574|FG000|Overall Study|Lack of Efficacy|4|||
156776999|NCT01047319|565933575|FG001|Overall Study|Lack of Efficacy|3|||
156777000|NCT01047319|565933576|FG002|Overall Study|Lack of Efficacy|3|||
156777001|NCT01047319|565933574|FG000|Overall Study|Death|5|||
156777002|NCT01047319|565933575|FG001|Overall Study|Death|1|||
156777003|NCT01047319|565933576|FG002|Overall Study|Death|5|||
156777004|NCT01047319|565933574|FG000|Overall Study|Pregnancy|13|||
156777005|NCT01047319|565933575|FG001|Overall Study|Pregnancy|8|||
156777006|NCT01047319|565933576|FG002|Overall Study|Pregnancy|8|||
156777007|NCT01047319|565933574|FG000|Overall Study|Physician Decision|12|||
156777008|NCT01047319|565933575|FG001|Overall Study|Physician Decision|9|||
156777009|NCT01047319|565933576|FG002|Overall Study|Physician Decision|10|||
156777010|NCT01047319|565933574|FG000|Overall Study|Lost to Follow-up|14|||
156777011|NCT01047319|565933575|FG001|Overall Study|Lost to Follow-up|10|||
156777012|NCT01047319|565933576|FG002|Overall Study|Lost to Follow-up|10|||
156777013|NCT01047319|565933574|FG000|Overall Study|Adverse Event|16|||
156777014|NCT01047319|565933575|FG001|Overall Study|Adverse Event|27|||
156777015|NCT01047319|565933576|FG002|Overall Study|Adverse Event|21|||
156777016|NCT01047319|565933574|FG000|Overall Study|Withdrawal by Subject|77|||
156777017|NCT01047319|565933575|FG001|Overall Study|Withdrawal by Subject|75|||
156777018|NCT01047319|565933576|FG002|Overall Study|Withdrawal by Subject|87|||
156777019|NCT01047319|565933574|FG000|Overall Study|Study terminated by Sponsor|198|||
156777020|NCT01047319|565933575|FG001|Overall Study|Study terminated by Sponsor|215|||
156777021|NCT01047319|565933576|FG002|Overall Study|Study terminated by Sponsor|203|||
156777022|NCT00770809|565935203|FG000|Overall Study|Adverse Event|9|||
156777023|NCT00770809|565935204|FG001|Overall Study|Adverse Event|1|||
156777024|NCT00770809|565935205|FG002|Overall Study|Adverse Event|12|||
156777025|NCT00770809|565935203|FG000|Overall Study|Death|1|||
156777026|NCT00770809|565935204|FG001|Overall Study|Death|0|||
156777027|NCT00770809|565935205|FG002|Overall Study|Death|0|||
156777028|NCT00770809|565935203|FG000|Overall Study|Withdrawal by Subject|3|||
156777029|NCT00770809|565935204|FG001|Overall Study|Withdrawal by Subject|3|||
156777030|NCT00770809|565935205|FG002|Overall Study|Withdrawal by Subject|7|||
156777031|NCT00770809|565935203|FG000|Overall Study|Progression|2|||
156777032|NCT00770809|565935204|FG001|Overall Study|Progression|2|||
156777033|NCT00770809|565935205|FG002|Overall Study|Progression|0|||
156777034|NCT00770809|565935203|FG000|Overall Study|Complicating illness|0|||
156777035|NCT00770809|565935204|FG001|Overall Study|Complicating illness|0|||
156777036|NCT00770809|565935205|FG002|Overall Study|Complicating illness|1|||
156777037|NCT00770809|565935203|FG000|Overall Study|Other Medical Reasons|2|||
156429994|NCT03536884|564663345|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156777038|NCT00770809|565935204|FG001|Overall Study|Other Medical Reasons|4|||
156777039|NCT00770809|565935205|FG002|Overall Study|Other Medical Reasons|3|||
156777040|NCT05028569|565935206|FG000|Double-Blind Phase|Death|0|||
156777041|NCT05028569|565935207|FG001|Double-Blind Phase|Death|0|||
156777042|NCT05028569|565935208|FG002|Double-Blind Phase|Death|0|||
156777043|NCT05028569|565935209|FG003|Double-Blind Phase|Death|1|||
156777044|NCT05028569|565935210|FG004|Double-Blind Phase|Death|0|||
156777045|NCT05028569|565935211|FG005|Double-Blind Phase|Death|0|||
156777046|NCT05028569|565935212|FG006|Double-Blind Phase|Death|0|||
156429995|NCT03536884|564663346|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156777047|NCT05028569|565935206|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156777048|NCT05028569|565935207|FG001|Double-Blind Phase|Lost to Follow-up|6|||
156777049|NCT05028569|565935208|FG002|Double-Blind Phase|Lost to Follow-up|3|||
156666213|NCT02563561|565527497|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
156666214|NCT02563561|565527498|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
156666215|NCT02563561|565527499|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
156666216|NCT02563561|565527497|FG000|Overall Study|Withdrew of Consent|1|||
156666217|NCT02563561|565527498|FG001|Overall Study|Withdrew of Consent|1|||
156666218|NCT02563561|565527499|FG002|Overall Study|Withdrew of Consent|2|||
156666219|NCT02563561|565527497|FG000|Overall Study|Lost to Follow-up|1|||
156666220|NCT02563561|565527498|FG001|Overall Study|Lost to Follow-up|1|||
156666221|NCT02563561|565527499|FG002|Overall Study|Lost to Follow-up|0|||
156666222|NCT02563561|565527497|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
156666223|NCT02563561|565527498|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
156666224|NCT02563561|565527499|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
156666225|NCT02563561|565527497|FG000|Overall Study|Investigator Decision|3|||
156666226|NCT02563561|565527498|FG001|Overall Study|Investigator Decision|4|||
156666227|NCT02563561|565527499|FG002|Overall Study|Investigator Decision|2|||
156666228|NCT02563561|565527497|FG000|Overall Study|Sponsor Decision|5|||
156666229|NCT02563561|565527498|FG001|Overall Study|Sponsor Decision|2|||
156666230|NCT02563561|565527499|FG002|Overall Study|Sponsor Decision|4|||
156666231|NCT02563561|565527497|FG000|Overall Study|Other|1|||
156666232|NCT02563561|565527498|FG001|Overall Study|Other|5|||
156666233|NCT02563561|565527499|FG002|Overall Study|Other|2|||
156666234|NCT03769896|565527500|FG000|Open-label Phase|Lack of Efficacy|5|||
156666235|NCT03769896|565527501|FG001|Open-label Phase|Lack of Efficacy|0|||
156666236|NCT03769896|565527500|FG000|Open-label Phase|Adverse Event|3|||
156666237|NCT03769896|565527501|FG001|Open-label Phase|Adverse Event|0|||
156666238|NCT03769896|565527500|FG000|Open-label Phase|Withdrawal by Subject|1|||
156666239|NCT03769896|565527501|FG001|Open-label Phase|Withdrawal by Subject|0|||
156666240|NCT01015703|565527502|FG000|Overall Study|Withdrawal by Subject|0|||
156666241|NCT01015703|565527503|FG001|Overall Study|Withdrawal by Subject|1|||
156666242|NCT01015703|565527504|FG002|Overall Study|Withdrawal by Subject|0|||
156666243|NCT01015703|565527505|FG003|Overall Study|Withdrawal by Subject|0|||
156666244|NCT01015703|565527506|FG004|Overall Study|Withdrawal by Subject|0|||
156666245|NCT01015703|565527502|FG000|Overall Study|Adverse Event|1|||
156666246|NCT01015703|565527503|FG001|Overall Study|Adverse Event|0|||
156666247|NCT01015703|565527504|FG002|Overall Study|Adverse Event|0|||
156666248|NCT01015703|565527505|FG003|Overall Study|Adverse Event|0|||
156666249|NCT01015703|565527506|FG004|Overall Study|Adverse Event|0|||
156666250|NCT01015703|565527502|FG000|Overall Study|Protocol Violation|1|||
156666251|NCT01015703|565527503|FG001|Overall Study|Protocol Violation|0|||
156666252|NCT01015703|565527504|FG002|Overall Study|Protocol Violation|0|||
156666253|NCT01015703|565527505|FG003|Overall Study|Protocol Violation|0|||
156666254|NCT01015703|565527506|FG004|Overall Study|Protocol Violation|0|||
156666255|NCT03122535|565527507|FG000|Overall Study|Lost to Follow-up|68|||
156666256|NCT03122535|565527508|FG001|Overall Study|Lost to Follow-up|68|||
156666257|NCT03122535|565527507|FG000|Overall Study|Physician Decision|3|||
156666258|NCT03122535|565527508|FG001|Overall Study|Physician Decision|3|||
156666259|NCT03122535|565527507|FG000|Overall Study|Withdrawal by Subject|2|||
156666260|NCT03122535|565527508|FG001|Overall Study|Withdrawal by Subject|2|||
156666261|NCT02646124|565527509|FG000|Overall Study|Lost to Follow-up|0|||
156666262|NCT02646124|565527510|FG001|Overall Study|Lost to Follow-up|2|||
156666263|NCT00467363|565527513|FG000|Overall Study|Lost to Follow-up|80|||
156666264|NCT00467363|565527514|FG001|Overall Study|Lost to Follow-up|70|||
156666265|NCT04533594|565527515|FG000|Overall Study|Death|26|||
156666266|NCT02017223|565527516|FG000|Overall Study|Algorithm problems|2|||
156666267|NCT01401647|565527517|FG000|Overall Study|Withdrawal by Subject|1|||
156666268|NCT01401647|565527518|FG001|Overall Study|Withdrawal by Subject|5|||
156666269|NCT01401647|565527519|FG002|Overall Study|Withdrawal by Subject|2|||
156666270|NCT01401647|565527517|FG000|Overall Study|Lost to Follow-up|3|||
156666271|NCT01401647|565527518|FG001|Overall Study|Lost to Follow-up|3|||
156666272|NCT01401647|565527519|FG002|Overall Study|Lost to Follow-up|1|||
156666273|NCT01675765|565527520|FG000|Overall Study|Progressive disease|4|||
156666274|NCT01675765|565527521|FG001|Overall Study|Progressive disease|4|||
156666275|NCT01675765|565527520|FG000|Overall Study|Adverse Event|1|||
156666276|NCT01675765|565527521|FG001|Overall Study|Adverse Event|2|||
156666277|NCT01675765|565527520|FG000|Overall Study|Withdrawal by Subject|2|||
156666278|NCT01675765|565527521|FG001|Overall Study|Withdrawal by Subject|0|||
156777050|NCT05028569|565935209|FG003|Double-Blind Phase|Lost to Follow-up|9|||
156777051|NCT05028569|565935210|FG004|Double-Blind Phase|Lost to Follow-up|0|||
156777052|NCT05028569|565935211|FG005|Double-Blind Phase|Lost to Follow-up|0|||
156666279|NCT01675765|565527520|FG000|Overall Study|Death|1|||
156666280|NCT01675765|565527521|FG001|Overall Study|Death|0|||
156666281|NCT01675765|565527520|FG000|Overall Study|Clinical progression|3|||
156666282|NCT01675765|565527521|FG001|Overall Study|Clinical progression|2|||
156666283|NCT02057458|565527531|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
156666284|NCT02057458|565527532|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
156666285|NCT02057458|565527533|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
156666286|NCT02057458|565527531|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
156666287|NCT02057458|565527532|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
156666288|NCT02057458|565527533|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
156666289|NCT02057458|565527531|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
156666290|NCT02057458|565527532|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
156666291|NCT02057458|565527533|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
156666292|NCT04263649|565527534|FG000|Overall Study|Adverse Event|53|||
156666293|NCT04263649|565527534|FG000|Overall Study|Lost to Follow-up|3|||
156666294|NCT04263649|565527534|FG000|Overall Study|Death|29|||
156666295|NCT04263649|565527534|FG000|Overall Study|Device deficiency|19|||
156666296|NCT04263649|565527534|FG000|Overall Study|other reasons|11|||
156666297|NCT05169710|565527536|FG000|Overall Study|Adverse Event|1|||
156666298|NCT05169710|565527537|FG001|Overall Study|Adverse Event|2|||
156666299|NCT05169710|565527538|FG002|Overall Study|Adverse Event|2|||
156666300|NCT05169710|565527536|FG000|Overall Study|Lost to Follow-up|0|||
156666301|NCT05169710|565527537|FG001|Overall Study|Lost to Follow-up|0|||
156666302|NCT05169710|565527538|FG002|Overall Study|Lost to Follow-up|1|||
156666303|NCT05169710|565527536|FG000|Overall Study|Withdrawal by Subject|2|||
156666304|NCT05169710|565527537|FG001|Overall Study|Withdrawal by Subject|1|||
156666305|NCT05169710|565527538|FG002|Overall Study|Withdrawal by Subject|0|||
156666306|NCT05169710|565527536|FG000|Overall Study|Other Study Discontinuation Reason|0|||
156666307|NCT05169710|565527537|FG001|Overall Study|Other Study Discontinuation Reason|2|||
156666308|NCT05169710|565527538|FG002|Overall Study|Other Study Discontinuation Reason|0|||
156666309|NCT00836056|565527548|FG000|First Intervention|Adverse Event|1|||
156666310|NCT00836056|565527549|FG001|First Intervention|Adverse Event|0|||
156666311|NCT00846495|565527553|FG000|Overall Study|Lost to Follow-up|1|||
156666312|NCT00846495|565527554|FG001|Overall Study|Lost to Follow-up|0|||
156666313|NCT00846495|565527553|FG000|Overall Study|Adverse Event|5|||
156666314|NCT00846495|565527554|FG001|Overall Study|Adverse Event|1|||
156666315|NCT00846495|565527553|FG000|Overall Study|Lack of Efficacy|1|||
156666316|NCT00846495|565527554|FG001|Overall Study|Lack of Efficacy|2|||
156666317|NCT00846495|565527553|FG000|Overall Study|Physician Decision|1|||
156666318|NCT00846495|565527554|FG001|Overall Study|Physician Decision|0|||
156666319|NCT01079988|565527555|FG000|Overall Study|Lost to Follow-up|0|||
156666320|NCT01079988|565527556|FG001|Overall Study|Lost to Follow-up|0|||
156666321|NCT01079988|565527557|FG002|Overall Study|Lost to Follow-up|0|||
156666322|NCT01079988|565527558|FG003|Overall Study|Lost to Follow-up|1|||
156666323|NCT01079988|565527559|FG004|Overall Study|Lost to Follow-up|0|||
156666324|NCT01079988|565527555|FG000|Overall Study|Lack of Efficacy|1|||
156666325|NCT01079988|565527556|FG001|Overall Study|Lack of Efficacy|0|||
156666326|NCT01079988|565527557|FG002|Overall Study|Lack of Efficacy|0|||
156666327|NCT01079988|565527558|FG003|Overall Study|Lack of Efficacy|0|||
156666328|NCT01079988|565527559|FG004|Overall Study|Lack of Efficacy|0|||
156666329|NCT01079988|565527555|FG000|Overall Study|Other|0|||
156666330|NCT01079988|565527556|FG001|Overall Study|Other|0|||
156666331|NCT01079988|565527557|FG002|Overall Study|Other|0|||
156666332|NCT01079988|565527558|FG003|Overall Study|Other|2|||
156666333|NCT01079988|565527559|FG004|Overall Study|Other|1|||
156666334|NCT03546842|565527560|FG000|Overall Study|Protocol Violation|1|||
156666335|NCT03546842|565527560|FG000|Overall Study|Withdrawal by Subject|2|||
156666336|NCT01265056|565527562|FG000|Initial Study Period|Withdrawal by Subject|1|||
156666337|NCT01265056|565527563|FG001|Initial Study Period|Withdrawal by Subject|1|||
156666338|NCT01265056|565527562|FG000|Initial Study Period|Withdrawal by Subject|1|||
156666339|NCT01265056|565527563|FG001|Initial Study Period|Withdrawal by Subject|1|||
156666340|NCT01265056|565527562|FG000|Follow up|Lost to Follow-up|7|||
156666341|NCT01265056|565527563|FG001|Follow up|Lost to Follow-up|3|||
156666342|NCT02711852|565527564|FG000|Overall Study|Death|5|||
156666343|NCT02711852|565527564|FG000|Overall Study|Lost to Follow-up|1|||
156666344|NCT02711852|565527564|FG000|Overall Study|Completed follow-up|3|||
156666345|NCT02711852|565527564|FG000|Overall Study|Withdrawal by Subject|1|||
156666346|NCT03459807|565527568|FG000|Overall Study|Withdrawal due to transplant|0|||
156666347|NCT03459807|565527569|FG001|Overall Study|Withdrawal due to transplant|1|||
156666348|NCT03586726|565527572|FG000|Overall Study|Withdrawal by Subject|1|||
156666349|NCT00576056|565527573|FG000|Overall Study|Adverse Event|1|||
156666350|NCT00576056|565527573|FG000|Overall Study|Death|1|||
156666351|NCT00576056|565527573|FG000|Overall Study|Lack of Efficacy|1|||
156666352|NCT00576056|565527573|FG000|Overall Study|Withdrawal by Subject|2|||
156666353|NCT00576056|565527573|FG000|Overall Study|did not meet eligibility criteria|8|||
156666354|NCT00576056|565527573|FG000|Overall Study|Physician Decision|1|||
156666355|NCT03197883|565527574|FG000|Overall Study|Adverse Event|1|||
156666356|NCT03197883|565527575|FG001|Overall Study|Adverse Event|1|||
156666357|NCT03197883|565527574|FG000|Overall Study|Lost to Follow-up|1|||
156666358|NCT03197883|565527575|FG001|Overall Study|Lost to Follow-up|0|||
156666359|NCT03197883|565527574|FG000|Overall Study|Protocol Violation|1|||
156666360|NCT03197883|565527575|FG001|Overall Study|Protocol Violation|0|||
156666361|NCT03197883|565527574|FG000|Overall Study|Other (Not Specified)|0|||
156666362|NCT03197883|565527575|FG001|Overall Study|Other (Not Specified)|5|||
156666363|NCT03031847|565527576|FG000|Overall Study|Death|1|||
156666364|NCT03031847|565527577|FG001|Overall Study|Death|1|||
156666365|NCT03031847|565527578|FG002|Overall Study|Death|2|||
156666366|NCT03031847|565527579|FG003|Overall Study|Death|3|||
156666367|NCT03031847|565527576|FG000|Overall Study|Lost to Follow-up|1|||
156666368|NCT03031847|565527577|FG001|Overall Study|Lost to Follow-up|1|||
156666369|NCT03031847|565527578|FG002|Overall Study|Lost to Follow-up|2|||
156666370|NCT03031847|565527579|FG003|Overall Study|Lost to Follow-up|3|||
156666371|NCT03273153|565527580|FG000|Overall Study|Adverse Event|1|||
156666372|NCT03273153|565527581|FG001|Overall Study|Adverse Event|2|||
156666373|NCT03273153|565527580|FG000|Overall Study|Missing|0|||
156666374|NCT03273153|565527581|FG001|Overall Study|Missing|2|||
156666375|NCT03273153|565527580|FG000|Overall Study|Other|3|||
156666376|NCT03273153|565527581|FG001|Overall Study|Other|2|||
156666377|NCT03273153|565527580|FG000|Overall Study|Symptomatic Deterioration|0|||
156666378|NCT03273153|565527581|FG001|Overall Study|Symptomatic Deterioration|1|||
156666379|NCT03273153|565527580|FG000|Overall Study|Progressive Disease|6|||
156666380|NCT03273153|565527581|FG001|Overall Study|Progressive Disease|5|||
156666381|NCT03273153|565527580|FG000|Overall Study|Physician Decision|1|||
156666382|NCT03273153|565527581|FG001|Overall Study|Physician Decision|3|||
156666383|NCT03273153|565527580|FG000|Overall Study|Study Terminated by Sponsor|112|||
156325288|NCT00910988|564290913|FG001|Overall Study|Lost to Follow-up|4|||
156325289|NCT00910988|564290914|FG002|Overall Study|Lost to Follow-up|3|||
156666384|NCT03273153|565527581|FG001|Overall Study|Study Terminated by Sponsor|102|||
156666385|NCT03273153|565527580|FG000|Overall Study|Withdrawal by Subject|26|||
156666386|NCT03273153|565527581|FG001|Overall Study|Withdrawal by Subject|25|||
156666387|NCT03273153|565527580|FG000|Overall Study|Protocol Deviation|3|||
156666388|NCT03273153|565527581|FG001|Overall Study|Protocol Deviation|0|||
156666389|NCT03273153|565527580|FG000|Overall Study|Lost to Follow-up|6|||
156666390|NCT03273153|565527581|FG001|Overall Study|Lost to Follow-up|11|||
156666391|NCT03273153|565527580|FG000|Overall Study|Death|66|||
156666392|NCT03273153|565527581|FG001|Overall Study|Death|69|||
156666393|NCT00838539|565527584|FG000|Overall Study|Disease Progression|2|||
156666394|NCT00838539|565527585|FG001|Overall Study|Disease Progression|4|||
156666395|NCT00838539|565527586|FG002|Overall Study|Disease Progression|3|||
156666396|NCT00838539|565527587|FG003|Overall Study|Disease Progression|2|||
156666397|NCT00838539|565527588|FG004|Overall Study|Disease Progression|4|||
156666398|NCT00838539|565527589|FG005|Overall Study|Disease Progression|2|||
156666399|NCT00838539|565527590|FG006|Overall Study|Disease Progression|3|||
156666400|NCT00838539|565527591|FG007|Overall Study|Disease Progression|4|||
156666401|NCT00838539|565527592|FG008|Overall Study|Disease Progression|4|||
156666402|NCT00838539|565527593|FG009|Overall Study|Disease Progression|5|||
156666403|NCT00838539|565527594|FG010|Overall Study|Disease Progression|1|||
156666404|NCT00838539|565527595|FG011|Overall Study|Disease Progression|4|||
156777053|NCT05028569|565935212|FG006|Double-Blind Phase|Lost to Follow-up|0|||
156777054|NCT05028569|565935206|FG000|Double-Blind Phase|Protocol Deviation|0|||
156777055|NCT05028569|565935207|FG001|Double-Blind Phase|Protocol Deviation|2|||
156777056|NCT05028569|565935208|FG002|Double-Blind Phase|Protocol Deviation|0|||
156777057|NCT05028569|565935209|FG003|Double-Blind Phase|Protocol Deviation|0|||
156777058|NCT05028569|565935210|FG004|Double-Blind Phase|Protocol Deviation|0|||
156777059|NCT05028569|565935211|FG005|Double-Blind Phase|Protocol Deviation|0|||
156777060|NCT05028569|565935212|FG006|Double-Blind Phase|Protocol Deviation|0|||
156777061|NCT05028569|565935206|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156777062|NCT05028569|565935207|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
156777063|NCT05028569|565935208|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
156777064|NCT05028569|565935209|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
156777065|NCT05028569|565935210|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156777066|NCT05028569|565935211|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
156777067|NCT05028569|565935212|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
156777068|NCT05028569|565935206|FG000|Double-Blind Phase|Other, not specified|0|||
156777069|NCT05028569|565935207|FG001|Double-Blind Phase|Other, not specified|5|||
156777070|NCT05028569|565935208|FG002|Double-Blind Phase|Other, not specified|4|||
156777071|NCT05028569|565935209|FG003|Double-Blind Phase|Other, not specified|6|||
156777072|NCT05028569|565935210|FG004|Double-Blind Phase|Other, not specified|0|||
156325290|NCT00910988|564290915|FG003|Overall Study|Lost to Follow-up|0|||
156325291|NCT03194490|564290926|FG000|Overall Study|Lost to Follow-up|1|||
156325292|NCT03194490|564290927|FG001|Overall Study|Lost to Follow-up|3|||
156325293|NCT03194490|564290926|FG000|Overall Study|participant developed specific neck pain|1|||
156325294|NCT03194490|564290927|FG001|Overall Study|participant developed specific neck pain|0|||
156524670|NCT00819390|565015668|FG000|Overall Study|Withdrawal by Subject|2|||
156666405|NCT00838539|565527584|FG000|Overall Study|Adverse Event|1|||
156666406|NCT00838539|565527585|FG001|Overall Study|Adverse Event|1|||
156666407|NCT00838539|565527586|FG002|Overall Study|Adverse Event|1|||
156666408|NCT00838539|565527587|FG003|Overall Study|Adverse Event|1|||
156666409|NCT00838539|565527588|FG004|Overall Study|Adverse Event|2|||
156666410|NCT00838539|565527589|FG005|Overall Study|Adverse Event|1|||
156666411|NCT00838539|565527590|FG006|Overall Study|Adverse Event|0|||
156666412|NCT00838539|565527591|FG007|Overall Study|Adverse Event|2|||
156666413|NCT00838539|565527592|FG008|Overall Study|Adverse Event|0|||
156666414|NCT00838539|565527593|FG009|Overall Study|Adverse Event|1|||
156666415|NCT00838539|565527594|FG010|Overall Study|Adverse Event|2|||
156666416|NCT00838539|565527595|FG011|Overall Study|Adverse Event|0|||
156777073|NCT05028569|565935211|FG005|Double-Blind Phase|Other, not specified|0|||
156777074|NCT05028569|565935212|FG006|Double-Blind Phase|Other, not specified|0|||
156777075|NCT05028569|565935206|FG000|Open-Label Phase|Death|0|||
156777076|NCT05028569|565935207|FG001|Open-Label Phase|Death|0|||
156777077|NCT05028569|565935208|FG002|Open-Label Phase|Death|0|||
156777078|NCT05028569|565935209|FG003|Open-Label Phase|Death|0|||
156777079|NCT05028569|565935210|FG004|Open-Label Phase|Death|0|||
156777080|NCT05028569|565935211|FG005|Open-Label Phase|Death|0|||
156777081|NCT05028569|565935212|FG006|Open-Label Phase|Death|1|||
156777082|NCT05028569|565935206|FG000|Open-Label Phase|Lost to Follow-up|0|||
156777083|NCT05028569|565935207|FG001|Open-Label Phase|Lost to Follow-up|0|||
156777084|NCT05028569|565935208|FG002|Open-Label Phase|Lost to Follow-up|0|||
156777085|NCT05028569|565935209|FG003|Open-Label Phase|Lost to Follow-up|0|||
156777086|NCT05028569|565935210|FG004|Open-Label Phase|Lost to Follow-up|5|||
156777087|NCT05028569|565935211|FG005|Open-Label Phase|Lost to Follow-up|5|||
156777088|NCT05028569|565935212|FG006|Open-Label Phase|Lost to Follow-up|4|||
156777089|NCT05028569|565935206|FG000|Open-Label Phase|Protocol Deviation|0|||
156777090|NCT05028569|565935207|FG001|Open-Label Phase|Protocol Deviation|0|||
156777091|NCT05028569|565935208|FG002|Open-Label Phase|Protocol Deviation|0|||
156777092|NCT05028569|565935209|FG003|Open-Label Phase|Protocol Deviation|0|||
156666417|NCT00838539|565527584|FG000|Overall Study|Withdrawal by Subject|0|||
156666418|NCT00838539|565527585|FG001|Overall Study|Withdrawal by Subject|1|||
156666419|NCT00838539|565527586|FG002|Overall Study|Withdrawal by Subject|0|||
156666420|NCT00838539|565527587|FG003|Overall Study|Withdrawal by Subject|0|||
156666421|NCT00838539|565527588|FG004|Overall Study|Withdrawal by Subject|0|||
156666422|NCT00838539|565527589|FG005|Overall Study|Withdrawal by Subject|0|||
156666423|NCT00838539|565527590|FG006|Overall Study|Withdrawal by Subject|0|||
156666424|NCT00838539|565527591|FG007|Overall Study|Withdrawal by Subject|0|||
156666425|NCT00838539|565527592|FG008|Overall Study|Withdrawal by Subject|0|||
156666426|NCT00838539|565527593|FG009|Overall Study|Withdrawal by Subject|1|||
156777093|NCT05028569|565935210|FG004|Open-Label Phase|Protocol Deviation|1|||
156777094|NCT05028569|565935211|FG005|Open-Label Phase|Protocol Deviation|0|||
156777095|NCT05028569|565935212|FG006|Open-Label Phase|Protocol Deviation|0|||
156777096|NCT05028569|565935206|FG000|Open-Label Phase|Pregnancy|0|||
156777097|NCT05028569|565935207|FG001|Open-Label Phase|Pregnancy|0|||
156777098|NCT05028569|565935208|FG002|Open-Label Phase|Pregnancy|0|||
156777099|NCT05028569|565935209|FG003|Open-Label Phase|Pregnancy|0|||
156777100|NCT05028569|565935210|FG004|Open-Label Phase|Pregnancy|0|||
156777101|NCT05028569|565935211|FG005|Open-Label Phase|Pregnancy|1|||
156777102|NCT05028569|565935212|FG006|Open-Label Phase|Pregnancy|0|||
156777103|NCT05028569|565935206|FG000|Open-Label Phase|Withdrawal by Subject|0|||
156777104|NCT05028569|565935207|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156777105|NCT05028569|565935208|FG002|Open-Label Phase|Withdrawal by Subject|0|||
156777106|NCT05028569|565935209|FG003|Open-Label Phase|Withdrawal by Subject|0|||
156777107|NCT05028569|565935210|FG004|Open-Label Phase|Withdrawal by Subject|15|||
156777108|NCT05028569|565935211|FG005|Open-Label Phase|Withdrawal by Subject|8|||
156777109|NCT05028569|565935212|FG006|Open-Label Phase|Withdrawal by Subject|13|||
156777110|NCT05028569|565935206|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
156777111|NCT05028569|565935207|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
156777112|NCT05028569|565935208|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
156777113|NCT05028569|565935209|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
156777114|NCT05028569|565935210|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
156777115|NCT05028569|565935211|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
156777116|NCT05028569|565935212|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
156777117|NCT05028569|565935206|FG000|Open-Label Phase|Other, not specified|0|||
156777118|NCT05028569|565935207|FG001|Open-Label Phase|Other, not specified|0|||
156777119|NCT05028569|565935208|FG002|Open-Label Phase|Other, not specified|0|||
156777120|NCT05028569|565935209|FG003|Open-Label Phase|Other, not specified|0|||
156777121|NCT05028569|565935210|FG004|Open-Label Phase|Other, not specified|6|||
156777122|NCT05028569|565935211|FG005|Open-Label Phase|Other, not specified|5|||
156777123|NCT05028569|565935212|FG006|Open-Label Phase|Other, not specified|7|||
156777124|NCT05028569|565935206|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777125|NCT05028569|565935207|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777126|NCT05028569|565935208|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777127|NCT05028569|565935209|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777128|NCT05028569|565935210|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777129|NCT05028569|565935211|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
156777130|NCT05028569|565935212|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156666427|NCT00838539|565527594|FG010|Overall Study|Withdrawal by Subject|2|||
156777131|NCT05028569|565935206|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777132|NCT05028569|565935207|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777133|NCT05028569|565935208|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156666428|NCT00838539|565527595|FG011|Overall Study|Withdrawal by Subject|0|||
156666429|NCT00838539|565527584|FG000|Overall Study|Death|0|||
156666430|NCT00838539|565527585|FG001|Overall Study|Death|0|||
156666431|NCT00838539|565527586|FG002|Overall Study|Death|0|||
156666432|NCT00838539|565527587|FG003|Overall Study|Death|0|||
156666433|NCT00838539|565527588|FG004|Overall Study|Death|0|||
156666434|NCT00838539|565527589|FG005|Overall Study|Death|0|||
156666435|NCT00838539|565527590|FG006|Overall Study|Death|1|||
156666436|NCT00838539|565527591|FG007|Overall Study|Death|0|||
156777134|NCT05028569|565935209|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777135|NCT05028569|565935210|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777136|NCT05028569|565935211|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777137|NCT05028569|565935212|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
156777138|NCT01136954|565935216|FG000|Overall Study|Adverse Event|3|||
156777139|NCT01136954|565935217|FG001|Overall Study|Adverse Event|2|||
156777140|NCT01136954|565935216|FG000|Overall Study|Withdrawal by Subject|6|||
156777141|NCT01136954|565935217|FG001|Overall Study|Withdrawal by Subject|2|||
156777142|NCT01136954|565935216|FG000|Overall Study|Lack of Efficacy|14|||
156777143|NCT01136954|565935217|FG001|Overall Study|Lack of Efficacy|13|||
156777144|NCT01136954|565935216|FG000|Overall Study|Physician Decision|0|||
156777145|NCT01136954|565935217|FG001|Overall Study|Physician Decision|1|||
156777146|NCT01136954|565935216|FG000|Overall Study|Other|1|||
156777147|NCT01136954|565935217|FG001|Overall Study|Other|3|||
156777148|NCT04190225|565935228|FG000|Overall Study|Lost to Follow-up|2|||
156777149|NCT04190225|565935229|FG001|Overall Study|Lost to Follow-up|3|||
156777150|NCT04190225|565935228|FG000|Overall Study|Withdrawal by Subject|3|||
156777151|NCT04190225|565935229|FG001|Overall Study|Withdrawal by Subject|2|||
156777152|NCT04190225|565935228|FG000|Overall Study|Unrelated health condition|2|||
156777153|NCT04190225|565935229|FG001|Overall Study|Unrelated health condition|0|||
156777154|NCT02362451|565935230|FG000|Overall Study|Withdrawal by Subject|0|||
156777155|NCT02362451|565935231|FG001|Overall Study|Withdrawal by Subject|1|||
156777156|NCT02362451|565935230|FG000|Overall Study|Lack of Efficacy|2|||
156777157|NCT02362451|565935231|FG001|Overall Study|Lack of Efficacy|0|||
156777158|NCT02362451|565935230|FG000|Overall Study|Progression|1|||
156777159|NCT02362451|565935231|FG001|Overall Study|Progression|0|||
156777160|NCT02362451|565935230|FG000|Overall Study|Participant chose other therapy.|1|||
156777161|NCT02362451|565935231|FG001|Overall Study|Participant chose other therapy.|0|||
156777162|NCT01732783|565935234|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
156777163|NCT01732783|565935235|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
156777164|NCT01732783|565935236|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
156777165|NCT01732783|565935234|FG000|Overall Study|Death|13|||
156777166|NCT01732783|565935235|FG001|Overall Study|Death|4|||
156777167|NCT01732783|565935236|FG002|Overall Study|Death|1|||
156777168|NCT01732783|565935234|FG000|Overall Study|Lost to Follow-up|7|||
156777169|NCT01732783|565935235|FG001|Overall Study|Lost to Follow-up|1|||
156777170|NCT01732783|565935236|FG002|Overall Study|Lost to Follow-up|1|||
156777171|NCT01732783|565935234|FG000|Overall Study|Administrative Decision|8|||
156777172|NCT01732783|565935235|FG001|Overall Study|Administrative Decision|2|||
156777173|NCT01732783|565935236|FG002|Overall Study|Administrative Decision|1|||
156777174|NCT01732783|565935234|FG000|Overall Study|Withdrawal by Subject|1|||
156777175|NCT01732783|565935235|FG001|Overall Study|Withdrawal by Subject|0|||
156777176|NCT01732783|565935236|FG002|Overall Study|Withdrawal by Subject|0|||
156777177|NCT01838876|565935237|FG000|Overall Study|Adverse Event|49|||
156777178|NCT01838876|565935237|FG000|Overall Study|Insufficient Therapeutic Response|10|||
156777179|NCT01838876|565935237|FG000|Overall Study|Protocol Violation|34|||
156777180|NCT01838876|565935237|FG000|Overall Study|Withdrawal of Consent|33|||
156777181|NCT01838876|565935237|FG000|Overall Study|Lost to Follow-up|21|||
156777182|NCT01838876|565935237|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
156777183|NCT01838876|565935237|FG000|Overall Study|Reason not Specified|7|||
156777184|NCT01838876|565935237|FG000|Overall Study|Did not meet eligibility criteria|78|||
156777185|NCT00689936|565935238|FG000|Active Treatment Phase|Adverse Event|68|||
156777186|NCT00689936|565935239|FG001|Active Treatment Phase|Adverse Event|71|||
156777187|NCT00689936|565935240|FG002|Active Treatment Phase|Adverse Event|76|||
156666437|NCT00838539|565527592|FG008|Overall Study|Death|0|||
156325295|NCT03911843|564290928|FG000|Overall Study|Adverse Event|2|||
156666438|NCT00838539|565527593|FG009|Overall Study|Death|0|||
156777188|NCT00689936|565935238|FG000|Active Treatment Phase|Disease Progression|273|||
156777189|NCT00689936|565935239|FG001|Active Treatment Phase|Disease Progression|362|||
156777190|NCT00689936|565935240|FG002|Active Treatment Phase|Disease Progression|339|||
156777191|NCT00689936|565935238|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
156777192|NCT00689936|565935239|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
156777193|NCT00689936|565935240|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
156777194|NCT00689936|565935238|FG000|Active Treatment Phase|Death|60|||
156777195|NCT00689936|565935239|FG001|Active Treatment Phase|Death|28|||
156325296|NCT03911843|564290929|FG001|Overall Study|Adverse Event|0|||
156666439|NCT00838539|565527594|FG010|Overall Study|Death|0|||
156666440|NCT00838539|565527595|FG011|Overall Study|Death|0|||
156666441|NCT00838539|565527584|FG000|Overall Study|Physician Decision|0|||
156666442|NCT00838539|565527585|FG001|Overall Study|Physician Decision|0|||
156666443|NCT00838539|565527586|FG002|Overall Study|Physician Decision|0|||
156666444|NCT00838539|565527587|FG003|Overall Study|Physician Decision|0|||
156666445|NCT00838539|565527588|FG004|Overall Study|Physician Decision|0|||
156777196|NCT00689936|565935240|FG002|Active Treatment Phase|Death|37|||
156777197|NCT00689936|565935238|FG000|Active Treatment Phase|Lost to Follow-up|0|||
156777198|NCT00689936|565935239|FG001|Active Treatment Phase|Lost to Follow-up|2|||
156777199|NCT00689936|565935240|FG002|Active Treatment Phase|Lost to Follow-up|2|||
156777200|NCT00689936|565935238|FG000|Active Treatment Phase|Protocol Violation|2|||
156777201|NCT00689936|565935239|FG001|Active Treatment Phase|Protocol Violation|2|||
156777202|NCT00689936|565935240|FG002|Active Treatment Phase|Protocol Violation|4|||
156777203|NCT00689936|565935238|FG000|Active Treatment Phase|Study Close Out|64|||
156777204|NCT00689936|565935239|FG001|Active Treatment Phase|Study Close Out|26|||
156777205|NCT00689936|565935240|FG002|Active Treatment Phase|Study Close Out|21|||
156777206|NCT00689936|565935238|FG000|Active Treatment Phase|Miscellaneous|52|||
156777207|NCT00689936|565935239|FG001|Active Treatment Phase|Miscellaneous|34|||
156777208|NCT00689936|565935240|FG002|Active Treatment Phase|Miscellaneous|47|||
156666446|NCT00838539|565527589|FG005|Overall Study|Physician Decision|0|||
156666447|NCT00838539|565527590|FG006|Overall Study|Physician Decision|0|||
156666448|NCT00838539|565527591|FG007|Overall Study|Physician Decision|0|||
156666449|NCT00838539|565527592|FG008|Overall Study|Physician Decision|1|||
156666450|NCT00838539|565527593|FG009|Overall Study|Physician Decision|0|||
156666451|NCT00838539|565527594|FG010|Overall Study|Physician Decision|0|||
156666452|NCT00838539|565527595|FG011|Overall Study|Physician Decision|0|||
156666453|NCT00838539|565527584|FG000|Overall Study|Clinical Progression|0|||
156666454|NCT00838539|565527585|FG001|Overall Study|Clinical Progression|0|||
156666455|NCT00838539|565527586|FG002|Overall Study|Clinical Progression|0|||
156666456|NCT00838539|565527587|FG003|Overall Study|Clinical Progression|0|||
156666457|NCT00838539|565527588|FG004|Overall Study|Clinical Progression|0|||
156666458|NCT00838539|565527589|FG005|Overall Study|Clinical Progression|0|||
156666459|NCT00838539|565527590|FG006|Overall Study|Clinical Progression|1|||
156666460|NCT00838539|565527591|FG007|Overall Study|Clinical Progression|0|||
156666461|NCT00838539|565527592|FG008|Overall Study|Clinical Progression|0|||
156666462|NCT00838539|565527593|FG009|Overall Study|Clinical Progression|0|||
156666463|NCT00838539|565527594|FG010|Overall Study|Clinical Progression|0|||
156666464|NCT00838539|565527595|FG011|Overall Study|Clinical Progression|0|||
156666465|NCT00838539|565527584|FG000|Overall Study|Symptomatic Deterioration|0|||
156666466|NCT00838539|565527585|FG001|Overall Study|Symptomatic Deterioration|0|||
156666467|NCT00838539|565527586|FG002|Overall Study|Symptomatic Deterioration|1|||
156666468|NCT00838539|565527587|FG003|Overall Study|Symptomatic Deterioration|1|||
156666469|NCT00838539|565527588|FG004|Overall Study|Symptomatic Deterioration|0|||
156666470|NCT00838539|565527589|FG005|Overall Study|Symptomatic Deterioration|1|||
156666471|NCT00838539|565527590|FG006|Overall Study|Symptomatic Deterioration|0|||
156666472|NCT00838539|565527591|FG007|Overall Study|Symptomatic Deterioration|0|||
156666473|NCT00838539|565527592|FG008|Overall Study|Symptomatic Deterioration|0|||
156666474|NCT00838539|565527593|FG009|Overall Study|Symptomatic Deterioration|1|||
156666475|NCT00838539|565527594|FG010|Overall Study|Symptomatic Deterioration|0|||
156666476|NCT00838539|565527595|FG011|Overall Study|Symptomatic Deterioration|0|||
156666477|NCT01908205|565527596|FG000|Overall Study|Lost to Follow-up|2|||
156666478|NCT01908205|565527597|FG001|Overall Study|Lost to Follow-up|0|||
156666479|NCT01908205|565527596|FG000|Overall Study|Withdrawal by Subject|3|||
156666480|NCT01908205|565527597|FG001|Overall Study|Withdrawal by Subject|1|||
156666481|NCT02612337|565527599|FG000|Overall Study|Lack of Efficacy|1|||
156666482|NCT02612337|565527600|FG001|Overall Study|Lack of Efficacy|0|||
156666483|NCT02612337|565527599|FG000|Overall Study|Withdrawal by Subject|2|||
156666484|NCT02612337|565527600|FG001|Overall Study|Withdrawal by Subject|2|||
156666485|NCT02612337|565527599|FG000|Overall Study|Did not receive study drug|0|||
156666486|NCT02612337|565527600|FG001|Overall Study|Did not receive study drug|1|||
156666487|NCT03420300|565527601|FG000|Overall Study|Death|2|||
156666488|NCT02242201|565527609|FG000|Overall Study|preoperative identified neuropathy|2|||
156666489|NCT02242201|565527610|FG001|Overall Study|preoperative identified neuropathy|0|||
156666490|NCT02242201|565527611|FG002|Overall Study|preoperative identified neuropathy|0|||
156666491|NCT02242201|565527609|FG000|Overall Study|planned post-op anticoagulation|1|||
156666492|NCT02242201|565527610|FG001|Overall Study|planned post-op anticoagulation|0|||
156666493|NCT02242201|565527611|FG002|Overall Study|planned post-op anticoagulation|0|||
156666494|NCT02242201|565527609|FG000|Overall Study|changed surgical procedure|1|||
156666495|NCT02242201|565527610|FG001|Overall Study|changed surgical procedure|0|||
156666496|NCT02242201|565527611|FG002|Overall Study|changed surgical procedure|0|||
156666497|NCT02242201|565527609|FG000|Overall Study|postponed surgery|0|||
156666498|NCT02242201|565527610|FG001|Overall Study|postponed surgery|0|||
156666499|NCT02242201|565527611|FG002|Overall Study|postponed surgery|1|||
156666500|NCT02242201|565527609|FG000|Overall Study|preoperative opioid consumption|0|||
156666501|NCT02242201|565527610|FG001|Overall Study|preoperative opioid consumption|1|||
156429996|NCT03536884|564663347|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156429997|NCT03536884|564663348|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156429998|NCT03536884|564663349|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156429999|NCT03536884|564663350|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156430000|NCT03536884|564663351|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156430001|NCT03536884|564663352|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
156430002|NCT03536884|564663353|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156430003|NCT03536884|564663354|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156430004|NCT03536884|564663355|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
156430005|NCT03536884|564663344|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430006|NCT03536884|564663345|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430007|NCT03536884|564663346|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430008|NCT03536884|564663347|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430009|NCT03536884|564663348|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430010|NCT03536884|564663349|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430011|NCT03536884|564663350|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430012|NCT03536884|564663351|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430013|NCT03536884|564663352|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156430014|NCT03536884|564663353|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
156430015|NCT03536884|564663354|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
156430016|NCT03536884|564663355|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
156430017|NCT03536884|564663344|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430018|NCT03536884|564663345|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430019|NCT03536884|564663346|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430020|NCT03536884|564663347|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430021|NCT03536884|564663348|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430022|NCT03536884|564663349|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430023|NCT03536884|564663350|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430024|NCT03536884|564663351|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430025|NCT03536884|564663352|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156430026|NCT03536884|564663353|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
156430027|NCT03536884|564663354|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
156430028|NCT03536884|564663355|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
156777209|NCT00689936|565935238|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
156777210|NCT00689936|565935239|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
156777211|NCT00689936|565935240|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
156777212|NCT01682031|565935241|FG000|Overall Study|Withdrawal by Subject|0|||
156777213|NCT01682031|565935242|FG001|Overall Study|Withdrawal by Subject|1|||
156777214|NCT01682031|565935241|FG000|Overall Study|Adverse Event|0|||
156777215|NCT01682031|565935242|FG001|Overall Study|Adverse Event|2|||
156777216|NCT01682031|565935241|FG000|Overall Study|MRI results indicate increased nodul|0|||
156777217|NCT01682031|565935242|FG001|Overall Study|MRI results indicate increased nodul|1|||
156777218|NCT01682031|565935241|FG000|Overall Study|Patient could not swallow tablets|1|||
156777219|NCT01682031|565935242|FG001|Overall Study|Patient could not swallow tablets|0|||
156777220|NCT01682031|565935241|FG000|Overall Study|Patient stopped selenium on his own|0|||
156777221|NCT01682031|565935242|FG001|Overall Study|Patient stopped selenium on his own|1|||
156777222|NCT03881371|565935247|FG000|Overall Study|Adverse Event|8|||
156777223|NCT03881371|565935248|FG001|Overall Study|Adverse Event|9|||
156777224|NCT03881371|565935247|FG000|Overall Study|Death|1|||
156777225|NCT03881371|565935248|FG001|Overall Study|Death|0|||
156777226|NCT03881371|565935247|FG000|Overall Study|Lost to Follow-up|1|||
156777227|NCT03881371|565935248|FG001|Overall Study|Lost to Follow-up|0|||
156777228|NCT03881371|565935247|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156777229|NCT03881371|565935248|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156777230|NCT03881371|565935247|FG000|Overall Study|Physician Decision|3|||
156430029|NCT03536884|564663344|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430030|NCT03536884|564663345|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430031|NCT03536884|564663346|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156460562|NCT04625725|564781648|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
156777231|NCT03881371|565935248|FG001|Overall Study|Physician Decision|3|||
156777232|NCT03881371|565935247|FG000|Overall Study|Withdrawal by Subject|2|||
156777233|NCT03881371|565935248|FG001|Overall Study|Withdrawal by Subject|10|||
156777234|NCT03881371|565935247|FG000|Overall Study|Discontinuation from Study|1|||
156777235|NCT03881371|565935248|FG001|Overall Study|Discontinuation from Study|0|||
156777236|NCT03330197|565935254|FG000|Overall Study|Adverse Event|0|||
156777237|NCT03330197|565935255|FG001|Overall Study|Adverse Event|1|||
156777238|NCT03330197|565935254|FG000|Overall Study|Withdrawal by Subject|0|||
156777239|NCT03330197|565935255|FG001|Overall Study|Withdrawal by Subject|1|||
156777240|NCT01564407|565935259|FG000|Overall Study|Lost to Follow-up|0|||
156777241|NCT01564407|565935260|FG001|Overall Study|Lost to Follow-up|1|||
156666502|NCT02242201|565527611|FG002|Overall Study|preoperative opioid consumption|0|||
156666503|NCT04149964|565527612|FG000|Overall Study|Lost to Follow-up|19|||
156666504|NCT04149964|565527613|FG001|Overall Study|Lost to Follow-up|18|||
156666505|NCT01697696|565527616|FG000|Overall Study|Study terminated by sponsor|0|||
156666506|NCT01697696|565527617|FG001|Overall Study|Study terminated by sponsor|3|||
156666507|NCT01697696|565527616|FG000|Overall Study|Protocol deviation|1|||
156666508|NCT01697696|565527617|FG001|Overall Study|Protocol deviation|0|||
156666509|NCT01697696|565527616|FG000|Overall Study|Physician Decision|1|||
156666510|NCT01697696|565527617|FG001|Overall Study|Physician Decision|0|||
156666511|NCT01697696|565527616|FG000|Overall Study|Death|4|||
156666512|NCT01697696|565527617|FG001|Overall Study|Death|2|||
156666513|NCT01697696|565527616|FG000|Overall Study|Lost to Follow-up|10|||
156666514|NCT01697696|565527617|FG001|Overall Study|Lost to Follow-up|7|||
156777242|NCT01564407|565935261|FG002|Overall Study|Lost to Follow-up|0|||
156777243|NCT01564407|565935262|FG003|Overall Study|Lost to Follow-up|0|||
156777244|NCT01564407|565935263|FG004|Overall Study|Lost to Follow-up|0|||
156777245|NCT01564407|565935259|FG000|Overall Study|Withdrawal by Subject|0|||
156777246|NCT01564407|565935260|FG001|Overall Study|Withdrawal by Subject|1|||
156777247|NCT01564407|565935261|FG002|Overall Study|Withdrawal by Subject|0|||
156777248|NCT01564407|565935262|FG003|Overall Study|Withdrawal by Subject|0|||
156777249|NCT01564407|565935263|FG004|Overall Study|Withdrawal by Subject|0|||
156777250|NCT01564407|565935259|FG000|Overall Study|funding lost, study ended|0|||
156777251|NCT01564407|565935260|FG001|Overall Study|funding lost, study ended|0|||
156777252|NCT01564407|565935261|FG002|Overall Study|funding lost, study ended|0|||
156777253|NCT01564407|565935262|FG003|Overall Study|funding lost, study ended|1|||
156777254|NCT01564407|565935263|FG004|Overall Study|funding lost, study ended|0|||
156777255|NCT02879695|565935267|FG000|Overall Study|Did not start study treatment|2|||
156777256|NCT02879695|565935268|FG001|Overall Study|Did not start study treatment|0|||
156777257|NCT02879695|565935269|FG002|Overall Study|Did not start study treatment|3|||
156777258|NCT02879695|565935270|FG003|Overall Study|Did not start study treatment|0|||
156777259|NCT00976027|565935271|FG000|Overall Study|Serious Adverse Event|36|||
156777260|NCT00976027|565935272|FG001|Overall Study|Serious Adverse Event|17|||
156777261|NCT00976027|565935271|FG000|Overall Study|Adverse Event|0|||
156777262|NCT00976027|565935272|FG001|Overall Study|Adverse Event|2|||
156777263|NCT00976027|565935271|FG000|Overall Study|Protocol Violation|60|||
156777264|NCT00976027|565935272|FG001|Overall Study|Protocol Violation|27|||
156777265|NCT00976027|565935271|FG000|Overall Study|Lost to Follow-up|208|||
156777266|NCT00976027|565935272|FG001|Overall Study|Lost to Follow-up|103|||
156777267|NCT00976027|565935271|FG000|Overall Study|Withdrawal by Subject|107|||
156777268|NCT00976027|565935272|FG001|Overall Study|Withdrawal by Subject|66|||
156777269|NCT01771107|565935277|FG000|Overall Study|Adverse Event|1|||
156777270|NCT01771107|565935278|FG001|Overall Study|Adverse Event|3|||
156777271|NCT01771107|565935277|FG000|Overall Study|Withdrawal by Subject|0|||
156777272|NCT01771107|565935278|FG001|Overall Study|Withdrawal by Subject|2|||
156777273|NCT01771107|565935277|FG000|Overall Study|Lost to Follow-up|0|||
156777274|NCT01771107|565935278|FG001|Overall Study|Lost to Follow-up|1|||
156777275|NCT01771107|565935277|FG000|Overall Study|participant moved|0|||
156777276|NCT01771107|565935278|FG001|Overall Study|participant moved|1|||
156777277|NCT01771107|565935277|FG000|Overall Study|Other|0|||
156777278|NCT01771107|565935278|FG001|Overall Study|Other|1|||
156777279|NCT01160614|565935279|FG000|Overall Study|Withdrawal by Subject|0|||
156777280|NCT01160614|565935280|FG001|Overall Study|Withdrawal by Subject|2|||
156777281|NCT03805841|565935281|FG000|Overall Study|Clinical Progression|2|||
156777282|NCT03805841|565935282|FG001|Overall Study|Clinical Progression|0|||
156777283|NCT03805841|565935283|FG002|Overall Study|Clinical Progression|0|||
156777284|NCT03805841|565935281|FG000|Overall Study|Death|0|||
156777285|NCT03805841|565935282|FG001|Overall Study|Death|3|||
156777286|NCT03805841|565935283|FG002|Overall Study|Death|1|||
156777287|NCT03805841|565935281|FG000|Overall Study|Lost to Follow-up|0|||
156325297|NCT03911843|564290928|FG000|Overall Study|Protocol Violation|2|||
156325298|NCT03911843|564290929|FG001|Overall Study|Protocol Violation|0|||
156325299|NCT03911843|564290928|FG000|Overall Study|Lost to Follow-up|0|||
156325300|NCT03911843|564290929|FG001|Overall Study|Lost to Follow-up|1|||
156666515|NCT01697696|565527616|FG000|Overall Study|Subject/guardian decision|31|||
156777288|NCT03805841|565935282|FG001|Overall Study|Lost to Follow-up|0|||
156777289|NCT03805841|565935283|FG002|Overall Study|Lost to Follow-up|1|||
156777290|NCT03805841|565935281|FG000|Overall Study|Withdrawal by Subject|2|||
156777291|NCT03805841|565935282|FG001|Overall Study|Withdrawal by Subject|3|||
156777292|NCT03805841|565935283|FG002|Overall Study|Withdrawal by Subject|0|||
156777293|NCT03805841|565935281|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
156777294|NCT03805841|565935282|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
156777295|NCT03805841|565935283|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
156777296|NCT05248386|565935284|FG000|Overall Study|Technical problems|0|||
156666516|NCT01697696|565527617|FG001|Overall Study|Subject/guardian decision|35|||
156777297|NCT05248386|565935285|FG001|Overall Study|Technical problems|1|||
156666517|NCT01424644|565527618|FG000|Overall Study|Adverse Event|2|||
156666518|NCT01424644|565527619|FG001|Overall Study|Adverse Event|0|||
156430032|NCT03536884|564663347|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430033|NCT03536884|564663348|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430034|NCT03536884|564663349|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430035|NCT03536884|564663350|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430036|NCT03536884|564663351|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430037|NCT03536884|564663352|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430038|NCT03536884|564663353|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430039|NCT03536884|564663354|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
156430040|NCT03536884|564663355|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156430041|NCT03536884|564663344|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430042|NCT03536884|564663345|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430043|NCT03536884|564663346|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430044|NCT03536884|564663347|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430045|NCT03536884|564663348|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156666519|NCT01424644|565527618|FG000|Overall Study|Withdrawal by Subject|9|||
156666520|NCT01424644|565527619|FG001|Overall Study|Withdrawal by Subject|12|||
156666521|NCT01424644|565527618|FG000|Overall Study|Lost to Follow-up|16|||
156666522|NCT01424644|565527619|FG001|Overall Study|Lost to Follow-up|12|||
156666523|NCT01424644|565527618|FG000|Overall Study|Protocol Violation|4|||
156666524|NCT01424644|565527619|FG001|Overall Study|Protocol Violation|3|||
156666525|NCT01424644|565527618|FG000|Overall Study|Administrative Reason|1|||
156666526|NCT01424644|565527619|FG001|Overall Study|Administrative Reason|0|||
156666527|NCT01424644|565527618|FG000|Overall Study|Unable to Classify|1|||
156666528|NCT01424644|565527619|FG001|Overall Study|Unable to Classify|0|||
156666529|NCT01577381|565527627|FG000|Overall Study|Discontinued|2|||
156666530|NCT01577381|565527628|FG001|Overall Study|Discontinued|1|||
156666531|NCT01577381|565527629|FG002|Overall Study|Discontinued|2|||
156666532|NCT01577381|565527630|FG003|Overall Study|Discontinued|2|||
156666533|NCT01577381|565527627|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
156666534|NCT01577381|565527628|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
156666535|NCT01577381|565527629|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
156666536|NCT01577381|565527630|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
156666537|NCT01313780|565527631|FG000|Overall Study|Lack of Efficacy|4|||
156666538|NCT01313780|565527632|FG001|Overall Study|Lack of Efficacy|2|||
156666539|NCT01313780|565527631|FG000|Overall Study|Adverse Event|6|||
156666540|NCT01313780|565527632|FG001|Overall Study|Adverse Event|11|||
156666541|NCT01313780|565527631|FG000|Overall Study|Withdrawal by Subject|2|||
156666542|NCT01313780|565527632|FG001|Overall Study|Withdrawal by Subject|8|||
156666543|NCT01313780|565527631|FG000|Overall Study|Protocol Violation|10|||
156666544|NCT01313780|565527632|FG001|Overall Study|Protocol Violation|4|||
156666545|NCT01313780|565527631|FG000|Overall Study|missing data|3|||
156666546|NCT01313780|565527632|FG001|Overall Study|missing data|3|||
156666547|NCT00857454|565528778|FG000|Overall Study|Withdrawal by Subject|2|||
156666548|NCT00857454|565528778|FG000|Overall Study|Lost to Follow-up|1|||
156666549|NCT00857454|565528778|FG000|Overall Study|Adverse Event|2|||
156666550|NCT00857454|565528778|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
156666551|NCT00857454|565528778|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
156666552|NCT00857454|565528778|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
156666553|NCT03154047|565528779|FG000|Overall Study|Death|1|||
156666554|NCT03154047|565528779|FG000|Overall Study|Study terminated by sponsor|76|||
156666555|NCT03154047|565528779|FG000|Overall Study|Withdrawal by Subject|3|||
156666556|NCT00365365|565528780|FG000|Overall Study|Randomized but not treated|0|||
156666557|NCT00365365|565528781|FG001|Overall Study|Randomized but not treated|2|||
156666558|NCT00365365|565528782|FG002|Overall Study|Randomized but not treated|0|||
156666559|NCT00365365|565528780|FG000|Overall Study|Poor compliance to protocol|0|||
156666560|NCT00365365|565528781|FG001|Overall Study|Poor compliance to protocol|1|||
156666561|NCT00365365|565528782|FG002|Overall Study|Poor compliance to protocol|0|||
156666562|NCT00365365|565528780|FG000|Overall Study|Lost to Follow-up|3|||
156666563|NCT00365365|565528781|FG001|Overall Study|Lost to Follow-up|3|||
156666564|NCT00365365|565528782|FG002|Overall Study|Lost to Follow-up|3|||
156666565|NCT00365365|565528780|FG000|Overall Study|Death|1|||
156666566|NCT00365365|565528781|FG001|Overall Study|Death|3|||
156666567|NCT00365365|565528782|FG002|Overall Study|Death|0|||
156666568|NCT00365365|565528780|FG000|Overall Study|Subject's request|11|||
156666569|NCT00365365|565528781|FG001|Overall Study|Subject's request|13|||
156666570|NCT00365365|565528782|FG002|Overall Study|Subject's request|1|||
156666571|NCT00365365|565528780|FG000|Overall Study|Disease progression/relapse|9|||
156666572|NCT00365365|565528781|FG001|Overall Study|Disease progression/relapse|6|||
156666573|NCT00365365|565528782|FG002|Overall Study|Disease progression/relapse|7|||
156666574|NCT00365365|565528780|FG000|Overall Study|Adverse Event|6|||
156666575|NCT00365365|565528781|FG001|Overall Study|Adverse Event|6|||
156666576|NCT00365365|565528782|FG002|Overall Study|Adverse Event|3|||
156666577|NCT00365365|565528780|FG000|Overall Study|Moved|2|||
156777298|NCT05248386|565935284|FG000|Overall Study|Withdrawal by Subject|15|||
156777299|NCT05248386|565935285|FG001|Overall Study|Withdrawal by Subject|10|||
156777300|NCT05248386|565935284|FG000|Overall Study|Physician Decision|0|||
156777301|NCT05248386|565935285|FG001|Overall Study|Physician Decision|1|||
156777302|NCT05248386|565935284|FG000|Overall Study|Adverse Event|2|||
156777303|NCT05248386|565935285|FG001|Overall Study|Adverse Event|4|||
156777304|NCT05248386|565935284|FG000|Overall Study|Other|1|||
156777305|NCT05248386|565935285|FG001|Overall Study|Other|0|||
156777306|NCT05248386|565935284|FG000|Overall Study|Lack of Efficacy|14|||
156777307|NCT05248386|565935285|FG001|Overall Study|Lack of Efficacy|12|||
156777308|NCT01723774|565935286|FG000|Neoadjuvant|Ki67 > 10%|4|||
156777309|NCT01723774|565935287|FG001|Neoadjuvant|Ki67 > 10%|0|||
156777310|NCT01723774|565935288|FG002|Neoadjuvant|Ki67 > 10%|10|||
156777311|NCT01723774|565935289|FG003|Neoadjuvant|Ki67 > 10%|0|||
156777312|NCT01723774|565935286|FG000|Neoadjuvant|Withdrawal by Subject|3|||
156777313|NCT01723774|565935287|FG001|Neoadjuvant|Withdrawal by Subject|1|||
156777314|NCT01723774|565935288|FG002|Neoadjuvant|Withdrawal by Subject|0|||
156777315|NCT01723774|565935289|FG003|Neoadjuvant|Withdrawal by Subject|0|||
156777316|NCT01723774|565935286|FG000|Neoadjuvant|Disease progression|0|||
156777317|NCT01723774|565935287|FG001|Neoadjuvant|Disease progression|1|||
156777318|NCT01723774|565935288|FG002|Neoadjuvant|Disease progression|1|||
156777319|NCT01723774|565935289|FG003|Neoadjuvant|Disease progression|0|||
156777320|NCT01723774|565935286|FG000|Neoadjuvant|Adverse Event|0|||
156777321|NCT01723774|565935287|FG001|Neoadjuvant|Adverse Event|1|||
156777322|NCT01723774|565935288|FG002|Neoadjuvant|Adverse Event|2|||
156777323|NCT01723774|565935289|FG003|Neoadjuvant|Adverse Event|0|||
156666578|NCT00365365|565528781|FG001|Overall Study|Moved|0|||
156666579|NCT00365365|565528782|FG002|Overall Study|Moved|0|||
156666580|NCT00365365|565528780|FG000|Overall Study|New cancer|1|||
156666581|NCT00365365|565528781|FG001|Overall Study|New cancer|0|||
156777324|NCT01723774|565935286|FG000|Neoadjuvant|High estradiol|0|||
156777325|NCT01723774|565935287|FG001|Neoadjuvant|High estradiol|1|||
156777326|NCT01723774|565935288|FG002|Neoadjuvant|High estradiol|0|||
156777327|NCT01723774|565935289|FG003|Neoadjuvant|High estradiol|0|||
156777328|NCT01910441|565935290|FG000|Overall Study|Sponsor decision|0|||
156777329|NCT01910441|565935291|FG001|Overall Study|Sponsor decision|2|||
156777330|NCT01910441|565935290|FG000|Overall Study|Lost to Follow-up|6|||
156777331|NCT01910441|565935291|FG001|Overall Study|Lost to Follow-up|5|||
156777332|NCT01910441|565935290|FG000|Overall Study|Withdrawal by Subject|0|||
156777333|NCT01910441|565935291|FG001|Overall Study|Withdrawal by Subject|1|||
156777334|NCT01910441|565935290|FG000|Overall Study|Non-compliance|0|||
156777335|NCT01910441|565935291|FG001|Overall Study|Non-compliance|1|||
156777336|NCT01910441|565935290|FG000|Overall Study|Adverse Event|1|||
156777337|NCT01910441|565935291|FG001|Overall Study|Adverse Event|0|||
156777338|NCT01910441|565935290|FG000|Overall Study|Physician Decision|0|||
156777339|NCT01910441|565935291|FG001|Overall Study|Physician Decision|1|||
156777340|NCT02964182|565935292|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777341|NCT02964182|565935293|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
156777342|NCT02964182|565935294|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777343|NCT02964182|565935295|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777344|NCT02964182|565935296|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777345|NCT02964182|565935297|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
156777346|NCT02964182|565935298|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777347|NCT02964182|565935299|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777348|NCT02964182|565935292|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156430046|NCT03536884|564663349|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430047|NCT03536884|564663350|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430048|NCT03536884|564663351|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430049|NCT03536884|564663352|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156666582|NCT00365365|565528782|FG002|Overall Study|New cancer|0|||
156666583|NCT00365365|565528780|FG000|Overall Study|Withdrew consent|1|||
156666584|NCT00365365|565528781|FG001|Overall Study|Withdrew consent|1|||
156666585|NCT00365365|565528782|FG002|Overall Study|Withdrew consent|0|||
156666586|NCT00365365|565528780|FG000|Overall Study|Second malignancy|0|||
156666587|NCT00365365|565528781|FG001|Overall Study|Second malignancy|1|||
156666588|NCT00365365|565528782|FG002|Overall Study|Second malignancy|0|||
156666589|NCT00365365|565528780|FG000|Overall Study|Patient/physician decision|0|||
156666590|NCT00365365|565528781|FG001|Overall Study|Patient/physician decision|0|||
156666591|NCT00365365|565528782|FG002|Overall Study|Patient/physician decision|1|||
156666592|NCT00984022|565528783|FG000|Overall Study|Lost to Follow-up|10|||
156666593|NCT00984022|565528784|FG001|Overall Study|Lost to Follow-up|14|||
156666594|NCT00573443|565528788|FG000|Double-Blind Phase|Lost to Follow-up|1|||
156666595|NCT00573443|565528789|FG001|Double-Blind Phase|Lost to Follow-up|3|||
156666596|NCT00573443|565528790|FG002|Double-Blind Phase|Lost to Follow-up|2|||
156666597|NCT00573443|565528788|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
156666598|NCT00573443|565528789|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
156666599|NCT00573443|565528790|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
156666600|NCT00573443|565528788|FG000|Double-Blind Phase|Adverse Event|1|||
156666601|NCT00573443|565528789|FG001|Double-Blind Phase|Adverse Event|5|||
156666602|NCT00573443|565528790|FG002|Double-Blind Phase|Adverse Event|0|||
156666603|NCT00573443|565528788|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
156666604|NCT00573443|565528789|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
156666605|NCT00573443|565528790|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
156666606|NCT00573443|565528788|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
156666607|NCT00573443|565528789|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
156666608|NCT00573443|565528790|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
156666609|NCT00573443|565528788|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
156666610|NCT00573443|565528789|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
156666611|NCT00573443|565528790|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
156666612|NCT00573443|565528788|FG000|Double-Blind Phase|Protocol Violation|0|||
156666613|NCT00573443|565528789|FG001|Double-Blind Phase|Protocol Violation|2|||
156666614|NCT00573443|565528790|FG002|Double-Blind Phase|Protocol Violation|1|||
156666615|NCT00573443|565528788|FG000|Double-Blind Phase|Other|0|||
156666616|NCT00573443|565528789|FG001|Double-Blind Phase|Other|2|||
156666617|NCT00573443|565528790|FG002|Double-Blind Phase|Other|3|||
156666618|NCT00573443|565528788|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
156666619|NCT00573443|565528789|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
156666620|NCT00573443|565528790|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
156666621|NCT00573443|565528788|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
156666622|NCT00573443|565528789|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
156666623|NCT00573443|565528790|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
156666624|NCT00573443|565528788|FG000|Open-Label Extension Phase|Adverse Event|3|||
156666625|NCT00573443|565528789|FG001|Open-Label Extension Phase|Adverse Event|0|||
156777349|NCT02964182|565935293|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156666626|NCT00573443|565528790|FG002|Open-Label Extension Phase|Adverse Event|0|||
156777350|NCT02964182|565935294|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777351|NCT02964182|565935295|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777352|NCT02964182|565935296|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777353|NCT02964182|565935297|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
156777354|NCT02964182|565935298|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777355|NCT02964182|565935299|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777356|NCT02964182|565935292|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777357|NCT02964182|565935293|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
156777358|NCT02964182|565935294|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777359|NCT02964182|565935295|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777360|NCT02964182|565935296|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777361|NCT02964182|565935297|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
156777362|NCT02964182|565935298|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777363|NCT02964182|565935299|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777364|NCT02964182|565935292|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777365|NCT02964182|565935293|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777366|NCT02964182|565935294|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
156777367|NCT02964182|565935295|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
156777368|NCT02964182|565935296|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777369|NCT02964182|565935297|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777370|NCT02964182|565935298|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
156777371|NCT02964182|565935299|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777372|NCT02964182|565935292|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777373|NCT02964182|565935293|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777374|NCT02964182|565935294|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
156777375|NCT02964182|565935295|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
156777376|NCT02964182|565935296|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777377|NCT02964182|565935297|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777378|NCT02964182|565935298|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777379|NCT02964182|565935299|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
156777380|NCT02964182|565935292|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777381|NCT02964182|565935293|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777382|NCT02964182|565935294|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
156325301|NCT01505647|564290930|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
156325302|NCT01505647|564290931|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
156325303|NCT01505647|564290930|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
156666627|NCT00573443|565528788|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
156666628|NCT00573443|565528789|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
156666629|NCT00573443|565528790|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
156666630|NCT00573443|565528788|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
156777383|NCT02964182|565935295|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
156777384|NCT02964182|565935296|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777385|NCT02964182|565935297|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777386|NCT02964182|565935298|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777387|NCT02964182|565935299|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156325304|NCT01505647|564290931|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
156430050|NCT03536884|564663353|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430051|NCT03536884|564663354|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
156430052|NCT03536884|564663355|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
156430053|NCT03536884|564663344|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156430054|NCT03536884|564663345|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156666631|NCT00573443|565528789|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
156666632|NCT00573443|565528790|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
156666633|NCT00573443|565528788|FG000|Open-Label Extension Phase|Protocol Violation|2|||
156666634|NCT00573443|565528789|FG001|Open-Label Extension Phase|Protocol Violation|0|||
156666635|NCT00573443|565528790|FG002|Open-Label Extension Phase|Protocol Violation|0|||
156666636|NCT00573443|565528788|FG000|Open-Label Extension Phase|Other|2|||
156666637|NCT00573443|565528789|FG001|Open-Label Extension Phase|Other|0|||
156666638|NCT00573443|565528790|FG002|Open-Label Extension Phase|Other|0|||
156666639|NCT03020615|565528792|FG000|Overall Study|Physician Decision|3|||
156666640|NCT03020615|565528793|FG001|Overall Study|Physician Decision|1|||
156666641|NCT03020615|565528794|FG002|Overall Study|Physician Decision|2|||
156666642|NCT03020615|565528792|FG000|Overall Study|Parent/guardian/patient choice|3|||
156666643|NCT03020615|565528793|FG001|Overall Study|Parent/guardian/patient choice|0|||
156666644|NCT03020615|565528794|FG002|Overall Study|Parent/guardian/patient choice|4|||
156666645|NCT03020615|565528792|FG000|Overall Study|Screen failure|0|||
156666646|NCT03020615|565528793|FG001|Overall Study|Screen failure|0|||
156666647|NCT03020615|565528794|FG002|Overall Study|Screen failure|1|||
156666648|NCT03020615|565528792|FG000|Overall Study|Death|1|||
156666649|NCT03020615|565528793|FG001|Overall Study|Death|0|||
156666650|NCT03020615|565528794|FG002|Overall Study|Death|0|||
156666651|NCT03020615|565528792|FG000|Overall Study|Lost to Follow-up|0|||
156666652|NCT03020615|565528793|FG001|Overall Study|Lost to Follow-up|1|||
156666653|NCT03020615|565528794|FG002|Overall Study|Lost to Follow-up|0|||
156666654|NCT01273805|565528795|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
156666655|NCT01273805|565528796|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
156666656|NCT02647944|565528797|FG000|Overall Study|Withdrawal by Subject|0|||
156666657|NCT02647944|565528798|FG001|Overall Study|Withdrawal by Subject|3|||
156666658|NCT02647944|565528797|FG000|Overall Study|Adverse Event|2|||
156666659|NCT02647944|565528798|FG001|Overall Study|Adverse Event|0|||
156666660|NCT02077465|565528800|FG000|Overall Study|Withdrew Consent|0|||
156666661|NCT02077465|565528801|FG001|Overall Study|Withdrew Consent|1|||
156666662|NCT02077465|565528800|FG000|Overall Study|Lost to Follow-up|1|||
156666663|NCT02077465|565528801|FG001|Overall Study|Lost to Follow-up|0|||
156666664|NCT04627038|565528802|FG000|Overall Study|Adverse Event|36|||
156666665|NCT04627038|565528803|FG001|Overall Study|Adverse Event|8|||
156666666|NCT04627038|565528802|FG000|Overall Study|Lost to Follow-up|1|||
156666667|NCT04627038|565528803|FG001|Overall Study|Lost to Follow-up|0|||
156666668|NCT04627038|565528802|FG000|Overall Study|Physician Decision|0|||
156666669|NCT04627038|565528803|FG001|Overall Study|Physician Decision|1|||
156666670|NCT04627038|565528802|FG000|Overall Study|Protocol Violation|3|||
156666671|NCT04627038|565528803|FG001|Overall Study|Protocol Violation|1|||
156666672|NCT04627038|565528802|FG000|Overall Study|Withdrawal by Subject|13|||
156666673|NCT04627038|565528803|FG001|Overall Study|Withdrawal by Subject|3|||
156666674|NCT04627038|565528802|FG000|Overall Study|Non-compliance with study drug|0|||
156666675|NCT04627038|565528803|FG001|Overall Study|Non-compliance with study drug|1|||
156666676|NCT04627038|565528802|FG000|Overall Study|Prohibited Concomitant Medication|1|||
156666677|NCT04627038|565528803|FG001|Overall Study|Prohibited Concomitant Medication|0|||
156666678|NCT02760368|565528804|FG000|Overall Study|Withdrawal by Subject|8|||
156666679|NCT02760368|565528805|FG001|Overall Study|Withdrawal by Subject|12|||
156666680|NCT02760368|565528806|FG002|Overall Study|Withdrawal by Subject|9|||
156666681|NCT02760368|565528804|FG000|Overall Study|Screen Failure|0|||
156666682|NCT02760368|565528805|FG001|Overall Study|Screen Failure|0|||
156666683|NCT02760368|565528806|FG002|Overall Study|Screen Failure|1|||
156666684|NCT02760368|565528804|FG000|Overall Study|Death|0|||
156666685|NCT02760368|565528805|FG001|Overall Study|Death|1|||
156666686|NCT02760368|565528806|FG002|Overall Study|Death|0|||
156666687|NCT02760368|565528804|FG000|Overall Study|Withdrawal by Sponsor|0|||
156666688|NCT02760368|565528805|FG001|Overall Study|Withdrawal by Sponsor|0|||
156666689|NCT02760368|565528806|FG002|Overall Study|Withdrawal by Sponsor|1|||
156666690|NCT00794963|565528807|FG000|Overall Study|Withdrawal by Subject|1|||
156666691|NCT00794963|565528808|FG001|Overall Study|Withdrawal by Subject|4|||
156666692|NCT01037114|565528809|FG000|Year 20|Others|1|||
156666693|NCT01602419|565528810|FG000|Overall Study|Not treated with Wilate|9|||
156666694|NCT01602419|565528810|FG000|Overall Study|Adverse Drug Reaction|4|||
156666695|NCT01602419|565528810|FG000|Overall Study|Insurance issues|3|||
156666696|NCT01602419|565528810|FG000|Overall Study|Changed treatment centre|1|||
156666697|NCT01602419|565528810|FG000|Overall Study|Treatment centre closed|1|||
156666698|NCT01602419|565528810|FG000|Overall Study|Withdrawal by Subject|5|||
156666699|NCT01602419|565528810|FG000|Overall Study|Lost to Follow-up|6|||
156666700|NCT02682784|565528822|FG000|Overall Study|Withdrawal by Subject|0|||
156666701|NCT02682784|565528823|FG001|Overall Study|Withdrawal by Subject|2|||
156777388|NCT02964182|565935292|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777389|NCT02964182|565935293|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777390|NCT02964182|565935294|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
156777391|NCT02964182|565935295|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
156777392|NCT02964182|565935296|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777393|NCT02964182|565935297|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777394|NCT02964182|565935298|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
156777395|NCT02964182|565935299|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777396|NCT03621592|565935302|FG000|Overall Study|Lost to Follow-up|1|||
156777397|NCT03621592|565935303|FG001|Overall Study|Lost to Follow-up|0|||
156777398|NCT03621592|565935302|FG000|Overall Study|Lack of Improvement|1|||
156777399|NCT03621592|565935303|FG001|Overall Study|Lack of Improvement|0|||
156777400|NCT03621592|565935302|FG000|Overall Study|Preference to receive wound care closer to home|1|||
156777401|NCT03621592|565935303|FG001|Overall Study|Preference to receive wound care closer to home|0|||
156777402|NCT03621592|565935302|FG000|Overall Study|Lack of healing|0|||
156777403|NCT03621592|565935303|FG001|Overall Study|Lack of healing|2|||
156777404|NCT04967222|565935304|FG000|Randomized|Lost to Follow-up|0|||
156777405|NCT04967222|565935305|FG001|Randomized|Lost to Follow-up|1|||
156777406|NCT04967222|565935306|FG002|Randomized|Lost to Follow-up|1|||
156777407|NCT04967222|565935304|FG000|Randomized|Physician Decision|0|||
156777408|NCT04967222|565935305|FG001|Randomized|Physician Decision|0|||
156777409|NCT04967222|565935306|FG002|Randomized|Physician Decision|1|||
156777410|NCT04967222|565935304|FG000|Randomized|Withdrawal by Subject|0|||
156777411|NCT04967222|565935305|FG001|Randomized|Withdrawal by Subject|0|||
156777412|NCT04967222|565935306|FG002|Randomized|Withdrawal by Subject|2|||
156777413|NCT04967222|565935304|FG000|Randomized|abnormal finding in MRI|0|||
156777414|NCT04967222|565935305|FG001|Randomized|abnormal finding in MRI|2|||
156777415|NCT04967222|565935306|FG002|Randomized|abnormal finding in MRI|0|||
156777416|NCT04958707|565935314|FG000|Post Intervention|Withdrawal by Subject|1|||
156777417|NCT04958707|565935315|FG001|Post Intervention|Withdrawal by Subject|0|||
156777418|NCT04958707|565935316|FG002|Post Intervention|Withdrawal by Subject|0|||
156777419|NCT04958707|565935314|FG000|3 Months Follow- up|Lost to Follow-up|0|||
156777420|NCT04958707|565935315|FG001|3 Months Follow- up|Lost to Follow-up|3|||
156777421|NCT04958707|565935316|FG002|3 Months Follow- up|Lost to Follow-up|0|||
156777422|NCT04958707|565935314|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
156777423|NCT04958707|565935315|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
156777424|NCT04958707|565935316|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
156777425|NCT02629159|565935319|FG000|Overall Study|Adverse Event|17|||
156777426|NCT02629159|565935320|FG001|Overall Study|Adverse Event|20|||
156777427|NCT02629159|565935321|FG002|Overall Study|Adverse Event|22|||
156777428|NCT02629159|565935319|FG000|Overall Study|Withdrawal by Subject|22|||
156777429|NCT02629159|565935320|FG001|Overall Study|Withdrawal by Subject|11|||
156777430|NCT02629159|565935321|FG002|Overall Study|Withdrawal by Subject|15|||
156777431|NCT02629159|565935319|FG000|Overall Study|Lost to Follow-up|7|||
156777432|NCT02629159|565935320|FG001|Overall Study|Lost to Follow-up|4|||
156666702|NCT02682784|565528824|FG002|Overall Study|Withdrawal by Subject|1|||
156666703|NCT02682784|565528825|FG003|Overall Study|Withdrawal by Subject|2|||
156666704|NCT02682784|565528822|FG000|Overall Study|Physician Decision|1|||
156666705|NCT02682784|565528823|FG001|Overall Study|Physician Decision|0|||
156666706|NCT02682784|565528824|FG002|Overall Study|Physician Decision|1|||
156666707|NCT02682784|565528825|FG003|Overall Study|Physician Decision|1|||
156666708|NCT01702987|565528826|FG000|Overall Study|Withdrawal by Subject|1|||
156777433|NCT02629159|565935321|FG002|Overall Study|Lost to Follow-up|5|||
156777434|NCT02629159|565935319|FG000|Overall Study|Lack of Efficacy|4|||
156777435|NCT02629159|565935320|FG001|Overall Study|Lack of Efficacy|0|||
156777436|NCT02629159|565935321|FG002|Overall Study|Lack of Efficacy|1|||
156460563|NCT04625725|564781649|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
156666709|NCT01702987|565528827|FG001|Overall Study|Withdrawal by Subject|0|||
156666710|NCT03181594|565528828|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
156666711|NCT03181594|565528828|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
156666712|NCT03181594|565528828|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
156666713|NCT03181594|565528828|FG000|Initial Study Protocol (12-month FU)|Death|1|||
156666714|NCT03181594|565528828|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
156666715|NCT03181594|565528828|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
156777437|NCT02629159|565935319|FG000|Overall Study|Other|6|||
156777438|NCT02629159|565935320|FG001|Overall Study|Other|4|||
156777439|NCT02629159|565935321|FG002|Overall Study|Other|8|||
156777440|NCT05523297|565935331|FG000|Overall Study|Death|7|||
156777441|NCT05523297|565935332|FG001|Overall Study|Death|8|||
156777442|NCT05523297|565935331|FG000|Overall Study|Lost to Follow-up|2|||
156777443|NCT05523297|565935332|FG001|Overall Study|Lost to Follow-up|1|||
156777444|NCT00830765|565935333|FG000|Overall Study|Protocol Violation|3|||
156666716|NCT00473330|565528835|FG000|Core Study|Adverse Event|4|||
156777445|NCT00830765|565935334|FG001|Overall Study|Protocol Violation|2|||
156777446|NCT02390284|565935335|FG000|Overall Study|Physician Decision|0|||
156777447|NCT02390284|565935336|FG001|Overall Study|Physician Decision|0|||
156777448|NCT02390284|565935337|FG002|Overall Study|Physician Decision|9|||
156666717|NCT00473330|565528836|FG001|Core Study|Adverse Event|4|||
156666718|NCT00473330|565528837|FG002|Core Study|Adverse Event|1|||
156666719|NCT00473330|565528835|FG000|Core Study|Death|6|||
156666720|NCT00473330|565528836|FG001|Core Study|Death|4|||
156666721|NCT00473330|565528837|FG002|Core Study|Death|4|||
156666722|NCT00473330|565528835|FG000|Core Study|Lost to Follow-up|5|||
156666723|NCT00473330|565528836|FG001|Core Study|Lost to Follow-up|5|||
156666724|NCT00473330|565528837|FG002|Core Study|Lost to Follow-up|10|||
156666725|NCT00473330|565528835|FG000|Core Study|Physician Decision|2|||
156666726|NCT00473330|565528836|FG001|Core Study|Physician Decision|1|||
156666727|NCT00473330|565528837|FG002|Core Study|Physician Decision|3|||
156666728|NCT00473330|565528835|FG000|Core Study|Subject Non-compliance|1|||
156666729|NCT00473330|565528836|FG001|Core Study|Subject Non-compliance|2|||
156666730|NCT00473330|565528837|FG002|Core Study|Subject Non-compliance|1|||
156666731|NCT00473330|565528835|FG000|Core Study|Subject Required Other Therapy|0|||
156666732|NCT00473330|565528836|FG001|Core Study|Subject Required Other Therapy|1|||
156777449|NCT00724945|565935340|FG000|Period 1|non-compliance|1|||
156777450|NCT00724945|565935341|FG001|Period 1|non-compliance|0|||
156777451|NCT00724945|565935340|FG000|Period 1|Adverse Event|1|||
156777452|NCT00724945|565935341|FG001|Period 1|Adverse Event|1|||
156666733|NCT00473330|565528837|FG002|Core Study|Subject Required Other Therapy|3|||
156666734|NCT00473330|565528835|FG000|Core Study|Subject's Decision|9|||
156666735|NCT00473330|565528836|FG001|Core Study|Subject's Decision|8|||
156777453|NCT00724945|565935340|FG000|Period 1|Lost to Follow-up|1|||
156777454|NCT00724945|565935341|FG001|Period 1|Lost to Follow-up|0|||
156777455|NCT00724945|565935340|FG000|Period 2|lens comfort issue|3|||
156777456|NCT00724945|565935341|FG001|Period 2|lens comfort issue|0|||
156777457|NCT00724945|565935340|FG000|Period 2|lens physiology issue|1|||
156777458|NCT00724945|565935341|FG001|Period 2|lens physiology issue|0|||
156777459|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
156777460|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
156777461|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
156777462|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
156777463|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
156777464|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
156777465|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
156777466|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
156777467|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
156777468|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
156777469|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
156777470|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
156777471|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
156777472|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
156777473|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
156777474|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
156777475|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
156777476|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
156777477|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Removal|1|||
156777478|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Removal|0|||
156777479|NCT05166876|565935344|FG000|Overall Study|Withdrawal by Subject|1|||
156777480|NCT05166876|565935345|FG001|Overall Study|Withdrawal by Subject|0|||
156777481|NCT05166876|565935346|FG002|Overall Study|Withdrawal by Subject|0|||
156777482|NCT00658528|565935347|FG000|Overall Study|Adverse Event|5|||
156777483|NCT00658528|565935348|FG001|Overall Study|Adverse Event|7|||
156777484|NCT00658528|565935347|FG000|Overall Study|Lost to Follow-up|14|||
156777485|NCT00658528|565935348|FG001|Overall Study|Lost to Follow-up|22|||
156777486|NCT00658528|565935347|FG000|Overall Study|Withdrawal by Subject|8|||
156777487|NCT00658528|565935348|FG001|Overall Study|Withdrawal by Subject|6|||
156777488|NCT00658528|565935347|FG000|Overall Study|Withdrawal of consent|5|||
156777489|NCT00658528|565935348|FG001|Overall Study|Withdrawal of consent|6|||
156777490|NCT00658528|565935347|FG000|Overall Study|Other|8|||
156777491|NCT00658528|565935348|FG001|Overall Study|Other|4|||
156777492|NCT02811159|565935354|FG000|Treatment Course 1|Lost to Follow-up|1|||
156777493|NCT05759338|565935355|FG000|Overall Study|Withdrawal by Subject|3|||
156777494|NCT04409002|565935356|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
156777495|NCT04611126|565935358|FG000|Overall Study|TIL expansion unsuccessful|1|||
156777496|NCT04611126|565935359|FG001|Overall Study|TIL expansion unsuccessful|0|||
156777497|NCT02328014|565936930|FG000|Overall Study|Adverse Event|1|||
156777498|NCT02328014|565936931|FG001|Overall Study|Adverse Event|0|||
156666736|NCT00473330|565528837|FG002|Core Study|Subject's Decision|19|||
156666737|NCT00473330|565528835|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
156666738|NCT00473330|565528836|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
156666739|NCT00473330|565528837|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
156777499|NCT02328014|565936932|FG002|Overall Study|Adverse Event|0|||
156777500|NCT02328014|565936933|FG003|Overall Study|Adverse Event|1|||
156777501|NCT02328014|565936930|FG000|Overall Study|Death|0|||
156777502|NCT02328014|565936931|FG001|Overall Study|Death|0|||
156777503|NCT02328014|565936932|FG002|Overall Study|Death|0|||
156777504|NCT02328014|565936933|FG003|Overall Study|Death|4|||
156777505|NCT02328014|565936930|FG000|Overall Study|Physician Decision|0|||
156777506|NCT02328014|565936931|FG001|Overall Study|Physician Decision|0|||
156777507|NCT02328014|565936932|FG002|Overall Study|Physician Decision|0|||
156777508|NCT02328014|565936933|FG003|Overall Study|Physician Decision|1|||
156777509|NCT02328014|565936930|FG000|Overall Study|Disease Progression|1|||
156777510|NCT02328014|565936931|FG001|Overall Study|Disease Progression|0|||
156777511|NCT02328014|565936932|FG002|Overall Study|Disease Progression|1|||
156777512|NCT02328014|565936933|FG003|Overall Study|Disease Progression|3|||
156777513|NCT02328014|565936930|FG000|Overall Study|Study Terminated by Sponsor|4|||
156777514|NCT02328014|565936931|FG001|Overall Study|Study Terminated by Sponsor|1|||
156777515|NCT02328014|565936932|FG002|Overall Study|Study Terminated by Sponsor|1|||
156777516|NCT02328014|565936933|FG003|Overall Study|Study Terminated by Sponsor|0|||
156777517|NCT02328014|565936930|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
156777518|NCT02328014|565936931|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
156777519|NCT02328014|565936932|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
156777520|NCT02328014|565936933|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
156777521|NCT02328014|565936930|FG000|Overall Study|Withdrawal by Subject|0|||
156777522|NCT02328014|565936931|FG001|Overall Study|Withdrawal by Subject|0|||
156777523|NCT02328014|565936932|FG002|Overall Study|Withdrawal by Subject|0|||
156777524|NCT02328014|565936933|FG003|Overall Study|Withdrawal by Subject|1|||
156777525|NCT04429971|565936942|FG000|Overall Study|Lost to Follow-up|7|||
156777526|NCT04429971|565936943|FG001|Overall Study|Lost to Follow-up|8|||
156777527|NCT05522751|565936949|FG000|Overall Study|Adverse Event|1|||
156777528|NCT04044690|565936951|FG000|Period 1|Lack of Efficacy|1|||
156777529|NCT04044690|565936952|FG001|Period 1|Lack of Efficacy|1|||
156777530|NCT04044690|565936951|FG000|Period 1|Adverse Event|4|||
156777531|NCT04044690|565936952|FG001|Period 1|Adverse Event|2|||
156777532|NCT04044690|565936951|FG000|Period 1|Physician Decision|0|||
156777533|NCT04044690|565936952|FG001|Period 1|Physician Decision|1|||
156777534|NCT04044690|565936951|FG000|Period 1|Withdrawal by Subject|2|||
156777535|NCT04044690|565936952|FG001|Period 1|Withdrawal by Subject|5|||
156777536|NCT04044690|565936951|FG000|Period 1|Protocol Deviation|2|||
156777537|NCT04044690|565936952|FG001|Period 1|Protocol Deviation|0|||
156777538|NCT04044690|565936951|FG000|Period 1|Site Terminated by Sponsor|0|||
156777539|NCT04044690|565936952|FG001|Period 1|Site Terminated by Sponsor|1|||
156777540|NCT04044690|565936951|FG000|Period 1|Study Terminated by Sponsor|0|||
156777541|NCT04044690|565936952|FG001|Period 1|Study Terminated by Sponsor|1|||
156777542|NCT04044690|565936951|FG000|Period 1|Death|1|||
156777543|NCT04044690|565936952|FG001|Period 1|Death|1|||
156777544|NCT04044690|565936951|FG000|Period 1|Other: Unspecified|1|||
156777545|NCT04044690|565936952|FG001|Period 1|Other: Unspecified|0|||
156777546|NCT04044690|565936951|FG000|Period 2|Lack of Efficacy|0|||
156777547|NCT04044690|565936952|FG001|Period 2|Lack of Efficacy|1|||
156777548|NCT04044690|565936951|FG000|Period 2|Adverse Event|0|||
156777549|NCT04044690|565936952|FG001|Period 2|Adverse Event|1|||
156777550|NCT04044690|565936951|FG000|Period 2|Physician Decision|0|||
156777551|NCT04044690|565936952|FG001|Period 2|Physician Decision|2|||
156777552|NCT04044690|565936951|FG000|Period 2|Withdrawal by Subject|5|||
156777553|NCT04044690|565936952|FG001|Period 2|Withdrawal by Subject|5|||
156777554|NCT04044690|565936951|FG000|Period 2|Lost to Follow-up|0|||
156777555|NCT04044690|565936952|FG001|Period 2|Lost to Follow-up|1|||
156777556|NCT04044690|565936951|FG000|Period 2|Site Terminated by Sponsor|1|||
156777557|NCT04044690|565936952|FG001|Period 2|Site Terminated by Sponsor|3|||
156777558|NCT04044690|565936951|FG000|Period 2|Study Terminated by Sponsor|8|||
156777559|NCT04044690|565936952|FG001|Period 2|Study Terminated by Sponsor|3|||
156777560|NCT04044690|565936951|FG000|Period 2|Death|1|||
156777561|NCT04044690|565936952|FG001|Period 2|Death|0|||
156777562|NCT04044690|565936951|FG000|Period 2|Other: Unspecified|1|||
156777563|NCT04044690|565936952|FG001|Period 2|Other: Unspecified|1|||
156777564|NCT04044690|565936951|FG000|Period 3|Site Terminated by Sponsor|1|||
156460564|NCT04625725|564781650|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
156777565|NCT04044690|565936952|FG001|Period 3|Site Terminated by Sponsor|2|||
156777566|NCT04044690|565936951|FG000|Period 3|Study Terminated by Sponsor|24|||
156777567|NCT04044690|565936952|FG001|Period 3|Study Terminated by Sponsor|18|||
156777568|NCT04044690|565936951|FG000|Period 3|Missing|0|||
156777569|NCT04044690|565936952|FG001|Period 3|Missing|2|||
156777570|NCT01582451|565936958|FG000|Overall Study|Adverse Event|1|||
156777571|NCT01582451|565936959|FG001|Overall Study|Adverse Event|3|||
156777572|NCT01582451|565936958|FG000|Overall Study|Death|3|||
156777573|NCT01582451|565936959|FG001|Overall Study|Death|3|||
156777574|NCT01582451|565936958|FG000|Overall Study|Lost to Follow-up|0|||
156777575|NCT01582451|565936959|FG001|Overall Study|Lost to Follow-up|2|||
156777576|NCT01582451|565936958|FG000|Overall Study|Protocol Violation|11|||
156777577|NCT01582451|565936959|FG001|Overall Study|Protocol Violation|3|||
156325305|NCT01505647|564290930|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
156325306|NCT01505647|564290931|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
156325307|NCT01505647|564290930|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
156325308|NCT01505647|564290931|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
156325309|NCT01505647|564290930|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
156325310|NCT01505647|564290931|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
156325311|NCT01758289|564290932|FG000|Overall Study|Premature Study Termination|44|||
156325312|NCT01758289|564290932|FG000|Overall Study|Adverse Event|9|||
156325313|NCT01574079|564290933|FG000|Overall Study|Physician Decision|0|||
156325314|NCT01574079|564290934|FG001|Overall Study|Physician Decision|2|||
156325315|NCT01574079|564290933|FG000|Overall Study|Lost to Follow-up|1|||
156325316|NCT01574079|564290934|FG001|Overall Study|Lost to Follow-up|0|||
156325317|NCT03640559|564290940|FG000|Overall Study|Physician Decision|1|||
156325318|NCT03640559|564290941|FG001|Overall Study|Physician Decision|1|||
156325319|NCT03640559|564290940|FG000|Overall Study|Withdrawal by Subject|1|||
156325320|NCT03640559|564290941|FG001|Overall Study|Withdrawal by Subject|0|||
156325321|NCT01436162|564290942|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
156325322|NCT01436162|564290943|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
156325323|NCT01436162|564290944|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
156325324|NCT01436162|564290942|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
156666740|NCT00473330|565528835|FG000|Open-label Extension Through Month 48|Death|2|||
156666741|NCT00473330|565528836|FG001|Open-label Extension Through Month 48|Death|0|||
156666742|NCT00473330|565528837|FG002|Open-label Extension Through Month 48|Death|0|||
156666743|NCT00473330|565528835|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
156666744|NCT00473330|565528836|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
156666745|NCT00473330|565528837|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
156666746|NCT00473330|565528835|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
156666747|NCT00473330|565528836|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
156666748|NCT00473330|565528837|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
156666749|NCT00473330|565528835|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
156777578|NCT01582451|565936958|FG000|Overall Study|Withdrawal by Subject|13|||
156777579|NCT01582451|565936959|FG001|Overall Study|Withdrawal by Subject|9|||
156777580|NCT01582451|565936958|FG000|Overall Study|Physician Decision|3|||
156777581|NCT01582451|565936959|FG001|Overall Study|Physician Decision|0|||
156777582|NCT01582451|565936958|FG000|Overall Study|Sponsor Decision|1|||
156777583|NCT01582451|565936959|FG001|Overall Study|Sponsor Decision|0|||
156777584|NCT05472142|565936962|FG000|Total Participants|Lost to Follow-up|312|||
156777585|NCT05472142|565936963|FG001|Total Participants|Lost to Follow-up|0|||
156777586|NCT05472142|565936962|FG000|Clinic Patients|Lost to Follow-up|312|||
156777587|NCT05472142|565936963|FG001|Clinic Patients|Lost to Follow-up|0|||
156777588|NCT04092777|565936964|FG000|Overall Study|Lost to Follow-up|28|||
156777589|NCT04092777|565936965|FG001|Overall Study|Lost to Follow-up|46|||
156777590|NCT04092777|565936964|FG000|Overall Study|Withdrawal by Subject|8|||
156777591|NCT04092777|565936965|FG001|Overall Study|Withdrawal by Subject|5|||
156777592|NCT03765073|565936966|FG000|Stage 1|Lost to Follow-up|1|||
156777593|NCT03765073|565936967|FG001|Stage 1|Lost to Follow-up|0|||
156777594|NCT03765073|565936968|FG002|Stage 1|Lost to Follow-up|0|||
156777595|NCT03765073|565936969|FG003|Stage 1|Lost to Follow-up|0|||
156777596|NCT03765073|565936970|FG004|Stage 1|Lost to Follow-up|0|||
156777597|NCT03765073|565936971|FG005|Stage 1|Lost to Follow-up|0|||
156777598|NCT03765073|565936972|FG006|Stage 1|Lost to Follow-up|0|||
156777599|NCT03765073|565936973|FG007|Stage 1|Lost to Follow-up|0|||
156777600|NCT03765073|565936974|FG008|Stage 1|Lost to Follow-up|0|||
156777601|NCT03765073|565936975|FG009|Stage 1|Lost to Follow-up|0|||
156777602|NCT03765073|565936976|FG010|Stage 1|Lost to Follow-up|0|||
156777603|NCT03765073|565936977|FG011|Stage 1|Lost to Follow-up|0|||
156777604|NCT03765073|565936978|FG012|Stage 1|Lost to Follow-up|0|||
156777605|NCT03765073|565936979|FG013|Stage 1|Lost to Follow-up|0|||
156777606|NCT03765073|565936980|FG014|Stage 1|Lost to Follow-up|0|||
156777607|NCT03765073|565936981|FG015|Stage 1|Lost to Follow-up|0|||
156777608|NCT03765073|565936982|FG016|Stage 1|Lost to Follow-up|0|||
156777609|NCT03765073|565936983|FG017|Stage 1|Lost to Follow-up|0|||
156777610|NCT03765073|565936984|FG018|Stage 1|Lost to Follow-up|0|||
156777611|NCT03765073|565936985|FG019|Stage 1|Lost to Follow-up|0|||
156777612|NCT03765073|565936986|FG020|Stage 1|Lost to Follow-up|0|||
156777613|NCT03765073|565936966|FG000|Stage 1|Withdrawal by participant|0|||
156777614|NCT03765073|565936967|FG001|Stage 1|Withdrawal by participant|1|||
156777615|NCT03765073|565936968|FG002|Stage 1|Withdrawal by participant|0|||
156777616|NCT03765073|565936969|FG003|Stage 1|Withdrawal by participant|0|||
156325325|NCT01436162|564290943|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
156325326|NCT01436162|564290944|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
156777617|NCT03765073|565936970|FG004|Stage 1|Withdrawal by participant|0|||
156777618|NCT03765073|565936971|FG005|Stage 1|Withdrawal by participant|0|||
156777619|NCT03765073|565936972|FG006|Stage 1|Withdrawal by participant|0|||
156777620|NCT03765073|565936973|FG007|Stage 1|Withdrawal by participant|0|||
156777621|NCT03765073|565936974|FG008|Stage 1|Withdrawal by participant|0|||
156777622|NCT03765073|565936975|FG009|Stage 1|Withdrawal by participant|0|||
156777623|NCT03765073|565936976|FG010|Stage 1|Withdrawal by participant|0|||
156777624|NCT03765073|565936977|FG011|Stage 1|Withdrawal by participant|0|||
156777625|NCT03765073|565936978|FG012|Stage 1|Withdrawal by participant|0|||
156777626|NCT03765073|565936979|FG013|Stage 1|Withdrawal by participant|0|||
156777627|NCT03765073|565936980|FG014|Stage 1|Withdrawal by participant|0|||
156777628|NCT03765073|565936981|FG015|Stage 1|Withdrawal by participant|0|||
156777629|NCT03765073|565936982|FG016|Stage 1|Withdrawal by participant|0|||
156777630|NCT03765073|565936983|FG017|Stage 1|Withdrawal by participant|0|||
156777631|NCT03765073|565936984|FG018|Stage 1|Withdrawal by participant|0|||
156777632|NCT03765073|565936985|FG019|Stage 1|Withdrawal by participant|0|||
156777633|NCT03765073|565936986|FG020|Stage 1|Withdrawal by participant|0|||
156777634|NCT03765073|565936966|FG000|Stage 2|Death|0|||
156777635|NCT03765073|565936967|FG001|Stage 2|Death|0|||
156777636|NCT03765073|565936968|FG002|Stage 2|Death|0|||
156777637|NCT03765073|565936969|FG003|Stage 2|Death|0|||
156777638|NCT03765073|565936970|FG004|Stage 2|Death|0|||
156777639|NCT03765073|565936971|FG005|Stage 2|Death|0|||
156777640|NCT03765073|565936972|FG006|Stage 2|Death|0|||
156777641|NCT03765073|565936973|FG007|Stage 2|Death|0|||
156777642|NCT03765073|565936974|FG008|Stage 2|Death|0|||
156777643|NCT03765073|565936975|FG009|Stage 2|Death|1|||
156777644|NCT03765073|565936976|FG010|Stage 2|Death|0|||
156777645|NCT03765073|565936977|FG011|Stage 2|Death|1|||
156777646|NCT03765073|565936978|FG012|Stage 2|Death|0|||
156777647|NCT03765073|565936979|FG013|Stage 2|Death|0|||
156777648|NCT03765073|565936980|FG014|Stage 2|Death|0|||
156777649|NCT03765073|565936981|FG015|Stage 2|Death|0|||
156777650|NCT03765073|565936982|FG016|Stage 2|Death|2|||
156777651|NCT03765073|565936983|FG017|Stage 2|Death|0|||
156777652|NCT03765073|565936984|FG018|Stage 2|Death|0|||
156777653|NCT03765073|565936985|FG019|Stage 2|Death|0|||
156777654|NCT03765073|565936986|FG020|Stage 2|Death|0|||
156777655|NCT03765073|565936966|FG000|Stage 2|Lost to Follow-up|0|||
156777656|NCT03765073|565936967|FG001|Stage 2|Lost to Follow-up|0|||
156777657|NCT03765073|565936968|FG002|Stage 2|Lost to Follow-up|0|||
156777658|NCT03765073|565936969|FG003|Stage 2|Lost to Follow-up|5|||
156777659|NCT03765073|565936970|FG004|Stage 2|Lost to Follow-up|1|||
156777660|NCT03765073|565936971|FG005|Stage 2|Lost to Follow-up|0|||
156777661|NCT03765073|565936972|FG006|Stage 2|Lost to Follow-up|3|||
156777662|NCT03765073|565936973|FG007|Stage 2|Lost to Follow-up|3|||
156777663|NCT03765073|565936974|FG008|Stage 2|Lost to Follow-up|1|||
156777664|NCT03765073|565936975|FG009|Stage 2|Lost to Follow-up|6|||
156777665|NCT03765073|565936976|FG010|Stage 2|Lost to Follow-up|5|||
156777666|NCT03765073|565936977|FG011|Stage 2|Lost to Follow-up|1|||
156777667|NCT03765073|565936978|FG012|Stage 2|Lost to Follow-up|1|||
156777668|NCT03765073|565936979|FG013|Stage 2|Lost to Follow-up|3|||
156777669|NCT03765073|565936980|FG014|Stage 2|Lost to Follow-up|3|||
156777670|NCT03765073|565936981|FG015|Stage 2|Lost to Follow-up|1|||
156777671|NCT03765073|565936982|FG016|Stage 2|Lost to Follow-up|6|||
156777672|NCT03765073|565936983|FG017|Stage 2|Lost to Follow-up|0|||
156777673|NCT03765073|565936984|FG018|Stage 2|Lost to Follow-up|0|||
156777674|NCT03765073|565936985|FG019|Stage 2|Lost to Follow-up|0|||
156777675|NCT03765073|565936986|FG020|Stage 2|Lost to Follow-up|0|||
156777676|NCT03765073|565936966|FG000|Stage 2|Other|0|||
156777677|NCT03765073|565936967|FG001|Stage 2|Other|0|||
156777678|NCT03765073|565936968|FG002|Stage 2|Other|0|||
156777679|NCT03765073|565936969|FG003|Stage 2|Other|0|||
156777680|NCT03765073|565936970|FG004|Stage 2|Other|0|||
156430055|NCT03536884|564663346|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156430056|NCT03536884|564663347|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156460565|NCT04625725|564781651|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
156777681|NCT03765073|565936971|FG005|Stage 2|Other|0|||
156777682|NCT03765073|565936972|FG006|Stage 2|Other|0|||
156777683|NCT03765073|565936973|FG007|Stage 2|Other|1|||
156777684|NCT03765073|565936974|FG008|Stage 2|Other|1|||
156777685|NCT03765073|565936975|FG009|Stage 2|Other|3|||
156777686|NCT03765073|565936976|FG010|Stage 2|Other|0|||
156777687|NCT03765073|565936977|FG011|Stage 2|Other|0|||
156777688|NCT03765073|565936978|FG012|Stage 2|Other|0|||
156777689|NCT03765073|565936979|FG013|Stage 2|Other|0|||
156777690|NCT03765073|565936980|FG014|Stage 2|Other|0|||
156777691|NCT03765073|565936981|FG015|Stage 2|Other|1|||
156777692|NCT03765073|565936982|FG016|Stage 2|Other|2|||
156777693|NCT03765073|565936983|FG017|Stage 2|Other|0|||
156777694|NCT03765073|565936984|FG018|Stage 2|Other|0|||
156777695|NCT03765073|565936985|FG019|Stage 2|Other|0|||
156777696|NCT03765073|565936986|FG020|Stage 2|Other|0|||
156777697|NCT03765073|565936966|FG000|Stage 2|Withdrawal by parent/guardian|0|||
156777698|NCT03765073|565936967|FG001|Stage 2|Withdrawal by parent/guardian|0|||
156777699|NCT03765073|565936968|FG002|Stage 2|Withdrawal by parent/guardian|0|||
156777700|NCT03765073|565936969|FG003|Stage 2|Withdrawal by parent/guardian|0|||
156777701|NCT03765073|565936970|FG004|Stage 2|Withdrawal by parent/guardian|0|||
156777702|NCT03765073|565936971|FG005|Stage 2|Withdrawal by parent/guardian|0|||
156777703|NCT03765073|565936972|FG006|Stage 2|Withdrawal by parent/guardian|0|||
156777704|NCT03765073|565936973|FG007|Stage 2|Withdrawal by parent/guardian|0|||
156777705|NCT03765073|565936974|FG008|Stage 2|Withdrawal by parent/guardian|0|||
156777706|NCT03765073|565936975|FG009|Stage 2|Withdrawal by parent/guardian|0|||
156777707|NCT03765073|565936976|FG010|Stage 2|Withdrawal by parent/guardian|3|||
156430057|NCT03536884|564663348|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156430058|NCT03536884|564663349|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156430059|NCT03536884|564663350|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156430060|NCT03536884|564663351|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156430061|NCT03536884|564663352|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156430062|NCT03536884|564663353|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156430063|NCT03536884|564663354|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
156777708|NCT03765073|565936977|FG011|Stage 2|Withdrawal by parent/guardian|3|||
156777709|NCT03765073|565936978|FG012|Stage 2|Withdrawal by parent/guardian|3|||
156777710|NCT03765073|565936979|FG013|Stage 2|Withdrawal by parent/guardian|1|||
156777711|NCT03765073|565936980|FG014|Stage 2|Withdrawal by parent/guardian|1|||
156777712|NCT03765073|565936981|FG015|Stage 2|Withdrawal by parent/guardian|0|||
156777713|NCT03765073|565936982|FG016|Stage 2|Withdrawal by parent/guardian|3|||
156777714|NCT03765073|565936983|FG017|Stage 2|Withdrawal by parent/guardian|0|||
156777715|NCT03765073|565936984|FG018|Stage 2|Withdrawal by parent/guardian|0|||
156777716|NCT03765073|565936985|FG019|Stage 2|Withdrawal by parent/guardian|0|||
156777717|NCT03765073|565936986|FG020|Stage 2|Withdrawal by parent/guardian|0|||
156777718|NCT03765073|565936966|FG000|Stage 2|Withdrawal by Subject|0|||
156777719|NCT03765073|565936967|FG001|Stage 2|Withdrawal by Subject|0|||
156777720|NCT03765073|565936968|FG002|Stage 2|Withdrawal by Subject|0|||
156777721|NCT03765073|565936969|FG003|Stage 2|Withdrawal by Subject|3|||
156777722|NCT03765073|565936970|FG004|Stage 2|Withdrawal by Subject|3|||
156777723|NCT03765073|565936971|FG005|Stage 2|Withdrawal by Subject|3|||
156777724|NCT03765073|565936972|FG006|Stage 2|Withdrawal by Subject|0|||
156777725|NCT03765073|565936973|FG007|Stage 2|Withdrawal by Subject|1|||
156777726|NCT03765073|565936974|FG008|Stage 2|Withdrawal by Subject|0|||
156777727|NCT03765073|565936975|FG009|Stage 2|Withdrawal by Subject|5|||
156777728|NCT03765073|565936976|FG010|Stage 2|Withdrawal by Subject|0|||
156777729|NCT03765073|565936977|FG011|Stage 2|Withdrawal by Subject|0|||
156777730|NCT03765073|565936978|FG012|Stage 2|Withdrawal by Subject|0|||
156777731|NCT03765073|565936979|FG013|Stage 2|Withdrawal by Subject|0|||
156777732|NCT03765073|565936980|FG014|Stage 2|Withdrawal by Subject|0|||
156777733|NCT03765073|565936981|FG015|Stage 2|Withdrawal by Subject|0|||
156777734|NCT03765073|565936982|FG016|Stage 2|Withdrawal by Subject|0|||
156777735|NCT03765073|565936983|FG017|Stage 2|Withdrawal by Subject|0|||
156777736|NCT03765073|565936984|FG018|Stage 2|Withdrawal by Subject|0|||
156777737|NCT03765073|565936985|FG019|Stage 2|Withdrawal by Subject|0|||
156777738|NCT03765073|565936986|FG020|Stage 2|Withdrawal by Subject|0|||
156777739|NCT03765073|565936966|FG000|Stage 3|Adverse Event|0|||
156777740|NCT03765073|565936967|FG001|Stage 3|Adverse Event|0|||
156777741|NCT03765073|565936968|FG002|Stage 3|Adverse Event|0|||
156777742|NCT03765073|565936969|FG003|Stage 3|Adverse Event|0|||
156777743|NCT03765073|565936970|FG004|Stage 3|Adverse Event|0|||
156777744|NCT03765073|565936971|FG005|Stage 3|Adverse Event|0|||
156777745|NCT03765073|565936972|FG006|Stage 3|Adverse Event|0|||
156777746|NCT03765073|565936973|FG007|Stage 3|Adverse Event|0|||
156777747|NCT03765073|565936974|FG008|Stage 3|Adverse Event|0|||
156777748|NCT03765073|565936975|FG009|Stage 3|Adverse Event|0|||
156777749|NCT03765073|565936976|FG010|Stage 3|Adverse Event|0|||
156777750|NCT03765073|565936977|FG011|Stage 3|Adverse Event|0|||
156777751|NCT03765073|565936978|FG012|Stage 3|Adverse Event|0|||
156777752|NCT03765073|565936979|FG013|Stage 3|Adverse Event|0|||
156777753|NCT03765073|565936980|FG014|Stage 3|Adverse Event|0|||
156777754|NCT03765073|565936981|FG015|Stage 3|Adverse Event|0|||
156777755|NCT03765073|565936982|FG016|Stage 3|Adverse Event|0|||
156777756|NCT03765073|565936983|FG017|Stage 3|Adverse Event|0|||
156777757|NCT03765073|565936984|FG018|Stage 3|Adverse Event|1|||
156777758|NCT03765073|565936985|FG019|Stage 3|Adverse Event|0|||
156777759|NCT03765073|565936986|FG020|Stage 3|Adverse Event|0|||
156777760|NCT03765073|565936966|FG000|Stage 3|Death|0|||
156777761|NCT03765073|565936967|FG001|Stage 3|Death|0|||
156777762|NCT03765073|565936968|FG002|Stage 3|Death|0|||
156777763|NCT03765073|565936969|FG003|Stage 3|Death|0|||
156777764|NCT03765073|565936970|FG004|Stage 3|Death|0|||
156777765|NCT03765073|565936971|FG005|Stage 3|Death|0|||
156777766|NCT03765073|565936972|FG006|Stage 3|Death|0|||
156777767|NCT03765073|565936973|FG007|Stage 3|Death|0|||
156777768|NCT03765073|565936974|FG008|Stage 3|Death|0|||
156777769|NCT03765073|565936975|FG009|Stage 3|Death|0|||
156777770|NCT03765073|565936976|FG010|Stage 3|Death|0|||
156777771|NCT03765073|565936977|FG011|Stage 3|Death|0|||
156777772|NCT03765073|565936978|FG012|Stage 3|Death|0|||
156777773|NCT03765073|565936979|FG013|Stage 3|Death|0|||
156777774|NCT03765073|565936980|FG014|Stage 3|Death|0|||
156777775|NCT03765073|565936981|FG015|Stage 3|Death|0|||
156777776|NCT03765073|565936982|FG016|Stage 3|Death|0|||
156777777|NCT03765073|565936983|FG017|Stage 3|Death|0|||
156777778|NCT03765073|565936984|FG018|Stage 3|Death|0|||
156777779|NCT03765073|565936985|FG019|Stage 3|Death|3|||
156777780|NCT03765073|565936986|FG020|Stage 3|Death|2|||
156777781|NCT03765073|565936966|FG000|Stage 3|Lost to Follow-up|0|||
156777782|NCT03765073|565936967|FG001|Stage 3|Lost to Follow-up|0|||
156666750|NCT00473330|565528836|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
156666751|NCT00473330|565528837|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
156666752|NCT00473330|565528835|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
156666753|NCT00473330|565528836|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
156666754|NCT00473330|565528837|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
156666755|NCT00473330|565528835|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
156666756|NCT00473330|565528836|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
156666757|NCT00473330|565528837|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
156666758|NCT00473330|565528835|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
156666759|NCT00473330|565528836|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
156666760|NCT00473330|565528837|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
156666761|NCT00473330|565528835|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
156666762|NCT00473330|565528836|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
156666763|NCT00473330|565528837|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
156666764|NCT00473330|565528835|FG000|Open-label Extension Through Month 60|Death|2|||
156666765|NCT00473330|565528836|FG001|Open-label Extension Through Month 60|Death|2|||
156666766|NCT00473330|565528837|FG002|Open-label Extension Through Month 60|Death|1|||
156666767|NCT00473330|565528835|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
156666768|NCT00473330|565528836|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
156666769|NCT00473330|565528837|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
156666770|NCT00473330|565528835|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
156666771|NCT00473330|565528836|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
156666772|NCT00473330|565528837|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
156777783|NCT03765073|565936968|FG002|Stage 3|Lost to Follow-up|0|||
156777784|NCT03765073|565936969|FG003|Stage 3|Lost to Follow-up|0|||
156777785|NCT03765073|565936970|FG004|Stage 3|Lost to Follow-up|0|||
156777786|NCT03765073|565936971|FG005|Stage 3|Lost to Follow-up|0|||
156777787|NCT03765073|565936972|FG006|Stage 3|Lost to Follow-up|0|||
156777788|NCT03765073|565936973|FG007|Stage 3|Lost to Follow-up|0|||
156777789|NCT03765073|565936974|FG008|Stage 3|Lost to Follow-up|0|||
156777790|NCT03765073|565936975|FG009|Stage 3|Lost to Follow-up|0|||
156777791|NCT03765073|565936976|FG010|Stage 3|Lost to Follow-up|0|||
156777792|NCT03765073|565936977|FG011|Stage 3|Lost to Follow-up|0|||
156777793|NCT03765073|565936978|FG012|Stage 3|Lost to Follow-up|0|||
156777794|NCT03765073|565936979|FG013|Stage 3|Lost to Follow-up|0|||
156777795|NCT03765073|565936980|FG014|Stage 3|Lost to Follow-up|0|||
156777796|NCT03765073|565936981|FG015|Stage 3|Lost to Follow-up|0|||
156777797|NCT03765073|565936982|FG016|Stage 3|Lost to Follow-up|0|||
156777798|NCT03765073|565936983|FG017|Stage 3|Lost to Follow-up|8|||
156777799|NCT03765073|565936984|FG018|Stage 3|Lost to Follow-up|5|||
156777800|NCT03765073|565936985|FG019|Stage 3|Lost to Follow-up|7|||
156777801|NCT03765073|565936986|FG020|Stage 3|Lost to Follow-up|4|||
156777802|NCT03765073|565936966|FG000|Stage 3|No longer meets eligibility criteria|0|||
156777803|NCT03765073|565936967|FG001|Stage 3|No longer meets eligibility criteria|0|||
156777804|NCT03765073|565936968|FG002|Stage 3|No longer meets eligibility criteria|0|||
156777805|NCT03765073|565936969|FG003|Stage 3|No longer meets eligibility criteria|0|||
156777806|NCT03765073|565936970|FG004|Stage 3|No longer meets eligibility criteria|0|||
156777807|NCT03765073|565936971|FG005|Stage 3|No longer meets eligibility criteria|0|||
156777808|NCT03765073|565936972|FG006|Stage 3|No longer meets eligibility criteria|0|||
156777809|NCT03765073|565936973|FG007|Stage 3|No longer meets eligibility criteria|0|||
156777810|NCT03765073|565936974|FG008|Stage 3|No longer meets eligibility criteria|0|||
156777811|NCT03765073|565936975|FG009|Stage 3|No longer meets eligibility criteria|0|||
156777812|NCT03765073|565936976|FG010|Stage 3|No longer meets eligibility criteria|0|||
156524671|NCT00819390|565015669|FG001|Overall Study|Withdrawal by Subject|0|||
156524672|NCT00819390|565015670|FG002|Overall Study|Withdrawal by Subject|0|||
156524673|NCT00819390|565015671|FG003|Overall Study|Withdrawal by Subject|0|||
156524674|NCT00819390|565015668|FG000|Overall Study|Adverse Event|0|||
156524675|NCT00819390|565015669|FG001|Overall Study|Adverse Event|0|||
156524676|NCT00819390|565015670|FG002|Overall Study|Adverse Event|1|||
156524677|NCT00819390|565015671|FG003|Overall Study|Adverse Event|0|||
156524678|NCT01209780|565015672|FG000|Overall Study|Adverse Event|0|||
156524679|NCT01209780|565015673|FG001|Overall Study|Adverse Event|1|||
156524680|NCT01209780|565015674|FG002|Overall Study|Adverse Event|0|||
156524681|NCT01209780|565015675|FG003|Overall Study|Adverse Event|0|||
156524682|NCT01209780|565015676|FG004|Overall Study|Adverse Event|0|||
156524683|NCT01209780|565015672|FG000|Overall Study|Withdrawal by Subject|9|||
156524684|NCT01209780|565015673|FG001|Overall Study|Withdrawal by Subject|2|||
156777813|NCT03765073|565936977|FG011|Stage 3|No longer meets eligibility criteria|0|||
156777814|NCT03765073|565936978|FG012|Stage 3|No longer meets eligibility criteria|0|||
156777815|NCT03765073|565936979|FG013|Stage 3|No longer meets eligibility criteria|0|||
156777816|NCT03765073|565936980|FG014|Stage 3|No longer meets eligibility criteria|0|||
156524685|NCT01209780|565015674|FG002|Overall Study|Withdrawal by Subject|1|||
156666773|NCT00473330|565528835|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
156666774|NCT00473330|565528836|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
156666775|NCT00473330|565528837|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
156666776|NCT00473330|565528835|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
156666777|NCT00473330|565528836|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
156666778|NCT00473330|565528837|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
156666779|NCT00473330|565528835|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
156666780|NCT00473330|565528836|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
156666781|NCT00473330|565528837|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
156666782|NCT00473330|565528835|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
156666783|NCT00473330|565528836|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
156666784|NCT00473330|565528837|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
156666785|NCT01975948|565528839|FG000|Overall Study|Withdrawal by Subject|17|||
156666786|NCT01975948|565528840|FG001|Overall Study|Withdrawal by Subject|21|||
156666787|NCT01975948|565528841|FG002|Overall Study|Withdrawal by Subject|7|||
156666788|NCT01975948|565528842|FG003|Overall Study|Withdrawal by Subject|6|||
156666789|NCT00365846|565528843|FG000|Overall Study|Lost to Follow-up|1|||
156666790|NCT00904215|565528844|FG000|Overall Study|Adverse Event|25|||
156666791|NCT00904215|565528844|FG000|Overall Study|Protocol Violation|10|||
156777817|NCT03765073|565936981|FG015|Stage 3|No longer meets eligibility criteria|0|||
156777818|NCT03765073|565936982|FG016|Stage 3|No longer meets eligibility criteria|0|||
156777819|NCT03765073|565936983|FG017|Stage 3|No longer meets eligibility criteria|0|||
156777820|NCT03765073|565936984|FG018|Stage 3|No longer meets eligibility criteria|1|||
156777821|NCT03765073|565936985|FG019|Stage 3|No longer meets eligibility criteria|0|||
156777822|NCT03765073|565936986|FG020|Stage 3|No longer meets eligibility criteria|1|||
156777823|NCT03765073|565936966|FG000|Stage 3|Other|0|||
156777824|NCT03765073|565936967|FG001|Stage 3|Other|0|||
156777825|NCT03765073|565936968|FG002|Stage 3|Other|0|||
156777826|NCT03765073|565936969|FG003|Stage 3|Other|0|||
156777827|NCT03765073|565936970|FG004|Stage 3|Other|0|||
156777828|NCT03765073|565936971|FG005|Stage 3|Other|0|||
156666792|NCT00904215|565528844|FG000|Overall Study|Lost to Follow-up|63|||
156666793|NCT00904215|565528844|FG000|Overall Study|Withdrawal by Subject|9|||
156666794|NCT00904215|565528844|FG000|Overall Study|Other|28|||
156666795|NCT00640562|565528845|FG000|Overall Study|Adverse Event|8|||
156666796|NCT00640562|565528846|FG001|Overall Study|Adverse Event|5|||
156666797|NCT00640562|565528845|FG000|Overall Study|Lack of Efficacy|1|||
156666798|NCT00640562|565528846|FG001|Overall Study|Lack of Efficacy|4|||
156666799|NCT00640562|565528845|FG000|Overall Study|Protocol Violation|2|||
156666800|NCT00640562|565528846|FG001|Overall Study|Protocol Violation|4|||
156777829|NCT03765073|565936972|FG006|Stage 3|Other|0|||
156777830|NCT03765073|565936973|FG007|Stage 3|Other|0|||
156777831|NCT03765073|565936974|FG008|Stage 3|Other|0|||
156777832|NCT03765073|565936975|FG009|Stage 3|Other|0|||
156777833|NCT03765073|565936976|FG010|Stage 3|Other|0|||
156777834|NCT03765073|565936977|FG011|Stage 3|Other|0|||
156777835|NCT03765073|565936978|FG012|Stage 3|Other|0|||
156777836|NCT03765073|565936979|FG013|Stage 3|Other|0|||
156777837|NCT03765073|565936980|FG014|Stage 3|Other|0|||
156777838|NCT03765073|565936981|FG015|Stage 3|Other|0|||
156777839|NCT03765073|565936982|FG016|Stage 3|Other|0|||
156777840|NCT03765073|565936983|FG017|Stage 3|Other|1|||
156777841|NCT03765073|565936984|FG018|Stage 3|Other|2|||
156777842|NCT03765073|565936985|FG019|Stage 3|Other|2|||
156777843|NCT03765073|565936986|FG020|Stage 3|Other|2|||
156777844|NCT03765073|565936966|FG000|Stage 3|Withdrawal by parent/guardian|0|||
156777845|NCT03765073|565936967|FG001|Stage 3|Withdrawal by parent/guardian|0|||
156524686|NCT01209780|565015675|FG003|Overall Study|Withdrawal by Subject|1|||
156524687|NCT01209780|565015676|FG004|Overall Study|Withdrawal by Subject|0|||
156777846|NCT03765073|565936968|FG002|Stage 3|Withdrawal by parent/guardian|0|||
156777847|NCT03765073|565936969|FG003|Stage 3|Withdrawal by parent/guardian|0|||
156777848|NCT03765073|565936970|FG004|Stage 3|Withdrawal by parent/guardian|0|||
156777849|NCT03765073|565936971|FG005|Stage 3|Withdrawal by parent/guardian|0|||
156524688|NCT01209780|565015672|FG000|Overall Study|Lost to Follow-up|17|||
156666801|NCT00640562|565528845|FG000|Overall Study|Withdrawal by Subject|6|||
156666802|NCT00640562|565528846|FG001|Overall Study|Withdrawal by Subject|10|||
156777850|NCT03765073|565936972|FG006|Stage 3|Withdrawal by parent/guardian|0|||
156777851|NCT03765073|565936973|FG007|Stage 3|Withdrawal by parent/guardian|0|||
156777852|NCT03765073|565936974|FG008|Stage 3|Withdrawal by parent/guardian|0|||
156777853|NCT03765073|565936975|FG009|Stage 3|Withdrawal by parent/guardian|0|||
156777854|NCT03765073|565936976|FG010|Stage 3|Withdrawal by parent/guardian|0|||
156777855|NCT03765073|565936977|FG011|Stage 3|Withdrawal by parent/guardian|0|||
156777856|NCT03765073|565936978|FG012|Stage 3|Withdrawal by parent/guardian|0|||
156777857|NCT03765073|565936979|FG013|Stage 3|Withdrawal by parent/guardian|0|||
156777858|NCT03765073|565936980|FG014|Stage 3|Withdrawal by parent/guardian|0|||
156777859|NCT03765073|565936981|FG015|Stage 3|Withdrawal by parent/guardian|0|||
156777860|NCT03765073|565936982|FG016|Stage 3|Withdrawal by parent/guardian|0|||
156777861|NCT03765073|565936983|FG017|Stage 3|Withdrawal by parent/guardian|0|||
156777862|NCT03765073|565936984|FG018|Stage 3|Withdrawal by parent/guardian|0|||
156777863|NCT03765073|565936985|FG019|Stage 3|Withdrawal by parent/guardian|6|||
156777864|NCT03765073|565936986|FG020|Stage 3|Withdrawal by parent/guardian|9|||
156777865|NCT03765073|565936966|FG000|Stage 3|Withdrawal by Subject|0|||
156777866|NCT03765073|565936967|FG001|Stage 3|Withdrawal by Subject|0|||
156777867|NCT03765073|565936968|FG002|Stage 3|Withdrawal by Subject|0|||
156777868|NCT03765073|565936969|FG003|Stage 3|Withdrawal by Subject|0|||
156777869|NCT03765073|565936970|FG004|Stage 3|Withdrawal by Subject|0|||
156777870|NCT03765073|565936971|FG005|Stage 3|Withdrawal by Subject|0|||
156777871|NCT03765073|565936972|FG006|Stage 3|Withdrawal by Subject|0|||
156777872|NCT03765073|565936973|FG007|Stage 3|Withdrawal by Subject|0|||
156777873|NCT03765073|565936974|FG008|Stage 3|Withdrawal by Subject|0|||
156777874|NCT03765073|565936975|FG009|Stage 3|Withdrawal by Subject|0|||
156777875|NCT03765073|565936976|FG010|Stage 3|Withdrawal by Subject|0|||
156777876|NCT03765073|565936977|FG011|Stage 3|Withdrawal by Subject|0|||
156777877|NCT03765073|565936978|FG012|Stage 3|Withdrawal by Subject|0|||
156524689|NCT01209780|565015673|FG001|Overall Study|Lost to Follow-up|12|||
156524690|NCT01209780|565015674|FG002|Overall Study|Lost to Follow-up|3|||
156524691|NCT01209780|565015675|FG003|Overall Study|Lost to Follow-up|9|||
156524692|NCT01209780|565015676|FG004|Overall Study|Lost to Follow-up|4|||
156524693|NCT01209780|565015672|FG000|Overall Study|Protocol Violation|0|||
156524694|NCT01209780|565015673|FG001|Overall Study|Protocol Violation|1|||
156524695|NCT01209780|565015674|FG002|Overall Study|Protocol Violation|0|||
156524696|NCT01209780|565015675|FG003|Overall Study|Protocol Violation|0|||
156524697|NCT01209780|565015676|FG004|Overall Study|Protocol Violation|0|||
156524698|NCT01209780|565015672|FG000|Overall Study|Inappropriate enrollment|0|||
156524699|NCT01209780|565015673|FG001|Overall Study|Inappropriate enrollment|2|||
156524700|NCT01209780|565015674|FG002|Overall Study|Inappropriate enrollment|0|||
156524701|NCT01209780|565015675|FG003|Overall Study|Inappropriate enrollment|0|||
156524702|NCT01209780|565015676|FG004|Overall Study|Inappropriate enrollment|1|||
156524703|NCT02709096|565015677|FG000|Overall Study|non-compliance|1|||
156524704|NCT02709096|565015678|FG001|Overall Study|non-compliance|1|||
156524705|NCT00818649|565015679|FG000|Overall Study|Declining performance status|2|||
156524706|NCT00818649|565015679|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
156524707|NCT00818649|565015679|FG000|Overall Study|Adverse Event|1|||
156524708|NCT03513588|565015680|FG000|Overall Study|Lost to Follow-up|0|||
156524709|NCT03513588|565015681|FG001|Overall Study|Lost to Follow-up|1|||
156524710|NCT03513588|565015682|FG002|Overall Study|Lost to Follow-up|1|||
156524711|NCT03513588|565015680|FG000|Overall Study|Study dosing paused by sponsor|1|||
156524712|NCT03513588|565015681|FG001|Overall Study|Study dosing paused by sponsor|1|||
156524713|NCT03513588|565015682|FG002|Overall Study|Study dosing paused by sponsor|0|||
156524714|NCT03513588|565015680|FG000|Overall Study|Death|0|||
156524715|NCT03513588|565015681|FG001|Overall Study|Death|0|||
156524716|NCT03513588|565015682|FG002|Overall Study|Death|1|||
156524717|NCT00505284|565015683|FG000|Overall Study|Adverse Event|3|||
156524718|NCT00505284|565015684|FG001|Overall Study|Adverse Event|7|||
156524719|NCT00505284|565015685|FG002|Overall Study|Adverse Event|9|||
156524720|NCT00505284|565015686|FG003|Overall Study|Adverse Event|14|||
156524721|NCT00505284|565015687|FG004|Overall Study|Adverse Event|22|||
156524722|NCT00505284|565015683|FG000|Overall Study|Protocol Violation|0|||
156524723|NCT00505284|565015684|FG001|Overall Study|Protocol Violation|1|||
156524724|NCT00505284|565015685|FG002|Overall Study|Protocol Violation|1|||
156524725|NCT00505284|565015686|FG003|Overall Study|Protocol Violation|0|||
156524726|NCT00505284|565015687|FG004|Overall Study|Protocol Violation|0|||
156524727|NCT00505284|565015683|FG000|Overall Study|Withdrawal by Subject|2|||
156524728|NCT00505284|565015684|FG001|Overall Study|Withdrawal by Subject|6|||
156524729|NCT00505284|565015685|FG002|Overall Study|Withdrawal by Subject|1|||
156524730|NCT00505284|565015686|FG003|Overall Study|Withdrawal by Subject|0|||
156524731|NCT00505284|565015687|FG004|Overall Study|Withdrawal by Subject|6|||
156524732|NCT00505284|565015683|FG000|Overall Study|Lack of Efficacy|0|||
156524733|NCT00505284|565015684|FG001|Overall Study|Lack of Efficacy|1|||
156524734|NCT00505284|565015685|FG002|Overall Study|Lack of Efficacy|1|||
156524735|NCT00505284|565015686|FG003|Overall Study|Lack of Efficacy|1|||
156524736|NCT00505284|565015687|FG004|Overall Study|Lack of Efficacy|1|||
156524737|NCT00505284|565015683|FG000|Overall Study|Physician Decision|0|||
156524738|NCT00505284|565015684|FG001|Overall Study|Physician Decision|1|||
156777878|NCT03765073|565936979|FG013|Stage 3|Withdrawal by Subject|0|||
156777879|NCT03765073|565936980|FG014|Stage 3|Withdrawal by Subject|0|||
156524739|NCT00505284|565015685|FG002|Overall Study|Physician Decision|0|||
156524740|NCT00505284|565015686|FG003|Overall Study|Physician Decision|0|||
156524741|NCT00505284|565015687|FG004|Overall Study|Physician Decision|0|||
156524742|NCT00505284|565015683|FG000|Overall Study|Other|5|||
156524743|NCT00505284|565015684|FG001|Overall Study|Other|0|||
156524744|NCT00505284|565015685|FG002|Overall Study|Other|0|||
156524745|NCT00505284|565015686|FG003|Overall Study|Other|4|||
156777880|NCT03765073|565936981|FG015|Stage 3|Withdrawal by Subject|0|||
156777881|NCT03765073|565936982|FG016|Stage 3|Withdrawal by Subject|0|||
156777882|NCT03765073|565936983|FG017|Stage 3|Withdrawal by Subject|8|||
156777883|NCT03765073|565936984|FG018|Stage 3|Withdrawal by Subject|11|||
156777884|NCT03765073|565936985|FG019|Stage 3|Withdrawal by Subject|0|||
156777885|NCT03765073|565936986|FG020|Stage 3|Withdrawal by Subject|0|||
156777886|NCT02550795|565936987|FG000|Overall Study|Physician Decision|0|||
156777887|NCT02550795|565936988|FG001|Overall Study|Physician Decision|1|||
156777888|NCT02550795|565936989|FG002|Overall Study|Physician Decision|0|||
156777889|NCT02225587|565936990|FG000|Overall Study|Adverse Event|5|||
156777890|NCT02225587|565936991|FG001|Overall Study|Adverse Event|5|||
156777891|NCT02225587|565936990|FG000|Overall Study|Lost to Follow-up|5|||
156777892|NCT02225587|565936991|FG001|Overall Study|Lost to Follow-up|5|||
156666803|NCT00640562|565528845|FG000|Overall Study|Known risperidone intolerance|0|||
156666804|NCT00640562|565528846|FG001|Overall Study|Known risperidone intolerance|1|||
156666805|NCT00640562|565528845|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
156666806|NCT00640562|565528846|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
156666807|NCT00640562|565528845|FG000|Overall Study|Low study drug dose|0|||
156666808|NCT00640562|565528846|FG001|Overall Study|Low study drug dose|1|||
156666809|NCT00640562|565528845|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
156666810|NCT00640562|565528846|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
156666811|NCT00448591|565528847|FG000|Overall Study|Withdrawal by Subject|178|||
156666812|NCT00448591|565528847|FG000|Overall Study|Progressive Disease|1382|||
156666813|NCT00448591|565528847|FG000|Overall Study|Adverse Event|382|||
156666814|NCT00448591|565528847|FG000|Overall Study|Protocol Violation|41|||
156666815|NCT00448591|565528847|FG000|Overall Study|Lost to Follow-up|19|||
156666816|NCT00448591|565528847|FG000|Overall Study|Treatment Regimen Completed|70|||
156666817|NCT00448591|565528847|FG000|Overall Study|Other|154|||
156666818|NCT00448591|565528847|FG000|Overall Study|Termination of Study|70|||
156666819|NCT02937870|565528848|FG000|Overall Study|Adverse Event|1|||
156666820|NCT02937870|565528848|FG000|Overall Study|Protocol Deviation|2|||
156666821|NCT00244764|565528849|FG000|Overall Study|Adverse Event|37|||
156666822|NCT00244764|565528849|FG000|Overall Study|Lost to Follow-up|23|||
156666823|NCT00244764|565528849|FG000|Overall Study|Withdrawal by Subject|12|||
156666824|NCT00244764|565528849|FG000|Overall Study|Disease Progression|13|||
156666825|NCT00244764|565528849|FG000|Overall Study|Protocol Violation|2|||
156666826|NCT00244764|565528849|FG000|Overall Study|Death|1|||
156666827|NCT00244764|565528849|FG000|Overall Study|Off Study Medication for >21 Days|1|||
156666828|NCT00244764|565528849|FG000|Overall Study|Declining Performance Status|1|||
156666829|NCT00244764|565528849|FG000|Overall Study|Participant was Hospitalized until Death|1|||
156666830|NCT00244764|565528849|FG000|Overall Study|Primary Investigator Discretion|2|||
156666831|NCT00244764|565528849|FG000|Overall Study|Sponsor Terminated Study|2|||
156666832|NCT00244764|565528849|FG000|Overall Study|Developed Secondary Malignancy|1|||
156666833|NCT03017885|565528850|FG000|Overall Study|Adverse Event|2|||
156666834|NCT03017885|565528851|FG001|Overall Study|Adverse Event|0|||
156666835|NCT03017885|565528852|FG002|Overall Study|Adverse Event|0|||
156666836|NCT03017885|565528853|FG003|Overall Study|Adverse Event|0|||
156666837|NCT03017885|565528854|FG004|Overall Study|Adverse Event|0|||
156666838|NCT03017885|565528855|FG005|Overall Study|Adverse Event|0|||
156666839|NCT03017885|565528850|FG000|Overall Study|Progression of disease|4|||
156666840|NCT03017885|565528851|FG001|Overall Study|Progression of disease|3|||
156666841|NCT03017885|565528852|FG002|Overall Study|Progression of disease|4|||
156666842|NCT03017885|565528853|FG003|Overall Study|Progression of disease|0|||
156666843|NCT03017885|565528854|FG004|Overall Study|Progression of disease|0|||
156666844|NCT03017885|565528855|FG005|Overall Study|Progression of disease|0|||
156666845|NCT03017885|565528850|FG000|Overall Study|Other than listed|1|||
156666846|NCT03017885|565528851|FG001|Overall Study|Other than listed|2|||
156666847|NCT03017885|565528852|FG002|Overall Study|Other than listed|1|||
156666848|NCT03017885|565528853|FG003|Overall Study|Other than listed|0|||
156524746|NCT00505284|565015687|FG004|Overall Study|Other|4|||
156524747|NCT01275131|565015688|FG000|Period 1|Withdrawal by Subject|1|||
156524748|NCT01275131|565015689|FG001|Period 1|Withdrawal by Subject|0|||
156524749|NCT01275131|565015690|FG002|Period 1|Withdrawal by Subject|3|||
156524750|NCT01275131|565015691|FG003|Period 1|Withdrawal by Subject|2|||
156777893|NCT02225587|565936990|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156666849|NCT03017885|565528854|FG004|Overall Study|Other than listed|0|||
156666850|NCT03017885|565528855|FG005|Overall Study|Other than listed|0|||
156777894|NCT02225587|565936991|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156524751|NCT01275131|565015688|FG000|Period 1|Physician Decision|1|||
156524752|NCT01275131|565015689|FG001|Period 1|Physician Decision|0|||
156666851|NCT03017885|565528850|FG000|Overall Study|Lost to Follow-up|2|||
156666852|NCT03017885|565528851|FG001|Overall Study|Lost to Follow-up|0|||
156666853|NCT03017885|565528852|FG002|Overall Study|Lost to Follow-up|3|||
156666854|NCT03017885|565528853|FG003|Overall Study|Lost to Follow-up|0|||
156666855|NCT03017885|565528854|FG004|Overall Study|Lost to Follow-up|0|||
156666856|NCT03017885|565528855|FG005|Overall Study|Lost to Follow-up|0|||
156666857|NCT03017885|565528850|FG000|Overall Study|Change to other anti-cancer therapy|0|||
156666858|NCT03017885|565528851|FG001|Overall Study|Change to other anti-cancer therapy|0|||
156666859|NCT03017885|565528852|FG002|Overall Study|Change to other anti-cancer therapy|1|||
156777895|NCT02225587|565936990|FG000|Overall Study|Physician Decision|2|||
156777896|NCT02225587|565936991|FG001|Overall Study|Physician Decision|0|||
156777897|NCT02225587|565936990|FG000|Overall Study|Protocol Violation|1|||
156666860|NCT03017885|565528853|FG003|Overall Study|Change to other anti-cancer therapy|0|||
156666861|NCT03017885|565528854|FG004|Overall Study|Change to other anti-cancer therapy|0|||
156666862|NCT03017885|565528855|FG005|Overall Study|Change to other anti-cancer therapy|0|||
156666863|NCT02158663|565528856|FG000|Overall Study|Withdrawal by Subject|5|||
156666864|NCT02158663|565528857|FG001|Overall Study|Withdrawal by Subject|4|||
156666865|NCT00965185|565528860|FG000|Overall Study|Lost to Follow-up|2|||
156666866|NCT00965185|565528861|FG001|Overall Study|Lost to Follow-up|0|||
156666867|NCT00965185|565528860|FG000|Overall Study|Withdrawal by Subject|0|||
156666868|NCT00965185|565528861|FG001|Overall Study|Withdrawal by Subject|1|||
156666869|NCT05323396|565528862|FG000|Overall Study|Lost to Follow-up|1|||
156666870|NCT05323396|565528863|FG001|Overall Study|Lost to Follow-up|35|||
156666871|NCT05323396|565528862|FG000|Overall Study|Pregnancy|1|||
156666872|NCT05323396|565528863|FG001|Overall Study|Pregnancy|0|||
156666873|NCT03681470|565528865|FG000|Overall Study|Lack of Efficacy|3|||
156666874|NCT03681470|565528865|FG000|Overall Study|Lost to Follow-up|1|||
156666875|NCT03681470|565528865|FG000|Overall Study|Protocol Violation|3|||
156666876|NCT03681470|565528865|FG000|Overall Study|Withdrawal by Subject|1|||
156666877|NCT03500692|565528870|FG000|Overall Study|Death|163|||
156666878|NCT03500692|565528870|FG000|Overall Study|Lost to Follow-up|75|||
156666879|NCT03500692|565528870|FG000|Overall Study|Termination Reasons|3|||
156666880|NCT02305758|565528871|FG000|Overall Study|Death|27|||
156666881|NCT02305758|565528872|FG001|Overall Study|Death|27|||
156666882|NCT02305758|565528871|FG000|Overall Study|Withdrew consent|9|||
156666883|NCT02305758|565528872|FG001|Overall Study|Withdrew consent|2|||
156666884|NCT02305758|565528871|FG000|Overall Study|Lost to Follow-up|6|||
156666885|NCT02305758|565528872|FG001|Overall Study|Lost to Follow-up|1|||
156666886|NCT02305758|565528871|FG000|Overall Study|Study Terminated by Sponsor|21|||
156666887|NCT02305758|565528872|FG001|Overall Study|Study Terminated by Sponsor|34|||
156666888|NCT02305758|565528871|FG000|Overall Study|Other, not specified|2|||
156666889|NCT02305758|565528872|FG001|Overall Study|Other, not specified|1|||
156666890|NCT05593965|565528873|FG000|1st Intervention (1 Day)|Technical error|1|||
156666891|NCT05593965|565528874|FG001|1st Intervention (1 Day)|Technical error|0|||
156666892|NCT02272777|565528875|FG000|Overall Study|Adverse Event|0|||
156666893|NCT02272777|565528876|FG001|Overall Study|Adverse Event|1|||
156666894|NCT02272777|565528875|FG000|Overall Study|Withdrawal by Subject|0|||
156666895|NCT02272777|565528876|FG001|Overall Study|Withdrawal by Subject|3|||
156666896|NCT02272777|565528875|FG000|Overall Study|Lost to Follow-up|2|||
156666897|NCT02272777|565528876|FG001|Overall Study|Lost to Follow-up|0|||
156666898|NCT02272777|565528875|FG000|Overall Study|Other|2|||
156666899|NCT02272777|565528876|FG001|Overall Study|Other|0|||
156666900|NCT02066922|565528879|FG000|Overall Study|Adverse Event|1|||
156666901|NCT00440297|565528880|FG000|Overall Study|Adverse Event|8|||
156666902|NCT00440297|565528881|FG001|Overall Study|Adverse Event|5|||
156666903|NCT00440297|565528880|FG000|Overall Study|Lost to Follow-up|1|||
156666904|NCT00440297|565528881|FG001|Overall Study|Lost to Follow-up|0|||
156666905|NCT00440297|565528880|FG000|Overall Study|Physician Decision|1|||
156666906|NCT00440297|565528881|FG001|Overall Study|Physician Decision|0|||
156666907|NCT00440297|565528880|FG000|Overall Study|Protocol Violation|11|||
156666908|NCT00440297|565528881|FG001|Overall Study|Protocol Violation|7|||
156666909|NCT00440297|565528880|FG000|Overall Study|Withdrawal by Subject|1|||
156666910|NCT00440297|565528881|FG001|Overall Study|Withdrawal by Subject|6|||
156666911|NCT00440297|565528880|FG000|Overall Study|Randomized by mistake|1|||
156666912|NCT00440297|565528881|FG001|Overall Study|Randomized by mistake|0|||
156666913|NCT03206177|565528882|FG000|Overall Study|Withdrawal by Subject|1|||
156666914|NCT02024932|565528883|FG000|Overall Study|Adverse Event|2|||
156666915|NCT02024932|565528884|FG001|Overall Study|Adverse Event|3|||
156666916|NCT02024932|565528885|FG002|Overall Study|Adverse Event|0|||
156777898|NCT02225587|565936991|FG001|Overall Study|Protocol Violation|0|||
156777899|NCT02225587|565936990|FG000|Overall Study|Participant Moved|1|||
156777900|NCT02225587|565936991|FG001|Overall Study|Participant Moved|0|||
156777901|NCT02225587|565936990|FG000|Overall Study|Withdrawal by Subject|13|||
156666917|NCT02024932|565528886|FG003|Overall Study|Adverse Event|0|||
156666918|NCT02024932|565528887|FG004|Overall Study|Adverse Event|2|||
156666919|NCT02024932|565528888|FG005|Overall Study|Adverse Event|0|||
156666920|NCT02024932|565528883|FG000|Overall Study|Abnormal laboratory value|0|||
156666921|NCT02024932|565528884|FG001|Overall Study|Abnormal laboratory value|0|||
156666922|NCT02024932|565528885|FG002|Overall Study|Abnormal laboratory value|0|||
156666923|NCT02024932|565528886|FG003|Overall Study|Abnormal laboratory value|2|||
156666924|NCT02024932|565528887|FG004|Overall Study|Abnormal laboratory value|0|||
156666925|NCT02024932|565528888|FG005|Overall Study|Abnormal laboratory value|0|||
156666926|NCT02445339|565528889|FG000|Overall Study|Physician Decision|1|||
156666927|NCT02445339|565528890|FG001|Overall Study|Physician Decision|0|||
156666928|NCT02445339|565528889|FG000|Overall Study|Lost to Follow-up|11|||
156666929|NCT02445339|565528890|FG001|Overall Study|Lost to Follow-up|15|||
156666930|NCT03020641|565528891|FG000|Overall Study|Lost to Follow-up|0|||
156666931|NCT03020641|565528892|FG001|Overall Study|Lost to Follow-up|1|||
156666932|NCT03020641|565528891|FG000|Overall Study|Converted to open surgery|2|||
156777902|NCT02225587|565936991|FG001|Overall Study|Withdrawal by Subject|28|||
156777903|NCT04063163|565936992|FG000|Overall Study|Death|281|||
156666933|NCT03020641|565528892|FG001|Overall Study|Converted to open surgery|1|||
156666934|NCT03020641|565528891|FG000|Overall Study|for surgery not performed|0|||
156666935|NCT03020641|565528892|FG001|Overall Study|for surgery not performed|1|||
156666936|NCT00727961|565528893|FG000|Overall Study|Lost to Follow-up|1|||
156666937|NCT00727961|565528893|FG000|Overall Study|Adverse Event|4|||
156666938|NCT00727961|565528893|FG000|Overall Study|Patient's refusal|2|||
156666939|NCT00727961|565528893|FG000|Overall Study|Progression|30|||
156666940|NCT03238781|565528894|FG000|Overall Study|Adverse Event|1|||
156666941|NCT03238781|565528895|FG001|Overall Study|Adverse Event|1|||
156666942|NCT03238781|565528896|FG002|Overall Study|Adverse Event|2|||
156666943|NCT03238781|565528894|FG000|Overall Study|Lost to Follow-up|2|||
156666944|NCT03238781|565528895|FG001|Overall Study|Lost to Follow-up|1|||
156666945|NCT03238781|565528896|FG002|Overall Study|Lost to Follow-up|2|||
156666946|NCT03238781|565528894|FG000|Overall Study|Withdrawal by Subject|23|||
156666947|NCT03238781|565528895|FG001|Overall Study|Withdrawal by Subject|14|||
156666948|NCT03238781|565528896|FG002|Overall Study|Withdrawal by Subject|16|||
156666949|NCT03238781|565528894|FG000|Overall Study|Decision by sponsor|0|||
156666950|NCT03238781|565528895|FG001|Overall Study|Decision by sponsor|1|||
156666951|NCT03238781|565528896|FG002|Overall Study|Decision by sponsor|0|||
156666952|NCT03161405|565528897|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
156666953|NCT00837486|565528898|FG000|Blinded-treatment Phase|Physician Decision|1|||
156666954|NCT00837486|565528899|FG001|Blinded-treatment Phase|Physician Decision|0|||
156666955|NCT00837486|565528898|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
156666956|NCT00837486|565528899|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
156666957|NCT00837486|565528898|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
156666958|NCT00837486|565528899|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
156666959|NCT00837486|565528898|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
156666960|NCT00837486|565528899|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
156666961|NCT02186821|565528900|FG000|Overall Study|Adverse Event|9|||
156666962|NCT02186821|565528900|FG000|Overall Study|Death|2|||
156666963|NCT02186821|565528900|FG000|Overall Study|Disease progression|32|||
156666964|NCT02186821|565528900|FG000|Overall Study|Protocol Violation|1|||
156666965|NCT02186821|565528900|FG000|Overall Study|Physician Decision|1|||
156666966|NCT02186821|565528900|FG000|Overall Study|Study terminated by sponsor|2|||
156666967|NCT01421277|565528901|FG000|Overall Study|Lack of qualifying event|0|||
156666968|NCT01421277|565528902|FG001|Overall Study|Lack of qualifying event|61|||
156666969|NCT01421277|565528901|FG000|Overall Study|Incomplete baseline data|0|||
156666970|NCT01421277|565528902|FG001|Overall Study|Incomplete baseline data|31|||
156666971|NCT02039908|565528903|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
156666972|NCT02039908|565528904|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
156666973|NCT02039908|565528905|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
156666974|NCT02039908|565528906|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
156666975|NCT02039908|565528903|FG000|Phase 1-Summer|Protocol Violation|6|||
156666976|NCT02039908|565528904|FG001|Phase 1-Summer|Protocol Violation|0|||
156666977|NCT02039908|565528905|FG002|Phase 1-Summer|Protocol Violation|0|||
156666978|NCT02039908|565528906|FG003|Phase 1-Summer|Protocol Violation|0|||
156666979|NCT02039908|565528903|FG000|Phase 2-School Year|Lost to Follow-up|0|||
156666980|NCT02039908|565528904|FG001|Phase 2-School Year|Lost to Follow-up|0|||
156666981|NCT02039908|565528905|FG002|Phase 2-School Year|Lost to Follow-up|1|||
156666982|NCT02039908|565528906|FG003|Phase 2-School Year|Lost to Follow-up|3|||
156666983|NCT02039908|565528903|FG000|Phase 2-School Year|Protocol Violation|0|||
156666984|NCT02039908|565528904|FG001|Phase 2-School Year|Protocol Violation|0|||
156666985|NCT02039908|565528905|FG002|Phase 2-School Year|Protocol Violation|3|||
156666986|NCT02039908|565528906|FG003|Phase 2-School Year|Protocol Violation|0|||
156666987|NCT02039908|565528903|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
156666988|NCT02039908|565528904|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
156666989|NCT02039908|565528905|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
156666990|NCT02039908|565528906|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
156666991|NCT00731783|565528907|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
156666992|NCT00731783|565528908|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
156666993|NCT00731783|565528907|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
156666994|NCT00731783|565528908|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
156666995|NCT00731783|565528907|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
156666996|NCT00731783|565528908|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
156666997|NCT00731783|565528907|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
156666998|NCT00731783|565528908|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
156666999|NCT02847650|565530136|FG000|Overall Study|Adverse Event|2|||
156667000|NCT02847650|565530137|FG001|Overall Study|Adverse Event|4|||
156667001|NCT02847650|565530136|FG000|Overall Study|Lost to Follow-up|1|||
156667002|NCT02847650|565530137|FG001|Overall Study|Lost to Follow-up|0|||
156667003|NCT02847650|565530136|FG000|Overall Study|Protocol Violation|0|||
156667004|NCT02847650|565530137|FG001|Overall Study|Protocol Violation|1|||
156667005|NCT02847650|565530136|FG000|Overall Study|Withdrawal by Subject|1|||
156667006|NCT02847650|565530137|FG001|Overall Study|Withdrawal by Subject|1|||
156667007|NCT03772522|565530138|FG000|Pre-intervention|Withdrawal by Subject|3|||
156667008|NCT03772522|565530139|FG001|Pre-intervention|Withdrawal by Subject|4|||
156667009|NCT03772522|565530138|FG000|Intervention|Withdrawal by Subject|1|||
156667010|NCT03772522|565530139|FG001|Intervention|Withdrawal by Subject|0|||
156667011|NCT03772522|565530138|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
156667012|NCT03772522|565530139|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
156667013|NCT03071575|565530140|FG000|Overall Study|Death|0|||
156667014|NCT03071575|565530141|FG001|Overall Study|Death|1|||
156667015|NCT03071575|565530140|FG000|Overall Study|Lost to Follow-up|5|||
156667016|NCT03071575|565530141|FG001|Overall Study|Lost to Follow-up|11|||
156667017|NCT03071575|565530140|FG000|Overall Study|Withdrawal by Subject|4|||
156667018|NCT03071575|565530141|FG001|Overall Study|Withdrawal by Subject|2|||
156667019|NCT00218257|565530142|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
156667020|NCT00218257|565530143|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
156667021|NCT00579345|565530144|FG000|Overall Study|Withdrawal by Subject|2|||
156667022|NCT00579345|565530145|FG001|Overall Study|Withdrawal by Subject|0|||
156667023|NCT00579345|565530146|FG002|Overall Study|Withdrawal by Subject|0|||
156667024|NCT00579345|565530147|FG003|Overall Study|Withdrawal by Subject|0|||
156667025|NCT00579345|565530148|FG004|Overall Study|Withdrawal by Subject|0|||
156667026|NCT00579345|565530149|FG005|Overall Study|Withdrawal by Subject|0|||
156667027|NCT00579345|565530150|FG006|Overall Study|Withdrawal by Subject|0|||
156667028|NCT00579345|565530151|FG007|Overall Study|Withdrawal by Subject|1|||
156667029|NCT00579345|565530144|FG000|Overall Study|Lost to Follow-up|1|||
156667030|NCT00579345|565530145|FG001|Overall Study|Lost to Follow-up|0|||
156667031|NCT00579345|565530146|FG002|Overall Study|Lost to Follow-up|0|||
156667032|NCT00579345|565530147|FG003|Overall Study|Lost to Follow-up|0|||
156667033|NCT00579345|565530148|FG004|Overall Study|Lost to Follow-up|0|||
156667034|NCT00579345|565530149|FG005|Overall Study|Lost to Follow-up|0|||
156667035|NCT00579345|565530150|FG006|Overall Study|Lost to Follow-up|0|||
156667036|NCT00579345|565530151|FG007|Overall Study|Lost to Follow-up|0|||
156667037|NCT00579345|565530144|FG000|Overall Study|Adverse Event|0|||
156667038|NCT00579345|565530145|FG001|Overall Study|Adverse Event|0|||
156667039|NCT00579345|565530146|FG002|Overall Study|Adverse Event|1|||
156667040|NCT00579345|565530147|FG003|Overall Study|Adverse Event|0|||
156667041|NCT00579345|565530148|FG004|Overall Study|Adverse Event|0|||
156667042|NCT00579345|565530149|FG005|Overall Study|Adverse Event|0|||
156667043|NCT00579345|565530150|FG006|Overall Study|Adverse Event|0|||
156667044|NCT00579345|565530151|FG007|Overall Study|Adverse Event|0|||
156667045|NCT00579345|565530144|FG000|Overall Study|Protocol Violation|1|||
156667046|NCT00579345|565530145|FG001|Overall Study|Protocol Violation|0|||
156667047|NCT00579345|565530146|FG002|Overall Study|Protocol Violation|0|||
156667048|NCT00579345|565530147|FG003|Overall Study|Protocol Violation|0|||
156667049|NCT00579345|565530148|FG004|Overall Study|Protocol Violation|0|||
156667050|NCT00579345|565530149|FG005|Overall Study|Protocol Violation|0|||
156667051|NCT00579345|565530150|FG006|Overall Study|Protocol Violation|0|||
156667052|NCT00579345|565530151|FG007|Overall Study|Protocol Violation|1|||
156667053|NCT00579345|565530144|FG000|Overall Study|Death|1|||
156667054|NCT00579345|565530145|FG001|Overall Study|Death|1|||
156667055|NCT00579345|565530146|FG002|Overall Study|Death|1|||
156667056|NCT00579345|565530147|FG003|Overall Study|Death|1|||
156667057|NCT00579345|565530148|FG004|Overall Study|Death|0|||
156667058|NCT00579345|565530149|FG005|Overall Study|Death|0|||
156667059|NCT00579345|565530150|FG006|Overall Study|Death|0|||
156667060|NCT00579345|565530151|FG007|Overall Study|Death|0|||
156667061|NCT02267187|565530157|FG000|Overall Study|Physician Decision|2|||
156667062|NCT02267187|565530157|FG000|Overall Study|Screen fail|3|||
156667063|NCT03255733|565530158|FG000|Overall Study|Lost to Follow-up|4|||
156667064|NCT03874715|565530163|FG000|Overall Study|Adverse Event|2|||
156667065|NCT03874715|565530164|FG001|Overall Study|Adverse Event|0|||
156667066|NCT03874715|565530163|FG000|Overall Study|Poor compliance to protocol|5|||
156667067|NCT03874715|565530164|FG001|Overall Study|Poor compliance to protocol|1|||
156667068|NCT03874715|565530163|FG000|Overall Study|Withdrawal by Subject|1|||
156667069|NCT03874715|565530164|FG001|Overall Study|Withdrawal by Subject|0|||
156667070|NCT03874715|565530163|FG000|Overall Study|Other-unspecified|1|||
156667071|NCT03874715|565530164|FG001|Overall Study|Other-unspecified|0|||
156667072|NCT00934050|565530165|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
156667073|NCT00934050|565530166|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
156667074|NCT00934050|565530167|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
156667075|NCT00934050|565530168|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
156667076|NCT00934050|565530169|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
156667077|NCT00934050|565530170|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
156524753|NCT01275131|565015690|FG002|Period 1|Physician Decision|0|||
156667078|NCT00934050|565530165|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
156667079|NCT00934050|565530166|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
156667080|NCT00934050|565530167|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
156667081|NCT00934050|565530168|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
156667082|NCT00934050|565530169|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
156667083|NCT00934050|565530170|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
156667084|NCT00934050|565530165|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
156667085|NCT00934050|565530166|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
156667086|NCT00934050|565530167|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
156667087|NCT00934050|565530168|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
156667088|NCT00934050|565530169|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
156667089|NCT00934050|565530170|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
156667090|NCT00934050|565530165|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
156667091|NCT00934050|565530166|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
156667092|NCT00934050|565530167|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
156667093|NCT00934050|565530168|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
156667094|NCT00934050|565530169|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
156667095|NCT00934050|565530170|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
156667096|NCT00934050|565530165|FG000|Enrolled After 15 Dec 2009|Death|0|||
156667097|NCT00934050|565530166|FG001|Enrolled After 15 Dec 2009|Death|0|||
156667098|NCT00934050|565530167|FG002|Enrolled After 15 Dec 2009|Death|0|||
156667099|NCT00934050|565530168|FG003|Enrolled After 15 Dec 2009|Death|0|||
156667100|NCT00934050|565530169|FG004|Enrolled After 15 Dec 2009|Death|0|||
156667101|NCT00934050|565530170|FG005|Enrolled After 15 Dec 2009|Death|1|||
156667102|NCT00934050|565530165|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
156667103|NCT00934050|565530166|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
156667104|NCT00934050|565530167|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
156667105|NCT00934050|565530168|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
156667106|NCT00934050|565530169|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
156667107|NCT00934050|565530170|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
156667108|NCT00934050|565530165|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
156667109|NCT00934050|565530166|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
156667110|NCT00934050|565530167|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
156667111|NCT00934050|565530168|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
156667112|NCT00934050|565530169|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
156667113|NCT00934050|565530170|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
156667114|NCT03570749|565530173|FG000|Overall Study|Ongoing|26|||
156667115|NCT03570749|565530174|FG001|Overall Study|Ongoing|25|||
156667116|NCT03570749|565530175|FG002|Overall Study|Ongoing|25|||
156667117|NCT03570749|565530176|FG003|Overall Study|Ongoing|26|||
156667118|NCT03570749|565530177|FG004|Overall Study|Ongoing|140|||
156667119|NCT03570749|565530178|FG005|Overall Study|Ongoing|142|||
156667120|NCT03570749|565530179|FG006|Overall Study|Ongoing|220|||
156667121|NCT03570749|565530173|FG000|Overall Study|Adverse Event|0|||
156667122|NCT03570749|565530174|FG001|Overall Study|Adverse Event|0|||
156667123|NCT03570749|565530175|FG002|Overall Study|Adverse Event|0|||
156667124|NCT03570749|565530176|FG003|Overall Study|Adverse Event|0|||
156667125|NCT03570749|565530177|FG004|Overall Study|Adverse Event|2|||
156667126|NCT03570749|565530178|FG005|Overall Study|Adverse Event|3|||
156667127|NCT03570749|565530179|FG006|Overall Study|Adverse Event|6|||
156667128|NCT03570749|565530173|FG000|Overall Study|Lack of Efficacy|0|||
156667129|NCT03570749|565530174|FG001|Overall Study|Lack of Efficacy|0|||
156667130|NCT03570749|565530175|FG002|Overall Study|Lack of Efficacy|0|||
156667131|NCT03570749|565530176|FG003|Overall Study|Lack of Efficacy|0|||
156524754|NCT01275131|565015691|FG003|Period 1|Physician Decision|0|||
156524755|NCT01275131|565015688|FG000|Period 2 (Crossover)|Adverse Event|0|||
156524756|NCT01275131|565015689|FG001|Period 2 (Crossover)|Adverse Event|1|||
156524757|NCT01275131|565015690|FG002|Period 2 (Crossover)|Adverse Event|0|||
156667132|NCT03570749|565530177|FG004|Overall Study|Lack of Efficacy|8|||
156667133|NCT03570749|565530178|FG005|Overall Study|Lack of Efficacy|2|||
156667134|NCT03570749|565530179|FG006|Overall Study|Lack of Efficacy|7|||
156667135|NCT03570749|565530173|FG000|Overall Study|Lost to Follow-up|0|||
156667136|NCT03570749|565530174|FG001|Overall Study|Lost to Follow-up|0|||
156667137|NCT03570749|565530175|FG002|Overall Study|Lost to Follow-up|0|||
156777904|NCT04063163|565936993|FG001|Overall Study|Death|166|||
156524758|NCT01275131|565015691|FG003|Period 2 (Crossover)|Adverse Event|0|||
156524759|NCT01275131|565015688|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
156524760|NCT01275131|565015689|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
156524761|NCT01275131|565015690|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
156524762|NCT01275131|565015691|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
156524763|NCT00953745|565015694|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
156524764|NCT00953745|565015695|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
156667138|NCT03570749|565530176|FG003|Overall Study|Lost to Follow-up|0|||
156667139|NCT03570749|565530177|FG004|Overall Study|Lost to Follow-up|5|||
156667140|NCT03570749|565530178|FG005|Overall Study|Lost to Follow-up|10|||
156667141|NCT03570749|565530179|FG006|Overall Study|Lost to Follow-up|10|||
156667142|NCT03570749|565530173|FG000|Overall Study|Pregnancy|0|||
156667143|NCT03570749|565530174|FG001|Overall Study|Pregnancy|0|||
156667144|NCT03570749|565530175|FG002|Overall Study|Pregnancy|0|||
156667145|NCT03570749|565530176|FG003|Overall Study|Pregnancy|0|||
156667146|NCT03570749|565530177|FG004|Overall Study|Pregnancy|0|||
156667147|NCT03570749|565530178|FG005|Overall Study|Pregnancy|1|||
156667148|NCT03570749|565530179|FG006|Overall Study|Pregnancy|1|||
156667149|NCT03570749|565530173|FG000|Overall Study|Screen Fail|0|||
156667150|NCT03570749|565530174|FG001|Overall Study|Screen Fail|0|||
156667151|NCT03570749|565530175|FG002|Overall Study|Screen Fail|0|||
156667152|NCT03570749|565530176|FG003|Overall Study|Screen Fail|0|||
156667153|NCT03570749|565530177|FG004|Overall Study|Screen Fail|0|||
156667154|NCT03570749|565530178|FG005|Overall Study|Screen Fail|0|||
156667155|NCT03570749|565530179|FG006|Overall Study|Screen Fail|1|||
156667156|NCT03570749|565530173|FG000|Overall Study|Withdrawal by Subject|2|||
156667157|NCT03570749|565530174|FG001|Overall Study|Withdrawal by Subject|3|||
156667158|NCT03570749|565530175|FG002|Overall Study|Withdrawal by Subject|2|||
156667159|NCT03570749|565530176|FG003|Overall Study|Withdrawal by Subject|1|||
156667160|NCT03570749|565530177|FG004|Overall Study|Withdrawal by Subject|17|||
156667161|NCT03570749|565530178|FG005|Overall Study|Withdrawal by Subject|12|||
156667162|NCT03570749|565530179|FG006|Overall Study|Withdrawal by Subject|15|||
156667163|NCT03570749|565530173|FG000|Overall Study|Other|0|||
156667164|NCT03570749|565530174|FG001|Overall Study|Other|0|||
156667165|NCT03570749|565530175|FG002|Overall Study|Other|0|||
156667166|NCT03570749|565530176|FG003|Overall Study|Other|0|||
156667167|NCT03570749|565530177|FG004|Overall Study|Other|17|||
156667168|NCT03570749|565530178|FG005|Overall Study|Other|14|||
156667169|NCT03570749|565530179|FG006|Overall Study|Other|21|||
156667170|NCT01796171|565530182|FG000|Enrolled|Death|0|||
156667171|NCT01796171|565530183|FG001|Enrolled|Death|0|||
156667172|NCT01796171|565530184|FG002|Enrolled|Death|0|||
156667173|NCT01796171|565530185|FG003|Enrolled|Death|0|||
156667174|NCT01796171|565530186|FG004|Enrolled|Death|0|||
156667175|NCT01796171|565530187|FG005|Enrolled|Death|0|||
156667176|NCT01796171|565530188|FG006|Enrolled|Death|0|||
156667177|NCT01796171|565530189|FG007|Enrolled|Death|0|||
156667178|NCT01796171|565530190|FG008|Enrolled|Death|0|||
156667179|NCT01796171|565530191|FG009|Enrolled|Death|0|||
156667180|NCT01796171|565530192|FG010|Enrolled|Death|0|||
156667181|NCT01796171|565530193|FG011|Enrolled|Death|0|||
156667182|NCT01796171|565530194|FG012|Enrolled|Death|0|||
156667183|NCT01796171|565530195|FG013|Enrolled|Death|0|||
156667184|NCT01796171|565530196|FG014|Enrolled|Death|1|||
156667185|NCT01796171|565530182|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
156667186|NCT01796171|565530183|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
156667187|NCT01796171|565530184|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
156777905|NCT04063163|565936992|FG000|Overall Study|Lost to Follow-up|12|||
156777906|NCT04063163|565936993|FG001|Overall Study|Lost to Follow-up|8|||
156777907|NCT04063163|565936992|FG000|Overall Study|Withdrawal by Subject|19|||
156777908|NCT04063163|565936993|FG001|Overall Study|Withdrawal by Subject|10|||
156777909|NCT02572167|565936996|FG000|Overall Study|Withdrawal by Subject|0|||
156777910|NCT02572167|565936997|FG001|Overall Study|Withdrawal by Subject|3|||
156777911|NCT02572167|565936998|FG002|Overall Study|Withdrawal by Subject|0|||
156777912|NCT02572167|565936996|FG000|Overall Study|Lost to Follow-up|2|||
156777913|NCT02572167|565936997|FG001|Overall Study|Lost to Follow-up|5|||
156777914|NCT02572167|565936998|FG002|Overall Study|Lost to Follow-up|3|||
156777915|NCT02572167|565936996|FG000|Overall Study|Death|0|||
156777916|NCT02572167|565936997|FG001|Overall Study|Death|8|||
156777917|NCT02572167|565936998|FG002|Overall Study|Death|3|||
156777918|NCT02572167|565936996|FG000|Overall Study|Did not meet inclusion criteria|0|||
156524765|NCT00953745|565015694|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
156524766|NCT00953745|565015695|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
156524767|NCT00953745|565015694|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
156524768|NCT00953745|565015695|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
156524769|NCT00953745|565015694|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
156524770|NCT00953745|565015695|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
156524771|NCT00953745|565015694|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
156524772|NCT00953745|565015695|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
156524773|NCT00953745|565015694|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
156524774|NCT00953745|565015695|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
156524775|NCT03110185|565015699|FG000|Overall Study|Death|0|||
156524776|NCT03110185|565015700|FG001|Overall Study|Death|1|||
156524777|NCT03110185|565015699|FG000|Overall Study|Withdrawal by Subject|2|||
156524778|NCT03110185|565015700|FG001|Overall Study|Withdrawal by Subject|7|||
156524779|NCT03110185|565015699|FG000|Overall Study|Time Constraints|0|||
156667188|NCT01796171|565530185|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
156667189|NCT01796171|565530186|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
156777919|NCT02572167|565936997|FG001|Overall Study|Did not meet inclusion criteria|0|||
156777920|NCT02572167|565936998|FG002|Overall Study|Did not meet inclusion criteria|1|||
156777921|NCT02572167|565936996|FG000|Overall Study|Study closure by Sponsor|4|||
156777922|NCT02572167|565936997|FG001|Overall Study|Study closure by Sponsor|40|||
156777923|NCT02572167|565936998|FG002|Overall Study|Study closure by Sponsor|24|||
156777924|NCT00580840|565936999|FG000|Run-in|Adverse Event|17|||
156667190|NCT01796171|565530187|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
156667191|NCT01796171|565530188|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
156667192|NCT01796171|565530189|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
156667193|NCT01796171|565530190|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
156667194|NCT01796171|565530191|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
156667195|NCT01796171|565530192|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
156777925|NCT00580840|565937000|FG001|Run-in|Adverse Event|0|||
156777926|NCT00580840|565937001|FG002|Run-in|Adverse Event|0|||
156777927|NCT00580840|565937002|FG003|Run-in|Adverse Event|0|||
156777928|NCT00580840|565936999|FG000|Run-in|Lack of Efficacy|93|||
156777929|NCT00580840|565937000|FG001|Run-in|Lack of Efficacy|0|||
156777930|NCT00580840|565937001|FG002|Run-in|Lack of Efficacy|0|||
156777931|NCT00580840|565937002|FG003|Run-in|Lack of Efficacy|0|||
156777932|NCT00580840|565936999|FG000|Run-in|Loss of Efficacy|1|||
156777933|NCT00580840|565937000|FG001|Run-in|Loss of Efficacy|0|||
156777934|NCT00580840|565937001|FG002|Run-in|Loss of Efficacy|0|||
156777935|NCT00580840|565937002|FG003|Run-in|Loss of Efficacy|0|||
156777936|NCT00580840|565936999|FG000|Run-in|Lost to Follow-up|4|||
156777937|NCT00580840|565937000|FG001|Run-in|Lost to Follow-up|0|||
156777938|NCT00580840|565937001|FG002|Run-in|Lost to Follow-up|0|||
156777939|NCT00580840|565937002|FG003|Run-in|Lost to Follow-up|0|||
156777940|NCT00580840|565936999|FG000|Run-in|Withdrawal by Subject|5|||
156777941|NCT00580840|565937000|FG001|Run-in|Withdrawal by Subject|0|||
156777942|NCT00580840|565937001|FG002|Run-in|Withdrawal by Subject|0|||
156777943|NCT00580840|565937002|FG003|Run-in|Withdrawal by Subject|0|||
156777944|NCT00580840|565936999|FG000|Run-in|Other: Per Sponsor Request|2|||
156777945|NCT00580840|565937000|FG001|Run-in|Other: Per Sponsor Request|0|||
156777946|NCT00580840|565937001|FG002|Run-in|Other: Per Sponsor Request|0|||
156777947|NCT00580840|565937002|FG003|Run-in|Other: Per Sponsor Request|0|||
156777948|NCT00580840|565936999|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
156777949|NCT00580840|565937000|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
156777950|NCT00580840|565937001|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
156777951|NCT00580840|565937002|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
156777952|NCT00580840|565936999|FG000|Run-in|Other: Exclusionary Lab Value|1|||
156777953|NCT00580840|565937000|FG001|Run-in|Other: Exclusionary Lab Value|0|||
156777954|NCT00580840|565937001|FG002|Run-in|Other: Exclusionary Lab Value|0|||
156777955|NCT00580840|565937002|FG003|Run-in|Other: Exclusionary Lab Value|0|||
156777956|NCT00580840|565936999|FG000|Double-Blind|Adverse Event|0|||
156777957|NCT00580840|565937000|FG001|Double-Blind|Adverse Event|3|||
156777958|NCT00580840|565937001|FG002|Double-Blind|Adverse Event|4|||
156777959|NCT00580840|565937002|FG003|Double-Blind|Adverse Event|1|||
156777960|NCT00580840|565936999|FG000|Double-Blind|Loss of Efficacy|0|||
156777961|NCT00580840|565937000|FG001|Double-Blind|Loss of Efficacy|1|||
156777962|NCT00580840|565937001|FG002|Double-Blind|Loss of Efficacy|2|||
156777963|NCT00580840|565937002|FG003|Double-Blind|Loss of Efficacy|10|||
156777964|NCT00580840|565936999|FG000|Double-Blind|Lost to Follow-up|0|||
156777965|NCT00580840|565937000|FG001|Double-Blind|Lost to Follow-up|1|||
156777966|NCT00580840|565937001|FG002|Double-Blind|Lost to Follow-up|0|||
156777967|NCT00580840|565937002|FG003|Double-Blind|Lost to Follow-up|2|||
156777968|NCT00580840|565936999|FG000|Double-Blind|Withdrawal by Subject|0|||
156777969|NCT00580840|565937000|FG001|Double-Blind|Withdrawal by Subject|1|||
156777970|NCT00580840|565937001|FG002|Double-Blind|Withdrawal by Subject|2|||
156777971|NCT00580840|565937002|FG003|Double-Blind|Withdrawal by Subject|2|||
156777972|NCT00580840|565936999|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
156777973|NCT00580840|565937000|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
156777974|NCT00580840|565937001|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
156777975|NCT00580840|565937002|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
156777976|NCT00580840|565936999|FG000|Double-Blind|Other: Forbidden Medication|0|||
156777977|NCT00580840|565937000|FG001|Double-Blind|Other: Forbidden Medication|0|||
156777978|NCT00580840|565937001|FG002|Double-Blind|Other: Forbidden Medication|1|||
156777979|NCT00580840|565937002|FG003|Double-Blind|Other: Forbidden Medication|0|||
156777980|NCT02296125|565937004|FG000|Overall Study|Withdrawal by Subject|18|||
156777981|NCT02296125|565937005|FG001|Overall Study|Withdrawal by Subject|8|||
156777982|NCT02296125|565937006|FG002|Overall Study|Withdrawal by Subject|6|||
156777983|NCT02296125|565937007|FG003|Overall Study|Withdrawal by Subject|2|||
156777984|NCT02296125|565937004|FG000|Overall Study|Adverse Event|41|||
156777985|NCT02296125|565937005|FG001|Overall Study|Adverse Event|52|||
156777986|NCT02296125|565937006|FG002|Overall Study|Adverse Event|9|||
156777987|NCT02296125|565937007|FG003|Overall Study|Adverse Event|4|||
156777988|NCT02296125|565937004|FG000|Overall Study|Severe non-compliance to protocol|0|||
156777989|NCT02296125|565937005|FG001|Overall Study|Severe non-compliance to protocol|1|||
156777990|NCT02296125|565937006|FG002|Overall Study|Severe non-compliance to protocol|0|||
156777991|NCT02296125|565937007|FG003|Overall Study|Severe non-compliance to protocol|0|||
156777992|NCT02296125|565937004|FG000|Overall Study|Condition under investigation worsened|153|||
156777993|NCT02296125|565937005|FG001|Overall Study|Condition under investigation worsened|199|||
156777994|NCT02296125|565937006|FG002|Overall Study|Condition under investigation worsened|39|||
156777995|NCT02296125|565937007|FG003|Overall Study|Condition under investigation worsened|56|||
156777996|NCT02296125|565937004|FG000|Overall Study|Any reason not specifically recorded|6|||
156777997|NCT02296125|565937005|FG001|Overall Study|Any reason not specifically recorded|4|||
156777998|NCT02296125|565937006|FG002|Overall Study|Any reason not specifically recorded|2|||
156777999|NCT02296125|565937007|FG003|Overall Study|Any reason not specifically recorded|0|||
156778000|NCT00984399|565937008|FG000|Overall Study|Adverse Event|0|||
156778001|NCT00984399|565937009|FG001|Overall Study|Adverse Event|1|||
156778002|NCT00984399|565937008|FG000|Overall Study|Physician Decision|1|||
156667196|NCT01796171|565530193|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
156667197|NCT01796171|565530194|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
156667198|NCT01796171|565530195|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
156667199|NCT01796171|565530196|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
156667200|NCT01796171|565530182|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667201|NCT01796171|565530183|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667202|NCT01796171|565530184|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667203|NCT01796171|565530185|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667204|NCT01796171|565530186|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667205|NCT01796171|565530187|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667206|NCT01796171|565530188|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667207|NCT01796171|565530189|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667208|NCT01796171|565530190|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667209|NCT01796171|565530191|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667210|NCT01796171|565530192|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667211|NCT01796171|565530193|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667212|NCT01796171|565530194|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667213|NCT01796171|565530195|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
156667214|NCT01796171|565530196|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
156667215|NCT01796171|565530182|FG000|Treatment Period With Betalutin|Progressive disease|0|||
156667216|NCT01796171|565530183|FG001|Treatment Period With Betalutin|Progressive disease|1|||
156667217|NCT01796171|565530184|FG002|Treatment Period With Betalutin|Progressive disease|0|||
156667218|NCT01796171|565530185|FG003|Treatment Period With Betalutin|Progressive disease|0|||
156667219|NCT01796171|565530186|FG004|Treatment Period With Betalutin|Progressive disease|0|||
156667220|NCT01796171|565530187|FG005|Treatment Period With Betalutin|Progressive disease|0|||
156667221|NCT01796171|565530188|FG006|Treatment Period With Betalutin|Progressive disease|0|||
156667222|NCT01796171|565530189|FG007|Treatment Period With Betalutin|Progressive disease|0|||
156667223|NCT01796171|565530190|FG008|Treatment Period With Betalutin|Progressive disease|0|||
156667224|NCT01796171|565530191|FG009|Treatment Period With Betalutin|Progressive disease|0|||
156667225|NCT01796171|565530192|FG010|Treatment Period With Betalutin|Progressive disease|0|||
156667226|NCT01796171|565530193|FG011|Treatment Period With Betalutin|Progressive disease|0|||
156667227|NCT01796171|565530194|FG012|Treatment Period With Betalutin|Progressive disease|0|||
156667228|NCT01796171|565530195|FG013|Treatment Period With Betalutin|Progressive disease|0|||
156667229|NCT01796171|565530196|FG014|Treatment Period With Betalutin|Progressive disease|0|||
156667230|NCT01796171|565530182|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667231|NCT01796171|565530183|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667232|NCT01796171|565530184|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667233|NCT01796171|565530185|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667234|NCT01796171|565530186|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667235|NCT01796171|565530187|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667236|NCT01796171|565530188|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667237|NCT01796171|565530189|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667238|NCT01796171|565530190|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
156667239|NCT01796171|565530191|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667240|NCT01796171|565530192|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
156667241|NCT01796171|565530193|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
156667242|NCT01796171|565530194|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667243|NCT01796171|565530195|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667244|NCT01796171|565530196|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
156667245|NCT01796171|565530182|FG000|Treatment Period With Betalutin|Physician Decision|0|||
156667246|NCT01796171|565530183|FG001|Treatment Period With Betalutin|Physician Decision|0|||
156524780|NCT03110185|565015700|FG001|Overall Study|Time Constraints|6|||
156524781|NCT03110185|565015699|FG000|Overall Study|Conflict with care|5|||
156524782|NCT03110185|565015700|FG001|Overall Study|Conflict with care|12|||
156524783|NCT03110185|565015699|FG000|Overall Study|Protocol Violation|1|||
156524784|NCT03110185|565015700|FG001|Overall Study|Protocol Violation|4|||
156524785|NCT03110185|565015699|FG000|Overall Study|MRI Incompatible|2|||
156524786|NCT03110185|565015700|FG001|Overall Study|MRI Incompatible|0|||
156524787|NCT03110185|565015699|FG000|Overall Study|Patient Refusal|0|||
156524788|NCT03110185|565015700|FG001|Overall Study|Patient Refusal|1|||
156667247|NCT01796171|565530184|FG002|Treatment Period With Betalutin|Physician Decision|0|||
156667248|NCT01796171|565530185|FG003|Treatment Period With Betalutin|Physician Decision|0|||
156667249|NCT01796171|565530186|FG004|Treatment Period With Betalutin|Physician Decision|0|||
156667250|NCT01796171|565530187|FG005|Treatment Period With Betalutin|Physician Decision|0|||
156524789|NCT02053792|565015701|FG000|Overall Study|Physician Decision|0|||
156524790|NCT02053792|565015702|FG001|Overall Study|Physician Decision|1|||
156524791|NCT02053792|565015701|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
156667251|NCT01796171|565530188|FG006|Treatment Period With Betalutin|Physician Decision|0|||
156667252|NCT01796171|565530189|FG007|Treatment Period With Betalutin|Physician Decision|0|||
156667253|NCT01796171|565530190|FG008|Treatment Period With Betalutin|Physician Decision|0|||
156667254|NCT01796171|565530191|FG009|Treatment Period With Betalutin|Physician Decision|0|||
156667255|NCT01796171|565530192|FG010|Treatment Period With Betalutin|Physician Decision|5|||
156667256|NCT01796171|565530193|FG011|Treatment Period With Betalutin|Physician Decision|1|||
156667257|NCT01796171|565530194|FG012|Treatment Period With Betalutin|Physician Decision|1|||
156667258|NCT01796171|565530195|FG013|Treatment Period With Betalutin|Physician Decision|0|||
156667259|NCT01796171|565530196|FG014|Treatment Period With Betalutin|Physician Decision|0|||
156667260|NCT01796171|565530182|FG000|Treatment Period With Betalutin|Death|0|||
156667261|NCT01796171|565530183|FG001|Treatment Period With Betalutin|Death|0|||
156667262|NCT01796171|565530184|FG002|Treatment Period With Betalutin|Death|0|||
156667263|NCT01796171|565530185|FG003|Treatment Period With Betalutin|Death|0|||
156667264|NCT01796171|565530186|FG004|Treatment Period With Betalutin|Death|0|||
156667265|NCT01796171|565530187|FG005|Treatment Period With Betalutin|Death|0|||
156667266|NCT01796171|565530188|FG006|Treatment Period With Betalutin|Death|0|||
156667267|NCT01796171|565530189|FG007|Treatment Period With Betalutin|Death|0|||
156667268|NCT01796171|565530190|FG008|Treatment Period With Betalutin|Death|0|||
156667269|NCT01796171|565530191|FG009|Treatment Period With Betalutin|Death|0|||
156667270|NCT01796171|565530192|FG010|Treatment Period With Betalutin|Death|2|||
156667271|NCT01796171|565530193|FG011|Treatment Period With Betalutin|Death|0|||
156667272|NCT01796171|565530194|FG012|Treatment Period With Betalutin|Death|0|||
156667273|NCT01796171|565530195|FG013|Treatment Period With Betalutin|Death|0|||
156667274|NCT01796171|565530196|FG014|Treatment Period With Betalutin|Death|0|||
156667275|NCT01796171|565530182|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
156667276|NCT01796171|565530183|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
156667277|NCT01796171|565530184|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
156667278|NCT01796171|565530185|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
156667279|NCT01796171|565530186|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
156667280|NCT01796171|565530187|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
156667281|NCT01796171|565530188|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
156667282|NCT01796171|565530189|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
156667283|NCT01796171|565530190|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
156667284|NCT01796171|565530191|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
156667285|NCT01796171|565530192|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
156667286|NCT01796171|565530193|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
156667287|NCT01796171|565530194|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
156667288|NCT01796171|565530195|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
156667289|NCT01796171|565530196|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
156667290|NCT01796171|565530182|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667291|NCT01796171|565530183|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667292|NCT01796171|565530184|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667293|NCT01796171|565530185|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667294|NCT01796171|565530186|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667295|NCT01796171|565530187|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667296|NCT01796171|565530188|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667297|NCT01796171|565530189|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667298|NCT01796171|565530190|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667299|NCT01796171|565530191|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667300|NCT01796171|565530192|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
156667301|NCT01796171|565530193|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
156667302|NCT01796171|565530194|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667303|NCT01796171|565530195|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156667304|NCT01796171|565530196|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
156524792|NCT02053792|565015702|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
156325327|NCT01436162|564290942|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
156325328|NCT01436162|564290943|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
156325329|NCT01436162|564290944|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
156325330|NCT01436162|564290942|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
156325331|NCT01436162|564290943|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
156325332|NCT01436162|564290944|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
156325333|NCT01436162|564290942|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
156325334|NCT01436162|564290943|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156325335|NCT01436162|564290944|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156667305|NCT01796171|565530182|FG000|Follow-up Period|Start of further anticancer therapy|4|||
156325336|NCT01436162|564290942|FG000|Single-blind Lead-in Phase|Other|107|||
156325337|NCT01436162|564290943|FG001|Single-blind Lead-in Phase|Other|0|||
156667306|NCT01796171|565530183|FG001|Follow-up Period|Start of further anticancer therapy|25|||
156667307|NCT01796171|565530184|FG002|Follow-up Period|Start of further anticancer therapy|2|||
156667308|NCT01796171|565530185|FG003|Follow-up Period|Start of further anticancer therapy|1|||
156667309|NCT01796171|565530186|FG004|Follow-up Period|Start of further anticancer therapy|2|||
156667310|NCT01796171|565530187|FG005|Follow-up Period|Start of further anticancer therapy|2|||
156667311|NCT01796171|565530188|FG006|Follow-up Period|Start of further anticancer therapy|1|||
156667312|NCT01796171|565530189|FG007|Follow-up Period|Start of further anticancer therapy|15|||
156667313|NCT01796171|565530190|FG008|Follow-up Period|Start of further anticancer therapy|2|||
156667314|NCT01796171|565530191|FG009|Follow-up Period|Start of further anticancer therapy|0|||
156667315|NCT01796171|565530192|FG010|Follow-up Period|Start of further anticancer therapy|0|||
156667316|NCT01796171|565530193|FG011|Follow-up Period|Start of further anticancer therapy|0|||
156667317|NCT01796171|565530194|FG012|Follow-up Period|Start of further anticancer therapy|0|||
156667318|NCT01796171|565530195|FG013|Follow-up Period|Start of further anticancer therapy|0|||
156667319|NCT01796171|565530196|FG014|Follow-up Period|Start of further anticancer therapy|0|||
156667320|NCT01796171|565530182|FG000|Follow-up Period|Progressive disease|0|||
156667321|NCT01796171|565530183|FG001|Follow-up Period|Progressive disease|1|||
156667322|NCT01796171|565530184|FG002|Follow-up Period|Progressive disease|0|||
156667323|NCT01796171|565530185|FG003|Follow-up Period|Progressive disease|0|||
156667324|NCT01796171|565530186|FG004|Follow-up Period|Progressive disease|0|||
156667325|NCT01796171|565530187|FG005|Follow-up Period|Progressive disease|0|||
156667326|NCT01796171|565530188|FG006|Follow-up Period|Progressive disease|0|||
156667327|NCT01796171|565530189|FG007|Follow-up Period|Progressive disease|3|||
156667328|NCT01796171|565530190|FG008|Follow-up Period|Progressive disease|0|||
156667329|NCT01796171|565530191|FG009|Follow-up Period|Progressive disease|0|||
156667330|NCT01796171|565530192|FG010|Follow-up Period|Progressive disease|0|||
156667331|NCT01796171|565530193|FG011|Follow-up Period|Progressive disease|0|||
156667332|NCT01796171|565530194|FG012|Follow-up Period|Progressive disease|0|||
156667333|NCT01796171|565530195|FG013|Follow-up Period|Progressive disease|0|||
156667334|NCT01796171|565530196|FG014|Follow-up Period|Progressive disease|0|||
156667335|NCT01796171|565530182|FG000|Follow-up Period|Physician Decision|0|||
156667336|NCT01796171|565530183|FG001|Follow-up Period|Physician Decision|2|||
156667337|NCT01796171|565530184|FG002|Follow-up Period|Physician Decision|0|||
156667338|NCT01796171|565530185|FG003|Follow-up Period|Physician Decision|0|||
156667339|NCT01796171|565530186|FG004|Follow-up Period|Physician Decision|0|||
156667340|NCT01796171|565530187|FG005|Follow-up Period|Physician Decision|0|||
156667341|NCT01796171|565530188|FG006|Follow-up Period|Physician Decision|0|||
156667342|NCT01796171|565530189|FG007|Follow-up Period|Physician Decision|0|||
156667343|NCT01796171|565530190|FG008|Follow-up Period|Physician Decision|0|||
156667344|NCT01796171|565530191|FG009|Follow-up Period|Physician Decision|0|||
156667345|NCT01796171|565530192|FG010|Follow-up Period|Physician Decision|5|||
156667346|NCT01796171|565530193|FG011|Follow-up Period|Physician Decision|0|||
156667347|NCT01796171|565530194|FG012|Follow-up Period|Physician Decision|0|||
156667348|NCT01796171|565530195|FG013|Follow-up Period|Physician Decision|0|||
156667349|NCT01796171|565530196|FG014|Follow-up Period|Physician Decision|0|||
156667350|NCT01796171|565530182|FG000|Follow-up Period|Withdrawal by Subject|0|||
156667351|NCT01796171|565530183|FG001|Follow-up Period|Withdrawal by Subject|1|||
156667352|NCT01796171|565530184|FG002|Follow-up Period|Withdrawal by Subject|0|||
156667353|NCT01796171|565530185|FG003|Follow-up Period|Withdrawal by Subject|0|||
156667354|NCT01796171|565530186|FG004|Follow-up Period|Withdrawal by Subject|0|||
156667355|NCT01796171|565530187|FG005|Follow-up Period|Withdrawal by Subject|1|||
156667356|NCT01796171|565530188|FG006|Follow-up Period|Withdrawal by Subject|0|||
156667357|NCT01796171|565530189|FG007|Follow-up Period|Withdrawal by Subject|0|||
156667358|NCT01796171|565530190|FG008|Follow-up Period|Withdrawal by Subject|0|||
156667359|NCT01796171|565530191|FG009|Follow-up Period|Withdrawal by Subject|0|||
156667360|NCT01796171|565530192|FG010|Follow-up Period|Withdrawal by Subject|3|||
156667361|NCT01796171|565530193|FG011|Follow-up Period|Withdrawal by Subject|1|||
156667362|NCT01796171|565530194|FG012|Follow-up Period|Withdrawal by Subject|0|||
156667363|NCT01796171|565530195|FG013|Follow-up Period|Withdrawal by Subject|0|||
156524793|NCT02053792|565015701|FG000|Overall Study|Lack of Efficacy|1|||
156524794|NCT02053792|565015702|FG001|Overall Study|Lack of Efficacy|0|||
156524795|NCT02053792|565015701|FG000|Overall Study|Adverse Event|1|||
156524796|NCT02053792|565015702|FG001|Overall Study|Adverse Event|0|||
156524797|NCT02053792|565015701|FG000|Overall Study|Withdrawal by Subject|2|||
156778003|NCT00984399|565937009|FG001|Overall Study|Physician Decision|0|||
156524798|NCT02053792|565015702|FG001|Overall Study|Withdrawal by Subject|2|||
156778004|NCT00984399|565937008|FG000|Overall Study|Withdrawal by Subject|1|||
156667364|NCT01796171|565530196|FG014|Follow-up Period|Withdrawal by Subject|0|||
156667365|NCT01796171|565530182|FG000|Follow-up Period|Death|0|||
156778005|NCT00984399|565937009|FG001|Overall Study|Withdrawal by Subject|1|||
156667366|NCT01796171|565530183|FG001|Follow-up Period|Death|0|||
156524799|NCT02053792|565015701|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
156778006|NCT00984399|565937008|FG000|Overall Study|Protocol Violation|0|||
156667367|NCT01796171|565530184|FG002|Follow-up Period|Death|0|||
156667368|NCT01796171|565530185|FG003|Follow-up Period|Death|0|||
156667369|NCT01796171|565530186|FG004|Follow-up Period|Death|0|||
156667370|NCT01796171|565530187|FG005|Follow-up Period|Death|0|||
156667371|NCT01796171|565530188|FG006|Follow-up Period|Death|1|||
156778007|NCT00984399|565937009|FG001|Overall Study|Protocol Violation|1|||
156778008|NCT00984399|565937008|FG000|Overall Study|Pts did not start treatment|2|||
156778009|NCT00984399|565937009|FG001|Overall Study|Pts did not start treatment|2|||
156778010|NCT03636477|565937012|FG000|Overall Study|Adverse Event|0|||
156778011|NCT03636477|565937013|FG001|Overall Study|Adverse Event|0|||
156778012|NCT03636477|565937014|FG002|Overall Study|Adverse Event|1|||
156778013|NCT02382380|565937016|FG000|Overall Study|Withdrawal by Subject|2|||
156778014|NCT02382380|565937017|FG001|Overall Study|Withdrawal by Subject|2|||
156778015|NCT02382380|565937016|FG000|Overall Study|Lost to Follow-up|0|||
156778016|NCT02382380|565937017|FG001|Overall Study|Lost to Follow-up|1|||
156778017|NCT01295944|565937018|FG000|Overall Study|Switched to alternative treatment|1|||
156778018|NCT01295944|565937018|FG000|Overall Study|Ineligible|9|||
156778019|NCT01295944|565937018|FG000|Overall Study|Withdrawal by Subject|1|||
156778020|NCT01295944|565937018|FG000|Overall Study|Participant chose to be treated in Peru|1|||
156778021|NCT01295944|565937018|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
156524800|NCT02053792|565015702|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
156524801|NCT02053792|565015701|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
156524802|NCT02053792|565015702|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
156778022|NCT01295944|565937018|FG000|Overall Study|Physician Decision|1|||
156778023|NCT01295944|565937018|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
156778024|NCT01295944|565937018|FG000|Overall Study|Disease progression|4|||
156778025|NCT01295944|565937018|FG000|Overall Study|Transferred care before starting new treatment|1|||
156778026|NCT03785366|565937019|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
156778027|NCT03785366|565937020|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
156778028|NCT03785366|565937019|FG000|Overall Study|Lost to Follow-up|1|||
156778029|NCT03785366|565937020|FG001|Overall Study|Lost to Follow-up|0|||
156778030|NCT03785366|565937019|FG000|Overall Study|Partial IUD Expulsion|0|||
156778031|NCT03785366|565937020|FG001|Overall Study|Partial IUD Expulsion|2|||
156778032|NCT03785366|565937019|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
156778033|NCT03785366|565937020|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
156778034|NCT03036254|565937027|FG000|Overall Study|Adverse Event|6|||
156778035|NCT03036254|565937028|FG001|Overall Study|Adverse Event|4|||
156778036|NCT03036254|565937027|FG000|Overall Study|Death|3|||
156778037|NCT03036254|565937028|FG001|Overall Study|Death|1|||
156778038|NCT03036254|565937027|FG000|Overall Study|Lack of Efficacy|5|||
156778039|NCT03036254|565937028|FG001|Overall Study|Lack of Efficacy|1|||
156778040|NCT03036254|565937027|FG000|Overall Study|Withdrawal by Subject|3|||
156778041|NCT03036254|565937028|FG001|Overall Study|Withdrawal by Subject|5|||
156778042|NCT02783274|565937029|FG000|Overall Study|Withdrawal by Subject|16|||
156778043|NCT02783274|565937029|FG000|Overall Study|Physician Decision|6|||
156778044|NCT02783274|565937029|FG000|Overall Study|Death|9|||
156778045|NCT02783274|565937029|FG000|Overall Study|Lost to Follow-up|22|||
156778046|NCT02783274|565937029|FG000|Overall Study|Other|22|||
156778047|NCT05722015|565937033|FG000|Overall Study|Death|57|||
156778048|NCT05722015|565937034|FG001|Overall Study|Death|37|||
156778049|NCT05722015|565937033|FG000|Overall Study|Lost to Follow-up|1|||
156778050|NCT05722015|565937034|FG001|Overall Study|Lost to Follow-up|0|||
156778051|NCT05722015|565937033|FG000|Overall Study|Withdrawal by Subject|5|||
156778052|NCT05722015|565937034|FG001|Overall Study|Withdrawal by Subject|1|||
156524803|NCT03075410|565015703|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
156524804|NCT03075410|565015704|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
156524805|NCT03075410|565015705|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
156524806|NCT03075410|565015706|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
156524807|NCT03075410|565015707|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
156524808|NCT03075410|565015708|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
156524809|NCT03075410|565015709|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
156524810|NCT03075410|565015710|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
156524811|NCT03075410|565015711|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
156524812|NCT03075410|565015703|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
156524813|NCT03075410|565015704|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
156778053|NCT05722015|565937033|FG000|Overall Study|Participants Ongoing|188|||
156778054|NCT05722015|565937034|FG001|Overall Study|Participants Ongoing|88|||
156778055|NCT01802281|565937035|FG000|Overall Study|Death|1|||
156778056|NCT01802281|565937036|FG001|Overall Study|Death|2|||
156778057|NCT01802281|565937035|FG000|Overall Study|Withdrawal by Subject|2|||
156778058|NCT01802281|565937036|FG001|Overall Study|Withdrawal by Subject|1|||
156778059|NCT01802281|565937035|FG000|Overall Study|Ineligible|5|||
156778060|NCT01802281|565937036|FG001|Overall Study|Ineligible|3|||
156778061|NCT00927472|565937037|FG000|Overall Study|Withdrawal by Subject|10|||
156778062|NCT00927472|565937038|FG001|Overall Study|Withdrawal by Subject|11|||
156778063|NCT00927472|565937037|FG000|Overall Study|Lost to Follow-up|1|||
156778064|NCT00927472|565937038|FG001|Overall Study|Lost to Follow-up|6|||
156778065|NCT00927472|565937037|FG000|Overall Study|Protocol Violation|0|||
156778066|NCT00927472|565937038|FG001|Overall Study|Protocol Violation|1|||
156778067|NCT00927472|565937037|FG000|Overall Study|Post treatment Assessment out of window|0|||
156778068|NCT00927472|565937038|FG001|Overall Study|Post treatment Assessment out of window|4|||
156778069|NCT05317546|565937041|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
156778070|NCT05317546|565937042|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
156778071|NCT05020743|565937047|FG000|Overall Study|Enrollment in Interventional Study|2|||
156778072|NCT05020743|565937048|FG001|Overall Study|Enrollment in Interventional Study|9|||
156778073|NCT05020743|565937049|FG002|Overall Study|Enrollment in Interventional Study|0|||
156778074|NCT05020743|565937047|FG000|Overall Study|Withdrawal by Subject|0|||
156778075|NCT05020743|565937048|FG001|Overall Study|Withdrawal by Subject|3|||
156778076|NCT05020743|565937049|FG002|Overall Study|Withdrawal by Subject|1|||
156778077|NCT05020743|565937047|FG000|Overall Study|Lost to Follow-up|1|||
156778078|NCT05020743|565937048|FG001|Overall Study|Lost to Follow-up|0|||
156778079|NCT05020743|565937049|FG002|Overall Study|Lost to Follow-up|0|||
156778080|NCT05020743|565937047|FG000|Overall Study|Study Termination by Sponsor|10|||
156778081|NCT05020743|565937048|FG001|Overall Study|Study Termination by Sponsor|11|||
156778082|NCT05020743|565937049|FG002|Overall Study|Study Termination by Sponsor|10|||
156778083|NCT03488524|565937050|FG000|Overall Study|Withdrawal by Subject|51|||
156778084|NCT03488524|565937050|FG000|Overall Study|Death|19|||
156778085|NCT03488524|565937050|FG000|Overall Study|Study Sponsor|11|||
156778086|NCT03488524|565937050|FG000|Overall Study|Physician Decision|4|||
156778087|NCT03488524|565937050|FG000|Overall Study|Lost to Follow-up|3|||
156778088|NCT01299909|565937051|FG000|Overall Study|Lost to Follow-up|22|||
156778089|NCT01299909|565937052|FG001|Overall Study|Lost to Follow-up|18|||
156778090|NCT01299909|565937053|FG002|Overall Study|Lost to Follow-up|17|||
156778091|NCT01811238|565937054|FG000|Overall Study|Withdrawal by Subject|42|||
156778092|NCT01811238|565937054|FG000|Overall Study|Adverse Event|25|||
156778093|NCT01811238|565937054|FG000|Overall Study|Protocol Violation|4|||
156778094|NCT01811238|565937054|FG000|Overall Study|Lack of Efficacy|4|||
156430064|NCT03536884|564663355|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
156430065|NCT03301220|564663356|FG000|Overall Study|Death|26|||
156430066|NCT03301220|564663357|FG001|Overall Study|Death|15|||
156430067|NCT03301220|564663356|FG000|Overall Study|Withdrawal by Subject|23|||
156430068|NCT03301220|564663357|FG001|Overall Study|Withdrawal by Subject|12|||
156430069|NCT03301220|564663356|FG000|Overall Study|Lost to Follow-up|1|||
156430070|NCT03301220|564663357|FG001|Overall Study|Lost to Follow-up|1|||
156430071|NCT03301220|564663356|FG000|Overall Study|Randomized in error|1|||
156430072|NCT03301220|564663357|FG001|Overall Study|Randomized in error|1|||
156430073|NCT03301220|564663356|FG000|Overall Study|Randomized but not treated|0|||
156430074|NCT03301220|564663357|FG001|Overall Study|Randomized but not treated|1|||
156430075|NCT03301220|564663356|FG000|Overall Study|Ongoing followup|145|||
156430076|NCT03301220|564663357|FG001|Overall Study|Ongoing followup|163|||
156430077|NCT03301220|564663356|FG000|Overall Study|Principal Investigator and participant decision|0|||
156430078|NCT03301220|564663357|FG001|Overall Study|Principal Investigator and participant decision|1|||
156430079|NCT03451851|564663358|FG000|PCP: Week 0 -16|Adverse Event|1|||
156430080|NCT03451851|564663359|FG001|PCP: Week 0 -16|Adverse Event|0|||
156430081|NCT03451851|564663360|FG002|PCP: Week 0 -16|Adverse Event|0|||
156430082|NCT03451851|564663361|FG003|PCP: Week 0 -16|Adverse Event|0|||
156430083|NCT03451851|564663362|FG004|PCP: Week 0 -16|Adverse Event|0|||
156430084|NCT03451851|564663363|FG005|PCP: Week 0 -16|Adverse Event|0|||
156430085|NCT03451851|564663364|FG006|PCP: Week 0 -16|Adverse Event|1|||
156430086|NCT03451851|564663365|FG007|PCP: Week 0 -16|Adverse Event|0|||
156430087|NCT03451851|564663358|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
156430088|NCT03451851|564663359|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
156524814|NCT03075410|565015705|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
156524815|NCT03075410|565015706|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
156778095|NCT01811238|565937054|FG000|Overall Study|subject refused study medication|6|||
156778096|NCT01922934|565937058|FG000|Eligible Patients|Death|0|||
156778097|NCT01922934|565937059|FG001|Eligible Patients|Death|7|||
156778098|NCT01922934|565937058|FG000|Eligible Patients|Physician Decision|17|||
156778099|NCT01922934|565937059|FG001|Eligible Patients|Physician Decision|0|||
156778100|NCT01922934|565937058|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
156778101|NCT01922934|565937059|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
156778102|NCT01922934|565937058|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
156778103|NCT01922934|565937059|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
156778104|NCT01922934|565937058|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
156778105|NCT01922934|565937059|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
156778106|NCT01922934|565937058|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
156778107|NCT01922934|565937059|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
156778108|NCT01147458|565937062|FG000|First Intervention|Study terminated by sponsor|8|||
156778109|NCT01147458|565937063|FG001|First Intervention|Study terminated by sponsor|8|||
156778110|NCT01147458|565937064|FG002|First Intervention|Study terminated by sponsor|7|||
156778111|NCT01147458|565937065|FG003|First Intervention|Study terminated by sponsor|8|||
156430089|NCT03451851|564663360|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
156430090|NCT03451851|564663361|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
156778112|NCT01147458|565937062|FG000|First Intervention|Protocol Violation|2|||
156778113|NCT01147458|565937063|FG001|First Intervention|Protocol Violation|3|||
156778114|NCT01147458|565937064|FG002|First Intervention|Protocol Violation|2|||
156778115|NCT01147458|565937065|FG003|First Intervention|Protocol Violation|3|||
156778116|NCT01147458|565937062|FG000|First Intervention|Withdrawal by Subject|3|||
156778117|NCT01147458|565937063|FG001|First Intervention|Withdrawal by Subject|0|||
156778118|NCT01147458|565937064|FG002|First Intervention|Withdrawal by Subject|1|||
156778119|NCT01147458|565937065|FG003|First Intervention|Withdrawal by Subject|0|||
156778120|NCT01147458|565937062|FG000|First Intervention|Adverse Event|0|||
156778121|NCT01147458|565937063|FG001|First Intervention|Adverse Event|3|||
156778122|NCT01147458|565937064|FG002|First Intervention|Adverse Event|2|||
156778123|NCT01147458|565937065|FG003|First Intervention|Adverse Event|3|||
156778124|NCT01147458|565937062|FG000|First Intervention|Other|1|||
156778125|NCT01147458|565937063|FG001|First Intervention|Other|2|||
156778126|NCT01147458|565937064|FG002|First Intervention|Other|0|||
156778127|NCT01147458|565937065|FG003|First Intervention|Other|0|||
156778128|NCT01147458|565937062|FG000|Second Intervention|Study terminated by sponsor|7|||
156778129|NCT01147458|565937063|FG001|Second Intervention|Study terminated by sponsor|5|||
156778130|NCT01147458|565937064|FG002|Second Intervention|Study terminated by sponsor|5|||
156778131|NCT01147458|565937065|FG003|Second Intervention|Study terminated by sponsor|3|||
156778132|NCT01147458|565937062|FG000|Second Intervention|Protocol Violation|0|||
156778133|NCT01147458|565937063|FG001|Second Intervention|Protocol Violation|1|||
156778134|NCT01147458|565937064|FG002|Second Intervention|Protocol Violation|1|||
156778135|NCT01147458|565937065|FG003|Second Intervention|Protocol Violation|0|||
156778136|NCT01147458|565937062|FG000|Second Intervention|Withdrawal by Subject|0|||
156778137|NCT01147458|565937063|FG001|Second Intervention|Withdrawal by Subject|1|||
156778138|NCT01147458|565937064|FG002|Second Intervention|Withdrawal by Subject|0|||
156778139|NCT01147458|565937065|FG003|Second Intervention|Withdrawal by Subject|0|||
156778140|NCT01147458|565937062|FG000|Second Intervention|Adverse Event|2|||
156778141|NCT01147458|565937063|FG001|Second Intervention|Adverse Event|0|||
156778142|NCT01147458|565937064|FG002|Second Intervention|Adverse Event|1|||
156778143|NCT01147458|565937065|FG003|Second Intervention|Adverse Event|1|||
156778144|NCT01147458|565937062|FG000|Second Intervention|Other|0|||
156778145|NCT01147458|565937063|FG001|Second Intervention|Other|0|||
156778146|NCT01147458|565937064|FG002|Second Intervention|Other|1|||
156778147|NCT01147458|565937065|FG003|Second Intervention|Other|0|||
156778148|NCT04603066|565937077|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
156778149|NCT04603066|565937078|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
156778150|NCT00487188|565938104|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
156778151|NCT00487188|565938105|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
156778152|NCT00487188|565938106|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
156778153|NCT00487188|565938104|FG000|Induction Phase|Adverse Event|5|||
156778154|NCT00487188|565938105|FG001|Induction Phase|Adverse Event|0|||
156778155|NCT00487188|565938106|FG002|Induction Phase|Adverse Event|0|||
156778156|NCT00487188|565938104|FG000|Induction Phase|Lack of Efficacy|0|||
156778157|NCT00487188|565938105|FG001|Induction Phase|Lack of Efficacy|1|||
156778158|NCT00487188|565938106|FG002|Induction Phase|Lack of Efficacy|0|||
156778159|NCT00487188|565938104|FG000|Induction Phase|Protocol Violation|1|||
156778160|NCT00487188|565938105|FG001|Induction Phase|Protocol Violation|0|||
156778161|NCT00487188|565938106|FG002|Induction Phase|Protocol Violation|0|||
156524816|NCT03075410|565015707|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
156524817|NCT03075410|565015708|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
156524818|NCT03075410|565015709|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
156524819|NCT03075410|565015710|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
156524820|NCT03075410|565015711|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
156524821|NCT01427751|565015712|FG000|Overall Study|Adverse Event|18|||
156524822|NCT01427751|565015713|FG001|Overall Study|Adverse Event|2|||
156524823|NCT01427751|565015712|FG000|Overall Study|No further treatment benefit expected|5|||
156524824|NCT01427751|565015713|FG001|Overall Study|No further treatment benefit expected|1|||
156524825|NCT01427751|565015712|FG000|Overall Study|Lost to Follow-up|3|||
156524826|NCT01427751|565015713|FG001|Overall Study|Lost to Follow-up|1|||
156524827|NCT01427751|565015712|FG000|Overall Study|Withdrawal of consent|2|||
156524828|NCT01427751|565015713|FG001|Overall Study|Withdrawal of consent|2|||
156778162|NCT00487188|565938104|FG000|Induction Phase|Refused Treatment|1|||
156778163|NCT00487188|565938105|FG001|Induction Phase|Refused Treatment|2|||
156778164|NCT00487188|565938106|FG002|Induction Phase|Refused Treatment|0|||
156778165|NCT00487188|565938104|FG000|Induction Phase|Lost to Follow-up|2|||
156778166|NCT00487188|565938105|FG001|Induction Phase|Lost to Follow-up|2|||
156778167|NCT00487188|565938106|FG002|Induction Phase|Lost to Follow-up|0|||
156778168|NCT00487188|565938104|FG000|Induction Phase|Administrative|0|||
156778169|NCT00487188|565938105|FG001|Induction Phase|Administrative|1|||
156524829|NCT01427751|565015712|FG000|Overall Study|Protocol Violation|6|||
156524830|NCT01427751|565015713|FG001|Overall Study|Protocol Violation|4|||
156778170|NCT00487188|565938106|FG002|Induction Phase|Administrative|0|||
156778171|NCT00487188|565938104|FG000|Maintenance Phase|Adverse Event|1|||
156778172|NCT00487188|565938105|FG001|Maintenance Phase|Adverse Event|0|||
156778173|NCT00487188|565938106|FG002|Maintenance Phase|Adverse Event|0|||
156667372|NCT01796171|565530189|FG007|Follow-up Period|Death|0|||
156667373|NCT01796171|565530190|FG008|Follow-up Period|Death|0|||
156667374|NCT01796171|565530191|FG009|Follow-up Period|Death|0|||
156667375|NCT01796171|565530192|FG010|Follow-up Period|Death|17|||
156325338|NCT01436162|564290944|FG002|Single-blind Lead-in Phase|Other|0|||
156325339|NCT01436162|564290942|FG000|Randomized Phase|Adverse Event|1|||
156325340|NCT01436162|564290943|FG001|Randomized Phase|Adverse Event|5|||
156325341|NCT01436162|564290944|FG002|Randomized Phase|Adverse Event|6|||
156325342|NCT01436162|564290942|FG000|Randomized Phase|Protocol Violation|4|||
156325343|NCT01436162|564290943|FG001|Randomized Phase|Protocol Violation|4|||
156325344|NCT01436162|564290944|FG002|Randomized Phase|Protocol Violation|2|||
156325345|NCT01436162|564290942|FG000|Randomized Phase|Withdrawal by Subject|16|||
156325346|NCT01436162|564290943|FG001|Randomized Phase|Withdrawal by Subject|9|||
156325347|NCT01436162|564290944|FG002|Randomized Phase|Withdrawal by Subject|8|||
156325348|NCT01436162|564290942|FG000|Randomized Phase|Lost to Follow-up|17|||
156325349|NCT01436162|564290943|FG001|Randomized Phase|Lost to Follow-up|5|||
156325350|NCT01436162|564290944|FG002|Randomized Phase|Lost to Follow-up|4|||
156325351|NCT01436162|564290942|FG000|Randomized Phase|Lack of Efficacy|0|||
156325352|NCT01436162|564290943|FG001|Randomized Phase|Lack of Efficacy|1|||
156325353|NCT01436162|564290944|FG002|Randomized Phase|Lack of Efficacy|1|||
156325354|NCT01436162|564290942|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
156325355|NCT01436162|564290943|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
156325356|NCT01436162|564290944|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
156325357|NCT01436162|564290942|FG000|Randomized Phase|Other|2|||
156325358|NCT01436162|564290943|FG001|Randomized Phase|Other|5|||
156325359|NCT01436162|564290944|FG002|Randomized Phase|Other|4|||
156325360|NCT02750943|564290947|FG000|Overall Study|Lost to Follow-up|1|||
156325361|NCT02750943|564290948|FG001|Overall Study|Lost to Follow-up|2|||
156325362|NCT02750943|564290947|FG000|Overall Study|Withdrawal by Subject|5|||
156325363|NCT02750943|564290948|FG001|Overall Study|Withdrawal by Subject|7|||
156325364|NCT04597918|564290949|FG000|Overall Study|Withdrawal by Subject|6|||
156325365|NCT04597918|564290949|FG000|Overall Study|Lost to Follow-up|3|||
156325366|NCT04597918|564290949|FG000|Overall Study|Death|1|||
156325367|NCT00458536|564290952|FG000|Overall Study|Disease progression prior to treatment|7|||
156325368|NCT00458536|564290952|FG000|Overall Study|Unable to make vaccine|3|||
156325369|NCT00458536|564290952|FG000|Overall Study|No measurable disease after surgery|2|||
156325370|NCT00458536|564290952|FG000|Overall Study|Did not have renal cell carcinoma|2|||
156325371|NCT00458536|564290952|FG000|Overall Study|Patient did not have surgery|1|||
156325372|NCT00458536|564290952|FG000|Overall Study|Ineligible due to toxicity|1|||
156325373|NCT00458536|564290952|FG000|Overall Study|Withdrawal by Subject|1|||
156325374|NCT00458536|564290952|FG000|Overall Study|Progressive disease during treatment|2|||
156325375|NCT05140382|564290953|FG000|Overall Study|Death|3|||
156325376|NCT05140382|564290954|FG001|Overall Study|Death|0|||
156325377|NCT05140382|564290955|FG002|Overall Study|Death|0|||
156325378|NCT05140382|564290953|FG000|Overall Study|Investigator decision|1|||
156325379|NCT05140382|564290954|FG001|Overall Study|Investigator decision|0|||
156325380|NCT05140382|564290955|FG002|Overall Study|Investigator decision|0|||
156325381|NCT05140382|564290953|FG000|Overall Study|Other|4|||
156325382|NCT05140382|564290954|FG001|Overall Study|Other|0|||
156325383|NCT05140382|564290955|FG002|Overall Study|Other|1|||
156325384|NCT05140382|564290953|FG000|Overall Study|Progressive disease|20|||
156325385|NCT05140382|564290954|FG001|Overall Study|Progressive disease|1|||
156325386|NCT05140382|564290955|FG002|Overall Study|Progressive disease|12|||
156325387|NCT05140382|564290953|FG000|Overall Study|Subjective disease progression|2|||
156325388|NCT05140382|564290954|FG001|Overall Study|Subjective disease progression|1|||
156325389|NCT05140382|564290955|FG002|Overall Study|Subjective disease progression|0|||
156325390|NCT05140382|564290953|FG000|Overall Study|Unknown at data cut-off|0|||
156325391|NCT05140382|564290954|FG001|Overall Study|Unknown at data cut-off|0|||
156325392|NCT05140382|564290955|FG002|Overall Study|Unknown at data cut-off|1|||
156325393|NCT05140382|564290953|FG000|Overall Study|Withdrawal by Subject|1|||
156325394|NCT05140382|564290954|FG001|Overall Study|Withdrawal by Subject|0|||
156325395|NCT05140382|564290955|FG002|Overall Study|Withdrawal by Subject|4|||
156325396|NCT05140382|564290953|FG000|Overall Study|Withdrawal of consent|0|||
156325397|NCT05140382|564290954|FG001|Overall Study|Withdrawal of consent|0|||
156325398|NCT05140382|564290955|FG002|Overall Study|Withdrawal of consent|1|||
156325399|NCT05419908|564290957|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
156667376|NCT01796171|565530193|FG011|Follow-up Period|Death|9|||
156667377|NCT01796171|565530194|FG012|Follow-up Period|Death|1|||
156325400|NCT05419908|564290958|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
156325401|NCT05419908|564290957|FG000|Overall Study|Serious Adverse Event|0|||
156325402|NCT05419908|564290958|FG001|Overall Study|Serious Adverse Event|2|||
156325403|NCT05419908|564290957|FG000|Overall Study|Withdrawal by Subject|2|||
156325404|NCT05419908|564290958|FG001|Overall Study|Withdrawal by Subject|0|||
156325405|NCT05419908|564290957|FG000|Overall Study|Miscellaneous|1|||
156325406|NCT05419908|564290958|FG001|Overall Study|Miscellaneous|1|||
156667378|NCT01796171|565530195|FG013|Follow-up Period|Death|0|||
156667379|NCT01796171|565530196|FG014|Follow-up Period|Death|0|||
156325407|NCT01927341|564292403|FG000|Phase 1b|Lost to Follow-up|1|||
156325408|NCT01927341|564292404|FG001|Phase 1b|Lost to Follow-up|0|||
156325409|NCT01927341|564292405|FG002|Phase 1b|Lost to Follow-up|0|||
156325410|NCT01927341|564292406|FG003|Phase 1b|Lost to Follow-up|0|||
156325411|NCT01927341|564292407|FG004|Phase 1b|Lost to Follow-up|0|||
156325412|NCT01927341|564292403|FG000|Phase 1b|Death|2|||
156325413|NCT01927341|564292404|FG001|Phase 1b|Death|0|||
156325414|NCT01927341|564292405|FG002|Phase 1b|Death|0|||
156325415|NCT01927341|564292406|FG003|Phase 1b|Death|0|||
156325416|NCT01927341|564292407|FG004|Phase 1b|Death|0|||
156325417|NCT01927341|564292403|FG000|Phase 1b|Follow-up completed|7|||
156325418|NCT01927341|564292404|FG001|Phase 1b|Follow-up completed|0|||
156325419|NCT01927341|564292405|FG002|Phase 1b|Follow-up completed|0|||
156325420|NCT01927341|564292406|FG003|Phase 1b|Follow-up completed|0|||
156325421|NCT01927341|564292407|FG004|Phase 1b|Follow-up completed|0|||
156325422|NCT01927341|564292403|FG000|Phase 2|Lost to Follow-up|0|||
156325423|NCT01927341|564292404|FG001|Phase 2|Lost to Follow-up|1|||
156325424|NCT01927341|564292405|FG002|Phase 2|Lost to Follow-up|0|||
156325425|NCT01927341|564292406|FG003|Phase 2|Lost to Follow-up|0|||
156325426|NCT01927341|564292407|FG004|Phase 2|Lost to Follow-up|0|||
156325427|NCT01927341|564292403|FG000|Phase 2|Participant withdrew consent|0|||
156325428|NCT01927341|564292404|FG001|Phase 2|Participant withdrew consent|2|||
156325429|NCT01927341|564292405|FG002|Phase 2|Participant withdrew consent|1|||
156325430|NCT01927341|564292406|FG003|Phase 2|Participant withdrew consent|2|||
156325431|NCT01927341|564292407|FG004|Phase 2|Participant withdrew consent|3|||
156325432|NCT01927341|564292403|FG000|Phase 2|Death|0|||
156325433|NCT01927341|564292404|FG001|Phase 2|Death|4|||
156325434|NCT01927341|564292405|FG002|Phase 2|Death|0|||
156325435|NCT01927341|564292406|FG003|Phase 2|Death|3|||
156325436|NCT01927341|564292407|FG004|Phase 2|Death|2|||
156325437|NCT01927341|564292403|FG000|Phase 2|New cancer therapy|0|||
156325438|NCT01927341|564292404|FG001|Phase 2|New cancer therapy|1|||
156325439|NCT01927341|564292405|FG002|Phase 2|New cancer therapy|0|||
156325440|NCT01927341|564292406|FG003|Phase 2|New cancer therapy|4|||
156325441|NCT01927341|564292407|FG004|Phase 2|New cancer therapy|1|||
156325442|NCT01927341|564292403|FG000|Phase 2|Disease progression|0|||
156325443|NCT01927341|564292404|FG001|Phase 2|Disease progression|1|||
156325444|NCT01927341|564292405|FG002|Phase 2|Disease progression|1|||
156325445|NCT01927341|564292406|FG003|Phase 2|Disease progression|1|||
156325446|NCT01927341|564292407|FG004|Phase 2|Disease progression|0|||
156325447|NCT01927341|564292403|FG000|Phase 2|Follow-up completed|0|||
156325448|NCT01927341|564292404|FG001|Phase 2|Follow-up completed|6|||
156325449|NCT01927341|564292405|FG002|Phase 2|Follow-up completed|3|||
156325450|NCT01927341|564292406|FG003|Phase 2|Follow-up completed|5|||
156325451|NCT01927341|564292407|FG004|Phase 2|Follow-up completed|2|||
156325452|NCT00451451|564292408|FG000|Overall Study|Adverse Event|11|||
156325453|NCT00451451|564292409|FG001|Overall Study|Adverse Event|21|||
156325454|NCT00451451|564292410|FG002|Overall Study|Adverse Event|26|||
156325455|NCT00451451|564292411|FG003|Overall Study|Adverse Event|10|||
156325456|NCT00451451|564292408|FG000|Overall Study|Lost to Follow-up|11|||
156325457|NCT00451451|564292409|FG001|Overall Study|Lost to Follow-up|9|||
156325458|NCT00451451|564292410|FG002|Overall Study|Lost to Follow-up|8|||
156325459|NCT00451451|564292411|FG003|Overall Study|Lost to Follow-up|11|||
156325460|NCT00451451|564292408|FG000|Overall Study|Consent Withdrawn|14|||
156325461|NCT00451451|564292409|FG001|Overall Study|Consent Withdrawn|9|||
156325462|NCT00451451|564292410|FG002|Overall Study|Consent Withdrawn|17|||
156325463|NCT00451451|564292411|FG003|Overall Study|Consent Withdrawn|17|||
156325464|NCT00451451|564292408|FG000|Overall Study|Investigator Decision|6|||
156778174|NCT00487188|565938104|FG000|Maintenance Phase|Death|1|||
156524831|NCT01427751|565015712|FG000|Overall Study|Death|2|||
156325465|NCT00451451|564292409|FG001|Overall Study|Investigator Decision|2|||
156325466|NCT00451451|564292410|FG002|Overall Study|Investigator Decision|1|||
156325467|NCT00451451|564292411|FG003|Overall Study|Investigator Decision|2|||
156524832|NCT01427751|565015713|FG001|Overall Study|Death|0|||
156325468|NCT00451451|564292408|FG000|Overall Study|Subject Non-Compliance|8|||
156667380|NCT01796171|565530182|FG000|Follow-up Period|Patient transferred to other hospital|0|||
156325469|NCT00451451|564292409|FG001|Overall Study|Subject Non-Compliance|4|||
156325470|NCT00451451|564292410|FG002|Overall Study|Subject Non-Compliance|3|||
156325471|NCT00451451|564292411|FG003|Overall Study|Subject Non-Compliance|3|||
156325472|NCT00451451|564292408|FG000|Overall Study|Death|1|||
156325473|NCT00451451|564292409|FG001|Overall Study|Death|0|||
156325474|NCT00451451|564292410|FG002|Overall Study|Death|0|||
156325475|NCT00451451|564292411|FG003|Overall Study|Death|1|||
156325476|NCT00451451|564292408|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
156325477|NCT00451451|564292409|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
156325478|NCT00451451|564292410|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
156325479|NCT00451451|564292411|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
156325480|NCT00089284|564292417|FG000|Overall Study|Adverse event before starting treatment|0|||
156524833|NCT01427751|565015712|FG000|Overall Study|Other miscellaneous reasons|6|||
156667381|NCT01796171|565530183|FG001|Follow-up Period|Patient transferred to other hospital|1|||
156667382|NCT01796171|565530184|FG002|Follow-up Period|Patient transferred to other hospital|0|||
156778175|NCT00487188|565938105|FG001|Maintenance Phase|Death|0|||
156778176|NCT00487188|565938106|FG002|Maintenance Phase|Death|0|||
156778177|NCT00487188|565938104|FG000|Maintenance Phase|Lost to Follow-up|1|||
156778178|NCT00487188|565938105|FG001|Maintenance Phase|Lost to Follow-up|0|||
156778179|NCT00487188|565938106|FG002|Maintenance Phase|Lost to Follow-up|0|||
156778180|NCT00487188|565938104|FG000|Maintenance Phase|Administrative|0|||
156778181|NCT00487188|565938105|FG001|Maintenance Phase|Administrative|0|||
156778182|NCT00487188|565938106|FG002|Maintenance Phase|Administrative|1|||
156778183|NCT03483584|565938111|FG000|Overall Study|Lost to Follow-up|40|||
156778184|NCT03483584|565938112|FG001|Overall Study|Lost to Follow-up|7|||
156778185|NCT03483584|565938111|FG000|Overall Study|Withdrawal by Subject|4|||
156778186|NCT03483584|565938112|FG001|Overall Study|Withdrawal by Subject|1|||
156778187|NCT00005047|565938113|FG000|Overall Study|Withdrawal by Subject|12|||
156778188|NCT00005047|565938114|FG001|Overall Study|Withdrawal by Subject|0|||
156778189|NCT00005047|565938115|FG002|Overall Study|Withdrawal by Subject|0|||
156778190|NCT00005047|565938116|FG003|Overall Study|Withdrawal by Subject|0|||
156778191|NCT00005047|565938113|FG000|Overall Study|Adverse Event|5|||
156778192|NCT00005047|565938114|FG001|Overall Study|Adverse Event|0|||
156778193|NCT00005047|565938115|FG002|Overall Study|Adverse Event|0|||
156778194|NCT00005047|565938116|FG003|Overall Study|Adverse Event|0|||
156778195|NCT00005047|565938113|FG000|Overall Study|Lost to Follow-up|1|||
156778196|NCT00005047|565938114|FG001|Overall Study|Lost to Follow-up|0|||
156778197|NCT00005047|565938115|FG002|Overall Study|Lost to Follow-up|0|||
156778198|NCT00005047|565938116|FG003|Overall Study|Lost to Follow-up|0|||
156778199|NCT00005047|565938113|FG000|Overall Study|Lack of Efficacy|1|||
156778200|NCT00005047|565938114|FG001|Overall Study|Lack of Efficacy|0|||
156778201|NCT00005047|565938115|FG002|Overall Study|Lack of Efficacy|0|||
156778202|NCT00005047|565938116|FG003|Overall Study|Lack of Efficacy|0|||
156778203|NCT03240874|565938123|FG000|Overall Study|Lost to Follow-up|0|||
156778204|NCT03240874|565938124|FG001|Overall Study|Lost to Follow-up|2|||
156778205|NCT03240874|565938125|FG002|Overall Study|Lost to Follow-up|4|||
156778206|NCT03240874|565938126|FG003|Overall Study|Lost to Follow-up|1|||
156778207|NCT01964404|565938127|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
156778208|NCT01964404|565938128|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
156778209|NCT01964404|565938129|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
156778210|NCT01964404|565938130|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
156778211|NCT01964404|565938131|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
156778212|NCT01964404|565938132|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
156778213|NCT01964404|565938133|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
156778214|NCT01964404|565938134|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
156778215|NCT01964404|565938135|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
156778216|NCT01964404|565938136|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
156778217|NCT01964404|565938127|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
156778218|NCT01964404|565938128|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
156778219|NCT01964404|565938129|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
156778220|NCT01964404|565938130|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
156778221|NCT01964404|565938131|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778222|NCT01964404|565938132|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778223|NCT01964404|565938133|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778224|NCT01964404|565938134|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778225|NCT01964404|565938135|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778226|NCT01964404|565938136|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778227|NCT01964404|565938127|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
156778228|NCT01964404|565938128|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
156778229|NCT01964404|565938129|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778230|NCT01964404|565938130|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
156778231|NCT01964404|565938131|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778232|NCT01964404|565938132|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156524834|NCT01427751|565015713|FG001|Overall Study|Other miscellaneous reasons|4|||
156524835|NCT00368992|565015720|FG000|Overall Study|Ineligible|5|||
156524836|NCT00368992|565015720|FG000|Overall Study|Refused treatment|3|||
156524837|NCT00368992|565015720|FG000|Overall Study|Lack of Efficacy|63|||
156524838|NCT00368992|565015720|FG000|Overall Study|Adverse Event|26|||
156524839|NCT00368992|565015720|FG000|Overall Study|Death|4|||
156524840|NCT00368992|565015720|FG000|Overall Study|Other|9|||
156524841|NCT00790751|565015727|FG000|Overall Study|Protocol non-compliance|16|||
156524842|NCT00790751|565015728|FG001|Overall Study|Protocol non-compliance|16|||
156524843|NCT00790751|565015729|FG002|Overall Study|Protocol non-compliance|10|||
156778233|NCT01964404|565938133|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778234|NCT01964404|565938134|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778235|NCT01964404|565938135|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156524844|NCT00790751|565015730|FG003|Overall Study|Protocol non-compliance|11|||
156778236|NCT01964404|565938136|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778237|NCT05528510|565938137|FG000|Overall Study|Death|1|||
156778238|NCT05528510|565938138|FG001|Overall Study|Death|0|||
156778239|NCT05528510|565938139|FG002|Overall Study|Death|0|||
156524845|NCT00790751|565015727|FG000|Overall Study|Lost to Follow-up|4|||
156325481|NCT00089284|564292418|FG001|Overall Study|Adverse event before starting treatment|0|||
156325482|NCT00089284|564292419|FG002|Overall Study|Adverse event before starting treatment|0|||
156325483|NCT00089284|564292420|FG003|Overall Study|Adverse event before starting treatment|0|||
156325484|NCT00089284|564292421|FG004|Overall Study|Adverse event before starting treatment|0|||
156325485|NCT00089284|564292422|FG005|Overall Study|Adverse event before starting treatment|0|||
156325486|NCT00089284|564292423|FG006|Overall Study|Adverse event before starting treatment|1|||
156325487|NCT02437513|564292424|FG000|Overall Study|Withdrawal by Subject|2|||
156325488|NCT03956056|564292427|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
156325489|NCT03956056|564292427|FG000|Overall Study|Lack of Efficacy|1|||
156325490|NCT03403374|564292428|FG000|Overall Study|Lost to Follow-up|1|||
156325491|NCT01092507|564292432|FG000|Overall Study|Withdrawal by Subject|2|||
156325492|NCT01092507|564292433|FG001|Overall Study|Withdrawal by Subject|0|||
156325493|NCT04629508|564292436|FG000|Overall Study|Adverse Event|1|||
156325494|NCT04629508|564292436|FG000|Overall Study|Death|2|||
156325495|NCT04629508|564292436|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
156325496|NCT04073368|564292437|FG000|Overall Study|Adverse Event|2|||
156325497|NCT04073368|564292438|FG001|Overall Study|Adverse Event|0|||
156325498|NCT04073368|564292439|FG002|Overall Study|Adverse Event|1|||
156667383|NCT01796171|565530185|FG003|Follow-up Period|Patient transferred to other hospital|0|||
156667384|NCT01796171|565530186|FG004|Follow-up Period|Patient transferred to other hospital|0|||
156667385|NCT01796171|565530187|FG005|Follow-up Period|Patient transferred to other hospital|0|||
156667386|NCT01796171|565530188|FG006|Follow-up Period|Patient transferred to other hospital|0|||
156667387|NCT01796171|565530189|FG007|Follow-up Period|Patient transferred to other hospital|0|||
156667388|NCT01796171|565530190|FG008|Follow-up Period|Patient transferred to other hospital|0|||
156778240|NCT05528510|565938137|FG000|Overall Study|Lost to Follow-up|1|||
156778241|NCT05528510|565938138|FG001|Overall Study|Lost to Follow-up|0|||
156778242|NCT05528510|565938139|FG002|Overall Study|Lost to Follow-up|0|||
156778243|NCT05528510|565938137|FG000|Overall Study|Withdrawal by Subject|4|||
156778244|NCT05528510|565938138|FG001|Overall Study|Withdrawal by Subject|1|||
156778245|NCT05528510|565938139|FG002|Overall Study|Withdrawal by Subject|3|||
156778246|NCT05528510|565938137|FG000|Overall Study|Other|2|||
156778247|NCT05528510|565938138|FG001|Overall Study|Other|2|||
156778248|NCT05528510|565938139|FG002|Overall Study|Other|1|||
156778249|NCT05350202|565938140|FG000|Visit 1 - Baseline|Not-treated|18|||
156778250|NCT05350202|565938141|FG001|Visit 1 - Baseline|Not-treated|0|||
156778251|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
156778252|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
156778253|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
156778254|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
156778255|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
156778256|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
156778257|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
156778258|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
156778259|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
156778260|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
156778261|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
156778262|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
156778263|NCT04707469|565938142|FG000|Overall Study|Site closure|0|||
156778264|NCT04707469|565938143|FG001|Overall Study|Site closure|2|||
156778265|NCT04707469|565938144|FG002|Overall Study|Site closure|0|||
156778266|NCT04707469|565938142|FG000|Overall Study|Physician Decision|2|||
156778267|NCT04707469|565938143|FG001|Overall Study|Physician Decision|2|||
156778268|NCT04707469|565938144|FG002|Overall Study|Physician Decision|2|||
156667389|NCT01796171|565530191|FG009|Follow-up Period|Patient transferred to other hospital|0|||
156667390|NCT01796171|565530192|FG010|Follow-up Period|Patient transferred to other hospital|0|||
156667391|NCT01796171|565530193|FG011|Follow-up Period|Patient transferred to other hospital|0|||
156667392|NCT01796171|565530194|FG012|Follow-up Period|Patient transferred to other hospital|0|||
156667393|NCT01796171|565530195|FG013|Follow-up Period|Patient transferred to other hospital|0|||
156667394|NCT01796171|565530196|FG014|Follow-up Period|Patient transferred to other hospital|0|||
156667395|NCT01796171|565530182|FG000|Follow-up Period|Sponsor Decision|0|||
156667396|NCT01796171|565530183|FG001|Follow-up Period|Sponsor Decision|0|||
156667397|NCT01796171|565530184|FG002|Follow-up Period|Sponsor Decision|0|||
156667398|NCT01796171|565530185|FG003|Follow-up Period|Sponsor Decision|0|||
156667399|NCT01796171|565530186|FG004|Follow-up Period|Sponsor Decision|0|||
156667400|NCT01796171|565530187|FG005|Follow-up Period|Sponsor Decision|0|||
156667401|NCT01796171|565530188|FG006|Follow-up Period|Sponsor Decision|0|||
156667402|NCT01796171|565530189|FG007|Follow-up Period|Sponsor Decision|0|||
156667403|NCT01796171|565530190|FG008|Follow-up Period|Sponsor Decision|0|||
156667404|NCT01796171|565530191|FG009|Follow-up Period|Sponsor Decision|0|||
156667405|NCT01796171|565530192|FG010|Follow-up Period|Sponsor Decision|40|||
156667406|NCT01796171|565530193|FG011|Follow-up Period|Sponsor Decision|15|||
156667407|NCT01796171|565530194|FG012|Follow-up Period|Sponsor Decision|7|||
156667408|NCT01796171|565530195|FG013|Follow-up Period|Sponsor Decision|0|||
156667409|NCT01796171|565530196|FG014|Follow-up Period|Sponsor Decision|0|||
156667410|NCT00418561|565530197|FG000|Overall Study|Participant's (guardian's) decision|0|||
156667411|NCT00418561|565530198|FG001|Overall Study|Participant's (guardian's) decision|1|||
156667412|NCT00418561|565530199|FG002|Overall Study|Participant's (guardian's) decision|0|||
156325499|NCT04073368|564292440|FG003|Overall Study|Adverse Event|1|||
156325500|NCT04073368|564292437|FG000|Overall Study|Withdrawal by Subject|2|||
156325501|NCT04073368|564292438|FG001|Overall Study|Withdrawal by Subject|2|||
156325502|NCT04073368|564292439|FG002|Overall Study|Withdrawal by Subject|1|||
156325503|NCT04073368|564292440|FG003|Overall Study|Withdrawal by Subject|1|||
156325504|NCT04073368|564292437|FG000|Overall Study|Lost to Follow-up|1|||
156325505|NCT04073368|564292438|FG001|Overall Study|Lost to Follow-up|1|||
156325506|NCT04073368|564292439|FG002|Overall Study|Lost to Follow-up|1|||
156325507|NCT04073368|564292440|FG003|Overall Study|Lost to Follow-up|0|||
156325508|NCT04073368|564292437|FG000|Overall Study|Protocol Violation|0|||
156325509|NCT04073368|564292438|FG001|Overall Study|Protocol Violation|1|||
156325510|NCT04073368|564292439|FG002|Overall Study|Protocol Violation|0|||
156325511|NCT04073368|564292440|FG003|Overall Study|Protocol Violation|0|||
156325512|NCT04073368|564292437|FG000|Overall Study|Subject noncompliance|7|||
156325513|NCT04073368|564292438|FG001|Overall Study|Subject noncompliance|4|||
156524846|NCT00790751|565015728|FG001|Overall Study|Lost to Follow-up|9|||
156325514|NCT04073368|564292439|FG002|Overall Study|Subject noncompliance|0|||
156325515|NCT04073368|564292440|FG003|Overall Study|Subject noncompliance|0|||
156667413|NCT00829309|565530200|FG000|Washout: 7 Days|Protocol Violation|1|||
156667414|NCT00829309|565530201|FG001|Washout: 7 Days|Protocol Violation|0|||
156667415|NCT01083693|565530204|FG000|Overall Study|Adverse Event|1|||
156667416|NCT01083693|565530205|FG001|Overall Study|Adverse Event|1|||
156667417|NCT01083693|565530206|FG002|Overall Study|Adverse Event|0|||
156667418|NCT01083693|565530204|FG000|Overall Study|Lost to Follow-up|2|||
156667419|NCT01083693|565530205|FG001|Overall Study|Lost to Follow-up|0|||
156667420|NCT01083693|565530206|FG002|Overall Study|Lost to Follow-up|2|||
156667421|NCT01083693|565530204|FG000|Overall Study|Lack of effectiveness|13|||
156667422|NCT01083693|565530205|FG001|Overall Study|Lack of effectiveness|2|||
156667423|NCT01083693|565530206|FG002|Overall Study|Lack of effectiveness|2|||
156667424|NCT01083693|565530204|FG000|Overall Study|Patient Moved|0|||
156667425|NCT01083693|565530205|FG001|Overall Study|Patient Moved|1|||
156667426|NCT01083693|565530206|FG002|Overall Study|Patient Moved|0|||
156667427|NCT01083693|565530204|FG000|Overall Study|Complete remission|0|||
156667428|NCT01083693|565530205|FG001|Overall Study|Complete remission|1|||
156667429|NCT01083693|565530206|FG002|Overall Study|Complete remission|0|||
156667430|NCT01083693|565530204|FG000|Overall Study|Other medical condition/surgery|1|||
156667431|NCT01083693|565530205|FG001|Overall Study|Other medical condition/surgery|1|||
156667432|NCT01083693|565530206|FG002|Overall Study|Other medical condition/surgery|0|||
156667433|NCT01083693|565530204|FG000|Overall Study|Withdrawal by Subject|3|||
156667434|NCT01083693|565530205|FG001|Overall Study|Withdrawal by Subject|0|||
156667435|NCT01083693|565530206|FG002|Overall Study|Withdrawal by Subject|2|||
156667436|NCT01083693|565530204|FG000|Overall Study|Reason unknown|0|||
156667437|NCT01083693|565530205|FG001|Overall Study|Reason unknown|0|||
156667438|NCT01083693|565530206|FG002|Overall Study|Reason unknown|1|||
156667439|NCT00834418|565530207|FG000|Overall Study|Adverse Event|0|||
156667440|NCT00834418|565530208|FG001|Overall Study|Adverse Event|2|||
156667441|NCT01705574|565530209|FG000|Double-Blind Phase|Lost to Follow-up|12|||
156667442|NCT01705574|565530210|FG001|Double-Blind Phase|Lost to Follow-up|16|||
156667443|NCT01705574|565530211|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156667444|NCT01705574|565530212|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156667445|NCT01705574|565530209|FG000|Double-Blind Phase|Adverse Event|3|||
156667446|NCT01705574|565530210|FG001|Double-Blind Phase|Adverse Event|10|||
156667447|NCT01705574|565530211|FG002|Double-Blind Phase|Adverse Event|0|||
156667448|NCT01705574|565530212|FG003|Double-Blind Phase|Adverse Event|0|||
156667449|NCT01705574|565530209|FG000|Double-Blind Phase|Withdrew Consent|8|||
156667450|NCT01705574|565530210|FG001|Double-Blind Phase|Withdrew Consent|5|||
156667451|NCT01705574|565530211|FG002|Double-Blind Phase|Withdrew Consent|0|||
156667452|NCT01705574|565530212|FG003|Double-Blind Phase|Withdrew Consent|0|||
156667453|NCT01705574|565530209|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
156667454|NCT01705574|565530210|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
156667455|NCT01705574|565530211|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
156667456|NCT01705574|565530212|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
156667457|NCT01705574|565530209|FG000|Double-Blind Phase|Pregnancy|1|||
156667458|NCT01705574|565530210|FG001|Double-Blind Phase|Pregnancy|1|||
156667459|NCT01705574|565530211|FG002|Double-Blind Phase|Pregnancy|0|||
156667460|NCT01705574|565530212|FG003|Double-Blind Phase|Pregnancy|0|||
156667461|NCT01705574|565530209|FG000|Double-Blind Phase|Protocol Violation|1|||
156667462|NCT01705574|565530210|FG001|Double-Blind Phase|Protocol Violation|0|||
156667463|NCT01705574|565530211|FG002|Double-Blind Phase|Protocol Violation|0|||
156667464|NCT01705574|565530212|FG003|Double-Blind Phase|Protocol Violation|0|||
156667465|NCT01705574|565530209|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
156667466|NCT01705574|565530210|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
156667467|NCT01705574|565530211|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
156667468|NCT01705574|565530212|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
156667469|NCT01705574|565530209|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
156667470|NCT01705574|565530210|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
156667471|NCT01705574|565530211|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
156325516|NCT00736879|564292443|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
156325517|NCT00736879|564292444|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
156325518|NCT00736879|564292445|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
156325519|NCT00736879|564292446|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
156325520|NCT00736879|564292443|FG000|Double Blind Treatment Period|Adverse Event|0|||
156325521|NCT00736879|564292444|FG001|Double Blind Treatment Period|Adverse Event|1|||
156325522|NCT00736879|564292445|FG002|Double Blind Treatment Period|Adverse Event|1|||
156325523|NCT00736879|564292446|FG003|Double Blind Treatment Period|Adverse Event|0|||
156325524|NCT00736879|564292443|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
156325525|NCT00736879|564292444|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
156325526|NCT00736879|564292445|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
156325527|NCT00736879|564292446|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
156325528|NCT00736879|564292443|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
156325529|NCT00736879|564292444|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
156325530|NCT00736879|564292445|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
156325531|NCT00736879|564292446|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
156325532|NCT00736879|564292443|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
156325533|NCT00736879|564292444|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
156325534|NCT00736879|564292445|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
156325535|NCT00736879|564292446|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
156325536|NCT00736879|564292443|FG000|Double Blind Treatment Period|No longer met criteria|0|||
156325537|NCT00736879|564292444|FG001|Double Blind Treatment Period|No longer met criteria|1|||
156325538|NCT00736879|564292445|FG002|Double Blind Treatment Period|No longer met criteria|0|||
156325539|NCT00736879|564292446|FG003|Double Blind Treatment Period|No longer met criteria|0|||
156325540|NCT00736879|564292443|FG000|Double Blind Treatment Period|non-specified|0|||
156325541|NCT00736879|564292444|FG001|Double Blind Treatment Period|non-specified|1|||
156325542|NCT00736879|564292445|FG002|Double Blind Treatment Period|non-specified|0|||
156325543|NCT00736879|564292446|FG003|Double Blind Treatment Period|non-specified|0|||
156325544|NCT00736879|564292443|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
156325545|NCT00736879|564292444|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
156325546|NCT00736879|564292445|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
156325547|NCT00736879|564292446|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
156325548|NCT00736879|564292443|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
156325549|NCT00736879|564292444|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
156325550|NCT00736879|564292445|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
156325551|NCT00736879|564292446|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
156325552|NCT01031381|564292447|FG000|Overall Study|Physician Decision|3|||
156325553|NCT01031381|564292447|FG000|Overall Study|Withdrawal by Subject|6|||
156325554|NCT00147251|564292448|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
156325555|NCT00147251|564292449|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
156325556|NCT01367119|564292456|FG000|Overall Study|Adverse Event|1|||
156325557|NCT01367119|564292457|FG001|Overall Study|Adverse Event|0|||
156325558|NCT01367119|564292456|FG000|Overall Study|Withdrawal by Subject|1|||
156325559|NCT01367119|564292457|FG001|Overall Study|Withdrawal by Subject|1|||
156325560|NCT03880461|564292460|FG000|Overall Study|Determined ineligible after enrollment|45|||
156325561|NCT03880461|564292461|FG001|Overall Study|Determined ineligible after enrollment|44|||
156325562|NCT03880461|564292460|FG000|Overall Study|No weight measurement after enrollment|24|||
156325563|NCT03880461|564292461|FG001|Overall Study|No weight measurement after enrollment|17|||
156325564|NCT00064298|564292463|FG000|Overall Study|Withdrawal by Subject|2|||
156325565|NCT00064298|564292464|FG001|Overall Study|Withdrawal by Subject|1|||
156325566|NCT00064298|564292463|FG000|Overall Study|Lost to Follow-up|2|||
156325567|NCT00064298|564292464|FG001|Overall Study|Lost to Follow-up|2|||
156325568|NCT00064298|564292463|FG000|Overall Study|Death|0|||
156325569|NCT00064298|564292464|FG001|Overall Study|Death|1|||
156325570|NCT00064298|564292463|FG000|Overall Study|Disease Progression|2|||
156778269|NCT04707469|565938142|FG000|Overall Study|Death|1|||
156667472|NCT01705574|565530212|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
156325571|NCT00064298|564292464|FG001|Overall Study|Disease Progression|1|||
156325572|NCT02220998|564292465|FG000|Overall Study|Randomized but Never Treated|1|||
156325573|NCT02220998|564292466|FG001|Overall Study|Randomized but Never Treated|2|||
156325574|NCT02220998|564292465|FG000|Overall Study|Death|2|||
156325575|NCT02220998|564292466|FG001|Overall Study|Death|0|||
156778270|NCT04707469|565938143|FG001|Overall Study|Death|6|||
156778271|NCT04707469|565938144|FG002|Overall Study|Death|2|||
156524847|NCT00790751|565015729|FG002|Overall Study|Lost to Follow-up|4|||
156524848|NCT00790751|565015730|FG003|Overall Study|Lost to Follow-up|5|||
156524849|NCT00790751|565015727|FG000|Overall Study|Adverse Event|5|||
156524850|NCT00790751|565015728|FG001|Overall Study|Adverse Event|3|||
156524851|NCT00790751|565015729|FG002|Overall Study|Adverse Event|5|||
156524852|NCT00790751|565015730|FG003|Overall Study|Adverse Event|4|||
156524853|NCT00790751|565015727|FG000|Overall Study|Requirement for restricted medication|0|||
156524854|NCT00790751|565015728|FG001|Overall Study|Requirement for restricted medication|2|||
156524855|NCT00790751|565015729|FG002|Overall Study|Requirement for restricted medication|0|||
156524856|NCT00790751|565015730|FG003|Overall Study|Requirement for restricted medication|0|||
156524857|NCT00790751|565015727|FG000|Overall Study|Death|0|||
156524858|NCT00790751|565015728|FG001|Overall Study|Death|0|||
156524859|NCT00790751|565015729|FG002|Overall Study|Death|1|||
156524860|NCT00790751|565015730|FG003|Overall Study|Death|0|||
156524861|NCT00790751|565015727|FG000|Overall Study|Physician Decision|0|||
156524862|NCT00790751|565015728|FG001|Overall Study|Physician Decision|0|||
156524863|NCT00790751|565015729|FG002|Overall Study|Physician Decision|0|||
156524864|NCT00790751|565015730|FG003|Overall Study|Physician Decision|1|||
156524865|NCT02427464|565015731|FG000|Overall Study|Adverse Event|6|||
156524866|NCT02427464|565015732|FG001|Overall Study|Adverse Event|1|||
156524867|NCT02427464|565015731|FG000|Overall Study|Lost to Follow-up|16|||
156524868|NCT02427464|565015732|FG001|Overall Study|Lost to Follow-up|5|||
156524869|NCT02427464|565015731|FG000|Overall Study|Physician Decision|2|||
156524870|NCT02427464|565015732|FG001|Overall Study|Physician Decision|0|||
156524871|NCT02427464|565015731|FG000|Overall Study|Withdrawal by Subject|10|||
156524872|NCT02427464|565015732|FG001|Overall Study|Withdrawal by Subject|8|||
156524873|NCT02427464|565015731|FG000|Overall Study|Noncompliance|16|||
156524874|NCT02427464|565015732|FG001|Overall Study|Noncompliance|10|||
156524875|NCT05330312|565015734|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
156524876|NCT05330312|565015735|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
156524877|NCT05330312|565015736|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
156524878|NCT05330312|565015734|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
156325576|NCT02220998|564292465|FG000|Overall Study|Lack of Efficacy|0|||
156325577|NCT02220998|564292466|FG001|Overall Study|Lack of Efficacy|5|||
156325578|NCT02220998|564292465|FG000|Overall Study|Lost to Follow-up|4|||
156325579|NCT02220998|564292466|FG001|Overall Study|Lost to Follow-up|4|||
156325580|NCT01982331|564292467|FG000|Received Vaccination 2|Adverse Event|1|||
156325581|NCT01982331|564292468|FG001|Received Vaccination 2|Adverse Event|2|||
156667473|NCT01705574|565530209|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
156667474|NCT01705574|565530210|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
156325582|NCT01982331|564292467|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
156524879|NCT05330312|565015735|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
156524880|NCT05330312|565015736|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
156524881|NCT05330312|565015734|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
156524882|NCT05330312|565015735|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
156524883|NCT05330312|565015736|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
156524884|NCT05330312|565015734|FG000|Pivotal Investigation - Part 2|Death|1|||
156524885|NCT05330312|565015735|FG001|Pivotal Investigation - Part 2|Death|4|||
156524886|NCT05330312|565015736|FG002|Pivotal Investigation - Part 2|Death|0|||
156524887|NCT04737187|565015737|FG000|Overall Study|Switched to marketed drug|32|||
156524888|NCT04737187|565015738|FG001|Overall Study|Switched to marketed drug|4|||
156524889|NCT04737187|565015737|FG000|Overall Study|Radiological Progressive Disease|145|||
156325583|NCT01982331|564292468|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
156325584|NCT01982331|564292467|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
156325585|NCT01982331|564292468|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
156325586|NCT02280473|564292475|FG000|Overall Study|Adverse Event|1|||
156325587|NCT02280473|564292476|FG001|Overall Study|Adverse Event|1|||
156325588|NCT02280473|564292475|FG000|Overall Study|Lack of Efficacy|0|||
156325589|NCT02280473|564292476|FG001|Overall Study|Lack of Efficacy|1|||
156325590|NCT02280473|564292475|FG000|Overall Study|Lost to Follow-up|0|||
156325591|NCT02280473|564292476|FG001|Overall Study|Lost to Follow-up|1|||
156325592|NCT01539317|564292477|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
156524890|NCT04737187|565015738|FG001|Overall Study|Radiological Progressive Disease|146|||
156667475|NCT01705574|565530211|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
156667476|NCT01705574|565530212|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
156667477|NCT01705574|565530209|FG000|Open-Label Extension Phase|Adverse Event|3|||
156667478|NCT01705574|565530210|FG001|Open-Label Extension Phase|Adverse Event|0|||
156667479|NCT01705574|565530211|FG002|Open-Label Extension Phase|Adverse Event|0|||
156667480|NCT01705574|565530212|FG003|Open-Label Extension Phase|Adverse Event|1|||
156667481|NCT01705574|565530209|FG000|Open-Label Extension Phase|Death|2|||
156667482|NCT01705574|565530210|FG001|Open-Label Extension Phase|Death|0|||
156667483|NCT01705574|565530211|FG002|Open-Label Extension Phase|Death|1|||
156667484|NCT01705574|565530212|FG003|Open-Label Extension Phase|Death|0|||
156667485|NCT01705574|565530209|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
156667486|NCT01705574|565530210|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
156524891|NCT04737187|565015737|FG000|Overall Study|Clinical Progressive Disease|20|||
156524892|NCT04737187|565015738|FG001|Overall Study|Clinical Progressive Disease|20|||
156524893|NCT04737187|565015737|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
156524894|NCT04737187|565015738|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
156524895|NCT04737187|565015737|FG000|Overall Study|Adverse Event|16|||
156524896|NCT04737187|565015738|FG001|Overall Study|Adverse Event|16|||
156524897|NCT04737187|565015737|FG000|Overall Study|Physician Decision|2|||
156524898|NCT04737187|565015738|FG001|Overall Study|Physician Decision|0|||
156667487|NCT01705574|565530211|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
156667488|NCT01705574|565530212|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
156325593|NCT01539317|564292478|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
156325594|NCT02961218|564292479|FG000|Overall Study|Lost to Follow-up|0|||
156325595|NCT02961218|564292480|FG001|Overall Study|Lost to Follow-up|2|||
156325596|NCT02961218|564292479|FG000|Overall Study|Physician Decision|0|||
156325597|NCT02961218|564292480|FG001|Overall Study|Physician Decision|2|||
156325598|NCT02961218|564292479|FG000|Overall Study|Subject/Guardian Decision|3|||
156325599|NCT02961218|564292480|FG001|Overall Study|Subject/Guardian Decision|1|||
156325600|NCT01462227|564292481|FG000|Second Assignment|Lost to Follow-up|1|||
156325601|NCT01462227|564292482|FG001|Second Assignment|Lost to Follow-up|0|||
156325602|NCT01462227|564292483|FG002|Second Assignment|Lost to Follow-up|0|||
156325603|NCT01462227|564292484|FG003|Second Assignment|Lost to Follow-up|0|||
156325604|NCT01462227|564292481|FG000|Second Assignment|Protocol Violation|0|||
156667489|NCT01705574|565530209|FG000|Open-Label Extension Phase|Physician Decision|0|||
156667490|NCT01705574|565530210|FG001|Open-Label Extension Phase|Physician Decision|0|||
156667491|NCT01705574|565530211|FG002|Open-Label Extension Phase|Physician Decision|2|||
156667492|NCT01705574|565530212|FG003|Open-Label Extension Phase|Physician Decision|0|||
156667493|NCT01705574|565530209|FG000|Open-Label Extension Phase|Pregnancy|0|||
156667494|NCT01705574|565530210|FG001|Open-Label Extension Phase|Pregnancy|0|||
156667495|NCT01705574|565530211|FG002|Open-Label Extension Phase|Pregnancy|1|||
156667496|NCT01705574|565530212|FG003|Open-Label Extension Phase|Pregnancy|1|||
156667497|NCT04567186|565530217|FG000|Period 1|COVID-19 related|1|||
156667498|NCT04567186|565530218|FG001|Period 1|COVID-19 related|0|||
156667499|NCT04567186|565530217|FG000|Period 1|Protocol Violation|0|||
156667500|NCT04567186|565530218|FG001|Period 1|Protocol Violation|1|||
156667501|NCT04567186|565530217|FG000|Period 1|Adverse Event|0|||
156667502|NCT04567186|565530218|FG001|Period 1|Adverse Event|2|||
156667503|NCT04567186|565530217|FG000|Period 2|COVID-19 Related|0|||
156667504|NCT04567186|565530218|FG001|Period 2|COVID-19 Related|1|||
156667505|NCT04567186|565530217|FG000|Period 2|Protocol Violation|0|||
156667506|NCT04567186|565530218|FG001|Period 2|Protocol Violation|1|||
156667507|NCT04567186|565530217|FG000|Period 2|Lost to Follow-up|0|||
156667508|NCT04567186|565530218|FG001|Period 2|Lost to Follow-up|1|||
156667509|NCT04567186|565530217|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
156667510|NCT04567186|565530218|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
156667511|NCT02472366|565530219|FG000|Overall Study|Lost to Follow-up|1|||
156667512|NCT02472366|565530220|FG001|Overall Study|Lost to Follow-up|0|||
156667513|NCT03699020|565530223|FG000|Overall Study|Withdrawal by Subject|3|||
156667514|NCT03699020|565530224|FG001|Overall Study|Withdrawal by Subject|2|||
156667515|NCT04274686|565530227|FG000|Overall Study|Physician Decision|1|||
156667516|NCT04274686|565530228|FG001|Overall Study|Physician Decision|0|||
156667517|NCT00905840|565530229|FG000|Overall Study|Lost to Follow-up|11|||
156667518|NCT00905840|565530229|FG000|Overall Study|Death|3|||
156667519|NCT00905840|565530229|FG000|Overall Study|Withdrawal by Subject|1|||
156667520|NCT00905840|565530229|FG000|Overall Study|Adverse Event|1|||
156667521|NCT00448019|565530230|FG000|Overall Study|Withdrawal by Subject|3|||
156667522|NCT00448019|565530230|FG000|Overall Study|Disease progression|1|||
156667523|NCT00448019|565530230|FG000|Overall Study|Death|2|||
156667524|NCT00448019|565530230|FG000|Overall Study|Insurance Issues|1|||
156667525|NCT00089661|565530231|FG000|Overall Study|Adverse Event|0|||
156667526|NCT00089661|565530232|FG001|Overall Study|Adverse Event|2|||
156667527|NCT00089661|565530231|FG000|Overall Study|Death|1|||
156667528|NCT00089661|565530232|FG001|Overall Study|Death|0|||
156667529|NCT00089661|565530231|FG000|Overall Study|Lost to Follow-up|0|||
156667530|NCT00089661|565530232|FG001|Overall Study|Lost to Follow-up|3|||
156667531|NCT00089661|565530231|FG000|Overall Study|Withdrawal by Subject|11|||
156667532|NCT00089661|565530232|FG001|Overall Study|Withdrawal by Subject|9|||
156667533|NCT00089661|565530231|FG000|Overall Study|Disease progression|1|||
156667534|NCT00089661|565530232|FG001|Overall Study|Disease progression|3|||
156667535|NCT00089661|565530231|FG000|Overall Study|Ineligibility determined|4|||
156667536|NCT00089661|565530232|FG001|Overall Study|Ineligibility determined|4|||
156667537|NCT00089661|565530231|FG000|Overall Study|Noncompliance|2|||
156667538|NCT00089661|565530232|FG001|Overall Study|Noncompliance|4|||
156667539|NCT00089661|565530231|FG000|Overall Study|Other|2|||
156667540|NCT00089661|565530232|FG001|Overall Study|Other|1|||
156667541|NCT01827163|565530233|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
156325605|NCT01462227|564292482|FG001|Second Assignment|Protocol Violation|1|||
156325606|NCT01462227|564292483|FG002|Second Assignment|Protocol Violation|1|||
156325607|NCT01462227|564292484|FG003|Second Assignment|Protocol Violation|0|||
156325608|NCT02393690|564292485|FG000|Overall Study|Ineligible|0|||
156325609|NCT02393690|564292486|FG001|Overall Study|Ineligible|1|||
156325610|NCT00591266|564292487|FG000|Overall Study|Adverse Event|2|||
156325611|NCT00591266|564292488|FG001|Overall Study|Adverse Event|2|||
156325612|NCT00591266|564292489|FG002|Overall Study|Adverse Event|3|||
156325613|NCT00591266|564292487|FG000|Overall Study|Lost to Follow-up|0|||
156524899|NCT04737187|565015737|FG000|Overall Study|Withdrawal by Subject|5|||
156524900|NCT04737187|565015738|FG001|Overall Study|Withdrawal by Subject|8|||
156524901|NCT03464097|565015739|FG000|Overall Study|Withdrawal by Subject|15|||
156524902|NCT03464097|565015740|FG001|Overall Study|Withdrawal by Subject|13|||
156524903|NCT03464097|565015741|FG002|Overall Study|Withdrawal by Subject|11|||
156524904|NCT03464097|565015739|FG000|Overall Study|Study terminated by sponsor|47|||
156524905|NCT03464097|565015740|FG001|Overall Study|Study terminated by sponsor|44|||
156524906|NCT03464097|565015741|FG002|Overall Study|Study terminated by sponsor|40|||
156524907|NCT03464097|565015739|FG000|Overall Study|Pregnancy|0|||
156524908|NCT03464097|565015740|FG001|Overall Study|Pregnancy|1|||
156524909|NCT03464097|565015741|FG002|Overall Study|Pregnancy|0|||
156524910|NCT03464097|565015739|FG000|Overall Study|Other reasons|5|||
156524911|NCT03464097|565015740|FG001|Overall Study|Other reasons|12|||
156524912|NCT03464097|565015741|FG002|Overall Study|Other reasons|14|||
156524913|NCT03464097|565015739|FG000|Overall Study|Lost to Follow-up|0|||
156667542|NCT01827163|565530233|FG000|Overall Study|Adverse Event|9|||
156667543|NCT03375463|565530234|FG000|Period 1|Lost to Follow-up|0|||
156667544|NCT03375463|565530235|FG001|Period 1|Lost to Follow-up|0|||
156667545|NCT03375463|565530236|FG002|Period 1|Lost to Follow-up|1|||
156667546|NCT03375463|565530237|FG003|Period 1|Lost to Follow-up|0|||
156524914|NCT03464097|565015740|FG001|Overall Study|Lost to Follow-up|1|||
156524915|NCT03464097|565015741|FG002|Overall Study|Lost to Follow-up|1|||
156524916|NCT03464097|565015739|FG000|Overall Study|Lack of Efficacy|11|||
156524917|NCT03464097|565015740|FG001|Overall Study|Lack of Efficacy|18|||
156524918|NCT03464097|565015741|FG002|Overall Study|Lack of Efficacy|30|||
156524919|NCT03464097|565015739|FG000|Overall Study|Death|1|||
156524920|NCT03464097|565015740|FG001|Overall Study|Death|0|||
156524921|NCT03464097|565015741|FG002|Overall Study|Death|0|||
156524922|NCT03464097|565015739|FG000|Overall Study|Adverse Event|13|||
156524923|NCT03464097|565015740|FG001|Overall Study|Adverse Event|6|||
156524924|NCT03464097|565015741|FG002|Overall Study|Adverse Event|8|||
156524925|NCT05572021|565015742|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
156524926|NCT05572021|565015743|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
156524927|NCT03432260|565015744|FG000|Overall Study|Lost to Follow-up|1|||
156524928|NCT03432260|565015745|FG001|Overall Study|Lost to Follow-up|1|||
156524929|NCT03432260|565015746|FG002|Overall Study|Lost to Follow-up|0|||
156524930|NCT03432260|565015747|FG003|Overall Study|Lost to Follow-up|0|||
156524931|NCT03432260|565015748|FG004|Overall Study|Lost to Follow-up|1|||
156524932|NCT02186847|565015749|FG000|Overall Study|Protocol Violation|3|||
156667547|NCT03375463|565530238|FG004|Period 1|Lost to Follow-up|0|||
156778272|NCT04707469|565938142|FG000|Overall Study|Lost to Follow-up|9|||
156778273|NCT04707469|565938143|FG001|Overall Study|Lost to Follow-up|19|||
156778274|NCT04707469|565938144|FG002|Overall Study|Lost to Follow-up|14|||
156778275|NCT04707469|565938142|FG000|Overall Study|Withdrawal by Subject|17|||
156667548|NCT03375463|565530239|FG005|Period 1|Lost to Follow-up|0|||
156667549|NCT03375463|565530234|FG000|Period 1|Adverse Event|0|||
156667550|NCT03375463|565530235|FG001|Period 1|Adverse Event|0|||
156667551|NCT03375463|565530236|FG002|Period 1|Adverse Event|0|||
156667552|NCT03375463|565530237|FG003|Period 1|Adverse Event|0|||
156667553|NCT03375463|565530238|FG004|Period 1|Adverse Event|1|||
156667554|NCT03375463|565530239|FG005|Period 1|Adverse Event|0|||
156667555|NCT03375463|565530234|FG000|Period 2|Lost to Follow-up|1|||
156667556|NCT03375463|565530235|FG001|Period 2|Lost to Follow-up|1|||
156667557|NCT03375463|565530236|FG002|Period 2|Lost to Follow-up|0|||
156667558|NCT03375463|565530237|FG003|Period 2|Lost to Follow-up|0|||
156667559|NCT03375463|565530238|FG004|Period 2|Lost to Follow-up|0|||
156667560|NCT03375463|565530239|FG005|Period 2|Lost to Follow-up|0|||
156667561|NCT03620747|565530241|FG000|Overall Study|Participant decision|7|||
156667562|NCT03620747|565530241|FG000|Overall Study|Adverse Event|6|||
156667563|NCT03620747|565530241|FG000|Overall Study|Lack of Efficacy|1|||
156667564|NCT03620747|565530241|FG000|Overall Study|Poor compliance to protocol|2|||
156667565|NCT03620747|565530241|FG000|Overall Study|Other-unspecified|3|||
156667566|NCT00850174|565530251|FG000|Washout: One Week|Withdrawal by Subject|0|||
156667567|NCT00850174|565530252|FG001|Washout: One Week|Withdrawal by Subject|2|||
156667568|NCT00850174|565530251|FG000|Second Intervention|Withdrawal by Subject|1|||
156667569|NCT00850174|565530252|FG001|Second Intervention|Withdrawal by Subject|0|||
156667570|NCT01513174|565530253|FG000|Overall Study|Inclusion Error|1|||
156667571|NCT01513174|565530254|FG001|Overall Study|Inclusion Error|7|||
156667572|NCT01513174|565530253|FG000|Overall Study|Not receive study treatment|3|||
156778276|NCT04707469|565938143|FG001|Overall Study|Withdrawal by Subject|16|||
156778277|NCT04707469|565938144|FG002|Overall Study|Withdrawal by Subject|12|||
156778278|NCT05556057|565938145|FG000|Overall Study|Lost to Follow-up|5|||
156778279|NCT05556057|565938146|FG001|Overall Study|Lost to Follow-up|4|||
156778280|NCT05556057|565938145|FG000|Overall Study|Withdrawal by Subject|0|||
156778281|NCT05556057|565938146|FG001|Overall Study|Withdrawal by Subject|2|||
156778282|NCT02003924|565938149|FG000|Double-blind Phase|Lost to Follow-up|2|||
156778283|NCT02003924|565938150|FG001|Double-blind Phase|Lost to Follow-up|1|||
156778284|NCT02003924|565938151|FG002|Double-blind Phase|Lost to Follow-up|0|||
156778285|NCT02003924|565938149|FG000|Double-blind Phase|Protocol Violation|1|||
156778286|NCT02003924|565938150|FG001|Double-blind Phase|Protocol Violation|2|||
156778287|NCT02003924|565938151|FG002|Double-blind Phase|Protocol Violation|0|||
156778288|NCT02003924|565938149|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
156778289|NCT02003924|565938150|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
156778290|NCT02003924|565938151|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
156778291|NCT02003924|565938149|FG000|Double-blind Phase|Disease Progression|229|||
156778292|NCT02003924|565938150|FG001|Double-blind Phase|Disease Progression|247|||
156778293|NCT02003924|565938151|FG002|Double-blind Phase|Disease Progression|0|||
156778294|NCT02003924|565938149|FG000|Double-blind Phase|Adverse Event|120|||
156778295|NCT02003924|565938150|FG001|Double-blind Phase|Adverse Event|31|||
156778296|NCT02003924|565938151|FG002|Double-blind Phase|Adverse Event|0|||
156778297|NCT02003924|565938149|FG000|Double-blind Phase|Randomized But not Treated|3|||
156778298|NCT02003924|565938150|FG001|Double-blind Phase|Randomized But not Treated|3|||
156778299|NCT02003924|565938151|FG002|Double-blind Phase|Randomized But not Treated|0|||
156778300|NCT02003924|565938149|FG000|Double-blind Phase|Other|29|||
156778301|NCT02003924|565938150|FG001|Double-blind Phase|Other|50|||
156778302|NCT02003924|565938151|FG002|Double-blind Phase|Other|0|||
156778303|NCT02003924|565938149|FG000|Open-label Phase|Lost to Follow-up|0|||
156778304|NCT02003924|565938150|FG001|Open-label Phase|Lost to Follow-up|0|||
156778305|NCT02003924|565938151|FG002|Open-label Phase|Lost to Follow-up|1|||
156778306|NCT02003924|565938149|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
156778307|NCT02003924|565938150|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
156778308|NCT02003924|565938151|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
156778309|NCT02003924|565938149|FG000|Open-label Phase|Disease Progression|59|||
156778310|NCT02003924|565938150|FG001|Open-label Phase|Disease Progression|0|||
156778311|NCT02003924|565938151|FG002|Open-label Phase|Disease Progression|5|||
156778312|NCT02003924|565938149|FG000|Open-label Phase|Adverse Event|25|||
156778313|NCT02003924|565938150|FG001|Open-label Phase|Adverse Event|0|||
156778314|NCT02003924|565938151|FG002|Open-label Phase|Adverse Event|10|||
156778315|NCT02003924|565938149|FG000|Open-label Phase|Other|7|||
156778316|NCT02003924|565938150|FG001|Open-label Phase|Other|0|||
156778317|NCT02003924|565938151|FG002|Open-label Phase|Other|0|||
156778318|NCT02003924|565938149|FG000|Long-term Follow-up Phase|Death|288|||
156778319|NCT02003924|565938150|FG001|Long-term Follow-up Phase|Death|174|||
156430091|NCT03451851|564663362|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
156430092|NCT03451851|564663363|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
156430093|NCT03451851|564663364|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
156430094|NCT03451851|564663365|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
156430095|NCT03451851|564663358|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
156430096|NCT03451851|564663359|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
156430097|NCT03451851|564663360|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
156430098|NCT03451851|564663361|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
156430099|NCT03451851|564663362|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
156430100|NCT03451851|564663363|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
156430101|NCT03451851|564663364|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
156430102|NCT03451851|564663365|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
156430103|NCT03451851|564663358|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
156430104|NCT03451851|564663359|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
156430105|NCT03451851|564663360|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
156430106|NCT03451851|564663361|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
156430107|NCT03451851|564663362|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
156430108|NCT03451851|564663363|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
156430109|NCT03451851|564663364|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
156778320|NCT02003924|565938151|FG002|Long-term Follow-up Phase|Death|4|||
156778321|NCT02003924|565938149|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
156778322|NCT02003924|565938150|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
156778323|NCT02003924|565938151|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
156778324|NCT02003924|565938149|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
156778325|NCT02003924|565938150|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
156778326|NCT02003924|565938151|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
156778327|NCT02003924|565938149|FG000|Long-term Follow-up Phase|Other|5|||
156778328|NCT02003924|565938150|FG001|Long-term Follow-up Phase|Other|2|||
156778329|NCT02003924|565938151|FG002|Long-term Follow-up Phase|Other|1|||
156524933|NCT02186847|565015750|FG001|Overall Study|Protocol Violation|0|||
156524934|NCT03319849|565015751|FG000|Overall Study|Adverse Event|1|||
156524935|NCT03319849|565015752|FG001|Overall Study|Adverse Event|0|||
156524936|NCT03319849|565015751|FG000|Overall Study|Physician Decision|0|||
156524937|NCT03319849|565015752|FG001|Overall Study|Physician Decision|1|||
156524938|NCT03319849|565015751|FG000|Overall Study|Withdrawal by Subject|0|||
156524939|NCT03319849|565015752|FG001|Overall Study|Withdrawal by Subject|1|||
156524940|NCT03319849|565015751|FG000|Overall Study|COVID-19|0|||
156524941|NCT03319849|565015752|FG001|Overall Study|COVID-19|1|||
156524942|NCT03319849|565015751|FG000|Overall Study|Other|1|||
156524943|NCT03319849|565015752|FG001|Overall Study|Other|2|||
156325614|NCT00591266|564292488|FG001|Overall Study|Lost to Follow-up|1|||
156325615|NCT00591266|564292489|FG002|Overall Study|Lost to Follow-up|0|||
156325616|NCT00591266|564292487|FG000|Overall Study|Protocol Violation|0|||
156325617|NCT00591266|564292488|FG001|Overall Study|Protocol Violation|0|||
156325618|NCT00591266|564292489|FG002|Overall Study|Protocol Violation|1|||
156325619|NCT00591266|564292487|FG000|Overall Study|Withdrawal by Subject|6|||
156325620|NCT00591266|564292488|FG001|Overall Study|Withdrawal by Subject|2|||
156325621|NCT00591266|564292489|FG002|Overall Study|Withdrawal by Subject|5|||
156325622|NCT00591266|564292487|FG000|Overall Study|Lack of Efficacy|0|||
156325623|NCT00591266|564292488|FG001|Overall Study|Lack of Efficacy|2|||
156325624|NCT00591266|564292489|FG002|Overall Study|Lack of Efficacy|0|||
156325625|NCT00591266|564292487|FG000|Overall Study|Other|1|||
156325626|NCT00591266|564292488|FG001|Overall Study|Other|4|||
156325627|NCT00591266|564292489|FG002|Overall Study|Other|5|||
156325628|NCT03488927|564292490|FG000|Overall Study|Withdrawal by Subject|44|||
156325629|NCT03488927|564292491|FG001|Overall Study|Withdrawal by Subject|118|||
156325630|NCT03488927|564292492|FG002|Overall Study|Withdrawal by Subject|217|||
156325631|NCT05298306|564292493|FG000|Overall Study|Physician Decision|0|||
156325632|NCT05298306|564292494|FG001|Overall Study|Physician Decision|0|||
156325633|NCT05298306|564292495|FG002|Overall Study|Physician Decision|0|||
156325634|NCT05298306|564292496|FG003|Overall Study|Physician Decision|1|||
156325635|NCT05298306|564292497|FG004|Overall Study|Physician Decision|0|||
156325636|NCT05298306|564292498|FG005|Overall Study|Physician Decision|0|||
156325637|NCT03497676|564292500|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
156325638|NCT03497676|564292501|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
156325639|NCT03497676|564292502|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
156325640|NCT03497676|564292503|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
156325641|NCT03497676|564292500|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
156325642|NCT03497676|564292501|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
156325643|NCT03497676|564292502|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
156325644|NCT03497676|564292503|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
156325645|NCT03497676|564292500|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
156325646|NCT03497676|564292501|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
156325647|NCT03497676|564292502|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
156325648|NCT03497676|564292503|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
156325649|NCT03497676|564292500|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
156325650|NCT03497676|564292501|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
156325651|NCT03497676|564292502|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
156325652|NCT03497676|564292503|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
156325653|NCT03497676|564292500|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
156325654|NCT03497676|564292501|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
156325655|NCT03497676|564292502|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
156325656|NCT03497676|564292503|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
156325657|NCT03497676|564292500|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
156325658|NCT03497676|564292501|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
156325659|NCT03497676|564292502|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
156325660|NCT03497676|564292503|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
156325661|NCT03497676|564292500|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
156325662|NCT03497676|564292501|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
156325663|NCT03497676|564292502|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
156325664|NCT03497676|564292503|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
156325665|NCT03497676|564292500|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
156325666|NCT03497676|564292501|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
156325667|NCT03497676|564292502|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
156524944|NCT03319849|565015751|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
156524945|NCT03319849|565015752|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
156524946|NCT03319849|565015751|FG000|Overall Study|Lost to Follow-up|0|||
156524947|NCT03319849|565015752|FG001|Overall Study|Lost to Follow-up|2|||
156524948|NCT00112047|565015753|FG000|Randomized Phase|Lost to Follow-up|26|||
156778330|NCT00832975|565938164|FG000|Overall Study|Lost to Follow-up|7|||
156778331|NCT00832975|565938164|FG000|Overall Study|Protocol Violation|6|||
156778332|NCT00832975|565938164|FG000|Overall Study|Death|5|||
156778333|NCT00832975|565938164|FG000|Overall Study|Physician Decision|4|||
156778334|NCT00832975|565938164|FG000|Overall Study|Withdrawal by Subject|3|||
156778335|NCT00832975|565938164|FG000|Overall Study|Other reasons|14|||
156778336|NCT06081829|565938165|FG000|Overall Study|Participants still on-study|8|||
156778337|NCT06081829|565938165|FG000|Overall Study|Death|4|||
156778338|NCT01525589|565938166|FG000|Overall Study|Non-treatment-related AE|1|||
156778339|NCT01525589|565938167|FG001|Overall Study|Non-treatment-related AE|0|||
156778340|NCT01525589|565938168|FG002|Overall Study|Non-treatment-related AE|0|||
156778341|NCT01525589|565938166|FG000|Overall Study|Progressive disease|48|||
156778342|NCT01525589|565938167|FG001|Overall Study|Progressive disease|15|||
156778343|NCT01525589|565938168|FG002|Overall Study|Progressive disease|29|||
156778344|NCT01525589|565938166|FG000|Overall Study|Never treated|2|||
156778345|NCT01525589|565938167|FG001|Overall Study|Never treated|0|||
156778346|NCT01525589|565938168|FG002|Overall Study|Never treated|0|||
156778347|NCT01525589|565938166|FG000|Overall Study|Physician Decision|4|||
156778348|NCT01525589|565938167|FG001|Overall Study|Physician Decision|2|||
156524949|NCT00112047|565015754|FG001|Randomized Phase|Lost to Follow-up|33|||
156524950|NCT00112047|565015753|FG000|Randomized Phase|Adverse Event|10|||
156524951|NCT00112047|565015754|FG001|Randomized Phase|Adverse Event|10|||
156524952|NCT00112047|565015753|FG000|Randomized Phase|Withrawal of consent|10|||
156524953|NCT00112047|565015754|FG001|Randomized Phase|Withrawal of consent|18|||
156524954|NCT00112047|565015753|FG000|Randomized Phase|Sub-optimal virological response|3|||
156524955|NCT00112047|565015754|FG001|Randomized Phase|Sub-optimal virological response|13|||
156524956|NCT00112047|565015753|FG000|Randomized Phase|Noncompliance|8|||
156524957|NCT00112047|565015754|FG001|Randomized Phase|Noncompliance|4|||
156524958|NCT00112047|565015753|FG000|Randomized Phase|Protocol Violation|2|||
156524959|NCT00112047|565015754|FG001|Randomized Phase|Protocol Violation|0|||
156524960|NCT00112047|565015753|FG000|Randomized Phase|Pregnancy|3|||
156524961|NCT00112047|565015754|FG001|Randomized Phase|Pregnancy|1|||
156524962|NCT00112047|565015753|FG000|Randomized Phase|Death|1|||
156524963|NCT00112047|565015754|FG001|Randomized Phase|Death|3|||
156524964|NCT00112047|565015753|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
156524965|NCT00112047|565015754|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
156524966|NCT00112047|565015753|FG000|Randomized Phase|Inability to swallow pills|0|||
156524967|NCT00112047|565015754|FG001|Randomized Phase|Inability to swallow pills|1|||
156524968|NCT00112047|565015753|FG000|Randomized Phase|Incarceration|3|||
156524969|NCT00112047|565015754|FG001|Randomized Phase|Incarceration|2|||
156524970|NCT00112047|565015753|FG000|Randomized Phase|Moved out of State|0|||
156524971|NCT00112047|565015754|FG001|Randomized Phase|Moved out of State|1|||
156524972|NCT00112047|565015753|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
156524973|NCT00112047|565015754|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
156524974|NCT00112047|565015753|FG000|Randomized Phase|High Hepatitis B DNA|0|||
156524975|NCT00112047|565015754|FG001|Randomized Phase|High Hepatitis B DNA|1|||
156524976|NCT00112047|565015753|FG000|Atripla Phase|Adverse Event|2|||
156524977|NCT00112047|565015754|FG001|Atripla Phase|Adverse Event|1|||
156524978|NCT00112047|565015753|FG000|Atripla Phase|Lost to Follow-up|5|||
156524979|NCT00112047|565015754|FG001|Atripla Phase|Lost to Follow-up|7|||
156524980|NCT00112047|565015753|FG000|Atripla Phase|Pregnancy|0|||
156524981|NCT00112047|565015754|FG001|Atripla Phase|Pregnancy|1|||
156524982|NCT00112047|565015753|FG000|Atripla Phase|Death|0|||
156524983|NCT00112047|565015754|FG001|Atripla Phase|Death|2|||
156524984|NCT00112047|565015753|FG000|Atripla Phase|Withdrew consent|7|||
156524985|NCT00112047|565015754|FG001|Atripla Phase|Withdrew consent|7|||
156524986|NCT00112047|565015753|FG000|Atripla Phase|Sub-optimal virological response|0|||
156524987|NCT00112047|565015754|FG001|Atripla Phase|Sub-optimal virological response|1|||
156524988|NCT00112047|565015753|FG000|Atripla Phase|Non-compliance|1|||
156524989|NCT00112047|565015754|FG001|Atripla Phase|Non-compliance|0|||
156524990|NCT00112047|565015753|FG000|Atripla Phase|Other|3|||
156524991|NCT00112047|565015754|FG001|Atripla Phase|Other|1|||
156524992|NCT01307579|565015755|FG000|Overall Study|Death|3|||
156524993|NCT01307579|565015756|FG001|Overall Study|Death|6|||
156524994|NCT01307579|565015755|FG000|Overall Study|Physician Decision|26|||
156524995|NCT01307579|565015756|FG001|Overall Study|Physician Decision|29|||
156524996|NCT01307579|565015755|FG000|Overall Study|Withdrawal by Subject|7|||
156524997|NCT01307579|565015756|FG001|Overall Study|Withdrawal by Subject|3|||
156524998|NCT01307579|565015755|FG000|Overall Study|Institutional diagnosis of IFD|21|||
156524999|NCT01307579|565015756|FG001|Overall Study|Institutional diagnosis of IFD|36|||
156525000|NCT01307579|565015755|FG000|Overall Study|Begin conditioning for HSCT|42|||
156525001|NCT01307579|565015756|FG001|Overall Study|Begin conditioning for HSCT|44|||
156778349|NCT01525589|565938168|FG002|Overall Study|Physician Decision|2|||
156778350|NCT01525589|565938166|FG000|Overall Study|Death|0|||
156778351|NCT01525589|565938167|FG001|Overall Study|Death|0|||
156778352|NCT01525589|565938168|FG002|Overall Study|Death|2|||
156778353|NCT01525589|565938166|FG000|Overall Study|Treatment-related AE|1|||
156778354|NCT01525589|565938167|FG001|Overall Study|Treatment-related AE|1|||
156325668|NCT03497676|564292503|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
156325669|NCT02204007|564292510|FG000|Overall Study|Surgery Canceled|1|||
156325670|NCT02204007|564292511|FG001|Overall Study|Surgery Canceled|1|||
156325671|NCT02819518|564292512|FG000|Overall Study|Death|9|||
156325672|NCT02819518|564292513|FG001|Overall Study|Death|12|||
156325673|NCT02819518|564292514|FG002|Overall Study|Death|9|||
156325674|NCT02819518|564292515|FG003|Overall Study|Death|475|||
156325675|NCT02819518|564292516|FG004|Overall Study|Death|244|||
156325676|NCT02819518|564292512|FG000|Overall Study|Withdrawal by Subject|0|||
156325677|NCT02819518|564292513|FG001|Overall Study|Withdrawal by Subject|0|||
156325678|NCT02819518|564292514|FG002|Overall Study|Withdrawal by Subject|0|||
156325679|NCT02819518|564292515|FG003|Overall Study|Withdrawal by Subject|25|||
156325680|NCT02819518|564292516|FG004|Overall Study|Withdrawal by Subject|8|||
156325681|NCT02819518|564292512|FG000|Overall Study|Lost to Follow-up|0|||
156325682|NCT02819518|564292513|FG001|Overall Study|Lost to Follow-up|0|||
156325683|NCT02819518|564292514|FG002|Overall Study|Lost to Follow-up|0|||
156325684|NCT02819518|564292515|FG003|Overall Study|Lost to Follow-up|0|||
156325685|NCT02819518|564292516|FG004|Overall Study|Lost to Follow-up|1|||
156325686|NCT02819518|564292512|FG000|Overall Study|Sponsor Decision|1|||
156325687|NCT02819518|564292513|FG001|Overall Study|Sponsor Decision|1|||
156325688|NCT02819518|564292514|FG002|Overall Study|Sponsor Decision|0|||
156325689|NCT02819518|564292515|FG003|Overall Study|Sponsor Decision|34|||
156325690|NCT02819518|564292516|FG004|Overall Study|Sponsor Decision|17|||
156325691|NCT02819518|564292512|FG000|Overall Study|Transferred to extension study|1|||
156325692|NCT02819518|564292513|FG001|Overall Study|Transferred to extension study|1|||
156325693|NCT02819518|564292514|FG002|Overall Study|Transferred to extension study|1|||
156325694|NCT02819518|564292515|FG003|Overall Study|Transferred to extension study|32|||
156325695|NCT02819518|564292516|FG004|Overall Study|Transferred to extension study|11|||
156325696|NCT00880165|564292517|FG000|Overall Study|Withdrawal by Subject|27|||
156325697|NCT00880165|564292518|FG001|Overall Study|Withdrawal by Subject|23|||
156325698|NCT00880165|564292517|FG000|Overall Study|Not diagnosed with OSA|14|||
156325699|NCT00880165|564292518|FG001|Overall Study|Not diagnosed with OSA|8|||
156325700|NCT00880165|564292517|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
156325701|NCT00880165|564292518|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
156325702|NCT00880165|564292517|FG000|Overall Study|Lost to follow|9|||
156325703|NCT00880165|564292518|FG001|Overall Study|Lost to follow|15|||
156325704|NCT00667602|564292521|FG000|Overall Study|Withdrawal by Subject|4|||
156325705|NCT00667602|564292522|FG001|Overall Study|Withdrawal by Subject|9|||
156325706|NCT00667602|564292523|FG002|Overall Study|Withdrawal by Subject|10|||
156325707|NCT00667602|564292521|FG000|Overall Study|Lost to Follow-up|4|||
156325708|NCT00667602|564292522|FG001|Overall Study|Lost to Follow-up|5|||
156325709|NCT00667602|564292523|FG002|Overall Study|Lost to Follow-up|6|||
156325710|NCT00667602|564292521|FG000|Overall Study|Administrative reason|0|||
156325711|NCT00667602|564292522|FG001|Overall Study|Administrative reason|0|||
156325712|NCT00667602|564292523|FG002|Overall Study|Administrative reason|2|||
156325713|NCT00667602|564292521|FG000|Overall Study|Protocol Violation|0|||
156325714|NCT00667602|564292522|FG001|Overall Study|Protocol Violation|1|||
156325715|NCT00667602|564292523|FG002|Overall Study|Protocol Violation|0|||
156325716|NCT02301988|564292525|FG000|Overall Study|Withdrawal by Subject|2|||
156325717|NCT02301988|564292526|FG001|Overall Study|Withdrawal by Subject|1|||
156325718|NCT02301988|564292525|FG000|Overall Study|Physician Decision|2|||
156325719|NCT02301988|564292526|FG001|Overall Study|Physician Decision|2|||
156325720|NCT02301988|564292525|FG000|Overall Study|Unknown Reason|1|||
156325721|NCT02301988|564292526|FG001|Overall Study|Unknown Reason|3|||
156325722|NCT02301988|564292525|FG000|Overall Study|Lack of Efficacy|3|||
156325723|NCT02301988|564292526|FG001|Overall Study|Lack of Efficacy|2|||
156325724|NCT02301988|564292525|FG000|Overall Study|Death|1|||
156325725|NCT02301988|564292526|FG001|Overall Study|Death|0|||
156325726|NCT02301988|564292525|FG000|Overall Study|Adverse Event|1|||
156778355|NCT01525589|565938168|FG002|Overall Study|Treatment-related AE|2|||
156325727|NCT02301988|564292526|FG001|Overall Study|Adverse Event|1|||
156325728|NCT02891161|564292529|FG000|Study Treatment|Disease Progression|2|||
156325729|NCT02891161|564292530|FG001|Study Treatment|Disease Progression|4|||
156325730|NCT02891161|564292529|FG000|Study Treatment|AE/Side Effects/Complications|1|||
156325731|NCT02891161|564292530|FG001|Study Treatment|AE/Side Effects/Complications|5|||
156325732|NCT02891161|564292529|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
156325733|NCT02891161|564292530|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
156325734|NCT02891161|564292529|FG000|Follow up|Death|4|||
156325735|NCT02891161|564292530|FG001|Follow up|Death|8|||
156325736|NCT02891161|564292529|FG000|Follow up|Refused to Follow up|0|||
156325737|NCT02891161|564292530|FG001|Follow up|Refused to Follow up|2|||
156325738|NCT02891161|564292529|FG000|Follow up|Symptomatic deterioration|0|||
156325739|NCT02891161|564292530|FG001|Follow up|Symptomatic deterioration|1|||
156325740|NCT02891161|564292529|FG000|Follow up|Study terminated|0|||
156325741|NCT02891161|564292530|FG001|Follow up|Study terminated|6|||
156325742|NCT01931202|564292532|FG000|Overall Study|Withdrawal by Subject|0|||
156325743|NCT01931202|564292533|FG001|Overall Study|Withdrawal by Subject|0|||
156325744|NCT01931202|564292534|FG002|Overall Study|Withdrawal by Subject|2|||
156778356|NCT01525589|565938166|FG000|Overall Study|Other reasons|0|||
156778357|NCT01525589|565938167|FG001|Overall Study|Other reasons|1|||
156778358|NCT01525589|565938168|FG002|Overall Study|Other reasons|0|||
156778359|NCT01525589|565938166|FG000|Overall Study|Withdrawal by Subject|0|||
156778360|NCT01525589|565938167|FG001|Overall Study|Withdrawal by Subject|1|||
156778361|NCT01525589|565938168|FG002|Overall Study|Withdrawal by Subject|0|||
156778362|NCT02924376|565938169|FG000|Overall Study|Progressive Disease|4|||
156778363|NCT02924376|565938170|FG001|Overall Study|Progressive Disease|0|||
156778364|NCT02924376|565938171|FG002|Overall Study|Progressive Disease|1|||
156778365|NCT02924376|565938172|FG003|Overall Study|Progressive Disease|0|||
156778366|NCT02924376|565938169|FG000|Overall Study|Death|73|||
156778367|NCT02924376|565938170|FG001|Overall Study|Death|18|||
156778368|NCT02924376|565938171|FG002|Overall Study|Death|15|||
156778369|NCT02924376|565938172|FG003|Overall Study|Death|2|||
156778370|NCT02924376|565938169|FG000|Overall Study|Lost to Follow-up|3|||
156778371|NCT02924376|565938170|FG001|Overall Study|Lost to Follow-up|0|||
156778372|NCT02924376|565938171|FG002|Overall Study|Lost to Follow-up|0|||
156778373|NCT02924376|565938172|FG003|Overall Study|Lost to Follow-up|0|||
156778374|NCT02924376|565938169|FG000|Overall Study|Study Terminated by Sponsor|19|||
156778375|NCT02924376|565938170|FG001|Overall Study|Study Terminated by Sponsor|0|||
156778376|NCT02924376|565938171|FG002|Overall Study|Study Terminated by Sponsor|0|||
156778377|NCT02924376|565938172|FG003|Overall Study|Study Terminated by Sponsor|0|||
156778378|NCT02924376|565938169|FG000|Overall Study|Physician Decision|1|||
156778379|NCT02924376|565938170|FG001|Overall Study|Physician Decision|0|||
156778380|NCT02924376|565938171|FG002|Overall Study|Physician Decision|0|||
156778381|NCT02924376|565938172|FG003|Overall Study|Physician Decision|0|||
156778382|NCT02924376|565938169|FG000|Overall Study|Withdrawal by Subject|7|||
156778383|NCT02924376|565938170|FG001|Overall Study|Withdrawal by Subject|2|||
156778384|NCT02924376|565938171|FG002|Overall Study|Withdrawal by Subject|1|||
156778385|NCT02924376|565938172|FG003|Overall Study|Withdrawal by Subject|0|||
156778386|NCT02924376|565938169|FG000|Overall Study|Rolled Over to Another Study|1|||
156778387|NCT02924376|565938170|FG001|Overall Study|Rolled Over to Another Study|0|||
156525002|NCT01307579|565015755|FG000|Overall Study|Refractory or relapsed AML|38|||
156525003|NCT01307579|565015756|FG001|Overall Study|Refractory or relapsed AML|23|||
156525004|NCT01307579|565015755|FG000|Overall Study|Ineligible|3|||
156525005|NCT01307579|565015756|FG001|Overall Study|Ineligible|4|||
156525006|NCT01340196|565016981|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
156778388|NCT02924376|565938171|FG002|Overall Study|Rolled Over to Another Study|0|||
156778389|NCT02924376|565938172|FG003|Overall Study|Rolled Over to Another Study|0|||
156778390|NCT04835441|565938173|FG000|Overall Study|Physician Decision|4|||
156778391|NCT04835441|565938174|FG001|Overall Study|Physician Decision|4|||
156778392|NCT04835441|565938173|FG000|Overall Study|Other|1|||
156778393|NCT04835441|565938174|FG001|Overall Study|Other|1|||
156778394|NCT04835441|565938173|FG000|Overall Study|Lost to Follow-up|0|||
156778395|NCT04835441|565938174|FG001|Overall Study|Lost to Follow-up|1|||
156778396|NCT03069989|565938175|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
156778397|NCT03069989|565938176|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
156778398|NCT02145390|565938180|FG000|Overall Study|Withdrawal by Subject|1|||
156778399|NCT00177671|565939224|FG000|Overall Study|Withdrawal by Subject|5|||
156778400|NCT00177671|565939225|FG001|Overall Study|Withdrawal by Subject|6|||
156778401|NCT00177671|565939224|FG000|Overall Study|medical complications|2|||
156778402|NCT00177671|565939225|FG001|Overall Study|medical complications|0|||
156778403|NCT00177671|565939224|FG000|Overall Study|Adverse Event|6|||
156778404|NCT00177671|565939225|FG001|Overall Study|Adverse Event|0|||
156778405|NCT00177671|565939224|FG000|Overall Study|Physician Decision|12|||
156778406|NCT00177671|565939225|FG001|Overall Study|Physician Decision|8|||
156778407|NCT02293499|565939226|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
156778408|NCT02293499|565939227|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
156778409|NCT02293499|565939228|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
156325745|NCT01931202|564292532|FG000|Overall Study|Lost to Follow-up|0|||
156325746|NCT01931202|564292533|FG001|Overall Study|Lost to Follow-up|5|||
156325747|NCT01931202|564292534|FG002|Overall Study|Lost to Follow-up|2|||
156325748|NCT01074047|564292541|FG000|Treatment Phase|Adverse Event|89|||
156325749|NCT01074047|564292542|FG001|Treatment Phase|Adverse Event|66|||
156325750|NCT01074047|564292541|FG000|Treatment Phase|Disease Progression|16|||
156325751|NCT01074047|564292542|FG001|Treatment Phase|Disease Progression|21|||
156325752|NCT01074047|564292541|FG000|Treatment Phase|Withdrawal by Subject|27|||
156325753|NCT01074047|564292542|FG001|Treatment Phase|Withdrawal by Subject|48|||
156325754|NCT01074047|564292541|FG000|Treatment Phase|Death|53|||
156325755|NCT01074047|564292542|FG001|Treatment Phase|Death|58|||
156325756|NCT01074047|564292541|FG000|Treatment Phase|Lost to Follow-up|0|||
156325757|NCT01074047|564292542|FG001|Treatment Phase|Lost to Follow-up|1|||
156325758|NCT01074047|564292541|FG000|Treatment Phase|Protocol Violation|0|||
156325759|NCT01074047|564292542|FG001|Treatment Phase|Protocol Violation|1|||
156325760|NCT01074047|564292541|FG000|Treatment Phase|Miscellaneous|32|||
156525007|NCT00604279|565016986|FG000|Overall Study|Lack of Efficacy|22|||
156525008|NCT00604279|565016987|FG001|Overall Study|Lack of Efficacy|9|||
156525009|NCT00604279|565016986|FG000|Overall Study|Lost to Follow-up|9|||
156525010|NCT00604279|565016987|FG001|Overall Study|Lost to Follow-up|14|||
156525011|NCT00604279|565016986|FG000|Overall Study|Pregnancy|2|||
156525012|NCT00604279|565016987|FG001|Overall Study|Pregnancy|0|||
156525013|NCT00604279|565016986|FG000|Overall Study|Protocol Violation|3|||
156525014|NCT00604279|565016987|FG001|Overall Study|Protocol Violation|1|||
156525015|NCT00604279|565016986|FG000|Overall Study|Withdrawal by Subject|16|||
156525016|NCT00604279|565016987|FG001|Overall Study|Withdrawal by Subject|5|||
156525017|NCT00604279|565016986|FG000|Overall Study|Adverse Event|4|||
156525018|NCT00604279|565016987|FG001|Overall Study|Adverse Event|5|||
156525019|NCT00604279|565016986|FG000|Overall Study|Other|8|||
156525020|NCT00604279|565016987|FG001|Overall Study|Other|4|||
156525021|NCT03938545|565016988|FG000|Overall Study|Lost to Follow-up|0|||
156525022|NCT03938545|565016989|FG001|Overall Study|Lost to Follow-up|0|||
156525023|NCT03938545|565016990|FG002|Overall Study|Lost to Follow-up|0|||
156525024|NCT03938545|565016991|FG003|Overall Study|Lost to Follow-up|1|||
156525025|NCT03938545|565016988|FG000|Overall Study|Non-compliance with study drug|0|||
156525026|NCT03938545|565016989|FG001|Overall Study|Non-compliance with study drug|0|||
156525027|NCT03938545|565016990|FG002|Overall Study|Non-compliance with study drug|1|||
156525028|NCT03938545|565016991|FG003|Overall Study|Non-compliance with study drug|0|||
156525029|NCT03938545|565016988|FG000|Overall Study|Pregnancy|1|||
156525030|NCT03938545|565016989|FG001|Overall Study|Pregnancy|0|||
156525031|NCT03938545|565016990|FG002|Overall Study|Pregnancy|0|||
156525032|NCT03938545|565016991|FG003|Overall Study|Pregnancy|0|||
156525033|NCT03938545|565016988|FG000|Overall Study|Study terminated by sponsor|6|||
156525034|NCT03938545|565016989|FG001|Overall Study|Study terminated by sponsor|4|||
156525035|NCT03938545|565016990|FG002|Overall Study|Study terminated by sponsor|2|||
156525036|NCT03938545|565016991|FG003|Overall Study|Study terminated by sponsor|4|||
156525037|NCT03938545|565016988|FG000|Overall Study|Withdrawal by Subject|0|||
156525038|NCT03938545|565016989|FG001|Overall Study|Withdrawal by Subject|1|||
156525039|NCT03938545|565016990|FG002|Overall Study|Withdrawal by Subject|0|||
156525040|NCT03938545|565016991|FG003|Overall Study|Withdrawal by Subject|0|||
156525041|NCT03938545|565016988|FG000|Overall Study|Adverse Event|1|||
156525042|NCT03938545|565016989|FG001|Overall Study|Adverse Event|0|||
156525043|NCT03938545|565016990|FG002|Overall Study|Adverse Event|0|||
156525044|NCT03938545|565016991|FG003|Overall Study|Adverse Event|0|||
156525045|NCT00355056|565016992|FG000|Randomization Period|Early Termination|4|||
156525046|NCT00355056|565016993|FG001|Randomization Period|Early Termination|6|||
156525047|NCT01060540|565016994|FG000|Overall Study|Withdrawal by Subject|10|||
156525048|NCT01060540|565016995|FG001|Overall Study|Withdrawal by Subject|20|||
156525049|NCT01060540|565016994|FG000|Overall Study|Lost to Follow-up|52|||
156525050|NCT01060540|565016995|FG001|Overall Study|Lost to Follow-up|43|||
156525051|NCT01060540|565016994|FG000|Overall Study|Death|2|||
156525052|NCT01060540|565016995|FG001|Overall Study|Death|1|||
156525053|NCT01060540|565016994|FG000|Overall Study|Physician Decision|0|||
156525054|NCT01060540|565016995|FG001|Overall Study|Physician Decision|1|||
156525055|NCT00816400|565016999|FG000|Overall Study|Death|2|||
156525056|NCT00816400|565017000|FG001|Overall Study|Death|3|||
156525057|NCT00816400|565017001|FG002|Overall Study|Death|3|||
156525058|NCT00816400|565017002|FG003|Overall Study|Death|3|||
156525059|NCT00816400|565017003|FG004|Overall Study|Death|2|||
156325761|NCT01074047|564292542|FG001|Treatment Phase|Miscellaneous|39|||
156325762|NCT01074047|564292541|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
156325763|NCT01074047|564292542|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
156325764|NCT01074047|564292541|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
156325765|NCT01074047|564292542|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
156325766|NCT01074047|564292541|FG000|Survival Follow-Up Phase|Death|116|||
156325767|NCT01074047|564292542|FG001|Survival Follow-Up Phase|Death|124|||
156325768|NCT01074047|564292541|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
156325769|NCT01074047|564292542|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
156325770|NCT01074047|564292541|FG000|Extension Phase|Physician Decision|1|||
156325771|NCT01074047|564292542|FG001|Extension Phase|Physician Decision|0|||
156325772|NCT01074047|564292541|FG000|Extension Phase|Adverse Event|5|||
156325773|NCT01074047|564292542|FG001|Extension Phase|Adverse Event|0|||
156325774|NCT01074047|564292541|FG000|Extension Phase|Disease Progression|9|||
156325775|NCT01074047|564292542|FG001|Extension Phase|Disease Progression|0|||
156325776|NCT01074047|564292541|FG000|Extension Phase|Withdrawal by Subject|2|||
156325777|NCT01074047|564292542|FG001|Extension Phase|Withdrawal by Subject|0|||
156325778|NCT01074047|564292541|FG000|Extension Phase|Death|5|||
156325779|NCT01074047|564292542|FG001|Extension Phase|Death|0|||
156325780|NCT01876810|564292543|FG000|Overall Study|Physician Decision|0|||
156525060|NCT00816400|565017004|FG005|Overall Study|Death|3|||
156525061|NCT00816400|565017005|FG006|Overall Study|Death|2|||
156525062|NCT00816400|565017006|FG007|Overall Study|Death|5|||
156325781|NCT01876810|564292544|FG001|Overall Study|Physician Decision|1|||
156525063|NCT00816400|565017007|FG008|Overall Study|Death|6|||
156525064|NCT00816400|565016999|FG000|Overall Study|In hospice care at the end of the study|0|||
156525065|NCT00816400|565017000|FG001|Overall Study|In hospice care at the end of the study|0|||
156525066|NCT00816400|565017001|FG002|Overall Study|In hospice care at the end of the study|2|||
156525067|NCT00816400|565017002|FG003|Overall Study|In hospice care at the end of the study|0|||
156525068|NCT00816400|565017003|FG004|Overall Study|In hospice care at the end of the study|0|||
156525069|NCT00816400|565017004|FG005|Overall Study|In hospice care at the end of the study|0|||
156525070|NCT00816400|565017005|FG006|Overall Study|In hospice care at the end of the study|0|||
156525071|NCT00816400|565017006|FG007|Overall Study|In hospice care at the end of the study|0|||
156525072|NCT00816400|565017007|FG008|Overall Study|In hospice care at the end of the study|0|||
156525073|NCT01222507|565017011|FG000|Overall Study|Physician Decision|1|||
156525074|NCT01222507|565017011|FG000|Overall Study|Withdrawal by Subject|1|||
156525075|NCT02647320|565017012|FG000|Overall Study|Adverse Event|0|||
156525076|NCT02647320|565017013|FG001|Overall Study|Adverse Event|1|||
156525077|NCT02647320|565017014|FG002|Overall Study|Adverse Event|3|||
156525078|NCT02647320|565017015|FG003|Overall Study|Adverse Event|2|||
156525079|NCT02647320|565017016|FG004|Overall Study|Adverse Event|1|||
156525080|NCT02647320|565017012|FG000|Overall Study|Protocol Violation|0|||
156525081|NCT02647320|565017013|FG001|Overall Study|Protocol Violation|0|||
156525082|NCT02647320|565017014|FG002|Overall Study|Protocol Violation|3|||
156525083|NCT02647320|565017015|FG003|Overall Study|Protocol Violation|0|||
156525084|NCT02647320|565017016|FG004|Overall Study|Protocol Violation|0|||
156525085|NCT02647320|565017012|FG000|Overall Study|Withdrawal by Subject|7|||
156525086|NCT02647320|565017013|FG001|Overall Study|Withdrawal by Subject|4|||
156525087|NCT02647320|565017014|FG002|Overall Study|Withdrawal by Subject|2|||
156525088|NCT02647320|565017015|FG003|Overall Study|Withdrawal by Subject|2|||
156525089|NCT02647320|565017016|FG004|Overall Study|Withdrawal by Subject|7|||
156525090|NCT02647320|565017012|FG000|Overall Study|Persistent hyperglycemia|0|||
156525091|NCT02647320|565017013|FG001|Overall Study|Persistent hyperglycemia|1|||
156525092|NCT02647320|565017014|FG002|Overall Study|Persistent hyperglycemia|1|||
156525093|NCT02647320|565017015|FG003|Overall Study|Persistent hyperglycemia|1|||
156525094|NCT02647320|565017016|FG004|Overall Study|Persistent hyperglycemia|1|||
156525095|NCT02647320|565017012|FG000|Overall Study|Study terminated by sponsor|1|||
156525096|NCT02647320|565017013|FG001|Overall Study|Study terminated by sponsor|1|||
156525097|NCT02647320|565017014|FG002|Overall Study|Study terminated by sponsor|1|||
156525098|NCT02647320|565017015|FG003|Overall Study|Study terminated by sponsor|1|||
156525099|NCT02647320|565017016|FG004|Overall Study|Study terminated by sponsor|2|||
156525100|NCT02647320|565017012|FG000|Overall Study|Reason not provided|0|||
156525101|NCT02647320|565017013|FG001|Overall Study|Reason not provided|0|||
156525102|NCT02647320|565017014|FG002|Overall Study|Reason not provided|1|||
156525103|NCT02647320|565017015|FG003|Overall Study|Reason not provided|0|||
156525104|NCT02647320|565017016|FG004|Overall Study|Reason not provided|2|||
156525105|NCT02647320|565017012|FG000|Overall Study|Lost to Follow-up|1|||
156525106|NCT02647320|565017013|FG001|Overall Study|Lost to Follow-up|1|||
156525107|NCT02647320|565017014|FG002|Overall Study|Lost to Follow-up|0|||
156525108|NCT02647320|565017015|FG003|Overall Study|Lost to Follow-up|0|||
156525109|NCT02647320|565017016|FG004|Overall Study|Lost to Follow-up|0|||
156525110|NCT02647320|565017012|FG000|Overall Study|Develop anemia|1|||
156525111|NCT02647320|565017013|FG001|Overall Study|Develop anemia|0|||
156525112|NCT02647320|565017014|FG002|Overall Study|Develop anemia|0|||
156525113|NCT02647320|565017015|FG003|Overall Study|Develop anemia|0|||
156525114|NCT02647320|565017016|FG004|Overall Study|Develop anemia|0|||
156525115|NCT02647320|565017012|FG000|Overall Study|Lack of Efficacy|0|||
156525116|NCT02647320|565017013|FG001|Overall Study|Lack of Efficacy|0|||
156525117|NCT02647320|565017014|FG002|Overall Study|Lack of Efficacy|0|||
156525118|NCT02647320|565017015|FG003|Overall Study|Lack of Efficacy|1|||
156525119|NCT02647320|565017016|FG004|Overall Study|Lack of Efficacy|0|||
156525120|NCT02647320|565017012|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
156525121|NCT02647320|565017013|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
156525122|NCT02647320|565017014|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
156525123|NCT02647320|565017015|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
156525124|NCT02647320|565017016|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
156525125|NCT00596427|565017017|FG000|Overall Study|Withdrawal by Subject|2|||
156525126|NCT00596427|565017018|FG001|Overall Study|Withdrawal by Subject|2|||
156525127|NCT00596427|565017017|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
156525128|NCT00596427|565017018|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
156525129|NCT00596427|565017017|FG000|Overall Study|Protocol Violation|1|||
156525130|NCT00596427|565017018|FG001|Overall Study|Protocol Violation|0|||
156525131|NCT02401867|565017023|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
156525132|NCT02401867|565017023|FG000|Analysis|Cervical assay could not be conducted|9|||
156525133|NCT01650246|565017024|FG000|Overall Study|Adverse Event|23|||
156525134|NCT01650246|565017024|FG000|Overall Study|Protocol Violation|5|||
156525135|NCT01650246|565017024|FG000|Overall Study|Sponsor terminated study|53|||
156525136|NCT01650246|565017024|FG000|Overall Study|Lost to Follow-up|5|||
156525137|NCT01650246|565017024|FG000|Overall Study|Withdrawal by Subject|26|||
156525138|NCT01650246|565017024|FG000|Overall Study|Death|1|||
156525139|NCT01650246|565017024|FG000|Overall Study|Lack of Efficacy|30|||
156525140|NCT00081770|565017025|FG000|Overall Study|Adverse Event|130|||
156525141|NCT00081770|565017026|FG001|Overall Study|Adverse Event|98|||
156525142|NCT00081770|565017027|FG002|Overall Study|Adverse Event|136|||
156525143|NCT00081770|565017025|FG000|Overall Study|Lack of Efficacy|262|||
156525144|NCT00081770|565017026|FG001|Overall Study|Lack of Efficacy|357|||
156525145|NCT00081770|565017027|FG002|Overall Study|Lack of Efficacy|211|||
156525146|NCT00081770|565017025|FG000|Overall Study|Lost to Follow-up|45|||
156525147|NCT00081770|565017026|FG001|Overall Study|Lost to Follow-up|34|||
156525148|NCT00081770|565017027|FG002|Overall Study|Lost to Follow-up|45|||
156525149|NCT00081770|565017025|FG000|Overall Study|Protocol Violation|15|||
156525150|NCT00081770|565017026|FG001|Overall Study|Protocol Violation|10|||
156525151|NCT00081770|565017027|FG002|Overall Study|Protocol Violation|10|||
156525152|NCT00081770|565017025|FG000|Overall Study|Withdrawal by Subject|45|||
156525153|NCT00081770|565017026|FG001|Overall Study|Withdrawal by Subject|40|||
156525154|NCT00081770|565017027|FG002|Overall Study|Withdrawal by Subject|42|||
156525155|NCT00081770|565017025|FG000|Overall Study|Did not meet protocol eligibility|2|||
156525156|NCT00081770|565017026|FG001|Overall Study|Did not meet protocol eligibility|0|||
156525157|NCT00081770|565017027|FG002|Overall Study|Did not meet protocol eligibility|3|||
156525158|NCT00081770|565017025|FG000|Overall Study|Administrative|1|||
156525159|NCT00081770|565017026|FG001|Overall Study|Administrative|0|||
156325782|NCT05169567|564292548|FG000|Overall Study|On study treatment|116|||
156325783|NCT05169567|564292549|FG001|Overall Study|On study treatment|128|||
156325784|NCT05169567|564292548|FG000|Overall Study|Lost to Follow-up|1|||
156325785|NCT05169567|564292549|FG001|Overall Study|Lost to Follow-up|0|||
156325786|NCT05169567|564292548|FG000|Overall Study|Withdrawal by Subject|25|||
156325787|NCT05169567|564292549|FG001|Overall Study|Withdrawal by Subject|21|||
156325788|NCT02211638|564292550|FG000|Overall Study|Case Report Forms Uncollected|291|||
156325789|NCT02211638|564292550|FG000|Overall Study|Protocol Violation|692|||
156325790|NCT04041700|564292553|FG000|Overall Study|Pregnancy|1|||
156325791|NCT04041700|564292553|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
156325792|NCT02775903|564292554|FG000|Overall Study|Death|7|||
156325793|NCT02775903|564292555|FG001|Overall Study|Death|11|||
156325794|NCT02775903|564292556|FG002|Overall Study|Death|12|||
156325795|NCT02775903|564292557|FG003|Overall Study|Death|11|||
156325796|NCT02775903|564292554|FG000|Overall Study|Adverse Event|0|||
156325797|NCT02775903|564292555|FG001|Overall Study|Adverse Event|1|||
156325798|NCT02775903|564292556|FG002|Overall Study|Adverse Event|12|||
156325799|NCT02775903|564292557|FG003|Overall Study|Adverse Event|3|||
156325800|NCT02775903|564292554|FG000|Overall Study|Progressive disease|15|||
156325801|NCT02775903|564292555|FG001|Overall Study|Progressive disease|14|||
156325802|NCT02775903|564292556|FG002|Overall Study|Progressive disease|30|||
156325803|NCT02775903|564292557|FG003|Overall Study|Progressive disease|20|||
156325804|NCT02775903|564292554|FG000|Overall Study|Lack of Efficacy|2|||
156325805|NCT02775903|564292555|FG001|Overall Study|Lack of Efficacy|2|||
156325806|NCT02775903|564292556|FG002|Overall Study|Lack of Efficacy|2|||
156325807|NCT02775903|564292557|FG003|Overall Study|Lack of Efficacy|6|||
156325808|NCT02775903|564292554|FG000|Overall Study|Withdrawal by Subject|7|||
156325809|NCT02775903|564292555|FG001|Overall Study|Withdrawal by Subject|5|||
156325810|NCT02775903|564292556|FG002|Overall Study|Withdrawal by Subject|5|||
156325811|NCT02775903|564292557|FG003|Overall Study|Withdrawal by Subject|8|||
156325812|NCT02775903|564292554|FG000|Overall Study|Other reasons|7|||
156325813|NCT02775903|564292555|FG001|Overall Study|Other reasons|8|||
156325814|NCT02775903|564292556|FG002|Overall Study|Other reasons|2|||
156325815|NCT02775903|564292557|FG003|Overall Study|Other reasons|12|||
156325816|NCT03120624|564292560|FG000|Overall Study|Withdrawal by Subject|0|||
156325817|NCT03120624|564292561|FG001|Overall Study|Withdrawal by Subject|1|||
156325818|NCT03120624|564292562|FG002|Overall Study|Withdrawal by Subject|0|||
156325819|NCT03120624|564292563|FG003|Overall Study|Withdrawal by Subject|0|||
156325820|NCT03120624|564292564|FG004|Overall Study|Withdrawal by Subject|0|||
156325821|NCT03120624|564292565|FG005|Overall Study|Withdrawal by Subject|0|||
156325822|NCT03120624|564292566|FG006|Overall Study|Withdrawal by Subject|0|||
156325823|NCT03120624|564292567|FG007|Overall Study|Withdrawal by Subject|0|||
156325824|NCT03670836|564292568|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
156325825|NCT03670836|564292569|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
156325826|NCT03670836|564292568|FG000|Per Protocol Population (PP)|Physician Decision|9|||
156525160|NCT00081770|565017027|FG002|Overall Study|Administrative|1|||
156325827|NCT03670836|564292569|FG001|Per Protocol Population (PP)|Physician Decision|10|||
156325828|NCT03670836|564292568|FG000|Per Protocol Population (PP)|Physician Decision|4|||
156325829|NCT03670836|564292569|FG001|Per Protocol Population (PP)|Physician Decision|6|||
156325830|NCT03670836|564292568|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
156325831|NCT03670836|564292569|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
156525161|NCT00081770|565017025|FG000|Overall Study|Other|2|||
156325832|NCT01104701|564294180|FG000|Overall Study|Withdrawal by Subject|0|||
156325833|NCT01104701|564294181|FG001|Overall Study|Withdrawal by Subject|1|||
156325834|NCT01104701|564294182|FG002|Overall Study|Withdrawal by Subject|2|||
156525162|NCT00081770|565017026|FG001|Overall Study|Other|7|||
156525163|NCT00081770|565017027|FG002|Overall Study|Other|8|||
156525164|NCT03435497|565017029|FG000|Overall Study|Lost to Follow-up|1|||
156778410|NCT02293499|565939226|FG000|Intervention - Camp|Withdrawal by Subject|3|||
156778411|NCT02293499|565939227|FG001|Intervention - Camp|Withdrawal by Subject|6|||
156778412|NCT02293499|565939228|FG002|Intervention - Camp|Withdrawal by Subject|2|||
156778413|NCT02293499|565939226|FG000|Intervention - Camp|these are those not showing up at camp|24|||
156778414|NCT02293499|565939227|FG001|Intervention - Camp|these are those not showing up at camp|28|||
156778415|NCT02293499|565939228|FG002|Intervention - Camp|these are those not showing up at camp|4|||
156778416|NCT02293499|565939226|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
156778417|NCT02293499|565939227|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
156778418|NCT02293499|565939228|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
156778419|NCT02293499|565939226|FG000|3 Month Follow Up|Lost to Follow-up|14|||
156778420|NCT02293499|565939227|FG001|3 Month Follow Up|Lost to Follow-up|15|||
156778421|NCT02293499|565939228|FG002|3 Month Follow Up|Lost to Follow-up|6|||
156778422|NCT02293499|565939226|FG000|6 Month Follow Up|Lost to Follow-up|17|||
156778423|NCT02293499|565939227|FG001|6 Month Follow Up|Lost to Follow-up|27|||
156778424|NCT02293499|565939228|FG002|6 Month Follow Up|Lost to Follow-up|6|||
156778425|NCT02293499|565939226|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
156778426|NCT02293499|565939227|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
156778427|NCT02293499|565939228|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
156778428|NCT02293499|565939226|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
156778429|NCT02293499|565939227|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
156778430|NCT02293499|565939228|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
156778431|NCT02293499|565939226|FG000|9 Month Follow Up|Lost to Follow-up|24|||
156778432|NCT02293499|565939227|FG001|9 Month Follow Up|Lost to Follow-up|28|||
156778433|NCT02293499|565939228|FG002|9 Month Follow Up|Lost to Follow-up|4|||
156778434|NCT02293499|565939226|FG000|12 Month Follow Up|Lost to Follow-up|26|||
156778435|NCT02293499|565939227|FG001|12 Month Follow Up|Lost to Follow-up|25|||
156778436|NCT02293499|565939228|FG002|12 Month Follow Up|Lost to Follow-up|6|||
156778437|NCT02293499|565939226|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
156778438|NCT02293499|565939227|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
156778439|NCT02293499|565939228|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
156778440|NCT02293499|565939226|FG000|15 Month Follow Up|Lost to Follow-up|22|||
156778441|NCT02293499|565939227|FG001|15 Month Follow Up|Lost to Follow-up|22|||
156778442|NCT02293499|565939228|FG002|15 Month Follow Up|Lost to Follow-up|7|||
156778443|NCT01787838|565939233|FG000|Overall Study|refused|1413|||
156778444|NCT01991314|565939237|FG000|Overall Study|Adverse Event|5|||
156778445|NCT01991314|565939238|FG001|Overall Study|Adverse Event|1|||
156778446|NCT01991314|565939237|FG000|Overall Study|Lost to Follow-up|6|||
156778447|NCT01991314|565939238|FG001|Overall Study|Lost to Follow-up|10|||
156778448|NCT01750346|565939239|FG000|Overall Study|Adverse Event|1|||
156778449|NCT01750346|565939240|FG001|Overall Study|Adverse Event|0|||
156778450|NCT01750346|565939241|FG002|Overall Study|Adverse Event|0|||
156778451|NCT01001104|565939242|FG000|Overall Study|Adverse Event|2|||
156778452|NCT01001104|565939243|FG001|Overall Study|Adverse Event|1|||
156778453|NCT01001104|565939244|FG002|Overall Study|Adverse Event|0|||
156778454|NCT01001104|565939245|FG003|Overall Study|Adverse Event|0|||
156778455|NCT01001104|565939242|FG000|Overall Study|Lost to Follow-up|0|||
156778456|NCT01001104|565939243|FG001|Overall Study|Lost to Follow-up|0|||
156778457|NCT01001104|565939244|FG002|Overall Study|Lost to Follow-up|1|||
156778458|NCT01001104|565939245|FG003|Overall Study|Lost to Follow-up|0|||
156778459|NCT01001104|565939242|FG000|Overall Study|Entry Criteria Not Met|0|||
156778460|NCT01001104|565939243|FG001|Overall Study|Entry Criteria Not Met|0|||
156778461|NCT01001104|565939244|FG002|Overall Study|Entry Criteria Not Met|0|||
156778462|NCT01001104|565939245|FG003|Overall Study|Entry Criteria Not Met|1|||
156778463|NCT01001104|565939242|FG000|Overall Study|Withdrawal by Subject|0|||
156778464|NCT01001104|565939243|FG001|Overall Study|Withdrawal by Subject|0|||
156778465|NCT01001104|565939244|FG002|Overall Study|Withdrawal by Subject|0|||
156778466|NCT01001104|565939245|FG003|Overall Study|Withdrawal by Subject|2|||
156778467|NCT02034591|565939246|FG000|Overall Study|Withdrawal by Subject|0|||
156778468|NCT02034591|565939247|FG001|Overall Study|Withdrawal by Subject|0|||
156778469|NCT02034591|565939248|FG002|Overall Study|Withdrawal by Subject|0|||
156778470|NCT02034591|565939249|FG003|Overall Study|Withdrawal by Subject|0|||
156778471|NCT02034591|565939250|FG004|Overall Study|Withdrawal by Subject|1|||
156778472|NCT02034591|565939251|FG005|Overall Study|Withdrawal by Subject|0|||
156778473|NCT00599313|565939252|FG000|Overall Study|Adverse Event|19|||
156778474|NCT00599313|565939252|FG000|Overall Study|Disease Progression|12|||
156778475|NCT00599313|565939252|FG000|Overall Study|Patient Request|4|||
156778476|NCT00599313|565939252|FG000|Overall Study|Ineligible|1|||
156778477|NCT00356590|565939253|FG000|Overall Study|Adverse Event|54|||
156778478|NCT00356590|565939253|FG000|Overall Study|Death|10|||
156778479|NCT00356590|565939253|FG000|Overall Study|Lost to Follow-up|35|||
156778480|NCT00356590|565939253|FG000|Overall Study|Physician Decision|46|||
156778481|NCT00356590|565939253|FG000|Overall Study|Withdrawal by Subject|41|||
156778482|NCT00356590|565939253|FG000|Overall Study|Completed month 12 only|2|||
156778483|NCT00356590|565939253|FG000|Overall Study|Protocol issues|6|||
156778484|NCT00356590|565939253|FG000|Overall Study|Response status|28|||
156778485|NCT00356590|565939253|FG000|Overall Study|Other|52|||
156778486|NCT00712920|565939254|FG000|Overall Study|Adverse Event|3|||
156778487|NCT00712920|565939255|FG001|Overall Study|Adverse Event|4|||
156778488|NCT00712920|565939256|FG002|Overall Study|Adverse Event|7|||
156778489|NCT00712920|565939254|FG000|Overall Study|Withdrawal by Subject|4|||
156778490|NCT00712920|565939255|FG001|Overall Study|Withdrawal by Subject|2|||
156778491|NCT00712920|565939256|FG002|Overall Study|Withdrawal by Subject|1|||
156778492|NCT00712920|565939254|FG000|Overall Study|Lost to Follow-up|1|||
156778493|NCT00712920|565939255|FG001|Overall Study|Lost to Follow-up|4|||
156778494|NCT00712920|565939256|FG002|Overall Study|Lost to Follow-up|0|||
156778495|NCT00712920|565939254|FG000|Overall Study|Lack of Efficacy|1|||
156778496|NCT00712920|565939255|FG001|Overall Study|Lack of Efficacy|0|||
156778497|NCT00712920|565939256|FG002|Overall Study|Lack of Efficacy|1|||
156778498|NCT00712920|565939254|FG000|Overall Study|Other|5|||
156778499|NCT00712920|565939255|FG001|Overall Study|Other|7|||
156778500|NCT00712920|565939256|FG002|Overall Study|Other|3|||
156778501|NCT00712920|565939254|FG000|Overall Study|Non-compliance|3|||
156778502|NCT00712920|565939255|FG001|Overall Study|Non-compliance|0|||
156778503|NCT00712920|565939256|FG002|Overall Study|Non-compliance|0|||
156778504|NCT02489773|565939257|FG000|Overall Study|Lost to Follow-up|4|||
156778505|NCT02489773|565939258|FG001|Overall Study|Lost to Follow-up|1|||
156778506|NCT02489773|565939257|FG000|Overall Study|Physician Decision|1|||
156778507|NCT02489773|565939258|FG001|Overall Study|Physician Decision|0|||
156778508|NCT02489773|565939257|FG000|Overall Study|Withdrawal by Subject|1|||
156778509|NCT02489773|565939258|FG001|Overall Study|Withdrawal by Subject|0|||
156778510|NCT02489773|565939257|FG000|Overall Study|Leave the country or the state|1|||
156778511|NCT02489773|565939258|FG001|Overall Study|Leave the country or the state|1|||
156778512|NCT02696616|565939260|FG000|Overall Study|Adverse Event|0|||
156778513|NCT02696616|565939261|FG001|Overall Study|Adverse Event|1|||
156778514|NCT02696616|565939262|FG002|Overall Study|Adverse Event|0|||
156778515|NCT02696616|565939263|FG003|Overall Study|Adverse Event|0|||
156778516|NCT02696616|565939264|FG004|Overall Study|Adverse Event|0|||
156778517|NCT02696616|565939265|FG005|Overall Study|Adverse Event|0|||
156778518|NCT02696616|565939266|FG006|Overall Study|Adverse Event|0|||
156778519|NCT01970371|565939267|FG000|Overall Study|Death|8|||
156778520|NCT01970371|565939268|FG001|Overall Study|Death|13|||
156778521|NCT01970371|565939269|FG002|Overall Study|Death|12|||
156778522|NCT01970371|565939267|FG000|Overall Study|Lost to Follow-up|0|||
156778523|NCT01970371|565939268|FG001|Overall Study|Lost to Follow-up|0|||
156778524|NCT01970371|565939269|FG002|Overall Study|Lost to Follow-up|1|||
156778525|NCT01481779|565939270|FG000|Overall Study|Adverse Event|23|||
156778526|NCT01481779|565939271|FG001|Overall Study|Adverse Event|5|||
156778527|NCT01481779|565939270|FG000|Overall Study|Lost to Follow-up|3|||
156778528|NCT01481779|565939271|FG001|Overall Study|Lost to Follow-up|2|||
156778529|NCT01481779|565939270|FG000|Overall Study|Protocol Violation|2|||
156778530|NCT01481779|565939271|FG001|Overall Study|Protocol Violation|3|||
156778531|NCT01481779|565939270|FG000|Overall Study|Withdrawal by Subject|26|||
156778532|NCT01481779|565939271|FG001|Overall Study|Withdrawal by Subject|13|||
156778533|NCT01481779|565939270|FG000|Overall Study|Physician Decision|13|||
156778534|NCT01481779|565939271|FG001|Overall Study|Physician Decision|4|||
156778535|NCT01481779|565939270|FG000|Overall Study|Sponsor Decision|3|||
156778536|NCT01481779|565939271|FG001|Overall Study|Sponsor Decision|1|||
156778537|NCT06420232|565939277|FG000|Overall Study|Withdrawal by Subject|3|||
156778538|NCT01697579|565939278|FG000|Base Study-Cycle 1|Adverse Event|1|||
156778539|NCT01697579|565939279|FG001|Base Study-Cycle 1|Adverse Event|0|||
156778540|NCT01697579|565939280|FG002|Base Study-Cycle 1|Adverse Event|0|||
156778541|NCT01697579|565939281|FG003|Base Study-Cycle 1|Adverse Event|0|||
156778542|NCT01697579|565939282|FG004|Base Study-Cycle 1|Adverse Event|0|||
156778543|NCT01697579|565939283|FG005|Base Study-Cycle 1|Adverse Event|0|||
156778544|NCT01697579|565939284|FG006|Base Study-Cycle 1|Adverse Event|0|||
156778545|NCT01697579|565939278|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
156778546|NCT01697579|565939279|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778547|NCT01697579|565939280|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778548|NCT01697579|565939281|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778549|NCT01697579|565939282|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778550|NCT01697579|565939283|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778551|NCT01697579|565939284|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778552|NCT01697579|565939278|FG000|Base Study-Cycle 1|Protocol Violation|0|||
156778553|NCT01697579|565939279|FG001|Base Study-Cycle 1|Protocol Violation|0|||
156778554|NCT01697579|565939280|FG002|Base Study-Cycle 1|Protocol Violation|0|||
156778555|NCT01697579|565939281|FG003|Base Study-Cycle 1|Protocol Violation|0|||
156778556|NCT01697579|565939282|FG004|Base Study-Cycle 1|Protocol Violation|3|||
156778557|NCT01697579|565939283|FG005|Base Study-Cycle 1|Protocol Violation|0|||
156778558|NCT01697579|565939284|FG006|Base Study-Cycle 1|Protocol Violation|0|||
156778559|NCT01697579|565939278|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778560|NCT01697579|565939279|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
156778561|NCT01697579|565939280|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778562|NCT01697579|565939281|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778563|NCT01697579|565939282|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778564|NCT01697579|565939283|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778565|NCT01697579|565939284|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778566|NCT01697579|565939278|FG000|Base Study-Cycle 1|Technical Problems|0|||
156778567|NCT01697579|565939279|FG001|Base Study-Cycle 1|Technical Problems|0|||
156778568|NCT01697579|565939280|FG002|Base Study-Cycle 1|Technical Problems|1|||
156778569|NCT01697579|565939281|FG003|Base Study-Cycle 1|Technical Problems|1|||
156778570|NCT01697579|565939282|FG004|Base Study-Cycle 1|Technical Problems|0|||
156778571|NCT01697579|565939283|FG005|Base Study-Cycle 1|Technical Problems|0|||
156778572|NCT01697579|565939284|FG006|Base Study-Cycle 1|Technical Problems|0|||
156778573|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Death|0|||
156778574|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Death|0|||
156778575|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Death|0|||
156778576|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Death|0|||
156778577|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Death|0|||
156778578|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Death|0|||
156778579|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Death|2|||
156778580|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156778581|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156778582|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156430110|NCT03451851|564663365|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
156430111|NCT03451851|564663358|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
156430112|NCT03451851|564663359|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
156430113|NCT03451851|564663360|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
156430114|NCT03451851|564663361|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
156430115|NCT03451851|564663362|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
156778583|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156778584|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156778585|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
156778586|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
156778587|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778588|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778589|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778590|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778591|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778592|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
156778593|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
156778594|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778595|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778596|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778597|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778598|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778599|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778600|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
156778601|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156778602|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156778603|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156778604|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156778605|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156667573|NCT01513174|565530254|FG001|Overall Study|Not receive study treatment|1|||
156667574|NCT01363765|565530257|FG000|Overall Study|non-diagnostic|2621|||
156667575|NCT01363765|565530258|FG001|Overall Study|non-diagnostic|1124|||
156430116|NCT03451851|564663363|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
156430117|NCT03451851|564663364|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
156430118|NCT03451851|564663365|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
156430119|NCT03451851|564663358|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
156430120|NCT03451851|564663359|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
156667576|NCT01363765|565530257|FG000|Overall Study|duplicate records|736|||
156667577|NCT01363765|565530258|FG001|Overall Study|duplicate records|3177|||
156667578|NCT01363765|565530257|FG000|Overall Study|non-resident|156|||
156667579|NCT01363765|565530258|FG001|Overall Study|non-resident|76|||
156667580|NCT01363765|565530257|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
156667581|NCT01363765|565530258|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
156667582|NCT01363765|565530257|FG000|Overall Study|smear during intervention|2170|||
156667583|NCT01363765|565530258|FG001|Overall Study|smear during intervention|0|||
156667584|NCT01900626|565530259|FG000|Overall Study|study was closed due to low enrollment|1|||
156667585|NCT01900626|565530260|FG001|Overall Study|study was closed due to low enrollment|1|||
156667586|NCT00635492|565530261|FG000|Overall Study|Death|12|||
156667587|NCT00635492|565530262|FG001|Overall Study|Death|40|||
156667588|NCT00635492|565530261|FG000|Overall Study|Lost to Follow-up|151|||
156667589|NCT00635492|565530262|FG001|Overall Study|Lost to Follow-up|172|||
156667590|NCT00635492|565530261|FG000|Overall Study|Physician Decision|32|||
156778606|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
156778607|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
156778608|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778609|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778610|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778611|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156525165|NCT03435497|565017030|FG001|Overall Study|Lost to Follow-up|0|||
156525166|NCT03435497|565017029|FG000|Overall Study|Death|1|||
156525167|NCT03435497|565017030|FG001|Overall Study|Death|0|||
156525168|NCT03435497|565017029|FG000|Overall Study|Withdrawal by Subject|0|||
156525169|NCT03435497|565017030|FG001|Overall Study|Withdrawal by Subject|4|||
156525170|NCT03435497|565017029|FG000|Overall Study|Wrong survey administered|0|||
156778612|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778613|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
156778614|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778615|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778616|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778617|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778618|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778619|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778620|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
156778621|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
156778622|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778623|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778624|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778625|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778626|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778627|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
156778628|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
156778629|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156778630|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156778631|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156778632|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156525171|NCT03435497|565017030|FG001|Overall Study|Wrong survey administered|2|||
156525172|NCT01072877|565017031|FG000|Overall Study|Lost to Follow-up|1|||
156525173|NCT01072877|565017032|FG001|Overall Study|Lost to Follow-up|1|||
156525174|NCT01072877|565017033|FG002|Overall Study|Lost to Follow-up|0|||
156525175|NCT01072877|565017034|FG003|Overall Study|Lost to Follow-up|2|||
156525176|NCT01072877|565017035|FG004|Overall Study|Lost to Follow-up|0|||
156525177|NCT01614197|565017044|FG000|Overall Study|Withdrawal by Subject|0|||
156525178|NCT01614197|565017045|FG001|Overall Study|Withdrawal by Subject|1|||
156525179|NCT01614197|565017046|FG002|Overall Study|Withdrawal by Subject|0|||
156525180|NCT01614197|565017047|FG003|Overall Study|Withdrawal by Subject|0|||
156525181|NCT03628898|565017049|FG000|Overall Study|Device deficiency|1|||
156525182|NCT03442985|565017050|FG000|Overall Study|Sponsor Request|55|||
156525183|NCT03442985|565017051|FG001|Overall Study|Sponsor Request|60|||
156525184|NCT03442985|565017052|FG002|Overall Study|Sponsor Request|54|||
156525185|NCT03442985|565017050|FG000|Overall Study|Lost to Follow-up|5|||
156525186|NCT03442985|565017051|FG001|Overall Study|Lost to Follow-up|2|||
156525187|NCT03442985|565017052|FG002|Overall Study|Lost to Follow-up|7|||
156525188|NCT03442985|565017050|FG000|Overall Study|Withdrawal by Subject|2|||
156525189|NCT03442985|565017051|FG001|Overall Study|Withdrawal by Subject|3|||
156525190|NCT03442985|565017052|FG002|Overall Study|Withdrawal by Subject|4|||
156525191|NCT03442985|565017050|FG000|Overall Study|Adverse Event|0|||
156778633|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156778634|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156525192|NCT03442985|565017051|FG001|Overall Study|Adverse Event|1|||
156525193|NCT03442985|565017052|FG002|Overall Study|Adverse Event|0|||
156525194|NCT04754477|565017053|FG000|Overall Study|Withdrawal by Subject|1|||
156525195|NCT00655863|565017054|FG000|Overall Study|Lost to Follow-up|0|||
156525196|NCT00655863|565017055|FG001|Overall Study|Lost to Follow-up|0|||
156525197|NCT00655863|565017056|FG002|Overall Study|Lost to Follow-up|1|||
156525198|NCT01774110|565017061|FG000|Overall Study|Lost to Follow-up|7|||
156525199|NCT02203695|565017062|FG000|Overall Study|Patient withdrew consent|1|||
156525200|NCT02203695|565017063|FG001|Overall Study|Patient withdrew consent|1|||
156525201|NCT02203695|565017062|FG000|Overall Study|Started non-study treatment|1|||
156525202|NCT02203695|565017063|FG001|Overall Study|Started non-study treatment|0|||
156525203|NCT00846391|565017064|FG000|Overall Study|Physician Decision|0|||
156525204|NCT00846391|565017065|FG001|Overall Study|Physician Decision|0|||
156667591|NCT00635492|565530262|FG001|Overall Study|Physician Decision|22|||
156525205|NCT00846391|565017066|FG002|Overall Study|Physician Decision|1|||
156525206|NCT00846391|565017064|FG000|Overall Study|Study Terminated by Sponsor|1|||
156525207|NCT00846391|565017065|FG001|Overall Study|Study Terminated by Sponsor|2|||
156525208|NCT00846391|565017066|FG002|Overall Study|Study Terminated by Sponsor|2|||
156525209|NCT03575143|565017067|FG000|Overall Study|Lost to Follow-up|0|||
156525210|NCT03575143|565017068|FG001|Overall Study|Lost to Follow-up|0|||
156525211|NCT03575143|565017069|FG002|Overall Study|Lost to Follow-up|4|||
156525212|NCT03575143|565017067|FG000|Overall Study|Withdrawal by Subject|0|||
156525213|NCT03575143|565017068|FG001|Overall Study|Withdrawal by Subject|0|||
156525214|NCT03575143|565017069|FG002|Overall Study|Withdrawal by Subject|5|||
156525215|NCT03575143|565017067|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
156525216|NCT03575143|565017068|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
156525217|NCT03575143|565017069|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
156525218|NCT00899548|565017078|FG000|Overall Study|Physician Decision|3|||
156525219|NCT04781387|565017079|FG000|Overall Study|Withdrawal by Subject|1|||
156525220|NCT04781387|565017080|FG001|Overall Study|Withdrawal by Subject|0|||
156525221|NCT04781387|565017081|FG002|Overall Study|Withdrawal by Subject|1|||
156525222|NCT04781387|565017079|FG000|Overall Study|Lost to Follow-up|1|||
156525223|NCT04781387|565017080|FG001|Overall Study|Lost to Follow-up|0|||
156525224|NCT04781387|565017081|FG002|Overall Study|Lost to Follow-up|0|||
156525225|NCT01636960|565017083|FG000|Induction Phase|Adverse Event|2|||
156525226|NCT01636960|565017083|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
156525227|NCT01636960|565017083|FG000|Maintenance Phase|Adverse Event|3|||
156525228|NCT01636960|565017083|FG000|Maintenance Phase|Progressive disease|1|||
156525229|NCT01580969|565017084|FG000|Overall Study|Physician Decision|3|||
156525230|NCT01580969|565017085|FG001|Overall Study|Physician Decision|0|||
156525231|NCT01580969|565017086|FG002|Overall Study|Physician Decision|0|||
156525232|NCT01745848|565017087|FG000|Overall Study|Adverse Event|6|||
156525233|NCT00679627|565017088|FG000|Overall Study|Death|41|||
156525234|NCT00679627|565017089|FG001|Overall Study|Death|29|||
156525235|NCT00679627|565017088|FG000|Overall Study|Adverse Event|43|||
156525236|NCT00679627|565017089|FG001|Overall Study|Adverse Event|53|||
156525237|NCT00679627|565017088|FG000|Overall Study|Withdrawal by Subject|168|||
156525238|NCT00679627|565017089|FG001|Overall Study|Withdrawal by Subject|172|||
156525239|NCT00679627|565017088|FG000|Overall Study|Lost to Follow-up|22|||
156525240|NCT00679627|565017089|FG001|Overall Study|Lost to Follow-up|26|||
156525241|NCT00679627|565017088|FG000|Overall Study|Early Study Closure|425|||
156525242|NCT00679627|565017089|FG001|Overall Study|Early Study Closure|405|||
156525243|NCT00448123|565017091|FG000|Overall Study|Lost to Follow-up|9|||
156525244|NCT00448123|565017092|FG001|Overall Study|Lost to Follow-up|6|||
156525245|NCT00448123|565017091|FG000|Overall Study|Physician Decision|6|||
156525246|NCT00448123|565017092|FG001|Overall Study|Physician Decision|6|||
156525247|NCT06338462|565017095|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
156525248|NCT01001832|565017099|FG000|Short-term Period|Adverse Event|2|||
156667592|NCT00635492|565530261|FG000|Overall Study|Sponsor decision|2|||
156667593|NCT00635492|565530262|FG001|Overall Study|Sponsor decision|3|||
156525249|NCT01001832|565017100|FG001|Short-term Period|Adverse Event|3|||
156525250|NCT01001832|565017099|FG000|Long-term Period|Adverse Event|2|||
156525251|NCT01001832|565017100|FG001|Long-term Period|Adverse Event|1|||
156525252|NCT01001832|565017099|FG000|Long-term Period|Withdrawal by Subject|1|||
156525253|NCT01001832|565017100|FG001|Long-term Period|Withdrawal by Subject|0|||
156525254|NCT01001832|565017099|FG000|Long-term Period|Lack of Efficacy|0|||
156525255|NCT01001832|565017100|FG001|Long-term Period|Lack of Efficacy|2|||
156525256|NCT01001832|565017099|FG000|Long-term Period|Other|1|||
156525257|NCT01001832|565017100|FG001|Long-term Period|Other|2|||
156525258|NCT01001832|565017099|FG000|Follow-up Period|Withdrawal by Subject|1|||
156525259|NCT01001832|565017100|FG001|Follow-up Period|Withdrawal by Subject|0|||
156525260|NCT01001832|565017099|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
156525261|NCT01001832|565017100|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
156525262|NCT01001832|565017099|FG000|Follow-up Period|Other|2|||
156525263|NCT01001832|565017100|FG001|Follow-up Period|Other|1|||
156667594|NCT00635492|565530261|FG000|Overall Study|Withdrawal by Subject|82|||
156525264|NCT03581825|565017108|FG000|Period 1|Lens Discomfort|1|||
156525265|NCT03581825|565017109|FG001|Period 1|Lens Discomfort|0|||
156525266|NCT03581825|565017108|FG000|Period 2|Unsatisfactory Vision to Test|0|||
156667595|NCT00635492|565530262|FG001|Overall Study|Withdrawal by Subject|45|||
156667596|NCT01200810|565530268|FG000|Overall Study|Physician Decision|1|||
156667597|NCT01200810|565530269|FG001|Overall Study|Physician Decision|0|||
156667598|NCT01200810|565530268|FG000|Overall Study|Withdrawal by Subject|1|||
156667599|NCT01200810|565530269|FG001|Overall Study|Withdrawal by Subject|2|||
156667600|NCT01200810|565530268|FG000|Overall Study|Sponsor stopped making study drug|3|||
156667601|NCT01200810|565530269|FG001|Overall Study|Sponsor stopped making study drug|3|||
156667602|NCT03500341|565530273|FG000|Overall Study|Withdrawn prior to Completion|2|||
156667603|NCT00838630|565530276|FG000|First Intervention|Adverse Event|1|||
156667604|NCT00838630|565530277|FG001|First Intervention|Adverse Event|0|||
156778635|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
156778636|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778637|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778638|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778639|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778640|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778641|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778642|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
156778643|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778644|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778645|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778646|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778647|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778648|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778649|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
156778650|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778651|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778652|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778653|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778654|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778655|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
156778656|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
156778657|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778658|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778659|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778660|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778661|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778662|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778663|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
156778664|NCT04225039|565939287|FG000|Overall Study|Withdrawal by Subject|1|||
156778665|NCT04225039|565939288|FG001|Overall Study|Withdrawal by Subject|0|||
156778666|NCT04225039|565939289|FG002|Overall Study|Withdrawal by Subject|0|||
156778667|NCT04225039|565939290|FG003|Overall Study|Withdrawal by Subject|1|||
156778668|NCT04225039|565939287|FG000|Overall Study|Currently active on study treatment|0|||
156778669|NCT04225039|565939288|FG001|Overall Study|Currently active on study treatment|1|||
156778670|NCT04225039|565939289|FG002|Overall Study|Currently active on study treatment|0|||
156778671|NCT04225039|565939290|FG003|Overall Study|Currently active on study treatment|0|||
156778672|NCT04225039|565939287|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
156778673|NCT04225039|565939288|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
156778674|NCT04225039|565939289|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
156778675|NCT04225039|565939290|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
156778676|NCT04225039|565939287|FG000|Overall Study|Ineligible for treatment|0|||
156778677|NCT04225039|565939288|FG001|Overall Study|Ineligible for treatment|0|||
156778678|NCT04225039|565939289|FG002|Overall Study|Ineligible for treatment|0|||
156778679|NCT04225039|565939290|FG003|Overall Study|Ineligible for treatment|4|||
156778680|NCT00975923|565939291|FG000|Overall Study|Withdrawal by Subject|0|||
156778681|NCT00975923|565939292|FG001|Overall Study|Withdrawal by Subject|1|||
156778682|NCT05567172|565939293|FG000|Overall Study|Death|3|||
156778683|NCT03168672|565939296|FG000|Overall Study|Withdrawal by Subject|13|||
156778684|NCT03168672|565939296|FG000|Overall Study|Death|3|||
156778685|NCT03168672|565939296|FG000|Overall Study|Investigator's Decision|137|||
156778686|NCT03168672|565939296|FG000|Overall Study|Adverse Event|1|||
156778687|NCT03168672|565939296|FG000|Overall Study|Other|2|||
156778688|NCT03168672|565939296|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
156778689|NCT00433537|565939297|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
156778690|NCT00433537|565939298|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
156778691|NCT00433537|565939299|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
156778692|NCT00433537|565939297|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
156778693|NCT00433537|565939298|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
156525267|NCT03581825|565017109|FG001|Period 2|Unsatisfactory Vision to Test|1|||
156525268|NCT00345293|565017110|FG000|Overall Study|Unable to access line for sample|1|||
156525269|NCT00345293|565017111|FG001|Overall Study|Unable to access line for sample|0|||
156525270|NCT00345293|565017110|FG000|Overall Study|Withdrawal by Subject|1|||
156525271|NCT00345293|565017111|FG001|Overall Study|Withdrawal by Subject|0|||
156525272|NCT04873232|565017113|FG000|Overall Study|Lost to Follow-up|1|||
156778694|NCT00433537|565939299|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
156778695|NCT00433537|565939297|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
156525273|NCT04873232|565017114|FG001|Overall Study|Lost to Follow-up|4|||
156525274|NCT04873232|565017113|FG000|Overall Study|Withdrawal by Subject|1|||
156525275|NCT04873232|565017114|FG001|Overall Study|Withdrawal by Subject|0|||
156778696|NCT00433537|565939298|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
156778697|NCT00433537|565939299|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
156778698|NCT00433537|565939297|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
156778699|NCT00433537|565939298|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
156778700|NCT00433537|565939299|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
156778701|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
156778702|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
156778703|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
156778704|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
156778705|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
156778706|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
156778707|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
156778708|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
156778709|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
156778710|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
156778711|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
156778712|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
156778713|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
156778714|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
156778715|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
156778716|NCT04635423|565939312|FG000|Overall Study|Ongoing|493|||
156778717|NCT04635423|565939313|FG001|Overall Study|Ongoing|501|||
156778718|NCT04635423|565939312|FG000|Overall Study|Withdrawal by Subject|36|||
156778719|NCT04635423|565939313|FG001|Overall Study|Withdrawal by Subject|29|||
156778720|NCT04364646|565939318|FG000|Overall Study|Lost to Follow-up|1|||
156778721|NCT04364646|565939319|FG001|Overall Study|Lost to Follow-up|0|||
156778722|NCT04364646|565939318|FG000|Overall Study|Withdrawal by Subject|7|||
156778723|NCT04364646|565939319|FG001|Overall Study|Withdrawal by Subject|14|||
156778724|NCT04364646|565939318|FG000|Overall Study|Protocol Violation|4|||
156778725|NCT04364646|565939319|FG001|Overall Study|Protocol Violation|5|||
156778726|NCT02555878|565939321|FG000|Overall Study|Lost to Follow-up|2|||
156778727|NCT02555878|565939322|FG001|Overall Study|Lost to Follow-up|3|||
156778728|NCT02555878|565939321|FG000|Overall Study|Withdrawal by Subject|48|||
156778729|NCT02555878|565939322|FG001|Overall Study|Withdrawal by Subject|48|||
156778730|NCT02555878|565939321|FG000|Overall Study|Adverse Event|12|||
156778731|NCT02555878|565939322|FG001|Overall Study|Adverse Event|8|||
156778732|NCT02555878|565939321|FG000|Overall Study|Death|74|||
156778733|NCT02555878|565939322|FG001|Overall Study|Death|59|||
156778734|NCT02555878|565939321|FG000|Overall Study|Protocol Violation|1|||
156778735|NCT02555878|565939322|FG001|Overall Study|Protocol Violation|2|||
156778736|NCT02555878|565939321|FG000|Overall Study|Physician Decision|12|||
156778737|NCT02555878|565939322|FG001|Overall Study|Physician Decision|13|||
156778738|NCT02555878|565939321|FG000|Overall Study|Other|17|||
156778739|NCT02555878|565939322|FG001|Overall Study|Other|17|||
156778740|NCT03608033|565939325|FG000|Treatment Period|Death|0|||
156778741|NCT03608033|565939326|FG001|Treatment Period|Death|1|||
156778742|NCT03608033|565939325|FG000|Treatment Period|Adverse Event|1|||
156778743|NCT03608033|565939326|FG001|Treatment Period|Adverse Event|5|||
156778744|NCT03608033|565939325|FG000|Treatment Period|Lack of Efficacy|4|||
156778745|NCT03608033|565939326|FG001|Treatment Period|Lack of Efficacy|3|||
156778746|NCT03608033|565939325|FG000|Treatment Period|Lost to Follow-up|2|||
156778747|NCT03608033|565939326|FG001|Treatment Period|Lost to Follow-up|6|||
156778748|NCT03608033|565939325|FG000|Treatment Period|Physician Decision|6|||
156778749|NCT03608033|565939326|FG001|Treatment Period|Physician Decision|10|||
156778750|NCT03608033|565939325|FG000|Treatment Period|Pregnancy|1|||
156778751|NCT03608033|565939326|FG001|Treatment Period|Pregnancy|0|||
156778752|NCT03608033|565939325|FG000|Treatment Period|Protocol Violation|1|||
156778753|NCT03608033|565939326|FG001|Treatment Period|Protocol Violation|2|||
156778754|NCT03608033|565939325|FG000|Treatment Period|Withdrawal by Subject|46|||
156525276|NCT00601419|565019264|FG000|Overall Study|Lost to Follow-up|3|||
156525277|NCT00601419|565019264|FG000|Overall Study|Missed Visits|1|||
156778755|NCT03608033|565939326|FG001|Treatment Period|Withdrawal by Subject|45|||
156778756|NCT03608033|565939325|FG000|Treatment Period|Study terminated by sponsor|82|||
156778757|NCT03608033|565939326|FG001|Treatment Period|Study terminated by sponsor|68|||
156778758|NCT03608033|565939325|FG000|Treatment Period|Site Terminated by Sponsor|1|||
156778759|NCT03608033|565939326|FG001|Treatment Period|Site Terminated by Sponsor|0|||
156778760|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Adverse Event|1|||
156778761|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Adverse Event|0|||
156778762|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
156778763|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
156778764|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
156778765|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
156778766|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
156778767|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
156525278|NCT01786174|565019265|FG000|Overall Study|Discontinued Study Drug|2|||
156525279|NCT01786174|565019266|FG001|Overall Study|Discontinued Study Drug|0|||
156525280|NCT00995020|565019267|FG000|Overall Study|margin analysis not performed|2|||
156525281|NCT00995020|565019268|FG001|Overall Study|margin analysis not performed|5|||
156525282|NCT00995020|565019267|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
156525283|NCT00995020|565019268|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
156525284|NCT00876694|565019271|FG000|Overall Study|Adverse Event|10|||
156525285|NCT00876694|565019272|FG001|Overall Study|Adverse Event|7|||
156525286|NCT00876694|565019271|FG000|Overall Study|Subject withdrew consent|6|||
156525287|NCT00876694|565019272|FG001|Overall Study|Subject withdrew consent|4|||
156525288|NCT00876694|565019271|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156525289|NCT00876694|565019272|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156525290|NCT00876694|565019271|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156525291|NCT00876694|565019272|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156525292|NCT00876694|565019271|FG000|Overall Study|Administrative problems|1|||
156525293|NCT00876694|565019272|FG001|Overall Study|Administrative problems|1|||
156525294|NCT00876694|565019271|FG000|Overall Study|Death|1|||
156525295|NCT00876694|565019272|FG001|Overall Study|Death|0|||
156525296|NCT00288509|565019273|FG000|Treatment Cycle 1|Adverse Event|1|||
156525297|NCT00288509|565019273|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
156525298|NCT00288509|565019273|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
156525299|NCT00288509|565019273|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
156525300|NCT00288509|565019273|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
156525301|NCT00288509|565019273|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
156525302|NCT00288509|565019273|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
156525303|NCT00288509|565019273|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
156525304|NCT00288509|565019273|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
156325835|NCT01104701|564294183|FG003|Overall Study|Withdrawal by Subject|1|||
156325836|NCT01104701|564294180|FG000|Overall Study|Adverse Event|0|||
156325837|NCT01104701|564294181|FG001|Overall Study|Adverse Event|0|||
156325838|NCT01104701|564294182|FG002|Overall Study|Adverse Event|0|||
156325839|NCT01104701|564294183|FG003|Overall Study|Adverse Event|1|||
156325840|NCT01104701|564294180|FG000|Overall Study|Physician Decision|0|||
156325841|NCT01104701|564294181|FG001|Overall Study|Physician Decision|2|||
156325842|NCT01104701|564294182|FG002|Overall Study|Physician Decision|0|||
156325843|NCT01104701|564294183|FG003|Overall Study|Physician Decision|0|||
156325844|NCT01397201|564294184|FG000|Overall Study|Not treated|0|||
156325845|NCT01397201|564294185|FG001|Overall Study|Not treated|0|||
156325846|NCT01397201|564294186|FG002|Overall Study|Not treated|1|||
156325847|NCT01397201|564294187|FG003|Overall Study|Not treated|0|||
156325848|NCT01397201|564294188|FG004|Overall Study|Not treated|0|||
156325849|NCT01397201|564294184|FG000|Overall Study|Not yet defined|3|||
156325850|NCT01397201|564294185|FG001|Overall Study|Not yet defined|6|||
156325851|NCT01397201|564294186|FG002|Overall Study|Not yet defined|5|||
156325852|NCT01397201|564294187|FG003|Overall Study|Not yet defined|5|||
156325853|NCT01397201|564294188|FG004|Overall Study|Not yet defined|4|||
156325854|NCT01397201|564294184|FG000|Overall Study|Adverse Event|2|||
156325855|NCT01397201|564294185|FG001|Overall Study|Adverse Event|0|||
156325856|NCT01397201|564294186|FG002|Overall Study|Adverse Event|0|||
156325857|NCT01397201|564294187|FG003|Overall Study|Adverse Event|0|||
156325858|NCT01397201|564294188|FG004|Overall Study|Adverse Event|0|||
156325859|NCT00423722|564294192|FG000|Overall Study|Death|4|||
156325860|NCT00423722|564294193|FG001|Overall Study|Death|4|||
156325861|NCT00423722|564294192|FG000|Overall Study|Declined to participate|2|||
156325862|NCT00423722|564294193|FG001|Overall Study|Declined to participate|3|||
156325863|NCT00423722|564294192|FG000|Overall Study|Unable to complete questionnaires|4|||
156325864|NCT00423722|564294193|FG001|Overall Study|Unable to complete questionnaires|4|||
156325865|NCT00423722|564294192|FG000|Overall Study|Withdrawal by Subject|4|||
156325866|NCT00423722|564294193|FG001|Overall Study|Withdrawal by Subject|2|||
156325867|NCT00215683|564294196|FG000|Overall Study|Adverse Event|15|||
156325868|NCT00215683|564294197|FG001|Overall Study|Adverse Event|16|||
156325869|NCT00215683|564294198|FG002|Overall Study|Adverse Event|15|||
156325870|NCT00215683|564294196|FG000|Overall Study|Lack of Efficacy|5|||
156325871|NCT00215683|564294197|FG001|Overall Study|Lack of Efficacy|1|||
156325872|NCT00215683|564294198|FG002|Overall Study|Lack of Efficacy|2|||
156325873|NCT00215683|564294196|FG000|Overall Study|Lost to Follow-up|0|||
156325874|NCT00215683|564294197|FG001|Overall Study|Lost to Follow-up|2|||
156325875|NCT00215683|564294198|FG002|Overall Study|Lost to Follow-up|1|||
156325876|NCT00215683|564294196|FG000|Overall Study|Withdrawal by Subject|9|||
156325877|NCT00215683|564294197|FG001|Overall Study|Withdrawal by Subject|4|||
156325878|NCT00215683|564294198|FG002|Overall Study|Withdrawal by Subject|13|||
156525305|NCT00288509|565019273|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
156525306|NCT00288509|565019273|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
156525307|NCT00288509|565019273|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
156325879|NCT00215683|564294196|FG000|Overall Study|Physician Decision|0|||
156325880|NCT00215683|564294197|FG001|Overall Study|Physician Decision|0|||
156525308|NCT00288509|565019273|FG000|Treatment Cycle 4|Physician Decision|4|||
156525309|NCT00288509|565019273|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
156667605|NCT00838630|565530276|FG000|Washout: 7 Days|Protocol Violation|1|||
156667606|NCT00838630|565530277|FG001|Washout: 7 Days|Protocol Violation|0|||
156778768|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
156778769|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
156778770|NCT03483012|565939327|FG000|Overall Study|Lack of Efficacy|6|||
156778771|NCT05253807|565939328|FG000|Overall Study|Death|1|||
156778772|NCT05253807|565939329|FG001|Overall Study|Death|4|||
156778773|NCT05253807|565939328|FG000|Overall Study|Withdrawal by Subject|1|||
156778774|NCT05253807|565939329|FG001|Overall Study|Withdrawal by Subject|0|||
156778775|NCT05253807|565939328|FG000|Overall Study|Study Terminated by Sponsor|1|||
156778776|NCT05253807|565939329|FG001|Overall Study|Study Terminated by Sponsor|1|||
156778777|NCT02360579|565939330|FG000|Initial|Death|16|||
156778778|NCT02360579|565939331|FG001|Initial|Death|49|||
156778779|NCT02360579|565939332|FG002|Initial|Death|0|||
156778780|NCT02360579|565939333|FG003|Initial|Death|71|||
156778781|NCT02360579|565939330|FG000|Initial|Lost to Follow-up|0|||
156525310|NCT02382016|565019274|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
156525311|NCT02382016|565019275|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
156525312|NCT02382016|565019274|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
156525313|NCT02382016|565019275|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
156525314|NCT02382016|565019274|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
156525315|NCT02382016|565019275|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
156525316|NCT02382016|565019274|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
156667607|NCT02699866|565530278|FG000|Overall Study|Withdrawal by Subject|3|||
156667608|NCT02699866|565530278|FG000|Overall Study|Physician Decision|2|||
156667609|NCT02699866|565530278|FG000|Overall Study|Adverse Event|3|||
156667610|NCT04022954|565530281|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
156667611|NCT04022954|565530281|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
156667612|NCT04022954|565530281|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
156667613|NCT04400890|565530282|FG000|Overall Study|Withdrawal by Subject|3|||
156667614|NCT04400890|565530283|FG001|Overall Study|Withdrawal by Subject|2|||
156667615|NCT03925532|565530284|FG000|Overall Study|Lost to Follow-up|1|||
156667616|NCT00723710|565530289|FG000|Overall Study|Disease progression|48|||
156667617|NCT00723710|565530289|FG000|Overall Study|Adverse Event|88|||
156667618|NCT00723710|565530289|FG000|Overall Study|Withdrawal by Subject|36|||
156667619|NCT00723710|565530289|FG000|Overall Study|Physician Decision|2|||
156667620|NCT01001208|565530290|FG000|Overall Study|Adverse Event|10|||
156667621|NCT01001208|565530291|FG001|Overall Study|Adverse Event|5|||
156667622|NCT01001208|565530290|FG000|Overall Study|Lost to Follow-up|5|||
156667623|NCT01001208|565530291|FG001|Overall Study|Lost to Follow-up|9|||
156667624|NCT01001208|565530290|FG000|Overall Study|Physician Decision|1|||
156667625|NCT01001208|565530291|FG001|Overall Study|Physician Decision|0|||
156667626|NCT01001208|565530290|FG000|Overall Study|Withdrawal by Subject|4|||
156667627|NCT01001208|565530291|FG001|Overall Study|Withdrawal by Subject|5|||
156667628|NCT01001208|565530290|FG000|Overall Study|Ineligibility Determined|4|||
156667629|NCT01001208|565530291|FG001|Overall Study|Ineligibility Determined|2|||
156667630|NCT01001208|565530290|FG000|Overall Study|Noncompliance|4|||
156667631|NCT01001208|565530291|FG001|Overall Study|Noncompliance|7|||
156667632|NCT01001208|565530290|FG000|Overall Study|Disease Progression|0|||
156667633|NCT01001208|565530291|FG001|Overall Study|Disease Progression|3|||
156667634|NCT01001208|565530290|FG000|Overall Study|Other|0|||
156667635|NCT01001208|565530291|FG001|Overall Study|Other|2|||
156667636|NCT01723397|565530293|FG000|Study Period 1|Protocol Violation|0|||
156667637|NCT01723397|565530294|FG001|Study Period 1|Protocol Violation|1|||
156667638|NCT01723397|565530293|FG000|Study Period 2|Protocol Violation|0|||
156667639|NCT01723397|565530294|FG001|Study Period 2|Protocol Violation|1|||
156667640|NCT02739997|565530295|FG000|Overall Study|Death|1|||
156667641|NCT02739997|565530295|FG000|Overall Study|Withdrawal by Subject|1|||
156667642|NCT00833937|565530298|FG000|Washout|Withdrawal by Subject|1|||
156667643|NCT00833937|565530299|FG001|Washout|Withdrawal by Subject|0|||
156667644|NCT01353664|565530300|FG000|Overall Study|Other|3|||
156667645|NCT01353664|565530300|FG000|Overall Study|Disease Progression|16|||
156667646|NCT02655679|565530302|FG000|Overall Study|Adverse Event|0|||
156667647|NCT02655679|565530303|FG001|Overall Study|Adverse Event|1|||
156667648|NCT02655679|565530304|FG002|Overall Study|Adverse Event|0|||
156667649|NCT02655679|565530305|FG003|Overall Study|Adverse Event|0|||
156667650|NCT02655679|565530306|FG004|Overall Study|Adverse Event|0|||
156667651|NCT02655679|565530302|FG000|Overall Study|Withdrawal by Subject|1|||
156667652|NCT02655679|565530303|FG001|Overall Study|Withdrawal by Subject|1|||
156667653|NCT02655679|565530304|FG002|Overall Study|Withdrawal by Subject|0|||
156667654|NCT02655679|565530305|FG003|Overall Study|Withdrawal by Subject|3|||
156667655|NCT02655679|565530306|FG004|Overall Study|Withdrawal by Subject|1|||
156667656|NCT02655679|565530302|FG000|Overall Study|Inability to Comply with the Protocol|1|||
156667657|NCT02655679|565530303|FG001|Overall Study|Inability to Comply with the Protocol|0|||
156667658|NCT02655679|565530304|FG002|Overall Study|Inability to Comply with the Protocol|0|||
156525317|NCT02382016|565019275|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
156525318|NCT02382016|565019274|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
156525319|NCT02382016|565019275|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
156525320|NCT02382016|565019274|FG000|Open-label (OL) Treatment Period|Death|4|||
156525321|NCT02382016|565019275|FG001|Open-label (OL) Treatment Period|Death|0|||
156525322|NCT02382016|565019274|FG000|OL Extension Period|Physician Decision|3|||
156525323|NCT02382016|565019275|FG001|OL Extension Period|Physician Decision|0|||
156525324|NCT02382016|565019274|FG000|OL Extension Period|Death|2|||
156525325|NCT02382016|565019275|FG001|OL Extension Period|Death|0|||
156525326|NCT02382016|565019274|FG000|OL Extension Period|Withdrawal by Subject|1|||
156525327|NCT02382016|565019275|FG001|OL Extension Period|Withdrawal by Subject|0|||
156525328|NCT00084266|565019276|FG000|Overall Study|Death|42|||
156525329|NCT00084266|565019277|FG001|Overall Study|Death|39|||
156525330|NCT00084266|565019276|FG000|Overall Study|Adverse Event|8|||
156525331|NCT00084266|565019277|FG001|Overall Study|Adverse Event|5|||
156525332|NCT00084266|565019276|FG000|Overall Study|Lack of Efficacy|2|||
156525333|NCT00084266|565019277|FG001|Overall Study|Lack of Efficacy|4|||
156525334|NCT00084266|565019276|FG000|Overall Study|Lost to Follow-up|5|||
156525335|NCT00084266|565019277|FG001|Overall Study|Lost to Follow-up|3|||
156525336|NCT00084266|565019276|FG000|Overall Study|Participant not willing to participate|3|||
156525337|NCT00084266|565019277|FG001|Overall Study|Participant not willing to participate|8|||
156525338|NCT00084266|565019276|FG000|Overall Study|Other|360|||
156525339|NCT00084266|565019277|FG001|Overall Study|Other|344|||
156525340|NCT00084266|565019276|FG000|Overall Study|Randomized not treated|21|||
156525341|NCT00084266|565019277|FG001|Overall Study|Randomized not treated|20|||
156525342|NCT00730171|565019278|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
156525343|NCT00730171|565019278|FG000|Overall Study|Adverse Event|193|||
156525344|NCT00730171|565019278|FG000|Overall Study|Protocol Violation|48|||
156525345|NCT00730171|565019278|FG000|Overall Study|Withdrawal by Subject|202|||
156525346|NCT00730171|565019278|FG000|Overall Study|Lost to Follow-up|121|||
156525347|NCT00730171|565019278|FG000|Overall Study|Insufficient Therapeutic Response|141|||
156325881|NCT00215683|564294198|FG002|Overall Study|Physician Decision|1|||
156325882|NCT00215683|564294196|FG000|Overall Study|Difficult to attend visits|0|||
156325883|NCT00215683|564294197|FG001|Overall Study|Difficult to attend visits|1|||
156325884|NCT00215683|564294198|FG002|Overall Study|Difficult to attend visits|0|||
156325885|NCT00215683|564294196|FG000|Overall Study|No study drug available|0|||
156325886|NCT00215683|564294197|FG001|Overall Study|No study drug available|1|||
156325887|NCT00215683|564294198|FG002|Overall Study|No study drug available|0|||
156325888|NCT00215683|564294196|FG000|Overall Study|Intermittent therapy required|0|||
156325889|NCT00215683|564294197|FG001|Overall Study|Intermittent therapy required|1|||
156325890|NCT00215683|564294198|FG002|Overall Study|Intermittent therapy required|0|||
156325891|NCT02171065|564294199|FG000|Overall Study|Withdrawal by Subject|1|||
156325892|NCT02171065|564294200|FG001|Overall Study|Withdrawal by Subject|0|||
156325893|NCT02171065|564294201|FG002|Overall Study|Withdrawal by Subject|0|||
156325894|NCT02171065|564294199|FG000|Overall Study|Lost to Follow-up|0|||
156325895|NCT02171065|564294200|FG001|Overall Study|Lost to Follow-up|0|||
156325896|NCT02171065|564294201|FG002|Overall Study|Lost to Follow-up|1|||
156325897|NCT00674973|564294202|FG000|Overall Study|Insufficient Therapeutic Response|77|||
156325898|NCT00674973|564294203|FG001|Overall Study|Insufficient Therapeutic Response|72|||
156325899|NCT00674973|564294202|FG000|Overall Study|Refused Treatment|1|||
156325900|NCT00674973|564294203|FG001|Overall Study|Refused Treatment|5|||
156325901|NCT00674973|564294202|FG000|Overall Study|Failure to Return|1|||
156325902|NCT00674973|564294203|FG001|Overall Study|Failure to Return|0|||
156325903|NCT00674973|564294202|FG000|Overall Study|Adverse Event|2|||
156325904|NCT00674973|564294203|FG001|Overall Study|Adverse Event|9|||
156325905|NCT00674973|564294202|FG000|Overall Study|Death|19|||
156325906|NCT00674973|564294203|FG001|Overall Study|Death|15|||
156325907|NCT00674973|564294202|FG000|Overall Study|Protocol Violation|0|||
156325908|NCT00674973|564294203|FG001|Overall Study|Protocol Violation|1|||
156325909|NCT00084838|564294206|FG000|Overall Study|Death|1|||
156325910|NCT00084838|564294206|FG000|Overall Study|Adverse Event|2|||
156325911|NCT00084838|564294206|FG000|Overall Study|Withdrawal by Subject|1|||
156325912|NCT00084838|564294206|FG000|Overall Study|Progressive Disease|4|||
156325913|NCT00084838|564294206|FG000|Overall Study|Pt Non-Compliance|1|||
156325914|NCT00084838|564294206|FG000|Overall Study|Ineligible|4|||
156325915|NCT00518687|564294207|FG000|Overall Study|Adverse Event|201|||
156325916|NCT00518687|564294208|FG001|Overall Study|Adverse Event|177|||
156325917|NCT00518687|564294207|FG000|Overall Study|Lost to Follow-up|144|||
156325918|NCT00518687|564294208|FG001|Overall Study|Lost to Follow-up|155|||
156325919|NCT00518687|564294207|FG000|Overall Study|Physician Decision|42|||
156325920|NCT00518687|564294208|FG001|Overall Study|Physician Decision|48|||
156325921|NCT00518687|564294207|FG000|Overall Study|Progressive disease|2|||
156325922|NCT00518687|564294208|FG001|Overall Study|Progressive disease|2|||
156525348|NCT00730171|565019278|FG000|Overall Study|Other|61|||
156325923|NCT00518687|564294207|FG000|Overall Study|Protocol Violation|8|||
156525349|NCT01729156|565019279|FG000|Overall Study|Withdrawal by Subject|1|||
156525350|NCT01729156|565019280|FG001|Overall Study|Withdrawal by Subject|0|||
156525351|NCT01729156|565019281|FG002|Overall Study|Withdrawal by Subject|0|||
156525352|NCT01215422|565019282|FG000|Overall Study|Relocation|1|||
156525353|NCT01215422|565019283|FG001|Overall Study|Relocation|0|||
156525354|NCT01215422|565019284|FG002|Overall Study|Relocation|0|||
156525355|NCT01215422|565019285|FG003|Overall Study|Relocation|0|||
156525356|NCT01215422|565019282|FG000|Overall Study|Failed intubations|0|||
156525357|NCT01215422|565019283|FG001|Overall Study|Failed intubations|0|||
156525358|NCT01215422|565019284|FG002|Overall Study|Failed intubations|3|||
156525359|NCT01215422|565019285|FG003|Overall Study|Failed intubations|8|||
156525360|NCT01215422|565019282|FG000|Overall Study|Did not complete all intubations|7|||
156525361|NCT01215422|565019283|FG001|Overall Study|Did not complete all intubations|0|||
156525362|NCT01215422|565019284|FG002|Overall Study|Did not complete all intubations|0|||
156525363|NCT01215422|565019285|FG003|Overall Study|Did not complete all intubations|0|||
156667659|NCT02655679|565530305|FG003|Overall Study|Inability to Comply with the Protocol|0|||
156667660|NCT02655679|565530306|FG004|Overall Study|Inability to Comply with the Protocol|0|||
156667661|NCT02655679|565530302|FG000|Overall Study|Lost to Follow-up|0|||
156667662|NCT02655679|565530303|FG001|Overall Study|Lost to Follow-up|1|||
156525364|NCT01256658|565019288|FG000|Period 1|Lost to Follow-up|837|||
156325924|NCT00518687|564294208|FG001|Overall Study|Protocol Violation|10|||
156325925|NCT00518687|564294207|FG000|Overall Study|Study terminated by sponsor|930|||
156325926|NCT00518687|564294208|FG001|Overall Study|Study terminated by sponsor|918|||
156325927|NCT00518687|564294207|FG000|Overall Study|Withdrawal by Subject|110|||
156325928|NCT00518687|564294208|FG001|Overall Study|Withdrawal by Subject|110|||
156325929|NCT00851630|564294210|FG000|Overall Study|Death|2|||
156325930|NCT00851630|564294211|FG001|Overall Study|Death|1|||
156325931|NCT00851630|564294210|FG000|Overall Study|Clinical failure|0|||
156325932|NCT00851630|564294211|FG001|Overall Study|Clinical failure|1|||
156325933|NCT00401531|564294212|FG000|Overall Study|Adverse Event|2|||
156325934|NCT00401531|564294213|FG001|Overall Study|Adverse Event|0|||
156325935|NCT00401531|564294212|FG000|Overall Study|Protocol Violation|3|||
156325936|NCT00401531|564294213|FG001|Overall Study|Protocol Violation|7|||
156325937|NCT00401531|564294212|FG000|Overall Study|Lost to Follow-up|1|||
156325938|NCT00401531|564294213|FG001|Overall Study|Lost to Follow-up|1|||
156325939|NCT00401531|564294212|FG000|Overall Study|Withdrawal by Subject|3|||
156325940|NCT00401531|564294213|FG001|Overall Study|Withdrawal by Subject|2|||
156325941|NCT01614600|564294218|FG000|Overall Study|Unacceptable fit|1|||
156325942|NCT01614600|564294218|FG000|Overall Study|Discomfort|1|||
156325943|NCT01614600|564294218|FG000|Overall Study|Unable to remove lens at the end of day|1|||
156325944|NCT01614600|564294218|FG000|Overall Study|Protocol deviation|1|||
156325945|NCT00422097|564294219|FG000|Dose Level 2|Still on treatment|0|||
156325946|NCT00422097|564294220|FG001|Dose Level 2|Still on treatment|1|||
156325947|NCT00422097|564294221|FG002|Dose Level 2|Still on treatment|0|||
156325948|NCT00422097|564294222|FG003|Dose Level 2|Still on treatment|0|||
156325949|NCT00422097|564294223|FG004|Dose Level 2|Still on treatment|0|||
156325950|NCT00422097|564294224|FG005|Dose Level 2|Still on treatment|0|||
156325951|NCT00422097|564294225|FG006|Dose Level 2|Still on treatment|0|||
156325952|NCT00422097|564294226|FG007|Dose Level 2|Still on treatment|0|||
156325953|NCT02360995|564294227|FG000|Overall Study|Lost to Follow-up|2|||
156325954|NCT02360995|564294228|FG001|Overall Study|Lost to Follow-up|0|||
156325955|NCT02360995|564294229|FG002|Overall Study|Lost to Follow-up|2|||
156325956|NCT02360995|564294227|FG000|Overall Study|Withdrawal by Subject|0|||
156325957|NCT02360995|564294228|FG001|Overall Study|Withdrawal by Subject|1|||
156325958|NCT02360995|564294229|FG002|Overall Study|Withdrawal by Subject|0|||
156325959|NCT02231918|564294230|FG000|Overall Study|Withdrawal by Subject|0|||
156325960|NCT02231918|564294231|FG001|Overall Study|Withdrawal by Subject|1|||
156325961|NCT02231918|564294232|FG002|Overall Study|Withdrawal by Subject|0|||
156325962|NCT02231918|564294230|FG000|Overall Study|Adverse Event|0|||
156325963|NCT02231918|564294231|FG001|Overall Study|Adverse Event|0|||
156325964|NCT02231918|564294232|FG002|Overall Study|Adverse Event|1|||
156325965|NCT02395666|564294233|FG000|Overall Study|Physician Decision|3|||
156325966|NCT02395666|564294234|FG001|Overall Study|Physician Decision|0|||
156325967|NCT02395666|564294233|FG000|Overall Study|Lost to Follow-up|1|||
156325968|NCT02395666|564294234|FG001|Overall Study|Lost to Follow-up|0|||
156325969|NCT02395666|564294233|FG000|Overall Study|Withdrawal by Subject|2|||
156325970|NCT02395666|564294234|FG001|Overall Study|Withdrawal by Subject|1|||
156325971|NCT00145600|564294239|FG000|Overall Study|Death|1|||
156325972|NCT00145600|564294240|FG001|Overall Study|Death|2|||
156325973|NCT00145600|564294241|FG002|Overall Study|Death|2|||
156325974|NCT00145600|564294242|FG003|Overall Study|Death|6|||
156325975|NCT00145600|564294239|FG000|Overall Study|Ineligible|3|||
156325976|NCT00145600|564294240|FG001|Overall Study|Ineligible|0|||
156525365|NCT01256658|565019289|FG001|Period 1|Lost to Follow-up|661|||
156525366|NCT01256658|565019288|FG000|Period 1|Withdrawal by Subject|35|||
156525367|NCT01256658|565019289|FG001|Period 1|Withdrawal by Subject|43|||
156525368|NCT01256658|565019288|FG000|Period 1|Death|48|||
156325977|NCT00145600|564294241|FG002|Overall Study|Ineligible|1|||
156325978|NCT00145600|564294242|FG003|Overall Study|Ineligible|5|||
156525369|NCT01256658|565019289|FG001|Period 1|Death|44|||
156325979|NCT00145600|564294239|FG000|Overall Study|Lost to Follow-up|2|||
156325980|NCT00145600|564294240|FG001|Overall Study|Lost to Follow-up|6|||
156325981|NCT00145600|564294241|FG002|Overall Study|Lost to Follow-up|2|||
156778782|NCT02360579|565939331|FG001|Initial|Lost to Follow-up|4|||
156778783|NCT02360579|565939332|FG002|Initial|Lost to Follow-up|0|||
156778784|NCT02360579|565939333|FG003|Initial|Lost to Follow-up|1|||
156778785|NCT02360579|565939330|FG000|Initial|Withdrawal by Subject|0|||
156778786|NCT02360579|565939331|FG001|Initial|Withdrawal by Subject|0|||
156778787|NCT02360579|565939332|FG002|Initial|Withdrawal by Subject|0|||
156778788|NCT02360579|565939333|FG003|Initial|Withdrawal by Subject|3|||
156778789|NCT02360579|565939330|FG000|Initial|Other|7|||
156778790|NCT02360579|565939331|FG001|Initial|Other|0|||
156667663|NCT02655679|565530304|FG002|Overall Study|Lost to Follow-up|1|||
156667664|NCT02655679|565530305|FG003|Overall Study|Lost to Follow-up|1|||
156667665|NCT02655679|565530306|FG004|Overall Study|Lost to Follow-up|0|||
156667666|NCT02655679|565530302|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156667667|NCT02655679|565530303|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156667668|NCT02655679|565530304|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156667669|NCT02655679|565530305|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156667670|NCT02655679|565530306|FG004|Overall Study|Other Miscellaneous Reasons|0|||
156778791|NCT02360579|565939332|FG002|Initial|Other|0|||
156778792|NCT02360579|565939333|FG003|Initial|Other|0|||
156778793|NCT02360579|565939330|FG000|Initial|Did not receive TIL|8|||
156778794|NCT02360579|565939331|FG001|Initial|Did not receive TIL|11|||
156778795|NCT02360579|565939332|FG002|Initial|Did not receive TIL|0|||
156778796|NCT02360579|565939333|FG003|Initial|Did not receive TIL|22|||
156778797|NCT02360579|565939330|FG000|Retreatment|Death|0|||
156778798|NCT02360579|565939331|FG001|Retreatment|Death|0|||
156778799|NCT02360579|565939332|FG002|Retreatment|Death|11|||
156778800|NCT02360579|565939333|FG003|Retreatment|Death|0|||
156778801|NCT03682848|565939336|FG000|Overall Study|Withdrawal by Subject|3|||
156778802|NCT03682848|565939336|FG000|Overall Study|Site closed|5|||
156778803|NCT03682848|565939336|FG000|Overall Study|Protocol Deviation|1|||
156778804|NCT03682848|565939336|FG000|Overall Study|Adverse Event|2|||
156778805|NCT03682848|565939336|FG000|Overall Study|Lack of Efficacy|1|||
156808571|NCT01070979|566052717|FG002|Overall Study|Withdrawal by Subject|1|||
156808572|NCT01070979|566052715|FG000|Overall Study|No study drug taken|0|||
156808573|NCT01070979|566052716|FG001|Overall Study|No study drug taken|1|||
156808574|NCT01070979|566052717|FG002|Overall Study|No study drug taken|0|||
156808575|NCT00142792|566052718|FG000|Overall Study|Death|0|||
156808576|NCT00142792|566052719|FG001|Overall Study|Death|0|||
156808577|NCT00142792|566052720|FG002|Overall Study|Death|1|||
156808578|NCT00142792|566052718|FG000|Overall Study|Withdrawal by Subject|3|||
156808579|NCT00142792|566052719|FG001|Overall Study|Withdrawal by Subject|2|||
156808580|NCT00142792|566052720|FG002|Overall Study|Withdrawal by Subject|3|||
156808581|NCT00142792|566052718|FG000|Overall Study|Lost to Follow-up|8|||
156808582|NCT00142792|566052719|FG001|Overall Study|Lost to Follow-up|11|||
156808583|NCT00142792|566052720|FG002|Overall Study|Lost to Follow-up|7|||
156808584|NCT00142792|566052718|FG000|Overall Study|No category|1|||
156808585|NCT00142792|566052719|FG001|Overall Study|No category|2|||
156808586|NCT00142792|566052720|FG002|Overall Study|No category|1|||
156808587|NCT03069716|566052721|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
156808588|NCT03069716|566052722|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
156808589|NCT03069716|566052723|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
156808590|NCT03069716|566052721|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
156808591|NCT03069716|566052722|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
156808592|NCT03069716|566052723|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
156808593|NCT03069716|566052721|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
156808594|NCT03069716|566052722|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
156808595|NCT03069716|566052723|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
156525370|NCT00719563|565019294|FG000|Overall Study|Adverse Event|16|||
156525371|NCT00719563|565019295|FG001|Overall Study|Adverse Event|13|||
156525372|NCT00719563|565019294|FG000|Overall Study|Medical condition changed|3|||
156667671|NCT04115293|565532351|FG000|Overall Study|Adverse Event|0|||
156667672|NCT04115293|565532352|FG001|Overall Study|Adverse Event|2|||
156667673|NCT04115293|565532351|FG000|Overall Study|Withdrawal by Subject|2|||
156667674|NCT04115293|565532352|FG001|Overall Study|Withdrawal by Subject|1|||
156667675|NCT04115293|565532351|FG000|Overall Study|Physician Decision|1|||
156808596|NCT03069716|566052721|FG000|Randomized Treatment|Withdrawal by Subject|0|||
156808597|NCT03069716|566052722|FG001|Randomized Treatment|Withdrawal by Subject|2|||
156808598|NCT03069716|566052723|FG002|Randomized Treatment|Withdrawal by Subject|0|||
156808599|NCT01673126|566052724|FG000|Overall Study|change of diagnosis|4|||
156808600|NCT01673126|566052725|FG001|Overall Study|change of diagnosis|3|||
156808601|NCT00237042|566052728|FG000|Treatment|Became ineligible post-randomization|0|||
156808602|NCT00237042|566052729|FG001|Treatment|Became ineligible post-randomization|1|||
156808603|NCT00237042|566052730|FG002|Treatment|Became ineligible post-randomization|16|||
156808604|NCT00237042|566052728|FG000|Treatment|Moved out of state|1|||
156808605|NCT00237042|566052729|FG001|Treatment|Moved out of state|1|||
156667676|NCT04115293|565532352|FG001|Overall Study|Physician Decision|0|||
156667677|NCT04115293|565532351|FG000|Overall Study|Death|1|||
156808606|NCT00237042|566052730|FG002|Treatment|Moved out of state|1|||
156808607|NCT00237042|566052728|FG000|Treatment|Completed no treatment|5|||
156808608|NCT00237042|566052729|FG001|Treatment|Completed no treatment|5|||
156525373|NCT00719563|565019295|FG001|Overall Study|Medical condition changed|5|||
156525374|NCT00719563|565019294|FG000|Overall Study|Lack of Efficacy|3|||
156525375|NCT00719563|565019295|FG001|Overall Study|Lack of Efficacy|7|||
156525376|NCT00719563|565019294|FG000|Overall Study|Personal reasons|6|||
156525377|NCT00719563|565019295|FG001|Overall Study|Personal reasons|7|||
156525378|NCT00719563|565019294|FG000|Overall Study|Unknown reasons|4|||
156525379|NCT00719563|565019295|FG001|Overall Study|Unknown reasons|6|||
156525380|NCT00719563|565019294|FG000|Overall Study|Noncompliant|1|||
156525381|NCT00719563|565019295|FG001|Overall Study|Noncompliant|1|||
156525382|NCT00719563|565019294|FG000|Overall Study|Lost to Follow-up|5|||
156525383|NCT00719563|565019295|FG001|Overall Study|Lost to Follow-up|3|||
156525384|NCT01386788|565019300|FG000|Overall Study|Lost to Follow-up|2|||
156525385|NCT00462865|565019301|FG000|Overall Study|Adverse Event|1|||
156525386|NCT02120625|565019303|FG000|Overall Study|Physician Decision|2|||
156525387|NCT04142450|565019304|FG000|Overall Study|Screen Failure|1|||
156525388|NCT04142450|565019304|FG000|Overall Study|Lost to Follow-up|1|||
156525389|NCT00120406|565019305|FG000|Overall Study|Death|9|||
156525390|NCT00120406|565019306|FG001|Overall Study|Death|4|||
156525391|NCT00120406|565019305|FG000|Overall Study|Withdrawal by Subject|5|||
156525392|NCT00120406|565019306|FG001|Overall Study|Withdrawal by Subject|7|||
156525393|NCT00120406|565019305|FG000|Overall Study|Lost to Follow-up|5|||
156525394|NCT00120406|565019306|FG001|Overall Study|Lost to Follow-up|2|||
156525395|NCT00120406|565019305|FG000|Overall Study|received non-study stent|0|||
156525396|NCT00120406|565019306|FG001|Overall Study|received non-study stent|2|||
156525397|NCT00120406|565019305|FG000|Overall Study|patient moved but has not withdrawn|0|||
156525398|NCT00120406|565019306|FG001|Overall Study|patient moved but has not withdrawn|1|||
156525399|NCT06336603|565019307|FG000|Overall Study|Withdrawal by Subject|1|||
156525400|NCT06336603|565019307|FG000|Overall Study|Lost to Follow-up|2|||
156525401|NCT00762970|565019313|FG000|Overall Study|Withdrawal by Subject|7|||
156525402|NCT00762970|565019314|FG001|Overall Study|Withdrawal by Subject|4|||
156525403|NCT00762970|565019315|FG002|Overall Study|Withdrawal by Subject|0|||
156525404|NCT00762970|565019313|FG000|Overall Study|Protocol Violation|3|||
156525405|NCT00762970|565019314|FG001|Overall Study|Protocol Violation|1|||
156525406|NCT00762970|565019315|FG002|Overall Study|Protocol Violation|1|||
156525407|NCT00762970|565019313|FG000|Overall Study|Lost to Follow-up|1|||
156525408|NCT00762970|565019314|FG001|Overall Study|Lost to Follow-up|2|||
156525409|NCT00762970|565019315|FG002|Overall Study|Lost to Follow-up|0|||
156525410|NCT00762970|565019313|FG000|Overall Study|Difficulty of handling lens|1|||
156525411|NCT00762970|565019314|FG001|Overall Study|Difficulty of handling lens|2|||
156525412|NCT00762970|565019315|FG002|Overall Study|Difficulty of handling lens|0|||
156525413|NCT01480674|565019316|FG000|Overall Study|Death|23|||
156525414|NCT01480674|565019316|FG000|Overall Study|Lost to Follow-up|2|||
156525415|NCT01480674|565019316|FG000|Overall Study|visit not done|10|||
156525416|NCT01295034|565019317|FG000|Overall Study|Lost to Follow-up|5|||
156525417|NCT01295034|565019318|FG001|Overall Study|Lost to Follow-up|5|||
156525418|NCT03249714|565019319|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
156525419|NCT03249714|565019320|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
156525420|NCT03249714|565019319|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
156525421|NCT03249714|565019320|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
156525422|NCT03249714|565019319|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
156525423|NCT03249714|565019320|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
156525424|NCT03249714|565019319|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
156525425|NCT03249714|565019320|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
156525426|NCT00879762|565019323|FG000|Overall Study|Lost to Follow-up|3|||
156525427|NCT00879762|565019324|FG001|Overall Study|Lost to Follow-up|1|||
156525428|NCT01313637|565019329|FG000|Overall Study|Adverse Event|17|||
156525429|NCT01313637|565019330|FG001|Overall Study|Adverse Event|24|||
156325982|NCT00145600|564294242|FG003|Overall Study|Lost to Follow-up|4|||
156325983|NCT00145600|564294239|FG000|Overall Study|Noncompliance|1|||
156325984|NCT00145600|564294240|FG001|Overall Study|Noncompliance|0|||
156325985|NCT00145600|564294241|FG002|Overall Study|Noncompliance|0|||
156325986|NCT00145600|564294242|FG003|Overall Study|Noncompliance|0|||
156325987|NCT00145600|564294239|FG000|Overall Study|Withdrawal by Subject|1|||
156325988|NCT00145600|564294240|FG001|Overall Study|Withdrawal by Subject|2|||
156325989|NCT00145600|564294241|FG002|Overall Study|Withdrawal by Subject|0|||
156325990|NCT00145600|564294242|FG003|Overall Study|Withdrawal by Subject|1|||
156325991|NCT04087213|564294243|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
156325992|NCT04087213|564294243|FG000|In-Facility Introduction|Adverse Event|1|||
156525430|NCT01313637|565019331|FG002|Overall Study|Adverse Event|25|||
156525431|NCT01313637|565019332|FG003|Overall Study|Adverse Event|18|||
156525432|NCT01313637|565019329|FG000|Overall Study|Lack of Efficacy|44|||
156525433|NCT01313637|565019330|FG001|Overall Study|Lack of Efficacy|38|||
156525434|NCT01313637|565019331|FG002|Overall Study|Lack of Efficacy|37|||
156525435|NCT01313637|565019332|FG003|Overall Study|Lack of Efficacy|24|||
156525436|NCT01313637|565019329|FG000|Overall Study|Protocol Violation|4|||
156325993|NCT04087213|564294243|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
156325994|NCT04087213|564294243|FG000|Assisted Evaluable Period|Personal reasons|3|||
156525437|NCT01313637|565019330|FG001|Overall Study|Protocol Violation|3|||
156778806|NCT00143507|565940583|FG000|Overall Study|Death|572|||
156778807|NCT00143507|565940584|FG001|Overall Study|Death|547|||
156778808|NCT00143507|565940583|FG000|Overall Study|Withdrawal by Subject|114|||
156778809|NCT00143507|565940584|FG001|Overall Study|Withdrawal by Subject|102|||
156778810|NCT00143507|565940583|FG000|Overall Study|Lost to Follow-up|1|||
156778811|NCT00143507|565940584|FG001|Overall Study|Lost to Follow-up|0|||
156778812|NCT00143507|565940583|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
156778813|NCT00143507|565940584|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
156778814|NCT00690898|565940585|FG000|SCREENING|Screen failure|18|||
156778815|NCT00690898|565940585|FG000|TREATMENT|Adverse Event|3|||
156778816|NCT00690898|565940585|FG000|TREATMENT|Lack of Efficacy|18|||
156778817|NCT00690898|565940585|FG000|TREATMENT|Withdrawal by Subject|4|||
156778818|NCT00690898|565940585|FG000|TREATMENT|Other (not otherwise specified)|1|||
156778819|NCT05977868|565940586|FG000|Overall Study|Withdrawal by Subject|1|||
156778820|NCT05977868|565940587|FG001|Overall Study|Withdrawal by Subject|2|||
156778821|NCT05977868|565940586|FG000|Overall Study|Transitioned to comfort care|1|||
156778822|NCT05977868|565940587|FG001|Overall Study|Transitioned to comfort care|0|||
156778823|NCT00970944|565940589|FG000|Overall Study|Death|1|||
156778824|NCT00970944|565940590|FG001|Overall Study|Death|0|||
156778825|NCT00970944|565940589|FG000|Overall Study|Physician Decision|0|||
156778826|NCT00970944|565940590|FG001|Overall Study|Physician Decision|2|||
156778827|NCT02008370|565940591|FG000|Overall Study|Lost to Follow-up|7|||
156778828|NCT00662259|565940592|FG000|Overall Study|Adverse Event|2|||
156778829|NCT00662259|565940593|FG001|Overall Study|Adverse Event|0|||
156778830|NCT00972738|565940594|FG000|Overall Study|Adverse Event|7|||
156778831|NCT00972738|565940595|FG001|Overall Study|Adverse Event|1|||
156778832|NCT00972738|565940596|FG002|Overall Study|Adverse Event|8|||
156778833|NCT00972738|565940594|FG000|Overall Study|Protocol Violation|2|||
156778834|NCT00972738|565940595|FG001|Overall Study|Protocol Violation|1|||
156778835|NCT00972738|565940596|FG002|Overall Study|Protocol Violation|3|||
156778836|NCT00972738|565940594|FG000|Overall Study|Lost to Follow-up|1|||
156778837|NCT00972738|565940595|FG001|Overall Study|Lost to Follow-up|0|||
156778838|NCT00972738|565940596|FG002|Overall Study|Lost to Follow-up|1|||
156778839|NCT00972738|565940594|FG000|Overall Study|Lack of Efficacy|5|||
156525438|NCT01313637|565019331|FG002|Overall Study|Protocol Violation|11|||
156525439|NCT01313637|565019332|FG003|Overall Study|Protocol Violation|5|||
156525440|NCT01313637|565019329|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
156525441|NCT01313637|565019330|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
156525442|NCT01313637|565019331|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
156525443|NCT01313637|565019332|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
156525444|NCT01313637|565019329|FG000|Overall Study|Lost to Follow-up|0|||
156525445|NCT01313637|565019330|FG001|Overall Study|Lost to Follow-up|2|||
156525446|NCT01313637|565019331|FG002|Overall Study|Lost to Follow-up|1|||
156525447|NCT01313637|565019332|FG003|Overall Study|Lost to Follow-up|3|||
156525448|NCT01313637|565019329|FG000|Overall Study|Withdrawal by Subject|11|||
156525449|NCT01313637|565019330|FG001|Overall Study|Withdrawal by Subject|13|||
156525450|NCT01313637|565019331|FG002|Overall Study|Withdrawal by Subject|18|||
156525451|NCT01313637|565019332|FG003|Overall Study|Withdrawal by Subject|15|||
156525452|NCT00795951|565019338|FG000|Overall Study|Lost to Follow-up|1|||
156525453|NCT00795951|565019338|FG000|Overall Study|Withdrawal by Subject|1|||
156525454|NCT04572841|565019340|FG000|Overall Study|Adverse Event|1|||
156525455|NCT04572841|565019341|FG001|Overall Study|Adverse Event|1|||
156525456|NCT04572841|565019340|FG000|Overall Study|Withdrawal by Subject|2|||
156525457|NCT04572841|565019341|FG001|Overall Study|Withdrawal by Subject|1|||
156525458|NCT04661878|565019342|FG000|Overall Study|Lost to Follow-up|6|||
156525459|NCT04661878|565019343|FG001|Overall Study|Lost to Follow-up|5|||
156525460|NCT00712673|565019346|FG000|Overall Study|Adverse Event|3|||
156525461|NCT00712673|565019347|FG001|Overall Study|Adverse Event|3|||
156525462|NCT00712673|565019348|FG002|Overall Study|Adverse Event|21|||
156667678|NCT04115293|565532352|FG001|Overall Study|Death|1|||
156667679|NCT02674152|565532353|FG000|Overall Study|Personal Reasons|1|||
156525463|NCT00712673|565019349|FG003|Overall Study|Adverse Event|26|||
156667680|NCT02674152|565532354|FG001|Overall Study|Personal Reasons|0|||
156778840|NCT00972738|565940595|FG001|Overall Study|Lack of Efficacy|1|||
156778841|NCT00972738|565940596|FG002|Overall Study|Lack of Efficacy|11|||
156778842|NCT00972738|565940594|FG000|Overall Study|Withdrawal by Subject|5|||
156778843|NCT00972738|565940595|FG001|Overall Study|Withdrawal by Subject|1|||
156778844|NCT00972738|565940596|FG002|Overall Study|Withdrawal by Subject|4|||
156778845|NCT00972738|565940594|FG000|Overall Study|Moved|0|||
156778846|NCT00972738|565940595|FG001|Overall Study|Moved|0|||
156778847|NCT00972738|565940596|FG002|Overall Study|Moved|1|||
156778848|NCT00972738|565940594|FG000|Overall Study|Other|1|||
156525464|NCT00712673|565019346|FG000|Overall Study|Lack of Efficacy|2|||
156525465|NCT00712673|565019347|FG001|Overall Study|Lack of Efficacy|8|||
156525466|NCT00712673|565019348|FG002|Overall Study|Lack of Efficacy|8|||
156778849|NCT00972738|565940595|FG001|Overall Study|Other|2|||
156525467|NCT00712673|565019349|FG003|Overall Study|Lack of Efficacy|6|||
156525468|NCT00712673|565019346|FG000|Overall Study|Poor Compliance to Protocol|3|||
156525469|NCT00712673|565019347|FG001|Overall Study|Poor Compliance to Protocol|3|||
156525470|NCT00712673|565019348|FG002|Overall Study|Poor Compliance to Protocol|4|||
156525471|NCT00712673|565019349|FG003|Overall Study|Poor Compliance to Protocol|16|||
156525472|NCT00712673|565019346|FG000|Overall Study|Lost to Follow-up|1|||
156525473|NCT00712673|565019347|FG001|Overall Study|Lost to Follow-up|0|||
156525474|NCT00712673|565019348|FG002|Overall Study|Lost to Follow-up|2|||
156525475|NCT00712673|565019349|FG003|Overall Study|Lost to Follow-up|0|||
156525476|NCT00712673|565019346|FG000|Overall Study|Withdrawal by Subject|6|||
156525477|NCT00712673|565019347|FG001|Overall Study|Withdrawal by Subject|7|||
156525478|NCT00712673|565019348|FG002|Overall Study|Withdrawal by Subject|15|||
156525479|NCT00712673|565019349|FG003|Overall Study|Withdrawal by Subject|20|||
156525480|NCT00712673|565019346|FG000|Overall Study|Familial and Personal Reasons|5|||
156525481|NCT00712673|565019347|FG001|Overall Study|Familial and Personal Reasons|0|||
156525482|NCT00712673|565019348|FG002|Overall Study|Familial and Personal Reasons|5|||
156525483|NCT00712673|565019349|FG003|Overall Study|Familial and Personal Reasons|2|||
156525484|NCT00712673|565019346|FG000|Overall Study|Investigator's Decision|1|||
156525485|NCT00712673|565019347|FG001|Overall Study|Investigator's Decision|0|||
156525486|NCT00712673|565019348|FG002|Overall Study|Investigator's Decision|0|||
156525487|NCT00712673|565019349|FG003|Overall Study|Investigator's Decision|0|||
156525488|NCT00712673|565019346|FG000|Overall Study|Protocol Violation|0|||
156525489|NCT00712673|565019347|FG001|Overall Study|Protocol Violation|0|||
156525490|NCT00712673|565019348|FG002|Overall Study|Protocol Violation|2|||
156525491|NCT00712673|565019349|FG003|Overall Study|Protocol Violation|0|||
156525492|NCT01323647|565019350|FG000|Overall Study|Migrated/moved from study area|2|||
156525493|NCT01323647|565019351|FG001|Overall Study|Migrated/moved from study area|0|||
156525494|NCT01323647|565019350|FG000|Overall Study|Withdrawal by Subject|5|||
156525495|NCT01323647|565019351|FG001|Overall Study|Withdrawal by Subject|0|||
156525496|NCT01323647|565019350|FG000|Overall Study|Lost to Follow-up|2|||
156525497|NCT01323647|565019351|FG001|Overall Study|Lost to Follow-up|0|||
156525498|NCT03603028|565019352|FG000|Overall Study|Withdrawal by Subject|1|||
156525499|NCT02768870|565019355|FG000|Overall Study|Death|1|||
156525500|NCT02768870|565019355|FG000|Overall Study|Reoperation|6|||
156525501|NCT02768870|565019355|FG000|Overall Study|Lost to Follow-up|1|||
156525502|NCT02768870|565019355|FG000|Overall Study|Exit|4|||
156525503|NCT02963610|565019356|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
156525504|NCT00063154|565019357|FG000|Overall Study|Disease progression|27|||
156778850|NCT00972738|565940596|FG002|Overall Study|Other|1|||
156778851|NCT03915067|565940598|FG000|Overall Study|Adverse Event|0|||
156778852|NCT03915067|565940599|FG001|Overall Study|Adverse Event|0|||
156778853|NCT03915067|565940600|FG002|Overall Study|Adverse Event|1|||
156778854|NCT03915067|565940598|FG000|Overall Study|Withdrawal by Subject|4|||
156778855|NCT03915067|565940599|FG001|Overall Study|Withdrawal by Subject|3|||
156778856|NCT03915067|565940600|FG002|Overall Study|Withdrawal by Subject|0|||
156778857|NCT03915067|565940598|FG000|Overall Study|Lost to Follow-up|3|||
156778858|NCT03915067|565940599|FG001|Overall Study|Lost to Follow-up|2|||
156778859|NCT03915067|565940600|FG002|Overall Study|Lost to Follow-up|0|||
156778860|NCT03915067|565940598|FG000|Overall Study|Protocol Deviation|0|||
156778861|NCT03915067|565940599|FG001|Overall Study|Protocol Deviation|0|||
156778862|NCT03915067|565940600|FG002|Overall Study|Protocol Deviation|1|||
156778863|NCT03915067|565940598|FG000|Overall Study|Covid-19 Related Issues|2|||
156778864|NCT03915067|565940599|FG001|Overall Study|Covid-19 Related Issues|4|||
156778865|NCT03915067|565940600|FG002|Overall Study|Covid-19 Related Issues|4|||
156778866|NCT03915067|565940598|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
156778867|NCT03915067|565940599|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
156778868|NCT03915067|565940600|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
156778869|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
156778870|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
156778871|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
156778872|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
156778873|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
156778874|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
156778875|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
156778876|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
156778877|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
156778878|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
156778879|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Death|0|||
156778880|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Death|0|||
156778881|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Death|1|||
156778882|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Death|0|||
156778883|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Death|0|||
156778884|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
156778885|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
156778886|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
156778887|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
156778888|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
156525505|NCT00063154|565019357|FG000|Overall Study|Adverse Event|2|||
156667681|NCT02674152|565532355|FG002|Overall Study|Personal Reasons|0|||
156778889|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Other|2|||
156778890|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Other|1|||
156778891|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Other|0|||
156778892|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Other|0|||
156778893|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Other|0|||
156778894|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
156778895|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
156778896|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
156778897|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
156778898|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
156778899|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
156778900|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
156778901|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
156778902|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
156778903|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
156778904|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
156778905|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
156778906|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
156778907|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
156778908|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
156778909|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
156778910|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
156778911|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
156778912|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
156778913|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
156778914|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
156778915|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
156778916|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
156778917|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
156778918|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
156778919|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
156778920|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
156778921|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
156778922|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
156778923|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
156778924|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
156778925|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
156778926|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
156778927|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
156778928|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
156778929|NCT03317496|565940601|FG000|Phase 2: Treatment|Adverse Event|0|||
156778930|NCT03317496|565940602|FG001|Phase 2: Treatment|Adverse Event|0|||
156778931|NCT03317496|565940603|FG002|Phase 2: Treatment|Adverse Event|0|||
156778932|NCT03317496|565940604|FG003|Phase 2: Treatment|Adverse Event|0|||
156778933|NCT03317496|565940605|FG004|Phase 2: Treatment|Adverse Event|6|||
156778934|NCT03317496|565940601|FG000|Phase 2: Treatment|Progressive disease|0|||
156778935|NCT03317496|565940602|FG001|Phase 2: Treatment|Progressive disease|0|||
156778936|NCT03317496|565940603|FG002|Phase 2: Treatment|Progressive disease|0|||
156778937|NCT03317496|565940604|FG003|Phase 2: Treatment|Progressive disease|0|||
156778938|NCT03317496|565940605|FG004|Phase 2: Treatment|Progressive disease|22|||
156778939|NCT03317496|565940601|FG000|Phase 2: Treatment|Other|0|||
156778940|NCT03317496|565940602|FG001|Phase 2: Treatment|Other|0|||
156778941|NCT03317496|565940603|FG002|Phase 2: Treatment|Other|0|||
156778942|NCT03317496|565940604|FG003|Phase 2: Treatment|Other|0|||
156778943|NCT03317496|565940605|FG004|Phase 2: Treatment|Other|4|||
156778944|NCT03317496|565940601|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
156778945|NCT03317496|565940602|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
156778946|NCT03317496|565940603|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
156430121|NCT03451851|564663360|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
156430122|NCT03451851|564663361|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
156430123|NCT03451851|564663362|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
156430124|NCT03451851|564663363|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
156430125|NCT03451851|564663364|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
156430126|NCT03451851|564663365|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
156430127|NCT07214922|564663368|FG000|Overall Study|Adverse Event|0|||
156430128|NCT07214922|564663369|FG001|Overall Study|Adverse Event|0|||
156430129|NCT07214922|564663370|FG002|Overall Study|Adverse Event|1|||
156667682|NCT02674152|565532356|FG003|Overall Study|Personal Reasons|1|||
156430130|NCT07214922|564663371|FG003|Overall Study|Adverse Event|0|||
156778947|NCT03317496|565940604|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
156778948|NCT03317496|565940605|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
156778949|NCT03317496|565940601|FG000|Phase 2: Treatment|Physician Decision|0|||
156778950|NCT03317496|565940602|FG001|Phase 2: Treatment|Physician Decision|0|||
156778951|NCT03317496|565940603|FG002|Phase 2: Treatment|Physician Decision|0|||
156778952|NCT03317496|565940604|FG003|Phase 2: Treatment|Physician Decision|0|||
156778953|NCT03317496|565940605|FG004|Phase 2: Treatment|Physician Decision|1|||
156778954|NCT03317496|565940601|FG000|Phase 2: Treatment|Death|0|||
156778955|NCT03317496|565940602|FG001|Phase 2: Treatment|Death|0|||
156778956|NCT03317496|565940603|FG002|Phase 2: Treatment|Death|0|||
156778957|NCT03317496|565940604|FG003|Phase 2: Treatment|Death|0|||
156778958|NCT03317496|565940605|FG004|Phase 2: Treatment|Death|1|||
156778959|NCT03317496|565940601|FG000|Phase 2: Follow-up|Death|0|||
156778960|NCT03317496|565940602|FG001|Phase 2: Follow-up|Death|0|||
156430131|NCT07214922|564663368|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
156430132|NCT07214922|564663369|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
156430133|NCT07214922|564663370|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
156430134|NCT07214922|564663371|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
156430135|NCT00567879|564664543|FG000|Overall Study|Adverse Event|2|||
156430136|NCT00567879|564664544|FG001|Overall Study|Adverse Event|0|||
156778961|NCT03317496|565940603|FG002|Phase 2: Follow-up|Death|0|||
156778962|NCT03317496|565940604|FG003|Phase 2: Follow-up|Death|0|||
156778963|NCT03317496|565940605|FG004|Phase 2: Follow-up|Death|24|||
156778964|NCT03317496|565940601|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
156430137|NCT00567879|564664545|FG002|Overall Study|Adverse Event|1|||
156430138|NCT00567879|564664546|FG003|Overall Study|Adverse Event|0|||
156430139|NCT00567879|564664547|FG004|Overall Study|Adverse Event|1|||
156430140|NCT00567879|564664548|FG005|Overall Study|Adverse Event|0|||
156430141|NCT00567879|564664543|FG000|Overall Study|Abnormal test procedure(s)|0|||
156430142|NCT00567879|564664544|FG001|Overall Study|Abnormal test procedure(s)|0|||
156430143|NCT00567879|564664545|FG002|Overall Study|Abnormal test procedure(s)|1|||
156430144|NCT00567879|564664546|FG003|Overall Study|Abnormal test procedure(s)|0|||
156778965|NCT03317496|565940602|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
156778966|NCT03317496|565940603|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
156778967|NCT03317496|565940604|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
156778968|NCT03317496|565940605|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
156778969|NCT03317496|565940601|FG000|Phase 2: Follow-up|Other|0|||
156778970|NCT03317496|565940602|FG001|Phase 2: Follow-up|Other|0|||
156778971|NCT03317496|565940603|FG002|Phase 2: Follow-up|Other|0|||
156778972|NCT03317496|565940604|FG003|Phase 2: Follow-up|Other|0|||
156778973|NCT03317496|565940605|FG004|Phase 2: Follow-up|Other|1|||
156778974|NCT03317496|565940601|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
156778975|NCT03317496|565940602|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
156778976|NCT03317496|565940603|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
156778977|NCT03317496|565940604|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
156778978|NCT03317496|565940605|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
156778979|NCT02693418|565940606|FG000|Overall Study|Lost to Follow-up|1|||
156778980|NCT02693418|565940607|FG001|Overall Study|Lost to Follow-up|2|||
156778981|NCT02693418|565940608|FG002|Overall Study|Lost to Follow-up|0|||
156778982|NCT02693418|565940609|FG003|Overall Study|Lost to Follow-up|0|||
156778983|NCT02693418|565940610|FG004|Overall Study|Lost to Follow-up|0|||
156778984|NCT02693418|565940606|FG000|Overall Study|Menses during study period|0|||
156778985|NCT02693418|565940607|FG001|Overall Study|Menses during study period|0|||
156778986|NCT02693418|565940608|FG002|Overall Study|Menses during study period|2|||
156778987|NCT02693418|565940609|FG003|Overall Study|Menses during study period|0|||
156525506|NCT00063154|565019357|FG000|Overall Study|Physician Decision|10|||
156525507|NCT00063154|565019357|FG000|Overall Study|Death|3|||
156525508|NCT00063154|565019357|FG000|Overall Study|Reason unspecified|1|||
156525509|NCT00063154|565019357|FG000|Overall Study|Did not receive treatment|8|||
156525510|NCT00640016|565019358|FG000|Overall Study|Withdrawal by Subject|0|||
156525511|NCT00640016|565019359|FG001|Overall Study|Withdrawal by Subject|1|||
156525512|NCT00640016|565019360|FG002|Overall Study|Withdrawal by Subject|0|||
156525513|NCT00640016|565019361|FG003|Overall Study|Withdrawal by Subject|0|||
156525514|NCT00640016|565019358|FG000|Overall Study|Study termination|2|||
156525515|NCT00640016|565019359|FG001|Overall Study|Study termination|1|||
156525516|NCT00640016|565019360|FG002|Overall Study|Study termination|3|||
156525517|NCT00640016|565019361|FG003|Overall Study|Study termination|2|||
156667683|NCT02674152|565532357|FG004|Overall Study|Personal Reasons|1|||
156778988|NCT02693418|565940610|FG004|Overall Study|Menses during study period|0|||
156778989|NCT01793935|565940617|FG000|Overall Study|Pregnancy|1|||
156430145|NCT00567879|564664547|FG004|Overall Study|Abnormal test procedure(s)|0|||
156430146|NCT00567879|564664548|FG005|Overall Study|Abnormal test procedure(s)|0|||
156430147|NCT00567879|564664543|FG000|Overall Study|Withdrawal by Subject|0|||
156430148|NCT00567879|564664544|FG001|Overall Study|Withdrawal by Subject|0|||
156430149|NCT00567879|564664545|FG002|Overall Study|Withdrawal by Subject|3|||
156430150|NCT00567879|564664546|FG003|Overall Study|Withdrawal by Subject|1|||
156430151|NCT00567879|564664547|FG004|Overall Study|Withdrawal by Subject|0|||
156778990|NCT01793935|565940618|FG001|Overall Study|Pregnancy|0|||
156525518|NCT00640016|565019358|FG000|Overall Study|Adverse Event|0|||
156525519|NCT00640016|565019359|FG001|Overall Study|Adverse Event|0|||
156778991|NCT01793935|565940617|FG000|Overall Study|Protocol Violation|2|||
156430152|NCT00567879|564664548|FG005|Overall Study|Withdrawal by Subject|0|||
156430153|NCT00567879|564664543|FG000|Overall Study|New cancer therapy|0|||
156430154|NCT00567879|564664544|FG001|Overall Study|New cancer therapy|0|||
156430155|NCT00567879|564664545|FG002|Overall Study|New cancer therapy|1|||
156430156|NCT00567879|564664546|FG003|Overall Study|New cancer therapy|0|||
156430157|NCT00567879|564664547|FG004|Overall Study|New cancer therapy|0|||
156430158|NCT00567879|564664548|FG005|Overall Study|New cancer therapy|0|||
156430159|NCT00567879|564664543|FG000|Overall Study|Disease progression|5|||
156430160|NCT00567879|564664544|FG001|Overall Study|Disease progression|7|||
156430161|NCT00567879|564664545|FG002|Overall Study|Disease progression|15|||
156430162|NCT00567879|564664546|FG003|Overall Study|Disease progression|5|||
156430163|NCT00567879|564664547|FG004|Overall Study|Disease progression|11|||
156430164|NCT00567879|564664548|FG005|Overall Study|Disease progression|3|||
156430165|NCT00470626|564664549|FG000|Overall Study|Lost to Follow-up|10|||
156430166|NCT00470626|564664549|FG000|Overall Study|Withdrawal by Subject|7|||
156430167|NCT01249092|564664551|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
156430168|NCT01249092|564664551|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
156430169|NCT02380742|564664552|FG000|Overall Study|Withdrawal by Subject|1|||
156430170|NCT02380742|564664553|FG001|Overall Study|Withdrawal by Subject|0|||
156430171|NCT03518112|564664556|FG000|Overall Study|Withdrawal by Subject|1|||
156430172|NCT01546155|564664557|FG000|Overall Study|could not tolerate long scan duration|3|||
156430173|NCT02930343|564664558|FG000|Overall Study|Lost to Follow-up|9|||
156430174|NCT02930343|564664559|FG001|Overall Study|Lost to Follow-up|7|||
156430175|NCT01729819|564664563|FG000|Overall Study|Adverse Event|2|||
156430176|NCT01729819|564664564|FG001|Overall Study|Adverse Event|4|||
156430177|NCT01729819|564664563|FG000|Overall Study|Lack of Efficacy|1|||
156430178|NCT01729819|564664564|FG001|Overall Study|Lack of Efficacy|0|||
156430179|NCT01729819|564664563|FG000|Overall Study|Lost to Follow-up|2|||
156430180|NCT01729819|564664564|FG001|Overall Study|Lost to Follow-up|0|||
156430181|NCT01729819|564664563|FG000|Overall Study|Other reason|1|||
156430182|NCT01729819|564664564|FG001|Overall Study|Other reason|0|||
156430183|NCT01729819|564664563|FG000|Overall Study|Protocol Violation|0|||
156430184|NCT01729819|564664564|FG001|Overall Study|Protocol Violation|1|||
156430185|NCT01729819|564664563|FG000|Overall Study|Withdrawal by Subject|0|||
156430186|NCT01729819|564664564|FG001|Overall Study|Withdrawal by Subject|2|||
156430187|NCT01025843|564664565|FG000|Washout 4|Withdrawal by Subject|0|||
156430188|NCT01025843|564664566|FG001|Washout 4|Withdrawal by Subject|0|||
156430189|NCT01025843|564664567|FG002|Washout 4|Withdrawal by Subject|1|||
156430190|NCT01025843|564664568|FG003|Washout 4|Withdrawal by Subject|1|||
156430191|NCT01025843|564664569|FG004|Washout 4|Withdrawal by Subject|0|||
156430192|NCT01025843|564664570|FG005|Washout 4|Withdrawal by Subject|0|||
156430193|NCT01025843|564664571|FG006|Washout 4|Withdrawal by Subject|0|||
156430194|NCT01025843|564664572|FG007|Washout 4|Withdrawal by Subject|0|||
156430195|NCT01025843|564664573|FG008|Washout 4|Withdrawal by Subject|0|||
156430196|NCT01025843|564664574|FG009|Washout 4|Withdrawal by Subject|0|||
156430197|NCT01649791|564664575|FG000|Overall Study|Disease Progression|2|||
156430198|NCT01649791|564664575|FG000|Overall Study|Adverse Event|1|||
156430199|NCT00364286|564664576|FG000|Overall Study|Withdrawal by Subject|1|||
156430200|NCT00364286|564664576|FG000|Overall Study|Adverse Event|2|||
156430201|NCT02814643|564664577|FG000|Overall Study|Lost to Follow-up|0|||
156430202|NCT02814643|564664578|FG001|Overall Study|Lost to Follow-up|1|||
156430203|NCT02814643|564664577|FG000|Overall Study|Withdrawal by Subject|1|||
156430204|NCT02814643|564664578|FG001|Overall Study|Withdrawal by Subject|2|||
156430205|NCT01227278|564664581|FG000|Overall Study|Withdrawal by Subject|4|||
156430206|NCT01227278|564664582|FG001|Overall Study|Withdrawal by Subject|4|||
156430207|NCT01227278|564664581|FG000|Overall Study|Death|0|||
156430208|NCT01227278|564664582|FG001|Overall Study|Death|2|||
156430209|NCT01227278|564664581|FG000|Overall Study|Other|1|||
156430210|NCT01227278|564664582|FG001|Overall Study|Other|2|||
156430211|NCT00420316|564664583|FG000|Overall Study|Withdrawal by Subject|0|||
156430212|NCT00420316|564664584|FG001|Overall Study|Withdrawal by Subject|1|||
156430213|NCT00420316|564664583|FG000|Overall Study|Lost to Follow-up|12|||
156430214|NCT00420316|564664584|FG001|Overall Study|Lost to Follow-up|8|||
156525520|NCT00640016|565019360|FG002|Overall Study|Adverse Event|0|||
156525521|NCT00640016|565019361|FG003|Overall Study|Adverse Event|1|||
156667684|NCT02674152|565532353|FG000|Overall Study|Other adverse event or clinical progression|0|||
156667685|NCT02674152|565532354|FG001|Overall Study|Other adverse event or clinical progression|1|||
156430215|NCT01281813|564664599|FG000|Overall Study|Adverse Event|0|||
156430216|NCT01281813|564664600|FG001|Overall Study|Adverse Event|0|||
156430217|NCT01281813|564664601|FG002|Overall Study|Adverse Event|10|||
156430218|NCT01281813|564664599|FG000|Overall Study|Lost to Follow-up|0|||
156430219|NCT01281813|564664600|FG001|Overall Study|Lost to Follow-up|0|||
156430220|NCT01281813|564664601|FG002|Overall Study|Lost to Follow-up|31|||
156430221|NCT01281813|564664599|FG000|Overall Study|Withdrawal by Subject|0|||
156430222|NCT01281813|564664600|FG001|Overall Study|Withdrawal by Subject|0|||
156430223|NCT01281813|564664601|FG002|Overall Study|Withdrawal by Subject|13|||
156525522|NCT02924064|565019363|FG000|Overall Study|Adverse Event|2|||
156430224|NCT01281813|564664599|FG000|Overall Study|Subject Non-Compliant|0|||
156430225|NCT01281813|564664600|FG001|Overall Study|Subject Non-Compliant|0|||
156430226|NCT01281813|564664601|FG002|Overall Study|Subject Non-Compliant|6|||
156430227|NCT01281813|564664599|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
156430228|NCT01281813|564664600|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
156430229|NCT01281813|564664601|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
156430230|NCT01281813|564664599|FG000|Overall Study|Sponsor's Decision|4|||
156430231|NCT01281813|564664600|FG001|Overall Study|Sponsor's Decision|3|||
156430232|NCT01281813|564664601|FG002|Overall Study|Sponsor's Decision|7|||
156430233|NCT01281813|564664599|FG000|Overall Study|Switched to Commercially Available Medication|0|||
156430234|NCT01281813|564664600|FG001|Overall Study|Switched to Commercially Available Medication|0|||
156430235|NCT01281813|564664601|FG002|Overall Study|Switched to Commercially Available Medication|26|||
156430236|NCT01281813|564664599|FG000|Overall Study|Other|0|||
156430237|NCT01281813|564664600|FG001|Overall Study|Other|1|||
156430238|NCT01281813|564664601|FG002|Overall Study|Other|39|||
156430239|NCT03546907|564664602|FG000|Overall Study|Lack of Efficacy|1|||
156430240|NCT03546907|564664603|FG001|Overall Study|Lack of Efficacy|1|||
156430241|NCT03546907|564664602|FG000|Overall Study|Withdrawal by Subject|8|||
156430242|NCT03546907|564664603|FG001|Overall Study|Withdrawal by Subject|9|||
156430243|NCT03546907|564664602|FG000|Overall Study|Adverse events (AEs)|7|||
156430244|NCT03546907|564664603|FG001|Overall Study|Adverse events (AEs)|10|||
156430245|NCT03546907|564664602|FG000|Overall Study|Other-unspecified|1|||
156430246|NCT03546907|564664603|FG001|Overall Study|Other-unspecified|1|||
156430247|NCT03720210|564664604|FG000|Overall Study|Lost to Follow-up|1|||
156430248|NCT04033432|564664605|FG000|Overall Study|Progressive Disease|8|||
156430249|NCT04033432|564664605|FG000|Overall Study|Adverse Event|4|||
156430250|NCT04033432|564664605|FG000|Overall Study|Death|1|||
156430251|NCT02274493|564664611|FG000|Overall Study|Withdrawal by Subject|1|||
156430252|NCT00558363|564664612|FG000|Overall Study|Physician Decision|18|||
156430253|NCT00558363|564664613|FG001|Overall Study|Physician Decision|4|||
156430254|NCT00558363|564664612|FG000|Overall Study|Withdrawal by Subject|11|||
156430255|NCT00558363|564664613|FG001|Overall Study|Withdrawal by Subject|4|||
156430256|NCT00558363|564664612|FG000|Overall Study|Adverse Event|5|||
156430257|NCT00558363|564664613|FG001|Overall Study|Adverse Event|5|||
156430258|NCT00558363|564664612|FG000|Overall Study|Lack of Efficacy|2|||
156430259|NCT00558363|564664613|FG001|Overall Study|Lack of Efficacy|2|||
156430260|NCT00558363|564664612|FG000|Overall Study|Protocol Violation|2|||
156430261|NCT00558363|564664613|FG001|Overall Study|Protocol Violation|1|||
156430262|NCT00558363|564664612|FG000|Overall Study|Lost to Follow-up|0|||
156430263|NCT00558363|564664613|FG001|Overall Study|Lost to Follow-up|1|||
156430264|NCT00558363|564664612|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
156430265|NCT00558363|564664613|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
156430266|NCT00558363|564664612|FG000|Overall Study|Randomized in Error|1|||
156430267|NCT00558363|564664613|FG001|Overall Study|Randomized in Error|2|||
156430268|NCT00558363|564664612|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
156430269|NCT00558363|564664613|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
156430270|NCT02174562|564664614|FG000|Overall Study|Withdrawal by Subject|7|||
156430271|NCT02174562|564664615|FG001|Overall Study|Withdrawal by Subject|2|||
156430272|NCT02174562|564664614|FG000|Overall Study|Death|2|||
156430273|NCT02174562|564664615|FG001|Overall Study|Death|0|||
156430274|NCT02174562|564664614|FG000|Overall Study|Lost to Follow-up|0|||
156430275|NCT02174562|564664615|FG001|Overall Study|Lost to Follow-up|3|||
156430276|NCT03201809|564664616|FG000|Overall Study|Lost to Follow-up|2|||
156430277|NCT03201809|564664617|FG001|Overall Study|Lost to Follow-up|0|||
156430278|NCT01651949|564664619|FG000|Overall Study|Unknown status|4|||
156430279|NCT01651949|564664620|FG001|Overall Study|Unknown status|4|||
156430280|NCT01651949|564664621|FG002|Overall Study|Unknown status|0|||
156430281|NCT01651949|564664619|FG000|Overall Study|Lost to Follow-up|30|||
156430282|NCT01651949|564664620|FG001|Overall Study|Lost to Follow-up|56|||
156430283|NCT01651949|564664621|FG002|Overall Study|Lost to Follow-up|20|||
156430284|NCT01651949|564664619|FG000|Overall Study|Protocol Violation|0|||
156430285|NCT01651949|564664620|FG001|Overall Study|Protocol Violation|2|||
156430286|NCT01651949|564664621|FG002|Overall Study|Protocol Violation|1|||
156430287|NCT01651949|564664619|FG000|Overall Study|Physician Decision|0|||
156430288|NCT01651949|564664620|FG001|Overall Study|Physician Decision|2|||
156430289|NCT01651949|564664621|FG002|Overall Study|Physician Decision|0|||
156430290|NCT01651949|564664619|FG000|Overall Study|Adverse Event|0|||
156430291|NCT01651949|564664620|FG001|Overall Study|Adverse Event|2|||
156430292|NCT01651949|564664621|FG002|Overall Study|Adverse Event|1|||
156430293|NCT01651949|564664619|FG000|Overall Study|Screen failure|2|||
156430294|NCT01651949|564664620|FG001|Overall Study|Screen failure|2|||
156430295|NCT01651949|564664621|FG002|Overall Study|Screen failure|0|||
156430296|NCT01651949|564664619|FG000|Overall Study|Withdrawal by Subject|17|||
156430297|NCT01651949|564664620|FG001|Overall Study|Withdrawal by Subject|18|||
156430298|NCT01651949|564664621|FG002|Overall Study|Withdrawal by Subject|9|||
156430299|NCT02155829|564664624|FG000|Overall Study|Adverse Event|1|||
156430300|NCT02155829|564664625|FG001|Overall Study|Adverse Event|0|||
156430301|NCT02155829|564664624|FG000|Overall Study|Withdrawal by Subject|3|||
156430302|NCT02155829|564664625|FG001|Overall Study|Withdrawal by Subject|3|||
156430303|NCT02155829|564664624|FG000|Overall Study|Protocol Violation|2|||
156430304|NCT02155829|564664625|FG001|Overall Study|Protocol Violation|0|||
156430305|NCT00771849|564664626|FG000|Overall Study|Lost to Follow-up|1|||
156430306|NCT00771849|564664627|FG001|Overall Study|Lost to Follow-up|2|||
156430307|NCT00771849|564664626|FG000|Overall Study|Withdrawal by Subject|1|||
156430308|NCT00771849|564664627|FG001|Overall Study|Withdrawal by Subject|1|||
156430309|NCT00771849|564664626|FG000|Overall Study|Not vaccinated|0|||
156430310|NCT00771849|564664627|FG001|Overall Study|Not vaccinated|1|||
156430311|NCT03058991|564664632|FG000|Overall Study|Lost to Follow-up|17|||
156430312|NCT03058991|564664633|FG001|Overall Study|Lost to Follow-up|12|||
156430313|NCT03058991|564664634|FG002|Overall Study|Lost to Follow-up|12|||
156430314|NCT03058991|564664632|FG000|Overall Study|Withdrawal by Subject|1|||
156430315|NCT03058991|564664633|FG001|Overall Study|Withdrawal by Subject|0|||
156430316|NCT03058991|564664634|FG002|Overall Study|Withdrawal by Subject|0|||
156430317|NCT01689519|564664635|FG000|Intent to Treat|Death|157|||
156430318|NCT01689519|564664636|FG001|Intent to Treat|Death|167|||
156430319|NCT01689519|564664635|FG000|Intent to Treat|Lost to Follow-up|4|||
156430320|NCT01689519|564664636|FG001|Intent to Treat|Lost to Follow-up|8|||
156430321|NCT01689519|564664635|FG000|Intent to Treat|Other|2|||
156430322|NCT01689519|564664636|FG001|Intent to Treat|Other|4|||
156430323|NCT01689519|564664635|FG000|Intent to Treat|Physician Decision|4|||
156430324|NCT01689519|564664636|FG001|Intent to Treat|Physician Decision|1|||
156430325|NCT01689519|564664635|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
156430326|NCT01689519|564664636|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
156430327|NCT01689519|564664635|FG000|Intent to Treat|Withdrawal by Subject|21|||
156430328|NCT01689519|564664636|FG001|Intent to Treat|Withdrawal by Subject|20|||
156430329|NCT01689519|564664635|FG000|Safety Population|Death|158|||
156430330|NCT01689519|564664636|FG001|Safety Population|Death|165|||
156430331|NCT01689519|564664635|FG000|Safety Population|Lost to Follow-up|4|||
156430332|NCT01689519|564664636|FG001|Safety Population|Lost to Follow-up|8|||
156430333|NCT01689519|564664635|FG000|Safety Population|Other|2|||
156430334|NCT01689519|564664636|FG001|Safety Population|Other|4|||
156430335|NCT01689519|564664635|FG000|Safety Population|Physician Decision|4|||
156430336|NCT01689519|564664636|FG001|Safety Population|Physician Decision|1|||
156430337|NCT01689519|564664635|FG000|Safety Population|Study Terminated By Sponsor|60|||
156430338|NCT01689519|564664636|FG001|Safety Population|Study Terminated By Sponsor|47|||
156430339|NCT01689519|564664635|FG000|Safety Population|Withdrawal by Subject|20|||
156430340|NCT01689519|564664636|FG001|Safety Population|Withdrawal by Subject|20|||
156430341|NCT02982213|564664641|FG000|Overall Study|Did not complete follow up questionnaire|5|||
156430342|NCT02982213|564664642|FG001|Overall Study|Did not complete follow up questionnaire|1|||
156430343|NCT01549652|564664644|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
156430344|NCT01549652|564664645|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
156430345|NCT01549652|564664646|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
156430346|NCT01549652|564664647|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
156430347|NCT01549652|564664644|FG000|Overall Study|Study Drug Titration Failure|5|||
156430348|NCT01549652|564664645|FG001|Overall Study|Study Drug Titration Failure|6|||
156430349|NCT01549652|564664646|FG002|Overall Study|Study Drug Titration Failure|0|||
156430350|NCT01549652|564664647|FG003|Overall Study|Study Drug Titration Failure|0|||
156430351|NCT01549652|564664644|FG000|Overall Study|Withdrawal Effect|0|||
156430352|NCT01549652|564664645|FG001|Overall Study|Withdrawal Effect|2|||
156430353|NCT01549652|564664646|FG002|Overall Study|Withdrawal Effect|0|||
156430354|NCT01549652|564664647|FG003|Overall Study|Withdrawal Effect|0|||
156430355|NCT01549652|564664644|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
156430356|NCT01549652|564664645|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
156430357|NCT01549652|564664646|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
156430358|NCT01549652|564664647|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
156430359|NCT01549652|564664644|FG000|Overall Study|Problem with Infusion|1|||
156430360|NCT01549652|564664645|FG001|Overall Study|Problem with Infusion|0|||
156430361|NCT01549652|564664646|FG002|Overall Study|Problem with Infusion|0|||
156430362|NCT01549652|564664647|FG003|Overall Study|Problem with Infusion|0|||
156430363|NCT01549652|564664644|FG000|Overall Study|Titration Non-Compliance|1|||
156525523|NCT02924064|565019364|FG001|Overall Study|Adverse Event|2|||
156525524|NCT02924064|565019363|FG000|Overall Study|Lost to Follow-up|0|||
156430364|NCT01549652|564664645|FG001|Overall Study|Titration Non-Compliance|3|||
156430365|NCT01549652|564664646|FG002|Overall Study|Titration Non-Compliance|4|||
156525525|NCT02924064|565019364|FG001|Overall Study|Lost to Follow-up|2|||
156525526|NCT02924064|565019363|FG000|Overall Study|Physician Decision|0|||
156430366|NCT01549652|564664647|FG003|Overall Study|Titration Non-Compliance|5|||
156430367|NCT01549652|564664644|FG000|Overall Study|Titration Side Effects|0|||
156430368|NCT01549652|564664645|FG001|Overall Study|Titration Side Effects|0|||
156430369|NCT01549652|564664646|FG002|Overall Study|Titration Side Effects|6|||
156430370|NCT01549652|564664647|FG003|Overall Study|Titration Side Effects|3|||
156430371|NCT01549652|564664644|FG000|Overall Study|Withdrawal by Subject|0|||
156430372|NCT01549652|564664645|FG001|Overall Study|Withdrawal by Subject|0|||
156430373|NCT01549652|564664646|FG002|Overall Study|Withdrawal by Subject|5|||
156525527|NCT02924064|565019364|FG001|Overall Study|Physician Decision|2|||
156525528|NCT02924064|565019363|FG000|Overall Study|Protocol Violation|1|||
156325995|NCT04087213|564294243|FG000|Transition Period B|Renal Transplantation|1|||
156325996|NCT00735254|564294248|FG000|Overall Study|Protocol Violation|1|||
156325997|NCT00735254|564294249|FG001|Overall Study|Protocol Violation|1|||
156325998|NCT00735254|564294250|FG002|Overall Study|Protocol Violation|1|||
156325999|NCT00735254|564294251|FG003|Overall Study|Protocol Violation|0|||
156326000|NCT06400979|564294255|FG000|Overall Study|Lost to Follow-up|29|||
156326001|NCT06400979|564294255|FG000|Overall Study|Withdrawal by Subject|1|||
156326002|NCT02694523|564294256|FG000|Part A|Adverse Event|7|||
156326003|NCT02694523|564294257|FG001|Part A|Adverse Event|3|||
156326004|NCT02694523|564294258|FG002|Part A|Adverse Event|0|||
156430374|NCT01549652|564664647|FG003|Overall Study|Withdrawal by Subject|3|||
156430375|NCT00835380|564664654|FG000|Overall Study|Withdrawal by Subject|2|||
156430376|NCT03247543|564664655|FG000|Overall Study|Adverse Event|3|||
156430377|NCT03247543|564664656|FG001|Overall Study|Adverse Event|6|||
156430378|NCT03247543|564664657|FG002|Overall Study|Adverse Event|4|||
156430379|NCT03247543|564664655|FG000|Overall Study|Lost to Follow-up|10|||
156430380|NCT03247543|564664656|FG001|Overall Study|Lost to Follow-up|7|||
156430381|NCT03247543|564664657|FG002|Overall Study|Lost to Follow-up|8|||
156430382|NCT03247543|564664655|FG000|Overall Study|Consent withdrawn by caregiver|2|||
156430383|NCT03247543|564664656|FG001|Overall Study|Consent withdrawn by caregiver|2|||
156430384|NCT03247543|564664657|FG002|Overall Study|Consent withdrawn by caregiver|9|||
156430385|NCT03247543|564664655|FG000|Overall Study|Withdrawal by Subject|0|||
156430386|NCT03247543|564664656|FG001|Overall Study|Withdrawal by Subject|0|||
156430387|NCT03247543|564664657|FG002|Overall Study|Withdrawal by Subject|1|||
156430388|NCT03247543|564664655|FG000|Overall Study|Failure to Follow study procedures|1|||
156430389|NCT03247543|564664656|FG001|Overall Study|Failure to Follow study procedures|3|||
156430390|NCT03247543|564664657|FG002|Overall Study|Failure to Follow study procedures|1|||
156430391|NCT03247543|564664655|FG000|Overall Study|Lack of Efficacy|1|||
156430392|NCT03247543|564664656|FG001|Overall Study|Lack of Efficacy|0|||
156430393|NCT03247543|564664657|FG002|Overall Study|Lack of Efficacy|0|||
156430394|NCT03247543|564664655|FG000|Overall Study|Non-compliance with study visits|0|||
156430395|NCT03247543|564664656|FG001|Overall Study|Non-compliance with study visits|1|||
156430396|NCT03247543|564664657|FG002|Overall Study|Non-compliance with study visits|0|||
156430397|NCT02059980|564664664|FG000|Overall Study|Lost to Follow-up|2|||
156525529|NCT02924064|565019364|FG001|Overall Study|Protocol Violation|3|||
156525530|NCT02924064|565019363|FG000|Overall Study|Withdrawal by Subject|4|||
156525531|NCT02924064|565019364|FG001|Overall Study|Withdrawal by Subject|5|||
156525532|NCT02924064|565019363|FG000|Overall Study|Other|17|||
156525533|NCT02924064|565019364|FG001|Overall Study|Other|29|||
156326005|NCT02694523|564294259|FG003|Part A|Adverse Event|0|||
156326006|NCT02694523|564294260|FG004|Part A|Adverse Event|0|||
156326007|NCT02694523|564294261|FG005|Part A|Adverse Event|0|||
156326008|NCT02694523|564294262|FG006|Part A|Adverse Event|0|||
156326009|NCT02694523|564294256|FG000|Part A|Protocol Violation|1|||
156326010|NCT02694523|564294257|FG001|Part A|Protocol Violation|0|||
156326011|NCT02694523|564294258|FG002|Part A|Protocol Violation|0|||
156326012|NCT02694523|564294259|FG003|Part A|Protocol Violation|0|||
156326013|NCT02694523|564294260|FG004|Part A|Protocol Violation|0|||
156326014|NCT02694523|564294261|FG005|Part A|Protocol Violation|0|||
156326015|NCT02694523|564294262|FG006|Part A|Protocol Violation|0|||
156326016|NCT02694523|564294256|FG000|Part A|Lost to Follow-up|1|||
156326017|NCT02694523|564294257|FG001|Part A|Lost to Follow-up|2|||
156326018|NCT02694523|564294258|FG002|Part A|Lost to Follow-up|0|||
156326019|NCT02694523|564294259|FG003|Part A|Lost to Follow-up|0|||
156326020|NCT02694523|564294260|FG004|Part A|Lost to Follow-up|0|||
156326021|NCT02694523|564294261|FG005|Part A|Lost to Follow-up|0|||
156326022|NCT02694523|564294262|FG006|Part A|Lost to Follow-up|0|||
156326023|NCT02694523|564294256|FG000|Part A|Withdrawal by Subject|3|||
156326024|NCT02694523|564294257|FG001|Part A|Withdrawal by Subject|1|||
156326025|NCT02694523|564294258|FG002|Part A|Withdrawal by Subject|0|||
156326026|NCT02694523|564294259|FG003|Part A|Withdrawal by Subject|0|||
156326027|NCT02694523|564294260|FG004|Part A|Withdrawal by Subject|0|||
156326028|NCT02694523|564294261|FG005|Part A|Withdrawal by Subject|0|||
156326029|NCT02694523|564294262|FG006|Part A|Withdrawal by Subject|0|||
156326030|NCT02694523|564294256|FG000|Part A|Other|1|||
156326031|NCT02694523|564294257|FG001|Part A|Other|1|||
156326032|NCT02694523|564294258|FG002|Part A|Other|0|||
156326033|NCT02694523|564294259|FG003|Part A|Other|0|||
156326034|NCT02694523|564294260|FG004|Part A|Other|0|||
156430398|NCT02059980|564664665|FG001|Overall Study|Lost to Follow-up|1|||
156430399|NCT01321606|564664666|FG000|Overall Study|Lost to Follow-up|0|||
156430400|NCT01321606|564664667|FG001|Overall Study|Lost to Follow-up|0|||
156430401|NCT01321606|564664668|FG002|Overall Study|Lost to Follow-up|0|||
156326035|NCT02694523|564294261|FG005|Part A|Other|0|||
156430402|NCT01321606|564664669|FG003|Overall Study|Lost to Follow-up|1|||
156430403|NCT01253226|564664670|FG000|Overall Study|Adverse Event|0|||
156525534|NCT02699983|565019365|FG000|Overall Study|Withdrawal by Subject|1|||
156326036|NCT02694523|564294262|FG006|Part A|Other|0|||
156326037|NCT02694523|564294256|FG000|Part B|Adverse Event|0|||
156326038|NCT02694523|564294257|FG001|Part B|Adverse Event|0|||
156326039|NCT02694523|564294258|FG002|Part B|Adverse Event|7|||
156326040|NCT02694523|564294259|FG003|Part B|Adverse Event|1|||
156430404|NCT01253226|564664671|FG001|Overall Study|Adverse Event|0|||
156430405|NCT01253226|564664672|FG002|Overall Study|Adverse Event|1|||
156430406|NCT01253226|564664673|FG003|Overall Study|Adverse Event|0|||
156430407|NCT01253226|564664674|FG004|Overall Study|Adverse Event|0|||
156430408|NCT01253226|564664670|FG000|Overall Study|Death|0|||
156430409|NCT01253226|564664671|FG001|Overall Study|Death|1|||
156430410|NCT01253226|564664672|FG002|Overall Study|Death|0|||
156430411|NCT01253226|564664673|FG003|Overall Study|Death|0|||
156430412|NCT01253226|564664674|FG004|Overall Study|Death|0|||
156430413|NCT01253226|564664670|FG000|Overall Study|Physician Decision|0|||
156430414|NCT01253226|564664671|FG001|Overall Study|Physician Decision|0|||
156430415|NCT01253226|564664672|FG002|Overall Study|Physician Decision|0|||
156430416|NCT01253226|564664673|FG003|Overall Study|Physician Decision|0|||
156430417|NCT01253226|564664674|FG004|Overall Study|Physician Decision|2|||
156326041|NCT02694523|564294260|FG004|Part B|Adverse Event|1|||
156326042|NCT02694523|564294261|FG005|Part B|Adverse Event|2|||
156326043|NCT02694523|564294262|FG006|Part B|Adverse Event|0|||
156326044|NCT02694523|564294256|FG000|Part B|Protocol Violation|0|||
156326045|NCT02694523|564294257|FG001|Part B|Protocol Violation|0|||
156326046|NCT02694523|564294258|FG002|Part B|Protocol Violation|1|||
156326047|NCT02694523|564294259|FG003|Part B|Protocol Violation|0|||
156326048|NCT02694523|564294260|FG004|Part B|Protocol Violation|0|||
156326049|NCT02694523|564294261|FG005|Part B|Protocol Violation|0|||
156326050|NCT02694523|564294262|FG006|Part B|Protocol Violation|0|||
156326051|NCT02694523|564294256|FG000|Part B|Lost to Follow-up|0|||
156326052|NCT02694523|564294257|FG001|Part B|Lost to Follow-up|0|||
156326053|NCT02694523|564294258|FG002|Part B|Lost to Follow-up|2|||
156326054|NCT02694523|564294259|FG003|Part B|Lost to Follow-up|3|||
156326055|NCT02694523|564294260|FG004|Part B|Lost to Follow-up|2|||
156326056|NCT02694523|564294261|FG005|Part B|Lost to Follow-up|0|||
156326057|NCT02694523|564294262|FG006|Part B|Lost to Follow-up|1|||
156326058|NCT02694523|564294256|FG000|Part B|Withdrawal by Subject|0|||
156326059|NCT02694523|564294257|FG001|Part B|Withdrawal by Subject|0|||
156326060|NCT02694523|564294258|FG002|Part B|Withdrawal by Subject|9|||
156326061|NCT02694523|564294259|FG003|Part B|Withdrawal by Subject|0|||
156326062|NCT02694523|564294260|FG004|Part B|Withdrawal by Subject|1|||
156326063|NCT02694523|564294261|FG005|Part B|Withdrawal by Subject|3|||
156326064|NCT02694523|564294262|FG006|Part B|Withdrawal by Subject|0|||
156326065|NCT02694523|564294256|FG000|Part B|Other|0|||
156326066|NCT02694523|564294257|FG001|Part B|Other|0|||
156326067|NCT02694523|564294258|FG002|Part B|Other|1|||
156326068|NCT02694523|564294259|FG003|Part B|Other|0|||
156326069|NCT02694523|564294260|FG004|Part B|Other|0|||
156326070|NCT02694523|564294261|FG005|Part B|Other|0|||
156326071|NCT02694523|564294262|FG006|Part B|Other|1|||
156326072|NCT00573248|564294267|FG000|Overall Study|scheduling conflicts|15|||
156326073|NCT00573248|564294268|FG001|Overall Study|scheduling conflicts|11|||
156326074|NCT04505540|564294269|FG000|Baseline|Protocol Violation|10|||
156326075|NCT04505540|564294269|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
156326076|NCT04505540|564294269|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
156326077|NCT04505540|564294269|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
156326078|NCT04505540|564294269|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
156326079|NCT04505540|564294269|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
156326080|NCT04505540|564294269|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
156326081|NCT04505540|564294269|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
156326082|NCT04505540|564294269|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
156326083|NCT04505540|564294269|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
156326084|NCT04505540|564294269|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
156326085|NCT04505540|564294269|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
156326086|NCT04505540|564294269|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
156326087|NCT05342532|564294270|FG000|Overall Study|Adverse Event|5|||
156326088|NCT05342532|564294271|FG001|Overall Study|Adverse Event|20|||
156326089|NCT05342532|564294270|FG000|Overall Study|Lost to Follow-up|10|||
156326090|NCT05342532|564294271|FG001|Overall Study|Lost to Follow-up|15|||
156326091|NCT01390220|564294276|FG000|Test Dose Phase|Adverse Event|17|||
156326092|NCT01390220|564294277|FG001|Test Dose Phase|Adverse Event|0|||
156326093|NCT01390220|564294278|FG002|Test Dose Phase|Adverse Event|0|||
156326094|NCT01390220|564294276|FG000|Test Dose Phase|Withdrawal by Subject|8|||
156326095|NCT01390220|564294277|FG001|Test Dose Phase|Withdrawal by Subject|0|||
156326096|NCT01390220|564294278|FG002|Test Dose Phase|Withdrawal by Subject|0|||
156430418|NCT01253226|564664670|FG000|Overall Study|Withdrawal by Subject|0|||
156326097|NCT01390220|564294276|FG000|Test Dose Phase|Lost to Follow-up|2|||
156326098|NCT01390220|564294277|FG001|Test Dose Phase|Lost to Follow-up|0|||
156326099|NCT01390220|564294278|FG002|Test Dose Phase|Lost to Follow-up|0|||
156326100|NCT01390220|564294276|FG000|Test Dose Phase|Protocol Violation|8|||
156326101|NCT01390220|564294277|FG001|Test Dose Phase|Protocol Violation|0|||
156326102|NCT01390220|564294278|FG002|Test Dose Phase|Protocol Violation|0|||
156430419|NCT01253226|564664671|FG001|Overall Study|Withdrawal by Subject|0|||
156430420|NCT01253226|564664672|FG002|Overall Study|Withdrawal by Subject|0|||
156430421|NCT01253226|564664673|FG003|Overall Study|Withdrawal by Subject|1|||
156326103|NCT01390220|564294276|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
156326104|NCT01390220|564294277|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
156326105|NCT01390220|564294278|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
156326106|NCT01390220|564294276|FG000|Test Dose Phase|Study/Site closure|6|||
156326107|NCT01390220|564294277|FG001|Test Dose Phase|Study/Site closure|0|||
156326108|NCT01390220|564294278|FG002|Test Dose Phase|Study/Site closure|0|||
156326109|NCT01390220|564294276|FG000|Test Dose Phase|Caregiver no longer available|5|||
156326110|NCT01390220|564294277|FG001|Test Dose Phase|Caregiver no longer available|0|||
156326111|NCT01390220|564294278|FG002|Test Dose Phase|Caregiver no longer available|0|||
156326112|NCT01390220|564294276|FG000|Test Dose Phase|Noncompliance|2|||
156326113|NCT01390220|564294277|FG001|Test Dose Phase|Noncompliance|0|||
156326114|NCT01390220|564294278|FG002|Test Dose Phase|Noncompliance|0|||
156326115|NCT01390220|564294276|FG000|Test Dose Phase|Logistical|6|||
156326116|NCT01390220|564294277|FG001|Test Dose Phase|Logistical|0|||
156326117|NCT01390220|564294278|FG002|Test Dose Phase|Logistical|0|||
156326118|NCT01390220|564294276|FG000|Comparative Phase|Withdrawal by Subject|0|||
156326119|NCT01390220|564294277|FG001|Comparative Phase|Withdrawal by Subject|1|||
156326120|NCT01390220|564294278|FG002|Comparative Phase|Withdrawal by Subject|0|||
156326121|NCT00249288|564294279|FG000|Overall Study|Lost to Follow-up|3|||
156326122|NCT00249288|564294280|FG001|Overall Study|Lost to Follow-up|3|||
156326123|NCT00249288|564294279|FG000|Overall Study|Withdrawal by Subject|2|||
156326124|NCT00249288|564294280|FG001|Overall Study|Withdrawal by Subject|2|||
156326125|NCT03059446|564294281|FG000|Overall Study|Adverse Event|11|||
156326126|NCT03059446|564294281|FG000|Overall Study|Withdrawal of Consent|16|||
156326127|NCT03059446|564294281|FG000|Overall Study|Lost to Follow-up|3|||
156326128|NCT03059446|564294281|FG000|Overall Study|Protocol Violation|1|||
156326129|NCT03059446|564294281|FG000|Overall Study|Study Terminated by Sponsor|131|||
156326130|NCT03059446|564294281|FG000|Overall Study|Reason not Specified|5|||
156326131|NCT00136604|564294282|FG000|Overall Study|Lost to Follow-up|1|||
156326132|NCT00136604|564294283|FG001|Overall Study|Lost to Follow-up|0|||
156326133|NCT00136604|564294284|FG002|Overall Study|Lost to Follow-up|0|||
156326134|NCT00136604|564294285|FG003|Overall Study|Lost to Follow-up|0|||
156326135|NCT00136604|564294286|FG004|Overall Study|Lost to Follow-up|1|||
156326136|NCT00136604|564294282|FG000|Overall Study|Migrated/moved from study area|0|||
156326137|NCT00136604|564294283|FG001|Overall Study|Migrated/moved from study area|1|||
156326138|NCT00136604|564294284|FG002|Overall Study|Migrated/moved from study area|0|||
156326139|NCT00136604|564294285|FG003|Overall Study|Migrated/moved from study area|0|||
156326140|NCT00136604|564294286|FG004|Overall Study|Migrated/moved from study area|0|||
156326141|NCT03091777|564294287|FG000|Overall Study|Pregnancy|2|||
156326142|NCT03091777|564294288|FG001|Overall Study|Pregnancy|1|||
156326143|NCT03091777|564294289|FG002|Overall Study|Pregnancy|0|||
156326144|NCT03091777|564294287|FG000|Overall Study|Adverse Event|2|||
156326145|NCT03091777|564294288|FG001|Overall Study|Adverse Event|1|||
156326146|NCT03091777|564294289|FG002|Overall Study|Adverse Event|4|||
156326147|NCT03091777|564294287|FG000|Overall Study|Withdrawal by Subject|4|||
156326148|NCT03091777|564294288|FG001|Overall Study|Withdrawal by Subject|2|||
156326149|NCT03091777|564294289|FG002|Overall Study|Withdrawal by Subject|6|||
156326150|NCT03091777|564294287|FG000|Overall Study|Protocol Violation|2|||
156326151|NCT03091777|564294288|FG001|Overall Study|Protocol Violation|1|||
156326152|NCT03091777|564294289|FG002|Overall Study|Protocol Violation|1|||
156326153|NCT03091777|564294287|FG000|Overall Study|Lost to Follow-up|12|||
156326154|NCT03091777|564294288|FG001|Overall Study|Lost to Follow-up|14|||
156326155|NCT03091777|564294289|FG002|Overall Study|Lost to Follow-up|7|||
156326156|NCT03091777|564294287|FG000|Overall Study|Lack of Efficacy|0|||
156326157|NCT03091777|564294288|FG001|Overall Study|Lack of Efficacy|0|||
156326158|NCT03091777|564294289|FG002|Overall Study|Lack of Efficacy|5|||
156326159|NCT03091777|564294287|FG000|Overall Study|Noncompliance with study drug|2|||
156326160|NCT03091777|564294288|FG001|Overall Study|Noncompliance with study drug|3|||
156326161|NCT03091777|564294289|FG002|Overall Study|Noncompliance with study drug|1|||
156326162|NCT03091777|564294287|FG000|Overall Study|Physician Decision|1|||
156326163|NCT03091777|564294288|FG001|Overall Study|Physician Decision|0|||
156326164|NCT03091777|564294289|FG002|Overall Study|Physician Decision|1|||
156326165|NCT03091777|564294287|FG000|Overall Study|Abnormal Laboratory Value|7|||
156326166|NCT03091777|564294288|FG001|Overall Study|Abnormal Laboratory Value|11|||
156326167|NCT03091777|564294289|FG002|Overall Study|Abnormal Laboratory Value|12|||
156326168|NCT02536833|564294290|FG000|Overall Study|Discontinued Before Treatment|0|||
156430422|NCT01253226|564664674|FG004|Overall Study|Withdrawal by Subject|0|||
156430423|NCT01582945|564664675|FG000|Overall Study|Intolerable side-effects|1|||
156326169|NCT02536833|564294291|FG001|Overall Study|Discontinued Before Treatment|0|||
156326170|NCT02536833|564294292|FG002|Overall Study|Discontinued Before Treatment|1|||
156326171|NCT02536833|564294293|FG003|Overall Study|Discontinued Before Treatment|2|||
156326172|NCT02536833|564294290|FG000|Overall Study|Adverse Event|1|||
156326173|NCT02536833|564294291|FG001|Overall Study|Adverse Event|3|||
156326174|NCT02536833|564294292|FG002|Overall Study|Adverse Event|4|||
156430424|NCT01582945|564664675|FG000|Overall Study|Scheduling conflicts|1|||
156430425|NCT01726023|564664676|FG000|Overall Study|Death|1|||
156430426|NCT01726023|564664677|FG001|Overall Study|Death|1|||
156430427|NCT01726023|564664676|FG000|Overall Study|Lost to Follow-up|5|||
156430428|NCT01726023|564664677|FG001|Overall Study|Lost to Follow-up|10|||
156430429|NCT01726023|564664676|FG000|Overall Study|Other Eligibility criteria|7|||
156430430|NCT01726023|564664677|FG001|Overall Study|Other Eligibility criteria|7|||
156430431|NCT01726023|564664676|FG000|Overall Study|Withdrawal by Subject|16|||
156667686|NCT02674152|565532355|FG002|Overall Study|Other adverse event or clinical progression|0|||
156667687|NCT02674152|565532356|FG003|Overall Study|Other adverse event or clinical progression|3|||
156430432|NCT01726023|564664677|FG001|Overall Study|Withdrawal by Subject|8|||
156430433|NCT01155869|564664687|FG000|Overall Study|Lost to Follow-up|3|||
156430434|NCT01155869|564664688|FG001|Overall Study|Lost to Follow-up|1|||
156430435|NCT00881335|564664690|FG000|Overall Study|Lost to Follow-up|3|||
156430436|NCT00881335|564664691|FG001|Overall Study|Lost to Follow-up|2|||
156430437|NCT05824351|564664692|FG000|Overall Study|Adverse Event|6|||
156430438|NCT03722446|564664693|FG000|Overall Study|Protocol Violation|15|||
156430439|NCT03722446|564664694|FG001|Overall Study|Protocol Violation|2|||
156430440|NCT00482729|564666074|FG000|Overall Study|Adverse Event|29|||
156430441|NCT00482729|564666075|FG001|Overall Study|Adverse Event|33|||
156430442|NCT00482729|564666074|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
156430443|NCT00482729|564666075|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
156430444|NCT00482729|564666074|FG000|Overall Study|Hyperglycemia Criteria|7|||
156430445|NCT00482729|564666075|FG001|Overall Study|Hyperglycemia Criteria|5|||
156430446|NCT00482729|564666074|FG000|Overall Study|Lack of Efficacy|4|||
156430447|NCT00482729|564666075|FG001|Overall Study|Lack of Efficacy|16|||
156430448|NCT00482729|564666074|FG000|Overall Study|Lost to Follow-up|86|||
156430449|NCT00482729|564666075|FG001|Overall Study|Lost to Follow-up|66|||
156430450|NCT00482729|564666074|FG000|Overall Study|Physician Decision|10|||
156430451|NCT00482729|564666075|FG001|Overall Study|Physician Decision|7|||
156430452|NCT00482729|564666074|FG000|Overall Study|Pregnancy|4|||
156430453|NCT00482729|564666075|FG001|Overall Study|Pregnancy|2|||
156430454|NCT00482729|564666074|FG000|Overall Study|Protocol Violation|10|||
156430455|NCT00482729|564666075|FG001|Overall Study|Protocol Violation|18|||
156430456|NCT00482729|564666074|FG000|Overall Study|Withdrawal by Subject|67|||
156430457|NCT00482729|564666075|FG001|Overall Study|Withdrawal by Subject|69|||
156430458|NCT01090024|564666080|FG000|Period 1|Met exclusion criteria|0|||
156430459|NCT01090024|564666081|FG001|Period 1|Met exclusion criteria|0|||
156430460|NCT01090024|564666082|FG002|Period 1|Met exclusion criteria|0|||
156430461|NCT01090024|564666083|FG003|Period 1|Met exclusion criteria|0|||
156430462|NCT01090024|564666084|FG004|Period 1|Met exclusion criteria|0|||
156430463|NCT01090024|564666085|FG005|Period 1|Met exclusion criteria|0|||
156430464|NCT01090024|564666086|FG006|Period 1|Met exclusion criteria|0|||
156430465|NCT01090024|564666087|FG007|Period 1|Met exclusion criteria|0|||
156430466|NCT01090024|564666088|FG008|Period 1|Met exclusion criteria|0|||
156430467|NCT01090024|564666089|FG009|Period 1|Met exclusion criteria|0|||
156430468|NCT01090024|564666090|FG010|Period 1|Met exclusion criteria|0|||
156430469|NCT01090024|564666091|FG011|Period 1|Met exclusion criteria|0|||
156430470|NCT01090024|564666092|FG012|Period 1|Met exclusion criteria|0|||
156430471|NCT01090024|564666093|FG013|Period 1|Met exclusion criteria|0|||
156430472|NCT01090024|564666094|FG014|Period 1|Met exclusion criteria|1|||
156430473|NCT01090024|564666095|FG015|Period 1|Met exclusion criteria|0|||
156430474|NCT01090024|564666096|FG016|Period 1|Met exclusion criteria|0|||
156430475|NCT01090024|564666097|FG017|Period 1|Met exclusion criteria|0|||
156430476|NCT01090024|564666080|FG000|Period 1|Adverse Event|0|||
156430477|NCT01090024|564666081|FG001|Period 1|Adverse Event|0|||
156430478|NCT01090024|564666082|FG002|Period 1|Adverse Event|0|||
156430479|NCT01090024|564666083|FG003|Period 1|Adverse Event|0|||
156430480|NCT01090024|564666084|FG004|Period 1|Adverse Event|0|||
156430481|NCT01090024|564666085|FG005|Period 1|Adverse Event|0|||
156430482|NCT01090024|564666086|FG006|Period 1|Adverse Event|0|||
156430483|NCT01090024|564666087|FG007|Period 1|Adverse Event|0|||
156667688|NCT02674152|565532357|FG004|Overall Study|Other adverse event or clinical progression|0|||
156667689|NCT02674152|565532353|FG000|Overall Study|Dose-limiting toxicity|0|||
156430484|NCT01090024|564666088|FG008|Period 1|Adverse Event|0|||
156667690|NCT02674152|565532354|FG001|Overall Study|Dose-limiting toxicity|0|||
156430485|NCT01090024|564666089|FG009|Period 1|Adverse Event|1|||
156430486|NCT01090024|564666090|FG010|Period 1|Adverse Event|0|||
156430487|NCT01090024|564666091|FG011|Period 1|Adverse Event|1|||
156430488|NCT01090024|564666092|FG012|Period 1|Adverse Event|0|||
156430489|NCT01090024|564666093|FG013|Period 1|Adverse Event|0|||
156430490|NCT01090024|564666094|FG014|Period 1|Adverse Event|0|||
156430491|NCT01090024|564666095|FG015|Period 1|Adverse Event|0|||
156430492|NCT01090024|564666096|FG016|Period 1|Adverse Event|0|||
156430493|NCT01090024|564666097|FG017|Period 1|Adverse Event|1|||
156430494|NCT01090024|564666080|FG000|Period 1|Withdrawal by Subject|0|||
156430495|NCT01090024|564666081|FG001|Period 1|Withdrawal by Subject|0|||
156430496|NCT01090024|564666082|FG002|Period 1|Withdrawal by Subject|0|||
156430497|NCT01090024|564666083|FG003|Period 1|Withdrawal by Subject|1|||
156430498|NCT01090024|564666084|FG004|Period 1|Withdrawal by Subject|0|||
156430499|NCT01090024|564666085|FG005|Period 1|Withdrawal by Subject|0|||
156430500|NCT01090024|564666086|FG006|Period 1|Withdrawal by Subject|0|||
156430501|NCT01090024|564666087|FG007|Period 1|Withdrawal by Subject|0|||
156430502|NCT01090024|564666088|FG008|Period 1|Withdrawal by Subject|0|||
156525535|NCT02699983|565019366|FG001|Overall Study|Withdrawal by Subject|0|||
156430503|NCT01090024|564666089|FG009|Period 1|Withdrawal by Subject|0|||
156430504|NCT01090024|564666090|FG010|Period 1|Withdrawal by Subject|0|||
156430505|NCT01090024|564666091|FG011|Period 1|Withdrawal by Subject|0|||
156430506|NCT01090024|564666092|FG012|Period 1|Withdrawal by Subject|0|||
156430507|NCT01090024|564666093|FG013|Period 1|Withdrawal by Subject|0|||
156430508|NCT01090024|564666094|FG014|Period 1|Withdrawal by Subject|0|||
156430509|NCT01090024|564666095|FG015|Period 1|Withdrawal by Subject|0|||
156430510|NCT01090024|564666096|FG016|Period 1|Withdrawal by Subject|0|||
156430511|NCT01090024|564666097|FG017|Period 1|Withdrawal by Subject|0|||
156430512|NCT01090024|564666080|FG000|Period 1|Lost to Follow-up|0|||
156430513|NCT01090024|564666081|FG001|Period 1|Lost to Follow-up|1|||
156525536|NCT01287065|565019367|FG000|Treatment Period 1|Adverse Event|0|||
156667691|NCT02674152|565532355|FG002|Overall Study|Dose-limiting toxicity|0|||
156667692|NCT02674152|565532356|FG003|Overall Study|Dose-limiting toxicity|0|||
156525537|NCT01287065|565019368|FG001|Treatment Period 1|Adverse Event|0|||
156525538|NCT01287065|565019369|FG002|Treatment Period 1|Adverse Event|0|||
156525539|NCT01287065|565019370|FG003|Treatment Period 1|Adverse Event|0|||
156525540|NCT01287065|565019371|FG004|Treatment Period 1|Adverse Event|1|||
156525541|NCT01287065|565019372|FG005|Treatment Period 1|Adverse Event|0|||
156525542|NCT01287065|565019367|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156525543|NCT01287065|565019368|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156525544|NCT01287065|565019369|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156525545|NCT01287065|565019370|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156525546|NCT01287065|565019371|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156525547|NCT01287065|565019372|FG005|Treatment Period 1|Withdrawal by Subject|1|||
156525548|NCT01259726|565019373|FG000|Overall Study|Death|1|||
156525549|NCT01259726|565019374|FG001|Overall Study|Death|0|||
156525550|NCT01259726|565019375|FG002|Overall Study|Death|0|||
156525551|NCT01259726|565019376|FG003|Overall Study|Death|0|||
156525552|NCT01259726|565019373|FG000|Overall Study|Physician Decision|2|||
156525553|NCT01259726|565019374|FG001|Overall Study|Physician Decision|0|||
156525554|NCT01259726|565019375|FG002|Overall Study|Physician Decision|1|||
156525555|NCT01259726|565019376|FG003|Overall Study|Physician Decision|1|||
156525556|NCT01259726|565019373|FG000|Overall Study|Withdrawal by Subject|1|||
156525557|NCT01259726|565019374|FG001|Overall Study|Withdrawal by Subject|3|||
156525558|NCT01259726|565019375|FG002|Overall Study|Withdrawal by Subject|2|||
156525559|NCT01259726|565019376|FG003|Overall Study|Withdrawal by Subject|1|||
156525560|NCT01259726|565019373|FG000|Overall Study|Lost to Follow-up|1|||
156525561|NCT01259726|565019374|FG001|Overall Study|Lost to Follow-up|1|||
156525562|NCT01259726|565019375|FG002|Overall Study|Lost to Follow-up|1|||
156525563|NCT01259726|565019376|FG003|Overall Study|Lost to Follow-up|3|||
156525564|NCT01211197|565019378|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156525565|NCT01211197|565019379|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156525566|NCT01211197|565019380|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156525567|NCT01211197|565019381|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156525568|NCT01211197|565019382|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156525569|NCT01211197|565019383|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156525570|NCT01211197|565019378|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
156525571|NCT01211197|565019379|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
156525572|NCT01211197|565019380|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
156525573|NCT01211197|565019381|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
156525574|NCT01211197|565019382|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
156525575|NCT01211197|565019383|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
156525576|NCT00261846|565019384|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
156525577|NCT00261846|565019385|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
156525578|NCT00261846|565019386|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
156525579|NCT00261846|565019387|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525580|NCT00261846|565019388|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525581|NCT00261846|565019389|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525582|NCT00261846|565019390|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525583|NCT00261846|565019391|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525584|NCT00261846|565019392|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525585|NCT00261846|565019393|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525586|NCT00261846|565019394|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525587|NCT00261846|565019395|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
156525588|NCT00261846|565019384|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156525589|NCT00261846|565019385|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156525590|NCT00261846|565019386|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156525591|NCT00261846|565019387|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
156430514|NCT01090024|564666082|FG002|Period 1|Lost to Follow-up|0|||
156430515|NCT01090024|564666083|FG003|Period 1|Lost to Follow-up|0|||
156430516|NCT01090024|564666084|FG004|Period 1|Lost to Follow-up|0|||
156525592|NCT00261846|565019388|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156778992|NCT01793935|565940618|FG001|Overall Study|Protocol Violation|1|||
156430517|NCT01090024|564666085|FG005|Period 1|Lost to Follow-up|0|||
156430518|NCT01090024|564666086|FG006|Period 1|Lost to Follow-up|0|||
156430519|NCT01090024|564666087|FG007|Period 1|Lost to Follow-up|0|||
156430520|NCT01090024|564666088|FG008|Period 1|Lost to Follow-up|0|||
156430521|NCT01090024|564666089|FG009|Period 1|Lost to Follow-up|0|||
156430522|NCT01090024|564666090|FG010|Period 1|Lost to Follow-up|0|||
156430523|NCT01090024|564666091|FG011|Period 1|Lost to Follow-up|0|||
156430524|NCT01090024|564666092|FG012|Period 1|Lost to Follow-up|0|||
156430525|NCT01090024|564666093|FG013|Period 1|Lost to Follow-up|0|||
156430526|NCT01090024|564666094|FG014|Period 1|Lost to Follow-up|0|||
156430527|NCT01090024|564666095|FG015|Period 1|Lost to Follow-up|0|||
156430528|NCT01090024|564666096|FG016|Period 1|Lost to Follow-up|0|||
156430529|NCT01090024|564666097|FG017|Period 1|Lost to Follow-up|0|||
156430530|NCT01090024|564666080|FG000|Period 2|Lost to Follow-up|0|||
156430531|NCT01090024|564666081|FG001|Period 2|Lost to Follow-up|0|||
156430532|NCT01090024|564666082|FG002|Period 2|Lost to Follow-up|0|||
156778993|NCT01793935|565940617|FG000|Overall Study|Adverse Event|2|||
156778994|NCT01793935|565940618|FG001|Overall Study|Adverse Event|0|||
156778995|NCT01793935|565940617|FG000|Overall Study|Patient did not take study medication|1|||
156778996|NCT01793935|565940618|FG001|Overall Study|Patient did not take study medication|1|||
156778997|NCT01793935|565940617|FG000|Overall Study|Lost to Follow-up|0|||
156778998|NCT01793935|565940618|FG001|Overall Study|Lost to Follow-up|1|||
156778999|NCT01121926|565940619|FG000|First Intervention Period|Adverse Event|1|||
156779000|NCT01121926|565940620|FG001|First Intervention Period|Adverse Event|0|||
156779001|NCT01121926|565940619|FG000|Washout Period|Adverse Event|0|||
156779002|NCT01121926|565940620|FG001|Washout Period|Adverse Event|1|||
156430533|NCT01090024|564666083|FG003|Period 2|Lost to Follow-up|1|||
156430534|NCT01090024|564666084|FG004|Period 2|Lost to Follow-up|0|||
156430535|NCT01090024|564666085|FG005|Period 2|Lost to Follow-up|0|||
156430536|NCT01090024|564666086|FG006|Period 2|Lost to Follow-up|0|||
156430537|NCT01090024|564666087|FG007|Period 2|Lost to Follow-up|0|||
156430538|NCT01090024|564666088|FG008|Period 2|Lost to Follow-up|0|||
156430539|NCT01090024|564666089|FG009|Period 2|Lost to Follow-up|0|||
156430540|NCT01090024|564666090|FG010|Period 2|Lost to Follow-up|0|||
156430541|NCT01090024|564666091|FG011|Period 2|Lost to Follow-up|0|||
156430542|NCT01090024|564666092|FG012|Period 2|Lost to Follow-up|0|||
156430543|NCT01090024|564666093|FG013|Period 2|Lost to Follow-up|0|||
156430544|NCT01090024|564666094|FG014|Period 2|Lost to Follow-up|0|||
156430545|NCT01090024|564666095|FG015|Period 2|Lost to Follow-up|0|||
156430546|NCT01090024|564666096|FG016|Period 2|Lost to Follow-up|0|||
156430547|NCT01090024|564666097|FG017|Period 2|Lost to Follow-up|0|||
156430548|NCT01090024|564666080|FG000|Period 2|Adverse Event|1|||
156430549|NCT01090024|564666081|FG001|Period 2|Adverse Event|0|||
156430550|NCT01090024|564666082|FG002|Period 2|Adverse Event|0|||
156430551|NCT01090024|564666083|FG003|Period 2|Adverse Event|0|||
156430552|NCT01090024|564666084|FG004|Period 2|Adverse Event|0|||
156430553|NCT01090024|564666085|FG005|Period 2|Adverse Event|0|||
156430554|NCT01090024|564666086|FG006|Period 2|Adverse Event|0|||
156430555|NCT01090024|564666087|FG007|Period 2|Adverse Event|0|||
156430556|NCT01090024|564666088|FG008|Period 2|Adverse Event|0|||
156430557|NCT01090024|564666089|FG009|Period 2|Adverse Event|0|||
156430558|NCT01090024|564666090|FG010|Period 2|Adverse Event|0|||
156430559|NCT01090024|564666091|FG011|Period 2|Adverse Event|0|||
156430560|NCT01090024|564666092|FG012|Period 2|Adverse Event|0|||
156430561|NCT01090024|564666093|FG013|Period 2|Adverse Event|0|||
156430562|NCT01090024|564666094|FG014|Period 2|Adverse Event|0|||
156525593|NCT00261846|565019389|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156430563|NCT01090024|564666095|FG015|Period 2|Adverse Event|0|||
156430564|NCT01090024|564666096|FG016|Period 2|Adverse Event|0|||
156430565|NCT01090024|564666097|FG017|Period 2|Adverse Event|0|||
156430566|NCT01090024|564666080|FG000|Period 3|Withdrawal by Subject|0|||
156430567|NCT01090024|564666081|FG001|Period 3|Withdrawal by Subject|0|||
156430568|NCT01090024|564666082|FG002|Period 3|Withdrawal by Subject|0|||
156430569|NCT01090024|564666083|FG003|Period 3|Withdrawal by Subject|0|||
156430570|NCT01090024|564666084|FG004|Period 3|Withdrawal by Subject|0|||
156430571|NCT01090024|564666085|FG005|Period 3|Withdrawal by Subject|0|||
156430572|NCT01090024|564666086|FG006|Period 3|Withdrawal by Subject|0|||
156430573|NCT01090024|564666087|FG007|Period 3|Withdrawal by Subject|0|||
156430574|NCT01090024|564666088|FG008|Period 3|Withdrawal by Subject|0|||
156430575|NCT01090024|564666089|FG009|Period 3|Withdrawal by Subject|0|||
156430576|NCT01090024|564666090|FG010|Period 3|Withdrawal by Subject|0|||
156430577|NCT01090024|564666091|FG011|Period 3|Withdrawal by Subject|0|||
156430578|NCT01090024|564666092|FG012|Period 3|Withdrawal by Subject|0|||
156430579|NCT01090024|564666093|FG013|Period 3|Withdrawal by Subject|0|||
156430580|NCT01090024|564666094|FG014|Period 3|Withdrawal by Subject|0|||
156779003|NCT01121926|565940619|FG000|Washout Period|Positive pregnancy test|0|||
156430581|NCT01090024|564666095|FG015|Period 3|Withdrawal by Subject|1|||
156430582|NCT01090024|564666096|FG016|Period 3|Withdrawal by Subject|0|||
156430583|NCT01090024|564666097|FG017|Period 3|Withdrawal by Subject|0|||
156430584|NCT01090024|564666080|FG000|Period 3|Protocol Violation|0|||
156430585|NCT01090024|564666081|FG001|Period 3|Protocol Violation|0|||
156430586|NCT01090024|564666082|FG002|Period 3|Protocol Violation|0|||
156326175|NCT02536833|564294293|FG003|Overall Study|Adverse Event|1|||
156326176|NCT02536833|564294290|FG000|Overall Study|Lost to Follow-up|2|||
156326177|NCT02536833|564294291|FG001|Overall Study|Lost to Follow-up|1|||
156326178|NCT02536833|564294292|FG002|Overall Study|Lost to Follow-up|2|||
156326179|NCT02536833|564294293|FG003|Overall Study|Lost to Follow-up|2|||
156326180|NCT02536833|564294290|FG000|Overall Study|Physician Decision|0|||
156326181|NCT02536833|564294291|FG001|Overall Study|Physician Decision|0|||
156326182|NCT02536833|564294292|FG002|Overall Study|Physician Decision|0|||
156326183|NCT02536833|564294293|FG003|Overall Study|Physician Decision|1|||
156326184|NCT02536833|564294290|FG000|Overall Study|Site Terminated by Sponsor|2|||
156326185|NCT02536833|564294291|FG001|Overall Study|Site Terminated by Sponsor|2|||
156326186|NCT02536833|564294292|FG002|Overall Study|Site Terminated by Sponsor|2|||
156326187|NCT02536833|564294293|FG003|Overall Study|Site Terminated by Sponsor|2|||
156326188|NCT02536833|564294290|FG000|Overall Study|Subject Non-Compliance|0|||
156326189|NCT02536833|564294291|FG001|Overall Study|Subject Non-Compliance|1|||
156326190|NCT02536833|564294292|FG002|Overall Study|Subject Non-Compliance|1|||
156326191|NCT02536833|564294293|FG003|Overall Study|Subject Non-Compliance|0|||
156326192|NCT02536833|564294290|FG000|Overall Study|Withdrawal by Subject|4|||
156326193|NCT02536833|564294291|FG001|Overall Study|Withdrawal by Subject|3|||
156326194|NCT02536833|564294292|FG002|Overall Study|Withdrawal by Subject|5|||
156326195|NCT02536833|564294293|FG003|Overall Study|Withdrawal by Subject|11|||
156326196|NCT01528215|564294294|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
156326197|NCT01528215|564294295|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
156326198|NCT01528215|564294294|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
156326199|NCT01528215|564294295|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
156326200|NCT01528215|564294294|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
156326201|NCT01528215|564294295|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
156326202|NCT01528215|564294294|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
156326203|NCT01528215|564294295|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
156326204|NCT02766465|564294296|FG000|Overall Study|Withdrawal by Subject|0|||
156326205|NCT02766465|564294297|FG001|Overall Study|Withdrawal by Subject|10|||
156326206|NCT01907100|564294298|FG000|Overall Study|PD based on modified RECIST criteria|31|||
156326207|NCT01907100|564294299|FG001|Overall Study|PD based on modified RECIST criteria|32|||
156326208|NCT01907100|564294300|FG002|Overall Study|PD based on modified RECIST criteria|95|||
156326209|NCT01907100|564294301|FG003|Overall Study|PD based on modified RECIST criteria|92|||
156326210|NCT01907100|564294298|FG000|Overall Study|Withdrawal by Subject|2|||
156326211|NCT01907100|564294299|FG001|Overall Study|Withdrawal by Subject|5|||
156326212|NCT01907100|564294300|FG002|Overall Study|Withdrawal by Subject|10|||
156326213|NCT01907100|564294301|FG003|Overall Study|Withdrawal by Subject|13|||
156326214|NCT01907100|564294298|FG000|Overall Study|Protocol Violation|0|||
156326215|NCT01907100|564294299|FG001|Overall Study|Protocol Violation|0|||
156326216|NCT01907100|564294300|FG002|Overall Study|Protocol Violation|1|||
156326217|NCT01907100|564294301|FG003|Overall Study|Protocol Violation|1|||
156326218|NCT01907100|564294298|FG000|Overall Study|Lost to Follow-up|0|||
156326219|NCT01907100|564294299|FG001|Overall Study|Lost to Follow-up|0|||
156326220|NCT01907100|564294300|FG002|Overall Study|Lost to Follow-up|0|||
156326221|NCT01907100|564294301|FG003|Overall Study|Lost to Follow-up|1|||
156326222|NCT01907100|564294298|FG000|Overall Study|Not treated|2|||
156326223|NCT01907100|564294299|FG001|Overall Study|Not treated|0|||
156326224|NCT01907100|564294300|FG002|Overall Study|Not treated|1|||
156326225|NCT01907100|564294301|FG003|Overall Study|Not treated|2|||
156326226|NCT01907100|564294298|FG000|Overall Study|Other than reasons specified|1|||
156326227|NCT01907100|564294299|FG001|Overall Study|Other than reasons specified|0|||
156326228|NCT01907100|564294300|FG002|Overall Study|Other than reasons specified|10|||
156326229|NCT01907100|564294301|FG003|Overall Study|Other than reasons specified|6|||
156326230|NCT01907100|564294298|FG000|Overall Study|Adverse event (AE)|6|||
156326231|NCT01907100|564294299|FG001|Overall Study|Adverse event (AE)|3|||
156326232|NCT01907100|564294300|FG002|Overall Study|Adverse event (AE)|22|||
156326233|NCT01907100|564294301|FG003|Overall Study|Adverse event (AE)|23|||
156326234|NCT01907100|564294298|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
156326235|NCT01907100|564294299|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
156326236|NCT01907100|564294300|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
156326237|NCT01907100|564294301|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
156326238|NCT00760084|564294310|FG000|Overall Study|Physician Decision|5|||
156326239|NCT00760084|564294310|FG000|Overall Study|Withdrawal by Subject|2|||
156326240|NCT00760084|564294310|FG000|Overall Study|Progressive Disease|3|||
156326241|NCT02567552|564294311|FG000|Overall Study|Adverse Event|0|||
156326242|NCT02567552|564294312|FG001|Overall Study|Adverse Event|1|||
156326243|NCT00171054|564294313|FG000|Overall Study|Protocol Violation|1|||
156326244|NCT00171054|564294314|FG001|Overall Study|Protocol Violation|2|||
156326245|NCT00171054|564294313|FG000|Overall Study|Patient withdrew consent|1|||
156525594|NCT00261846|565019390|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156326246|NCT00171054|564294314|FG001|Overall Study|Patient withdrew consent|0|||
156326247|NCT00171054|564294313|FG000|Overall Study|Lost to Follow-up|0|||
156326248|NCT00171054|564294314|FG001|Overall Study|Lost to Follow-up|1|||
156430587|NCT01090024|564666083|FG003|Period 3|Protocol Violation|0|||
156430588|NCT01090024|564666084|FG004|Period 3|Protocol Violation|0|||
156430589|NCT01090024|564666085|FG005|Period 3|Protocol Violation|0|||
156430590|NCT01090024|564666086|FG006|Period 3|Protocol Violation|0|||
156430591|NCT01090024|564666087|FG007|Period 3|Protocol Violation|0|||
156430592|NCT01090024|564666088|FG008|Period 3|Protocol Violation|1|||
156430593|NCT01090024|564666089|FG009|Period 3|Protocol Violation|0|||
156430594|NCT01090024|564666090|FG010|Period 3|Protocol Violation|0|||
156430595|NCT01090024|564666091|FG011|Period 3|Protocol Violation|0|||
156430596|NCT01090024|564666092|FG012|Period 3|Protocol Violation|0|||
156430597|NCT01090024|564666093|FG013|Period 3|Protocol Violation|0|||
156430598|NCT01090024|564666094|FG014|Period 3|Protocol Violation|0|||
156430599|NCT01090024|564666095|FG015|Period 3|Protocol Violation|0|||
156430600|NCT01090024|564666096|FG016|Period 3|Protocol Violation|0|||
156430601|NCT01090024|564666097|FG017|Period 3|Protocol Violation|0|||
156430602|NCT01090024|564666080|FG000|Period 3|Adverse Event|0|||
156430603|NCT01090024|564666081|FG001|Period 3|Adverse Event|0|||
156430604|NCT01090024|564666082|FG002|Period 3|Adverse Event|0|||
156430605|NCT01090024|564666083|FG003|Period 3|Adverse Event|0|||
156430606|NCT01090024|564666084|FG004|Period 3|Adverse Event|0|||
156430607|NCT01090024|564666085|FG005|Period 3|Adverse Event|1|||
156430608|NCT01090024|564666086|FG006|Period 3|Adverse Event|0|||
156430609|NCT01090024|564666087|FG007|Period 3|Adverse Event|0|||
156430610|NCT01090024|564666088|FG008|Period 3|Adverse Event|0|||
156430611|NCT01090024|564666089|FG009|Period 3|Adverse Event|0|||
156430612|NCT01090024|564666090|FG010|Period 3|Adverse Event|0|||
156430613|NCT01090024|564666091|FG011|Period 3|Adverse Event|0|||
156430614|NCT01090024|564666092|FG012|Period 3|Adverse Event|0|||
156430615|NCT01090024|564666093|FG013|Period 3|Adverse Event|0|||
156430616|NCT01090024|564666094|FG014|Period 3|Adverse Event|0|||
156430617|NCT01090024|564666095|FG015|Period 3|Adverse Event|0|||
156430618|NCT01090024|564666096|FG016|Period 3|Adverse Event|0|||
156430619|NCT01090024|564666097|FG017|Period 3|Adverse Event|0|||
156430620|NCT01897233|564666098|FG000|Part B (24 Weeks)|Adverse Event|1|||
156430621|NCT01897233|564666098|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
156430622|NCT01897233|564666098|FG000|Part B (24 Weeks)|Physician Decision|1|||
156430623|NCT00628862|564666103|FG000|Overall Study|Adverse Event|6|||
156430624|NCT00628862|564666104|FG001|Overall Study|Adverse Event|8|||
156430625|NCT00628862|564666105|FG002|Overall Study|Adverse Event|10|||
156430626|NCT00628862|564666103|FG000|Overall Study|Withdrawal by Subject|4|||
156430627|NCT00628862|564666104|FG001|Overall Study|Withdrawal by Subject|6|||
156430628|NCT00628862|564666105|FG002|Overall Study|Withdrawal by Subject|11|||
156430629|NCT00628862|564666103|FG000|Overall Study|Lost to Follow-up|0|||
156430630|NCT00628862|564666104|FG001|Overall Study|Lost to Follow-up|2|||
156430631|NCT00628862|564666105|FG002|Overall Study|Lost to Follow-up|1|||
156430632|NCT00628862|564666103|FG000|Overall Study|Protocol Violation|1|||
156430633|NCT00628862|564666104|FG001|Overall Study|Protocol Violation|0|||
156430634|NCT00628862|564666105|FG002|Overall Study|Protocol Violation|0|||
156430635|NCT00628862|564666103|FG000|Overall Study|COPD Exacerbation|0|||
156430636|NCT00628862|564666104|FG001|Overall Study|COPD Exacerbation|1|||
156430637|NCT00628862|564666105|FG002|Overall Study|COPD Exacerbation|0|||
156430638|NCT00868192|564666108|FG000|Overall Study|Ineligible|4|||
156430639|NCT00798096|564666111|FG000|Overall Study|Ongoing|2|||
156430640|NCT03670602|564666112|FG000|Overall Study|Lost to Follow-up|1|||
156430641|NCT03670602|564666113|FG001|Overall Study|Lost to Follow-up|0|||
156430642|NCT03670602|564666112|FG000|Overall Study|Withdrawal by Subject|0|||
156430643|NCT03670602|564666113|FG001|Overall Study|Withdrawal by Subject|3|||
156430644|NCT03383887|564666114|FG000|Overall Study|Lost to Follow-up|0|||
156430645|NCT03383887|564666115|FG001|Overall Study|Lost to Follow-up|1|||
156430646|NCT00975806|564666122|FG000|Overall Study|Adverse Event|2|||
156430647|NCT00975806|564666123|FG001|Overall Study|Adverse Event|1|||
156430648|NCT00975806|564666124|FG002|Overall Study|Adverse Event|2|||
156430649|NCT00975806|564666122|FG000|Overall Study|Disease Progression|1|||
156430650|NCT00975806|564666123|FG001|Overall Study|Disease Progression|5|||
156430651|NCT00975806|564666124|FG002|Overall Study|Disease Progression|1|||
156430652|NCT00975806|564666122|FG000|Overall Study|Withdrawal by Subject|1|||
156430653|NCT00975806|564666123|FG001|Overall Study|Withdrawal by Subject|0|||
156430654|NCT00975806|564666124|FG002|Overall Study|Withdrawal by Subject|0|||
156430655|NCT00975806|564666122|FG000|Overall Study|Death|0|||
156430656|NCT00975806|564666123|FG001|Overall Study|Death|1|||
156430657|NCT00975806|564666124|FG002|Overall Study|Death|0|||
156430658|NCT00975806|564666122|FG000|Overall Study|Physician decision and disease related|1|||
156430659|NCT00975806|564666123|FG001|Overall Study|Physician decision and disease related|0|||
156430660|NCT00975806|564666124|FG002|Overall Study|Physician decision and disease related|1|||
156430661|NCT00246012|564666125|FG000|Overall Study|Adverse Event|0|||
156430662|NCT00246012|564666126|FG001|Overall Study|Adverse Event|0|||
156430663|NCT00246012|564666127|FG002|Overall Study|Adverse Event|0|||
156430664|NCT00246012|564666128|FG003|Overall Study|Adverse Event|0|||
156430665|NCT00246012|564666129|FG004|Overall Study|Adverse Event|0|||
156430666|NCT00246012|564666130|FG005|Overall Study|Adverse Event|1|||
156430667|NCT00246012|564666131|FG006|Overall Study|Adverse Event|0|||
156430668|NCT00246012|564666132|FG007|Overall Study|Adverse Event|0|||
156430669|NCT00246012|564666133|FG008|Overall Study|Adverse Event|2|||
156430670|NCT00246012|564666125|FG000|Overall Study|Withdrawal by Subject|0|||
156430671|NCT00246012|564666126|FG001|Overall Study|Withdrawal by Subject|0|||
156430672|NCT00246012|564666127|FG002|Overall Study|Withdrawal by Subject|0|||
156430673|NCT00246012|564666128|FG003|Overall Study|Withdrawal by Subject|0|||
156430674|NCT00246012|564666129|FG004|Overall Study|Withdrawal by Subject|0|||
156430675|NCT00246012|564666130|FG005|Overall Study|Withdrawal by Subject|1|||
156430676|NCT00246012|564666131|FG006|Overall Study|Withdrawal by Subject|0|||
156430677|NCT00246012|564666132|FG007|Overall Study|Withdrawal by Subject|0|||
156430678|NCT00246012|564666133|FG008|Overall Study|Withdrawal by Subject|0|||
156430679|NCT00246012|564666125|FG000|Overall Study|Disease progression|3|||
156430680|NCT00246012|564666126|FG001|Overall Study|Disease progression|1|||
156430681|NCT00246012|564666127|FG002|Overall Study|Disease progression|2|||
156779004|NCT01121926|565940620|FG001|Washout Period|Positive pregnancy test|1|||
156779005|NCT02782468|565940621|FG000|Overall Study|Progressive Disease|2|||
156779006|NCT02782468|565940622|FG001|Overall Study|Progressive Disease|5|||
156779007|NCT02782468|565940623|FG002|Overall Study|Progressive Disease|0|||
156779008|NCT02782468|565940624|FG003|Overall Study|Progressive Disease|4|||
156779009|NCT02782468|565940621|FG000|Overall Study|Adverse Event|0|||
156779010|NCT02782468|565940622|FG001|Overall Study|Adverse Event|2|||
156779011|NCT02782468|565940623|FG002|Overall Study|Adverse Event|2|||
156779012|NCT02782468|565940624|FG003|Overall Study|Adverse Event|3|||
156779013|NCT02782468|565940621|FG000|Overall Study|Other|0|||
156779014|NCT02782468|565940622|FG001|Overall Study|Other|0|||
156779015|NCT02782468|565940623|FG002|Overall Study|Other|1|||
156779016|NCT02782468|565940624|FG003|Overall Study|Other|1|||
156779017|NCT02782468|565940621|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
156779018|NCT02782468|565940622|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
156779019|NCT02782468|565940623|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
156779020|NCT02782468|565940624|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
156779021|NCT02782468|565940621|FG000|Overall Study|Symptomatic Deterioration|0|||
156779022|NCT02782468|565940622|FG001|Overall Study|Symptomatic Deterioration|0|||
156779023|NCT02782468|565940623|FG002|Overall Study|Symptomatic Deterioration|0|||
156430682|NCT00246012|564666128|FG003|Overall Study|Disease progression|3|||
156430683|NCT00246012|564666129|FG004|Overall Study|Disease progression|3|||
156430684|NCT00246012|564666130|FG005|Overall Study|Disease progression|25|||
156430685|NCT00246012|564666131|FG006|Overall Study|Disease progression|30|||
156430686|NCT00246012|564666132|FG007|Overall Study|Disease progression|27|||
156430687|NCT00246012|564666133|FG008|Overall Study|Disease progression|26|||
156430688|NCT00246012|564666125|FG000|Overall Study|Other|0|||
156430689|NCT00246012|564666126|FG001|Overall Study|Other|0|||
156430690|NCT00246012|564666127|FG002|Overall Study|Other|0|||
156430691|NCT00246012|564666128|FG003|Overall Study|Other|0|||
156430692|NCT00246012|564666129|FG004|Overall Study|Other|0|||
156430693|NCT00246012|564666130|FG005|Overall Study|Other|0|||
156430694|NCT00246012|564666131|FG006|Overall Study|Other|0|||
156430695|NCT00246012|564666132|FG007|Overall Study|Other|1|||
156430696|NCT00246012|564666133|FG008|Overall Study|Other|0|||
156430697|NCT00246012|564666125|FG000|Overall Study|Randomly assigned but not treated|0|||
156430698|NCT00246012|564666126|FG001|Overall Study|Randomly assigned but not treated|0|||
156430699|NCT00246012|564666127|FG002|Overall Study|Randomly assigned but not treated|0|||
156430700|NCT00246012|564666128|FG003|Overall Study|Randomly assigned but not treated|0|||
156430701|NCT00246012|564666129|FG004|Overall Study|Randomly assigned but not treated|0|||
156430702|NCT00246012|564666130|FG005|Overall Study|Randomly assigned but not treated|1|||
156430703|NCT00246012|564666131|FG006|Overall Study|Randomly assigned but not treated|1|||
156430704|NCT00246012|564666132|FG007|Overall Study|Randomly assigned but not treated|0|||
156430705|NCT00246012|564666133|FG008|Overall Study|Randomly assigned but not treated|0|||
156430706|NCT01806714|564666136|FG000|Overall Study|No functioning phone number|200|||
156430707|NCT01806714|564666137|FG001|Overall Study|No functioning phone number|170|||
156430708|NCT01585038|564666138|FG000|Overall Study|Adverse Event|2|||
156430709|NCT01585038|564666139|FG001|Overall Study|Adverse Event|2|||
156430710|NCT00678795|564666140|FG000|Overall Study|Adverse Event|7|||
156430711|NCT00678795|564666141|FG001|Overall Study|Adverse Event|3|||
156525595|NCT00261846|565019391|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156779024|NCT02782468|565940624|FG003|Overall Study|Symptomatic Deterioration|1|||
156779025|NCT02782468|565940621|FG000|Overall Study|Withdrawal by Subject|1|||
156779026|NCT02782468|565940622|FG001|Overall Study|Withdrawal by Subject|0|||
156779027|NCT02782468|565940623|FG002|Overall Study|Withdrawal by Subject|0|||
156779028|NCT02782468|565940624|FG003|Overall Study|Withdrawal by Subject|0|||
156779029|NCT00817063|565940631|FG000|Overall Study|Adverse Event|32|||
156779030|NCT00817063|565940632|FG001|Overall Study|Adverse Event|13|||
156779031|NCT00817063|565940631|FG000|Overall Study|Death|1|||
156525596|NCT00261846|565019392|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
156779032|NCT00817063|565940632|FG001|Overall Study|Death|1|||
156779033|NCT00817063|565940631|FG000|Overall Study|Lack of Efficacy|33|||
156779034|NCT00817063|565940632|FG001|Overall Study|Lack of Efficacy|86|||
156779035|NCT00817063|565940631|FG000|Overall Study|Failure to Return|13|||
156430712|NCT00678795|564666140|FG000|Overall Study|Withdrawal by Subject|3|||
156430713|NCT00678795|564666141|FG001|Overall Study|Withdrawal by Subject|0|||
156430714|NCT00678795|564666140|FG000|Overall Study|Protocol Violation|0|||
156430715|NCT00678795|564666141|FG001|Overall Study|Protocol Violation|1|||
156430716|NCT00678795|564666140|FG000|Overall Study|Lost to Follow-up|0|||
156430717|NCT00678795|564666141|FG001|Overall Study|Lost to Follow-up|1|||
156430718|NCT00678795|564666140|FG000|Overall Study|Lack of Efficacy|1|||
156430719|NCT00678795|564666141|FG001|Overall Study|Lack of Efficacy|1|||
156430720|NCT04107805|564666144|FG000|Overall Study|Adverse Event|0|||
156430721|NCT04107805|564666145|FG001|Overall Study|Adverse Event|0|||
156430722|NCT04107805|564666146|FG002|Overall Study|Adverse Event|0|||
156430723|NCT04107805|564666147|FG003|Overall Study|Adverse Event|1|||
156430724|NCT04107805|564666148|FG004|Overall Study|Adverse Event|0|||
156430725|NCT04107805|564666149|FG005|Overall Study|Adverse Event|1|||
156430726|NCT04107805|564666150|FG006|Overall Study|Adverse Event|0|||
156430727|NCT04107805|564666151|FG007|Overall Study|Adverse Event|0|||
156430728|NCT04107805|564666152|FG008|Overall Study|Adverse Event|1|||
156430729|NCT02750709|564666153|FG000|Treatment Period 1|Adverse Event|0|||
156430730|NCT02750709|564666154|FG001|Treatment Period 1|Adverse Event|0|||
156779036|NCT00817063|565940632|FG001|Overall Study|Failure to Return|12|||
156779037|NCT00817063|565940631|FG000|Overall Study|Violation of Selection at Entry|7|||
156779038|NCT00817063|565940632|FG001|Overall Study|Violation of Selection at Entry|4|||
156779039|NCT00817063|565940631|FG000|Overall Study|Protocol Violation|3|||
156779040|NCT00817063|565940632|FG001|Overall Study|Protocol Violation|8|||
156779041|NCT00817063|565940631|FG000|Overall Study|Withdrawal by Subject|17|||
156779042|NCT00817063|565940632|FG001|Overall Study|Withdrawal by Subject|37|||
156779043|NCT00817063|565940631|FG000|Overall Study|Early Improvement|19|||
156779044|NCT00817063|565940632|FG001|Overall Study|Early Improvement|4|||
156779045|NCT00817063|565940631|FG000|Overall Study|Administrative|10|||
156779046|NCT00817063|565940632|FG001|Overall Study|Administrative|4|||
156779047|NCT00817063|565940631|FG000|Overall Study|Abnormality of Laboratory Test|2|||
156779048|NCT00817063|565940632|FG001|Overall Study|Abnormality of Laboratory Test|1|||
156779049|NCT01496456|565940633|FG000|Overall Study|Protocol Violation|1|||
156779050|NCT01496456|565940633|FG000|Overall Study|Lost to Follow-up|7|||
156779051|NCT04919161|565940634|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
156779052|NCT04919161|565940635|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
156779053|NCT04919161|565940634|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
156779054|NCT04919161|565940635|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
156779055|NCT04919161|565940634|FG000|Overall Study|Acute ankle sprain after session 1|0|||
156779056|NCT04919161|565940635|FG001|Overall Study|Acute ankle sprain after session 1|1|||
156779057|NCT01044498|565940639|FG000|Overall Study|Withdrew consent|1|||
156779058|NCT01044498|565940640|FG001|Overall Study|Withdrew consent|1|||
156779059|NCT01044498|565940639|FG000|Overall Study|Adverse Event|1|||
156779060|NCT01044498|565940640|FG001|Overall Study|Adverse Event|1|||
156779061|NCT01044498|565940639|FG000|Overall Study|Other|1|||
156779062|NCT01044498|565940640|FG001|Overall Study|Other|0|||
156779063|NCT03487445|565940643|FG000|Randomization|Not treated for administrative reasons|1|||
156779064|NCT03487445|565940644|FG001|Randomization|Not treated for administrative reasons|0|||
156779065|NCT04132050|565940649|FG000|Period I (Double-blind Period)|Adverse Event|3|||
156430731|NCT02750709|564666155|FG002|Treatment Period 1|Adverse Event|0|||
156430732|NCT02750709|564666156|FG003|Treatment Period 1|Adverse Event|0|||
156779066|NCT04132050|565940650|FG001|Period I (Double-blind Period)|Adverse Event|0|||
156779067|NCT04132050|565940649|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
156779068|NCT04132050|565940650|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
156779069|NCT04132050|565940649|FG000|R788 Treatment Period|Adverse Event|5|||
156779070|NCT04132050|565940650|FG001|R788 Treatment Period|Adverse Event|0|||
156779071|NCT04132050|565940649|FG000|R788 Treatment Period|Lack of Efficacy|5|||
156779072|NCT04132050|565940650|FG001|R788 Treatment Period|Lack of Efficacy|0|||
156779073|NCT04132050|565940649|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
156779074|NCT04132050|565940650|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
156779075|NCT02246777|565940651|FG000|Overall Study|Adverse Event|2|||
156779076|NCT02246777|565940651|FG000|Overall Study|Change of residence|1|||
156779077|NCT04556097|565940652|FG000|Overall Study|Death|0|||
156779078|NCT04556097|565940653|FG001|Overall Study|Death|5|||
156779079|NCT04556097|565940654|FG002|Overall Study|Death|0|||
156779080|NCT04556097|565940655|FG003|Overall Study|Death|0|||
156779081|NCT04556097|565940652|FG000|Overall Study|No caregiver|43|||
156779082|NCT04556097|565940653|FG001|Overall Study|No caregiver|53|||
156779083|NCT04556097|565940654|FG002|Overall Study|No caregiver|0|||
156779084|NCT04556097|565940655|FG003|Overall Study|No caregiver|0|||
156779085|NCT04556097|565940652|FG000|Overall Study|Ineligible, SNF|2|||
156779086|NCT04556097|565940653|FG001|Overall Study|Ineligible, SNF|2|||
156779087|NCT04556097|565940654|FG002|Overall Study|Ineligible, SNF|0|||
156779088|NCT04556097|565940655|FG003|Overall Study|Ineligible, SNF|0|||
156779089|NCT04556097|565940652|FG000|Overall Study|Ineligible, health|3|||
156779090|NCT04556097|565940653|FG001|Overall Study|Ineligible, health|4|||
156779091|NCT04556097|565940654|FG002|Overall Study|Ineligible, health|0|||
156430733|NCT02750709|564666157|FG004|Treatment Period 1|Adverse Event|0|||
156430734|NCT02750709|564666158|FG005|Treatment Period 1|Adverse Event|1|||
156430735|NCT01191086|564666159|FG000|Overall Study|Adverse Event|20|||
156430736|NCT01191086|564666159|FG000|Overall Study|Lack of Efficacy|10|||
156430737|NCT01191086|564666159|FG000|Overall Study|Lost to Follow-up|4|||
156430738|NCT01191086|564666159|FG000|Overall Study|Physician Decision|2|||
156430739|NCT01191086|564666159|FG000|Overall Study|Withdrawal by Subject|24|||
156430740|NCT01191086|564666159|FG000|Overall Study|Discontinuation criterion met|1|||
156430741|NCT01191086|564666159|FG000|Overall Study|Other|1|||
156430742|NCT00608907|564666161|FG000|Overall Study|Adverse Event|6|||
156430743|NCT00608907|564666162|FG001|Overall Study|Adverse Event|0|||
156430744|NCT00608907|564666163|FG002|Overall Study|Adverse Event|1|||
156430745|NCT00608907|564666161|FG000|Overall Study|Death|1|||
156430746|NCT00608907|564666162|FG001|Overall Study|Death|0|||
156430747|NCT00608907|564666163|FG002|Overall Study|Death|0|||
156430748|NCT00608907|564666161|FG000|Overall Study|Withdrawal by Subject|4|||
156430749|NCT00608907|564666162|FG001|Overall Study|Withdrawal by Subject|0|||
156779092|NCT04556097|565940655|FG003|Overall Study|Ineligible, health|0|||
156779093|NCT04556097|565940652|FG000|Overall Study|Ineligible, language|0|||
156779094|NCT04556097|565940653|FG001|Overall Study|Ineligible, language|1|||
156779095|NCT04556097|565940654|FG002|Overall Study|Ineligible, language|0|||
156430750|NCT00608907|564666163|FG002|Overall Study|Withdrawal by Subject|0|||
156430751|NCT00608907|564666161|FG000|Overall Study|Progressive Disease|1|||
156430752|NCT00608907|564666162|FG001|Overall Study|Progressive Disease|0|||
156430753|NCT00608907|564666163|FG002|Overall Study|Progressive Disease|0|||
156430754|NCT02596035|564666164|FG000|Overall Study|Disease Progression|64|||
156430755|NCT02596035|564666165|FG001|Overall Study|Disease Progression|32|||
156430756|NCT02596035|564666166|FG002|Overall Study|Disease Progression|1|||
156430757|NCT02596035|564666164|FG000|Overall Study|study drug toxicity|12|||
156430758|NCT02596035|564666165|FG001|Overall Study|study drug toxicity|3|||
156430759|NCT02596035|564666166|FG002|Overall Study|study drug toxicity|0|||
156430760|NCT02596035|564666164|FG000|Overall Study|AE unrelated to study drug|5|||
156430761|NCT02596035|564666165|FG001|Overall Study|AE unrelated to study drug|2|||
156430762|NCT02596035|564666166|FG002|Overall Study|AE unrelated to study drug|0|||
156430763|NCT02596035|564666164|FG000|Overall Study|participant request to discontinue study treatment|2|||
156430764|NCT02596035|564666165|FG001|Overall Study|participant request to discontinue study treatment|0|||
156430765|NCT02596035|564666166|FG002|Overall Study|participant request to discontinue study treatment|0|||
156430766|NCT02596035|564666164|FG000|Overall Study|participant withdrew consent|2|||
156430767|NCT02596035|564666165|FG001|Overall Study|participant withdrew consent|2|||
156667693|NCT02674152|565532357|FG004|Overall Study|Dose-limiting toxicity|1|||
156430768|NCT02596035|564666166|FG002|Overall Study|participant withdrew consent|0|||
156430769|NCT02596035|564666164|FG000|Overall Study|Poor/Non Comlpiance|0|||
156430770|NCT02596035|564666165|FG001|Overall Study|Poor/Non Comlpiance|1|||
156430771|NCT02596035|564666166|FG002|Overall Study|Poor/Non Comlpiance|0|||
156430772|NCT02596035|564666164|FG000|Overall Study|participant no longer meets study criteria|1|||
156430773|NCT02596035|564666165|FG001|Overall Study|participant no longer meets study criteria|0|||
156430774|NCT02596035|564666166|FG002|Overall Study|participant no longer meets study criteria|0|||
156525597|NCT00261846|565019393|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156667694|NCT02674152|565532353|FG000|Overall Study|Progressive Disease|2|||
156667695|NCT02674152|565532354|FG001|Overall Study|Progressive Disease|1|||
156667696|NCT02674152|565532355|FG002|Overall Study|Progressive Disease|1|||
156667697|NCT02674152|565532356|FG003|Overall Study|Progressive Disease|13|||
156667698|NCT02674152|565532357|FG004|Overall Study|Progressive Disease|2|||
156667699|NCT02674152|565532353|FG000|Overall Study|Adverse Event|0|||
156667700|NCT02674152|565532354|FG001|Overall Study|Adverse Event|0|||
156667701|NCT02674152|565532355|FG002|Overall Study|Adverse Event|1|||
156667702|NCT02674152|565532356|FG003|Overall Study|Adverse Event|0|||
156667703|NCT02674152|565532357|FG004|Overall Study|Adverse Event|1|||
156667704|NCT02571907|565532358|FG000|Overall Study|Death|4|||
156667705|NCT02571907|565532358|FG000|Overall Study|Lost to Follow-up|3|||
156667706|NCT02571907|565532358|FG000|Overall Study|Withdrawal by Subject|3|||
156667707|NCT03447353|565532362|FG000|Overall Study|Failure at Screening Visit|2|||
156667708|NCT03447353|565532362|FG000|Overall Study|Lost to Follow-up|4|||
156667709|NCT03447353|565532362|FG000|Overall Study|Scheduling Conflicts|3|||
156667710|NCT03447353|565532362|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
156667711|NCT02175095|565532363|FG000|Overall Study|Withdrawal by Subject|3|||
156667712|NCT02635750|565532364|FG000|Part 1, Period 2|Adverse Event|1|||
156667713|NCT02635750|565532365|FG001|Part 1, Period 2|Adverse Event|0|||
156667714|NCT02635750|565532366|FG002|Part 1, Period 2|Adverse Event|0|||
156667715|NCT00462345|565532367|FG000|Overall Study|Withdrawal by Subject|2|||
156667716|NCT00462345|565532367|FG000|Overall Study|Did not complete second course|1|||
156667717|NCT02642653|565532369|FG000|Overall Study|Adverse Event|2|||
156667718|NCT02642653|565532370|FG001|Overall Study|Adverse Event|0|||
156667719|NCT02875392|565532374|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
156667720|NCT02875392|565532375|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
156326249|NCT00171054|564294313|FG000|Overall Study|Adverse Event|8|||
156326250|NCT00171054|564294314|FG001|Overall Study|Adverse Event|8|||
156326251|NCT00171054|564294313|FG000|Overall Study|Condition no longer required study drug|0|||
156326252|NCT00171054|564294314|FG001|Overall Study|Condition no longer required study drug|1|||
156326253|NCT00395538|564294315|FG000|Overall Study|Did not re-consent to revised protocol|1|||
156326254|NCT00395538|564294316|FG001|Overall Study|Did not re-consent to revised protocol|10|||
156326255|NCT00395538|564294317|FG002|Overall Study|Did not re-consent to revised protocol|0|||
156326256|NCT00395538|564294315|FG000|Overall Study|FDA partial hold on PTH|0|||
156326257|NCT00395538|564294316|FG001|Overall Study|FDA partial hold on PTH|0|||
156326258|NCT00395538|564294317|FG002|Overall Study|FDA partial hold on PTH|11|||
156326259|NCT00395538|564294315|FG000|Overall Study|Failed screening|0|||
156326260|NCT00395538|564294316|FG001|Overall Study|Failed screening|0|||
156326261|NCT00395538|564294317|FG002|Overall Study|Failed screening|4|||
156326262|NCT00395538|564294315|FG000|Overall Study|Switch to Natpara|0|||
156326263|NCT00395538|564294316|FG001|Overall Study|Switch to Natpara|0|||
156326264|NCT00395538|564294317|FG002|Overall Study|Switch to Natpara|3|||
156326265|NCT00395538|564294315|FG000|Overall Study|Adverse Event|1|||
156326266|NCT00395538|564294316|FG001|Overall Study|Adverse Event|0|||
156326267|NCT00395538|564294317|FG002|Overall Study|Adverse Event|2|||
156326268|NCT00395538|564294315|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
156326269|NCT00395538|564294316|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
156326270|NCT00395538|564294317|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
156326271|NCT00395538|564294315|FG000|Overall Study|Non-compliance with study protocol|0|||
156326272|NCT00395538|564294316|FG001|Overall Study|Non-compliance with study protocol|1|||
156326273|NCT00395538|564294317|FG002|Overall Study|Non-compliance with study protocol|0|||
156326274|NCT00395538|564294315|FG000|Overall Study|PTH resistance|0|||
156326275|NCT00395538|564294316|FG001|Overall Study|PTH resistance|0|||
156326276|NCT00395538|564294317|FG002|Overall Study|PTH resistance|1|||
156326277|NCT00395538|564294315|FG000|Overall Study|Pregnancy|1|||
156326278|NCT00395538|564294316|FG001|Overall Study|Pregnancy|0|||
156326279|NCT00395538|564294317|FG002|Overall Study|Pregnancy|0|||
156326280|NCT00395538|564294315|FG000|Overall Study|Partial recovery of parathyroid function|0|||
156326281|NCT00395538|564294316|FG001|Overall Study|Partial recovery of parathyroid function|0|||
156326282|NCT00395538|564294317|FG002|Overall Study|Partial recovery of parathyroid function|1|||
156326283|NCT00395538|564294315|FG000|Overall Study|Participant elected to discontinue|0|||
156326284|NCT00395538|564294316|FG001|Overall Study|Participant elected to discontinue|0|||
156326285|NCT00395538|564294317|FG002|Overall Study|Participant elected to discontinue|1|||
156326286|NCT04669535|564294319|FG000|Overall Study|Death|1|||
156326287|NCT04669535|564294320|FG001|Overall Study|Death|1|||
156326288|NCT04669535|564294321|FG002|Overall Study|Death|0|||
156326289|NCT04669535|564294322|FG003|Overall Study|Death|0|||
156326290|NCT04382755|564294323|FG000|Overall Study|Withdrawal by Subject|1|||
156326291|NCT04382755|564294324|FG001|Overall Study|Withdrawal by Subject|0|||
156326292|NCT04382755|564294323|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
156326293|NCT04382755|564294324|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
156326294|NCT04382755|564294323|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
156326295|NCT04382755|564294324|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
156430775|NCT02596035|564666164|FG000|Overall Study|other reasons|11|||
156430776|NCT02596035|564666165|FG001|Overall Study|other reasons|4|||
156430777|NCT02596035|564666166|FG002|Overall Study|other reasons|0|||
156430778|NCT03523962|564666168|FG000|Closed Fractures|Death|86|||
156430779|NCT03523962|564666169|FG001|Closed Fractures|Death|71|||
156430780|NCT03523962|564666170|FG002|Closed Fractures|Death|0|||
156430781|NCT03523962|564666171|FG003|Closed Fractures|Death|0|||
156430782|NCT03523962|564666168|FG000|Closed Fractures|Lost to Follow-up|62|||
156430783|NCT03523962|564666169|FG001|Closed Fractures|Lost to Follow-up|36|||
156430784|NCT03523962|564666170|FG002|Closed Fractures|Lost to Follow-up|0|||
156430785|NCT03523962|564666171|FG003|Closed Fractures|Lost to Follow-up|0|||
156430786|NCT03523962|564666168|FG000|Closed Fractures|Withdrawal by Subject|19|||
156430787|NCT03523962|564666169|FG001|Closed Fractures|Withdrawal by Subject|29|||
156430788|NCT03523962|564666170|FG002|Closed Fractures|Withdrawal by Subject|0|||
156430789|NCT03523962|564666171|FG003|Closed Fractures|Withdrawal by Subject|0|||
156430790|NCT03523962|564666168|FG000|Closed Fractures|Incarceration|1|||
156430791|NCT03523962|564666169|FG001|Closed Fractures|Incarceration|4|||
156430792|NCT03523962|564666170|FG002|Closed Fractures|Incarceration|0|||
156430793|NCT03523962|564666171|FG003|Closed Fractures|Incarceration|0|||
156430794|NCT03523962|564666168|FG000|Open Fractures|Death|0|||
156430795|NCT03523962|564666169|FG001|Open Fractures|Death|0|||
156430796|NCT03523962|564666170|FG002|Open Fractures|Death|11|||
156430797|NCT03523962|564666171|FG003|Open Fractures|Death|6|||
156430798|NCT03523962|564666168|FG000|Open Fractures|Lost to Follow-up|0|||
156667721|NCT01660243|565532381|FG000|Overall Study|Adverse Event|1|||
156326296|NCT03552965|564294332|FG000|Overall Study|Death|1|||
156326297|NCT03552965|564294333|FG001|Overall Study|Death|1|||
156430799|NCT03523962|564666169|FG001|Open Fractures|Lost to Follow-up|0|||
156430800|NCT03523962|564666170|FG002|Open Fractures|Lost to Follow-up|15|||
156779096|NCT04556097|565940655|FG003|Overall Study|Ineligible, language|0|||
156779097|NCT04556097|565940652|FG000|Overall Study|Ineligible, no longer in care management|0|||
156779098|NCT04556097|565940653|FG001|Overall Study|Ineligible, no longer in care management|2|||
156779099|NCT04556097|565940654|FG002|Overall Study|Ineligible, no longer in care management|1|||
156779100|NCT04556097|565940655|FG003|Overall Study|Ineligible, no longer in care management|0|||
156779101|NCT04556097|565940652|FG000|Overall Study|No dementia|13|||
156779102|NCT04556097|565940653|FG001|Overall Study|No dementia|3|||
156779103|NCT04556097|565940654|FG002|Overall Study|No dementia|0|||
156779104|NCT04556097|565940655|FG003|Overall Study|No dementia|0|||
156779105|NCT04556097|565940652|FG000|Overall Study|Missing identifier|2|||
156779106|NCT04556097|565940653|FG001|Overall Study|Missing identifier|4|||
156779107|NCT04556097|565940654|FG002|Overall Study|Missing identifier|0|||
156779108|NCT04556097|565940655|FG003|Overall Study|Missing identifier|0|||
156779109|NCT04556097|565940652|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
156779110|NCT04556097|565940653|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
156779111|NCT04556097|565940654|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
156779112|NCT04556097|565940655|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
156779113|NCT05436613|565940656|FG000|Overall Study|Lost to Follow-up|9|||
156779114|NCT05436613|565940656|FG000|Overall Study|Withdrawal by Subject|3|||
156779115|NCT06239610|565940661|FG000|Overall Study|no usable migration data for minimum of one day|11|||
156779116|NCT00765076|565940662|FG000|Overall Study|Adverse Event|1|||
156779117|NCT00765076|565940663|FG001|Overall Study|Adverse Event|0|||
156779118|NCT00765076|565940664|FG002|Overall Study|Adverse Event|0|||
156779119|NCT00765076|565940662|FG000|Overall Study|Withdrawal by Subject|0|||
156779120|NCT00765076|565940663|FG001|Overall Study|Withdrawal by Subject|0|||
156779121|NCT00765076|565940664|FG002|Overall Study|Withdrawal by Subject|1|||
156779122|NCT01164475|565940665|FG000|Overall Study|Lack of Efficacy|1|||
156779123|NCT01164475|565940666|FG001|Overall Study|Lack of Efficacy|0|||
156779124|NCT01164475|565940665|FG000|Overall Study|Other|0|||
156779125|NCT01164475|565940666|FG001|Overall Study|Other|1|||
156779126|NCT01164475|565940665|FG000|Overall Study|Progressive disease|0|||
156779127|NCT01164475|565940666|FG001|Overall Study|Progressive disease|1|||
156779128|NCT01164475|565940665|FG000|Overall Study|Protocol Violation|1|||
156779129|NCT01164475|565940666|FG001|Overall Study|Protocol Violation|0|||
156779130|NCT02335944|565940667|FG000|Treatment Phase|Progressive Disease|2|||
156779131|NCT02335944|565940668|FG001|Treatment Phase|Progressive Disease|5|||
156779132|NCT02335944|565940669|FG002|Treatment Phase|Progressive Disease|2|||
156779133|NCT02335944|565940670|FG003|Treatment Phase|Progressive Disease|11|||
156779134|NCT02335944|565940671|FG004|Treatment Phase|Progressive Disease|4|||
156779135|NCT02335944|565940672|FG005|Treatment Phase|Progressive Disease|25|||
156779136|NCT02335944|565940673|FG006|Treatment Phase|Progressive Disease|2|||
156779137|NCT02335944|565940674|FG007|Treatment Phase|Progressive Disease|30|||
156866137|NCT01342211|566269177|FG002|Overall Study|Withdrawal by Subject|0|||
156667722|NCT01660243|565532382|FG001|Overall Study|Adverse Event|0|||
156667723|NCT01660243|565532383|FG002|Overall Study|Adverse Event|1|||
156667724|NCT01660243|565532384|FG003|Overall Study|Adverse Event|0|||
156667725|NCT01660243|565532381|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
156667726|NCT01660243|565532382|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
156667727|NCT01660243|565532383|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
156667728|NCT01660243|565532384|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
156667729|NCT01660243|565532381|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
156667730|NCT01660243|565532382|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
156667731|NCT01660243|565532383|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
156667732|NCT01660243|565532384|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
156667733|NCT01660243|565532381|FG000|Overall Study|Randomization error|0|||
156667734|NCT01660243|565532382|FG001|Overall Study|Randomization error|0|||
156667735|NCT01660243|565532383|FG002|Overall Study|Randomization error|0|||
156667736|NCT01660243|565532384|FG003|Overall Study|Randomization error|1|||
156667737|NCT03025087|565532385|FG000|Overall Study|Physician Decision|3|||
156667738|NCT03025087|565532386|FG001|Overall Study|Physician Decision|3|||
156667739|NCT03025087|565532387|FG002|Overall Study|Physician Decision|0|||
156667740|NCT03025087|565532388|FG003|Overall Study|Physician Decision|0|||
156667741|NCT03025087|565532389|FG004|Overall Study|Physician Decision|0|||
156667742|NCT03025087|565532385|FG000|Overall Study|Withdrawal by Subject|1|||
156667743|NCT03025087|565532386|FG001|Overall Study|Withdrawal by Subject|1|||
156667744|NCT03025087|565532387|FG002|Overall Study|Withdrawal by Subject|0|||
156667745|NCT03025087|565532388|FG003|Overall Study|Withdrawal by Subject|0|||
156667746|NCT03025087|565532389|FG004|Overall Study|Withdrawal by Subject|0|||
156667747|NCT03025087|565532385|FG000|Overall Study|Unable to complete MRI|2|||
156667748|NCT03025087|565532386|FG001|Overall Study|Unable to complete MRI|2|||
156525598|NCT00261846|565019394|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156525599|NCT00261846|565019395|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
156525600|NCT00261846|565019384|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
156525601|NCT00261846|565019385|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
156525602|NCT00261846|565019386|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
156525603|NCT00261846|565019387|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
156525604|NCT00261846|565019388|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
156525605|NCT00261846|565019389|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
156525606|NCT00261846|565019390|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
156525607|NCT00261846|565019391|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
156525608|NCT00261846|565019392|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
156525609|NCT00261846|565019393|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
156525610|NCT00261846|565019394|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
156525611|NCT00261846|565019395|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
156525612|NCT00261846|565019384|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
156525613|NCT00261846|565019385|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
156525614|NCT00261846|565019386|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
156525615|NCT00261846|565019387|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
156525616|NCT00261846|565019388|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
156525617|NCT00261846|565019389|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
156525618|NCT00261846|565019390|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
156525619|NCT00261846|565019391|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
156525620|NCT00261846|565019392|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
156525621|NCT00261846|565019393|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
156525622|NCT00261846|565019394|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
156525623|NCT00261846|565019395|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
156525624|NCT00261846|565019384|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
156525625|NCT00261846|565019385|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
156525626|NCT00261846|565019386|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
156525627|NCT00261846|565019387|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
156525628|NCT00261846|565019388|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
156525629|NCT00261846|565019389|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
156525630|NCT00261846|565019390|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
156525631|NCT00261846|565019391|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
156525632|NCT00261846|565019392|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
156525633|NCT00261846|565019393|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
156525634|NCT00261846|565019394|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
156525635|NCT00261846|565019395|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
156525636|NCT00261846|565019384|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
156525637|NCT00261846|565019385|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
156525638|NCT00261846|565019386|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
156525639|NCT00261846|565019387|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
156525640|NCT00261846|565019388|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
156525641|NCT00261846|565019389|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
156525642|NCT00261846|565019390|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
156525643|NCT00261846|565019391|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
156525644|NCT00261846|565019392|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
156525645|NCT00261846|565019393|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
156525646|NCT00261846|565019394|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
156525647|NCT00261846|565019395|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
156525648|NCT00261846|565019384|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
156779138|NCT02335944|565940675|FG008|Treatment Phase|Progressive Disease|27|||
156779139|NCT02335944|565940676|FG009|Treatment Phase|Progressive Disease|0|||
156779140|NCT02335944|565940667|FG000|Treatment Phase|Adverse Event|2|||
156779141|NCT02335944|565940668|FG001|Treatment Phase|Adverse Event|0|||
156779142|NCT02335944|565940669|FG002|Treatment Phase|Adverse Event|0|||
156525649|NCT00261846|565019385|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
156525650|NCT00261846|565019386|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
156525651|NCT00261846|565019387|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
156525652|NCT00261846|565019388|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
156525653|NCT00261846|565019389|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
156525654|NCT00261846|565019390|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
156525655|NCT00261846|565019391|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
156779143|NCT02335944|565940670|FG003|Treatment Phase|Adverse Event|2|||
156525656|NCT00261846|565019392|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
156779144|NCT02335944|565940671|FG004|Treatment Phase|Adverse Event|1|||
156525657|NCT00261846|565019393|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
156525658|NCT00261846|565019394|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
156525659|NCT00261846|565019395|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
156525660|NCT01776424|565019396|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
156525661|NCT01776424|565019397|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
156525662|NCT01776424|565019398|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
156779145|NCT02335944|565940672|FG005|Treatment Phase|Adverse Event|15|||
156779146|NCT02335944|565940673|FG006|Treatment Phase|Adverse Event|0|||
156779147|NCT02335944|565940674|FG007|Treatment Phase|Adverse Event|5|||
156779148|NCT02335944|565940675|FG008|Treatment Phase|Adverse Event|7|||
156779149|NCT02335944|565940676|FG009|Treatment Phase|Adverse Event|0|||
156779150|NCT02335944|565940667|FG000|Treatment Phase|Physician Decision|0|||
156779151|NCT02335944|565940668|FG001|Treatment Phase|Physician Decision|0|||
156779152|NCT02335944|565940669|FG002|Treatment Phase|Physician Decision|0|||
156779153|NCT02335944|565940670|FG003|Treatment Phase|Physician Decision|1|||
156779154|NCT02335944|565940671|FG004|Treatment Phase|Physician Decision|0|||
156779155|NCT02335944|565940672|FG005|Treatment Phase|Physician Decision|6|||
156779156|NCT02335944|565940673|FG006|Treatment Phase|Physician Decision|1|||
156779157|NCT02335944|565940674|FG007|Treatment Phase|Physician Decision|2|||
156779158|NCT02335944|565940675|FG008|Treatment Phase|Physician Decision|1|||
156779159|NCT02335944|565940676|FG009|Treatment Phase|Physician Decision|0|||
156779160|NCT02335944|565940667|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
156779161|NCT02335944|565940668|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
156779162|NCT02335944|565940669|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
156779163|NCT02335944|565940670|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
156779164|NCT02335944|565940671|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
156779165|NCT02335944|565940672|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
156779166|NCT02335944|565940673|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
156779167|NCT02335944|565940674|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
156779168|NCT02335944|565940675|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
156779169|NCT02335944|565940676|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
156779170|NCT02335944|565940667|FG000|Treatment Phase|Subject/Guardian Decision|0|||
156779171|NCT02335944|565940668|FG001|Treatment Phase|Subject/Guardian Decision|0|||
156779172|NCT02335944|565940669|FG002|Treatment Phase|Subject/Guardian Decision|1|||
156779173|NCT02335944|565940670|FG003|Treatment Phase|Subject/Guardian Decision|0|||
156779174|NCT02335944|565940671|FG004|Treatment Phase|Subject/Guardian Decision|0|||
156779175|NCT02335944|565940672|FG005|Treatment Phase|Subject/Guardian Decision|1|||
156779176|NCT02335944|565940673|FG006|Treatment Phase|Subject/Guardian Decision|0|||
156779177|NCT02335944|565940674|FG007|Treatment Phase|Subject/Guardian Decision|4|||
156779178|NCT02335944|565940675|FG008|Treatment Phase|Subject/Guardian Decision|0|||
156779179|NCT02335944|565940676|FG009|Treatment Phase|Subject/Guardian Decision|0|||
156779180|NCT02335944|565940667|FG000|Post-treatment Follow-up|Progressive Disease|0|||
156779181|NCT02335944|565940668|FG001|Post-treatment Follow-up|Progressive Disease|0|||
156779182|NCT02335944|565940669|FG002|Post-treatment Follow-up|Progressive Disease|0|||
156779183|NCT02335944|565940670|FG003|Post-treatment Follow-up|Progressive Disease|1|||
156779184|NCT02335944|565940671|FG004|Post-treatment Follow-up|Progressive Disease|0|||
156779185|NCT02335944|565940672|FG005|Post-treatment Follow-up|Progressive Disease|9|||
156779186|NCT02335944|565940673|FG006|Post-treatment Follow-up|Progressive Disease|0|||
156779187|NCT02335944|565940674|FG007|Post-treatment Follow-up|Progressive Disease|2|||
156779188|NCT02335944|565940675|FG008|Post-treatment Follow-up|Progressive Disease|3|||
156779189|NCT02335944|565940676|FG009|Post-treatment Follow-up|Progressive Disease|0|||
156779190|NCT02335944|565940667|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779191|NCT02335944|565940668|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779192|NCT02335944|565940669|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779193|NCT02335944|565940670|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779194|NCT02335944|565940671|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779195|NCT02335944|565940672|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
156779196|NCT02335944|565940673|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779197|NCT02335944|565940674|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779198|NCT02335944|565940675|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779199|NCT02335944|565940676|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779200|NCT02335944|565940667|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779201|NCT02335944|565940668|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779202|NCT02335944|565940669|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779203|NCT02335944|565940670|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779204|NCT02335944|565940671|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779205|NCT02335944|565940672|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779206|NCT02335944|565940673|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779207|NCT02335944|565940674|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
156779208|NCT02335944|565940675|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779209|NCT02335944|565940676|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779210|NCT02335944|565940667|FG000|Post-treatment Follow-up|Adverse Event|0|||
156779211|NCT02335944|565940668|FG001|Post-treatment Follow-up|Adverse Event|0|||
156779212|NCT02335944|565940669|FG002|Post-treatment Follow-up|Adverse Event|0|||
156779213|NCT02335944|565940670|FG003|Post-treatment Follow-up|Adverse Event|0|||
156779214|NCT02335944|565940671|FG004|Post-treatment Follow-up|Adverse Event|0|||
156779215|NCT02335944|565940672|FG005|Post-treatment Follow-up|Adverse Event|1|||
156525663|NCT01776424|565019396|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
156779216|NCT02335944|565940673|FG006|Post-treatment Follow-up|Adverse Event|0|||
156779217|NCT02335944|565940674|FG007|Post-treatment Follow-up|Adverse Event|0|||
156326298|NCT03552965|564294332|FG000|Overall Study|Lost to Follow-up|1|||
156326299|NCT03552965|564294333|FG001|Overall Study|Lost to Follow-up|1|||
156779218|NCT02335944|565940675|FG008|Post-treatment Follow-up|Adverse Event|0|||
156779219|NCT02335944|565940676|FG009|Post-treatment Follow-up|Adverse Event|0|||
156779220|NCT02335944|565940667|FG000|Post-treatment Follow-up|Death|0|||
156779221|NCT02335944|565940668|FG001|Post-treatment Follow-up|Death|0|||
156779222|NCT02335944|565940669|FG002|Post-treatment Follow-up|Death|0|||
156779223|NCT02335944|565940670|FG003|Post-treatment Follow-up|Death|1|||
156779224|NCT02335944|565940671|FG004|Post-treatment Follow-up|Death|0|||
156779225|NCT02335944|565940672|FG005|Post-treatment Follow-up|Death|1|||
156779226|NCT02335944|565940673|FG006|Post-treatment Follow-up|Death|0|||
156779227|NCT02335944|565940674|FG007|Post-treatment Follow-up|Death|0|||
156779228|NCT02335944|565940675|FG008|Post-treatment Follow-up|Death|0|||
156779229|NCT02335944|565940676|FG009|Post-treatment Follow-up|Death|0|||
156779230|NCT02335944|565940667|FG000|Post-treatment Follow-up|Physician Decision|1|||
156779231|NCT02335944|565940668|FG001|Post-treatment Follow-up|Physician Decision|0|||
156779232|NCT02335944|565940669|FG002|Post-treatment Follow-up|Physician Decision|0|||
156779233|NCT02335944|565940670|FG003|Post-treatment Follow-up|Physician Decision|0|||
156779234|NCT02335944|565940671|FG004|Post-treatment Follow-up|Physician Decision|0|||
156779235|NCT02335944|565940672|FG005|Post-treatment Follow-up|Physician Decision|0|||
156779236|NCT02335944|565940673|FG006|Post-treatment Follow-up|Physician Decision|0|||
156779237|NCT02335944|565940674|FG007|Post-treatment Follow-up|Physician Decision|1|||
156779238|NCT02335944|565940675|FG008|Post-treatment Follow-up|Physician Decision|0|||
156779239|NCT02335944|565940676|FG009|Post-treatment Follow-up|Physician Decision|0|||
156779240|NCT02406612|565940677|FG000|Overall Study|Screening Failure|3|||
156779241|NCT02406612|565940678|FG001|Overall Study|Screening Failure|0|||
156779242|NCT02406612|565940677|FG000|Overall Study|Intra-procedural Exclusion|1|||
156779243|NCT02406612|565940678|FG001|Overall Study|Intra-procedural Exclusion|3|||
156779244|NCT02406612|565940677|FG000|Overall Study|Guidewire Failure|0|||
156779245|NCT02406612|565940678|FG001|Overall Study|Guidewire Failure|1|||
156779246|NCT02900976|565940685|FG000|Overall Study|Adverse Event|0|||
156779247|NCT02900976|565940686|FG001|Overall Study|Adverse Event|1|||
156779248|NCT02900976|565940685|FG000|Overall Study|Physician Decision|0|||
156779249|NCT02900976|565940686|FG001|Overall Study|Physician Decision|2|||
156779250|NCT02900976|565940685|FG000|Overall Study|Progressive disease|0|||
156779251|NCT02900976|565940686|FG001|Overall Study|Progressive disease|6|||
156779252|NCT02337686|565940699|FG000|Overall Study|Adverse Event|1|||
156430801|NCT03523962|564666171|FG003|Open Fractures|Lost to Follow-up|8|||
156430802|NCT03523962|564666168|FG000|Open Fractures|Withdrawal by Subject|0|||
156430803|NCT03523962|564666169|FG001|Open Fractures|Withdrawal by Subject|0|||
156430804|NCT03523962|564666170|FG002|Open Fractures|Withdrawal by Subject|6|||
156430805|NCT03523962|564666171|FG003|Open Fractures|Withdrawal by Subject|2|||
156430806|NCT03523962|564666168|FG000|Open Fractures|Incarceration|0|||
156430807|NCT03523962|564666169|FG001|Open Fractures|Incarceration|0|||
156430808|NCT03523962|564666170|FG002|Open Fractures|Incarceration|1|||
156430809|NCT03523962|564666171|FG003|Open Fractures|Incarceration|0|||
156430810|NCT03593070|564666172|FG000|Overall Study|administrative withdrawal|1|||
156430811|NCT03593070|564666173|FG001|Overall Study|administrative withdrawal|1|||
156430812|NCT04550039|564666179|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
156430813|NCT04550039|564666180|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
156430814|NCT04550039|564666179|FG000|Overall Study|patient self-withdrew from study|0|||
156430815|NCT04550039|564666180|FG001|Overall Study|patient self-withdrew from study|1|||
156430816|NCT00554801|564666183|FG000|Overall Study|left area before completion|5|||
156430817|NCT00554801|564666184|FG001|Overall Study|left area before completion|0|||
156430818|NCT00554801|564666183|FG000|Overall Study|Withdrawal by Subject|14|||
156430819|NCT00554801|564666184|FG001|Overall Study|Withdrawal by Subject|0|||
156430820|NCT05196737|564666185|FG000|Non-intervention Week|Lost to Follow-up|2|||
156525664|NCT01776424|565019397|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
156525665|NCT01776424|565019398|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
156326300|NCT03552965|564294332|FG000|Overall Study|Physician Decision|1|||
156326301|NCT03552965|564294333|FG001|Overall Study|Physician Decision|1|||
156326302|NCT03552965|564294332|FG000|Overall Study|Withdrawal by Subject|0|||
156326303|NCT03552965|564294333|FG001|Overall Study|Withdrawal by Subject|2|||
156326304|NCT03552965|564294332|FG000|Overall Study|Continuation not in patient best interest|1|||
156326305|NCT03552965|564294333|FG001|Overall Study|Continuation not in patient best interest|0|||
156326306|NCT03552965|564294332|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
156430821|NCT05196737|564666185|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
156430822|NCT00828945|564666188|FG000|Overall Study|Death|4|||
156430823|NCT00828945|564666188|FG000|Overall Study|Participant was missing|1|||
156430824|NCT00828945|564666188|FG000|Overall Study|Other|36|||
156430825|NCT04222959|564666189|FG000|Overall Study|Lost to Follow-up|76|||
156430826|NCT04222959|564666190|FG001|Overall Study|Lost to Follow-up|28|||
156779253|NCT00876395|565942525|FG000|Overall Study|Untreated|8|||
156779254|NCT00876395|565942526|FG001|Overall Study|Untreated|1|||
156326307|NCT03552965|564294333|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
156430827|NCT00708097|564666203|FG000|Period 1|Protocol Violation|0|||
156667749|NCT03025087|565532387|FG002|Overall Study|Unable to complete MRI|0|||
156667750|NCT03025087|565532388|FG003|Overall Study|Unable to complete MRI|0|||
156667751|NCT03025087|565532389|FG004|Overall Study|Unable to complete MRI|0|||
156667752|NCT00508651|565532390|FG000|Overall Study|Lost to Follow-up|3|||
156667753|NCT00508651|565532391|FG001|Overall Study|Lost to Follow-up|1|||
156667754|NCT00508651|565532390|FG000|Overall Study|Withdrawal by Subject|1|||
156667755|NCT00508651|565532391|FG001|Overall Study|Withdrawal by Subject|1|||
156667756|NCT00461786|565532392|FG000|Overall Study|Entry Criteria Not Met|2|||
156667757|NCT00461786|565532392|FG000|Overall Study|Inevaluable (Never Treated)|1|||
156667758|NCT02576938|565532393|FG000|Overall Study|Adverse Event|5|||
156667759|NCT02576938|565532394|FG001|Overall Study|Adverse Event|3|||
156667760|NCT02576938|565532395|FG002|Overall Study|Adverse Event|6|||
156667761|NCT02576938|565532393|FG000|Overall Study|Protocol Violation|1|||
156667762|NCT02576938|565532394|FG001|Overall Study|Protocol Violation|1|||
156667763|NCT02576938|565532395|FG002|Overall Study|Protocol Violation|1|||
156667764|NCT02576938|565532393|FG000|Overall Study|Withdrawal by Subject|3|||
156667765|NCT02576938|565532394|FG001|Overall Study|Withdrawal by Subject|2|||
156667766|NCT02576938|565532395|FG002|Overall Study|Withdrawal by Subject|4|||
156667767|NCT02576938|565532393|FG000|Overall Study|Lack of Efficacy|9|||
156667768|NCT02576938|565532394|FG001|Overall Study|Lack of Efficacy|4|||
156667769|NCT02576938|565532395|FG002|Overall Study|Lack of Efficacy|0|||
156667770|NCT02576938|565532393|FG000|Overall Study|Lost to Follow-up|2|||
156667771|NCT02576938|565532394|FG001|Overall Study|Lost to Follow-up|0|||
156667772|NCT02576938|565532395|FG002|Overall Study|Lost to Follow-up|1|||
156667773|NCT02576938|565532393|FG000|Overall Study|Physician Decision|0|||
156667774|NCT02576938|565532394|FG001|Overall Study|Physician Decision|1|||
156667775|NCT02576938|565532395|FG002|Overall Study|Physician Decision|0|||
156667776|NCT02576938|565532393|FG000|Overall Study|Met Exclusion Criteria|0|||
156667777|NCT02576938|565532394|FG001|Overall Study|Met Exclusion Criteria|1|||
156667778|NCT02576938|565532395|FG002|Overall Study|Met Exclusion Criteria|0|||
156667779|NCT03098394|565532399|FG000|Overall Study|Pregnancy|0|||
156667780|NCT03098394|565532400|FG001|Overall Study|Pregnancy|1|||
156667781|NCT01518972|565532403|FG000|Overall Study|Lost to Follow-up|2|||
156667782|NCT01518972|565532404|FG001|Overall Study|Lost to Follow-up|1|||
156667783|NCT01518972|565532403|FG000|Overall Study|Withdrawal by Subject|1|||
156667784|NCT01518972|565532404|FG001|Overall Study|Withdrawal by Subject|0|||
156667785|NCT01518972|565532403|FG000|Overall Study|Moved from area|1|||
156667786|NCT01518972|565532404|FG001|Overall Study|Moved from area|0|||
156667787|NCT01518972|565532403|FG000|Overall Study|Transportation problems|1|||
156667788|NCT01518972|565532404|FG001|Overall Study|Transportation problems|0|||
156667789|NCT01518972|565532403|FG000|Overall Study|Exclusionary medical condition|1|||
156667790|NCT01518972|565532404|FG001|Overall Study|Exclusionary medical condition|0|||
156667791|NCT01518972|565532403|FG000|Overall Study|Missed safety visits|0|||
156667792|NCT01518972|565532404|FG001|Overall Study|Missed safety visits|1|||
156667793|NCT01518972|565532403|FG000|Overall Study|Exclusionary medication|0|||
156667794|NCT01518972|565532404|FG001|Overall Study|Exclusionary medication|1|||
156779255|NCT00876395|565942525|FG000|Overall Study|Adverse Event|63|||
156779256|NCT00876395|565942526|FG001|Overall Study|Adverse Event|11|||
156779257|NCT00876395|565942525|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156779258|NCT00876395|565942526|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156779259|NCT00876395|565942525|FG000|Overall Study|Disease progression|259|||
156326308|NCT04571515|564294334|FG000|Overall Study|Physician Decision|0|||
156326309|NCT04571515|564294335|FG001|Overall Study|Physician Decision|0|||
156326310|NCT04571515|564294336|FG002|Overall Study|Physician Decision|0|||
156326311|NCT04571515|564294337|FG003|Overall Study|Physician Decision|0|||
156326312|NCT04571515|564294338|FG004|Overall Study|Physician Decision|1|||
156326313|NCT04571515|564294334|FG000|Overall Study|Withdrawal by Subject|0|||
156326314|NCT04571515|564294335|FG001|Overall Study|Withdrawal by Subject|0|||
156326315|NCT04571515|564294336|FG002|Overall Study|Withdrawal by Subject|0|||
156326316|NCT04571515|564294337|FG003|Overall Study|Withdrawal by Subject|0|||
156326317|NCT04571515|564294338|FG004|Overall Study|Withdrawal by Subject|1|||
156326318|NCT04571515|564294334|FG000|Overall Study|insufficient pain|1|||
156326319|NCT04571515|564294335|FG001|Overall Study|insufficient pain|0|||
156326320|NCT04571515|564294336|FG002|Overall Study|insufficient pain|0|||
156326321|NCT04571515|564294337|FG003|Overall Study|insufficient pain|0|||
156326322|NCT04571515|564294338|FG004|Overall Study|insufficient pain|1|||
156326323|NCT02160782|564296012|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
156326324|NCT02160782|564296013|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
156326325|NCT02160782|564296014|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
156326326|NCT02160782|564296015|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
156326327|NCT02160782|564296016|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
156779260|NCT00876395|565942526|FG001|Overall Study|Disease progression|162|||
156326328|NCT02160782|564296012|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
156326329|NCT02160782|564296013|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
156326330|NCT02160782|564296014|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
156326331|NCT02160782|564296015|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
156326332|NCT02160782|564296016|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
156525666|NCT01776424|565019396|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
156525667|NCT01776424|565019397|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
156525668|NCT01776424|565019398|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
156525669|NCT01776424|565019396|FG000|LTOLE Part (Open Label)|Refused|5|||
156525670|NCT01776424|565019397|FG001|LTOLE Part (Open Label)|Refused|2|||
156525671|NCT01776424|565019398|FG002|LTOLE Part (Open Label)|Refused|11|||
156525672|NCT01776424|565019396|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
156525673|NCT01776424|565019397|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
156525674|NCT01776424|565019398|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
156525675|NCT02294227|565019399|FG000|Overall Study|Death|0|||
156525676|NCT02294227|565019400|FG001|Overall Study|Death|0|||
156525677|NCT02294227|565019401|FG002|Overall Study|Death|1|||
156525678|NCT02294227|565019399|FG000|Overall Study|Subject/Guardian Decision|6|||
156525679|NCT02294227|565019400|FG001|Overall Study|Subject/Guardian Decision|3|||
156525680|NCT02294227|565019401|FG002|Overall Study|Subject/Guardian Decision|7|||
156525681|NCT02294227|565019399|FG000|Overall Study|Physician Decision|1|||
156525682|NCT02294227|565019400|FG001|Overall Study|Physician Decision|2|||
156525683|NCT02294227|565019401|FG002|Overall Study|Physician Decision|1|||
156525684|NCT02294227|565019399|FG000|Overall Study|Lost to Follow-up|1|||
156525685|NCT02294227|565019400|FG001|Overall Study|Lost to Follow-up|0|||
156525686|NCT02294227|565019401|FG002|Overall Study|Lost to Follow-up|0|||
156525687|NCT02294227|565019399|FG000|Overall Study|Lack of Efficacy|11|||
156525688|NCT02294227|565019400|FG001|Overall Study|Lack of Efficacy|12|||
156525689|NCT02294227|565019401|FG002|Overall Study|Lack of Efficacy|8|||
156525690|NCT02294227|565019399|FG000|Overall Study|Adverse Event|6|||
156525691|NCT02294227|565019400|FG001|Overall Study|Adverse Event|8|||
156525692|NCT02294227|565019401|FG002|Overall Study|Adverse Event|2|||
156525693|NCT00887432|565019402|FG000|Overall Study|Start Excluded Therapy|3|||
156525694|NCT00887432|565019403|FG001|Overall Study|Start Excluded Therapy|0|||
156525695|NCT00887432|565019402|FG000|Overall Study|Did not complete treatment|6|||
156525696|NCT00887432|565019403|FG001|Overall Study|Did not complete treatment|8|||
156525697|NCT00887432|565019402|FG000|Overall Study|Protocol Violation|2|||
156525698|NCT00887432|565019403|FG001|Overall Study|Protocol Violation|3|||
156525699|NCT00887432|565019402|FG000|Overall Study|Withdrawal by Subject|3|||
156525700|NCT00887432|565019403|FG001|Overall Study|Withdrawal by Subject|2|||
156525701|NCT00887432|565019402|FG000|Overall Study|Lost to Follow-up|1|||
156525702|NCT00887432|565019403|FG001|Overall Study|Lost to Follow-up|0|||
156525703|NCT00887432|565019402|FG000|Overall Study|No reason provided|0|||
156525704|NCT00887432|565019403|FG001|Overall Study|No reason provided|1|||
156525705|NCT02318797|565019407|FG000|Overall Study|Death|3|||
156525706|NCT02318797|565019408|FG001|Overall Study|Death|6|||
156525707|NCT02318797|565019407|FG000|Overall Study|Lost to Follow-up|85|||
156525708|NCT02318797|565019408|FG001|Overall Study|Lost to Follow-up|96|||
156525709|NCT01079741|565019414|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
156525710|NCT01079741|565019415|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
156525711|NCT01079741|565019416|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
156525712|NCT01079741|565019417|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
156525713|NCT01079741|565019418|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
156525714|NCT01079741|565019414|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
156525715|NCT01079741|565019415|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
156525716|NCT01079741|565019416|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
156779261|NCT00876395|565942525|FG000|Overall Study|New cancer therapy|25|||
156779262|NCT00876395|565942526|FG001|Overall Study|New cancer therapy|7|||
156779263|NCT00876395|565942525|FG000|Overall Study|Protocol Violation|5|||
156779264|NCT00876395|565942526|FG001|Overall Study|Protocol Violation|2|||
156779265|NCT00876395|565942525|FG000|Overall Study|Withdrawal by Subject|66|||
156779266|NCT00876395|565942526|FG001|Overall Study|Withdrawal by Subject|33|||
156779267|NCT00876395|565942525|FG000|Overall Study|Lost to Follow-up|2|||
156779268|NCT00876395|565942526|FG001|Overall Study|Lost to Follow-up|0|||
156779269|NCT00876395|565942525|FG000|Overall Study|Administrative problems|39|||
156779270|NCT00876395|565942526|FG001|Overall Study|Administrative problems|23|||
156779271|NCT00876395|565942525|FG000|Overall Study|Death|12|||
156779272|NCT00876395|565942526|FG001|Overall Study|Death|0|||
156779273|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Other|4|||
156779274|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Other|1|||
156779275|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
156779276|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156779277|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
156779278|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
156779279|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
156779280|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
156779281|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Death|1|||
156779282|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Death|2|||
156779283|NCT02175758|565942548|FG000|Treatment Phase|Lost to Follow-up|0|||
156779284|NCT02175758|565942549|FG001|Treatment Phase|Lost to Follow-up|1|||
156779285|NCT02175758|565942550|FG002|Treatment Phase|Lost to Follow-up|0|||
156779286|NCT02175758|565942551|FG003|Treatment Phase|Lost to Follow-up|0|||
156667795|NCT01518972|565532403|FG000|Overall Study|Declined medication starting on day 12|0|||
156667796|NCT01518972|565532404|FG001|Overall Study|Declined medication starting on day 12|1|||
156667797|NCT01294917|565532407|FG000|Overall Study|Relocation|5|||
156667798|NCT01294917|565532407|FG000|Overall Study|Inconvenience|1|||
156667799|NCT02159950|565532411|FG000|Overall Study|Adverse Event|0|||
156667800|NCT02159950|565532412|FG001|Overall Study|Adverse Event|1|||
156667801|NCT02159950|565532411|FG000|Overall Study|Progression|0|||
156667802|NCT02159950|565532412|FG001|Overall Study|Progression|1|||
156667803|NCT00003659|565532414|FG000|Overall Study|Withdrawal by Subject|3|||
156667804|NCT03285594|565532420|FG000|Overall Study|At the Participant's Own Request|10|||
156667805|NCT03285594|565532421|FG001|Overall Study|At the Participant's Own Request|5|||
156667806|NCT03285594|565532422|FG002|Overall Study|At the Participant's Own Request|21|||
156667807|NCT03285594|565532420|FG000|Overall Study|Adverse Event|2|||
156667808|NCT03285594|565532421|FG001|Overall Study|Adverse Event|2|||
156667809|NCT03285594|565532422|FG002|Overall Study|Adverse Event|6|||
156667810|NCT03285594|565532420|FG000|Overall Study|Poor Compliance to Protocol|0|||
156667811|NCT03285594|565532421|FG001|Overall Study|Poor Compliance to Protocol|0|||
156667812|NCT03285594|565532422|FG002|Overall Study|Poor Compliance to Protocol|1|||
156667813|NCT03285594|565532420|FG000|Overall Study|Lost to Follow-up|0|||
156667814|NCT03285594|565532421|FG001|Overall Study|Lost to Follow-up|0|||
156667815|NCT03285594|565532422|FG002|Overall Study|Lost to Follow-up|1|||
156667816|NCT03285594|565532420|FG000|Overall Study|Reason Not Specified|3|||
156667817|NCT03285594|565532421|FG001|Overall Study|Reason Not Specified|4|||
156667818|NCT03285594|565532422|FG002|Overall Study|Reason Not Specified|8|||
156667819|NCT03733444|565532423|FG000|Overall Study|Adverse Event|8|||
156667820|NCT03733444|565532424|FG001|Overall Study|Adverse Event|10|||
156667821|NCT03733444|565532425|FG002|Overall Study|Adverse Event|5|||
156667822|NCT03733444|565532423|FG000|Overall Study|Death|20|||
156667823|NCT03733444|565532424|FG001|Overall Study|Death|19|||
156667824|NCT03733444|565532425|FG002|Overall Study|Death|11|||
156667825|NCT03733444|565532423|FG000|Overall Study|Lost to Follow-up|3|||
156667826|NCT03733444|565532424|FG001|Overall Study|Lost to Follow-up|0|||
156667827|NCT03733444|565532425|FG002|Overall Study|Lost to Follow-up|1|||
156667828|NCT03733444|565532423|FG000|Overall Study|Lack of Efficacy|0|||
156667829|NCT03733444|565532424|FG001|Overall Study|Lack of Efficacy|1|||
156525717|NCT01079741|565019417|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
156326333|NCT02160782|564296012|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
156326334|NCT02160782|564296013|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
156326335|NCT02160782|564296014|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
156326336|NCT02160782|564296015|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
156525718|NCT01079741|565019418|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
156525719|NCT00511472|565019419|FG000|Overall Study|Clinical Adverse Event|1|||
156525720|NCT00511472|565019420|FG001|Overall Study|Clinical Adverse Event|2|||
156525721|NCT00511472|565019419|FG000|Overall Study|Laboratory Adverse Event|0|||
156525722|NCT00511472|565019420|FG001|Overall Study|Laboratory Adverse Event|2|||
156525723|NCT00511472|565019419|FG000|Overall Study|Not reported|2|||
156525724|NCT00511472|565019420|FG001|Overall Study|Not reported|2|||
156525725|NCT00446992|565019421|FG000|Overall Study|Adverse Event|11|||
156525726|NCT00446992|565019421|FG000|Overall Study|Lost to Follow-up|5|||
156525727|NCT00406653|565019422|FG000|Induction Period|Adverse Event|1|||
156525728|NCT00406653|565019423|FG001|Induction Period|Adverse Event|10|||
156525729|NCT00406653|565019424|FG002|Induction Period|Adverse Event|4|||
156525730|NCT00406653|565019425|FG003|Induction Period|Adverse Event|11|||
156525731|NCT00406653|565019426|FG004|Induction Period|Adverse Event|0|||
156525732|NCT00406653|565019427|FG005|Induction Period|Adverse Event|0|||
156525733|NCT00406653|565019428|FG006|Induction Period|Adverse Event|0|||
156525734|NCT00406653|565019422|FG000|Induction Period|Lack of Efficacy|11|||
156525735|NCT00406653|565019423|FG001|Induction Period|Lack of Efficacy|14|||
156667830|NCT03733444|565532425|FG002|Overall Study|Lack of Efficacy|1|||
156326337|NCT02160782|564296016|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
156326338|NCT02160782|564296012|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
156326339|NCT02160782|564296013|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
156326340|NCT02160782|564296014|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
156525736|NCT00406653|565019424|FG002|Induction Period|Lack of Efficacy|8|||
156525737|NCT00406653|565019425|FG003|Induction Period|Lack of Efficacy|10|||
156525738|NCT00406653|565019426|FG004|Induction Period|Lack of Efficacy|0|||
156525739|NCT00406653|565019427|FG005|Induction Period|Lack of Efficacy|0|||
156525740|NCT00406653|565019428|FG006|Induction Period|Lack of Efficacy|0|||
156667831|NCT03733444|565532423|FG000|Overall Study|Physician Decision|2|||
156667832|NCT03733444|565532424|FG001|Overall Study|Physician Decision|1|||
156667833|NCT03733444|565532425|FG002|Overall Study|Physician Decision|0|||
156779287|NCT02175758|565942552|FG004|Treatment Phase|Lost to Follow-up|0|||
156667834|NCT03733444|565532423|FG000|Overall Study|Protocol Violation|2|||
156667835|NCT03733444|565532424|FG001|Overall Study|Protocol Violation|1|||
156667836|NCT03733444|565532425|FG002|Overall Study|Protocol Violation|0|||
156667837|NCT03733444|565532423|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
156667838|NCT03733444|565532424|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
156667839|NCT03733444|565532425|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
156667840|NCT03733444|565532423|FG000|Overall Study|Study Terminated by Sponsor|203|||
156667841|NCT03733444|565532424|FG001|Overall Study|Study Terminated by Sponsor|209|||
156667842|NCT03733444|565532425|FG002|Overall Study|Study Terminated by Sponsor|221|||
156667843|NCT03733444|565532423|FG000|Overall Study|Withdrawal by Subject|19|||
156667844|NCT03733444|565532424|FG001|Overall Study|Withdrawal by Subject|18|||
156667845|NCT03733444|565532425|FG002|Overall Study|Withdrawal by Subject|16|||
156667846|NCT03733444|565532423|FG000|Overall Study|Miscellaneous|1|||
156667847|NCT03733444|565532424|FG001|Overall Study|Miscellaneous|0|||
156667848|NCT03733444|565532425|FG002|Overall Study|Miscellaneous|1|||
156667849|NCT03733444|565532423|FG000|Overall Study|Not Treated|1|||
156667850|NCT03733444|565532424|FG001|Overall Study|Not Treated|2|||
156667851|NCT03733444|565532425|FG002|Overall Study|Not Treated|1|||
156667852|NCT02258074|565532426|FG000|Overall Study|Withdrawal by Subject|1|||
156667853|NCT02258074|565532427|FG001|Overall Study|Withdrawal by Subject|0|||
156667854|NCT02258074|565532428|FG002|Overall Study|Withdrawal by Subject|0|||
156667855|NCT02258074|565532429|FG003|Overall Study|Withdrawal by Subject|0|||
156667856|NCT04405570|565532430|FG000|Overall Study|Adverse Event|0|||
156667857|NCT04405570|565532431|FG001|Overall Study|Adverse Event|1|||
156667858|NCT04405570|565532432|FG002|Overall Study|Adverse Event|1|||
156667859|NCT04405570|565532433|FG003|Overall Study|Adverse Event|1|||
156667860|NCT04405570|565532430|FG000|Overall Study|Lost to Follow-up|0|||
156667861|NCT04405570|565532431|FG001|Overall Study|Lost to Follow-up|1|||
156667862|NCT04405570|565532432|FG002|Overall Study|Lost to Follow-up|0|||
156667863|NCT04405570|565532433|FG003|Overall Study|Lost to Follow-up|0|||
156667864|NCT04405570|565532430|FG000|Overall Study|Physician Decision|0|||
156667865|NCT04405570|565532431|FG001|Overall Study|Physician Decision|0|||
156667866|NCT04405570|565532432|FG002|Overall Study|Physician Decision|1|||
156667867|NCT04405570|565532433|FG003|Overall Study|Physician Decision|0|||
156667868|NCT04405570|565532430|FG000|Overall Study|Withdrawal by Subject|0|||
156667869|NCT04405570|565532431|FG001|Overall Study|Withdrawal by Subject|1|||
156667870|NCT04405570|565532432|FG002|Overall Study|Withdrawal by Subject|1|||
156667871|NCT04405570|565532433|FG003|Overall Study|Withdrawal by Subject|0|||
156779288|NCT02175758|565942553|FG005|Treatment Phase|Lost to Follow-up|0|||
156779289|NCT02175758|565942548|FG000|Treatment Phase|Adverse Event|0|||
156779290|NCT02175758|565942549|FG001|Treatment Phase|Adverse Event|0|||
156779291|NCT02175758|565942550|FG002|Treatment Phase|Adverse Event|0|||
156779292|NCT02175758|565942551|FG003|Treatment Phase|Adverse Event|0|||
156779293|NCT02175758|565942552|FG004|Treatment Phase|Adverse Event|1|||
156779294|NCT02175758|565942553|FG005|Treatment Phase|Adverse Event|0|||
156779295|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
156779296|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
156779297|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
156779298|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
156779299|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
156779300|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
156779301|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156779302|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156779303|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
156779304|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
156779305|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
156779306|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
156779307|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
156779308|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
156779309|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
156779310|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
156779311|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156667872|NCT04405570|565532430|FG000|Overall Study|Randomized not dosed|0|||
156667873|NCT04405570|565532431|FG001|Overall Study|Randomized not dosed|2|||
156667874|NCT04405570|565532432|FG002|Overall Study|Randomized not dosed|0|||
156779312|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
156779313|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156667875|NCT04405570|565532433|FG003|Overall Study|Randomized not dosed|0|||
156667876|NCT04499963|565532434|FG000|Overall Study|Adverse Event|3|||
156779314|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156779315|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
156667877|NCT04499963|565532435|FG001|Overall Study|Adverse Event|0|||
156667878|NCT04499963|565532434|FG000|Overall Study|Death|3|||
156667879|NCT04499963|565532435|FG001|Overall Study|Death|0|||
156667880|NCT04499963|565532434|FG000|Overall Study|Lack of Efficacy|7|||
156667881|NCT04499963|565532435|FG001|Overall Study|Lack of Efficacy|0|||
156667882|NCT04499963|565532434|FG000|Overall Study|Lost to Follow-up|2|||
156667883|NCT04499963|565532435|FG001|Overall Study|Lost to Follow-up|0|||
156779316|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
156779317|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
156779318|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
156779319|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
156779320|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
156779321|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
156779322|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
156779323|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
156779324|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
156779325|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
156779326|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
156779327|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
156779328|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
156779329|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
156779330|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
156779331|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
156779332|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
156779333|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
156779334|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
156779335|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
156779336|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
156779337|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
156779338|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
156779339|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
156779340|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
156779341|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
156779342|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
156779343|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
156779344|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
156779345|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
156779346|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
156779347|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
156779348|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
156779349|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
156779350|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
156779351|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
156779352|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
156779353|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
156779354|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
156779355|NCT01500083|565942560|FG000|Overall Study|Adverse Event|4|||
156779356|NCT01500083|565942561|FG001|Overall Study|Adverse Event|17|||
156779357|NCT01500083|565942560|FG000|Overall Study|Death|0|||
156779358|NCT01500083|565942561|FG001|Overall Study|Death|2|||
156779359|NCT01500083|565942560|FG000|Overall Study|Lost to Follow-up|1|||
156779360|NCT01500083|565942561|FG001|Overall Study|Lost to Follow-up|0|||
156779361|NCT01500083|565942560|FG000|Overall Study|Withdrawal of Consent|0|||
156779362|NCT01500083|565942561|FG001|Overall Study|Withdrawal of Consent|1|||
156779363|NCT01500083|565942560|FG000|Overall Study|Disease Progression|2|||
156779364|NCT01500083|565942561|FG001|Overall Study|Disease Progression|10|||
156779365|NCT01500083|565942560|FG000|Overall Study|Investigator Discretion|3|||
156779366|NCT01500083|565942561|FG001|Overall Study|Investigator Discretion|8|||
156779367|NCT01500083|565942560|FG000|Overall Study|Other Reasons|2|||
156779368|NCT01500083|565942561|FG001|Overall Study|Other Reasons|5|||
156779369|NCT00741611|565942562|FG000|Overall Study|Death|0|||
156779370|NCT00741611|565942563|FG001|Overall Study|Death|0|||
156779371|NCT00741611|565942564|FG002|Overall Study|Death|1|||
156779372|NCT00741611|565942562|FG000|Overall Study|Withdrawal by Subject|0|||
156779373|NCT00741611|565942563|FG001|Overall Study|Withdrawal by Subject|2|||
156779374|NCT00741611|565942564|FG002|Overall Study|Withdrawal by Subject|2|||
156779375|NCT01555931|565942567|FG000|Overall Study|Lost to Follow-up|2|||
156779376|NCT01555931|565942568|FG001|Overall Study|Lost to Follow-up|5|||
156779377|NCT01510756|565942569|FG000|Overall Study|Death|1|||
156779378|NCT01510756|565942569|FG000|Overall Study|Lack of Efficacy|2|||
156779379|NCT01510756|565942569|FG000|Overall Study|Physician Decision|1|||
156430828|NCT00708097|564666204|FG001|Period 1|Protocol Violation|1|||
156430829|NCT00708097|564666205|FG002|Period 1|Protocol Violation|0|||
156430830|NCT00708097|564666206|FG003|Period 1|Protocol Violation|2|||
156430831|NCT00708097|564666207|FG004|Period 1|Protocol Violation|0|||
156430832|NCT00708097|564666203|FG000|Period 1|Other Reason|0|||
156430833|NCT00708097|564666204|FG001|Period 1|Other Reason|0|||
156430834|NCT00708097|564666205|FG002|Period 1|Other Reason|0|||
156430835|NCT00708097|564666206|FG003|Period 1|Other Reason|0|||
156430836|NCT00708097|564666207|FG004|Period 1|Other Reason|1|||
156430837|NCT00708097|564666203|FG000|Period 2|Protocol Violation|0|||
156667884|NCT01208337|565532438|FG000|Overall Study|Death|3|||
156667885|NCT03663179|565532444|FG000|Overall Study|Withdrawal by Subject|2|||
156667886|NCT03663179|565532445|FG001|Overall Study|Withdrawal by Subject|0|||
156667887|NCT03663179|565532444|FG000|Overall Study|Lost to Follow-up|1|||
156667888|NCT03663179|565532445|FG001|Overall Study|Lost to Follow-up|1|||
156667889|NCT03663179|565532444|FG000|Overall Study|Revealed exclusionary condition|1|||
156667890|NCT03663179|565532445|FG001|Overall Study|Revealed exclusionary condition|0|||
156667891|NCT00984126|565532446|FG000|Overall Study|Protocol Violation|0|||
156667892|NCT00984126|565532447|FG001|Overall Study|Protocol Violation|0|||
156667893|NCT00984126|565532448|FG002|Overall Study|Protocol Violation|1|||
156667894|NCT00984126|565532449|FG003|Overall Study|Protocol Violation|2|||
156667895|NCT00984126|565532446|FG000|Overall Study|Adverse Event|0|||
156667896|NCT00984126|565532447|FG001|Overall Study|Adverse Event|0|||
156667897|NCT00984126|565532448|FG002|Overall Study|Adverse Event|0|||
156667898|NCT00984126|565532449|FG003|Overall Study|Adverse Event|2|||
156779380|NCT01922011|565942570|FG000|Overall Study|Protocol Violation|0|||
156779381|NCT01922011|565942571|FG001|Overall Study|Protocol Violation|1|||
156779382|NCT01922011|565942570|FG000|Overall Study|Physician Decision|0|||
156779383|NCT01922011|565942571|FG001|Overall Study|Physician Decision|1|||
156779384|NCT01922011|565942570|FG000|Overall Study|Parent/Guardian Decision|3|||
156779385|NCT01922011|565942571|FG001|Overall Study|Parent/Guardian Decision|0|||
156779386|NCT01922011|565942570|FG000|Overall Study|Lost to Follow-up|0|||
156779387|NCT01922011|565942571|FG001|Overall Study|Lost to Follow-up|1|||
156779388|NCT01922011|565942570|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
156779389|NCT01922011|565942571|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
156779390|NCT01922011|565942570|FG000|Overall Study|Not Treated|1|||
156779391|NCT01922011|565942571|FG001|Overall Study|Not Treated|0|||
156779392|NCT01922011|565942570|FG000|Overall Study|Lack of willing home health agency|1|||
156779393|NCT01922011|565942571|FG001|Overall Study|Lack of willing home health agency|0|||
156779394|NCT01922011|565942570|FG000|Overall Study|Randomized in error|1|||
156779395|NCT01922011|565942571|FG001|Overall Study|Randomized in error|0|||
156779396|NCT02299167|565942572|FG000|Overall Study|patients were excluded from the study|11|||
156779397|NCT05696847|565942579|FG000|Overall Study|Withdrawal by Subject|1|||
156779398|NCT05696847|565942580|FG001|Overall Study|Withdrawal by Subject|0|||
156779399|NCT05696847|565942581|FG002|Overall Study|Withdrawal by Subject|0|||
156779400|NCT05696847|565942582|FG003|Overall Study|Withdrawal by Subject|0|||
156779401|NCT05696847|565942583|FG004|Overall Study|Withdrawal by Subject|0|||
156779402|NCT05696847|565942584|FG005|Overall Study|Withdrawal by Subject|0|||
156779403|NCT05696847|565942579|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156779404|NCT05696847|565942580|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156779405|NCT05696847|565942581|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156779406|NCT05696847|565942582|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156779407|NCT05696847|565942583|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156779408|NCT05696847|565942584|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156779409|NCT05696847|565942579|FG000|Overall Study|Adverse Event|0|||
156779410|NCT05696847|565942580|FG001|Overall Study|Adverse Event|0|||
156779411|NCT05696847|565942581|FG002|Overall Study|Adverse Event|0|||
156779412|NCT05696847|565942582|FG003|Overall Study|Adverse Event|0|||
156779413|NCT05696847|565942583|FG004|Overall Study|Adverse Event|0|||
156779414|NCT05696847|565942584|FG005|Overall Study|Adverse Event|1|||
156779415|NCT05696847|565942579|FG000|Overall Study|Sponsor Decision|0|||
156779416|NCT05696847|565942580|FG001|Overall Study|Sponsor Decision|0|||
156779417|NCT05696847|565942581|FG002|Overall Study|Sponsor Decision|0|||
156779418|NCT05696847|565942582|FG003|Overall Study|Sponsor Decision|1|||
156779419|NCT05696847|565942583|FG004|Overall Study|Sponsor Decision|0|||
156779420|NCT05696847|565942584|FG005|Overall Study|Sponsor Decision|0|||
156779421|NCT02903914|565942585|FG000|Overall Study|Adverse Event|0|||
156779422|NCT02903914|565942586|FG001|Overall Study|Adverse Event|0|||
156779423|NCT02903914|565942587|FG002|Overall Study|Adverse Event|1|||
156779424|NCT02903914|565942588|FG003|Overall Study|Adverse Event|0|||
156779425|NCT02903914|565942589|FG004|Overall Study|Adverse Event|0|||
156779426|NCT02903914|565942590|FG005|Overall Study|Adverse Event|0|||
156779427|NCT02903914|565942591|FG006|Overall Study|Adverse Event|2|||
156779428|NCT02903914|565942592|FG007|Overall Study|Adverse Event|0|||
156667899|NCT00984126|565532446|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
156667900|NCT00984126|565532447|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
156779429|NCT02903914|565942585|FG000|Overall Study|Withdrawal by Subject|3|||
156667901|NCT00984126|565532448|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
156667902|NCT00984126|565532449|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
156667903|NCT00984126|565532446|FG000|Overall Study|Withdrawal criteria|0|||
156667904|NCT00984126|565532447|FG001|Overall Study|Withdrawal criteria|1|||
156779430|NCT02903914|565942586|FG001|Overall Study|Withdrawal by Subject|1|||
156779431|NCT02903914|565942587|FG002|Overall Study|Withdrawal by Subject|28|||
156779432|NCT02903914|565942588|FG003|Overall Study|Withdrawal by Subject|0|||
156779433|NCT02903914|565942589|FG004|Overall Study|Withdrawal by Subject|1|||
156779434|NCT02903914|565942590|FG005|Overall Study|Withdrawal by Subject|2|||
156779435|NCT02903914|565942591|FG006|Overall Study|Withdrawal by Subject|12|||
156779436|NCT02903914|565942592|FG007|Overall Study|Withdrawal by Subject|0|||
156667905|NCT00984126|565532448|FG002|Overall Study|Withdrawal criteria|3|||
156667906|NCT00984126|565532449|FG003|Overall Study|Withdrawal criteria|9|||
156667907|NCT01029340|565532450|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
156667908|NCT01029340|565532451|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
156667909|NCT01029340|565532452|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
156667910|NCT01029340|565532453|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
156667911|NCT01029340|565532454|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
156667912|NCT01029340|565532455|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
156667913|NCT01029340|565532450|FG000|Part B Treatment Period|Protocol Violation|0|||
156667914|NCT01029340|565532451|FG001|Part B Treatment Period|Protocol Violation|0|||
156667915|NCT01029340|565532452|FG002|Part B Treatment Period|Protocol Violation|1|||
156667916|NCT01029340|565532453|FG003|Part B Treatment Period|Protocol Violation|0|||
156667917|NCT01029340|565532454|FG004|Part B Treatment Period|Protocol Violation|0|||
156667918|NCT01029340|565532455|FG005|Part B Treatment Period|Protocol Violation|0|||
156667919|NCT01029340|565532450|FG000|Extension Period|Adverse Event|0|||
156667920|NCT01029340|565532451|FG001|Extension Period|Adverse Event|0|||
156667921|NCT01029340|565532452|FG002|Extension Period|Adverse Event|0|||
156667922|NCT01029340|565532453|FG003|Extension Period|Adverse Event|0|||
156667923|NCT01029340|565532454|FG004|Extension Period|Adverse Event|0|||
156667924|NCT01029340|565532455|FG005|Extension Period|Adverse Event|1|||
156667925|NCT01029340|565532450|FG000|Extension Period|starting another study|0|||
156667926|NCT01029340|565532451|FG001|Extension Period|starting another study|0|||
156667927|NCT01029340|565532452|FG002|Extension Period|starting another study|0|||
156667928|NCT01029340|565532453|FG003|Extension Period|starting another study|0|||
156667929|NCT01029340|565532454|FG004|Extension Period|starting another study|0|||
156667930|NCT01029340|565532455|FG005|Extension Period|starting another study|8|||
156667931|NCT01029340|565532450|FG000|Extension Period|non-compliance|0|||
156667932|NCT01029340|565532451|FG001|Extension Period|non-compliance|0|||
156667933|NCT01029340|565532452|FG002|Extension Period|non-compliance|0|||
156667934|NCT01029340|565532453|FG003|Extension Period|non-compliance|0|||
156667935|NCT01029340|565532454|FG004|Extension Period|non-compliance|0|||
156667936|NCT01029340|565532455|FG005|Extension Period|non-compliance|1|||
156667937|NCT01029340|565532450|FG000|Extension Period|Withdrawal by Subject|0|||
156667938|NCT01029340|565532451|FG001|Extension Period|Withdrawal by Subject|0|||
156667939|NCT01029340|565532452|FG002|Extension Period|Withdrawal by Subject|0|||
156667940|NCT01029340|565532453|FG003|Extension Period|Withdrawal by Subject|0|||
156667941|NCT01029340|565532454|FG004|Extension Period|Withdrawal by Subject|0|||
156667942|NCT01029340|565532455|FG005|Extension Period|Withdrawal by Subject|1|||
156667943|NCT01029340|565532450|FG000|Extension Period|Physician Decision|0|||
156525741|NCT00406653|565019422|FG000|Induction Period|Lost to Follow-up|0|||
156525742|NCT00406653|565019423|FG001|Induction Period|Lost to Follow-up|2|||
156525743|NCT00406653|565019424|FG002|Induction Period|Lost to Follow-up|0|||
156525744|NCT00406653|565019425|FG003|Induction Period|Lost to Follow-up|0|||
156525745|NCT00406653|565019426|FG004|Induction Period|Lost to Follow-up|0|||
156525746|NCT00406653|565019427|FG005|Induction Period|Lost to Follow-up|0|||
156525747|NCT00406653|565019428|FG006|Induction Period|Lost to Follow-up|0|||
156525748|NCT00406653|565019422|FG000|Induction Period|Withdrawal of Consent|2|||
156525749|NCT00406653|565019423|FG001|Induction Period|Withdrawal of Consent|5|||
156525750|NCT00406653|565019424|FG002|Induction Period|Withdrawal of Consent|1|||
156525751|NCT00406653|565019425|FG003|Induction Period|Withdrawal of Consent|2|||
156525752|NCT00406653|565019426|FG004|Induction Period|Withdrawal of Consent|0|||
156525753|NCT00406653|565019427|FG005|Induction Period|Withdrawal of Consent|0|||
156525754|NCT00406653|565019428|FG006|Induction Period|Withdrawal of Consent|0|||
156525755|NCT00406653|565019422|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
156525756|NCT00406653|565019423|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
156525757|NCT00406653|565019424|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
156525758|NCT00406653|565019425|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
156525759|NCT00406653|565019426|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
156525760|NCT00406653|565019427|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
156525761|NCT00406653|565019428|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
156525762|NCT00406653|565019422|FG000|Induction Period|Pregnancy|1|||
156525763|NCT00406653|565019423|FG001|Induction Period|Pregnancy|0|||
156525764|NCT00406653|565019424|FG002|Induction Period|Pregnancy|0|||
156525765|NCT00406653|565019425|FG003|Induction Period|Pregnancy|0|||
156525766|NCT00406653|565019426|FG004|Induction Period|Pregnancy|0|||
156525767|NCT00406653|565019427|FG005|Induction Period|Pregnancy|0|||
156525768|NCT00406653|565019428|FG006|Induction Period|Pregnancy|0|||
156525769|NCT00406653|565019422|FG000|Induction Period|Declined participation but followup done|0|||
156525770|NCT00406653|565019423|FG001|Induction Period|Declined participation but followup done|2|||
156525771|NCT00406653|565019424|FG002|Induction Period|Declined participation but followup done|1|||
156525772|NCT00406653|565019425|FG003|Induction Period|Declined participation but followup done|1|||
156667944|NCT01029340|565532451|FG001|Extension Period|Physician Decision|0|||
156667945|NCT01029340|565532452|FG002|Extension Period|Physician Decision|0|||
156667946|NCT01029340|565532453|FG003|Extension Period|Physician Decision|0|||
156667947|NCT01029340|565532454|FG004|Extension Period|Physician Decision|0|||
156667948|NCT01029340|565532455|FG005|Extension Period|Physician Decision|1|||
156667949|NCT02648347|565532459|FG000|Overall Study|Death|174|||
156667950|NCT02648347|565532460|FG001|Overall Study|Death|167|||
156667951|NCT02648347|565532459|FG000|Overall Study|Withdrawal by Subject|16|||
156667952|NCT02648347|565532460|FG001|Overall Study|Withdrawal by Subject|9|||
156667953|NCT02648347|565532459|FG000|Overall Study|Lost to Follow-up|18|||
156667954|NCT02648347|565532460|FG001|Overall Study|Lost to Follow-up|21|||
156667955|NCT02648347|565532459|FG000|Overall Study|Missing|1|||
156667956|NCT02648347|565532460|FG001|Overall Study|Missing|0|||
156667957|NCT02196675|565532464|FG000|Overall Study|Withdrawal by Subject|1|||
156667958|NCT02196675|565532465|FG001|Overall Study|Withdrawal by Subject|0|||
156667959|NCT02196675|565532466|FG002|Overall Study|Withdrawal by Subject|0|||
156667960|NCT02196675|565532464|FG000|Overall Study|Intra-operative surgical exclusion|1|||
156667961|NCT02196675|565532465|FG001|Overall Study|Intra-operative surgical exclusion|1|||
156667962|NCT02196675|565532466|FG002|Overall Study|Intra-operative surgical exclusion|0|||
156667963|NCT02196675|565532464|FG000|Overall Study|Protocol Violation|0|||
156667964|NCT02196675|565532465|FG001|Overall Study|Protocol Violation|1|||
156667965|NCT02196675|565532466|FG002|Overall Study|Protocol Violation|0|||
156667966|NCT02196675|565532464|FG000|Overall Study|Death|0|||
156667967|NCT02196675|565532465|FG001|Overall Study|Death|0|||
156667968|NCT02196675|565532466|FG002|Overall Study|Death|1|||
156667969|NCT02009163|565532467|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
156667970|NCT02009163|565532468|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
156667971|NCT02009163|565532469|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
156667972|NCT02009163|565532467|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
156667973|NCT02009163|565532468|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
156667974|NCT02009163|565532469|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
156667975|NCT02009163|565532467|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
156667976|NCT02009163|565532468|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
156667977|NCT02009163|565532469|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
156779437|NCT02903914|565942585|FG000|Overall Study|Progressive Disease|1|||
156779438|NCT02903914|565942586|FG001|Overall Study|Progressive Disease|0|||
156326341|NCT02160782|564296015|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
156326342|NCT02160782|564296016|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
156326343|NCT02160782|564296012|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
156326344|NCT02160782|564296013|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
156326345|NCT02160782|564296014|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
156326346|NCT02160782|564296015|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
156326347|NCT02160782|564296016|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
156326348|NCT02160782|564296012|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
156326349|NCT02160782|564296013|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
156326350|NCT02160782|564296014|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
156326351|NCT02160782|564296015|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
156326352|NCT02160782|564296016|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
156326353|NCT02160782|564296012|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
156326354|NCT02160782|564296013|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
156326355|NCT02160782|564296014|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
156326356|NCT02160782|564296015|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
156326357|NCT02160782|564296016|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
156326358|NCT02598960|564296021|FG000|Treatment Period|Disease Progression|4|||
156326359|NCT02598960|564296022|FG001|Treatment Period|Disease Progression|4|||
156326360|NCT02598960|564296023|FG002|Treatment Period|Disease Progression|4|||
156326361|NCT02598960|564296024|FG003|Treatment Period|Disease Progression|6|||
156326362|NCT02598960|564296025|FG004|Treatment Period|Disease Progression|8|||
156326363|NCT02598960|564296026|FG005|Treatment Period|Disease Progression|2|||
156326364|NCT02598960|564296027|FG006|Treatment Period|Disease Progression|2|||
156326365|NCT02598960|564296028|FG007|Treatment Period|Disease Progression|3|||
156326366|NCT02598960|564296029|FG008|Treatment Period|Disease Progression|7|||
156326367|NCT02598960|564296030|FG009|Treatment Period|Disease Progression|9|||
156326368|NCT02598960|564296031|FG010|Treatment Period|Disease Progression|7|||
156326369|NCT02598960|564296032|FG011|Treatment Period|Disease Progression|143|||
156326370|NCT02598960|564296033|FG012|Treatment Period|Disease Progression|23|||
156326371|NCT02598960|564296021|FG000|Treatment Period|Study drug toxicity|0|||
156326372|NCT02598960|564296022|FG001|Treatment Period|Study drug toxicity|0|||
156326373|NCT02598960|564296023|FG002|Treatment Period|Study drug toxicity|0|||
156326374|NCT02598960|564296024|FG003|Treatment Period|Study drug toxicity|0|||
156667978|NCT02009163|565532467|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
156667979|NCT02009163|565532468|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
156779439|NCT02903914|565942587|FG002|Overall Study|Progressive Disease|4|||
156779440|NCT02903914|565942588|FG003|Overall Study|Progressive Disease|0|||
156525773|NCT00406653|565019426|FG004|Induction Period|Declined participation but followup done|0|||
156525774|NCT00406653|565019427|FG005|Induction Period|Declined participation but followup done|0|||
156525775|NCT00406653|565019428|FG006|Induction Period|Declined participation but followup done|0|||
156779441|NCT02903914|565942589|FG004|Overall Study|Progressive Disease|0|||
156779442|NCT02903914|565942590|FG005|Overall Study|Progressive Disease|0|||
156779443|NCT02903914|565942591|FG006|Overall Study|Progressive Disease|2|||
156779444|NCT02903914|565942592|FG007|Overall Study|Progressive Disease|0|||
156779445|NCT02903914|565942585|FG000|Overall Study|Death|0|||
156779446|NCT02903914|565942586|FG001|Overall Study|Death|0|||
156779447|NCT02903914|565942587|FG002|Overall Study|Death|9|||
156779448|NCT02903914|565942588|FG003|Overall Study|Death|0|||
156779449|NCT02903914|565942589|FG004|Overall Study|Death|1|||
156779450|NCT02903914|565942590|FG005|Overall Study|Death|3|||
156779451|NCT02903914|565942591|FG006|Overall Study|Death|24|||
156779452|NCT02903914|565942592|FG007|Overall Study|Death|2|||
156779453|NCT02903914|565942585|FG000|Overall Study|Lost to Follow-up|0|||
156779454|NCT02903914|565942586|FG001|Overall Study|Lost to Follow-up|1|||
156779455|NCT02903914|565942587|FG002|Overall Study|Lost to Follow-up|0|||
156779456|NCT02903914|565942588|FG003|Overall Study|Lost to Follow-up|0|||
156779457|NCT02903914|565942589|FG004|Overall Study|Lost to Follow-up|2|||
156779458|NCT02903914|565942590|FG005|Overall Study|Lost to Follow-up|0|||
156779459|NCT02903914|565942591|FG006|Overall Study|Lost to Follow-up|1|||
156779460|NCT02903914|565942592|FG007|Overall Study|Lost to Follow-up|0|||
156779461|NCT02903914|565942585|FG000|Overall Study|Physician Decision|0|||
156779462|NCT02903914|565942586|FG001|Overall Study|Physician Decision|0|||
156779463|NCT02903914|565942587|FG002|Overall Study|Physician Decision|1|||
156779464|NCT02903914|565942588|FG003|Overall Study|Physician Decision|0|||
156779465|NCT02903914|565942589|FG004|Overall Study|Physician Decision|0|||
156779466|NCT02903914|565942590|FG005|Overall Study|Physician Decision|0|||
156779467|NCT02903914|565942591|FG006|Overall Study|Physician Decision|1|||
156779468|NCT02903914|565942592|FG007|Overall Study|Physician Decision|0|||
156779469|NCT02903914|565942585|FG000|Overall Study|Symptomatic Deterioration|0|||
156779470|NCT02903914|565942586|FG001|Overall Study|Symptomatic Deterioration|0|||
156779471|NCT02903914|565942587|FG002|Overall Study|Symptomatic Deterioration|1|||
156430838|NCT00708097|564666204|FG001|Period 2|Protocol Violation|1|||
156430839|NCT00708097|564666205|FG002|Period 2|Protocol Violation|1|||
156430840|NCT00708097|564666206|FG003|Period 2|Protocol Violation|1|||
156430841|NCT00708097|564666207|FG004|Period 2|Protocol Violation|0|||
156430842|NCT00603447|564666208|FG000|Overall Study|Adverse Event|0|||
156430843|NCT00603447|564666209|FG001|Overall Study|Adverse Event|1|||
156430844|NCT00603447|564666210|FG002|Overall Study|Adverse Event|1|||
156430845|NCT00603447|564666211|FG003|Overall Study|Adverse Event|2|||
156430846|NCT00603447|564666212|FG004|Overall Study|Adverse Event|1|||
156430847|NCT00603447|564666213|FG005|Overall Study|Adverse Event|2|||
156430848|NCT00603447|564666214|FG006|Overall Study|Adverse Event|10|||
156430849|NCT00603447|564666208|FG000|Overall Study|Other|0|||
156430850|NCT00603447|564666209|FG001|Overall Study|Other|0|||
156430851|NCT00603447|564666210|FG002|Overall Study|Other|1|||
156525776|NCT00406653|565019422|FG000|Induction Period|Given prohibited drug|0|||
156525777|NCT00406653|565019423|FG001|Induction Period|Given prohibited drug|1|||
156525778|NCT00406653|565019424|FG002|Induction Period|Given prohibited drug|2|||
156525779|NCT00406653|565019425|FG003|Induction Period|Given prohibited drug|0|||
156779472|NCT02903914|565942588|FG003|Overall Study|Symptomatic Deterioration|0|||
156779473|NCT02903914|565942589|FG004|Overall Study|Symptomatic Deterioration|0|||
156779474|NCT02903914|565942590|FG005|Overall Study|Symptomatic Deterioration|0|||
156525780|NCT00406653|565019426|FG004|Induction Period|Given prohibited drug|0|||
156525781|NCT00406653|565019427|FG005|Induction Period|Given prohibited drug|0|||
156525782|NCT00406653|565019428|FG006|Induction Period|Given prohibited drug|0|||
156525783|NCT00406653|565019422|FG000|Induction Period|Incarcerated|0|||
156525784|NCT00406653|565019423|FG001|Induction Period|Incarcerated|0|||
156525785|NCT00406653|565019424|FG002|Induction Period|Incarcerated|1|||
156525786|NCT00406653|565019425|FG003|Induction Period|Incarcerated|0|||
156525787|NCT00406653|565019426|FG004|Induction Period|Incarcerated|0|||
156525788|NCT00406653|565019427|FG005|Induction Period|Incarcerated|0|||
156525789|NCT00406653|565019428|FG006|Induction Period|Incarcerated|0|||
156525790|NCT00406653|565019422|FG000|Induction Period|Patient relocated|0|||
156525791|NCT00406653|565019423|FG001|Induction Period|Patient relocated|0|||
156525792|NCT00406653|565019424|FG002|Induction Period|Patient relocated|1|||
156525793|NCT00406653|565019425|FG003|Induction Period|Patient relocated|0|||
156525794|NCT00406653|565019426|FG004|Induction Period|Patient relocated|0|||
156525795|NCT00406653|565019427|FG005|Induction Period|Patient relocated|0|||
156779475|NCT02903914|565942591|FG006|Overall Study|Symptomatic Deterioration|0|||
156779476|NCT02903914|565942592|FG007|Overall Study|Symptomatic Deterioration|0|||
156779477|NCT02903914|565942585|FG000|Overall Study|New Cancer Therapy|2|||
156779478|NCT02903914|565942586|FG001|Overall Study|New Cancer Therapy|2|||
156430852|NCT00603447|564666211|FG003|Overall Study|Other|0|||
156430853|NCT00603447|564666212|FG004|Overall Study|Other|3|||
156430854|NCT00603447|564666213|FG005|Overall Study|Other|0|||
156430855|NCT00603447|564666214|FG006|Overall Study|Other|13|||
156430856|NCT00603447|564666208|FG000|Overall Study|Withdrew Consent|0|||
156525796|NCT00406653|565019428|FG006|Induction Period|Patient relocated|0|||
156525797|NCT00406653|565019422|FG000|Maintenance Period|Adverse Event|0|||
156779479|NCT02903914|565942587|FG002|Overall Study|New Cancer Therapy|21|||
156779480|NCT02903914|565942588|FG003|Overall Study|New Cancer Therapy|4|||
156779481|NCT02903914|565942589|FG004|Overall Study|New Cancer Therapy|3|||
156779482|NCT02903914|565942590|FG005|Overall Study|New Cancer Therapy|6|||
156779483|NCT02903914|565942591|FG006|Overall Study|New Cancer Therapy|56|||
156779484|NCT02903914|565942592|FG007|Overall Study|New Cancer Therapy|3|||
156779485|NCT02903914|565942585|FG000|Overall Study|Didn't Return to Site|1|||
156779486|NCT02903914|565942586|FG001|Overall Study|Didn't Return to Site|0|||
156779487|NCT02903914|565942587|FG002|Overall Study|Didn't Return to Site|1|||
156779488|NCT02903914|565942588|FG003|Overall Study|Didn't Return to Site|1|||
156779489|NCT02903914|565942589|FG004|Overall Study|Didn't Return to Site|0|||
156779490|NCT02903914|565942590|FG005|Overall Study|Didn't Return to Site|0|||
156779491|NCT02903914|565942591|FG006|Overall Study|Didn't Return to Site|2|||
156779492|NCT02903914|565942592|FG007|Overall Study|Didn't Return to Site|0|||
156779493|NCT02903914|565942585|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
156779494|NCT02903914|565942586|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
156779495|NCT02903914|565942587|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
156779496|NCT02903914|565942588|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
156779497|NCT02903914|565942589|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
156525798|NCT00406653|565019423|FG001|Maintenance Period|Adverse Event|0|||
156525799|NCT00406653|565019424|FG002|Maintenance Period|Adverse Event|0|||
156525800|NCT00406653|565019425|FG003|Maintenance Period|Adverse Event|0|||
156525801|NCT00406653|565019426|FG004|Maintenance Period|Adverse Event|1|||
156525802|NCT00406653|565019427|FG005|Maintenance Period|Adverse Event|1|||
156525803|NCT00406653|565019428|FG006|Maintenance Period|Adverse Event|0|||
156525804|NCT00406653|565019422|FG000|Maintenance Period|Lack of Efficacy|0|||
156525805|NCT00406653|565019423|FG001|Maintenance Period|Lack of Efficacy|0|||
156525806|NCT00406653|565019424|FG002|Maintenance Period|Lack of Efficacy|0|||
156525807|NCT00406653|565019425|FG003|Maintenance Period|Lack of Efficacy|0|||
156525808|NCT00406653|565019426|FG004|Maintenance Period|Lack of Efficacy|20|||
156525809|NCT00406653|565019427|FG005|Maintenance Period|Lack of Efficacy|26|||
156525810|NCT00406653|565019428|FG006|Maintenance Period|Lack of Efficacy|0|||
156525811|NCT00406653|565019422|FG000|Maintenance Period|Lost to Follow-up|0|||
156525812|NCT00406653|565019423|FG001|Maintenance Period|Lost to Follow-up|0|||
156525813|NCT00406653|565019424|FG002|Maintenance Period|Lost to Follow-up|0|||
156525814|NCT00406653|565019425|FG003|Maintenance Period|Lost to Follow-up|0|||
156525815|NCT00406653|565019426|FG004|Maintenance Period|Lost to Follow-up|2|||
156525816|NCT00406653|565019427|FG005|Maintenance Period|Lost to Follow-up|1|||
156525817|NCT00406653|565019428|FG006|Maintenance Period|Lost to Follow-up|0|||
156525818|NCT00406653|565019422|FG000|Maintenance Period|Withdrawal of Consent|0|||
156525819|NCT00406653|565019423|FG001|Maintenance Period|Withdrawal of Consent|0|||
156525820|NCT00406653|565019424|FG002|Maintenance Period|Withdrawal of Consent|0|||
156525821|NCT00406653|565019425|FG003|Maintenance Period|Withdrawal of Consent|0|||
156525822|NCT00406653|565019426|FG004|Maintenance Period|Withdrawal of Consent|2|||
156525823|NCT00406653|565019427|FG005|Maintenance Period|Withdrawal of Consent|0|||
156525824|NCT00406653|565019428|FG006|Maintenance Period|Withdrawal of Consent|0|||
156525825|NCT00406653|565019422|FG000|Maintenance Period|Pregnancy|0|||
156525826|NCT00406653|565019423|FG001|Maintenance Period|Pregnancy|0|||
156525827|NCT00406653|565019424|FG002|Maintenance Period|Pregnancy|0|||
156525828|NCT00406653|565019425|FG003|Maintenance Period|Pregnancy|0|||
156525829|NCT00406653|565019426|FG004|Maintenance Period|Pregnancy|0|||
156525830|NCT00406653|565019427|FG005|Maintenance Period|Pregnancy|1|||
156525831|NCT00406653|565019428|FG006|Maintenance Period|Pregnancy|0|||
156525832|NCT00406653|565019422|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
156525833|NCT00406653|565019423|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
156525834|NCT00406653|565019424|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
156525835|NCT00406653|565019425|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
156525836|NCT00406653|565019426|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
156525837|NCT00406653|565019427|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
156525838|NCT00406653|565019428|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
156525839|NCT00406653|565019422|FG000|Maintenance Period|Error in disease score evaluation|0|||
156525840|NCT00406653|565019423|FG001|Maintenance Period|Error in disease score evaluation|0|||
156525841|NCT00406653|565019424|FG002|Maintenance Period|Error in disease score evaluation|0|||
156525842|NCT00406653|565019425|FG003|Maintenance Period|Error in disease score evaluation|0|||
156525843|NCT00406653|565019426|FG004|Maintenance Period|Error in disease score evaluation|1|||
156525844|NCT00406653|565019427|FG005|Maintenance Period|Error in disease score evaluation|0|||
156525845|NCT00406653|565019428|FG006|Maintenance Period|Error in disease score evaluation|0|||
156525846|NCT00406653|565019422|FG000|Open-Label Period|Death|0|||
156525847|NCT00406653|565019423|FG001|Open-Label Period|Death|0|||
156525848|NCT00406653|565019424|FG002|Open-Label Period|Death|0|||
156525849|NCT00406653|565019425|FG003|Open-Label Period|Death|0|||
156779498|NCT02903914|565942590|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
156779499|NCT02903914|565942591|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
156667980|NCT02009163|565532469|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
156667981|NCT02009163|565532467|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
156667982|NCT02009163|565532468|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
156667983|NCT02009163|565532469|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
156667984|NCT02009163|565532467|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
156667985|NCT02009163|565532468|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
156667986|NCT02009163|565532469|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
156667987|NCT02009163|565532467|FG000|Open-label Period (Non-randomized)|Other|13|||
156667988|NCT02009163|565532468|FG001|Open-label Period (Non-randomized)|Other|0|||
156667989|NCT02009163|565532469|FG002|Open-label Period (Non-randomized)|Other|0|||
156667990|NCT02009163|565532467|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
156667991|NCT02009163|565532468|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
156667992|NCT02009163|565532469|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
156667993|NCT02009163|565532467|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
156667994|NCT02009163|565532468|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
156667995|NCT02009163|565532469|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
156667996|NCT02009163|565532467|FG000|Randomized-withdrawal Period|Adverse Event|0|||
156667997|NCT02009163|565532468|FG001|Randomized-withdrawal Period|Adverse Event|0|||
156667998|NCT02009163|565532469|FG002|Randomized-withdrawal Period|Adverse Event|6|||
156667999|NCT02009163|565532467|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
156668000|NCT02009163|565532468|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
156525850|NCT00406653|565019426|FG004|Open-Label Period|Death|0|||
156525851|NCT00406653|565019427|FG005|Open-Label Period|Death|0|||
156525852|NCT00406653|565019428|FG006|Open-Label Period|Death|1|||
156525853|NCT00406653|565019422|FG000|Open-Label Period|Adverse Event|0|||
156525854|NCT00406653|565019423|FG001|Open-Label Period|Adverse Event|0|||
156525855|NCT00406653|565019424|FG002|Open-Label Period|Adverse Event|0|||
156525856|NCT00406653|565019425|FG003|Open-Label Period|Adverse Event|0|||
156525857|NCT00406653|565019426|FG004|Open-Label Period|Adverse Event|0|||
156525858|NCT00406653|565019427|FG005|Open-Label Period|Adverse Event|0|||
156525859|NCT00406653|565019428|FG006|Open-Label Period|Adverse Event|18|||
156525860|NCT00406653|565019422|FG000|Open-Label Period|Lack of Efficacy|0|||
156525861|NCT00406653|565019423|FG001|Open-Label Period|Lack of Efficacy|0|||
156525862|NCT00406653|565019424|FG002|Open-Label Period|Lack of Efficacy|0|||
156525863|NCT00406653|565019425|FG003|Open-Label Period|Lack of Efficacy|0|||
156525864|NCT00406653|565019426|FG004|Open-Label Period|Lack of Efficacy|0|||
156525865|NCT00406653|565019427|FG005|Open-Label Period|Lack of Efficacy|0|||
156525866|NCT00406653|565019428|FG006|Open-Label Period|Lack of Efficacy|160|||
156525867|NCT00406653|565019422|FG000|Open-Label Period|Lost to Follow-up|0|||
156525868|NCT00406653|565019423|FG001|Open-Label Period|Lost to Follow-up|0|||
156525869|NCT00406653|565019424|FG002|Open-Label Period|Lost to Follow-up|0|||
156525870|NCT00406653|565019425|FG003|Open-Label Period|Lost to Follow-up|0|||
156525871|NCT00406653|565019426|FG004|Open-Label Period|Lost to Follow-up|0|||
156326375|NCT02598960|564296025|FG004|Treatment Period|Study drug toxicity|0|||
156326376|NCT02598960|564296026|FG005|Treatment Period|Study drug toxicity|0|||
156525872|NCT00406653|565019427|FG005|Open-Label Period|Lost to Follow-up|0|||
156525873|NCT00406653|565019428|FG006|Open-Label Period|Lost to Follow-up|6|||
156525874|NCT00406653|565019422|FG000|Open-Label Period|Withdrawal of Consent|0|||
156525875|NCT00406653|565019423|FG001|Open-Label Period|Withdrawal of Consent|0|||
156525876|NCT00406653|565019424|FG002|Open-Label Period|Withdrawal of Consent|0|||
156525877|NCT00406653|565019425|FG003|Open-Label Period|Withdrawal of Consent|0|||
156525878|NCT00406653|565019426|FG004|Open-Label Period|Withdrawal of Consent|0|||
156525879|NCT00406653|565019427|FG005|Open-Label Period|Withdrawal of Consent|0|||
156525880|NCT00406653|565019428|FG006|Open-Label Period|Withdrawal of Consent|11|||
156525881|NCT00406653|565019422|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
156525882|NCT00406653|565019423|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
156525883|NCT00406653|565019424|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
156525884|NCT00406653|565019425|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
156525885|NCT00406653|565019426|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
156326377|NCT02598960|564296027|FG006|Treatment Period|Study drug toxicity|0|||
156326378|NCT02598960|564296028|FG007|Treatment Period|Study drug toxicity|0|||
156326379|NCT02598960|564296029|FG008|Treatment Period|Study drug toxicity|0|||
156326380|NCT02598960|564296030|FG009|Treatment Period|Study drug toxicity|1|||
156326381|NCT02598960|564296031|FG010|Treatment Period|Study drug toxicity|0|||
156326382|NCT02598960|564296032|FG011|Treatment Period|Study drug toxicity|3|||
156326383|NCT02598960|564296033|FG012|Treatment Period|Study drug toxicity|0|||
156326384|NCT02598960|564296021|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
156326385|NCT02598960|564296022|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
156525886|NCT00406653|565019427|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
156525887|NCT00406653|565019428|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
156668001|NCT02009163|565532469|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
156326386|NCT02598960|564296023|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
156668002|NCT02009163|565532467|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
156779500|NCT02903914|565942592|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
156779501|NCT02903914|565942585|FG000|Overall Study|Follow-up Did Not Occur|0|||
156779502|NCT02903914|565942586|FG001|Overall Study|Follow-up Did Not Occur|1|||
156779503|NCT02903914|565942587|FG002|Overall Study|Follow-up Did Not Occur|1|||
156779504|NCT02903914|565942588|FG003|Overall Study|Follow-up Did Not Occur|0|||
156779505|NCT02903914|565942589|FG004|Overall Study|Follow-up Did Not Occur|2|||
156779506|NCT02903914|565942590|FG005|Overall Study|Follow-up Did Not Occur|0|||
156779507|NCT02903914|565942591|FG006|Overall Study|Follow-up Did Not Occur|8|||
156779508|NCT02903914|565942592|FG007|Overall Study|Follow-up Did Not Occur|0|||
156779509|NCT02903914|565942585|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
156779510|NCT02903914|565942586|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
156779511|NCT02903914|565942587|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
156779512|NCT02903914|565942588|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
156779513|NCT02903914|565942589|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
156779514|NCT02903914|565942590|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
156779515|NCT02903914|565942591|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
156779516|NCT02903914|565942592|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
156779517|NCT02903914|565942585|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779518|NCT02903914|565942586|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779519|NCT02903914|565942587|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
156779520|NCT02903914|565942588|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779521|NCT02903914|565942589|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779522|NCT02903914|565942590|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
156779523|NCT02903914|565942591|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779524|NCT02903914|565942592|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779525|NCT02903914|565942585|FG000|Overall Study|Clinical Disease Progression|0|||
156779526|NCT02903914|565942586|FG001|Overall Study|Clinical Disease Progression|0|||
156779527|NCT02903914|565942587|FG002|Overall Study|Clinical Disease Progression|2|||
156779528|NCT02903914|565942588|FG003|Overall Study|Clinical Disease Progression|0|||
156779529|NCT02903914|565942589|FG004|Overall Study|Clinical Disease Progression|0|||
156779530|NCT02903914|565942590|FG005|Overall Study|Clinical Disease Progression|0|||
156779531|NCT02903914|565942591|FG006|Overall Study|Clinical Disease Progression|0|||
156779532|NCT02903914|565942592|FG007|Overall Study|Clinical Disease Progression|0|||
156779533|NCT02903914|565942585|FG000|Overall Study|Completed Follow-up Period|0|||
156779534|NCT02903914|565942586|FG001|Overall Study|Completed Follow-up Period|0|||
156779535|NCT02903914|565942587|FG002|Overall Study|Completed Follow-up Period|6|||
156779536|NCT02903914|565942588|FG003|Overall Study|Completed Follow-up Period|2|||
156779537|NCT02903914|565942589|FG004|Overall Study|Completed Follow-up Period|1|||
156779538|NCT02903914|565942590|FG005|Overall Study|Completed Follow-up Period|0|||
156779539|NCT02903914|565942591|FG006|Overall Study|Completed Follow-up Period|9|||
156779540|NCT02903914|565942592|FG007|Overall Study|Completed Follow-up Period|1|||
156779541|NCT02903914|565942585|FG000|Overall Study|Taken off Treatment per Protocol|0|||
156779542|NCT02903914|565942586|FG001|Overall Study|Taken off Treatment per Protocol|0|||
156779543|NCT02903914|565942587|FG002|Overall Study|Taken off Treatment per Protocol|0|||
156779544|NCT02903914|565942588|FG003|Overall Study|Taken off Treatment per Protocol|0|||
156779545|NCT02903914|565942589|FG004|Overall Study|Taken off Treatment per Protocol|0|||
156779546|NCT02903914|565942590|FG005|Overall Study|Taken off Treatment per Protocol|1|||
156779547|NCT02903914|565942591|FG006|Overall Study|Taken off Treatment per Protocol|0|||
156779548|NCT02903914|565942592|FG007|Overall Study|Taken off Treatment per Protocol|0|||
156430857|NCT00603447|564666209|FG001|Overall Study|Withdrew Consent|2|||
156430858|NCT00603447|564666210|FG002|Overall Study|Withdrew Consent|0|||
156430859|NCT00603447|564666211|FG003|Overall Study|Withdrew Consent|0|||
156525888|NCT00406653|565019422|FG000|Open-Label Period|Pregnancy|0|||
156525889|NCT00406653|565019423|FG001|Open-Label Period|Pregnancy|0|||
156525890|NCT00406653|565019424|FG002|Open-Label Period|Pregnancy|0|||
156525891|NCT00406653|565019425|FG003|Open-Label Period|Pregnancy|0|||
156525892|NCT00406653|565019426|FG004|Open-Label Period|Pregnancy|0|||
156525893|NCT00406653|565019427|FG005|Open-Label Period|Pregnancy|0|||
156525894|NCT00406653|565019428|FG006|Open-Label Period|Pregnancy|2|||
156525895|NCT00406653|565019422|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
156525896|NCT00406653|565019423|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
156525897|NCT00406653|565019424|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
156525898|NCT00406653|565019425|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
156525899|NCT00406653|565019426|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
156668003|NCT02009163|565532468|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
156430860|NCT00603447|564666212|FG004|Overall Study|Withdrew Consent|1|||
156430861|NCT00603447|564666213|FG005|Overall Study|Withdrew Consent|0|||
156430862|NCT00603447|564666214|FG006|Overall Study|Withdrew Consent|1|||
156430863|NCT03425643|564666217|FG000|Overall Study|Withdrawal by Subject|10|||
156430864|NCT03425643|564666218|FG001|Overall Study|Withdrawal by Subject|12|||
156525900|NCT00406653|565019427|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
156668004|NCT02009163|565532469|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
156668005|NCT02009163|565532467|FG000|Randomized-withdrawal Period|Pregnancy|0|||
156668006|NCT02009163|565532468|FG001|Randomized-withdrawal Period|Pregnancy|0|||
156668007|NCT02009163|565532469|FG002|Randomized-withdrawal Period|Pregnancy|2|||
156668008|NCT02009163|565532467|FG000|Randomized-withdrawal Period|Other|0|||
156668009|NCT02009163|565532468|FG001|Randomized-withdrawal Period|Other|9|||
156668010|NCT02009163|565532469|FG002|Randomized-withdrawal Period|Other|5|||
156668011|NCT00359281|565532470|FG000|Overall Study|Adverse Event|1|||
156668012|NCT00359281|565532471|FG001|Overall Study|Adverse Event|0|||
156668013|NCT00359281|565532472|FG002|Overall Study|Adverse Event|0|||
156668014|NCT00359281|565532473|FG003|Overall Study|Adverse Event|0|||
156668015|NCT00359281|565532474|FG004|Overall Study|Adverse Event|0|||
156668016|NCT00359281|565532475|FG005|Overall Study|Adverse Event|0|||
156668017|NCT00359281|565532476|FG006|Overall Study|Adverse Event|1|||
156668018|NCT00359281|565532477|FG007|Overall Study|Adverse Event|0|||
156668019|NCT00359281|565532478|FG008|Overall Study|Adverse Event|0|||
156668020|NCT00359281|565532470|FG000|Overall Study|Withdrawal by Subject|0|||
156668021|NCT00359281|565532471|FG001|Overall Study|Withdrawal by Subject|0|||
156668022|NCT00359281|565532472|FG002|Overall Study|Withdrawal by Subject|0|||
156668023|NCT00359281|565532473|FG003|Overall Study|Withdrawal by Subject|0|||
156668024|NCT00359281|565532474|FG004|Overall Study|Withdrawal by Subject|0|||
156668025|NCT00359281|565532475|FG005|Overall Study|Withdrawal by Subject|0|||
156668026|NCT00359281|565532476|FG006|Overall Study|Withdrawal by Subject|1|||
156668027|NCT00359281|565532477|FG007|Overall Study|Withdrawal by Subject|0|||
156668028|NCT00359281|565532478|FG008|Overall Study|Withdrawal by Subject|0|||
156668029|NCT00838279|565532479|FG000|Washout|Protocol Violation|1|||
156668030|NCT00838279|565532480|FG001|Washout|Protocol Violation|0|||
156668031|NCT00838279|565532479|FG000|Washout|Withdrawal by Subject|0|||
156668032|NCT00838279|565532480|FG001|Washout|Withdrawal by Subject|1|||
156668033|NCT04608188|565532481|FG000|Overall Study|Withdrawal by Subject|4|||
156668034|NCT04608188|565532482|FG001|Overall Study|Withdrawal by Subject|8|||
156668035|NCT01415986|565532484|FG000|Overall Study|Lost to Follow-up|1|||
156668036|NCT04419311|565532485|FG000|Overall Study|Lost to Follow-up|1|||
156668037|NCT04419311|565532486|FG001|Overall Study|Lost to Follow-up|0|||
156668038|NCT03122457|565532498|FG000|Overall Study|Withdrawal by Subject|6|||
156668039|NCT01045161|565532500|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
156668040|NCT01045161|565532501|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
156668041|NCT01045161|565532502|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
156668042|NCT01045161|565532500|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
156668043|NCT01045161|565532501|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
156668044|NCT01045161|565532502|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
156668045|NCT01045161|565532500|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
156668046|NCT01045161|565532501|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
156668047|NCT01045161|565532502|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
156668048|NCT01045161|565532500|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
156668049|NCT01045161|565532501|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
156668050|NCT01045161|565532502|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
156668051|NCT01045161|565532500|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
156668052|NCT01045161|565532501|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
156668053|NCT01045161|565532502|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
156668054|NCT01045161|565532500|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
156668055|NCT01045161|565532501|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
156668056|NCT01045161|565532502|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
156668057|NCT01045161|565532500|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
156668058|NCT01045161|565532501|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
156668059|NCT01045161|565532502|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
156668060|NCT01045161|565532500|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
156668061|NCT01045161|565532501|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
156668062|NCT01045161|565532502|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
156668063|NCT01045161|565532500|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
156668064|NCT01045161|565532501|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
156668065|NCT01045161|565532502|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
156668066|NCT01045161|565532500|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
156326387|NCT02598960|564296024|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
156668067|NCT01045161|565532501|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
156668068|NCT01045161|565532502|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
156668069|NCT01045161|565532500|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
156326388|NCT02598960|564296025|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
156668070|NCT01045161|565532501|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
156668071|NCT01045161|565532502|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
156525901|NCT00406653|565019428|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
156525902|NCT00406653|565019422|FG000|Open-Label Period|Declined participation but followup done|0|||
156326389|NCT02598960|564296026|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
156326390|NCT02598960|564296027|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
156326391|NCT02598960|564296028|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
156326392|NCT02598960|564296029|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
156326393|NCT02598960|564296030|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
156326394|NCT02598960|564296031|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
156326395|NCT02598960|564296032|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
156326396|NCT02598960|564296033|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
156326397|NCT02598960|564296021|FG000|Treatment Period|participant request to discontinue|0|||
156326398|NCT02598960|564296022|FG001|Treatment Period|participant request to discontinue|1|||
156326399|NCT02598960|564296023|FG002|Treatment Period|participant request to discontinue|0|||
156326400|NCT02598960|564296024|FG003|Treatment Period|participant request to discontinue|0|||
156326401|NCT02598960|564296025|FG004|Treatment Period|participant request to discontinue|1|||
156326402|NCT02598960|564296026|FG005|Treatment Period|participant request to discontinue|0|||
156326403|NCT02598960|564296027|FG006|Treatment Period|participant request to discontinue|0|||
156326404|NCT02598960|564296028|FG007|Treatment Period|participant request to discontinue|0|||
156326405|NCT02598960|564296029|FG008|Treatment Period|participant request to discontinue|0|||
156326406|NCT02598960|564296030|FG009|Treatment Period|participant request to discontinue|0|||
156326407|NCT02598960|564296031|FG010|Treatment Period|participant request to discontinue|1|||
156326408|NCT02598960|564296032|FG011|Treatment Period|participant request to discontinue|4|||
156326409|NCT02598960|564296033|FG012|Treatment Period|participant request to discontinue|0|||
156326410|NCT02598960|564296021|FG000|Treatment Period|participant withdrew consent|0|||
156326411|NCT02598960|564296022|FG001|Treatment Period|participant withdrew consent|0|||
156326412|NCT02598960|564296023|FG002|Treatment Period|participant withdrew consent|0|||
156326413|NCT02598960|564296024|FG003|Treatment Period|participant withdrew consent|0|||
156326414|NCT02598960|564296025|FG004|Treatment Period|participant withdrew consent|0|||
156326415|NCT02598960|564296026|FG005|Treatment Period|participant withdrew consent|0|||
156326416|NCT02598960|564296027|FG006|Treatment Period|participant withdrew consent|0|||
156326417|NCT02598960|564296028|FG007|Treatment Period|participant withdrew consent|0|||
156326418|NCT02598960|564296029|FG008|Treatment Period|participant withdrew consent|0|||
156326419|NCT02598960|564296030|FG009|Treatment Period|participant withdrew consent|0|||
156326420|NCT02598960|564296031|FG010|Treatment Period|participant withdrew consent|0|||
156326421|NCT02598960|564296032|FG011|Treatment Period|participant withdrew consent|3|||
156326422|NCT02598960|564296033|FG012|Treatment Period|participant withdrew consent|0|||
156326423|NCT02598960|564296021|FG000|Treatment Period|No longer meets study criteria|0|||
156326424|NCT02598960|564296022|FG001|Treatment Period|No longer meets study criteria|0|||
156326425|NCT02598960|564296023|FG002|Treatment Period|No longer meets study criteria|0|||
156326426|NCT02598960|564296024|FG003|Treatment Period|No longer meets study criteria|0|||
156326427|NCT02598960|564296025|FG004|Treatment Period|No longer meets study criteria|0|||
156326428|NCT02598960|564296026|FG005|Treatment Period|No longer meets study criteria|0|||
156326429|NCT02598960|564296027|FG006|Treatment Period|No longer meets study criteria|0|||
156326430|NCT02598960|564296028|FG007|Treatment Period|No longer meets study criteria|0|||
156326431|NCT02598960|564296029|FG008|Treatment Period|No longer meets study criteria|0|||
156326432|NCT02598960|564296030|FG009|Treatment Period|No longer meets study criteria|0|||
156326433|NCT02598960|564296031|FG010|Treatment Period|No longer meets study criteria|0|||
156326434|NCT02598960|564296032|FG011|Treatment Period|No longer meets study criteria|1|||
156326435|NCT02598960|564296033|FG012|Treatment Period|No longer meets study criteria|0|||
156326436|NCT02598960|564296021|FG000|Treatment Period|Other Reasons|0|||
156326437|NCT02598960|564296022|FG001|Treatment Period|Other Reasons|0|||
156326438|NCT02598960|564296023|FG002|Treatment Period|Other Reasons|0|||
156326439|NCT02598960|564296024|FG003|Treatment Period|Other Reasons|0|||
156326440|NCT02598960|564296025|FG004|Treatment Period|Other Reasons|0|||
156326441|NCT02598960|564296026|FG005|Treatment Period|Other Reasons|0|||
156326442|NCT02598960|564296027|FG006|Treatment Period|Other Reasons|0|||
156326443|NCT02598960|564296028|FG007|Treatment Period|Other Reasons|0|||
156326444|NCT02598960|564296029|FG008|Treatment Period|Other Reasons|0|||
156326445|NCT02598960|564296030|FG009|Treatment Period|Other Reasons|0|||
156326446|NCT02598960|564296031|FG010|Treatment Period|Other Reasons|0|||
156326447|NCT02598960|564296032|FG011|Treatment Period|Other Reasons|0|||
156326448|NCT02598960|564296033|FG012|Treatment Period|Other Reasons|1|||
156326449|NCT02598960|564296021|FG000|Participants Entering Follow Up Period|Death|1|||
156326450|NCT02598960|564296022|FG001|Participants Entering Follow Up Period|Death|0|||
156326451|NCT02598960|564296023|FG002|Participants Entering Follow Up Period|Death|0|||
156326452|NCT02598960|564296024|FG003|Participants Entering Follow Up Period|Death|0|||
156326453|NCT02598960|564296025|FG004|Participants Entering Follow Up Period|Death|0|||
156326454|NCT02598960|564296026|FG005|Participants Entering Follow Up Period|Death|0|||
156326455|NCT02598960|564296027|FG006|Participants Entering Follow Up Period|Death|0|||
156525903|NCT00406653|565019423|FG001|Open-Label Period|Declined participation but followup done|0|||
156668072|NCT01045161|565532500|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
156668073|NCT01045161|565532501|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
156668074|NCT01045161|565532502|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
156668075|NCT01045161|565532500|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
156668076|NCT01045161|565532501|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
156668077|NCT01045161|565532502|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
156668078|NCT01045161|565532500|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
156668079|NCT01045161|565532501|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
156668080|NCT01045161|565532502|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
156668081|NCT01854047|565532503|FG000|Overall Study|Lack of Efficacy|1|||
156668082|NCT01854047|565532504|FG001|Overall Study|Lack of Efficacy|0|||
156668083|NCT01854047|565532505|FG002|Overall Study|Lack of Efficacy|0|||
156668084|NCT01854047|565532506|FG003|Overall Study|Lack of Efficacy|0|||
156668085|NCT01854047|565532507|FG004|Overall Study|Lack of Efficacy|0|||
156668086|NCT01854047|565532503|FG000|Overall Study|Poor compliance to protocol|3|||
156668087|NCT01854047|565532504|FG001|Overall Study|Poor compliance to protocol|0|||
156668088|NCT01854047|565532505|FG002|Overall Study|Poor compliance to protocol|2|||
156668089|NCT01854047|565532506|FG003|Overall Study|Poor compliance to protocol|0|||
156668090|NCT01854047|565532507|FG004|Overall Study|Poor compliance to protocol|0|||
156668091|NCT01854047|565532503|FG000|Overall Study|Adverse Event|5|||
156668092|NCT01854047|565532504|FG001|Overall Study|Adverse Event|4|||
156668093|NCT01854047|565532505|FG002|Overall Study|Adverse Event|6|||
156668094|NCT01854047|565532506|FG003|Overall Study|Adverse Event|10|||
156668095|NCT01854047|565532507|FG004|Overall Study|Adverse Event|7|||
156668096|NCT01854047|565532503|FG000|Overall Study|Randomized but not treated|0|||
156668097|NCT01854047|565532504|FG001|Overall Study|Randomized but not treated|1|||
156668098|NCT01854047|565532505|FG002|Overall Study|Randomized but not treated|2|||
156668099|NCT01854047|565532506|FG003|Overall Study|Randomized but not treated|0|||
156668100|NCT01854047|565532507|FG004|Overall Study|Randomized but not treated|4|||
156668101|NCT01854047|565532503|FG000|Overall Study|Other than specified above|3|||
156668102|NCT01854047|565532504|FG001|Overall Study|Other than specified above|3|||
156668103|NCT01854047|565532505|FG002|Overall Study|Other than specified above|3|||
156668104|NCT01854047|565532506|FG003|Overall Study|Other than specified above|5|||
156668105|NCT01854047|565532507|FG004|Overall Study|Other than specified above|8|||
156668106|NCT03686033|565532508|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
156668107|NCT03686033|565532509|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
156668108|NCT03686033|565532510|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
156668109|NCT03686033|565532511|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
156668110|NCT03686033|565532512|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
156668111|NCT03686033|565532513|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
156668112|NCT01302548|565532515|FG000|Overall Study|Lost to Follow-up|2|||
156668113|NCT01302548|565532516|FG001|Overall Study|Lost to Follow-up|1|||
156668114|NCT01237054|565532517|FG000|Overall Study|imaging 10C0096|1|||
156668115|NCT02089997|565532531|FG000|Overall Study|Case report forms uncollected|99|||
156668116|NCT02089997|565532531|FG000|Overall Study|Protocol Violation|147|||
156668117|NCT00095212|565532534|FG000|Overall Study|Withdrawal by Subject|1|||
156668118|NCT00095212|565532535|FG001|Overall Study|Withdrawal by Subject|3|||
156668119|NCT02374853|565532539|FG000|Overall Study|Surgery Cancelled|5|||
156668120|NCT02374853|565532540|FG001|Overall Study|Surgery Cancelled|11|||
156668121|NCT02281084|565532541|FG000|Overall Study|Death|21|||
156668122|NCT02281084|565532542|FG001|Overall Study|Death|18|||
156779549|NCT02903914|565942585|FG000|Overall Study|Refused Further Treatment/Contact|0|||
156779550|NCT02903914|565942586|FG001|Overall Study|Refused Further Treatment/Contact|0|||
156779551|NCT02903914|565942587|FG002|Overall Study|Refused Further Treatment/Contact|0|||
156779552|NCT02903914|565942588|FG003|Overall Study|Refused Further Treatment/Contact|0|||
156779553|NCT02903914|565942589|FG004|Overall Study|Refused Further Treatment/Contact|0|||
156779554|NCT02903914|565942590|FG005|Overall Study|Refused Further Treatment/Contact|0|||
156430865|NCT03425643|564666217|FG000|Overall Study|Lost to Follow-up|2|||
156430866|NCT03425643|564666218|FG001|Overall Study|Lost to Follow-up|0|||
156430867|NCT03425643|564666217|FG000|Overall Study|Death|109|||
156430868|NCT03425643|564666218|FG001|Overall Study|Death|141|||
156430869|NCT03425643|564666217|FG000|Overall Study|Ongoing in study|276|||
156430870|NCT03425643|564666218|FG001|Overall Study|Ongoing in study|247|||
156668123|NCT02281084|565532543|FG002|Overall Study|Death|3|||
156668124|NCT02281084|565532544|FG003|Overall Study|Death|5|||
156668125|NCT02281084|565532541|FG000|Overall Study|Adverse Event|1|||
156668126|NCT02281084|565532542|FG001|Overall Study|Adverse Event|0|||
156668127|NCT02281084|565532543|FG002|Overall Study|Adverse Event|0|||
156668128|NCT02281084|565532544|FG003|Overall Study|Adverse Event|0|||
156668129|NCT02281084|565532541|FG000|Overall Study|Withdrawal by Subject|2|||
156668130|NCT02281084|565532542|FG001|Overall Study|Withdrawal by Subject|2|||
156668131|NCT02281084|565532543|FG002|Overall Study|Withdrawal by Subject|0|||
156668132|NCT02281084|565532544|FG003|Overall Study|Withdrawal by Subject|0|||
156668133|NCT02281084|565532541|FG000|Overall Study|Site Closure by Sponsor|5|||
156668134|NCT02281084|565532542|FG001|Overall Study|Site Closure by Sponsor|1|||
156668135|NCT02281084|565532543|FG002|Overall Study|Site Closure by Sponsor|2|||
156668136|NCT02281084|565532544|FG003|Overall Study|Site Closure by Sponsor|0|||
156668137|NCT02335658|565532545|FG000|Overall Study|Adverse Event|18|||
156668138|NCT02335658|565532546|FG001|Overall Study|Adverse Event|12|||
156668139|NCT02335658|565532545|FG000|Overall Study|Lack of Efficacy|4|||
156668140|NCT02335658|565532546|FG001|Overall Study|Lack of Efficacy|5|||
156668141|NCT02335658|565532545|FG000|Overall Study|Pregnancy|1|||
156668142|NCT02335658|565532546|FG001|Overall Study|Pregnancy|0|||
156668143|NCT02335658|565532545|FG000|Overall Study|Withdrawal by Subject|13|||
156668144|NCT02335658|565532546|FG001|Overall Study|Withdrawal by Subject|21|||
156668145|NCT02335658|565532545|FG000|Overall Study|non-compliance|2|||
156668146|NCT02335658|565532546|FG001|Overall Study|non-compliance|3|||
156668147|NCT02335658|565532545|FG000|Overall Study|other reason|2|||
156668148|NCT02335658|565532546|FG001|Overall Study|other reason|3|||
156668149|NCT02032888|565532547|FG000|Treatment Period|Poor compliance/noncompliance|1|||
156668150|NCT02032888|565532548|FG001|Treatment Period|Poor compliance/noncompliance|1|||
156668151|NCT02032888|565532549|FG002|Treatment Period|Poor compliance/noncompliance|0|||
156668152|NCT02032888|565532547|FG000|Treatment Period|Other|1|||
156668153|NCT02032888|565532548|FG001|Treatment Period|Other|1|||
156668154|NCT02032888|565532549|FG002|Treatment Period|Other|0|||
156668155|NCT02032888|565532547|FG000|Follow-up Period|Lost to Follow-up|1|||
156668156|NCT02032888|565532548|FG001|Follow-up Period|Lost to Follow-up|1|||
156668157|NCT02032888|565532549|FG002|Follow-up Period|Lost to Follow-up|0|||
156668158|NCT02032888|565532547|FG000|Follow-up Period|Death|1|||
156668159|NCT02032888|565532548|FG001|Follow-up Period|Death|1|||
156668160|NCT02032888|565532549|FG002|Follow-up Period|Death|0|||
156779555|NCT02903914|565942591|FG006|Overall Study|Refused Further Treatment/Contact|1|||
156779556|NCT02903914|565942592|FG007|Overall Study|Refused Further Treatment/Contact|0|||
156779557|NCT02903914|565942585|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779558|NCT02903914|565942586|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779559|NCT02903914|565942587|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779560|NCT02903914|565942588|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779561|NCT02903914|565942589|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779562|NCT02903914|565942590|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779563|NCT02903914|565942591|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
156779564|NCT02903914|565942592|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779565|NCT02989389|565942595|FG000|Period 1|Lost to Follow-up|0|||
156779566|NCT02989389|565942596|FG001|Period 1|Lost to Follow-up|1|||
156779567|NCT02989389|565942597|FG002|Period 1|Lost to Follow-up|0|||
156779568|NCT02989389|565942598|FG003|Period 1|Lost to Follow-up|0|||
156779569|NCT02989389|565942599|FG004|Period 1|Lost to Follow-up|0|||
156779570|NCT02989389|565942600|FG005|Period 1|Lost to Follow-up|0|||
156779571|NCT02989389|565942601|FG006|Period 1|Lost to Follow-up|0|||
156779572|NCT02989389|565942602|FG007|Period 1|Lost to Follow-up|0|||
156779573|NCT02989389|565942603|FG008|Period 1|Lost to Follow-up|0|||
156779574|NCT02989389|565942604|FG009|Period 1|Lost to Follow-up|0|||
156779575|NCT02989389|565942595|FG000|Period 1|Physician Decision|0|||
156779576|NCT02989389|565942596|FG001|Period 1|Physician Decision|0|||
156779577|NCT02989389|565942597|FG002|Period 1|Physician Decision|0|||
156779578|NCT02989389|565942598|FG003|Period 1|Physician Decision|0|||
156779579|NCT02989389|565942599|FG004|Period 1|Physician Decision|0|||
156779580|NCT02989389|565942600|FG005|Period 1|Physician Decision|0|||
156779581|NCT02989389|565942601|FG006|Period 1|Physician Decision|0|||
156779582|NCT02989389|565942602|FG007|Period 1|Physician Decision|0|||
156779583|NCT02989389|565942603|FG008|Period 1|Physician Decision|1|||
156668161|NCT02032888|565532547|FG000|Follow-up Period|Other|1|||
156668162|NCT02032888|565532548|FG001|Follow-up Period|Other|0|||
156668163|NCT02032888|565532549|FG002|Follow-up Period|Other|0|||
156668164|NCT01754597|565532552|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
156668165|NCT01754597|565532553|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
156668166|NCT00819741|565532554|FG000|Overall Study|Adverse Event|5|||
156779584|NCT02989389|565942604|FG009|Period 1|Physician Decision|0|||
156779585|NCT01018979|565942605|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
156779586|NCT01018979|565942606|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
156779587|NCT01018979|565942605|FG000|Overall Study|Not received at least one dose|0|||
156779588|NCT01018979|565942606|FG001|Overall Study|Not received at least one dose|1|||
156779589|NCT03506477|565942607|FG000|Overall Study|Withdrawal by Subject|1|||
156668167|NCT00819741|565532555|FG001|Overall Study|Adverse Event|2|||
156668168|NCT00819741|565532554|FG000|Overall Study|Lack of Efficacy|0|||
156668169|NCT00819741|565532555|FG001|Overall Study|Lack of Efficacy|2|||
156779590|NCT03506477|565942608|FG001|Overall Study|Withdrawal by Subject|0|||
156779591|NCT03462680|565942609|FG000|Overall Study|Withdrawal by Subject|3|||
156779592|NCT03462680|565942610|FG001|Overall Study|Withdrawal by Subject|5|||
156668170|NCT00819741|565532554|FG000|Overall Study|Lost to Follow-up|3|||
156668171|NCT00819741|565532555|FG001|Overall Study|Lost to Follow-up|1|||
156668172|NCT00819741|565532554|FG000|Overall Study|Protocol Violation|3|||
156668173|NCT00819741|565532555|FG001|Overall Study|Protocol Violation|4|||
156779593|NCT02516241|565942616|FG000|Overall Study|Death|255|||
156668174|NCT00819741|565532554|FG000|Overall Study|Withdrawal by Subject|2|||
156668175|NCT00819741|565532555|FG001|Overall Study|Withdrawal by Subject|2|||
156668176|NCT00819741|565532554|FG000|Overall Study|Unclassified|6|||
156668177|NCT00819741|565532555|FG001|Overall Study|Unclassified|0|||
156668178|NCT00819741|565532554|FG000|Overall Study|Reasons unknown|3|||
156668179|NCT00819741|565532555|FG001|Overall Study|Reasons unknown|3|||
156668180|NCT01597245|565532556|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
156668181|NCT01597245|565532557|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
156668182|NCT01597245|565532558|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
156668183|NCT01597245|565532559|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
156668184|NCT01597245|565532560|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668185|NCT01597245|565532561|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668186|NCT01597245|565532562|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156779594|NCT02516241|565942617|FG001|Overall Study|Death|262|||
156779595|NCT02516241|565942618|FG002|Overall Study|Death|270|||
156779596|NCT02516241|565942616|FG000|Overall Study|Lost to Follow-up|1|||
156779597|NCT02516241|565942617|FG001|Overall Study|Lost to Follow-up|1|||
156779598|NCT02516241|565942618|FG002|Overall Study|Lost to Follow-up|3|||
156779599|NCT02516241|565942616|FG000|Overall Study|Withdrawal by Subject|2|||
156779600|NCT02516241|565942617|FG001|Overall Study|Withdrawal by Subject|7|||
156779601|NCT02516241|565942618|FG002|Overall Study|Withdrawal by Subject|12|||
156779602|NCT02516241|565942616|FG000|Overall Study|participants ongoing at data cut-off|84|||
156779603|NCT02516241|565942617|FG001|Overall Study|participants ongoing at data cut-off|76|||
156779604|NCT02516241|565942618|FG002|Overall Study|participants ongoing at data cut-off|59|||
156779605|NCT01063114|565942619|FG000|Overall Study|Lost to Follow-up|1|||
156779606|NCT00462462|565942624|FG000|Overall Study|Physician Decision|0|||
156779607|NCT00462462|565942625|FG001|Overall Study|Physician Decision|1|||
156779608|NCT01163617|565942626|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779609|NCT01163617|565942627|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
156779610|NCT01163617|565942628|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779611|NCT01163617|565942629|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779612|NCT01163617|565942630|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779613|NCT01163617|565942631|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779614|NCT01163617|565942632|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779615|NCT01163617|565942633|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779616|NCT01163617|565942626|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779617|NCT01163617|565942627|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
156779618|NCT01163617|565942628|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779619|NCT01163617|565942629|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779620|NCT01163617|565942630|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779621|NCT01163617|565942631|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779622|NCT01163617|565942632|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779623|NCT01163617|565942633|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779624|NCT01163617|565942626|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779625|NCT01163617|565942627|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779626|NCT01163617|565942628|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
156779627|NCT01163617|565942629|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779628|NCT01163617|565942630|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779629|NCT01163617|565942631|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779630|NCT01163617|565942632|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779631|NCT01163617|565942633|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779632|NCT02875080|565942634|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
156779633|NCT02875080|565942635|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
156779634|NCT02875080|565942636|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
156779635|NCT02394756|565942637|FG000|Period 1|Lens Discomfort|0|||
156779636|NCT02394756|565942638|FG001|Period 1|Lens Discomfort|0|||
156779637|NCT02394756|565942639|FG002|Period 1|Lens Discomfort|0|||
156779638|NCT02394756|565942640|FG003|Period 1|Lens Discomfort|0|||
156779639|NCT02394756|565942641|FG004|Period 1|Lens Discomfort|0|||
156668187|NCT01597245|565532563|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668188|NCT01597245|565532564|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668189|NCT01597245|565532565|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156779640|NCT02394756|565942642|FG005|Period 1|Lens Discomfort|1|||
156866138|NCT01342211|566269178|FG003|Overall Study|Withdrawal by Subject|1|||
156866139|NCT01342211|566269179|FG004|Overall Study|Withdrawal by Subject|0|||
156866140|NCT01342211|566269175|FG000|Overall Study|Randomized, but not Treated|0|||
156866141|NCT01342211|566269176|FG001|Overall Study|Randomized, but not Treated|2|||
156866142|NCT01342211|566269177|FG002|Overall Study|Randomized, but not Treated|0|||
156668190|NCT01597245|565532566|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668191|NCT01597245|565532567|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668192|NCT01597245|565532568|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668193|NCT01597245|565532569|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668194|NCT01597245|565532570|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668195|NCT01597245|565532571|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668196|NCT01597245|565532572|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668197|NCT01597245|565532573|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668198|NCT01597245|565532574|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668199|NCT01597245|565532575|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668200|NCT01597245|565532576|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
156668201|NCT01597245|565532556|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
156668202|NCT01597245|565532557|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
156668203|NCT01597245|565532558|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
156668204|NCT01597245|565532559|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
156668205|NCT01597245|565532560|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668206|NCT01597245|565532561|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668207|NCT01597245|565532562|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668208|NCT01597245|565532563|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668209|NCT01597245|565532564|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668210|NCT01597245|565532565|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668211|NCT01597245|565532566|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668212|NCT01597245|565532567|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668213|NCT01597245|565532568|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668214|NCT01597245|565532569|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668215|NCT01597245|565532570|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668216|NCT01597245|565532571|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668217|NCT01597245|565532572|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668218|NCT01597245|565532573|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668219|NCT01597245|565532574|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668220|NCT01597245|565532575|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668221|NCT01597245|565532576|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
156668222|NCT01597245|565532556|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
156668223|NCT01597245|565532557|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
156668224|NCT01597245|565532558|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
156668225|NCT01597245|565532559|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
156668226|NCT01597245|565532560|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668227|NCT01597245|565532561|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668228|NCT01597245|565532562|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668229|NCT01597245|565532563|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668230|NCT01597245|565532564|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156779641|NCT02394756|565942637|FG000|Period 1|Withdrawal by Subject|0|||
156779642|NCT02394756|565942638|FG001|Period 1|Withdrawal by Subject|1|||
156779643|NCT02394756|565942639|FG002|Period 1|Withdrawal by Subject|1|||
156779644|NCT02394756|565942640|FG003|Period 1|Withdrawal by Subject|1|||
156668231|NCT01597245|565532565|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668232|NCT01597245|565532566|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668233|NCT01597245|565532567|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156779645|NCT02394756|565942641|FG004|Period 1|Withdrawal by Subject|0|||
156779646|NCT02394756|565942642|FG005|Period 1|Withdrawal by Subject|0|||
156525904|NCT00406653|565019424|FG002|Open-Label Period|Declined participation but followup done|0|||
156525905|NCT00406653|565019425|FG003|Open-Label Period|Declined participation but followup done|0|||
156525906|NCT00406653|565019426|FG004|Open-Label Period|Declined participation but followup done|0|||
156525907|NCT00406653|565019427|FG005|Open-Label Period|Declined participation but followup done|0|||
156525908|NCT00406653|565019428|FG006|Open-Label Period|Declined participation but followup done|8|||
156525909|NCT00406653|565019422|FG000|Open-Label Period|Discontinued by Sponsor|0|||
156525910|NCT00406653|565019423|FG001|Open-Label Period|Discontinued by Sponsor|0|||
156525911|NCT00406653|565019424|FG002|Open-Label Period|Discontinued by Sponsor|0|||
156525912|NCT00406653|565019425|FG003|Open-Label Period|Discontinued by Sponsor|0|||
156525913|NCT00406653|565019426|FG004|Open-Label Period|Discontinued by Sponsor|0|||
156525914|NCT00406653|565019427|FG005|Open-Label Period|Discontinued by Sponsor|0|||
156525915|NCT00406653|565019428|FG006|Open-Label Period|Discontinued by Sponsor|1|||
156525916|NCT00406653|565019422|FG000|Open-Label Period|Refused followup|0|||
156779647|NCT02394756|565942637|FG000|Period 2|Unsatisfactory Visual Response|0|||
156779648|NCT02394756|565942638|FG001|Period 2|Unsatisfactory Visual Response|0|||
156525917|NCT00406653|565019423|FG001|Open-Label Period|Refused followup|0|||
156779649|NCT02394756|565942639|FG002|Period 2|Unsatisfactory Visual Response|0|||
156779650|NCT02394756|565942640|FG003|Period 2|Unsatisfactory Visual Response|0|||
156866143|NCT01342211|566269178|FG003|Overall Study|Randomized, but not Treated|0|||
156866144|NCT01342211|566269179|FG004|Overall Study|Randomized, but not Treated|1|||
156866145|NCT02594124|566269182|FG000|Overall Study|Adverse Event|0|||
156866146|NCT02594124|566269183|FG001|Overall Study|Adverse Event|5|||
156866147|NCT02594124|566269184|FG002|Overall Study|Adverse Event|8|||
156866148|NCT02594124|566269185|FG003|Overall Study|Adverse Event|1|||
156866149|NCT02594124|566269186|FG004|Overall Study|Adverse Event|0|||
156866150|NCT02594124|566269187|FG005|Overall Study|Adverse Event|0|||
156866151|NCT02594124|566269188|FG006|Overall Study|Adverse Event|2|||
156866152|NCT02594124|566269189|FG007|Overall Study|Adverse Event|2|||
156525918|NCT00406653|565019424|FG002|Open-Label Period|Refused followup|0|||
156525919|NCT00406653|565019425|FG003|Open-Label Period|Refused followup|0|||
156525920|NCT00406653|565019426|FG004|Open-Label Period|Refused followup|0|||
156326456|NCT02598960|564296028|FG007|Participants Entering Follow Up Period|Death|0|||
156326457|NCT02598960|564296029|FG008|Participants Entering Follow Up Period|Death|0|||
156326458|NCT02598960|564296030|FG009|Participants Entering Follow Up Period|Death|1|||
156326459|NCT02598960|564296031|FG010|Participants Entering Follow Up Period|Death|0|||
156326460|NCT02598960|564296032|FG011|Participants Entering Follow Up Period|Death|11|||
156326461|NCT02598960|564296033|FG012|Participants Entering Follow Up Period|Death|2|||
156326462|NCT02598960|564296021|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326463|NCT02598960|564296022|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326464|NCT02598960|564296023|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326465|NCT02598960|564296024|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326466|NCT02598960|564296025|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326467|NCT02598960|564296026|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326468|NCT02598960|564296027|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326469|NCT02598960|564296028|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326470|NCT02598960|564296029|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326471|NCT02598960|564296030|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326472|NCT02598960|564296031|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326473|NCT02598960|564296032|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
156326474|NCT02598960|564296033|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
156326475|NCT02598960|564296021|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
156326476|NCT02598960|564296022|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
156326477|NCT02598960|564296023|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
156326478|NCT02598960|564296024|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
156326479|NCT02598960|564296025|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
156326480|NCT02598960|564296026|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
156326481|NCT02598960|564296027|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
156326482|NCT02598960|564296028|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
156326483|NCT02598960|564296029|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
156326484|NCT02598960|564296030|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
156326485|NCT02598960|564296031|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
156326486|NCT02598960|564296032|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
156326487|NCT02598960|564296033|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
156326488|NCT02598960|564296021|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326489|NCT02598960|564296022|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326490|NCT02598960|564296023|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326491|NCT02598960|564296024|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326492|NCT02598960|564296025|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326493|NCT02598960|564296026|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326494|NCT02598960|564296027|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326495|NCT02598960|564296028|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326496|NCT02598960|564296029|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326497|NCT02598960|564296030|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326498|NCT02598960|564296031|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326499|NCT02598960|564296032|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
156326500|NCT02598960|564296033|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156326501|NCT02598960|564296021|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
156326502|NCT02598960|564296022|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
156326503|NCT02598960|564296023|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
156326504|NCT02598960|564296024|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
156866153|NCT02594124|566269190|FG008|Overall Study|Adverse Event|0|||
156866154|NCT02594124|566269182|FG000|Overall Study|Withdrawal by Subject|2|||
156866155|NCT02594124|566269183|FG001|Overall Study|Withdrawal by Subject|3|||
156866156|NCT02594124|566269184|FG002|Overall Study|Withdrawal by Subject|5|||
156866157|NCT02594124|566269185|FG003|Overall Study|Withdrawal by Subject|1|||
156668234|NCT01597245|565532568|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668235|NCT01597245|565532569|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668236|NCT01597245|565532570|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668237|NCT01597245|565532571|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668238|NCT01597245|565532572|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668239|NCT01597245|565532573|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668240|NCT01597245|565532574|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668241|NCT01597245|565532575|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668242|NCT01597245|565532576|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
156668243|NCT01597245|565532556|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
156668244|NCT01597245|565532557|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
156668245|NCT01597245|565532558|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
156668246|NCT01597245|565532559|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668247|NCT01597245|565532560|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668248|NCT01597245|565532561|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668249|NCT01597245|565532562|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668250|NCT01597245|565532563|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668251|NCT01597245|565532564|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668252|NCT01597245|565532565|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668253|NCT01597245|565532566|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668254|NCT01597245|565532567|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668255|NCT01597245|565532568|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668256|NCT01597245|565532569|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668257|NCT01597245|565532570|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668258|NCT01597245|565532571|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668259|NCT01597245|565532572|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668260|NCT01597245|565532573|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668261|NCT01597245|565532574|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668262|NCT01597245|565532575|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668263|NCT01597245|565532576|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
156668264|NCT01597245|565532556|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
156668265|NCT01597245|565532557|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668266|NCT01597245|565532558|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668267|NCT01597245|565532559|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
156668268|NCT01597245|565532560|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668269|NCT01597245|565532561|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668270|NCT01597245|565532562|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668271|NCT01597245|565532563|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668272|NCT01597245|565532564|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668273|NCT01597245|565532565|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668274|NCT01597245|565532566|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668275|NCT01597245|565532567|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668276|NCT01597245|565532568|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668277|NCT01597245|565532569|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668278|NCT01597245|565532570|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668279|NCT01597245|565532571|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668280|NCT01597245|565532572|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668281|NCT01597245|565532573|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668282|NCT01597245|565532574|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668283|NCT01597245|565532575|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668284|NCT01597245|565532576|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
156668285|NCT01597245|565532556|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
156668286|NCT01597245|565532557|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
156668287|NCT01597245|565532558|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
156668288|NCT01597245|565532559|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668289|NCT01597245|565532560|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156866158|NCT02594124|566269186|FG004|Overall Study|Withdrawal by Subject|8|||
156866159|NCT02594124|566269187|FG005|Overall Study|Withdrawal by Subject|4|||
156866160|NCT02594124|566269188|FG006|Overall Study|Withdrawal by Subject|13|||
156866161|NCT02594124|566269189|FG007|Overall Study|Withdrawal by Subject|19|||
156866162|NCT02594124|566269190|FG008|Overall Study|Withdrawal by Subject|0|||
156866163|NCT02594124|566269182|FG000|Overall Study|Physician Decision|0|||
156866164|NCT02594124|566269183|FG001|Overall Study|Physician Decision|2|||
156866165|NCT02594124|566269184|FG002|Overall Study|Physician Decision|0|||
156668290|NCT01597245|565532561|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668291|NCT01597245|565532562|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668292|NCT01597245|565532563|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668293|NCT01597245|565532564|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668294|NCT01597245|565532565|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668295|NCT01597245|565532566|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668296|NCT01597245|565532567|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668297|NCT01597245|565532568|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668298|NCT01597245|565532569|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668299|NCT01597245|565532570|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668300|NCT01597245|565532571|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668301|NCT01597245|565532572|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668302|NCT01597245|565532573|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668303|NCT01597245|565532574|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668304|NCT01597245|565532575|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668305|NCT01597245|565532576|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
156668306|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668307|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668308|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668309|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668310|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668311|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
156668312|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
156668313|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668314|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668315|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668316|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668317|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668318|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668319|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668320|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668321|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668322|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668323|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668324|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668325|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668326|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
156668327|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668328|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668329|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668330|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668331|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
156668332|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
156668333|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
156668334|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
156668335|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668336|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
156668337|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668338|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668339|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668340|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668341|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668342|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156866166|NCT02594124|566269185|FG003|Overall Study|Physician Decision|0|||
156866167|NCT02594124|566269186|FG004|Overall Study|Physician Decision|0|||
156866168|NCT02594124|566269187|FG005|Overall Study|Physician Decision|0|||
156866169|NCT02594124|566269188|FG006|Overall Study|Physician Decision|0|||
156866170|NCT02594124|566269189|FG007|Overall Study|Physician Decision|1|||
156866171|NCT02594124|566269190|FG008|Overall Study|Physician Decision|0|||
156866172|NCT02594124|566269182|FG000|Overall Study|Commercial drug|0|||
156668343|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668344|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668345|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156866173|NCT02594124|566269183|FG001|Overall Study|Commercial drug|1|||
156866174|NCT02594124|566269184|FG002|Overall Study|Commercial drug|6|||
156866175|NCT02594124|566269185|FG003|Overall Study|Commercial drug|3|||
156430871|NCT04133363|564666219|FG000|Overall Study|Lost to Follow-up|2|||
156668346|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668347|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
156668348|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668349|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668350|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668351|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668352|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668353|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
156668354|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668355|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668356|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
156668357|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668358|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
156668359|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
156668360|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
156668361|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668362|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668363|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668364|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668365|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668366|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668367|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668368|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
156668369|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668370|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668371|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156866176|NCT02594124|566269186|FG004|Overall Study|Commercial drug|0|||
156866177|NCT02594124|566269187|FG005|Overall Study|Commercial drug|0|||
156866178|NCT02594124|566269188|FG006|Overall Study|Commercial drug|7|||
156866179|NCT02594124|566269189|FG007|Overall Study|Commercial drug|11|||
156866180|NCT02594124|566269190|FG008|Overall Study|Commercial drug|2|||
156866181|NCT02594124|566269182|FG000|Overall Study|Reason Not Specified|1|||
156866182|NCT02594124|566269183|FG001|Overall Study|Reason Not Specified|3|||
156866183|NCT02594124|566269184|FG002|Overall Study|Reason Not Specified|4|||
156866184|NCT02594124|566269185|FG003|Overall Study|Reason Not Specified|0|||
156866185|NCT02594124|566269186|FG004|Overall Study|Reason Not Specified|0|||
156866186|NCT02594124|566269187|FG005|Overall Study|Reason Not Specified|1|||
156866187|NCT02594124|566269188|FG006|Overall Study|Reason Not Specified|1|||
156866188|NCT02594124|566269189|FG007|Overall Study|Reason Not Specified|6|||
156866189|NCT02594124|566269190|FG008|Overall Study|Reason Not Specified|1|||
156866190|NCT01824836|566269191|FG000|Overall Study|Adverse Event|48|||
156866191|NCT01824836|566269191|FG000|Overall Study|Withdrawal by Subject|63|||
156866192|NCT01824836|566269191|FG000|Overall Study|Other complicating disease|116|||
156866193|NCT01824836|566269191|FG000|Overall Study|Disease progression|5|||
156866194|NCT01824836|566269191|FG000|Overall Study|Alternative therapy|2|||
156866195|NCT01824836|566269191|FG000|Overall Study|Depression|1|||
156866196|NCT01824836|566269191|FG000|Overall Study|Non-compliance|3|||
156866197|NCT01824836|566269191|FG000|Overall Study|Patient regained ovarian function|3|||
156866198|NCT01824836|566269191|FG000|Overall Study|Lost to Follow-up|8|||
156866199|NCT01824836|566269191|FG000|Overall Study|Physician Decision|2|||
156866200|NCT01824836|566269191|FG000|Overall Study|Research office was closed|3|||
156668372|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668373|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
156866201|NCT01824836|566269191|FG000|Overall Study|Relocation|3|||
156866202|NCT01824836|566269191|FG000|Overall Study|Insurance-related issue|1|||
156866203|NCT01824836|566269191|FG000|Overall Study|Transportation issue|1|||
156866204|NCT01824836|566269191|FG000|Overall Study|Patient transferred care|1|||
156866205|NCT01824836|566269191|FG000|Overall Study|Unknown reasons|4|||
156866206|NCT01824836|566269191|FG000|Overall Study|Never started treatment|16|||
156866207|NCT05523089|566269192|FG000|Overall Study|Withdrawal by Subject|1|||
156668374|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
156668375|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
156668376|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
156668377|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
156866208|NCT05523089|566269193|FG001|Overall Study|Withdrawal by Subject|0|||
156866209|NCT05523089|566269194|FG002|Overall Study|Withdrawal by Subject|0|||
156866210|NCT05523089|566269192|FG000|Overall Study|Lost to Follow-up|1|||
156866211|NCT05523089|566269193|FG001|Overall Study|Lost to Follow-up|0|||
156866212|NCT05523089|566269194|FG002|Overall Study|Lost to Follow-up|0|||
156866213|NCT01148979|566271113|FG000|Overall Study|Lost to Follow-up|0|||
156866214|NCT01148979|566271114|FG001|Overall Study|Lost to Follow-up|1|||
156866215|NCT05291520|566271115|FG000|Overall Study|Lost to Follow-up|0|||
156668378|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
156668379|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
156668380|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
156668381|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
156668382|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668383|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668384|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668385|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668386|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668387|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668388|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668389|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
156668390|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668391|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668392|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668393|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668394|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
156668395|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
156668396|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
156668397|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668398|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
156668399|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
156668400|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
156668401|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
156668402|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
156668403|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668404|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668405|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668406|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668407|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668408|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668409|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668410|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
156668411|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668412|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668413|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668414|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668415|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
156668416|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668417|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668418|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668419|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
156668420|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
156668421|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
156668422|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668423|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
156668424|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668425|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668426|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668427|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668428|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668429|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668430|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668431|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
156668432|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156525921|NCT00406653|565019427|FG005|Open-Label Period|Refused followup|0|||
156525922|NCT00406653|565019428|FG006|Open-Label Period|Refused followup|1|||
156525923|NCT00940108|565019429|FG000|Overall Study|Adverse Event|2|||
156525924|NCT00940108|565019430|FG001|Overall Study|Adverse Event|4|||
156525925|NCT00940108|565019431|FG002|Overall Study|Adverse Event|0|||
156525926|NCT00940108|565019432|FG003|Overall Study|Adverse Event|2|||
156525927|NCT00940108|565019429|FG000|Overall Study|Withdrew Consent|2|||
156525928|NCT00940108|565019430|FG001|Overall Study|Withdrew Consent|1|||
156525929|NCT00940108|565019431|FG002|Overall Study|Withdrew Consent|0|||
156525930|NCT00940108|565019432|FG003|Overall Study|Withdrew Consent|1|||
156525931|NCT00940108|565019429|FG000|Overall Study|Dose 2 contraindicated|1|||
156525932|NCT00940108|565019430|FG001|Overall Study|Dose 2 contraindicated|1|||
156525933|NCT00940108|565019431|FG002|Overall Study|Dose 2 contraindicated|0|||
156525934|NCT00940108|565019432|FG003|Overall Study|Dose 2 contraindicated|1|||
156525935|NCT00940108|565019429|FG000|Overall Study|Declined further vaccination|0|||
156525936|NCT00940108|565019430|FG001|Overall Study|Declined further vaccination|1|||
156525937|NCT00940108|565019431|FG002|Overall Study|Declined further vaccination|3|||
156808609|NCT00237042|566052730|FG002|Treatment|Completed no treatment|21|||
156808610|NCT00237042|566052728|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
156808611|NCT00237042|566052729|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
156808612|NCT00237042|566052730|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
156808613|NCT00237042|566052728|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
156808614|NCT00237042|566052729|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
156808615|NCT00237042|566052730|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
156808616|NCT03132467|566052735|FG000|Overall Study|Adverse Event|2|||
156808617|NCT03132467|566052735|FG000|Overall Study|Withdrawal by Subject|2|||
156808618|NCT01365455|566052742|FG000|Induction Period|Adverse Event|5|||
156808619|NCT01365455|566052743|FG001|Induction Period|Adverse Event|3|||
156808620|NCT01365455|566052744|FG002|Induction Period|Adverse Event|4|||
156808621|NCT01365455|566052745|FG003|Induction Period|Adverse Event|0|||
156808622|NCT01365455|566052746|FG004|Induction Period|Adverse Event|0|||
156808623|NCT01365455|566052742|FG000|Induction Period|Lack of Efficacy|1|||
156808624|NCT01365455|566052743|FG001|Induction Period|Lack of Efficacy|1|||
156808625|NCT01365455|566052744|FG002|Induction Period|Lack of Efficacy|0|||
156808626|NCT01365455|566052745|FG003|Induction Period|Lack of Efficacy|0|||
156808627|NCT01365455|566052746|FG004|Induction Period|Lack of Efficacy|0|||
156808628|NCT01365455|566052742|FG000|Induction Period|Pregnancy|0|||
156808629|NCT01365455|566052743|FG001|Induction Period|Pregnancy|1|||
156808630|NCT01365455|566052744|FG002|Induction Period|Pregnancy|0|||
156808631|NCT01365455|566052745|FG003|Induction Period|Pregnancy|0|||
156808632|NCT01365455|566052746|FG004|Induction Period|Pregnancy|0|||
156808633|NCT01365455|566052742|FG000|Induction Period|Protocol deviation|0|||
156808634|NCT01365455|566052743|FG001|Induction Period|Protocol deviation|1|||
156808635|NCT01365455|566052744|FG002|Induction Period|Protocol deviation|1|||
156808636|NCT01365455|566052745|FG003|Induction Period|Protocol deviation|0|||
156808637|NCT01365455|566052746|FG004|Induction Period|Protocol deviation|0|||
156808638|NCT01365455|566052742|FG000|Induction Period|Subject/guardian decision|9|||
156808639|NCT01365455|566052743|FG001|Induction Period|Subject/guardian decision|1|||
156808640|NCT01365455|566052744|FG002|Induction Period|Subject/guardian decision|8|||
156808641|NCT01365455|566052745|FG003|Induction Period|Subject/guardian decision|0|||
156808642|NCT01365455|566052746|FG004|Induction Period|Subject/guardian decision|0|||
156808643|NCT01365455|566052742|FG000|Induction Period|Lost to Follow-up|0|||
156808644|NCT01365455|566052743|FG001|Induction Period|Lost to Follow-up|0|||
156808645|NCT01365455|566052744|FG002|Induction Period|Lost to Follow-up|3|||
156808646|NCT01365455|566052745|FG003|Induction Period|Lost to Follow-up|0|||
156808647|NCT01365455|566052746|FG004|Induction Period|Lost to Follow-up|0|||
156808648|NCT01365455|566052742|FG000|Maintenance Period|Adverse Event|12|||
156808649|NCT01365455|566052743|FG001|Maintenance Period|Adverse Event|5|||
156808650|NCT01365455|566052744|FG002|Maintenance Period|Adverse Event|1|||
156808651|NCT01365455|566052745|FG003|Maintenance Period|Adverse Event|2|||
156808652|NCT01365455|566052746|FG004|Maintenance Period|Adverse Event|4|||
156808653|NCT01365455|566052742|FG000|Maintenance Period|Lack of Efficacy|10|||
156808654|NCT01365455|566052743|FG001|Maintenance Period|Lack of Efficacy|2|||
156808655|NCT01365455|566052744|FG002|Maintenance Period|Lack of Efficacy|0|||
156808656|NCT01365455|566052745|FG003|Maintenance Period|Lack of Efficacy|2|||
156808657|NCT01365455|566052746|FG004|Maintenance Period|Lack of Efficacy|2|||
156808658|NCT01365455|566052742|FG000|Maintenance Period|Lost to Follow-up|2|||
156808659|NCT01365455|566052743|FG001|Maintenance Period|Lost to Follow-up|4|||
156808660|NCT01365455|566052744|FG002|Maintenance Period|Lost to Follow-up|0|||
156808661|NCT01365455|566052745|FG003|Maintenance Period|Lost to Follow-up|0|||
156808662|NCT01365455|566052746|FG004|Maintenance Period|Lost to Follow-up|3|||
156808663|NCT01365455|566052742|FG000|Maintenance Period|Non-compliance with study treatment|0|||
156808664|NCT01365455|566052743|FG001|Maintenance Period|Non-compliance with study treatment|0|||
156808665|NCT01365455|566052744|FG002|Maintenance Period|Non-compliance with study treatment|0|||
156808666|NCT01365455|566052745|FG003|Maintenance Period|Non-compliance with study treatment|1|||
156808667|NCT01365455|566052746|FG004|Maintenance Period|Non-compliance with study treatment|0|||
156808668|NCT01365455|566052742|FG000|Maintenance Period|Physician Decision|0|||
156808669|NCT01365455|566052743|FG001|Maintenance Period|Physician Decision|1|||
156808670|NCT01365455|566052744|FG002|Maintenance Period|Physician Decision|0|||
156808671|NCT01365455|566052745|FG003|Maintenance Period|Physician Decision|0|||
156808672|NCT01365455|566052746|FG004|Maintenance Period|Physician Decision|1|||
156808673|NCT01365455|566052742|FG000|Maintenance Period|Pregnancy|0|||
156668433|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668434|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668435|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668436|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
156668437|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
156668438|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
156668439|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668440|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
156668441|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
156668442|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
156668443|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
156668444|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
156668445|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668446|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668447|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668448|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668449|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668450|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668451|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668452|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
156668453|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668454|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668455|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668456|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668457|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668458|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
156668459|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668460|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668461|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
156668462|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
156668463|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
156668464|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
156668465|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668466|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668467|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668468|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668469|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668470|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668471|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668472|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668473|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
156668474|NCT01597245|565532556|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668475|NCT01597245|565532557|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668476|NCT01597245|565532558|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668477|NCT01597245|565532559|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668478|NCT01597245|565532560|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668479|NCT01597245|565532561|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668480|NCT01597245|565532562|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156525938|NCT00940108|565019432|FG003|Overall Study|Declined further vaccination|0|||
156525939|NCT00940108|565019429|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
156525940|NCT00940108|565019430|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
156525941|NCT00940108|565019431|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
156525942|NCT00940108|565019432|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
156525943|NCT00940108|565019429|FG000|Overall Study|Viral illness after Dose 1|0|||
156525944|NCT00940108|565019430|FG001|Overall Study|Viral illness after Dose 1|1|||
156525945|NCT00940108|565019431|FG002|Overall Study|Viral illness after Dose 1|0|||
156326505|NCT02598960|564296025|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
156326506|NCT02598960|564296026|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
156326507|NCT02598960|564296027|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
156326508|NCT02598960|564296028|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
156326509|NCT02598960|564296029|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
156525946|NCT00940108|565019432|FG003|Overall Study|Viral illness after Dose 1|0|||
156668481|NCT01597245|565532563|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668482|NCT01597245|565532564|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156326510|NCT02598960|564296030|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
156668483|NCT01597245|565532565|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668484|NCT01597245|565532566|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
156668485|NCT01597245|565532567|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668486|NCT01597245|565532568|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668487|NCT01597245|565532569|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668488|NCT01597245|565532570|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668489|NCT01597245|565532571|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668490|NCT01597245|565532572|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668491|NCT01597245|565532573|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668492|NCT01597245|565532574|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668493|NCT01597245|565532575|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668494|NCT01597245|565532576|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
156668495|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668496|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668497|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668498|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668499|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668500|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668501|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668502|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668503|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668504|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668505|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668506|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668507|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668508|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
156668509|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
156668510|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
156668511|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668512|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668513|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668514|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668515|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
156668516|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668517|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668518|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668519|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668520|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668521|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668522|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668523|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668524|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668525|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668526|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668527|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668528|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668529|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
156668530|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
156668531|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
156668532|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668533|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668534|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668535|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668536|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
156668537|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668538|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668539|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668540|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668541|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668542|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668543|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668544|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668545|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156808674|NCT01365455|566052743|FG001|Maintenance Period|Pregnancy|4|||
156668546|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668547|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668548|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668549|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668550|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156866216|NCT05291520|566271116|FG001|Overall Study|Lost to Follow-up|0|||
156525947|NCT00940108|565019429|FG000|Overall Study|Diagnosed with H1N1|0|||
156525948|NCT00940108|565019430|FG001|Overall Study|Diagnosed with H1N1|0|||
156525949|NCT00940108|565019431|FG002|Overall Study|Diagnosed with H1N1|0|||
156525950|NCT00940108|565019432|FG003|Overall Study|Diagnosed with H1N1|1|||
156525951|NCT02019927|565019433|FG000|Overall Study|Lost to Follow-up|2|||
156525952|NCT02019927|565019434|FG001|Overall Study|Lost to Follow-up|4|||
156525953|NCT02019927|565019435|FG002|Overall Study|Lost to Follow-up|1|||
156525954|NCT02019927|565019436|FG003|Overall Study|Lost to Follow-up|2|||
156525955|NCT02019927|565019437|FG004|Overall Study|Lost to Follow-up|3|||
156525956|NCT02019927|565019438|FG005|Overall Study|Lost to Follow-up|1|||
156525957|NCT01668667|565019446|FG000|Overall Study|Adverse Event|3|||
156525958|NCT01668667|565019447|FG001|Overall Study|Adverse Event|6|||
156525959|NCT01668667|565019448|FG002|Overall Study|Adverse Event|4|||
156525960|NCT01668667|565019449|FG003|Overall Study|Adverse Event|4|||
156525961|NCT01668667|565019446|FG000|Overall Study|Lack of Efficacy|3|||
156525962|NCT01668667|565019447|FG001|Overall Study|Lack of Efficacy|2|||
156525963|NCT01668667|565019448|FG002|Overall Study|Lack of Efficacy|2|||
156525964|NCT01668667|565019449|FG003|Overall Study|Lack of Efficacy|3|||
156525965|NCT01668667|565019446|FG000|Overall Study|Protocol Violation|6|||
156525966|NCT01668667|565019447|FG001|Overall Study|Protocol Violation|10|||
156525967|NCT01668667|565019448|FG002|Overall Study|Protocol Violation|12|||
156525968|NCT01668667|565019449|FG003|Overall Study|Protocol Violation|5|||
156525969|NCT01668667|565019446|FG000|Overall Study|Lost to Follow-up|9|||
156525970|NCT01668667|565019447|FG001|Overall Study|Lost to Follow-up|4|||
156525971|NCT01668667|565019448|FG002|Overall Study|Lost to Follow-up|7|||
156525972|NCT01668667|565019449|FG003|Overall Study|Lost to Follow-up|6|||
156525973|NCT01668667|565019446|FG000|Overall Study|Physician Decision|3|||
156525974|NCT01668667|565019447|FG001|Overall Study|Physician Decision|0|||
156525975|NCT01668667|565019448|FG002|Overall Study|Physician Decision|1|||
156525976|NCT01668667|565019449|FG003|Overall Study|Physician Decision|0|||
156525977|NCT01668667|565019446|FG000|Overall Study|Withdrawal by Subject|7|||
156525978|NCT01668667|565019447|FG001|Overall Study|Withdrawal by Subject|4|||
156525979|NCT01668667|565019448|FG002|Overall Study|Withdrawal by Subject|5|||
156525980|NCT01668667|565019449|FG003|Overall Study|Withdrawal by Subject|5|||
156525981|NCT04576455|565019450|FG000|Overall Study|Ongoing in the Study|48|||
156525982|NCT04576455|565019451|FG001|Overall Study|Ongoing in the Study|58|||
156525983|NCT04576455|565019450|FG000|Overall Study|Death|83|||
156525984|NCT04576455|565019451|FG001|Overall Study|Death|77|||
156525985|NCT04576455|565019450|FG000|Overall Study|Lost to Follow-up|4|||
156525986|NCT04576455|565019451|FG001|Overall Study|Lost to Follow-up|5|||
156525987|NCT04576455|565019450|FG000|Overall Study|Withdrawal by Subject|16|||
156525988|NCT04576455|565019451|FG001|Overall Study|Withdrawal by Subject|12|||
156525989|NCT05677893|565021419|FG000|Overall Study|Withdrawal by Subject|0|||
156525990|NCT05677893|565021420|FG001|Overall Study|Withdrawal by Subject|0|||
156525991|NCT05677893|565021421|FG002|Overall Study|Withdrawal by Subject|0|||
156525992|NCT05677893|565021422|FG003|Overall Study|Withdrawal by Subject|0|||
156525993|NCT05677893|565021423|FG004|Overall Study|Withdrawal by Subject|1|||
156866217|NCT05291520|566271117|FG002|Overall Study|Lost to Follow-up|1|||
156866218|NCT01347112|566271118|FG000|Overall Study|Withdrawal by Subject|1|||
156866219|NCT01347112|566271119|FG001|Overall Study|Withdrawal by Subject|7|||
156866220|NCT01347112|566271118|FG000|Overall Study|Lost to Follow-up|3|||
156866221|NCT01347112|566271119|FG001|Overall Study|Lost to Follow-up|5|||
156866222|NCT05462756|566271136|FG000|Treatment Period|Adverse Event|3|||
156866223|NCT05462756|566271137|FG001|Treatment Period|Adverse Event|0|||
156525994|NCT05677893|565021424|FG005|Overall Study|Withdrawal by Subject|1|||
156525995|NCT05677893|565021425|FG006|Overall Study|Withdrawal by Subject|0|||
156525996|NCT05677893|565021419|FG000|Overall Study|Others|1|||
156866224|NCT05462756|566271136|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
156866225|NCT05462756|566271137|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
156866226|NCT05462756|566271136|FG000|Treatment Period|Death|0|||
156866227|NCT05462756|566271137|FG001|Treatment Period|Death|1|||
156525997|NCT05677893|565021420|FG001|Overall Study|Others|0|||
156525998|NCT05677893|565021421|FG002|Overall Study|Others|0|||
156525999|NCT05677893|565021422|FG003|Overall Study|Others|0|||
156526000|NCT05677893|565021423|FG004|Overall Study|Others|0|||
156526001|NCT05677893|565021424|FG005|Overall Study|Others|0|||
156526002|NCT05677893|565021425|FG006|Overall Study|Others|0|||
156526003|NCT03217266|565021426|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
156526004|NCT03217266|565021427|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
156526005|NCT03217266|565021428|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
156526006|NCT03217266|565021429|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
156526007|NCT03217266|565021426|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
156668551|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
156668552|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
156668553|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668554|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668555|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668556|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668557|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
156668558|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668559|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668560|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668561|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668562|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668563|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668564|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668565|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668566|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668567|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668568|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668569|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668570|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668571|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668572|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
156668573|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
156668574|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668575|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668576|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668577|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668578|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
156668579|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668580|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668581|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668582|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668583|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668584|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668585|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668586|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668587|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668588|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668589|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668590|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668591|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668592|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
156668593|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
156668594|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
156668595|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668596|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668597|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668598|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668599|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
156668600|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
156866228|NCT05462756|566271136|FG000|Treatment Period|Lost to Follow-up|2|||
156866229|NCT05462756|566271137|FG001|Treatment Period|Lost to Follow-up|1|||
156866230|NCT05462756|566271136|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
156866231|NCT05462756|566271137|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
156668601|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668602|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668603|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668604|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668605|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668606|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668607|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668608|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
156866232|NCT05462756|566271136|FG000|Treatment Period|Physician Decision|2|||
156866233|NCT05462756|566271137|FG001|Treatment Period|Physician Decision|0|||
156866234|NCT05462756|566271136|FG000|Treatment Period|Protocol Violation|0|||
156668609|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668610|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668611|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668612|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668613|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
156866235|NCT05462756|566271137|FG001|Treatment Period|Protocol Violation|1|||
156866236|NCT05462756|566271136|FG000|Treatment Period|Withdrawal by Subject|5|||
156866237|NCT05462756|566271137|FG001|Treatment Period|Withdrawal by Subject|12|||
156866238|NCT05462756|566271136|FG000|Follow-Up Period|Adverse Event|1|||
156866239|NCT05462756|566271137|FG001|Follow-Up Period|Adverse Event|0|||
156866240|NCT05462756|566271136|FG000|Follow-Up Period|Death|1|||
156866241|NCT05462756|566271137|FG001|Follow-Up Period|Death|0|||
156866242|NCT05462756|566271136|FG000|Follow-Up Period|Lost to Follow-up|3|||
156866243|NCT05462756|566271137|FG001|Follow-Up Period|Lost to Follow-up|1|||
156866244|NCT05462756|566271136|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156866245|NCT05462756|566271137|FG001|Follow-Up Period|Withdrawal by Subject|4|||
156668614|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
156668615|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
156668616|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668617|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668618|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668619|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668620|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
156668621|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668622|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668623|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668624|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668625|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668626|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668627|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668628|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668629|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668630|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668631|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668632|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668633|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668634|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668635|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
156668636|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
156668637|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668638|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668639|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668640|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668641|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
156668642|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668643|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668644|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156526008|NCT03217266|565021427|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
156526009|NCT03217266|565021428|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
156526010|NCT03217266|565021429|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
156526011|NCT03217266|565021426|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
156866246|NCT02536976|566271143|FG000|Overall Study|Physician Decision|0|||
156866247|NCT02536976|566271144|FG001|Overall Study|Physician Decision|1|||
156866248|NCT01389596|566271147|FG000|Overall Study|Protocol Violation|3|||
156526012|NCT03217266|565021427|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
156668645|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668646|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668647|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668648|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668649|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668650|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668651|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668652|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668653|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668654|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156866249|NCT01389596|566271148|FG001|Overall Study|Protocol Violation|4|||
156866250|NCT01389596|566271149|FG002|Overall Study|Protocol Violation|3|||
156526013|NCT03217266|565021428|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
156668655|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668656|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
156668657|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
156668658|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668659|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668660|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668661|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668662|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
156668663|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668664|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668665|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668666|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668667|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668668|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668669|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668670|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668671|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668672|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668673|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668674|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668675|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668676|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668677|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
156668678|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
156668679|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668680|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668681|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668682|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668683|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
156668684|NCT01597245|565532556|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668685|NCT01597245|565532557|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668686|NCT01597245|565532558|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668687|NCT01597245|565532559|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668688|NCT01597245|565532560|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668689|NCT01597245|565532561|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668690|NCT01597245|565532562|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668691|NCT01597245|565532563|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668692|NCT01597245|565532564|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668693|NCT01597245|565532565|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668694|NCT01597245|565532566|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668695|NCT01597245|565532567|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668696|NCT01597245|565532568|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668697|NCT01597245|565532569|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
156668698|NCT01597245|565532570|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668699|NCT01597245|565532571|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668700|NCT01597245|565532572|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668701|NCT01597245|565532573|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668702|NCT01597245|565532574|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668703|NCT01597245|565532575|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668704|NCT01597245|565532576|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
156668705|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668706|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668707|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668708|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668709|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156779651|NCT02394756|565942641|FG004|Period 2|Unsatisfactory Visual Response|1|||
156779652|NCT02394756|565942642|FG005|Period 2|Unsatisfactory Visual Response|0|||
156779653|NCT02916771|565942643|FG000|Overall Study|Withdrawal by Subject|9|||
156779654|NCT02916771|565942643|FG000|Overall Study|Physician Decision|1|||
156779655|NCT02916771|565942643|FG000|Overall Study|Began treatment for another active malignancy|1|||
156779656|NCT06455111|565942645|FG000|Overall Study|Withdrawal by Subject|11|||
156779657|NCT06455111|565942646|FG001|Overall Study|Withdrawal by Subject|4|||
156779658|NCT03611946|565942651|FG000|Overall Study|Withdrawal by Subject|0|||
156779659|NCT03611946|565942652|FG001|Overall Study|Withdrawal by Subject|0|||
156779660|NCT03611946|565942653|FG002|Overall Study|Withdrawal by Subject|1|||
156668710|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668711|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668712|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668713|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668714|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668715|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668716|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668717|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668718|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668719|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668720|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
156668721|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
156668722|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
156668723|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
156668724|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
156668725|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
156668726|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668727|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668728|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668729|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668730|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668731|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668732|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668733|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668734|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668735|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668736|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668737|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668738|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668739|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668740|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668741|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668742|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
156668743|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
156668744|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
156668745|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
156668746|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
156668747|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668748|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668749|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668750|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668751|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668752|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668753|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668754|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668755|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668756|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668757|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668758|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668759|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668760|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668761|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668762|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668763|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
156668764|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668765|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
156668766|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
156668767|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
156526014|NCT03217266|565021429|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
156526015|NCT02101034|565021430|FG000|Overall Study|Enrolled but did not start treatment|0|||
156526016|NCT02101034|565021431|FG001|Overall Study|Enrolled but did not start treatment|0|||
156668768|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668769|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668770|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668771|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668772|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668773|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668774|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668775|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668776|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668777|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668778|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668779|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668780|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668781|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668782|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668783|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668784|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668785|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
156668786|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
156668787|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
156668788|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
156668789|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668790|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668791|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668792|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668793|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668794|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668795|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668796|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668797|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668798|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668799|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668800|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668801|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668802|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668803|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668804|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668805|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
156668806|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668807|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
156668808|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
156668809|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
156668810|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668811|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668812|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156326511|NCT02598960|564296031|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
156326512|NCT02598960|564296032|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
156326513|NCT02598960|564296033|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
156326514|NCT00398411|564296034|FG000|Overall Study|Death|0|||
156326515|NCT00398411|564296035|FG001|Overall Study|Death|1|||
156326516|NCT03061097|564296040|FG000|Overall Study|Withdrawal by Subject|0|||
156326517|NCT03061097|564296041|FG001|Overall Study|Withdrawal by Subject|3|||
156326518|NCT00595465|564296042|FG000|Overall Study|Adverse Event|4|||
156326519|NCT00595465|564296043|FG001|Overall Study|Adverse Event|3|||
156326520|NCT00595465|564296044|FG002|Overall Study|Adverse Event|3|||
156326521|NCT00595465|564296042|FG000|Overall Study|Pregnancy|0|||
156326522|NCT00595465|564296043|FG001|Overall Study|Pregnancy|0|||
156326523|NCT00595465|564296044|FG002|Overall Study|Pregnancy|1|||
156326524|NCT00595465|564296042|FG000|Overall Study|Protocol Violation|2|||
156326525|NCT00595465|564296043|FG001|Overall Study|Protocol Violation|1|||
156326526|NCT00595465|564296044|FG002|Overall Study|Protocol Violation|0|||
156326527|NCT00595465|564296042|FG000|Overall Study|Lost to Follow-up|0|||
156326528|NCT00595465|564296043|FG001|Overall Study|Lost to Follow-up|0|||
156326529|NCT00595465|564296044|FG002|Overall Study|Lost to Follow-up|2|||
156326530|NCT00595465|564296042|FG000|Overall Study|administrative reason|0|||
156668813|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156866251|NCT01389596|566271147|FG000|Overall Study|Withdrawal by Subject|1|||
156326531|NCT00595465|564296043|FG001|Overall Study|administrative reason|0|||
156326532|NCT00595465|564296044|FG002|Overall Study|administrative reason|1|||
156668814|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668815|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668816|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668817|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668818|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668819|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668820|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668821|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668822|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668823|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668824|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668825|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668826|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
156668827|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668828|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
156668829|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
156668830|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
156668831|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668832|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668833|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668834|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668835|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668836|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668837|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668838|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156526017|NCT02101034|565021432|FG002|Overall Study|Enrolled but did not start treatment|1|||
156526018|NCT02101034|565021433|FG003|Overall Study|Enrolled but did not start treatment|0|||
156526019|NCT02101034|565021434|FG004|Overall Study|Enrolled but did not start treatment|0|||
156526020|NCT01390181|565021435|FG000|Overall Study|Lost to Follow-up|1|||
156526021|NCT01390181|565021435|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
156526022|NCT01101477|565021440|FG000|Overall Study|Protocol Violation|5|||
156526023|NCT01101477|565021441|FG001|Overall Study|Protocol Violation|3|||
156526024|NCT01101477|565021442|FG002|Overall Study|Protocol Violation|1|||
156526025|NCT00720941|565021443|FG000|Overall Study|Protocol Violation|1|||
156526026|NCT00720941|565021444|FG001|Overall Study|Protocol Violation|2|||
156526027|NCT00720941|565021443|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
156526028|NCT00720941|565021444|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
156526029|NCT00720941|565021443|FG000|Overall Study|Lost to Follow-up|20|||
156668839|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668840|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668841|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668842|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668843|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668844|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668845|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668846|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668847|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
156668848|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668849|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668850|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
156668851|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
156668852|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668853|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668854|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668855|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668856|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668857|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668858|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668859|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668860|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668861|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668862|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156526030|NCT00720941|565021444|FG001|Overall Study|Lost to Follow-up|15|||
156526031|NCT00720941|565021443|FG000|Overall Study|Physician Decision|14|||
156668863|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668864|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668865|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668866|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668867|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668868|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
156668869|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668870|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668871|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
156668872|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
156668873|NCT01597245|565532556|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668874|NCT01597245|565532557|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668875|NCT01597245|565532558|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668876|NCT01597245|565532559|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668877|NCT01597245|565532560|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668878|NCT01597245|565532561|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668879|NCT01597245|565532562|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668880|NCT01597245|565532563|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668881|NCT01597245|565532564|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668882|NCT01597245|565532565|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668883|NCT01597245|565532566|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156808675|NCT01365455|566052744|FG002|Maintenance Period|Pregnancy|0|||
156808676|NCT01365455|566052745|FG003|Maintenance Period|Pregnancy|0|||
156808677|NCT01365455|566052746|FG004|Maintenance Period|Pregnancy|2|||
156808678|NCT01365455|566052742|FG000|Maintenance Period|Protocol deviation|1|||
156808679|NCT01365455|566052743|FG001|Maintenance Period|Protocol deviation|1|||
156808680|NCT01365455|566052744|FG002|Maintenance Period|Protocol deviation|0|||
156808681|NCT01365455|566052745|FG003|Maintenance Period|Protocol deviation|0|||
156808682|NCT01365455|566052746|FG004|Maintenance Period|Protocol deviation|0|||
156808683|NCT01365455|566052742|FG000|Maintenance Period|Subject/guardian decision|4|||
156808684|NCT01365455|566052743|FG001|Maintenance Period|Subject/guardian decision|6|||
156808685|NCT01365455|566052744|FG002|Maintenance Period|Subject/guardian decision|2|||
156808686|NCT01365455|566052745|FG003|Maintenance Period|Subject/guardian decision|4|||
156808687|NCT01365455|566052746|FG004|Maintenance Period|Subject/guardian decision|1|||
156808688|NCT03965403|566052747|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
156808689|NCT04267926|566054428|FG000|Overall Study|abnormal labs. No longer eligible|0|||
156808690|NCT04267926|566054429|FG001|Overall Study|abnormal labs. No longer eligible|0|||
156808691|NCT04267926|566054430|FG002|Overall Study|abnormal labs. No longer eligible|1|||
156808692|NCT04267926|566054428|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
156808693|NCT04267926|566054429|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
156808694|NCT04267926|566054430|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
156808695|NCT03718325|566054431|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
156808696|NCT03718325|566054432|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
156808697|NCT03718325|566054433|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
156808698|NCT03718325|566054431|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
156808699|NCT03718325|566054432|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
156808700|NCT03718325|566054433|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
156808701|NCT00972023|566054438|FG000|Overall Study|Withdrawal by Subject|1|||
156808702|NCT03052608|566054440|FG000|Treatment Phase|Adverse Event|10|||
156808703|NCT03052608|566054441|FG001|Treatment Phase|Adverse Event|12|||
156808704|NCT03052608|566054440|FG000|Treatment Phase|Death|6|||
156808705|NCT03052608|566054441|FG001|Treatment Phase|Death|4|||
156808706|NCT03052608|566054440|FG000|Treatment Phase|Withdrawal by Subject|4|||
156808707|NCT03052608|566054441|FG001|Treatment Phase|Withdrawal by Subject|12|||
156808708|NCT03052608|566054440|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
156808709|NCT03052608|566054441|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
156808710|NCT03052608|566054440|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
156808711|NCT03052608|566054441|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
156808712|NCT03052608|566054440|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
156808713|NCT03052608|566054441|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
156808714|NCT03052608|566054440|FG000|Treatment Phase|Ongoing|103|||
156808715|NCT03052608|566054441|FG001|Treatment Phase|Ongoing|31|||
156808716|NCT03052608|566054440|FG000|Long-Term Follow-up Phase|Death|23|||
156808717|NCT03052608|566054441|FG001|Long-Term Follow-up Phase|Death|28|||
156808718|NCT03052608|566054440|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
156866252|NCT01389596|566271148|FG001|Overall Study|Withdrawal by Subject|2|||
156866253|NCT01389596|566271149|FG002|Overall Study|Withdrawal by Subject|2|||
156866254|NCT01389596|566271147|FG000|Overall Study|Insufficient Clinical Response|3|||
156866255|NCT01389596|566271148|FG001|Overall Study|Insufficient Clinical Response|4|||
156866256|NCT01389596|566271149|FG002|Overall Study|Insufficient Clinical Response|5|||
156866257|NCT01389596|566271147|FG000|Overall Study|Adverse Event|1|||
156866258|NCT01389596|566271148|FG001|Overall Study|Adverse Event|4|||
156866259|NCT01389596|566271149|FG002|Overall Study|Adverse Event|0|||
156866260|NCT01389596|566271147|FG000|Overall Study|Death|0|||
156866261|NCT01389596|566271148|FG001|Overall Study|Death|1|||
156866262|NCT01389596|566271149|FG002|Overall Study|Death|0|||
156866263|NCT01389596|566271147|FG000|Overall Study|Other Unspecified|2|||
156866264|NCT01389596|566271148|FG001|Overall Study|Other Unspecified|1|||
156866265|NCT01389596|566271149|FG002|Overall Study|Other Unspecified|0|||
156866266|NCT01671319|566271150|FG000|Overall Study|Withdrawal by Subject|1|||
156866267|NCT01709084|566271151|FG000|Overall Study|Lost to Follow-up|4|||
156866268|NCT01709084|566271152|FG001|Overall Study|Lost to Follow-up|7|||
156866269|NCT01709084|566271151|FG000|Overall Study|Withdrawal by Subject|2|||
156866270|NCT01709084|566271152|FG001|Overall Study|Withdrawal by Subject|2|||
156866271|NCT01709084|566271151|FG000|Overall Study|Adverse Event|5|||
156866272|NCT01709084|566271152|FG001|Overall Study|Adverse Event|0|||
156866273|NCT01709084|566271151|FG000|Overall Study|Other|5|||
156866274|NCT01709084|566271152|FG001|Overall Study|Other|3|||
156430872|NCT04133363|564666220|FG001|Overall Study|Lost to Follow-up|1|||
156430873|NCT04133363|564666221|FG002|Overall Study|Lost to Follow-up|4|||
156430874|NCT01838200|564666222|FG000|Overall Study|Adverse Event|0|||
156430875|NCT01838200|564666223|FG001|Overall Study|Adverse Event|2|||
156430876|NCT01838200|564666222|FG000|Overall Study|Progressive disease|3|||
156430877|NCT01838200|564666223|FG001|Overall Study|Progressive disease|0|||
156430878|NCT03354390|564666224|FG000|Level 1|Death|2|||
156430879|NCT03354390|564666225|FG001|Level 1|Death|0|||
156430880|NCT03354390|564666226|FG002|Level 1|Death|0|||
156430881|NCT03354390|564666227|FG003|Level 1|Death|0|||
156430882|NCT03354390|564666224|FG000|Level 1|Physician Decision|1|||
156866275|NCT01709084|566271151|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
156866276|NCT01709084|566271152|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
156866277|NCT01709084|566271151|FG000|Overall Study|Not Treated|0|||
156866278|NCT01709084|566271152|FG001|Overall Study|Not Treated|2|||
156866279|NCT00214201|566271153|FG000|Overall Study|Withdrawal by Subject|2|||
156866280|NCT00214201|566271154|FG001|Overall Study|Withdrawal by Subject|0|||
156866281|NCT00214201|566271153|FG000|Overall Study|Death|0|||
156866282|NCT00214201|566271154|FG001|Overall Study|Death|2|||
156866283|NCT01354899|566271155|FG000|Overall Study|discharge from the hospital|2|||
156866284|NCT01354899|566271155|FG000|Overall Study|Protocol Violation|1|||
156866285|NCT00463567|566271156|FG000|Overall Study|Adverse Event|29|||
156866286|NCT00463567|566271157|FG001|Overall Study|Adverse Event|26|||
156866287|NCT00463567|566271158|FG002|Overall Study|Adverse Event|17|||
156866288|NCT00463567|566271159|FG003|Overall Study|Adverse Event|46|||
156866289|NCT00463567|566271160|FG004|Overall Study|Adverse Event|10|||
156866290|NCT00463567|566271161|FG005|Overall Study|Adverse Event|10|||
156866291|NCT00463567|566271162|FG006|Overall Study|Adverse Event|4|||
156866292|NCT00463567|566271156|FG000|Overall Study|Withdrawal by Subject|29|||
156866293|NCT00463567|566271157|FG001|Overall Study|Withdrawal by Subject|22|||
156866294|NCT00463567|566271158|FG002|Overall Study|Withdrawal by Subject|20|||
156866295|NCT00463567|566271159|FG003|Overall Study|Withdrawal by Subject|37|||
156866296|NCT00463567|566271160|FG004|Overall Study|Withdrawal by Subject|6|||
156866297|NCT00463567|566271161|FG005|Overall Study|Withdrawal by Subject|5|||
156866298|NCT00463567|566271162|FG006|Overall Study|Withdrawal by Subject|1|||
156866299|NCT00463567|566271156|FG000|Overall Study|Protocol Deviation|13|||
156866300|NCT00463567|566271157|FG001|Overall Study|Protocol Deviation|9|||
156866301|NCT00463567|566271158|FG002|Overall Study|Protocol Deviation|14|||
156866302|NCT00463567|566271159|FG003|Overall Study|Protocol Deviation|11|||
156866303|NCT00463567|566271160|FG004|Overall Study|Protocol Deviation|1|||
156866304|NCT00463567|566271161|FG005|Overall Study|Protocol Deviation|1|||
156866305|NCT00463567|566271162|FG006|Overall Study|Protocol Deviation|2|||
156866306|NCT00463567|566271156|FG000|Overall Study|Lost to Follow-up|12|||
156866307|NCT00463567|566271157|FG001|Overall Study|Lost to Follow-up|6|||
156866308|NCT00463567|566271158|FG002|Overall Study|Lost to Follow-up|13|||
156866309|NCT00463567|566271159|FG003|Overall Study|Lost to Follow-up|8|||
156866310|NCT00463567|566271160|FG004|Overall Study|Lost to Follow-up|1|||
156430883|NCT03354390|564666225|FG001|Level 1|Physician Decision|0|||
156430884|NCT03354390|564666226|FG002|Level 1|Physician Decision|0|||
156866311|NCT00463567|566271161|FG005|Overall Study|Lost to Follow-up|1|||
156866312|NCT00463567|566271162|FG006|Overall Study|Lost to Follow-up|1|||
156866313|NCT00463567|566271156|FG000|Overall Study|Administrative problems|5|||
156866314|NCT00463567|566271157|FG001|Overall Study|Administrative problems|3|||
156866315|NCT00463567|566271158|FG002|Overall Study|Administrative problems|6|||
156866316|NCT00463567|566271159|FG003|Overall Study|Administrative problems|9|||
156866317|NCT00463567|566271160|FG004|Overall Study|Administrative problems|3|||
156866318|NCT00463567|566271161|FG005|Overall Study|Administrative problems|2|||
156326533|NCT00107783|564296045|FG000|Overall Study|Adverse Event|0|||
156326534|NCT00107783|564296046|FG001|Overall Study|Adverse Event|2|||
156326535|NCT00107783|564296045|FG000|Overall Study|Death|0|||
156326536|NCT00107783|564296046|FG001|Overall Study|Death|1|||
156326537|NCT00107783|564296045|FG000|Overall Study|Withdrawal by Subject|2|||
156326538|NCT00107783|564296046|FG001|Overall Study|Withdrawal by Subject|0|||
156326539|NCT00107783|564296045|FG000|Overall Study|Second hip replacement|1|||
156326540|NCT00107783|564296046|FG001|Overall Study|Second hip replacement|1|||
156326541|NCT00331864|564296054|FG000|Overall Study|Adverse Event|30|||
156326542|NCT00331864|564296055|FG001|Overall Study|Adverse Event|1|||
156326543|NCT00331864|564296054|FG000|Overall Study|Lack of Efficacy|4|||
156326544|NCT00331864|564296055|FG001|Overall Study|Lack of Efficacy|0|||
156326545|NCT00331864|564296054|FG000|Overall Study|Protocol Violation|3|||
156326546|NCT00331864|564296055|FG001|Overall Study|Protocol Violation|0|||
156326547|NCT00331864|564296054|FG000|Overall Study|Withdrawal by Subject|10|||
156326548|NCT00331864|564296055|FG001|Overall Study|Withdrawal by Subject|0|||
156326549|NCT00331864|564296054|FG000|Overall Study|Lost to Follow-up|4|||
156326550|NCT00331864|564296055|FG001|Overall Study|Lost to Follow-up|3|||
156326551|NCT00331864|564296054|FG000|Overall Study|Administrative Problems|1|||
156326552|NCT00331864|564296055|FG001|Overall Study|Administrative Problems|0|||
156326553|NCT00331864|564296054|FG000|Overall Study|Death|6|||
156326554|NCT00331864|564296055|FG001|Overall Study|Death|0|||
156326555|NCT02611960|564296056|FG000|Overall Study|Adverse Event|7|||
156326556|NCT02611960|564296057|FG001|Overall Study|Adverse Event|8|||
156326557|NCT02611960|564296056|FG000|Overall Study|Death|98|||
156326558|NCT02611960|564296057|FG001|Overall Study|Death|92|||
156326559|NCT02611960|564296056|FG000|Overall Study|Withdrawal by Subject|1|||
156326560|NCT02611960|564296057|FG001|Overall Study|Withdrawal by Subject|5|||
156326561|NCT02611960|564296056|FG000|Overall Study|Sponsor Decision|11|||
156326562|NCT02611960|564296057|FG001|Overall Study|Sponsor Decision|11|||
156326563|NCT00137631|564296058|FG000|Overall Study|Lost to Follow-up|37|||
156326564|NCT00137631|564296059|FG001|Overall Study|Lost to Follow-up|41|||
156326565|NCT00085709|564296071|FG000|Overall Study|Adverse Event|8|||
156326566|NCT00085709|564296072|FG001|Overall Study|Adverse Event|0|||
156326567|NCT00085709|564296071|FG000|Overall Study|Death|8|||
156326568|NCT00085709|564296072|FG001|Overall Study|Death|2|||
156326569|NCT00085709|564296071|FG000|Overall Study|Refusal unrelated to adverse events|1|||
156326570|NCT00085709|564296072|FG001|Overall Study|Refusal unrelated to adverse events|2|||
156326571|NCT00085709|564296071|FG000|Overall Study|Progression|3|||
156326572|NCT00085709|564296072|FG001|Overall Study|Progression|4|||
156326573|NCT00085709|564296071|FG000|Overall Study|Not protocol specified|12|||
156326574|NCT00085709|564296072|FG001|Overall Study|Not protocol specified|22|||
156326575|NCT00085709|564296071|FG000|Overall Study|Not eligible|19|||
156326576|NCT00085709|564296072|FG001|Overall Study|Not eligible|19|||
156326577|NCT00085709|564296071|FG000|Overall Study|Withdrawal by Subject|2|||
156326578|NCT00085709|564296072|FG001|Overall Study|Withdrawal by Subject|1|||
156326579|NCT00293215|564296073|FG000|Overall Study|Progressive disease|3|||
156326580|NCT00293215|564296074|FG001|Overall Study|Progressive disease|1|||
156326581|NCT00293215|564296073|FG000|Overall Study|Adverse Event|2|||
156326582|NCT00293215|564296074|FG001|Overall Study|Adverse Event|2|||
156326583|NCT01409434|564296075|FG000|Overall Study|Protocol Violation|4|||
156326584|NCT04131556|564296076|FG000|Overall Study|Adverse Event|1|||
156326585|NCT04131556|564296076|FG000|Overall Study|Withdrawal by Subject|1|||
156326586|NCT01229371|564296077|FG000|Overall Study|Withdrawal by Subject|0|||
156326587|NCT01229371|564296078|FG001|Overall Study|Withdrawal by Subject|1|||
156326588|NCT01229371|564296079|FG002|Overall Study|Withdrawal by Subject|0|||
156326589|NCT01229371|564296080|FG003|Overall Study|Withdrawal by Subject|0|||
156326590|NCT02213042|564296081|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
156326591|NCT02213042|564296082|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
156326592|NCT02213042|564296083|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
156326593|NCT02213042|564296081|FG000|Overall Study|Adverse Event|2|||
156326594|NCT02213042|564296082|FG001|Overall Study|Adverse Event|1|||
156326595|NCT02213042|564296083|FG002|Overall Study|Adverse Event|0|||
156326596|NCT02213042|564296081|FG000|Overall Study|Withdrawal by Subject|0|||
156326597|NCT02213042|564296082|FG001|Overall Study|Withdrawal by Subject|1|||
156326598|NCT02213042|564296083|FG002|Overall Study|Withdrawal by Subject|1|||
156326599|NCT02213042|564296081|FG000|Overall Study|Protocol Violation|1|||
156326600|NCT02213042|564296082|FG001|Overall Study|Protocol Violation|0|||
156326601|NCT02213042|564296083|FG002|Overall Study|Protocol Violation|0|||
156326602|NCT02213042|564296081|FG000|Overall Study|Investigator discretion|0|||
156866319|NCT00463567|566271162|FG006|Overall Study|Administrative problems|2|||
156866320|NCT00463567|566271156|FG000|Overall Study|Lack of Efficacy|4|||
156326603|NCT02213042|564296082|FG001|Overall Study|Investigator discretion|0|||
156326604|NCT02213042|564296083|FG002|Overall Study|Investigator discretion|1|||
156326605|NCT04622735|564296084|FG000|Overall Study|Lost to Follow-up|1|||
156326606|NCT04622735|564296085|FG001|Overall Study|Lost to Follow-up|2|||
156326607|NCT04622735|564296086|FG002|Overall Study|Lost to Follow-up|1|||
156326608|NCT04622735|564296084|FG000|Overall Study|Adverse Event|0|||
156866321|NCT00463567|566271157|FG001|Overall Study|Lack of Efficacy|9|||
156866322|NCT00463567|566271158|FG002|Overall Study|Lack of Efficacy|9|||
156866323|NCT00463567|566271159|FG003|Overall Study|Lack of Efficacy|17|||
156866324|NCT00463567|566271160|FG004|Overall Study|Lack of Efficacy|1|||
156866325|NCT00463567|566271161|FG005|Overall Study|Lack of Efficacy|0|||
156866326|NCT00463567|566271162|FG006|Overall Study|Lack of Efficacy|1|||
156866327|NCT00463567|566271156|FG000|Overall Study|Abnormal lab value(s)|1|||
156866328|NCT00463567|566271157|FG001|Overall Study|Abnormal lab value(s)|1|||
156866329|NCT00463567|566271158|FG002|Overall Study|Abnormal lab value(s)|2|||
156866330|NCT00463567|566271159|FG003|Overall Study|Abnormal lab value(s)|1|||
156866331|NCT00463567|566271160|FG004|Overall Study|Abnormal lab value(s)|1|||
156866332|NCT00463567|566271161|FG005|Overall Study|Abnormal lab value(s)|0|||
156866333|NCT00463567|566271162|FG006|Overall Study|Abnormal lab value(s)|0|||
156866334|NCT00463567|566271156|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156866335|NCT00463567|566271157|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156866336|NCT00463567|566271158|FG002|Overall Study|Abnormal test procedure result(s)|6|||
156866337|NCT00463567|566271159|FG003|Overall Study|Abnormal test procedure result(s)|2|||
156866338|NCT00463567|566271160|FG004|Overall Study|Abnormal test procedure result(s)|0|||
156866339|NCT00463567|566271161|FG005|Overall Study|Abnormal test procedure result(s)|2|||
156668884|NCT01597245|565532567|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668885|NCT01597245|565532568|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156866340|NCT00463567|566271162|FG006|Overall Study|Abnormal test procedure result(s)|0|||
156866341|NCT00463567|566271156|FG000|Overall Study|Death|1|||
156866342|NCT00463567|566271157|FG001|Overall Study|Death|0|||
156866343|NCT00463567|566271158|FG002|Overall Study|Death|2|||
156866344|NCT00463567|566271159|FG003|Overall Study|Death|0|||
156866345|NCT00463567|566271160|FG004|Overall Study|Death|0|||
156326609|NCT04622735|564296085|FG001|Overall Study|Adverse Event|0|||
156326610|NCT04622735|564296086|FG002|Overall Study|Adverse Event|1|||
156326611|NCT04622735|564296084|FG000|Overall Study|Protocol Violation|1|||
156326612|NCT04622735|564296085|FG001|Overall Study|Protocol Violation|0|||
156668886|NCT01597245|565532569|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668887|NCT01597245|565532570|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668888|NCT01597245|565532571|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668889|NCT01597245|565532572|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668890|NCT01597245|565532573|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668891|NCT01597245|565532574|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668892|NCT01597245|565532575|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
156668893|NCT01597245|565532576|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
156668894|NCT01802320|565532577|FG000|Overall Study|Death|1|||
156668895|NCT01802320|565532577|FG000|Overall Study|Withdrawal by Subject|1|||
156668896|NCT04299087|565534125|FG000|Overall Study|Lost to Follow-up|2|||
156668897|NCT04299087|565534126|FG001|Overall Study|Lost to Follow-up|1|||
156668898|NCT00594035|565534127|FG000|Overall Study|Lost to Follow-up|1|||
156668899|NCT00594035|565534128|FG001|Overall Study|Lost to Follow-up|1|||
156668900|NCT00594035|565534127|FG000|Overall Study|Withdrawal by Subject|1|||
156668901|NCT00594035|565534128|FG001|Overall Study|Withdrawal by Subject|0|||
156668902|NCT00594035|565534127|FG000|Overall Study|Subject transferred to nursing home|0|||
156668903|NCT00594035|565534128|FG001|Overall Study|Subject transferred to nursing home|1|||
156668904|NCT00594035|565534127|FG000|Overall Study|Subject couldn't return due to job|0|||
156668905|NCT00594035|565534128|FG001|Overall Study|Subject couldn't return due to job|1|||
156668906|NCT00795821|565534129|FG000|Acute Treatment Phase|Adverse Event|23|||
156668907|NCT00795821|565534130|FG001|Acute Treatment Phase|Adverse Event|4|||
156668908|NCT00795821|565534129|FG000|Acute Treatment Phase|Death|1|||
156668909|NCT00795821|565534130|FG001|Acute Treatment Phase|Death|0|||
156668910|NCT00795821|565534129|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
156668911|NCT00795821|565534130|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
156668912|NCT00795821|565534129|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
156668913|NCT00795821|565534130|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
156668914|NCT00795821|565534129|FG000|Acute Treatment Phase|Physician Decision|1|||
156668915|NCT00795821|565534130|FG001|Acute Treatment Phase|Physician Decision|1|||
156668916|NCT00795821|565534129|FG000|Acute Treatment Phase|Protocol Violation|1|||
156668917|NCT00795821|565534130|FG001|Acute Treatment Phase|Protocol Violation|2|||
156668918|NCT00795821|565534129|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
156668919|NCT00795821|565534130|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
156866346|NCT00463567|566271161|FG005|Overall Study|Death|0|||
156866347|NCT00463567|566271162|FG006|Overall Study|Death|0|||
156866348|NCT00641667|566271165|FG000|Overall Study|Withdrawal by Subject|1|||
156866349|NCT00641667|566271165|FG000|Overall Study|Adverse Event|1|||
156866350|NCT00641667|566271165|FG000|Overall Study|Physician Decision|1|||
156326613|NCT04622735|564296086|FG002|Overall Study|Protocol Violation|0|||
156326614|NCT03026088|564296088|FG000|Overall Study|Study termination|20|||
156326615|NCT00761579|564296089|FG000|Overall Study|Adverse Event|10|||
156326616|NCT00761579|564296089|FG000|Overall Study|Death|2|||
156326617|NCT00761579|564296089|FG000|Overall Study|Lack of Efficacy|21|||
156668920|NCT00795821|565534129|FG000|Long-term Extension Phase|Adverse Event|25|||
156668921|NCT00795821|565534130|FG001|Long-term Extension Phase|Adverse Event|32|||
156668922|NCT00795821|565534129|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
156668923|NCT00795821|565534130|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
156668924|NCT00795821|565534129|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
156668925|NCT00795821|565534130|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
156668926|NCT00795821|565534129|FG000|Long-term Extension Phase|Physician Decision|1|||
156668927|NCT00795821|565534130|FG001|Long-term Extension Phase|Physician Decision|2|||
156668928|NCT00795821|565534129|FG000|Long-term Extension Phase|Protocol Violation|3|||
156668929|NCT00795821|565534130|FG001|Long-term Extension Phase|Protocol Violation|5|||
156668930|NCT00795821|565534129|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
156668931|NCT00795821|565534130|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
156668932|NCT00795821|565534129|FG000|Taper Phase|Adverse Event|2|||
156668933|NCT00795821|565534130|FG001|Taper Phase|Adverse Event|0|||
156668934|NCT00795821|565534129|FG000|Taper Phase|Lost to Follow-up|1|||
156668935|NCT00795821|565534130|FG001|Taper Phase|Lost to Follow-up|0|||
156668936|NCT00795821|565534129|FG000|Taper Phase|Physician Decision|2|||
156668937|NCT00795821|565534130|FG001|Taper Phase|Physician Decision|0|||
156668938|NCT00795821|565534129|FG000|Taper Phase|Withdrawal by Subject|4|||
156668939|NCT00795821|565534130|FG001|Taper Phase|Withdrawal by Subject|0|||
156668940|NCT00712959|565534137|FG000|Overall Study|Protocol Violation|3|||
156668941|NCT00712959|565534138|FG001|Overall Study|Protocol Violation|1|||
156668942|NCT00712959|565534137|FG000|Overall Study|Lost to Follow-up|13|||
156668943|NCT00712959|565534138|FG001|Overall Study|Lost to Follow-up|2|||
156668944|NCT00712959|565534137|FG000|Overall Study|Withdrawal by Subject|3|||
156668945|NCT00712959|565534138|FG001|Overall Study|Withdrawal by Subject|0|||
156668946|NCT00835991|565534139|FG000|First Intervention|Adverse Event|0|||
156668947|NCT00835991|565534140|FG001|First Intervention|Adverse Event|1|||
156668948|NCT00835991|565534139|FG000|Washout|Protocol Violation|0|||
156668949|NCT00835991|565534140|FG001|Washout|Protocol Violation|2|||
156668950|NCT00835991|565534139|FG000|Washout|Withdrawal by Subject|3|||
156668951|NCT00835991|565534140|FG001|Washout|Withdrawal by Subject|1|||
156668952|NCT03616535|565534141|FG000|Overall Study|Death|2|||
156668953|NCT03616535|565534142|FG001|Overall Study|Death|0|||
156668954|NCT03616535|565534143|FG002|Overall Study|Death|0|||
156668955|NCT03616535|565534144|FG003|Overall Study|Death|1|||
156668956|NCT03616535|565534141|FG000|Overall Study|Lost to Follow-up|2|||
156668957|NCT03616535|565534142|FG001|Overall Study|Lost to Follow-up|1|||
156668958|NCT03616535|565534143|FG002|Overall Study|Lost to Follow-up|0|||
156668959|NCT03616535|565534144|FG003|Overall Study|Lost to Follow-up|2|||
156668960|NCT03616535|565534141|FG000|Overall Study|Withdrawal by Subject|1|||
156668961|NCT03616535|565534142|FG001|Overall Study|Withdrawal by Subject|2|||
156668962|NCT03616535|565534143|FG002|Overall Study|Withdrawal by Subject|5|||
156668963|NCT03616535|565534144|FG003|Overall Study|Withdrawal by Subject|1|||
156668964|NCT03616535|565534141|FG000|Overall Study|Not specified or change in eligibility|2|||
156668965|NCT03616535|565534142|FG001|Overall Study|Not specified or change in eligibility|3|||
156668966|NCT03616535|565534143|FG002|Overall Study|Not specified or change in eligibility|3|||
156668967|NCT03616535|565534144|FG003|Overall Study|Not specified or change in eligibility|1|||
156668968|NCT02146105|565534145|FG000|Overall Study|Adverse Event|1|||
156668969|NCT02146105|565534145|FG000|Overall Study|Withdrawal by Subject|5|||
156668970|NCT02718326|565534148|FG000|Overall Study|Adverse Event|4|||
156668971|NCT02718326|565534149|FG001|Overall Study|Adverse Event|9|||
156668972|NCT02718326|565534150|FG002|Overall Study|Adverse Event|0|||
156668973|NCT02718326|565534148|FG000|Overall Study|Death|8|||
156668974|NCT02718326|565534149|FG001|Overall Study|Death|1|||
156668975|NCT02718326|565534150|FG002|Overall Study|Death|2|||
156668976|NCT02718326|565534148|FG000|Overall Study|Withdrawal by Subject|4|||
156668977|NCT02718326|565534149|FG001|Overall Study|Withdrawal by Subject|9|||
156668978|NCT02718326|565534150|FG002|Overall Study|Withdrawal by Subject|6|||
156668979|NCT02718326|565534148|FG000|Overall Study|Lost to Follow-up|18|||
156668980|NCT02718326|565534149|FG001|Overall Study|Lost to Follow-up|5|||
156668981|NCT02718326|565534150|FG002|Overall Study|Lost to Follow-up|14|||
156326618|NCT00761579|564296089|FG000|Overall Study|Lost to Follow-up|16|||
156668982|NCT02718326|565534148|FG000|Overall Study|Protocol Deviation|1|||
156326619|NCT00761579|564296089|FG000|Overall Study|Pregnancy|1|||
156326620|NCT00761579|564296089|FG000|Overall Study|Withdrawal by Subject|34|||
156326621|NCT00761579|564296089|FG000|Overall Study|Lack of compliance|2|||
156326622|NCT00761579|564296089|FG000|Overall Study|Protocol deviation|1|||
156668983|NCT02718326|565534149|FG001|Overall Study|Protocol Deviation|0|||
156668984|NCT02718326|565534150|FG002|Overall Study|Protocol Deviation|0|||
156668985|NCT02718326|565534148|FG000|Overall Study|Pregnancy|1|||
156668986|NCT02718326|565534149|FG001|Overall Study|Pregnancy|0|||
156668987|NCT02718326|565534150|FG002|Overall Study|Pregnancy|0|||
156668988|NCT02436005|565534154|FG000|Second Intervention|Adverse Event|0|||
156668989|NCT02436005|565534155|FG001|Second Intervention|Adverse Event|1|||
156668990|NCT00583453|565534156|FG000|Overall Study|discontinued intervention|0|||
156668991|NCT00583453|565534157|FG001|Overall Study|discontinued intervention|2|||
156668992|NCT00905606|565534158|FG000|Period 1|Adverse Event|0|||
156668993|NCT00905606|565534159|FG001|Period 1|Adverse Event|1|||
156668994|NCT00905606|565534158|FG000|Washout|Withdrawal by Subject|1|||
156668995|NCT00905606|565534159|FG001|Washout|Withdrawal by Subject|0|||
156668996|NCT01558635|565534160|FG000|Overall Study|Death|1|||
156668997|NCT01558635|565534160|FG000|Overall Study|Withdrawal by Subject|2|||
156668998|NCT01558635|565534160|FG000|Overall Study|Physician Decision|1|||
156668999|NCT01558635|565534160|FG000|Overall Study|Subject received other treatment|1|||
156669000|NCT01558635|565534160|FG000|Overall Study|Reveal XT was explanted|1|||
156669001|NCT00455312|565534161|FG000|Overall Study|Death|0|||
156669002|NCT00455312|565534162|FG001|Overall Study|Death|1|||
156669003|NCT03868891|565534163|FG000|Overall Study|Adverse Event|1|||
156669004|NCT03868891|565534164|FG001|Overall Study|Adverse Event|0|||
156669005|NCT03868891|565534163|FG000|Overall Study|Lost to Follow-up|2|||
156669006|NCT03868891|565534164|FG001|Overall Study|Lost to Follow-up|1|||
156669007|NCT03868891|565534163|FG000|Overall Study|COVID-19 Restrictions|1|||
156669008|NCT03868891|565534164|FG001|Overall Study|COVID-19 Restrictions|2|||
156669009|NCT00777023|565534165|FG000|Overall Study|Adverse Event|15|||
156669010|NCT00777023|565534166|FG001|Overall Study|Adverse Event|21|||
156669011|NCT00777023|565534167|FG002|Overall Study|Adverse Event|8|||
156669012|NCT00777023|565534165|FG000|Overall Study|Lack of Efficacy|1|||
156669013|NCT00777023|565534166|FG001|Overall Study|Lack of Efficacy|0|||
156669014|NCT00777023|565534167|FG002|Overall Study|Lack of Efficacy|14|||
156669015|NCT00777023|565534165|FG000|Overall Study|Protocol Violation|2|||
156669016|NCT00777023|565534166|FG001|Overall Study|Protocol Violation|1|||
156669017|NCT00777023|565534167|FG002|Overall Study|Protocol Violation|1|||
156669018|NCT00777023|565534165|FG000|Overall Study|Lost to Follow-up|2|||
156669019|NCT00777023|565534166|FG001|Overall Study|Lost to Follow-up|3|||
156669020|NCT00777023|565534167|FG002|Overall Study|Lost to Follow-up|3|||
156669021|NCT00777023|565534165|FG000|Overall Study|Death|0|||
156669022|NCT00777023|565534166|FG001|Overall Study|Death|1|||
156669023|NCT00777023|565534167|FG002|Overall Study|Death|0|||
156669024|NCT00777023|565534165|FG000|Overall Study|Withdrawal by Subject|7|||
156669025|NCT00777023|565534166|FG001|Overall Study|Withdrawal by Subject|7|||
156669026|NCT00777023|565534167|FG002|Overall Study|Withdrawal by Subject|8|||
156669027|NCT00777023|565534165|FG000|Overall Study|Missing data|1|||
156669028|NCT00777023|565534166|FG001|Overall Study|Missing data|1|||
156669029|NCT00777023|565534167|FG002|Overall Study|Missing data|0|||
156669030|NCT00777023|565534165|FG000|Overall Study|Reasons not specified|4|||
156669031|NCT00777023|565534166|FG001|Overall Study|Reasons not specified|4|||
156669032|NCT00777023|565534167|FG002|Overall Study|Reasons not specified|2|||
156669033|NCT00777023|565534165|FG000|Overall Study|Last dose date unknown|3|||
156669034|NCT00777023|565534166|FG001|Overall Study|Last dose date unknown|3|||
156669035|NCT00777023|565534167|FG002|Overall Study|Last dose date unknown|1|||
156669036|NCT02659150|565534168|FG000|Subject Enrollment|Physician Decision|3|||
156669037|NCT02659150|565534168|FG000|Subject Enrollment|Withdrawal by Subject|2|||
156669038|NCT02659150|565534168|FG000|Baseline Imaging|Withdrawal by Subject|1|||
156669039|NCT02659150|565534168|FG000|Baseline Imaging|Physician Decision|1|||
156669040|NCT02659150|565534168|FG000|Study Drug Dosing|Adverse Event|1|||
156669041|NCT02246920|565534169|FG000|Overall Study|Adverse Event|3|||
156669042|NCT02246920|565534170|FG001|Overall Study|Adverse Event|1|||
156669043|NCT02246920|565534171|FG002|Overall Study|Adverse Event|1|||
156669044|NCT02246920|565534169|FG000|Overall Study|Lost to Follow-up|2|||
156669045|NCT02246920|565534170|FG001|Overall Study|Lost to Follow-up|1|||
156526032|NCT00720941|565021444|FG001|Overall Study|Physician Decision|12|||
156326623|NCT00761579|564296089|FG000|Overall Study|Drug overdose|1|||
156326624|NCT00761579|564296089|FG000|Overall Study|Aggravation of depression|1|||
156326625|NCT00761579|564296089|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
156326626|NCT00761579|564296089|FG000|Overall Study|Lost survey form|1|||
156326627|NCT00761579|564296089|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
156326628|NCT00950911|564296091|FG000|Overall Study|Adverse Event|0|||
156526033|NCT00720941|565021443|FG000|Overall Study|Withdrawal by Subject|29|||
156526034|NCT00720941|565021444|FG001|Overall Study|Withdrawal by Subject|36|||
156526035|NCT00294554|565021449|FG000|Overall Study|Lack of Efficacy|0|||
156526036|NCT00294554|565021450|FG001|Overall Study|Lack of Efficacy|1|||
156526037|NCT00294554|565021449|FG000|Overall Study|Physician Decision|0|||
156669046|NCT02246920|565534171|FG002|Overall Study|Lost to Follow-up|0|||
156669047|NCT02246920|565534169|FG000|Overall Study|Protocol Violation|2|||
156669048|NCT02246920|565534170|FG001|Overall Study|Protocol Violation|5|||
156669049|NCT02246920|565534171|FG002|Overall Study|Protocol Violation|1|||
156669050|NCT02246920|565534169|FG000|Overall Study|Withdrawal by Subject|0|||
156669051|NCT02246920|565534170|FG001|Overall Study|Withdrawal by Subject|0|||
156669052|NCT02246920|565534171|FG002|Overall Study|Withdrawal by Subject|1|||
156326629|NCT00950911|564296092|FG001|Overall Study|Adverse Event|2|||
156326630|NCT00950911|564296091|FG000|Overall Study|Death|4|||
156526038|NCT00294554|565021450|FG001|Overall Study|Physician Decision|1|||
156526039|NCT01717989|565021451|FG000|Overall Study|Ineligibility determined|6|||
156669053|NCT02678286|565534172|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
156669054|NCT02678286|565534173|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
156669055|NCT02678286|565534172|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
156326631|NCT00950911|564296092|FG001|Overall Study|Death|6|||
156326632|NCT00950911|564296091|FG000|Overall Study|Disease progression|2|||
156326633|NCT00950911|564296092|FG001|Overall Study|Disease progression|2|||
156326634|NCT00950911|564296091|FG000|Overall Study|Consent withdrawn|1|||
156326635|NCT00950911|564296092|FG001|Overall Study|Consent withdrawn|3|||
156326636|NCT00950911|564296091|FG000|Overall Study|Administrative decision|3|||
156326637|NCT00950911|564296092|FG001|Overall Study|Administrative decision|1|||
156326638|NCT00950911|564296091|FG000|Overall Study|Ineligibility determined|1|||
156326639|NCT00950911|564296092|FG001|Overall Study|Ineligibility determined|0|||
156326640|NCT00950911|564296091|FG000|Overall Study|Noncompliance|1|||
156326641|NCT00950911|564296092|FG001|Overall Study|Noncompliance|0|||
156326642|NCT00950911|564296091|FG000|Overall Study|Poor performance status|0|||
156326643|NCT00950911|564296092|FG001|Overall Study|Poor performance status|1|||
156326644|NCT02600351|564296093|FG000|Overall Study|Lack of Efficacy|3|||
156326645|NCT02600351|564296094|FG001|Overall Study|Lack of Efficacy|0|||
156326646|NCT02600351|564296095|FG002|Overall Study|Lack of Efficacy|5|||
156326647|NCT02600351|564296096|FG003|Overall Study|Lack of Efficacy|2|||
156326648|NCT02600351|564296093|FG000|Overall Study|Lost to Follow-up|1|||
156326649|NCT02600351|564296094|FG001|Overall Study|Lost to Follow-up|0|||
156326650|NCT02600351|564296095|FG002|Overall Study|Lost to Follow-up|0|||
156326651|NCT02600351|564296096|FG003|Overall Study|Lost to Follow-up|0|||
156326652|NCT02600351|564296093|FG000|Overall Study|Randomized but Not Treated|1|||
156326653|NCT02600351|564296094|FG001|Overall Study|Randomized but Not Treated|0|||
156326654|NCT02600351|564296095|FG002|Overall Study|Randomized but Not Treated|1|||
156326655|NCT02600351|564296096|FG003|Overall Study|Randomized but Not Treated|3|||
156326656|NCT02063880|564296097|FG000|Overall Study|Death|21|||
156326657|NCT02063880|564296098|FG001|Overall Study|Death|18|||
156326658|NCT02063880|564296097|FG000|Overall Study|Lost to Follow-up|7|||
156326659|NCT02063880|564296098|FG001|Overall Study|Lost to Follow-up|7|||
156326660|NCT02063880|564296097|FG000|Overall Study|Ineligible|0|||
156326661|NCT02063880|564296098|FG001|Overall Study|Ineligible|2|||
156326662|NCT00567593|564296099|FG000|Overall Study|Adverse Event|1|||
156326663|NCT00567593|564296099|FG000|Overall Study|Physician Decision|1|||
156326664|NCT02106910|564296100|FG000|Overall Study|Lost to Follow-up|1|||
156326665|NCT02106910|564296101|FG001|Overall Study|Lost to Follow-up|1|||
156326666|NCT02476422|564296104|FG000|Overall Study|Subject/guardian decision|0|||
156326667|NCT02476422|564296105|FG001|Overall Study|Subject/guardian decision|1|||
156326668|NCT03960554|564296112|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
156326669|NCT03960554|564296113|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
156326670|NCT02545075|564296116|FG000|Randomization|Lost to Follow-up|0|||
156326671|NCT02545075|564296117|FG001|Randomization|Lost to Follow-up|1|||
156326672|NCT02545075|564296116|FG000|Randomization|Withdrawal by Subject|0|||
156326673|NCT02545075|564296117|FG001|Randomization|Withdrawal by Subject|6|||
156326674|NCT02545075|564296116|FG000|Treatment|Disease progression|71|||
156326675|NCT02545075|564296117|FG001|Treatment|Disease progression|32|||
156326676|NCT02545075|564296116|FG000|Treatment|Participant dicontinued study treatment|7|||
156326677|NCT02545075|564296117|FG001|Treatment|Participant dicontinued study treatment|9|||
156326678|NCT02545075|564296116|FG000|Treatment|Withdrawal by Subject|1|||
156326679|NCT02545075|564296117|FG001|Treatment|Withdrawal by Subject|0|||
156326680|NCT02545075|564296116|FG000|Treatment|Adverse event not related to study drug|1|||
156326681|NCT02545075|564296117|FG001|Treatment|Adverse event not related to study drug|0|||
156326682|NCT02545075|564296116|FG000|Treatment|Death|1|||
156326683|NCT02545075|564296117|FG001|Treatment|Death|0|||
156326684|NCT02545075|564296116|FG000|Treatment|Participant drug toxicity|1|||
156326685|NCT02545075|564296117|FG001|Treatment|Participant drug toxicity|0|||
156326686|NCT02545075|564296116|FG000|Treatment|Completed treatment|40|||
156326687|NCT02545075|564296117|FG001|Treatment|Completed treatment|12|||
156326688|NCT01272661|564296127|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
156326689|NCT01272661|564296128|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
156326690|NCT01272661|564296129|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
156326691|NCT01086423|564296130|FG000|Overall Study|Protocol Violation|0|||
156326692|NCT01086423|564296131|FG001|Overall Study|Protocol Violation|0|||
156326693|NCT01086423|564296132|FG002|Overall Study|Protocol Violation|1|||
156326694|NCT01086423|564296130|FG000|Overall Study|Migrated/moved from study area|2|||
156326695|NCT01086423|564296131|FG001|Overall Study|Migrated/moved from study area|0|||
156326696|NCT01086423|564296132|FG002|Overall Study|Migrated/moved from study area|4|||
156326697|NCT01086423|564296130|FG000|Overall Study|Adverse event, fatal|1|||
156326698|NCT01086423|564296131|FG001|Overall Study|Adverse event, fatal|1|||
156326699|NCT01086423|564296132|FG002|Overall Study|Adverse event, fatal|0|||
156326700|NCT01086423|564296130|FG000|Overall Study|Adverse event, non-fatal|2|||
156326701|NCT01086423|564296131|FG001|Overall Study|Adverse event, non-fatal|1|||
156430885|NCT03354390|564666227|FG003|Level 1|Physician Decision|0|||
156326702|NCT01086423|564296132|FG002|Overall Study|Adverse event, non-fatal|0|||
156326703|NCT01086423|564296130|FG000|Overall Study|Withdrawal by Subject|5|||
156326704|NCT01086423|564296131|FG001|Overall Study|Withdrawal by Subject|1|||
156326705|NCT01086423|564296132|FG002|Overall Study|Withdrawal by Subject|3|||
156326706|NCT01086423|564296130|FG000|Overall Study|Lost to Follow-up|0|||
156669056|NCT02678286|565534173|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
156669057|NCT02678286|565534172|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
156669058|NCT02678286|565534173|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
156669059|NCT02678286|565534172|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
156669060|NCT02678286|565534173|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
156669061|NCT02678286|565534172|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
156669062|NCT02678286|565534173|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
156669063|NCT02909907|565534181|FG000|Overall Study|Withdrawal by Subject|0|||
156669064|NCT02909907|565534182|FG001|Overall Study|Withdrawal by Subject|1|||
156669065|NCT02902211|565534183|FG000|First Three Months|Withdrawal by Subject|7|||
156669066|NCT02902211|565534184|FG001|First Three Months|Withdrawal by Subject|3|||
156669067|NCT00571064|565534189|FG000|Overall Study|Adverse Event|13|||
156669068|NCT00571064|565534189|FG000|Overall Study|Protocol Violation|4|||
156669069|NCT00571064|565534189|FG000|Overall Study|Withdrawal by Subject|2|||
156669070|NCT00571064|565534189|FG000|Overall Study|Other|2|||
156669071|NCT03637764|565534191|FG000|Overall Study|Adverse Event|2|||
156669072|NCT03637764|565534192|FG001|Overall Study|Adverse Event|0|||
156669073|NCT03637764|565534193|FG002|Overall Study|Adverse Event|0|||
156669074|NCT03637764|565534194|FG003|Overall Study|Adverse Event|1|||
156669075|NCT03637764|565534191|FG000|Overall Study|Progressive Disease|23|||
156669076|NCT03637764|565534192|FG001|Overall Study|Progressive Disease|23|||
156669077|NCT03637764|565534193|FG002|Overall Study|Progressive Disease|18|||
156669078|NCT03637764|565534194|FG003|Overall Study|Progressive Disease|31|||
156669079|NCT03637764|565534191|FG000|Overall Study|Withdrawal by Subject|1|||
156669080|NCT03637764|565534192|FG001|Overall Study|Withdrawal by Subject|3|||
156669081|NCT03637764|565534193|FG002|Overall Study|Withdrawal by Subject|0|||
156669082|NCT03637764|565534194|FG003|Overall Study|Withdrawal by Subject|1|||
156669083|NCT02648438|565534195|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156669084|NCT02648438|565534196|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
156669085|NCT02648438|565534197|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
156669086|NCT02648438|565534195|FG000|Overall Study|Protocol Violation|2|||
156669087|NCT02648438|565534196|FG001|Overall Study|Protocol Violation|0|||
156669088|NCT02648438|565534197|FG002|Overall Study|Protocol Violation|0|||
156669089|NCT02648438|565534195|FG000|Overall Study|Withdrawal by Subject|1|||
156669090|NCT02648438|565534196|FG001|Overall Study|Withdrawal by Subject|1|||
156669091|NCT02648438|565534197|FG002|Overall Study|Withdrawal by Subject|0|||
156669092|NCT03138967|565534200|FG000|Overall Study|Death|0|||
156669093|NCT03138967|565534201|FG001|Overall Study|Death|1|||
156669094|NCT03138967|565534200|FG000|Overall Study|Physician Decision|1|||
156669095|NCT03138967|565534201|FG001|Overall Study|Physician Decision|3|||
156669096|NCT04604275|565534202|FG000|Washout-1 Week|Withdrawal by Subject|1|||
156669097|NCT04604275|565534203|FG001|Washout-1 Week|Withdrawal by Subject|0|||
156669098|NCT05446870|565534204|FG000|Overall Study|Death|6|||
156669099|NCT05446870|565534205|FG001|Overall Study|Death|5|||
156669100|NCT05446870|565534204|FG000|Overall Study|Lost to Follow-up|0|||
156669101|NCT05446870|565534205|FG001|Overall Study|Lost to Follow-up|1|||
156669102|NCT05446870|565534204|FG000|Overall Study|Physician Decision|52|||
156669103|NCT05446870|565534205|FG001|Overall Study|Physician Decision|53|||
156669104|NCT05446870|565534204|FG000|Overall Study|Withdrawal by Subject|3|||
156669105|NCT05446870|565534205|FG001|Overall Study|Withdrawal by Subject|3|||
156669106|NCT04108858|565534206|FG000|Overall Study|Adverse Event|1|||
156669107|NCT01615198|565534207|FG000|Overall Study|Withdrawal by Subject|5|||
156669108|NCT01615198|565534208|FG001|Overall Study|Withdrawal by Subject|5|||
156669109|NCT01615198|565534207|FG000|Overall Study|Protocol deviation|1|||
156669110|NCT01615198|565534208|FG001|Overall Study|Protocol deviation|1|||
156669111|NCT01615198|565534207|FG000|Overall Study|Physician Decision|5|||
156669112|NCT01615198|565534208|FG001|Overall Study|Physician Decision|1|||
156669113|NCT01615198|565534207|FG000|Overall Study|Lost to Follow-up|1|||
156326707|NCT01086423|564296131|FG001|Overall Study|Lost to Follow-up|0|||
156669114|NCT01615198|565534208|FG001|Overall Study|Lost to Follow-up|1|||
156669115|NCT01615198|565534207|FG000|Overall Study|Lack of Efficacy|1|||
156669116|NCT01615198|565534208|FG001|Overall Study|Lack of Efficacy|6|||
156669117|NCT01615198|565534207|FG000|Overall Study|Adverse Event|11|||
156326708|NCT01086423|564296132|FG002|Overall Study|Lost to Follow-up|1|||
156669118|NCT01615198|565534208|FG001|Overall Study|Adverse Event|5|||
156669119|NCT01686438|565534209|FG000|Overall Study|Lost to Follow-up|8|||
156669120|NCT01686438|565534210|FG001|Overall Study|Lost to Follow-up|9|||
156669121|NCT01686438|565534211|FG002|Overall Study|Lost to Follow-up|10|||
156326709|NCT00925990|564296133|FG000|Overall Study|Adverse Event|1|||
156326710|NCT00925990|564296134|FG001|Overall Study|Adverse Event|3|||
156326711|NCT00925990|564296133|FG000|Overall Study|Withdrawal by Subject|2|||
156326712|NCT00925990|564296134|FG001|Overall Study|Withdrawal by Subject|2|||
156326713|NCT00925990|564296133|FG000|Overall Study|Lost to Follow-up|1|||
156326714|NCT00925990|564296134|FG001|Overall Study|Lost to Follow-up|3|||
156669122|NCT01686438|565534209|FG000|Overall Study|Adverse Event|0|||
156326715|NCT00925990|564296133|FG000|Overall Study|Physician Decision|1|||
156669123|NCT01686438|565534210|FG001|Overall Study|Adverse Event|0|||
156326716|NCT00925990|564296134|FG001|Overall Study|Physician Decision|1|||
156669124|NCT01686438|565534211|FG002|Overall Study|Adverse Event|1|||
156669125|NCT01686438|565534209|FG000|Overall Study|Protocol Violation|0|||
156669126|NCT01686438|565534210|FG001|Overall Study|Protocol Violation|0|||
156669127|NCT01686438|565534211|FG002|Overall Study|Protocol Violation|1|||
156669128|NCT01686438|565534209|FG000|Overall Study|Withdrawal by Subject|0|||
156669129|NCT01686438|565534210|FG001|Overall Study|Withdrawal by Subject|0|||
156669130|NCT01686438|565534211|FG002|Overall Study|Withdrawal by Subject|1|||
156669131|NCT01864174|565534214|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
156526040|NCT01717989|565021451|FG000|Overall Study|Protocol deviation|6|||
156526041|NCT01717989|565021451|FG000|Overall Study|Withdrawal by Subject|11|||
156526042|NCT01717989|565021451|FG000|Overall Study|Physician Decision|2|||
156526043|NCT01717989|565021451|FG000|Overall Study|Lost to Follow-up|11|||
156526044|NCT01717989|565021451|FG000|Overall Study|Death|439|||
156526045|NCT01717989|565021451|FG000|Overall Study|Protocol-specified criteria|551|||
156526046|NCT01717989|565021451|FG000|Overall Study|Other|40|||
156526047|NCT02598557|565021452|FG000|Overall Study|Withdrawal by Subject|1|||
156526048|NCT02598557|565021453|FG001|Overall Study|Withdrawal by Subject|0|||
156526049|NCT02598557|565021454|FG002|Overall Study|Withdrawal by Subject|1|||
156526050|NCT02598557|565021452|FG000|Overall Study|Participant did not start treatment|2|||
156526051|NCT02598557|565021453|FG001|Overall Study|Participant did not start treatment|1|||
156526052|NCT02598557|565021454|FG002|Overall Study|Participant did not start treatment|1|||
156526053|NCT02598557|565021452|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
156526054|NCT02598557|565021453|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
156526055|NCT02598557|565021454|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
156526056|NCT02598557|565021452|FG000|Overall Study|Adverse Event|1|||
156526057|NCT02598557|565021453|FG001|Overall Study|Adverse Event|1|||
156526058|NCT02598557|565021454|FG002|Overall Study|Adverse Event|0|||
156526059|NCT03224325|565021455|FG000|Overall Study|Adverse Event|1|||
156526060|NCT03224325|565021456|FG001|Overall Study|Adverse Event|0|||
156526061|NCT03224325|565021457|FG002|Overall Study|Adverse Event|0|||
156526062|NCT03224325|565021458|FG003|Overall Study|Adverse Event|0|||
156526063|NCT03224325|565021459|FG004|Overall Study|Adverse Event|0|||
156526064|NCT03224325|565021460|FG005|Overall Study|Adverse Event|0|||
156526065|NCT03224325|565021461|FG006|Overall Study|Adverse Event|1|||
156526066|NCT03224325|565021455|FG000|Overall Study|Withdrawal by Subject|0|||
156526067|NCT03224325|565021456|FG001|Overall Study|Withdrawal by Subject|0|||
156526068|NCT03224325|565021457|FG002|Overall Study|Withdrawal by Subject|0|||
156526069|NCT03224325|565021458|FG003|Overall Study|Withdrawal by Subject|1|||
156526070|NCT03224325|565021459|FG004|Overall Study|Withdrawal by Subject|0|||
156326717|NCT00925990|564296133|FG000|Overall Study|moved out of state, missed medication|0|||
156326718|NCT00925990|564296134|FG001|Overall Study|moved out of state, missed medication|2|||
156326719|NCT00750880|564296135|FG000|Overall Study|Adverse Event|76|||
156526071|NCT03224325|565021460|FG005|Overall Study|Withdrawal by Subject|0|||
156526072|NCT03224325|565021461|FG006|Overall Study|Withdrawal by Subject|0|||
156526073|NCT02864381|565021462|FG000|Overall Study|Death|58|||
156526074|NCT02864381|565021463|FG001|Overall Study|Death|61|||
156526075|NCT02864381|565021462|FG000|Overall Study|Withdrew Consent|5|||
156526076|NCT02864381|565021463|FG001|Overall Study|Withdrew Consent|6|||
156669132|NCT01864174|565534215|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
156669133|NCT01864174|565534214|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
156526077|NCT02864381|565021462|FG000|Overall Study|Reason Unknown|7|||
156526078|NCT02864381|565021463|FG001|Overall Study|Reason Unknown|3|||
156526079|NCT02864381|565021462|FG000|Overall Study|Lost to Follow-up|1|||
156526080|NCT02864381|565021463|FG001|Overall Study|Lost to Follow-up|1|||
156526081|NCT02864381|565021462|FG000|Overall Study|Investigator's Discretion|1|||
156526082|NCT02864381|565021463|FG001|Overall Study|Investigator's Discretion|0|||
156526083|NCT02864381|565021462|FG000|Overall Study|Protocol Violation|0|||
156526084|NCT02864381|565021463|FG001|Overall Study|Protocol Violation|1|||
156526085|NCT02986334|565021464|FG000|Overall Study|Withdrawal by Subject|0|||
156669134|NCT01864174|565534215|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
156526086|NCT02986334|565021465|FG001|Overall Study|Withdrawal by Subject|1|||
156526087|NCT02986334|565021466|FG002|Overall Study|Withdrawal by Subject|2|||
156526088|NCT02986334|565021464|FG000|Overall Study|Lost to Follow-up|1|||
156526089|NCT02986334|565021465|FG001|Overall Study|Lost to Follow-up|2|||
156526090|NCT02986334|565021466|FG002|Overall Study|Lost to Follow-up|1|||
156526091|NCT02986334|565021464|FG000|Overall Study|Adverse Event|0|||
156526092|NCT02986334|565021465|FG001|Overall Study|Adverse Event|2|||
156526093|NCT02986334|565021466|FG002|Overall Study|Adverse Event|1|||
156326720|NCT00750880|564296135|FG000|Overall Study|Death|4|||
156526094|NCT02986334|565021464|FG000|Overall Study|non compliance in phone ratings|2|||
156526095|NCT02986334|565021465|FG001|Overall Study|non compliance in phone ratings|1|||
156526096|NCT02986334|565021466|FG002|Overall Study|non compliance in phone ratings|2|||
156526097|NCT02986334|565021464|FG000|Overall Study|undisclosed comorbidities|0|||
156526098|NCT02986334|565021465|FG001|Overall Study|undisclosed comorbidities|1|||
156526099|NCT02986334|565021466|FG002|Overall Study|undisclosed comorbidities|1|||
156526100|NCT01138007|565021467|FG000|Overall Study|Adverse Event|4|||
156669135|NCT01864174|565534214|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
156669136|NCT01864174|565534215|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
156669137|NCT01864174|565534214|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
156669138|NCT01864174|565534215|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
156669139|NCT01864174|565534214|FG000|Double Blind - Compliant Randomized|Death|1|||
156669140|NCT01864174|565534215|FG001|Double Blind - Compliant Randomized|Death|0|||
156669141|NCT01864174|565534214|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
156669142|NCT01864174|565534215|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
156669143|NCT01864174|565534214|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
156669144|NCT01864174|565534215|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
156669145|NCT01864174|565534214|FG000|Double Blind - Compliant Randomized|Other|6|||
156669146|NCT01864174|565534215|FG001|Double Blind - Compliant Randomized|Other|10|||
156669147|NCT01864174|565534214|FG000|Off Treatment Follow-Up|Other|2|||
156669148|NCT01864174|565534215|FG001|Off Treatment Follow-Up|Other|0|||
156669149|NCT01864174|565534214|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
156669150|NCT01864174|565534215|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
156669151|NCT00468286|565534216|FG000|Overall Study|Adverse Event|1|||
156669152|NCT00468286|565534217|FG001|Overall Study|Adverse Event|6|||
156669153|NCT00468286|565534216|FG000|Overall Study|Protocol Violation|2|||
156669154|NCT00468286|565534217|FG001|Overall Study|Protocol Violation|2|||
156669155|NCT00468286|565534216|FG000|Overall Study|Withdrawal by Subject|4|||
156669156|NCT00468286|565534217|FG001|Overall Study|Withdrawal by Subject|3|||
156669157|NCT00468286|565534216|FG000|Overall Study|Physician Decision|0|||
156669158|NCT00468286|565534217|FG001|Overall Study|Physician Decision|1|||
156669159|NCT02453386|565534221|FG000|Overall Study|Adverse Event|22|||
156669160|NCT02453386|565534222|FG001|Overall Study|Adverse Event|30|||
156669161|NCT02453386|565534223|FG002|Overall Study|Adverse Event|15|||
156669162|NCT02453386|565534221|FG000|Overall Study|Protocol Violation|1|||
156669163|NCT02453386|565534222|FG001|Overall Study|Protocol Violation|0|||
156669164|NCT02453386|565534223|FG002|Overall Study|Protocol Violation|1|||
156669165|NCT02453386|565534221|FG000|Overall Study|Withdrawal by Subject|10|||
156669166|NCT02453386|565534222|FG001|Overall Study|Withdrawal by Subject|9|||
156669167|NCT02453386|565534223|FG002|Overall Study|Withdrawal by Subject|9|||
156669168|NCT02453386|565534221|FG000|Overall Study|Sponsor Terminated Study|14|||
156669169|NCT02453386|565534222|FG001|Overall Study|Sponsor Terminated Study|8|||
156669170|NCT02453386|565534223|FG002|Overall Study|Sponsor Terminated Study|11|||
156669171|NCT02453386|565534221|FG000|Overall Study|Subject Terminated by Sponsor|1|||
156669172|NCT02453386|565534222|FG001|Overall Study|Subject Terminated by Sponsor|1|||
156669173|NCT02453386|565534223|FG002|Overall Study|Subject Terminated by Sponsor|1|||
156669174|NCT02453386|565534221|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
156669175|NCT02453386|565534222|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
156669176|NCT02453386|565534223|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
156669177|NCT02453386|565534221|FG000|Overall Study|Lost to Follow-up|0|||
156669178|NCT02453386|565534222|FG001|Overall Study|Lost to Follow-up|0|||
156669179|NCT02453386|565534223|FG002|Overall Study|Lost to Follow-up|1|||
156669180|NCT02453386|565534221|FG000|Overall Study|Other|1|||
156669181|NCT02453386|565534222|FG001|Overall Study|Other|0|||
156669182|NCT02453386|565534223|FG002|Overall Study|Other|1|||
156669183|NCT02601625|565534224|FG000|Overall Study|Lost to Follow-up|0|||
156669184|NCT02601625|565534225|FG001|Overall Study|Lost to Follow-up|0|||
156669185|NCT02601625|565534226|FG002|Overall Study|Lost to Follow-up|1|||
156669186|NCT02601625|565534227|FG003|Overall Study|Lost to Follow-up|1|||
156669187|NCT01289262|565534230|FG000|Overall Study|Lost to Follow-up|29|||
156669188|NCT01289262|565534231|FG001|Overall Study|Lost to Follow-up|16|||
156669189|NCT01289262|565534230|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
156669190|NCT01289262|565534231|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
156669191|NCT01474551|565534238|FG000|Overall Study|Death|1|||
156669192|NCT01921062|565534239|FG000|Overall Study|Withdrawal by Subject|0|||
156669193|NCT01921062|565534240|FG001|Overall Study|Withdrawal by Subject|7|||
156669194|NCT01921062|565534239|FG000|Overall Study|Adverse Event|5|||
156669195|NCT01921062|565534240|FG001|Overall Study|Adverse Event|6|||
156669196|NCT01921062|565534239|FG000|Overall Study|Protocol Violation|0|||
156669197|NCT01921062|565534240|FG001|Overall Study|Protocol Violation|1|||
156669198|NCT01921062|565534239|FG000|Overall Study|VMIQ score > 72|4|||
156669199|NCT01921062|565534240|FG001|Overall Study|VMIQ score > 72|1|||
156669200|NCT01921062|565534239|FG000|Overall Study|Logistic error|0|||
156669201|NCT01921062|565534240|FG001|Overall Study|Logistic error|1|||
156669202|NCT02409355|565534246|FG000|Overall Study|Withdrawal by Subject|1|||
156669203|NCT02409355|565534247|FG001|Overall Study|Withdrawal by Subject|0|||
156669204|NCT02409355|565534246|FG000|Overall Study|Death|1|||
156669205|NCT02409355|565534247|FG001|Overall Study|Death|1|||
156669206|NCT02409355|565534246|FG000|Overall Study|Study terminated by Sponsor|2|||
156669207|NCT02409355|565534247|FG001|Overall Study|Study terminated by Sponsor|3|||
156669208|NCT03290781|565534257|FG000|Overall Study|Adverse Event|5|||
156669209|NCT03290781|565534258|FG001|Overall Study|Adverse Event|7|||
156669210|NCT03290781|565534259|FG002|Overall Study|Adverse Event|4|||
156669211|NCT03290781|565534260|FG003|Overall Study|Adverse Event|1|||
156669212|NCT03290781|565534261|FG004|Overall Study|Adverse Event|0|||
156669213|NCT03290781|565534262|FG005|Overall Study|Adverse Event|0|||
156669214|NCT03290781|565534263|FG006|Overall Study|Adverse Event|0|||
156669215|NCT03290781|565534257|FG000|Overall Study|Death|0|||
156669216|NCT03290781|565534258|FG001|Overall Study|Death|0|||
156669217|NCT03290781|565534259|FG002|Overall Study|Death|1|||
156669218|NCT03290781|565534260|FG003|Overall Study|Death|0|||
156669219|NCT03290781|565534261|FG004|Overall Study|Death|1|||
156669220|NCT03290781|565534262|FG005|Overall Study|Death|0|||
156669221|NCT03290781|565534263|FG006|Overall Study|Death|0|||
156669222|NCT03290781|565534257|FG000|Overall Study|Withdrawal by Subject|6|||
156669223|NCT03290781|565534258|FG001|Overall Study|Withdrawal by Subject|5|||
156669224|NCT03290781|565534259|FG002|Overall Study|Withdrawal by Subject|9|||
156669225|NCT03290781|565534260|FG003|Overall Study|Withdrawal by Subject|10|||
156669226|NCT03290781|565534261|FG004|Overall Study|Withdrawal by Subject|1|||
156669227|NCT03290781|565534262|FG005|Overall Study|Withdrawal by Subject|2|||
156669228|NCT03290781|565534263|FG006|Overall Study|Withdrawal by Subject|0|||
156669229|NCT03290781|565534257|FG000|Overall Study|Physician Decision|0|||
156669230|NCT03290781|565534258|FG001|Overall Study|Physician Decision|1|||
156669231|NCT03290781|565534259|FG002|Overall Study|Physician Decision|0|||
156669232|NCT03290781|565534260|FG003|Overall Study|Physician Decision|0|||
156669233|NCT03290781|565534261|FG004|Overall Study|Physician Decision|0|||
156669234|NCT03290781|565534262|FG005|Overall Study|Physician Decision|0|||
156669235|NCT03290781|565534263|FG006|Overall Study|Physician Decision|0|||
156669236|NCT03290781|565534257|FG000|Overall Study|Site Terminated by Sponsor|1|||
156669237|NCT03290781|565534258|FG001|Overall Study|Site Terminated by Sponsor|0|||
156669238|NCT03290781|565534259|FG002|Overall Study|Site Terminated by Sponsor|2|||
156669239|NCT03290781|565534260|FG003|Overall Study|Site Terminated by Sponsor|1|||
156669240|NCT03290781|565534261|FG004|Overall Study|Site Terminated by Sponsor|0|||
156669241|NCT03290781|565534262|FG005|Overall Study|Site Terminated by Sponsor|0|||
156669242|NCT03290781|565534263|FG006|Overall Study|Site Terminated by Sponsor|0|||
156669243|NCT03290781|565534257|FG000|Overall Study|Lost to Follow-up|0|||
156669244|NCT03290781|565534258|FG001|Overall Study|Lost to Follow-up|0|||
156669245|NCT03290781|565534259|FG002|Overall Study|Lost to Follow-up|0|||
156669246|NCT03290781|565534260|FG003|Overall Study|Lost to Follow-up|1|||
156669247|NCT03290781|565534261|FG004|Overall Study|Lost to Follow-up|0|||
156669248|NCT03290781|565534262|FG005|Overall Study|Lost to Follow-up|0|||
156669249|NCT03290781|565534263|FG006|Overall Study|Lost to Follow-up|0|||
156669250|NCT03290781|565534257|FG000|Overall Study|Protocol Deviation|2|||
156669251|NCT03290781|565534258|FG001|Overall Study|Protocol Deviation|0|||
156669252|NCT03290781|565534259|FG002|Overall Study|Protocol Deviation|0|||
156669253|NCT03290781|565534260|FG003|Overall Study|Protocol Deviation|1|||
156669254|NCT03290781|565534261|FG004|Overall Study|Protocol Deviation|0|||
156669255|NCT03290781|565534262|FG005|Overall Study|Protocol Deviation|0|||
156669256|NCT03290781|565534263|FG006|Overall Study|Protocol Deviation|0|||
156669257|NCT03290781|565534257|FG000|Overall Study|Disease Relapse|32|||
156669258|NCT03290781|565534258|FG001|Overall Study|Disease Relapse|5|||
156669259|NCT03290781|565534259|FG002|Overall Study|Disease Relapse|38|||
156669260|NCT03290781|565534260|FG003|Overall Study|Disease Relapse|7|||
156669261|NCT03290781|565534261|FG004|Overall Study|Disease Relapse|3|||
156669262|NCT03290781|565534262|FG005|Overall Study|Disease Relapse|1|||
156866351|NCT00641667|566271165|FG000|Overall Study|Worsening of underlying disease|3|||
156866352|NCT01124006|566271166|FG000|Overall Study|Withdrawal by Subject|2|||
156669263|NCT03290781|565534263|FG006|Overall Study|Disease Relapse|4|||
156866353|NCT01124006|566271167|FG001|Overall Study|Withdrawal by Subject|2|||
156866354|NCT01124006|566271168|FG002|Overall Study|Withdrawal by Subject|0|||
156866355|NCT01124006|566271166|FG000|Overall Study|Lost to Follow-up|1|||
156866356|NCT01124006|566271167|FG001|Overall Study|Lost to Follow-up|0|||
156866357|NCT01124006|566271168|FG002|Overall Study|Lost to Follow-up|1|||
156866358|NCT01124006|566271166|FG000|Overall Study|Other|0|||
156866359|NCT01124006|566271167|FG001|Overall Study|Other|0|||
156669264|NCT03290781|565534257|FG000|Overall Study|Other|3|||
156669265|NCT03290781|565534258|FG001|Overall Study|Other|0|||
156669266|NCT03290781|565534259|FG002|Overall Study|Other|2|||
156669267|NCT03290781|565534260|FG003|Overall Study|Other|2|||
156669268|NCT03290781|565534261|FG004|Overall Study|Other|0|||
156669269|NCT03290781|565534262|FG005|Overall Study|Other|0|||
156866360|NCT01124006|566271168|FG002|Overall Study|Other|1|||
156669270|NCT03290781|565534263|FG006|Overall Study|Other|0|||
156669271|NCT02957942|565534264|FG000|Overall Study|Withdrawal by Subject|0|||
156669272|NCT02957942|565534265|FG001|Overall Study|Withdrawal by Subject|1|||
156669273|NCT02957942|565534264|FG000|Overall Study|Practicing experiment protocol|0|||
156669274|NCT02957942|565534265|FG001|Overall Study|Practicing experiment protocol|6|||
156669275|NCT04611789|565534280|FG000|Overall Study|Lost to Follow-up|1|||
156669276|NCT04611789|565534281|FG001|Overall Study|Lost to Follow-up|0|||
156866361|NCT01712399|566271172|FG000|Overall Study|Lost to Follow-up|1|||
156866362|NCT01712399|566271172|FG000|Overall Study|Withdrawal by Subject|39|||
156866363|NCT01712399|566271172|FG000|Overall Study|Death|1|||
156866364|NCT01712399|566271172|FG000|Overall Study|Adverse Event|11|||
156866365|NCT01712399|566271172|FG000|Overall Study|Study closure|345|||
156669277|NCT04611789|565534282|FG002|Overall Study|Lost to Follow-up|0|||
156669278|NCT02820350|565534284|FG000|Overall Study|Withdrawal by Subject|3|||
156669279|NCT02820350|565534284|FG000|Overall Study|Death|4|||
156669280|NCT03801707|565534285|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
156669281|NCT05265624|565535760|FG000|Overall Study|Lost to Follow-up|3|||
156669282|NCT05265624|565535761|FG001|Overall Study|Lost to Follow-up|0|||
156669283|NCT05265624|565535760|FG000|Overall Study|Withdrawal by Subject|1|||
156669284|NCT05265624|565535761|FG001|Overall Study|Withdrawal by Subject|0|||
156669285|NCT00834717|565535768|FG000|First Intervention|Adverse Event|1|||
156669286|NCT00834717|565535769|FG001|First Intervention|Adverse Event|0|||
156669287|NCT00834717|565535768|FG000|First Intervention|Withdrawal by Subject|0|||
156669288|NCT00834717|565535769|FG001|First Intervention|Withdrawal by Subject|1|||
156669289|NCT03697109|565535773|FG000|Open-label (OL) Phase|Adverse Event|24|||
156669290|NCT03697109|565535774|FG001|Open-label (OL) Phase|Adverse Event|0|||
156669291|NCT03697109|565535775|FG002|Open-label (OL) Phase|Adverse Event|0|||
156669292|NCT03697109|565535773|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
156669293|NCT03697109|565535774|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
156669294|NCT03697109|565535775|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
156669295|NCT03697109|565535773|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
156669296|NCT03697109|565535774|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
156669297|NCT03697109|565535775|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
156669298|NCT03697109|565535773|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
156669299|NCT03697109|565535774|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
156669300|NCT03697109|565535775|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
156669301|NCT03697109|565535773|FG000|Open-label (OL) Phase|Physician Decision|2|||
156669302|NCT03697109|565535774|FG001|Open-label (OL) Phase|Physician Decision|0|||
156669303|NCT03697109|565535775|FG002|Open-label (OL) Phase|Physician Decision|0|||
156669304|NCT03697109|565535773|FG000|Open-label (OL) Phase|Death|2|||
156669305|NCT03697109|565535774|FG001|Open-label (OL) Phase|Death|0|||
156669306|NCT03697109|565535775|FG002|Open-label (OL) Phase|Death|0|||
156669307|NCT03697109|565535773|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
156669308|NCT03697109|565535774|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
156669309|NCT03697109|565535775|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
156669310|NCT03697109|565535773|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
156669311|NCT03697109|565535774|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
156669312|NCT03697109|565535775|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
156669313|NCT03697109|565535773|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
156669314|NCT03697109|565535774|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
156326721|NCT00750880|564296135|FG000|Overall Study|Lack of Efficacy|46|||
156326722|NCT00750880|564296135|FG000|Overall Study|Lost to Follow-up|10|||
156326723|NCT00750880|564296135|FG000|Overall Study|Protocol Violation|15|||
156326724|NCT00750880|564296135|FG000|Overall Study|Withdrawal by Subject|33|||
156326725|NCT00750880|564296135|FG000|Overall Study|Physician Decision|20|||
156326726|NCT00750880|564296135|FG000|Overall Study|Administrative|11|||
156326727|NCT02057393|564296140|FG000|Overall Study|Withdrawal by Subject|1|||
156326728|NCT02057393|564296140|FG000|Overall Study|Patient did not meet criteria|1|||
156326729|NCT03180684|564296141|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
156326730|NCT03180684|564296142|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
156326731|NCT03180684|564296141|FG000|Overall Study|Physician Decision|1|||
156326732|NCT03180684|564296142|FG001|Overall Study|Physician Decision|0|||
156326733|NCT03180684|564296141|FG000|Overall Study|Lost to Follow-up|1|||
156326734|NCT03180684|564296142|FG001|Overall Study|Lost to Follow-up|0|||
156326735|NCT03180684|564296141|FG000|Overall Study|Progressive Disease|1|||
156326736|NCT03180684|564296142|FG001|Overall Study|Progressive Disease|0|||
156326737|NCT01130103|564296146|FG000|Randomized Treatment|Adverse Event|1|||
156326738|NCT01130103|564296147|FG001|Randomized Treatment|Adverse Event|1|||
156326739|NCT01130103|564296146|FG000|Randomized Treatment|Lost to Follow-up|1|||
156326740|NCT01130103|564296147|FG001|Randomized Treatment|Lost to Follow-up|0|||
156326741|NCT01130103|564296146|FG000|Randomized Treatment|Protocol Violation|3|||
156326742|NCT01130103|564296147|FG001|Randomized Treatment|Protocol Violation|2|||
156326743|NCT01130103|564296146|FG000|Randomized Treatment|Withdrawal by Subject|1|||
156326744|NCT01130103|564296147|FG001|Randomized Treatment|Withdrawal by Subject|2|||
156326745|NCT01130103|564296146|FG000|Maintenance Treatment|Lack of Efficacy|0|||
156326746|NCT01130103|564296147|FG001|Maintenance Treatment|Lack of Efficacy|1|||
156326747|NCT01130103|564296146|FG000|Maintenance Treatment|Lost to Follow-up|1|||
156326748|NCT01130103|564296147|FG001|Maintenance Treatment|Lost to Follow-up|1|||
156326749|NCT01130103|564296146|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
156326750|NCT01130103|564296147|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
156326751|NCT03614975|564296148|FG000|Overall Study|Physician Decision|7|||
156326752|NCT03614975|564296149|FG001|Overall Study|Physician Decision|5|||
156326753|NCT03614975|564296148|FG000|Overall Study|Withdrawal by Subject|2|||
156326754|NCT03614975|564296149|FG001|Overall Study|Withdrawal by Subject|2|||
156669315|NCT03697109|565535775|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
156669316|NCT04516967|565535776|FG000|Core Phase|Adverse Event|2|||
156669317|NCT04516967|565535777|FG001|Core Phase|Adverse Event|1|||
156669318|NCT04516967|565535778|FG002|Core Phase|Adverse Event|0|||
156669319|NCT04516967|565535776|FG000|Core Phase|Physician Decision|1|||
156669320|NCT04516967|565535777|FG001|Core Phase|Physician Decision|1|||
156669321|NCT04516967|565535778|FG002|Core Phase|Physician Decision|0|||
156669322|NCT04516967|565535776|FG000|Core Phase|Lack of Efficacy|7|||
156669323|NCT04516967|565535777|FG001|Core Phase|Lack of Efficacy|18|||
156669324|NCT04516967|565535778|FG002|Core Phase|Lack of Efficacy|0|||
156669325|NCT02301975|565535781|FG000|Overall Study|Adverse Event|8|||
156669326|NCT02301975|565535782|FG001|Overall Study|Adverse Event|3|||
156669327|NCT02301975|565535783|FG002|Overall Study|Adverse Event|2|||
156669328|NCT02301975|565535781|FG000|Overall Study|Lack of Efficacy|1|||
156669329|NCT02301975|565535782|FG001|Overall Study|Lack of Efficacy|1|||
156669330|NCT02301975|565535783|FG002|Overall Study|Lack of Efficacy|1|||
156669331|NCT02301975|565535781|FG000|Overall Study|Protocol Violation|3|||
156669332|NCT02301975|565535782|FG001|Overall Study|Protocol Violation|5|||
156779661|NCT03611946|565942654|FG003|Overall Study|Withdrawal by Subject|0|||
156779662|NCT06717399|565942662|FG000|Overall Study|Death|1|||
156779663|NCT03043573|565942663|FG000|Overall Study|Lost to Follow-up|3|||
156779664|NCT03043573|565942664|FG001|Overall Study|Lost to Follow-up|3|||
156779665|NCT03043573|565942663|FG000|Overall Study|Physician Decision|0|||
156779666|NCT03043573|565942664|FG001|Overall Study|Physician Decision|5|||
156779667|NCT03043573|565942663|FG000|Overall Study|Withdrawal by Subject|0|||
156779668|NCT03043573|565942664|FG001|Overall Study|Withdrawal by Subject|4|||
156779669|NCT04333498|565943825|FG000|Overall Study|Lost to Follow-up|1|||
156779670|NCT04333498|565943826|FG001|Overall Study|Lost to Follow-up|0|||
156779671|NCT04333498|565943825|FG000|Overall Study|Lost to Follow-up|0|||
156779672|NCT04333498|565943826|FG001|Overall Study|Lost to Follow-up|1|||
156779673|NCT00484159|565943827|FG000|Overall Study|Lost to Follow-up|1|||
156779674|NCT00484159|565943828|FG001|Overall Study|Lost to Follow-up|1|||
156779675|NCT00484159|565943829|FG002|Overall Study|Lost to Follow-up|0|||
156779676|NCT04766333|565943830|FG000|Overall Study|Lost to Follow-up|40|||
156779677|NCT04766333|565943831|FG001|Overall Study|Lost to Follow-up|826|||
156779678|NCT01312129|565943832|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
156779679|NCT01312129|565943833|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
156779680|NCT01239680|565943834|FG000|Overall Study|Withdrawal by Subject|2|||
156779681|NCT01239680|565943835|FG001|Overall Study|Withdrawal by Subject|0|||
156779682|NCT02260986|565943838|FG000|Overall Study|Adverse Event|24|||
156779683|NCT02260986|565943839|FG001|Overall Study|Adverse Event|0|||
156779684|NCT02260986|565943840|FG002|Overall Study|Adverse Event|11|||
156779685|NCT02260986|565943838|FG000|Overall Study|Lack of Efficacy|27|||
156779686|NCT02260986|565943839|FG001|Overall Study|Lack of Efficacy|3|||
156779687|NCT02260986|565943840|FG002|Overall Study|Lack of Efficacy|0|||
156779688|NCT02260986|565943838|FG000|Overall Study|Protocol Violation|14|||
156779689|NCT02260986|565943839|FG001|Overall Study|Protocol Violation|5|||
156326755|NCT03614975|564296148|FG000|Overall Study|Specimens not in lab batch shipment|1|||
156326756|NCT03614975|564296149|FG001|Overall Study|Specimens not in lab batch shipment|1|||
156326757|NCT00450385|564296150|FG000|Overall Study|Death|3|||
156326758|NCT00450385|564296150|FG000|Overall Study|Protocol Violation|1|||
156326759|NCT00450385|564296150|FG000|Overall Study|Withdrawal by Subject|2|||
156326760|NCT00450385|564296150|FG000|Overall Study|Lack of Efficacy|2|||
156326761|NCT00450385|564296150|FG000|Overall Study|Adverse Event|1|||
156326762|NCT00450385|564296150|FG000|Overall Study|Physician Decision|1|||
156326763|NCT00450385|564296150|FG000|Overall Study|Other|3|||
156326764|NCT02314143|564296151|FG000|Overall Study|Adverse Event|0|||
156326765|NCT02314143|564296152|FG001|Overall Study|Adverse Event|6|||
156326766|NCT02314143|564296153|FG002|Overall Study|Adverse Event|4|||
156326767|NCT02314143|564296151|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
156326768|NCT02314143|564296152|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
156326769|NCT02314143|564296153|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
156326770|NCT02314143|564296151|FG000|Overall Study|Physician Decision|2|||
156326771|NCT02314143|564296152|FG001|Overall Study|Physician Decision|1|||
156326772|NCT02314143|564296153|FG002|Overall Study|Physician Decision|0|||
156430886|NCT03354390|564666224|FG000|Level 2|Physician Decision|0|||
156430887|NCT03354390|564666225|FG001|Level 2|Physician Decision|2|||
156779690|NCT02260986|565943840|FG002|Overall Study|Protocol Violation|16|||
156779691|NCT02260986|565943838|FG000|Overall Study|Car accident|0|||
156779692|NCT02260986|565943839|FG001|Overall Study|Car accident|0|||
156779693|NCT02260986|565943840|FG002|Overall Study|Car accident|1|||
156779694|NCT02260986|565943838|FG000|Overall Study|Withdrawal by Subject|17|||
156779695|NCT02260986|565943839|FG001|Overall Study|Withdrawal by Subject|4|||
156326773|NCT02314143|564296151|FG000|Overall Study|Withdrawal by Subject|1|||
156326774|NCT02314143|564296152|FG001|Overall Study|Withdrawal by Subject|0|||
156326775|NCT02314143|564296153|FG002|Overall Study|Withdrawal by Subject|1|||
156326776|NCT00089674|564296155|FG000|Overall Study|Physician Decision|4|||
156326777|NCT00089674|564296156|FG001|Overall Study|Physician Decision|2|||
156669333|NCT02301975|565535783|FG002|Overall Study|Protocol Violation|3|||
156669334|NCT02301975|565535781|FG000|Overall Study|Lost to Follow-up|0|||
156669335|NCT02301975|565535782|FG001|Overall Study|Lost to Follow-up|2|||
156779696|NCT02260986|565943840|FG002|Overall Study|Withdrawal by Subject|9|||
156326778|NCT00089674|564296155|FG000|Overall Study|Adverse Event|23|||
156326779|NCT00089674|564296156|FG001|Overall Study|Adverse Event|29|||
156326780|NCT00089674|564296155|FG000|Overall Study|Withdrawal by Subject|143|||
156326781|NCT00089674|564296156|FG001|Overall Study|Withdrawal by Subject|127|||
156326782|NCT00089674|564296155|FG000|Overall Study|Death|43|||
156326783|NCT00089674|564296156|FG001|Overall Study|Death|43|||
156326784|NCT00089674|564296155|FG000|Overall Study|Disease progression|21|||
156326785|NCT00089674|564296156|FG001|Overall Study|Disease progression|23|||
156326786|NCT00089674|564296155|FG000|Overall Study|Ineligibility determined|8|||
156326787|NCT00089674|564296156|FG001|Overall Study|Ineligibility determined|10|||
156326788|NCT00089674|564296155|FG000|Overall Study|Lost to Follow-up|21|||
156326789|NCT00089674|564296156|FG001|Overall Study|Lost to Follow-up|17|||
156326790|NCT00089674|564296155|FG000|Overall Study|Noncompliance|7|||
156326791|NCT00089674|564296156|FG001|Overall Study|Noncompliance|3|||
156326792|NCT00089674|564296155|FG000|Overall Study|Other|5|||
156326793|NCT00089674|564296156|FG001|Overall Study|Other|9|||
156326794|NCT00089674|564296155|FG000|Overall Study|Requirement for alternative therapy|14|||
156326795|NCT00089674|564296156|FG001|Overall Study|Requirement for alternative therapy|4|||
156526101|NCT01138007|565021468|FG001|Overall Study|Adverse Event|12|||
156526102|NCT01138007|565021469|FG002|Overall Study|Adverse Event|9|||
156326796|NCT03963401|564296157|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
156326797|NCT03963401|564296158|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
156326798|NCT03963401|564296159|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
156326799|NCT03963401|564296160|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
156526103|NCT01138007|565021467|FG000|Overall Study|Lack of Efficacy|2|||
156526104|NCT01138007|565021468|FG001|Overall Study|Lack of Efficacy|0|||
156526105|NCT01138007|565021469|FG002|Overall Study|Lack of Efficacy|6|||
156526106|NCT01138007|565021467|FG000|Overall Study|Protocol Violation|2|||
156526107|NCT01138007|565021468|FG001|Overall Study|Protocol Violation|3|||
156526108|NCT01138007|565021469|FG002|Overall Study|Protocol Violation|2|||
156526109|NCT01138007|565021467|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
156526110|NCT01138007|565021468|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
156526111|NCT01138007|565021469|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
156526112|NCT01138007|565021467|FG000|Overall Study|Lost to Follow-up|3|||
156526113|NCT01138007|565021468|FG001|Overall Study|Lost to Follow-up|3|||
156526114|NCT01138007|565021469|FG002|Overall Study|Lost to Follow-up|5|||
156526115|NCT01138007|565021467|FG000|Overall Study|Physician Decision|0|||
156526116|NCT01138007|565021468|FG001|Overall Study|Physician Decision|5|||
156526117|NCT01138007|565021469|FG002|Overall Study|Physician Decision|3|||
156526118|NCT01138007|565021467|FG000|Overall Study|Withdrawal by Subject|5|||
156526119|NCT01138007|565021468|FG001|Overall Study|Withdrawal by Subject|6|||
156526120|NCT01138007|565021469|FG002|Overall Study|Withdrawal by Subject|15|||
156526121|NCT03548987|565021470|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
156526122|NCT03548987|565021471|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
156526123|NCT03548987|565021470|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
156526124|NCT03548987|565021471|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
156526125|NCT03548987|565021470|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
156526126|NCT03548987|565021471|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
156526127|NCT03548987|565021470|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
156526128|NCT03548987|565021471|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
156526129|NCT03548987|565021470|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
156526130|NCT03548987|565021471|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
156526131|NCT03548987|565021470|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
156526132|NCT03548987|565021471|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
156526133|NCT03548987|565021470|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
156526134|NCT03548987|565021471|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
156526135|NCT03548987|565021470|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
156526136|NCT03548987|565021471|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
156526137|NCT03548987|565021470|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
156526138|NCT03548987|565021471|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
156526139|NCT03548987|565021470|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
156526140|NCT03548987|565021471|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
156526141|NCT03548987|565021470|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
156526142|NCT03548987|565021471|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
156526143|NCT03548987|565021470|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
156326800|NCT03963401|564296161|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
156526144|NCT03548987|565021471|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
156526145|NCT03548987|565021470|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
156526146|NCT03548987|565021471|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
156669336|NCT02301975|565535783|FG002|Overall Study|Lost to Follow-up|2|||
156326801|NCT03963401|564296162|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
156326802|NCT03963401|564296157|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
156326803|NCT03963401|564296158|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
156669337|NCT02301975|565535781|FG000|Overall Study|Physician Decision|4|||
156669338|NCT02301975|565535782|FG001|Overall Study|Physician Decision|2|||
156669339|NCT02301975|565535783|FG002|Overall Study|Physician Decision|3|||
156669340|NCT02301975|565535781|FG000|Overall Study|Withdrawal by Subject|15|||
156669341|NCT02301975|565535782|FG001|Overall Study|Withdrawal by Subject|12|||
156669342|NCT02301975|565535783|FG002|Overall Study|Withdrawal by Subject|11|||
156669343|NCT02149420|565535784|FG000|Core Study|Administrative problems|0|||
156669344|NCT02149420|565535785|FG001|Core Study|Administrative problems|1|||
156669345|NCT02149420|565535786|FG002|Core Study|Administrative problems|2|||
156669346|NCT02149420|565535784|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
156669347|NCT02149420|565535785|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
156669348|NCT02149420|565535786|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
156669349|NCT04278560|565535788|FG000|Overall Study|Adverse Event|1|||
156669350|NCT04278560|565535789|FG001|Overall Study|Adverse Event|2|||
156669351|NCT04278560|565535788|FG000|Overall Study|Withdrawal by Subject|0|||
156669352|NCT04278560|565535789|FG001|Overall Study|Withdrawal by Subject|1|||
156669353|NCT00834067|565535790|FG000|Washout of 21 Days|Protocol Violation|0|||
156669354|NCT00834067|565535791|FG001|Washout of 21 Days|Protocol Violation|1|||
156669355|NCT00440518|565535793|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
156669356|NCT00440518|565535794|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
156669357|NCT00440518|565535795|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
156669358|NCT00440518|565535793|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
156669359|NCT00440518|565535794|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
156669360|NCT00440518|565535795|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
156669361|NCT00440518|565535793|FG000|Randomized /Titration Period|Protocol Deviation|1|||
156669362|NCT00440518|565535794|FG001|Randomized /Titration Period|Protocol Deviation|0|||
156669363|NCT00440518|565535795|FG002|Randomized /Titration Period|Protocol Deviation|0|||
156669364|NCT00440518|565535793|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
156669365|NCT00440518|565535794|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
156669366|NCT00440518|565535795|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
156669367|NCT00440518|565535793|FG000|Randomized /Titration Period|Other|1|||
156669368|NCT00440518|565535794|FG001|Randomized /Titration Period|Other|0|||
156669369|NCT00440518|565535795|FG002|Randomized /Titration Period|Other|0|||
156669370|NCT00440518|565535793|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
156669371|NCT00440518|565535794|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
156669372|NCT00440518|565535795|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
156669373|NCT00440518|565535793|FG000|Randomized /Titration Period|Adverse Event|2|||
156669374|NCT00440518|565535794|FG001|Randomized /Titration Period|Adverse Event|3|||
156669375|NCT00440518|565535795|FG002|Randomized /Titration Period|Adverse Event|0|||
156669376|NCT00440518|565535793|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
156669377|NCT00440518|565535794|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
156669378|NCT00440518|565535795|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
156669379|NCT00440518|565535793|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
156669380|NCT00440518|565535794|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
156669381|NCT00440518|565535795|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
156669382|NCT00440518|565535793|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
156669383|NCT00440518|565535794|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
156669384|NCT00440518|565535795|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
156669385|NCT00440518|565535793|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
156669386|NCT00440518|565535794|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
156669387|NCT00440518|565535795|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
156669388|NCT00440518|565535793|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
156669389|NCT00440518|565535794|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
156669390|NCT00440518|565535795|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
156669391|NCT00440518|565535793|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
156669392|NCT00440518|565535794|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
156669393|NCT00440518|565535795|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
156669394|NCT00561015|565535796|FG000|Overall Study|Adverse Event|0|||
156669395|NCT00561015|565535797|FG001|Overall Study|Adverse Event|0|||
156326804|NCT03963401|564296159|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
156326805|NCT03963401|564296160|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
156326806|NCT03963401|564296161|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
156326807|NCT03963401|564296162|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
156326808|NCT03963401|564296157|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
156326809|NCT03963401|564296158|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
156326810|NCT03963401|564296159|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
156430888|NCT03354390|564666226|FG002|Level 2|Physician Decision|0|||
156669396|NCT00561015|565535798|FG002|Overall Study|Adverse Event|0|||
156669397|NCT00561015|565535799|FG003|Overall Study|Adverse Event|0|||
156669398|NCT00561015|565535800|FG004|Overall Study|Adverse Event|1|||
156669399|NCT00561015|565535801|FG005|Overall Study|Adverse Event|0|||
156669400|NCT00561015|565535796|FG000|Overall Study|Lost to Follow-up|2|||
156669401|NCT00561015|565535797|FG001|Overall Study|Lost to Follow-up|0|||
156669402|NCT00561015|565535798|FG002|Overall Study|Lost to Follow-up|0|||
156669403|NCT00561015|565535799|FG003|Overall Study|Lost to Follow-up|1|||
156669404|NCT00561015|565535800|FG004|Overall Study|Lost to Follow-up|0|||
156669405|NCT00561015|565535801|FG005|Overall Study|Lost to Follow-up|3|||
156669406|NCT00561015|565535796|FG000|Overall Study|Participant non-compliance|2|||
156669407|NCT00561015|565535797|FG001|Overall Study|Participant non-compliance|0|||
156669408|NCT00561015|565535798|FG002|Overall Study|Participant non-compliance|0|||
156669409|NCT00561015|565535799|FG003|Overall Study|Participant non-compliance|0|||
156669410|NCT00561015|565535800|FG004|Overall Study|Participant non-compliance|0|||
156669411|NCT00561015|565535801|FG005|Overall Study|Participant non-compliance|0|||
156669412|NCT01319383|565535802|FG000|Overall Study|No ex vivo or in vivo response|4|||
156669413|NCT01319383|565535803|FG001|Overall Study|No ex vivo or in vivo response|0|||
156669414|NCT01319383|565535802|FG000|Overall Study|Physician Decision|3|||
156669415|NCT01319383|565535803|FG001|Overall Study|Physician Decision|0|||
156669416|NCT01319383|565535802|FG000|Overall Study|Lack of Efficacy|5|||
156669417|NCT01319383|565535803|FG001|Overall Study|Lack of Efficacy|9|||
156669418|NCT01319383|565535802|FG000|Overall Study|No in vivo response to interval doses|0|||
156669419|NCT01319383|565535803|FG001|Overall Study|No in vivo response to interval doses|1|||
156669420|NCT03086460|565535806|FG000|Study Participants|Lost to Follow-up|2|||
156669421|NCT03086460|565535806|FG000|Study Participants|Protocol Violation|1|||
156669422|NCT03086460|565535806|FG000|Study Participants|Withdrawal by Subject|6|||
156669423|NCT03086460|565535806|FG000|Treatment A|Lost to Follow-up|1|||
156669424|NCT03086460|565535806|FG000|Treatment A|Protocol Violation|1|||
156669425|NCT03086460|565535806|FG000|Treatment A|Withdrawal by Subject|2|||
156669426|NCT03086460|565535806|FG000|Treatment C|Withdrawal by Subject|2|||
156669427|NCT03086460|565535806|FG000|Treatment E|Lost to Follow-up|1|||
156669428|NCT03086460|565535806|FG000|Treatment E|Withdrawal by Subject|3|||
156669429|NCT03247972|565535807|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
156669430|NCT03247972|565535807|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
156669431|NCT00968812|565535808|FG000|Overall Study|Adverse Event|30|||
156669432|NCT00968812|565535809|FG001|Overall Study|Adverse Event|46|||
156669433|NCT00968812|565535810|FG002|Overall Study|Adverse Event|33|||
156669434|NCT00968812|565535808|FG000|Overall Study|Death|2|||
156669435|NCT00968812|565535809|FG001|Overall Study|Death|2|||
156669436|NCT00968812|565535810|FG002|Overall Study|Death|1|||
156669437|NCT00968812|565535808|FG000|Overall Study|Lack of Efficacy|9|||
156669438|NCT00968812|565535809|FG001|Overall Study|Lack of Efficacy|7|||
156669439|NCT00968812|565535810|FG002|Overall Study|Lack of Efficacy|16|||
156669440|NCT00968812|565535808|FG000|Overall Study|Lost to Follow-up|17|||
156669441|NCT00968812|565535809|FG001|Overall Study|Lost to Follow-up|12|||
156669442|NCT00968812|565535810|FG002|Overall Study|Lost to Follow-up|11|||
156669443|NCT00968812|565535808|FG000|Overall Study|Physician Decision|8|||
156669444|NCT00968812|565535809|FG001|Overall Study|Physician Decision|5|||
156669445|NCT00968812|565535810|FG002|Overall Study|Physician Decision|9|||
156669446|NCT00968812|565535808|FG000|Overall Study|Protocol Violation|7|||
156669447|NCT00968812|565535809|FG001|Overall Study|Protocol Violation|4|||
156669448|NCT00968812|565535810|FG002|Overall Study|Protocol Violation|3|||
156669449|NCT00968812|565535808|FG000|Overall Study|Withdrawal by Subject|17|||
156669450|NCT00968812|565535809|FG001|Overall Study|Withdrawal by Subject|23|||
156669451|NCT00968812|565535810|FG002|Overall Study|Withdrawal by Subject|25|||
156669452|NCT00968812|565535808|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
156669453|NCT00968812|565535809|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
156669454|NCT00968812|565535810|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
156669455|NCT00968812|565535808|FG000|Overall Study|Noncompliance with study drug|4|||
156669456|NCT00968812|565535809|FG001|Overall Study|Noncompliance with study drug|1|||
156669457|NCT00968812|565535810|FG002|Overall Study|Noncompliance with study drug|6|||
156669458|NCT00968812|565535808|FG000|Overall Study|Unable to take rescue therapy|12|||
156669459|NCT00968812|565535809|FG001|Overall Study|Unable to take rescue therapy|12|||
156669460|NCT00968812|565535810|FG002|Overall Study|Unable to take rescue therapy|17|||
156669461|NCT00968812|565535808|FG000|Overall Study|Other|25|||
156326811|NCT03963401|564296160|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
156326812|NCT03963401|564296161|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
156669462|NCT00968812|565535809|FG001|Overall Study|Other|37|||
156669463|NCT00968812|565535810|FG002|Overall Study|Other|40|||
156669464|NCT00609674|565535811|FG000|Overall Study|Adverse Event|1|||
156669465|NCT00609674|565535812|FG001|Overall Study|Adverse Event|1|||
156669466|NCT00609674|565535811|FG000|Overall Study|Protocol Violation|3|||
156669467|NCT00609674|565535812|FG001|Overall Study|Protocol Violation|5|||
156779697|NCT02260986|565943838|FG000|Overall Study|Incorrect randomization|0|||
156779698|NCT02260986|565943839|FG001|Overall Study|Incorrect randomization|1|||
156669468|NCT00609674|565535811|FG000|Overall Study|Lost to Follow-up|1|||
156669469|NCT00609674|565535812|FG001|Overall Study|Lost to Follow-up|0|||
156669470|NCT00609674|565535811|FG000|Overall Study|Withdrew consent|2|||
156326813|NCT03963401|564296162|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
156326814|NCT03963401|564296157|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156326815|NCT03963401|564296158|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
156326816|NCT03963401|564296159|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156326817|NCT03963401|564296160|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156326818|NCT03963401|564296161|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156326819|NCT03963401|564296162|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156326820|NCT03963401|564296157|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
156326821|NCT03963401|564296158|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
156326822|NCT03963401|564296159|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
156326823|NCT03963401|564296160|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
156326824|NCT03963401|564296161|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
156326825|NCT03963401|564296162|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
156326826|NCT03963401|564296157|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
156326827|NCT03963401|564296158|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
156326828|NCT03963401|564296159|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
156326829|NCT03963401|564296160|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
156326830|NCT03963401|564296161|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
156326831|NCT03963401|564296162|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
156326832|NCT03963401|564296157|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156326833|NCT03963401|564296158|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156326834|NCT03963401|564296159|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
156326835|NCT03963401|564296160|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156326836|NCT03963401|564296161|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156326837|NCT03963401|564296162|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156326838|NCT03963401|564296157|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
156326839|NCT03963401|564296158|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156326840|NCT03963401|564296159|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156326841|NCT03963401|564296160|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156326842|NCT03963401|564296161|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156326843|NCT03963401|564296162|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156326844|NCT03963401|564296157|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
156326845|NCT03963401|564296158|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
156326846|NCT03963401|564296159|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
156326847|NCT03963401|564296160|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
156326848|NCT03963401|564296161|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
156326849|NCT03963401|564296162|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
156326850|NCT03963401|564296157|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
156326851|NCT03963401|564296158|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156326852|NCT03963401|564296159|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156326853|NCT03963401|564296160|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156326854|NCT03963401|564296161|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156326855|NCT03963401|564296162|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156326856|NCT03963401|564296157|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
156326857|NCT03963401|564296158|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
156326858|NCT03963401|564296159|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
156326859|NCT03963401|564296160|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
156326860|NCT03963401|564296161|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
156326861|NCT03963401|564296162|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
156326862|NCT01476644|564296163|FG000|Overall Study|Death|5|||
156326863|NCT01476644|564296163|FG000|Overall Study|moved to another state|2|||
156326864|NCT01476644|564296163|FG000|Overall Study|Lost to Follow-up|19|||
156326865|NCT01476644|564296163|FG000|Overall Study|Withdrawal by Subject|13|||
156326866|NCT00586066|564296164|FG000|Overall Study|Lost to Follow-up|6|||
156326867|NCT00586066|564296165|FG001|Overall Study|Lost to Follow-up|3|||
156326868|NCT00586066|564296164|FG000|Overall Study|Lack of Efficacy|5|||
156866366|NCT01357850|566271173|FG000|Overall Study|Lost to Follow-up|1|||
156866367|NCT01357850|566271174|FG001|Overall Study|Lost to Follow-up|0|||
156866368|NCT01357850|566271175|FG002|Overall Study|Lost to Follow-up|0|||
156866369|NCT01357850|566271176|FG003|Overall Study|Lost to Follow-up|0|||
156866370|NCT04610281|566271177|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
156866371|NCT04610281|566271178|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
156866372|NCT01803607|566271180|FG000|Overall Study|Adverse Event|5|||
156866373|NCT01803607|566271181|FG001|Overall Study|Adverse Event|3|||
156866374|NCT01803607|566271180|FG000|Overall Study|Lack of Efficacy|0|||
156866375|NCT01803607|566271181|FG001|Overall Study|Lack of Efficacy|1|||
156669471|NCT00609674|565535812|FG001|Overall Study|Withdrew consent|1|||
156669472|NCT03872128|565535823|FG000|Overall Study|Dropped out before treatment|1|||
156669473|NCT03872128|565535824|FG001|Overall Study|Dropped out before treatment|0|||
156669474|NCT03872128|565535825|FG002|Overall Study|Dropped out before treatment|4|||
156669475|NCT03872128|565535823|FG000|Overall Study|Lost to Follow-up|2|||
156669476|NCT03872128|565535824|FG001|Overall Study|Lost to Follow-up|5|||
156669477|NCT03872128|565535825|FG002|Overall Study|Lost to Follow-up|8|||
156669478|NCT02558491|565535830|FG000|First Invention|Withdrawal by Subject|3|||
156669479|NCT02558491|565535831|FG001|First Invention|Withdrawal by Subject|1|||
156669480|NCT02558491|565535830|FG000|First Invention|Data collection issues|1|||
156669481|NCT02558491|565535831|FG001|First Invention|Data collection issues|0|||
156669482|NCT02558491|565535830|FG000|First Invention|Stopping criteria|0|||
156669483|NCT02558491|565535831|FG001|First Invention|Stopping criteria|1|||
156669484|NCT02558491|565535830|FG000|First Invention|Changed parameters during trial|1|||
156669485|NCT02558491|565535831|FG001|First Invention|Changed parameters during trial|0|||
156669486|NCT02558491|565535830|FG000|Second Intervention|Withdrawal by Subject|1|||
156669487|NCT02558491|565535831|FG001|Second Intervention|Withdrawal by Subject|0|||
156669488|NCT02558491|565535830|FG000|Second Intervention|Stopping Criteria|1|||
156669489|NCT02558491|565535831|FG001|Second Intervention|Stopping Criteria|0|||
156669490|NCT00834431|565535834|FG000|First Intervention|Adverse Event|0|||
156669491|NCT00834431|565535835|FG001|First Intervention|Adverse Event|1|||
156669492|NCT00834431|565535834|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
156669493|NCT00834431|565535835|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
156669494|NCT01788423|565535838|FG000|Overall Study|See Comments in Completed (above)|0|||
156669495|NCT01788423|565535839|FG001|Overall Study|See Comments in Completed (above)|4|||
156669496|NCT01788423|565535840|FG002|Overall Study|See Comments in Completed (above)|5|||
156669497|NCT02689505|565535842|FG000|Overall Study|Progressive disease|2|||
156669498|NCT02689505|565535843|FG001|Overall Study|Progressive disease|2|||
156669499|NCT02689505|565535844|FG002|Overall Study|Progressive disease|3|||
156669500|NCT02689505|565535845|FG003|Overall Study|Progressive disease|9|||
156669501|NCT02689505|565535846|FG004|Overall Study|Progressive disease|1|||
156669502|NCT02689505|565535842|FG000|Overall Study|Dose Limiting Toxicity|0|||
156669503|NCT02689505|565535843|FG001|Overall Study|Dose Limiting Toxicity|1|||
156669504|NCT02689505|565535844|FG002|Overall Study|Dose Limiting Toxicity|0|||
156669505|NCT02689505|565535845|FG003|Overall Study|Dose Limiting Toxicity|0|||
156669506|NCT02689505|565535846|FG004|Overall Study|Dose Limiting Toxicity|2|||
156669507|NCT02689505|565535842|FG000|Overall Study|Other AE or clinical progression|0|||
156669508|NCT02689505|565535843|FG001|Overall Study|Other AE or clinical progression|2|||
156669509|NCT02689505|565535844|FG002|Overall Study|Other AE or clinical progression|0|||
156669510|NCT02689505|565535845|FG003|Overall Study|Other AE or clinical progression|2|||
156669511|NCT02689505|565535846|FG004|Overall Study|Other AE or clinical progression|0|||
156669512|NCT03792477|565535852|FG000|Overall Study|Adverse Event|0|||
156669513|NCT03792477|565535853|FG001|Overall Study|Adverse Event|0|||
156669514|NCT03792477|565535854|FG002|Overall Study|Adverse Event|0|||
156669515|NCT03792477|565535855|FG003|Overall Study|Adverse Event|1|||
156669516|NCT03792477|565535856|FG004|Overall Study|Adverse Event|0|||
156669517|NCT03792477|565535852|FG000|Overall Study|Lost to Follow-up|0|||
156669518|NCT03792477|565535853|FG001|Overall Study|Lost to Follow-up|0|||
156669519|NCT03792477|565535854|FG002|Overall Study|Lost to Follow-up|2|||
156669520|NCT03792477|565535855|FG003|Overall Study|Lost to Follow-up|0|||
156669521|NCT03792477|565535856|FG004|Overall Study|Lost to Follow-up|0|||
156669522|NCT03792477|565535852|FG000|Overall Study|Other|0|||
156669523|NCT03792477|565535853|FG001|Overall Study|Other|0|||
156669524|NCT03792477|565535854|FG002|Overall Study|Other|0|||
156669525|NCT03792477|565535855|FG003|Overall Study|Other|0|||
156526147|NCT03548987|565021470|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
156526148|NCT03548987|565021471|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
156526149|NCT05580588|565021472|FG000|Overall Study|Lack of Efficacy|12|||
156526150|NCT02875977|565021475|FG000|Overall Study|Lost to Follow-up|42|||
156326869|NCT00586066|564296165|FG001|Overall Study|Lack of Efficacy|3|||
156326870|NCT00586066|564296164|FG000|Overall Study|Adverse Event|2|||
156326871|NCT00586066|564296165|FG001|Overall Study|Adverse Event|2|||
156326872|NCT00586066|564296164|FG000|Overall Study|Physician Decision|1|||
156326873|NCT00586066|564296165|FG001|Overall Study|Physician Decision|0|||
156326874|NCT00586066|564296164|FG000|Overall Study|Withdrawal of consent|4|||
156669526|NCT03792477|565535856|FG004|Overall Study|Other|1|||
156669527|NCT00840411|565535858|FG000|First Intervention|Adverse Event|1|||
156669528|NCT00840411|565535859|FG001|First Intervention|Adverse Event|0|||
156669529|NCT00840411|565535858|FG000|Washout|Withdrawal by Subject|1|||
156669530|NCT00840411|565535859|FG001|Washout|Withdrawal by Subject|0|||
156669531|NCT01576042|565535862|FG000|Overall Study|Physician Decision|2|||
156526151|NCT02875977|565021476|FG001|Overall Study|Lost to Follow-up|29|||
156669532|NCT01576042|565535863|FG001|Overall Study|Physician Decision|0|||
156669533|NCT00465270|565535864|FG000|Overall Study|Death|7|||
156669534|NCT00465270|565535865|FG001|Overall Study|Death|11|||
156326875|NCT00586066|564296165|FG001|Overall Study|Withdrawal of consent|2|||
156669535|NCT00465270|565535864|FG000|Overall Study|Withdrawal by Subject|34|||
156669536|NCT00465270|565535865|FG001|Overall Study|Withdrawal by Subject|78|||
156526152|NCT00928447|565021485|FG000|Overall Study|Withdrawal by Subject|1|||
156526153|NCT00928447|565021485|FG000|Overall Study|Investigator's decision|1|||
156526154|NCT01259284|565021486|FG000|Overall Study|Study Termination|2|||
156526155|NCT01259284|565021487|FG001|Overall Study|Study Termination|0|||
156526156|NCT01259284|565021488|FG002|Overall Study|Study Termination|0|||
156526157|NCT00069238|565021489|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
156526158|NCT00069238|565021490|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
156526159|NCT00069238|565021491|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
156526160|NCT00069238|565021489|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
156526161|NCT00069238|565021490|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
156526162|NCT00069238|565021491|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
156526163|NCT00069238|565021489|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
156526164|NCT00069238|565021490|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
156526165|NCT00069238|565021491|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
156526166|NCT00926211|565021493|FG000|Overall Study|Lost to Follow-up|1|||
156526167|NCT01032382|565021494|FG000|Overall Study|Disease dissemination|1|||
156526168|NCT01032382|565021495|FG001|Overall Study|Disease dissemination|1|||
156526169|NCT01032382|565021494|FG000|Overall Study|Treatment failure|3|||
156526170|NCT01032382|565021495|FG001|Overall Study|Treatment failure|1|||
156526171|NCT01032382|565021494|FG000|Overall Study|Index lesion relapse|1|||
156526172|NCT01032382|565021495|FG001|Overall Study|Index lesion relapse|3|||
156526173|NCT04508023|565021496|FG000|Overall Study|Withdrawal by Subject|1|||
156526174|NCT04508023|565021497|FG001|Overall Study|Withdrawal by Subject|2|||
156526175|NCT00511901|565021498|FG000|Overall Study|Withdrawal by Subject|1|||
156526176|NCT00511901|565021499|FG001|Overall Study|Withdrawal by Subject|3|||
156526177|NCT02988622|565021500|FG000|Overall Study|Lost to Follow-up|17|||
156526178|NCT01204398|565021504|FG000|Overall Study|Adverse Event|1|||
156526179|NCT03261700|565021505|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
156526180|NCT03261700|565021506|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
156526181|NCT03562247|565021507|FG000|Overall Study|Lost to Follow-up|3|||
156526182|NCT03562247|565021508|FG001|Overall Study|Lost to Follow-up|1|||
156526183|NCT03562247|565021509|FG002|Overall Study|Lost to Follow-up|1|||
156526184|NCT00983931|565021510|FG000|14 Day Washout Period|Physician Decision|1|||
156526185|NCT01281969|565021513|FG000|Overall Study|not randomized didn't meet criteria|0|||
156526186|NCT01281969|565021514|FG001|Overall Study|not randomized didn't meet criteria|0|||
156526187|NCT01281969|565021515|FG002|Overall Study|not randomized didn't meet criteria|7|||
156526188|NCT01281969|565021513|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
156526189|NCT01281969|565021514|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
156526190|NCT01281969|565021515|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
156526191|NCT01281969|565021513|FG000|Overall Study|not randomized, child consent not given|0|||
156526192|NCT01281969|565021514|FG001|Overall Study|not randomized, child consent not given|0|||
156526193|NCT01281969|565021515|FG002|Overall Study|not randomized, child consent not given|2|||
156526194|NCT01723254|565021517|FG000|Overall Study|Conflict with work schedule|0|||
156526195|NCT01723254|565021518|FG001|Overall Study|Conflict with work schedule|0|||
156526196|NCT01723254|565021519|FG002|Overall Study|Conflict with work schedule|0|||
156526197|NCT01723254|565021520|FG003|Overall Study|Conflict with work schedule|0|||
156526198|NCT01723254|565021521|FG004|Overall Study|Conflict with work schedule|0|||
156526199|NCT01723254|565021522|FG005|Overall Study|Conflict with work schedule|0|||
156526200|NCT01723254|565021523|FG006|Overall Study|Conflict with work schedule|0|||
156526201|NCT01723254|565021524|FG007|Overall Study|Conflict with work schedule|1|||
156526202|NCT01723254|565021517|FG000|Overall Study|Personal issues|0|||
156526203|NCT01723254|565021518|FG001|Overall Study|Personal issues|0|||
156526204|NCT01723254|565021519|FG002|Overall Study|Personal issues|0|||
156526205|NCT01723254|565021520|FG003|Overall Study|Personal issues|0|||
156526206|NCT01723254|565021521|FG004|Overall Study|Personal issues|0|||
156526207|NCT01723254|565021522|FG005|Overall Study|Personal issues|1|||
156526208|NCT01723254|565021523|FG006|Overall Study|Personal issues|0|||
156526209|NCT01723254|565021524|FG007|Overall Study|Personal issues|0|||
156526210|NCT01723254|565021517|FG000|Overall Study|No longer have time to participate|0|||
156526211|NCT01723254|565021518|FG001|Overall Study|No longer have time to participate|0|||
156526212|NCT01723254|565021519|FG002|Overall Study|No longer have time to participate|0|||
156526213|NCT01723254|565021520|FG003|Overall Study|No longer have time to participate|1|||
156526214|NCT01723254|565021521|FG004|Overall Study|No longer have time to participate|0|||
156526215|NCT01723254|565021522|FG005|Overall Study|No longer have time to participate|0|||
156526216|NCT01723254|565021523|FG006|Overall Study|No longer have time to participate|0|||
156526217|NCT01723254|565021524|FG007|Overall Study|No longer have time to participate|0|||
156526218|NCT01723254|565021517|FG000|Overall Study|Move/Left to another country/city|0|||
156526219|NCT01723254|565021518|FG001|Overall Study|Move/Left to another country/city|0|||
156526220|NCT01723254|565021519|FG002|Overall Study|Move/Left to another country/city|2|||
156526221|NCT01723254|565021520|FG003|Overall Study|Move/Left to another country/city|1|||
156526222|NCT01723254|565021521|FG004|Overall Study|Move/Left to another country/city|1|||
156526223|NCT01723254|565021522|FG005|Overall Study|Move/Left to another country/city|0|||
156526224|NCT01723254|565021523|FG006|Overall Study|Move/Left to another country/city|0|||
156669537|NCT00465270|565535864|FG000|Overall Study|Lost to Follow-up|60|||
156669538|NCT00465270|565535865|FG001|Overall Study|Lost to Follow-up|67|||
156669539|NCT00465270|565535864|FG000|Overall Study|Investigator request|3|||
156669540|NCT00465270|565535865|FG001|Overall Study|Investigator request|4|||
156669541|NCT03233724|565535866|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
156669542|NCT03233724|565535867|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
156669543|NCT03233724|565535868|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
156669544|NCT03233724|565535869|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
156669545|NCT03233724|565535870|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
156669546|NCT03233724|565535866|FG000|Phase I Dose Escalation|Best interest of participant|1|||
156669547|NCT03233724|565535867|FG001|Phase I Dose Escalation|Best interest of participant|1|||
156669548|NCT03233724|565535868|FG002|Phase I Dose Escalation|Best interest of participant|1|||
156669549|NCT03233724|565535869|FG003|Phase I Dose Escalation|Best interest of participant|0|||
156669550|NCT03233724|565535870|FG004|Phase I Dose Escalation|Best interest of participant|0|||
156669551|NCT03233724|565535866|FG000|Phase I Dose Escalation|Physician Decision|0|||
156669552|NCT03233724|565535867|FG001|Phase I Dose Escalation|Physician Decision|0|||
156669553|NCT03233724|565535868|FG002|Phase I Dose Escalation|Physician Decision|1|||
156669554|NCT03233724|565535869|FG003|Phase I Dose Escalation|Physician Decision|0|||
156669555|NCT03233724|565535870|FG004|Phase I Dose Escalation|Physician Decision|0|||
156669556|NCT03233724|565535866|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
156669557|NCT03233724|565535867|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
156669558|NCT03233724|565535868|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
156669559|NCT03233724|565535869|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
156669560|NCT03233724|565535870|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
156669561|NCT00651820|565535873|FG000|Overall Study|Lost to Follow-up|2|||
156669562|NCT02388191|565535874|FG000|Overall Study|Patient did not receive IUD|1|||
156669563|NCT02388191|565535875|FG001|Overall Study|Patient did not receive IUD|0|||
156669564|NCT01911676|565535876|FG000|Period 1 of Study|Withdrawal by Subject|4|||
156669565|NCT01911676|565535877|FG001|Period 1 of Study|Withdrawal by Subject|2|||
156669566|NCT01911676|565535878|FG002|Period 1 of Study|Withdrawal by Subject|1|||
156669567|NCT01911676|565535879|FG003|Period 1 of Study|Withdrawal by Subject|2|||
156669568|NCT01911676|565535876|FG000|Period 1 of Study|Physician Decision|2|||
156669569|NCT01911676|565535877|FG001|Period 1 of Study|Physician Decision|0|||
156669570|NCT01911676|565535878|FG002|Period 1 of Study|Physician Decision|0|||
156669571|NCT01911676|565535879|FG003|Period 1 of Study|Physician Decision|1|||
156669572|NCT01911676|565535876|FG000|Period 2 of Study|Physician Decision|2|||
156669573|NCT01911676|565535877|FG001|Period 2 of Study|Physician Decision|0|||
156669574|NCT01911676|565535878|FG002|Period 2 of Study|Physician Decision|0|||
156669575|NCT01911676|565535879|FG003|Period 2 of Study|Physician Decision|1|||
156669576|NCT01911676|565535876|FG000|Period 2 of Study|Lost to Follow-up|0|||
156669577|NCT01911676|565535877|FG001|Period 2 of Study|Lost to Follow-up|0|||
156669578|NCT01911676|565535878|FG002|Period 2 of Study|Lost to Follow-up|0|||
156669579|NCT01911676|565535879|FG003|Period 2 of Study|Lost to Follow-up|1|||
156669580|NCT00773253|565535880|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
156669581|NCT00773253|565535881|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
156669582|NCT03173547|565535885|FG000|Overall Study|Adverse Event|2|||
156669583|NCT03173547|565535886|FG001|Overall Study|Adverse Event|0|||
156326876|NCT02676466|564296166|FG000|Overall Study|Death|0|||
156326877|NCT02676466|564296167|FG001|Overall Study|Death|2|||
156326878|NCT02676466|564296168|FG002|Overall Study|Death|1|||
156326879|NCT02676466|564296169|FG003|Overall Study|Death|0|||
156326880|NCT02676466|564296170|FG004|Overall Study|Death|0|||
156326881|NCT02676466|564296171|FG005|Overall Study|Death|0|||
156326882|NCT02676466|564296172|FG006|Overall Study|Death|0|||
156326883|NCT02676466|564296173|FG007|Overall Study|Death|0|||
156326884|NCT02676466|564296166|FG000|Overall Study|Withdrawal by Subject|4|||
156326885|NCT02676466|564296167|FG001|Overall Study|Withdrawal by Subject|3|||
156326886|NCT02676466|564296168|FG002|Overall Study|Withdrawal by Subject|1|||
156669584|NCT03173547|565535885|FG000|Overall Study|Withdrawal by Subject|2|||
156669585|NCT03173547|565535886|FG001|Overall Study|Withdrawal by Subject|2|||
156669586|NCT00657553|565535887|FG000|Overall Study|low accrual, no analysis run|5|||
156669587|NCT00657553|565535888|FG001|Overall Study|low accrual, no analysis run|5|||
156669588|NCT01566721|565535889|FG000|Treatment Period|Withdrawal by Subject|35|||
156669589|NCT01566721|565535890|FG001|Treatment Period|Withdrawal by Subject|9|||
156669590|NCT01566721|565535889|FG000|Treatment Period|Disease Progression/Recurrence|37|||
156669591|NCT01566721|565535890|FG001|Treatment Period|Disease Progression/Recurrence|13|||
156326887|NCT02676466|564296169|FG003|Overall Study|Withdrawal by Subject|0|||
156326888|NCT02676466|564296170|FG004|Overall Study|Withdrawal by Subject|3|||
156326889|NCT02676466|564296171|FG005|Overall Study|Withdrawal by Subject|1|||
156326890|NCT02676466|564296172|FG006|Overall Study|Withdrawal by Subject|1|||
156669592|NCT01566721|565535889|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
156669593|NCT01566721|565535890|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
156669594|NCT01566721|565535889|FG000|Treatment Period|Other|13|||
156669595|NCT01566721|565535890|FG001|Treatment Period|Other|2|||
156669596|NCT01566721|565535889|FG000|Treatment Period|Lack of Compliance|5|||
156669597|NCT01566721|565535890|FG001|Treatment Period|Lack of Compliance|1|||
156669598|NCT01566721|565535889|FG000|Treatment Period|Adverse Event|100|||
156669599|NCT01566721|565535890|FG001|Treatment Period|Adverse Event|30|||
156669600|NCT01566721|565535889|FG000|Treatment Period|Pregnancy|1|||
156669601|NCT01566721|565535890|FG001|Treatment Period|Pregnancy|0|||
156669602|NCT01566721|565535889|FG000|Safety Follow-up|Physician Decision|6|||
156669603|NCT01566721|565535890|FG001|Safety Follow-up|Physician Decision|4|||
156669604|NCT01566721|565535889|FG000|Safety Follow-up|Lost to Follow-up|101|||
156669605|NCT01566721|565535890|FG001|Safety Follow-up|Lost to Follow-up|48|||
156669606|NCT01566721|565535889|FG000|Safety Follow-up|Withdrawal by Subject|155|||
156669607|NCT01566721|565535890|FG001|Safety Follow-up|Withdrawal by Subject|49|||
156669608|NCT01566721|565535889|FG000|Safety Follow-up|Death|28|||
156669609|NCT01566721|565535890|FG001|Safety Follow-up|Death|4|||
156669610|NCT01566721|565535889|FG000|Safety Follow-up|Non-compliance|7|||
156669611|NCT01566721|565535890|FG001|Safety Follow-up|Non-compliance|3|||
156669612|NCT01566721|565535889|FG000|Safety Follow-up|Protocol Violation|7|||
156669613|NCT01566721|565535890|FG001|Safety Follow-up|Protocol Violation|0|||
156669614|NCT01566721|565535889|FG000|Safety Follow-up|Site closure|2|||
156669615|NCT01566721|565535890|FG001|Safety Follow-up|Site closure|3|||
156669616|NCT01566721|565535889|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
156669617|NCT01566721|565535890|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
156669618|NCT01566721|565535889|FG000|Safety Follow-up|Missing|7|||
156669619|NCT01566721|565535890|FG001|Safety Follow-up|Missing|2|||
156669620|NCT01566721|565535889|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
156669621|NCT01566721|565535890|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
156669622|NCT01566721|565535889|FG000|Safety Follow-up|Sponsor decision|1|||
156669623|NCT01566721|565535890|FG001|Safety Follow-up|Sponsor decision|0|||
156669624|NCT01566721|565535889|FG000|Safety Follow-up|Adverse Event|8|||
156669625|NCT01566721|565535890|FG001|Safety Follow-up|Adverse Event|4|||
156669626|NCT00446563|565535891|FG000|Overall Study|Adverse Event|4|||
156669627|NCT00446563|565535892|FG001|Overall Study|Adverse Event|3|||
156669628|NCT00446563|565535891|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156669629|NCT00446563|565535892|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156669630|NCT00446563|565535891|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156669631|NCT00446563|565535892|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156669632|NCT00446563|565535891|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156669633|NCT00446563|565535892|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156669634|NCT00446563|565535891|FG000|Overall Study|Withdrawal by Subject|2|||
156669635|NCT00446563|565535892|FG001|Overall Study|Withdrawal by Subject|1|||
156669636|NCT00446563|565535891|FG000|Overall Study|Administrative problems|0|||
156669637|NCT00446563|565535892|FG001|Overall Study|Administrative problems|1|||
156669638|NCT03769025|565535893|FG000|Overall Study|Withdrawal by Subject|1|||
156669639|NCT03769025|565535894|FG001|Overall Study|Withdrawal by Subject|1|||
156669640|NCT03769025|565535893|FG000|Overall Study|Lost to Follow-up|4|||
156669641|NCT03769025|565535894|FG001|Overall Study|Lost to Follow-up|3|||
156669642|NCT01169558|565535895|FG000|Overall Study|Disease progression|98|||
156669643|NCT01169558|565535895|FG000|Overall Study|Adverse Event|25|||
156669644|NCT01169558|565535895|FG000|Overall Study|Withdrawal of Consent|8|||
156669645|NCT01169558|565535895|FG000|Overall Study|Medical Decision|7|||
156669646|NCT01169558|565535895|FG000|Overall Study|Stable Disease|4|||
156669647|NCT01169558|565535895|FG000|Overall Study|Lost to Follow-up|4|||
156669648|NCT01169558|565535895|FG000|Overall Study|Need for Surgery|4|||
156669649|NCT01169558|565535895|FG000|Overall Study|Non-compliance|2|||
156669650|NCT01169558|565535895|FG000|Overall Study|Protocol Violation|2|||
156326891|NCT02676466|564296173|FG007|Overall Study|Withdrawal by Subject|1|||
156326892|NCT01857583|564296180|FG000|Overall Study|Adverse Event|0|||
156326893|NCT01857583|564296181|FG001|Overall Study|Adverse Event|0|||
156326894|NCT01857583|564296182|FG002|Overall Study|Adverse Event|1|||
156326895|NCT01857583|564296183|FG003|Overall Study|Adverse Event|1|||
156326896|NCT01857583|564296180|FG000|Overall Study|Death|0|||
156326897|NCT01857583|564296181|FG001|Overall Study|Death|1|||
156326898|NCT01857583|564296182|FG002|Overall Study|Death|1|||
156669651|NCT01169558|565535895|FG000|Overall Study|Partial response|2|||
156669652|NCT02911701|565535900|FG000|Overall Study|Withdrawal by Subject|2|||
156669653|NCT02911701|565535901|FG001|Overall Study|Withdrawal by Subject|4|||
156669654|NCT02911701|565535900|FG000|Overall Study|Adverse Event|1|||
156669655|NCT02911701|565535901|FG001|Overall Study|Adverse Event|0|||
156326899|NCT01857583|564296183|FG003|Overall Study|Death|0|||
156669656|NCT03134222|565535902|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
156669657|NCT03134222|565535903|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
156669658|NCT03134222|565535904|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
156669659|NCT03134222|565535905|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
156866376|NCT01803607|566271180|FG000|Overall Study|Protocol Violation|3|||
156669660|NCT03134222|565535906|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
156669661|NCT03134222|565535902|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
156669662|NCT03134222|565535903|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
156669663|NCT03134222|565535904|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
156669664|NCT03134222|565535905|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
156669665|NCT03134222|565535906|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
156669666|NCT03134222|565535902|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
156669667|NCT03134222|565535903|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
156669668|NCT03134222|565535904|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
156669669|NCT03134222|565535905|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
156669670|NCT03134222|565535906|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
156669671|NCT03134222|565535902|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
156669672|NCT03134222|565535903|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
156669673|NCT03134222|565535904|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
156669674|NCT03134222|565535905|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
156669675|NCT03134222|565535906|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
156669676|NCT03134222|565535902|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
156669677|NCT03134222|565535903|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
156669678|NCT03134222|565535904|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
156669679|NCT03134222|565535905|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
156669680|NCT03134222|565535906|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
156669681|NCT03134222|565535902|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
156669682|NCT03134222|565535903|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
156669683|NCT03134222|565535904|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
156669684|NCT03134222|565535905|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
156669685|NCT03134222|565535906|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
156669686|NCT03134222|565535902|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
156669687|NCT03134222|565535903|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
156669688|NCT03134222|565535904|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
156669689|NCT03134222|565535905|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
156669690|NCT03134222|565535906|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
156669691|NCT03134222|565535902|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
156669692|NCT03134222|565535903|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
156669693|NCT03134222|565535904|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
156669694|NCT03134222|565535905|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
156669695|NCT03134222|565535906|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
156669696|NCT02605928|565535907|FG000|Overall Study|Model tuning phase|28|||
156669697|NCT02605928|565535907|FG000|Overall Study|Lack of Efficacy|5|||
156669698|NCT03482882|565535910|FG000|Overall Study|Adverse Event|3|||
156669699|NCT03482882|565535910|FG000|Overall Study|Lost to Follow-up|1|||
156669700|NCT03482882|565535910|FG000|Overall Study|Protocol Violation|2|||
156669701|NCT03482882|565535910|FG000|Overall Study|Not further specified|1|||
156669702|NCT04659603|565535913|FG000|Overall Study|Study terminated by sponsor|0|||
156669703|NCT04659603|565535914|FG001|Overall Study|Study terminated by sponsor|0|||
156669704|NCT04659603|565535915|FG002|Overall Study|Study terminated by sponsor|2|||
156669705|NCT04659603|565535913|FG000|Overall Study|Withdrawal by Subject|0|||
156669706|NCT04659603|565535914|FG001|Overall Study|Withdrawal by Subject|5|||
156669707|NCT04659603|565535915|FG002|Overall Study|Withdrawal by Subject|0|||
156669708|NCT04659603|565535913|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
156669709|NCT04659603|565535914|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
156669710|NCT04659603|565535915|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
156669711|NCT01110005|565535916|FG000|Overall Study|ineligible|1|||
156669712|NCT01110005|565535917|FG001|Overall Study|ineligible|2|||
156669713|NCT01110005|565535916|FG000|Overall Study|missing consent|3|||
156669714|NCT01110005|565535917|FG001|Overall Study|missing consent|2|||
156669715|NCT01110005|565535916|FG000|Overall Study|Withdrawal by Subject|0|||
156669716|NCT01110005|565535917|FG001|Overall Study|Withdrawal by Subject|1|||
156669717|NCT04646213|565535918|FG000|Overall Study|Physician Decision|3|||
156669718|NCT04646213|565535918|FG000|Overall Study|Withdrawal by Subject|2|||
156669719|NCT02441309|565535921|FG000|Overall Study|Disease progression|2|||
156669720|NCT02441309|565535922|FG001|Overall Study|Disease progression|1|||
156669721|NCT02441309|565535923|FG002|Overall Study|Disease progression|2|||
156669722|NCT02441309|565535921|FG000|Overall Study|Adverse Event|0|||
156669723|NCT02441309|565535922|FG001|Overall Study|Adverse Event|1|||
156669724|NCT02441309|565535923|FG002|Overall Study|Adverse Event|0|||
156326900|NCT01857583|564296180|FG000|Overall Study|Physician Decision|0|||
156326901|NCT01857583|564296181|FG001|Overall Study|Physician Decision|0|||
156326902|NCT01857583|564296182|FG002|Overall Study|Physician Decision|0|||
156326903|NCT01857583|564296183|FG003|Overall Study|Physician Decision|1|||
156669725|NCT02441309|565535921|FG000|Overall Study|Withdrawal by Subject|1|||
156669726|NCT02441309|565535922|FG001|Overall Study|Withdrawal by Subject|0|||
156866377|NCT01803607|566271181|FG001|Overall Study|Protocol Violation|2|||
156669727|NCT02441309|565535923|FG002|Overall Study|Withdrawal by Subject|1|||
156669728|NCT00119015|565535929|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
156669729|NCT00119015|565535930|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
156669730|NCT00119015|565535931|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
156669731|NCT00001703|565537380|FG000|Overall Study|progressed disease|2|||
156669732|NCT00001703|565537380|FG000|Overall Study|No evidence of disease|1|||
156669733|NCT00001703|565537380|FG000|Overall Study|recurrent disease|2|||
156669734|NCT02286739|565537381|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
156669735|NCT02286739|565537382|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
156669736|NCT02286739|565537381|FG000|Overall Study|No Verasense type documented|0|||
156669737|NCT02286739|565537382|FG001|Overall Study|No Verasense type documented|23|||
156669738|NCT02286739|565537381|FG000|Overall Study|Adverse Event|1|||
156669739|NCT02286739|565537382|FG001|Overall Study|Adverse Event|2|||
156669740|NCT02286739|565537381|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
156779699|NCT02260986|565943840|FG002|Overall Study|Incorrect randomization|0|||
156779700|NCT02260986|565943838|FG000|Overall Study|Lack of investigation product supply|2|||
156779701|NCT02260986|565943839|FG001|Overall Study|Lack of investigation product supply|0|||
156779702|NCT02260986|565943840|FG002|Overall Study|Lack of investigation product supply|1|||
156779703|NCT02260986|565943838|FG000|Overall Study|Lost to Follow-up|4|||
156779704|NCT02260986|565943839|FG001|Overall Study|Lost to Follow-up|0|||
156779705|NCT02260986|565943840|FG002|Overall Study|Lost to Follow-up|3|||
156779706|NCT02260986|565943838|FG000|Overall Study|Pregnancy|2|||
156779707|NCT02260986|565943839|FG001|Overall Study|Pregnancy|0|||
156779708|NCT02260986|565943840|FG002|Overall Study|Pregnancy|0|||
156779709|NCT00313170|565943842|FG000|Overall Study|Death|2|||
156669741|NCT02286739|565537382|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
156779710|NCT00313170|565943843|FG001|Overall Study|Death|4|||
156866378|NCT01803607|566271180|FG000|Overall Study|Study terminated by sponsor|54|||
156866379|NCT01803607|566271181|FG001|Overall Study|Study terminated by sponsor|56|||
156866380|NCT01803607|566271180|FG000|Overall Study|Withdrawal by Subject|6|||
156866381|NCT01803607|566271181|FG001|Overall Study|Withdrawal by Subject|5|||
156866382|NCT02266888|566271192|FG000|Overall Study|Death|2|||
156866383|NCT02266888|566271193|FG001|Overall Study|Death|2|||
156866384|NCT02266888|566271194|FG002|Overall Study|Death|4|||
156866385|NCT02266888|566271195|FG003|Overall Study|Death|2|||
156866386|NCT02266888|566271192|FG000|Overall Study|Physician Decision|0|||
156866387|NCT02266888|566271193|FG001|Overall Study|Physician Decision|1|||
156866388|NCT02266888|566271194|FG002|Overall Study|Physician Decision|2|||
156866389|NCT02266888|566271195|FG003|Overall Study|Physician Decision|2|||
156866390|NCT02266888|566271192|FG000|Overall Study|Study Terminated|5|||
156866391|NCT02266888|566271193|FG001|Overall Study|Study Terminated|1|||
156866392|NCT02266888|566271194|FG002|Overall Study|Study Terminated|0|||
156866393|NCT02266888|566271195|FG003|Overall Study|Study Terminated|0|||
156866394|NCT02266888|566271192|FG000|Overall Study|No Longer Eligible|0|||
156866395|NCT02266888|566271193|FG001|Overall Study|No Longer Eligible|0|||
156866396|NCT02266888|566271194|FG002|Overall Study|No Longer Eligible|0|||
156866397|NCT02266888|566271195|FG003|Overall Study|No Longer Eligible|2|||
156866398|NCT02266888|566271192|FG000|Overall Study|Randomization Closed|0|||
156866399|NCT02266888|566271193|FG001|Overall Study|Randomization Closed|0|||
156866400|NCT02266888|566271194|FG002|Overall Study|Randomization Closed|4|||
156866401|NCT02266888|566271195|FG003|Overall Study|Randomization Closed|0|||
156866402|NCT02266888|566271192|FG000|Overall Study|Personnel unavailable at transplant|0|||
156866403|NCT02266888|566271193|FG001|Overall Study|Personnel unavailable at transplant|0|||
156866404|NCT02266888|566271194|FG002|Overall Study|Personnel unavailable at transplant|0|||
156866405|NCT02266888|566271195|FG003|Overall Study|Personnel unavailable at transplant|1|||
156866406|NCT02266888|566271192|FG000|Overall Study|Transfer of care|0|||
156866407|NCT02266888|566271193|FG001|Overall Study|Transfer of care|0|||
156866408|NCT02266888|566271194|FG002|Overall Study|Transfer of care|1|||
156866409|NCT02266888|566271195|FG003|Overall Study|Transfer of care|0|||
156866410|NCT02351856|566271196|FG000|Overall Study|Adverse Event|2|||
156866411|NCT02351856|566271196|FG000|Overall Study|Physician Decision|5|||
156866412|NCT02351856|566271196|FG000|Overall Study|Study terminated by sponsor|1|||
156866413|NCT01458392|566271201|FG000|Overall Study|Death|2|||
156866414|NCT01458392|566271202|FG001|Overall Study|Death|11|||
156866415|NCT01458392|566271203|FG002|Overall Study|Death|22|||
156669742|NCT00834795|565537383|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
156779711|NCT00313170|565943844|FG002|Overall Study|Death|2|||
156866416|NCT01458392|566271201|FG000|Overall Study|At the discretion of the sponsor|0|||
156866417|NCT01458392|566271202|FG001|Overall Study|At the discretion of the sponsor|2|||
156866418|NCT01458392|566271203|FG002|Overall Study|At the discretion of the sponsor|7|||
156866419|NCT01458392|566271201|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
156866420|NCT01458392|566271202|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
156866421|NCT01458392|566271203|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
156866422|NCT01281124|566271212|FG000|Overall Study|Death|1|||
156866423|NCT01198795|566271213|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
156526225|NCT01723254|565021524|FG007|Overall Study|Move/Left to another country/city|0|||
156526226|NCT01723254|565021517|FG000|Overall Study|Protocol Violation|0|||
156526227|NCT01723254|565021518|FG001|Overall Study|Protocol Violation|1|||
156526228|NCT01723254|565021519|FG002|Overall Study|Protocol Violation|0|||
156669743|NCT00834795|565537384|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
156669744|NCT00834795|565537383|FG000|Second Intervention|Adverse Event|1|||
156669745|NCT00834795|565537384|FG001|Second Intervention|Adverse Event|0|||
156669746|NCT02057835|565537389|FG000|Overall Study|Withdrawal by Subject|0|||
156669747|NCT02057835|565537390|FG001|Overall Study|Withdrawal by Subject|2|||
156669748|NCT02057835|565537391|FG002|Overall Study|Withdrawal by Subject|0|||
156669749|NCT02057835|565537392|FG003|Overall Study|Withdrawal by Subject|0|||
156669750|NCT02057835|565537393|FG004|Overall Study|Withdrawal by Subject|0|||
156669751|NCT02057835|565537394|FG005|Overall Study|Withdrawal by Subject|0|||
156669752|NCT02057835|565537395|FG006|Overall Study|Withdrawal by Subject|0|||
156669753|NCT02057835|565537396|FG007|Overall Study|Withdrawal by Subject|0|||
156669754|NCT02057835|565537397|FG008|Overall Study|Withdrawal by Subject|0|||
156669755|NCT02057835|565537398|FG009|Overall Study|Withdrawal by Subject|0|||
156669756|NCT02222818|565537399|FG000|Period 1|Eligibility criteria not met|0|||
156669757|NCT02222818|565537400|FG001|Period 1|Eligibility criteria not met|3|||
156669758|NCT01376037|565537401|FG000|Overall Study|Lost to Follow-up|0|||
156669759|NCT01376037|565537402|FG001|Overall Study|Lost to Follow-up|2|||
156669760|NCT02328040|565537403|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
156669761|NCT02328040|565537404|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
156669762|NCT06284525|565537407|FG000|Overall Study|Withdrawal by Subject|1|||
156669763|NCT03165994|565537408|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
156669764|NCT03165994|565537408|FG000|Overall Study|Death|2|||
156669765|NCT03165994|565537408|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
156669766|NCT03165994|565537408|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
156669767|NCT03165994|565537408|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
156669768|NCT03165994|565537408|FG000|Overall Study|Miscellaneous|1|||
156669769|NCT00519194|565537409|FG000|Overall Study|Withdrawal by Subject|9|||
156669770|NCT00519194|565537409|FG000|Overall Study|Death|9|||
156669771|NCT00519194|565537409|FG000|Overall Study|Lost to Follow-up|3|||
156669772|NCT01111461|565537410|FG000|Overall Study|Adverse Event|32|||
156669773|NCT01111461|565537410|FG000|Overall Study|Participant choice|11|||
156669774|NCT01111461|565537410|FG000|Overall Study|Lost to Follow-up|1|||
156669775|NCT01111461|565537410|FG000|Overall Study|Withdrawal by Subject|1|||
156669776|NCT01111461|565537410|FG000|Overall Study|Other|6|||
156669777|NCT00163657|565537413|FG000|Overall Study|Death|12|||
156669778|NCT00163657|565537414|FG001|Overall Study|Death|14|||
156669779|NCT00163657|565537415|FG002|Overall Study|Death|19|||
156669780|NCT00163657|565537413|FG000|Overall Study|graft loss|4|||
156669781|NCT00163657|565537414|FG001|Overall Study|graft loss|1|||
156669782|NCT00163657|565537415|FG002|Overall Study|graft loss|2|||
156669783|NCT00163657|565537413|FG000|Overall Study|Withdrawal by Subject|2|||
156669784|NCT00163657|565537414|FG001|Overall Study|Withdrawal by Subject|3|||
156669785|NCT00163657|565537415|FG002|Overall Study|Withdrawal by Subject|2|||
156669786|NCT00163657|565537413|FG000|Overall Study|Physician Decision|0|||
156669787|NCT00163657|565537414|FG001|Overall Study|Physician Decision|1|||
156669788|NCT00163657|565537415|FG002|Overall Study|Physician Decision|1|||
156669789|NCT00163657|565537413|FG000|Overall Study|Non Compliance|1|||
156669790|NCT00163657|565537414|FG001|Overall Study|Non Compliance|0|||
156669791|NCT00163657|565537415|FG002|Overall Study|Non Compliance|0|||
156669792|NCT00163657|565537413|FG000|Overall Study|Lost to Follow-up|1|||
156669793|NCT00163657|565537414|FG001|Overall Study|Lost to Follow-up|3|||
156669794|NCT00163657|565537415|FG002|Overall Study|Lost to Follow-up|10|||
156669795|NCT00163657|565537413|FG000|Overall Study|Other reason|0|||
156669796|NCT00163657|565537414|FG001|Overall Study|Other reason|1|||
156669797|NCT00163657|565537415|FG002|Overall Study|Other reason|3|||
156669798|NCT01531894|565537418|FG000|Overall Study|Physician Decision|8|||
156669799|NCT01531894|565537418|FG000|Overall Study|Death|1|||
156669800|NCT06195579|565537419|FG000|Overall Study|Withdrawal by Subject|1|||
156669801|NCT02545283|565537420|FG000|Overall Study|Lost to Follow-up|2|||
156669802|NCT02545283|565537421|FG001|Overall Study|Lost to Follow-up|4|||
156669803|NCT02545283|565537420|FG000|Overall Study|Withdrawal by Subject|5|||
156669804|NCT02545283|565537421|FG001|Overall Study|Withdrawal by Subject|9|||
156669805|NCT02545283|565537420|FG000|Overall Study|Death|109|||
156526229|NCT01723254|565021520|FG003|Overall Study|Protocol Violation|0|||
156669806|NCT02545283|565537421|FG001|Overall Study|Death|211|||
156669807|NCT02545283|565537420|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
156526230|NCT01723254|565021521|FG004|Overall Study|Protocol Violation|0|||
156526231|NCT01723254|565021522|FG005|Overall Study|Protocol Violation|0|||
156669808|NCT02545283|565537421|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
156669809|NCT02545283|565537420|FG000|Overall Study|Study Terminated By Sponsor|33|||
156669810|NCT02545283|565537421|FG001|Overall Study|Study Terminated By Sponsor|71|||
156526232|NCT01723254|565021523|FG006|Overall Study|Protocol Violation|0|||
156669811|NCT03635320|565537422|FG000|Overall Study|not implanted the device|1|||
156526233|NCT01723254|565021524|FG007|Overall Study|Protocol Violation|0|||
156526234|NCT01723254|565021517|FG000|Overall Study|Withdrawal by Subject|1|||
156669812|NCT03635320|565537423|FG001|Overall Study|not implanted the device|2|||
156669813|NCT03635320|565537422|FG000|Overall Study|Withdrawal by Subject|11|||
156326904|NCT01857583|564296180|FG000|Overall Study|Withdrawal by Subject|1|||
156326905|NCT01857583|564296181|FG001|Overall Study|Withdrawal by Subject|0|||
156326906|NCT01857583|564296182|FG002|Overall Study|Withdrawal by Subject|1|||
156326907|NCT01857583|564296183|FG003|Overall Study|Withdrawal by Subject|2|||
156326908|NCT00285207|564296186|FG000|Overall Study|Lost to Follow-up|3|||
156326909|NCT00285207|564296187|FG001|Overall Study|Lost to Follow-up|2|||
156326910|NCT00285207|564296186|FG000|Overall Study|Withdrawal by Subject|5|||
156326911|NCT00285207|564296187|FG001|Overall Study|Withdrawal by Subject|2|||
156326912|NCT00285207|564296186|FG000|Overall Study|Pregnancy|1|||
156326913|NCT00285207|564296187|FG001|Overall Study|Pregnancy|1|||
156326914|NCT00285207|564296186|FG000|Overall Study|non-compliance|0|||
156326915|NCT00285207|564296187|FG001|Overall Study|non-compliance|1|||
156326916|NCT01846104|564297414|FG000|Overall Study|Withdrawal by Subject|1|||
156326917|NCT02007512|564297422|FG000|Double Blind Treatment Period|Adverse Event|4|||
156326918|NCT02007512|564297423|FG001|Double Blind Treatment Period|Adverse Event|6|||
156326919|NCT02007512|564297424|FG002|Double Blind Treatment Period|Adverse Event|2|||
156326920|NCT02007512|564297425|FG003|Double Blind Treatment Period|Adverse Event|2|||
156326921|NCT02007512|564297422|FG000|Double Blind Treatment Period|Death|1|||
156326922|NCT02007512|564297423|FG001|Double Blind Treatment Period|Death|0|||
156326923|NCT02007512|564297424|FG002|Double Blind Treatment Period|Death|0|||
156326924|NCT02007512|564297425|FG003|Double Blind Treatment Period|Death|0|||
156326925|NCT02007512|564297422|FG000|Double Blind Treatment Period|Disease progression|51|||
156326926|NCT02007512|564297423|FG001|Double Blind Treatment Period|Disease progression|50|||
156326927|NCT02007512|564297424|FG002|Double Blind Treatment Period|Disease progression|57|||
156326928|NCT02007512|564297425|FG003|Double Blind Treatment Period|Disease progression|52|||
156326929|NCT02007512|564297422|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
156326930|NCT02007512|564297423|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
156326931|NCT02007512|564297424|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
156326932|NCT02007512|564297425|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
156326933|NCT02007512|564297422|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156326934|NCT02007512|564297423|FG001|Double Blind Treatment Period|Protocol Violation|0|||
156326935|NCT02007512|564297424|FG002|Double Blind Treatment Period|Protocol Violation|0|||
156326936|NCT02007512|564297425|FG003|Double Blind Treatment Period|Protocol Violation|1|||
156326937|NCT02007512|564297422|FG000|Double Blind Treatment Period|Other|2|||
156326938|NCT02007512|564297423|FG001|Double Blind Treatment Period|Other|1|||
156326939|NCT02007512|564297424|FG002|Double Blind Treatment Period|Other|1|||
156326940|NCT02007512|564297425|FG003|Double Blind Treatment Period|Other|2|||
156326941|NCT02007512|564297422|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
156326942|NCT02007512|564297423|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
156326943|NCT02007512|564297424|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
156326944|NCT02007512|564297425|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
156326945|NCT02007512|564297422|FG000|Open Label Treatment Period|Adverse Event|1|||
156326946|NCT02007512|564297423|FG001|Open Label Treatment Period|Adverse Event|0|||
156326947|NCT02007512|564297424|FG002|Open Label Treatment Period|Adverse Event|0|||
156326948|NCT02007512|564297425|FG003|Open Label Treatment Period|Adverse Event|0|||
156326949|NCT02007512|564297422|FG000|Open Label Treatment Period|Other|1|||
156326950|NCT02007512|564297423|FG001|Open Label Treatment Period|Other|1|||
156326951|NCT02007512|564297424|FG002|Open Label Treatment Period|Other|0|||
156326952|NCT02007512|564297425|FG003|Open Label Treatment Period|Other|0|||
156326953|NCT02007512|564297422|FG000|Open Label Treatment Period|Disease progression|23|||
156326954|NCT02007512|564297423|FG001|Open Label Treatment Period|Disease progression|11|||
156326955|NCT02007512|564297424|FG002|Open Label Treatment Period|Disease progression|0|||
156326956|NCT02007512|564297425|FG003|Open Label Treatment Period|Disease progression|0|||
156326957|NCT03611010|564297428|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
156326958|NCT03611010|564297429|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
156326959|NCT03611010|564297430|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
156326960|NCT03611010|564297431|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
156326961|NCT02413372|564297436|FG000|Treatment|Lost to Follow-up|0|||
156326962|NCT02413372|564297437|FG001|Treatment|Lost to Follow-up|2|||
156326963|NCT02413372|564297438|FG002|Treatment|Lost to Follow-up|1|||
156326964|NCT02413372|564297436|FG000|Treatment|Withdrawal by Subject|1|||
156326965|NCT02413372|564297437|FG001|Treatment|Withdrawal by Subject|0|||
156326966|NCT02413372|564297438|FG002|Treatment|Withdrawal by Subject|0|||
156326967|NCT02413372|564297436|FG000|Follow-up|Lost to Follow-up|1|||
156326968|NCT02413372|564297437|FG001|Follow-up|Lost to Follow-up|1|||
156326969|NCT02413372|564297438|FG002|Follow-up|Lost to Follow-up|0|||
156326970|NCT02413372|564297436|FG000|Follow-up|Subject Withdrew Consent|1|||
156326971|NCT02413372|564297437|FG001|Follow-up|Subject Withdrew Consent|0|||
156326972|NCT02413372|564297438|FG002|Follow-up|Subject Withdrew Consent|1|||
156326973|NCT02413372|564297436|FG000|Follow-up|Subject unable to return for visit|0|||
156669814|NCT03635320|565537423|FG001|Overall Study|Withdrawal by Subject|6|||
156669815|NCT00804856|565537427|FG000|Overall Study|Progressive Disease|3|||
156669816|NCT00804856|565537428|FG001|Overall Study|Progressive Disease|2|||
156669817|NCT00804856|565537429|FG002|Overall Study|Progressive Disease|4|||
156669818|NCT00804856|565537430|FG003|Overall Study|Progressive Disease|6|||
156669819|NCT00804856|565537431|FG004|Overall Study|Progressive Disease|4|||
156669820|NCT00804856|565537432|FG005|Overall Study|Progressive Disease|1|||
156669821|NCT00804856|565537433|FG006|Overall Study|Progressive Disease|8|||
156669822|NCT00804856|565537434|FG007|Overall Study|Progressive Disease|2|||
156669823|NCT00804856|565537435|FG008|Overall Study|Progressive Disease|4|||
156669824|NCT00804856|565537436|FG009|Overall Study|Progressive Disease|5|||
156669825|NCT00804856|565537437|FG010|Overall Study|Progressive Disease|12|||
156669826|NCT00804856|565537438|FG011|Overall Study|Progressive Disease|2|||
156669827|NCT00804856|565537439|FG012|Overall Study|Progressive Disease|2|||
156669828|NCT00804856|565537440|FG013|Overall Study|Progressive Disease|26|||
156669829|NCT00804856|565537441|FG014|Overall Study|Progressive Disease|20|||
156669830|NCT00804856|565537427|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669831|NCT00804856|565537428|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669832|NCT00804856|565537429|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669833|NCT00804856|565537430|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669834|NCT00804856|565537431|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156669835|NCT00804856|565537432|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669836|NCT00804856|565537433|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669837|NCT00804856|565537434|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669838|NCT00804856|565537435|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669839|NCT00804856|565537436|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669840|NCT00804856|565537437|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669841|NCT00804856|565537438|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669842|NCT00804856|565537439|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669843|NCT00804856|565537440|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156669844|NCT00804856|565537441|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156669845|NCT00804856|565537427|FG000|Overall Study|Other Adverse Event|1|||
156669846|NCT00804856|565537428|FG001|Overall Study|Other Adverse Event|1|||
156669847|NCT00804856|565537429|FG002|Overall Study|Other Adverse Event|1|||
156669848|NCT00804856|565537430|FG003|Overall Study|Other Adverse Event|2|||
156669849|NCT00804856|565537431|FG004|Overall Study|Other Adverse Event|2|||
156669850|NCT00804856|565537432|FG005|Overall Study|Other Adverse Event|1|||
156669851|NCT00804856|565537433|FG006|Overall Study|Other Adverse Event|3|||
156669852|NCT00804856|565537434|FG007|Overall Study|Other Adverse Event|0|||
156669853|NCT00804856|565537435|FG008|Overall Study|Other Adverse Event|0|||
156669854|NCT00804856|565537436|FG009|Overall Study|Other Adverse Event|1|||
156669855|NCT00804856|565537437|FG010|Overall Study|Other Adverse Event|5|||
156669856|NCT00804856|565537438|FG011|Overall Study|Other Adverse Event|2|||
156669857|NCT00804856|565537439|FG012|Overall Study|Other Adverse Event|0|||
156669858|NCT00804856|565537440|FG013|Overall Study|Other Adverse Event|6|||
156669859|NCT00804856|565537441|FG014|Overall Study|Other Adverse Event|13|||
156669860|NCT00804856|565537427|FG000|Overall Study|Non compliance with protocol|0|||
156669861|NCT00804856|565537428|FG001|Overall Study|Non compliance with protocol|0|||
156669862|NCT00804856|565537429|FG002|Overall Study|Non compliance with protocol|0|||
156669863|NCT00804856|565537430|FG003|Overall Study|Non compliance with protocol|0|||
156669864|NCT00804856|565537431|FG004|Overall Study|Non compliance with protocol|0|||
156669865|NCT00804856|565537432|FG005|Overall Study|Non compliance with protocol|0|||
156669866|NCT00804856|565537433|FG006|Overall Study|Non compliance with protocol|0|||
156669867|NCT00804856|565537434|FG007|Overall Study|Non compliance with protocol|0|||
156669868|NCT00804856|565537435|FG008|Overall Study|Non compliance with protocol|0|||
156866424|NCT01198795|566271213|FG000|Overall Study|Withdrawal by Subject|17|||
156866425|NCT01198795|566271213|FG000|Overall Study|Lost to Follow-up|15|||
156866426|NCT01198795|566271213|FG000|Overall Study|Adverse Event|9|||
156866427|NCT01198795|566271213|FG000|Overall Study|Lack of Efficacy|5|||
156866428|NCT01198795|566271213|FG000|Overall Study|Protocol Violation|2|||
156866429|NCT01198795|566271213|FG000|Overall Study|Other Reason|4|||
156866430|NCT03038100|566271214|FG000|Overall Study|Death|289|||
156866431|NCT03038100|566271215|FG001|Overall Study|Death|272|||
156866432|NCT03038100|566271214|FG000|Overall Study|Lost to Follow-up|9|||
156866433|NCT03038100|566271215|FG001|Overall Study|Lost to Follow-up|10|||
156866434|NCT03038100|566271214|FG000|Overall Study|Protocol Deviation|1|||
156866435|NCT03038100|566271215|FG001|Overall Study|Protocol Deviation|4|||
156526235|NCT01723254|565021518|FG001|Overall Study|Withdrawal by Subject|2|||
156669869|NCT00804856|565537436|FG009|Overall Study|Non compliance with protocol|0|||
156669870|NCT00804856|565537437|FG010|Overall Study|Non compliance with protocol|0|||
156669871|NCT00804856|565537438|FG011|Overall Study|Non compliance with protocol|0|||
156669872|NCT00804856|565537439|FG012|Overall Study|Non compliance with protocol|0|||
156669873|NCT00804856|565537440|FG013|Overall Study|Non compliance with protocol|2|||
156669874|NCT00804856|565537441|FG014|Overall Study|Non compliance with protocol|0|||
156866436|NCT03038100|566271214|FG000|Overall Study|Withdrawal by Subject|45|||
156866437|NCT03038100|566271215|FG001|Overall Study|Withdrawal by Subject|51|||
156669875|NCT00804856|565537427|FG000|Overall Study|Refused to continue medication|0|||
156669876|NCT00804856|565537428|FG001|Overall Study|Refused to continue medication|0|||
156669877|NCT00804856|565537429|FG002|Overall Study|Refused to continue medication|0|||
156669878|NCT00804856|565537430|FG003|Overall Study|Refused to continue medication|1|||
156669879|NCT00804856|565537431|FG004|Overall Study|Refused to continue medication|1|||
156669880|NCT00804856|565537432|FG005|Overall Study|Refused to continue medication|0|||
156669881|NCT00804856|565537433|FG006|Overall Study|Refused to continue medication|0|||
156669882|NCT00804856|565537434|FG007|Overall Study|Refused to continue medication|0|||
156669883|NCT00804856|565537435|FG008|Overall Study|Refused to continue medication|0|||
156669884|NCT00804856|565537436|FG009|Overall Study|Refused to continue medication|0|||
156669885|NCT00804856|565537437|FG010|Overall Study|Refused to continue medication|3|||
156669886|NCT00804856|565537438|FG011|Overall Study|Refused to continue medication|0|||
156669887|NCT00804856|565537439|FG012|Overall Study|Refused to continue medication|1|||
156669888|NCT00804856|565537440|FG013|Overall Study|Refused to continue medication|1|||
156669889|NCT00804856|565537441|FG014|Overall Study|Refused to continue medication|5|||
156669890|NCT00804856|565537427|FG000|Overall Study|Other reason than listed above|0|||
156669891|NCT00804856|565537428|FG001|Overall Study|Other reason than listed above|0|||
156669892|NCT00804856|565537429|FG002|Overall Study|Other reason than listed above|0|||
156669893|NCT00804856|565537430|FG003|Overall Study|Other reason than listed above|0|||
156669894|NCT00804856|565537431|FG004|Overall Study|Other reason than listed above|0|||
156669895|NCT00804856|565537432|FG005|Overall Study|Other reason than listed above|1|||
156669896|NCT00804856|565537433|FG006|Overall Study|Other reason than listed above|0|||
156669897|NCT00804856|565537434|FG007|Overall Study|Other reason than listed above|0|||
156669898|NCT00804856|565537435|FG008|Overall Study|Other reason than listed above|1|||
156669899|NCT00804856|565537436|FG009|Overall Study|Other reason than listed above|0|||
156669900|NCT00804856|565537437|FG010|Overall Study|Other reason than listed above|3|||
156669901|NCT00804856|565537438|FG011|Overall Study|Other reason than listed above|1|||
156669902|NCT00804856|565537439|FG012|Overall Study|Other reason than listed above|1|||
156669903|NCT00804856|565537440|FG013|Overall Study|Other reason than listed above|10|||
156669904|NCT00804856|565537441|FG014|Overall Study|Other reason than listed above|3|||
156669905|NCT03343535|565537442|FG000|Overall Study|Lost to Follow-up|1|||
156669906|NCT03343535|565537442|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
156669907|NCT03343535|565537442|FG000|Overall Study|Death|12|||
156669908|NCT03049748|565537443|FG000|Overall Study|Lost to Follow-up|1|||
156669909|NCT03049748|565537444|FG001|Overall Study|Lost to Follow-up|0|||
156669910|NCT03049748|565537443|FG000|Overall Study|Death|3|||
156669911|NCT03049748|565537444|FG001|Overall Study|Death|0|||
156669912|NCT03049748|565537443|FG000|Overall Study|Withdrawal by Subject|0|||
156669913|NCT03049748|565537444|FG001|Overall Study|Withdrawal by Subject|3|||
156669914|NCT03049748|565537443|FG000|Overall Study|Protocol Violation|0|||
156669915|NCT03049748|565537444|FG001|Overall Study|Protocol Violation|2|||
156669916|NCT03049748|565537443|FG000|Overall Study|Moved out of state (relocation)|0|||
156669917|NCT03049748|565537444|FG001|Overall Study|Moved out of state (relocation)|1|||
156669918|NCT01735994|565537445|FG000|Overall Study|Withdrawal by Subject|6|||
156669919|NCT01735994|565537446|FG001|Overall Study|Withdrawal by Subject|4|||
156669920|NCT01735994|565537445|FG000|Overall Study|Injury|2|||
156669921|NCT01735994|565537446|FG001|Overall Study|Injury|0|||
156669922|NCT01735994|565537445|FG000|Overall Study|Kicked off team|5|||
156669923|NCT01735994|565537446|FG001|Overall Study|Kicked off team|0|||
156669924|NCT01735994|565537445|FG000|Overall Study|Lost to Follow-up|50|||
156669925|NCT01735994|565537446|FG001|Overall Study|Lost to Follow-up|62|||
156669926|NCT01158118|565537447|FG000|Overall Study|Screen failure|1|||
156669927|NCT01158118|565537448|FG001|Overall Study|Screen failure|0|||
156669928|NCT01158118|565537447|FG000|Overall Study|Donor match was a screen failure|0|||
156669929|NCT01158118|565537448|FG001|Overall Study|Donor match was a screen failure|1|||
156669930|NCT01158118|565537447|FG000|Overall Study|Suffered stroke prior to transplant|0|||
156669931|NCT01158118|565537448|FG001|Overall Study|Suffered stroke prior to transplant|1|||
156526236|NCT01723254|565021519|FG002|Overall Study|Withdrawal by Subject|1|||
156526237|NCT01723254|565021520|FG003|Overall Study|Withdrawal by Subject|0|||
156526238|NCT01723254|565021521|FG004|Overall Study|Withdrawal by Subject|1|||
156669932|NCT01158118|565537447|FG000|Overall Study|Death|0|||
156669933|NCT01158118|565537448|FG001|Overall Study|Death|1|||
156669934|NCT04994535|565537449|FG000|Overall Study|Lost to Follow-up|7|||
156326974|NCT02413372|564297437|FG001|Follow-up|Subject unable to return for visit|0|||
156326975|NCT02413372|564297438|FG002|Follow-up|Subject unable to return for visit|1|||
156326976|NCT00760214|564297445|FG000|Overall Study|Adverse Event|8|||
156669935|NCT04994535|565537450|FG001|Overall Study|Lost to Follow-up|7|||
156326977|NCT00760214|564297446|FG001|Overall Study|Adverse Event|9|||
156326978|NCT00760214|564297447|FG002|Overall Study|Adverse Event|12|||
156526239|NCT01723254|565021522|FG005|Overall Study|Withdrawal by Subject|1|||
156669936|NCT04994535|565537449|FG000|Overall Study|Withdrawal by Subject|10|||
156669937|NCT04994535|565537450|FG001|Overall Study|Withdrawal by Subject|7|||
156669938|NCT04994535|565537449|FG000|Overall Study|Other|1|||
156669939|NCT04994535|565537450|FG001|Overall Study|Other|1|||
156669940|NCT00960297|565537454|FG000|Overall Study|Physician Decision|1|||
156669941|NCT00960297|565537454|FG000|Overall Study|Venous port infection|1|||
156669942|NCT00960297|565537454|FG000|Overall Study|Disease progression|1|||
156669943|NCT02849457|565537462|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
156669944|NCT02849457|565537463|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
156669945|NCT02849457|565537464|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
156669946|NCT02849457|565537465|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
156669947|NCT04408794|565537469|FG000|Overall Study|Adverse Event|43|||
156669948|NCT04408794|565537469|FG000|Overall Study|Infrequent study drug usage|43|||
156669949|NCT04408794|565537469|FG000|Overall Study|Lack of Efficacy|61|||
156669950|NCT04408794|565537469|FG000|Overall Study|Lost to Follow-up|33|||
156669951|NCT04408794|565537469|FG000|Overall Study|Non-compliance|6|||
156669952|NCT04408794|565537469|FG000|Overall Study|Physician Decision|1|||
156669953|NCT04408794|565537469|FG000|Overall Study|Pregnancy|6|||
156669954|NCT04408794|565537469|FG000|Overall Study|Protocol Deviation|9|||
156669955|NCT04408794|565537469|FG000|Overall Study|Sheehan-STS Result|1|||
156669956|NCT04408794|565537469|FG000|Overall Study|Withdrawal by Subject|57|||
156669957|NCT04408794|565537469|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
156669958|NCT04408794|565537469|FG000|Overall Study|Never Treated Migraine|5|||
156669959|NCT03437265|565537472|FG000|Overall Study|Protocol Violation|6|||
156669960|NCT04238754|565537478|FG000|Washout - 1 Week|Lost to Follow-up|1|||
156669961|NCT04238754|565537479|FG001|Washout - 1 Week|Lost to Follow-up|0|||
156669962|NCT01175018|565537480|FG000|Overall Study|Adverse Event|3|||
156669963|NCT01175018|565537481|FG001|Overall Study|Adverse Event|1|||
156669964|NCT00556322|565537483|FG000|Overall Study|Insufficient therapeutic response|158|||
156866438|NCT03038100|566271214|FG000|Overall Study|Study Terminated By Sponsor|305|||
156866439|NCT03038100|566271215|FG001|Overall Study|Study Terminated By Sponsor|311|||
156866440|NCT03038100|566271214|FG000|Overall Study|Physician Decision|1|||
156866441|NCT03038100|566271215|FG001|Overall Study|Physician Decision|3|||
156866442|NCT02038933|566271216|FG000|Overall Study|Disease progression|104|||
156866443|NCT02038933|566271216|FG000|Overall Study|Study drug toxicity|6|||
156669965|NCT00556322|565537484|FG001|Overall Study|Insufficient therapeutic response|168|||
156669966|NCT00556322|565537483|FG000|Overall Study|Adverse Event|7|||
156669967|NCT00556322|565537484|FG001|Overall Study|Adverse Event|4|||
156669968|NCT00556322|565537483|FG000|Overall Study|Other|4|||
156669969|NCT00556322|565537484|FG001|Overall Study|Other|1|||
156669970|NCT00556322|565537483|FG000|Overall Study|Lost to Follow-up|5|||
156669971|NCT00556322|565537484|FG001|Overall Study|Lost to Follow-up|3|||
156669972|NCT00556322|565537483|FG000|Overall Study|Withdrawal by Subject|19|||
156669973|NCT00556322|565537484|FG001|Overall Study|Withdrawal by Subject|7|||
156669974|NCT00556322|565537483|FG000|Overall Study|Protocol Violation|5|||
156669975|NCT00556322|565537484|FG001|Overall Study|Protocol Violation|1|||
156669976|NCT00556322|565537483|FG000|Overall Study|Ongoing at data cutoff|3|||
156669977|NCT00556322|565537484|FG001|Overall Study|Ongoing at data cutoff|5|||
156669978|NCT00556322|565537483|FG000|Overall Study|Death|20|||
156669979|NCT00556322|565537484|FG001|Overall Study|Death|14|||
156669980|NCT00835263|565537485|FG000|Second Intervention|Adverse Event|1|||
156669981|NCT00835263|565537486|FG001|Second Intervention|Adverse Event|0|||
156669982|NCT01913405|565537487|FG000|Overall Study|Withdrawal by Subject|1|||
156669983|NCT01913405|565537487|FG000|Overall Study|Adverse Event|1|||
156669984|NCT03987191|565537490|FG000|Overall Study|COVID-19 related research disruption|0|||
156669985|NCT03987191|565537491|FG001|Overall Study|COVID-19 related research disruption|2|||
156669986|NCT01020474|565537492|FG000|Overall Study|Adverse Event|4|||
156669987|NCT01020474|565537493|FG001|Overall Study|Adverse Event|4|||
156669988|NCT01020474|565537492|FG000|Overall Study|Protocol Violation|0|||
156866444|NCT02038933|566271216|FG000|Overall Study|Adverse event unrelated to study drug|6|||
156866445|NCT02038933|566271216|FG000|Overall Study|Participant request to discontinue treatment|2|||
156866446|NCT02038933|566271216|FG000|Overall Study|Lost to Follow-up|1|||
156669989|NCT01020474|565537493|FG001|Overall Study|Protocol Violation|2|||
156669990|NCT01020474|565537492|FG000|Overall Study|Withdrawal by Subject|5|||
156669991|NCT01020474|565537493|FG001|Overall Study|Withdrawal by Subject|7|||
156866447|NCT02038933|566271216|FG000|Overall Study|Other reasons|2|||
156866448|NCT03250273|566271249|FG000|Overall Study|Disease Progression|2|||
156866449|NCT03250273|566271250|FG001|Overall Study|Disease Progression|11|||
156526240|NCT01723254|565021523|FG006|Overall Study|Withdrawal by Subject|1|||
156526241|NCT01723254|565021524|FG007|Overall Study|Withdrawal by Subject|2|||
156526242|NCT04640077|565021528|FG000|Period 1|Withdrawal by Subject|4|||
156526243|NCT04640077|565021529|FG001|Period 1|Withdrawal by Subject|5|||
156526244|NCT04640077|565021530|FG002|Period 1|Withdrawal by Subject|0|||
156526245|NCT04640077|565021528|FG000|Period 1|Adverse Event|1|||
156526246|NCT04640077|565021529|FG001|Period 1|Adverse Event|1|||
156669992|NCT01020474|565537492|FG000|Overall Study|Other Reasons|1|||
156669993|NCT01020474|565537493|FG001|Overall Study|Other Reasons|1|||
156669994|NCT01020474|565537492|FG000|Overall Study|Insufficient Clinical Response|0|||
156669995|NCT01020474|565537493|FG001|Overall Study|Insufficient Clinical Response|3|||
156866450|NCT03250273|566271249|FG000|Overall Study|Death|0|||
156866451|NCT03250273|566271250|FG001|Overall Study|Death|1|||
156866452|NCT00706238|566271251|FG000|Overall Study|Disease progression|4|||
156866453|NCT00706238|566271251|FG000|Overall Study|Other|1|||
156866454|NCT00936715|566271252|FG000|Overall Study|Investigators Discretion|1|||
156866455|NCT00936715|566271252|FG000|Overall Study|Protocol Violation|1|||
156866456|NCT00936715|566271252|FG000|Overall Study|Safety or Tolerability Reasons|4|||
156866457|NCT01337960|566271255|FG000|Overall Study|Lost to Follow-up|1|||
156526247|NCT04640077|565021530|FG002|Period 1|Adverse Event|0|||
156526248|NCT04640077|565021528|FG000|Period 1|Screen Failure|2|||
156526249|NCT04640077|565021529|FG001|Period 1|Screen Failure|0|||
156526250|NCT04640077|565021530|FG002|Period 1|Screen Failure|0|||
156526251|NCT04640077|565021528|FG000|Period 2|Withdrawal by Subject|0|||
156526252|NCT04640077|565021529|FG001|Period 2|Withdrawal by Subject|0|||
156526253|NCT04640077|565021530|FG002|Period 2|Withdrawal by Subject|18|||
156526254|NCT04640077|565021528|FG000|Period 2|Adverse Event|0|||
156526255|NCT04640077|565021529|FG001|Period 2|Adverse Event|0|||
156526256|NCT04640077|565021530|FG002|Period 2|Adverse Event|6|||
156526257|NCT04640077|565021528|FG000|Period 2|Lost to Follow-up|0|||
156526258|NCT04640077|565021529|FG001|Period 2|Lost to Follow-up|0|||
156526259|NCT04640077|565021530|FG002|Period 2|Lost to Follow-up|2|||
156526260|NCT04640077|565021528|FG000|Period 2|Death|0|||
156526261|NCT04640077|565021529|FG001|Period 2|Death|0|||
156526262|NCT04640077|565021530|FG002|Period 2|Death|2|||
156526263|NCT04640077|565021528|FG000|Period 2|Progressive Disease|0|||
156526264|NCT04640077|565021529|FG001|Period 2|Progressive Disease|0|||
156526265|NCT04640077|565021530|FG002|Period 2|Progressive Disease|1|||
156526266|NCT04640077|565021528|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
156526267|NCT04640077|565021529|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
156526268|NCT04640077|565021530|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
156526269|NCT01257425|565021531|FG000|Overall Study|Lack of Efficacy|3|||
156526270|NCT01257425|565021532|FG001|Overall Study|Lack of Efficacy|3|||
156526271|NCT01257425|565021531|FG000|Overall Study|Adverse Event|1|||
156526272|NCT01257425|565021532|FG001|Overall Study|Adverse Event|1|||
156526273|NCT01257425|565021531|FG000|Overall Study|Protocol Violation|1|||
156526274|NCT01257425|565021532|FG001|Overall Study|Protocol Violation|1|||
156526275|NCT01257425|565021531|FG000|Overall Study|Withdrawal by Subject|0|||
156526276|NCT01257425|565021532|FG001|Overall Study|Withdrawal by Subject|1|||
156526277|NCT01257425|565021531|FG000|Overall Study|Death|1|||
156526278|NCT01257425|565021532|FG001|Overall Study|Death|0|||
156526279|NCT02409368|565021534|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
156526280|NCT02409368|565021535|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
156526281|NCT02409368|565021536|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
156526282|NCT02409368|565021537|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
156526283|NCT02409368|565021534|FG000|ECOG Reclassification|Death|1|||
156526284|NCT02409368|565021535|FG001|ECOG Reclassification|Death|5|||
156526285|NCT02409368|565021536|FG002|ECOG Reclassification|Death|0|||
156526286|NCT02409368|565021537|FG003|ECOG Reclassification|Death|0|||
156526287|NCT02409368|565021534|FG000|ECOG Reclassification|Disease Progression|113|||
156526288|NCT02409368|565021535|FG001|ECOG Reclassification|Disease Progression|382|||
156526289|NCT02409368|565021536|FG002|ECOG Reclassification|Disease Progression|70|||
156526290|NCT02409368|565021537|FG003|ECOG Reclassification|Disease Progression|1|||
156526291|NCT02409368|565021534|FG000|ECOG Reclassification|Lost to Follow-up|1|||
156526292|NCT02409368|565021535|FG001|ECOG Reclassification|Lost to Follow-up|5|||
156526293|NCT02409368|565021536|FG002|ECOG Reclassification|Lost to Follow-up|0|||
156526294|NCT02409368|565021537|FG003|ECOG Reclassification|Lost to Follow-up|0|||
156526295|NCT02409368|565021534|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
156526296|NCT02409368|565021535|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
156526297|NCT02409368|565021536|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
156526298|NCT02409368|565021537|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
156526299|NCT02409368|565021534|FG000|ECOG Reclassification|Poor/non-compliance|0|||
156526300|NCT02409368|565021535|FG001|ECOG Reclassification|Poor/non-compliance|3|||
156526301|NCT02409368|565021536|FG002|ECOG Reclassification|Poor/non-compliance|2|||
156526302|NCT02409368|565021537|FG003|ECOG Reclassification|Poor/non-compliance|0|||
156526303|NCT02409368|565021534|FG000|ECOG Reclassification|Study drug toxicity|17|||
156526304|NCT02409368|565021535|FG001|ECOG Reclassification|Study drug toxicity|42|||
156526305|NCT02409368|565021536|FG002|ECOG Reclassification|Study drug toxicity|7|||
156526306|NCT02409368|565021537|FG003|ECOG Reclassification|Study drug toxicity|0|||
156526307|NCT02409368|565021534|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
156526308|NCT02409368|565021535|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
156526309|NCT02409368|565021536|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
156526310|NCT02409368|565021537|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
156526311|NCT02409368|565021534|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
156526312|NCT02409368|565021535|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
156866458|NCT01337960|566271256|FG001|Overall Study|Lost to Follow-up|0|||
156866459|NCT01337960|566271257|FG002|Overall Study|Lost to Follow-up|0|||
156669996|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
156669997|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
156669998|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
156669999|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
156670000|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
156670001|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
156670002|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156670003|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156670004|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
156670005|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
156670006|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
156670007|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
156670008|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
156670009|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
156670010|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
156670011|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
156670012|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
156670013|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
156670014|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
156670015|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
156670016|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Death|0|||
156670017|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Death|1|||
156670018|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Death|0|||
156670019|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Death|0|||
156670020|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
156670021|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
156670022|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
156670023|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
156670024|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
156670025|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
156670026|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
156670027|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
156670028|NCT01940341|565537495|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
156670029|NCT01940341|565537496|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
156670030|NCT01940341|565537497|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
156670031|NCT01940341|565537498|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
156779712|NCT00313170|565943842|FG000|Overall Study|Adverse Event|1|||
156326979|NCT00760214|564297445|FG000|Overall Study|Protocol Violation|3|||
156326980|NCT00760214|564297446|FG001|Overall Study|Protocol Violation|0|||
156326981|NCT00760214|564297447|FG002|Overall Study|Protocol Violation|3|||
156326982|NCT00760214|564297445|FG000|Overall Study|Lost to Follow-up|0|||
156326983|NCT00760214|564297446|FG001|Overall Study|Lost to Follow-up|0|||
156326984|NCT00760214|564297447|FG002|Overall Study|Lost to Follow-up|1|||
156326985|NCT00760214|564297445|FG000|Overall Study|Withdrawal by Subject|12|||
156326986|NCT00760214|564297446|FG001|Overall Study|Withdrawal by Subject|14|||
156326987|NCT00760214|564297447|FG002|Overall Study|Withdrawal by Subject|13|||
156670032|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
156670033|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
156326988|NCT00760214|564297445|FG000|Overall Study|Lack of Efficacy|3|||
156326989|NCT00760214|564297446|FG001|Overall Study|Lack of Efficacy|2|||
156326990|NCT00760214|564297447|FG002|Overall Study|Lack of Efficacy|4|||
156326991|NCT00760214|564297445|FG000|Overall Study|Pregnancy|0|||
156326992|NCT00760214|564297446|FG001|Overall Study|Pregnancy|0|||
156326993|NCT00760214|564297447|FG002|Overall Study|Pregnancy|1|||
156326994|NCT00760214|564297445|FG000|Overall Study|Physician Decision|1|||
156326995|NCT00760214|564297446|FG001|Overall Study|Physician Decision|1|||
156326996|NCT00760214|564297447|FG002|Overall Study|Physician Decision|1|||
156326997|NCT00760214|564297445|FG000|Overall Study|Other|3|||
156326998|NCT00760214|564297446|FG001|Overall Study|Other|4|||
156326999|NCT00760214|564297447|FG002|Overall Study|Other|6|||
156327000|NCT00700570|564297448|FG000|Overall Study|Adverse Event|2|||
156327001|NCT00700570|564297449|FG001|Overall Study|Adverse Event|6|||
156327002|NCT00700570|564297448|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
156327003|NCT00700570|564297449|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
156327004|NCT00700570|564297448|FG000|Overall Study|Disease Progression|8|||
156327005|NCT00700570|564297449|FG001|Overall Study|Disease Progression|11|||
156327006|NCT00700570|564297448|FG000|Overall Study|Withdrawal by Subject|1|||
156327007|NCT00700570|564297449|FG001|Overall Study|Withdrawal by Subject|6|||
156327008|NCT01134315|564297450|FG000|Overall Study|Adverse Event|1|||
156670034|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
156670035|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
156670036|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
156670037|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
156670038|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
156670039|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
156670040|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
156670041|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
156670042|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
156670043|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
156670044|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
156670045|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
156670046|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
156670047|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
156670048|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
156670049|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
156670050|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
156670051|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
156670052|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
156670053|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
156670054|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
156670055|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
156670056|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
156670057|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
156670058|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
156670059|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
156670060|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
156670061|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
156670062|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
156670063|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
156670064|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
156670065|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
156670066|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
156670067|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
156670068|NCT01940341|565537495|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
156670069|NCT01940341|565537496|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
156670070|NCT01940341|565537497|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
156670071|NCT01940341|565537498|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
156670072|NCT01231906|565537499|FG000|Overall Study|Lack of Efficacy|75|||
156670073|NCT01231906|565537500|FG001|Overall Study|Lack of Efficacy|68|||
156670074|NCT01231906|565537499|FG000|Overall Study|Lost to Follow-up|1|||
156670075|NCT01231906|565537500|FG001|Overall Study|Lost to Follow-up|0|||
156670076|NCT01231906|565537499|FG000|Overall Study|Physician Decision|34|||
156670077|NCT01231906|565537500|FG001|Overall Study|Physician Decision|24|||
156670078|NCT01231906|565537499|FG000|Overall Study|Withdrawal by Subject|0|||
156670079|NCT01231906|565537500|FG001|Overall Study|Withdrawal by Subject|4|||
156670080|NCT01231906|565537499|FG000|Overall Study|Ineligible|10|||
156670081|NCT01231906|565537500|FG001|Overall Study|Ineligible|3|||
156670082|NCT01231906|565537499|FG000|Overall Study|No treatment|1|||
156670083|NCT01231906|565537500|FG001|Overall Study|No treatment|2|||
156866460|NCT01337960|566271255|FG000|Overall Study|Withdrawal by Subject|1|||
156866461|NCT01337960|566271256|FG001|Overall Study|Withdrawal by Subject|0|||
156866462|NCT01337960|566271257|FG002|Overall Study|Withdrawal by Subject|0|||
156670084|NCT05341622|565537501|FG000|Overall Study|Death|0|||
156670085|NCT05341622|565537502|FG001|Overall Study|Death|0|||
156670086|NCT05341622|565537503|FG002|Overall Study|Death|0|||
156670087|NCT05341622|565537504|FG003|Overall Study|Death|0|||
156670088|NCT05341622|565537505|FG004|Overall Study|Death|1|||
156670089|NCT05341622|565537506|FG005|Overall Study|Death|0|||
156670090|NCT05341622|565537507|FG006|Overall Study|Death|0|||
156670091|NCT05341622|565537508|FG007|Overall Study|Death|1|||
156670092|NCT05341622|565537501|FG000|Overall Study|Invalid Address|0|||
156670093|NCT05341622|565537502|FG001|Overall Study|Invalid Address|1|||
156670094|NCT05341622|565537503|FG002|Overall Study|Invalid Address|0|||
156670095|NCT05341622|565537504|FG003|Overall Study|Invalid Address|0|||
156670096|NCT05341622|565537505|FG004|Overall Study|Invalid Address|0|||
156670097|NCT05341622|565537506|FG005|Overall Study|Invalid Address|0|||
156670098|NCT05341622|565537507|FG006|Overall Study|Invalid Address|0|||
156670099|NCT05341622|565537508|FG007|Overall Study|Invalid Address|0|||
156670100|NCT05341622|565537501|FG000|Overall Study|Ineligible|26|||
156430889|NCT03354390|564666227|FG003|Level 2|Physician Decision|0|||
156670101|NCT05341622|565537502|FG001|Overall Study|Ineligible|21|||
156866463|NCT03877510|566271258|FG000|Overall Study|Death|6|||
156670102|NCT05341622|565537503|FG002|Overall Study|Ineligible|28|||
156670103|NCT05341622|565537504|FG003|Overall Study|Ineligible|24|||
156670104|NCT05341622|565537505|FG004|Overall Study|Ineligible|29|||
156670105|NCT05341622|565537506|FG005|Overall Study|Ineligible|31|||
156670106|NCT05341622|565537507|FG006|Overall Study|Ineligible|28|||
156670107|NCT05341622|565537508|FG007|Overall Study|Ineligible|26|||
156670108|NCT02658084|565537509|FG000|Overall Study|Withdrawal by Subject|1|||
156670109|NCT02658084|565537510|FG001|Overall Study|Withdrawal by Subject|0|||
156670110|NCT02658084|565537509|FG000|Overall Study|Study Termination|1|||
156670111|NCT02658084|565537510|FG001|Overall Study|Study Termination|0|||
156670112|NCT00811655|565537515|FG000|Overall Study|Physician Decision|1|||
156670113|NCT00859430|565537521|FG000|First Intervention|Withdrawal by Subject|0|||
156670114|NCT00859430|565537522|FG001|First Intervention|Withdrawal by Subject|1|||
156670115|NCT02255149|565538812|FG000|Overall Study|Lost to Follow-up|2|||
156670116|NCT02255149|565538812|FG000|Overall Study|Withdrawal by Subject|1|||
156670117|NCT02255149|565538812|FG000|Overall Study|Withdrawal by PI|1|||
156670118|NCT02255149|565538812|FG000|Overall Study|Implant Failure|1|||
156670119|NCT05604170|565538813|FG000|Overall Study|Lack of Efficacy|5|||
156670120|NCT05604170|565538813|FG000|Overall Study|Adverse Event|6|||
156670121|NCT05604170|565538813|FG000|Overall Study|Physician Decision|6|||
156670122|NCT05604170|565538813|FG000|Overall Study|Lost to Follow-up|6|||
156670123|NCT05604170|565538813|FG000|Overall Study|Withdrawal by Subject|11|||
156670124|NCT05604170|565538813|FG000|Overall Study|Early study termination by sponsor|77|||
156670125|NCT05604170|565538813|FG000|Overall Study|Other|6|||
156670126|NCT03032172|565538816|FG000|Treatment Period|Adverse Event|0|||
156670127|NCT03032172|565538817|FG001|Treatment Period|Adverse Event|1|||
156670128|NCT03032172|565538818|FG002|Treatment Period|Adverse Event|0|||
156670129|NCT03032172|565538819|FG003|Treatment Period|Adverse Event|0|||
156670130|NCT03032172|565538820|FG004|Treatment Period|Adverse Event|0|||
156670131|NCT03032172|565538821|FG005|Treatment Period|Adverse Event|0|||
156670132|NCT03032172|565538822|FG006|Treatment Period|Adverse Event|0|||
156670133|NCT03032172|565538823|FG007|Treatment Period|Adverse Event|0|||
156670134|NCT03032172|565538816|FG000|Treatment Period|Lack of Efficacy|0|||
156670135|NCT03032172|565538817|FG001|Treatment Period|Lack of Efficacy|1|||
156670136|NCT03032172|565538818|FG002|Treatment Period|Lack of Efficacy|0|||
156866464|NCT03877510|566271258|FG000|Overall Study|Lost to Follow-up|2|||
156866465|NCT03877510|566271258|FG000|Overall Study|Non-compliance with study drug|2|||
156866466|NCT03877510|566271258|FG000|Overall Study|Lack of Efficacy|14|||
156866467|NCT03877510|566271258|FG000|Overall Study|Adverse Event|20|||
156866468|NCT03877510|566271258|FG000|Overall Study|Withdrawal by Subject|22|||
156866469|NCT03877510|566271258|FG000|Overall Study|Miscellaneous|1|||
156866470|NCT03763877|566271260|FG000|Overall Study|Withdrawal by Subject|3|||
156866471|NCT03763877|566271261|FG001|Overall Study|Withdrawal by Subject|1|||
156866472|NCT03763877|566271262|FG002|Overall Study|Withdrawal by Subject|3|||
156866473|NCT03763877|566271263|FG003|Overall Study|Withdrawal by Subject|4|||
156866474|NCT03763877|566271260|FG000|Overall Study|Adverse Event|1|||
156866475|NCT03763877|566271261|FG001|Overall Study|Adverse Event|1|||
156866476|NCT03763877|566271262|FG002|Overall Study|Adverse Event|3|||
156866477|NCT03763877|566271263|FG003|Overall Study|Adverse Event|1|||
156866478|NCT03763877|566271260|FG000|Overall Study|Protocol Violation|1|||
156866479|NCT03763877|566271261|FG001|Overall Study|Protocol Violation|1|||
156866480|NCT03763877|566271262|FG002|Overall Study|Protocol Violation|0|||
156866481|NCT03763877|566271263|FG003|Overall Study|Protocol Violation|0|||
156866482|NCT03763877|566271260|FG000|Overall Study|Lost to Follow-up|0|||
156866483|NCT03763877|566271261|FG001|Overall Study|Lost to Follow-up|1|||
156866484|NCT03763877|566271262|FG002|Overall Study|Lost to Follow-up|1|||
156866485|NCT03763877|566271263|FG003|Overall Study|Lost to Follow-up|0|||
156866486|NCT03040336|566271264|FG000|Overall Study|Death|1|||
156866487|NCT03040336|566271265|FG001|Overall Study|Death|0|||
156670137|NCT03032172|565538819|FG003|Treatment Period|Lack of Efficacy|0|||
156866488|NCT03040336|566271264|FG000|Overall Study|Withdrawal by Subject|2|||
156670138|NCT03032172|565538820|FG004|Treatment Period|Lack of Efficacy|0|||
156670139|NCT03032172|565538821|FG005|Treatment Period|Lack of Efficacy|0|||
156670140|NCT03032172|565538822|FG006|Treatment Period|Lack of Efficacy|0|||
156670141|NCT03032172|565538823|FG007|Treatment Period|Lack of Efficacy|0|||
156866489|NCT03040336|566271265|FG001|Overall Study|Withdrawal by Subject|3|||
156866490|NCT01774721|566271273|FG000|Overall Study|Death|133|||
156866491|NCT01774721|566271274|FG001|Overall Study|Death|152|||
156670142|NCT03032172|565538816|FG000|Treatment Period|Non-compliance With Study Drug|0|||
156670143|NCT03032172|565538817|FG001|Treatment Period|Non-compliance With Study Drug|1|||
156670144|NCT03032172|565538818|FG002|Treatment Period|Non-compliance With Study Drug|0|||
156866492|NCT01774721|566271273|FG000|Overall Study|Withdrawal by Subject|20|||
156866493|NCT01774721|566271274|FG001|Overall Study|Withdrawal by Subject|14|||
156670145|NCT03032172|565538819|FG003|Treatment Period|Non-compliance With Study Drug|0|||
156670146|NCT03032172|565538820|FG004|Treatment Period|Non-compliance With Study Drug|0|||
156670147|NCT03032172|565538821|FG005|Treatment Period|Non-compliance With Study Drug|0|||
156670148|NCT03032172|565538822|FG006|Treatment Period|Non-compliance With Study Drug|0|||
156670149|NCT03032172|565538823|FG007|Treatment Period|Non-compliance With Study Drug|0|||
156866494|NCT01774721|566271273|FG000|Overall Study|Lost to Follow-up|6|||
156670150|NCT03032172|565538816|FG000|Treatment Period|Reason Not Specified|0|||
156670151|NCT03032172|565538817|FG001|Treatment Period|Reason Not Specified|4|||
156670152|NCT03032172|565538818|FG002|Treatment Period|Reason Not Specified|1|||
156670153|NCT03032172|565538819|FG003|Treatment Period|Reason Not Specified|0|||
156670154|NCT03032172|565538820|FG004|Treatment Period|Reason Not Specified|0|||
156670155|NCT03032172|565538821|FG005|Treatment Period|Reason Not Specified|0|||
156670156|NCT03032172|565538822|FG006|Treatment Period|Reason Not Specified|0|||
156670157|NCT03032172|565538823|FG007|Treatment Period|Reason Not Specified|0|||
156670158|NCT03032172|565538816|FG000|Treatment Period|Physician Decision|0|||
156670159|NCT03032172|565538817|FG001|Treatment Period|Physician Decision|2|||
156670160|NCT03032172|565538818|FG002|Treatment Period|Physician Decision|1|||
156670161|NCT03032172|565538819|FG003|Treatment Period|Physician Decision|0|||
156670162|NCT03032172|565538820|FG004|Treatment Period|Physician Decision|0|||
156670163|NCT03032172|565538821|FG005|Treatment Period|Physician Decision|0|||
156670164|NCT03032172|565538822|FG006|Treatment Period|Physician Decision|0|||
156670165|NCT03032172|565538823|FG007|Treatment Period|Physician Decision|0|||
156670166|NCT03032172|565538816|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
156670167|NCT03032172|565538817|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
156670168|NCT03032172|565538818|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
156670169|NCT03032172|565538819|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
156670170|NCT03032172|565538820|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
156670171|NCT03032172|565538821|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
156670172|NCT03032172|565538822|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
156670173|NCT03032172|565538823|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
156670174|NCT03032172|565538816|FG000|Treatment Period|Withdrawal by Subject|2|||
156670175|NCT03032172|565538817|FG001|Treatment Period|Withdrawal by Subject|0|||
156327009|NCT01134315|564297451|FG001|Overall Study|Adverse Event|2|||
156670176|NCT03032172|565538818|FG002|Treatment Period|Withdrawal by Subject|3|||
156526313|NCT02409368|565021536|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
156526314|NCT02409368|565021537|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
156526315|NCT02409368|565021534|FG000|ECOG Reclassification|Participant withdrew consent|2|||
156526316|NCT02409368|565021535|FG001|ECOG Reclassification|Participant withdrew consent|3|||
156526317|NCT02409368|565021536|FG002|ECOG Reclassification|Participant withdrew consent|4|||
156526318|NCT02409368|565021537|FG003|ECOG Reclassification|Participant withdrew consent|0|||
156526319|NCT02409368|565021534|FG000|ECOG Reclassification|Other Reasons|5|||
156526320|NCT02409368|565021535|FG001|ECOG Reclassification|Other Reasons|26|||
156526321|NCT02409368|565021536|FG002|ECOG Reclassification|Other Reasons|2|||
156526322|NCT02409368|565021537|FG003|ECOG Reclassification|Other Reasons|0|||
156526323|NCT02409368|565021534|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
156526324|NCT02409368|565021535|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
156526325|NCT02409368|565021536|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
156526326|NCT02409368|565021537|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
156526327|NCT01296347|565021539|FG000|Allocation|Withdrawal by Subject|1|||
156526328|NCT01296347|565021540|FG001|Allocation|Withdrawal by Subject|2|||
156526329|NCT01296347|565021539|FG000|Allocation|Lack of Efficacy|1|||
156526330|NCT01296347|565021540|FG001|Allocation|Lack of Efficacy|2|||
156526331|NCT01296347|565021539|FG000|Allocation|not received infusion|1|||
156526332|NCT01296347|565021540|FG001|Allocation|not received infusion|0|||
156526333|NCT01296347|565021539|FG000|6 Week Follow up|Death|0|||
156526334|NCT01296347|565021540|FG001|6 Week Follow up|Death|1|||
156526335|NCT01296347|565021539|FG000|3 Month Follow up|Death|1|||
156526336|NCT01296347|565021540|FG001|3 Month Follow up|Death|0|||
156526337|NCT01296347|565021539|FG000|3 Month Follow up|Lost to Follow-up|0|||
156526338|NCT01296347|565021540|FG001|3 Month Follow up|Lost to Follow-up|1|||
156526339|NCT01296347|565021539|FG000|6 Month Follow up|Death|2|||
156526340|NCT01296347|565021540|FG001|6 Month Follow up|Death|1|||
156526341|NCT01296347|565021539|FG000|6 Month Follow up|Lost to Follow-up|0|||
156526342|NCT01296347|565021540|FG001|6 Month Follow up|Lost to Follow-up|1|||
156526343|NCT01296347|565021539|FG000|12 Month Follow up|Lost to Follow-up|3|||
156526344|NCT01296347|565021540|FG001|12 Month Follow up|Lost to Follow-up|1|||
156526345|NCT01296347|565021539|FG000|12 Month Follow up|Death|1|||
156526346|NCT01296347|565021540|FG001|12 Month Follow up|Death|1|||
156526347|NCT01296347|565021539|FG000|12 Month Follow up|Withdrawal by Subject|0|||
156327010|NCT01134315|564297450|FG000|Overall Study|Other Reason|8|||
156526348|NCT01296347|565021540|FG001|12 Month Follow up|Withdrawal by Subject|1|||
156526349|NCT02240693|565021541|FG000|Overall Study|Adverse Event|0|||
156526350|NCT02240693|565021542|FG001|Overall Study|Adverse Event|0|||
156526351|NCT02240693|565021543|FG002|Overall Study|Adverse Event|0|||
156526352|NCT02240693|565021544|FG003|Overall Study|Adverse Event|0|||
156526353|NCT02240693|565021545|FG004|Overall Study|Adverse Event|1|||
156327011|NCT01134315|564297451|FG001|Overall Study|Other Reason|17|||
156526354|NCT02240693|565021541|FG000|Overall Study|Withdrawal by Subject|0|||
156526355|NCT02240693|565021542|FG001|Overall Study|Withdrawal by Subject|0|||
156526356|NCT02240693|565021543|FG002|Overall Study|Withdrawal by Subject|2|||
156526357|NCT02240693|565021544|FG003|Overall Study|Withdrawal by Subject|1|||
156526358|NCT02240693|565021545|FG004|Overall Study|Withdrawal by Subject|0|||
156526359|NCT02240693|565021541|FG000|Overall Study|Other than specified|0|||
156526360|NCT02240693|565021542|FG001|Overall Study|Other than specified|0|||
156526361|NCT02240693|565021543|FG002|Overall Study|Other than specified|2|||
156526362|NCT02240693|565021544|FG003|Overall Study|Other than specified|0|||
156526363|NCT02240693|565021545|FG004|Overall Study|Other than specified|0|||
156526364|NCT03343301|565021546|FG000|Overall Study|Withdrawal by Subject|1|||
156526365|NCT03343301|565021547|FG001|Overall Study|Withdrawal by Subject|1|||
156526366|NCT03343301|565021546|FG000|Overall Study|Death|0|||
156526367|NCT03343301|565021547|FG001|Overall Study|Death|2|||
156526368|NCT03343301|565021546|FG000|Overall Study|Other|0|||
156526369|NCT03343301|565021547|FG001|Overall Study|Other|6|||
156526370|NCT03343301|565021546|FG000|Overall Study|Missing|2|||
156526371|NCT03343301|565021547|FG001|Overall Study|Missing|0|||
156670177|NCT03032172|565538819|FG003|Treatment Period|Withdrawal by Subject|0|||
156670178|NCT03032172|565538820|FG004|Treatment Period|Withdrawal by Subject|0|||
156670179|NCT03032172|565538821|FG005|Treatment Period|Withdrawal by Subject|0|||
156670180|NCT03032172|565538822|FG006|Treatment Period|Withdrawal by Subject|0|||
156670181|NCT03032172|565538823|FG007|Treatment Period|Withdrawal by Subject|0|||
156670182|NCT03032172|565538816|FG000|Open-label Extension Period|Death|0|||
156670183|NCT03032172|565538817|FG001|Open-label Extension Period|Death|0|||
156670184|NCT03032172|565538818|FG002|Open-label Extension Period|Death|0|||
156670185|NCT03032172|565538819|FG003|Open-label Extension Period|Death|0|||
156670186|NCT03032172|565538820|FG004|Open-label Extension Period|Death|0|||
156670187|NCT03032172|565538821|FG005|Open-label Extension Period|Death|0|||
156670188|NCT03032172|565538822|FG006|Open-label Extension Period|Death|0|||
156670189|NCT03032172|565538823|FG007|Open-label Extension Period|Death|2|||
156670190|NCT03032172|565538816|FG000|Open-label Extension Period|Reason Not Specified|0|||
156670191|NCT03032172|565538817|FG001|Open-label Extension Period|Reason Not Specified|0|||
156670192|NCT03032172|565538818|FG002|Open-label Extension Period|Reason Not Specified|0|||
156670193|NCT03032172|565538819|FG003|Open-label Extension Period|Reason Not Specified|0|||
156526372|NCT02668185|565021550|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
156526373|NCT02668185|565021551|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
156526374|NCT02668185|565021550|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
156526375|NCT02668185|565021551|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
156526376|NCT02668185|565021550|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
156526377|NCT02668185|565021551|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
156526378|NCT02668185|565021550|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
156526379|NCT02668185|565021551|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
156526380|NCT01013597|565021552|FG000|Overall Study|Withdrawal by Subject|1|||
156526381|NCT00427895|565021553|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
156526382|NCT00427895|565021554|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
156526383|NCT00427895|565021555|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
156526384|NCT00427895|565021556|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
156526385|NCT00427895|565021557|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
156526386|NCT00427895|565021558|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
156526387|NCT00427895|565021559|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
156327012|NCT04587271|564297452|FG000|Overall Study|Lost to Follow-up|2|||
156327013|NCT04587271|564297453|FG001|Overall Study|Lost to Follow-up|2|||
156327014|NCT04587271|564297454|FG002|Overall Study|Lost to Follow-up|0|||
156327015|NCT04587271|564297455|FG003|Overall Study|Lost to Follow-up|2|||
156327016|NCT04587271|564297456|FG004|Overall Study|Lost to Follow-up|2|||
156327017|NCT04587271|564297457|FG005|Overall Study|Lost to Follow-up|0|||
156327018|NCT04587271|564297452|FG000|Overall Study|Caregiver brought child to visits|0|||
156327019|NCT04587271|564297453|FG001|Overall Study|Caregiver brought child to visits|0|||
156670194|NCT03032172|565538820|FG004|Open-label Extension Period|Reason Not Specified|0|||
156670195|NCT03032172|565538821|FG005|Open-label Extension Period|Reason Not Specified|5|||
156670196|NCT03032172|565538822|FG006|Open-label Extension Period|Reason Not Specified|3|||
156670197|NCT03032172|565538823|FG007|Open-label Extension Period|Reason Not Specified|0|||
156866495|NCT01774721|566271274|FG001|Overall Study|Lost to Follow-up|7|||
156526388|NCT00427895|565021560|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
156526389|NCT00427895|565021553|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156526390|NCT00427895|565021554|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156526391|NCT00427895|565021555|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156526392|NCT00427895|565021556|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156526393|NCT00427895|565021557|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156526394|NCT00427895|565021558|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156670198|NCT03032172|565538816|FG000|Open-label Extension Period|Pregnancy|0|||
156670199|NCT03032172|565538817|FG001|Open-label Extension Period|Pregnancy|0|||
156866496|NCT01774721|566271273|FG000|Overall Study|Did not meet eligibility criteria|0|||
156670200|NCT03032172|565538818|FG002|Open-label Extension Period|Pregnancy|0|||
156670201|NCT03032172|565538819|FG003|Open-label Extension Period|Pregnancy|0|||
156670202|NCT03032172|565538820|FG004|Open-label Extension Period|Pregnancy|0|||
156670203|NCT03032172|565538821|FG005|Open-label Extension Period|Pregnancy|0|||
156670204|NCT03032172|565538822|FG006|Open-label Extension Period|Pregnancy|1|||
156670205|NCT03032172|565538823|FG007|Open-label Extension Period|Pregnancy|0|||
156670206|NCT03032172|565538816|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
156670207|NCT03032172|565538817|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
156670208|NCT03032172|565538818|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
156670209|NCT03032172|565538819|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
156670210|NCT03032172|565538820|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
156670211|NCT03032172|565538821|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
156670212|NCT03032172|565538822|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
156670213|NCT03032172|565538823|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
156670214|NCT03600805|565538829|FG000|Overall Study|Adverse Event|2|||
156670215|NCT03600805|565538830|FG001|Overall Study|Adverse Event|1|||
156670216|NCT03600805|565538831|FG002|Overall Study|Adverse Event|1|||
156670217|NCT03600805|565538832|FG003|Overall Study|Adverse Event|7|||
156670218|NCT03600805|565538829|FG000|Overall Study|Lack of Efficacy|2|||
156670219|NCT03600805|565538830|FG001|Overall Study|Lack of Efficacy|1|||
156670220|NCT03600805|565538831|FG002|Overall Study|Lack of Efficacy|0|||
156670221|NCT03600805|565538832|FG003|Overall Study|Lack of Efficacy|0|||
156670222|NCT03600805|565538829|FG000|Overall Study|Withdrawal by Subject|1|||
156670223|NCT03600805|565538830|FG001|Overall Study|Withdrawal by Subject|0|||
156670224|NCT03600805|565538831|FG002|Overall Study|Withdrawal by Subject|0|||
156670225|NCT03600805|565538832|FG003|Overall Study|Withdrawal by Subject|1|||
156670226|NCT03600805|565538829|FG000|Overall Study|Other unspecified|14|||
156670227|NCT03600805|565538830|FG001|Overall Study|Other unspecified|6|||
156670228|NCT03600805|565538831|FG002|Overall Study|Other unspecified|7|||
156670229|NCT03600805|565538832|FG003|Overall Study|Other unspecified|11|||
156670230|NCT01471353|565538837|FG000|Overall Study|remain on study|3|||
156670231|NCT03123094|565538838|FG000|Overall Study|Withdrawal by Subject|0|||
156670232|NCT03123094|565538839|FG001|Overall Study|Withdrawal by Subject|2|||
156670233|NCT03123094|565538840|FG002|Overall Study|Withdrawal by Subject|1|||
156670234|NCT03123094|565538841|FG003|Overall Study|Withdrawal by Subject|0|||
156670235|NCT03123094|565538842|FG004|Overall Study|Withdrawal by Subject|1|||
156670236|NCT00604162|565538843|FG000|Overall Study|Physician Decision|3|||
156670237|NCT00604162|565538843|FG000|Overall Study|Withdrawal by Subject|1|||
156670238|NCT00736190|565538850|FG000|Overall Study|Pregnancy|1|||
156670239|NCT00736190|565538850|FG000|Overall Study|Withdrawal by Subject|1|||
156670240|NCT00736190|565538850|FG000|Overall Study|Adverse Event|1|||
156670241|NCT05014828|565538851|FG000|Overall Study|Study Completed by Sponsor|16|||
156670242|NCT05014828|565538852|FG001|Overall Study|Study Completed by Sponsor|16|||
156670243|NCT05014828|565538853|FG002|Overall Study|Study Completed by Sponsor|3|||
156670244|NCT05014828|565538854|FG003|Overall Study|Study Completed by Sponsor|3|||
156670245|NCT05014828|565538851|FG000|Overall Study|Death|11|||
156670246|NCT05014828|565538852|FG001|Overall Study|Death|6|||
156670247|NCT05014828|565538853|FG002|Overall Study|Death|0|||
156670248|NCT05014828|565538854|FG003|Overall Study|Death|0|||
156670249|NCT05014828|565538851|FG000|Overall Study|Lost to Follow-up|0|||
156670250|NCT05014828|565538852|FG001|Overall Study|Lost to Follow-up|0|||
156670251|NCT05014828|565538853|FG002|Overall Study|Lost to Follow-up|2|||
156670252|NCT05014828|565538854|FG003|Overall Study|Lost to Follow-up|0|||
156670253|NCT05014828|565538851|FG000|Overall Study|Miscellaneous.|0|||
156670254|NCT05014828|565538852|FG001|Overall Study|Miscellaneous.|1|||
156670255|NCT05014828|565538853|FG002|Overall Study|Miscellaneous.|0|||
156670256|NCT05014828|565538854|FG003|Overall Study|Miscellaneous.|0|||
156670257|NCT02682238|565538858|FG000|Overall Study|Lost to Follow-up|0|||
156670258|NCT02682238|565538859|FG001|Overall Study|Lost to Follow-up|2|||
156670259|NCT02682238|565538858|FG000|Overall Study|Withdrawal by Subject|1|||
156670260|NCT02682238|565538859|FG001|Overall Study|Withdrawal by Subject|0|||
156670261|NCT02682238|565538858|FG000|Overall Study|Adverse Event|1|||
156670262|NCT02682238|565538859|FG001|Overall Study|Adverse Event|0|||
156670263|NCT02682238|565538858|FG000|Overall Study|Non-compliance with Study Drug|1|||
156670264|NCT02682238|565538859|FG001|Overall Study|Non-compliance with Study Drug|0|||
156670265|NCT02682238|565538858|FG000|Overall Study|Non-compliance with Protocol|0|||
156670266|NCT02682238|565538859|FG001|Overall Study|Non-compliance with Protocol|2|||
156670267|NCT01370317|565538860|FG000|Overall Study|Participant withdrew consent|1|||
156670268|NCT01370317|565538861|FG001|Overall Study|Participant withdrew consent|0|||
156866497|NCT01774721|566271274|FG001|Overall Study|Did not meet eligibility criteria|3|||
156670269|NCT01370317|565538860|FG000|Overall Study|Protocol deviation|0|||
156670270|NCT01370317|565538861|FG001|Overall Study|Protocol deviation|1|||
156670271|NCT00075478|565538863|FG000|Overall Study|not eligible|1|||
156670272|NCT00075478|565538864|FG001|Overall Study|not eligible|0|||
156670273|NCT00075478|565538863|FG000|Overall Study|Physician Decision|0|||
156670274|NCT00075478|565538864|FG001|Overall Study|Physician Decision|1|||
156670275|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
156670276|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
156670277|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
156670278|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
156670279|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
156670280|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
156670281|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
156670282|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
156670283|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
156670284|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
156670285|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
156670286|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
156779713|NCT00313170|565943843|FG001|Overall Study|Adverse Event|2|||
156779714|NCT00313170|565943844|FG002|Overall Study|Adverse Event|0|||
156779715|NCT00313170|565943842|FG000|Overall Study|Disease progression|31|||
156779716|NCT00313170|565943843|FG001|Overall Study|Disease progression|26|||
156779717|NCT00313170|565943844|FG002|Overall Study|Disease progression|27|||
156779718|NCT00313170|565943842|FG000|Overall Study|Withdrawal by Subject|1|||
156779719|NCT00313170|565943843|FG001|Overall Study|Withdrawal by Subject|0|||
156779720|NCT00313170|565943844|FG002|Overall Study|Withdrawal by Subject|1|||
156779721|NCT00313170|565943842|FG000|Overall Study|Incorrect enrollment|0|||
156779722|NCT00313170|565943843|FG001|Overall Study|Incorrect enrollment|2|||
156779723|NCT00313170|565943844|FG002|Overall Study|Incorrect enrollment|1|||
156779724|NCT00313170|565943842|FG000|Overall Study|Lost to Follow-up|0|||
156779725|NCT00313170|565943843|FG001|Overall Study|Lost to Follow-up|0|||
156779726|NCT00313170|565943844|FG002|Overall Study|Lost to Follow-up|1|||
156779727|NCT00313170|565943842|FG000|Overall Study|Progression (investigators opinion)|1|||
156779728|NCT00313170|565943843|FG001|Overall Study|Progression (investigators opinion)|0|||
156779729|NCT00313170|565943844|FG002|Overall Study|Progression (investigators opinion)|0|||
156779730|NCT02827708|565943845|FG000|Overall Study|Lost to Follow-up|3|||
156779731|NCT02827708|565943846|FG001|Overall Study|Lost to Follow-up|1|||
156779732|NCT02827708|565943845|FG000|Overall Study|Withdrawal by Subject|1|||
156779733|NCT02827708|565943846|FG001|Overall Study|Withdrawal by Subject|2|||
156779734|NCT02827708|565943845|FG000|Overall Study|Death|1|||
156779735|NCT02827708|565943846|FG001|Overall Study|Death|2|||
156779736|NCT00407511|565943847|FG000|Overall Study|Adverse Event|9|||
156779737|NCT00407511|565943847|FG000|Overall Study|Lost to Follow-up|4|||
156779738|NCT00407511|565943847|FG000|Overall Study|Other|5|||
156779739|NCT00407511|565943847|FG000|Overall Study|Withdrawal by Subject|4|||
156779740|NCT01521364|565943848|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
156779741|NCT01521364|565943848|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
156779742|NCT02636283|565943849|FG000|Overall Study|Adverse Event|2|||
156779743|NCT02636283|565943850|FG001|Overall Study|Adverse Event|0|||
156779744|NCT02636283|565943849|FG000|Overall Study|Trial Terminated Prematurely|0|||
156779745|NCT02636283|565943850|FG001|Overall Study|Trial Terminated Prematurely|3|||
156779746|NCT03418675|565943851|FG000|Overall Study|Lost to Follow-up|13|||
156779747|NCT03418675|565943852|FG001|Overall Study|Lost to Follow-up|10|||
156779748|NCT03418675|565943851|FG000|Overall Study|Adverse Event|2|||
156779749|NCT03418675|565943852|FG001|Overall Study|Adverse Event|0|||
156779750|NCT01879852|565943853|FG000|Overall Study|Withdrawal by Subject|2|||
156779751|NCT01879852|565943854|FG001|Overall Study|Withdrawal by Subject|0|||
156779752|NCT02115386|565943855|FG000|Overall Study|Protocol Violation|1|||
156779753|NCT02115386|565943855|FG000|Overall Study|Administrative - trial was terminated|6|||
156779754|NCT04398134|565943860|FG000|Overall Study|Adverse Event|0|||
156779755|NCT04398134|565943861|FG001|Overall Study|Adverse Event|0|||
156779756|NCT04398134|565943862|FG002|Overall Study|Adverse Event|1|||
156779757|NCT04398134|565943863|FG003|Overall Study|Adverse Event|0|||
156779758|NCT04398134|565943860|FG000|Overall Study|Withdrawal by Subject|2|||
156779759|NCT04398134|565943861|FG001|Overall Study|Withdrawal by Subject|0|||
156779760|NCT04398134|565943862|FG002|Overall Study|Withdrawal by Subject|0|||
156779761|NCT04398134|565943863|FG003|Overall Study|Withdrawal by Subject|1|||
156779762|NCT04398134|565943860|FG000|Overall Study|Study Terminated by Sponsor|30|||
156779763|NCT04398134|565943861|FG001|Overall Study|Study Terminated by Sponsor|11|||
156779764|NCT04398134|565943862|FG002|Overall Study|Study Terminated by Sponsor|32|||
156779765|NCT04398134|565943863|FG003|Overall Study|Study Terminated by Sponsor|11|||
156779766|NCT05513950|565943866|FG000|Overall Study|Not treated due to technical reasons|0|||
156779767|NCT05513950|565943867|FG001|Overall Study|Not treated due to technical reasons|0|||
156779768|NCT05513950|565943868|FG002|Overall Study|Not treated due to technical reasons|1|||
156779769|NCT05513950|565943869|FG003|Overall Study|Not treated due to technical reasons|0|||
156779770|NCT00221104|565943872|FG000|Overall Study|Adverse Event|1|||
156779771|NCT00221104|565943873|FG001|Overall Study|Adverse Event|0|||
156779772|NCT00221104|565943872|FG000|Overall Study|Physician Decision|1|||
156779773|NCT00221104|565943873|FG001|Overall Study|Physician Decision|0|||
156779774|NCT00221104|565943872|FG000|Overall Study|Protocol Violation|2|||
156779775|NCT00221104|565943873|FG001|Overall Study|Protocol Violation|0|||
156779776|NCT00221104|565943872|FG000|Overall Study|Withdrawal by Subject|42|||
156670287|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
156670288|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
156670289|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
156670290|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
156670291|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
156670292|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
156670293|NCT01667679|565538868|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
156670294|NCT01667679|565538869|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
156670295|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
156670296|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
156670297|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
156670298|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
156670299|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
156670300|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
156670301|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
156670302|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
156670303|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
156670304|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
156670305|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
156670306|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
156670307|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
156670308|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
156670309|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
156670310|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
156670311|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
156670312|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
156670313|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
156670314|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
156670315|NCT01667679|565538868|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
156670316|NCT01667679|565538869|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
156670317|NCT03249454|565538874|FG000|Overall Study|Withdrawal by Subject|0|||
156670318|NCT03249454|565538875|FG001|Overall Study|Withdrawal by Subject|0|||
156670319|NCT03249454|565538876|FG002|Overall Study|Withdrawal by Subject|0|||
156670320|NCT03249454|565538877|FG003|Overall Study|Withdrawal by Subject|0|||
156670321|NCT03249454|565538878|FG004|Overall Study|Withdrawal by Subject|0|||
156670322|NCT03249454|565538879|FG005|Overall Study|Withdrawal by Subject|0|||
156670323|NCT03249454|565538880|FG006|Overall Study|Withdrawal by Subject|0|||
156670324|NCT03249454|565538881|FG007|Overall Study|Withdrawal by Subject|0|||
156670325|NCT03249454|565538882|FG008|Overall Study|Withdrawal by Subject|0|||
156670326|NCT03249454|565538883|FG009|Overall Study|Withdrawal by Subject|1|||
156670327|NCT03249454|565538884|FG010|Overall Study|Withdrawal by Subject|1|||
156670328|NCT01103713|565538885|FG000|Overall Study|Lost to Follow-up|2|||
156670329|NCT01103713|565538885|FG000|Overall Study|Withdrawal by Subject|8|||
156670330|NCT01103713|565538885|FG000|Overall Study|Study terminated by sponsor|2|||
156670331|NCT01103713|565538885|FG000|Overall Study|Other|1|||
156670332|NCT02645409|565538886|FG000|Overall Study|Withdrawal by Subject|3|||
156670333|NCT02645409|565538887|FG001|Overall Study|Withdrawal by Subject|0|||
156670334|NCT02645409|565538886|FG000|Overall Study|Physician Decision|1|||
156670335|NCT02645409|565538887|FG001|Overall Study|Physician Decision|0|||
156670336|NCT02089685|565538888|FG000|Overall Study|Adverse Event|1|||
156670337|NCT02089685|565538889|FG001|Overall Study|Adverse Event|0|||
156670338|NCT02089685|565538890|FG002|Overall Study|Adverse Event|0|||
156670339|NCT02089685|565538891|FG003|Overall Study|Adverse Event|0|||
156670340|NCT02089685|565538892|FG004|Overall Study|Adverse Event|1|||
156670341|NCT02089685|565538893|FG005|Overall Study|Adverse Event|0|||
156670342|NCT02089685|565538888|FG000|Overall Study|Clinical Progression|4|||
156670343|NCT02089685|565538889|FG001|Overall Study|Clinical Progression|0|||
156670344|NCT02089685|565538890|FG002|Overall Study|Clinical Progression|0|||
156670345|NCT02089685|565538891|FG003|Overall Study|Clinical Progression|5|||
156670346|NCT02089685|565538892|FG004|Overall Study|Clinical Progression|1|||
156670347|NCT02089685|565538893|FG005|Overall Study|Clinical Progression|2|||
156327020|NCT04587271|564297454|FG002|Overall Study|Caregiver brought child to visits|0|||
156670348|NCT02089685|565538888|FG000|Overall Study|Excluded Medication|1|||
156670349|NCT02089685|565538889|FG001|Overall Study|Excluded Medication|0|||
156670350|NCT02089685|565538890|FG002|Overall Study|Excluded Medication|0|||
156779777|NCT00221104|565943873|FG001|Overall Study|Withdrawal by Subject|29|||
156327021|NCT04587271|564297455|FG003|Overall Study|Caregiver brought child to visits|1|||
156327022|NCT04587271|564297456|FG004|Overall Study|Caregiver brought child to visits|0|||
156670351|NCT02089685|565538891|FG003|Overall Study|Excluded Medication|11|||
156670352|NCT02089685|565538892|FG004|Overall Study|Excluded Medication|2|||
156670353|NCT02089685|565538893|FG005|Overall Study|Excluded Medication|1|||
156670354|NCT02089685|565538888|FG000|Overall Study|Progressive disease|13|||
156670355|NCT02089685|565538889|FG001|Overall Study|Progressive disease|10|||
156670356|NCT02089685|565538890|FG002|Overall Study|Progressive disease|3|||
156670357|NCT02089685|565538891|FG003|Overall Study|Progressive disease|51|||
156670358|NCT02089685|565538892|FG004|Overall Study|Progressive disease|17|||
156670359|NCT02089685|565538893|FG005|Overall Study|Progressive disease|12|||
156670360|NCT02089685|565538888|FG000|Overall Study|Follow up ended by sponsor|2|||
156670361|NCT02089685|565538889|FG001|Overall Study|Follow up ended by sponsor|2|||
156670362|NCT02089685|565538890|FG002|Overall Study|Follow up ended by sponsor|0|||
156670363|NCT02089685|565538891|FG003|Overall Study|Follow up ended by sponsor|70|||
156670364|NCT02089685|565538892|FG004|Overall Study|Follow up ended by sponsor|26|||
156670365|NCT02089685|565538893|FG005|Overall Study|Follow up ended by sponsor|26|||
156670366|NCT02089685|565538888|FG000|Overall Study|Withdrawal by Subject|0|||
156670367|NCT02089685|565538889|FG001|Overall Study|Withdrawal by Subject|2|||
156670368|NCT02089685|565538890|FG002|Overall Study|Withdrawal by Subject|0|||
156670369|NCT02089685|565538891|FG003|Overall Study|Withdrawal by Subject|8|||
156670370|NCT02089685|565538892|FG004|Overall Study|Withdrawal by Subject|1|||
156670371|NCT02089685|565538893|FG005|Overall Study|Withdrawal by Subject|1|||
156670372|NCT02089685|565538888|FG000|Overall Study|Status not recorded|1|||
156670373|NCT02089685|565538889|FG001|Overall Study|Status not recorded|0|||
156670374|NCT02089685|565538890|FG002|Overall Study|Status not recorded|0|||
156670375|NCT02089685|565538891|FG003|Overall Study|Status not recorded|0|||
156670376|NCT02089685|565538892|FG004|Overall Study|Status not recorded|1|||
156670377|NCT02089685|565538893|FG005|Overall Study|Status not recorded|0|||
156670378|NCT02089685|565538888|FG000|Overall Study|Death|0|||
156866498|NCT01774721|566271273|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
156866499|NCT01774721|566271274|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
156670379|NCT02089685|565538889|FG001|Overall Study|Death|0|||
156670380|NCT02089685|565538890|FG002|Overall Study|Death|0|||
156670381|NCT02089685|565538891|FG003|Overall Study|Death|7|||
156670382|NCT02089685|565538892|FG004|Overall Study|Death|2|||
156670383|NCT02089685|565538893|FG005|Overall Study|Death|5|||
156670384|NCT02089685|565538888|FG000|Overall Study|Lost to Follow-up|0|||
156670385|NCT02089685|565538889|FG001|Overall Study|Lost to Follow-up|0|||
156670386|NCT02089685|565538890|FG002|Overall Study|Lost to Follow-up|0|||
156670387|NCT02089685|565538891|FG003|Overall Study|Lost to Follow-up|1|||
156670388|NCT02089685|565538892|FG004|Overall Study|Lost to Follow-up|0|||
156670389|NCT02089685|565538893|FG005|Overall Study|Lost to Follow-up|0|||
156670390|NCT02089685|565538888|FG000|Overall Study|Physician Decision|0|||
156670391|NCT02089685|565538889|FG001|Overall Study|Physician Decision|0|||
156670392|NCT02089685|565538890|FG002|Overall Study|Physician Decision|0|||
156670393|NCT02089685|565538891|FG003|Overall Study|Physician Decision|0|||
156670394|NCT02089685|565538892|FG004|Overall Study|Physician Decision|0|||
156670395|NCT02089685|565538893|FG005|Overall Study|Physician Decision|4|||
156670396|NCT02089685|565538888|FG000|Overall Study|Screen failure|1|||
156670397|NCT02089685|565538889|FG001|Overall Study|Screen failure|0|||
156670398|NCT02089685|565538890|FG002|Overall Study|Screen failure|0|||
156670399|NCT02089685|565538891|FG003|Overall Study|Screen failure|0|||
156670400|NCT02089685|565538892|FG004|Overall Study|Screen failure|0|||
156670401|NCT02089685|565538893|FG005|Overall Study|Screen failure|0|||
156670402|NCT03552393|565538896|FG000|Core Period|Kidney Transplant|1|||
156866500|NCT01774721|566271273|FG000|Overall Study|Study terminated by sponsor|5|||
156866501|NCT01774721|566271274|FG001|Overall Study|Study terminated by sponsor|0|||
156866502|NCT01774721|566271273|FG000|Overall Study|Disease progression|5|||
156866503|NCT01774721|566271274|FG001|Overall Study|Disease progression|0|||
156866504|NCT02282605|566271275|FG000|Overall Study|negative SA result on Day -1|3|||
156670403|NCT03552393|565538896|FG000|Core Period|Prohibited Medication|1|||
156670404|NCT03552393|565538896|FG000|Safety Extension Period|Kidney Transplant|4|||
156670405|NCT04887415|565538899|FG000|Overall Study|Lost to Follow-up|2|||
156670406|NCT05646251|565538900|FG000|Overall Study|Physician Decision|1|||
156670407|NCT05646251|565538901|FG001|Overall Study|Physician Decision|0|||
156670408|NCT05646251|565538902|FG002|Overall Study|Physician Decision|2|||
156670409|NCT01249651|565538906|FG000|Overall Study|Withdrawal by Subject|4|||
156670410|NCT01249651|565538906|FG000|Overall Study|Adverse Event|1|||
156670411|NCT01249651|565538906|FG000|Overall Study|Protocol Violation|1|||
156670412|NCT01249651|565538906|FG000|Overall Study|Sponsor Decision|1|||
156670413|NCT00813592|565538907|FG000|Overall Study|Disease assessment was not completed per|2|||
156670414|NCT01588236|565538912|FG000|Overall Study|Adverse Event|5|||
156670415|NCT01588236|565538913|FG001|Overall Study|Adverse Event|4|||
156670416|NCT01588236|565538914|FG002|Overall Study|Adverse Event|1|||
156670417|NCT01588236|565538912|FG000|Overall Study|Lost to Follow-up|8|||
156430890|NCT03354390|564666224|FG000|Level 2|Lack of Efficacy|0|||
156670418|NCT01588236|565538913|FG001|Overall Study|Lost to Follow-up|13|||
156670419|NCT01588236|565538914|FG002|Overall Study|Lost to Follow-up|6|||
156670420|NCT01588236|565538912|FG000|Overall Study|Physician Decision|1|||
156670421|NCT01588236|565538913|FG001|Overall Study|Physician Decision|2|||
156670422|NCT01588236|565538914|FG002|Overall Study|Physician Decision|0|||
156670423|NCT01588236|565538912|FG000|Overall Study|Protocol Violation|0|||
156670424|NCT01588236|565538913|FG001|Overall Study|Protocol Violation|1|||
156670425|NCT01588236|565538914|FG002|Overall Study|Protocol Violation|1|||
156670426|NCT01588236|565538912|FG000|Overall Study|Withdrawal by Subject|14|||
156670427|NCT01588236|565538913|FG001|Overall Study|Withdrawal by Subject|16|||
156670428|NCT01588236|565538914|FG002|Overall Study|Withdrawal by Subject|18|||
156670429|NCT01588236|565538912|FG000|Overall Study|Exclusion Criteria met during study|2|||
156670430|NCT01588236|565538913|FG001|Overall Study|Exclusion Criteria met during study|1|||
156670431|NCT01588236|565538914|FG002|Overall Study|Exclusion Criteria met during study|0|||
156670432|NCT01588236|565538912|FG000|Overall Study|sponsor decision|1|||
156670433|NCT01588236|565538913|FG001|Overall Study|sponsor decision|6|||
156670434|NCT01588236|565538914|FG002|Overall Study|sponsor decision|2|||
156670435|NCT03873272|565538915|FG000|Overall Study|Withdrawal by Subject|2|||
156670436|NCT03873272|565538916|FG001|Overall Study|Withdrawal by Subject|0|||
156670437|NCT03873272|565538917|FG002|Overall Study|Withdrawal by Subject|1|||
156670438|NCT03873272|565538915|FG000|Overall Study|Death|0|||
156670439|NCT03873272|565538916|FG001|Overall Study|Death|2|||
156670440|NCT03873272|565538917|FG002|Overall Study|Death|1|||
156670441|NCT00787254|565538918|FG000|Overall Study|Adverse Event|24|||
156670442|NCT00787254|565538919|FG001|Overall Study|Adverse Event|23|||
156670443|NCT00787254|565538918|FG000|Overall Study|Protocol Violation|26|||
156670444|NCT00787254|565538919|FG001|Overall Study|Protocol Violation|23|||
156670445|NCT00787254|565538918|FG000|Overall Study|Withdrawal by Subject|16|||
156670446|NCT00787254|565538919|FG001|Overall Study|Withdrawal by Subject|11|||
156670447|NCT00787254|565538918|FG000|Overall Study|Lack of Efficacy|4|||
156670448|NCT00787254|565538919|FG001|Overall Study|Lack of Efficacy|15|||
156670449|NCT00787254|565538918|FG000|Overall Study|NSAIDs discontinuation|1|||
156670450|NCT00787254|565538919|FG001|Overall Study|NSAIDs discontinuation|2|||
156670451|NCT00787254|565538918|FG000|Overall Study|Institution closed|1|||
156670452|NCT00787254|565538919|FG001|Overall Study|Institution closed|0|||
156670453|NCT00787254|565538918|FG000|Overall Study|Physician Decision|4|||
156670454|NCT00787254|565538919|FG001|Overall Study|Physician Decision|8|||
156670455|NCT03761173|565538924|FG000|Overall Study|Lost to Follow-up|93|||
156670456|NCT03761173|565538924|FG000|Overall Study|Withdrawal by Subject|74|||
156670457|NCT03761173|565538924|FG000|Overall Study|Death|45|||
156670458|NCT03761173|565538924|FG000|Overall Study|Withdrawal for Other Reasons|29|||
156670459|NCT03761173|565538924|FG000|Overall Study|Protocol Violation|1|||
156670460|NCT00316186|565538925|FG000|Overall Study|Adverse Event|6|||
156670461|NCT00316186|565538925|FG000|Overall Study|Disease Progression|4|||
156670462|NCT00316186|565538925|FG000|Overall Study|Lost to Follow-up|1|||
156670463|NCT00316186|565538925|FG000|Overall Study|Other|1|||
156670464|NCT05152576|565538927|FG000|Overall Study|Lost to Follow-up|3|||
156670465|NCT05152576|565538928|FG001|Overall Study|Lost to Follow-up|0|||
156670466|NCT05152576|565538929|FG002|Overall Study|Lost to Follow-up|0|||
156670467|NCT05152576|565538930|FG003|Overall Study|Lost to Follow-up|1|||
156670468|NCT05152576|565538927|FG000|Overall Study|Withdrawal by Subject|0|||
156670469|NCT05152576|565538928|FG001|Overall Study|Withdrawal by Subject|1|||
156670470|NCT05152576|565538929|FG002|Overall Study|Withdrawal by Subject|0|||
156670471|NCT05152576|565538930|FG003|Overall Study|Withdrawal by Subject|1|||
156670472|NCT05152576|565538927|FG000|Overall Study|Other|2|||
156670473|NCT05152576|565538928|FG001|Overall Study|Other|0|||
156670474|NCT05152576|565538929|FG002|Overall Study|Other|0|||
156327023|NCT04587271|564297457|FG005|Overall Study|Caregiver brought child to visits|0|||
156327024|NCT02360111|564297458|FG000|Overall Study|Death|2|||
156327025|NCT01933217|564297459|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
156327026|NCT01933217|564297460|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
156327027|NCT01933217|564297459|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
156327028|NCT01933217|564297460|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
156327029|NCT02180165|564297461|FG000|Overall Study|Not Treated|0|||
156327030|NCT02180165|564297462|FG001|Overall Study|Not Treated|0|||
156327031|NCT02180165|564297463|FG002|Overall Study|Not Treated|1|||
156670475|NCT05152576|565538930|FG003|Overall Study|Other|0|||
156670476|NCT01952691|565540740|FG000|Overall Study|Lost to Follow-up|2|||
156670477|NCT00199901|565540741|FG000|Overall Study|Protocol Violation|2|||
156670478|NCT00199901|565540742|FG001|Overall Study|Protocol Violation|0|||
156670479|NCT00199901|565540741|FG000|Overall Study|Withdrawal by Subject|1|||
156670480|NCT00199901|565540742|FG001|Overall Study|Withdrawal by Subject|0|||
156670481|NCT00199901|565540741|FG000|Overall Study|Progressive Disease|24|||
156670482|NCT00199901|565540742|FG001|Overall Study|Progressive Disease|24|||
156670483|NCT05776901|565540745|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
156327032|NCT02180165|564297464|FG003|Overall Study|Not Treated|0|||
156327033|NCT02180165|564297461|FG000|Overall Study|Adverse Event|7|||
156327034|NCT02180165|564297462|FG001|Overall Study|Adverse Event|0|||
156670484|NCT00373256|565540769|FG000|Overall Study|Adverse Event (AE)|1|||
156670485|NCT00373256|565540770|FG001|Overall Study|Adverse Event (AE)|5|||
156670486|NCT00373256|565540769|FG000|Overall Study|Lost to Follow-up|2|||
156670487|NCT00373256|565540770|FG001|Overall Study|Lost to Follow-up|1|||
156670488|NCT00373256|565540769|FG000|Overall Study|Death|9|||
156670489|NCT00373256|565540770|FG001|Overall Study|Death|8|||
156670490|NCT00373256|565540769|FG000|Overall Study|Objective Progression or Relapse|111|||
156670491|NCT00373256|565540770|FG001|Overall Study|Objective Progression or Relapse|104|||
156526395|NCT00427895|565021559|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156526396|NCT00427895|565021560|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
156526397|NCT00427895|565021553|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
156526398|NCT00427895|565021554|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
156526399|NCT00427895|565021555|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
156526400|NCT00427895|565021556|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
156526401|NCT00427895|565021557|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
156526402|NCT00427895|565021558|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
156526403|NCT00427895|565021559|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
156526404|NCT00427895|565021560|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
156526405|NCT00427895|565021553|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
156526406|NCT00427895|565021554|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
156526407|NCT00427895|565021555|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
156526408|NCT00427895|565021556|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
156526409|NCT00427895|565021557|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
156526410|NCT00427895|565021558|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
156526411|NCT00427895|565021559|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
156526412|NCT00427895|565021560|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
156526413|NCT00427895|565021553|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
156526414|NCT00427895|565021554|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
156526415|NCT00427895|565021555|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
156526416|NCT00427895|565021556|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
156526417|NCT00427895|565021557|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
156526418|NCT00427895|565021558|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
156526419|NCT00427895|565021559|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
156526420|NCT00427895|565021560|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
156526421|NCT00427895|565021553|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
156526422|NCT00427895|565021554|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
156526423|NCT00427895|565021555|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
156526424|NCT00427895|565021556|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
156526425|NCT00427895|565021557|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
156526426|NCT00427895|565021558|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
156526427|NCT00427895|565021559|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
156526428|NCT00427895|565021560|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
156526429|NCT00427895|565021553|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
156526430|NCT00427895|565021554|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
156526431|NCT00427895|565021555|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
156526432|NCT00427895|565021556|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
156526433|NCT00427895|565021557|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
156526434|NCT00427895|565021558|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
156526435|NCT00427895|565021559|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
156526436|NCT00427895|565021560|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
156526437|NCT00427895|565021553|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
156526438|NCT00427895|565021554|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
156526439|NCT00427895|565021555|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
156526440|NCT00427895|565021556|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
156526441|NCT00427895|565021557|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
156526442|NCT00427895|565021558|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
156526443|NCT00427895|565021559|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
156526444|NCT00427895|565021560|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
156526445|NCT00427895|565021553|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
156526446|NCT00427895|565021554|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
156526447|NCT00427895|565021555|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
156526448|NCT00427895|565021556|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
156526449|NCT00427895|565021557|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
156526450|NCT00427895|565021558|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
156526451|NCT00427895|565021559|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
156526452|NCT00427895|565021560|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
156526453|NCT00427895|565021553|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
156526454|NCT00427895|565021554|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
156526455|NCT00427895|565021555|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
156526456|NCT00427895|565021556|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
156526457|NCT00427895|565021557|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
156526458|NCT00427895|565021558|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
156526459|NCT00427895|565021559|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
156526460|NCT00427895|565021560|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
156526461|NCT00427895|565021553|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
156526462|NCT00427895|565021554|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
156670492|NCT00373256|565540769|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
156670493|NCT00373256|565540770|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
156670494|NCT00373256|565540769|FG000|Overall Study|Other|73|||
156670495|NCT00373256|565540770|FG001|Overall Study|Other|107|||
156670496|NCT00373256|565540769|FG000|Overall Study|Protocol Violation|0|||
156670497|NCT00373256|565540770|FG001|Overall Study|Protocol Violation|2|||
156670498|NCT00373256|565540769|FG000|Overall Study|Study Terminated by Sponsor|41|||
156670499|NCT00373256|565540770|FG001|Overall Study|Study Terminated by Sponsor|13|||
156670500|NCT00834522|565540771|FG000|Washout|Adverse Event|1|||
156670501|NCT00834522|565540772|FG001|Washout|Adverse Event|0|||
156670502|NCT00834522|565540771|FG000|Washout|Withdrawal by Subject|2|||
156670503|NCT00834522|565540772|FG001|Washout|Withdrawal by Subject|1|||
156670504|NCT00824291|565540781|FG000|Overall Study|Adverse Event|15|||
156670505|NCT00824291|565540782|FG001|Overall Study|Adverse Event|6|||
156670506|NCT00824291|565540781|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
156670507|NCT00824291|565540782|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
156670508|NCT00824291|565540781|FG000|Overall Study|Lost to Follow-up|11|||
156670509|NCT00824291|565540782|FG001|Overall Study|Lost to Follow-up|9|||
156670510|NCT00824291|565540781|FG000|Overall Study|Non-compliance|1|||
156670511|NCT00824291|565540782|FG001|Overall Study|Non-compliance|1|||
156670512|NCT00824291|565540781|FG000|Overall Study|Protocol Violation|4|||
156670513|NCT00824291|565540782|FG001|Overall Study|Protocol Violation|1|||
156670514|NCT00824291|565540781|FG000|Overall Study|Withdrawal by Subject|14|||
156670515|NCT00824291|565540782|FG001|Overall Study|Withdrawal by Subject|8|||
156670516|NCT00824291|565540781|FG000|Overall Study|Lack of Efficacy|7|||
156670517|NCT00824291|565540782|FG001|Overall Study|Lack of Efficacy|8|||
156670518|NCT00824291|565540781|FG000|Overall Study|Participant on prohibited medication|1|||
156670519|NCT00824291|565540782|FG001|Overall Study|Participant on prohibited medication|0|||
156670520|NCT00123734|565540786|FG000|Overall Study|Death|3|||
156670521|NCT00123734|565540786|FG000|Overall Study|Lost to Follow-up|3|||
156670522|NCT00123734|565540786|FG000|Overall Study|Dropout|1|||
156670523|NCT00123734|565540786|FG000|Overall Study|Withdrawal by Subject|1|||
156670524|NCT00113386|565540787|FG000|Overall Study|Withdrawal by Subject|1|||
156670525|NCT00113386|565540788|FG001|Overall Study|Withdrawal by Subject|0|||
156670526|NCT00113386|565540787|FG000|Overall Study|Physician Decision|0|||
156670527|NCT00113386|565540788|FG001|Overall Study|Physician Decision|1|||
156670528|NCT00113386|565540787|FG000|Overall Study|Toxicity|3|||
156670529|NCT00113386|565540788|FG001|Overall Study|Toxicity|0|||
156670530|NCT00113386|565540787|FG000|Overall Study|Ineligible|1|||
156670531|NCT00113386|565540788|FG001|Overall Study|Ineligible|2|||
156670532|NCT00113386|565540787|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
156670533|NCT00113386|565540788|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
156670534|NCT00834340|565540789|FG000|Washout|Adverse Event|1|||
156670535|NCT00834340|565540790|FG001|Washout|Adverse Event|0|||
156670536|NCT00834340|565540789|FG000|Washout|Withdrawal by Subject|1|||
156670537|NCT00834340|565540790|FG001|Washout|Withdrawal by Subject|0|||
156670538|NCT00395694|565540791|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
156670539|NCT00395694|565540792|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
156670540|NCT00395694|565540791|FG000|Continuation Phase|Adverse Event|1|||
156670541|NCT00395694|565540792|FG001|Continuation Phase|Adverse Event|0|||
156670542|NCT00395694|565540791|FG000|Continuation Phase|Lack of Efficacy|12|||
156670543|NCT00395694|565540792|FG001|Continuation Phase|Lack of Efficacy|11|||
156670544|NCT00395694|565540791|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
156526463|NCT00427895|565021555|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
156526464|NCT00427895|565021556|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
156526465|NCT00427895|565021557|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
156526466|NCT00427895|565021558|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
156670545|NCT00395694|565540792|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
156670546|NCT00395694|565540791|FG000|Continuation Phase|Poor Compliance|1|||
156670547|NCT00395694|565540792|FG001|Continuation Phase|Poor Compliance|0|||
156670548|NCT00395694|565540791|FG000|Continuation Phase|Withdrawal by Subject|0|||
156670549|NCT00395694|565540792|FG001|Continuation Phase|Withdrawal by Subject|2|||
156670550|NCT00392665|565540795|FG000|Overall Study|Death|16|||
156670551|NCT00392665|565540796|FG001|Overall Study|Death|14|||
156670552|NCT00392665|565540795|FG000|Overall Study|Lost to Follow-up|1|||
156670553|NCT00392665|565540796|FG001|Overall Study|Lost to Follow-up|1|||
156670554|NCT03673670|565540797|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
156670555|NCT03673670|565540798|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
156670556|NCT03673670|565540799|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
156670557|NCT03673670|565540800|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
156670558|NCT03673670|565540801|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
156670559|NCT03673670|565540802|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
156670560|NCT03673670|565540797|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
156670561|NCT03673670|565540798|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
156670562|NCT03673670|565540799|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
156670563|NCT03673670|565540800|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
156526467|NCT00427895|565021559|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
156670564|NCT03673670|565540801|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
156866505|NCT02282605|566271276|FG001|Overall Study|negative SA result on Day -1|0|||
156866506|NCT02282605|566271277|FG002|Overall Study|negative SA result on Day -1|0|||
156866507|NCT00836693|566271278|FG000|Overall Study|Adverse Event|4|||
156670565|NCT03673670|565540802|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
156670566|NCT03673670|565540797|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
156670567|NCT03673670|565540798|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
156866508|NCT00836693|566271279|FG001|Overall Study|Adverse Event|1|||
156866509|NCT00836693|566271278|FG000|Overall Study|Sponsor Decision|0|||
156866510|NCT00836693|566271279|FG001|Overall Study|Sponsor Decision|1|||
156866511|NCT00836693|566271278|FG000|Overall Study|Physician Decision|2|||
156866512|NCT00836693|566271279|FG001|Overall Study|Physician Decision|0|||
156866513|NCT00836693|566271278|FG000|Overall Study|Withdrawal by Subject|9|||
156866514|NCT00836693|566271279|FG001|Overall Study|Withdrawal by Subject|4|||
156866515|NCT00836693|566271278|FG000|Overall Study|Protocol Violation|1|||
156866516|NCT00836693|566271279|FG001|Overall Study|Protocol Violation|0|||
156866517|NCT00836693|566271278|FG000|Overall Study|Lost to Follow-up|1|||
156866518|NCT00836693|566271279|FG001|Overall Study|Lost to Follow-up|0|||
156866519|NCT03938259|566271280|FG000|Overall Study|unable to establish baseline for ventilation|1|||
156866520|NCT03938259|566271281|FG001|Overall Study|unable to establish baseline for ventilation|1|||
156866521|NCT01213472|566271282|FG000|Overall Study|Recurrence/Progressive disease|25|||
156866522|NCT01213472|566271282|FG000|Overall Study|Withdrawal by Subject|1|||
156866523|NCT01213472|566271282|FG000|Overall Study|Physician Decision|1|||
156866524|NCT00129402|566271283|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
156866525|NCT00129402|566271284|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
156866526|NCT00129402|566271285|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
156866527|NCT00129402|566271286|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
156866528|NCT00129402|566271287|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
156866529|NCT00129402|566271288|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
156866530|NCT00129402|566271289|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
156866531|NCT00129402|566271283|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866532|NCT00129402|566271284|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866533|NCT00129402|566271285|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866534|NCT00129402|566271286|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866535|NCT00129402|566271287|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866536|NCT00129402|566271288|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
156866537|NCT00129402|566271289|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866538|NCT00129402|566271283|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866539|NCT00129402|566271284|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866540|NCT00129402|566271285|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866541|NCT00129402|566271286|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
156866542|NCT00129402|566271287|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866543|NCT00129402|566271288|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866544|NCT00129402|566271289|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866545|NCT00129402|566271283|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866546|NCT00129402|566271284|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866547|NCT00129402|566271285|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
156866548|NCT00129402|566271286|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866549|NCT00129402|566271287|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
156866550|NCT00129402|566271288|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866551|NCT00129402|566271289|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866552|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866553|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866554|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
156866555|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866556|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866557|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866558|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866559|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866560|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866561|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
156670568|NCT03673670|565540799|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
156670569|NCT03673670|565540800|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
156866562|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866563|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866564|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
156866565|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156670570|NCT03673670|565540801|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
156670571|NCT03673670|565540802|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
156670572|NCT03673670|565540797|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
156670573|NCT03673670|565540798|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
156670574|NCT03673670|565540799|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
156670575|NCT03673670|565540800|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
156670576|NCT03673670|565540801|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
156670577|NCT03673670|565540802|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
156670578|NCT03673670|565540797|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
156670579|NCT03673670|565540798|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
156670580|NCT03673670|565540799|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
156670581|NCT03673670|565540800|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
156670582|NCT03673670|565540801|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
156670583|NCT03673670|565540802|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
156670584|NCT03673670|565540797|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
156670585|NCT03673670|565540798|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
156670586|NCT03673670|565540799|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
156670587|NCT03673670|565540800|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
156670588|NCT03673670|565540801|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
156670589|NCT03673670|565540802|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
156670590|NCT03673670|565540797|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
156670591|NCT03673670|565540798|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
156670592|NCT03673670|565540799|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
156670593|NCT03673670|565540800|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
156670594|NCT03673670|565540801|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
156670595|NCT03673670|565540802|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
156670596|NCT01058668|565540803|FG000|Double-blind Treatment Phase|Adverse Event|8|||
156670597|NCT01058668|565540804|FG001|Double-blind Treatment Phase|Adverse Event|15|||
156670598|NCT01058668|565540805|FG002|Double-blind Treatment Phase|Adverse Event|25|||
156670599|NCT01058668|565540803|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
156670600|NCT01058668|565540804|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
156670601|NCT01058668|565540805|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
156670602|NCT01058668|565540803|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
156670603|NCT01058668|565540804|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
156670604|NCT01058668|565540805|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
156670605|NCT01058668|565540803|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
156670606|NCT01058668|565540804|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
156670607|NCT01058668|565540805|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
156670608|NCT01058668|565540803|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156670609|NCT01058668|565540804|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
156670610|NCT01058668|565540805|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
156670611|NCT01058668|565540803|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
156670612|NCT01058668|565540804|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
156866566|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866567|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866568|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
156866569|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866570|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866571|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866572|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866573|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866574|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866575|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
156866576|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866577|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866578|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
156866579|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866580|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
156866581|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
156866582|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
156670613|NCT01058668|565540805|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
156866583|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
156866584|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
156670614|NCT02294786|565540808|FG000|Overall Study|Withdrawal by Subject|0|||
156670615|NCT02294786|565540809|FG001|Overall Study|Withdrawal by Subject|1|||
156670616|NCT02294786|565540808|FG000|Overall Study|Physician Decision|6|||
156327035|NCT02180165|564297463|FG002|Overall Study|Adverse Event|18|||
156526468|NCT00427895|565021560|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
156526469|NCT00427895|565021553|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
156526470|NCT00427895|565021554|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
156526471|NCT00427895|565021555|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
156526472|NCT00427895|565021556|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
156526473|NCT00427895|565021557|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
156526474|NCT00427895|565021558|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
156526475|NCT00427895|565021559|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
156526476|NCT00427895|565021560|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
156526477|NCT00427895|565021553|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
156526478|NCT00427895|565021554|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
156526479|NCT00427895|565021555|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
156526480|NCT00427895|565021556|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
156526481|NCT00427895|565021557|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
156526482|NCT00427895|565021558|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
156526483|NCT00427895|565021559|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
156526484|NCT00427895|565021560|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
156526485|NCT00427895|565021553|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
156526486|NCT00427895|565021554|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
156526487|NCT00427895|565021555|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
156526488|NCT00427895|565021556|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
156526489|NCT00427895|565021557|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
156526490|NCT00427895|565021558|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
156526491|NCT00427895|565021559|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
156526492|NCT00427895|565021560|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
156526493|NCT00427895|565021553|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
156526494|NCT00427895|565021554|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
156526495|NCT00427895|565021555|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
156526496|NCT00427895|565021556|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
156526497|NCT00427895|565021557|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
156526498|NCT00427895|565021558|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
156526499|NCT00427895|565021559|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
156526500|NCT00427895|565021560|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
156526501|NCT00427895|565021553|FG000|Vax 1/Year 1 Follow-up|Death|1|||
156526502|NCT00427895|565021554|FG001|Vax 1/Year 1 Follow-up|Death|0|||
156526503|NCT00427895|565021555|FG002|Vax 1/Year 1 Follow-up|Death|0|||
156526504|NCT00427895|565021556|FG003|Vax 1/Year 1 Follow-up|Death|0|||
156526505|NCT00427895|565021557|FG004|Vax 1/Year 1 Follow-up|Death|0|||
156526506|NCT00427895|565021558|FG005|Vax 1/Year 1 Follow-up|Death|0|||
156526507|NCT00427895|565021559|FG006|Vax 1/Year 1 Follow-up|Death|0|||
156526508|NCT00427895|565021560|FG007|Vax 1/Year 1 Follow-up|Death|0|||
156526509|NCT00427895|565021553|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
156526510|NCT00427895|565021554|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
156526511|NCT00427895|565021555|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
156526512|NCT00427895|565021556|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
156526513|NCT00427895|565021557|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
156526514|NCT00427895|565021558|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
156526515|NCT00427895|565021559|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
156526516|NCT00427895|565021560|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
156526517|NCT00427895|565021553|FG000|Vax 1/Year 1 Follow-up|Other|0|||
156526518|NCT00427895|565021554|FG001|Vax 1/Year 1 Follow-up|Other|0|||
156526519|NCT00427895|565021555|FG002|Vax 1/Year 1 Follow-up|Other|0|||
156526520|NCT00427895|565021556|FG003|Vax 1/Year 1 Follow-up|Other|2|||
156526521|NCT00427895|565021557|FG004|Vax 1/Year 1 Follow-up|Other|0|||
156526522|NCT00427895|565021558|FG005|Vax 1/Year 1 Follow-up|Other|0|||
156526523|NCT00427895|565021559|FG006|Vax 1/Year 1 Follow-up|Other|0|||
156526524|NCT00427895|565021560|FG007|Vax 1/Year 1 Follow-up|Other|0|||
156526525|NCT00427895|565021553|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
156526526|NCT00427895|565021554|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
156526527|NCT00427895|565021555|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
156526528|NCT00427895|565021556|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
156537831|NCT05111041|565062869|FG000|Overall Study|Withdrawal by Subject|1|||
156327036|NCT02180165|564297464|FG003|Overall Study|Adverse Event|3|||
156327037|NCT02180165|564297461|FG000|Overall Study|Lack of Efficacy|0|||
156327038|NCT02180165|564297462|FG001|Overall Study|Lack of Efficacy|1|||
156327039|NCT02180165|564297463|FG002|Overall Study|Lack of Efficacy|3|||
156327040|NCT02180165|564297464|FG003|Overall Study|Lack of Efficacy|2|||
156327041|NCT02180165|564297461|FG000|Overall Study|Physician Decision|1|||
156327042|NCT02180165|564297462|FG001|Overall Study|Physician Decision|0|||
156327043|NCT02180165|564297463|FG002|Overall Study|Physician Decision|5|||
156327044|NCT02180165|564297464|FG003|Overall Study|Physician Decision|0|||
156327045|NCT02180165|564297461|FG000|Overall Study|Withdrawal by Subject|3|||
156327046|NCT02180165|564297462|FG001|Overall Study|Withdrawal by Subject|0|||
156327047|NCT02180165|564297463|FG002|Overall Study|Withdrawal by Subject|2|||
156430891|NCT03354390|564666225|FG001|Level 2|Lack of Efficacy|1|||
156430892|NCT03354390|564666226|FG002|Level 2|Lack of Efficacy|0|||
156430893|NCT03354390|564666227|FG003|Level 2|Lack of Efficacy|0|||
156430894|NCT03354390|564666224|FG000|Level 2|Lost to Follow-up|0|||
156430895|NCT03354390|564666225|FG001|Level 2|Lost to Follow-up|1|||
156430896|NCT03354390|564666226|FG002|Level 2|Lost to Follow-up|0|||
156430897|NCT03354390|564666227|FG003|Level 2|Lost to Follow-up|0|||
156430898|NCT03354390|564666224|FG000|Level 3|Death|0|||
156430899|NCT03354390|564666225|FG001|Level 3|Death|0|||
156430900|NCT03354390|564666226|FG002|Level 3|Death|1|||
156430901|NCT03354390|564666227|FG003|Level 3|Death|0|||
156430902|NCT03354390|564666224|FG000|Level 3|Physician Decision|0|||
156430903|NCT03354390|564666225|FG001|Level 3|Physician Decision|0|||
156430904|NCT03354390|564666226|FG002|Level 3|Physician Decision|2|||
156430905|NCT03354390|564666227|FG003|Level 3|Physician Decision|0|||
156430906|NCT03354390|564666224|FG000|Level 4|Death|0|||
156430907|NCT03354390|564666225|FG001|Level 4|Death|0|||
156430908|NCT03354390|564666226|FG002|Level 4|Death|0|||
156430909|NCT03354390|564666227|FG003|Level 4|Death|3|||
156430910|NCT00777556|564667777|FG000|Overall Study|Inappropriate self-selection|34|||
156430911|NCT00777556|564667777|FG000|Overall Study|Dispensed but did not use product|12|||
156430912|NCT00777556|564667777|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
156430913|NCT02689349|564667778|FG000|Overall Study|Not implanted|4|||
156430914|NCT02689349|564667779|FG001|Overall Study|Not implanted|0|||
156430915|NCT02689349|564667778|FG000|Overall Study|Withdrawal by Subject|9|||
156430916|NCT02689349|564667779|FG001|Overall Study|Withdrawal by Subject|0|||
156430917|NCT00486759|564667788|FG000|Treatment|Adverse event/intercurrent illness|86|||
156430918|NCT00486759|564667789|FG001|Treatment|Adverse event/intercurrent illness|39|||
156430919|NCT00486759|564667788|FG000|Treatment|Insufficient therapeutic response|37|||
156430920|NCT00486759|564667789|FG001|Treatment|Insufficient therapeutic response|39|||
156430921|NCT00486759|564667788|FG000|Treatment|Death|17|||
156430922|NCT00486759|564667789|FG001|Treatment|Death|10|||
156430923|NCT00486759|564667788|FG000|Treatment|Withdrew consent|15|||
156430924|NCT00486759|564667789|FG001|Treatment|Withdrew consent|12|||
156430925|NCT00486759|564667788|FG000|Treatment|Administrative/reason not specified|17|||
156430926|NCT00486759|564667789|FG001|Treatment|Administrative/reason not specified|21|||
156430927|NCT00486759|564667788|FG000|Treatment|Refused treatment|10|||
156430928|NCT00486759|564667789|FG001|Treatment|Refused treatment|7|||
156430929|NCT00486759|564667788|FG000|Treatment|Violation of selection criteria at entry|3|||
156430930|NCT00486759|564667789|FG001|Treatment|Violation of selection criteria at entry|3|||
156430931|NCT00486759|564667788|FG000|Treatment|Other protocol violation|1|||
156430932|NCT00486759|564667789|FG001|Treatment|Other protocol violation|5|||
156430933|NCT00486759|564667788|FG000|Treatment|Failure to return|1|||
156430934|NCT00486759|564667789|FG001|Treatment|Failure to return|1|||
156430935|NCT00486759|564667788|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
156430936|NCT00486759|564667789|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
156430937|NCT00486759|564667788|FG000|Safety Follow-up|Death|40|||
156430938|NCT00486759|564667789|FG001|Safety Follow-up|Death|29|||
156430939|NCT00486759|564667788|FG000|Safety Follow-up|Withdrew consent|32|||
156430940|NCT00486759|564667789|FG001|Safety Follow-up|Withdrew consent|23|||
156430941|NCT00486759|564667788|FG000|Safety Follow-up|Failure to return|9|||
156779778|NCT00221104|565943872|FG000|Overall Study|Others|37|||
156430942|NCT00486759|564667789|FG001|Safety Follow-up|Failure to return|6|||
156430943|NCT00486759|564667788|FG000|Safety Follow-up|Administrative/not specified|8|||
156430944|NCT00486759|564667789|FG001|Safety Follow-up|Administrative/not specified|6|||
156430945|NCT00486759|564667788|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
156430946|NCT00486759|564667789|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
156430947|NCT00486759|564667788|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
156430948|NCT00486759|564667789|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
156430949|NCT01185522|564667790|FG000|Overall Study|Lack of Efficacy|28|||
156430950|NCT01185522|564667790|FG000|Overall Study|Lost to Follow-up|19|||
156430951|NCT01185522|564667790|FG000|Overall Study|Withdrawal by Subject|10|||
156430952|NCT01185522|564667790|FG000|Overall Study|Poor tolerance|39|||
156430953|NCT01185522|564667790|FG000|Overall Study|Other reasons|12|||
156430954|NCT02987543|564667791|FG000|Overall Study|Ongoing study at data cut off|49|||
156430955|NCT02987543|564667792|FG001|Overall Study|Ongoing study at data cut off|21|||
156430956|NCT02987543|564667793|FG002|Overall Study|Ongoing study at data cut off|19|||
156430957|NCT02987543|564667794|FG003|Overall Study|Ongoing study at data cut off|12|||
156430958|NCT02987543|564667791|FG000|Overall Study|Death|88|||
156430959|NCT02987543|564667792|FG001|Overall Study|Death|54|||
156430960|NCT02987543|564667793|FG002|Overall Study|Death|67|||
156430961|NCT02987543|564667794|FG003|Overall Study|Death|28|||
156430962|NCT02987543|564667791|FG000|Overall Study|Lost to Follow-up|3|||
156430963|NCT02987543|564667792|FG001|Overall Study|Lost to Follow-up|0|||
156430964|NCT02987543|564667793|FG002|Overall Study|Lost to Follow-up|1|||
156430965|NCT02987543|564667794|FG003|Overall Study|Lost to Follow-up|0|||
156430966|NCT02987543|564667791|FG000|Overall Study|Screen failure|0|||
156430967|NCT02987543|564667792|FG001|Overall Study|Screen failure|0|||
156430968|NCT02987543|564667793|FG002|Overall Study|Screen failure|0|||
156670617|NCT02294786|565540809|FG001|Overall Study|Physician Decision|7|||
156670618|NCT02294786|565540808|FG000|Overall Study|Lost to Follow-up|1|||
156670619|NCT02294786|565540809|FG001|Overall Study|Lost to Follow-up|2|||
156670620|NCT02294786|565540808|FG000|Overall Study|Protocol Violation|1|||
156670621|NCT02294786|565540809|FG001|Overall Study|Protocol Violation|0|||
156670622|NCT02294786|565540808|FG000|Overall Study|Adverse Event|1|||
156670623|NCT02294786|565540809|FG001|Overall Study|Adverse Event|1|||
156670624|NCT02294786|565540808|FG000|Overall Study|Death|2|||
156670625|NCT02294786|565540809|FG001|Overall Study|Death|3|||
156670626|NCT01778010|565540810|FG000|Overall Study|Withdrawal by Subject|2|||
156670627|NCT01778010|565540810|FG000|Overall Study|abnormal ECG before meds|1|||
156670628|NCT01778010|565540810|FG000|Overall Study|Arrested|1|||
156670629|NCT01778010|565540810|FG000|Overall Study|rash while on placebo|1|||
156670630|NCT02159183|565540813|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
156670631|NCT02159183|565540814|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
156670632|NCT02159183|565540813|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
156670633|NCT02159183|565540814|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
156670634|NCT02159183|565540813|FG000|Analysis After the 36 Months Follow-up|Death|0|||
156670635|NCT02159183|565540814|FG001|Analysis After the 36 Months Follow-up|Death|1|||
156670636|NCT02159183|565540813|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
156670637|NCT02159183|565540814|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
156670638|NCT02159183|565540813|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
156670639|NCT02159183|565540814|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
156670640|NCT01444378|565540820|FG000|Overall Study|Lost to Follow-up|1|||
156670641|NCT01444378|565540820|FG000|Overall Study|Withdrawal by Subject|1|||
156670642|NCT01444378|565540820|FG000|Overall Study|Death|3|||
156526529|NCT00427895|565021557|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
156430969|NCT02987543|564667794|FG003|Overall Study|Screen failure|1|||
156430970|NCT02987543|564667791|FG000|Overall Study|Withdrawal by Subject|21|||
156430971|NCT02987543|564667792|FG001|Overall Study|Withdrawal by Subject|7|||
156430972|NCT02987543|564667793|FG002|Overall Study|Withdrawal by Subject|7|||
156430973|NCT02987543|564667794|FG003|Overall Study|Withdrawal by Subject|6|||
156430974|NCT02987543|564667791|FG000|Overall Study|Study terminated by sponsor|1|||
156430975|NCT02987543|564667792|FG001|Overall Study|Study terminated by sponsor|0|||
156430976|NCT02987543|564667793|FG002|Overall Study|Study terminated by sponsor|0|||
156430977|NCT02987543|564667794|FG003|Overall Study|Study terminated by sponsor|0|||
156430978|NCT02987543|564667791|FG000|Overall Study|Investigator decision|0|||
156430979|NCT02987543|564667792|FG001|Overall Study|Investigator decision|1|||
156430980|NCT02987543|564667793|FG002|Overall Study|Investigator decision|0|||
156430981|NCT02987543|564667794|FG003|Overall Study|Investigator decision|0|||
156430982|NCT02987543|564667791|FG000|Overall Study|Disease progression|0|||
156430983|NCT02987543|564667792|FG001|Overall Study|Disease progression|0|||
156430984|NCT02987543|564667793|FG002|Overall Study|Disease progression|0|||
156430985|NCT02987543|564667794|FG003|Overall Study|Disease progression|1|||
156430986|NCT03646669|564667797|FG000|Overall Study|Withdrawal by Subject|5|||
156430987|NCT03646669|564667798|FG001|Overall Study|Withdrawal by Subject|0|||
156430988|NCT00377455|564667799|FG000|Overall Study|Withdrawal by Subject|1|||
156430989|NCT00309452|564667800|FG000|Overall Study|Withdrawal by Subject|3|||
156430990|NCT00309452|564667801|FG001|Overall Study|Withdrawal by Subject|0|||
156430991|NCT00771667|564667802|FG000|Induction Phase|Adverse Event|5|||
156430992|NCT00771667|564667803|FG001|Induction Phase|Adverse Event|2|||
156430993|NCT00771667|564667804|FG002|Induction Phase|Adverse Event|4|||
156526530|NCT00427895|565021558|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
156526531|NCT00427895|565021559|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
156670643|NCT01444378|565540820|FG000|Overall Study|Administrative Closure Of The Study|2|||
156670644|NCT01444378|565540820|FG000|Overall Study|Missed Visits|10|||
156670645|NCT02911792|565540821|FG000|Overall Study|Lost to Follow-up|3|||
156327048|NCT02180165|564297464|FG003|Overall Study|Withdrawal by Subject|1|||
156327049|NCT03923738|564297468|FG000|Period 1|Adverse Event|1|||
156327050|NCT03923738|564297468|FG000|Period 1|Withdrawal by Subject|1|||
156526532|NCT00427895|565021560|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
156670646|NCT02911792|565540822|FG001|Overall Study|Lost to Follow-up|3|||
156670647|NCT02911792|565540823|FG002|Overall Study|Lost to Follow-up|3|||
156327051|NCT05246397|564297469|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
156327052|NCT03875768|564297470|FG000|Overall Study|Lost to Follow-up|16|||
156327053|NCT03875768|564297471|FG001|Overall Study|Lost to Follow-up|13|||
156327054|NCT03875768|564297470|FG000|Overall Study|Withdrawal by Subject|10|||
156327055|NCT03875768|564297471|FG001|Overall Study|Withdrawal by Subject|21|||
156327056|NCT03875768|564297470|FG000|Overall Study|Did not complete assessment|21|||
156327057|NCT03875768|564297471|FG001|Overall Study|Did not complete assessment|12|||
156327058|NCT03875768|564297470|FG000|Overall Study|Became ineligible|1|||
156430994|NCT00771667|564667805|FG003|Induction Phase|Adverse Event|1|||
156670648|NCT02911792|565540824|FG003|Overall Study|Lost to Follow-up|3|||
156670649|NCT00840073|565540825|FG000|Second Intervention|Missed 72 hour blood draw|1|||
156670650|NCT00840073|565540826|FG001|Second Intervention|Missed 72 hour blood draw|1|||
156526533|NCT00585195|565021562|FG000|Overall Study|Adverse Event|0|||
156526534|NCT00585195|565021563|FG001|Overall Study|Adverse Event|0|||
156526535|NCT00585195|565021564|FG002|Overall Study|Adverse Event|0|||
156526536|NCT00585195|565021565|FG003|Overall Study|Adverse Event|0|||
156526537|NCT00585195|565021566|FG004|Overall Study|Adverse Event|2|||
156526538|NCT00585195|565021567|FG005|Overall Study|Adverse Event|1|||
156526539|NCT00585195|565021568|FG006|Overall Study|Adverse Event|0|||
156526540|NCT00585195|565021569|FG007|Overall Study|Adverse Event|1|||
156526541|NCT00585195|565021570|FG008|Overall Study|Adverse Event|0|||
156526542|NCT00585195|565021571|FG009|Overall Study|Adverse Event|0|||
156526543|NCT00585195|565021572|FG010|Overall Study|Adverse Event|3|||
156526544|NCT00585195|565021573|FG011|Overall Study|Adverse Event|0|||
156526545|NCT00585195|565021574|FG012|Overall Study|Adverse Event|8|||
156526546|NCT00585195|565021575|FG013|Overall Study|Adverse Event|6|||
156526547|NCT00585195|565021576|FG014|Overall Study|Adverse Event|4|||
156526548|NCT00585195|565021577|FG015|Overall Study|Adverse Event|1|||
156526549|NCT00585195|565021578|FG016|Overall Study|Adverse Event|14|||
156526550|NCT00585195|565021579|FG017|Overall Study|Adverse Event|9|||
156526551|NCT00585195|565021580|FG018|Overall Study|Adverse Event|2|||
156526552|NCT00585195|565021581|FG019|Overall Study|Adverse Event|3|||
156526553|NCT00585195|565021582|FG020|Overall Study|Adverse Event|1|||
156526554|NCT00585195|565021562|FG000|Overall Study|Progressive Disease|2|||
156526555|NCT00585195|565021563|FG001|Overall Study|Progressive Disease|2|||
156526556|NCT00585195|565021564|FG002|Overall Study|Progressive Disease|5|||
156526557|NCT00585195|565021565|FG003|Overall Study|Progressive Disease|4|||
156526558|NCT00585195|565021566|FG004|Overall Study|Progressive Disease|6|||
156526559|NCT00585195|565021567|FG005|Overall Study|Progressive Disease|4|||
156526560|NCT00585195|565021568|FG006|Overall Study|Progressive Disease|6|||
156526561|NCT00585195|565021569|FG007|Overall Study|Progressive Disease|3|||
156526562|NCT00585195|565021570|FG008|Overall Study|Progressive Disease|0|||
156526563|NCT00585195|565021571|FG009|Overall Study|Progressive Disease|5|||
156526564|NCT00585195|565021572|FG010|Overall Study|Progressive Disease|2|||
156526565|NCT00585195|565021573|FG011|Overall Study|Progressive Disease|25|||
156526566|NCT00585195|565021574|FG012|Overall Study|Progressive Disease|29|||
156526567|NCT00585195|565021575|FG013|Overall Study|Progressive Disease|26|||
156526568|NCT00585195|565021576|FG014|Overall Study|Progressive Disease|21|||
156526569|NCT00585195|565021577|FG015|Overall Study|Progressive Disease|12|||
156526570|NCT00585195|565021578|FG016|Overall Study|Progressive Disease|94|||
156526571|NCT00585195|565021579|FG017|Overall Study|Progressive Disease|42|||
156526572|NCT00585195|565021580|FG018|Overall Study|Progressive Disease|4|||
156526573|NCT00585195|565021581|FG019|Overall Study|Progressive Disease|9|||
156526574|NCT00585195|565021582|FG020|Overall Study|Progressive Disease|8|||
156526575|NCT00585195|565021562|FG000|Overall Study|Withdrawal by Subject|1|||
156526576|NCT00585195|565021563|FG001|Overall Study|Withdrawal by Subject|1|||
156526577|NCT00585195|565021564|FG002|Overall Study|Withdrawal by Subject|2|||
156526578|NCT00585195|565021565|FG003|Overall Study|Withdrawal by Subject|2|||
156526579|NCT00585195|565021566|FG004|Overall Study|Withdrawal by Subject|0|||
156327059|NCT03875768|564297471|FG001|Overall Study|Became ineligible|0|||
156526580|NCT00585195|565021567|FG005|Overall Study|Withdrawal by Subject|0|||
156526581|NCT00585195|565021568|FG006|Overall Study|Withdrawal by Subject|0|||
156526582|NCT00585195|565021569|FG007|Overall Study|Withdrawal by Subject|1|||
156526583|NCT00585195|565021570|FG008|Overall Study|Withdrawal by Subject|0|||
156526584|NCT00585195|565021571|FG009|Overall Study|Withdrawal by Subject|0|||
156526585|NCT00585195|565021572|FG010|Overall Study|Withdrawal by Subject|3|||
156526586|NCT00585195|565021573|FG011|Overall Study|Withdrawal by Subject|8|||
156526587|NCT00585195|565021574|FG012|Overall Study|Withdrawal by Subject|15|||
156526588|NCT00585195|565021575|FG013|Overall Study|Withdrawal by Subject|0|||
156526589|NCT00585195|565021576|FG014|Overall Study|Withdrawal by Subject|3|||
156526590|NCT00585195|565021577|FG015|Overall Study|Withdrawal by Subject|0|||
156526591|NCT00585195|565021578|FG016|Overall Study|Withdrawal by Subject|7|||
156327060|NCT01925274|564297472|FG000|Overall Study|Death|1|||
156327061|NCT01925274|564297473|FG001|Overall Study|Death|0|||
156327062|NCT01925274|564297474|FG002|Overall Study|Death|0|||
156327063|NCT01925274|564297472|FG000|Overall Study|Lost to Follow-up|0|||
156327064|NCT01925274|564297473|FG001|Overall Study|Lost to Follow-up|1|||
156327065|NCT01925274|564297474|FG002|Overall Study|Lost to Follow-up|0|||
156526592|NCT00585195|565021579|FG017|Overall Study|Withdrawal by Subject|1|||
156526593|NCT00585195|565021580|FG018|Overall Study|Withdrawal by Subject|2|||
156526594|NCT00585195|565021581|FG019|Overall Study|Withdrawal by Subject|2|||
156526595|NCT00585195|565021582|FG020|Overall Study|Withdrawal by Subject|0|||
156526596|NCT00585195|565021562|FG000|Overall Study|Other|0|||
156526597|NCT00585195|565021563|FG001|Overall Study|Other|1|||
156526598|NCT00585195|565021564|FG002|Overall Study|Other|1|||
156526599|NCT00585195|565021565|FG003|Overall Study|Other|1|||
156526600|NCT00585195|565021566|FG004|Overall Study|Other|0|||
156526601|NCT00585195|565021567|FG005|Overall Study|Other|1|||
156526602|NCT00585195|565021568|FG006|Overall Study|Other|0|||
156526603|NCT00585195|565021569|FG007|Overall Study|Other|0|||
156526604|NCT00585195|565021570|FG008|Overall Study|Other|2|||
156327066|NCT01925274|564297472|FG000|Overall Study|Withdrawal by Subject|1|||
156430995|NCT00771667|564667806|FG004|Induction Phase|Adverse Event|0|||
156430996|NCT00771667|564667807|FG005|Induction Phase|Adverse Event|0|||
156430997|NCT00771667|564667808|FG006|Induction Phase|Adverse Event|0|||
156430998|NCT00771667|564667809|FG007|Induction Phase|Adverse Event|0|||
156430999|NCT00771667|564667810|FG008|Induction Phase|Adverse Event|0|||
156431000|NCT00771667|564667811|FG009|Induction Phase|Adverse Event|0|||
156431001|NCT00771667|564667802|FG000|Induction Phase|Lack of Efficacy|9|||
156670651|NCT03256695|565540827|FG000|Overall Study|Adverse Event|8|||
156670652|NCT03256695|565540827|FG000|Overall Study|Death|2|||
156670653|NCT03256695|565540827|FG000|Overall Study|Withdrawal by Subject|14|||
156670654|NCT03256695|565540827|FG000|Overall Study|Non-compliance with study drug|1|||
156670655|NCT03256695|565540827|FG000|Overall Study|Lost to Follow-up|3|||
156670656|NCT03256695|565540827|FG000|Overall Study|Lack of Efficacy|3|||
156670657|NCT03256695|565540827|FG000|Overall Study|Protocol Violation|5|||
156670658|NCT03256695|565540827|FG000|Overall Study|Other than specified|3|||
156670659|NCT03406156|565540831|FG000|Overall Study|Death|9|||
156670660|NCT03406156|565540832|FG001|Overall Study|Death|3|||
156670661|NCT03406156|565540831|FG000|Overall Study|Withdrawal by Subject|1|||
156670662|NCT03406156|565540832|FG001|Overall Study|Withdrawal by Subject|2|||
156670663|NCT03406156|565540831|FG000|Overall Study|COVID-19 infection|1|||
156670664|NCT03406156|565540832|FG001|Overall Study|COVID-19 infection|0|||
156670665|NCT03406156|565540831|FG000|Overall Study|Non-compliance with study procedures|1|||
156866585|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
156431002|NCT00771667|564667803|FG001|Induction Phase|Lack of Efficacy|2|||
156431003|NCT00771667|564667804|FG002|Induction Phase|Lack of Efficacy|4|||
156431004|NCT00771667|564667805|FG003|Induction Phase|Lack of Efficacy|3|||
156431005|NCT00771667|564667806|FG004|Induction Phase|Lack of Efficacy|0|||
156431006|NCT00771667|564667807|FG005|Induction Phase|Lack of Efficacy|0|||
156431007|NCT00771667|564667808|FG006|Induction Phase|Lack of Efficacy|0|||
156431008|NCT00771667|564667809|FG007|Induction Phase|Lack of Efficacy|0|||
156431009|NCT00771667|564667810|FG008|Induction Phase|Lack of Efficacy|0|||
156431010|NCT00771667|564667811|FG009|Induction Phase|Lack of Efficacy|0|||
156431011|NCT00771667|564667802|FG000|Induction Phase|Lost to Follow-up|1|||
156431012|NCT00771667|564667803|FG001|Induction Phase|Lost to Follow-up|0|||
156431013|NCT00771667|564667804|FG002|Induction Phase|Lost to Follow-up|1|||
156431014|NCT00771667|564667805|FG003|Induction Phase|Lost to Follow-up|0|||
156431015|NCT00771667|564667806|FG004|Induction Phase|Lost to Follow-up|0|||
156431016|NCT00771667|564667807|FG005|Induction Phase|Lost to Follow-up|0|||
156431017|NCT00771667|564667808|FG006|Induction Phase|Lost to Follow-up|0|||
156431018|NCT00771667|564667809|FG007|Induction Phase|Lost to Follow-up|0|||
156431019|NCT00771667|564667810|FG008|Induction Phase|Lost to Follow-up|0|||
156431020|NCT00771667|564667811|FG009|Induction Phase|Lost to Follow-up|0|||
156431021|NCT00771667|564667802|FG000|Induction Phase|Other|4|||
156431022|NCT00771667|564667803|FG001|Induction Phase|Other|6|||
156431023|NCT00771667|564667804|FG002|Induction Phase|Other|3|||
156431024|NCT00771667|564667805|FG003|Induction Phase|Other|4|||
156431025|NCT00771667|564667806|FG004|Induction Phase|Other|0|||
156431026|NCT00771667|564667807|FG005|Induction Phase|Other|0|||
156431027|NCT00771667|564667808|FG006|Induction Phase|Other|0|||
156431028|NCT00771667|564667809|FG007|Induction Phase|Other|0|||
156431029|NCT00771667|564667810|FG008|Induction Phase|Other|0|||
156431030|NCT00771667|564667811|FG009|Induction Phase|Other|0|||
156431031|NCT00771667|564667802|FG000|Maintenance Phase|Adverse Event|0|||
156431032|NCT00771667|564667803|FG001|Maintenance Phase|Adverse Event|0|||
156431033|NCT00771667|564667804|FG002|Maintenance Phase|Adverse Event|0|||
156431034|NCT00771667|564667805|FG003|Maintenance Phase|Adverse Event|0|||
156431035|NCT00771667|564667806|FG004|Maintenance Phase|Adverse Event|1|||
156431036|NCT00771667|564667807|FG005|Maintenance Phase|Adverse Event|3|||
156431037|NCT00771667|564667808|FG006|Maintenance Phase|Adverse Event|5|||
156431038|NCT00771667|564667809|FG007|Maintenance Phase|Adverse Event|1|||
156431039|NCT00771667|564667810|FG008|Maintenance Phase|Adverse Event|8|||
156431040|NCT00771667|564667811|FG009|Maintenance Phase|Adverse Event|7|||
156431041|NCT00771667|564667802|FG000|Maintenance Phase|Lack of Efficacy|0|||
156431042|NCT00771667|564667803|FG001|Maintenance Phase|Lack of Efficacy|0|||
156431043|NCT00771667|564667804|FG002|Maintenance Phase|Lack of Efficacy|0|||
156431044|NCT00771667|564667805|FG003|Maintenance Phase|Lack of Efficacy|0|||
156431045|NCT00771667|564667806|FG004|Maintenance Phase|Lack of Efficacy|1|||
156431046|NCT00771667|564667807|FG005|Maintenance Phase|Lack of Efficacy|3|||
156431047|NCT00771667|564667808|FG006|Maintenance Phase|Lack of Efficacy|3|||
156431048|NCT00771667|564667809|FG007|Maintenance Phase|Lack of Efficacy|2|||
156431049|NCT00771667|564667810|FG008|Maintenance Phase|Lack of Efficacy|11|||
156431050|NCT00771667|564667811|FG009|Maintenance Phase|Lack of Efficacy|7|||
156431051|NCT00771667|564667802|FG000|Maintenance Phase|Other|0|||
156431052|NCT00771667|564667803|FG001|Maintenance Phase|Other|0|||
156431053|NCT00771667|564667804|FG002|Maintenance Phase|Other|0|||
156431054|NCT00771667|564667805|FG003|Maintenance Phase|Other|0|||
156431055|NCT00771667|564667806|FG004|Maintenance Phase|Other|0|||
156431056|NCT00771667|564667807|FG005|Maintenance Phase|Other|1|||
156431057|NCT00771667|564667808|FG006|Maintenance Phase|Other|2|||
156431058|NCT00771667|564667809|FG007|Maintenance Phase|Other|2|||
156431059|NCT00771667|564667810|FG008|Maintenance Phase|Other|3|||
156431060|NCT00771667|564667811|FG009|Maintenance Phase|Other|3|||
156431061|NCT03265210|564667812|FG000|Overall Study|Withdrawal by Subject|7|||
156431062|NCT03265210|564667813|FG001|Overall Study|Withdrawal by Subject|9|||
156431063|NCT03265210|564667812|FG000|Overall Study|Lost to Follow-up|2|||
156431064|NCT03265210|564667813|FG001|Overall Study|Lost to Follow-up|0|||
156431065|NCT03265210|564667812|FG000|Overall Study|Physician Decision|2|||
156431066|NCT03265210|564667813|FG001|Overall Study|Physician Decision|0|||
156431067|NCT03265210|564667812|FG000|Overall Study|Adverse Event|1|||
156431068|NCT03265210|564667813|FG001|Overall Study|Adverse Event|0|||
156431069|NCT01883492|564667814|FG000|Overall Study|Lost to Follow-up|3|||
156431070|NCT01883492|564667815|FG001|Overall Study|Lost to Follow-up|4|||
156431071|NCT01883492|564667814|FG000|Overall Study|Surgery on contra-lateral hip|0|||
156431072|NCT01883492|564667815|FG001|Overall Study|Surgery on contra-lateral hip|1|||
156431073|NCT01883492|564667814|FG000|Overall Study|Poor X-ray quality|7|||
156431074|NCT01883492|564667815|FG001|Overall Study|Poor X-ray quality|4|||
156431075|NCT01883492|564667814|FG000|Overall Study|Withdrawal by Subject|1|||
156431076|NCT01883492|564667815|FG001|Overall Study|Withdrawal by Subject|0|||
156431077|NCT01883492|564667814|FG000|Overall Study|inappropriate implant used|1|||
156431078|NCT01883492|564667815|FG001|Overall Study|inappropriate implant used|1|||
156431079|NCT01883492|564667814|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
156431080|NCT01883492|564667815|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
156431081|NCT00549848|564667817|FG000|Overall Study|Death|1|||
156431082|NCT00549848|564667818|FG001|Overall Study|Death|4|||
156431083|NCT00549848|564667819|FG002|Overall Study|Death|13|||
156431084|NCT00549848|564667817|FG000|Overall Study|Physician Decision|0|||
156526605|NCT00585195|565021571|FG009|Overall Study|Other|1|||
156431085|NCT00549848|564667818|FG001|Overall Study|Physician Decision|0|||
156431086|NCT00549848|564667819|FG002|Overall Study|Physician Decision|4|||
156431087|NCT00549848|564667817|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
156431088|NCT00549848|564667818|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
156431089|NCT00549848|564667819|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
156431090|NCT00549848|564667817|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
156431091|NCT00549848|564667818|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
156431092|NCT00549848|564667819|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
156431093|NCT00549848|564667817|FG000|Overall Study|Participant/Family Withdraw|2|||
156431094|NCT00549848|564667818|FG001|Overall Study|Participant/Family Withdraw|3|||
156431095|NCT00549848|564667819|FG002|Overall Study|Participant/Family Withdraw|5|||
156526606|NCT00585195|565021572|FG010|Overall Study|Other|0|||
156526607|NCT00585195|565021573|FG011|Overall Study|Other|19|||
156327067|NCT01925274|564297473|FG001|Overall Study|Withdrawal by Subject|2|||
156327068|NCT01925274|564297474|FG002|Overall Study|Withdrawal by Subject|0|||
156327069|NCT01925274|564297472|FG000|Overall Study|Study terminated by sponsor|4|||
156327070|NCT01925274|564297473|FG001|Overall Study|Study terminated by sponsor|0|||
156327071|NCT01925274|564297474|FG002|Overall Study|Study terminated by sponsor|0|||
156327072|NCT01925274|564297472|FG000|Overall Study|Protocol amendment|1|||
156327073|NCT01925274|564297473|FG001|Overall Study|Protocol amendment|3|||
156327074|NCT01925274|564297474|FG002|Overall Study|Protocol amendment|6|||
156327075|NCT04327674|564297480|FG000|Overall Study|Protocol Violation|19|||
156327076|NCT00723398|564297481|FG000|Overall Study|Withdrawal by Subject|2|||
156327077|NCT00723398|564297482|FG001|Overall Study|Withdrawal by Subject|6|||
156327078|NCT00723398|564297483|FG002|Overall Study|Withdrawal by Subject|4|||
156327079|NCT00723398|564297484|FG003|Overall Study|Withdrawal by Subject|4|||
156327080|NCT00723398|564297485|FG004|Overall Study|Withdrawal by Subject|4|||
156327081|NCT00723398|564297481|FG000|Overall Study|Protocol Violation|2|||
156327082|NCT00723398|564297482|FG001|Overall Study|Protocol Violation|1|||
156327083|NCT00723398|564297483|FG002|Overall Study|Protocol Violation|5|||
156327084|NCT00723398|564297484|FG003|Overall Study|Protocol Violation|0|||
156327085|NCT00723398|564297485|FG004|Overall Study|Protocol Violation|0|||
156327086|NCT00723398|564297481|FG000|Overall Study|Physician Decision|2|||
156327087|NCT00723398|564297482|FG001|Overall Study|Physician Decision|2|||
156327088|NCT00723398|564297483|FG002|Overall Study|Physician Decision|5|||
156327089|NCT00723398|564297484|FG003|Overall Study|Physician Decision|0|||
156327090|NCT00723398|564297485|FG004|Overall Study|Physician Decision|1|||
156327091|NCT00723398|564297481|FG000|Overall Study|Adverse Event|0|||
156327092|NCT00723398|564297482|FG001|Overall Study|Adverse Event|5|||
156327093|NCT00723398|564297483|FG002|Overall Study|Adverse Event|3|||
156327094|NCT00723398|564297484|FG003|Overall Study|Adverse Event|1|||
156327095|NCT00723398|564297485|FG004|Overall Study|Adverse Event|4|||
156327096|NCT00723398|564297481|FG000|Overall Study|Lost to Follow-up|0|||
156327097|NCT00723398|564297482|FG001|Overall Study|Lost to Follow-up|1|||
156526608|NCT00585195|565021574|FG012|Overall Study|Other|24|||
156670666|NCT03406156|565540832|FG001|Overall Study|Non-compliance with study procedures|1|||
156327098|NCT00723398|564297483|FG002|Overall Study|Lost to Follow-up|0|||
156327099|NCT00723398|564297484|FG003|Overall Study|Lost to Follow-up|0|||
156327100|NCT00723398|564297485|FG004|Overall Study|Lost to Follow-up|0|||
156327101|NCT00267189|564297486|FG000|Overall Study|Patient withdrew consent|1|||
156327102|NCT00267189|564297487|FG001|Overall Study|Patient withdrew consent|1|||
156327103|NCT00267189|564297486|FG000|Overall Study|Death|1|||
156431096|NCT00549848|564667817|FG000|Overall Study|Second Malignancy|1|||
156431097|NCT00549848|564667818|FG001|Overall Study|Second Malignancy|0|||
156431098|NCT00549848|564667819|FG002|Overall Study|Second Malignancy|0|||
156431099|NCT00549848|564667817|FG000|Overall Study|Transplant|3|||
156431100|NCT00549848|564667818|FG001|Overall Study|Transplant|3|||
156431101|NCT00549848|564667819|FG002|Overall Study|Transplant|18|||
156431102|NCT00549848|564667817|FG000|Overall Study|Unacceptable Toxicity|1|||
156431103|NCT00549848|564667818|FG001|Overall Study|Unacceptable Toxicity|6|||
156431104|NCT00549848|564667819|FG002|Overall Study|Unacceptable Toxicity|6|||
156431105|NCT02377362|564667820|FG000|Part A Second Treatment|Protocol Violation|0|||
156431106|NCT02377362|564667821|FG001|Part A Second Treatment|Protocol Violation|0|||
156431107|NCT02377362|564667822|FG002|Part A Second Treatment|Protocol Violation|0|||
156431108|NCT02377362|564667823|FG003|Part A Second Treatment|Protocol Violation|0|||
156431109|NCT02377362|564667824|FG004|Part A Second Treatment|Protocol Violation|1|||
156431110|NCT02377362|564667825|FG005|Part A Second Treatment|Protocol Violation|0|||
156431111|NCT02377362|564667826|FG006|Part A Second Treatment|Protocol Violation|0|||
156431112|NCT02377362|564667827|FG007|Part A Second Treatment|Protocol Violation|0|||
156431113|NCT02377362|564667828|FG008|Part A Second Treatment|Protocol Violation|0|||
156431114|NCT02377362|564667829|FG009|Part A Second Treatment|Protocol Violation|0|||
156431115|NCT02377362|564667830|FG010|Part A Second Treatment|Protocol Violation|0|||
156431116|NCT02377362|564667831|FG011|Part A Second Treatment|Protocol Violation|0|||
156431117|NCT02377362|564667832|FG012|Part A Second Treatment|Protocol Violation|0|||
156431118|NCT02377362|564667820|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431119|NCT02377362|564667821|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431120|NCT02377362|564667822|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
156526609|NCT00585195|565021575|FG013|Overall Study|Other|7|||
156431121|NCT02377362|564667823|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
156431122|NCT02377362|564667824|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
156431123|NCT02377362|564667825|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
156431124|NCT02377362|564667826|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431125|NCT02377362|564667827|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431126|NCT02377362|564667828|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431127|NCT02377362|564667829|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431128|NCT02377362|564667830|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431129|NCT02377362|564667831|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431130|NCT02377362|564667832|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
156431131|NCT02377362|564667820|FG000|Part B Overall|Protocol Violation|0|||
156431132|NCT02377362|564667821|FG001|Part B Overall|Protocol Violation|0|||
156431133|NCT02377362|564667822|FG002|Part B Overall|Protocol Violation|0|||
156431134|NCT02377362|564667823|FG003|Part B Overall|Protocol Violation|0|||
156526610|NCT00585195|565021576|FG014|Overall Study|Other|11|||
156526611|NCT00585195|565021577|FG015|Overall Study|Other|3|||
156526612|NCT00585195|565021578|FG016|Overall Study|Other|28|||
156526613|NCT00585195|565021579|FG017|Overall Study|Other|12|||
156526614|NCT00585195|565021580|FG018|Overall Study|Other|10|||
156431135|NCT02377362|564667824|FG004|Part B Overall|Protocol Violation|0|||
156431136|NCT02377362|564667825|FG005|Part B Overall|Protocol Violation|0|||
156431137|NCT02377362|564667826|FG006|Part B Overall|Protocol Violation|0|||
156431138|NCT02377362|564667827|FG007|Part B Overall|Protocol Violation|0|||
156431139|NCT02377362|564667828|FG008|Part B Overall|Protocol Violation|0|||
156431140|NCT02377362|564667829|FG009|Part B Overall|Protocol Violation|1|||
156431141|NCT02377362|564667830|FG010|Part B Overall|Protocol Violation|0|||
156431142|NCT02377362|564667831|FG011|Part B Overall|Protocol Violation|0|||
156431143|NCT02377362|564667832|FG012|Part B Overall|Protocol Violation|0|||
156431144|NCT02377362|564667820|FG000|Part B Overall|Adverse Event|0|||
156431145|NCT02377362|564667821|FG001|Part B Overall|Adverse Event|0|||
156431146|NCT02377362|564667822|FG002|Part B Overall|Adverse Event|0|||
156431147|NCT02377362|564667823|FG003|Part B Overall|Adverse Event|0|||
156431148|NCT02377362|564667824|FG004|Part B Overall|Adverse Event|0|||
156431149|NCT02377362|564667825|FG005|Part B Overall|Adverse Event|0|||
156431150|NCT02377362|564667826|FG006|Part B Overall|Adverse Event|1|||
156431151|NCT02377362|564667827|FG007|Part B Overall|Adverse Event|1|||
156431152|NCT02377362|564667828|FG008|Part B Overall|Adverse Event|0|||
156431153|NCT02377362|564667829|FG009|Part B Overall|Adverse Event|0|||
156431154|NCT02377362|564667830|FG010|Part B Overall|Adverse Event|0|||
156526615|NCT00585195|565021581|FG019|Overall Study|Other|4|||
156526616|NCT00585195|565021582|FG020|Overall Study|Other|2|||
156431155|NCT02377362|564667831|FG011|Part B Overall|Adverse Event|0|||
156526617|NCT00585195|565021562|FG000|Overall Study|Randomized not treated|0|||
156526618|NCT00585195|565021563|FG001|Overall Study|Randomized not treated|0|||
156431156|NCT02377362|564667832|FG012|Part B Overall|Adverse Event|0|||
156431157|NCT02377362|564667820|FG000|Part B Overall|Withdrawal by Subject|0|||
156431158|NCT02377362|564667821|FG001|Part B Overall|Withdrawal by Subject|0|||
156431159|NCT02377362|564667822|FG002|Part B Overall|Withdrawal by Subject|0|||
156526619|NCT00585195|565021564|FG002|Overall Study|Randomized not treated|1|||
156526620|NCT00585195|565021565|FG003|Overall Study|Randomized not treated|0|||
156670667|NCT03406156|565540831|FG000|Overall Study|Lost to Follow-up|0|||
156670668|NCT03406156|565540832|FG001|Overall Study|Lost to Follow-up|2|||
156670669|NCT03406156|565540831|FG000|Overall Study|Other, not specified|72|||
156670670|NCT03406156|565540832|FG001|Overall Study|Other, not specified|28|||
156670671|NCT02838420|565540834|FG000|Overall Study|Ongoing in Study|113|||
156670672|NCT02838420|565540835|FG001|Overall Study|Ongoing in Study|45|||
156670673|NCT02838420|565540834|FG000|Overall Study|Lost to Follow-up|1|||
156670674|NCT02838420|565540835|FG001|Overall Study|Lost to Follow-up|0|||
156670675|NCT02838420|565540834|FG000|Overall Study|Withdrawal by Subject|3|||
156670676|NCT02838420|565540835|FG001|Overall Study|Withdrawal by Subject|4|||
156670677|NCT02838420|565540834|FG000|Overall Study|Death|8|||
156670678|NCT02838420|565540835|FG001|Overall Study|Death|13|||
156670679|NCT02964039|565540836|FG000|Overall Study|Medical reason unrelated to study participation|1|||
156670680|NCT02964039|565540837|FG001|Overall Study|Medical reason unrelated to study participation|0|||
156670681|NCT02964039|565540838|FG002|Overall Study|Medical reason unrelated to study participation|3|||
156670682|NCT02964039|565540836|FG000|Overall Study|Research shutdown due to pandemic|2|||
156670683|NCT02964039|565540837|FG001|Overall Study|Research shutdown due to pandemic|0|||
156670684|NCT02964039|565540838|FG002|Overall Study|Research shutdown due to pandemic|1|||
156670685|NCT02964039|565540836|FG000|Overall Study|Withdrawal by Subject|0|||
156670686|NCT02964039|565540837|FG001|Overall Study|Withdrawal by Subject|1|||
156670687|NCT02964039|565540838|FG002|Overall Study|Withdrawal by Subject|0|||
156670688|NCT02964039|565540836|FG000|Overall Study|Lost to Follow-up|1|||
156670689|NCT02964039|565540837|FG001|Overall Study|Lost to Follow-up|0|||
156670690|NCT02964039|565540838|FG002|Overall Study|Lost to Follow-up|1|||
156670691|NCT05479058|565540839|FG000|Overall Study|Withdrawal by Subject|1|||
156670692|NCT05479058|565540840|FG001|Overall Study|Withdrawal by Subject|1|||
156670693|NCT05479058|565540839|FG000|Overall Study|Study terminated by sponsor|10|||
156670694|NCT05479058|565540840|FG001|Overall Study|Study terminated by sponsor|10|||
156670695|NCT05630885|565540841|FG000|Study Completion|Took prohibited medications|2|||
156670696|NCT05630885|565540842|FG001|Study Completion|Took prohibited medications|0|||
156670697|NCT05630885|565540841|FG000|Study Completion|Non-compliance with study drug|1|||
156670698|NCT05630885|565540842|FG001|Study Completion|Non-compliance with study drug|0|||
156670699|NCT05630885|565540841|FG000|Study Completion|Adverse Event|1|||
156670700|NCT05630885|565540842|FG001|Study Completion|Adverse Event|0|||
156670701|NCT05630885|565540841|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
156670702|NCT05630885|565540842|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
156670703|NCT05630885|565540841|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
156670704|NCT05630885|565540842|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
156670705|NCT03419403|565540845|FG000|Overall Study|Withdrawal by Subject|5|||
156670706|NCT03419403|565540846|FG001|Overall Study|Withdrawal by Subject|2|||
156670707|NCT03419403|565540847|FG002|Overall Study|Withdrawal by Subject|5|||
156670708|NCT03419403|565540848|FG003|Overall Study|Withdrawal by Subject|1|||
156670709|NCT03419403|565540845|FG000|Overall Study|Progressive disease (per protocol)|0|||
156670710|NCT03419403|565540846|FG001|Overall Study|Progressive disease (per protocol)|2|||
156670711|NCT03419403|565540847|FG002|Overall Study|Progressive disease (per protocol)|2|||
156670712|NCT03419403|565540848|FG003|Overall Study|Progressive disease (per protocol)|0|||
156670713|NCT03419403|565540845|FG000|Overall Study|Other, not specified|6|||
156670714|NCT03419403|565540846|FG001|Overall Study|Other, not specified|4|||
156670715|NCT03419403|565540847|FG002|Overall Study|Other, not specified|5|||
156670716|NCT03419403|565540848|FG003|Overall Study|Other, not specified|1|||
156670717|NCT03419403|565540845|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
156670718|NCT03419403|565540846|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
156670719|NCT03419403|565540847|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
156670720|NCT03419403|565540848|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
156670721|NCT00796653|565540851|FG000|Overall Study|Adverse Event|19|||
156670722|NCT00796653|565540852|FG001|Overall Study|Adverse Event|16|||
156670723|NCT00796653|565540853|FG002|Overall Study|Adverse Event|16|||
156670724|NCT00796653|565540854|FG003|Overall Study|Adverse Event|16|||
156670725|NCT00796653|565540851|FG000|Overall Study|Lost to Follow-up|2|||
156670726|NCT00796653|565540852|FG001|Overall Study|Lost to Follow-up|1|||
156670727|NCT00796653|565540853|FG002|Overall Study|Lost to Follow-up|2|||
156670728|NCT00796653|565540854|FG003|Overall Study|Lost to Follow-up|3|||
156670729|NCT00796653|565540851|FG000|Overall Study|Withdrawal by Subject|16|||
156526621|NCT00585195|565021566|FG004|Overall Study|Randomized not treated|1|||
156526622|NCT00585195|565021567|FG005|Overall Study|Randomized not treated|0|||
156670730|NCT00796653|565540852|FG001|Overall Study|Withdrawal by Subject|8|||
156670731|NCT00796653|565540853|FG002|Overall Study|Withdrawal by Subject|8|||
156670732|NCT00796653|565540854|FG003|Overall Study|Withdrawal by Subject|13|||
156670733|NCT00796653|565540851|FG000|Overall Study|Lack of Efficacy|8|||
156670734|NCT00796653|565540852|FG001|Overall Study|Lack of Efficacy|1|||
156526623|NCT00585195|565021568|FG006|Overall Study|Randomized not treated|1|||
156526624|NCT00585195|565021569|FG007|Overall Study|Randomized not treated|0|||
156670735|NCT00796653|565540853|FG002|Overall Study|Lack of Efficacy|3|||
156670736|NCT00796653|565540854|FG003|Overall Study|Lack of Efficacy|2|||
156670737|NCT00796653|565540851|FG000|Overall Study|Non compliance with protocol|2|||
156670738|NCT00796653|565540852|FG001|Overall Study|Non compliance with protocol|2|||
156670739|NCT00796653|565540853|FG002|Overall Study|Non compliance with protocol|0|||
156670740|NCT00796653|565540854|FG003|Overall Study|Non compliance with protocol|2|||
156670741|NCT00796653|565540851|FG000|Overall Study|Other reason not described above|4|||
156670742|NCT00796653|565540852|FG001|Overall Study|Other reason not described above|9|||
156670743|NCT00796653|565540853|FG002|Overall Study|Other reason not described above|7|||
156670744|NCT00796653|565540854|FG003|Overall Study|Other reason not described above|4|||
156670745|NCT02414152|565540857|FG000|Overall Study|Withdrawal by Subject|1|||
156670746|NCT02414152|565540857|FG000|Overall Study|Lack of Efficacy|1|||
156670747|NCT00841698|565540859|FG000|First Intervention|Withdrawal by Subject|1|||
156670748|NCT00841698|565540860|FG001|First Intervention|Withdrawal by Subject|0|||
156670749|NCT00191815|565540863|FG000|Overall Study|Adverse Event|2|||
156670750|NCT00191815|565540863|FG000|Overall Study|Disease progression or relapse|24|||
156670751|NCT00191815|565540863|FG000|Overall Study|Death|2|||
156670752|NCT00191815|565540863|FG000|Overall Study|Protocol Violation|3|||
156670753|NCT00191815|565540863|FG000|Overall Study|Physician Decision|2|||
156670754|NCT00191815|565540863|FG000|Overall Study|Withdrawal by Subject|7|||
156670755|NCT01218867|565540866|FG000|Overall Study|Death during treatment|0|||
156670756|NCT01218867|565540867|FG001|Overall Study|Death during treatment|0|||
156670757|NCT01218867|565540868|FG002|Overall Study|Death during treatment|0|||
156670758|NCT01218867|565540869|FG003|Overall Study|Death during treatment|0|||
156670759|NCT01218867|565540870|FG004|Overall Study|Death during treatment|0|||
156670760|NCT01218867|565540871|FG005|Overall Study|Death during treatment|0|||
156670761|NCT01218867|565540872|FG006|Overall Study|Death during treatment|1|||
156670762|NCT01218867|565540873|FG007|Overall Study|Death during treatment|0|||
156670763|NCT01218867|565540874|FG008|Overall Study|Death during treatment|0|||
156670764|NCT01218867|565540875|FG009|Overall Study|Death during treatment|0|||
156670765|NCT01218867|565540876|FG010|Overall Study|Death during treatment|0|||
156670766|NCT00251979|565540877|FG000|Overall Study|Protocol Violation|3|||
156670767|NCT00251979|565540878|FG001|Overall Study|Protocol Violation|5|||
156670768|NCT00251979|565540877|FG000|Overall Study|Adverse Event|11|||
156670769|NCT00251979|565540878|FG001|Overall Study|Adverse Event|17|||
156670770|NCT00251979|565540877|FG000|Overall Study|Withdrawal by Subject|13|||
156670771|NCT00251979|565540878|FG001|Overall Study|Withdrawal by Subject|7|||
156670772|NCT00251979|565540877|FG000|Overall Study|Lost to Follow-up|8|||
156670773|NCT00251979|565540878|FG001|Overall Study|Lost to Follow-up|6|||
156670774|NCT00251979|565540877|FG000|Overall Study|Death|3|||
156670775|NCT00251979|565540878|FG001|Overall Study|Death|5|||
156670776|NCT01348789|565540886|FG000|Overall Study|Protocol Violation|2|||
156670777|NCT01348789|565540886|FG000|Overall Study|Withdrawal by Subject|2|||
156670778|NCT01878292|565540887|FG000|Randomized|Protocol Violation|1|||
156670779|NCT01878292|565540888|FG001|Randomized|Protocol Violation|0|||
156670780|NCT01878292|565540889|FG002|Randomized|Protocol Violation|0|||
156670781|NCT01878292|565540887|FG000|Randomized|Lost to Follow-up|1|||
156670782|NCT01878292|565540888|FG001|Randomized|Lost to Follow-up|0|||
156670783|NCT01878292|565540889|FG002|Randomized|Lost to Follow-up|0|||
156670784|NCT01878292|565540887|FG000|Randomized|Adverse Event|1|||
156670785|NCT01878292|565540888|FG001|Randomized|Adverse Event|0|||
156670786|NCT01878292|565540889|FG002|Randomized|Adverse Event|0|||
156670787|NCT01878292|565540887|FG000|Double-blind Treatment Period|Other Reasons|2|||
156670788|NCT01878292|565540888|FG001|Double-blind Treatment Period|Other Reasons|0|||
156670789|NCT01878292|565540889|FG002|Double-blind Treatment Period|Other Reasons|0|||
156670790|NCT01878292|565540887|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
156670791|NCT01878292|565540888|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
156670792|NCT01878292|565540889|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
156670793|NCT01878292|565540887|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
156670794|NCT01878292|565540888|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
156670795|NCT01878292|565540889|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
156670796|NCT01878292|565540887|FG000|Double-blind Treatment Period|Protocol Violation|3|||
156670797|NCT01878292|565540888|FG001|Double-blind Treatment Period|Protocol Violation|4|||
156670798|NCT01878292|565540889|FG002|Double-blind Treatment Period|Protocol Violation|2|||
156526625|NCT00585195|565021570|FG008|Overall Study|Randomized not treated|0|||
156526626|NCT00585195|565021571|FG009|Overall Study|Randomized not treated|0|||
156526627|NCT00585195|565021572|FG010|Overall Study|Randomized not treated|2|||
156526628|NCT00585195|565021573|FG011|Overall Study|Randomized not treated|0|||
156526629|NCT00585195|565021574|FG012|Overall Study|Randomized not treated|0|||
156670799|NCT01878292|565540887|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
156670800|NCT01878292|565540888|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
156670801|NCT01878292|565540889|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
156670802|NCT01878292|565540887|FG000|Double-blind Treatment Period|Adverse Event|4|||
156670803|NCT01878292|565540888|FG001|Double-blind Treatment Period|Adverse Event|9|||
156526630|NCT00585195|565021575|FG013|Overall Study|Randomized not treated|0|||
156526631|NCT00585195|565021576|FG014|Overall Study|Randomized not treated|0|||
156526632|NCT00585195|565021577|FG015|Overall Study|Randomized not treated|1|||
156670804|NCT01878292|565540889|FG002|Double-blind Treatment Period|Adverse Event|8|||
156670805|NCT01878292|565540887|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
156670806|NCT01878292|565540888|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
156670807|NCT01878292|565540889|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
156670808|NCT00323882|565540890|FG000|Overall Study|Adverse Event|2|||
156670809|NCT00323882|565540891|FG001|Overall Study|Adverse Event|1|||
156670810|NCT00323882|565540892|FG002|Overall Study|Adverse Event|1|||
156670811|NCT00323882|565540893|FG003|Overall Study|Adverse Event|1|||
156670812|NCT00323882|565540894|FG004|Overall Study|Adverse Event|3|||
156670813|NCT00323882|565540890|FG000|Overall Study|Disease Progression|6|||
156670814|NCT00323882|565540891|FG001|Overall Study|Disease Progression|4|||
156670815|NCT00323882|565540892|FG002|Overall Study|Disease Progression|10|||
156670816|NCT00323882|565540893|FG003|Overall Study|Disease Progression|5|||
156670817|NCT00323882|565540894|FG004|Overall Study|Disease Progression|22|||
156670818|NCT00323882|565540890|FG000|Overall Study|Death|0|||
156670819|NCT00323882|565540891|FG001|Overall Study|Death|1|||
156670820|NCT00323882|565540892|FG002|Overall Study|Death|1|||
156670821|NCT00323882|565540893|FG003|Overall Study|Death|0|||
156670822|NCT00323882|565540894|FG004|Overall Study|Death|5|||
156670823|NCT00323882|565540890|FG000|Overall Study|Lost to Follow-up|0|||
156670824|NCT00323882|565540891|FG001|Overall Study|Lost to Follow-up|0|||
156670825|NCT00323882|565540892|FG002|Overall Study|Lost to Follow-up|1|||
156670826|NCT00323882|565540893|FG003|Overall Study|Lost to Follow-up|0|||
156670827|NCT00323882|565540894|FG004|Overall Study|Lost to Follow-up|1|||
156670828|NCT00323882|565540890|FG000|Overall Study|Other|0|||
156670829|NCT00323882|565540891|FG001|Overall Study|Other|0|||
156670830|NCT00323882|565540892|FG002|Overall Study|Other|0|||
156670831|NCT00323882|565540893|FG003|Overall Study|Other|1|||
156670832|NCT00323882|565540894|FG004|Overall Study|Other|1|||
156670833|NCT00429416|565540895|FG000|Overall Study|Death|1|||
156670834|NCT02530905|565540896|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
156670835|NCT02530905|565540897|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
156670836|NCT02530905|565540898|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
156670837|NCT00415363|565540904|FG000|Overall Study|Withdrawal by Subject|4|||
156670838|NCT00415363|565540905|FG001|Overall Study|Withdrawal by Subject|4|||
156670839|NCT00415363|565540904|FG000|Overall Study|Adverse Event|4|||
156670840|NCT00415363|565540905|FG001|Overall Study|Adverse Event|4|||
156670841|NCT00415363|565540904|FG000|Overall Study|Lost to Follow-up|2|||
156670842|NCT00415363|565540905|FG001|Overall Study|Lost to Follow-up|1|||
156526633|NCT00585195|565021578|FG016|Overall Study|Randomized not treated|0|||
156526634|NCT00585195|565021579|FG017|Overall Study|Randomized not treated|1|||
156526635|NCT00585195|565021580|FG018|Overall Study|Randomized not treated|3|||
156526636|NCT00585195|565021581|FG019|Overall Study|Randomized not treated|0|||
156526637|NCT00585195|565021582|FG020|Overall Study|Randomized not treated|2|||
156526638|NCT00585195|565021562|FG000|Overall Study|Death|0|||
156526639|NCT00585195|565021563|FG001|Overall Study|Death|0|||
156526640|NCT00585195|565021564|FG002|Overall Study|Death|0|||
156670843|NCT00415363|565540904|FG000|Overall Study|Physician Decision|3|||
156431160|NCT02377362|564667823|FG003|Part B Overall|Withdrawal by Subject|0|||
156431161|NCT02377362|564667824|FG004|Part B Overall|Withdrawal by Subject|0|||
156431162|NCT02377362|564667825|FG005|Part B Overall|Withdrawal by Subject|0|||
156431163|NCT02377362|564667826|FG006|Part B Overall|Withdrawal by Subject|1|||
156431164|NCT02377362|564667827|FG007|Part B Overall|Withdrawal by Subject|0|||
156431165|NCT02377362|564667828|FG008|Part B Overall|Withdrawal by Subject|0|||
156670844|NCT00415363|565540905|FG001|Overall Study|Physician Decision|1|||
156670845|NCT00415363|565540904|FG000|Overall Study|Death|16|||
156670846|NCT00415363|565540905|FG001|Overall Study|Death|12|||
156670847|NCT00415363|565540904|FG000|Overall Study|Progressive disease|26|||
156526641|NCT00585195|565021565|FG003|Overall Study|Death|0|||
156431166|NCT02377362|564667829|FG009|Part B Overall|Withdrawal by Subject|0|||
156670848|NCT00415363|565540905|FG001|Overall Study|Progressive disease|32|||
156431167|NCT02377362|564667830|FG010|Part B Overall|Withdrawal by Subject|0|||
156431168|NCT02377362|564667831|FG011|Part B Overall|Withdrawal by Subject|1|||
156431169|NCT02377362|564667832|FG012|Part B Overall|Withdrawal by Subject|0|||
156431170|NCT01120275|564667835|FG000|Overall Study|Adverse Event|3|||
156431171|NCT01120275|564667835|FG000|Overall Study|Progression|27|||
156431172|NCT01120275|564667835|FG000|Overall Study|Ineligible|3|||
156431173|NCT01120275|564667835|FG000|Overall Study|Withdrawal by Subject|1|||
156526642|NCT00585195|565021566|FG004|Overall Study|Death|0|||
156526643|NCT00585195|565021567|FG005|Overall Study|Death|0|||
156526644|NCT00585195|565021568|FG006|Overall Study|Death|0|||
156526645|NCT00585195|565021569|FG007|Overall Study|Death|0|||
156526646|NCT00585195|565021570|FG008|Overall Study|Death|1|||
156526647|NCT00585195|565021571|FG009|Overall Study|Death|0|||
156670849|NCT03123471|565540908|FG000|Placebo-controlled Phase|Adverse Event|3|||
156670850|NCT03123471|565540909|FG001|Placebo-controlled Phase|Adverse Event|8|||
156670851|NCT03123471|565540908|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
156670852|NCT03123471|565540909|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
156670853|NCT03123471|565540908|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
156670854|NCT03123471|565540909|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
156670855|NCT03123471|565540908|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
156670856|NCT03123471|565540909|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
156670857|NCT03123471|565540908|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
156670858|NCT03123471|565540909|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
156670859|NCT03123471|565540908|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
156670860|NCT03123471|565540909|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
156670861|NCT03123471|565540908|FG000|Placebo-controlled Phase|Miscellaneous|0|||
156670862|NCT03123471|565540909|FG001|Placebo-controlled Phase|Miscellaneous|1|||
156670863|NCT03123471|565540908|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
156670864|NCT03123471|565540909|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
156670865|NCT03123471|565540908|FG000|Apremilast Extension Phase|Adverse Event|1|||
156670866|NCT03123471|565540909|FG001|Apremilast Extension Phase|Adverse Event|5|||
156670867|NCT03123471|565540908|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
156670868|NCT03123471|565540909|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
156670869|NCT03123471|565540908|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
156670870|NCT03123471|565540909|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
156670871|NCT01136174|565540911|FG000|Overall Study|Adverse Event|0|||
156670872|NCT01136174|565540912|FG001|Overall Study|Adverse Event|0|||
156670873|NCT01136174|565540913|FG002|Overall Study|Adverse Event|0|||
156670874|NCT01136174|565540914|FG003|Overall Study|Adverse Event|4|||
156670875|NCT01030133|565540919|FG000|Overall Study|failed to experience pain at level 7/10|2|||
156670876|NCT01030133|565540920|FG001|Overall Study|failed to experience pain at level 7/10|2|||
156670877|NCT01958294|565542900|FG000|Overall Study|Clinical Circumstances|2|||
156670878|NCT00682461|565542902|FG000|Overall Study|Adverse Event|5|||
156670879|NCT00682461|565542903|FG001|Overall Study|Adverse Event|7|||
156670880|NCT00682461|565542902|FG000|Overall Study|Lost to Follow-up|8|||
156670881|NCT00682461|565542903|FG001|Overall Study|Lost to Follow-up|5|||
156670882|NCT00682461|565542902|FG000|Overall Study|Withdrawal by Subject|12|||
156670883|NCT00682461|565542903|FG001|Overall Study|Withdrawal by Subject|19|||
156670884|NCT00665925|565542904|FG000|Overall Study|Lack of Efficacy|10|||
156670885|NCT00665925|565542905|FG001|Overall Study|Lack of Efficacy|8|||
156670886|NCT00665925|565542906|FG002|Overall Study|Lack of Efficacy|9|||
156670887|NCT00665925|565542907|FG003|Overall Study|Lack of Efficacy|8|||
156670888|NCT00665925|565542904|FG000|Overall Study|Lost to Follow-up|1|||
156670889|NCT00665925|565542905|FG001|Overall Study|Lost to Follow-up|2|||
156670890|NCT00665925|565542906|FG002|Overall Study|Lost to Follow-up|2|||
156670891|NCT00665925|565542907|FG003|Overall Study|Lost to Follow-up|2|||
156670892|NCT00665925|565542904|FG000|Overall Study|Withdrawal by Subject|2|||
156670893|NCT00665925|565542905|FG001|Overall Study|Withdrawal by Subject|2|||
156670894|NCT00665925|565542906|FG002|Overall Study|Withdrawal by Subject|3|||
156670895|NCT00665925|565542907|FG003|Overall Study|Withdrawal by Subject|2|||
156670896|NCT00665925|565542904|FG000|Overall Study|Physician Decision|0|||
156670897|NCT00665925|565542905|FG001|Overall Study|Physician Decision|0|||
156670898|NCT00665925|565542906|FG002|Overall Study|Physician Decision|1|||
156670899|NCT00665925|565542907|FG003|Overall Study|Physician Decision|2|||
156670900|NCT00665925|565542904|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
156670901|NCT00665925|565542905|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
156670902|NCT00665925|565542906|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
156670903|NCT00665925|565542907|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
156670904|NCT00665925|565542904|FG000|Overall Study|Adverse Event|1|||
156670905|NCT00665925|565542905|FG001|Overall Study|Adverse Event|5|||
156670906|NCT00665925|565542906|FG002|Overall Study|Adverse Event|10|||
156670907|NCT00665925|565542907|FG003|Overall Study|Adverse Event|5|||
156670908|NCT00665925|565542904|FG000|Overall Study|Enrolled by mistake|0|||
156670909|NCT00665925|565542905|FG001|Overall Study|Enrolled by mistake|0|||
156670910|NCT00665925|565542906|FG002|Overall Study|Enrolled by mistake|0|||
156670911|NCT00665925|565542907|FG003|Overall Study|Enrolled by mistake|1|||
156670912|NCT00665925|565542904|FG000|Overall Study|Due to exclusion criteria|1|||
156327104|NCT00267189|564297487|FG001|Overall Study|Death|0|||
156327105|NCT00267189|564297486|FG000|Overall Study|Missing|3|||
156327106|NCT00267189|564297487|FG001|Overall Study|Missing|0|||
156327107|NCT00751621|564297488|FG000|Overall Study|Adverse Event|1|||
156327108|NCT00751621|564297488|FG000|Overall Study|Withdrawal by Subject|1|||
156327109|NCT00751621|564297488|FG000|Overall Study|Subject moved to another country|1|||
156327110|NCT00751621|564297488|FG000|Overall Study|Poor adherence to asthma treatment|1|||
156327111|NCT01123850|564297491|FG000|Overall Study|Slow enrollment|45|||
156327112|NCT04508140|564297492|FG000|Overall Study|Adverse Event|2|||
156327113|NCT04508140|564297493|FG001|Overall Study|Adverse Event|2|||
156327114|NCT04508140|564297492|FG000|Overall Study|Withdrawal by Subject|0|||
156327115|NCT04508140|564297493|FG001|Overall Study|Withdrawal by Subject|2|||
156327116|NCT04508140|564297492|FG000|Overall Study|progressive disease|9|||
156327117|NCT04508140|564297493|FG001|Overall Study|progressive disease|3|||
156327118|NCT04795622|564297497|FG000|Overall Study|Adverse Event|1|||
156670913|NCT00665925|565542905|FG001|Overall Study|Due to exclusion criteria|0|||
156670914|NCT00665925|565542906|FG002|Overall Study|Due to exclusion criteria|0|||
156670915|NCT00665925|565542907|FG003|Overall Study|Due to exclusion criteria|0|||
156670916|NCT04035187|565542908|FG000|Overall Study|Withdrawal by Subject|2|||
156670917|NCT04035187|565542909|FG001|Overall Study|Withdrawal by Subject|1|||
156670918|NCT04035187|565542910|FG002|Overall Study|Withdrawal by Subject|0|||
156670919|NCT04035187|565542911|FG003|Overall Study|Withdrawal by Subject|0|||
156670920|NCT04035187|565542908|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
156670921|NCT04035187|565542909|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
156670922|NCT04035187|565542910|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
156670923|NCT04035187|565542911|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
156670924|NCT01547286|565542924|FG000|Overall Study|Did not meet all eligibility criteria|1|||
156670925|NCT01547286|565542924|FG000|Overall Study|Physician Decision|1|||
156670926|NCT03415308|565542927|FG000|Overall Study|Lost to Follow-up|0|||
156670927|NCT03415308|565542928|FG001|Overall Study|Lost to Follow-up|0|||
156670928|NCT03415308|565542929|FG002|Overall Study|Lost to Follow-up|1|||
156670929|NCT03415308|565542927|FG000|Overall Study|Scheduling Conflicts|0|||
156670930|NCT03415308|565542928|FG001|Overall Study|Scheduling Conflicts|0|||
156670931|NCT03415308|565542929|FG002|Overall Study|Scheduling Conflicts|7|||
156670932|NCT00081653|565542930|FG000|Overall Study|Adverse Event|23|||
156670933|NCT00081653|565542931|FG001|Overall Study|Adverse Event|17|||
156670934|NCT00081653|565542930|FG000|Overall Study|Lost to Follow-up|2|||
156670935|NCT00081653|565542931|FG001|Overall Study|Lost to Follow-up|4|||
156670936|NCT00081653|565542930|FG000|Overall Study|Refused Treatment|18|||
156670937|NCT00081653|565542931|FG001|Overall Study|Refused Treatment|14|||
156670938|NCT00081653|565542930|FG000|Overall Study|Low bone mineral density|1|||
156670939|NCT00081653|565542931|FG001|Overall Study|Low bone mineral density|0|||
156670940|NCT00081653|565542930|FG000|Overall Study|Bone loss|2|||
156670941|NCT00081653|565542931|FG001|Overall Study|Bone loss|0|||
156670942|NCT00081653|565542930|FG000|Overall Study|Participant leaving country|1|||
156670943|NCT00081653|565542931|FG001|Overall Study|Participant leaving country|0|||
156670944|NCT00081653|565542930|FG000|Overall Study|Loss of bone mass|0|||
156670945|NCT00081653|565542931|FG001|Overall Study|Loss of bone mass|2|||
156670946|NCT03246503|565542932|FG000|Overall Study|Lost to Follow-up|23|||
156670947|NCT03246503|565542932|FG000|Overall Study|Withdrawal by Subject|20|||
156670948|NCT03246503|565542932|FG000|Overall Study|Physician Decision|5|||
156670949|NCT03246503|565542932|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
156670950|NCT03128723|565542935|FG000|Overall Study|Withdrawal by Subject|2|||
156670951|NCT00673660|565542937|FG000|Overall Study|Lost to Follow-up|107|||
156670952|NCT00933686|565542938|FG000|Overall Study|Protocol Violation|0|||
156670953|NCT00933686|565542939|FG001|Overall Study|Protocol Violation|1|||
156670954|NCT00933686|565542938|FG000|Overall Study|Lost to Follow-up|2|||
156670955|NCT00933686|565542939|FG001|Overall Study|Lost to Follow-up|2|||
156670956|NCT00933686|565542938|FG000|Overall Study|Withdrawal by Subject|6|||
156670957|NCT00933686|565542939|FG001|Overall Study|Withdrawal by Subject|5|||
156670958|NCT00933686|565542938|FG000|Overall Study|Adverse Event|1|||
156670959|NCT00933686|565542939|FG001|Overall Study|Adverse Event|1|||
156670960|NCT00933686|565542938|FG000|Overall Study|Physician Decision|1|||
156670961|NCT00933686|565542939|FG001|Overall Study|Physician Decision|0|||
156670962|NCT00933686|565542938|FG000|Overall Study|Failure to show up at endpoint visits|0|||
156670963|NCT00933686|565542939|FG001|Overall Study|Failure to show up at endpoint visits|2|||
156670964|NCT01244620|565542940|FG000|Overall Study|Study terminated|4|||
156670965|NCT01244620|565542941|FG001|Overall Study|Study terminated|4|||
156670966|NCT01244620|565542942|FG002|Overall Study|Study terminated|4|||
156431174|NCT01120275|564667835|FG000|Overall Study|Refusal|1|||
156670967|NCT01244620|565542943|FG003|Overall Study|Study terminated|4|||
156670968|NCT02321098|565542944|FG000|12 Weeks Treament|Lost to Follow-up|1|||
156670969|NCT02321098|565542945|FG001|12 Weeks Treament|Lost to Follow-up|1|||
156670970|NCT02321098|565542946|FG002|12 Weeks Treament|Lost to Follow-up|0|||
156670971|NCT02321098|565542944|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
156670972|NCT02321098|565542945|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
156670973|NCT02321098|565542946|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
156670974|NCT02321098|565542944|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
156670975|NCT02321098|565542945|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
156670976|NCT02321098|565542946|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
156670977|NCT02321098|565542944|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
156327119|NCT04795622|564297498|FG001|Overall Study|Adverse Event|0|||
156327120|NCT04795622|564297497|FG000|Overall Study|Withdrawal by Subject|3|||
156327121|NCT04795622|564297498|FG001|Overall Study|Withdrawal by Subject|3|||
156327122|NCT04795622|564297497|FG000|Overall Study|Protocol Violation|0|||
156327123|NCT04795622|564297498|FG001|Overall Study|Protocol Violation|2|||
156327124|NCT04795622|564297497|FG000|Overall Study|Lost to Follow-up|2|||
156327125|NCT04795622|564297498|FG001|Overall Study|Lost to Follow-up|3|||
156327126|NCT04795622|564297497|FG000|Overall Study|Other|7|||
156327127|NCT04795622|564297498|FG001|Overall Study|Other|8|||
156327128|NCT01437878|564297501|FG000|Overall Study|Withdrawal by Subject|1|||
156670978|NCT02321098|565542945|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
156670979|NCT02321098|565542946|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
156670980|NCT01663233|565542947|FG000|Overall Study|Withdrawal by Subject|3|||
156670981|NCT01663233|565542948|FG001|Overall Study|Withdrawal by Subject|2|||
156670982|NCT01663233|565542947|FG000|Overall Study|Protocol Deviation|1|||
156670983|NCT01663233|565542948|FG001|Overall Study|Protocol Deviation|4|||
156670984|NCT01663233|565542947|FG000|Overall Study|Lost to Follow-up|0|||
156670985|NCT01663233|565542948|FG001|Overall Study|Lost to Follow-up|1|||
156670986|NCT00796328|565542951|FG000|Overall Study|experienced hypotension requiring tx|6|||
156670987|NCT03261167|565542952|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
156670988|NCT03261167|565542953|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
156670989|NCT03261167|565542952|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
156670990|NCT03261167|565542953|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
156670991|NCT03261167|565542952|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
156670992|NCT03261167|565542953|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
156670993|NCT03261167|565542952|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
156670994|NCT03261167|565542953|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
156670995|NCT03261167|565542952|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
156670996|NCT03261167|565542953|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
156670997|NCT03669861|565542956|FG000|Overall Study|Disease Flare|5|||
156670998|NCT03669861|565542956|FG000|Overall Study|Lack of Efficacy|2|||
156670999|NCT02760927|565542961|FG000|Overall Study|Tube Slippage from Device|1|||
156671000|NCT00705666|565542962|FG000|Overall Study|No post-treatment questionnaire|279|||
156671001|NCT00705666|565542962|FG000|Overall Study|Withdrawal by Subject|21|||
156671002|NCT00705666|565542962|FG000|Overall Study|Physician Decision|7|||
156671003|NCT00705666|565542962|FG000|Overall Study|Lost to Follow-up|5|||
156671004|NCT00705666|565542962|FG000|Overall Study|Death|1|||
156671005|NCT00705666|565542962|FG000|Overall Study|Adverse Event|4|||
156671006|NCT00705666|565542962|FG000|Overall Study|Other|12|||
156671007|NCT00705666|565542962|FG000|Overall Study|Other|2|||
156671008|NCT00705666|565542962|FG000|Overall Study|Lack of data|3|||
156671009|NCT00705666|565542962|FG000|Overall Study|Untreated|5|||
156671010|NCT02105272|565542964|FG000|Overall Study|Adverse Event|1|||
156671011|NCT02105272|565542965|FG001|Overall Study|Adverse Event|2|||
156671012|NCT02105272|565542964|FG000|Overall Study|Physician Decision|0|||
156671013|NCT02105272|565542965|FG001|Overall Study|Physician Decision|1|||
156671014|NCT02105272|565542964|FG000|Overall Study|Protocol Violation|2|||
156671015|NCT02105272|565542965|FG001|Overall Study|Protocol Violation|0|||
156671016|NCT02105272|565542964|FG000|Overall Study|Withdrawal by Subject|2|||
156671017|NCT02105272|565542965|FG001|Overall Study|Withdrawal by Subject|0|||
156671018|NCT04078022|565542978|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
156671019|NCT04078022|565542979|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
156671020|NCT01250912|565542980|FG000|Overall Study|Lost to Follow-up|1|||
156671021|NCT01929863|565542981|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
156671022|NCT01929863|565542982|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
156671023|NCT01929863|565542981|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
156671024|NCT01929863|565542982|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
156671025|NCT01929863|565542981|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
156671026|NCT01929863|565542982|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
156671027|NCT02152163|565542985|FG000|Overall Study|Physician Decision|12|||
156671028|NCT02152163|565542986|FG001|Overall Study|Physician Decision|13|||
156671029|NCT02358538|565542987|FG000|Through Week 26|Adverse Event|0|||
156671030|NCT02358538|565542988|FG001|Through Week 26|Adverse Event|1|||
156671031|NCT02358538|565542989|FG002|Through Week 26|Adverse Event|1|||
156671032|NCT02358538|565542990|FG003|Through Week 26|Adverse Event|2|||
156671033|NCT02358538|565542987|FG000|Through Week 26|Lack of Efficacy|1|||
156671034|NCT02358538|565542988|FG001|Through Week 26|Lack of Efficacy|1|||
156671035|NCT02358538|565542989|FG002|Through Week 26|Lack of Efficacy|3|||
156671036|NCT02358538|565542990|FG003|Through Week 26|Lack of Efficacy|3|||
156671037|NCT02358538|565542987|FG000|Through Week 26|Withdrawal by Subject|1|||
156671038|NCT02358538|565542988|FG001|Through Week 26|Withdrawal by Subject|0|||
156671039|NCT02358538|565542989|FG002|Through Week 26|Withdrawal by Subject|0|||
156671040|NCT02358538|565542990|FG003|Through Week 26|Withdrawal by Subject|0|||
156671041|NCT02358538|565542987|FG000|Through Week 26|Non-Compliance|0|||
156671042|NCT02358538|565542988|FG001|Through Week 26|Non-Compliance|0|||
156671043|NCT02358538|565542989|FG002|Through Week 26|Non-Compliance|1|||
156671044|NCT02358538|565542990|FG003|Through Week 26|Non-Compliance|0|||
156671045|NCT02358538|565542987|FG000|Through Week 26|Family did not see benefit from IP|1|||
156671046|NCT02358538|565542988|FG001|Through Week 26|Family did not see benefit from IP|0|||
156671047|NCT02358538|565542989|FG002|Through Week 26|Family did not see benefit from IP|0|||
156671048|NCT02358538|565542990|FG003|Through Week 26|Family did not see benefit from IP|0|||
156671049|NCT02358538|565542987|FG000|52 Week Extension Period|Lack of Efficacy|0|||
156671050|NCT02358538|565542988|FG001|52 Week Extension Period|Lack of Efficacy|0|||
156671051|NCT02358538|565542989|FG002|52 Week Extension Period|Lack of Efficacy|2|||
156671052|NCT02358538|565542990|FG003|52 Week Extension Period|Lack of Efficacy|4|||
156671053|NCT01686477|565542991|FG000|Feeding Intervention|Death|1|||
156671054|NCT01686477|565542992|FG001|Feeding Intervention|Death|0|||
156671055|NCT01686477|565542993|FG002|Feeding Intervention|Death|1|||
156671056|NCT01686477|565542991|FG000|Feeding Intervention|Withdrawal by Subject|0|||
156671057|NCT01686477|565542992|FG001|Feeding Intervention|Withdrawal by Subject|6|||
156671058|NCT01686477|565542993|FG002|Feeding Intervention|Withdrawal by Subject|0|||
156671059|NCT01686477|565542991|FG000|Feeding Intervention|Physician Decision|1|||
156671060|NCT01686477|565542992|FG001|Feeding Intervention|Physician Decision|2|||
156671061|NCT01686477|565542993|FG002|Feeding Intervention|Physician Decision|0|||
156671062|NCT01686477|565542991|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
156671063|NCT01686477|565542992|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
156526648|NCT00585195|565021572|FG010|Overall Study|Death|1|||
156431175|NCT01120275|564667835|FG000|Overall Study|Not specific|1|||
156431176|NCT00290732|564667837|FG000|Overall Study|Inability to instill drug intraductally.|0|||
156431177|NCT00290732|564667838|FG001|Overall Study|Inability to instill drug intraductally.|1|||
156431178|NCT00290732|564667839|FG002|Overall Study|Inability to instill drug intraductally.|1|||
156431179|NCT00290732|564667840|FG003|Overall Study|Inability to instill drug intraductally.|0|||
156431180|NCT00290732|564667841|FG004|Overall Study|Inability to instill drug intraductally.|0|||
156431181|NCT02736799|564667842|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
156431182|NCT02736799|564667843|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
156431183|NCT02736799|564667844|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
156431184|NCT02736799|564667845|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
156431185|NCT01833832|564667846|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
156431186|NCT01156116|564667847|FG000|Overall Study|Withdrawal by Subject|3|||
156431187|NCT01156116|564667848|FG001|Overall Study|Withdrawal by Subject|1|||
156431188|NCT01156116|564667847|FG000|Overall Study|CPAP intolerance|2|||
156431189|NCT01156116|564667848|FG001|Overall Study|CPAP intolerance|0|||
156431190|NCT00843193|564667849|FG000|Overall Study|Adverse Event|2|||
156431191|NCT00843193|564667850|FG001|Overall Study|Adverse Event|4|||
156431192|NCT00843193|564667849|FG000|Overall Study|Lack of Efficacy|1|||
156431193|NCT00843193|564667850|FG001|Overall Study|Lack of Efficacy|1|||
156431194|NCT00843193|564667849|FG000|Overall Study|Protocol Violation|1|||
156431195|NCT00843193|564667850|FG001|Overall Study|Protocol Violation|2|||
156431196|NCT00843193|564667849|FG000|Overall Study|Lost to Follow-up|1|||
156431197|NCT00843193|564667850|FG001|Overall Study|Lost to Follow-up|0|||
156431198|NCT00843193|564667849|FG000|Overall Study|Physician Decision|0|||
156431199|NCT00843193|564667850|FG001|Overall Study|Physician Decision|1|||
156431200|NCT00843193|564667849|FG000|Overall Study|Withdrawal by Subject|3|||
156431201|NCT00843193|564667850|FG001|Overall Study|Withdrawal by Subject|3|||
156431202|NCT02057718|564667851|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
156431203|NCT02057718|564667852|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
156431204|NCT02057718|564667851|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
156431205|NCT02057718|564667852|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
156431206|NCT02057718|564667851|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
156671064|NCT01686477|565542993|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
156671065|NCT01686477|565542991|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
156431207|NCT02057718|564667852|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
156526649|NCT00585195|565021573|FG011|Overall Study|Death|1|||
156431208|NCT02057718|564667851|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
156431209|NCT02057718|564667852|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
156431210|NCT02057718|564667851|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
156431211|NCT02057718|564667852|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
156431212|NCT02057718|564667851|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
156431213|NCT02057718|564667852|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
156431214|NCT02057718|564667851|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
156431215|NCT02057718|564667852|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
156431216|NCT02057718|564667851|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
156431217|NCT02057718|564667852|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
156431218|NCT02057718|564667851|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
156431219|NCT02057718|564667852|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
156431220|NCT02057718|564667851|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
156431221|NCT02057718|564667852|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
156431222|NCT02057718|564667851|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
156431223|NCT02057718|564667852|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
156526650|NCT00585195|565021574|FG012|Overall Study|Death|7|||
156526651|NCT00585195|565021575|FG013|Overall Study|Death|2|||
156526652|NCT00585195|565021576|FG014|Overall Study|Death|8|||
156671066|NCT01686477|565542992|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
156671067|NCT01686477|565542993|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
156671068|NCT01686477|565542991|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
156671069|NCT01686477|565542992|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
156671070|NCT01686477|565542993|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
156671071|NCT01686477|565542991|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
156671072|NCT01686477|565542992|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
156671073|NCT01686477|565542993|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
156671074|NCT01686477|565542991|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
156671075|NCT01686477|565542992|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
156671076|NCT01686477|565542993|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
156671077|NCT01686477|565542991|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
156671078|NCT01686477|565542992|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
156671079|NCT01686477|565542993|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
156671080|NCT01686477|565542991|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
156671081|NCT01686477|565542992|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
156671082|NCT01686477|565542993|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
156671083|NCT06999265|565542994|FG000|Overall Study|Lost to Follow-up|1|||
156671084|NCT06999265|565542995|FG001|Overall Study|Lost to Follow-up|1|||
156671085|NCT00730691|565542996|FG000|Overall Study|Adverse Event|4|||
156671086|NCT00730691|565542997|FG001|Overall Study|Adverse Event|8|||
156671087|NCT00730691|565542998|FG002|Overall Study|Adverse Event|11|||
156671088|NCT00730691|565542999|FG003|Overall Study|Adverse Event|11|||
156671089|NCT00730691|565543000|FG004|Overall Study|Adverse Event|23|||
156671090|NCT00730691|565542996|FG000|Overall Study|Lack of Efficacy|4|||
156671091|NCT00730691|565542997|FG001|Overall Study|Lack of Efficacy|4|||
156671092|NCT00730691|565542998|FG002|Overall Study|Lack of Efficacy|2|||
156671093|NCT00730691|565542999|FG003|Overall Study|Lack of Efficacy|1|||
156526653|NCT00585195|565021577|FG015|Overall Study|Death|2|||
156526654|NCT00585195|565021578|FG016|Overall Study|Death|11|||
156526655|NCT00585195|565021579|FG017|Overall Study|Death|0|||
156526656|NCT00585195|565021580|FG018|Overall Study|Death|0|||
156526657|NCT00585195|565021581|FG019|Overall Study|Death|0|||
156526658|NCT00585195|565021582|FG020|Overall Study|Death|1|||
156526659|NCT00585195|565021562|FG000|Overall Study|Lost to Follow-up|0|||
156526660|NCT00585195|565021563|FG001|Overall Study|Lost to Follow-up|0|||
156526661|NCT00585195|565021564|FG002|Overall Study|Lost to Follow-up|0|||
156526662|NCT00585195|565021565|FG003|Overall Study|Lost to Follow-up|0|||
156526663|NCT00585195|565021566|FG004|Overall Study|Lost to Follow-up|0|||
156526664|NCT00585195|565021567|FG005|Overall Study|Lost to Follow-up|0|||
156526665|NCT00585195|565021568|FG006|Overall Study|Lost to Follow-up|0|||
156526666|NCT00585195|565021569|FG007|Overall Study|Lost to Follow-up|0|||
156526667|NCT00585195|565021570|FG008|Overall Study|Lost to Follow-up|0|||
156526668|NCT00585195|565021571|FG009|Overall Study|Lost to Follow-up|0|||
156526669|NCT00585195|565021572|FG010|Overall Study|Lost to Follow-up|0|||
156526670|NCT00585195|565021573|FG011|Overall Study|Lost to Follow-up|0|||
156526671|NCT00585195|565021574|FG012|Overall Study|Lost to Follow-up|1|||
156526672|NCT00585195|565021575|FG013|Overall Study|Lost to Follow-up|0|||
156526673|NCT00585195|565021576|FG014|Overall Study|Lost to Follow-up|0|||
156526674|NCT00585195|565021577|FG015|Overall Study|Lost to Follow-up|0|||
156526675|NCT00585195|565021578|FG016|Overall Study|Lost to Follow-up|0|||
156526676|NCT00585195|565021579|FG017|Overall Study|Lost to Follow-up|2|||
156526677|NCT00585195|565021580|FG018|Overall Study|Lost to Follow-up|0|||
156526678|NCT00585195|565021581|FG019|Overall Study|Lost to Follow-up|0|||
156526679|NCT00585195|565021582|FG020|Overall Study|Lost to Follow-up|0|||
156526680|NCT00585195|565021562|FG000|Overall Study|Site Terminated by Sponsor|0|||
156526681|NCT00585195|565021563|FG001|Overall Study|Site Terminated by Sponsor|0|||
156526682|NCT00585195|565021564|FG002|Overall Study|Site Terminated by Sponsor|0|||
156526683|NCT00585195|565021565|FG003|Overall Study|Site Terminated by Sponsor|0|||
156526684|NCT00585195|565021566|FG004|Overall Study|Site Terminated by Sponsor|0|||
156526685|NCT00585195|565021567|FG005|Overall Study|Site Terminated by Sponsor|0|||
156526686|NCT00585195|565021568|FG006|Overall Study|Site Terminated by Sponsor|0|||
156671094|NCT00730691|565543000|FG004|Overall Study|Lack of Efficacy|1|||
156671095|NCT00730691|565542996|FG000|Overall Study|Non-compliance with Study Drug|6|||
156671096|NCT00730691|565542997|FG001|Overall Study|Non-compliance with Study Drug|1|||
156671097|NCT00730691|565542998|FG002|Overall Study|Non-compliance with Study Drug|6|||
156671098|NCT00730691|565542999|FG003|Overall Study|Non-compliance with Study Drug|3|||
156526687|NCT00585195|565021569|FG007|Overall Study|Site Terminated by Sponsor|0|||
156526688|NCT00585195|565021570|FG008|Overall Study|Site Terminated by Sponsor|0|||
156526689|NCT00585195|565021571|FG009|Overall Study|Site Terminated by Sponsor|0|||
156526690|NCT00585195|565021572|FG010|Overall Study|Site Terminated by Sponsor|0|||
156526691|NCT00585195|565021573|FG011|Overall Study|Site Terminated by Sponsor|0|||
156671099|NCT00730691|565543000|FG004|Overall Study|Non-compliance with Study Drug|3|||
156526692|NCT00585195|565021574|FG012|Overall Study|Site Terminated by Sponsor|1|||
156526693|NCT00585195|565021575|FG013|Overall Study|Site Terminated by Sponsor|0|||
156671100|NCT00730691|565542996|FG000|Overall Study|Protocol Deviations|3|||
156671101|NCT00730691|565542997|FG001|Overall Study|Protocol Deviations|5|||
156671102|NCT00730691|565542998|FG002|Overall Study|Protocol Deviations|3|||
156671103|NCT00730691|565542999|FG003|Overall Study|Protocol Deviations|7|||
156671104|NCT00730691|565543000|FG004|Overall Study|Protocol Deviations|5|||
156671105|NCT00730691|565542996|FG000|Overall Study|Withdrawal of Consent|7|||
156671106|NCT00730691|565542997|FG001|Overall Study|Withdrawal of Consent|9|||
156671107|NCT00730691|565542998|FG002|Overall Study|Withdrawal of Consent|3|||
156671108|NCT00730691|565542999|FG003|Overall Study|Withdrawal of Consent|6|||
156671109|NCT00730691|565543000|FG004|Overall Study|Withdrawal of Consent|3|||
156671110|NCT00730691|565542996|FG000|Overall Study|Lost to Follow-up|11|||
156671111|NCT00730691|565542997|FG001|Overall Study|Lost to Follow-up|8|||
156671112|NCT00730691|565542998|FG002|Overall Study|Lost to Follow-up|13|||
156671113|NCT00730691|565542999|FG003|Overall Study|Lost to Follow-up|15|||
156671114|NCT00730691|565543000|FG004|Overall Study|Lost to Follow-up|13|||
156671115|NCT00730691|565542996|FG000|Overall Study|Other|1|||
156671116|NCT00730691|565542997|FG001|Overall Study|Other|1|||
156671117|NCT00730691|565542998|FG002|Overall Study|Other|1|||
156671118|NCT00730691|565542999|FG003|Overall Study|Other|2|||
156671119|NCT00730691|565543000|FG004|Overall Study|Other|2|||
156671120|NCT02178787|565543001|FG000|Overall Study|Lost to Follow-up|1|||
156671121|NCT02178787|565543002|FG001|Overall Study|Lost to Follow-up|0|||
156671122|NCT02178787|565543001|FG000|Overall Study|Withdrawal by Subject|0|||
156671123|NCT02178787|565543002|FG001|Overall Study|Withdrawal by Subject|2|||
156671124|NCT02178787|565543001|FG000|Overall Study|No TCD window|3|||
156671125|NCT02178787|565543002|FG001|Overall Study|No TCD window|7|||
156671126|NCT02178787|565543001|FG000|Overall Study|Physician Decision|1|||
156671127|NCT02178787|565543002|FG001|Overall Study|Physician Decision|0|||
156671128|NCT02554890|565543003|FG000|Double-blind|Adverse Event|45|||
156671129|NCT02554890|565543004|FG001|Double-blind|Adverse Event|51|||
156671130|NCT02554890|565543003|FG000|Double-blind|Death|6|||
156671131|NCT02554890|565543004|FG001|Double-blind|Death|4|||
156671132|NCT02554890|565543003|FG000|Double-blind|Protocol Violation|1|||
156671133|NCT02554890|565543004|FG001|Double-blind|Protocol Violation|1|||
156671134|NCT02554890|565543003|FG000|Double-blind|Physician Decision|4|||
156671135|NCT02554890|565543004|FG001|Double-blind|Physician Decision|3|||
156671136|NCT02554890|565543003|FG000|Double-blind|Subject/Guardian decision|21|||
156671137|NCT02554890|565543004|FG001|Double-blind|Subject/Guardian decision|16|||
156671138|NCT02554890|565543003|FG000|Double-blind|Lost to Follow-up|7|||
156671139|NCT02554890|565543004|FG001|Double-blind|Lost to Follow-up|5|||
156671140|NCT02554890|565543003|FG000|Double-blind|Technical problems|1|||
156671141|NCT02554890|565543004|FG001|Double-blind|Technical problems|0|||
156671142|NCT02554890|565543003|FG000|Double-blind|Withdrawal by Subject|5|||
156671143|NCT02554890|565543004|FG001|Double-blind|Withdrawal by Subject|6|||
156671144|NCT02554890|565543003|FG000|Double-blind|Noncompliance with study treatment|6|||
156671145|NCT02554890|565543004|FG001|Double-blind|Noncompliance with study treatment|5|||
156671146|NCT02554890|565543003|FG000|Open-label|Adverse Event|0|||
156671147|NCT02554890|565543004|FG001|Open-label|Adverse Event|30|||
156671148|NCT02554890|565543003|FG000|Open-label|Death|0|||
156671149|NCT02554890|565543004|FG001|Open-label|Death|1|||
156671150|NCT02554890|565543003|FG000|Open-label|Physician Decision|0|||
156671151|NCT02554890|565543004|FG001|Open-label|Physician Decision|1|||
156671152|NCT02554890|565543003|FG000|Open-label|Subject/Guardian decision|0|||
156671153|NCT02554890|565543004|FG001|Open-label|Subject/Guardian decision|11|||
156671154|NCT02554890|565543003|FG000|Open-label|Lost to Follow-up|0|||
156671155|NCT02554890|565543004|FG001|Open-label|Lost to Follow-up|7|||
156671156|NCT02554890|565543003|FG000|Open-label|Technical problems|0|||
156671157|NCT02554890|565543004|FG001|Open-label|Technical problems|1|||
156327129|NCT01437878|564297502|FG001|Overall Study|Withdrawal by Subject|0|||
156671158|NCT02554890|565543003|FG000|Open-label|Withdrawal by Subject|0|||
156671159|NCT02554890|565543004|FG001|Open-label|Withdrawal by Subject|1|||
156671160|NCT03649477|565543010|FG000|Overall Study|Adverse Event|2|||
156671161|NCT03649477|565543011|FG001|Overall Study|Adverse Event|0|||
156671162|NCT03649477|565543012|FG002|Overall Study|Adverse Event|0|||
156671163|NCT04544410|565543013|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
156671164|NCT04544410|565543014|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
156671165|NCT04544410|565543013|FG000|Double-blind Treatment Period|Adverse Event|1|||
156671166|NCT04544410|565543014|FG001|Double-blind Treatment Period|Adverse Event|0|||
156671167|NCT04544410|565543013|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
156671168|NCT04544410|565543014|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
156671169|NCT04544410|565543013|FG000|Double-blind Treatment Period|Protocol Violation|1|||
156671170|NCT04544410|565543014|FG001|Double-blind Treatment Period|Protocol Violation|0|||
156671171|NCT04544410|565543013|FG000|Open-Label Treatment Period|Study Terminated|15|||
156327130|NCT01070043|564297503|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
156671172|NCT04544410|565543014|FG001|Open-Label Treatment Period|Study Terminated|19|||
156671173|NCT04544410|565543013|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
156671174|NCT04544410|565543014|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
156671175|NCT04544410|565543013|FG000|Open-Label Treatment Period|Adverse Event|0|||
156671176|NCT04544410|565543014|FG001|Open-Label Treatment Period|Adverse Event|1|||
156671177|NCT04544410|565543013|FG000|Open-Label Treatment Period|Physician Decision|1|||
156671178|NCT04544410|565543014|FG001|Open-Label Treatment Period|Physician Decision|0|||
156671179|NCT04544410|565543013|FG000|Open-Label Treatment Period|Other|0|||
156671180|NCT04544410|565543014|FG001|Open-Label Treatment Period|Other|1|||
156671181|NCT04493684|565543015|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
156671182|NCT04493684|565543016|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671183|NCT04493684|565543017|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
156671184|NCT04493684|565543018|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671185|NCT04493684|565543019|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671186|NCT04493684|565543020|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
156671187|NCT04493684|565543021|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671188|NCT04493684|565543022|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671189|NCT04493684|565543023|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671190|NCT04493684|565543024|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671191|NCT04493684|565543025|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671192|NCT04493684|565543026|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671193|NCT04493684|565543027|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671194|NCT04493684|565543028|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671195|NCT04493684|565543029|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671196|NCT04493684|565543030|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671197|NCT04493684|565543031|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
156671198|NCT04493684|565543015|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
156671199|NCT04493684|565543016|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671200|NCT04493684|565543017|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671201|NCT04493684|565543018|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671202|NCT04493684|565543019|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671203|NCT04493684|565543020|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671204|NCT04493684|565543021|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671205|NCT04493684|565543022|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671206|NCT04493684|565543023|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671207|NCT04493684|565543024|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671208|NCT04493684|565543025|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671209|NCT04493684|565543026|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156431224|NCT00542386|564667853|FG000|Overall Study|Adverse Event|1|||
156431225|NCT00542386|564667854|FG001|Overall Study|Adverse Event|7|||
156431226|NCT00542386|564667855|FG002|Overall Study|Adverse Event|7|||
156431227|NCT00542386|564667856|FG003|Overall Study|Adverse Event|8|||
156431228|NCT00542386|564667857|FG004|Overall Study|Adverse Event|13|||
156431229|NCT00542386|564667858|FG005|Overall Study|Adverse Event|4|||
156431230|NCT00542386|564667853|FG000|Overall Study|Death|0|||
156431231|NCT00542386|564667854|FG001|Overall Study|Death|0|||
156431232|NCT00542386|564667855|FG002|Overall Study|Death|1|||
156431233|NCT00542386|564667856|FG003|Overall Study|Death|2|||
156431234|NCT00542386|564667857|FG004|Overall Study|Death|1|||
156431235|NCT00542386|564667858|FG005|Overall Study|Death|2|||
156431236|NCT00542386|564667853|FG000|Overall Study|Lack of Efficacy|32|||
156431237|NCT00542386|564667854|FG001|Overall Study|Lack of Efficacy|12|||
156431238|NCT00542386|564667855|FG002|Overall Study|Lack of Efficacy|10|||
156431239|NCT00542386|564667856|FG003|Overall Study|Lack of Efficacy|13|||
156431240|NCT00542386|564667857|FG004|Overall Study|Lack of Efficacy|7|||
156431241|NCT00542386|564667858|FG005|Overall Study|Lack of Efficacy|31|||
156431242|NCT00542386|564667853|FG000|Overall Study|Physician Decision|1|||
156431243|NCT00542386|564667854|FG001|Overall Study|Physician Decision|0|||
156431244|NCT00542386|564667855|FG002|Overall Study|Physician Decision|0|||
156431245|NCT00542386|564667856|FG003|Overall Study|Physician Decision|1|||
156431246|NCT00542386|564667857|FG004|Overall Study|Physician Decision|0|||
156431247|NCT00542386|564667858|FG005|Overall Study|Physician Decision|0|||
156431248|NCT00542386|564667853|FG000|Overall Study|Protocol Violation|0|||
156431249|NCT00542386|564667854|FG001|Overall Study|Protocol Violation|0|||
156431250|NCT00542386|564667855|FG002|Overall Study|Protocol Violation|1|||
156431251|NCT00542386|564667856|FG003|Overall Study|Protocol Violation|0|||
156431252|NCT00542386|564667857|FG004|Overall Study|Protocol Violation|0|||
156431253|NCT00542386|564667858|FG005|Overall Study|Protocol Violation|4|||
156431254|NCT00542386|564667853|FG000|Overall Study|Withdrawal by Subject|5|||
156431255|NCT00542386|564667854|FG001|Overall Study|Withdrawal by Subject|8|||
156431256|NCT00542386|564667855|FG002|Overall Study|Withdrawal by Subject|10|||
156431257|NCT00542386|564667856|FG003|Overall Study|Withdrawal by Subject|11|||
156431258|NCT00542386|564667857|FG004|Overall Study|Withdrawal by Subject|15|||
156431259|NCT00542386|564667858|FG005|Overall Study|Withdrawal by Subject|7|||
156431260|NCT00542386|564667853|FG000|Overall Study|Other Reasons|4|||
156671210|NCT04493684|565543027|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671211|NCT04493684|565543028|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671212|NCT04493684|565543029|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671213|NCT04493684|565543030|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671214|NCT04493684|565543031|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
156671215|NCT04493684|565543015|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671216|NCT04493684|565543016|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671217|NCT04493684|565543017|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671218|NCT04493684|565543018|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671219|NCT04493684|565543019|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671220|NCT04493684|565543020|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671221|NCT04493684|565543021|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
156671222|NCT04493684|565543022|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671223|NCT04493684|565543023|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671224|NCT04493684|565543024|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671225|NCT04493684|565543025|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671226|NCT04493684|565543026|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671227|NCT04493684|565543027|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671228|NCT04493684|565543028|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671229|NCT04493684|565543029|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671230|NCT04493684|565543030|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671231|NCT04493684|565543031|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
156671232|NCT04493684|565543015|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
156671233|NCT04493684|565543016|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671234|NCT04493684|565543017|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671235|NCT04493684|565543018|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671236|NCT04493684|565543019|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671237|NCT04493684|565543020|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671238|NCT04493684|565543021|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671239|NCT04493684|565543022|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671240|NCT04493684|565543023|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671241|NCT04493684|565543024|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671242|NCT04493684|565543025|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671243|NCT04493684|565543026|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671244|NCT04493684|565543027|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671245|NCT04493684|565543028|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671246|NCT04493684|565543029|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156431261|NCT00542386|564667854|FG001|Overall Study|Other Reasons|1|||
156431262|NCT00542386|564667855|FG002|Overall Study|Other Reasons|4|||
156431263|NCT00542386|564667856|FG003|Overall Study|Other Reasons|3|||
156431264|NCT00542386|564667857|FG004|Overall Study|Other Reasons|4|||
156431265|NCT00542386|564667858|FG005|Overall Study|Other Reasons|2|||
156431266|NCT00197015|564667859|FG000|Overall Study|Adverse Event|3|||
156431267|NCT00197015|564667860|FG001|Overall Study|Adverse Event|0|||
156431268|NCT00197015|564667861|FG002|Overall Study|Adverse Event|1|||
156431269|NCT00197015|564667859|FG000|Overall Study|Protocol Violation|0|||
156671247|NCT04493684|565543030|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671248|NCT04493684|565543031|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
156671249|NCT04493684|565543015|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671250|NCT04493684|565543016|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671251|NCT04493684|565543017|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671252|NCT04493684|565543018|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671253|NCT04493684|565543019|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671254|NCT04493684|565543020|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
156671255|NCT04493684|565543021|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671256|NCT04493684|565543022|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671257|NCT04493684|565543023|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671258|NCT04493684|565543024|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671259|NCT04493684|565543025|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671260|NCT04493684|565543026|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671261|NCT04493684|565543027|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671262|NCT04493684|565543028|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156779779|NCT00221104|565943873|FG001|Overall Study|Others|47|||
156431270|NCT00197015|564667860|FG001|Overall Study|Protocol Violation|3|||
156431271|NCT00197015|564667861|FG002|Overall Study|Protocol Violation|3|||
156671263|NCT04493684|565543029|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671264|NCT04493684|565543030|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671265|NCT04493684|565543031|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
156671266|NCT04493684|565543015|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671267|NCT04493684|565543016|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671268|NCT04493684|565543017|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156327131|NCT01070043|564297504|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
156327132|NCT01070043|564297505|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
156327133|NCT01070043|564297503|FG000|Double-Blind Treatment|Adverse Event|0|||
156327134|NCT01070043|564297504|FG001|Double-Blind Treatment|Adverse Event|0|||
156327135|NCT01070043|564297505|FG002|Double-Blind Treatment|Adverse Event|2|||
156327136|NCT00471146|564297506|FG000|Overall Study|Adverse Event|32|||
156327137|NCT00471146|564297507|FG001|Overall Study|Adverse Event|33|||
156327138|NCT00471146|564297506|FG000|Overall Study|Withdrawal by Subject|14|||
156327139|NCT00471146|564297507|FG001|Overall Study|Withdrawal by Subject|11|||
156327140|NCT00471146|564297506|FG000|Overall Study|Death|11|||
156327141|NCT00471146|564297507|FG001|Overall Study|Death|12|||
156327142|NCT00471146|564297506|FG000|Overall Study|Lost to Follow-up|4|||
156327143|NCT00471146|564297507|FG001|Overall Study|Lost to Follow-up|2|||
156327144|NCT00471146|564297506|FG000|Overall Study|Protocol Violation|2|||
156327145|NCT00471146|564297507|FG001|Overall Study|Protocol Violation|2|||
156327146|NCT00471146|564297506|FG000|Overall Study|Objective progression or relapse|84|||
156327147|NCT00471146|564297507|FG001|Overall Study|Objective progression or relapse|87|||
156327148|NCT00471146|564297506|FG000|Overall Study|Global deterioration of health status|12|||
156327149|NCT00471146|564297507|FG001|Overall Study|Global deterioration of health status|14|||
156327150|NCT00471146|564297506|FG000|Overall Study|Randomized but not treated|9|||
156327151|NCT00471146|564297507|FG001|Overall Study|Randomized but not treated|8|||
156327152|NCT00471146|564297506|FG000|Overall Study|Other|4|||
156327153|NCT00471146|564297507|FG001|Overall Study|Other|5|||
156327154|NCT01090973|564297510|FG000|Overall Study|Disease progression|1|||
156327155|NCT00445978|564297511|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
156327156|NCT00445978|564297511|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
156327157|NCT00445978|564297511|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
156327158|NCT00445978|564297511|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
156327159|NCT00445978|564297511|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
156327160|NCT00445978|564297511|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
156327161|NCT00445978|564297511|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
156327162|NCT00445978|564297511|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
156327163|NCT00445978|564297511|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
156327164|NCT02059005|564297512|FG000|Overall Study|Death|1|||
156327165|NCT02059005|564297513|FG001|Overall Study|Death|3|||
156327166|NCT02059005|564297512|FG000|Overall Study|Lost to Follow-up|19|||
156327167|NCT02059005|564297513|FG001|Overall Study|Lost to Follow-up|19|||
156327168|NCT02059005|564297512|FG000|Overall Study|Incarceration|0|||
156327169|NCT02059005|564297513|FG001|Overall Study|Incarceration|1|||
156327170|NCT02059005|564297512|FG000|Overall Study|Inpatient|0|||
156327171|NCT02059005|564297513|FG001|Overall Study|Inpatient|1|||
156327172|NCT00739596|564297518|FG000|Overall Study|Adverse Event|12|||
156327173|NCT00739596|564297519|FG001|Overall Study|Adverse Event|6|||
156327174|NCT00739596|564297518|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
156327175|NCT00739596|564297519|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156327176|NCT00739596|564297518|FG000|Overall Study|Patient Withdrew Consent|8|||
156327177|NCT00739596|564297519|FG001|Overall Study|Patient Withdrew Consent|8|||
156327178|NCT00739596|564297518|FG000|Overall Study|Lost to Follow-up|0|||
156327179|NCT00739596|564297519|FG001|Overall Study|Lost to Follow-up|2|||
156327180|NCT00739596|564297518|FG000|Overall Study|Protocol Deviation|1|||
156327181|NCT00739596|564297519|FG001|Overall Study|Protocol Deviation|1|||
156327182|NCT00908011|564297520|FG000|Overall Study|Withdrawal by Subject|2|||
156327183|NCT00908011|564297521|FG001|Overall Study|Withdrawal by Subject|2|||
156327184|NCT02520661|564297522|FG000|Overall Study|Lost to Follow-up|7|||
156327185|NCT02520661|564297523|FG001|Overall Study|Lost to Follow-up|3|||
156327186|NCT02520661|564297522|FG000|Overall Study|Admitted from ED|49|||
156327187|NCT02520661|564297523|FG001|Overall Study|Admitted from ED|48|||
156327188|NCT02520661|564297522|FG000|Overall Study|ED greater than 24 hours|29|||
156327189|NCT02520661|564297523|FG001|Overall Study|ED greater than 24 hours|38|||
156327190|NCT02520661|564297522|FG000|Overall Study|other ineligibility|14|||
156327191|NCT02520661|564297523|FG001|Overall Study|other ineligibility|22|||
156327192|NCT02520661|564297522|FG000|Overall Study|Withdrawal by Subject|7|||
156327193|NCT02520661|564297523|FG001|Overall Study|Withdrawal by Subject|16|||
156327194|NCT00843726|564297524|FG000|Overall Study|Death|1|||
156327195|NCT00843726|564297525|FG001|Overall Study|Death|0|||
156327196|NCT00843726|564297524|FG000|Overall Study|Withdrawal by Subject|0|||
156327197|NCT00843726|564297525|FG001|Overall Study|Withdrawal by Subject|1|||
156327198|NCT01083485|564299189|FG000|Overall Study|Adverse Event|0|||
156671269|NCT04493684|565543018|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156526694|NCT00585195|565021576|FG014|Overall Study|Site Terminated by Sponsor|0|||
156526695|NCT00585195|565021577|FG015|Overall Study|Site Terminated by Sponsor|0|||
156431272|NCT00197015|564667859|FG000|Overall Study|Withdrawal by Subject|17|||
156431273|NCT00197015|564667860|FG001|Overall Study|Withdrawal by Subject|37|||
156431274|NCT00197015|564667861|FG002|Overall Study|Withdrawal by Subject|34|||
156431275|NCT00197015|564667859|FG000|Overall Study|Lost to Follow-up|28|||
156431276|NCT00197015|564667860|FG001|Overall Study|Lost to Follow-up|46|||
156431277|NCT00197015|564667861|FG002|Overall Study|Lost to Follow-up|37|||
156431278|NCT00197015|564667859|FG000|Overall Study|Other|2|||
156431279|NCT00197015|564667860|FG001|Overall Study|Other|3|||
156431280|NCT00197015|564667861|FG002|Overall Study|Other|2|||
156431281|NCT04511650|564667864|FG000|Overall Study|Lost to Follow-up|1|||
156431282|NCT04511650|564667865|FG001|Overall Study|Lost to Follow-up|0|||
156431283|NCT04511650|564667866|FG002|Overall Study|Lost to Follow-up|0|||
156431284|NCT04511650|564667864|FG000|Overall Study|Withdrawal by Subject|1|||
156431285|NCT04511650|564667865|FG001|Overall Study|Withdrawal by Subject|0|||
156431286|NCT04511650|564667866|FG002|Overall Study|Withdrawal by Subject|0|||
156431287|NCT04511650|564667864|FG000|Overall Study|reason not provided|0|||
156526696|NCT00585195|565021578|FG016|Overall Study|Site Terminated by Sponsor|0|||
156526697|NCT00585195|565021579|FG017|Overall Study|Site Terminated by Sponsor|0|||
156526698|NCT00585195|565021580|FG018|Overall Study|Site Terminated by Sponsor|0|||
156526699|NCT00585195|565021581|FG019|Overall Study|Site Terminated by Sponsor|0|||
156327199|NCT01083485|564299190|FG001|Overall Study|Adverse Event|1|||
156327200|NCT01083485|564299189|FG000|Overall Study|Protocol Violation|1|||
156327201|NCT01083485|564299190|FG001|Overall Study|Protocol Violation|0|||
156327202|NCT01083485|564299189|FG000|Overall Study|Withdrawal by Subject|5|||
156327203|NCT01083485|564299190|FG001|Overall Study|Withdrawal by Subject|2|||
156327204|NCT01083485|564299189|FG000|Overall Study|Other|1|||
156327205|NCT01083485|564299190|FG001|Overall Study|Other|0|||
156327206|NCT05108922|564299191|FG000|Overall Study|Adverse Event|2|||
156327207|NCT05108922|564299192|FG001|Overall Study|Adverse Event|3|||
156327208|NCT05108922|564299191|FG000|Overall Study|Lost to Follow-up|2|||
156327209|NCT05108922|564299192|FG001|Overall Study|Lost to Follow-up|1|||
156327210|NCT05108922|564299191|FG000|Overall Study|Inadvertent enrollment|0|||
156327211|NCT05108922|564299192|FG001|Overall Study|Inadvertent enrollment|1|||
156327212|NCT05108922|564299191|FG000|Overall Study|Physician Decision|2|||
156327213|NCT05108922|564299192|FG001|Overall Study|Physician Decision|3|||
156327214|NCT05108922|564299191|FG000|Overall Study|Protocol deviation|1|||
156327215|NCT05108922|564299192|FG001|Overall Study|Protocol deviation|0|||
156327216|NCT05108922|564299191|FG000|Overall Study|Screen failure|1|||
156327217|NCT05108922|564299192|FG001|Overall Study|Screen failure|0|||
156327218|NCT05108922|564299191|FG000|Overall Study|Withdrawal by Subject|11|||
156327219|NCT05108922|564299192|FG001|Overall Study|Withdrawal by Subject|8|||
156327220|NCT05036369|564299193|FG000|Overall Study|Run In non compliance|1|||
156327221|NCT05036369|564299194|FG001|Overall Study|Run In non compliance|2|||
156327222|NCT05036369|564299193|FG000|Overall Study|Change in eligibility criteria|0|||
156327223|NCT05036369|564299194|FG001|Overall Study|Change in eligibility criteria|1|||
156327224|NCT02095223|564299196|FG000|Overall Study|Withdrawal by Subject|1|||
156327225|NCT02095223|564299197|FG001|Overall Study|Withdrawal by Subject|0|||
156327226|NCT01397162|564299198|FG000|Overall Study|Adverse Event|4|||
156327227|NCT01397162|564299199|FG001|Overall Study|Adverse Event|0|||
156327228|NCT01397162|564299200|FG002|Overall Study|Adverse Event|0|||
156327229|NCT01397162|564299201|FG003|Overall Study|Adverse Event|0|||
156327230|NCT01397162|564299202|FG004|Overall Study|Adverse Event|0|||
156327231|NCT01397162|564299198|FG000|Overall Study|Not yet defined|3|||
156327232|NCT01397162|564299199|FG001|Overall Study|Not yet defined|4|||
156327233|NCT01397162|564299200|FG002|Overall Study|Not yet defined|3|||
156327234|NCT01397162|564299201|FG003|Overall Study|Not yet defined|5|||
156431288|NCT04511650|564667865|FG001|Overall Study|reason not provided|0|||
156431289|NCT04511650|564667866|FG002|Overall Study|reason not provided|1|||
156431290|NCT04511650|564667864|FG000|Overall Study|Death|1|||
156431291|NCT04511650|564667865|FG001|Overall Study|Death|1|||
156431292|NCT04511650|564667866|FG002|Overall Study|Death|1|||
156431293|NCT03525119|564667874|FG000|Overall Study|Adverse Event|0|||
156431294|NCT03525119|564667875|FG001|Overall Study|Adverse Event|1|||
156431295|NCT03525119|564667876|FG002|Overall Study|Adverse Event|0|||
156431296|NCT03525119|564667874|FG000|Overall Study|Lost to Follow-up|32|||
156431297|NCT03525119|564667875|FG001|Overall Study|Lost to Follow-up|33|||
156526700|NCT00585195|565021582|FG020|Overall Study|Site Terminated by Sponsor|0|||
156327235|NCT01397162|564299202|FG004|Overall Study|Not yet defined|3|||
156327236|NCT01507298|564299207|FG000|Overall Study|Protocol Violation|0|||
156327237|NCT01507298|564299208|FG001|Overall Study|Protocol Violation|6|||
156431298|NCT03525119|564667876|FG002|Overall Study|Lost to Follow-up|37|||
156431299|NCT03525119|564667874|FG000|Overall Study|Withdrawal by Subject|5|||
156526701|NCT00585195|565021562|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
156526702|NCT00585195|565021563|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
156327238|NCT03906461|564299209|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
156327239|NCT03906461|564299209|FG000|Completed 12-month Follow-up|Missed Visit|6|||
156431300|NCT03525119|564667875|FG001|Overall Study|Withdrawal by Subject|4|||
156671270|NCT04493684|565543019|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671271|NCT04493684|565543020|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671272|NCT04493684|565543021|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671273|NCT04493684|565543022|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671274|NCT04493684|565543023|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671275|NCT04493684|565543024|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671276|NCT04493684|565543025|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671277|NCT04493684|565543026|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
156671278|NCT04493684|565543027|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671279|NCT04493684|565543028|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671280|NCT04493684|565543029|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671281|NCT04493684|565543030|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671282|NCT04493684|565543031|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
156671283|NCT04493684|565543015|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671284|NCT04493684|565543016|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671285|NCT04493684|565543017|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671286|NCT04493684|565543018|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671287|NCT04493684|565543019|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156526703|NCT00585195|565021564|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
156526704|NCT00585195|565021565|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
156671288|NCT04493684|565543020|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671289|NCT04493684|565543021|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671290|NCT04493684|565543022|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671291|NCT04493684|565543023|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671292|NCT04493684|565543024|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156327240|NCT01920555|564299210|FG000|Overall Study|Physician Decision|1|||
156327241|NCT01920555|564299211|FG001|Overall Study|Physician Decision|2|||
156671293|NCT04493684|565543025|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671294|NCT04493684|565543026|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671295|NCT04493684|565543027|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671296|NCT04493684|565543028|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671297|NCT04493684|565543029|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671298|NCT04493684|565543030|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
156671299|NCT04493684|565543031|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
156671300|NCT04493684|565543015|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671301|NCT04493684|565543016|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671302|NCT04493684|565543017|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671303|NCT04493684|565543018|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671304|NCT04493684|565543019|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671305|NCT04493684|565543020|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671306|NCT04493684|565543021|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671307|NCT04493684|565543022|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671308|NCT04493684|565543023|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671309|NCT04493684|565543024|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671310|NCT04493684|565543025|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671311|NCT04493684|565543026|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671312|NCT04493684|565543027|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671313|NCT04493684|565543028|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671314|NCT04493684|565543029|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671315|NCT04493684|565543030|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
156671316|NCT04493684|565543031|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
156671317|NCT04825275|565544143|FG000|Overall Study|Withdrawal by Subject|1|||
156671318|NCT04825275|565544144|FG001|Overall Study|Withdrawal by Subject|0|||
156671319|NCT06298396|565544147|FG000|Default MAP|Protocol Violation|1|||
156671320|NCT06137781|565544148|FG000|Baseline measurements|Lost to Follow-up|2|||
156671321|NCT06137781|565544148|FG000|Baseline measurements|Withdrawal by Subject|1|||
156671322|NCT06137781|565544148|FG000|Baseline measurements|Expedited surgery|1|||
156671323|NCT06137781|565544148|FG000|Intervention period|Lost to Follow-up|2|||
156327242|NCT01920555|564299212|FG002|Overall Study|Physician Decision|1|||
156327243|NCT01920555|564299213|FG003|Overall Study|Physician Decision|2|||
156327244|NCT01920555|564299214|FG004|Overall Study|Physician Decision|0|||
156327245|NCT01920555|564299210|FG000|Overall Study|Lack of Efficacy|2|||
156327246|NCT01920555|564299211|FG001|Overall Study|Lack of Efficacy|0|||
156327247|NCT01920555|564299212|FG002|Overall Study|Lack of Efficacy|0|||
156327248|NCT01920555|564299213|FG003|Overall Study|Lack of Efficacy|0|||
156327249|NCT01920555|564299214|FG004|Overall Study|Lack of Efficacy|0|||
156327250|NCT01920555|564299210|FG000|Overall Study|Travel Difficulties|1|||
156327251|NCT01920555|564299211|FG001|Overall Study|Travel Difficulties|1|||
156327252|NCT01920555|564299212|FG002|Overall Study|Travel Difficulties|0|||
156327253|NCT01920555|564299213|FG003|Overall Study|Travel Difficulties|0|||
156327254|NCT01920555|564299214|FG004|Overall Study|Travel Difficulties|1|||
156327255|NCT01920555|564299210|FG000|Overall Study|Lost to Follow-up|0|||
156327256|NCT01920555|564299211|FG001|Overall Study|Lost to Follow-up|1|||
156327257|NCT01920555|564299212|FG002|Overall Study|Lost to Follow-up|0|||
156327258|NCT01920555|564299213|FG003|Overall Study|Lost to Follow-up|1|||
156327259|NCT01920555|564299214|FG004|Overall Study|Lost to Follow-up|0|||
156327260|NCT01795638|564299217|FG000|Overall Study|Death|0|||
156327261|NCT01795638|564299218|FG001|Overall Study|Death|3|||
156327262|NCT01795638|564299217|FG000|Overall Study|transferred to quaternary hospital|2|||
156327263|NCT01795638|564299218|FG001|Overall Study|transferred to quaternary hospital|3|||
156327264|NCT01795638|564299217|FG000|Overall Study|Protocol Violation|3|||
156327265|NCT01795638|564299218|FG001|Overall Study|Protocol Violation|0|||
156327266|NCT01795638|564299217|FG000|Overall Study|discharged from hospital|7|||
156327267|NCT01795638|564299218|FG001|Overall Study|discharged from hospital|5|||
156327268|NCT01795638|564299217|FG000|Overall Study|Withdrawal by Subject|1|||
156327269|NCT01795638|564299218|FG001|Overall Study|Withdrawal by Subject|0|||
156327270|NCT02570074|564299219|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
156327271|NCT02570074|564299220|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
156327272|NCT01859143|564299221|FG000|Overall Study|Lost to Follow-up|2|||
156327273|NCT01859143|564299222|FG001|Overall Study|Lost to Follow-up|0|||
156327274|NCT00611533|564299223|FG000|First Intervention (6 Weeks)|Never started study|0|||
156327275|NCT00611533|564299224|FG001|First Intervention (6 Weeks)|Never started study|1|||
156327276|NCT00611533|564299223|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
156327277|NCT00611533|564299224|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
156327278|NCT00611533|564299223|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
156327279|NCT00611533|564299224|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
156327280|NCT02943460|564299226|FG000|Blinded Study Phase|Adverse Event|3|||
156327281|NCT02943460|564299227|FG001|Blinded Study Phase|Adverse Event|0|||
156327282|NCT02943460|564299228|FG002|Blinded Study Phase|Adverse Event|0|||
156327283|NCT02943460|564299226|FG000|Blinded Study Phase|Withdrew Consent|0|||
156327284|NCT02943460|564299227|FG001|Blinded Study Phase|Withdrew Consent|1|||
156327285|NCT02943460|564299228|FG002|Blinded Study Phase|Withdrew Consent|0|||
156327286|NCT02943460|564299226|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
156327287|NCT02943460|564299227|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
156327288|NCT02943460|564299228|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
156327289|NCT02943460|564299226|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
156327290|NCT02943460|564299227|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
156327291|NCT02943460|564299228|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
156327292|NCT02943460|564299226|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
156327293|NCT02943460|564299227|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
156327294|NCT02943460|564299228|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
156327295|NCT00809354|564299232|FG000|Overall Study|Adverse Event|32|||
156327296|NCT00809354|564299233|FG001|Overall Study|Adverse Event|45|||
156327297|NCT00809354|564299234|FG002|Overall Study|Adverse Event|37|||
156327298|NCT00809354|564299235|FG003|Overall Study|Adverse Event|53|||
156327299|NCT00809354|564299236|FG004|Overall Study|Adverse Event|26|||
156327300|NCT00809354|564299237|FG005|Overall Study|Adverse Event|33|||
156327301|NCT00809354|564299238|FG006|Overall Study|Adverse Event|44|||
156327302|NCT00809354|564299239|FG007|Overall Study|Adverse Event|40|||
156327303|NCT00809354|564299240|FG008|Overall Study|Adverse Event|46|||
156526705|NCT00585195|565021566|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
156526706|NCT00585195|565021567|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
156526707|NCT00585195|565021568|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
156526708|NCT00585195|565021569|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
156526709|NCT00585195|565021570|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
156526710|NCT00585195|565021571|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
156526711|NCT00585195|565021572|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
156526712|NCT00585195|565021573|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
156526713|NCT00585195|565021574|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
156526714|NCT00585195|565021575|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
156526715|NCT00585195|565021576|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
156526716|NCT00585195|565021577|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
156526717|NCT00585195|565021578|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
156526718|NCT00585195|565021579|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
156526719|NCT00585195|565021580|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
156327304|NCT00809354|564299241|FG009|Overall Study|Adverse Event|26|||
156327305|NCT00809354|564299232|FG000|Overall Study|Lack of Efficacy|23|||
156327306|NCT00809354|564299233|FG001|Overall Study|Lack of Efficacy|23|||
156327307|NCT00809354|564299234|FG002|Overall Study|Lack of Efficacy|22|||
156327308|NCT00809354|564299235|FG003|Overall Study|Lack of Efficacy|15|||
156327309|NCT00809354|564299236|FG004|Overall Study|Lack of Efficacy|40|||
156671324|NCT06137781|565544148|FG000|Intervention period|Withdrawal by Subject|3|||
156671325|NCT06137781|565544148|FG000|Intervention period|Expedited surgery|1|||
156671326|NCT06137781|565544148|FG000|Intervention period|Adverse Event|1|||
156671327|NCT02591420|565544149|FG000|Overall Study|Lost to Follow-up|0|||
156671328|NCT02591420|565544150|FG001|Overall Study|Lost to Follow-up|1|||
156671329|NCT02591420|565544151|FG002|Overall Study|Lost to Follow-up|2|||
156671330|NCT03056755|565544152|FG000|Core Phase|Progressive disease|89|||
156671331|NCT03056755|565544153|FG001|Core Phase|Progressive disease|88|||
156671332|NCT03056755|565544154|FG002|Core Phase|Progressive disease|90|||
156671333|NCT03056755|565544152|FG000|Core Phase|Adverse Event|20|||
156671334|NCT03056755|565544153|FG001|Core Phase|Adverse Event|14|||
156671335|NCT03056755|565544154|FG002|Core Phase|Adverse Event|13|||
156671336|NCT03056755|565544152|FG000|Core Phase|Physician Decision|7|||
156671337|NCT03056755|565544153|FG001|Core Phase|Physician Decision|13|||
156671338|NCT03056755|565544154|FG002|Core Phase|Physician Decision|5|||
156671339|NCT03056755|565544152|FG000|Core Phase|Subject/guardian decision|5|||
156671340|NCT03056755|565544153|FG001|Core Phase|Subject/guardian decision|8|||
156671341|NCT03056755|565544154|FG002|Core Phase|Subject/guardian decision|4|||
156671342|NCT03056755|565544152|FG000|Core Phase|Death|3|||
156671343|NCT03056755|565544153|FG001|Core Phase|Death|2|||
156671344|NCT03056755|565544154|FG002|Core Phase|Death|4|||
156671345|NCT03056755|565544152|FG000|Core Phase|Protocol deviation|1|||
156671346|NCT03056755|565544153|FG001|Core Phase|Protocol deviation|1|||
156671347|NCT03056755|565544154|FG002|Core Phase|Protocol deviation|0|||
156671348|NCT03056755|565544152|FG000|Core Phase|Technical problems|1|||
156671349|NCT03056755|565544153|FG001|Core Phase|Technical problems|0|||
156671350|NCT03056755|565544154|FG002|Core Phase|Technical problems|0|||
156671351|NCT03056755|565544152|FG000|Extension Phase|Physician Decision|1|||
156671352|NCT03056755|565544153|FG001|Extension Phase|Physician Decision|0|||
156671353|NCT03056755|565544154|FG002|Extension Phase|Physician Decision|3|||
156671354|NCT03056755|565544152|FG000|Extension Phase|Adverse Event|0|||
156671355|NCT03056755|565544153|FG001|Extension Phase|Adverse Event|0|||
156671356|NCT03056755|565544154|FG002|Extension Phase|Adverse Event|1|||
156671357|NCT03056755|565544152|FG000|Extension Phase|Subject/guardian decision|0|||
156671358|NCT03056755|565544153|FG001|Extension Phase|Subject/guardian decision|0|||
156671359|NCT03056755|565544154|FG002|Extension Phase|Subject/guardian decision|1|||
156671360|NCT06144424|565544155|FG000|Overall Study|Withdrawal by Subject|2|||
156671361|NCT06144424|565544156|FG001|Overall Study|Withdrawal by Subject|0|||
156671362|NCT06144424|565544155|FG000|Overall Study|Incarceration|1|||
156671363|NCT06144424|565544156|FG001|Overall Study|Incarceration|0|||
156671364|NCT01528696|565544159|FG000|Overall Study|See detailed description|18|||
156671365|NCT01528696|565544160|FG001|Overall Study|See detailed description|19|||
156671366|NCT01056484|565544161|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
156671367|NCT01056484|565544162|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
156526720|NCT00585195|565021581|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
156526721|NCT00585195|565021582|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
156526722|NCT00770341|565021583|FG000|Overall Study|Did not meet eligibility criteria|1|||
156526723|NCT00770341|565021584|FG001|Overall Study|Did not meet eligibility criteria|0|||
156526724|NCT00770341|565021585|FG002|Overall Study|Did not meet eligibility criteria|0|||
156526725|NCT00770341|565021583|FG000|Overall Study|Withdrawal by Subject|0|||
156526726|NCT00770341|565021584|FG001|Overall Study|Withdrawal by Subject|1|||
156526727|NCT00770341|565021585|FG002|Overall Study|Withdrawal by Subject|0|||
156526728|NCT00770341|565021583|FG000|Overall Study|Clinical Adverse Event|3|||
156526729|NCT00770341|565021584|FG001|Overall Study|Clinical Adverse Event|1|||
156526730|NCT00770341|565021585|FG002|Overall Study|Clinical Adverse Event|2|||
156526731|NCT00770341|565021583|FG000|Overall Study|Laboratory adverse event|3|||
156526732|NCT00770341|565021584|FG001|Overall Study|Laboratory adverse event|3|||
156526733|NCT00770341|565021585|FG002|Overall Study|Laboratory adverse event|0|||
156671368|NCT01056484|565544161|FG000|Randomized Controlled Trial|Physician Decision|1|||
156671369|NCT01056484|565544162|FG001|Randomized Controlled Trial|Physician Decision|0|||
156526734|NCT00770341|565021583|FG000|Overall Study|Lack of Efficacy|3|||
156526735|NCT00770341|565021584|FG001|Overall Study|Lack of Efficacy|0|||
156526736|NCT00770341|565021585|FG002|Overall Study|Lack of Efficacy|1|||
156526737|NCT00770341|565021583|FG000|Overall Study|Other|1|||
156526738|NCT00770341|565021584|FG001|Overall Study|Other|0|||
156526739|NCT00770341|565021585|FG002|Overall Study|Other|0|||
156526740|NCT00770341|565021583|FG000|Overall Study|Not treated|1|||
156526741|NCT00770341|565021584|FG001|Overall Study|Not treated|0|||
156526742|NCT00770341|565021585|FG002|Overall Study|Not treated|0|||
156526743|NCT02796560|565021591|FG000|Overall Study|Adverse Event|2|||
156671370|NCT01056484|565544161|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
156671371|NCT01056484|565544162|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
156526744|NCT02796560|565021592|FG001|Overall Study|Adverse Event|0|||
156526745|NCT02796560|565021591|FG000|Overall Study|Withdrawal by Subject|2|||
156671372|NCT00446966|565544165|FG000|Overall Study|Lost to Follow-up|10|||
156671373|NCT00446966|565544166|FG001|Overall Study|Lost to Follow-up|7|||
156526746|NCT02796560|565021592|FG001|Overall Study|Withdrawal by Subject|2|||
156526747|NCT02533570|565021593|FG000|Overall Study|Adverse Event|0|||
156671374|NCT00835575|565544167|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
156671375|NCT00835575|565544168|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
156671376|NCT00836472|565544169|FG000|Washout|Adverse Event|1|||
156671377|NCT00836472|565544170|FG001|Washout|Adverse Event|2|||
156671378|NCT00836472|565544169|FG000|Washout|Withdrawal by Subject|1|||
156671379|NCT00836472|565544170|FG001|Washout|Withdrawal by Subject|1|||
156671380|NCT01695239|565544171|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
156671381|NCT01695239|565544172|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
156671382|NCT01695239|565544173|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
156671383|NCT01695239|565544174|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
156671384|NCT01695239|565544175|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671385|NCT01695239|565544176|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671386|NCT01695239|565544177|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671387|NCT01695239|565544178|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671388|NCT01695239|565544179|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671389|NCT01695239|565544180|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671390|NCT01695239|565544181|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671391|NCT01695239|565544182|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671392|NCT01695239|565544183|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671393|NCT01695239|565544184|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
156671394|NCT01695239|565544171|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
156671395|NCT01695239|565544172|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
156671396|NCT01695239|565544173|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
156671397|NCT01695239|565544174|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
156671398|NCT01695239|565544175|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671399|NCT01695239|565544176|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671400|NCT01695239|565544177|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671401|NCT01695239|565544178|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671402|NCT01695239|565544179|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671403|NCT01695239|565544180|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671404|NCT01695239|565544181|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671405|NCT01695239|565544182|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671406|NCT01695239|565544183|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671407|NCT01695239|565544184|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156671408|NCT01695239|565544171|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
156671409|NCT01695239|565544172|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671410|NCT01695239|565544173|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
156671411|NCT01695239|565544174|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671412|NCT01695239|565544175|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671413|NCT01695239|565544176|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671414|NCT01695239|565544177|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671415|NCT01695239|565544178|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671416|NCT01695239|565544179|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671417|NCT01695239|565544180|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671418|NCT01695239|565544181|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671419|NCT01695239|565544182|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671420|NCT01695239|565544183|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671421|NCT01695239|565544184|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156671422|NCT01695239|565544171|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
156526748|NCT02533570|565021594|FG001|Overall Study|Adverse Event|1|||
156526749|NCT02533570|565021595|FG002|Overall Study|Adverse Event|1|||
156526750|NCT01163916|565021597|FG000|Overall Study|Withdrawal by Subject|2|||
156526751|NCT01163916|565021598|FG001|Overall Study|Withdrawal by Subject|0|||
156526752|NCT01163916|565021599|FG002|Overall Study|Withdrawal by Subject|2|||
156526753|NCT01163916|565021597|FG000|Overall Study|Adverse Event|2|||
156526754|NCT01163916|565021598|FG001|Overall Study|Adverse Event|0|||
156526755|NCT01163916|565021599|FG002|Overall Study|Adverse Event|1|||
156526756|NCT01163916|565021597|FG000|Overall Study|Lack of Efficacy|2|||
156526757|NCT01163916|565021598|FG001|Overall Study|Lack of Efficacy|0|||
156526758|NCT01163916|565021599|FG002|Overall Study|Lack of Efficacy|1|||
156526759|NCT01163916|565021597|FG000|Overall Study|Other|24|||
156526760|NCT01163916|565021598|FG001|Overall Study|Other|4|||
156526761|NCT01163916|565021599|FG002|Overall Study|Other|16|||
156526762|NCT00529958|565021600|FG000|2-Year Follow-up|Lost to Follow-up|1|||
156526763|NCT00529958|565021601|FG001|2-Year Follow-up|Lost to Follow-up|2|||
156671423|NCT01695239|565544172|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
156526764|NCT00529958|565021602|FG002|2-Year Follow-up|Lost to Follow-up|2|||
156526765|NCT00529958|565021600|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
156526766|NCT00529958|565021601|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
156526767|NCT00529958|565021602|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
156526768|NCT00529958|565021600|FG000|5-Year Follow-up|Lost to Follow-up|2|||
156526769|NCT00529958|565021601|FG001|5-Year Follow-up|Lost to Follow-up|3|||
156671424|NCT01695239|565544173|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
156671425|NCT01695239|565544174|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671426|NCT01695239|565544175|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671427|NCT01695239|565544176|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671428|NCT01695239|565544177|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671429|NCT01695239|565544178|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671430|NCT01695239|565544179|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671431|NCT01695239|565544180|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671432|NCT01695239|565544181|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671433|NCT01695239|565544182|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671434|NCT01695239|565544183|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671435|NCT01695239|565544184|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156671436|NCT01695239|565544171|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
156671437|NCT01695239|565544172|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671438|NCT01695239|565544173|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
156671439|NCT01695239|565544174|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671440|NCT01695239|565544175|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671441|NCT01695239|565544176|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671442|NCT01695239|565544177|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671443|NCT01695239|565544178|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671444|NCT01695239|565544179|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671445|NCT01695239|565544180|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671446|NCT01695239|565544181|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671447|NCT01695239|565544182|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671448|NCT01695239|565544183|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671449|NCT01695239|565544184|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
156671450|NCT01695239|565544171|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
156671451|NCT01695239|565544172|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671452|NCT01695239|565544173|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
156671453|NCT01695239|565544174|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671454|NCT01695239|565544175|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671455|NCT01695239|565544176|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671456|NCT01695239|565544177|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671457|NCT01695239|565544178|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671458|NCT01695239|565544179|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671459|NCT01695239|565544180|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671460|NCT01695239|565544181|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671461|NCT01695239|565544182|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671462|NCT01695239|565544183|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671463|NCT01695239|565544184|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156671464|NCT01695239|565544171|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
156671465|NCT01695239|565544172|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671466|NCT01695239|565544173|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671467|NCT01695239|565544174|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671468|NCT01695239|565544175|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671469|NCT01695239|565544176|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671470|NCT01695239|565544177|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671471|NCT01695239|565544178|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671472|NCT01695239|565544179|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671473|NCT01695239|565544180|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671474|NCT01695239|565544181|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671475|NCT01695239|565544182|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671476|NCT01695239|565544183|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671477|NCT01695239|565544184|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156671478|NCT01695239|565544171|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671479|NCT01695239|565544172|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671480|NCT01695239|565544173|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671481|NCT01695239|565544174|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671482|NCT01695239|565544175|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671483|NCT01695239|565544176|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671484|NCT01695239|565544177|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671485|NCT01695239|565544178|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
156671486|NCT01695239|565544179|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671487|NCT01695239|565544180|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156779780|NCT01757847|565943879|FG000|Overall Study|Withdrawal by Subject|3|||
156779781|NCT01757847|565943880|FG001|Overall Study|Withdrawal by Subject|4|||
156671488|NCT01695239|565544181|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671489|NCT01695239|565544182|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671490|NCT01695239|565544183|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671491|NCT01695239|565544184|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
156671492|NCT01695239|565544171|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671493|NCT01695239|565544172|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671494|NCT01695239|565544173|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671495|NCT01695239|565544174|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671496|NCT01695239|565544175|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671497|NCT01695239|565544176|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671498|NCT01695239|565544177|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671499|NCT01695239|565544178|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
156671500|NCT01695239|565544179|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671501|NCT01695239|565544180|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671502|NCT01695239|565544181|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671503|NCT01695239|565544182|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671504|NCT01695239|565544183|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671505|NCT01695239|565544184|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
156671506|NCT01695239|565544171|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671507|NCT01695239|565544172|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671508|NCT01695239|565544173|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671509|NCT01695239|565544174|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671510|NCT01695239|565544175|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671511|NCT01695239|565544176|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671512|NCT01695239|565544177|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671513|NCT01695239|565544178|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
156671514|NCT01695239|565544179|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671515|NCT01695239|565544180|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671516|NCT01695239|565544181|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671517|NCT01695239|565544182|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671518|NCT01695239|565544183|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671519|NCT01695239|565544184|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
156671520|NCT01695239|565544171|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671521|NCT01695239|565544172|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671522|NCT01695239|565544173|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671523|NCT01695239|565544174|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671524|NCT01695239|565544175|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671525|NCT01695239|565544176|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671526|NCT01695239|565544177|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671527|NCT01695239|565544178|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671528|NCT01695239|565544179|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
156671529|NCT01695239|565544180|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
156671530|NCT01695239|565544181|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671531|NCT01695239|565544182|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671532|NCT01695239|565544183|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671533|NCT01695239|565544184|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
156671534|NCT01695239|565544171|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
156671535|NCT01695239|565544172|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
156671536|NCT01695239|565544173|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
156671537|NCT01695239|565544174|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
156671538|NCT01695239|565544175|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
156671539|NCT01695239|565544176|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
156671540|NCT01695239|565544177|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
156671541|NCT01695239|565544178|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
156671542|NCT01695239|565544179|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
156671543|NCT01695239|565544180|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
156671544|NCT01695239|565544181|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
156671545|NCT01695239|565544182|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
156671546|NCT01695239|565544183|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
156671547|NCT01695239|565544184|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
156671548|NCT01695239|565544171|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671549|NCT01695239|565544172|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671550|NCT01695239|565544173|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671551|NCT01695239|565544174|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671552|NCT01695239|565544175|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671553|NCT01695239|565544176|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671554|NCT01695239|565544177|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671555|NCT01695239|565544178|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671556|NCT01695239|565544179|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
156671557|NCT01695239|565544180|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
156671558|NCT01695239|565544181|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671559|NCT01695239|565544182|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671560|NCT01695239|565544183|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671561|NCT01695239|565544184|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
156671562|NCT01695239|565544171|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
156671563|NCT01695239|565544172|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
156671564|NCT01695239|565544173|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
156671565|NCT01695239|565544174|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
156671566|NCT01695239|565544175|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
156671567|NCT01695239|565544176|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
156671568|NCT01695239|565544177|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
156671569|NCT01695239|565544178|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
156671570|NCT01695239|565544179|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
156671571|NCT01695239|565544180|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
156671572|NCT01695239|565544181|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
156671573|NCT01695239|565544182|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
156671574|NCT01695239|565544183|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
156671575|NCT01695239|565544184|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
156671576|NCT01695239|565544171|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671577|NCT01695239|565544172|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671578|NCT01695239|565544173|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671579|NCT01695239|565544174|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671580|NCT01695239|565544175|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671581|NCT01695239|565544176|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671582|NCT01695239|565544177|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671583|NCT01695239|565544178|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671584|NCT01695239|565544179|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
156671585|NCT01695239|565544180|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
156671586|NCT01695239|565544181|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671587|NCT01695239|565544182|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671588|NCT01695239|565544183|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671589|NCT01695239|565544184|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
156671590|NCT01695239|565544171|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671591|NCT01695239|565544172|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671592|NCT01695239|565544173|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671593|NCT01695239|565544174|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671594|NCT01695239|565544175|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671595|NCT01695239|565544176|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671596|NCT01695239|565544177|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671597|NCT01695239|565544178|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671598|NCT01695239|565544179|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
156671599|NCT01695239|565544180|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
156671600|NCT01695239|565544181|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671601|NCT01695239|565544182|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671602|NCT01695239|565544183|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671603|NCT01695239|565544184|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
156671604|NCT01695239|565544171|FG000|Extension Long-Term Extension Periods|Death|0|||
156526770|NCT00529958|565021602|FG002|5-Year Follow-up|Lost to Follow-up|1|||
156526771|NCT00529958|565021600|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
156526772|NCT00529958|565021601|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
156526773|NCT00529958|565021602|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
156526774|NCT03816332|565021603|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
156526775|NCT03816332|565021603|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
156526776|NCT03534284|565021606|FG000|Overall Study|Death|2|||
156526777|NCT03534284|565021607|FG001|Overall Study|Death|3|||
156526778|NCT03534284|565021608|FG002|Overall Study|Death|3|||
156671605|NCT01695239|565544172|FG001|Extension Long-Term Extension Periods|Death|0|||
156526779|NCT03534284|565021606|FG000|Overall Study|Withdrawal by Subject|5|||
156526780|NCT03534284|565021607|FG001|Overall Study|Withdrawal by Subject|0|||
156526781|NCT03534284|565021608|FG002|Overall Study|Withdrawal by Subject|0|||
156526782|NCT03316300|565021609|FG000|Overall Study|Withdrawal by Subject|3|||
156671606|NCT01695239|565544173|FG002|Extension Long-Term Extension Periods|Death|0|||
156671607|NCT01695239|565544174|FG003|Extension Long-Term Extension Periods|Death|0|||
156671608|NCT01695239|565544175|FG004|Extension Long-Term Extension Periods|Death|0|||
156671609|NCT01695239|565544176|FG005|Extension Long-Term Extension Periods|Death|0|||
156671610|NCT01695239|565544177|FG006|Extension Long-Term Extension Periods|Death|0|||
156671611|NCT01695239|565544178|FG007|Extension Long-Term Extension Periods|Death|0|||
156671612|NCT01695239|565544179|FG008|Extension Long-Term Extension Periods|Death|1|||
156671613|NCT01695239|565544180|FG009|Extension Long-Term Extension Periods|Death|0|||
156671614|NCT01695239|565544181|FG010|Extension Long-Term Extension Periods|Death|0|||
156671615|NCT01695239|565544182|FG011|Extension Long-Term Extension Periods|Death|0|||
156671616|NCT01695239|565544183|FG012|Extension Long-Term Extension Periods|Death|0|||
156671617|NCT01695239|565544184|FG013|Extension Long-Term Extension Periods|Death|0|||
156671618|NCT01695239|565544171|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671619|NCT01695239|565544172|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671620|NCT01695239|565544173|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671621|NCT01695239|565544174|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671622|NCT01695239|565544175|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671623|NCT01695239|565544176|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671624|NCT01695239|565544177|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671625|NCT01695239|565544178|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671626|NCT01695239|565544179|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671627|NCT01695239|565544180|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671628|NCT01695239|565544181|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156671629|NCT01695239|565544182|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
156671630|NCT01695239|565544183|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
156671631|NCT01695239|565544184|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
156671632|NCT01695239|565544171|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671633|NCT01695239|565544172|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671634|NCT01695239|565544173|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671635|NCT01695239|565544174|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671636|NCT01695239|565544175|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671637|NCT01695239|565544176|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671638|NCT01695239|565544177|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671639|NCT01695239|565544178|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671640|NCT01695239|565544179|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671641|NCT01695239|565544180|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671642|NCT01695239|565544181|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671643|NCT01695239|565544182|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156671644|NCT01695239|565544183|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
156671645|NCT01695239|565544184|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
156671646|NCT01695239|565544171|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671647|NCT01695239|565544172|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671648|NCT01695239|565544173|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671649|NCT01695239|565544174|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671650|NCT01695239|565544175|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671651|NCT01695239|565544176|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671652|NCT01695239|565544177|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671653|NCT01695239|565544178|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671654|NCT01695239|565544179|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671655|NCT01695239|565544180|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671656|NCT01695239|565544181|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671657|NCT01695239|565544182|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671658|NCT01695239|565544183|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
156671659|NCT01695239|565544184|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
156671660|NCT01695239|565544171|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671661|NCT01695239|565544172|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671662|NCT01695239|565544173|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671663|NCT01695239|565544174|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671664|NCT01695239|565544175|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671665|NCT01695239|565544176|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671666|NCT01695239|565544177|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671667|NCT01695239|565544178|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671668|NCT01695239|565544179|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671669|NCT01695239|565544180|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671670|NCT01695239|565544181|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671671|NCT01695239|565544182|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156866586|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
156671672|NCT01695239|565544183|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156671673|NCT01695239|565544184|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
156671674|NCT03502811|565544187|FG000|Overall Study|Death|157|||
156671675|NCT03502811|565544187|FG000|Overall Study|Withdrawal by Subject|105|||
156671676|NCT03502811|565544187|FG000|Overall Study|Lost to Follow-up|26|||
156671677|NCT03502811|565544187|FG000|Overall Study|No Visits (Missed)|31|||
156671678|NCT05239195|565544188|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
156671679|NCT05239195|565544189|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
156671680|NCT02241551|565544190|FG000|Overall Study|Adverse Event|1|||
156671681|NCT02241551|565544191|FG001|Overall Study|Adverse Event|0|||
156671682|NCT01839279|565544201|FG000|Overall Study|Adverse Event|4|||
156671683|NCT01839279|565544202|FG001|Overall Study|Adverse Event|1|||
156671684|NCT01839279|565544203|FG002|Overall Study|Adverse Event|1|||
156671685|NCT01839279|565544201|FG000|Overall Study|Withdrawal by Subject|4|||
156671686|NCT01839279|565544202|FG001|Overall Study|Withdrawal by Subject|1|||
156671687|NCT01839279|565544203|FG002|Overall Study|Withdrawal by Subject|1|||
156671688|NCT01839279|565544201|FG000|Overall Study|Classified as 'Other'|5|||
156671689|NCT01839279|565544202|FG001|Overall Study|Classified as 'Other'|0|||
156671690|NCT01839279|565544203|FG002|Overall Study|Classified as 'Other'|0|||
156671691|NCT00107991|565544211|FG000|Eligibility Assessment|Disease not severe enough|7|||
156671692|NCT00107991|565544211|FG000|Eligibility Assessment|Unwilling to participate|7|||
156671693|NCT00107991|565544211|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
156671694|NCT00107991|565544211|FG000|Eligibility Assessment|Abnormal labs|2|||
156671695|NCT00107991|565544211|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
156671696|NCT00107991|565544211|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
156671697|NCT00107991|565544211|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
156671698|NCT00107991|565544211|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
156671699|NCT00107991|565544211|FG000|12 Week Treatment Period|Adverse Event|1|||
156671700|NCT00107991|565544211|FG000|12 Week Treatment Period|Protocol Violation|1|||
156671701|NCT00107991|565544211|FG000|12 Week Treatment Period|Incarcerated|1|||
156671702|NCT00107991|565544211|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
156671703|NCT03930732|565544212|FG000|Overall Study|Adverse Event|9|||
156671704|NCT03930732|565544213|FG001|Overall Study|Adverse Event|7|||
156671705|NCT03930732|565544212|FG000|Overall Study|Poor compliance to protocol|0|||
156671706|NCT03930732|565544213|FG001|Overall Study|Poor compliance to protocol|1|||
156671707|NCT03930732|565544212|FG000|Overall Study|Withdrawal by Subject|23|||
156671708|NCT03930732|565544213|FG001|Overall Study|Withdrawal by Subject|11|||
156671709|NCT03930732|565544212|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
156671710|NCT03930732|565544213|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
156671711|NCT03930732|565544212|FG000|Overall Study|Other reason not related to COVID-19|5|||
156671712|NCT03930732|565544213|FG001|Overall Study|Other reason not related to COVID-19|8|||
156671713|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Adverse Event|11|||
156671714|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Adverse Event|23|||
156671715|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Adverse Event|29|||
156671716|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Adverse Event|2|||
156671717|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Adverse Event|8|||
156671718|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
156671719|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
156671720|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
156671721|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
156671722|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
156671723|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
156671724|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
156671725|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
156671726|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
156671727|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
156671728|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
156671729|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
156671730|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
156671731|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
156671732|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
156671733|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
156671734|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
156671735|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
156671736|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
156671737|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
156671738|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
156671739|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
156671740|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
156671741|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
156671742|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
156671743|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
156671744|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
156671745|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
156671746|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
156671747|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
156671748|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Move|0|||
156671749|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Move|1|||
156671750|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Move|0|||
156671751|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Move|0|||
156671752|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Move|0|||
156671753|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
156671754|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
156671755|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
156671756|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
156671757|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
156671758|NCT00318461|565544220|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
156671759|NCT00318461|565544221|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
156671760|NCT00318461|565544222|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
156671761|NCT00318461|565544223|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
156671762|NCT00318461|565544224|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
156671763|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Work commitment|0|||
156671764|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Work commitment|0|||
156671765|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Work commitment|0|||
156671766|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Work commitment|0|||
156671767|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Work commitment|1|||
156671768|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Investigator decision|0|||
156671769|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Investigator decision|0|||
156671770|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Investigator decision|0|||
156671771|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Investigator decision|0|||
156671772|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Investigator decision|1|||
156671773|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Lack of time|1|||
156671774|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Lack of time|0|||
156671775|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Lack of time|0|||
156671776|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Lack of time|0|||
156671777|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Lack of time|0|||
156671778|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
156671779|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
156671780|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
156671781|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
156671782|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
156671783|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
156671784|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
156671785|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
156671786|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
156671787|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
156671788|NCT00318461|565544220|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
156671789|NCT00318461|565544221|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
156671790|NCT00318461|565544222|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
156671791|NCT00318461|565544223|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
156671792|NCT00318461|565544224|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
156671793|NCT00318461|565544220|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
156671794|NCT00318461|565544221|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
156671795|NCT00318461|565544222|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
156671796|NCT00318461|565544223|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
156671797|NCT00318461|565544224|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
156671798|NCT00318461|565544220|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
156671799|NCT00318461|565544221|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
156671800|NCT00318461|565544222|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
156327310|NCT00809354|564299237|FG005|Overall Study|Lack of Efficacy|19|||
156327311|NCT00809354|564299238|FG006|Overall Study|Lack of Efficacy|21|||
156327312|NCT00809354|564299239|FG007|Overall Study|Lack of Efficacy|15|||
156327313|NCT00809354|564299240|FG008|Overall Study|Lack of Efficacy|18|||
156671801|NCT00318461|565544223|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
156671802|NCT00318461|565544224|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
156327314|NCT00809354|564299241|FG009|Overall Study|Lack of Efficacy|38|||
156327315|NCT00809354|564299232|FG000|Overall Study|Lost to Follow-up|10|||
156671803|NCT00318461|565544220|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
156866587|NCT00129402|566271283|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
156327316|NCT00809354|564299233|FG001|Overall Study|Lost to Follow-up|11|||
156671804|NCT00318461|565544221|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
156671805|NCT00318461|565544222|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
156671806|NCT00318461|565544223|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
156671807|NCT00318461|565544224|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
156671808|NCT00318461|565544220|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
156671809|NCT00318461|565544221|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
156671810|NCT00318461|565544222|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
156671811|NCT00318461|565544223|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
156671812|NCT00318461|565544224|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
156671813|NCT00318461|565544220|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
156671814|NCT00318461|565544221|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
156671815|NCT00318461|565544222|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
156671816|NCT00318461|565544223|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
156671817|NCT00318461|565544224|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
156671818|NCT03084471|565544227|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
156671819|NCT03084471|565544227|FG000|Overall Study|Condition under investigation worsened|84|||
156671820|NCT03084471|565544227|FG000|Overall Study|Lack of therapeutic response|2|||
156671821|NCT03084471|565544227|FG000|Overall Study|Protocol Violation|1|||
156671822|NCT03084471|565544227|FG000|Overall Study|Adverse Event|73|||
156671823|NCT03084471|565544227|FG000|Overall Study|Withdrawal by Subject|12|||
156671824|NCT03084471|565544227|FG000|Overall Study|Disease relapse|181|||
156671825|NCT03084471|565544227|FG000|Overall Study|Subjective disease progression|359|||
156671826|NCT03084471|565544227|FG000|Overall Study|Other (as recorded)|33|||
156671827|NCT03084471|565544227|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
156671828|NCT00505622|565544228|FG000|Overall Study|Adverse Event|5|||
156671829|NCT00505622|565544229|FG001|Overall Study|Adverse Event|6|||
156671830|NCT00505622|565544230|FG002|Overall Study|Adverse Event|4|||
156671831|NCT00505622|565544228|FG000|Overall Study|Protocol Violation|1|||
156671832|NCT00505622|565544229|FG001|Overall Study|Protocol Violation|1|||
156671833|NCT00505622|565544230|FG002|Overall Study|Protocol Violation|0|||
156671834|NCT00505622|565544228|FG000|Overall Study|Withdrawal by Subject|0|||
156671835|NCT00505622|565544229|FG001|Overall Study|Withdrawal by Subject|3|||
156671836|NCT00505622|565544230|FG002|Overall Study|Withdrawal by Subject|2|||
156671837|NCT00505622|565544228|FG000|Overall Study|Study termination by sponsor|115|||
156671838|NCT00505622|565544229|FG001|Overall Study|Study termination by sponsor|98|||
156671839|NCT00505622|565544230|FG002|Overall Study|Study termination by sponsor|90|||
156671840|NCT01757392|565544239|FG000|Overall Study|Withdrawal by Subject|1|||
156671841|NCT01757392|565544239|FG000|Overall Study|Screen Fail|3|||
156671842|NCT00207090|565544242|FG000|Overall Study|Study drug toxicity|3|||
156671843|NCT00207090|565544242|FG000|Overall Study|Chest wall mass larger|1|||
156671844|NCT00207090|565544242|FG000|Overall Study|Disease progression/relapse|2|||
156671845|NCT00207090|565544242|FG000|Overall Study|Physician Decision|1|||
156671846|NCT00835692|565544243|FG000|First Intervention|Withdrawal by Subject|1|||
156671847|NCT00835692|565544244|FG001|First Intervention|Withdrawal by Subject|0|||
156671848|NCT03644550|565544249|FG000|Overall Study|Withdrawal by Subject|3|||
156671849|NCT03644550|565544249|FG000|Overall Study|Progressive disease|15|||
156671850|NCT00830024|565544256|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
156671851|NCT00830024|565544257|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
156671852|NCT02430480|565544258|FG000|Overall Study|Death|1|||
156671853|NCT02430480|565544258|FG000|Overall Study|Anesthesia concerns|1|||
156671854|NCT02430480|565544258|FG000|Overall Study|Progressed on treatment|1|||
156671855|NCT01097577|565544266|FG000|Overall Study|Adverse Event|0|||
156671856|NCT01097577|565544267|FG001|Overall Study|Adverse Event|1|||
156671857|NCT01963728|565544270|FG000|Overall Study|Study terminated early|0|||
156671858|NCT01963728|565544271|FG001|Overall Study|Study terminated early|1|||
156671859|NCT02566850|565545657|FG000|Overall Study|Protocol Violation|1|||
156671860|NCT05710718|565545658|FG000|Overall Study|Withdrawal by Subject|5|||
156526783|NCT03316300|565021610|FG001|Overall Study|Withdrawal by Subject|2|||
156526784|NCT03316300|565021609|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
156526785|NCT03316300|565021610|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
156526786|NCT03316300|565021609|FG000|Overall Study|Adverse Event|1|||
156526787|NCT03316300|565021610|FG001|Overall Study|Adverse Event|0|||
156526788|NCT03316300|565021609|FG000|Overall Study|COVID-19|0|||
156671861|NCT05710718|565545659|FG001|Overall Study|Withdrawal by Subject|1|||
156671862|NCT05710718|565545658|FG000|Overall Study|Lost to Follow-up|0|||
156671863|NCT05710718|565545659|FG001|Overall Study|Lost to Follow-up|1|||
156671864|NCT05710718|565545658|FG000|Overall Study|Death|0|||
156671865|NCT05710718|565545659|FG001|Overall Study|Death|1|||
156671866|NCT04372238|565545660|FG000|Overall Study|Duplicate|3|||
156671867|NCT04372238|565545661|FG001|Overall Study|Duplicate|3|||
156671868|NCT04372238|565545660|FG000|Overall Study|Did not consent for data linkage|6|||
156671869|NCT04372238|565545661|FG001|Overall Study|Did not consent for data linkage|10|||
156671870|NCT04241458|565545662|FG000|Overall Study|Withdrawal by Subject|0|||
156526789|NCT03316300|565021610|FG001|Overall Study|COVID-19|1|||
156526790|NCT03164564|565021611|FG000|Overall Study|Death|3|||
156671871|NCT04241458|565545663|FG001|Overall Study|Withdrawal by Subject|0|||
156671872|NCT04241458|565545664|FG002|Overall Study|Withdrawal by Subject|0|||
156671873|NCT04241458|565545665|FG003|Overall Study|Withdrawal by Subject|0|||
156671874|NCT04241458|565545666|FG004|Overall Study|Withdrawal by Subject|1|||
156671875|NCT05005442|565545667|FG000|Overall Study|Death|14|||
156671876|NCT05005442|565545668|FG001|Overall Study|Death|10|||
156671877|NCT05005442|565545669|FG002|Overall Study|Death|8|||
156671878|NCT05005442|565545670|FG003|Overall Study|Death|22|||
156671879|NCT05005442|565545671|FG004|Overall Study|Death|13|||
156671880|NCT05005442|565545672|FG005|Overall Study|Death|15|||
156671881|NCT05005442|565545667|FG000|Overall Study|Lost to Follow-up|0|||
156671882|NCT05005442|565545668|FG001|Overall Study|Lost to Follow-up|2|||
156671883|NCT05005442|565545669|FG002|Overall Study|Lost to Follow-up|0|||
156671884|NCT05005442|565545670|FG003|Overall Study|Lost to Follow-up|0|||
156671885|NCT05005442|565545671|FG004|Overall Study|Lost to Follow-up|1|||
156671886|NCT05005442|565545672|FG005|Overall Study|Lost to Follow-up|0|||
156671887|NCT05005442|565545667|FG000|Overall Study|Physician Decision|0|||
156671888|NCT05005442|565545668|FG001|Overall Study|Physician Decision|0|||
156671889|NCT05005442|565545669|FG002|Overall Study|Physician Decision|1|||
156671890|NCT05005442|565545670|FG003|Overall Study|Physician Decision|0|||
156671891|NCT05005442|565545671|FG004|Overall Study|Physician Decision|2|||
156671892|NCT05005442|565545672|FG005|Overall Study|Physician Decision|0|||
156671893|NCT05005442|565545667|FG000|Overall Study|Sponsor decision|26|||
156671894|NCT05005442|565545668|FG001|Overall Study|Sponsor decision|26|||
156671895|NCT05005442|565545669|FG002|Overall Study|Sponsor decision|10|||
156671896|NCT05005442|565545670|FG003|Overall Study|Sponsor decision|5|||
156671897|NCT05005442|565545671|FG004|Overall Study|Sponsor decision|9|||
156671898|NCT05005442|565545672|FG005|Overall Study|Sponsor decision|12|||
156671899|NCT05005442|565545667|FG000|Overall Study|Withdrawal by Subject|2|||
156671900|NCT05005442|565545668|FG001|Overall Study|Withdrawal by Subject|2|||
156671901|NCT05005442|565545669|FG002|Overall Study|Withdrawal by Subject|1|||
156671902|NCT05005442|565545670|FG003|Overall Study|Withdrawal by Subject|3|||
156671903|NCT05005442|565545671|FG004|Overall Study|Withdrawal by Subject|0|||
156671904|NCT05005442|565545672|FG005|Overall Study|Withdrawal by Subject|5|||
156671905|NCT05005442|565545667|FG000|Overall Study|Site terminated by sponsor|0|||
156671906|NCT05005442|565545668|FG001|Overall Study|Site terminated by sponsor|2|||
156671907|NCT05005442|565545669|FG002|Overall Study|Site terminated by sponsor|0|||
156671908|NCT05005442|565545670|FG003|Overall Study|Site terminated by sponsor|0|||
156671909|NCT05005442|565545671|FG004|Overall Study|Site terminated by sponsor|0|||
156671910|NCT05005442|565545672|FG005|Overall Study|Site terminated by sponsor|1|||
156671911|NCT03696160|565545679|FG000|Overall Study|Withdrew before IMP dosing|2|||
156671912|NCT03696160|565545680|FG001|Overall Study|Withdrew before IMP dosing|3|||
156671913|NCT00334815|565545683|FG000|Overall Study|Adverse Event|3|||
156671914|NCT00334815|565545684|FG001|Overall Study|Adverse Event|2|||
156671915|NCT00334815|565545683|FG000|Overall Study|Death|0|||
156671916|NCT00334815|565545684|FG001|Overall Study|Death|2|||
156671917|NCT00334815|565545683|FG000|Overall Study|Progression|1|||
156671918|NCT00334815|565545684|FG001|Overall Study|Progression|0|||
156671919|NCT00334815|565545683|FG000|Overall Study|ineligible|1|||
156671920|NCT00334815|565545684|FG001|Overall Study|ineligible|1|||
156671921|NCT00334815|565545683|FG000|Overall Study|patient refused treatment|0|||
156671922|NCT00334815|565545684|FG001|Overall Study|patient refused treatment|1|||
156671923|NCT00334815|565545683|FG000|Overall Study|Physician Decision|2|||
156671924|NCT00334815|565545684|FG001|Overall Study|Physician Decision|4|||
156671925|NCT04970810|565545685|FG000|Overall Study|deemed ineligible after randomization|3|||
156671926|NCT04970810|565545686|FG001|Overall Study|deemed ineligible after randomization|0|||
156671927|NCT04970810|565545687|FG002|Overall Study|deemed ineligible after randomization|4|||
156671928|NCT04742491|565545690|FG000|Overall Study|Death|2|||
156671929|NCT04742491|565545691|FG001|Overall Study|Death|0|||
156671930|NCT04742491|565545690|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
156671931|NCT04742491|565545691|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
156671932|NCT04742491|565545690|FG000|Overall Study|Lost to Follow-up|6|||
156671933|NCT04742491|565545691|FG001|Overall Study|Lost to Follow-up|8|||
156671934|NCT04742491|565545690|FG000|Overall Study|Withdrawal by Subject|4|||
156671935|NCT04742491|565545691|FG001|Overall Study|Withdrawal by Subject|2|||
156671936|NCT04742491|565545690|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
156671937|NCT04742491|565545691|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
156671938|NCT04742491|565545690|FG000|Overall Study|Participant refused further participation|2|||
156671939|NCT04742491|565545691|FG001|Overall Study|Participant refused further participation|7|||
156671940|NCT04742491|565545690|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
156671941|NCT04742491|565545691|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
156671942|NCT04742491|565545690|FG000|Overall Study|Other reasons|3|||
156671943|NCT04742491|565545691|FG001|Overall Study|Other reasons|4|||
156671944|NCT03317899|565545695|FG000|Overall Study|Death|6|||
156671945|NCT03317899|565545696|FG001|Overall Study|Death|9|||
156671946|NCT02751424|565545698|FG000|Part 2|Adverse Event|0|||
156671947|NCT02751424|565545699|FG001|Part 2|Adverse Event|0|||
156671948|NCT02751424|565545700|FG002|Part 2|Adverse Event|0|||
156671949|NCT02751424|565545701|FG003|Part 2|Adverse Event|0|||
156671950|NCT02751424|565545702|FG004|Part 2|Adverse Event|0|||
156671951|NCT02751424|565545703|FG005|Part 2|Adverse Event|0|||
156671952|NCT02751424|565545704|FG006|Part 2|Adverse Event|0|||
156671953|NCT02751424|565545705|FG007|Part 2|Adverse Event|5|||
156671954|NCT02751424|565545706|FG008|Part 2|Adverse Event|0|||
156671955|NCT02197416|565545707|FG000|Overall Study|Other reasons|0|||
156671956|NCT02197416|565545708|FG001|Overall Study|Other reasons|2|||
156671957|NCT02197416|565545709|FG002|Overall Study|Other reasons|5|||
156671958|NCT02197416|565545707|FG000|Overall Study|Withdrawal by Subject|0|||
156671959|NCT02197416|565545708|FG001|Overall Study|Withdrawal by Subject|2|||
156671960|NCT02197416|565545709|FG002|Overall Study|Withdrawal by Subject|1|||
156671961|NCT02197416|565545707|FG000|Overall Study|Protocol Violation|1|||
156671962|NCT02197416|565545708|FG001|Overall Study|Protocol Violation|0|||
156671963|NCT02197416|565545709|FG002|Overall Study|Protocol Violation|1|||
156671964|NCT02197416|565545707|FG000|Overall Study|Adverse Event|0|||
156671965|NCT02197416|565545708|FG001|Overall Study|Adverse Event|0|||
156671966|NCT02197416|565545709|FG002|Overall Study|Adverse Event|1|||
156671967|NCT01492439|565545710|FG000|Overall Study|Withdrew from RTE|4|||
156671968|NCT01492439|565545711|FG001|Overall Study|Withdrew from RTE|9|||
156671969|NCT00716625|565545712|FG000|Overall Study|Safety was not Assessable|1|||
156671970|NCT01204294|565545713|FG000|Overall Study|Adverse Event|2|||
156671971|NCT01204294|565545714|FG001|Overall Study|Adverse Event|6|||
156671972|NCT01204294|565545715|FG002|Overall Study|Adverse Event|0|||
156671973|NCT01204294|565545716|FG003|Overall Study|Adverse Event|7|||
156671974|NCT01204294|565545717|FG004|Overall Study|Adverse Event|1|||
156671975|NCT01204294|565545718|FG005|Overall Study|Adverse Event|4|||
156671976|NCT01204294|565545719|FG006|Overall Study|Adverse Event|0|||
156671977|NCT01204294|565545713|FG000|Overall Study|Protocol Violation|1|||
156671978|NCT01204294|565545714|FG001|Overall Study|Protocol Violation|0|||
156671979|NCT01204294|565545715|FG002|Overall Study|Protocol Violation|2|||
156671980|NCT01204294|565545716|FG003|Overall Study|Protocol Violation|1|||
156671981|NCT01204294|565545717|FG004|Overall Study|Protocol Violation|0|||
156671982|NCT01204294|565545718|FG005|Overall Study|Protocol Violation|0|||
156671983|NCT01204294|565545719|FG006|Overall Study|Protocol Violation|0|||
156671984|NCT01204294|565545713|FG000|Overall Study|Withdrawal by Subject|0|||
156671985|NCT01204294|565545714|FG001|Overall Study|Withdrawal by Subject|2|||
156671986|NCT01204294|565545715|FG002|Overall Study|Withdrawal by Subject|2|||
156671987|NCT01204294|565545716|FG003|Overall Study|Withdrawal by Subject|1|||
156671988|NCT01204294|565545717|FG004|Overall Study|Withdrawal by Subject|1|||
156671989|NCT01204294|565545718|FG005|Overall Study|Withdrawal by Subject|1|||
156671990|NCT01204294|565545719|FG006|Overall Study|Withdrawal by Subject|2|||
156671991|NCT01204294|565545713|FG000|Overall Study|Lack of Efficacy|0|||
156671992|NCT01204294|565545714|FG001|Overall Study|Lack of Efficacy|0|||
156671993|NCT01204294|565545715|FG002|Overall Study|Lack of Efficacy|0|||
156671994|NCT01204294|565545716|FG003|Overall Study|Lack of Efficacy|2|||
156671995|NCT01204294|565545717|FG004|Overall Study|Lack of Efficacy|0|||
156671996|NCT01204294|565545718|FG005|Overall Study|Lack of Efficacy|0|||
156526791|NCT03164564|565021612|FG001|Overall Study|Death|0|||
156526792|NCT03164564|565021611|FG000|Overall Study|Withdrawal by Subject|20|||
156526793|NCT03164564|565021612|FG001|Overall Study|Withdrawal by Subject|15|||
156526794|NCT03164564|565021611|FG000|Overall Study|Lost to Follow-up|2|||
156526795|NCT03164564|565021612|FG001|Overall Study|Lost to Follow-up|0|||
156526796|NCT03164564|565021611|FG000|Overall Study|Physician Decision|0|||
156526797|NCT03164564|565021612|FG001|Overall Study|Physician Decision|1|||
156526798|NCT03164564|565021611|FG000|Overall Study|Adverse Event|0|||
156526799|NCT03164564|565021612|FG001|Overall Study|Adverse Event|1|||
156671997|NCT01204294|565545719|FG006|Overall Study|Lack of Efficacy|0|||
156671998|NCT01204294|565545713|FG000|Overall Study|Other (house moving)|0|||
156671999|NCT01204294|565545714|FG001|Overall Study|Other (house moving)|0|||
156672000|NCT01204294|565545715|FG002|Overall Study|Other (house moving)|1|||
156672001|NCT01204294|565545716|FG003|Overall Study|Other (house moving)|0|||
156672002|NCT01204294|565545717|FG004|Overall Study|Other (house moving)|0|||
156672003|NCT01204294|565545718|FG005|Overall Study|Other (house moving)|0|||
156672004|NCT01204294|565545719|FG006|Overall Study|Other (house moving)|0|||
156672005|NCT02075463|565545720|FG000|Overall Study|Adverse Event|3|||
156672006|NCT02075463|565545720|FG000|Overall Study|Par. reached stopping criteria|4|||
156672007|NCT02075463|565545720|FG000|Overall Study|Withdrawal by Subject|1|||
156526800|NCT03164564|565021611|FG000|Overall Study|Ongoing|1586|||
156526801|NCT03164564|565021612|FG001|Overall Study|Ongoing|1586|||
156526802|NCT04002401|565021613|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
156526803|NCT04002401|565021613|FG000|Overall Study|Death|10|||
156526804|NCT04002401|565021613|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
156672008|NCT01527006|565545721|FG000|Core Study|Adverse Event|0|||
156672009|NCT01527006|565545722|FG001|Core Study|Adverse Event|2|||
156672010|NCT01527006|565545721|FG000|Core Study|Lost to Follow-up|0|||
156672011|NCT01527006|565545722|FG001|Core Study|Lost to Follow-up|1|||
156672012|NCT01527006|565545721|FG000|Core Study|Subject Choice|1|||
156672013|NCT01527006|565545722|FG001|Core Study|Subject Choice|0|||
156672014|NCT01527006|565545721|FG000|Core Study|Inadequate Therapeutic Effect|1|||
156672015|NCT01527006|565545722|FG001|Core Study|Inadequate Therapeutic Effect|0|||
156672016|NCT01527006|565545721|FG000|Core Study|Withdrawal by Subject|0|||
156672017|NCT01527006|565545722|FG001|Core Study|Withdrawal by Subject|1|||
156672018|NCT01527006|565545721|FG000|Core Study|Other|0|||
156327317|NCT00809354|564299234|FG002|Overall Study|Lost to Follow-up|8|||
156327318|NCT00809354|564299235|FG003|Overall Study|Lost to Follow-up|13|||
156327319|NCT00809354|564299236|FG004|Overall Study|Lost to Follow-up|6|||
156327320|NCT00809354|564299237|FG005|Overall Study|Lost to Follow-up|2|||
156327321|NCT00809354|564299238|FG006|Overall Study|Lost to Follow-up|0|||
156327322|NCT00809354|564299239|FG007|Overall Study|Lost to Follow-up|5|||
156327323|NCT00809354|564299240|FG008|Overall Study|Lost to Follow-up|4|||
156327324|NCT00809354|564299241|FG009|Overall Study|Lost to Follow-up|0|||
156327325|NCT00809354|564299232|FG000|Overall Study|Protocol Violation|7|||
156327326|NCT00809354|564299233|FG001|Overall Study|Protocol Violation|14|||
156327327|NCT00809354|564299234|FG002|Overall Study|Protocol Violation|14|||
156327328|NCT00809354|564299235|FG003|Overall Study|Protocol Violation|12|||
156327329|NCT00809354|564299236|FG004|Overall Study|Protocol Violation|14|||
156327330|NCT00809354|564299237|FG005|Overall Study|Protocol Violation|6|||
156327331|NCT00809354|564299238|FG006|Overall Study|Protocol Violation|4|||
156327332|NCT00809354|564299239|FG007|Overall Study|Protocol Violation|6|||
156672019|NCT01527006|565545722|FG001|Core Study|Other|2|||
156672020|NCT01527006|565545721|FG000|Extension Phase|Adverse Event|4|||
156327333|NCT00809354|564299240|FG008|Overall Study|Protocol Violation|9|||
156327334|NCT00809354|564299241|FG009|Overall Study|Protocol Violation|3|||
156327335|NCT00809354|564299232|FG000|Overall Study|Withdrawal by Subject|32|||
156431301|NCT03525119|564667876|FG002|Overall Study|Withdrawal by Subject|2|||
156431302|NCT03525119|564667874|FG000|Overall Study|Reason not Specified|2|||
156431303|NCT03525119|564667875|FG001|Overall Study|Reason not Specified|1|||
156431304|NCT03525119|564667876|FG002|Overall Study|Reason not Specified|2|||
156431305|NCT03525119|564667874|FG000|Overall Study|Randomized but not Vaccinated|1|||
156431306|NCT03525119|564667875|FG001|Overall Study|Randomized but not Vaccinated|0|||
156431307|NCT03525119|564667876|FG002|Overall Study|Randomized but not Vaccinated|2|||
156672021|NCT01527006|565545722|FG001|Extension Phase|Adverse Event|2|||
156672022|NCT01527006|565545721|FG000|Extension Phase|Lost to Follow-up|0|||
156672023|NCT01527006|565545722|FG001|Extension Phase|Lost to Follow-up|1|||
156672024|NCT01527006|565545721|FG000|Extension Phase|Subject Choice|1|||
156672025|NCT01527006|565545722|FG001|Extension Phase|Subject Choice|1|||
156672026|NCT01527006|565545721|FG000|Extension Phase|Inadequate therapeutic effect|1|||
156431308|NCT01186848|564667877|FG000|Overall Study|Lost to Follow-up|4|||
156431309|NCT01186848|564667877|FG000|Overall Study|Withdrawal by Subject|2|||
156672027|NCT01527006|565545722|FG001|Extension Phase|Inadequate therapeutic effect|1|||
156672028|NCT01527006|565545721|FG000|Extension Phase|Other|0|||
156672029|NCT01527006|565545722|FG001|Extension Phase|Other|3|||
156672030|NCT01383486|565545723|FG000|Overall Study|Lost to Follow-up|10|||
156672031|NCT01383486|565545723|FG000|Overall Study|Incomplete information for analysis|2|||
156672032|NCT01383486|565545723|FG000|Overall Study|Did not take any product|6|||
156431310|NCT01186848|564667877|FG000|Overall Study|Adverse Event|2|||
156672033|NCT00245063|565545724|FG000|Overall Study|Adverse Event|6|||
156672034|NCT00245063|565545725|FG001|Overall Study|Adverse Event|5|||
156431311|NCT00158054|564667878|FG000|Overall Study|Refused to continue|3|||
156431312|NCT00158054|564667879|FG001|Overall Study|Refused to continue|0|||
156431313|NCT00158054|564667878|FG000|Overall Study|Unavailable for follow up|7|||
156672035|NCT00245063|565545724|FG000|Overall Study|Death|1|||
156672036|NCT00245063|565545725|FG001|Overall Study|Death|0|||
156672037|NCT03199963|565545731|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
156672038|NCT03199963|565545732|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
156672039|NCT03199963|565545731|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
156672040|NCT03199963|565545732|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
156672041|NCT03199963|565545731|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
156672042|NCT03199963|565545732|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
156431314|NCT00158054|564667879|FG001|Overall Study|Unavailable for follow up|3|||
156431315|NCT00414648|564667880|FG000|Overall Study|Adverse Event|5|||
156672043|NCT03199963|565545731|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
156672044|NCT03199963|565545732|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
156672045|NCT03199963|565545731|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
156779782|NCT01078662|565943883|FG000|Overall Study|Death|41|||
156327336|NCT00809354|564299233|FG001|Overall Study|Withdrawal by Subject|27|||
156327337|NCT00809354|564299234|FG002|Overall Study|Withdrawal by Subject|31|||
156327338|NCT00809354|564299235|FG003|Overall Study|Withdrawal by Subject|33|||
156431316|NCT00414648|564667881|FG001|Overall Study|Adverse Event|5|||
156431317|NCT00414648|564667880|FG000|Overall Study|Death|0|||
156327339|NCT00809354|564299236|FG004|Overall Study|Withdrawal by Subject|34|||
156327340|NCT00809354|564299237|FG005|Overall Study|Withdrawal by Subject|29|||
156431318|NCT00414648|564667881|FG001|Overall Study|Death|1|||
156672046|NCT03199963|565545732|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
156672047|NCT03199963|565545731|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
156672048|NCT03199963|565545732|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
156672049|NCT00466167|565545733|FG000|Overall Study|Adverse Event|8|||
156672050|NCT00466167|565545734|FG001|Overall Study|Adverse Event|8|||
156672051|NCT00466167|565545735|FG002|Overall Study|Adverse Event|7|||
156672052|NCT00466167|565545733|FG000|Overall Study|Lack of Efficacy|2|||
156672053|NCT00466167|565545734|FG001|Overall Study|Lack of Efficacy|0|||
156672054|NCT00466167|565545735|FG002|Overall Study|Lack of Efficacy|3|||
156672055|NCT00466167|565545733|FG000|Overall Study|Protocol Violation|1|||
156672056|NCT00466167|565545734|FG001|Overall Study|Protocol Violation|1|||
156672057|NCT00466167|565545735|FG002|Overall Study|Protocol Violation|2|||
156672058|NCT00466167|565545733|FG000|Overall Study|Lost to Follow-up|3|||
156672059|NCT00466167|565545734|FG001|Overall Study|Lost to Follow-up|2|||
156672060|NCT00466167|565545735|FG002|Overall Study|Lost to Follow-up|2|||
156672061|NCT00466167|565545733|FG000|Overall Study|Withdrawal by Subject|4|||
156672062|NCT00466167|565545734|FG001|Overall Study|Withdrawal by Subject|1|||
156672063|NCT00466167|565545735|FG002|Overall Study|Withdrawal by Subject|6|||
156672064|NCT00466167|565545733|FG000|Overall Study|patient did not meet inclusion criteria|1|||
156672065|NCT00466167|565545734|FG001|Overall Study|patient did not meet inclusion criteria|0|||
156672066|NCT00466167|565545735|FG002|Overall Study|patient did not meet inclusion criteria|1|||
156672067|NCT00466167|565545733|FG000|Overall Study|Not treated|1|||
156672068|NCT00466167|565545734|FG001|Overall Study|Not treated|0|||
156672069|NCT00466167|565545735|FG002|Overall Study|Not treated|0|||
156672070|NCT04128761|565545740|FG000|Overall Study|Lost to Follow-up|5|||
156672071|NCT04128761|565545741|FG001|Overall Study|Lost to Follow-up|6|||
156672072|NCT06539676|565545742|FG000|Overall Study|Early study termination|1|||
156672073|NCT06539676|565545743|FG001|Overall Study|Early study termination|0|||
156672074|NCT06539676|565545744|FG002|Overall Study|Early study termination|6|||
156672075|NCT01848938|565545752|FG000|Overall Study|Lost to Follow-up|1|||
156672076|NCT01848938|565545753|FG001|Overall Study|Lost to Follow-up|1|||
156672077|NCT00835536|565545754|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
156672078|NCT00835536|565545755|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
156672079|NCT04589650|565545758|FG000|Overall Study|Subject decision|6|||
156672080|NCT04589650|565545759|FG001|Overall Study|Subject decision|2|||
156672081|NCT04589650|565545760|FG002|Overall Study|Subject decision|2|||
156672082|NCT04589650|565545761|FG003|Overall Study|Subject decision|0|||
156672083|NCT04589650|565545762|FG004|Overall Study|Subject decision|0|||
156672084|NCT04589650|565545763|FG005|Overall Study|Subject decision|0|||
156672085|NCT04589650|565545758|FG000|Overall Study|Adverse Event|3|||
156672086|NCT04589650|565545759|FG001|Overall Study|Adverse Event|1|||
156672087|NCT04589650|565545760|FG002|Overall Study|Adverse Event|1|||
156672088|NCT04589650|565545761|FG003|Overall Study|Adverse Event|1|||
156672089|NCT04589650|565545762|FG004|Overall Study|Adverse Event|0|||
156672090|NCT04589650|565545763|FG005|Overall Study|Adverse Event|1|||
156672091|NCT04589650|565545758|FG000|Overall Study|Physician Decision|1|||
156672092|NCT04589650|565545759|FG001|Overall Study|Physician Decision|1|||
156672093|NCT04589650|565545760|FG002|Overall Study|Physician Decision|0|||
156672094|NCT04589650|565545761|FG003|Overall Study|Physician Decision|0|||
156672095|NCT04589650|565545762|FG004|Overall Study|Physician Decision|0|||
156672096|NCT04589650|565545763|FG005|Overall Study|Physician Decision|0|||
156672097|NCT04589650|565545758|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156672098|NCT04589650|565545759|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156672099|NCT04589650|565545760|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156672100|NCT04589650|565545761|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156431319|NCT00414648|564667880|FG000|Overall Study|Lack of Efficacy|0|||
156431320|NCT00414648|564667881|FG001|Overall Study|Lack of Efficacy|2|||
156431321|NCT00414648|564667880|FG000|Overall Study|Withdrawal by Subject|0|||
156431322|NCT00414648|564667881|FG001|Overall Study|Withdrawal by Subject|1|||
156431323|NCT05484726|564667885|FG000|Overall Study|Protocol Violation|3|||
156431324|NCT05484726|564667886|FG001|Overall Study|Protocol Violation|3|||
156431325|NCT05484726|564667885|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
156431326|NCT05484726|564667886|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
156431327|NCT05484726|564667885|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
156431328|NCT05484726|564667886|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
156431329|NCT05484726|564667885|FG000|Overall Study|continued need of mechanical ventilation|2|||
156431330|NCT05484726|564667886|FG001|Overall Study|continued need of mechanical ventilation|3|||
156431331|NCT05484726|564667885|FG000|Overall Study|Withdrawal by Subject|2|||
156431332|NCT05484726|564667886|FG001|Overall Study|Withdrawal by Subject|3|||
156431333|NCT05484726|564667885|FG000|Overall Study|IVH (G III & IV)|2|||
156431334|NCT05484726|564667886|FG001|Overall Study|IVH (G III & IV)|1|||
156431335|NCT05484726|564667885|FG000|Overall Study|NEC (stage II & III)|2|||
156431336|NCT05484726|564667886|FG001|Overall Study|NEC (stage II & III)|3|||
156672101|NCT04589650|565545762|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
156672102|NCT04589650|565545763|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
156672103|NCT04589650|565545758|FG000|Overall Study|Death|0|||
156672104|NCT04589650|565545759|FG001|Overall Study|Death|0|||
156672105|NCT04589650|565545760|FG002|Overall Study|Death|0|||
156672106|NCT04589650|565545761|FG003|Overall Study|Death|1|||
156672107|NCT04589650|565545762|FG004|Overall Study|Death|0|||
156672108|NCT04589650|565545763|FG005|Overall Study|Death|0|||
156672109|NCT04589650|565545758|FG000|Overall Study|Guardian Decision|0|||
156672110|NCT04589650|565545759|FG001|Overall Study|Guardian Decision|0|||
156672111|NCT04589650|565545760|FG002|Overall Study|Guardian Decision|0|||
156672112|NCT04589650|565545761|FG003|Overall Study|Guardian Decision|1|||
156672113|NCT04589650|565545762|FG004|Overall Study|Guardian Decision|0|||
156672114|NCT04589650|565545763|FG005|Overall Study|Guardian Decision|0|||
156672115|NCT00950989|565545764|FG000|Overall Study|Death|0|||
156672116|NCT00950989|565545765|FG001|Overall Study|Death|0|||
156672117|NCT00950989|565545766|FG002|Overall Study|Death|1|||
156672118|NCT00950989|565545767|FG003|Overall Study|Death|0|||
156672119|NCT00950989|565545764|FG000|Overall Study|Administrative Decision|0|||
156672120|NCT00950989|565545765|FG001|Overall Study|Administrative Decision|1|||
156672121|NCT00950989|565545766|FG002|Overall Study|Administrative Decision|0|||
156672122|NCT00950989|565545767|FG003|Overall Study|Administrative Decision|0|||
156672123|NCT00950989|565545764|FG000|Overall Study|Disease Progression|0|||
156672124|NCT00950989|565545765|FG001|Overall Study|Disease Progression|0|||
156672125|NCT00950989|565545766|FG002|Overall Study|Disease Progression|1|||
156672126|NCT00950989|565545767|FG003|Overall Study|Disease Progression|0|||
156672127|NCT00950989|565545764|FG000|Overall Study|Withdrawal by Subject|2|||
156672128|NCT00950989|565545765|FG001|Overall Study|Withdrawal by Subject|1|||
156672129|NCT00950989|565545766|FG002|Overall Study|Withdrawal by Subject|0|||
156672130|NCT00950989|565545767|FG003|Overall Study|Withdrawal by Subject|0|||
156672131|NCT00950989|565545764|FG000|Overall Study|Adverse Event|2|||
156672132|NCT00950989|565545765|FG001|Overall Study|Adverse Event|1|||
156672133|NCT00950989|565545766|FG002|Overall Study|Adverse Event|1|||
156672134|NCT00950989|565545767|FG003|Overall Study|Adverse Event|0|||
156672135|NCT03804983|565545768|FG000|Overall Study|Adverse Event|0|||
156672136|NCT03804983|565545769|FG001|Overall Study|Adverse Event|1|||
156672137|NCT03804983|565545768|FG000|Overall Study|Family Obligation|1|||
156672138|NCT03804983|565545769|FG001|Overall Study|Family Obligation|0|||
156672139|NCT01154231|565545770|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
156672140|NCT01154231|565545770|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
156672141|NCT01440803|565546530|FG000|Overall Study|Met study stopping rule|2|||
156672142|NCT01440803|565546531|FG001|Overall Study|Met study stopping rule|1|||
156672143|NCT01440803|565546530|FG000|Overall Study|Lost to Follow-up|0|||
156672144|NCT01440803|565546531|FG001|Overall Study|Lost to Follow-up|2|||
156672145|NCT01440803|565546530|FG000|Overall Study|Withdrawal by Subject|0|||
156672146|NCT01440803|565546531|FG001|Overall Study|Withdrawal by Subject|1|||
156672147|NCT03913377|565546533|FG000|Period 1|Test Article no longer available|0|||
156672148|NCT03913377|565546534|FG001|Period 1|Test Article no longer available|1|||
156672149|NCT03913377|565546535|FG002|Period 1|Test Article no longer available|0|||
156672150|NCT03913377|565546533|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
156672151|NCT03913377|565546534|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
156672152|NCT03913377|565546535|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
156672153|NCT04349267|565546536|FG000|Overall Study|Adverse Event|0|||
156672154|NCT04349267|565546537|FG001|Overall Study|Adverse Event|0|||
156672155|NCT04349267|565546538|FG002|Overall Study|Adverse Event|0|||
156672156|NCT04349267|565546539|FG003|Overall Study|Adverse Event|0|||
156672157|NCT04349267|565546540|FG004|Overall Study|Adverse Event|0|||
156672158|NCT04349267|565546541|FG005|Overall Study|Adverse Event|1|||
156431337|NCT02104765|564667889|FG000|Overall Study|Lost to Follow-up|0|||
156672159|NCT04349267|565546542|FG006|Overall Study|Adverse Event|0|||
156672160|NCT04349267|565546536|FG000|Overall Study|Other reason|0|||
156672161|NCT04349267|565546537|FG001|Overall Study|Other reason|1|||
156672162|NCT04349267|565546538|FG002|Overall Study|Other reason|0|||
156672163|NCT04349267|565546539|FG003|Overall Study|Other reason|0|||
156672164|NCT04349267|565546540|FG004|Overall Study|Other reason|1|||
156672165|NCT04349267|565546541|FG005|Overall Study|Other reason|1|||
156672166|NCT04349267|565546542|FG006|Overall Study|Other reason|1|||
156431338|NCT02104765|564667890|FG001|Overall Study|Lost to Follow-up|0|||
156431339|NCT02104765|564667891|FG002|Overall Study|Lost to Follow-up|1|||
156431340|NCT02104765|564667892|FG003|Overall Study|Lost to Follow-up|0|||
156431341|NCT02104765|564667893|FG004|Overall Study|Lost to Follow-up|0|||
156431342|NCT02104765|564667894|FG005|Overall Study|Lost to Follow-up|0|||
156431343|NCT02104765|564667895|FG006|Overall Study|Lost to Follow-up|0|||
156431344|NCT02104765|564667889|FG000|Overall Study|Withdrawal by Subject|0|||
156431345|NCT02104765|564667890|FG001|Overall Study|Withdrawal by Subject|0|||
156431346|NCT02104765|564667891|FG002|Overall Study|Withdrawal by Subject|0|||
156431347|NCT02104765|564667892|FG003|Overall Study|Withdrawal by Subject|1|||
156672167|NCT04349267|565546536|FG000|Overall Study|Disease Progression|2|||
156672168|NCT04349267|565546537|FG001|Overall Study|Disease Progression|0|||
156431348|NCT02104765|564667893|FG004|Overall Study|Withdrawal by Subject|1|||
156672169|NCT04349267|565546538|FG002|Overall Study|Disease Progression|2|||
156672170|NCT04349267|565546539|FG003|Overall Study|Disease Progression|3|||
156672171|NCT04349267|565546540|FG004|Overall Study|Disease Progression|3|||
156672172|NCT04349267|565546541|FG005|Overall Study|Disease Progression|7|||
156672173|NCT04349267|565546542|FG006|Overall Study|Disease Progression|10|||
156672174|NCT04349267|565546536|FG000|Overall Study|Participant withdrew consent|0|||
156672175|NCT04349267|565546537|FG001|Overall Study|Participant withdrew consent|1|||
156672176|NCT04349267|565546538|FG002|Overall Study|Participant withdrew consent|0|||
156672177|NCT04349267|565546539|FG003|Overall Study|Participant withdrew consent|0|||
156672178|NCT04349267|565546540|FG004|Overall Study|Participant withdrew consent|0|||
156672179|NCT04349267|565546541|FG005|Overall Study|Participant withdrew consent|0|||
156672180|NCT04349267|565546542|FG006|Overall Study|Participant withdrew consent|1|||
156672181|NCT03689400|565546543|FG000|Overall Study|Lost to Follow-up|4|||
156672182|NCT04618211|565546544|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
156672183|NCT04618211|565546545|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
156672184|NCT04618211|565546546|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
156672185|NCT04618211|565546544|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
156672186|NCT04618211|565546545|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
156672187|NCT04618211|565546546|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
156672188|NCT04618211|565546544|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
156672189|NCT04618211|565546545|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
156672190|NCT04618211|565546546|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
156672191|NCT05919823|565546547|FG000|Pre-Treatment Period|Screen failure|1|||
156672192|NCT05919823|565546548|FG001|Pre-Treatment Period|Screen failure|0|||
156672193|NCT05919823|565546549|FG002|Pre-Treatment Period|Screen failure|0|||
156672194|NCT05919823|565546550|FG003|Pre-Treatment Period|Screen failure|0|||
156672195|NCT05919823|565546547|FG000|Pre-Treatment Period|Protocol Violation|0|||
156672196|NCT05919823|565546548|FG001|Pre-Treatment Period|Protocol Violation|1|||
156672197|NCT05919823|565546549|FG002|Pre-Treatment Period|Protocol Violation|0|||
156672198|NCT05919823|565546550|FG003|Pre-Treatment Period|Protocol Violation|0|||
156672199|NCT05919823|565546547|FG000|Double-Blind Period|Adverse Event|8|||
156672200|NCT05919823|565546548|FG001|Double-Blind Period|Adverse Event|9|||
156672201|NCT05919823|565546549|FG002|Double-Blind Period|Adverse Event|0|||
156672202|NCT05919823|565546550|FG003|Double-Blind Period|Adverse Event|0|||
156672203|NCT05919823|565546547|FG000|Double-Blind Period|Protocol Violation|2|||
156672204|NCT05919823|565546548|FG001|Double-Blind Period|Protocol Violation|1|||
156672205|NCT05919823|565546549|FG002|Double-Blind Period|Protocol Violation|0|||
156672206|NCT05919823|565546550|FG003|Double-Blind Period|Protocol Violation|0|||
156672207|NCT05919823|565546547|FG000|Double-Blind Period|Participant withdrew consent|11|||
156672208|NCT05919823|565546548|FG001|Double-Blind Period|Participant withdrew consent|7|||
156672209|NCT05919823|565546549|FG002|Double-Blind Period|Participant withdrew consent|0|||
156672210|NCT05919823|565546550|FG003|Double-Blind Period|Participant withdrew consent|0|||
156672211|NCT05919823|565546547|FG000|Double-Blind Period|Other reasons|2|||
156672212|NCT05919823|565546548|FG001|Double-Blind Period|Other reasons|3|||
156672213|NCT05919823|565546549|FG002|Double-Blind Period|Other reasons|0|||
156672214|NCT05919823|565546550|FG003|Double-Blind Period|Other reasons|0|||
156672215|NCT05919823|565546547|FG000|Open Label Period|Adverse Event|0|||
156672216|NCT05919823|565546548|FG001|Open Label Period|Adverse Event|0|||
156672217|NCT05919823|565546549|FG002|Open Label Period|Adverse Event|2|||
156327341|NCT00809354|564299238|FG006|Overall Study|Withdrawal by Subject|27|||
156526805|NCT04002401|565021613|FG000|Overall Study|Enrolled but Never Treated|1|||
156526806|NCT04002401|565021613|FG000|Overall Study|Lost to Follow-up|1|||
156526807|NCT00423930|565021614|FG000|Overall Study|Withdrawal by Subject|2|||
156526808|NCT02337751|565021615|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
156526809|NCT02337751|565021616|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
156526810|NCT02337751|565021615|FG000|Overall Study|Voluntary Withdrawal|6|||
156526811|NCT02337751|565021616|FG001|Overall Study|Voluntary Withdrawal|8|||
156526812|NCT02337751|565021615|FG000|Overall Study|Lack of Efficacy|2|||
156526813|NCT02337751|565021616|FG001|Overall Study|Lack of Efficacy|5|||
156526814|NCT02337751|565021615|FG000|Overall Study|Investigator's Judgement|1|||
156526815|NCT02337751|565021616|FG001|Overall Study|Investigator's Judgement|0|||
156526816|NCT01340651|565021617|FG000|Overall Study|Adverse Event|3|||
156526817|NCT01340651|565021617|FG000|Overall Study|Consent Withdrawn|2|||
156526818|NCT01340651|565021617|FG000|Overall Study|Commercial Supply per Sponsor|12|||
156526819|NCT01315353|565021618|FG000|Overall Study|Death|2|||
156526820|NCT01315353|565021619|FG001|Overall Study|Death|1|||
156526821|NCT01315353|565021620|FG002|Overall Study|Death|0|||
156526822|NCT01315353|565021618|FG000|Overall Study|Withdrawal by Subject|2|||
156672218|NCT05919823|565546550|FG003|Open Label Period|Adverse Event|4|||
156672219|NCT05919823|565546547|FG000|Open Label Period|Lost to Follow-up|0|||
156779783|NCT01078662|565943884|FG001|Overall Study|Death|103|||
156526823|NCT01315353|565021619|FG001|Overall Study|Withdrawal by Subject|6|||
156526824|NCT01315353|565021620|FG002|Overall Study|Withdrawal by Subject|1|||
156526825|NCT01315353|565021618|FG000|Overall Study|Lost to Follow-up|13|||
156526826|NCT01315353|565021619|FG001|Overall Study|Lost to Follow-up|6|||
156526827|NCT01315353|565021620|FG002|Overall Study|Lost to Follow-up|6|||
156672220|NCT05919823|565546548|FG001|Open Label Period|Lost to Follow-up|0|||
156672221|NCT05919823|565546549|FG002|Open Label Period|Lost to Follow-up|1|||
156672222|NCT05919823|565546550|FG003|Open Label Period|Lost to Follow-up|0|||
156672223|NCT05919823|565546547|FG000|Open Label Period|Protocol Violation|0|||
156672224|NCT05919823|565546548|FG001|Open Label Period|Protocol Violation|0|||
156672225|NCT05919823|565546549|FG002|Open Label Period|Protocol Violation|0|||
156672226|NCT05919823|565546550|FG003|Open Label Period|Protocol Violation|1|||
156672227|NCT05919823|565546547|FG000|Open Label Period|Participant withdrew consent|0|||
156672228|NCT05919823|565546548|FG001|Open Label Period|Participant withdrew consent|0|||
156672229|NCT05919823|565546549|FG002|Open Label Period|Participant withdrew consent|8|||
156672230|NCT05919823|565546550|FG003|Open Label Period|Participant withdrew consent|6|||
156672231|NCT05919823|565546547|FG000|Open Label Period|Death|0|||
156672232|NCT05919823|565546548|FG001|Open Label Period|Death|0|||
156672233|NCT05919823|565546549|FG002|Open Label Period|Death|0|||
156672234|NCT05919823|565546550|FG003|Open Label Period|Death|1|||
156672235|NCT05919823|565546547|FG000|Open Label Period|Other reasons|0|||
156672236|NCT05919823|565546548|FG001|Open Label Period|Other reasons|0|||
156672237|NCT05919823|565546549|FG002|Open Label Period|Other reasons|9|||
156672238|NCT05919823|565546550|FG003|Open Label Period|Other reasons|5|||
156672239|NCT01648582|565546551|FG000|Overall Study|Adverse Event|6|||
156672240|NCT01648582|565546552|FG001|Overall Study|Adverse Event|11|||
156672241|NCT01648582|565546553|FG002|Overall Study|Adverse Event|2|||
156672242|NCT01648582|565546551|FG000|Overall Study|Lost to Follow-up|9|||
156672243|NCT01648582|565546552|FG001|Overall Study|Lost to Follow-up|6|||
156672244|NCT01648582|565546553|FG002|Overall Study|Lost to Follow-up|8|||
156672245|NCT01648582|565546551|FG000|Overall Study|Protocol Violation|1|||
156672246|NCT01648582|565546552|FG001|Overall Study|Protocol Violation|2|||
156672247|NCT01648582|565546553|FG002|Overall Study|Protocol Violation|1|||
156672248|NCT01648582|565546551|FG000|Overall Study|Withdrawal by Subject|15|||
156672249|NCT01648582|565546552|FG001|Overall Study|Withdrawal by Subject|17|||
156672250|NCT01648582|565546553|FG002|Overall Study|Withdrawal by Subject|17|||
156672251|NCT01648582|565546551|FG000|Overall Study|Physician Decision|0|||
156672252|NCT01648582|565546552|FG001|Overall Study|Physician Decision|1|||
156672253|NCT01648582|565546553|FG002|Overall Study|Physician Decision|3|||
156672254|NCT01648582|565546551|FG000|Overall Study|Death|1|||
156672255|NCT01648582|565546552|FG001|Overall Study|Death|0|||
156672256|NCT01648582|565546553|FG002|Overall Study|Death|0|||
156672257|NCT01648582|565546551|FG000|Overall Study|Sponsor Decision|0|||
156672258|NCT01648582|565546552|FG001|Overall Study|Sponsor Decision|1|||
156672259|NCT01648582|565546553|FG002|Overall Study|Sponsor Decision|1|||
156672260|NCT03534193|565546562|FG000|Overall Study|Lost to Follow-up|1|||
156672261|NCT03534193|565546563|FG001|Overall Study|Lost to Follow-up|3|||
156672262|NCT04414930|565546564|FG000|Overall Study|Withdrawal by Subject|1|||
156672263|NCT04414930|565546565|FG001|Overall Study|Withdrawal by Subject|3|||
156672264|NCT05470699|565546566|FG000|Overall Study|Did not receive intervention|13|||
156672265|NCT05470699|565546566|FG000|Overall Study|Ineligible|1|||
156672266|NCT01983969|565546570|FG000|Overall Study|Disease Progression|0|||
156672267|NCT01983969|565546571|FG001|Overall Study|Disease Progression|1|||
156672268|NCT01983969|565546572|FG002|Overall Study|Disease Progression|0|||
156672269|NCT02619682|565546573|FG000|Overall Study|Withdrawal by Subject|3|||
156672270|NCT02619682|565546573|FG000|Overall Study|Lack of Efficacy|8|||
156672271|NCT02619682|565546573|FG000|Overall Study|new secondary cancer|1|||
156672272|NCT02619682|565546573|FG000|Overall Study|post surgery complications|2|||
156672273|NCT00268203|565546574|FG000|Overall Study|Lost to Follow-up|92|||
156672274|NCT00268203|565546574|FG000|Overall Study|Withdrawal by Subject|9|||
156672275|NCT00268203|565546574|FG000|Overall Study|Received Other NHL Therapy|7|||
156672276|NCT00268203|565546574|FG000|Overall Study|Progressive Disease|359|||
156672277|NCT00268203|565546574|FG000|Overall Study|Death|84|||
156672278|NCT00268203|565546574|FG000|Overall Study|Reason Not Specified|34|||
156672279|NCT00268203|565546574|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
156672280|NCT06041256|565546577|FG000|Overall Study|Withdrawal by Subject|1|||
156672281|NCT06041256|565546578|FG001|Overall Study|Withdrawal by Subject|0|||
156327342|NCT00809354|564299239|FG007|Overall Study|Withdrawal by Subject|19|||
156327343|NCT00809354|564299240|FG008|Overall Study|Withdrawal by Subject|18|||
156327344|NCT00809354|564299241|FG009|Overall Study|Withdrawal by Subject|20|||
156672282|NCT06041256|565546579|FG002|Overall Study|Withdrawal by Subject|3|||
156672283|NCT06041256|565546580|FG003|Overall Study|Withdrawal by Subject|1|||
156672284|NCT06041256|565546581|FG004|Overall Study|Withdrawal by Subject|1|||
156672285|NCT06041256|565546577|FG000|Overall Study|Rescue|17|||
156672286|NCT06041256|565546578|FG001|Overall Study|Rescue|6|||
156779784|NCT01078662|565943885|FG002|Overall Study|Death|18|||
156327345|NCT00809354|564299232|FG000|Overall Study|Other|10|||
156672287|NCT06041256|565546579|FG002|Overall Study|Rescue|9|||
156672288|NCT06041256|565546580|FG003|Overall Study|Rescue|6|||
156672289|NCT06041256|565546581|FG004|Overall Study|Rescue|2|||
156672290|NCT03114891|565546582|FG000|First Treatment Round|Lost to Follow-up|0|||
156672291|NCT03114891|565546583|FG001|First Treatment Round|Lost to Follow-up|1|||
156672292|NCT03114891|565546584|FG002|First Treatment Round|Lost to Follow-up|1|||
156672293|NCT03114891|565546585|FG003|First Treatment Round|Lost to Follow-up|0|||
156672294|NCT03114891|565546582|FG000|First Treatment Round|Withdrawal by Subject|0|||
156672295|NCT03114891|565546583|FG001|First Treatment Round|Withdrawal by Subject|2|||
156672296|NCT03114891|565546584|FG002|First Treatment Round|Withdrawal by Subject|0|||
156672297|NCT03114891|565546585|FG003|First Treatment Round|Withdrawal by Subject|1|||
156672298|NCT03114891|565546582|FG000|3 Week Break|Lost to Follow-up|1|||
156672299|NCT03114891|565546583|FG001|3 Week Break|Lost to Follow-up|0|||
156672300|NCT03114891|565546584|FG002|3 Week Break|Lost to Follow-up|0|||
156672301|NCT03114891|565546585|FG003|3 Week Break|Lost to Follow-up|1|||
156672302|NCT03114891|565546582|FG000|3 Week Break|Withdrawal by Subject|0|||
156672303|NCT03114891|565546583|FG001|3 Week Break|Withdrawal by Subject|1|||
156672304|NCT03114891|565546584|FG002|3 Week Break|Withdrawal by Subject|0|||
156672305|NCT03114891|565546585|FG003|3 Week Break|Withdrawal by Subject|0|||
156672306|NCT03114891|565546582|FG000|Second Treatment Round|Lost to Follow-up|1|||
156672307|NCT03114891|565546583|FG001|Second Treatment Round|Lost to Follow-up|0|||
156672308|NCT03114891|565546584|FG002|Second Treatment Round|Lost to Follow-up|0|||
156672309|NCT03114891|565546585|FG003|Second Treatment Round|Lost to Follow-up|0|||
156672310|NCT03114891|565546582|FG000|Second Treatment Round|Physician Decision|1|||
156672311|NCT03114891|565546583|FG001|Second Treatment Round|Physician Decision|0|||
156672312|NCT03114891|565546584|FG002|Second Treatment Round|Physician Decision|0|||
156672313|NCT03114891|565546585|FG003|Second Treatment Round|Physician Decision|0|||
156672314|NCT00772603|565547443|FG000|Overall Study|Withdrawal by Subject|11|||
156672315|NCT00772603|565547444|FG001|Overall Study|Withdrawal by Subject|10|||
156672316|NCT00772603|565547445|FG002|Overall Study|Withdrawal by Subject|6|||
156672317|NCT00772603|565547443|FG000|Overall Study|Adverse Event|37|||
156672318|NCT00772603|565547444|FG001|Overall Study|Adverse Event|18|||
156672319|NCT00772603|565547445|FG002|Overall Study|Adverse Event|10|||
156672320|NCT00772603|565547443|FG000|Overall Study|Subject Non-compliance|1|||
156672321|NCT00772603|565547444|FG001|Overall Study|Subject Non-compliance|6|||
156672322|NCT00772603|565547445|FG002|Overall Study|Subject Non-compliance|4|||
156672323|NCT00772603|565547443|FG000|Overall Study|Protocol Violation|0|||
156672324|NCT00772603|565547444|FG001|Overall Study|Protocol Violation|1|||
156672325|NCT00772603|565547445|FG002|Overall Study|Protocol Violation|1|||
156672326|NCT00772603|565547443|FG000|Overall Study|Lost to Follow-up|1|||
156672327|NCT00772603|565547444|FG001|Overall Study|Lost to Follow-up|5|||
156672328|NCT00772603|565547445|FG002|Overall Study|Lost to Follow-up|2|||
156672329|NCT00772603|565547443|FG000|Overall Study|Physician Decision|0|||
156672330|NCT00772603|565547444|FG001|Overall Study|Physician Decision|0|||
156672331|NCT00772603|565547445|FG002|Overall Study|Physician Decision|1|||
156672332|NCT00772603|565547443|FG000|Overall Study|Other|2|||
156672333|NCT00772603|565547444|FG001|Overall Study|Other|0|||
156672334|NCT00772603|565547445|FG002|Overall Study|Other|2|||
156672335|NCT00859521|565547448|FG000|Washout|Withdrawal by Subject|0|||
156672336|NCT00859521|565547449|FG001|Washout|Withdrawal by Subject|1|||
156672337|NCT02125461|565547450|FG000|Overall Study|Withdrawal by Subject|30|||
156672338|NCT02125461|565547451|FG001|Overall Study|Withdrawal by Subject|16|||
156672339|NCT02125461|565547450|FG000|Overall Study|Lost to Follow-up|8|||
156672340|NCT02125461|565547451|FG001|Overall Study|Lost to Follow-up|3|||
156672341|NCT02125461|565547450|FG000|Overall Study|Death|260|||
156672342|NCT02125461|565547451|FG001|Overall Study|Death|149|||
156672343|NCT02125461|565547450|FG000|Overall Study|Missing Termination Reason|0|||
156672344|NCT02125461|565547451|FG001|Overall Study|Missing Termination Reason|1|||
156672345|NCT03552484|565547452|FG000|Overall Study|Death|6|||
156672346|NCT03552484|565547453|FG001|Overall Study|Death|4|||
156672347|NCT03552484|565547452|FG000|Overall Study|Lost to Follow-up|0|||
156431349|NCT02104765|564667894|FG005|Overall Study|Withdrawal by Subject|0|||
156431350|NCT02104765|564667895|FG006|Overall Study|Withdrawal by Subject|1|||
156431351|NCT04771273|564667896|FG000|Dose Escalation Period|Not treated with trial medication|0|||
156431352|NCT04771273|564667897|FG001|Dose Escalation Period|Not treated with trial medication|1|||
156431353|NCT04771273|564667898|FG002|Dose Escalation Period|Not treated with trial medication|1|||
156431354|NCT04771273|564667899|FG003|Dose Escalation Period|Not treated with trial medication|0|||
156431355|NCT04771273|564667896|FG000|Dose Escalation Period|Other reasons than listed|2|||
156431356|NCT04771273|564667897|FG001|Dose Escalation Period|Other reasons than listed|0|||
156431357|NCT04771273|564667898|FG002|Dose Escalation Period|Other reasons than listed|2|||
156431358|NCT04771273|564667899|FG003|Dose Escalation Period|Other reasons than listed|1|||
156431359|NCT04771273|564667896|FG000|Dose Escalation Period|Protocol Violation|0|||
156431360|NCT04771273|564667897|FG001|Dose Escalation Period|Protocol Violation|0|||
156672348|NCT03552484|565547453|FG001|Overall Study|Lost to Follow-up|16|||
156672349|NCT02699463|565547454|FG000|Overall Study|Lost to Follow-up|11|||
156866588|NCT00129402|566271284|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
156431361|NCT04771273|564667898|FG002|Dose Escalation Period|Protocol Violation|3|||
156431362|NCT04771273|564667899|FG003|Dose Escalation Period|Protocol Violation|1|||
156431363|NCT04771273|564667896|FG000|Dose Escalation Period|Burden of study procedures|1|||
156431364|NCT04771273|564667897|FG001|Dose Escalation Period|Burden of study procedures|0|||
156672350|NCT02699463|565547455|FG001|Overall Study|Lost to Follow-up|8|||
156672351|NCT02699463|565547454|FG000|Overall Study|Withdrawal by Subject|4|||
156672352|NCT02699463|565547455|FG001|Overall Study|Withdrawal by Subject|1|||
156672353|NCT02488239|565547458|FG000|Overall Study|Death|3|||
156672354|NCT02488239|565547458|FG000|Overall Study|Withdrawal by Subject|3|||
156672355|NCT02488239|565547458|FG000|Overall Study|Physician Decision|2|||
156672356|NCT02488239|565547458|FG000|Overall Study|Consent ineligible|1|||
156672357|NCT02488239|565547458|FG000|Overall Study|Did not undergo implant procedure|1|||
156672358|NCT01370733|565547462|FG000|Overall Study|Withdrawal by Subject|8|||
156672359|NCT01370733|565547463|FG001|Overall Study|Withdrawal by Subject|8|||
156672360|NCT01370733|565547462|FG000|Overall Study|Lost to Follow-up|3|||
156672361|NCT01370733|565547463|FG001|Overall Study|Lost to Follow-up|0|||
156672362|NCT01370733|565547462|FG000|Overall Study|Adverse Event|2|||
156672363|NCT01370733|565547463|FG001|Overall Study|Adverse Event|4|||
156672364|NCT01370733|565547462|FG000|Overall Study|Lack of Efficacy|3|||
156672365|NCT01370733|565547463|FG001|Overall Study|Lack of Efficacy|5|||
156672366|NCT01370733|565547462|FG000|Overall Study|Physician Decision|0|||
156672367|NCT01370733|565547463|FG001|Overall Study|Physician Decision|2|||
156672368|NCT01370733|565547462|FG000|Overall Study|Protocol Violation|1|||
156672369|NCT01370733|565547463|FG001|Overall Study|Protocol Violation|3|||
156672370|NCT03325881|565547464|FG000|Overall Study|Protocol Violation|0|||
156672371|NCT03325881|565547465|FG001|Overall Study|Protocol Violation|1|||
156672372|NCT03325881|565547464|FG000|Overall Study|Withdrawal by Subject|0|||
156672373|NCT03325881|565547465|FG001|Overall Study|Withdrawal by Subject|2|||
156672374|NCT03325881|565547464|FG000|Overall Study|Lack of Efficacy|2|||
156672375|NCT03325881|565547465|FG001|Overall Study|Lack of Efficacy|0|||
156672376|NCT03325881|565547464|FG000|Overall Study|Not treated|1|||
156672377|NCT03325881|565547465|FG001|Overall Study|Not treated|0|||
156672378|NCT03676634|565547466|FG000|Overall Study|Red blood cell loss|1|||
156672379|NCT03676634|565547466|FG000|Overall Study|Out-of-limit pulse|2|||
156672380|NCT00909038|565547471|FG000|Overall Study|Protocol Violation|187|||
156672381|NCT00909038|565547471|FG000|Overall Study|Non-evaluable Subjects|230|||
156672382|NCT00909753|565547474|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
156672383|NCT00909753|565547475|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
156672384|NCT00909753|565547474|FG000|Period: Second Intervention|Protocol Violation|1|||
156672385|NCT00909753|565547475|FG001|Period: Second Intervention|Protocol Violation|0|||
156672386|NCT01895335|565547480|FG000|Overall Study|Adverse Event|106|||
156672387|NCT01895335|565547480|FG000|Overall Study|Lack of Efficacy|53|||
156672388|NCT01895335|565547480|FG000|Overall Study|Poor Compliance to Protocol|11|||
156672389|NCT01895335|565547480|FG000|Overall Study|Included But Not treated|1|||
156672390|NCT01895335|565547480|FG000|Overall Study|Other than Specified Above|44|||
156672391|NCT03480763|565547481|FG000|Overall Study|Withdrawal by Subject|18|||
156672392|NCT03480763|565547482|FG001|Overall Study|Withdrawal by Subject|10|||
156672393|NCT03480763|565547481|FG000|Overall Study|Lost to Follow-up|4|||
156672394|NCT03480763|565547482|FG001|Overall Study|Lost to Follow-up|7|||
156672395|NCT03480763|565547481|FG000|Overall Study|non-study pneumococcal vaccine|1|||
156672396|NCT03480763|565547482|FG001|Overall Study|non-study pneumococcal vaccine|0|||
156672397|NCT03480763|565547481|FG000|Overall Study|oncological treatment|0|||
156672398|NCT03480763|565547482|FG001|Overall Study|oncological treatment|2|||
156672399|NCT03480763|565547481|FG000|Overall Study|pain with vaccination|1|||
156672400|NCT03480763|565547482|FG001|Overall Study|pain with vaccination|0|||
156672401|NCT01647828|565547485|FG000|Overall Study|Death|3|||
156672402|NCT01647828|565547486|FG001|Overall Study|Death|4|||
156672403|NCT01647828|565547487|FG002|Overall Study|Death|4|||
156672404|NCT01647828|565547488|FG003|Overall Study|Death|5|||
156672405|NCT01647828|565547489|FG004|Overall Study|Death|6|||
156672406|NCT01647828|565547490|FG005|Overall Study|Death|3|||
156672407|NCT01647828|565547491|FG006|Overall Study|Death|10|||
156672408|NCT01647828|565547492|FG007|Overall Study|Death|60|||
156672409|NCT01647828|565547493|FG008|Overall Study|Death|71|||
156672410|NCT01647828|565547485|FG000|Overall Study|Withdrawal by Subject|2|||
156672411|NCT01647828|565547486|FG001|Overall Study|Withdrawal by Subject|0|||
156672412|NCT01647828|565547487|FG002|Overall Study|Withdrawal by Subject|0|||
156672413|NCT01647828|565547488|FG003|Overall Study|Withdrawal by Subject|1|||
156672414|NCT01647828|565547489|FG004|Overall Study|Withdrawal by Subject|0|||
156672415|NCT01647828|565547490|FG005|Overall Study|Withdrawal by Subject|0|||
156672416|NCT01647828|565547491|FG006|Overall Study|Withdrawal by Subject|1|||
156672417|NCT01647828|565547492|FG007|Overall Study|Withdrawal by Subject|0|||
156672418|NCT01647828|565547493|FG008|Overall Study|Withdrawal by Subject|2|||
156672419|NCT01647828|565547485|FG000|Overall Study|Study terminated by Sponsor|0|||
156672420|NCT01647828|565547486|FG001|Overall Study|Study terminated by Sponsor|0|||
156672421|NCT01647828|565547487|FG002|Overall Study|Study terminated by Sponsor|0|||
156672422|NCT01647828|565547488|FG003|Overall Study|Study terminated by Sponsor|0|||
156672423|NCT01647828|565547489|FG004|Overall Study|Study terminated by Sponsor|0|||
156672424|NCT01647828|565547490|FG005|Overall Study|Study terminated by Sponsor|0|||
156431365|NCT04771273|564667898|FG002|Dose Escalation Period|Burden of study procedures|0|||
156672425|NCT01647828|565547491|FG006|Overall Study|Study terminated by Sponsor|1|||
156672426|NCT01647828|565547492|FG007|Overall Study|Study terminated by Sponsor|26|||
156672427|NCT01647828|565547493|FG008|Overall Study|Study terminated by Sponsor|16|||
156672428|NCT01647828|565547485|FG000|Overall Study|Lost to Follow-up|0|||
156672429|NCT01647828|565547486|FG001|Overall Study|Lost to Follow-up|0|||
156672430|NCT01647828|565547487|FG002|Overall Study|Lost to Follow-up|0|||
156672431|NCT01647828|565547488|FG003|Overall Study|Lost to Follow-up|0|||
156672432|NCT01647828|565547489|FG004|Overall Study|Lost to Follow-up|0|||
156672433|NCT01647828|565547490|FG005|Overall Study|Lost to Follow-up|0|||
156672434|NCT01647828|565547491|FG006|Overall Study|Lost to Follow-up|0|||
156672435|NCT01647828|565547492|FG007|Overall Study|Lost to Follow-up|2|||
156672436|NCT01647828|565547493|FG008|Overall Study|Lost to Follow-up|0|||
156672437|NCT00115063|565547494|FG000|Overall Study|Lost to Follow-up|98|||
156672438|NCT00115063|565547495|FG001|Overall Study|Lost to Follow-up|104|||
156672439|NCT00115063|565547494|FG000|Overall Study|Death|1|||
156672440|NCT00115063|565547495|FG001|Overall Study|Death|0|||
156672441|NCT00185458|565547498|FG000|Contraception Phase|Adverse Event|37|||
156672442|NCT00185458|565547498|FG000|Contraception Phase|Lost to Follow-up|10|||
156672443|NCT00185458|565547498|FG000|Contraception Phase|Protocol Violation|2|||
156672444|NCT00185458|565547498|FG000|Contraception Phase|Physician Decision|2|||
156672445|NCT00185458|565547498|FG000|Contraception Phase|Withdrawal by Subject|7|||
156672446|NCT00185458|565547498|FG000|HRT Phase|Adverse Event|18|||
156672447|NCT00185458|565547498|FG000|HRT Phase|Lost to Follow-up|4|||
156672448|NCT00185458|565547498|FG000|HRT Phase|Protocol Violation|2|||
156672449|NCT00185458|565547498|FG000|HRT Phase|Withdrawal by Subject|3|||
156672450|NCT03600376|565547499|FG000|Overall Study|Adverse Event|1|||
156672451|NCT03600376|565547500|FG001|Overall Study|Adverse Event|1|||
156672452|NCT03600376|565547499|FG000|Overall Study|Transferred to other facility|1|||
156672453|NCT03600376|565547500|FG001|Overall Study|Transferred to other facility|0|||
156672454|NCT03600376|565547499|FG000|Overall Study|Investigator Decision|0|||
156672455|NCT03600376|565547500|FG001|Overall Study|Investigator Decision|4|||
156672456|NCT03600376|565547499|FG000|Overall Study|Determined to be ineligible for study|0|||
156672457|NCT03600376|565547500|FG001|Overall Study|Determined to be ineligible for study|1|||
156672458|NCT00796562|565547504|FG000|Overall Study|Death|49|||
156672459|NCT05655520|565547505|FG000|Overall Study|Adverse Event|2|||
156672460|NCT05655520|565547506|FG001|Overall Study|Adverse Event|3|||
156672461|NCT05655520|565547505|FG000|Overall Study|Physician Decision|2|||
156672462|NCT05655520|565547506|FG001|Overall Study|Physician Decision|0|||
156672463|NCT05655520|565547505|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156672464|NCT05655520|565547506|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156672465|NCT05655520|565547505|FG000|Overall Study|Lost to Follow-up|1|||
156672466|NCT05655520|565547506|FG001|Overall Study|Lost to Follow-up|0|||
156672467|NCT05655520|565547505|FG000|Overall Study|Withdrawal by Subject|4|||
156672468|NCT05655520|565547506|FG001|Overall Study|Withdrawal by Subject|4|||
156672469|NCT05655520|565547505|FG000|Overall Study|Study Terminated by Sponsor|61|||
156672470|NCT05655520|565547506|FG001|Overall Study|Study Terminated by Sponsor|68|||
156672471|NCT00424047|565547507|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
156672472|NCT00424047|565547508|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
156672473|NCT00424047|565547507|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
156672474|NCT00424047|565547508|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
156672475|NCT00424047|565547507|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
156672476|NCT00424047|565547508|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
156672477|NCT00424047|565547507|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
156672478|NCT00424047|565547508|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
156672479|NCT00424047|565547507|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
156672480|NCT00424047|565547508|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
156672481|NCT00424047|565547507|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
156672482|NCT00424047|565547508|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
156672483|NCT00424047|565547507|FG000|On Study at Time of Unblinding|Adverse Event|22|||
156672484|NCT00424047|565547508|FG001|On Study at Time of Unblinding|Adverse Event|12|||
156672485|NCT00424047|565547507|FG000|On Study at Time of Unblinding|Progression of disease|92|||
156672486|NCT00424047|565547508|FG001|On Study at Time of Unblinding|Progression of disease|128|||
156672487|NCT00424047|565547507|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
156672488|NCT00424047|565547508|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
156672489|NCT00424047|565547507|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
156672490|NCT00424047|565547508|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
156672491|NCT00424047|565547507|FG000|On Study at Time of Unblinding|Death|11|||
156672492|NCT00424047|565547508|FG001|On Study at Time of Unblinding|Death|11|||
156672493|NCT00424047|565547507|FG000|On Study at Time of Unblinding|Other|5|||
156672494|NCT00424047|565547508|FG001|On Study at Time of Unblinding|Other|4|||
156672495|NCT00424047|565547507|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
156672496|NCT00424047|565547508|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
156672497|NCT00424047|565547507|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
156672498|NCT00424047|565547508|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
156672499|NCT00424047|565547507|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
156672500|NCT00424047|565547508|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
156672501|NCT00424047|565547507|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
156672502|NCT00424047|565547508|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
156672503|NCT00424047|565547507|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
156431366|NCT04771273|564667899|FG003|Dose Escalation Period|Burden of study procedures|0|||
156431367|NCT04771273|564667896|FG000|Dose Escalation Period|Change of residence|0|||
156431368|NCT04771273|564667897|FG001|Dose Escalation Period|Change of residence|0|||
156431369|NCT04771273|564667898|FG002|Dose Escalation Period|Change of residence|0|||
156431370|NCT04771273|564667899|FG003|Dose Escalation Period|Change of residence|1|||
156431371|NCT04771273|564667896|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
156431372|NCT04771273|564667897|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
156431373|NCT04771273|564667898|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
156431374|NCT04771273|564667899|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
156431375|NCT04771273|564667896|FG000|Dose Escalation Period|Adverse Event|8|||
156431376|NCT04771273|564667897|FG001|Dose Escalation Period|Adverse Event|9|||
156431377|NCT04771273|564667898|FG002|Dose Escalation Period|Adverse Event|12|||
156431378|NCT04771273|564667899|FG003|Dose Escalation Period|Adverse Event|2|||
156431379|NCT04771273|564667896|FG000|Maintenance Period|Other than listed|4|||
156431380|NCT04771273|564667897|FG001|Maintenance Period|Other than listed|2|||
156431381|NCT04771273|564667898|FG002|Maintenance Period|Other than listed|0|||
156431382|NCT04771273|564667899|FG003|Maintenance Period|Other than listed|3|||
156431383|NCT04771273|564667896|FG000|Maintenance Period|Burden of study procedures|1|||
156431384|NCT04771273|564667897|FG001|Maintenance Period|Burden of study procedures|0|||
156431385|NCT04771273|564667898|FG002|Maintenance Period|Burden of study procedures|0|||
156431386|NCT04771273|564667899|FG003|Maintenance Period|Burden of study procedures|0|||
156431387|NCT04771273|564667896|FG000|Maintenance Period|Change of residence|0|||
156431388|NCT04771273|564667897|FG001|Maintenance Period|Change of residence|1|||
156431389|NCT04771273|564667898|FG002|Maintenance Period|Change of residence|3|||
156431390|NCT04771273|564667899|FG003|Maintenance Period|Change of residence|0|||
156431391|NCT04771273|564667896|FG000|Maintenance Period|Perceived lack of efficacy|0|||
156431392|NCT04771273|564667897|FG001|Maintenance Period|Perceived lack of efficacy|0|||
156431393|NCT04771273|564667898|FG002|Maintenance Period|Perceived lack of efficacy|0|||
156431394|NCT04771273|564667899|FG003|Maintenance Period|Perceived lack of efficacy|1|||
156431395|NCT04771273|564667896|FG000|Maintenance Period|Adverse Event|4|||
156431396|NCT04771273|564667897|FG001|Maintenance Period|Adverse Event|5|||
156431397|NCT04771273|564667898|FG002|Maintenance Period|Adverse Event|5|||
156431398|NCT04771273|564667899|FG003|Maintenance Period|Adverse Event|0|||
156431399|NCT00462943|564667900|FG000|Overall Study|Failure to achieve a response|5|||
156431400|NCT00462943|564667901|FG001|Overall Study|Failure to achieve a response|5|||
156431401|NCT00462943|564667902|FG002|Overall Study|Failure to achieve a response|1|||
156431402|NCT00462943|564667900|FG000|Overall Study|Adverse Event|6|||
156431403|NCT00462943|564667901|FG001|Overall Study|Adverse Event|4|||
156431404|NCT00462943|564667902|FG002|Overall Study|Adverse Event|1|||
156431405|NCT00462943|564667900|FG000|Overall Study|Protocol Violation|1|||
156431406|NCT00462943|564667901|FG001|Overall Study|Protocol Violation|0|||
156431407|NCT00462943|564667902|FG002|Overall Study|Protocol Violation|0|||
156431408|NCT00462943|564667900|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
156431409|NCT00462943|564667901|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
156431410|NCT00462943|564667902|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
156431411|NCT00462943|564667900|FG000|Overall Study|Disease Progression|15|||
156431412|NCT00462943|564667901|FG001|Overall Study|Disease Progression|15|||
156431413|NCT00462943|564667902|FG002|Overall Study|Disease Progression|9|||
156431414|NCT00462943|564667900|FG000|Overall Study|Death|5|||
156431415|NCT00462943|564667901|FG001|Overall Study|Death|2|||
156431416|NCT00462943|564667902|FG002|Overall Study|Death|7|||
156431417|NCT00462943|564667900|FG000|Overall Study|Stem Cell Transplant|1|||
156431418|NCT00462943|564667901|FG001|Overall Study|Stem Cell Transplant|1|||
156431419|NCT00462943|564667902|FG002|Overall Study|Stem Cell Transplant|0|||
156431420|NCT00462943|564667900|FG000|Overall Study|Bone Marrow Transplant|1|||
156431421|NCT00462943|564667901|FG001|Overall Study|Bone Marrow Transplant|0|||
156431422|NCT00462943|564667902|FG002|Overall Study|Bone Marrow Transplant|0|||
156431423|NCT00462943|564667900|FG000|Overall Study|Required Lymphocyte Infusion|1|||
156431424|NCT00462943|564667901|FG001|Overall Study|Required Lymphocyte Infusion|0|||
156431425|NCT00462943|564667902|FG002|Overall Study|Required Lymphocyte Infusion|0|||
156431426|NCT00462943|564667900|FG000|Overall Study|Transplant - not specified|1|||
156431427|NCT00462943|564667901|FG001|Overall Study|Transplant - not specified|0|||
156431428|NCT00462943|564667902|FG002|Overall Study|Transplant - not specified|1|||
156431429|NCT00462943|564667900|FG000|Overall Study|Physician Decision|1|||
156431430|NCT00462943|564667901|FG001|Overall Study|Physician Decision|0|||
156431431|NCT00462943|564667902|FG002|Overall Study|Physician Decision|0|||
156431432|NCT00462943|564667900|FG000|Overall Study|Withdrawal by Subject|0|||
156431433|NCT00462943|564667901|FG001|Overall Study|Withdrawal by Subject|1|||
156431434|NCT00462943|564667902|FG002|Overall Study|Withdrawal by Subject|0|||
156431435|NCT00995709|564667903|FG000|Overall Study|Adverse Event|4|||
156431436|NCT00995709|564667904|FG001|Overall Study|Adverse Event|2|||
156431437|NCT00995709|564667905|FG002|Overall Study|Adverse Event|0|||
156431438|NCT00995709|564667903|FG000|Overall Study|Lack of Efficacy|0|||
156431439|NCT00995709|564667904|FG001|Overall Study|Lack of Efficacy|1|||
156431440|NCT00995709|564667905|FG002|Overall Study|Lack of Efficacy|4|||
156672504|NCT00424047|565547508|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
156672505|NCT01010503|565547510|FG000|Overall Study|Adverse Event|1|||
156672506|NCT01010503|565547510|FG000|Overall Study|Death|1|||
156672507|NCT06336356|565547511|FG000|Overall Study|Withdrawal by Subject|1|||
156672508|NCT06336356|565547512|FG001|Overall Study|Withdrawal by Subject|0|||
156672509|NCT06336356|565547511|FG000|Overall Study|Lost to Follow Up|1|||
156672510|NCT06336356|565547512|FG001|Overall Study|Lost to Follow Up|0|||
156672511|NCT05871151|565547515|FG000|Overall Study|Lost to Follow-up|1|||
156672512|NCT05871151|565547516|FG001|Overall Study|Lost to Follow-up|0|||
156672513|NCT05871151|565547515|FG000|Overall Study|Unrelated illness|0|||
156672514|NCT05871151|565547516|FG001|Overall Study|Unrelated illness|1|||
156672515|NCT01750294|565548870|FG000|Overall Study|Withdrawal by Subject|1|||
156672516|NCT01750294|565548870|FG000|Overall Study|Safety Endpoint|1|||
156672517|NCT01624233|565548871|FG000|Period 2 - Induction|Adverse Event|1|||
156672518|NCT01624233|565548871|FG000|Period 3 - Maintenance|Adverse Event|2|||
156672519|NCT01624233|565548871|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
156672520|NCT01624233|565548871|FG000|Period 3 - Maintenance|Physician Decision|2|||
156672521|NCT01624233|565548871|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
156672522|NCT01624233|565548871|FG000|Period 4 - Drug Free Period|Relapsed|61|||
156672523|NCT01624233|565548871|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
156672524|NCT01624233|565548871|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
156672525|NCT01624233|565548871|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
156672526|NCT01624233|565548871|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
156672527|NCT01624233|565548871|FG000|Period 6: Follow-up|Adverse Event|3|||
156672528|NCT01624233|565548871|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
156672529|NCT01624233|565548871|FG000|Period 6: Follow-up|Physician Decision|1|||
156672530|NCT01624233|565548871|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
156672531|NCT03121586|565548872|FG000|Overall Study|Study terminated by sponsor|0|||
156672532|NCT03121586|565548873|FG001|Overall Study|Study terminated by sponsor|0|||
156672533|NCT03121586|565548874|FG002|Overall Study|Study terminated by sponsor|99|||
156672534|NCT03121586|565548872|FG000|Overall Study|Withdrawal by Subject|37|||
156672535|NCT03121586|565548873|FG001|Overall Study|Withdrawal by Subject|14|||
156672536|NCT03121586|565548874|FG002|Overall Study|Withdrawal by Subject|9|||
156672537|NCT03121586|565548872|FG000|Overall Study|Not further specified|6|||
156672538|NCT03121586|565548873|FG001|Overall Study|Not further specified|11|||
156672539|NCT03121586|565548874|FG002|Overall Study|Not further specified|10|||
156672540|NCT03121586|565548872|FG000|Overall Study|Adverse Event|16|||
156672541|NCT03121586|565548873|FG001|Overall Study|Adverse Event|5|||
156672542|NCT03121586|565548874|FG002|Overall Study|Adverse Event|6|||
156672543|NCT03121586|565548872|FG000|Overall Study|Protocol Violation|0|||
156672544|NCT03121586|565548873|FG001|Overall Study|Protocol Violation|5|||
156672545|NCT03121586|565548874|FG002|Overall Study|Protocol Violation|0|||
156672546|NCT03121586|565548872|FG000|Overall Study|Lack of Efficacy|3|||
156672547|NCT03121586|565548873|FG001|Overall Study|Lack of Efficacy|3|||
156672548|NCT03121586|565548874|FG002|Overall Study|Lack of Efficacy|1|||
156672549|NCT03121586|565548872|FG000|Overall Study|Physician Decision|2|||
156672550|NCT03121586|565548873|FG001|Overall Study|Physician Decision|2|||
156672551|NCT03121586|565548874|FG002|Overall Study|Physician Decision|0|||
156672552|NCT03121586|565548872|FG000|Overall Study|Noncompliance with study drug|5|||
156672553|NCT03121586|565548873|FG001|Overall Study|Noncompliance with study drug|3|||
156672554|NCT03121586|565548874|FG002|Overall Study|Noncompliance with study drug|5|||
156672555|NCT03121586|565548872|FG000|Overall Study|Lost to Follow-up|4|||
156672556|NCT03121586|565548873|FG001|Overall Study|Lost to Follow-up|2|||
156672557|NCT03121586|565548874|FG002|Overall Study|Lost to Follow-up|0|||
156672558|NCT03121586|565548872|FG000|Overall Study|Death|2|||
156672559|NCT03121586|565548873|FG001|Overall Study|Death|0|||
156672560|NCT03121586|565548874|FG002|Overall Study|Death|0|||
156672561|NCT06381102|565548875|FG000|Washout 5 Days|Withdrawal by Subject|0|||
156672562|NCT06381102|565548876|FG001|Washout 5 Days|Withdrawal by Subject|2|||
156672563|NCT02832063|565548878|FG000|Overall Study|Adverse Event|2|||
156672564|NCT02832063|565548879|FG001|Overall Study|Adverse Event|1|||
156672565|NCT02832063|565548878|FG000|Overall Study|Physician Decision|5|||
156672566|NCT02832063|565548879|FG001|Overall Study|Physician Decision|7|||
156327346|NCT00809354|564299233|FG001|Overall Study|Other|2|||
156327347|NCT00809354|564299234|FG002|Overall Study|Other|7|||
156327348|NCT00809354|564299235|FG003|Overall Study|Other|10|||
156327349|NCT00809354|564299236|FG004|Overall Study|Other|5|||
156327350|NCT00809354|564299237|FG005|Overall Study|Other|3|||
156327351|NCT00809354|564299238|FG006|Overall Study|Other|2|||
156327352|NCT00809354|564299239|FG007|Overall Study|Other|3|||
156327353|NCT00809354|564299240|FG008|Overall Study|Other|4|||
156327354|NCT00809354|564299241|FG009|Overall Study|Other|3|||
156327355|NCT00809354|564299232|FG000|Overall Study|Study terminated by sponsor|138|||
156327356|NCT00809354|564299233|FG001|Overall Study|Study terminated by sponsor|134|||
156327357|NCT00809354|564299234|FG002|Overall Study|Study terminated by sponsor|129|||
156327358|NCT00809354|564299235|FG003|Overall Study|Study terminated by sponsor|120|||
156327359|NCT00809354|564299236|FG004|Overall Study|Study terminated by sponsor|126|||
156327360|NCT00809354|564299237|FG005|Overall Study|Study terminated by sponsor|133|||
156672567|NCT02832063|565548878|FG000|Overall Study|Lost to Follow-up|15|||
156672568|NCT02832063|565548879|FG001|Overall Study|Lost to Follow-up|8|||
156672569|NCT02832063|565548878|FG000|Overall Study|Withdrawal by Subject|10|||
156672570|NCT02832063|565548879|FG001|Overall Study|Withdrawal by Subject|21|||
156672571|NCT02832063|565548878|FG000|Overall Study|Other|2|||
156672572|NCT02832063|565548879|FG001|Overall Study|Other|1|||
156672573|NCT03733730|565548880|FG000|Overall Study|Lost to Follow-up|1|||
156672574|NCT03733730|565548881|FG001|Overall Study|Lost to Follow-up|32|||
156672575|NCT03733730|565548880|FG000|Overall Study|Other|1|||
156672576|NCT03733730|565548881|FG001|Overall Study|Other|0|||
156672577|NCT03733730|565548880|FG000|Overall Study|Adverse Event|0|||
156672578|NCT03733730|565548881|FG001|Overall Study|Adverse Event|4|||
156672579|NCT03733730|565548880|FG000|Overall Study|Death|0|||
156672580|NCT03733730|565548881|FG001|Overall Study|Death|5|||
156672581|NCT03733730|565548880|FG000|Overall Study|Withdrawal by Subject|0|||
156672582|NCT03733730|565548881|FG001|Overall Study|Withdrawal by Subject|8|||
156672583|NCT01987765|565548882|FG000|Overall Study|Protocol Violation|65|||
156672584|NCT01987765|565548882|FG000|Overall Study|Lost to Follow-up|37|||
156672585|NCT01564394|565548887|FG000|Overall Study|Withdrawal by Subject|6|||
156672586|NCT01564394|565548888|FG001|Overall Study|Withdrawal by Subject|10|||
156672587|NCT00443651|565548889|FG000|Overall Study|Death|1|||
156672588|NCT00443651|565548890|FG001|Overall Study|Death|5|||
156672589|NCT00443651|565548889|FG000|Overall Study|Adverse Event|5|||
156672590|NCT00443651|565548890|FG001|Overall Study|Adverse Event|6|||
156672591|NCT00443651|565548889|FG000|Overall Study|Lost to Follow-up|18|||
156672592|NCT00443651|565548890|FG001|Overall Study|Lost to Follow-up|12|||
156672593|NCT00443651|565548889|FG000|Overall Study|Patient's/Guardian's Decision|58|||
156672594|NCT00443651|565548890|FG001|Overall Study|Patient's/Guardian's Decision|30|||
156672595|NCT00443651|565548889|FG000|Overall Study|Physician Decision|13|||
156672596|NCT00443651|565548890|FG001|Overall Study|Physician Decision|4|||
156672597|NCT00443651|565548889|FG000|Overall Study|Pregnancy|0|||
156672598|NCT00443651|565548890|FG001|Overall Study|Pregnancy|1|||
156672599|NCT03606174|565548891|FG000|Overall Study|Death|37|||
156672600|NCT03606174|565548892|FG001|Overall Study|Death|15|||
156672601|NCT03606174|565548893|FG002|Overall Study|Death|15|||
156672602|NCT03606174|565548894|FG003|Overall Study|Death|7|||
156672603|NCT03606174|565548895|FG004|Overall Study|Death|35|||
156672604|NCT03606174|565548896|FG005|Overall Study|Death|12|||
156672605|NCT03606174|565548897|FG006|Overall Study|Death|35|||
156672606|NCT03606174|565548898|FG007|Overall Study|Death|8|||
156672607|NCT03606174|565548899|FG008|Overall Study|Death|5|||
156672608|NCT03606174|565548900|FG009|Overall Study|Death|3|||
156672609|NCT03606174|565548901|FG010|Overall Study|Death|0|||
156672610|NCT03606174|565548891|FG000|Overall Study|Lost to Follow-up|0|||
156672611|NCT03606174|565548892|FG001|Overall Study|Lost to Follow-up|0|||
156672612|NCT03606174|565548893|FG002|Overall Study|Lost to Follow-up|0|||
156672613|NCT03606174|565548894|FG003|Overall Study|Lost to Follow-up|0|||
156672614|NCT03606174|565548895|FG004|Overall Study|Lost to Follow-up|1|||
156672615|NCT03606174|565548896|FG005|Overall Study|Lost to Follow-up|1|||
156672616|NCT03606174|565548897|FG006|Overall Study|Lost to Follow-up|0|||
156672617|NCT03606174|565548898|FG007|Overall Study|Lost to Follow-up|0|||
156672618|NCT03606174|565548899|FG008|Overall Study|Lost to Follow-up|0|||
156672619|NCT03606174|565548900|FG009|Overall Study|Lost to Follow-up|0|||
156672620|NCT03606174|565548901|FG010|Overall Study|Lost to Follow-up|0|||
156672621|NCT03606174|565548891|FG000|Overall Study|Withdrawal by Subject|6|||
156672622|NCT03606174|565548892|FG001|Overall Study|Withdrawal by Subject|0|||
156672623|NCT03606174|565548893|FG002|Overall Study|Withdrawal by Subject|0|||
156672624|NCT03606174|565548894|FG003|Overall Study|Withdrawal by Subject|1|||
156672625|NCT03606174|565548895|FG004|Overall Study|Withdrawal by Subject|2|||
156672626|NCT03606174|565548896|FG005|Overall Study|Withdrawal by Subject|1|||
156672627|NCT03606174|565548897|FG006|Overall Study|Withdrawal by Subject|4|||
156672628|NCT03606174|565548898|FG007|Overall Study|Withdrawal by Subject|0|||
156672629|NCT03606174|565548899|FG008|Overall Study|Withdrawal by Subject|0|||
156672630|NCT03606174|565548900|FG009|Overall Study|Withdrawal by Subject|0|||
156431441|NCT00995709|564667903|FG000|Overall Study|Withdrawal by Subject|0|||
156431442|NCT00995709|564667904|FG001|Overall Study|Withdrawal by Subject|4|||
156431443|NCT00995709|564667905|FG002|Overall Study|Withdrawal by Subject|1|||
156431444|NCT00995709|564667903|FG000|Overall Study|Lost to Follow-up|1|||
156431445|NCT00995709|564667904|FG001|Overall Study|Lost to Follow-up|0|||
156431446|NCT00995709|564667905|FG002|Overall Study|Lost to Follow-up|0|||
156431447|NCT00995709|564667903|FG000|Overall Study|Death|0|||
156431448|NCT00995709|564667904|FG001|Overall Study|Death|1|||
156431449|NCT00995709|564667905|FG002|Overall Study|Death|0|||
156431450|NCT00995709|564667903|FG000|Overall Study|Protocol Violation|2|||
156431451|NCT00995709|564667904|FG001|Overall Study|Protocol Violation|1|||
156431452|NCT00995709|564667905|FG002|Overall Study|Protocol Violation|0|||
156672631|NCT03606174|565548901|FG010|Overall Study|Withdrawal by Subject|1|||
156672632|NCT03606174|565548891|FG000|Overall Study|Study Terminated by Sponsor|5|||
156672633|NCT03606174|565548892|FG001|Overall Study|Study Terminated by Sponsor|7|||
156672634|NCT03606174|565548893|FG002|Overall Study|Study Terminated by Sponsor|3|||
156672635|NCT03606174|565548894|FG003|Overall Study|Study Terminated by Sponsor|0|||
156526828|NCT01315353|565021618|FG000|Overall Study|Unwilling to adhere to requirements|5|||
156526829|NCT01315353|565021619|FG001|Overall Study|Unwilling to adhere to requirements|5|||
156526830|NCT01315353|565021620|FG002|Overall Study|Unwilling to adhere to requirements|4|||
156526831|NCT01315353|565021618|FG000|Overall Study|Site closing|7|||
156526832|NCT01315353|565021619|FG001|Overall Study|Site closing|4|||
156526833|NCT01315353|565021620|FG002|Overall Study|Site closing|0|||
156526834|NCT01315353|565021618|FG000|Overall Study|Taken off study by site in error|0|||
156526835|NCT01315353|565021619|FG001|Overall Study|Taken off study by site in error|1|||
156526836|NCT01315353|565021620|FG002|Overall Study|Taken off study by site in error|0|||
156526837|NCT01315353|565021618|FG000|Overall Study|Inadvertent randomization/assignment|0|||
156526838|NCT01315353|565021619|FG001|Overall Study|Inadvertent randomization/assignment|0|||
156526839|NCT01315353|565021620|FG002|Overall Study|Inadvertent randomization/assignment|2|||
156327361|NCT00809354|564299238|FG006|Overall Study|Study terminated by sponsor|124|||
156327362|NCT00809354|564299239|FG007|Overall Study|Study terminated by sponsor|148|||
156526840|NCT01009580|565021621|FG000|Overall Study|Adverse Event|4|||
156526841|NCT01009580|565021622|FG001|Overall Study|Adverse Event|4|||
156327363|NCT00809354|564299240|FG008|Overall Study|Study terminated by sponsor|127|||
156327364|NCT00809354|564299241|FG009|Overall Study|Study terminated by sponsor|135|||
156327365|NCT00809354|564299232|FG000|Overall Study|Withdrawn due to pregnancy|0|||
156327366|NCT00809354|564299233|FG001|Overall Study|Withdrawn due to pregnancy|1|||
156327367|NCT00809354|564299234|FG002|Overall Study|Withdrawn due to pregnancy|0|||
156327368|NCT00809354|564299235|FG003|Overall Study|Withdrawn due to pregnancy|0|||
156327369|NCT00809354|564299236|FG004|Overall Study|Withdrawn due to pregnancy|0|||
156327370|NCT00809354|564299237|FG005|Overall Study|Withdrawn due to pregnancy|0|||
156327371|NCT00809354|564299238|FG006|Overall Study|Withdrawn due to pregnancy|0|||
156327372|NCT00809354|564299239|FG007|Overall Study|Withdrawn due to pregnancy|0|||
156327373|NCT00809354|564299240|FG008|Overall Study|Withdrawn due to pregnancy|0|||
156327374|NCT00809354|564299241|FG009|Overall Study|Withdrawn due to pregnancy|0|||
156327375|NCT00809354|564299232|FG000|Overall Study|Randomized but not Treated|3|||
156327376|NCT00809354|564299233|FG001|Overall Study|Randomized but not Treated|1|||
156327377|NCT00809354|564299234|FG002|Overall Study|Randomized but not Treated|6|||
156327378|NCT00809354|564299235|FG003|Overall Study|Randomized but not Treated|0|||
156327379|NCT00809354|564299236|FG004|Overall Study|Randomized but not Treated|5|||
156327380|NCT00809354|564299237|FG005|Overall Study|Randomized but not Treated|0|||
156327381|NCT00809354|564299238|FG006|Overall Study|Randomized but not Treated|1|||
156327382|NCT00809354|564299239|FG007|Overall Study|Randomized but not Treated|1|||
156327383|NCT00809354|564299240|FG008|Overall Study|Randomized but not Treated|2|||
156327384|NCT00809354|564299241|FG009|Overall Study|Randomized but not Treated|1|||
156327385|NCT00809354|564299232|FG000|Overall Study|Death|0|||
156327386|NCT00809354|564299233|FG001|Overall Study|Death|0|||
156327387|NCT00809354|564299234|FG002|Overall Study|Death|0|||
156327388|NCT00809354|564299235|FG003|Overall Study|Death|0|||
156327389|NCT00809354|564299236|FG004|Overall Study|Death|0|||
156327390|NCT00809354|564299237|FG005|Overall Study|Death|0|||
156327391|NCT00809354|564299238|FG006|Overall Study|Death|0|||
156327392|NCT00809354|564299239|FG007|Overall Study|Death|1|||
156327393|NCT00809354|564299240|FG008|Overall Study|Death|0|||
156327394|NCT00809354|564299241|FG009|Overall Study|Death|0|||
156327395|NCT01225887|564299249|FG000|Overall Study|Ineligible:required test not done|2|||
156327396|NCT01225887|564299249|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
156327397|NCT01225887|564299249|FG000|Overall Study|Ineligible:inadequate pathology|2|||
156327398|NCT01400815|564299257|FG000|Overall Study|Adverse Event|3|||
156327399|NCT01400815|564299258|FG001|Overall Study|Adverse Event|0|||
156327400|NCT01400815|564299257|FG000|Overall Study|Death|0|||
156327401|NCT01400815|564299258|FG001|Overall Study|Death|1|||
156327402|NCT01400815|564299257|FG000|Overall Study|Lost to Follow-up|18|||
156327403|NCT01400815|564299258|FG001|Overall Study|Lost to Follow-up|11|||
156327404|NCT01400815|564299257|FG000|Overall Study|Protocol Violation|0|||
156327405|NCT01400815|564299258|FG001|Overall Study|Protocol Violation|1|||
156327406|NCT01400815|564299257|FG000|Overall Study|Physician Decision|1|||
156327407|NCT01400815|564299258|FG001|Overall Study|Physician Decision|0|||
156327408|NCT01400815|564299257|FG000|Overall Study|Withdrawal by Subject|15|||
156327409|NCT01400815|564299258|FG001|Overall Study|Withdrawal by Subject|8|||
156327410|NCT01400815|564299257|FG000|Overall Study|Subject in jail|1|||
156327411|NCT01400815|564299258|FG001|Overall Study|Subject in jail|0|||
156327412|NCT00857415|564299267|FG000|Overall Study|Image acquisition failure|2|||
156327413|NCT00857415|564299268|FG001|Overall Study|Image acquisition failure|0|||
156327414|NCT00857415|564299267|FG000|Overall Study|Invalid image or not imaged|3|||
156327415|NCT00857415|564299268|FG001|Overall Study|Invalid image or not imaged|0|||
156526842|NCT01009580|565021621|FG000|Overall Study|Lack of Efficacy|0|||
156526843|NCT01009580|565021622|FG001|Overall Study|Lack of Efficacy|1|||
156327416|NCT00857415|564299267|FG000|Overall Study|Subject still living at end of study|110|||
156327417|NCT00857415|564299268|FG001|Overall Study|Subject still living at end of study|0|||
156327418|NCT00857415|564299267|FG000|Overall Study|Deceased with no autopsy|2|||
156526844|NCT01009580|565021621|FG000|Overall Study|Protocol Violation|2|||
156327419|NCT00857415|564299268|FG001|Overall Study|Deceased with no autopsy|0|||
156327420|NCT01822678|564299269|FG000|Overall Study|Withdrawal by Subject|5|||
156672636|NCT03606174|565548895|FG004|Overall Study|Study Terminated by Sponsor|11|||
156672637|NCT03606174|565548896|FG005|Overall Study|Study Terminated by Sponsor|6|||
156672638|NCT03606174|565548897|FG006|Overall Study|Study Terminated by Sponsor|12|||
156672639|NCT03606174|565548898|FG007|Overall Study|Study Terminated by Sponsor|1|||
156672640|NCT03606174|565548899|FG008|Overall Study|Study Terminated by Sponsor|3|||
156672641|NCT03606174|565548900|FG009|Overall Study|Study Terminated by Sponsor|1|||
156672642|NCT03606174|565548901|FG010|Overall Study|Study Terminated by Sponsor|2|||
156672643|NCT03606174|565548891|FG000|Overall Study|Miscellaneous|1|||
156672644|NCT03606174|565548892|FG001|Overall Study|Miscellaneous|1|||
156672645|NCT03606174|565548893|FG002|Overall Study|Miscellaneous|0|||
156672646|NCT03606174|565548894|FG003|Overall Study|Miscellaneous|1|||
156672647|NCT03606174|565548895|FG004|Overall Study|Miscellaneous|4|||
156672648|NCT03606174|565548896|FG005|Overall Study|Miscellaneous|7|||
156672649|NCT03606174|565548897|FG006|Overall Study|Miscellaneous|5|||
156672650|NCT03606174|565548898|FG007|Overall Study|Miscellaneous|0|||
156672651|NCT03606174|565548899|FG008|Overall Study|Miscellaneous|0|||
156672652|NCT03606174|565548900|FG009|Overall Study|Miscellaneous|0|||
156672653|NCT03606174|565548901|FG010|Overall Study|Miscellaneous|1|||
156672654|NCT01609257|565548902|FG000|Overall Study|Lost to Follow-up|2|||
156672655|NCT01609257|565548903|FG001|Overall Study|Lost to Follow-up|1|||
156672656|NCT01609257|565548902|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
156672657|NCT01609257|565548903|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
156672658|NCT01609257|565548902|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
156672659|NCT01609257|565548903|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
156672660|NCT00469898|565548918|FG000|Overall Study|Adverse Event|7|||
156672661|NCT00469898|565548918|FG000|Overall Study|Withdrawal by Subject|4|||
156672662|NCT00469898|565548918|FG000|Overall Study|Death|4|||
156672663|NCT00469898|565548918|FG000|Overall Study|Disease progression|9|||
156672664|NCT00469898|565548918|FG000|Overall Study|Decreased performance status|1|||
156672665|NCT02663349|565548921|FG000|Overall Study|Withdrawal by Subject|6|||
156672666|NCT01896934|565548922|FG000|Overall Study|Adverse Event|1|||
156672667|NCT01896934|565548922|FG000|Overall Study|Withdrawal by Subject|1|||
156672668|NCT00316277|565548924|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
156672669|NCT00316277|565548925|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
156672670|NCT00316277|565548924|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
156672671|NCT00316277|565548925|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
156672672|NCT00316277|565548924|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
156672673|NCT00316277|565548925|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
156672674|NCT00316277|565548924|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
156672675|NCT00316277|565548925|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
156672676|NCT00316277|565548924|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
156672677|NCT00316277|565548925|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
156526845|NCT01009580|565021622|FG001|Overall Study|Protocol Violation|3|||
156526846|NCT01009580|565021621|FG000|Overall Study|Withdrawal Criteria|4|||
156526847|NCT01009580|565021622|FG001|Overall Study|Withdrawal Criteria|6|||
156526848|NCT01009580|565021621|FG000|Overall Study|Unclassified|17|||
156526849|NCT01009580|565021622|FG001|Overall Study|Unclassified|21|||
156526850|NCT02544217|565023632|FG000|Overall Study|Withdrawal by Subject|1|||
156526851|NCT02544217|565023633|FG001|Overall Study|Withdrawal by Subject|1|||
156526852|NCT02544217|565023634|FG002|Overall Study|Withdrawal by Subject|0|||
156526853|NCT02544217|565023635|FG003|Overall Study|Withdrawal by Subject|0|||
156526854|NCT02544217|565023636|FG004|Overall Study|Withdrawal by Subject|0|||
156526855|NCT02544217|565023637|FG005|Overall Study|Withdrawal by Subject|0|||
156526856|NCT00667355|565023638|FG000|Overall Study|Adverse Event|5|||
156526857|NCT00667355|565023638|FG000|Overall Study|Lost to Follow-up|1|||
156526858|NCT00667355|565023638|FG000|Overall Study|Other reason was not specified|5|||
156526859|NCT00887679|565023639|FG000|Overall Study|Withdrawal by Subject|1|||
156526860|NCT00887679|565023639|FG000|Overall Study|Lost to Follow-up|4|||
156526861|NCT00887679|565023639|FG000|Overall Study|Physician Decision|5|||
156526862|NCT02683941|565023640|FG000|Double-blind Phase|Adverse Event|0|||
156526863|NCT02683941|565023641|FG001|Double-blind Phase|Adverse Event|1|||
156526864|NCT02683941|565023640|FG000|Double-blind Phase|Withdrawal by Subject|4|||
156672678|NCT00927069|565548926|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
156526865|NCT02683941|565023641|FG001|Double-blind Phase|Withdrawal by Subject|2|||
156526866|NCT02683941|565023640|FG000|Double-blind Phase|Lost to Follow-up|1|||
156526867|NCT02683941|565023641|FG001|Double-blind Phase|Lost to Follow-up|0|||
156526868|NCT02683941|565023640|FG000|Double-blind Phase|Disease Progression|5|||
156526869|NCT02683941|565023641|FG001|Double-blind Phase|Disease Progression|2|||
156526870|NCT02683941|565023640|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
156526871|NCT02683941|565023641|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
156672679|NCT00927069|565548927|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
156526872|NCT02683941|565023640|FG000|Open-label Treatment Phase|Disease Progression|1|||
156672680|NCT00927069|565548928|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
156672681|NCT00927069|565548929|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
156672682|NCT00927069|565548926|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
156672683|NCT00927069|565548927|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
156672684|NCT00927069|565548928|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
156672685|NCT00927069|565548929|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
156672686|NCT00927069|565548926|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
156672687|NCT00927069|565548927|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
156672688|NCT00927069|565548928|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
156672689|NCT00927069|565548929|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
156672690|NCT00927069|565548926|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
156672691|NCT00927069|565548927|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
156672692|NCT00927069|565548928|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
156672693|NCT00927069|565548929|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
156672694|NCT00927069|565548926|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
156672695|NCT00927069|565548927|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
156672696|NCT00927069|565548928|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
156672697|NCT00927069|565548929|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
156672698|NCT00848536|565548930|FG000|Overall Study|Adverse Event|2|||
156672699|NCT00848536|565548931|FG001|Overall Study|Adverse Event|2|||
156672700|NCT00848536|565548930|FG000|Overall Study|Withdrawal by Subject|0|||
156672701|NCT00848536|565548931|FG001|Overall Study|Withdrawal by Subject|1|||
156672702|NCT00848536|565548930|FG000|Overall Study|Protocol Violation|0|||
156672703|NCT00848536|565548931|FG001|Overall Study|Protocol Violation|1|||
156672704|NCT00848536|565548930|FG000|Overall Study|Noncompliance|1|||
156672705|NCT00848536|565548931|FG001|Overall Study|Noncompliance|0|||
156672706|NCT00848536|565548930|FG000|Overall Study|Inadequate Control of IOP|1|||
156672707|NCT00848536|565548931|FG001|Overall Study|Inadequate Control of IOP|1|||
156672708|NCT00848536|565548930|FG000|Overall Study|Patient Moved|0|||
156672709|NCT00848536|565548931|FG001|Overall Study|Patient Moved|2|||
156672710|NCT04089553|565548932|FG000|Overall Study|Death|1|||
156672711|NCT04089553|565548933|FG001|Overall Study|Death|1|||
156672712|NCT04089553|565548932|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
156672713|NCT04089553|565548933|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
156672714|NCT04089553|565548932|FG000|Overall Study|Withdrawal by Subject|3|||
156672715|NCT04089553|565548933|FG001|Overall Study|Withdrawal by Subject|3|||
156672716|NCT04089553|565548932|FG000|Overall Study|Physician Decision|1|||
156672717|NCT04089553|565548933|FG001|Overall Study|Physician Decision|0|||
156672718|NCT04089553|565548932|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
156672719|NCT04089553|565548933|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
156672720|NCT04089553|565548932|FG000|Overall Study|Other|1|||
156672721|NCT04089553|565548933|FG001|Overall Study|Other|0|||
156672722|NCT04089553|565548932|FG000|Overall Study|Adverse Event|1|||
156672723|NCT04089553|565548933|FG001|Overall Study|Adverse Event|1|||
156672724|NCT01175135|565548938|FG000|Overall Study|Adverse Event|2|||
156672725|NCT01175135|565548939|FG001|Overall Study|Adverse Event|5|||
156672726|NCT01175135|565548940|FG002|Overall Study|Adverse Event|3|||
156672727|NCT01175135|565548941|FG003|Overall Study|Adverse Event|4|||
156672728|NCT01175135|565548938|FG000|Overall Study|Death|1|||
156672729|NCT01175135|565548939|FG001|Overall Study|Death|0|||
156672730|NCT01175135|565548940|FG002|Overall Study|Death|0|||
156672731|NCT01175135|565548941|FG003|Overall Study|Death|0|||
156672732|NCT01175135|565548938|FG000|Overall Study|Lack of Efficacy|4|||
156672733|NCT01175135|565548939|FG001|Overall Study|Lack of Efficacy|5|||
156672734|NCT01175135|565548940|FG002|Overall Study|Lack of Efficacy|0|||
156672735|NCT01175135|565548941|FG003|Overall Study|Lack of Efficacy|5|||
156672736|NCT01175135|565548938|FG000|Overall Study|Lost to Follow-up|1|||
156672737|NCT01175135|565548939|FG001|Overall Study|Lost to Follow-up|2|||
156672738|NCT01175135|565548940|FG002|Overall Study|Lost to Follow-up|0|||
156672739|NCT01175135|565548941|FG003|Overall Study|Lost to Follow-up|0|||
156672740|NCT01175135|565548938|FG000|Overall Study|Protocol Violation|1|||
156672741|NCT01175135|565548939|FG001|Overall Study|Protocol Violation|1|||
156327421|NCT01822678|564299270|FG001|Overall Study|Withdrawal by Subject|4|||
156327422|NCT01822678|564299271|FG002|Overall Study|Withdrawal by Subject|4|||
156526873|NCT02683941|565023641|FG001|Open-label Treatment Phase|Disease Progression|2|||
156526874|NCT02683941|565023640|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
156526875|NCT02683941|565023641|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
156526876|NCT02683941|565023640|FG000|Open-label Treatment Phase|Other|1|||
156327423|NCT01822678|564299269|FG000|Overall Study|Adverse Event|4|||
156327424|NCT01822678|564299270|FG001|Overall Study|Adverse Event|3|||
156327425|NCT01822678|564299271|FG002|Overall Study|Adverse Event|1|||
156672742|NCT01175135|565548940|FG002|Overall Study|Protocol Violation|0|||
156672743|NCT01175135|565548941|FG003|Overall Study|Protocol Violation|0|||
156672744|NCT01175135|565548938|FG000|Overall Study|Withdrawal by Subject|4|||
156672745|NCT01175135|565548939|FG001|Overall Study|Withdrawal by Subject|8|||
156672746|NCT01175135|565548940|FG002|Overall Study|Withdrawal by Subject|5|||
156672747|NCT01175135|565548941|FG003|Overall Study|Withdrawal by Subject|5|||
156672748|NCT01175135|565548938|FG000|Overall Study|Other|3|||
156672749|NCT01175135|565548939|FG001|Overall Study|Other|1|||
156672750|NCT01175135|565548940|FG002|Overall Study|Other|3|||
156672751|NCT01175135|565548941|FG003|Overall Study|Other|0|||
156672752|NCT01175135|565548938|FG000|Overall Study|Randomized But Not Treated|0|||
156327426|NCT01822678|564299269|FG000|Overall Study|Lack of Efficacy|3|||
156327427|NCT01822678|564299270|FG001|Overall Study|Lack of Efficacy|6|||
156327428|NCT01822678|564299271|FG002|Overall Study|Lack of Efficacy|5|||
156672753|NCT01175135|565548939|FG001|Overall Study|Randomized But Not Treated|0|||
156672754|NCT01175135|565548940|FG002|Overall Study|Randomized But Not Treated|1|||
156672755|NCT01175135|565548941|FG003|Overall Study|Randomized But Not Treated|0|||
156672756|NCT01572662|565548944|FG000|Overall Study|Withdrawal by Subject|1|||
156672757|NCT01572662|565548945|FG001|Overall Study|Withdrawal by Subject|0|||
156672758|NCT01572662|565548944|FG000|Overall Study|Physician Decision|0|||
156672759|NCT01572662|565548945|FG001|Overall Study|Physician Decision|1|||
156672760|NCT03364192|565548946|FG000|Overall Study|Ineligible|10|||
156672761|NCT03364192|565548946|FG000|Overall Study|Withdrawal by Subject|5|||
156672762|NCT03364192|565548946|FG000|Overall Study|Lost to Follow-up|1|||
156672763|NCT04692155|565548949|FG000|Overall Study|Death|1|||
156672764|NCT01535222|565548950|FG000|Overall Study|Inclusion/exclusion|0|||
156672765|NCT01535222|565548951|FG001|Overall Study|Inclusion/exclusion|0|||
156672766|NCT01535222|565548952|FG002|Overall Study|Inclusion/exclusion|1|||
156672767|NCT01535222|565548953|FG003|Overall Study|Inclusion/exclusion|0|||
156672768|NCT01535222|565548954|FG004|Overall Study|Inclusion/exclusion|0|||
156672769|NCT01535222|565548955|FG005|Overall Study|Inclusion/exclusion|0|||
156672770|NCT00935012|565548958|FG000|Overall Study|Death|19|||
156672771|NCT00935012|565548958|FG000|Overall Study|Withdrawal by Subject|3|||
156672772|NCT00935012|565548958|FG000|Overall Study|Other|5|||
156672773|NCT00935012|565548958|FG000|Overall Study|Adverse Event|2|||
156672774|NCT01442155|565548959|FG000|Overall Study|Complete remission|35|||
156672775|NCT01442155|565548959|FG000|Overall Study|Recurrence|26|||
156672776|NCT01442155|565548959|FG000|Overall Study|Adverse Event|2|||
156672777|NCT01442155|565548959|FG000|Overall Study|Lost to Follow-up|2|||
156672778|NCT01590563|565548966|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
156672779|NCT02294981|565548967|FG000|Overall Study|Lost to Follow-up|1|||
156672780|NCT03214588|565548970|FG000|Overall Study|Adverse Event|1|||
156672781|NCT03214588|565548971|FG001|Overall Study|Adverse Event|0|||
156672782|NCT03214588|565548972|FG002|Overall Study|Adverse Event|2|||
156672783|NCT03214588|565548970|FG000|Overall Study|Reason Not Specified|0|||
156672784|NCT03214588|565548971|FG001|Overall Study|Reason Not Specified|1|||
156672785|NCT03214588|565548972|FG002|Overall Study|Reason Not Specified|0|||
156672786|NCT02911025|565548973|FG000|Overall Study|Lost to Follow-up|3|||
156672787|NCT03719040|565548974|FG000|Overall Study|Withdrawal by Subject|177|||
156672788|NCT03719040|565548974|FG000|Overall Study|Lost to Follow-up|26|||
156672789|NCT06647173|565548979|FG000|Overall Study|Lost to Follow-up|24|||
156672790|NCT01838681|565548980|FG000|Period A|Adverse Event|39|||
156672791|NCT01838681|565548981|FG001|Period A|Adverse Event|0|||
156672792|NCT01838681|565548982|FG002|Period A|Adverse Event|0|||
156672793|NCT01838681|565548983|FG003|Period A|Adverse Event|0|||
156672794|NCT01838681|565548980|FG000|Period A|Lack of Efficacy|21|||
156672795|NCT01838681|565548981|FG001|Period A|Lack of Efficacy|0|||
156672796|NCT01838681|565548982|FG002|Period A|Lack of Efficacy|0|||
156672797|NCT01838681|565548983|FG003|Period A|Lack of Efficacy|0|||
156672798|NCT01838681|565548980|FG000|Period A|Early response|148|||
156672799|NCT01838681|565548981|FG001|Period A|Early response|0|||
156672800|NCT01838681|565548982|FG002|Period A|Early response|0|||
156672801|NCT01838681|565548983|FG003|Period A|Early response|0|||
156672802|NCT01838681|565548980|FG000|Period A|Withdrawal by Subject|70|||
156672803|NCT01838681|565548981|FG001|Period A|Withdrawal by Subject|0|||
156672804|NCT01838681|565548982|FG002|Period A|Withdrawal by Subject|0|||
156672805|NCT01838681|565548983|FG003|Period A|Withdrawal by Subject|0|||
156327429|NCT01822678|564299269|FG000|Overall Study|Lost to Follow-up|0|||
156327430|NCT01822678|564299270|FG001|Overall Study|Lost to Follow-up|2|||
156327431|NCT01822678|564299271|FG002|Overall Study|Lost to Follow-up|1|||
156327432|NCT00764504|564299272|FG000|Overall Study|Death|12|||
156327433|NCT00764504|564299273|FG001|Overall Study|Death|6|||
156327434|NCT00764504|564299274|FG002|Overall Study|Death|13|||
156327435|NCT00764504|564299272|FG000|Overall Study|Revision of Device|12|||
156327436|NCT00764504|564299273|FG001|Overall Study|Revision of Device|23|||
156327437|NCT00764504|564299274|FG002|Overall Study|Revision of Device|14|||
156672806|NCT01838681|565548980|FG000|Period A|Protocol Violation|16|||
156672807|NCT01838681|565548981|FG001|Period A|Protocol Violation|0|||
156672808|NCT01838681|565548982|FG002|Period A|Protocol Violation|0|||
156672809|NCT01838681|565548983|FG003|Period A|Protocol Violation|0|||
156431453|NCT01697319|564667907|FG000|Primary Phase|Withdrawal by Subject|1|||
156431454|NCT01697319|564667907|FG000|Extension Phase|Terminated by Sponsor|15|||
156431455|NCT00604721|564667912|FG000|Overall Study|Physician Decision|1|||
156672810|NCT01838681|565548980|FG000|Period A|Non-compliance with IMP|6|||
156327438|NCT00764504|564299272|FG000|Overall Study|Physician Decision|1|||
156327439|NCT00764504|564299273|FG001|Overall Study|Physician Decision|0|||
156327440|NCT00764504|564299274|FG002|Overall Study|Physician Decision|0|||
156672811|NCT01838681|565548981|FG001|Period A|Non-compliance with IMP|0|||
156672812|NCT01838681|565548982|FG002|Period A|Non-compliance with IMP|0|||
156672813|NCT01838681|565548983|FG003|Period A|Non-compliance with IMP|0|||
156672814|NCT01838681|565548980|FG000|Period A|Lost to Follow-up|4|||
156672815|NCT01838681|565548981|FG001|Period A|Lost to Follow-up|0|||
156672816|NCT01838681|565548982|FG002|Period A|Lost to Follow-up|0|||
156672817|NCT01838681|565548983|FG003|Period A|Lost to Follow-up|0|||
156672818|NCT01838681|565548980|FG000|Period A|Withdrawal before treatment|4|||
156672819|NCT01838681|565548981|FG001|Period A|Withdrawal before treatment|0|||
156672820|NCT01838681|565548982|FG002|Period A|Withdrawal before treatment|0|||
156672821|NCT01838681|565548983|FG003|Period A|Withdrawal before treatment|0|||
156672822|NCT01838681|565548980|FG000|Period A|Administrative or other reasons|17|||
156672823|NCT01838681|565548981|FG001|Period A|Administrative or other reasons|0|||
156672824|NCT01838681|565548982|FG002|Period A|Administrative or other reasons|0|||
156672825|NCT01838681|565548983|FG003|Period A|Administrative or other reasons|0|||
156672826|NCT01838681|565548980|FG000|Period B/A+|Adverse Event|0|||
156672827|NCT01838681|565548981|FG001|Period B/A+|Adverse Event|13|||
156672828|NCT01838681|565548982|FG002|Period B/A+|Adverse Event|27|||
156672829|NCT01838681|565548983|FG003|Period B/A+|Adverse Event|16|||
156672830|NCT01838681|565548980|FG000|Period B/A+|Lack of Efficacy|0|||
156672831|NCT01838681|565548981|FG001|Period B/A+|Lack of Efficacy|9|||
156672832|NCT01838681|565548982|FG002|Period B/A+|Lack of Efficacy|11|||
156672833|NCT01838681|565548983|FG003|Period B/A+|Lack of Efficacy|6|||
156672834|NCT01838681|565548980|FG000|Period B/A+|Withdrawal by Subject|0|||
156672835|NCT01838681|565548981|FG001|Period B/A+|Withdrawal by Subject|28|||
156672836|NCT01838681|565548982|FG002|Period B/A+|Withdrawal by Subject|35|||
156672837|NCT01838681|565548983|FG003|Period B/A+|Withdrawal by Subject|47|||
156672838|NCT01838681|565548980|FG000|Period B/A+|Protocol Violation|0|||
156672839|NCT01838681|565548981|FG001|Period B/A+|Protocol Violation|1|||
156672840|NCT01838681|565548982|FG002|Period B/A+|Protocol Violation|4|||
156672841|NCT01838681|565548983|FG003|Period B/A+|Protocol Violation|6|||
156672842|NCT01838681|565548980|FG000|Period B/A+|Non-compliance with IMP|0|||
156672843|NCT01838681|565548981|FG001|Period B/A+|Non-compliance with IMP|2|||
156672844|NCT01838681|565548982|FG002|Period B/A+|Non-compliance with IMP|3|||
156672845|NCT01838681|565548983|FG003|Period B/A+|Non-compliance with IMP|3|||
156672846|NCT01838681|565548980|FG000|Period B/A+|Lost to Follow-up|0|||
156672847|NCT01838681|565548981|FG001|Period B/A+|Lost to Follow-up|2|||
156672848|NCT01838681|565548982|FG002|Period B/A+|Lost to Follow-up|5|||
156672849|NCT01838681|565548983|FG003|Period B/A+|Lost to Follow-up|11|||
156672850|NCT01838681|565548980|FG000|Period B/A+|Withdrawal before treatment|0|||
156672851|NCT01838681|565548981|FG001|Period B/A+|Withdrawal before treatment|1|||
156672852|NCT01838681|565548982|FG002|Period B/A+|Withdrawal before treatment|0|||
156672853|NCT01838681|565548983|FG003|Period B/A+|Withdrawal before treatment|0|||
156672854|NCT01838681|565548980|FG000|Period B/A+|Administrative or other reasons|0|||
156672855|NCT01838681|565548981|FG001|Period B/A+|Administrative or other reasons|6|||
156672856|NCT01838681|565548982|FG002|Period B/A+|Administrative or other reasons|10|||
156672857|NCT01838681|565548983|FG003|Period B/A+|Administrative or other reasons|28|||
156672858|NCT05248204|565548984|FG000|Overall Study|Lost to Follow-up|13|||
156672859|NCT05248204|565548985|FG001|Overall Study|Lost to Follow-up|13|||
156672860|NCT05248204|565548984|FG000|Overall Study|Protocol Violation|1|||
156672861|NCT05248204|565548985|FG001|Overall Study|Protocol Violation|0|||
156672862|NCT03100344|565548986|FG000|Overall Study|Adverse Event|0|||
156672863|NCT03100344|565548987|FG001|Overall Study|Adverse Event|3|||
156672864|NCT03100344|565548988|FG002|Overall Study|Adverse Event|2|||
156672865|NCT03100344|565548989|FG003|Overall Study|Adverse Event|3|||
156672866|NCT03100344|565548986|FG000|Overall Study|Lack of Efficacy|2|||
156672867|NCT03100344|565548987|FG001|Overall Study|Lack of Efficacy|0|||
156672868|NCT03100344|565548988|FG002|Overall Study|Lack of Efficacy|0|||
156672869|NCT03100344|565548989|FG003|Overall Study|Lack of Efficacy|0|||
156672870|NCT03100344|565548986|FG000|Overall Study|Protocol Violation|1|||
156672871|NCT03100344|565548987|FG001|Overall Study|Protocol Violation|0|||
156672872|NCT03100344|565548988|FG002|Overall Study|Protocol Violation|0|||
156672873|NCT03100344|565548989|FG003|Overall Study|Protocol Violation|0|||
156672874|NCT03100344|565548986|FG000|Overall Study|Withdrawal by Subject|10|||
156526877|NCT02683941|565023641|FG001|Open-label Treatment Phase|Other|0|||
156526878|NCT02683941|565023640|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
156526879|NCT02683941|565023641|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
156526880|NCT02683941|565023640|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
156526881|NCT02683941|565023641|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
156526882|NCT02683941|565023640|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
156526883|NCT02683941|565023641|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
156526884|NCT02683941|565023640|FG000|Open-label Follow-up Phase|Other|8|||
156672875|NCT03100344|565548987|FG001|Overall Study|Withdrawal by Subject|7|||
156526885|NCT02683941|565023641|FG001|Open-label Follow-up Phase|Other|1|||
156526886|NCT02075541|565023643|FG000|Overall Study|Serious Adverse Event|1|||
156672876|NCT03100344|565548988|FG002|Overall Study|Withdrawal by Subject|4|||
156672877|NCT03100344|565548989|FG003|Overall Study|Withdrawal by Subject|8|||
156672878|NCT03100344|565548986|FG000|Overall Study|Lost to Follow-up|1|||
156672879|NCT03100344|565548987|FG001|Overall Study|Lost to Follow-up|1|||
156672880|NCT03100344|565548988|FG002|Overall Study|Lost to Follow-up|1|||
156672881|NCT03100344|565548989|FG003|Overall Study|Lost to Follow-up|1|||
156672882|NCT00725322|565548990|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
156672883|NCT00725322|565548991|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
156672884|NCT00725322|565548990|FG000|Washout (28 Days)|Protocol Violation|0|||
156672885|NCT00725322|565548991|FG001|Washout (28 Days)|Protocol Violation|1|||
156672886|NCT04827394|565548994|FG000|Overall Study|Physician Decision|0|||
156672887|NCT04827394|565548995|FG001|Overall Study|Physician Decision|2|||
156672888|NCT03215706|565548996|FG000|Randomization|Adverse Event unrelated to study drug|1|||
156672889|NCT03215706|565548997|FG001|Randomization|Adverse Event unrelated to study drug|0|||
156672890|NCT03215706|565548996|FG000|Randomization|participant withdrew consent|1|||
156672891|NCT03215706|565548997|FG001|Randomization|participant withdrew consent|3|||
156672892|NCT03215706|565548996|FG000|Randomization|no longer meets study criteria|1|||
156672893|NCT03215706|565548997|FG001|Randomization|no longer meets study criteria|4|||
156672894|NCT03215706|565548996|FG000|Randomization|other reasons|0|||
156672895|NCT03215706|565548997|FG001|Randomization|other reasons|2|||
156672896|NCT03215706|565548996|FG000|Treatment Period|Disease Progression|184|||
156672897|NCT03215706|565548997|FG001|Treatment Period|Disease Progression|174|||
156672898|NCT03215706|565548996|FG000|Treatment Period|Study Drug Toxicity|70|||
156672899|NCT03215706|565548997|FG001|Treatment Period|Study Drug Toxicity|24|||
156672900|NCT03215706|565548996|FG000|Treatment Period|Death|7|||
156672901|NCT03215706|565548997|FG001|Treatment Period|Death|1|||
156672902|NCT03215706|565548996|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
156672903|NCT03215706|565548997|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
156672904|NCT03215706|565548996|FG000|Treatment Period|Request to D/C treatment|2|||
156672905|NCT03215706|565548997|FG001|Treatment Period|Request to D/C treatment|10|||
156672906|NCT03215706|565548996|FG000|Treatment Period|Participant withdrew consent|4|||
156672907|NCT03215706|565548997|FG001|Treatment Period|Participant withdrew consent|5|||
156672908|NCT03215706|565548996|FG000|Treatment Period|Lost to Follow-up|0|||
156672909|NCT03215706|565548997|FG001|Treatment Period|Lost to Follow-up|1|||
156672910|NCT03215706|565548996|FG000|Treatment Period|Administrative reason by sponsor|0|||
156672911|NCT03215706|565548997|FG001|Treatment Period|Administrative reason by sponsor|2|||
156672912|NCT03215706|565548996|FG000|Treatment Period|other reasons|10|||
156672913|NCT03215706|565548997|FG001|Treatment Period|other reasons|5|||
156672914|NCT03215706|565548996|FG000|Treatment Period|Not reported|1|||
156672915|NCT03215706|565548997|FG001|Treatment Period|Not reported|0|||
156672916|NCT00640341|565550561|FG000|Overall Study|Adverse Event|0|||
156672917|NCT00640341|565550562|FG001|Overall Study|Adverse Event|0|||
156672918|NCT00640341|565550563|FG002|Overall Study|Adverse Event|1|||
156672919|NCT00640341|565550561|FG000|Overall Study|Positive Slit Lamp Findings|0|||
156672920|NCT00640341|565550562|FG001|Overall Study|Positive Slit Lamp Findings|0|||
156672921|NCT00640341|565550563|FG002|Overall Study|Positive Slit Lamp Findings|1|||
156672922|NCT00640341|565550561|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
156672923|NCT00640341|565550562|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
156672924|NCT00640341|565550563|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
156672925|NCT00640341|565550561|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
156526887|NCT02075541|565023644|FG001|Overall Study|Serious Adverse Event|4|||
156526888|NCT02075541|565023643|FG000|Overall Study|Protocol Violation|1|||
156672926|NCT00640341|565550562|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
156672927|NCT00640341|565550563|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
156672928|NCT00640341|565550561|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
156672929|NCT00640341|565550562|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
156672930|NCT00640341|565550563|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
156672931|NCT00640341|565550561|FG000|Overall Study|Lost to Follow-up|2|||
156672932|NCT00640341|565550562|FG001|Overall Study|Lost to Follow-up|0|||
156327441|NCT00764504|564299272|FG000|Overall Study|Withdrawal by Subject|1|||
156327442|NCT00764504|564299273|FG001|Overall Study|Withdrawal by Subject|7|||
156526889|NCT02075541|565023644|FG001|Overall Study|Protocol Violation|0|||
156526890|NCT02075541|565023643|FG000|Overall Study|Withdrawal by Subject|1|||
156526891|NCT02075541|565023644|FG001|Overall Study|Withdrawal by Subject|3|||
156526892|NCT02075541|565023643|FG000|Overall Study|Sponsor study termination|0|||
156526893|NCT02075541|565023644|FG001|Overall Study|Sponsor study termination|1|||
156526894|NCT02075541|565023643|FG000|Overall Study|Other- unable to perform study procedure|1|||
156327443|NCT00764504|564299274|FG002|Overall Study|Withdrawal by Subject|4|||
156327444|NCT00764504|564299272|FG000|Overall Study|Lost to Follow-up|40|||
156327445|NCT00764504|564299273|FG001|Overall Study|Lost to Follow-up|34|||
156327446|NCT00764504|564299274|FG002|Overall Study|Lost to Follow-up|72|||
156327447|NCT02448810|564299275|FG000|Overall Study|Adverse Event|0|||
156327448|NCT02448810|564299276|FG001|Overall Study|Adverse Event|0|||
156327449|NCT02448810|564299277|FG002|Overall Study|Adverse Event|1|||
156327450|NCT02448810|564299278|FG003|Overall Study|Adverse Event|0|||
156327451|NCT02448810|564299279|FG004|Overall Study|Adverse Event|0|||
156327452|NCT02448810|564299280|FG005|Overall Study|Adverse Event|0|||
156327453|NCT02448810|564299281|FG006|Overall Study|Adverse Event|0|||
156327454|NCT02448810|564299282|FG007|Overall Study|Adverse Event|0|||
156327455|NCT02448810|564299275|FG000|Overall Study|Withdrawal by Subject|0|||
156327456|NCT02448810|564299276|FG001|Overall Study|Withdrawal by Subject|0|||
156327457|NCT02448810|564299277|FG002|Overall Study|Withdrawal by Subject|1|||
156526895|NCT02075541|565023644|FG001|Overall Study|Other- unable to perform study procedure|0|||
156327458|NCT02448810|564299278|FG003|Overall Study|Withdrawal by Subject|0|||
156431456|NCT00604721|564667912|FG000|Overall Study|Withdrawal by Subject|1|||
156431457|NCT01838551|564667916|FG000|Overall Study|Adverse Event|16|||
156431458|NCT01838551|564667916|FG000|Overall Study|Death|1|||
156431459|NCT01838551|564667916|FG000|Overall Study|Lack of Efficacy|10|||
156431460|NCT01838551|564667916|FG000|Overall Study|Physician Decision|4|||
156431461|NCT01838551|564667916|FG000|Overall Study|Withdrawal by Subject|10|||
156431462|NCT01838551|564667916|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
156431463|NCT00906282|564667917|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
156431464|NCT00906282|564667917|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
156431465|NCT00906282|564667917|FG000|Preoperative Chemotherapy|Progressive disease|6|||
156431466|NCT00906282|564667917|FG000|Preoperative Chemotherapy|Toxicity|1|||
156431467|NCT02163915|564667922|FG000|Overall Study|Withdrawal by Subject|2|||
156431468|NCT02163915|564667923|FG001|Overall Study|Withdrawal by Subject|0|||
156431469|NCT02163915|564667924|FG002|Overall Study|Withdrawal by Subject|2|||
156431470|NCT02163915|564667925|FG003|Overall Study|Withdrawal by Subject|2|||
156672933|NCT00640341|565550563|FG002|Overall Study|Lost to Follow-up|0|||
156672934|NCT00640341|565550561|FG000|Overall Study|Withdrawal by Subject|4|||
156672935|NCT00640341|565550562|FG001|Overall Study|Withdrawal by Subject|0|||
156672936|NCT00640341|565550563|FG002|Overall Study|Withdrawal by Subject|1|||
156672937|NCT00640341|565550561|FG000|Overall Study|Unacceptable Lens Movement|1|||
156672938|NCT00640341|565550562|FG001|Overall Study|Unacceptable Lens Movement|0|||
156431471|NCT02163915|564667926|FG004|Overall Study|Withdrawal by Subject|2|||
156431472|NCT02163915|564667922|FG000|Overall Study|Study termination|1|||
156431473|NCT02163915|564667923|FG001|Overall Study|Study termination|0|||
156431474|NCT02163915|564667924|FG002|Overall Study|Study termination|0|||
156431475|NCT02163915|564667925|FG003|Overall Study|Study termination|0|||
156431476|NCT02163915|564667926|FG004|Overall Study|Study termination|2|||
156431477|NCT02163915|564667922|FG000|Overall Study|Physician Decision|0|||
156431478|NCT02163915|564667923|FG001|Overall Study|Physician Decision|0|||
156431479|NCT02163915|564667924|FG002|Overall Study|Physician Decision|0|||
156672939|NCT00640341|565550563|FG002|Overall Study|Unacceptable Lens Movement|0|||
156672940|NCT00640341|565550561|FG000|Overall Study|Poor fit/Uncomfortable|4|||
156431480|NCT02163915|564667925|FG003|Overall Study|Physician Decision|1|||
156431481|NCT02163915|564667926|FG004|Overall Study|Physician Decision|0|||
156431482|NCT01751724|564667927|FG000|Overall Study|extubated bef.start assigned treatment|1|||
156431483|NCT01751724|564667928|FG001|Overall Study|extubated bef.start assigned treatment|0|||
156431484|NCT01751724|564667927|FG000|Overall Study|withdrawn by parent|0|||
156431485|NCT01751724|564667928|FG001|Overall Study|withdrawn by parent|2|||
156431486|NCT03395353|564667929|FG000|Overall Study|Adverse Event|20|||
156431487|NCT03395353|564667929|FG000|Overall Study|Protocol Violation|1|||
156431488|NCT03395353|564667929|FG000|Overall Study|Lack of Efficacy|3|||
156431489|NCT03395353|564667929|FG000|Overall Study|Withdrawal by Subject|24|||
156431490|NCT03395353|564667929|FG000|Overall Study|Discontinued visit|1|||
156431491|NCT03395353|564667929|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
156431492|NCT03395353|564667929|FG000|Overall Study|Physician Decision|4|||
156431493|NCT03395353|564667929|FG000|Overall Study|Early termination of overall study|33|||
156431494|NCT02685033|564667930|FG000|Overall Study|Withdrawal of Consent|0|||
156431495|NCT02685033|564667931|FG001|Overall Study|Withdrawal of Consent|1|||
156431496|NCT02685033|564667930|FG000|Overall Study|Lost to Follow-up|2|||
156431497|NCT02685033|564667931|FG001|Overall Study|Lost to Follow-up|1|||
156431498|NCT02685033|564667930|FG000|Overall Study|Adverse Event|1|||
156431499|NCT02685033|564667931|FG001|Overall Study|Adverse Event|0|||
156431500|NCT02013037|564667932|FG000|Overall Study|Death|6|||
156431501|NCT02013037|564667932|FG000|Overall Study|Withdrawal by Subject|1|||
156431502|NCT02013037|564667932|FG000|Overall Study|Awaiting Transplantation|7|||
156672941|NCT00640341|565550562|FG001|Overall Study|Poor fit/Uncomfortable|0|||
156672942|NCT00640341|565550563|FG002|Overall Study|Poor fit/Uncomfortable|0|||
156672943|NCT00640341|565550561|FG000|Overall Study|Ineligable at Baseline|5|||
156672944|NCT00640341|565550562|FG001|Overall Study|Ineligable at Baseline|3|||
156672945|NCT00640341|565550563|FG002|Overall Study|Ineligable at Baseline|2|||
156672946|NCT00640341|565550561|FG000|Overall Study|Adverse event and positive slit lamp|1|||
156672947|NCT00640341|565550562|FG001|Overall Study|Adverse event and positive slit lamp|0|||
156672948|NCT00640341|565550563|FG002|Overall Study|Adverse event and positive slit lamp|0|||
156672949|NCT03578809|565550564|FG000|Overall Study|Death|0|||
156672950|NCT03578809|565550565|FG001|Overall Study|Death|2|||
156672951|NCT03578809|565550566|FG002|Overall Study|Death|0|||
156672952|NCT03578809|565550567|FG003|Overall Study|Death|1|||
156672953|NCT03578809|565550564|FG000|Overall Study|Lost to Follow-up|0|||
156431503|NCT02013037|564667932|FG000|Overall Study|Transplanted without DSA|2|||
156431504|NCT01049503|564669463|FG000|Overall Study|Lost to Follow-up|11|||
156431505|NCT01049503|564669464|FG001|Overall Study|Lost to Follow-up|12|||
156431506|NCT01049503|564669465|FG002|Overall Study|Lost to Follow-up|24|||
156431507|NCT01049503|564669466|FG003|Overall Study|Lost to Follow-up|26|||
156431508|NCT01049503|564669467|FG004|Overall Study|Lost to Follow-up|27|||
156431509|NCT01049503|564669468|FG005|Overall Study|Lost to Follow-up|8|||
156672954|NCT03578809|565550565|FG001|Overall Study|Lost to Follow-up|1|||
156672955|NCT03578809|565550566|FG002|Overall Study|Lost to Follow-up|0|||
156431510|NCT00726596|564669469|FG000|Overall Study|Adverse Event|2|||
156431511|NCT00726596|564669470|FG001|Overall Study|Adverse Event|1|||
156431512|NCT00726596|564669469|FG000|Overall Study|Withdrawal by Subject|3|||
156431513|NCT00726596|564669470|FG001|Overall Study|Withdrawal by Subject|3|||
156431514|NCT00954707|564669471|FG000|Overall Study|Death|34|||
156431515|NCT00954707|564669471|FG000|Overall Study|Withdrawal by Subject|100|||
156431516|NCT00954707|564669471|FG000|Overall Study|Lost to Follow-up|33|||
156431517|NCT02962674|564669473|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
156431518|NCT02488980|564669482|FG000|Overall Study|Protocol Violation|2|||
156431519|NCT02488980|564669483|FG001|Overall Study|Protocol Violation|2|||
156431520|NCT02488980|564669484|FG002|Overall Study|Protocol Violation|2|||
156431521|NCT05193318|564669488|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
156431522|NCT05193318|564669488|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
156431523|NCT00957658|564669489|FG000|Overall Study|Death|1|||
156431524|NCT00957658|564669489|FG000|Overall Study|Lost to Follow-up|4|||
156431525|NCT00957658|564669489|FG000|Overall Study|Withdrawal by Subject|12|||
156431526|NCT00957658|564669489|FG000|Overall Study|Revision|1|||
156431527|NCT00957658|564669489|FG000|Overall Study|Incomplete 2 yr data|28|||
156431528|NCT00957658|564669489|FG000|Overall Study|Site termination|10|||
156431529|NCT00957658|564669489|FG000|Overall Study|unwilling/unable to return|2|||
156431530|NCT00957658|564669489|FG000|Overall Study|surgery cancelled|2|||
156431531|NCT00957658|564669489|FG000|Overall Study|Protocol Violation|5|||
156431532|NCT00906035|564669493|FG000|Overall Study|Withdrawal by Subject|2|||
156431533|NCT00906035|564669494|FG001|Overall Study|Withdrawal by Subject|3|||
156431534|NCT00906035|564669495|FG002|Overall Study|Withdrawal by Subject|0|||
156672956|NCT03578809|565550567|FG003|Overall Study|Lost to Follow-up|0|||
156672957|NCT03578809|565550564|FG000|Overall Study|Withdrawal by Subject|3|||
156672958|NCT03578809|565550565|FG001|Overall Study|Withdrawal by Subject|5|||
156672959|NCT03578809|565550566|FG002|Overall Study|Withdrawal by Subject|2|||
156672960|NCT03578809|565550567|FG003|Overall Study|Withdrawal by Subject|0|||
156672961|NCT03578809|565550564|FG000|Overall Study|Other|3|||
156672962|NCT03578809|565550565|FG001|Overall Study|Other|6|||
156672963|NCT03578809|565550566|FG002|Overall Study|Other|2|||
156672964|NCT03578809|565550567|FG003|Overall Study|Other|8|||
156672965|NCT01541215|565550570|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
156431535|NCT00130637|564669496|FG000|Overall Study|Adverse Event|2|||
156431536|NCT00130637|564669496|FG000|Overall Study|Withdrawal by Subject|1|||
156431537|NCT00139737|564669497|FG000|Overall Study|Withdrawal by Subject|190|||
156431538|NCT00139737|564669497|FG000|Overall Study|Adverse Event|58|||
156431539|NCT00139737|564669497|FG000|Overall Study|Lack of Efficacy|40|||
156431540|NCT00139737|564669497|FG000|Overall Study|Lost to Follow-up|8|||
156431541|NCT00139737|564669497|FG000|Overall Study|Death|3|||
156431542|NCT00139737|564669497|FG000|Overall Study|Laboratory Abnormality|2|||
156431543|NCT00139737|564669497|FG000|Overall Study|Protocol Violation|18|||
156431544|NCT00139737|564669497|FG000|Overall Study|Withdrew During Screening Phase|8|||
156431545|NCT00139737|564669497|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
156431546|NCT00139737|564669497|FG000|Overall Study|Screened, Not Treated|13|||
156431547|NCT00217672|564669500|FG000|Allocation|Ineligible|2|||
156431548|NCT00217672|564669501|FG001|Allocation|Ineligible|0|||
156431549|NCT00217672|564669500|FG000|Treatment|disease progression|33|||
156431550|NCT00217672|564669501|FG001|Treatment|disease progression|4|||
156431551|NCT00217672|564669500|FG000|Treatment|Adverse Event|18|||
156431552|NCT00217672|564669501|FG001|Treatment|Adverse Event|2|||
156431553|NCT00217672|564669500|FG000|Treatment|reqd treatment not permitted by protocol|6|||
156431554|NCT00217672|564669501|FG001|Treatment|reqd treatment not permitted by protocol|0|||
156431555|NCT00217672|564669500|FG000|Treatment|Physician Decision|6|||
156431556|NCT00217672|564669501|FG001|Treatment|Physician Decision|0|||
156431557|NCT00217672|564669500|FG000|Treatment|insurance issues|1|||
156431558|NCT00217672|564669501|FG001|Treatment|insurance issues|1|||
156431559|NCT00217672|564669500|FG000|Treatment|Death|2|||
156431560|NCT00217672|564669501|FG001|Treatment|Death|0|||
156431561|NCT00217672|564669500|FG000|Treatment|secondary malignancy|1|||
156431562|NCT00217672|564669501|FG001|Treatment|secondary malignancy|0|||
156431563|NCT00217672|564669500|FG000|Follow-up|Withdrawal by Subject|4|||
156431564|NCT00217672|564669501|FG001|Follow-up|Withdrawal by Subject|0|||
156431565|NCT00217672|564669500|FG000|Follow-up|Lost to Follow-up|1|||
156431566|NCT00217672|564669501|FG001|Follow-up|Lost to Follow-up|0|||
156431567|NCT01591616|564669502|FG000|Overall Study|Withdrawal by Subject|1|||
156431568|NCT03781336|564669503|FG000|Overall Study|Withdrawal by Subject|2|||
156431569|NCT03781336|564669504|FG001|Overall Study|Withdrawal by Subject|2|||
156431570|NCT01972152|564669505|FG000|First Treatment Visit|Lost to Follow-up|0|||
156431571|NCT01972152|564669506|FG001|First Treatment Visit|Lost to Follow-up|1|||
156431572|NCT01972152|564669507|FG002|First Treatment Visit|Lost to Follow-up|0|||
156431573|NCT01972152|564669508|FG003|First Treatment Visit|Lost to Follow-up|0|||
156431574|NCT01972152|564669509|FG004|First Treatment Visit|Lost to Follow-up|0|||
156431575|NCT01972152|564669510|FG005|First Treatment Visit|Lost to Follow-up|0|||
156431576|NCT01972152|564669505|FG000|Second Treatment Visit|Protocol Violation|0|||
156431577|NCT01972152|564669506|FG001|Second Treatment Visit|Protocol Violation|1|||
156672966|NCT01541215|565550571|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
156672967|NCT01541215|565550570|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
156672968|NCT01541215|565550571|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
156672969|NCT01541215|565550570|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
156672970|NCT01541215|565550571|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
156672971|NCT01541215|565550570|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
156672972|NCT01541215|565550571|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
156672973|NCT01541215|565550570|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
156672974|NCT01541215|565550571|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
156672975|NCT01541215|565550570|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
156672976|NCT01541215|565550571|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
156672977|NCT00830258|565550572|FG000|First Intervention|Adverse Event|1|||
156672978|NCT00830258|565550573|FG001|First Intervention|Adverse Event|0|||
156672979|NCT00830258|565550572|FG000|Washout: 7 Days|Protocol Violation|1|||
156672980|NCT00830258|565550573|FG001|Washout: 7 Days|Protocol Violation|0|||
156672981|NCT03599193|565550574|FG000|Overall Study|Adverse Event|0|||
156672982|NCT03599193|565550575|FG001|Overall Study|Adverse Event|2|||
156672983|NCT03599193|565550574|FG000|Overall Study|Withdrawal by Subject|1|||
156672984|NCT03599193|565550575|FG001|Overall Study|Withdrawal by Subject|0|||
156672985|NCT03599193|565550574|FG000|Overall Study|Protocol Violation|1|||
156672986|NCT03599193|565550575|FG001|Overall Study|Protocol Violation|0|||
156672987|NCT03599193|565550574|FG000|Overall Study|Lost to Follow-up|0|||
156672988|NCT03599193|565550575|FG001|Overall Study|Lost to Follow-up|1|||
156672989|NCT00798603|565550576|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
156672990|NCT00798603|565550576|FG000|Overall Study|Withdrawal by Subject|10|||
156526896|NCT00731120|565023645|FG000|Overall Study|Adverse Event|7|||
156526897|NCT00731120|565023646|FG001|Overall Study|Adverse Event|6|||
156526898|NCT00731120|565023647|FG002|Overall Study|Adverse Event|8|||
156526899|NCT00731120|565023645|FG000|Overall Study|Lack of Efficacy|4|||
156526900|NCT00731120|565023646|FG001|Overall Study|Lack of Efficacy|5|||
156526901|NCT00731120|565023647|FG002|Overall Study|Lack of Efficacy|4|||
156526902|NCT00731120|565023645|FG000|Overall Study|Noncompliance with Study Drug|3|||
156526903|NCT00731120|565023646|FG001|Overall Study|Noncompliance with Study Drug|3|||
156526904|NCT00731120|565023647|FG002|Overall Study|Noncompliance with Study Drug|1|||
156526905|NCT00731120|565023645|FG000|Overall Study|Protocol Deviations|1|||
156526906|NCT00731120|565023646|FG001|Overall Study|Protocol Deviations|6|||
156526907|NCT00731120|565023647|FG002|Overall Study|Protocol Deviations|1|||
156526908|NCT00731120|565023645|FG000|Overall Study|Withdrawal of Consent|13|||
156526909|NCT00731120|565023646|FG001|Overall Study|Withdrawal of Consent|8|||
156526910|NCT00731120|565023647|FG002|Overall Study|Withdrawal of Consent|4|||
156526911|NCT00731120|565023645|FG000|Overall Study|Lost to Follow-up|10|||
156526912|NCT00731120|565023646|FG001|Overall Study|Lost to Follow-up|15|||
156526913|NCT00731120|565023647|FG002|Overall Study|Lost to Follow-up|17|||
156526914|NCT00731120|565023645|FG000|Overall Study|Other|4|||
156526915|NCT00731120|565023646|FG001|Overall Study|Other|0|||
156526916|NCT00731120|565023647|FG002|Overall Study|Other|1|||
156526917|NCT02434939|565023648|FG000|Overall Study|Lack of Efficacy|34|||
156526918|NCT02434939|565023649|FG001|Overall Study|Lack of Efficacy|48|||
156526919|NCT02434939|565023648|FG000|Overall Study|Withdrawal by Subject|3|||
156526920|NCT02434939|565023649|FG001|Overall Study|Withdrawal by Subject|0|||
156526921|NCT02434939|565023648|FG000|Overall Study|Adverse Event|0|||
156526922|NCT02434939|565023649|FG001|Overall Study|Adverse Event|1|||
156526923|NCT03181451|565023650|FG000|Overall Study|Adverse Event|0|||
156526924|NCT03181451|565023651|FG001|Overall Study|Adverse Event|1|||
156526925|NCT03181451|565023652|FG002|Overall Study|Adverse Event|0|||
156526926|NCT03181451|565023650|FG000|Overall Study|Withdrawal by Subject|0|||
156526927|NCT03181451|565023651|FG001|Overall Study|Withdrawal by Subject|1|||
156526928|NCT03181451|565023652|FG002|Overall Study|Withdrawal by Subject|0|||
156526929|NCT01326533|565023653|FG000|Overall Study|Lost to Follow-up|2|||
156526930|NCT01326533|565023654|FG001|Overall Study|Lost to Follow-up|0|||
156526931|NCT01326533|565023653|FG000|Overall Study|Withdrawal by Subject|1|||
156526932|NCT01326533|565023654|FG001|Overall Study|Withdrawal by Subject|0|||
156672991|NCT00798603|565550576|FG000|Overall Study|Adverse Event|22|||
156672992|NCT00798603|565550576|FG000|Overall Study|Physician Decision|1|||
156672993|NCT00798603|565550576|FG000|Overall Study|Lack of insurance coverage|1|||
156672994|NCT00835705|565550577|FG000|First Intervention|Difficulty with vein|1|||
156672995|NCT00835705|565550578|FG001|First Intervention|Difficulty with vein|0|||
156672996|NCT00835705|565550577|FG000|Second Intervention|Difficulty with vein|1|||
156672997|NCT00835705|565550578|FG001|Second Intervention|Difficulty with vein|0|||
156526933|NCT01326533|565023653|FG000|Overall Study|Adverse Event|1|||
156526934|NCT01326533|565023654|FG001|Overall Study|Adverse Event|0|||
156672998|NCT01116739|565550581|FG000|Overall Study|Child had 2 years of HS|110|||
156526935|NCT04079803|565023655|FG000|Overall Study|Withdrawal by Subject|0|||
156526936|NCT04079803|565023656|FG001|Overall Study|Withdrawal by Subject|0|||
156526937|NCT04079803|565023657|FG002|Overall Study|Withdrawal by Subject|1|||
156526938|NCT00807235|565023665|FG000|Overall Study|Adverse Event|1|||
156526939|NCT00807235|565023666|FG001|Overall Study|Adverse Event|0|||
156431578|NCT01972152|564669507|FG002|Second Treatment Visit|Protocol Violation|0|||
156431579|NCT01972152|564669508|FG003|Second Treatment Visit|Protocol Violation|0|||
156431580|NCT01972152|564669509|FG004|Second Treatment Visit|Protocol Violation|0|||
156431581|NCT01972152|564669510|FG005|Second Treatment Visit|Protocol Violation|0|||
156431582|NCT01959412|564669511|FG000|Overall Study|Protocol deviation|1|||
156431583|NCT01959412|564669512|FG001|Overall Study|Protocol deviation|1|||
156431584|NCT01959412|564669513|FG002|Overall Study|Protocol deviation|0|||
156431585|NCT01959412|564669514|FG003|Overall Study|Protocol deviation|1|||
156431586|NCT01959412|564669515|FG004|Overall Study|Protocol deviation|3|||
156431587|NCT01959412|564669516|FG005|Overall Study|Protocol deviation|0|||
156431588|NCT01959412|564669511|FG000|Overall Study|Adverse Event|0|||
156431589|NCT01959412|564669512|FG001|Overall Study|Adverse Event|0|||
156431590|NCT01959412|564669513|FG002|Overall Study|Adverse Event|0|||
156431591|NCT01959412|564669514|FG003|Overall Study|Adverse Event|1|||
156431592|NCT01959412|564669515|FG004|Overall Study|Adverse Event|0|||
156431593|NCT01959412|564669516|FG005|Overall Study|Adverse Event|0|||
156431594|NCT04379713|564669521|FG000|Overall Study|Adverse Event|2|||
156431595|NCT04379713|564669522|FG001|Overall Study|Adverse Event|0|||
156431596|NCT04379713|564669521|FG000|Overall Study|Physician Decision|2|||
156431597|NCT04379713|564669522|FG001|Overall Study|Physician Decision|1|||
156672999|NCT01116739|565550582|FG001|Overall Study|Child had 2 years of HS|128|||
156673000|NCT01116739|565550581|FG000|Overall Study|Withdrawal by Subject|6|||
156673001|NCT01116739|565550582|FG001|Overall Study|Withdrawal by Subject|0|||
156673002|NCT01116739|565550581|FG000|Overall Study|child too young|2|||
156673003|NCT01116739|565550582|FG001|Overall Study|child too young|6|||
156673004|NCT01116739|565550581|FG000|Overall Study|child not enrolled in head start|10|||
156673005|NCT01116739|565550582|FG001|Overall Study|child not enrolled in head start|2|||
156673006|NCT01116739|565550581|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
156673007|NCT01116739|565550582|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
156673008|NCT05511935|565550583|FG000|Overall Study|Lost to Follow-up|9|||
156431598|NCT04379713|564669521|FG000|Overall Study|Protocol Violation|11|||
156431599|NCT04379713|564669522|FG001|Overall Study|Protocol Violation|6|||
156431600|NCT04379713|564669521|FG000|Overall Study|No longer met eligibility criteria|14|||
156431601|NCT04379713|564669522|FG001|Overall Study|No longer met eligibility criteria|11|||
156431602|NCT04379713|564669521|FG000|Overall Study|Withdrawal by parent/guardian|36|||
156431603|NCT04379713|564669522|FG001|Overall Study|Withdrawal by parent/guardian|15|||
156431604|NCT04379713|564669521|FG000|Overall Study|Lost to Follow-up|31|||
156431605|NCT04379713|564669522|FG001|Overall Study|Lost to Follow-up|21|||
156431606|NCT00509769|564669523|FG000|Overall Study|Progressive disease|77|||
156431607|NCT00509769|564669523|FG000|Overall Study|Adverse Event|4|||
156431608|NCT00509769|564669523|FG000|Overall Study|Patient's decision|1|||
156431609|NCT00509769|564669523|FG000|Overall Study|Physician Decision|8|||
156431610|NCT00509769|564669523|FG000|Overall Study|Use of prohibited therapies during study|1|||
156431611|NCT04567888|564669524|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
156431612|NCT04567888|564669525|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
156431613|NCT04567888|564669524|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
156431614|NCT04567888|564669525|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
156431615|NCT04567888|564669524|FG000|Overall Study|Reported Unusual Birth Year|2|||
156431616|NCT04567888|564669525|FG001|Overall Study|Reported Unusual Birth Year|3|||
156431617|NCT04567888|564669524|FG000|Overall Study|Duplicate Responses|0|||
156673009|NCT05511935|565550584|FG001|Overall Study|Lost to Follow-up|27|||
156673010|NCT05090839|565550585|FG000|Overall Study|Lost to Follow-up|2|||
156673011|NCT05090839|565550586|FG001|Overall Study|Lost to Follow-up|3|||
156526940|NCT01012713|565023669|FG000|Overall Study|Lack of Efficacy|3|||
156431618|NCT04567888|564669525|FG001|Overall Study|Duplicate Responses|1|||
156431619|NCT01157182|564669526|FG000|Washout of 28 Days|Adverse Event|2|||
156431620|NCT01157182|564669527|FG001|Washout of 28 Days|Adverse Event|0|||
156431621|NCT01490580|564669528|FG000|Overall Study|Parents withdrew consent|0|||
156431622|NCT01490580|564669529|FG001|Overall Study|Parents withdrew consent|2|||
156431623|NCT00878722|564669530|FG000|Overall Study|Progressive disease|3|||
156431624|NCT00878722|564669531|FG001|Overall Study|Progressive disease|3|||
156431625|NCT00878722|564669532|FG002|Overall Study|Progressive disease|3|||
156431626|NCT00878722|564669533|FG003|Overall Study|Progressive disease|7|||
156431627|NCT00878722|564669534|FG004|Overall Study|Progressive disease|7|||
156431628|NCT00878722|564669535|FG005|Overall Study|Progressive disease|1|||
156431629|NCT00878722|564669536|FG006|Overall Study|Progressive disease|4|||
156526941|NCT01242800|565023670|FG000|Overall Study|Patient refusal|0|||
156431630|NCT00878722|564669537|FG007|Overall Study|Progressive disease|3|||
156431631|NCT00878722|564669530|FG000|Overall Study|Death|0|||
156431632|NCT00878722|564669531|FG001|Overall Study|Death|0|||
156431633|NCT00878722|564669532|FG002|Overall Study|Death|0|||
156431634|NCT00878722|564669533|FG003|Overall Study|Death|1|||
156431635|NCT00878722|564669534|FG004|Overall Study|Death|0|||
156431636|NCT00878722|564669535|FG005|Overall Study|Death|1|||
156431637|NCT00878722|564669536|FG006|Overall Study|Death|0|||
156431638|NCT00878722|564669537|FG007|Overall Study|Death|2|||
156431639|NCT00878722|564669530|FG000|Overall Study|Adverse Event|0|||
156431640|NCT00878722|564669531|FG001|Overall Study|Adverse Event|0|||
156673012|NCT05090839|565550587|FG002|Overall Study|Lost to Follow-up|1|||
156673013|NCT05090839|565550588|FG003|Overall Study|Lost to Follow-up|1|||
156673014|NCT04406194|565550589|FG000|Period 1|Withdrawal by Subject|0|||
156673015|NCT04406194|565550590|FG001|Period 1|Withdrawal by Subject|1|||
156673016|NCT04102345|565550591|FG000|Overall Study|Withdrawal by Subject|1|||
156673017|NCT04102345|565550592|FG001|Overall Study|Withdrawal by Subject|0|||
156673018|NCT03499353|565550593|FG000|Treatment|Adverse Event|3|||
156673019|NCT03499353|565550593|FG000|Treatment|Progressive Disease|10|||
156673020|NCT03499353|565550593|FG000|Treatment|Other|1|||
156673021|NCT03499353|565550593|FG000|Treatment|Withdrawal by Subject|2|||
156673022|NCT03499353|565550593|FG000|Long-Term Follow-up|Death|2|||
156673023|NCT03499353|565550593|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
156673024|NCT03499353|565550593|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
156673025|NCT01015287|565550594|FG000|Overall Study|Death|21|||
156673026|NCT01015287|565550595|FG001|Overall Study|Death|16|||
156673027|NCT01015287|565550594|FG000|Overall Study|Adverse Event|1|||
156673028|NCT01015287|565550595|FG001|Overall Study|Adverse Event|0|||
156673029|NCT01015287|565550594|FG000|Overall Study|Sponsor Decision|3|||
156673030|NCT01015287|565550595|FG001|Overall Study|Sponsor Decision|7|||
156673031|NCT01015287|565550594|FG000|Overall Study|Physician Decision|19|||
156673032|NCT01015287|565550595|FG001|Overall Study|Physician Decision|21|||
156673033|NCT01015287|565550594|FG000|Overall Study|Withdrawal by Subject|14|||
156673034|NCT01015287|565550595|FG001|Overall Study|Withdrawal by Subject|19|||
156673035|NCT01015287|565550594|FG000|Overall Study|Entry Criteria not Met|11|||
156526942|NCT01242800|565023671|FG001|Overall Study|Patient refusal|10|||
156526943|NCT01242800|565023670|FG000|Overall Study|Physician Decision|0|||
156526944|NCT01242800|565023671|FG001|Overall Study|Physician Decision|1|||
156526945|NCT01242800|565023670|FG000|Overall Study|Disease progression|0|||
156526946|NCT01242800|565023671|FG001|Overall Study|Disease progression|3|||
156526947|NCT01242800|565023670|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
156526948|NCT01242800|565023671|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
156526949|NCT01242800|565023670|FG000|Overall Study|Reasons not reported|0|||
156526950|NCT01242800|565023671|FG001|Overall Study|Reasons not reported|4|||
156526951|NCT02447172|565023673|FG000|Overall Study|Adverse Event|11|||
156526952|NCT02447172|565023674|FG001|Overall Study|Adverse Event|8|||
156526953|NCT02447172|565023675|FG002|Overall Study|Adverse Event|7|||
156526954|NCT02447172|565023673|FG000|Overall Study|Death|3|||
156526955|NCT02447172|565023674|FG001|Overall Study|Death|1|||
156526956|NCT02447172|565023675|FG002|Overall Study|Death|0|||
156526957|NCT02447172|565023673|FG000|Overall Study|Protocol Violation|2|||
156526958|NCT02447172|565023674|FG001|Overall Study|Protocol Violation|1|||
156526959|NCT02447172|565023675|FG002|Overall Study|Protocol Violation|2|||
156526960|NCT02447172|565023673|FG000|Overall Study|Lost to Follow-up|7|||
156526961|NCT02447172|565023674|FG001|Overall Study|Lost to Follow-up|4|||
156526962|NCT02447172|565023675|FG002|Overall Study|Lost to Follow-up|4|||
156526963|NCT02447172|565023673|FG000|Overall Study|Withdrawal by Subject|5|||
156526964|NCT02447172|565023674|FG001|Overall Study|Withdrawal by Subject|1|||
156526965|NCT02447172|565023675|FG002|Overall Study|Withdrawal by Subject|3|||
156526966|NCT02447172|565023673|FG000|Overall Study|protocol specific treatment unrelated|3|||
156526967|NCT02447172|565023674|FG001|Overall Study|protocol specific treatment unrelated|0|||
156526968|NCT02447172|565023675|FG002|Overall Study|protocol specific treatment unrelated|2|||
156526969|NCT01910181|565023680|FG000|Overall Study|Death|37|||
156526970|NCT01910181|565023680|FG000|Overall Study|Lost to Follow-up|3|||
156526971|NCT01910181|565023680|FG000|Overall Study|Study Terminated by Sponsor|6|||
156526972|NCT02656823|565023681|FG000|Overall Study|Adverse Event|3|||
156526973|NCT02656823|565023681|FG000|Overall Study|Lost to Follow-up|2|||
156526974|NCT03567434|565023685|FG000|Overall Study|Lost to Follow-up|1|||
156526975|NCT03567434|565023686|FG001|Overall Study|Lost to Follow-up|3|||
156673036|NCT01015287|565550595|FG001|Overall Study|Entry Criteria not Met|14|||
156327459|NCT02448810|564299279|FG004|Overall Study|Withdrawal by Subject|3|||
156327460|NCT02448810|564299280|FG005|Overall Study|Withdrawal by Subject|5|||
156327461|NCT02448810|564299281|FG006|Overall Study|Withdrawal by Subject|0|||
156327462|NCT02448810|564299282|FG007|Overall Study|Withdrawal by Subject|2|||
156327463|NCT02448810|564299275|FG000|Overall Study|Other (study terminated by sponsor)|0|||
156327464|NCT02448810|564299276|FG001|Overall Study|Other (study terminated by sponsor)|0|||
156327465|NCT02448810|564299277|FG002|Overall Study|Other (study terminated by sponsor)|0|||
156526976|NCT04469270|565023690|FG000|Overall Study|Adverse Event|2|||
156526977|NCT04469270|565023691|FG001|Overall Study|Adverse Event|0|||
156526978|NCT04469270|565023690|FG000|Overall Study|Lost to Follow-up|4|||
156526979|NCT04469270|565023691|FG001|Overall Study|Lost to Follow-up|3|||
156526980|NCT04469270|565023690|FG000|Overall Study|Withdrawal by Subject|7|||
156526981|NCT04469270|565023691|FG001|Overall Study|Withdrawal by Subject|3|||
156526982|NCT04469270|565023690|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
156673037|NCT01015287|565550594|FG000|Overall Study|Lost to Follow-up|2|||
156673038|NCT01015287|565550595|FG001|Overall Study|Lost to Follow-up|1|||
156673039|NCT01015287|565550594|FG000|Overall Study|Protocol Violation|1|||
156673040|NCT01015287|565550595|FG001|Overall Study|Protocol Violation|1|||
156327466|NCT02448810|564299278|FG003|Overall Study|Other (study terminated by sponsor)|0|||
156673041|NCT01592240|565550596|FG000|Overall Study|Adverse Event|1|||
156673042|NCT01592240|565550597|FG001|Overall Study|Adverse Event|0|||
156673043|NCT01592240|565550598|FG002|Overall Study|Adverse Event|0|||
156673044|NCT01592240|565550599|FG003|Overall Study|Adverse Event|1|||
156673045|NCT01592240|565550600|FG004|Overall Study|Adverse Event|1|||
156673046|NCT01592240|565550601|FG005|Overall Study|Adverse Event|0|||
156526983|NCT04469270|565023691|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
156526984|NCT04469270|565023690|FG000|Overall Study|missing|1|||
156526985|NCT04469270|565023691|FG001|Overall Study|missing|0|||
156526986|NCT05269355|565023699|FG000|Overall Study|Progressive Disease|104|||
156526987|NCT05269355|565023700|FG001|Overall Study|Progressive Disease|68|||
156526988|NCT05269355|565023699|FG000|Overall Study|Study Terminated by Sponsor|87|||
156526989|NCT05269355|565023700|FG001|Overall Study|Study Terminated by Sponsor|29|||
156526990|NCT05269355|565023699|FG000|Overall Study|Adverse Event|15|||
156526991|NCT05269355|565023700|FG001|Overall Study|Adverse Event|8|||
156673047|NCT01592240|565550602|FG006|Overall Study|Adverse Event|0|||
156673048|NCT01592240|565550596|FG000|Overall Study|Death|0|||
156673049|NCT01592240|565550597|FG001|Overall Study|Death|1|||
156526992|NCT05269355|565023699|FG000|Overall Study|Withdrawal by Subject|18|||
156526993|NCT05269355|565023700|FG001|Overall Study|Withdrawal by Subject|5|||
156526994|NCT05269355|565023699|FG000|Overall Study|Physician Decision|6|||
156526995|NCT05269355|565023700|FG001|Overall Study|Physician Decision|4|||
156526996|NCT05269355|565023699|FG000|Overall Study|Death|3|||
156526997|NCT05269355|565023700|FG001|Overall Study|Death|5|||
156526998|NCT05269355|565023699|FG000|Overall Study|Other Than Specified|5|||
156526999|NCT05269355|565023700|FG001|Overall Study|Other Than Specified|1|||
156527000|NCT05269355|565023699|FG000|Overall Study|Randomized But Not Treated|1|||
156527001|NCT05269355|565023700|FG001|Overall Study|Randomized But Not Treated|0|||
156527002|NCT03705832|565023701|FG000|Overall Study|Physician Decision|0|||
156527003|NCT03705832|565023702|FG001|Overall Study|Physician Decision|1|||
156527004|NCT03705832|565023701|FG000|Overall Study|Withdrawal by Subject|1|||
156527005|NCT03705832|565023702|FG001|Overall Study|Withdrawal by Subject|0|||
156527006|NCT01050790|565023703|FG000|Overall Study|Adverse Event|1|||
156527007|NCT01880528|565023704|FG000|Overall Study|Other|1|||
156527008|NCT01880528|565023705|FG001|Overall Study|Other|1|||
156527009|NCT00081497|565023706|FG000|Overall Study|Adverse Event|2|||
156527010|NCT00081497|565023707|FG001|Overall Study|Adverse Event|0|||
156527011|NCT00081497|565023706|FG000|Overall Study|Death|0|||
156527012|NCT00081497|565023707|FG001|Overall Study|Death|1|||
156527013|NCT00081497|565023706|FG000|Overall Study|Withdrawal by Subject|1|||
156527014|NCT00081497|565023707|FG001|Overall Study|Withdrawal by Subject|0|||
156327467|NCT02448810|564299279|FG004|Overall Study|Other (study terminated by sponsor)|4|||
156327468|NCT02448810|564299280|FG005|Overall Study|Other (study terminated by sponsor)|2|||
156527015|NCT00081497|565023706|FG000|Overall Study|Non-compliance|0|||
156527016|NCT00081497|565023707|FG001|Overall Study|Non-compliance|1|||
156527017|NCT01439360|565023708|FG000|Overall Study|Adverse Event|4|||
156527018|NCT01439360|565023709|FG001|Overall Study|Adverse Event|16|||
156527019|NCT01439360|565023708|FG000|Overall Study|Lost to Follow-up|43|||
156527020|NCT01439360|565023709|FG001|Overall Study|Lost to Follow-up|58|||
156527021|NCT01439360|565023708|FG000|Overall Study|Others|10|||
156527022|NCT01439360|565023709|FG001|Overall Study|Others|5|||
156527023|NCT01439360|565023708|FG000|Overall Study|Protocol Violation|1|||
156527024|NCT01439360|565023709|FG001|Overall Study|Protocol Violation|0|||
156527025|NCT01439360|565023708|FG000|Overall Study|Withdrawal by Subject|140|||
156527026|NCT01439360|565023709|FG001|Overall Study|Withdrawal by Subject|129|||
156527027|NCT02390245|565023711|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
156527028|NCT02390245|565023712|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
156527029|NCT02390245|565023713|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
156327469|NCT02448810|564299281|FG006|Overall Study|Other (study terminated by sponsor)|2|||
156327470|NCT02448810|564299282|FG007|Overall Study|Other (study terminated by sponsor)|1|||
156327471|NCT02448810|564299275|FG000|Overall Study|Death|1|||
156327472|NCT02448810|564299276|FG001|Overall Study|Death|0|||
156327473|NCT02448810|564299277|FG002|Overall Study|Death|1|||
156327474|NCT02448810|564299278|FG003|Overall Study|Death|0|||
156327475|NCT02448810|564299279|FG004|Overall Study|Death|1|||
156327476|NCT02448810|564299280|FG005|Overall Study|Death|0|||
156327477|NCT02448810|564299281|FG006|Overall Study|Death|0|||
156327478|NCT02448810|564299282|FG007|Overall Study|Death|0|||
156327479|NCT02448810|564299275|FG000|Overall Study|Other (Progressive disease)|2|||
156527030|NCT02390245|565023711|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
156527031|NCT02390245|565023712|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
156527032|NCT02390245|565023713|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
156673050|NCT01592240|565550598|FG002|Overall Study|Death|0|||
156673051|NCT01592240|565550599|FG003|Overall Study|Death|0|||
156673052|NCT01592240|565550600|FG004|Overall Study|Death|0|||
156673053|NCT01592240|565550601|FG005|Overall Study|Death|0|||
156327480|NCT02448810|564299276|FG001|Overall Study|Other (Progressive disease)|2|||
156327481|NCT02448810|564299277|FG002|Overall Study|Other (Progressive disease)|0|||
156327482|NCT02448810|564299278|FG003|Overall Study|Other (Progressive disease)|3|||
156431641|NCT00878722|564669532|FG002|Overall Study|Adverse Event|0|||
156431642|NCT00878722|564669533|FG003|Overall Study|Adverse Event|0|||
156431643|NCT00878722|564669534|FG004|Overall Study|Adverse Event|0|||
156431644|NCT00878722|564669535|FG005|Overall Study|Adverse Event|0|||
156431645|NCT00878722|564669536|FG006|Overall Study|Adverse Event|2|||
156431646|NCT00878722|564669537|FG007|Overall Study|Adverse Event|0|||
156431647|NCT00878722|564669530|FG000|Overall Study|Withdrawal by Subject|0|||
156431648|NCT00878722|564669531|FG001|Overall Study|Withdrawal by Subject|0|||
156431649|NCT00878722|564669532|FG002|Overall Study|Withdrawal by Subject|0|||
156431650|NCT00878722|564669533|FG003|Overall Study|Withdrawal by Subject|0|||
156431651|NCT00878722|564669534|FG004|Overall Study|Withdrawal by Subject|0|||
156431652|NCT00878722|564669535|FG005|Overall Study|Withdrawal by Subject|0|||
156431653|NCT00878722|564669536|FG006|Overall Study|Withdrawal by Subject|0|||
156431654|NCT00878722|564669537|FG007|Overall Study|Withdrawal by Subject|2|||
156431655|NCT00878722|564669530|FG000|Overall Study|Relapse|0|||
156431656|NCT00878722|564669531|FG001|Overall Study|Relapse|0|||
156431657|NCT00878722|564669532|FG002|Overall Study|Relapse|0|||
156431658|NCT00878722|564669533|FG003|Overall Study|Relapse|1|||
156431659|NCT00878722|564669534|FG004|Overall Study|Relapse|0|||
156431660|NCT00878722|564669535|FG005|Overall Study|Relapse|0|||
156431661|NCT00878722|564669536|FG006|Overall Study|Relapse|0|||
156431662|NCT00878722|564669537|FG007|Overall Study|Relapse|0|||
156431663|NCT00383188|564669538|FG000|Overall Study|Adverse Event|4|||
156431664|NCT00383188|564669539|FG001|Overall Study|Adverse Event|7|||
156431665|NCT00383188|564669540|FG002|Overall Study|Adverse Event|9|||
156431666|NCT00383188|564669541|FG003|Overall Study|Adverse Event|8|||
156431667|NCT00383188|564669542|FG004|Overall Study|Adverse Event|8|||
156431668|NCT00383188|564669538|FG000|Overall Study|Lack of Efficacy|9|||
156431669|NCT00383188|564669539|FG001|Overall Study|Lack of Efficacy|3|||
156431670|NCT00383188|564669540|FG002|Overall Study|Lack of Efficacy|3|||
156431671|NCT00383188|564669541|FG003|Overall Study|Lack of Efficacy|2|||
156431672|NCT00383188|564669542|FG004|Overall Study|Lack of Efficacy|6|||
156431673|NCT00383188|564669538|FG000|Overall Study|Other|3|||
156431674|NCT00383188|564669539|FG001|Overall Study|Other|1|||
156431675|NCT00383188|564669540|FG002|Overall Study|Other|0|||
156431676|NCT00383188|564669541|FG003|Overall Study|Other|2|||
156431677|NCT00383188|564669542|FG004|Overall Study|Other|6|||
156431678|NCT00383188|564669538|FG000|Overall Study|No longer willing to participate|1|||
156431679|NCT00383188|564669539|FG001|Overall Study|No longer willing to participate|0|||
156431680|NCT00383188|564669540|FG002|Overall Study|No longer willing to participate|1|||
156431681|NCT00383188|564669541|FG003|Overall Study|No longer willing to participate|0|||
156431682|NCT00383188|564669542|FG004|Overall Study|No longer willing to participate|2|||
156673054|NCT01592240|565550602|FG006|Overall Study|Death|0|||
156673055|NCT01592240|565550596|FG000|Overall Study|Lost to Follow-up|1|||
156673056|NCT01592240|565550597|FG001|Overall Study|Lost to Follow-up|3|||
156673057|NCT01592240|565550598|FG002|Overall Study|Lost to Follow-up|1|||
156673058|NCT01592240|565550599|FG003|Overall Study|Lost to Follow-up|0|||
156673059|NCT01592240|565550600|FG004|Overall Study|Lost to Follow-up|3|||
156673060|NCT01592240|565550601|FG005|Overall Study|Lost to Follow-up|2|||
156673061|NCT01592240|565550602|FG006|Overall Study|Lost to Follow-up|0|||
156673062|NCT01592240|565550596|FG000|Overall Study|Protocol Violation|0|||
156673063|NCT01592240|565550597|FG001|Overall Study|Protocol Violation|0|||
156673064|NCT01592240|565550598|FG002|Overall Study|Protocol Violation|0|||
156673065|NCT01592240|565550599|FG003|Overall Study|Protocol Violation|0|||
156673066|NCT01592240|565550600|FG004|Overall Study|Protocol Violation|0|||
156673067|NCT01592240|565550601|FG005|Overall Study|Protocol Violation|1|||
156673068|NCT01592240|565550602|FG006|Overall Study|Protocol Violation|0|||
156673069|NCT01592240|565550596|FG000|Overall Study|Withdrawal by Subject|0|||
156673070|NCT01592240|565550597|FG001|Overall Study|Withdrawal by Subject|4|||
156673071|NCT01592240|565550598|FG002|Overall Study|Withdrawal by Subject|4|||
156673072|NCT01592240|565550599|FG003|Overall Study|Withdrawal by Subject|1|||
156673073|NCT01592240|565550600|FG004|Overall Study|Withdrawal by Subject|3|||
156673074|NCT01592240|565550601|FG005|Overall Study|Withdrawal by Subject|0|||
156673075|NCT01592240|565550602|FG006|Overall Study|Withdrawal by Subject|2|||
156673076|NCT01592240|565550596|FG000|Overall Study|Other|0|||
156673077|NCT01592240|565550597|FG001|Overall Study|Other|3|||
156673078|NCT01592240|565550598|FG002|Overall Study|Other|1|||
156673079|NCT01592240|565550599|FG003|Overall Study|Other|1|||
156431683|NCT00383188|564669538|FG000|Overall Study|Lost to Follow-up|0|||
156431684|NCT00383188|564669539|FG001|Overall Study|Lost to Follow-up|0|||
156431685|NCT00383188|564669540|FG002|Overall Study|Lost to Follow-up|0|||
156431686|NCT00383188|564669541|FG003|Overall Study|Lost to Follow-up|0|||
156431687|NCT00383188|564669542|FG004|Overall Study|Lost to Follow-up|1|||
156431688|NCT01104415|564669546|FG000|Core Phase|Consent withdrawn by subjects|1|||
156431689|NCT01104415|564669547|FG001|Core Phase|Consent withdrawn by subjects|0|||
156431690|NCT01104415|564669546|FG000|Extension Period|Progressive disease|0|||
156431691|NCT01104415|564669547|FG001|Extension Period|Progressive disease|4|||
156431692|NCT01104415|564669546|FG000|Extension Period|Death|0|||
156673080|NCT01592240|565550600|FG004|Overall Study|Other|0|||
156673081|NCT01592240|565550601|FG005|Overall Study|Other|0|||
156673082|NCT01592240|565550602|FG006|Overall Study|Other|1|||
156673083|NCT01592240|565550596|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
156431693|NCT01104415|564669547|FG001|Extension Period|Death|1|||
156431694|NCT01104415|564669546|FG000|Extension Period|Physician Decision|0|||
156431695|NCT01104415|564669547|FG001|Extension Period|Physician Decision|1|||
156431696|NCT01104415|564669546|FG000|Extension Period|Transition to Study LX1606.302|0|||
156431697|NCT01104415|564669547|FG001|Extension Period|Transition to Study LX1606.302|4|||
156431698|NCT01104415|564669546|FG000|Extension Period|Heart surgery/feeling miserable|0|||
156431699|NCT01104415|564669547|FG001|Extension Period|Heart surgery/feeling miserable|1|||
156431700|NCT00988637|564669548|FG000|Overall Study|Lost to Follow-up|2|||
156431701|NCT00988637|564669549|FG001|Overall Study|Lost to Follow-up|1|||
156431702|NCT00988637|564669548|FG000|Overall Study|Withdrawal by Subject|1|||
156431703|NCT00988637|564669549|FG001|Overall Study|Withdrawal by Subject|1|||
156431704|NCT00988637|564669548|FG000|Overall Study|non-compliance with study drug|0|||
156431705|NCT00988637|564669549|FG001|Overall Study|non-compliance with study drug|1|||
156431706|NCT01839877|564669552|FG000|Overall Study|Protocol Violation|1|||
156431707|NCT00597519|564669553|FG000|Overall Study|Death|1|||
156431708|NCT03098030|564669554|FG000|Overall Study|Death|10|||
156431709|NCT03098030|564669555|FG001|Overall Study|Death|156|||
156431710|NCT03098030|564669556|FG002|Overall Study|Death|156|||
156431711|NCT03098030|564669557|FG003|Overall Study|Death|82|||
156431712|NCT03098030|564669554|FG000|Overall Study|Withdrawal by Subject|0|||
156431713|NCT03098030|564669555|FG001|Overall Study|Withdrawal by Subject|7|||
156431714|NCT03098030|564669556|FG002|Overall Study|Withdrawal by Subject|8|||
156431715|NCT03098030|564669557|FG003|Overall Study|Withdrawal by Subject|2|||
156431716|NCT03098030|564669554|FG000|Overall Study|Lost to Follow-up|0|||
156673084|NCT01592240|565550597|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
156673085|NCT01592240|565550598|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
156673086|NCT01592240|565550599|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
156673087|NCT01592240|565550600|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
156673088|NCT01592240|565550601|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
156673089|NCT01592240|565550602|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
156673090|NCT01205035|565550603|FG000|Overall Study|Withdrawal by Subject|1|||
156673091|NCT01205035|565550604|FG001|Overall Study|Withdrawal by Subject|0|||
156673092|NCT01205035|565550603|FG000|Overall Study|Physician Decision|1|||
156673093|NCT01205035|565550604|FG001|Overall Study|Physician Decision|0|||
156431717|NCT03098030|564669555|FG001|Overall Study|Lost to Follow-up|0|||
156431718|NCT03098030|564669556|FG002|Overall Study|Lost to Follow-up|2|||
156431719|NCT03098030|564669557|FG003|Overall Study|Lost to Follow-up|1|||
156431720|NCT03612804|564669558|FG000|Overall Study|Death|0|||
156431721|NCT03612804|564669559|FG001|Overall Study|Death|7|||
156431722|NCT03612804|564669560|FG002|Overall Study|Death|0|||
156431723|NCT03612804|564669561|FG003|Overall Study|Death|8|||
156673094|NCT02451696|565550605|FG000|Overall Study|Surgery postponed|1|||
156673095|NCT02451696|565550606|FG001|Overall Study|Surgery postponed|0|||
156673096|NCT01557751|565550607|FG000|Overall Study|Physician Decision|3|||
156673097|NCT04590027|565550608|FG000|Overall Study|Lost to Follow-up|17|||
156673098|NCT04590027|565550609|FG001|Overall Study|Lost to Follow-up|14|||
156527033|NCT05437510|565023716|FG000|Overall Study|Adverse Event|2|||
156527034|NCT05437510|565023717|FG001|Overall Study|Adverse Event|1|||
156527035|NCT05437510|565023716|FG000|Overall Study|Protocol Deviation|1|||
156527036|NCT05437510|565023717|FG001|Overall Study|Protocol Deviation|6|||
156527037|NCT05437510|565023716|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
156527038|NCT05437510|565023717|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
156431724|NCT03612804|564669558|FG000|Overall Study|Medication copay coverage issues|0|||
156431725|NCT03612804|564669559|FG001|Overall Study|Medication copay coverage issues|0|||
156431726|NCT03612804|564669560|FG002|Overall Study|Medication copay coverage issues|0|||
156431727|NCT03612804|564669561|FG003|Overall Study|Medication copay coverage issues|17|||
156431728|NCT03612804|564669558|FG000|Overall Study|Not current smoker at time of screening|0|||
156431729|NCT03612804|564669559|FG001|Overall Study|Not current smoker at time of screening|1|||
156431730|NCT03612804|564669560|FG002|Overall Study|Not current smoker at time of screening|0|||
156431731|NCT03612804|564669561|FG003|Overall Study|Not current smoker at time of screening|3|||
156431732|NCT03612804|564669558|FG000|Overall Study|Non-veteran status|0|||
156431733|NCT03612804|564669559|FG001|Overall Study|Non-veteran status|1|||
156431734|NCT03612804|564669560|FG002|Overall Study|Non-veteran status|0|||
156673099|NCT04590027|565550608|FG000|Overall Study|Protocol Violation|0|||
156673100|NCT04590027|565550609|FG001|Overall Study|Protocol Violation|3|||
156527039|NCT05437510|565023716|FG000|Overall Study|Lost to Follow-up|265|||
156527040|NCT05437510|565023717|FG001|Overall Study|Lost to Follow-up|358|||
156673101|NCT03276754|565550610|FG000|Overall Study|Withdrawal of informed consent|4|||
156673102|NCT03276754|565550610|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
156673103|NCT03276754|565550610|FG000|Overall Study|Lost to Follow-up|27|||
156673104|NCT03276754|565550610|FG000|Overall Study|No data reported at Month 24|31|||
156431735|NCT03612804|564669561|FG003|Overall Study|Non-veteran status|0|||
156431736|NCT03612804|564669558|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
156431737|NCT03612804|564669559|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
156431738|NCT03612804|564669560|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
156431739|NCT03612804|564669561|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
156431740|NCT03612804|564669558|FG000|Overall Study|Provider retired from VA|0|||
156431741|NCT03612804|564669559|FG001|Overall Study|Provider retired from VA|0|||
156431742|NCT03612804|564669560|FG002|Overall Study|Provider retired from VA|2|||
156431743|NCT03612804|564669561|FG003|Overall Study|Provider retired from VA|0|||
156431744|NCT03612804|564669558|FG000|Overall Study|Withdrawal by Subject|0|||
156431745|NCT03612804|564669559|FG001|Overall Study|Withdrawal by Subject|0|||
156431746|NCT03612804|564669560|FG002|Overall Study|Withdrawal by Subject|7|||
156431747|NCT03612804|564669561|FG003|Overall Study|Withdrawal by Subject|0|||
156431748|NCT03612804|564669558|FG000|Overall Study|Provider involved with study activities|1|||
156431749|NCT03612804|564669559|FG001|Overall Study|Provider involved with study activities|0|||
156431750|NCT03612804|564669560|FG002|Overall Study|Provider involved with study activities|0|||
156431751|NCT03612804|564669561|FG003|Overall Study|Provider involved with study activities|0|||
156431752|NCT04391309|564669562|FG000|Overall Study|Death|1|||
156431753|NCT04391309|564669563|FG001|Overall Study|Death|1|||
156431754|NCT04391309|564669562|FG000|Overall Study|Lost to Follow-up|3|||
156431755|NCT04391309|564669563|FG001|Overall Study|Lost to Follow-up|2|||
156431756|NCT04391309|564669562|FG000|Overall Study|Withdrawal by Subject|2|||
156431757|NCT04391309|564669563|FG001|Overall Study|Withdrawal by Subject|2|||
156431758|NCT03396913|564669564|FG000|Overall Study|Lost to Follow-up|0|||
156527041|NCT03573401|565023718|FG000|Overall Study|Withdrawal by Subject|2|||
156673105|NCT03276754|565550610|FG000|Overall Study|Death|39|||
156327483|NCT02448810|564299279|FG004|Overall Study|Other (Progressive disease)|23|||
156327484|NCT02448810|564299280|FG005|Overall Study|Other (Progressive disease)|9|||
156327485|NCT02448810|564299281|FG006|Overall Study|Other (Progressive disease)|14|||
156327486|NCT02448810|564299282|FG007|Overall Study|Other (Progressive disease)|5|||
156327487|NCT02448810|564299275|FG000|Overall Study|Lost to Follow-up|0|||
156327488|NCT02448810|564299276|FG001|Overall Study|Lost to Follow-up|1|||
156327489|NCT02448810|564299277|FG002|Overall Study|Lost to Follow-up|0|||
156327490|NCT02448810|564299278|FG003|Overall Study|Lost to Follow-up|0|||
156327491|NCT02448810|564299279|FG004|Overall Study|Lost to Follow-up|0|||
156327492|NCT02448810|564299280|FG005|Overall Study|Lost to Follow-up|0|||
156327493|NCT02448810|564299281|FG006|Overall Study|Lost to Follow-up|0|||
156327494|NCT02448810|564299282|FG007|Overall Study|Lost to Follow-up|0|||
156327495|NCT02448810|564299275|FG000|Overall Study|Other (unspecified)|0|||
156327496|NCT02448810|564299276|FG001|Overall Study|Other (unspecified)|0|||
156327497|NCT02448810|564299277|FG002|Overall Study|Other (unspecified)|0|||
156327498|NCT02448810|564299278|FG003|Overall Study|Other (unspecified)|0|||
156327499|NCT02448810|564299279|FG004|Overall Study|Other (unspecified)|0|||
156327500|NCT02448810|564299280|FG005|Overall Study|Other (unspecified)|0|||
156327501|NCT02448810|564299281|FG006|Overall Study|Other (unspecified)|2|||
156327502|NCT02448810|564299282|FG007|Overall Study|Other (unspecified)|0|||
156327503|NCT00470847|564299285|FG000|Overall Study|Pt still receiving treatment|1|||
156327504|NCT01610271|564299292|FG000|Overall Study|Surgery not complete|0|||
156327505|NCT01610271|564299293|FG001|Overall Study|Surgery not complete|1|||
156327506|NCT01610271|564299292|FG000|Overall Study|Prosthesis not implanted|2|||
156327507|NCT01610271|564299293|FG001|Overall Study|Prosthesis not implanted|3|||
156327508|NCT01638819|564299294|FG000|Overall Study|Lost to Follow-up|1|||
156327509|NCT01638819|564299295|FG001|Overall Study|Lost to Follow-up|0|||
156327510|NCT00467610|564299300|FG000|Overall Study|Withdrawal by Subject|1|||
156327511|NCT01369615|564299301|FG000|Overall Study|Withdrawal by Subject|0|||
156327512|NCT01369615|564299302|FG001|Overall Study|Withdrawal by Subject|1|||
156327513|NCT01369615|564299301|FG000|Overall Study|Lost to Follow-up|0|||
156327514|NCT01369615|564299302|FG001|Overall Study|Lost to Follow-up|1|||
156327515|NCT04263454|564299303|FG000|Overall Study|Adverse Event|0|||
156327516|NCT04263454|564299304|FG001|Overall Study|Adverse Event|2|||
156327517|NCT04263454|564299303|FG000|Overall Study|Physician Decision|3|||
156327518|NCT04263454|564299304|FG001|Overall Study|Physician Decision|5|||
156327519|NCT04263454|564299303|FG000|Overall Study|Poor Data Quality|0|||
156327520|NCT04263454|564299304|FG001|Overall Study|Poor Data Quality|1|||
156327521|NCT00986479|564299305|FG000|Period 1|Improved mood|1|||
156327522|NCT00986479|564299306|FG001|Period 1|Improved mood|0|||
156327523|NCT00986479|564299305|FG000|Period 1|Administrative reasons|1|||
156327524|NCT00986479|564299306|FG001|Period 1|Administrative reasons|0|||
156327525|NCT01721070|564299307|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
156327526|NCT02035475|564299308|FG000|Overall Study|Withdrawal by Subject|4|||
156327527|NCT02035475|564299308|FG000|Overall Study|Physician Decision|1|||
156327528|NCT02035475|564299308|FG000|Overall Study|Equipment Error|1|||
156327529|NCT01460368|564299309|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156327530|NCT01460368|564299310|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156327531|NCT01460368|564299311|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156327532|NCT01460368|564299312|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156327533|NCT01460368|564299313|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
156327534|NCT01460368|564299314|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156327535|NCT01460368|564299315|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156327536|NCT01460368|564299309|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156673106|NCT04547192|565550611|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
156327537|NCT01460368|564299310|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
156327538|NCT01460368|564299311|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156327539|NCT01460368|564299312|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156327540|NCT01460368|564299313|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156327541|NCT01460368|564299314|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156327542|NCT01460368|564299315|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
156327543|NCT01460368|564299309|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156327544|NCT01460368|564299310|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
156327545|NCT01460368|564299311|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156327546|NCT01460368|564299312|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156327547|NCT01460368|564299313|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156327548|NCT01460368|564299314|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156327549|NCT01460368|564299315|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156327550|NCT01460368|564299309|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156327551|NCT01460368|564299310|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156327552|NCT01460368|564299311|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
156327553|NCT01460368|564299312|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156327554|NCT01460368|564299313|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156327555|NCT01460368|564299314|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156327556|NCT01460368|564299315|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156327557|NCT01460368|564299309|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
156327558|NCT01460368|564299310|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
156327559|NCT01460368|564299311|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
156327560|NCT01460368|564299312|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
156327561|NCT01460368|564299313|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
156327562|NCT01460368|564299314|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
156327563|NCT01460368|564299315|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
156327564|NCT02322021|564299316|FG000|Core Phase|Adverse Event|1|||
156327565|NCT02322021|564299317|FG001|Core Phase|Adverse Event|3|||
156327566|NCT02322021|564299318|FG002|Core Phase|Adverse Event|4|||
156327567|NCT02322021|564299319|FG003|Core Phase|Adverse Event|2|||
156327568|NCT02322021|564299320|FG004|Core Phase|Adverse Event|0|||
156327569|NCT02322021|564299316|FG000|Core Phase|Participant Choice|4|||
156327570|NCT02322021|564299317|FG001|Core Phase|Participant Choice|5|||
156327571|NCT02322021|564299318|FG002|Core Phase|Participant Choice|4|||
156327572|NCT02322021|564299319|FG003|Core Phase|Participant Choice|2|||
156327573|NCT02322021|564299320|FG004|Core Phase|Participant Choice|0|||
156327574|NCT02322021|564299316|FG000|Core Phase|Lost to Follow-up|0|||
156327575|NCT02322021|564299317|FG001|Core Phase|Lost to Follow-up|0|||
156327576|NCT02322021|564299318|FG002|Core Phase|Lost to Follow-up|0|||
156327577|NCT02322021|564299319|FG003|Core Phase|Lost to Follow-up|1|||
156327578|NCT02322021|564299320|FG004|Core Phase|Lost to Follow-up|0|||
156327579|NCT02322021|564299316|FG000|Core Phase|Other|0|||
156327580|NCT02322021|564299317|FG001|Core Phase|Other|0|||
156327581|NCT02322021|564299318|FG002|Core Phase|Other|1|||
156327582|NCT02322021|564299319|FG003|Core Phase|Other|0|||
156327583|NCT02322021|564299320|FG004|Core Phase|Other|0|||
156327584|NCT02322021|564299316|FG000|Extension Phase|Adverse Event|0|||
156327585|NCT02322021|564299317|FG001|Extension Phase|Adverse Event|0|||
156327586|NCT02322021|564299318|FG002|Extension Phase|Adverse Event|0|||
156327587|NCT02322021|564299319|FG003|Extension Phase|Adverse Event|0|||
156327588|NCT02322021|564299320|FG004|Extension Phase|Adverse Event|3|||
156327589|NCT02322021|564299316|FG000|Extension Phase|Participant Choice|0|||
156327590|NCT02322021|564299317|FG001|Extension Phase|Participant Choice|0|||
156327591|NCT02322021|564299318|FG002|Extension Phase|Participant Choice|0|||
156327592|NCT02322021|564299319|FG003|Extension Phase|Participant Choice|0|||
156327593|NCT02322021|564299320|FG004|Extension Phase|Participant Choice|6|||
156327594|NCT02322021|564299316|FG000|Extension Phase|Other|0|||
156327595|NCT02322021|564299317|FG001|Extension Phase|Other|0|||
156327596|NCT02322021|564299318|FG002|Extension Phase|Other|0|||
156327597|NCT02322021|564299319|FG003|Extension Phase|Other|0|||
156327598|NCT02322021|564299320|FG004|Extension Phase|Other|3|||
156327599|NCT02322021|564299316|FG000|Extension Phase|Lost to Follow-up|0|||
156327600|NCT02322021|564299317|FG001|Extension Phase|Lost to Follow-up|0|||
156327601|NCT02322021|564299318|FG002|Extension Phase|Lost to Follow-up|0|||
156327602|NCT02322021|564299319|FG003|Extension Phase|Lost to Follow-up|0|||
156327603|NCT02322021|564299320|FG004|Extension Phase|Lost to Follow-up|1|||
156327604|NCT02322021|564299316|FG000|Extension Phase|Study terminated by sponsor|0|||
156327605|NCT02322021|564299317|FG001|Extension Phase|Study terminated by sponsor|0|||
156673107|NCT04547192|565550612|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
156673108|NCT04547192|565550613|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
156673109|NCT04547192|565550614|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
156673110|NCT04547192|565550611|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
156431759|NCT03396913|564669565|FG001|Overall Study|Lost to Follow-up|6|||
156431760|NCT02781584|564669566|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
156431761|NCT02781584|564669567|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
156431762|NCT02781584|564669568|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
156431763|NCT02781584|564669569|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
156431764|NCT02781584|564669570|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
156431765|NCT02781584|564669571|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
156431766|NCT02781584|564669572|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
156431767|NCT02781584|564669573|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
156431768|NCT02781584|564669574|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
156431769|NCT02781584|564669575|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
156431770|NCT02781584|564669576|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
156431771|NCT02781584|564669577|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
156431772|NCT02781584|564669578|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
156431773|NCT02781584|564669566|FG000|Pre-treatment Phase|Adverse Event|0|||
156431774|NCT02781584|564669567|FG001|Pre-treatment Phase|Adverse Event|0|||
156431775|NCT02781584|564669568|FG002|Pre-treatment Phase|Adverse Event|0|||
156431776|NCT02781584|564669569|FG003|Pre-treatment Phase|Adverse Event|0|||
156431777|NCT02781584|564669570|FG004|Pre-treatment Phase|Adverse Event|0|||
156527042|NCT03573401|565023719|FG001|Overall Study|Withdrawal by Subject|0|||
156527043|NCT03573401|565023718|FG000|Overall Study|Subject non-compliance with study schedule|1|||
156527044|NCT03573401|565023719|FG001|Overall Study|Subject non-compliance with study schedule|0|||
156527045|NCT03573401|565023718|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
156527046|NCT03573401|565023719|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
156527047|NCT03573401|565023718|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
156527048|NCT03573401|565023719|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
156527049|NCT01195545|565025201|FG000|Overall Study|Protocol Violation|4|||
156527050|NCT02425644|565025203|FG000|Overall Study|Lost to Follow-up|2|||
156527051|NCT02425644|565025204|FG001|Overall Study|Lost to Follow-up|3|||
156527052|NCT02425644|565025203|FG000|Overall Study|Withdrawal by Subject|41|||
156527053|NCT02425644|565025204|FG001|Overall Study|Withdrawal by Subject|36|||
156527054|NCT02425644|565025203|FG000|Overall Study|Lack of Efficacy|3|||
156527055|NCT02425644|565025204|FG001|Overall Study|Lack of Efficacy|10|||
156527056|NCT02425644|565025203|FG000|Overall Study|Adverse Event|13|||
156527057|NCT02425644|565025204|FG001|Overall Study|Adverse Event|3|||
156527058|NCT02425644|565025203|FG000|Overall Study|Death|0|||
156527059|NCT02425644|565025204|FG001|Overall Study|Death|2|||
156527060|NCT02425644|565025203|FG000|Overall Study|Other|18|||
156527061|NCT02425644|565025204|FG001|Overall Study|Other|17|||
156527062|NCT00300781|565025205|FG000|Overall Study|Disease Progression|55|||
156527063|NCT00300781|565025206|FG001|Overall Study|Disease Progression|52|||
156527064|NCT00300781|565025205|FG000|Overall Study|Adverse Event|5|||
156527065|NCT00300781|565025206|FG001|Overall Study|Adverse Event|6|||
156527066|NCT00300781|565025205|FG000|Overall Study|Withdrawal by Subject|1|||
156527067|NCT00300781|565025206|FG001|Overall Study|Withdrawal by Subject|2|||
156527068|NCT00300781|565025205|FG000|Overall Study|Physician Decision|1|||
156527069|NCT00300781|565025206|FG001|Overall Study|Physician Decision|0|||
156527070|NCT00300781|565025205|FG000|Overall Study|Not Recorded|0|||
156527071|NCT00300781|565025206|FG001|Overall Study|Not Recorded|1|||
156527072|NCT00300781|565025205|FG000|Overall Study|Symptomatic Deterioration|1|||
156527073|NCT00300781|565025206|FG001|Overall Study|Symptomatic Deterioration|0|||
156527074|NCT00300781|565025205|FG000|Overall Study|Lost to Follow-up|0|||
156527075|NCT00300781|565025206|FG001|Overall Study|Lost to Follow-up|1|||
156527076|NCT00792805|565025207|FG000|Overall Study|Adverse Event|12|||
156527077|NCT00792805|565025208|FG001|Overall Study|Adverse Event|10|||
156527078|NCT00792805|565025209|FG002|Overall Study|Adverse Event|10|||
156527079|NCT00792805|565025207|FG000|Overall Study|Subject withdrew consent|5|||
156527080|NCT00792805|565025208|FG001|Overall Study|Subject withdrew consent|6|||
156527081|NCT00792805|565025209|FG002|Overall Study|Subject withdrew consent|5|||
156527082|NCT00792805|565025207|FG000|Overall Study|Administrative problems|2|||
156527083|NCT00792805|565025208|FG001|Overall Study|Administrative problems|0|||
156527084|NCT00792805|565025209|FG002|Overall Study|Administrative problems|4|||
156527085|NCT00792805|565025207|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156527086|NCT00792805|565025208|FG001|Overall Study|Abnormal test procedure result(s)|2|||
156527087|NCT00792805|565025209|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156527088|NCT00792805|565025207|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156527089|NCT00792805|565025208|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156527090|NCT00792805|565025209|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
156527091|NCT00792805|565025207|FG000|Overall Study|Lost to Follow-up|1|||
156527092|NCT00792805|565025208|FG001|Overall Study|Lost to Follow-up|1|||
156527093|NCT00792805|565025209|FG002|Overall Study|Lost to Follow-up|6|||
156527094|NCT00792805|565025207|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156527095|NCT00792805|565025208|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156673111|NCT04547192|565550612|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
156673112|NCT04547192|565550613|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
156431778|NCT02781584|564669571|FG005|Pre-treatment Phase|Adverse Event|0|||
156431779|NCT02781584|564669572|FG006|Pre-treatment Phase|Adverse Event|0|||
156431780|NCT02781584|564669573|FG007|Pre-treatment Phase|Adverse Event|0|||
156431781|NCT02781584|564669574|FG008|Pre-treatment Phase|Adverse Event|0|||
156431782|NCT02781584|564669575|FG009|Pre-treatment Phase|Adverse Event|0|||
156431783|NCT02781584|564669576|FG010|Pre-treatment Phase|Adverse Event|0|||
156431784|NCT02781584|564669577|FG011|Pre-treatment Phase|Adverse Event|1|||
156431785|NCT02781584|564669578|FG012|Pre-treatment Phase|Adverse Event|0|||
156431786|NCT02781584|564669566|FG000|Treatment Phase|Withdrew Consent|0|||
156431787|NCT02781584|564669567|FG001|Treatment Phase|Withdrew Consent|0|||
156431788|NCT02781584|564669568|FG002|Treatment Phase|Withdrew Consent|0|||
156431789|NCT02781584|564669569|FG003|Treatment Phase|Withdrew Consent|0|||
156431790|NCT02781584|564669570|FG004|Treatment Phase|Withdrew Consent|0|||
156431791|NCT02781584|564669571|FG005|Treatment Phase|Withdrew Consent|1|||
156431792|NCT02781584|564669572|FG006|Treatment Phase|Withdrew Consent|0|||
156431793|NCT02781584|564669573|FG007|Treatment Phase|Withdrew Consent|0|||
156431794|NCT02781584|564669574|FG008|Treatment Phase|Withdrew Consent|0|||
156431795|NCT02781584|564669575|FG009|Treatment Phase|Withdrew Consent|0|||
156431796|NCT02781584|564669576|FG010|Treatment Phase|Withdrew Consent|1|||
156431797|NCT02781584|564669577|FG011|Treatment Phase|Withdrew Consent|2|||
156431798|NCT02781584|564669578|FG012|Treatment Phase|Withdrew Consent|0|||
156431799|NCT02781584|564669566|FG000|Treatment Phase|Adverse Event|0|||
156431800|NCT02781584|564669567|FG001|Treatment Phase|Adverse Event|0|||
156431801|NCT02781584|564669568|FG002|Treatment Phase|Adverse Event|0|||
156431802|NCT02781584|564669569|FG003|Treatment Phase|Adverse Event|0|||
156431803|NCT02781584|564669570|FG004|Treatment Phase|Adverse Event|0|||
156431804|NCT02781584|564669571|FG005|Treatment Phase|Adverse Event|0|||
156431805|NCT02781584|564669572|FG006|Treatment Phase|Adverse Event|0|||
156431806|NCT02781584|564669573|FG007|Treatment Phase|Adverse Event|1|||
156431807|NCT02781584|564669574|FG008|Treatment Phase|Adverse Event|0|||
156431808|NCT02781584|564669575|FG009|Treatment Phase|Adverse Event|0|||
156431809|NCT02781584|564669576|FG010|Treatment Phase|Adverse Event|0|||
156431810|NCT02781584|564669577|FG011|Treatment Phase|Adverse Event|0|||
156431811|NCT02781584|564669578|FG012|Treatment Phase|Adverse Event|0|||
156431812|NCT05826431|564669579|FG000|Overall Study|Withdrawal by Subject|1|||
156431813|NCT00768651|564669582|FG000|Overall Study|Withdrawal by Subject|1|||
156431814|NCT02357784|564669586|FG000|Overall Study|Withdrawal by Subject|1|||
156431815|NCT02698241|564669591|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
156431816|NCT02698241|564669591|FG000|Overall Study|Screening not met|7|||
156431817|NCT02698241|564669591|FG000|Overall Study|Withdrawal by Subject|7|||
156431818|NCT02698241|564669591|FG000|Overall Study|Physician Decision|2|||
156431819|NCT02698241|564669591|FG000|Overall Study|Subject underwent system modification|2|||
156431820|NCT02698241|564669591|FG000|Overall Study|Lost to Follow-up|3|||
156431821|NCT02698241|564669591|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
156431822|NCT02698241|564669591|FG000|Overall Study|geographic and licensing issue|1|||
156431823|NCT02698241|564669591|FG000|Overall Study|Death|2|||
156431824|NCT01543685|564669594|FG000|Overall Study|Lack of Efficacy|1|||
156431825|NCT01543685|564669595|FG001|Overall Study|Lack of Efficacy|2|||
156431826|NCT01543685|564669596|FG002|Overall Study|Lack of Efficacy|2|||
156431827|NCT01543685|564669597|FG003|Overall Study|Lack of Efficacy|0|||
156431828|NCT01543685|564669598|FG004|Overall Study|Lack of Efficacy|2|||
156431829|NCT01543685|564669594|FG000|Overall Study|Adverse Event|2|||
156431830|NCT01543685|564669595|FG001|Overall Study|Adverse Event|1|||
156431831|NCT01543685|564669596|FG002|Overall Study|Adverse Event|0|||
156431832|NCT01543685|564669597|FG003|Overall Study|Adverse Event|0|||
156431833|NCT01543685|564669598|FG004|Overall Study|Adverse Event|2|||
156431834|NCT04776213|564669599|FG000|Overall Study|Other|1|||
156527096|NCT00792805|565025209|FG002|Overall Study|Abnormal laboratory value(s)|1|||
156431835|NCT04776213|564669599|FG000|Overall Study|Withdrawal by Subject|7|||
156431836|NCT04776213|564669599|FG000|Overall Study|Protocol Violation|1|||
156431837|NCT04776213|564669599|FG000|Overall Study|Lost to Follow-up|2|||
156431838|NCT02908464|564669600|FG000|Overall Study|Withdrawal by Subject|2|||
156527097|NCT00792805|565025207|FG000|Overall Study|Protocol deviation|0|||
156527098|NCT00792805|565025208|FG001|Overall Study|Protocol deviation|1|||
156527099|NCT00792805|565025209|FG002|Overall Study|Protocol deviation|1|||
156527100|NCT02072434|565025213|FG000|Overall Study|Protocol Violation|10|||
156527101|NCT02072434|565025214|FG001|Overall Study|Protocol Violation|9|||
156527102|NCT02072434|565025213|FG000|Overall Study|Physician Decision|5|||
156527103|NCT02072434|565025214|FG001|Overall Study|Physician Decision|10|||
156431839|NCT02908464|564669601|FG001|Overall Study|Withdrawal by Subject|1|||
156527104|NCT02072434|565025213|FG000|Overall Study|Adverse event, serious fatal|1|||
156527105|NCT02072434|565025214|FG001|Overall Study|Adverse event, serious fatal|6|||
156527106|NCT02072434|565025213|FG000|Overall Study|Adverse Event|7|||
156431840|NCT02908464|564669600|FG000|Overall Study|Found ineligible after randomization|0|||
156431841|NCT02908464|564669601|FG001|Overall Study|Found ineligible after randomization|2|||
156431842|NCT02317016|564669607|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
156431843|NCT02317016|564669607|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
156431844|NCT02317016|564669607|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
156527107|NCT02072434|565025214|FG001|Overall Study|Adverse Event|6|||
156431845|NCT02317016|564669607|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
156431846|NCT02317016|564669607|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
156431847|NCT02317016|564669607|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
156431848|NCT02317016|564669607|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
156431849|NCT01981356|564669608|FG000|Overall Study|Lost to Follow-up|4|||
156431850|NCT01981356|564669609|FG001|Overall Study|Lost to Follow-up|1|||
156431851|NCT01981356|564669608|FG000|Overall Study|Withdrawal by Subject|1|||
156431852|NCT01981356|564669609|FG001|Overall Study|Withdrawal by Subject|1|||
156431853|NCT01981356|564669608|FG000|Overall Study|Protocol Violation|2|||
156431854|NCT01981356|564669609|FG001|Overall Study|Protocol Violation|0|||
156431855|NCT02465359|564669612|FG000|Overall Study|Lack of Efficacy|1|||
156431856|NCT02465359|564669612|FG000|Overall Study|Withdrawal by Subject|1|||
156431857|NCT02465359|564669612|FG000|Overall Study|Adverse Event|1|||
156431858|NCT01278862|564669613|FG000|Overall Study|Lost to Follow-up|1|||
156431859|NCT01278862|564669614|FG001|Overall Study|Lost to Follow-up|1|||
156431860|NCT02952261|564669615|FG000|Overall Study|Withdrawal by Subject|4|||
156431861|NCT02952261|564669616|FG001|Overall Study|Withdrawal by Subject|5|||
156431862|NCT02952261|564669615|FG000|Overall Study|Protocol Violation|1|||
156431863|NCT02952261|564669616|FG001|Overall Study|Protocol Violation|0|||
156431864|NCT00798265|564669617|FG000|Overall Study|Lost to Follow-up|1|||
156431865|NCT00798265|564669618|FG001|Overall Study|Lost to Follow-up|10|||
156431866|NCT00798265|564669617|FG000|Overall Study|Study closing|7|||
156431867|NCT00798265|564669618|FG001|Overall Study|Study closing|6|||
156431868|NCT00798265|564669617|FG000|Overall Study|Withdrawal by Subject|0|||
156431869|NCT00798265|564669618|FG001|Overall Study|Withdrawal by Subject|1|||
156431870|NCT00798265|564669617|FG000|Overall Study|Screen failure|0|||
156431871|NCT00798265|564669618|FG001|Overall Study|Screen failure|1|||
156431872|NCT03141788|564669619|FG000|Overall Study|Lost to Follow-up|1|||
156431873|NCT03141788|564669619|FG000|Overall Study|Protocol Violation|3|||
156431874|NCT03141788|564669619|FG000|Overall Study|Withdrawal by Subject|4|||
156431875|NCT00589667|564670980|FG000|Overall Study|Adverse Event|2|||
156431876|NCT00589667|564670980|FG000|Overall Study|Withdrawal by Subject|1|||
156431877|NCT00357396|564670987|FG000|Overall Study|Adverse Event|1|||
156431878|NCT00357396|564670988|FG001|Overall Study|Adverse Event|0|||
156431879|NCT00487578|564670989|FG000|Overall Study|Adverse Event|1|||
156431880|NCT00487578|564670990|FG001|Overall Study|Adverse Event|2|||
156431881|NCT00487578|564670989|FG000|Overall Study|Lack of Efficacy|0|||
156431882|NCT00487578|564670990|FG001|Overall Study|Lack of Efficacy|1|||
156431883|NCT00487578|564670989|FG000|Overall Study|Lost to Follow-up|0|||
156431884|NCT00487578|564670990|FG001|Overall Study|Lost to Follow-up|1|||
156431885|NCT00726999|564670991|FG000|Overall Study|Physician Decision|0|||
156431886|NCT00726999|564670992|FG001|Overall Study|Physician Decision|1|||
156431887|NCT00726999|564670991|FG000|Overall Study|Withdrawal by Subject|2|||
156431888|NCT00726999|564670992|FG001|Overall Study|Withdrawal by Subject|0|||
156431889|NCT00726999|564670991|FG000|Overall Study|Protocol Violation|1|||
156431890|NCT00726999|564670992|FG001|Overall Study|Protocol Violation|0|||
156527108|NCT02072434|565025213|FG000|Overall Study|Withdrawal by Subject|17|||
156527109|NCT02072434|565025214|FG001|Overall Study|Withdrawal by Subject|29|||
156527110|NCT02072434|565025213|FG000|Overall Study|Other|14|||
156527111|NCT02072434|565025214|FG001|Overall Study|Other|29|||
156527112|NCT02072434|565025213|FG000|Overall Study|Lost to Follow-up|0|||
156527113|NCT02072434|565025214|FG001|Overall Study|Lost to Follow-up|1|||
156527114|NCT02525861|565025217|FG000|Overall Study|Adverse Event|1|||
156527115|NCT02525861|565025218|FG001|Overall Study|Adverse Event|0|||
156527116|NCT02525861|565025217|FG000|Overall Study|Withdrawal by Subject|0|||
156527117|NCT02525861|565025218|FG001|Overall Study|Withdrawal by Subject|1|||
156527118|NCT02525861|565025217|FG000|Overall Study|Physician Decision|0|||
156527119|NCT02525861|565025218|FG001|Overall Study|Physician Decision|1|||
156527120|NCT00888433|565025219|FG000|Overall Study|Withdrawal by Subject|1|||
156527121|NCT00888433|565025220|FG001|Overall Study|Withdrawal by Subject|2|||
156527122|NCT00888433|565025219|FG000|Overall Study|Missed Visit|2|||
156527123|NCT00888433|565025220|FG001|Overall Study|Missed Visit|1|||
156527124|NCT00402363|565025221|FG000|Overall Study|Adverse Event|9|||
156431891|NCT02810080|564670994|FG000|Overall Study|Adverse Event|3|||
156431892|NCT02810080|564670995|FG001|Overall Study|Adverse Event|0|||
156431893|NCT02810080|564670994|FG000|Overall Study|Death|0|||
156431894|NCT02810080|564670995|FG001|Overall Study|Death|2|||
156431895|NCT02810080|564670994|FG000|Overall Study|Physician Decision|4|||
156431896|NCT02810080|564670995|FG001|Overall Study|Physician Decision|0|||
156431897|NCT02810080|564670994|FG000|Overall Study|Withdrawal by Subject|0|||
156431898|NCT02810080|564670995|FG001|Overall Study|Withdrawal by Subject|2|||
156431899|NCT02614560|564670999|FG000|Overall Study|Death|6|||
156431900|NCT02614560|564671000|FG001|Overall Study|Death|2|||
156431901|NCT02192606|564671001|FG000|Overall Study|surgery type was changed|1|||
156431902|NCT02192606|564671002|FG001|Overall Study|surgery type was changed|1|||
156527125|NCT00402363|565025222|FG001|Overall Study|Adverse Event|14|||
156527126|NCT00402363|565025223|FG002|Overall Study|Adverse Event|2|||
156527127|NCT00402363|565025224|FG003|Overall Study|Adverse Event|2|||
156431903|NCT02192606|564671001|FG000|Overall Study|Physician Decision|1|||
156431904|NCT02192606|564671002|FG001|Overall Study|Physician Decision|2|||
156431905|NCT02192606|564671001|FG000|Overall Study|3D equipment rep unable to join|0|||
156431906|NCT02192606|564671002|FG001|Overall Study|3D equipment rep unable to join|1|||
156431907|NCT00738699|564671003|FG000|Overall Study|Withdrawal by Subject|5|||
156431908|NCT00738699|564671004|FG001|Overall Study|Withdrawal by Subject|0|||
156431909|NCT00738699|564671003|FG000|Overall Study|Lost to Follow-up|1|||
156431910|NCT00738699|564671004|FG001|Overall Study|Lost to Follow-up|0|||
156431911|NCT00738699|564671003|FG000|Overall Study|Death|144|||
156431912|NCT00738699|564671004|FG001|Overall Study|Death|68|||
156431913|NCT00738699|564671003|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
156431914|NCT00738699|564671004|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
156431915|NCT00738699|564671003|FG000|Overall Study|Other|2|||
156431916|NCT00738699|564671004|FG001|Overall Study|Other|0|||
156431917|NCT05174013|564671005|FG000|Overall Study|Lost to Follow-up|0|||
156431918|NCT05174013|564671006|FG001|Overall Study|Lost to Follow-up|0|||
156431919|NCT05174013|564671007|FG002|Overall Study|Lost to Follow-up|0|||
156431920|NCT05174013|564671008|FG003|Overall Study|Lost to Follow-up|1|||
156431921|NCT05174013|564671009|FG004|Overall Study|Lost to Follow-up|0|||
156431922|NCT05174013|564671010|FG005|Overall Study|Lost to Follow-up|0|||
156431923|NCT05174013|564671005|FG000|Overall Study|Withdrawal by Subject|0|||
156431924|NCT05174013|564671006|FG001|Overall Study|Withdrawal by Subject|0|||
156431925|NCT05174013|564671007|FG002|Overall Study|Withdrawal by Subject|1|||
156431926|NCT05174013|564671008|FG003|Overall Study|Withdrawal by Subject|0|||
156431927|NCT05174013|564671009|FG004|Overall Study|Withdrawal by Subject|0|||
156431928|NCT05174013|564671010|FG005|Overall Study|Withdrawal by Subject|0|||
156431929|NCT00753012|564671014|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
156431930|NCT00753012|564671015|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
156431931|NCT00753012|564671014|FG000|Overall Study|Adverse Event|2|||
156431932|NCT00753012|564671015|FG001|Overall Study|Adverse Event|0|||
156431933|NCT00753012|564671014|FG000|Overall Study|Withdrawal by Subject|0|||
156431934|NCT00753012|564671015|FG001|Overall Study|Withdrawal by Subject|1|||
156431935|NCT00753012|564671014|FG000|Overall Study|Lost to Follow-up|4|||
156431936|NCT00753012|564671015|FG001|Overall Study|Lost to Follow-up|0|||
156431937|NCT00753012|564671014|FG000|Overall Study|Confounded endpoint data|1|||
156431938|NCT00753012|564671015|FG001|Overall Study|Confounded endpoint data|0|||
156431939|NCT00864682|564671016|FG000|Overall Study|Protocol Violation|2|||
156431940|NCT00864682|564671017|FG001|Overall Study|Protocol Violation|1|||
156431941|NCT00864682|564671018|FG002|Overall Study|Protocol Violation|2|||
156431942|NCT00094809|564671020|FG000|Overall Study|Protocol deviation|2|||
156431943|NCT00094809|564671021|FG001|Overall Study|Protocol deviation|2|||
156431944|NCT00094809|564671020|FG000|Overall Study|Noncompliance|1|||
156431945|NCT00094809|564671021|FG001|Overall Study|Noncompliance|0|||
156431946|NCT00094809|564671020|FG000|Overall Study|Adverse Event|3|||
156431947|NCT00094809|564671021|FG001|Overall Study|Adverse Event|1|||
156431948|NCT00094809|564671020|FG000|Overall Study|Withdrawal by Subject|8|||
156431949|NCT00094809|564671021|FG001|Overall Study|Withdrawal by Subject|9|||
156431950|NCT00094809|564671020|FG000|Overall Study|Disease progression|3|||
156431951|NCT00094809|564671021|FG001|Overall Study|Disease progression|3|||
156431952|NCT00094809|564671020|FG000|Overall Study|Physician Decision|3|||
156431953|NCT00094809|564671021|FG001|Overall Study|Physician Decision|5|||
156431954|NCT00094809|564671020|FG000|Overall Study|Lost to Follow-up|6|||
156431955|NCT00094809|564671021|FG001|Overall Study|Lost to Follow-up|6|||
156431956|NCT00094809|564671020|FG000|Overall Study|Death|19|||
156431957|NCT00094809|564671021|FG001|Overall Study|Death|25|||
156431958|NCT00094809|564671020|FG000|Overall Study|Protocol-specified criteria|1|||
156431959|NCT00094809|564671021|FG001|Overall Study|Protocol-specified criteria|1|||
156431960|NCT00094809|564671020|FG000|Overall Study|Other|2|||
156431961|NCT00094809|564671021|FG001|Overall Study|Other|4|||
156431962|NCT00094809|564671020|FG000|Overall Study|Informed consent signed after treatment|1|||
156431963|NCT00094809|564671021|FG001|Overall Study|Informed consent signed after treatment|0|||
156431964|NCT00094809|564671020|FG000|Overall Study|Study drug not received|2|||
156673113|NCT04547192|565550614|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
156673114|NCT04547192|565550611|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
156673115|NCT04547192|565550612|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
156673116|NCT04547192|565550613|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
156673117|NCT04547192|565550614|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
156673118|NCT04547192|565550611|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
156673119|NCT04547192|565550612|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
156673120|NCT04547192|565550613|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
156527128|NCT00402363|565025221|FG000|Overall Study|Withdrew Consent|10|||
156431965|NCT00094809|564671021|FG001|Overall Study|Study drug not received|8|||
156431966|NCT00094809|564671020|FG000|Overall Study|Other|1|||
156431967|NCT00094809|564671021|FG001|Overall Study|Other|1|||
156431968|NCT04889664|564671022|FG000|Screen|Lost to Follow-up|1|||
156673121|NCT04547192|565550614|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
156431969|NCT04889664|564671022|FG000|Screen|Failed to meet screening criteria|1|||
156431970|NCT04889664|564671022|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
156673122|NCT04547192|565550611|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
156673123|NCT04547192|565550612|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
156673124|NCT04547192|565550613|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
156673125|NCT04547192|565550614|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
156673126|NCT01484912|565550615|FG000|Overall Study|Withdrawal by Subject|1|||
156673127|NCT01484912|565550616|FG001|Overall Study|Withdrawal by Subject|0|||
156673128|NCT01484912|565550615|FG000|Overall Study|Physician Decision|0|||
156673129|NCT01484912|565550616|FG001|Overall Study|Physician Decision|1|||
156673130|NCT00829712|565550617|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
156673131|NCT00829712|565550618|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
156673132|NCT01188681|565550619|FG000|Overall Study|bladder cancer|0|||
156673133|NCT01188681|565550620|FG001|Overall Study|bladder cancer|0|||
156673134|NCT01188681|565550621|FG002|Overall Study|bladder cancer|1|||
156673135|NCT01188681|565550622|FG003|Overall Study|bladder cancer|0|||
156673136|NCT01188681|565550619|FG000|Overall Study|Withdrawal by Subject|0|||
156673137|NCT01188681|565550620|FG001|Overall Study|Withdrawal by Subject|0|||
156673138|NCT01188681|565550621|FG002|Overall Study|Withdrawal by Subject|0|||
156673139|NCT01188681|565550622|FG003|Overall Study|Withdrawal by Subject|1|||
156673140|NCT04345653|565550624|FG000|Overall Study|Withdrawal by Subject|2|||
156673141|NCT00418938|565550625|FG000|Overall Study|Reimbursement|1|||
156673142|NCT00418938|565550626|FG001|Overall Study|Reimbursement|0|||
156673143|NCT00418938|565550625|FG000|Overall Study|Administrative decision|3|||
156327606|NCT02322021|564299318|FG002|Extension Phase|Study terminated by sponsor|0|||
156327607|NCT02322021|564299319|FG003|Extension Phase|Study terminated by sponsor|0|||
156327608|NCT02322021|564299320|FG004|Extension Phase|Study terminated by sponsor|28|||
156327609|NCT02047227|564299321|FG000|Overall Study|Adverse Event|2|||
156327610|NCT02047227|564299322|FG001|Overall Study|Adverse Event|4|||
156327611|NCT02047227|564299321|FG000|Overall Study|Lost to Follow-up|0|||
156673144|NCT00418938|565550626|FG001|Overall Study|Administrative decision|3|||
156673145|NCT00418938|565550625|FG000|Overall Study|Withdrawal by Subject|16|||
156327612|NCT02047227|564299322|FG001|Overall Study|Lost to Follow-up|3|||
156327613|NCT02047227|564299321|FG000|Overall Study|Protocol Violation|1|||
156327614|NCT02047227|564299322|FG001|Overall Study|Protocol Violation|0|||
156327615|NCT02047227|564299321|FG000|Overall Study|Spontaneous pregnancy|1|||
156327616|NCT02047227|564299322|FG001|Overall Study|Spontaneous pregnancy|0|||
156327617|NCT02047227|564299321|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
156327618|NCT02047227|564299322|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
156327619|NCT02047227|564299321|FG000|Overall Study|No oocytes retrieved|21|||
156327620|NCT02047227|564299322|FG001|Overall Study|No oocytes retrieved|20|||
156327621|NCT02047227|564299321|FG000|Overall Study|No fertilization|61|||
156327622|NCT02047227|564299322|FG001|Overall Study|No fertilization|51|||
156327623|NCT02047227|564299321|FG000|Overall Study|Intention to freeze all embryos|1|||
156327624|NCT02047227|564299322|FG001|Overall Study|Intention to freeze all embryos|0|||
156327625|NCT02047227|564299321|FG000|Overall Study|All embryos discarded|12|||
156327626|NCT02047227|564299322|FG001|Overall Study|All embryos discarded|11|||
156327627|NCT02047227|564299321|FG000|Overall Study|Other|10|||
156327628|NCT02047227|564299322|FG001|Overall Study|Other|9|||
156327629|NCT01385371|564299329|FG000|Overall Study|Adverse Event|54|||
156327630|NCT01385371|564299330|FG001|Overall Study|Adverse Event|19|||
156327631|NCT01385371|564299329|FG000|Overall Study|Lost to Follow-up|16|||
156327632|NCT01385371|564299330|FG001|Overall Study|Lost to Follow-up|16|||
156327633|NCT01385371|564299329|FG000|Overall Study|Withdrawal by Subject|52|||
156327634|NCT01385371|564299330|FG001|Overall Study|Withdrawal by Subject|39|||
156327635|NCT01385371|564299329|FG000|Overall Study|Protocol Violation|25|||
156327636|NCT01385371|564299330|FG001|Overall Study|Protocol Violation|21|||
156673146|NCT00418938|565550626|FG001|Overall Study|Withdrawal by Subject|15|||
156673147|NCT00418938|565550625|FG000|Overall Study|Lost to Follow-up|1|||
156673148|NCT00418938|565550626|FG001|Overall Study|Lost to Follow-up|3|||
156673149|NCT00418938|565550625|FG000|Overall Study|Adverse Event|1|||
156673150|NCT00418938|565550626|FG001|Overall Study|Adverse Event|1|||
156673151|NCT00418938|565550625|FG000|Overall Study|On-going|1|||
156673152|NCT00418938|565550626|FG001|Overall Study|On-going|1|||
156673153|NCT00418938|565550625|FG000|Overall Study|Ineligibility Determined|1|||
156673154|NCT00418938|565550626|FG001|Overall Study|Ineligibility Determined|0|||
156673155|NCT00205777|565550627|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
156673156|NCT00205777|565550628|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
156327637|NCT01385371|564299329|FG000|Overall Study|Administrative|2|||
156327638|NCT01385371|564299330|FG001|Overall Study|Administrative|2|||
156327639|NCT02001181|564299333|FG000|Overall Study|Adverse Event|0|||
156327640|NCT02001181|564299334|FG001|Overall Study|Adverse Event|2|||
156327641|NCT02001181|564299333|FG000|Overall Study|Lost to Follow-up|1|||
156673157|NCT00205777|565550629|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
156673158|NCT00205777|565550630|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
156673159|NCT00205777|565550631|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
156673160|NCT00205777|565550632|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
156673161|NCT00205777|565550627|FG000|Core Study (Up to 3 Years)|Death|9|||
156673162|NCT00205777|565550628|FG001|Core Study (Up to 3 Years)|Death|7|||
156673163|NCT00205777|565550629|FG002|Core Study (Up to 3 Years)|Death|14|||
156673164|NCT00205777|565550630|FG003|Core Study (Up to 3 Years)|Death|7|||
156673165|NCT00205777|565550631|FG004|Core Study (Up to 3 Years)|Death|0|||
156673166|NCT00205777|565550632|FG005|Core Study (Up to 3 Years)|Death|0|||
156673167|NCT00205777|565550627|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
156673168|NCT00205777|565550628|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
156673169|NCT00205777|565550629|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
156673170|NCT00205777|565550630|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
156673171|NCT00205777|565550631|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
156673172|NCT00205777|565550632|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
156673173|NCT00205777|565550627|FG000|Core Study (Up to 3 Years)|Other Event|49|||
156673174|NCT00205777|565550628|FG001|Core Study (Up to 3 Years)|Other Event|52|||
156673175|NCT00205777|565550629|FG002|Core Study (Up to 3 Years)|Other Event|41|||
156673176|NCT00205777|565550630|FG003|Core Study (Up to 3 Years)|Other Event|58|||
156673177|NCT00205777|565550631|FG004|Core Study (Up to 3 Years)|Other Event|0|||
156673178|NCT00205777|565550632|FG005|Core Study (Up to 3 Years)|Other Event|0|||
156673179|NCT00205777|565550627|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
156673180|NCT00205777|565550628|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
156327642|NCT02001181|564299334|FG001|Overall Study|Lost to Follow-up|0|||
156327643|NCT02001181|564299333|FG000|Overall Study|Withdrawal by Subject|0|||
156327644|NCT02001181|564299334|FG001|Overall Study|Withdrawal by Subject|1|||
156327645|NCT03438383|564299339|FG000|Overall Study|Protocol Violation|9|||
156327646|NCT03438383|564299340|FG001|Overall Study|Protocol Violation|3|||
156327647|NCT02435069|564299341|FG000|Dose Response - First Intervention|Adverse Event|0|||
156327648|NCT02435069|564299342|FG001|Dose Response - First Intervention|Adverse Event|1|||
156327649|NCT02435069|564299343|FG002|Dose Response - First Intervention|Adverse Event|1|||
156327650|NCT02435069|564299344|FG003|Dose Response - First Intervention|Adverse Event|0|||
156327651|NCT02435069|564299345|FG004|Dose Response - First Intervention|Adverse Event|0|||
156327652|NCT02435069|564299341|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
156327653|NCT02435069|564299342|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
156327654|NCT02435069|564299343|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
156327655|NCT02435069|564299344|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
156327656|NCT02435069|564299345|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
156327657|NCT01528033|564299346|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
156327658|NCT01528033|564299347|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
156327659|NCT01528033|564299346|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
156327660|NCT01528033|564299347|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
156327661|NCT01528033|564299346|FG000|Primary Endpoint Assessment ITT|Death|2|||
156327662|NCT01528033|564299347|FG001|Primary Endpoint Assessment ITT|Death|2|||
156327663|NCT01528033|564299346|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
156327664|NCT01528033|564299347|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
156327665|NCT01528033|564299346|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
156327666|NCT01528033|564299347|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
156327667|NCT01528033|564299346|FG000|Follow Up|No data available|46|||
156327668|NCT01528033|564299347|FG001|Follow Up|No data available|44|||
156327669|NCT03112590|564299348|FG000|Overall Study|Adverse Event|0|||
156327670|NCT03112590|564299349|FG001|Overall Study|Adverse Event|1|||
156327671|NCT03112590|564299350|FG002|Overall Study|Adverse Event|0|||
156327672|NCT02436681|564299353|FG000|Overall Study|Lost to Follow-up|10|||
156327673|NCT02436681|564299353|FG000|Overall Study|Withdrawal by Subject|2|||
156327674|NCT02436681|564299353|FG000|Overall Study|Death|2|||
156327675|NCT02030938|564299356|FG000|Overall Study|Lost to Follow-up|4|||
156327676|NCT02030938|564299356|FG000|Overall Study|Withdrawal by Subject|1|||
156327677|NCT03954132|564299358|FG000|Overall Study|Adverse Event|2|||
156327678|NCT03954132|564299359|FG001|Overall Study|Adverse Event|0|||
156327679|NCT03954132|564299358|FG000|Overall Study|Patient's wish|5|||
156327680|NCT03954132|564299359|FG001|Overall Study|Patient's wish|0|||
156327681|NCT03954132|564299358|FG000|Overall Study|Lost to Follow-up|10|||
156327682|NCT03954132|564299359|FG001|Overall Study|Lost to Follow-up|0|||
156327683|NCT03954132|564299358|FG000|Overall Study|Screening failure|0|||
156327684|NCT03954132|564299359|FG001|Overall Study|Screening failure|1|||
156327685|NCT03954132|564299358|FG000|Overall Study|No registration after Visit 1|5|||
156327686|NCT03954132|564299359|FG001|Overall Study|No registration after Visit 1|2|||
156327687|NCT03954132|564299358|FG000|Overall Study|Other reason than listed|2|||
156327688|NCT03954132|564299359|FG001|Overall Study|Other reason than listed|2|||
156327689|NCT03954132|564299358|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
156327690|NCT03954132|564299359|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
156327691|NCT03954132|564299358|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
156327692|NCT03954132|564299359|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
156327693|NCT00891462|564301345|FG000|Overall Study|Withdrawal by Subject|9|||
156327694|NCT00891462|564301346|FG001|Overall Study|Withdrawal by Subject|6|||
156327695|NCT00891462|564301347|FG002|Overall Study|Withdrawal by Subject|7|||
156673181|NCT00205777|565550629|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
156431971|NCT02469064|564671028|FG000|Overall Study|Request not to receive intervention.|1|||
156431972|NCT02469064|564671029|FG001|Overall Study|Request not to receive intervention.|3|||
156431973|NCT02506257|564671032|FG000|Overall Study|Adverse Event|0|||
156431974|NCT02506257|564671033|FG001|Overall Study|Adverse Event|2|||
156431975|NCT02506257|564671034|FG002|Overall Study|Adverse Event|3|||
156431976|NCT02506257|564671035|FG003|Overall Study|Adverse Event|0|||
156431977|NCT02506257|564671032|FG000|Overall Study|Protocol Violation|0|||
156431978|NCT02506257|564671033|FG001|Overall Study|Protocol Violation|0|||
156431979|NCT02506257|564671034|FG002|Overall Study|Protocol Violation|1|||
156431980|NCT02506257|564671035|FG003|Overall Study|Protocol Violation|0|||
156431981|NCT00964366|564671036|FG000|Overall Study|Did not qualify at Day 1|1|||
156431982|NCT00964366|564671037|FG001|Overall Study|Did not qualify at Day 1|0|||
156431983|NCT00964366|564671036|FG000|Overall Study|Withdrawal by Subject|0|||
156431984|NCT00964366|564671037|FG001|Overall Study|Withdrawal by Subject|1|||
156431985|NCT02046616|564671039|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
156431986|NCT02046616|564671039|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
156431987|NCT02046616|564671039|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
156431988|NCT02046616|564671039|FG000|24-Week Treatment Period|Physician Decision|3|||
156431989|NCT02046616|564671039|FG000|24-Week Treatment Period|Other|1|||
156431990|NCT02046616|564671039|FG000|8-Week FU Period|Lost to Follow-up|1|||
156431991|NCT02957539|564671042|FG000|Baseline to Week 16|Lost to Follow-up|8|||
156431992|NCT02957539|564671043|FG001|Baseline to Week 16|Lost to Follow-up|10|||
156431993|NCT02957539|564671044|FG002|Baseline to Week 16|Lost to Follow-up|16|||
156431994|NCT02957539|564671042|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
156431995|NCT02957539|564671043|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
156431996|NCT02957539|564671044|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
156431997|NCT02957539|564671042|FG000|Week 16 to 32|Withdrawal by Subject|3|||
156431998|NCT02957539|564671043|FG001|Week 16 to 32|Withdrawal by Subject|3|||
156431999|NCT02957539|564671044|FG002|Week 16 to 32|Withdrawal by Subject|1|||
156432000|NCT02957539|564671042|FG000|Week 16 to 32|Lost to Follow-up|8|||
156432001|NCT02957539|564671043|FG001|Week 16 to 32|Lost to Follow-up|7|||
156432002|NCT02957539|564671044|FG002|Week 16 to 32|Lost to Follow-up|5|||
156432003|NCT02957539|564671042|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
156432004|NCT02957539|564671043|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
156432005|NCT02957539|564671044|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
156432006|NCT02957539|564671042|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
156432007|NCT02957539|564671043|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
156432008|NCT02957539|564671044|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
156432009|NCT04842604|564671049|FG000|Overall Study|Death|1|||
156432010|NCT04842604|564671050|FG001|Overall Study|Death|0|||
156432011|NCT04842604|564671049|FG000|Overall Study|Other|4|||
156432012|NCT04842604|564671050|FG001|Overall Study|Other|4|||
156432013|NCT04842604|564671049|FG000|Overall Study|Randomized but not treated|1|||
156432014|NCT04842604|564671050|FG001|Overall Study|Randomized but not treated|0|||
156432015|NCT00344019|564671052|FG000|Overall Study|did not meet final inclusion criteria|0|||
156432016|NCT00344019|564671053|FG001|Overall Study|did not meet final inclusion criteria|0|||
156432017|NCT00344019|564671054|FG002|Overall Study|did not meet final inclusion criteria|74|||
156432018|NCT01193153|564671055|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
156432019|NCT01193153|564671056|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
156432020|NCT01193153|564671055|FG000|Open-label Lead in Period|Pregnancy|1|||
156432021|NCT01193153|564671056|FG001|Open-label Lead in Period|Pregnancy|0|||
156432022|NCT01193153|564671055|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
156432023|NCT01193153|564671056|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
156432024|NCT01193153|564671055|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
156432025|NCT01193153|564671056|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
156432026|NCT01193153|564671055|FG000|Open-label Lead in Period|Other|14|||
156432027|NCT01193153|564671056|FG001|Open-label Lead in Period|Other|0|||
156432028|NCT01193153|564671055|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
156432029|NCT01193153|564671056|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
156432030|NCT01193153|564671055|FG000|Open-label Lead in Period|Adverse Event|41|||
156432031|NCT01193153|564671056|FG001|Open-label Lead in Period|Adverse Event|0|||
156432032|NCT01193153|564671055|FG000|Open-label Lead in Period|Death|1|||
156432033|NCT01193153|564671056|FG001|Open-label Lead in Period|Death|0|||
156432034|NCT01193153|564671055|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
156432035|NCT01193153|564671056|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
156432036|NCT01193153|564671055|FG000|Open-label Stabilization Period|Adverse Event|9|||
156432037|NCT01193153|564671056|FG001|Open-label Stabilization Period|Adverse Event|0|||
156432038|NCT01193153|564671055|FG000|Open-label Stabilization Period|Death|2|||
156432039|NCT01193153|564671056|FG001|Open-label Stabilization Period|Death|0|||
156432040|NCT01193153|564671055|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
156432041|NCT01193153|564671056|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
156432042|NCT01193153|564671055|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
156432043|NCT01193153|564671056|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
156432044|NCT01193153|564671055|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
156432045|NCT01193153|564671056|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
156432046|NCT01193153|564671055|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
156432047|NCT01193153|564671056|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
156432048|NCT01193153|564671055|FG000|Open-label Stabilization Period|Other|8|||
156432049|NCT01193153|564671056|FG001|Open-label Stabilization Period|Other|0|||
156432050|NCT01193153|564671055|FG000|Double Blind Relapse Prevention Period|Other|2|||
156432051|NCT01193153|564671056|FG001|Double Blind Relapse Prevention Period|Other|3|||
156432052|NCT01193153|564671055|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
156432053|NCT01193153|564671056|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
156432054|NCT01193153|564671055|FG000|Double Blind Relapse Prevention Period|Death|2|||
156432055|NCT01193153|564671056|FG001|Double Blind Relapse Prevention Period|Death|0|||
156432056|NCT01193153|564671055|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
156432057|NCT01193153|564671056|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
156432058|NCT01193153|564671055|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
156432059|NCT01193153|564671056|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
156432060|NCT01193153|564671055|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
156432061|NCT01193153|564671056|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
156432062|NCT01193153|564671055|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
156432063|NCT01193153|564671056|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
156432064|NCT01193153|564671055|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
156432065|NCT01193153|564671056|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
156432066|NCT01563354|564671059|FG000|Core Phase|Adverse Event|5|||
156432067|NCT01563354|564671060|FG001|Core Phase|Adverse Event|15|||
156432068|NCT01563354|564671061|FG002|Core Phase|Adverse Event|13|||
156673182|NCT00205777|565550630|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
156673183|NCT00205777|565550631|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
156673184|NCT00205777|565550632|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
156673185|NCT00205777|565550627|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
156673186|NCT00205777|565550628|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
156673187|NCT00205777|565550629|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
156673188|NCT00205777|565550630|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
156673189|NCT00205777|565550631|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
156673190|NCT00205777|565550632|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
156673191|NCT00205777|565550627|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
156673192|NCT00205777|565550628|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
156673193|NCT00205777|565550629|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
156673194|NCT00205777|565550630|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
156673195|NCT00205777|565550631|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
156673196|NCT00205777|565550632|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
156673197|NCT00205777|565550627|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
156673198|NCT00205777|565550628|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
156673199|NCT00205777|565550629|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
156673200|NCT00205777|565550630|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
156673201|NCT00205777|565550631|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
156673202|NCT00205777|565550632|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
156673203|NCT00205777|565550627|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
156673204|NCT00205777|565550628|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
156673205|NCT00205777|565550629|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
156673206|NCT00205777|565550630|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
156673207|NCT00205777|565550631|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
156673208|NCT00205777|565550632|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
156673209|NCT00205777|565550627|FG000|Completed Core Study, Entered SE I|Other Event|52|||
156673210|NCT00205777|565550628|FG001|Completed Core Study, Entered SE I|Other Event|46|||
156527129|NCT00402363|565025222|FG001|Overall Study|Withdrew Consent|5|||
156527130|NCT00402363|565025223|FG002|Overall Study|Withdrew Consent|2|||
156432069|NCT01563354|564671059|FG000|Core Phase|Withdrawal by Subject|1|||
156432070|NCT01563354|564671060|FG001|Core Phase|Withdrawal by Subject|0|||
156432071|NCT01563354|564671061|FG002|Core Phase|Withdrawal by Subject|3|||
156432072|NCT01563354|564671059|FG000|Core Phase|Lost to Follow-up|1|||
156432073|NCT01563354|564671060|FG001|Core Phase|Lost to Follow-up|0|||
156432074|NCT01563354|564671061|FG002|Core Phase|Lost to Follow-up|0|||
156432075|NCT01563354|564671059|FG000|Core Phase|Death|1|||
156673211|NCT00205777|565550629|FG002|Completed Core Study, Entered SE I|Other Event|47|||
156779785|NCT01078662|565943886|FG003|Overall Study|Death|5|||
156527131|NCT00402363|565025224|FG003|Overall Study|Withdrew Consent|1|||
156432076|NCT01563354|564671060|FG001|Core Phase|Death|5|||
156432077|NCT01563354|564671061|FG002|Core Phase|Death|2|||
156432078|NCT01563354|564671059|FG000|Core Phase|Diseasse progression|18|||
156527132|NCT00402363|565025221|FG000|Overall Study|Protocol Violation|3|||
156527133|NCT00402363|565025222|FG001|Overall Study|Protocol Violation|5|||
156527134|NCT00402363|565025223|FG002|Overall Study|Protocol Violation|0|||
156432079|NCT01563354|564671060|FG001|Core Phase|Diseasse progression|7|||
156432080|NCT01563354|564671061|FG002|Core Phase|Diseasse progression|8|||
156432081|NCT01563354|564671059|FG000|Core Phase|Protocol deviation|2|||
156432082|NCT01563354|564671060|FG001|Core Phase|Protocol deviation|0|||
156432083|NCT01563354|564671061|FG002|Core Phase|Protocol deviation|0|||
156432084|NCT01563354|564671059|FG000|Core Phase|PI decision - did not enter extension|0|||
156432085|NCT01563354|564671060|FG001|Core Phase|PI decision - did not enter extension|1|||
156432086|NCT01563354|564671061|FG002|Core Phase|PI decision - did not enter extension|0|||
156432087|NCT01563354|564671059|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
156432088|NCT01563354|564671060|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
156432089|NCT01563354|564671061|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
156432090|NCT01563354|564671059|FG000|Extension Phase|Adverse Event|0|||
156432091|NCT01563354|564671060|FG001|Extension Phase|Adverse Event|3|||
156432092|NCT01563354|564671061|FG002|Extension Phase|Adverse Event|2|||
156432093|NCT01563354|564671059|FG000|Extension Phase|Withdrawal by Subject|0|||
156432094|NCT01563354|564671060|FG001|Extension Phase|Withdrawal by Subject|1|||
156432095|NCT01563354|564671061|FG002|Extension Phase|Withdrawal by Subject|0|||
156432096|NCT01563354|564671059|FG000|Extension Phase|Administration problems|3|||
156432097|NCT01563354|564671060|FG001|Extension Phase|Administration problems|2|||
156432098|NCT01563354|564671061|FG002|Extension Phase|Administration problems|3|||
156432099|NCT01563354|564671059|FG000|Extension Phase|Disease progression|9|||
156432100|NCT01563354|564671060|FG001|Extension Phase|Disease progression|8|||
156432101|NCT01563354|564671061|FG002|Extension Phase|Disease progression|10|||
156432102|NCT02503202|564671062|FG000|Base Study: Up to Month 6|Death|1|||
156432103|NCT02503202|564671063|FG001|Base Study: Up to Month 6|Death|1|||
156432104|NCT02503202|564671064|FG002|Base Study: Up to Month 6|Death|0|||
156432105|NCT02503202|564671065|FG003|Base Study: Up to Month 6|Death|0|||
156432106|NCT02503202|564671066|FG004|Base Study: Up to Month 6|Death|0|||
156432107|NCT02503202|564671062|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
156432108|NCT02503202|564671063|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
156432109|NCT02503202|564671064|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
156432110|NCT02503202|564671065|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
156432111|NCT02503202|564671066|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
156432112|NCT02503202|564671062|FG000|Base Study: Up to Month 6|Physician Decision|0|||
156432113|NCT02503202|564671063|FG001|Base Study: Up to Month 6|Physician Decision|0|||
156432114|NCT02503202|564671064|FG002|Base Study: Up to Month 6|Physician Decision|0|||
156432115|NCT02503202|564671065|FG003|Base Study: Up to Month 6|Physician Decision|0|||
156432116|NCT02503202|564671066|FG004|Base Study: Up to Month 6|Physician Decision|1|||
156432117|NCT02503202|564671062|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
156432118|NCT02503202|564671063|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
156432119|NCT02503202|564671064|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
156432120|NCT02503202|564671065|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
156432121|NCT02503202|564671066|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
156432122|NCT02503202|564671062|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
156432123|NCT02503202|564671063|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
156432124|NCT02503202|564671064|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
156432125|NCT02503202|564671065|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
156432126|NCT02503202|564671066|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
156432127|NCT02503202|564671062|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
156432128|NCT02503202|564671063|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
156432129|NCT02503202|564671064|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
156432130|NCT02503202|564671065|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
156432131|NCT02503202|564671066|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
156432132|NCT02503202|564671062|FG000|Extension: Month 6 to 24|Death|1|||
156432133|NCT02503202|564671063|FG001|Extension: Month 6 to 24|Death|0|||
156432134|NCT02503202|564671064|FG002|Extension: Month 6 to 24|Death|0|||
156432135|NCT02503202|564671065|FG003|Extension: Month 6 to 24|Death|0|||
156432136|NCT02503202|564671066|FG004|Extension: Month 6 to 24|Death|0|||
156527135|NCT00402363|565025224|FG003|Overall Study|Protocol Violation|3|||
156527136|NCT00402363|565025221|FG000|Overall Study|Lost to Follow-up|5|||
156432137|NCT02503202|564671062|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
156432138|NCT02503202|564671063|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
156432139|NCT02503202|564671064|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
156432140|NCT02503202|564671065|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
156527137|NCT00402363|565025222|FG001|Overall Study|Lost to Follow-up|4|||
156527138|NCT00402363|565025223|FG002|Overall Study|Lost to Follow-up|0|||
156527139|NCT00402363|565025224|FG003|Overall Study|Lost to Follow-up|2|||
156527140|NCT00402363|565025221|FG000|Overall Study|"Captured as Other"|6|||
156432141|NCT02503202|564671066|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
156432142|NCT02503202|564671062|FG000|Extension: Month 6 to 24|Physician Decision|1|||
156432143|NCT02503202|564671063|FG001|Extension: Month 6 to 24|Physician Decision|0|||
156432144|NCT02503202|564671064|FG002|Extension: Month 6 to 24|Physician Decision|1|||
156432145|NCT02503202|564671065|FG003|Extension: Month 6 to 24|Physician Decision|3|||
156673212|NCT00205777|565550630|FG003|Completed Core Study, Entered SE I|Other Event|50|||
156673213|NCT00205777|565550631|FG004|Completed Core Study, Entered SE I|Other Event|0|||
156432146|NCT02503202|564671066|FG004|Extension: Month 6 to 24|Physician Decision|0|||
156432147|NCT02503202|564671062|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
156673214|NCT00205777|565550632|FG005|Completed Core Study, Entered SE I|Other Event|0|||
156673215|NCT00205777|565550627|FG000|Study Extension I|Adverse Event|57|||
156673216|NCT00205777|565550628|FG001|Study Extension I|Adverse Event|0|||
156432148|NCT02503202|564671063|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
156432149|NCT02503202|564671064|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
156432150|NCT02503202|564671065|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
156432151|NCT02503202|564671066|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
156432152|NCT00770965|564671094|FG000|Safety Set|Withdrawal by Subject|0|||
156432153|NCT00770965|564671095|FG001|Safety Set|Withdrawal by Subject|0|||
156432154|NCT00770965|564671096|FG002|Safety Set|Withdrawal by Subject|0|||
156432155|NCT00770965|564671097|FG003|Safety Set|Withdrawal by Subject|1|||
156432156|NCT00770965|564671094|FG000|Safety Set|Protocol deviation|0|||
156432157|NCT00770965|564671095|FG001|Safety Set|Protocol deviation|0|||
156432158|NCT00770965|564671096|FG002|Safety Set|Protocol deviation|1|||
156432159|NCT00770965|564671097|FG003|Safety Set|Protocol deviation|0|||
156432160|NCT00770965|564671094|FG000|Excluded Set|Administrative problems|14|||
156432161|NCT00770965|564671095|FG001|Excluded Set|Administrative problems|12|||
156432162|NCT00770965|564671096|FG002|Excluded Set|Administrative problems|12|||
156432163|NCT00770965|564671097|FG003|Excluded Set|Administrative problems|10|||
156432164|NCT00770965|564671094|FG000|Excluded Set|Withdrawal by Subject|1|||
156432165|NCT00770965|564671095|FG001|Excluded Set|Withdrawal by Subject|1|||
156432166|NCT00770965|564671096|FG002|Excluded Set|Withdrawal by Subject|2|||
156432167|NCT00770965|564671097|FG003|Excluded Set|Withdrawal by Subject|3|||
156432168|NCT02371746|564671098|FG000|Overall Study|Consent withdrawn|0|||
156432169|NCT02371746|564671099|FG001|Overall Study|Consent withdrawn|0|||
156432170|NCT02371746|564671100|FG002|Overall Study|Consent withdrawn|0|||
156432171|NCT02371746|564671101|FG003|Overall Study|Consent withdrawn|0|||
156432172|NCT02371746|564671102|FG004|Overall Study|Consent withdrawn|0|||
156432173|NCT02371746|564671103|FG005|Overall Study|Consent withdrawn|0|||
156432174|NCT02371746|564671104|FG006|Overall Study|Consent withdrawn|1|||
156432175|NCT00754936|564671105|FG000|Overall Study|Lost to Follow-up|3|||
156432176|NCT00754936|564671105|FG000|Overall Study|Physician Decision|1|||
156432177|NCT00754936|564671105|FG000|Overall Study|Withdrawal by Subject|2|||
156432178|NCT00754936|564671105|FG000|Overall Study|Side Effects|3|||
156432179|NCT00754936|564671105|FG000|Overall Study|Inter-current medical events|3|||
156432180|NCT00619645|564671106|FG000|Overall Study|Adverse Event|1|||
156432181|NCT00410124|564671107|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
156432182|NCT00410124|564671108|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
156432183|NCT00410124|564671107|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
156432184|NCT00410124|564671108|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
156673217|NCT00205777|565550629|FG002|Study Extension I|Adverse Event|0|||
156673218|NCT00205777|565550630|FG003|Study Extension I|Adverse Event|61|||
156673219|NCT00205777|565550631|FG004|Study Extension I|Adverse Event|58|||
156673220|NCT00205777|565550632|FG005|Study Extension I|Adverse Event|0|||
156673221|NCT00205777|565550627|FG000|Study Extension I|Death|5|||
156673222|NCT00205777|565550628|FG001|Study Extension I|Death|0|||
156673223|NCT00205777|565550629|FG002|Study Extension I|Death|0|||
156673224|NCT00205777|565550630|FG003|Study Extension I|Death|1|||
156673225|NCT00205777|565550631|FG004|Study Extension I|Death|2|||
156673226|NCT00205777|565550632|FG005|Study Extension I|Death|0|||
156673227|NCT00205777|565550627|FG000|Study Extension I|Withdrawal by Subject|99|||
156673228|NCT00205777|565550628|FG001|Study Extension I|Withdrawal by Subject|0|||
156673229|NCT00205777|565550629|FG002|Study Extension I|Withdrawal by Subject|0|||
156432185|NCT00410124|564671107|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
156432186|NCT00410124|564671108|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
156432187|NCT00410124|564671107|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
156432188|NCT00410124|564671108|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
156527141|NCT00402363|565025222|FG001|Overall Study|"Captured as Other"|2|||
156432189|NCT00410124|564671107|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
156527142|NCT00402363|565025223|FG002|Overall Study|"Captured as Other"|2|||
156527143|NCT00402363|565025224|FG003|Overall Study|"Captured as Other"|2|||
156527144|NCT00937833|565025234|FG000|Overall Study|Protocol Violation|1|||
156527145|NCT00937833|565025235|FG001|Overall Study|Protocol Violation|2|||
156673230|NCT00205777|565550630|FG003|Study Extension I|Withdrawal by Subject|106|||
156673231|NCT00205777|565550631|FG004|Study Extension I|Withdrawal by Subject|89|||
156673232|NCT00205777|565550632|FG005|Study Extension I|Withdrawal by Subject|0|||
156673233|NCT00205777|565550627|FG000|Study Extension I|Protocol Violation|4|||
156432190|NCT00410124|564671108|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
156432191|NCT00410124|564671107|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
156432192|NCT00410124|564671108|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
156673234|NCT00205777|565550628|FG001|Study Extension I|Protocol Violation|0|||
156673235|NCT00205777|565550629|FG002|Study Extension I|Protocol Violation|0|||
156673236|NCT00205777|565550630|FG003|Study Extension I|Protocol Violation|8|||
156673237|NCT00205777|565550631|FG004|Study Extension I|Protocol Violation|8|||
156673238|NCT00205777|565550632|FG005|Study Extension I|Protocol Violation|0|||
156673239|NCT00205777|565550627|FG000|Study Extension I|Lack of Efficacy|0|||
156673240|NCT00205777|565550628|FG001|Study Extension I|Lack of Efficacy|0|||
156673241|NCT00205777|565550629|FG002|Study Extension I|Lack of Efficacy|0|||
156673242|NCT00205777|565550630|FG003|Study Extension I|Lack of Efficacy|1|||
156673243|NCT00205777|565550631|FG004|Study Extension I|Lack of Efficacy|2|||
156673244|NCT00205777|565550632|FG005|Study Extension I|Lack of Efficacy|0|||
156673245|NCT00205777|565550627|FG000|Study Extension I|Failed to return|15|||
156673246|NCT00205777|565550628|FG001|Study Extension I|Failed to return|0|||
156673247|NCT00205777|565550629|FG002|Study Extension I|Failed to return|0|||
156673248|NCT00205777|565550630|FG003|Study Extension I|Failed to return|17|||
156673249|NCT00205777|565550631|FG004|Study Extension I|Failed to return|13|||
156673250|NCT00205777|565550632|FG005|Study Extension I|Failed to return|0|||
156673251|NCT00205777|565550627|FG000|Study Extension I|Other Event|34|||
156673252|NCT00205777|565550628|FG001|Study Extension I|Other Event|0|||
156673253|NCT00205777|565550629|FG002|Study Extension I|Other Event|0|||
156673254|NCT00205777|565550630|FG003|Study Extension I|Other Event|34|||
156673255|NCT00205777|565550631|FG004|Study Extension I|Other Event|29|||
156673256|NCT00205777|565550632|FG005|Study Extension I|Other Event|0|||
156673257|NCT00205777|565550627|FG000|Study Extension I|Withdrawn as per protocol|0|||
156673258|NCT00205777|565550628|FG001|Study Extension I|Withdrawn as per protocol|0|||
156673259|NCT00205777|565550629|FG002|Study Extension I|Withdrawn as per protocol|1070|||
156673260|NCT00205777|565550630|FG003|Study Extension I|Withdrawn as per protocol|0|||
156673261|NCT00205777|565550631|FG004|Study Extension I|Withdrawn as per protocol|0|||
156673262|NCT00205777|565550632|FG005|Study Extension I|Withdrawn as per protocol|0|||
156673263|NCT00205777|565550627|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
156327696|NCT00891462|564301345|FG000|Overall Study|Adverse Event|7|||
156327697|NCT00891462|564301346|FG001|Overall Study|Adverse Event|8|||
156327698|NCT00891462|564301347|FG002|Overall Study|Adverse Event|7|||
156327699|NCT00891462|564301345|FG000|Overall Study|Lack of Efficacy|10|||
156327700|NCT00891462|564301346|FG001|Overall Study|Lack of Efficacy|5|||
156327701|NCT00891462|564301347|FG002|Overall Study|Lack of Efficacy|1|||
156327702|NCT00891462|564301345|FG000|Overall Study|COPD exacerbation|7|||
156327703|NCT00891462|564301346|FG001|Overall Study|COPD exacerbation|4|||
156327704|NCT00891462|564301347|FG002|Overall Study|COPD exacerbation|1|||
156327705|NCT00891462|564301345|FG000|Overall Study|Other Reason|2|||
156327706|NCT00891462|564301346|FG001|Overall Study|Other Reason|5|||
156327707|NCT00891462|564301347|FG002|Overall Study|Other Reason|3|||
156327708|NCT00891462|564301345|FG000|Overall Study|Protocol Violation|2|||
156327709|NCT00891462|564301346|FG001|Overall Study|Protocol Violation|1|||
156327710|NCT00891462|564301347|FG002|Overall Study|Protocol Violation|3|||
156327711|NCT00891462|564301345|FG000|Overall Study|Inclusion/exclusion criteria|0|||
156327712|NCT00891462|564301346|FG001|Overall Study|Inclusion/exclusion criteria|2|||
156327713|NCT00891462|564301347|FG002|Overall Study|Inclusion/exclusion criteria|2|||
156327714|NCT00891462|564301345|FG000|Overall Study|Lost to Follow-up|0|||
156327715|NCT00891462|564301346|FG001|Overall Study|Lost to Follow-up|2|||
156327716|NCT00891462|564301347|FG002|Overall Study|Lost to Follow-up|0|||
156327717|NCT01854658|564301348|FG000|Overall Study|Protocol Violation|6|||
156327718|NCT01854658|564301349|FG001|Overall Study|Protocol Violation|2|||
156327719|NCT01854658|564301350|FG002|Overall Study|Protocol Violation|2|||
156327720|NCT01854658|564301351|FG003|Overall Study|Protocol Violation|1|||
156327721|NCT01854658|564301348|FG000|Overall Study|Physician Decision|7|||
156327722|NCT01854658|564301349|FG001|Overall Study|Physician Decision|5|||
156327723|NCT01854658|564301350|FG002|Overall Study|Physician Decision|2|||
156327724|NCT01854658|564301351|FG003|Overall Study|Physician Decision|4|||
156327725|NCT01854658|564301348|FG000|Overall Study|Lost to Follow-up|8|||
156327726|NCT01854658|564301349|FG001|Overall Study|Lost to Follow-up|9|||
156327727|NCT01854658|564301350|FG002|Overall Study|Lost to Follow-up|8|||
156327728|NCT01854658|564301351|FG003|Overall Study|Lost to Follow-up|4|||
156327729|NCT01854658|564301348|FG000|Overall Study|Withdrawal by Subject|28|||
156327730|NCT01854658|564301349|FG001|Overall Study|Withdrawal by Subject|21|||
156327731|NCT01854658|564301350|FG002|Overall Study|Withdrawal by Subject|29|||
156327732|NCT01854658|564301351|FG003|Overall Study|Withdrawal by Subject|15|||
156327733|NCT01854658|564301348|FG000|Overall Study|Protocol-specified criteria|15|||
156432193|NCT00410124|564671107|FG000|Core Phase Double Blind (15 Months)|Death|7|||
156432194|NCT00410124|564671108|FG001|Core Phase Double Blind (15 Months)|Death|4|||
156432195|NCT00410124|564671107|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
156432196|NCT00410124|564671108|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
156779786|NCT01078662|565943887|FG004|Overall Study|Death|8|||
156327734|NCT01854658|564301349|FG001|Overall Study|Protocol-specified criteria|15|||
156327735|NCT01854658|564301350|FG002|Overall Study|Protocol-specified criteria|10|||
156327736|NCT01854658|564301351|FG003|Overall Study|Protocol-specified criteria|7|||
156327737|NCT01854658|564301348|FG000|Overall Study|Lack of Efficacy|3|||
156327738|NCT01854658|564301349|FG001|Overall Study|Lack of Efficacy|8|||
156327739|NCT01854658|564301350|FG002|Overall Study|Lack of Efficacy|4|||
156673264|NCT00205777|565550628|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
156673265|NCT00205777|565550629|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
156673266|NCT00205777|565550630|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
156673267|NCT00205777|565550631|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
156673268|NCT00205777|565550632|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
156673269|NCT00205777|565550627|FG000|Study Extension II|Adverse Event|0|||
156673270|NCT00205777|565550628|FG001|Study Extension II|Adverse Event|0|||
156673271|NCT00205777|565550629|FG002|Study Extension II|Adverse Event|0|||
156527146|NCT00937833|565025234|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
156527147|NCT00937833|565025235|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
156527148|NCT00937833|565025234|FG000|Overall Study|Lost to Follow-up|10|||
156527149|NCT00937833|565025235|FG001|Overall Study|Lost to Follow-up|8|||
156527150|NCT00937833|565025234|FG000|Overall Study|Withdrawal by Subject|4|||
156527151|NCT00937833|565025235|FG001|Overall Study|Withdrawal by Subject|6|||
156527152|NCT01607554|565025237|FG000|Overall Study|Disease progression|2|||
156673272|NCT00205777|565550630|FG003|Study Extension II|Adverse Event|14|||
156527153|NCT00162032|565025238|FG000|Overall Study|Lost to Follow-up|4|||
156527154|NCT00162032|565025239|FG001|Overall Study|Lost to Follow-up|2|||
156527155|NCT00162032|565025238|FG000|Overall Study|Reason not specified|1|||
156527156|NCT00162032|565025239|FG001|Overall Study|Reason not specified|0|||
156527157|NCT03952806|565025240|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
156527158|NCT03952806|565025241|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
156527159|NCT03952806|565025240|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
156527160|NCT03952806|565025241|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
156527161|NCT03952806|565025240|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
156527162|NCT03952806|565025241|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
156527163|NCT03952806|565025240|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
156527164|NCT03952806|565025241|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
156527165|NCT03952806|565025240|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
156327740|NCT01854658|564301351|FG003|Overall Study|Lack of Efficacy|7|||
156527166|NCT03952806|565025241|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
156527167|NCT03952806|565025240|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
156527168|NCT03952806|565025241|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
156527169|NCT03952806|565025240|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
156527170|NCT03952806|565025241|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
156527171|NCT03952806|565025240|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
156673273|NCT00205777|565550631|FG004|Study Extension II|Adverse Event|0|||
156327741|NCT01854658|564301348|FG000|Overall Study|Adverse Event|21|||
156327742|NCT01854658|564301349|FG001|Overall Study|Adverse Event|14|||
156327743|NCT01854658|564301350|FG002|Overall Study|Adverse Event|23|||
156327744|NCT01854658|564301351|FG003|Overall Study|Adverse Event|19|||
156327745|NCT01854658|564301348|FG000|Overall Study|Administrative reasons|5|||
156327746|NCT01854658|564301349|FG001|Overall Study|Administrative reasons|1|||
156327747|NCT01854658|564301350|FG002|Overall Study|Administrative reasons|2|||
156327748|NCT01854658|564301351|FG003|Overall Study|Administrative reasons|2|||
156327749|NCT00195273|564301352|FG000|Overall Study|Adverse Event|9|||
156327750|NCT00195273|564301353|FG001|Overall Study|Adverse Event|9|||
156327751|NCT00195273|564301352|FG000|Overall Study|Protocol deviation|0|||
156327752|NCT00195273|564301353|FG001|Overall Study|Protocol deviation|1|||
156327753|NCT00195273|564301352|FG000|Overall Study|Lack of Efficacy|3|||
156327754|NCT00195273|564301353|FG001|Overall Study|Lack of Efficacy|1|||
156327755|NCT00195273|564301352|FG000|Overall Study|Procedural complications|9|||
156327756|NCT00195273|564301353|FG001|Overall Study|Procedural complications|3|||
156327757|NCT02367131|564301357|FG000|Overall Study|Adverse Event|64|||
156327758|NCT02367131|564301357|FG000|Overall Study|No visit since the first visit|3|||
156327759|NCT02367131|564301357|FG000|Overall Study|Request by patient|53|||
156327760|NCT02367131|564301357|FG000|Overall Study|Improvement/remission|2|||
156327761|NCT02367131|564301357|FG000|Overall Study|No change/progressive disease|78|||
156327762|NCT02367131|564301357|FG000|Overall Study|Other than stated above|20|||
156327763|NCT02367131|564301357|FG000|Overall Study|Not treated|2|||
156327764|NCT05061966|564301369|FG000|Overall Study|Lost to Follow-up|13|||
156327765|NCT05061966|564301370|FG001|Overall Study|Lost to Follow-up|13|||
156327766|NCT02923427|564301371|FG000|Overall Study|convert to laparatomy|2|||
156327767|NCT02923427|564301372|FG001|Overall Study|convert to laparatomy|2|||
156327768|NCT02923427|564301371|FG000|Overall Study|destaturation|1|||
156327769|NCT02923427|564301372|FG001|Overall Study|destaturation|0|||
156327770|NCT02923427|564301371|FG000|Overall Study|can not replace LMA|1|||
156327771|NCT02923427|564301372|FG001|Overall Study|can not replace LMA|0|||
156327772|NCT01325623|564301373|FG000|Overall Study|Withdrawal by Subject|3|||
156327773|NCT01539642|564301379|FG000|Overall Study|Lack of Efficacy|20|||
156327774|NCT01539642|564301380|FG001|Overall Study|Lack of Efficacy|18|||
156327775|NCT01539642|564301379|FG000|Overall Study|Patient ready for early discharge|8|||
156527172|NCT03952806|565025241|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
156432197|NCT00410124|564671107|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
156432198|NCT00410124|564671108|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
156432199|NCT00410124|564671107|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
156432200|NCT00410124|564671108|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
156432201|NCT00410124|564671107|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
156432202|NCT00410124|564671108|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
156432203|NCT00410124|564671107|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
156432204|NCT00410124|564671108|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
156432205|NCT00410124|564671107|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
156432206|NCT00410124|564671108|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
156432207|NCT00410124|564671107|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
156432208|NCT00410124|564671108|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
156432209|NCT00410124|564671107|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
156432210|NCT00410124|564671108|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
156432211|NCT00410124|564671107|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
156432212|NCT00410124|564671108|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
156432213|NCT00319436|564671109|FG000|Overall Study|Withdrawal by Subject|6|||
156432214|NCT00319436|564671110|FG001|Overall Study|Withdrawal by Subject|7|||
156432215|NCT01161498|564671113|FG000|Overall Study|Disease Progression|0|||
156432216|NCT01161498|564671114|FG001|Overall Study|Disease Progression|1|||
156432217|NCT04436120|564671116|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
156432218|NCT04436120|564671117|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
156432219|NCT04436120|564671118|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
156432220|NCT04436120|564671119|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
156432221|NCT04436120|564671120|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
156432222|NCT04436120|564671121|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
156432223|NCT04436120|564671122|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
156432224|NCT00038103|564671127|FG000|Overall Study|Adverse Event|5|||
156432225|NCT00038103|564671128|FG001|Overall Study|Adverse Event|6|||
156432226|NCT00038103|564671127|FG000|Overall Study|Lack of Efficacy|48|||
156432227|NCT00038103|564671128|FG001|Overall Study|Lack of Efficacy|41|||
156432228|NCT00038103|564671127|FG000|Overall Study|Withdrawal by Subject|0|||
156432229|NCT00038103|564671128|FG001|Overall Study|Withdrawal by Subject|3|||
156432230|NCT00038103|564671127|FG000|Overall Study|Lost to Follow-up|0|||
156432231|NCT00038103|564671128|FG001|Overall Study|Lost to Follow-up|3|||
156432232|NCT00038103|564671127|FG000|Overall Study|Protocol Violation|0|||
156432233|NCT00038103|564671128|FG001|Overall Study|Protocol Violation|2|||
156432234|NCT00038103|564671127|FG000|Overall Study|Sponsor Decision|0|||
156432235|NCT00038103|564671128|FG001|Overall Study|Sponsor Decision|1|||
156432236|NCT00038103|564671127|FG000|Overall Study|Randomized/never treated|2|||
156432237|NCT00038103|564671128|FG001|Overall Study|Randomized/never treated|0|||
156432238|NCT01144182|564671131|FG000|Overall Study|Death|5|||
156432239|NCT01144182|564671132|FG001|Overall Study|Death|6|||
156432240|NCT01144182|564671131|FG000|Overall Study|Withdrawal by Subject|3|||
156432241|NCT01144182|564671132|FG001|Overall Study|Withdrawal by Subject|6|||
156432242|NCT01144182|564671131|FG000|Overall Study|Lost to Follow-up|9|||
156432243|NCT01144182|564671132|FG001|Overall Study|Lost to Follow-up|9|||
156432244|NCT03254394|564671137|FG000|Overall Study|Withdrawal by Subject|0|||
156432245|NCT03254394|564671138|FG001|Overall Study|Withdrawal by Subject|2|||
156432246|NCT01867580|564671141|FG000|Overall Study|Withdrawal by Subject|2|||
156432247|NCT01867580|564671142|FG001|Overall Study|Withdrawal by Subject|3|||
156432248|NCT01867580|564671141|FG000|Overall Study|Physician Decision|17|||
156432249|NCT01867580|564671142|FG001|Overall Study|Physician Decision|12|||
156432250|NCT01867580|564671141|FG000|Overall Study|Lost to Follow-up|3|||
156432251|NCT01867580|564671142|FG001|Overall Study|Lost to Follow-up|5|||
156432252|NCT01867580|564671141|FG000|Overall Study|Sponsor terminated study|1|||
156432253|NCT01867580|564671142|FG001|Overall Study|Sponsor terminated study|0|||
156432254|NCT01867580|564671141|FG000|Overall Study|Missed follow-up assessment|2|||
156432255|NCT01867580|564671142|FG001|Overall Study|Missed follow-up assessment|1|||
156432256|NCT01867580|564671141|FG000|Overall Study|Interruption to therapy|3|||
156432257|NCT01867580|564671142|FG001|Overall Study|Interruption to therapy|0|||
156432258|NCT01867580|564671141|FG000|Overall Study|Osteomyelitis|0|||
156432259|NCT01867580|564671142|FG001|Overall Study|Osteomyelitis|1|||
156432260|NCT01867580|564671141|FG000|Overall Study|Continuation of therapy|0|||
156527173|NCT03952806|565025240|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
156432261|NCT01867580|564671142|FG001|Overall Study|Continuation of therapy|1|||
156432262|NCT01867580|564671141|FG000|Overall Study|Wound recurrence|0|||
156432263|NCT01867580|564671142|FG001|Overall Study|Wound recurrence|1|||
156432264|NCT02812966|564671146|FG000|Overall Study|Death|1|||
156432265|NCT02812966|564671147|FG001|Overall Study|Death|0|||
156432266|NCT01066923|564671148|FG000|Overall Study|Withdrawal by Subject|3|||
156432267|NCT01066923|564671149|FG001|Overall Study|Withdrawal by Subject|3|||
156432268|NCT01066923|564671150|FG002|Overall Study|Withdrawal by Subject|8|||
156432269|NCT01066923|564671151|FG003|Overall Study|Withdrawal by Subject|8|||
156432270|NCT03538041|564673711|FG000|12-Week Treatment Period|Adverse Event|1|||
156432271|NCT03538041|564673712|FG001|12-Week Treatment Period|Adverse Event|1|||
156432272|NCT03538041|564673711|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
156432273|NCT03538041|564673712|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
156432274|NCT03538041|564673711|FG000|Treatment Extension Period|Adverse Event|4|||
156432275|NCT03538041|564673712|FG001|Treatment Extension Period|Adverse Event|1|||
156432276|NCT03538041|564673711|FG000|Treatment Extension Period|Physician Decision|1|||
156432277|NCT03538041|564673712|FG001|Treatment Extension Period|Physician Decision|1|||
156432278|NCT03538041|564673711|FG000|Treatment Extension Period|Lack of Efficacy|1|||
156432279|NCT03538041|564673712|FG001|Treatment Extension Period|Lack of Efficacy|4|||
156432280|NCT03538041|564673711|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
156432281|NCT03538041|564673712|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
156432282|NCT03538041|564673711|FG000|Treatment Extension Period|Death|0|||
156432283|NCT03538041|564673712|FG001|Treatment Extension Period|Death|1|||
156432284|NCT02577523|564673714|FG000|Overall Study|Adverse Event|1|||
156432285|NCT02577523|564673715|FG001|Overall Study|Adverse Event|1|||
156432286|NCT02577523|564673714|FG000|Overall Study|Lack of Efficacy|1|||
156432287|NCT02577523|564673715|FG001|Overall Study|Lack of Efficacy|1|||
156432288|NCT02577523|564673714|FG000|Overall Study|Withdrawal by Subject|1|||
156432289|NCT02577523|564673715|FG001|Overall Study|Withdrawal by Subject|0|||
156432290|NCT02525796|564673716|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
156432291|NCT02525796|564673717|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
156432292|NCT02525796|564673718|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
156432293|NCT02525796|564673716|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
156432294|NCT02525796|564673717|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
156432295|NCT02525796|564673718|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
156432296|NCT02525796|564673716|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
156432297|NCT02525796|564673717|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
156432298|NCT02525796|564673718|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
156432299|NCT02525796|564673716|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
156432300|NCT02525796|564673717|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
156432301|NCT02525796|564673718|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
156432302|NCT02525796|564673716|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
156432303|NCT02525796|564673717|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
156432304|NCT02525796|564673718|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
156432305|NCT00391846|564673721|FG000|Overall Study|Adverse Event|4|||
156432306|NCT00391846|564673722|FG001|Overall Study|Adverse Event|1|||
156432307|NCT00391846|564673721|FG000|Overall Study|Did not meet the required elig. crit|2|||
156432308|NCT00391846|564673722|FG001|Overall Study|Did not meet the required elig. crit|2|||
156432309|NCT00391846|564673721|FG000|Overall Study|Withdrawal by Subject|2|||
156432310|NCT00391846|564673722|FG001|Overall Study|Withdrawal by Subject|3|||
156432311|NCT00391846|564673721|FG000|Overall Study|Developed study specific DC criteria|0|||
156432312|NCT00391846|564673722|FG001|Overall Study|Developed study specific DC criteria|1|||
156432313|NCT00970307|564673725|FG000|Overall Study|Serious Adverse Event|1|||
156432314|NCT00970307|564673726|FG001|Overall Study|Serious Adverse Event|0|||
156432315|NCT00970307|564673727|FG002|Overall Study|Serious Adverse Event|0|||
156432316|NCT00970307|564673725|FG000|Overall Study|Withdrawal by Subject|2|||
156432317|NCT00970307|564673726|FG001|Overall Study|Withdrawal by Subject|3|||
156432318|NCT00970307|564673727|FG002|Overall Study|Withdrawal by Subject|2|||
156432319|NCT02034916|564673734|FG000|Overall Study|Death|39|||
156432320|NCT02034916|564673735|FG001|Overall Study|Death|28|||
156432321|NCT02034916|564673734|FG000|Overall Study|Withdrawal by Subject|2|||
156432322|NCT02034916|564673735|FG001|Overall Study|Withdrawal by Subject|1|||
156432323|NCT02034916|564673734|FG000|Overall Study|Lost to Follow-up|4|||
156432324|NCT02034916|564673735|FG001|Overall Study|Lost to Follow-up|1|||
156432325|NCT02034916|564673734|FG000|Overall Study|Study terminated by sponsor|4|||
156432326|NCT02034916|564673735|FG001|Overall Study|Study terminated by sponsor|5|||
156432327|NCT01370694|564673750|FG000|Overall Study|Switched to rituximab|4|||
156432328|NCT01370694|564673750|FG000|Overall Study|Progressive disease|2|||
156527174|NCT03952806|565025241|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
156432329|NCT01119950|564673751|FG000|Overall Study|Adverse Event|25|||
156432330|NCT01119950|564673751|FG000|Overall Study|Withdrawal by Subject|9|||
156432331|NCT01119950|564673751|FG000|Overall Study|Protocol Violation|5|||
156527175|NCT03952806|565025240|FG000|OLE Phase (48 Weeks)|Other|16|||
156432332|NCT01119950|564673751|FG000|Overall Study|Lost to Follow-up|4|||
156432333|NCT01119950|564673751|FG000|Overall Study|Administrative|2|||
156432334|NCT01119950|564673751|FG000|Overall Study|Abnormal lab value|1|||
156432335|NCT01119950|564673751|FG000|Overall Study|Death|1|||
156527176|NCT03952806|565025241|FG001|OLE Phase (48 Weeks)|Other|13|||
156432336|NCT01988233|564673753|FG000|Overall Study|Lost to Follow-up|64|||
156432337|NCT01988233|564673754|FG001|Overall Study|Lost to Follow-up|51|||
156432338|NCT03621761|564673759|FG000|Overall Study|Lost to Follow-up|1|||
156432339|NCT03621761|564673760|FG001|Overall Study|Lost to Follow-up|1|||
156432340|NCT03621761|564673761|FG002|Overall Study|Lost to Follow-up|2|||
156432341|NCT03621761|564673759|FG000|Overall Study|Withdrawal by Subject|2|||
156432342|NCT03621761|564673760|FG001|Overall Study|Withdrawal by Subject|1|||
156432343|NCT03621761|564673761|FG002|Overall Study|Withdrawal by Subject|1|||
156432344|NCT03621761|564673759|FG000|Overall Study|Became Ineligible|0|||
156432345|NCT03621761|564673760|FG001|Overall Study|Became Ineligible|2|||
156432346|NCT03621761|564673761|FG002|Overall Study|Became Ineligible|0|||
156432347|NCT01191788|564673762|FG000|Overall Study|Lost to Follow-up|21|||
156432348|NCT01191788|564673763|FG001|Overall Study|Lost to Follow-up|22|||
156432349|NCT01050569|564673764|FG000|Overall Study|Lost to Follow-up|20|||
156432350|NCT01050569|564673765|FG001|Overall Study|Lost to Follow-up|14|||
156432351|NCT01050569|564673766|FG002|Overall Study|Lost to Follow-up|16|||
156432352|NCT01050569|564673764|FG000|Overall Study|Withdrawal by Subject|9|||
156432353|NCT01050569|564673765|FG001|Overall Study|Withdrawal by Subject|3|||
156432354|NCT01050569|564673766|FG002|Overall Study|Withdrawal by Subject|11|||
156432355|NCT01050569|564673764|FG000|Overall Study|Lack of Efficacy|5|||
156432356|NCT01050569|564673765|FG001|Overall Study|Lack of Efficacy|4|||
156432357|NCT01050569|564673766|FG002|Overall Study|Lack of Efficacy|3|||
156432358|NCT01050569|564673764|FG000|Overall Study|Adverse Event|1|||
156432359|NCT01050569|564673765|FG001|Overall Study|Adverse Event|0|||
156432360|NCT01050569|564673766|FG002|Overall Study|Adverse Event|0|||
156432361|NCT01050569|564673764|FG000|Overall Study|Physician Decision|3|||
156432362|NCT01050569|564673765|FG001|Overall Study|Physician Decision|3|||
156432363|NCT01050569|564673766|FG002|Overall Study|Physician Decision|3|||
156432364|NCT03939819|564673769|FG000|Overall Study|Death|2|||
156432365|NCT03939819|564673770|FG001|Overall Study|Death|0|||
156432366|NCT02148133|564673771|FG000|Overall Study|Investigator discretion|1|||
156432367|NCT02148133|564673771|FG000|Overall Study|Lack of Efficacy|1|||
156432368|NCT02148133|564673771|FG000|Overall Study|Protocol deviation|1|||
156432369|NCT02148133|564673771|FG000|Overall Study|Protocol-defined stopping criteria|2|||
156432370|NCT03808883|564673772|FG000|Overall Study|Withdrawal by Subject|2|||
156432371|NCT03808883|564673773|FG001|Overall Study|Withdrawal by Subject|0|||
156432372|NCT03808883|564673772|FG000|Overall Study|Did not complete pre test or post test survey|4|||
156432373|NCT03808883|564673773|FG001|Overall Study|Did not complete pre test or post test survey|3|||
156432374|NCT00079183|564673782|FG000|Overall Study|Withdrawal by Subject|4|||
156432375|NCT00079183|564673782|FG000|Overall Study|Study medication non-compliance|2|||
156432376|NCT00079183|564673782|FG000|Overall Study|Specimen collection non-compliance|1|||
156432377|NCT02613364|564673783|FG000|Overall Study|Other|19|||
156432378|NCT02613364|564673784|FG001|Overall Study|Other|29|||
156432379|NCT02613364|564673785|FG002|Overall Study|Other|17|||
156432380|NCT02613364|564673783|FG000|Overall Study|Too time consuming|21|||
156432381|NCT02613364|564673784|FG001|Overall Study|Too time consuming|26|||
156432382|NCT02613364|564673785|FG002|Overall Study|Too time consuming|26|||
156432383|NCT02613364|564673783|FG000|Overall Study|Withdrawal by Subject|13|||
156432384|NCT02613364|564673784|FG001|Overall Study|Withdrawal by Subject|18|||
156432385|NCT02613364|564673785|FG002|Overall Study|Withdrawal by Subject|17|||
156432386|NCT02613364|564673783|FG000|Overall Study|Medical|12|||
156432387|NCT02613364|564673784|FG001|Overall Study|Medical|13|||
156432388|NCT02613364|564673785|FG002|Overall Study|Medical|9|||
156432389|NCT02613364|564673783|FG000|Overall Study|Disliked Study Procedure|1|||
156432390|NCT02613364|564673784|FG001|Overall Study|Disliked Study Procedure|1|||
156432391|NCT02613364|564673785|FG002|Overall Study|Disliked Study Procedure|4|||
156432392|NCT02613364|564673783|FG000|Overall Study|Disliked Intervention|0|||
156432393|NCT02613364|564673784|FG001|Overall Study|Disliked Intervention|3|||
156673274|NCT00205777|565550632|FG005|Study Extension II|Adverse Event|30|||
156432394|NCT02613364|564673785|FG002|Overall Study|Disliked Intervention|3|||
156432395|NCT01909336|564673786|FG000|Overall Study|Lost to Follow-up|4|||
156432396|NCT01909336|564673787|FG001|Overall Study|Lost to Follow-up|2|||
156432397|NCT01909336|564673788|FG002|Overall Study|Lost to Follow-up|2|||
156673275|NCT00205777|565550627|FG000|Study Extension II|Death|0|||
156673276|NCT00205777|565550628|FG001|Study Extension II|Death|0|||
156673277|NCT00205777|565550629|FG002|Study Extension II|Death|0|||
156673278|NCT00205777|565550630|FG003|Study Extension II|Death|2|||
156673279|NCT00205777|565550631|FG004|Study Extension II|Death|0|||
156673280|NCT00205777|565550632|FG005|Study Extension II|Death|5|||
156673281|NCT00205777|565550627|FG000|Study Extension II|Withdrawal by Subject|0|||
156432398|NCT01909336|564673786|FG000|Overall Study|Physician Decision|0|||
156432399|NCT01909336|564673787|FG001|Overall Study|Physician Decision|1|||
156432400|NCT01909336|564673788|FG002|Overall Study|Physician Decision|1|||
156432401|NCT01235949|564673789|FG000|Primary Phase|Migrated/moved from study area|1|||
156432402|NCT01235949|564673790|FG001|Primary Phase|Migrated/moved from study area|1|||
156673282|NCT00205777|565550628|FG001|Study Extension II|Withdrawal by Subject|0|||
156432403|NCT01235949|564673791|FG002|Primary Phase|Migrated/moved from study area|0|||
156432404|NCT01235949|564673792|FG003|Primary Phase|Migrated/moved from study area|0|||
156432405|NCT01235949|564673793|FG004|Primary Phase|Migrated/moved from study area|1|||
156432406|NCT01235949|564673794|FG005|Primary Phase|Migrated/moved from study area|2|||
156432407|NCT01235949|564673795|FG006|Primary Phase|Migrated/moved from study area|0|||
156432408|NCT01235949|564673796|FG007|Primary Phase|Migrated/moved from study area|0|||
156432409|NCT01235949|564673797|FG008|Primary Phase|Migrated/moved from study area|0|||
156432410|NCT01235949|564673798|FG009|Primary Phase|Migrated/moved from study area|0|||
156432411|NCT01235949|564673799|FG010|Primary Phase|Migrated/moved from study area|0|||
156432412|NCT01235949|564673800|FG011|Primary Phase|Migrated/moved from study area|0|||
156432413|NCT01235949|564673801|FG012|Primary Phase|Migrated/moved from study area|0|||
156432414|NCT01235949|564673802|FG013|Primary Phase|Migrated/moved from study area|0|||
156432415|NCT01235949|564673803|FG014|Primary Phase|Migrated/moved from study area|0|||
156527177|NCT01137955|565025242|FG000|Overall Study|Withdrawal by Subject|5|||
156527178|NCT01137955|565025243|FG001|Overall Study|Withdrawal by Subject|4|||
156327776|NCT01539642|564301380|FG001|Overall Study|Patient ready for early discharge|7|||
156432416|NCT01235949|564673804|FG015|Primary Phase|Migrated/moved from study area|0|||
156432417|NCT01235949|564673805|FG016|Primary Phase|Migrated/moved from study area|0|||
156432418|NCT01235949|564673806|FG017|Primary Phase|Migrated/moved from study area|0|||
156432419|NCT01235949|564673789|FG000|Primary Phase|Adverse Event|0|||
156432420|NCT01235949|564673790|FG001|Primary Phase|Adverse Event|0|||
156432421|NCT01235949|564673791|FG002|Primary Phase|Adverse Event|0|||
156432422|NCT01235949|564673792|FG003|Primary Phase|Adverse Event|1|||
156432423|NCT01235949|564673793|FG004|Primary Phase|Adverse Event|0|||
156432424|NCT01235949|564673794|FG005|Primary Phase|Adverse Event|0|||
156432425|NCT01235949|564673795|FG006|Primary Phase|Adverse Event|0|||
156432426|NCT01235949|564673796|FG007|Primary Phase|Adverse Event|0|||
156432427|NCT01235949|564673797|FG008|Primary Phase|Adverse Event|0|||
156432428|NCT01235949|564673798|FG009|Primary Phase|Adverse Event|0|||
156432429|NCT01235949|564673799|FG010|Primary Phase|Adverse Event|0|||
156432430|NCT01235949|564673800|FG011|Primary Phase|Adverse Event|0|||
156432431|NCT01235949|564673801|FG012|Primary Phase|Adverse Event|0|||
156432432|NCT01235949|564673802|FG013|Primary Phase|Adverse Event|0|||
156432433|NCT01235949|564673803|FG014|Primary Phase|Adverse Event|0|||
156432434|NCT01235949|564673804|FG015|Primary Phase|Adverse Event|0|||
156432435|NCT01235949|564673805|FG016|Primary Phase|Adverse Event|0|||
156432436|NCT01235949|564673806|FG017|Primary Phase|Adverse Event|0|||
156432437|NCT01235949|564673789|FG000|Primary Phase|Withdrawal by Subject|3|||
156432438|NCT01235949|564673790|FG001|Primary Phase|Withdrawal by Subject|2|||
156432439|NCT01235949|564673791|FG002|Primary Phase|Withdrawal by Subject|2|||
156527179|NCT02027701|565025247|FG000|Overall Study|Adverse Event|3|||
156527180|NCT02027701|565025247|FG000|Overall Study|Lack of Efficacy|8|||
156527181|NCT02027701|565025247|FG000|Overall Study|Physician Decision|2|||
156527182|NCT02027701|565025247|FG000|Overall Study|Withdrawal by Subject|3|||
156527183|NCT00756470|565025248|FG000|Overall Study|Withdrawal by Subject|1|||
156527184|NCT00756470|565025248|FG000|Overall Study|Adverse Event|4|||
156527185|NCT00820027|565025249|FG000|Overall Study|Adverse Event|15|||
156527186|NCT00820027|565025250|FG001|Overall Study|Adverse Event|8|||
156527187|NCT00820027|565025251|FG002|Overall Study|Adverse Event|10|||
156527188|NCT00820027|565025252|FG003|Overall Study|Adverse Event|5|||
156527189|NCT00820027|565025249|FG000|Overall Study|Lack of Efficacy|2|||
156527190|NCT00820027|565025250|FG001|Overall Study|Lack of Efficacy|1|||
156527191|NCT00820027|565025251|FG002|Overall Study|Lack of Efficacy|2|||
156327777|NCT01539642|564301379|FG000|Overall Study|Adverse Event|6|||
156327778|NCT01539642|564301380|FG001|Overall Study|Adverse Event|4|||
156327779|NCT01539642|564301379|FG000|Overall Study|Withdrawal by Subject|2|||
156327780|NCT01539642|564301380|FG001|Overall Study|Withdrawal by Subject|2|||
156327781|NCT00598702|564301381|FG000|Overall Study|Other|0|||
156327782|NCT00598702|564301382|FG001|Overall Study|Other|2|||
156327783|NCT00598702|564301383|FG002|Overall Study|Other|0|||
156327784|NCT00598702|564301384|FG003|Overall Study|Other|0|||
156327785|NCT00598702|564301385|FG004|Overall Study|Other|0|||
156327786|NCT00598702|564301386|FG005|Overall Study|Other|1|||
156327787|NCT00598702|564301387|FG006|Overall Study|Other|0|||
156327788|NCT00598702|564301388|FG007|Overall Study|Other|0|||
156327789|NCT00598702|564301381|FG000|Overall Study|Early discharge from hospital|0|||
156327790|NCT00598702|564301382|FG001|Overall Study|Early discharge from hospital|0|||
156327791|NCT00598702|564301383|FG002|Overall Study|Early discharge from hospital|2|||
156327792|NCT00598702|564301384|FG003|Overall Study|Early discharge from hospital|5|||
156327793|NCT00598702|564301385|FG004|Overall Study|Early discharge from hospital|0|||
156432440|NCT01235949|564673792|FG003|Primary Phase|Withdrawal by Subject|0|||
156432441|NCT01235949|564673793|FG004|Primary Phase|Withdrawal by Subject|0|||
156432442|NCT01235949|564673794|FG005|Primary Phase|Withdrawal by Subject|3|||
156527192|NCT00820027|565025252|FG003|Overall Study|Lack of Efficacy|2|||
156432443|NCT01235949|564673795|FG006|Primary Phase|Withdrawal by Subject|0|||
156432444|NCT01235949|564673796|FG007|Primary Phase|Withdrawal by Subject|0|||
156432445|NCT01235949|564673797|FG008|Primary Phase|Withdrawal by Subject|0|||
156432446|NCT01235949|564673798|FG009|Primary Phase|Withdrawal by Subject|0|||
156432447|NCT01235949|564673799|FG010|Primary Phase|Withdrawal by Subject|0|||
156527193|NCT00820027|565025249|FG000|Overall Study|Physician Decision|0|||
156527194|NCT00820027|565025250|FG001|Overall Study|Physician Decision|1|||
156432448|NCT01235949|564673800|FG011|Primary Phase|Withdrawal by Subject|0|||
156432449|NCT01235949|564673801|FG012|Primary Phase|Withdrawal by Subject|0|||
156432450|NCT01235949|564673802|FG013|Primary Phase|Withdrawal by Subject|0|||
156432451|NCT01235949|564673803|FG014|Primary Phase|Withdrawal by Subject|0|||
156432452|NCT01235949|564673804|FG015|Primary Phase|Withdrawal by Subject|0|||
156432453|NCT01235949|564673805|FG016|Primary Phase|Withdrawal by Subject|0|||
156432454|NCT01235949|564673806|FG017|Primary Phase|Withdrawal by Subject|0|||
156432455|NCT01235949|564673789|FG000|Primary Phase|Lost to Follow-up|0|||
156432456|NCT01235949|564673790|FG001|Primary Phase|Lost to Follow-up|0|||
156432457|NCT01235949|564673791|FG002|Primary Phase|Lost to Follow-up|1|||
156432458|NCT01235949|564673792|FG003|Primary Phase|Lost to Follow-up|1|||
156432459|NCT01235949|564673793|FG004|Primary Phase|Lost to Follow-up|0|||
156432460|NCT01235949|564673794|FG005|Primary Phase|Lost to Follow-up|2|||
156432461|NCT01235949|564673795|FG006|Primary Phase|Lost to Follow-up|0|||
156432462|NCT01235949|564673796|FG007|Primary Phase|Lost to Follow-up|0|||
156432463|NCT01235949|564673797|FG008|Primary Phase|Lost to Follow-up|0|||
156432464|NCT01235949|564673798|FG009|Primary Phase|Lost to Follow-up|0|||
156432465|NCT01235949|564673799|FG010|Primary Phase|Lost to Follow-up|0|||
156432466|NCT01235949|564673800|FG011|Primary Phase|Lost to Follow-up|0|||
156432467|NCT01235949|564673801|FG012|Primary Phase|Lost to Follow-up|0|||
156432468|NCT01235949|564673802|FG013|Primary Phase|Lost to Follow-up|0|||
156432469|NCT01235949|564673803|FG014|Primary Phase|Lost to Follow-up|0|||
156432470|NCT01235949|564673804|FG015|Primary Phase|Lost to Follow-up|0|||
156432471|NCT01235949|564673805|FG016|Primary Phase|Lost to Follow-up|0|||
156432472|NCT01235949|564673806|FG017|Primary Phase|Lost to Follow-up|0|||
156432473|NCT01235949|564673789|FG000|Booster Phase|Migrated/moved from study area|0|||
156432474|NCT01235949|564673790|FG001|Booster Phase|Migrated/moved from study area|0|||
156432475|NCT01235949|564673791|FG002|Booster Phase|Migrated/moved from study area|0|||
156432476|NCT01235949|564673792|FG003|Booster Phase|Migrated/moved from study area|0|||
156432477|NCT01235949|564673793|FG004|Booster Phase|Migrated/moved from study area|0|||
156432478|NCT01235949|564673794|FG005|Booster Phase|Migrated/moved from study area|0|||
156432479|NCT01235949|564673795|FG006|Booster Phase|Migrated/moved from study area|0|||
156432480|NCT01235949|564673796|FG007|Booster Phase|Migrated/moved from study area|0|||
156432481|NCT01235949|564673797|FG008|Booster Phase|Migrated/moved from study area|0|||
156432482|NCT01235949|564673798|FG009|Booster Phase|Migrated/moved from study area|0|||
156432483|NCT01235949|564673799|FG010|Booster Phase|Migrated/moved from study area|0|||
156432484|NCT01235949|564673800|FG011|Booster Phase|Migrated/moved from study area|1|||
156432485|NCT01235949|564673801|FG012|Booster Phase|Migrated/moved from study area|1|||
156432486|NCT01235949|564673802|FG013|Booster Phase|Migrated/moved from study area|0|||
156432487|NCT01235949|564673803|FG014|Booster Phase|Migrated/moved from study area|0|||
156432488|NCT01235949|564673804|FG015|Booster Phase|Migrated/moved from study area|0|||
156432489|NCT01235949|564673805|FG016|Booster Phase|Migrated/moved from study area|0|||
156432490|NCT01235949|564673806|FG017|Booster Phase|Migrated/moved from study area|1|||
156432491|NCT01235949|564673789|FG000|Booster Phase|Adverse Event|0|||
156432492|NCT01235949|564673790|FG001|Booster Phase|Adverse Event|0|||
156432493|NCT01235949|564673791|FG002|Booster Phase|Adverse Event|0|||
156432494|NCT01235949|564673792|FG003|Booster Phase|Adverse Event|0|||
156432495|NCT01235949|564673793|FG004|Booster Phase|Adverse Event|0|||
156432496|NCT01235949|564673794|FG005|Booster Phase|Adverse Event|0|||
156432497|NCT01235949|564673795|FG006|Booster Phase|Adverse Event|0|||
156432498|NCT01235949|564673796|FG007|Booster Phase|Adverse Event|0|||
156432499|NCT01235949|564673797|FG008|Booster Phase|Adverse Event|0|||
156432500|NCT01235949|564673798|FG009|Booster Phase|Adverse Event|0|||
156432501|NCT01235949|564673799|FG010|Booster Phase|Adverse Event|0|||
156432502|NCT01235949|564673800|FG011|Booster Phase|Adverse Event|0|||
156432503|NCT01235949|564673801|FG012|Booster Phase|Adverse Event|0|||
156432504|NCT01235949|564673802|FG013|Booster Phase|Adverse Event|0|||
156432505|NCT01235949|564673803|FG014|Booster Phase|Adverse Event|0|||
156432506|NCT01235949|564673804|FG015|Booster Phase|Adverse Event|1|||
156432507|NCT01235949|564673805|FG016|Booster Phase|Adverse Event|0|||
156432508|NCT01235949|564673806|FG017|Booster Phase|Adverse Event|0|||
156432509|NCT01235949|564673789|FG000|Booster Phase|Withdrawal by Subject|0|||
156432510|NCT01235949|564673790|FG001|Booster Phase|Withdrawal by Subject|0|||
156432511|NCT01235949|564673791|FG002|Booster Phase|Withdrawal by Subject|0|||
156432512|NCT01235949|564673792|FG003|Booster Phase|Withdrawal by Subject|0|||
156432513|NCT01235949|564673793|FG004|Booster Phase|Withdrawal by Subject|0|||
156432514|NCT01235949|564673794|FG005|Booster Phase|Withdrawal by Subject|0|||
156432515|NCT01235949|564673795|FG006|Booster Phase|Withdrawal by Subject|0|||
156432516|NCT01235949|564673796|FG007|Booster Phase|Withdrawal by Subject|1|||
156432517|NCT01235949|564673797|FG008|Booster Phase|Withdrawal by Subject|1|||
156432518|NCT01235949|564673798|FG009|Booster Phase|Withdrawal by Subject|0|||
156432519|NCT01235949|564673799|FG010|Booster Phase|Withdrawal by Subject|1|||
156432520|NCT01235949|564673800|FG011|Booster Phase|Withdrawal by Subject|1|||
156432521|NCT01235949|564673801|FG012|Booster Phase|Withdrawal by Subject|2|||
156432522|NCT01235949|564673802|FG013|Booster Phase|Withdrawal by Subject|0|||
156432523|NCT01235949|564673803|FG014|Booster Phase|Withdrawal by Subject|2|||
156527195|NCT00820027|565025251|FG002|Overall Study|Physician Decision|1|||
156432524|NCT01235949|564673804|FG015|Booster Phase|Withdrawal by Subject|0|||
156432525|NCT01235949|564673805|FG016|Booster Phase|Withdrawal by Subject|0|||
156432526|NCT01235949|564673806|FG017|Booster Phase|Withdrawal by Subject|0|||
156432527|NCT01235949|564673789|FG000|Booster Phase|Lost to Follow-up|0|||
156432528|NCT01235949|564673790|FG001|Booster Phase|Lost to Follow-up|0|||
156432529|NCT01235949|564673791|FG002|Booster Phase|Lost to Follow-up|0|||
156432530|NCT01235949|564673792|FG003|Booster Phase|Lost to Follow-up|0|||
156432531|NCT01235949|564673793|FG004|Booster Phase|Lost to Follow-up|0|||
156432532|NCT01235949|564673794|FG005|Booster Phase|Lost to Follow-up|0|||
156432533|NCT01235949|564673795|FG006|Booster Phase|Lost to Follow-up|0|||
156432534|NCT01235949|564673796|FG007|Booster Phase|Lost to Follow-up|0|||
156432535|NCT01235949|564673797|FG008|Booster Phase|Lost to Follow-up|1|||
156432536|NCT01235949|564673798|FG009|Booster Phase|Lost to Follow-up|1|||
156432537|NCT01235949|564673799|FG010|Booster Phase|Lost to Follow-up|1|||
156432538|NCT01235949|564673800|FG011|Booster Phase|Lost to Follow-up|1|||
156432539|NCT01235949|564673801|FG012|Booster Phase|Lost to Follow-up|0|||
156432540|NCT01235949|564673802|FG013|Booster Phase|Lost to Follow-up|0|||
156432541|NCT01235949|564673803|FG014|Booster Phase|Lost to Follow-up|0|||
156432542|NCT01235949|564673804|FG015|Booster Phase|Lost to Follow-up|0|||
156432543|NCT01235949|564673805|FG016|Booster Phase|Lost to Follow-up|0|||
156432544|NCT01235949|564673806|FG017|Booster Phase|Lost to Follow-up|1|||
156432545|NCT00436644|564673807|FG000|Overall Study|Adverse Event|2|||
156432546|NCT00436644|564673807|FG000|Overall Study|Death|1|||
156432547|NCT04364269|564673812|FG000|Overall Study|Adverse Event|1|||
156432548|NCT04364269|564673813|FG001|Overall Study|Adverse Event|0|||
156432549|NCT04364269|564673814|FG002|Overall Study|Adverse Event|0|||
156432550|NCT04364269|564673812|FG000|Overall Study|Withdrawal by Subject|0|||
156432551|NCT04364269|564673813|FG001|Overall Study|Withdrawal by Subject|1|||
156432552|NCT04364269|564673814|FG002|Overall Study|Withdrawal by Subject|0|||
156432553|NCT02026258|564673815|FG000|Randomized|Did not start treatment|2|||
156432554|NCT02026258|564673816|FG001|Randomized|Did not start treatment|1|||
156432555|NCT02026258|564673815|FG000|Randomized|Change in treatment plan|1|||
156432556|NCT02026258|564673816|FG001|Randomized|Change in treatment plan|0|||
156432557|NCT02026258|564673815|FG000|Randomized|Presence of periodontal disease|1|||
156432558|NCT02026258|564673816|FG001|Randomized|Presence of periodontal disease|1|||
156432559|NCT02026258|564673815|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
156432560|NCT02026258|564673816|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
156432561|NCT02026258|564673815|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
156432562|NCT02026258|564673816|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
156673283|NCT00205777|565550629|FG002|Study Extension II|Withdrawal by Subject|0|||
156432563|NCT00371566|564673819|FG000|Treatment Phase|Withdrawal by Subject|0|||
156432564|NCT00371566|564673820|FG001|Treatment Phase|Withdrawal by Subject|1|||
156432565|NCT00371566|564673819|FG000|Treatment Phase|Adverse Event|0|||
156432566|NCT00371566|564673820|FG001|Treatment Phase|Adverse Event|1|||
156432567|NCT00371566|564673819|FG000|Treatment Phase|Protocol Violation|0|||
156432568|NCT00371566|564673820|FG001|Treatment Phase|Protocol Violation|1|||
156432569|NCT00371566|564673819|FG000|Chemoradiation Phase|Physician Decision|2|||
156432570|NCT00371566|564673820|FG001|Chemoradiation Phase|Physician Decision|0|||
156432571|NCT00371566|564673819|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
156432572|NCT00371566|564673820|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
156432573|NCT00371566|564673819|FG000|Chemoradiation Phase|Non compliant|0|||
156432574|NCT00371566|564673820|FG001|Chemoradiation Phase|Non compliant|1|||
156432575|NCT00371566|564673819|FG000|Chemoradiation Phase|Progressive Disease|1|||
156673284|NCT00205777|565550630|FG003|Study Extension II|Withdrawal by Subject|35|||
156673285|NCT00205777|565550631|FG004|Study Extension II|Withdrawal by Subject|0|||
156673286|NCT00205777|565550632|FG005|Study Extension II|Withdrawal by Subject|59|||
156673287|NCT00205777|565550627|FG000|Study Extension II|Protocol Violation|0|||
156673288|NCT00205777|565550628|FG001|Study Extension II|Protocol Violation|0|||
156432576|NCT00371566|564673820|FG001|Chemoradiation Phase|Progressive Disease|1|||
156432577|NCT00371566|564673819|FG000|Chemoradiation Phase|Death|2|||
156673289|NCT00205777|565550629|FG002|Study Extension II|Protocol Violation|0|||
156673290|NCT00205777|565550630|FG003|Study Extension II|Protocol Violation|1|||
156673291|NCT00205777|565550631|FG004|Study Extension II|Protocol Violation|0|||
156673292|NCT00205777|565550632|FG005|Study Extension II|Protocol Violation|10|||
156432578|NCT00371566|564673820|FG001|Chemoradiation Phase|Death|0|||
156432579|NCT00371566|564673819|FG000|Follow Up Phase|Death|0|||
156432580|NCT00371566|564673820|FG001|Follow Up Phase|Death|5|||
156432581|NCT00371566|564673819|FG000|Follow Up Phase|Disease progression|1|||
156432582|NCT00371566|564673820|FG001|Follow Up Phase|Disease progression|0|||
156432583|NCT00371566|564673819|FG000|Follow Up Phase|Withdrawal by Subject|0|||
156432584|NCT00371566|564673820|FG001|Follow Up Phase|Withdrawal by Subject|1|||
156432585|NCT00371566|564673819|FG000|Follow Up Phase|Physician Decision|1|||
156527196|NCT00820027|565025252|FG003|Overall Study|Physician Decision|0|||
156432586|NCT00371566|564673820|FG001|Follow Up Phase|Physician Decision|1|||
156432587|NCT00371566|564673819|FG000|Follow Up Phase|Lost to Follow-up|1|||
156432588|NCT00371566|564673820|FG001|Follow Up Phase|Lost to Follow-up|0|||
156673293|NCT00205777|565550627|FG000|Study Extension II|Lack of Efficacy|0|||
156432589|NCT02534350|564673821|FG000|Overall Study|Randomized But Not Treated|1|||
156432590|NCT02534350|564673822|FG001|Overall Study|Randomized But Not Treated|0|||
156432591|NCT02534350|564673821|FG000|Overall Study|Protocol Violation|1|||
156432592|NCT02534350|564673822|FG001|Overall Study|Protocol Violation|0|||
156432593|NCT02534350|564673821|FG000|Overall Study|Withdrew Consent|2|||
156432594|NCT02534350|564673822|FG001|Overall Study|Withdrew Consent|0|||
156432595|NCT02341625|564673827|FG000|Overall Study|Disease Progression|2|||
156432596|NCT02341625|564673828|FG001|Overall Study|Disease Progression|2|||
156432597|NCT02341625|564673829|FG002|Overall Study|Disease Progression|3|||
156432598|NCT02341625|564673830|FG003|Overall Study|Disease Progression|6|||
156432599|NCT02341625|564673831|FG004|Overall Study|Disease Progression|7|||
156432600|NCT02341625|564673832|FG005|Overall Study|Disease Progression|7|||
156432601|NCT02341625|564673833|FG006|Overall Study|Disease Progression|28|||
156432602|NCT02341625|564673834|FG007|Overall Study|Disease Progression|5|||
156432603|NCT02341625|564673835|FG008|Overall Study|Disease Progression|4|||
156432604|NCT02341625|564673836|FG009|Overall Study|Disease Progression|19|||
156432605|NCT02341625|564673827|FG000|Overall Study|Study Drug Toxicity|0|||
156432606|NCT02341625|564673828|FG001|Overall Study|Study Drug Toxicity|0|||
156432607|NCT02341625|564673829|FG002|Overall Study|Study Drug Toxicity|0|||
156432608|NCT02341625|564673830|FG003|Overall Study|Study Drug Toxicity|1|||
156432609|NCT02341625|564673831|FG004|Overall Study|Study Drug Toxicity|0|||
156432610|NCT02341625|564673832|FG005|Overall Study|Study Drug Toxicity|3|||
156432611|NCT02341625|564673833|FG006|Overall Study|Study Drug Toxicity|10|||
156432612|NCT02341625|564673834|FG007|Overall Study|Study Drug Toxicity|0|||
156432613|NCT02341625|564673835|FG008|Overall Study|Study Drug Toxicity|0|||
156432614|NCT02341625|564673836|FG009|Overall Study|Study Drug Toxicity|3|||
156432615|NCT02341625|564673827|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156432616|NCT02341625|564673828|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156432617|NCT02341625|564673829|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156432618|NCT02341625|564673830|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156432619|NCT02341625|564673831|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156432620|NCT02341625|564673832|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156432621|NCT02341625|564673833|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
156432622|NCT02341625|564673834|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
156432623|NCT02341625|564673835|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156432624|NCT02341625|564673836|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
156432625|NCT02341625|564673827|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
156432626|NCT02341625|564673828|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
156432627|NCT02341625|564673829|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
156432628|NCT02341625|564673830|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
156432629|NCT02341625|564673831|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
156432630|NCT02341625|564673832|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
156432631|NCT02341625|564673833|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
156432632|NCT02341625|564673834|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
156432633|NCT02341625|564673835|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
156432634|NCT02341625|564673836|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
156432635|NCT02341625|564673827|FG000|Overall Study|Participant Withdrew Consent|0|||
156432636|NCT02341625|564673828|FG001|Overall Study|Participant Withdrew Consent|0|||
156432637|NCT02341625|564673829|FG002|Overall Study|Participant Withdrew Consent|0|||
156432638|NCT02341625|564673830|FG003|Overall Study|Participant Withdrew Consent|1|||
156432639|NCT02341625|564673831|FG004|Overall Study|Participant Withdrew Consent|0|||
156432640|NCT02341625|564673832|FG005|Overall Study|Participant Withdrew Consent|0|||
156432641|NCT02341625|564673833|FG006|Overall Study|Participant Withdrew Consent|0|||
156432642|NCT02341625|564673834|FG007|Overall Study|Participant Withdrew Consent|0|||
156432643|NCT02341625|564673835|FG008|Overall Study|Participant Withdrew Consent|0|||
156432644|NCT02341625|564673836|FG009|Overall Study|Participant Withdrew Consent|0|||
156432645|NCT02341625|564673827|FG000|Overall Study|Completed Treatment as per Protocol|0|||
156432646|NCT02341625|564673828|FG001|Overall Study|Completed Treatment as per Protocol|0|||
156432647|NCT02341625|564673829|FG002|Overall Study|Completed Treatment as per Protocol|0|||
156432648|NCT02341625|564673830|FG003|Overall Study|Completed Treatment as per Protocol|0|||
156432649|NCT02341625|564673831|FG004|Overall Study|Completed Treatment as per Protocol|0|||
156432650|NCT02341625|564673832|FG005|Overall Study|Completed Treatment as per Protocol|0|||
156432651|NCT02341625|564673833|FG006|Overall Study|Completed Treatment as per Protocol|0|||
156432652|NCT02341625|564673834|FG007|Overall Study|Completed Treatment as per Protocol|0|||
156432653|NCT02341625|564673835|FG008|Overall Study|Completed Treatment as per Protocol|0|||
156432654|NCT02341625|564673836|FG009|Overall Study|Completed Treatment as per Protocol|1|||
156432655|NCT02341625|564673827|FG000|Overall Study|Other Reasons|0|||
156432656|NCT02341625|564673828|FG001|Overall Study|Other Reasons|0|||
156432657|NCT02341625|564673829|FG002|Overall Study|Other Reasons|0|||
156432658|NCT02341625|564673830|FG003|Overall Study|Other Reasons|0|||
156432659|NCT02341625|564673831|FG004|Overall Study|Other Reasons|1|||
156432660|NCT02341625|564673832|FG005|Overall Study|Other Reasons|0|||
156432661|NCT02341625|564673833|FG006|Overall Study|Other Reasons|5|||
156432662|NCT02341625|564673834|FG007|Overall Study|Other Reasons|0|||
156432663|NCT02341625|564673835|FG008|Overall Study|Other Reasons|0|||
156432664|NCT02341625|564673836|FG009|Overall Study|Other Reasons|2|||
156432665|NCT02341625|564673827|FG000|Overall Study|Not Reported|0|||
156432666|NCT02341625|564673828|FG001|Overall Study|Not Reported|0|||
156432667|NCT02341625|564673829|FG002|Overall Study|Not Reported|0|||
156432668|NCT02341625|564673830|FG003|Overall Study|Not Reported|0|||
156432669|NCT02341625|564673831|FG004|Overall Study|Not Reported|0|||
156432670|NCT02341625|564673832|FG005|Overall Study|Not Reported|0|||
156432671|NCT02341625|564673833|FG006|Overall Study|Not Reported|0|||
156673294|NCT00205777|565550628|FG001|Study Extension II|Lack of Efficacy|0|||
156673295|NCT00205777|565550629|FG002|Study Extension II|Lack of Efficacy|0|||
156673296|NCT00205777|565550630|FG003|Study Extension II|Lack of Efficacy|0|||
156673297|NCT00205777|565550631|FG004|Study Extension II|Lack of Efficacy|0|||
156673298|NCT00205777|565550632|FG005|Study Extension II|Lack of Efficacy|1|||
156673299|NCT00205777|565550627|FG000|Study Extension II|Failed to return|0|||
156673300|NCT00205777|565550628|FG001|Study Extension II|Failed to return|0|||
156673301|NCT00205777|565550629|FG002|Study Extension II|Failed to return|0|||
156673302|NCT00205777|565550630|FG003|Study Extension II|Failed to return|14|||
156673303|NCT00205777|565550631|FG004|Study Extension II|Failed to return|0|||
156673304|NCT00205777|565550632|FG005|Study Extension II|Failed to return|26|||
156673305|NCT00205777|565550627|FG000|Study Extension II|Other Event|0|||
156673306|NCT00205777|565550628|FG001|Study Extension II|Other Event|0|||
156673307|NCT00205777|565550629|FG002|Study Extension II|Other Event|0|||
156673308|NCT00205777|565550630|FG003|Study Extension II|Other Event|12|||
156673309|NCT00205777|565550631|FG004|Study Extension II|Other Event|0|||
156673310|NCT00205777|565550632|FG005|Study Extension II|Other Event|20|||
156673311|NCT00205777|565550627|FG000|Study Extension II|Enrolled but not treated|0|||
156673312|NCT00205777|565550628|FG001|Study Extension II|Enrolled but not treated|0|||
156673313|NCT00205777|565550629|FG002|Study Extension II|Enrolled but not treated|0|||
156673314|NCT00205777|565550630|FG003|Study Extension II|Enrolled but not treated|71|||
156673315|NCT00205777|565550631|FG004|Study Extension II|Enrolled but not treated|0|||
156673316|NCT00205777|565550632|FG005|Study Extension II|Enrolled but not treated|131|||
156673317|NCT03808376|565550633|FG000|Overall Study|Withdrawal by Subject|10|||
156432672|NCT02341625|564673834|FG007|Overall Study|Not Reported|0|||
156432673|NCT02341625|564673835|FG008|Overall Study|Not Reported|0|||
156432674|NCT02341625|564673836|FG009|Overall Study|Not Reported|3|||
156432675|NCT00177216|564673837|FG000|Overall Study|Withdrawal by Subject|6|||
156432676|NCT00177216|564673838|FG001|Overall Study|Withdrawal by Subject|3|||
156432677|NCT00177216|564673839|FG002|Overall Study|Withdrawal by Subject|1|||
156432678|NCT00639002|564673840|FG000|Overall Study|Death|1|||
156432679|NCT00639002|564673840|FG000|Overall Study|Adverse Event|1|||
156432680|NCT00639002|564673840|FG000|Overall Study|Protocol Violation|1|||
156432681|NCT00639002|564673840|FG000|Overall Study|Disease progression|3|||
156432682|NCT00639002|564673840|FG000|Overall Study|Physician Decision|6|||
156432683|NCT00639002|564673840|FG000|Overall Study|Lack of Efficacy|1|||
156432684|NCT03310983|564673846|FG000|Overall Study|Lost to Follow-up|15|||
156432685|NCT03310983|564673847|FG001|Overall Study|Lost to Follow-up|17|||
156432686|NCT03368001|564673849|FG000|Allocation|Lost to Pretest|16|||
156432687|NCT03368001|564673850|FG001|Allocation|Lost to Pretest|25|||
156432688|NCT03368001|564673849|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
156432689|NCT03368001|564673850|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
156432690|NCT03368001|564673849|FG000|Posttest|Lost to Posttest|7|||
156432691|NCT03368001|564673850|FG001|Posttest|Lost to Posttest|11|||
156432692|NCT03368001|564673849|FG000|Posttest|Discontinued Intervention|6|||
156432693|NCT03368001|564673850|FG001|Posttest|Discontinued Intervention|19|||
156432694|NCT03368001|564673849|FG000|Follow-up|Lost to Follow-up|6|||
156673318|NCT00700739|565550637|FG000|Overall Study|Lost to Follow-up|4|||
156673319|NCT00700739|565550638|FG001|Overall Study|Lost to Follow-up|4|||
156673320|NCT00003470|565550642|FG000|Overall Study|Not evaluable|6|||
156432695|NCT03368001|564673850|FG001|Follow-up|Lost to Follow-up|3|||
156673321|NCT03503318|565550646|FG000|Overall Study|Death|1|||
156673322|NCT03503318|565550647|FG001|Overall Study|Death|0|||
156673323|NCT03503318|565550648|FG002|Overall Study|Death|4|||
156673324|NCT03503318|565550646|FG000|Overall Study|Adverse Event|3|||
156673325|NCT03503318|565550647|FG001|Overall Study|Adverse Event|4|||
156432696|NCT01656304|564673858|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
156432697|NCT01093534|564673859|FG000|Overall Study|Adverse Event|2|||
156432698|NCT01093534|564673860|FG001|Overall Study|Adverse Event|5|||
156432699|NCT01093534|564673861|FG002|Overall Study|Adverse Event|2|||
156432700|NCT01093534|564673859|FG000|Overall Study|Lack of Efficacy|2|||
156673326|NCT03503318|565550648|FG002|Overall Study|Adverse Event|2|||
156673327|NCT03503318|565550646|FG000|Overall Study|Withdrawal by Subject|12|||
156673328|NCT03503318|565550647|FG001|Overall Study|Withdrawal by Subject|17|||
156673329|NCT03503318|565550648|FG002|Overall Study|Withdrawal by Subject|16|||
156432701|NCT01093534|564673860|FG001|Overall Study|Lack of Efficacy|1|||
156432702|NCT01093534|564673861|FG002|Overall Study|Lack of Efficacy|1|||
156673330|NCT03503318|565550646|FG000|Overall Study|Protocol Violation|5|||
156673331|NCT03503318|565550647|FG001|Overall Study|Protocol Violation|0|||
156673332|NCT03503318|565550648|FG002|Overall Study|Protocol Violation|3|||
156673333|NCT03503318|565550646|FG000|Overall Study|Lost to Follow-up|17|||
156673334|NCT03503318|565550647|FG001|Overall Study|Lost to Follow-up|15|||
156673335|NCT03503318|565550648|FG002|Overall Study|Lost to Follow-up|12|||
156673336|NCT03503318|565550646|FG000|Overall Study|Other than specified|1|||
156673337|NCT03503318|565550647|FG001|Overall Study|Other than specified|3|||
156673338|NCT03503318|565550648|FG002|Overall Study|Other than specified|3|||
156673339|NCT01794845|565550649|FG000|Overall Study|Withdrawal by Subject|1|||
156673340|NCT02139826|565550650|FG000|Overall Study|Adverse Event|1|||
156673341|NCT00867360|565550651|FG000|Overall Study|Withdrawal by Subject|1|||
156673342|NCT00867360|565550652|FG001|Overall Study|Withdrawal by Subject|0|||
156673343|NCT00867360|565550651|FG000|Overall Study|Physician Decision|0|||
156673344|NCT00867360|565550652|FG001|Overall Study|Physician Decision|1|||
156673345|NCT01004510|565550656|FG000|Overall Study|Adverse Event|1|||
156673346|NCT03218787|565550662|FG000|Overall Study|Lost to Follow-up|12|||
156673347|NCT03218787|565550662|FG000|Overall Study|Withdrawal by Subject|72|||
156673348|NCT03218787|565550662|FG000|Overall Study|Physician Decision|11|||
156673349|NCT03218787|565550662|FG000|Overall Study|Death|111|||
156673350|NCT02923349|565550663|FG000|Overall Study|Other|1|||
156673351|NCT02923349|565550664|FG001|Overall Study|Other|2|||
156673352|NCT02923349|565550665|FG002|Overall Study|Other|4|||
156673353|NCT02923349|565550666|FG003|Overall Study|Other|1|||
156673354|NCT02923349|565550667|FG004|Overall Study|Other|3|||
156673355|NCT02923349|565550668|FG005|Overall Study|Other|0|||
156673356|NCT02923349|565550669|FG006|Overall Study|Other|1|||
156673357|NCT02923349|565550663|FG000|Overall Study|Withdrawal by Subject|2|||
156673358|NCT02923349|565550664|FG001|Overall Study|Withdrawal by Subject|2|||
156673359|NCT02923349|565550665|FG002|Overall Study|Withdrawal by Subject|8|||
156673360|NCT02923349|565550666|FG003|Overall Study|Withdrawal by Subject|10|||
156673361|NCT02923349|565550667|FG004|Overall Study|Withdrawal by Subject|12|||
156673362|NCT02923349|565550668|FG005|Overall Study|Withdrawal by Subject|3|||
156673363|NCT02923349|565550669|FG006|Overall Study|Withdrawal by Subject|0|||
156673364|NCT02923349|565550663|FG000|Overall Study|Physician Decision|0|||
156673365|NCT02923349|565550664|FG001|Overall Study|Physician Decision|0|||
156673366|NCT02923349|565550665|FG002|Overall Study|Physician Decision|0|||
156673367|NCT02923349|565550666|FG003|Overall Study|Physician Decision|1|||
156673368|NCT02923349|565550667|FG004|Overall Study|Physician Decision|1|||
156673369|NCT02923349|565550668|FG005|Overall Study|Physician Decision|0|||
156673370|NCT02923349|565550669|FG006|Overall Study|Physician Decision|2|||
156673371|NCT02923349|565550663|FG000|Overall Study|Lost to Follow-up|0|||
156673372|NCT02923349|565550664|FG001|Overall Study|Lost to Follow-up|0|||
156673373|NCT02923349|565550665|FG002|Overall Study|Lost to Follow-up|3|||
156673374|NCT02923349|565550666|FG003|Overall Study|Lost to Follow-up|0|||
156527197|NCT00820027|565025249|FG000|Overall Study|Protocol Violation|3|||
156527198|NCT00820027|565025250|FG001|Overall Study|Protocol Violation|0|||
156527199|NCT00820027|565025251|FG002|Overall Study|Protocol Violation|4|||
156527200|NCT00820027|565025252|FG003|Overall Study|Protocol Violation|0|||
156527201|NCT00820027|565025249|FG000|Overall Study|Withdrawal by Subject|6|||
156527202|NCT00820027|565025250|FG001|Overall Study|Withdrawal by Subject|4|||
156527203|NCT00820027|565025251|FG002|Overall Study|Withdrawal by Subject|4|||
156432703|NCT01093534|564673859|FG000|Overall Study|Withdrawal by Subject|5|||
156432704|NCT01093534|564673860|FG001|Overall Study|Withdrawal by Subject|7|||
156432705|NCT01093534|564673861|FG002|Overall Study|Withdrawal by Subject|2|||
156673375|NCT02923349|565550667|FG004|Overall Study|Lost to Follow-up|1|||
156432706|NCT01093534|564673859|FG000|Overall Study|Other|1|||
156432707|NCT01093534|564673860|FG001|Overall Study|Other|3|||
156432708|NCT01093534|564673861|FG002|Overall Study|Other|4|||
156432709|NCT00741988|564673862|FG000|Overall Study|Adverse Event|2|||
156432710|NCT00741988|564673863|FG001|Overall Study|Adverse Event|4|||
156432711|NCT00741988|564673862|FG000|Overall Study|Lack of Efficacy|2|||
156432712|NCT00741988|564673863|FG001|Overall Study|Lack of Efficacy|0|||
156432713|NCT03008915|564673866|FG000|Treatment 1|Withdrawal by Subject|0|||
156432714|NCT03008915|564673867|FG001|Treatment 1|Withdrawal by Subject|1|||
156432715|NCT00712166|564673870|FG000|Overall Study|Noncompliance|0|||
156432716|NCT00712166|564673871|FG001|Overall Study|Noncompliance|1|||
156432717|NCT01773122|564673872|FG000|Overall Study|Due to amended age eligibility criteria|3|||
156527204|NCT00820027|565025252|FG003|Overall Study|Withdrawal by Subject|6|||
156673376|NCT02923349|565550668|FG005|Overall Study|Lost to Follow-up|1|||
156673377|NCT02923349|565550669|FG006|Overall Study|Lost to Follow-up|0|||
156432718|NCT01773122|564673873|FG001|Overall Study|Due to amended age eligibility criteria|1|||
156432719|NCT01773122|564673874|FG002|Overall Study|Due to amended age eligibility criteria|0|||
156527205|NCT02604433|565025253|FG000|Overall Study|Withdrawal by Subject|37|||
156673378|NCT02923349|565550663|FG000|Overall Study|Death|1|||
156673379|NCT02923349|565550664|FG001|Overall Study|Death|0|||
156673380|NCT02923349|565550665|FG002|Overall Study|Death|2|||
156673381|NCT02923349|565550666|FG003|Overall Study|Death|4|||
156673382|NCT02923349|565550667|FG004|Overall Study|Death|2|||
156673383|NCT02923349|565550668|FG005|Overall Study|Death|3|||
156673384|NCT02923349|565550669|FG006|Overall Study|Death|0|||
156673385|NCT01120028|565550672|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
156673386|NCT01120028|565550673|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
156673387|NCT01120028|565550674|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
156673388|NCT01120028|565550675|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
156673389|NCT01120028|565550672|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
156673390|NCT01120028|565550673|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
156673391|NCT01120028|565550674|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
156673392|NCT01120028|565550675|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
156673393|NCT01248728|565550676|FG000|Overall Study|Adverse Event|1|||
156673394|NCT01248728|565550677|FG001|Overall Study|Adverse Event|1|||
156673395|NCT01248728|565550676|FG000|Overall Study|Withdrawal by Subject|2|||
156673396|NCT01248728|565550677|FG001|Overall Study|Withdrawal by Subject|1|||
156673397|NCT01248728|565550676|FG000|Overall Study|Lack of Efficacy|1|||
156673398|NCT01248728|565550677|FG001|Overall Study|Lack of Efficacy|0|||
156673399|NCT01841554|565550678|FG000|Overall Study|Death|7|||
156673400|NCT01841554|565550678|FG000|Overall Study|No Implantation|1|||
156673401|NCT01841554|565550678|FG000|Overall Study|Discontinued Follow Up|5|||
156673402|NCT01841554|565550678|FG000|Overall Study|Study exit due to secondary intervention|6|||
156673403|NCT00312897|565550679|FG000|Overall Study|Adverse Event|1|||
156673404|NCT00312897|565550680|FG001|Overall Study|Adverse Event|0|||
156673405|NCT00312897|565550679|FG000|Overall Study|Lost to Follow-up|2|||
156673406|NCT00312897|565550680|FG001|Overall Study|Lost to Follow-up|0|||
156673407|NCT00312897|565550679|FG000|Overall Study|Physician Decision|1|||
156673408|NCT00312897|565550680|FG001|Overall Study|Physician Decision|0|||
156673409|NCT00312897|565550679|FG000|Overall Study|Withdrawal by Subject|1|||
156673410|NCT00312897|565550680|FG001|Overall Study|Withdrawal by Subject|3|||
156527206|NCT02604433|565025254|FG001|Overall Study|Withdrawal by Subject|16|||
156527207|NCT02604433|565025253|FG000|Overall Study|Adverse Event|4|||
156527208|NCT02604433|565025254|FG001|Overall Study|Adverse Event|0|||
156527209|NCT02604433|565025253|FG000|Overall Study|Other reasons|3|||
156432720|NCT01773122|564673875|FG003|Overall Study|Due to amended age eligibility criteria|1|||
156432721|NCT02289560|564673876|FG000|Overall Study|Lost to Follow-up|6|||
156432722|NCT02289560|564673876|FG000|Overall Study|Alternative Treatment|4|||
156432723|NCT02289560|564673876|FG000|Overall Study|Inadequate Treatment|2|||
156432724|NCT02289560|564673876|FG000|Overall Study|Withdrawal by Subject|23|||
156432725|NCT02540213|564673877|FG000|Overall Study|Death/adverse event|18|||
156432726|NCT02540213|564673877|FG000|Overall Study|Administrative reasons|3|||
156432727|NCT02540213|564673877|FG000|Overall Study|Kidney transplant|3|||
156432728|NCT02540213|564673877|FG000|Overall Study|Lack of Efficacy|6|||
156432729|NCT02540213|564673877|FG000|Overall Study|Consent withdrawn|7|||
156432730|NCT02540213|564673877|FG000|Overall Study|Enrolled but not treated|2|||
156432731|NCT01264718|564673878|FG000|Overall Study|Lost to Follow-up|3|||
156432732|NCT01264718|564673879|FG001|Overall Study|Lost to Follow-up|2|||
156527210|NCT02604433|565025254|FG001|Overall Study|Other reasons|5|||
156527211|NCT02604433|565025253|FG000|Overall Study|Death|4|||
156527212|NCT02604433|565025254|FG001|Overall Study|Death|1|||
156527213|NCT02604433|565025253|FG000|Overall Study|Transition to Rollover Protocol|169|||
156527214|NCT02604433|565025254|FG001|Overall Study|Transition to Rollover Protocol|82|||
156527215|NCT02604433|565025253|FG000|Overall Study|Physician Decision|1|||
156527216|NCT02604433|565025254|FG001|Overall Study|Physician Decision|1|||
156432733|NCT01264718|564673878|FG000|Overall Study|Withdrawal by Subject|9|||
156432734|NCT01264718|564673879|FG001|Overall Study|Withdrawal by Subject|15|||
156432735|NCT01264718|564673878|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
156432736|NCT01264718|564673879|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
156432737|NCT03386929|564673882|FG000|Overall Study|Death|0|||
156432738|NCT03386929|564673883|FG001|Overall Study|Death|0|||
156432739|NCT03386929|564673884|FG002|Overall Study|Death|1|||
156432740|NCT03386929|564673882|FG000|Overall Study|Withdrawal by Subject|0|||
156432741|NCT03386929|564673883|FG001|Overall Study|Withdrawal by Subject|1|||
156527217|NCT02604433|565025253|FG000|Overall Study|Lack of Efficacy|0|||
156527218|NCT02604433|565025254|FG001|Overall Study|Lack of Efficacy|1|||
156527219|NCT03285178|565025255|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
156527220|NCT03285178|565025256|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
156432742|NCT03386929|564673884|FG002|Overall Study|Withdrawal by Subject|0|||
156527221|NCT03285178|565025257|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
156527222|NCT03285178|565025258|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
156673411|NCT00312897|565550679|FG000|Overall Study|Pregnancy|1|||
156673412|NCT00312897|565550680|FG001|Overall Study|Pregnancy|0|||
156432743|NCT03386929|564673882|FG000|Overall Study|Physician Decision|0|||
156432744|NCT03386929|564673883|FG001|Overall Study|Physician Decision|0|||
156527223|NCT03285178|565025259|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
156432745|NCT03386929|564673884|FG002|Overall Study|Physician Decision|1|||
156673413|NCT00312897|565550679|FG000|Overall Study|discontinued prior to getting treatment|0|||
156673414|NCT00312897|565550680|FG001|Overall Study|discontinued prior to getting treatment|3|||
156673415|NCT01117623|565552577|FG000|Overall Study|Adverse Event|0|||
156673416|NCT01117623|565552578|FG001|Overall Study|Adverse Event|2|||
156673417|NCT01117623|565552579|FG002|Overall Study|Adverse Event|4|||
156673418|NCT01117623|565552580|FG003|Overall Study|Adverse Event|0|||
156673419|NCT01117623|565552581|FG004|Overall Study|Adverse Event|2|||
156673420|NCT01117623|565552582|FG005|Overall Study|Adverse Event|0|||
156673421|NCT01117623|565552583|FG006|Overall Study|Adverse Event|0|||
156673422|NCT01117623|565552584|FG007|Overall Study|Adverse Event|2|||
156673423|NCT01117623|565552577|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
156673424|NCT01117623|565552578|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
156673425|NCT01117623|565552579|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
156673426|NCT01117623|565552580|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
156673427|NCT01117623|565552581|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
156673428|NCT01117623|565552582|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
156673429|NCT01117623|565552583|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
156673430|NCT01117623|565552584|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
156673431|NCT01117623|565552577|FG000|Overall Study|Withdrawal by Subject|0|||
156673432|NCT01117623|565552578|FG001|Overall Study|Withdrawal by Subject|0|||
156673433|NCT01117623|565552579|FG002|Overall Study|Withdrawal by Subject|2|||
156673434|NCT01117623|565552580|FG003|Overall Study|Withdrawal by Subject|0|||
156673435|NCT01117623|565552581|FG004|Overall Study|Withdrawal by Subject|0|||
156673436|NCT01117623|565552582|FG005|Overall Study|Withdrawal by Subject|1|||
156673437|NCT01117623|565552583|FG006|Overall Study|Withdrawal by Subject|1|||
156673438|NCT01117623|565552584|FG007|Overall Study|Withdrawal by Subject|1|||
156673439|NCT01117623|565552577|FG000|Overall Study|Non-compliance with study medication|0|||
156673440|NCT01117623|565552578|FG001|Overall Study|Non-compliance with study medication|0|||
156673441|NCT01117623|565552579|FG002|Overall Study|Non-compliance with study medication|0|||
156673442|NCT01117623|565552580|FG003|Overall Study|Non-compliance with study medication|0|||
156673443|NCT01117623|565552581|FG004|Overall Study|Non-compliance with study medication|0|||
156673444|NCT01117623|565552582|FG005|Overall Study|Non-compliance with study medication|0|||
156673445|NCT01117623|565552583|FG006|Overall Study|Non-compliance with study medication|0|||
156673446|NCT01117623|565552584|FG007|Overall Study|Non-compliance with study medication|1|||
156673447|NCT01117623|565552577|FG000|Overall Study|Invest. text: completed all planned txs|0|||
156673448|NCT01117623|565552578|FG001|Overall Study|Invest. text: completed all planned txs|0|||
156673449|NCT01117623|565552579|FG002|Overall Study|Invest. text: completed all planned txs|0|||
156673450|NCT01117623|565552580|FG003|Overall Study|Invest. text: completed all planned txs|0|||
156673451|NCT01117623|565552581|FG004|Overall Study|Invest. text: completed all planned txs|0|||
156673452|NCT01117623|565552582|FG005|Overall Study|Invest. text: completed all planned txs|1|||
156673453|NCT01117623|565552583|FG006|Overall Study|Invest. text: completed all planned txs|0|||
156673454|NCT01117623|565552584|FG007|Overall Study|Invest. text: completed all planned txs|0|||
156673455|NCT02727192|565552590|FG000|Overall Study|Lost to Follow-up|1|||
156673456|NCT02727192|565552591|FG001|Overall Study|Lost to Follow-up|0|||
156673457|NCT02727192|565552592|FG002|Overall Study|Lost to Follow-up|0|||
156673458|NCT00928057|565552593|FG000|Overall Study|Adverse Event|1|||
156673459|NCT00928057|565552594|FG001|Overall Study|Adverse Event|2|||
156673460|NCT00928057|565552593|FG000|Overall Study|Withdrawal by Subject|1|||
156673461|NCT00928057|565552594|FG001|Overall Study|Withdrawal by Subject|0|||
156673462|NCT00928057|565552593|FG000|Overall Study|Lost to Follow-up|0|||
156673463|NCT00928057|565552594|FG001|Overall Study|Lost to Follow-up|1|||
156673464|NCT00928057|565552593|FG000|Overall Study|Protocol Violation|0|||
156673465|NCT00928057|565552594|FG001|Overall Study|Protocol Violation|1|||
156673466|NCT03206749|565552595|FG000|Overall Study|Withdrawal of consent|5|||
156673467|NCT03206749|565552596|FG001|Overall Study|Withdrawal of consent|3|||
156673468|NCT03206749|565552597|FG002|Overall Study|Withdrawal of consent|6|||
156673469|NCT03206749|565552595|FG000|Overall Study|Lost to Follow-up|0|||
156673470|NCT03206749|565552596|FG001|Overall Study|Lost to Follow-up|0|||
156673471|NCT03206749|565552597|FG002|Overall Study|Lost to Follow-up|1|||
156673472|NCT03674892|565552598|FG000|Overall Study|Lack of Efficacy|5|||
156673473|NCT03674892|565552598|FG000|Overall Study|Lost to Follow-up|3|||
156673474|NCT03674892|565552598|FG000|Overall Study|Migraine|2|||
156673475|NCT03674892|565552598|FG000|Overall Study|Excessive Tearing|1|||
156673476|NCT03674892|565552598|FG000|Overall Study|Increased Eye Pain|1|||
156673477|NCT03674892|565552598|FG000|Overall Study|Increased Facial Pain|1|||
156673478|NCT03674892|565552598|FG000|Overall Study|Sinus Irritation|1|||
156673479|NCT03674892|565552598|FG000|Overall Study|Sinus Infection|1|||
156673480|NCT05099380|565552599|FG000|Overall Study|Subject enrolled in error|1|||
156673481|NCT05099380|565552600|FG001|Overall Study|Subject enrolled in error|0|||
156673482|NCT05099380|565552599|FG000|Overall Study|Study Procedure|1|||
156673483|NCT05099380|565552600|FG001|Overall Study|Study Procedure|0|||
156432746|NCT03386929|564673882|FG000|Overall Study|Progression|4|||
156432747|NCT03386929|564673883|FG001|Overall Study|Progression|4|||
156432748|NCT03386929|564673884|FG002|Overall Study|Progression|0|||
156673484|NCT05099380|565552599|FG000|Overall Study|Protocol Violation|1|||
156673485|NCT05099380|565552600|FG001|Overall Study|Protocol Violation|0|||
156673486|NCT05099380|565552599|FG000|Overall Study|Adverse Event|1|||
156673487|NCT05099380|565552600|FG001|Overall Study|Adverse Event|1|||
156673488|NCT05099380|565552599|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
156673489|NCT05099380|565552600|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
156673490|NCT01959672|565552606|FG000|Overall Study|Death|1|||
156673491|NCT02392195|565552607|FG000|Overall Study|Lost to Follow-up|4|||
156673492|NCT02392195|565552607|FG000|Overall Study|Withdrawal by Subject|4|||
156673493|NCT00840216|565552608|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
156673494|NCT00840216|565552609|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
156673495|NCT00545792|565552612|FG000|Overall Study|Withdrawal by Subject|1|||
156673496|NCT05041361|565552614|FG000|Overall Study|Lost to Follow-up|1|||
156673497|NCT05041361|565552615|FG001|Overall Study|Lost to Follow-up|3|||
156673498|NCT01642277|565552616|FG000|Overall Study|Adverse Event|10|||
156673499|NCT01642277|565552617|FG001|Overall Study|Adverse Event|0|||
156673500|NCT01642277|565552616|FG000|Overall Study|Physician Decision|2|||
156673501|NCT01642277|565552617|FG001|Overall Study|Physician Decision|0|||
156673502|NCT01642277|565552616|FG000|Overall Study|Protocol Violation|1|||
156673503|NCT01642277|565552617|FG001|Overall Study|Protocol Violation|0|||
156673504|NCT01642277|565552616|FG000|Overall Study|Withdrawal by Subject|11|||
156673505|NCT01642277|565552617|FG001|Overall Study|Withdrawal by Subject|0|||
156673506|NCT03679598|565552618|FG000|Overall Study|Adverse Event|2|||
156673507|NCT03679598|565552619|FG001|Overall Study|Adverse Event|0|||
156673508|NCT03605342|565552620|FG000|Overall Study|Withdrawal by Subject|9|||
156673509|NCT03605342|565552621|FG001|Overall Study|Withdrawal by Subject|7|||
156673510|NCT03605342|565552620|FG000|Overall Study|Lost to Follow-up|1|||
156673511|NCT03605342|565552621|FG001|Overall Study|Lost to Follow-up|1|||
156673512|NCT02842853|565552624|FG000|Overall Study|Non-compliance with the protocol|3|||
156673513|NCT02842853|565552625|FG001|Overall Study|Non-compliance with the protocol|7|||
156673514|NCT02842853|565552626|FG002|Overall Study|Non-compliance with the protocol|2|||
156673515|NCT02842853|565552627|FG003|Overall Study|Non-compliance with the protocol|5|||
156673516|NCT02842853|565552624|FG000|Overall Study|Subject met exclusion criteria|0|||
156673517|NCT02842853|565552625|FG001|Overall Study|Subject met exclusion criteria|1|||
156673518|NCT02842853|565552626|FG002|Overall Study|Subject met exclusion criteria|0|||
156673519|NCT02842853|565552627|FG003|Overall Study|Subject met exclusion criteria|0|||
156673520|NCT02842853|565552624|FG000|Overall Study|Withdrawal by Subject|11|||
156673521|NCT02842853|565552625|FG001|Overall Study|Withdrawal by Subject|13|||
156673522|NCT02842853|565552626|FG002|Overall Study|Withdrawal by Subject|9|||
156673523|NCT02842853|565552627|FG003|Overall Study|Withdrawal by Subject|8|||
156673524|NCT02842853|565552624|FG000|Overall Study|Lost to Follow-up|9|||
156673525|NCT02842853|565552625|FG001|Overall Study|Lost to Follow-up|13|||
156673526|NCT02842853|565552626|FG002|Overall Study|Lost to Follow-up|10|||
156673527|NCT02842853|565552627|FG003|Overall Study|Lost to Follow-up|11|||
156673528|NCT01380782|565552628|FG000|Overall Study|Adverse Event|0|||
156673529|NCT01380782|565552629|FG001|Overall Study|Adverse Event|1|||
156673530|NCT01380782|565552630|FG002|Overall Study|Adverse Event|0|||
156673531|NCT01380782|565552631|FG003|Overall Study|Adverse Event|0|||
156673532|NCT01380782|565552628|FG000|Overall Study|Death|1|||
156673533|NCT01380782|565552629|FG001|Overall Study|Death|0|||
156673534|NCT01380782|565552630|FG002|Overall Study|Death|0|||
156673535|NCT01380782|565552631|FG003|Overall Study|Death|0|||
156673536|NCT01380782|565552628|FG000|Overall Study|Lack of Efficacy|10|||
156673537|NCT01380782|565552629|FG001|Overall Study|Lack of Efficacy|9|||
156673538|NCT01380782|565552630|FG002|Overall Study|Lack of Efficacy|10|||
156432749|NCT03386929|564673882|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
156432750|NCT03386929|564673883|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
156432751|NCT03386929|564673884|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
156432752|NCT03386929|564673882|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
156432753|NCT03386929|564673883|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
156432754|NCT03386929|564673884|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
156432755|NCT00536380|564673885|FG000|Overall Study|Adverse Event|0|||
156432756|NCT00536380|564673886|FG001|Overall Study|Adverse Event|2|||
156432757|NCT00536380|564673887|FG002|Overall Study|Adverse Event|2|||
156432758|NCT00536380|564673885|FG000|Overall Study|Lost to Follow-up|0|||
156673539|NCT01380782|565552631|FG003|Overall Study|Lack of Efficacy|3|||
156673540|NCT01380782|565552628|FG000|Overall Study|Physician Decision|1|||
156673541|NCT01380782|565552629|FG001|Overall Study|Physician Decision|0|||
156673542|NCT01380782|565552630|FG002|Overall Study|Physician Decision|0|||
156673543|NCT01380782|565552631|FG003|Overall Study|Physician Decision|0|||
156673544|NCT01380782|565552628|FG000|Overall Study|Withdrawal by Subject|0|||
156673545|NCT01380782|565552629|FG001|Overall Study|Withdrawal by Subject|0|||
156673546|NCT01380782|565552630|FG002|Overall Study|Withdrawal by Subject|1|||
156673547|NCT01380782|565552631|FG003|Overall Study|Withdrawal by Subject|1|||
156673548|NCT01403194|565552635|FG000|Overall Study|Screen Failure|2|||
156673549|NCT01403194|565552635|FG000|Overall Study|Lost to Follow-up|8|||
156673550|NCT03428750|565552636|FG000|Overall Study|Withdrawal by Subject|11|||
156673551|NCT03428750|565552637|FG001|Overall Study|Withdrawal by Subject|10|||
156673552|NCT03428750|565552636|FG000|Overall Study|Lost to Follow-up|3|||
156673553|NCT03428750|565552637|FG001|Overall Study|Lost to Follow-up|9|||
156673554|NCT03428750|565552636|FG000|Overall Study|Adverse Event|9|||
156673555|NCT03428750|565552637|FG001|Overall Study|Adverse Event|1|||
156673556|NCT03428750|565552636|FG000|Overall Study|Protocol Violation|1|||
156673557|NCT03428750|565552637|FG001|Overall Study|Protocol Violation|0|||
156673558|NCT03428750|565552636|FG000|Overall Study|Administrative|0|||
156673559|NCT03428750|565552637|FG001|Overall Study|Administrative|1|||
156673560|NCT00274651|565552640|FG000|Overall Study|Adverse Event|6|||
156673561|NCT00274651|565552641|FG001|Overall Study|Adverse Event|3|||
156673562|NCT00274651|565552640|FG000|Overall Study|Lack of Efficacy|13|||
156673563|NCT00274651|565552641|FG001|Overall Study|Lack of Efficacy|6|||
156673564|NCT00274651|565552640|FG000|Overall Study|Death|1|||
156673565|NCT00274651|565552641|FG001|Overall Study|Death|3|||
156673566|NCT00274651|565552640|FG000|Overall Study|Withdrawal by Subject|0|||
156673567|NCT00274651|565552641|FG001|Overall Study|Withdrawal by Subject|1|||
156673568|NCT00274651|565552640|FG000|Overall Study|Physician Decision|8|||
156673569|NCT00274651|565552641|FG001|Overall Study|Physician Decision|7|||
156673570|NCT05133180|565552644|FG000|Overall Study|Withdrawal of consent|1|||
156673571|NCT05133180|565552645|FG001|Overall Study|Withdrawal of consent|1|||
156673572|NCT05133180|565552644|FG000|Overall Study|Lost to Follow-up|1|||
156673573|NCT05133180|565552645|FG001|Overall Study|Lost to Follow-up|1|||
156673574|NCT05133180|565552644|FG000|Overall Study|Documented disease progression|0|||
156673575|NCT05133180|565552645|FG001|Overall Study|Documented disease progression|1|||
156673576|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
156673577|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
156673578|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
156673579|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
156673580|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
156673581|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
156673582|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
156673583|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
156673584|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
156673585|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
156673586|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
156673587|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
156673588|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
156673589|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
156673590|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
156673591|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
156673592|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
156673593|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
156673594|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
156673595|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
156673596|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
156527224|NCT03285178|565025260|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
156527225|NCT03285178|565025261|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
156527226|NCT03285178|565025255|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
156527227|NCT03285178|565025256|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
156673597|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
156527228|NCT03285178|565025257|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
156527229|NCT03285178|565025258|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
156527230|NCT03285178|565025259|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
156527231|NCT03285178|565025260|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
156527232|NCT03285178|565025261|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
156527233|NCT03285178|565025255|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
156527234|NCT03285178|565025256|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
156527235|NCT03285178|565025257|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
156673598|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
156673599|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
156673600|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
156673601|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
156673602|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
156673603|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
156673604|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
156673605|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
156673606|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
156673607|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
156673608|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
156673609|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
156673610|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
156673611|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
156673612|NCT04194801|565552646|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
156673613|NCT04194801|565552647|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
156673614|NCT04194801|565552648|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
156673615|NCT04194801|565552646|FG000|Part Ib/II End of Study|Death|2|||
156673616|NCT04194801|565552647|FG001|Part Ib/II End of Study|Death|3|||
156673617|NCT04194801|565552648|FG002|Part Ib/II End of Study|Death|3|||
156673618|NCT04194801|565552646|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
156673619|NCT04194801|565552647|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
156673620|NCT04194801|565552648|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
156673621|NCT04194801|565552646|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
156673622|NCT04194801|565552647|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
156673623|NCT04194801|565552648|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
156673624|NCT04194801|565552646|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
156673625|NCT04194801|565552647|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
156673626|NCT04194801|565552648|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
156673627|NCT04194801|565552646|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
156673628|NCT04194801|565552647|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
156673629|NCT04194801|565552648|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
156673630|NCT01604941|565552651|FG000|Overall Study|Adverse Event|1|||
156673631|NCT01604941|565552652|FG001|Overall Study|Adverse Event|2|||
156673632|NCT01604941|565552653|FG002|Overall Study|Adverse Event|0|||
156673633|NCT01604941|565552654|FG003|Overall Study|Adverse Event|0|||
156673634|NCT01604941|565552655|FG004|Overall Study|Adverse Event|1|||
156673635|NCT01604941|565552656|FG005|Overall Study|Adverse Event|5|||
156673636|NCT01604941|565552651|FG000|Overall Study|Non-compliance|1|||
156673637|NCT01604941|565552652|FG001|Overall Study|Non-compliance|0|||
156673638|NCT01604941|565552653|FG002|Overall Study|Non-compliance|0|||
156673639|NCT01604941|565552654|FG003|Overall Study|Non-compliance|0|||
156673640|NCT01604941|565552655|FG004|Overall Study|Non-compliance|0|||
156673641|NCT01604941|565552656|FG005|Overall Study|Non-compliance|0|||
156673642|NCT01604941|565552651|FG000|Overall Study|Participant Decision|0|||
156673643|NCT01604941|565552652|FG001|Overall Study|Participant Decision|0|||
156673644|NCT01604941|565552653|FG002|Overall Study|Participant Decision|0|||
156673645|NCT01604941|565552654|FG003|Overall Study|Participant Decision|0|||
156673646|NCT01604941|565552655|FG004|Overall Study|Participant Decision|0|||
156673647|NCT01604941|565552656|FG005|Overall Study|Participant Decision|2|||
156673648|NCT01604941|565552651|FG000|Overall Study|Early Study Termination|9|||
156673649|NCT01604941|565552652|FG001|Overall Study|Early Study Termination|2|||
156673650|NCT01604941|565552653|FG002|Overall Study|Early Study Termination|3|||
156673651|NCT01604941|565552654|FG003|Overall Study|Early Study Termination|3|||
156673652|NCT01604941|565552655|FG004|Overall Study|Early Study Termination|0|||
156673653|NCT01604941|565552656|FG005|Overall Study|Early Study Termination|0|||
156673654|NCT03366792|565552657|FG000|Overall Study|Withdrawal by Subject|7|||
156673655|NCT03366792|565552657|FG000|Overall Study|Lost to Follow-up|2|||
156673656|NCT03366792|565552657|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
156673657|NCT03366792|565552657|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
156673658|NCT03497130|565552658|FG000|Overall Study|Lost to Follow-up|1|||
156673659|NCT03497130|565552659|FG001|Overall Study|Lost to Follow-up|1|||
156673660|NCT02679729|565552661|FG000|Overall Study|Lost to Follow-up|0|||
156673661|NCT02679729|565552662|FG001|Overall Study|Lost to Follow-up|1|||
156673662|NCT02679729|565552663|FG002|Overall Study|Lost to Follow-up|0|||
156673663|NCT02679729|565552664|FG003|Overall Study|Lost to Follow-up|0|||
156673664|NCT02679729|565552665|FG004|Overall Study|Lost to Follow-up|1|||
156673665|NCT02679729|565552666|FG005|Overall Study|Lost to Follow-up|0|||
156673666|NCT02679729|565552667|FG006|Overall Study|Lost to Follow-up|0|||
156673667|NCT02679729|565552668|FG007|Overall Study|Lost to Follow-up|0|||
156673668|NCT02679729|565552669|FG008|Overall Study|Lost to Follow-up|0|||
156673669|NCT02679729|565552661|FG000|Overall Study|Participant decision|0|||
156432759|NCT00536380|564673886|FG001|Overall Study|Lost to Follow-up|0|||
156432760|NCT00536380|564673887|FG002|Overall Study|Lost to Follow-up|1|||
156673670|NCT02679729|565552662|FG001|Overall Study|Participant decision|1|||
156673671|NCT02679729|565552663|FG002|Overall Study|Participant decision|0|||
156432761|NCT00536380|564673885|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
156432762|NCT00536380|564673886|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
156432763|NCT00536380|564673887|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
156432764|NCT00536380|564673885|FG000|Overall Study|Withdrawal related to study drug|7|||
156673672|NCT02679729|565552664|FG003|Overall Study|Participant decision|0|||
156432765|NCT00536380|564673886|FG001|Overall Study|Withdrawal related to study drug|5|||
156432766|NCT00536380|564673887|FG002|Overall Study|Withdrawal related to study drug|2|||
156432767|NCT00536380|564673885|FG000|Overall Study|Noncompliance with protocol|3|||
156432768|NCT00536380|564673886|FG001|Overall Study|Noncompliance with protocol|2|||
156673673|NCT02679729|565552665|FG004|Overall Study|Participant decision|0|||
156673674|NCT02679729|565552666|FG005|Overall Study|Participant decision|0|||
156673675|NCT02679729|565552667|FG006|Overall Study|Participant decision|1|||
156673676|NCT02679729|565552668|FG007|Overall Study|Participant decision|0|||
156673677|NCT02679729|565552669|FG008|Overall Study|Participant decision|0|||
156673678|NCT00748566|565552670|FG000|Overall Study|Adverse Event|49|||
156673679|NCT00748566|565552670|FG000|Overall Study|Death|1|||
156673680|NCT00748566|565552670|FG000|Overall Study|Lack of Efficacy|12|||
156673681|NCT00748566|565552670|FG000|Overall Study|Lost to Follow-up|1|||
156673682|NCT00748566|565552670|FG000|Overall Study|Protocol Violation|13|||
156673683|NCT00748566|565552670|FG000|Overall Study|Withdrawal by Subject|22|||
156673684|NCT00748566|565552670|FG000|Overall Study|Study terminated by sponsor|5|||
156673685|NCT00748566|565552670|FG000|Overall Study|Other|9|||
156673686|NCT01442376|565552677|FG000|Overall Study|Adverse Event|0|||
156673687|NCT01442376|565552678|FG001|Overall Study|Adverse Event|3|||
156673688|NCT01442376|565552679|FG002|Overall Study|Adverse Event|2|||
156673689|NCT01442376|565552677|FG000|Overall Study|Death|0|||
156673690|NCT01442376|565552678|FG001|Overall Study|Death|1|||
156673691|NCT01442376|565552679|FG002|Overall Study|Death|1|||
156673692|NCT01442376|565552677|FG000|Overall Study|Withdrawal of consent|0|||
156673693|NCT01442376|565552678|FG001|Overall Study|Withdrawal of consent|0|||
156673694|NCT01442376|565552679|FG002|Overall Study|Withdrawal of consent|1|||
156527236|NCT03285178|565025258|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
156673695|NCT01442376|565552677|FG000|Overall Study|Patients not treated|2|||
156432769|NCT00536380|564673887|FG002|Overall Study|Noncompliance with protocol|2|||
156432770|NCT00536380|564673885|FG000|Overall Study|Did not meet protocol eligibility|0|||
156432771|NCT00536380|564673886|FG001|Overall Study|Did not meet protocol eligibility|0|||
156432772|NCT00536380|564673887|FG002|Overall Study|Did not meet protocol eligibility|1|||
156432773|NCT00536380|564673885|FG000|Overall Study|Administrative|0|||
156432774|NCT00536380|564673886|FG001|Overall Study|Administrative|0|||
156432775|NCT00536380|564673887|FG002|Overall Study|Administrative|1|||
156432776|NCT03545984|564673888|FG000|Overall Study|CSF cases not present during rotation|11|||
156432777|NCT03545984|564673889|FG001|Overall Study|CSF cases not present during rotation|9|||
156432778|NCT00387465|564673890|FG000|Overall Study|Withdrawal by Subject|0|||
156432779|NCT00387465|564673891|FG001|Overall Study|Withdrawal by Subject|1|||
156432780|NCT00387465|564673892|FG002|Overall Study|Withdrawal by Subject|0|||
156432781|NCT03418324|564673893|FG000|Overall Study|Death|0|||
156432782|NCT03418324|564673894|FG001|Overall Study|Death|1|||
156432783|NCT03418324|564673893|FG000|Overall Study|Physician Decision|1|||
156432784|NCT03418324|564673894|FG001|Overall Study|Physician Decision|1|||
156432785|NCT01768676|564673896|FG000|Overall Study|Adverse Event|3|||
156432786|NCT01768676|564673897|FG001|Overall Study|Adverse Event|3|||
156432787|NCT01768676|564673896|FG000|Overall Study|Lost to Follow-up|13|||
156432788|NCT01768676|564673897|FG001|Overall Study|Lost to Follow-up|16|||
156432789|NCT01768676|564673896|FG000|Overall Study|Protocol Violation|1|||
156432790|NCT01768676|564673897|FG001|Overall Study|Protocol Violation|1|||
156432791|NCT01768676|564673896|FG000|Overall Study|Physician Decision|4|||
156432792|NCT01768676|564673897|FG001|Overall Study|Physician Decision|1|||
156432793|NCT01768676|564673896|FG000|Overall Study|Withdrawal by Subject|3|||
156432794|NCT01768676|564673897|FG001|Overall Study|Withdrawal by Subject|10|||
156432795|NCT03121950|564673899|FG000|Overall Study|Withdrawal by Subject|11|||
156432796|NCT03121950|564673900|FG001|Overall Study|Withdrawal by Subject|2|||
156432797|NCT04248829|564673906|FG000|Overall Study|Disease progression|44|||
156432798|NCT04248829|564673907|FG001|Overall Study|Disease progression|109|||
156432799|NCT04248829|564673906|FG000|Overall Study|Adverse Event|19|||
156432800|NCT04248829|564673907|FG001|Overall Study|Adverse Event|18|||
156432801|NCT04248829|564673906|FG000|Overall Study|Withdrawal by Subject|11|||
156432802|NCT04248829|564673907|FG001|Overall Study|Withdrawal by Subject|2|||
156432803|NCT04248829|564673906|FG000|Overall Study|Lost to Follow-up|0|||
156432804|NCT04248829|564673907|FG001|Overall Study|Lost to Follow-up|1|||
156673696|NCT01442376|565552678|FG001|Overall Study|Patients not treated|3|||
156673697|NCT01442376|565552679|FG002|Overall Study|Patients not treated|1|||
156673698|NCT01442376|565552677|FG000|Overall Study|Not eligible for subsequent cycles|1|||
156673699|NCT01442376|565552678|FG001|Overall Study|Not eligible for subsequent cycles|2|||
156673700|NCT01442376|565552679|FG002|Overall Study|Not eligible for subsequent cycles|0|||
156432805|NCT04248829|564673906|FG000|Overall Study|Death|12|||
156432806|NCT04248829|564673907|FG001|Overall Study|Death|14|||
156432807|NCT04248829|564673906|FG000|Overall Study|Physician Decision|2|||
156432808|NCT04248829|564673907|FG001|Overall Study|Physician Decision|4|||
156432809|NCT04248829|564673906|FG000|Overall Study|Any reason not specifically recorded|0|||
156432810|NCT04248829|564673907|FG001|Overall Study|Any reason not specifically recorded|2|||
156673701|NCT04404725|565552680|FG000|First Intervention|Withdrawal by Subject|0|||
156673702|NCT04404725|565552681|FG001|First Intervention|Withdrawal by Subject|2|||
156673703|NCT04404725|565552680|FG000|Second Intervention|Adverse Event|1|||
156673704|NCT04404725|565552681|FG001|Second Intervention|Adverse Event|1|||
156673705|NCT04404725|565552680|FG000|Second Intervention|Withdrawal by Subject|0|||
156673706|NCT04404725|565552681|FG001|Second Intervention|Withdrawal by Subject|1|||
156673707|NCT01075516|565552682|FG000|Overall Study|Death|5|||
156673708|NCT01075516|565552683|FG001|Overall Study|Death|9|||
156673709|NCT01075516|565552682|FG000|Overall Study|Lost to Follow-up|10|||
156673710|NCT01075516|565552683|FG001|Overall Study|Lost to Follow-up|2|||
156673711|NCT01075516|565552682|FG000|Overall Study|Withdrawal by Subject|3|||
156673712|NCT01075516|565552683|FG001|Overall Study|Withdrawal by Subject|5|||
156673713|NCT02252016|565552684|FG000|Overall Study|Lost to Follow-up|2|||
156673714|NCT02252016|565552685|FG001|Overall Study|Lost to Follow-up|1|||
156673715|NCT02252016|565552684|FG000|Overall Study|Physician Decision|1|||
156673716|NCT02252016|565552685|FG001|Overall Study|Physician Decision|0|||
156673717|NCT02252016|565552684|FG000|Overall Study|Withdrawal by Subject|0|||
156673718|NCT02252016|565552685|FG001|Overall Study|Withdrawal by Subject|2|||
156673719|NCT04631562|565552686|FG000|Overall Study|Withdrawal by Subject|0|||
156673720|NCT04631562|565552687|FG001|Overall Study|Withdrawal by Subject|0|||
156673721|NCT04631562|565552688|FG002|Overall Study|Withdrawal by Subject|0|||
156673722|NCT04631562|565552689|FG003|Overall Study|Withdrawal by Subject|0|||
156673723|NCT04631562|565552690|FG004|Overall Study|Withdrawal by Subject|0|||
156673724|NCT04631562|565552691|FG005|Overall Study|Withdrawal by Subject|0|||
156673725|NCT04631562|565552692|FG006|Overall Study|Withdrawal by Subject|0|||
156673726|NCT04631562|565552693|FG007|Overall Study|Withdrawal by Subject|1|||
156673727|NCT04631562|565552694|FG008|Overall Study|Withdrawal by Subject|0|||
156673728|NCT04631562|565552686|FG000|Overall Study|Other|0|||
156673729|NCT04631562|565552687|FG001|Overall Study|Other|0|||
156673730|NCT04631562|565552688|FG002|Overall Study|Other|0|||
156673731|NCT04631562|565552689|FG003|Overall Study|Other|0|||
156673732|NCT04631562|565552690|FG004|Overall Study|Other|0|||
156673733|NCT04631562|565552691|FG005|Overall Study|Other|0|||
156673734|NCT04631562|565552692|FG006|Overall Study|Other|0|||
156673735|NCT04631562|565552693|FG007|Overall Study|Other|0|||
156673736|NCT04631562|565552694|FG008|Overall Study|Other|1|||
156673737|NCT04631562|565552686|FG000|Overall Study|Lost to Follow-up|0|||
156673738|NCT04631562|565552687|FG001|Overall Study|Lost to Follow-up|0|||
156527237|NCT03285178|565025259|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
156527238|NCT03285178|565025260|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
156527239|NCT03285178|565025261|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
156673739|NCT04631562|565552688|FG002|Overall Study|Lost to Follow-up|0|||
156673740|NCT04631562|565552689|FG003|Overall Study|Lost to Follow-up|1|||
156527240|NCT03285178|565025255|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
156527241|NCT03285178|565025256|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
156527242|NCT03285178|565025257|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
156527243|NCT03285178|565025258|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
156527244|NCT03285178|565025259|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
156527245|NCT03285178|565025260|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
156527246|NCT03285178|565025261|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
156527247|NCT03285178|565025255|FG000|Single-Blind Run-In Period|Physician Decision|2|||
156527248|NCT03285178|565025256|FG001|Single-Blind Run-In Period|Physician Decision|0|||
156527249|NCT03285178|565025257|FG002|Single-Blind Run-In Period|Physician Decision|0|||
156527250|NCT03285178|565025258|FG003|Single-Blind Run-In Period|Physician Decision|0|||
156527251|NCT03285178|565025259|FG004|Single-Blind Run-In Period|Physician Decision|0|||
156527252|NCT03285178|565025260|FG005|Single-Blind Run-In Period|Physician Decision|0|||
156527253|NCT03285178|565025261|FG006|Single-Blind Run-In Period|Physician Decision|0|||
156527254|NCT03285178|565025255|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
156527255|NCT03285178|565025256|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
156527256|NCT03285178|565025257|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
156527257|NCT03285178|565025258|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
156527258|NCT03285178|565025259|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
156327794|NCT00598702|564301386|FG005|Overall Study|Early discharge from hospital|10|||
156327795|NCT00598702|564301387|FG006|Overall Study|Early discharge from hospital|1|||
156327796|NCT00598702|564301388|FG007|Overall Study|Early discharge from hospital|0|||
156527259|NCT03285178|565025260|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
156673741|NCT04631562|565552690|FG004|Overall Study|Lost to Follow-up|0|||
156673742|NCT04631562|565552691|FG005|Overall Study|Lost to Follow-up|0|||
156673743|NCT04631562|565552692|FG006|Overall Study|Lost to Follow-up|0|||
156673744|NCT04631562|565552693|FG007|Overall Study|Lost to Follow-up|0|||
156673745|NCT04631562|565552694|FG008|Overall Study|Lost to Follow-up|0|||
156673746|NCT04631562|565552686|FG000|Overall Study|Adverse Event|0|||
156673747|NCT04631562|565552687|FG001|Overall Study|Adverse Event|0|||
156673748|NCT04631562|565552688|FG002|Overall Study|Adverse Event|0|||
156673749|NCT04631562|565552689|FG003|Overall Study|Adverse Event|0|||
156527260|NCT03285178|565025261|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
156527261|NCT03285178|565025255|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156527262|NCT03285178|565025256|FG001|Double-Blind Treatment Period|Adverse Event|0|||
156432811|NCT02132702|564673908|FG000|Overall Study|Protocol Violation|2|||
156432812|NCT02132702|564673908|FG000|Overall Study|Adverse Event|3|||
156432813|NCT02132702|564673908|FG000|Overall Study|Withdrawal by Subject|3|||
156432814|NCT02299336|564673909|FG000|Overall Study|Withdrawal by Subject|11|||
156527263|NCT03285178|565025257|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156527264|NCT03285178|565025258|FG003|Double-Blind Treatment Period|Adverse Event|0|||
156432815|NCT02299336|564673909|FG000|Overall Study|Adverse Event|1|||
156432816|NCT02299336|564673909|FG000|Overall Study|Death|1|||
156432817|NCT02299336|564673909|FG000|Overall Study|Lost to Follow-up|1|||
156432818|NCT01304147|564673912|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
156527265|NCT03285178|565025259|FG004|Double-Blind Treatment Period|Adverse Event|0|||
156527266|NCT03285178|565025260|FG005|Double-Blind Treatment Period|Adverse Event|0|||
156432819|NCT01304147|564673913|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
156432820|NCT01244828|564673914|FG000|Overall Study|Adverse Event|37|||
156432821|NCT01244828|564673914|FG000|Overall Study|Withdrawal by Subject|31|||
156432822|NCT01244828|564673914|FG000|Overall Study|Lack of Efficacy|7|||
156432823|NCT01244828|564673914|FG000|Overall Study|Lost to Follow-up|2|||
156432824|NCT01244828|564673914|FG000|Overall Study|Other reason (not specified)|1|||
156527267|NCT03285178|565025261|FG006|Double-Blind Treatment Period|Adverse Event|2|||
156527268|NCT03285178|565025255|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156527269|NCT03285178|565025256|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
156527270|NCT03285178|565025257|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
156527271|NCT03285178|565025258|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
156527272|NCT03285178|565025259|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
156527273|NCT03285178|565025260|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
156527274|NCT03285178|565025261|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
156527275|NCT03285178|565025255|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156527276|NCT03285178|565025256|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156527277|NCT03285178|565025257|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156527278|NCT03285178|565025258|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156527279|NCT03285178|565025259|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156527280|NCT03285178|565025260|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156527281|NCT03285178|565025261|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156527282|NCT03285178|565025255|FG000|Double-Blind Treatment Period|COVID-19|0|||
156527283|NCT03285178|565025256|FG001|Double-Blind Treatment Period|COVID-19|0|||
156527284|NCT03285178|565025257|FG002|Double-Blind Treatment Period|COVID-19|1|||
156527285|NCT03285178|565025258|FG003|Double-Blind Treatment Period|COVID-19|0|||
156527286|NCT03285178|565025259|FG004|Double-Blind Treatment Period|COVID-19|0|||
156527287|NCT03285178|565025260|FG005|Double-Blind Treatment Period|COVID-19|0|||
156527288|NCT03285178|565025261|FG006|Double-Blind Treatment Period|COVID-19|0|||
156527289|NCT01128738|565025262|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
156527290|NCT01128738|565025263|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
156527291|NCT01128738|565025262|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
156527292|NCT01128738|565025263|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
156527293|NCT01128738|565025262|FG000|Second TP|Lost to Follow-up|0|||
156527294|NCT01128738|565025263|FG001|Second TP|Lost to Follow-up|1|||
156527295|NCT01128738|565025262|FG000|Second TP|Withdrawal by Subject|0|||
156527296|NCT01128738|565025263|FG001|Second TP|Withdrawal by Subject|2|||
156527297|NCT05116046|565025266|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156527298|NCT05116046|565025267|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156527299|NCT05116046|565025268|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156527300|NCT05116046|565025266|FG000|Overall Study|Study terminated by sponsor|14|||
156527301|NCT05116046|565025267|FG001|Overall Study|Study terminated by sponsor|16|||
156527302|NCT05116046|565025268|FG002|Overall Study|Study terminated by sponsor|1|||
156432825|NCT05233085|564673915|FG000|Overall Study|Adverse Event|1|||
156432826|NCT05233085|564673916|FG001|Overall Study|Adverse Event|0|||
156432827|NCT05233085|564673917|FG002|Overall Study|Adverse Event|0|||
156432828|NCT05233085|564673918|FG003|Overall Study|Adverse Event|0|||
156432829|NCT01212757|564673919|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
156432830|NCT01212757|564673920|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
156432831|NCT01212757|564673921|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
156527303|NCT00687973|565025269|FG000|Overall Study|Adverse Event|18|||
156527304|NCT00687973|565025270|FG001|Overall Study|Adverse Event|28|||
156527305|NCT00687973|565025269|FG000|Overall Study|Lack of Efficacy|2|||
156527306|NCT00687973|565025270|FG001|Overall Study|Lack of Efficacy|3|||
156527307|NCT00687973|565025269|FG000|Overall Study|Protocol Violation|1|||
156432832|NCT01212757|564673922|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156432833|NCT01212757|564673923|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156432834|NCT01212757|564673924|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156673750|NCT04631562|565552690|FG004|Overall Study|Adverse Event|0|||
156673751|NCT04631562|565552691|FG005|Overall Study|Adverse Event|0|||
156673752|NCT04631562|565552692|FG006|Overall Study|Adverse Event|1|||
156673753|NCT04631562|565552693|FG007|Overall Study|Adverse Event|0|||
156673754|NCT04631562|565552694|FG008|Overall Study|Adverse Event|0|||
156673755|NCT03498560|565552697|FG000|Overall Study|Found Ineligible|2|||
156673756|NCT03498560|565552697|FG000|Overall Study|Withdrawal by Subject|14|||
156673757|NCT03498560|565552697|FG000|Overall Study|Lost to Follow-up|4|||
156673758|NCT03498560|565552697|FG000|Overall Study|Death|1|||
156673759|NCT00112437|565552700|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
156673760|NCT00112437|565552701|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
156673761|NCT00112437|565552702|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
156673762|NCT00112437|565552703|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
156673763|NCT00112437|565552704|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
156673764|NCT00112437|565552705|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673765|NCT00112437|565552706|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673766|NCT00112437|565552707|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673767|NCT00112437|565552708|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673768|NCT00112437|565552709|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673769|NCT00112437|565552710|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673770|NCT00112437|565552711|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673771|NCT00112437|565552712|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673772|NCT00112437|565552713|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673773|NCT00112437|565552714|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673774|NCT00112437|565552715|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673775|NCT00112437|565552716|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673776|NCT00112437|565552717|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673777|NCT00112437|565552718|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673778|NCT00112437|565552719|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673779|NCT00112437|565552720|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673780|NCT00112437|565552721|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673781|NCT00112437|565552722|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673782|NCT00112437|565552723|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673783|NCT00112437|565552724|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673784|NCT00112437|565552725|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
156673785|NCT00112437|565552700|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673786|NCT00112437|565552701|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
156673787|NCT00112437|565552702|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673788|NCT00112437|565552703|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673789|NCT00112437|565552704|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673790|NCT00112437|565552705|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673791|NCT00112437|565552706|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673792|NCT00112437|565552707|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673793|NCT00112437|565552708|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673794|NCT00112437|565552709|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673795|NCT00112437|565552710|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673796|NCT00112437|565552711|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673797|NCT00112437|565552712|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673798|NCT00112437|565552713|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673799|NCT00112437|565552714|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673800|NCT00112437|565552715|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673801|NCT00112437|565552716|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673802|NCT00112437|565552717|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673803|NCT00112437|565552718|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673804|NCT00112437|565552719|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156527308|NCT00687973|565025270|FG001|Overall Study|Protocol Violation|2|||
156527309|NCT00687973|565025269|FG000|Overall Study|Administrative Reasons|0|||
156527310|NCT00687973|565025270|FG001|Overall Study|Administrative Reasons|2|||
156527311|NCT00687973|565025269|FG000|Overall Study|Withdrawal by Subject|3|||
156527312|NCT00687973|565025270|FG001|Overall Study|Withdrawal by Subject|3|||
156527313|NCT03353350|565025280|FG000|30-week Core Treatment Period|Protocol Violation|1|||
156527314|NCT03353350|565025281|FG001|30-week Core Treatment Period|Protocol Violation|1|||
156527315|NCT03353350|565025282|FG002|30-week Core Treatment Period|Protocol Violation|1|||
156527316|NCT03353350|565025283|FG003|30-week Core Treatment Period|Protocol Violation|0|||
156673805|NCT00112437|565552720|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673806|NCT00112437|565552721|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673807|NCT00112437|565552722|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673808|NCT00112437|565552723|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673809|NCT00112437|565552724|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673810|NCT00112437|565552725|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
156673811|NCT00112437|565552700|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673812|NCT00112437|565552701|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
156527317|NCT03353350|565025280|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
156527318|NCT03353350|565025281|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
156527319|NCT03353350|565025282|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
156527320|NCT03353350|565025283|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
156527321|NCT03353350|565025280|FG000|30-week Core Treatment Period|Adverse Event|0|||
156527322|NCT03353350|565025281|FG001|30-week Core Treatment Period|Adverse Event|4|||
156527323|NCT03353350|565025282|FG002|30-week Core Treatment Period|Adverse Event|2|||
156527324|NCT03353350|565025283|FG003|30-week Core Treatment Period|Adverse Event|3|||
156527325|NCT03353350|565025280|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
156527326|NCT03353350|565025281|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
156527327|NCT03353350|565025282|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
156527328|NCT03353350|565025283|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
156527329|NCT03353350|565025280|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
156527330|NCT03353350|565025281|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
156527331|NCT03353350|565025282|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
156527332|NCT03353350|565025283|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
156527333|NCT03353350|565025280|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
156527334|NCT03353350|565025281|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
156527335|NCT03353350|565025282|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
156527336|NCT03353350|565025283|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
156527337|NCT03353350|565025280|FG000|26-week Treatment Extension Period|Adverse Event|1|||
156527338|NCT03353350|565025281|FG001|26-week Treatment Extension Period|Adverse Event|0|||
156527339|NCT03353350|565025282|FG002|26-week Treatment Extension Period|Adverse Event|0|||
156527340|NCT03353350|565025283|FG003|26-week Treatment Extension Period|Adverse Event|1|||
156527341|NCT03353350|565025280|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
156527342|NCT03353350|565025281|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
156527343|NCT03353350|565025282|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
156527344|NCT03353350|565025283|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
156527345|NCT00985153|565025284|FG000|Overall Study|Lost to Follow-up|16|||
156527346|NCT00985153|565025285|FG001|Overall Study|Lost to Follow-up|19|||
156527347|NCT00985153|565025286|FG002|Overall Study|Lost to Follow-up|17|||
156527348|NCT00985153|565025287|FG003|Overall Study|Lost to Follow-up|20|||
156527349|NCT00985153|565025284|FG000|Overall Study|Protocol Violation|3|||
156527350|NCT00985153|565025285|FG001|Overall Study|Protocol Violation|2|||
156527351|NCT00985153|565025286|FG002|Overall Study|Protocol Violation|4|||
156527352|NCT00985153|565025287|FG003|Overall Study|Protocol Violation|3|||
156527353|NCT00985153|565025284|FG000|Overall Study|Withdrawal by Subject|6|||
156527354|NCT00985153|565025285|FG001|Overall Study|Withdrawal by Subject|11|||
156527355|NCT00985153|565025286|FG002|Overall Study|Withdrawal by Subject|11|||
156527356|NCT00985153|565025287|FG003|Overall Study|Withdrawal by Subject|10|||
156527357|NCT00985153|565025284|FG000|Overall Study|Missed One or More Bleeds|7|||
156527358|NCT00985153|565025285|FG001|Overall Study|Missed One or More Bleeds|7|||
156527359|NCT00985153|565025286|FG002|Overall Study|Missed One or More Bleeds|8|||
156527360|NCT00985153|565025287|FG003|Overall Study|Missed One or More Bleeds|10|||
156527361|NCT00985153|565025284|FG000|Overall Study|Incomplete Safety Follow-up|3|||
156527362|NCT00985153|565025285|FG001|Overall Study|Incomplete Safety Follow-up|5|||
156527363|NCT00985153|565025286|FG002|Overall Study|Incomplete Safety Follow-up|4|||
156527364|NCT00985153|565025287|FG003|Overall Study|Incomplete Safety Follow-up|4|||
156527365|NCT03370471|565025288|FG000|Overall Study|Withdrawal by Subject|6|||
156527366|NCT03370471|565025289|FG001|Overall Study|Withdrawal by Subject|1|||
156527367|NCT03370471|565025288|FG000|Overall Study|Unable to access veins for blood draw|0|||
156527368|NCT03370471|565025289|FG001|Overall Study|Unable to access veins for blood draw|1|||
156527369|NCT03370471|565025288|FG000|Overall Study|Screen fail|1|||
156527370|NCT03370471|565025289|FG001|Overall Study|Screen fail|0|||
156527371|NCT00561951|565025291|FG000|Overall Study|Adverse Event|11|||
156527372|NCT00561951|565025292|FG001|Overall Study|Adverse Event|14|||
156527373|NCT00561951|565025293|FG002|Overall Study|Adverse Event|14|||
156527374|NCT00561951|565025291|FG000|Overall Study|Lack of Efficacy|5|||
156527375|NCT00561951|565025292|FG001|Overall Study|Lack of Efficacy|3|||
156527376|NCT00561951|565025293|FG002|Overall Study|Lack of Efficacy|2|||
156527377|NCT00561951|565025291|FG000|Overall Study|Lost to Follow-up|1|||
156527378|NCT00561951|565025292|FG001|Overall Study|Lost to Follow-up|1|||
156527379|NCT00561951|565025293|FG002|Overall Study|Lost to Follow-up|0|||
156527380|NCT00561951|565025291|FG000|Overall Study|Withdrawal by Subject|10|||
156527381|NCT00561951|565025292|FG001|Overall Study|Withdrawal by Subject|9|||
156527382|NCT00561951|565025293|FG002|Overall Study|Withdrawal by Subject|10|||
156527383|NCT00561951|565025291|FG000|Overall Study|Protocol Violation|4|||
156527384|NCT00561951|565025292|FG001|Overall Study|Protocol Violation|3|||
156527385|NCT00561951|565025293|FG002|Overall Study|Protocol Violation|4|||
156527386|NCT00561951|565025291|FG000|Overall Study|Physician Decision|1|||
156527387|NCT00561951|565025292|FG001|Overall Study|Physician Decision|0|||
156527388|NCT00561951|565025293|FG002|Overall Study|Physician Decision|0|||
156527389|NCT00561951|565025291|FG000|Overall Study|Pregnancy|0|||
156673813|NCT00112437|565552702|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673814|NCT00112437|565552703|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673815|NCT00112437|565552704|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673816|NCT00112437|565552705|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673817|NCT00112437|565552706|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673818|NCT00112437|565552707|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673819|NCT00112437|565552708|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673820|NCT00112437|565552709|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673821|NCT00112437|565552710|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673822|NCT00112437|565552711|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673823|NCT00112437|565552712|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673824|NCT00112437|565552713|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673825|NCT00112437|565552714|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673826|NCT00112437|565552715|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673827|NCT00112437|565552716|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673828|NCT00112437|565552717|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673829|NCT00112437|565552718|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673830|NCT00112437|565552719|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673831|NCT00112437|565552720|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673832|NCT00112437|565552721|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673833|NCT00112437|565552722|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673834|NCT00112437|565552723|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673835|NCT00112437|565552724|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673836|NCT00112437|565552725|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
156673837|NCT00112437|565552700|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
156673838|NCT00112437|565552701|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673839|NCT00112437|565552702|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
156673840|NCT00112437|565552703|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
156673841|NCT00112437|565552704|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
156673842|NCT00112437|565552705|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673843|NCT00112437|565552706|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673844|NCT00112437|565552707|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673845|NCT00112437|565552708|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673846|NCT00112437|565552709|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673847|NCT00112437|565552710|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673848|NCT00112437|565552711|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673849|NCT00112437|565552712|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673850|NCT00112437|565552713|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673851|NCT00112437|565552714|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673852|NCT00112437|565552715|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673853|NCT00112437|565552716|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673854|NCT00112437|565552717|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673855|NCT00112437|565552718|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673856|NCT00112437|565552719|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673857|NCT00112437|565552720|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673858|NCT00112437|565552721|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673859|NCT00112437|565552722|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156527390|NCT00561951|565025292|FG001|Overall Study|Pregnancy|1|||
156527391|NCT00561951|565025293|FG002|Overall Study|Pregnancy|0|||
156527392|NCT00561951|565025291|FG000|Overall Study|Meet Withdrawal Criterion|0|||
156527393|NCT00561951|565025292|FG001|Overall Study|Meet Withdrawal Criterion|1|||
156527394|NCT00561951|565025293|FG002|Overall Study|Meet Withdrawal Criterion|1|||
156527395|NCT00561951|565025291|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
156527396|NCT00561951|565025292|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
156527397|NCT00561951|565025293|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
156527398|NCT01765179|565025294|FG000|Overall Study|Adverse Event|3|||
156527399|NCT01765179|565025294|FG000|Overall Study|Lost to Follow-up|5|||
156527400|NCT01765179|565025294|FG000|Overall Study|Non-compliance with study drug|2|||
156527401|NCT01765179|565025294|FG000|Overall Study|Protocol Violation|1|||
156673860|NCT00112437|565552723|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673861|NCT00112437|565552724|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673862|NCT00112437|565552725|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
156673863|NCT00112437|565552700|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
156673864|NCT00112437|565552701|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
156673865|NCT00112437|565552702|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
156673866|NCT00112437|565552703|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
156673867|NCT00112437|565552704|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
156673868|NCT00112437|565552705|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156527402|NCT01765179|565025294|FG000|Overall Study|Withdrawal by Subject|8|||
156527403|NCT01765179|565025294|FG000|Overall Study|Hematocrit >54%|3|||
156527404|NCT01765179|565025294|FG000|Overall Study|prohibited med|1|||
156673869|NCT00112437|565552706|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673870|NCT00112437|565552707|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673871|NCT00112437|565552708|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673872|NCT00112437|565552709|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673873|NCT00112437|565552710|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673874|NCT00112437|565552711|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673875|NCT00112437|565552712|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673876|NCT00112437|565552713|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673877|NCT00112437|565552714|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673878|NCT00112437|565552715|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673879|NCT00112437|565552716|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673880|NCT00112437|565552717|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673881|NCT00112437|565552718|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673882|NCT00112437|565552719|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673883|NCT00112437|565552720|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673884|NCT00112437|565552721|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673885|NCT00112437|565552722|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673886|NCT00112437|565552723|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673887|NCT00112437|565552724|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673888|NCT00112437|565552725|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
156673889|NCT00112437|565552700|FG000|Year 1 (12-Month Base Study)|moved|0|||
156673890|NCT00112437|565552701|FG001|Year 1 (12-Month Base Study)|moved|1|||
156673891|NCT00112437|565552702|FG002|Year 1 (12-Month Base Study)|moved|1|||
156673892|NCT00112437|565552703|FG003|Year 1 (12-Month Base Study)|moved|0|||
156673893|NCT00112437|565552704|FG004|Year 1 (12-Month Base Study)|moved|0|||
156673894|NCT00112437|565552705|FG005|Year 1 (12-Month Base Study)|moved|0|||
156673895|NCT00112437|565552706|FG006|Year 1 (12-Month Base Study)|moved|0|||
156673896|NCT00112437|565552707|FG007|Year 1 (12-Month Base Study)|moved|0|||
156673897|NCT00112437|565552708|FG008|Year 1 (12-Month Base Study)|moved|0|||
156673898|NCT00112437|565552709|FG009|Year 1 (12-Month Base Study)|moved|0|||
156527405|NCT01765179|565025294|FG000|Overall Study|Out of country unable to finish study|1|||
156527406|NCT01765179|565025294|FG000|Overall Study|lack of venous access|1|||
156527407|NCT01765179|565025294|FG000|Overall Study|work conflict|1|||
156527408|NCT01765179|565025294|FG000|Overall Study|Ca elevated 10.6|1|||
156527409|NCT02640157|565025295|FG000|Overall Study|Adverse Event|2|||
156527410|NCT02640157|565025296|FG001|Overall Study|Adverse Event|2|||
156527411|NCT02640157|565025297|FG002|Overall Study|Adverse Event|1|||
156527412|NCT02640157|565025295|FG000|Overall Study|Withdrew consent|2|||
156527413|NCT02640157|565025296|FG001|Overall Study|Withdrew consent|0|||
156527414|NCT02640157|565025297|FG002|Overall Study|Withdrew consent|2|||
156527415|NCT02640157|565025295|FG000|Overall Study|Lost to Follow-up|9|||
156527416|NCT02640157|565025296|FG001|Overall Study|Lost to Follow-up|2|||
156527417|NCT02640157|565025297|FG002|Overall Study|Lost to Follow-up|7|||
156527418|NCT02640157|565025295|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
156527419|NCT02640157|565025296|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
156527420|NCT02640157|565025297|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
156527421|NCT01596621|565025298|FG000|Overall Study|Death|4|||
156527422|NCT01596621|565025298|FG000|Overall Study|Withdrawal by Subject|9|||
156527423|NCT01596621|565025298|FG000|Overall Study|Disease Progression|49|||
156527424|NCT01596621|565025298|FG000|Overall Study|Lost to Follow-up|3|||
156527425|NCT01596621|565025298|FG000|Overall Study|Other than specified|13|||
156527426|NCT00710021|565025299|FG000|Overall Study|Lost to Follow-up|1|||
156527427|NCT00710021|565025300|FG001|Overall Study|Lost to Follow-up|0|||
156527428|NCT00710021|565025301|FG002|Overall Study|Lost to Follow-up|0|||
156527429|NCT00710021|565025299|FG000|Overall Study|Subject's Decision|0|||
156527430|NCT00710021|565025300|FG001|Overall Study|Subject's Decision|1|||
156527431|NCT00710021|565025301|FG002|Overall Study|Subject's Decision|0|||
156673899|NCT00112437|565552710|FG010|Year 1 (12-Month Base Study)|moved|0|||
156527432|NCT00710021|565025299|FG000|Overall Study|Subject misrandomized|0|||
156527433|NCT00710021|565025300|FG001|Overall Study|Subject misrandomized|1|||
156527434|NCT00710021|565025301|FG002|Overall Study|Subject misrandomized|1|||
156527435|NCT00710021|565025299|FG000|Overall Study|Physician Decision|0|||
156527436|NCT00710021|565025300|FG001|Overall Study|Physician Decision|1|||
156527437|NCT00710021|565025301|FG002|Overall Study|Physician Decision|0|||
156527438|NCT01679405|565025302|FG000|Overall Study|Death|2|||
156527439|NCT01679405|565025303|FG001|Overall Study|Death|5|||
156527440|NCT04677179|565025304|FG000|Induction Treatment Period|Adverse Event|1|||
156673900|NCT00112437|565552711|FG011|Year 1 (12-Month Base Study)|moved|0|||
156673901|NCT00112437|565552712|FG012|Year 1 (12-Month Base Study)|moved|0|||
156673902|NCT00112437|565552713|FG013|Year 1 (12-Month Base Study)|moved|0|||
156673903|NCT00112437|565552714|FG014|Year 1 (12-Month Base Study)|moved|0|||
156673904|NCT00112437|565552715|FG015|Year 1 (12-Month Base Study)|moved|0|||
156527441|NCT04677179|565025305|FG001|Induction Treatment Period|Adverse Event|0|||
156673905|NCT00112437|565552716|FG016|Year 1 (12-Month Base Study)|moved|0|||
156673906|NCT00112437|565552717|FG017|Year 1 (12-Month Base Study)|moved|0|||
156673907|NCT00112437|565552718|FG018|Year 1 (12-Month Base Study)|moved|0|||
156673908|NCT00112437|565552719|FG019|Year 1 (12-Month Base Study)|moved|0|||
156673909|NCT00112437|565552720|FG020|Year 1 (12-Month Base Study)|moved|0|||
156673910|NCT00112437|565552721|FG021|Year 1 (12-Month Base Study)|moved|0|||
156673911|NCT00112437|565552722|FG022|Year 1 (12-Month Base Study)|moved|0|||
156673912|NCT00112437|565552723|FG023|Year 1 (12-Month Base Study)|moved|0|||
156673913|NCT00112437|565552724|FG024|Year 1 (12-Month Base Study)|moved|0|||
156673914|NCT00112437|565552725|FG025|Year 1 (12-Month Base Study)|moved|0|||
156673915|NCT00112437|565552700|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673916|NCT00112437|565552701|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673917|NCT00112437|565552702|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673918|NCT00112437|565552703|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
156673919|NCT00112437|565552704|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673920|NCT00112437|565552705|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673921|NCT00112437|565552706|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673922|NCT00112437|565552707|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673923|NCT00112437|565552708|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673924|NCT00112437|565552709|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673925|NCT00112437|565552710|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673926|NCT00112437|565552711|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673927|NCT00112437|565552712|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673928|NCT00112437|565552713|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673929|NCT00112437|565552714|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673930|NCT00112437|565552715|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673931|NCT00112437|565552716|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673932|NCT00112437|565552717|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673933|NCT00112437|565552718|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673934|NCT00112437|565552719|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156527442|NCT04677179|565025306|FG002|Induction Treatment Period|Adverse Event|0|||
156527443|NCT04677179|565025307|FG003|Induction Treatment Period|Adverse Event|0|||
156527444|NCT04677179|565025308|FG004|Induction Treatment Period|Adverse Event|0|||
156527445|NCT04677179|565025309|FG005|Induction Treatment Period|Adverse Event|0|||
156527446|NCT04677179|565025310|FG006|Induction Treatment Period|Adverse Event|0|||
156527447|NCT04677179|565025311|FG007|Induction Treatment Period|Adverse Event|0|||
156527448|NCT04677179|565025312|FG008|Induction Treatment Period|Adverse Event|0|||
156527449|NCT04677179|565025313|FG009|Induction Treatment Period|Adverse Event|0|||
156527450|NCT04677179|565025304|FG000|Induction Treatment Period|Physician Decision|1|||
156527451|NCT04677179|565025305|FG001|Induction Treatment Period|Physician Decision|0|||
156527452|NCT04677179|565025306|FG002|Induction Treatment Period|Physician Decision|1|||
156527453|NCT04677179|565025307|FG003|Induction Treatment Period|Physician Decision|0|||
156527454|NCT04677179|565025308|FG004|Induction Treatment Period|Physician Decision|0|||
156432835|NCT01212757|564673925|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156432836|NCT01212757|564673926|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156432837|NCT01212757|564673927|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156432838|NCT01212757|564673919|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
156432839|NCT01212757|564673920|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
156432840|NCT01212757|564673921|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
156432841|NCT01212757|564673922|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156432842|NCT01212757|564673923|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156432843|NCT01212757|564673924|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156432844|NCT01212757|564673925|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156432845|NCT01212757|564673926|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156432846|NCT01212757|564673927|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156432847|NCT01212757|564673919|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
156432848|NCT01212757|564673920|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
156432849|NCT01212757|564673921|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
156432850|NCT01212757|564673922|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156432851|NCT01212757|564673923|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156432852|NCT01212757|564673924|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156432853|NCT01212757|564673925|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156432854|NCT01212757|564673926|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156432855|NCT01212757|564673927|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156432856|NCT01212757|564673919|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
156673935|NCT00112437|565552720|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673936|NCT00112437|565552721|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673937|NCT00112437|565552722|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673938|NCT00112437|565552723|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673939|NCT00112437|565552724|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673940|NCT00112437|565552725|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
156673941|NCT00112437|565552700|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673942|NCT00112437|565552701|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673943|NCT00112437|565552702|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673944|NCT00112437|565552703|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673945|NCT00112437|565552704|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
156673946|NCT00112437|565552705|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673947|NCT00112437|565552706|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673948|NCT00112437|565552707|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673949|NCT00112437|565552708|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673950|NCT00112437|565552709|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673951|NCT00112437|565552710|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673952|NCT00112437|565552711|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673953|NCT00112437|565552712|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673954|NCT00112437|565552713|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673955|NCT00112437|565552714|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673956|NCT00112437|565552715|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673957|NCT00112437|565552716|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673958|NCT00112437|565552717|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673959|NCT00112437|565552718|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673960|NCT00112437|565552719|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673961|NCT00112437|565552720|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673962|NCT00112437|565552721|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673963|NCT00112437|565552722|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673964|NCT00112437|565552723|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673965|NCT00112437|565552724|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673966|NCT00112437|565552725|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
156673967|NCT00112437|565552700|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
156673968|NCT00112437|565552701|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
156673969|NCT00112437|565552702|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
156673970|NCT00112437|565552703|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
156673971|NCT00112437|565552704|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
156673972|NCT00112437|565552705|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
156673973|NCT00112437|565552706|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
156673974|NCT00112437|565552707|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
156673975|NCT00112437|565552708|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
156673976|NCT00112437|565552709|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
156673977|NCT00112437|565552710|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
156673978|NCT00112437|565552711|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
156673979|NCT00112437|565552712|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
156673980|NCT00112437|565552713|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
156673981|NCT00112437|565552714|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
156673982|NCT00112437|565552715|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
156673983|NCT00112437|565552716|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
156673984|NCT00112437|565552717|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
156673985|NCT00112437|565552718|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
156673986|NCT00112437|565552719|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
156673987|NCT00112437|565552720|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
156527455|NCT04677179|565025309|FG005|Induction Treatment Period|Physician Decision|0|||
156527456|NCT04677179|565025310|FG006|Induction Treatment Period|Physician Decision|0|||
156527457|NCT04677179|565025311|FG007|Induction Treatment Period|Physician Decision|0|||
156527458|NCT04677179|565025312|FG008|Induction Treatment Period|Physician Decision|0|||
156527459|NCT04677179|565025313|FG009|Induction Treatment Period|Physician Decision|0|||
156527460|NCT04677179|565025304|FG000|Induction Treatment Period|Protocol Violation|0|||
156527461|NCT04677179|565025305|FG001|Induction Treatment Period|Protocol Violation|1|||
156527462|NCT04677179|565025306|FG002|Induction Treatment Period|Protocol Violation|0|||
156673988|NCT00112437|565552721|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
156527463|NCT04677179|565025307|FG003|Induction Treatment Period|Protocol Violation|0|||
156527464|NCT04677179|565025308|FG004|Induction Treatment Period|Protocol Violation|0|||
156673989|NCT00112437|565552722|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
156673990|NCT00112437|565552723|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
156673991|NCT00112437|565552724|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
156673992|NCT00112437|565552725|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
156673993|NCT00112437|565552700|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156673994|NCT00112437|565552701|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156673995|NCT00112437|565552702|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156673996|NCT00112437|565552703|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156673997|NCT00112437|565552704|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156673998|NCT00112437|565552705|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
156673999|NCT00112437|565552706|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
156674000|NCT00112437|565552707|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674001|NCT00112437|565552708|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674002|NCT00112437|565552709|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
156674003|NCT00112437|565552710|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674004|NCT00112437|565552711|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674005|NCT00112437|565552712|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674006|NCT00112437|565552713|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674007|NCT00112437|565552714|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674008|NCT00112437|565552715|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674009|NCT00112437|565552716|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674010|NCT00112437|565552717|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674011|NCT00112437|565552718|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674012|NCT00112437|565552719|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674013|NCT00112437|565552720|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674014|NCT00112437|565552721|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674015|NCT00112437|565552722|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674016|NCT00112437|565552723|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674017|NCT00112437|565552724|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674018|NCT00112437|565552725|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
156674019|NCT00112437|565552700|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674020|NCT00112437|565552701|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674021|NCT00112437|565552702|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674022|NCT00112437|565552703|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674023|NCT00112437|565552704|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674024|NCT00112437|565552705|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674025|NCT00112437|565552706|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674026|NCT00112437|565552707|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674027|NCT00112437|565552708|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
156674028|NCT00112437|565552709|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674029|NCT00112437|565552710|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674030|NCT00112437|565552711|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674031|NCT00112437|565552712|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674032|NCT00112437|565552713|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674033|NCT00112437|565552714|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674034|NCT00112437|565552715|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674035|NCT00112437|565552716|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674036|NCT00112437|565552717|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674037|NCT00112437|565552718|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674038|NCT00112437|565552719|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674039|NCT00112437|565552720|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674040|NCT00112437|565552721|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674041|NCT00112437|565552722|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674042|NCT00112437|565552723|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674043|NCT00112437|565552724|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674044|NCT00112437|565552725|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
156674045|NCT00112437|565552700|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
156432857|NCT01212757|564673920|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156432858|NCT01212757|564673921|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
156432859|NCT01212757|564673922|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156674046|NCT00112437|565552701|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674047|NCT00112437|565552702|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674048|NCT00112437|565552703|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674049|NCT00112437|565552704|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674050|NCT00112437|565552705|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674051|NCT00112437|565552706|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674052|NCT00112437|565552707|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674053|NCT00112437|565552708|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
156674054|NCT00112437|565552709|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674055|NCT00112437|565552710|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674056|NCT00112437|565552711|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
156432860|NCT01212757|564673923|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156674057|NCT00112437|565552712|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674058|NCT00112437|565552713|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674059|NCT00112437|565552714|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674060|NCT00112437|565552715|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674061|NCT00112437|565552716|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674062|NCT00112437|565552717|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674063|NCT00112437|565552718|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674064|NCT00112437|565552719|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674065|NCT00112437|565552720|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674066|NCT00112437|565552721|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674067|NCT00112437|565552722|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674068|NCT00112437|565552723|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674069|NCT00112437|565552724|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674070|NCT00112437|565552725|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
156674071|NCT00112437|565552700|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674072|NCT00112437|565552701|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674073|NCT00112437|565552702|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674074|NCT00112437|565552703|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674075|NCT00112437|565552704|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674076|NCT00112437|565552705|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
156674077|NCT00112437|565552706|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
156674078|NCT00112437|565552707|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
156674079|NCT00112437|565552708|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
156674080|NCT00112437|565552709|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
156674081|NCT00112437|565552710|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674082|NCT00112437|565552711|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674083|NCT00112437|565552712|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674084|NCT00112437|565552713|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674085|NCT00112437|565552714|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674086|NCT00112437|565552715|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674087|NCT00112437|565552716|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674088|NCT00112437|565552717|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674089|NCT00112437|565552718|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674090|NCT00112437|565552719|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674091|NCT00112437|565552720|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674092|NCT00112437|565552721|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674093|NCT00112437|565552722|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674094|NCT00112437|565552723|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674095|NCT00112437|565552724|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674096|NCT00112437|565552725|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
156674097|NCT00112437|565552700|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674098|NCT00112437|565552701|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674099|NCT00112437|565552702|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674100|NCT00112437|565552703|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674101|NCT00112437|565552704|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674102|NCT00112437|565552705|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674103|NCT00112437|565552706|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674104|NCT00112437|565552707|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674105|NCT00112437|565552708|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674106|NCT00112437|565552709|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
156327797|NCT00598702|564301381|FG000|Overall Study|Adverse Event|0|||
156327798|NCT00598702|564301382|FG001|Overall Study|Adverse Event|0|||
156327799|NCT00598702|564301383|FG002|Overall Study|Adverse Event|0|||
156327800|NCT00598702|564301384|FG003|Overall Study|Adverse Event|1|||
156327801|NCT00598702|564301385|FG004|Overall Study|Adverse Event|0|||
156327802|NCT00598702|564301386|FG005|Overall Study|Adverse Event|0|||
156327803|NCT00598702|564301387|FG006|Overall Study|Adverse Event|0|||
156327804|NCT00598702|564301388|FG007|Overall Study|Adverse Event|0|||
156327805|NCT00598702|564301381|FG000|Overall Study|Withdrawal by Subject|0|||
156327806|NCT00598702|564301382|FG001|Overall Study|Withdrawal by Subject|0|||
156327807|NCT00598702|564301383|FG002|Overall Study|Withdrawal by Subject|0|||
156327808|NCT00598702|564301384|FG003|Overall Study|Withdrawal by Subject|1|||
156327809|NCT00598702|564301385|FG004|Overall Study|Withdrawal by Subject|1|||
156327810|NCT00598702|564301386|FG005|Overall Study|Withdrawal by Subject|0|||
156327811|NCT00598702|564301387|FG006|Overall Study|Withdrawal by Subject|0|||
156327812|NCT00598702|564301388|FG007|Overall Study|Withdrawal by Subject|0|||
156327813|NCT00598702|564301381|FG000|Overall Study|Physician Decision|0|||
156327814|NCT00598702|564301382|FG001|Overall Study|Physician Decision|0|||
156327815|NCT00598702|564301383|FG002|Overall Study|Physician Decision|0|||
156327816|NCT00598702|564301384|FG003|Overall Study|Physician Decision|0|||
156327817|NCT00598702|564301385|FG004|Overall Study|Physician Decision|1|||
156432861|NCT01212757|564673924|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156527465|NCT04677179|565025309|FG005|Induction Treatment Period|Protocol Violation|0|||
156527466|NCT04677179|565025310|FG006|Induction Treatment Period|Protocol Violation|0|||
156527467|NCT04677179|565025311|FG007|Induction Treatment Period|Protocol Violation|0|||
156527468|NCT04677179|565025312|FG008|Induction Treatment Period|Protocol Violation|0|||
156527469|NCT04677179|565025313|FG009|Induction Treatment Period|Protocol Violation|0|||
156527470|NCT04677179|565025304|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
156527471|NCT04677179|565025305|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
156527472|NCT04677179|565025306|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
156527473|NCT04677179|565025307|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
156527474|NCT04677179|565025308|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
156527475|NCT04677179|565025309|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
156527476|NCT04677179|565025310|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
156527477|NCT04677179|565025311|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
156527478|NCT04677179|565025312|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
156527479|NCT04677179|565025313|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
156527480|NCT04677179|565025304|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
156527481|NCT04677179|565025305|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
156527482|NCT04677179|565025306|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
156527483|NCT04677179|565025307|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
156527484|NCT04677179|565025308|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
156527485|NCT04677179|565025309|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
156527486|NCT04677179|565025310|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
156527487|NCT04677179|565025311|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
156527488|NCT04677179|565025312|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
156527489|NCT04677179|565025313|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
156527490|NCT04677179|565025304|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
156432862|NCT01212757|564673925|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156432863|NCT01212757|564673926|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156432864|NCT01212757|564673927|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156432865|NCT01212757|564673919|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
156432866|NCT01212757|564673920|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
156432867|NCT01212757|564673921|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
156432868|NCT01212757|564673922|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156432869|NCT01212757|564673923|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156527491|NCT04677179|565025305|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
156527492|NCT04677179|565025306|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
156527493|NCT04677179|565025307|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
156527494|NCT04677179|565025308|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
156527495|NCT04677179|565025309|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
156527496|NCT04677179|565025310|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
156527497|NCT04677179|565025311|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
156527498|NCT04677179|565025312|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
156527499|NCT04677179|565025313|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
156527500|NCT04677179|565025304|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527501|NCT04677179|565025305|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527502|NCT04677179|565025306|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527503|NCT04677179|565025307|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
156527504|NCT04677179|565025308|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527505|NCT04677179|565025309|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527506|NCT04677179|565025310|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527507|NCT04677179|565025311|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527508|NCT04677179|565025312|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527509|NCT04677179|565025313|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
156527510|NCT04677179|565025304|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
156527511|NCT04677179|565025305|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
156527512|NCT04677179|565025306|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
156527513|NCT04677179|565025307|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
156527514|NCT04677179|565025308|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
156527515|NCT04677179|565025309|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
156527516|NCT04677179|565025310|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
156527517|NCT04677179|565025311|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
156527518|NCT04677179|565025312|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
156527519|NCT04677179|565025313|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
156527520|NCT04677179|565025304|FG000|Extension Treatment Period|Lack of Efficacy|0|||
156527521|NCT04677179|565025305|FG001|Extension Treatment Period|Lack of Efficacy|0|||
156866589|NCT00129402|566271285|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
156674107|NCT00112437|565552710|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674108|NCT00112437|565552711|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674109|NCT00112437|565552712|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674110|NCT00112437|565552713|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674111|NCT00112437|565552714|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674112|NCT00112437|565552715|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674113|NCT00112437|565552716|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674114|NCT00112437|565552717|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674115|NCT00112437|565552718|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674116|NCT00112437|565552719|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674117|NCT00112437|565552720|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674118|NCT00112437|565552721|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674119|NCT00112437|565552722|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674120|NCT00112437|565552723|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674121|NCT00112437|565552724|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674122|NCT00112437|565552725|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
156674123|NCT00112437|565552700|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674124|NCT00112437|565552701|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674125|NCT00112437|565552702|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674126|NCT00112437|565552703|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674127|NCT00112437|565552704|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674128|NCT00112437|565552705|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674129|NCT00112437|565552706|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674130|NCT00112437|565552707|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674131|NCT00112437|565552708|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674132|NCT00112437|565552709|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
156674133|NCT00112437|565552710|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674134|NCT00112437|565552711|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674135|NCT00112437|565552712|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674136|NCT00112437|565552713|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674137|NCT00112437|565552714|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674138|NCT00112437|565552715|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674139|NCT00112437|565552716|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674140|NCT00112437|565552717|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674141|NCT00112437|565552718|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674142|NCT00112437|565552719|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674143|NCT00112437|565552720|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674144|NCT00112437|565552721|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674145|NCT00112437|565552722|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674146|NCT00112437|565552723|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674147|NCT00112437|565552724|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674148|NCT00112437|565552725|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
156674149|NCT00112437|565552700|FG000|Year 2 (12-Month Extension)|Moved|0|||
156674150|NCT00112437|565552701|FG001|Year 2 (12-Month Extension)|Moved|0|||
156674151|NCT00112437|565552702|FG002|Year 2 (12-Month Extension)|Moved|0|||
156674152|NCT00112437|565552703|FG003|Year 2 (12-Month Extension)|Moved|0|||
156674153|NCT00112437|565552704|FG004|Year 2 (12-Month Extension)|Moved|0|||
156674154|NCT00112437|565552705|FG005|Year 2 (12-Month Extension)|Moved|0|||
156674155|NCT00112437|565552706|FG006|Year 2 (12-Month Extension)|Moved|0|||
156674156|NCT00112437|565552707|FG007|Year 2 (12-Month Extension)|Moved|0|||
156674157|NCT00112437|565552708|FG008|Year 2 (12-Month Extension)|Moved|0|||
156674158|NCT00112437|565552709|FG009|Year 2 (12-Month Extension)|Moved|1|||
156674159|NCT00112437|565552710|FG010|Year 2 (12-Month Extension)|Moved|0|||
156674160|NCT00112437|565552711|FG011|Year 2 (12-Month Extension)|Moved|0|||
156674161|NCT00112437|565552712|FG012|Year 2 (12-Month Extension)|Moved|0|||
156674162|NCT00112437|565552713|FG013|Year 2 (12-Month Extension)|Moved|0|||
156674163|NCT00112437|565552714|FG014|Year 2 (12-Month Extension)|Moved|0|||
156674164|NCT00112437|565552715|FG015|Year 2 (12-Month Extension)|Moved|0|||
156674165|NCT00112437|565552716|FG016|Year 2 (12-Month Extension)|Moved|0|||
156674166|NCT00112437|565552717|FG017|Year 2 (12-Month Extension)|Moved|0|||
156674167|NCT00112437|565552718|FG018|Year 2 (12-Month Extension)|Moved|0|||
156674168|NCT00112437|565552719|FG019|Year 2 (12-Month Extension)|Moved|0|||
156674169|NCT00112437|565552720|FG020|Year 2 (12-Month Extension)|Moved|0|||
156674170|NCT00112437|565552721|FG021|Year 2 (12-Month Extension)|Moved|0|||
156674171|NCT00112437|565552722|FG022|Year 2 (12-Month Extension)|Moved|0|||
156674172|NCT00112437|565552723|FG023|Year 2 (12-Month Extension)|Moved|0|||
156674173|NCT00112437|565552724|FG024|Year 2 (12-Month Extension)|Moved|0|||
156674174|NCT00112437|565552725|FG025|Year 2 (12-Month Extension)|Moved|0|||
156674175|NCT00112437|565552700|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
156674176|NCT00112437|565552701|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
156674177|NCT00112437|565552702|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
156674178|NCT00112437|565552703|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
156674179|NCT00112437|565552704|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
156674180|NCT00112437|565552705|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
156674181|NCT00112437|565552706|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
156674182|NCT00112437|565552707|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
156674183|NCT00112437|565552708|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
156674184|NCT00112437|565552709|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
156674185|NCT00112437|565552710|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
156674186|NCT00112437|565552711|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
156674187|NCT00112437|565552712|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
156674188|NCT00112437|565552713|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
156674189|NCT00112437|565552714|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
156674190|NCT00112437|565552715|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
156674191|NCT00112437|565552716|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
156674192|NCT00112437|565552717|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
156674193|NCT00112437|565552718|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
156674194|NCT00112437|565552719|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
156674195|NCT00112437|565552720|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
156674196|NCT00112437|565552721|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
156674197|NCT00112437|565552722|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
156674198|NCT00112437|565552723|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
156674199|NCT00112437|565552724|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
156674200|NCT00112437|565552725|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
156674201|NCT00112437|565552700|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674202|NCT00112437|565552701|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674203|NCT00112437|565552702|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674204|NCT00112437|565552703|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674205|NCT00112437|565552704|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674206|NCT00112437|565552705|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674207|NCT00112437|565552706|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674208|NCT00112437|565552707|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674209|NCT00112437|565552708|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674210|NCT00112437|565552709|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674211|NCT00112437|565552710|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674212|NCT00112437|565552711|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
156674213|NCT00112437|565552712|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674214|NCT00112437|565552713|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
156674215|NCT00112437|565552714|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674216|NCT00112437|565552715|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
156674217|NCT00112437|565552716|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674218|NCT00112437|565552717|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674219|NCT00112437|565552718|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
156674220|NCT00112437|565552719|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674221|NCT00112437|565552720|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674222|NCT00112437|565552721|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674223|NCT00112437|565552722|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674224|NCT00112437|565552723|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674225|NCT00112437|565552724|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674226|NCT00112437|565552725|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
156674227|NCT00112437|565552700|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674228|NCT00112437|565552701|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674229|NCT00112437|565552702|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674230|NCT00112437|565552703|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674231|NCT00112437|565552704|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674232|NCT00112437|565552705|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674233|NCT00112437|565552706|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674234|NCT00112437|565552707|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674235|NCT00112437|565552708|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674236|NCT00112437|565552709|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674237|NCT00112437|565552710|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674238|NCT00112437|565552711|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674239|NCT00112437|565552712|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156527522|NCT04677179|565025306|FG002|Extension Treatment Period|Lack of Efficacy|0|||
156674240|NCT00112437|565552713|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156527523|NCT04677179|565025307|FG003|Extension Treatment Period|Lack of Efficacy|0|||
156527524|NCT04677179|565025308|FG004|Extension Treatment Period|Lack of Efficacy|0|||
156527525|NCT04677179|565025309|FG005|Extension Treatment Period|Lack of Efficacy|0|||
156674241|NCT00112437|565552714|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674242|NCT00112437|565552715|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
156674243|NCT00112437|565552716|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674244|NCT00112437|565552717|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674245|NCT00112437|565552718|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674246|NCT00112437|565552719|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674247|NCT00112437|565552720|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674248|NCT00112437|565552721|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674249|NCT00112437|565552722|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674250|NCT00112437|565552723|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674251|NCT00112437|565552724|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674252|NCT00112437|565552725|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
156674253|NCT00112437|565552700|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674254|NCT00112437|565552701|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674255|NCT00112437|565552702|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674256|NCT00112437|565552703|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674257|NCT00112437|565552704|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674258|NCT00112437|565552705|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674259|NCT00112437|565552706|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674260|NCT00112437|565552707|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674261|NCT00112437|565552708|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674262|NCT00112437|565552709|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674263|NCT00112437|565552710|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674264|NCT00112437|565552711|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674265|NCT00112437|565552712|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674266|NCT00112437|565552713|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674267|NCT00112437|565552714|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674268|NCT00112437|565552715|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
156674269|NCT00112437|565552716|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674270|NCT00112437|565552717|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674271|NCT00112437|565552718|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674272|NCT00112437|565552719|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674273|NCT00112437|565552720|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674274|NCT00112437|565552721|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674275|NCT00112437|565552722|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674276|NCT00112437|565552723|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674277|NCT00112437|565552724|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674278|NCT00112437|565552725|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
156674279|NCT00112437|565552700|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674280|NCT00112437|565552701|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674281|NCT00112437|565552702|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674282|NCT00112437|565552703|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674283|NCT00112437|565552704|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674284|NCT00112437|565552705|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674285|NCT00112437|565552706|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674286|NCT00112437|565552707|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674287|NCT00112437|565552708|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674288|NCT00112437|565552709|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674289|NCT00112437|565552710|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156527526|NCT04677179|565025310|FG006|Extension Treatment Period|Lack of Efficacy|6|||
156527527|NCT04677179|565025311|FG007|Extension Treatment Period|Lack of Efficacy|0|||
156527528|NCT04677179|565025312|FG008|Extension Treatment Period|Lack of Efficacy|0|||
156527529|NCT04677179|565025313|FG009|Extension Treatment Period|Lack of Efficacy|0|||
156527530|NCT04677179|565025304|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
156527531|NCT04677179|565025305|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
156527532|NCT04677179|565025306|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
156527533|NCT04677179|565025307|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
156527534|NCT04677179|565025308|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
156527535|NCT04677179|565025309|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
156527536|NCT04677179|565025310|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
156527537|NCT04677179|565025311|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
156527538|NCT04677179|565025312|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
156527539|NCT04677179|565025313|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
156527540|NCT04677179|565025304|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
156527541|NCT04677179|565025305|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
156527542|NCT04677179|565025306|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
156527543|NCT04677179|565025307|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
156527544|NCT04677179|565025308|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
156527545|NCT04677179|565025309|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
156527546|NCT04677179|565025310|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
156527547|NCT04677179|565025311|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
156527548|NCT04677179|565025312|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
156527549|NCT04677179|565025313|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
156527550|NCT04677179|565025304|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
156527551|NCT04677179|565025305|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
156527552|NCT04677179|565025306|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
156527553|NCT04677179|565025307|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
156674290|NCT00112437|565552711|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
156674291|NCT00112437|565552712|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674292|NCT00112437|565552713|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674293|NCT00112437|565552714|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
156674294|NCT00112437|565552715|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674295|NCT00112437|565552716|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674296|NCT00112437|565552717|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674297|NCT00112437|565552718|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674298|NCT00112437|565552719|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674299|NCT00112437|565552720|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674300|NCT00112437|565552721|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674301|NCT00112437|565552722|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674302|NCT00112437|565552723|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674303|NCT00112437|565552724|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674304|NCT00112437|565552725|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
156674305|NCT00112437|565552700|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674306|NCT00112437|565552701|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674307|NCT00112437|565552702|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674308|NCT00112437|565552703|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674309|NCT00112437|565552704|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674310|NCT00112437|565552705|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674311|NCT00112437|565552706|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674312|NCT00112437|565552707|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674313|NCT00112437|565552708|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674314|NCT00112437|565552709|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674315|NCT00112437|565552710|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
156674316|NCT00112437|565552711|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
156674317|NCT00112437|565552712|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674318|NCT00112437|565552713|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674319|NCT00112437|565552714|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674320|NCT00112437|565552715|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674321|NCT00112437|565552716|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674322|NCT00112437|565552717|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674323|NCT00112437|565552718|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674324|NCT00112437|565552719|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674325|NCT00112437|565552720|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674326|NCT00112437|565552721|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674327|NCT00112437|565552722|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674328|NCT00112437|565552723|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674329|NCT00112437|565552724|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674330|NCT00112437|565552725|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
156674331|NCT00112437|565552700|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674332|NCT00112437|565552701|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674333|NCT00112437|565552702|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674334|NCT00112437|565552703|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674335|NCT00112437|565552704|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674336|NCT00112437|565552705|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674337|NCT00112437|565552706|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674338|NCT00112437|565552707|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674339|NCT00112437|565552708|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674340|NCT00112437|565552709|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674341|NCT00112437|565552710|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674342|NCT00112437|565552711|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674343|NCT00112437|565552712|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156327818|NCT00598702|564301386|FG005|Overall Study|Physician Decision|0|||
156327819|NCT00598702|564301387|FG006|Overall Study|Physician Decision|0|||
156674344|NCT00112437|565552713|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156527554|NCT04677179|565025308|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
156327820|NCT00598702|564301388|FG007|Overall Study|Physician Decision|0|||
156327821|NCT00598702|564301381|FG000|Overall Study|Dose limiting toxicity|0|||
156527555|NCT04677179|565025309|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
156527556|NCT04677179|565025310|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
156674345|NCT00112437|565552714|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674346|NCT00112437|565552715|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674347|NCT00112437|565552716|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156432870|NCT01212757|564673924|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156432871|NCT01212757|564673925|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156674348|NCT00112437|565552717|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674349|NCT00112437|565552718|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156432872|NCT01212757|564673926|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156432873|NCT01212757|564673927|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156432874|NCT01212757|564673919|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156432875|NCT01212757|564673920|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
156432876|NCT01212757|564673921|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
156432877|NCT01212757|564673922|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156432878|NCT01212757|564673923|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156432879|NCT01212757|564673924|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156432880|NCT01212757|564673925|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156432881|NCT01212757|564673926|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156674350|NCT00112437|565552719|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674351|NCT00112437|565552720|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
156674352|NCT00112437|565552721|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
156674353|NCT00112437|565552722|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674354|NCT00112437|565552723|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674355|NCT00112437|565552724|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674356|NCT00112437|565552725|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
156674357|NCT00112437|565552700|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674358|NCT00112437|565552701|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674359|NCT00112437|565552702|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674360|NCT00112437|565552703|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674361|NCT00112437|565552704|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674362|NCT00112437|565552705|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674363|NCT00112437|565552706|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674364|NCT00112437|565552707|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674365|NCT00112437|565552708|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674366|NCT00112437|565552709|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674367|NCT00112437|565552710|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674368|NCT00112437|565552711|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674369|NCT00112437|565552712|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674370|NCT00112437|565552713|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674371|NCT00112437|565552714|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674372|NCT00112437|565552715|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674373|NCT00112437|565552716|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674374|NCT00112437|565552717|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674375|NCT00112437|565552718|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674376|NCT00112437|565552719|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674377|NCT00112437|565552720|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
156674378|NCT00112437|565552721|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674379|NCT00112437|565552722|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674380|NCT00112437|565552723|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674381|NCT00112437|565552724|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674382|NCT00112437|565552725|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
156674383|NCT00112437|565552700|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674384|NCT00112437|565552701|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674385|NCT00112437|565552702|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674386|NCT00112437|565552703|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674387|NCT00112437|565552704|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674388|NCT00112437|565552705|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674389|NCT00112437|565552706|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674390|NCT00112437|565552707|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674391|NCT00112437|565552708|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674392|NCT00112437|565552709|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674393|NCT00112437|565552710|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674394|NCT00112437|565552711|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674395|NCT00112437|565552712|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674396|NCT00112437|565552713|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156779787|NCT01078662|565943883|FG000|Overall Study|Patients reached data cut-off|12|||
156779788|NCT01078662|565943884|FG001|Overall Study|Patients reached data cut-off|53|||
156674397|NCT00112437|565552714|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674398|NCT00112437|565552715|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674399|NCT00112437|565552716|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674400|NCT00112437|565552717|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674401|NCT00112437|565552718|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674402|NCT00112437|565552719|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674403|NCT00112437|565552720|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674404|NCT00112437|565552721|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
156674405|NCT00112437|565552722|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156432882|NCT01212757|564673927|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156432883|NCT01212757|564673919|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
156432884|NCT01212757|564673920|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
156432885|NCT01212757|564673921|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156432886|NCT01212757|564673922|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156432887|NCT01212757|564673923|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156432888|NCT01212757|564673924|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156674406|NCT00112437|565552723|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674407|NCT00112437|565552724|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674408|NCT00112437|565552725|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
156674409|NCT00112437|565552700|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674410|NCT00112437|565552701|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674411|NCT00112437|565552702|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674412|NCT00112437|565552703|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674413|NCT00112437|565552704|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674414|NCT00112437|565552705|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674415|NCT00112437|565552706|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674416|NCT00112437|565552707|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674417|NCT00112437|565552708|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674418|NCT00112437|565552709|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674419|NCT00112437|565552710|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674420|NCT00112437|565552711|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674421|NCT00112437|565552712|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674422|NCT00112437|565552713|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
156432889|NCT01212757|564673925|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156432890|NCT01212757|564673926|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156432891|NCT01212757|564673927|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156432892|NCT01212757|564673919|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
156432893|NCT01212757|564673920|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
156432894|NCT01212757|564673921|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
156674423|NCT00112437|565552714|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674424|NCT00112437|565552715|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674425|NCT00112437|565552716|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674426|NCT00112437|565552717|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674427|NCT00112437|565552718|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
156527557|NCT04677179|565025311|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
156527558|NCT04677179|565025312|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
156527559|NCT04677179|565025313|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
156527560|NCT04677179|565025304|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156527561|NCT04677179|565025305|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156527562|NCT04677179|565025306|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156527563|NCT04677179|565025307|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156527564|NCT04677179|565025308|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156527565|NCT04677179|565025309|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156527566|NCT04677179|565025310|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156527567|NCT04677179|565025311|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
156527568|NCT04677179|565025312|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
156432895|NCT01212757|564673922|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
156432896|NCT01212757|564673923|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
156432897|NCT01212757|564673924|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
156432898|NCT01212757|564673925|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
156674428|NCT00112437|565552719|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
156432899|NCT01212757|564673926|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
156432900|NCT01212757|564673927|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
156432901|NCT01212757|564673919|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
156432902|NCT01212757|564673920|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
156527569|NCT04677179|565025313|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156527570|NCT04677179|565025304|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156674429|NCT00112437|565552720|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
156779789|NCT01078662|565943885|FG002|Overall Study|Patients reached data cut-off|2|||
156674430|NCT00112437|565552721|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
156674431|NCT00112437|565552722|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674432|NCT00112437|565552723|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674433|NCT00112437|565552724|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674434|NCT00112437|565552725|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
156674435|NCT00112437|565552700|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674436|NCT00112437|565552701|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674437|NCT00112437|565552702|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674438|NCT00112437|565552703|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674439|NCT00112437|565552704|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674440|NCT00112437|565552705|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674441|NCT00112437|565552706|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674442|NCT00112437|565552707|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674443|NCT00112437|565552708|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674444|NCT00112437|565552709|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674445|NCT00112437|565552710|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674446|NCT00112437|565552711|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674447|NCT00112437|565552712|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674448|NCT00112437|565552713|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674449|NCT00112437|565552714|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674450|NCT00112437|565552715|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674451|NCT00112437|565552716|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674452|NCT00112437|565552717|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674453|NCT00112437|565552718|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674454|NCT00112437|565552719|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674455|NCT00112437|565552720|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
156674456|NCT00112437|565552721|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
156674457|NCT00112437|565552722|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674458|NCT00112437|565552723|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674459|NCT00112437|565552724|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674460|NCT00112437|565552725|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
156674461|NCT00112437|565552700|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674462|NCT00112437|565552701|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674463|NCT00112437|565552702|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674464|NCT00112437|565552703|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674465|NCT00112437|565552704|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674466|NCT00112437|565552705|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674467|NCT00112437|565552706|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674468|NCT00112437|565552707|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674469|NCT00112437|565552708|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674470|NCT00112437|565552709|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674471|NCT00112437|565552710|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674472|NCT00112437|565552711|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674473|NCT00112437|565552712|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674474|NCT00112437|565552713|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674475|NCT00112437|565552714|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674476|NCT00112437|565552715|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674477|NCT00112437|565552716|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674478|NCT00112437|565552717|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674479|NCT00112437|565552718|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156327822|NCT00598702|564301382|FG001|Overall Study|Dose limiting toxicity|0|||
156327823|NCT00598702|564301383|FG002|Overall Study|Dose limiting toxicity|0|||
156327824|NCT00598702|564301384|FG003|Overall Study|Dose limiting toxicity|1|||
156327825|NCT00598702|564301385|FG004|Overall Study|Dose limiting toxicity|1|||
156327826|NCT00598702|564301386|FG005|Overall Study|Dose limiting toxicity|1|||
156327827|NCT00598702|564301387|FG006|Overall Study|Dose limiting toxicity|0|||
156327828|NCT00598702|564301388|FG007|Overall Study|Dose limiting toxicity|0|||
156327829|NCT02556203|564301389|FG000|Overall Study|Withdrawal by Subject|21|||
156327830|NCT02556203|564301390|FG001|Overall Study|Withdrawal by Subject|21|||
156327831|NCT02556203|564301389|FG000|Overall Study|Lost to Follow-up|5|||
156327832|NCT02556203|564301390|FG001|Overall Study|Lost to Follow-up|5|||
156327833|NCT02556203|564301389|FG000|Overall Study|Adverse Event|1|||
156327834|NCT02556203|564301390|FG001|Overall Study|Adverse Event|0|||
156327835|NCT04171765|564301396|FG000|Overall Study|Adverse Event|2|||
156327836|NCT04171765|564301397|FG001|Overall Study|Adverse Event|0|||
156674480|NCT00112437|565552719|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674481|NCT00112437|565552720|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674482|NCT00112437|565552721|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674483|NCT00112437|565552722|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
156674484|NCT00112437|565552723|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
156674485|NCT00112437|565552724|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
156674486|NCT00112437|565552725|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
156674487|NCT00112437|565552700|FG000|Years 6-10 (60-Month Extension)|Death|0|||
156674488|NCT00112437|565552701|FG001|Years 6-10 (60-Month Extension)|Death|0|||
156674489|NCT00112437|565552702|FG002|Years 6-10 (60-Month Extension)|Death|0|||
156674490|NCT00112437|565552703|FG003|Years 6-10 (60-Month Extension)|Death|0|||
156674491|NCT00112437|565552704|FG004|Years 6-10 (60-Month Extension)|Death|0|||
156674492|NCT00112437|565552705|FG005|Years 6-10 (60-Month Extension)|Death|0|||
156674493|NCT00112437|565552706|FG006|Years 6-10 (60-Month Extension)|Death|0|||
156674494|NCT00112437|565552707|FG007|Years 6-10 (60-Month Extension)|Death|0|||
156674495|NCT00112437|565552708|FG008|Years 6-10 (60-Month Extension)|Death|0|||
156674496|NCT00112437|565552709|FG009|Years 6-10 (60-Month Extension)|Death|0|||
156674497|NCT00112437|565552710|FG010|Years 6-10 (60-Month Extension)|Death|0|||
156674498|NCT00112437|565552711|FG011|Years 6-10 (60-Month Extension)|Death|0|||
156674499|NCT00112437|565552712|FG012|Years 6-10 (60-Month Extension)|Death|0|||
156674500|NCT00112437|565552713|FG013|Years 6-10 (60-Month Extension)|Death|0|||
156674501|NCT00112437|565552714|FG014|Years 6-10 (60-Month Extension)|Death|0|||
156674502|NCT00112437|565552715|FG015|Years 6-10 (60-Month Extension)|Death|0|||
156674503|NCT00112437|565552716|FG016|Years 6-10 (60-Month Extension)|Death|0|||
156674504|NCT00112437|565552717|FG017|Years 6-10 (60-Month Extension)|Death|0|||
156674505|NCT00112437|565552718|FG018|Years 6-10 (60-Month Extension)|Death|0|||
156674506|NCT00112437|565552719|FG019|Years 6-10 (60-Month Extension)|Death|0|||
156674507|NCT00112437|565552720|FG020|Years 6-10 (60-Month Extension)|Death|0|||
156674508|NCT00112437|565552721|FG021|Years 6-10 (60-Month Extension)|Death|0|||
156674509|NCT00112437|565552722|FG022|Years 6-10 (60-Month Extension)|Death|0|||
156674510|NCT00112437|565552723|FG023|Years 6-10 (60-Month Extension)|Death|2|||
156674511|NCT00112437|565552724|FG024|Years 6-10 (60-Month Extension)|Death|0|||
156674512|NCT00112437|565552725|FG025|Years 6-10 (60-Month Extension)|Death|0|||
156674513|NCT00112437|565552700|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674514|NCT00112437|565552701|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674515|NCT00112437|565552702|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674516|NCT00112437|565552703|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674517|NCT00112437|565552704|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674518|NCT00112437|565552705|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674519|NCT00112437|565552706|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674520|NCT00112437|565552707|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674521|NCT00112437|565552708|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674522|NCT00112437|565552709|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674523|NCT00112437|565552710|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674524|NCT00112437|565552711|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674525|NCT00112437|565552712|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674526|NCT00112437|565552713|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674527|NCT00112437|565552714|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674528|NCT00112437|565552715|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674529|NCT00112437|565552716|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674530|NCT00112437|565552717|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156527571|NCT04677179|565025305|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156527572|NCT04677179|565025306|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156527573|NCT04677179|565025307|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156527574|NCT04677179|565025308|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156527575|NCT04677179|565025309|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156527576|NCT04677179|565025310|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156527577|NCT04677179|565025311|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
156527578|NCT04677179|565025312|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156527579|NCT04677179|565025313|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156527580|NCT04677179|565025304|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156527581|NCT04677179|565025305|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156527582|NCT04677179|565025306|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156674531|NCT00112437|565552718|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156527583|NCT04677179|565025307|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156527584|NCT04677179|565025308|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156527585|NCT04677179|565025309|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156527586|NCT04677179|565025310|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156527587|NCT04677179|565025311|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
156527588|NCT04677179|565025312|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
156527589|NCT04677179|565025313|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156674532|NCT00112437|565552719|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674533|NCT00112437|565552720|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674534|NCT00112437|565552721|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674535|NCT00112437|565552722|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674536|NCT00112437|565552723|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674537|NCT00112437|565552724|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
156674538|NCT00112437|565552725|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
156674539|NCT00112437|565552700|FG000|Years 6-10 (60-Month Extension)|Other|0|||
156674540|NCT00112437|565552701|FG001|Years 6-10 (60-Month Extension)|Other|0|||
156674541|NCT00112437|565552702|FG002|Years 6-10 (60-Month Extension)|Other|0|||
156674542|NCT00112437|565552703|FG003|Years 6-10 (60-Month Extension)|Other|0|||
156674543|NCT00112437|565552704|FG004|Years 6-10 (60-Month Extension)|Other|0|||
156674544|NCT00112437|565552705|FG005|Years 6-10 (60-Month Extension)|Other|0|||
156674545|NCT00112437|565552706|FG006|Years 6-10 (60-Month Extension)|Other|0|||
156674546|NCT00112437|565552707|FG007|Years 6-10 (60-Month Extension)|Other|0|||
156674547|NCT00112437|565552708|FG008|Years 6-10 (60-Month Extension)|Other|0|||
156674548|NCT00112437|565552709|FG009|Years 6-10 (60-Month Extension)|Other|0|||
156674549|NCT00112437|565552710|FG010|Years 6-10 (60-Month Extension)|Other|0|||
156674550|NCT00112437|565552711|FG011|Years 6-10 (60-Month Extension)|Other|0|||
156674551|NCT00112437|565552712|FG012|Years 6-10 (60-Month Extension)|Other|0|||
156674552|NCT00112437|565552713|FG013|Years 6-10 (60-Month Extension)|Other|0|||
156674553|NCT00112437|565552714|FG014|Years 6-10 (60-Month Extension)|Other|0|||
156674554|NCT00112437|565552715|FG015|Years 6-10 (60-Month Extension)|Other|0|||
156674555|NCT00112437|565552716|FG016|Years 6-10 (60-Month Extension)|Other|0|||
156674556|NCT00112437|565552717|FG017|Years 6-10 (60-Month Extension)|Other|0|||
156674557|NCT00112437|565552718|FG018|Years 6-10 (60-Month Extension)|Other|0|||
156674558|NCT00112437|565552719|FG019|Years 6-10 (60-Month Extension)|Other|0|||
156674559|NCT00112437|565552720|FG020|Years 6-10 (60-Month Extension)|Other|0|||
156674560|NCT00112437|565552721|FG021|Years 6-10 (60-Month Extension)|Other|0|||
156674561|NCT00112437|565552722|FG022|Years 6-10 (60-Month Extension)|Other|0|||
156674562|NCT00112437|565552723|FG023|Years 6-10 (60-Month Extension)|Other|0|||
156674563|NCT00112437|565552724|FG024|Years 6-10 (60-Month Extension)|Other|1|||
156674564|NCT00112437|565552725|FG025|Years 6-10 (60-Month Extension)|Other|0|||
156674565|NCT00112437|565552700|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674566|NCT00112437|565552701|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674567|NCT00112437|565552702|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674568|NCT00112437|565552703|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674569|NCT00112437|565552704|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674570|NCT00112437|565552705|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674571|NCT00112437|565552706|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674572|NCT00112437|565552707|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674573|NCT00112437|565552708|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674574|NCT00112437|565552709|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674575|NCT00112437|565552710|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674576|NCT00112437|565552711|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674577|NCT00112437|565552712|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674578|NCT00112437|565552713|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674579|NCT00112437|565552714|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674580|NCT00112437|565552715|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674581|NCT00112437|565552716|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674582|NCT00112437|565552717|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674583|NCT00112437|565552718|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674584|NCT00112437|565552719|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674585|NCT00112437|565552720|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674586|NCT00112437|565552721|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674587|NCT00112437|565552722|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674588|NCT00112437|565552723|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
156674589|NCT00112437|565552724|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674590|NCT00112437|565552725|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
156674591|NCT00112437|565552700|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674592|NCT00112437|565552701|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674593|NCT00112437|565552702|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674594|NCT00112437|565552703|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674595|NCT00112437|565552704|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674596|NCT00112437|565552705|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674597|NCT00112437|565552706|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674598|NCT00112437|565552707|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674599|NCT00112437|565552708|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674600|NCT00112437|565552709|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674601|NCT00112437|565552710|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674602|NCT00112437|565552711|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674603|NCT00112437|565552712|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674604|NCT00112437|565552713|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674605|NCT00112437|565552714|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674606|NCT00112437|565552715|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674607|NCT00112437|565552716|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674608|NCT00112437|565552717|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674609|NCT00112437|565552718|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674610|NCT00112437|565552719|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674611|NCT00112437|565552720|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674612|NCT00112437|565552721|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674613|NCT00112437|565552722|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
156674614|NCT00112437|565552723|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
156674615|NCT00112437|565552724|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
156674616|NCT00112437|565552725|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
156674617|NCT01824576|565552728|FG000|Overall Study|Device deficiency|2|||
156674618|NCT00436163|565552729|FG000|Overall Study|Lost to Follow-up|2|||
156674619|NCT00436163|565552729|FG000|Overall Study|Adverse Event|1|||
156674620|NCT02896296|565552730|FG000|Overall Study|Adverse Event|1|||
156674621|NCT02896296|565552730|FG000|Overall Study|Lost to Follow-up|19|||
156674622|NCT02896296|565552730|FG000|Overall Study|Pregnancy|1|||
156674623|NCT02896296|565552730|FG000|Overall Study|Physician Decision|2|||
156674624|NCT02896296|565552730|FG000|Overall Study|Withdrawal by Subject|10|||
156674625|NCT02896296|565552730|FG000|Overall Study|Site closing|7|||
156674626|NCT02896296|565552730|FG000|Overall Study|Incarceration|1|||
156674627|NCT02896296|565552730|FG000|Overall Study|Relocation|1|||
156674628|NCT02597049|565552731|FG000|Overall Study|Lost to Follow-up|0|||
156674629|NCT02597049|565552732|FG001|Overall Study|Lost to Follow-up|3|||
156674630|NCT02597049|565552733|FG002|Overall Study|Lost to Follow-up|2|||
156674631|NCT02597049|565552731|FG000|Overall Study|Withdrawal by Subject|2|||
156674632|NCT02597049|565552732|FG001|Overall Study|Withdrawal by Subject|2|||
156674633|NCT02597049|565552733|FG002|Overall Study|Withdrawal by Subject|1|||
156674634|NCT02597049|565552731|FG000|Overall Study|Adverse Event|2|||
156674635|NCT02597049|565552732|FG001|Overall Study|Adverse Event|0|||
156674636|NCT02597049|565552733|FG002|Overall Study|Adverse Event|0|||
156674637|NCT02597049|565552731|FG000|Overall Study|Death|2|||
156674638|NCT02597049|565552732|FG001|Overall Study|Death|0|||
156674639|NCT02597049|565552733|FG002|Overall Study|Death|0|||
156674640|NCT02597049|565552731|FG000|Overall Study|Noncompliant with Study Visits|1|||
156674641|NCT02597049|565552732|FG001|Overall Study|Noncompliant with Study Visits|0|||
156674642|NCT02597049|565552733|FG002|Overall Study|Noncompliant with Study Visits|0|||
156674643|NCT03250117|565552737|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
156674644|NCT03250117|565552738|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
156674645|NCT03250117|565552739|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
156674646|NCT03250117|565552740|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
156674647|NCT04063878|565552741|FG000|Overall Study|Withdrawal by Subject|2|||
156674648|NCT04063878|565552741|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
156674649|NCT02751827|565552742|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
156674650|NCT02751827|565552743|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
156674651|NCT02751827|565552744|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
156674652|NCT00147498|565552745|FG000|Overall Study|Adverse Event|1|||
156674653|NCT00147498|565552746|FG001|Overall Study|Adverse Event|6|||
156674654|NCT00147498|565552747|FG002|Overall Study|Adverse Event|7|||
156674655|NCT00147498|565552748|FG003|Overall Study|Adverse Event|3|||
156674656|NCT00147498|565552745|FG000|Overall Study|Lack of Efficacy|1|||
156674657|NCT00147498|565552746|FG001|Overall Study|Lack of Efficacy|1|||
156674658|NCT00147498|565552747|FG002|Overall Study|Lack of Efficacy|1|||
156527590|NCT04677179|565025304|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156527591|NCT04677179|565025305|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156527592|NCT04677179|565025306|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156527593|NCT04677179|565025307|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156527594|NCT04677179|565025308|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156527595|NCT04677179|565025309|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156527596|NCT04677179|565025310|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156527597|NCT04677179|565025311|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
156527598|NCT04677179|565025312|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
156674659|NCT00147498|565552748|FG003|Overall Study|Lack of Efficacy|8|||
156674660|NCT00147498|565552745|FG000|Overall Study|Laboratory abnormality|0|||
156674661|NCT00147498|565552746|FG001|Overall Study|Laboratory abnormality|0|||
156674662|NCT00147498|565552747|FG002|Overall Study|Laboratory abnormality|2|||
156674663|NCT00147498|565552748|FG003|Overall Study|Laboratory abnormality|0|||
156779790|NCT01078662|565943886|FG003|Overall Study|Patients reached data cut-off|2|||
156674664|NCT00147498|565552745|FG000|Overall Study|Participant defaulted|0|||
156674665|NCT00147498|565552746|FG001|Overall Study|Participant defaulted|1|||
156674666|NCT00147498|565552747|FG002|Overall Study|Participant defaulted|4|||
156674667|NCT00147498|565552748|FG003|Overall Study|Participant defaulted|3|||
156674668|NCT00147498|565552745|FG000|Overall Study|Other|1|||
156674669|NCT00147498|565552746|FG001|Overall Study|Other|1|||
156674670|NCT00147498|565552747|FG002|Overall Study|Other|3|||
156674671|NCT00147498|565552748|FG003|Overall Study|Other|3|||
156674672|NCT01229150|565552751|FG000|Overall Study|Toxicity|2|||
156674673|NCT01229150|565552752|FG001|Overall Study|Toxicity|2|||
156674674|NCT01229150|565552753|FG002|Overall Study|Toxicity|0|||
156674675|NCT01229150|565552754|FG003|Overall Study|Toxicity|0|||
156674676|NCT01473953|565552757|FG000|Overall Study|Other|1|||
156674677|NCT01473953|565552758|FG001|Overall Study|Other|0|||
156674678|NCT01473953|565552759|FG002|Overall Study|Other|0|||
156674679|NCT01473953|565552760|FG003|Overall Study|Other|0|||
156674680|NCT01473953|565552761|FG004|Overall Study|Other|0|||
156674681|NCT04633564|565552762|FG000|Period 1|Adverse Event|28|||
156674682|NCT04633564|565552763|FG001|Period 1|Adverse Event|19|||
156674683|NCT04633564|565552762|FG000|Period 1|Death|8|||
156674684|NCT04633564|565552763|FG001|Period 1|Death|7|||
156674685|NCT04633564|565552762|FG000|Period 1|Lost to Follow-up|3|||
156674686|NCT04633564|565552763|FG001|Period 1|Lost to Follow-up|5|||
156674687|NCT04633564|565552762|FG000|Period 1|Physician Decision|4|||
156674688|NCT04633564|565552763|FG001|Period 1|Physician Decision|12|||
156674689|NCT04633564|565552762|FG000|Period 1|Protocol Violation|0|||
156432903|NCT01212757|564673921|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
156432904|NCT01212757|564673922|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
156432905|NCT01212757|564673923|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
156432906|NCT01212757|564673924|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
156674690|NCT04633564|565552763|FG001|Period 1|Protocol Violation|1|||
156674691|NCT04633564|565552762|FG000|Period 1|Withdrawal by Subject|10|||
156674692|NCT04633564|565552763|FG001|Period 1|Withdrawal by Subject|8|||
156674693|NCT04633564|565552762|FG000|Period 1|Progressive disease|47|||
156674694|NCT04633564|565552763|FG001|Period 1|Progressive disease|51|||
156674695|NCT04633564|565552762|FG000|Period 1|Terminated by Sponsor|8|||
156674696|NCT04633564|565552763|FG001|Period 1|Terminated by Sponsor|6|||
156674697|NCT04633564|565552762|FG000|Period 2|Adverse Event|3|||
156674698|NCT04633564|565552763|FG001|Period 2|Adverse Event|4|||
156674699|NCT04633564|565552762|FG000|Period 2|Death|0|||
156674700|NCT04633564|565552763|FG001|Period 2|Death|2|||
156674701|NCT04633564|565552762|FG000|Period 2|Lost to Follow-up|0|||
156674702|NCT04633564|565552763|FG001|Period 2|Lost to Follow-up|1|||
156674703|NCT04633564|565552762|FG000|Period 2|Physician Decision|2|||
156674704|NCT04633564|565552763|FG001|Period 2|Physician Decision|4|||
156674705|NCT04633564|565552762|FG000|Period 2|Withdrawal by Subject|5|||
156674706|NCT04633564|565552763|FG001|Period 2|Withdrawal by Subject|1|||
156674707|NCT04633564|565552762|FG000|Period 2|Progressive Disease|74|||
156674708|NCT04633564|565552763|FG001|Period 2|Progressive Disease|82|||
156674709|NCT04633564|565552762|FG000|Period 2|Terminated by Sponsor|9|||
156674710|NCT04633564|565552763|FG001|Period 2|Terminated by Sponsor|3|||
156674711|NCT01279486|565552764|FG000|Overall Study|Lost to Follow-up|1|||
156674712|NCT04198363|565552767|FG000|Overall Study|Adverse Event|1|||
156674713|NCT04198363|565552768|FG001|Overall Study|Adverse Event|1|||
156674714|NCT04198363|565552767|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
156674715|NCT04198363|565552768|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
156674716|NCT04198363|565552767|FG000|Overall Study|Reason not Specified|1|||
156674717|NCT04198363|565552768|FG001|Overall Study|Reason not Specified|0|||
156674718|NCT03500094|565552774|FG000|Overall Study|Withdrawal by Subject|1|||
156674719|NCT03500094|565552774|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
156674720|NCT03500094|565552774|FG000|Overall Study|Lost to Follow-up|1|||
156674721|NCT03506633|565554718|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
156674722|NCT03506633|565554719|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
156674723|NCT00258856|565554723|FG000|Overall Study|Lost to Follow-up|1|||
156432907|NCT01212757|564673925|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
156432908|NCT01212757|564673926|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
156674724|NCT00258856|565554724|FG001|Overall Study|Lost to Follow-up|0|||
156674725|NCT00258856|565554725|FG002|Overall Study|Lost to Follow-up|2|||
156674726|NCT00258856|565554726|FG003|Overall Study|Lost to Follow-up|0|||
156674727|NCT00258856|565554723|FG000|Overall Study|Non-compliance|2|||
156674728|NCT00258856|565554724|FG001|Overall Study|Non-compliance|0|||
156674729|NCT00258856|565554725|FG002|Overall Study|Non-compliance|0|||
156674730|NCT00258856|565554726|FG003|Overall Study|Non-compliance|1|||
156674731|NCT03247686|565554727|FG000|Overall Study|Withdrawal by Subject|1|||
156674732|NCT03247686|565554728|FG001|Overall Study|Withdrawal by Subject|2|||
156674733|NCT02488109|565554734|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
156674734|NCT02488109|565554735|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
156674735|NCT02488109|565554734|FG000|12-month Follow-Up|Lost to Follow-up|4|||
156674736|NCT02488109|565554735|FG001|12-month Follow-Up|Lost to Follow-up|7|||
156674737|NCT02302716|565554736|FG000|Overall Study|Adverse Event|1|||
156674738|NCT02302716|565554737|FG001|Overall Study|Adverse Event|1|||
156674739|NCT02302716|565554736|FG000|Overall Study|Death|0|||
156674740|NCT02302716|565554737|FG001|Overall Study|Death|1|||
156674741|NCT02302716|565554736|FG000|Overall Study|Lack of Efficacy|0|||
156674742|NCT02302716|565554737|FG001|Overall Study|Lack of Efficacy|1|||
156674743|NCT02302716|565554736|FG000|Overall Study|Lost to Follow-up|2|||
156674744|NCT02302716|565554737|FG001|Overall Study|Lost to Follow-up|4|||
156674745|NCT02302716|565554736|FG000|Overall Study|Physician Decision|3|||
156674746|NCT02302716|565554737|FG001|Overall Study|Physician Decision|4|||
156674747|NCT02302716|565554736|FG000|Overall Study|Withdrawal by Subject|13|||
156674748|NCT02302716|565554737|FG001|Overall Study|Withdrawal by Subject|7|||
156674749|NCT02302716|565554736|FG000|Overall Study|Protocol Violation|0|||
156674750|NCT02302716|565554737|FG001|Overall Study|Protocol Violation|1|||
156674751|NCT00557245|565554745|FG000|Overall Study|Lost to Follow-up|7|||
156674752|NCT00557245|565554746|FG001|Overall Study|Lost to Follow-up|8|||
156674753|NCT00557245|565554747|FG002|Overall Study|Lost to Follow-up|10|||
156674754|NCT00557245|565554745|FG000|Overall Study|Ineligible|5|||
156674755|NCT00557245|565554746|FG001|Overall Study|Ineligible|4|||
156674756|NCT00557245|565554747|FG002|Overall Study|Ineligible|2|||
156674757|NCT00521586|565554751|FG000|Initial Vaccination (Year 0)|Subject request|8|||
156674758|NCT00521586|565554752|FG001|Initial Vaccination (Year 0)|Subject request|11|||
156674759|NCT00521586|565554751|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
156674760|NCT00521586|565554752|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
156674761|NCT00521586|565554751|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
156674762|NCT00521586|565554752|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
156674763|NCT00521586|565554751|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
156674764|NCT00521586|565554752|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
156674765|NCT00521586|565554751|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
156674766|NCT00521586|565554752|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
156674767|NCT00521586|565554751|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
156674768|NCT00521586|565554752|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
156674769|NCT00521586|565554751|FG000|Initial Vaccination (Year 0)|Death|1|||
156674770|NCT00521586|565554752|FG001|Initial Vaccination (Year 0)|Death|0|||
156674771|NCT00521586|565554751|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
156674772|NCT00521586|565554752|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
156674773|NCT00521586|565554751|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
156674774|NCT00521586|565554752|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
156674775|NCT00521586|565554751|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
156674776|NCT00521586|565554752|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
156674777|NCT00521586|565554751|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
156674778|NCT00521586|565554752|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
156674779|NCT00521586|565554751|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
156674780|NCT00521586|565554752|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
156674781|NCT00521586|565554751|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
156527599|NCT04677179|565025313|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
156527600|NCT01536015|565025314|FG000|Overall Study|Adverse Event|1|||
156674782|NCT00521586|565554752|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
156674783|NCT00521586|565554751|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
156674784|NCT00521586|565554752|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
156674785|NCT00521586|565554751|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
156674786|NCT00521586|565554752|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
156674787|NCT00521586|565554751|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
156674788|NCT00521586|565554752|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
156674789|NCT00521586|565554751|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
156674790|NCT00521586|565554752|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
156674791|NCT00521586|565554751|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
156674792|NCT00521586|565554752|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
156674793|NCT00521586|565554751|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
156674794|NCT00521586|565554752|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
156674795|NCT00828321|565554753|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
156674796|NCT00828321|565554754|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
156674797|NCT00828321|565554753|FG000|Second Intervention|Protocol Violation|0|||
156674798|NCT00828321|565554754|FG001|Second Intervention|Protocol Violation|1|||
156327837|NCT04171765|564301398|FG002|Overall Study|Adverse Event|1|||
156327838|NCT04171765|564301399|FG003|Overall Study|Adverse Event|0|||
156327839|NCT04171765|564301396|FG000|Overall Study|Lost to Follow-up|0|||
156327840|NCT04171765|564301397|FG001|Overall Study|Lost to Follow-up|2|||
156327841|NCT04171765|564301398|FG002|Overall Study|Lost to Follow-up|2|||
156327842|NCT04171765|564301399|FG003|Overall Study|Lost to Follow-up|2|||
156327843|NCT04171765|564301396|FG000|Overall Study|Week 58 visit missed|0|||
156327844|NCT04171765|564301397|FG001|Overall Study|Week 58 visit missed|0|||
156327845|NCT04171765|564301398|FG002|Overall Study|Week 58 visit missed|1|||
156327846|NCT04171765|564301399|FG003|Overall Study|Week 58 visit missed|0|||
156432909|NCT01212757|564673927|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
156432910|NCT01212757|564673919|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
156432911|NCT01212757|564673920|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
156432912|NCT01212757|564673921|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
156674799|NCT02997176|565554755|FG000|Overall Study|Adverse Event|0|||
156674800|NCT02997176|565554756|FG001|Overall Study|Adverse Event|0|||
156674801|NCT02997176|565554757|FG002|Overall Study|Adverse Event|0|||
156674802|NCT02997176|565554758|FG003|Overall Study|Adverse Event|8|||
156674803|NCT02997176|565554755|FG000|Overall Study|Progressive Disease|1|||
156674804|NCT02997176|565554756|FG001|Overall Study|Progressive Disease|0|||
156674805|NCT02997176|565554757|FG002|Overall Study|Progressive Disease|1|||
156674806|NCT02997176|565554758|FG003|Overall Study|Progressive Disease|1|||
156674807|NCT02997176|565554755|FG000|Overall Study|Death|0|||
156674808|NCT02997176|565554756|FG001|Overall Study|Death|0|||
156674809|NCT02997176|565554757|FG002|Overall Study|Death|1|||
156674810|NCT02997176|565554758|FG003|Overall Study|Death|1|||
156674811|NCT02997176|565554755|FG000|Overall Study|Withdrawal by Subject|0|||
156674812|NCT02997176|565554756|FG001|Overall Study|Withdrawal by Subject|2|||
156674813|NCT02997176|565554757|FG002|Overall Study|Withdrawal by Subject|0|||
156674814|NCT02997176|565554758|FG003|Overall Study|Withdrawal by Subject|1|||
156674815|NCT00691704|565554762|FG000|Induction Therapy|Disease Progression|1|||
156674816|NCT00691704|565554762|FG000|Induction Therapy|Active Hepatitis|1|||
156674817|NCT00691704|565554762|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
156674818|NCT00691704|565554762|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
156674819|NCT00691704|565554762|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
156674820|NCT02888756|565554763|FG000|Analytical Treatment Interruption|Physician Decision|10|||
156674821|NCT02888756|565554764|FG001|Analytical Treatment Interruption|Physician Decision|6|||
156674822|NCT02888756|565554765|FG002|Analytical Treatment Interruption|Physician Decision|5|||
156674823|NCT05497557|565554771|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
156674824|NCT05497557|565554772|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
156674825|NCT05497557|565554773|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
156674826|NCT00198133|565554775|FG000|Overall Study|Disease progression|2|||
156674827|NCT00198133|565554776|FG001|Overall Study|Disease progression|5|||
156674828|NCT00198133|565554775|FG000|Overall Study|Adverse Event|1|||
156674829|NCT00198133|565554776|FG001|Overall Study|Adverse Event|3|||
156674830|NCT00198133|565554775|FG000|Overall Study|Withdrawal by Subject|1|||
156674831|NCT00198133|565554776|FG001|Overall Study|Withdrawal by Subject|0|||
156674832|NCT00198133|565554775|FG000|Overall Study|Physician Decision|1|||
156674833|NCT00198133|565554776|FG001|Overall Study|Physician Decision|0|||
156674834|NCT02752074|565554777|FG000|Overall Study|Lost to Follow-up|1|||
156674835|NCT02752074|565554778|FG001|Overall Study|Lost to Follow-up|4|||
156674836|NCT02752074|565554777|FG000|Overall Study|Death|146|||
156674837|NCT02752074|565554778|FG001|Overall Study|Death|129|||
156674838|NCT02752074|565554777|FG000|Overall Study|Withdrawal by Subject|9|||
156674839|NCT02752074|565554778|FG001|Overall Study|Withdrawal by Subject|10|||
156674840|NCT00488774|565554779|FG000|Overall Study|Withdrawal of consent|2|||
156674841|NCT00488774|565554780|FG001|Overall Study|Withdrawal of consent|2|||
156674842|NCT00488774|565554781|FG002|Overall Study|Withdrawal of consent|2|||
156674843|NCT00488774|565554782|FG003|Overall Study|Withdrawal of consent|0|||
156674844|NCT00488774|565554779|FG000|Overall Study|Other|6|||
156674845|NCT00488774|565554780|FG001|Overall Study|Other|3|||
156674846|NCT00488774|565554781|FG002|Overall Study|Other|2|||
156674847|NCT00488774|565554782|FG003|Overall Study|Other|2|||
156674848|NCT00488774|565554779|FG000|Overall Study|Lost to Follow-up|0|||
156674849|NCT00488774|565554780|FG001|Overall Study|Lost to Follow-up|0|||
156674850|NCT00488774|565554781|FG002|Overall Study|Lost to Follow-up|1|||
156674851|NCT00488774|565554782|FG003|Overall Study|Lost to Follow-up|1|||
156674852|NCT05523895|565554783|FG000|Overall Study|Adverse Event|2|||
156674853|NCT05523895|565554784|FG001|Overall Study|Adverse Event|1|||
156674854|NCT05523895|565554785|FG002|Overall Study|Adverse Event|1|||
156674855|NCT05523895|565554783|FG000|Overall Study|Lost to Follow-up|0|||
156674856|NCT05523895|565554784|FG001|Overall Study|Lost to Follow-up|1|||
156674857|NCT05523895|565554785|FG002|Overall Study|Lost to Follow-up|2|||
156674858|NCT05523895|565554783|FG000|Overall Study|Noncompliance with study drug|1|||
156674859|NCT05523895|565554784|FG001|Overall Study|Noncompliance with study drug|1|||
156674860|NCT05523895|565554785|FG002|Overall Study|Noncompliance with study drug|1|||
156674861|NCT05523895|565554783|FG000|Overall Study|Protocol Violation|0|||
156527601|NCT01536015|565025315|FG001|Overall Study|Adverse Event|4|||
156674862|NCT05523895|565554784|FG001|Overall Study|Protocol Violation|2|||
156674863|NCT05523895|565554785|FG002|Overall Study|Protocol Violation|0|||
156674864|NCT05523895|565554783|FG000|Overall Study|Withdrawal by Subject|1|||
156674865|NCT05523895|565554784|FG001|Overall Study|Withdrawal by Subject|3|||
156674866|NCT05523895|565554785|FG002|Overall Study|Withdrawal by Subject|1|||
156674867|NCT05523895|565554783|FG000|Overall Study|Not further specified|0|||
156674868|NCT05523895|565554784|FG001|Overall Study|Not further specified|3|||
156674869|NCT05523895|565554785|FG002|Overall Study|Not further specified|1|||
156674870|NCT02213263|565554786|FG000|Overall Study|Insufficient clinical response|4|||
156674871|NCT02213263|565554787|FG001|Overall Study|Insufficient clinical response|3|||
156527602|NCT01536015|565025314|FG000|Overall Study|Lost to Follow-up|0|||
156527603|NCT01536015|565025315|FG001|Overall Study|Lost to Follow-up|1|||
156527604|NCT01536015|565025314|FG000|Overall Study|Inclusion Criterion not met|2|||
156527605|NCT01536015|565025315|FG001|Overall Study|Inclusion Criterion not met|0|||
156527606|NCT01536015|565025314|FG000|Overall Study|Study closure|5|||
156527607|NCT01536015|565025315|FG001|Overall Study|Study closure|5|||
156674872|NCT02213263|565554786|FG000|Overall Study|Lost to Follow-up|0|||
156674873|NCT02213263|565554787|FG001|Overall Study|Lost to Follow-up|1|||
156674874|NCT02213263|565554786|FG000|Overall Study|No longer willing to participate|3|||
156674875|NCT02213263|565554787|FG001|Overall Study|No longer willing to participate|4|||
156674876|NCT02213263|565554786|FG000|Overall Study|Progressive disease|20|||
156674877|NCT02213263|565554787|FG001|Overall Study|Progressive disease|14|||
156674878|NCT02213263|565554786|FG000|Overall Study|Protocol Violation|0|||
156674879|NCT02213263|565554787|FG001|Overall Study|Protocol Violation|1|||
156674880|NCT02213263|565554786|FG000|Overall Study|Adverse Event|1|||
156674881|NCT02213263|565554787|FG001|Overall Study|Adverse Event|3|||
156674882|NCT05752721|565554788|FG000|Overall Study|Lost to Follow-up|22|||
156674883|NCT05752721|565554789|FG001|Overall Study|Lost to Follow-up|20|||
156674884|NCT05752721|565554788|FG000|Overall Study|Withdrawal by Subject|15|||
156674885|NCT05752721|565554789|FG001|Overall Study|Withdrawal by Subject|12|||
156674886|NCT00263588|565554790|FG000|Overall Study|Death|54|||
156674887|NCT00263588|565554791|FG001|Overall Study|Death|90|||
156674888|NCT00263588|565554790|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
156674889|NCT00263588|565554791|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
156674890|NCT00263588|565554790|FG000|Overall Study|Lost to Follow-up|7|||
156527608|NCT01201265|565025318|FG000|Overall Study|Death|14|||
156527609|NCT01201265|565025318|FG000|Overall Study|Insufficient Therapeutic Response|3|||
156527610|NCT01201265|565025318|FG000|Overall Study|Lost to Follow-up|10|||
156527611|NCT01201265|565025318|FG000|Overall Study|Withdrawal by Subject|7|||
156527612|NCT01201265|565025318|FG000|Overall Study|Disease Progression|4|||
156527613|NCT02041520|565025319|FG000|Overall Study|Adverse Event|2|||
156527614|NCT02041520|565025320|FG001|Overall Study|Adverse Event|1|||
156527615|NCT02041520|565025319|FG000|Overall Study|Withdrawal by Subject|3|||
156527616|NCT02041520|565025320|FG001|Overall Study|Withdrawal by Subject|4|||
156527617|NCT02041520|565025319|FG000|Overall Study|Protocol Violation|1|||
156674891|NCT00263588|565554791|FG001|Overall Study|Lost to Follow-up|10|||
156527618|NCT02041520|565025320|FG001|Overall Study|Protocol Violation|0|||
156674892|NCT00263588|565554790|FG000|Overall Study|Withdrawal by Subject|3|||
156674893|NCT00263588|565554791|FG001|Overall Study|Withdrawal by Subject|4|||
156674894|NCT00263588|565554790|FG000|Overall Study|Protocol Violation|0|||
156674895|NCT00263588|565554791|FG001|Overall Study|Protocol Violation|1|||
156674896|NCT00263588|565554790|FG000|Overall Study|Investigator decision|7|||
156527619|NCT02041520|565025319|FG000|Overall Study|Lost to Follow-up|0|||
156527620|NCT02041520|565025320|FG001|Overall Study|Lost to Follow-up|1|||
156527621|NCT02041520|565025319|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
156527622|NCT02041520|565025320|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
156527623|NCT00413972|565025321|FG000|Overall Study|Adverse Event|2|||
156527624|NCT00413972|565025322|FG001|Overall Study|Adverse Event|1|||
156527625|NCT00413972|565025323|FG002|Overall Study|Adverse Event|0|||
156527626|NCT00413972|565025324|FG003|Overall Study|Adverse Event|0|||
156527627|NCT00413972|565025321|FG000|Overall Study|Lost to Follow-up|1|||
156527628|NCT00413972|565025322|FG001|Overall Study|Lost to Follow-up|2|||
156527629|NCT00413972|565025323|FG002|Overall Study|Lost to Follow-up|1|||
156527630|NCT00413972|565025324|FG003|Overall Study|Lost to Follow-up|0|||
156527631|NCT00413972|565025321|FG000|Overall Study|Withdrawal by Subject|4|||
156527632|NCT00413972|565025322|FG001|Overall Study|Withdrawal by Subject|5|||
156527633|NCT00413972|565025323|FG002|Overall Study|Withdrawal by Subject|7|||
156527634|NCT00413972|565025324|FG003|Overall Study|Withdrawal by Subject|2|||
156527635|NCT00413972|565025321|FG000|Overall Study|Protocol Violation|0|||
156527636|NCT00413972|565025322|FG001|Overall Study|Protocol Violation|0|||
156527637|NCT00413972|565025323|FG002|Overall Study|Protocol Violation|2|||
156527638|NCT00413972|565025324|FG003|Overall Study|Protocol Violation|0|||
156527639|NCT00413972|565025321|FG000|Overall Study|Other|0|||
156674897|NCT00263588|565554791|FG001|Overall Study|Investigator decision|15|||
156674898|NCT00263588|565554790|FG000|Overall Study|Sponsor terminated study|0|||
156674899|NCT00263588|565554791|FG001|Overall Study|Sponsor terminated study|1|||
156674900|NCT00216736|565554798|FG000|Overall Study|Lost to Follow-up|1|||
156674901|NCT00216736|565554799|FG001|Overall Study|Lost to Follow-up|1|||
156674902|NCT00807495|565554800|FG000|Overall Study|Adverse Event|6|||
156674903|NCT00807495|565554801|FG001|Overall Study|Adverse Event|3|||
156674904|NCT00807495|565554802|FG002|Overall Study|Adverse Event|1|||
156674905|NCT00807495|565554803|FG003|Overall Study|Adverse Event|1|||
156527640|NCT00413972|565025322|FG001|Overall Study|Other|0|||
156527641|NCT00413972|565025323|FG002|Overall Study|Other|0|||
156527642|NCT00413972|565025324|FG003|Overall Study|Other|1|||
156527643|NCT01898923|565025327|FG000|Overall Study|Lack of Efficacy|5|||
156527644|NCT01898923|565025328|FG001|Overall Study|Lack of Efficacy|6|||
156674906|NCT00807495|565554804|FG004|Overall Study|Adverse Event|2|||
156674907|NCT00807495|565554800|FG000|Overall Study|Withdrawal by Patient|2|||
156674908|NCT00807495|565554801|FG001|Overall Study|Withdrawal by Patient|0|||
156674909|NCT00807495|565554802|FG002|Overall Study|Withdrawal by Patient|1|||
156674910|NCT00807495|565554803|FG003|Overall Study|Withdrawal by Patient|0|||
156674911|NCT00807495|565554804|FG004|Overall Study|Withdrawal by Patient|0|||
156674912|NCT00807495|565554800|FG000|Overall Study|Reason Not Specified|0|||
156674913|NCT00807495|565554801|FG001|Overall Study|Reason Not Specified|3|||
156674914|NCT00807495|565554802|FG002|Overall Study|Reason Not Specified|2|||
156674915|NCT00807495|565554803|FG003|Overall Study|Reason Not Specified|0|||
156674916|NCT00807495|565554804|FG004|Overall Study|Reason Not Specified|3|||
156674917|NCT00841542|565554806|FG000|Period 1|Adverse Event|1|||
156674918|NCT00841542|565554807|FG001|Period 1|Adverse Event|0|||
156674919|NCT01906372|565554808|FG000|Overall Study|Withdrawal by Subject|2|||
156527645|NCT01898923|565025327|FG000|Overall Study|Adverse Event|3|||
156527646|NCT01898923|565025328|FG001|Overall Study|Adverse Event|1|||
156674920|NCT03629054|565554809|FG000|Period 2 (4 Days)|Not treated|0|||
156674921|NCT03629054|565554810|FG001|Period 2 (4 Days)|Not treated|1|||
156674922|NCT00924638|565554817|FG000|Overall Study|Death|3|||
156674923|NCT00924638|565554818|FG001|Overall Study|Death|2|||
156527647|NCT01898923|565025327|FG000|Overall Study|Lost to Follow-up|0|||
156527648|NCT01898923|565025328|FG001|Overall Study|Lost to Follow-up|1|||
156527649|NCT01898923|565025327|FG000|Overall Study|Withdrawal by Subject|4|||
156527650|NCT01898923|565025328|FG001|Overall Study|Withdrawal by Subject|7|||
156527651|NCT01898923|565025327|FG000|Overall Study|Physician Decision|3|||
156527652|NCT01898923|565025328|FG001|Overall Study|Physician Decision|4|||
156527653|NCT01898923|565025327|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
156527654|NCT01898923|565025328|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
156527655|NCT02678247|565025331|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
156527656|NCT02678247|565025332|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
156527657|NCT02678247|565025331|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
156527658|NCT02678247|565025332|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
156527659|NCT02678247|565025331|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
156527660|NCT02678247|565025332|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
156527661|NCT02678247|565025331|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
156527662|NCT02678247|565025332|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
156527663|NCT02678247|565025331|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
156527664|NCT02678247|565025332|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
156527665|NCT02678247|565025331|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
156527666|NCT02678247|565025332|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
156527667|NCT00723021|565025335|FG000|Intervention Period 4|Adverse Event|0|||
156527668|NCT00723021|565025336|FG001|Intervention Period 4|Adverse Event|0|||
156527669|NCT00723021|565025337|FG002|Intervention Period 4|Adverse Event|0|||
156527670|NCT00723021|565025338|FG003|Intervention Period 4|Adverse Event|0|||
156527671|NCT00723021|565025339|FG004|Intervention Period 4|Adverse Event|1|||
156527672|NCT02739360|565025341|FG000|Overall Study|Adverse Event|1|||
156527673|NCT02739360|565025341|FG000|Overall Study|Study terminated by Sponsor|2|||
156527674|NCT00026208|565025344|FG000|Overall Study|Complications of auto accident|1|||
156527675|NCT00026208|565025345|FG001|Overall Study|Complications of auto accident|0|||
156527676|NCT02881957|565025349|FG000|Overall Study|Comfort care|0|||
156527677|NCT02881957|565025350|FG001|Overall Study|Comfort care|1|||
156527678|NCT02881957|565025349|FG000|Overall Study|Concurrent trial enrollment|0|||
156527679|NCT02881957|565025350|FG001|Overall Study|Concurrent trial enrollment|1|||
156527680|NCT02881957|565025349|FG000|Overall Study|Discharged within 48 hours|0|||
156527681|NCT02881957|565025350|FG001|Overall Study|Discharged within 48 hours|1|||
156527682|NCT02881957|565025349|FG000|Overall Study|Withdrawal by Subject|2|||
156527683|NCT02881957|565025350|FG001|Overall Study|Withdrawal by Subject|1|||
156527684|NCT02881957|565025349|FG000|Overall Study|Protocol Violation|1|||
156527685|NCT02881957|565025350|FG001|Overall Study|Protocol Violation|0|||
156527686|NCT02254278|565025351|FG000|Overall Study|Protocol Violation|1|||
156527687|NCT02254278|565025352|FG001|Overall Study|Protocol Violation|1|||
156527688|NCT00826111|565026857|FG000|Overall Study|Lost to Follow-up|0|||
156527689|NCT00826111|565026858|FG001|Overall Study|Lost to Follow-up|1|||
156527690|NCT00826111|565026857|FG000|Overall Study|Protocol Violation|1|||
156527691|NCT00826111|565026858|FG001|Overall Study|Protocol Violation|0|||
156527692|NCT00826111|565026857|FG000|Overall Study|Withdrawal by Subject|5|||
156527693|NCT00826111|565026858|FG001|Overall Study|Withdrawal by Subject|0|||
156527694|NCT00826111|565026857|FG000|Overall Study|Physician Decision|1|||
156527695|NCT00826111|565026858|FG001|Overall Study|Physician Decision|1|||
156527696|NCT02805725|565026859|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
156674924|NCT00924638|565554817|FG000|Overall Study|Lost to Follow-up|1|||
156674925|NCT00924638|565554818|FG001|Overall Study|Lost to Follow-up|1|||
156674926|NCT00924638|565554817|FG000|Overall Study|Withdrawal by Subject|5|||
156674927|NCT00924638|565554818|FG001|Overall Study|Withdrawal by Subject|7|||
156674928|NCT00924638|565554817|FG000|Overall Study|Physician Decision|3|||
156674929|NCT00924638|565554818|FG001|Overall Study|Physician Decision|3|||
156674930|NCT01316055|565554819|FG000|Overall Study|Lost to Follow-up|1|||
156674931|NCT01316055|565554820|FG001|Overall Study|Lost to Follow-up|0|||
156674932|NCT01316055|565554821|FG002|Overall Study|Lost to Follow-up|0|||
156674933|NCT00624286|565554823|FG000|Overall Study|Protocol Deviation|7|||
156674934|NCT00624286|565554824|FG001|Overall Study|Protocol Deviation|9|||
156674935|NCT00624286|565554823|FG000|Overall Study|Adverse Event|6|||
156674936|NCT00624286|565554824|FG001|Overall Study|Adverse Event|3|||
156674937|NCT00624286|565554823|FG000|Overall Study|Withdrawal by Subject|5|||
156674938|NCT00624286|565554824|FG001|Overall Study|Withdrawal by Subject|4|||
156674939|NCT00624286|565554823|FG000|Overall Study|Lost to Follow-up|3|||
156674940|NCT00624286|565554824|FG001|Overall Study|Lost to Follow-up|2|||
156527697|NCT02805725|565026860|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
156527698|NCT02805725|565026861|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
156674941|NCT00624286|565554823|FG000|Overall Study|Administrative problems|3|||
156674942|NCT00624286|565554824|FG001|Overall Study|Administrative problems|0|||
156674943|NCT00624286|565554823|FG000|Overall Study|Lack of Efficacy|1|||
156674944|NCT00624286|565554824|FG001|Overall Study|Lack of Efficacy|6|||
156674945|NCT00624286|565554823|FG000|Overall Study|Not stated|0|||
156674946|NCT00624286|565554824|FG001|Overall Study|Not stated|1|||
156674947|NCT00624286|565554823|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156674948|NCT00624286|565554824|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156674949|NCT00624286|565554823|FG000|Overall Study|Death|0|||
156674950|NCT00624286|565554824|FG001|Overall Study|Death|1|||
156674951|NCT02845336|565554828|FG000|Overall Study|Lost to Follow-up|3|||
156674952|NCT02845336|565554829|FG001|Overall Study|Lost to Follow-up|1|||
156674953|NCT02845336|565554828|FG000|Overall Study|Inability to get medication|2|||
156674954|NCT02845336|565554829|FG001|Overall Study|Inability to get medication|0|||
156674955|NCT03488108|565554831|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
156674956|NCT03488108|565554832|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
156674957|NCT03488108|565554831|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
156674958|NCT03488108|565554832|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
156674959|NCT00674128|565554835|FG000|Overall Study|Withdrawal by Subject|25|||
156432913|NCT01212757|564673922|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
156432914|NCT01212757|564673923|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
156432915|NCT01212757|564673924|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
156432916|NCT01212757|564673925|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
156432917|NCT01212757|564673926|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
156432918|NCT01212757|564673927|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
156432919|NCT01212757|564673919|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156432920|NCT01212757|564673920|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
156432921|NCT01212757|564673921|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
156432922|NCT01212757|564673922|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
156432923|NCT01212757|564673923|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
156432924|NCT01212757|564673924|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
156432925|NCT01212757|564673925|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156432926|NCT01212757|564673926|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156432927|NCT01212757|564673927|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156432928|NCT01212757|564673919|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156432929|NCT01212757|564673920|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
156432930|NCT01212757|564673921|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156432931|NCT01212757|564673922|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156432932|NCT01212757|564673923|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
156432933|NCT01212757|564673924|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156432934|NCT01212757|564673925|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156432935|NCT01212757|564673926|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156432936|NCT01212757|564673927|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156432937|NCT01212757|564673919|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
156432938|NCT01212757|564673920|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
156432939|NCT01212757|564673921|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
156432940|NCT01212757|564673922|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
156432941|NCT01212757|564673923|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
156432942|NCT01212757|564673924|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
156432943|NCT01212757|564673925|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
156674960|NCT00674128|565554836|FG001|Overall Study|Withdrawal by Subject|23|||
156674961|NCT01825798|565554845|FG000|Overall Study|Adverse Event|1|||
156674962|NCT01825798|565554846|FG001|Overall Study|Adverse Event|5|||
156674963|NCT01825798|565554845|FG000|Overall Study|Lost to Follow-up|1|||
156674964|NCT01825798|565554846|FG001|Overall Study|Lost to Follow-up|0|||
156674965|NCT02471807|565554856|FG000|Overall Study|Death|14|||
156674966|NCT02471807|565554856|FG000|Overall Study|Withdrawal by Subject|2|||
156674967|NCT02471807|565554856|FG000|Overall Study|Explant|5|||
156674968|NCT02471807|565554856|FG000|Overall Study|Lost to Follow-up|1|||
156674969|NCT00834873|565554857|FG000|First Intervention|Adverse Event|0|||
156674970|NCT00834873|565554858|FG001|First Intervention|Adverse Event|1|||
156674971|NCT02055547|565554859|FG000|Overall Study|Protocol Violation|0|||
156674972|NCT02055547|565554860|FG001|Overall Study|Protocol Violation|0|||
156674973|NCT02055547|565554861|FG002|Overall Study|Protocol Violation|1|||
156674974|NCT02055547|565554862|FG003|Overall Study|Protocol Violation|0|||
156674975|NCT02055547|565554863|FG004|Overall Study|Protocol Violation|0|||
156674976|NCT02055547|565554864|FG005|Overall Study|Protocol Violation|0|||
156674977|NCT02055547|565554865|FG006|Overall Study|Protocol Violation|1|||
156674978|NCT02055547|565554866|FG007|Overall Study|Protocol Violation|0|||
156674979|NCT02055547|565554867|FG008|Overall Study|Protocol Violation|0|||
156327847|NCT04171765|564301396|FG000|Overall Study|Study terminated by sponsor|2|||
156327848|NCT04171765|564301397|FG001|Overall Study|Study terminated by sponsor|0|||
156327849|NCT04171765|564301398|FG002|Overall Study|Study terminated by sponsor|0|||
156327850|NCT04171765|564301399|FG003|Overall Study|Study terminated by sponsor|0|||
156327851|NCT04171765|564301396|FG000|Overall Study|Withdrawal by Subject|1|||
156327852|NCT04171765|564301397|FG001|Overall Study|Withdrawal by Subject|0|||
156327853|NCT04171765|564301398|FG002|Overall Study|Withdrawal by Subject|0|||
156327854|NCT04171765|564301399|FG003|Overall Study|Withdrawal by Subject|3|||
156327855|NCT04137224|564301407|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
156327856|NCT04137224|564301408|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
156674980|NCT02055547|565554868|FG009|Overall Study|Protocol Violation|0|||
156674981|NCT02055547|565554869|FG010|Overall Study|Protocol Violation|0|||
156674982|NCT02055547|565554870|FG011|Overall Study|Protocol Violation|0|||
156674983|NCT02055547|565554871|FG012|Overall Study|Protocol Violation|0|||
156674984|NCT02055547|565554872|FG013|Overall Study|Protocol Violation|0|||
156674985|NCT02055547|565554873|FG014|Overall Study|Protocol Violation|0|||
156674986|NCT02055547|565554874|FG015|Overall Study|Protocol Violation|0|||
156674987|NCT02055547|565554875|FG016|Overall Study|Protocol Violation|0|||
156674988|NCT02055547|565554876|FG017|Overall Study|Protocol Violation|0|||
156674989|NCT02055547|565554877|FG018|Overall Study|Protocol Violation|0|||
156674990|NCT02055547|565554859|FG000|Overall Study|Physician Decision|0|||
156674991|NCT02055547|565554860|FG001|Overall Study|Physician Decision|1|||
156674992|NCT02055547|565554861|FG002|Overall Study|Physician Decision|1|||
156674993|NCT02055547|565554862|FG003|Overall Study|Physician Decision|0|||
156674994|NCT02055547|565554863|FG004|Overall Study|Physician Decision|1|||
156674995|NCT02055547|565554864|FG005|Overall Study|Physician Decision|0|||
156674996|NCT02055547|565554865|FG006|Overall Study|Physician Decision|0|||
156674997|NCT02055547|565554866|FG007|Overall Study|Physician Decision|0|||
156674998|NCT02055547|565554867|FG008|Overall Study|Physician Decision|0|||
156674999|NCT02055547|565554868|FG009|Overall Study|Physician Decision|1|||
156675000|NCT02055547|565554869|FG010|Overall Study|Physician Decision|1|||
156675001|NCT02055547|565554870|FG011|Overall Study|Physician Decision|0|||
156675002|NCT02055547|565554871|FG012|Overall Study|Physician Decision|0|||
156675003|NCT02055547|565554872|FG013|Overall Study|Physician Decision|0|||
156675004|NCT02055547|565554873|FG014|Overall Study|Physician Decision|0|||
156675005|NCT02055547|565554874|FG015|Overall Study|Physician Decision|0|||
156675006|NCT02055547|565554875|FG016|Overall Study|Physician Decision|0|||
156675007|NCT02055547|565554876|FG017|Overall Study|Physician Decision|0|||
156675008|NCT02055547|565554877|FG018|Overall Study|Physician Decision|0|||
156675009|NCT02055547|565554859|FG000|Overall Study|Adverse Event|0|||
156675010|NCT02055547|565554860|FG001|Overall Study|Adverse Event|0|||
156675011|NCT02055547|565554861|FG002|Overall Study|Adverse Event|0|||
156675012|NCT02055547|565554862|FG003|Overall Study|Adverse Event|0|||
156675013|NCT02055547|565554863|FG004|Overall Study|Adverse Event|0|||
156675014|NCT02055547|565554864|FG005|Overall Study|Adverse Event|0|||
156675015|NCT02055547|565554865|FG006|Overall Study|Adverse Event|1|||
156675016|NCT02055547|565554866|FG007|Overall Study|Adverse Event|0|||
156675017|NCT02055547|565554867|FG008|Overall Study|Adverse Event|1|||
156675018|NCT02055547|565554868|FG009|Overall Study|Adverse Event|0|||
156675019|NCT02055547|565554869|FG010|Overall Study|Adverse Event|0|||
156675020|NCT02055547|565554870|FG011|Overall Study|Adverse Event|0|||
156327857|NCT04137224|564301407|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
156527699|NCT02805725|565026862|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
156527700|NCT02805725|565026863|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
156675021|NCT02055547|565554871|FG012|Overall Study|Adverse Event|0|||
156675022|NCT02055547|565554872|FG013|Overall Study|Adverse Event|0|||
156675023|NCT02055547|565554873|FG014|Overall Study|Adverse Event|0|||
156675024|NCT02055547|565554874|FG015|Overall Study|Adverse Event|0|||
156675025|NCT02055547|565554875|FG016|Overall Study|Adverse Event|0|||
156675026|NCT02055547|565554876|FG017|Overall Study|Adverse Event|0|||
156675027|NCT02055547|565554877|FG018|Overall Study|Adverse Event|0|||
156675028|NCT02055547|565554859|FG000|Overall Study|Withdrawal by Subject|0|||
156675029|NCT02055547|565554860|FG001|Overall Study|Withdrawal by Subject|0|||
156675030|NCT02055547|565554861|FG002|Overall Study|Withdrawal by Subject|0|||
156675031|NCT02055547|565554862|FG003|Overall Study|Withdrawal by Subject|0|||
156675032|NCT02055547|565554863|FG004|Overall Study|Withdrawal by Subject|0|||
156527701|NCT02805725|565026859|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
156527702|NCT02805725|565026860|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
156527703|NCT02805725|565026861|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
156527704|NCT02805725|565026862|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
156527705|NCT02805725|565026863|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
156527706|NCT02805725|565026859|FG000|Phase II|Protocol Violation|0|||
156527707|NCT02805725|565026860|FG001|Phase II|Protocol Violation|0|||
156527708|NCT02805725|565026861|FG002|Phase II|Protocol Violation|0|||
156527709|NCT02805725|565026862|FG003|Phase II|Protocol Violation|0|||
156527710|NCT02805725|565026863|FG004|Phase II|Protocol Violation|6|||
156527711|NCT03511053|565026866|FG000|Overall Study|Withdrawal by Subject|1|||
156527712|NCT02720536|565026867|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
156527713|NCT02720536|565026867|FG000|Overall Study|PR - pregnancy|2|||
156527714|NCT02720536|565026867|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
156527715|NCT02720536|565026867|FG000|Overall Study|PR - death|1|||
156527716|NCT02720536|565026867|FG000|Overall Study|PR - adverse event|1|||
156527717|NCT02720536|565026867|FG000|Overall Study|PR - abnormal lab value(s)|1|||
156527718|NCT02720536|565026867|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
156527719|NCT01028222|565026868|FG000|Overall Study|Protocol deviation|1|||
156527720|NCT01028222|565026869|FG001|Overall Study|Protocol deviation|0|||
156527721|NCT01028222|565026868|FG000|Overall Study|Disease progression|33|||
156527722|NCT01028222|565026869|FG001|Overall Study|Disease progression|9|||
156527723|NCT01028222|565026868|FG000|Overall Study|Administrative problems|1|||
156527724|NCT01028222|565026869|FG001|Overall Study|Administrative problems|1|||
156527725|NCT01028222|565026868|FG000|Overall Study|Lost to Follow-up|0|||
156527726|NCT01028222|565026869|FG001|Overall Study|Lost to Follow-up|1|||
156432944|NCT01212757|564673926|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
156432945|NCT01212757|564673927|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
156432946|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
156432947|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
156432948|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
156432949|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
156432950|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
156432951|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
156432952|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
156432953|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
156432954|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
156432955|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
156432956|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
156432957|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
156432958|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
156432959|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
156432960|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
156432961|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
156432962|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
156432963|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
156432964|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
156432965|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
156432966|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
156432967|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
156432968|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
156675033|NCT02055547|565554864|FG005|Overall Study|Withdrawal by Subject|1|||
156675034|NCT02055547|565554865|FG006|Overall Study|Withdrawal by Subject|0|||
156675035|NCT02055547|565554866|FG007|Overall Study|Withdrawal by Subject|0|||
156675036|NCT02055547|565554867|FG008|Overall Study|Withdrawal by Subject|1|||
156675037|NCT02055547|565554868|FG009|Overall Study|Withdrawal by Subject|0|||
156675038|NCT02055547|565554869|FG010|Overall Study|Withdrawal by Subject|0|||
156675039|NCT02055547|565554870|FG011|Overall Study|Withdrawal by Subject|0|||
156675040|NCT02055547|565554871|FG012|Overall Study|Withdrawal by Subject|0|||
156527727|NCT01028222|565026868|FG000|Overall Study|Withdrawal by Subject|1|||
156432969|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
156432970|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
156432971|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
156527728|NCT01028222|565026869|FG001|Overall Study|Withdrawal by Subject|0|||
156527729|NCT01028222|565026868|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
156527730|NCT01028222|565026869|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
156527731|NCT01028222|565026868|FG000|Overall Study|Adverse Event|2|||
156527732|NCT01028222|565026869|FG001|Overall Study|Adverse Event|0|||
156675041|NCT02055547|565554872|FG013|Overall Study|Withdrawal by Subject|1|||
156675042|NCT02055547|565554873|FG014|Overall Study|Withdrawal by Subject|0|||
156432972|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
156432973|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156527733|NCT00146328|565026870|FG000|Overall Study|Adverse Event|39|||
156675043|NCT02055547|565554874|FG015|Overall Study|Withdrawal by Subject|1|||
156675044|NCT02055547|565554875|FG016|Overall Study|Withdrawal by Subject|0|||
156675045|NCT02055547|565554876|FG017|Overall Study|Withdrawal by Subject|0|||
156675046|NCT02055547|565554877|FG018|Overall Study|Withdrawal by Subject|0|||
156675047|NCT02055547|565554859|FG000|Overall Study|Lost to Follow-up|0|||
156675048|NCT02055547|565554860|FG001|Overall Study|Lost to Follow-up|0|||
156675049|NCT02055547|565554861|FG002|Overall Study|Lost to Follow-up|1|||
156675050|NCT02055547|565554862|FG003|Overall Study|Lost to Follow-up|0|||
156675051|NCT02055547|565554863|FG004|Overall Study|Lost to Follow-up|0|||
156675052|NCT02055547|565554864|FG005|Overall Study|Lost to Follow-up|0|||
156675053|NCT02055547|565554865|FG006|Overall Study|Lost to Follow-up|0|||
156675054|NCT02055547|565554866|FG007|Overall Study|Lost to Follow-up|0|||
156527734|NCT00146328|565026871|FG001|Overall Study|Adverse Event|48|||
156527735|NCT00146328|565026872|FG002|Overall Study|Adverse Event|79|||
156527736|NCT00146328|565026870|FG000|Overall Study|Protocol Violation|11|||
156527737|NCT00146328|565026871|FG001|Overall Study|Protocol Violation|6|||
156527738|NCT00146328|565026872|FG002|Overall Study|Protocol Violation|12|||
156527739|NCT00146328|565026870|FG000|Overall Study|Lost to Follow-up|7|||
156527740|NCT00146328|565026871|FG001|Overall Study|Lost to Follow-up|4|||
156527741|NCT00146328|565026872|FG002|Overall Study|Lost to Follow-up|7|||
156527742|NCT00146328|565026870|FG000|Overall Study|Withdrawal by Subject|16|||
156527743|NCT00146328|565026871|FG001|Overall Study|Withdrawal by Subject|16|||
156527744|NCT00146328|565026872|FG002|Overall Study|Withdrawal by Subject|22|||
156527745|NCT00146328|565026870|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
156527746|NCT00146328|565026871|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
156527747|NCT00146328|565026872|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
156527748|NCT00146328|565026870|FG000|Overall Study|Trial ended/site closed|8|||
156527749|NCT00146328|565026871|FG001|Overall Study|Trial ended/site closed|2|||
156527750|NCT00146328|565026872|FG002|Overall Study|Trial ended/site closed|19|||
156527751|NCT00146328|565026870|FG000|Overall Study|Patient decision to end|0|||
156527752|NCT00146328|565026871|FG001|Overall Study|Patient decision to end|1|||
156527753|NCT00146328|565026872|FG002|Overall Study|Patient decision to end|6|||
156527754|NCT00146328|565026870|FG000|Overall Study|Enroll into other trial|2|||
156527755|NCT00146328|565026871|FG001|Overall Study|Enroll into other trial|4|||
156527756|NCT00146328|565026872|FG002|Overall Study|Enroll into other trial|2|||
156527757|NCT00146328|565026870|FG000|Overall Study|Death|0|||
156527758|NCT00146328|565026871|FG001|Overall Study|Death|1|||
156527759|NCT00146328|565026872|FG002|Overall Study|Death|1|||
156527760|NCT00146328|565026870|FG000|Overall Study|Moved|2|||
156527761|NCT00146328|565026871|FG001|Overall Study|Moved|0|||
156527762|NCT00146328|565026872|FG002|Overall Study|Moved|0|||
156527763|NCT00146328|565026870|FG000|Overall Study|Interaction with other medication|2|||
156527764|NCT00146328|565026871|FG001|Overall Study|Interaction with other medication|0|||
156527765|NCT00146328|565026872|FG002|Overall Study|Interaction with other medication|1|||
156527766|NCT00567268|565026873|FG000|Overall Study|Protocol Violation|7|||
156527767|NCT00567268|565026873|FG000|Overall Study|Lost to Follow-up|36|||
156527768|NCT00567268|565026873|FG000|Overall Study|No Visit After First Day of Treatment|2|||
156527769|NCT00567268|565026873|FG000|Overall Study|No Drug Administration|4|||
156527770|NCT00567268|565026873|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
156527771|NCT01117454|565026874|FG000|Overall Study|Pregnancy|0|||
156527772|NCT01117454|565026875|FG001|Overall Study|Pregnancy|1|||
156527773|NCT03278106|565026881|FG000|Overall Study|No protocol treatment|1|||
156527774|NCT02175004|565026882|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
156527775|NCT02175004|565026883|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
156527776|NCT02175004|565026882|FG000|Overall Study|Investigator Judgment|1|||
156527777|NCT02175004|565026883|FG001|Overall Study|Investigator Judgment|4|||
156327858|NCT04137224|564301408|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
156327859|NCT04137224|564301407|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
156675055|NCT02055547|565554867|FG008|Overall Study|Lost to Follow-up|0|||
156675056|NCT02055547|565554868|FG009|Overall Study|Lost to Follow-up|0|||
156675057|NCT02055547|565554869|FG010|Overall Study|Lost to Follow-up|0|||
156327860|NCT04137224|564301408|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
156527778|NCT02175004|565026882|FG000|Overall Study|Voluntary Withdrawal|6|||
156527779|NCT02175004|565026883|FG001|Overall Study|Voluntary Withdrawal|19|||
156527780|NCT02175004|565026882|FG000|Overall Study|Liver Transplant|1|||
156675058|NCT02055547|565554870|FG011|Overall Study|Lost to Follow-up|0|||
156675059|NCT02055547|565554871|FG012|Overall Study|Lost to Follow-up|0|||
156675060|NCT02055547|565554872|FG013|Overall Study|Lost to Follow-up|0|||
156675061|NCT02055547|565554873|FG014|Overall Study|Lost to Follow-up|0|||
156527781|NCT02175004|565026883|FG001|Overall Study|Liver Transplant|0|||
156527782|NCT02175004|565026882|FG000|Overall Study|Disease Progression|1|||
156527783|NCT02175004|565026883|FG001|Overall Study|Disease Progression|0|||
156527784|NCT02175004|565026882|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
156527785|NCT02175004|565026883|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
156527786|NCT00973362|565026884|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
156675062|NCT02055547|565554874|FG015|Overall Study|Lost to Follow-up|0|||
156527787|NCT00973362|565026885|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
156527788|NCT00973362|565026884|FG000|Baseline Evaluation|No colposcopy visit|62|||
156527789|NCT00973362|565026885|FG001|Baseline Evaluation|No colposcopy visit|0|||
156432974|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
156432975|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
156432976|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156432977|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156432978|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156432979|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156432980|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
156432981|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
156432982|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
156432983|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
156432984|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
156432985|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
156432986|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
156675063|NCT02055547|565554875|FG016|Overall Study|Lost to Follow-up|0|||
156675064|NCT02055547|565554876|FG017|Overall Study|Lost to Follow-up|0|||
156675065|NCT02055547|565554877|FG018|Overall Study|Lost to Follow-up|0|||
156675066|NCT01456221|565554878|FG000|Overall Study|Withdrawal by Subject|56|||
156432987|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
156432988|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
156432989|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
156432990|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
156432991|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
156432992|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
156432993|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
156432994|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
156432995|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
156432996|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
156432997|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
156432998|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
156675067|NCT01456221|565554879|FG001|Overall Study|Withdrawal by Subject|49|||
156675068|NCT01456221|565554878|FG000|Overall Study|Lost to Follow-up|1|||
156675069|NCT01456221|565554879|FG001|Overall Study|Lost to Follow-up|4|||
156675070|NCT01456221|565554878|FG000|Overall Study|Received medication|3|||
156675071|NCT01456221|565554879|FG001|Overall Study|Received medication|2|||
156675072|NCT01456221|565554878|FG000|Overall Study|Incomplete data|4|||
156675073|NCT01456221|565554879|FG001|Overall Study|Incomplete data|2|||
156675074|NCT02272803|565554880|FG000|Overall Study|Disease progression|16|||
156675075|NCT02272803|565554881|FG001|Overall Study|Disease progression|8|||
156675076|NCT02272803|565554880|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
156675077|NCT02272803|565554881|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
156675078|NCT02272803|565554880|FG000|Overall Study|Study drug toxicity|4|||
156675079|NCT02272803|565554881|FG001|Overall Study|Study drug toxicity|9|||
156675080|NCT02272803|565554880|FG000|Overall Study|Participant request to discontinue study treatment|3|||
156675081|NCT02272803|565554881|FG001|Overall Study|Participant request to discontinue study treatment|7|||
156675082|NCT02272803|565554880|FG000|Overall Study|Maximum clinical benefit|4|||
156675083|NCT02272803|565554881|FG001|Overall Study|Maximum clinical benefit|2|||
156675084|NCT02272803|565554880|FG000|Overall Study|Poor/non-compliance|2|||
156675085|NCT02272803|565554881|FG001|Overall Study|Poor/non-compliance|2|||
156675086|NCT02272803|565554880|FG000|Overall Study|Withdrawal by Subject|2|||
156675087|NCT02272803|565554881|FG001|Overall Study|Withdrawal by Subject|1|||
156675088|NCT02272803|565554880|FG000|Overall Study|Death|0|||
156675089|NCT02272803|565554881|FG001|Overall Study|Death|1|||
156675090|NCT02272803|565554880|FG000|Overall Study|Other reasons|1|||
156675091|NCT02272803|565554881|FG001|Overall Study|Other reasons|3|||
156675092|NCT02272803|565554880|FG000|Overall Study|Administrative reason by sponsor|5|||
156675093|NCT02272803|565554881|FG001|Overall Study|Administrative reason by sponsor|4|||
156675094|NCT02611323|565554882|FG000|Overall Study|Death|3|||
156675095|NCT02611323|565554883|FG001|Overall Study|Death|1|||
156675096|NCT02611323|565554884|FG002|Overall Study|Death|0|||
156675097|NCT02611323|565554885|FG003|Overall Study|Death|0|||
156675098|NCT02611323|565554886|FG004|Overall Study|Death|1|||
156675099|NCT02611323|565554887|FG005|Overall Study|Death|1|||
156675100|NCT02611323|565554888|FG006|Overall Study|Death|8|||
156675101|NCT02611323|565554889|FG007|Overall Study|Death|0|||
156675102|NCT02611323|565554890|FG008|Overall Study|Death|4|||
156675103|NCT02611323|565554891|FG009|Overall Study|Death|6|||
156432999|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
156675104|NCT02611323|565554892|FG010|Overall Study|Death|26|||
156675105|NCT02611323|565554882|FG000|Overall Study|Lost to Follow-up|1|||
156675106|NCT02611323|565554883|FG001|Overall Study|Lost to Follow-up|0|||
156675107|NCT02611323|565554884|FG002|Overall Study|Lost to Follow-up|0|||
156675108|NCT02611323|565554885|FG003|Overall Study|Lost to Follow-up|0|||
156675109|NCT02611323|565554886|FG004|Overall Study|Lost to Follow-up|0|||
156675110|NCT02611323|565554887|FG005|Overall Study|Lost to Follow-up|0|||
156675111|NCT02611323|565554888|FG006|Overall Study|Lost to Follow-up|3|||
156675112|NCT02611323|565554889|FG007|Overall Study|Lost to Follow-up|0|||
156675113|NCT02611323|565554890|FG008|Overall Study|Lost to Follow-up|0|||
156675114|NCT02611323|565554891|FG009|Overall Study|Lost to Follow-up|0|||
156527790|NCT00973362|565026884|FG000|Baseline Evaluation|Inevaluable|686|||
156527791|NCT00973362|565026885|FG001|Baseline Evaluation|Inevaluable|223|||
156527792|NCT00973362|565026884|FG000|3-Year Follow-up|Lost to Follow-up|17|||
156527793|NCT00973362|565026885|FG001|3-Year Follow-up|Lost to Follow-up|0|||
156527794|NCT00325039|565026888|FG000|Overall Study|Lost to Follow-up|18|||
156527795|NCT00325039|565026889|FG001|Overall Study|Lost to Follow-up|14|||
156527796|NCT01009203|565026891|FG000|Overall Study|Withdrawal by Subject|1|||
156527797|NCT01009203|565026891|FG000|Overall Study|Adverse Event|5|||
156527798|NCT01009203|565026891|FG000|Overall Study|Treatment-unrelated death|1|||
156527799|NCT00892723|565026895|FG000|Overall Study|Lost to Follow-up|1|||
156527800|NCT00892723|565026896|FG001|Overall Study|Lost to Follow-up|3|||
156527801|NCT00892723|565026897|FG002|Overall Study|Lost to Follow-up|1|||
156527802|NCT00892723|565026895|FG000|Overall Study|Withdrawal by Subject|1|||
156527803|NCT00892723|565026896|FG001|Overall Study|Withdrawal by Subject|1|||
156527804|NCT00892723|565026897|FG002|Overall Study|Withdrawal by Subject|1|||
156527805|NCT02974088|565026898|FG000|Overall Study|Lost to Follow-up|0|||
156527806|NCT02974088|565026899|FG001|Overall Study|Lost to Follow-up|2|||
156527807|NCT02974088|565026898|FG000|Overall Study|Adverse Event|0|||
156527808|NCT02974088|565026899|FG001|Overall Study|Adverse Event|1|||
156527809|NCT00150969|565026902|FG000|24 Month Main Study|Adverse Event|3|||
156527810|NCT00150969|565026903|FG001|24 Month Main Study|Adverse Event|4|||
156527811|NCT00150969|565026902|FG000|24 Month Main Study|Death|1|||
156527812|NCT00150969|565026903|FG001|24 Month Main Study|Death|1|||
156527813|NCT00150969|565026902|FG000|24 Month Main Study|Lack of Efficacy|1|||
156527814|NCT00150969|565026903|FG001|24 Month Main Study|Lack of Efficacy|8|||
156527815|NCT00150969|565026902|FG000|24 Month Main Study|Lost to Follow-up|3|||
156527816|NCT00150969|565026903|FG001|24 Month Main Study|Lost to Follow-up|2|||
156527817|NCT00150969|565026902|FG000|24 Month Main Study|Protocol Violation|4|||
156527818|NCT00150969|565026903|FG001|24 Month Main Study|Protocol Violation|2|||
156527819|NCT00150969|565026902|FG000|24 Month Main Study|Withdrawal by Subject|7|||
156527820|NCT00150969|565026903|FG001|24 Month Main Study|Withdrawal by Subject|4|||
156527821|NCT00150969|565026902|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
156527822|NCT00150969|565026903|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
156527823|NCT00150969|565026902|FG000|24-48 Month Extension|Lack of Efficacy|0|||
156527824|NCT00150969|565026903|FG001|24-48 Month Extension|Lack of Efficacy|1|||
156527825|NCT00150969|565026902|FG000|24-48 Month Extension|Adverse Event|1|||
156527826|NCT00150969|565026903|FG001|24-48 Month Extension|Adverse Event|3|||
156527827|NCT00150969|565026902|FG000|24-48 Month Extension|Other Reason|81|||
156527828|NCT00150969|565026903|FG001|24-48 Month Extension|Other Reason|91|||
156527829|NCT00146757|565026904|FG000|Overall Study|Death|1|||
156527830|NCT00146757|565026905|FG001|Overall Study|Death|0|||
156527831|NCT00146757|565026904|FG000|Overall Study|Adverse Event|1|||
156527832|NCT00146757|565026905|FG001|Overall Study|Adverse Event|0|||
156527833|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
156527834|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
156527835|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
156527836|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
156527837|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
156527838|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
156527839|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
156527840|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
156527841|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
156527842|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
156527843|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
156527844|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
156527845|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
156527846|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
156527847|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
156527848|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
156675115|NCT02611323|565554892|FG010|Overall Study|Lost to Follow-up|2|||
156527849|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
156527850|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
156527851|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
156675116|NCT02611323|565554882|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
156675117|NCT02611323|565554883|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
156327861|NCT01954342|564301411|FG000|Overall Study|Missing data from 13-16week study visit|0|||
156527852|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
156527853|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
156527854|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
156527855|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
156527856|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
156527857|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
156527858|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
156527859|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
156527860|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
156527861|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
156527862|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
156527863|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Other|10|||
156527864|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Other|7|||
156527865|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Other|8|||
156527866|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Other|8|||
156527867|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Other|0|||
156527868|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
156527869|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
156527870|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
156527871|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
156527872|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
156527873|NCT00615836|565026906|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
156527874|NCT00615836|565026907|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
156527875|NCT00615836|565026908|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
156527876|NCT00615836|565026909|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
156527877|NCT00615836|565026910|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
156527878|NCT01630434|565026911|FG000|Overall Study|Donor lungs turned down|1|||
156527879|NCT01630434|565026912|FG001|Overall Study|Donor lungs turned down|0|||
156527880|NCT01630434|565026911|FG000|Overall Study|Protocol Violation|9|||
156527881|NCT01630434|565026912|FG001|Overall Study|Protocol Violation|4|||
156527882|NCT01630434|565026911|FG000|Overall Study|Death|20|||
156527883|NCT01630434|565026912|FG001|Overall Study|Death|26|||
156527884|NCT02121834|565026914|FG000|Overall Study|Protocol Violation|0|||
156527885|NCT02121834|565026915|FG001|Overall Study|Protocol Violation|1|||
156527886|NCT02121834|565026916|FG002|Overall Study|Protocol Violation|0|||
156527887|NCT02121834|565026917|FG003|Overall Study|Protocol Violation|0|||
156527888|NCT02121834|565026918|FG004|Overall Study|Protocol Violation|0|||
156527889|NCT02121834|565026919|FG005|Overall Study|Protocol Violation|0|||
156527890|NCT02121834|565026920|FG006|Overall Study|Protocol Violation|0|||
156527891|NCT02121834|565026914|FG000|Overall Study|Withdrawal by Subject|0|||
156527892|NCT02121834|565026915|FG001|Overall Study|Withdrawal by Subject|1|||
156527893|NCT02121834|565026916|FG002|Overall Study|Withdrawal by Subject|1|||
156527894|NCT02121834|565026917|FG003|Overall Study|Withdrawal by Subject|0|||
156527895|NCT02121834|565026918|FG004|Overall Study|Withdrawal by Subject|0|||
156527896|NCT02121834|565026919|FG005|Overall Study|Withdrawal by Subject|0|||
156527897|NCT02121834|565026920|FG006|Overall Study|Withdrawal by Subject|0|||
156527898|NCT02121834|565026914|FG000|Overall Study|Lost to Follow-up|0|||
156527899|NCT02121834|565026915|FG001|Overall Study|Lost to Follow-up|0|||
156527900|NCT02121834|565026916|FG002|Overall Study|Lost to Follow-up|1|||
156527901|NCT02121834|565026917|FG003|Overall Study|Lost to Follow-up|0|||
156527902|NCT02121834|565026918|FG004|Overall Study|Lost to Follow-up|0|||
156527903|NCT02121834|565026919|FG005|Overall Study|Lost to Follow-up|0|||
156527904|NCT02121834|565026920|FG006|Overall Study|Lost to Follow-up|0|||
156527905|NCT02578862|565026921|FG000|Overall Study|Withdrawal by Subject|0|||
156527906|NCT02578862|565026922|FG001|Overall Study|Withdrawal by Subject|1|||
156527907|NCT02578862|565026921|FG000|Overall Study|Unplanned unilateral procedure|0|||
156527908|NCT02578862|565026922|FG001|Overall Study|Unplanned unilateral procedure|1|||
156527909|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
156527910|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
156527911|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Death|0|||
156527912|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Death|2|||
156527913|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
156527914|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
156527915|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
156527916|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
156527917|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
156527918|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
156527919|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
156527920|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
156527921|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
156527922|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
156527923|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
156527924|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
156675118|NCT02611323|565554884|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
156675119|NCT02611323|565554885|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
156675120|NCT02611323|565554886|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
156675121|NCT02611323|565554887|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
156527925|NCT00343252|565026932|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
156527926|NCT00343252|565026933|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
156527927|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
156527928|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
156527929|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Death|3|||
156527930|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Death|3|||
156527931|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
156527932|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
156527933|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
156527934|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
156527935|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
156527936|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
156675122|NCT02611323|565554888|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
156675123|NCT02611323|565554889|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
156675124|NCT02611323|565554890|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
156675125|NCT02611323|565554891|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
156675126|NCT02611323|565554892|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
156675127|NCT02611323|565554882|FG000|Overall Study|Progressive Disease|0|||
156675128|NCT02611323|565554883|FG001|Overall Study|Progressive Disease|0|||
156675129|NCT02611323|565554884|FG002|Overall Study|Progressive Disease|0|||
156675130|NCT02611323|565554885|FG003|Overall Study|Progressive Disease|0|||
156675131|NCT02611323|565554886|FG004|Overall Study|Progressive Disease|0|||
156675132|NCT02611323|565554887|FG005|Overall Study|Progressive Disease|0|||
156675133|NCT02611323|565554888|FG006|Overall Study|Progressive Disease|0|||
156675134|NCT02611323|565554889|FG007|Overall Study|Progressive Disease|0|||
156675135|NCT02611323|565554890|FG008|Overall Study|Progressive Disease|0|||
156675136|NCT02611323|565554891|FG009|Overall Study|Progressive Disease|0|||
156675137|NCT02611323|565554892|FG010|Overall Study|Progressive Disease|1|||
156675138|NCT02611323|565554882|FG000|Overall Study|Withdrawal by Subject|1|||
156675139|NCT02611323|565554883|FG001|Overall Study|Withdrawal by Subject|0|||
156675140|NCT02611323|565554884|FG002|Overall Study|Withdrawal by Subject|0|||
156675141|NCT02611323|565554885|FG003|Overall Study|Withdrawal by Subject|0|||
156675142|NCT02611323|565554886|FG004|Overall Study|Withdrawal by Subject|0|||
156675143|NCT02611323|565554887|FG005|Overall Study|Withdrawal by Subject|0|||
156675144|NCT02611323|565554888|FG006|Overall Study|Withdrawal by Subject|0|||
156675145|NCT02611323|565554889|FG007|Overall Study|Withdrawal by Subject|1|||
156675146|NCT02611323|565554890|FG008|Overall Study|Withdrawal by Subject|0|||
156675147|NCT02611323|565554891|FG009|Overall Study|Withdrawal by Subject|1|||
156675148|NCT02611323|565554892|FG010|Overall Study|Withdrawal by Subject|0|||
156675149|NCT01899053|565554895|FG000|Overall Study|Progressive Disease|4|||
156675150|NCT01899053|565554896|FG001|Overall Study|Progressive Disease|0|||
156675151|NCT01899053|565554897|FG002|Overall Study|Progressive Disease|3|||
156675152|NCT01899053|565554898|FG003|Overall Study|Progressive Disease|0|||
156675153|NCT01899053|565554899|FG004|Overall Study|Progressive Disease|3|||
156675154|NCT01899053|565554900|FG005|Overall Study|Progressive Disease|1|||
156675155|NCT01899053|565554901|FG006|Overall Study|Progressive Disease|1|||
156675156|NCT01899053|565554902|FG007|Overall Study|Progressive Disease|1|||
156675157|NCT01899053|565554903|FG008|Overall Study|Progressive Disease|4|||
156675158|NCT01899053|565554904|FG009|Overall Study|Progressive Disease|3|||
156675159|NCT01899053|565554905|FG010|Overall Study|Progressive Disease|12|||
156675160|NCT01899053|565554906|FG011|Overall Study|Progressive Disease|5|||
156675161|NCT01899053|565554907|FG012|Overall Study|Progressive Disease|8|||
156675162|NCT01899053|565554908|FG013|Overall Study|Progressive Disease|17|||
156675163|NCT01899053|565554895|FG000|Overall Study|Adverse Event|1|||
156675164|NCT01899053|565554896|FG001|Overall Study|Adverse Event|1|||
156675165|NCT01899053|565554897|FG002|Overall Study|Adverse Event|1|||
156675166|NCT01899053|565554898|FG003|Overall Study|Adverse Event|3|||
156675167|NCT01899053|565554899|FG004|Overall Study|Adverse Event|1|||
156675168|NCT01899053|565554900|FG005|Overall Study|Adverse Event|1|||
156675169|NCT01899053|565554901|FG006|Overall Study|Adverse Event|1|||
156675170|NCT01899053|565554902|FG007|Overall Study|Adverse Event|0|||
156675171|NCT01899053|565554903|FG008|Overall Study|Adverse Event|2|||
156675172|NCT01899053|565554904|FG009|Overall Study|Adverse Event|0|||
156675173|NCT01899053|565554905|FG010|Overall Study|Adverse Event|3|||
156675174|NCT01899053|565554906|FG011|Overall Study|Adverse Event|1|||
156675175|NCT01899053|565554907|FG012|Overall Study|Adverse Event|2|||
156675176|NCT01899053|565554908|FG013|Overall Study|Adverse Event|2|||
156675177|NCT01899053|565554895|FG000|Overall Study|Reason Not Specified|0|||
156675178|NCT01899053|565554896|FG001|Overall Study|Reason Not Specified|0|||
156675179|NCT01899053|565554897|FG002|Overall Study|Reason Not Specified|0|||
156675180|NCT01899053|565554898|FG003|Overall Study|Reason Not Specified|0|||
156675181|NCT01899053|565554899|FG004|Overall Study|Reason Not Specified|0|||
156675182|NCT01899053|565554900|FG005|Overall Study|Reason Not Specified|0|||
156675183|NCT01899053|565554901|FG006|Overall Study|Reason Not Specified|1|||
156675184|NCT01899053|565554902|FG007|Overall Study|Reason Not Specified|0|||
156675185|NCT01899053|565554903|FG008|Overall Study|Reason Not Specified|0|||
156675186|NCT01899053|565554904|FG009|Overall Study|Reason Not Specified|0|||
156675187|NCT01899053|565554905|FG010|Overall Study|Reason Not Specified|0|||
156675188|NCT01899053|565554906|FG011|Overall Study|Reason Not Specified|0|||
156675189|NCT01899053|565554907|FG012|Overall Study|Reason Not Specified|1|||
156675190|NCT01899053|565554908|FG013|Overall Study|Reason Not Specified|0|||
156675191|NCT01899053|565554895|FG000|Overall Study|Withdrawal by Subject|1|||
156675192|NCT01899053|565554896|FG001|Overall Study|Withdrawal by Subject|1|||
156433000|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
156433001|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
156433002|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
156433003|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
156433004|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
156433005|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
156433006|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
156433007|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
156433008|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
156433009|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
156433010|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
156433011|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
156433012|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
156433013|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
156433014|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
156433015|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
156433016|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
156433017|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
156433018|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156433019|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
156433020|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
156433021|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156433022|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156433023|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156433024|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156433025|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
156433026|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
156433027|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
156433028|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
156433029|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
156433030|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
156433031|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
156433032|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
156433033|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
156433034|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
156433035|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
156433036|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
156433037|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
156433038|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
156433039|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
156433040|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
156433041|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
156433042|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
156433043|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
156433044|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
156433045|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
156433046|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
156433047|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
156433048|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
156433049|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
156433050|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
156433051|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
156433052|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
156433053|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
156675193|NCT01899053|565554897|FG002|Overall Study|Withdrawal by Subject|2|||
156527937|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
156527938|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
156527939|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
156527940|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
156433054|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
156433055|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
156433056|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
156433057|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
156433058|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
156433059|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
156675194|NCT01899053|565554898|FG003|Overall Study|Withdrawal by Subject|0|||
156675195|NCT01899053|565554899|FG004|Overall Study|Withdrawal by Subject|2|||
156675196|NCT01899053|565554900|FG005|Overall Study|Withdrawal by Subject|0|||
156675197|NCT01899053|565554901|FG006|Overall Study|Withdrawal by Subject|0|||
156675198|NCT01899053|565554902|FG007|Overall Study|Withdrawal by Subject|1|||
156675199|NCT01899053|565554903|FG008|Overall Study|Withdrawal by Subject|0|||
156675200|NCT01899053|565554904|FG009|Overall Study|Withdrawal by Subject|0|||
156527941|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
156527942|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
156527943|NCT00343252|565026932|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
156527944|NCT00343252|565026933|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
156527945|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
156527946|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
156527947|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Death|4|||
156527948|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Death|5|||
156527949|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
156527950|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
156527951|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
156675201|NCT01899053|565554905|FG010|Overall Study|Withdrawal by Subject|0|||
156675202|NCT01899053|565554906|FG011|Overall Study|Withdrawal by Subject|0|||
156675203|NCT01899053|565554907|FG012|Overall Study|Withdrawal by Subject|1|||
156675204|NCT01899053|565554908|FG013|Overall Study|Withdrawal by Subject|1|||
156433060|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
156433061|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
156675205|NCT01899053|565554895|FG000|Overall Study|Protocol Violation|0|||
156675206|NCT01899053|565554896|FG001|Overall Study|Protocol Violation|0|||
156675207|NCT01899053|565554897|FG002|Overall Study|Protocol Violation|1|||
156675208|NCT01899053|565554898|FG003|Overall Study|Protocol Violation|0|||
156675209|NCT01899053|565554899|FG004|Overall Study|Protocol Violation|0|||
156675210|NCT01899053|565554900|FG005|Overall Study|Protocol Violation|0|||
156675211|NCT01899053|565554901|FG006|Overall Study|Protocol Violation|0|||
156675212|NCT01899053|565554902|FG007|Overall Study|Protocol Violation|0|||
156675213|NCT01899053|565554903|FG008|Overall Study|Protocol Violation|0|||
156675214|NCT01899053|565554904|FG009|Overall Study|Protocol Violation|0|||
156675215|NCT01899053|565554905|FG010|Overall Study|Protocol Violation|0|||
156675216|NCT01899053|565554906|FG011|Overall Study|Protocol Violation|0|||
156675217|NCT01899053|565554907|FG012|Overall Study|Protocol Violation|0|||
156675218|NCT01899053|565554908|FG013|Overall Study|Protocol Violation|0|||
156675219|NCT01899053|565554895|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
156675220|NCT01899053|565554896|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
156675221|NCT01899053|565554897|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675222|NCT01899053|565554898|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675223|NCT01899053|565554899|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675224|NCT01899053|565554900|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675225|NCT01899053|565554901|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675226|NCT01899053|565554902|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675227|NCT01899053|565554903|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675228|NCT01899053|565554904|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675229|NCT01899053|565554905|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
156675230|NCT01899053|565554906|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675231|NCT01899053|565554907|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675232|NCT01899053|565554908|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
156675233|NCT01899053|565554895|FG000|Overall Study|Symptomatic Deterioration|0|||
156675234|NCT01899053|565554896|FG001|Overall Study|Symptomatic Deterioration|0|||
156675235|NCT01899053|565554897|FG002|Overall Study|Symptomatic Deterioration|0|||
156675236|NCT01899053|565554898|FG003|Overall Study|Symptomatic Deterioration|0|||
156675237|NCT01899053|565554899|FG004|Overall Study|Symptomatic Deterioration|0|||
156675238|NCT01899053|565554900|FG005|Overall Study|Symptomatic Deterioration|1|||
156675239|NCT01899053|565554901|FG006|Overall Study|Symptomatic Deterioration|0|||
156675240|NCT01899053|565554902|FG007|Overall Study|Symptomatic Deterioration|1|||
156675241|NCT01899053|565554903|FG008|Overall Study|Symptomatic Deterioration|0|||
156433062|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
156675242|NCT01899053|565554904|FG009|Overall Study|Symptomatic Deterioration|0|||
156675243|NCT01899053|565554905|FG010|Overall Study|Symptomatic Deterioration|0|||
156675244|NCT01899053|565554906|FG011|Overall Study|Symptomatic Deterioration|1|||
156675245|NCT01899053|565554907|FG012|Overall Study|Symptomatic Deterioration|2|||
156675246|NCT01899053|565554908|FG013|Overall Study|Symptomatic Deterioration|0|||
156675247|NCT00227370|565554910|FG000|Overall Study|Withdrawal by Subject|1|||
156675248|NCT00227370|565554911|FG001|Overall Study|Withdrawal by Subject|2|||
156675249|NCT00227370|565554910|FG000|Overall Study|Death|3|||
156675250|NCT00227370|565554911|FG001|Overall Study|Death|4|||
156675251|NCT00227370|565554910|FG000|Overall Study|Adverse Event|6|||
156675252|NCT00227370|565554911|FG001|Overall Study|Adverse Event|11|||
156675253|NCT00227370|565554910|FG000|Overall Study|Physician Decision|9|||
156675254|NCT00227370|565554911|FG001|Overall Study|Physician Decision|6|||
156675255|NCT00227370|565554910|FG000|Overall Study|Other reasons|2|||
156675256|NCT00227370|565554911|FG001|Overall Study|Other reasons|1|||
156675257|NCT02011945|565554915|FG000|Overall Study|Participant requested to Discontinue|0|||
156675258|NCT02011945|565554916|FG001|Overall Study|Participant requested to Discontinue|1|||
156675259|NCT02011945|565554917|FG002|Overall Study|Participant requested to Discontinue|1|||
156675260|NCT02011945|565554915|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
156675261|NCT02011945|565554916|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
156675262|NCT02011945|565554917|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
156675263|NCT02011945|565554915|FG000|Overall Study|Study Drug Toxicity|0|||
156675264|NCT02011945|565554916|FG001|Overall Study|Study Drug Toxicity|0|||
156675265|NCT02011945|565554917|FG002|Overall Study|Study Drug Toxicity|1|||
156675266|NCT02011945|565554915|FG000|Overall Study|Treatment Failure|0|||
156675267|NCT02011945|565554916|FG001|Overall Study|Treatment Failure|7|||
156675268|NCT02011945|565554917|FG002|Overall Study|Treatment Failure|6|||
156675269|NCT02011945|565554915|FG000|Overall Study|No Longer Meets Study Criteria|1|||
156675270|NCT02011945|565554916|FG001|Overall Study|No Longer Meets Study Criteria|0|||
156675271|NCT02011945|565554917|FG002|Overall Study|No Longer Meets Study Criteria|0|||
156675272|NCT02011945|565554915|FG000|Overall Study|Proceeded to stem cell transplant|0|||
156675273|NCT02011945|565554916|FG001|Overall Study|Proceeded to stem cell transplant|0|||
156527952|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
156527953|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
156527954|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
156527955|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
156527956|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
156527957|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
156527958|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
156527959|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
156527960|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
156527961|NCT00343252|565026932|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
156527962|NCT00343252|565026933|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
156527963|NCT01026454|565026934|FG000|Second Intervention|Pregnancy|1|||
156527964|NCT01026454|565026935|FG001|Second Intervention|Pregnancy|1|||
156527965|NCT00394953|565026938|FG000|First Treatment Period|Adverse Event|1|||
156527966|NCT00394953|565026939|FG001|First Treatment Period|Adverse Event|2|||
156527967|NCT00394953|565026938|FG000|First Treatment Period|Death|6|||
156527968|NCT00394953|565026939|FG001|First Treatment Period|Death|7|||
156527969|NCT00394953|565026938|FG000|First Treatment Period|Lack of Efficacy|1|||
156527970|NCT00394953|565026939|FG001|First Treatment Period|Lack of Efficacy|1|||
156527971|NCT00394953|565026938|FG000|First Treatment Period|Withdrawal by Subject|6|||
156527972|NCT00394953|565026939|FG001|First Treatment Period|Withdrawal by Subject|3|||
156527973|NCT00394953|565026938|FG000|First Treatment Period|Lost to Follow-up|0|||
156527974|NCT00394953|565026939|FG001|First Treatment Period|Lost to Follow-up|1|||
156527975|NCT00394953|565026938|FG000|First Treatment Period|Renal transplant|11|||
156527976|NCT00394953|565026939|FG001|First Treatment Period|Renal transplant|7|||
156527977|NCT00394953|565026938|FG000|First Treatment Period|Not defined|4|||
156527978|NCT00394953|565026939|FG001|First Treatment Period|Not defined|1|||
156527979|NCT00394953|565026938|FG000|Second Treatment Period|Adverse Event|2|||
156527980|NCT00394953|565026939|FG001|Second Treatment Period|Adverse Event|5|||
156527981|NCT00394953|565026938|FG000|Second Treatment Period|Death|8|||
156675274|NCT02011945|565554917|FG002|Overall Study|Proceeded to stem cell transplant|1|||
156675275|NCT02011945|565554915|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
156527982|NCT00394953|565026939|FG001|Second Treatment Period|Death|4|||
156527983|NCT00394953|565026938|FG000|Second Treatment Period|Lack of Efficacy|9|||
156527984|NCT00394953|565026939|FG001|Second Treatment Period|Lack of Efficacy|47|||
156527985|NCT00394953|565026938|FG000|Second Treatment Period|Withdrawal by Subject|3|||
156675276|NCT02011945|565554916|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
156675277|NCT02011945|565554917|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
156675278|NCT00902538|565554918|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
156675279|NCT00902538|565554919|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
156675280|NCT00902538|565554920|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
156675281|NCT00902538|565554921|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
156675282|NCT00902538|565554922|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
156675283|NCT00902538|565554923|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
156675284|NCT00902538|565554918|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
156675285|NCT00902538|565554919|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
156527986|NCT00394953|565026939|FG001|Second Treatment Period|Withdrawal by Subject|3|||
156527987|NCT00394953|565026938|FG000|Second Treatment Period|Lost to Follow-up|0|||
156527988|NCT00394953|565026939|FG001|Second Treatment Period|Lost to Follow-up|1|||
156527989|NCT00394953|565026938|FG000|Second Treatment Period|Renal transplant|4|||
156433063|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
156433064|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
156433065|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
156433066|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
156433067|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
156433068|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
156433069|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
156433070|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
156433071|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
156433072|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
156433073|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
156433074|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
156433075|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
156433076|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
156433077|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
156433078|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
156433079|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
156433080|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
156433081|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156675286|NCT00902538|565554920|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
156675287|NCT00902538|565554921|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
156433082|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
156527990|NCT00394953|565026939|FG001|Second Treatment Period|Renal transplant|6|||
156527991|NCT00394953|565026938|FG000|Second Treatment Period|Not defined|3|||
156527992|NCT00394953|565026939|FG001|Second Treatment Period|Not defined|8|||
156527993|NCT03021954|565026947|FG000|Overall Study|Lost to Follow-up|10|||
156527994|NCT03021954|565026948|FG001|Overall Study|Lost to Follow-up|43|||
156527995|NCT03021954|565026947|FG000|Overall Study|Subjects had avulsion trauma|4|||
156527996|NCT03021954|565026948|FG001|Overall Study|Subjects had avulsion trauma|1|||
156527997|NCT02196714|565026951|FG000|Overall Study|Protocol Violation|0|||
156527998|NCT02196714|565026952|FG001|Overall Study|Protocol Violation|0|||
156527999|NCT02196714|565026953|FG002|Overall Study|Protocol Violation|1|||
156528000|NCT02196714|565026954|FG003|Overall Study|Protocol Violation|0|||
156528001|NCT01592864|565026956|FG000|Overall Study|Withdrawal by Subject|0|||
156528002|NCT01592864|565026957|FG001|Overall Study|Withdrawal by Subject|1|||
156528003|NCT03037619|565026962|FG000|Overall Study|Lost to Follow-up|0|||
156528004|NCT03037619|565026963|FG001|Overall Study|Lost to Follow-up|1|||
156528005|NCT01294683|565026966|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
156528006|NCT01294683|565026967|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
156528007|NCT01294683|565026966|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
156528008|NCT01294683|565026967|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
156528009|NCT01294683|565026966|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
156528010|NCT01294683|565026967|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
156528011|NCT01294683|565026966|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
156528012|NCT01294683|565026967|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
156528013|NCT01294683|565026966|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
156528014|NCT01294683|565026967|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
156528015|NCT01294683|565026966|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
156433083|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
156433084|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156433085|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156433086|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156433087|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156433088|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
156528016|NCT01294683|565026967|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
156528017|NCT01294683|565026966|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
156528018|NCT01294683|565026967|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
156528019|NCT01294683|565026966|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
156528020|NCT01294683|565026967|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
156528021|NCT01294683|565026966|FG000|Post Crossover (Period III)|Adverse Event|6|||
156528022|NCT01294683|565026967|FG001|Post Crossover (Period III)|Adverse Event|6|||
156675288|NCT00902538|565554922|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
156675289|NCT00902538|565554923|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
156675290|NCT00902538|565554918|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
156675291|NCT00902538|565554919|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
156675292|NCT00902538|565554920|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
156675293|NCT00902538|565554921|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
156675294|NCT00902538|565554922|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
156675295|NCT00902538|565554923|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
156675296|NCT00902538|565554918|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
156675297|NCT00902538|565554919|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
156675298|NCT00902538|565554920|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
156675299|NCT00902538|565554921|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
156675300|NCT00902538|565554922|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
156675301|NCT00902538|565554923|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
156675302|NCT00902538|565554918|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
156675303|NCT00902538|565554919|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
156528023|NCT01294683|565026966|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
156528024|NCT01294683|565026967|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
156528025|NCT01294683|565026966|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
156675304|NCT00902538|565554920|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
156675305|NCT00902538|565554921|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
156675306|NCT00902538|565554922|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
156675307|NCT00902538|565554923|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
156675308|NCT00902538|565554918|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
156528026|NCT01294683|565026967|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
156528027|NCT01294683|565026966|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
156528028|NCT01294683|565026967|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
156528029|NCT01881750|565026968|FG000|Overall Study|Changes in concomitant therapies|2|||
156528030|NCT01881750|565026969|FG001|Overall Study|Changes in concomitant therapies|3|||
156528031|NCT01881750|565026968|FG000|Overall Study|Lost to Follow-up|0|||
156528032|NCT01881750|565026969|FG001|Overall Study|Lost to Follow-up|1|||
156675309|NCT00902538|565554919|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
156675310|NCT00902538|565554920|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
156675311|NCT00902538|565554921|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
156675312|NCT00902538|565554922|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
156528033|NCT00307125|565026970|FG000|Screening Phase|Adverse Event|1|||
156528034|NCT00307125|565026971|FG001|Screening Phase|Adverse Event|0|||
156528035|NCT00307125|565026972|FG002|Screening Phase|Adverse Event|0|||
156528036|NCT00307125|565026970|FG000|Screening Phase|Protocol Violation|27|||
156528037|NCT00307125|565026971|FG001|Screening Phase|Protocol Violation|0|||
156528038|NCT00307125|565026972|FG002|Screening Phase|Protocol Violation|0|||
156528039|NCT00307125|565026970|FG000|Screening Phase|Lost to Follow-up|87|||
156528040|NCT00307125|565026971|FG001|Screening Phase|Lost to Follow-up|0|||
156528041|NCT00307125|565026972|FG002|Screening Phase|Lost to Follow-up|0|||
156528042|NCT00307125|565026970|FG000|Screening Phase|Death|10|||
156528043|NCT00307125|565026971|FG001|Screening Phase|Death|0|||
156528044|NCT00307125|565026972|FG002|Screening Phase|Death|0|||
156528045|NCT00307125|565026970|FG000|Screening Phase|Withdrawal by Subject|77|||
156528046|NCT00307125|565026971|FG001|Screening Phase|Withdrawal by Subject|0|||
156528047|NCT00307125|565026972|FG002|Screening Phase|Withdrawal by Subject|0|||
156528048|NCT00307125|565026970|FG000|Screening Phase|Physician Decision|26|||
156528049|NCT00307125|565026971|FG001|Screening Phase|Physician Decision|0|||
156528050|NCT00307125|565026972|FG002|Screening Phase|Physician Decision|0|||
156528051|NCT00307125|565026970|FG000|Screening Phase|Sponsor Decision|4|||
156528052|NCT00307125|565026971|FG001|Screening Phase|Sponsor Decision|0|||
156528053|NCT00307125|565026972|FG002|Screening Phase|Sponsor Decision|0|||
156528054|NCT00307125|565026970|FG000|Screening Phase|Study Terminated|17|||
156528055|NCT00307125|565026971|FG001|Screening Phase|Study Terminated|0|||
156528056|NCT00307125|565026972|FG002|Screening Phase|Study Terminated|0|||
156528057|NCT00307125|565026970|FG000|Screening Phase|Graft Loss|3|||
156528058|NCT00307125|565026971|FG001|Screening Phase|Graft Loss|0|||
156528059|NCT00307125|565026972|FG002|Screening Phase|Graft Loss|0|||
156528060|NCT00307125|565026970|FG000|Screening Phase|Graft Failure|8|||
156528061|NCT00307125|565026971|FG001|Screening Phase|Graft Failure|0|||
156528062|NCT00307125|565026972|FG002|Screening Phase|Graft Failure|0|||
156528063|NCT00307125|565026970|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
156528064|NCT00307125|565026971|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
156528065|NCT00307125|565026972|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
156528066|NCT00307125|565026970|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
156528067|NCT00307125|565026971|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
156675313|NCT00902538|565554923|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
156528068|NCT00307125|565026972|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
156528069|NCT00307125|565026970|FG000|Screening Phase|Moved or transferred facilities|34|||
156528070|NCT00307125|565026971|FG001|Screening Phase|Moved or transferred facilities|0|||
156528071|NCT00307125|565026972|FG002|Screening Phase|Moved or transferred facilities|0|||
156528072|NCT00307125|565026970|FG000|Screening Phase|Received Pancreas Transplant|8|||
156528073|NCT00307125|565026971|FG001|Screening Phase|Received Pancreas Transplant|0|||
156528074|NCT00307125|565026972|FG002|Screening Phase|Received Pancreas Transplant|0|||
156528075|NCT00307125|565026970|FG000|Screening Phase|Ineligible for pilot|4|||
156528076|NCT00307125|565026971|FG001|Screening Phase|Ineligible for pilot|0|||
156528077|NCT00307125|565026972|FG002|Screening Phase|Ineligible for pilot|0|||
156528078|NCT00307125|565026970|FG000|Screening Phase|Try to get pregnant|1|||
156528079|NCT00307125|565026971|FG001|Screening Phase|Try to get pregnant|0|||
156528080|NCT00307125|565026972|FG002|Screening Phase|Try to get pregnant|0|||
156528081|NCT00307125|565026970|FG000|Screening Phase|Developed acute leukemia|1|||
156528082|NCT00307125|565026971|FG001|Screening Phase|Developed acute leukemia|0|||
156528083|NCT00307125|565026972|FG002|Screening Phase|Developed acute leukemia|0|||
156528084|NCT00307125|565026970|FG000|Screening Phase|Metastatic colon cancer|1|||
156528085|NCT00307125|565026971|FG001|Screening Phase|Metastatic colon cancer|0|||
156528086|NCT00307125|565026972|FG002|Screening Phase|Metastatic colon cancer|0|||
156528087|NCT00307125|565026970|FG000|Screening Phase|Malignancy|1|||
156528088|NCT00307125|565026971|FG001|Screening Phase|Malignancy|0|||
156528089|NCT00307125|565026972|FG002|Screening Phase|Malignancy|0|||
156675314|NCT00902538|565554918|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
156675315|NCT00902538|565554919|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
156528090|NCT00307125|565026970|FG000|Screening Phase|PAK|1|||
156528091|NCT00307125|565026971|FG001|Screening Phase|PAK|0|||
156528092|NCT00307125|565026972|FG002|Screening Phase|PAK|0|||
156528093|NCT00307125|565026970|FG000|Screening Phase|Ineligible|1|||
156528094|NCT00307125|565026971|FG001|Screening Phase|Ineligible|0|||
156528095|NCT00307125|565026972|FG002|Screening Phase|Ineligible|0|||
156528096|NCT00307125|565026970|FG000|Screening Phase|Screen Error|1|||
156528097|NCT00307125|565026971|FG001|Screening Phase|Screen Error|0|||
156528098|NCT00307125|565026972|FG002|Screening Phase|Screen Error|0|||
156528099|NCT00307125|565026970|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
156528100|NCT00307125|565026971|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
156528101|NCT00307125|565026972|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
156528102|NCT00307125|565026970|FG000|Screening Phase|AMR and treated with rituximab|1|||
156528103|NCT00307125|565026971|FG001|Screening Phase|AMR and treated with rituximab|0|||
156528104|NCT00307125|565026972|FG002|Screening Phase|AMR and treated with rituximab|0|||
156675316|NCT00902538|565554920|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
156675317|NCT00902538|565554921|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
156675318|NCT00902538|565554922|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
156675319|NCT00902538|565554923|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
156675320|NCT00902538|565554918|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
156675321|NCT00902538|565554919|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
156675322|NCT00902538|565554920|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
156675323|NCT00902538|565554921|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
156675324|NCT00902538|565554922|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
156675325|NCT00902538|565554923|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
156675326|NCT00902538|565554918|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
156675327|NCT00902538|565554919|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
156675328|NCT00902538|565554920|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
156675329|NCT00902538|565554921|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
156675330|NCT00902538|565554922|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
156675331|NCT00902538|565554923|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
156675332|NCT00902538|565554918|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
156675333|NCT00902538|565554919|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
156675334|NCT00902538|565554920|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
156675335|NCT00902538|565554921|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
156675336|NCT00902538|565554922|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
156675337|NCT00902538|565554923|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
156675338|NCT00902538|565554918|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
156675339|NCT00902538|565554919|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
156675340|NCT00902538|565554920|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
156528105|NCT00307125|565026970|FG000|Screening Phase|Coronary artery bypass|1|||
156528106|NCT00307125|565026971|FG001|Screening Phase|Coronary artery bypass|0|||
156528107|NCT00307125|565026972|FG002|Screening Phase|Coronary artery bypass|0|||
156528108|NCT00307125|565026970|FG000|Pilot Phase|Lost to Follow-up|0|||
156528109|NCT00307125|565026971|FG001|Pilot Phase|Lost to Follow-up|1|||
156327862|NCT01954342|564301412|FG001|Overall Study|Missing data from 13-16week study visit|0|||
156528110|NCT00307125|565026972|FG002|Pilot Phase|Lost to Follow-up|0|||
156528111|NCT00307125|565026970|FG000|Pilot Phase|Withdrawal by Subject|0|||
156528112|NCT00307125|565026971|FG001|Pilot Phase|Withdrawal by Subject|1|||
156528113|NCT00307125|565026972|FG002|Pilot Phase|Withdrawal by Subject|1|||
156528114|NCT00051363|565026973|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
156528115|NCT00051363|565026974|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
156528116|NCT00051363|565026973|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
156528117|NCT00051363|565026974|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
156528118|NCT00051363|565026973|FG000|Overall Study|Death|2|||
156528119|NCT00051363|565026974|FG001|Overall Study|Death|2|||
156528120|NCT00051363|565026973|FG000|Overall Study|Excluded Pre-Randomization|2|||
156528121|NCT00051363|565026974|FG001|Overall Study|Excluded Pre-Randomization|5|||
156528122|NCT01290601|565026975|FG000|Overall Study|Adverse Event|0|||
156528123|NCT01290601|565026976|FG001|Overall Study|Adverse Event|2|||
156528124|NCT01290601|565026977|FG002|Overall Study|Adverse Event|0|||
156528125|NCT01290601|565026978|FG003|Overall Study|Adverse Event|0|||
156528126|NCT01290601|565026975|FG000|Overall Study|Lack of Efficacy|2|||
156528127|NCT01290601|565026976|FG001|Overall Study|Lack of Efficacy|1|||
156528128|NCT01290601|565026977|FG002|Overall Study|Lack of Efficacy|0|||
156528129|NCT01290601|565026978|FG003|Overall Study|Lack of Efficacy|0|||
156528130|NCT01290601|565026975|FG000|Overall Study|Lost to Follow-up|7|||
156528131|NCT01290601|565026976|FG001|Overall Study|Lost to Follow-up|2|||
156528132|NCT01290601|565026977|FG002|Overall Study|Lost to Follow-up|0|||
156528133|NCT01290601|565026978|FG003|Overall Study|Lost to Follow-up|0|||
156528134|NCT01290601|565026975|FG000|Overall Study|Other|1|||
156528135|NCT01290601|565026976|FG001|Overall Study|Other|0|||
156528136|NCT01290601|565026977|FG002|Overall Study|Other|0|||
156528137|NCT01290601|565026978|FG003|Overall Study|Other|0|||
156528138|NCT01290601|565026975|FG000|Overall Study|Protocol Violation|1|||
156528139|NCT01290601|565026976|FG001|Overall Study|Protocol Violation|0|||
156528140|NCT01290601|565026977|FG002|Overall Study|Protocol Violation|0|||
156528141|NCT01290601|565026978|FG003|Overall Study|Protocol Violation|0|||
156528142|NCT02571049|565026979|FG000|Screening|Did not meet entry criteria|2|||
156528143|NCT02571049|565026980|FG001|Screening|Did not meet entry criteria|2|||
156528144|NCT02571049|565026979|FG000|Randomization|No migraine attack|0|||
156528145|NCT02571049|565026980|FG001|Randomization|No migraine attack|1|||
156528146|NCT02571049|565026979|FG000|Randomization|Adverse Event|0|||
156528147|NCT02571049|565026980|FG001|Randomization|Adverse Event|1|||
156528148|NCT01055262|565026983|FG000|Overall Study|Adverse Event|5|||
156528149|NCT01055262|565026983|FG000|Overall Study|Protocol Violation|3|||
156528150|NCT01055262|565026983|FG000|Overall Study|Uncooperativeness|1|||
156528151|NCT00752622|565026985|FG000|Induction Phase|Adverse Event|3|||
156528152|NCT00752622|565026985|FG000|Induction Phase|Other|3|||
156528153|NCT00752622|565026985|FG000|Induction Phase|Non-responder|14|||
156528154|NCT00752622|565026985|FG000|Induction Phase|Withdrawal by Subject|1|||
156528155|NCT00752622|565026985|FG000|Induction Phase|Premature study termination|14|||
156528156|NCT00752622|565026985|FG000|Observational Phase|Premature Study Termination|36|||
156528157|NCT00752622|565026985|FG000|Observational Phase|Non-responder|2|||
156528158|NCT00752622|565026985|FG000|Observational Phase|Withdrawal by Subject|2|||
156528159|NCT00752622|565026985|FG000|Observational Phase|Adverse Event|1|||
156528160|NCT00752622|565026985|FG000|Observational Phase|Other|2|||
156528161|NCT00752622|565026985|FG000|Interventional Phase|Non-responder|2|||
156528162|NCT00752622|565026985|FG000|Interventional Phase|Physician Decision|1|||
156528163|NCT00752622|565026985|FG000|Interventional Phase|Premature Study Termination|5|||
156528164|NCT00421707|565026986|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
156528165|NCT00421707|565026987|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
156528166|NCT00421707|565026986|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
156528167|NCT00421707|565026987|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
156528168|NCT00421707|565026986|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
156528169|NCT00421707|565026987|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
156528170|NCT00421707|565026986|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
156528171|NCT00421707|565026987|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
156528172|NCT00421707|565026986|FG000|Period 2: Washout|Adverse Event|1|||
156528173|NCT00421707|565026987|FG001|Period 2: Washout|Adverse Event|1|||
156528174|NCT00421707|565026986|FG000|Period 2: Washout|Withdrawal by Subject|0|||
156528175|NCT00421707|565026987|FG001|Period 2: Washout|Withdrawal by Subject|1|||
156528176|NCT00421707|565026986|FG000|Period 2: Washout|Lost to Follow-up|0|||
156528177|NCT00421707|565026987|FG001|Period 2: Washout|Lost to Follow-up|1|||
156528178|NCT00421707|565026986|FG000|Period 2: Washout|Other: Pregnancy|0|||
156528179|NCT00421707|565026987|FG001|Period 2: Washout|Other: Pregnancy|1|||
156528180|NCT00421707|565026986|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
156528181|NCT00421707|565026987|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
156675341|NCT00902538|565554921|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
156528182|NCT00421707|565026986|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
156528183|NCT00421707|565026987|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
156528184|NCT00421707|565026986|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
156528185|NCT00421707|565026987|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
156528186|NCT05056987|565026988|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
156528187|NCT05056987|565026989|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
156528188|NCT05056987|565026988|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
156528189|NCT05056987|565026989|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
156528190|NCT00803270|565026990|FG000|Overall Study|Lost to Follow-up|1|||
156528191|NCT00803270|565026991|FG001|Overall Study|Lost to Follow-up|2|||
156528192|NCT00971243|565026992|FG000|Double Blind Period|Adverse Event|2|||
156528193|NCT00971243|565026993|FG001|Double Blind Period|Adverse Event|3|||
156675342|NCT00902538|565554922|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
156675343|NCT00902538|565554923|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
156675344|NCT00902538|565554918|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
156675345|NCT00902538|565554919|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
156675346|NCT00902538|565554920|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
156675347|NCT00902538|565554921|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
156675348|NCT00902538|565554922|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
156675349|NCT00902538|565554923|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
156675350|NCT00902538|565554918|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
156675351|NCT00902538|565554919|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
156675352|NCT00902538|565554920|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
156675353|NCT00902538|565554921|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
156675354|NCT00902538|565554922|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
156675355|NCT00902538|565554923|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
156675356|NCT00902538|565554918|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
156675357|NCT00902538|565554919|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
156327863|NCT01954342|564301413|FG002|Overall Study|Missing data from 13-16week study visit|0|||
156327864|NCT01954342|564301414|FG003|Overall Study|Missing data from 13-16week study visit|1|||
156528194|NCT00971243|565026994|FG002|Double Blind Period|Adverse Event|2|||
156528195|NCT00971243|565026995|FG003|Double Blind Period|Adverse Event|2|||
156528196|NCT00971243|565026996|FG004|Double Blind Period|Adverse Event|3|||
156528197|NCT00971243|565026992|FG000|Double Blind Period|Lost to Follow-up|0|||
156528198|NCT00971243|565026993|FG001|Double Blind Period|Lost to Follow-up|1|||
156528199|NCT00971243|565026994|FG002|Double Blind Period|Lost to Follow-up|1|||
156528200|NCT00971243|565026995|FG003|Double Blind Period|Lost to Follow-up|0|||
156528201|NCT00971243|565026996|FG004|Double Blind Period|Lost to Follow-up|1|||
156528202|NCT00971243|565026992|FG000|Double Blind Period|Physician Decision|10|||
156528203|NCT00971243|565026993|FG001|Double Blind Period|Physician Decision|6|||
156528204|NCT00971243|565026994|FG002|Double Blind Period|Physician Decision|7|||
156528205|NCT00971243|565026995|FG003|Double Blind Period|Physician Decision|6|||
156528206|NCT00971243|565026996|FG004|Double Blind Period|Physician Decision|7|||
156528207|NCT00971243|565026992|FG000|Double Blind Period|Protocol Violation|2|||
156528208|NCT00971243|565026993|FG001|Double Blind Period|Protocol Violation|0|||
156528209|NCT00971243|565026994|FG002|Double Blind Period|Protocol Violation|3|||
156528210|NCT00971243|565026995|FG003|Double Blind Period|Protocol Violation|2|||
156528211|NCT00971243|565026996|FG004|Double Blind Period|Protocol Violation|2|||
156528212|NCT00971243|565026992|FG000|Double Blind Period|Withdrawal by Subject|4|||
156528213|NCT00971243|565026993|FG001|Double Blind Period|Withdrawal by Subject|1|||
156528214|NCT00971243|565026994|FG002|Double Blind Period|Withdrawal by Subject|4|||
156528215|NCT00971243|565026995|FG003|Double Blind Period|Withdrawal by Subject|4|||
156528216|NCT00971243|565026996|FG004|Double Blind Period|Withdrawal by Subject|4|||
156528217|NCT00971243|565026992|FG000|Double Blind Period|Other reasons|1|||
156528218|NCT00971243|565026993|FG001|Double Blind Period|Other reasons|0|||
156528219|NCT00971243|565026994|FG002|Double Blind Period|Other reasons|2|||
156528220|NCT00971243|565026995|FG003|Double Blind Period|Other reasons|0|||
156327865|NCT01954342|564301411|FG000|Overall Study|Miscarriage|0|||
156327866|NCT01954342|564301412|FG001|Overall Study|Miscarriage|0|||
156327867|NCT01954342|564301413|FG002|Overall Study|Miscarriage|0|||
156327868|NCT01954342|564301414|FG003|Overall Study|Miscarriage|3|||
156327869|NCT01954342|564301411|FG000|Overall Study|Lost to Follow-up|0|||
156327870|NCT01954342|564301412|FG001|Overall Study|Lost to Follow-up|0|||
156327871|NCT01954342|564301413|FG002|Overall Study|Lost to Follow-up|0|||
156327872|NCT01954342|564301414|FG003|Overall Study|Lost to Follow-up|5|||
156327873|NCT01954342|564301411|FG000|Overall Study|Preterm delivery|0|||
156327874|NCT01954342|564301412|FG001|Overall Study|Preterm delivery|0|||
156327875|NCT01954342|564301413|FG002|Overall Study|Preterm delivery|0|||
156327876|NCT01954342|564301414|FG003|Overall Study|Preterm delivery|3|||
156327877|NCT01954342|564301411|FG000|Overall Study|Pre-eclampsia|0|||
156327878|NCT01954342|564301412|FG001|Overall Study|Pre-eclampsia|0|||
156327879|NCT01954342|564301413|FG002|Overall Study|Pre-eclampsia|0|||
156327880|NCT01954342|564301414|FG003|Overall Study|Pre-eclampsia|4|||
156327881|NCT01954342|564301411|FG000|Overall Study|Unreliable Data|0|||
156327882|NCT01954342|564301412|FG001|Overall Study|Unreliable Data|0|||
156327883|NCT01954342|564301413|FG002|Overall Study|Unreliable Data|0|||
156528221|NCT00971243|565026996|FG004|Double Blind Period|Other reasons|1|||
156528222|NCT00971243|565026992|FG000|Open-label Period|Adverse Event|1|||
156528223|NCT00971243|565026993|FG001|Open-label Period|Adverse Event|0|||
156528224|NCT00971243|565026994|FG002|Open-label Period|Adverse Event|1|||
156528225|NCT00971243|565026995|FG003|Open-label Period|Adverse Event|1|||
156528226|NCT00971243|565026996|FG004|Open-label Period|Adverse Event|0|||
156528227|NCT00971243|565026992|FG000|Open-label Period|Physician Decision|5|||
156528228|NCT00971243|565026993|FG001|Open-label Period|Physician Decision|9|||
156528229|NCT00971243|565026994|FG002|Open-label Period|Physician Decision|3|||
156528230|NCT00971243|565026995|FG003|Open-label Period|Physician Decision|7|||
156327884|NCT01954342|564301414|FG003|Overall Study|Unreliable Data|2|||
156528231|NCT00971243|565026996|FG004|Open-label Period|Physician Decision|2|||
156528232|NCT00971243|565026992|FG000|Open-label Period|Protocol Violation|1|||
156528233|NCT00971243|565026993|FG001|Open-label Period|Protocol Violation|1|||
156528234|NCT00971243|565026994|FG002|Open-label Period|Protocol Violation|1|||
156528235|NCT00971243|565026995|FG003|Open-label Period|Protocol Violation|0|||
156528236|NCT00971243|565026996|FG004|Open-label Period|Protocol Violation|1|||
156528237|NCT00971243|565026992|FG000|Open-label Period|Withdrawal by Subject|1|||
156528238|NCT00971243|565026993|FG001|Open-label Period|Withdrawal by Subject|0|||
156528239|NCT00971243|565026994|FG002|Open-label Period|Withdrawal by Subject|0|||
156528240|NCT00971243|565026995|FG003|Open-label Period|Withdrawal by Subject|2|||
156528241|NCT00971243|565026996|FG004|Open-label Period|Withdrawal by Subject|1|||
156528242|NCT00971243|565026992|FG000|Open-label Period|Other reason|0|||
156528243|NCT00971243|565026993|FG001|Open-label Period|Other reason|0|||
156528244|NCT00971243|565026994|FG002|Open-label Period|Other reason|0|||
156528245|NCT00971243|565026995|FG003|Open-label Period|Other reason|0|||
156528246|NCT00971243|565026996|FG004|Open-label Period|Other reason|2|||
156528247|NCT02903368|565026999|FG000|Part 1|Adverse Event|3|||
156528248|NCT02903368|565027000|FG001|Part 1|Adverse Event|0|||
156528249|NCT02903368|565027001|FG002|Part 1|Adverse Event|0|||
156528250|NCT02903368|565027002|FG003|Part 1|Adverse Event|0|||
156528251|NCT02903368|565026999|FG000|Part 1|Withdrawal by Subject|1|||
156528252|NCT02903368|565027000|FG001|Part 1|Withdrawal by Subject|0|||
156528253|NCT02903368|565027001|FG002|Part 1|Withdrawal by Subject|0|||
156528254|NCT02903368|565027002|FG003|Part 1|Withdrawal by Subject|0|||
156528255|NCT02903368|565026999|FG000|Part 2|Adverse Event|0|||
156528256|NCT02903368|565027000|FG001|Part 2|Adverse Event|0|||
156528257|NCT02903368|565027001|FG002|Part 2|Adverse Event|5|||
156528258|NCT02903368|565027002|FG003|Part 2|Adverse Event|0|||
156528259|NCT02903368|565026999|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
156528260|NCT02903368|565027000|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
156528261|NCT02903368|565027001|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
156528262|NCT02903368|565027002|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
156528263|NCT02903368|565026999|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
156528264|NCT02903368|565027000|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
156528265|NCT02903368|565027001|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
156528266|NCT02903368|565027002|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
156528267|NCT02903368|565026999|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
156528268|NCT02903368|565027000|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
156528269|NCT02903368|565027001|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
156528270|NCT02903368|565027002|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
156528271|NCT03769181|565028957|FG000|Overall Study|Adverse Event|1|||
156528272|NCT03769181|565028958|FG001|Overall Study|Adverse Event|0|||
156528273|NCT03769181|565028959|FG002|Overall Study|Adverse Event|2|||
156675358|NCT00902538|565554920|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
156327885|NCT00566501|564301415|FG000|Overall Study|Adverse Event|68|||
156327886|NCT00566501|564301416|FG001|Overall Study|Adverse Event|59|||
156327887|NCT00566501|564301415|FG000|Overall Study|Medication Non-compliance|5|||
156327888|NCT00566501|564301416|FG001|Overall Study|Medication Non-compliance|0|||
156327889|NCT00566501|564301415|FG000|Overall Study|Protocol Violation|2|||
156327890|NCT00566501|564301416|FG001|Overall Study|Protocol Violation|2|||
156327891|NCT00566501|564301415|FG000|Overall Study|Request of Investigator or Sponsor|6|||
156327892|NCT00566501|564301416|FG001|Overall Study|Request of Investigator or Sponsor|7|||
156327893|NCT00566501|564301415|FG000|Overall Study|Withdrawal by Subject|33|||
156327894|NCT00566501|564301416|FG001|Overall Study|Withdrawal by Subject|30|||
156327895|NCT00566501|564301415|FG000|Overall Study|Lack of Efficacy|8|||
156327896|NCT00566501|564301416|FG001|Overall Study|Lack of Efficacy|3|||
156327897|NCT00566501|564301415|FG000|Overall Study|Other|25|||
156327898|NCT00566501|564301416|FG001|Overall Study|Other|21|||
156327899|NCT01368432|564301419|FG000|Overall Study|Lost to Follow-up|0|||
156528274|NCT03769181|565028960|FG003|Overall Study|Adverse Event|4|||
156528275|NCT03769181|565028957|FG000|Overall Study|Withdrawal by Subject|1|||
156528276|NCT03769181|565028958|FG001|Overall Study|Withdrawal by Subject|0|||
156528277|NCT03769181|565028959|FG002|Overall Study|Withdrawal by Subject|2|||
156528278|NCT03769181|565028960|FG003|Overall Study|Withdrawal by Subject|1|||
156327900|NCT01368432|564301420|FG001|Overall Study|Lost to Follow-up|1|||
156528279|NCT03769181|565028957|FG000|Overall Study|Progressive disease|9|||
156528280|NCT03769181|565028958|FG001|Overall Study|Progressive disease|7|||
156528281|NCT03769181|565028959|FG002|Overall Study|Progressive disease|13|||
156528282|NCT03769181|565028960|FG003|Overall Study|Progressive disease|6|||
156528283|NCT03769181|565028957|FG000|Overall Study|Other - Unspecified|2|||
156528284|NCT03769181|565028958|FG001|Overall Study|Other - Unspecified|1|||
156528285|NCT03769181|565028959|FG002|Overall Study|Other - Unspecified|0|||
156528286|NCT03769181|565028960|FG003|Overall Study|Other - Unspecified|0|||
156528287|NCT01485354|565028961|FG000|Overall Study|Withdrawal by Subject|5|||
156528288|NCT03566810|565028962|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
156528289|NCT03566810|565028963|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
156528290|NCT03566810|565028964|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
156528291|NCT03566810|565028965|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
156528292|NCT03338192|565028967|FG000|Year One to Year Two|High Blood Pressure|7|||
156528293|NCT03338192|565028968|FG001|Year One to Year Two|High Blood Pressure|1|||
156528294|NCT03338192|565028967|FG000|Year One to Year Two|HIV +|1|||
156528295|NCT03338192|565028968|FG001|Year One to Year Two|HIV +|0|||
156528296|NCT03338192|565028967|FG000|Year Two to Year Four|High Blood Pressure|1|||
156528297|NCT03338192|565028968|FG001|Year Two to Year Four|High Blood Pressure|0|||
156528298|NCT03338192|565028967|FG000|Year Two to Year Four|HIV +|2|||
156528299|NCT03338192|565028968|FG001|Year Two to Year Four|HIV +|0|||
156528300|NCT03338192|565028967|FG000|Year Four to Year Six|High Blood Pressure|2|||
156327901|NCT00984568|564301426|FG000|Overall Study|Withdrawal by Subject|1|||
156327902|NCT00984568|564301427|FG001|Overall Study|Withdrawal by Subject|2|||
156327903|NCT00984568|564301426|FG000|Overall Study|Lack of Efficacy|2|||
156327904|NCT00984568|564301427|FG001|Overall Study|Lack of Efficacy|0|||
156327905|NCT00984568|564301426|FG000|Overall Study|Adverse Event|2|||
156327906|NCT00984568|564301427|FG001|Overall Study|Adverse Event|0|||
156327907|NCT00984568|564301426|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
156327908|NCT00984568|564301427|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
156327909|NCT00984568|564301426|FG000|Overall Study|Lost to Follow-up|0|||
156327910|NCT00984568|564301427|FG001|Overall Study|Lost to Follow-up|1|||
156327911|NCT00984568|564301426|FG000|Overall Study|Opportunistic Infection|1|||
156327912|NCT00984568|564301427|FG001|Overall Study|Opportunistic Infection|0|||
156327913|NCT00984568|564301426|FG000|Overall Study|Unknown Reason|1|||
156327914|NCT00984568|564301427|FG001|Overall Study|Unknown Reason|3|||
156327915|NCT00437320|564301428|FG000|Overall Study|Participant request|2|||
156327916|NCT00437320|564301429|FG001|Overall Study|Participant request|1|||
156327917|NCT00437320|564301430|FG002|Overall Study|Participant request|4|||
156327918|NCT02791594|564301435|FG000|Overall Study|Physician Decision|2|||
156327919|NCT02310321|564301437|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
156327920|NCT02310321|564301438|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
156327921|NCT02310321|564301439|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
156327922|NCT02310321|564301437|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
156327923|NCT02310321|564301438|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
156327924|NCT02310321|564301439|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
156327925|NCT02310321|564301437|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
156327926|NCT02310321|564301438|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
156327927|NCT02310321|564301439|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
156327928|NCT02310321|564301437|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
156327929|NCT02310321|564301438|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
156327930|NCT02310321|564301439|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
156327931|NCT02310321|564301437|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
156327932|NCT02310321|564301438|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
156327933|NCT02310321|564301439|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
156327934|NCT02310321|564301437|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
156327935|NCT02310321|564301438|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
156338178|NCT02264639|564336573|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
156338179|NCT02264639|564336569|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
156338180|NCT02264639|564336570|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
156338181|NCT02264639|564336571|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
156338182|NCT02264639|564336572|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
156338183|NCT02264639|564336573|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
156338184|NCT02264639|564336569|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
156338185|NCT02264639|564336570|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
156338186|NCT02264639|564336571|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
156338187|NCT02264639|564336572|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
156338188|NCT02264639|564336573|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
156338189|NCT01416272|564336577|FG000|Overall Study|Unacceptable distance visual acuity|2|||
156338190|NCT01416272|564336577|FG000|Overall Study|Lost to Follow-up|1|||
156338191|NCT01416272|564336577|FG000|Overall Study|Study related complaints|1|||
156528301|NCT03338192|565028968|FG001|Year Four to Year Six|High Blood Pressure|1|||
156528302|NCT00985166|565028971|FG000|Overall Study|Lost to Follow-up|3|||
156528303|NCT00985166|565028972|FG001|Overall Study|Lost to Follow-up|2|||
156528304|NCT00985166|565028973|FG002|Overall Study|Lost to Follow-up|2|||
156528305|NCT00985166|565028971|FG000|Overall Study|Withdrawal by Subject|3|||
156528306|NCT00985166|565028972|FG001|Overall Study|Withdrawal by Subject|2|||
156528307|NCT00985166|565028973|FG002|Overall Study|Withdrawal by Subject|0|||
156528308|NCT00985166|565028971|FG000|Overall Study|Test not done|2|||
156528309|NCT00985166|565028972|FG001|Overall Study|Test not done|0|||
156528310|NCT00985166|565028973|FG002|Overall Study|Test not done|4|||
156528311|NCT00985166|565028971|FG000|Overall Study|Other|1|||
156528312|NCT00985166|565028972|FG001|Overall Study|Other|0|||
156528313|NCT00985166|565028973|FG002|Overall Study|Other|1|||
156528314|NCT02276872|565028974|FG000|Overall Study|Adverse Event|1|||
156528315|NCT02276872|565028975|FG001|Overall Study|Adverse Event|0|||
156528316|NCT02276872|565028976|FG002|Overall Study|Adverse Event|0|||
156528317|NCT04175808|565028977|FG000|Part A|Miscellaneous|2|||
156528318|NCT04175808|565028978|FG001|Part A|Miscellaneous|0|||
156528319|NCT04175808|565028979|FG002|Part A|Miscellaneous|0|||
156528320|NCT04175808|565028980|FG003|Part A|Miscellaneous|0|||
156528321|NCT04175808|565028981|FG004|Part A|Miscellaneous|0|||
156528322|NCT04175808|565028982|FG005|Part A|Miscellaneous|0|||
156528323|NCT04175808|565028983|FG006|Part A|Miscellaneous|0|||
156528324|NCT00818389|565028985|FG000|Overall Study|Death|1|||
156528325|NCT00818389|565028986|FG001|Overall Study|Death|3|||
156528326|NCT00818389|565028985|FG000|Overall Study|ALS Disease Progression|1|||
156528327|NCT00818389|565028986|FG001|Overall Study|ALS Disease Progression|0|||
156528328|NCT00818389|565028985|FG000|Overall Study|Withdrawal by Subject|2|||
156327936|NCT02310321|564301439|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
156327937|NCT02310321|564301437|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
156327938|NCT02310321|564301438|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
156327939|NCT02310321|564301439|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
156327940|NCT02310321|564301437|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
156327941|NCT02310321|564301438|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
156327942|NCT02310321|564301439|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
156327943|NCT02310321|564301437|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
156327944|NCT02310321|564301438|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
156327945|NCT02310321|564301439|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
156327946|NCT02310321|564301437|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
156327947|NCT02310321|564301438|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
156327948|NCT02310321|564301439|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
156327949|NCT02310321|564301437|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
156327950|NCT02310321|564301438|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
156327951|NCT02310321|564301439|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
156327952|NCT02310321|564301437|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
156327953|NCT02310321|564301438|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
156528329|NCT00818389|565028986|FG001|Overall Study|Withdrawal by Subject|2|||
156528330|NCT00818389|565028985|FG000|Overall Study|Adverse Event|0|||
156528331|NCT00818389|565028986|FG001|Overall Study|Adverse Event|1|||
156528332|NCT04263909|565028987|FG000|Overall Study|Physician Decision|1|||
156675359|NCT00902538|565554921|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
156675360|NCT00902538|565554922|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
156675361|NCT00902538|565554923|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
156675362|NCT00902538|565554918|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
156675363|NCT00902538|565554919|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
156675364|NCT00902538|565554920|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
156675365|NCT00902538|565554921|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
156675366|NCT00902538|565554922|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
156675367|NCT00902538|565554923|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
156675368|NCT00902538|565554918|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
156675369|NCT00902538|565554919|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
156675370|NCT00902538|565554920|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
156675371|NCT00902538|565554921|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
156675372|NCT00902538|565554922|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
156675373|NCT00902538|565554923|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
156675374|NCT00902538|565554918|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
156528333|NCT04263909|565028988|FG001|Overall Study|Physician Decision|0|||
156528334|NCT04263909|565028989|FG002|Overall Study|Physician Decision|0|||
156528335|NCT04263909|565028987|FG000|Overall Study|Adverse Event|3|||
156528336|NCT04263909|565028988|FG001|Overall Study|Adverse Event|0|||
156528337|NCT04263909|565028989|FG002|Overall Study|Adverse Event|0|||
156675375|NCT00902538|565554919|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
156528338|NCT04263909|565028987|FG000|Overall Study|Protocol Violation|5|||
156528339|NCT04263909|565028988|FG001|Overall Study|Protocol Violation|0|||
156528340|NCT04263909|565028989|FG002|Overall Study|Protocol Violation|0|||
156528341|NCT00068588|565028990|FG000|Overall Study|Adverse Event|0|||
156528342|NCT00068588|565028991|FG001|Overall Study|Adverse Event|0|||
156528343|NCT00068588|565028992|FG002|Overall Study|Adverse Event|2|||
156528344|NCT00068588|565028990|FG000|Overall Study|Withdrawal by Subject|0|||
156528345|NCT00068588|565028991|FG001|Overall Study|Withdrawal by Subject|0|||
156528346|NCT00068588|565028992|FG002|Overall Study|Withdrawal by Subject|1|||
156528347|NCT00068588|565028990|FG000|Overall Study|Poor KPS|0|||
156528348|NCT00068588|565028991|FG001|Overall Study|Poor KPS|0|||
156528349|NCT00068588|565028992|FG002|Overall Study|Poor KPS|1|||
156528350|NCT03840486|565028993|FG000|Overall Study|Withdrawal by Subject|0|||
156528351|NCT03840486|565028994|FG001|Overall Study|Withdrawal by Subject|1|||
156528352|NCT03840486|565028995|FG002|Overall Study|Withdrawal by Subject|0|||
156528353|NCT03840486|565028996|FG003|Overall Study|Withdrawal by Subject|0|||
156528354|NCT03840486|565028997|FG004|Overall Study|Withdrawal by Subject|0|||
156528355|NCT03840486|565028998|FG005|Overall Study|Withdrawal by Subject|0|||
156528356|NCT03840486|565028999|FG006|Overall Study|Withdrawal by Subject|0|||
156528357|NCT03840486|565029000|FG007|Overall Study|Withdrawal by Subject|0|||
156528358|NCT03840486|565029001|FG008|Overall Study|Withdrawal by Subject|0|||
156528359|NCT03840486|565029002|FG009|Overall Study|Withdrawal by Subject|0|||
156528360|NCT03840486|565029003|FG010|Overall Study|Withdrawal by Subject|0|||
156528361|NCT03840486|565029004|FG011|Overall Study|Withdrawal by Subject|0|||
156528362|NCT01128894|565029005|FG000|Overall Study|Adverse Event|31|||
156528363|NCT01128894|565029006|FG001|Overall Study|Adverse Event|41|||
156528364|NCT01128894|565029005|FG000|Overall Study|Protocol Violation|2|||
156528365|NCT01128894|565029006|FG001|Overall Study|Protocol Violation|1|||
156528366|NCT01128894|565029005|FG000|Overall Study|Noncompliance|4|||
156528367|NCT01128894|565029006|FG001|Overall Study|Noncompliance|5|||
156528368|NCT01128894|565029005|FG000|Overall Study|Lost to Follow-up|8|||
156528369|NCT01128894|565029006|FG001|Overall Study|Lost to Follow-up|8|||
156528370|NCT01128894|565029005|FG000|Overall Study|Withdrawal by Subject|10|||
156528371|NCT01128894|565029006|FG001|Overall Study|Withdrawal by Subject|12|||
156528372|NCT01128894|565029005|FG000|Overall Study|Physician Decision|2|||
156528373|NCT01128894|565029006|FG001|Overall Study|Physician Decision|1|||
156528374|NCT01128894|565029005|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
156528375|NCT01128894|565029006|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
156528376|NCT03437278|565029007|FG000|Overall Study|Adverse Event|0|||
156528377|NCT03437278|565029008|FG001|Overall Study|Adverse Event|0|||
156528378|NCT03437278|565029009|FG002|Overall Study|Adverse Event|1|||
156528379|NCT03437278|565029007|FG000|Overall Study|Progressive disease|1|||
156528380|NCT03437278|565029008|FG001|Overall Study|Progressive disease|0|||
156528381|NCT03437278|565029009|FG002|Overall Study|Progressive disease|0|||
156528382|NCT03437278|565029007|FG000|Overall Study|Physician Decision|1|||
156528383|NCT03437278|565029008|FG001|Overall Study|Physician Decision|0|||
156528384|NCT03437278|565029009|FG002|Overall Study|Physician Decision|1|||
156528385|NCT02202551|565029010|FG000|Overall Study|Adverse Event|8|||
156528386|NCT02202551|565029011|FG001|Overall Study|Adverse Event|19|||
156528387|NCT02202551|565029012|FG002|Overall Study|Adverse Event|5|||
156528388|NCT02202551|565029013|FG003|Overall Study|Adverse Event|9|||
156528389|NCT02202551|565029010|FG000|Overall Study|Death|3|||
156528390|NCT02202551|565029011|FG001|Overall Study|Death|2|||
156528391|NCT02202551|565029012|FG002|Overall Study|Death|1|||
156528392|NCT02202551|565029013|FG003|Overall Study|Death|1|||
156528393|NCT02202551|565029010|FG000|Overall Study|Lost to Follow-up|0|||
156528394|NCT02202551|565029011|FG001|Overall Study|Lost to Follow-up|1|||
156528395|NCT02202551|565029012|FG002|Overall Study|Lost to Follow-up|0|||
156528396|NCT02202551|565029013|FG003|Overall Study|Lost to Follow-up|1|||
156528397|NCT02202551|565029010|FG000|Overall Study|Needed to take excluded medication|0|||
156528398|NCT02202551|565029011|FG001|Overall Study|Needed to take excluded medication|2|||
156528399|NCT02202551|565029012|FG002|Overall Study|Needed to take excluded medication|0|||
156528400|NCT02202551|565029013|FG003|Overall Study|Needed to take excluded medication|1|||
156528401|NCT02202551|565029010|FG000|Overall Study|Subject moved away|0|||
156528402|NCT02202551|565029011|FG001|Overall Study|Subject moved away|1|||
156528403|NCT02202551|565029012|FG002|Overall Study|Subject moved away|0|||
156528404|NCT02202551|565029013|FG003|Overall Study|Subject moved away|0|||
156528405|NCT02202551|565029010|FG000|Overall Study|DBS surgery|3|||
156528406|NCT02202551|565029011|FG001|Overall Study|DBS surgery|0|||
156528407|NCT02202551|565029012|FG002|Overall Study|DBS surgery|0|||
156528408|NCT02202551|565029013|FG003|Overall Study|DBS surgery|0|||
156528409|NCT02202551|565029010|FG000|Overall Study|Dyskinesia upon taper|1|||
156528410|NCT02202551|565029011|FG001|Overall Study|Dyskinesia upon taper|0|||
156528411|NCT02202551|565029012|FG002|Overall Study|Dyskinesia upon taper|0|||
156528412|NCT02202551|565029013|FG003|Overall Study|Dyskinesia upon taper|0|||
156528413|NCT02202551|565029010|FG000|Overall Study|Lack of Efficacy|0|||
156528414|NCT02202551|565029011|FG001|Overall Study|Lack of Efficacy|1|||
156528415|NCT02202551|565029012|FG002|Overall Study|Lack of Efficacy|0|||
156528416|NCT02202551|565029013|FG003|Overall Study|Lack of Efficacy|0|||
156528417|NCT02202551|565029010|FG000|Overall Study|Physician Decision|1|||
156528418|NCT02202551|565029011|FG001|Overall Study|Physician Decision|0|||
156528419|NCT02202551|565029012|FG002|Overall Study|Physician Decision|0|||
156528420|NCT02202551|565029013|FG003|Overall Study|Physician Decision|0|||
156528421|NCT02202551|565029010|FG000|Overall Study|Site closure|3|||
156528422|NCT02202551|565029011|FG001|Overall Study|Site closure|0|||
156528423|NCT02202551|565029012|FG002|Overall Study|Site closure|0|||
156528424|NCT02202551|565029013|FG003|Overall Study|Site closure|1|||
156528425|NCT02202551|565029010|FG000|Overall Study|Unable to complete visits per protocol|1|||
156528426|NCT02202551|565029011|FG001|Overall Study|Unable to complete visits per protocol|0|||
156528427|NCT02202551|565029012|FG002|Overall Study|Unable to complete visits per protocol|0|||
156528428|NCT02202551|565029013|FG003|Overall Study|Unable to complete visits per protocol|0|||
156528429|NCT02202551|565029010|FG000|Overall Study|Worsening Dyskinesia|0|||
156528430|NCT02202551|565029011|FG001|Overall Study|Worsening Dyskinesia|0|||
156528431|NCT02202551|565029012|FG002|Overall Study|Worsening Dyskinesia|0|||
156528432|NCT02202551|565029013|FG003|Overall Study|Worsening Dyskinesia|1|||
156528433|NCT02202551|565029010|FG000|Overall Study|Protocol Violation|0|||
156528434|NCT02202551|565029011|FG001|Overall Study|Protocol Violation|1|||
156528435|NCT02202551|565029012|FG002|Overall Study|Protocol Violation|0|||
156528436|NCT02202551|565029013|FG003|Overall Study|Protocol Violation|0|||
156528437|NCT02202551|565029010|FG000|Overall Study|Sponsor's decision|2|||
156528438|NCT02202551|565029011|FG001|Overall Study|Sponsor's decision|0|||
156528439|NCT02202551|565029012|FG002|Overall Study|Sponsor's decision|0|||
156528440|NCT02202551|565029013|FG003|Overall Study|Sponsor's decision|0|||
156528441|NCT02202551|565029010|FG000|Overall Study|Subject unwilling to proceed|1|||
156528442|NCT02202551|565029011|FG001|Overall Study|Subject unwilling to proceed|5|||
156528443|NCT02202551|565029012|FG002|Overall Study|Subject unwilling to proceed|3|||
156528444|NCT02202551|565029013|FG003|Overall Study|Subject unwilling to proceed|5|||
156528445|NCT02202551|565029010|FG000|Overall Study|Subject consent withdrawn|0|||
156528446|NCT02202551|565029011|FG001|Overall Study|Subject consent withdrawn|3|||
156528447|NCT02202551|565029012|FG002|Overall Study|Subject consent withdrawn|1|||
156528448|NCT02202551|565029013|FG003|Overall Study|Subject consent withdrawn|2|||
156528449|NCT02202551|565029010|FG000|Overall Study|eGFR<50mL/min/m2|2|||
156528450|NCT02202551|565029011|FG001|Overall Study|eGFR<50mL/min/m2|2|||
156528451|NCT02202551|565029012|FG002|Overall Study|eGFR<50mL/min/m2|0|||
156528452|NCT02202551|565029013|FG003|Overall Study|eGFR<50mL/min/m2|1|||
156528453|NCT02349451|565029014|FG000|Overall Study|Withdrawal by Subject|0|||
156528454|NCT02349451|565029015|FG001|Overall Study|Withdrawal by Subject|1|||
156528455|NCT02349451|565029016|FG002|Overall Study|Withdrawal by Subject|2|||
156528456|NCT02349451|565029017|FG003|Overall Study|Withdrawal by Subject|1|||
156528457|NCT02147353|565029018|FG000|Overall Study|Lost to Follow-up|2|||
156528458|NCT02147353|565029019|FG001|Overall Study|Lost to Follow-up|0|||
156528459|NCT02147353|565029018|FG000|Overall Study|unable to make visits|4|||
156528460|NCT02147353|565029019|FG001|Overall Study|unable to make visits|0|||
156528461|NCT02147353|565029018|FG000|Overall Study|medication noncompliance|3|||
156528462|NCT02147353|565029019|FG001|Overall Study|medication noncompliance|0|||
156528463|NCT02076178|565029022|FG000|Oral Phase|Adverse Event|0|||
156528464|NCT02076178|565029023|FG001|Oral Phase|Adverse Event|7|||
156528465|NCT02076178|565029022|FG000|Oral Phase|Withdrawal by Subject|0|||
156528466|NCT02076178|565029023|FG001|Oral Phase|Withdrawal by Subject|4|||
156528467|NCT02076178|565029022|FG000|Oral Phase|Physician Decision|0|||
156528468|NCT02076178|565029023|FG001|Oral Phase|Physician Decision|1|||
156528469|NCT02076178|565029022|FG000|Injection Phase|Protocol defined stopping criteria|1|||
156528470|NCT02076178|565029023|FG001|Injection Phase|Protocol defined stopping criteria|0|||
156528471|NCT02076178|565029022|FG000|Injection Phase|Withdrawal by Subject|0|||
156528472|NCT02076178|565029023|FG001|Injection Phase|Withdrawal by Subject|3|||
156528473|NCT02076178|565029022|FG000|Injection Phase|Physician Decision|0|||
156528474|NCT02076178|565029023|FG001|Injection Phase|Physician Decision|3|||
156528475|NCT02076178|565029022|FG000|Injection Phase|Lost to Follow-up|0|||
156528476|NCT02076178|565029023|FG001|Injection Phase|Lost to Follow-up|1|||
156528477|NCT02893930|565029024|FG000|Overall Study|Adverse Event|3|||
156528478|NCT02893930|565029024|FG000|Overall Study|Death|1|||
156528479|NCT02893930|565029024|FG000|Overall Study|Disease progression|5|||
156528480|NCT02893930|565029024|FG000|Overall Study|Withdrawal by Subject|2|||
156528481|NCT02893930|565029024|FG000|Overall Study|Physician Decision|1|||
156528482|NCT02893930|565029024|FG000|Overall Study|Ineligible|1|||
156528483|NCT01142596|565029025|FG000|Overall Study|Withdrawal by Subject|9|||
156528484|NCT01142596|565029026|FG001|Overall Study|Withdrawal by Subject|35|||
156528485|NCT01142596|565029025|FG000|Overall Study|Adverse Event|8|||
156528486|NCT01142596|565029026|FG001|Overall Study|Adverse Event|35|||
156528487|NCT01142596|565029025|FG000|Overall Study|Lack of Efficacy|5|||
156528488|NCT01142596|565029026|FG001|Overall Study|Lack of Efficacy|9|||
156528489|NCT01142596|565029025|FG000|Overall Study|Lost to Follow-up|2|||
156528490|NCT01142596|565029026|FG001|Overall Study|Lost to Follow-up|3|||
156528491|NCT01142596|565029025|FG000|Overall Study|Other reason (not specified)|5|||
156528492|NCT01142596|565029026|FG001|Overall Study|Other reason (not specified)|4|||
156528493|NCT02349360|565029027|FG000|Overall Study|Withdrawal by Subject|0|||
156528494|NCT02349360|565029028|FG001|Overall Study|Withdrawal by Subject|1|||
156528495|NCT01054846|565029029|FG000|Overall Study|Lost to Follow-up|76|||
156528496|NCT01054846|565029030|FG001|Overall Study|Lost to Follow-up|17|||
156528497|NCT02446886|565029039|FG000|Overall Study|Adverse Event|1|||
156528498|NCT02446886|565029040|FG001|Overall Study|Adverse Event|3|||
156528499|NCT02446886|565029039|FG000|Overall Study|Withdrawal by Subject|1|||
156528500|NCT02446886|565029040|FG001|Overall Study|Withdrawal by Subject|1|||
156528501|NCT01971203|565029043|FG000|Overall Study|Protocol Violation|3|||
156528502|NCT01971203|565029044|FG001|Overall Study|Protocol Violation|2|||
156528503|NCT01971203|565029043|FG000|Overall Study|Withdrawal by Subject|5|||
156528504|NCT01971203|565029044|FG001|Overall Study|Withdrawal by Subject|6|||
156528505|NCT01971203|565029043|FG000|Overall Study|Adverse Event|1|||
156528506|NCT01971203|565029044|FG001|Overall Study|Adverse Event|0|||
156528507|NCT00775450|565029051|FG000|Overall Study|Serious Adverse Event|2|||
156528508|NCT00775450|565029052|FG001|Overall Study|Serious Adverse Event|0|||
156528509|NCT00775450|565029053|FG002|Overall Study|Serious Adverse Event|0|||
156528510|NCT00775450|565029054|FG003|Overall Study|Serious Adverse Event|0|||
156528511|NCT00775450|565029055|FG004|Overall Study|Serious Adverse Event|0|||
156528512|NCT00775450|565029051|FG000|Overall Study|Protocol Violation|0|||
156528513|NCT00775450|565029052|FG001|Overall Study|Protocol Violation|0|||
156528514|NCT00775450|565029053|FG002|Overall Study|Protocol Violation|0|||
156528515|NCT00775450|565029054|FG003|Overall Study|Protocol Violation|0|||
156528516|NCT00775450|565029055|FG004|Overall Study|Protocol Violation|1|||
156528517|NCT00775450|565029051|FG000|Overall Study|Withdrawal by Subject|1|||
156528518|NCT00775450|565029052|FG001|Overall Study|Withdrawal by Subject|0|||
156528519|NCT00775450|565029053|FG002|Overall Study|Withdrawal by Subject|0|||
156528520|NCT00775450|565029054|FG003|Overall Study|Withdrawal by Subject|0|||
156528521|NCT00775450|565029055|FG004|Overall Study|Withdrawal by Subject|1|||
156528522|NCT01749540|565029063|FG000|Overall Study|Protocol Violation|0|||
156528523|NCT01749540|565029064|FG001|Overall Study|Protocol Violation|0|||
156528524|NCT01749540|565029065|FG002|Overall Study|Protocol Violation|0|||
156528525|NCT01749540|565029066|FG003|Overall Study|Protocol Violation|0|||
156528526|NCT01749540|565029067|FG004|Overall Study|Protocol Violation|0|||
156528527|NCT01749540|565029068|FG005|Overall Study|Protocol Violation|1|||
156528528|NCT01749540|565029069|FG006|Overall Study|Protocol Violation|1|||
156528529|NCT01749540|565029063|FG000|Overall Study|Withdrawal by Subject|0|||
156528530|NCT01749540|565029064|FG001|Overall Study|Withdrawal by Subject|0|||
156528531|NCT01749540|565029065|FG002|Overall Study|Withdrawal by Subject|0|||
156528532|NCT01749540|565029066|FG003|Overall Study|Withdrawal by Subject|1|||
156528533|NCT01749540|565029067|FG004|Overall Study|Withdrawal by Subject|0|||
156528534|NCT01749540|565029068|FG005|Overall Study|Withdrawal by Subject|0|||
156528535|NCT01749540|565029069|FG006|Overall Study|Withdrawal by Subject|0|||
156528536|NCT01749540|565029063|FG000|Overall Study|Initiated into extension study A536-06|0|||
156528537|NCT01749540|565029064|FG001|Overall Study|Initiated into extension study A536-06|0|||
156528538|NCT01749540|565029065|FG002|Overall Study|Initiated into extension study A536-06|0|||
156528539|NCT01749540|565029066|FG003|Overall Study|Initiated into extension study A536-06|0|||
156528540|NCT01749540|565029067|FG004|Overall Study|Initiated into extension study A536-06|0|||
156528541|NCT01749540|565029068|FG005|Overall Study|Initiated into extension study A536-06|2|||
156528542|NCT01749540|565029069|FG006|Overall Study|Initiated into extension study A536-06|24|||
156528543|NCT00576836|565029070|FG000|Overall Study|Death|0|||
156528544|NCT00576836|565029071|FG001|Overall Study|Death|1|||
156528545|NCT00576836|565029070|FG000|Overall Study|Physician Decision|0|||
156528546|NCT00576836|565029071|FG001|Overall Study|Physician Decision|1|||
156528547|NCT00392327|565029074|FG000|Overall Study|Death|1|||
156528548|NCT00392327|565029075|FG001|Overall Study|Death|0|||
156528549|NCT00392327|565029076|FG002|Overall Study|Death|1|||
156528550|NCT00392327|565029077|FG003|Overall Study|Death|0|||
156528551|NCT00392327|565029078|FG004|Overall Study|Death|0|||
156528552|NCT00392327|565029079|FG005|Overall Study|Death|0|||
156528553|NCT00392327|565029080|FG006|Overall Study|Death|0|||
156528554|NCT00392327|565029081|FG007|Overall Study|Death|0|||
156528555|NCT00392327|565029074|FG000|Overall Study|Lack of Efficacy|8|||
156528556|NCT00392327|565029075|FG001|Overall Study|Lack of Efficacy|8|||
156528557|NCT00392327|565029076|FG002|Overall Study|Lack of Efficacy|9|||
156528558|NCT00392327|565029077|FG003|Overall Study|Lack of Efficacy|6|||
156528559|NCT00392327|565029078|FG004|Overall Study|Lack of Efficacy|3|||
156528560|NCT00392327|565029079|FG005|Overall Study|Lack of Efficacy|3|||
156528561|NCT00392327|565029080|FG006|Overall Study|Lack of Efficacy|3|||
156528562|NCT00392327|565029081|FG007|Overall Study|Lack of Efficacy|3|||
156528563|NCT00392327|565029074|FG000|Overall Study|Physician Decision|3|||
156528564|NCT00392327|565029075|FG001|Overall Study|Physician Decision|5|||
156528565|NCT00392327|565029076|FG002|Overall Study|Physician Decision|2|||
156528566|NCT00392327|565029077|FG003|Overall Study|Physician Decision|2|||
156528567|NCT00392327|565029078|FG004|Overall Study|Physician Decision|0|||
156528568|NCT00392327|565029079|FG005|Overall Study|Physician Decision|1|||
156528569|NCT00392327|565029080|FG006|Overall Study|Physician Decision|5|||
156528570|NCT00392327|565029081|FG007|Overall Study|Physician Decision|3|||
156528571|NCT00392327|565029074|FG000|Overall Study|Protocol Violation|0|||
156528572|NCT00392327|565029075|FG001|Overall Study|Protocol Violation|0|||
156528573|NCT00392327|565029076|FG002|Overall Study|Protocol Violation|1|||
156528574|NCT00392327|565029077|FG003|Overall Study|Protocol Violation|0|||
156528575|NCT00392327|565029078|FG004|Overall Study|Protocol Violation|0|||
156528576|NCT00392327|565029079|FG005|Overall Study|Protocol Violation|0|||
156528577|NCT00392327|565029080|FG006|Overall Study|Protocol Violation|0|||
156528578|NCT00392327|565029081|FG007|Overall Study|Protocol Violation|0|||
156528579|NCT00392327|565029074|FG000|Overall Study|Withdrawal by Subject|3|||
156528580|NCT00392327|565029075|FG001|Overall Study|Withdrawal by Subject|2|||
156528581|NCT00392327|565029076|FG002|Overall Study|Withdrawal by Subject|4|||
156528582|NCT00392327|565029077|FG003|Overall Study|Withdrawal by Subject|6|||
156528583|NCT00392327|565029078|FG004|Overall Study|Withdrawal by Subject|0|||
156528584|NCT00392327|565029079|FG005|Overall Study|Withdrawal by Subject|1|||
156528585|NCT00392327|565029080|FG006|Overall Study|Withdrawal by Subject|1|||
156528586|NCT00392327|565029081|FG007|Overall Study|Withdrawal by Subject|5|||
156528587|NCT00392327|565029074|FG000|Overall Study|Ineligible|0|||
156528588|NCT00392327|565029075|FG001|Overall Study|Ineligible|4|||
156528589|NCT00392327|565029076|FG002|Overall Study|Ineligible|3|||
156528590|NCT00392327|565029077|FG003|Overall Study|Ineligible|2|||
156528591|NCT00392327|565029078|FG004|Overall Study|Ineligible|0|||
156528592|NCT00392327|565029079|FG005|Overall Study|Ineligible|0|||
156528593|NCT00392327|565029080|FG006|Overall Study|Ineligible|0|||
156528594|NCT00392327|565029081|FG007|Overall Study|Ineligible|0|||
156528595|NCT00894686|565029082|FG000|Overall Study|Withdrawal by Subject|50|||
156528596|NCT00894686|565029082|FG000|Overall Study|Physician Decision|1|||
156528597|NCT00894686|565029082|FG000|Overall Study|Other|5|||
156528598|NCT00178126|565029083|FG000|Overall Study|Lost to Follow-up|21|||
156528599|NCT00178126|565029084|FG001|Overall Study|Lost to Follow-up|21|||
156528600|NCT00178126|565029083|FG000|Overall Study|did not receive intervention|4|||
156528601|NCT00178126|565029084|FG001|Overall Study|did not receive intervention|6|||
156528602|NCT01575028|565029085|FG000|Overall Study|Physician Decision|0|||
156528603|NCT01575028|565029086|FG001|Overall Study|Physician Decision|1|||
156528604|NCT01182194|565029087|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
156528605|NCT01182194|565029088|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
156528606|NCT01948908|565029089|FG000|Overall Study|Protocol Violation|1|||
156528607|NCT01948908|565029090|FG001|Overall Study|Protocol Violation|0|||
156528608|NCT01948908|565029091|FG002|Overall Study|Protocol Violation|2|||
156528609|NCT01585987|565029092|FG000|Randomized|Withdrawal by Subject|0|||
156528610|NCT01585987|565029093|FG001|Randomized|Withdrawal by Subject|4|||
156528611|NCT01585987|565029092|FG000|Randomized|No longer met criteria|0|||
156528612|NCT01585987|565029093|FG001|Randomized|No longer met criteria|2|||
156528613|NCT01585987|565029092|FG000|Treated|Disease Progression|39|||
156528614|NCT01585987|565029093|FG001|Treated|Disease Progression|36|||
156528615|NCT01585987|565029092|FG000|Treated|Study Drug Toxicity|9|||
156528616|NCT01585987|565029093|FG001|Treated|Study Drug Toxicity|5|||
156528617|NCT01585987|565029092|FG000|Treated|Adverse Event|3|||
156528618|NCT01585987|565029093|FG001|Treated|Adverse Event|0|||
156528619|NCT01585987|565029092|FG000|Treated|Withdrawal by Subject|1|||
156528620|NCT01585987|565029093|FG001|Treated|Withdrawal by Subject|2|||
156528621|NCT01585987|565029092|FG000|Treated|Death|1|||
156528622|NCT01585987|565029093|FG001|Treated|Death|0|||
156528623|NCT01585987|565029092|FG000|Treated|Lost to Follow-up|0|||
156528624|NCT01585987|565029093|FG001|Treated|Lost to Follow-up|1|||
156528625|NCT01585987|565029092|FG000|Treated|Maximum Clinical Benefit|0|||
156528626|NCT01585987|565029093|FG001|Treated|Maximum Clinical Benefit|1|||
156528627|NCT01585987|565029092|FG000|Treated|Non-Specified|1|||
156528628|NCT01585987|565029093|FG001|Treated|Non-Specified|2|||
156528629|NCT01585987|565029092|FG000|Treated|Subject Request|0|||
156528630|NCT01585987|565029093|FG001|Treated|Subject Request|1|||
156528631|NCT01585987|565029092|FG000|Treated|Poor/Non-Compliance|0|||
156528632|NCT01585987|565029093|FG001|Treated|Poor/Non-Compliance|1|||
156528633|NCT03291587|565029094|FG000|Overall Study|Lost to Follow-up|62|||
156528634|NCT03291587|565029095|FG001|Overall Study|Lost to Follow-up|43|||
156528635|NCT03291587|565029094|FG000|Overall Study|Refused to Answer|5|||
156528636|NCT03291587|565029095|FG001|Overall Study|Refused to Answer|2|||
156528637|NCT03291587|565029094|FG000|Overall Study|Death|2|||
156528638|NCT03291587|565029095|FG001|Overall Study|Death|4|||
156528639|NCT03291587|565029094|FG000|Overall Study|Not interested in participating|8|||
156528640|NCT03291587|565029095|FG001|Overall Study|Not interested in participating|6|||
156528641|NCT03291587|565029094|FG000|Overall Study|Too busy to participate|4|||
156528642|NCT03291587|565029095|FG001|Overall Study|Too busy to participate|2|||
156528643|NCT00796120|565029097|FG000|Overall Study|Death|3|||
156528644|NCT00796120|565029098|FG001|Overall Study|Death|0|||
156528645|NCT00796120|565029097|FG000|Overall Study|Adverse Event|11|||
156528646|NCT00796120|565029098|FG001|Overall Study|Adverse Event|6|||
156528647|NCT00796120|565029097|FG000|Overall Study|Progressive disease|22|||
156528648|NCT00796120|565029098|FG001|Overall Study|Progressive disease|13|||
156528649|NCT00796120|565029097|FG000|Overall Study|Participant refusal|3|||
156528650|NCT00796120|565029098|FG001|Overall Study|Participant refusal|4|||
156528651|NCT00796120|565029097|FG000|Overall Study|Other|6|||
156528652|NCT00796120|565029098|FG001|Overall Study|Other|17|||
156528653|NCT00796120|565029097|FG000|Overall Study|Physician Decision|16|||
156528654|NCT00796120|565029098|FG001|Overall Study|Physician Decision|17|||
156433089|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
156433090|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
156433091|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
156433092|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
156433093|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
156433094|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
156433095|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
156433096|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
156433097|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
156433098|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
156433099|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
156433100|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
156433101|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
156433102|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
156433103|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
156433104|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
156433105|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
156433106|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
156433107|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
156433108|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156433109|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
156433110|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
156433111|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156433112|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156433113|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156433114|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156433115|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
156433116|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
156433117|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
156433118|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
156433119|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
156433120|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
156433121|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
156433122|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
156433123|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
156433124|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
156433125|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
156433126|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
156433127|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
156433128|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
156433129|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
156433130|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
156433131|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
156433132|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
156433133|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
156433134|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
156433135|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
156433136|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
156433137|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
156433138|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
156433139|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
156433140|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
156433141|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
156433142|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
156433143|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
156433144|NCT01212757|564673919|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
156433145|NCT01212757|564673920|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
156433146|NCT01212757|564673921|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
156433147|NCT01212757|564673922|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
156433148|NCT01212757|564673923|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
156433149|NCT01212757|564673924|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
156433150|NCT01212757|564673925|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
156433151|NCT01212757|564673926|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
156433152|NCT01212757|564673927|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
156433153|NCT00573833|564673928|FG000|Overall Study|Not Treated|2|||
156433154|NCT05052983|564673929|FG000|Overall Study|Lack of Efficacy|3|||
156433155|NCT05052983|564673930|FG001|Overall Study|Lack of Efficacy|12|||
156433156|NCT05052983|564673929|FG000|Overall Study|Adverse Event|1|||
156433157|NCT05052983|564673930|FG001|Overall Study|Adverse Event|0|||
156528655|NCT00796120|565029097|FG000|Overall Study|Randomized but not treated|0|||
156528656|NCT00796120|565029098|FG001|Overall Study|Randomized but not treated|3|||
156528657|NCT02520284|565029101|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
156528658|NCT02520284|565029102|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
156528659|NCT02520284|565029103|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
156528660|NCT02520284|565029101|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
156528661|NCT02520284|565029102|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
156528662|NCT02520284|565029103|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
156528663|NCT02520284|565029101|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
156528664|NCT02520284|565029102|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
156528665|NCT02520284|565029103|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
156528666|NCT02520284|565029101|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
156528667|NCT02520284|565029102|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
156528668|NCT02520284|565029103|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
156528669|NCT02520284|565029101|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
156528670|NCT02520284|565029102|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
156528671|NCT02520284|565029103|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
156528672|NCT02520284|565029101|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
156528673|NCT02520284|565029102|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
156528674|NCT02520284|565029103|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
156528675|NCT02520284|565029101|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
156528676|NCT02520284|565029102|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
156528677|NCT02520284|565029103|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
156528678|NCT02520284|565029101|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
156528679|NCT02520284|565029102|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
156528680|NCT02520284|565029103|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
156528681|NCT02520284|565029101|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
156528682|NCT02520284|565029102|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
156528683|NCT02520284|565029103|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
156528684|NCT02520284|565029101|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
156528685|NCT02520284|565029102|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
156528686|NCT02520284|565029103|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
156528687|NCT02520284|565029101|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
156528688|NCT02520284|565029102|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
156528689|NCT02520284|565029103|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
156528690|NCT03737474|565029104|FG000|Overall Study|Adverse Event|18|||
156528691|NCT03737474|565029105|FG001|Overall Study|Adverse Event|48|||
156528692|NCT03737474|565029104|FG000|Overall Study|Lack of Efficacy|1|||
156528693|NCT03737474|565029105|FG001|Overall Study|Lack of Efficacy|3|||
156528694|NCT03737474|565029104|FG000|Overall Study|Protocol Violation|0|||
156528695|NCT03737474|565029105|FG001|Overall Study|Protocol Violation|8|||
156528696|NCT03737474|565029104|FG000|Overall Study|Withdrawal by Subject|5|||
156528697|NCT03737474|565029105|FG001|Overall Study|Withdrawal by Subject|20|||
156528698|NCT03737474|565029104|FG000|Overall Study|Non-compliance With Study Drug|0|||
156528699|NCT03737474|565029105|FG001|Overall Study|Non-compliance With Study Drug|1|||
156528700|NCT03737474|565029104|FG000|Overall Study|Physician Decision|1|||
156528701|NCT03737474|565029105|FG001|Overall Study|Physician Decision|4|||
156528702|NCT01139658|565029108|FG000|Overall Study|Adverse Event|10|||
156528703|NCT01139658|565029109|FG001|Overall Study|Adverse Event|27|||
156528704|NCT01139658|565029108|FG000|Overall Study|Lack of Efficacy|15|||
156528705|NCT01139658|565029109|FG001|Overall Study|Lack of Efficacy|7|||
156528706|NCT01139658|565029108|FG000|Overall Study|Withdrawal by Subject|2|||
156528707|NCT01139658|565029109|FG001|Overall Study|Withdrawal by Subject|4|||
156528708|NCT01139658|565029108|FG000|Overall Study|No documentation of treatment|1|||
156528709|NCT01139658|565029109|FG001|Overall Study|No documentation of treatment|0|||
156528710|NCT01139658|565029108|FG000|Overall Study|Other|28|||
156528711|NCT01139658|565029109|FG001|Overall Study|Other|75|||
156528712|NCT03282240|565029110|FG000|Overall Study|Adverse Event|2|||
156528713|NCT03282240|565029111|FG001|Overall Study|Adverse Event|2|||
156528714|NCT03282240|565029112|FG002|Overall Study|Adverse Event|0|||
156528715|NCT03282240|565029110|FG000|Overall Study|Lost to Follow-up|3|||
156528716|NCT03282240|565029111|FG001|Overall Study|Lost to Follow-up|0|||
156528717|NCT03282240|565029112|FG002|Overall Study|Lost to Follow-up|0|||
156528718|NCT03282240|565029110|FG000|Overall Study|Protocol Deviation|4|||
156528719|NCT03282240|565029111|FG001|Overall Study|Protocol Deviation|1|||
156528720|NCT03282240|565029112|FG002|Overall Study|Protocol Deviation|2|||
156528721|NCT03282240|565029110|FG000|Overall Study|Withdrawal by Subject|1|||
156528722|NCT03282240|565029111|FG001|Overall Study|Withdrawal by Subject|0|||
156528723|NCT03282240|565029112|FG002|Overall Study|Withdrawal by Subject|1|||
156779791|NCT01078662|565943887|FG004|Overall Study|Patients reached data cut-off|3|||
156433158|NCT01070888|564676117|FG000|First Intervention (14 Days)|Adverse Event|0|||
156433159|NCT01070888|564676118|FG001|First Intervention (14 Days)|Adverse Event|1|||
156433160|NCT01070888|564676117|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
156433161|NCT01070888|564676118|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
156433162|NCT01070888|564676117|FG000|Washout (14 Days)|Physician Decision|1|||
156433163|NCT01070888|564676118|FG001|Washout (14 Days)|Physician Decision|0|||
156433164|NCT02631148|564676119|FG000|Overall Study|8 were ineligible|8|||
156433165|NCT02631148|564676120|FG001|Overall Study|8 were ineligible|0|||
156433166|NCT02631148|564676119|FG000|Overall Study|Withdrawal by Subject|1|||
156433167|NCT02631148|564676120|FG001|Overall Study|Withdrawal by Subject|0|||
156433168|NCT02631148|564676119|FG000|Overall Study|PAH not available to study participant|1|||
156433169|NCT02631148|564676120|FG001|Overall Study|PAH not available to study participant|0|||
156433170|NCT00955825|564676122|FG000|Overall Study|Adverse Event|15|||
156433171|NCT00955825|564676123|FG001|Overall Study|Adverse Event|2|||
156433172|NCT00955825|564676122|FG000|Overall Study|Withdrawal by Subject|4|||
156433173|NCT00955825|564676123|FG001|Overall Study|Withdrawal by Subject|6|||
156433174|NCT00955825|564676122|FG000|Overall Study|Any other reason not above-mentioned|7|||
156433175|NCT00955825|564676123|FG001|Overall Study|Any other reason not above-mentioned|9|||
156433176|NCT01198275|564676124|FG000|Overall Study|Adverse Event|2|||
156433177|NCT01198275|564676125|FG001|Overall Study|Adverse Event|3|||
156433178|NCT01198275|564676124|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
156433179|NCT01198275|564676125|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
156433180|NCT00150176|564676126|FG000|Overall Study|Adverse Event|16|||
156433181|NCT00150176|564676127|FG001|Overall Study|Adverse Event|53|||
156433182|NCT00150176|564676126|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
156433183|NCT00150176|564676127|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
156433184|NCT00150176|564676126|FG000|Overall Study|Withdrawal by Subject|19|||
156433185|NCT00150176|564676127|FG001|Overall Study|Withdrawal by Subject|12|||
156433186|NCT00150176|564676126|FG000|Overall Study|Lost to Follow-up|3|||
156433187|NCT00150176|564676127|FG001|Overall Study|Lost to Follow-up|3|||
156433188|NCT00150176|564676126|FG000|Overall Study|OTHER|11|||
156433189|NCT00150176|564676127|FG001|Overall Study|OTHER|13|||
156433190|NCT04035668|564676128|FG000|Overall Study|Adverse Event|3|||
156433191|NCT04035668|564676129|FG001|Overall Study|Adverse Event|4|||
156433192|NCT04035668|564676130|FG002|Overall Study|Adverse Event|2|||
156433193|NCT04035668|564676128|FG000|Overall Study|Lost to Follow-up|0|||
156433194|NCT04035668|564676129|FG001|Overall Study|Lost to Follow-up|1|||
156433195|NCT04035668|564676130|FG002|Overall Study|Lost to Follow-up|0|||
156433196|NCT04035668|564676128|FG000|Overall Study|Physician Decision|2|||
156433197|NCT04035668|564676129|FG001|Overall Study|Physician Decision|1|||
156433198|NCT04035668|564676130|FG002|Overall Study|Physician Decision|1|||
156433199|NCT04035668|564676128|FG000|Overall Study|Subject Decision|2|||
156433200|NCT04035668|564676129|FG001|Overall Study|Subject Decision|2|||
156433201|NCT04035668|564676130|FG002|Overall Study|Subject Decision|0|||
156433202|NCT02385669|564676131|FG000|Overall Study|Adverse Event|2|||
156433203|NCT02477670|564676132|FG000|Stage 1|Adverse Event|2|||
156433204|NCT02477670|564676133|FG001|Stage 1|Adverse Event|7|||
156433205|NCT02477670|564676134|FG002|Stage 1|Adverse Event|0|||
156433206|NCT02477670|564676135|FG003|Stage 1|Adverse Event|0|||
156433207|NCT02477670|564676136|FG004|Stage 1|Adverse Event|0|||
156433208|NCT02477670|564676137|FG005|Stage 1|Adverse Event|0|||
156433209|NCT02477670|564676138|FG006|Stage 1|Adverse Event|0|||
156433210|NCT02477670|564676132|FG000|Stage 1|Lost to Follow-up|0|||
156433211|NCT02477670|564676133|FG001|Stage 1|Lost to Follow-up|2|||
156433212|NCT02477670|564676134|FG002|Stage 1|Lost to Follow-up|0|||
156433213|NCT02477670|564676135|FG003|Stage 1|Lost to Follow-up|0|||
156433214|NCT02477670|564676136|FG004|Stage 1|Lost to Follow-up|0|||
156433215|NCT02477670|564676137|FG005|Stage 1|Lost to Follow-up|0|||
156433216|NCT02477670|564676138|FG006|Stage 1|Lost to Follow-up|0|||
156433217|NCT02477670|564676132|FG000|Stage 1|Withdrawal by Subject|1|||
156433218|NCT02477670|564676133|FG001|Stage 1|Withdrawal by Subject|2|||
156433219|NCT02477670|564676134|FG002|Stage 1|Withdrawal by Subject|0|||
156433220|NCT02477670|564676135|FG003|Stage 1|Withdrawal by Subject|0|||
156433221|NCT02477670|564676136|FG004|Stage 1|Withdrawal by Subject|0|||
156433222|NCT02477670|564676137|FG005|Stage 1|Withdrawal by Subject|0|||
156433223|NCT02477670|564676138|FG006|Stage 1|Withdrawal by Subject|0|||
156433224|NCT02477670|564676132|FG000|Stage 1|Non-compliance with Study Drug|1|||
156433225|NCT02477670|564676133|FG001|Stage 1|Non-compliance with Study Drug|2|||
156433226|NCT02477670|564676134|FG002|Stage 1|Non-compliance with Study Drug|0|||
156433227|NCT02477670|564676135|FG003|Stage 1|Non-compliance with Study Drug|0|||
156433228|NCT02477670|564676136|FG004|Stage 1|Non-compliance with Study Drug|0|||
156433229|NCT02477670|564676137|FG005|Stage 1|Non-compliance with Study Drug|0|||
156433230|NCT02477670|564676138|FG006|Stage 1|Non-compliance with Study Drug|0|||
156433231|NCT02477670|564676132|FG000|Stage 2|Adverse Event|0|||
156433232|NCT02477670|564676133|FG001|Stage 2|Adverse Event|0|||
156433233|NCT02477670|564676134|FG002|Stage 2|Adverse Event|1|||
156433234|NCT02477670|564676135|FG003|Stage 2|Adverse Event|0|||
156433235|NCT02477670|564676136|FG004|Stage 2|Adverse Event|0|||
156433236|NCT02477670|564676137|FG005|Stage 2|Adverse Event|0|||
156433237|NCT02477670|564676138|FG006|Stage 2|Adverse Event|0|||
156528724|NCT01675479|565029113|FG000|Overall Study|Lost to Follow-up|11|||
156528725|NCT02910739|565029114|FG000|Overall Study|Adverse Event|1|||
156528726|NCT02910739|565029115|FG001|Overall Study|Adverse Event|0|||
156528727|NCT02910739|565029116|FG002|Overall Study|Adverse Event|0|||
156528728|NCT02910739|565029117|FG003|Overall Study|Adverse Event|0|||
156528729|NCT01572922|565029120|FG000|Overall Study|Adverse Event|1|||
156528730|NCT01572922|565029120|FG000|Overall Study|Protocol Violation|1|||
156528731|NCT01572922|565029120|FG000|Overall Study|Death|1|||
156528732|NCT06515483|565029122|FG000|Overall Study|Subject withdraw due to family issues|1|||
156528733|NCT06515483|565029123|FG001|Overall Study|Subject withdraw due to family issues|0|||
156528734|NCT00147823|565029129|FG000|Overall Study|Lost to Follow-up|6|||
156528735|NCT00147823|565029130|FG001|Overall Study|Lost to Follow-up|12|||
156528736|NCT00147823|565029129|FG000|Overall Study|Physician Decision|1|||
156528737|NCT00147823|565029130|FG001|Overall Study|Physician Decision|0|||
156528738|NCT00147823|565029129|FG000|Overall Study|Withdrawal by Subject|0|||
156528739|NCT00147823|565029130|FG001|Overall Study|Withdrawal by Subject|1|||
156528740|NCT00147823|565029129|FG000|Overall Study|Did not receive vitoss due to infection|6|||
156528741|NCT00147823|565029130|FG001|Overall Study|Did not receive vitoss due to infection|2|||
156528742|NCT04751656|565030949|FG000|Overall Study|Lost to Follow-up|1|||
156528743|NCT01103245|565030952|FG000|Overall Study|Withdrawal by Subject|1|||
156528744|NCT01103245|565030953|FG001|Overall Study|Withdrawal by Subject|0|||
156528745|NCT01103245|565030954|FG002|Overall Study|Withdrawal by Subject|3|||
156528746|NCT01103245|565030955|FG003|Overall Study|Withdrawal by Subject|0|||
156528747|NCT01103245|565030952|FG000|Overall Study|Inadequate IV access|1|||
156528748|NCT01103245|565030953|FG001|Overall Study|Inadequate IV access|0|||
156528749|NCT01103245|565030954|FG002|Overall Study|Inadequate IV access|0|||
156528750|NCT01103245|565030955|FG003|Overall Study|Inadequate IV access|0|||
156528751|NCT01103245|565030952|FG000|Overall Study|Adverse Event|0|||
156528752|NCT01103245|565030953|FG001|Overall Study|Adverse Event|2|||
156528753|NCT01103245|565030954|FG002|Overall Study|Adverse Event|1|||
156528754|NCT01103245|565030955|FG003|Overall Study|Adverse Event|0|||
156528755|NCT01103245|565030952|FG000|Overall Study|Physician Decision|1|||
156528756|NCT01103245|565030953|FG001|Overall Study|Physician Decision|0|||
156528757|NCT01103245|565030954|FG002|Overall Study|Physician Decision|0|||
156528758|NCT01103245|565030955|FG003|Overall Study|Physician Decision|0|||
156528759|NCT04796896|565030958|FG000|Overall Study|Adverse Event|1|||
156528760|NCT04796896|565030959|FG001|Overall Study|Adverse Event|0|||
156528761|NCT04796896|565030960|FG002|Overall Study|Adverse Event|0|||
156528762|NCT04796896|565030961|FG003|Overall Study|Adverse Event|0|||
156528763|NCT04796896|565030962|FG004|Overall Study|Adverse Event|0|||
156327954|NCT02310321|564301439|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
156327955|NCT02310321|564301437|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
156327956|NCT02310321|564301438|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
156327957|NCT02310321|564301439|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
156327958|NCT02310321|564301437|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
156327959|NCT02310321|564301438|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
156327960|NCT02310321|564301439|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
156327961|NCT02310321|564301437|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
156327962|NCT02310321|564301438|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
156327963|NCT02310321|564301439|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
156327964|NCT02310321|564301437|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
156327965|NCT02310321|564301438|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
156327966|NCT02310321|564301439|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
156327967|NCT02310321|564301437|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
156327968|NCT02310321|564301438|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
156327969|NCT02310321|564301439|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
156327970|NCT02310321|564301437|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
156327971|NCT02310321|564301438|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
156327972|NCT02310321|564301439|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
156327973|NCT02310321|564301437|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
156327974|NCT02310321|564301438|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
156528764|NCT04796896|565030963|FG005|Overall Study|Adverse Event|1|||
156528765|NCT04796896|565030964|FG006|Overall Study|Adverse Event|1|||
156528766|NCT04796896|565030965|FG007|Overall Study|Adverse Event|0|||
156528767|NCT04796896|565030966|FG008|Overall Study|Adverse Event|1|||
156528768|NCT04796896|565030967|FG009|Overall Study|Adverse Event|1|||
156528769|NCT04796896|565030968|FG010|Overall Study|Adverse Event|1|||
156528770|NCT04796896|565030969|FG011|Overall Study|Adverse Event|0|||
156528771|NCT04796896|565030958|FG000|Overall Study|Lost to Follow-up|24|||
156528772|NCT04796896|565030959|FG001|Overall Study|Lost to Follow-up|15|||
156528773|NCT04796896|565030960|FG002|Overall Study|Lost to Follow-up|6|||
156528774|NCT04796896|565030961|FG003|Overall Study|Lost to Follow-up|4|||
156528775|NCT04796896|565030962|FG004|Overall Study|Lost to Follow-up|21|||
156528776|NCT04796896|565030963|FG005|Overall Study|Lost to Follow-up|55|||
156528777|NCT04796896|565030964|FG006|Overall Study|Lost to Follow-up|237|||
156528778|NCT04796896|565030965|FG007|Overall Study|Lost to Follow-up|52|||
156528779|NCT04796896|565030966|FG008|Overall Study|Lost to Follow-up|221|||
156528780|NCT04796896|565030967|FG009|Overall Study|Lost to Follow-up|43|||
156528781|NCT04796896|565030968|FG010|Overall Study|Lost to Follow-up|142|||
156528782|NCT04796896|565030969|FG011|Overall Study|Lost to Follow-up|18|||
156528783|NCT04796896|565030958|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
156528784|NCT04796896|565030959|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
156528785|NCT04796896|565030960|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
156528786|NCT04796896|565030961|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
156528787|NCT04796896|565030962|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
156528788|NCT04796896|565030963|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
156528789|NCT04796896|565030964|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
156528790|NCT04796896|565030965|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
156528791|NCT04796896|565030966|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
156528792|NCT04796896|565030967|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
156528793|NCT04796896|565030968|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
156528794|NCT04796896|565030969|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
156528795|NCT04796896|565030958|FG000|Overall Study|Physician Decision|1|||
156528796|NCT04796896|565030959|FG001|Overall Study|Physician Decision|0|||
156528797|NCT04796896|565030960|FG002|Overall Study|Physician Decision|0|||
156433238|NCT02477670|564676132|FG000|Stage 2|Antipsychotic Medication Changed|0|||
156433239|NCT02477670|564676133|FG001|Stage 2|Antipsychotic Medication Changed|0|||
156528798|NCT04796896|565030961|FG003|Overall Study|Physician Decision|0|||
156528799|NCT04796896|565030962|FG004|Overall Study|Physician Decision|0|||
156528800|NCT04796896|565030963|FG005|Overall Study|Physician Decision|3|||
156528801|NCT04796896|565030964|FG006|Overall Study|Physician Decision|18|||
156528802|NCT04796896|565030965|FG007|Overall Study|Physician Decision|1|||
156528803|NCT04796896|565030966|FG008|Overall Study|Physician Decision|7|||
156528804|NCT04796896|565030967|FG009|Overall Study|Physician Decision|0|||
156528805|NCT04796896|565030968|FG010|Overall Study|Physician Decision|5|||
156528806|NCT04796896|565030969|FG011|Overall Study|Physician Decision|0|||
156528807|NCT04796896|565030958|FG000|Overall Study|Withdrawal by Subject|36|||
156528808|NCT04796896|565030959|FG001|Overall Study|Withdrawal by Subject|31|||
156528809|NCT04796896|565030960|FG002|Overall Study|Withdrawal by Subject|11|||
156528810|NCT04796896|565030961|FG003|Overall Study|Withdrawal by Subject|8|||
156528811|NCT04796896|565030962|FG004|Overall Study|Withdrawal by Subject|16|||
156528812|NCT04796896|565030963|FG005|Overall Study|Withdrawal by Subject|162|||
156528813|NCT04796896|565030964|FG006|Overall Study|Withdrawal by Subject|299|||
156779792|NCT01078662|565943883|FG000|Overall Study|Withdrawal by Subject|4|||
156779793|NCT01078662|565943884|FG001|Overall Study|Withdrawal by Subject|11|||
156779794|NCT01078662|565943885|FG002|Overall Study|Withdrawal by Subject|1|||
156779795|NCT01078662|565943886|FG003|Overall Study|Withdrawal by Subject|0|||
156779796|NCT01078662|565943887|FG004|Overall Study|Withdrawal by Subject|0|||
156433240|NCT02477670|564676134|FG002|Stage 2|Antipsychotic Medication Changed|1|||
156433241|NCT02477670|564676135|FG003|Stage 2|Antipsychotic Medication Changed|0|||
156433242|NCT02477670|564676136|FG004|Stage 2|Antipsychotic Medication Changed|0|||
156433243|NCT02477670|564676137|FG005|Stage 2|Antipsychotic Medication Changed|0|||
156433244|NCT02477670|564676138|FG006|Stage 2|Antipsychotic Medication Changed|0|||
156433245|NCT02477670|564676132|FG000|Stage 2|Withdrawal by Subject|0|||
156433246|NCT02477670|564676133|FG001|Stage 2|Withdrawal by Subject|0|||
156433247|NCT02477670|564676134|FG002|Stage 2|Withdrawal by Subject|0|||
156433248|NCT02477670|564676135|FG003|Stage 2|Withdrawal by Subject|1|||
156433249|NCT02477670|564676136|FG004|Stage 2|Withdrawal by Subject|0|||
156433250|NCT02477670|564676137|FG005|Stage 2|Withdrawal by Subject|0|||
156433251|NCT02477670|564676138|FG006|Stage 2|Withdrawal by Subject|0|||
156433252|NCT00004124|564676139|FG000|Overall Study|Received no protocol therapy|12|||
156433253|NCT00004124|564676140|FG001|Overall Study|Received no protocol therapy|20|||
156433254|NCT02937831|564676141|FG000|Overall Study|Protocol Violation|4|||
156779797|NCT01078662|565943883|FG000|Overall Study|Protocol Violation|0|||
156779798|NCT01078662|565943884|FG001|Overall Study|Protocol Violation|1|||
156779799|NCT01078662|565943885|FG002|Overall Study|Protocol Violation|0|||
156779800|NCT01078662|565943886|FG003|Overall Study|Protocol Violation|0|||
156779801|NCT01078662|565943887|FG004|Overall Study|Protocol Violation|0|||
156779802|NCT01078662|565943883|FG000|Overall Study|Lost to Follow-up|1|||
156779803|NCT01078662|565943884|FG001|Overall Study|Lost to Follow-up|0|||
156433255|NCT02224924|564676146|FG000|Overall Study|Withdrawal by Subject|7|||
156433256|NCT02224924|564676147|FG001|Overall Study|Withdrawal by Subject|6|||
156528814|NCT04796896|565030965|FG007|Overall Study|Withdrawal by Subject|149|||
156779804|NCT01078662|565943885|FG002|Overall Study|Lost to Follow-up|0|||
156779805|NCT01078662|565943886|FG003|Overall Study|Lost to Follow-up|0|||
156779806|NCT01078662|565943887|FG004|Overall Study|Lost to Follow-up|0|||
156779807|NCT00325416|565943888|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
156433257|NCT02224924|564676146|FG000|Overall Study|Biopsy cancelled|20|||
156528815|NCT04796896|565030966|FG008|Overall Study|Withdrawal by Subject|303|||
156433258|NCT02224924|564676147|FG001|Overall Study|Biopsy cancelled|14|||
156433259|NCT02224924|564676146|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
156433260|NCT02224924|564676147|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
156433261|NCT02224924|564676146|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
156433262|NCT02224924|564676147|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
156433263|NCT03923491|564676148|FG000|Overall Study|Lost to Follow-up|5|||
156433264|NCT03923491|564676149|FG001|Overall Study|Lost to Follow-up|8|||
156433265|NCT03923491|564676148|FG000|Overall Study|Withdrawal by Subject|4|||
156433266|NCT03923491|564676149|FG001|Overall Study|Withdrawal by Subject|6|||
156433267|NCT03823300|564676154|FG000|Overall Study|Withdrawal by Subject|16|||
156433268|NCT03823300|564676155|FG001|Overall Study|Withdrawal by Subject|22|||
156433269|NCT03823300|564676154|FG000|Overall Study|Death|10|||
156433270|NCT03823300|564676155|FG001|Overall Study|Death|14|||
156433271|NCT03823300|564676154|FG000|Overall Study|Adverse Event|3|||
156433272|NCT03823300|564676155|FG001|Overall Study|Adverse Event|5|||
156433273|NCT03823300|564676154|FG000|Overall Study|Physician Decision|1|||
156433274|NCT03823300|564676155|FG001|Overall Study|Physician Decision|7|||
156433275|NCT03823300|564676154|FG000|Overall Study|Lost to Follow-up|1|||
156433276|NCT03823300|564676155|FG001|Overall Study|Lost to Follow-up|3|||
156433277|NCT03823300|564676154|FG000|Overall Study|Protocol Violation|1|||
156433278|NCT03823300|564676155|FG001|Overall Study|Protocol Violation|1|||
156433279|NCT03823300|564676154|FG000|Overall Study|Lack of Efficacy|1|||
156433280|NCT03823300|564676155|FG001|Overall Study|Lack of Efficacy|1|||
156433281|NCT03823300|564676154|FG000|Overall Study|Not Eligible|0|||
156433282|NCT03823300|564676155|FG001|Overall Study|Not Eligible|1|||
156433283|NCT03823300|564676154|FG000|Overall Study|Other|1|||
156433284|NCT03823300|564676155|FG001|Overall Study|Other|0|||
156433285|NCT03622580|564676156|FG000|Overall Study|Death|16|||
156433286|NCT03622580|564676157|FG001|Overall Study|Death|21|||
156433287|NCT03622580|564676158|FG002|Overall Study|Death|13|||
156433288|NCT03622580|564676156|FG000|Overall Study|Adverse Event|6|||
156433289|NCT03622580|564676157|FG001|Overall Study|Adverse Event|6|||
156433290|NCT03622580|564676158|FG002|Overall Study|Adverse Event|5|||
156433291|NCT03622580|564676156|FG000|Overall Study|Withdrawal by Subject|12|||
156433292|NCT03622580|564676157|FG001|Overall Study|Withdrawal by Subject|7|||
156433293|NCT03622580|564676158|FG002|Overall Study|Withdrawal by Subject|19|||
156433294|NCT03622580|564676156|FG000|Overall Study|Lost to Follow-up|12|||
156433295|NCT03622580|564676157|FG001|Overall Study|Lost to Follow-up|9|||
156433296|NCT03622580|564676158|FG002|Overall Study|Lost to Follow-up|9|||
156433297|NCT03622580|564676156|FG000|Overall Study|Protocol Violation|1|||
156433298|NCT03622580|564676157|FG001|Overall Study|Protocol Violation|0|||
156433299|NCT03622580|564676158|FG002|Overall Study|Protocol Violation|1|||
156433300|NCT03622580|564676156|FG000|Overall Study|Physician Decision|3|||
156433301|NCT03622580|564676157|FG001|Overall Study|Physician Decision|0|||
156433302|NCT03622580|564676158|FG002|Overall Study|Physician Decision|1|||
156433303|NCT03622580|564676156|FG000|Overall Study|Pregnancy|0|||
156433304|NCT03622580|564676157|FG001|Overall Study|Pregnancy|1|||
156433305|NCT03622580|564676158|FG002|Overall Study|Pregnancy|0|||
156433306|NCT03622580|564676156|FG000|Overall Study|Lack of Efficacy|0|||
156433307|NCT03622580|564676157|FG001|Overall Study|Lack of Efficacy|0|||
156433308|NCT03622580|564676158|FG002|Overall Study|Lack of Efficacy|1|||
156433309|NCT03622580|564676156|FG000|Overall Study|Other|2|||
156433310|NCT03622580|564676157|FG001|Overall Study|Other|0|||
156433311|NCT03622580|564676158|FG002|Overall Study|Other|3|||
156433312|NCT03959241|564676161|FG000|Overall Study|Withdrawal by Subject|7|||
156433313|NCT03959241|564676162|FG001|Overall Study|Withdrawal by Subject|8|||
156433314|NCT03959241|564676161|FG000|Overall Study|Lost to Follow-up|1|||
156779808|NCT00325416|565943889|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
156779809|NCT00325416|565943888|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
156779810|NCT00325416|565943889|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
156779811|NCT00325416|565943888|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
156779812|NCT00325416|565943889|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
156779813|NCT00325416|565943888|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
156433315|NCT03959241|564676162|FG001|Overall Study|Lost to Follow-up|0|||
156779814|NCT00325416|565943889|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
156433316|NCT03959241|564676161|FG000|Overall Study|Move to Hospice Care|1|||
156433317|NCT03959241|564676162|FG001|Overall Study|Move to Hospice Care|0|||
156433318|NCT03959241|564676161|FG000|Overall Study|Screen Failure|1|||
156433319|NCT03959241|564676162|FG001|Overall Study|Screen Failure|0|||
156433320|NCT03959241|564676161|FG000|Overall Study|Disease Relapse|0|||
156433321|NCT03959241|564676162|FG001|Overall Study|Disease Relapse|1|||
156433322|NCT03959241|564676161|FG000|Overall Study|Off Study|1|||
156433323|NCT03959241|564676162|FG001|Overall Study|Off Study|0|||
156433324|NCT01713530|564676166|FG000|Overall Study|Adverse Event|0|||
156433325|NCT01713530|564676167|FG001|Overall Study|Adverse Event|5|||
156433326|NCT01713530|564676166|FG000|Overall Study|Withdrawal criteria|21|||
156433327|NCT01713530|564676167|FG001|Overall Study|Withdrawal criteria|12|||
156433328|NCT01713530|564676166|FG000|Overall Study|Unclassified|4|||
156433329|NCT01713530|564676167|FG001|Overall Study|Unclassified|2|||
156433330|NCT00758602|564676168|FG000|Overall Study|Adverse Event|11|||
156433331|NCT00758602|564676169|FG001|Overall Study|Adverse Event|10|||
156433332|NCT00758602|564676168|FG000|Overall Study|Lost to Follow-up|4|||
156433333|NCT00758602|564676169|FG001|Overall Study|Lost to Follow-up|3|||
156433334|NCT00758602|564676168|FG000|Overall Study|Withdrawal by Subject|1|||
156433335|NCT00758602|564676169|FG001|Overall Study|Withdrawal by Subject|3|||
156433336|NCT00758602|564676168|FG000|Overall Study|Protocol Violation|0|||
156433337|NCT00758602|564676169|FG001|Overall Study|Protocol Violation|2|||
156433338|NCT00758602|564676168|FG000|Overall Study|Death|0|||
156433339|NCT00758602|564676169|FG001|Overall Study|Death|1|||
156433340|NCT00758602|564676168|FG000|Overall Study|Reason not specified|3|||
156433341|NCT00758602|564676169|FG001|Overall Study|Reason not specified|3|||
156433342|NCT05046132|564676170|FG000|Overall Study|Adverse Event|4|||
156433343|NCT05046132|564676171|FG001|Overall Study|Adverse Event|0|||
156433344|NCT05046132|564676172|FG002|Overall Study|Adverse Event|0|||
156433345|NCT05046132|564676170|FG000|Overall Study|Withdrawal by Subject|3|||
156433346|NCT05046132|564676171|FG001|Overall Study|Withdrawal by Subject|0|||
156433347|NCT05046132|564676172|FG002|Overall Study|Withdrawal by Subject|0|||
156433348|NCT05046132|564676170|FG000|Overall Study|Positive Covid19 Result.|0|||
156433349|NCT05046132|564676171|FG001|Overall Study|Positive Covid19 Result.|1|||
156433350|NCT05046132|564676172|FG002|Overall Study|Positive Covid19 Result.|0|||
156433351|NCT02441036|564676173|FG000|Overall Study|No tissue resected|0|||
156779815|NCT00325416|565943888|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
156779816|NCT00325416|565943889|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
156779817|NCT00325416|565943888|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
156779818|NCT00325416|565943889|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
156779819|NCT03018938|565943892|FG000|Overall Study|Death|0|||
156779820|NCT03018938|565943893|FG001|Overall Study|Death|1|||
156779821|NCT03018938|565943892|FG000|Overall Study|Lost to Follow-up|21|||
156779822|NCT03018938|565943893|FG001|Overall Study|Lost to Follow-up|32|||
156779823|NCT03018938|565943892|FG000|Overall Study|Withdrawal by Subject|38|||
156779824|NCT03018938|565943893|FG001|Overall Study|Withdrawal by Subject|45|||
156779825|NCT03018938|565943892|FG000|Overall Study|Physician Decision|3|||
156779826|NCT03018938|565943893|FG001|Overall Study|Physician Decision|2|||
156779827|NCT03018938|565943892|FG000|Overall Study|Sponsor Decision|0|||
156779828|NCT03018938|565943893|FG001|Overall Study|Sponsor Decision|1|||
156779829|NCT03018938|565943892|FG000|Overall Study|Screen failure-After randomization|4|||
156779830|NCT03018938|565943893|FG001|Overall Study|Screen failure-After randomization|2|||
156779831|NCT03018938|565943892|FG000|Overall Study|Not recorded|0|||
156779832|NCT03018938|565943893|FG001|Overall Study|Not recorded|2|||
156779833|NCT00191100|565943896|FG000|Overall Study|Adverse Event|18|||
156779834|NCT00191100|565943897|FG001|Overall Study|Adverse Event|1|||
156779835|NCT00191100|565943896|FG000|Overall Study|Lost to Follow-up|2|||
156779836|NCT00191100|565943897|FG001|Overall Study|Lost to Follow-up|0|||
156779837|NCT00191100|565943896|FG000|Overall Study|Patient Moved|0|||
156779838|NCT00191100|565943897|FG001|Overall Study|Patient Moved|1|||
156779839|NCT00191100|565943896|FG000|Overall Study|Withdrawal by Subject|9|||
156779840|NCT00191100|565943897|FG001|Overall Study|Withdrawal by Subject|3|||
156779841|NCT00191100|565943896|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
156779842|NCT00191100|565943897|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
156779843|NCT00191100|565943896|FG000|Overall Study|Clinical Relapse|2|||
156779844|NCT00191100|565943897|FG001|Overall Study|Clinical Relapse|1|||
156779845|NCT00191100|565943896|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
156779846|NCT00191100|565943897|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
156779847|NCT00191100|565943896|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
156779848|NCT00191100|565943897|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
156779849|NCT00191100|565943896|FG000|Overall Study|Physician Decision|3|||
156779850|NCT00191100|565943897|FG001|Overall Study|Physician Decision|1|||
156779851|NCT00191100|565943896|FG000|Overall Study|Death from Study Drug Toxicity|2|||
156779852|NCT00191100|565943897|FG001|Overall Study|Death from Study Drug Toxicity|0|||
156779853|NCT00191100|565943896|FG000|Overall Study|Protocol Violation|1|||
156779854|NCT00191100|565943897|FG001|Overall Study|Protocol Violation|1|||
156779855|NCT00191100|565943896|FG000|Overall Study|Death from Other Cause|1|||
156779856|NCT00191100|565943897|FG001|Overall Study|Death from Other Cause|0|||
156779857|NCT00191100|565943896|FG000|Overall Study|Reason Not Specified|0|||
156779858|NCT00191100|565943897|FG001|Overall Study|Reason Not Specified|1|||
156779859|NCT02830087|565943898|FG000|Overall Study|No study staff to follow-up patients|4|||
156433352|NCT02441036|564676174|FG001|Overall Study|No tissue resected|1|||
156433353|NCT02441036|564676175|FG002|Overall Study|No tissue resected|0|||
156433354|NCT02441036|564676176|FG003|Overall Study|No tissue resected|1|||
156433355|NCT02441036|564676177|FG004|Overall Study|No tissue resected|0|||
156433356|NCT00855465|564676185|FG000|Treatment Period|Adverse Event|4|||
156433357|NCT00855465|564676186|FG001|Treatment Period|Adverse Event|2|||
156433358|NCT00855465|564676185|FG000|Treatment Period|Death|2|||
156779860|NCT02830087|565943899|FG001|Overall Study|No study staff to follow-up patients|4|||
156779861|NCT02830087|565943900|FG002|Overall Study|No study staff to follow-up patients|4|||
156779862|NCT02830087|565943901|FG003|Overall Study|No study staff to follow-up patients|3|||
156779863|NCT02830087|565943902|FG004|Overall Study|No study staff to follow-up patients|3|||
156779864|NCT02830087|565943903|FG005|Overall Study|No study staff to follow-up patients|3|||
156779865|NCT02872714|565943905|FG000|Overall Study|Progressive Disease|1|||
156779866|NCT02872714|565943906|FG001|Overall Study|Progressive Disease|2|||
156779867|NCT02872714|565943907|FG002|Overall Study|Progressive Disease|0|||
156779868|NCT02872714|565943908|FG003|Overall Study|Progressive Disease|0|||
156779869|NCT02872714|565943909|FG004|Overall Study|Progressive Disease|0|||
156779870|NCT02872714|565943905|FG000|Overall Study|Death|87|||
156779871|NCT02872714|565943906|FG001|Overall Study|Death|36|||
156779872|NCT02872714|565943907|FG002|Overall Study|Death|8|||
156779873|NCT02872714|565943908|FG003|Overall Study|Death|81|||
156779874|NCT02872714|565943909|FG004|Overall Study|Death|2|||
156779875|NCT02872714|565943905|FG000|Overall Study|Lost to Follow-up|2|||
156779876|NCT02872714|565943906|FG001|Overall Study|Lost to Follow-up|1|||
156779877|NCT02872714|565943907|FG002|Overall Study|Lost to Follow-up|0|||
156779878|NCT02872714|565943908|FG003|Overall Study|Lost to Follow-up|3|||
156779879|NCT02872714|565943909|FG004|Overall Study|Lost to Follow-up|0|||
156779880|NCT02872714|565943905|FG000|Overall Study|Physician Decision|0|||
156779881|NCT02872714|565943906|FG001|Overall Study|Physician Decision|0|||
156779882|NCT02872714|565943907|FG002|Overall Study|Physician Decision|0|||
156779883|NCT02872714|565943908|FG003|Overall Study|Physician Decision|1|||
156779884|NCT02872714|565943909|FG004|Overall Study|Physician Decision|0|||
156779885|NCT02872714|565943905|FG000|Overall Study|Withdrawal by Subject|1|||
156779886|NCT02872714|565943906|FG001|Overall Study|Withdrawal by Subject|3|||
156779887|NCT02872714|565943907|FG002|Overall Study|Withdrawal by Subject|0|||
156779888|NCT02872714|565943908|FG003|Overall Study|Withdrawal by Subject|2|||
156779889|NCT02872714|565943909|FG004|Overall Study|Withdrawal by Subject|0|||
156779890|NCT02872714|565943905|FG000|Overall Study|Captured as Other|2|||
156779891|NCT02872714|565943906|FG001|Overall Study|Captured as Other|0|||
156779892|NCT02872714|565943907|FG002|Overall Study|Captured as Other|0|||
156779893|NCT02872714|565943908|FG003|Overall Study|Captured as Other|1|||
156779894|NCT02872714|565943909|FG004|Overall Study|Captured as Other|0|||
156779895|NCT00479232|565944853|FG000|Overall Study|Adverse Event|0|||
156779896|NCT00479232|565944854|FG001|Overall Study|Adverse Event|0|||
156779897|NCT00479232|565944855|FG002|Overall Study|Adverse Event|5|||
156779898|NCT00479232|565944856|FG003|Overall Study|Adverse Event|0|||
156779899|NCT00479232|565944857|FG004|Overall Study|Adverse Event|0|||
156779900|NCT00479232|565944858|FG005|Overall Study|Adverse Event|10|||
156779901|NCT00479232|565944853|FG000|Overall Study|Deviation from Protocol|0|||
156779902|NCT00479232|565944854|FG001|Overall Study|Deviation from Protocol|0|||
156779903|NCT00479232|565944855|FG002|Overall Study|Deviation from Protocol|1|||
156779904|NCT00479232|565944856|FG003|Overall Study|Deviation from Protocol|0|||
156779905|NCT00479232|565944857|FG004|Overall Study|Deviation from Protocol|0|||
156779906|NCT00479232|565944858|FG005|Overall Study|Deviation from Protocol|0|||
156779907|NCT00479232|565944853|FG000|Overall Study|Lack of Efficacy|0|||
156779908|NCT00479232|565944854|FG001|Overall Study|Lack of Efficacy|0|||
156779909|NCT00479232|565944855|FG002|Overall Study|Lack of Efficacy|2|||
156779910|NCT00479232|565944856|FG003|Overall Study|Lack of Efficacy|0|||
156779911|NCT00479232|565944857|FG004|Overall Study|Lack of Efficacy|0|||
156779912|NCT00479232|565944858|FG005|Overall Study|Lack of Efficacy|4|||
156779913|NCT00479232|565944853|FG000|Overall Study|Physician Decision|0|||
156779914|NCT00479232|565944854|FG001|Overall Study|Physician Decision|0|||
156779915|NCT00479232|565944855|FG002|Overall Study|Physician Decision|2|||
156779916|NCT00479232|565944856|FG003|Overall Study|Physician Decision|0|||
156779917|NCT00479232|565944857|FG004|Overall Study|Physician Decision|0|||
156779918|NCT00479232|565944858|FG005|Overall Study|Physician Decision|1|||
156779919|NCT00479232|565944853|FG000|Overall Study|Progressive Disease|3|||
156779920|NCT00479232|565944854|FG001|Overall Study|Progressive Disease|1|||
156779921|NCT00479232|565944855|FG002|Overall Study|Progressive Disease|12|||
156779922|NCT00479232|565944856|FG003|Overall Study|Progressive Disease|3|||
156779923|NCT00479232|565944857|FG004|Overall Study|Progressive Disease|3|||
156779924|NCT00479232|565944858|FG005|Overall Study|Progressive Disease|12|||
156779925|NCT00479232|565944853|FG000|Overall Study|Withdrew Consent|0|||
156779926|NCT00479232|565944854|FG001|Overall Study|Withdrew Consent|2|||
156779927|NCT00479232|565944855|FG002|Overall Study|Withdrew Consent|6|||
156779928|NCT00479232|565944856|FG003|Overall Study|Withdrew Consent|0|||
156779929|NCT00479232|565944857|FG004|Overall Study|Withdrew Consent|1|||
156779930|NCT00479232|565944858|FG005|Overall Study|Withdrew Consent|3|||
156779931|NCT05399771|565944859|FG000|Overall Study|Physician Decision|3|||
156779932|NCT05399771|565944859|FG000|Overall Study|Adverse Event|1|||
156779933|NCT05177094|565944867|FG000|Overall Study|Adverse Event|5|||
156779934|NCT05177094|565944868|FG001|Overall Study|Adverse Event|5|||
156779935|NCT05177094|565944867|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
156779936|NCT05177094|565944868|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
156779937|NCT05177094|565944867|FG000|Overall Study|Protocol Deviation|3|||
156779938|NCT05177094|565944868|FG001|Overall Study|Protocol Deviation|0|||
156779939|NCT05177094|565944867|FG000|Overall Study|Withdrawal by Subject|6|||
156779940|NCT05177094|565944868|FG001|Overall Study|Withdrawal by Subject|3|||
156779941|NCT05177094|565944867|FG000|Overall Study|Participant could not tolerate long study visits|1|||
156779942|NCT05177094|565944868|FG001|Overall Study|Participant could not tolerate long study visits|0|||
156779943|NCT01033942|565944869|FG000|Overall Study|Withdrawal by Subject|1|||
156779944|NCT01033942|565944870|FG001|Overall Study|Withdrawal by Subject|1|||
156779945|NCT01033942|565944871|FG002|Overall Study|Withdrawal by Subject|1|||
156779946|NCT01033942|565944869|FG000|Overall Study|Lost to Follow-up|1|||
156779947|NCT01033942|565944870|FG001|Overall Study|Lost to Follow-up|0|||
156779948|NCT01033942|565944871|FG002|Overall Study|Lost to Follow-up|0|||
156779949|NCT01033942|565944869|FG000|Overall Study|Enrolled in Extension Study|0|||
156779950|NCT01033942|565944870|FG001|Overall Study|Enrolled in Extension Study|3|||
156779951|NCT01033942|565944871|FG002|Overall Study|Enrolled in Extension Study|0|||
156779952|NCT00529035|565944873|FG000|Overall Study|Withdrawal by Subject|1|||
156779953|NCT02493855|565944874|FG000|Overall Study|Non-compliance|1|||
156779954|NCT02493855|565944875|FG001|Overall Study|Non-compliance|0|||
156779955|NCT02493855|565944876|FG002|Overall Study|Non-compliance|0|||
156779956|NCT02493855|565944874|FG000|Overall Study|Adverse Event|0|||
156779957|NCT02493855|565944875|FG001|Overall Study|Adverse Event|1|||
156779958|NCT02493855|565944876|FG002|Overall Study|Adverse Event|0|||
156779959|NCT02493855|565944874|FG000|Overall Study|Withdrawal by Subject|1|||
156779960|NCT02493855|565944875|FG001|Overall Study|Withdrawal by Subject|0|||
156779961|NCT02493855|565944876|FG002|Overall Study|Withdrawal by Subject|0|||
156779962|NCT03086343|565944879|FG000|Period 1|Adverse Event|7|||
156779963|NCT03086343|565944880|FG001|Period 1|Adverse Event|7|||
156779964|NCT03086343|565944881|FG002|Period 1|Adverse Event|0|||
156779965|NCT03086343|565944882|FG003|Period 1|Adverse Event|1|||
156779966|NCT03086343|565944879|FG000|Period 1|Withdrawal by Subject|6|||
156779967|NCT03086343|565944880|FG001|Period 1|Withdrawal by Subject|10|||
156779968|NCT03086343|565944881|FG002|Period 1|Withdrawal by Subject|0|||
156779969|NCT03086343|565944882|FG003|Period 1|Withdrawal by Subject|0|||
156779970|NCT03086343|565944879|FG000|Period 1|Lost to Follow-up|1|||
156779971|NCT03086343|565944880|FG001|Period 1|Lost to Follow-up|3|||
156779972|NCT03086343|565944881|FG002|Period 1|Lost to Follow-up|1|||
156779973|NCT03086343|565944882|FG003|Period 1|Lost to Follow-up|0|||
156779974|NCT03086343|565944879|FG000|Period 1|Other, Not Specified|10|||
156779975|NCT03086343|565944880|FG001|Period 1|Other, Not Specified|12|||
156779976|NCT03086343|565944881|FG002|Period 1|Other, Not Specified|2|||
156779977|NCT03086343|565944882|FG003|Period 1|Other, Not Specified|1|||
156779978|NCT03086343|565944879|FG000|Period 1|Missing|1|||
156779979|NCT03086343|565944880|FG001|Period 1|Missing|0|||
156779980|NCT03086343|565944881|FG002|Period 1|Missing|0|||
156779981|NCT03086343|565944882|FG003|Period 1|Missing|0|||
156779982|NCT03086343|565944879|FG000|Period 2|Adverse Event|20|||
156779983|NCT03086343|565944880|FG001|Period 2|Adverse Event|11|||
156779984|NCT03086343|565944881|FG002|Period 2|Adverse Event|1|||
156779985|NCT03086343|565944882|FG003|Period 2|Adverse Event|2|||
156779986|NCT03086343|565944879|FG000|Period 2|Withdrawal by Subject|15|||
156779987|NCT03086343|565944880|FG001|Period 2|Withdrawal by Subject|25|||
156779988|NCT03086343|565944881|FG002|Period 2|Withdrawal by Subject|2|||
156779989|NCT03086343|565944882|FG003|Period 2|Withdrawal by Subject|2|||
156779990|NCT03086343|565944879|FG000|Period 2|Lost to Follow-up|6|||
156779991|NCT03086343|565944880|FG001|Period 2|Lost to Follow-up|11|||
156779992|NCT03086343|565944881|FG002|Period 2|Lost to Follow-up|1|||
156779993|NCT03086343|565944882|FG003|Period 2|Lost to Follow-up|0|||
156779994|NCT03086343|565944879|FG000|Period 2|COVID-19 Infection|5|||
156779995|NCT03086343|565944880|FG001|Period 2|COVID-19 Infection|0|||
156779996|NCT03086343|565944881|FG002|Period 2|COVID-19 Infection|0|||
156779997|NCT03086343|565944882|FG003|Period 2|COVID-19 Infection|0|||
156779998|NCT03086343|565944879|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
156779999|NCT03086343|565944880|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
156780000|NCT03086343|565944881|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
156780001|NCT03086343|565944882|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
156780002|NCT03086343|565944879|FG000|Period 2|Other, Not Specified|23|||
156780003|NCT03086343|565944880|FG001|Period 2|Other, Not Specified|22|||
156780004|NCT03086343|565944881|FG002|Period 2|Other, Not Specified|2|||
156780005|NCT03086343|565944882|FG003|Period 2|Other, Not Specified|4|||
156780006|NCT04900272|565944883|FG000|Overall Study|Lost to Follow-up|2|||
156780007|NCT04900272|565944883|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
156780008|NCT04900272|565944883|FG000|Overall Study|Withdrawal by Subject|1|||
156780009|NCT01625182|565944885|FG000|Overall Study|Administrative problems|1|||
156338192|NCT01235689|564336578|FG000|Overall Study|Adverse Event|12|||
156338193|NCT01235689|564336579|FG001|Overall Study|Adverse Event|16|||
156338194|NCT01235689|564336578|FG000|Overall Study|Lack of Efficacy|12|||
156780010|NCT01625182|565944886|FG001|Overall Study|Administrative problems|0|||
156780011|NCT01625182|565944885|FG000|Overall Study|Protocol deviation|0|||
156780012|NCT01625182|565944886|FG001|Overall Study|Protocol deviation|2|||
156780013|NCT01625182|565944885|FG000|Overall Study|Adverse Event|2|||
156780014|NCT01625182|565944886|FG001|Overall Study|Adverse Event|0|||
156780015|NCT01625182|565944885|FG000|Overall Study|Withdrawal by Subject|5|||
156780016|NCT01625182|565944886|FG001|Overall Study|Withdrawal by Subject|1|||
156780017|NCT01625182|565944885|FG000|Overall Study|Lack of Efficacy|12|||
156780018|NCT01625182|565944886|FG001|Overall Study|Lack of Efficacy|8|||
156433359|NCT00855465|564676186|FG001|Treatment Period|Death|2|||
156433360|NCT00855465|564676185|FG000|Treatment Period|Lack of Efficacy|2|||
156433361|NCT00855465|564676186|FG001|Treatment Period|Lack of Efficacy|1|||
156780019|NCT05059080|565944887|FG000|Overall Study|Withdrawal by Subject|3|||
156780020|NCT05059080|565944887|FG000|Overall Study|Study Terminated by Sponsor|64|||
156780021|NCT01047501|565944888|FG000|Overall Study|Adverse Event|7|||
156780022|NCT01047501|565944889|FG001|Overall Study|Adverse Event|8|||
156780023|NCT01047501|565944890|FG002|Overall Study|Adverse Event|5|||
156780024|NCT01047501|565944888|FG000|Overall Study|Withdrew Consent|6|||
156780025|NCT01047501|565944889|FG001|Overall Study|Withdrew Consent|2|||
156780026|NCT01047501|565944890|FG002|Overall Study|Withdrew Consent|4|||
156780027|NCT01047501|565944888|FG000|Overall Study|Lost to Follow-up|0|||
156780028|NCT01047501|565944889|FG001|Overall Study|Lost to Follow-up|1|||
156780029|NCT01047501|565944890|FG002|Overall Study|Lost to Follow-up|1|||
156780030|NCT01047501|565944888|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
156780031|NCT01047501|565944889|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
156780032|NCT01047501|565944890|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
156780033|NCT01047501|565944888|FG000|Overall Study|Death|1|||
156780034|NCT01047501|565944889|FG001|Overall Study|Death|0|||
156780035|NCT01047501|565944890|FG002|Overall Study|Death|0|||
156780036|NCT01047501|565944888|FG000|Overall Study|Other discontinuation|1|||
156780037|NCT01047501|565944889|FG001|Overall Study|Other discontinuation|0|||
156780038|NCT01047501|565944890|FG002|Overall Study|Other discontinuation|1|||
156780039|NCT01047501|565944888|FG000|Overall Study|Investigator judgement|0|||
156780040|NCT01047501|565944889|FG001|Overall Study|Investigator judgement|0|||
156780041|NCT01047501|565944890|FG002|Overall Study|Investigator judgement|1|||
156780042|NCT02447029|565944891|FG000|Overall Study|Withdrawal by Subject|3|||
156780043|NCT02447029|565944892|FG001|Overall Study|Withdrawal by Subject|2|||
156780044|NCT03600428|565944896|FG000|Overall Study|Not eligible|0|||
156780045|NCT03600428|565944897|FG001|Overall Study|Not eligible|1|||
156780046|NCT03600428|565944896|FG000|Overall Study|Lost to Follow-up|5|||
156780047|NCT03600428|565944897|FG001|Overall Study|Lost to Follow-up|4|||
156780048|NCT01666652|565944901|FG000|Overall Study|Serious Adverse Event|0|||
156780049|NCT01666652|565944902|FG001|Overall Study|Serious Adverse Event|0|||
156780050|NCT01666652|565944903|FG002|Overall Study|Serious Adverse Event|0|||
156780051|NCT01666652|565944904|FG003|Overall Study|Serious Adverse Event|1|||
156780052|NCT01666652|565944905|FG004|Overall Study|Serious Adverse Event|0|||
156780053|NCT01666652|565944901|FG000|Overall Study|Withdrawal by Subject|0|||
156780054|NCT01666652|565944902|FG001|Overall Study|Withdrawal by Subject|0|||
156780055|NCT01666652|565944903|FG002|Overall Study|Withdrawal by Subject|0|||
156780056|NCT01666652|565944904|FG003|Overall Study|Withdrawal by Subject|0|||
156780057|NCT01666652|565944905|FG004|Overall Study|Withdrawal by Subject|1|||
156780058|NCT01666652|565944901|FG000|Overall Study|Moved from study area|1|||
156780059|NCT01666652|565944902|FG001|Overall Study|Moved from study area|0|||
156780060|NCT01666652|565944903|FG002|Overall Study|Moved from study area|0|||
156780061|NCT01666652|565944904|FG003|Overall Study|Moved from study area|2|||
156780062|NCT01666652|565944905|FG004|Overall Study|Moved from study area|0|||
156780063|NCT01666652|565944901|FG000|Overall Study|Lost to Follow-up|1|||
156780064|NCT01666652|565944902|FG001|Overall Study|Lost to Follow-up|1|||
156780065|NCT01666652|565944903|FG002|Overall Study|Lost to Follow-up|1|||
156780066|NCT01666652|565944904|FG003|Overall Study|Lost to Follow-up|1|||
156780067|NCT01666652|565944905|FG004|Overall Study|Lost to Follow-up|0|||
156780068|NCT00088153|565944906|FG000|Overall Study|Physician Decision|3|||
156780069|NCT00088153|565944907|FG001|Overall Study|Physician Decision|3|||
156780070|NCT00088153|565944906|FG000|Overall Study|Withdrawal by Subject|10|||
156780071|NCT00088153|565944907|FG001|Overall Study|Withdrawal by Subject|10|||
156780072|NCT00088153|565944906|FG000|Overall Study|Lost to Follow-up|11|||
156780073|NCT00088153|565944907|FG001|Overall Study|Lost to Follow-up|12|||
156780074|NCT01695746|565944908|FG000|Overall Study|Adverse Event|1|||
156780075|NCT01695746|565944908|FG000|Overall Study|Non-compliance by the participant|3|||
156780076|NCT01695746|565944908|FG000|Overall Study|Protocol Violation|5|||
156780077|NCT01695746|565944908|FG000|Overall Study|Participant not willing to participate|3|||
156780078|NCT04598828|565944909|FG000|Overall Study|Physician Decision|1|||
156780079|NCT04598828|565944910|FG001|Overall Study|Physician Decision|0|||
156780080|NCT04598828|565944909|FG000|Overall Study|Withdrawal by Subject|0|||
156780081|NCT04598828|565944910|FG001|Overall Study|Withdrawal by Subject|1|||
156780082|NCT04598828|565944909|FG000|Overall Study|Withdrawal by Subject|0|||
156780083|NCT04598828|565944910|FG001|Overall Study|Withdrawal by Subject|1|||
156780084|NCT02324153|565944911|FG000|Overall Study|Withdrawal by Subject|4|||
156780085|NCT02324153|565944912|FG001|Overall Study|Withdrawal by Subject|1|||
156780086|NCT02324153|565944911|FG000|Overall Study|Surgery postponed after randomization|3|||
156780087|NCT02324153|565944912|FG001|Overall Study|Surgery postponed after randomization|0|||
156780088|NCT02324153|565944911|FG000|Overall Study|Developed delirium preoperatively|1|||
156780089|NCT02324153|565944912|FG001|Overall Study|Developed delirium preoperatively|0|||
156780090|NCT01937299|565944916|FG000|Overall Study|Adverse Event|13|||
156780091|NCT01937299|565944917|FG001|Overall Study|Adverse Event|0|||
156780092|NCT01937299|565944916|FG000|Overall Study|Lack of Efficacy|0|||
156780093|NCT01937299|565944917|FG001|Overall Study|Lack of Efficacy|4|||
156780094|NCT01937299|565944916|FG000|Overall Study|Withdrawal by Subject|1|||
156780095|NCT01937299|565944917|FG001|Overall Study|Withdrawal by Subject|0|||
156780096|NCT04017962|565944918|FG000|Overall Study|Death|2|||
156780097|NCT04017962|565944919|FG001|Overall Study|Death|0|||
156780098|NCT04017962|565944918|FG000|Overall Study|Lost to Follow-up|2|||
156780099|NCT04017962|565944919|FG001|Overall Study|Lost to Follow-up|0|||
156780100|NCT04017962|565944918|FG000|Overall Study|Physician Decision|1|||
156780101|NCT04017962|565944919|FG001|Overall Study|Physician Decision|0|||
156780102|NCT04017962|565944918|FG000|Overall Study|Discontinued LTV|5|||
156780103|NCT04017962|565944919|FG001|Overall Study|Discontinued LTV|0|||
156780104|NCT00700635|565944920|FG000|Overall Study|Adverse Event|1|||
156780105|NCT00700635|565944921|FG001|Overall Study|Adverse Event|0|||
156780106|NCT00700635|565944922|FG002|Overall Study|Adverse Event|0|||
156780107|NCT00700635|565944920|FG000|Overall Study|Lost to Follow-up|1|||
156780108|NCT00700635|565944921|FG001|Overall Study|Lost to Follow-up|3|||
156780109|NCT00700635|565944922|FG002|Overall Study|Lost to Follow-up|0|||
156780110|NCT00700635|565944920|FG000|Overall Study|Protocol Violation|2|||
156780111|NCT00700635|565944921|FG001|Overall Study|Protocol Violation|2|||
156780112|NCT00700635|565944922|FG002|Overall Study|Protocol Violation|0|||
156780113|NCT00700635|565944920|FG000|Overall Study|Withdrawal by Subject|7|||
156780114|NCT00700635|565944921|FG001|Overall Study|Withdrawal by Subject|3|||
156780115|NCT00700635|565944922|FG002|Overall Study|Withdrawal by Subject|1|||
156780116|NCT01260948|565944924|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
156780117|NCT01260948|565944925|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
156780118|NCT01260948|565944924|FG000|Second Intervention|Emesis|0|||
156780119|NCT01260948|565944925|FG001|Second Intervention|Emesis|1|||
156780120|NCT00768053|565944926|FG000|Overall Study|Adverse Event|10|||
156780121|NCT00768053|565944926|FG000|Overall Study|Lost to Follow-up|1|||
156780122|NCT01202591|565944927|FG000|Overall Study|Adverse Event|2|||
156780123|NCT01202591|565944928|FG001|Overall Study|Adverse Event|1|||
156780124|NCT01202591|565944929|FG002|Overall Study|Adverse Event|4|||
156780125|NCT01202591|565944930|FG003|Overall Study|Adverse Event|4|||
156433362|NCT00855465|564676185|FG000|Treatment Period|Non-compliance|1|||
156433363|NCT00855465|564676186|FG001|Treatment Period|Non-compliance|0|||
156433364|NCT00855465|564676185|FG000|Treatment Period|Protocol Violation|2|||
156433365|NCT00855465|564676186|FG001|Treatment Period|Protocol Violation|0|||
156433366|NCT00855465|564676185|FG000|Treatment Period|Withdrawal by Subject|2|||
156433367|NCT00855465|564676186|FG001|Treatment Period|Withdrawal by Subject|0|||
156433368|NCT00855465|564676185|FG000|Treatment Period|Not treated|1|||
156433369|NCT00855465|564676186|FG001|Treatment Period|Not treated|0|||
156433370|NCT00855465|564676185|FG000|Follow-up Period (FUP)|Adverse Event|0|||
156433371|NCT00855465|564676186|FG001|Follow-up Period (FUP)|Adverse Event|1|||
156433372|NCT00855465|564676185|FG000|Follow-up Period (FUP)|Death|0|||
156433373|NCT00855465|564676186|FG001|Follow-up Period (FUP)|Death|1|||
156433374|NCT00855465|564676185|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
156433375|NCT00855465|564676186|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
156433376|NCT00855465|564676185|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
156433377|NCT00855465|564676186|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
156433378|NCT00855465|564676185|FG000|Follow-up Period (FUP)|Missing|1|||
156433379|NCT00855465|564676186|FG001|Follow-up Period (FUP)|Missing|0|||
156433380|NCT03743246|564676187|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
156433381|NCT03743246|564676188|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
156433382|NCT03743246|564676189|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
156433383|NCT03743246|564676190|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
156433384|NCT03743246|564676187|FG000|Pre-Treatment Period|Death|0|||
156433385|NCT03743246|564676188|FG001|Pre-Treatment Period|Death|1|||
156780126|NCT01202591|565944931|FG004|Overall Study|Adverse Event|0|||
156780127|NCT01202591|565944932|FG005|Overall Study|Adverse Event|0|||
156780128|NCT01202591|565944927|FG000|Overall Study|Other reason as per investigator|3|||
156433386|NCT03743246|564676189|FG002|Pre-Treatment Period|Death|0|||
156433387|NCT03743246|564676190|FG003|Pre-Treatment Period|Death|1|||
156433388|NCT03743246|564676187|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
156433389|NCT03743246|564676188|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
156433390|NCT03743246|564676189|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
156780129|NCT01202591|565944928|FG001|Overall Study|Other reason as per investigator|4|||
156780130|NCT01202591|565944929|FG002|Overall Study|Other reason as per investigator|7|||
156780131|NCT01202591|565944930|FG003|Overall Study|Other reason as per investigator|3|||
156780132|NCT01202591|565944931|FG004|Overall Study|Other reason as per investigator|1|||
156780133|NCT01202591|565944932|FG005|Overall Study|Other reason as per investigator|3|||
156780134|NCT01202591|565944927|FG000|Overall Study|Withdrawal by Subject|0|||
156780135|NCT01202591|565944928|FG001|Overall Study|Withdrawal by Subject|0|||
156780136|NCT01202591|565944929|FG002|Overall Study|Withdrawal by Subject|0|||
156780137|NCT01202591|565944930|FG003|Overall Study|Withdrawal by Subject|0|||
156780138|NCT01202591|565944931|FG004|Overall Study|Withdrawal by Subject|2|||
156780139|NCT01202591|565944932|FG005|Overall Study|Withdrawal by Subject|1|||
156433391|NCT03743246|564676190|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
156433392|NCT03743246|564676187|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
156780140|NCT01202591|565944927|FG000|Overall Study|Objective Disease Progression|0|||
156780141|NCT01202591|565944928|FG001|Overall Study|Objective Disease Progression|0|||
156780142|NCT01202591|565944929|FG002|Overall Study|Objective Disease Progression|0|||
156780143|NCT01202591|565944930|FG003|Overall Study|Objective Disease Progression|0|||
156780144|NCT01202591|565944931|FG004|Overall Study|Objective Disease Progression|2|||
156780145|NCT01202591|565944932|FG005|Overall Study|Objective Disease Progression|0|||
156780146|NCT03580928|565944935|FG000|Overall Study|Death|0|||
156780147|NCT03580928|565944936|FG001|Overall Study|Death|3|||
156780148|NCT03580928|565944935|FG000|Overall Study|Withdrawal by Subject|2|||
156780149|NCT03580928|565944936|FG001|Overall Study|Withdrawal by Subject|1|||
156780150|NCT03580928|565944935|FG000|Overall Study|Lost to Follow-up|2|||
156780151|NCT03580928|565944936|FG001|Overall Study|Lost to Follow-up|0|||
156780152|NCT03580928|565944935|FG000|Overall Study|Progressive Disease|0|||
156780153|NCT03580928|565944936|FG001|Overall Study|Progressive Disease|1|||
156780154|NCT04633447|565946168|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
156780155|NCT04633447|565946169|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
156780156|NCT04633447|565946168|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
156780157|NCT04633447|565946169|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
156780158|NCT04633447|565946168|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
156780159|NCT04633447|565946169|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
156780160|NCT04633447|565946168|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
156780161|NCT04633447|565946169|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
156780162|NCT04633447|565946168|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
156780163|NCT04633447|565946169|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
156780164|NCT04633447|565946168|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
156780165|NCT04633447|565946169|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
156780166|NCT03807843|565946171|FG000|Overall Study|Lost to Follow-up|1|||
156780167|NCT03807843|565946172|FG001|Overall Study|Lost to Follow-up|0|||
156780168|NCT05276804|565946181|FG000|Overall Study|screen failure|23|||
156780169|NCT05276804|565946182|FG001|Overall Study|screen failure|0|||
156780170|NCT00898807|565946183|FG000|Overall Study|Withdrawal by Subject|5|||
156780171|NCT00898807|565946184|FG001|Overall Study|Withdrawal by Subject|3|||
156780172|NCT00898807|565946183|FG000|Overall Study|Family pressure to discontinue|2|||
156780173|NCT00898807|565946184|FG001|Overall Study|Family pressure to discontinue|2|||
156780174|NCT00898807|565946183|FG000|Overall Study|Lost to Follow-up|1|||
156780175|NCT00898807|565946184|FG001|Overall Study|Lost to Follow-up|3|||
156780176|NCT00898807|565946183|FG000|Overall Study|Death|0|||
156780177|NCT00898807|565946184|FG001|Overall Study|Death|1|||
156780178|NCT01482221|565946187|FG000|Overall Study|Lack of Efficacy|1|||
156780179|NCT01482221|565946188|FG001|Overall Study|Lack of Efficacy|0|||
156780180|NCT01482221|565946189|FG002|Overall Study|Lack of Efficacy|1|||
156780181|NCT01482221|565946187|FG000|Overall Study|Lost to Follow-up|3|||
156780182|NCT01482221|565946188|FG001|Overall Study|Lost to Follow-up|2|||
156433393|NCT03743246|564676188|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
156433394|NCT03743246|564676189|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
156433395|NCT03743246|564676190|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
156433396|NCT03743246|564676187|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
156433397|NCT03743246|564676188|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
156433398|NCT03743246|564676189|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
156433399|NCT03743246|564676190|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
156433400|NCT03743246|564676187|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
156433401|NCT03743246|564676188|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
156433402|NCT03743246|564676189|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
156433403|NCT03743246|564676190|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
156433404|NCT03743246|564676187|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
156433405|NCT03743246|564676188|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
156433406|NCT03743246|564676189|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
156433407|NCT03743246|564676190|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
156433408|NCT03743246|564676187|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
156433409|NCT03743246|564676188|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
156433410|NCT03743246|564676189|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
156433411|NCT03743246|564676190|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
156780183|NCT01482221|565946189|FG002|Overall Study|Lost to Follow-up|1|||
156780184|NCT01482221|565946187|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
156780185|NCT01482221|565946188|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
156780186|NCT01482221|565946189|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
156780187|NCT01482221|565946187|FG000|Overall Study|Condition under Investigation Worsened|3|||
156780188|NCT01482221|565946188|FG001|Overall Study|Condition under Investigation Worsened|2|||
156780189|NCT01482221|565946189|FG002|Overall Study|Condition under Investigation Worsened|4|||
156433412|NCT03743246|564676187|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
156433413|NCT03743246|564676188|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
156433414|NCT03743246|564676189|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
156433415|NCT03743246|564676190|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
156433416|NCT01596504|564676191|FG000|Overall Study|Participant's Private Reason|0|||
156433417|NCT01596504|564676192|FG001|Overall Study|Participant's Private Reason|1|||
156433418|NCT01596504|564676193|FG002|Overall Study|Participant's Private Reason|0|||
156433419|NCT01596504|564676191|FG000|Overall Study|Adverse Event|1|||
156675376|NCT00902538|565554920|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
156675377|NCT00902538|565554921|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
156675378|NCT00902538|565554922|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
156675379|NCT00902538|565554923|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
156675380|NCT03531827|565554924|FG000|Overall Study|Adverse Event|2|||
156780190|NCT01482221|565946187|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
156780191|NCT01482221|565946188|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
156780192|NCT01482221|565946189|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
156780193|NCT01482221|565946187|FG000|Overall Study|Adverse Event|1|||
156780194|NCT01482221|565946188|FG001|Overall Study|Adverse Event|7|||
156780195|NCT01482221|565946189|FG002|Overall Study|Adverse Event|3|||
156780196|NCT01482221|565946187|FG000|Overall Study|Withdrawal by Subject|10|||
156780197|NCT01482221|565946188|FG001|Overall Study|Withdrawal by Subject|7|||
156780198|NCT01482221|565946189|FG002|Overall Study|Withdrawal by Subject|12|||
156780199|NCT01482221|565946187|FG000|Overall Study|Incorrect randomization|0|||
156780200|NCT01482221|565946188|FG001|Overall Study|Incorrect randomization|1|||
156780201|NCT01482221|565946189|FG002|Overall Study|Incorrect randomization|0|||
156780202|NCT01482221|565946187|FG000|Overall Study|Physician Decision|0|||
156780203|NCT01482221|565946188|FG001|Overall Study|Physician Decision|1|||
156780204|NCT01482221|565946189|FG002|Overall Study|Physician Decision|0|||
156780205|NCT00263562|565946190|FG000|Overall Study|Protocol Violation|3|||
156780206|NCT00263562|565946191|FG001|Overall Study|Protocol Violation|0|||
156780207|NCT04602000|565946192|FG000|Overall Study|Withdrawal by Subject|3|||
156780208|NCT04602000|565946193|FG001|Overall Study|Withdrawal by Subject|6|||
156780209|NCT04602000|565946194|FG002|Overall Study|Withdrawal by Subject|3|||
156780210|NCT04602000|565946195|FG003|Overall Study|Withdrawal by Subject|27|||
156780211|NCT04602000|565946196|FG004|Overall Study|Withdrawal by Subject|39|||
156780212|NCT04602000|565946192|FG000|Overall Study|Physician Decision|1|||
156780213|NCT04602000|565946193|FG001|Overall Study|Physician Decision|0|||
156780214|NCT04602000|565946194|FG002|Overall Study|Physician Decision|0|||
156780215|NCT04602000|565946195|FG003|Overall Study|Physician Decision|2|||
156780216|NCT04602000|565946196|FG004|Overall Study|Physician Decision|2|||
156780217|NCT04602000|565946192|FG000|Overall Study|Death|0|||
156780218|NCT04602000|565946193|FG001|Overall Study|Death|1|||
156780219|NCT04602000|565946194|FG002|Overall Study|Death|0|||
156780220|NCT04602000|565946195|FG003|Overall Study|Death|1|||
156780221|NCT04602000|565946196|FG004|Overall Study|Death|2|||
156780222|NCT04602000|565946192|FG000|Overall Study|Lost to Follow-up|0|||
156780223|NCT04602000|565946193|FG001|Overall Study|Lost to Follow-up|0|||
156780224|NCT04602000|565946194|FG002|Overall Study|Lost to Follow-up|0|||
156780225|NCT04602000|565946195|FG003|Overall Study|Lost to Follow-up|3|||
156780226|NCT04602000|565946196|FG004|Overall Study|Lost to Follow-up|4|||
156780227|NCT04602000|565946192|FG000|Overall Study|Other|4|||
156780228|NCT04602000|565946193|FG001|Overall Study|Other|1|||
156780229|NCT04602000|565946194|FG002|Overall Study|Other|2|||
156780230|NCT04602000|565946195|FG003|Overall Study|Other|5|||
156780231|NCT04602000|565946196|FG004|Overall Study|Other|4|||
156780232|NCT04602000|565946192|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
156780233|NCT04602000|565946193|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
156780234|NCT04602000|565946194|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
156780235|NCT04602000|565946195|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
156780236|NCT04602000|565946196|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
156780237|NCT05607043|565946197|FG000|Overall Study|Lost to Follow-up|2|||
156780238|NCT05427916|565946204|FG000|Overall Study|Adverse Event|3|||
156780239|NCT05427916|565946205|FG001|Overall Study|Adverse Event|0|||
156675381|NCT03531827|565554925|FG001|Overall Study|Adverse Event|0|||
156675382|NCT03531827|565554924|FG000|Overall Study|Progressive disease|1|||
156780240|NCT05427916|565946204|FG000|Overall Study|Lack of Efficacy|6|||
156780241|NCT05427916|565946205|FG001|Overall Study|Lack of Efficacy|0|||
156780242|NCT05427916|565946204|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
156780243|NCT05427916|565946205|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
156675383|NCT03531827|565554925|FG001|Overall Study|Progressive disease|0|||
156675384|NCT03067987|565554926|FG000|Overall Study|Lost to Follow-up|7|||
156780244|NCT00429299|565946208|FG000|Overall Study|Disease Progression|1|||
156780245|NCT00429299|565946209|FG001|Overall Study|Disease Progression|1|||
156780246|NCT00429299|565946210|FG002|Overall Study|Disease Progression|0|||
156780247|NCT00429299|565946208|FG000|Overall Study|Adverse Event|2|||
156433420|NCT01596504|564676192|FG001|Overall Study|Adverse Event|2|||
156433421|NCT01596504|564676193|FG002|Overall Study|Adverse Event|1|||
156433422|NCT01596504|564676191|FG000|Overall Study|Withdrawal by Subject|1|||
156433423|NCT01596504|564676192|FG001|Overall Study|Withdrawal by Subject|0|||
156433424|NCT01596504|564676193|FG002|Overall Study|Withdrawal by Subject|0|||
156433425|NCT04173572|564676194|FG000|Overall Study|Withdrawal by Subject|1|||
156433426|NCT04173572|564676195|FG001|Overall Study|Withdrawal by Subject|5|||
156780248|NCT00429299|565946209|FG001|Overall Study|Adverse Event|5|||
156780249|NCT00429299|565946210|FG002|Overall Study|Adverse Event|1|||
156780250|NCT00429299|565946208|FG000|Overall Study|Protocol Violation|1|||
156780251|NCT00429299|565946209|FG001|Overall Study|Protocol Violation|0|||
156780252|NCT00429299|565946210|FG002|Overall Study|Protocol Violation|0|||
156780253|NCT00429299|565946208|FG000|Overall Study|Withdrawal by Subject|0|||
156780254|NCT00429299|565946209|FG001|Overall Study|Withdrawal by Subject|1|||
156780255|NCT00429299|565946210|FG002|Overall Study|Withdrawal by Subject|3|||
156780256|NCT04871113|565946211|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780257|NCT04871113|565946212|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780258|NCT04871113|565946213|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780259|NCT04871113|565946214|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780260|NCT04871113|565946215|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780261|NCT04871113|565946216|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
156780262|NCT04871113|565946217|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780263|NCT04871113|565946218|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780264|NCT04871113|565946219|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780265|NCT04871113|565946220|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780266|NCT04871113|565946211|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780267|NCT04871113|565946212|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780268|NCT04871113|565946213|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780269|NCT04871113|565946214|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780270|NCT04871113|565946215|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780271|NCT04871113|565946216|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780272|NCT04871113|565946217|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
156780273|NCT04871113|565946218|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
156780274|NCT04871113|565946219|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780275|NCT04871113|565946220|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780276|NCT01257542|565946221|FG000|Overall Study|Protocol Violation|3|||
156780277|NCT01257542|565946222|FG001|Overall Study|Protocol Violation|5|||
156780278|NCT01257542|565946221|FG000|Overall Study|Withdrawal by Subject|0|||
156780279|NCT01257542|565946222|FG001|Overall Study|Withdrawal by Subject|2|||
156780280|NCT00549328|565946226|FG000|Overall Study|Adverse Event|2|||
156780281|NCT00549328|565946226|FG000|Overall Study|Disease Progression|10|||
156780282|NCT00549328|565946226|FG000|Overall Study|Death|1|||
156780283|NCT00549328|565946226|FG000|Overall Study|Use of Prohibited Medication|1|||
156780284|NCT00770484|565946227|FG000|Overall Study|Withdrawal by Subject|1|||
156780285|NCT00770484|565946228|FG001|Overall Study|Withdrawal by Subject|0|||
156780286|NCT00153920|565946229|FG000|Overall Study|Adverse Event|9|||
156780287|NCT00153920|565946229|FG000|Overall Study|Progressive Disease|9|||
156780288|NCT00153920|565946229|FG000|Overall Study|Physician Decision|3|||
156780289|NCT00153920|565946229|FG000|Overall Study|Lack of Response|3|||
156780290|NCT00153920|565946229|FG000|Overall Study|Death|2|||
156780291|NCT00153920|565946229|FG000|Overall Study|Withdrawal by Subject|1|||
156780292|NCT00153920|565946229|FG000|Overall Study|Non-Protocol Therapy|1|||
156780293|NCT00153920|565946229|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
156780294|NCT00153920|565946229|FG000|Overall Study|Progressive Disease before Trt|1|||
156780295|NCT05630755|565946230|FG000|Overall Study|Lost to Follow-up|7|||
156780296|NCT05630755|565946231|FG001|Overall Study|Lost to Follow-up|0|||
156780297|NCT05630755|565946230|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
156780298|NCT05630755|565946231|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
156780299|NCT05630755|565946230|FG000|Overall Study|Withdrawal by Subject|9|||
156780300|NCT05630755|565946231|FG001|Overall Study|Withdrawal by Subject|3|||
156780301|NCT05630755|565946230|FG000|Overall Study|Participant moved away from trial site|0|||
156780302|NCT05630755|565946231|FG001|Overall Study|Participant moved away from trial site|1|||
156780303|NCT05630755|565946230|FG000|Overall Study|Status not Recorded|316|||
156780304|NCT05630755|565946231|FG001|Overall Study|Status not Recorded|161|||
156780305|NCT04868682|565946232|FG000|Post-treatment|Lost to Follow-up|1|||
156780306|NCT04868682|565946233|FG001|Post-treatment|Lost to Follow-up|1|||
156780307|NCT04868682|565946232|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
156780308|NCT04868682|565946233|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
156433427|NCT04173572|564676194|FG000|Overall Study|Lost to Follow-up|3|||
156780309|NCT04868682|565946232|FG000|Six-month Assessment|Lost to Follow-up|1|||
156433428|NCT04173572|564676195|FG001|Overall Study|Lost to Follow-up|1|||
156780310|NCT04868682|565946233|FG001|Six-month Assessment|Lost to Follow-up|0|||
156780311|NCT04868682|565946232|FG000|Six-month Assessment|Death|1|||
156780312|NCT04868682|565946233|FG001|Six-month Assessment|Death|0|||
156780313|NCT04868682|565946232|FG000|Six-month Assessment|Refused|0|||
156780314|NCT04868682|565946233|FG001|Six-month Assessment|Refused|1|||
156780315|NCT04868682|565946232|FG000|12-month Assessment|Lost to Follow-up|2|||
156780316|NCT04868682|565946233|FG001|12-month Assessment|Lost to Follow-up|1|||
156780317|NCT04868682|565946232|FG000|12-month Assessment|Death|0|||
156780318|NCT04868682|565946233|FG001|12-month Assessment|Death|1|||
156780319|NCT03384966|565946234|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
156780320|NCT03384966|565946235|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
156780321|NCT03384966|565946236|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
156780322|NCT03384966|565946234|FG000|Follow-up Period|Adverse Event|1|||
156780323|NCT03384966|565946235|FG001|Follow-up Period|Adverse Event|0|||
156780324|NCT03384966|565946236|FG002|Follow-up Period|Adverse Event|0|||
156780325|NCT03880565|565946237|FG000|Overall Study|Withdrawal by Subject|1|||
156780326|NCT03880565|565946238|FG001|Overall Study|Withdrawal by Subject|0|||
156780327|NCT02202616|565946239|FG000|Overall Study|Screen failed|24|||
156780328|NCT02202616|565946239|FG000|Overall Study|Adverse Event|32|||
156780329|NCT02202616|565946239|FG000|Overall Study|Protocol deviation|18|||
156780330|NCT02202616|565946239|FG000|Overall Study|Patient withdrew consent|12|||
156780331|NCT02202616|565946239|FG000|Overall Study|Lost to Follow-up|6|||
156780332|NCT02202616|565946239|FG000|Overall Study|Administrative problems|6|||
156780333|NCT02202616|565946239|FG000|Overall Study|Abnormal test procedure result|1|||
156780334|NCT02202616|565946239|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156780335|NCT00367458|565946240|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
156780336|NCT00367458|565946241|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
156780337|NCT00776997|565946243|FG000|Overall Study|Adverse Event|2|||
156780338|NCT01716156|565946244|FG000|Overall Study|Protocol Violation|1|||
156780339|NCT01716156|565946245|FG001|Overall Study|Protocol Violation|0|||
156780340|NCT01716156|565946246|FG002|Overall Study|Protocol Violation|0|||
156780341|NCT01716156|565946244|FG000|Overall Study|Withdrawal by Subject|0|||
156780342|NCT01716156|565946245|FG001|Overall Study|Withdrawal by Subject|1|||
156780343|NCT01716156|565946246|FG002|Overall Study|Withdrawal by Subject|2|||
156780344|NCT01716156|565946244|FG000|Overall Study|Lost to Follow-up|1|||
156780345|NCT01716156|565946245|FG001|Overall Study|Lost to Follow-up|0|||
156780346|NCT01716156|565946246|FG002|Overall Study|Lost to Follow-up|0|||
156780347|NCT05221866|565946249|FG000|Overall Study|Withdrawal by Subject|5|||
156780348|NCT05221866|565946250|FG001|Overall Study|Withdrawal by Subject|7|||
156780349|NCT05221866|565946251|FG002|Overall Study|Withdrawal by Subject|6|||
156780350|NCT05221866|565946252|FG003|Overall Study|Withdrawal by Subject|4|||
156780351|NCT05221866|565946249|FG000|Overall Study|Physician Decision|3|||
156780352|NCT05221866|565946250|FG001|Overall Study|Physician Decision|2|||
156780353|NCT05221866|565946251|FG002|Overall Study|Physician Decision|1|||
156780354|NCT05221866|565946252|FG003|Overall Study|Physician Decision|4|||
156780355|NCT05221866|565946249|FG000|Overall Study|Lost to Follow-up|12|||
156780356|NCT05221866|565946250|FG001|Overall Study|Lost to Follow-up|17|||
156780357|NCT05221866|565946251|FG002|Overall Study|Lost to Follow-up|14|||
156780358|NCT05221866|565946252|FG003|Overall Study|Lost to Follow-up|14|||
156780359|NCT05221866|565946249|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
156780360|NCT05221866|565946250|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
156780361|NCT05221866|565946251|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
156780362|NCT05221866|565946252|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
156780363|NCT04470427|565946253|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
156780364|NCT04470427|565946254|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
156780365|NCT04470427|565946255|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
156780366|NCT04470427|565946256|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
156780367|NCT04470427|565946257|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
156780368|NCT04470427|565946258|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
156780369|NCT04470427|565946253|FG000|Part B :Open-label|Other than specified|0|||
156780370|NCT04470427|565946254|FG001|Part B :Open-label|Other than specified|0|||
156780371|NCT04470427|565946255|FG002|Part B :Open-label|Other than specified|788|||
156780372|NCT04470427|565946256|FG003|Part B :Open-label|Other than specified|0|||
156780373|NCT04470427|565946257|FG004|Part B :Open-label|Other than specified|523|||
156780374|NCT04470427|565946258|FG005|Part B :Open-label|Other than specified|0|||
156780375|NCT04470427|565946253|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
156780376|NCT04470427|565946254|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
156780377|NCT04470427|565946255|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
156780378|NCT04470427|565946256|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
156780379|NCT04470427|565946257|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
156780380|NCT04470427|565946258|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
156327975|NCT02310321|564301439|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
156780381|NCT04470427|565946253|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
156780382|NCT04470427|565946254|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
156780383|NCT04470427|565946255|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
156780384|NCT04470427|565946256|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
156780385|NCT04470427|565946257|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
156780386|NCT04470427|565946258|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
156780387|NCT04057365|565946259|FG000|Overall Study|Withdrawal by Subject|2|||
156780388|NCT04057365|565946260|FG001|Overall Study|Withdrawal by Subject|0|||
156780389|NCT04738487|565946261|FG000|Overall Study|Participant Ongoing in Study|298|||
156780390|NCT04738487|565946262|FG001|Overall Study|Participant Ongoing in Study|297|||
156780391|NCT04738487|565946261|FG000|Overall Study|Withdrawal by Subject|7|||
156780392|NCT04738487|565946262|FG001|Overall Study|Withdrawal by Subject|9|||
156780393|NCT04738487|565946261|FG000|Overall Study|Lost to Follow-up|2|||
156780394|NCT04738487|565946262|FG001|Overall Study|Lost to Follow-up|0|||
156780395|NCT04738487|565946261|FG000|Overall Study|Death|287|||
156780396|NCT04738487|565946262|FG001|Overall Study|Death|306|||
156780397|NCT02717611|565946263|FG000|Overall Study|Death|13|||
156780398|NCT02717611|565946263|FG000|Overall Study|Withdrawal by Subject|6|||
156780399|NCT02717611|565946263|FG000|Overall Study|Active, not recruiting|40|||
156780400|NCT02717611|565946263|FG000|Overall Study|Complicating disease|1|||
156780401|NCT04818112|565946264|FG000|Overall Study|Withdrawal by Subject|54|||
156780402|NCT04818112|565946265|FG001|Overall Study|Withdrawal by Subject|12|||
156780403|NCT04818112|565946264|FG000|Overall Study|Lost to Follow-up|38|||
156780404|NCT04818112|565946265|FG001|Overall Study|Lost to Follow-up|10|||
156780405|NCT02676973|565946266|FG000|Overall Study|Withdrawal by Subject|9|||
156780406|NCT02676973|565946267|FG001|Overall Study|Withdrawal by Subject|8|||
156780407|NCT02676973|565946268|FG002|Overall Study|Withdrawal by Subject|11|||
156780408|NCT02676973|565946266|FG000|Overall Study|Lost to Follow-up|8|||
156780409|NCT02676973|565946267|FG001|Overall Study|Lost to Follow-up|12|||
156780410|NCT02676973|565946268|FG002|Overall Study|Lost to Follow-up|8|||
156780411|NCT02676973|565946266|FG000|Overall Study|Death|2|||
156780412|NCT02676973|565946267|FG001|Overall Study|Death|1|||
156780413|NCT02676973|565946268|FG002|Overall Study|Death|5|||
156780414|NCT01913353|565946270|FG000|Overall Study|Adverse Event|2|||
156780415|NCT01913353|565946271|FG001|Overall Study|Adverse Event|0|||
156780416|NCT01913353|565946270|FG000|Overall Study|Physician Decision|0|||
156780417|NCT01913353|565946271|FG001|Overall Study|Physician Decision|2|||
156780418|NCT01913353|565946270|FG000|Overall Study|Withdrawal by Subject|20|||
156780419|NCT01913353|565946271|FG001|Overall Study|Withdrawal by Subject|6|||
156780420|NCT01913353|565946270|FG000|Overall Study|multiple reasons|10|||
156780421|NCT01913353|565946271|FG001|Overall Study|multiple reasons|7|||
156780422|NCT00385840|565946272|FG000|Overall Study|Adverse Event|1|||
156780423|NCT00385840|565946273|FG001|Overall Study|Adverse Event|1|||
156780424|NCT00385840|565946272|FG000|Overall Study|Lost to Follow-up|3|||
156780425|NCT00385840|565946273|FG001|Overall Study|Lost to Follow-up|13|||
156780426|NCT05172570|565946274|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
156780427|NCT05172570|565946275|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
156780428|NCT05172570|565946276|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
156780429|NCT05172570|565946274|FG000|Overall Study|PI Decision due to equipment shortages|0|||
156780430|NCT05172570|565946275|FG001|Overall Study|PI Decision due to equipment shortages|0|||
156780431|NCT05172570|565946276|FG002|Overall Study|PI Decision due to equipment shortages|1|||
156780432|NCT06170827|565946282|FG000|Overall Study|Withdrawal by Subject|1|||
156780433|NCT06170827|565946283|FG001|Overall Study|Withdrawal by Subject|1|||
156780434|NCT00632359|565946284|FG000|Overall Study|Withdrawal by Subject|2|||
156780435|NCT04941898|565947090|FG000|Overall Study|Protocol Violation|1|||
156780436|NCT00003456|565947091|FG000|Overall Study|Not evaluable|8|||
156780437|NCT00420407|565947093|FG000|Overall Study|Lost to Follow-up|0|||
156780438|NCT00420407|565947094|FG001|Overall Study|Lost to Follow-up|3|||
156780439|NCT00420407|565947093|FG000|Overall Study|Physician Decision|2|||
156780440|NCT00420407|565947094|FG001|Overall Study|Physician Decision|1|||
156780441|NCT00420407|565947093|FG000|Overall Study|subject identified as detainee|1|||
156780442|NCT00420407|565947094|FG001|Overall Study|subject identified as detainee|0|||
156780443|NCT00420407|565947093|FG000|Overall Study|subject identified as Jehovah's witness|1|||
156780444|NCT00420407|565947094|FG001|Overall Study|subject identified as Jehovah's witness|0|||
156780445|NCT00420407|565947093|FG000|Overall Study|Withdrawal by Subject|0|||
156780446|NCT00420407|565947094|FG001|Overall Study|Withdrawal by Subject|2|||
156780447|NCT03641924|565947095|FG000|Overall Study|Withdrawal by Subject|26|||
156780448|NCT03641924|565947095|FG000|Overall Study|Lost to Follow-up|16|||
156780449|NCT03641924|565947095|FG000|Overall Study|Protocol Violation|10|||
156327976|NCT02310321|564301437|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
156327977|NCT02310321|564301438|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
156780450|NCT01565694|565947096|FG000|Dose-Titration Period|Adverse Event|4|||
156327978|NCT02310321|564301439|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
156780451|NCT01565694|565947096|FG000|Dose-Titration Period|Protocol Violation|10|||
156675385|NCT03067987|565554927|FG001|Overall Study|Lost to Follow-up|10|||
156675386|NCT03067987|565554926|FG000|Overall Study|Protocol Violation|1|||
156675387|NCT03067987|565554927|FG001|Overall Study|Protocol Violation|2|||
156675388|NCT03067987|565554926|FG000|Overall Study|Withdrawal by Subject|2|||
156675389|NCT03067987|565554927|FG001|Overall Study|Withdrawal by Subject|1|||
156780452|NCT01565694|565947096|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
156780453|NCT01373229|565947097|FG000|Overall Study|Death|3|||
156780454|NCT01373229|565947097|FG000|Overall Study|Physician Decision|3|||
156780455|NCT03234881|565947098|FG000|Overall Study|Lost to Follow-up|9|||
156780456|NCT03234881|565947099|FG001|Overall Study|Lost to Follow-up|3|||
156780457|NCT00541229|565947102|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
156780458|NCT00541229|565947103|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
156780459|NCT00541229|565947104|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
156780460|NCT00541229|565947105|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
156780461|NCT00541229|565947106|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
156780462|NCT00541229|565947107|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
156780463|NCT00541229|565947102|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780464|NCT00541229|565947103|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780465|NCT00541229|565947104|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780466|NCT00541229|565947105|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780467|NCT00541229|565947106|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780468|NCT00541229|565947107|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
156780469|NCT00541229|565947102|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780470|NCT00541229|565947103|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780471|NCT00541229|565947104|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780472|NCT00541229|565947105|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780473|NCT00541229|565947106|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780474|NCT00541229|565947107|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
156780475|NCT00541229|565947102|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
156780476|NCT00541229|565947103|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
156780477|NCT00541229|565947104|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
156780478|NCT00541229|565947105|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
156780479|NCT00541229|565947106|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
156780480|NCT00541229|565947107|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
156780481|NCT00541229|565947102|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
156780482|NCT00541229|565947103|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
156780483|NCT00541229|565947104|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
156780484|NCT00541229|565947105|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
156780485|NCT00541229|565947106|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
156780486|NCT00541229|565947107|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
156780487|NCT00541229|565947102|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
156780488|NCT00541229|565947103|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
156780489|NCT00541229|565947104|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
156780490|NCT00541229|565947105|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
156780491|NCT00541229|565947106|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
156675390|NCT02316223|565556773|FG000|Overall Study|Lack of Efficacy|0|||
156675391|NCT02316223|565556774|FG001|Overall Study|Lack of Efficacy|1|||
156675392|NCT02316223|565556775|FG002|Overall Study|Lack of Efficacy|1|||
156675393|NCT02316223|565556773|FG000|Overall Study|Lost to Follow-up|27|||
156675394|NCT02316223|565556774|FG001|Overall Study|Lost to Follow-up|34|||
156675395|NCT02316223|565556775|FG002|Overall Study|Lost to Follow-up|36|||
156675396|NCT02316223|565556773|FG000|Overall Study|COPD Diagnosis|3|||
156675397|NCT02316223|565556774|FG001|Overall Study|COPD Diagnosis|2|||
156675398|NCT02316223|565556775|FG002|Overall Study|COPD Diagnosis|3|||
156675399|NCT02316223|565556773|FG000|Overall Study|Reside outside study area|1|||
156675400|NCT02316223|565556774|FG001|Overall Study|Reside outside study area|1|||
156675401|NCT02316223|565556775|FG002|Overall Study|Reside outside study area|1|||
156675402|NCT02316223|565556773|FG000|Overall Study|No asthma|2|||
156675403|NCT02316223|565556774|FG001|Overall Study|No asthma|0|||
156675404|NCT02316223|565556775|FG002|Overall Study|No asthma|0|||
156675405|NCT02316223|565556773|FG000|Overall Study|Discontinued by PI|11|||
156675406|NCT02316223|565556774|FG001|Overall Study|Discontinued by PI|19|||
156675407|NCT02316223|565556775|FG002|Overall Study|Discontinued by PI|3|||
156675408|NCT00529763|565556776|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
156675409|NCT00529763|565556777|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
156675410|NCT00529763|565556778|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
156675411|NCT00529763|565556776|FG000|Overall Study|Death|1|||
156780492|NCT00541229|565947107|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
156780493|NCT00541229|565947102|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780494|NCT00541229|565947103|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
156675412|NCT00529763|565556777|FG001|Overall Study|Death|1|||
156675413|NCT00529763|565556778|FG002|Overall Study|Death|1|||
156675414|NCT00529763|565556776|FG000|Overall Study|Disease Progression|10|||
156675415|NCT00529763|565556777|FG001|Overall Study|Disease Progression|16|||
156780495|NCT00541229|565947104|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780496|NCT00541229|565947105|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780497|NCT00541229|565947106|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780498|NCT00541229|565947107|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
156780499|NCT00541229|565947102|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
156780500|NCT00541229|565947103|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
156780501|NCT00541229|565947104|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
156780502|NCT00541229|565947105|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
156780503|NCT00541229|565947106|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
156780504|NCT00541229|565947107|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
156780505|NCT00541229|565947102|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
156780506|NCT00541229|565947103|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
156780507|NCT00541229|565947104|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
156780508|NCT00541229|565947105|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
156780509|NCT00541229|565947106|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
156780510|NCT00541229|565947107|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
156780511|NCT00541229|565947102|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
156780512|NCT00541229|565947103|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
156780513|NCT00541229|565947104|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
156780514|NCT00541229|565947105|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
156780515|NCT00541229|565947106|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
156780516|NCT00541229|565947107|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
156780517|NCT00541229|565947102|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
156780518|NCT00541229|565947103|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780519|NCT00541229|565947104|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780520|NCT00541229|565947105|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780521|NCT00541229|565947106|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780522|NCT00541229|565947107|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780523|NCT00541229|565947102|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780524|NCT00541229|565947103|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780525|NCT00541229|565947104|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780526|NCT00541229|565947105|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780527|NCT00541229|565947106|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
156780528|NCT00541229|565947107|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780529|NCT00541229|565947102|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
156780530|NCT00541229|565947103|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
156780531|NCT00541229|565947104|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
156780532|NCT00541229|565947105|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
156780533|NCT00541229|565947106|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
156780534|NCT00541229|565947107|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
156780535|NCT00541229|565947102|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
156780536|NCT00541229|565947103|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
156780537|NCT00541229|565947104|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
156780538|NCT00541229|565947105|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
156780539|NCT00541229|565947106|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
156780540|NCT00541229|565947107|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
156780541|NCT00541229|565947102|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780542|NCT00541229|565947103|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780543|NCT00541229|565947104|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780544|NCT00541229|565947105|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780545|NCT00541229|565947106|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780546|NCT00541229|565947107|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
156780547|NCT00541229|565947102|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780548|NCT00541229|565947103|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780549|NCT00541229|565947104|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
156780550|NCT00541229|565947105|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780551|NCT00541229|565947106|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780552|NCT00541229|565947107|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780553|NCT03720847|565947108|FG000|Washout|Physician Decision|1|||
156780554|NCT03720847|565947109|FG001|Washout|Physician Decision|2|||
156780555|NCT01500096|565947110|FG000|Overall Study|Lost to Follow-up|1|||
156780556|NCT01500096|565947111|FG001|Overall Study|Lost to Follow-up|0|||
156327979|NCT02310321|564301437|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
156780557|NCT01500096|565947112|FG002|Overall Study|Lost to Follow-up|0|||
156780558|NCT01500096|565947113|FG003|Overall Study|Lost to Follow-up|2|||
156327980|NCT02310321|564301438|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
156327981|NCT02310321|564301439|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
156780559|NCT03033901|565947114|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
156780560|NCT03033901|565947114|FG000|Overall Study|Refused PSG|23|||
156780561|NCT03033901|565947114|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
156780562|NCT03033901|565947114|FG000|Overall Study|Missing Oximetry Data|3|||
156780563|NCT00639379|565947115|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
156780564|NCT00639379|565947116|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
156780565|NCT00639379|565947115|FG000|Period 1 - 2 Weeks|lens issue|3|||
156780566|NCT00639379|565947116|FG001|Period 1 - 2 Weeks|lens issue|0|||
156780567|NCT00924651|565947117|FG000|Overall Study|Chemo started too soon|2|||
156780568|NCT00924651|565947118|FG001|Overall Study|Chemo started too soon|3|||
156780569|NCT00924651|565947117|FG000|Overall Study|No Reason|3|||
156780570|NCT00924651|565947118|FG001|Overall Study|No Reason|7|||
156780571|NCT00924651|565947117|FG000|Overall Study|Overwhelmed|6|||
156780572|NCT00924651|565947118|FG001|Overall Study|Overwhelmed|6|||
156780573|NCT00924651|565947117|FG000|Overall Study|Noncompliant|1|||
156780574|NCT00924651|565947118|FG001|Overall Study|Noncompliant|4|||
156780575|NCT00924651|565947117|FG000|Overall Study|Medical|1|||
156780576|NCT00924651|565947118|FG001|Overall Study|Medical|3|||
156780577|NCT00924651|565947117|FG000|Overall Study|Changed Mind|10|||
156780578|NCT00924651|565947118|FG001|Overall Study|Changed Mind|1|||
156780579|NCT00924651|565947117|FG000|Overall Study|Incomplete Form|2|||
156780580|NCT00924651|565947118|FG001|Overall Study|Incomplete Form|1|||
156780581|NCT01797185|565947119|FG000|Overall Study|Adverse Event|5|||
156780582|NCT01797185|565947120|FG001|Overall Study|Adverse Event|15|||
156780583|NCT01797185|565947121|FG002|Overall Study|Adverse Event|6|||
156780584|NCT01797185|565947119|FG000|Overall Study|Withdrawal by Subject|6|||
156780585|NCT01797185|565947120|FG001|Overall Study|Withdrawal by Subject|9|||
156780586|NCT01797185|565947121|FG002|Overall Study|Withdrawal by Subject|5|||
156780587|NCT01797185|565947119|FG000|Overall Study|Site terminated|8|||
156780588|NCT01797185|565947120|FG001|Overall Study|Site terminated|4|||
156780589|NCT01797185|565947121|FG002|Overall Study|Site terminated|0|||
156780590|NCT01797185|565947119|FG000|Overall Study|Lost to Follow-up|2|||
156780591|NCT01797185|565947120|FG001|Overall Study|Lost to Follow-up|6|||
156780592|NCT01797185|565947121|FG002|Overall Study|Lost to Follow-up|1|||
156780593|NCT01797185|565947119|FG000|Overall Study|Withdrawn per sponsor|5|||
156780594|NCT01797185|565947120|FG001|Overall Study|Withdrawn per sponsor|0|||
156780595|NCT01797185|565947121|FG002|Overall Study|Withdrawn per sponsor|0|||
156780596|NCT01797185|565947119|FG000|Overall Study|Physician Decision|1|||
156780597|NCT01797185|565947120|FG001|Overall Study|Physician Decision|3|||
156780598|NCT01797185|565947121|FG002|Overall Study|Physician Decision|0|||
156780599|NCT01797185|565947119|FG000|Overall Study|Protocol Violation|1|||
156780600|NCT01797185|565947120|FG001|Overall Study|Protocol Violation|1|||
156780601|NCT01797185|565947121|FG002|Overall Study|Protocol Violation|0|||
156780602|NCT00723944|565947122|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
156780603|NCT00723944|565947123|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
156780604|NCT00723944|565947122|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
156780605|NCT00723944|565947123|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
156780606|NCT00723944|565947122|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
156780607|NCT00723944|565947123|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
156780608|NCT01847209|565947124|FG000|Overall Study|Withdrawal by Subject|1|||
156780609|NCT01847209|565947124|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
156780610|NCT00729586|565947125|FG000|Overall Study|Ineligible|0|||
156780611|NCT00729586|565947126|FG001|Overall Study|Ineligible|1|||
156780612|NCT00729586|565947125|FG000|Overall Study|never treated|1|||
156780613|NCT00729586|565947126|FG001|Overall Study|never treated|0|||
156780614|NCT02737618|565947129|FG000|Overall Study|Withdrawal by Subject|9|||
156780615|NCT02513199|565947130|FG000|Treatment|Death|1|||
156780616|NCT02513199|565947130|FG000|Treatment|Lost to Follow-up|1|||
156780617|NCT02513199|565947130|FG000|Follow-Up|Death|11|||
156780618|NCT02397837|565947136|FG000|Overall Study|Withdrawal by Subject|6|||
156780619|NCT02397837|565947137|FG001|Overall Study|Withdrawal by Subject|5|||
156780620|NCT02397837|565947136|FG000|Overall Study|Physician Decision|1|||
156780621|NCT02397837|565947137|FG001|Overall Study|Physician Decision|1|||
156780622|NCT02506036|565947143|FG000|First Intervention (4-6 Weeks)|Death|1|||
156780623|NCT02506036|565947144|FG001|First Intervention (4-6 Weeks)|Death|0|||
156780624|NCT02506036|565947143|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
156780625|NCT02506036|565947144|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
156780626|NCT02506036|565947143|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
156780627|NCT02506036|565947144|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
156780628|NCT02536794|565947146|FG000|Reached 1st Response Assessment|Adverse Event|2|||
156780629|NCT02536794|565947146|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
156780630|NCT02536794|565947146|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
156780631|NCT02536794|565947146|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
156780632|NCT02536794|565947146|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
156780633|NCT02536794|565947146|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
156780634|NCT01410604|565947147|FG000|Overall Study|Adverse Event|2|||
156780635|NCT01410604|565947148|FG001|Overall Study|Adverse Event|1|||
156780636|NCT01410604|565947147|FG000|Overall Study|Lost to Follow-up|1|||
156780637|NCT01410604|565947148|FG001|Overall Study|Lost to Follow-up|0|||
156780638|NCT01410604|565947147|FG000|Overall Study|Physician Decision|0|||
156780639|NCT01410604|565947148|FG001|Overall Study|Physician Decision|1|||
156780640|NCT01178411|565947153|FG000|Overall Study|Adverse Event|5|||
156780641|NCT01178411|565947153|FG000|Overall Study|Withdrawal by Subject|4|||
156780642|NCT01178411|565947153|FG000|Overall Study|Protocol Violation|1|||
156780643|NCT01178411|565947153|FG000|Overall Study|Progressive disease per RECIST|32|||
156780644|NCT01178411|565947153|FG000|Overall Study|Progressive disease per clinician|9|||
156780645|NCT01178411|565947153|FG000|Overall Study|Physician Decision|6|||
156780646|NCT01178411|565947153|FG000|Overall Study|Death|1|||
156780647|NCT01178411|565947153|FG000|Overall Study|No reason provided|1|||
156780648|NCT01178411|565947153|FG000|Overall Study|Drug manufacturing ended|1|||
156780649|NCT02453048|565947154|FG000|Overall Study|Only part of initial 6 mo. study|0|||
156780650|NCT02453048|565947155|FG001|Overall Study|Only part of initial 6 mo. study|0|||
156780651|NCT02453048|565947156|FG002|Overall Study|Only part of initial 6 mo. study|0|||
156780652|NCT02453048|565947157|FG003|Overall Study|Only part of initial 6 mo. study|0|||
156780653|NCT02453048|565947158|FG004|Overall Study|Only part of initial 6 mo. study|6|||
156780654|NCT02453048|565947154|FG000|Overall Study|Lost to Follow-up|0|||
156780655|NCT02453048|565947155|FG001|Overall Study|Lost to Follow-up|1|||
156780656|NCT02453048|565947156|FG002|Overall Study|Lost to Follow-up|2|||
156780657|NCT02453048|565947157|FG003|Overall Study|Lost to Follow-up|0|||
156780658|NCT02453048|565947158|FG004|Overall Study|Lost to Follow-up|0|||
156780659|NCT01239745|565947159|FG000|Overall Study|Study terminated by sponsor|45|||
156780660|NCT01239745|565947159|FG000|Overall Study|Adverse Event|1|||
156780661|NCT00726557|565947160|FG000|Overall Study|Screening failure|4|||
156780662|NCT00726557|565947160|FG000|Overall Study|No end of treatment documentation|37|||
156675416|NCT00529763|565556778|FG002|Overall Study|Disease Progression|11|||
156675417|NCT00529763|565556776|FG000|Overall Study|Lost to Follow-up|1|||
156675418|NCT00529763|565556777|FG001|Overall Study|Lost to Follow-up|2|||
156675419|NCT00529763|565556778|FG002|Overall Study|Lost to Follow-up|3|||
156675420|NCT00529763|565556776|FG000|Overall Study|Stem Cell Transplant|0|||
156675421|NCT00529763|565556777|FG001|Overall Study|Stem Cell Transplant|3|||
156675422|NCT00529763|565556778|FG002|Overall Study|Stem Cell Transplant|1|||
156675423|NCT00529763|565556776|FG000|Overall Study|Study Drug Toxicity|3|||
156675424|NCT00529763|565556777|FG001|Overall Study|Study Drug Toxicity|6|||
156675425|NCT00529763|565556778|FG002|Overall Study|Study Drug Toxicity|4|||
156675426|NCT00529763|565556776|FG000|Overall Study|Participant Withdrew Consent|2|||
156675427|NCT00529763|565556777|FG001|Overall Study|Participant Withdrew Consent|3|||
156675428|NCT00529763|565556778|FG002|Overall Study|Participant Withdrew Consent|4|||
156675429|NCT00529763|565556776|FG000|Overall Study|Other reasons|2|||
156675430|NCT00529763|565556777|FG001|Overall Study|Other reasons|0|||
156675431|NCT00529763|565556778|FG002|Overall Study|Other reasons|2|||
156675432|NCT00529763|565556776|FG000|Overall Study|Participant request to discontinue treatment|1|||
156675433|NCT00529763|565556777|FG001|Overall Study|Participant request to discontinue treatment|1|||
156675434|NCT00529763|565556778|FG002|Overall Study|Participant request to discontinue treatment|3|||
156675435|NCT03669250|565556779|FG000|Overall Study|Adverse Event|0|||
156675436|NCT03669250|565556780|FG001|Overall Study|Adverse Event|0|||
156675437|NCT03669250|565556781|FG002|Overall Study|Adverse Event|0|||
156675438|NCT03669250|565556782|FG003|Overall Study|Adverse Event|0|||
156675439|NCT03669250|565556783|FG004|Overall Study|Adverse Event|1|||
156675440|NCT03669250|565556784|FG005|Overall Study|Adverse Event|0|||
156675441|NCT03669250|565556779|FG000|Overall Study|Withdrawal by Subject|0|||
156675442|NCT03669250|565556780|FG001|Overall Study|Withdrawal by Subject|1|||
156675443|NCT03669250|565556781|FG002|Overall Study|Withdrawal by Subject|0|||
156675444|NCT03669250|565556782|FG003|Overall Study|Withdrawal by Subject|1|||
156675445|NCT03669250|565556783|FG004|Overall Study|Withdrawal by Subject|0|||
156675446|NCT03669250|565556784|FG005|Overall Study|Withdrawal by Subject|0|||
156675447|NCT03234907|565556785|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
156675448|NCT03234907|565556786|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
156675449|NCT03234907|565556787|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
156675450|NCT03234907|565556788|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
156675451|NCT03234907|565556789|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
156675452|NCT03234907|565556790|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
156675453|NCT03234907|565556785|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
156675454|NCT03234907|565556786|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
156675455|NCT03234907|565556787|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
156675456|NCT03234907|565556788|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
156675457|NCT03234907|565556789|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
156675458|NCT03234907|565556790|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
156675459|NCT03234907|565556785|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
156675460|NCT03234907|565556786|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
156780663|NCT00726557|565947160|FG000|Overall Study|No follow-up documentation available|55|||
156780664|NCT00726557|565947160|FG000|Overall Study|Treatment less than 3 months|17|||
156780665|NCT00726557|565947160|FG000|Overall Study|Inclusion criteria not met|15|||
156780666|NCT00081458|565947163|FG000|Overall Study|Adverse Event|1|||
156780667|NCT00081458|565947164|FG001|Overall Study|Adverse Event|5|||
156780668|NCT00081458|565947165|FG002|Overall Study|Adverse Event|2|||
156780669|NCT00081458|565947163|FG000|Overall Study|Withdrawal by Subject|0|||
156780670|NCT00081458|565947164|FG001|Overall Study|Withdrawal by Subject|3|||
156780671|NCT00081458|565947165|FG002|Overall Study|Withdrawal by Subject|1|||
156327982|NCT02310321|564301437|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
156327983|NCT02310321|564301438|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
156327984|NCT02310321|564301439|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
156327985|NCT02310321|564301437|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
156327986|NCT02310321|564301438|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
156327987|NCT02310321|564301439|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
156327988|NCT04950166|564301440|FG000|Overall Study|Withdrawal by Subject|1|||
156327989|NCT01698905|564301441|FG000|Overall Study|Adverse Event|4|||
156675461|NCT03234907|565556787|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
156675462|NCT03234907|565556788|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
156675463|NCT03234907|565556789|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
156675464|NCT03234907|565556790|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
156675465|NCT03234907|565556785|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
156675466|NCT03234907|565556786|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
156675467|NCT03234907|565556787|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
156675468|NCT03234907|565556788|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
156675469|NCT03234907|565556789|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
156675470|NCT03234907|565556790|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
156675471|NCT03234907|565556785|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
156675472|NCT03234907|565556786|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
156675473|NCT03234907|565556787|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
156675474|NCT03234907|565556788|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
156675475|NCT03234907|565556789|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
156675476|NCT03234907|565556790|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
156675477|NCT03234907|565556785|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
156675478|NCT03234907|565556786|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
156675479|NCT03234907|565556787|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
156675480|NCT03234907|565556788|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
156675481|NCT03234907|565556789|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
156675482|NCT03234907|565556790|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
156675483|NCT03234907|565556785|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
156675484|NCT03234907|565556786|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
156675485|NCT03234907|565556787|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
156675486|NCT03234907|565556788|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
156675487|NCT03234907|565556789|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
156675488|NCT03234907|565556790|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
156675489|NCT02986139|565556793|FG000|Overall Study|Sponsor Decision|1|||
156675490|NCT02986139|565556794|FG001|Overall Study|Sponsor Decision|2|||
156675491|NCT02986139|565556793|FG000|Overall Study|Withdrawal by Subject|0|||
156675492|NCT02986139|565556794|FG001|Overall Study|Withdrawal by Subject|1|||
156675493|NCT02986139|565556793|FG000|Overall Study|Lost to Follow-up|0|||
156675494|NCT02986139|565556794|FG001|Overall Study|Lost to Follow-up|1|||
156675495|NCT00414726|565556795|FG000|Overall Study|Withdrawal by Subject|0|||
156780672|NCT00081458|565947163|FG000|Overall Study|Randomized but not dosed|0|||
156780673|NCT00081458|565947164|FG001|Overall Study|Randomized but not dosed|0|||
156780674|NCT00081458|565947165|FG002|Overall Study|Randomized but not dosed|1|||
156780675|NCT03097315|565947170|FG000|Overall Study|Withdrawal by Subject|1|||
156780676|NCT01946802|565947171|FG000|Overall Study|Death|1|||
156780677|NCT01946802|565947171|FG000|Overall Study|Withdrawal by Subject|2|||
156780678|NCT01946802|565947171|FG000|Overall Study|Combined septic shock|1|||
156780679|NCT01946802|565947171|FG000|Overall Study|Protocol Violation|1|||
156780680|NCT00195429|565947172|FG000|Overall Study|Adverse Event|2|||
156780681|NCT00195429|565947173|FG001|Overall Study|Adverse Event|4|||
156780682|NCT00195429|565947172|FG000|Overall Study|Lack of Efficacy|2|||
156780683|NCT00195429|565947173|FG001|Overall Study|Lack of Efficacy|1|||
156780684|NCT00195429|565947172|FG000|Overall Study|Lost to Follow-up|1|||
156780685|NCT00195429|565947173|FG001|Overall Study|Lost to Follow-up|0|||
156780686|NCT01334515|565947178|FG000|Overall Study|Adverse Event|1|||
156780687|NCT01334515|565947179|FG001|Overall Study|Adverse Event|6|||
156780688|NCT01334515|565947178|FG000|Overall Study|Death|1|||
156780689|NCT01334515|565947179|FG001|Overall Study|Death|0|||
156780690|NCT01334515|565947178|FG000|Overall Study|Lack of Efficacy|8|||
156780691|NCT01334515|565947179|FG001|Overall Study|Lack of Efficacy|21|||
156780692|NCT01334515|565947178|FG000|Overall Study|Physician Decision|1|||
156780693|NCT01334515|565947179|FG001|Overall Study|Physician Decision|1|||
156780694|NCT01334515|565947178|FG000|Overall Study|Withdrawal by Subject|1|||
156780695|NCT01334515|565947179|FG001|Overall Study|Withdrawal by Subject|1|||
156780696|NCT04327271|565947180|FG000|Overall Study|Death|1|||
156780697|NCT04327271|565947181|FG001|Overall Study|Death|0|||
156780698|NCT04327271|565947180|FG000|Overall Study|Withdrawal by Subject|1|||
156528816|NCT04796896|565030967|FG009|Overall Study|Withdrawal by Subject|94|||
156528817|NCT04796896|565030968|FG010|Overall Study|Withdrawal by Subject|192|||
156528818|NCT04796896|565030969|FG011|Overall Study|Withdrawal by Subject|16|||
156327990|NCT01698905|564301441|FG000|Overall Study|Physician Decision|2|||
156327991|NCT01698905|564301441|FG000|Overall Study|Pregnancy|1|||
156327992|NCT01698905|564301441|FG000|Overall Study|Protocol Violation|1|||
156327993|NCT01698905|564301441|FG000|Overall Study|Subject/guardian decision|2|||
156327994|NCT01698905|564301441|FG000|Overall Study|Death|1|||
156327995|NCT05896748|564301442|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
156327996|NCT05896748|564301442|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
156327997|NCT05896748|564301442|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
156327998|NCT05896748|564301442|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
156327999|NCT05896748|564301442|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
156328000|NCT02456103|564301444|FG000|Overall Study|Study Closure|207|||
156328001|NCT02456103|564301444|FG000|Overall Study|Physician Decision|1|||
156328002|NCT02456103|564301444|FG000|Overall Study|Required prohibited medications|5|||
156328003|NCT02456103|564301444|FG000|Overall Study|Protocol Violation|1|||
156328004|NCT02456103|564301444|FG000|Overall Study|Adverse Event|5|||
156328005|NCT02456103|564301444|FG000|Overall Study|Abnormal Laboratory Value|2|||
156328006|NCT02456103|564301444|FG000|Overall Study|Lost to Follow-up|1|||
156328007|NCT02456103|564301444|FG000|Overall Study|Withdrawal by Subject|24|||
156328008|NCT00568685|564301445|FG000|Overall Study|Adverse Event|2|||
156328009|NCT00568685|564301446|FG001|Overall Study|Adverse Event|3|||
156328010|NCT00568685|564301447|FG002|Overall Study|Adverse Event|3|||
156328011|NCT00568685|564301445|FG000|Overall Study|Withdrawal by Subject|7|||
156328012|NCT00568685|564301446|FG001|Overall Study|Withdrawal by Subject|2|||
156328013|NCT00568685|564301447|FG002|Overall Study|Withdrawal by Subject|2|||
156328014|NCT00568685|564301445|FG000|Overall Study|Protocol Violation|1|||
156328015|NCT00568685|564301446|FG001|Overall Study|Protocol Violation|0|||
156328016|NCT00568685|564301447|FG002|Overall Study|Protocol Violation|0|||
156328017|NCT00923936|564301450|FG000|Overall Study|progressive disease on study|2|||
156328018|NCT00923936|564301451|FG001|Overall Study|progressive disease on study|1|||
156328019|NCT00923936|564301450|FG000|Overall Study|Adverse Event|2|||
156328020|NCT00923936|564301451|FG001|Overall Study|Adverse Event|1|||
156328021|NCT00923936|564301450|FG000|Overall Study|Lost to follow up|2|||
156328022|NCT00923936|564301451|FG001|Overall Study|Lost to follow up|0|||
156328023|NCT00923936|564301450|FG000|Overall Study|Continuing in follow up period|2|||
156328024|NCT00923936|564301451|FG001|Overall Study|Continuing in follow up period|1|||
156328025|NCT03538431|564301452|FG000|Overall Study|Physician Decision|0|||
156328026|NCT03538431|564301453|FG001|Overall Study|Physician Decision|1|||
156328027|NCT03538431|564301452|FG000|Overall Study|Withdrawal by Subject|1|||
156328028|NCT03538431|564301453|FG001|Overall Study|Withdrawal by Subject|0|||
156328029|NCT05394350|564301454|FG000|Overall Study|Death|2|||
156328030|NCT05394350|564301455|FG001|Overall Study|Death|2|||
156328031|NCT05394350|564301456|FG002|Overall Study|Death|4|||
156328032|NCT05394350|564301457|FG003|Overall Study|Death|0|||
156328033|NCT05394350|564301458|FG004|Overall Study|Death|1|||
156328034|NCT05394350|564301459|FG005|Overall Study|Death|0|||
156328035|NCT05394350|564301454|FG000|Overall Study|Study terminated by sponsor|1|||
156328036|NCT05394350|564301455|FG001|Overall Study|Study terminated by sponsor|1|||
156328037|NCT05394350|564301456|FG002|Overall Study|Study terminated by sponsor|7|||
156328038|NCT05394350|564301457|FG003|Overall Study|Study terminated by sponsor|3|||
156328039|NCT05394350|564301458|FG004|Overall Study|Study terminated by sponsor|2|||
156328040|NCT05394350|564301459|FG005|Overall Study|Study terminated by sponsor|4|||
156328041|NCT01231347|564301462|FG000|Overall Study|Full Consent withdrawn|19|||
156328042|NCT01231347|564301463|FG001|Overall Study|Full Consent withdrawn|19|||
156328043|NCT01231347|564301464|FG002|Overall Study|Full Consent withdrawn|11|||
156328044|NCT01231347|564301462|FG000|Overall Study|Lost to Follow-up|4|||
156328045|NCT01231347|564301463|FG001|Overall Study|Lost to Follow-up|2|||
156328046|NCT01231347|564301464|FG002|Overall Study|Lost to Follow-up|2|||
156328047|NCT01231347|564301462|FG000|Overall Study|Death|202|||
156328048|NCT01231347|564301463|FG001|Overall Study|Death|210|||
156328049|NCT01231347|564301464|FG002|Overall Study|Death|101|||
156328050|NCT01231347|564301462|FG000|Overall Study|other event|7|||
156328051|NCT01231347|564301463|FG001|Overall Study|other event|9|||
156328052|NCT01231347|564301464|FG002|Overall Study|other event|3|||
156328053|NCT02027376|564301477|FG000|Overall Study|Death|1|||
156328054|NCT02027376|564301478|FG001|Overall Study|Death|0|||
156328055|NCT02027376|564301479|FG002|Overall Study|Death|0|||
156328056|NCT01626495|564301480|FG000|Overall Study|Adverse Event|3|||
156328057|NCT01626495|564301480|FG000|Overall Study|Disease progression|27|||
156328058|NCT01626495|564301480|FG000|Overall Study|Withdrawal by Subject|1|||
156675496|NCT00414726|565556796|FG001|Overall Study|Withdrawal by Subject|1|||
156675497|NCT02107196|565556797|FG000|12-week Treatment Period|Adverse Event|6|||
156675498|NCT02107196|565556798|FG001|12-week Treatment Period|Adverse Event|3|||
156675499|NCT02107196|565556797|FG000|12-week Treatment Period|Lack of Efficacy|2|||
156675500|NCT02107196|565556798|FG001|12-week Treatment Period|Lack of Efficacy|1|||
156675501|NCT02107196|565556797|FG000|12-week Treatment Period|Lost to Follow-up|3|||
156675502|NCT02107196|565556798|FG001|12-week Treatment Period|Lost to Follow-up|6|||
156675503|NCT02107196|565556797|FG000|12-week Treatment Period|Physician Decision|0|||
156675504|NCT02107196|565556798|FG001|12-week Treatment Period|Physician Decision|1|||
156675505|NCT02107196|565556797|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
156675506|NCT02107196|565556798|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
156328059|NCT01626495|564301480|FG000|Overall Study|Administrative problem|1|||
156328060|NCT01626495|564301480|FG000|Overall Study|Death|2|||
156328061|NCT01626495|564301480|FG000|Overall Study|Physician Decision|1|||
156328062|NCT01626495|564301480|FG000|Overall Study|New cancer therapy|16|||
156328063|NCT01626495|564301480|FG000|Overall Study|Manufacturing failure|1|||
156675507|NCT02107196|565556797|FG000|12-week Treatment Period|Protocol Violation|7|||
156675508|NCT02107196|565556798|FG001|12-week Treatment Period|Protocol Violation|8|||
156675509|NCT02107196|565556797|FG000|12-week Treatment Period|Reason Missing|11|||
156328064|NCT02979197|564301485|FG000|Overall Study|Adverse Event|4|||
156328065|NCT02979197|564301486|FG001|Overall Study|Adverse Event|2|||
156328066|NCT02979197|564301487|FG002|Overall Study|Adverse Event|0|||
156328067|NCT02979197|564301485|FG000|Overall Study|Protocol Violation|0|||
156675510|NCT02107196|565556798|FG001|12-week Treatment Period|Reason Missing|8|||
156675511|NCT02107196|565556797|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
156675512|NCT02107196|565556798|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
156675513|NCT02107196|565556797|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
156675514|NCT02107196|565556798|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
156675515|NCT02107196|565556797|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
156675516|NCT02107196|565556798|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
156675517|NCT02107196|565556797|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
156675518|NCT02107196|565556798|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
156675519|NCT00660660|565556801|FG000|Overall Study|Adverse Event|1|||
156675520|NCT00660660|565556802|FG001|Overall Study|Adverse Event|0|||
156675521|NCT00660660|565556801|FG000|Overall Study|Lost to Follow-up|0|||
156675522|NCT00660660|565556802|FG001|Overall Study|Lost to Follow-up|6|||
156675523|NCT00660660|565556801|FG000|Overall Study|Lack of Efficacy|0|||
156675524|NCT00660660|565556802|FG001|Overall Study|Lack of Efficacy|2|||
156675525|NCT00660660|565556801|FG000|Overall Study|Withdrawal by Subject|3|||
156675526|NCT00660660|565556802|FG001|Overall Study|Withdrawal by Subject|0|||
156675527|NCT00660660|565556801|FG000|Overall Study|Incorrect enrollment and other|0|||
156675528|NCT00660660|565556802|FG001|Overall Study|Incorrect enrollment and other|1|||
156675529|NCT00660660|565556801|FG000|Overall Study|New medication after randomization|1|||
156675530|NCT00660660|565556802|FG001|Overall Study|New medication after randomization|0|||
156675531|NCT01630616|565556803|FG000|Overall Study|Adverse Event|0|||
156675532|NCT01630616|565556804|FG001|Overall Study|Adverse Event|0|||
156675533|NCT01630616|565556805|FG002|Overall Study|Adverse Event|0|||
156675534|NCT01630616|565556806|FG003|Overall Study|Adverse Event|1|||
156675535|NCT01630616|565556807|FG004|Overall Study|Adverse Event|0|||
156675536|NCT01630616|565556808|FG005|Overall Study|Adverse Event|0|||
156675537|NCT01630616|565556803|FG000|Overall Study|Withdrawal by Subject|0|||
156675538|NCT01630616|565556804|FG001|Overall Study|Withdrawal by Subject|0|||
156675539|NCT01630616|565556805|FG002|Overall Study|Withdrawal by Subject|0|||
156675540|NCT01630616|565556806|FG003|Overall Study|Withdrawal by Subject|2|||
156675541|NCT01630616|565556807|FG004|Overall Study|Withdrawal by Subject|0|||
156675542|NCT01630616|565556808|FG005|Overall Study|Withdrawal by Subject|0|||
156675543|NCT01993186|565556809|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
156675544|NCT01993186|565556810|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
156675545|NCT01993186|565556809|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
156675546|NCT01993186|565556810|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
156675547|NCT01993186|565556809|FG000|Open-Label Extension Period|Other, Not Specified|0|||
156675548|NCT01993186|565556810|FG001|Open-Label Extension Period|Other, Not Specified|1|||
156675549|NCT01993186|565556809|FG000|Open-Label Extension Period|Adverse Event|1|||
156675550|NCT01993186|565556810|FG001|Open-Label Extension Period|Adverse Event|0|||
156675551|NCT01993186|565556809|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
156675552|NCT01993186|565556810|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
156675553|NCT01993186|565556809|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
156675554|NCT01993186|565556810|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
156675555|NCT01993186|565556809|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
156675556|NCT01993186|565556810|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
156328068|NCT02979197|564301486|FG001|Overall Study|Protocol Violation|1|||
156328069|NCT02979197|564301487|FG002|Overall Study|Protocol Violation|0|||
156433429|NCT00395018|564676196|FG000|On-Treatment|Death|4|||
156433430|NCT00395018|564676196|FG000|On-Treatment|Other Reason|2|||
156433431|NCT00395018|564676196|FG000|On-Treatment|Poor/non-compliance|2|||
156433432|NCT00395018|564676196|FG000|On-Treatment|Subject no longer meets study criteria|2|||
156433433|NCT00395018|564676196|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
156433434|NCT00395018|564676196|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
156433435|NCT00395018|564676196|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
156433436|NCT04439799|564676197|FG000|Overall Study|Lost to Follow-up|6|||
156433437|NCT04439799|564676198|FG001|Overall Study|Lost to Follow-up|6|||
156433438|NCT04439799|564676197|FG000|Overall Study|Withdrawal by Subject|2|||
156433439|NCT04439799|564676198|FG001|Overall Study|Withdrawal by Subject|6|||
156433440|NCT04439799|564676197|FG000|Overall Study|Adverse Event|2|||
156433441|NCT04439799|564676198|FG001|Overall Study|Adverse Event|5|||
156433442|NCT00530842|564676202|FG000|Overall Study|Adverse Event|10|||
156433443|NCT00530842|564676203|FG001|Overall Study|Adverse Event|6|||
156433444|NCT00530842|564676202|FG000|Overall Study|Lack of Efficacy|2|||
156433445|NCT00530842|564676203|FG001|Overall Study|Lack of Efficacy|1|||
156433446|NCT00530842|564676202|FG000|Overall Study|Lost to Follow-up|0|||
156433447|NCT00530842|564676203|FG001|Overall Study|Lost to Follow-up|4|||
156433448|NCT00530842|564676202|FG000|Overall Study|Protocol Violation|3|||
156433449|NCT00530842|564676203|FG001|Overall Study|Protocol Violation|2|||
156433450|NCT00530842|564676202|FG000|Overall Study|Withdrawal by Subject|4|||
156433451|NCT00530842|564676203|FG001|Overall Study|Withdrawal by Subject|5|||
156433452|NCT00530842|564676202|FG000|Overall Study|Individual different reasons|4|||
156433453|NCT00530842|564676203|FG001|Overall Study|Individual different reasons|3|||
156433454|NCT00530842|564676202|FG000|Period 1|Adverse Event|7|||
156433455|NCT00530842|564676203|FG001|Period 1|Adverse Event|3|||
156433456|NCT00530842|564676202|FG000|Period 1|Lack of Efficacy|1|||
156433457|NCT00530842|564676203|FG001|Period 1|Lack of Efficacy|1|||
156433458|NCT00530842|564676202|FG000|Period 1|Protocol Violation|2|||
156433459|NCT00530842|564676203|FG001|Period 1|Protocol Violation|1|||
156433460|NCT00530842|564676202|FG000|Period 1|Withdrawal by Subject|2|||
156433461|NCT00530842|564676203|FG001|Period 1|Withdrawal by Subject|3|||
156433462|NCT00530842|564676202|FG000|Period 1|Individual different reasons|2|||
156433463|NCT00530842|564676203|FG001|Period 1|Individual different reasons|3|||
156433464|NCT00530842|564676202|FG000|Period 2|Adverse Event|3|||
156433465|NCT00530842|564676203|FG001|Period 2|Adverse Event|3|||
156433466|NCT00530842|564676202|FG000|Period 2|Lack of Efficacy|1|||
156433467|NCT00530842|564676203|FG001|Period 2|Lack of Efficacy|0|||
156433468|NCT00530842|564676202|FG000|Period 2|Lost to Follow-up|0|||
156433469|NCT00530842|564676203|FG001|Period 2|Lost to Follow-up|4|||
156433470|NCT00530842|564676202|FG000|Period 2|Protocol Violation|1|||
156433471|NCT00530842|564676203|FG001|Period 2|Protocol Violation|0|||
156433472|NCT00530842|564676202|FG000|Period 2|Withdrawal by Subject|1|||
156433473|NCT00530842|564676203|FG001|Period 2|Withdrawal by Subject|2|||
156433474|NCT00530842|564676202|FG000|Period 2|Individual different reasons|2|||
156433475|NCT00530842|564676203|FG001|Period 2|Individual different reasons|0|||
156433476|NCT00972504|564676204|FG000|Overall Study|Adverse Event|2|||
156433477|NCT00972504|564676204|FG000|Overall Study|Investigator discretion|1|||
156433478|NCT03478696|564676220|FG000|Overall Study|Adverse Event|1|||
156433479|NCT03478696|564676221|FG001|Overall Study|Adverse Event|5|||
156433480|NCT03478696|564676220|FG000|Overall Study|Lost to Follow-up|1|||
156433481|NCT03478696|564676221|FG001|Overall Study|Lost to Follow-up|0|||
156433482|NCT03478696|564676220|FG000|Overall Study|Physician Decision|6|||
156433483|NCT03478696|564676221|FG001|Overall Study|Physician Decision|3|||
156433484|NCT03478696|564676220|FG000|Overall Study|Withdrawal by Subject|9|||
156433485|NCT03478696|564676221|FG001|Overall Study|Withdrawal by Subject|4|||
156433486|NCT03257813|564676222|FG000|Overall Study|Protocol Violation|6|||
156433487|NCT03257813|564676223|FG001|Overall Study|Protocol Violation|3|||
156433488|NCT02878330|564676224|FG000|Overall Study|Death|3|||
156433489|NCT02878330|564676225|FG001|Overall Study|Death|2|||
156433490|NCT02878330|564676224|FG000|Overall Study|Lost to Follow-up|11|||
156433491|NCT02878330|564676225|FG001|Overall Study|Lost to Follow-up|26|||
156433492|NCT02878330|564676224|FG000|Overall Study|Withdrawal by Subject|11|||
156433493|NCT02878330|564676225|FG001|Overall Study|Withdrawal by Subject|21|||
156433494|NCT02878330|564676224|FG000|Overall Study|Other|4|||
156433495|NCT02878330|564676225|FG001|Overall Study|Other|7|||
156433496|NCT04246762|564676226|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
156433497|NCT03615924|564676231|FG000|Overall Study|Withdrawal by Subject|2|||
156433498|NCT03615924|564676232|FG001|Overall Study|Withdrawal by Subject|5|||
156433499|NCT03615924|564676231|FG000|Overall Study|Death|3|||
156433500|NCT03615924|564676232|FG001|Overall Study|Death|1|||
156433501|NCT03615924|564676231|FG000|Overall Study|Lost to Follow-up|1|||
156433502|NCT03615924|564676232|FG001|Overall Study|Lost to Follow-up|0|||
156433503|NCT03615924|564676231|FG000|Overall Study|Randomized in error|1|||
156433504|NCT03615924|564676232|FG001|Overall Study|Randomized in error|0|||
156433505|NCT03615924|564676231|FG000|Overall Study|Study termination by Sponsor|94|||
156433506|NCT03615924|564676232|FG001|Overall Study|Study termination by Sponsor|86|||
156433507|NCT00716144|564676233|FG000|Overall Study|Withdrawal by Subject|4|||
156433508|NCT00716144|564676234|FG001|Overall Study|Withdrawal by Subject|2|||
156675557|NCT04523480|565556811|FG000|Overall Study|Lost to Follow-up|30|||
156675558|NCT04523480|565556812|FG001|Overall Study|Lost to Follow-up|35|||
156675559|NCT04523480|565556813|FG002|Overall Study|Lost to Follow-up|0|||
156675560|NCT00385736|565556815|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
156675561|NCT00385736|565556816|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
156675562|NCT00385736|565556817|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
156675563|NCT00385736|565556815|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
156675564|NCT00385736|565556816|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
156675565|NCT00385736|565556817|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
156675566|NCT00385736|565556815|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
156675567|NCT00385736|565556816|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
156675568|NCT00385736|565556817|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
156675569|NCT00385736|565556815|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
156675570|NCT00385736|565556816|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
156675571|NCT00385736|565556817|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
156675572|NCT00385736|565556815|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
156675573|NCT00385736|565556816|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
156433509|NCT00716144|564676235|FG002|Overall Study|Withdrawal by Subject|6|||
156433510|NCT00716144|564676236|FG003|Overall Study|Withdrawal by Subject|6|||
156433511|NCT00716144|564676233|FG000|Overall Study|Lost to Follow-up|2|||
156433512|NCT00716144|564676234|FG001|Overall Study|Lost to Follow-up|2|||
156675574|NCT00385736|565556817|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
156675575|NCT00385736|565556815|FG000|Efficacy Analysis Set - Induction|Other|0|||
156675576|NCT00385736|565556816|FG001|Efficacy Analysis Set - Induction|Other|0|||
156675577|NCT00385736|565556817|FG002|Efficacy Analysis Set - Induction|Other|1|||
156675578|NCT00385736|565556815|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
156675579|NCT00385736|565556816|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
156675580|NCT00385736|565556817|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
156675581|NCT00385736|565556815|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
156675582|NCT00385736|565556816|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
156675583|NCT00385736|565556817|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
156675584|NCT00385736|565556815|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
156675585|NCT00385736|565556816|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
156675586|NCT00385736|565556817|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
156675587|NCT00385736|565556815|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
156675588|NCT00385736|565556816|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
156675589|NCT00385736|565556817|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
156675590|NCT00385736|565556815|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
156675591|NCT00385736|565556816|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
156675592|NCT00385736|565556817|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
156675593|NCT00385736|565556815|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
156675594|NCT00385736|565556816|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
156675595|NCT00385736|565556817|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
156675596|NCT00385736|565556815|FG000|Safety Analysis Set|Adverse Event|23|||
156675597|NCT00385736|565556816|FG001|Safety Analysis Set|Adverse Event|15|||
156675598|NCT00385736|565556817|FG002|Safety Analysis Set|Adverse Event|23|||
156675599|NCT00385736|565556815|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
156675600|NCT00385736|565556816|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
156675601|NCT00385736|565556817|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
156675602|NCT00385736|565556815|FG000|Safety Analysis Set|Lost to Follow-up|0|||
156675603|NCT00385736|565556816|FG001|Safety Analysis Set|Lost to Follow-up|2|||
156675604|NCT00385736|565556817|FG002|Safety Analysis Set|Lost to Follow-up|2|||
156675605|NCT00385736|565556815|FG000|Safety Analysis Set|Lack of Efficacy|38|||
156675606|NCT00385736|565556816|FG001|Safety Analysis Set|Lack of Efficacy|16|||
156675607|NCT00385736|565556817|FG002|Safety Analysis Set|Lack of Efficacy|31|||
156675608|NCT00385736|565556815|FG000|Safety Analysis Set|Protocol Violation|2|||
156675609|NCT00385736|565556816|FG001|Safety Analysis Set|Protocol Violation|1|||
156675610|NCT00385736|565556817|FG002|Safety Analysis Set|Protocol Violation|6|||
156675611|NCT00385736|565556815|FG000|Safety Analysis Set|Other|1|||
156675612|NCT00385736|565556816|FG001|Safety Analysis Set|Other|4|||
156675613|NCT00385736|565556817|FG002|Safety Analysis Set|Other|4|||
156675614|NCT01701063|565556820|FG000|Overall Study|Lost to Follow-up|0|||
156675615|NCT01701063|565556821|FG001|Overall Study|Lost to Follow-up|1|||
156675616|NCT01701063|565556822|FG002|Overall Study|Lost to Follow-up|0|||
156675617|NCT01701063|565556820|FG000|Overall Study|Withdrawal by Subject|0|||
156675618|NCT01701063|565556821|FG001|Overall Study|Withdrawal by Subject|0|||
156675619|NCT01701063|565556822|FG002|Overall Study|Withdrawal by Subject|1|||
156675620|NCT01701063|565556820|FG000|Overall Study|Other|0|||
156675621|NCT01701063|565556821|FG001|Overall Study|Other|0|||
156675622|NCT01701063|565556822|FG002|Overall Study|Other|1|||
156675623|NCT01919112|565556823|FG000|Secondary Analysis-day 30|Death|1|||
156675624|NCT01919112|565556824|FG001|Secondary Analysis-day 30|Death|1|||
156675625|NCT01919112|565556825|FG002|Secondary Analysis-day 30|Death|1|||
156675626|NCT01919112|565556823|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
156675627|NCT01919112|565556824|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
156675628|NCT01919112|565556825|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
156675629|NCT02043132|565556826|FG000|Overall Study|Lost to Follow-up|1|||
156675630|NCT02043132|565556827|FG001|Overall Study|Lost to Follow-up|1|||
156433513|NCT00716144|564676235|FG002|Overall Study|Lost to Follow-up|1|||
156433514|NCT00716144|564676236|FG003|Overall Study|Lost to Follow-up|2|||
156675631|NCT02043132|565556826|FG000|Overall Study|screen failures|4|||
156675632|NCT02043132|565556827|FG001|Overall Study|screen failures|8|||
156433515|NCT00716144|564676233|FG000|Overall Study|Adverse Event|0|||
156433516|NCT00716144|564676234|FG001|Overall Study|Adverse Event|0|||
156433517|NCT00716144|564676235|FG002|Overall Study|Adverse Event|0|||
156433518|NCT00716144|564676236|FG003|Overall Study|Adverse Event|2|||
156433519|NCT00716144|564676233|FG000|Overall Study|Non-compliance|1|||
156433520|NCT00716144|564676234|FG001|Overall Study|Non-compliance|0|||
156433521|NCT00716144|564676235|FG002|Overall Study|Non-compliance|0|||
156433522|NCT00716144|564676236|FG003|Overall Study|Non-compliance|0|||
156433523|NCT00716144|564676233|FG000|Overall Study|Protocol Violation|2|||
156433524|NCT00716144|564676234|FG001|Overall Study|Protocol Violation|0|||
156433525|NCT00716144|564676235|FG002|Overall Study|Protocol Violation|1|||
156433526|NCT00716144|564676236|FG003|Overall Study|Protocol Violation|0|||
156433527|NCT00716144|564676233|FG000|Overall Study|Physician Decision|0|||
156433528|NCT00716144|564676234|FG001|Overall Study|Physician Decision|1|||
156433529|NCT00716144|564676235|FG002|Overall Study|Physician Decision|2|||
156433530|NCT00716144|564676236|FG003|Overall Study|Physician Decision|2|||
156433531|NCT00716144|564676233|FG000|Overall Study|Intercurrent illness|0|||
156433532|NCT00716144|564676234|FG001|Overall Study|Intercurrent illness|0|||
156433533|NCT00716144|564676235|FG002|Overall Study|Intercurrent illness|1|||
156433534|NCT00716144|564676236|FG003|Overall Study|Intercurrent illness|0|||
156433535|NCT00716144|564676233|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
156433536|NCT00716144|564676234|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
156433537|NCT00716144|564676235|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
156433538|NCT00716144|564676236|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
156433539|NCT00716144|564676233|FG000|Overall Study|Adverse event: left foot pain|0|||
156433540|NCT00716144|564676234|FG001|Overall Study|Adverse event: left foot pain|1|||
156433541|NCT00716144|564676235|FG002|Overall Study|Adverse event: left foot pain|0|||
156433542|NCT00716144|564676236|FG003|Overall Study|Adverse event: left foot pain|0|||
156433543|NCT00716144|564676233|FG000|Overall Study|Clinical Depression|0|||
156433544|NCT00716144|564676234|FG001|Overall Study|Clinical Depression|1|||
156433545|NCT00716144|564676235|FG002|Overall Study|Clinical Depression|0|||
156433546|NCT00716144|564676236|FG003|Overall Study|Clinical Depression|0|||
156433547|NCT02914522|564676237|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
156433548|NCT02914522|564676238|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
156433549|NCT02914522|564676239|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
156433550|NCT02914522|564676240|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
156433551|NCT02914522|564676241|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
156433552|NCT02914522|564676242|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
156433553|NCT02914522|564676243|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
156433554|NCT02914522|564676244|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
156433555|NCT02914522|564676245|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
156433556|NCT02914522|564676246|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
156433557|NCT02914522|564676247|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
156433558|NCT02914522|564676237|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
156433559|NCT02914522|564676238|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
156433560|NCT02914522|564676239|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
156433561|NCT02914522|564676240|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
156433562|NCT02914522|564676241|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
156675633|NCT04474405|565556828|FG000|Overall Study|Withdrawal by Subject|0|||
156675634|NCT04474405|565556829|FG001|Overall Study|Withdrawal by Subject|0|||
156675635|NCT04474405|565556830|FG002|Overall Study|Withdrawal by Subject|1|||
156675636|NCT04474405|565556831|FG003|Overall Study|Withdrawal by Subject|0|||
156675637|NCT04474405|565556832|FG004|Overall Study|Withdrawal by Subject|1|||
156675638|NCT04474405|565556833|FG005|Overall Study|Withdrawal by Subject|0|||
156433563|NCT02914522|564676242|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
156433564|NCT02914522|564676243|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
156433565|NCT02914522|564676244|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
156433566|NCT02914522|564676245|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
156433567|NCT02914522|564676246|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
156433568|NCT02914522|564676247|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
156433569|NCT02914522|564676237|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
156433570|NCT02914522|564676238|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
156433571|NCT02914522|564676239|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
156675639|NCT04474405|565556828|FG000|Overall Study|Other|0|||
156675640|NCT04474405|565556829|FG001|Overall Study|Other|0|||
156675641|NCT04474405|565556830|FG002|Overall Study|Other|0|||
156675642|NCT04474405|565556831|FG003|Overall Study|Other|0|||
156675643|NCT04474405|565556832|FG004|Overall Study|Other|3|||
156675644|NCT04474405|565556833|FG005|Overall Study|Other|0|||
156675645|NCT00918645|565556834|FG000|Overall Study|Withdrawal by Subject|1|||
156675646|NCT03446768|565556835|FG000|Overall Study|Withdrawal by Subject|0|||
156675647|NCT03446768|565556836|FG001|Overall Study|Withdrawal by Subject|1|||
156675648|NCT00635648|565556837|FG000|Overall Study|Adverse Event|12|||
156675649|NCT00635648|565556837|FG000|Overall Study|Withdrawal by Subject|9|||
156675650|NCT00635648|565556837|FG000|Overall Study|Physician Decision|4|||
156675651|NCT00635648|565556837|FG000|Overall Study|Rapid progression of baseline disease|4|||
156675652|NCT00635648|565556837|FG000|Overall Study|Use of other antifungal agent needed|1|||
156675653|NCT00635648|565556837|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
156675654|NCT00635648|565556837|FG000|Overall Study|Noncompliance with protocol|1|||
156328070|NCT02979197|564301485|FG000|Overall Study|Subject unable to commit to study dates|0|||
156328071|NCT02979197|564301486|FG001|Overall Study|Subject unable to commit to study dates|1|||
156328072|NCT02979197|564301487|FG002|Overall Study|Subject unable to commit to study dates|0|||
156328073|NCT01414608|564301490|FG000|Overall Study|Ineligible|5|||
156328074|NCT01414608|564301491|FG001|Overall Study|Ineligible|2|||
156328075|NCT05156073|564301492|FG000|Overall Study|Patient canceled appointment with PCP|1|||
156328076|NCT03635788|564301496|FG000|Step 1|Death|1|||
156328077|NCT03635788|564301497|FG001|Step 1|Death|0|||
156328078|NCT03635788|564301498|FG002|Step 1|Death|0|||
156328079|NCT03635788|564301496|FG000|Step 1|Lost to Follow-up|31|||
156328080|NCT03635788|564301497|FG001|Step 1|Lost to Follow-up|0|||
156328081|NCT03635788|564301498|FG002|Step 1|Lost to Follow-up|0|||
156328082|NCT03635788|564301496|FG000|Step 1|Pregnancy|1|||
156328083|NCT03635788|564301497|FG001|Step 1|Pregnancy|0|||
156328084|NCT03635788|564301498|FG002|Step 1|Pregnancy|0|||
156328085|NCT03635788|564301496|FG000|Step 1|Protocol Violation|8|||
156328086|NCT03635788|564301497|FG001|Step 1|Protocol Violation|0|||
156328087|NCT03635788|564301498|FG002|Step 1|Protocol Violation|0|||
156328088|NCT03635788|564301496|FG000|Step 1|Withdrawal by Subject|13|||
156328089|NCT03635788|564301497|FG001|Step 1|Withdrawal by Subject|0|||
156328090|NCT03635788|564301498|FG002|Step 1|Withdrawal by Subject|0|||
156328091|NCT03635788|564301496|FG000|Step 1|Other reasons|12|||
156328092|NCT03635788|564301497|FG001|Step 1|Other reasons|0|||
156328093|NCT03635788|564301498|FG002|Step 1|Other reasons|0|||
156328094|NCT03635788|564301496|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
156328095|NCT03635788|564301497|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
156328096|NCT03635788|564301498|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
156328097|NCT03635788|564301496|FG000|Step 2|Lost to Follow-up|0|||
156328098|NCT03635788|564301497|FG001|Step 2|Lost to Follow-up|8|||
156328099|NCT03635788|564301498|FG002|Step 2|Lost to Follow-up|15|||
156328100|NCT03635788|564301496|FG000|Step 2|Withdrawal by Subject|0|||
156328101|NCT03635788|564301497|FG001|Step 2|Withdrawal by Subject|6|||
156328102|NCT03635788|564301498|FG002|Step 2|Withdrawal by Subject|6|||
156328103|NCT03635788|564301496|FG000|Step 2|Death|0|||
156328104|NCT03635788|564301497|FG001|Step 2|Death|2|||
156328105|NCT03635788|564301498|FG002|Step 2|Death|0|||
156328106|NCT03635788|564301496|FG000|Step 2|Incarceration|0|||
156328107|NCT03635788|564301497|FG001|Step 2|Incarceration|2|||
156328108|NCT03635788|564301498|FG002|Step 2|Incarceration|0|||
156328109|NCT03635788|564301496|FG000|Step 2|Non-Compliance With Study Requirements|0|||
156328110|NCT03635788|564301497|FG001|Step 2|Non-Compliance With Study Requirements|1|||
156328111|NCT03635788|564301498|FG002|Step 2|Non-Compliance With Study Requirements|1|||
156328112|NCT03635788|564301496|FG000|Step 2|Confounding Medical Condition|0|||
156328113|NCT03635788|564301497|FG001|Step 2|Confounding Medical Condition|0|||
156328114|NCT03635788|564301498|FG002|Step 2|Confounding Medical Condition|1|||
156328115|NCT03635788|564301496|FG000|Step 2|Out Of State With No Plan To Return|0|||
156328116|NCT03635788|564301497|FG001|Step 2|Out Of State With No Plan To Return|1|||
156328117|NCT03635788|564301498|FG002|Step 2|Out Of State With No Plan To Return|0|||
156328118|NCT03635788|564301496|FG000|Step 2|Switched To Injectables|0|||
156328119|NCT03635788|564301497|FG001|Step 2|Switched To Injectables|0|||
156328120|NCT03635788|564301498|FG002|Step 2|Switched To Injectables|1|||
156328121|NCT03635788|564301496|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
156328122|NCT03635788|564301497|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
156328123|NCT03635788|564301498|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
156328124|NCT05430022|564301499|FG000|Overall Study|Withdrawal by Subject|4|||
156328125|NCT05430022|564301500|FG001|Overall Study|Withdrawal by Subject|4|||
156328126|NCT05521906|564301501|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
156328127|NCT05521906|564301502|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
156328128|NCT03148275|564301505|FG000|Overall Study|Death|6|||
156328129|NCT03148275|564301505|FG000|Overall Study|Adverse Event|3|||
156675655|NCT00635648|565556837|FG000|Overall Study|Other reason|2|||
156675656|NCT03827395|565556841|FG000|Overall Study|Lost to Follow-up|1|||
156675657|NCT03827395|565556842|FG001|Overall Study|Lost to Follow-up|0|||
156675658|NCT03827395|565556841|FG000|Overall Study|Protocol Violation|1|||
156675659|NCT03827395|565556842|FG001|Overall Study|Protocol Violation|0|||
156328130|NCT03148275|564301505|FG000|Overall Study|Liver transplant|2|||
156328131|NCT03148275|564301505|FG000|Overall Study|Patient decision|5|||
156433572|NCT02914522|564676240|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
156433573|NCT02914522|564676241|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
156433574|NCT02914522|564676242|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
156433575|NCT02914522|564676243|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
156433576|NCT02914522|564676244|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
156433577|NCT02914522|564676245|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
156433578|NCT02914522|564676246|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
156433579|NCT02914522|564676247|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
156433580|NCT02914522|564676237|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
156433581|NCT02914522|564676238|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
156433582|NCT02914522|564676239|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
156433583|NCT02914522|564676240|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
156433584|NCT02914522|564676241|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
156433585|NCT02914522|564676242|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
156433586|NCT02914522|564676243|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
156433587|NCT02914522|564676244|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
156433588|NCT02914522|564676245|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
156433589|NCT02914522|564676246|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
156433590|NCT02914522|564676247|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
156433591|NCT02914522|564676237|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433592|NCT02914522|564676238|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433593|NCT02914522|564676239|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433594|NCT02914522|564676240|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433595|NCT02914522|564676241|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
156433596|NCT02914522|564676242|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433597|NCT02914522|564676243|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433598|NCT02914522|564676244|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433599|NCT02914522|564676245|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433600|NCT02914522|564676246|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433601|NCT02914522|564676247|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
156433602|NCT02914522|564676237|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
156433603|NCT02914522|564676238|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433604|NCT02914522|564676239|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433605|NCT02914522|564676240|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433606|NCT02914522|564676241|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433607|NCT02914522|564676242|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433608|NCT02914522|564676243|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433609|NCT02914522|564676244|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433610|NCT02914522|564676245|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433611|NCT02914522|564676246|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433612|NCT02914522|564676247|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
156433613|NCT02914522|564676237|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
156433614|NCT02914522|564676238|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
156433615|NCT02914522|564676239|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
156433616|NCT02914522|564676240|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
156433617|NCT02914522|564676241|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
156433618|NCT02914522|564676242|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
156433619|NCT02914522|564676243|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
156433620|NCT02914522|564676244|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
156433621|NCT02914522|564676245|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
156433622|NCT02914522|564676246|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
156675660|NCT03827395|565556841|FG000|Overall Study|Became ineligible after enrollment|1|||
156675661|NCT03827395|565556842|FG001|Overall Study|Became ineligible after enrollment|2|||
156675662|NCT04723693|565556843|FG000|Overall Study|Withdrawal by Subject|2|||
156675663|NCT00294047|565556844|FG000|Month 48|Adverse Event|28|||
156675664|NCT00294047|565556845|FG001|Month 48|Adverse Event|13|||
156675665|NCT00294047|565556844|FG000|Month 48|Protocol Violation|4|||
156675666|NCT00294047|565556845|FG001|Month 48|Protocol Violation|4|||
156675667|NCT00294047|565556844|FG000|Month 48|Withdrawal by Subject|111|||
156675668|NCT00294047|565556845|FG001|Month 48|Withdrawal by Subject|115|||
156675669|NCT00294047|565556844|FG000|Month 48|Lost to Follow-up|272|||
156675670|NCT00294047|565556845|FG001|Month 48|Lost to Follow-up|287|||
156675671|NCT00294047|565556844|FG000|Month 48|Other|10|||
156675672|NCT00294047|565556845|FG001|Month 48|Other|14|||
156675673|NCT00294047|565556844|FG000|Month 84|Adverse Event|4|||
156675674|NCT00294047|565556845|FG001|Month 84|Adverse Event|2|||
156433623|NCT02914522|564676247|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
156433624|NCT02914522|564676237|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
156675675|NCT00294047|565556844|FG000|Month 84|Protocol Violation|1|||
156675676|NCT00294047|565556845|FG001|Month 84|Protocol Violation|1|||
156675677|NCT00294047|565556844|FG000|Month 84|Withdrawal by Subject|33|||
156433625|NCT02914522|564676238|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
156433626|NCT02914522|564676239|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
156433627|NCT02914522|564676240|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
156433628|NCT02914522|564676241|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
156433629|NCT02914522|564676242|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
156433630|NCT02914522|564676243|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
156433631|NCT02914522|564676244|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
156433632|NCT02914522|564676245|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
156433633|NCT02914522|564676246|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
156433634|NCT02914522|564676247|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
156433635|NCT02914522|564676237|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
156433636|NCT02914522|564676238|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
156433637|NCT02914522|564676239|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
156433638|NCT02914522|564676240|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
156433639|NCT02914522|564676241|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
156433640|NCT02914522|564676242|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
156433641|NCT02914522|564676243|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
156433642|NCT02914522|564676244|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
156433643|NCT02914522|564676245|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
156433644|NCT02914522|564676246|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
156433645|NCT02914522|564676247|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
156433646|NCT02914522|564676237|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
156433647|NCT02914522|564676238|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
156433648|NCT02914522|564676239|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
156433649|NCT02914522|564676240|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
156433650|NCT02914522|564676241|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
156433651|NCT02914522|564676242|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
156433652|NCT02914522|564676243|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
156433653|NCT02914522|564676244|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
156433654|NCT02914522|564676245|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
156433655|NCT02914522|564676246|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
156433656|NCT02914522|564676247|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
156433657|NCT02914522|564676237|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
156433658|NCT02914522|564676238|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
156433659|NCT02914522|564676239|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
156433660|NCT02914522|564676240|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
156433661|NCT02914522|564676241|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
156433662|NCT02914522|564676242|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
156433663|NCT02914522|564676243|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
156433664|NCT02914522|564676244|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
156433665|NCT02914522|564676245|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
156433666|NCT02914522|564676246|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
156433667|NCT02914522|564676247|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
156433668|NCT02914522|564676237|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
156433669|NCT02914522|564676238|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
156675678|NCT00294047|565556845|FG001|Month 84|Withdrawal by Subject|31|||
156675679|NCT00294047|565556844|FG000|Month 84|Lost to Follow-up|187|||
156675680|NCT00294047|565556845|FG001|Month 84|Lost to Follow-up|190|||
156675681|NCT00294047|565556844|FG000|Month 84|Absent Cervix|2|||
156675682|NCT00294047|565556845|FG001|Month 84|Absent Cervix|0|||
156675683|NCT00294047|565556844|FG000|Month 84|Work related reasons|4|||
156528819|NCT04796896|565030958|FG000|Overall Study|Other Than Specified|6|||
156528820|NCT04796896|565030959|FG001|Overall Study|Other Than Specified|5|||
156528821|NCT04796896|565030960|FG002|Overall Study|Other Than Specified|3|||
156433670|NCT02914522|564676239|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
156433671|NCT02914522|564676240|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
156433672|NCT02914522|564676241|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
156433673|NCT02914522|564676242|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
156433674|NCT02914522|564676243|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
156433675|NCT02914522|564676244|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
156433676|NCT02914522|564676245|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
156433677|NCT02914522|564676246|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
156675684|NCT00294047|565556845|FG001|Month 84|Work related reasons|2|||
156675685|NCT00294047|565556844|FG000|Month 84|Center closed, subject did not transfer|1|||
156675686|NCT00294047|565556845|FG001|Month 84|Center closed, subject did not transfer|0|||
156675687|NCT00294047|565556844|FG000|Month 84|Family problems|2|||
156328132|NCT03148275|564301505|FG000|Overall Study|transition to commercial drug|1|||
156328133|NCT03148275|564301505|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
156328134|NCT05098938|564301506|FG000|Overall Study|Adverse Event|4|||
156328135|NCT05098938|564301507|FG001|Overall Study|Adverse Event|3|||
156328136|NCT05098938|564301506|FG000|Overall Study|inclusion/exclusion criteria change|11|||
156328137|NCT05098938|564301507|FG001|Overall Study|inclusion/exclusion criteria change|5|||
156328138|NCT05098938|564301506|FG000|Overall Study|lack of compliance|26|||
156328139|NCT05098938|564301507|FG001|Overall Study|lack of compliance|19|||
156328140|NCT05098938|564301506|FG000|Overall Study|Lost to Follow-up|37|||
156328141|NCT05098938|564301507|FG001|Overall Study|Lost to Follow-up|40|||
156328142|NCT05098938|564301506|FG000|Overall Study|Lost in treatment period|17|||
156328143|NCT05098938|564301507|FG001|Overall Study|Lost in treatment period|13|||
156328144|NCT05098938|564301506|FG000|Overall Study|Met an exclusion criterion|0|||
156328145|NCT05098938|564301507|FG001|Overall Study|Met an exclusion criterion|3|||
156328146|NCT05098938|564301506|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
156328147|NCT05098938|564301507|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
156328148|NCT05098938|564301506|FG000|Overall Study|Physician Decision|25|||
156328149|NCT05098938|564301507|FG001|Overall Study|Physician Decision|32|||
156328150|NCT05098938|564301506|FG000|Overall Study|Run in failure in treatment phase|1|||
156328151|NCT05098938|564301507|FG001|Overall Study|Run in failure in treatment phase|1|||
156328152|NCT05098938|564301506|FG000|Overall Study|Withdrawal by Subject|0|||
156328153|NCT05098938|564301507|FG001|Overall Study|Withdrawal by Subject|3|||
156328154|NCT05098938|564301506|FG000|Overall Study|Run-in Failure in early study|505|||
156328155|NCT05098938|564301507|FG001|Overall Study|Run-in Failure in early study|514|||
156328156|NCT05098938|564301506|FG000|Overall Study|IMP delivery missed|1|||
156328157|NCT05098938|564301507|FG001|Overall Study|IMP delivery missed|5|||
156328158|NCT05098938|564301506|FG000|Overall Study|6 months visit was missed|2|||
156328159|NCT05098938|564301507|FG001|Overall Study|6 months visit was missed|0|||
156328160|NCT05098938|564301506|FG000|Overall Study|fit for use was not completed within window|3|||
156328161|NCT05098938|564301507|FG001|Overall Study|fit for use was not completed within window|0|||
156328162|NCT05098938|564301506|FG000|Overall Study|V2 visit was not completed within window|0|||
156328163|NCT05098938|564301507|FG001|Overall Study|V2 visit was not completed within window|1|||
156328164|NCT05098938|564301506|FG000|Overall Study|exclusionary medication use|1|||
156328165|NCT05098938|564301507|FG001|Overall Study|exclusionary medication use|2|||
156328166|NCT05098938|564301506|FG000|Overall Study|change in medication|1|||
156328167|NCT05098938|564301507|FG001|Overall Study|change in medication|0|||
156328168|NCT05098938|564301506|FG000|Overall Study|treatment failure|2|||
156328169|NCT05098938|564301507|FG001|Overall Study|treatment failure|1|||
156328170|NCT01828320|564301508|FG000|Overall Study|Lost to Follow-up|1|||
156328171|NCT01828320|564301509|FG001|Overall Study|Lost to Follow-up|3|||
156328172|NCT01828320|564301508|FG000|Overall Study|Withdrawal by Subject|7|||
156328173|NCT01828320|564301509|FG001|Overall Study|Withdrawal by Subject|2|||
156328174|NCT03803683|564301510|FG000|Overall Study|Lost to Follow-up|41|||
156328175|NCT03803683|564301511|FG001|Overall Study|Lost to Follow-up|18|||
156328176|NCT03803683|564301512|FG002|Overall Study|Lost to Follow-up|12|||
156328177|NCT03803683|564301510|FG000|Overall Study|Withdrawal by Subject|9|||
156328178|NCT03803683|564301511|FG001|Overall Study|Withdrawal by Subject|1|||
156328179|NCT03803683|564301512|FG002|Overall Study|Withdrawal by Subject|4|||
156328180|NCT00492050|564301513|FG000|Overall Study|Adverse Event|1|||
156328181|NCT00492050|564301513|FG000|Overall Study|Lack of Efficacy|1|||
156328182|NCT00492050|564301513|FG000|Overall Study|Withdrawal by Subject|3|||
156328183|NCT00492050|564301513|FG000|Overall Study|Unable to collect SCT|2|||
156328184|NCT00492050|564301513|FG000|Overall Study|Progressive Disease|2|||
156328185|NCT04493333|564303167|FG000|Overall Study|Withdrawal by Subject|1|||
156328186|NCT04493333|564303168|FG001|Overall Study|Withdrawal by Subject|1|||
156675688|NCT00294047|565556845|FG001|Month 84|Family problems|2|||
156328187|NCT04493333|564303167|FG000|Overall Study|Ineligible|0|||
156328188|NCT04493333|564303168|FG001|Overall Study|Ineligible|1|||
156328189|NCT04493333|564303167|FG000|Overall Study|Noncompliance|2|||
156328190|NCT04493333|564303168|FG001|Overall Study|Noncompliance|1|||
156328191|NCT02206048|564303174|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
156328192|NCT02925923|564303175|FG000|Overall Study|blood samples hemolyzed|0|||
156328193|NCT02925923|564303176|FG001|Overall Study|blood samples hemolyzed|2|||
156328194|NCT00866788|564303180|FG000|Overall Study|Adverse Event|0|||
156328195|NCT00866788|564303181|FG001|Overall Study|Adverse Event|2|||
156675689|NCT00294047|565556844|FG000|Month 84|Lack of time|3|||
156675690|NCT00294047|565556845|FG001|Month 84|Lack of time|1|||
156675691|NCT00294047|565556844|FG000|Month 84|Personal reason|2|||
156675692|NCT00294047|565556845|FG001|Month 84|Personal reason|4|||
156675693|NCT00294047|565556844|FG000|Month 84|Subject does not want male physician|1|||
156675694|NCT00294047|565556845|FG001|Month 84|Subject does not want male physician|0|||
156675695|NCT00294047|565556844|FG000|Month 84|Transport reimbursement delayed|0|||
156675696|NCT00294047|565556845|FG001|Month 84|Transport reimbursement delayed|1|||
156675697|NCT00294047|565556844|FG000|Month 84|Unable to reach study site|1|||
156675698|NCT00294047|565556845|FG001|Month 84|Unable to reach study site|0|||
156433678|NCT02914522|564676247|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
156433679|NCT02914522|564676237|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
156433680|NCT02914522|564676238|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
156433681|NCT02914522|564676239|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
156433682|NCT02914522|564676240|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
156433683|NCT02914522|564676241|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
156433684|NCT02914522|564676242|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
156433685|NCT02914522|564676243|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
156433686|NCT02914522|564676244|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
156433687|NCT02914522|564676245|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
156433688|NCT02914522|564676246|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
156433689|NCT02914522|564676247|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
156433690|NCT02914522|564676237|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433691|NCT02914522|564676238|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433692|NCT02914522|564676239|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433693|NCT02914522|564676240|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433694|NCT02914522|564676241|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433695|NCT02914522|564676242|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433696|NCT02914522|564676243|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433697|NCT02914522|564676244|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
156433698|NCT02914522|564676245|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
156433699|NCT02914522|564676246|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433700|NCT02914522|564676247|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
156433701|NCT02914522|564676237|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433702|NCT02914522|564676238|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433703|NCT02914522|564676239|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433704|NCT02914522|564676240|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433705|NCT02914522|564676241|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433706|NCT02914522|564676242|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433707|NCT02914522|564676243|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433708|NCT02914522|564676244|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433709|NCT02914522|564676245|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
156433710|NCT02914522|564676246|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
156433711|NCT02914522|564676247|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
156433712|NCT02914522|564676237|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433713|NCT02914522|564676238|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433714|NCT02914522|564676239|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433715|NCT02914522|564676240|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433716|NCT02914522|564676241|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433717|NCT02914522|564676242|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433718|NCT02914522|564676243|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433719|NCT02914522|564676244|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433720|NCT02914522|564676245|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433721|NCT02914522|564676246|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
156675699|NCT00294047|565556844|FG000|Month 84|Under investigation locally|1|||
156675700|NCT00294047|565556845|FG001|Month 84|Under investigation locally|0|||
156675701|NCT00294047|565556844|FG000|Month 84|Visit missed|0|||
156675702|NCT00294047|565556845|FG001|Month 84|Visit missed|1|||
156433722|NCT02914522|564676247|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
156433723|NCT02807493|564676253|FG000|Overall Study|Adverse Event|5|||
156433724|NCT02807493|564676254|FG001|Overall Study|Adverse Event|2|||
156433725|NCT02807493|564676253|FG000|Overall Study|Lost to Follow-up|6|||
156433726|NCT02807493|564676254|FG001|Overall Study|Lost to Follow-up|0|||
156433727|NCT02807493|564676253|FG000|Overall Study|Physician Decision|4|||
156433728|NCT02807493|564676254|FG001|Overall Study|Physician Decision|1|||
156433729|NCT02807493|564676253|FG000|Overall Study|Protocol Violation|7|||
156675703|NCT00294047|565556844|FG000|Month 84|No consent for Month 84 Follow-up|731|||
156675704|NCT00294047|565556845|FG001|Month 84|No consent for Month 84 Follow-up|754|||
156675705|NCT02157974|565556846|FG000|Overall Study|Withdrawal by Subject|0|||
156675706|NCT02157974|565556847|FG001|Overall Study|Withdrawal by Subject|1|||
156675707|NCT02157974|565556848|FG002|Overall Study|Withdrawal by Subject|0|||
156675708|NCT02157974|565556849|FG003|Overall Study|Withdrawal by Subject|0|||
156675709|NCT02157974|565556850|FG004|Overall Study|Withdrawal by Subject|0|||
156675710|NCT02157974|565556846|FG000|Overall Study|Screen Failure|0|||
156675711|NCT02157974|565556847|FG001|Overall Study|Screen Failure|1|||
156675712|NCT02157974|565556848|FG002|Overall Study|Screen Failure|0|||
156675713|NCT02157974|565556849|FG003|Overall Study|Screen Failure|0|||
156675714|NCT02157974|565556850|FG004|Overall Study|Screen Failure|0|||
156433730|NCT02807493|564676254|FG001|Overall Study|Protocol Violation|0|||
156433731|NCT02807493|564676253|FG000|Overall Study|Withdrawal by Subject|17|||
156433732|NCT02807493|564676254|FG001|Overall Study|Withdrawal by Subject|10|||
156433733|NCT02807493|564676253|FG000|Overall Study|Other withdrawal|17|||
156433734|NCT02807493|564676254|FG001|Overall Study|Other withdrawal|0|||
156433735|NCT02807493|564676253|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
156433736|NCT02807493|564676254|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
156433737|NCT01227707|564676255|FG000|Overall Study|Adverse Event|10|||
156433738|NCT01227707|564676255|FG000|Overall Study|Progression of disease|3|||
156433739|NCT01227707|564676255|FG000|Overall Study|Withdrawal by Subject|1|||
156433740|NCT01227707|564676255|FG000|Overall Study|Patient non-compliance|3|||
156433741|NCT01227707|564676255|FG000|Overall Study|Medical decision|6|||
156433742|NCT01227707|564676255|FG000|Overall Study|Death|1|||
156433743|NCT00823979|564676258|FG000|Overall Study|Lack of Efficacy|13|||
156433744|NCT00823979|564676259|FG001|Overall Study|Lack of Efficacy|16|||
156433745|NCT00823979|564676260|FG002|Overall Study|Lack of Efficacy|9|||
156433746|NCT00823979|564676258|FG000|Overall Study|Lost to Follow-up|2|||
156433747|NCT00823979|564676259|FG001|Overall Study|Lost to Follow-up|1|||
156433748|NCT00823979|564676260|FG002|Overall Study|Lost to Follow-up|0|||
156433749|NCT00823979|564676258|FG000|Overall Study|Withdrawal by Subject|2|||
156433750|NCT00823979|564676259|FG001|Overall Study|Withdrawal by Subject|3|||
156433751|NCT00823979|564676260|FG002|Overall Study|Withdrawal by Subject|2|||
156433752|NCT00823979|564676258|FG000|Overall Study|Protocol Violation|1|||
156433753|NCT00823979|564676259|FG001|Overall Study|Protocol Violation|1|||
156433754|NCT00823979|564676260|FG002|Overall Study|Protocol Violation|0|||
156433755|NCT00823979|564676258|FG000|Overall Study|Pregnancy|0|||
156433756|NCT00823979|564676259|FG001|Overall Study|Pregnancy|1|||
156433757|NCT00823979|564676260|FG002|Overall Study|Pregnancy|0|||
156433758|NCT00823979|564676258|FG000|Overall Study|Adverse Event|0|||
156433759|NCT00823979|564676259|FG001|Overall Study|Adverse Event|2|||
156433760|NCT00823979|564676260|FG002|Overall Study|Adverse Event|4|||
156433761|NCT00823979|564676258|FG000|Overall Study|Other|2|||
156780699|NCT04327271|565947181|FG001|Overall Study|Withdrawal by Subject|0|||
156780700|NCT04327271|565947180|FG000|Overall Study|randomization error (data capture)|4|||
156780701|NCT04327271|565947181|FG001|Overall Study|randomization error (data capture)|3|||
156780702|NCT04339972|565947182|FG000|Overall Study|Scheduling Issues|3|||
156780703|NCT04339972|565947183|FG001|Overall Study|Scheduling Issues|3|||
156780704|NCT04339972|565947182|FG000|Overall Study|dropout|1|||
156780705|NCT04339972|565947183|FG001|Overall Study|dropout|1|||
156780706|NCT04339972|565947182|FG000|Overall Study|Technical issues|1|||
156780707|NCT04339972|565947183|FG001|Overall Study|Technical issues|0|||
156780708|NCT04339972|565947182|FG000|Overall Study|Claustraphobia|0|||
156780709|NCT04339972|565947183|FG001|Overall Study|Claustraphobia|1|||
156433762|NCT00823979|564676259|FG001|Overall Study|Other|0|||
156433763|NCT00823979|564676260|FG002|Overall Study|Other|1|||
156433764|NCT00823979|564676258|FG000|Overall Study|Randomized but not Treated|4|||
156433765|NCT00823979|564676259|FG001|Overall Study|Randomized but not Treated|3|||
156433766|NCT00823979|564676260|FG002|Overall Study|Randomized but not Treated|1|||
156433767|NCT00823979|564676258|FG000|Overall Study|Study Terminated by Sponsor|5|||
156433768|NCT00823979|564676259|FG001|Overall Study|Study Terminated by Sponsor|5|||
156433769|NCT00823979|564676260|FG002|Overall Study|Study Terminated by Sponsor|7|||
156433770|NCT03523091|564676261|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
156433771|NCT03523091|564676262|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
156433772|NCT03523091|564676261|FG000|Overall Study|Withdrawal by Subject|0|||
156433773|NCT03523091|564676262|FG001|Overall Study|Withdrawal by Subject|3|||
156433774|NCT03523091|564676261|FG000|Overall Study|Increase Botox dose|0|||
156433775|NCT03523091|564676262|FG001|Overall Study|Increase Botox dose|1|||
156528822|NCT04796896|565030961|FG003|Overall Study|Other Than Specified|2|||
156528823|NCT04796896|565030962|FG004|Overall Study|Other Than Specified|6|||
156528824|NCT04796896|565030963|FG005|Overall Study|Other Than Specified|31|||
156528825|NCT04796896|565030964|FG006|Overall Study|Other Than Specified|86|||
156528826|NCT04796896|565030965|FG007|Overall Study|Other Than Specified|66|||
156528827|NCT04796896|565030966|FG008|Overall Study|Other Than Specified|388|||
156528828|NCT04796896|565030967|FG009|Overall Study|Other Than Specified|48|||
156528829|NCT04796896|565030968|FG010|Overall Study|Other Than Specified|258|||
156528830|NCT04796896|565030969|FG011|Overall Study|Other Than Specified|4|||
156780710|NCT02112552|565947185|FG000|Overall Study|Withdrawal by Subject|1|||
156780711|NCT02112552|565947185|FG000|Overall Study|Adverse Event|1|||
156433776|NCT00811057|564676263|FG000|Overall Study|Protocol Violation|5|||
156433777|NCT00811057|564676264|FG001|Overall Study|Protocol Violation|10|||
156528831|NCT04796896|565030958|FG000|Overall Study|Protocol Deviation|0|||
156433778|NCT00811057|564676265|FG002|Overall Study|Protocol Violation|10|||
156433779|NCT01769391|564676268|FG000|Overall Study|Death|10|||
156528832|NCT04796896|565030959|FG001|Overall Study|Protocol Deviation|0|||
156433780|NCT01769391|564676269|FG001|Overall Study|Death|1|||
156528833|NCT04796896|565030960|FG002|Overall Study|Protocol Deviation|0|||
156780712|NCT04822194|565947187|FG000|Overall Study|Withdrawal by Subject|5|||
156433781|NCT01769391|564676268|FG000|Overall Study|Adverse Event|0|||
156528834|NCT04796896|565030961|FG003|Overall Study|Protocol Deviation|1|||
156528835|NCT04796896|565030962|FG004|Overall Study|Protocol Deviation|1|||
156528836|NCT04796896|565030963|FG005|Overall Study|Protocol Deviation|2|||
156780713|NCT04822194|565947188|FG001|Overall Study|Withdrawal by Subject|4|||
156528837|NCT04796896|565030964|FG006|Overall Study|Protocol Deviation|2|||
156528838|NCT04796896|565030965|FG007|Overall Study|Protocol Deviation|2|||
156528839|NCT04796896|565030966|FG008|Overall Study|Protocol Deviation|2|||
156528840|NCT04796896|565030967|FG009|Overall Study|Protocol Deviation|1|||
156528841|NCT04796896|565030968|FG010|Overall Study|Protocol Deviation|0|||
156528842|NCT04796896|565030969|FG011|Overall Study|Protocol Deviation|0|||
156528843|NCT04796896|565030958|FG000|Overall Study|Missing|0|||
156528844|NCT04796896|565030959|FG001|Overall Study|Missing|0|||
156528845|NCT04796896|565030960|FG002|Overall Study|Missing|0|||
156528846|NCT04796896|565030961|FG003|Overall Study|Missing|0|||
156528847|NCT04796896|565030962|FG004|Overall Study|Missing|0|||
156528848|NCT04796896|565030963|FG005|Overall Study|Missing|0|||
156528849|NCT04796896|565030964|FG006|Overall Study|Missing|2|||
156528850|NCT04796896|565030965|FG007|Overall Study|Missing|1|||
156528851|NCT04796896|565030966|FG008|Overall Study|Missing|2|||
156528852|NCT04796896|565030967|FG009|Overall Study|Missing|1|||
156528853|NCT04796896|565030968|FG010|Overall Study|Missing|1|||
156528854|NCT04796896|565030969|FG011|Overall Study|Missing|0|||
156528855|NCT04796896|565030958|FG000|Overall Study|Death|0|||
156780714|NCT04822194|565947187|FG000|Overall Study|Technical issues with MR scanner|1|||
156780715|NCT04822194|565947188|FG001|Overall Study|Technical issues with MR scanner|0|||
156328196|NCT00866788|564303182|FG002|Overall Study|Adverse Event|0|||
156328197|NCT00866788|564303183|FG003|Overall Study|Adverse Event|1|||
156328198|NCT00866788|564303180|FG000|Overall Study|Lost to Follow-up|1|||
156328199|NCT00866788|564303181|FG001|Overall Study|Lost to Follow-up|1|||
156328200|NCT00866788|564303182|FG002|Overall Study|Lost to Follow-up|0|||
156328201|NCT00866788|564303183|FG003|Overall Study|Lost to Follow-up|2|||
156328202|NCT00866788|564303180|FG000|Overall Study|Withdrawal by Subject|2|||
156328203|NCT00866788|564303181|FG001|Overall Study|Withdrawal by Subject|1|||
156328204|NCT00866788|564303182|FG002|Overall Study|Withdrawal by Subject|0|||
156328205|NCT00866788|564303183|FG003|Overall Study|Withdrawal by Subject|1|||
156328206|NCT00866788|564303180|FG000|Overall Study|Pregnancy|0|||
156328207|NCT00866788|564303181|FG001|Overall Study|Pregnancy|1|||
156328208|NCT00866788|564303182|FG002|Overall Study|Pregnancy|0|||
156328209|NCT00866788|564303183|FG003|Overall Study|Pregnancy|0|||
156328210|NCT00866788|564303180|FG000|Overall Study|Disease progression|3|||
156328211|NCT00866788|564303181|FG001|Overall Study|Disease progression|1|||
156328212|NCT00866788|564303182|FG002|Overall Study|Disease progression|1|||
156328213|NCT00866788|564303183|FG003|Overall Study|Disease progression|0|||
156328214|NCT00866788|564303180|FG000|Overall Study|Physician Decision|0|||
156328215|NCT00866788|564303181|FG001|Overall Study|Physician Decision|0|||
156328216|NCT00866788|564303182|FG002|Overall Study|Physician Decision|1|||
156328217|NCT00866788|564303183|FG003|Overall Study|Physician Decision|1|||
156328218|NCT02349061|564303184|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
156328219|NCT02349061|564303185|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
156328220|NCT02349061|564303186|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
156328221|NCT02349061|564303184|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
156328222|NCT02349061|564303185|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
156328223|NCT02349061|564303186|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
156328224|NCT02349061|564303184|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
156328225|NCT02349061|564303185|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
156328226|NCT02349061|564303186|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
156328227|NCT02349061|564303184|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
156328228|NCT02349061|564303185|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
156328229|NCT02349061|564303186|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
156328230|NCT02349061|564303184|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
156328231|NCT02349061|564303185|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
156328232|NCT02349061|564303186|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
156328233|NCT02349061|564303184|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
156328234|NCT02349061|564303185|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
156328235|NCT02349061|564303186|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
156328236|NCT02349061|564303184|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
156328237|NCT02349061|564303185|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
156528856|NCT04796896|565030959|FG001|Overall Study|Death|0|||
156528857|NCT04796896|565030960|FG002|Overall Study|Death|0|||
156780716|NCT04822194|565947187|FG000|Overall Study|Lost to Follow-up|5|||
156328238|NCT02349061|564303186|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
156328239|NCT02349061|564303184|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
156328240|NCT02349061|564303185|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
156528858|NCT04796896|565030961|FG003|Overall Study|Death|0|||
156528859|NCT04796896|565030962|FG004|Overall Study|Death|0|||
156528860|NCT04796896|565030963|FG005|Overall Study|Death|0|||
156528861|NCT04796896|565030964|FG006|Overall Study|Death|0|||
156528862|NCT04796896|565030965|FG007|Overall Study|Death|0|||
156528863|NCT04796896|565030966|FG008|Overall Study|Death|1|||
156433782|NCT01769391|564676269|FG001|Overall Study|Adverse Event|3|||
156433783|NCT01769391|564676268|FG000|Overall Study|Progressive Disease|1|||
156433784|NCT01769391|564676269|FG001|Overall Study|Progressive Disease|2|||
156433785|NCT01769391|564676268|FG000|Overall Study|Withdrawal by Subject|4|||
156433786|NCT01769391|564676269|FG001|Overall Study|Withdrawal by Subject|3|||
156433787|NCT01769391|564676268|FG000|Overall Study|Investigator Decision|2|||
156433788|NCT01769391|564676269|FG001|Overall Study|Investigator Decision|0|||
156433789|NCT03544515|564677775|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
156433790|NCT03544515|564677776|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
156433791|NCT03544515|564677775|FG000|Overall Study|Lost to Follow-up|2|||
156433792|NCT03544515|564677776|FG001|Overall Study|Lost to Follow-up|0|||
156433793|NCT03169244|564677777|FG000|Overall Study|Lost to Follow-up|1|||
156433794|NCT03169244|564677778|FG001|Overall Study|Lost to Follow-up|2|||
156433795|NCT03169244|564677777|FG000|Overall Study|Adverse Event|1|||
156433796|NCT03169244|564677778|FG001|Overall Study|Adverse Event|0|||
156433797|NCT03169244|564677777|FG000|Overall Study|Withdrawal by Subject|2|||
156433798|NCT03169244|564677778|FG001|Overall Study|Withdrawal by Subject|2|||
156433799|NCT03169244|564677777|FG000|Overall Study|Physician Decision|1|||
156433800|NCT03169244|564677778|FG001|Overall Study|Physician Decision|0|||
156433801|NCT00178399|564677779|FG000|Overall Study|Physician Decision|4|||
156433802|NCT00178399|564677779|FG000|Overall Study|Withdrawal by Subject|8|||
156433803|NCT00178399|564677779|FG000|Overall Study|Lost to Follow-up|1|||
156433804|NCT01376089|564677782|FG000|Overall Study|Patient received no contrast media|3|||
156433805|NCT01376089|564677783|FG001|Overall Study|Patient received no contrast media|4|||
156433806|NCT01458210|564677786|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
156433807|NCT01458210|564677786|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
156433808|NCT01458210|564677786|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
156433809|NCT01458210|564677786|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
156433810|NCT03287622|564677790|FG000|Overall Study|Withdrawal by Subject|1|||
156433811|NCT03287622|564677791|FG001|Overall Study|Withdrawal by Subject|0|||
156433812|NCT03287622|564677790|FG000|Overall Study|Lost to Follow-up|27|||
156433813|NCT03287622|564677791|FG001|Overall Study|Lost to Follow-up|15|||
156433814|NCT03287622|564677790|FG000|Overall Study|No prescripion after surgery|28|||
156433815|NCT03287622|564677791|FG001|Overall Study|No prescripion after surgery|31|||
156433816|NCT03287622|564677790|FG000|Overall Study|prolonged Length of stay|2|||
156433817|NCT03287622|564677791|FG001|Overall Study|prolonged Length of stay|0|||
156433818|NCT03287622|564677790|FG000|Overall Study|surgery related|0|||
156433819|NCT03287622|564677791|FG001|Overall Study|surgery related|2|||
156433820|NCT01616654|564677795|FG000|Overall Study|Lack of Efficacy|1|||
156433821|NCT01616654|564677796|FG001|Overall Study|Lack of Efficacy|0|||
156433822|NCT01616654|564677797|FG002|Overall Study|Lack of Efficacy|0|||
156433823|NCT01616654|564677798|FG003|Overall Study|Lack of Efficacy|0|||
156433824|NCT01616654|564677799|FG004|Overall Study|Lack of Efficacy|1|||
156433825|NCT01616654|564677795|FG000|Overall Study|Adverse Event|0|||
156433826|NCT01616654|564677796|FG001|Overall Study|Adverse Event|1|||
156433827|NCT01616654|564677797|FG002|Overall Study|Adverse Event|2|||
156780717|NCT04822194|565947188|FG001|Overall Study|Lost to Follow-up|7|||
156433828|NCT01616654|564677798|FG003|Overall Study|Adverse Event|1|||
156433829|NCT01616654|564677799|FG004|Overall Study|Adverse Event|0|||
156433830|NCT01616654|564677795|FG000|Overall Study|Withdrawal by Subject|2|||
156433831|NCT01616654|564677796|FG001|Overall Study|Withdrawal by Subject|2|||
156433832|NCT01616654|564677797|FG002|Overall Study|Withdrawal by Subject|3|||
156433833|NCT01616654|564677798|FG003|Overall Study|Withdrawal by Subject|1|||
156433834|NCT01616654|564677799|FG004|Overall Study|Withdrawal by Subject|5|||
156433835|NCT01616654|564677795|FG000|Overall Study|Protocol Violation|0|||
156433836|NCT01616654|564677796|FG001|Overall Study|Protocol Violation|5|||
156433837|NCT01616654|564677797|FG002|Overall Study|Protocol Violation|2|||
156433838|NCT01616654|564677798|FG003|Overall Study|Protocol Violation|4|||
156433839|NCT01616654|564677799|FG004|Overall Study|Protocol Violation|4|||
156433840|NCT01616654|564677795|FG000|Overall Study|Lost to Follow-up|1|||
156433841|NCT01616654|564677796|FG001|Overall Study|Lost to Follow-up|0|||
156433842|NCT01616654|564677797|FG002|Overall Study|Lost to Follow-up|3|||
156433843|NCT01616654|564677798|FG003|Overall Study|Lost to Follow-up|2|||
156433844|NCT01616654|564677799|FG004|Overall Study|Lost to Follow-up|1|||
156433845|NCT01616654|564677795|FG000|Overall Study|Pregnancy|1|||
156433846|NCT01616654|564677796|FG001|Overall Study|Pregnancy|0|||
156433847|NCT01616654|564677797|FG002|Overall Study|Pregnancy|0|||
156433848|NCT01616654|564677798|FG003|Overall Study|Pregnancy|0|||
156433849|NCT01616654|564677799|FG004|Overall Study|Pregnancy|1|||
156433850|NCT01930045|564677802|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
156433851|NCT01930045|564677803|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
156433852|NCT01930045|564677804|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
156433853|NCT01930045|564677805|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
156780718|NCT00640289|565947191|FG000|Overall Study|Death|3|||
156433854|NCT01930045|564677806|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
156433855|NCT01930045|564677807|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
156528864|NCT04796896|565030967|FG009|Overall Study|Death|0|||
156433856|NCT01930045|564677802|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
156433857|NCT01930045|564677803|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
156433858|NCT01930045|564677804|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
156433859|NCT01930045|564677805|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
156433860|NCT01930045|564677806|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
156433861|NCT01930045|564677807|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
156433862|NCT00241644|564677808|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
156433863|NCT00241644|564677809|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
156433864|NCT00241644|564677810|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
156433865|NCT00241644|564677811|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
156433866|NCT00241644|564677808|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
156433867|NCT00241644|564677809|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
156433868|NCT00241644|564677810|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
156433869|NCT00241644|564677811|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
156433870|NCT00241644|564677808|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
156433871|NCT00241644|564677809|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
156433872|NCT00241644|564677810|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
156433873|NCT00241644|564677811|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
156433874|NCT00241644|564677808|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
156433875|NCT00241644|564677809|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
156433876|NCT00241644|564677810|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
156433877|NCT00241644|564677811|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
156433878|NCT00241644|564677808|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
156675715|NCT02157974|565556846|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
156675716|NCT02157974|565556847|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
156675717|NCT02157974|565556848|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
156675718|NCT02157974|565556849|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
156675719|NCT02157974|565556850|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
156675720|NCT00506831|565556853|FG000|Overall Study|Death|1|||
156675721|NCT00506831|565556853|FG000|Overall Study|Withdrawal by Subject|1|||
156675722|NCT01410227|565556857|FG000|Overall Study|Adverse Event|1|||
156675723|NCT01410227|565556858|FG001|Overall Study|Adverse Event|0|||
156675724|NCT01410227|565556859|FG002|Overall Study|Adverse Event|0|||
156675725|NCT01410227|565556860|FG003|Overall Study|Adverse Event|0|||
156675726|NCT01410227|565556857|FG000|Overall Study|Withdrawal by Subject|3|||
156675727|NCT01410227|565556858|FG001|Overall Study|Withdrawal by Subject|0|||
156675728|NCT01410227|565556859|FG002|Overall Study|Withdrawal by Subject|1|||
156433879|NCT00241644|564677809|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
156433880|NCT00241644|564677810|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
156433881|NCT00241644|564677811|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
156433882|NCT00241644|564677808|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
156433883|NCT00241644|564677809|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
156433884|NCT00241644|564677810|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
156433885|NCT00241644|564677811|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
156675729|NCT01410227|565556860|FG003|Overall Study|Withdrawal by Subject|0|||
156675730|NCT01410227|565556857|FG000|Overall Study|Pregnancy|0|||
156675731|NCT01410227|565556858|FG001|Overall Study|Pregnancy|0|||
156675732|NCT01410227|565556859|FG002|Overall Study|Pregnancy|0|||
156675733|NCT01410227|565556860|FG003|Overall Study|Pregnancy|1|||
156675734|NCT01410227|565556857|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
156433886|NCT00241644|564677808|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
156433887|NCT00241644|564677809|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
156433888|NCT00241644|564677810|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
156433889|NCT00241644|564677811|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
156433890|NCT00241644|564677808|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
156433891|NCT00241644|564677809|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
156675735|NCT01410227|565556858|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
156675736|NCT01410227|565556859|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
156675737|NCT01410227|565556860|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
156433892|NCT00241644|564677810|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
156433893|NCT00241644|564677811|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
156433894|NCT00241644|564677808|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
156433895|NCT00241644|564677809|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
156433896|NCT00241644|564677810|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
156433897|NCT00241644|564677811|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
156675738|NCT01808651|565556861|FG000|Study Period 1|Lost to Follow-up|1|||
156675739|NCT01808651|565556862|FG001|Study Period 1|Lost to Follow-up|3|||
156675740|NCT01808651|565556863|FG002|Study Period 1|Lost to Follow-up|0|||
156675741|NCT01808651|565556861|FG000|Study Period 1|Protocol Violation|1|||
156675742|NCT01808651|565556862|FG001|Study Period 1|Protocol Violation|0|||
156433898|NCT00241644|564677808|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
156433899|NCT00241644|564677809|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
156433900|NCT00241644|564677810|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
156433901|NCT00241644|564677811|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
156433902|NCT00241644|564677808|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
156433903|NCT00241644|564677809|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
156433904|NCT00241644|564677810|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
156433905|NCT00241644|564677811|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
156433906|NCT00241644|564677808|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
156433907|NCT00241644|564677809|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
156433908|NCT00241644|564677810|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
156433909|NCT00241644|564677811|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
156433910|NCT00241644|564677808|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
156433911|NCT00241644|564677809|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
156433912|NCT00241644|564677810|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
156433913|NCT00241644|564677811|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
156433914|NCT00545844|564677812|FG000|Overall Study|Lost to Follow-up|9|||
156433915|NCT00545844|564677812|FG000|Overall Study|Protocol Violation|1|||
156433916|NCT00545844|564677812|FG000|Overall Study|Withdrawal by Subject|2|||
156433917|NCT01087762|564677813|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
156433918|NCT01087762|564677814|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
156433919|NCT01087762|564677815|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
156433920|NCT01087762|564677816|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
156433921|NCT01087762|564677817|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
156433922|NCT01087762|564677813|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
156433923|NCT01087762|564677814|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
156433924|NCT01087762|564677815|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
156433925|NCT01087762|564677816|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
156433926|NCT01087762|564677817|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
156433927|NCT01087762|564677813|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
156433928|NCT01087762|564677814|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
156433929|NCT01087762|564677815|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
156433930|NCT01087762|564677816|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
156433931|NCT01087762|564677817|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
156433932|NCT01087762|564677813|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
156433933|NCT01087762|564677814|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
156433934|NCT01087762|564677815|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
156433935|NCT01087762|564677816|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
156433936|NCT01087762|564677817|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
156433937|NCT01087762|564677813|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
156433938|NCT01087762|564677814|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
156433939|NCT01087762|564677815|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
156433940|NCT01087762|564677816|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
156433941|NCT01087762|564677817|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
156433942|NCT01087762|564677813|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
156433943|NCT01087762|564677814|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
156528865|NCT04796896|565030968|FG010|Overall Study|Death|0|||
156528866|NCT04796896|565030969|FG011|Overall Study|Death|0|||
156528867|NCT02021292|565030970|FG000|Overall Study|Physician Decision|0|||
156528868|NCT02021292|565030971|FG001|Overall Study|Physician Decision|1|||
156528869|NCT02021292|565030970|FG000|Overall Study|Lost to Follow-up|0|||
156528870|NCT02021292|565030971|FG001|Overall Study|Lost to Follow-up|1|||
156528871|NCT02021292|565030970|FG000|Overall Study|Death|0|||
156528872|NCT02021292|565030971|FG001|Overall Study|Death|1|||
156528873|NCT05972733|565030974|FG000|Overall Study|Lost to Follow-up|2|||
156528874|NCT05972733|565030974|FG000|Overall Study|Withdrawal by Subject|1|||
156528875|NCT01177787|565030975|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
156528876|NCT01177787|565030975|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
156528877|NCT01177787|565030975|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
156528878|NCT01676909|565030980|FG000|Overall Study|Withdrawal by Subject|3|||
156528879|NCT01676909|565030981|FG001|Overall Study|Withdrawal by Subject|5|||
156528880|NCT01676909|565030980|FG000|Overall Study|Lost to Follow-up|15|||
156528881|NCT01676909|565030981|FG001|Overall Study|Lost to Follow-up|9|||
156528882|NCT04615247|565030982|FG000|Overall Study|Adverse Event|0|||
156528883|NCT04615247|565030983|FG001|Overall Study|Adverse Event|2|||
156528884|NCT04615247|565030982|FG000|Overall Study|Withdrawal by Subject|1|||
156528885|NCT04615247|565030983|FG001|Overall Study|Withdrawal by Subject|1|||
156528886|NCT00823901|565030986|FG000|Overall Study|Adverse Event|1|||
156528887|NCT00823901|565030987|FG001|Overall Study|Adverse Event|1|||
156528888|NCT00823901|565030986|FG000|Overall Study|Lack of Efficacy|1|||
156528889|NCT00823901|565030987|FG001|Overall Study|Lack of Efficacy|0|||
156433944|NCT01087762|564677815|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
156433945|NCT01087762|564677816|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
156433946|NCT01087762|564677817|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
156433947|NCT01087762|564677813|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
156433948|NCT01087762|564677814|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
156433949|NCT01087762|564677815|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
156433950|NCT01087762|564677816|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
156433951|NCT01087762|564677817|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
156433952|NCT01087762|564677813|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
156433953|NCT01087762|564677814|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
156433954|NCT01087762|564677815|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
156433955|NCT01087762|564677816|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
156433956|NCT01087762|564677817|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
156433957|NCT01087762|564677813|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
156433958|NCT01087762|564677814|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
156675743|NCT01808651|565556863|FG002|Study Period 1|Protocol Violation|1|||
156675744|NCT01808651|565556861|FG000|Study Period 1|Physician Decision|3|||
156675745|NCT01808651|565556862|FG001|Study Period 1|Physician Decision|2|||
156433959|NCT01087762|564677815|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
156675746|NCT01808651|565556863|FG002|Study Period 1|Physician Decision|0|||
156433960|NCT01087762|564677816|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
156433961|NCT01087762|564677817|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
156433962|NCT01087762|564677813|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
156433963|NCT01087762|564677814|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
156433964|NCT01087762|564677815|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
156433965|NCT01087762|564677816|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
156433966|NCT01087762|564677817|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
156433967|NCT01087762|564677813|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
156433968|NCT01087762|564677814|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
156433969|NCT01087762|564677815|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
156433970|NCT01087762|564677816|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
156433971|NCT01087762|564677817|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
156433972|NCT01087762|564677813|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
156433973|NCT01087762|564677814|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
156433974|NCT01087762|564677815|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
156433975|NCT01087762|564677816|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
156433976|NCT01087762|564677817|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
156433977|NCT01087762|564677813|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
156433978|NCT01087762|564677814|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
156433979|NCT01087762|564677815|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
156433980|NCT01087762|564677816|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
156433981|NCT01087762|564677817|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
156433982|NCT01329328|564677818|FG000|Overall Study|Withdrawal by Subject|2|||
156433983|NCT01329328|564677819|FG001|Overall Study|Withdrawal by Subject|4|||
156433984|NCT01329328|564677820|FG002|Overall Study|Withdrawal by Subject|3|||
156433985|NCT01565928|564677821|FG000|Overall Study|Adverse Event|3|||
156433986|NCT01565928|564677821|FG000|Overall Study|Other|3|||
156433987|NCT01565928|564677821|FG000|Overall Study|Progressive Disease|13|||
156433988|NCT01565928|564677821|FG000|Overall Study|Withdrawal by Subject|1|||
156433989|NCT01565928|564677821|FG000|Overall Study|Death|2|||
156433990|NCT01183780|564677825|FG000|Overall Study|Withdrawal by Subject|25|||
156433991|NCT01183780|564677826|FG001|Overall Study|Withdrawal by Subject|14|||
156433992|NCT01183780|564677825|FG000|Overall Study|Lost to Follow-up|6|||
156433993|NCT01183780|564677826|FG001|Overall Study|Lost to Follow-up|11|||
156433994|NCT00612586|564677829|FG000|Overall Study|Adverse Event|6|||
156675747|NCT01808651|565556861|FG000|Study Period 1|Lack of Efficacy|2|||
156675748|NCT01808651|565556862|FG001|Study Period 1|Lack of Efficacy|1|||
156675749|NCT01808651|565556863|FG002|Study Period 1|Lack of Efficacy|0|||
156675750|NCT01808651|565556861|FG000|Study Period 1|Adverse Event|10|||
156675751|NCT01808651|565556862|FG001|Study Period 1|Adverse Event|4|||
156675752|NCT01808651|565556863|FG002|Study Period 1|Adverse Event|1|||
156675753|NCT01808651|565556861|FG000|Study Period 1|Participant Decision|9|||
156675754|NCT01808651|565556862|FG001|Study Period 1|Participant Decision|7|||
156675755|NCT01808651|565556863|FG002|Study Period 1|Participant Decision|3|||
156675756|NCT00585286|565556865|FG000|Overall Study|Lost to Follow-up|1|||
156675757|NCT00608322|565556869|FG000|Overall Study|Death|2|||
156433995|NCT00612586|564677830|FG001|Overall Study|Adverse Event|2|||
156675758|NCT00608322|565556870|FG001|Overall Study|Death|1|||
156675759|NCT04002648|565556871|FG000|Overall Study|Lost to Follow-up|2|||
156675760|NCT04002648|565556872|FG001|Overall Study|Lost to Follow-up|0|||
156675761|NCT00606281|565556877|FG000|Overall Study|Adverse Event|11|||
156675762|NCT00606281|565556878|FG001|Overall Study|Adverse Event|12|||
156528890|NCT00823901|565030986|FG000|Overall Study|Lost to Follow-up|2|||
156528891|NCT00823901|565030987|FG001|Overall Study|Lost to Follow-up|1|||
156528892|NCT01369511|565030988|FG000|Overall Study|Adverse Event|1|||
156528893|NCT01369511|565030989|FG001|Overall Study|Adverse Event|1|||
156528894|NCT01369511|565030990|FG002|Overall Study|Adverse Event|5|||
156528895|NCT01369511|565030991|FG003|Overall Study|Adverse Event|0|||
156528896|NCT01369511|565030988|FG000|Overall Study|Entry criteria not met|2|||
156528897|NCT01369511|565030989|FG001|Overall Study|Entry criteria not met|0|||
156528898|NCT01369511|565030990|FG002|Overall Study|Entry criteria not met|0|||
156528899|NCT01369511|565030991|FG003|Overall Study|Entry criteria not met|1|||
156528900|NCT01369511|565030988|FG000|Overall Study|Lost to Follow-up|0|||
156528901|NCT01369511|565030989|FG001|Overall Study|Lost to Follow-up|1|||
156528902|NCT01369511|565030990|FG002|Overall Study|Lost to Follow-up|1|||
156528903|NCT01369511|565030991|FG003|Overall Study|Lost to Follow-up|2|||
156528904|NCT01369511|565030988|FG000|Overall Study|Protocol Violation|0|||
156528905|NCT01369511|565030989|FG001|Overall Study|Protocol Violation|1|||
156528906|NCT01369511|565030990|FG002|Overall Study|Protocol Violation|0|||
156528907|NCT01369511|565030991|FG003|Overall Study|Protocol Violation|2|||
156528908|NCT01369511|565030988|FG000|Overall Study|Physician Decision|3|||
156528909|NCT01369511|565030989|FG001|Overall Study|Physician Decision|4|||
156528910|NCT01369511|565030990|FG002|Overall Study|Physician Decision|0|||
156528911|NCT01369511|565030991|FG003|Overall Study|Physician Decision|0|||
156528912|NCT01369511|565030988|FG000|Overall Study|Sponsor decision|2|||
156528913|NCT01369511|565030989|FG001|Overall Study|Sponsor decision|0|||
156528914|NCT01369511|565030990|FG002|Overall Study|Sponsor decision|1|||
156528915|NCT01369511|565030991|FG003|Overall Study|Sponsor decision|0|||
156528916|NCT01369511|565030988|FG000|Overall Study|Withdrawal by Subject|5|||
156528917|NCT01369511|565030989|FG001|Overall Study|Withdrawal by Subject|6|||
156433996|NCT00612586|564677829|FG000|Overall Study|Death|1|||
156433997|NCT00612586|564677830|FG001|Overall Study|Death|0|||
156433998|NCT00612586|564677829|FG000|Overall Study|Entry Criteria Not Met|0|||
156433999|NCT00612586|564677830|FG001|Overall Study|Entry Criteria Not Met|2|||
156434000|NCT00612586|564677829|FG000|Overall Study|Withdrawal by Subject|7|||
156434001|NCT00612586|564677830|FG001|Overall Study|Withdrawal by Subject|9|||
156434002|NCT00612586|564677829|FG000|Overall Study|Physician Decision|1|||
156434003|NCT00612586|564677830|FG001|Overall Study|Physician Decision|2|||
156434004|NCT00612586|564677829|FG000|Overall Study|Sponsor Decision|1|||
156434005|NCT00612586|564677830|FG001|Overall Study|Sponsor Decision|1|||
156675763|NCT00606281|565556877|FG000|Overall Study|Death|1|||
156675764|NCT00606281|565556878|FG001|Overall Study|Death|0|||
156675765|NCT00606281|565556877|FG000|Overall Study|Lack of Efficacy|28|||
156675766|NCT00606281|565556878|FG001|Overall Study|Lack of Efficacy|35|||
156675767|NCT00606281|565556877|FG000|Overall Study|Physician Decision|0|||
156675768|NCT00606281|565556878|FG001|Overall Study|Physician Decision|1|||
156528918|NCT01369511|565030990|FG002|Overall Study|Withdrawal by Subject|4|||
156528919|NCT01369511|565030991|FG003|Overall Study|Withdrawal by Subject|6|||
156434006|NCT00612586|564677829|FG000|Overall Study|Progressive Disease|26|||
156434007|NCT00612586|564677830|FG001|Overall Study|Progressive Disease|24|||
156434008|NCT00612586|564677829|FG000|Overall Study|Randomized and Not Treated|1|||
156434009|NCT00612586|564677830|FG001|Overall Study|Randomized and Not Treated|1|||
156434010|NCT00762606|564677831|FG000|Overall Study|Lost to Follow-up|18|||
156434011|NCT00762606|564677832|FG001|Overall Study|Lost to Follow-up|13|||
156434012|NCT00949975|564677834|FG000|Overall Study|Voluntary discontinuation|6|||
156434013|NCT00949975|564677835|FG001|Overall Study|Voluntary discontinuation|5|||
156434014|NCT00949975|564677836|FG002|Overall Study|Voluntary discontinuation|3|||
156434015|NCT00949975|564677837|FG003|Overall Study|Voluntary discontinuation|6|||
156434016|NCT00949975|564677834|FG000|Overall Study|Adverse Event|11|||
156434017|NCT00949975|564677835|FG001|Overall Study|Adverse Event|11|||
156434018|NCT00949975|564677836|FG002|Overall Study|Adverse Event|10|||
156434019|NCT00949975|564677837|FG003|Overall Study|Adverse Event|10|||
156434020|NCT00949975|564677834|FG000|Overall Study|Safety reason|0|||
156434021|NCT00949975|564677835|FG001|Overall Study|Safety reason|1|||
156434022|NCT00949975|564677836|FG002|Overall Study|Safety reason|0|||
156434023|NCT00949975|564677837|FG003|Overall Study|Safety reason|0|||
156528920|NCT01376349|565030993|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
156528921|NCT01376349|565030994|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
156434024|NCT00949975|564677834|FG000|Overall Study|Study-specific criteria|0|||
156528922|NCT01376349|565030995|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
156434025|NCT00949975|564677835|FG001|Overall Study|Study-specific criteria|1|||
156528923|NCT01376349|565030993|FG000|Raondomized Treatment|Adverse Event|13|||
156528924|NCT01376349|565030994|FG001|Raondomized Treatment|Adverse Event|17|||
156528925|NCT01376349|565030995|FG002|Raondomized Treatment|Adverse Event|14|||
156675769|NCT00606281|565556877|FG000|Overall Study|Protocol Violation|3|||
156528926|NCT01376349|565030993|FG000|Raondomized Treatment|Unkown|1|||
156675770|NCT00606281|565556878|FG001|Overall Study|Protocol Violation|3|||
156675771|NCT00606281|565556877|FG000|Overall Study|Withdrawal by Subject|11|||
156675772|NCT00606281|565556878|FG001|Overall Study|Withdrawal by Subject|13|||
156434026|NCT00949975|564677836|FG002|Overall Study|Study-specific criteria|1|||
156434027|NCT00949975|564677837|FG003|Overall Study|Study-specific criteria|0|||
156434028|NCT00949975|564677834|FG000|Overall Study|Incorrect enrolment|5|||
156434029|NCT00949975|564677835|FG001|Overall Study|Incorrect enrolment|10|||
156434030|NCT00949975|564677836|FG002|Overall Study|Incorrect enrolment|4|||
156434031|NCT00949975|564677837|FG003|Overall Study|Incorrect enrolment|7|||
156434032|NCT00949975|564677834|FG000|Overall Study|Severe non-compliance|3|||
156434033|NCT00949975|564677835|FG001|Overall Study|Severe non-compliance|1|||
156434034|NCT00949975|564677836|FG002|Overall Study|Severe non-compliance|0|||
156434035|NCT00949975|564677837|FG003|Overall Study|Severe non-compliance|2|||
156434036|NCT00949975|564677834|FG000|Overall Study|Lost to Follow-up|1|||
156434037|NCT00949975|564677835|FG001|Overall Study|Lost to Follow-up|0|||
156434038|NCT00949975|564677836|FG002|Overall Study|Lost to Follow-up|1|||
156434039|NCT00949975|564677837|FG003|Overall Study|Lost to Follow-up|3|||
156434040|NCT00949975|564677834|FG000|Overall Study|Other|1|||
156434041|NCT00949975|564677835|FG001|Overall Study|Other|0|||
156434042|NCT00949975|564677836|FG002|Overall Study|Other|0|||
156434043|NCT00949975|564677837|FG003|Overall Study|Other|0|||
156434044|NCT00880048|564677847|FG000|Overall Study|Adverse Event|2|||
156434045|NCT00880048|564677848|FG001|Overall Study|Adverse Event|3|||
156434046|NCT00880048|564677849|FG002|Overall Study|Adverse Event|5|||
156434047|NCT00880048|564677847|FG000|Overall Study|Lack of Efficacy|1|||
156434048|NCT00880048|564677848|FG001|Overall Study|Lack of Efficacy|2|||
156434049|NCT00880048|564677849|FG002|Overall Study|Lack of Efficacy|2|||
156434050|NCT00880048|564677847|FG000|Overall Study|Protocol Violation|4|||
156434051|NCT00880048|564677848|FG001|Overall Study|Protocol Violation|6|||
156434052|NCT00880048|564677849|FG002|Overall Study|Protocol Violation|5|||
156434053|NCT00880048|564677847|FG000|Overall Study|Lost to Follow-up|6|||
156434054|NCT00880048|564677848|FG001|Overall Study|Lost to Follow-up|6|||
156434055|NCT00880048|564677849|FG002|Overall Study|Lost to Follow-up|5|||
156434056|NCT00880048|564677847|FG000|Overall Study|Physician Decision|1|||
156434057|NCT00880048|564677848|FG001|Overall Study|Physician Decision|1|||
156434058|NCT00880048|564677849|FG002|Overall Study|Physician Decision|7|||
156434059|NCT00880048|564677847|FG000|Overall Study|Withdrawal by Subject|5|||
156434060|NCT00880048|564677848|FG001|Overall Study|Withdrawal by Subject|8|||
156434061|NCT00880048|564677849|FG002|Overall Study|Withdrawal by Subject|5|||
156434062|NCT00880048|564677847|FG000|Overall Study|Study closed/terminated|9|||
156434063|NCT00880048|564677848|FG001|Overall Study|Study closed/terminated|7|||
156434064|NCT00880048|564677849|FG002|Overall Study|Study closed/terminated|6|||
156434065|NCT01069341|564677854|FG000|Overall Study|Lost to Follow-up|1|||
156434066|NCT03299816|564677859|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
156434067|NCT03299816|564677860|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
156434068|NCT03299816|564677859|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
156434069|NCT03299816|564677860|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
156434070|NCT03299816|564677859|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
156434071|NCT03299816|564677860|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
156434072|NCT00082810|564677861|FG000|Overall Study|Adverse Event|3|||
156434073|NCT00082810|564677861|FG000|Overall Study|Progressive disease|24|||
156434074|NCT00082810|564677861|FG000|Overall Study|Withdrawal by Subject|4|||
156434075|NCT00790790|564677865|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
156434076|NCT00790790|564677866|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
156434077|NCT00790790|564677867|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
156434078|NCT00790790|564677865|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
156434079|NCT00790790|564677866|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
156434080|NCT00790790|564677867|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
156434081|NCT00790790|564677865|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
156434082|NCT00790790|564677866|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
156434083|NCT00790790|564677867|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
156434084|NCT00790790|564677865|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
156434085|NCT00790790|564677866|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
156434086|NCT00790790|564677867|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
156434087|NCT00790790|564677865|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
156434088|NCT00790790|564677866|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
156434089|NCT00790790|564677867|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
156434090|NCT02808338|564677869|FG000|Screening|Screen Failure|10|||
156434091|NCT02808338|564677869|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
156434092|NCT02808338|564677869|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
156434093|NCT02194933|564677870|FG000|Overall Study|Lost to Follow-up|1|||
156434094|NCT02194933|564677871|FG001|Overall Study|Lost to Follow-up|2|||
156434095|NCT02194933|564677870|FG000|Overall Study|Participant met withdrawal criteria|1|||
156434096|NCT02194933|564677871|FG001|Overall Study|Participant met withdrawal criteria|3|||
156434097|NCT02194933|564677870|FG000|Overall Study|Withdrawal by Subject|0|||
156434098|NCT02194933|564677871|FG001|Overall Study|Withdrawal by Subject|2|||
156434099|NCT02194933|564677870|FG000|Overall Study|Lack of Efficacy|1|||
156434100|NCT02194933|564677871|FG001|Overall Study|Lack of Efficacy|2|||
156434101|NCT00756730|564677874|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
156434102|NCT00756730|564677875|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
156434103|NCT00756730|564677874|FG000|Overall Study|persistent low-level viremmia|0|||
156434104|NCT00756730|564677875|FG001|Overall Study|persistent low-level viremmia|1|||
156434105|NCT05382104|564677879|FG000|Period 2 (2 Days)|Adverse Event|0|||
156434106|NCT05382104|564677880|FG001|Period 2 (2 Days)|Adverse Event|1|||
156434107|NCT05382104|564677881|FG002|Period 2 (2 Days)|Adverse Event|0|||
156434108|NCT05382104|564677882|FG003|Period 2 (2 Days)|Adverse Event|0|||
156434109|NCT05382104|564677883|FG004|Period 2 (2 Days)|Adverse Event|0|||
156434110|NCT05382104|564677884|FG005|Period 2 (2 Days)|Adverse Event|0|||
156434111|NCT01493778|564677886|FG000|Overall Study|Withdrawal by Subject|8|||
156434112|NCT04210180|564677887|FG000|Overall Study|Withdrawal by Subject|2|||
156434113|NCT05190419|564677888|FG000|Overall Study|Lack of Efficacy|8|||
156434114|NCT05190419|564677889|FG001|Overall Study|Lack of Efficacy|0|||
156434115|NCT05190419|564677890|FG002|Overall Study|Lack of Efficacy|1|||
156434116|NCT05190419|564677891|FG003|Overall Study|Lack of Efficacy|0|||
156434117|NCT05190419|564677888|FG000|Overall Study|Withdrawal by Subject|7|||
156434118|NCT05190419|564677889|FG001|Overall Study|Withdrawal by Subject|1|||
156434119|NCT05190419|564677890|FG002|Overall Study|Withdrawal by Subject|2|||
156434120|NCT05190419|564677891|FG003|Overall Study|Withdrawal by Subject|2|||
156780719|NCT00640289|565947191|FG000|Overall Study|Withdrawal by Subject|1|||
156780720|NCT00640289|565947191|FG000|Overall Study|Lost to Follow-up|1|||
156780721|NCT00640289|565947191|FG000|Overall Study|Data collected under different amendment|2|||
156780722|NCT00640289|565947191|FG000|Overall Study|Transferred to another center|1|||
156780723|NCT00640289|565947191|FG000|Overall Study|Missing status|5|||
156780724|NCT03550209|565947192|FG000|Overall Study|Lost to Follow-up|1|||
156780725|NCT03550209|565947193|FG001|Overall Study|Lost to Follow-up|0|||
156780726|NCT03550209|565947194|FG002|Overall Study|Lost to Follow-up|1|||
156780727|NCT03550209|565947195|FG003|Overall Study|Lost to Follow-up|0|||
156780728|NCT03550209|565947192|FG000|Overall Study|Withdrawal by Subject|0|||
156780729|NCT03550209|565947193|FG001|Overall Study|Withdrawal by Subject|3|||
156780730|NCT03550209|565947194|FG002|Overall Study|Withdrawal by Subject|1|||
156780731|NCT03550209|565947195|FG003|Overall Study|Withdrawal by Subject|2|||
156780732|NCT03550209|565947192|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
156780733|NCT03550209|565947193|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
156780734|NCT03550209|565947194|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
156780735|NCT03550209|565947195|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
156780736|NCT01127061|565948382|FG000|Overall Study|Lost to Follow-up|7|||
156780737|NCT01127061|565948383|FG001|Overall Study|Lost to Follow-up|10|||
156780738|NCT01127061|565948382|FG000|Overall Study|Physician Decision|3|||
156780739|NCT01127061|565948383|FG001|Overall Study|Physician Decision|3|||
156780740|NCT03921541|565948384|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
156780741|NCT03921541|565948385|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
156780742|NCT00182637|565948386|FG000|Overall Study|Adverse Event|2|||
156780743|NCT00182637|565948386|FG000|Overall Study|Disease Progression|1|||
156780744|NCT02143778|565948393|FG000|Overall Study|Withdrawal by Subject|2|||
156780745|NCT02143778|565948393|FG000|Overall Study|Device malfunction|1|||
156780746|NCT03637374|565948394|FG000|Overall Study|Death|2|||
156780747|NCT03637374|565948395|FG001|Overall Study|Death|0|||
156780748|NCT00933166|565948397|FG000|Overall Study|Lost to Follow-up|4|||
156780749|NCT00933166|565948397|FG000|Overall Study|Lack of Efficacy|9|||
156780750|NCT00933166|565948397|FG000|Overall Study|Unavailable|4|||
156780751|NCT00933166|565948397|FG000|Overall Study|Withdrawal by Subject|1|||
156780752|NCT02948400|565948402|FG000|Overall Study|Withdrawal by Subject|17|||
156780753|NCT02948400|565948403|FG001|Overall Study|Withdrawal by Subject|10|||
156780754|NCT02948400|565948402|FG000|Overall Study|failed to attend appointments|47|||
156780755|NCT02948400|565948403|FG001|Overall Study|failed to attend appointments|34|||
156780756|NCT02948400|565948402|FG000|Overall Study|COVID-related closure|6|||
156780757|NCT02948400|565948403|FG001|Overall Study|COVID-related closure|2|||
156434121|NCT05190419|564677888|FG000|Overall Study|Adverse Event|2|||
156434122|NCT05190419|564677889|FG001|Overall Study|Adverse Event|10|||
156434123|NCT05190419|564677890|FG002|Overall Study|Adverse Event|11|||
156434124|NCT05190419|564677891|FG003|Overall Study|Adverse Event|21|||
156434125|NCT05190419|564677888|FG000|Overall Study|Lost to Follow-up|1|||
156434126|NCT05190419|564677889|FG001|Overall Study|Lost to Follow-up|2|||
156434127|NCT05190419|564677890|FG002|Overall Study|Lost to Follow-up|3|||
156434128|NCT05190419|564677891|FG003|Overall Study|Lost to Follow-up|1|||
156434129|NCT05190419|564677888|FG000|Overall Study|Other|1|||
156434130|NCT05190419|564677889|FG001|Overall Study|Other|1|||
156434131|NCT05190419|564677890|FG002|Overall Study|Other|0|||
156434132|NCT05190419|564677891|FG003|Overall Study|Other|3|||
156434133|NCT03210402|564677892|FG000|Overall Study|Withdrawal by Subject|0|||
156434134|NCT03210402|564677893|FG001|Overall Study|Withdrawal by Subject|1|||
156434135|NCT02517307|564677906|FG000|Overall Study|Withdrawal by Subject|1|||
156434136|NCT02517307|564677907|FG001|Overall Study|Withdrawal by Subject|0|||
156434137|NCT02517307|564677908|FG002|Overall Study|Withdrawal by Subject|1|||
156434138|NCT02517307|564677909|FG003|Overall Study|Withdrawal by Subject|0|||
156434139|NCT02517307|564677906|FG000|Overall Study|Protocol Violation|0|||
156434140|NCT02517307|564677907|FG001|Overall Study|Protocol Violation|0|||
156434141|NCT02517307|564677908|FG002|Overall Study|Protocol Violation|1|||
156434142|NCT02517307|564677909|FG003|Overall Study|Protocol Violation|1|||
156434143|NCT03863834|564677916|FG000|Overall Study|Lost to Follow-up|3|||
156434144|NCT02685488|564677917|FG000|Overall Study|Withdrawal by Subject|0|||
156434145|NCT02685488|564677918|FG001|Overall Study|Withdrawal by Subject|1|||
156434146|NCT03538054|564677919|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
156434147|NCT03538054|564677919|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
156434148|NCT03538054|564677919|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
156434149|NCT02351180|564677920|FG000|Overall Study|Withdrawal by Subject|1|||
156434150|NCT02351180|564677921|FG001|Overall Study|Withdrawal by Subject|0|||
156434151|NCT00208767|564677922|FG000|Overall Study|Adverse Event|9|||
156434152|NCT00208767|564677923|FG001|Overall Study|Adverse Event|1|||
156434153|NCT00208767|564677922|FG000|Overall Study|Withdrawal by Subject|14|||
156434154|NCT00208767|564677923|FG001|Overall Study|Withdrawal by Subject|3|||
156434155|NCT00208767|564677922|FG000|Overall Study|Death|1|||
156434156|NCT00208767|564677923|FG001|Overall Study|Death|0|||
156434157|NCT00208767|564677922|FG000|Overall Study|Lost to Follow-up|3|||
156434158|NCT00208767|564677923|FG001|Overall Study|Lost to Follow-up|3|||
156434159|NCT00605033|564677924|FG000|Overall Study|Adverse Event|2|||
156434160|NCT00605033|564677925|FG001|Overall Study|Adverse Event|2|||
156434161|NCT00605033|564677924|FG000|Overall Study|Lost to Follow-up|1|||
156434162|NCT00605033|564677925|FG001|Overall Study|Lost to Follow-up|1|||
156434163|NCT00605033|564677924|FG000|Overall Study|Withdrawal by Subject|3|||
156434164|NCT00605033|564677925|FG001|Overall Study|Withdrawal by Subject|4|||
156434165|NCT00605033|564677924|FG000|Overall Study|Protocol Violation|1|||
156434166|NCT00605033|564677925|FG001|Overall Study|Protocol Violation|1|||
156434167|NCT02754479|564677926|FG000|Overall Study|Lost to Follow-up|1|||
156434168|NCT03183518|564677927|FG000|Overall Study|Other (Not specified)|2|||
156434169|NCT03183518|564677927|FG000|Overall Study|Other (Withdrawal of consent)|1|||
156434170|NCT04493242|564677930|FG000|Overall Study|Death|10|||
156434171|NCT04493242|564677931|FG001|Overall Study|Death|14|||
156434172|NCT04493242|564677932|FG002|Overall Study|Death|16|||
156434173|NCT04493242|564677930|FG000|Overall Study|Lost to Follow-up|1|||
156434174|NCT04493242|564677931|FG001|Overall Study|Lost to Follow-up|1|||
156434175|NCT04493242|564677932|FG002|Overall Study|Lost to Follow-up|0|||
156434176|NCT04493242|564677930|FG000|Overall Study|Withdrawal by Subject|1|||
156434177|NCT04493242|564677931|FG001|Overall Study|Withdrawal by Subject|0|||
156434178|NCT04493242|564677932|FG002|Overall Study|Withdrawal by Subject|0|||
156434179|NCT04493242|564677930|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
156434180|NCT04493242|564677931|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
156434181|NCT04493242|564677932|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
156434182|NCT04493242|564677930|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
156434183|NCT04493242|564677931|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
156434184|NCT04493242|564677932|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
156434185|NCT00849147|564677933|FG000|Overall Study|Withdrawal by Subject|1|||
156434186|NCT00849147|564677933|FG000|Overall Study|Protocol Violation|2|||
156434187|NCT00849147|564677933|FG000|Overall Study|Disease Relapse/Progression|2|||
156434188|NCT03284957|564680176|FG000|Overall Study|Adverse Event|0|||
156434189|NCT03284957|564680177|FG001|Overall Study|Adverse Event|0|||
156434190|NCT03284957|564680178|FG002|Overall Study|Adverse Event|0|||
156434191|NCT03284957|564680179|FG003|Overall Study|Adverse Event|0|||
156434192|NCT03284957|564680180|FG004|Overall Study|Adverse Event|0|||
156434193|NCT03284957|564680181|FG005|Overall Study|Adverse Event|1|||
156434194|NCT03284957|564680182|FG006|Overall Study|Adverse Event|1|||
156434195|NCT03284957|564680183|FG007|Overall Study|Adverse Event|1|||
156434196|NCT03284957|564680184|FG008|Overall Study|Adverse Event|0|||
156434197|NCT03284957|564680185|FG009|Overall Study|Adverse Event|4|||
156434198|NCT03284957|564680186|FG010|Overall Study|Adverse Event|1|||
156434199|NCT03284957|564680187|FG011|Overall Study|Adverse Event|1|||
156434200|NCT03284957|564680188|FG012|Overall Study|Adverse Event|0|||
156434201|NCT03284957|564680189|FG013|Overall Study|Adverse Event|0|||
156434202|NCT03284957|564680190|FG014|Overall Study|Adverse Event|0|||
156434203|NCT03284957|564680191|FG015|Overall Study|Adverse Event|0|||
156434204|NCT03284957|564680176|FG000|Overall Study|Progressive Disease|3|||
156434205|NCT03284957|564680177|FG001|Overall Study|Progressive Disease|3|||
156434206|NCT03284957|564680178|FG002|Overall Study|Progressive Disease|4|||
156434207|NCT03284957|564680179|FG003|Overall Study|Progressive Disease|3|||
156434208|NCT03284957|564680180|FG004|Overall Study|Progressive Disease|3|||
156434209|NCT03284957|564680181|FG005|Overall Study|Progressive Disease|5|||
156434210|NCT03284957|564680182|FG006|Overall Study|Progressive Disease|45|||
156434211|NCT03284957|564680183|FG007|Overall Study|Progressive Disease|8|||
156434212|NCT03284957|564680184|FG008|Overall Study|Progressive Disease|5|||
156434213|NCT03284957|564680185|FG009|Overall Study|Progressive Disease|18|||
156434214|NCT03284957|564680186|FG010|Overall Study|Progressive Disease|7|||
156434215|NCT03284957|564680187|FG011|Overall Study|Progressive Disease|2|||
156434216|NCT03284957|564680188|FG012|Overall Study|Progressive Disease|3|||
156434217|NCT03284957|564680189|FG013|Overall Study|Progressive Disease|1|||
156434218|NCT03284957|564680190|FG014|Overall Study|Progressive Disease|1|||
156434219|NCT03284957|564680191|FG015|Overall Study|Progressive Disease|2|||
156434220|NCT03284957|564680176|FG000|Overall Study|Withdrawal by Subject|0|||
156434221|NCT03284957|564680177|FG001|Overall Study|Withdrawal by Subject|0|||
156434222|NCT03284957|564680178|FG002|Overall Study|Withdrawal by Subject|0|||
156434223|NCT03284957|564680179|FG003|Overall Study|Withdrawal by Subject|0|||
156434224|NCT03284957|564680180|FG004|Overall Study|Withdrawal by Subject|0|||
156434225|NCT03284957|564680181|FG005|Overall Study|Withdrawal by Subject|0|||
156434226|NCT03284957|564680182|FG006|Overall Study|Withdrawal by Subject|0|||
156434227|NCT03284957|564680183|FG007|Overall Study|Withdrawal by Subject|0|||
156434228|NCT03284957|564680184|FG008|Overall Study|Withdrawal by Subject|0|||
156434229|NCT03284957|564680185|FG009|Overall Study|Withdrawal by Subject|2|||
156434230|NCT03284957|564680186|FG010|Overall Study|Withdrawal by Subject|0|||
156434231|NCT03284957|564680187|FG011|Overall Study|Withdrawal by Subject|0|||
156434232|NCT03284957|564680188|FG012|Overall Study|Withdrawal by Subject|0|||
156434233|NCT03284957|564680189|FG013|Overall Study|Withdrawal by Subject|0|||
156434234|NCT03284957|564680190|FG014|Overall Study|Withdrawal by Subject|0|||
156434235|NCT03284957|564680191|FG015|Overall Study|Withdrawal by Subject|0|||
156434236|NCT03284957|564680176|FG000|Overall Study|Other|0|||
156434237|NCT03284957|564680177|FG001|Overall Study|Other|0|||
156434238|NCT03284957|564680178|FG002|Overall Study|Other|0|||
156434239|NCT03284957|564680179|FG003|Overall Study|Other|0|||
156434240|NCT03284957|564680180|FG004|Overall Study|Other|0|||
156434241|NCT03284957|564680181|FG005|Overall Study|Other|0|||
156434242|NCT03284957|564680182|FG006|Overall Study|Other|3|||
156434243|NCT03284957|564680183|FG007|Overall Study|Other|0|||
156434244|NCT03284957|564680184|FG008|Overall Study|Other|1|||
156434245|NCT03284957|564680185|FG009|Overall Study|Other|6|||
156434246|NCT03284957|564680186|FG010|Overall Study|Other|0|||
156434247|NCT03284957|564680187|FG011|Overall Study|Other|0|||
156434248|NCT03284957|564680188|FG012|Overall Study|Other|0|||
156434249|NCT03284957|564680189|FG013|Overall Study|Other|0|||
156434250|NCT03284957|564680190|FG014|Overall Study|Other|2|||
156434251|NCT03284957|564680191|FG015|Overall Study|Other|0|||
156434252|NCT04517864|564680192|FG000|Placebo-Controlled Phase|Adverse Event|1|||
156434253|NCT04517864|564680193|FG001|Placebo-Controlled Phase|Adverse Event|0|||
156434254|NCT04517864|564680194|FG002|Placebo-Controlled Phase|Adverse Event|0|||
156434255|NCT04517864|564680192|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
156434256|NCT04517864|564680193|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
156434257|NCT04517864|564680194|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
156434258|NCT04517864|564680192|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
156434259|NCT04517864|564680193|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
156434260|NCT04517864|564680194|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
156434261|NCT04517864|564680192|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
156434262|NCT04517864|564680193|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
156434263|NCT04517864|564680194|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
156434264|NCT04517864|564680192|FG000|Active Therapy Extension Phase|Adverse Event|1|||
156434265|NCT04517864|564680193|FG001|Active Therapy Extension Phase|Adverse Event|0|||
156434266|NCT04517864|564680194|FG002|Active Therapy Extension Phase|Adverse Event|0|||
156434267|NCT04517864|564680192|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
156434268|NCT04517864|564680193|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
156434269|NCT04517864|564680194|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
156434270|NCT04517864|564680192|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
156434271|NCT04517864|564680193|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
156434272|NCT04517864|564680194|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
156434273|NCT04517864|564680192|FG000|Active Therapy Extension Phase|Physician Decision|1|||
156434274|NCT04517864|564680193|FG001|Active Therapy Extension Phase|Physician Decision|0|||
156434275|NCT04517864|564680194|FG002|Active Therapy Extension Phase|Physician Decision|0|||
156434276|NCT04517864|564680192|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
156434277|NCT04517864|564680193|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
156434278|NCT04517864|564680194|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
156434279|NCT04517864|564680192|FG000|Extension Phase|Adverse Event|0|||
156434280|NCT04517864|564680193|FG001|Extension Phase|Adverse Event|0|||
156434281|NCT04517864|564680194|FG002|Extension Phase|Adverse Event|1|||
156434282|NCT04517864|564680192|FG000|Extension Phase|Lack of Efficacy|0|||
156434283|NCT04517864|564680193|FG001|Extension Phase|Lack of Efficacy|0|||
156434284|NCT04517864|564680194|FG002|Extension Phase|Lack of Efficacy|2|||
156434285|NCT04517864|564680192|FG000|Extension Phase|Study Terminated By Sponsor|0|||
156434286|NCT04517864|564680193|FG001|Extension Phase|Study Terminated By Sponsor|0|||
156780758|NCT02948400|565948402|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
156434287|NCT04517864|564680194|FG002|Extension Phase|Study Terminated By Sponsor|32|||
156434288|NCT04517864|564680192|FG000|Extension Phase|Withdrawal by Subject|0|||
156434289|NCT04517864|564680193|FG001|Extension Phase|Withdrawal by Subject|0|||
156434290|NCT04517864|564680194|FG002|Extension Phase|Withdrawal by Subject|3|||
156528927|NCT01376349|565030994|FG001|Raondomized Treatment|Unkown|2|||
156434291|NCT04517864|564680192|FG000|Extension Phase|Approved Drug Available for Indication|0|||
156434292|NCT04517864|564680193|FG001|Extension Phase|Approved Drug Available for Indication|0|||
156434293|NCT04517864|564680194|FG002|Extension Phase|Approved Drug Available for Indication|7|||
156434294|NCT04722003|564680197|FG000|Overall Study|Lost to Follow-up|2|||
156434295|NCT04722003|564680198|FG001|Overall Study|Lost to Follow-up|0|||
156434296|NCT04722003|564680197|FG000|Overall Study|Physician Decision|1|||
156434297|NCT04722003|564680198|FG001|Overall Study|Physician Decision|0|||
156434298|NCT00708032|564680199|FG000|Overall Study|Adverse Event|0|||
156434299|NCT00708032|564680200|FG001|Overall Study|Adverse Event|2|||
156434300|NCT00708032|564680199|FG000|Overall Study|Lost to Follow-up|1|||
156434301|NCT00708032|564680200|FG001|Overall Study|Lost to Follow-up|2|||
156434302|NCT00708032|564680199|FG000|Overall Study|Pregnancy|0|||
156434303|NCT00708032|564680200|FG001|Overall Study|Pregnancy|1|||
156434304|NCT00708032|564680199|FG000|Overall Study|Poor vision|0|||
156434305|NCT00708032|564680200|FG001|Overall Study|Poor vision|6|||
156434306|NCT00708032|564680199|FG000|Overall Study|Visit out of range at month 12|4|||
156434307|NCT00708032|564680200|FG001|Overall Study|Visit out of range at month 12|1|||
156434308|NCT00708032|564680199|FG000|Overall Study|Did not meet protocol criteria|1|||
156434309|NCT00708032|564680200|FG001|Overall Study|Did not meet protocol criteria|2|||
156434310|NCT00708032|564680199|FG000|Overall Study|Protocol Violation|4|||
156434311|NCT00708032|564680200|FG001|Overall Study|Protocol Violation|1|||
156434312|NCT00708032|564680199|FG000|Overall Study|Withdrawal by Subject|0|||
156434313|NCT00708032|564680200|FG001|Overall Study|Withdrawal by Subject|1|||
156434314|NCT00446550|564680205|FG000|Overall Study|Adverse Event|1|||
156434315|NCT00446550|564680206|FG001|Overall Study|Adverse Event|0|||
156434316|NCT01759264|564680207|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
156434317|NCT01759264|564680207|FG000|Overall Study|Adverse Event|1|||
156434318|NCT01759264|564680207|FG000|Overall Study|Other|2|||
156434319|NCT01759264|564680207|FG000|Overall Study|Lost to Follow-up|2|||
156434320|NCT01759264|564680207|FG000|Overall Study|Withdrawal by Subject|3|||
156434321|NCT01759264|564680207|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
156434322|NCT02027558|564680208|FG000|Overall Study|Death|0|||
156434323|NCT02027558|564680209|FG001|Overall Study|Death|1|||
156434324|NCT02027558|564680208|FG000|Overall Study|Withdrawal by Subject|2|||
156434325|NCT02027558|564680209|FG001|Overall Study|Withdrawal by Subject|0|||
156434326|NCT02027558|564680208|FG000|Overall Study|Lost to Follow-up|4|||
156434327|NCT02027558|564680209|FG001|Overall Study|Lost to Follow-up|1|||
156434328|NCT02027558|564680208|FG000|Overall Study|Refused assessment|3|||
156434329|NCT02027558|564680209|FG001|Overall Study|Refused assessment|0|||
156434330|NCT00114244|564680210|FG000|Overall Study|Adverse Event|2|||
156434331|NCT00114244|564680211|FG001|Overall Study|Adverse Event|5|||
156434332|NCT00114244|564680210|FG000|Overall Study|Withdrawal by Subject|0|||
156434333|NCT00114244|564680211|FG001|Overall Study|Withdrawal by Subject|2|||
156434334|NCT00393848|564680212|FG000|Overall Study|Surgical schedule|0|||
156434335|NCT00393848|564680213|FG001|Overall Study|Surgical schedule|0|||
156675773|NCT00606281|565556877|FG000|Overall Study|Progression to depressive phase|1|||
156675774|NCT00606281|565556878|FG001|Overall Study|Progression to depressive phase|1|||
156675775|NCT00606281|565556877|FG000|Overall Study|Change of residence or other commitments|1|||
156675776|NCT00606281|565556878|FG001|Overall Study|Change of residence or other commitments|1|||
156675777|NCT00540423|565556880|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156675778|NCT00540423|565556881|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156675779|NCT00540423|565556882|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156675780|NCT00540423|565556880|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
156675781|NCT00540423|565556881|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
156675782|NCT00540423|565556882|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
156675783|NCT03131895|565556883|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
156675784|NCT03131895|565556884|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
156675785|NCT03131895|565556885|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
156675786|NCT03131895|565556886|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
156675787|NCT03131895|565556883|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
156675788|NCT03131895|565556884|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
156675789|NCT03131895|565556885|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
156434336|NCT00393848|564680214|FG002|Overall Study|Surgical schedule|0|||
156434337|NCT00393848|564680215|FG003|Overall Study|Surgical schedule|1|||
156434338|NCT00393848|564680212|FG000|Overall Study|Personal reasons|0|||
156434339|NCT00393848|564680213|FG001|Overall Study|Personal reasons|0|||
156434340|NCT00393848|564680214|FG002|Overall Study|Personal reasons|2|||
156434341|NCT00393848|564680215|FG003|Overall Study|Personal reasons|0|||
156434342|NCT02694978|564680220|FG000|Overall Study|Adverse Event|10|||
156434343|NCT02694978|564680221|FG001|Overall Study|Adverse Event|9|||
156434344|NCT02694978|564680220|FG000|Overall Study|Withdrawal by Subject|22|||
156434345|NCT02694978|564680221|FG001|Overall Study|Withdrawal by Subject|19|||
156434346|NCT02694978|564680220|FG000|Overall Study|Lost to Follow-up|14|||
156434347|NCT02694978|564680221|FG001|Overall Study|Lost to Follow-up|17|||
156675790|NCT03131895|565556886|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
156675791|NCT03131895|565556883|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156434348|NCT02694978|564680220|FG000|Overall Study|Death|4|||
156434349|NCT02694978|564680221|FG001|Overall Study|Death|1|||
156434350|NCT02694978|564680220|FG000|Overall Study|Other-Decision of Participant|6|||
156434351|NCT02694978|564680221|FG001|Overall Study|Other-Decision of Participant|1|||
156434352|NCT02694978|564680220|FG000|Overall Study|Other-Investigator's decision|1|||
156434353|NCT02694978|564680221|FG001|Overall Study|Other-Investigator's decision|0|||
156434354|NCT02694978|564680220|FG000|Overall Study|Other-Unable to be reached|0|||
156434355|NCT02694978|564680221|FG001|Overall Study|Other-Unable to be reached|1|||
156434356|NCT02694978|564680220|FG000|Overall Study|Other-Protocol noncompliant|2|||
156434357|NCT02694978|564680221|FG001|Overall Study|Other-Protocol noncompliant|1|||
156434358|NCT02694978|564680220|FG000|Overall Study|Other-Personal reasons|3|||
156434359|NCT02694978|564680221|FG001|Overall Study|Other-Personal reasons|3|||
156434360|NCT02694978|564680220|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
156434361|NCT02694978|564680221|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
156780759|NCT02948400|565948403|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
156780760|NCT02948400|565948402|FG000|Overall Study|motion sickness in virtual reality|2|||
156780761|NCT02948400|565948403|FG001|Overall Study|motion sickness in virtual reality|0|||
156780762|NCT02403271|565948404|FG000|Period 1|Other varied reasons|1|||
156780763|NCT02403271|565948405|FG001|Period 1|Other varied reasons|0|||
156780764|NCT02403271|565948404|FG000|Period 2|Withdrawal by Subject|0|||
156780765|NCT02403271|565948405|FG001|Period 2|Withdrawal by Subject|14|||
156780766|NCT02403271|565948404|FG000|Period 2|Death|0|||
156780767|NCT02403271|565948405|FG001|Period 2|Death|84|||
156780768|NCT02403271|565948404|FG000|Period 2|Lost to Follow-up|0|||
156780769|NCT02403271|565948405|FG001|Period 2|Lost to Follow-up|2|||
156780770|NCT02403271|565948404|FG000|Period 2|Study Terminated by Sponsor|0|||
156780771|NCT02403271|565948405|FG001|Period 2|Study Terminated by Sponsor|14|||
156780772|NCT02403271|565948404|FG000|Period 2|Other varied reasons|0|||
156780773|NCT02403271|565948405|FG001|Period 2|Other varied reasons|10|||
156780774|NCT03925220|565948406|FG000|Overall Study|Withdrawal by Subject|4|||
156780775|NCT03925220|565948407|FG001|Overall Study|Withdrawal by Subject|4|||
156780776|NCT03925220|565948408|FG002|Overall Study|Withdrawal by Subject|4|||
156780777|NCT03925220|565948409|FG003|Overall Study|Withdrawal by Subject|4|||
156780778|NCT03925220|565948406|FG000|Overall Study|Lost to Follow-up|40|||
156780779|NCT03925220|565948407|FG001|Overall Study|Lost to Follow-up|46|||
156780780|NCT03925220|565948408|FG002|Overall Study|Lost to Follow-up|37|||
156780781|NCT03925220|565948409|FG003|Overall Study|Lost to Follow-up|38|||
156780782|NCT05561140|565948410|FG000|Randomized Treatment Period|Adverse Event|1|||
156780783|NCT05561140|565948411|FG001|Randomized Treatment Period|Adverse Event|0|||
156780784|NCT05561140|565948410|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
156780785|NCT05561140|565948411|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
156780786|NCT05561140|565948410|FG000|Open Label Treatment Period|Adverse Event|6|||
156780787|NCT05561140|565948411|FG001|Open Label Treatment Period|Adverse Event|4|||
156780788|NCT05561140|565948410|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
156780789|NCT05561140|565948411|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
156780790|NCT05561140|565948410|FG000|Open Label Treatment Period|Physician Decision|0|||
156780791|NCT05561140|565948411|FG001|Open Label Treatment Period|Physician Decision|1|||
156780792|NCT05561140|565948410|FG000|Open Label Treatment Period|Pregnancy|1|||
156434362|NCT01613716|564680224|FG000|Overall Study|screen failures|3|||
156434363|NCT01613716|564680224|FG000|Overall Study|Lost to Follow-up|4|||
156434364|NCT00419094|564680230|FG000|Overall Study|Adverse Event|3|||
156434365|NCT00419094|564680231|FG001|Overall Study|Adverse Event|7|||
156434366|NCT00419094|564680230|FG000|Overall Study|Lack of Efficacy|1|||
156434367|NCT00419094|564680231|FG001|Overall Study|Lack of Efficacy|0|||
156434368|NCT00419094|564680230|FG000|Overall Study|Lost to Follow-up|0|||
156434369|NCT00419094|564680231|FG001|Overall Study|Lost to Follow-up|2|||
156434370|NCT00419094|564680230|FG000|Overall Study|Protocol Violation|1|||
156434371|NCT00419094|564680231|FG001|Overall Study|Protocol Violation|14|||
156434372|NCT00419094|564680230|FG000|Overall Study|Withdrawal of consent|1|||
156434373|NCT00419094|564680231|FG001|Overall Study|Withdrawal of consent|5|||
156434374|NCT00419094|564680230|FG000|Overall Study|Other: Error determining exit criteria|1|||
156434375|NCT00419094|564680231|FG001|Overall Study|Other: Error determining exit criteria|0|||
156434376|NCT00419094|564680230|FG000|Overall Study|Other: Patient non-compliant|0|||
156434377|NCT00419094|564680231|FG001|Overall Study|Other: Patient non-compliant|1|||
156434378|NCT00419094|564680230|FG000|Overall Study|Other: No contact for extended period|0|||
156434379|NCT00419094|564680231|FG001|Overall Study|Other: No contact for extended period|1|||
156434380|NCT01811706|564680232|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
156434381|NCT01811706|564680233|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
156434382|NCT03557008|564680234|FG000|Overall Study|Withdrawal by Subject|2|||
156434383|NCT03557008|564680235|FG001|Overall Study|Withdrawal by Subject|2|||
156434384|NCT03557008|564680234|FG000|Overall Study|Early termination from study|3|||
156434385|NCT03557008|564680235|FG001|Overall Study|Early termination from study|1|||
156434386|NCT03020745|564680238|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434387|NCT03020745|564680239|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434388|NCT03020745|564680240|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434389|NCT03020745|564680241|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434390|NCT03020745|564680242|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434391|NCT03020745|564680243|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434392|NCT03020745|564680244|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434393|NCT03020745|564680245|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434394|NCT03020745|564680246|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
156434395|NCT03020745|564680247|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
156434396|NCT03020745|564680238|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434397|NCT03020745|564680239|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434398|NCT03020745|564680240|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434399|NCT03020745|564680241|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434400|NCT03020745|564680242|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434401|NCT03020745|564680243|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434402|NCT03020745|564680244|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434403|NCT03020745|564680245|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
156434404|NCT03020745|564680246|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434405|NCT03020745|564680247|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
156434406|NCT03020745|564680238|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
156434407|NCT03020745|564680239|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
156434408|NCT03020745|564680240|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
156434409|NCT03020745|564680241|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
156434410|NCT03020745|564680242|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
156434411|NCT03020745|564680243|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
156434412|NCT03020745|564680244|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
156434413|NCT03020745|564680245|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
156434414|NCT03020745|564680246|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
156434415|NCT03020745|564680247|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
156434416|NCT03020745|564680238|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434417|NCT03020745|564680239|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434418|NCT03020745|564680240|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434419|NCT03020745|564680241|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434420|NCT03020745|564680242|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434421|NCT03020745|564680243|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434422|NCT03020745|564680244|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434423|NCT03020745|564680245|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434424|NCT03020745|564680246|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
156434425|NCT03020745|564680247|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
156434426|NCT00743444|564680248|FG000|First Intervention|Catheter placement problems|0|||
156434427|NCT00743444|564680249|FG001|First Intervention|Catheter placement problems|1|||
156434428|NCT00743444|564680248|FG000|Washout Period|Adverse Event|0|||
156434429|NCT00743444|564680249|FG001|Washout Period|Adverse Event|1|||
156434430|NCT00186186|564680250|FG000|Overall Study|Lack of Efficacy|3|||
156434431|NCT00186186|564680250|FG000|Overall Study|Withdrawal by Subject|3|||
156434432|NCT00186186|564680250|FG000|Overall Study|Not reported as to reason|2|||
156434433|NCT00807144|564680251|FG000|Overall Study|Lost to Follow-up|0|||
156434434|NCT00807144|564680252|FG001|Overall Study|Lost to Follow-up|1|||
156434435|NCT02567656|564680255|FG000|Overall Study|Premature discontinuation due to PD|1|||
156434436|NCT02567656|564680256|FG001|Overall Study|Premature discontinuation due to PD|1|||
156434437|NCT02567656|564680257|FG002|Overall Study|Premature discontinuation due to PD|2|||
156434438|NCT02567656|564680258|FG003|Overall Study|Premature discontinuation due to PD|0|||
156434439|NCT02567656|564680259|FG004|Overall Study|Premature discontinuation due to PD|0|||
156434440|NCT02567656|564680260|FG005|Overall Study|Premature discontinuation due to PD|0|||
156434441|NCT02057692|564680265|FG000|Overall Study|Adverse Event|1|||
156434442|NCT02057692|564680266|FG001|Overall Study|Adverse Event|0|||
156434443|NCT02057692|564680267|FG002|Overall Study|Adverse Event|0|||
156434444|NCT02057692|564680268|FG003|Overall Study|Adverse Event|0|||
156434445|NCT02057692|564680265|FG000|Overall Study|Lost to Follow-up|0|||
156434446|NCT02057692|564680266|FG001|Overall Study|Lost to Follow-up|0|||
156434447|NCT02057692|564680267|FG002|Overall Study|Lost to Follow-up|0|||
156434448|NCT02057692|564680268|FG003|Overall Study|Lost to Follow-up|1|||
156434449|NCT00943735|564680269|FG000|Overall Study|Adverse Event|12|||
156434450|NCT00943735|564680269|FG000|Overall Study|Withdrawal by Subject|8|||
156434451|NCT00943735|564680269|FG000|Overall Study|Death|1|||
156434452|NCT00943735|564680269|FG000|Overall Study|Other|8|||
156434453|NCT00943735|564680269|FG000|Overall Study|Other|3|||
156434454|NCT00486330|564680270|FG000|Overall Study|Adverse Event|2|||
156434455|NCT01027286|564680271|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
156528928|NCT01376349|565030995|FG002|Raondomized Treatment|Unkown|1|||
156434456|NCT01027286|564680272|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
156434457|NCT01027286|564680271|FG000|Overall Study|Lost to Follow-up|0|||
156434458|NCT01027286|564680272|FG001|Overall Study|Lost to Follow-up|1|||
156528929|NCT01376349|565030993|FG000|Raondomized Treatment|Alternative Treatment|0|||
156434459|NCT03804918|564680273|FG000|Overall Study|Participant did not use the app|1|||
156434460|NCT01405924|564680274|FG000|Overall Study|Protocol Violation|8|||
156434461|NCT01405924|564680274|FG000|Overall Study|Missing/Incomplete Data|2|||
156434462|NCT02393716|564680275|FG000|Overall Study|Death|29|||
156434463|NCT02393716|564680275|FG000|Overall Study|Withdrawal by Subject|8|||
156434464|NCT02393716|564680275|FG000|Overall Study|Device Explanted|8|||
156434465|NCT02393716|564680275|FG000|Overall Study|Missed visit|16|||
156434466|NCT01924767|564680276|FG000|Overall Study|Adverse Event|1|||
156434467|NCT01924767|564680277|FG001|Overall Study|Adverse Event|0|||
156434468|NCT01924767|564680278|FG002|Overall Study|Adverse Event|1|||
156434469|NCT01924767|564680279|FG003|Overall Study|Adverse Event|0|||
156434470|NCT01924767|564680280|FG004|Overall Study|Adverse Event|0|||
156434471|NCT03987451|564680281|FG000|Overall Study|Lost to Follow-up|1|||
156434472|NCT03987451|564680282|FG001|Overall Study|Lost to Follow-up|0|||
156434473|NCT03987451|564680281|FG000|Overall Study|Withdrawal by Subject|1|||
156434474|NCT03987451|564680282|FG001|Overall Study|Withdrawal by Subject|1|||
156434475|NCT03192046|564680283|FG000|Overall Study|Withdrawal by Subject|1|||
156434476|NCT03192046|564680284|FG001|Overall Study|Withdrawal by Subject|1|||
156434477|NCT01505881|564680285|FG000|Overall Study|Adverse Event|0|||
156434478|NCT01505881|564680286|FG001|Overall Study|Adverse Event|1|||
156434479|NCT01505881|564680285|FG000|Overall Study|Lost to Follow-up|2|||
156434480|NCT01505881|564680286|FG001|Overall Study|Lost to Follow-up|0|||
156434481|NCT01505881|564680285|FG000|Overall Study|Withdrawal by Subject|2|||
156434482|NCT01505881|564680286|FG001|Overall Study|Withdrawal by Subject|0|||
156434483|NCT01194154|564680287|FG000|Overall Study|Adverse Event|12|||
156434484|NCT01194154|564680288|FG001|Overall Study|Adverse Event|7|||
156434485|NCT01194154|564680287|FG000|Overall Study|Lost to Follow-up|2|||
156434486|NCT01194154|564680288|FG001|Overall Study|Lost to Follow-up|3|||
156434487|NCT01194154|564680287|FG000|Overall Study|Protocol Violation|0|||
156434488|NCT01194154|564680288|FG001|Overall Study|Protocol Violation|1|||
156434489|NCT01194154|564680287|FG000|Overall Study|Withdrawal by Subject|5|||
156434490|NCT01194154|564680288|FG001|Overall Study|Withdrawal by Subject|6|||
156434491|NCT01194154|564680287|FG000|Overall Study|Blood pressure increase|5|||
156434492|NCT01194154|564680288|FG001|Overall Study|Blood pressure increase|3|||
156434493|NCT01194154|564680287|FG000|Overall Study|Hemoglobin decrease|0|||
156528930|NCT01376349|565030994|FG001|Raondomized Treatment|Alternative Treatment|0|||
156528931|NCT01376349|565030995|FG002|Raondomized Treatment|Alternative Treatment|1|||
156528932|NCT00718640|565030996|FG000|Overall Study|Adverse Event|4|||
156528933|NCT00718640|565030996|FG000|Overall Study|Death|1|||
156528934|NCT00718640|565030996|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
156528935|NCT05193500|565030999|FG000|Overall Study|Withdrawal by Subject|7|||
156528936|NCT05193500|565031000|FG001|Overall Study|Withdrawal by Subject|4|||
156528937|NCT05193500|565031001|FG002|Overall Study|Withdrawal by Subject|3|||
156528938|NCT05193500|565031002|FG003|Overall Study|Withdrawal by Subject|5|||
156528939|NCT01978262|565031003|FG000|Overall Study|Withdrawal by Subject|9|||
156528940|NCT01978262|565031003|FG000|Overall Study|Lost to Follow-up|2|||
156528941|NCT02982187|565031004|FG000|Overall Study|Withdrawal by Subject|0|||
156528942|NCT02982187|565031005|FG001|Overall Study|Withdrawal by Subject|0|||
156780793|NCT05561140|565948411|FG001|Open Label Treatment Period|Pregnancy|0|||
156780794|NCT05561140|565948410|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
156780795|NCT05561140|565948411|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
156528943|NCT02982187|565031006|FG002|Overall Study|Withdrawal by Subject|0|||
156528944|NCT02982187|565031007|FG003|Overall Study|Withdrawal by Subject|0|||
156528945|NCT02982187|565031008|FG004|Overall Study|Withdrawal by Subject|0|||
156528946|NCT02982187|565031009|FG005|Overall Study|Withdrawal by Subject|0|||
156528947|NCT02982187|565031010|FG006|Overall Study|Withdrawal by Subject|1|||
156528948|NCT02982187|565031011|FG007|Overall Study|Withdrawal by Subject|0|||
156528949|NCT02168842|565031012|FG000|Overall Study|Withdrawal by Subject|5|||
156528950|NCT02168842|565031013|FG001|Overall Study|Withdrawal by Subject|3|||
156434494|NCT01194154|564680288|FG001|Overall Study|Hemoglobin decrease|1|||
156434495|NCT01194154|564680287|FG000|Overall Study|Hemoglobin increase|12|||
156434496|NCT01194154|564680288|FG001|Overall Study|Hemoglobin increase|3|||
156434497|NCT01194154|564680287|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
156434498|NCT01194154|564680288|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
156434499|NCT01194154|564680287|FG000|Overall Study|Treatment with prohibited medication|4|||
156434500|NCT01194154|564680288|FG001|Overall Study|Treatment with prohibited medication|5|||
156528951|NCT02168842|565031012|FG000|Overall Study|Lost to Follow-up|0|||
156780796|NCT05561140|565948410|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
156434501|NCT01194154|564680287|FG000|Overall Study|Other|4|||
156434502|NCT01194154|564680288|FG001|Overall Study|Other|0|||
156434503|NCT01194154|564680287|FG000|Overall Study|Did not receive study medication|2|||
156434504|NCT01194154|564680288|FG001|Overall Study|Did not receive study medication|4|||
156434505|NCT01147341|564680289|FG000|Double Blind Period|Lack of Efficacy|1|||
156434506|NCT01147341|564680290|FG001|Double Blind Period|Lack of Efficacy|1|||
156434507|NCT01147341|564680289|FG000|Double Blind Period|Withdrawal by Subject|0|||
156528952|NCT02168842|565031013|FG001|Overall Study|Lost to Follow-up|2|||
156780797|NCT05561140|565948411|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
156780798|NCT05561140|565948410|FG000|Open Label Treatment Period|Other|1|||
156780799|NCT05561140|565948411|FG001|Open Label Treatment Period|Other|0|||
156780800|NCT05774977|565948414|FG000|Overall Study|Withdrawal by Subject|2|||
156780801|NCT03301714|565948416|FG000|Overall Study|Lost to Follow-up|10|||
156780802|NCT03301714|565948417|FG001|Overall Study|Lost to Follow-up|4|||
156780803|NCT03301714|565948418|FG002|Overall Study|Lost to Follow-up|4|||
156780804|NCT03301714|565948416|FG000|Overall Study|Did not receive allocated intervention|0|||
156780805|NCT03301714|565948417|FG001|Overall Study|Did not receive allocated intervention|2|||
156780806|NCT03301714|565948418|FG002|Overall Study|Did not receive allocated intervention|3|||
156780807|NCT03349515|565948425|FG000|Overall Study|Lack of Efficacy|2|||
156780808|NCT03349515|565948426|FG001|Overall Study|Lack of Efficacy|0|||
156780809|NCT03349515|565948425|FG000|Overall Study|Physician Decision|3|||
156780810|NCT03349515|565948426|FG001|Overall Study|Physician Decision|1|||
156780811|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
156780812|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
156780813|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
156780814|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Death|1|||
156780815|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Death|0|||
156780816|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Death|0|||
156780817|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
156780818|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
156780819|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
156780820|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
156780821|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
156780822|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
156780823|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
156780824|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
156780825|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
156780826|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
156780827|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
156780828|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
156780829|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
156780830|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
156780831|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
156780832|NCT05073315|565948429|FG000|Period 2|Adverse Event|0|||
156780833|NCT05073315|565948430|FG001|Period 2|Adverse Event|3|||
156780834|NCT05073315|565948431|FG002|Period 2|Adverse Event|6|||
156780835|NCT05073315|565948429|FG000|Period 2|Lost to Follow-up|0|||
156780836|NCT05073315|565948430|FG001|Period 2|Lost to Follow-up|5|||
156780837|NCT05073315|565948431|FG002|Period 2|Lost to Follow-up|5|||
156780838|NCT05073315|565948429|FG000|Period 2|Withdrawal by Subject|0|||
156780839|NCT05073315|565948430|FG001|Period 2|Withdrawal by Subject|4|||
156780840|NCT05073315|565948431|FG002|Period 2|Withdrawal by Subject|9|||
156780841|NCT05073315|565948429|FG000|Period 2|Protocol Violation|0|||
156780842|NCT05073315|565948430|FG001|Period 2|Protocol Violation|0|||
156780843|NCT05073315|565948431|FG002|Period 2|Protocol Violation|1|||
156780844|NCT01529268|565948432|FG000|Overall Study|Lost to Follow-up|9|||
156780845|NCT01529268|565948433|FG001|Overall Study|Lost to Follow-up|3|||
156780846|NCT01529268|565948432|FG000|Overall Study|Moved|3|||
156780847|NCT01529268|565948433|FG001|Overall Study|Moved|0|||
156780848|NCT00303953|565948434|FG000|Overall Study|Ineligible|1|||
156780849|NCT00303953|565948434|FG000|Overall Study|Death|1|||
156780850|NCT00303953|565948434|FG000|Overall Study|Adverse Event|4|||
156780851|NCT00303953|565948434|FG000|Overall Study|Lack of Efficacy|12|||
156780852|NCT00303953|565948434|FG000|Overall Study|Physician Decision|1|||
156780853|NCT04069520|565948435|FG000|Overall Study|Lost to Follow-up|0|||
156780854|NCT04069520|565948436|FG001|Overall Study|Lost to Follow-up|2|||
156780855|NCT04069520|565948435|FG000|Overall Study|Withdrawal by Subject|0|||
156780856|NCT04069520|565948436|FG001|Overall Study|Withdrawal by Subject|1|||
156780857|NCT04069520|565948435|FG000|Overall Study|Prior Injury|1|||
156780858|NCT04069520|565948436|FG001|Overall Study|Prior Injury|0|||
156338195|NCT01235689|564336579|FG001|Overall Study|Lack of Efficacy|5|||
156338196|NCT01235689|564336578|FG000|Overall Study|Withdrawal by Subject|3|||
156338197|NCT01235689|564336579|FG001|Overall Study|Withdrawal by Subject|4|||
156338198|NCT01235689|564336578|FG000|Overall Study|Lost to Follow-up|1|||
156338199|NCT01235689|564336579|FG001|Overall Study|Lost to Follow-up|2|||
156338200|NCT01235689|564336578|FG000|Overall Study|Miscellaneous|1|||
156338201|NCT01235689|564336579|FG001|Overall Study|Miscellaneous|5|||
156338202|NCT02217878|564336580|FG000|Overall Study|required morphine due to chest pain|1|||
156338203|NCT02217878|564336581|FG001|Overall Study|required morphine due to chest pain|2|||
156338204|NCT02217878|564336580|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
156338205|NCT02217878|564336581|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
156338206|NCT01390649|564336582|FG000|Overall Study|Physician Decision|1|||
156338207|NCT00389597|564336583|FG000|Overall Study|Lost to Follow-up|8|||
156338208|NCT00389597|564336584|FG001|Overall Study|Lost to Follow-up|6|||
156780859|NCT04069520|565948435|FG000|Overall Study|Orthodontia|1|||
156780860|NCT04069520|565948436|FG001|Overall Study|Orthodontia|0|||
156780861|NCT04069520|565948435|FG000|Overall Study|Cut from team|0|||
156780862|NCT04069520|565948436|FG001|Overall Study|Cut from team|2|||
156780863|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
156780864|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
156780865|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
156780866|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
156675792|NCT03131895|565556884|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
156675793|NCT03131895|565556885|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156675794|NCT03131895|565556886|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
156675795|NCT03131895|565556883|FG000|Washout Period (at Least 5 Days)|Other|0|||
156675796|NCT03131895|565556884|FG001|Washout Period (at Least 5 Days)|Other|0|||
156675797|NCT03131895|565556885|FG002|Washout Period (at Least 5 Days)|Other|2|||
156780867|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
156780868|NCT00849472|565948437|FG000|Weekly Paclitaxel|Disease Progression|1|||
156780869|NCT00849472|565948437|FG000|Weekly Paclitaxel|Adverse Event|11|||
156780870|NCT00849472|565948437|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
156780871|NCT00849472|565948437|FG000|Weekly Paclitaxel|Physician Decision|3|||
156780872|NCT00849472|565948437|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
156780873|NCT00849472|565948437|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
156780874|NCT00849472|565948437|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
156780875|NCT00849472|565948437|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
156780876|NCT00849472|565948437|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
156780877|NCT00849472|565948437|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
156780878|NCT00849472|565948437|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
156780879|NCT00849472|565948437|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
156780880|NCT00825175|565948438|FG000|Overall Study|Withdrawal by Subject|0|||
156780881|NCT00825175|565948439|FG001|Overall Study|Withdrawal by Subject|5|||
156780882|NCT03998462|565948443|FG000|Overall Study|Withdrawal by Subject|10|||
156780883|NCT03998462|565948444|FG001|Overall Study|Withdrawal by Subject|4|||
156780884|NCT03998462|565948443|FG000|Overall Study|Lost to Follow-up|1|||
156780885|NCT03998462|565948444|FG001|Overall Study|Lost to Follow-up|0|||
156780886|NCT03998462|565948443|FG000|Overall Study|Technical Difficulties|1|||
156780887|NCT03998462|565948444|FG001|Overall Study|Technical Difficulties|2|||
156434508|NCT01147341|564680290|FG001|Double Blind Period|Withdrawal by Subject|1|||
156780888|NCT05710224|565948445|FG000|Overall Study|Death|1|||
156780889|NCT05710224|565948446|FG001|Overall Study|Death|0|||
156780890|NCT05710224|565948445|FG000|Overall Study|Lost to Follow-up|16|||
156780891|NCT05710224|565948446|FG001|Overall Study|Lost to Follow-up|7|||
156780892|NCT05710224|565948445|FG000|Overall Study|Withdrawal by Subject|4|||
156780893|NCT05710224|565948446|FG001|Overall Study|Withdrawal by Subject|6|||
156780894|NCT05710224|565948445|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156780895|NCT05710224|565948446|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
156780896|NCT05710224|565948445|FG000|Overall Study|Participants Left The City|0|||
156780897|NCT05710224|565948446|FG001|Overall Study|Participants Left The City|2|||
156780898|NCT03369223|565948449|FG000|Overall Study|Lost to Follow-up|0|||
156780899|NCT03369223|565948450|FG001|Overall Study|Lost to Follow-up|0|||
156780900|NCT03369223|565948451|FG002|Overall Study|Lost to Follow-up|0|||
156780901|NCT03369223|565948452|FG003|Overall Study|Lost to Follow-up|0|||
156780902|NCT03369223|565948453|FG004|Overall Study|Lost to Follow-up|0|||
156780903|NCT03369223|565948454|FG005|Overall Study|Lost to Follow-up|0|||
156780904|NCT03369223|565948455|FG006|Overall Study|Lost to Follow-up|0|||
156434509|NCT01147341|564680289|FG000|Open Label Period|Lack of Efficacy|3|||
156675798|NCT03131895|565556886|FG003|Washout Period (at Least 5 Days)|Other|0|||
156675799|NCT03131895|565556883|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
156675800|NCT03131895|565556884|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
156675801|NCT03131895|565556885|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
156675802|NCT03131895|565556886|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
156675803|NCT03131895|565556883|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
156675804|NCT03131895|565556884|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
156675805|NCT03131895|565556885|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
156675806|NCT03131895|565556886|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
156675807|NCT00918684|565556891|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
156675808|NCT00918684|565556891|FG000|Treatment Phase|Lack of Efficacy|6|||
156675809|NCT00918684|565556891|FG000|Treatment Phase|Lost to Follow-up|2|||
156434510|NCT01147341|564680290|FG001|Open Label Period|Lack of Efficacy|0|||
156434511|NCT01147341|564680289|FG000|Open Label Period|Subject moved|1|||
156434512|NCT01147341|564680290|FG001|Open Label Period|Subject moved|0|||
156434513|NCT01901276|564680291|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
156434514|NCT01901276|564680292|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
156434515|NCT02314117|564680293|FG000|Overall Study|Lost to Follow-up|9|||
156780905|NCT03369223|565948456|FG007|Overall Study|Lost to Follow-up|0|||
156780906|NCT03369223|565948457|FG008|Overall Study|Lost to Follow-up|0|||
156780907|NCT03369223|565948458|FG009|Overall Study|Lost to Follow-up|0|||
156780908|NCT03369223|565948459|FG010|Overall Study|Lost to Follow-up|0|||
156780909|NCT03369223|565948460|FG011|Overall Study|Lost to Follow-up|0|||
156780910|NCT03369223|565948461|FG012|Overall Study|Lost to Follow-up|0|||
156780911|NCT03369223|565948462|FG013|Overall Study|Lost to Follow-up|0|||
156780912|NCT03369223|565948463|FG014|Overall Study|Lost to Follow-up|0|||
156780913|NCT03369223|565948464|FG015|Overall Study|Lost to Follow-up|0|||
156780914|NCT03369223|565948465|FG016|Overall Study|Lost to Follow-up|0|||
156780915|NCT03369223|565948466|FG017|Overall Study|Lost to Follow-up|0|||
156780916|NCT03369223|565948467|FG018|Overall Study|Lost to Follow-up|2|||
156780917|NCT03369223|565948468|FG019|Overall Study|Lost to Follow-up|1|||
156780918|NCT03369223|565948449|FG000|Overall Study|Participant no longer meets study criteria|0|||
156780919|NCT03369223|565948450|FG001|Overall Study|Participant no longer meets study criteria|0|||
156780920|NCT03369223|565948451|FG002|Overall Study|Participant no longer meets study criteria|0|||
156780921|NCT03369223|565948452|FG003|Overall Study|Participant no longer meets study criteria|0|||
156780922|NCT03369223|565948453|FG004|Overall Study|Participant no longer meets study criteria|0|||
156780923|NCT03369223|565948454|FG005|Overall Study|Participant no longer meets study criteria|0|||
156780924|NCT03369223|565948455|FG006|Overall Study|Participant no longer meets study criteria|0|||
156780925|NCT03369223|565948456|FG007|Overall Study|Participant no longer meets study criteria|0|||
156780926|NCT03369223|565948457|FG008|Overall Study|Participant no longer meets study criteria|0|||
156780927|NCT03369223|565948458|FG009|Overall Study|Participant no longer meets study criteria|0|||
156780928|NCT03369223|565948459|FG010|Overall Study|Participant no longer meets study criteria|0|||
156780929|NCT03369223|565948460|FG011|Overall Study|Participant no longer meets study criteria|0|||
156780930|NCT03369223|565948461|FG012|Overall Study|Participant no longer meets study criteria|0|||
156780931|NCT03369223|565948462|FG013|Overall Study|Participant no longer meets study criteria|0|||
156780932|NCT03369223|565948463|FG014|Overall Study|Participant no longer meets study criteria|2|||
156780933|NCT03369223|565948464|FG015|Overall Study|Participant no longer meets study criteria|0|||
156780934|NCT03369223|565948465|FG016|Overall Study|Participant no longer meets study criteria|2|||
156780935|NCT03369223|565948466|FG017|Overall Study|Participant no longer meets study criteria|0|||
156780936|NCT03369223|565948467|FG018|Overall Study|Participant no longer meets study criteria|0|||
156780937|NCT03369223|565948468|FG019|Overall Study|Participant no longer meets study criteria|0|||
156780938|NCT03369223|565948449|FG000|Overall Study|Other reasons|0|||
156780939|NCT03369223|565948450|FG001|Overall Study|Other reasons|0|||
156780940|NCT03369223|565948451|FG002|Overall Study|Other reasons|0|||
156780941|NCT03369223|565948452|FG003|Overall Study|Other reasons|0|||
156780942|NCT03369223|565948453|FG004|Overall Study|Other reasons|0|||
156780943|NCT03369223|565948454|FG005|Overall Study|Other reasons|0|||
156780944|NCT03369223|565948455|FG006|Overall Study|Other reasons|0|||
156780945|NCT03369223|565948456|FG007|Overall Study|Other reasons|0|||
156780946|NCT03369223|565948457|FG008|Overall Study|Other reasons|0|||
156780947|NCT03369223|565948458|FG009|Overall Study|Other reasons|0|||
156780948|NCT03369223|565948459|FG010|Overall Study|Other reasons|0|||
156780949|NCT03369223|565948460|FG011|Overall Study|Other reasons|0|||
156780950|NCT03369223|565948461|FG012|Overall Study|Other reasons|0|||
156780951|NCT03369223|565948462|FG013|Overall Study|Other reasons|1|||
156780952|NCT03369223|565948463|FG014|Overall Study|Other reasons|2|||
156780953|NCT03369223|565948464|FG015|Overall Study|Other reasons|0|||
156780954|NCT03369223|565948465|FG016|Overall Study|Other reasons|1|||
156780955|NCT03369223|565948466|FG017|Overall Study|Other reasons|0|||
156780956|NCT03369223|565948467|FG018|Overall Study|Other reasons|0|||
156780957|NCT03369223|565948468|FG019|Overall Study|Other reasons|2|||
156780958|NCT03369223|565948449|FG000|Overall Study|Death|0|||
156675810|NCT00918684|565556891|FG000|Treatment Phase|Physician Decision|8|||
156675811|NCT00918684|565556891|FG000|Treatment Phase|Protocol Violation|1|||
156675812|NCT00918684|565556891|FG000|Treatment Phase|Withdrawal by Subject|8|||
156675813|NCT00463684|565556897|FG000|Overall Study|Withdrawal by Subject|1|||
156675814|NCT00463684|565556897|FG000|Overall Study|Lost to Follow-up|3|||
156675815|NCT02462837|565556898|FG000|Overall Study|pt developed hives|1|||
156675816|NCT02462837|565556899|FG001|Overall Study|pt developed hives|0|||
156675817|NCT02462837|565556898|FG000|Overall Study|Withdrawal by Subject|1|||
156675818|NCT02462837|565556899|FG001|Overall Study|Withdrawal by Subject|0|||
156675819|NCT00906399|565556900|FG000|Year 1|Randomized But Not Treated|0|||
156675820|NCT00906399|565556901|FG001|Year 1|Randomized But Not Treated|1|||
156675821|NCT00906399|565556902|FG002|Year 1|Randomized But Not Treated|3|||
156675822|NCT00906399|565556903|FG003|Year 1|Randomized But Not Treated|0|||
156780959|NCT03369223|565948450|FG001|Overall Study|Death|0|||
156780960|NCT03369223|565948451|FG002|Overall Study|Death|0|||
156780961|NCT03369223|565948452|FG003|Overall Study|Death|0|||
156780962|NCT03369223|565948453|FG004|Overall Study|Death|0|||
156780963|NCT03369223|565948454|FG005|Overall Study|Death|0|||
156780964|NCT03369223|565948455|FG006|Overall Study|Death|0|||
156780965|NCT03369223|565948456|FG007|Overall Study|Death|0|||
156780966|NCT03369223|565948457|FG008|Overall Study|Death|0|||
156780967|NCT03369223|565948458|FG009|Overall Study|Death|0|||
156780968|NCT03369223|565948459|FG010|Overall Study|Death|0|||
156780969|NCT03369223|565948460|FG011|Overall Study|Death|0|||
156780970|NCT03369223|565948461|FG012|Overall Study|Death|0|||
156780971|NCT03369223|565948462|FG013|Overall Study|Death|1|||
156780972|NCT03369223|565948463|FG014|Overall Study|Death|0|||
156780973|NCT03369223|565948464|FG015|Overall Study|Death|0|||
156780974|NCT03369223|565948465|FG016|Overall Study|Death|0|||
156780975|NCT03369223|565948466|FG017|Overall Study|Death|0|||
156780976|NCT03369223|565948467|FG018|Overall Study|Death|1|||
156780977|NCT03369223|565948468|FG019|Overall Study|Death|0|||
156780978|NCT03369223|565948449|FG000|Overall Study|Adverse event unrelated to study drug|0|||
156780979|NCT03369223|565948450|FG001|Overall Study|Adverse event unrelated to study drug|0|||
156780980|NCT03369223|565948451|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156780981|NCT03369223|565948452|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156780982|NCT03369223|565948453|FG004|Overall Study|Adverse event unrelated to study drug|0|||
156780983|NCT03369223|565948454|FG005|Overall Study|Adverse event unrelated to study drug|0|||
156780984|NCT03369223|565948455|FG006|Overall Study|Adverse event unrelated to study drug|1|||
156780985|NCT03369223|565948456|FG007|Overall Study|Adverse event unrelated to study drug|0|||
156780986|NCT03369223|565948457|FG008|Overall Study|Adverse event unrelated to study drug|0|||
156780987|NCT03369223|565948458|FG009|Overall Study|Adverse event unrelated to study drug|1|||
156780988|NCT03369223|565948459|FG010|Overall Study|Adverse event unrelated to study drug|0|||
156780989|NCT03369223|565948460|FG011|Overall Study|Adverse event unrelated to study drug|0|||
156780990|NCT03369223|565948461|FG012|Overall Study|Adverse event unrelated to study drug|0|||
156780991|NCT03369223|565948462|FG013|Overall Study|Adverse event unrelated to study drug|4|||
156780992|NCT03369223|565948463|FG014|Overall Study|Adverse event unrelated to study drug|2|||
156780993|NCT03369223|565948464|FG015|Overall Study|Adverse event unrelated to study drug|0|||
156780994|NCT03369223|565948465|FG016|Overall Study|Adverse event unrelated to study drug|2|||
156780995|NCT03369223|565948466|FG017|Overall Study|Adverse event unrelated to study drug|1|||
156780996|NCT03369223|565948467|FG018|Overall Study|Adverse event unrelated to study drug|3|||
156780997|NCT03369223|565948468|FG019|Overall Study|Adverse event unrelated to study drug|2|||
156780998|NCT03369223|565948449|FG000|Overall Study|Disease progression|6|||
156780999|NCT03369223|565948450|FG001|Overall Study|Disease progression|8|||
156781000|NCT03369223|565948451|FG002|Overall Study|Disease progression|5|||
156781001|NCT03369223|565948452|FG003|Overall Study|Disease progression|1|||
156781002|NCT03369223|565948453|FG004|Overall Study|Disease progression|9|||
156781003|NCT03369223|565948454|FG005|Overall Study|Disease progression|9|||
156781004|NCT03369223|565948455|FG006|Overall Study|Disease progression|4|||
156781005|NCT03369223|565948456|FG007|Overall Study|Disease progression|6|||
156781006|NCT03369223|565948457|FG008|Overall Study|Disease progression|10|||
156781007|NCT03369223|565948458|FG009|Overall Study|Disease progression|7|||
156781008|NCT03369223|565948459|FG010|Overall Study|Disease progression|4|||
156781009|NCT03369223|565948460|FG011|Overall Study|Disease progression|1|||
156781010|NCT03369223|565948461|FG012|Overall Study|Disease progression|1|||
156781011|NCT03369223|565948462|FG013|Overall Study|Disease progression|25|||
156781012|NCT03369223|565948463|FG014|Overall Study|Disease progression|22|||
156781013|NCT03369223|565948464|FG015|Overall Study|Disease progression|2|||
156781014|NCT03369223|565948465|FG016|Overall Study|Disease progression|10|||
156781015|NCT03369223|565948466|FG017|Overall Study|Disease progression|1|||
156781016|NCT03369223|565948467|FG018|Overall Study|Disease progression|18|||
156781017|NCT03369223|565948468|FG019|Overall Study|Disease progression|28|||
156781018|NCT03369223|565948449|FG000|Overall Study|Study drug toxicity|0|||
156781019|NCT03369223|565948450|FG001|Overall Study|Study drug toxicity|1|||
156781020|NCT03369223|565948451|FG002|Overall Study|Study drug toxicity|4|||
156781021|NCT03369223|565948452|FG003|Overall Study|Study drug toxicity|0|||
156781022|NCT03369223|565948453|FG004|Overall Study|Study drug toxicity|1|||
156781023|NCT03369223|565948454|FG005|Overall Study|Study drug toxicity|2|||
156781024|NCT03369223|565948455|FG006|Overall Study|Study drug toxicity|4|||
156781025|NCT03369223|565948456|FG007|Overall Study|Study drug toxicity|2|||
156781026|NCT03369223|565948457|FG008|Overall Study|Study drug toxicity|2|||
156781027|NCT03369223|565948458|FG009|Overall Study|Study drug toxicity|0|||
156781028|NCT03369223|565948459|FG010|Overall Study|Study drug toxicity|6|||
156781029|NCT03369223|565948460|FG011|Overall Study|Study drug toxicity|1|||
156781030|NCT03369223|565948461|FG012|Overall Study|Study drug toxicity|2|||
156781031|NCT03369223|565948462|FG013|Overall Study|Study drug toxicity|19|||
156781032|NCT03369223|565948463|FG014|Overall Study|Study drug toxicity|19|||
156781033|NCT03369223|565948464|FG015|Overall Study|Study drug toxicity|0|||
156781034|NCT03369223|565948465|FG016|Overall Study|Study drug toxicity|18|||
156781035|NCT03369223|565948466|FG017|Overall Study|Study drug toxicity|3|||
156781036|NCT03369223|565948467|FG018|Overall Study|Study drug toxicity|11|||
156528953|NCT02168842|565031012|FG000|Overall Study|Death|2|||
156528954|NCT02168842|565031013|FG001|Overall Study|Death|1|||
156781037|NCT03369223|565948468|FG019|Overall Study|Study drug toxicity|7|||
156781038|NCT03369223|565948449|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156781039|NCT03369223|565948450|FG001|Overall Study|Participant request to discontinue study treatment|1|||
156781040|NCT03369223|565948451|FG002|Overall Study|Participant request to discontinue study treatment|0|||
156528955|NCT02168842|565031012|FG000|Overall Study|Physician Decision|1|||
156528956|NCT02168842|565031013|FG001|Overall Study|Physician Decision|2|||
156781041|NCT03369223|565948452|FG003|Overall Study|Participant request to discontinue study treatment|0|||
156434516|NCT02314117|564680294|FG001|Overall Study|Lost to Follow-up|14|||
156434517|NCT02314117|564680293|FG000|Overall Study|Withdrawal by Subject|3|||
156434518|NCT02314117|564680294|FG001|Overall Study|Withdrawal by Subject|2|||
156434519|NCT02954848|564680295|FG000|Overall Study|Randomized but Not Treated|0|||
156781042|NCT03369223|565948453|FG004|Overall Study|Participant request to discontinue study treatment|1|||
156781043|NCT03369223|565948454|FG005|Overall Study|Participant request to discontinue study treatment|1|||
156781044|NCT03369223|565948455|FG006|Overall Study|Participant request to discontinue study treatment|1|||
156781045|NCT03369223|565948456|FG007|Overall Study|Participant request to discontinue study treatment|0|||
156781046|NCT03369223|565948457|FG008|Overall Study|Participant request to discontinue study treatment|0|||
156781047|NCT03369223|565948458|FG009|Overall Study|Participant request to discontinue study treatment|0|||
156781048|NCT03369223|565948459|FG010|Overall Study|Participant request to discontinue study treatment|0|||
156781049|NCT03369223|565948460|FG011|Overall Study|Participant request to discontinue study treatment|0|||
156781050|NCT03369223|565948461|FG012|Overall Study|Participant request to discontinue study treatment|0|||
156781051|NCT03369223|565948462|FG013|Overall Study|Participant request to discontinue study treatment|1|||
156528957|NCT01794923|565031027|FG000|Overall Study|Adverse Event|0|||
156528958|NCT01794923|565031028|FG001|Overall Study|Adverse Event|0|||
156528959|NCT01794923|565031029|FG002|Overall Study|Adverse Event|1|||
156528960|NCT03267940|565031041|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
156528961|NCT03267940|565031042|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
156528962|NCT03267940|565031043|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
156528963|NCT03267940|565031044|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
156528964|NCT03267940|565031045|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
156528965|NCT03267940|565031046|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
156528966|NCT03267940|565031041|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
156528967|NCT03267940|565031042|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
156528968|NCT03267940|565031043|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
156528969|NCT03267940|565031044|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
156528970|NCT03267940|565031045|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
156675823|NCT00906399|565556904|FG004|Year 1|Randomized But Not Treated|0|||
156675824|NCT00906399|565556905|FG005|Year 1|Randomized But Not Treated|0|||
156434520|NCT02954848|564680296|FG001|Overall Study|Randomized but Not Treated|1|||
156434521|NCT02954848|564680295|FG000|Overall Study|Adverse Event|2|||
156434522|NCT02954848|564680296|FG001|Overall Study|Adverse Event|3|||
156434523|NCT02954848|564680295|FG000|Overall Study|Withdrawal by Participant|0|||
156434524|NCT02954848|564680296|FG001|Overall Study|Withdrawal by Participant|1|||
156434525|NCT01802632|564680297|FG000|Overall Study|Death|28|||
156434526|NCT01802632|564680298|FG001|Overall Study|Death|1|||
156434527|NCT01802632|564680299|FG002|Overall Study|Death|38|||
156434528|NCT01802632|564680300|FG003|Overall Study|Death|0|||
156434529|NCT01802632|564680301|FG004|Overall Study|Death|2|||
156434530|NCT01802632|564680302|FG005|Overall Study|Death|0|||
156434531|NCT01802632|564680297|FG000|Overall Study|Withdrawal by Subject|4|||
156434532|NCT01802632|564680298|FG001|Overall Study|Withdrawal by Subject|2|||
156434533|NCT01802632|564680299|FG002|Overall Study|Withdrawal by Subject|7|||
156434534|NCT01802632|564680300|FG003|Overall Study|Withdrawal by Subject|3|||
156434535|NCT01802632|564680301|FG004|Overall Study|Withdrawal by Subject|0|||
156434536|NCT01802632|564680302|FG005|Overall Study|Withdrawal by Subject|1|||
156434537|NCT01802632|564680297|FG000|Overall Study|Objective Disease Progression|1|||
156434538|NCT01802632|564680298|FG001|Overall Study|Objective Disease Progression|12|||
156434539|NCT01802632|564680299|FG002|Overall Study|Objective Disease Progression|104|||
156434540|NCT01802632|564680300|FG003|Overall Study|Objective Disease Progression|6|||
156434541|NCT01802632|564680301|FG004|Overall Study|Objective Disease Progression|4|||
156434542|NCT01802632|564680302|FG005|Overall Study|Objective Disease Progression|4|||
156434543|NCT01802632|564680297|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
156434544|NCT01802632|564680298|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
156434545|NCT01802632|564680299|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
156434546|NCT01802632|564680300|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
156434547|NCT01802632|564680301|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
156434548|NCT01802632|564680302|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
156675825|NCT00906399|565556906|FG006|Year 1|Randomized But Not Treated|0|||
156675826|NCT00906399|565556900|FG000|Year 1|Adverse Event|4|||
156675827|NCT00906399|565556901|FG001|Year 1|Adverse Event|22|||
156675828|NCT00906399|565556902|FG002|Year 1|Adverse Event|24|||
156675829|NCT00906399|565556903|FG003|Year 1|Adverse Event|0|||
156675830|NCT00906399|565556904|FG004|Year 1|Adverse Event|0|||
156675831|NCT00906399|565556905|FG005|Year 1|Adverse Event|0|||
156675832|NCT00906399|565556906|FG006|Year 1|Adverse Event|0|||
156675833|NCT00906399|565556900|FG000|Year 1|Lost to Follow-up|4|||
156675834|NCT00906399|565556901|FG001|Year 1|Lost to Follow-up|4|||
156675835|NCT00906399|565556902|FG002|Year 1|Lost to Follow-up|2|||
156675836|NCT00906399|565556903|FG003|Year 1|Lost to Follow-up|0|||
156781052|NCT03369223|565948463|FG014|Overall Study|Participant request to discontinue study treatment|1|||
156781053|NCT03369223|565948464|FG015|Overall Study|Participant request to discontinue study treatment|0|||
156781054|NCT03369223|565948465|FG016|Overall Study|Participant request to discontinue study treatment|0|||
156781055|NCT03369223|565948466|FG017|Overall Study|Participant request to discontinue study treatment|0|||
156781056|NCT03369223|565948467|FG018|Overall Study|Participant request to discontinue study treatment|1|||
156781057|NCT03369223|565948468|FG019|Overall Study|Participant request to discontinue study treatment|0|||
156781058|NCT03369223|565948449|FG000|Overall Study|Participant withdrew consent|0|||
156781059|NCT03369223|565948450|FG001|Overall Study|Participant withdrew consent|1|||
156781060|NCT03369223|565948451|FG002|Overall Study|Participant withdrew consent|1|||
156781061|NCT03369223|565948452|FG003|Overall Study|Participant withdrew consent|0|||
156781062|NCT03369223|565948453|FG004|Overall Study|Participant withdrew consent|0|||
156781063|NCT03369223|565948454|FG005|Overall Study|Participant withdrew consent|0|||
156781064|NCT03369223|565948455|FG006|Overall Study|Participant withdrew consent|1|||
156781065|NCT03369223|565948456|FG007|Overall Study|Participant withdrew consent|1|||
156781066|NCT03369223|565948457|FG008|Overall Study|Participant withdrew consent|1|||
156781067|NCT03369223|565948458|FG009|Overall Study|Participant withdrew consent|0|||
156781068|NCT03369223|565948459|FG010|Overall Study|Participant withdrew consent|0|||
156781069|NCT03369223|565948460|FG011|Overall Study|Participant withdrew consent|1|||
156781070|NCT03369223|565948461|FG012|Overall Study|Participant withdrew consent|0|||
156781071|NCT03369223|565948462|FG013|Overall Study|Participant withdrew consent|0|||
156781072|NCT03369223|565948463|FG014|Overall Study|Participant withdrew consent|3|||
156781073|NCT03369223|565948464|FG015|Overall Study|Participant withdrew consent|0|||
156781074|NCT03369223|565948465|FG016|Overall Study|Participant withdrew consent|1|||
156781075|NCT03369223|565948466|FG017|Overall Study|Participant withdrew consent|0|||
156781076|NCT03369223|565948467|FG018|Overall Study|Participant withdrew consent|4|||
156781077|NCT03369223|565948468|FG019|Overall Study|Participant withdrew consent|2|||
156434549|NCT01802632|564680297|FG000|Overall Study|Other (not specified)|0|||
156434550|NCT01802632|564680298|FG001|Overall Study|Other (not specified)|0|||
156434551|NCT01802632|564680299|FG002|Overall Study|Other (not specified)|7|||
156434552|NCT01802632|564680300|FG003|Overall Study|Other (not specified)|1|||
156781078|NCT03369223|565948449|FG000|Overall Study|Randomized but not treated|0|||
156781079|NCT03369223|565948450|FG001|Overall Study|Randomized but not treated|0|||
156781080|NCT03369223|565948451|FG002|Overall Study|Randomized but not treated|0|||
156781081|NCT03369223|565948452|FG003|Overall Study|Randomized but not treated|0|||
156781082|NCT03369223|565948453|FG004|Overall Study|Randomized but not treated|0|||
156781083|NCT03369223|565948454|FG005|Overall Study|Randomized but not treated|0|||
156781084|NCT03369223|565948455|FG006|Overall Study|Randomized but not treated|0|||
156781085|NCT03369223|565948456|FG007|Overall Study|Randomized but not treated|0|||
156781086|NCT03369223|565948457|FG008|Overall Study|Randomized but not treated|0|||
156781087|NCT03369223|565948458|FG009|Overall Study|Randomized but not treated|0|||
156781088|NCT03369223|565948459|FG010|Overall Study|Randomized but not treated|0|||
156781089|NCT03369223|565948460|FG011|Overall Study|Randomized but not treated|0|||
156781090|NCT03369223|565948461|FG012|Overall Study|Randomized but not treated|0|||
156781091|NCT03369223|565948462|FG013|Overall Study|Randomized but not treated|1|||
156781092|NCT03369223|565948463|FG014|Overall Study|Randomized but not treated|1|||
156781093|NCT03369223|565948464|FG015|Overall Study|Randomized but not treated|0|||
156434553|NCT01802632|564680301|FG004|Overall Study|Other (not specified)|0|||
156434554|NCT01802632|564680302|FG005|Overall Study|Other (not specified)|1|||
156434555|NCT01184508|564680306|FG000|Overall Study|Adverse Event|4|||
156434556|NCT01184508|564680307|FG001|Overall Study|Adverse Event|6|||
156434557|NCT01184508|564680306|FG000|Overall Study|Lack of Efficacy|1|||
156434558|NCT01184508|564680307|FG001|Overall Study|Lack of Efficacy|1|||
156434559|NCT01184508|564680306|FG000|Overall Study|Lost to Follow-up|1|||
156434560|NCT01184508|564680307|FG001|Overall Study|Lost to Follow-up|1|||
156434561|NCT01184508|564680306|FG000|Overall Study|Physician Decision|1|||
156434562|NCT01184508|564680307|FG001|Overall Study|Physician Decision|0|||
156434563|NCT01184508|564680306|FG000|Overall Study|Protocol Violation|3|||
156434564|NCT01184508|564680307|FG001|Overall Study|Protocol Violation|1|||
156434565|NCT01184508|564680306|FG000|Overall Study|Sponsor Decision|5|||
156434566|NCT01184508|564680307|FG001|Overall Study|Sponsor Decision|2|||
156434567|NCT01184508|564680306|FG000|Overall Study|Withdrawal by Subject|1|||
156434568|NCT01184508|564680307|FG001|Overall Study|Withdrawal by Subject|3|||
156781094|NCT03369223|565948465|FG016|Overall Study|Randomized but not treated|0|||
156781095|NCT03369223|565948466|FG017|Overall Study|Randomized but not treated|0|||
156781096|NCT03369223|565948467|FG018|Overall Study|Randomized but not treated|0|||
156781097|NCT03369223|565948468|FG019|Overall Study|Randomized but not treated|0|||
156781098|NCT04615507|565948470|FG000|Period 1|Covid-19 exposure|2|||
156434569|NCT01184508|564680306|FG000|Overall Study|Randomized, Not Treated|0|||
156434570|NCT01184508|564680307|FG001|Overall Study|Randomized, Not Treated|1|||
156434571|NCT02020616|564680315|FG000|Overall Study|Adverse Event|0|||
156781099|NCT04615507|565948471|FG001|Period 1|Covid-19 exposure|1|||
156781100|NCT04615507|565948470|FG000|Period 2|Covid-19 exposure|0|||
156781101|NCT04615507|565948471|FG001|Period 2|Covid-19 exposure|1|||
156781102|NCT04615507|565948470|FG000|Period 2|Protocol Violation|1|||
156781103|NCT04615507|565948471|FG001|Period 2|Protocol Violation|0|||
156781104|NCT04615507|565948470|FG000|Period 2|Withdrawal by Subject|1|||
156781105|NCT04615507|565948471|FG001|Period 2|Withdrawal by Subject|0|||
156781106|NCT04615507|565948470|FG000|Period 2|Adverse Event|0|||
156781107|NCT04615507|565948471|FG001|Period 2|Adverse Event|1|||
156781108|NCT04615507|565948470|FG000|Period 3|Covid-19 exposure|0|||
156781109|NCT04615507|565948471|FG001|Period 3|Covid-19 exposure|1|||
156781110|NCT03976375|565948474|FG000|Overall Study|Death|158|||
156781111|NCT03976375|565948475|FG001|Overall Study|Death|160|||
156781112|NCT03976375|565948476|FG002|Overall Study|Death|42|||
156781113|NCT03976375|565948474|FG000|Overall Study|Lost to Follow-up|2|||
156781114|NCT03976375|565948475|FG001|Overall Study|Lost to Follow-up|1|||
156781115|NCT03976375|565948476|FG002|Overall Study|Lost to Follow-up|1|||
156781116|NCT03976375|565948474|FG000|Overall Study|Withdrawal by Subject|5|||
156781117|NCT03976375|565948475|FG001|Overall Study|Withdrawal by Subject|9|||
156781118|NCT03976375|565948476|FG002|Overall Study|Withdrawal by Subject|4|||
156781119|NCT03976375|565948474|FG000|Overall Study|Sponsor decision|20|||
156781120|NCT03976375|565948475|FG001|Overall Study|Sponsor decision|19|||
156781121|NCT03976375|565948476|FG002|Overall Study|Sponsor decision|1|||
156781122|NCT03091439|565948477|FG000|Overall Study|Study Terminated by the Sponsor|1|||
156781123|NCT03091439|565948478|FG001|Overall Study|Study Terminated by the Sponsor|0|||
156781124|NCT03122106|565948479|FG000|Overall Study|Not enough tissue|1|||
156781125|NCT03122106|565948479|FG000|Overall Study|Disease progression during screening|2|||
156781126|NCT03122106|565948479|FG000|Overall Study|Poor RNA quality for vaccine|1|||
156781127|NCT02347787|565948480|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
156781128|NCT02347787|565948481|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
156781129|NCT02347787|565948480|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
156781130|NCT02347787|565948481|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
156781131|NCT02347787|565948480|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
156781132|NCT02347787|565948481|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
156781133|NCT02347787|565948480|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
156781134|NCT02347787|565948481|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
156781135|NCT00308685|565948482|FG000|Overall Study|Lost to Follow-up|1|||
156781136|NCT00308685|565948483|FG001|Overall Study|Lost to Follow-up|0|||
156781137|NCT00308685|565948482|FG000|Overall Study|Need to administer prohibited medication|1|||
156781138|NCT00308685|565948483|FG001|Overall Study|Need to administer prohibited medication|2|||
156781139|NCT00308685|565948482|FG000|Overall Study|Other than specified|1|||
156781140|NCT00308685|565948483|FG001|Overall Study|Other than specified|3|||
156781141|NCT03244189|565948484|FG000|Overall Study|Death|0|||
156781142|NCT03244189|565948485|FG001|Overall Study|Death|2|||
156781143|NCT03244189|565948484|FG000|Overall Study|Lost to Follow-up|92|||
156781144|NCT03244189|565948485|FG001|Overall Study|Lost to Follow-up|107|||
156781145|NCT03244189|565948484|FG000|Overall Study|Physician Decision|4|||
156781146|NCT03244189|565948485|FG001|Overall Study|Physician Decision|2|||
156781147|NCT03244189|565948484|FG000|Overall Study|Pregnancy|7|||
156781148|NCT03244189|565948485|FG001|Overall Study|Pregnancy|5|||
156781149|NCT03244189|565948484|FG000|Overall Study|Protocol Violation|0|||
156781150|NCT03244189|565948485|FG001|Overall Study|Protocol Violation|2|||
156781151|NCT03244189|565948484|FG000|Overall Study|Withdrawal by Subject|45|||
156781152|NCT03244189|565948485|FG001|Overall Study|Withdrawal by Subject|23|||
156781153|NCT03244189|565948484|FG000|Overall Study|Technical Problems|2|||
156781154|NCT03244189|565948485|FG001|Overall Study|Technical Problems|0|||
156781155|NCT03599713|565948486|FG000|Overall Study|Death|38|||
156781156|NCT03599713|565948487|FG001|Overall Study|Death|3|||
156781157|NCT03599713|565948486|FG000|Overall Study|Withdrawal by Subject|17|||
156781158|NCT03599713|565948487|FG001|Overall Study|Withdrawal by Subject|0|||
156781159|NCT03599713|565948486|FG000|Overall Study|Lost to Follow-up|4|||
156781160|NCT03599713|565948487|FG001|Overall Study|Lost to Follow-up|0|||
156781161|NCT03599713|565948486|FG000|Overall Study|Discontinued Due to End of Study|42|||
156781162|NCT03599713|565948487|FG001|Overall Study|Discontinued Due to End of Study|3|||
156781163|NCT02850406|565948490|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781164|NCT02850406|565948491|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781165|NCT02850406|565948492|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781166|NCT02850406|565948493|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
156781167|NCT02850406|565948494|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781168|NCT02850406|565948495|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781169|NCT02850406|565948496|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781170|NCT02850406|565948497|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781171|NCT02850406|565948490|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781172|NCT02850406|565948491|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781173|NCT02850406|565948492|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
156781174|NCT02850406|565948493|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
156781175|NCT02850406|565948494|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781176|NCT02850406|565948495|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781177|NCT02850406|565948496|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781178|NCT02850406|565948497|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781179|NCT02850406|565948490|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781180|NCT02850406|565948491|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781181|NCT02850406|565948492|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
156781182|NCT02850406|565948493|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781183|NCT02850406|565948494|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781184|NCT02850406|565948495|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781185|NCT02850406|565948496|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781186|NCT02850406|565948497|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781187|NCT02850406|565948490|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
156781188|NCT02850406|565948491|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
156781189|NCT02850406|565948492|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
156781190|NCT02850406|565948493|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
156781191|NCT02850406|565948494|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
156781192|NCT02850406|565948495|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
156781193|NCT02850406|565948496|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
156781194|NCT02850406|565948497|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
156781195|NCT02850406|565948490|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781196|NCT02850406|565948491|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781197|NCT02850406|565948492|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781198|NCT02850406|565948493|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781199|NCT02850406|565948494|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
156781200|NCT02850406|565948495|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
156781201|NCT02850406|565948496|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781202|NCT02850406|565948497|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781203|NCT02850406|565948490|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781204|NCT02850406|565948491|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781205|NCT02850406|565948492|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781206|NCT02850406|565948493|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781207|NCT02850406|565948494|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
156781208|NCT02850406|565948495|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
156781209|NCT02850406|565948496|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781210|NCT02850406|565948497|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781211|NCT02850406|565948490|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781212|NCT02850406|565948491|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781213|NCT02850406|565948492|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781214|NCT02850406|565948493|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781215|NCT02850406|565948494|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
156434572|NCT02020616|564680316|FG001|Overall Study|Adverse Event|0|||
156434573|NCT02020616|564680317|FG002|Overall Study|Adverse Event|0|||
156781216|NCT02850406|565948495|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781217|NCT02850406|565948496|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781218|NCT02850406|565948497|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781219|NCT02850406|565948490|FG000|Part C (Up to 52 Weeks)|Other|0|||
156781220|NCT02850406|565948491|FG001|Part C (Up to 52 Weeks)|Other|0|||
156781221|NCT02850406|565948492|FG002|Part C (Up to 52 Weeks)|Other|0|||
156781222|NCT02850406|565948493|FG003|Part C (Up to 52 Weeks)|Other|0|||
156781223|NCT02850406|565948494|FG004|Part C (Up to 52 Weeks)|Other|1|||
156781224|NCT02850406|565948495|FG005|Part C (Up to 52 Weeks)|Other|3|||
156781225|NCT02850406|565948496|FG006|Part C (Up to 52 Weeks)|Other|0|||
156434574|NCT02020616|564680318|FG003|Overall Study|Adverse Event|0|||
156434575|NCT02020616|564680319|FG004|Overall Study|Adverse Event|0|||
156434576|NCT02020616|564680320|FG005|Overall Study|Adverse Event|1|||
156434577|NCT02020616|564680321|FG006|Overall Study|Adverse Event|1|||
156675837|NCT00906399|565556904|FG004|Year 1|Lost to Follow-up|0|||
156675838|NCT00906399|565556905|FG005|Year 1|Lost to Follow-up|0|||
156434578|NCT02020616|564680315|FG000|Overall Study|Physician Decision|0|||
156434579|NCT02020616|564680316|FG001|Overall Study|Physician Decision|0|||
156434580|NCT02020616|564680317|FG002|Overall Study|Physician Decision|0|||
156434581|NCT02020616|564680318|FG003|Overall Study|Physician Decision|0|||
156434582|NCT02020616|564680319|FG004|Overall Study|Physician Decision|0|||
156434583|NCT02020616|564680320|FG005|Overall Study|Physician Decision|1|||
156434584|NCT02020616|564680321|FG006|Overall Study|Physician Decision|2|||
156434585|NCT02020616|564680315|FG000|Overall Study|Withdrawal by Subject|0|||
156434586|NCT02020616|564680316|FG001|Overall Study|Withdrawal by Subject|0|||
156434587|NCT02020616|564680317|FG002|Overall Study|Withdrawal by Subject|1|||
156675839|NCT00906399|565556906|FG006|Year 1|Lost to Follow-up|0|||
156675840|NCT00906399|565556900|FG000|Year 1|Withdrawal by Subject|30|||
156675841|NCT00906399|565556901|FG001|Year 1|Withdrawal by Subject|32|||
156675842|NCT00906399|565556902|FG002|Year 1|Withdrawal by Subject|36|||
156675843|NCT00906399|565556903|FG003|Year 1|Withdrawal by Subject|0|||
156434588|NCT02020616|564680318|FG003|Overall Study|Withdrawal by Subject|0|||
156781226|NCT02850406|565948497|FG007|Part C (Up to 52 Weeks)|Other|0|||
156675844|NCT00906399|565556904|FG004|Year 1|Withdrawal by Subject|0|||
156675845|NCT00906399|565556905|FG005|Year 1|Withdrawal by Subject|0|||
156781227|NCT02850406|565948490|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781228|NCT02850406|565948491|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781229|NCT02850406|565948492|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
156675846|NCT00906399|565556906|FG006|Year 1|Withdrawal by Subject|0|||
156675847|NCT00906399|565556900|FG000|Year 1|Physician Decision|0|||
156675848|NCT00906399|565556901|FG001|Year 1|Physician Decision|1|||
156675849|NCT00906399|565556902|FG002|Year 1|Physician Decision|3|||
156675850|NCT00906399|565556903|FG003|Year 1|Physician Decision|0|||
156675851|NCT00906399|565556904|FG004|Year 1|Physician Decision|0|||
156675852|NCT00906399|565556905|FG005|Year 1|Physician Decision|0|||
156528971|NCT03267940|565031046|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
156528972|NCT03267940|565031041|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
156528973|NCT03267940|565031042|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
156528974|NCT03267940|565031043|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
156434589|NCT02020616|564680319|FG004|Overall Study|Withdrawal by Subject|0|||
156434590|NCT02020616|564680320|FG005|Overall Study|Withdrawal by Subject|1|||
156434591|NCT02020616|564680321|FG006|Overall Study|Withdrawal by Subject|1|||
156434592|NCT02020616|564680315|FG000|Overall Study|Lost to Follow-up|0|||
156434593|NCT02020616|564680316|FG001|Overall Study|Lost to Follow-up|1|||
156781230|NCT02850406|565948493|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781231|NCT02850406|565948494|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781232|NCT02850406|565948495|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781233|NCT02850406|565948496|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
156781234|NCT02850406|565948497|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781235|NCT02850406|565948490|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781236|NCT02850406|565948491|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781237|NCT02850406|565948492|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781238|NCT02850406|565948493|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781239|NCT02850406|565948494|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781240|NCT02850406|565948495|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781241|NCT02850406|565948496|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781242|NCT02850406|565948497|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
156781243|NCT02850406|565948490|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781244|NCT02850406|565948491|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781245|NCT02850406|565948492|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781246|NCT02850406|565948493|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781247|NCT02850406|565948494|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781248|NCT02850406|565948495|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781249|NCT02850406|565948496|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
156781250|NCT02850406|565948497|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
156781251|NCT02850406|565948490|FG000|Part D (Up to 52 Weeks)|Other|0|||
156781252|NCT02850406|565948491|FG001|Part D (Up to 52 Weeks)|Other|0|||
156781253|NCT02850406|565948492|FG002|Part D (Up to 52 Weeks)|Other|0|||
156781254|NCT02850406|565948493|FG003|Part D (Up to 52 Weeks)|Other|0|||
156781255|NCT02850406|565948494|FG004|Part D (Up to 52 Weeks)|Other|0|||
156781256|NCT02850406|565948495|FG005|Part D (Up to 52 Weeks)|Other|0|||
156781257|NCT02850406|565948496|FG006|Part D (Up to 52 Weeks)|Other|0|||
156781258|NCT02850406|565948497|FG007|Part D (Up to 52 Weeks)|Other|1|||
156781259|NCT05578872|565948498|FG000|Overall Study|Withdrawal by Subject|2|||
156781260|NCT05578872|565948499|FG001|Overall Study|Withdrawal by Subject|1|||
156781261|NCT05578872|565948498|FG000|Overall Study|Adverse Event|1|||
156781262|NCT05578872|565948499|FG001|Overall Study|Adverse Event|1|||
156781263|NCT05578872|565948498|FG000|Overall Study|Physician Decision|1|||
156781264|NCT05578872|565948499|FG001|Overall Study|Physician Decision|2|||
156781265|NCT05578872|565948498|FG000|Overall Study|Progressive disease|10|||
156528975|NCT03267940|565031044|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
156781266|NCT05578872|565948499|FG001|Overall Study|Progressive disease|9|||
156781267|NCT05578872|565948498|FG000|Overall Study|Sponsor decision|0|||
156781268|NCT05578872|565948499|FG001|Overall Study|Sponsor decision|1|||
156781269|NCT05578872|565948498|FG000|Overall Study|Toxicity and Patient's decision|0|||
156781270|NCT05578872|565948499|FG001|Overall Study|Toxicity and Patient's decision|1|||
156781271|NCT00587457|565949997|FG000|Overall Study|Adverse Event|1|||
156781272|NCT00587457|565949998|FG001|Overall Study|Adverse Event|2|||
156781273|NCT00587457|565949999|FG002|Overall Study|Adverse Event|1|||
156781274|NCT00587457|565949997|FG000|Overall Study|Disease progression|2|||
156781275|NCT00587457|565949998|FG001|Overall Study|Disease progression|0|||
156781276|NCT00587457|565949999|FG002|Overall Study|Disease progression|2|||
156434594|NCT02020616|564680317|FG002|Overall Study|Lost to Follow-up|0|||
156434595|NCT02020616|564680318|FG003|Overall Study|Lost to Follow-up|1|||
156434596|NCT02020616|564680319|FG004|Overall Study|Lost to Follow-up|1|||
156675853|NCT00906399|565556906|FG006|Year 1|Physician Decision|0|||
156675854|NCT00906399|565556900|FG000|Year 1|Death|2|||
156675855|NCT00906399|565556901|FG001|Year 1|Death|1|||
156675856|NCT00906399|565556902|FG002|Year 1|Death|1|||
156434597|NCT02020616|564680320|FG005|Overall Study|Lost to Follow-up|1|||
156675857|NCT00906399|565556903|FG003|Year 1|Death|0|||
156675858|NCT00906399|565556904|FG004|Year 1|Death|0|||
156675859|NCT00906399|565556905|FG005|Year 1|Death|0|||
156675860|NCT00906399|565556906|FG006|Year 1|Death|0|||
156781277|NCT00587457|565949997|FG000|Overall Study|Initiation of alternative therapy|0|||
156434598|NCT02020616|564680321|FG006|Overall Study|Lost to Follow-up|0|||
156434599|NCT02020616|564680315|FG000|Overall Study|Early Termination Criteria Met|0|||
156434600|NCT02020616|564680316|FG001|Overall Study|Early Termination Criteria Met|0|||
156434601|NCT02020616|564680317|FG002|Overall Study|Early Termination Criteria Met|1|||
156434602|NCT02020616|564680318|FG003|Overall Study|Early Termination Criteria Met|0|||
156434603|NCT02020616|564680319|FG004|Overall Study|Early Termination Criteria Met|0|||
156434604|NCT02020616|564680320|FG005|Overall Study|Early Termination Criteria Met|1|||
156528976|NCT03267940|565031045|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
156781278|NCT00587457|565949998|FG001|Overall Study|Initiation of alternative therapy|1|||
156781279|NCT00587457|565949999|FG002|Overall Study|Initiation of alternative therapy|0|||
156781280|NCT00587457|565949997|FG000|Overall Study|Undefined|0|||
156781281|NCT00587457|565949998|FG001|Overall Study|Undefined|0|||
156781282|NCT00587457|565949999|FG002|Overall Study|Undefined|1|||
156781283|NCT00587457|565949997|FG000|Overall Study|Development of neutralizing Abs|0|||
156781284|NCT00587457|565949998|FG001|Overall Study|Development of neutralizing Abs|0|||
156781285|NCT00587457|565949999|FG002|Overall Study|Development of neutralizing Abs|1|||
156781286|NCT03439839|565950000|FG000|Overall Study|Death|3|||
156781287|NCT03439839|565950001|FG001|Overall Study|Death|0|||
156781288|NCT03298061|565950012|FG000|Overall Study|Adverse Event|3|||
156781289|NCT03298061|565950012|FG000|Overall Study|Lack of Efficacy|6|||
156781290|NCT03298061|565950012|FG000|Overall Study|Protocol Violation|1|||
156781291|NCT03298061|565950012|FG000|Overall Study|Physician Decision|7|||
156781292|NCT03298061|565950012|FG000|Overall Study|Withdrawal by Subject|10|||
156781293|NCT04307394|565950015|FG000|Overall Study|Lost to Follow-up|3|||
156781294|NCT04307394|565950015|FG000|Overall Study|Withdrawal by Subject|2|||
156781295|NCT00416949|565950017|FG000|Overall Study|Patients refused to participate|5|||
156781296|NCT02383173|565950020|FG000|Overall Study|Palliative Care Team withdrew|0|||
156781297|NCT02383173|565950021|FG001|Overall Study|Palliative Care Team withdrew|2|||
156781298|NCT00800540|565950022|FG000|Period One: 6 Weeks|Noncompliance|1|||
156781299|NCT00800540|565950023|FG001|Period One: 6 Weeks|Noncompliance|0|||
156781300|NCT00800540|565950022|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
156781301|NCT00800540|565950023|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
156781302|NCT00800540|565950022|FG000|Period 2: 6 Weeks|Adverse Event|0|||
156781303|NCT00800540|565950023|FG001|Period 2: 6 Weeks|Adverse Event|1|||
156781304|NCT05950906|565950024|FG000|Overall Study|Adverse Event|0|||
156781305|NCT05950906|565950025|FG001|Overall Study|Adverse Event|0|||
156781306|NCT05950906|565950026|FG002|Overall Study|Adverse Event|0|||
156781307|NCT05950906|565950027|FG003|Overall Study|Adverse Event|0|||
156781308|NCT05950906|565950028|FG004|Overall Study|Adverse Event|0|||
156781309|NCT05950906|565950029|FG005|Overall Study|Adverse Event|0|||
156781310|NCT05950906|565950030|FG006|Overall Study|Adverse Event|0|||
156781311|NCT05950906|565950031|FG007|Overall Study|Adverse Event|0|||
156781312|NCT05950906|565950032|FG008|Overall Study|Adverse Event|0|||
156781313|NCT05950906|565950033|FG009|Overall Study|Adverse Event|0|||
156781314|NCT05950906|565950034|FG010|Overall Study|Adverse Event|0|||
156781315|NCT05950906|565950035|FG011|Overall Study|Adverse Event|0|||
156781316|NCT05950906|565950036|FG012|Overall Study|Adverse Event|1|||
156781317|NCT05950906|565950037|FG013|Overall Study|Adverse Event|0|||
156781318|NCT05950906|565950024|FG000|Overall Study|Physician Decision|0|||
156781319|NCT05950906|565950025|FG001|Overall Study|Physician Decision|0|||
156781320|NCT05950906|565950026|FG002|Overall Study|Physician Decision|0|||
156781321|NCT05950906|565950027|FG003|Overall Study|Physician Decision|0|||
156781322|NCT05950906|565950028|FG004|Overall Study|Physician Decision|0|||
156781323|NCT05950906|565950029|FG005|Overall Study|Physician Decision|0|||
156781324|NCT05950906|565950030|FG006|Overall Study|Physician Decision|0|||
156781325|NCT05950906|565950031|FG007|Overall Study|Physician Decision|0|||
156781326|NCT05950906|565950032|FG008|Overall Study|Physician Decision|0|||
156781327|NCT05950906|565950033|FG009|Overall Study|Physician Decision|0|||
156781328|NCT05950906|565950034|FG010|Overall Study|Physician Decision|0|||
156781329|NCT05950906|565950035|FG011|Overall Study|Physician Decision|0|||
156781330|NCT05950906|565950036|FG012|Overall Study|Physician Decision|1|||
156781331|NCT05950906|565950037|FG013|Overall Study|Physician Decision|0|||
156781332|NCT02969018|565950042|FG000|Overall Study|Adverse Event|2|||
156781333|NCT02969018|565950043|FG001|Overall Study|Adverse Event|4|||
156781334|NCT02969018|565950044|FG002|Overall Study|Adverse Event|1|||
156781335|NCT02969018|565950045|FG003|Overall Study|Adverse Event|2|||
156781336|NCT02969018|565950046|FG004|Overall Study|Adverse Event|0|||
156781337|NCT02969018|565950047|FG005|Overall Study|Adverse Event|1|||
156781338|NCT02969018|565950048|FG006|Overall Study|Adverse Event|2|||
156781339|NCT02969018|565950049|FG007|Overall Study|Adverse Event|0|||
156781340|NCT02969018|565950042|FG000|Overall Study|Lack of Efficacy|0|||
156781341|NCT02969018|565950043|FG001|Overall Study|Lack of Efficacy|1|||
156781342|NCT02969018|565950044|FG002|Overall Study|Lack of Efficacy|0|||
156866590|NCT00129402|566271286|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
156434605|NCT02020616|564680321|FG006|Overall Study|Early Termination Criteria Met|0|||
156434606|NCT02020616|564680315|FG000|Overall Study|Randomized in Error|0|||
156781343|NCT02969018|565950045|FG003|Overall Study|Lack of Efficacy|0|||
156781344|NCT02969018|565950046|FG004|Overall Study|Lack of Efficacy|1|||
156781345|NCT02969018|565950047|FG005|Overall Study|Lack of Efficacy|1|||
156781346|NCT02969018|565950048|FG006|Overall Study|Lack of Efficacy|1|||
156781347|NCT02969018|565950049|FG007|Overall Study|Lack of Efficacy|1|||
156781348|NCT02969018|565950042|FG000|Overall Study|Lost to Follow-up|1|||
156781349|NCT02969018|565950043|FG001|Overall Study|Lost to Follow-up|2|||
156781350|NCT02969018|565950044|FG002|Overall Study|Lost to Follow-up|2|||
156781351|NCT02969018|565950045|FG003|Overall Study|Lost to Follow-up|0|||
156781352|NCT02969018|565950046|FG004|Overall Study|Lost to Follow-up|1|||
156781353|NCT02969018|565950047|FG005|Overall Study|Lost to Follow-up|1|||
156781354|NCT02969018|565950048|FG006|Overall Study|Lost to Follow-up|0|||
156781355|NCT02969018|565950049|FG007|Overall Study|Lost to Follow-up|1|||
156781356|NCT02969018|565950042|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781357|NCT02969018|565950043|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781358|NCT02969018|565950044|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781359|NCT02969018|565950045|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781360|NCT02969018|565950046|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781361|NCT02969018|565950047|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781362|NCT02969018|565950048|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
156781363|NCT02969018|565950049|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781364|NCT02969018|565950042|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156781365|NCT02969018|565950043|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156781366|NCT02969018|565950044|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156781367|NCT02969018|565950045|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156781368|NCT02969018|565950046|FG004|Overall Study|Non-Compliance With Study Drug|0|||
156781369|NCT02969018|565950047|FG005|Overall Study|Non-Compliance With Study Drug|0|||
156781370|NCT02969018|565950048|FG006|Overall Study|Non-Compliance With Study Drug|0|||
156781371|NCT02969018|565950049|FG007|Overall Study|Non-Compliance With Study Drug|0|||
156528977|NCT03267940|565031046|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
156528978|NCT03267940|565031041|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
156528979|NCT03267940|565031042|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
156528980|NCT03267940|565031043|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
156528981|NCT03267940|565031044|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
156528982|NCT03267940|565031045|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
156528983|NCT03267940|565031046|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
156528984|NCT03267940|565031041|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
156528985|NCT03267940|565031042|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
156528986|NCT03267940|565031043|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
156528987|NCT03267940|565031044|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
156528988|NCT03267940|565031045|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
156528989|NCT03267940|565031046|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
156528990|NCT03267940|565031041|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
156528991|NCT03267940|565031042|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
156528992|NCT03267940|565031043|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
156528993|NCT03267940|565031044|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
156528994|NCT03267940|565031045|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
156528995|NCT03267940|565031046|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
156528996|NCT03267940|565031041|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
156528997|NCT03267940|565031042|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
156528998|NCT03267940|565031043|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
156528999|NCT03267940|565031044|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
156529000|NCT03267940|565031045|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
156529001|NCT03267940|565031046|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
156529002|NCT03267940|565031041|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
156529003|NCT03267940|565031042|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
156529004|NCT03267940|565031043|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
156529005|NCT03267940|565031044|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
156529006|NCT03267940|565031045|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
156529007|NCT03267940|565031046|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
156529008|NCT03267940|565031041|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
156529009|NCT03267940|565031042|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
156529010|NCT03267940|565031043|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
156781372|NCT02969018|565950042|FG000|Overall Study|Other|0|||
156781373|NCT02969018|565950043|FG001|Overall Study|Other|0|||
156781374|NCT02969018|565950044|FG002|Overall Study|Other|0|||
156781375|NCT02969018|565950045|FG003|Overall Study|Other|1|||
156781376|NCT02969018|565950046|FG004|Overall Study|Other|0|||
156781377|NCT02969018|565950047|FG005|Overall Study|Other|0|||
156781378|NCT02969018|565950048|FG006|Overall Study|Other|0|||
156781379|NCT02969018|565950049|FG007|Overall Study|Other|2|||
156434607|NCT02020616|564680316|FG001|Overall Study|Randomized in Error|0|||
156434608|NCT02020616|564680317|FG002|Overall Study|Randomized in Error|0|||
156434609|NCT02020616|564680318|FG003|Overall Study|Randomized in Error|1|||
156434610|NCT02020616|564680319|FG004|Overall Study|Randomized in Error|0|||
156434611|NCT02020616|564680320|FG005|Overall Study|Randomized in Error|0|||
156781380|NCT02969018|565950042|FG000|Overall Study|Pregnancy|0|||
156781381|NCT02969018|565950043|FG001|Overall Study|Pregnancy|0|||
156781382|NCT02969018|565950044|FG002|Overall Study|Pregnancy|0|||
156781383|NCT02969018|565950045|FG003|Overall Study|Pregnancy|0|||
156781384|NCT02969018|565950046|FG004|Overall Study|Pregnancy|0|||
156781385|NCT02969018|565950047|FG005|Overall Study|Pregnancy|1|||
156781386|NCT02969018|565950048|FG006|Overall Study|Pregnancy|0|||
156781387|NCT02969018|565950049|FG007|Overall Study|Pregnancy|0|||
156781388|NCT02969018|565950042|FG000|Overall Study|Protocol Violation|0|||
156781389|NCT02969018|565950043|FG001|Overall Study|Protocol Violation|0|||
156781390|NCT02969018|565950044|FG002|Overall Study|Protocol Violation|1|||
156781391|NCT02969018|565950045|FG003|Overall Study|Protocol Violation|1|||
156781392|NCT02969018|565950046|FG004|Overall Study|Protocol Violation|0|||
156781393|NCT02969018|565950047|FG005|Overall Study|Protocol Violation|0|||
156781394|NCT02969018|565950048|FG006|Overall Study|Protocol Violation|0|||
156781395|NCT02969018|565950049|FG007|Overall Study|Protocol Violation|0|||
156781396|NCT02969018|565950042|FG000|Overall Study|Withdrawal by Subject|0|||
156781397|NCT02969018|565950043|FG001|Overall Study|Withdrawal by Subject|1|||
156781398|NCT02969018|565950044|FG002|Overall Study|Withdrawal by Subject|2|||
156781399|NCT02969018|565950045|FG003|Overall Study|Withdrawal by Subject|1|||
156781400|NCT02969018|565950046|FG004|Overall Study|Withdrawal by Subject|0|||
156781401|NCT02969018|565950047|FG005|Overall Study|Withdrawal by Subject|4|||
156781402|NCT02969018|565950048|FG006|Overall Study|Withdrawal by Subject|4|||
156781403|NCT02969018|565950049|FG007|Overall Study|Withdrawal by Subject|3|||
156781404|NCT04790201|565950050|FG000|Overall Study|Lost to Follow-up|0|||
156781405|NCT04790201|565950051|FG001|Overall Study|Lost to Follow-up|0|||
156781406|NCT04790201|565950052|FG002|Overall Study|Lost to Follow-up|2|||
156781407|NCT04790201|565950050|FG000|Overall Study|Death|0|||
156781408|NCT04790201|565950051|FG001|Overall Study|Death|1|||
156781409|NCT04790201|565950052|FG002|Overall Study|Death|0|||
156781410|NCT04790201|565950050|FG000|Overall Study|Protocol Violation|1|||
156781411|NCT04790201|565950051|FG001|Overall Study|Protocol Violation|0|||
156781412|NCT04790201|565950052|FG002|Overall Study|Protocol Violation|1|||
156781413|NCT04795323|565950057|FG000|Overall Study|Did not interact with TARA|1|||
156781414|NCT04795323|565950058|FG001|Overall Study|Did not interact with TARA|0|||
156781415|NCT01479530|565950059|FG000|Overall Study|Adverse Event|5|||
156781416|NCT01479530|565950060|FG001|Overall Study|Adverse Event|6|||
156781417|NCT01479530|565950059|FG000|Overall Study|Lack of Efficacy|0|||
156781418|NCT01479530|565950060|FG001|Overall Study|Lack of Efficacy|1|||
156781419|NCT01479530|565950059|FG000|Overall Study|Protocol Violation|2|||
156781420|NCT01479530|565950060|FG001|Overall Study|Protocol Violation|3|||
156781421|NCT01479530|565950059|FG000|Overall Study|Withdrawal of Consent|3|||
156781422|NCT01479530|565950060|FG001|Overall Study|Withdrawal of Consent|2|||
156781423|NCT02836769|565950061|FG000|Overall Study|Lost to Follow-up|10|||
156781424|NCT02836769|565950061|FG000|Overall Study|Medical withdrawal|2|||
156781425|NCT02836769|565950061|FG000|Overall Study|Withdrawal by Subject|3|||
156781426|NCT02503865|565950068|FG000|Overall Study|Moved out of area|1|||
156781427|NCT02503865|565950069|FG001|Overall Study|Moved out of area|8|||
156781428|NCT02503865|565950070|FG002|Overall Study|Moved out of area|0|||
156781429|NCT02503865|565950068|FG000|Overall Study|Refused treatment|4|||
156781430|NCT02503865|565950069|FG001|Overall Study|Refused treatment|39|||
156781431|NCT02503865|565950070|FG002|Overall Study|Refused treatment|2|||
156781432|NCT04465955|565950071|FG000|Overall Study|Withdrew consent|6|||
156781433|NCT04465955|565950072|FG001|Overall Study|Withdrew consent|10|||
156781434|NCT04465955|565950073|FG002|Overall Study|Withdrew consent|7|||
156781435|NCT04465955|565950071|FG000|Overall Study|Adverse Event|6|||
156781436|NCT04465955|565950072|FG001|Overall Study|Adverse Event|5|||
156781437|NCT04465955|565950073|FG002|Overall Study|Adverse Event|1|||
156781438|NCT04465955|565950071|FG000|Overall Study|Lost to Follow-up|2|||
156781439|NCT04465955|565950072|FG001|Overall Study|Lost to Follow-up|0|||
156781440|NCT04465955|565950073|FG002|Overall Study|Lost to Follow-up|3|||
156781441|NCT04465955|565950071|FG000|Overall Study|Other|1|||
156781442|NCT04465955|565950072|FG001|Overall Study|Other|1|||
156781443|NCT04465955|565950073|FG002|Overall Study|Other|3|||
156781444|NCT00021255|565950074|FG000|Overall Study|Death|1|||
156434612|NCT02020616|564680321|FG006|Overall Study|Randomized in Error|0|||
156434613|NCT02020616|564680315|FG000|Overall Study|Lack of Efficacy|0|||
156781445|NCT00021255|565950075|FG001|Overall Study|Death|0|||
156781446|NCT00021255|565950076|FG002|Overall Study|Death|2|||
156781447|NCT00021255|565950074|FG000|Overall Study|Breast cancer relapse|5|||
156781448|NCT00021255|565950075|FG001|Overall Study|Breast cancer relapse|18|||
156781449|NCT00021255|565950076|FG002|Overall Study|Breast cancer relapse|11|||
156781450|NCT00021255|565950074|FG000|Overall Study|Second primary malignancy|0|||
156781451|NCT00021255|565950075|FG001|Overall Study|Second primary malignancy|4|||
156781452|NCT00021255|565950076|FG002|Overall Study|Second primary malignancy|1|||
156781453|NCT00021255|565950074|FG000|Overall Study|Withdrawal by Subject|41|||
156529011|NCT03267940|565031044|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
156781454|NCT00021255|565950075|FG001|Overall Study|Withdrawal by Subject|64|||
156781455|NCT00021255|565950076|FG002|Overall Study|Withdrawal by Subject|26|||
156434614|NCT02020616|564680316|FG001|Overall Study|Lack of Efficacy|0|||
156529012|NCT03267940|565031045|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
156529013|NCT03267940|565031046|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
156529014|NCT01074216|565031047|FG000|Overall Study|Physician Decision|1|||
156434615|NCT02020616|564680317|FG002|Overall Study|Lack of Efficacy|0|||
156434616|NCT02020616|564680318|FG003|Overall Study|Lack of Efficacy|0|||
156434617|NCT02020616|564680319|FG004|Overall Study|Lack of Efficacy|1|||
156434618|NCT02020616|564680320|FG005|Overall Study|Lack of Efficacy|0|||
156434619|NCT02020616|564680321|FG006|Overall Study|Lack of Efficacy|0|||
156434620|NCT05019729|564680322|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
156434621|NCT05019729|564680323|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
156434622|NCT05019729|564680324|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
156434623|NCT05019729|564680325|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
156434624|NCT05019729|564680326|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
156434625|NCT05019729|564680327|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
156434626|NCT03768206|564680338|FG000|Overall Study|Lost to Follow-up|2|||
156434627|NCT03768206|564680339|FG001|Overall Study|Lost to Follow-up|1|||
156434628|NCT03768206|564680338|FG000|Overall Study|Withdrawal by Subject|0|||
156434629|NCT03768206|564680339|FG001|Overall Study|Withdrawal by Subject|1|||
156434630|NCT05328297|564682170|FG000|Overall Study|Adverse Event|5|||
156434631|NCT05328297|564682171|FG001|Overall Study|Adverse Event|7|||
156434632|NCT05328297|564682170|FG000|Overall Study|Withdrawal by Subject|4|||
156434633|NCT05328297|564682171|FG001|Overall Study|Withdrawal by Subject|3|||
156434634|NCT05328297|564682170|FG000|Overall Study|Lack of Efficacy|1|||
156434635|NCT05328297|564682171|FG001|Overall Study|Lack of Efficacy|0|||
156434636|NCT05328297|564682170|FG000|Overall Study|Lost to Follow-up|1|||
156434637|NCT05328297|564682171|FG001|Overall Study|Lost to Follow-up|0|||
156434638|NCT05328297|564682170|FG000|Overall Study|Protocol Violation|1|||
156434639|NCT05328297|564682171|FG001|Overall Study|Protocol Violation|0|||
156434640|NCT05328297|564682170|FG000|Overall Study|Randomized but not treated|1|||
156434641|NCT05328297|564682171|FG001|Overall Study|Randomized but not treated|1|||
156434642|NCT05147233|564682172|FG000|Overall Study|Adverse Event|0|||
156434643|NCT05147233|564682173|FG001|Overall Study|Adverse Event|1|||
156434644|NCT05147233|564682172|FG000|Overall Study|Lost to Follow-up|1|||
156434645|NCT05147233|564682173|FG001|Overall Study|Lost to Follow-up|1|||
156434646|NCT05147233|564682172|FG000|Overall Study|Protocol Violation|0|||
156434647|NCT05147233|564682173|FG001|Overall Study|Protocol Violation|1|||
156434648|NCT05147233|564682172|FG000|Overall Study|Withdrawal by Subject|2|||
156434649|NCT05147233|564682173|FG001|Overall Study|Withdrawal by Subject|1|||
156434650|NCT04513522|564682174|FG000|Overall Study|Other reasons|1|||
156434651|NCT04513522|564682174|FG000|Overall Study|Adverse event unrelated to study drug|9|||
156434652|NCT04513522|564682174|FG000|Overall Study|Study drug toxicity|14|||
156434653|NCT04513522|564682174|FG000|Overall Study|Disease progression|39|||
156434654|NCT04513522|564682174|FG000|Overall Study|Participants withdrew consent|2|||
156434655|NCT03351075|564682177|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
156434656|NCT03351075|564682178|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
156434657|NCT03351075|564682177|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
156434658|NCT03351075|564682178|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
156434659|NCT03351075|564682177|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
156434660|NCT03351075|564682178|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
156434661|NCT03351075|564682177|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
156434662|NCT03351075|564682178|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
156434663|NCT05219253|564682183|FG000|Overall Study|Withdrawal by Subject|1|||
156434664|NCT05219253|564682184|FG001|Overall Study|Withdrawal by Subject|2|||
156434665|NCT03086369|564682185|FG000|Overall Study|Lost to Follow-up|1|||
156434666|NCT03086369|564682186|FG001|Overall Study|Lost to Follow-up|0|||
156434667|NCT03086369|564682187|FG002|Overall Study|Lost to Follow-up|0|||
156434668|NCT03086369|564682188|FG003|Overall Study|Lost to Follow-up|2|||
156434669|NCT03086369|564682189|FG004|Overall Study|Lost to Follow-up|1|||
156529015|NCT01074216|565031047|FG000|Overall Study|Not Treated|12|||
156434670|NCT03086369|564682185|FG000|Overall Study|Physician Decision|0|||
156434671|NCT03086369|564682186|FG001|Overall Study|Physician Decision|0|||
156434672|NCT03086369|564682187|FG002|Overall Study|Physician Decision|0|||
156529016|NCT01323634|565031048|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
156529017|NCT01323634|565031049|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
156434673|NCT03086369|564682188|FG003|Overall Study|Physician Decision|1|||
156434674|NCT03086369|564682189|FG004|Overall Study|Physician Decision|2|||
156434675|NCT03086369|564682185|FG000|Overall Study|Withdrawal by Subject|0|||
156434676|NCT03086369|564682186|FG001|Overall Study|Withdrawal by Subject|0|||
156529018|NCT01323634|565031050|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
156434677|NCT03086369|564682187|FG002|Overall Study|Withdrawal by Subject|0|||
156434678|NCT03086369|564682188|FG003|Overall Study|Withdrawal by Subject|5|||
156434679|NCT03086369|564682189|FG004|Overall Study|Withdrawal by Subject|3|||
156434680|NCT03086369|564682185|FG000|Overall Study|Progressive Disease|0|||
156434681|NCT03086369|564682186|FG001|Overall Study|Progressive Disease|0|||
156434682|NCT03086369|564682187|FG002|Overall Study|Progressive Disease|0|||
156434683|NCT03086369|564682188|FG003|Overall Study|Progressive Disease|1|||
156434684|NCT03086369|564682189|FG004|Overall Study|Progressive Disease|1|||
156434685|NCT04860258|564682190|FG000|Overall Study|Withdrawal by Subject|0|||
156434686|NCT04860258|564682191|FG001|Overall Study|Withdrawal by Subject|0|||
156434687|NCT04860258|564682192|FG002|Overall Study|Withdrawal by Subject|4|||
156434688|NCT04860258|564682193|FG003|Overall Study|Withdrawal by Subject|1|||
156434689|NCT04860258|564682194|FG004|Overall Study|Withdrawal by Subject|4|||
156434690|NCT04860258|564682195|FG005|Overall Study|Withdrawal by Subject|1|||
156434691|NCT04860258|564682196|FG006|Overall Study|Withdrawal by Subject|0|||
156434692|NCT00028769|564682199|FG000|Overall Study|Adverse Event|2|||
156434693|NCT00028769|564682199|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
156529019|NCT01323634|565031048|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
156529020|NCT01323634|565031049|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
156529021|NCT01323634|565031050|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
156529022|NCT01323634|565031048|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
156529023|NCT01323634|565031049|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156529024|NCT01323634|565031050|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156529025|NCT01323634|565031048|FG000|2-week Run-in Period|Physician Decision|5|||
156529026|NCT01323634|565031049|FG001|2-week Run-in Period|Physician Decision|0|||
156529027|NCT01323634|565031050|FG002|2-week Run-in Period|Physician Decision|0|||
156434694|NCT00028769|564682199|FG000|Overall Study|Progression or Death|31|||
156434695|NCT00028769|564682199|FG000|Overall Study|Other - Not Protocol Specified|1|||
156434696|NCT00028769|564682199|FG000|Overall Study|Ineligible|5|||
156434697|NCT00028769|564682199|FG000|Overall Study|Not Analyzable|1|||
156434698|NCT02496702|564682202|FG000|Overall Study|Lost to Follow-up|8|||
156434699|NCT02496702|564682203|FG001|Overall Study|Lost to Follow-up|6|||
156434700|NCT02496702|564682202|FG000|Overall Study|Only partially tested|0|||
156434701|NCT02496702|564682203|FG001|Overall Study|Only partially tested|2|||
156434702|NCT01499134|564682206|FG000|Overall Study|Withdrawal by Subject|0|||
156434703|NCT01499134|564682207|FG001|Overall Study|Withdrawal by Subject|1|||
156434704|NCT00941655|564682210|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
156434705|NCT00941655|564682211|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
156434706|NCT00941655|564682210|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
156434707|NCT00941655|564682211|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
156434708|NCT00941655|564682210|FG000|Overall Study|progressed while on chemo|0|||
156434709|NCT00941655|564682211|FG001|Overall Study|progressed while on chemo|2|||
156434710|NCT00941655|564682210|FG000|Overall Study|refused further treatment|0|||
156434711|NCT00941655|564682211|FG001|Overall Study|refused further treatment|1|||
156434712|NCT00941655|564682210|FG000|Overall Study|withdrew consent|0|||
156434713|NCT00941655|564682211|FG001|Overall Study|withdrew consent|1|||
156434714|NCT00941655|564682210|FG000|Overall Study|non-compliant|0|||
156434715|NCT00941655|564682211|FG001|Overall Study|non-compliant|1|||
156434716|NCT02698891|564682212|FG000|Overall Study|Withdrawal by Subject|2|||
156434717|NCT02698891|564682212|FG000|Overall Study|deemed ineligible|1|||
156434718|NCT02698891|564682212|FG000|Overall Study|Adverse Event|9|||
156434719|NCT00516386|564682213|FG000|Overall Study|not interested in the study|4|||
156434720|NCT00516386|564682213|FG000|Overall Study|Lost to Follow-up|2|||
156434721|NCT03262935|564682216|FG000|Overall Study|Withdrawal by Subject|6|||
156434722|NCT03262935|564682217|FG001|Overall Study|Withdrawal by Subject|7|||
156434723|NCT03262935|564682216|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
156434724|NCT03262935|564682217|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
156529028|NCT01323634|565031048|FG000|2-week Run-in Period|Protocol Violation|1|||
156434725|NCT03262935|564682216|FG000|Overall Study|Death|181|||
156434726|NCT03262935|564682217|FG001|Overall Study|Death|94|||
156434727|NCT03262935|564682216|FG000|Overall Study|Lost to Follow-up|9|||
156434728|NCT03262935|564682217|FG001|Overall Study|Lost to Follow-up|4|||
156434729|NCT03262935|564682216|FG000|Overall Study|Other reason|5|||
156434730|NCT03262935|564682217|FG001|Overall Study|Other reason|0|||
156434731|NCT00813904|564682224|FG000|Overall Study|Death|1|||
156434732|NCT01648140|564682227|FG000|Overall Study|Physician Decision|1|||
156434733|NCT01648140|564682228|FG001|Overall Study|Physician Decision|0|||
156434734|NCT01648140|564682229|FG002|Overall Study|Physician Decision|0|||
156434735|NCT01648140|564682230|FG003|Overall Study|Physician Decision|0|||
156434736|NCT01648140|564682227|FG000|Overall Study|Lack of Efficacy|4|||
156434737|NCT01648140|564682228|FG001|Overall Study|Lack of Efficacy|7|||
156529029|NCT01323634|565031049|FG001|2-week Run-in Period|Protocol Violation|0|||
156529030|NCT01323634|565031050|FG002|2-week Run-in Period|Protocol Violation|0|||
156434738|NCT01648140|564682229|FG002|Overall Study|Lack of Efficacy|1|||
156434739|NCT01648140|564682230|FG003|Overall Study|Lack of Efficacy|0|||
156434740|NCT01648140|564682227|FG000|Overall Study|Adverse Event|3|||
156434741|NCT01648140|564682228|FG001|Overall Study|Adverse Event|1|||
156781456|NCT00021255|565950074|FG000|Overall Study|Lost to Follow-up|0|||
156781457|NCT00021255|565950075|FG001|Overall Study|Lost to Follow-up|2|||
156781458|NCT00021255|565950076|FG002|Overall Study|Lost to Follow-up|3|||
156781459|NCT00021255|565950074|FG000|Overall Study|Cardiac toxicity|0|||
156781460|NCT00021255|565950075|FG001|Overall Study|Cardiac toxicity|61|||
156781461|NCT00021255|565950076|FG002|Overall Study|Cardiac toxicity|32|||
156781462|NCT00021255|565950074|FG000|Overall Study|Herceptin toxicity|0|||
156781463|NCT00021255|565950075|FG001|Overall Study|Herceptin toxicity|22|||
156781464|NCT00021255|565950076|FG002|Overall Study|Herceptin toxicity|6|||
156781465|NCT00021255|565950074|FG000|Overall Study|Adverse Event|46|||
156781466|NCT00021255|565950075|FG001|Overall Study|Adverse Event|30|||
156781467|NCT00021255|565950076|FG002|Overall Study|Adverse Event|18|||
156781468|NCT00021255|565950074|FG000|Overall Study|Protocol Violation|0|||
156781469|NCT00021255|565950075|FG001|Overall Study|Protocol Violation|2|||
156781470|NCT00021255|565950076|FG002|Overall Study|Protocol Violation|0|||
156781471|NCT00021255|565950074|FG000|Overall Study|Other than specified above|0|||
156781472|NCT00021255|565950075|FG001|Overall Study|Other than specified above|38|||
156781473|NCT00021255|565950076|FG002|Overall Study|Other than specified above|19|||
156781474|NCT00021255|565950074|FG000|Overall Study|Missing|0|||
156781475|NCT00021255|565950075|FG001|Overall Study|Missing|27|||
156781476|NCT00021255|565950076|FG002|Overall Study|Missing|13|||
156781477|NCT00021255|565950074|FG000|Overall Study|Randomized but not treated|28|||
156781478|NCT00021255|565950075|FG001|Overall Study|Randomized but not treated|2|||
156781479|NCT00021255|565950076|FG002|Overall Study|Randomized but not treated|18|||
156781480|NCT01132755|565950079|FG000|Overall Study|Procedure not done due to medical reason|23|||
156781481|NCT01132755|565950079|FG000|Overall Study|Protocol Violation|15|||
156781482|NCT01132755|565950079|FG000|Overall Study|Withdrawal by Subject|4|||
156781483|NCT02232698|565950080|FG000|Overall Study|Pregnancy|1|||
156781484|NCT02232698|565950081|FG001|Overall Study|Pregnancy|1|||
156781485|NCT02232698|565950080|FG000|Overall Study|Met exclusion criteria|1|||
156781486|NCT02232698|565950081|FG001|Overall Study|Met exclusion criteria|1|||
156781487|NCT02232698|565950080|FG000|Overall Study|Had device-associated symptoms|7|||
156781488|NCT02232698|565950081|FG001|Overall Study|Had device-associated symptoms|0|||
156781489|NCT02232698|565950080|FG000|Overall Study|Non-compliance with study device|1|||
156781490|NCT02232698|565950081|FG001|Overall Study|Non-compliance with study device|4|||
156781491|NCT02232698|565950080|FG000|Overall Study|Allocated to control group|0|||
156781492|NCT02232698|565950081|FG001|Overall Study|Allocated to control group|3|||
156781493|NCT02232698|565950080|FG000|Overall Study|Withdrawal by Subject|0|||
156781494|NCT02232698|565950081|FG001|Overall Study|Withdrawal by Subject|11|||
156781495|NCT02393755|565950082|FG000|Overall Study|Withdrawal by Subject|0|||
156781496|NCT02393755|565950083|FG001|Overall Study|Withdrawal by Subject|3|||
156338209|NCT00389597|564336585|FG002|Overall Study|Lost to Follow-up|4|||
156338210|NCT00389597|564336586|FG003|Overall Study|Lost to Follow-up|6|||
156338211|NCT00005044|564336587|FG000|Overall Study|Protocol Violation|37|||
156338212|NCT00005044|564336588|FG001|Overall Study|Protocol Violation|46|||
156338213|NCT00005044|564336587|FG000|Overall Study|Withdrawal by Subject|1|||
156338214|NCT00005044|564336588|FG001|Overall Study|Withdrawal by Subject|5|||
156338215|NCT00005044|564336587|FG000|Overall Study|No protocol treatment|0|||
156338216|NCT00005044|564336588|FG001|Overall Study|No protocol treatment|1|||
156338217|NCT00806351|564336589|FG000|Overall Study|Death|5|||
156338218|NCT00806351|564336590|FG001|Overall Study|Death|4|||
156338219|NCT01201785|564336591|FG000|Overall Study|Lost to Follow-up|16|||
156338220|NCT05248867|564336592|FG000|Double-blind Period|Lost to Follow-up|0|||
156338221|NCT05248867|564336593|FG001|Double-blind Period|Lost to Follow-up|3|||
156338222|NCT05248867|564336594|FG002|Double-blind Period|Lost to Follow-up|0|||
156338223|NCT05248867|564336595|FG003|Double-blind Period|Lost to Follow-up|0|||
156338224|NCT05248867|564336596|FG004|Double-blind Period|Lost to Follow-up|0|||
156338225|NCT05248867|564336597|FG005|Double-blind Period|Lost to Follow-up|0|||
156338226|NCT05248867|564336592|FG000|Double-blind Period|Withdrawal by Subject|5|||
156338227|NCT05248867|564336593|FG001|Double-blind Period|Withdrawal by Subject|14|||
156338228|NCT05248867|564336594|FG002|Double-blind Period|Withdrawal by Subject|0|||
156338229|NCT05248867|564336595|FG003|Double-blind Period|Withdrawal by Subject|0|||
156338230|NCT05248867|564336596|FG004|Double-blind Period|Withdrawal by Subject|0|||
156338231|NCT05248867|564336597|FG005|Double-blind Period|Withdrawal by Subject|0|||
156338232|NCT05248867|564336592|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156338233|NCT05248867|564336593|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
156338234|NCT05248867|564336594|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156338235|NCT05248867|564336595|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156338236|NCT05248867|564336596|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156338237|NCT05248867|564336597|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156338238|NCT05248867|564336592|FG000|Double-blind Period|Other, not specified|3|||
156338239|NCT05248867|564336593|FG001|Double-blind Period|Other, not specified|8|||
156338240|NCT05248867|564336594|FG002|Double-blind Period|Other, not specified|0|||
156338241|NCT05248867|564336595|FG003|Double-blind Period|Other, not specified|0|||
156338242|NCT05248867|564336596|FG004|Double-blind Period|Other, not specified|0|||
156781497|NCT02393755|565950082|FG000|Overall Study|Adverse Event|0|||
156781498|NCT02393755|565950083|FG001|Overall Study|Adverse Event|2|||
156781499|NCT02393755|565950082|FG000|Overall Study|Physician Decision|0|||
156781500|NCT02393755|565950083|FG001|Overall Study|Physician Decision|2|||
156781501|NCT01327703|565950084|FG000|Second Treatment Period|Adverse Event|1|||
156781502|NCT01327703|565950085|FG001|Second Treatment Period|Adverse Event|1|||
156781503|NCT01327703|565950084|FG000|Second Treatment Period|Protocol Violation|0|||
156781504|NCT01327703|565950085|FG001|Second Treatment Period|Protocol Violation|1|||
156781505|NCT05324371|565950087|FG000|Overall Study|Withdrawal by Subject|1|||
156781506|NCT05324371|565950087|FG000|Overall Study|Death|1|||
156781507|NCT01131585|565950088|FG000|Overall Study|Adverse Event|0|||
156781508|NCT01131585|565950089|FG001|Overall Study|Adverse Event|2|||
156781509|NCT01131585|565950088|FG000|Overall Study|Abnormal laboratory value|1|||
156781510|NCT01131585|565950089|FG001|Overall Study|Abnormal laboratory value|0|||
156781511|NCT01131585|565950088|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156781512|NCT01131585|565950089|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156781513|NCT01131585|565950088|FG000|Overall Study|Protocol Violation|2|||
156781514|NCT01131585|565950089|FG001|Overall Study|Protocol Violation|1|||
156781515|NCT01131585|565950088|FG000|Overall Study|Withdrawal by Subject|3|||
156781516|NCT01131585|565950089|FG001|Overall Study|Withdrawal by Subject|3|||
156781517|NCT01131585|565950088|FG000|Overall Study|Lost to Follow-up|0|||
156781518|NCT01131585|565950089|FG001|Overall Study|Lost to Follow-up|1|||
156434742|NCT01648140|564682229|FG002|Overall Study|Adverse Event|2|||
156434743|NCT01648140|564682230|FG003|Overall Study|Adverse Event|0|||
156434744|NCT01648140|564682227|FG000|Overall Study|Withdrawal by Subject|2|||
156434745|NCT01648140|564682228|FG001|Overall Study|Withdrawal by Subject|3|||
156434746|NCT01648140|564682229|FG002|Overall Study|Withdrawal by Subject|3|||
156434747|NCT01648140|564682230|FG003|Overall Study|Withdrawal by Subject|2|||
156434748|NCT01648140|564682227|FG000|Overall Study|Lost to Follow-up|2|||
156434749|NCT01648140|564682228|FG001|Overall Study|Lost to Follow-up|1|||
156434750|NCT01648140|564682229|FG002|Overall Study|Lost to Follow-up|2|||
156434751|NCT01648140|564682230|FG003|Overall Study|Lost to Follow-up|0|||
156434752|NCT04347954|564682231|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
156434753|NCT04347954|564682232|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
156434754|NCT04347954|564682233|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
156434755|NCT04347954|564682231|FG000|Overall Study|Lost to Follow-up|0|||
156434756|NCT04347954|564682232|FG001|Overall Study|Lost to Follow-up|1|||
156434757|NCT04347954|564682233|FG002|Overall Study|Lost to Follow-up|0|||
156781519|NCT01131585|565950088|FG000|Overall Study|Administrative problems|1|||
156781520|NCT01131585|565950089|FG001|Overall Study|Administrative problems|1|||
156781521|NCT01131585|565950088|FG000|Overall Study|Study termination|78|||
156781522|NCT01131585|565950089|FG001|Overall Study|Study termination|32|||
156781523|NCT00927082|565950090|FG000|Overall Study|Lost to Follow-up|9|||
156781524|NCT00927082|565950091|FG001|Overall Study|Lost to Follow-up|8|||
156781525|NCT00927082|565950092|FG002|Overall Study|Lost to Follow-up|12|||
156781526|NCT00927082|565950093|FG003|Overall Study|Lost to Follow-up|16|||
156781527|NCT00927082|565950090|FG000|Overall Study|Withdrawal by Subject|3|||
156781528|NCT00927082|565950091|FG001|Overall Study|Withdrawal by Subject|2|||
156781529|NCT00927082|565950092|FG002|Overall Study|Withdrawal by Subject|7|||
156781530|NCT00927082|565950093|FG003|Overall Study|Withdrawal by Subject|2|||
156781531|NCT00927082|565950090|FG000|Overall Study|Death|0|||
156781532|NCT00927082|565950091|FG001|Overall Study|Death|0|||
156529031|NCT01323634|565031048|FG000|2-week Run-in Period|Adverse Event|1|||
156529032|NCT01323634|565031049|FG001|2-week Run-in Period|Adverse Event|0|||
156529033|NCT01323634|565031050|FG002|2-week Run-in Period|Adverse Event|0|||
156529034|NCT01323634|565031048|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
156529035|NCT01323634|565031049|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
156529036|NCT01323634|565031050|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
156529037|NCT01323634|565031048|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156529038|NCT01323634|565031049|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
156781533|NCT00927082|565950092|FG002|Overall Study|Death|1|||
156781534|NCT00927082|565950093|FG003|Overall Study|Death|0|||
156781535|NCT00927082|565950090|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
156781536|NCT00927082|565950091|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
156781537|NCT00927082|565950092|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
156781538|NCT00927082|565950093|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
156781539|NCT00812097|565950094|FG000|Overall Study|Death|3|||
156781540|NCT00812097|565950095|FG001|Overall Study|Death|10|||
156781541|NCT00812097|565950096|FG002|Overall Study|Death|3|||
156781542|NCT00812097|565950097|FG003|Overall Study|Death|3|||
156781543|NCT00812097|565950094|FG000|Overall Study|Withdrawal by Subject|14|||
156781544|NCT00812097|565950095|FG001|Overall Study|Withdrawal by Subject|12|||
156781545|NCT00812097|565950096|FG002|Overall Study|Withdrawal by Subject|8|||
156434758|NCT05641311|564682234|FG000|Dosing Period 1|Adverse Event|1|||
156529039|NCT01323634|565031050|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
156781546|NCT00812097|565950097|FG003|Overall Study|Withdrawal by Subject|2|||
156781547|NCT00812097|565950094|FG000|Overall Study|Lost to Follow-up|90|||
156781548|NCT00812097|565950095|FG001|Overall Study|Lost to Follow-up|14|||
156781549|NCT00812097|565950096|FG002|Overall Study|Lost to Follow-up|17|||
156781550|NCT00812097|565950097|FG003|Overall Study|Lost to Follow-up|5|||
156781551|NCT00812097|565950094|FG000|Overall Study|Explantation of study device(s)|27|||
156328241|NCT02349061|564303186|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
156328242|NCT02349061|564303184|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
156328243|NCT02349061|564303185|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
156328244|NCT02349061|564303186|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
156328245|NCT02349061|564303184|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
156328246|NCT02349061|564303185|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
156328247|NCT02349061|564303186|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
156328248|NCT02349061|564303184|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
156328249|NCT02349061|564303185|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
156328250|NCT02349061|564303186|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
156328251|NCT02349061|564303184|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
156328252|NCT02349061|564303185|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
156328253|NCT02349061|564303186|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
156328254|NCT02349061|564303184|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
156328255|NCT02349061|564303185|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
156328256|NCT02349061|564303186|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
156328257|NCT02339285|564303187|FG000|Overall Study|Withdrawal by Subject|0|||
156328258|NCT02339285|564303188|FG001|Overall Study|Withdrawal by Subject|1|||
156328259|NCT02339285|564303189|FG002|Overall Study|Withdrawal by Subject|1|||
156328260|NCT02339285|564303187|FG000|Overall Study|Lost to Follow-up|1|||
156328261|NCT02339285|564303188|FG001|Overall Study|Lost to Follow-up|1|||
156328262|NCT02339285|564303189|FG002|Overall Study|Lost to Follow-up|1|||
156328263|NCT02339285|564303187|FG000|Overall Study|Protocol Deviation|0|||
156328264|NCT02339285|564303188|FG001|Overall Study|Protocol Deviation|1|||
156328265|NCT02339285|564303189|FG002|Overall Study|Protocol Deviation|0|||
156328266|NCT00282412|564303192|FG000|Overall Study|Death|2|||
156328267|NCT00426231|564303193|FG000|Overall Study|Withdrawal by Subject|9|||
156328268|NCT00426231|564303194|FG001|Overall Study|Withdrawal by Subject|12|||
156328269|NCT03911713|564303195|FG000|Overall Study|Lost to Follow-up|0|||
156328270|NCT03911713|564303196|FG001|Overall Study|Lost to Follow-up|2|||
156328271|NCT03911713|564303197|FG002|Overall Study|Lost to Follow-up|0|||
156328272|NCT03911713|564303198|FG003|Overall Study|Lost to Follow-up|0|||
156328273|NCT03911713|564303199|FG004|Overall Study|Lost to Follow-up|0|||
156328274|NCT03911713|564303195|FG000|Overall Study|Other|0|||
156328275|NCT03911713|564303196|FG001|Overall Study|Other|0|||
156328276|NCT03911713|564303197|FG002|Overall Study|Other|0|||
156328277|NCT03911713|564303198|FG003|Overall Study|Other|1|||
156328278|NCT03911713|564303199|FG004|Overall Study|Other|0|||
156328279|NCT03911713|564303195|FG000|Overall Study|Randomized, Never Dosed|1|||
156328280|NCT03911713|564303196|FG001|Overall Study|Randomized, Never Dosed|0|||
156328281|NCT03911713|564303197|FG002|Overall Study|Randomized, Never Dosed|0|||
156328282|NCT03911713|564303198|FG003|Overall Study|Randomized, Never Dosed|1|||
156328283|NCT03911713|564303199|FG004|Overall Study|Randomized, Never Dosed|0|||
156328284|NCT00108433|564303201|FG000|Overall Study|Lack of Efficacy|1|||
156328285|NCT00108433|564303202|FG001|Overall Study|Lack of Efficacy|2|||
156328286|NCT00108433|564303201|FG000|Overall Study|Death|3|||
156328287|NCT00108433|564303202|FG001|Overall Study|Death|0|||
156328288|NCT00108433|564303201|FG000|Overall Study|Adverse Event|3|||
156328289|NCT00108433|564303202|FG001|Overall Study|Adverse Event|1|||
156328290|NCT00108433|564303201|FG000|Overall Study|Other|14|||
156328291|NCT00108433|564303202|FG001|Overall Study|Other|14|||
156328292|NCT02203071|564303203|FG000|Overall Study|Lost to Follow-up|3|||
156328293|NCT02203071|564303204|FG001|Overall Study|Lost to Follow-up|1|||
156328294|NCT01193660|564303205|FG000|Overall Study|Withdrawal by Subject|2|||
156328295|NCT01193660|564303206|FG001|Overall Study|Withdrawal by Subject|3|||
156328296|NCT01193660|564303207|FG002|Overall Study|Withdrawal by Subject|1|||
156328297|NCT01193660|564303205|FG000|Overall Study|Death|1|||
156328298|NCT01193660|564303206|FG001|Overall Study|Death|0|||
156328299|NCT01193660|564303207|FG002|Overall Study|Death|0|||
156328300|NCT01193660|564303205|FG000|Overall Study|Physician Decision|1|||
156328301|NCT01193660|564303206|FG001|Overall Study|Physician Decision|0|||
156328302|NCT01193660|564303207|FG002|Overall Study|Physician Decision|1|||
156328303|NCT02595970|564303208|FG000|Overall Study|Withdrawal by Subject|2|||
156328304|NCT02595970|564303208|FG000|Overall Study|Physician Decision|2|||
156328305|NCT02595970|564303208|FG000|Overall Study|Protocol Violation|4|||
156328306|NCT02595970|564303208|FG000|Overall Study|Adverse Event|5|||
156328307|NCT02595970|564303208|FG000|Overall Study|Lack of Efficacy|7|||
156328308|NCT01886716|564303209|FG000|Week 1|Lost to Follow-up|0|||
156328309|NCT01886716|564303210|FG001|Week 1|Lost to Follow-up|0|||
156328310|NCT01886716|564303211|FG002|Week 1|Lost to Follow-up|2|||
156328311|NCT01886716|564303212|FG003|Week 1|Lost to Follow-up|2|||
156328312|NCT01886716|564303209|FG000|Week 2|Lost to Follow-up|3|||
156781552|NCT00812097|565950095|FG001|Overall Study|Explantation of study device(s)|29|||
156781553|NCT00812097|565950096|FG002|Overall Study|Explantation of study device(s)|14|||
156781554|NCT00812097|565950097|FG003|Overall Study|Explantation of study device(s)|20|||
156781555|NCT00812097|565950094|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
156781556|NCT00812097|565950095|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
156781557|NCT00812097|565950096|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
156781558|NCT00812097|565950097|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
156781559|NCT01786109|565950099|FG000|Overall Study|fail manometry barostat tube placement|1|||
156781560|NCT01786109|565950100|FG001|Overall Study|fail manometry barostat tube placement|0|||
156781561|NCT01786109|565950101|FG002|Overall Study|fail manometry barostat tube placement|0|||
156781562|NCT01786109|565950099|FG000|Overall Study|unrelated illness|0|||
156781563|NCT01786109|565950100|FG001|Overall Study|unrelated illness|0|||
156434759|NCT05641311|564682235|FG001|Dosing Period 1|Adverse Event|0|||
156434760|NCT02969863|564682240|FG000|Overall Study|Physician Decision|1|||
156781564|NCT01786109|565950101|FG002|Overall Study|unrelated illness|1|||
156781565|NCT01786109|565950099|FG000|Overall Study|adverse effects colon preparation|0|||
156781566|NCT01786109|565950100|FG001|Overall Study|adverse effects colon preparation|0|||
156781567|NCT01786109|565950101|FG002|Overall Study|adverse effects colon preparation|1|||
156434761|NCT02969863|564682241|FG001|Overall Study|Physician Decision|0|||
156434762|NCT02969863|564682242|FG002|Overall Study|Physician Decision|0|||
156434763|NCT02969863|564682243|FG003|Overall Study|Physician Decision|0|||
156434764|NCT02969863|564682244|FG004|Overall Study|Physician Decision|0|||
156781568|NCT00317369|565950104|FG000|Overall Study|Adverse Event|2|||
156781569|NCT00317369|565950105|FG001|Overall Study|Adverse Event|1|||
156675861|NCT00906399|565556900|FG000|Year 1|Other|4|||
156675862|NCT00906399|565556901|FG001|Year 1|Other|2|||
156675863|NCT00906399|565556902|FG002|Year 1|Other|7|||
156675864|NCT00906399|565556903|FG003|Year 1|Other|0|||
156675865|NCT00906399|565556904|FG004|Year 1|Other|0|||
156675866|NCT00906399|565556905|FG005|Year 1|Other|0|||
156675867|NCT00906399|565556906|FG006|Year 1|Other|0|||
156675868|NCT00906399|565556900|FG000|Year 2|Adverse Event|0|||
156675869|NCT00906399|565556901|FG001|Year 2|Adverse Event|0|||
156675870|NCT00906399|565556902|FG002|Year 2|Adverse Event|0|||
156675871|NCT00906399|565556903|FG003|Year 2|Adverse Event|9|||
156675872|NCT00906399|565556904|FG004|Year 2|Adverse Event|8|||
156675873|NCT00906399|565556905|FG005|Year 2|Adverse Event|11|||
156675874|NCT00906399|565556906|FG006|Year 2|Adverse Event|6|||
156675875|NCT00906399|565556900|FG000|Year 2|Lost to Follow-up|0|||
156675876|NCT00906399|565556901|FG001|Year 2|Lost to Follow-up|0|||
156675877|NCT00906399|565556902|FG002|Year 2|Lost to Follow-up|0|||
156675878|NCT00906399|565556903|FG003|Year 2|Lost to Follow-up|1|||
156675879|NCT00906399|565556904|FG004|Year 2|Lost to Follow-up|4|||
156675880|NCT00906399|565556905|FG005|Year 2|Lost to Follow-up|2|||
156675881|NCT00906399|565556906|FG006|Year 2|Lost to Follow-up|4|||
156675882|NCT00906399|565556900|FG000|Year 2|Withdrawal by Subject|0|||
156675883|NCT00906399|565556901|FG001|Year 2|Withdrawal by Subject|0|||
156675884|NCT00906399|565556902|FG002|Year 2|Withdrawal by Subject|0|||
156675885|NCT00906399|565556903|FG003|Year 2|Withdrawal by Subject|17|||
156675886|NCT00906399|565556904|FG004|Year 2|Withdrawal by Subject|18|||
156675887|NCT00906399|565556905|FG005|Year 2|Withdrawal by Subject|27|||
156675888|NCT00906399|565556906|FG006|Year 2|Withdrawal by Subject|13|||
156675889|NCT00906399|565556900|FG000|Year 2|Physician Decision|0|||
156675890|NCT00906399|565556901|FG001|Year 2|Physician Decision|0|||
156675891|NCT00906399|565556902|FG002|Year 2|Physician Decision|0|||
156675892|NCT00906399|565556903|FG003|Year 2|Physician Decision|0|||
156675893|NCT00906399|565556904|FG004|Year 2|Physician Decision|2|||
156675894|NCT00906399|565556905|FG005|Year 2|Physician Decision|6|||
156675895|NCT00906399|565556906|FG006|Year 2|Physician Decision|3|||
156675896|NCT00906399|565556900|FG000|Year 2|Death|0|||
156675897|NCT00906399|565556901|FG001|Year 2|Death|0|||
156675898|NCT00906399|565556902|FG002|Year 2|Death|0|||
156781570|NCT00317369|565950106|FG002|Overall Study|Adverse Event|0|||
156434765|NCT02969863|564682245|FG005|Overall Study|Physician Decision|0|||
156675899|NCT00906399|565556903|FG003|Year 2|Death|1|||
156675900|NCT00906399|565556904|FG004|Year 2|Death|0|||
156675901|NCT00906399|565556905|FG005|Year 2|Death|0|||
156675902|NCT00906399|565556906|FG006|Year 2|Death|3|||
156434766|NCT02705586|564682246|FG000|Overall Study|Health Issues|2|||
156434767|NCT02705586|564682246|FG000|Overall Study|Transportation Difficulties|5|||
156675903|NCT00906399|565556900|FG000|Year 2|Other|0|||
156675904|NCT00906399|565556901|FG001|Year 2|Other|0|||
156675905|NCT00906399|565556902|FG002|Year 2|Other|0|||
156675906|NCT00906399|565556903|FG003|Year 2|Other|2|||
156675907|NCT00906399|565556904|FG004|Year 2|Other|3|||
156781571|NCT00317369|565950104|FG000|Overall Study|Lack of Efficacy|0|||
156675908|NCT00906399|565556905|FG005|Year 2|Other|1|||
156675909|NCT00906399|565556906|FG006|Year 2|Other|0|||
156675910|NCT01559363|565556907|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
156675911|NCT01559363|565556908|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
156675912|NCT01559363|565556909|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
156675913|NCT01559363|565556910|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
156675914|NCT01559363|565556911|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
156675915|NCT01559363|565556912|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
156675916|NCT01559363|565556907|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
156675917|NCT01559363|565556908|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
156675918|NCT01559363|565556909|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
156675919|NCT01559363|565556910|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
156675920|NCT01559363|565556911|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
156675921|NCT01559363|565556912|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
156675922|NCT01559363|565556907|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
156675923|NCT01559363|565556908|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
156675924|NCT01559363|565556909|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
156781572|NCT00317369|565950105|FG001|Overall Study|Lack of Efficacy|1|||
156781573|NCT00317369|565950106|FG002|Overall Study|Lack of Efficacy|1|||
156781574|NCT00317369|565950104|FG000|Overall Study|Withdrawal by Subject|0|||
156781575|NCT00317369|565950105|FG001|Overall Study|Withdrawal by Subject|0|||
156781576|NCT00317369|565950106|FG002|Overall Study|Withdrawal by Subject|1|||
156781577|NCT02949934|565950111|FG000|Natural Drinking Period|Adverse Event|1|||
156781578|NCT02949934|565950112|FG001|Natural Drinking Period|Adverse Event|0|||
156781579|NCT02949934|565950113|FG002|Natural Drinking Period|Adverse Event|0|||
156781580|NCT02949934|565950114|FG003|Natural Drinking Period|Adverse Event|1|||
156781581|NCT02949934|565950115|FG004|Natural Drinking Period|Adverse Event|0|||
156781582|NCT02949934|565950116|FG005|Natural Drinking Period|Adverse Event|0|||
156781583|NCT02949934|565950111|FG000|Natural Drinking Period|Lost to Follow-up|0|||
156781584|NCT02949934|565950112|FG001|Natural Drinking Period|Lost to Follow-up|0|||
156781585|NCT02949934|565950113|FG002|Natural Drinking Period|Lost to Follow-up|0|||
156781586|NCT02949934|565950114|FG003|Natural Drinking Period|Lost to Follow-up|0|||
156781587|NCT02949934|565950115|FG004|Natural Drinking Period|Lost to Follow-up|1|||
156781588|NCT02949934|565950116|FG005|Natural Drinking Period|Lost to Follow-up|0|||
156781589|NCT02949934|565950111|FG000|Neuroimaging|Protocol Violation|2|||
156781590|NCT02949934|565950112|FG001|Neuroimaging|Protocol Violation|0|||
156781591|NCT02949934|565950113|FG002|Neuroimaging|Protocol Violation|0|||
156781592|NCT02949934|565950114|FG003|Neuroimaging|Protocol Violation|0|||
156781593|NCT02949934|565950115|FG004|Neuroimaging|Protocol Violation|1|||
156781594|NCT02949934|565950116|FG005|Neuroimaging|Protocol Violation|0|||
156781595|NCT02949934|565950111|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
156781596|NCT02949934|565950112|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
156781597|NCT02949934|565950113|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
156781598|NCT02949934|565950114|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
156781599|NCT02949934|565950115|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
156781600|NCT02949934|565950116|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
156781601|NCT02949934|565950111|FG000|Neuroimaging|Not scanned|0|||
156781602|NCT02949934|565950112|FG001|Neuroimaging|Not scanned|0|||
156781603|NCT02949934|565950113|FG002|Neuroimaging|Not scanned|1|||
156781604|NCT02949934|565950114|FG003|Neuroimaging|Not scanned|0|||
156781605|NCT02949934|565950115|FG004|Neuroimaging|Not scanned|0|||
156675925|NCT01559363|565556910|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
156675926|NCT01559363|565556911|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
156675927|NCT01559363|565556912|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
156781606|NCT02949934|565950116|FG005|Neuroimaging|Not scanned|2|||
156781607|NCT02949934|565950111|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
156675928|NCT01559363|565556907|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
156675929|NCT01559363|565556908|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
156675930|NCT01559363|565556909|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
156675931|NCT01559363|565556910|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
156675932|NCT01559363|565556911|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
156675933|NCT01559363|565556912|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
156675934|NCT01559363|565556907|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
156675935|NCT01559363|565556908|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
156434768|NCT02705586|564682246|FG000|Overall Study|Vacation/Planned Absence|1|||
156434769|NCT02045836|564682247|FG000|Overall Study|Adverse Event|4|||
156434770|NCT02045836|564682248|FG001|Overall Study|Adverse Event|4|||
156434771|NCT02045836|564682247|FG000|Overall Study|Withdrawal by Subject|1|||
156434772|NCT02045836|564682248|FG001|Overall Study|Withdrawal by Subject|1|||
156675936|NCT01559363|565556909|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
156675937|NCT01559363|565556910|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
156675938|NCT01559363|565556911|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
156675939|NCT01559363|565556912|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
156675940|NCT01559363|565556907|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
156781608|NCT02949934|565950112|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
156434773|NCT02045836|564682247|FG000|Overall Study|Lost to Follow-up|4|||
156781609|NCT02949934|565950113|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
156781610|NCT02949934|565950114|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
156675941|NCT01559363|565556908|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
156675942|NCT01559363|565556909|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
156675943|NCT01559363|565556910|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
156675944|NCT01559363|565556911|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
156675945|NCT01559363|565556912|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
156675946|NCT01559363|565556907|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
156675947|NCT01559363|565556908|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
156675948|NCT01559363|565556909|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
156675949|NCT01559363|565556910|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
156675950|NCT01559363|565556911|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
156675951|NCT01559363|565556912|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
156675952|NCT05098743|565556917|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
156675953|NCT05098743|565556918|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
156675954|NCT05098743|565556917|FG000|Overall Study|Lost to Follow-up|1|||
156529040|NCT01323634|565031048|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
156529041|NCT01323634|565031049|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
156529042|NCT01323634|565031050|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
156529043|NCT01323634|565031048|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156529044|NCT01323634|565031049|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
156529045|NCT01323634|565031050|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
156529046|NCT01323634|565031048|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
156529047|NCT01323634|565031049|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
156529048|NCT01323634|565031050|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
156328313|NCT01886716|564303210|FG001|Week 2|Lost to Follow-up|2|||
156328314|NCT01886716|564303211|FG002|Week 2|Lost to Follow-up|1|||
156328315|NCT01886716|564303212|FG003|Week 2|Lost to Follow-up|3|||
156328316|NCT01886716|564303209|FG000|Week 3|Lost to Follow-up|1|||
156328317|NCT01886716|564303210|FG001|Week 3|Lost to Follow-up|1|||
156328318|NCT01886716|564303211|FG002|Week 3|Lost to Follow-up|0|||
156328319|NCT01886716|564303212|FG003|Week 3|Lost to Follow-up|1|||
156328320|NCT02572388|564303213|FG000|Overall Study|Withdrawal by Subject|1|||
156328321|NCT02572388|564303214|FG001|Overall Study|Withdrawal by Subject|1|||
156328322|NCT02572388|564303215|FG002|Overall Study|Withdrawal by Subject|2|||
156328323|NCT02572388|564303216|FG003|Overall Study|Withdrawal by Subject|2|||
156328324|NCT01051466|564303218|FG000|Overall Study|Adverse Event|1|||
156328325|NCT01051466|564303219|FG001|Overall Study|Adverse Event|0|||
156328326|NCT01051466|564303218|FG000|Overall Study|Lost to Follow-up|1|||
156328327|NCT01051466|564303219|FG001|Overall Study|Lost to Follow-up|1|||
156328328|NCT01051466|564303218|FG000|Overall Study|Withdrawal by Subject|5|||
156328329|NCT01051466|564303219|FG001|Overall Study|Withdrawal by Subject|1|||
156328330|NCT01051466|564303218|FG000|Overall Study|Entry Criteria Not Met|0|||
156328331|NCT01051466|564303219|FG001|Overall Study|Entry Criteria Not Met|3|||
156328332|NCT01051466|564303218|FG000|Overall Study|Physician Decision|1|||
156328333|NCT01051466|564303219|FG001|Overall Study|Physician Decision|0|||
156328334|NCT00810108|564303220|FG000|Overall Study|Withdrawal by Subject|1|||
156328335|NCT00810108|564303221|FG001|Overall Study|Withdrawal by Subject|0|||
156328336|NCT04806503|564303222|FG000|Overall Study|Lost to Follow-up|0|||
156328337|NCT04806503|564303223|FG001|Overall Study|Lost to Follow-up|0|||
156328338|NCT04806503|564303224|FG002|Overall Study|Lost to Follow-up|1|||
156328339|NCT04806503|564303225|FG003|Overall Study|Lost to Follow-up|0|||
156529049|NCT01323634|565031048|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156529050|NCT01323634|565031049|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
156529051|NCT01323634|565031050|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
156529052|NCT01323634|565031048|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
156529053|NCT01323634|565031049|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
156675955|NCT05098743|565556918|FG001|Overall Study|Lost to Follow-up|2|||
156675956|NCT02452463|565556919|FG000|Overall Study|Death|1|||
156675957|NCT02452463|565556920|FG001|Overall Study|Death|0|||
156781611|NCT02949934|565950115|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
156781612|NCT02949934|565950116|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
156781613|NCT02949934|565950111|FG000|Bar Laboratory|Adverse Event|1|||
156675958|NCT02452463|565556921|FG002|Overall Study|Death|0|||
156781614|NCT02949934|565950112|FG001|Bar Laboratory|Adverse Event|0|||
156781615|NCT02949934|565950113|FG002|Bar Laboratory|Adverse Event|2|||
156781616|NCT02949934|565950114|FG003|Bar Laboratory|Adverse Event|0|||
156328340|NCT04806503|564303226|FG004|Overall Study|Lost to Follow-up|0|||
156328341|NCT04806503|564303222|FG000|Overall Study|Withdrawal by Subject|1|||
156328342|NCT04806503|564303223|FG001|Overall Study|Withdrawal by Subject|0|||
156328343|NCT04806503|564303224|FG002|Overall Study|Withdrawal by Subject|1|||
156328344|NCT04806503|564303225|FG003|Overall Study|Withdrawal by Subject|1|||
156328345|NCT04806503|564303226|FG004|Overall Study|Withdrawal by Subject|1|||
156328346|NCT04806503|564303222|FG000|Overall Study|Adverse Event|1|||
156675959|NCT02452463|565556919|FG000|Overall Study|Study Suspended|1|||
156328347|NCT04806503|564303223|FG001|Overall Study|Adverse Event|1|||
156328348|NCT04806503|564303224|FG002|Overall Study|Adverse Event|0|||
156328349|NCT04806503|564303225|FG003|Overall Study|Adverse Event|1|||
156328350|NCT04806503|564303226|FG004|Overall Study|Adverse Event|0|||
156328351|NCT03589469|564303227|FG000|Overall Study|Withdrawal by Subject|8|||
156328352|NCT03589469|564303227|FG000|Overall Study|Physician Decision|20|||
156328353|NCT03589469|564303227|FG000|Overall Study|Death|97|||
156328354|NCT03589469|564303227|FG000|Overall Study|Lost to Follow-up|8|||
156328355|NCT03589469|564303227|FG000|Overall Study|Miscellaneous|1|||
156328356|NCT03793556|564303230|FG000|Overall Study|Withdrawal by Subject|12|||
156328357|NCT03793556|564303231|FG001|Overall Study|Withdrawal by Subject|1|||
156328358|NCT03793556|564303230|FG000|Overall Study|Lost to Follow-up|1|||
156328359|NCT03793556|564303231|FG001|Overall Study|Lost to Follow-up|1|||
156328360|NCT04416633|564303232|FG000|Overall Study|Death|1|||
156328361|NCT04416633|564303232|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
156328362|NCT04416633|564303232|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
156328363|NCT04416633|564303232|FG000|Overall Study|Adverse Event|6|||
156328364|NCT04416633|564303232|FG000|Overall Study|Withdrawal by Subject|6|||
156328365|NCT05021081|564303233|FG000|Phase 2|Subject enrolled in error|1|||
156328366|NCT05021081|564303234|FG001|Phase 2|Subject enrolled in error|1|||
156328367|NCT05021081|564303235|FG002|Phase 2|Subject enrolled in error|0|||
156328368|NCT00100178|564303236|FG000|Overall Study|Lost to Follow-up|0|||
156328369|NCT00100178|564303237|FG001|Overall Study|Lost to Follow-up|6|||
156328370|NCT00100178|564303238|FG002|Overall Study|Lost to Follow-up|5|||
156328371|NCT00100178|564303236|FG000|Overall Study|Adverse Event|2|||
156328372|NCT00100178|564303237|FG001|Overall Study|Adverse Event|2|||
156328373|NCT00100178|564303238|FG002|Overall Study|Adverse Event|1|||
156328374|NCT00100178|564303236|FG000|Overall Study|Withdrawal by Subject|1|||
156328375|NCT00100178|564303237|FG001|Overall Study|Withdrawal by Subject|1|||
156328376|NCT00100178|564303238|FG002|Overall Study|Withdrawal by Subject|1|||
156328377|NCT00100178|564303236|FG000|Overall Study|Physician Decision|6|||
156328378|NCT00100178|564303237|FG001|Overall Study|Physician Decision|1|||
156328379|NCT00100178|564303238|FG002|Overall Study|Physician Decision|3|||
156328380|NCT02477839|564303241|FG000|Overall Study|Adverse Event|0|||
156328381|NCT02477839|564303242|FG001|Overall Study|Adverse Event|1|||
156328382|NCT02477839|564303241|FG000|Overall Study|Protocol Violation|0|||
156328383|NCT02477839|564303242|FG001|Overall Study|Protocol Violation|2|||
156328384|NCT02477839|564303241|FG000|Overall Study|Withdrawal by Subject|3|||
156328385|NCT02477839|564303242|FG001|Overall Study|Withdrawal by Subject|3|||
156328386|NCT02477839|564303241|FG000|Overall Study|Participant had PGS during V6|0|||
156328387|NCT02477839|564303242|FG001|Overall Study|Participant had PGS during V6|1|||
156328388|NCT02477839|564303241|FG000|Overall Study|Parents decided to stop medication|0|||
156328389|NCT02477839|564303242|FG001|Overall Study|Parents decided to stop medication|1|||
156328390|NCT02477839|564303241|FG000|Overall Study|Lack of tolerability|0|||
156328391|NCT02477839|564303242|FG001|Overall Study|Lack of tolerability|1|||
156328392|NCT02477839|564303241|FG000|Overall Study|Exclusion criterion|0|||
156328393|NCT02477839|564303242|FG001|Overall Study|Exclusion criterion|1|||
156328394|NCT01439568|564303243|FG000|Overall Study|Lost to Follow-up|1|||
156328395|NCT01439568|564303244|FG001|Overall Study|Lost to Follow-up|0|||
156328396|NCT01439568|564303243|FG000|Overall Study|Withdrawal by Subject|2|||
156328397|NCT01439568|564303244|FG001|Overall Study|Withdrawal by Subject|2|||
156328398|NCT03161093|564303245|FG000|Overall Study|Protocol Violation|11|||
156328399|NCT03161093|564303246|FG001|Overall Study|Protocol Violation|14|||
156328400|NCT03161093|564303247|FG002|Overall Study|Protocol Violation|6|||
156328401|NCT03161093|564303248|FG003|Overall Study|Protocol Violation|13|||
156328402|NCT03161093|564303249|FG004|Overall Study|Protocol Violation|1|||
156328403|NCT03161093|564303250|FG005|Overall Study|Protocol Violation|0|||
156328404|NCT03161093|564303245|FG000|Overall Study|Adverse Event|5|||
156328405|NCT03161093|564303246|FG001|Overall Study|Adverse Event|21|||
156328406|NCT03161093|564303247|FG002|Overall Study|Adverse Event|16|||
156328407|NCT03161093|564303248|FG003|Overall Study|Adverse Event|35|||
156328408|NCT03161093|564303249|FG004|Overall Study|Adverse Event|2|||
156328409|NCT03161093|564303250|FG005|Overall Study|Adverse Event|1|||
156328410|NCT03161093|564303245|FG000|Overall Study|Lack of Efficacy|9|||
156328411|NCT03161093|564303246|FG001|Overall Study|Lack of Efficacy|13|||
156328412|NCT03161093|564303247|FG002|Overall Study|Lack of Efficacy|9|||
156328413|NCT03161093|564303248|FG003|Overall Study|Lack of Efficacy|24|||
156328414|NCT03161093|564303249|FG004|Overall Study|Lack of Efficacy|4|||
156328415|NCT03161093|564303250|FG005|Overall Study|Lack of Efficacy|1|||
156328416|NCT03161093|564303245|FG000|Overall Study|Physician Decision|0|||
156328417|NCT03161093|564303246|FG001|Overall Study|Physician Decision|1|||
156328418|NCT03161093|564303247|FG002|Overall Study|Physician Decision|0|||
156328419|NCT03161093|564303248|FG003|Overall Study|Physician Decision|2|||
156328420|NCT03161093|564303249|FG004|Overall Study|Physician Decision|17|||
156328421|NCT03161093|564303250|FG005|Overall Study|Physician Decision|15|||
156328422|NCT03161093|564303245|FG000|Overall Study|Withdrawal by Subject|24|||
156434774|NCT02045836|564682248|FG001|Overall Study|Lost to Follow-up|7|||
156434775|NCT02045836|564682247|FG000|Overall Study|Migrated from study area|0|||
156434776|NCT02045836|564682248|FG001|Overall Study|Migrated from study area|2|||
156434777|NCT00057837|564682249|FG000|Overall Study|Progression/relapse|12|||
156434778|NCT00057837|564682250|FG001|Overall Study|Progression/relapse|14|||
156434779|NCT00057837|564682249|FG000|Overall Study|Adverse Event|2|||
156434780|NCT00057837|564682250|FG001|Overall Study|Adverse Event|12|||
156434781|NCT00057837|564682249|FG000|Overall Study|Death|5|||
156434782|NCT00057837|564682250|FG001|Overall Study|Death|4|||
156434783|NCT00057837|564682249|FG000|Overall Study|Withdrawal by Subject|5|||
156434784|NCT00057837|564682250|FG001|Overall Study|Withdrawal by Subject|3|||
156434785|NCT00057837|564682249|FG000|Overall Study|Alternative therapy|0|||
156434786|NCT00057837|564682250|FG001|Overall Study|Alternative therapy|1|||
156434787|NCT00057837|564682249|FG000|Overall Study|Other complicating disease|2|||
156434788|NCT00057837|564682250|FG001|Overall Study|Other complicating disease|1|||
156434789|NCT00057837|564682249|FG000|Overall Study|Physician Decision|1|||
156434790|NCT00057837|564682250|FG001|Overall Study|Physician Decision|0|||
156434791|NCT00057837|564682249|FG000|Overall Study|Ineligible|3|||
156675960|NCT02452463|565556920|FG001|Overall Study|Study Suspended|0|||
156675961|NCT02452463|565556921|FG002|Overall Study|Study Suspended|0|||
156675962|NCT02452463|565556919|FG000|Overall Study|Recommended by DSMB|0|||
156675963|NCT02452463|565556920|FG001|Overall Study|Recommended by DSMB|1|||
156866591|NCT00129402|566271287|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
156866592|NCT00129402|566271288|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
156866593|NCT00129402|566271289|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
156675964|NCT02452463|565556921|FG002|Overall Study|Recommended by DSMB|0|||
156675965|NCT02452463|565556919|FG000|Overall Study|Withdrawal by Subject|0|||
156675966|NCT02452463|565556920|FG001|Overall Study|Withdrawal by Subject|1|||
156675967|NCT02452463|565556921|FG002|Overall Study|Withdrawal by Subject|0|||
156675968|NCT01073631|565556922|FG000|Overall Study|Death|82|||
156675969|NCT01073631|565556922|FG000|Overall Study|Adverse Event|24|||
156675970|NCT01073631|565556922|FG000|Overall Study|Other|63|||
156675971|NCT00849797|565556925|FG000|First Intervention|bad veins|1|||
156675972|NCT00849797|565556926|FG001|First Intervention|bad veins|0|||
156675973|NCT00849797|565556925|FG000|First Intervention|Adverse Event|0|||
156675974|NCT00849797|565556926|FG001|First Intervention|Adverse Event|1|||
156675975|NCT00849797|565556925|FG000|Washout: One Week|Withdrawal by Subject|0|||
156675976|NCT00849797|565556926|FG001|Washout: One Week|Withdrawal by Subject|2|||
156675977|NCT01494532|565556927|FG000|Overall Study|Adverse Event|4|||
156675978|NCT01494532|565556928|FG001|Overall Study|Adverse Event|1|||
156675979|NCT01494532|565556929|FG002|Overall Study|Adverse Event|8|||
156675980|NCT01494532|565556930|FG003|Overall Study|Adverse Event|6|||
156675981|NCT01494532|565556931|FG004|Overall Study|Adverse Event|5|||
156675982|NCT01494532|565556932|FG005|Overall Study|Adverse Event|0|||
156675983|NCT01494532|565556927|FG000|Overall Study|Lack of Efficacy|0|||
156675984|NCT01494532|565556928|FG001|Overall Study|Lack of Efficacy|0|||
156675985|NCT01494532|565556929|FG002|Overall Study|Lack of Efficacy|0|||
156675986|NCT01494532|565556930|FG003|Overall Study|Lack of Efficacy|0|||
156675987|NCT01494532|565556931|FG004|Overall Study|Lack of Efficacy|2|||
156675988|NCT01494532|565556932|FG005|Overall Study|Lack of Efficacy|0|||
156675989|NCT01494532|565556927|FG000|Overall Study|Protocol deviation|2|||
156675990|NCT01494532|565556928|FG001|Overall Study|Protocol deviation|1|||
156675991|NCT01494532|565556929|FG002|Overall Study|Protocol deviation|3|||
156675992|NCT01494532|565556930|FG003|Overall Study|Protocol deviation|2|||
156675993|NCT01494532|565556931|FG004|Overall Study|Protocol deviation|3|||
156675994|NCT01494532|565556932|FG005|Overall Study|Protocol deviation|0|||
156675995|NCT01494532|565556927|FG000|Overall Study|Protocol-defined stopping criteria|0|||
156675996|NCT01494532|565556928|FG001|Overall Study|Protocol-defined stopping criteria|0|||
156675997|NCT01494532|565556929|FG002|Overall Study|Protocol-defined stopping criteria|1|||
156675998|NCT01494532|565556930|FG003|Overall Study|Protocol-defined stopping criteria|0|||
156675999|NCT01494532|565556931|FG004|Overall Study|Protocol-defined stopping criteria|0|||
156676000|NCT01494532|565556932|FG005|Overall Study|Protocol-defined stopping criteria|0|||
156676001|NCT01494532|565556927|FG000|Overall Study|Lost to Follow-up|1|||
156676002|NCT01494532|565556928|FG001|Overall Study|Lost to Follow-up|0|||
156676003|NCT01494532|565556929|FG002|Overall Study|Lost to Follow-up|0|||
156676004|NCT01494532|565556930|FG003|Overall Study|Lost to Follow-up|2|||
156676005|NCT01494532|565556931|FG004|Overall Study|Lost to Follow-up|0|||
156676006|NCT01494532|565556932|FG005|Overall Study|Lost to Follow-up|0|||
156676007|NCT01494532|565556927|FG000|Overall Study|Physician Decision|0|||
156676008|NCT01494532|565556928|FG001|Overall Study|Physician Decision|1|||
156676009|NCT01494532|565556929|FG002|Overall Study|Physician Decision|1|||
156676010|NCT01494532|565556930|FG003|Overall Study|Physician Decision|2|||
156434792|NCT00057837|564682250|FG001|Overall Study|Ineligible|3|||
156434793|NCT00057837|564682249|FG000|Overall Study|Never started treatment|1|||
156434794|NCT00057837|564682250|FG001|Overall Study|Never started treatment|1|||
156434795|NCT02000817|564682251|FG000|Overall Study|Withdrawal by Subject|2|||
156676011|NCT01494532|565556931|FG004|Overall Study|Physician Decision|0|||
156434796|NCT02000817|564682252|FG001|Overall Study|Withdrawal by Subject|0|||
156434797|NCT02000817|564682253|FG002|Overall Study|Withdrawal by Subject|0|||
156781617|NCT02949934|565950115|FG004|Bar Laboratory|Adverse Event|1|||
156781618|NCT02949934|565950116|FG005|Bar Laboratory|Adverse Event|0|||
156781619|NCT02949934|565950111|FG000|Bar Laboratory|Protocol Violation|0|||
156676012|NCT01494532|565556932|FG005|Overall Study|Physician Decision|0|||
156676013|NCT01494532|565556927|FG000|Overall Study|Withdrawal by Subject|3|||
156676014|NCT01494532|565556928|FG001|Overall Study|Withdrawal by Subject|1|||
156676015|NCT01494532|565556929|FG002|Overall Study|Withdrawal by Subject|4|||
156676016|NCT01494532|565556930|FG003|Overall Study|Withdrawal by Subject|3|||
156676017|NCT01494532|565556931|FG004|Overall Study|Withdrawal by Subject|2|||
156676018|NCT01494532|565556932|FG005|Overall Study|Withdrawal by Subject|0|||
156676019|NCT00679081|565556933|FG000|Overall Study|Lost to Follow-up|1|||
156676020|NCT01891357|565556937|FG000|Overall Study|Protocol Violation|3|||
156676021|NCT03733145|565556938|FG000|Overall Study|screenfail|3|||
156676022|NCT03733145|565556939|FG001|Overall Study|screenfail|3|||
156676023|NCT03733145|565556940|FG002|Overall Study|screenfail|2|||
156676024|NCT01404988|565556943|FG000|Overall Study|Death|2|||
156676025|NCT01404988|565556944|FG001|Overall Study|Death|0|||
156676026|NCT01404988|565556945|FG002|Overall Study|Death|2|||
156676027|NCT01404988|565556943|FG000|Overall Study|Adverse Event|1|||
156676028|NCT01404988|565556944|FG001|Overall Study|Adverse Event|0|||
156676029|NCT01404988|565556945|FG002|Overall Study|Adverse Event|0|||
156676030|NCT01404988|565556943|FG000|Overall Study|Withdrawal by Subject|2|||
156676031|NCT01404988|565556944|FG001|Overall Study|Withdrawal by Subject|2|||
156676032|NCT01404988|565556945|FG002|Overall Study|Withdrawal by Subject|0|||
156676033|NCT01404988|565556943|FG000|Overall Study|Lost to Follow-up|1|||
156676034|NCT01404988|565556944|FG001|Overall Study|Lost to Follow-up|2|||
156781620|NCT02949934|565950112|FG001|Bar Laboratory|Protocol Violation|0|||
156781621|NCT02949934|565950113|FG002|Bar Laboratory|Protocol Violation|0|||
156781622|NCT02949934|565950114|FG003|Bar Laboratory|Protocol Violation|1|||
156781623|NCT02949934|565950115|FG004|Bar Laboratory|Protocol Violation|0|||
156781624|NCT02949934|565950116|FG005|Bar Laboratory|Protocol Violation|0|||
156781625|NCT00118287|565950120|FG000|Overall Study|Intracranial haemorrhage|1|||
156781626|NCT00118287|565950120|FG000|Overall Study|Muscle pain|1|||
156781627|NCT03010501|565950122|FG000|Study Week 1|Withdrawal by Subject|2|||
156781628|NCT03010501|565950123|FG001|Study Week 1|Withdrawal by Subject|1|||
156781629|NCT03010501|565950124|FG002|Study Week 1|Withdrawal by Subject|0|||
156781630|NCT03010501|565950125|FG003|Study Week 1|Withdrawal by Subject|2|||
156781631|NCT03010501|565950126|FG004|Study Week 1|Withdrawal by Subject|0|||
156781632|NCT03010501|565950127|FG005|Study Week 1|Withdrawal by Subject|0|||
156781633|NCT03010501|565950122|FG000|Study Week 3|Withdrawal by Subject|0|||
156781634|NCT03010501|565950123|FG001|Study Week 3|Withdrawal by Subject|0|||
156781635|NCT03010501|565950124|FG002|Study Week 3|Withdrawal by Subject|0|||
156781636|NCT03010501|565950125|FG003|Study Week 3|Withdrawal by Subject|1|||
156781637|NCT03010501|565950126|FG004|Study Week 3|Withdrawal by Subject|0|||
156781638|NCT03010501|565950127|FG005|Study Week 3|Withdrawal by Subject|0|||
156781639|NCT00544882|565950132|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
156781640|NCT00544882|565950133|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
156781641|NCT00544882|565950134|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
156781642|NCT00544882|565950132|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
156781643|NCT00544882|565950133|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
156781644|NCT00544882|565950134|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
156781645|NCT00544882|565950132|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
156866594|NCT00129402|566271283|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866595|NCT00129402|566271284|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866596|NCT00129402|566271285|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866597|NCT00129402|566271286|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866598|NCT00129402|566271287|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866599|NCT00129402|566271288|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866600|NCT00129402|566271289|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
156866601|NCT00129402|566271283|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866602|NCT00129402|566271284|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866603|NCT00129402|566271285|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866604|NCT00129402|566271286|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866605|NCT00129402|566271287|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866606|NCT00129402|566271288|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866607|NCT00129402|566271289|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
156676035|NCT01404988|565556945|FG002|Overall Study|Lost to Follow-up|1|||
156676036|NCT00829764|565556946|FG000|First Intervention|Adverse Event|1|||
156676037|NCT00829764|565556947|FG001|First Intervention|Adverse Event|0|||
156676038|NCT00829764|565556946|FG000|First Intervention|Withdrawal by Subject|1|||
156676039|NCT00829764|565556947|FG001|First Intervention|Withdrawal by Subject|1|||
156676040|NCT00477594|565556948|FG000|Year 1 and Year 2|Adverse Event|4|||
156781646|NCT00544882|565950133|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
156676041|NCT00477594|565556949|FG001|Year 1 and Year 2|Adverse Event|2|||
156781647|NCT00544882|565950134|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
156781648|NCT00544882|565950132|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
156781649|NCT00544882|565950133|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
156781650|NCT00544882|565950134|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
156328423|NCT03161093|564303246|FG001|Overall Study|Withdrawal by Subject|73|||
156328424|NCT03161093|564303247|FG002|Overall Study|Withdrawal by Subject|44|||
156328425|NCT03161093|564303248|FG003|Overall Study|Withdrawal by Subject|97|||
156328426|NCT03161093|564303249|FG004|Overall Study|Withdrawal by Subject|11|||
156328427|NCT03161093|564303250|FG005|Overall Study|Withdrawal by Subject|10|||
156328428|NCT03161093|564303245|FG000|Overall Study|Lost to Follow-up|3|||
156328429|NCT03161093|564303246|FG001|Overall Study|Lost to Follow-up|12|||
156328430|NCT03161093|564303247|FG002|Overall Study|Lost to Follow-up|4|||
156328431|NCT03161093|564303248|FG003|Overall Study|Lost to Follow-up|7|||
156328432|NCT03161093|564303249|FG004|Overall Study|Lost to Follow-up|8|||
156328433|NCT03161093|564303250|FG005|Overall Study|Lost to Follow-up|13|||
156328434|NCT03161093|564303245|FG000|Overall Study|Death|3|||
156328435|NCT03161093|564303246|FG001|Overall Study|Death|9|||
156328436|NCT03161093|564303247|FG002|Overall Study|Death|7|||
156328437|NCT03161093|564303248|FG003|Overall Study|Death|9|||
156328438|NCT03161093|564303249|FG004|Overall Study|Death|0|||
156328439|NCT03161093|564303250|FG005|Overall Study|Death|0|||
156328440|NCT03161093|564303245|FG000|Overall Study|Unknown - Not reported|0|||
156328441|NCT03161093|564303246|FG001|Overall Study|Unknown - Not reported|1|||
156328442|NCT03161093|564303247|FG002|Overall Study|Unknown - Not reported|0|||
156328443|NCT03161093|564303248|FG003|Overall Study|Unknown - Not reported|0|||
156328444|NCT03161093|564303249|FG004|Overall Study|Unknown - Not reported|0|||
156328445|NCT03161093|564303250|FG005|Overall Study|Unknown - Not reported|1|||
156328446|NCT00570765|564303251|FG000|DB Phase|Withdrawal by Subject|1|||
156328447|NCT00570765|564303252|FG001|DB Phase|Withdrawal by Subject|0|||
156328448|NCT00570765|564303253|FG002|DB Phase|Withdrawal by Subject|0|||
156328449|NCT00570765|564303254|FG003|DB Phase|Withdrawal by Subject|0|||
156328450|NCT00570765|564303251|FG000|DB Phase|Protocol Violation|0|||
156328451|NCT00570765|564303252|FG001|DB Phase|Protocol Violation|1|||
156328452|NCT00570765|564303253|FG002|DB Phase|Protocol Violation|0|||
156328453|NCT00570765|564303254|FG003|DB Phase|Protocol Violation|0|||
156328454|NCT00570765|564303251|FG000|DB Phase|Adverse Event|3|||
156328455|NCT00570765|564303252|FG001|DB Phase|Adverse Event|6|||
156328456|NCT00570765|564303253|FG002|DB Phase|Adverse Event|0|||
156328457|NCT00570765|564303254|FG003|DB Phase|Adverse Event|0|||
156328458|NCT00570765|564303251|FG000|DB Phase|Did Not Receive Study Drug|0|||
156328459|NCT00570765|564303252|FG001|DB Phase|Did Not Receive Study Drug|0|||
156328460|NCT00570765|564303253|FG002|DB Phase|Did Not Receive Study Drug|1|||
156328461|NCT00570765|564303254|FG003|DB Phase|Did Not Receive Study Drug|0|||
156328462|NCT00570765|564303251|FG000|LTSE Phase|Withdrawal by Subject|0|||
156328463|NCT00570765|564303252|FG001|LTSE Phase|Withdrawal by Subject|0|||
156328464|NCT00570765|564303253|FG002|LTSE Phase|Withdrawal by Subject|0|||
156328465|NCT00570765|564303254|FG003|LTSE Phase|Withdrawal by Subject|1|||
156328466|NCT00570765|564303251|FG000|LTSE Phase|Adverse Event|0|||
156328467|NCT00570765|564303252|FG001|LTSE Phase|Adverse Event|0|||
156328468|NCT00570765|564303253|FG002|LTSE Phase|Adverse Event|0|||
156328469|NCT00570765|564303254|FG003|LTSE Phase|Adverse Event|7|||
156328470|NCT00570765|564303251|FG000|LTSE Phase|Physician Decision|0|||
156328471|NCT00570765|564303252|FG001|LTSE Phase|Physician Decision|0|||
156328472|NCT00570765|564303253|FG002|LTSE Phase|Physician Decision|0|||
156328473|NCT00570765|564303254|FG003|LTSE Phase|Physician Decision|4|||
156328474|NCT01669928|564303255|FG000|First Intervention|Withdrawal by Subject|3|||
156328475|NCT01669928|564303256|FG001|First Intervention|Withdrawal by Subject|5|||
156328476|NCT00057876|564303259|FG000|Overall Study|Adverse Event|8|||
156328477|NCT00057876|564303260|FG001|Overall Study|Adverse Event|8|||
156328478|NCT00057876|564303259|FG000|Overall Study|Death|2|||
156328479|NCT00057876|564303260|FG001|Overall Study|Death|1|||
156328480|NCT00057876|564303259|FG000|Overall Study|Withdrawal by Subject|5|||
156328481|NCT00057876|564303260|FG001|Overall Study|Withdrawal by Subject|6|||
156328482|NCT00057876|564303259|FG000|Overall Study|Lack of Efficacy|10|||
156328483|NCT00057876|564303260|FG001|Overall Study|Lack of Efficacy|8|||
156328484|NCT00057876|564303259|FG000|Overall Study|Ineligible|1|||
156328485|NCT00057876|564303260|FG001|Overall Study|Ineligible|2|||
156328486|NCT00057876|564303259|FG000|Overall Study|other reason|2|||
156328487|NCT00057876|564303260|FG001|Overall Study|other reason|2|||
156328488|NCT00057876|564303259|FG000|Overall Study|other complicating disease|1|||
156328489|NCT00057876|564303260|FG001|Overall Study|other complicating disease|0|||
156328490|NCT02758171|564303261|FG000|Wash-out|Withdrawal by Subject|1|||
156328491|NCT02758171|564303262|FG001|Wash-out|Withdrawal by Subject|0|||
156328492|NCT02758171|564303261|FG000|Wash-out|Other reason|1|||
156328493|NCT02758171|564303262|FG001|Wash-out|Other reason|0|||
156328494|NCT01649804|564303266|FG000|Overall Study|Administrative/Other|8|||
156328495|NCT03719586|564303267|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
156328496|NCT03719586|564303268|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
156781651|NCT00544882|565950132|FG000|Cycle 3: Follow-up|Noncompliance|0|||
156676042|NCT00477594|565556948|FG000|Year 1 and Year 2|Physician Decision|2|||
156676043|NCT00477594|565556949|FG001|Year 1 and Year 2|Physician Decision|1|||
156676044|NCT00477594|565556948|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
156676045|NCT00477594|565556949|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
156676046|NCT00477594|565556948|FG000|Year 1 and Year 2|Other|1|||
156676047|NCT00477594|565556949|FG001|Year 1 and Year 2|Other|0|||
156676048|NCT00477594|565556948|FG000|Year 3|Adverse Event|1|||
156676049|NCT00477594|565556949|FG001|Year 3|Adverse Event|0|||
156676050|NCT00477594|565556948|FG000|Year 3|Withdrawal by Subject|1|||
156676051|NCT00477594|565556949|FG001|Year 3|Withdrawal by Subject|0|||
156676052|NCT00477594|565556948|FG000|Follow-up Period|Withdrawal by Subject|2|||
156328497|NCT03719586|564303269|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
156328498|NCT03719586|564303270|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
156328499|NCT01199731|564303271|FG000|Overall Study|Adverse Event|0|||
156328500|NCT01199731|564303272|FG001|Overall Study|Adverse Event|1|||
156328501|NCT01199731|564303273|FG002|Overall Study|Adverse Event|0|||
156328502|NCT01199731|564303271|FG000|Overall Study|Study closed/terminated|7|||
156328503|NCT01199731|564303272|FG001|Overall Study|Study closed/terminated|9|||
156328504|NCT01199731|564303273|FG002|Overall Study|Study closed/terminated|7|||
156328505|NCT01199731|564303271|FG000|Overall Study|Lost to Follow-up|0|||
156328506|NCT01199731|564303272|FG001|Overall Study|Lost to Follow-up|0|||
156328507|NCT01199731|564303273|FG002|Overall Study|Lost to Follow-up|2|||
156328508|NCT01199731|564303271|FG000|Overall Study|Physician Decision|0|||
156328509|NCT01199731|564303272|FG001|Overall Study|Physician Decision|1|||
156328510|NCT01199731|564303273|FG002|Overall Study|Physician Decision|1|||
156328511|NCT01199731|564303271|FG000|Overall Study|Withdrawal by Subject|2|||
156328512|NCT01199731|564303272|FG001|Overall Study|Withdrawal by Subject|0|||
156328513|NCT01199731|564303273|FG002|Overall Study|Withdrawal by Subject|0|||
156328514|NCT01465191|564303274|FG000|Overall Study|Protocol Violation|6|||
156328515|NCT01465191|564303275|FG001|Overall Study|Protocol Violation|3|||
156328516|NCT01465191|564303276|FG002|Overall Study|Protocol Violation|3|||
156328517|NCT01465191|564303274|FG000|Overall Study|Lost to Follow-up|3|||
156328518|NCT01465191|564303275|FG001|Overall Study|Lost to Follow-up|6|||
156328519|NCT01465191|564303276|FG002|Overall Study|Lost to Follow-up|4|||
156328520|NCT00943124|564303277|FG000|Period 1|Withdrawal by Subject|1|||
156328521|NCT00943124|564303278|FG001|Period 1|Withdrawal by Subject|1|||
156328522|NCT00943124|564303277|FG000|Period 1|Did Not Follow Study Procedures|1|||
156328523|NCT00943124|564303278|FG001|Period 1|Did Not Follow Study Procedures|0|||
156328524|NCT00943124|564303277|FG000|Period 1|Personal Reasons|0|||
156328525|NCT00943124|564303278|FG001|Period 1|Personal Reasons|1|||
156328526|NCT02992132|564303279|FG000|Overall Study|Adverse Event|4|||
156328527|NCT02992132|564303280|FG001|Overall Study|Adverse Event|1|||
156328528|NCT02992132|564303281|FG002|Overall Study|Adverse Event|3|||
156328529|NCT02992132|564303279|FG000|Overall Study|Lack of Efficacy|2|||
156328530|NCT02992132|564303280|FG001|Overall Study|Lack of Efficacy|0|||
156328531|NCT02992132|564303281|FG002|Overall Study|Lack of Efficacy|0|||
156328532|NCT02992132|564303279|FG000|Overall Study|Non-compliance with study drug|2|||
156328533|NCT02992132|564303280|FG001|Overall Study|Non-compliance with study drug|0|||
156328534|NCT02992132|564303281|FG002|Overall Study|Non-compliance with study drug|0|||
156328535|NCT02992132|564303279|FG000|Overall Study|Progressive disease|1|||
156328536|NCT02992132|564303280|FG001|Overall Study|Progressive disease|0|||
156328537|NCT02992132|564303281|FG002|Overall Study|Progressive disease|0|||
156328538|NCT02992132|564303279|FG000|Overall Study|Protocol Violation|2|||
156328539|NCT02992132|564303280|FG001|Overall Study|Protocol Violation|2|||
156328540|NCT02992132|564303281|FG002|Overall Study|Protocol Violation|0|||
156328541|NCT02992132|564303279|FG000|Overall Study|Caregiver withdrew consent|2|||
156328542|NCT02992132|564303280|FG001|Overall Study|Caregiver withdrew consent|3|||
156328543|NCT02992132|564303281|FG002|Overall Study|Caregiver withdrew consent|2|||
156328544|NCT02992132|564303279|FG000|Overall Study|Withdrawal by Subject|0|||
156328545|NCT02992132|564303280|FG001|Overall Study|Withdrawal by Subject|2|||
156328546|NCT02992132|564303281|FG002|Overall Study|Withdrawal by Subject|1|||
156328547|NCT02992132|564303279|FG000|Overall Study|Physician Decision|0|||
156328548|NCT02992132|564303280|FG001|Overall Study|Physician Decision|0|||
156328549|NCT02992132|564303281|FG002|Overall Study|Physician Decision|1|||
156328550|NCT01916967|564303287|FG000|Overall Study|Adverse Event|0|||
156676053|NCT00477594|565556949|FG001|Follow-up Period|Withdrawal by Subject|1|||
156676054|NCT00477594|565556948|FG000|Follow-up Period|Other|1|||
156328551|NCT01916967|564303288|FG001|Overall Study|Adverse Event|0|||
156328552|NCT01916967|564303289|FG002|Overall Study|Adverse Event|2|||
156328553|NCT01916967|564303287|FG000|Overall Study|Lack of Efficacy|0|||
156328554|NCT01916967|564303288|FG001|Overall Study|Lack of Efficacy|0|||
156328555|NCT01916967|564303289|FG002|Overall Study|Lack of Efficacy|6|||
156328556|NCT01916967|564303287|FG000|Overall Study|Physician Decision|0|||
156328557|NCT01916967|564303288|FG001|Overall Study|Physician Decision|0|||
156328558|NCT01916967|564303289|FG002|Overall Study|Physician Decision|1|||
156434798|NCT02000817|564682254|FG003|Overall Study|Withdrawal by Subject|0|||
156328559|NCT01916967|564303287|FG000|Overall Study|Protocol Violation|0|||
156328560|NCT01916967|564303288|FG001|Overall Study|Protocol Violation|1|||
156676055|NCT00477594|565556949|FG001|Follow-up Period|Other|0|||
156676056|NCT01109849|565558678|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
156676057|NCT01109849|565558679|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
156676058|NCT01109849|565558680|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
156676059|NCT01109849|565558681|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
156781652|NCT00544882|565950133|FG001|Cycle 3: Follow-up|Noncompliance|1|||
156781653|NCT00544882|565950134|FG002|Cycle 3: Follow-up|Noncompliance|0|||
156781654|NCT00544882|565950132|FG000|Cycle 3: Follow-up|Pregnancy|0|||
156781655|NCT00544882|565950133|FG001|Cycle 3: Follow-up|Pregnancy|1|||
156781656|NCT00544882|565950134|FG002|Cycle 3: Follow-up|Pregnancy|0|||
156781657|NCT04937387|565950135|FG000|Overall Study|Adverse Event|1|||
156781658|NCT04937387|565950136|FG001|Overall Study|Adverse Event|0|||
156781659|NCT04937387|565950137|FG002|Overall Study|Adverse Event|2|||
156781660|NCT04937387|565950138|FG003|Overall Study|Adverse Event|0|||
156781661|NCT04937387|565950135|FG000|Overall Study|Lack of Efficacy|1|||
156781662|NCT04937387|565950136|FG001|Overall Study|Lack of Efficacy|0|||
156781663|NCT04937387|565950137|FG002|Overall Study|Lack of Efficacy|0|||
156781664|NCT04937387|565950138|FG003|Overall Study|Lack of Efficacy|1|||
156781665|NCT04937387|565950135|FG000|Overall Study|Withdrawal by Subject|1|||
156781666|NCT04937387|565950136|FG001|Overall Study|Withdrawal by Subject|0|||
156781667|NCT04937387|565950137|FG002|Overall Study|Withdrawal by Subject|1|||
156781668|NCT04937387|565950138|FG003|Overall Study|Withdrawal by Subject|1|||
156781669|NCT04937387|565950135|FG000|Overall Study|Randomized in error|0|||
156781670|NCT04937387|565950136|FG001|Overall Study|Randomized in error|0|||
156781671|NCT04937387|565950137|FG002|Overall Study|Randomized in error|0|||
156781672|NCT04937387|565950138|FG003|Overall Study|Randomized in error|1|||
156781673|NCT02583269|565950139|FG000|Overall Study|Patient hospitalized prior to start|1|||
156781674|NCT02583269|565950140|FG001|Overall Study|Patient hospitalized prior to start|0|||
156781675|NCT02583269|565950141|FG002|Overall Study|Patient hospitalized prior to start|0|||
156676060|NCT01109849|565558682|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
156676061|NCT01109849|565558678|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
156676062|NCT01109849|565558679|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
156676063|NCT01109849|565558680|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
156676064|NCT01109849|565558681|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
156676065|NCT01109849|565558682|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
156676066|NCT01109849|565558678|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
156676067|NCT01109849|565558679|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
156676068|NCT01109849|565558680|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
156676069|NCT01109849|565558681|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
156676070|NCT01109849|565558682|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
156676071|NCT01109849|565558678|FG000|Initial Randomization: ADHD Treatment|move away|2|||
156676072|NCT01109849|565558679|FG001|Initial Randomization: ADHD Treatment|move away|7|||
156676073|NCT01109849|565558680|FG002|Initial Randomization: ADHD Treatment|move away|0|||
156676074|NCT01109849|565558681|FG003|Initial Randomization: ADHD Treatment|move away|0|||
156676075|NCT01109849|565558682|FG004|Initial Randomization: ADHD Treatment|move away|0|||
156676076|NCT01109849|565558678|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
156676077|NCT01109849|565558679|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
156676078|NCT01109849|565558680|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
156676079|NCT01109849|565558681|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
156781676|NCT02583269|565950142|FG003|Overall Study|Patient hospitalized prior to start|0|||
156676080|NCT01109849|565558682|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
156676081|NCT01109849|565558678|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
156676082|NCT01109849|565558679|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
156676083|NCT01109849|565558680|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
156676084|NCT01109849|565558681|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
156676085|NCT01109849|565558682|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
156676086|NCT03969641|565558685|FG000|Overall Study|Lost to Follow-up|5|||
156676087|NCT03969641|565558686|FG001|Overall Study|Lost to Follow-up|3|||
156676088|NCT03969641|565558685|FG000|Overall Study|Withdrawal by Subject|1|||
156781677|NCT02583269|565950143|FG004|Overall Study|Patient hospitalized prior to start|0|||
156781678|NCT02369458|565950145|FG000|Overall Study|Determined to be not eligible|1|||
156781679|NCT02369458|565950146|FG001|Overall Study|Determined to be not eligible|0|||
156781680|NCT05399485|565951468|FG000|DBT Phase|Other|6|||
156781681|NCT05399485|565951469|FG001|DBT Phase|Other|5|||
156781682|NCT05399485|565951468|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
156781683|NCT05399485|565951469|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
156781684|NCT05399485|565951468|FG000|DBT Phase|Withdrawal by Subject|3|||
156781685|NCT05399485|565951469|FG001|DBT Phase|Withdrawal by Subject|2|||
156781686|NCT05399485|565951468|FG000|DBT Phase|Protocol Violation|2|||
156781687|NCT05399485|565951469|FG001|DBT Phase|Protocol Violation|1|||
156781688|NCT05399485|565951468|FG000|DBT Phase|Physician Decision|0|||
156781689|NCT05399485|565951469|FG001|DBT Phase|Physician Decision|1|||
156676089|NCT03969641|565558686|FG001|Overall Study|Withdrawal by Subject|2|||
156676090|NCT03969641|565558685|FG000|Overall Study|Found to be ineligible|1|||
156676091|NCT03969641|565558686|FG001|Overall Study|Found to be ineligible|1|||
156676092|NCT03969641|565558685|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
156676093|NCT03969641|565558686|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
156676094|NCT03969641|565558685|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
156676095|NCT03969641|565558686|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
156676096|NCT03969641|565558685|FG000|Overall Study|Elective termination|0|||
156676097|NCT03969641|565558686|FG001|Overall Study|Elective termination|1|||
156676098|NCT00754052|565558695|FG000|Overall Study|Study terminated by Sponsor|5|||
156676099|NCT00754052|565558696|FG001|Overall Study|Study terminated by Sponsor|3|||
156676100|NCT02658019|565558700|FG000|Overall Study|Adverse Event|1|||
156676101|NCT02485158|565558704|FG000|Overall Study|Withdrawal by Subject|3|||
156676102|NCT02485158|565558704|FG000|Overall Study|expected drug side effect|1|||
156676103|NCT01098851|565558705|FG000|Overall Study|Equipment failure|1|||
156676104|NCT01098851|565558706|FG001|Overall Study|Equipment failure|0|||
156676105|NCT03087786|565558707|FG000|Overall Study|Withdrawal by Subject|2|||
156676106|NCT03087786|565558708|FG001|Overall Study|Withdrawal by Subject|0|||
156676107|NCT02583048|565558710|FG000|Overall Study|Withdrawal by Subject|0|||
156676108|NCT02583048|565558711|FG001|Overall Study|Withdrawal by Subject|1|||
156676109|NCT02583048|565558712|FG002|Overall Study|Withdrawal by Subject|0|||
156676110|NCT02583048|565558710|FG000|Overall Study|Failed to meet eligibility criterion|0|||
156676111|NCT02583048|565558711|FG001|Overall Study|Failed to meet eligibility criterion|0|||
156676112|NCT02583048|565558712|FG002|Overall Study|Failed to meet eligibility criterion|1|||
156676113|NCT00516295|565558716|FG000|Overall Study|Lack of Efficacy|2|||
156676114|NCT00516295|565558717|FG001|Overall Study|Lack of Efficacy|0|||
156676115|NCT00516295|565558718|FG002|Overall Study|Lack of Efficacy|0|||
156676116|NCT00516295|565558716|FG000|Overall Study|Ineligible|1|||
156676117|NCT00516295|565558717|FG001|Overall Study|Ineligible|0|||
156676118|NCT00516295|565558718|FG002|Overall Study|Ineligible|0|||
156676119|NCT02313558|565558724|FG000|Overall Study|Withdrawal by Subject|2|||
156676120|NCT02313558|565558725|FG001|Overall Study|Withdrawal by Subject|0|||
156676121|NCT02313558|565558724|FG000|Overall Study|Lost to Follow-up|4|||
156676122|NCT02313558|565558725|FG001|Overall Study|Lost to Follow-up|4|||
156676123|NCT04158687|565558726|FG000|Overall Study|Adverse Event|2|||
156676124|NCT04158687|565558727|FG001|Overall Study|Adverse Event|3|||
156676125|NCT04158687|565558728|FG002|Overall Study|Adverse Event|0|||
156676126|NCT04158687|565558729|FG003|Overall Study|Adverse Event|3|||
156676127|NCT04158687|565558726|FG000|Overall Study|Lost to Follow-up|5|||
156676128|NCT04158687|565558727|FG001|Overall Study|Lost to Follow-up|12|||
156676129|NCT04158687|565558728|FG002|Overall Study|Lost to Follow-up|4|||
156676130|NCT04158687|565558729|FG003|Overall Study|Lost to Follow-up|5|||
156676131|NCT04158687|565558726|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
156676132|NCT04158687|565558727|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
156676133|NCT04158687|565558728|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
156676134|NCT04158687|565558729|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
156781690|NCT05399485|565951468|FG000|DBT Phase|Adverse Event|2|||
156781691|NCT05399485|565951469|FG001|DBT Phase|Adverse Event|1|||
156781692|NCT05399485|565951468|FG000|OLE Phase|Protocol deviation|1|||
156781693|NCT05399485|565951469|FG001|OLE Phase|Protocol deviation|0|||
156781694|NCT05399485|565951468|FG000|OLE Phase|Other|5|||
156781695|NCT05399485|565951469|FG001|OLE Phase|Other|5|||
156781696|NCT05399485|565951468|FG000|OLE Phase|Withdrawal by Subject|12|||
156781697|NCT05399485|565951469|FG001|OLE Phase|Withdrawal by Subject|7|||
156781698|NCT05399485|565951468|FG000|OLE Phase|Pregnancy|0|||
156866608|NCT00129402|566271283|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156676135|NCT04158687|565558726|FG000|Overall Study|Non-Compliance with Study Medication|2|||
156676136|NCT04158687|565558727|FG001|Overall Study|Non-Compliance with Study Medication|2|||
156676137|NCT04158687|565558728|FG002|Overall Study|Non-Compliance with Study Medication|3|||
156676138|NCT04158687|565558729|FG003|Overall Study|Non-Compliance with Study Medication|0|||
156676139|NCT04158687|565558726|FG000|Overall Study|Investigator Decision|0|||
156676140|NCT04158687|565558727|FG001|Overall Study|Investigator Decision|0|||
156676141|NCT04158687|565558728|FG002|Overall Study|Investigator Decision|2|||
156676142|NCT04158687|565558729|FG003|Overall Study|Investigator Decision|0|||
156676143|NCT04158687|565558726|FG000|Overall Study|Protocol Violation|0|||
156676144|NCT04158687|565558727|FG001|Overall Study|Protocol Violation|2|||
156676145|NCT04158687|565558728|FG002|Overall Study|Protocol Violation|1|||
156676146|NCT04158687|565558729|FG003|Overall Study|Protocol Violation|0|||
156676147|NCT04158687|565558726|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
156676148|NCT04158687|565558727|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
156676149|NCT04158687|565558728|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
156676150|NCT04158687|565558729|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
156676151|NCT04158687|565558726|FG000|Overall Study|Reason not Specified|3|||
156676152|NCT04158687|565558727|FG001|Overall Study|Reason not Specified|2|||
156781699|NCT05399485|565951469|FG001|OLE Phase|Pregnancy|2|||
156781700|NCT05399485|565951468|FG000|OLE Phase|Physician Decision|3|||
156676153|NCT04158687|565558728|FG002|Overall Study|Reason not Specified|4|||
156676154|NCT04158687|565558729|FG003|Overall Study|Reason not Specified|4|||
156676155|NCT00640393|565558730|FG000|Part 1|Lost to Follow-up|2|||
156676156|NCT00640393|565558731|FG001|Part 1|Lost to Follow-up|0|||
156676157|NCT00640393|565558732|FG002|Part 1|Lost to Follow-up|0|||
156676158|NCT00640393|565558730|FG000|Part 1|Withdrawal by Subject|3|||
156676159|NCT00640393|565558731|FG001|Part 1|Withdrawal by Subject|0|||
156676160|NCT00640393|565558732|FG002|Part 1|Withdrawal by Subject|0|||
156676161|NCT00640393|565558730|FG000|Randomization|Withdrawn per protocol|17|||
156676162|NCT00640393|565558731|FG001|Randomization|Withdrawn per protocol|0|||
156676163|NCT00640393|565558732|FG002|Randomization|Withdrawn per protocol|0|||
156676164|NCT00640393|565558730|FG000|Randomization|Never randomized by site|2|||
156676165|NCT00640393|565558731|FG001|Randomization|Never randomized by site|0|||
156676166|NCT00640393|565558732|FG002|Randomization|Never randomized by site|0|||
156676167|NCT00640393|565558730|FG000|Part 2|Lost to Follow-up|0|||
156676168|NCT00640393|565558731|FG001|Part 2|Lost to Follow-up|2|||
156676169|NCT00640393|565558732|FG002|Part 2|Lost to Follow-up|2|||
156676170|NCT00640393|565558730|FG000|Part 2|Withdrawal by Subject|0|||
156676171|NCT00640393|565558731|FG001|Part 2|Withdrawal by Subject|6|||
156676172|NCT00640393|565558732|FG002|Part 2|Withdrawal by Subject|1|||
156676173|NCT00640393|565558730|FG000|Part 2|Non-adherence|0|||
156676174|NCT00640393|565558731|FG001|Part 2|Non-adherence|1|||
156676175|NCT00640393|565558732|FG002|Part 2|Non-adherence|0|||
156676176|NCT00640393|565558730|FG000|Part 2|Adverse Event|0|||
156676177|NCT00640393|565558731|FG001|Part 2|Adverse Event|1|||
156676178|NCT00640393|565558732|FG002|Part 2|Adverse Event|0|||
156676179|NCT02554877|565558737|FG000|Overall Study|Adverse Event|2|||
156676180|NCT02554877|565558738|FG001|Overall Study|Adverse Event|0|||
156676181|NCT02554877|565558739|FG002|Overall Study|Adverse Event|0|||
156676182|NCT02554877|565558740|FG003|Overall Study|Adverse Event|1|||
156676183|NCT02554877|565558737|FG000|Overall Study|Lost to Follow-up|1|||
156676184|NCT02554877|565558738|FG001|Overall Study|Lost to Follow-up|1|||
156676185|NCT02554877|565558739|FG002|Overall Study|Lost to Follow-up|1|||
156676186|NCT02554877|565558740|FG003|Overall Study|Lost to Follow-up|2|||
156676187|NCT02554877|565558737|FG000|Overall Study|Did not meet entrance criteria|0|||
156676188|NCT02554877|565558738|FG001|Overall Study|Did not meet entrance criteria|0|||
156676189|NCT02554877|565558739|FG002|Overall Study|Did not meet entrance criteria|1|||
156676190|NCT02554877|565558740|FG003|Overall Study|Did not meet entrance criteria|0|||
156676191|NCT02554877|565558737|FG000|Overall Study|No longer met eligibility criteria|1|||
156676192|NCT02554877|565558738|FG001|Overall Study|No longer met eligibility criteria|0|||
156676193|NCT02554877|565558739|FG002|Overall Study|No longer met eligibility criteria|1|||
156676194|NCT02554877|565558740|FG003|Overall Study|No longer met eligibility criteria|1|||
156676195|NCT02554877|565558737|FG000|Overall Study|Protocol Violation|3|||
156676196|NCT02554877|565558738|FG001|Overall Study|Protocol Violation|1|||
156676197|NCT02554877|565558739|FG002|Overall Study|Protocol Violation|1|||
156676198|NCT02554877|565558740|FG003|Overall Study|Protocol Violation|0|||
156676199|NCT02554877|565558737|FG000|Overall Study|Other|1|||
156676200|NCT02554877|565558738|FG001|Overall Study|Other|3|||
156676201|NCT02554877|565558739|FG002|Overall Study|Other|0|||
156676202|NCT02554877|565558740|FG003|Overall Study|Other|3|||
156676203|NCT02554877|565558737|FG000|Overall Study|Insufficient clinical response|4|||
156676204|NCT02554877|565558738|FG001|Overall Study|Insufficient clinical response|0|||
156676205|NCT02554877|565558739|FG002|Overall Study|Insufficient clinical response|0|||
156676206|NCT02554877|565558740|FG003|Overall Study|Insufficient clinical response|0|||
156676207|NCT02554877|565558737|FG000|Overall Study|No longer willing to participate|0|||
156676208|NCT02554877|565558738|FG001|Overall Study|No longer willing to participate|2|||
156676209|NCT02554877|565558739|FG002|Overall Study|No longer willing to participate|2|||
156676210|NCT02554877|565558740|FG003|Overall Study|No longer willing to participate|0|||
156676211|NCT00835666|565558741|FG000|Washout|Protocol Violation|1|||
156676212|NCT00835666|565558742|FG001|Washout|Protocol Violation|0|||
156676213|NCT00835666|565558741|FG000|Washout|Withdrawal by Subject|1|||
156676214|NCT00835666|565558742|FG001|Washout|Withdrawal by Subject|0|||
156676215|NCT01537887|565558743|FG000|Period 1|Physician Decision|0|||
156676216|NCT01537887|565558744|FG001|Period 1|Physician Decision|0|||
156676217|NCT01537887|565558745|FG002|Period 1|Physician Decision|0|||
156676218|NCT01537887|565558746|FG003|Period 1|Physician Decision|0|||
156676219|NCT01537887|565558747|FG004|Period 1|Physician Decision|1|||
156434799|NCT02000817|564682251|FG000|Overall Study|Adverse Event|0|||
156676220|NCT01537887|565558748|FG005|Period 1|Physician Decision|1|||
156676221|NCT01537887|565558743|FG000|Period 1|Did not receive treatment|0|||
156781701|NCT05399485|565951469|FG001|OLE Phase|Physician Decision|0|||
156781702|NCT05399485|565951468|FG000|OLE Phase|Adverse Event|2|||
156676222|NCT01537887|565558744|FG001|Period 1|Did not receive treatment|0|||
156676223|NCT01537887|565558745|FG002|Period 1|Did not receive treatment|1|||
156781703|NCT05399485|565951469|FG001|OLE Phase|Adverse Event|2|||
156676224|NCT01537887|565558746|FG003|Period 1|Did not receive treatment|0|||
156676225|NCT01537887|565558747|FG004|Period 1|Did not receive treatment|0|||
156676226|NCT01537887|565558748|FG005|Period 1|Did not receive treatment|0|||
156676227|NCT01537887|565558743|FG000|Period 2|Withdrawal by Subject|0|||
156676228|NCT01537887|565558744|FG001|Period 2|Withdrawal by Subject|1|||
156676229|NCT01537887|565558745|FG002|Period 2|Withdrawal by Subject|0|||
156676230|NCT01537887|565558746|FG003|Period 2|Withdrawal by Subject|0|||
156676231|NCT01537887|565558747|FG004|Period 2|Withdrawal by Subject|0|||
156676232|NCT01537887|565558748|FG005|Period 2|Withdrawal by Subject|0|||
156676233|NCT01537887|565558743|FG000|Period 3|Adverse Event|0|||
156676234|NCT01537887|565558744|FG001|Period 3|Adverse Event|0|||
156676235|NCT01537887|565558745|FG002|Period 3|Adverse Event|1|||
156676236|NCT01537887|565558746|FG003|Period 3|Adverse Event|0|||
156676237|NCT01537887|565558747|FG004|Period 3|Adverse Event|0|||
156676238|NCT01537887|565558748|FG005|Period 3|Adverse Event|0|||
156676239|NCT01537887|565558743|FG000|Period 3|Withdrawal by Subject|0|||
156676240|NCT01537887|565558744|FG001|Period 3|Withdrawal by Subject|1|||
156676241|NCT01537887|565558745|FG002|Period 3|Withdrawal by Subject|0|||
156676242|NCT01537887|565558746|FG003|Period 3|Withdrawal by Subject|0|||
156676243|NCT01537887|565558747|FG004|Period 3|Withdrawal by Subject|0|||
156676244|NCT01537887|565558748|FG005|Period 3|Withdrawal by Subject|0|||
156676245|NCT03236311|565558749|FG000|Overall Study|Study terminated by sponsor|0|||
156676246|NCT03236311|565558750|FG001|Overall Study|Study terminated by sponsor|2|||
156676247|NCT03236311|565558749|FG000|Overall Study|Adverse Event|0|||
156676248|NCT03236311|565558750|FG001|Overall Study|Adverse Event|1|||
156676249|NCT00669162|565558751|FG000|Overall Study|Withdrawal by Subject|1|||
156676250|NCT01174186|565558752|FG000|Overall Study|Lost to Follow-up|0|||
156676251|NCT01174186|565558753|FG001|Overall Study|Lost to Follow-up|1|||
156676252|NCT01174186|565558752|FG000|Overall Study|Withdrawal by Subject|0|||
156676253|NCT01174186|565558753|FG001|Overall Study|Withdrawal by Subject|2|||
156676254|NCT05274763|565558754|FG000|Overall Study|Lost to Follow-up|1|||
156676255|NCT01051349|565558755|FG000|Overall Study|Adverse Event|88|||
156676256|NCT01051349|565558755|FG000|Overall Study|Consent Withdrawn|54|||
156676257|NCT01051349|565558755|FG000|Overall Study|Investigator Decision|6|||
156676258|NCT01051349|565558755|FG000|Overall Study|Lost to Follow-up|6|||
156676259|NCT01051349|565558755|FG000|Overall Study|Subject non-compliance|7|||
156676260|NCT01051349|565558755|FG000|Overall Study|Reason not Specified|12|||
156781704|NCT01363076|565951470|FG000|Overall Study|Withdrawal by Subject|0|||
156781705|NCT01363076|565951471|FG001|Overall Study|Withdrawal by Subject|1|||
156781706|NCT04706403|565951472|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
156781707|NCT04706403|565951473|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
156781708|NCT04706403|565951474|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
156676261|NCT00484679|565558756|FG000|Overall Study|Withdrawal by Subject|3|||
156781709|NCT04706403|565951475|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
156781710|NCT04706403|565951476|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
156781711|NCT02642679|565951477|FG000|Overall Study|Withdrawal by Subject|1|||
156781712|NCT02642679|565951477|FG000|Overall Study|Physician Decision|1|||
156781713|NCT02642679|565951477|FG000|Overall Study|Physician Decision|1|||
156781714|NCT01105130|565951478|FG000|Overall Study|Withdrawal by Subject|4|||
156781715|NCT01105130|565951479|FG001|Overall Study|Withdrawal by Subject|6|||
156781716|NCT01105130|565951480|FG002|Overall Study|Withdrawal by Subject|2|||
156781717|NCT01105130|565951478|FG000|Overall Study|Never Started|2|||
156781718|NCT01105130|565951479|FG001|Overall Study|Never Started|2|||
156781719|NCT01105130|565951480|FG002|Overall Study|Never Started|4|||
156781720|NCT01105130|565951478|FG000|Overall Study|Toxicity|1|||
156781721|NCT01105130|565951479|FG001|Overall Study|Toxicity|3|||
156781722|NCT01105130|565951480|FG002|Overall Study|Toxicity|2|||
156328561|NCT01916967|564303289|FG002|Overall Study|Protocol Violation|0|||
156676262|NCT00402103|565558757|FG000|Overall Study|Adverse Event|60|||
156676263|NCT00402103|565558758|FG001|Overall Study|Adverse Event|7|||
156676264|NCT00402103|565558757|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156676265|NCT00402103|565558758|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156676266|NCT00402103|565558757|FG000|Overall Study|Condition no longer requires study drug|2|||
156676267|NCT00402103|565558758|FG001|Overall Study|Condition no longer requires study drug|0|||
156676268|NCT00402103|565558757|FG000|Overall Study|Protocol Deviation|8|||
156328562|NCT00764491|564303290|FG000|Overall Study|Lost to Follow-up|35|||
156328563|NCT00764491|564303291|FG001|Overall Study|Lost to Follow-up|17|||
156328564|NCT02038452|564303292|FG000|Overall Study|Withdrawal by Subject|7|||
156328565|NCT02038452|564303293|FG001|Overall Study|Withdrawal by Subject|9|||
156781723|NCT01105130|565951478|FG000|Overall Study|Multiple Reasons|3|||
156781724|NCT01105130|565951479|FG001|Overall Study|Multiple Reasons|0|||
156781725|NCT01105130|565951480|FG002|Overall Study|Multiple Reasons|2|||
156781726|NCT02927145|565951481|FG000|Initial Recruitment|Withdrawal by Subject|0|||
156781727|NCT02927145|565951482|FG001|Initial Recruitment|Withdrawal by Subject|1|||
156328566|NCT02038452|564303292|FG000|Overall Study|Lost to Follow-up|31|||
156676269|NCT00402103|565558758|FG001|Overall Study|Protocol Deviation|0|||
156676270|NCT00402103|565558757|FG000|Overall Study|Patient withdrew consent|12|||
156676271|NCT00402103|565558758|FG001|Overall Study|Patient withdrew consent|1|||
156676272|NCT00402103|565558757|FG000|Overall Study|Lost to Follow-up|6|||
156676273|NCT00402103|565558758|FG001|Overall Study|Lost to Follow-up|3|||
156676274|NCT00402103|565558757|FG000|Overall Study|Administrative problems|2|||
156676275|NCT00402103|565558758|FG001|Overall Study|Administrative problems|0|||
156676276|NCT00418145|565558761|FG000|Overall Study|study terminated|6|||
156676277|NCT00425308|565558762|FG000|Overall Study|Adverse Event|2|||
156676278|NCT00425308|565558763|FG001|Overall Study|Adverse Event|1|||
156676279|NCT00425308|565558762|FG000|Overall Study|Withdrawal by Subject|1|||
156676280|NCT00425308|565558763|FG001|Overall Study|Withdrawal by Subject|0|||
156676281|NCT00425308|565558762|FG000|Overall Study|Death|1|||
156676282|NCT00425308|565558763|FG001|Overall Study|Death|0|||
156676283|NCT01075282|565558765|FG000|Overall Study|Withdrawal by Subject|11|||
156676284|NCT01075282|565558766|FG001|Overall Study|Withdrawal by Subject|7|||
156676285|NCT01075282|565558767|FG002|Overall Study|Withdrawal by Subject|11|||
156676286|NCT01075282|565558765|FG000|Overall Study|Adverse Event|9|||
156676287|NCT01075282|565558766|FG001|Overall Study|Adverse Event|8|||
156676288|NCT01075282|565558767|FG002|Overall Study|Adverse Event|5|||
156676289|NCT01075282|565558765|FG000|Overall Study|Entry Criteria Not Met|3|||
156676290|NCT01075282|565558766|FG001|Overall Study|Entry Criteria Not Met|2|||
156676291|NCT01075282|565558767|FG002|Overall Study|Entry Criteria Not Met|0|||
156676292|NCT01075282|565558765|FG000|Overall Study|Lost to Follow-up|3|||
156676293|NCT01075282|565558766|FG001|Overall Study|Lost to Follow-up|3|||
156676294|NCT01075282|565558767|FG002|Overall Study|Lost to Follow-up|3|||
156676295|NCT01075282|565558765|FG000|Overall Study|Physician Decision|3|||
156676296|NCT01075282|565558766|FG001|Overall Study|Physician Decision|3|||
156676297|NCT01075282|565558767|FG002|Overall Study|Physician Decision|3|||
156676298|NCT01075282|565558765|FG000|Overall Study|Lack of Efficacy|1|||
156676299|NCT01075282|565558766|FG001|Overall Study|Lack of Efficacy|1|||
156676300|NCT01075282|565558767|FG002|Overall Study|Lack of Efficacy|0|||
156676301|NCT01075282|565558765|FG000|Overall Study|Treatment Non-compliance|1|||
156676302|NCT01075282|565558766|FG001|Overall Study|Treatment Non-compliance|2|||
156676303|NCT01075282|565558767|FG002|Overall Study|Treatment Non-compliance|2|||
156676304|NCT01075282|565558765|FG000|Overall Study|Protocol Violation|0|||
156676305|NCT01075282|565558766|FG001|Overall Study|Protocol Violation|2|||
156676306|NCT01075282|565558767|FG002|Overall Study|Protocol Violation|1|||
156676307|NCT01075282|565558765|FG000|Overall Study|Death|0|||
156676308|NCT01075282|565558766|FG001|Overall Study|Death|1|||
156676309|NCT01075282|565558767|FG002|Overall Study|Death|2|||
156676310|NCT00367133|565558768|FG000|2 Years|Death|20|||
156676311|NCT00367133|565558769|FG001|2 Years|Death|12|||
156676312|NCT00367133|565558770|FG002|2 Years|Death|12|||
156434800|NCT02000817|564682252|FG001|Overall Study|Adverse Event|1|||
156434801|NCT02000817|564682253|FG002|Overall Study|Adverse Event|0|||
156434802|NCT02000817|564682254|FG003|Overall Study|Adverse Event|0|||
156434803|NCT02000817|564682251|FG000|Overall Study|Lost to Follow-up|0|||
156434804|NCT02000817|564682252|FG001|Overall Study|Lost to Follow-up|0|||
156434805|NCT02000817|564682253|FG002|Overall Study|Lost to Follow-up|1|||
156434806|NCT02000817|564682254|FG003|Overall Study|Lost to Follow-up|0|||
156434807|NCT03383146|564682255|FG000|Overall Study|Screen Failure|1|||
156434808|NCT03383146|564682256|FG001|Overall Study|Screen Failure|0|||
156434809|NCT03383146|564682255|FG000|Overall Study|Adverse Event|6|||
156434810|NCT03383146|564682256|FG001|Overall Study|Adverse Event|18|||
156434811|NCT03383146|564682255|FG000|Overall Study|Lack of Efficacy|0|||
156434812|NCT03383146|564682256|FG001|Overall Study|Lack of Efficacy|3|||
156434813|NCT03383146|564682255|FG000|Overall Study|Withdrawal by Subject|20|||
156434814|NCT03383146|564682256|FG001|Overall Study|Withdrawal by Subject|36|||
156434815|NCT03383146|564682255|FG000|Overall Study|Lost to Follow-up|5|||
156434816|NCT03383146|564682256|FG001|Overall Study|Lost to Follow-up|15|||
156434817|NCT03383146|564682255|FG000|Overall Study|Death|0|||
156434818|NCT03383146|564682256|FG001|Overall Study|Death|2|||
156434819|NCT03383146|564682255|FG000|Overall Study|Physician Decision|0|||
156434820|NCT03383146|564682256|FG001|Overall Study|Physician Decision|1|||
156529054|NCT01323634|565031050|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
156529055|NCT01759407|565031051|FG000|Overall Study|Protocol Violation|0|||
156676313|NCT00367133|565558768|FG000|2 Years|Dropped|34|||
156434821|NCT03383146|564682255|FG000|Overall Study|Protocol Deviation|1|||
156434822|NCT03383146|564682256|FG001|Overall Study|Protocol Deviation|8|||
156434823|NCT03383146|564682255|FG000|Overall Study|Study Terminated by the Sponsor|48|||
156434824|NCT03383146|564682256|FG001|Overall Study|Study Terminated by the Sponsor|95|||
156434825|NCT03383146|564682255|FG000|Overall Study|Reason not Specified|4|||
156434826|NCT03383146|564682256|FG001|Overall Study|Reason not Specified|6|||
156676314|NCT00367133|565558769|FG001|2 Years|Dropped|19|||
156676315|NCT00367133|565558770|FG002|2 Years|Dropped|33|||
156676316|NCT00367133|565558768|FG000|2 Years|Missed visit|4|||
156676317|NCT00367133|565558769|FG001|2 Years|Missed visit|5|||
156676318|NCT00367133|565558770|FG002|2 Years|Missed visit|4|||
156676319|NCT00847535|565558771|FG000|Overall Study|Withdrawal by Subject|2|||
156676320|NCT00847535|565558772|FG001|Overall Study|Withdrawal by Subject|1|||
156676321|NCT00847535|565558773|FG002|Overall Study|Withdrawal by Subject|1|||
156676322|NCT00847535|565558771|FG000|Overall Study|Lost to Follow-up|0|||
156676323|NCT00847535|565558772|FG001|Overall Study|Lost to Follow-up|1|||
156676324|NCT00847535|565558773|FG002|Overall Study|Lost to Follow-up|0|||
156676325|NCT01252953|565558774|FG000|Overall Study|Withdrawal by Subject|16|||
156676326|NCT01252953|565558775|FG001|Overall Study|Withdrawal by Subject|17|||
156676327|NCT01252953|565558774|FG000|Overall Study|Lost to Follow-up|22|||
156676328|NCT01252953|565558775|FG001|Overall Study|Lost to Follow-up|21|||
156676329|NCT00840203|565558776|FG000|First Intervention|Protocol Violation|1|||
156676330|NCT00840203|565558777|FG001|First Intervention|Protocol Violation|1|||
156676331|NCT00840203|565558776|FG000|Washout|Protocol Violation|1|||
156676332|NCT00840203|565558777|FG001|Washout|Protocol Violation|0|||
156676333|NCT00989950|565558782|FG000|Randomized Phase|Protocol Violation|1|||
156676334|NCT00989950|565558783|FG001|Randomized Phase|Protocol Violation|0|||
156676335|NCT00989950|565558784|FG002|Randomized Phase|Protocol Violation|0|||
156676336|NCT00989950|565558785|FG003|Randomized Phase|Protocol Violation|0|||
156676337|NCT00989950|565558782|FG000|Randomized Phase|Adverse Event|0|||
156676338|NCT00989950|565558783|FG001|Randomized Phase|Adverse Event|1|||
156676339|NCT00989950|565558784|FG002|Randomized Phase|Adverse Event|0|||
156676340|NCT00989950|565558785|FG003|Randomized Phase|Adverse Event|0|||
156676341|NCT02054715|565558788|FG000|Baseline/Follow-up 1|Refused|1|||
156676342|NCT02054715|565558789|FG001|Baseline/Follow-up 1|Refused|3|||
156676343|NCT02054715|565558788|FG000|Baseline/Follow-up 1|Medical|0|||
156676344|NCT02054715|565558789|FG001|Baseline/Follow-up 1|Medical|1|||
156676345|NCT02054715|565558788|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
156676346|NCT02054715|565558789|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
156676347|NCT02054715|565558788|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
156676348|NCT02054715|565558789|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
156676349|NCT02054715|565558788|FG000|Baseline/Follow-up 1|No Reason|0|||
156676350|NCT02054715|565558789|FG001|Baseline/Follow-up 1|No Reason|1|||
156676351|NCT02054715|565558788|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
156676352|NCT02054715|565558789|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
156676353|NCT02054715|565558788|FG000|Baseline/Follow-up 1|Ineligible|3|||
156676354|NCT02054715|565558789|FG001|Baseline/Follow-up 1|Ineligible|0|||
156676355|NCT02054715|565558788|FG000|Baseline/Follow-up 1|Hospitalization|1|||
156676356|NCT02054715|565558789|FG001|Baseline/Follow-up 1|Hospitalization|0|||
156676357|NCT02054715|565558788|FG000|Baseline/Follow-up 1|Changed Mind|1|||
156676358|NCT02054715|565558789|FG001|Baseline/Follow-up 1|Changed Mind|0|||
156676359|NCT02054715|565558788|FG000|Follow-up 2|Lost to Followup|3|||
156676360|NCT02054715|565558789|FG001|Follow-up 2|Lost to Followup|1|||
156676361|NCT02054715|565558788|FG000|Follow-up 2|Refused|3|||
156676362|NCT02054715|565558789|FG001|Follow-up 2|Refused|2|||
156676363|NCT02054715|565558788|FG000|Follow-up 2|Followup Not Completed|3|||
156676364|NCT02054715|565558789|FG001|Follow-up 2|Followup Not Completed|4|||
156676365|NCT02054715|565558788|FG000|Follow-up 2|Ineligible|4|||
156676366|NCT02054715|565558789|FG001|Follow-up 2|Ineligible|5|||
156676367|NCT02054715|565558788|FG000|Follow-up 2|Death|3|||
156676368|NCT02054715|565558789|FG001|Follow-up 2|Death|3|||
156676369|NCT02054715|565558788|FG000|Follow-up 2|Hospitalization|0|||
156676370|NCT02054715|565558789|FG001|Follow-up 2|Hospitalization|2|||
156676371|NCT02054715|565558788|FG000|Follow-up 2|Changed MD/Facility|0|||
156676372|NCT02054715|565558789|FG001|Follow-up 2|Changed MD/Facility|1|||
156676373|NCT02054715|565558788|FG000|Follow-up 2|Changed Mind|0|||
156676374|NCT02054715|565558789|FG001|Follow-up 2|Changed Mind|1|||
156676375|NCT02054715|565558788|FG000|Follow-up 2|No Reason|2|||
156676376|NCT02054715|565558789|FG001|Follow-up 2|No Reason|0|||
156676377|NCT02054715|565558788|FG000|Follow-up 2|Treatment Change or Delay|1|||
156676378|NCT02054715|565558789|FG001|Follow-up 2|Treatment Change or Delay|0|||
156676379|NCT00863330|565558790|FG000|Overall Study|study terminated early due to administra|6|||
156676380|NCT02615249|565558793|FG000|Overall Study|Withdrawal by Subject|1|||
156676381|NCT04025021|565558794|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
156676382|NCT04025021|565558795|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
156676383|NCT03966911|565558797|FG000|Overall Study|Adverse Event|1|||
156676384|NCT03966911|565558798|FG001|Overall Study|Adverse Event|1|||
156781728|NCT02927145|565951483|FG002|Initial Recruitment|Withdrawal by Subject|1|||
156781729|NCT02927145|565951484|FG003|Initial Recruitment|Withdrawal by Subject|4|||
156781730|NCT02927145|565951485|FG004|Initial Recruitment|Withdrawal by Subject|1|||
156781731|NCT02927145|565951486|FG005|Initial Recruitment|Withdrawal by Subject|1|||
156781732|NCT02927145|565951487|FG006|Initial Recruitment|Withdrawal by Subject|0|||
156781733|NCT02927145|565951488|FG007|Initial Recruitment|Withdrawal by Subject|0|||
156676385|NCT03966911|565558797|FG000|Overall Study|Withdrawal by Subject|8|||
156676386|NCT03966911|565558798|FG001|Overall Study|Withdrawal by Subject|2|||
156676387|NCT03966911|565558797|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
156676388|NCT03966911|565558798|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
156676389|NCT00985751|565558799|FG000|Overall Study|Adverse Event|0|||
156676390|NCT00985751|565558800|FG001|Overall Study|Adverse Event|0|||
156676391|NCT00985751|565558801|FG002|Overall Study|Adverse Event|0|||
156676392|NCT00985751|565558802|FG003|Overall Study|Adverse Event|0|||
156781734|NCT02927145|565951489|FG008|Initial Recruitment|Withdrawal by Subject|2|||
156781735|NCT02927145|565951481|FG000|Initial Recruitment|Adverse Event|0|||
156676393|NCT00985751|565558803|FG004|Overall Study|Adverse Event|1|||
156676394|NCT01986647|565558805|FG000|Overall Study|Lost to Follow-up|4|||
156676395|NCT01986647|565558806|FG001|Overall Study|Lost to Follow-up|1|||
156676396|NCT01986647|565558807|FG002|Overall Study|Lost to Follow-up|4|||
156676397|NCT01986647|565558808|FG003|Overall Study|Lost to Follow-up|4|||
156676398|NCT01986647|565558805|FG000|Overall Study|Withdrawal by Subject|1|||
156676399|NCT01986647|565558806|FG001|Overall Study|Withdrawal by Subject|3|||
156676400|NCT01986647|565558807|FG002|Overall Study|Withdrawal by Subject|2|||
156676401|NCT01986647|565558808|FG003|Overall Study|Withdrawal by Subject|3|||
156676402|NCT01986647|565558805|FG000|Overall Study|Health|5|||
156676403|NCT01986647|565558806|FG001|Overall Study|Health|3|||
156676404|NCT01986647|565558807|FG002|Overall Study|Health|6|||
156676405|NCT01986647|565558808|FG003|Overall Study|Health|4|||
156676406|NCT00868998|565558809|FG000|Overall Study|Screen Failure|1|||
156676407|NCT00868998|565558809|FG000|Overall Study|Withdrawal by Subject|1|||
156676408|NCT00868998|565558809|FG000|Overall Study|Progression of disease|2|||
156676409|NCT00868998|565558809|FG000|Overall Study|Death|1|||
156676410|NCT01483820|565558810|FG000|Overall Study|Lack of Efficacy|6|||
156676411|NCT01483820|565558810|FG000|Overall Study|Adverse Event|1|||
156676412|NCT01483820|565558810|FG000|Overall Study|Death|1|||
156676413|NCT00474188|565558813|FG000|Overall Study|Withdrawal by Subject|1|||
156676414|NCT00474188|565558813|FG000|Overall Study|Study discontinued by sponsor|5|||
156676415|NCT03541252|565558816|FG000|Overall Study|Withdrawal by Subject|1|||
156676416|NCT01960296|565558823|FG000|Overall Study|Postponed surgery|1|||
156676417|NCT01960296|565558824|FG001|Overall Study|Postponed surgery|0|||
156676418|NCT01960296|565558823|FG000|Overall Study|Received different procedure|1|||
156676419|NCT01960296|565558824|FG001|Overall Study|Received different procedure|3|||
156676420|NCT02003391|565558825|FG000|Overall Study|Withdrawal by Subject|2|||
156676421|NCT02003391|565558826|FG001|Overall Study|Withdrawal by Subject|1|||
156676422|NCT02003391|565558825|FG000|Overall Study|Protocol Violation|0|||
156676423|NCT02003391|565558826|FG001|Overall Study|Protocol Violation|1|||
156676424|NCT02003391|565558825|FG000|Overall Study|Adverse Event|1|||
156676425|NCT02003391|565558826|FG001|Overall Study|Adverse Event|0|||
156676426|NCT00858403|565558827|FG000|Overall Study|Withdrawal by Subject|1|||
156781736|NCT02927145|565951482|FG001|Initial Recruitment|Adverse Event|0|||
156781737|NCT02927145|565951483|FG002|Initial Recruitment|Adverse Event|0|||
156529056|NCT01759407|565031052|FG001|Overall Study|Protocol Violation|2|||
156529057|NCT02092220|565031057|FG000|Period 1|Unrelated Illness|0|||
156781738|NCT02927145|565951484|FG003|Initial Recruitment|Adverse Event|0|||
156529058|NCT02092220|565031058|FG001|Period 1|Unrelated Illness|2|||
156529059|NCT02092220|565031057|FG000|Period 2|Severe Hypoglycaemia|1|||
156434827|NCT01317420|564682257|FG000|Overall Study|Progressive disease according to RECIST|2|||
156434828|NCT01317420|564682258|FG001|Overall Study|Progressive disease according to RECIST|3|||
156434829|NCT01317420|564682259|FG002|Overall Study|Progressive disease according to RECIST|3|||
156434830|NCT01317420|564682260|FG003|Overall Study|Progressive disease according to RECIST|3|||
156434831|NCT01317420|564682261|FG004|Overall Study|Progressive disease according to RECIST|3|||
156434832|NCT01317420|564682262|FG005|Overall Study|Progressive disease according to RECIST|3|||
156434833|NCT01317420|564682263|FG006|Overall Study|Progressive disease according to RECIST|3|||
156434834|NCT01317420|564682264|FG007|Overall Study|Progressive disease according to RECIST|3|||
156434835|NCT01317420|564682265|FG008|Overall Study|Progressive disease according to RECIST|3|||
156434836|NCT01317420|564682266|FG009|Overall Study|Progressive disease according to RECIST|2|||
156434837|NCT01317420|564682267|FG010|Overall Study|Progressive disease according to RECIST|3|||
156529060|NCT02092220|565031058|FG001|Period 2|Severe Hypoglycaemia|0|||
156529061|NCT02092220|565031057|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
156676427|NCT00858403|565558827|FG000|Overall Study|Death|3|||
156676428|NCT00858403|565558827|FG000|Overall Study|Disease Progression|1|||
156676429|NCT02264977|565558828|FG000|Overall Study|Death|3|||
156676430|NCT02264977|565558828|FG000|Overall Study|Physician Decision|1|||
156676431|NCT02264977|565558828|FG000|Overall Study|Refuse to return|1|||
156781739|NCT02927145|565951485|FG004|Initial Recruitment|Adverse Event|2|||
156434838|NCT01317420|564682268|FG011|Overall Study|Progressive disease according to RECIST|11|||
156529062|NCT02092220|565031058|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
156529063|NCT00960531|565031059|FG000|Overall Study|Lack of Efficacy|1|||
156529064|NCT00960531|565031060|FG001|Overall Study|Lack of Efficacy|0|||
156529065|NCT00960531|565031061|FG002|Overall Study|Lack of Efficacy|0|||
156676432|NCT00243347|565558829|FG000|Overall Study|Lack of Efficacy|4|||
156676433|NCT00243347|565558829|FG000|Overall Study|Adverse Event|2|||
156676434|NCT00243347|565558829|FG000|Overall Study|Death|1|||
156676435|NCT00243347|565558829|FG000|Overall Study|Withdrawal by Subject|5|||
156676436|NCT00243347|565558829|FG000|Overall Study|Condition worsened|7|||
156676437|NCT03573544|565558830|FG000|Overall Study|Adverse Event|0|||
156676438|NCT03573544|565558831|FG001|Overall Study|Adverse Event|0|||
156676439|NCT03573544|565558832|FG002|Overall Study|Adverse Event|0|||
156676440|NCT03573544|565558833|FG003|Overall Study|Adverse Event|3|||
156676441|NCT03573544|565558834|FG004|Overall Study|Adverse Event|1|||
156676442|NCT03573544|565558835|FG005|Overall Study|Adverse Event|0|||
156676443|NCT03573544|565558836|FG006|Overall Study|Adverse Event|2|||
156676444|NCT03573544|565558837|FG007|Overall Study|Adverse Event|0|||
156676445|NCT03573544|565558830|FG000|Overall Study|Physician Decision|0|||
156676446|NCT03573544|565558831|FG001|Overall Study|Physician Decision|0|||
156676447|NCT03573544|565558832|FG002|Overall Study|Physician Decision|0|||
156676448|NCT03573544|565558833|FG003|Overall Study|Physician Decision|0|||
156676449|NCT03573544|565558834|FG004|Overall Study|Physician Decision|0|||
156676450|NCT03573544|565558835|FG005|Overall Study|Physician Decision|0|||
156676451|NCT03573544|565558836|FG006|Overall Study|Physician Decision|1|||
156676452|NCT03573544|565558837|FG007|Overall Study|Physician Decision|0|||
156676453|NCT03573544|565558830|FG000|Overall Study|Withdrawal by Subject|2|||
156676454|NCT03573544|565558831|FG001|Overall Study|Withdrawal by Subject|0|||
156676455|NCT03573544|565558832|FG002|Overall Study|Withdrawal by Subject|0|||
156781740|NCT02927145|565951486|FG005|Initial Recruitment|Adverse Event|0|||
156781741|NCT02927145|565951487|FG006|Initial Recruitment|Adverse Event|0|||
156781742|NCT02927145|565951488|FG007|Initial Recruitment|Adverse Event|0|||
156676456|NCT03573544|565558833|FG003|Overall Study|Withdrawal by Subject|1|||
156676457|NCT03573544|565558834|FG004|Overall Study|Withdrawal by Subject|1|||
156676458|NCT03573544|565558835|FG005|Overall Study|Withdrawal by Subject|1|||
156676459|NCT03573544|565558836|FG006|Overall Study|Withdrawal by Subject|0|||
156676460|NCT03573544|565558837|FG007|Overall Study|Withdrawal by Subject|1|||
156676461|NCT03573544|565558830|FG000|Overall Study|Disease progression|3|||
156676462|NCT03573544|565558831|FG001|Overall Study|Disease progression|3|||
156676463|NCT03573544|565558832|FG002|Overall Study|Disease progression|6|||
156676464|NCT03573544|565558833|FG003|Overall Study|Disease progression|4|||
156676465|NCT03573544|565558834|FG004|Overall Study|Disease progression|5|||
156676466|NCT03573544|565558835|FG005|Overall Study|Disease progression|7|||
156676467|NCT03573544|565558836|FG006|Overall Study|Disease progression|6|||
156676468|NCT03573544|565558837|FG007|Overall Study|Disease progression|7|||
156676469|NCT03846193|565558840|FG000|Overall Study|Physician Decision|0|||
156676470|NCT03846193|565558841|FG001|Overall Study|Physician Decision|0|||
156676471|NCT03846193|565558842|FG002|Overall Study|Physician Decision|1|||
156676472|NCT03846193|565558843|FG003|Overall Study|Physician Decision|0|||
156676473|NCT03846193|565558844|FG004|Overall Study|Physician Decision|0|||
156676474|NCT03846193|565558840|FG000|Overall Study|Lost to Follow-up|0|||
156676475|NCT03846193|565558841|FG001|Overall Study|Lost to Follow-up|0|||
156676476|NCT03846193|565558842|FG002|Overall Study|Lost to Follow-up|0|||
156676477|NCT03846193|565558843|FG003|Overall Study|Lost to Follow-up|0|||
156676478|NCT03846193|565558844|FG004|Overall Study|Lost to Follow-up|1|||
156676479|NCT03846193|565558840|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
156676480|NCT03846193|565558841|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
156676481|NCT03846193|565558842|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
156676482|NCT03846193|565558843|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
156676483|NCT03846193|565558844|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
156676484|NCT04594252|565558852|FG000|Overall Study|Adverse Event|0|||
156676485|NCT04594252|565558853|FG001|Overall Study|Adverse Event|2|||
156676486|NCT04661202|565560852|FG000|Overall Study|Withdrawal by Subject|1|||
156676487|NCT04661202|565560853|FG001|Overall Study|Withdrawal by Subject|1|||
156676488|NCT04661202|565560852|FG000|Overall Study|Lack of Efficacy|2|||
156676489|NCT04661202|565560853|FG001|Overall Study|Lack of Efficacy|0|||
156676490|NCT02725515|565560854|FG000|Overall Study|Refused infusion (no study treatment)|1|||
156676491|NCT02725515|565560855|FG001|Overall Study|Refused infusion (no study treatment)|0|||
156676492|NCT02725515|565560854|FG000|Overall Study|Loss of Improvement per Protocol|14|||
156676493|NCT02725515|565560855|FG001|Overall Study|Loss of Improvement per Protocol|25|||
156676494|NCT02725515|565560854|FG000|Overall Study|Withdrawal by Subject|2|||
156676495|NCT02725515|565560855|FG001|Overall Study|Withdrawal by Subject|1|||
156676496|NCT02725515|565560854|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156676497|NCT02725515|565560855|FG001|Overall Study|Non-Compliance With Study Drug|3|||
156676498|NCT02725515|565560854|FG000|Overall Study|Lost to Follow-up|1|||
156676499|NCT02725515|565560855|FG001|Overall Study|Lost to Follow-up|1|||
156328567|NCT02038452|564303293|FG001|Overall Study|Lost to Follow-up|28|||
156529066|NCT00960531|565031062|FG003|Overall Study|Lack of Efficacy|0|||
156529067|NCT00960531|565031063|FG004|Overall Study|Lack of Efficacy|0|||
156529068|NCT00960531|565031064|FG005|Overall Study|Lack of Efficacy|0|||
156529069|NCT00960531|565031065|FG006|Overall Study|Lack of Efficacy|0|||
156529070|NCT00960531|565031066|FG007|Overall Study|Lack of Efficacy|0|||
156529071|NCT00960531|565031067|FG008|Overall Study|Lack of Efficacy|0|||
156529072|NCT00960531|565031068|FG009|Overall Study|Lack of Efficacy|0|||
156529073|NCT00960531|565031059|FG000|Overall Study|Withdrawal by Subject|1|||
156529074|NCT00960531|565031060|FG001|Overall Study|Withdrawal by Subject|0|||
156529075|NCT00960531|565031061|FG002|Overall Study|Withdrawal by Subject|5|||
156676500|NCT02725515|565560854|FG000|Overall Study|Adverse Event|7|||
156676501|NCT02725515|565560855|FG001|Overall Study|Adverse Event|2|||
156676502|NCT02725515|565560854|FG000|Overall Study|No Documented Disease Improvement|0|||
156676503|NCT02725515|565560855|FG001|Overall Study|No Documented Disease Improvement|1|||
156676504|NCT02725515|565560854|FG000|Overall Study|Completed Study Under Original Protocol|0|||
156676505|NCT02725515|565560855|FG001|Overall Study|Completed Study Under Original Protocol|1|||
156676506|NCT02725515|565560854|FG000|Overall Study|Lack of Response|0|||
156676507|NCT02725515|565560855|FG001|Overall Study|Lack of Response|1|||
156676508|NCT00183196|565560860|FG000|Overall Study|Withdrawal by Subject|18|||
156676509|NCT00183196|565560861|FG001|Overall Study|Withdrawal by Subject|11|||
156676510|NCT00183196|565560862|FG002|Overall Study|Withdrawal by Subject|13|||
156676511|NCT00183196|565560860|FG000|Overall Study|Adverse Event|1|||
156676512|NCT00183196|565560861|FG001|Overall Study|Adverse Event|2|||
156676513|NCT00183196|565560862|FG002|Overall Study|Adverse Event|2|||
156676514|NCT00183196|565560860|FG000|Overall Study|Legal event|1|||
156676515|NCT00183196|565560861|FG001|Overall Study|Legal event|1|||
156676516|NCT00183196|565560862|FG002|Overall Study|Legal event|1|||
156676517|NCT00183196|565560860|FG000|Overall Study|Required more intensive care|0|||
156676518|NCT00183196|565560861|FG001|Overall Study|Required more intensive care|1|||
156676519|NCT00183196|565560862|FG002|Overall Study|Required more intensive care|2|||
156676520|NCT01911429|565560863|FG000|Overall Study|Adverse Event|5|||
156676521|NCT01911429|565560864|FG001|Overall Study|Adverse Event|3|||
156676522|NCT01911429|565560865|FG002|Overall Study|Adverse Event|9|||
156676523|NCT01911429|565560863|FG000|Overall Study|Lack of Efficacy|1|||
156676524|NCT01911429|565560864|FG001|Overall Study|Lack of Efficacy|2|||
156676525|NCT01911429|565560865|FG002|Overall Study|Lack of Efficacy|4|||
156676526|NCT01911429|565560863|FG000|Overall Study|Lost to Follow-up|0|||
156676527|NCT01911429|565560864|FG001|Overall Study|Lost to Follow-up|0|||
156676528|NCT01911429|565560865|FG002|Overall Study|Lost to Follow-up|1|||
156676529|NCT01911429|565560863|FG000|Overall Study|Protocol Violation|0|||
156676530|NCT01911429|565560864|FG001|Overall Study|Protocol Violation|0|||
156676531|NCT01911429|565560865|FG002|Overall Study|Protocol Violation|1|||
156676532|NCT01911429|565560863|FG000|Overall Study|Withdrawal by Subject|5|||
156676533|NCT01911429|565560864|FG001|Overall Study|Withdrawal by Subject|5|||
156676534|NCT01911429|565560865|FG002|Overall Study|Withdrawal by Subject|4|||
156676535|NCT01911429|565560863|FG000|Overall Study|Accidental randomization|0|||
156676536|NCT01911429|565560864|FG001|Overall Study|Accidental randomization|0|||
156676537|NCT01911429|565560865|FG002|Overall Study|Accidental randomization|1|||
156676538|NCT01911429|565560863|FG000|Overall Study|subject left study|1|||
156676539|NCT01911429|565560864|FG001|Overall Study|subject left study|0|||
156676540|NCT01911429|565560865|FG002|Overall Study|subject left study|0|||
156676541|NCT03540160|565560868|FG000|Overall Study|Protocol Violation|1|||
156676542|NCT03540160|565560868|FG000|Overall Study|Physician Decision|8|||
156676543|NCT03540160|565560868|FG000|Overall Study|Lack of Efficacy|60|||
156676544|NCT03540160|565560868|FG000|Overall Study|Pregnancy|1|||
156676545|NCT03540160|565560868|FG000|Overall Study|Adverse Event|20|||
156676546|NCT03540160|565560868|FG000|Overall Study|Withdrawal by Subject|68|||
156676547|NCT03540160|565560868|FG000|Overall Study|COVID-19|2|||
156676548|NCT03540160|565560868|FG000|Overall Study|Study Closure|10|||
156676549|NCT03540160|565560868|FG000|Overall Study|Lost to Follow-up|18|||
156676550|NCT03540160|565560868|FG000|Overall Study|Sponsor decision|191|||
156676551|NCT01944722|565560869|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
156676552|NCT01944722|565560869|FG000|Overall Study|Specimen Shipping Issues|34|||
156676553|NCT01944722|565560869|FG000|Overall Study|Improper Storage/Transport|5|||
156676554|NCT01944722|565560869|FG000|Overall Study|Insufficient Volume for Test|1|||
156676555|NCT01944722|565560869|FG000|Overall Study|Missing Specimens|3|||
156676556|NCT01944722|565560869|FG000|Overall Study|Specimens Mislabeled|2|||
156676557|NCT01944722|565560869|FG000|Overall Study|Withdrawal by Subject|8|||
156676558|NCT01944722|565560869|FG000|Overall Study|NILM Subjects <30 years old|8106|||
156676559|NCT01944722|565560869|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
156676560|NCT01944722|565560869|FG000|Overall Study|>ASCUS Cytology|1122|||
156676561|NCT02906917|565560873|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
156676562|NCT02906917|565560874|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
156676563|NCT02906917|565560873|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
156676564|NCT02906917|565560874|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
156676565|NCT02906917|565560873|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
156676566|NCT02906917|565560874|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
156676567|NCT02906917|565560873|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
156676568|NCT02906917|565560874|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
156676569|NCT02906917|565560873|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
156676570|NCT02906917|565560874|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
156781743|NCT02927145|565951489|FG008|Initial Recruitment|Adverse Event|0|||
156328568|NCT01934972|564303294|FG000|Overall Study|Withdrawal by Subject|9|||
156676571|NCT02906917|565560873|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
156676572|NCT02906917|565560874|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
156781744|NCT02927145|565951481|FG000|Invitation for Additional Challenge|Pregnancy|0|||
156781745|NCT02927145|565951482|FG001|Invitation for Additional Challenge|Pregnancy|0|||
156676573|NCT02906917|565560873|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
156676574|NCT02906917|565560874|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
156676575|NCT02906917|565560873|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
156676576|NCT02906917|565560874|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
156676577|NCT01370083|565560875|FG000|Overall Study|Lost to Follow-up|2|||
156676578|NCT01370083|565560876|FG001|Overall Study|Lost to Follow-up|0|||
156676579|NCT01370083|565560875|FG000|Overall Study|Adverse Event|0|||
156676580|NCT01370083|565560876|FG001|Overall Study|Adverse Event|1|||
156676581|NCT02450539|565560877|FG000|Overall Study|Withdrawal by Subject|12|||
156676582|NCT02450539|565560878|FG001|Overall Study|Withdrawal by Subject|6|||
156676583|NCT02450539|565560877|FG000|Overall Study|Lost to Follow-up|4|||
156676584|NCT02450539|565560878|FG001|Overall Study|Lost to Follow-up|1|||
156676585|NCT03358147|565560882|FG000|Overall Study|Withdrawal by Subject|13|||
156676586|NCT03358147|565560883|FG001|Overall Study|Withdrawal by Subject|19|||
156676587|NCT03358147|565560884|FG002|Overall Study|Withdrawal by Subject|16|||
156676588|NCT03358147|565560885|FG003|Overall Study|Withdrawal by Subject|10|||
156676589|NCT03358147|565560886|FG004|Overall Study|Withdrawal by Subject|5|||
156676590|NCT03358147|565560882|FG000|Overall Study|Adverse Event|3|||
156676591|NCT03358147|565560883|FG001|Overall Study|Adverse Event|9|||
156676592|NCT03358147|565560884|FG002|Overall Study|Adverse Event|7|||
156676593|NCT03358147|565560885|FG003|Overall Study|Adverse Event|5|||
156676594|NCT03358147|565560886|FG004|Overall Study|Adverse Event|2|||
156676595|NCT03358147|565560882|FG000|Overall Study|Lost to Follow-up|4|||
156676596|NCT03358147|565560883|FG001|Overall Study|Lost to Follow-up|3|||
156676597|NCT03358147|565560884|FG002|Overall Study|Lost to Follow-up|7|||
156676598|NCT03358147|565560885|FG003|Overall Study|Lost to Follow-up|6|||
156676599|NCT03358147|565560886|FG004|Overall Study|Lost to Follow-up|4|||
156676600|NCT03358147|565560882|FG000|Overall Study|Major Protocol Deviation|11|||
156676601|NCT03358147|565560883|FG001|Overall Study|Major Protocol Deviation|3|||
156676602|NCT03358147|565560884|FG002|Overall Study|Major Protocol Deviation|2|||
156676603|NCT03358147|565560885|FG003|Overall Study|Major Protocol Deviation|3|||
156676604|NCT03358147|565560886|FG004|Overall Study|Major Protocol Deviation|1|||
156676605|NCT03358147|565560882|FG000|Overall Study|Protocol specified criteria|2|||
156676606|NCT03358147|565560883|FG001|Overall Study|Protocol specified criteria|3|||
156676607|NCT03358147|565560884|FG002|Overall Study|Protocol specified criteria|0|||
156676608|NCT03358147|565560885|FG003|Overall Study|Protocol specified criteria|3|||
156676609|NCT03358147|565560886|FG004|Overall Study|Protocol specified criteria|1|||
156676610|NCT03358147|565560882|FG000|Overall Study|Physician Decision|1|||
156676611|NCT03358147|565560883|FG001|Overall Study|Physician Decision|0|||
156676612|NCT03358147|565560884|FG002|Overall Study|Physician Decision|1|||
156676613|NCT03358147|565560885|FG003|Overall Study|Physician Decision|6|||
156676614|NCT03358147|565560886|FG004|Overall Study|Physician Decision|1|||
156676615|NCT03358147|565560882|FG000|Overall Study|Administrative reasons|0|||
156676616|NCT03358147|565560883|FG001|Overall Study|Administrative reasons|1|||
156781746|NCT02927145|565951483|FG002|Invitation for Additional Challenge|Pregnancy|0|||
156781747|NCT02927145|565951484|FG003|Invitation for Additional Challenge|Pregnancy|0|||
156781748|NCT02927145|565951485|FG004|Invitation for Additional Challenge|Pregnancy|0|||
156781749|NCT02927145|565951486|FG005|Invitation for Additional Challenge|Pregnancy|0|||
156781750|NCT02927145|565951487|FG006|Invitation for Additional Challenge|Pregnancy|1|||
156781751|NCT02927145|565951488|FG007|Invitation for Additional Challenge|Pregnancy|0|||
156781752|NCT02927145|565951489|FG008|Invitation for Additional Challenge|Pregnancy|0|||
156781753|NCT01471574|565951497|FG000|Treatment Period|Lack of Efficacy|12|||
156781754|NCT01471574|565951498|FG001|Treatment Period|Lack of Efficacy|4|||
156676617|NCT03358147|565560884|FG002|Overall Study|Administrative reasons|0|||
156676618|NCT03358147|565560885|FG003|Overall Study|Administrative reasons|3|||
156676619|NCT03358147|565560886|FG004|Overall Study|Administrative reasons|0|||
156781755|NCT01471574|565951499|FG002|Treatment Period|Lack of Efficacy|14|||
156781756|NCT01471574|565951500|FG003|Treatment Period|Lack of Efficacy|1|||
156781757|NCT01471574|565951497|FG000|Treatment Period|Adverse Event|7|||
156781758|NCT01471574|565951498|FG001|Treatment Period|Adverse Event|3|||
156676620|NCT03358147|565560882|FG000|Overall Study|Lack of Efficacy|0|||
156676621|NCT03358147|565560883|FG001|Overall Study|Lack of Efficacy|1|||
156676622|NCT03358147|565560884|FG002|Overall Study|Lack of Efficacy|1|||
156676623|NCT03358147|565560885|FG003|Overall Study|Lack of Efficacy|0|||
156676624|NCT03358147|565560886|FG004|Overall Study|Lack of Efficacy|0|||
156781759|NCT01471574|565951499|FG002|Treatment Period|Adverse Event|6|||
156781760|NCT01471574|565951500|FG003|Treatment Period|Adverse Event|1|||
156781761|NCT01471574|565951497|FG000|Treatment Period|Withdrawal by Subject|5|||
156781762|NCT01471574|565951498|FG001|Treatment Period|Withdrawal by Subject|1|||
156781763|NCT01471574|565951499|FG002|Treatment Period|Withdrawal by Subject|1|||
156781764|NCT01471574|565951500|FG003|Treatment Period|Withdrawal by Subject|0|||
156676625|NCT00731939|565560894|FG000|Overall Study|Adverse Event|6|||
156781765|NCT01471574|565951497|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
156781766|NCT01471574|565951498|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
156781767|NCT01471574|565951499|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
156676626|NCT00731939|565560894|FG000|Overall Study|Lost to Follow-up|15|||
156676627|NCT00731939|565560894|FG000|Overall Study|Not implanted with study device|9|||
156676628|NCT00731939|565560894|FG000|Overall Study|Withdrawal by Subject|2|||
156328569|NCT01934972|564303295|FG001|Overall Study|Withdrawal by Subject|6|||
156676629|NCT00731939|565560894|FG000|Overall Study|Did not meet enrollment criteria|2|||
156676630|NCT02280863|565560895|FG000|Integrated Platform|Met stopping criteria|0|||
156676631|NCT02280863|565560896|FG001|Integrated Platform|Met stopping criteria|1|||
156781768|NCT01471574|565951500|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
156676632|NCT02890992|565560899|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
156676633|NCT02890992|565560900|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
156676634|NCT02890992|565560901|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
156676635|NCT02890992|565560902|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
156676636|NCT02890992|565560903|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
156676637|NCT02890992|565560904|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
156676638|NCT02890992|565560905|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
156676639|NCT02890992|565560906|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
156676640|NCT02890992|565560899|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
156676641|NCT02890992|565560900|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
156676642|NCT02890992|565560901|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
156676643|NCT02890992|565560902|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
156676644|NCT02890992|565560903|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
156676645|NCT02890992|565560904|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
156676646|NCT02890992|565560905|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
156676647|NCT02890992|565560906|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
156676648|NCT02890992|565560899|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
156676649|NCT02890992|565560900|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
156676650|NCT02890992|565560901|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
156676651|NCT02890992|565560902|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
156676652|NCT02890992|565560903|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
156676653|NCT02890992|565560904|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
156676654|NCT02890992|565560905|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
156676655|NCT02890992|565560906|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
156676656|NCT02622386|565560907|FG000|First Assignment|Withdrawal by Subject|3|||
156676657|NCT02622386|565560908|FG001|First Assignment|Withdrawal by Subject|2|||
156676658|NCT02622386|565560907|FG000|Washout|Withdrawal by Subject|4|||
156676659|NCT02622386|565560908|FG001|Washout|Withdrawal by Subject|4|||
156676660|NCT02622386|565560907|FG000|Second Assignment|Withdrawal by Subject|0|||
156676661|NCT02622386|565560908|FG001|Second Assignment|Withdrawal by Subject|2|||
156676662|NCT02704091|565560909|FG000|Overall Study|Adverse Event|4|||
156676663|NCT02704091|565560910|FG001|Overall Study|Adverse Event|3|||
156676664|NCT02704091|565560909|FG000|Overall Study|Protocol Violation|5|||
156676665|NCT02704091|565560910|FG001|Overall Study|Protocol Violation|3|||
156676666|NCT02704091|565560909|FG000|Overall Study|Consent withdrawn|4|||
156676667|NCT02704091|565560910|FG001|Overall Study|Consent withdrawn|4|||
156676668|NCT02704091|565560909|FG000|Overall Study|Lost to Follow-up|13|||
156676669|NCT02704091|565560910|FG001|Overall Study|Lost to Follow-up|5|||
156676670|NCT02704091|565560909|FG000|Overall Study|Other|2|||
156676671|NCT02704091|565560910|FG001|Overall Study|Other|8|||
156676672|NCT02412852|565560911|FG000|Overall Study|Withdrawal by Subject|0|||
156676673|NCT02412852|565560912|FG001|Overall Study|Withdrawal by Subject|1|||
156676674|NCT02412852|565560913|FG002|Overall Study|Withdrawal by Subject|0|||
156676675|NCT02412852|565560914|FG003|Overall Study|Withdrawal by Subject|0|||
156676676|NCT02412852|565560911|FG000|Overall Study|Physician Decision|0|||
156676677|NCT02412852|565560912|FG001|Overall Study|Physician Decision|0|||
156676678|NCT02412852|565560913|FG002|Overall Study|Physician Decision|0|||
156676679|NCT02412852|565560914|FG003|Overall Study|Physician Decision|1|||
156676680|NCT00985439|565560915|FG000|Overall Study|Adverse Event|0|||
156676681|NCT00985439|565560916|FG001|Overall Study|Adverse Event|0|||
156676682|NCT00985439|565560917|FG002|Overall Study|Adverse Event|1|||
156676683|NCT00985439|565560918|FG003|Overall Study|Adverse Event|0|||
156676684|NCT00472212|565560919|FG000|Overall Study|Lost to Follow-up|6|||
156676685|NCT00472212|565560920|FG001|Overall Study|Lost to Follow-up|4|||
156676686|NCT05604014|565560923|FG000|Overall Study|Lost to Follow-up|13|||
156676687|NCT00101439|565560943|FG000|Period 2|Withdrawal by Subject|0|||
156676688|NCT00101439|565560944|FG001|Period 2|Withdrawal by Subject|2|||
156676689|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
156676690|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
156676691|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
156676692|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
156676693|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
156676694|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
156676695|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
156328570|NCT01278160|564303296|FG000|Overall Study|Adverse Event|1|||
156328571|NCT01278160|564303297|FG001|Overall Study|Adverse Event|1|||
156676696|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
156676697|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
156676698|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
156328572|NCT01278160|564303296|FG000|Overall Study|Lost to Follow-up|0|||
156328573|NCT01278160|564303297|FG001|Overall Study|Lost to Follow-up|1|||
156676699|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
156676700|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
156676701|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
156676702|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
156676703|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
156676704|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
156676705|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
156676706|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
156676707|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
156676708|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
156676709|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
156676710|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
156676711|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
156676712|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
156676713|NCT00073307|565560950|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
156676714|NCT00073307|565560951|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
156676715|NCT00073307|565560952|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
156676716|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
156676717|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
156676718|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
156676719|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
156676720|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
156676721|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
156676722|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
156676723|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
156676724|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
156676725|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
156676726|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
156676727|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
156676728|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
156676729|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
156676730|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
156676731|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
156676732|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
156676733|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
156781769|NCT01471574|565951497|FG000|Treatment Period|Lost to Follow-up|1|||
156781770|NCT01471574|565951498|FG001|Treatment Period|Lost to Follow-up|2|||
156781771|NCT01471574|565951499|FG002|Treatment Period|Lost to Follow-up|2|||
156781772|NCT01471574|565951500|FG003|Treatment Period|Lost to Follow-up|0|||
156781773|NCT01471574|565951497|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
156781774|NCT01471574|565951498|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
156781775|NCT01471574|565951499|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
156781776|NCT01471574|565951500|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
156781777|NCT01471574|565951497|FG000|Treatment Period|Other|1|||
156781778|NCT01471574|565951498|FG001|Treatment Period|Other|0|||
156781779|NCT01471574|565951499|FG002|Treatment Period|Other|0|||
156781780|NCT01471574|565951500|FG003|Treatment Period|Other|0|||
156781781|NCT01471574|565951497|FG000|Follow-up Period|Withdrawal by Subject|3|||
156781782|NCT01471574|565951498|FG001|Follow-up Period|Withdrawal by Subject|0|||
156781783|NCT01471574|565951499|FG002|Follow-up Period|Withdrawal by Subject|3|||
156781784|NCT01471574|565951500|FG003|Follow-up Period|Withdrawal by Subject|1|||
156781785|NCT01471574|565951497|FG000|Follow-up Period|Lost to Follow-up|4|||
156328574|NCT01278160|564303296|FG000|Overall Study|Withdrawal by Subject|3|||
156328575|NCT01278160|564303297|FG001|Overall Study|Withdrawal by Subject|2|||
156328576|NCT01278160|564303296|FG000|Overall Study|Unclassified|1|||
156328577|NCT01278160|564303297|FG001|Overall Study|Unclassified|2|||
156328578|NCT00304239|564303299|FG000|Overall Study|Protocol Deviations/Violations|15|||
156328579|NCT00304239|564303300|FG001|Overall Study|Protocol Deviations/Violations|0|||
156328580|NCT00304239|564303299|FG000|Overall Study|Adverse Event|2|||
156328581|NCT00304239|564303300|FG001|Overall Study|Adverse Event|0|||
156328582|NCT03643159|564303301|FG000|Overall Study|Adverse Event|1|||
156328583|NCT03643159|564303301|FG000|Overall Study|Withdrawal by Subject|1|||
156328584|NCT00932737|564303304|FG000|Overall Study|Not treated in second episode|1|||
156328585|NCT00932737|564303305|FG001|Overall Study|Not treated in second episode|0|||
156328586|NCT00932737|564303304|FG000|Overall Study|Adverse Event|0|||
156781786|NCT01471574|565951498|FG001|Follow-up Period|Lost to Follow-up|1|||
156781787|NCT01471574|565951499|FG002|Follow-up Period|Lost to Follow-up|3|||
156676734|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
156676735|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
156676736|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
156676737|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
156676738|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
156676739|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
156676740|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
156676741|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
156676742|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
156676743|NCT00073307|565560950|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
156676744|NCT00073307|565560951|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
156676745|NCT00073307|565560952|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
156676746|NCT01438060|565560953|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
156676747|NCT01438060|565560954|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
156676748|NCT01438060|565560953|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
156676749|NCT01438060|565560954|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
156676750|NCT01438060|565560953|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
156676751|NCT01438060|565560954|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
156676752|NCT01438060|565560953|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
156676753|NCT01438060|565560954|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
156676754|NCT01438060|565560953|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
156328587|NCT00932737|564303305|FG001|Overall Study|Adverse Event|1|||
156328588|NCT02949700|564303308|FG000|Phase I|Withdrawal by Subject|1|||
156328589|NCT02949700|564303309|FG001|Phase I|Withdrawal by Subject|1|||
156676755|NCT01438060|565560954|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
156676756|NCT01438060|565560953|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
156676757|NCT01438060|565560954|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
156676758|NCT01438060|565560953|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
156676759|NCT01438060|565560954|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
156676760|NCT01438060|565560953|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
156676761|NCT01438060|565560954|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
156676762|NCT01438060|565560953|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
156676763|NCT01438060|565560954|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
156676764|NCT01438060|565560953|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
156676765|NCT01438060|565560954|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
156676766|NCT01438060|565560953|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
156676767|NCT01438060|565560954|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
156676768|NCT01438060|565560953|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
156676769|NCT01438060|565560954|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
156676770|NCT01438060|565560953|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
156676771|NCT01438060|565560954|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
156676772|NCT01438060|565560953|FG000|On Study Beyond Week 140|Adverse Event|0|||
156676773|NCT01438060|565560954|FG001|On Study Beyond Week 140|Adverse Event|2|||
156676774|NCT01438060|565560953|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
156676775|NCT01438060|565560954|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
156676776|NCT01438060|565560953|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
156676777|NCT01438060|565560954|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
156676778|NCT01438060|565560953|FG000|On Study Beyond Week 140|Death|0|||
156676779|NCT01438060|565560954|FG001|On Study Beyond Week 140|Death|1|||
156676780|NCT01438060|565560953|FG000|On Study Beyond Week 140|Other Reason|0|||
156676781|NCT01438060|565560954|FG001|On Study Beyond Week 140|Other Reason|3|||
156676782|NCT00858780|565560955|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
156676783|NCT00858780|565560956|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
156676784|NCT00858780|565560957|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
156781788|NCT01471574|565951500|FG003|Follow-up Period|Lost to Follow-up|2|||
156781789|NCT01471574|565951497|FG000|Follow-up Period|Death|0|||
156781790|NCT01471574|565951498|FG001|Follow-up Period|Death|0|||
156781791|NCT01471574|565951499|FG002|Follow-up Period|Death|1|||
156781792|NCT01471574|565951500|FG003|Follow-up Period|Death|0|||
156781793|NCT01471574|565951497|FG000|Follow-up Period|Follow-up no longer required|0|||
156781794|NCT01471574|565951498|FG001|Follow-up Period|Follow-up no longer required|1|||
156781795|NCT01471574|565951499|FG002|Follow-up Period|Follow-up no longer required|0|||
156781796|NCT01471574|565951500|FG003|Follow-up Period|Follow-up no longer required|0|||
156781797|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
156781798|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
156781799|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
156328590|NCT02949700|564303310|FG002|Phase I|Withdrawal by Subject|0|||
156676785|NCT00858780|565560958|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
156676786|NCT00858780|565560959|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
156676787|NCT00858780|565560955|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
156676788|NCT00858780|565560956|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
156676789|NCT00858780|565560957|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
156676790|NCT00858780|565560958|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
156676791|NCT00858780|565560959|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
156676792|NCT00858780|565560955|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
156676793|NCT00858780|565560956|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
156676794|NCT00858780|565560957|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
156676795|NCT00858780|565560958|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
156676796|NCT00858780|565560959|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
156676797|NCT00858780|565560955|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
156676798|NCT00858780|565560956|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
156676799|NCT00858780|565560957|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
156676800|NCT00858780|565560958|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
156676801|NCT00858780|565560959|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
156676802|NCT00858780|565560955|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
156676803|NCT00858780|565560956|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
156676804|NCT00858780|565560957|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
156676805|NCT00858780|565560958|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
156676806|NCT00858780|565560959|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
156676807|NCT00858780|565560955|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
156676808|NCT00858780|565560956|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
156676809|NCT00858780|565560957|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
156676810|NCT00858780|565560958|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
156676811|NCT00858780|565560959|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
156676812|NCT03499873|565560960|FG000|Overall Study|Withdrawal by Subject|4|||
156676813|NCT03499873|565560961|FG001|Overall Study|Withdrawal by Subject|6|||
156676814|NCT03499873|565560962|FG002|Overall Study|Withdrawal by Subject|1|||
156676815|NCT03499873|565560960|FG000|Overall Study|Subjects condition worsened|0|||
156676816|NCT03499873|565560961|FG001|Overall Study|Subjects condition worsened|3|||
156676817|NCT03499873|565560962|FG002|Overall Study|Subjects condition worsened|11|||
156676818|NCT03499873|565560960|FG000|Overall Study|Adverse Event|8|||
156676819|NCT03499873|565560961|FG001|Overall Study|Adverse Event|3|||
156676820|NCT03499873|565560962|FG002|Overall Study|Adverse Event|6|||
156676821|NCT03499873|565560960|FG000|Overall Study|Physician Decision|1|||
156676822|NCT03499873|565560961|FG001|Overall Study|Physician Decision|0|||
156676823|NCT03499873|565560962|FG002|Overall Study|Physician Decision|0|||
156676824|NCT03499873|565560960|FG000|Overall Study|Administrative reasons|0|||
156676825|NCT03499873|565560961|FG001|Overall Study|Administrative reasons|1|||
156676826|NCT03499873|565560962|FG002|Overall Study|Administrative reasons|0|||
156676827|NCT03499873|565560960|FG000|Overall Study|Concomitant therapy|5|||
156676828|NCT03499873|565560961|FG001|Overall Study|Concomitant therapy|4|||
156676829|NCT03499873|565560962|FG002|Overall Study|Concomitant therapy|7|||
156676830|NCT03499873|565560960|FG000|Overall Study|Miscellaneous|1|||
156676831|NCT03499873|565560961|FG001|Overall Study|Miscellaneous|2|||
156676832|NCT03499873|565560962|FG002|Overall Study|Miscellaneous|2|||
156676833|NCT03499873|565560960|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
156676834|NCT03499873|565560961|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
156676835|NCT03499873|565560962|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
156676836|NCT01964950|565560963|FG000|Overall Study|Protocol Violation|25|||
156676837|NCT01149057|565560964|FG000|Overall Study|Lack of Efficacy|16|||
156676838|NCT01149057|565560964|FG000|Overall Study|Adverse Event|13|||
156676839|NCT01149057|565560964|FG000|Overall Study|Withdrawal by Subject|9|||
156676840|NCT01149057|565560964|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
156676841|NCT01149057|565560964|FG000|Overall Study|B Cell Depletion|4|||
156676842|NCT01149057|565560964|FG000|Overall Study|Participant Non-Compliance|2|||
156676843|NCT01149057|565560964|FG000|Overall Study|Lost to Follow-up|1|||
156676844|NCT01149057|565560964|FG000|Overall Study|High Parathyroid Hormone Value|1|||
156676845|NCT01149057|565560964|FG000|Overall Study|Other|6|||
156676846|NCT03602339|565560965|FG000|Overall Study|Withdrawal by Subject|9|||
156676847|NCT03602339|565560965|FG000|Overall Study|Physician Decision|2|||
156676848|NCT03602339|565560965|FG000|Overall Study|Other reason|4|||
156676849|NCT01297504|565560966|FG000|Overall Study|Invalid Consent|1|||
156676850|NCT01297504|565560966|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
156676851|NCT01297504|565560966|FG000|Overall Study|No Study Visits|4|||
156676852|NCT01297504|565560966|FG000|Overall Study|Death|3|||
156676853|NCT01297504|565560966|FG000|Overall Study|Lost to Follow-up|43|||
156676854|NCT01297504|565560966|FG000|Overall Study|Withdrawal by Subject|9|||
156676855|NCT01297504|565560966|FG000|Overall Study|Site Closure|3|||
156676856|NCT01297504|565560966|FG000|Overall Study|Protocol Violation|3|||
156676857|NCT01190865|565560973|FG000|Overall Study|Withdrawal by Subject|1|||
156676858|NCT01190865|565560973|FG000|Overall Study|Non-compliance|2|||
156676859|NCT00574847|565560976|FG000|Overall Study|Adverse Event|2|||
156676860|NCT00574847|565560977|FG001|Overall Study|Adverse Event|0|||
156676861|NCT00574847|565560976|FG000|Overall Study|Death|1|||
156676862|NCT00574847|565560977|FG001|Overall Study|Death|0|||
156676863|NCT00574847|565560976|FG000|Overall Study|Withdrawal by Subject|2|||
156676864|NCT00574847|565560977|FG001|Overall Study|Withdrawal by Subject|2|||
156676865|NCT00574847|565560976|FG000|Overall Study|Physician Decision|1|||
156676866|NCT00574847|565560977|FG001|Overall Study|Physician Decision|0|||
156676867|NCT00574847|565560976|FG000|Overall Study|Did not receive medication (declined)|2|||
156676868|NCT00574847|565560977|FG001|Overall Study|Did not receive medication (declined)|5|||
156676869|NCT00957021|565560978|FG000|Overall Study|Death|5|||
156676870|NCT00957021|565560978|FG000|Overall Study|Lost to Follow-up|8|||
156676871|NCT00957021|565560978|FG000|Overall Study|Withdrawal by Subject|34|||
156676872|NCT00957021|565560978|FG000|Overall Study|No 2 yr ROM data|35|||
156676873|NCT00957021|565560978|FG000|Overall Study|Revised study component by 2 yr visit|8|||
156676874|NCT00957021|565560978|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
156676875|NCT00957021|565560978|FG000|Overall Study|Surgery Cancelled|9|||
156676876|NCT00957021|565560978|FG000|Overall Study|Termination due to language issue|2|||
156676877|NCT01087502|565560979|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
156676878|NCT01087502|565560980|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
156676879|NCT01087502|565560979|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
156676880|NCT01087502|565560980|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
156676881|NCT01087502|565560979|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
156676882|NCT01087502|565560980|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
156676883|NCT01087502|565560979|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
156676884|NCT01087502|565560980|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
156676885|NCT01087502|565560979|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
156676886|NCT01087502|565560980|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
156676887|NCT01087502|565560979|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
156676888|NCT01087502|565560980|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
156676889|NCT01087502|565560979|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
156676890|NCT01087502|565560980|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
156676891|NCT01087502|565560979|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
156676892|NCT01087502|565560980|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
156676893|NCT01087502|565560979|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
156676894|NCT01087502|565560980|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
156676895|NCT01087502|565560979|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
156676896|NCT01087502|565560980|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
156676897|NCT01087502|565560979|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
156676898|NCT01087502|565560980|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
156676899|NCT01087502|565560979|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
156676900|NCT01087502|565560980|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
156676901|NCT01653704|565560981|FG000|Overall Study|Technical failure during recording|1|||
156676902|NCT01653704|565560982|FG001|Overall Study|Technical failure during recording|1|||
156676903|NCT01653704|565560981|FG000|Overall Study|Performance not reflective of training|1|||
156676904|NCT01653704|565560982|FG001|Overall Study|Performance not reflective of training|0|||
156676905|NCT02705716|565560983|FG000|Overall Study|Adverse Event|0|||
156676906|NCT02705716|565560984|FG001|Overall Study|Adverse Event|1|||
156676907|NCT02705716|565560983|FG000|Overall Study|Protocol Violation|3|||
156781800|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
156781801|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
156781802|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
156781803|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
156434839|NCT01317420|564682269|FG012|Overall Study|Progressive disease according to RECIST|16|||
156434840|NCT01317420|564682257|FG000|Overall Study|Other adverse event|1|||
156781804|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
156781805|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
156676908|NCT02705716|565560984|FG001|Overall Study|Protocol Violation|0|||
156676909|NCT02705716|565560983|FG000|Overall Study|Withdrawal of Consent|1|||
156676910|NCT02705716|565560984|FG001|Overall Study|Withdrawal of Consent|1|||
156781806|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
156781807|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
156676911|NCT01151618|565560985|FG000|Overall Study|Adverse Event|2|||
156866609|NCT00129402|566271284|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156676912|NCT01151618|565560985|FG000|Overall Study|Withdrawal by Subject|7|||
156676913|NCT00562718|565560986|FG000|Overall Study|Death|1|||
156676914|NCT00562718|565560986|FG000|Overall Study|Withdrawal by Subject|3|||
156676915|NCT00562718|565560986|FG000|Overall Study|Adverse Event|4|||
156676916|NCT00562718|565560986|FG000|Overall Study|Lack of Efficacy|2|||
156676917|NCT00562718|565560986|FG000|Overall Study|not stated|1|||
156676918|NCT02227238|565560987|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
156676919|NCT02227238|565560988|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
156676920|NCT02227238|565560989|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
156676921|NCT02227238|565560987|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
156676922|NCT02227238|565560988|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
156676923|NCT02227238|565560989|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
156676924|NCT02227238|565560987|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
156676925|NCT02227238|565560988|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
156676926|NCT02227238|565560989|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
156676927|NCT02227238|565560987|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
156676928|NCT02227238|565560988|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
156676929|NCT02227238|565560989|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
156676930|NCT02227238|565560987|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
156676931|NCT02227238|565560988|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
156676932|NCT02227238|565560989|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
156676933|NCT02227238|565560987|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
156676934|NCT02227238|565560988|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
156676935|NCT02227238|565560989|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
156676936|NCT02227238|565560987|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
156676937|NCT02227238|565560988|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
156676938|NCT02227238|565560989|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
156676939|NCT02227238|565560987|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
156676940|NCT02227238|565560988|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
156676941|NCT02227238|565560989|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
156676942|NCT02227238|565560987|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
156676943|NCT02227238|565560988|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
156676944|NCT02227238|565560989|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
156676945|NCT02227238|565560987|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
156676946|NCT02227238|565560988|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
156676947|NCT02227238|565560989|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
156676948|NCT02227238|565560987|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
156676949|NCT02227238|565560988|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
156676950|NCT02227238|565560989|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
156676951|NCT02227238|565560987|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
156676952|NCT02227238|565560988|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
156676953|NCT02227238|565560989|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
156676954|NCT02227238|565560987|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
156676955|NCT02227238|565560988|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
156676956|NCT02227238|565560989|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
156676957|NCT02227238|565560987|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
156676958|NCT02227238|565560988|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
156676959|NCT02227238|565560989|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
156676960|NCT01507662|565560994|FG000|Overall Study|Death|26|||
156676961|NCT01507662|565560995|FG001|Overall Study|Death|18|||
156676962|NCT01507662|565560994|FG000|Overall Study|Withdrawal by Subject|290|||
156676963|NCT01507662|565560995|FG001|Overall Study|Withdrawal by Subject|287|||
156676964|NCT01507662|565560994|FG000|Overall Study|Lost to Follow-up|498|||
156676965|NCT01507662|565560995|FG001|Overall Study|Lost to Follow-up|523|||
156676966|NCT01507662|565560994|FG000|Overall Study|Proxy interview done|2|||
156676967|NCT01507662|565560995|FG001|Overall Study|Proxy interview done|3|||
156676968|NCT01663896|565561000|FG000|Overall Study|Various reasons|43|||
156781808|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
156781809|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
156781810|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
156781811|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
156781812|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
156781813|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
156781814|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
156781815|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
156781816|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
156781817|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
156781818|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
156781819|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
156781820|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
156866610|NCT00129402|566271285|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156676969|NCT05412121|565561003|FG000|Overall Study|Withdrawal by Subject|4|||
156676970|NCT05412121|565561003|FG000|Overall Study|Physician Decision|1|||
156676971|NCT05412121|565561003|FG000|Overall Study|Lost to Follow-up|5|||
156676972|NCT01962298|565561004|FG000|Overall Study|Protocol Violation|1|||
156676973|NCT01962298|565561005|FG001|Overall Study|Protocol Violation|0|||
156676974|NCT01962298|565561006|FG002|Overall Study|Protocol Violation|1|||
156676975|NCT01962298|565561007|FG003|Overall Study|Protocol Violation|1|||
156676976|NCT01962298|565561008|FG004|Overall Study|Protocol Violation|0|||
156676977|NCT01962298|565561004|FG000|Overall Study|Data quality insufficient|2|||
156676978|NCT01962298|565561005|FG001|Overall Study|Data quality insufficient|0|||
156676979|NCT01962298|565561006|FG002|Overall Study|Data quality insufficient|3|||
156676980|NCT01962298|565561007|FG003|Overall Study|Data quality insufficient|1|||
156676981|NCT01962298|565561008|FG004|Overall Study|Data quality insufficient|4|||
156676982|NCT01962298|565561004|FG000|Overall Study|Insufficient data|0|||
156676983|NCT01962298|565561005|FG001|Overall Study|Insufficient data|2|||
156676984|NCT01962298|565561006|FG002|Overall Study|Insufficient data|1|||
156676985|NCT01962298|565561007|FG003|Overall Study|Insufficient data|0|||
156676986|NCT01962298|565561008|FG004|Overall Study|Insufficient data|1|||
156676987|NCT01962298|565561004|FG000|Overall Study|Incorrect data recorded|0|||
156676988|NCT01962298|565561005|FG001|Overall Study|Incorrect data recorded|1|||
156676989|NCT01962298|565561006|FG002|Overall Study|Incorrect data recorded|0|||
156676990|NCT01962298|565561007|FG003|Overall Study|Incorrect data recorded|0|||
156676991|NCT01962298|565561008|FG004|Overall Study|Incorrect data recorded|0|||
156676992|NCT01962298|565561004|FG000|Overall Study|Physician Decision|0|||
156676993|NCT01962298|565561005|FG001|Overall Study|Physician Decision|1|||
156676994|NCT01962298|565561006|FG002|Overall Study|Physician Decision|0|||
156676995|NCT01962298|565561007|FG003|Overall Study|Physician Decision|0|||
156676996|NCT01962298|565561008|FG004|Overall Study|Physician Decision|1|||
156676997|NCT04476277|565561009|FG000|Overall Study|Withdrawal by Subject|0|||
156676998|NCT04476277|565561010|FG001|Overall Study|Withdrawal by Subject|0|||
156676999|NCT04476277|565561011|FG002|Overall Study|Withdrawal by Subject|1|||
156677000|NCT04476277|565561012|FG003|Overall Study|Withdrawal by Subject|0|||
156677001|NCT01576705|565561013|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
156677002|NCT01576705|565561014|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
156677003|NCT01576705|565561015|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
156677004|NCT01576705|565561016|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
156677005|NCT01576705|565561013|FG000|Overall Study|invalid ICF|0|||
156677006|NCT01576705|565561014|FG001|Overall Study|invalid ICF|1|||
156677007|NCT01576705|565561015|FG002|Overall Study|invalid ICF|0|||
156677008|NCT01576705|565561016|FG003|Overall Study|invalid ICF|0|||
156677009|NCT03727139|565561017|FG000|Overall Study|Protocol Violation|60|||
156677010|NCT00566722|565561018|FG000|Overall Study|Adverse Event|0|||
156677011|NCT00566722|565561019|FG001|Overall Study|Adverse Event|1|||
156677012|NCT00566722|565561020|FG002|Overall Study|Adverse Event|0|||
156677013|NCT00566722|565561018|FG000|Overall Study|Withdrawal by Subject|0|||
156677014|NCT00566722|565561019|FG001|Overall Study|Withdrawal by Subject|0|||
156677015|NCT00566722|565561020|FG002|Overall Study|Withdrawal by Subject|1|||
156677016|NCT00566722|565561018|FG000|Overall Study|Lost to Follow-up|1|||
156677017|NCT00566722|565561019|FG001|Overall Study|Lost to Follow-up|1|||
156677018|NCT00566722|565561020|FG002|Overall Study|Lost to Follow-up|1|||
156677019|NCT00566722|565561018|FG000|Overall Study|Lack of Efficacy|1|||
156677020|NCT00566722|565561019|FG001|Overall Study|Lack of Efficacy|2|||
156677021|NCT00566722|565561020|FG002|Overall Study|Lack of Efficacy|4|||
156677022|NCT00566722|565561018|FG000|Overall Study|Did not meet exclusion criteria|0|||
156677023|NCT00566722|565561019|FG001|Overall Study|Did not meet exclusion criteria|0|||
156677024|NCT00566722|565561020|FG002|Overall Study|Did not meet exclusion criteria|2|||
156677025|NCT00566722|565561018|FG000|Overall Study|Serious adverse event|0|||
156677026|NCT00566722|565561019|FG001|Overall Study|Serious adverse event|1|||
156677027|NCT00566722|565561020|FG002|Overall Study|Serious adverse event|0|||
156677028|NCT00566722|565561018|FG000|Overall Study|Noncompliant with drug administration|0|||
156677029|NCT00566722|565561019|FG001|Overall Study|Noncompliant with drug administration|0|||
156677030|NCT00566722|565561020|FG002|Overall Study|Noncompliant with drug administration|1|||
156677031|NCT03961204|565561021|FG000|Overall Study|Withdrawal by Subject|2|||
156677032|NCT03961204|565561021|FG000|Overall Study|Lost to Follow-up|3|||
156677033|NCT03961204|565561021|FG000|Overall Study|Other|1|||
156677034|NCT03961204|565561021|FG000|Overall Study|Missing|1|||
156677035|NCT01401062|565561028|FG000|Overall Study|Death|9|||
156866611|NCT00129402|566271286|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156434841|NCT01317420|564682258|FG001|Overall Study|Other adverse event|0|||
156677036|NCT01401062|565561029|FG001|Overall Study|Death|7|||
156677037|NCT01401062|565561028|FG000|Overall Study|Physician Decision|1|||
156677038|NCT01401062|565561029|FG001|Overall Study|Physician Decision|0|||
156677039|NCT01401062|565561028|FG000|Overall Study|Withdrawal by Subject|1|||
156677040|NCT01401062|565561029|FG001|Overall Study|Withdrawal by Subject|1|||
156677041|NCT01131260|565561030|FG000|Overall Study|Randomization error|5|||
156677042|NCT01131260|565561031|FG001|Overall Study|Randomization error|1|||
156677043|NCT01131260|565561030|FG000|Overall Study|Declined to continue participation|8|||
156677044|NCT01131260|565561031|FG001|Overall Study|Declined to continue participation|13|||
156677045|NCT01131260|565561030|FG000|Overall Study|Physician Decision|22|||
156677046|NCT01131260|565561031|FG001|Overall Study|Physician Decision|24|||
156677047|NCT01131260|565561030|FG000|Overall Study|Technical problems|7|||
156677048|NCT01131260|565561031|FG001|Overall Study|Technical problems|6|||
156677049|NCT01131260|565561030|FG000|Overall Study|Staff error|2|||
156677050|NCT01131260|565561031|FG001|Overall Study|Staff error|1|||
156677051|NCT01131260|565561030|FG000|Overall Study|Ineligible|0|||
156677052|NCT01131260|565561031|FG001|Overall Study|Ineligible|2|||
156677053|NCT01018862|565561034|FG000|Overall Study|Adverse Event|2|||
156677054|NCT01018862|565561035|FG001|Overall Study|Adverse Event|0|||
156677055|NCT01018862|565561036|FG002|Overall Study|Adverse Event|6|||
156677056|NCT01018862|565561034|FG000|Overall Study|Lack of Efficacy|1|||
156677057|NCT01018862|565561035|FG001|Overall Study|Lack of Efficacy|0|||
156677058|NCT01018862|565561036|FG002|Overall Study|Lack of Efficacy|2|||
156677059|NCT01018862|565561034|FG000|Overall Study|Lost to Follow-up|3|||
156677060|NCT01018862|565561035|FG001|Overall Study|Lost to Follow-up|1|||
156677061|NCT01018862|565561036|FG002|Overall Study|Lost to Follow-up|0|||
156677062|NCT01018862|565561034|FG000|Overall Study|Protocol Violation|1|||
156677063|NCT01018862|565561035|FG001|Overall Study|Protocol Violation|3|||
156677064|NCT01018862|565561036|FG002|Overall Study|Protocol Violation|3|||
156677065|NCT01018862|565561034|FG000|Overall Study|Withdrawal by Subject|1|||
156677066|NCT01018862|565561035|FG001|Overall Study|Withdrawal by Subject|2|||
156677067|NCT01018862|565561036|FG002|Overall Study|Withdrawal by Subject|1|||
156677068|NCT01018862|565561034|FG000|Overall Study|administrative problems|5|||
156677069|NCT01018862|565561035|FG001|Overall Study|administrative problems|4|||
156677070|NCT01018862|565561036|FG002|Overall Study|administrative problems|4|||
156677071|NCT01968031|565561040|FG000|Overall Study|Adverse Event|13|||
156677072|NCT01968031|565561041|FG001|Overall Study|Adverse Event|10|||
156677073|NCT01968031|565561042|FG002|Overall Study|Adverse Event|22|||
156677074|NCT01968031|565561040|FG000|Overall Study|Withdrawal by Subject|3|||
156677075|NCT01968031|565561041|FG001|Overall Study|Withdrawal by Subject|7|||
156677076|NCT01968031|565561042|FG002|Overall Study|Withdrawal by Subject|3|||
156677077|NCT01968031|565561040|FG000|Overall Study|Did not meet entry criteria|1|||
156677078|NCT01968031|565561041|FG001|Overall Study|Did not meet entry criteria|1|||
156677079|NCT01968031|565561042|FG002|Overall Study|Did not meet entry criteria|1|||
156677080|NCT01968031|565561040|FG000|Overall Study|Noncompliance|0|||
156677081|NCT01968031|565561041|FG001|Overall Study|Noncompliance|0|||
156677082|NCT01968031|565561042|FG002|Overall Study|Noncompliance|2|||
156677083|NCT01968031|565561040|FG000|Overall Study|Failed inclusion criteria|0|||
156677084|NCT01968031|565561041|FG001|Overall Study|Failed inclusion criteria|2|||
156677085|NCT01968031|565561042|FG002|Overall Study|Failed inclusion criteria|0|||
156677086|NCT01968031|565561040|FG000|Overall Study|Death|0|||
156677087|NCT01968031|565561041|FG001|Overall Study|Death|0|||
156677088|NCT01968031|565561042|FG002|Overall Study|Death|1|||
156677089|NCT01968031|565561040|FG000|Overall Study|Prohibited concomitant medication|1|||
156677090|NCT01968031|565561041|FG001|Overall Study|Prohibited concomitant medication|0|||
156677091|NCT01968031|565561042|FG002|Overall Study|Prohibited concomitant medication|0|||
156677092|NCT00840879|565561043|FG000|Second Intervention|Withdrawal by Subject|1|||
156677093|NCT00840879|565561044|FG001|Second Intervention|Withdrawal by Subject|0|||
156677094|NCT04573309|565562575|FG000|Overall Study|Protocol Violation|1|||
156677095|NCT04573309|565562576|FG001|Overall Study|Protocol Violation|0|||
156677096|NCT01691430|565562577|FG000|Overall Study|Death|17|||
156677097|NCT01691430|565562578|FG001|Overall Study|Death|16|||
156677098|NCT01691430|565562577|FG000|Overall Study|Withdrawal by Subject|5|||
156677099|NCT01691430|565562578|FG001|Overall Study|Withdrawal by Subject|1|||
156677100|NCT01691430|565562577|FG000|Overall Study|Lost to Follow-up|0|||
156677101|NCT01691430|565562578|FG001|Overall Study|Lost to Follow-up|3|||
156677102|NCT01894230|565562579|FG000|Overall Study|Lost to Follow-up|2|||
156677103|NCT01894230|565562580|FG001|Overall Study|Lost to Follow-up|2|||
156677104|NCT01894230|565562579|FG000|Overall Study|Withdrawal by Subject|4|||
156677105|NCT01894230|565562580|FG001|Overall Study|Withdrawal by Subject|4|||
156677106|NCT01894230|565562579|FG000|Overall Study|Non-adherent|0|||
156677107|NCT01894230|565562580|FG001|Overall Study|Non-adherent|1|||
156677108|NCT01894230|565562579|FG000|Overall Study|Death|1|||
156677109|NCT01894230|565562580|FG001|Overall Study|Death|0|||
156677110|NCT00642993|565562581|FG000|Overall Study|Adverse Event|85|||
156677111|NCT00642993|565562582|FG001|Overall Study|Adverse Event|4|||
156677112|NCT00642993|565562581|FG000|Overall Study|Lost to Follow-up|8|||
156677113|NCT00642993|565562582|FG001|Overall Study|Lost to Follow-up|4|||
156677114|NCT00642993|565562581|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
156677115|NCT00642993|565562582|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
156677116|NCT00642993|565562581|FG000|Overall Study|Protocol Violation|1|||
156677117|NCT00642993|565562582|FG001|Overall Study|Protocol Violation|4|||
156677118|NCT00642993|565562581|FG000|Overall Study|Did not meet protocol eligibility|0|||
156677119|NCT00642993|565562582|FG001|Overall Study|Did not meet protocol eligibility|1|||
156328591|NCT02949700|564303311|FG003|Phase I|Withdrawal by Subject|0|||
156677120|NCT00642993|565562581|FG000|Overall Study|Administrative|1|||
156677121|NCT00642993|565562582|FG001|Overall Study|Administrative|0|||
156677122|NCT00757705|565562583|FG000|Overall Study|Adverse Event|19|||
156677123|NCT00757705|565562583|FG000|Overall Study|Lost to Follow-up|16|||
156677124|NCT00757705|565562583|FG000|Overall Study|Withdrawal by Subject|25|||
156677125|NCT00757705|565562583|FG000|Overall Study|Insufficient Response|26|||
156677126|NCT00757705|565562583|FG000|Overall Study|Ineligible to continue|8|||
156677127|NCT00757705|565562583|FG000|Overall Study|Non-compliant|9|||
156677128|NCT00757705|565562583|FG000|Overall Study|Other|18|||
156677129|NCT02651987|565562584|FG000|Overall Study|Adverse Event|2|||
156677130|NCT02651987|565562585|FG001|Overall Study|Adverse Event|2|||
156677131|NCT02651987|565562584|FG000|Overall Study|Consent Withdrawn|2|||
156677132|NCT02651987|565562585|FG001|Overall Study|Consent Withdrawn|0|||
156677133|NCT02651987|565562584|FG000|Overall Study|Local PD|0|||
156677134|NCT02651987|565562585|FG001|Overall Study|Local PD|2|||
156677135|NCT02651987|565562584|FG000|Overall Study|Investigator Decision|1|||
156677136|NCT02651987|565562585|FG001|Overall Study|Investigator Decision|1|||
156677137|NCT00856349|565562586|FG000|Overall Study|Death|418|||
156677138|NCT00856349|565562586|FG000|Overall Study|Withdrawal by Subject|116|||
156677139|NCT00856349|565562586|FG000|Overall Study|Lost to Follow-up|91|||
156677140|NCT00856349|565562586|FG000|Overall Study|Protocol Violation|38|||
156677141|NCT00856349|565562586|FG000|Overall Study|Physician Decision|13|||
156677142|NCT00856349|565562586|FG000|Overall Study|Subject relocation|104|||
156677143|NCT00856349|565562586|FG000|Overall Study|Device explant|33|||
156677144|NCT00856349|565562586|FG000|Overall Study|Site closure|78|||
156677145|NCT00856349|565562586|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
156677146|NCT00687739|565562587|FG000|Overall Study|Lost to Follow-up|2|||
156677147|NCT00687739|565562588|FG001|Overall Study|Lost to Follow-up|2|||
156677148|NCT00687739|565562589|FG002|Overall Study|Lost to Follow-up|1|||
156677149|NCT00687739|565562590|FG003|Overall Study|Lost to Follow-up|2|||
156677150|NCT00687739|565562587|FG000|Overall Study|Adverse Event|0|||
156677151|NCT00687739|565562588|FG001|Overall Study|Adverse Event|1|||
156677152|NCT00687739|565562589|FG002|Overall Study|Adverse Event|1|||
156677153|NCT00687739|565562590|FG003|Overall Study|Adverse Event|0|||
156677154|NCT03599362|565562595|FG000|Overall Study|Screen Failure|3|||
156677155|NCT01923740|565562596|FG000|Overall Study|Lost to Follow-up|4|||
156677156|NCT01923740|565562597|FG001|Overall Study|Lost to Follow-up|9|||
156677157|NCT01923740|565562596|FG000|Overall Study|Withdrawal by Subject|2|||
156677158|NCT01923740|565562597|FG001|Overall Study|Withdrawal by Subject|0|||
156677159|NCT03707587|565562598|FG000|Overall Study|Death|0|||
156677160|NCT03707587|565562599|FG001|Overall Study|Death|1|||
156677161|NCT00834444|565562602|FG000|First Intervention|Adverse Event|1|||
156677162|NCT00834444|565562603|FG001|First Intervention|Adverse Event|0|||
156677163|NCT00834444|565562602|FG000|First Intervention|Intolerance to Venopuncture|0|||
156677164|NCT00834444|565562603|FG001|First Intervention|Intolerance to Venopuncture|1|||
156677165|NCT00834444|565562602|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
156677166|NCT00834444|565562603|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
156677167|NCT00834444|565562602|FG000|Second Intervention|Adverse Event|1|||
156677168|NCT00834444|565562603|FG001|Second Intervention|Adverse Event|0|||
156677169|NCT02072096|565562606|FG000|Overall Study|Lack of Efficacy|18|||
156677170|NCT02072096|565562607|FG001|Overall Study|Lack of Efficacy|29|||
156677171|NCT02072096|565562606|FG000|Overall Study|Protocol Violation|7|||
156677172|NCT02072096|565562607|FG001|Overall Study|Protocol Violation|7|||
156677173|NCT02072096|565562606|FG000|Overall Study|Withdrawal by Subject|5|||
156677174|NCT02072096|565562607|FG001|Overall Study|Withdrawal by Subject|7|||
156677175|NCT02072096|565562606|FG000|Overall Study|Adverse Event|5|||
156677176|NCT02072096|565562607|FG001|Overall Study|Adverse Event|2|||
156677177|NCT02072096|565562606|FG000|Overall Study|No Reason Provided|4|||
156677178|NCT02072096|565562607|FG001|Overall Study|No Reason Provided|2|||
156677179|NCT02072096|565562606|FG000|Overall Study|Death|2|||
156677180|NCT02072096|565562607|FG001|Overall Study|Death|0|||
156677181|NCT02072096|565562606|FG000|Overall Study|Physician Decision|0|||
156677182|NCT02072096|565562607|FG001|Overall Study|Physician Decision|1|||
156677183|NCT02072096|565562606|FG000|Overall Study|Study Terminated by Sponsor|43|||
156677184|NCT02072096|565562607|FG001|Overall Study|Study Terminated by Sponsor|30|||
156677185|NCT02072096|565562606|FG000|Overall Study|Lost to Follow-up|1|||
156781821|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
156677186|NCT02072096|565562607|FG001|Overall Study|Lost to Follow-up|0|||
156677187|NCT03158727|565562608|FG000|Overall Study|Withdrawal by Subject|2|||
156781822|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
156677188|NCT03158727|565562609|FG001|Overall Study|Withdrawal by Subject|6|||
156677189|NCT03158727|565562608|FG000|Overall Study|Death|11|||
156677190|NCT03158727|565562609|FG001|Overall Study|Death|12|||
156677191|NCT03158727|565562608|FG000|Overall Study|Lost to Follow-up|1|||
156677192|NCT03158727|565562609|FG001|Overall Study|Lost to Follow-up|0|||
156677193|NCT03158727|565562608|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
156781823|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
156677194|NCT03158727|565562609|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
156677195|NCT03158727|565562608|FG000|Overall Study|Visit 11 not done by mistake|0|||
156677196|NCT03158727|565562609|FG001|Overall Study|Visit 11 not done by mistake|1|||
156328592|NCT02949700|564303308|FG000|Phase I|Protocol Violation|1|||
156677197|NCT03158727|565562608|FG000|Overall Study|Enrolled, not treated|1|||
156677198|NCT03158727|565562609|FG001|Overall Study|Enrolled, not treated|0|||
156677199|NCT01634139|565562610|FG000|Overall Study|Non compliant with protocol|1|||
156677200|NCT01634139|565562611|FG001|Overall Study|Non compliant with protocol|0|||
156677201|NCT01634139|565562612|FG002|Overall Study|Non compliant with protocol|0|||
156677202|NCT01634139|565562610|FG000|Overall Study|Consent withdrawn not due to AE|4|||
156677203|NCT01634139|565562611|FG001|Overall Study|Consent withdrawn not due to AE|3|||
156677204|NCT01634139|565562612|FG002|Overall Study|Consent withdrawn not due to AE|2|||
156677205|NCT01634139|565562610|FG000|Overall Study|Other|4|||
156677206|NCT01634139|565562611|FG001|Overall Study|Other|0|||
156866612|NCT00129402|566271287|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156328593|NCT02949700|564303309|FG001|Phase I|Protocol Violation|0|||
156677207|NCT01634139|565562612|FG002|Overall Study|Other|3|||
156677208|NCT01634139|565562610|FG000|Overall Study|Lost to Follow-up|0|||
156677209|NCT01634139|565562611|FG001|Overall Study|Lost to Follow-up|2|||
156677210|NCT01634139|565562612|FG002|Overall Study|Lost to Follow-up|0|||
156677211|NCT01634139|565562610|FG000|Overall Study|Not treated|1|||
156677212|NCT01634139|565562611|FG001|Overall Study|Not treated|1|||
156677213|NCT01634139|565562612|FG002|Overall Study|Not treated|0|||
156677214|NCT02336074|565562628|FG000|Overall Study|Adverse Event|0|||
156677215|NCT02336074|565562629|FG001|Overall Study|Adverse Event|2|||
156677216|NCT00958724|565562630|FG000|Overall Study|Disease Progression|6|||
156677217|NCT02121184|565562632|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
156677218|NCT02121184|565562633|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
156677219|NCT02121184|565562632|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
156677220|NCT02121184|565562633|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
156677221|NCT02121184|565562632|FG000|Overall Study|Emergency cesarean section required|0|||
156677222|NCT02121184|565562633|FG001|Overall Study|Emergency cesarean section required|2|||
156677223|NCT02121184|565562632|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
156677224|NCT02121184|565562633|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
156677225|NCT04567329|565562639|FG000|Overall Study|Withdrawal by Subject|5|||
156677226|NCT04567329|565562640|FG001|Overall Study|Withdrawal by Subject|6|||
156677227|NCT04567329|565562639|FG000|Overall Study|Protocol Violation|2|||
156677228|NCT04567329|565562640|FG001|Overall Study|Protocol Violation|3|||
156677229|NCT04567329|565562639|FG000|Overall Study|Discontinued|2|||
156677230|NCT04567329|565562640|FG001|Overall Study|Discontinued|2|||
156677231|NCT04567329|565562639|FG000|Overall Study|Lost to Follow-up|0|||
156677232|NCT04567329|565562640|FG001|Overall Study|Lost to Follow-up|1|||
156677233|NCT04567329|565562639|FG000|Overall Study|Lack of Efficacy|0|||
156677234|NCT04567329|565562640|FG001|Overall Study|Lack of Efficacy|1|||
156677235|NCT02933060|565562641|FG000|Overall Study|Withdrawal by Subject|0|||
156677236|NCT02933060|565562642|FG001|Overall Study|Withdrawal by Subject|1|||
156677237|NCT01945580|565562643|FG000|Overall Study|Withdrawal by Subject|13|||
156677238|NCT01945580|565562644|FG001|Overall Study|Withdrawal by Subject|35|||
156677239|NCT01945580|565562643|FG000|Overall Study|Physician Decision|3|||
156677240|NCT01945580|565562644|FG001|Overall Study|Physician Decision|2|||
156677241|NCT01945580|565562643|FG000|Overall Study|Lost to Follow-up|26|||
156677242|NCT01945580|565562644|FG001|Overall Study|Lost to Follow-up|39|||
156677243|NCT01945580|565562643|FG000|Overall Study|Death|7|||
156677244|NCT01945580|565562644|FG001|Overall Study|Death|2|||
156677245|NCT01945580|565562643|FG000|Overall Study|Patient moved out of state|0|||
156677246|NCT01945580|565562644|FG001|Overall Study|Patient moved out of state|1|||
156677247|NCT01945580|565562643|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
156677248|NCT01945580|565562644|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
156677249|NCT01945580|565562643|FG000|Overall Study|Family illness - unable to return|0|||
156677250|NCT01945580|565562644|FG001|Overall Study|Family illness - unable to return|1|||
156677251|NCT01945580|565562643|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
156677252|NCT01945580|565562644|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
156677253|NCT01945580|565562643|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
156677254|NCT01945580|565562644|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
156677255|NCT01945580|565562643|FG000|Overall Study|Noncompliance with 36 month visit|1|||
156677256|NCT01945580|565562644|FG001|Overall Study|Noncompliance with 36 month visit|0|||
156677257|NCT01945580|565562643|FG000|Overall Study|The patient moved.|1|||
156677258|NCT01945580|565562644|FG001|Overall Study|The patient moved.|0|||
156677259|NCT01945580|565562643|FG000|Overall Study|No data available|0|||
156677260|NCT01945580|565562644|FG001|Overall Study|No data available|2|||
156677261|NCT03306277|565562646|FG000|Overall Study|Death|1|||
156677262|NCT03306277|565562646|FG000|Overall Study|Adverse Event|1|||
156677263|NCT03306277|565562646|FG000|Overall Study|Withdrawal by Subject|1|||
156677264|NCT00829452|565562650|FG000|First Intervention|Withdrawal by Subject|0|||
156328594|NCT02949700|564303310|FG002|Phase I|Protocol Violation|0|||
156677265|NCT00829452|565562651|FG001|First Intervention|Withdrawal by Subject|1|||
156677266|NCT00829452|565562650|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
156677267|NCT00829452|565562651|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
156677268|NCT00829452|565562650|FG000|Second Intervention|Physician Decision|0|||
156677269|NCT00829452|565562651|FG001|Second Intervention|Physician Decision|1|||
156677270|NCT01370863|565562658|FG000|Overall Study|Adverse Event|1|||
156677271|NCT01370863|565562659|FG001|Overall Study|Adverse Event|1|||
156677272|NCT01370863|565562658|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
156677273|NCT01370863|565562659|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
156677274|NCT01370863|565562658|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
156677275|NCT01370863|565562659|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
156677276|NCT00881751|565562662|FG000|Overall Study|Physician Decision|0|||
156677277|NCT00881751|565562663|FG001|Overall Study|Physician Decision|1|||
156677278|NCT00881751|565562662|FG000|Overall Study|Adverse Event|0|||
156677279|NCT00881751|565562663|FG001|Overall Study|Adverse Event|2|||
156677280|NCT00881751|565562662|FG000|Overall Study|Withdrawal by Subject|0|||
156677281|NCT00881751|565562663|FG001|Overall Study|Withdrawal by Subject|2|||
156677282|NCT03885934|565562670|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
156677283|NCT03885934|565562671|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
156677284|NCT03885934|565562672|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
156677285|NCT03885934|565562673|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
156677286|NCT03885934|565562674|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
156677287|NCT03885934|565562675|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
156677288|NCT04060251|565562676|FG000|Overall Study|Study terminated due to low enrollment.|7|||
156677289|NCT04060251|565562677|FG001|Overall Study|Study terminated due to low enrollment.|5|||
156677290|NCT04060251|565562678|FG002|Overall Study|Study terminated due to low enrollment.|7|||
156677291|NCT04060251|565562676|FG000|Overall Study|Adverse Event|1|||
156677292|NCT04060251|565562677|FG001|Overall Study|Adverse Event|1|||
156677293|NCT04060251|565562678|FG002|Overall Study|Adverse Event|0|||
156677294|NCT00999687|565562685|FG000|First Intervention|Withdrawal by Subject|1|||
156677295|NCT00999687|565562685|FG000|Second Intervention|Withdrawal by Subject|2|||
156677296|NCT00999687|565562685|FG000|Second Intervention|Lack of Efficacy|1|||
156677297|NCT00842309|565562688|FG000|Overall Study|Withdrawal by Subject|3|||
156677298|NCT00842309|565562689|FG001|Overall Study|Withdrawal by Subject|1|||
156677299|NCT03105297|565562690|FG000|Baseline Phase (Day 1)|Other|21|||
156677300|NCT03105297|565562690|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
156677301|NCT03105297|565562690|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
156677302|NCT01390948|565562691|FG000|Overall Study|End of Study|1|||
156677303|NCT01390948|565562692|FG001|Overall Study|End of Study|0|||
156677304|NCT01390948|565562693|FG002|Overall Study|End of Study|0|||
156677305|NCT01390948|565562691|FG000|Overall Study|Withdrew consent|2|||
156677306|NCT01390948|565562692|FG001|Overall Study|Withdrew consent|2|||
156677307|NCT01390948|565562693|FG002|Overall Study|Withdrew consent|0|||
156677308|NCT01390948|565562691|FG000|Overall Study|Progressive Disease|2|||
156677309|NCT01390948|565562692|FG001|Overall Study|Progressive Disease|5|||
156677310|NCT01390948|565562693|FG002|Overall Study|Progressive Disease|0|||
156677311|NCT01390948|565562691|FG000|Overall Study|Death during follow-up|10|||
156677312|NCT01390948|565562692|FG001|Overall Study|Death during follow-up|11|||
156677313|NCT01390948|565562693|FG002|Overall Study|Death during follow-up|1|||
156677314|NCT02218216|565562698|FG000|Overall Study|Study terminated before completed|6|||
156677315|NCT02218216|565562699|FG001|Overall Study|Study terminated before completed|0|||
156677316|NCT02218216|565562700|FG002|Overall Study|Study terminated before completed|0|||
156677317|NCT05740098|565562703|FG000|Overall Study|Lost to Follow-up|26|||
156677318|NCT05740098|565562704|FG001|Overall Study|Lost to Follow-up|17|||
156677319|NCT05740098|565562705|FG002|Overall Study|Lost to Follow-up|21|||
156677320|NCT03867760|565562706|FG000|Overall Study|Lost to Follow-up|2|||
156677321|NCT03867760|565562707|FG001|Overall Study|Lost to Follow-up|3|||
156677322|NCT03867760|565562706|FG000|Overall Study|Withdrawal by Subject|1|||
156677323|NCT03867760|565562707|FG001|Overall Study|Withdrawal by Subject|2|||
156677324|NCT03867760|565562706|FG000|Overall Study|subject could not meet study logistics|3|||
156677325|NCT03867760|565562707|FG001|Overall Study|subject could not meet study logistics|3|||
156677326|NCT03684928|565562711|FG000|First Intervention|Lost to Follow-up|0|||
156677327|NCT03684928|565562712|FG001|First Intervention|Lost to Follow-up|1|||
156677328|NCT03684928|565562711|FG000|First Intervention|Withdrawal by Subject|0|||
156677329|NCT03684928|565562712|FG001|First Intervention|Withdrawal by Subject|2|||
156677330|NCT03684928|565562711|FG000|Second Intervention|Soft Tissue Injury|1|||
156677331|NCT03684928|565562712|FG001|Second Intervention|Soft Tissue Injury|0|||
156677332|NCT02300987|565564175|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
156677333|NCT02300987|565564176|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
156677334|NCT02300987|565564175|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
156677335|NCT02300987|565564176|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
156677336|NCT02300987|565564175|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
156677337|NCT02300987|565564176|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
156677338|NCT02300987|565564175|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
156677339|NCT02300987|565564176|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
156677340|NCT02300987|565564175|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
156677341|NCT02300987|565564176|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
156677342|NCT02219009|565564177|FG000|Overall Study|Withdrawal by Subject|5|||
156677343|NCT02219009|565564178|FG001|Overall Study|Withdrawal by Subject|1|||
156677344|NCT02219009|565564177|FG000|Overall Study|Adverse Event|2|||
156677345|NCT02219009|565564178|FG001|Overall Study|Adverse Event|4|||
156677346|NCT02219009|565564177|FG000|Overall Study|Lost to Follow-up|2|||
156677347|NCT02219009|565564178|FG001|Overall Study|Lost to Follow-up|2|||
156677348|NCT02219009|565564177|FG000|Overall Study|Protocol deviation|1|||
156677349|NCT02219009|565564178|FG001|Overall Study|Protocol deviation|0|||
156677350|NCT02219009|565564177|FG000|Overall Study|Physician Decision|0|||
156677351|NCT02219009|565564178|FG001|Overall Study|Physician Decision|1|||
156677352|NCT00660387|565564179|FG000|Overall Study|Adverse Event|1|||
156677353|NCT00660387|565564180|FG001|Overall Study|Adverse Event|2|||
156677354|NCT00660387|565564179|FG000|Overall Study|Lack of Efficacy|0|||
156677355|NCT00660387|565564180|FG001|Overall Study|Lack of Efficacy|1|||
156677356|NCT00660387|565564179|FG000|Overall Study|Protocol Violation|1|||
156677357|NCT00660387|565564180|FG001|Overall Study|Protocol Violation|0|||
156677358|NCT03086135|565564181|FG000|Overall Study|Adverse Event|1|||
156677359|NCT03086135|565564181|FG000|Overall Study|Lost to Follow-up|2|||
156677360|NCT02259348|565564182|FG000|Overall Study|Donors|6|||
156677361|NCT02259348|565564182|FG000|Overall Study|Death|4|||
156677362|NCT01622660|565564183|FG000|Overall Study|Adverse Event|1|||
156677363|NCT04211766|565564184|FG000|Overall Study|Withdrawal by Subject|5|||
156677364|NCT04211766|565564185|FG001|Overall Study|Withdrawal by Subject|1|||
156677365|NCT00960154|565564186|FG000|Overall Study|Study termination|25|||
156677366|NCT00960154|565564187|FG001|Overall Study|Study termination|25|||
156677367|NCT04408924|565564191|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
156677368|NCT04408924|565564191|FG000|Overall Study|Lost to Follow-up|3|||
156677369|NCT04408924|565564191|FG000|Overall Study|Withdrawal by Subject|5|||
156677370|NCT04408924|565564191|FG000|Overall Study|Sponsor Decision|2|||
156677371|NCT00486434|565564192|FG000|Overall Study|Withdrawal by Subject|34|||
156677372|NCT00486434|565564193|FG001|Overall Study|Withdrawal by Subject|39|||
156677373|NCT00486434|565564192|FG000|Overall Study|Adverse Event|118|||
156677374|NCT00486434|565564193|FG001|Overall Study|Adverse Event|44|||
156677375|NCT00486434|565564192|FG000|Overall Study|Protocol Violation|22|||
156677376|NCT00486434|565564193|FG001|Overall Study|Protocol Violation|21|||
156677377|NCT00486434|565564192|FG000|Overall Study|Lack of Efficacy|12|||
156677378|NCT00486434|565564193|FG001|Overall Study|Lack of Efficacy|19|||
156677379|NCT00486434|565564192|FG000|Overall Study|Lost to Follow-up|2|||
156677380|NCT00486434|565564193|FG001|Overall Study|Lost to Follow-up|3|||
156677381|NCT00486434|565564192|FG000|Overall Study|Death|1|||
156677382|NCT00486434|565564193|FG001|Overall Study|Death|2|||
156677383|NCT00486434|565564192|FG000|Overall Study|Personal reasons|5|||
156677384|NCT00486434|565564193|FG001|Overall Study|Personal reasons|6|||
156677385|NCT02218541|565564194|FG000|Overall Study|Lost to Follow-up|2|||
156677386|NCT02218541|565564195|FG001|Overall Study|Lost to Follow-up|1|||
156677387|NCT02218541|565564194|FG000|Overall Study|Implant Failure|4|||
156677388|NCT02218541|565564195|FG001|Overall Study|Implant Failure|1|||
156677389|NCT02578641|565564196|FG000|Overall Study|Adverse Event|5|||
156677390|NCT02578641|565564197|FG001|Overall Study|Adverse Event|15|||
156677391|NCT02578641|565564196|FG000|Overall Study|Death|16|||
156677392|NCT02578641|565564197|FG001|Overall Study|Death|8|||
156677393|NCT02578641|565564196|FG000|Overall Study|Lost to Follow-up|0|||
156677394|NCT02578641|565564197|FG001|Overall Study|Lost to Follow-up|1|||
156677395|NCT02578641|565564196|FG000|Overall Study|Withdrawal by Subject|14|||
156677396|NCT02578641|565564197|FG001|Overall Study|Withdrawal by Subject|7|||
156677397|NCT02578641|565564196|FG000|Overall Study|Progressive Disease|69|||
156677398|NCT02578641|565564197|FG001|Overall Study|Progressive Disease|21|||
156677399|NCT02578641|565564196|FG000|Overall Study|No Study Drug|2|||
156677400|NCT02578641|565564197|FG001|Overall Study|No Study Drug|0|||
156677401|NCT02578641|565564196|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
156677402|NCT02578641|565564197|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
156677403|NCT02578641|565564196|FG000|Overall Study|Non-compliance with Study Schedule|1|||
156781824|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
156677404|NCT02578641|565564197|FG001|Overall Study|Non-compliance with Study Schedule|0|||
156677405|NCT02578641|565564196|FG000|Overall Study|Other|1|||
156677406|NCT02578641|565564197|FG001|Overall Study|Other|10|||
156677407|NCT02578641|565564196|FG000|Overall Study|Not treated|1|||
156677408|NCT02578641|565564197|FG001|Overall Study|Not treated|4|||
156677409|NCT02694536|565564199|FG000|Overall Study|Progressive Disease|40|||
156677410|NCT02694536|565564199|FG000|Overall Study|Lost to Follow-up|1|||
156677411|NCT02694536|565564199|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
156677412|NCT02694536|565564199|FG000|Overall Study|Withdrawal by Subject|8|||
156677413|NCT02694536|565564199|FG000|Overall Study|Death|8|||
156677414|NCT02694536|565564199|FG000|Overall Study|Other|22|||
156677415|NCT01266902|565564203|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
156781825|NCT03677401|565951505|FG000|Overall Study|Adverse Event|4|||
156677416|NCT01266902|565564204|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
156677417|NCT01266902|565564205|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
156677418|NCT01266902|565564203|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
156677419|NCT01266902|565564204|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
156677420|NCT01266902|565564205|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
156677421|NCT01266902|565564203|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
156677422|NCT01266902|565564204|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
156677423|NCT01266902|565564205|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
156677424|NCT01266902|565564203|FG000|Period 1 (Main Study)|Adverse Event|3|||
156677425|NCT01266902|565564204|FG001|Period 1 (Main Study)|Adverse Event|11|||
156677426|NCT01266902|565564205|FG002|Period 1 (Main Study)|Adverse Event|0|||
156677427|NCT01266902|565564203|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
156677428|NCT01266902|565564204|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
156677429|NCT01266902|565564205|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
156677430|NCT01266902|565564203|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
156677431|NCT01266902|565564204|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
156677432|NCT01266902|565564205|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
156677433|NCT01266902|565564203|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
156677434|NCT01266902|565564204|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
156677435|NCT01266902|565564205|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
156677436|NCT01266902|565564203|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
156677437|NCT01266902|565564204|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
156677438|NCT01266902|565564205|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
156677439|NCT01266902|565564203|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
156677440|NCT01266902|565564204|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
156677441|NCT01266902|565564205|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
156677442|NCT01266902|565564203|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
156677443|NCT01266902|565564204|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
156677444|NCT01266902|565564205|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
156677445|NCT05562011|565564206|FG000|Overall Study|Withdrawal by Subject|3|||
156677446|NCT05562011|565564206|FG000|Overall Study|Lost to Follow-up|1|||
156677447|NCT05562011|565564206|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
156677448|NCT05562011|565564206|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
156677449|NCT05562011|565564206|FG000|Overall Study|Device malfunction|13|||
156677450|NCT04411680|565564207|FG000|Treatment Period|Adverse Event|3|||
156677451|NCT04411680|565564208|FG001|Treatment Period|Adverse Event|0|||
156677452|NCT04411680|565564207|FG000|Treatment Period|Discharged from hospital|18|||
156677453|NCT04411680|565564208|FG001|Treatment Period|Discharged from hospital|7|||
156677454|NCT04411680|565564207|FG000|Treatment Period|Missed 1 or more doses|8|||
156677455|NCT04411680|565564208|FG001|Treatment Period|Missed 1 or more doses|0|||
156677456|NCT04411680|565564207|FG000|Treatment Period|Transferred to another hospital|0|||
156677457|NCT04411680|565564208|FG001|Treatment Period|Transferred to another hospital|1|||
156677458|NCT04411680|565564207|FG000|Follow up Period|Withdrawal by Subject|2|||
156677459|NCT04411680|565564208|FG001|Follow up Period|Withdrawal by Subject|0|||
156677460|NCT04411680|565564207|FG000|Follow up Period|Lost to Follow-up|5|||
156677461|NCT04411680|565564208|FG001|Follow up Period|Lost to Follow-up|6|||
156677462|NCT04411680|565564207|FG000|Follow up Period|Death|11|||
156677463|NCT04411680|565564208|FG001|Follow up Period|Death|8|||
156677464|NCT05034874|565564209|FG000|Overall Study|Withdrawal by Subject|6|||
156677465|NCT05034874|565564210|FG001|Overall Study|Withdrawal by Subject|6|||
156677466|NCT05034874|565564209|FG000|Overall Study|Lost to Follow-up|18|||
156677467|NCT05034874|565564210|FG001|Overall Study|Lost to Follow-up|8|||
156677468|NCT05034874|565564209|FG000|Overall Study|Physician Decision|0|||
156677469|NCT05034874|565564210|FG001|Overall Study|Physician Decision|1|||
156677470|NCT05034874|565564209|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
156677471|NCT05034874|565564210|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
156677472|NCT03101358|565564211|FG000|Overall Study|Non-compliance with study schedule|1|||
156677473|NCT03101358|565564212|FG001|Overall Study|Non-compliance with study schedule|0|||
156677474|NCT03101358|565564213|FG002|Overall Study|Non-compliance with study schedule|0|||
156677475|NCT03101358|565564214|FG003|Overall Study|Non-compliance with study schedule|1|||
156677476|NCT03101358|565564211|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
156677477|NCT03101358|565564212|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
156677478|NCT03101358|565564213|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
156677479|NCT03101358|565564214|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
156328595|NCT02949700|564303311|FG003|Phase I|Protocol Violation|0|||
156677480|NCT03101358|565564211|FG000|Overall Study|Physician Decision|1|||
156677481|NCT03101358|565564212|FG001|Overall Study|Physician Decision|0|||
156677482|NCT03101358|565564213|FG002|Overall Study|Physician Decision|0|||
156677483|NCT03101358|565564214|FG003|Overall Study|Physician Decision|3|||
156677484|NCT03101358|565564211|FG000|Overall Study|Adverse Event|0|||
156677485|NCT03101358|565564212|FG001|Overall Study|Adverse Event|0|||
156677486|NCT03101358|565564213|FG002|Overall Study|Adverse Event|1|||
156677487|NCT03101358|565564214|FG003|Overall Study|Adverse Event|0|||
156677488|NCT03101358|565564211|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
156677489|NCT03101358|565564212|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
156677490|NCT03101358|565564213|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
156677491|NCT03101358|565564214|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
156677492|NCT03101358|565564211|FG000|Overall Study|Lost to Follow-up|1|||
156677493|NCT03101358|565564212|FG001|Overall Study|Lost to Follow-up|0|||
156677494|NCT03101358|565564213|FG002|Overall Study|Lost to Follow-up|0|||
156529076|NCT00960531|565031062|FG003|Overall Study|Withdrawal by Subject|2|||
156529077|NCT00960531|565031063|FG004|Overall Study|Withdrawal by Subject|0|||
156529078|NCT00960531|565031064|FG005|Overall Study|Withdrawal by Subject|0|||
156529079|NCT00960531|565031065|FG006|Overall Study|Withdrawal by Subject|2|||
156677495|NCT03101358|565564214|FG003|Overall Study|Lost to Follow-up|1|||
156677496|NCT00474058|565564215|FG000|Overall Study|Adverse Event|11|||
156677497|NCT00474058|565564216|FG001|Overall Study|Adverse Event|6|||
156677498|NCT00474058|565564215|FG000|Overall Study|Lack of Efficacy|0|||
156677499|NCT00474058|565564216|FG001|Overall Study|Lack of Efficacy|4|||
156677500|NCT00474058|565564215|FG000|Overall Study|Withdrawal by Subject|11|||
156677501|NCT00474058|565564216|FG001|Overall Study|Withdrawal by Subject|7|||
156677502|NCT00474058|565564215|FG000|Overall Study|Other|2|||
156677503|NCT00474058|565564216|FG001|Overall Study|Other|0|||
156677504|NCT02640235|565564217|FG000|Overall Study|Withdrawal by Subject|7|||
156677505|NCT02640235|565564218|FG001|Overall Study|Withdrawal by Subject|6|||
156677506|NCT02640235|565564217|FG000|Overall Study|Lost to Follow-up|4|||
156677507|NCT02640235|565564218|FG001|Overall Study|Lost to Follow-up|3|||
156677508|NCT02640235|565564217|FG000|Overall Study|Death|2|||
156677509|NCT02640235|565564218|FG001|Overall Study|Death|3|||
156677510|NCT02640235|565564217|FG000|Overall Study|Other|1|||
156677511|NCT02640235|565564218|FG001|Overall Study|Other|2|||
156677512|NCT02426918|565564219|FG000|Overall Study|Adverse Event|2|||
156677513|NCT02426918|565564220|FG001|Overall Study|Adverse Event|2|||
156677514|NCT02426918|565564221|FG002|Overall Study|Adverse Event|0|||
156677515|NCT02426918|565564219|FG000|Overall Study|Physician Decision|1|||
156677516|NCT02426918|565564220|FG001|Overall Study|Physician Decision|1|||
156677517|NCT02426918|565564221|FG002|Overall Study|Physician Decision|1|||
156677518|NCT02426918|565564219|FG000|Overall Study|Withdrawal by Subject|5|||
156677519|NCT02426918|565564220|FG001|Overall Study|Withdrawal by Subject|5|||
156677520|NCT02426918|565564221|FG002|Overall Study|Withdrawal by Subject|4|||
156677521|NCT02426918|565564219|FG000|Overall Study|Other|9|||
156677522|NCT02426918|565564220|FG001|Overall Study|Other|11|||
156677523|NCT02426918|565564221|FG002|Overall Study|Other|9|||
156677524|NCT01496118|565564222|FG000|Overall Study|Disease progression|3|||
156677525|NCT01496118|565564223|FG001|Overall Study|Disease progression|2|||
156677526|NCT01496118|565564224|FG002|Overall Study|Disease progression|3|||
156677527|NCT01496118|565564225|FG003|Overall Study|Disease progression|1|||
156677528|NCT01496118|565564226|FG004|Overall Study|Disease progression|2|||
156677529|NCT01496118|565564227|FG005|Overall Study|Disease progression|2|||
156677530|NCT01496118|565564228|FG006|Overall Study|Disease progression|14|||
156781826|NCT03677401|565951506|FG001|Overall Study|Adverse Event|14|||
156781827|NCT03677401|565951505|FG000|Overall Study|Lack of Efficacy|3|||
156781828|NCT03677401|565951506|FG001|Overall Study|Lack of Efficacy|1|||
156781829|NCT03677401|565951505|FG000|Overall Study|Withdrawal by Subject|2|||
156781830|NCT03677401|565951506|FG001|Overall Study|Withdrawal by Subject|2|||
156781831|NCT03677401|565951505|FG000|Overall Study|Sponsor decision|0|||
156781832|NCT03677401|565951506|FG001|Overall Study|Sponsor decision|1|||
156781833|NCT03677401|565951505|FG000|Overall Study|Reason Unspecified|1|||
156781834|NCT03677401|565951506|FG001|Overall Study|Reason Unspecified|0|||
156781835|NCT03927157|565951508|FG000|Overall Study|Adverse Event|1|||
156781836|NCT03927157|565951509|FG001|Overall Study|Adverse Event|3|||
156781837|NCT03927157|565951508|FG000|Overall Study|Protocol Violation|1|||
156677531|NCT01496118|565564229|FG007|Overall Study|Disease progression|10|||
156677532|NCT01496118|565564222|FG000|Overall Study|Physician Decision|0|||
156677533|NCT01496118|565564223|FG001|Overall Study|Physician Decision|0|||
156677534|NCT01496118|565564224|FG002|Overall Study|Physician Decision|0|||
156677535|NCT01496118|565564225|FG003|Overall Study|Physician Decision|0|||
156677536|NCT01496118|565564226|FG004|Overall Study|Physician Decision|1|||
156677537|NCT01496118|565564227|FG005|Overall Study|Physician Decision|0|||
156677538|NCT01496118|565564228|FG006|Overall Study|Physician Decision|3|||
156677539|NCT01496118|565564229|FG007|Overall Study|Physician Decision|6|||
156677540|NCT01496118|565564222|FG000|Overall Study|Adverse Event|1|||
156781838|NCT03927157|565951509|FG001|Overall Study|Protocol Violation|2|||
156781839|NCT03927157|565951508|FG000|Overall Study|Withdrawal by Subject|8|||
156677541|NCT01496118|565564223|FG001|Overall Study|Adverse Event|1|||
156677542|NCT01496118|565564224|FG002|Overall Study|Adverse Event|0|||
156677543|NCT01496118|565564225|FG003|Overall Study|Adverse Event|0|||
156677544|NCT01496118|565564226|FG004|Overall Study|Adverse Event|0|||
156677545|NCT01496118|565564227|FG005|Overall Study|Adverse Event|0|||
156677546|NCT01496118|565564228|FG006|Overall Study|Adverse Event|6|||
156677547|NCT01496118|565564229|FG007|Overall Study|Adverse Event|10|||
156677548|NCT01496118|565564222|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
156677549|NCT01496118|565564223|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
156677550|NCT01496118|565564224|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
156677551|NCT01496118|565564225|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
156677552|NCT01496118|565564226|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
156677553|NCT01496118|565564227|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
156677554|NCT01496118|565564228|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
156677555|NCT01496118|565564229|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
156677556|NCT01496118|565564222|FG000|Overall Study|Death|0|||
156677557|NCT01496118|565564223|FG001|Overall Study|Death|0|||
156677558|NCT01496118|565564224|FG002|Overall Study|Death|0|||
156677559|NCT01496118|565564225|FG003|Overall Study|Death|0|||
156677560|NCT01496118|565564226|FG004|Overall Study|Death|0|||
156677561|NCT01496118|565564227|FG005|Overall Study|Death|0|||
156677562|NCT01496118|565564228|FG006|Overall Study|Death|1|||
156677563|NCT01496118|565564229|FG007|Overall Study|Death|1|||
156677564|NCT01496118|565564222|FG000|Overall Study|Withdrawal by Subject|0|||
156677565|NCT01496118|565564223|FG001|Overall Study|Withdrawal by Subject|0|||
156677566|NCT01496118|565564224|FG002|Overall Study|Withdrawal by Subject|0|||
156677567|NCT01496118|565564225|FG003|Overall Study|Withdrawal by Subject|2|||
156677568|NCT01496118|565564226|FG004|Overall Study|Withdrawal by Subject|0|||
156677569|NCT01496118|565564227|FG005|Overall Study|Withdrawal by Subject|1|||
156677570|NCT01496118|565564228|FG006|Overall Study|Withdrawal by Subject|6|||
156677571|NCT01496118|565564229|FG007|Overall Study|Withdrawal by Subject|3|||
156677572|NCT00841659|565564234|FG000|Washout: 2 Weeks|Protocol Violation|1|||
156677573|NCT00841659|565564235|FG001|Washout: 2 Weeks|Protocol Violation|0|||
156677574|NCT04608448|565564239|FG000|Overall Study|Withdrawal by Subject|1|||
156677575|NCT04608448|565564239|FG000|Overall Study|Adverse Event|1|||
156677576|NCT00654186|565564240|FG000|Overall Study|Withdrawal by Subject|5|||
156677577|NCT05616728|565564241|FG000|Overall Study|Lost to Follow-up|0|||
156677578|NCT05616728|565564242|FG001|Overall Study|Lost to Follow-up|0|||
156677579|NCT05616728|565564243|FG002|Overall Study|Lost to Follow-up|1|||
156677580|NCT05616728|565564241|FG000|Overall Study|Withdrawal by Subject|1|||
156677581|NCT05616728|565564242|FG001|Overall Study|Withdrawal by Subject|1|||
156677582|NCT05616728|565564243|FG002|Overall Study|Withdrawal by Subject|0|||
156677583|NCT05616728|565564241|FG000|Overall Study|Physician Decision|1|||
156677584|NCT05616728|565564242|FG001|Overall Study|Physician Decision|1|||
156677585|NCT05616728|565564243|FG002|Overall Study|Physician Decision|1|||
156677586|NCT05616728|565564241|FG000|Overall Study|Other|0|||
156677587|NCT05616728|565564242|FG001|Overall Study|Other|2|||
156677588|NCT05616728|565564243|FG002|Overall Study|Other|0|||
156677589|NCT00577655|565564246|FG000|Overall Study|Patient Request|0|||
156677590|NCT00577655|565564247|FG001|Overall Study|Patient Request|2|||
156677591|NCT00577655|565564246|FG000|Overall Study|Protocol Violation|0|||
156677592|NCT00577655|565564247|FG001|Overall Study|Protocol Violation|1|||
156677593|NCT00577655|565564246|FG000|Overall Study|Lost to Follow-up|1|||
156677594|NCT00577655|565564247|FG001|Overall Study|Lost to Follow-up|1|||
156677595|NCT01024855|565564248|FG000|Overall Study|Inclusion/exclusion criteria|1|||
156677596|NCT00875524|565564253|FG000|Overall Study|Serious adverse event|0|||
156677597|NCT00875524|565564254|FG001|Overall Study|Serious adverse event|1|||
156677598|NCT00875524|565564253|FG000|Overall Study|Protocol Violation|4|||
156677599|NCT00875524|565564254|FG001|Overall Study|Protocol Violation|0|||
156677600|NCT00875524|565564253|FG000|Overall Study|Lost to Follow-up|1|||
156677601|NCT00875524|565564254|FG001|Overall Study|Lost to Follow-up|0|||
156677602|NCT00875524|565564253|FG000|Overall Study|Withdrawal by Subject|3|||
156781840|NCT03927157|565951509|FG001|Overall Study|Withdrawal by Subject|21|||
156781841|NCT03927157|565951508|FG000|Overall Study|Due to COVID-19 pandemic|5|||
156781842|NCT03927157|565951509|FG001|Overall Study|Due to COVID-19 pandemic|2|||
156781843|NCT03927157|565951508|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
156781844|NCT03927157|565951509|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
156781845|NCT03927157|565951508|FG000|Overall Study|Other than above|0|||
156328596|NCT02949700|564303308|FG000|Phase II|Withdrawal by Subject|0|||
156677603|NCT00875524|565564254|FG001|Overall Study|Withdrawal by Subject|5|||
156677604|NCT02436200|565564257|FG000|Overall Study|Significant outlier|1|||
156677605|NCT01926119|565564264|FG000|Overall Study|Withdrawal by Subject|1|||
156677606|NCT02654145|565564270|FG000|Overall Study|Lack of Efficacy|1|||
156677607|NCT02654145|565564270|FG000|Overall Study|Protocol Violation|1|||
156677608|NCT02654145|565564270|FG000|Overall Study|Withdrawal by Subject|5|||
156677609|NCT01968551|565564273|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
156781846|NCT03927157|565951509|FG001|Overall Study|Other than above|1|||
156677610|NCT01968551|565564274|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
156677611|NCT01968551|565564275|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
156677612|NCT01968551|565564273|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
156677613|NCT01968551|565564274|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
156677614|NCT01968551|565564275|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
156677615|NCT01968551|565564273|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
156677616|NCT01968551|565564274|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
156677617|NCT01968551|565564275|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
156677618|NCT01968551|565564273|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
156677619|NCT01968551|565564274|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
156677620|NCT01968551|565564275|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
156677621|NCT01968551|565564273|FG000|Extension Phase|Adverse Event|0|||
156677622|NCT01968551|565564274|FG001|Extension Phase|Adverse Event|0|||
156677623|NCT01968551|565564275|FG002|Extension Phase|Adverse Event|2|||
156677624|NCT01968551|565564273|FG000|Extension Phase|Death|0|||
156677625|NCT01968551|565564274|FG001|Extension Phase|Death|1|||
156677626|NCT01968551|565564275|FG002|Extension Phase|Death|0|||
156677627|NCT01968551|565564273|FG000|Extension Phase|Withdrew Consent|0|||
156677628|NCT01968551|565564274|FG001|Extension Phase|Withdrew Consent|0|||
156677629|NCT01968551|565564275|FG002|Extension Phase|Withdrew Consent|1|||
156677630|NCT01968551|565564273|FG000|Extension Phase|Lost to Follow-up|1|||
156677631|NCT01968551|565564274|FG001|Extension Phase|Lost to Follow-up|0|||
156677632|NCT01968551|565564275|FG002|Extension Phase|Lost to Follow-up|1|||
156677633|NCT00645853|565564276|FG000|Overall Study|Adverse Event|18|||
156677634|NCT00645853|565564277|FG001|Overall Study|Adverse Event|7|||
156677635|NCT00645853|565564276|FG000|Overall Study|AZ study closure in Hungary|60|||
156677636|NCT00645853|565564277|FG001|Overall Study|AZ study closure in Hungary|40|||
156677637|NCT00645853|565564276|FG000|Overall Study|Withdrawal by Subject|5|||
156677638|NCT00645853|565564277|FG001|Overall Study|Withdrawal by Subject|2|||
156677639|NCT00645853|565564276|FG000|Overall Study|Protocol Violation|0|||
156677640|NCT00645853|565564277|FG001|Overall Study|Protocol Violation|2|||
156677641|NCT00645853|565564276|FG000|Overall Study|Discontinuation criteria|2|||
156677642|NCT00645853|565564277|FG001|Overall Study|Discontinuation criteria|2|||
156781847|NCT02265744|565951510|FG000|Overall Study|Poor/Non-compliance|1|||
156781848|NCT02265744|565951511|FG001|Overall Study|Poor/Non-compliance|1|||
156781849|NCT02265744|565951512|FG002|Overall Study|Poor/Non-compliance|0|||
156781850|NCT02265744|565951513|FG003|Overall Study|Poor/Non-compliance|0|||
156781851|NCT02265744|565951514|FG004|Overall Study|Poor/Non-compliance|2|||
156781852|NCT02265744|565951510|FG000|Overall Study|Lost to Follow-up|0|||
156781853|NCT02265744|565951511|FG001|Overall Study|Lost to Follow-up|0|||
156529080|NCT00960531|565031066|FG007|Overall Study|Withdrawal by Subject|0|||
156529081|NCT00960531|565031067|FG008|Overall Study|Withdrawal by Subject|1|||
156529082|NCT00960531|565031068|FG009|Overall Study|Withdrawal by Subject|0|||
156529083|NCT00960531|565031059|FG000|Overall Study|Caregiver Request|2|||
156529084|NCT00960531|565031060|FG001|Overall Study|Caregiver Request|0|||
156529085|NCT00960531|565031061|FG002|Overall Study|Caregiver Request|6|||
156529086|NCT00960531|565031062|FG003|Overall Study|Caregiver Request|5|||
156529087|NCT00960531|565031063|FG004|Overall Study|Caregiver Request|0|||
156529088|NCT00960531|565031064|FG005|Overall Study|Caregiver Request|2|||
156529089|NCT00960531|565031065|FG006|Overall Study|Caregiver Request|3|||
156529090|NCT00960531|565031066|FG007|Overall Study|Caregiver Request|1|||
156529091|NCT00960531|565031067|FG008|Overall Study|Caregiver Request|3|||
156677643|NCT00645853|565564276|FG000|Overall Study|recall of ICF, planned operation, death|7|||
156677644|NCT00645853|565564277|FG001|Overall Study|recall of ICF, planned operation, death|4|||
156677645|NCT00819169|565564278|FG000|Overall Study|Withdrawal by Subject|2|||
156677646|NCT00819169|565564279|FG001|Overall Study|Withdrawal by Subject|0|||
156677647|NCT00819169|565564280|FG002|Overall Study|Withdrawal by Subject|0|||
156529092|NCT00960531|565031068|FG009|Overall Study|Caregiver Request|0|||
156529093|NCT00960531|565031059|FG000|Overall Study|Investigator Request|0|||
156529094|NCT00960531|565031060|FG001|Overall Study|Investigator Request|0|||
156529095|NCT00960531|565031061|FG002|Overall Study|Investigator Request|1|||
156529096|NCT00960531|565031062|FG003|Overall Study|Investigator Request|0|||
156529097|NCT00960531|565031063|FG004|Overall Study|Investigator Request|0|||
156529098|NCT00960531|565031064|FG005|Overall Study|Investigator Request|0|||
156529099|NCT00960531|565031065|FG006|Overall Study|Investigator Request|0|||
156529100|NCT00960531|565031066|FG007|Overall Study|Investigator Request|0|||
156677648|NCT00819169|565564281|FG003|Overall Study|Withdrawal by Subject|1|||
156529101|NCT00960531|565031067|FG008|Overall Study|Investigator Request|0|||
156529102|NCT00960531|565031068|FG009|Overall Study|Investigator Request|0|||
156781854|NCT02265744|565951512|FG002|Overall Study|Lost to Follow-up|0|||
156529103|NCT00960531|565031059|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
156529104|NCT00960531|565031060|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
156529105|NCT00960531|565031061|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
156529106|NCT00960531|565031062|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
156677649|NCT00819169|565564282|FG004|Overall Study|Withdrawal by Subject|1|||
156677650|NCT00819169|565564283|FG005|Overall Study|Withdrawal by Subject|1|||
156677651|NCT00819169|565564284|FG006|Overall Study|Withdrawal by Subject|5|||
156781855|NCT02265744|565951513|FG003|Overall Study|Lost to Follow-up|1|||
156781856|NCT02265744|565951514|FG004|Overall Study|Lost to Follow-up|0|||
156677652|NCT00819169|565564285|FG007|Overall Study|Withdrawal by Subject|1|||
156677653|NCT00819169|565564286|FG008|Overall Study|Withdrawal by Subject|4|||
156677654|NCT00819169|565564278|FG000|Overall Study|Lost to Follow-up|0|||
156677655|NCT00819169|565564279|FG001|Overall Study|Lost to Follow-up|2|||
156677656|NCT00819169|565564280|FG002|Overall Study|Lost to Follow-up|0|||
156677657|NCT00819169|565564281|FG003|Overall Study|Lost to Follow-up|1|||
156529107|NCT00960531|565031063|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
156677658|NCT00819169|565564282|FG004|Overall Study|Lost to Follow-up|0|||
156677659|NCT00819169|565564283|FG005|Overall Study|Lost to Follow-up|6|||
156529108|NCT00960531|565031064|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
156529109|NCT00960531|565031065|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
156529110|NCT00960531|565031066|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
156529111|NCT00960531|565031067|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
156529112|NCT00960531|565031068|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
156529113|NCT00960531|565031059|FG000|Overall Study|Lost to Follow-up|0|||
156529114|NCT00960531|565031060|FG001|Overall Study|Lost to Follow-up|0|||
156529115|NCT00960531|565031061|FG002|Overall Study|Lost to Follow-up|1|||
156529116|NCT00960531|565031062|FG003|Overall Study|Lost to Follow-up|0|||
156529117|NCT00960531|565031063|FG004|Overall Study|Lost to Follow-up|0|||
156529118|NCT00960531|565031064|FG005|Overall Study|Lost to Follow-up|0|||
156529119|NCT00960531|565031065|FG006|Overall Study|Lost to Follow-up|1|||
156677660|NCT00819169|565564284|FG006|Overall Study|Lost to Follow-up|2|||
156677661|NCT00819169|565564285|FG007|Overall Study|Lost to Follow-up|2|||
156677662|NCT00819169|565564286|FG008|Overall Study|Lost to Follow-up|1|||
156781857|NCT02265744|565951510|FG000|Overall Study|Death|0|||
156529120|NCT00960531|565031066|FG007|Overall Study|Lost to Follow-up|0|||
156529121|NCT00960531|565031067|FG008|Overall Study|Lost to Follow-up|0|||
156529122|NCT00960531|565031068|FG009|Overall Study|Lost to Follow-up|0|||
156529123|NCT00960531|565031059|FG000|Overall Study|Failed to Return|2|||
156529124|NCT00960531|565031060|FG001|Overall Study|Failed to Return|0|||
156529125|NCT00960531|565031061|FG002|Overall Study|Failed to Return|0|||
156529126|NCT00960531|565031062|FG003|Overall Study|Failed to Return|0|||
156529127|NCT00960531|565031063|FG004|Overall Study|Failed to Return|0|||
156529128|NCT00960531|565031064|FG005|Overall Study|Failed to Return|0|||
156529129|NCT00960531|565031065|FG006|Overall Study|Failed to Return|0|||
156529130|NCT00960531|565031066|FG007|Overall Study|Failed to Return|2|||
156529131|NCT00960531|565031067|FG008|Overall Study|Failed to Return|0|||
156529132|NCT00960531|565031068|FG009|Overall Study|Failed to Return|0|||
156529133|NCT00960531|565031059|FG000|Overall Study|Adverse Event (AE)|2|||
156529134|NCT00960531|565031060|FG001|Overall Study|Adverse Event (AE)|0|||
156529135|NCT00960531|565031061|FG002|Overall Study|Adverse Event (AE)|0|||
156529136|NCT00960531|565031062|FG003|Overall Study|Adverse Event (AE)|0|||
156529137|NCT00960531|565031063|FG004|Overall Study|Adverse Event (AE)|0|||
156781858|NCT02265744|565951511|FG001|Overall Study|Death|0|||
156781859|NCT02265744|565951512|FG002|Overall Study|Death|0|||
156529138|NCT00960531|565031064|FG005|Overall Study|Adverse Event (AE)|1|||
156529139|NCT00960531|565031065|FG006|Overall Study|Adverse Event (AE)|2|||
156529140|NCT00960531|565031066|FG007|Overall Study|Adverse Event (AE)|0|||
156529141|NCT00960531|565031067|FG008|Overall Study|Adverse Event (AE)|2|||
156529142|NCT00960531|565031068|FG009|Overall Study|Adverse Event (AE)|0|||
156529143|NCT00960531|565031059|FG000|Overall Study|Reason not Specified|2|||
156529144|NCT00960531|565031060|FG001|Overall Study|Reason not Specified|1|||
156529145|NCT00960531|565031061|FG002|Overall Study|Reason not Specified|13|||
156781860|NCT02265744|565951513|FG003|Overall Study|Death|2|||
156781861|NCT02265744|565951514|FG004|Overall Study|Death|0|||
156781862|NCT02265744|565951510|FG000|Overall Study|Withdrawal by Subject|2|||
156781863|NCT02265744|565951511|FG001|Overall Study|Withdrawal by Subject|0|||
156781864|NCT02265744|565951512|FG002|Overall Study|Withdrawal by Subject|0|||
156781865|NCT02265744|565951513|FG003|Overall Study|Withdrawal by Subject|2|||
156781866|NCT02265744|565951514|FG004|Overall Study|Withdrawal by Subject|0|||
156781867|NCT02265744|565951510|FG000|Overall Study|Participant request to discontinue|2|||
156781868|NCT02265744|565951511|FG001|Overall Study|Participant request to discontinue|2|||
156781869|NCT02265744|565951512|FG002|Overall Study|Participant request to discontinue|2|||
156781870|NCT02265744|565951513|FG003|Overall Study|Participant request to discontinue|0|||
156781871|NCT02265744|565951514|FG004|Overall Study|Participant request to discontinue|0|||
156781872|NCT02265744|565951510|FG000|Overall Study|Adverse Event|8|||
156529146|NCT00960531|565031062|FG003|Overall Study|Reason not Specified|1|||
156529147|NCT00960531|565031063|FG004|Overall Study|Reason not Specified|2|||
156529148|NCT00960531|565031064|FG005|Overall Study|Reason not Specified|0|||
156529149|NCT00960531|565031065|FG006|Overall Study|Reason not Specified|16|||
156529150|NCT00960531|565031066|FG007|Overall Study|Reason not Specified|0|||
156677663|NCT00819169|565564278|FG000|Overall Study|Death|1|||
156677664|NCT00819169|565564279|FG001|Overall Study|Death|1|||
156781873|NCT02265744|565951511|FG001|Overall Study|Adverse Event|4|||
156781874|NCT02265744|565951512|FG002|Overall Study|Adverse Event|9|||
156781875|NCT02265744|565951513|FG003|Overall Study|Adverse Event|8|||
156781876|NCT02265744|565951514|FG004|Overall Study|Adverse Event|2|||
156781877|NCT02265744|565951510|FG000|Overall Study|Lack of Efficacy|2|||
156677665|NCT00819169|565564280|FG002|Overall Study|Death|3|||
156677666|NCT00819169|565564281|FG003|Overall Study|Death|8|||
156677667|NCT00819169|565564282|FG004|Overall Study|Death|5|||
156677668|NCT00819169|565564283|FG005|Overall Study|Death|7|||
156677669|NCT00819169|565564284|FG006|Overall Study|Death|9|||
156677670|NCT00819169|565564285|FG007|Overall Study|Death|4|||
156677671|NCT00819169|565564286|FG008|Overall Study|Death|7|||
156677672|NCT00819169|565564278|FG000|Overall Study|Ineligibility determined|0|||
156677673|NCT00819169|565564279|FG001|Overall Study|Ineligibility determined|0|||
156677674|NCT00819169|565564280|FG002|Overall Study|Ineligibility determined|0|||
156677675|NCT00819169|565564281|FG003|Overall Study|Ineligibility determined|2|||
156677676|NCT00819169|565564282|FG004|Overall Study|Ineligibility determined|0|||
156677677|NCT00819169|565564283|FG005|Overall Study|Ineligibility determined|0|||
156529151|NCT00960531|565031067|FG008|Overall Study|Reason not Specified|8|||
156529152|NCT00960531|565031068|FG009|Overall Study|Reason not Specified|1|||
156529153|NCT00593957|565031069|FG000|Overall Study|Physician Decision|0|||
156529154|NCT00593957|565031070|FG001|Overall Study|Physician Decision|1|||
156529155|NCT00593957|565031071|FG002|Overall Study|Physician Decision|2|||
156529156|NCT02411578|565031072|FG000|Crossover Trial Phase|Pregnancy|0|||
156529157|NCT02411578|565031073|FG001|Crossover Trial Phase|Pregnancy|1|||
156677678|NCT00819169|565564284|FG006|Overall Study|Ineligibility determined|0|||
156677679|NCT00819169|565564285|FG007|Overall Study|Ineligibility determined|0|||
156677680|NCT00819169|565564286|FG008|Overall Study|Ineligibility determined|1|||
156677681|NCT00819169|565564278|FG000|Overall Study|Adverse Event|0|||
156677682|NCT00819169|565564279|FG001|Overall Study|Adverse Event|0|||
156529158|NCT00494481|565031074|FG000|Overall Study|Condition under investigation worsened|11|||
156529159|NCT00494481|565031075|FG001|Overall Study|Condition under investigation worsened|13|||
156529160|NCT00494481|565031074|FG000|Overall Study|Adverse Event|15|||
156529161|NCT00494481|565031075|FG001|Overall Study|Adverse Event|11|||
156529162|NCT00494481|565031074|FG000|Overall Study|Other|1|||
156529163|NCT00494481|565031075|FG001|Overall Study|Other|0|||
156529164|NCT00494481|565031074|FG000|Overall Study|Never received IP|2|||
156529165|NCT00494481|565031075|FG001|Overall Study|Never received IP|0|||
156529166|NCT00332189|565031076|FG000|Overall Study|Adverse Event|3|||
156529167|NCT00332189|565031076|FG000|Overall Study|Uncooperative/Noncompliant|3|||
156529168|NCT00332189|565031076|FG000|Overall Study|Withdrawal by Subject|9|||
156529169|NCT00332189|565031076|FG000|Overall Study|Lack of Efficacy|4|||
156529170|NCT00332189|565031076|FG000|Overall Study|Moved out of country|2|||
156529171|NCT02370043|565031077|FG000|Overall Study|Withdrawal by Subject|0|||
156529172|NCT02370043|565031078|FG001|Overall Study|Withdrawal by Subject|0|||
156529173|NCT02370043|565031079|FG002|Overall Study|Withdrawal by Subject|0|||
156529174|NCT02370043|565031080|FG003|Overall Study|Withdrawal by Subject|0|||
156529175|NCT02370043|565031081|FG004|Overall Study|Withdrawal by Subject|1|||
156529176|NCT02370043|565031082|FG005|Overall Study|Withdrawal by Subject|1|||
156529177|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
156529178|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
156529179|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
156529180|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
156529181|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
156529182|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
156529183|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
156529184|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
156529185|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
156529186|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
156529187|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
156529188|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
156529189|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
156529190|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
156529191|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
156529192|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
156529193|NCT01231516|565031083|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
156529194|NCT01231516|565031084|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
156529195|NCT01231516|565031083|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
156529196|NCT01231516|565031084|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
156529197|NCT01231516|565031083|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
156781878|NCT02265744|565951511|FG001|Overall Study|Lack of Efficacy|4|||
156781879|NCT02265744|565951512|FG002|Overall Study|Lack of Efficacy|3|||
156529198|NCT01231516|565031084|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
156677683|NCT00819169|565564280|FG002|Overall Study|Adverse Event|0|||
156677684|NCT00819169|565564281|FG003|Overall Study|Adverse Event|0|||
156677685|NCT00819169|565564282|FG004|Overall Study|Adverse Event|1|||
156677686|NCT00819169|565564283|FG005|Overall Study|Adverse Event|0|||
156677687|NCT00819169|565564284|FG006|Overall Study|Adverse Event|0|||
156677688|NCT00819169|565564285|FG007|Overall Study|Adverse Event|0|||
156677689|NCT00819169|565564286|FG008|Overall Study|Adverse Event|0|||
156677690|NCT00819169|565564278|FG000|Overall Study|Administrative Decision|0|||
156677691|NCT00819169|565564279|FG001|Overall Study|Administrative Decision|0|||
156677692|NCT00819169|565564280|FG002|Overall Study|Administrative Decision|0|||
156677693|NCT00819169|565564281|FG003|Overall Study|Administrative Decision|0|||
156677694|NCT00819169|565564282|FG004|Overall Study|Administrative Decision|1|||
156677695|NCT00819169|565564283|FG005|Overall Study|Administrative Decision|2|||
156677696|NCT00819169|565564284|FG006|Overall Study|Administrative Decision|0|||
156677697|NCT00819169|565564285|FG007|Overall Study|Administrative Decision|2|||
156677698|NCT00819169|565564286|FG008|Overall Study|Administrative Decision|0|||
156677699|NCT02637141|565564288|FG000|Overall Study|Adverse Event|1|||
156677700|NCT02637141|565564289|FG001|Overall Study|Adverse Event|1|||
156677701|NCT02637141|565564290|FG002|Overall Study|Adverse Event|0|||
156677702|NCT02637141|565564288|FG000|Overall Study|Withdrawal by Subject|1|||
156677703|NCT02637141|565564289|FG001|Overall Study|Withdrawal by Subject|1|||
156677704|NCT02637141|565564290|FG002|Overall Study|Withdrawal by Subject|1|||
156677705|NCT00406393|565564294|FG000|Overall Study|Did not undergo transplantation|2|||
156677706|NCT00406393|565564295|FG001|Overall Study|Did not undergo transplantation|1|||
156677707|NCT00487435|565564296|FG000|Overall Study|Adverse Event|146|||
156677708|NCT00487435|565564296|FG000|Overall Study|Death|2|||
156677709|NCT00487435|565564296|FG000|Overall Study|Lack of Efficacy|33|||
156677710|NCT00487435|565564296|FG000|Overall Study|Lost to Follow-up|54|||
156677711|NCT00487435|565564296|FG000|Overall Study|Pregnancy|2|||
156677712|NCT00487435|565564296|FG000|Overall Study|Withdrawal by Subject|132|||
156677713|NCT00487435|565564296|FG000|Overall Study|Resolution Of Pain|1|||
156677714|NCT00487435|565564296|FG000|Overall Study|Study Medication Non-Compliant|32|||
156677715|NCT00487435|565564296|FG000|Overall Study|Other|83|||
156677716|NCT01155531|565564297|FG000|Overall Study|Adverse Event|0|||
156677717|NCT01155531|565564298|FG001|Overall Study|Adverse Event|0|||
156677718|NCT01155531|565564299|FG002|Overall Study|Adverse Event|1|||
156677719|NCT01155531|565564300|FG003|Overall Study|Adverse Event|0|||
156677720|NCT01155531|565564297|FG000|Overall Study|Lost to Follow-up|0|||
156677721|NCT01155531|565564298|FG001|Overall Study|Lost to Follow-up|0|||
156677722|NCT01155531|565564299|FG002|Overall Study|Lost to Follow-up|0|||
156677723|NCT01155531|565564300|FG003|Overall Study|Lost to Follow-up|1|||
156677724|NCT01155531|565564297|FG000|Overall Study|Withdrawal by Subject|1|||
156677725|NCT01155531|565564298|FG001|Overall Study|Withdrawal by Subject|0|||
156677726|NCT01155531|565564299|FG002|Overall Study|Withdrawal by Subject|1|||
156677727|NCT01155531|565564300|FG003|Overall Study|Withdrawal by Subject|0|||
156677728|NCT00380588|565564301|FG000|Overall Study|Unequivocal Disease Progression|25|||
156677729|NCT00380588|565564302|FG001|Overall Study|Unequivocal Disease Progression|34|||
156677730|NCT00380588|565564301|FG000|Overall Study|Next Cycle Not Started|4|||
156677731|NCT00380588|565564302|FG001|Overall Study|Next Cycle Not Started|0|||
156677732|NCT00380588|565564301|FG000|Overall Study|Adverse Event|7|||
156677733|NCT00380588|565564302|FG001|Overall Study|Adverse Event|3|||
156677734|NCT00380588|565564301|FG000|Overall Study|Withdrawal by Subject|1|||
156677735|NCT00380588|565564302|FG001|Overall Study|Withdrawal by Subject|3|||
156677736|NCT00380588|565564301|FG000|Overall Study|Physician Decision|2|||
156677737|NCT00380588|565564302|FG001|Overall Study|Physician Decision|0|||
156328597|NCT02949700|564303309|FG001|Phase II|Withdrawal by Subject|0|||
156328598|NCT02949700|564303310|FG002|Phase II|Withdrawal by Subject|0|||
156328599|NCT02949700|564303311|FG003|Phase II|Withdrawal by Subject|2|||
156328600|NCT02949700|564303308|FG000|Phase II|Protocol Violation|0|||
156328601|NCT02949700|564303309|FG001|Phase II|Protocol Violation|0|||
156328602|NCT02949700|564303310|FG002|Phase II|Protocol Violation|1|||
156328603|NCT02949700|564303311|FG003|Phase II|Protocol Violation|3|||
156529199|NCT01231516|565031083|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
156529200|NCT01231516|565031084|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
156529201|NCT01231516|565031083|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
156529202|NCT01231516|565031084|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
156328604|NCT00973349|564303312|FG000|Overall Study|Adverse Event|0|||
156328605|NCT00973349|564303313|FG001|Overall Study|Adverse Event|0|||
156328606|NCT00973349|564303314|FG002|Overall Study|Adverse Event|0|||
156328607|NCT00973349|564303315|FG003|Overall Study|Adverse Event|0|||
156677738|NCT02096705|565564303|FG000|Treatment|Adverse Event|6|||
156677739|NCT02096705|565564304|FG001|Treatment|Adverse Event|3|||
156677740|NCT02096705|565564303|FG000|Treatment|Subject request to discontinue treatment|1|||
156677741|NCT02096705|565564304|FG001|Treatment|Subject request to discontinue treatment|1|||
156677742|NCT02096705|565564303|FG000|Treatment|Withdrawal by Subject|1|||
156677743|NCT02096705|565564304|FG001|Treatment|Withdrawal by Subject|0|||
156677744|NCT02096705|565564303|FG000|Treatment|Other|1|||
156677745|NCT02096705|565564304|FG001|Treatment|Other|1|||
156677746|NCT02096705|565564303|FG000|Follow-up|Withdrawal by Subject|1|||
156677747|NCT02096705|565564304|FG001|Follow-up|Withdrawal by Subject|0|||
156677748|NCT02096705|565564303|FG000|Follow-up|Adverse Event|2|||
156677749|NCT02096705|565564304|FG001|Follow-up|Adverse Event|2|||
156677750|NCT02096705|565564303|FG000|Follow-up|Subjects not reporting status|1|||
156677751|NCT02096705|565564304|FG001|Follow-up|Subjects not reporting status|2|||
156677752|NCT02905435|565564305|FG000|Overall Study|Death|2|||
156677753|NCT02905435|565564305|FG000|Overall Study|Physician Decision|1|||
156677754|NCT02905435|565564305|FG000|Overall Study|Lost to Follow-up|4|||
156677755|NCT02377349|565564309|FG000|Overall Study|Serious Adverse Event|1|||
156677756|NCT02377349|565564310|FG001|Overall Study|Serious Adverse Event|0|||
156677757|NCT02377349|565564309|FG000|Overall Study|Protocol Violation|3|||
156677758|NCT02377349|565564310|FG001|Overall Study|Protocol Violation|2|||
156677759|NCT02377349|565564309|FG000|Overall Study|Withdrawal by Subject|5|||
156677760|NCT02377349|565564310|FG001|Overall Study|Withdrawal by Subject|3|||
156677761|NCT02377349|565564309|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
156677762|NCT02377349|565564310|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
156677763|NCT02377349|565564309|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
156677764|NCT02377349|565564310|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
156677765|NCT02377349|565564309|FG000|Overall Study|Other|0|||
156677766|NCT02377349|565564310|FG001|Overall Study|Other|1|||
156677767|NCT03614728|565564319|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
156677768|NCT03614728|565564320|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
156677769|NCT03614728|565564321|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
156677770|NCT03614728|565564322|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
156677771|NCT03614728|565564319|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
156677772|NCT03614728|565564320|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
156677773|NCT03614728|565564321|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
156677774|NCT03614728|565564322|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
156677775|NCT01958476|565564323|FG000|Overall Study|Parent requested exclusion from analysis|1|||
156677776|NCT01958476|565564324|FG001|Overall Study|Parent requested exclusion from analysis|0|||
156677777|NCT02670551|565564325|FG000|Overall Study|Adverse Event|4|||
156677778|NCT02670551|565564326|FG001|Overall Study|Adverse Event|7|||
156677779|NCT02670551|565564327|FG002|Overall Study|Adverse Event|9|||
156529203|NCT01231516|565031083|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
156529204|NCT01231516|565031084|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
156529205|NCT01231516|565031083|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
156529206|NCT01231516|565031084|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
156529207|NCT01231516|565031083|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
156529208|NCT01231516|565031084|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
156529209|NCT05266586|565031087|FG000|Overall Study|Adverse Event|2|||
156529210|NCT05266586|565031088|FG001|Overall Study|Adverse Event|2|||
156529211|NCT05266586|565031089|FG002|Overall Study|Adverse Event|1|||
156529212|NCT05266586|565031087|FG000|Overall Study|Withdrawal by Subject|1|||
156529213|NCT05266586|565031088|FG001|Overall Study|Withdrawal by Subject|0|||
156529214|NCT05266586|565031089|FG002|Overall Study|Withdrawal by Subject|1|||
156328608|NCT00973349|564303316|FG004|Overall Study|Adverse Event|1|||
156677780|NCT02670551|565564325|FG000|Overall Study|Lack of Efficacy|2|||
156677781|NCT02670551|565564326|FG001|Overall Study|Lack of Efficacy|0|||
156677782|NCT02670551|565564327|FG002|Overall Study|Lack of Efficacy|3|||
156677783|NCT02670551|565564325|FG000|Overall Study|Withdrawal of Consent|6|||
156677784|NCT02670551|565564326|FG001|Overall Study|Withdrawal of Consent|3|||
156677785|NCT02670551|565564327|FG002|Overall Study|Withdrawal of Consent|8|||
156677786|NCT02670551|565564325|FG000|Overall Study|Lost to Follow-up|5|||
156677787|NCT02670551|565564326|FG001|Overall Study|Lost to Follow-up|7|||
156677788|NCT02670551|565564327|FG002|Overall Study|Lost to Follow-up|6|||
156677789|NCT02670551|565564325|FG000|Overall Study|Protocol Violation|1|||
156677790|NCT02670551|565564326|FG001|Overall Study|Protocol Violation|0|||
156677791|NCT02670551|565564327|FG002|Overall Study|Protocol Violation|0|||
156677792|NCT02670551|565564325|FG000|Overall Study|Noncompliance with study drug|3|||
156677793|NCT02670551|565564326|FG001|Overall Study|Noncompliance with study drug|3|||
156677794|NCT02670551|565564327|FG002|Overall Study|Noncompliance with study drug|2|||
156677795|NCT02670551|565564325|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156677796|NCT02670551|565564326|FG001|Overall Study|Other Miscellaneous Reasons|3|||
156677797|NCT02670551|565564327|FG002|Overall Study|Other Miscellaneous Reasons|3|||
156677798|NCT02670551|565564325|FG000|Overall Study|Did Not Receive Treatment|5|||
156677799|NCT02670551|565564326|FG001|Overall Study|Did Not Receive Treatment|3|||
156677800|NCT02670551|565564327|FG002|Overall Study|Did Not Receive Treatment|0|||
156677801|NCT00714051|565564328|FG000|Overall Study|Withdrawal by Subject|1|||
156677802|NCT00714051|565564329|FG001|Overall Study|Withdrawal by Subject|0|||
156677803|NCT00714051|565564328|FG000|Overall Study|Death|0|||
156677804|NCT00714051|565564329|FG001|Overall Study|Death|1|||
156677805|NCT03868631|565564330|FG000|Baseline to Week 6|Adverse Event|0|||
156677806|NCT03868631|565564331|FG001|Baseline to Week 6|Adverse Event|3|||
156677807|NCT03868631|565564330|FG000|Baseline to Week 6|Protocol Violation|1|||
156677808|NCT03868631|565564331|FG001|Baseline to Week 6|Protocol Violation|1|||
156529215|NCT05266586|565031087|FG000|Overall Study|Non-compliance with study drug|0|||
156529216|NCT05266586|565031088|FG001|Overall Study|Non-compliance with study drug|1|||
156677809|NCT03868631|565564330|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
156677810|NCT03868631|565564331|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
156529217|NCT05266586|565031089|FG002|Overall Study|Non-compliance with study drug|0|||
156529218|NCT05266586|565031087|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
156781880|NCT02265744|565951513|FG003|Overall Study|Lack of Efficacy|4|||
156781881|NCT02265744|565951514|FG004|Overall Study|Lack of Efficacy|5|||
156529219|NCT05266586|565031088|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
156529220|NCT05266586|565031089|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
156529221|NCT02225353|565031090|FG000|Overall Study|Lost to Follow-up|0|||
156529222|NCT02225353|565031091|FG001|Overall Study|Lost to Follow-up|1|||
156529223|NCT02225353|565031092|FG002|Overall Study|Lost to Follow-up|3|||
156529224|NCT02225353|565031090|FG000|Overall Study|Protocol Violation|4|||
156328609|NCT00973349|564303317|FG005|Overall Study|Adverse Event|0|||
156328610|NCT00973349|564303318|FG006|Overall Study|Adverse Event|0|||
156328611|NCT00973349|564303319|FG007|Overall Study|Adverse Event|0|||
156328612|NCT00973349|564303320|FG008|Overall Study|Adverse Event|1|||
156328613|NCT00973349|564303321|FG009|Overall Study|Adverse Event|0|||
156328614|NCT00973349|564303322|FG010|Overall Study|Adverse Event|0|||
156328615|NCT00973349|564303323|FG011|Overall Study|Adverse Event|0|||
156328616|NCT00973349|564303324|FG012|Overall Study|Adverse Event|0|||
156328617|NCT00973349|564303325|FG013|Overall Study|Adverse Event|0|||
156328618|NCT00973349|564303326|FG014|Overall Study|Adverse Event|1|||
156328619|NCT00973349|564303327|FG015|Overall Study|Adverse Event|0|||
156328620|NCT00973349|564303312|FG000|Overall Study|Withdrawal by Subject|1|||
156328621|NCT00973349|564303313|FG001|Overall Study|Withdrawal by Subject|2|||
156328622|NCT00973349|564303314|FG002|Overall Study|Withdrawal by Subject|2|||
156328623|NCT00973349|564303315|FG003|Overall Study|Withdrawal by Subject|3|||
156328624|NCT00973349|564303316|FG004|Overall Study|Withdrawal by Subject|2|||
156328625|NCT00973349|564303317|FG005|Overall Study|Withdrawal by Subject|0|||
156328626|NCT00973349|564303318|FG006|Overall Study|Withdrawal by Subject|2|||
156328627|NCT00973349|564303319|FG007|Overall Study|Withdrawal by Subject|2|||
156328628|NCT00973349|564303320|FG008|Overall Study|Withdrawal by Subject|0|||
156328629|NCT00973349|564303321|FG009|Overall Study|Withdrawal by Subject|2|||
156328630|NCT00973349|564303322|FG010|Overall Study|Withdrawal by Subject|0|||
156328631|NCT00973349|564303323|FG011|Overall Study|Withdrawal by Subject|1|||
156328632|NCT00973349|564303324|FG012|Overall Study|Withdrawal by Subject|0|||
156328633|NCT00973349|564303325|FG013|Overall Study|Withdrawal by Subject|0|||
156328634|NCT00973349|564303326|FG014|Overall Study|Withdrawal by Subject|0|||
156328635|NCT00973349|564303327|FG015|Overall Study|Withdrawal by Subject|0|||
156328636|NCT00973349|564303312|FG000|Overall Study|Lost to Follow-up|3|||
156328637|NCT00973349|564303313|FG001|Overall Study|Lost to Follow-up|1|||
156328638|NCT00973349|564303314|FG002|Overall Study|Lost to Follow-up|2|||
156328639|NCT00973349|564303315|FG003|Overall Study|Lost to Follow-up|2|||
156328640|NCT00973349|564303316|FG004|Overall Study|Lost to Follow-up|1|||
156328641|NCT00973349|564303317|FG005|Overall Study|Lost to Follow-up|3|||
156328642|NCT00973349|564303318|FG006|Overall Study|Lost to Follow-up|0|||
156328643|NCT00973349|564303319|FG007|Overall Study|Lost to Follow-up|1|||
156328644|NCT00973349|564303320|FG008|Overall Study|Lost to Follow-up|2|||
156328645|NCT00973349|564303321|FG009|Overall Study|Lost to Follow-up|1|||
156328646|NCT00973349|564303322|FG010|Overall Study|Lost to Follow-up|0|||
156328647|NCT00973349|564303323|FG011|Overall Study|Lost to Follow-up|1|||
156328648|NCT00973349|564303324|FG012|Overall Study|Lost to Follow-up|0|||
156328649|NCT00973349|564303325|FG013|Overall Study|Lost to Follow-up|0|||
156328650|NCT00973349|564303326|FG014|Overall Study|Lost to Follow-up|0|||
156328651|NCT00973349|564303327|FG015|Overall Study|Lost to Follow-up|1|||
156328652|NCT00973349|564303312|FG000|Overall Study|Inappropriate enrolment|0|||
156328653|NCT00973349|564303313|FG001|Overall Study|Inappropriate enrolment|0|||
156328654|NCT00973349|564303314|FG002|Overall Study|Inappropriate enrolment|1|||
156328655|NCT00973349|564303315|FG003|Overall Study|Inappropriate enrolment|0|||
156328656|NCT00973349|564303316|FG004|Overall Study|Inappropriate enrolment|0|||
156328657|NCT00973349|564303317|FG005|Overall Study|Inappropriate enrolment|0|||
156328658|NCT00973349|564303318|FG006|Overall Study|Inappropriate enrolment|0|||
156328659|NCT00973349|564303319|FG007|Overall Study|Inappropriate enrolment|0|||
156328660|NCT00973349|564303320|FG008|Overall Study|Inappropriate enrolment|0|||
156328661|NCT00973349|564303321|FG009|Overall Study|Inappropriate enrolment|2|||
156328662|NCT00973349|564303322|FG010|Overall Study|Inappropriate enrolment|0|||
156328663|NCT00973349|564303323|FG011|Overall Study|Inappropriate enrolment|0|||
156328664|NCT00973349|564303324|FG012|Overall Study|Inappropriate enrolment|1|||
156328665|NCT00973349|564303325|FG013|Overall Study|Inappropriate enrolment|0|||
156328666|NCT00973349|564303326|FG014|Overall Study|Inappropriate enrolment|1|||
156328667|NCT00973349|564303327|FG015|Overall Study|Inappropriate enrolment|1|||
156328668|NCT00973349|564303312|FG000|Overall Study|Protocol Violation|0|||
156328669|NCT00973349|564303313|FG001|Overall Study|Protocol Violation|0|||
156328670|NCT00973349|564303314|FG002|Overall Study|Protocol Violation|0|||
156328671|NCT00973349|564303315|FG003|Overall Study|Protocol Violation|0|||
156781882|NCT02265744|565951510|FG000|Overall Study|Reason not provided by Investigator|1|||
156328672|NCT00973349|564303316|FG004|Overall Study|Protocol Violation|0|||
156328673|NCT00973349|564303317|FG005|Overall Study|Protocol Violation|0|||
156328674|NCT00973349|564303318|FG006|Overall Study|Protocol Violation|0|||
156677811|NCT03868631|565564330|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
156677812|NCT03868631|565564331|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
156677813|NCT03868631|565564330|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
156677814|NCT03868631|565564331|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
156781883|NCT02265744|565951511|FG001|Overall Study|Reason not provided by Investigator|0|||
156781884|NCT02265744|565951512|FG002|Overall Study|Reason not provided by Investigator|0|||
156781885|NCT02265744|565951513|FG003|Overall Study|Reason not provided by Investigator|2|||
156781886|NCT02265744|565951514|FG004|Overall Study|Reason not provided by Investigator|0|||
156781887|NCT02265744|565951510|FG000|Overall Study|Administrative reason by sponsor|3|||
156781888|NCT02265744|565951511|FG001|Overall Study|Administrative reason by sponsor|2|||
156781889|NCT02265744|565951512|FG002|Overall Study|Administrative reason by sponsor|2|||
156781890|NCT02265744|565951513|FG003|Overall Study|Administrative reason by sponsor|3|||
156781891|NCT02265744|565951514|FG004|Overall Study|Administrative reason by sponsor|3|||
156781892|NCT02265744|565951510|FG000|Overall Study|Subject no longer meets study criteria|0|||
156781893|NCT02265744|565951511|FG001|Overall Study|Subject no longer meets study criteria|0|||
156781894|NCT02265744|565951512|FG002|Overall Study|Subject no longer meets study criteria|0|||
156781895|NCT02265744|565951513|FG003|Overall Study|Subject no longer meets study criteria|0|||
156781896|NCT02265744|565951514|FG004|Overall Study|Subject no longer meets study criteria|1|||
156781897|NCT02265744|565951510|FG000|Overall Study|Pregnancy|1|||
156781898|NCT02265744|565951511|FG001|Overall Study|Pregnancy|2|||
156781899|NCT02265744|565951512|FG002|Overall Study|Pregnancy|1|||
156781900|NCT02265744|565951513|FG003|Overall Study|Pregnancy|1|||
156781901|NCT02265744|565951514|FG004|Overall Study|Pregnancy|0|||
156781902|NCT06262607|565951515|FG000|Overall Study|Physician Decision|0|||
156781903|NCT06262607|565951516|FG001|Overall Study|Physician Decision|1|||
156781904|NCT06262607|565951515|FG000|Overall Study|Withdrawal by Subject|2|||
156781905|NCT06262607|565951516|FG001|Overall Study|Withdrawal by Subject|0|||
156781906|NCT00923702|565951517|FG000|Overall Study|Ongoing enrollment|0|||
156781907|NCT00923702|565951518|FG001|Overall Study|Ongoing enrollment|0|||
156781908|NCT00923702|565951519|FG002|Overall Study|Ongoing enrollment|0|||
156781909|NCT00923702|565951520|FG003|Overall Study|Ongoing enrollment|0|||
156781910|NCT00923702|565951521|FG004|Overall Study|Ongoing enrollment|354|||
156781911|NCT02541903|565951525|FG000|Overall Study|Death|1|||
156781912|NCT02448043|565951526|FG000|Overall Study|Withdrawal by Subject|2|||
156781913|NCT02448043|565951527|FG001|Overall Study|Withdrawal by Subject|2|||
156781914|NCT02448043|565951526|FG000|Overall Study|Protocol Violation|1|||
156781915|NCT02448043|565951527|FG001|Overall Study|Protocol Violation|2|||
156781916|NCT00827242|565951529|FG000|Overall Study|Withdrawal by Subject|2|||
156781917|NCT00827242|565951530|FG001|Overall Study|Withdrawal by Subject|4|||
156781918|NCT00827242|565951529|FG000|Overall Study|Protocol Violation|1|||
156781919|NCT00827242|565951530|FG001|Overall Study|Protocol Violation|3|||
156781920|NCT00827242|565951529|FG000|Overall Study|Lost to Follow-up|0|||
156781921|NCT00827242|565951530|FG001|Overall Study|Lost to Follow-up|3|||
156781922|NCT00827242|565951529|FG000|Overall Study|Adverse Event Excluding Death|2|||
156781923|NCT00827242|565951530|FG001|Overall Study|Adverse Event Excluding Death|1|||
156781924|NCT00827242|565951529|FG000|Overall Study|Entry Criteria Not Met|4|||
156781925|NCT00827242|565951530|FG001|Overall Study|Entry Criteria Not Met|1|||
156781926|NCT00827242|565951529|FG000|Overall Study|Physician Decision|2|||
156781927|NCT00827242|565951530|FG001|Overall Study|Physician Decision|0|||
156781928|NCT00827242|565951529|FG000|Overall Study|Death|1|||
156781929|NCT00827242|565951530|FG001|Overall Study|Death|0|||
156328675|NCT00973349|564303319|FG007|Overall Study|Protocol Violation|0|||
156328676|NCT00973349|564303320|FG008|Overall Study|Protocol Violation|1|||
156328677|NCT00973349|564303321|FG009|Overall Study|Protocol Violation|0|||
156328678|NCT00973349|564303322|FG010|Overall Study|Protocol Violation|0|||
156328679|NCT00973349|564303323|FG011|Overall Study|Protocol Violation|0|||
156328680|NCT00973349|564303324|FG012|Overall Study|Protocol Violation|0|||
156677815|NCT03868631|565564330|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
156677816|NCT03868631|565564331|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
156677817|NCT00835081|565564332|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156781930|NCT00827242|565951529|FG000|Overall Study|Lack of Efficacy|1|||
156781931|NCT00827242|565951530|FG001|Overall Study|Lack of Efficacy|0|||
156781932|NCT05762679|565951531|FG000|Overall Study|Withdrawal by Subject|1|||
156781933|NCT05762679|565951531|FG000|Overall Study|No analyzable imaging data|1|||
156781934|NCT03142750|565951536|FG000|Overall Study|Lost to Follow-up|4|||
156781935|NCT03142750|565951537|FG001|Overall Study|Lost to Follow-up|1|||
156781936|NCT00303628|565951540|FG000|Overall Study|Disease progression|0|||
156328681|NCT00973349|564303325|FG013|Overall Study|Protocol Violation|0|||
156328682|NCT00973349|564303326|FG014|Overall Study|Protocol Violation|0|||
156328683|NCT00973349|564303327|FG015|Overall Study|Protocol Violation|0|||
156781937|NCT00303628|565951541|FG001|Overall Study|Disease progression|1|||
156781938|NCT00303628|565951540|FG000|Overall Study|Adverse Event|26|||
156781939|NCT00303628|565951541|FG001|Overall Study|Adverse Event|36|||
156781940|NCT00303628|565951540|FG000|Overall Study|Death|0|||
156328684|NCT00973349|564303312|FG000|Overall Study|Unable to classify|0|||
156328685|NCT00973349|564303313|FG001|Overall Study|Unable to classify|0|||
156781941|NCT00303628|565951541|FG001|Overall Study|Death|1|||
156781942|NCT00303628|565951540|FG000|Overall Study|Withdrawal by Subject|11|||
156781943|NCT00303628|565951541|FG001|Overall Study|Withdrawal by Subject|20|||
156781944|NCT00303628|565951540|FG000|Overall Study|Alternative therapy|2|||
156781945|NCT00303628|565951541|FG001|Overall Study|Alternative therapy|0|||
156781946|NCT00303628|565951540|FG000|Overall Study|Other complicating disease|0|||
156781947|NCT00303628|565951541|FG001|Overall Study|Other complicating disease|1|||
156781948|NCT00303628|565951540|FG000|Overall Study|Not start protocol therapy|3|||
156781949|NCT00303628|565951541|FG001|Overall Study|Not start protocol therapy|5|||
156781950|NCT00303628|565951540|FG000|Overall Study|Other|8|||
156781951|NCT00303628|565951541|FG001|Overall Study|Other|9|||
156781952|NCT04925934|565951542|FG000|Overall Study|Adverse Event|1|||
156781953|NCT04925934|565951543|FG001|Overall Study|Adverse Event|0|||
156781954|NCT04925934|565951544|FG002|Overall Study|Adverse Event|0|||
156781955|NCT04925934|565951542|FG000|Overall Study|Lost to Follow-up|2|||
156781956|NCT04925934|565951543|FG001|Overall Study|Lost to Follow-up|0|||
156781957|NCT04925934|565951544|FG002|Overall Study|Lost to Follow-up|1|||
156781958|NCT04925934|565951542|FG000|Overall Study|Death|0|||
156781959|NCT04925934|565951543|FG001|Overall Study|Death|1|||
156781960|NCT04925934|565951544|FG002|Overall Study|Death|0|||
156328686|NCT00973349|564303314|FG002|Overall Study|Unable to classify|0|||
156781961|NCT04925934|565951542|FG000|Overall Study|Withdrawal by Subject|8|||
156781962|NCT04925934|565951543|FG001|Overall Study|Withdrawal by Subject|5|||
156781963|NCT04925934|565951544|FG002|Overall Study|Withdrawal by Subject|9|||
156781964|NCT04925934|565951542|FG000|Overall Study|Other|2|||
156781965|NCT04925934|565951543|FG001|Overall Study|Other|2|||
156781966|NCT04925934|565951544|FG002|Overall Study|Other|2|||
156781967|NCT04925934|565951542|FG000|Overall Study|Eastern European Conflict|7|||
156781968|NCT04925934|565951543|FG001|Overall Study|Eastern European Conflict|3|||
156781969|NCT04925934|565951544|FG002|Overall Study|Eastern European Conflict|2|||
156781970|NCT00376506|565951545|FG000|Overall Study|Death|0|||
156781971|NCT00376506|565951546|FG001|Overall Study|Death|2|||
156781972|NCT03158688|565951547|FG000|Overall Study|Withdrawal by Subject|14|||
156781973|NCT03158688|565951548|FG001|Overall Study|Withdrawal by Subject|28|||
156434842|NCT01317420|564682259|FG002|Overall Study|Other adverse event|0|||
156434843|NCT01317420|564682260|FG003|Overall Study|Other adverse event|0|||
156434844|NCT01317420|564682261|FG004|Overall Study|Other adverse event|0|||
156434845|NCT01317420|564682262|FG005|Overall Study|Other adverse event|0|||
156529225|NCT02225353|565031091|FG001|Overall Study|Protocol Violation|5|||
156529226|NCT02225353|565031092|FG002|Overall Study|Protocol Violation|12|||
156328687|NCT00973349|564303315|FG003|Overall Study|Unable to classify|0|||
156328688|NCT00973349|564303316|FG004|Overall Study|Unable to classify|1|||
156328689|NCT00973349|564303317|FG005|Overall Study|Unable to classify|1|||
156328690|NCT00973349|564303318|FG006|Overall Study|Unable to classify|0|||
156328691|NCT00973349|564303319|FG007|Overall Study|Unable to classify|0|||
156328692|NCT00973349|564303320|FG008|Overall Study|Unable to classify|0|||
156328693|NCT00973349|564303321|FG009|Overall Study|Unable to classify|1|||
156328694|NCT00973349|564303322|FG010|Overall Study|Unable to classify|0|||
156328695|NCT00973349|564303323|FG011|Overall Study|Unable to classify|0|||
156328696|NCT00973349|564303324|FG012|Overall Study|Unable to classify|0|||
156328697|NCT00973349|564303325|FG013|Overall Study|Unable to classify|0|||
156328698|NCT00973349|564303326|FG014|Overall Study|Unable to classify|0|||
156328699|NCT00973349|564303327|FG015|Overall Study|Unable to classify|0|||
156328700|NCT02898116|564303328|FG000|Overall Study|Adverse Event|1|||
156328701|NCT02898116|564303328|FG000|Overall Study|Progressive disease|1|||
156328702|NCT05597020|564303333|FG000|Washout|Forbidden medication|2|||
156328703|NCT05597020|564303334|FG001|Washout|Forbidden medication|0|||
156328704|NCT05597020|564303333|FG000|Treatment Period II|Advice from primary care physician|1|||
156328705|NCT05597020|564303334|FG001|Treatment Period II|Advice from primary care physician|0|||
156328706|NCT05597020|564303333|FG000|Treatment Period II|Subject lost investigational product|1|||
156328707|NCT05597020|564303334|FG001|Treatment Period II|Subject lost investigational product|0|||
156434846|NCT01317420|564682263|FG006|Overall Study|Other adverse event|0|||
156434847|NCT01317420|564682264|FG007|Overall Study|Other adverse event|0|||
156434848|NCT01317420|564682265|FG008|Overall Study|Other adverse event|0|||
156434849|NCT01317420|564682266|FG009|Overall Study|Other adverse event|0|||
156434850|NCT01317420|564682267|FG010|Overall Study|Other adverse event|0|||
156434851|NCT01317420|564682268|FG011|Overall Study|Other adverse event|0|||
156434852|NCT01317420|564682269|FG012|Overall Study|Other adverse event|2|||
156434853|NCT01317420|564682257|FG000|Overall Study|Non-compliant with protocol|0|||
156529227|NCT03707925|565031093|FG000|Overall Study|Inevaluable|1|||
156781974|NCT03158688|565951547|FG000|Overall Study|Decision by sponsor|13|||
156781975|NCT03158688|565951548|FG001|Overall Study|Decision by sponsor|37|||
156781976|NCT03158688|565951547|FG000|Overall Study|Lost to Follow-up|4|||
156328708|NCT05597020|564303333|FG000|Treatment Period II|Private reasons|0|||
156434854|NCT01317420|564682258|FG001|Overall Study|Non-compliant with protocol|0|||
156434855|NCT01317420|564682259|FG002|Overall Study|Non-compliant with protocol|0|||
156529228|NCT02876835|565031094|FG000|Treatment Period (51.1 Month)|Other|1|||
156328709|NCT05597020|564303334|FG001|Treatment Period II|Private reasons|1|||
156781977|NCT03158688|565951548|FG001|Overall Study|Lost to Follow-up|3|||
156781978|NCT03158688|565951547|FG000|Overall Study|Death|74|||
156434856|NCT01317420|564682260|FG003|Overall Study|Non-compliant with protocol|0|||
156434857|NCT01317420|564682261|FG004|Overall Study|Non-compliant with protocol|0|||
156434858|NCT01317420|564682262|FG005|Overall Study|Non-compliant with protocol|0|||
156434859|NCT01317420|564682263|FG006|Overall Study|Non-compliant with protocol|0|||
156434860|NCT01317420|564682264|FG007|Overall Study|Non-compliant with protocol|0|||
156434861|NCT01317420|564682265|FG008|Overall Study|Non-compliant with protocol|0|||
156434862|NCT01317420|564682266|FG009|Overall Study|Non-compliant with protocol|0|||
156434863|NCT01317420|564682267|FG010|Overall Study|Non-compliant with protocol|0|||
156434864|NCT01317420|564682268|FG011|Overall Study|Non-compliant with protocol|0|||
156434865|NCT01317420|564682269|FG012|Overall Study|Non-compliant with protocol|1|||
156434866|NCT01317420|564682257|FG000|Overall Study|Refused to cont. taking trial medication|0|||
156434867|NCT01317420|564682258|FG001|Overall Study|Refused to cont. taking trial medication|0|||
156434868|NCT01317420|564682259|FG002|Overall Study|Refused to cont. taking trial medication|0|||
156434869|NCT01317420|564682260|FG003|Overall Study|Refused to cont. taking trial medication|0|||
156434870|NCT01317420|564682261|FG004|Overall Study|Refused to cont. taking trial medication|0|||
156434871|NCT01317420|564682262|FG005|Overall Study|Refused to cont. taking trial medication|0|||
156434872|NCT01317420|564682263|FG006|Overall Study|Refused to cont. taking trial medication|0|||
156434873|NCT01317420|564682264|FG007|Overall Study|Refused to cont. taking trial medication|0|||
156434874|NCT01317420|564682265|FG008|Overall Study|Refused to cont. taking trial medication|0|||
156434875|NCT01317420|564682266|FG009|Overall Study|Refused to cont. taking trial medication|0|||
156434876|NCT01317420|564682267|FG010|Overall Study|Refused to cont. taking trial medication|0|||
156434877|NCT01317420|564682268|FG011|Overall Study|Refused to cont. taking trial medication|0|||
156434878|NCT01317420|564682269|FG012|Overall Study|Refused to cont. taking trial medication|1|||
156434879|NCT01317420|564682257|FG000|Overall Study|Reason other than those specified|0|||
156434880|NCT01317420|564682258|FG001|Overall Study|Reason other than those specified|0|||
156434881|NCT01317420|564682259|FG002|Overall Study|Reason other than those specified|0|||
156434882|NCT01317420|564682260|FG003|Overall Study|Reason other than those specified|0|||
156434883|NCT01317420|564682261|FG004|Overall Study|Reason other than those specified|0|||
156434884|NCT01317420|564682262|FG005|Overall Study|Reason other than those specified|0|||
156434885|NCT01317420|564682263|FG006|Overall Study|Reason other than those specified|0|||
156434886|NCT01317420|564682264|FG007|Overall Study|Reason other than those specified|0|||
156434887|NCT01317420|564682265|FG008|Overall Study|Reason other than those specified|0|||
156434888|NCT01317420|564682266|FG009|Overall Study|Reason other than those specified|1|||
156434889|NCT01317420|564682267|FG010|Overall Study|Reason other than those specified|0|||
156434890|NCT01317420|564682268|FG011|Overall Study|Reason other than those specified|0|||
156434891|NCT01317420|564682269|FG012|Overall Study|Reason other than those specified|0|||
156434892|NCT00367055|564682271|FG000|Overall Study|Adverse Event|6|||
156434893|NCT00367055|564682272|FG001|Overall Study|Adverse Event|3|||
156434894|NCT00367055|564682271|FG000|Overall Study|Patient's Willing|3|||
156434895|NCT00367055|564682272|FG001|Overall Study|Patient's Willing|2|||
156434896|NCT00367055|564682271|FG000|Overall Study|Lack of Efficacy|1|||
156434897|NCT00367055|564682272|FG001|Overall Study|Lack of Efficacy|2|||
156434898|NCT00367055|564682271|FG000|Overall Study|Lost to Follow-up|1|||
156434899|NCT00367055|564682272|FG001|Overall Study|Lost to Follow-up|1|||
156434900|NCT00367055|564682271|FG000|Overall Study|Protocol Violation|0|||
156434901|NCT00367055|564682272|FG001|Overall Study|Protocol Violation|1|||
156434902|NCT00367055|564682271|FG000|Overall Study|Stopping Criterion Met|0|||
156434903|NCT00367055|564682272|FG001|Overall Study|Stopping Criterion Met|1|||
156434904|NCT00367055|564682271|FG000|Overall Study|Participant Living too Far from Hospital|0|||
156434905|NCT00367055|564682272|FG001|Overall Study|Participant Living too Far from Hospital|1|||
156434906|NCT03586544|564682273|FG000|First Intervention|Adverse Event|0|||
156434907|NCT03586544|564682274|FG001|First Intervention|Adverse Event|1|||
156677818|NCT00835081|565564333|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156677819|NCT01139762|565564334|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
156677820|NCT01139762|565564335|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
156677821|NCT01139762|565564336|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
156677822|NCT01139762|565564334|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
156677823|NCT01139762|565564335|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
156677824|NCT01139762|565564336|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
156677825|NCT01139762|565564334|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
156677826|NCT01139762|565564335|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
156434908|NCT03586544|564682273|FG000|Second Intervention|Withdrawal by Subject|0|||
156434909|NCT03586544|564682274|FG001|Second Intervention|Withdrawal by Subject|1|||
156434910|NCT00539292|564682275|FG000|Overall Study|Physician Decision|1|||
156434911|NCT00539292|564682276|FG001|Overall Study|Physician Decision|0|||
156434912|NCT00324038|564682286|FG000|Overall Study|Adverse Event|38|||
156434913|NCT00324038|564682287|FG001|Overall Study|Adverse Event|23|||
156434914|NCT00324038|564682286|FG000|Overall Study|Lack of Efficacy|5|||
156434915|NCT00324038|564682287|FG001|Overall Study|Lack of Efficacy|13|||
156434916|NCT00324038|564682286|FG000|Overall Study|Lost to Follow-up|0|||
156434917|NCT00324038|564682287|FG001|Overall Study|Lost to Follow-up|2|||
156529229|NCT02876835|565031095|FG001|Treatment Period (51.1 Month)|Other|0|||
156328710|NCT01015131|564303335|FG000|Overall Study|Physician Decision|1|||
156328711|NCT01015131|564303335|FG000|Overall Study|Protocol Violation|1|||
156328712|NCT01015131|564303335|FG000|Overall Study|Withdrawal by Subject|2|||
156328713|NCT01015131|564303335|FG000|Overall Study|Other Protocol Specified Criteria|4|||
156328714|NCT02452697|564303338|FG000|Overall Study|Physician Decision|4|||
156328715|NCT02452697|564303339|FG001|Overall Study|Physician Decision|4|||
156328716|NCT02452697|564303340|FG002|Overall Study|Physician Decision|3|||
156328717|NCT02452697|564303341|FG003|Overall Study|Physician Decision|2|||
156677827|NCT01139762|565564336|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
156677828|NCT01139762|565564334|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
156677829|NCT01139762|565564335|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
156677830|NCT01139762|565564336|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
156677831|NCT01139762|565564334|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
156677832|NCT01139762|565564335|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
156677833|NCT01139762|565564336|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
156677834|NCT01139762|565564334|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
156677835|NCT01139762|565564335|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
156677836|NCT01139762|565564336|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
156677837|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
156677838|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
156677839|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
156677840|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Death|0|||
156677841|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Death|1|||
156677842|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Death|1|||
156677843|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
156677844|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
156677845|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
156677846|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
156677847|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
156677848|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
156677849|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
156677850|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
156677851|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
156677852|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
156677853|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
156677854|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
156677855|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
156677856|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
156781979|NCT03158688|565951548|FG001|Overall Study|Death|142|||
156529230|NCT02876835|565031094|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
156529231|NCT02876835|565031095|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
156529232|NCT02876835|565031094|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
156529233|NCT02876835|565031095|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
156529234|NCT02876835|565031094|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
156529235|NCT02876835|565031095|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
156529236|NCT01117857|565031096|FG000|Overall Study|Lost to Follow-up|4|||
156781980|NCT02942407|565951549|FG000|Overall Study|Lost to Follow-up|3|||
156781981|NCT02942407|565951550|FG001|Overall Study|Lost to Follow-up|2|||
156781982|NCT02942407|565951549|FG000|Overall Study|Withdrawal by Subject|7|||
156781983|NCT02942407|565951550|FG001|Overall Study|Withdrawal by Subject|9|||
156781984|NCT02942407|565951549|FG000|Overall Study|Death|16|||
156781985|NCT02942407|565951550|FG001|Overall Study|Death|13|||
156781986|NCT01944774|565951551|FG000|Overall Study|Withdrawal by Subject|2|||
156781987|NCT01944774|565951552|FG001|Overall Study|Withdrawal by Subject|3|||
156781988|NCT01944774|565951553|FG002|Overall Study|Withdrawal by Subject|3|||
156781989|NCT01944774|565951551|FG000|Overall Study|Adverse Event|3|||
156781990|NCT01944774|565951552|FG001|Overall Study|Adverse Event|2|||
156328718|NCT02452697|564303338|FG000|Overall Study|Withdrawal by Subject|1|||
156434918|NCT00324038|564682286|FG000|Overall Study|Other|6|||
156434919|NCT00324038|564682287|FG001|Overall Study|Other|13|||
156434920|NCT02770248|564682288|FG000|Overall Study|Adverse Event|0|||
156434921|NCT02770248|564682289|FG001|Overall Study|Adverse Event|1|||
156434922|NCT02770248|564682288|FG000|Overall Study|Randomized in error, prior to treatment|0|||
156434923|NCT02770248|564682289|FG001|Overall Study|Randomized in error, prior to treatment|1|||
156434924|NCT00361283|564682291|FG000|Overall Study|Lost to Follow-up|27|||
156434925|NCT01579916|564682292|FG000|Overall Study|Lost to Follow-up|6|||
156434926|NCT01579916|564682293|FG001|Overall Study|Lost to Follow-up|1|||
156434927|NCT01579916|564682292|FG000|Overall Study|Withdrawal by Subject|1|||
156434928|NCT01579916|564682293|FG001|Overall Study|Withdrawal by Subject|1|||
156434929|NCT01579916|564682292|FG000|Overall Study|Death|1|||
156328719|NCT02452697|564303339|FG001|Overall Study|Withdrawal by Subject|0|||
156328720|NCT02452697|564303340|FG002|Overall Study|Withdrawal by Subject|0|||
156328721|NCT02452697|564303341|FG003|Overall Study|Withdrawal by Subject|0|||
156328722|NCT02452697|564303338|FG000|Overall Study|still in follow-up|2|||
156328723|NCT02452697|564303339|FG001|Overall Study|still in follow-up|2|||
156328724|NCT02452697|564303340|FG002|Overall Study|still in follow-up|1|||
156328725|NCT02452697|564303341|FG003|Overall Study|still in follow-up|3|||
156328726|NCT00560885|564303342|FG000|Overall Study|Death|7|||
156328727|NCT00560885|564303342|FG000|Overall Study|Withdrawal by Subject|1|||
156328728|NCT02887859|564303343|FG000|Overall Study|Ongoing|6|||
156328729|NCT02887859|564303343|FG000|Overall Study|Adverse Event|7|||
156328730|NCT02887859|564303343|FG000|Overall Study|Death|1|||
156328731|NCT02887859|564303343|FG000|Overall Study|Physician Decision|1|||
156328732|NCT01554397|564303344|FG000|Overall Study|Withdrawal by Subject|1|||
156328733|NCT01554397|564303345|FG001|Overall Study|Withdrawal by Subject|0|||
156328734|NCT01554397|564303344|FG000|Overall Study|Ineligible|7|||
156328735|NCT01554397|564303345|FG001|Overall Study|Ineligible|0|||
156328736|NCT00257608|564305449|FG000|Chemotherapy Phase|Adverse Event|138|||
156328737|NCT00257608|564305450|FG001|Chemotherapy Phase|Adverse Event|0|||
156677857|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
156677858|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
156677859|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
156328738|NCT00257608|564305451|FG002|Chemotherapy Phase|Adverse Event|0|||
156328739|NCT00257608|564305449|FG000|Chemotherapy Phase|Disease progression|139|||
156328740|NCT00257608|564305450|FG001|Chemotherapy Phase|Disease progression|0|||
156328741|NCT00257608|564305451|FG002|Chemotherapy Phase|Disease progression|0|||
156328742|NCT00257608|564305449|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
156328743|NCT00257608|564305450|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
156677860|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
156677861|NCT01139762|565564334|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
156677862|NCT01139762|565564335|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
156677863|NCT01139762|565564336|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
156677864|NCT01675596|565564337|FG000|Overall Study|Death|6|||
156677865|NCT01675596|565564337|FG000|Overall Study|Exit with other reason|1|||
156677866|NCT01675596|565564337|FG000|Overall Study|Missed Visit|1|||
156677867|NCT00874276|565564338|FG000|Overall Study|Withdrawal by Subject|1|||
156677868|NCT00874276|565564339|FG001|Overall Study|Withdrawal by Subject|1|||
156677869|NCT04236596|565564340|FG000|Overall Study|Withdrawal by Subject|1|||
156677870|NCT04236596|565564340|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
156677871|NCT04236596|565564340|FG000|Overall Study|Participants did not receive implant at all|4|||
156677872|NCT02588339|565564342|FG000|Overall Study|Withdrawal by Subject|1|||
156677873|NCT02588339|565564342|FG000|Overall Study|GVHD Progression prior to treatment|2|||
156677874|NCT01520987|565565526|FG000|Overall Study|Withdrawal by Subject|1|||
156677875|NCT01520987|565565527|FG001|Overall Study|Withdrawal by Subject|0|||
156677876|NCT01520987|565565528|FG002|Overall Study|Withdrawal by Subject|0|||
156677877|NCT01520987|565565529|FG003|Overall Study|Withdrawal by Subject|0|||
156677878|NCT01520987|565565530|FG004|Overall Study|Withdrawal by Subject|0|||
156677879|NCT01520987|565565531|FG005|Overall Study|Withdrawal by Subject|1|||
156677880|NCT01520987|565565532|FG006|Overall Study|Withdrawal by Subject|0|||
156677881|NCT01520987|565565533|FG007|Overall Study|Withdrawal by Subject|0|||
156677882|NCT02005562|565565534|FG000|Overall Study|Death|2|||
156677883|NCT02005562|565565535|FG001|Overall Study|Death|2|||
156677884|NCT02005562|565565534|FG000|Overall Study|Graft loss|7|||
156677885|NCT02005562|565565535|FG001|Overall Study|Graft loss|6|||
156677886|NCT02005562|565565534|FG000|Overall Study|Withdrawal by Subject|2|||
156677887|NCT02005562|565565535|FG001|Overall Study|Withdrawal by Subject|2|||
156677888|NCT02005562|565565534|FG000|Overall Study|No transplant|1|||
156677889|NCT02005562|565565535|FG001|Overall Study|No transplant|4|||
156677890|NCT02005562|565565534|FG000|Overall Study|Physician Decision|0|||
156677891|NCT02005562|565565535|FG001|Overall Study|Physician Decision|1|||
156677892|NCT01023061|565565536|FG000|Overall Study|Withdrawal prior to treatment|2|||
156677893|NCT02966340|565565537|FG000|Overall Study|Adverse Event|0|||
156677894|NCT02966340|565565538|FG001|Overall Study|Adverse Event|1|||
156677895|NCT02966340|565565537|FG000|Overall Study|Lost to Follow-up|0|||
156677896|NCT02966340|565565538|FG001|Overall Study|Lost to Follow-up|1|||
156677897|NCT02966340|565565537|FG000|Overall Study|Withdrawal by Subject|1|||
156677898|NCT02966340|565565538|FG001|Overall Study|Withdrawal by Subject|0|||
156677899|NCT02966340|565565537|FG000|Overall Study|data acquisition error|1|||
156677900|NCT02966340|565565538|FG001|Overall Study|data acquisition error|0|||
156677901|NCT02966340|565565537|FG000|Overall Study|startle non-responder|1|||
156677902|NCT02966340|565565538|FG001|Overall Study|startle non-responder|1|||
156677903|NCT02664415|565565539|FG000|Overall Study|Adverse Event|1|||
156677904|NCT02664415|565565540|FG001|Overall Study|Adverse Event|0|||
156677905|NCT02034513|565565544|FG000|Overall Study|Adverse Event|11|||
156677906|NCT02034513|565565545|FG001|Overall Study|Adverse Event|10|||
156677907|NCT02034513|565565544|FG000|Overall Study|Lack of Efficacy|0|||
156434930|NCT01579916|564682293|FG001|Overall Study|Death|0|||
156434931|NCT03264456|564682296|FG000|Overall Study|Withdrawal by Subject|3|||
156434932|NCT03264456|564682296|FG000|Overall Study|Lost to Follow-up|1|||
156434933|NCT01123083|564682297|FG000|Overall Study|Investigator recommendation|1|||
156434934|NCT01123083|564682298|FG001|Overall Study|Investigator recommendation|1|||
156434935|NCT01123083|564682297|FG000|Overall Study|Administrative reasons|0|||
156434936|NCT01123083|564682298|FG001|Overall Study|Administrative reasons|4|||
156434937|NCT01123083|564682297|FG000|Overall Study|Lost to Follow-up|2|||
156434938|NCT01123083|564682298|FG001|Overall Study|Lost to Follow-up|6|||
156434939|NCT01123083|564682297|FG000|Overall Study|Adverse Event|1|||
156434940|NCT01123083|564682298|FG001|Overall Study|Adverse Event|0|||
156434941|NCT01123083|564682297|FG000|Overall Study|Withdrew for another reason not covered|0|||
156434942|NCT01123083|564682298|FG001|Overall Study|Withdrew for another reason not covered|1|||
156434943|NCT01123083|564682297|FG000|Overall Study|Participant/legal representative request|7|||
156434944|NCT01123083|564682298|FG001|Overall Study|Participant/legal representative request|3|||
156434945|NCT00961636|564682299|FG000|Overall Study|Adverse Event|35|||
156434946|NCT00961636|564682300|FG001|Overall Study|Adverse Event|54|||
156434947|NCT00961636|564682301|FG002|Overall Study|Adverse Event|13|||
156434948|NCT00961636|564682299|FG000|Overall Study|Flushing Symptoms|29|||
156677908|NCT02034513|565565545|FG001|Overall Study|Lack of Efficacy|1|||
156677909|NCT02034513|565565544|FG000|Overall Study|Lost to Follow-up|6|||
156677910|NCT02034513|565565545|FG001|Overall Study|Lost to Follow-up|7|||
156677911|NCT02034513|565565544|FG000|Overall Study|Pregnancy|0|||
156677912|NCT02034513|565565545|FG001|Overall Study|Pregnancy|3|||
156434949|NCT00961636|564682300|FG001|Overall Study|Flushing Symptoms|46|||
156434950|NCT00961636|564682301|FG002|Overall Study|Flushing Symptoms|3|||
156434951|NCT00961636|564682299|FG000|Overall Study|Lost to Follow-up|2|||
156434952|NCT00961636|564682300|FG001|Overall Study|Lost to Follow-up|3|||
156434953|NCT00961636|564682301|FG002|Overall Study|Lost to Follow-up|1|||
156434954|NCT00961636|564682299|FG000|Overall Study|Physician Decision|3|||
156434955|NCT00961636|564682300|FG001|Overall Study|Physician Decision|1|||
156434956|NCT00961636|564682301|FG002|Overall Study|Physician Decision|1|||
156434957|NCT00961636|564682299|FG000|Overall Study|Protocol Violation|9|||
156434958|NCT00961636|564682300|FG001|Overall Study|Protocol Violation|5|||
156434959|NCT00961636|564682301|FG002|Overall Study|Protocol Violation|1|||
156434960|NCT00961636|564682299|FG000|Overall Study|Withdrawal by Subject|29|||
156434961|NCT00961636|564682300|FG001|Overall Study|Withdrawal by Subject|22|||
156434962|NCT00961636|564682301|FG002|Overall Study|Withdrawal by Subject|13|||
156434963|NCT00290706|564682302|FG000|Overall Study|Withdrawal by Subject|2|||
156434964|NCT00290706|564682303|FG001|Overall Study|Withdrawal by Subject|0|||
156434965|NCT00290706|564682304|FG002|Overall Study|Withdrawal by Subject|0|||
156434966|NCT00290706|564682305|FG003|Overall Study|Withdrawal by Subject|0|||
156434967|NCT00290706|564682302|FG000|Overall Study|Progressive Disease|3|||
156434968|NCT00290706|564682303|FG001|Overall Study|Progressive Disease|5|||
156434969|NCT00290706|564682304|FG002|Overall Study|Progressive Disease|4|||
156434970|NCT00290706|564682305|FG003|Overall Study|Progressive Disease|10|||
156434971|NCT00290706|564682302|FG000|Overall Study|Adverse Event|0|||
156434972|NCT00290706|564682303|FG001|Overall Study|Adverse Event|1|||
156434973|NCT00290706|564682304|FG002|Overall Study|Adverse Event|2|||
156434974|NCT00290706|564682305|FG003|Overall Study|Adverse Event|0|||
156434975|NCT00290706|564682302|FG000|Overall Study|Receive auto transplant or radiation|0|||
156434976|NCT00290706|564682303|FG001|Overall Study|Receive auto transplant or radiation|0|||
156434977|NCT00290706|564682304|FG002|Overall Study|Receive auto transplant or radiation|0|||
156434978|NCT00290706|564682305|FG003|Overall Study|Receive auto transplant or radiation|1|||
156434979|NCT00290706|564682302|FG000|Overall Study|Physician Decision|0|||
156434980|NCT00290706|564682303|FG001|Overall Study|Physician Decision|0|||
156781991|NCT01944774|565951553|FG002|Overall Study|Adverse Event|3|||
156677913|NCT02034513|565565544|FG000|Overall Study|Protocol Violation|7|||
156677914|NCT02034513|565565545|FG001|Overall Study|Protocol Violation|10|||
156677915|NCT02034513|565565544|FG000|Overall Study|Withdrawal by Subject|25|||
156677916|NCT02034513|565565545|FG001|Overall Study|Withdrawal by Subject|25|||
156677917|NCT02034513|565565544|FG000|Overall Study|Unclassified|0|||
156781992|NCT01944774|565951551|FG000|Overall Study|Lack of Efficacy|1|||
156781993|NCT01944774|565951552|FG001|Overall Study|Lack of Efficacy|2|||
156781994|NCT01944774|565951553|FG002|Overall Study|Lack of Efficacy|2|||
156781995|NCT01944774|565951551|FG000|Overall Study|Lost to Follow-up|0|||
156434981|NCT00290706|564682304|FG002|Overall Study|Physician Decision|0|||
156434982|NCT00290706|564682305|FG003|Overall Study|Physician Decision|1|||
156434983|NCT01196429|564682309|FG000|Overall Study|Ineligible - inadequate pathology|1|||
156434984|NCT01196429|564682310|FG001|Overall Study|Ineligible - inadequate pathology|0|||
156434985|NCT01196429|564682309|FG000|Overall Study|Ineligible - wrong cell type|1|||
156434986|NCT01196429|564682310|FG001|Overall Study|Ineligible - wrong cell type|0|||
156434987|NCT01196429|564682309|FG000|Overall Study|Refused - Never Treated|1|||
156434988|NCT01196429|564682310|FG001|Overall Study|Refused - Never Treated|0|||
156434989|NCT02486588|564682311|FG000|Overall Study|Randomized in error- ineligible|738|||
156677918|NCT02034513|565565545|FG001|Overall Study|Unclassified|1|||
156677919|NCT02308241|565565546|FG000|Overall Study|Withdrawal by Subject|3|||
156677920|NCT00659815|565565547|FG000|Overall Study|Study related symptoms and complaints|2|||
156677921|NCT00659815|565565548|FG001|Overall Study|Study related symptoms and complaints|1|||
156677922|NCT00659815|565565547|FG000|Overall Study|Inability to maintain wearing schedule|1|||
156677923|NCT00659815|565565548|FG001|Overall Study|Inability to maintain wearing schedule|2|||
156781996|NCT01944774|565951552|FG001|Overall Study|Lost to Follow-up|1|||
156781997|NCT01944774|565951553|FG002|Overall Study|Lost to Follow-up|0|||
156781998|NCT00374868|565951554|FG000|Overall Study|Adverse Event|12|||
156781999|NCT00374868|565951554|FG000|Overall Study|Progressive Disease|7|||
156782000|NCT00374868|565951554|FG000|Overall Study|Physician Decision|13|||
156782001|NCT00374868|565951554|FG000|Overall Study|Lost to Follow-up|1|||
156782002|NCT00374868|565951554|FG000|Overall Study|Death|2|||
156782003|NCT00374868|565951554|FG000|Overall Study|Other - Not Specified|1|||
156782004|NCT03188185|565951555|FG000|Stage 1|Adverse Event|4|||
156782005|NCT03188185|565951556|FG001|Stage 1|Adverse Event|12|||
156782006|NCT03188185|565951557|FG002|Stage 1|Adverse Event|0|||
156782007|NCT03188185|565951558|FG003|Stage 1|Adverse Event|0|||
156782008|NCT03188185|565951555|FG000|Stage 1|Lack of Efficacy|0|||
156782009|NCT03188185|565951556|FG001|Stage 1|Lack of Efficacy|2|||
156782010|NCT03188185|565951557|FG002|Stage 1|Lack of Efficacy|0|||
156782011|NCT03188185|565951558|FG003|Stage 1|Lack of Efficacy|0|||
156782012|NCT03188185|565951555|FG000|Stage 1|Lost to Follow-up|6|||
156782013|NCT03188185|565951556|FG001|Stage 1|Lost to Follow-up|1|||
156782014|NCT03188185|565951557|FG002|Stage 1|Lost to Follow-up|0|||
156782015|NCT03188185|565951558|FG003|Stage 1|Lost to Follow-up|0|||
156677924|NCT00659815|565565547|FG000|Overall Study|Withdrawal by Subject|1|||
156677925|NCT00659815|565565548|FG001|Overall Study|Withdrawal by Subject|1|||
156677926|NCT02998541|565565551|FG000|Overall Study|Adverse Event|4|||
156677927|NCT02998541|565565552|FG001|Overall Study|Adverse Event|5|||
156677928|NCT02998541|565565553|FG002|Overall Study|Adverse Event|1|||
156677929|NCT02998541|565565551|FG000|Overall Study|Protocol Violation|1|||
156677930|NCT02998541|565565552|FG001|Overall Study|Protocol Violation|0|||
156677931|NCT02998541|565565553|FG002|Overall Study|Protocol Violation|0|||
156677932|NCT02998541|565565551|FG000|Overall Study|Withdrawal by Subject|3|||
156677933|NCT02998541|565565552|FG001|Overall Study|Withdrawal by Subject|1|||
156677934|NCT02998541|565565553|FG002|Overall Study|Withdrawal by Subject|0|||
156677935|NCT02998541|565565551|FG000|Overall Study|Lost to Follow-up|0|||
156677936|NCT02998541|565565552|FG001|Overall Study|Lost to Follow-up|3|||
156677937|NCT02998541|565565553|FG002|Overall Study|Lost to Follow-up|1|||
156677938|NCT02998541|565565551|FG000|Overall Study|Physician Decision|0|||
156677939|NCT02998541|565565552|FG001|Overall Study|Physician Decision|0|||
156677940|NCT02998541|565565553|FG002|Overall Study|Physician Decision|3|||
156677941|NCT02998541|565565551|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156677942|NCT02998541|565565552|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156677943|NCT02998541|565565553|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
156677944|NCT01513239|565565554|FG000|Period 1: Main Phase|Adverse Event|1|||
156677945|NCT01513239|565565555|FG001|Period 1: Main Phase|Adverse Event|1|||
156677946|NCT01513239|565565556|FG002|Period 1: Main Phase|Adverse Event|2|||
156782016|NCT03188185|565951555|FG000|Stage 1|Withdrawal by Subject|9|||
156782017|NCT03188185|565951556|FG001|Stage 1|Withdrawal by Subject|0|||
156782018|NCT03188185|565951557|FG002|Stage 1|Withdrawal by Subject|0|||
156434990|NCT02486588|564682312|FG001|Overall Study|Randomized in error- ineligible|750|||
156434991|NCT02486588|564682313|FG002|Overall Study|Randomized in error- ineligible|755|||
156434992|NCT02486588|564682314|FG003|Overall Study|Randomized in error- ineligible|738|||
156434993|NCT02486588|564682315|FG004|Overall Study|Randomized in error- ineligible|746|||
156434994|NCT02486588|564682316|FG005|Overall Study|Randomized in error- ineligible|746|||
156434995|NCT00688519|564682317|FG000|Overall Study|Adverse Event|2|||
156434996|NCT00688519|564682318|FG001|Overall Study|Adverse Event|3|||
156434997|NCT00688519|564682317|FG000|Overall Study|Lost to Follow-up|3|||
156434998|NCT00688519|564682318|FG001|Overall Study|Lost to Follow-up|3|||
156434999|NCT00688519|564682317|FG000|Overall Study|Lack of Efficacy|3|||
156435000|NCT00688519|564682318|FG001|Overall Study|Lack of Efficacy|1|||
156435001|NCT00688519|564682317|FG000|Overall Study|Withdrawal by Subject|7|||
156435002|NCT00688519|564682318|FG001|Overall Study|Withdrawal by Subject|6|||
156435003|NCT00688519|564682317|FG000|Overall Study|Prohibited medication|1|||
156435004|NCT00688519|564682318|FG001|Overall Study|Prohibited medication|0|||
156435005|NCT00688519|564682317|FG000|Overall Study|Non-compliance|0|||
156435006|NCT00688519|564682318|FG001|Overall Study|Non-compliance|1|||
156435007|NCT00688519|564682317|FG000|Overall Study|Subject moved out of state|1|||
156435008|NCT00688519|564682318|FG001|Overall Study|Subject moved out of state|0|||
156435009|NCT00688519|564682317|FG000|Overall Study|Investigator decision|1|||
156435010|NCT00688519|564682318|FG001|Overall Study|Investigator decision|0|||
156677947|NCT01513239|565565557|FG003|Period 1: Main Phase|Adverse Event|0|||
156677948|NCT01513239|565565558|FG004|Period 1: Main Phase|Adverse Event|0|||
156677949|NCT01513239|565565559|FG005|Period 1: Main Phase|Adverse Event|0|||
156677950|NCT01513239|565565554|FG000|Period 1: Main Phase|Death|29|||
156677951|NCT01513239|565565555|FG001|Period 1: Main Phase|Death|22|||
156782019|NCT03188185|565951558|FG003|Stage 1|Withdrawal by Subject|0|||
156782020|NCT03188185|565951555|FG000|Stage 1|Identified as a professional patient|0|||
156782021|NCT03188185|565951556|FG001|Stage 1|Identified as a professional patient|1|||
156782022|NCT03188185|565951557|FG002|Stage 1|Identified as a professional patient|0|||
156782023|NCT03188185|565951558|FG003|Stage 1|Identified as a professional patient|0|||
156782024|NCT03188185|565951555|FG000|Stage 2|Adverse Event|0|||
156782025|NCT03188185|565951556|FG001|Stage 2|Adverse Event|0|||
156782026|NCT03188185|565951557|FG002|Stage 2|Adverse Event|2|||
156782027|NCT03188185|565951558|FG003|Stage 2|Adverse Event|4|||
156782028|NCT03188185|565951555|FG000|Stage 2|Lack of Efficacy|0|||
156782029|NCT03188185|565951556|FG001|Stage 2|Lack of Efficacy|0|||
156782030|NCT03188185|565951557|FG002|Stage 2|Lack of Efficacy|3|||
156782031|NCT03188185|565951558|FG003|Stage 2|Lack of Efficacy|0|||
156782032|NCT03188185|565951555|FG000|Stage 2|Lost to Follow-up|0|||
156782033|NCT03188185|565951556|FG001|Stage 2|Lost to Follow-up|0|||
156782034|NCT03188185|565951557|FG002|Stage 2|Lost to Follow-up|1|||
156782035|NCT03188185|565951558|FG003|Stage 2|Lost to Follow-up|0|||
156782036|NCT03188185|565951555|FG000|Stage 2|Physician Decision|0|||
156782037|NCT03188185|565951556|FG001|Stage 2|Physician Decision|0|||
156782038|NCT03188185|565951557|FG002|Stage 2|Physician Decision|0|||
156782039|NCT03188185|565951558|FG003|Stage 2|Physician Decision|1|||
156782040|NCT03188185|565951555|FG000|Stage 2|Withdrawal by Subject|0|||
156782041|NCT03188185|565951556|FG001|Stage 2|Withdrawal by Subject|0|||
156782042|NCT03188185|565951557|FG002|Stage 2|Withdrawal by Subject|3|||
156782043|NCT03188185|565951558|FG003|Stage 2|Withdrawal by Subject|1|||
156782044|NCT00774748|565951559|FG000|Overall Study|Lost to Follow-up|3|||
156782045|NCT02965456|565951562|FG000|Overall Study|Lost to Follow-up|40|||
156782046|NCT02965456|565951563|FG001|Overall Study|Lost to Follow-up|18|||
156782047|NCT02965456|565951562|FG000|Overall Study|Subject Request|22|||
156782048|NCT02965456|565951563|FG001|Overall Study|Subject Request|13|||
156782049|NCT02965456|565951562|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
156782050|NCT02965456|565951563|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
156782051|NCT02965456|565951562|FG000|Overall Study|Adverse Event|3|||
156782052|NCT02965456|565951563|FG001|Overall Study|Adverse Event|0|||
156782053|NCT02965456|565951562|FG000|Overall Study|Noncompliance with Study Drug|1|||
156782054|NCT02965456|565951563|FG001|Overall Study|Noncompliance with Study Drug|1|||
156782055|NCT02965456|565951562|FG000|Overall Study|Worsening Condition|0|||
156782056|NCT02965456|565951563|FG001|Overall Study|Worsening Condition|2|||
156782057|NCT02965456|565951562|FG000|Overall Study|Lack of Efficacy|1|||
156782058|NCT02965456|565951563|FG001|Overall Study|Lack of Efficacy|0|||
156782059|NCT02965456|565951562|FG000|Overall Study|Physician Decision|0|||
156782060|NCT02965456|565951563|FG001|Overall Study|Physician Decision|1|||
156782061|NCT02965456|565951562|FG000|Overall Study|Pregnancy|1|||
156782062|NCT02965456|565951563|FG001|Overall Study|Pregnancy|0|||
156782063|NCT02965456|565951562|FG000|Overall Study|Protocol Violation|0|||
156782064|NCT02965456|565951563|FG001|Overall Study|Protocol Violation|1|||
156782065|NCT02965456|565951562|FG000|Overall Study|Participant ran out of study drug|0|||
156782066|NCT02965456|565951563|FG001|Overall Study|Participant ran out of study drug|1|||
156782067|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
156782068|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
156782069|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
156782070|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
156782071|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
156782072|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
156782073|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
156782074|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
156782075|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
156782076|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
156782077|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
156782078|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
156782079|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
156782080|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
156782081|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
156782082|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
156435011|NCT00688519|564682317|FG000|Overall Study|Subject moved out of area|1|||
156435012|NCT00688519|564682318|FG001|Overall Study|Subject moved out of area|0|||
156782083|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
156782084|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
156782085|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
156782086|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
156782087|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
156782088|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
156782089|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
156435013|NCT00688519|564682317|FG000|Overall Study|Pregnancy|0|||
156782090|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
156782091|NCT02337946|565951564|FG000|In-between Period|Without Informed Consent|1|||
156782092|NCT02337946|565951565|FG001|In-between Period|Without Informed Consent|0|||
156677952|NCT01513239|565565556|FG002|Period 1: Main Phase|Death|32|||
156677953|NCT01513239|565565557|FG003|Period 1: Main Phase|Death|0|||
156677954|NCT01513239|565565558|FG004|Period 1: Main Phase|Death|0|||
156677955|NCT01513239|565565559|FG005|Period 1: Main Phase|Death|0|||
156677956|NCT01513239|565565554|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
156677957|NCT01513239|565565555|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
156677958|NCT01513239|565565556|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
156677959|NCT01513239|565565557|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
156677960|NCT01513239|565565558|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
156677961|NCT01513239|565565559|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
156677962|NCT01513239|565565554|FG000|Period 1: Main Phase|Physician Decision|4|||
156677963|NCT01513239|565565555|FG001|Period 1: Main Phase|Physician Decision|4|||
156677964|NCT01513239|565565556|FG002|Period 1: Main Phase|Physician Decision|4|||
156677965|NCT01513239|565565557|FG003|Period 1: Main Phase|Physician Decision|0|||
156677966|NCT01513239|565565558|FG004|Period 1: Main Phase|Physician Decision|0|||
156677967|NCT01513239|565565559|FG005|Period 1: Main Phase|Physician Decision|0|||
156677968|NCT01513239|565565554|FG000|Period 1: Main Phase|Protocol Violation|2|||
156677969|NCT01513239|565565555|FG001|Period 1: Main Phase|Protocol Violation|2|||
156677970|NCT01513239|565565556|FG002|Period 1: Main Phase|Protocol Violation|2|||
156677971|NCT01513239|565565557|FG003|Period 1: Main Phase|Protocol Violation|0|||
156677972|NCT01513239|565565558|FG004|Period 1: Main Phase|Protocol Violation|0|||
156677973|NCT01513239|565565559|FG005|Period 1: Main Phase|Protocol Violation|0|||
156677974|NCT01513239|565565554|FG000|Period 1: Main Phase|Technical Problems|1|||
156677975|NCT01513239|565565555|FG001|Period 1: Main Phase|Technical Problems|2|||
156677976|NCT01513239|565565556|FG002|Period 1: Main Phase|Technical Problems|0|||
156677977|NCT01513239|565565557|FG003|Period 1: Main Phase|Technical Problems|0|||
156677978|NCT01513239|565565558|FG004|Period 1: Main Phase|Technical Problems|0|||
156677979|NCT01513239|565565559|FG005|Period 1: Main Phase|Technical Problems|0|||
156328744|NCT00257608|564305451|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
156529237|NCT01117857|565031096|FG000|Overall Study|Withdrawal by Subject|4|||
156529238|NCT01117857|565031096|FG000|Overall Study|Physician Decision|1|||
156529239|NCT04683731|565031097|FG000|Overall Study|Withdrawal by Subject|1|||
156328745|NCT00257608|564305449|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
156328746|NCT00257608|564305450|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
156328747|NCT00257608|564305451|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
156328748|NCT00257608|564305449|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
156328749|NCT00257608|564305450|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
156328750|NCT00257608|564305451|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
156328751|NCT00257608|564305449|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
156328752|NCT00257608|564305450|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
156328753|NCT00257608|564305451|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
156328754|NCT00257608|564305449|FG000|Chemotherapy Phase|Physician Decision|28|||
156328755|NCT00257608|564305450|FG001|Chemotherapy Phase|Physician Decision|0|||
156328756|NCT00257608|564305451|FG002|Chemotherapy Phase|Physician Decision|0|||
156328757|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Adverse Event|0|||
156328758|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Adverse Event|34|||
156328759|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Adverse Event|38|||
156328760|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Disease progression|0|||
156328761|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Disease progression|204|||
156328762|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Disease progression|168|||
156328763|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
156328764|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
156328765|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
156328766|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
156328767|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
156328768|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
156328769|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
156328770|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
156328771|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
156328772|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
156328773|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
156328774|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
156328775|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
156328776|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
156328777|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
156328778|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Physician Decision|0|||
156328779|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Physician Decision|8|||
156328780|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Physician Decision|11|||
156677980|NCT01513239|565565554|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
156677981|NCT01513239|565565555|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
156677982|NCT01513239|565565556|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
156677983|NCT01513239|565565557|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
156328781|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
156328782|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
156328783|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
156328784|NCT00257608|564305449|FG000|Post Chemotherapy Phase|Not treated|0|||
156328785|NCT00257608|564305450|FG001|Post Chemotherapy Phase|Not treated|4|||
156328786|NCT00257608|564305451|FG002|Post Chemotherapy Phase|Not treated|7|||
156328787|NCT03673046|564305452|FG000|Overall Study|Adverse Event|1|||
156328788|NCT03673046|564305453|FG001|Overall Study|Adverse Event|1|||
156328789|NCT03673046|564305452|FG000|Overall Study|Withdrawal by Subject|8|||
156328790|NCT03673046|564305453|FG001|Overall Study|Withdrawal by Subject|2|||
156328791|NCT03817879|564305454|FG000|Overall Study|Drop out|5|||
156328792|NCT03817879|564305455|FG001|Overall Study|Drop out|12|||
156328793|NCT03817879|564305454|FG000|Overall Study|Withdrawal by Subject|0|||
156328794|NCT03817879|564305455|FG001|Overall Study|Withdrawal by Subject|1|||
156328795|NCT03693300|564305456|FG000|Overall Study|Withdrawal by Subject|6|||
156328796|NCT03693300|564305457|FG001|Overall Study|Withdrawal by Subject|0|||
156677984|NCT01513239|565565558|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
156677985|NCT01513239|565565559|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
156677986|NCT01513239|565565554|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
156677987|NCT01513239|565565555|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
156328797|NCT03693300|564305456|FG000|Overall Study|Death|50|||
156328798|NCT03693300|564305457|FG001|Overall Study|Death|2|||
156328799|NCT03693300|564305456|FG000|Overall Study|Lost to Follow-up|2|||
156328800|NCT03693300|564305457|FG001|Overall Study|Lost to Follow-up|0|||
156677988|NCT01513239|565565556|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
156677989|NCT01513239|565565557|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
156328801|NCT00537238|564305458|FG000|Overall Study|Death|1|||
156328802|NCT00537238|564305459|FG001|Overall Study|Death|2|||
156328803|NCT00537238|564305458|FG000|Overall Study|Adverse Event|31|||
156328804|NCT00537238|564305459|FG001|Overall Study|Adverse Event|22|||
156328805|NCT00537238|564305458|FG000|Overall Study|Lack of Efficacy|20|||
156328806|NCT00537238|564305459|FG001|Overall Study|Lack of Efficacy|21|||
156328807|NCT00537238|564305458|FG000|Overall Study|Lost to Follow-up|12|||
156328808|NCT00537238|564305459|FG001|Overall Study|Lost to Follow-up|8|||
156328809|NCT00537238|564305458|FG000|Overall Study|Withdrawal by Subject|51|||
156328810|NCT00537238|564305459|FG001|Overall Study|Withdrawal by Subject|47|||
156328811|NCT00537238|564305458|FG000|Overall Study|Protocol Violation|15|||
156328812|NCT00537238|564305459|FG001|Overall Study|Protocol Violation|19|||
156328813|NCT00537238|564305458|FG000|Overall Study|Does not meet entrance criteria|0|||
156328814|NCT00537238|564305459|FG001|Overall Study|Does not meet entrance criteria|2|||
156328815|NCT00537238|564305458|FG000|Overall Study|Other|44|||
156328816|NCT00537238|564305459|FG001|Overall Study|Other|52|||
156328817|NCT00697073|564305460|FG000|Overall Study|Withdrawal by Subject|2|||
156435014|NCT00688519|564682318|FG001|Overall Study|Pregnancy|1|||
156435015|NCT02551055|564682321|FG000|Overall Study|Death|2|||
156435016|NCT02551055|564682322|FG001|Overall Study|Death|4|||
156435017|NCT02551055|564682323|FG002|Overall Study|Death|2|||
156677990|NCT01513239|565565558|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
156677991|NCT01513239|565565559|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
156677992|NCT01513239|565565554|FG000|Period 2: 9 Month Extension Phase|Death|0|||
156677993|NCT01513239|565565555|FG001|Period 2: 9 Month Extension Phase|Death|0|||
156677994|NCT01513239|565565556|FG002|Period 2: 9 Month Extension Phase|Death|0|||
156677995|NCT01513239|565565557|FG003|Period 2: 9 Month Extension Phase|Death|2|||
156677996|NCT01513239|565565558|FG004|Period 2: 9 Month Extension Phase|Death|5|||
156677997|NCT01513239|565565559|FG005|Period 2: 9 Month Extension Phase|Death|2|||
156677998|NCT01513239|565565554|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
156677999|NCT01513239|565565555|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
156678000|NCT01513239|565565556|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
156678001|NCT01513239|565565557|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
156328818|NCT00697073|564305460|FG000|Overall Study|Pregnancy|1|||
156328819|NCT00697073|564305460|FG000|Overall Study|non compliance and other|6|||
156328820|NCT03265665|564305465|FG000|24-week Data Collection|Withdrawal by Subject|2|||
156328821|NCT03265665|564305466|FG001|24-week Data Collection|Withdrawal by Subject|2|||
156328822|NCT03265665|564305465|FG000|24-week Data Collection|Lost to Follow-up|4|||
156328823|NCT03265665|564305466|FG001|24-week Data Collection|Lost to Follow-up|5|||
156435018|NCT02551055|564682324|FG003|Overall Study|Death|2|||
156435019|NCT02551055|564682325|FG004|Overall Study|Death|2|||
156435020|NCT02551055|564682326|FG005|Overall Study|Death|1|||
156435021|NCT02551055|564682327|FG006|Overall Study|Death|2|||
156435022|NCT02551055|564682328|FG007|Overall Study|Death|0|||
156435023|NCT02551055|564682321|FG000|Overall Study|Study Terminated by Sponsor|1|||
156435024|NCT02551055|564682322|FG001|Overall Study|Study Terminated by Sponsor|1|||
156435025|NCT02551055|564682323|FG002|Overall Study|Study Terminated by Sponsor|0|||
156435026|NCT02551055|564682324|FG003|Overall Study|Study Terminated by Sponsor|2|||
156435027|NCT02551055|564682325|FG004|Overall Study|Study Terminated by Sponsor|2|||
156435028|NCT02551055|564682326|FG005|Overall Study|Study Terminated by Sponsor|0|||
156435029|NCT02551055|564682327|FG006|Overall Study|Study Terminated by Sponsor|0|||
156435030|NCT02551055|564682328|FG007|Overall Study|Study Terminated by Sponsor|0|||
156435031|NCT02551055|564682321|FG000|Overall Study|Withdrawal by Subject|1|||
156435032|NCT02551055|564682322|FG001|Overall Study|Withdrawal by Subject|1|||
156435033|NCT02551055|564682323|FG002|Overall Study|Withdrawal by Subject|0|||
156435034|NCT02551055|564682324|FG003|Overall Study|Withdrawal by Subject|1|||
156435035|NCT02551055|564682325|FG004|Overall Study|Withdrawal by Subject|2|||
156435036|NCT02551055|564682326|FG005|Overall Study|Withdrawal by Subject|0|||
156435037|NCT02551055|564682327|FG006|Overall Study|Withdrawal by Subject|0|||
156435038|NCT02551055|564682328|FG007|Overall Study|Withdrawal by Subject|0|||
156435039|NCT02551055|564682321|FG000|Overall Study|Reason not specified|0|||
156435040|NCT02551055|564682322|FG001|Overall Study|Reason not specified|0|||
156435041|NCT02551055|564682323|FG002|Overall Study|Reason not specified|0|||
156435042|NCT02551055|564682324|FG003|Overall Study|Reason not specified|0|||
156435043|NCT02551055|564682325|FG004|Overall Study|Reason not specified|1|||
156435044|NCT02551055|564682326|FG005|Overall Study|Reason not specified|0|||
156435045|NCT02551055|564682327|FG006|Overall Study|Reason not specified|1|||
156435046|NCT02551055|564682328|FG007|Overall Study|Reason not specified|0|||
156435047|NCT00430300|564682329|FG000|Overall Study|Adverse Event|0|||
156435048|NCT00430300|564682330|FG001|Overall Study|Adverse Event|2|||
156435049|NCT00430300|564682331|FG002|Overall Study|Adverse Event|1|||
156435050|NCT00430300|564682332|FG003|Overall Study|Adverse Event|1|||
156435051|NCT00430300|564682329|FG000|Overall Study|Withdrawal by Subject|1|||
156435052|NCT00430300|564682330|FG001|Overall Study|Withdrawal by Subject|0|||
156435053|NCT00430300|564682331|FG002|Overall Study|Withdrawal by Subject|5|||
156435054|NCT00430300|564682332|FG003|Overall Study|Withdrawal by Subject|0|||
156435055|NCT00430300|564682329|FG000|Overall Study|Laboratory abnormality|1|||
156435056|NCT00430300|564682330|FG001|Overall Study|Laboratory abnormality|0|||
156435057|NCT00430300|564682331|FG002|Overall Study|Laboratory abnormality|0|||
156435058|NCT00430300|564682332|FG003|Overall Study|Laboratory abnormality|0|||
156435059|NCT00430300|564682329|FG000|Overall Study|Other|0|||
156435060|NCT00430300|564682330|FG001|Overall Study|Other|0|||
156435061|NCT00430300|564682331|FG002|Overall Study|Other|0|||
156435062|NCT00430300|564682332|FG003|Overall Study|Other|1|||
156435063|NCT02041104|564682337|FG000|Overall Study|Lost to Follow-up|1|||
156435064|NCT02041104|564682338|FG001|Overall Study|Lost to Follow-up|4|||
156435065|NCT02041104|564682337|FG000|Overall Study|discomfort during OGTT|0|||
156435066|NCT02041104|564682338|FG001|Overall Study|discomfort during OGTT|3|||
156435067|NCT01063517|564682339|FG000|Overall Study|Consent withdrawal|1|||
156435068|NCT01063517|564682340|FG001|Overall Study|Consent withdrawal|0|||
156435069|NCT01063517|564682339|FG000|Overall Study|Study reached data cut-off|19|||
156435070|NCT01063517|564682340|FG001|Overall Study|Study reached data cut-off|7|||
156435071|NCT01063517|564682339|FG000|Overall Study|Lost to Follow-up|4|||
156435072|NCT01063517|564682340|FG001|Overall Study|Lost to Follow-up|3|||
156435073|NCT01063517|564682339|FG000|Overall Study|Withdrawal by Subject|1|||
156435074|NCT01063517|564682340|FG001|Overall Study|Withdrawal by Subject|2|||
156435075|NCT01063517|564682339|FG000|Overall Study|Death|33|||
156678002|NCT01513239|565565558|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
156678003|NCT01513239|565565559|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
156678004|NCT01513239|565565554|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
156678005|NCT01513239|565565555|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
156435076|NCT01063517|564682340|FG001|Overall Study|Death|48|||
156678006|NCT01513239|565565556|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
156678007|NCT01513239|565565557|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
156678008|NCT01513239|565565558|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
156678009|NCT01513239|565565559|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
156435077|NCT02106442|564682342|FG000|Overall Study|Case Report Forms Uncollected|7|||
156435078|NCT02106442|564682342|FG000|Overall Study|Protocol Deviation|30|||
156435079|NCT03215927|564683490|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
156435080|NCT03215927|564683491|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
156435081|NCT03215927|564683490|FG000|Open Label Extension|Adverse Event|1|||
156435082|NCT03215927|564683491|FG001|Open Label Extension|Adverse Event|0|||
156435083|NCT03215927|564683490|FG000|Open Label Extension|Lack of Efficacy|1|||
156435084|NCT03215927|564683491|FG001|Open Label Extension|Lack of Efficacy|0|||
156435085|NCT03215927|564683490|FG000|Open Label Extension|Death|0|||
156435086|NCT03215927|564683491|FG001|Open Label Extension|Death|1|||
156435087|NCT05011396|564683492|FG000|Overall Study|Lost to Follow-up|3|||
156435088|NCT05011396|564683493|FG001|Overall Study|Lost to Follow-up|1|||
156435089|NCT05011396|564683492|FG000|Overall Study|Withdrawal by Subject|0|||
156435090|NCT05011396|564683493|FG001|Overall Study|Withdrawal by Subject|1|||
156435091|NCT05011396|564683492|FG000|Overall Study|Positive Drug Screen|0|||
156435092|NCT05011396|564683493|FG001|Overall Study|Positive Drug Screen|1|||
156435093|NCT04668339|564683494|FG000|Overall Study|Physician Decision|1|||
156435094|NCT04668339|564683495|FG001|Overall Study|Physician Decision|0|||
156678010|NCT01513239|565565554|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
156678011|NCT01513239|565565555|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
156678012|NCT01513239|565565556|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
156678013|NCT01513239|565565557|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
156678014|NCT01513239|565565558|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
156678015|NCT01513239|565565559|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
156678016|NCT00396162|565565560|FG000|Overall Study|Withdrawal by Subject|2|||
156678017|NCT00396162|565565561|FG001|Overall Study|Withdrawal by Subject|3|||
156678018|NCT01664039|565565565|FG000|Overall Study|Adverse Event|3|||
156678019|NCT01664039|565565566|FG001|Overall Study|Adverse Event|4|||
156678020|NCT01664039|565565565|FG000|Overall Study|Lost to Follow-up|1|||
156678021|NCT01664039|565565566|FG001|Overall Study|Lost to Follow-up|1|||
156678022|NCT01664039|565565565|FG000|Overall Study|Withdrawal by Subject|1|||
156678023|NCT01664039|565565566|FG001|Overall Study|Withdrawal by Subject|3|||
156678024|NCT01664039|565565565|FG000|Overall Study|Noncompliance|1|||
156678025|NCT01664039|565565566|FG001|Overall Study|Noncompliance|1|||
156678026|NCT01853176|565565567|FG000|Overall Study|Study terminated|4|||
156678027|NCT01853176|565565568|FG001|Overall Study|Study terminated|0|||
156678028|NCT00874822|565565569|FG000|Overall Study|excluded by criteria|8|||
156678029|NCT01168856|565565573|FG000|Overall Study|Lost to Follow-up|4|||
156678030|NCT01168856|565565574|FG001|Overall Study|Lost to Follow-up|34|||
156678031|NCT01168856|565565573|FG000|Overall Study|Withdrawal by Subject|6|||
156678032|NCT01168856|565565574|FG001|Overall Study|Withdrawal by Subject|8|||
156678033|NCT01168856|565565573|FG000|Overall Study|Physician Decision|2|||
156678034|NCT01168856|565565574|FG001|Overall Study|Physician Decision|1|||
156678035|NCT01168856|565565573|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
156678036|NCT01168856|565565574|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
156678037|NCT01168856|565565573|FG000|Overall Study|Participant received anti-HCV treatment|1|||
156678038|NCT01168856|565565574|FG001|Overall Study|Participant received anti-HCV treatment|0|||
156678039|NCT01168856|565565573|FG000|Overall Study|Death|0|||
156678040|NCT01168856|565565574|FG001|Overall Study|Death|2|||
156678041|NCT01168856|565565573|FG000|Overall Study|Other|1|||
156678042|NCT01168856|565565574|FG001|Overall Study|Other|291|||
156678043|NCT01168856|565565573|FG000|Overall Study|Protocol Violation|4|||
156678044|NCT01168856|565565574|FG001|Overall Study|Protocol Violation|6|||
156678045|NCT04442503|565565575|FG000|Overall Study|Adverse Event|1|||
156678046|NCT04442503|565565576|FG001|Overall Study|Adverse Event|1|||
156678047|NCT04442503|565565575|FG000|Overall Study|Lost to Follow-up|8|||
156678048|NCT04442503|565565576|FG001|Overall Study|Lost to Follow-up|6|||
156678049|NCT04442503|565565575|FG000|Overall Study|Physician Decision|0|||
156678050|NCT04442503|565565576|FG001|Overall Study|Physician Decision|2|||
156678051|NCT04442503|565565575|FG000|Overall Study|Withdrawal by Subject|3|||
156678052|NCT04442503|565565576|FG001|Overall Study|Withdrawal by Subject|4|||
156678053|NCT04442503|565565575|FG000|Overall Study|Reason not Specified|0|||
156678054|NCT04442503|565565576|FG001|Overall Study|Reason not Specified|1|||
156678055|NCT04442503|565565575|FG000|Overall Study|Randomized but not Treated|3|||
156678056|NCT04442503|565565576|FG001|Overall Study|Randomized but not Treated|1|||
156678057|NCT00387153|565565583|FG000|Overall Study|Adverse Event|1|||
156678058|NCT00387153|565565583|FG000|Overall Study|Disease Progression|3|||
156678059|NCT00387153|565565583|FG000|Overall Study|Lack of Response|4|||
156678060|NCT01867658|565565588|FG000|Overall Study|Withdrawal by Subject|6|||
156678061|NCT01867658|565565588|FG000|Overall Study|Death|2|||
156435095|NCT04668339|564683496|FG002|Overall Study|Physician Decision|1|||
156435096|NCT04668339|564683497|FG003|Overall Study|Physician Decision|1|||
156435097|NCT04668339|564683494|FG000|Overall Study|Lost to Follow-up|14|||
156435098|NCT04668339|564683495|FG001|Overall Study|Lost to Follow-up|12|||
156435099|NCT04668339|564683496|FG002|Overall Study|Lost to Follow-up|8|||
156435100|NCT04668339|564683497|FG003|Overall Study|Lost to Follow-up|5|||
156435101|NCT04668339|564683494|FG000|Overall Study|Adverse Event|0|||
156435102|NCT04668339|564683495|FG001|Overall Study|Adverse Event|0|||
156435103|NCT04668339|564683496|FG002|Overall Study|Adverse Event|1|||
156435104|NCT04668339|564683497|FG003|Overall Study|Adverse Event|0|||
156435105|NCT04668339|564683494|FG000|Overall Study|Other than specified|3|||
156435106|NCT04668339|564683495|FG001|Overall Study|Other than specified|0|||
156435107|NCT04668339|564683496|FG002|Overall Study|Other than specified|1|||
156435108|NCT04668339|564683497|FG003|Overall Study|Other than specified|0|||
156678062|NCT01867658|565565588|FG000|Overall Study|Subject could not be contacted|1|||
156678063|NCT02420353|565565589|FG000|Overall Study|Withdrawal by Subject|0|||
156678064|NCT02420353|565565590|FG001|Overall Study|Withdrawal by Subject|1|||
156678065|NCT00503867|565565591|FG000|Overall Study|Lost to Follow-up|1|||
156678066|NCT00503867|565565591|FG000|Overall Study|Adverse Event|1|||
156678067|NCT05004649|565565598|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
156678068|NCT05004649|565565598|FG000|Overall Study|Lost to Follow-up|1|||
156678069|NCT05004649|565565598|FG000|Overall Study|Withdrawal by Subject|2|||
156678070|NCT05004649|565565598|FG000|Overall Study|COVID-19|1|||
156678071|NCT00301964|565565599|FG000|Overall Study|Second primary|2|||
156678072|NCT00301964|565565599|FG000|Overall Study|Wrong primary|1|||
156678073|NCT00301964|565565599|FG000|Overall Study|Inadequate pathology|1|||
156678074|NCT02385708|565565601|FG000|Overall Study|Withdrawal by Subject|0|||
156678075|NCT02385708|565565602|FG001|Overall Study|Withdrawal by Subject|2|||
156678076|NCT02385708|565565601|FG000|Overall Study|Withdrawn - surgery canceled|2|||
156678077|NCT02385708|565565602|FG001|Overall Study|Withdrawn - surgery canceled|5|||
156678078|NCT02385708|565565601|FG000|Overall Study|Investigator decision|5|||
156678079|NCT02385708|565565602|FG001|Overall Study|Investigator decision|7|||
156678080|NCT02385708|565565601|FG000|Overall Study|Protocol Violation|1|||
156678081|NCT02385708|565565602|FG001|Overall Study|Protocol Violation|1|||
156678082|NCT02761915|565565603|FG000|Overall Study|Death|3|||
156678083|NCT02761915|565565604|FG001|Overall Study|Death|1|||
156678084|NCT02761915|565565605|FG002|Overall Study|Death|1|||
156678085|NCT02761915|565565606|FG003|Overall Study|Death|1|||
156678086|NCT02761915|565565607|FG004|Overall Study|Death|0|||
156678087|NCT02761915|565565608|FG005|Overall Study|Death|1|||
156678088|NCT02761915|565565603|FG000|Overall Study|Withdrawal by Subject|1|||
156678089|NCT02761915|565565604|FG001|Overall Study|Withdrawal by Subject|0|||
156678090|NCT02761915|565565605|FG002|Overall Study|Withdrawal by Subject|0|||
156678091|NCT02761915|565565606|FG003|Overall Study|Withdrawal by Subject|0|||
156678092|NCT02761915|565565607|FG004|Overall Study|Withdrawal by Subject|1|||
156678093|NCT02761915|565565608|FG005|Overall Study|Withdrawal by Subject|2|||
156678094|NCT02761915|565565603|FG000|Overall Study|Disease Progression|0|||
156678095|NCT02761915|565565604|FG001|Overall Study|Disease Progression|0|||
156678096|NCT02761915|565565605|FG002|Overall Study|Disease Progression|0|||
156678097|NCT02761915|565565606|FG003|Overall Study|Disease Progression|2|||
156678098|NCT02761915|565565607|FG004|Overall Study|Disease Progression|2|||
156678099|NCT02761915|565565608|FG005|Overall Study|Disease Progression|2|||
156678100|NCT00354835|565565609|FG000|Overall Study|Death|1|||
156678101|NCT00354835|565565610|FG001|Overall Study|Death|1|||
156678102|NCT00354835|565565609|FG000|Overall Study|Physician Decision|8|||
156678103|NCT00354835|565565610|FG001|Overall Study|Physician Decision|13|||
156678104|NCT00354835|565565609|FG000|Overall Study|Withdrawal by Subject|2|||
156678105|NCT00354835|565565610|FG001|Overall Study|Withdrawal by Subject|1|||
156678106|NCT00354835|565565609|FG000|Overall Study|Ineligible|17|||
156678107|NCT00354835|565565610|FG001|Overall Study|Ineligible|16|||
156678108|NCT00354835|565565609|FG000|Overall Study|Disease progression or relapse|15|||
156678109|NCT00354835|565565610|FG001|Overall Study|Disease progression or relapse|22|||
156678110|NCT00354835|565565609|FG000|Overall Study|Adverse Event|6|||
156678111|NCT00354835|565565610|FG001|Overall Study|Adverse Event|0|||
156678112|NCT00354835|565565609|FG000|Overall Study|Refusal of further therapy|3|||
156678113|NCT00354835|565565610|FG001|Overall Study|Refusal of further therapy|8|||
156678114|NCT01395017|565565613|FG000|Overall Study|Lost to Follow-up|1|||
156678115|NCT01395017|565565614|FG001|Overall Study|Lost to Follow-up|0|||
156678116|NCT01395017|565565613|FG000|Overall Study|Adverse Event|26|||
156678117|NCT01395017|565565614|FG001|Overall Study|Adverse Event|12|||
156678118|NCT01395017|565565613|FG000|Overall Study|Physician Decision|11|||
156678119|NCT01395017|565565614|FG001|Overall Study|Physician Decision|15|||
156678120|NCT01395017|565565613|FG000|Overall Study|Withdrawal by Subject|14|||
156678121|NCT01395017|565565614|FG001|Overall Study|Withdrawal by Subject|8|||
156678122|NCT01395017|565565613|FG000|Overall Study|Protocol deviation|1|||
156782093|NCT02337946|565951566|FG002|In-between Period|Without Informed Consent|0|||
156529240|NCT04683731|565031098|FG001|Overall Study|Withdrawal by Subject|0|||
156529241|NCT04683731|565031099|FG002|Overall Study|Withdrawal by Subject|3|||
156529242|NCT04683731|565031100|FG003|Overall Study|Withdrawal by Subject|2|||
156529243|NCT04683731|565031097|FG000|Overall Study|Determined patient was not eligible|3|||
156529244|NCT04683731|565031098|FG001|Overall Study|Determined patient was not eligible|3|||
156529245|NCT04683731|565031099|FG002|Overall Study|Determined patient was not eligible|12|||
156529246|NCT04683731|565031100|FG003|Overall Study|Determined patient was not eligible|3|||
156529247|NCT00883051|565031102|FG000|Overall Study|Lost to Follow-up|0|||
156529248|NCT00883051|565031103|FG001|Overall Study|Lost to Follow-up|0|||
156529249|NCT00883051|565031104|FG002|Overall Study|Lost to Follow-up|0|||
156529250|NCT00883051|565031105|FG003|Overall Study|Lost to Follow-up|0|||
156529251|NCT00883051|565031106|FG004|Overall Study|Lost to Follow-up|1|||
156529252|NCT00883051|565031102|FG000|Overall Study|Did not use study medication|24|||
156678123|NCT01395017|565565614|FG001|Overall Study|Protocol deviation|2|||
156678124|NCT01395017|565565613|FG000|Overall Study|Death|4|||
156678125|NCT01395017|565565614|FG001|Overall Study|Death|3|||
156678126|NCT01395017|565565613|FG000|Overall Study|Disease progression|42|||
156678127|NCT01395017|565565614|FG001|Overall Study|Disease progression|58|||
156678128|NCT01395017|565565613|FG000|Overall Study|Sponsor discontinued study|1|||
156678129|NCT01395017|565565614|FG001|Overall Study|Sponsor discontinued study|4|||
156678130|NCT03366428|565565615|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
156678131|NCT03366428|565565615|FG000|Overall Study|Adverse Event|12|||
156678132|NCT03366428|565565615|FG000|Overall Study|Clinical progression|2|||
156678133|NCT03366428|565565615|FG000|Overall Study|Withdrawal by Subject|4|||
156678134|NCT01046084|565565619|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
156678135|NCT01046084|565565620|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
156678136|NCT02166606|565565621|FG000|Overall Study|Adverse Event|3|||
156678137|NCT02166606|565565621|FG000|Overall Study|Death|31|||
156678138|NCT02166606|565565621|FG000|Overall Study|Protocol Violation|7|||
156678139|NCT02166606|565565621|FG000|Overall Study|Lost to Follow-up|30|||
156678140|NCT02166606|565565621|FG000|Overall Study|Withdrawal by Subject|1|||
156678141|NCT02166606|565565621|FG000|Overall Study|Physician Decision|1|||
156678142|NCT02166606|565565621|FG000|Overall Study|Device upgrade|1|||
156678143|NCT02166606|565565621|FG000|Overall Study|Enrolled after End of Enrollment|4|||
156678144|NCT01971645|565565624|FG000|Overall Study|Adverse Event|1|||
156678145|NCT01971645|565565625|FG001|Overall Study|Adverse Event|0|||
156678146|NCT01971645|565565626|FG002|Overall Study|Adverse Event|0|||
156678147|NCT01971645|565565624|FG000|Overall Study|Lost to Follow-up|1|||
156678148|NCT01971645|565565625|FG001|Overall Study|Lost to Follow-up|0|||
156678149|NCT01971645|565565626|FG002|Overall Study|Lost to Follow-up|1|||
156529253|NCT00883051|565031103|FG001|Overall Study|Did not use study medication|22|||
156529254|NCT00883051|565031104|FG002|Overall Study|Did not use study medication|29|||
156529255|NCT00883051|565031105|FG003|Overall Study|Did not use study medication|29|||
156529256|NCT00883051|565031106|FG004|Overall Study|Did not use study medication|17|||
156529257|NCT01411839|565031107|FG000|Overall Study|Lost to Follow-up|4|||
156529258|NCT01411839|565031108|FG001|Overall Study|Lost to Follow-up|3|||
156529259|NCT00959647|565031109|FG000|Overall Study|Adverse Event|2|||
156782094|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
156782095|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
156782096|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
156782097|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
156782098|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
156782099|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
156782100|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
156782101|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
156782102|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
156782103|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
156782104|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
156782105|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
156435109|NCT04668339|564683494|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
156435110|NCT04668339|564683495|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
156435111|NCT04668339|564683496|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
156435112|NCT04668339|564683497|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
156435113|NCT04668339|564683494|FG000|Overall Study|Vaccine not Administered|0|||
156435114|NCT04668339|564683495|FG001|Overall Study|Vaccine not Administered|0|||
156435115|NCT04668339|564683496|FG002|Overall Study|Vaccine not Administered|1|||
156435116|NCT04668339|564683497|FG003|Overall Study|Vaccine not Administered|0|||
156435117|NCT04668339|564683494|FG000|Overall Study|Protocol Violation|18|||
156435118|NCT04668339|564683495|FG001|Overall Study|Protocol Violation|23|||
156435119|NCT04668339|564683496|FG002|Overall Study|Protocol Violation|12|||
156435120|NCT04668339|564683497|FG003|Overall Study|Protocol Violation|20|||
156435121|NCT04668339|564683494|FG000|Overall Study|Withdrawal by Subject|45|||
156435122|NCT04668339|564683495|FG001|Overall Study|Withdrawal by Subject|46|||
156435123|NCT04668339|564683496|FG002|Overall Study|Withdrawal by Subject|46|||
156435124|NCT04668339|564683497|FG003|Overall Study|Withdrawal by Subject|27|||
156435125|NCT04668339|564683494|FG000|Overall Study|Study Terminated by Sponsor|59|||
156435126|NCT04668339|564683495|FG001|Overall Study|Study Terminated by Sponsor|59|||
156435127|NCT04668339|564683496|FG002|Overall Study|Study Terminated by Sponsor|71|||
156435128|NCT04668339|564683497|FG003|Overall Study|Study Terminated by Sponsor|1|||
156435129|NCT03253848|564683501|FG000|Overall Study|Adverse Event|7|||
156435130|NCT03253848|564683501|FG000|Overall Study|Death|5|||
156435131|NCT03253848|564683501|FG000|Overall Study|initiation of other treatments|3|||
156435132|NCT03253848|564683501|FG000|Overall Study|Other complicating disease|1|||
156435133|NCT03253848|564683501|FG000|Overall Study|Withdrawal by Subject|1|||
156435134|NCT03253848|564683501|FG000|Overall Study|Declining health|1|||
156435135|NCT01393119|564683502|FG000|Overall Study|Adverse Event|1|||
156435136|NCT01393119|564683503|FG001|Overall Study|Adverse Event|1|||
156435137|NCT01393119|564683504|FG002|Overall Study|Adverse Event|0|||
156435138|NCT01393119|564683505|FG003|Overall Study|Adverse Event|1|||
156435139|NCT01393119|564683502|FG000|Overall Study|Withdrawal by Subject|0|||
156435140|NCT01393119|564683503|FG001|Overall Study|Withdrawal by Subject|1|||
156435141|NCT01393119|564683504|FG002|Overall Study|Withdrawal by Subject|1|||
156435142|NCT01393119|564683505|FG003|Overall Study|Withdrawal by Subject|0|||
156435143|NCT01393119|564683502|FG000|Overall Study|Lack of Efficacy|1|||
156435144|NCT01393119|564683503|FG001|Overall Study|Lack of Efficacy|0|||
156435145|NCT01393119|564683504|FG002|Overall Study|Lack of Efficacy|2|||
156435146|NCT01393119|564683505|FG003|Overall Study|Lack of Efficacy|1|||
156529260|NCT00959647|565031109|FG000|Overall Study|Progressive disease|6|||
156678150|NCT01971645|565565624|FG000|Overall Study|Protocol Violation|0|||
156678151|NCT01971645|565565625|FG001|Overall Study|Protocol Violation|0|||
156678152|NCT01971645|565565626|FG002|Overall Study|Protocol Violation|1|||
156678153|NCT02943096|565565629|FG000|Overall Study|Lack of Efficacy|0|||
156435147|NCT01393119|564683502|FG000|Overall Study|Protocol Violation|0|||
156435148|NCT01393119|564683503|FG001|Overall Study|Protocol Violation|0|||
156435149|NCT01393119|564683504|FG002|Overall Study|Protocol Violation|1|||
156435150|NCT01393119|564683505|FG003|Overall Study|Protocol Violation|0|||
156435151|NCT01393119|564683502|FG000|Overall Study|Death|0|||
156435152|NCT01393119|564683503|FG001|Overall Study|Death|0|||
156435153|NCT01393119|564683504|FG002|Overall Study|Death|0|||
156435154|NCT01393119|564683505|FG003|Overall Study|Death|1|||
156435155|NCT01393119|564683502|FG000|Overall Study|Randomized but Not treated|1|||
156435156|NCT01393119|564683503|FG001|Overall Study|Randomized but Not treated|0|||
156435157|NCT01393119|564683504|FG002|Overall Study|Randomized but Not treated|1|||
156435158|NCT01393119|564683505|FG003|Overall Study|Randomized but Not treated|1|||
156435159|NCT01393119|564683502|FG000|Overall Study|Sponsor Termination of Study|11|||
156435160|NCT01393119|564683503|FG001|Overall Study|Sponsor Termination of Study|12|||
156435161|NCT01393119|564683504|FG002|Overall Study|Sponsor Termination of Study|9|||
156435162|NCT01393119|564683505|FG003|Overall Study|Sponsor Termination of Study|12|||
156435163|NCT01400776|564683506|FG000|Overall Study|Adverse Event|7|||
156435164|NCT01400776|564683507|FG001|Overall Study|Adverse Event|2|||
156435165|NCT01400776|564683508|FG002|Overall Study|Adverse Event|9|||
156435166|NCT01400776|564683509|FG003|Overall Study|Adverse Event|2|||
156435167|NCT01400776|564683506|FG000|Overall Study|Lost to Follow-up|1|||
156435168|NCT01400776|564683507|FG001|Overall Study|Lost to Follow-up|0|||
156435169|NCT01400776|564683508|FG002|Overall Study|Lost to Follow-up|4|||
156435170|NCT01400776|564683509|FG003|Overall Study|Lost to Follow-up|1|||
156435171|NCT01400776|564683506|FG000|Overall Study|Withdrew Consent|4|||
156435172|NCT01400776|564683507|FG001|Overall Study|Withdrew Consent|2|||
156435173|NCT01400776|564683508|FG002|Overall Study|Withdrew Consent|6|||
156435174|NCT01400776|564683509|FG003|Overall Study|Withdrew Consent|1|||
156435175|NCT01400776|564683506|FG000|Overall Study|Protocol Deviation|6|||
156435176|NCT01400776|564683507|FG001|Overall Study|Protocol Deviation|1|||
156435177|NCT01400776|564683508|FG002|Overall Study|Protocol Deviation|5|||
156435178|NCT01400776|564683509|FG003|Overall Study|Protocol Deviation|2|||
156435179|NCT01400776|564683506|FG000|Overall Study|Reason not Specified|3|||
156435180|NCT01400776|564683507|FG001|Overall Study|Reason not Specified|0|||
156435181|NCT01400776|564683508|FG002|Overall Study|Reason not Specified|4|||
156435182|NCT01400776|564683509|FG003|Overall Study|Reason not Specified|3|||
156435183|NCT02983617|564683521|FG000|Overall Study|Adverse Event|0|||
156435184|NCT02983617|564683522|FG001|Overall Study|Adverse Event|7|||
156678154|NCT02943096|565565630|FG001|Overall Study|Lack of Efficacy|1|||
156678155|NCT04203823|565565631|FG000|Overall Study|Withdrawal by Subject|2|||
156678156|NCT04203823|565565632|FG001|Overall Study|Withdrawal by Subject|2|||
156678157|NCT04203823|565565631|FG000|Overall Study|Adverse Event|1|||
156678158|NCT04203823|565565632|FG001|Overall Study|Adverse Event|1|||
156678159|NCT04203823|565565631|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156678160|NCT04203823|565565632|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
156678161|NCT03193021|565565633|FG000|Overall Study|Lost to Follow-up|1|||
156782106|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
156435185|NCT02983617|564683521|FG000|Overall Study|Death|0|||
156435186|NCT02983617|564683522|FG001|Overall Study|Death|1|||
156435187|NCT02983617|564683521|FG000|Overall Study|Investigator's Discretion|0|||
156435188|NCT02983617|564683522|FG001|Overall Study|Investigator's Discretion|1|||
156435189|NCT04218110|564683525|FG000|Overall Study|Withdrawal by Subject|0|||
156435190|NCT04218110|564683526|FG001|Overall Study|Withdrawal by Subject|0|||
156435191|NCT04218110|564683527|FG002|Overall Study|Withdrawal by Subject|0|||
156435192|NCT04218110|564683528|FG003|Overall Study|Withdrawal by Subject|1|||
156435193|NCT00002842|564683529|FG000|Overall Study|ineligible for surgical resection|27|||
156435194|NCT01867216|564683530|FG000|Overall Study|Withdrawal by Subject|2|||
156435195|NCT01867216|564683531|FG001|Overall Study|Withdrawal by Subject|0|||
156435196|NCT01867216|564683532|FG002|Overall Study|Withdrawal by Subject|0|||
156435197|NCT01867216|564683533|FG003|Overall Study|Withdrawal by Subject|0|||
156435198|NCT01867216|564683534|FG004|Overall Study|Withdrawal by Subject|1|||
156435199|NCT01867216|564683535|FG005|Overall Study|Withdrawal by Subject|0|||
156435200|NCT01867216|564683536|FG006|Overall Study|Withdrawal by Subject|1|||
156435201|NCT01867216|564683530|FG000|Overall Study|Physician Decision|1|||
156435202|NCT01867216|564683531|FG001|Overall Study|Physician Decision|0|||
156435203|NCT01867216|564683532|FG002|Overall Study|Physician Decision|0|||
156435204|NCT01867216|564683533|FG003|Overall Study|Physician Decision|0|||
156435205|NCT01867216|564683534|FG004|Overall Study|Physician Decision|0|||
156435206|NCT01867216|564683535|FG005|Overall Study|Physician Decision|0|||
156435207|NCT01867216|564683536|FG006|Overall Study|Physician Decision|0|||
156435208|NCT01867216|564683530|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
156435209|NCT01867216|564683531|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
156435210|NCT01867216|564683532|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
156435211|NCT01867216|564683533|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
156435212|NCT01867216|564683534|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
156678162|NCT03193021|565565634|FG001|Overall Study|Lost to Follow-up|1|||
156678163|NCT02286466|565565635|FG000|Overall Study|Death|1|||
156678164|NCT02286466|565565636|FG001|Overall Study|Death|3|||
156678165|NCT02286466|565565635|FG000|Overall Study|Withdrawal by Subject|5|||
156678166|NCT02286466|565565636|FG001|Overall Study|Withdrawal by Subject|2|||
156678167|NCT02286466|565565635|FG000|Overall Study|Lost to Follow-up|1|||
156678168|NCT02286466|565565636|FG001|Overall Study|Lost to Follow-up|4|||
156678169|NCT02286466|565565635|FG000|Overall Study|Declined Clinician Assessment|0|||
156678170|NCT02286466|565565636|FG001|Overall Study|Declined Clinician Assessment|1|||
156678171|NCT02957331|565565639|FG000|Overall Study|Protocol Violation|1|||
156678172|NCT02957331|565565640|FG001|Overall Study|Protocol Violation|0|||
156678173|NCT01120899|565567209|FG000|Overall Study|Withdrawal by Subject|3|||
156678174|NCT01490190|565567210|FG000|Overall Study|Withdrawal by Subject|9|||
156678175|NCT01490190|565567210|FG000|Overall Study|Adverse Event|17|||
156678176|NCT01490190|565567210|FG000|Overall Study|Protocol Violation|5|||
156678177|NCT01490190|565567210|FG000|Overall Study|Lost to Follow-up|13|||
156678178|NCT01490190|565567210|FG000|Overall Study|Relocation|1|||
156678179|NCT01490190|565567210|FG000|Overall Study|Inconvenience|1|||
156678180|NCT01490190|565567210|FG000|Overall Study|Ring expulsion|2|||
156678181|NCT02655224|565567216|FG000|Overall Study|Adverse Event|1|||
156678182|NCT02655224|565567217|FG001|Overall Study|Adverse Event|1|||
156678183|NCT01741545|565567228|FG000|Treatment Period|Lack of Efficacy|0|||
156678184|NCT01741545|565567229|FG001|Treatment Period|Lack of Efficacy|1|||
156678185|NCT01741545|565567228|FG000|Treatment Period|Adverse event, non-fatal|1|||
156328824|NCT03265665|564305465|FG000|36-week Data Collection|Lost to Follow-up|6|||
156328825|NCT03265665|564305466|FG001|36-week Data Collection|Lost to Follow-up|8|||
156328826|NCT01845818|564305469|FG000|Overall Study|Withdrawal by Subject|0|||
156328827|NCT01845818|564305470|FG001|Overall Study|Withdrawal by Subject|1|||
156328828|NCT01845818|564305469|FG000|Overall Study|Lost to Follow-up|7|||
156328829|NCT01845818|564305470|FG001|Overall Study|Lost to Follow-up|5|||
156328830|NCT01845818|564305469|FG000|Overall Study|Administrative Reasons|3|||
156328831|NCT01845818|564305470|FG001|Overall Study|Administrative Reasons|1|||
156328832|NCT01845818|564305469|FG000|Overall Study|Serious Adverse Event|1|||
156328833|NCT01845818|564305470|FG001|Overall Study|Serious Adverse Event|1|||
156328834|NCT01845818|564305469|FG000|Overall Study|Other|25|||
156328835|NCT01845818|564305470|FG001|Overall Study|Other|8|||
156328836|NCT01845818|564305469|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
156328837|NCT01845818|564305470|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
156328838|NCT01845818|564305469|FG000|Overall Study|No Follow-Up Data Available|4|||
156328839|NCT01845818|564305470|FG001|Overall Study|No Follow-Up Data Available|1|||
156328840|NCT01680965|564305471|FG000|Overall Study|Death|0|||
156328841|NCT01680965|564305472|FG001|Overall Study|Death|0|||
156328842|NCT01680965|564305473|FG002|Overall Study|Death|0|||
156328843|NCT01680965|564305474|FG003|Overall Study|Death|6|||
156328844|NCT00639678|564305483|FG000|Overall Study|Withdrawal by Subject|3|||
156328845|NCT00639678|564305484|FG001|Overall Study|Withdrawal by Subject|0|||
156435213|NCT01867216|564683535|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
156435214|NCT01867216|564683536|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
156435215|NCT00831415|564683537|FG000|Overall Study|Adverse Event|14|||
156435216|NCT00831415|564683537|FG000|Overall Study|Failed to return|3|||
156435217|NCT00831415|564683537|FG000|Overall Study|Physician Decision|6|||
156435218|NCT00831415|564683537|FG000|Overall Study|Lost to Follow-up|9|||
156435219|NCT00831415|564683537|FG000|Overall Study|Protocol Violation|3|||
156435220|NCT00831415|564683537|FG000|Overall Study|Withdrawal by Subject|35|||
156435221|NCT00831415|564683537|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
156435222|NCT00831415|564683537|FG000|Overall Study|Death|1|||
156435223|NCT01290224|564683538|FG000|Overall Study|Adverse Event|1|||
156435224|NCT01290224|564683538|FG000|Overall Study|Refused Further Treatment|4|||
156435225|NCT05694065|564683539|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
156435226|NCT05694065|564683539|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
156435227|NCT05694065|564683539|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
156435228|NCT00424762|564683540|FG000|Overall Study|Withdrawal by Subject|18|||
156435229|NCT00424762|564683541|FG001|Overall Study|Withdrawal by Subject|19|||
156435230|NCT00424762|564683540|FG000|Overall Study|Lost to Follow-up|2|||
156435231|NCT00424762|564683541|FG001|Overall Study|Lost to Follow-up|3|||
156435232|NCT00842257|564683548|FG000|Overall Study|Adverse Event|1|||
156435233|NCT00909363|564683552|FG000|Overall Study|Withdrawal by Subject|1|||
156435234|NCT00909363|564683553|FG001|Overall Study|Withdrawal by Subject|0|||
156435235|NCT00909363|564683554|FG002|Overall Study|Withdrawal by Subject|0|||
156435236|NCT00909363|564683552|FG000|Overall Study|Lack of Efficacy|1|||
156435237|NCT00909363|564683553|FG001|Overall Study|Lack of Efficacy|0|||
156435238|NCT00909363|564683554|FG002|Overall Study|Lack of Efficacy|0|||
156678186|NCT01741545|565567229|FG001|Treatment Period|Adverse event, non-fatal|3|||
156678187|NCT01741545|565567228|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
156328846|NCT00639678|564305485|FG002|Overall Study|Withdrawal by Subject|4|||
156678188|NCT01741545|565567229|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
156678189|NCT01741545|565567228|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
156678190|NCT01741545|565567229|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
156782107|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
156782108|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
156782109|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
156782110|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
156782111|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
156782112|NCT02513563|565951567|FG000|Overall Study|Death|4|||
156782113|NCT02513563|565951567|FG000|Overall Study|Withdrawal by Subject|4|||
156782114|NCT02513563|565951567|FG000|Overall Study|Physician Decision|1|||
156782115|NCT01068912|565951570|FG000|Overall Study|Adverse Event|2|||
156782116|NCT01068912|565951571|FG001|Overall Study|Adverse Event|3|||
156782117|NCT01068912|565951572|FG002|Overall Study|Adverse Event|2|||
156782118|NCT01068912|565951570|FG000|Overall Study|Withdrawal by Subject|5|||
156782119|NCT01068912|565951571|FG001|Overall Study|Withdrawal by Subject|6|||
156782120|NCT01068912|565951572|FG002|Overall Study|Withdrawal by Subject|6|||
156782121|NCT01068912|565951570|FG000|Overall Study|Lost to Follow-up|3|||
156782122|NCT01068912|565951571|FG001|Overall Study|Lost to Follow-up|7|||
156782123|NCT01068912|565951572|FG002|Overall Study|Lost to Follow-up|3|||
156328847|NCT00639678|564305486|FG003|Overall Study|Withdrawal by Subject|0|||
156328848|NCT00639678|564305483|FG000|Overall Study|Lost to Follow-up|1|||
156328849|NCT00639678|564305484|FG001|Overall Study|Lost to Follow-up|0|||
156328850|NCT00639678|564305485|FG002|Overall Study|Lost to Follow-up|6|||
156328851|NCT00639678|564305486|FG003|Overall Study|Lost to Follow-up|0|||
156328852|NCT00639678|564305483|FG000|Overall Study|Adverse Event|0|||
156328853|NCT00639678|564305484|FG001|Overall Study|Adverse Event|1|||
156328854|NCT00639678|564305485|FG002|Overall Study|Adverse Event|0|||
156328855|NCT00639678|564305486|FG003|Overall Study|Adverse Event|0|||
156328856|NCT00639678|564305483|FG000|Overall Study|Lack of Compliance|0|||
156328857|NCT00639678|564305484|FG001|Overall Study|Lack of Compliance|0|||
156328858|NCT00639678|564305485|FG002|Overall Study|Lack of Compliance|1|||
156328859|NCT00639678|564305486|FG003|Overall Study|Lack of Compliance|0|||
156328860|NCT01973569|564305487|FG000|Overall Study|Adverse Event|9|||
156328861|NCT01973569|564305488|FG001|Overall Study|Adverse Event|2|||
156328862|NCT01973569|564305489|FG002|Overall Study|Adverse Event|4|||
156328863|NCT01973569|564305487|FG000|Overall Study|Protocol Violation|2|||
156328864|NCT01973569|564305488|FG001|Overall Study|Protocol Violation|1|||
156328865|NCT01973569|564305489|FG002|Overall Study|Protocol Violation|3|||
156328866|NCT01973569|564305487|FG000|Overall Study|Withdrawal by Subject|7|||
156328867|NCT01973569|564305488|FG001|Overall Study|Withdrawal by Subject|5|||
156328868|NCT01973569|564305489|FG002|Overall Study|Withdrawal by Subject|2|||
156328869|NCT01973569|564305487|FG000|Overall Study|Invasive dental treatment|3|||
156328870|NCT01973569|564305488|FG001|Overall Study|Invasive dental treatment|5|||
156328871|NCT01973569|564305489|FG002|Overall Study|Invasive dental treatment|6|||
156328872|NCT01973569|564305487|FG000|Overall Study|Prohibited concomitant d|1|||
156328873|NCT01973569|564305488|FG001|Overall Study|Prohibited concomitant d|5|||
156328874|NCT01973569|564305489|FG002|Overall Study|Prohibited concomitant d|0|||
156328875|NCT01973569|564305487|FG000|Overall Study|Disease progression|0|||
156328876|NCT01973569|564305488|FG001|Overall Study|Disease progression|3|||
156328877|NCT01973569|564305489|FG002|Overall Study|Disease progression|0|||
156328878|NCT01973569|564305487|FG000|Overall Study|Other|1|||
156328879|NCT01973569|564305488|FG001|Overall Study|Other|1|||
156328880|NCT01973569|564305489|FG002|Overall Study|Other|0|||
156328881|NCT01973569|564305487|FG000|Overall Study|Did not receive study drug|6|||
156328882|NCT01973569|564305488|FG001|Overall Study|Did not receive study drug|3|||
156328883|NCT01973569|564305489|FG002|Overall Study|Did not receive study drug|3|||
156328884|NCT02436304|564305490|FG000|Overall Study|Lost to Follow-up|0|||
156328885|NCT02436304|564305491|FG001|Overall Study|Lost to Follow-up|1|||
156328886|NCT02436304|564305492|FG002|Overall Study|Lost to Follow-up|0|||
156328887|NCT02436304|564305490|FG000|Overall Study|Withdrawal by Subject|0|||
156328888|NCT02436304|564305491|FG001|Overall Study|Withdrawal by Subject|1|||
156328889|NCT02436304|564305492|FG002|Overall Study|Withdrawal by Subject|0|||
156328890|NCT02436304|564305490|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
156328891|NCT02436304|564305491|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
156328892|NCT02436304|564305492|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
156328893|NCT00785928|564305498|FG000|Treatment Phase|Adverse Event|1|||
156328894|NCT00785928|564305499|FG001|Treatment Phase|Adverse Event|1|||
156328895|NCT00785928|564305500|FG002|Treatment Phase|Adverse Event|2|||
156328896|NCT00785928|564305501|FG003|Treatment Phase|Adverse Event|0|||
156328897|NCT00785928|564305502|FG004|Treatment Phase|Adverse Event|0|||
156328898|NCT00785928|564305503|FG005|Treatment Phase|Adverse Event|0|||
156328899|NCT00785928|564305504|FG006|Treatment Phase|Adverse Event|2|||
156328900|NCT00785928|564305498|FG000|Treatment Phase|Inadequate Response|0|||
156328901|NCT00785928|564305499|FG001|Treatment Phase|Inadequate Response|1|||
156328902|NCT00785928|564305500|FG002|Treatment Phase|Inadequate Response|0|||
156328903|NCT00785928|564305501|FG003|Treatment Phase|Inadequate Response|0|||
156328904|NCT00785928|564305502|FG004|Treatment Phase|Inadequate Response|0|||
156328905|NCT00785928|564305503|FG005|Treatment Phase|Inadequate Response|0|||
156328906|NCT00785928|564305504|FG006|Treatment Phase|Inadequate Response|0|||
156782124|NCT01068912|565951570|FG000|Overall Study|Protocol Violation|0|||
156782125|NCT01068912|565951571|FG001|Overall Study|Protocol Violation|2|||
156678191|NCT01456962|565567230|FG000|Overall Study|Lost to Follow-up|2|||
156678192|NCT01456962|565567231|FG001|Overall Study|Lost to Follow-up|1|||
156678193|NCT03387462|565567232|FG000|Overall Study|Lost to Follow-up|1|||
156678194|NCT01460628|565567233|FG000|Overall Study|Adverse Event|3|||
156678195|NCT01460628|565567233|FG000|Overall Study|Withdrawal by Subject|2|||
156678196|NCT02854800|565567235|FG000|Overall Study|Protocol Violation|16|||
156678197|NCT02854800|565567236|FG001|Overall Study|Protocol Violation|11|||
156678198|NCT02854800|565567237|FG002|Overall Study|Protocol Violation|3|||
156678199|NCT02854800|565567235|FG000|Overall Study|Withdrawal by Subject|4|||
156678200|NCT02854800|565567236|FG001|Overall Study|Withdrawal by Subject|2|||
156678201|NCT02854800|565567237|FG002|Overall Study|Withdrawal by Subject|3|||
156678202|NCT02627963|565567238|FG000|Overall Study|Randomized but not treated|2|||
156678203|NCT02627963|565567239|FG001|Overall Study|Randomized but not treated|6|||
156678204|NCT03073798|565567240|FG000|Overall Study|Adverse Event|1|||
156678205|NCT03073798|565567240|FG000|Overall Study|Withdrawal by Subject|1|||
156678206|NCT05278858|565567241|FG000|Overall Study|Withdrawal by Subject|1|||
156678207|NCT00840658|565567242|FG000|Overall Study|Death|2|||
156678208|NCT00840658|565567243|FG001|Overall Study|Death|2|||
156678209|NCT00840658|565567244|FG002|Overall Study|Death|3|||
156678210|NCT00840658|565567245|FG003|Overall Study|Death|3|||
156678211|NCT00840658|565567242|FG000|Overall Study|Lost to Follow-up|3|||
156678212|NCT00840658|565567243|FG001|Overall Study|Lost to Follow-up|1|||
156678213|NCT00840658|565567244|FG002|Overall Study|Lost to Follow-up|2|||
156678214|NCT00840658|565567245|FG003|Overall Study|Lost to Follow-up|1|||
156678215|NCT02372006|565567257|FG000|Overall Study|Progressive disease|8|||
156678216|NCT02372006|565567258|FG001|Overall Study|Progressive disease|7|||
156678217|NCT02372006|565567259|FG002|Overall Study|Progressive disease|34|||
156678218|NCT02372006|565567257|FG000|Overall Study|Dose limiting toxicity|0|||
156678219|NCT02372006|565567258|FG001|Overall Study|Dose limiting toxicity|1|||
156678220|NCT02372006|565567259|FG002|Overall Study|Dose limiting toxicity|0|||
156678221|NCT02372006|565567257|FG000|Overall Study|Adverse Event|0|||
156678222|NCT02372006|565567258|FG001|Overall Study|Adverse Event|0|||
156678223|NCT02372006|565567259|FG002|Overall Study|Adverse Event|3|||
156678224|NCT02372006|565567257|FG000|Overall Study|Withdrawal by Subject|0|||
156678225|NCT02372006|565567258|FG001|Overall Study|Withdrawal by Subject|1|||
156678226|NCT02372006|565567259|FG002|Overall Study|Withdrawal by Subject|1|||
156678227|NCT02372006|565567257|FG000|Overall Study|Other reason for not completing|0|||
156678228|NCT02372006|565567258|FG001|Overall Study|Other reason for not completing|0|||
156678229|NCT02372006|565567259|FG002|Overall Study|Other reason for not completing|1|||
156678230|NCT01143337|565567260|FG000|Overall Study|Adverse Event|3|||
156678231|NCT01143337|565567261|FG001|Overall Study|Adverse Event|9|||
156678232|NCT01143337|565567262|FG002|Overall Study|Adverse Event|5|||
156678233|NCT01143337|565567260|FG000|Overall Study|Lack of Efficacy|6|||
156678234|NCT01143337|565567261|FG001|Overall Study|Lack of Efficacy|2|||
156678235|NCT01143337|565567262|FG002|Overall Study|Lack of Efficacy|1|||
156678236|NCT01143337|565567260|FG000|Overall Study|Protocol Violation|1|||
156678237|NCT01143337|565567261|FG001|Overall Study|Protocol Violation|0|||
156678238|NCT01143337|565567262|FG002|Overall Study|Protocol Violation|0|||
156678239|NCT01143337|565567260|FG000|Overall Study|Withdrawal by Subject|0|||
156678240|NCT01143337|565567261|FG001|Overall Study|Withdrawal by Subject|0|||
156678241|NCT01143337|565567262|FG002|Overall Study|Withdrawal by Subject|1|||
156782126|NCT01068912|565951572|FG002|Overall Study|Protocol Violation|0|||
156782127|NCT01068912|565951570|FG000|Overall Study|aggravation influenza|1|||
156782128|NCT01068912|565951571|FG001|Overall Study|aggravation influenza|1|||
156782129|NCT01068912|565951572|FG002|Overall Study|aggravation influenza|1|||
156782130|NCT01068912|565951570|FG000|Overall Study|other underlying illness|0|||
156782131|NCT01068912|565951571|FG001|Overall Study|other underlying illness|3|||
156678242|NCT01143337|565567260|FG000|Overall Study|Other reason|0|||
156678243|NCT01143337|565567261|FG001|Overall Study|Other reason|0|||
156782132|NCT01068912|565951572|FG002|Overall Study|other underlying illness|3|||
156678244|NCT01143337|565567262|FG002|Overall Study|Other reason|5|||
156678245|NCT04133311|565567263|FG000|Period 1 Double Masked Treatment Period|Death|1|||
156678246|NCT04133311|565567264|FG001|Period 1 Double Masked Treatment Period|Death|0|||
156678247|NCT04133311|565567265|FG002|Period 1 Double Masked Treatment Period|Death|0|||
156782133|NCT02965833|565951573|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
156328907|NCT00785928|564305498|FG000|Treatment Phase|Lack of Efficacy|0|||
156328908|NCT00785928|564305499|FG001|Treatment Phase|Lack of Efficacy|1|||
156678248|NCT04133311|565567266|FG003|Period 1 Double Masked Treatment Period|Death|0|||
156678249|NCT04133311|565567263|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
156678250|NCT04133311|565567264|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
156678251|NCT04133311|565567265|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
156678252|NCT04133311|565567266|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
156678253|NCT04133311|565567263|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
156678254|NCT04133311|565567264|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
156782134|NCT02965833|565951574|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
156678255|NCT04133311|565567265|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
156678256|NCT04133311|565567266|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
156678257|NCT04133311|565567263|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
156678258|NCT04133311|565567264|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
156678259|NCT04133311|565567265|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
156678260|NCT04133311|565567266|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
156678261|NCT04133311|565567263|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
156678262|NCT04133311|565567264|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
156782135|NCT02965833|565951573|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
156782136|NCT02965833|565951574|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
156782137|NCT02965833|565951573|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
156782138|NCT02965833|565951574|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
156782139|NCT02965833|565951573|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
156782140|NCT02965833|565951574|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
156782141|NCT02965833|565951573|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
156782142|NCT02965833|565951574|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
156782143|NCT03370302|565951575|FG000|Dose Escalation Phase|Other|0|||
156782144|NCT03370302|565951576|FG001|Dose Escalation Phase|Other|1|||
156782145|NCT03370302|565951577|FG002|Dose Escalation Phase|Other|1|||
156782146|NCT03370302|565951578|FG003|Dose Escalation Phase|Other|0|||
156782147|NCT03370302|565951579|FG004|Dose Escalation Phase|Other|0|||
156782148|NCT03370302|565951580|FG005|Dose Escalation Phase|Other|0|||
156782149|NCT03370302|565951575|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
156782150|NCT03370302|565951576|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
156782151|NCT03370302|565951577|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
156782152|NCT03370302|565951578|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156782153|NCT03370302|565951579|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
156782154|NCT03370302|565951580|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
156782155|NCT03370302|565951575|FG000|Dose Escalation Phase|Adverse Event|1|||
156782156|NCT03370302|565951576|FG001|Dose Escalation Phase|Adverse Event|0|||
156782157|NCT03370302|565951577|FG002|Dose Escalation Phase|Adverse Event|2|||
156782158|NCT03370302|565951578|FG003|Dose Escalation Phase|Adverse Event|0|||
156782159|NCT03370302|565951579|FG004|Dose Escalation Phase|Adverse Event|0|||
156782160|NCT03370302|565951580|FG005|Dose Escalation Phase|Adverse Event|0|||
156782161|NCT03370302|565951575|FG000|Dose Escalation Phase|Progressive Disease|2|||
156782162|NCT03370302|565951576|FG001|Dose Escalation Phase|Progressive Disease|4|||
156782163|NCT03370302|565951577|FG002|Dose Escalation Phase|Progressive Disease|2|||
156782164|NCT03370302|565951578|FG003|Dose Escalation Phase|Progressive Disease|0|||
156782165|NCT03370302|565951579|FG004|Dose Escalation Phase|Progressive Disease|3|||
156782166|NCT03370302|565951580|FG005|Dose Escalation Phase|Progressive Disease|1|||
156782167|NCT03370302|565951575|FG000|Dose Expansion Phase|Progressive Disease|0|||
156782168|NCT03370302|565951576|FG001|Dose Expansion Phase|Progressive Disease|0|||
156782169|NCT03370302|565951577|FG002|Dose Expansion Phase|Progressive Disease|0|||
156782170|NCT03370302|565951578|FG003|Dose Expansion Phase|Progressive Disease|6|||
156782171|NCT03370302|565951579|FG004|Dose Expansion Phase|Progressive Disease|0|||
156782172|NCT03370302|565951580|FG005|Dose Expansion Phase|Progressive Disease|0|||
156782173|NCT03442569|565951584|FG000|Overall Study|Subject was ineligible after enrollment|1|||
156782174|NCT03853798|565951585|FG000|Overall Study|Death|0|||
156782175|NCT03853798|565951586|FG001|Overall Study|Death|0|||
156782176|NCT03853798|565951587|FG002|Overall Study|Death|0|||
156782177|NCT03853798|565951588|FG003|Overall Study|Death|0|||
156782178|NCT03853798|565951589|FG004|Overall Study|Death|0|||
156782179|NCT03853798|565951590|FG005|Overall Study|Death|1|||
156782180|NCT03853798|565951591|FG006|Overall Study|Death|0|||
156782181|NCT03853798|565951592|FG007|Overall Study|Death|0|||
156678263|NCT04133311|565567265|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
156678264|NCT04133311|565567266|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
156678265|NCT04133311|565567263|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
156678266|NCT04133311|565567264|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
156678267|NCT04133311|565567265|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
156782182|NCT03853798|565951593|FG008|Overall Study|Death|0|||
156782183|NCT03853798|565951585|FG000|Overall Study|Adverse Event|0|||
156782184|NCT03853798|565951586|FG001|Overall Study|Adverse Event|0|||
156782185|NCT03853798|565951587|FG002|Overall Study|Adverse Event|2|||
156678268|NCT04133311|565567266|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
156782186|NCT03853798|565951588|FG003|Overall Study|Adverse Event|0|||
156782187|NCT03853798|565951589|FG004|Overall Study|Adverse Event|0|||
156782188|NCT03853798|565951590|FG005|Overall Study|Adverse Event|0|||
156782189|NCT03853798|565951591|FG006|Overall Study|Adverse Event|0|||
156782190|NCT03853798|565951592|FG007|Overall Study|Adverse Event|0|||
156782191|NCT03853798|565951593|FG008|Overall Study|Adverse Event|0|||
156782192|NCT03853798|565951585|FG000|Overall Study|Withdrawal by Subject|0|||
156782193|NCT03853798|565951586|FG001|Overall Study|Withdrawal by Subject|1|||
156782194|NCT03853798|565951587|FG002|Overall Study|Withdrawal by Subject|4|||
156782195|NCT03853798|565951588|FG003|Overall Study|Withdrawal by Subject|0|||
156782196|NCT03853798|565951589|FG004|Overall Study|Withdrawal by Subject|0|||
156782197|NCT03853798|565951590|FG005|Overall Study|Withdrawal by Subject|5|||
156782198|NCT03853798|565951591|FG006|Overall Study|Withdrawal by Subject|0|||
156782199|NCT03853798|565951592|FG007|Overall Study|Withdrawal by Subject|0|||
156782200|NCT03853798|565951593|FG008|Overall Study|Withdrawal by Subject|4|||
156782201|NCT03853798|565951585|FG000|Overall Study|Physician Decision|1|||
156782202|NCT03853798|565951586|FG001|Overall Study|Physician Decision|0|||
156782203|NCT03853798|565951587|FG002|Overall Study|Physician Decision|0|||
156782204|NCT03853798|565951588|FG003|Overall Study|Physician Decision|0|||
156678269|NCT04133311|565567263|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
156678270|NCT04133311|565567264|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
156678271|NCT04133311|565567265|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
156678272|NCT04133311|565567266|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
156678273|NCT04133311|565567263|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
156678274|NCT04133311|565567264|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
156678275|NCT04133311|565567265|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
156782205|NCT03853798|565951589|FG004|Overall Study|Physician Decision|0|||
156782206|NCT03853798|565951590|FG005|Overall Study|Physician Decision|0|||
156782207|NCT03853798|565951591|FG006|Overall Study|Physician Decision|0|||
156782208|NCT03853798|565951592|FG007|Overall Study|Physician Decision|0|||
156782209|NCT03853798|565951593|FG008|Overall Study|Physician Decision|1|||
156782210|NCT03853798|565951585|FG000|Overall Study|Lack of Efficacy|0|||
156782211|NCT03853798|565951586|FG001|Overall Study|Lack of Efficacy|0|||
156782212|NCT03853798|565951587|FG002|Overall Study|Lack of Efficacy|2|||
156782213|NCT03853798|565951588|FG003|Overall Study|Lack of Efficacy|0|||
156782214|NCT03853798|565951589|FG004|Overall Study|Lack of Efficacy|0|||
156782215|NCT03853798|565951590|FG005|Overall Study|Lack of Efficacy|0|||
156782216|NCT03853798|565951591|FG006|Overall Study|Lack of Efficacy|0|||
156782217|NCT03853798|565951592|FG007|Overall Study|Lack of Efficacy|0|||
156866613|NCT00129402|566271288|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156866614|NCT00129402|566271289|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
156866615|NCT00763035|566271290|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
156866616|NCT00763035|566271291|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
156866617|NCT00763035|566271290|FG000|First Intervention|Adverse Event|0|||
156866618|NCT00763035|566271291|FG001|First Intervention|Adverse Event|1|||
156866619|NCT00763035|566271290|FG000|Second Intervention|Adverse Event|1|||
156866620|NCT00763035|566271291|FG001|Second Intervention|Adverse Event|0|||
156866621|NCT00763035|566271290|FG000|Second Intervention|Physician Decision|2|||
156866622|NCT00763035|566271291|FG001|Second Intervention|Physician Decision|0|||
156866623|NCT02131259|566271292|FG000|Overall Study|Progressive disease|751|||
156866624|NCT02131259|566271292|FG000|Overall Study|Adverse Event|341|||
156866625|NCT02131259|566271292|FG000|Overall Study|Lost to Follow-up|7|||
156866626|NCT02131259|566271292|FG000|Overall Study|Relocation|32|||
156866627|NCT02131259|566271292|FG000|Overall Study|Other|63|||
156866628|NCT02131259|566271292|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
156866629|NCT02131259|566271292|FG000|Overall Study|Progressive disease/relocation|1|||
156866630|NCT02131259|566271292|FG000|Overall Study|Progressive disease/other|2|||
156866631|NCT02131259|566271292|FG000|Overall Study|AE/lost to follow-up|1|||
156866632|NCT02131259|566271292|FG000|Overall Study|AE/other|1|||
156866633|NCT02131259|566271292|FG000|Overall Study|Progressive disease/AE/other|1|||
156866634|NCT02131259|566271292|FG000|Overall Study|Missing|3|||
156866635|NCT01472289|566271293|FG000|Overall Study|Death|2|||
156866636|NCT02435992|566271294|FG000|Overall Study|non compliance with protocol|2|||
156866637|NCT02435992|566271295|FG001|Overall Study|non compliance with protocol|0|||
156866638|NCT02435992|566271296|FG002|Overall Study|non compliance with protocol|1|||
156866639|NCT02435992|566271297|FG003|Overall Study|non compliance with protocol|0|||
156866640|NCT02435992|566271298|FG004|Overall Study|non compliance with protocol|0|||
156866641|NCT02435992|566271294|FG000|Overall Study|Adverse Event|11|||
156866642|NCT02435992|566271295|FG001|Overall Study|Adverse Event|6|||
156866643|NCT02435992|566271296|FG002|Overall Study|Adverse Event|12|||
156866644|NCT02435992|566271297|FG003|Overall Study|Adverse Event|0|||
156866645|NCT02435992|566271298|FG004|Overall Study|Adverse Event|0|||
156866646|NCT02435992|566271294|FG000|Overall Study|Lack of Efficacy|4|||
156866647|NCT02435992|566271295|FG001|Overall Study|Lack of Efficacy|10|||
156866648|NCT02435992|566271296|FG002|Overall Study|Lack of Efficacy|9|||
156866649|NCT02435992|566271297|FG003|Overall Study|Lack of Efficacy|0|||
156678276|NCT04133311|565567266|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
156678277|NCT00728754|565567275|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
156782218|NCT03853798|565951593|FG008|Overall Study|Lack of Efficacy|1|||
156782219|NCT03853798|565951585|FG000|Overall Study|Approved Drug Available for Indication|0|||
156782220|NCT03853798|565951586|FG001|Overall Study|Approved Drug Available for Indication|0|||
156782221|NCT03853798|565951587|FG002|Overall Study|Approved Drug Available for Indication|1|||
156782222|NCT03853798|565951588|FG003|Overall Study|Approved Drug Available for Indication|0|||
156435239|NCT00922207|564683555|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
156678278|NCT00728754|565567276|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
156678279|NCT00728754|565567275|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
156678280|NCT00728754|565567276|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
156678281|NCT00728754|565567275|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
156678282|NCT00728754|565567276|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
156678283|NCT01859598|565567277|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
156678284|NCT00009945|565567278|FG000|Overall Study|no follow up data|7|||
156678285|NCT00009945|565567279|FG001|Overall Study|no follow up data|5|||
156678286|NCT00672984|565567280|FG000|First Intervention|Adverse Event|5|||
156678287|NCT00672984|565567281|FG001|First Intervention|Adverse Event|0|||
156678288|NCT00672984|565567282|FG002|First Intervention|Adverse Event|0|||
156678289|NCT00672984|565567280|FG000|First Intervention|Withdrawal by Subject|1|||
156678290|NCT00672984|565567281|FG001|First Intervention|Withdrawal by Subject|2|||
156678291|NCT00672984|565567282|FG002|First Intervention|Withdrawal by Subject|2|||
156782223|NCT03853798|565951589|FG004|Overall Study|Approved Drug Available for Indication|0|||
156782224|NCT03853798|565951590|FG005|Overall Study|Approved Drug Available for Indication|1|||
156782225|NCT03853798|565951591|FG006|Overall Study|Approved Drug Available for Indication|0|||
156782226|NCT03853798|565951592|FG007|Overall Study|Approved Drug Available for Indication|0|||
156782227|NCT03853798|565951593|FG008|Overall Study|Approved Drug Available for Indication|0|||
156782228|NCT03853798|565951585|FG000|Overall Study|Other un-specified|0|||
156782229|NCT03853798|565951586|FG001|Overall Study|Other un-specified|0|||
156782230|NCT03853798|565951587|FG002|Overall Study|Other un-specified|2|||
156782231|NCT03853798|565951588|FG003|Overall Study|Other un-specified|0|||
156782232|NCT03853798|565951589|FG004|Overall Study|Other un-specified|0|||
156782233|NCT03853798|565951590|FG005|Overall Study|Other un-specified|1|||
156782234|NCT03853798|565951591|FG006|Overall Study|Other un-specified|0|||
156782235|NCT03853798|565951592|FG007|Overall Study|Other un-specified|0|||
156782236|NCT03853798|565951593|FG008|Overall Study|Other un-specified|0|||
156782237|NCT02743494|565951594|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
156782238|NCT02743494|565951595|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
156782239|NCT02743494|565951594|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
156782240|NCT02743494|565951595|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
156782241|NCT02743494|565951594|FG000|Treatment Period|Disease recurrence|152|||
156782242|NCT02743494|565951595|FG001|Treatment Period|Disease recurrence|115|||
156782243|NCT02743494|565951594|FG000|Treatment Period|Study drug toxicity|56|||
156782244|NCT02743494|565951595|FG001|Treatment Period|Study drug toxicity|8|||
156782245|NCT02743494|565951594|FG000|Treatment Period|Death|1|||
156782246|NCT02743494|565951595|FG001|Treatment Period|Death|1|||
156782247|NCT02743494|565951594|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
156782248|NCT02743494|565951595|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
156782249|NCT02743494|565951594|FG000|Treatment Period|Participant request to discontinue treatment|31|||
156782250|NCT02743494|565951595|FG001|Treatment Period|Participant request to discontinue treatment|5|||
156782251|NCT02743494|565951594|FG000|Treatment Period|Participant withdrew consent|11|||
156782252|NCT02743494|565951595|FG001|Treatment Period|Participant withdrew consent|4|||
156782253|NCT02743494|565951594|FG000|Treatment Period|Lost to Follow-up|0|||
156782254|NCT02743494|565951595|FG001|Treatment Period|Lost to Follow-up|1|||
156782255|NCT02743494|565951594|FG000|Treatment Period|Poor/Non-compliance|2|||
156782256|NCT02743494|565951595|FG001|Treatment Period|Poor/Non-compliance|0|||
156782257|NCT02743494|565951594|FG000|Treatment Period|Other reasons|4|||
156782258|NCT02743494|565951595|FG001|Treatment Period|Other reasons|1|||
156782259|NCT02207608|565951596|FG000|Overall Study|Adverse Event|1|||
156782260|NCT02207608|565951597|FG001|Overall Study|Adverse Event|0|||
156782261|NCT05800145|565951598|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
156782262|NCT05800145|565951599|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156782263|NCT05800145|565951600|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156782264|NCT05800145|565951601|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
156782265|NCT05800145|565951602|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156782266|NCT05800145|565951603|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156782267|NCT05800145|565951598|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
156782268|NCT05800145|565951599|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
156782269|NCT05800145|565951600|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
156782270|NCT05800145|565951601|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
156782271|NCT05800145|565951602|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
156782272|NCT05800145|565951603|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
156782273|NCT05800145|565951598|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
156866650|NCT02435992|566271298|FG004|Overall Study|Lack of Efficacy|0|||
156782274|NCT05800145|565951599|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
156782275|NCT05800145|565951600|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
156782276|NCT05800145|565951601|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
156782277|NCT05800145|565951602|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
156866651|NCT02435992|566271294|FG000|Overall Study|Withdrawal by Subject|10|||
156866652|NCT02435992|566271295|FG001|Overall Study|Withdrawal by Subject|8|||
156866653|NCT02435992|566271296|FG002|Overall Study|Withdrawal by Subject|20|||
156866654|NCT02435992|566271297|FG003|Overall Study|Withdrawal by Subject|0|||
156866655|NCT02435992|566271298|FG004|Overall Study|Withdrawal by Subject|0|||
156866656|NCT02435992|566271294|FG000|Overall Study|Other Reason|1|||
156866657|NCT02435992|566271295|FG001|Overall Study|Other Reason|0|||
156866658|NCT02435992|566271296|FG002|Overall Study|Other Reason|0|||
156866659|NCT02435992|566271297|FG003|Overall Study|Other Reason|0|||
156866660|NCT02435992|566271298|FG004|Overall Study|Other Reason|0|||
156866661|NCT02435992|566271294|FG000|Overall Study|Physician Decision|0|||
156866662|NCT02435992|566271295|FG001|Overall Study|Physician Decision|0|||
156866663|NCT02435992|566271296|FG002|Overall Study|Physician Decision|1|||
156866664|NCT02435992|566271297|FG003|Overall Study|Physician Decision|0|||
156866665|NCT02435992|566271298|FG004|Overall Study|Physician Decision|0|||
156866666|NCT04298697|566271301|FG000|Overall Study|Lost to Follow-up|5|||
156866667|NCT04298697|566271302|FG001|Overall Study|Lost to Follow-up|5|||
156866668|NCT04298697|566271303|FG002|Overall Study|Lost to Follow-up|1|||
156866669|NCT04298697|566271304|FG003|Overall Study|Lost to Follow-up|0|||
156866670|NCT04298697|566271301|FG000|Overall Study|Withdrawal by Subject|0|||
156866671|NCT04298697|566271302|FG001|Overall Study|Withdrawal by Subject|3|||
156866672|NCT04298697|566271303|FG002|Overall Study|Withdrawal by Subject|2|||
156866673|NCT04298697|566271304|FG003|Overall Study|Withdrawal by Subject|3|||
156866674|NCT03205423|566271308|FG000|Overall Study|Personal|1|||
156866675|NCT03205423|566271309|FG001|Overall Study|Personal|1|||
156866676|NCT03205423|566271308|FG000|Overall Study|Physician Decision|0|||
156866677|NCT03205423|566271309|FG001|Overall Study|Physician Decision|2|||
156866678|NCT02749422|566271310|FG000|Overall Study|Lost to Follow-up|0|||
156866679|NCT02749422|566271311|FG001|Overall Study|Lost to Follow-up|2|||
156866680|NCT02749422|566271310|FG000|Overall Study|Ineligible|0|||
156866681|NCT02749422|566271311|FG001|Overall Study|Ineligible|1|||
156866682|NCT02638220|566271317|FG000|Overall Study|Lost to Follow-up|6|||
156866683|NCT02638220|566271317|FG000|Overall Study|Withdrawal by Subject|3|||
156866684|NCT02638220|566271317|FG000|Overall Study|Physician Decision|1|||
156866685|NCT02638220|566271317|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
156866686|NCT04323124|566271318|FG000|Overall Study|Adverse Event|0|||
156866687|NCT04323124|566271319|FG001|Overall Study|Adverse Event|0|||
156866688|NCT04323124|566271320|FG002|Overall Study|Adverse Event|0|||
156866689|NCT04323124|566271321|FG003|Overall Study|Adverse Event|0|||
156866690|NCT04323124|566271322|FG004|Overall Study|Adverse Event|0|||
156866691|NCT04323124|566271323|FG005|Overall Study|Adverse Event|1|||
156866692|NCT04323124|566271324|FG006|Overall Study|Adverse Event|0|||
156866693|NCT04323124|566271325|FG007|Overall Study|Adverse Event|1|||
156866694|NCT04323124|566271326|FG008|Overall Study|Adverse Event|1|||
156866695|NCT04323124|566271327|FG009|Overall Study|Adverse Event|0|||
156866696|NCT04323124|566271328|FG010|Overall Study|Adverse Event|0|||
156866697|NCT04323124|566271329|FG011|Overall Study|Adverse Event|0|||
156866698|NCT04323124|566271330|FG012|Overall Study|Adverse Event|0|||
156866699|NCT04323124|566271331|FG013|Overall Study|Adverse Event|0|||
156866700|NCT04323124|566271332|FG014|Overall Study|Adverse Event|0|||
156866701|NCT04323124|566271318|FG000|Overall Study|Other|0|||
156866702|NCT04323124|566271319|FG001|Overall Study|Other|0|||
156866703|NCT04323124|566271320|FG002|Overall Study|Other|0|||
156866704|NCT04323124|566271321|FG003|Overall Study|Other|0|||
156866705|NCT04323124|566271322|FG004|Overall Study|Other|1|||
156866706|NCT04323124|566271323|FG005|Overall Study|Other|0|||
156866707|NCT04323124|566271324|FG006|Overall Study|Other|0|||
156866708|NCT04323124|566271325|FG007|Overall Study|Other|0|||
156866709|NCT04323124|566271326|FG008|Overall Study|Other|1|||
156866710|NCT04323124|566271327|FG009|Overall Study|Other|0|||
156866711|NCT04323124|566271328|FG010|Overall Study|Other|0|||
156866712|NCT04323124|566271329|FG011|Overall Study|Other|0|||
156866713|NCT04323124|566271330|FG012|Overall Study|Other|0|||
156866714|NCT04323124|566271331|FG013|Overall Study|Other|0|||
156866715|NCT04323124|566271332|FG014|Overall Study|Other|0|||
156866716|NCT04323124|566271318|FG000|Overall Study|Coming from a red zone (COVID)|0|||
156866717|NCT04323124|566271319|FG001|Overall Study|Coming from a red zone (COVID)|0|||
156866718|NCT04323124|566271320|FG002|Overall Study|Coming from a red zone (COVID)|0|||
156866719|NCT04323124|566271321|FG003|Overall Study|Coming from a red zone (COVID)|0|||
156866720|NCT04323124|566271322|FG004|Overall Study|Coming from a red zone (COVID)|1|||
156328909|NCT00785928|564305500|FG002|Treatment Phase|Lack of Efficacy|1|||
156866721|NCT04323124|566271323|FG005|Overall Study|Coming from a red zone (COVID)|1|||
156866722|NCT04323124|566271324|FG006|Overall Study|Coming from a red zone (COVID)|0|||
156866723|NCT04323124|566271325|FG007|Overall Study|Coming from a red zone (COVID)|0|||
156328910|NCT00785928|564305501|FG003|Treatment Phase|Lack of Efficacy|0|||
156866724|NCT04323124|566271326|FG008|Overall Study|Coming from a red zone (COVID)|0|||
156866725|NCT04323124|566271327|FG009|Overall Study|Coming from a red zone (COVID)|0|||
156866726|NCT04323124|566271328|FG010|Overall Study|Coming from a red zone (COVID)|0|||
156866727|NCT04323124|566271329|FG011|Overall Study|Coming from a red zone (COVID)|0|||
156866728|NCT04323124|566271330|FG012|Overall Study|Coming from a red zone (COVID)|0|||
156678292|NCT00672984|565567280|FG000|First Intervention|Sponsor decision|3|||
156678293|NCT00672984|565567281|FG001|First Intervention|Sponsor decision|0|||
156678294|NCT00672984|565567282|FG002|First Intervention|Sponsor decision|0|||
156678295|NCT00672984|565567280|FG000|Second Intervention|Non-compliance with facility policies|0|||
156678296|NCT00672984|565567281|FG001|Second Intervention|Non-compliance with facility policies|2|||
156678297|NCT00672984|565567282|FG002|Second Intervention|Non-compliance with facility policies|0|||
156678298|NCT00672984|565567280|FG000|Second Intervention|Withdrawal by Subject|0|||
156678299|NCT00672984|565567281|FG001|Second Intervention|Withdrawal by Subject|3|||
156678300|NCT00672984|565567282|FG002|Second Intervention|Withdrawal by Subject|0|||
156678301|NCT00672984|565567280|FG000|Second Intervention|Protocol Violation|0|||
156678302|NCT00672984|565567281|FG001|Second Intervention|Protocol Violation|1|||
156678303|NCT00672984|565567282|FG002|Second Intervention|Protocol Violation|1|||
156678304|NCT00672984|565567280|FG000|Third Intervention|Adverse Event|1|||
156678305|NCT00672984|565567281|FG001|Third Intervention|Adverse Event|0|||
156678306|NCT00672984|565567282|FG002|Third Intervention|Adverse Event|1|||
156678307|NCT00573313|565567287|FG000|Overall Study|Protocol Violation|5|||
156678308|NCT00573313|565567288|FG001|Overall Study|Protocol Violation|0|||
156678309|NCT00573313|565567289|FG002|Overall Study|Protocol Violation|6|||
156866729|NCT04323124|566271331|FG013|Overall Study|Coming from a red zone (COVID)|0|||
156866730|NCT04323124|566271332|FG014|Overall Study|Coming from a red zone (COVID)|0|||
156866731|NCT04323124|566271318|FG000|Overall Study|No longer meets eligibility criteria|0|||
156866732|NCT04323124|566271319|FG001|Overall Study|No longer meets eligibility criteria|0|||
156866733|NCT04323124|566271320|FG002|Overall Study|No longer meets eligibility criteria|0|||
156678310|NCT00573313|565567290|FG003|Overall Study|Protocol Violation|0|||
156678311|NCT00295490|565567293|FG000|Overall Study|Protocol Violation|0|||
156678312|NCT00295490|565567294|FG001|Overall Study|Protocol Violation|0|||
156678313|NCT00295490|565567295|FG002|Overall Study|Protocol Violation|3|||
156678314|NCT00295490|565567296|FG003|Overall Study|Protocol Violation|3|||
156678315|NCT00295490|565567293|FG000|Overall Study|Withdrawal by Subject|0|||
156678316|NCT00295490|565567294|FG001|Overall Study|Withdrawal by Subject|2|||
156678317|NCT00295490|565567295|FG002|Overall Study|Withdrawal by Subject|0|||
156678318|NCT00295490|565567296|FG003|Overall Study|Withdrawal by Subject|1|||
156678319|NCT00295490|565567293|FG000|Overall Study|Lost to Follow-up|0|||
156678320|NCT00295490|565567294|FG001|Overall Study|Lost to Follow-up|0|||
156678321|NCT00295490|565567295|FG002|Overall Study|Lost to Follow-up|1|||
156678322|NCT00295490|565567296|FG003|Overall Study|Lost to Follow-up|0|||
156678323|NCT00295490|565567293|FG000|Overall Study|Adverse Event|1|||
156678324|NCT00295490|565567294|FG001|Overall Study|Adverse Event|0|||
156678325|NCT00295490|565567295|FG002|Overall Study|Adverse Event|0|||
156678326|NCT00295490|565567296|FG003|Overall Study|Adverse Event|0|||
156678327|NCT00295490|565567293|FG000|Overall Study|Other|0|||
156678328|NCT00295490|565567294|FG001|Overall Study|Other|2|||
156678329|NCT00295490|565567295|FG002|Overall Study|Other|0|||
156678330|NCT00295490|565567296|FG003|Overall Study|Other|1|||
156678331|NCT03255980|565567297|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
156678332|NCT03255980|565567298|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
156678333|NCT03255980|565567299|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
156678334|NCT03255980|565567300|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
156678335|NCT03255980|565567297|FG000|Overall Study|Adverse Event|1|||
156678336|NCT03255980|565567298|FG001|Overall Study|Adverse Event|1|||
156678337|NCT03255980|565567299|FG002|Overall Study|Adverse Event|0|||
156678338|NCT03255980|565567300|FG003|Overall Study|Adverse Event|1|||
156678339|NCT03255980|565567297|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
156678340|NCT03255980|565567298|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
156678341|NCT03255980|565567299|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
156678342|NCT03255980|565567300|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
156678343|NCT03255980|565567297|FG000|Overall Study|Lost to Follow-up|1|||
156678344|NCT03255980|565567298|FG001|Overall Study|Lost to Follow-up|1|||
156678345|NCT03255980|565567299|FG002|Overall Study|Lost to Follow-up|0|||
156678346|NCT03255980|565567300|FG003|Overall Study|Lost to Follow-up|3|||
156678347|NCT03255980|565567297|FG000|Overall Study|Withdrawal by Subject|0|||
156678348|NCT03255980|565567298|FG001|Overall Study|Withdrawal by Subject|1|||
156678349|NCT03255980|565567299|FG002|Overall Study|Withdrawal by Subject|0|||
156678350|NCT03255980|565567300|FG003|Overall Study|Withdrawal by Subject|3|||
156678351|NCT01597791|565567301|FG000|Overall Study|Physician Decision|2|||
156678352|NCT01597791|565567302|FG001|Overall Study|Physician Decision|1|||
156678353|NCT01597791|565567301|FG000|Overall Study|Cesarean Section|6|||
156678354|NCT01597791|565567302|FG001|Overall Study|Cesarean Section|7|||
156678355|NCT01597791|565567301|FG000|Overall Study|Subject withdrawal|0|||
156678356|NCT01597791|565567302|FG001|Overall Study|Subject withdrawal|1|||
156678357|NCT01597791|565567301|FG000|Overall Study|Protocol Violation|0|||
156866734|NCT04323124|566271321|FG003|Overall Study|No longer meets eligibility criteria|0|||
156678358|NCT01597791|565567302|FG001|Overall Study|Protocol Violation|1|||
156678359|NCT02611362|565567303|FG000|Overall Study|Withdrawal by Subject|7|||
156678360|NCT02611362|565567304|FG001|Overall Study|Withdrawal by Subject|2|||
156678361|NCT02611362|565567303|FG000|Overall Study|Lost to Follow-up|2|||
156678362|NCT02611362|565567304|FG001|Overall Study|Lost to Follow-up|4|||
156678363|NCT00354159|565567305|FG000|Randomized Study Period|Withdrawal by Subject|5|||
156678364|NCT00354159|565567306|FG001|Randomized Study Period|Withdrawal by Subject|3|||
156678365|NCT00354159|565567305|FG000|Randomized Study Period|Physician Decision|6|||
156678366|NCT00354159|565567306|FG001|Randomized Study Period|Physician Decision|10|||
156678367|NCT00354159|565567305|FG000|Randomized Study Period|Lost to Follow-up|4|||
156678368|NCT00354159|565567306|FG001|Randomized Study Period|Lost to Follow-up|0|||
156678369|NCT00354159|565567305|FG000|Randomized Study Period|Death|7|||
156678370|NCT00354159|565567306|FG001|Randomized Study Period|Death|9|||
156678371|NCT00354159|565567305|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
156678372|NCT00354159|565567306|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
156678373|NCT00354159|565567305|FG000|Long-term Follow-up|Physician Decision|127|||
156782278|NCT05800145|565951603|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
156782279|NCT05643794|565952725|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
156782280|NCT05643794|565952726|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
156782281|NCT05643794|565952727|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156782282|NCT05643794|565952725|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156782283|NCT05643794|565952726|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156782284|NCT05643794|565952727|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156782285|NCT05643794|565952725|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
156782286|NCT05643794|565952726|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
156782287|NCT05643794|565952727|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
156782288|NCT05643794|565952725|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
156529261|NCT00959647|565031109|FG000|Overall Study|Study terminated by sponsor|4|||
156782289|NCT05643794|565952726|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156782290|NCT05643794|565952727|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
156782291|NCT05643794|565952725|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
156782292|NCT05643794|565952726|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
156782293|NCT05643794|565952727|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
156529262|NCT00959647|565031109|FG000|Overall Study|Withdrawal by Subject|7|||
156529263|NCT05959629|565031112|FG000|Overall Study|partially necrotic/technical issues|2|||
156529264|NCT05959629|565031113|FG001|Overall Study|partially necrotic/technical issues|2|||
156529265|NCT01444651|565032600|FG000|Overall Study|Adverse Event|3|||
156529266|NCT01444651|565032601|FG001|Overall Study|Adverse Event|2|||
156529267|NCT01444651|565032600|FG000|Overall Study|Lost to Follow-up|5|||
156529268|NCT01444651|565032601|FG001|Overall Study|Lost to Follow-up|5|||
156529269|NCT01444651|565032600|FG000|Overall Study|Non-fasting|2|||
156529270|NCT01444651|565032601|FG001|Overall Study|Non-fasting|1|||
156529271|NCT01444651|565032600|FG000|Overall Study|Missing data|1|||
156529272|NCT01444651|565032601|FG001|Overall Study|Missing data|1|||
156529273|NCT01929980|565032604|FG000|Overall Study|Physician Decision|1|||
156529274|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
156529275|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
156529276|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
156529277|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
156529278|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
156529279|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
156529280|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
156529281|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
156529282|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
156529283|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
156529284|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
156529285|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
156529286|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Death|3|||
156529287|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Death|1|||
156529288|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
156529289|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
156529290|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Adverse Event|7|||
156529291|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Adverse Event|8|||
156529292|NCT03236246|565032605|FG000|24-Week Dose Titration Period|Captured as Other|1|||
156529293|NCT03236246|565032606|FG001|24-Week Dose Titration Period|Captured as Other|2|||
156529294|NCT03236246|565032605|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
156529295|NCT03236246|565032606|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
156529296|NCT03236246|565032605|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
156529297|NCT03236246|565032606|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
156529298|NCT03236246|565032605|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
156529299|NCT03236246|565032606|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
156678374|NCT00354159|565567306|FG001|Long-term Follow-up|Physician Decision|122|||
156678375|NCT00354159|565567305|FG000|Long-term Follow-up|Lost to Follow-up|1|||
156678376|NCT00354159|565567306|FG001|Long-term Follow-up|Lost to Follow-up|0|||
156678377|NCT00354159|565567305|FG000|Long-term Follow-up|Death|14|||
156678378|NCT00354159|565567306|FG001|Long-term Follow-up|Death|11|||
156678379|NCT00354159|565567305|FG000|Long-term Follow-up|Study Closed|29|||
156678380|NCT00354159|565567306|FG001|Long-term Follow-up|Study Closed|34|||
156678381|NCT02229084|565567308|FG000|Overall Study|Adverse Event|1|||
156678382|NCT02229084|565567309|FG001|Overall Study|Adverse Event|0|||
156678383|NCT02229084|565567310|FG002|Overall Study|Adverse Event|0|||
156678384|NCT02229084|565567311|FG003|Overall Study|Adverse Event|0|||
156678385|NCT02229084|565567312|FG004|Overall Study|Adverse Event|0|||
156678386|NCT02229084|565567313|FG005|Overall Study|Adverse Event|0|||
156678387|NCT02229084|565567314|FG006|Overall Study|Adverse Event|0|||
156678388|NCT02229084|565567308|FG000|Overall Study|Lost to Follow-up|0|||
156678389|NCT02229084|565567309|FG001|Overall Study|Lost to Follow-up|0|||
156678390|NCT02229084|565567310|FG002|Overall Study|Lost to Follow-up|1|||
156678391|NCT02229084|565567311|FG003|Overall Study|Lost to Follow-up|1|||
156678392|NCT02229084|565567312|FG004|Overall Study|Lost to Follow-up|0|||
156678393|NCT02229084|565567313|FG005|Overall Study|Lost to Follow-up|0|||
156678394|NCT02229084|565567314|FG006|Overall Study|Lost to Follow-up|1|||
156678395|NCT02229084|565567308|FG000|Overall Study|Physician Decision|0|||
156678396|NCT02229084|565567309|FG001|Overall Study|Physician Decision|0|||
156678397|NCT02229084|565567310|FG002|Overall Study|Physician Decision|0|||
156678398|NCT02229084|565567311|FG003|Overall Study|Physician Decision|1|||
156678399|NCT02229084|565567312|FG004|Overall Study|Physician Decision|3|||
156678400|NCT02229084|565567313|FG005|Overall Study|Physician Decision|0|||
156678401|NCT02229084|565567314|FG006|Overall Study|Physician Decision|1|||
156678402|NCT02229084|565567308|FG000|Overall Study|Withdrawal by Subject|0|||
156678403|NCT02229084|565567309|FG001|Overall Study|Withdrawal by Subject|0|||
156678404|NCT02229084|565567310|FG002|Overall Study|Withdrawal by Subject|1|||
156678405|NCT02229084|565567311|FG003|Overall Study|Withdrawal by Subject|0|||
156678406|NCT02229084|565567312|FG004|Overall Study|Withdrawal by Subject|1|||
156678407|NCT02229084|565567313|FG005|Overall Study|Withdrawal by Subject|1|||
156678408|NCT02229084|565567314|FG006|Overall Study|Withdrawal by Subject|1|||
156678409|NCT02229084|565567308|FG000|Overall Study|Death|0|||
156678410|NCT02229084|565567309|FG001|Overall Study|Death|0|||
156678411|NCT02229084|565567310|FG002|Overall Study|Death|0|||
156678412|NCT02229084|565567311|FG003|Overall Study|Death|0|||
156678413|NCT02229084|565567312|FG004|Overall Study|Death|0|||
156678414|NCT02229084|565567313|FG005|Overall Study|Death|0|||
156678415|NCT02229084|565567314|FG006|Overall Study|Death|1|||
156678416|NCT01728116|565567317|FG000|Overall Study|Sponsor Terminated Study|106|||
156678417|NCT01728116|565567318|FG001|Overall Study|Sponsor Terminated Study|35|||
156678418|NCT01728116|565567317|FG000|Overall Study|Withdrawal by Subject|16|||
156678419|NCT01728116|565567318|FG001|Overall Study|Withdrawal by Subject|9|||
156678420|NCT01728116|565567317|FG000|Overall Study|Adverse Event|13|||
156678421|NCT01728116|565567318|FG001|Overall Study|Adverse Event|0|||
156678422|NCT01728116|565567317|FG000|Overall Study|Procedure/device failure|7|||
156678423|NCT01728116|565567318|FG001|Overall Study|Procedure/device failure|0|||
156678424|NCT01728116|565567317|FG000|Overall Study|Lost to Follow-up|9|||
156678425|NCT01728116|565567318|FG001|Overall Study|Lost to Follow-up|2|||
156678426|NCT01728116|565567317|FG000|Overall Study|Physician Decision|2|||
156678427|NCT01728116|565567318|FG001|Overall Study|Physician Decision|0|||
156678428|NCT01728116|565567317|FG000|Overall Study|Subject Non-Compliance|2|||
156678429|NCT01728116|565567318|FG001|Overall Study|Subject Non-Compliance|0|||
156678430|NCT01728116|565567317|FG000|Overall Study|Inter-current finding at procedure|1|||
156678431|NCT01728116|565567318|FG001|Overall Study|Inter-current finding at procedure|0|||
156678432|NCT01728116|565567317|FG000|Overall Study|Incorrectly enrolled in Study|0|||
156678433|NCT01728116|565567318|FG001|Overall Study|Incorrectly enrolled in Study|1|||
156866735|NCT04323124|566271322|FG004|Overall Study|No longer meets eligibility criteria|0|||
156866736|NCT04323124|566271323|FG005|Overall Study|No longer meets eligibility criteria|0|||
156866737|NCT04323124|566271324|FG006|Overall Study|No longer meets eligibility criteria|0|||
156678434|NCT01728116|565567317|FG000|Overall Study|various not noted previously|5|||
156678435|NCT01728116|565567318|FG001|Overall Study|various not noted previously|0|||
156678436|NCT01559116|565567329|FG000|Overall Study|Adverse Event|10|||
156678437|NCT01559116|565567329|FG000|Overall Study|Lack of Efficacy|1|||
156678438|NCT01559116|565567329|FG000|Overall Study|Lost to Follow-up|1|||
156678439|NCT01559116|565567329|FG000|Overall Study|Protocol Violation|1|||
156678440|NCT01559116|565567329|FG000|Overall Study|Withdrawal by Subject|4|||
156678441|NCT01559116|565567329|FG000|Overall Study|other than stated above|9|||
156678442|NCT01532908|565567330|FG000|Overall Study|Not Transplanted|1|||
156678443|NCT01532908|565567331|FG001|Overall Study|Not Transplanted|0|||
156678444|NCT03277248|565567337|FG000|Overall Study|Adverse Event|3|||
156678445|NCT03277248|565567338|FG001|Overall Study|Adverse Event|1|||
156678446|NCT03277248|565567337|FG000|Overall Study|Subject Withdrawal of Consent|6|||
156678447|NCT03277248|565567338|FG001|Overall Study|Subject Withdrawal of Consent|23|||
156678448|NCT03277248|565567337|FG000|Overall Study|Investigator/Sponsor Decision|2|||
156678449|NCT03277248|565567338|FG001|Overall Study|Investigator/Sponsor Decision|2|||
156678450|NCT03277248|565567337|FG000|Overall Study|Pregnancy|4|||
156678451|NCT03277248|565567338|FG001|Overall Study|Pregnancy|1|||
156678452|NCT03277248|565567337|FG000|Overall Study|Lost to Follow-up|0|||
156678453|NCT03277248|565567338|FG001|Overall Study|Lost to Follow-up|2|||
156678454|NCT03277248|565567337|FG000|Overall Study|Lack of Efficacy|0|||
156678455|NCT03277248|565567338|FG001|Overall Study|Lack of Efficacy|2|||
156678456|NCT03277248|565567337|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
156678457|NCT03277248|565567338|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
156678458|NCT01993940|565567345|FG000|Overall Study|Adverse Event|16|||
156678459|NCT01993940|565567346|FG001|Overall Study|Adverse Event|11|||
156678460|NCT01993940|565567345|FG000|Overall Study|Withdrawal by Subject|15|||
156678461|NCT01993940|565567346|FG001|Overall Study|Withdrawal by Subject|19|||
156678462|NCT01993940|565567345|FG000|Overall Study|Lost to Follow-up|2|||
156678463|NCT01993940|565567346|FG001|Overall Study|Lost to Follow-up|5|||
156678464|NCT01993940|565567345|FG000|Overall Study|Protocol Violation|5|||
156678465|NCT01993940|565567346|FG001|Overall Study|Protocol Violation|8|||
156678466|NCT01993940|565567345|FG000|Overall Study|Death|1|||
156678467|NCT01993940|565567346|FG001|Overall Study|Death|0|||
156678468|NCT01993940|565567345|FG000|Overall Study|Other - Miscellaneous|1|||
156678469|NCT01993940|565567346|FG001|Overall Study|Other - Miscellaneous|1|||
156678470|NCT03922750|565567347|FG000|Overall Study|Unclassified|0|||
156678471|NCT03922750|565567348|FG001|Overall Study|Unclassified|0|||
156678472|NCT03922750|565567349|FG002|Overall Study|Unclassified|1|||
156678473|NCT03922750|565567347|FG000|Overall Study|Adverse Event|0|||
156678474|NCT03922750|565567348|FG001|Overall Study|Adverse Event|1|||
156678475|NCT03922750|565567349|FG002|Overall Study|Adverse Event|0|||
156678476|NCT01451541|565567350|FG000|Overall Study|Adverse Event|4|||
156678477|NCT01451541|565567351|FG001|Overall Study|Adverse Event|3|||
156678478|NCT01451541|565567352|FG002|Overall Study|Adverse Event|6|||
156678479|NCT01451541|565567350|FG000|Overall Study|Lack of Efficacy|2|||
156678480|NCT01451541|565567351|FG001|Overall Study|Lack of Efficacy|0|||
156678481|NCT01451541|565567352|FG002|Overall Study|Lack of Efficacy|0|||
156678482|NCT01451541|565567350|FG000|Overall Study|Lost to Follow-up|4|||
156678483|NCT01451541|565567351|FG001|Overall Study|Lost to Follow-up|4|||
156678484|NCT01451541|565567352|FG002|Overall Study|Lost to Follow-up|7|||
156678485|NCT01451541|565567350|FG000|Overall Study|Withdrawal by Subject|15|||
156678486|NCT01451541|565567351|FG001|Overall Study|Withdrawal by Subject|8|||
156678487|NCT01451541|565567352|FG002|Overall Study|Withdrawal by Subject|6|||
156678488|NCT01451541|565567350|FG000|Overall Study|randomization error, noncompliance|11|||
156678489|NCT01451541|565567351|FG001|Overall Study|randomization error, noncompliance|10|||
156678490|NCT01451541|565567352|FG002|Overall Study|randomization error, noncompliance|8|||
156678491|NCT00379353|565567357|FG000|Overall Study|Hospitalization|3|||
156678492|NCT00379353|565567358|FG001|Overall Study|Hospitalization|3|||
156678493|NCT00379353|565567357|FG000|Overall Study|Withdrawal by Subject|5|||
156678494|NCT00379353|565567358|FG001|Overall Study|Withdrawal by Subject|2|||
156678495|NCT00379353|565567357|FG000|Overall Study|Death|1|||
156678496|NCT00379353|565567358|FG001|Overall Study|Death|0|||
156678497|NCT00379353|565567357|FG000|Overall Study|Cardiac Tamponade|1|||
156678498|NCT00379353|565567358|FG001|Overall Study|Cardiac Tamponade|0|||
156678499|NCT00379353|565567357|FG000|Overall Study|Non-compliance|1|||
156678500|NCT00379353|565567358|FG001|Overall Study|Non-compliance|0|||
156678501|NCT00379353|565567357|FG000|Overall Study|Conflicting drug treatment|0|||
156678502|NCT00379353|565567358|FG001|Overall Study|Conflicting drug treatment|1|||
156678503|NCT05065619|565567359|FG000|Up to Day 42|Lost to Follow-up|1|||
156678504|NCT05065619|565567360|FG001|Up to Day 42|Lost to Follow-up|0|||
156678505|NCT05065619|565567359|FG000|Up to Day 42|Withdrawal by Subject|1|||
156678506|NCT05065619|565567360|FG001|Up to Day 42|Withdrawal by Subject|0|||
156678507|NCT05065619|565567359|FG000|After Day 43|Lost to Follow-up|1|||
156678508|NCT05065619|565567360|FG001|After Day 43|Lost to Follow-up|0|||
156678509|NCT05065619|565567359|FG000|After Day 43|Physician Decision|3|||
156678510|NCT05065619|565567360|FG001|After Day 43|Physician Decision|0|||
156678511|NCT05065619|565567359|FG000|After Day 43|Withdrawal by Subject|1|||
156678512|NCT05065619|565567360|FG001|After Day 43|Withdrawal by Subject|2|||
156678513|NCT05065619|565567359|FG000|After Day 43|Public vaccination|6|||
156678514|NCT05065619|565567360|FG001|After Day 43|Public vaccination|8|||
156678515|NCT05065619|565567359|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
156678516|NCT05065619|565567360|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
156678517|NCT05065619|565567359|FG000|After Day 43|Study Terminated by Sponsor|88|||
156678518|NCT05065619|565567360|FG001|After Day 43|Study Terminated by Sponsor|16|||
156678519|NCT00939523|565567361|FG000|Overall Study|Lack of Efficacy|1|||
156678520|NCT00939523|565567361|FG000|Overall Study|Physician Decision|2|||
156678521|NCT01050764|565567362|FG000|Overall Study|Death, before HSCT|1|||
156678522|NCT01050764|565567362|FG000|Overall Study|Donor mobilization failure, death|1|||
156678523|NCT01050764|565567362|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
156866738|NCT04323124|566271325|FG007|Overall Study|No longer meets eligibility criteria|1|||
156678524|NCT00570128|565567376|FG000|Overall Study|Adverse Event|1|||
156678525|NCT00570128|565567377|FG001|Overall Study|Adverse Event|0|||
156678526|NCT00570128|565567376|FG000|Overall Study|Lost to Follow-up|1|||
156866739|NCT04323124|566271326|FG008|Overall Study|No longer meets eligibility criteria|0|||
156866740|NCT04323124|566271327|FG009|Overall Study|No longer meets eligibility criteria|0|||
156866741|NCT04323124|566271328|FG010|Overall Study|No longer meets eligibility criteria|0|||
156866742|NCT04323124|566271329|FG011|Overall Study|No longer meets eligibility criteria|0|||
156866743|NCT04323124|566271330|FG012|Overall Study|No longer meets eligibility criteria|0|||
156866744|NCT04323124|566271331|FG013|Overall Study|No longer meets eligibility criteria|1|||
156866745|NCT04323124|566271332|FG014|Overall Study|No longer meets eligibility criteria|1|||
156866746|NCT04323124|566271318|FG000|Overall Study|Study terminated by sponsor|0|||
156866747|NCT04323124|566271319|FG001|Overall Study|Study terminated by sponsor|0|||
156866748|NCT04323124|566271320|FG002|Overall Study|Study terminated by sponsor|0|||
156866749|NCT04323124|566271321|FG003|Overall Study|Study terminated by sponsor|0|||
156866750|NCT04323124|566271322|FG004|Overall Study|Study terminated by sponsor|0|||
156866751|NCT04323124|566271323|FG005|Overall Study|Study terminated by sponsor|0|||
156866752|NCT04323124|566271324|FG006|Overall Study|Study terminated by sponsor|0|||
156328911|NCT00785928|564305502|FG004|Treatment Phase|Lack of Efficacy|0|||
156328912|NCT00785928|564305503|FG005|Treatment Phase|Lack of Efficacy|0|||
156678527|NCT00570128|565567377|FG001|Overall Study|Lost to Follow-up|0|||
156678528|NCT00570128|565567376|FG000|Overall Study|Withdrawal by Subject|2|||
156678529|NCT00570128|565567377|FG001|Overall Study|Withdrawal by Subject|0|||
156678530|NCT01426854|565567380|FG000|Overall Study|Adverse Event|1|||
156678531|NCT01426854|565567381|FG001|Overall Study|Adverse Event|5|||
156678532|NCT01426854|565567380|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
156678533|NCT01426854|565567381|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
156678534|NCT01426854|565567380|FG000|Overall Study|Lost to Follow-up|3|||
156678535|NCT01426854|565567381|FG001|Overall Study|Lost to Follow-up|0|||
156678536|NCT01426854|565567380|FG000|Overall Study|Noncompliance|0|||
156678537|NCT01426854|565567381|FG001|Overall Study|Noncompliance|1|||
156678538|NCT01426854|565567380|FG000|Overall Study|Treatment Failure|0|||
156678539|NCT01426854|565567381|FG001|Overall Study|Treatment Failure|16|||
156678540|NCT01426854|565567380|FG000|Overall Study|Protocol Deviation|0|||
156678541|NCT01426854|565567381|FG001|Overall Study|Protocol Deviation|1|||
156678542|NCT01426854|565567380|FG000|Overall Study|Other|3|||
156678543|NCT01426854|565567381|FG001|Overall Study|Other|2|||
156678544|NCT03555695|565567382|FG000|Overall Study|Withdrawal by Subject|1|||
156678545|NCT03555695|565567382|FG000|Overall Study|Lost to Follow-up|1|||
156678546|NCT03555695|565567382|FG000|Overall Study|appendicitis (unrelated)|1|||
156678547|NCT03555695|565567382|FG000|Overall Study|pre-existing sciatica|1|||
156678548|NCT00685334|565567390|FG000|Overall Study|Withdrawal by Subject|5|||
156678549|NCT00685334|565567391|FG001|Overall Study|Withdrawal by Subject|6|||
156678550|NCT00685334|565567390|FG000|Overall Study|Lost to Follow-up|4|||
156678551|NCT00685334|565567391|FG001|Overall Study|Lost to Follow-up|0|||
156678552|NCT00685334|565567390|FG000|Overall Study|Chose to enter hospital|1|||
156678553|NCT00685334|565567391|FG001|Overall Study|Chose to enter hospital|1|||
156678554|NCT00762411|565568960|FG000|Initial Treatment|Death|7|||
156678555|NCT00762411|565568961|FG001|Initial Treatment|Death|6|||
156678556|NCT00762411|565568960|FG000|Initial Treatment|Adverse Event|132|||
156678557|NCT00762411|565568961|FG001|Initial Treatment|Adverse Event|40|||
156678558|NCT00762411|565568960|FG000|Initial Treatment|Protocol Violation|4|||
156678559|NCT00762411|565568961|FG001|Initial Treatment|Protocol Violation|1|||
156678560|NCT00762411|565568960|FG000|Initial Treatment|Withdrawal by Subject|65|||
156678561|NCT00762411|565568961|FG001|Initial Treatment|Withdrawal by Subject|52|||
156678562|NCT00762411|565568960|FG000|Initial Treatment|Physician Decision|1|||
156678563|NCT00762411|565568961|FG001|Initial Treatment|Physician Decision|0|||
156678564|NCT00762411|565568960|FG000|Initial Treatment|Sponsor Decision|293|||
156678565|NCT00762411|565568961|FG001|Initial Treatment|Sponsor Decision|401|||
156678566|NCT00762411|565568960|FG000|Initial Treatment|Lost to Follow-up|5|||
156678567|NCT00762411|565568961|FG001|Initial Treatment|Lost to Follow-up|0|||
156678568|NCT00762411|565568960|FG000|Initial Treatment|Caregiver Decision|21|||
156678569|NCT00762411|565568961|FG001|Initial Treatment|Caregiver Decision|16|||
156678570|NCT00762411|565568960|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
156678571|NCT00762411|565568961|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
156678572|NCT00762411|565568960|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
156678573|NCT00762411|565568961|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
156678574|NCT00762411|565568960|FG000|Delayed Start|Adverse Event|0|||
156678575|NCT00762411|565568961|FG001|Delayed Start|Adverse Event|4|||
156678576|NCT00762411|565568960|FG000|Delayed Start|Protocol Violation|0|||
156866753|NCT04323124|566271325|FG007|Overall Study|Study terminated by sponsor|0|||
156866754|NCT04323124|566271326|FG008|Overall Study|Study terminated by sponsor|0|||
156866755|NCT04323124|566271327|FG009|Overall Study|Study terminated by sponsor|0|||
156529300|NCT03236246|565032605|FG000|24-Week Dose Maintenance Period|Death|0|||
156678577|NCT00762411|565568961|FG001|Delayed Start|Protocol Violation|1|||
156678578|NCT00762411|565568960|FG000|Delayed Start|Sponsor Decision|16|||
156678579|NCT00762411|565568961|FG001|Delayed Start|Sponsor Decision|20|||
156678580|NCT00762411|565568960|FG000|Delayed Start|Caregiver Decision|1|||
156328913|NCT00785928|564305504|FG006|Treatment Phase|Lack of Efficacy|0|||
156678581|NCT00762411|565568961|FG001|Delayed Start|Caregiver Decision|1|||
156678582|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
156678583|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
156678584|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
156678585|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
156678586|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
156678587|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
156678588|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
156678589|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
156678590|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
156678591|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
156678592|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
156678593|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
156678594|NCT02710214|565568965|FG000|Overall Study|Lost to Follow-up|1|||
156678595|NCT02710214|565568966|FG001|Overall Study|Lost to Follow-up|0|||
156678596|NCT02710214|565568965|FG000|Overall Study|Lack of Efficacy|0|||
156678597|NCT02710214|565568966|FG001|Overall Study|Lack of Efficacy|1|||
156678598|NCT02710214|565568965|FG000|Overall Study|Death|0|||
156678599|NCT02710214|565568966|FG001|Overall Study|Death|1|||
156678600|NCT02832167|565568967|FG000|Treatment Period 1|Disease progression|90|||
156678601|NCT02832167|565568967|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
156678602|NCT02832167|565568967|FG000|Treatment Period 1|Death|2|||
156678603|NCT02832167|565568967|FG000|Treatment Period 1|Study Drug Toxicity|6|||
156678604|NCT02832167|565568967|FG000|Treatment Period 1|Participant request to discontinue|9|||
156678605|NCT02832167|565568967|FG000|Treatment Period 1|No longer meet study criteria|1|||
156678606|NCT02832167|565568967|FG000|Treatment Period 1|Participant withdrew consent|3|||
156678607|NCT02832167|565568967|FG000|Treatment Period 1|Other reasons|6|||
156678608|NCT02832167|565568967|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
156678609|NCT02832167|565568967|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
156678610|NCT02832167|565568967|FG000|Transition From Period 1 to Period 2|Death|2|||
156678611|NCT02832167|565568967|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
156678612|NCT02832167|565568967|FG000|Treatment Period 2|Disease progression|69|||
156678613|NCT02832167|565568967|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
156678614|NCT02832167|565568967|FG000|Treatment Period 2|Maximum clinical benefit|1|||
156678615|NCT02832167|565568967|FG000|Treatment Period 2|Study Drug Toxicity|5|||
156678616|NCT02832167|565568967|FG000|Treatment Period 2|Participant request to discontinue|2|||
156678617|NCT02832167|565568967|FG000|Treatment Period 2|Participant withdrew consent|3|||
156866756|NCT04323124|566271328|FG010|Overall Study|Study terminated by sponsor|0|||
156866757|NCT04323124|566271329|FG011|Overall Study|Study terminated by sponsor|2|||
156435240|NCT00922207|564683556|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
156435241|NCT00922207|564683557|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
156678618|NCT02832167|565568967|FG000|Treatment Period 2|Other reasons|3|||
156678619|NCT01754376|565568968|FG000|Overall Study|Adverse Event|1|||
156678620|NCT01754376|565568968|FG000|Overall Study|Lack of Efficacy|2|||
156678621|NCT04590781|565568969|FG000|Overall Study|Death|0|||
156678622|NCT04590781|565568970|FG001|Overall Study|Death|2|||
156678623|NCT04590781|565568969|FG000|Overall Study|Withdrawal by Subject|2|||
156678624|NCT04590781|565568970|FG001|Overall Study|Withdrawal by Subject|0|||
156678625|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
156678626|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
156678627|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
156678628|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678629|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678630|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678631|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678632|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678633|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
156678634|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678635|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678636|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678637|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678638|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678639|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678640|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678641|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156678642|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678643|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156678644|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678645|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678646|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678647|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156435242|NCT00922207|564683555|FG000|Overall Study|Insufficient Therapeutic Response|0|||
156678648|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678649|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
156435243|NCT00922207|564683556|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156435244|NCT00922207|564683557|FG002|Overall Study|Insufficient Therapeutic Response|1|||
156435245|NCT00922207|564683555|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
156678650|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678651|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678652|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678653|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678654|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678655|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678656|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156435246|NCT00922207|564683556|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156866758|NCT04323124|566271330|FG012|Overall Study|Study terminated by sponsor|1|||
156866759|NCT04323124|566271331|FG013|Overall Study|Study terminated by sponsor|0|||
156866760|NCT04323124|566271332|FG014|Overall Study|Study terminated by sponsor|0|||
156866761|NCT02083354|566273364|FG000|Overall Study|Withdrawal by Subject|9|||
156866762|NCT02083354|566273364|FG000|Overall Study|Lost to Follow-up|1|||
156866763|NCT02083354|566273364|FG000|Overall Study|Adverse Event|3|||
156866764|NCT02083354|566273364|FG000|Overall Study|Disease progression|46|||
156866765|NCT02083354|566273364|FG000|Overall Study|Study closed/terminated|5|||
156866766|NCT03312634|566273365|FG000|Overall Study|Adverse Event|11|||
156866767|NCT03312634|566273366|FG001|Overall Study|Adverse Event|0|||
156866768|NCT03312634|566273365|FG000|Overall Study|Sponsor request|2|||
156866769|NCT03312634|566273366|FG001|Overall Study|Sponsor request|0|||
156866770|NCT03312634|566273365|FG000|Overall Study|Withdrawal by Subject|31|||
156866771|NCT03312634|566273366|FG001|Overall Study|Withdrawal by Subject|9|||
156866772|NCT03312634|566273365|FG000|Overall Study|Enrolled in an interventional study|0|||
156866773|NCT03312634|566273366|FG001|Overall Study|Enrolled in an interventional study|52|||
156866774|NCT03312634|566273365|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
156866775|NCT03312634|566273366|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
156866776|NCT03312634|566273365|FG000|Overall Study|Death|0|||
156866777|NCT03312634|566273366|FG001|Overall Study|Death|1|||
156866778|NCT03312634|566273365|FG000|Overall Study|Non-compliance|0|||
156866779|NCT03312634|566273366|FG001|Overall Study|Non-compliance|2|||
156866780|NCT03312634|566273365|FG000|Overall Study|Lost to Follow-up|0|||
156866781|NCT03312634|566273366|FG001|Overall Study|Lost to Follow-up|1|||
156866782|NCT03312634|566273365|FG000|Overall Study|Enrolled into non-interventional study|0|||
156866783|NCT03312634|566273366|FG001|Overall Study|Enrolled into non-interventional study|5|||
156435247|NCT00922207|564683557|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
156435248|NCT00922207|564683555|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
156435249|NCT00922207|564683556|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
156435250|NCT00922207|564683557|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
156435251|NCT00922207|564683555|FG000|Overall Study|Withdrew Consent|2|||
156435252|NCT00922207|564683556|FG001|Overall Study|Withdrew Consent|5|||
156866784|NCT03312634|566273365|FG000|Overall Study|Worsening clinical condition|0|||
156866785|NCT03312634|566273366|FG001|Overall Study|Worsening clinical condition|1|||
156866786|NCT03312634|566273365|FG000|Overall Study|Participant did not want to travel|0|||
156866787|NCT03312634|566273366|FG001|Overall Study|Participant did not want to travel|1|||
156866788|NCT03312634|566273365|FG000|Overall Study|Physician Decision|1|||
156866789|NCT03312634|566273366|FG001|Overall Study|Physician Decision|0|||
156866790|NCT03312634|566273365|FG000|Overall Study|Other|13|||
156866791|NCT03312634|566273366|FG001|Overall Study|Other|0|||
156866792|NCT00777153|566273367|FG000|Overall Study|Lost to Follow-up|1|||
156866793|NCT00777153|566273368|FG001|Overall Study|Lost to Follow-up|1|||
156866794|NCT00777153|566273369|FG002|Overall Study|Lost to Follow-up|0|||
156866795|NCT00777153|566273367|FG000|Overall Study|Death|85|||
156866796|NCT00777153|566273368|FG001|Overall Study|Death|73|||
156866797|NCT00777153|566273369|FG002|Overall Study|Death|33|||
156866798|NCT00777153|566273367|FG000|Overall Study|Withdrawal by Subject|3|||
156866799|NCT00777153|566273368|FG001|Overall Study|Withdrawal by Subject|4|||
156866800|NCT00777153|566273369|FG002|Overall Study|Withdrawal by Subject|3|||
156866801|NCT00777153|566273367|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
156678657|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678658|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678659|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
156866802|NCT00777153|566273368|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
156435253|NCT00922207|564683557|FG002|Overall Study|Withdrew Consent|2|||
156866803|NCT00777153|566273369|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
156435254|NCT00922207|564683555|FG000|Overall Study|Abnormality of Laboratory Test|0|||
156866804|NCT00554216|566273373|FG000|Overall Study|Lost to Follow-up|92|||
156866805|NCT00554216|566273374|FG001|Overall Study|Lost to Follow-up|31|||
156866806|NCT00554216|566273375|FG002|Overall Study|Lost to Follow-up|63|||
156866807|NCT00554216|566273373|FG000|Overall Study|Adverse Event|16|||
156866808|NCT00554216|566273374|FG001|Overall Study|Adverse Event|16|||
156866809|NCT00554216|566273375|FG002|Overall Study|Adverse Event|36|||
156866810|NCT00554216|566273373|FG000|Overall Study|Withdrawal by Subject|92|||
156678660|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678661|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678662|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678663|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678664|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678665|NCT04556734|565568971|FG000|OLE Period (28 Weeks)|Not reported|0|||
156678666|NCT04556734|565568972|FG001|OLE Period (28 Weeks)|Not reported|0|||
156678667|NCT04556734|565568973|FG002|OLE Period (28 Weeks)|Not reported|0|||
156678668|NCT04556734|565568974|FG003|OLE Period (28 Weeks)|Not reported|0|||
156678669|NCT04556734|565568975|FG004|OLE Period (28 Weeks)|Not reported|0|||
156678670|NCT04556734|565568976|FG005|OLE Period (28 Weeks)|Not reported|1|||
156678671|NCT04556734|565568977|FG006|OLE Period (28 Weeks)|Not reported|0|||
156678672|NCT04556734|565568978|FG007|OLE Period (28 Weeks)|Not reported|0|||
156678673|NCT04556734|565568971|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678674|NCT04556734|565568972|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678675|NCT04556734|565568973|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678676|NCT04556734|565568974|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678677|NCT04556734|565568975|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678678|NCT04556734|565568976|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678679|NCT04556734|565568977|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678680|NCT04556734|565568978|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
156678681|NCT04556734|565568971|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
156678682|NCT04556734|565568972|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
156678683|NCT04556734|565568973|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
156678684|NCT04556734|565568974|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
156782294|NCT05643794|565952725|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
156782295|NCT05643794|565952726|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
156782296|NCT05643794|565952727|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
156782297|NCT04167670|565952728|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
156782298|NCT04167670|565952729|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
156866811|NCT00554216|566273374|FG001|Overall Study|Withdrawal by Subject|31|||
156782299|NCT04167670|565952730|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
156782300|NCT04167670|565952728|FG000|Overall Study|Significant protocol deviation|3|||
156782301|NCT04167670|565952729|FG001|Overall Study|Significant protocol deviation|1|||
156782302|NCT04167670|565952730|FG002|Overall Study|Significant protocol deviation|0|||
156782303|NCT04167670|565952728|FG000|Overall Study|Lost to Follow-up|0|||
156782304|NCT04167670|565952729|FG001|Overall Study|Lost to Follow-up|3|||
156782305|NCT04167670|565952730|FG002|Overall Study|Lost to Follow-up|3|||
156782306|NCT04167670|565952728|FG000|Overall Study|Voluntary Withdrawal|0|||
156782307|NCT04167670|565952729|FG001|Overall Study|Voluntary Withdrawal|1|||
156782308|NCT04167670|565952730|FG002|Overall Study|Voluntary Withdrawal|1|||
156782309|NCT04167670|565952728|FG000|Overall Study|Withdrawal of Consent|4|||
156782310|NCT04167670|565952729|FG001|Overall Study|Withdrawal of Consent|1|||
156782311|NCT04167670|565952730|FG002|Overall Study|Withdrawal of Consent|3|||
156782312|NCT04167670|565952728|FG000|Overall Study|Miscellaneous|7|||
156782313|NCT04167670|565952729|FG001|Overall Study|Miscellaneous|5|||
156782314|NCT04167670|565952730|FG002|Overall Study|Miscellaneous|3|||
156782315|NCT04827446|565952731|FG000|Overall Study|Lost to Follow-up|1|||
156782316|NCT04827446|565952732|FG001|Overall Study|Lost to Follow-up|1|||
156782317|NCT04827446|565952731|FG000|Overall Study|Death|2|||
156782318|NCT04827446|565952732|FG001|Overall Study|Death|0|||
156782319|NCT04827446|565952731|FG000|Overall Study|Withdrawal by Subject|2|||
156782320|NCT04827446|565952732|FG001|Overall Study|Withdrawal by Subject|2|||
156782321|NCT01653262|565952735|FG000|Overall Study|Lack of Efficacy|1|||
156782322|NCT01653262|565952735|FG000|Overall Study|SAE, non-fatal|1|||
156782323|NCT01653262|565952735|FG000|Overall Study|AE, non-serious non-fatal|1|||
156866812|NCT00554216|566273375|FG002|Overall Study|Withdrawal by Subject|43|||
156866813|NCT00554216|566273373|FG000|Overall Study|Non compliance|10|||
156678685|NCT04556734|565568975|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
156678686|NCT04556734|565568976|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
156678687|NCT04556734|565568977|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
156678688|NCT04556734|565568978|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
156678689|NCT04556734|565568971|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156678690|NCT04556734|565568972|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156678691|NCT04556734|565568973|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156678692|NCT04556734|565568974|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
156678693|NCT04556734|565568975|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
156678694|NCT04556734|565568976|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
156782324|NCT03735498|565952736|FG000|Overall Study|Withdrawal by Subject|3|||
156782325|NCT03735498|565952736|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
156866814|NCT00554216|566273374|FG001|Overall Study|Non compliance|4|||
156678695|NCT04556734|565568977|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
156678696|NCT04556734|565568978|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156678697|NCT00820599|565568981|FG000|Overall Study|Death|129|||
156678698|NCT00820599|565568981|FG000|Overall Study|Withdrawal by Subject|2|||
156678699|NCT03686215|565568982|FG000|Overall Study|Adverse Event|0|||
156678700|NCT03686215|565568983|FG001|Overall Study|Adverse Event|0|||
156678701|NCT03686215|565568984|FG002|Overall Study|Adverse Event|7|||
156678702|NCT03686215|565568982|FG000|Overall Study|Physician Decision|0|||
156678703|NCT03686215|565568983|FG001|Overall Study|Physician Decision|0|||
156678704|NCT03686215|565568984|FG002|Overall Study|Physician Decision|1|||
156678705|NCT03686215|565568982|FG000|Overall Study|Protocol Violation|0|||
156678706|NCT03686215|565568983|FG001|Overall Study|Protocol Violation|0|||
156678707|NCT03686215|565568984|FG002|Overall Study|Protocol Violation|4|||
156678708|NCT03686215|565568982|FG000|Overall Study|Device issue|1|||
156678709|NCT03686215|565568983|FG001|Overall Study|Device issue|0|||
156678710|NCT03686215|565568984|FG002|Overall Study|Device issue|2|||
156678711|NCT00202839|565568985|FG000|Overall Study|Adverse Event|1|||
156678712|NCT00202839|565568986|FG001|Overall Study|Adverse Event|5|||
156678713|NCT00202839|565568985|FG000|Overall Study|Physician Decision|12|||
156678714|NCT00202839|565568986|FG001|Overall Study|Physician Decision|0|||
156678715|NCT00202839|565568985|FG000|Overall Study|Withdrawal by Subject|6|||
156678716|NCT00202839|565568986|FG001|Overall Study|Withdrawal by Subject|2|||
156678717|NCT00202839|565568985|FG000|Overall Study|Protocol Violation|2|||
156678718|NCT00202839|565568986|FG001|Overall Study|Protocol Violation|1|||
156678719|NCT00202839|565568985|FG000|Overall Study|Lost to Follow-up|3|||
156678720|NCT00202839|565568986|FG001|Overall Study|Lost to Follow-up|2|||
156678721|NCT04768296|565568987|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
156678722|NCT04768296|565568988|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
156678723|NCT00452348|565568989|FG000|Overall Study|Adverse Event|6|||
156678724|NCT00452348|565568990|FG001|Overall Study|Adverse Event|9|||
156678725|NCT00452348|565568989|FG000|Overall Study|Lack of Efficacy|10|||
156678726|NCT00452348|565568990|FG001|Overall Study|Lack of Efficacy|9|||
156678727|NCT00452348|565568989|FG000|Overall Study|Lost to Follow-up|14|||
156678728|NCT00452348|565568990|FG001|Overall Study|Lost to Follow-up|8|||
156678729|NCT00452348|565568989|FG000|Overall Study|Protocol Violation|22|||
156678730|NCT00452348|565568990|FG001|Overall Study|Protocol Violation|28|||
156678731|NCT00452348|565568989|FG000|Overall Study|Withdrawal by Subject|18|||
156678732|NCT00452348|565568990|FG001|Overall Study|Withdrawal by Subject|21|||
156678733|NCT00452348|565568989|FG000|Overall Study|Other|9|||
156678734|NCT00452348|565568990|FG001|Overall Study|Other|9|||
156678735|NCT03119662|565568991|FG000|Overall Study|Withdrawal by Subject|0|||
156678736|NCT03119662|565568992|FG001|Overall Study|Withdrawal by Subject|1|||
156678737|NCT02817828|565568993|FG000|Overall Study|Lost to Follow-up|41|||
156678738|NCT02817828|565568993|FG000|Overall Study|Adverse event not related to bleeding|104|||
156678739|NCT02817828|565568993|FG000|Overall Study|Adverse event related to bleeding|53|||
156678740|NCT02817828|565568993|FG000|Overall Study|Protocol Violation|11|||
156678741|NCT02817828|565568993|FG000|Overall Study|Pregnancy|7|||
156678742|NCT02817828|565568993|FG000|Overall Study|Pregnancy wish|15|||
156678743|NCT02817828|565568993|FG000|Overall Study|Withdrawal by Subject|78|||
156678744|NCT02817828|565568993|FG000|Overall Study|Other|26|||
156678745|NCT00522041|565568995|FG000|Overall Study|Adverse Event|9|||
156678746|NCT00522041|565568996|FG001|Overall Study|Adverse Event|3|||
156678747|NCT00522041|565568995|FG000|Overall Study|Protocol Violation|2|||
156678748|NCT00522041|565568996|FG001|Overall Study|Protocol Violation|0|||
156678749|NCT00522041|565568995|FG000|Overall Study|Lost to Follow-up|1|||
156678750|NCT00522041|565568996|FG001|Overall Study|Lost to Follow-up|4|||
156678751|NCT00522041|565568995|FG000|Overall Study|Voluntary withdrawal|5|||
156678752|NCT00522041|565568996|FG001|Overall Study|Voluntary withdrawal|4|||
156678753|NCT00522041|565568995|FG000|Overall Study|Did not receive treatment|0|||
156678754|NCT00522041|565568996|FG001|Overall Study|Did not receive treatment|1|||
156678755|NCT00874549|565568997|FG000|Overall Study|Adverse Event|0|||
156782326|NCT01112267|565952738|FG000|Overall Study|Adverse Event|24|||
156782327|NCT01112267|565952739|FG001|Overall Study|Adverse Event|6|||
156782328|NCT01112267|565952738|FG000|Overall Study|Withdrawal by Subject|3|||
156782329|NCT01112267|565952739|FG001|Overall Study|Withdrawal by Subject|5|||
156782330|NCT01112267|565952738|FG000|Overall Study|Protocol Violation|5|||
156782331|NCT01112267|565952739|FG001|Overall Study|Protocol Violation|3|||
156782332|NCT01112267|565952738|FG000|Overall Study|Participants not compliant|1|||
156678756|NCT00874549|565568998|FG001|Overall Study|Adverse Event|0|||
156678757|NCT00874549|565568999|FG002|Overall Study|Adverse Event|1|||
156678758|NCT00874549|565569000|FG003|Overall Study|Adverse Event|0|||
156678759|NCT00874549|565568997|FG000|Overall Study|Protocol Violation|1|||
156678760|NCT00874549|565568998|FG001|Overall Study|Protocol Violation|0|||
156678761|NCT00874549|565568999|FG002|Overall Study|Protocol Violation|2|||
156678762|NCT00874549|565569000|FG003|Overall Study|Protocol Violation|1|||
156678763|NCT00874549|565568997|FG000|Overall Study|Lost to Follow-up|0|||
156678764|NCT00874549|565568998|FG001|Overall Study|Lost to Follow-up|0|||
156678765|NCT00874549|565568999|FG002|Overall Study|Lost to Follow-up|1|||
156782333|NCT01112267|565952739|FG001|Overall Study|Participants not compliant|2|||
156866815|NCT00554216|566273375|FG002|Overall Study|Non compliance|5|||
156866816|NCT00554216|566273373|FG000|Overall Study|Pregnancy|2|||
156866817|NCT00554216|566273374|FG001|Overall Study|Pregnancy|1|||
156866818|NCT00554216|566273375|FG002|Overall Study|Pregnancy|14|||
156866819|NCT00554216|566273373|FG000|Overall Study|Restricted med|3|||
156866820|NCT00554216|566273374|FG001|Overall Study|Restricted med|1|||
156866821|NCT00554216|566273375|FG002|Overall Study|Restricted med|1|||
156866822|NCT00554216|566273373|FG000|Overall Study|Other|12|||
156866823|NCT00554216|566273374|FG001|Overall Study|Other|7|||
156866824|NCT00554216|566273375|FG002|Overall Study|Other|10|||
156866825|NCT00554216|566273373|FG000|Overall Study|Lack of Efficacy|15|||
156435255|NCT00922207|564683556|FG001|Overall Study|Abnormality of Laboratory Test|1|||
156435256|NCT00922207|564683557|FG002|Overall Study|Abnormality of Laboratory Test|1|||
156435257|NCT00367991|564683559|FG000|Overall Study|Withdrawal by Subject|1|||
156435258|NCT00367991|564683560|FG001|Overall Study|Withdrawal by Subject|1|||
156435259|NCT00367991|564683559|FG000|Overall Study|Adverse Event|1|||
156435260|NCT00367991|564683560|FG001|Overall Study|Adverse Event|1|||
156435261|NCT03515304|564683561|FG000|Overall Study|Lost to Follow-up|0|||
156435262|NCT03515304|564683562|FG001|Overall Study|Lost to Follow-up|3|||
156435263|NCT02950558|564683563|FG000|Overall Study|Lost to Follow-up|2|||
156435264|NCT02950558|564683564|FG001|Overall Study|Lost to Follow-up|0|||
156435265|NCT05686421|564683567|FG000|Overall Study|Screen failure|22|||
156435266|NCT05686421|564683568|FG001|Overall Study|Screen failure|0|||
156435267|NCT05686421|564683569|FG002|Overall Study|Screen failure|0|||
156435268|NCT05686421|564683570|FG003|Overall Study|Screen failure|0|||
156435269|NCT00940992|564683571|FG000|Overall Study|Adverse Event|2|||
156435270|NCT00940992|564683572|FG001|Overall Study|Adverse Event|0|||
156866826|NCT00554216|566273374|FG001|Overall Study|Lack of Efficacy|3|||
156866827|NCT00554216|566273375|FG002|Overall Study|Lack of Efficacy|0|||
156866828|NCT04040933|566273376|FG000|Overall Study|Protocol Violation|1|||
156866829|NCT04040933|566273376|FG000|Overall Study|Withdrawal by Subject|2|||
156866830|NCT00775190|566273377|FG000|Overall Study|Lost to Follow-up|2|||
156866831|NCT00775190|566273378|FG001|Overall Study|Lost to Follow-up|3|||
156435271|NCT00940992|564683573|FG002|Overall Study|Adverse Event|1|||
156435272|NCT00940992|564683571|FG000|Overall Study|subject request|2|||
156435273|NCT00940992|564683572|FG001|Overall Study|subject request|1|||
156678766|NCT00874549|565569000|FG003|Overall Study|Lost to Follow-up|0|||
156678767|NCT00874549|565568997|FG000|Overall Study|Withdrawal by Subject|0|||
156678768|NCT00874549|565568998|FG001|Overall Study|Withdrawal by Subject|1|||
156678769|NCT00874549|565568999|FG002|Overall Study|Withdrawal by Subject|0|||
156678770|NCT00874549|565569000|FG003|Overall Study|Withdrawal by Subject|1|||
156678771|NCT03343639|565569001|FG000|Overall Study|Withdrawal by Subject|10|||
156678772|NCT03343639|565569002|FG001|Overall Study|Withdrawal by Subject|6|||
156678773|NCT03343639|565569001|FG000|Overall Study|Lost to Follow-up|4|||
156678774|NCT03343639|565569002|FG001|Overall Study|Lost to Follow-up|5|||
156678775|NCT03343639|565569001|FG000|Overall Study|Protocol Violation|0|||
156678776|NCT03343639|565569002|FG001|Overall Study|Protocol Violation|1|||
156678777|NCT00735696|565569003|FG000|Overall Study|Withdrawal by Subject|1|||
156678778|NCT00735696|565569003|FG000|Overall Study|Enrolled but never Treated|1|||
156678779|NCT02786953|565569011|FG000|Overall Study|Withdrawal by Subject|3|||
156678780|NCT02786953|565569012|FG001|Overall Study|Withdrawal by Subject|0|||
156678781|NCT02786953|565569011|FG000|Overall Study|Physician Decision|0|||
156678782|NCT02786953|565569012|FG001|Overall Study|Physician Decision|1|||
156678783|NCT01186458|565569018|FG000|Overall Study|Adverse Event|1|||
156678784|NCT04281472|565569019|FG000|Stage A|Lack of Efficacy|8|||
156678785|NCT04281472|565569020|FG001|Stage A|Lack of Efficacy|0|||
156678786|NCT04281472|565569021|FG002|Stage A|Lack of Efficacy|0|||
156678787|NCT04281472|565569019|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
156678788|NCT04281472|565569020|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
156678789|NCT04281472|565569021|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
156678790|NCT04281472|565569019|FG000|Stage A|Adverse Event|20|||
156678791|NCT04281472|565569020|FG001|Stage A|Adverse Event|0|||
156678792|NCT04281472|565569021|FG002|Stage A|Adverse Event|0|||
156678793|NCT04281472|565569019|FG000|Stage A|Death|1|||
156678794|NCT04281472|565569020|FG001|Stage A|Death|0|||
156678795|NCT04281472|565569021|FG002|Stage A|Death|0|||
156678796|NCT04281472|565569019|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
156678797|NCT04281472|565569020|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
156678798|NCT04281472|565569021|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
156678799|NCT04281472|565569019|FG000|Stage A|Lost to Follow-up|2|||
156678800|NCT04281472|565569020|FG001|Stage A|Lost to Follow-up|0|||
156678801|NCT04281472|565569021|FG002|Stage A|Lost to Follow-up|0|||
156866832|NCT00775190|566273377|FG000|Overall Study|Withdrawal by Subject|1|||
156866833|NCT00775190|566273378|FG001|Overall Study|Withdrawal by Subject|2|||
156678802|NCT04281472|565569019|FG000|Stage A|Non-compliance with study drug|1|||
156866834|NCT00775190|566273377|FG000|Overall Study|Protocol Violation|1|||
156435274|NCT00940992|564683573|FG002|Overall Study|subject request|0|||
156678803|NCT04281472|565569020|FG001|Stage A|Non-compliance with study drug|0|||
156866835|NCT00775190|566273378|FG001|Overall Study|Protocol Violation|0|||
156435275|NCT00940992|564683571|FG000|Overall Study|Lost to Follow-up|0|||
156435276|NCT00940992|564683572|FG001|Overall Study|Lost to Follow-up|1|||
156435277|NCT00940992|564683573|FG002|Overall Study|Lost to Follow-up|1|||
156435278|NCT04221438|564683574|FG000|Overall Study|Adverse Event|1|||
156435279|NCT04221438|564683574|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
156435280|NCT01837641|564683582|FG000|Overall Study|Sponsor decision|1|||
156435281|NCT01837641|564683583|FG001|Overall Study|Sponsor decision|0|||
156435282|NCT01837641|564683584|FG002|Overall Study|Sponsor decision|0|||
156435283|NCT01837641|564683585|FG003|Overall Study|Sponsor decision|0|||
156435284|NCT01837641|564683586|FG004|Overall Study|Sponsor decision|0|||
156435285|NCT01837641|564683587|FG005|Overall Study|Sponsor decision|1|||
156435286|NCT01837641|564683588|FG006|Overall Study|Sponsor decision|0|||
156435287|NCT01837641|564683589|FG007|Overall Study|Sponsor decision|0|||
156435288|NCT01837641|564683582|FG000|Overall Study|Adverse Event|0|||
156435289|NCT01837641|564683583|FG001|Overall Study|Adverse Event|0|||
156435290|NCT01837641|564683584|FG002|Overall Study|Adverse Event|0|||
156435291|NCT01837641|564683585|FG003|Overall Study|Adverse Event|0|||
156435292|NCT01837641|564683586|FG004|Overall Study|Adverse Event|0|||
156435293|NCT01837641|564683587|FG005|Overall Study|Adverse Event|1|||
156435294|NCT01837641|564683588|FG006|Overall Study|Adverse Event|0|||
156435295|NCT01837641|564683589|FG007|Overall Study|Adverse Event|0|||
156435296|NCT01837641|564683582|FG000|Overall Study|Withdrawal by Subject|0|||
156435297|NCT01837641|564683583|FG001|Overall Study|Withdrawal by Subject|0|||
156435298|NCT01837641|564683584|FG002|Overall Study|Withdrawal by Subject|0|||
156435299|NCT01837641|564683585|FG003|Overall Study|Withdrawal by Subject|0|||
156435300|NCT01837641|564683586|FG004|Overall Study|Withdrawal by Subject|1|||
156435301|NCT01837641|564683587|FG005|Overall Study|Withdrawal by Subject|0|||
156435302|NCT01837641|564683588|FG006|Overall Study|Withdrawal by Subject|1|||
156435303|NCT01837641|564683589|FG007|Overall Study|Withdrawal by Subject|0|||
156435304|NCT00546871|564683592|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
156435305|NCT00546871|564683593|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
156435306|NCT00546871|564683592|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
156435307|NCT00546871|564683593|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
156435308|NCT00546871|564683592|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
156529301|NCT03236246|565032606|FG001|24-Week Dose Maintenance Period|Death|1|||
156529302|NCT03236246|565032605|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
156529303|NCT03236246|565032606|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
156529304|NCT02952001|565032609|FG000|Overall Study|Adverse Event|3|||
156529305|NCT02952001|565032610|FG001|Overall Study|Adverse Event|0|||
156529306|NCT02952001|565032609|FG000|Overall Study|Prohibited therapy|10|||
156529307|NCT02952001|565032610|FG001|Overall Study|Prohibited therapy|3|||
156529308|NCT02952001|565032609|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
156529309|NCT02952001|565032610|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
156529310|NCT01681628|565032613|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
156529311|NCT01681628|565032614|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
156529312|NCT01681628|565032613|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
156782334|NCT01112267|565952738|FG000|Overall Study|Participants not receive any study drug|1|||
156782335|NCT01112267|565952739|FG001|Overall Study|Participants not receive any study drug|2|||
156782336|NCT00160615|565952740|FG000|Overall Study|Adverse Event|5|||
156782337|NCT00160615|565952741|FG001|Overall Study|Adverse Event|12|||
156782338|NCT00160615|565952740|FG000|Overall Study|Withdrawal by Subject|0|||
156782339|NCT00160615|565952741|FG001|Overall Study|Withdrawal by Subject|2|||
156529313|NCT01681628|565032614|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
156529314|NCT01681628|565032613|FG000|19 Months Follow-up|Death|1|||
156529315|NCT01681628|565032614|FG001|19 Months Follow-up|Death|0|||
156782340|NCT00160615|565952740|FG000|Overall Study|Lack of Efficacy|11|||
156782341|NCT00160615|565952741|FG001|Overall Study|Lack of Efficacy|23|||
156782342|NCT00160615|565952740|FG000|Overall Study|Patient decision|1|||
156782343|NCT00160615|565952741|FG001|Overall Study|Patient decision|2|||
156782344|NCT00160615|565952740|FG000|Overall Study|Investigator decision|1|||
156782345|NCT00160615|565952741|FG001|Overall Study|Investigator decision|1|||
156782346|NCT00160615|565952740|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
156782347|NCT00160615|565952741|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
156782348|NCT00160615|565952740|FG000|Overall Study|Switch to surgical treatment|0|||
156782349|NCT00160615|565952741|FG001|Overall Study|Switch to surgical treatment|2|||
156782350|NCT00160615|565952740|FG000|Overall Study|Non-compliance was suspected|0|||
156782351|NCT00160615|565952741|FG001|Overall Study|Non-compliance was suspected|1|||
156782352|NCT00160615|565952740|FG000|Overall Study|Poor compliance|0|||
156782353|NCT00160615|565952741|FG001|Overall Study|Poor compliance|1|||
156782354|NCT02014103|565952742|FG000|Overall Study|Protocol Violation|7|||
156435309|NCT00546871|564683593|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
156435310|NCT00546871|564683592|FG000|Study Extension Period|Protocol Violation|1|||
156782355|NCT02014103|565952743|FG001|Overall Study|Protocol Violation|7|||
156782356|NCT02014103|565952742|FG000|Overall Study|Adverse Event|1|||
156782357|NCT02014103|565952743|FG001|Overall Study|Adverse Event|0|||
156678804|NCT04281472|565569021|FG002|Stage A|Non-compliance with study drug|0|||
156678805|NCT04281472|565569019|FG000|Stage A|Physician Decision|1|||
156678806|NCT04281472|565569020|FG001|Stage A|Physician Decision|0|||
156678807|NCT04281472|565569021|FG002|Stage A|Physician Decision|0|||
156678808|NCT04281472|565569019|FG000|Stage A|Prohibited medications|2|||
156678809|NCT04281472|565569020|FG001|Stage A|Prohibited medications|0|||
156678810|NCT04281472|565569021|FG002|Stage A|Prohibited medications|0|||
156678811|NCT04281472|565569019|FG000|Stage A|Withdrawal by Subject|11|||
156678812|NCT04281472|565569020|FG001|Stage A|Withdrawal by Subject|0|||
156678813|NCT04281472|565569021|FG002|Stage A|Withdrawal by Subject|0|||
156678814|NCT04281472|565569019|FG000|Stage A|Other|5|||
156678815|NCT04281472|565569020|FG001|Stage A|Other|0|||
156678816|NCT04281472|565569021|FG002|Stage A|Other|0|||
156678817|NCT04281472|565569019|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
156328914|NCT00785928|564305498|FG000|Treatment Phase|Physician Decision|0|||
156328915|NCT00785928|564305499|FG001|Treatment Phase|Physician Decision|0|||
156328916|NCT00785928|564305500|FG002|Treatment Phase|Physician Decision|0|||
156328917|NCT00785928|564305501|FG003|Treatment Phase|Physician Decision|0|||
156328918|NCT00785928|564305502|FG004|Treatment Phase|Physician Decision|1|||
156328919|NCT00785928|564305503|FG005|Treatment Phase|Physician Decision|0|||
156328920|NCT00785928|564305504|FG006|Treatment Phase|Physician Decision|0|||
156328921|NCT00785928|564305498|FG000|Treatment Phase|Sponsor Decision|1|||
156328922|NCT00785928|564305499|FG001|Treatment Phase|Sponsor Decision|0|||
156328923|NCT00785928|564305500|FG002|Treatment Phase|Sponsor Decision|0|||
156328924|NCT00785928|564305501|FG003|Treatment Phase|Sponsor Decision|0|||
156328925|NCT00785928|564305502|FG004|Treatment Phase|Sponsor Decision|0|||
156328926|NCT00785928|564305503|FG005|Treatment Phase|Sponsor Decision|0|||
156328927|NCT00785928|564305504|FG006|Treatment Phase|Sponsor Decision|1|||
156328928|NCT00785928|564305498|FG000|Treatment Phase|Withdrawal by Subject|1|||
156328929|NCT00785928|564305499|FG001|Treatment Phase|Withdrawal by Subject|2|||
156328930|NCT00785928|564305500|FG002|Treatment Phase|Withdrawal by Subject|0|||
156328931|NCT00785928|564305501|FG003|Treatment Phase|Withdrawal by Subject|0|||
156328932|NCT00785928|564305502|FG004|Treatment Phase|Withdrawal by Subject|1|||
156328933|NCT00785928|564305503|FG005|Treatment Phase|Withdrawal by Subject|0|||
156328934|NCT00785928|564305504|FG006|Treatment Phase|Withdrawal by Subject|0|||
156328935|NCT01675427|564305506|FG000|Overall Study|Withdrawal by Subject|7|||
156328936|NCT01675427|564305506|FG000|Overall Study|Participant Refused Sample Collection|18|||
156328937|NCT01675427|564305506|FG000|Overall Study|Sample not Collected by Mistake|2|||
156328938|NCT01675427|564305506|FG000|Overall Study|Lost to Follow-up|5|||
156328939|NCT01675427|564305506|FG000|Overall Study|Other|2|||
156328940|NCT00369122|564305511|FG000|Overall Study|Ineligible|10|||
156328941|NCT00369122|564305511|FG000|Overall Study|No protocol treatment|1|||
156328942|NCT00408629|564305514|FG000|Overall Study|Adverse Event|13|||
156328943|NCT00408629|564305515|FG001|Overall Study|Adverse Event|27|||
156678818|NCT04281472|565569020|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
156678819|NCT04281472|565569021|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
156678820|NCT04281472|565569019|FG000|Stage B|Adverse Event|0|||
156678821|NCT04281472|565569020|FG001|Stage B|Adverse Event|3|||
156678822|NCT04281472|565569021|FG002|Stage B|Adverse Event|0|||
156678823|NCT04281472|565569019|FG000|Stage B|Death|0|||
156678824|NCT04281472|565569020|FG001|Stage B|Death|0|||
156678825|NCT04281472|565569021|FG002|Stage B|Death|1|||
156678826|NCT04281472|565569019|FG000|Stage B|Lack of Efficacy|0|||
156678827|NCT04281472|565569020|FG001|Stage B|Lack of Efficacy|0|||
156678828|NCT04281472|565569021|FG002|Stage B|Lack of Efficacy|1|||
156678829|NCT04281472|565569019|FG000|Stage B|Lost to Follow-up|0|||
156678830|NCT04281472|565569020|FG001|Stage B|Lost to Follow-up|0|||
156678831|NCT04281472|565569021|FG002|Stage B|Lost to Follow-up|2|||
156678832|NCT04281472|565569019|FG000|Stage B|Prohibited medications|0|||
156678833|NCT04281472|565569020|FG001|Stage B|Prohibited medications|2|||
156678834|NCT04281472|565569021|FG002|Stage B|Prohibited medications|1|||
156678835|NCT04281472|565569019|FG000|Stage B|Protocol Violation|0|||
156678836|NCT04281472|565569020|FG001|Stage B|Protocol Violation|1|||
156678837|NCT04281472|565569021|FG002|Stage B|Protocol Violation|1|||
156678838|NCT04281472|565569019|FG000|Stage B|Sponsor decision|0|||
156678839|NCT04281472|565569020|FG001|Stage B|Sponsor decision|0|||
156678840|NCT04281472|565569021|FG002|Stage B|Sponsor decision|1|||
156678841|NCT04281472|565569019|FG000|Stage B|Withdrawal by Subject|0|||
156678842|NCT04281472|565569020|FG001|Stage B|Withdrawal by Subject|3|||
156678843|NCT04281472|565569021|FG002|Stage B|Withdrawal by Subject|3|||
156678844|NCT04281472|565569019|FG000|Stage B|Other|0|||
156678845|NCT04281472|565569020|FG001|Stage B|Other|3|||
156678846|NCT04281472|565569021|FG002|Stage B|Other|0|||
156328944|NCT00408629|564305514|FG000|Overall Study|Withdrawal by Subject|8|||
156678847|NCT04697173|565569025|FG000|Overall Study|Withdrawal by Subject|34|||
156678848|NCT04697173|565569026|FG001|Overall Study|Withdrawal by Subject|38|||
156678849|NCT01055834|565569027|FG000|Treatment Period I|Adverse Event|1|||
156678850|NCT01055834|565569028|FG001|Treatment Period I|Adverse Event|0|||
156678851|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Death|0|||
156678852|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Death|1|||
156678853|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
156678854|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
156678855|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
156678856|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
156678857|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
156678858|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
156678859|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
156678860|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
156678861|NCT01717313|565569029|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
156678862|NCT01717313|565569030|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
156678863|NCT01717313|565569029|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
156678864|NCT01717313|565569030|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
156678865|NCT01717313|565569029|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
156678866|NCT01717313|565569030|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
156678867|NCT01717313|565569029|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
156678868|NCT01717313|565569030|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
156678869|NCT03504085|565569031|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
156678870|NCT03504085|565569032|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
156678871|NCT03504085|565569031|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
156678872|NCT03504085|565569032|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
156678873|NCT01868243|565569034|FG000|Overall Study|Death|0|||
156678874|NCT01868243|565569035|FG001|Overall Study|Death|1|||
156678875|NCT00467597|565569037|FG000|Overall Study|Withdrawal by Subject|2|||
156678876|NCT00467597|565569038|FG001|Overall Study|Withdrawal by Subject|0|||
156782358|NCT02014103|565952742|FG000|Overall Study|Lost venous access|1|||
156782359|NCT02014103|565952743|FG001|Overall Study|Lost venous access|0|||
156782360|NCT02014103|565952742|FG000|Overall Study|Withdrawal by Subject|0|||
156782361|NCT02014103|565952743|FG001|Overall Study|Withdrawal by Subject|2|||
156782362|NCT05638737|565952744|FG000|Overall Study|Withdrawal by Subject|4|||
156782363|NCT05638737|565952745|FG001|Overall Study|Withdrawal by Subject|7|||
156782364|NCT02068794|565952746|FG000|Overall Study|Withdrawal by Subject|0|||
156782365|NCT02068794|565952747|FG001|Overall Study|Withdrawal by Subject|1|||
156782366|NCT02068794|565952748|FG002|Overall Study|Withdrawal by Subject|2|||
156782367|NCT02068794|565952746|FG000|Overall Study|Early Progression|1|||
156782368|NCT02068794|565952747|FG001|Overall Study|Early Progression|0|||
156678877|NCT01745094|565569039|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
156678878|NCT01745094|565569040|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
156678879|NCT01745094|565569041|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
156678880|NCT01745094|565569042|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
156678881|NCT01745094|565569039|FG000|Overall Study|Adverse Event|0|||
156678882|NCT01745094|565569040|FG001|Overall Study|Adverse Event|0|||
156678883|NCT01745094|565569041|FG002|Overall Study|Adverse Event|3|||
156678884|NCT01745094|565569042|FG003|Overall Study|Adverse Event|0|||
156678885|NCT01745094|565569039|FG000|Overall Study|Withdrawal by Subject|2|||
156678886|NCT01745094|565569040|FG001|Overall Study|Withdrawal by Subject|0|||
156678887|NCT01745094|565569041|FG002|Overall Study|Withdrawal by Subject|1|||
156678888|NCT01745094|565569042|FG003|Overall Study|Withdrawal by Subject|2|||
156678889|NCT01745094|565569039|FG000|Overall Study|Protocol Violation|1|||
156678890|NCT01745094|565569040|FG001|Overall Study|Protocol Violation|0|||
156678891|NCT01745094|565569041|FG002|Overall Study|Protocol Violation|3|||
156678892|NCT01745094|565569042|FG003|Overall Study|Protocol Violation|1|||
156678893|NCT01745094|565569039|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
156678894|NCT01745094|565569040|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
156678895|NCT01745094|565569041|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
156678896|NCT01745094|565569042|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
156678897|NCT01745094|565569039|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
156678898|NCT01745094|565569040|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
156678899|NCT01745094|565569041|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
156678900|NCT01745094|565569042|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
156678901|NCT01745094|565569039|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
156678902|NCT01745094|565569040|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
156678903|NCT01745094|565569041|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
156678904|NCT01745094|565569042|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
156678905|NCT04610580|565569043|FG000|Two-way Crossover Period|Adverse Event|1|||
156678906|NCT04610580|565569044|FG001|Two-way Crossover Period|Adverse Event|0|||
156678907|NCT04610580|565569045|FG002|Two-way Crossover Period|Adverse Event|0|||
156678908|NCT04610580|565569046|FG003|Two-way Crossover Period|Adverse Event|0|||
156678909|NCT04610580|565569047|FG004|Two-way Crossover Period|Adverse Event|0|||
156678910|NCT04610580|565569048|FG005|Two-way Crossover Period|Adverse Event|0|||
156782369|NCT02068794|565952748|FG002|Overall Study|Early Progression|1|||
156782370|NCT02068794|565952746|FG000|Overall Study|Ineligible|0|||
156782371|NCT02068794|565952747|FG001|Overall Study|Ineligible|0|||
156782372|NCT02068794|565952748|FG002|Overall Study|Ineligible|1|||
156435311|NCT00546871|564683593|FG001|Study Extension Period|Protocol Violation|0|||
156435312|NCT00546871|564683592|FG000|Study Extension Period|Withdrawal by Subject|0|||
156435313|NCT00546871|564683593|FG001|Study Extension Period|Withdrawal by Subject|1|||
156435314|NCT01713946|564683594|FG000|Overall Study|Death|0|||
156435315|NCT01713946|564683595|FG001|Overall Study|Death|2|||
156435316|NCT01713946|564683596|FG002|Overall Study|Death|2|||
156435317|NCT01713946|564683594|FG000|Overall Study|Adverse Event|19|||
156678911|NCT04610580|565569043|FG000|Two-way Crossover Period|Physician Decision|1|||
156678912|NCT04610580|565569044|FG001|Two-way Crossover Period|Physician Decision|0|||
156678913|NCT04610580|565569045|FG002|Two-way Crossover Period|Physician Decision|0|||
156678914|NCT04610580|565569046|FG003|Two-way Crossover Period|Physician Decision|0|||
156678915|NCT04610580|565569047|FG004|Two-way Crossover Period|Physician Decision|0|||
156678916|NCT04610580|565569048|FG005|Two-way Crossover Period|Physician Decision|0|||
156678917|NCT04610580|565569043|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
156678918|NCT04610580|565569044|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
156678919|NCT04610580|565569045|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
156678920|NCT04610580|565569046|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
156678921|NCT04610580|565569047|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
156678922|NCT04610580|565569048|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
156678923|NCT04610580|565569043|FG000|Two-way Crossover Period|Other than specified|0|||
156678924|NCT04610580|565569044|FG001|Two-way Crossover Period|Other than specified|1|||
156678925|NCT04610580|565569045|FG002|Two-way Crossover Period|Other than specified|0|||
156678926|NCT04610580|565569046|FG003|Two-way Crossover Period|Other than specified|0|||
156678927|NCT04610580|565569047|FG004|Two-way Crossover Period|Other than specified|0|||
156678928|NCT04610580|565569048|FG005|Two-way Crossover Period|Other than specified|0|||
156678929|NCT04610580|565569043|FG000|Washout Before Extension Period|Other than specified|0|||
156678930|NCT04610580|565569044|FG001|Washout Before Extension Period|Other than specified|1|||
156678931|NCT04610580|565569045|FG002|Washout Before Extension Period|Other than specified|0|||
156678932|NCT04610580|565569046|FG003|Washout Before Extension Period|Other than specified|0|||
156678933|NCT04610580|565569047|FG004|Washout Before Extension Period|Other than specified|0|||
156678934|NCT04610580|565569048|FG005|Washout Before Extension Period|Other than specified|0|||
156678935|NCT04610580|565569043|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
156678936|NCT04610580|565569044|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
156678937|NCT04610580|565569045|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
156678938|NCT04610580|565569046|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
156678939|NCT04610580|565569047|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
156678940|NCT04610580|565569048|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
156678941|NCT04610580|565569043|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678942|NCT04610580|565569044|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678943|NCT04610580|565569045|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678944|NCT04610580|565569046|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678945|NCT04610580|565569047|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
156678946|NCT04610580|565569048|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678947|NCT04164758|565569049|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
156678948|NCT04164758|565569050|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
156678949|NCT04164758|565569051|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
156678950|NCT04164758|565569049|FG000|Overall Study|Adverse Event|0|||
156678951|NCT04164758|565569050|FG001|Overall Study|Adverse Event|1|||
156678952|NCT04164758|565569051|FG002|Overall Study|Adverse Event|0|||
156678953|NCT01670097|565569052|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
156678954|NCT01670097|565569053|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
156678955|NCT01670097|565569052|FG000|Overall Study|Study burden|1|||
156678956|NCT01670097|565569053|FG001|Overall Study|Study burden|0|||
156678957|NCT01670097|565569052|FG000|Overall Study|COPD exacerbation|0|||
156678958|NCT01670097|565569053|FG001|Overall Study|COPD exacerbation|1|||
156678959|NCT01670097|565569052|FG000|Overall Study|Neutropenia|0|||
156678960|NCT01670097|565569053|FG001|Overall Study|Neutropenia|1|||
156678961|NCT01670097|565569052|FG000|Overall Study|Clinical deterioration|0|||
156678962|NCT01670097|565569053|FG001|Overall Study|Clinical deterioration|1|||
156678963|NCT01670097|565569052|FG000|Overall Study|Disease progression|0|||
156678964|NCT01670097|565569053|FG001|Overall Study|Disease progression|1|||
156678965|NCT01949532|565569054|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
156678966|NCT01949532|565569055|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
156435318|NCT01713946|564683595|FG001|Overall Study|Adverse Event|14|||
156435319|NCT01713946|564683596|FG002|Overall Study|Adverse Event|13|||
156678967|NCT01824498|565569056|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
156678968|NCT01824498|565569057|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
156435320|NCT01713946|564683594|FG000|Overall Study|Withdrawal by Subject|12|||
156435321|NCT01713946|564683595|FG001|Overall Study|Withdrawal by Subject|12|||
156678969|NCT01824498|565569058|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
156678970|NCT01824498|565569059|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
156678971|NCT01824498|565569060|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
156678972|NCT01824498|565569061|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
156678973|NCT00884390|565569063|FG000|Overall Study|Adverse Event|0|||
156678974|NCT00884390|565569064|FG001|Overall Study|Adverse Event|1|||
156678975|NCT00884390|565569063|FG000|Overall Study|Lost to Follow-up|0|||
156678976|NCT00884390|565569064|FG001|Overall Study|Lost to Follow-up|1|||
156678977|NCT00884390|565569063|FG000|Overall Study|Physician Decision|2|||
156678978|NCT00884390|565569064|FG001|Overall Study|Physician Decision|1|||
156678979|NCT00884390|565569063|FG000|Overall Study|Protocol Violation|4|||
156678980|NCT00884390|565569064|FG001|Overall Study|Protocol Violation|1|||
156678981|NCT00884390|565569063|FG000|Overall Study|Withdrawal by Subject|4|||
156678982|NCT00884390|565569064|FG001|Overall Study|Withdrawal by Subject|1|||
156678983|NCT00884390|565569063|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
156678984|NCT00884390|565569064|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
156678985|NCT00884390|565569063|FG000|Overall Study|Other|11|||
156678986|NCT00884390|565569064|FG001|Overall Study|Other|1|||
156678987|NCT01691612|565569067|FG000|Overall Study|deemed ineligible after 1st visit|6|||
156678988|NCT01691612|565569067|FG000|Overall Study|Adverse Event|1|||
156678989|NCT00533507|565569072|FG000|Overall Study|Withdrawal by Subject|1|||
156678990|NCT01528735|565569077|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
156678991|NCT01528735|565569078|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
156678992|NCT01528735|565569077|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
156678993|NCT01528735|565569078|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
156678994|NCT00757172|565569079|FG000|Overall Study|Withdrawal by Subject|4|||
156678995|NCT00757172|565569079|FG000|Overall Study|Physician Decision|3|||
156678996|NCT00757172|565569079|FG000|Overall Study|Progression|4|||
156678997|NCT01942135|565569081|FG000|Overall Study|Adverse Event|21|||
156678998|NCT01942135|565569082|FG001|Overall Study|Adverse Event|7|||
156678999|NCT01942135|565569081|FG000|Overall Study|Global Deterioration of Health Status|9|||
156679000|NCT01942135|565569082|FG001|Overall Study|Global Deterioration of Health Status|6|||
156679001|NCT01942135|565569081|FG000|Overall Study|Randomized Not Treated|2|||
156679002|NCT01942135|565569082|FG001|Overall Study|Randomized Not Treated|2|||
156679003|NCT01942135|565569081|FG000|Overall Study|Death|2|||
156679004|NCT01942135|565569082|FG001|Overall Study|Death|1|||
156679005|NCT01942135|565569081|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
156679006|NCT01942135|565569082|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
156679007|NCT01942135|565569081|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
156679008|NCT01942135|565569082|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
156679009|NCT01942135|565569081|FG000|Overall Study|Withdrawal by Subject|4|||
156679010|NCT01942135|565569082|FG001|Overall Study|Withdrawal by Subject|3|||
156679011|NCT01942135|565569081|FG000|Overall Study|Protocol Violation|1|||
156679012|NCT01942135|565569082|FG001|Overall Study|Protocol Violation|0|||
156679013|NCT01942135|565569081|FG000|Overall Study|Other|19|||
156679014|NCT01942135|565569082|FG001|Overall Study|Other|4|||
156679015|NCT01717040|565569083|FG000|Overall Study|Lost to Follow-up|2|||
156679016|NCT01717040|565569084|FG001|Overall Study|Lost to Follow-up|3|||
156679017|NCT01717040|565569083|FG000|Overall Study|Lack of Efficacy|1|||
156679018|NCT01717040|565569084|FG001|Overall Study|Lack of Efficacy|1|||
156679019|NCT01717040|565569083|FG000|Overall Study|Adverse Event|1|||
156679020|NCT01717040|565569084|FG001|Overall Study|Adverse Event|0|||
156679021|NCT01717040|565569083|FG000|Overall Study|Required Medication Change|0|||
156679022|NCT01717040|565569084|FG001|Overall Study|Required Medication Change|1|||
156679023|NCT01717040|565569083|FG000|Overall Study|New Substance Use Disorder|1|||
156679024|NCT01717040|565569084|FG001|Overall Study|New Substance Use Disorder|0|||
156679025|NCT01499043|565569085|FG000|Overall Study|Progressive disease (radiographic)|2|||
156782373|NCT04439175|565952750|FG000|Overall Study|Never started treatment|4|||
156782374|NCT04439175|565952750|FG000|Overall Study|Ineligible|5|||
156782375|NCT04439175|565952750|FG000|Overall Study|Adverse Event|6|||
156782376|NCT04439175|565952750|FG000|Overall Study|Death|4|||
156782377|NCT04439175|565952750|FG000|Overall Study|Disease progression|44|||
156782378|NCT04439175|565952750|FG000|Overall Study|Withdrawal by Subject|4|||
156679026|NCT01499043|565569085|FG000|Overall Study|Progressive disease (clinical)|1|||
156782379|NCT04439175|565952750|FG000|Overall Study|Alternative Therapy|1|||
156782380|NCT04439175|565952750|FG000|Overall Study|Other|2|||
156782381|NCT01022580|565952751|FG000|Overall Study|Death|18|||
156679027|NCT01499043|565569085|FG000|Overall Study|Withdrawal by Subject|2|||
156782382|NCT01022580|565952752|FG001|Overall Study|Death|22|||
156679028|NCT01499043|565569085|FG000|Overall Study|Adverse Event|1|||
156679029|NCT01596127|565569087|FG000|Overall Study|Patient Ineligible|1|||
156679030|NCT01566435|565569088|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
156679031|NCT00438633|565569089|FG000|Overall Study|Withdrawal by Subject|1|||
156679032|NCT00438633|565569090|FG001|Overall Study|Withdrawal by Subject|0|||
156679033|NCT00438633|565569089|FG000|Overall Study|Lost to Follow-up|15|||
156679034|NCT00438633|565569090|FG001|Overall Study|Lost to Follow-up|17|||
156782383|NCT00835978|565952753|FG000|Overall Study|Death|33|||
156782384|NCT00835978|565952754|FG001|Overall Study|Death|40|||
156782385|NCT00835978|565952755|FG002|Overall Study|Death|49|||
156679035|NCT03196284|565569091|FG000|Main Part|Withdrawal by Subject|0|||
156679036|NCT03196284|565569092|FG001|Main Part|Withdrawal by Subject|1|||
156679037|NCT03196284|565569093|FG002|Main Part|Withdrawal by Subject|0|||
156679038|NCT03196284|565569091|FG000|Extension Part|Lack of Efficacy|0|||
156679039|NCT03196284|565569092|FG001|Extension Part|Lack of Efficacy|0|||
156679040|NCT03196284|565569093|FG002|Extension Part|Lack of Efficacy|1|||
156679041|NCT03196284|565569091|FG000|Extension Part|Withdrawal by Subject|0|||
156679042|NCT03196284|565569092|FG001|Extension Part|Withdrawal by Subject|0|||
156679043|NCT03196284|565569093|FG002|Extension Part|Withdrawal by Subject|1|||
156679044|NCT03196284|565569091|FG000|Extension Part|Physician Decision|0|||
156866836|NCT01710501|566273379|FG000|Overall Study|Lost to Follow-up|2|||
156866837|NCT01710501|566273380|FG001|Overall Study|Lost to Follow-up|0|||
156866838|NCT01710501|566273381|FG002|Overall Study|Lost to Follow-up|0|||
156866839|NCT01942837|566273386|FG000|Overall Study|Death|1|||
156866840|NCT01942837|566273386|FG000|Overall Study|Symptomatic or radiographic progression|49|||
156866841|NCT01942837|566273386|FG000|Overall Study|Adverse Event|6|||
156866842|NCT01942837|566273386|FG000|Overall Study|Physician Decision|3|||
156866843|NCT01942837|566273386|FG000|Overall Study|Withdrawal by Subject|2|||
156866844|NCT01942837|566273386|FG000|Overall Study|Intercurrent Illness|1|||
156866845|NCT01942837|566273386|FG000|Overall Study|On treatment|3|||
156866846|NCT01942837|566273386|FG000|Overall Study|Never initiate the treatment|2|||
156866847|NCT01298648|566273387|FG000|Overall Study|Withdrawal by Subject|2|||
156866848|NCT01298648|566273387|FG000|Overall Study|Lost to Follow-up|21|||
156866849|NCT00918255|566273388|FG000|Overall Study|Adverse Event|1|||
156866850|NCT00918255|566273389|FG001|Overall Study|Adverse Event|0|||
156866851|NCT00918255|566273390|FG002|Overall Study|Adverse Event|0|||
156866852|NCT00918255|566273388|FG000|Overall Study|Withdrawal by Subject|1|||
156866853|NCT00918255|566273389|FG001|Overall Study|Withdrawal by Subject|0|||
156866854|NCT00918255|566273390|FG002|Overall Study|Withdrawal by Subject|2|||
156866855|NCT00918255|566273388|FG000|Overall Study|Lack of Efficacy|1|||
156866856|NCT00918255|566273389|FG001|Overall Study|Lack of Efficacy|0|||
156866857|NCT00918255|566273390|FG002|Overall Study|Lack of Efficacy|0|||
156866858|NCT00918255|566273388|FG000|Overall Study|Lost to Follow-up|1|||
156679045|NCT03196284|565569092|FG001|Extension Part|Physician Decision|0|||
156679046|NCT03196284|565569093|FG002|Extension Part|Physician Decision|1|||
156679047|NCT04729101|565570502|FG000|Overall Study|Adverse Event|1|||
156679048|NCT04729101|565570503|FG001|Overall Study|Adverse Event|0|||
156679049|NCT04729101|565570502|FG000|Overall Study|Physician Decision|1|||
156679050|NCT04729101|565570503|FG001|Overall Study|Physician Decision|0|||
156679051|NCT04729101|565570502|FG000|Overall Study|Withdrawal by Subject|1|||
156679052|NCT04729101|565570503|FG001|Overall Study|Withdrawal by Subject|0|||
156679053|NCT00274625|565570504|FG000|Overall Study|Lost to Follow-up|46|||
156679054|NCT00274625|565570505|FG001|Overall Study|Lost to Follow-up|54|||
156679055|NCT00274625|565570504|FG000|Overall Study|Excluded from analysis|14|||
156679056|NCT00274625|565570505|FG001|Overall Study|Excluded from analysis|8|||
156679057|NCT04264819|565570511|FG000|Overall Study|Physician Decision|19|||
156679058|NCT04264819|565570511|FG000|Overall Study|Adverse Event|12|||
156679059|NCT04264819|565570511|FG000|Overall Study|Withdrawal by Subject|11|||
156679060|NCT04264819|565570511|FG000|Overall Study|Lost to Follow-up|2|||
156679061|NCT04264819|565570511|FG000|Overall Study|Death|2|||
156679062|NCT01662024|565570516|FG000|Overall Study|Pregnancy|2|||
156679063|NCT01662024|565570516|FG000|Overall Study|Withdrawal by Subject|3|||
156679064|NCT00927251|565570519|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
156679065|NCT00544167|565570523|FG000|Overall Study|Adverse Event|21|||
156679066|NCT00544167|565570523|FG000|Overall Study|Physician Decision|8|||
156679067|NCT00084864|565570528|FG000|Overall Study|Adverse Event|1|||
156679068|NCT00084864|565570529|FG001|Overall Study|Adverse Event|0|||
156679069|NCT00084864|565570530|FG002|Overall Study|Adverse Event|0|||
156679070|NCT00084864|565570531|FG003|Overall Study|Adverse Event|0|||
156679071|NCT02460835|565570535|FG000|Overall Study|Disease progression prior to treatment|3|||
156679072|NCT02460835|565570535|FG000|Overall Study|Unable to complete planning scans|2|||
156679073|NCT02460835|565570535|FG000|Overall Study|Decrease in performance status|1|||
156679074|NCT02460835|565570535|FG000|Overall Study|Withdrawal by Subject|3|||
156679075|NCT02460835|565570535|FG000|Overall Study|Underwent fractionated RT|10|||
156679076|NCT02460835|565570535|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
156679077|NCT00063258|565570548|FG000|Overall Study|Physician Decision|2|||
156679078|NCT00063258|565570549|FG001|Overall Study|Physician Decision|0|||
156679079|NCT00063258|565570548|FG000|Overall Study|Lack of Efficacy|2|||
156679080|NCT00063258|565570549|FG001|Overall Study|Lack of Efficacy|0|||
156679081|NCT02483416|565570552|FG000|Overall Study|Other reason|0|||
156679082|NCT02483416|565570553|FG001|Overall Study|Other reason|1|||
156679083|NCT02483416|565570552|FG000|Overall Study|Treatment stop|3|||
156679084|NCT02483416|565570553|FG001|Overall Study|Treatment stop|0|||
156679085|NCT02587143|565570555|FG000|Overall Study|Adverse Event|1|||
156679086|NCT02587143|565570556|FG001|Overall Study|Adverse Event|0|||
156679087|NCT03314857|565570557|FG000|Overall Study|Death|4|||
156679088|NCT03314857|565570557|FG000|Overall Study|Physician Decision|1|||
156679089|NCT02754492|565570558|FG000|Overall Study|Protocol Violation|2|||
156679090|NCT02754492|565570559|FG001|Overall Study|Protocol Violation|2|||
156679091|NCT02754492|565570560|FG002|Overall Study|Protocol Violation|0|||
156679092|NCT02754492|565570561|FG003|Overall Study|Protocol Violation|1|||
156679093|NCT02754492|565570558|FG000|Overall Study|Withdrawal by Subject|2|||
156679094|NCT02754492|565570559|FG001|Overall Study|Withdrawal by Subject|0|||
156679095|NCT02754492|565570560|FG002|Overall Study|Withdrawal by Subject|0|||
156679096|NCT02754492|565570561|FG003|Overall Study|Withdrawal by Subject|0|||
156679097|NCT02754492|565570558|FG000|Overall Study|Equipment malfuntion|0|||
156679098|NCT02754492|565570559|FG001|Overall Study|Equipment malfuntion|0|||
156679099|NCT02754492|565570560|FG002|Overall Study|Equipment malfuntion|2|||
156679100|NCT02754492|565570561|FG003|Overall Study|Equipment malfuntion|5|||
156679101|NCT02754492|565570558|FG000|Overall Study|Adverse Event|0|||
156679102|NCT02754492|565570559|FG001|Overall Study|Adverse Event|0|||
156679103|NCT02754492|565570560|FG002|Overall Study|Adverse Event|0|||
156679104|NCT02754492|565570561|FG003|Overall Study|Adverse Event|13|||
156679105|NCT02754492|565570558|FG000|Overall Study|Venous access issues not resulting in AE|0|||
156679106|NCT02754492|565570559|FG001|Overall Study|Venous access issues not resulting in AE|0|||
156679107|NCT02754492|565570560|FG002|Overall Study|Venous access issues not resulting in AE|0|||
156679108|NCT02754492|565570561|FG003|Overall Study|Venous access issues not resulting in AE|4|||
156679109|NCT05387408|565570562|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
156679110|NCT01632306|565570572|FG000|Overall Study|Protocol Violation|1|||
156679111|NCT01632306|565570573|FG001|Overall Study|Protocol Violation|0|||
156679112|NCT01632306|565570574|FG002|Overall Study|Protocol Violation|0|||
156679113|NCT03480022|565570577|FG000|Overall Study|Pregnancy|2|||
156679114|NCT03480022|565570578|FG001|Overall Study|Pregnancy|0|||
156679115|NCT03480022|565570577|FG000|Overall Study|Adverse Event|6|||
156679116|NCT03480022|565570578|FG001|Overall Study|Adverse Event|0|||
156679117|NCT03480022|565570577|FG000|Overall Study|Lack of Efficacy|0|||
156679118|NCT03480022|565570578|FG001|Overall Study|Lack of Efficacy|2|||
156679119|NCT03480022|565570577|FG000|Overall Study|Physician Decision|0|||
156679120|NCT03480022|565570578|FG001|Overall Study|Physician Decision|1|||
156679121|NCT03480022|565570577|FG000|Overall Study|Withdrawal by Subject|2|||
156679122|NCT03480022|565570578|FG001|Overall Study|Withdrawal by Subject|0|||
156679123|NCT03480022|565570577|FG000|Overall Study|Medication concerns|1|||
156679124|NCT03480022|565570578|FG001|Overall Study|Medication concerns|0|||
156679125|NCT03480022|565570577|FG000|Overall Study|Family member COVID exposure|0|||
156679126|NCT03480022|565570578|FG001|Overall Study|Family member COVID exposure|1|||
156679127|NCT00881569|565570579|FG000|Overall Study|Disease progression|1|||
156679128|NCT00881569|565570580|FG001|Overall Study|Disease progression|1|||
156679129|NCT00668395|565570581|FG000|Overall Study|Withdrawal by Subject|4|||
156679130|NCT00668395|565570582|FG001|Overall Study|Withdrawal by Subject|4|||
156679131|NCT00668395|565570583|FG002|Overall Study|Withdrawal by Subject|1|||
156679132|NCT00668395|565570581|FG000|Overall Study|Adverse Event|1|||
156679133|NCT00668395|565570582|FG001|Overall Study|Adverse Event|1|||
156679134|NCT00668395|565570583|FG002|Overall Study|Adverse Event|0|||
156679135|NCT00668395|565570581|FG000|Overall Study|Physician Decision|1|||
156679136|NCT00668395|565570582|FG001|Overall Study|Physician Decision|1|||
156679137|NCT00668395|565570583|FG002|Overall Study|Physician Decision|0|||
156679138|NCT05665387|565570584|FG000|Overall Study|Withdrawal by Subject|1|||
156679139|NCT05665387|565570585|FG001|Overall Study|Withdrawal by Subject|0|||
156679140|NCT05665387|565570586|FG002|Overall Study|Withdrawal by Subject|1|||
156679141|NCT01567527|565570587|FG000|Conversion Phase.|Protocol deviation|3|||
156679142|NCT01567527|565570588|FG001|Conversion Phase.|Protocol deviation|0|||
156679143|NCT01567527|565570589|FG002|Conversion Phase.|Protocol deviation|0|||
156679144|NCT01567527|565570590|FG003|Conversion Phase.|Protocol deviation|0|||
156679145|NCT01567527|565570591|FG004|Conversion Phase.|Protocol deviation|0|||
156679146|NCT01567527|565570587|FG000|Conversion Phase.|Met withdrawal criteria|10|||
156679147|NCT01567527|565570588|FG001|Conversion Phase.|Met withdrawal criteria|0|||
156679148|NCT01567527|565570589|FG002|Conversion Phase.|Met withdrawal criteria|0|||
156679149|NCT01567527|565570590|FG003|Conversion Phase.|Met withdrawal criteria|0|||
156679150|NCT01567527|565570591|FG004|Conversion Phase.|Met withdrawal criteria|0|||
156679151|NCT01567527|565570587|FG000|Conversion Phase.|Withdrawal by Subject|32|||
156679152|NCT01567527|565570588|FG001|Conversion Phase.|Withdrawal by Subject|0|||
156679153|NCT01567527|565570589|FG002|Conversion Phase.|Withdrawal by Subject|0|||
156679154|NCT01567527|565570590|FG003|Conversion Phase.|Withdrawal by Subject|0|||
156679155|NCT01567527|565570591|FG004|Conversion Phase.|Withdrawal by Subject|0|||
156679156|NCT01567527|565570587|FG000|Conversion Phase.|Lost to Follow-up|16|||
156679157|NCT01567527|565570588|FG001|Conversion Phase.|Lost to Follow-up|0|||
156679158|NCT01567527|565570589|FG002|Conversion Phase.|Lost to Follow-up|0|||
156679159|NCT01567527|565570590|FG003|Conversion Phase.|Lost to Follow-up|0|||
156679160|NCT01567527|565570591|FG004|Conversion Phase.|Lost to Follow-up|0|||
156679161|NCT01567527|565570587|FG000|Conversion Phase.|Lack of Efficacy|2|||
156679162|NCT01567527|565570588|FG001|Conversion Phase.|Lack of Efficacy|0|||
156679163|NCT01567527|565570589|FG002|Conversion Phase.|Lack of Efficacy|0|||
156679164|NCT01567527|565570590|FG003|Conversion Phase.|Lack of Efficacy|0|||
156679165|NCT01567527|565570591|FG004|Conversion Phase.|Lack of Efficacy|0|||
156679166|NCT01567527|565570587|FG000|Conversion Phase.|Adverse Event|33|||
156679167|NCT01567527|565570588|FG001|Conversion Phase.|Adverse Event|0|||
156679168|NCT01567527|565570589|FG002|Conversion Phase.|Adverse Event|0|||
156679169|NCT01567527|565570590|FG003|Conversion Phase.|Adverse Event|0|||
156679170|NCT01567527|565570591|FG004|Conversion Phase.|Adverse Event|0|||
156679171|NCT01567527|565570587|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
156679172|NCT01567527|565570588|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
156679173|NCT01567527|565570589|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
156679174|NCT01567527|565570590|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
156679175|NCT01567527|565570591|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
156679176|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
156679177|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
156679178|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
156782386|NCT00835978|565952756|FG003|Overall Study|Death|4|||
156782387|NCT00835978|565952753|FG000|Overall Study|Lost to Follow-up|3|||
156782388|NCT00835978|565952754|FG001|Overall Study|Lost to Follow-up|4|||
156866859|NCT00918255|566273389|FG001|Overall Study|Lost to Follow-up|0|||
156866860|NCT00918255|566273390|FG002|Overall Study|Lost to Follow-up|2|||
156866861|NCT00918255|566273388|FG000|Overall Study|Exceeded allowed number of interventions|0|||
156866862|NCT00918255|566273389|FG001|Overall Study|Exceeded allowed number of interventions|0|||
156782389|NCT00835978|565952755|FG002|Overall Study|Lost to Follow-up|2|||
156782390|NCT00835978|565952756|FG003|Overall Study|Lost to Follow-up|1|||
156782391|NCT00835978|565952753|FG000|Overall Study|Other|5|||
156782392|NCT00835978|565952754|FG001|Overall Study|Other|1|||
156782393|NCT00835978|565952755|FG002|Overall Study|Other|8|||
156782394|NCT00835978|565952756|FG003|Overall Study|Other|0|||
156782395|NCT00835978|565952753|FG000|Overall Study|Objective progression or relapse|2|||
156782396|NCT00835978|565952754|FG001|Overall Study|Objective progression or relapse|0|||
156782397|NCT00835978|565952755|FG002|Overall Study|Objective progression or relapse|1|||
156782398|NCT00835978|565952756|FG003|Overall Study|Objective progression or relapse|0|||
156782399|NCT00835978|565952753|FG000|Overall Study|Adverse Event|1|||
156782400|NCT00835978|565952754|FG001|Overall Study|Adverse Event|0|||
156782401|NCT00835978|565952755|FG002|Overall Study|Adverse Event|1|||
156782402|NCT00835978|565952756|FG003|Overall Study|Adverse Event|0|||
156782403|NCT00835978|565952753|FG000|Overall Study|Withdrawal by Subject|0|||
156782404|NCT00835978|565952754|FG001|Overall Study|Withdrawal by Subject|3|||
156782405|NCT00835978|565952755|FG002|Overall Study|Withdrawal by Subject|0|||
156782406|NCT00835978|565952756|FG003|Overall Study|Withdrawal by Subject|5|||
156782407|NCT00835978|565952753|FG000|Overall Study|Study terminated by sponsor|12|||
156782408|NCT00835978|565952754|FG001|Overall Study|Study terminated by sponsor|8|||
156782409|NCT00835978|565952755|FG002|Overall Study|Study terminated by sponsor|30|||
156782410|NCT00835978|565952756|FG003|Overall Study|Study terminated by sponsor|0|||
156782411|NCT01617967|565952757|FG000|Overall Study|Protocol Violation|0|||
156782412|NCT01617967|565952758|FG001|Overall Study|Protocol Violation|0|||
156782413|NCT01617967|565952759|FG002|Overall Study|Protocol Violation|0|||
156782414|NCT01617967|565952760|FG003|Overall Study|Protocol Violation|1|||
156782415|NCT01617967|565952761|FG004|Overall Study|Protocol Violation|0|||
156782416|NCT01617967|565952762|FG005|Overall Study|Protocol Violation|0|||
156782417|NCT01617967|565952757|FG000|Overall Study|Withdrawal by Subject|0|||
156782418|NCT01617967|565952758|FG001|Overall Study|Withdrawal by Subject|0|||
156782419|NCT01617967|565952759|FG002|Overall Study|Withdrawal by Subject|0|||
156782420|NCT01617967|565952760|FG003|Overall Study|Withdrawal by Subject|0|||
156782421|NCT01617967|565952761|FG004|Overall Study|Withdrawal by Subject|0|||
156782422|NCT01617967|565952762|FG005|Overall Study|Withdrawal by Subject|1|||
156782423|NCT01617967|565952757|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
156782424|NCT01617967|565952758|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
156782425|NCT01617967|565952759|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
156782426|NCT01617967|565952760|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
156866863|NCT00918255|566273390|FG002|Overall Study|Exceeded allowed number of interventions|1|||
156866864|NCT00918255|566273388|FG000|Overall Study|Non-compliance|1|||
156679179|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
156679180|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
156679181|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
156679182|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
156679183|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
156782427|NCT01617967|565952761|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
156782428|NCT01617967|565952762|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
156782429|NCT00530075|565952763|FG000|Overall Study|Adverse Event|1|||
156782430|NCT00530075|565952763|FG000|Overall Study|Death|1|||
156782431|NCT00530075|565952763|FG000|Overall Study|Lack of Efficacy|3|||
156782432|NCT00530075|565952763|FG000|Overall Study|Protocol Violation|1|||
156782433|NCT00530075|565952763|FG000|Overall Study|Withdrawal by Subject|1|||
156782434|NCT01166945|565952766|FG000|Randomized|diagnosed with Group A strep|4|||
156782435|NCT01166945|565952767|FG001|Randomized|diagnosed with Group A strep|4|||
156679184|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
156679185|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
156679186|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
156679187|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
156679188|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
156679189|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
156679190|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
156679191|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
156679192|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
156679193|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
156679194|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
156679195|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
156679196|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
156679197|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
156679198|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
156679199|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
156679200|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
156679201|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
156782436|NCT01166945|565952766|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
156782437|NCT01166945|565952767|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
156782438|NCT01166945|565952766|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
156782439|NCT01166945|565952767|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
156782440|NCT01166945|565952766|FG000|Day 30|Lost to Follow-up|4|||
156782441|NCT01166945|565952767|FG001|Day 30|Lost to Follow-up|3|||
156782442|NCT01137812|565952768|FG000|Overall Study|Adverse Event|21|||
156782443|NCT01137812|565952769|FG001|Overall Study|Adverse Event|14|||
156782444|NCT01137812|565952768|FG000|Overall Study|Lost to Follow-up|6|||
156866865|NCT00918255|566273389|FG001|Overall Study|Non-compliance|0|||
156866866|NCT00918255|566273390|FG002|Overall Study|Non-compliance|0|||
156866867|NCT00918255|566273388|FG000|Overall Study|Investigator discretion|1|||
156866868|NCT00918255|566273389|FG001|Overall Study|Investigator discretion|0|||
156866869|NCT00918255|566273390|FG002|Overall Study|Investigator discretion|0|||
156866870|NCT04154904|566273391|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
156866871|NCT04154904|566273392|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
156866872|NCT04154904|566273393|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
156866873|NCT02392624|566273394|FG000|Overall Study|Withdrawal by Subject|15|||
156866874|NCT02392624|566273395|FG001|Overall Study|Withdrawal by Subject|12|||
156866875|NCT02392624|566273396|FG002|Overall Study|Withdrawal by Subject|9|||
156866876|NCT02392624|566273394|FG000|Overall Study|Adverse Event|4|||
156866877|NCT02392624|566273395|FG001|Overall Study|Adverse Event|1|||
156866878|NCT02392624|566273396|FG002|Overall Study|Adverse Event|2|||
156866879|NCT02392624|566273394|FG000|Overall Study|Pregnancy|1|||
156866880|NCT02392624|566273395|FG001|Overall Study|Pregnancy|0|||
156866881|NCT02392624|566273396|FG002|Overall Study|Pregnancy|0|||
156866882|NCT02392624|566273394|FG000|Overall Study|Protocol Violation|0|||
156866883|NCT02392624|566273395|FG001|Overall Study|Protocol Violation|0|||
156782445|NCT01137812|565952769|FG001|Overall Study|Lost to Follow-up|8|||
156782446|NCT01137812|565952768|FG000|Overall Study|Physician Decision|25|||
156782447|NCT01137812|565952769|FG001|Overall Study|Physician Decision|17|||
156782448|NCT01137812|565952768|FG000|Overall Study|Protocol Violation|5|||
156782449|NCT01137812|565952769|FG001|Overall Study|Protocol Violation|4|||
156782450|NCT01137812|565952768|FG000|Overall Study|Withdrawal by Subject|5|||
156782451|NCT01137812|565952769|FG001|Overall Study|Withdrawal by Subject|13|||
156866884|NCT02392624|566273396|FG002|Overall Study|Protocol Violation|1|||
156866885|NCT02392624|566273394|FG000|Overall Study|Sponsor/Investigator Decision|2|||
156866886|NCT02392624|566273395|FG001|Overall Study|Sponsor/Investigator Decision|1|||
156866887|NCT02392624|566273396|FG002|Overall Study|Sponsor/Investigator Decision|0|||
156866888|NCT02392624|566273394|FG000|Overall Study|Other|49|||
156866889|NCT02392624|566273395|FG001|Overall Study|Other|1|||
156866890|NCT02392624|566273396|FG002|Overall Study|Other|1|||
156679202|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
156679203|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
156679204|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
156679205|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
156679206|NCT01567527|565570587|FG000|IM Depot Stabilization.|Protocol deviation|0|||
156679207|NCT01567527|565570588|FG001|IM Depot Stabilization.|Protocol deviation|0|||
156679208|NCT01567527|565570589|FG002|IM Depot Stabilization.|Protocol deviation|5|||
156679209|NCT01567527|565570590|FG003|IM Depot Stabilization.|Protocol deviation|0|||
156679210|NCT01567527|565570591|FG004|IM Depot Stabilization.|Protocol deviation|0|||
156782452|NCT01137812|565952768|FG000|Overall Study|Death|2|||
156782453|NCT01137812|565952769|FG001|Overall Study|Death|0|||
156782454|NCT01137812|565952768|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
156866891|NCT03841604|566273397|FG000|Overall Study|Withdrawal by Subject|3|||
156679211|NCT01567527|565570587|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
156679212|NCT01567527|565570588|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
156679213|NCT01567527|565570589|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
156679214|NCT01567527|565570590|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
156679215|NCT01567527|565570591|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
156679216|NCT01567527|565570587|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
156679217|NCT01567527|565570588|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
156679218|NCT01567527|565570589|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
156679219|NCT01567527|565570590|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
156679220|NCT01567527|565570591|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
156679221|NCT01567527|565570587|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
156782455|NCT01137812|565952769|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
156866892|NCT03841604|566273398|FG001|Overall Study|Withdrawal by Subject|1|||
156866893|NCT03841604|566273397|FG000|Overall Study|Adverse Event|4|||
156866894|NCT03841604|566273398|FG001|Overall Study|Adverse Event|2|||
156782456|NCT01137812|565952768|FG000|Overall Study|Other|19|||
156782457|NCT01137812|565952769|FG001|Overall Study|Other|27|||
156782458|NCT05558410|565952776|FG000|Overall Study|Adverse Event|1|||
156782459|NCT05558410|565952777|FG001|Overall Study|Adverse Event|2|||
156782460|NCT05558410|565952778|FG002|Overall Study|Adverse Event|0|||
156782461|NCT05558410|565952776|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
156782462|NCT05558410|565952777|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
156782463|NCT05558410|565952778|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
156782464|NCT05558410|565952776|FG000|Overall Study|Lost to Follow-up|10|||
156782465|NCT05558410|565952777|FG001|Overall Study|Lost to Follow-up|17|||
156782466|NCT05558410|565952778|FG002|Overall Study|Lost to Follow-up|19|||
156782467|NCT05558410|565952776|FG000|Overall Study|Death|1|||
156782468|NCT05558410|565952777|FG001|Overall Study|Death|0|||
156782469|NCT05558410|565952778|FG002|Overall Study|Death|0|||
156782470|NCT05558410|565952776|FG000|Overall Study|Other non-compliance|0|||
156782471|NCT05558410|565952777|FG001|Overall Study|Other non-compliance|1|||
156782472|NCT05558410|565952778|FG002|Overall Study|Other non-compliance|2|||
156782473|NCT05558410|565952776|FG000|Overall Study|Sponsor Decision|1|||
156782474|NCT05558410|565952777|FG001|Overall Study|Sponsor Decision|0|||
156782475|NCT05558410|565952778|FG002|Overall Study|Sponsor Decision|0|||
156782476|NCT05558410|565952776|FG000|Overall Study|Other|1|||
156782477|NCT05558410|565952777|FG001|Overall Study|Other|0|||
156782478|NCT05558410|565952778|FG002|Overall Study|Other|1|||
156782479|NCT00574951|565952781|FG000|Overall Study|Ineligible - improper prior treatment|1|||
156782480|NCT05161936|565952782|FG000|Overall Study|Study terminated by Sponsor|1|||
156782481|NCT05161936|565952783|FG001|Overall Study|Study terminated by Sponsor|0|||
156782482|NCT05161936|565952784|FG002|Overall Study|Study terminated by Sponsor|0|||
156782483|NCT05161936|565952782|FG000|Overall Study|Withdrawal by Subject|0|||
156782484|NCT05161936|565952783|FG001|Overall Study|Withdrawal by Subject|0|||
156782485|NCT05161936|565952784|FG002|Overall Study|Withdrawal by Subject|1|||
156782486|NCT04425018|565952785|FG000|Overall Study|Withdrawal by Subject|1|||
156782487|NCT04425018|565952786|FG001|Overall Study|Withdrawal by Subject|2|||
156782488|NCT03407482|565952791|FG000|Overall Study|Adverse Event|12|||
156782489|NCT03407482|565952791|FG000|Overall Study|Disease Relapse|1|||
156782490|NCT03407482|565952791|FG000|Overall Study|Lost to Follow-up|1|||
156782491|NCT03407482|565952791|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156782492|NCT03407482|565952791|FG000|Overall Study|Pregnancy|2|||
156782493|NCT03407482|565952791|FG000|Overall Study|Protocol Violation|1|||
156782494|NCT03407482|565952791|FG000|Overall Study|Study Terminated By Sponsor|106|||
156782495|NCT03407482|565952791|FG000|Overall Study|Withdrawal by Subject|6|||
156866895|NCT03841604|566273397|FG000|Overall Study|Physician Decision|1|||
156435322|NCT01713946|564683596|FG002|Overall Study|Withdrawal by Subject|8|||
156679222|NCT01567527|565570588|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
156679223|NCT01567527|565570589|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
156679224|NCT01567527|565570590|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
156679225|NCT01567527|565570591|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
156679226|NCT01567527|565570587|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
156679227|NCT01567527|565570588|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
156679228|NCT01567527|565570589|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
156679229|NCT01567527|565570590|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
156782496|NCT03407482|565952791|FG000|Overall Study|Data Entry Error|1|||
156782497|NCT05179603|565952792|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
156782498|NCT05179603|565952792|FG000|Overall Study|Withdrawal by Subject|1|||
156782499|NCT05179603|565952792|FG000|Overall Study|Progressive disease|4|||
156782500|NCT05179603|565952792|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
156782501|NCT05937373|565952793|FG000|Overall Study|Out of Window|2|||
156782502|NCT05937373|565952794|FG001|Overall Study|Out of Window|0|||
156782503|NCT05937373|565952793|FG000|Overall Study|Device fell off prior to date of surgery|0|||
156782504|NCT05937373|565952794|FG001|Overall Study|Device fell off prior to date of surgery|2|||
156866896|NCT03841604|566273398|FG001|Overall Study|Physician Decision|0|||
156328945|NCT00408629|564305515|FG001|Overall Study|Withdrawal by Subject|4|||
156328946|NCT00408629|564305514|FG000|Overall Study|Lost to Follow-up|1|||
156328947|NCT00408629|564305515|FG001|Overall Study|Lost to Follow-up|1|||
156328948|NCT00408629|564305514|FG000|Overall Study|Lack of Efficacy|63|||
156328949|NCT00408629|564305515|FG001|Overall Study|Lack of Efficacy|73|||
156679230|NCT01567527|565570591|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
156679231|NCT01567527|565570587|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
156679232|NCT01567527|565570588|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
156679233|NCT01567527|565570589|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
156679234|NCT01567527|565570590|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
156679235|NCT01567527|565570591|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
156679236|NCT01567527|565570587|FG000|IM Depot Stabilization.|Adverse Event|0|||
156679237|NCT01567527|565570588|FG001|IM Depot Stabilization.|Adverse Event|0|||
156679238|NCT01567527|565570589|FG002|IM Depot Stabilization.|Adverse Event|37|||
156679239|NCT01567527|565570590|FG003|IM Depot Stabilization.|Adverse Event|0|||
156679240|NCT01567527|565570591|FG004|IM Depot Stabilization.|Adverse Event|0|||
156679241|NCT01567527|565570587|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
156679242|NCT01567527|565570588|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
156679243|NCT01567527|565570589|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
156679244|NCT01567527|565570590|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
156679245|NCT01567527|565570591|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
156679246|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
156679247|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
156679248|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
156679249|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
156679250|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
156679251|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
156679252|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
156679253|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
156679254|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
156679255|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
156679256|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
156679257|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
156679258|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
156679259|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
156679260|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
156679261|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
156679262|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
156679263|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
156679264|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
156679265|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
156679266|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156679267|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156679268|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156679269|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
156679270|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
156679271|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
156679272|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
156679273|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
156328950|NCT00408629|564305514|FG000|Overall Study|Protocol Violation|1|||
156328951|NCT00408629|564305515|FG001|Overall Study|Protocol Violation|5|||
156328952|NCT00408629|564305514|FG000|Overall Study|Miscellaneous|11|||
156679274|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
156679275|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
156679276|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
156679277|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
156679278|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
156679279|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
156679280|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
156679281|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156679282|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156679283|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156328953|NCT00408629|564305515|FG001|Overall Study|Miscellaneous|15|||
156435323|NCT01713946|564683594|FG000|Overall Study|Lack of Efficacy|8|||
156328954|NCT01461980|564305516|FG000|Overall Study|Other|9|||
156679284|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
156679285|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
156679286|NCT02311894|565570592|FG000|Overall Study|Discontinued in error|1|||
156679287|NCT02311894|565570592|FG000|Overall Study|Lost to Follow-up|1|||
156679288|NCT02311894|565570592|FG000|Overall Study|Adverse Event|1|||
156679289|NCT02311894|565570592|FG000|Overall Study|Withdrawal by Subject|1|||
156679290|NCT01211262|565570594|FG000|Overall Study|Progressive Disease|18|||
156679291|NCT01211262|565570595|FG001|Overall Study|Progressive Disease|9|||
156679292|NCT01211262|565570594|FG000|Overall Study|Adverse Event|4|||
156328955|NCT01461980|564305517|FG001|Overall Study|Other|8|||
156328956|NCT01461980|564305518|FG002|Overall Study|Other|6|||
156328957|NCT01461980|564305516|FG000|Overall Study|Medication error|7|||
156328958|NCT01461980|564305517|FG001|Overall Study|Medication error|5|||
156679293|NCT01211262|565570595|FG001|Overall Study|Adverse Event|0|||
156328959|NCT01461980|564305518|FG002|Overall Study|Medication error|6|||
156679294|NCT01211262|565570594|FG000|Overall Study|Withdrawal of Consent|1|||
156679295|NCT01211262|565570595|FG001|Overall Study|Withdrawal of Consent|0|||
156679296|NCT01211262|565570594|FG000|Overall Study|Other|0|||
156679297|NCT01211262|565570595|FG001|Overall Study|Other|1|||
156679298|NCT01277510|565570596|FG000|Double-blind Phase|Non-compliance|0|||
156679299|NCT01277510|565570597|FG001|Double-blind Phase|Non-compliance|1|||
156679300|NCT01277510|565570596|FG000|Double-blind Phase|Adverse Event|1|||
156328960|NCT01461980|564305516|FG000|Overall Study|Adverse Event|12|||
156328961|NCT01461980|564305517|FG001|Overall Study|Adverse Event|5|||
156679301|NCT01277510|565570597|FG001|Double-blind Phase|Adverse Event|0|||
156679302|NCT01277510|565570596|FG000|Double-blind Phase|Withdrawal by Subject|2|||
156679303|NCT01277510|565570597|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156679304|NCT01277510|565570596|FG000|Double-blind Phase|Administrative decision|7|||
156679305|NCT01277510|565570597|FG001|Double-blind Phase|Administrative decision|9|||
156679306|NCT01277510|565570596|FG000|Double-blind Phase|Death|0|||
156679307|NCT01277510|565570597|FG001|Double-blind Phase|Death|1|||
156679308|NCT01277510|565570596|FG000|Double-blind Phase|Protocol-specified criteria|2|||
156679309|NCT01277510|565570597|FG001|Double-blind Phase|Protocol-specified criteria|6|||
156679310|NCT01277510|565570596|FG000|Double-blind Phase|Other|1|||
156679311|NCT01277510|565570597|FG001|Double-blind Phase|Other|1|||
156679312|NCT01277510|565570596|FG000|Open-label Phase|Administrative decision|4|||
156679313|NCT01277510|565570597|FG001|Open-label Phase|Administrative decision|3|||
156679314|NCT01277510|565570596|FG000|Open-label Phase|Protocol-specified criteria|1|||
156679315|NCT01277510|565570597|FG001|Open-label Phase|Protocol-specified criteria|0|||
156679316|NCT01277510|565570596|FG000|Open-label Phase|Never received investigational product|2|||
156679317|NCT01277510|565570597|FG001|Open-label Phase|Never received investigational product|0|||
156679318|NCT04049097|565570599|FG000|Overall Study|Adverse Event|18|||
156679319|NCT04049097|565570599|FG000|Overall Study|Death|2|||
156679320|NCT04049097|565570599|FG000|Overall Study|Lost to Follow-up|1|||
156679321|NCT04049097|565570599|FG000|Overall Study|Physician Decision|2|||
156679322|NCT04049097|565570599|FG000|Overall Study|Withdrawal by Subject|9|||
156679323|NCT04049097|565570599|FG000|Overall Study|Protocol Violation|2|||
156679324|NCT04049097|565570599|FG000|Overall Study|Other|1|||
156679325|NCT04049097|565570599|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
156679326|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
156679327|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
156679328|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
156679329|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
156679330|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Death|3|||
156679331|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Death|1|||
156679332|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
156679333|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
156679334|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
156679335|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
156679336|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
156679337|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
156679338|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Adverse Event|2|||
156679339|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Adverse Event|11|||
156679340|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
156679341|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
156679342|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Death|2|||
156679343|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Death|2|||
156328962|NCT01461980|564305518|FG002|Overall Study|Adverse Event|6|||
156328963|NCT01461980|564305516|FG000|Overall Study|Protocol Violation|12|||
156328964|NCT01461980|564305517|FG001|Overall Study|Protocol Violation|19|||
156679344|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
156679345|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
156679346|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
156679347|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
156679348|NCT00021541|565570602|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
156679349|NCT00021541|565570603|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
156679350|NCT00021541|565570602|FG000|Period 1-First Treatment|Adverse Event|2|||
156679351|NCT00021541|565570603|FG001|Period 1-First Treatment|Adverse Event|1|||
156679352|NCT00021541|565570602|FG000|Period 1-First Treatment|non-adherence|3|||
156679353|NCT00021541|565570603|FG001|Period 1-First Treatment|non-adherence|0|||
156679354|NCT00021541|565570602|FG000|Period 1-First Treatment|Death|1|||
156679355|NCT00021541|565570603|FG001|Period 1-First Treatment|Death|0|||
156679356|NCT00021541|565570602|FG000|Period 1-First Treatment|Pts that did not progress|2|||
156679357|NCT00021541|565570603|FG001|Period 1-First Treatment|Pts that did not progress|2|||
156679358|NCT00021541|565570602|FG000|Period 1-First Treatment|Ineligible|0|||
156679359|NCT00021541|565570603|FG001|Period 1-First Treatment|Ineligible|2|||
156679360|NCT00021541|565570602|FG000|Period 2-crossover|refused phase B|2|||
156679361|NCT00021541|565570603|FG001|Period 2-crossover|refused phase B|2|||
156679362|NCT00021541|565570602|FG000|Period 2-crossover|Withdrawal by Subject|3|||
156679363|NCT00021541|565570603|FG001|Period 2-crossover|Withdrawal by Subject|4|||
156679364|NCT00021541|565570602|FG000|Period 2-crossover|Adverse Event|2|||
156679365|NCT00021541|565570603|FG001|Period 2-crossover|Adverse Event|2|||
156679366|NCT00021541|565570602|FG000|Period 2-crossover|non-adherence|1|||
156679367|NCT00021541|565570603|FG001|Period 2-crossover|non-adherence|0|||
156679368|NCT00021541|565570602|FG000|Period 2-crossover|Pts that did not progress|2|||
156679369|NCT00021541|565570603|FG001|Period 2-crossover|Pts that did not progress|3|||
156679370|NCT01874535|565570604|FG000|Overall Study|Lost to Follow-up|10|||
156679371|NCT01874535|565570605|FG001|Overall Study|Lost to Follow-up|9|||
156679372|NCT01874535|565570604|FG000|Overall Study|incomplete symptom resolution|45|||
156679373|NCT01874535|565570605|FG001|Overall Study|incomplete symptom resolution|35|||
156679374|NCT05263505|565570606|FG000|Overall Study|Adverse Event|0|||
156679375|NCT05263505|565570607|FG001|Overall Study|Adverse Event|1|||
156679376|NCT02616380|565570608|FG000|Overall Study|Lost to Follow-up|1|||
156679377|NCT02616380|565570608|FG000|Overall Study|Other|2|||
156679378|NCT02119936|565570609|FG000|Overall Study|Lost to Follow-up|10|||
156679379|NCT01929681|565570610|FG000|Overall Study|Withdrawal by Subject|1|||
156679380|NCT01929681|565570611|FG001|Overall Study|Withdrawal by Subject|0|||
156679381|NCT01929681|565570610|FG000|Overall Study|Physician Decision|1|||
156679382|NCT01929681|565570611|FG001|Overall Study|Physician Decision|1|||
156679383|NCT05315713|565570612|FG000|Overall Study|Death|5|||
156679384|NCT05315713|565570612|FG000|Overall Study|Progressive disease|1|||
156679385|NCT05315713|565570612|FG000|Overall Study|Withdrawal by Subject|1|||
156679386|NCT05315713|565570612|FG000|Overall Study|Study terminated by sponsor|1|||
156679387|NCT00556673|565570614|FG000|Overall Study|Protocol deviation|3|||
156679388|NCT00556673|565570615|FG001|Overall Study|Protocol deviation|2|||
156679389|NCT01971554|565570616|FG000|Overall Study|Lost to Follow-up|1|||
156782505|NCT05942040|565952795|FG000|Overall Study|No longer employed at study site.|0|||
156782506|NCT05942040|565952796|FG001|Overall Study|No longer employed at study site.|0|||
156782507|NCT05942040|565952797|FG002|Overall Study|No longer employed at study site.|3|||
156782508|NCT06061952|565952798|FG000|Overall Study|Withdrawal by Subject|1|||
156782509|NCT06061952|565952799|FG001|Overall Study|Withdrawal by Subject|2|||
156782510|NCT06061952|565952798|FG000|Overall Study|Lost to Follow-up|2|||
156782511|NCT06061952|565952799|FG001|Overall Study|Lost to Follow-up|2|||
156782512|NCT06142383|565952800|FG000|Overall Study|Mis-randomized|0|||
156782513|NCT06142383|565952801|FG001|Overall Study|Mis-randomized|0|||
156435324|NCT01713946|564683595|FG001|Overall Study|Lack of Efficacy|8|||
156679390|NCT01971554|565570617|FG001|Overall Study|Lost to Follow-up|0|||
156679391|NCT01971554|565570618|FG002|Overall Study|Lost to Follow-up|0|||
156679392|NCT01971554|565570619|FG003|Overall Study|Lost to Follow-up|0|||
156679393|NCT04194151|565570620|FG000|Overall Study|Physician Decision|1|||
156679394|NCT04194151|565570621|FG001|Overall Study|Physician Decision|1|||
156679395|NCT04194151|565570622|FG002|Overall Study|Physician Decision|1|||
156679396|NCT04194151|565570623|FG003|Overall Study|Physician Decision|1|||
156679397|NCT04194151|565570624|FG004|Overall Study|Physician Decision|0|||
156679398|NCT04194151|565570625|FG005|Overall Study|Physician Decision|1|||
156679399|NCT04194151|565570620|FG000|Overall Study|Monitorization problem|0|||
156679400|NCT04194151|565570621|FG001|Overall Study|Monitorization problem|1|||
156679401|NCT04194151|565570622|FG002|Overall Study|Monitorization problem|0|||
156679402|NCT04194151|565570623|FG003|Overall Study|Monitorization problem|0|||
156679403|NCT04194151|565570624|FG004|Overall Study|Monitorization problem|0|||
156679404|NCT04194151|565570625|FG005|Overall Study|Monitorization problem|0|||
156679405|NCT00421304|565570626|FG000|Overall Study|Lost to Follow-up|5|||
156679406|NCT00421304|565570627|FG001|Overall Study|Lost to Follow-up|2|||
156679407|NCT00421304|565570628|FG002|Overall Study|Lost to Follow-up|5|||
156679408|NCT00421304|565570626|FG000|Overall Study|Withdrawal by Subject|2|||
156679409|NCT00421304|565570627|FG001|Overall Study|Withdrawal by Subject|2|||
156782514|NCT06142383|565952802|FG002|Overall Study|Mis-randomized|1|||
156782515|NCT06142383|565952803|FG003|Overall Study|Mis-randomized|0|||
156782516|NCT06142383|565952804|FG004|Overall Study|Mis-randomized|0|||
156679410|NCT00421304|565570628|FG002|Overall Study|Withdrawal by Subject|2|||
156679411|NCT00421304|565570626|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
156679412|NCT00421304|565570627|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
156679413|NCT00421304|565570628|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
156679414|NCT00421304|565570626|FG000|Overall Study|Did not attend Day 360 visit|0|||
156679415|NCT00421304|565570627|FG001|Overall Study|Did not attend Day 360 visit|0|||
156679416|NCT00421304|565570628|FG002|Overall Study|Did not attend Day 360 visit|1|||
156679417|NCT01912807|565570629|FG000|Overall Study|Did not meet elegibility criteria|6|||
156679418|NCT01912807|565570630|FG001|Overall Study|Did not meet elegibility criteria|4|||
156679419|NCT01912807|565570629|FG000|Overall Study|Lost to Follow-up|36|||
156679420|NCT01912807|565570630|FG001|Overall Study|Lost to Follow-up|37|||
156679421|NCT04750239|565570631|FG000|Overall Study|Withdrawal by Subject|2|||
156679422|NCT04750239|565570631|FG000|Overall Study|Trial terminated by sponsor|1|||
156679423|NCT00919711|565570632|FG000|Overall Study|Withdrawal by Subject|15|||
156679424|NCT00919711|565570633|FG001|Overall Study|Withdrawal by Subject|7|||
156679425|NCT00919711|565570632|FG000|Overall Study|Adverse Event|13|||
156679426|NCT00919711|565570633|FG001|Overall Study|Adverse Event|3|||
156679427|NCT00919711|565570632|FG000|Overall Study|Other|1|||
156679428|NCT00919711|565570633|FG001|Overall Study|Other|2|||
156679429|NCT00919711|565570632|FG000|Overall Study|Administrative Decision|0|||
156679430|NCT00919711|565570633|FG001|Overall Study|Administrative Decision|1|||
156679431|NCT00919711|565570632|FG000|Overall Study|Lost to Follow-up|2|||
156679432|NCT00919711|565570633|FG001|Overall Study|Lost to Follow-up|0|||
156679433|NCT00919711|565570632|FG000|Overall Study|Death|1|||
156679434|NCT00919711|565570633|FG001|Overall Study|Death|0|||
156679435|NCT00919711|565570632|FG000|Overall Study|Noncompliance|1|||
156679436|NCT00919711|565570633|FG001|Overall Study|Noncompliance|0|||
156679437|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Adverse Event|8|||
156679438|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Adverse Event|5|||
156679439|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Adverse Event|9|||
156679440|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Adverse Event|0|||
156679441|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Adverse Event|0|||
156679442|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Adverse Event|0|||
156679443|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
156679444|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
156782517|NCT06142383|565952800|FG000|Overall Study|Adverse Event|0|||
156782518|NCT06142383|565952801|FG001|Overall Study|Adverse Event|1|||
156782519|NCT06142383|565952802|FG002|Overall Study|Adverse Event|1|||
156782520|NCT06142383|565952803|FG003|Overall Study|Adverse Event|0|||
156782521|NCT06142383|565952804|FG004|Overall Study|Adverse Event|0|||
156782522|NCT06142383|565952800|FG000|Overall Study|Death|0|||
156782523|NCT06142383|565952801|FG001|Overall Study|Death|1|||
156782524|NCT06142383|565952802|FG002|Overall Study|Death|3|||
156782525|NCT06142383|565952803|FG003|Overall Study|Death|0|||
156782526|NCT06142383|565952804|FG004|Overall Study|Death|1|||
156782527|NCT06142383|565952800|FG000|Overall Study|Study Terminated by Sponsor|20|||
156782528|NCT06142383|565952801|FG001|Overall Study|Study Terminated by Sponsor|17|||
156782529|NCT06142383|565952802|FG002|Overall Study|Study Terminated by Sponsor|33|||
156782530|NCT06142383|565952803|FG003|Overall Study|Study Terminated by Sponsor|0|||
156782531|NCT06142383|565952804|FG004|Overall Study|Study Terminated by Sponsor|21|||
156782532|NCT06142383|565952800|FG000|Overall Study|Subject Decision|0|||
156782533|NCT06142383|565952801|FG001|Overall Study|Subject Decision|1|||
156782534|NCT06142383|565952802|FG002|Overall Study|Subject Decision|2|||
156782535|NCT06142383|565952803|FG003|Overall Study|Subject Decision|0|||
156782536|NCT06142383|565952804|FG004|Overall Study|Subject Decision|0|||
156782537|NCT01685437|565952809|FG000|Overall Study|Withdrawal by Subject|22|||
156782538|NCT01685437|565952809|FG000|Overall Study|Lost to Follow-up|3|||
156782539|NCT01685437|565952809|FG000|Overall Study|Adverse Event|1|||
156782540|NCT01685437|565952809|FG000|Overall Study|Protocol Violation|4|||
156782541|NCT01685437|565952809|FG000|Overall Study|Unable to make visits due to work|1|||
156782542|NCT03770455|565952816|FG000|Overall Study|Screen failures|3|||
156782543|NCT01121575|565952817|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
156782544|NCT01121575|565952818|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
156782545|NCT01121575|565952819|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
156782546|NCT01121575|565952820|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
156782547|NCT01121575|565952821|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
156782548|NCT01121575|565952822|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
156782549|NCT01121575|565952817|FG000|Overall Study|Unspecified Reasons|8|||
156782550|NCT01121575|565952818|FG001|Overall Study|Unspecified Reasons|6|||
156782551|NCT01121575|565952819|FG002|Overall Study|Unspecified Reasons|7|||
156782552|NCT01121575|565952820|FG003|Overall Study|Unspecified Reasons|5|||
156782553|NCT01121575|565952821|FG004|Overall Study|Unspecified Reasons|13|||
156782554|NCT01121575|565952822|FG005|Overall Study|Unspecified Reasons|10|||
156782555|NCT01121575|565952817|FG000|Overall Study|Death|6|||
156782556|NCT01121575|565952818|FG001|Overall Study|Death|0|||
156866897|NCT01193244|566273399|FG000|Overall Study|Withdrawal by Subject|79|||
156866898|NCT01193244|566273400|FG001|Overall Study|Withdrawal by Subject|97|||
156866899|NCT01193244|566273399|FG000|Overall Study|Other|303|||
156866900|NCT01193244|566273400|FG001|Overall Study|Other|278|||
156866901|NCT01193244|566273399|FG000|Overall Study|Lost to Follow-up|6|||
156866902|NCT01193244|566273400|FG001|Overall Study|Lost to Follow-up|15|||
156866903|NCT01936870|566273401|FG000|Overall Study|No Visit After Treatment|176|||
156866904|NCT01936870|566273401|FG000|Overall Study|Protocol Violation|12|||
156866905|NCT01936870|566273401|FG000|Overall Study|No Drug Administration|1|||
156866906|NCT00248040|566273406|FG000|Overall Study|transplantectomy|2|||
156866907|NCT00248040|566273407|FG001|Overall Study|transplantectomy|1|||
156866908|NCT00248040|566273408|FG002|Overall Study|transplantectomy|3|||
156866909|NCT00248040|566273406|FG000|Overall Study|transplant cancelled post treat start|1|||
156866910|NCT00248040|566273407|FG001|Overall Study|transplant cancelled post treat start|0|||
156866911|NCT00248040|566273408|FG002|Overall Study|transplant cancelled post treat start|0|||
156866912|NCT00248040|566273406|FG000|Overall Study|Death|0|||
156866913|NCT00248040|566273407|FG001|Overall Study|Death|0|||
156866914|NCT00248040|566273408|FG002|Overall Study|Death|1|||
156866915|NCT00628108|566273416|FG000|Overall Study|Adverse Event|0|||
156866916|NCT00628108|566273417|FG001|Overall Study|Adverse Event|3|||
156866917|NCT00628108|566273416|FG000|Overall Study|Withdrawal by Subject|1|||
156866918|NCT00628108|566273417|FG001|Overall Study|Withdrawal by Subject|0|||
156866919|NCT03848832|566273418|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
156866920|NCT03848832|566273419|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
156866921|NCT03848832|566273420|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
156866922|NCT03848832|566273418|FG000|Overall Study|Withdrawal by Subject|0|||
156866923|NCT03848832|566273419|FG001|Overall Study|Withdrawal by Subject|0|||
156782557|NCT01121575|565952819|FG002|Overall Study|Death|0|||
156782558|NCT01121575|565952820|FG003|Overall Study|Death|1|||
156782559|NCT01121575|565952821|FG004|Overall Study|Death|7|||
156782560|NCT01121575|565952822|FG005|Overall Study|Death|1|||
156866924|NCT03848832|566273420|FG002|Overall Study|Withdrawal by Subject|1|||
156328965|NCT01461980|564305518|FG002|Overall Study|Protocol Violation|16|||
156328966|NCT01461980|564305516|FG000|Overall Study|No longer meets eligibility criteria|18|||
156328967|NCT01461980|564305517|FG001|Overall Study|No longer meets eligibility criteria|9|||
156782561|NCT03860584|565952833|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
156782562|NCT03860584|565952834|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
156782563|NCT03860584|565952833|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156782564|NCT03860584|565952834|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
156782565|NCT03860584|565952833|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
156782566|NCT03860584|565952834|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
156782567|NCT03860584|565952833|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
156782568|NCT03860584|565952834|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
156782569|NCT03971422|565954726|FG000|Overall Study|Lost to Follow-up|0|||
156782570|NCT03971422|565954727|FG001|Overall Study|Lost to Follow-up|1|||
156782571|NCT03971422|565954728|FG002|Overall Study|Lost to Follow-up|0|||
156782572|NCT03971422|565954726|FG000|Overall Study|Lack of Efficacy|5|||
156782573|NCT03971422|565954727|FG001|Overall Study|Lack of Efficacy|1|||
156782574|NCT03971422|565954728|FG002|Overall Study|Lack of Efficacy|1|||
156782575|NCT03971422|565954726|FG000|Overall Study|Adverse event, not fatal|2|||
156782576|NCT03971422|565954727|FG001|Overall Study|Adverse event, not fatal|2|||
156782577|NCT03971422|565954728|FG002|Overall Study|Adverse event, not fatal|5|||
156782578|NCT03971422|565954726|FG000|Overall Study|Worsening of MG Symptoms|1|||
156782579|NCT03971422|565954727|FG001|Overall Study|Worsening of MG Symptoms|4|||
156782580|NCT03971422|565954728|FG002|Overall Study|Worsening of MG Symptoms|2|||
156782581|NCT03971422|565954726|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
156782582|NCT03971422|565954727|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
156782583|NCT03971422|565954728|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
156782584|NCT03971422|565954726|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
156782585|NCT03971422|565954727|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
156866925|NCT03848832|566273418|FG000|Overall Study|Withdrawal (Covid-19)|0|||
156328968|NCT01461980|564305518|FG002|Overall Study|No longer meets eligibility criteria|19|||
156328969|NCT01461980|564305516|FG000|Overall Study|Lost to Follow-up|52|||
156328970|NCT01461980|564305517|FG001|Overall Study|Lost to Follow-up|53|||
156328971|NCT01461980|564305518|FG002|Overall Study|Lost to Follow-up|51|||
156782586|NCT03971422|565954728|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
156782587|NCT03971422|565954726|FG000|Overall Study|Due to COVID-19 pandemic|0|||
156782588|NCT03971422|565954727|FG001|Overall Study|Due to COVID-19 pandemic|1|||
156782589|NCT03971422|565954728|FG002|Overall Study|Due to COVID-19 pandemic|1|||
156782590|NCT01658878|565954729|FG000|Treatment Period|Disease Progression|1|||
156866926|NCT03848832|566273419|FG001|Overall Study|Withdrawal (Covid-19)|2|||
156866927|NCT03848832|566273420|FG002|Overall Study|Withdrawal (Covid-19)|0|||
156866928|NCT03848832|566273418|FG000|Overall Study|Physician Decision|2|||
156866929|NCT03848832|566273419|FG001|Overall Study|Physician Decision|1|||
156866930|NCT03848832|566273420|FG002|Overall Study|Physician Decision|3|||
156866931|NCT03848832|566273418|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
156529316|NCT01681628|565032613|FG000|19 Months Follow-up|Lost to Follow-up|61|||
156529317|NCT01681628|565032614|FG001|19 Months Follow-up|Lost to Follow-up|43|||
156529318|NCT01794520|565032615|FG000|Overall Study|Adverse events- related to progression|0|||
156529319|NCT01794520|565032616|FG001|Overall Study|Adverse events- related to progression|0|||
156529320|NCT01794520|565032617|FG002|Overall Study|Adverse events- related to progression|1|||
156529321|NCT01794520|565032618|FG003|Overall Study|Adverse events- related to progression|2|||
156529322|NCT01794520|565032619|FG004|Overall Study|Adverse events- related to progression|0|||
156529323|NCT01794520|565032620|FG005|Overall Study|Adverse events- related to progression|1|||
156529324|NCT01794520|565032621|FG006|Overall Study|Adverse events- related to progression|0|||
156529325|NCT01794520|565032615|FG000|Overall Study|Adverse event- not related to progression|1|||
156529326|NCT01794520|565032616|FG001|Overall Study|Adverse event- not related to progression|1|||
156529327|NCT01794520|565032617|FG002|Overall Study|Adverse event- not related to progression|0|||
156529328|NCT01794520|565032618|FG003|Overall Study|Adverse event- not related to progression|0|||
156529329|NCT01794520|565032619|FG004|Overall Study|Adverse event- not related to progression|2|||
156679445|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
156679446|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
156679447|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
156679448|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
156679449|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
156679450|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
156679451|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
156679452|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
156679453|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
156679454|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
156679455|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Physician Decision|4|||
156679456|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Physician Decision|0|||
156679457|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Physician Decision|2|||
156679458|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Physician Decision|0|||
156679459|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Physician Decision|0|||
156679460|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Physician Decision|0|||
156679461|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Pregnancy|1|||
156679462|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Pregnancy|2|||
156679463|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Pregnancy|0|||
156679464|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Pregnancy|0|||
156679465|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Pregnancy|0|||
156679466|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Pregnancy|0|||
156679467|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
156679468|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
156679469|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
156679470|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
156679471|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
156679472|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
156679473|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
156679474|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679475|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679476|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679477|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679478|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679479|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
156679480|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
156679481|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
156679482|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
156679483|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
156679484|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
156679485|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
156679486|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
156679487|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
156679488|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
156679489|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
156679490|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
156679491|NCT02614196|565570634|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
156679492|NCT02614196|565570635|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
156679493|NCT02614196|565570636|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
156679494|NCT02614196|565570637|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
156679495|NCT02614196|565570638|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
156328972|NCT01461980|564305516|FG000|Overall Study|No longer willing to participate|52|||
156679496|NCT02614196|565570639|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
156529330|NCT01794520|565032620|FG005|Overall Study|Adverse event- not related to progression|0|||
156866932|NCT03848832|566273419|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
156866933|NCT03848832|566273420|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
156866934|NCT03848832|566273418|FG000|Overall Study|Adverse Event|1|||
156866935|NCT03848832|566273419|FG001|Overall Study|Adverse Event|0|||
156866936|NCT03848832|566273420|FG002|Overall Study|Adverse Event|0|||
156866937|NCT00711191|566273428|FG000|Overall Study|Adverse Event|1|||
156866938|NCT00711191|566273429|FG001|Overall Study|Adverse Event|1|||
156866939|NCT00711191|566273430|FG002|Overall Study|Adverse Event|2|||
156866940|NCT00711191|566273428|FG000|Overall Study|Objective progression or relapse|2|||
156866941|NCT00711191|566273429|FG001|Overall Study|Objective progression or relapse|3|||
156866942|NCT00711191|566273430|FG002|Overall Study|Objective progression or relapse|7|||
156866943|NCT00711191|566273428|FG000|Overall Study|Withdrawal by Subject|0|||
156866944|NCT00711191|566273429|FG001|Overall Study|Withdrawal by Subject|1|||
156866945|NCT00711191|566273430|FG002|Overall Study|Withdrawal by Subject|3|||
156866946|NCT00084136|566273431|FG000|PI Comparison|Death|10|||
156866947|NCT00084136|566273432|FG001|PI Comparison|Death|9|||
156866948|NCT00084136|566273433|FG002|PI Comparison|Death|0|||
156866949|NCT00084136|566273431|FG000|PI Comparison|Lost to Follow-up|11|||
156782591|NCT01658878|565954730|FG001|Treatment Period|Disease Progression|3|||
156782592|NCT01658878|565954731|FG002|Treatment Period|Disease Progression|2|||
156782593|NCT01658878|565954732|FG003|Treatment Period|Disease Progression|1|||
156782594|NCT01658878|565954733|FG004|Treatment Period|Disease Progression|13|||
156782595|NCT01658878|565954734|FG005|Treatment Period|Disease Progression|3|||
156782596|NCT01658878|565954735|FG006|Treatment Period|Disease Progression|4|||
156782597|NCT01658878|565954736|FG007|Treatment Period|Disease Progression|3|||
156782598|NCT01658878|565954737|FG008|Treatment Period|Disease Progression|5|||
156782599|NCT01658878|565954738|FG009|Treatment Period|Disease Progression|3|||
156782600|NCT01658878|565954739|FG010|Treatment Period|Disease Progression|3|||
156782601|NCT01658878|565954740|FG011|Treatment Period|Disease Progression|4|||
156782602|NCT01658878|565954741|FG012|Treatment Period|Disease Progression|43|||
156782603|NCT01658878|565954742|FG013|Treatment Period|Disease Progression|48|||
156782604|NCT01658878|565954743|FG014|Treatment Period|Disease Progression|33|||
156782605|NCT01658878|565954744|FG015|Treatment Period|Disease Progression|46|||
156782606|NCT01658878|565954745|FG016|Treatment Period|Disease Progression|41|||
156782607|NCT01658878|565954746|FG017|Treatment Period|Disease Progression|42|||
156782608|NCT01658878|565954747|FG018|Treatment Period|Disease Progression|28|||
156782609|NCT01658878|565954748|FG019|Treatment Period|Disease Progression|37|||
156782610|NCT01658878|565954749|FG020|Treatment Period|Disease Progression|37|||
156782611|NCT01658878|565954750|FG021|Treatment Period|Disease Progression|39|||
156782612|NCT01658878|565954751|FG022|Treatment Period|Disease Progression|27|||
156782613|NCT01658878|565954752|FG023|Treatment Period|Disease Progression|19|||
156782614|NCT01658878|565954729|FG000|Treatment Period|Study Drug Toxicity|0|||
156782615|NCT01658878|565954730|FG001|Treatment Period|Study Drug Toxicity|0|||
156782616|NCT01658878|565954731|FG002|Treatment Period|Study Drug Toxicity|0|||
156782617|NCT01658878|565954732|FG003|Treatment Period|Study Drug Toxicity|1|||
156782618|NCT01658878|565954733|FG004|Treatment Period|Study Drug Toxicity|0|||
156782619|NCT01658878|565954734|FG005|Treatment Period|Study Drug Toxicity|0|||
156782620|NCT01658878|565954735|FG006|Treatment Period|Study Drug Toxicity|0|||
156782621|NCT01658878|565954736|FG007|Treatment Period|Study Drug Toxicity|0|||
156782622|NCT01658878|565954737|FG008|Treatment Period|Study Drug Toxicity|0|||
156782623|NCT01658878|565954738|FG009|Treatment Period|Study Drug Toxicity|0|||
156782624|NCT01658878|565954739|FG010|Treatment Period|Study Drug Toxicity|0|||
156782625|NCT01658878|565954740|FG011|Treatment Period|Study Drug Toxicity|0|||
156782626|NCT01658878|565954741|FG012|Treatment Period|Study Drug Toxicity|7|||
156782627|NCT01658878|565954742|FG013|Treatment Period|Study Drug Toxicity|1|||
156782628|NCT01658878|565954743|FG014|Treatment Period|Study Drug Toxicity|5|||
156782629|NCT01658878|565954744|FG015|Treatment Period|Study Drug Toxicity|0|||
156782630|NCT01658878|565954745|FG016|Treatment Period|Study Drug Toxicity|5|||
156782631|NCT01658878|565954746|FG017|Treatment Period|Study Drug Toxicity|10|||
156866950|NCT00084136|566273432|FG001|PI Comparison|Lost to Follow-up|8|||
156782632|NCT01658878|565954747|FG018|Treatment Period|Study Drug Toxicity|12|||
156782633|NCT01658878|565954748|FG019|Treatment Period|Study Drug Toxicity|4|||
156782634|NCT01658878|565954749|FG020|Treatment Period|Study Drug Toxicity|2|||
156866951|NCT00084136|566273433|FG002|PI Comparison|Lost to Follow-up|0|||
156328973|NCT01461980|564305517|FG001|Overall Study|No longer willing to participate|38|||
156782635|NCT01658878|565954750|FG021|Treatment Period|Study Drug Toxicity|3|||
156782636|NCT01658878|565954751|FG022|Treatment Period|Study Drug Toxicity|2|||
156782637|NCT01658878|565954752|FG023|Treatment Period|Study Drug Toxicity|6|||
156782638|NCT01658878|565954729|FG000|Treatment Period|Maximum Clinical Benefit|0|||
156782639|NCT01658878|565954730|FG001|Treatment Period|Maximum Clinical Benefit|0|||
156782640|NCT01658878|565954731|FG002|Treatment Period|Maximum Clinical Benefit|1|||
156866952|NCT00084136|566273431|FG000|PI Comparison|Withdrawal by Subject|33|||
156866953|NCT00084136|566273432|FG001|PI Comparison|Withdrawal by Subject|30|||
156866954|NCT00084136|566273433|FG002|PI Comparison|Withdrawal by Subject|0|||
156866955|NCT00084136|566273431|FG000|PI Comparison|Clinic site closed|1|||
156866956|NCT00084136|566273432|FG001|PI Comparison|Clinic site closed|0|||
156679497|NCT02614196|565570634|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
156679498|NCT02614196|565570635|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
156679499|NCT02614196|565570636|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
156679500|NCT02614196|565570637|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
156679501|NCT02614196|565570638|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
156679502|NCT02614196|565570639|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
156679503|NCT02614196|565570634|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
156679504|NCT02614196|565570635|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
156679505|NCT02614196|565570636|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
156679506|NCT02614196|565570637|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
156679507|NCT02614196|565570638|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
156679508|NCT02614196|565570639|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
156679509|NCT02614196|565570634|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
156679510|NCT02614196|565570635|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
156679511|NCT02614196|565570636|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
156782641|NCT01658878|565954732|FG003|Treatment Period|Maximum Clinical Benefit|0|||
156782642|NCT01658878|565954733|FG004|Treatment Period|Maximum Clinical Benefit|0|||
156782643|NCT01658878|565954734|FG005|Treatment Period|Maximum Clinical Benefit|0|||
156782644|NCT01658878|565954735|FG006|Treatment Period|Maximum Clinical Benefit|0|||
156782645|NCT01658878|565954736|FG007|Treatment Period|Maximum Clinical Benefit|0|||
156782646|NCT01658878|565954737|FG008|Treatment Period|Maximum Clinical Benefit|0|||
156782647|NCT01658878|565954738|FG009|Treatment Period|Maximum Clinical Benefit|0|||
156782648|NCT01658878|565954739|FG010|Treatment Period|Maximum Clinical Benefit|0|||
156782649|NCT01658878|565954740|FG011|Treatment Period|Maximum Clinical Benefit|0|||
156782650|NCT01658878|565954741|FG012|Treatment Period|Maximum Clinical Benefit|0|||
156782651|NCT01658878|565954742|FG013|Treatment Period|Maximum Clinical Benefit|0|||
156782652|NCT01658878|565954743|FG014|Treatment Period|Maximum Clinical Benefit|0|||
156782653|NCT01658878|565954744|FG015|Treatment Period|Maximum Clinical Benefit|0|||
156782654|NCT01658878|565954745|FG016|Treatment Period|Maximum Clinical Benefit|0|||
156782655|NCT01658878|565954746|FG017|Treatment Period|Maximum Clinical Benefit|0|||
156782656|NCT01658878|565954747|FG018|Treatment Period|Maximum Clinical Benefit|1|||
156782657|NCT01658878|565954748|FG019|Treatment Period|Maximum Clinical Benefit|1|||
156782658|NCT01658878|565954749|FG020|Treatment Period|Maximum Clinical Benefit|0|||
156782659|NCT01658878|565954750|FG021|Treatment Period|Maximum Clinical Benefit|0|||
156782660|NCT01658878|565954751|FG022|Treatment Period|Maximum Clinical Benefit|0|||
156782661|NCT01658878|565954752|FG023|Treatment Period|Maximum Clinical Benefit|0|||
156782662|NCT01658878|565954729|FG000|Treatment Period|Other Reasons|0|||
156782663|NCT01658878|565954730|FG001|Treatment Period|Other Reasons|0|||
156782664|NCT01658878|565954731|FG002|Treatment Period|Other Reasons|0|||
156782665|NCT01658878|565954732|FG003|Treatment Period|Other Reasons|1|||
156782666|NCT01658878|565954733|FG004|Treatment Period|Other Reasons|0|||
156782667|NCT01658878|565954734|FG005|Treatment Period|Other Reasons|0|||
156782668|NCT01658878|565954735|FG006|Treatment Period|Other Reasons|0|||
156782669|NCT01658878|565954736|FG007|Treatment Period|Other Reasons|0|||
156782670|NCT01658878|565954737|FG008|Treatment Period|Other Reasons|0|||
156782671|NCT01658878|565954738|FG009|Treatment Period|Other Reasons|0|||
156782672|NCT01658878|565954739|FG010|Treatment Period|Other Reasons|0|||
156782673|NCT01658878|565954740|FG011|Treatment Period|Other Reasons|0|||
156782674|NCT01658878|565954741|FG012|Treatment Period|Other Reasons|2|||
156782675|NCT01658878|565954742|FG013|Treatment Period|Other Reasons|0|||
156782676|NCT01658878|565954743|FG014|Treatment Period|Other Reasons|0|||
156782677|NCT01658878|565954744|FG015|Treatment Period|Other Reasons|2|||
156782678|NCT01658878|565954745|FG016|Treatment Period|Other Reasons|1|||
156782679|NCT01658878|565954746|FG017|Treatment Period|Other Reasons|1|||
156782680|NCT01658878|565954747|FG018|Treatment Period|Other Reasons|3|||
156782681|NCT01658878|565954748|FG019|Treatment Period|Other Reasons|1|||
156782682|NCT01658878|565954749|FG020|Treatment Period|Other Reasons|4|||
156782683|NCT01658878|565954750|FG021|Treatment Period|Other Reasons|0|||
156782684|NCT01658878|565954751|FG022|Treatment Period|Other Reasons|0|||
156782685|NCT01658878|565954752|FG023|Treatment Period|Other Reasons|4|||
156782686|NCT01658878|565954729|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866957|NCT00084136|566273433|FG002|PI Comparison|Clinic site closed|0|||
156782687|NCT01658878|565954730|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866958|NCT00084136|566273431|FG000|NRTI Comparison|Death|20|||
156679512|NCT02614196|565570637|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
156782688|NCT01658878|565954731|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782689|NCT01658878|565954732|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782690|NCT01658878|565954733|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782691|NCT01658878|565954734|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782692|NCT01658878|565954735|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782693|NCT01658878|565954736|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782694|NCT01658878|565954737|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782695|NCT01658878|565954738|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866959|NCT00084136|566273432|FG001|NRTI Comparison|Death|0|||
156679513|NCT02614196|565570638|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
156679514|NCT02614196|565570639|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
156679515|NCT00903877|565570640|FG000|Overall Study|Did not meet study criteria|33|||
156679516|NCT00903877|565570640|FG000|Overall Study|Withdrawal by Subject|3|||
156679517|NCT00903877|565570640|FG000|Overall Study|Adverse Event|2|||
156679518|NCT00903877|565570640|FG000|Overall Study|Lost to Follow-up|1|||
156679519|NCT00903877|565570640|FG000|Overall Study|Participation put on hold|4|||
156679520|NCT00087529|565570642|FG000|Overall Study|Death|1|||
156679521|NCT00087529|565570643|FG001|Overall Study|Death|0|||
156679522|NCT00087529|565570642|FG000|Overall Study|Adverse Event|0|||
156679523|NCT00087529|565570643|FG001|Overall Study|Adverse Event|8|||
156679524|NCT00087529|565570642|FG000|Overall Study|Pregnancy|0|||
156679525|NCT00087529|565570643|FG001|Overall Study|Pregnancy|1|||
156679526|NCT00087529|565570642|FG000|Overall Study|Lost to Follow-up|2|||
156679527|NCT00087529|565570643|FG001|Overall Study|Lost to Follow-up|3|||
156679528|NCT00087529|565570642|FG000|Overall Study|Participant Decision|14|||
156679529|NCT00087529|565570643|FG001|Overall Study|Participant Decision|37|||
156679530|NCT00087529|565570642|FG000|Overall Study|Physician Decision|4|||
156679531|NCT00087529|565570643|FG001|Overall Study|Physician Decision|8|||
156679532|NCT00087529|565570642|FG000|Overall Study|Initiation of Excluded Therapy|0|||
156679533|NCT00087529|565570643|FG001|Overall Study|Initiation of Excluded Therapy|1|||
156679534|NCT00087529|565570642|FG000|Overall Study|Participant Noncompliance|0|||
156679535|NCT00087529|565570643|FG001|Overall Study|Participant Noncompliance|1|||
156679536|NCT00087529|565570642|FG000|Overall Study|Disease Progression|5|||
156679537|NCT00087529|565570643|FG001|Overall Study|Disease Progression|4|||
156679538|NCT00087529|565570642|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
156679539|NCT00087529|565570643|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
156679540|NCT02535923|565570644|FG000|Overall Study|Lost to Follow-up|5|||
156679541|NCT02535923|565570645|FG001|Overall Study|Lost to Follow-up|5|||
156679542|NCT02535923|565570644|FG000|Overall Study|Withdrawal by Subject|4|||
156679543|NCT02535923|565570645|FG001|Overall Study|Withdrawal by Subject|3|||
156679544|NCT01562613|565570646|FG000|Overall Study|Lost to Follow-up|2|||
156679545|NCT01562613|565570646|FG000|Overall Study|Withdrawal by Subject|2|||
156679546|NCT04388787|565570649|FG000|Blinded Period|Patient could not follow instructions|1|||
156679547|NCT04388787|565570649|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
156679548|NCT00663234|565570650|FG000|Overall Study|Not willing to adhere to requirements|1|||
156679549|NCT01253564|565570653|FG000|Overall Study|Disease Progression|22|||
156679550|NCT01253564|565570653|FG000|Overall Study|Withdrawal by Subject|1|||
156679551|NCT01253564|565570653|FG000|Overall Study|Serious Adverse Event|1|||
156679552|NCT03694197|565570656|FG000|Overall Study|Adverse Event|9|||
156679553|NCT03694197|565570656|FG000|Overall Study|Protocol became inconvenient to participate|1|||
156679554|NCT03694197|565570656|FG000|Overall Study|Physician Decision|4|||
156679555|NCT03694197|565570656|FG000|Overall Study|Study terminated by sponsor|1350|||
156679556|NCT03694197|565570656|FG000|Overall Study|Participant moved|5|||
156679557|NCT03694197|565570656|FG000|Overall Study|Participant withdrew consent|10|||
156679558|NCT03694197|565570656|FG000|Overall Study|Related to IMP administration|1|||
156679559|NCT03694197|565570656|FG000|Overall Study|Not disclosed|5|||
156679560|NCT02940522|565572286|FG000|Overall Study|Lost to Follow-up|1|||
156679561|NCT02940522|565572287|FG001|Overall Study|Lost to Follow-up|2|||
156679562|NCT02940522|565572286|FG000|Overall Study|Withdrawal by Subject|1|||
156679563|NCT02940522|565572287|FG001|Overall Study|Withdrawal by Subject|0|||
156679564|NCT05135273|565572288|FG000|Overall Study|Recruited into the army|0|||
156679565|NCT05135273|565572289|FG001|Overall Study|Recruited into the army|0|||
156679566|NCT05135273|565572290|FG002|Overall Study|Recruited into the army|0|||
156679567|NCT05135273|565572291|FG003|Overall Study|Recruited into the army|0|||
156679568|NCT05135273|565572292|FG004|Overall Study|Recruited into the army|1|||
156679569|NCT05135273|565572293|FG005|Overall Study|Recruited into the army|0|||
156679570|NCT05135273|565572294|FG006|Overall Study|Recruited into the army|0|||
156679571|NCT05135273|565572295|FG007|Overall Study|Recruited into the army|0|||
156679572|NCT05135273|565572288|FG000|Overall Study|Moved away from study site|0|||
156679573|NCT05135273|565572289|FG001|Overall Study|Moved away from study site|0|||
156782696|NCT01658878|565954739|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782697|NCT01658878|565954740|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782698|NCT01658878|565954741|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782699|NCT01658878|565954742|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782700|NCT01658878|565954743|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
156782701|NCT01658878|565954744|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782702|NCT01658878|565954745|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866960|NCT00084136|566273433|FG002|NRTI Comparison|Death|18|||
156679574|NCT05135273|565572290|FG002|Overall Study|Moved away from study site|0|||
156679575|NCT05135273|565572291|FG003|Overall Study|Moved away from study site|0|||
156679576|NCT05135273|565572292|FG004|Overall Study|Moved away from study site|0|||
156679577|NCT05135273|565572293|FG005|Overall Study|Moved away from study site|1|||
156679578|NCT05135273|565572294|FG006|Overall Study|Moved away from study site|1|||
156679579|NCT05135273|565572295|FG007|Overall Study|Moved away from study site|0|||
156679580|NCT05135273|565572288|FG000|Overall Study|Travel|0|||
156679581|NCT05135273|565572289|FG001|Overall Study|Travel|0|||
156866961|NCT00084136|566273431|FG000|NRTI Comparison|Lost to Follow-up|14|||
156679582|NCT05135273|565572290|FG002|Overall Study|Travel|0|||
156679583|NCT05135273|565572291|FG003|Overall Study|Travel|0|||
156679584|NCT05135273|565572292|FG004|Overall Study|Travel|0|||
156679585|NCT05135273|565572293|FG005|Overall Study|Travel|0|||
156679586|NCT05135273|565572294|FG006|Overall Study|Travel|0|||
156679587|NCT05135273|565572295|FG007|Overall Study|Travel|1|||
156679588|NCT01680016|565572296|FG000|Overall Study|Adverse Event|0|||
156679589|NCT01680016|565572297|FG001|Overall Study|Adverse Event|0|||
156679590|NCT01680016|565572298|FG002|Overall Study|Adverse Event|1|||
156679591|NCT01680016|565572299|FG003|Overall Study|Adverse Event|4|||
156679592|NCT01680016|565572296|FG000|Overall Study|The Subject went out of The Trial|1|||
156679593|NCT01680016|565572297|FG001|Overall Study|The Subject went out of The Trial|0|||
156679594|NCT01680016|565572298|FG002|Overall Study|The Subject went out of The Trial|3|||
156679595|NCT01680016|565572299|FG003|Overall Study|The Subject went out of The Trial|0|||
156679596|NCT01680016|565572296|FG000|Overall Study|Protocol Violation|0|||
156679597|NCT01680016|565572297|FG001|Overall Study|Protocol Violation|1|||
156679598|NCT01680016|565572298|FG002|Overall Study|Protocol Violation|0|||
156679599|NCT01680016|565572299|FG003|Overall Study|Protocol Violation|0|||
156679600|NCT01680016|565572296|FG000|Overall Study|Withdrawal by Subject|5|||
156679601|NCT01680016|565572297|FG001|Overall Study|Withdrawal by Subject|7|||
156679602|NCT01680016|565572298|FG002|Overall Study|Withdrawal by Subject|1|||
156679603|NCT01680016|565572299|FG003|Overall Study|Withdrawal by Subject|1|||
156679604|NCT01958060|565572303|FG000|Overall Study|Not treated|2|||
156679605|NCT01958060|565572304|FG001|Overall Study|Not treated|0|||
156679606|NCT01958060|565572305|FG002|Overall Study|Not treated|0|||
156679607|NCT01958060|565572306|FG003|Overall Study|Not treated|0|||
156679608|NCT01958060|565572307|FG004|Overall Study|Not treated|1|||
156679609|NCT01958060|565572308|FG005|Overall Study|Not treated|0|||
156679610|NCT02846883|565572311|FG000|Overall Study|Death|0|||
156679611|NCT02846883|565572312|FG001|Overall Study|Death|1|||
156679612|NCT02846883|565572313|FG002|Overall Study|Death|1|||
156679613|NCT02846883|565572311|FG000|Overall Study|Lost to Follow-up|0|||
156679614|NCT02846883|565572312|FG001|Overall Study|Lost to Follow-up|0|||
156679615|NCT02846883|565572313|FG002|Overall Study|Lost to Follow-up|1|||
156679616|NCT02846883|565572311|FG000|Overall Study|Withdrawal by Subject|1|||
156679617|NCT02846883|565572312|FG001|Overall Study|Withdrawal by Subject|0|||
156679618|NCT02846883|565572313|FG002|Overall Study|Withdrawal by Subject|0|||
156679619|NCT02846883|565572311|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
156679620|NCT02846883|565572312|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
156679621|NCT02846883|565572313|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
156679622|NCT02846883|565572311|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
156679623|NCT02846883|565572312|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
156679624|NCT02846883|565572313|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
156679625|NCT00108628|565572318|FG000|Overall Study|Withdrawal by Subject|17|||
156679626|NCT00108628|565572319|FG001|Overall Study|Withdrawal by Subject|9|||
156679627|NCT00108628|565572318|FG000|Overall Study|Lack of Efficacy|2|||
156679628|NCT00108628|565572319|FG001|Overall Study|Lack of Efficacy|1|||
156679629|NCT00108628|565572318|FG000|Overall Study|Death|1|||
156679630|NCT00108628|565572319|FG001|Overall Study|Death|0|||
156679631|NCT01350934|565572320|FG000|Base Study|Adverse Event|6|||
156679632|NCT01350934|565572321|FG001|Base Study|Adverse Event|0|||
156679633|NCT01350934|565572320|FG000|Base Study|Lost to Follow-up|1|||
156679634|NCT01350934|565572321|FG001|Base Study|Lost to Follow-up|0|||
156679635|NCT01350934|565572320|FG000|Base Study|Protocol Violation|1|||
156679636|NCT01350934|565572321|FG001|Base Study|Protocol Violation|1|||
156679637|NCT01350934|565572320|FG000|Base Study|Withdrawal by Subject|1|||
156782703|NCT01658878|565954746|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
156782704|NCT01658878|565954747|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782705|NCT01658878|565954748|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782706|NCT01658878|565954749|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782707|NCT01658878|565954750|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782708|NCT01658878|565954751|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782709|NCT01658878|565954752|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866962|NCT00084136|566273432|FG001|NRTI Comparison|Lost to Follow-up|0|||
156866963|NCT00084136|566273433|FG002|NRTI Comparison|Lost to Follow-up|12|||
156679638|NCT01350934|565572321|FG001|Base Study|Withdrawal by Subject|2|||
156679639|NCT01350934|565572320|FG000|Base Study|Non-Compliance With Study Drug|2|||
156679640|NCT01350934|565572321|FG001|Base Study|Non-Compliance With Study Drug|0|||
156679641|NCT01350934|565572320|FG000|Extension Study|Adverse Event|2|||
156679642|NCT01350934|565572321|FG001|Extension Study|Adverse Event|1|||
156679643|NCT01350934|565572320|FG000|Extension Study|Lost to Follow-up|2|||
156679644|NCT01350934|565572321|FG001|Extension Study|Lost to Follow-up|0|||
156679645|NCT01350934|565572320|FG000|Extension Study|Protocol Violation|1|||
156866964|NCT00084136|566273431|FG000|NRTI Comparison|Withdrawal by Subject|54|||
156679646|NCT01350934|565572321|FG001|Extension Study|Protocol Violation|1|||
156679647|NCT01350934|565572320|FG000|Extension Study|Lack of Efficacy|0|||
156679648|NCT01350934|565572321|FG001|Extension Study|Lack of Efficacy|1|||
156679649|NCT01350934|565572320|FG000|Extension Study|Withdrawal by Subject|0|||
156679650|NCT01350934|565572321|FG001|Extension Study|Withdrawal by Subject|1|||
156679651|NCT03547635|565572322|FG000|Overall Study|Adverse Event|5|||
156679652|NCT03547635|565572323|FG001|Overall Study|Adverse Event|2|||
156679653|NCT03547635|565572324|FG002|Overall Study|Adverse Event|3|||
156679654|NCT03547635|565572322|FG000|Overall Study|Lost to Follow-up|1|||
156679655|NCT03547635|565572323|FG001|Overall Study|Lost to Follow-up|3|||
156679656|NCT03547635|565572324|FG002|Overall Study|Lost to Follow-up|4|||
156679657|NCT03547635|565572322|FG000|Overall Study|Withdrawal by Subject|1|||
156679658|NCT03547635|565572323|FG001|Overall Study|Withdrawal by Subject|0|||
156679659|NCT03547635|565572324|FG002|Overall Study|Withdrawal by Subject|0|||
156679660|NCT03547635|565572322|FG000|Overall Study|Withdrawal By PI|0|||
156679661|NCT03547635|565572323|FG001|Overall Study|Withdrawal By PI|1|||
156679662|NCT03547635|565572324|FG002|Overall Study|Withdrawal By PI|0|||
156679663|NCT03547635|565572322|FG000|Overall Study|Withdrawal by Sponsor|0|||
156679664|NCT03547635|565572323|FG001|Overall Study|Withdrawal by Sponsor|0|||
156679665|NCT03547635|565572324|FG002|Overall Study|Withdrawal by Sponsor|1|||
156679666|NCT03547635|565572322|FG000|Overall Study|Errant Randomization before Treatment|0|||
156679667|NCT03547635|565572323|FG001|Overall Study|Errant Randomization before Treatment|1|||
156679668|NCT03547635|565572324|FG002|Overall Study|Errant Randomization before Treatment|0|||
156679669|NCT03547635|565572322|FG000|Overall Study|Withdrawal by Subject|1|||
156679670|NCT03547635|565572323|FG001|Overall Study|Withdrawal by Subject|0|||
156679671|NCT03547635|565572324|FG002|Overall Study|Withdrawal by Subject|0|||
156679672|NCT01813435|565572325|FG000|Overall Study|did not finish experimental regimen|1902|||
156679673|NCT01813435|565572326|FG001|Overall Study|did not finish experimental regimen|770|||
156679674|NCT01813435|565572325|FG000|Overall Study|Lost to Follow-up|268|||
156679675|NCT01813435|565572326|FG001|Overall Study|Lost to Follow-up|237|||
156679676|NCT01011335|565572329|FG000|Overall Study|Lost to Follow-up|0|||
156679677|NCT01011335|565572330|FG001|Overall Study|Lost to Follow-up|0|||
156679678|NCT01011335|565572331|FG002|Overall Study|Lost to Follow-up|1|||
156679679|NCT01011335|565572332|FG003|Overall Study|Lost to Follow-up|1|||
156679680|NCT01011335|565572333|FG004|Overall Study|Lost to Follow-up|1|||
156679681|NCT01011335|565572334|FG005|Overall Study|Lost to Follow-up|1|||
156679682|NCT01011335|565572335|FG006|Overall Study|Lost to Follow-up|2|||
156679683|NCT01011335|565572336|FG007|Overall Study|Lost to Follow-up|2|||
156679684|NCT01011335|565572337|FG008|Overall Study|Lost to Follow-up|1|||
156679685|NCT01011335|565572338|FG009|Overall Study|Lost to Follow-up|0|||
156679686|NCT01011335|565572339|FG010|Overall Study|Lost to Follow-up|0|||
156679687|NCT01011335|565572340|FG011|Overall Study|Lost to Follow-up|1|||
156679688|NCT01011335|565572341|FG012|Overall Study|Lost to Follow-up|2|||
156679689|NCT01011335|565572329|FG000|Overall Study|Protocol Violation|0|||
156679690|NCT01011335|565572330|FG001|Overall Study|Protocol Violation|1|||
156679691|NCT01011335|565572331|FG002|Overall Study|Protocol Violation|0|||
156679692|NCT01011335|565572332|FG003|Overall Study|Protocol Violation|0|||
156679693|NCT01011335|565572333|FG004|Overall Study|Protocol Violation|0|||
156679694|NCT01011335|565572334|FG005|Overall Study|Protocol Violation|0|||
156679695|NCT01011335|565572335|FG006|Overall Study|Protocol Violation|0|||
156679696|NCT01011335|565572336|FG007|Overall Study|Protocol Violation|0|||
156679697|NCT01011335|565572337|FG008|Overall Study|Protocol Violation|0|||
156679698|NCT01011335|565572338|FG009|Overall Study|Protocol Violation|0|||
156679699|NCT01011335|565572339|FG010|Overall Study|Protocol Violation|0|||
156679700|NCT01011335|565572340|FG011|Overall Study|Protocol Violation|0|||
156679701|NCT01011335|565572341|FG012|Overall Study|Protocol Violation|0|||
156679702|NCT01011335|565572329|FG000|Overall Study|Moved/deployed or no booster|1|||
156679703|NCT01011335|565572330|FG001|Overall Study|Moved/deployed or no booster|0|||
156866965|NCT00084136|566273432|FG001|NRTI Comparison|Withdrawal by Subject|0|||
156866966|NCT00084136|566273433|FG002|NRTI Comparison|Withdrawal by Subject|38|||
156679704|NCT01011335|565572331|FG002|Overall Study|Moved/deployed or no booster|0|||
156866967|NCT00084136|566273431|FG000|NRTI Comparison|Clinic site closed|12|||
156435325|NCT01713946|564683596|FG002|Overall Study|Lack of Efficacy|14|||
156679705|NCT01011335|565572332|FG003|Overall Study|Moved/deployed or no booster|1|||
156679706|NCT01011335|565572333|FG004|Overall Study|Moved/deployed or no booster|0|||
156679707|NCT01011335|565572334|FG005|Overall Study|Moved/deployed or no booster|0|||
156679708|NCT01011335|565572335|FG006|Overall Study|Moved/deployed or no booster|1|||
156679709|NCT01011335|565572336|FG007|Overall Study|Moved/deployed or no booster|0|||
156679710|NCT01011335|565572337|FG008|Overall Study|Moved/deployed or no booster|1|||
156679711|NCT01011335|565572338|FG009|Overall Study|Moved/deployed or no booster|0|||
156679712|NCT01011335|565572339|FG010|Overall Study|Moved/deployed or no booster|2|||
156679713|NCT01011335|565572340|FG011|Overall Study|Moved/deployed or no booster|0|||
156679714|NCT01011335|565572341|FG012|Overall Study|Moved/deployed or no booster|0|||
156679715|NCT01011335|565572329|FG000|Overall Study|Adverse Event|0|||
156866968|NCT00084136|566273432|FG001|NRTI Comparison|Clinic site closed|0|||
156435326|NCT01713946|564683594|FG000|Overall Study|Protocol Violation|2|||
156866969|NCT00084136|566273433|FG002|NRTI Comparison|Clinic site closed|14|||
156866970|NCT00084136|566273431|FG000|NRTI Comparison|Not reason above|1|||
156866971|NCT00084136|566273432|FG001|NRTI Comparison|Not reason above|0|||
156866972|NCT00084136|566273433|FG002|NRTI Comparison|Not reason above|0|||
156866973|NCT01524796|566273434|FG000|Overall Study|Adverse Event|13|||
156866974|NCT01524796|566273434|FG000|Overall Study|Lack of Efficacy|3|||
156866975|NCT01524796|566273434|FG000|Overall Study|Lost to Follow-up|1|||
156866976|NCT01524796|566273434|FG000|Overall Study|The price|1|||
156866977|NCT01524796|566273434|FG000|Overall Study|Withdrawal by Subject|4|||
156866978|NCT01524796|566273434|FG000|Overall Study|Move|1|||
156866979|NCT01524796|566273434|FG000|Overall Study|Deterioration of pains|1|||
156866980|NCT01524796|566273434|FG000|Overall Study|Gall stone surgery|1|||
156866981|NCT01524796|566273434|FG000|Overall Study|Nervous about confidentiality|1|||
156866982|NCT01524796|566273434|FG000|Overall Study|Switch to carbamazapine|1|||
156679716|NCT01011335|565572330|FG001|Overall Study|Adverse Event|0|||
156679717|NCT01011335|565572331|FG002|Overall Study|Adverse Event|0|||
156435327|NCT01713946|564683595|FG001|Overall Study|Protocol Violation|4|||
156435328|NCT01713946|564683596|FG002|Overall Study|Protocol Violation|1|||
156435329|NCT01713946|564683594|FG000|Overall Study|Lost to Follow-up|0|||
156435330|NCT01713946|564683595|FG001|Overall Study|Lost to Follow-up|0|||
156435331|NCT01713946|564683596|FG002|Overall Study|Lost to Follow-up|1|||
156435332|NCT01713946|564683594|FG000|Overall Study|Administrative problems|1|||
156435333|NCT01713946|564683595|FG001|Overall Study|Administrative problems|0|||
156435334|NCT01713946|564683596|FG002|Overall Study|Administrative problems|0|||
156679718|NCT01011335|565572332|FG003|Overall Study|Adverse Event|0|||
156679719|NCT01011335|565572333|FG004|Overall Study|Adverse Event|0|||
156679720|NCT01011335|565572334|FG005|Overall Study|Adverse Event|0|||
156679721|NCT01011335|565572335|FG006|Overall Study|Adverse Event|0|||
156679722|NCT01011335|565572336|FG007|Overall Study|Adverse Event|0|||
156679723|NCT01011335|565572337|FG008|Overall Study|Adverse Event|0|||
156679724|NCT01011335|565572338|FG009|Overall Study|Adverse Event|0|||
156679725|NCT01011335|565572339|FG010|Overall Study|Adverse Event|4|||
156679726|NCT01011335|565572340|FG011|Overall Study|Adverse Event|0|||
156679727|NCT01011335|565572341|FG012|Overall Study|Adverse Event|1|||
156679728|NCT01765751|565572346|FG000|Overall Study|Lost to Follow-up|0|||
156679729|NCT01765751|565572347|FG001|Overall Study|Lost to Follow-up|2|||
156679730|NCT01765751|565572348|FG002|Overall Study|Lost to Follow-up|1|||
156679731|NCT01151280|565572351|FG000|Overall Study|Adverse Event|1|||
156679732|NCT01151280|565572351|FG000|Overall Study|Lack of Efficacy|3|||
156679733|NCT02435433|565572352|FG000|Overall Study|Withdrawal by Subject|2|||
156679734|NCT02435433|565572353|FG001|Overall Study|Withdrawal by Subject|3|||
156679735|NCT02435433|565572354|FG002|Overall Study|Withdrawal by Subject|1|||
156679736|NCT02435433|565572355|FG003|Overall Study|Withdrawal by Subject|0|||
156679737|NCT02435433|565572356|FG004|Overall Study|Withdrawal by Subject|0|||
156679738|NCT02435433|565572352|FG000|Overall Study|Lost to Follow-up|2|||
156679739|NCT02435433|565572353|FG001|Overall Study|Lost to Follow-up|2|||
156679740|NCT02435433|565572354|FG002|Overall Study|Lost to Follow-up|4|||
156679741|NCT02435433|565572355|FG003|Overall Study|Lost to Follow-up|1|||
156679742|NCT02435433|565572356|FG004|Overall Study|Lost to Follow-up|0|||
156679743|NCT01243151|565572357|FG000|Overall Study|Adverse Event|0|||
156679744|NCT01243151|565572358|FG001|Overall Study|Adverse Event|1|||
156679745|NCT01243151|565572359|FG002|Overall Study|Adverse Event|0|||
156679746|NCT01243151|565572360|FG003|Overall Study|Adverse Event|0|||
156679747|NCT01243151|565572361|FG004|Overall Study|Adverse Event|0|||
156679748|NCT01243151|565572357|FG000|Overall Study|Protocol Violation|0|||
156679749|NCT01243151|565572358|FG001|Overall Study|Protocol Violation|0|||
156679750|NCT01243151|565572359|FG002|Overall Study|Protocol Violation|1|||
156679751|NCT01243151|565572360|FG003|Overall Study|Protocol Violation|0|||
156679752|NCT01243151|565572361|FG004|Overall Study|Protocol Violation|0|||
156679753|NCT01243151|565572357|FG000|Overall Study|Other|0|||
156679754|NCT01243151|565572358|FG001|Overall Study|Other|0|||
156679755|NCT01243151|565572359|FG002|Overall Study|Other|0|||
156679756|NCT01243151|565572360|FG003|Overall Study|Other|1|||
156679757|NCT01243151|565572361|FG004|Overall Study|Other|0|||
156435335|NCT01713946|564683594|FG000|Overall Study|Did not continue in Ext|0|||
156679758|NCT01243151|565572357|FG000|Overall Study|Randomized but not treated|0|||
156679759|NCT01243151|565572358|FG001|Overall Study|Randomized but not treated|0|||
156679760|NCT01243151|565572359|FG002|Overall Study|Randomized but not treated|0|||
156679761|NCT01243151|565572360|FG003|Overall Study|Randomized but not treated|1|||
156679762|NCT01243151|565572361|FG004|Overall Study|Randomized but not treated|0|||
156679763|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
156679764|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
156679765|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
156679766|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
156866983|NCT01524796|566273434|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
156866984|NCT02612779|566273437|FG000|Overall Study|Administrative reason by sponsor|4|||
156866985|NCT02612779|566273438|FG001|Overall Study|Administrative reason by sponsor|1|||
156866986|NCT02612779|566273437|FG000|Overall Study|No longer meet study criteria|0|||
156679767|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
156679768|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
156679769|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
156679770|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
156679771|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
156679772|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
156679773|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
156679774|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
156679775|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
156679776|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
156679777|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
156679778|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
156679779|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
156679780|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
156679781|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
156679782|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
156679783|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
156679784|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
156679785|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
156679786|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
156679787|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
156679788|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
156679789|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
156679790|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
156679791|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
156679792|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
156679793|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
156679794|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
156679795|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
156679796|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
156679797|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
156679798|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
156679799|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
156679800|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
156679801|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
156679802|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
156679803|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
156679804|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
156679805|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
156679806|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
156679807|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
156679808|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
156679809|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
156679810|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
156435336|NCT01713946|564683595|FG001|Overall Study|Did not continue in Ext|3|||
156435337|NCT01713946|564683596|FG002|Overall Study|Did not continue in Ext|0|||
156435338|NCT01713946|564683594|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
156435339|NCT01713946|564683595|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
156679811|NCT01710358|565572365|FG000|Rescue Period|Adverse Event|0|||
156866987|NCT02612779|566273438|FG001|Overall Study|No longer meet study criteria|1|||
156866988|NCT02612779|566273437|FG000|Overall Study|Disease progression|29|||
156866989|NCT02612779|566273438|FG001|Overall Study|Disease progression|2|||
156866990|NCT02612779|566273437|FG000|Overall Study|Study drug toxicity|10|||
156866991|NCT02612779|566273438|FG001|Overall Study|Study drug toxicity|1|||
156866992|NCT02612779|566273437|FG000|Overall Study|Death|1|||
156435340|NCT01713946|564683596|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
156679812|NCT01710358|565572366|FG001|Rescue Period|Adverse Event|15|||
156679813|NCT01710358|565572367|FG002|Rescue Period|Adverse Event|0|||
156679814|NCT01710358|565572365|FG000|Rescue Period|Death|0|||
156679815|NCT01710358|565572366|FG001|Rescue Period|Death|1|||
156679816|NCT01710358|565572367|FG002|Rescue Period|Death|0|||
156679817|NCT01710358|565572365|FG000|Rescue Period|Lack of Efficacy|0|||
156679818|NCT01710358|565572366|FG001|Rescue Period|Lack of Efficacy|7|||
156679819|NCT01710358|565572367|FG002|Rescue Period|Lack of Efficacy|0|||
156679820|NCT01710358|565572365|FG000|Rescue Period|Withdrawal by Subject|0|||
156679821|NCT01710358|565572366|FG001|Rescue Period|Withdrawal by Subject|8|||
156679822|NCT01710358|565572367|FG002|Rescue Period|Withdrawal by Subject|0|||
156866993|NCT02612779|566273438|FG001|Overall Study|Death|0|||
156679823|NCT00799708|565572370|FG000|Overall Study|non-compliance|1|||
156679824|NCT00799708|565572371|FG001|Overall Study|non-compliance|0|||
156679825|NCT00799708|565572372|FG002|Overall Study|non-compliance|0|||
156679826|NCT00880334|565572373|FG000|Randomized Phase|Physician Decision|1|||
156679827|NCT00880334|565572374|FG001|Randomized Phase|Physician Decision|0|||
156679828|NCT00880334|565572373|FG000|Randomized Phase|Withdrawal by Subject|2|||
156679829|NCT00880334|565572374|FG001|Randomized Phase|Withdrawal by Subject|1|||
156679830|NCT00880334|565572373|FG000|Randomized Phase|Inadequate Labs|1|||
156679831|NCT00880334|565572374|FG001|Randomized Phase|Inadequate Labs|1|||
156679832|NCT00880334|565572373|FG000|Randomized Phase|Brain Metastasis|0|||
156679833|NCT00880334|565572374|FG001|Randomized Phase|Brain Metastasis|1|||
156679834|NCT00880334|565572373|FG000|Randomized Phase|Crossover Participants|0|||
156679835|NCT00880334|565572374|FG001|Randomized Phase|Crossover Participants|37|||
156679836|NCT02274558|565572379|FG000|Overall Study|Adverse Event|2|||
156679837|NCT02274558|565572380|FG001|Overall Study|Adverse Event|4|||
156679838|NCT02274558|565572381|FG002|Overall Study|Adverse Event|2|||
156679839|NCT02274558|565572379|FG000|Overall Study|Non-compliance|2|||
156679840|NCT02274558|565572380|FG001|Overall Study|Non-compliance|1|||
156679841|NCT02274558|565572381|FG002|Overall Study|Non-compliance|0|||
156679842|NCT02274558|565572379|FG000|Overall Study|Withdrawal by Subject|1|||
156679843|NCT02274558|565572380|FG001|Overall Study|Withdrawal by Subject|5|||
156679844|NCT02274558|565572381|FG002|Overall Study|Withdrawal by Subject|4|||
156679845|NCT02274558|565572379|FG000|Overall Study|Death|0|||
156679846|NCT02274558|565572380|FG001|Overall Study|Death|0|||
156679847|NCT02274558|565572381|FG002|Overall Study|Death|1|||
156679848|NCT02274558|565572379|FG000|Overall Study|Lost to Follow-up|2|||
156679849|NCT02274558|565572380|FG001|Overall Study|Lost to Follow-up|1|||
156679850|NCT02274558|565572381|FG002|Overall Study|Lost to Follow-up|1|||
156679851|NCT02274558|565572379|FG000|Overall Study|Physician Decision|0|||
156679852|NCT02274558|565572380|FG001|Overall Study|Physician Decision|2|||
156679853|NCT02274558|565572381|FG002|Overall Study|Physician Decision|1|||
156679854|NCT01119625|565572382|FG000|Overall Study|Lost to Follow-up|1|||
156679855|NCT01119625|565572383|FG001|Overall Study|Lost to Follow-up|2|||
156679856|NCT01119625|565572382|FG000|Overall Study|Withdrawal by Subject|2|||
156679857|NCT01119625|565572383|FG001|Overall Study|Withdrawal by Subject|1|||
156679858|NCT01119625|565572382|FG000|Overall Study|Other|0|||
156679859|NCT01119625|565572383|FG001|Overall Study|Other|1|||
156679860|NCT01721772|565572388|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
156679861|NCT01721772|565572389|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
156679862|NCT01721772|565572388|FG000|Pre-Treatment|Poor/non-compliance|0|||
156679863|NCT01721772|565572389|FG001|Pre-Treatment|Poor/non-compliance|1|||
156679864|NCT01721772|565572388|FG000|Pre-Treatment|Participant withdrew consent|0|||
156679865|NCT01721772|565572389|FG001|Pre-Treatment|Participant withdrew consent|1|||
156679866|NCT01721772|565572388|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
156679867|NCT01721772|565572389|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
156679868|NCT01721772|565572388|FG000|Treatment|Disease progression|119|||
156679869|NCT01721772|565572389|FG001|Treatment|Disease progression|168|||
156679870|NCT01721772|565572388|FG000|Treatment|Study drug toxicity|19|||
156679871|NCT01721772|565572389|FG001|Treatment|Study drug toxicity|10|||
156679872|NCT01721772|565572388|FG000|Treatment|Adverse event unrelated to study drug|7|||
156679873|NCT01721772|565572389|FG001|Treatment|Adverse event unrelated to study drug|7|||
156679874|NCT01721772|565572388|FG000|Treatment|Maximum clinical benefit|16|||
156679875|NCT01721772|565572389|FG001|Treatment|Maximum clinical benefit|4|||
156679876|NCT01721772|565572388|FG000|Treatment|Other|19|||
156679877|NCT01721772|565572389|FG001|Treatment|Other|2|||
156679878|NCT01721772|565572388|FG000|Treatment|Participant withdrew consent|2|||
156679879|NCT01721772|565572389|FG001|Treatment|Participant withdrew consent|5|||
156679880|NCT01721772|565572388|FG000|Treatment|Participant request to discontinue study treatment|21|||
156679881|NCT01721772|565572389|FG001|Treatment|Participant request to discontinue study treatment|8|||
156679882|NCT01721772|565572388|FG000|Treatment|Death|1|||
156679883|NCT01721772|565572389|FG001|Treatment|Death|0|||
156679884|NCT01721772|565572388|FG000|Treatment|Not reported|1|||
156679885|NCT01721772|565572389|FG001|Treatment|Not reported|0|||
156679886|NCT01721772|565572388|FG000|Treatment|Poor/non-compliance|1|||
156679887|NCT01721772|565572389|FG001|Treatment|Poor/non-compliance|0|||
156679888|NCT01721772|565572388|FG000|Treatment|Lost to Follow-up|0|||
156679889|NCT01721772|565572389|FG001|Treatment|Lost to Follow-up|1|||
156679890|NCT01408888|565572390|FG000|First Intervention|Adverse Event|0|||
156679891|NCT01408888|565572391|FG001|First Intervention|Adverse Event|1|||
156679892|NCT01408888|565572390|FG000|First Intervention|Withdrawal by Subject|0|||
156679893|NCT01408888|565572391|FG001|First Intervention|Withdrawal by Subject|2|||
156679894|NCT01408888|565572390|FG000|Second Intervention|Withdrawal by Subject|1|||
156679895|NCT01408888|565572391|FG001|Second Intervention|Withdrawal by Subject|0|||
156679896|NCT01408888|565572390|FG000|Second Intervention|Adverse Event|1|||
156679897|NCT01408888|565572391|FG001|Second Intervention|Adverse Event|0|||
156679898|NCT04542694|565572392|FG000|Overall Study|The need for prohibited therapy|2|||
156679899|NCT04542694|565572393|FG001|Overall Study|The need for prohibited therapy|0|||
156679900|NCT04542694|565572392|FG000|Overall Study|Adverse Event|1|||
156679901|NCT04542694|565572393|FG001|Overall Study|Adverse Event|0|||
156679902|NCT04542694|565572392|FG000|Overall Study|Protocol Violation|1|||
156679903|NCT04542694|565572393|FG001|Overall Study|Protocol Violation|0|||
156679904|NCT00969124|565572394|FG000|Overall Study|Protocol Violation|2|||
156679905|NCT00969124|565572394|FG000|Overall Study|Inadequate bowel preparation|15|||
156679906|NCT00969124|565572394|FG000|Overall Study|Inability to reach cecum|9|||
156679907|NCT00969124|565572394|FG000|Overall Study|Previously unrecognized disease|3|||
156679908|NCT00969124|565572394|FG000|Overall Study|Technical error|1|||
156679909|NCT00210639|565572395|FG000|Overall Study|Lost to Follow-up|37|||
156679910|NCT00210639|565572396|FG001|Overall Study|Lost to Follow-up|29|||
156679911|NCT00210639|565572395|FG000|Overall Study|Withdrawal by Subject|8|||
156679912|NCT00210639|565572396|FG001|Overall Study|Withdrawal by Subject|1|||
156782710|NCT01658878|565954729|FG000|Treatment Period|Poor/Non-compliance|0|||
156782711|NCT01658878|565954730|FG001|Treatment Period|Poor/Non-compliance|0|||
156782712|NCT01658878|565954731|FG002|Treatment Period|Poor/Non-compliance|0|||
156782713|NCT01658878|565954732|FG003|Treatment Period|Poor/Non-compliance|0|||
156782714|NCT01658878|565954733|FG004|Treatment Period|Poor/Non-compliance|0|||
156782715|NCT01658878|565954734|FG005|Treatment Period|Poor/Non-compliance|0|||
156782716|NCT01658878|565954735|FG006|Treatment Period|Poor/Non-compliance|0|||
156782717|NCT01658878|565954736|FG007|Treatment Period|Poor/Non-compliance|0|||
156782718|NCT01658878|565954737|FG008|Treatment Period|Poor/Non-compliance|0|||
156782719|NCT01658878|565954738|FG009|Treatment Period|Poor/Non-compliance|0|||
156782720|NCT01658878|565954739|FG010|Treatment Period|Poor/Non-compliance|0|||
156782721|NCT01658878|565954740|FG011|Treatment Period|Poor/Non-compliance|0|||
156782722|NCT01658878|565954741|FG012|Treatment Period|Poor/Non-compliance|0|||
156782723|NCT01658878|565954742|FG013|Treatment Period|Poor/Non-compliance|0|||
156782724|NCT01658878|565954743|FG014|Treatment Period|Poor/Non-compliance|0|||
156782725|NCT01658878|565954744|FG015|Treatment Period|Poor/Non-compliance|1|||
156782726|NCT01658878|565954745|FG016|Treatment Period|Poor/Non-compliance|0|||
156782727|NCT01658878|565954746|FG017|Treatment Period|Poor/Non-compliance|0|||
156782728|NCT01658878|565954747|FG018|Treatment Period|Poor/Non-compliance|0|||
156782729|NCT01658878|565954748|FG019|Treatment Period|Poor/Non-compliance|0|||
156782730|NCT01658878|565954749|FG020|Treatment Period|Poor/Non-compliance|0|||
156782731|NCT01658878|565954750|FG021|Treatment Period|Poor/Non-compliance|0|||
156782732|NCT01658878|565954751|FG022|Treatment Period|Poor/Non-compliance|0|||
156782733|NCT01658878|565954752|FG023|Treatment Period|Poor/Non-compliance|0|||
156782734|NCT01658878|565954729|FG000|Treatment Period|Participant Withdrew Consent|0|||
156782735|NCT01658878|565954730|FG001|Treatment Period|Participant Withdrew Consent|0|||
156782736|NCT01658878|565954731|FG002|Treatment Period|Participant Withdrew Consent|0|||
156782737|NCT01658878|565954732|FG003|Treatment Period|Participant Withdrew Consent|0|||
156782738|NCT01658878|565954733|FG004|Treatment Period|Participant Withdrew Consent|0|||
156782739|NCT01658878|565954734|FG005|Treatment Period|Participant Withdrew Consent|0|||
156782740|NCT01658878|565954735|FG006|Treatment Period|Participant Withdrew Consent|0|||
156782741|NCT01658878|565954736|FG007|Treatment Period|Participant Withdrew Consent|0|||
156782742|NCT01658878|565954737|FG008|Treatment Period|Participant Withdrew Consent|0|||
156782743|NCT01658878|565954738|FG009|Treatment Period|Participant Withdrew Consent|0|||
156782744|NCT01658878|565954739|FG010|Treatment Period|Participant Withdrew Consent|0|||
156782745|NCT01658878|565954740|FG011|Treatment Period|Participant Withdrew Consent|0|||
156782746|NCT01658878|565954741|FG012|Treatment Period|Participant Withdrew Consent|1|||
156782747|NCT01658878|565954742|FG013|Treatment Period|Participant Withdrew Consent|0|||
156782748|NCT01658878|565954743|FG014|Treatment Period|Participant Withdrew Consent|2|||
156782749|NCT01658878|565954744|FG015|Treatment Period|Participant Withdrew Consent|0|||
156782750|NCT01658878|565954745|FG016|Treatment Period|Participant Withdrew Consent|0|||
156782751|NCT01658878|565954746|FG017|Treatment Period|Participant Withdrew Consent|2|||
156782752|NCT01658878|565954747|FG018|Treatment Period|Participant Withdrew Consent|1|||
156782753|NCT01658878|565954748|FG019|Treatment Period|Participant Withdrew Consent|2|||
156782754|NCT01658878|565954749|FG020|Treatment Period|Participant Withdrew Consent|1|||
156782755|NCT01658878|565954750|FG021|Treatment Period|Participant Withdrew Consent|0|||
156782756|NCT01658878|565954751|FG022|Treatment Period|Participant Withdrew Consent|2|||
156782757|NCT01658878|565954752|FG023|Treatment Period|Participant Withdrew Consent|2|||
156782758|NCT01658878|565954729|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156679913|NCT00210639|565572395|FG000|Overall Study|Other|18|||
156679914|NCT00210639|565572396|FG001|Overall Study|Other|12|||
156679915|NCT00397254|565572397|FG000|Overall Study|Lost to Follow-up|2|||
156782759|NCT01658878|565954730|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782760|NCT01658878|565954731|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782761|NCT01658878|565954732|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782762|NCT01658878|565954733|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782763|NCT01658878|565954734|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156808719|NCT03052608|566054441|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
156808720|NCT03052608|566054440|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
156808721|NCT03052608|566054441|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
156679916|NCT00397254|565572398|FG001|Overall Study|Lost to Follow-up|2|||
156679917|NCT00152451|565572405|FG000|Overall Study|Adverse Event|4|||
156679918|NCT00323258|565572408|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
156679919|NCT00323258|565572409|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
156679920|NCT00323258|565572408|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
156679921|NCT00323258|565572409|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
156328974|NCT01461980|564305518|FG002|Overall Study|No longer willing to participate|54|||
156328975|NCT01461980|564305516|FG000|Overall Study|Randomized but not vaccinated|4|||
156328976|NCT01461980|564305517|FG001|Overall Study|Randomized but not vaccinated|8|||
156328977|NCT01461980|564305518|FG002|Overall Study|Randomized but not vaccinated|7|||
156328978|NCT00122109|564305519|FG000|Overall Study|Did not meet criteria|6|||
156328979|NCT00122109|564305520|FG001|Overall Study|Did not meet criteria|7|||
156328980|NCT03633617|564305521|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
156328981|NCT03633617|564305522|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
156328982|NCT03633617|564305523|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328983|NCT03633617|564305524|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328984|NCT03633617|564305525|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328985|NCT03633617|564305526|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328986|NCT03633617|564305527|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328987|NCT03633617|564305528|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328988|NCT03633617|564305529|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328989|NCT03633617|564305530|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328990|NCT03633617|564305531|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156328991|NCT03633617|564305521|FG000|Part A|Unconfirmed early termination visit|1|||
156328992|NCT03633617|564305522|FG001|Part A|Unconfirmed early termination visit|0|||
156328993|NCT03633617|564305523|FG002|Part A|Unconfirmed early termination visit|0|||
156328994|NCT03633617|564305524|FG003|Part A|Unconfirmed early termination visit|0|||
156679922|NCT00323258|565572408|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
156328995|NCT03633617|564305525|FG004|Part A|Unconfirmed early termination visit|0|||
156328996|NCT03633617|564305526|FG005|Part A|Unconfirmed early termination visit|0|||
156328997|NCT03633617|564305527|FG006|Part A|Unconfirmed early termination visit|0|||
156328998|NCT03633617|564305528|FG007|Part A|Unconfirmed early termination visit|0|||
156328999|NCT03633617|564305529|FG008|Part A|Unconfirmed early termination visit|0|||
156329000|NCT03633617|564305530|FG009|Part A|Unconfirmed early termination visit|0|||
156329001|NCT03633617|564305531|FG010|Part A|Unconfirmed early termination visit|0|||
156329002|NCT03633617|564305521|FG000|Part A|Adverse Event|0|||
156329003|NCT03633617|564305522|FG001|Part A|Adverse Event|1|||
156329004|NCT03633617|564305523|FG002|Part A|Adverse Event|0|||
156329005|NCT03633617|564305524|FG003|Part A|Adverse Event|0|||
156329006|NCT03633617|564305525|FG004|Part A|Adverse Event|0|||
156329007|NCT03633617|564305526|FG005|Part A|Adverse Event|0|||
156329008|NCT03633617|564305527|FG006|Part A|Adverse Event|0|||
156329009|NCT03633617|564305528|FG007|Part A|Adverse Event|0|||
156329010|NCT03633617|564305529|FG008|Part A|Adverse Event|0|||
156329011|NCT03633617|564305530|FG009|Part A|Adverse Event|0|||
156329012|NCT03633617|564305531|FG010|Part A|Adverse Event|0|||
156329013|NCT03633617|564305521|FG000|Part A|Pregnancy|1|||
156329014|NCT03633617|564305522|FG001|Part A|Pregnancy|0|||
156679923|NCT00323258|565572409|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
156679924|NCT00323258|565572408|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
156679925|NCT00323258|565572409|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
156679926|NCT00323258|565572408|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
156679927|NCT00323258|565572409|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
156679928|NCT00323258|565572408|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
156679929|NCT00323258|565572409|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
156679930|NCT00323258|565572408|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
156679931|NCT00323258|565572409|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
156679932|NCT01943435|565572419|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
156679933|NCT01943435|565572420|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
156679934|NCT01943435|565572421|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
156679935|NCT01943435|565572419|FG000|Intervention Period|Withdrawal by Subject|3|||
156679936|NCT01943435|565572420|FG001|Intervention Period|Withdrawal by Subject|3|||
156679937|NCT01943435|565572421|FG002|Intervention Period|Withdrawal by Subject|4|||
156679938|NCT01943435|565572419|FG000|2 Month Follow up|Lost to Follow-up|2|||
156329015|NCT03633617|564305523|FG002|Part A|Pregnancy|0|||
156329016|NCT03633617|564305524|FG003|Part A|Pregnancy|0|||
156329017|NCT03633617|564305525|FG004|Part A|Pregnancy|0|||
156679939|NCT01943435|565572420|FG001|2 Month Follow up|Lost to Follow-up|3|||
156679940|NCT01943435|565572421|FG002|2 Month Follow up|Lost to Follow-up|0|||
156679941|NCT01943435|565572419|FG000|6 Month Follow up|Lost to Follow-up|12|||
156866994|NCT02612779|566273437|FG000|Overall Study|Adverse event unrelated to study drug|5|||
156866995|NCT02612779|566273438|FG001|Overall Study|Adverse event unrelated to study drug|0|||
156866996|NCT02612779|566273437|FG000|Overall Study|Participant withdrew consent|4|||
156866997|NCT02612779|566273438|FG001|Overall Study|Participant withdrew consent|0|||
156866998|NCT02612779|566273437|FG000|Overall Study|Lost to Follow-up|1|||
156866999|NCT02612779|566273438|FG001|Overall Study|Lost to Follow-up|0|||
156867000|NCT02612779|566273437|FG000|Overall Study|Maximum clinical benefit|10|||
156867001|NCT02612779|566273438|FG001|Overall Study|Maximum clinical benefit|1|||
156867002|NCT02612779|566273437|FG000|Overall Study|Other reasons|4|||
156867003|NCT02612779|566273438|FG001|Overall Study|Other reasons|0|||
156867004|NCT02633306|566273441|FG000|Overall Study|Withdrawal by Subject|3|||
156867005|NCT01744977|566273442|FG000|Overall Study|Withdrawal by Subject|1|||
156867006|NCT01744977|566273443|FG001|Overall Study|Withdrawal by Subject|2|||
156867007|NCT01744977|566273442|FG000|Overall Study|Death|2|||
156867008|NCT01744977|566273443|FG001|Overall Study|Death|3|||
156867009|NCT01744977|566273442|FG000|Overall Study|Lost to Follow-up|2|||
156867010|NCT01744977|566273443|FG001|Overall Study|Lost to Follow-up|0|||
156867011|NCT01744977|566273442|FG000|Overall Study|No longer meets inclusion|6|||
156867012|NCT01744977|566273443|FG001|Overall Study|No longer meets inclusion|0|||
156867013|NCT03774576|566273446|FG000|Period 2|Adverse Event|1|||
156867014|NCT01746901|566273447|FG000|Naloxone Challenge Phase|Adverse Event|2|||
156867015|NCT01746901|566273448|FG001|Naloxone Challenge Phase|Adverse Event|0|||
156867016|NCT01746901|566273449|FG002|Naloxone Challenge Phase|Adverse Event|0|||
156867017|NCT01746901|566273450|FG003|Naloxone Challenge Phase|Adverse Event|0|||
156867018|NCT01746901|566273451|FG004|Naloxone Challenge Phase|Adverse Event|0|||
156867019|NCT01746901|566273452|FG005|Naloxone Challenge Phase|Adverse Event|0|||
156867020|NCT01746901|566273453|FG006|Naloxone Challenge Phase|Adverse Event|0|||
156867021|NCT01746901|566273454|FG007|Naloxone Challenge Phase|Adverse Event|0|||
156867022|NCT01746901|566273455|FG008|Naloxone Challenge Phase|Adverse Event|0|||
156867023|NCT01746901|566273447|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
156867024|NCT01746901|566273448|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867025|NCT01746901|566273449|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867026|NCT01746901|566273450|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867027|NCT01746901|566273451|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867028|NCT01746901|566273452|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867029|NCT01746901|566273453|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867030|NCT01746901|566273454|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156329018|NCT03633617|564305526|FG005|Part A|Pregnancy|0|||
156329019|NCT03633617|564305527|FG006|Part A|Pregnancy|0|||
156329020|NCT03633617|564305528|FG007|Part A|Pregnancy|0|||
156329021|NCT03633617|564305529|FG008|Part A|Pregnancy|0|||
156867031|NCT01746901|566273455|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867032|NCT01746901|566273447|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156679942|NCT01943435|565572420|FG001|6 Month Follow up|Lost to Follow-up|7|||
156679943|NCT01943435|565572421|FG002|6 Month Follow up|Lost to Follow-up|15|||
156679944|NCT01617096|565572428|FG000|Overall Study|Withdrawal by Subject|96|||
156679945|NCT01617096|565572429|FG001|Overall Study|Withdrawal by Subject|81|||
156679946|NCT01617096|565572428|FG000|Overall Study|Lost to Follow-up|37|||
156679947|NCT01617096|565572429|FG001|Overall Study|Lost to Follow-up|32|||
156679948|NCT01617096|565572428|FG000|Overall Study|Physician Decision|10|||
156679949|NCT01617096|565572429|FG001|Overall Study|Physician Decision|18|||
156679950|NCT01617096|565572428|FG000|Overall Study|Death|4|||
156679951|NCT01617096|565572429|FG001|Overall Study|Death|3|||
156679952|NCT01617096|565572428|FG000|Overall Study|Other|1|||
156679953|NCT01617096|565572429|FG001|Overall Study|Other|3|||
156679954|NCT04473326|565572434|FG000|Overall Study|Death|0|||
156679955|NCT04473326|565572435|FG001|Overall Study|Death|1|||
156679956|NCT04473326|565572434|FG000|Overall Study|Withdrawal by Subject|1|||
156679957|NCT04473326|565572435|FG001|Overall Study|Withdrawal by Subject|2|||
156867033|NCT01746901|566273448|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
156329022|NCT03633617|564305530|FG009|Part A|Pregnancy|0|||
156329023|NCT03633617|564305531|FG010|Part A|Pregnancy|0|||
156329024|NCT03633617|564305521|FG000|Part A|Withdrawal by Subject|0|||
156329025|NCT03633617|564305522|FG001|Part A|Withdrawal by Subject|1|||
156329026|NCT03633617|564305523|FG002|Part A|Withdrawal by Subject|0|||
156329027|NCT03633617|564305524|FG003|Part A|Withdrawal by Subject|0|||
156329028|NCT03633617|564305525|FG004|Part A|Withdrawal by Subject|0|||
156329029|NCT03633617|564305526|FG005|Part A|Withdrawal by Subject|0|||
156867034|NCT01746901|566273449|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867035|NCT01746901|566273450|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156329030|NCT03633617|564305527|FG006|Part A|Withdrawal by Subject|0|||
156329031|NCT03633617|564305528|FG007|Part A|Withdrawal by Subject|0|||
156329032|NCT03633617|564305529|FG008|Part A|Withdrawal by Subject|0|||
156329033|NCT03633617|564305530|FG009|Part A|Withdrawal by Subject|0|||
156679958|NCT02046122|565572436|FG000|Overall Study|Physician Decision|8|||
156679959|NCT02046122|565572436|FG000|Overall Study|Withdrawal by Subject|1|||
156679960|NCT04535986|565572439|FG000|Overall Study|Death|4|||
156867036|NCT01746901|566273451|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867037|NCT01746901|566273452|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867038|NCT01746901|566273453|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867039|NCT01746901|566273454|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867040|NCT01746901|566273455|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867041|NCT01746901|566273447|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867042|NCT01746901|566273448|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
156867043|NCT01746901|566273449|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
156867044|NCT01746901|566273450|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867045|NCT01746901|566273451|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867046|NCT01746901|566273452|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867047|NCT01746901|566273453|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867048|NCT01746901|566273454|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867049|NCT01746901|566273455|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867050|NCT01746901|566273447|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867051|NCT01746901|566273448|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
156867052|NCT01746901|566273449|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
156867053|NCT01746901|566273450|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867054|NCT01746901|566273451|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867055|NCT01746901|566273452|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867056|NCT01746901|566273453|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867057|NCT01746901|566273454|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867058|NCT01746901|566273455|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867059|NCT01746901|566273447|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867060|NCT01746901|566273448|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
156867061|NCT01746901|566273449|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
156867062|NCT01746901|566273450|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867063|NCT01746901|566273451|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156679961|NCT04535986|565572440|FG001|Overall Study|Death|5|||
156679962|NCT04535986|565572439|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
156679963|NCT04535986|565572440|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
156679964|NCT04535986|565572439|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
156867064|NCT01746901|566273452|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867065|NCT01746901|566273453|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867066|NCT01746901|566273454|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867067|NCT01746901|566273455|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867068|NCT01746901|566273447|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
156867069|NCT01746901|566273448|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
156867070|NCT01746901|566273449|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
156867071|NCT01746901|566273450|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
156679965|NCT04535986|565572440|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
156679966|NCT04535986|565572439|FG000|Overall Study|Adverse Event|10|||
156679967|NCT04535986|565572440|FG001|Overall Study|Adverse Event|1|||
156679968|NCT04535986|565572439|FG000|Overall Study|Lack of Efficacy|3|||
156679969|NCT04535986|565572440|FG001|Overall Study|Lack of Efficacy|2|||
156679970|NCT04535986|565572439|FG000|Overall Study|Investigator discretion|3|||
156679971|NCT04535986|565572440|FG001|Overall Study|Investigator discretion|0|||
156679972|NCT04535986|565572439|FG000|Overall Study|Withdrawal by Subject|32|||
156679973|NCT04535986|565572440|FG001|Overall Study|Withdrawal by Subject|14|||
156679974|NCT04535986|565572439|FG000|Overall Study|Lost to Follow-up|5|||
156679975|NCT04535986|565572440|FG001|Overall Study|Lost to Follow-up|3|||
156679976|NCT04535986|565572439|FG000|Overall Study|Other|7|||
156679977|NCT04535986|565572440|FG001|Overall Study|Other|3|||
156329034|NCT03633617|564305531|FG010|Part A|Withdrawal by Subject|0|||
156679978|NCT01196390|565572441|FG000|Overall Study|Protocol Violation|4|||
156329035|NCT03633617|564305521|FG000|Part B|Adverse Event|0|||
156329036|NCT03633617|564305522|FG001|Part B|Adverse Event|0|||
156329037|NCT03633617|564305523|FG002|Part B|Adverse Event|2|||
156329038|NCT03633617|564305524|FG003|Part B|Adverse Event|2|||
156329039|NCT03633617|564305525|FG004|Part B|Adverse Event|1|||
156329040|NCT03633617|564305526|FG005|Part B|Adverse Event|0|||
156329041|NCT03633617|564305527|FG006|Part B|Adverse Event|0|||
156329042|NCT03633617|564305528|FG007|Part B|Adverse Event|0|||
156329043|NCT03633617|564305529|FG008|Part B|Adverse Event|0|||
156329044|NCT03633617|564305530|FG009|Part B|Adverse Event|0|||
156329045|NCT03633617|564305531|FG010|Part B|Adverse Event|0|||
156329046|NCT03633617|564305521|FG000|Part B|Withdrawal by Subject|0|||
156329047|NCT03633617|564305522|FG001|Part B|Withdrawal by Subject|0|||
156329048|NCT03633617|564305523|FG002|Part B|Withdrawal by Subject|1|||
156679979|NCT01196390|565572442|FG001|Overall Study|Protocol Violation|5|||
156679980|NCT00252564|565572443|FG000|Overall Study|Adverse Event|17|||
156679981|NCT00252564|565572444|FG001|Overall Study|Adverse Event|13|||
156679982|NCT00252564|565572443|FG000|Overall Study|Unrelated Complication|2|||
156679983|NCT00252564|565572444|FG001|Overall Study|Unrelated Complication|1|||
156679984|NCT00252564|565572443|FG000|Overall Study|Disease Progression|14|||
156679985|NCT00252564|565572444|FG001|Overall Study|Disease Progression|20|||
156679986|NCT00252564|565572443|FG000|Overall Study|Death|0|||
156679987|NCT00252564|565572444|FG001|Overall Study|Death|3|||
156679988|NCT00252564|565572443|FG000|Overall Study|Physician Decision|1|||
156679989|NCT00252564|565572444|FG001|Overall Study|Physician Decision|0|||
156679990|NCT00252564|565572443|FG000|Overall Study|Lost to Follow-up|1|||
156679991|NCT00252564|565572444|FG001|Overall Study|Lost to Follow-up|0|||
156679992|NCT00252564|565572443|FG000|Overall Study|Patient Request|4|||
156679993|NCT00252564|565572444|FG001|Overall Study|Patient Request|5|||
156679994|NCT00252564|565572443|FG000|Overall Study|Withdrawal by Subject|0|||
156679995|NCT00252564|565572444|FG001|Overall Study|Withdrawal by Subject|2|||
156679996|NCT03141151|565572447|FG000|Overall Study|Lost to Follow-up|3|||
156679997|NCT03141151|565572448|FG001|Overall Study|Lost to Follow-up|2|||
156679998|NCT03141151|565572447|FG000|Overall Study|Withdrawal by Subject|3|||
156679999|NCT03141151|565572448|FG001|Overall Study|Withdrawal by Subject|2|||
156680000|NCT04561115|565572455|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
156680001|NCT04561115|565572456|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
156680002|NCT04561115|565572455|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
156680003|NCT04561115|565572456|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
156680004|NCT04561115|565572455|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
156680005|NCT04561115|565572456|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
156680006|NCT00743145|565572457|FG000|Overall Study|Withdrawal by Subject|1|||
156680007|NCT00743145|565572457|FG000|Overall Study|Adverse Event|2|||
156680008|NCT00743145|565572457|FG000|Overall Study|Pregnancy|1|||
156680009|NCT01097694|565572458|FG000|Overall Study|Adverse Event|5|||
156680010|NCT01097694|565572459|FG001|Overall Study|Adverse Event|0|||
156680011|NCT01097694|565572458|FG000|Overall Study|Lost to Follow-up|0|||
156680012|NCT01097694|565572459|FG001|Overall Study|Lost to Follow-up|3|||
156680013|NCT01097694|565572458|FG000|Overall Study|Withdrawal by Subject|3|||
156680014|NCT01097694|565572459|FG001|Overall Study|Withdrawal by Subject|1|||
156680015|NCT02179190|565572460|FG000|Enrollment|Exit Prior to Device Attempt|11|||
156680016|NCT02179190|565572460|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
156680017|NCT02179190|565572460|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
156680018|NCT02179190|565572460|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
156680019|NCT02179190|565572460|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
156680020|NCT02179190|565572460|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
156680021|NCT01188226|565574408|FG000|Overall Study|Withdrawal by Subject|4|||
156680022|NCT04980456|565574409|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
156680023|NCT04980456|565574410|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
156680024|NCT04980456|565574409|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
156680025|NCT04980456|565574410|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
156680026|NCT04980456|565574409|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
156680027|NCT04980456|565574410|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
156680028|NCT04980456|565574409|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
156680029|NCT04980456|565574410|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
156680030|NCT00442351|565574412|FG000|Overall Study|Administrative|6|||
156680031|NCT00442351|565574413|FG001|Overall Study|Administrative|5|||
156680032|NCT00442351|565574412|FG000|Overall Study|Did not meet protocol eligibility|1|||
156680033|NCT00442351|565574413|FG001|Overall Study|Did not meet protocol eligibility|0|||
156680034|NCT00442351|565574412|FG000|Overall Study|Other|0|||
156680035|NCT00442351|565574413|FG001|Overall Study|Other|1|||
156680036|NCT00500318|565574415|FG000|Overall Study|Adverse Event|3|||
156680037|NCT00500318|565574416|FG001|Overall Study|Adverse Event|8|||
156680038|NCT00500318|565574415|FG000|Overall Study|Protocol Violation|1|||
156680039|NCT00500318|565574416|FG001|Overall Study|Protocol Violation|3|||
156680040|NCT00500318|565574415|FG000|Overall Study|Withdrawal by Subject|1|||
156782764|NCT01658878|565954735|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782765|NCT01658878|565954736|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156329049|NCT03633617|564305524|FG003|Part B|Withdrawal by Subject|0|||
156329050|NCT03633617|564305525|FG004|Part B|Withdrawal by Subject|2|||
156329051|NCT03633617|564305526|FG005|Part B|Withdrawal by Subject|0|||
156329052|NCT03633617|564305527|FG006|Part B|Withdrawal by Subject|0|||
156680041|NCT00500318|565574416|FG001|Overall Study|Withdrawal by Subject|2|||
156680042|NCT00500318|565574415|FG000|Overall Study|Lack of Efficacy|0|||
156680043|NCT00500318|565574416|FG001|Overall Study|Lack of Efficacy|3|||
156680044|NCT00500318|565574415|FG000|Overall Study|Other Reason|0|||
156680045|NCT00500318|565574416|FG001|Overall Study|Other Reason|1|||
156680046|NCT01074008|565574437|FG000|Overall Study|Adverse Event|0|||
156680047|NCT01074008|565574438|FG001|Overall Study|Adverse Event|1|||
156680048|NCT01074008|565574439|FG002|Overall Study|Adverse Event|0|||
156680049|NCT01074008|565574440|FG003|Overall Study|Adverse Event|0|||
156680050|NCT01074008|565574441|FG004|Overall Study|Adverse Event|0|||
156680051|NCT01074008|565574442|FG005|Overall Study|Adverse Event|0|||
156680052|NCT01074008|565574443|FG006|Overall Study|Adverse Event|0|||
156680053|NCT01074008|565574444|FG007|Overall Study|Adverse Event|0|||
156680054|NCT01074008|565574445|FG008|Overall Study|Adverse Event|0|||
156680055|NCT01074008|565574437|FG000|Overall Study|Withdrawal by Subject|1|||
156680056|NCT01074008|565574438|FG001|Overall Study|Withdrawal by Subject|1|||
156680057|NCT01074008|565574439|FG002|Overall Study|Withdrawal by Subject|1|||
156680058|NCT01074008|565574440|FG003|Overall Study|Withdrawal by Subject|0|||
156680059|NCT01074008|565574441|FG004|Overall Study|Withdrawal by Subject|1|||
156680060|NCT01074008|565574442|FG005|Overall Study|Withdrawal by Subject|0|||
156680061|NCT01074008|565574443|FG006|Overall Study|Withdrawal by Subject|0|||
156680062|NCT01074008|565574444|FG007|Overall Study|Withdrawal by Subject|0|||
156680063|NCT01074008|565574445|FG008|Overall Study|Withdrawal by Subject|0|||
156680064|NCT01074008|565574437|FG000|Overall Study|Lost to Follow-up|0|||
156680065|NCT01074008|565574438|FG001|Overall Study|Lost to Follow-up|1|||
156680066|NCT01074008|565574439|FG002|Overall Study|Lost to Follow-up|1|||
156680067|NCT01074008|565574440|FG003|Overall Study|Lost to Follow-up|1|||
156680068|NCT01074008|565574441|FG004|Overall Study|Lost to Follow-up|1|||
156680069|NCT01074008|565574442|FG005|Overall Study|Lost to Follow-up|0|||
156680070|NCT01074008|565574443|FG006|Overall Study|Lost to Follow-up|1|||
156680071|NCT01074008|565574444|FG007|Overall Study|Lost to Follow-up|0|||
156680072|NCT01074008|565574445|FG008|Overall Study|Lost to Follow-up|4|||
156680073|NCT00224484|565574446|FG000|Overall Study|Serious Adverse Event|1|||
156680074|NCT00224484|565574447|FG001|Overall Study|Serious Adverse Event|1|||
156680075|NCT00224484|565574448|FG002|Overall Study|Serious Adverse Event|0|||
156680076|NCT00224484|565574446|FG000|Overall Study|Non-Serious Adverse Event|5|||
156680077|NCT00224484|565574447|FG001|Overall Study|Non-Serious Adverse Event|7|||
156680078|NCT00224484|565574448|FG002|Overall Study|Non-Serious Adverse Event|3|||
156680079|NCT00224484|565574446|FG000|Overall Study|Protocol Violation|2|||
156680080|NCT00224484|565574447|FG001|Overall Study|Protocol Violation|2|||
156680081|NCT00224484|565574448|FG002|Overall Study|Protocol Violation|0|||
156680082|NCT00224484|565574446|FG000|Overall Study|Withdrawal by Subject|49|||
156680083|NCT00224484|565574447|FG001|Overall Study|Withdrawal by Subject|18|||
156680084|NCT00224484|565574448|FG002|Overall Study|Withdrawal by Subject|16|||
156680085|NCT00224484|565574446|FG000|Overall Study|Migrated/moved from study area|18|||
156680086|NCT00224484|565574447|FG001|Overall Study|Migrated/moved from study area|5|||
156680087|NCT00224484|565574448|FG002|Overall Study|Migrated/moved from study area|5|||
156680088|NCT00224484|565574446|FG000|Overall Study|Lost to Follow-up|66|||
156680089|NCT00224484|565574447|FG001|Overall Study|Lost to Follow-up|28|||
156680090|NCT00224484|565574448|FG002|Overall Study|Lost to Follow-up|36|||
156680091|NCT00224484|565574446|FG000|Overall Study|Reason not specified|5|||
156680092|NCT00224484|565574447|FG001|Overall Study|Reason not specified|4|||
156680093|NCT00224484|565574448|FG002|Overall Study|Reason not specified|2|||
156680094|NCT01453153|565574456|FG000|Overall Study|Physician Decision|0|||
156680095|NCT01453153|565574457|FG001|Overall Study|Physician Decision|0|||
156680096|NCT01453153|565574458|FG002|Overall Study|Physician Decision|1|||
156680097|NCT01453153|565574456|FG000|Overall Study|Progressive Disease|3|||
156680098|NCT01453153|565574457|FG001|Overall Study|Progressive Disease|2|||
156680099|NCT01453153|565574458|FG002|Overall Study|Progressive Disease|16|||
156680100|NCT01453153|565574456|FG000|Overall Study|Withdrawal by Subject|0|||
156680101|NCT01453153|565574457|FG001|Overall Study|Withdrawal by Subject|1|||
156680102|NCT01453153|565574458|FG002|Overall Study|Withdrawal by Subject|2|||
156680103|NCT01453153|565574456|FG000|Overall Study|Adverse Event|1|||
156680104|NCT01453153|565574457|FG001|Overall Study|Adverse Event|1|||
156680105|NCT01453153|565574458|FG002|Overall Study|Adverse Event|1|||
156680106|NCT02415387|565574464|FG000|Overall Study|Withdrawal by Subject|6|||
156782766|NCT01658878|565954737|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782767|NCT01658878|565954738|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156808722|NCT03052608|566054440|FG000|Long-Term Follow-up Phase|Ongoing|122|||
156680107|NCT02415387|565574465|FG001|Overall Study|Withdrawal by Subject|1|||
156680108|NCT02415387|565574464|FG000|Overall Study|blood draw problem|0|||
156680109|NCT02415387|565574465|FG001|Overall Study|blood draw problem|1|||
156680110|NCT02415387|565574464|FG000|Overall Study|Protocol Violation|1|||
156680111|NCT02415387|565574465|FG001|Overall Study|Protocol Violation|0|||
156680112|NCT03243396|565574466|FG000|Overall Study|Lost to Follow-up|2|||
156680113|NCT03243396|565574467|FG001|Overall Study|Lost to Follow-up|3|||
156680114|NCT03243396|565574468|FG002|Overall Study|Lost to Follow-up|15|||
156680115|NCT03243396|565574469|FG003|Overall Study|Lost to Follow-up|8|||
156680116|NCT03243396|565574470|FG004|Overall Study|Lost to Follow-up|1|||
156680117|NCT03243396|565574471|FG005|Overall Study|Lost to Follow-up|4|||
156680118|NCT03243396|565574472|FG006|Overall Study|Lost to Follow-up|9|||
156680119|NCT03687242|565574473|FG000|Overall Study|Adverse Event|1|||
156680120|NCT01579006|565574475|FG000|Overall Study|Lack of Efficacy|10|||
156680121|NCT01579006|565574475|FG000|Overall Study|Adverse Event|13|||
156680122|NCT01579006|565574475|FG000|Overall Study|Withdrawal by Subject|5|||
156867072|NCT01746901|566273451|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
156867073|NCT01746901|566273452|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
156867074|NCT01746901|566273453|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
156867075|NCT01746901|566273454|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
156680123|NCT01579006|565574475|FG000|Overall Study|Non-compliance|3|||
156680124|NCT01579006|565574475|FG000|Overall Study|Due to participant's health fund|1|||
156680125|NCT01579006|565574475|FG000|Overall Study|Scheduled surgery|1|||
156680126|NCT02733627|565574477|FG000|Overall Study|Adverse Event|0|||
156680127|NCT02733627|565574478|FG001|Overall Study|Adverse Event|1|||
156680128|NCT02733627|565574479|FG002|Overall Study|Adverse Event|1|||
156680129|NCT02733627|565574480|FG003|Overall Study|Adverse Event|0|||
156680130|NCT02733627|565574477|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
156680131|NCT02733627|565574478|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
156680132|NCT02733627|565574479|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
156680133|NCT02733627|565574480|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
156680134|NCT05393271|565574481|FG000|Overall Study|Physician Decision|0|||
156680135|NCT05393271|565574482|FG001|Overall Study|Physician Decision|0|||
156867076|NCT01746901|566273455|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
156867077|NCT01746901|566273447|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867078|NCT01746901|566273448|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867079|NCT01746901|566273449|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867080|NCT01746901|566273450|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867081|NCT01746901|566273451|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867082|NCT01746901|566273452|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867083|NCT01746901|566273453|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867084|NCT01746901|566273454|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
156867085|NCT01746901|566273455|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867086|NCT01746901|566273447|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867087|NCT01746901|566273448|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
156680136|NCT05393271|565574483|FG002|Overall Study|Physician Decision|0|||
156680137|NCT05393271|565574484|FG003|Overall Study|Physician Decision|0|||
156680138|NCT05393271|565574485|FG004|Overall Study|Physician Decision|0|||
156680139|NCT05393271|565574486|FG005|Overall Study|Physician Decision|0|||
156680140|NCT05393271|565574487|FG006|Overall Study|Physician Decision|1|||
156680141|NCT05393271|565574488|FG007|Overall Study|Physician Decision|0|||
156680142|NCT05393271|565574489|FG008|Overall Study|Physician Decision|0|||
156680143|NCT05393271|565574490|FG009|Overall Study|Physician Decision|0|||
156680144|NCT05393271|565574491|FG010|Overall Study|Physician Decision|0|||
156867088|NCT01746901|566273449|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867089|NCT01746901|566273450|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867090|NCT01746901|566273451|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867091|NCT01746901|566273452|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
156867092|NCT01746901|566273453|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
156867093|NCT01746901|566273454|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867094|NCT01746901|566273455|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
156329053|NCT03633617|564305528|FG007|Part B|Withdrawal by Subject|0|||
156329054|NCT03633617|564305529|FG008|Part B|Withdrawal by Subject|0|||
156329055|NCT03633617|564305530|FG009|Part B|Withdrawal by Subject|0|||
156329056|NCT03633617|564305531|FG010|Part B|Withdrawal by Subject|0|||
156329057|NCT03633617|564305521|FG000|Part B|Lost to Follow-up|0|||
156329058|NCT03633617|564305522|FG001|Part B|Lost to Follow-up|0|||
156329059|NCT03633617|564305523|FG002|Part B|Lost to Follow-up|0|||
156329060|NCT03633617|564305524|FG003|Part B|Lost to Follow-up|0|||
156329061|NCT03633617|564305525|FG004|Part B|Lost to Follow-up|1|||
156329062|NCT03633617|564305526|FG005|Part B|Lost to Follow-up|0|||
156329063|NCT03633617|564305527|FG006|Part B|Lost to Follow-up|0|||
156329064|NCT03633617|564305528|FG007|Part B|Lost to Follow-up|0|||
156329065|NCT03633617|564305529|FG008|Part B|Lost to Follow-up|0|||
156329066|NCT03633617|564305530|FG009|Part B|Lost to Follow-up|0|||
156329067|NCT03633617|564305531|FG010|Part B|Lost to Follow-up|0|||
156329068|NCT03633617|564305521|FG000|Part B|Physician Decision|0|||
156329069|NCT03633617|564305522|FG001|Part B|Physician Decision|0|||
156329070|NCT03633617|564305523|FG002|Part B|Physician Decision|0|||
156329071|NCT03633617|564305524|FG003|Part B|Physician Decision|0|||
156329072|NCT03633617|564305525|FG004|Part B|Physician Decision|1|||
156329073|NCT03633617|564305526|FG005|Part B|Physician Decision|0|||
156329074|NCT03633617|564305527|FG006|Part B|Physician Decision|0|||
156329075|NCT03633617|564305528|FG007|Part B|Physician Decision|0|||
156329076|NCT03633617|564305529|FG008|Part B|Physician Decision|0|||
156329077|NCT03633617|564305530|FG009|Part B|Physician Decision|0|||
156329078|NCT03633617|564305531|FG010|Part B|Physician Decision|0|||
156680145|NCT03167606|565574492|FG000|Overall Study|Lost to Follow-up|73|||
156680146|NCT03167606|565574493|FG001|Overall Study|Lost to Follow-up|64|||
156680147|NCT03167606|565574492|FG000|Overall Study|Withdrawal by Subject|6|||
156680148|NCT03167606|565574493|FG001|Overall Study|Withdrawal by Subject|5|||
156680149|NCT03167606|565574492|FG000|Overall Study|Withdrawal by Investigator|0|||
156680150|NCT03167606|565574493|FG001|Overall Study|Withdrawal by Investigator|2|||
156680151|NCT01698554|565574500|FG000|Overall Study|Adverse Event|2|||
156680152|NCT01698554|565574501|FG001|Overall Study|Adverse Event|5|||
156680153|NCT01698554|565574502|FG002|Overall Study|Adverse Event|0|||
156680154|NCT01698554|565574503|FG003|Overall Study|Adverse Event|1|||
156680155|NCT01698554|565574500|FG000|Overall Study|Lost to Follow-up|1|||
156680156|NCT01698554|565574501|FG001|Overall Study|Lost to Follow-up|0|||
156680157|NCT01698554|565574502|FG002|Overall Study|Lost to Follow-up|0|||
156867095|NCT01746901|566273447|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867096|NCT01746901|566273448|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156680158|NCT01698554|565574503|FG003|Overall Study|Lost to Follow-up|0|||
156680159|NCT01698554|565574500|FG000|Overall Study|Personal Reasons|0|||
156680160|NCT01698554|565574501|FG001|Overall Study|Personal Reasons|5|||
156680161|NCT01698554|565574502|FG002|Overall Study|Personal Reasons|1|||
156680162|NCT01698554|565574503|FG003|Overall Study|Personal Reasons|1|||
156867097|NCT01746901|566273449|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867098|NCT01746901|566273450|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
156867099|NCT01746901|566273451|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867100|NCT01746901|566273452|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867101|NCT01746901|566273453|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867102|NCT01746901|566273454|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867103|NCT01746901|566273455|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867104|NCT01746901|566273447|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867105|NCT01746901|566273448|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867106|NCT01746901|566273449|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867107|NCT01746901|566273450|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867108|NCT01746901|566273451|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867109|NCT01746901|566273452|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
156867110|NCT01746901|566273453|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867111|NCT01746901|566273454|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867112|NCT01746901|566273455|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
156867113|NCT01746901|566273447|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867114|NCT01746901|566273448|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867115|NCT01746901|566273449|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867116|NCT01746901|566273450|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867117|NCT01746901|566273451|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867118|NCT01746901|566273452|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867119|NCT01746901|566273453|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
156867120|NCT01746901|566273454|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867121|NCT01746901|566273455|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
156867122|NCT03041038|566273456|FG000|Overall Study|Withdrawal by Subject|4|||
156867123|NCT03041038|566273457|FG001|Overall Study|Withdrawal by Subject|0|||
156867124|NCT03041038|566273456|FG000|Overall Study|Lost to Follow-up|1|||
156867125|NCT03041038|566273457|FG001|Overall Study|Lost to Follow-up|1|||
156867126|NCT03041038|566273456|FG000|Overall Study|Protocol Violation|1|||
156867127|NCT03041038|566273457|FG001|Overall Study|Protocol Violation|1|||
156867128|NCT00803569|566273458|FG000|Overall Study|Progressive Disease|3|||
156867129|NCT00803569|566273458|FG000|Overall Study|Noncompliance|1|||
156867130|NCT00930046|566273459|FG000|Overall Study|Wound catheter malfunctioned|1|||
156867131|NCT00930046|566273460|FG001|Overall Study|Wound catheter malfunctioned|2|||
156867132|NCT01598532|566273461|FG000|Overall Study|Lost to Follow-up|3|||
156867133|NCT01598532|566273461|FG000|Overall Study|Did not meet inclusion criteria|8|||
156867134|NCT00912808|566273462|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
156867135|NCT00912808|566273463|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
156867136|NCT00912808|566273462|FG000|Washout|Withdrawal by Subject|0|||
156867137|NCT00912808|566273463|FG001|Washout|Withdrawal by Subject|1|||
156680163|NCT01698554|565574500|FG000|Overall Study|Protocol Violation|2|||
156680164|NCT01698554|565574501|FG001|Overall Study|Protocol Violation|0|||
156867138|NCT00912808|566273462|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
156680165|NCT01698554|565574502|FG002|Overall Study|Protocol Violation|1|||
156867139|NCT00912808|566273463|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
156867140|NCT00912808|566273462|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
156867141|NCT00912808|566273463|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
156867142|NCT00702221|566273464|FG000|Overall Study|Adverse Event|4|||
156867143|NCT00702221|566273465|FG001|Overall Study|Adverse Event|3|||
156680166|NCT01698554|565574503|FG003|Overall Study|Protocol Violation|0|||
156680167|NCT01698554|565574500|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156680168|NCT01698554|565574501|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156680169|NCT01698554|565574502|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156867144|NCT02900378|566273466|FG000|Randomization (Visit 2)|Adverse Event|14|||
156867145|NCT02900378|566273467|FG001|Randomization (Visit 2)|Adverse Event|11|||
156867146|NCT02900378|566273466|FG000|Randomization (Visit 2)|Death|1|||
156867147|NCT02900378|566273467|FG001|Randomization (Visit 2)|Death|4|||
156867148|NCT02900378|566273466|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
156867149|NCT02900378|566273467|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
156867150|NCT02900378|566273466|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
156867151|NCT02900378|566273467|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
156867152|NCT02900378|566273466|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
156867153|NCT02900378|566273467|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
156867154|NCT02900378|566273466|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
156867155|NCT02900378|566273467|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
156867156|NCT02900378|566273466|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
156867157|NCT02900378|566273467|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
156867158|NCT03345784|566273472|FG000|Overall Study|Withdrawal by Subject|2|||
156867159|NCT03345784|566273473|FG001|Overall Study|Withdrawal by Subject|1|||
156680170|NCT01698554|565574503|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156680171|NCT00697827|565574504|FG000|Overall Study|enrolled but not treated|2|||
156680172|NCT00697827|565574505|FG001|Overall Study|enrolled but not treated|1|||
156680173|NCT03259165|565574506|FG000|Overall Study|COVID 19 pandemic|1|||
156680174|NCT03259165|565574507|FG001|Overall Study|COVID 19 pandemic|1|||
156680175|NCT03732833|565574514|FG000|Overall Study|Adverse Event|0|||
156680176|NCT03732833|565574515|FG001|Overall Study|Adverse Event|3|||
156680177|NCT03732833|565574516|FG002|Overall Study|Adverse Event|1|||
156680178|NCT03732833|565574514|FG000|Overall Study|Withdrawal by Subject|11|||
156680179|NCT03732833|565574515|FG001|Overall Study|Withdrawal by Subject|13|||
156680180|NCT03732833|565574516|FG002|Overall Study|Withdrawal by Subject|8|||
156680181|NCT03732833|565574514|FG000|Overall Study|Lost to Follow-up|3|||
156680182|NCT03732833|565574515|FG001|Overall Study|Lost to Follow-up|5|||
156680183|NCT03732833|565574516|FG002|Overall Study|Lost to Follow-up|4|||
156680184|NCT03732833|565574514|FG000|Overall Study|Pregnancy|0|||
156680185|NCT03732833|565574515|FG001|Overall Study|Pregnancy|2|||
156680186|NCT03732833|565574516|FG002|Overall Study|Pregnancy|0|||
156680187|NCT03732833|565574514|FG000|Overall Study|Physician Decision|2|||
156680188|NCT03732833|565574515|FG001|Overall Study|Physician Decision|3|||
156680189|NCT03732833|565574516|FG002|Overall Study|Physician Decision|1|||
156680190|NCT03732833|565574514|FG000|Overall Study|Covid-19 related and other reasons|2|||
156680191|NCT03732833|565574515|FG001|Overall Study|Covid-19 related and other reasons|7|||
156680192|NCT03732833|565574516|FG002|Overall Study|Covid-19 related and other reasons|3|||
156680193|NCT02004691|565574517|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
156680194|NCT02004691|565574518|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
156680195|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
156680196|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
156680197|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
156680198|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
156680199|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
156680200|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
156680201|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
156680202|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
156680203|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
156680204|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
156680205|NCT02623218|565574519|FG000|Overall Study|Lost to Follow-up|0|||
156680206|NCT02623218|565574520|FG001|Overall Study|Lost to Follow-up|1|||
156680207|NCT02623218|565574521|FG002|Overall Study|Lost to Follow-up|0|||
156680208|NCT02623218|565574522|FG003|Overall Study|Lost to Follow-up|0|||
156680209|NCT02623218|565574523|FG004|Overall Study|Lost to Follow-up|0|||
156680210|NCT01726803|565574524|FG000|Overall Study|Lost to Follow-up|6|||
156680211|NCT01726803|565574525|FG001|Overall Study|Lost to Follow-up|1|||
156680212|NCT01726803|565574524|FG000|Overall Study|Withdrawal by Subject|1|||
156680213|NCT01726803|565574525|FG001|Overall Study|Withdrawal by Subject|0|||
156329079|NCT03633617|564305521|FG000|Part B|COVID-19 Restrictions|0|||
156329080|NCT03633617|564305522|FG001|Part B|COVID-19 Restrictions|0|||
156329081|NCT03633617|564305523|FG002|Part B|COVID-19 Restrictions|1|||
156867160|NCT01249261|566273474|FG000|Overall Study|Withdrawal by Subject|1|||
156329082|NCT03633617|564305524|FG003|Part B|COVID-19 Restrictions|0|||
156329083|NCT03633617|564305525|FG004|Part B|COVID-19 Restrictions|0|||
156329084|NCT03633617|564305526|FG005|Part B|COVID-19 Restrictions|0|||
156329085|NCT03633617|564305527|FG006|Part B|COVID-19 Restrictions|0|||
156680214|NCT03980522|565574532|FG000|Treatment Period|Adverse Event|1|||
156680215|NCT03980522|565574533|FG001|Treatment Period|Adverse Event|0|||
156680216|NCT03980522|565574534|FG002|Treatment Period|Adverse Event|0|||
156680217|NCT03980522|565574535|FG003|Treatment Period|Adverse Event|0|||
156680218|NCT03980522|565574536|FG004|Treatment Period|Adverse Event|0|||
156680219|NCT01091363|565574537|FG000|Overall Study|Withdrawal by Subject|11|||
156867161|NCT01249261|566273475|FG001|Overall Study|Withdrawal by Subject|0|||
156867162|NCT01055197|566273483|FG000|Overall Study|Protocol Violation|7|||
156529331|NCT01794520|565032621|FG006|Overall Study|Adverse event- not related to progression|0|||
156680220|NCT01091363|565574538|FG001|Overall Study|Withdrawal by Subject|15|||
156680221|NCT01091363|565574537|FG000|Overall Study|Lost to Follow-up|2|||
156680222|NCT01091363|565574538|FG001|Overall Study|Lost to Follow-up|2|||
156680223|NCT00045162|565574539|FG000|Overall Study|Ineligible|12|||
156680224|NCT00045162|565574540|FG001|Overall Study|Ineligible|8|||
156680225|NCT00045162|565574539|FG000|Overall Study|Not treated|7|||
156680226|NCT00045162|565574540|FG001|Overall Study|Not treated|2|||
156680227|NCT00045162|565574539|FG000|Overall Study|Adverse Event|55|||
156680228|NCT00045162|565574540|FG001|Overall Study|Adverse Event|50|||
156680229|NCT00045162|565574539|FG000|Overall Study|Lack of Efficacy|32|||
156680230|NCT00045162|565574540|FG001|Overall Study|Lack of Efficacy|29|||
156680231|NCT00045162|565574539|FG000|Overall Study|Death|10|||
156680232|NCT00045162|565574540|FG001|Overall Study|Death|10|||
156680233|NCT00045162|565574539|FG000|Overall Study|Withdrawal by Subject|5|||
156680234|NCT00045162|565574540|FG001|Overall Study|Withdrawal by Subject|3|||
156680235|NCT00045162|565574539|FG000|Overall Study|Other|21|||
156680236|NCT00045162|565574540|FG001|Overall Study|Other|16|||
156680237|NCT03407729|565574541|FG000|Overall Study|Lost to Follow-up|2|||
156680238|NCT03407729|565574542|FG001|Overall Study|Lost to Follow-up|0|||
156680239|NCT03407729|565574541|FG000|Overall Study|Unable to schedule|0|||
156680240|NCT03407729|565574542|FG001|Overall Study|Unable to schedule|3|||
156680241|NCT00830167|565574545|FG000|Overall Study|Lack of Efficacy|26|||
156680242|NCT00830167|565574546|FG001|Overall Study|Lack of Efficacy|10|||
156680243|NCT00830167|565574545|FG000|Overall Study|Adverse Event|8|||
156680244|NCT00830167|565574546|FG001|Overall Study|Adverse Event|24|||
156680245|NCT00830167|565574545|FG000|Overall Study|Not meeting entrance criteria|2|||
156680246|NCT00830167|565574546|FG001|Overall Study|Not meeting entrance criteria|5|||
156680247|NCT00830167|565574545|FG000|Overall Study|Withdrawal by Subject|2|||
156680248|NCT00830167|565574546|FG001|Overall Study|Withdrawal by Subject|0|||
156680249|NCT00830167|565574545|FG000|Overall Study|Lost to Follow-up|0|||
156680250|NCT00830167|565574546|FG001|Overall Study|Lost to Follow-up|1|||
156782768|NCT01658878|565954739|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782769|NCT01658878|565954740|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782770|NCT01658878|565954741|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
156782771|NCT01658878|565954742|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
156782772|NCT01658878|565954743|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
156782773|NCT01658878|565954744|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
156782774|NCT01658878|565954745|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
156782775|NCT01658878|565954746|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
156782776|NCT01658878|565954747|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782777|NCT01658878|565954748|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
156782778|NCT01658878|565954749|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
156782779|NCT01658878|565954750|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
156782780|NCT01658878|565954751|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782781|NCT01658878|565954752|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
156782782|NCT01658878|565954729|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
156782783|NCT01658878|565954730|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
156782784|NCT01658878|565954731|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
156782785|NCT01658878|565954732|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
156782786|NCT01658878|565954733|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
156782787|NCT01658878|565954734|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
156782788|NCT01658878|565954735|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
156782789|NCT01658878|565954736|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
156782790|NCT01658878|565954737|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
156782791|NCT01658878|565954738|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
156782792|NCT01658878|565954739|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
156782793|NCT01658878|565954740|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
156782794|NCT01658878|565954741|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
156782795|NCT01658878|565954742|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
156782796|NCT01658878|565954743|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
156782797|NCT01658878|565954744|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
156329086|NCT03633617|564305528|FG007|Part B|COVID-19 Restrictions|0|||
156529332|NCT01794520|565032615|FG000|Overall Study|Progressive disease|5|||
156680251|NCT00830167|565574545|FG000|Overall Study|Protocol Violation|0|||
156680252|NCT00830167|565574546|FG001|Overall Study|Protocol Violation|1|||
156680253|NCT00830167|565574545|FG000|Overall Study|Other|2|||
156680254|NCT00830167|565574546|FG001|Overall Study|Other|2|||
156680255|NCT00360490|565574549|FG000|Overall Study|Adverse Event|4|||
156680256|NCT00360490|565574550|FG001|Overall Study|Adverse Event|2|||
156680257|NCT00360490|565574549|FG000|Overall Study|Lost to Follow-up|2|||
156680258|NCT00360490|565574550|FG001|Overall Study|Lost to Follow-up|1|||
156867163|NCT01055197|566273484|FG001|Overall Study|Protocol Violation|2|||
156867164|NCT01055197|566273483|FG000|Overall Study|Withdrawal by Subject|2|||
156867165|NCT01055197|566273484|FG001|Overall Study|Withdrawal by Subject|0|||
156867166|NCT00389610|566273485|FG000|Overall Study|Disease Progression|0|||
156867167|NCT00389610|566273486|FG001|Overall Study|Disease Progression|19|||
156867168|NCT00389610|566273485|FG000|Overall Study|Death|0|||
156867169|NCT00389610|566273486|FG001|Overall Study|Death|1|||
156867170|NCT00389610|566273485|FG000|Overall Study|Physician Decision|0|||
156867171|NCT00389610|566273486|FG001|Overall Study|Physician Decision|1|||
156867172|NCT00389610|566273485|FG000|Overall Study|Withdrawal by Subject|0|||
156867173|NCT00389610|566273486|FG001|Overall Study|Withdrawal by Subject|1|||
156867174|NCT00538902|566273487|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
156867175|NCT00538902|566273488|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
156867176|NCT00538902|566273489|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
156867177|NCT00538902|566273487|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
156867178|NCT00538902|566273488|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
156867179|NCT00538902|566273489|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
156867180|NCT00538902|566273487|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
156867181|NCT00538902|566273488|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
156867182|NCT00538902|566273489|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
156867183|NCT00538902|566273487|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
156867184|NCT00538902|566273488|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
156867185|NCT00538902|566273489|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
156867186|NCT00538902|566273487|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
156867187|NCT00538902|566273488|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
156867188|NCT00538902|566273489|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
156867189|NCT00538902|566273487|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
156867190|NCT00538902|566273488|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
156867191|NCT00538902|566273489|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
156867192|NCT00538902|566273487|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
156867193|NCT00538902|566273488|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
156867194|NCT00538902|566273489|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
156867195|NCT00538902|566273487|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
156867196|NCT00538902|566273488|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
156867197|NCT00538902|566273489|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
156867198|NCT01967940|566273494|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
156867199|NCT01967940|566273495|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
156867200|NCT01967940|566273496|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
156867201|NCT01967940|566273497|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
156867202|NCT01967940|566273494|FG000|Part 2|Adverse Event|0|||
156867203|NCT01967940|566273495|FG001|Part 2|Adverse Event|0|||
156867204|NCT01967940|566273496|FG002|Part 2|Adverse Event|0|||
156867205|NCT01967940|566273497|FG003|Part 2|Adverse Event|1|||
156867206|NCT01967940|566273494|FG000|Part 2|Unknown Reason|0|||
156867207|NCT01967940|566273495|FG001|Part 2|Unknown Reason|0|||
156867208|NCT01967940|566273496|FG002|Part 2|Unknown Reason|0|||
156867209|NCT01967940|566273497|FG003|Part 2|Unknown Reason|1|||
156867210|NCT04109547|566273498|FG000|Overall Study|Withdrawal by Subject|3|||
156867211|NCT04109547|566273499|FG001|Overall Study|Withdrawal by Subject|2|||
156867212|NCT04109547|566273500|FG002|Overall Study|Withdrawal by Subject|6|||
156867213|NCT04109547|566273501|FG003|Overall Study|Withdrawal by Subject|6|||
156867214|NCT04109547|566273498|FG000|Overall Study|Lost to Follow-up|0|||
156680259|NCT00360490|565574549|FG000|Overall Study|Physician Decision|2|||
156680260|NCT00360490|565574550|FG001|Overall Study|Physician Decision|1|||
156680261|NCT00360490|565574549|FG000|Overall Study|Protocol Violation|0|||
156680262|NCT00360490|565574550|FG001|Overall Study|Protocol Violation|4|||
156680263|NCT00360490|565574549|FG000|Overall Study|Withdrawal by Subject|1|||
156680264|NCT00360490|565574550|FG001|Overall Study|Withdrawal by Subject|3|||
156680265|NCT02289820|565574551|FG000|Overall Study|Withdrawal by Subject|2|||
156680266|NCT02289820|565574552|FG001|Overall Study|Withdrawal by Subject|1|||
156680267|NCT02289820|565574553|FG002|Overall Study|Withdrawal by Subject|2|||
156680268|NCT02289820|565574554|FG003|Overall Study|Withdrawal by Subject|1|||
156680269|NCT02289820|565574555|FG004|Overall Study|Withdrawal by Subject|0|||
156680270|NCT02289820|565574556|FG005|Overall Study|Withdrawal by Subject|0|||
156680271|NCT02289820|565574557|FG006|Overall Study|Withdrawal by Subject|1|||
156680272|NCT02289820|565574551|FG000|Overall Study|Death|0|||
156680273|NCT02289820|565574552|FG001|Overall Study|Death|0|||
156867215|NCT04109547|566273499|FG001|Overall Study|Lost to Follow-up|0|||
156867216|NCT04109547|566273500|FG002|Overall Study|Lost to Follow-up|0|||
156867217|NCT04109547|566273501|FG003|Overall Study|Lost to Follow-up|1|||
156867218|NCT04109547|566273498|FG000|Overall Study|Physician Decision|1|||
156867219|NCT04109547|566273499|FG001|Overall Study|Physician Decision|2|||
156867220|NCT04109547|566273500|FG002|Overall Study|Physician Decision|0|||
156867221|NCT04109547|566273501|FG003|Overall Study|Physician Decision|0|||
156867222|NCT01550003|566273502|FG000|Overall Study|Adverse Event|0|||
156867223|NCT01550003|566273503|FG001|Overall Study|Adverse Event|9|||
156867224|NCT01550003|566273504|FG002|Overall Study|Adverse Event|15|||
156867225|NCT01550003|566273502|FG000|Overall Study|Lack of Efficacy|4|||
156867226|NCT01550003|566273503|FG001|Overall Study|Lack of Efficacy|11|||
156867227|NCT01550003|566273504|FG002|Overall Study|Lack of Efficacy|15|||
156867228|NCT01550003|566273502|FG000|Overall Study|Protocol Violation|0|||
156867229|NCT01550003|566273503|FG001|Overall Study|Protocol Violation|3|||
156867230|NCT01550003|566273504|FG002|Overall Study|Protocol Violation|2|||
156867231|NCT01550003|566273502|FG000|Overall Study|Lost to Follow-up|1|||
156867232|NCT01550003|566273503|FG001|Overall Study|Lost to Follow-up|4|||
156867233|NCT01550003|566273504|FG002|Overall Study|Lost to Follow-up|8|||
156867234|NCT01550003|566273502|FG000|Overall Study|Consent withdrawn|2|||
156867235|NCT01550003|566273503|FG001|Overall Study|Consent withdrawn|11|||
156867236|NCT01550003|566273504|FG002|Overall Study|Consent withdrawn|23|||
156867237|NCT01550003|566273502|FG000|Overall Study|Missing|1|||
156867238|NCT01550003|566273503|FG001|Overall Study|Missing|0|||
156867239|NCT01550003|566273504|FG002|Overall Study|Missing|2|||
156867240|NCT01550003|566273502|FG000|Overall Study|Study closure as announced by sponsor|7|||
156867241|NCT01550003|566273503|FG001|Overall Study|Study closure as announced by sponsor|6|||
156867242|NCT01550003|566273504|FG002|Overall Study|Study closure as announced by sponsor|24|||
156867243|NCT01550003|566273502|FG000|Overall Study|Protocol Noncompliance|1|||
156867244|NCT01550003|566273503|FG001|Overall Study|Protocol Noncompliance|0|||
156867245|NCT01550003|566273504|FG002|Overall Study|Protocol Noncompliance|0|||
156867246|NCT01550003|566273502|FG000|Overall Study|Study closure|0|||
156867247|NCT01550003|566273503|FG001|Overall Study|Study closure|1|||
156867248|NCT01550003|566273504|FG002|Overall Study|Study closure|1|||
156680274|NCT02289820|565574553|FG002|Overall Study|Death|1|||
156680275|NCT02289820|565574554|FG003|Overall Study|Death|0|||
156680276|NCT02289820|565574555|FG004|Overall Study|Death|0|||
156680277|NCT02289820|565574556|FG005|Overall Study|Death|0|||
156680278|NCT02289820|565574557|FG006|Overall Study|Death|0|||
156680279|NCT02289820|565574551|FG000|Overall Study|Lost to Follow-up|0|||
156782798|NCT01658878|565954745|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
156867249|NCT01550003|566273502|FG000|Overall Study|Patient reached adulthood|0|||
156867250|NCT01550003|566273503|FG001|Overall Study|Patient reached adulthood|1|||
156680280|NCT02289820|565574552|FG001|Overall Study|Lost to Follow-up|0|||
156782799|NCT01658878|565954746|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
156782800|NCT01658878|565954747|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
156782801|NCT01658878|565954748|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
156782802|NCT01658878|565954749|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
156782803|NCT01658878|565954750|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
156782804|NCT01658878|565954751|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
156782805|NCT01658878|565954752|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
156782806|NCT01658878|565954729|FG000|Treatment Period|Death|0|||
156782807|NCT01658878|565954730|FG001|Treatment Period|Death|0|||
156782808|NCT01658878|565954731|FG002|Treatment Period|Death|0|||
156782809|NCT01658878|565954732|FG003|Treatment Period|Death|0|||
156782810|NCT01658878|565954733|FG004|Treatment Period|Death|0|||
156782811|NCT01658878|565954734|FG005|Treatment Period|Death|0|||
156782812|NCT01658878|565954735|FG006|Treatment Period|Death|0|||
156782813|NCT01658878|565954736|FG007|Treatment Period|Death|0|||
156782814|NCT01658878|565954737|FG008|Treatment Period|Death|0|||
156782815|NCT01658878|565954738|FG009|Treatment Period|Death|0|||
156782816|NCT01658878|565954739|FG010|Treatment Period|Death|0|||
156782817|NCT01658878|565954740|FG011|Treatment Period|Death|0|||
156782818|NCT01658878|565954741|FG012|Treatment Period|Death|1|||
156782819|NCT01658878|565954742|FG013|Treatment Period|Death|0|||
156782820|NCT01658878|565954743|FG014|Treatment Period|Death|0|||
156782821|NCT01658878|565954744|FG015|Treatment Period|Death|0|||
156782822|NCT01658878|565954745|FG016|Treatment Period|Death|1|||
156867251|NCT01550003|566273504|FG002|Overall Study|Patient reached adulthood|0|||
156867252|NCT01550003|566273502|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
156867253|NCT01550003|566273503|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
156867254|NCT01550003|566273504|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
156867255|NCT01550003|566273502|FG000|Overall Study|Sponsor's order|0|||
156867256|NCT01550003|566273503|FG001|Overall Study|Sponsor's order|3|||
156680281|NCT02289820|565574553|FG002|Overall Study|Lost to Follow-up|3|||
156680282|NCT02289820|565574554|FG003|Overall Study|Lost to Follow-up|1|||
156680283|NCT02289820|565574555|FG004|Overall Study|Lost to Follow-up|0|||
156782823|NCT01658878|565954746|FG017|Treatment Period|Death|1|||
156782824|NCT01658878|565954747|FG018|Treatment Period|Death|0|||
156782825|NCT01658878|565954748|FG019|Treatment Period|Death|0|||
156782826|NCT01658878|565954749|FG020|Treatment Period|Death|0|||
156782827|NCT01658878|565954750|FG021|Treatment Period|Death|2|||
156782828|NCT01658878|565954751|FG022|Treatment Period|Death|0|||
156782829|NCT01658878|565954752|FG023|Treatment Period|Death|0|||
156782830|NCT01658878|565954729|FG000|Treatment Period|Adverse Event|0|||
156867257|NCT01550003|566273504|FG002|Overall Study|Sponsor's order|3|||
156867258|NCT01550003|566273502|FG000|Overall Study|Sponsor's decision|1|||
156680284|NCT02289820|565574556|FG005|Overall Study|Lost to Follow-up|1|||
156680285|NCT02289820|565574557|FG006|Overall Study|Lost to Follow-up|1|||
156680286|NCT02289820|565574551|FG000|Overall Study|withdrawal of consent|0|||
156680287|NCT02289820|565574552|FG001|Overall Study|withdrawal of consent|1|||
156680288|NCT02289820|565574553|FG002|Overall Study|withdrawal of consent|0|||
156680289|NCT02289820|565574554|FG003|Overall Study|withdrawal of consent|0|||
156680290|NCT02289820|565574555|FG004|Overall Study|withdrawal of consent|0|||
156680291|NCT02289820|565574556|FG005|Overall Study|withdrawal of consent|0|||
156680292|NCT02289820|565574557|FG006|Overall Study|withdrawal of consent|0|||
156680293|NCT02005276|565574558|FG000|Overall Study|No longer interested|5|||
156680294|NCT02005276|565574559|FG001|Overall Study|No longer interested|2|||
156680295|NCT02005276|565574560|FG002|Overall Study|No longer interested|3|||
156680296|NCT02005276|565574561|FG003|Overall Study|No longer interested|3|||
156680297|NCT02786927|565574568|FG000|Overall Study|Adverse Event|1|||
156680298|NCT02786927|565574568|FG000|Overall Study|Protocol Violation|4|||
156680299|NCT01801917|565574569|FG000|Period 1 - Randomized|Adverse Event|1|||
156680300|NCT01801917|565574570|FG001|Period 1 - Randomized|Adverse Event|0|||
156680301|NCT01801917|565574571|FG002|Period 1 - Randomized|Adverse Event|1|||
156680302|NCT01801917|565574572|FG003|Period 1 - Randomized|Adverse Event|0|||
156680303|NCT03919695|565574573|FG000|3-month Follow-up|Death|1|||
156680304|NCT03919695|565574574|FG001|3-month Follow-up|Death|1|||
156680305|NCT03919695|565574573|FG000|3-month Follow-up|unable to contact|0|||
156680306|NCT03919695|565574574|FG001|3-month Follow-up|unable to contact|3|||
156680307|NCT03919695|565574573|FG000|3-month Follow-up|in prison|0|||
156680308|NCT03919695|565574574|FG001|3-month Follow-up|in prison|1|||
156680309|NCT03919695|565574573|FG000|6-month Follow-up|Death|0|||
156680310|NCT03919695|565574574|FG001|6-month Follow-up|Death|1|||
156680311|NCT03919695|565574573|FG000|6-month Follow-up|Lost to Follow-up|1|||
156680312|NCT03919695|565574574|FG001|6-month Follow-up|Lost to Follow-up|2|||
156680313|NCT03919695|565574573|FG000|6-month Follow-up|in prison|0|||
156680314|NCT03919695|565574574|FG001|6-month Follow-up|in prison|2|||
156680315|NCT03919695|565574573|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
156680316|NCT03919695|565574574|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
156680317|NCT03919695|565574573|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
156680318|NCT03919695|565574574|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
156680319|NCT01688882|565574575|FG000|Overall Study|Adverse Event|1|||
156680320|NCT01688882|565574576|FG001|Overall Study|Adverse Event|0|||
156680321|NCT01688882|565574575|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156680322|NCT01688882|565574576|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156680323|NCT01688882|565574575|FG000|Overall Study|Administrative problems|1|||
156680324|NCT01688882|565574576|FG001|Overall Study|Administrative problems|0|||
156782831|NCT01658878|565954730|FG001|Treatment Period|Adverse Event|0|||
156782832|NCT01658878|565954731|FG002|Treatment Period|Adverse Event|0|||
156782833|NCT01658878|565954732|FG003|Treatment Period|Adverse Event|0|||
156782834|NCT01658878|565954733|FG004|Treatment Period|Adverse Event|0|||
156782835|NCT01658878|565954734|FG005|Treatment Period|Adverse Event|0|||
156782836|NCT01658878|565954735|FG006|Treatment Period|Adverse Event|0|||
156782837|NCT01658878|565954736|FG007|Treatment Period|Adverse Event|0|||
156782838|NCT01658878|565954737|FG008|Treatment Period|Adverse Event|0|||
156782839|NCT01658878|565954738|FG009|Treatment Period|Adverse Event|0|||
156782840|NCT01658878|565954739|FG010|Treatment Period|Adverse Event|0|||
156782841|NCT01658878|565954740|FG011|Treatment Period|Adverse Event|0|||
156782842|NCT01658878|565954741|FG012|Treatment Period|Adverse Event|0|||
156782843|NCT01658878|565954742|FG013|Treatment Period|Adverse Event|0|||
156782844|NCT01658878|565954743|FG014|Treatment Period|Adverse Event|0|||
156782845|NCT01658878|565954744|FG015|Treatment Period|Adverse Event|0|||
156782846|NCT01658878|565954745|FG016|Treatment Period|Adverse Event|10|||
156782847|NCT01658878|565954746|FG017|Treatment Period|Adverse Event|3|||
156680325|NCT02416934|565574578|FG000|Overall Study|given steroids|1|||
156680326|NCT02416934|565574579|FG001|Overall Study|given steroids|2|||
156680327|NCT02416934|565574578|FG000|Overall Study|Lost to Follow-up|0|||
156680328|NCT02416934|565574579|FG001|Overall Study|Lost to Follow-up|2|||
156782848|NCT01658878|565954747|FG018|Treatment Period|Adverse Event|3|||
156782849|NCT01658878|565954748|FG019|Treatment Period|Adverse Event|2|||
156782850|NCT01658878|565954749|FG020|Treatment Period|Adverse Event|3|||
156782851|NCT01658878|565954750|FG021|Treatment Period|Adverse Event|3|||
156680329|NCT02416934|565574578|FG000|Overall Study|Withdrawal by Subject|1|||
156680330|NCT02416934|565574579|FG001|Overall Study|Withdrawal by Subject|0|||
156680331|NCT02416934|565574578|FG000|Overall Study|recruited during continuing renewal proc|0|||
156680332|NCT02416934|565574579|FG001|Overall Study|recruited during continuing renewal proc|1|||
156680333|NCT02416934|565574578|FG000|Overall Study|Protocol Violation|0|||
156680334|NCT02416934|565574579|FG001|Overall Study|Protocol Violation|1|||
156782852|NCT01658878|565954751|FG022|Treatment Period|Adverse Event|4|||
156782853|NCT01658878|565954752|FG023|Treatment Period|Adverse Event|3|||
156782854|NCT01658878|565954729|FG000|Treatment Period|Lost to Follow-up|0|||
156782855|NCT01658878|565954730|FG001|Treatment Period|Lost to Follow-up|0|||
156782856|NCT01658878|565954731|FG002|Treatment Period|Lost to Follow-up|0|||
156782857|NCT01658878|565954732|FG003|Treatment Period|Lost to Follow-up|0|||
156782858|NCT01658878|565954733|FG004|Treatment Period|Lost to Follow-up|0|||
156782859|NCT01658878|565954734|FG005|Treatment Period|Lost to Follow-up|0|||
156782860|NCT01658878|565954735|FG006|Treatment Period|Lost to Follow-up|0|||
156782861|NCT01658878|565954736|FG007|Treatment Period|Lost to Follow-up|0|||
156782862|NCT01658878|565954737|FG008|Treatment Period|Lost to Follow-up|0|||
156782863|NCT01658878|565954738|FG009|Treatment Period|Lost to Follow-up|0|||
156782864|NCT01658878|565954739|FG010|Treatment Period|Lost to Follow-up|0|||
156782865|NCT01658878|565954740|FG011|Treatment Period|Lost to Follow-up|0|||
156782866|NCT01658878|565954741|FG012|Treatment Period|Lost to Follow-up|0|||
156782867|NCT01658878|565954742|FG013|Treatment Period|Lost to Follow-up|0|||
156782868|NCT01658878|565954743|FG014|Treatment Period|Lost to Follow-up|0|||
156782869|NCT01658878|565954744|FG015|Treatment Period|Lost to Follow-up|0|||
156782870|NCT01658878|565954745|FG016|Treatment Period|Lost to Follow-up|1|||
156782871|NCT01658878|565954746|FG017|Treatment Period|Lost to Follow-up|0|||
156782872|NCT01658878|565954747|FG018|Treatment Period|Lost to Follow-up|1|||
156782873|NCT01658878|565954748|FG019|Treatment Period|Lost to Follow-up|1|||
156782874|NCT01658878|565954749|FG020|Treatment Period|Lost to Follow-up|0|||
156782875|NCT01658878|565954750|FG021|Treatment Period|Lost to Follow-up|0|||
156782876|NCT01658878|565954751|FG022|Treatment Period|Lost to Follow-up|1|||
156782877|NCT01658878|565954752|FG023|Treatment Period|Lost to Follow-up|0|||
156782878|NCT05417113|565954758|FG000|Overall Study|Lost to Follow-up|2|||
156782879|NCT05417113|565954759|FG001|Overall Study|Lost to Follow-up|2|||
156782880|NCT00134719|565954760|FG000|Primary Vaccination Phase|Adverse Event|4|||
156782881|NCT00134719|565954761|FG001|Primary Vaccination Phase|Adverse Event|0|||
156782882|NCT00134719|565954762|FG002|Primary Vaccination Phase|Adverse Event|0|||
156782883|NCT00134719|565954760|FG000|Primary Vaccination Phase|Protocol Violation|1|||
156782884|NCT00134719|565954761|FG001|Primary Vaccination Phase|Protocol Violation|0|||
156782885|NCT00134719|565954762|FG002|Primary Vaccination Phase|Protocol Violation|0|||
156782886|NCT00134719|565954760|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
156782887|NCT00134719|565954761|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
156782888|NCT00134719|565954762|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
156782889|NCT00134719|565954760|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
156782890|NCT00134719|565954761|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
156782891|NCT00134719|565954762|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
156782892|NCT00134719|565954760|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
156782893|NCT00134719|565954761|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
156782894|NCT00134719|565954762|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
156782895|NCT00134719|565954760|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
156782896|NCT00134719|565954761|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
156782897|NCT00134719|565954762|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
156782898|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782899|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
156782900|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
156782901|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782902|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782903|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782904|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782905|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
156782906|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782907|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
156782908|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782909|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782910|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782911|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782912|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782913|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782914|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
156782915|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782916|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782917|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156329087|NCT03633617|564305529|FG008|Part B|COVID-19 Restrictions|0|||
156329088|NCT03633617|564305530|FG009|Part B|COVID-19 Restrictions|0|||
156329089|NCT03633617|564305531|FG010|Part B|COVID-19 Restrictions|0|||
156338243|NCT05248867|564336597|FG005|Double-blind Period|Other, not specified|0|||
156782918|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782919|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
156782920|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782921|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782922|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782923|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156808723|NCT03052608|566054441|FG001|Long-Term Follow-up Phase|Ongoing|99|||
156529333|NCT01794520|565032616|FG001|Overall Study|Progressive disease|6|||
156782924|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782925|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782926|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782927|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782928|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
156782929|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782930|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782931|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782932|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782933|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
156782934|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782935|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782936|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782937|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782938|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782939|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782940|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
156782941|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
156782942|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
156782943|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
156782944|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
156782945|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
156782946|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
156782947|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782948|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782949|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782950|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
156782951|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782952|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782953|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782954|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
156782955|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782956|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782957|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782958|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782959|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782960|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782961|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782962|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
156782963|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782964|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782965|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782966|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782967|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782968|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
156782969|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156782970|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156867259|NCT01550003|566273503|FG001|Overall Study|Sponsor's decision|5|||
156329090|NCT03633617|564305521|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329091|NCT03633617|564305522|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329092|NCT03633617|564305523|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
156329093|NCT03633617|564305524|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329094|NCT03633617|564305525|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329095|NCT03633617|564305526|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329096|NCT03633617|564305527|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156529334|NCT01794520|565032617|FG002|Overall Study|Progressive disease|2|||
156529335|NCT01794520|565032618|FG003|Overall Study|Progressive disease|5|||
156782971|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
156782972|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156782973|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156782974|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156782975|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
156782976|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
156782977|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
156680335|NCT02416934|565574578|FG000|Overall Study|surgery started late|0|||
156680336|NCT02416934|565574579|FG001|Overall Study|surgery started late|1|||
156680337|NCT02416934|565574578|FG000|Overall Study|re-operation|1|||
156680338|NCT02416934|565574579|FG001|Overall Study|re-operation|0|||
156680339|NCT00494013|565574582|FG000|Overall Study|Adverse Event|0|||
156680340|NCT00494013|565574583|FG001|Overall Study|Adverse Event|1|||
156680341|NCT00494013|565574582|FG000|Overall Study|Entry Criteria Not Met|1|||
156680342|NCT00494013|565574583|FG001|Overall Study|Entry Criteria Not Met|4|||
156680343|NCT00494013|565574582|FG000|Overall Study|Lost to Follow-up|5|||
156680344|NCT00494013|565574583|FG001|Overall Study|Lost to Follow-up|6|||
156680345|NCT00494013|565574582|FG000|Overall Study|Physician Decision|3|||
156680346|NCT00494013|565574583|FG001|Overall Study|Physician Decision|5|||
156680347|NCT00494013|565574582|FG000|Overall Study|Protocol Violation|8|||
156680348|NCT00494013|565574583|FG001|Overall Study|Protocol Violation|5|||
156680349|NCT00494013|565574582|FG000|Overall Study|Withdrawal by Subject|13|||
156680350|NCT00494013|565574583|FG001|Overall Study|Withdrawal by Subject|14|||
156680351|NCT00494013|565574582|FG000|Overall Study|Sponsor Decision|0|||
156680352|NCT00494013|565574583|FG001|Overall Study|Sponsor Decision|1|||
156680353|NCT00633022|565574584|FG000|Overall Study|Adverse Event|1|||
156680354|NCT00633022|565574585|FG001|Overall Study|Adverse Event|0|||
156680355|NCT00633022|565574586|FG002|Overall Study|Adverse Event|5|||
156867260|NCT01550003|566273504|FG002|Overall Study|Sponsor's decision|4|||
156867261|NCT01550003|566273502|FG000|Overall Study|Subject mother passed away|0|||
156867262|NCT01550003|566273503|FG001|Overall Study|Subject mother passed away|1|||
156867263|NCT01550003|566273504|FG002|Overall Study|Subject mother passed away|0|||
156867264|NCT01550003|566273502|FG000|Overall Study|Discontinuation|0|||
156329097|NCT03633617|564305528|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329098|NCT03633617|564305529|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329099|NCT03633617|564305530|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329100|NCT03633617|564305531|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156329101|NCT03633617|564305521|FG000|Part C (& Follow-up)|Adverse Event|0|||
156329102|NCT03633617|564305522|FG001|Part C (& Follow-up)|Adverse Event|0|||
156329103|NCT03633617|564305523|FG002|Part C (& Follow-up)|Adverse Event|0|||
156329104|NCT03633617|564305524|FG003|Part C (& Follow-up)|Adverse Event|0|||
156329105|NCT03633617|564305525|FG004|Part C (& Follow-up)|Adverse Event|0|||
156329106|NCT03633617|564305526|FG005|Part C (& Follow-up)|Adverse Event|1|||
156329107|NCT03633617|564305527|FG006|Part C (& Follow-up)|Adverse Event|0|||
156329108|NCT03633617|564305528|FG007|Part C (& Follow-up)|Adverse Event|1|||
156329109|NCT03633617|564305529|FG008|Part C (& Follow-up)|Adverse Event|0|||
156329110|NCT03633617|564305530|FG009|Part C (& Follow-up)|Adverse Event|0|||
156329111|NCT03633617|564305531|FG010|Part C (& Follow-up)|Adverse Event|0|||
156329112|NCT03633617|564305521|FG000|Part C (& Follow-up)|Pregnancy|0|||
156329113|NCT03633617|564305522|FG001|Part C (& Follow-up)|Pregnancy|0|||
156329114|NCT03633617|564305523|FG002|Part C (& Follow-up)|Pregnancy|0|||
156329115|NCT03633617|564305524|FG003|Part C (& Follow-up)|Pregnancy|0|||
156329116|NCT03633617|564305525|FG004|Part C (& Follow-up)|Pregnancy|0|||
156329117|NCT03633617|564305526|FG005|Part C (& Follow-up)|Pregnancy|0|||
156329118|NCT03633617|564305527|FG006|Part C (& Follow-up)|Pregnancy|0|||
156329119|NCT03633617|564305528|FG007|Part C (& Follow-up)|Pregnancy|0|||
156329120|NCT03633617|564305529|FG008|Part C (& Follow-up)|Pregnancy|0|||
156329121|NCT03633617|564305530|FG009|Part C (& Follow-up)|Pregnancy|1|||
156329122|NCT03633617|564305531|FG010|Part C (& Follow-up)|Pregnancy|0|||
156329123|NCT03633617|564305521|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
156329124|NCT03633617|564305522|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
156329125|NCT03633617|564305523|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
156329126|NCT03633617|564305524|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
156329127|NCT03633617|564305525|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
156329128|NCT03633617|564305526|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
156329129|NCT03633617|564305527|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
156329130|NCT03633617|564305528|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
156329131|NCT03633617|564305529|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
156329132|NCT03633617|564305530|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
156329133|NCT03633617|564305531|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
156329134|NCT03633617|564305521|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
156329135|NCT03633617|564305522|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
156329136|NCT03633617|564305523|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
156329137|NCT03633617|564305524|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
156329138|NCT03633617|564305525|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
156329139|NCT03633617|564305526|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
156329140|NCT03633617|564305527|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
156329141|NCT03633617|564305528|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
156529336|NCT01794520|565032619|FG004|Overall Study|Progressive disease|27|||
156680356|NCT00633022|565574584|FG000|Overall Study|Physician Decision|0|||
156680357|NCT00633022|565574585|FG001|Overall Study|Physician Decision|1|||
156680358|NCT00633022|565574586|FG002|Overall Study|Physician Decision|0|||
156680359|NCT01751087|565574590|FG000|Overall Study|Withdrawal by Subject|1|||
156680360|NCT01751087|565574591|FG001|Overall Study|Withdrawal by Subject|0|||
156680361|NCT01751087|565574592|FG002|Overall Study|Withdrawal by Subject|0|||
156680362|NCT01751087|565574590|FG000|Overall Study|Physician Decision|0|||
156680363|NCT01751087|565574591|FG001|Overall Study|Physician Decision|0|||
156680364|NCT01751087|565574592|FG002|Overall Study|Physician Decision|1|||
156680365|NCT02293460|565575949|FG000|Overall Study|Protocol Violation|1|||
156680366|NCT02293460|565575949|FG000|Overall Study|Lack of Efficacy|2|||
156680367|NCT02293460|565575949|FG000|Overall Study|Adverse Event|2|||
156680368|NCT02293460|565575949|FG000|Overall Study|Withdrawal by Subject|1|||
156680369|NCT02805309|565575954|FG000|Overall Study|Lost to Follow-up|2|||
156680370|NCT02805309|565575955|FG001|Overall Study|Lost to Follow-up|2|||
156680371|NCT02805309|565575956|FG002|Overall Study|Lost to Follow-up|2|||
156680372|NCT02805309|565575954|FG000|Overall Study|Post-Randomization Exclusion|0|||
156680373|NCT02805309|565575955|FG001|Overall Study|Post-Randomization Exclusion|2|||
156680374|NCT02805309|565575956|FG002|Overall Study|Post-Randomization Exclusion|1|||
156680375|NCT01636934|565575957|FG000|Overall Study|Withdrawal by Subject|3|||
156680376|NCT01636934|565575958|FG001|Overall Study|Withdrawal by Subject|2|||
156680377|NCT01636934|565575957|FG000|Overall Study|Chemo cancel|1|||
156680378|NCT01636934|565575958|FG001|Overall Study|Chemo cancel|0|||
156680379|NCT01636934|565575957|FG000|Overall Study|Too ill to continue|1|||
156680380|NCT01636934|565575958|FG001|Overall Study|Too ill to continue|0|||
156680381|NCT01636934|565575957|FG000|Overall Study|Never started study medication|1|||
156680382|NCT01636934|565575958|FG001|Overall Study|Never started study medication|1|||
156680383|NCT03035890|565575963|FG000|Overall Study|Death|1|||
156680384|NCT00288704|565575967|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
156680385|NCT00288704|565575968|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
156680386|NCT00288704|565575969|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
156680387|NCT00288704|565575967|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
156680388|NCT00288704|565575968|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
156680389|NCT00288704|565575969|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
156680390|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
156680391|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
156680392|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
156680393|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
156680394|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
156680395|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
156680396|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
156680397|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
156680398|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
156680399|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
156680400|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
156680401|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
156680402|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
156680403|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
156680404|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
156680405|NCT02473393|565575970|FG000|Overall Study|Adverse Event|0|||
156680406|NCT02473393|565575971|FG001|Overall Study|Adverse Event|0|||
156680407|NCT02473393|565575972|FG002|Overall Study|Adverse Event|1|||
156680408|NCT02473393|565575973|FG003|Overall Study|Adverse Event|0|||
156680409|NCT02473393|565575970|FG000|Overall Study|Withdrawal by Subject|0|||
156680410|NCT02473393|565575971|FG001|Overall Study|Withdrawal by Subject|0|||
156680411|NCT02473393|565575972|FG002|Overall Study|Withdrawal by Subject|1|||
156680412|NCT02473393|565575973|FG003|Overall Study|Withdrawal by Subject|1|||
156680413|NCT01257581|565575975|FG000|Overall Study|Early Termination|3|||
156680414|NCT01257581|565575976|FG001|Overall Study|Early Termination|1|||
156680415|NCT01257581|565575977|FG002|Overall Study|Early Termination|2|||
156680416|NCT01257581|565575975|FG000|Overall Study|Death|2|||
156680417|NCT01257581|565575976|FG001|Overall Study|Death|2|||
156680418|NCT01257581|565575977|FG002|Overall Study|Death|4|||
156782978|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
156329142|NCT03633617|564305529|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
156680419|NCT01157234|565575978|FG000|Overall Study|Withdrawal by Subject|1|||
156680420|NCT01157234|565575979|FG001|Overall Study|Withdrawal by Subject|0|||
156680421|NCT02048813|565575992|FG000|Overall Study|Still on treatment|279|||
156680422|NCT02048813|565575993|FG001|Overall Study|Still on treatment|0|||
156680423|NCT02048813|565575992|FG000|Overall Study|Adverse Event|40|||
156680424|NCT02048813|565575993|FG001|Overall Study|Adverse Event|38|||
156680425|NCT02048813|565575992|FG000|Overall Study|Disease progression|13|||
156680426|NCT02048813|565575993|FG001|Overall Study|Disease progression|3|||
156680427|NCT02048813|565575992|FG000|Overall Study|Withdrawal by Subject|7|||
156680428|NCT02048813|565575993|FG001|Overall Study|Withdrawal by Subject|8|||
156680429|NCT02048813|565575992|FG000|Overall Study|Death|2|||
156680430|NCT02048813|565575993|FG001|Overall Study|Death|1|||
156680431|NCT02048813|565575992|FG000|Overall Study|Complication|2|||
156680432|NCT02048813|565575993|FG001|Overall Study|Complication|2|||
156680433|NCT02048813|565575992|FG000|Overall Study|Non-protocol therapy|0|||
156680434|NCT02048813|565575993|FG001|Overall Study|Non-protocol therapy|1|||
156680435|NCT02048813|565575992|FG000|Overall Study|Second primary cancer|2|||
156680436|NCT02048813|565575993|FG001|Overall Study|Second primary cancer|0|||
156680437|NCT02048813|565575992|FG000|Overall Study|Insurance|2|||
156680438|NCT02048813|565575993|FG001|Overall Study|Insurance|0|||
156680439|NCT02048813|565575992|FG000|Overall Study|Wound infection/healing|2|||
156680440|NCT02048813|565575993|FG001|Overall Study|Wound infection/healing|0|||
156680441|NCT02048813|565575992|FG000|Overall Study|Missed appointment|3|||
156680442|NCT02048813|565575993|FG001|Overall Study|Missed appointment|0|||
156680443|NCT02048813|565575992|FG000|Overall Study|Never started treatment|2|||
156680444|NCT02048813|565575993|FG001|Overall Study|Never started treatment|17|||
156680445|NCT01708954|565575994|FG000|Step 1|Disease progression|26|||
156680446|NCT01708954|565575995|FG001|Step 1|Disease progression|17|||
156680447|NCT01708954|565575996|FG002|Step 1|Disease progression|14|||
156680448|NCT01708954|565575994|FG000|Step 1|Adverse Event|3|||
156680449|NCT01708954|565575995|FG001|Step 1|Adverse Event|11|||
156680450|NCT01708954|565575996|FG002|Step 1|Adverse Event|13|||
156680451|NCT01708954|565575994|FG000|Step 1|Death|3|||
156680452|NCT01708954|565575995|FG001|Step 1|Death|2|||
156680453|NCT01708954|565575996|FG002|Step 1|Death|3|||
156680454|NCT01708954|565575994|FG000|Step 1|Withdrawal by Subject|2|||
156680455|NCT01708954|565575995|FG001|Step 1|Withdrawal by Subject|5|||
156680456|NCT01708954|565575996|FG002|Step 1|Withdrawal by Subject|3|||
156680457|NCT01708954|565575994|FG000|Step 1|Other complicating disease|0|||
156680458|NCT01708954|565575995|FG001|Step 1|Other complicating disease|2|||
156680459|NCT01708954|565575996|FG002|Step 1|Other complicating disease|0|||
156680460|NCT01708954|565575994|FG000|Step 1|Crossed over to Step 2|2|||
156680461|NCT01708954|565575995|FG001|Step 1|Crossed over to Step 2|0|||
156680462|NCT01708954|565575996|FG002|Step 1|Crossed over to Step 2|0|||
156680463|NCT01708954|565575994|FG000|Step 1|Symptomatic deterioration|1|||
156680464|NCT01708954|565575995|FG001|Step 1|Symptomatic deterioration|0|||
156680465|NCT01708954|565575996|FG002|Step 1|Symptomatic deterioration|1|||
156680466|NCT01708954|565575994|FG000|Step 1|Off-treatment reason not submitted|1|||
156680467|NCT01708954|565575995|FG001|Step 1|Off-treatment reason not submitted|1|||
156680468|NCT01708954|565575996|FG002|Step 1|Off-treatment reason not submitted|1|||
156680469|NCT01708954|565575994|FG000|Step 1|Ineligible or never received treatment|4|||
156680470|NCT01708954|565575995|FG001|Step 1|Ineligible or never received treatment|2|||
156680471|NCT01708954|565575996|FG002|Step 1|Ineligible or never received treatment|8|||
156782979|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
156782980|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
156782981|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
156782982|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
156782983|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
156782984|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
156782985|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
156782986|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
156782987|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
156782988|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
156782989|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
156782990|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
156782991|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
156782992|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
156782993|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
156782994|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
156782995|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
156782996|NCT01807520|565954763|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156782997|NCT01807520|565954764|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156782998|NCT01807520|565954765|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156782999|NCT01807520|565954766|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156329143|NCT03633617|564305530|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
156529337|NCT01794520|565032620|FG005|Overall Study|Progressive disease|18|||
156529338|NCT01794520|565032621|FG006|Overall Study|Progressive disease|0|||
156680472|NCT01708954|565575994|FG000|Step 2|Disease progression|9|||
156529339|NCT01794520|565032615|FG000|Overall Study|Withdrew consent|0|||
156680473|NCT01708954|565575995|FG001|Step 2|Disease progression|4|||
156680474|NCT01708954|565575996|FG002|Step 2|Disease progression|0|||
156680475|NCT01708954|565575994|FG000|Step 2|Adverse Event|3|||
156680476|NCT01708954|565575995|FG001|Step 2|Adverse Event|2|||
156680477|NCT01708954|565575996|FG002|Step 2|Adverse Event|0|||
156680478|NCT01708954|565575994|FG000|Step 2|Withdrawal by Subject|1|||
156680479|NCT01708954|565575995|FG001|Step 2|Withdrawal by Subject|1|||
156680480|NCT01708954|565575996|FG002|Step 2|Withdrawal by Subject|0|||
156680481|NCT05996198|565575997|FG000|Overall Study|Withdrawal by Subject|1|||
156680482|NCT05996198|565575998|FG001|Overall Study|Withdrawal by Subject|0|||
156867265|NCT01550003|566273503|FG001|Overall Study|Discontinuation|1|||
156680483|NCT01192776|565575999|FG000|Overall Study|Death|8|||
156680484|NCT01192776|565576000|FG001|Overall Study|Death|15|||
156680485|NCT01192776|565576001|FG002|Overall Study|Death|18|||
156680486|NCT01192776|565576002|FG003|Overall Study|Death|15|||
156680487|NCT01192776|565575999|FG000|Overall Study|Lost to Follow-up|3|||
156680488|NCT01192776|565576000|FG001|Overall Study|Lost to Follow-up|6|||
156680489|NCT01192776|565576001|FG002|Overall Study|Lost to Follow-up|3|||
156680490|NCT01192776|565576002|FG003|Overall Study|Lost to Follow-up|5|||
156680491|NCT00059332|565576006|FG000|Overall Study|Withdrawal by Subject|2|||
156680492|NCT00059332|565576007|FG001|Overall Study|Withdrawal by Subject|1|||
156680493|NCT00059332|565576006|FG000|Overall Study|Lost to Follow-up|1|||
156680494|NCT00059332|565576007|FG001|Overall Study|Lost to Follow-up|1|||
156680495|NCT00981799|565576010|FG000|Overall Study|Adverse Event|1|||
156680496|NCT00981799|565576011|FG001|Overall Study|Adverse Event|1|||
156783000|NCT01807520|565954767|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156783001|NCT01807520|565954768|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
156783002|NCT01807520|565954769|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156783003|NCT01807520|565954763|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783004|NCT01807520|565954764|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156867266|NCT01550003|566273504|FG002|Overall Study|Discontinuation|0|||
156867267|NCT01550003|566273502|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
156867268|NCT01550003|566273503|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
156867269|NCT01550003|566273504|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
156867270|NCT01550003|566273502|FG000|Overall Study|Site closure|0|||
156867271|NCT01550003|566273503|FG001|Overall Study|Site closure|2|||
156867272|NCT01550003|566273504|FG002|Overall Study|Site closure|0|||
156867273|NCT01550003|566273502|FG000|Overall Study|Pregnancy|0|||
156867274|NCT01550003|566273503|FG001|Overall Study|Pregnancy|1|||
156783005|NCT01807520|565954765|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783006|NCT01807520|565954766|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783007|NCT01807520|565954767|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783008|NCT01807520|565954768|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
156783009|NCT01807520|565954769|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783010|NCT01807520|565954763|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783011|NCT01807520|565954764|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783012|NCT01807520|565954765|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783013|NCT01807520|565954766|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783014|NCT01807520|565954767|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783015|NCT01807520|565954768|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
156783016|NCT01807520|565954769|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
156783017|NCT03928704|565954773|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783018|NCT03928704|565954774|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
156783019|NCT03928704|565954775|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783020|NCT03928704|565954776|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783021|NCT03928704|565954777|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783022|NCT03928704|565954778|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783023|NCT03928704|565954773|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
156783024|NCT03928704|565954774|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783025|NCT03928704|565954775|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783026|NCT03928704|565954776|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783027|NCT03928704|565954777|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783028|NCT03928704|565954778|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783029|NCT03928704|565954773|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
156783030|NCT03928704|565954774|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156783031|NCT03928704|565954775|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156783032|NCT03928704|565954776|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156867275|NCT01550003|566273504|FG002|Overall Study|Pregnancy|0|||
156867276|NCT01550003|566273502|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
156867277|NCT01550003|566273503|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
156867278|NCT01550003|566273504|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
156867279|NCT01550003|566273502|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
156680497|NCT00981799|565576012|FG002|Overall Study|Adverse Event|0|||
156783033|NCT03928704|565954777|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156867280|NCT01550003|566273503|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
156867281|NCT01550003|566273504|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
156680498|NCT00981799|565576013|FG003|Overall Study|Adverse Event|0|||
156680499|NCT03422068|565576016|FG000|Overall Study|Adverse Event|0|||
156680500|NCT03422068|565576017|FG001|Overall Study|Adverse Event|1|||
156680501|NCT03422068|565576016|FG000|Overall Study|Inconvenience to frequent study visits|0|||
156680502|NCT03422068|565576017|FG001|Overall Study|Inconvenience to frequent study visits|1|||
156680503|NCT02985398|565576018|FG000|Overall Study|Adverse Event|1|||
156680504|NCT02985398|565576018|FG000|Overall Study|Lost to Follow-up|4|||
156680505|NCT02985398|565576018|FG000|Overall Study|Withdrawal by Subject|8|||
156680506|NCT02985398|565576018|FG000|Overall Study|Study Burden|9|||
156680507|NCT01970592|565576023|FG000|Overall Study|Withdrawal by Subject|4|||
156680508|NCT01970592|565576023|FG000|Overall Study|Physician Decision|1|||
156329144|NCT03633617|564305531|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
156329145|NCT03633617|564305521|FG000|Part C (& Follow-up)|Physician Decision|0|||
156329146|NCT03633617|564305522|FG001|Part C (& Follow-up)|Physician Decision|0|||
156329147|NCT03633617|564305523|FG002|Part C (& Follow-up)|Physician Decision|0|||
156329148|NCT03633617|564305524|FG003|Part C (& Follow-up)|Physician Decision|0|||
156680509|NCT01970592|565576023|FG000|Overall Study|Adverse Event|1|||
156680510|NCT01320722|565576024|FG000|Overall Study|Did not Receive Intervention|3|||
156680511|NCT01320722|565576025|FG001|Overall Study|Did not Receive Intervention|2|||
156680512|NCT01320722|565576026|FG002|Overall Study|Did not Receive Intervention|1|||
156680513|NCT01320722|565576027|FG003|Overall Study|Did not Receive Intervention|1|||
156680514|NCT01320722|565576028|FG004|Overall Study|Did not Receive Intervention|2|||
156680515|NCT01320722|565576024|FG000|Overall Study|Lost to Follow-up|0|||
156680516|NCT01320722|565576025|FG001|Overall Study|Lost to Follow-up|1|||
156680517|NCT01320722|565576026|FG002|Overall Study|Lost to Follow-up|0|||
156680518|NCT01320722|565576027|FG003|Overall Study|Lost to Follow-up|1|||
156680519|NCT01320722|565576028|FG004|Overall Study|Lost to Follow-up|3|||
156680520|NCT01320722|565576024|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
156680521|NCT01320722|565576025|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
156680522|NCT01320722|565576026|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
156680523|NCT01320722|565576027|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
156680524|NCT01320722|565576028|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
156680525|NCT01320722|565576024|FG000|Overall Study|Participant Developed a Rash|0|||
156680526|NCT01320722|565576025|FG001|Overall Study|Participant Developed a Rash|0|||
156680527|NCT01320722|565576026|FG002|Overall Study|Participant Developed a Rash|2|||
156680528|NCT01320722|565576027|FG003|Overall Study|Participant Developed a Rash|1|||
156329149|NCT03633617|564305525|FG004|Part C (& Follow-up)|Physician Decision|0|||
156329150|NCT03633617|564305526|FG005|Part C (& Follow-up)|Physician Decision|0|||
156329151|NCT03633617|564305527|FG006|Part C (& Follow-up)|Physician Decision|0|||
156680529|NCT01320722|565576028|FG004|Overall Study|Participant Developed a Rash|1|||
156680530|NCT01320722|565576024|FG000|Overall Study|Non-compliant with Medication|0|||
156329152|NCT03633617|564305528|FG007|Part C (& Follow-up)|Physician Decision|1|||
156329153|NCT03633617|564305529|FG008|Part C (& Follow-up)|Physician Decision|0|||
156329154|NCT03633617|564305530|FG009|Part C (& Follow-up)|Physician Decision|0|||
156329155|NCT03633617|564305531|FG010|Part C (& Follow-up)|Physician Decision|1|||
156329156|NCT03633617|564305521|FG000|Part C (& Follow-up)|COVID-19 related|0|||
156329157|NCT03633617|564305522|FG001|Part C (& Follow-up)|COVID-19 related|0|||
156329158|NCT03633617|564305523|FG002|Part C (& Follow-up)|COVID-19 related|0|||
156329159|NCT03633617|564305524|FG003|Part C (& Follow-up)|COVID-19 related|0|||
156329160|NCT03633617|564305525|FG004|Part C (& Follow-up)|COVID-19 related|0|||
156329161|NCT03633617|564305526|FG005|Part C (& Follow-up)|COVID-19 related|1|||
156329162|NCT03633617|564305527|FG006|Part C (& Follow-up)|COVID-19 related|0|||
156329163|NCT03633617|564305528|FG007|Part C (& Follow-up)|COVID-19 related|0|||
156329164|NCT03633617|564305529|FG008|Part C (& Follow-up)|COVID-19 related|0|||
156329165|NCT03633617|564305530|FG009|Part C (& Follow-up)|COVID-19 related|0|||
156329166|NCT03633617|564305531|FG010|Part C (& Follow-up)|COVID-19 related|0|||
156329167|NCT03633617|564305521|FG000|Part C (& Follow-up)|Protocol Violation|0|||
156329168|NCT03633617|564305522|FG001|Part C (& Follow-up)|Protocol Violation|0|||
156329169|NCT03633617|564305523|FG002|Part C (& Follow-up)|Protocol Violation|0|||
156329170|NCT03633617|564305524|FG003|Part C (& Follow-up)|Protocol Violation|0|||
156329171|NCT03633617|564305525|FG004|Part C (& Follow-up)|Protocol Violation|0|||
156329172|NCT03633617|564305526|FG005|Part C (& Follow-up)|Protocol Violation|0|||
156329173|NCT03633617|564305527|FG006|Part C (& Follow-up)|Protocol Violation|0|||
156329174|NCT03633617|564305528|FG007|Part C (& Follow-up)|Protocol Violation|0|||
156329175|NCT03633617|564305529|FG008|Part C (& Follow-up)|Protocol Violation|0|||
156329176|NCT03633617|564305530|FG009|Part C (& Follow-up)|Protocol Violation|3|||
156329177|NCT03633617|564305531|FG010|Part C (& Follow-up)|Protocol Violation|1|||
156329178|NCT03633617|564305521|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
156329179|NCT03633617|564305522|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
156329180|NCT03633617|564305523|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
156329181|NCT03633617|564305524|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
156329182|NCT03633617|564305525|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
156329183|NCT03633617|564305526|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
156329184|NCT03633617|564305527|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
156680531|NCT01320722|565576025|FG001|Overall Study|Non-compliant with Medication|0|||
156680532|NCT01320722|565576026|FG002|Overall Study|Non-compliant with Medication|1|||
156680533|NCT01320722|565576027|FG003|Overall Study|Non-compliant with Medication|0|||
156680534|NCT01320722|565576028|FG004|Overall Study|Non-compliant with Medication|0|||
156783034|NCT03928704|565954778|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156783035|NCT03928704|565954773|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
156783036|NCT03928704|565954774|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
156783037|NCT03928704|565954775|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
156783038|NCT03928704|565954776|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
156783039|NCT03928704|565954777|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
156783040|NCT03928704|565954778|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
156783041|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783042|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783043|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
156783044|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783045|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783046|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783047|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783048|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783049|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
156783050|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783051|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783052|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783053|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
156783054|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
156783055|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
156783056|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
156783057|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
156783058|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
156783059|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783060|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783061|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
156783062|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783063|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783064|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783065|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783066|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783067|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783068|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783069|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783070|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
156783071|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783072|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783073|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783074|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783075|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783076|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
156783077|NCT01631188|565954779|FG000|Overall Study|Physician Decision|75|||
156783078|NCT04575324|565954782|FG000|Overall Study|Lost to Follow-up|29|||
156783079|NCT04575324|565954783|FG001|Overall Study|Lost to Follow-up|25|||
156783080|NCT04575324|565954782|FG000|Overall Study|Death|1|||
156783081|NCT04575324|565954783|FG001|Overall Study|Death|2|||
156783082|NCT04575324|565954782|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
156783083|NCT04575324|565954783|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
156783084|NCT02582632|565954785|FG000|Overall Study|Other|1|||
156783085|NCT00327171|565954786|FG000|Overall Study|Did not receive study medication|3|||
156783086|NCT00327171|565954787|FG001|Overall Study|Did not receive study medication|0|||
156783087|NCT00327171|565954786|FG000|Overall Study|Adverse Event|23|||
156783088|NCT00327171|565954787|FG001|Overall Study|Adverse Event|23|||
156329185|NCT03633617|564305528|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
156329186|NCT03633617|564305529|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
156329187|NCT03633617|564305530|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
156329188|NCT03633617|564305531|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
156329189|NCT01890746|564305532|FG000|Overall Study|Death|39|||
156329190|NCT01890746|564305533|FG001|Overall Study|Death|30|||
156329191|NCT01890746|564305532|FG000|Overall Study|Adverse Event|1|||
156329192|NCT01890746|564305533|FG001|Overall Study|Adverse Event|0|||
156329193|NCT01890746|564305532|FG000|Overall Study|Lost to Follow-up|4|||
156329194|NCT01890746|564305533|FG001|Overall Study|Lost to Follow-up|1|||
156329195|NCT01890746|564305532|FG000|Overall Study|Physician Decision|3|||
156329196|NCT01890746|564305533|FG001|Overall Study|Physician Decision|2|||
156329197|NCT01890746|564305532|FG000|Overall Study|Withdrawal by Subject|5|||
156529340|NCT01794520|565032616|FG001|Overall Study|Withdrew consent|0|||
156680535|NCT01320722|565576024|FG000|Overall Study|Adverse Event|0|||
156680536|NCT01320722|565576025|FG001|Overall Study|Adverse Event|0|||
156680537|NCT01320722|565576026|FG002|Overall Study|Adverse Event|3|||
156680538|NCT01320722|565576027|FG003|Overall Study|Adverse Event|6|||
156680539|NCT01320722|565576028|FG004|Overall Study|Adverse Event|0|||
156680540|NCT01320722|565576024|FG000|Overall Study|Not Compliant with Study Procedures|0|||
156680541|NCT01320722|565576025|FG001|Overall Study|Not Compliant with Study Procedures|0|||
156680542|NCT01320722|565576026|FG002|Overall Study|Not Compliant with Study Procedures|0|||
156680543|NCT01320722|565576027|FG003|Overall Study|Not Compliant with Study Procedures|4|||
156680544|NCT01320722|565576028|FG004|Overall Study|Not Compliant with Study Procedures|0|||
156680545|NCT01320722|565576024|FG000|Overall Study|Pregnancy|0|||
156680546|NCT01320722|565576025|FG001|Overall Study|Pregnancy|0|||
156680547|NCT01320722|565576026|FG002|Overall Study|Pregnancy|0|||
156680548|NCT01320722|565576027|FG003|Overall Study|Pregnancy|1|||
156680549|NCT01320722|565576028|FG004|Overall Study|Pregnancy|0|||
156680550|NCT01320722|565576024|FG000|Overall Study|Started an Exclusionary Medication|0|||
156680551|NCT01320722|565576025|FG001|Overall Study|Started an Exclusionary Medication|0|||
156680552|NCT01320722|565576026|FG002|Overall Study|Started an Exclusionary Medication|0|||
156680553|NCT01320722|565576027|FG003|Overall Study|Started an Exclusionary Medication|0|||
156680554|NCT01320722|565576028|FG004|Overall Study|Started an Exclusionary Medication|1|||
156680555|NCT01320722|565576024|FG000|Overall Study|Withdrew due to Health Condition|0|||
156680556|NCT01320722|565576025|FG001|Overall Study|Withdrew due to Health Condition|0|||
156680557|NCT01320722|565576026|FG002|Overall Study|Withdrew due to Health Condition|0|||
156680558|NCT01320722|565576027|FG003|Overall Study|Withdrew due to Health Condition|0|||
156680559|NCT01320722|565576028|FG004|Overall Study|Withdrew due to Health Condition|1|||
156680560|NCT00160524|565576029|FG000|Overall Study|Adverse Event|119|||
156680561|NCT00160524|565576029|FG000|Overall Study|Adverse Event and Other|94|||
156680562|NCT00160524|565576029|FG000|Overall Study|Protocol Violation|16|||
156680563|NCT00160524|565576029|FG000|Overall Study|Protocol Violation and Other|2|||
156680564|NCT00160524|565576029|FG000|Overall Study|Withdrawal by Subject|141|||
156680565|NCT00160524|565576029|FG000|Overall Study|Withdrawal by Subject and Other|17|||
156680566|NCT00160524|565576029|FG000|Overall Study|Physician Decision|27|||
156680567|NCT00160524|565576029|FG000|Overall Study|Physician Decision and Other|6|||
156680568|NCT00160524|565576029|FG000|Overall Study|Lost to Follow-up|13|||
156680569|NCT00160524|565576029|FG000|Overall Study|Lost to Follow-up and Other|1|||
156680570|NCT00160524|565576029|FG000|Overall Study|Lack of Efficacy|21|||
156680571|NCT00160524|565576029|FG000|Overall Study|Lack of Efficacy and Other|1|||
156680572|NCT00160524|565576029|FG000|Overall Study|Other|20|||
156680573|NCT04892147|565576034|FG000|Overall Study|Withdrawal by Subject|2|||
156783089|NCT00327171|565954786|FG000|Overall Study|Disease progression/lack of efficacy|68|||
156783090|NCT00327171|565954787|FG001|Overall Study|Disease progression/lack of efficacy|69|||
156783091|NCT00327171|565954786|FG000|Overall Study|Investigator/participant request|1|||
156783092|NCT00327171|565954787|FG001|Overall Study|Investigator/participant request|8|||
156783093|NCT00327171|565954786|FG000|Overall Study|Clinical progression|12|||
156783094|NCT00327171|565954787|FG001|Overall Study|Clinical progression|8|||
156783095|NCT00327171|565954786|FG000|Overall Study|Undisclosed history of ischemia|0|||
156783096|NCT00327171|565954787|FG001|Overall Study|Undisclosed history of ischemia|1|||
156783097|NCT00327171|565954786|FG000|Overall Study|Other|1|||
156783098|NCT00327171|565954787|FG001|Overall Study|Other|0|||
156783099|NCT01771913|565954788|FG000|Overall Study|Withdrawal by Subject|1|||
156783100|NCT01771913|565954789|FG001|Overall Study|Withdrawal by Subject|0|||
156783101|NCT01363440|565954790|FG000|Overall Study|Adverse Event|5|||
156783102|NCT01363440|565954791|FG001|Overall Study|Adverse Event|4|||
156783103|NCT01363440|565954792|FG002|Overall Study|Adverse Event|4|||
156783104|NCT01363440|565954790|FG000|Overall Study|Death|3|||
156783105|NCT01363440|565954791|FG001|Overall Study|Death|7|||
156783106|NCT01363440|565954792|FG002|Overall Study|Death|5|||
156783107|NCT01363440|565954790|FG000|Overall Study|Withdrawal by Subject|9|||
156783108|NCT01363440|565954791|FG001|Overall Study|Withdrawal by Subject|11|||
156783109|NCT01363440|565954792|FG002|Overall Study|Withdrawal by Subject|11|||
156783110|NCT01363440|565954790|FG000|Overall Study|Lost to Follow-up|2|||
156680574|NCT04892147|565576035|FG001|Overall Study|Withdrawal by Subject|0|||
156783111|NCT01363440|565954791|FG001|Overall Study|Lost to Follow-up|4|||
156783112|NCT01363440|565954792|FG002|Overall Study|Lost to Follow-up|5|||
156783113|NCT01363440|565954790|FG000|Overall Study|Other|4|||
156783114|NCT01363440|565954791|FG001|Overall Study|Other|5|||
156783115|NCT01363440|565954792|FG002|Overall Study|Other|2|||
156783116|NCT00992836|565954793|FG000|Overall Study|Lost to Follow-up|1|||
156783117|NCT00992836|565954793|FG000|Overall Study|Withdrawal by Subject|2|||
156680575|NCT01215721|565576037|FG000|Overall Study|Adverse Event|2|||
156680576|NCT01044433|565576038|FG000|Overall Study|Lost to Follow-up|3|||
156680577|NCT01044433|565576038|FG000|Overall Study|Withdrawal by Subject|3|||
156680578|NCT00826241|565576039|FG000|Overall Study|Withdrawal from Follow-up|1|||
156680579|NCT00826241|565576039|FG000|Overall Study|Withdrew consent|2|||
156680580|NCT00826241|565576039|FG000|Overall Study|Death|4|||
156680581|NCT00826241|565576039|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
156680582|NCT00826241|565576039|FG000|Overall Study|Non-compliance|1|||
156867282|NCT01550003|566273502|FG000|Overall Study|Switching to adult rheumatologist|0|||
156867283|NCT01550003|566273503|FG001|Overall Study|Switching to adult rheumatologist|0|||
156867284|NCT01550003|566273504|FG002|Overall Study|Switching to adult rheumatologist|1|||
156867285|NCT01550003|566273502|FG000|Overall Study|Patient transition to adult care|0|||
156867286|NCT01550003|566273503|FG001|Overall Study|Patient transition to adult care|0|||
156867287|NCT01550003|566273504|FG002|Overall Study|Patient transition to adult care|1|||
156867288|NCT01550003|566273502|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
156867289|NCT01550003|566273503|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
156867290|NCT01550003|566273504|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
156867291|NCT01550003|566273502|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
156867292|NCT01550003|566273503|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
156867293|NCT01550003|566273504|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
156867294|NCT01550003|566273502|FG000|Overall Study|Per Sponsor request|1|||
156867295|NCT01550003|566273503|FG001|Overall Study|Per Sponsor request|0|||
156867296|NCT01550003|566273504|FG002|Overall Study|Per Sponsor request|1|||
156867297|NCT01550003|566273502|FG000|Overall Study|Patient not compliance|0|||
156867298|NCT01550003|566273503|FG001|Overall Study|Patient not compliance|0|||
156867299|NCT01550003|566273504|FG002|Overall Study|Patient not compliance|1|||
156867300|NCT01550003|566273502|FG000|Overall Study|Non-compliance|0|||
156867301|NCT01550003|566273503|FG001|Overall Study|Non-compliance|0|||
156867302|NCT01550003|566273504|FG002|Overall Study|Non-compliance|1|||
156867303|NCT01550003|566273502|FG000|Overall Study|Study closed|0|||
156867304|NCT01550003|566273503|FG001|Overall Study|Study closed|1|||
156867305|NCT01550003|566273504|FG002|Overall Study|Study closed|0|||
156867306|NCT01550003|566273502|FG000|Overall Study|Transitioned to adult rheumatology|0|||
156867307|NCT01550003|566273503|FG001|Overall Study|Transitioned to adult rheumatology|0|||
156867308|NCT01550003|566273504|FG002|Overall Study|Transitioned to adult rheumatology|1|||
156867309|NCT05567783|566273505|FG000|Overall Study|Death|2|||
156867310|NCT05567783|566273506|FG001|Overall Study|Death|3|||
156867311|NCT05567783|566273507|FG002|Overall Study|Death|0|||
156867312|NCT05567783|566273505|FG000|Overall Study|Lost to Follow-up|25|||
156867313|NCT05567783|566273506|FG001|Overall Study|Lost to Follow-up|19|||
156867314|NCT05567783|566273507|FG002|Overall Study|Lost to Follow-up|17|||
156867315|NCT05567783|566273505|FG000|Overall Study|Physician Decision|10|||
156867316|NCT05567783|566273506|FG001|Overall Study|Physician Decision|7|||
156867317|NCT05567783|566273507|FG002|Overall Study|Physician Decision|9|||
156867318|NCT05567783|566273505|FG000|Overall Study|Study Terminated by Sponsor|924|||
156867319|NCT05567783|566273506|FG001|Overall Study|Study Terminated by Sponsor|937|||
156867320|NCT05567783|566273507|FG002|Overall Study|Study Terminated by Sponsor|941|||
156867321|NCT05567783|566273505|FG000|Overall Study|Withdrawal by Subject|23|||
156867322|NCT05567783|566273506|FG001|Overall Study|Withdrawal by Subject|27|||
156867323|NCT05567783|566273507|FG002|Overall Study|Withdrawal by Subject|24|||
156867324|NCT05567783|566273505|FG000|Overall Study|Incarcerated|1|||
156867325|NCT05567783|566273506|FG001|Overall Study|Incarcerated|0|||
156867326|NCT05567783|566273507|FG002|Overall Study|Incarcerated|0|||
156867327|NCT05567783|566273505|FG000|Overall Study|Participant randomized in error|4|||
156867328|NCT05567783|566273506|FG001|Overall Study|Participant randomized in error|2|||
156867329|NCT05567783|566273507|FG002|Overall Study|Participant randomized in error|2|||
156867330|NCT03675126|566273510|FG000|Overall Study|Study Terminated by Sponsor|9|||
156867331|NCT03675126|566273510|FG000|Overall Study|Death|2|||
156867332|NCT03675126|566273510|FG000|Overall Study|Withdrawal by Subject|4|||
156867333|NCT00001959|566273511|FG000|Overall Study|newly diagnosed colon cancer|1|||
156867334|NCT00001959|566273511|FG000|Overall Study|disabling sedation|1|||
156867335|NCT00001959|566273511|FG000|Overall Study|non-compliance|1|||
156867336|NCT02066181|566275598|FG000|Overall Study|Withdrawal by Subject|1|||
156867337|NCT02066181|566275599|FG001|Overall Study|Withdrawal by Subject|1|||
156867338|NCT01421719|566275600|FG000|Overall Study|Withdrawal by Subject|4|||
156867339|NCT03819114|566275605|FG000|Overall Study|Protocol Violation|0|||
156867340|NCT03819114|566275606|FG001|Overall Study|Protocol Violation|1|||
156867341|NCT03819114|566275607|FG002|Overall Study|Protocol Violation|1|||
156867342|NCT03819114|566275608|FG003|Overall Study|Protocol Violation|0|||
156867343|NCT03819114|566275605|FG000|Overall Study|Lost to Follow-up|0|||
156867344|NCT03819114|566275606|FG001|Overall Study|Lost to Follow-up|0|||
156867345|NCT03819114|566275607|FG002|Overall Study|Lost to Follow-up|1|||
156867346|NCT03819114|566275608|FG003|Overall Study|Lost to Follow-up|0|||
156867347|NCT02492763|566275611|FG000|Overall Study|Withdrawal by Subject|0|||
156867348|NCT02492763|566275612|FG001|Overall Study|Withdrawal by Subject|2|||
156867349|NCT02492763|566275613|FG002|Overall Study|Withdrawal by Subject|1|||
156867350|NCT02492763|566275614|FG003|Overall Study|Withdrawal by Subject|0|||
156867351|NCT02492763|566275611|FG000|Overall Study|Adverse Event|3|||
156867352|NCT02492763|566275612|FG001|Overall Study|Adverse Event|1|||
156867353|NCT02492763|566275613|FG002|Overall Study|Adverse Event|1|||
156867354|NCT02492763|566275614|FG003|Overall Study|Adverse Event|2|||
156867355|NCT02492763|566275611|FG000|Overall Study|Death|0|||
156867356|NCT02492763|566275612|FG001|Overall Study|Death|0|||
156867357|NCT02492763|566275613|FG002|Overall Study|Death|1|||
156783118|NCT00992836|565954793|FG000|Overall Study|Protocol Violation|2|||
156783119|NCT03695094|565954794|FG000|Overall Study|Adverse Event|1|||
156783120|NCT03695094|565954795|FG001|Overall Study|Adverse Event|1|||
156783121|NCT03695094|565954794|FG000|Overall Study|Withdrawal by Subject|1|||
156783122|NCT03695094|565954795|FG001|Overall Study|Withdrawal by Subject|0|||
156783123|NCT00266812|565954796|FG000|Overall Study|Disease Progression|9|||
156783124|NCT00266812|565954797|FG001|Overall Study|Disease Progression|3|||
156783125|NCT00266812|565954796|FG000|Overall Study|Death|5|||
156783126|NCT00266812|565954797|FG001|Overall Study|Death|4|||
156783127|NCT00266812|565954796|FG000|Overall Study|Adverse Event|3|||
156783128|NCT00266812|565954797|FG001|Overall Study|Adverse Event|1|||
156783129|NCT00266812|565954796|FG000|Overall Study|Protocol Violation|0|||
156783130|NCT00266812|565954797|FG001|Overall Study|Protocol Violation|1|||
156783131|NCT00266812|565954796|FG000|Overall Study|Withdrawal by Subject|0|||
156783132|NCT00266812|565954797|FG001|Overall Study|Withdrawal by Subject|2|||
156783133|NCT00266812|565954796|FG000|Overall Study|Discontinued before starting study drug|4|||
156783134|NCT00266812|565954797|FG001|Overall Study|Discontinued before starting study drug|0|||
156783135|NCT02323334|565954798|FG000|Period 3|Lost to Follow-up|0|||
156783136|NCT02323334|565954799|FG001|Period 3|Lost to Follow-up|0|||
156783137|NCT02323334|565954800|FG002|Period 3|Lost to Follow-up|1|||
156783138|NCT02323334|565954801|FG003|Period 3|Lost to Follow-up|0|||
156783139|NCT02323334|565954802|FG004|Period 3|Lost to Follow-up|0|||
156783140|NCT02323334|565954803|FG005|Period 3|Lost to Follow-up|0|||
156783141|NCT02323334|565954804|FG006|Period 3|Lost to Follow-up|0|||
156783142|NCT02323334|565954805|FG007|Period 3|Lost to Follow-up|0|||
156783143|NCT02323334|565954806|FG008|Period 3|Lost to Follow-up|0|||
156783144|NCT02323334|565954807|FG009|Period 3|Lost to Follow-up|0|||
156783145|NCT02323334|565954808|FG010|Period 3|Lost to Follow-up|0|||
156783146|NCT02323334|565954809|FG011|Period 3|Lost to Follow-up|0|||
156783147|NCT02323334|565954810|FG012|Period 3|Lost to Follow-up|0|||
156783148|NCT02323334|565954811|FG013|Period 3|Lost to Follow-up|0|||
156783149|NCT02323334|565954812|FG014|Period 3|Lost to Follow-up|0|||
156783150|NCT02323334|565954813|FG015|Period 3|Lost to Follow-up|0|||
156783151|NCT02323334|565954814|FG016|Period 3|Lost to Follow-up|0|||
156783152|NCT02323334|565954798|FG000|Period 3|Withdrawal by Subject|1|||
156783153|NCT02323334|565954799|FG001|Period 3|Withdrawal by Subject|0|||
156783154|NCT02323334|565954800|FG002|Period 3|Withdrawal by Subject|0|||
156783155|NCT02323334|565954801|FG003|Period 3|Withdrawal by Subject|0|||
156783156|NCT02323334|565954802|FG004|Period 3|Withdrawal by Subject|0|||
156783157|NCT02323334|565954803|FG005|Period 3|Withdrawal by Subject|0|||
156783158|NCT02323334|565954804|FG006|Period 3|Withdrawal by Subject|0|||
156783159|NCT02323334|565954805|FG007|Period 3|Withdrawal by Subject|0|||
156783160|NCT02323334|565954806|FG008|Period 3|Withdrawal by Subject|0|||
156783161|NCT02323334|565954807|FG009|Period 3|Withdrawal by Subject|0|||
156783162|NCT02323334|565954808|FG010|Period 3|Withdrawal by Subject|0|||
156783163|NCT02323334|565954809|FG011|Period 3|Withdrawal by Subject|0|||
156783164|NCT02323334|565954810|FG012|Period 3|Withdrawal by Subject|0|||
156783165|NCT02323334|565954811|FG013|Period 3|Withdrawal by Subject|0|||
156783166|NCT02323334|565954812|FG014|Period 3|Withdrawal by Subject|0|||
156783167|NCT02323334|565954813|FG015|Period 3|Withdrawal by Subject|0|||
156783168|NCT02323334|565954814|FG016|Period 3|Withdrawal by Subject|0|||
156783169|NCT01177410|565954821|FG000|Overall Study|Adverse Event|0|||
156783170|NCT01177410|565954822|FG001|Overall Study|Adverse Event|2|||
156783171|NCT01177410|565954823|FG002|Overall Study|Adverse Event|2|||
156783172|NCT01177410|565954821|FG000|Overall Study|Withdrawal by Subject|1|||
156783173|NCT01177410|565954822|FG001|Overall Study|Withdrawal by Subject|4|||
156783174|NCT01177410|565954823|FG002|Overall Study|Withdrawal by Subject|3|||
156783175|NCT01177410|565954821|FG000|Overall Study|Lost to Follow-up|0|||
156783176|NCT01177410|565954822|FG001|Overall Study|Lost to Follow-up|1|||
156783177|NCT01177410|565954823|FG002|Overall Study|Lost to Follow-up|0|||
156783178|NCT00471354|565954824|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
156783179|NCT00471354|565954824|FG000|Overall Study|Adverse Event|13|||
156783180|NCT00471354|565954824|FG000|Overall Study|Protocol Violation|12|||
156783181|NCT00471354|565954824|FG000|Overall Study|Withdrawal by Subject|1|||
156783182|NCT00471354|565954824|FG000|Overall Study|Physician Decision|4|||
156783183|NCT00471354|565954824|FG000|Overall Study|Sponsor Decision|1|||
156783184|NCT00471354|565954824|FG000|Overall Study|Lost to Follow-up|3|||
156783185|NCT00471354|565954824|FG000|Overall Study|Lack of Efficacy|5|||
156783186|NCT00471354|565954824|FG000|Overall Study|Patient/Caregiver Decision|12|||
156783187|NCT06204887|565954825|FG000|Overall Study|Lost to Follow-up|3|||
156783188|NCT06204887|565954826|FG001|Overall Study|Lost to Follow-up|4|||
156783189|NCT06204887|565954827|FG002|Overall Study|Lost to Follow-up|1|||
156783190|NCT06204887|565954828|FG003|Overall Study|Lost to Follow-up|6|||
156783191|NCT02762604|565954829|FG000|Overall Study|Lost to Follow-up|2|||
156783192|NCT02762604|565954830|FG001|Overall Study|Lost to Follow-up|7|||
156783193|NCT02762604|565954829|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
156783194|NCT02762604|565954830|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
156783195|NCT05128942|565954831|FG000|Overall Study|Withdrawal by Subject|1|||
156783196|NCT05128942|565954832|FG001|Overall Study|Withdrawal by Subject|0|||
156867358|NCT02492763|566275614|FG003|Overall Study|Death|0|||
156867359|NCT02492763|566275611|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
156867360|NCT02492763|566275612|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
156867361|NCT02492763|566275613|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
156867362|NCT02492763|566275614|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
156867363|NCT02492763|566275611|FG000|Overall Study|Lost to Follow-up|0|||
156867364|NCT02492763|566275612|FG001|Overall Study|Lost to Follow-up|0|||
156867365|NCT02492763|566275613|FG002|Overall Study|Lost to Follow-up|1|||
156867366|NCT02492763|566275614|FG003|Overall Study|Lost to Follow-up|0|||
156867367|NCT02492763|566275611|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156867368|NCT02492763|566275612|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156867369|NCT02492763|566275613|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156867370|NCT02492763|566275614|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156867371|NCT02492763|566275611|FG000|Overall Study|Screen Failure|0|||
156867372|NCT02492763|566275612|FG001|Overall Study|Screen Failure|0|||
156867373|NCT02492763|566275613|FG002|Overall Study|Screen Failure|0|||
156867374|NCT02492763|566275614|FG003|Overall Study|Screen Failure|1|||
156867375|NCT02492763|566275611|FG000|Overall Study|Study Terminated by Sponsor|13|||
156867376|NCT02492763|566275612|FG001|Overall Study|Study Terminated by Sponsor|10|||
156867377|NCT02492763|566275613|FG002|Overall Study|Study Terminated by Sponsor|6|||
156867378|NCT02492763|566275614|FG003|Overall Study|Study Terminated by Sponsor|10|||
156867379|NCT01772316|566275615|FG000|Overall Study|Serious adverse event|1|||
156867380|NCT01772316|566275615|FG000|Overall Study|Inform consent withdrawn|1|||
156867381|NCT01772316|566275615|FG000|Overall Study|Withdrawn by sponsor decision|5|||
156867382|NCT01760733|566275616|FG000|Waiting List|Death|18|||
156867383|NCT01760733|566275616|FG000|Waiting List|Removed from waiting list|41|||
156867384|NCT01760733|566275616|FG000|Waiting List|Not received a transplant yet|13|||
156867385|NCT01760733|566275616|FG000|Transplanted|Not reached 10 years post transplant|184|||
156867386|NCT01760733|566275616|FG000|Transplanted|Death|26|||
156867387|NCT01760733|566275616|FG000|Transplanted|Graft loss|7|||
156867388|NCT00815659|566275617|FG000|Overall Study|Adverse Event|9|||
156867389|NCT00815659|566275617|FG000|Overall Study|Withdrawal by Subject|9|||
156867390|NCT00815659|566275617|FG000|Overall Study|Lost to Follow-up|4|||
156867391|NCT00815659|566275617|FG000|Overall Study|Protocol Violation|1|||
156867392|NCT00719472|566275618|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
156867393|NCT00719472|566275618|FG000|Enrolled in Study|Subject decision to withdraw|8|||
156867394|NCT00719472|566275618|FG000|Enrolled in Study|Various Reasons|17|||
156867395|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
156867396|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Death|5|||
156867397|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
156867398|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
156867399|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
156867400|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
156867401|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
156867402|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Death|6|||
156867403|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Disease progression|3|||
156867404|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
156867405|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
156867406|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
156867407|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
156867408|NCT03847896|566275619|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
156435341|NCT01713946|564683594|FG000|Overall Study|Patients never switched to everolimus|0|||
156435342|NCT01713946|564683595|FG001|Overall Study|Patients never switched to everolimus|0|||
156435343|NCT01713946|564683596|FG002|Overall Study|Patients never switched to everolimus|5|||
156435344|NCT03516942|564683597|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
156435345|NCT03516942|564683597|FG000|Registration through baseline survey com|Death|8|||
156435346|NCT03516942|564683597|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
156435347|NCT03516942|564683597|FG000|T0: Baseline|LOST|13|||
156435348|NCT03516942|564683597|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
156435349|NCT03516942|564683597|FG000|T1: 3 Months Survey|Death|10|||
156435350|NCT03516942|564683597|FG000|T1: 3 Months Survey|Lost|163|||
156435351|NCT03516942|564683597|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
156435352|NCT03516942|564683597|FG000|T2: 6 Month Survey|Death|14|||
156435353|NCT03516942|564683597|FG000|T2: 6 Month Survey|Lost|180|||
156435354|NCT03516942|564683597|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
156435355|NCT03516942|564683597|FG000|T3: 12 Month Survey|Death|19|||
156435356|NCT03516942|564683597|FG000|T3: 12 Month Survey|Lost|209|||
156867409|NCT03847896|566275620|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
156867410|NCT03847896|566275621|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
156867411|NCT03847896|566275622|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
156867412|NCT03847896|566275623|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
156867413|NCT03847896|566275619|FG000|Overall Study|Withdrawal by Subject|2|||
156680583|NCT00826241|565576039|FG000|Overall Study|Progression of disease|1|||
156680584|NCT00826241|565576039|FG000|Overall Study|Patient refused follow-up|3|||
156680585|NCT00826241|565576039|FG000|Overall Study|Lost to Follow-up|9|||
156680586|NCT00826241|565576039|FG000|Overall Study|Could not obtain records|1|||
156680587|NCT00826241|565576039|FG000|Overall Study|Screen failure|2|||
156680588|NCT00826241|565576039|FG000|Overall Study|Pt unable to proceed to registration|1|||
156680589|NCT00826241|565576039|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
156680590|NCT03428945|565576042|FG000|Overall Study|Lost to Follow-up|5|||
156680591|NCT03428945|565576043|FG001|Overall Study|Lost to Follow-up|3|||
156680592|NCT03428945|565576042|FG000|Overall Study|Withdrawal by Subject|10|||
156680593|NCT03428945|565576043|FG001|Overall Study|Withdrawal by Subject|10|||
156680594|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
156680595|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
156680596|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
156680597|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
156680598|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
156680599|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
156680600|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
156680601|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
156680602|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
156680603|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
156680604|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
156680605|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
156680606|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
156680607|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
156680608|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
156680609|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
156680610|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
156680611|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
156680612|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
156680613|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
156680614|NCT01924364|565576047|FG000|Overall Study|Physician Decision|3|||
156680615|NCT00265785|565576048|FG000|Overall Study|Adverse Event|4|||
156680616|NCT00265785|565576048|FG000|Overall Study|Withdrawal by Subject|3|||
156680617|NCT00265785|565576048|FG000|Overall Study|Progression/Relapse|15|||
156680618|NCT00265785|565576048|FG000|Overall Study|Not protocol specified|2|||
156680619|NCT00265785|565576048|FG000|Overall Study|Ineligible|1|||
156680620|NCT00265785|565576048|FG000|Overall Study|Did not receive protocol treatment|2|||
156680621|NCT00124618|565576049|FG000|Overall Study|Ineligible|1|||
156680622|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
156680623|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
156680624|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
156680625|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
156680626|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
156680627|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
156680628|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
156680629|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
156680630|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
156680631|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
156680632|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
156680633|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
156680634|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
156680635|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
156680636|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
156680637|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
156680638|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
156680639|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
156680640|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
156680641|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
156680642|NCT00950300|565576050|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
156680643|NCT00950300|565576051|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
156680644|NCT00950300|565576050|FG000|TFFU Period|Death|4|||
156680645|NCT00950300|565576051|FG001|TFFU Period|Death|1|||
156680646|NCT00950300|565576050|FG000|TFFU Period|Refused Treatment|10|||
156680647|NCT00950300|565576051|FG001|TFFU Period|Refused Treatment|11|||
156680648|NCT00950300|565576050|FG000|TFFU Period|Failure to Return|16|||
156680649|NCT00950300|565576051|FG001|TFFU Period|Failure to Return|16|||
156680650|NCT00950300|565576050|FG000|TFFU Period|Recurrence of Disease|63|||
156680651|NCT00950300|565576051|FG001|TFFU Period|Recurrence of Disease|72|||
156680652|NCT00950300|565576050|FG000|TFFU Period|Other|4|||
156435357|NCT03779048|564684903|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
156435358|NCT03779048|564684904|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
156435359|NCT03779048|564684905|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
156867414|NCT03847896|566275620|FG001|Overall Study|Withdrawal by Subject|10|||
156867415|NCT03847896|566275621|FG002|Overall Study|Withdrawal by Subject|5|||
156867416|NCT03847896|566275622|FG003|Overall Study|Withdrawal by Subject|9|||
156867417|NCT03847896|566275623|FG004|Overall Study|Withdrawal by Subject|8|||
156867418|NCT03847896|566275619|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156867419|NCT03847896|566275620|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156867420|NCT03847896|566275621|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156867421|NCT03847896|566275622|FG003|Overall Study|Withdrawal by parent/guardian|0|||
156867422|NCT03847896|566275623|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156867423|NCT03847896|566275619|FG000|Overall Study|Adverse Event|2|||
156867424|NCT03847896|566275620|FG001|Overall Study|Adverse Event|1|||
156867425|NCT03847896|566275621|FG002|Overall Study|Adverse Event|3|||
156867426|NCT03847896|566275622|FG003|Overall Study|Adverse Event|2|||
156867427|NCT03847896|566275623|FG004|Overall Study|Adverse Event|4|||
156867428|NCT03847896|566275619|FG000|Overall Study|A severe exacerbation event|0|||
156680653|NCT00950300|565576051|FG001|TFFU Period|Other|3|||
156680654|NCT00950300|565576050|FG000|SFU Period|Death|44|||
156680655|NCT00950300|565576051|FG001|SFU Period|Death|42|||
156680656|NCT00950300|565576050|FG000|SFU Period|Lost to Follow-up|30|||
156680657|NCT00950300|565576051|FG001|SFU Period|Lost to Follow-up|28|||
156680658|NCT00950300|565576050|FG000|SFU Period|Withdrawal by Subject|4|||
156680659|NCT00950300|565576051|FG001|SFU Period|Withdrawal by Subject|8|||
156680660|NCT01539239|565576056|FG000|Overall Study|Death|5|||
156680661|NCT01539239|565576057|FG001|Overall Study|Death|5|||
156680662|NCT01539239|565576056|FG000|Overall Study|Lost to Follow-up|7|||
156680663|NCT01539239|565576057|FG001|Overall Study|Lost to Follow-up|12|||
156680664|NCT01337596|565576060|FG000|Overall Study|Withdrawal by Subject|0|||
156680665|NCT01337596|565576061|FG001|Overall Study|Withdrawal by Subject|0|||
156680666|NCT01337596|565576062|FG002|Overall Study|Withdrawal by Subject|0|||
156680667|NCT01337596|565576063|FG003|Overall Study|Withdrawal by Subject|0|||
156680668|NCT01337596|565576064|FG004|Overall Study|Withdrawal by Subject|2|||
156680669|NCT01337596|565576065|FG005|Overall Study|Withdrawal by Subject|0|||
156680670|NCT01337596|565576066|FG006|Overall Study|Withdrawal by Subject|0|||
156680671|NCT01337596|565576067|FG007|Overall Study|Withdrawal by Subject|0|||
156680672|NCT01337596|565576068|FG008|Overall Study|Withdrawal by Subject|0|||
156680673|NCT04640194|565576069|FG000|Overall Study|Adverse Event|3|||
156680674|NCT04640194|565576070|FG001|Overall Study|Adverse Event|7|||
156680675|NCT04640194|565576071|FG002|Overall Study|Adverse Event|0|||
156680676|NCT04640194|565576072|FG003|Overall Study|Adverse Event|5|||
156680677|NCT04640194|565576073|FG004|Overall Study|Adverse Event|0|||
156680678|NCT04640194|565576074|FG005|Overall Study|Adverse Event|4|||
156680679|NCT04640194|565576075|FG006|Overall Study|Adverse Event|0|||
156680680|NCT04640194|565576069|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
156680681|NCT04640194|565576070|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
156680682|NCT04640194|565576071|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
156783197|NCT05128942|565954833|FG002|Overall Study|Withdrawal by Subject|1|||
156783198|NCT05128942|565954834|FG003|Overall Study|Withdrawal by Subject|0|||
156783199|NCT05128942|565954835|FG004|Overall Study|Withdrawal by Subject|0|||
156783200|NCT05128942|565954836|FG005|Overall Study|Withdrawal by Subject|0|||
156783201|NCT05128942|565954837|FG006|Overall Study|Withdrawal by Subject|0|||
156783202|NCT05128942|565954838|FG007|Overall Study|Withdrawal by Subject|0|||
156783203|NCT05128942|565954839|FG008|Overall Study|Withdrawal by Subject|0|||
156783204|NCT05128942|565954831|FG000|Overall Study|Other|2|||
156783205|NCT05128942|565954832|FG001|Overall Study|Other|0|||
156783206|NCT05128942|565954833|FG002|Overall Study|Other|2|||
156783207|NCT05128942|565954834|FG003|Overall Study|Other|0|||
156867429|NCT03847896|566275620|FG001|Overall Study|A severe exacerbation event|0|||
156867430|NCT03847896|566275621|FG002|Overall Study|A severe exacerbation event|0|||
156867431|NCT03847896|566275622|FG003|Overall Study|A severe exacerbation event|0|||
156867432|NCT03847896|566275623|FG004|Overall Study|A severe exacerbation event|3|||
156867433|NCT03847896|566275619|FG000|Overall Study|Protocol Violation|0|||
156867434|NCT03847896|566275620|FG001|Overall Study|Protocol Violation|2|||
156867435|NCT03847896|566275621|FG002|Overall Study|Protocol Violation|1|||
156435360|NCT03779048|564684903|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
156435361|NCT03779048|564684904|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
156435362|NCT03779048|564684905|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
156435363|NCT03779048|564684903|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
156435364|NCT03779048|564684904|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
156529341|NCT01794520|565032617|FG002|Overall Study|Withdrew consent|1|||
156680683|NCT04640194|565576072|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
156680684|NCT04640194|565576073|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
156680685|NCT04640194|565576074|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
156680686|NCT04640194|565576075|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
156680687|NCT04640194|565576069|FG000|Overall Study|fibrinogen level too low|0|||
156680688|NCT04640194|565576070|FG001|Overall Study|fibrinogen level too low|0|||
156680689|NCT04640194|565576071|FG002|Overall Study|fibrinogen level too low|0|||
156680690|NCT04640194|565576072|FG003|Overall Study|fibrinogen level too low|1|||
156680691|NCT04640194|565576073|FG004|Overall Study|fibrinogen level too low|0|||
156680692|NCT04640194|565576074|FG005|Overall Study|fibrinogen level too low|0|||
156680693|NCT04640194|565576075|FG006|Overall Study|fibrinogen level too low|0|||
156680694|NCT04640194|565576069|FG000|Overall Study|mild bleeding|0|||
156680695|NCT04640194|565576070|FG001|Overall Study|mild bleeding|0|||
156680696|NCT04640194|565576071|FG002|Overall Study|mild bleeding|0|||
156680697|NCT04640194|565576072|FG003|Overall Study|mild bleeding|1|||
156680698|NCT04640194|565576073|FG004|Overall Study|mild bleeding|0|||
156680699|NCT04640194|565576074|FG005|Overall Study|mild bleeding|0|||
156680700|NCT04640194|565576075|FG006|Overall Study|mild bleeding|0|||
156680701|NCT04640194|565576069|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156529342|NCT01794520|565032618|FG003|Overall Study|Withdrew consent|1|||
156529343|NCT01794520|565032619|FG004|Overall Study|Withdrew consent|0|||
156680702|NCT04640194|565576070|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
156680703|NCT04640194|565576071|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680704|NCT04640194|565576072|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680705|NCT04640194|565576073|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680706|NCT04640194|565576074|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680707|NCT04640194|565576075|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680708|NCT03201003|565576079|FG000|Overall Study|Adverse Event|14|||
156680709|NCT03201003|565576080|FG001|Overall Study|Adverse Event|1|||
156680710|NCT03201003|565576079|FG000|Overall Study|Other reasons|5|||
156680711|NCT03201003|565576080|FG001|Overall Study|Other reasons|1|||
156680712|NCT03201003|565576079|FG000|Overall Study|Withdrawal by Subject|4|||
156680713|NCT03201003|565576080|FG001|Overall Study|Withdrawal by Subject|1|||
156680714|NCT03201003|565576079|FG000|Overall Study|Lost to Follow-up|2|||
156680715|NCT03201003|565576080|FG001|Overall Study|Lost to Follow-up|0|||
156680716|NCT03201003|565576079|FG000|Overall Study|Protocol Violation|1|||
156680717|NCT03201003|565576080|FG001|Overall Study|Protocol Violation|0|||
156680718|NCT00834613|565576081|FG000|First Intervention|Protocol Violation|1|||
156680719|NCT00834613|565576082|FG001|First Intervention|Protocol Violation|0|||
156680720|NCT01709903|565576086|FG000|Overall Study|administrative problems|2|||
156680721|NCT01709903|565576087|FG001|Overall Study|administrative problems|6|||
156680722|NCT01709903|565576086|FG000|Overall Study|Abnormal test procedure results|1|||
156680723|NCT01709903|565576087|FG001|Overall Study|Abnormal test procedure results|0|||
156680724|NCT01709903|565576086|FG000|Overall Study|In ability to use device|1|||
156680725|NCT01709903|565576087|FG001|Overall Study|In ability to use device|1|||
156680726|NCT01709903|565576086|FG000|Overall Study|no longer needed study drug|0|||
156680727|NCT01709903|565576087|FG001|Overall Study|no longer needed study drug|1|||
156680728|NCT01709903|565576086|FG000|Overall Study|Lost to Follow-up|0|||
156680729|NCT01709903|565576087|FG001|Overall Study|Lost to Follow-up|2|||
156680730|NCT01709903|565576086|FG000|Overall Study|Death|2|||
156680731|NCT01709903|565576087|FG001|Overall Study|Death|0|||
156680732|NCT01709903|565576086|FG000|Overall Study|Protocol Violation|3|||
156680733|NCT01709903|565576087|FG001|Overall Study|Protocol Violation|2|||
156680734|NCT01709903|565576086|FG000|Overall Study|Lack of Efficacy|3|||
156680735|NCT01709903|565576087|FG001|Overall Study|Lack of Efficacy|3|||
156680736|NCT01709903|565576086|FG000|Overall Study|Withdrawal by Subject|6|||
156680737|NCT01709903|565576087|FG001|Overall Study|Withdrawal by Subject|6|||
156783208|NCT05128942|565954835|FG004|Overall Study|Other|0|||
156783209|NCT05128942|565954836|FG005|Overall Study|Other|0|||
156783210|NCT05128942|565954837|FG006|Overall Study|Other|0|||
156783211|NCT05128942|565954838|FG007|Overall Study|Other|0|||
156783212|NCT05128942|565954839|FG008|Overall Study|Other|0|||
156783213|NCT05128942|565954831|FG000|Overall Study|Termination by Sponsor|2|||
156783214|NCT05128942|565954832|FG001|Overall Study|Termination by Sponsor|6|||
156783215|NCT05128942|565954833|FG002|Overall Study|Termination by Sponsor|14|||
156783216|NCT05128942|565954834|FG003|Overall Study|Termination by Sponsor|2|||
156783217|NCT05128942|565954835|FG004|Overall Study|Termination by Sponsor|4|||
156783218|NCT05128942|565954836|FG005|Overall Study|Termination by Sponsor|8|||
156783219|NCT05128942|565954837|FG006|Overall Study|Termination by Sponsor|11|||
156783220|NCT05128942|565954838|FG007|Overall Study|Termination by Sponsor|6|||
156783221|NCT05128942|565954839|FG008|Overall Study|Termination by Sponsor|0|||
156783222|NCT05128942|565954831|FG000|Overall Study|Adverse Event|0|||
156783223|NCT05128942|565954832|FG001|Overall Study|Adverse Event|0|||
156680738|NCT01709903|565576086|FG000|Overall Study|Adverse Event|11|||
156680739|NCT01709903|565576087|FG001|Overall Study|Adverse Event|18|||
156680740|NCT04490057|565576090|FG000|Stage 1|Death|1|||
156680741|NCT04490057|565576091|FG001|Stage 1|Death|2|||
156680742|NCT04490057|565576092|FG002|Stage 1|Death|0|||
156783224|NCT05128942|565954833|FG002|Overall Study|Adverse Event|0|||
156783225|NCT05128942|565954834|FG003|Overall Study|Adverse Event|0|||
156783226|NCT05128942|565954835|FG004|Overall Study|Adverse Event|0|||
156867436|NCT03847896|566275622|FG003|Overall Study|Protocol Violation|0|||
156867437|NCT03847896|566275623|FG004|Overall Study|Protocol Violation|2|||
156680743|NCT04490057|565576093|FG003|Stage 1|Death|0|||
156680744|NCT04490057|565576094|FG004|Stage 1|Death|0|||
156680745|NCT04490057|565576095|FG005|Stage 1|Death|0|||
156680746|NCT04490057|565576096|FG006|Stage 1|Death|0|||
156680747|NCT04490057|565576097|FG007|Stage 1|Death|0|||
156680748|NCT04490057|565576090|FG000|Stage 1|Withdrawal by Subject|2|||
156680749|NCT04490057|565576091|FG001|Stage 1|Withdrawal by Subject|0|||
156680750|NCT04490057|565576092|FG002|Stage 1|Withdrawal by Subject|0|||
156680751|NCT04490057|565576093|FG003|Stage 1|Withdrawal by Subject|0|||
156680752|NCT04490057|565576094|FG004|Stage 1|Withdrawal by Subject|0|||
156783227|NCT05128942|565954836|FG005|Overall Study|Adverse Event|0|||
156783228|NCT05128942|565954837|FG006|Overall Study|Adverse Event|1|||
156783229|NCT05128942|565954838|FG007|Overall Study|Adverse Event|1|||
156783230|NCT05128942|565954839|FG008|Overall Study|Adverse Event|0|||
156783231|NCT05128942|565954831|FG000|Overall Study|Lost to Follow-up|0|||
156783232|NCT05128942|565954832|FG001|Overall Study|Lost to Follow-up|0|||
156783233|NCT05128942|565954833|FG002|Overall Study|Lost to Follow-up|0|||
156783234|NCT05128942|565954834|FG003|Overall Study|Lost to Follow-up|0|||
156783235|NCT05128942|565954835|FG004|Overall Study|Lost to Follow-up|1|||
156783236|NCT05128942|565954836|FG005|Overall Study|Lost to Follow-up|0|||
156783237|NCT05128942|565954837|FG006|Overall Study|Lost to Follow-up|0|||
156783238|NCT05128942|565954838|FG007|Overall Study|Lost to Follow-up|0|||
156783239|NCT05128942|565954839|FG008|Overall Study|Lost to Follow-up|0|||
156783240|NCT05182125|565954843|FG000|Overall Study|Withdrawal by Subject|0|||
156783241|NCT05182125|565954844|FG001|Overall Study|Withdrawal by Subject|0|||
156783242|NCT05182125|565954845|FG002|Overall Study|Withdrawal by Subject|0|||
156783243|NCT05182125|565954846|FG003|Overall Study|Withdrawal by Subject|0|||
156783244|NCT05182125|565954847|FG004|Overall Study|Withdrawal by Subject|2|||
156783245|NCT05182125|565954848|FG005|Overall Study|Withdrawal by Subject|0|||
156783246|NCT05182125|565954843|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783247|NCT05182125|565954844|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783248|NCT05182125|565954845|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783249|NCT05182125|565954846|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
156783250|NCT05182125|565954847|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783251|NCT05182125|565954848|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783252|NCT05182125|565954843|FG000|Overall Study|Death|0|||
156783253|NCT05182125|565954844|FG001|Overall Study|Death|0|||
156783254|NCT05182125|565954845|FG002|Overall Study|Death|0|||
156783255|NCT05182125|565954846|FG003|Overall Study|Death|0|||
156783256|NCT05182125|565954847|FG004|Overall Study|Death|1|||
156783257|NCT05182125|565954848|FG005|Overall Study|Death|0|||
156783258|NCT05887401|565954850|FG000|Overall Study|Withdrawal by Subject|0|||
156783259|NCT05887401|565954851|FG001|Overall Study|Withdrawal by Subject|0|||
156783260|NCT05887401|565954852|FG002|Overall Study|Withdrawal by Subject|0|||
156783261|NCT05887401|565954853|FG003|Overall Study|Withdrawal by Subject|0|||
156783262|NCT05887401|565954854|FG004|Overall Study|Withdrawal by Subject|0|||
156783263|NCT05887401|565954855|FG005|Overall Study|Withdrawal by Subject|0|||
156783264|NCT05887401|565954856|FG006|Overall Study|Withdrawal by Subject|0|||
156783265|NCT05887401|565954857|FG007|Overall Study|Withdrawal by Subject|0|||
156783266|NCT05887401|565954858|FG008|Overall Study|Withdrawal by Subject|0|||
156783267|NCT05887401|565954859|FG009|Overall Study|Withdrawal by Subject|1|||
156783268|NCT05887401|565954860|FG010|Overall Study|Withdrawal by Subject|0|||
156783269|NCT05887401|565954861|FG011|Overall Study|Withdrawal by Subject|0|||
156867438|NCT03847896|566275619|FG000|Overall Study|Lost to Follow-up|0|||
156867439|NCT03847896|566275620|FG001|Overall Study|Lost to Follow-up|0|||
156867440|NCT03847896|566275621|FG002|Overall Study|Lost to Follow-up|0|||
156867441|NCT03847896|566275622|FG003|Overall Study|Lost to Follow-up|1|||
156867442|NCT03847896|566275623|FG004|Overall Study|Lost to Follow-up|0|||
156867443|NCT03847896|566275619|FG000|Overall Study|Condition under investigation worsened|0|||
156867444|NCT03847896|566275620|FG001|Overall Study|Condition under investigation worsened|0|||
156435365|NCT03779048|564684905|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
156680753|NCT04490057|565576095|FG005|Stage 1|Withdrawal by Subject|0|||
156680754|NCT04490057|565576096|FG006|Stage 1|Withdrawal by Subject|0|||
156680755|NCT04490057|565576097|FG007|Stage 1|Withdrawal by Subject|0|||
156680756|NCT04490057|565576090|FG000|Stage 2|Death|0|||
156680757|NCT04490057|565576091|FG001|Stage 2|Death|0|||
156783270|NCT05887401|565954862|FG012|Overall Study|Withdrawal by Subject|0|||
156783271|NCT05887401|565954863|FG013|Overall Study|Withdrawal by Subject|0|||
156783272|NCT05887401|565954864|FG014|Overall Study|Withdrawal by Subject|0|||
156783273|NCT05887401|565954865|FG015|Overall Study|Withdrawal by Subject|1|||
156783274|NCT05887401|565954850|FG000|Overall Study|Lost to Follow-up|0|||
156783275|NCT05887401|565954851|FG001|Overall Study|Lost to Follow-up|1|||
156783276|NCT05887401|565954852|FG002|Overall Study|Lost to Follow-up|1|||
156783277|NCT05887401|565954853|FG003|Overall Study|Lost to Follow-up|2|||
156783278|NCT05887401|565954854|FG004|Overall Study|Lost to Follow-up|0|||
156680758|NCT04490057|565576092|FG002|Stage 2|Death|0|||
156680759|NCT04490057|565576093|FG003|Stage 2|Death|0|||
156680760|NCT04490057|565576094|FG004|Stage 2|Death|1|||
156680761|NCT04490057|565576095|FG005|Stage 2|Death|0|||
156680762|NCT04490057|565576096|FG006|Stage 2|Death|0|||
156680763|NCT04490057|565576097|FG007|Stage 2|Death|0|||
156680764|NCT04490057|565576090|FG000|Stage 2|Lost to Follow-up|0|||
156680765|NCT04490057|565576091|FG001|Stage 2|Lost to Follow-up|0|||
156680766|NCT04490057|565576092|FG002|Stage 2|Lost to Follow-up|0|||
156680767|NCT04490057|565576093|FG003|Stage 2|Lost to Follow-up|11|||
156680768|NCT04490057|565576094|FG004|Stage 2|Lost to Follow-up|17|||
156680769|NCT04490057|565576095|FG005|Stage 2|Lost to Follow-up|4|||
156680770|NCT04490057|565576096|FG006|Stage 2|Lost to Follow-up|21|||
156680771|NCT04490057|565576097|FG007|Stage 2|Lost to Follow-up|14|||
156680772|NCT04584983|565576100|FG000|Overall Study|Parental request for withdraw|2|||
156680773|NCT04584983|565576101|FG001|Overall Study|Parental request for withdraw|0|||
156680774|NCT05377489|565576102|FG000|Overall Study|Withdrawal by Subject|122|||
156680775|NCT05377489|565576102|FG000|Overall Study|Lost to Follow-up|21|||
156680776|NCT05377489|565576102|FG000|Overall Study|Lack of Efficacy|10|||
156680777|NCT05377489|565576102|FG000|Overall Study|Adverse Event|5|||
156680778|NCT05377489|565576102|FG000|Overall Study|Death|4|||
156783279|NCT05887401|565954855|FG005|Overall Study|Lost to Follow-up|0|||
156783280|NCT05887401|565954856|FG006|Overall Study|Lost to Follow-up|0|||
156783281|NCT05887401|565954857|FG007|Overall Study|Lost to Follow-up|0|||
156783282|NCT05887401|565954858|FG008|Overall Study|Lost to Follow-up|1|||
156783283|NCT05887401|565954859|FG009|Overall Study|Lost to Follow-up|1|||
156783284|NCT05887401|565954860|FG010|Overall Study|Lost to Follow-up|2|||
156783285|NCT05887401|565954861|FG011|Overall Study|Lost to Follow-up|1|||
156783286|NCT05887401|565954862|FG012|Overall Study|Lost to Follow-up|0|||
156783287|NCT05887401|565954863|FG013|Overall Study|Lost to Follow-up|0|||
156783288|NCT05887401|565954864|FG014|Overall Study|Lost to Follow-up|0|||
156783289|NCT05887401|565954865|FG015|Overall Study|Lost to Follow-up|0|||
156783290|NCT04530526|565954866|FG000|Overall Study|Withdrawal by Subject|6|||
156783291|NCT06461455|565954867|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
156783292|NCT06461455|565954868|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
156783293|NCT06461455|565954867|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
156783294|NCT06461455|565954868|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
156783295|NCT06461455|565954867|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
156783296|NCT06461455|565954868|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
156783297|NCT06991803|565954871|FG000|Overall Study|Lost to Follow-up|0|||
156783298|NCT06991803|565954872|FG001|Overall Study|Lost to Follow-up|4|||
156783299|NCT06991803|565954873|FG002|Overall Study|Lost to Follow-up|0|||
156783300|NCT06991803|565954874|FG003|Overall Study|Lost to Follow-up|3|||
156783301|NCT06991803|565954875|FG004|Overall Study|Lost to Follow-up|2|||
156783302|NCT06991803|565954876|FG005|Overall Study|Lost to Follow-up|5|||
156783303|NCT03520569|565955461|FG000|Overall Study|Withdrawal by Subject|1|||
156783304|NCT00784927|565955462|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
156783305|NCT00784927|565955462|FG000|Overall Study|Protocol Violation|1|||
156783306|NCT00784927|565955462|FG000|Overall Study|Ineligible|1|||
156783307|NCT05141357|565955463|FG000|Overall Study|Adverse Event|3|||
156783308|NCT05141357|565955463|FG000|Overall Study|Lack of Efficacy|2|||
156783309|NCT05887908|565955464|FG000|Overall Study|Adverse Event|6|||
156783310|NCT05887908|565955465|FG001|Overall Study|Adverse Event|1|||
156783311|NCT05887908|565955466|FG002|Overall Study|Adverse Event|1|||
156783312|NCT05887908|565955464|FG000|Overall Study|Physician Decision|4|||
156783313|NCT05887908|565955465|FG001|Overall Study|Physician Decision|1|||
156783314|NCT05887908|565955466|FG002|Overall Study|Physician Decision|0|||
156783315|NCT05887908|565955464|FG000|Overall Study|Withdrawal by Subject|3|||
156783316|NCT05887908|565955465|FG001|Overall Study|Withdrawal by Subject|2|||
156783317|NCT05887908|565955466|FG002|Overall Study|Withdrawal by Subject|3|||
156783318|NCT05887908|565955464|FG000|Overall Study|Ineligibility after the start of the study|4|||
156783319|NCT05887908|565955465|FG001|Overall Study|Ineligibility after the start of the study|1|||
156783320|NCT05887908|565955466|FG002|Overall Study|Ineligibility after the start of the study|0|||
156783321|NCT05887908|565955464|FG000|Overall Study|Subject non-compliance|4|||
156680779|NCT05377489|565576102|FG000|Overall Study|Physician Decision|3|||
156783322|NCT05887908|565955465|FG001|Overall Study|Subject non-compliance|0|||
156783323|NCT05887908|565955466|FG002|Overall Study|Subject non-compliance|4|||
156783324|NCT05887908|565955464|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
156783325|NCT05887908|565955465|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
156783326|NCT05887908|565955466|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
156783327|NCT05887908|565955464|FG000|Overall Study|Pregnancy|0|||
156783328|NCT05887908|565955465|FG001|Overall Study|Pregnancy|1|||
156783329|NCT05887908|565955466|FG002|Overall Study|Pregnancy|0|||
156783330|NCT05887908|565955464|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
156680780|NCT05377489|565576102|FG000|Overall Study|Protocol Violation|1|||
156680781|NCT05377489|565576102|FG000|Overall Study|Other|9|||
156680782|NCT00724958|565576103|FG000|Overall Study|Adverse Event|28|||
156783331|NCT05887908|565955465|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
156680783|NCT00724958|565576103|FG000|Overall Study|Loss of Response|40|||
156783332|NCT05887908|565955466|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
156783333|NCT05887908|565955464|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
156783334|NCT05887908|565955465|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
156783335|NCT05887908|565955466|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
156783336|NCT05887908|565955464|FG000|Overall Study|Other Reason|3|||
156783337|NCT05887908|565955465|FG001|Overall Study|Other Reason|3|||
156783338|NCT05887908|565955466|FG002|Overall Study|Other Reason|3|||
156783339|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
156783340|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
156783341|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
156783342|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
156783343|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
156783344|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
156783345|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
156783346|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
156783347|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
156783348|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
156783349|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
156783350|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
156783351|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
156783352|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
156783353|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
156783354|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
156783355|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
156783356|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
156783357|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
156783358|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
156783359|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
156783360|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
156783361|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
156783362|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
156783363|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
156783364|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
156783365|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
156783366|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
156783367|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
156783368|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
156783369|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
156783370|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
156783371|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
156783372|NCT04740567|565955475|FG000|Overall Study|Death|31|||
156783373|NCT04740567|565955476|FG001|Overall Study|Death|43|||
156783374|NCT04740567|565955475|FG000|Overall Study|Lost to Follow-up|2|||
156783375|NCT04740567|565955476|FG001|Overall Study|Lost to Follow-up|11|||
156783376|NCT04740567|565955475|FG000|Overall Study|Patient declined to participate|13|||
156783377|NCT04740567|565955476|FG001|Overall Study|Patient declined to participate|26|||
156783378|NCT04740567|565955475|FG000|Overall Study|Patient was physically incapable|1|||
156783379|NCT04740567|565955476|FG001|Overall Study|Patient was physically incapable|3|||
156783380|NCT04740567|565955475|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
156783381|NCT04740567|565955476|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
156783382|NCT06132386|565955477|FG000|Overall Study|ineligble laboratory|1|||
156783383|NCT06132386|565955478|FG001|Overall Study|ineligble laboratory|0|||
156783384|NCT06132386|565955479|FG002|Overall Study|ineligble laboratory|0|||
156783385|NCT06132386|565955480|FG003|Overall Study|ineligble laboratory|0|||
156783386|NCT06132386|565955481|FG004|Overall Study|ineligble laboratory|1|||
156783387|NCT06132386|565955482|FG005|Overall Study|ineligble laboratory|0|||
156783388|NCT06132386|565955477|FG000|Overall Study|ineligible vital signs|0|||
156783389|NCT06132386|565955478|FG001|Overall Study|ineligible vital signs|1|||
156783390|NCT06132386|565955479|FG002|Overall Study|ineligible vital signs|0|||
156783391|NCT06132386|565955480|FG003|Overall Study|ineligible vital signs|0|||
156783392|NCT06132386|565955481|FG004|Overall Study|ineligible vital signs|0|||
156783393|NCT06132386|565955482|FG005|Overall Study|ineligible vital signs|0|||
156783394|NCT03833167|565955483|FG000|Overall Study|Withdrawal by Subject|4|||
156435366|NCT01286272|564684906|FG000|Overall Study|Ineligible after beginning treatment|1|||
156435367|NCT01286272|564684907|FG001|Overall Study|Ineligible after beginning treatment|3|||
156783395|NCT03833167|565955484|FG001|Overall Study|Withdrawal by Subject|6|||
156435368|NCT04001829|564684910|FG000|Overall Study|Never start protocol therapy|5|||
156680784|NCT00724958|565576103|FG000|Overall Study|No Response|18|||
156680785|NCT00724958|565576103|FG000|Overall Study|Remission|7|||
156680786|NCT00724958|565576103|FG000|Overall Study|Other Reason|76|||
156680787|NCT00724958|565576103|FG000|Overall Study|No documentation for end of therapy|13|||
156680788|NCT00697619|565576104|FG000|Overall Study|Lack of Efficacy|2|||
156329198|NCT01890746|564305533|FG001|Overall Study|Withdrawal by Subject|8|||
156329199|NCT03257371|564305536|FG000|Overall Study|Lost to Follow-up|1|||
156329200|NCT01578330|564305538|FG000|Overall Study|Adverse Event|2|||
156329201|NCT01578330|564305538|FG000|Overall Study|Protocol Violation|5|||
156329202|NCT01050543|564305539|FG000|Overall Study|Withdrawal by Subject|0|||
156329203|NCT01050543|564305540|FG001|Overall Study|Withdrawal by Subject|2|||
156329204|NCT01050543|564305539|FG000|Overall Study|Protocol Violation|0|||
156329205|NCT01050543|564305540|FG001|Overall Study|Protocol Violation|1|||
156329206|NCT01050543|564305539|FG000|Overall Study|Administrative|4|||
156329207|NCT01050543|564305540|FG001|Overall Study|Administrative|1|||
156329208|NCT03053271|564305543|FG000|Overall Study|Did not meet randomization criteria|3|||
156329209|NCT03053271|564305543|FG000|Overall Study|Withdrawal by Subject|1|||
156329210|NCT00580970|564305544|FG000|Pre-treatment|Non-compliance|1|||
156329211|NCT00580970|564305544|FG000|Treatment (Lovastatin)|Non-compliance|6|||
156329212|NCT00580970|564305544|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
156329213|NCT00580970|564305544|FG000|Treatment (Lovastatin)|Physician Decision|4|||
156329214|NCT00580970|564305544|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
156329215|NCT00580970|564305544|FG000|Treatment (Lovastatin)|Death|1|||
156329216|NCT02124161|564305547|FG000|Overall Study|Other unspecified|0|||
156329217|NCT02124161|564305548|FG001|Overall Study|Other unspecified|1|||
156329218|NCT02124161|564305547|FG000|Overall Study|Death|1|||
156529344|NCT01794520|565032620|FG005|Overall Study|Withdrew consent|0|||
156680789|NCT00697619|565576105|FG001|Overall Study|Lack of Efficacy|2|||
156680790|NCT00697619|565576104|FG000|Overall Study|Adverse Event|4|||
156680791|NCT00697619|565576105|FG001|Overall Study|Adverse Event|6|||
156329219|NCT02124161|564305548|FG001|Overall Study|Death|0|||
156329220|NCT02124161|564305547|FG000|Overall Study|Protocol Violation|2|||
156329221|NCT02124161|564305548|FG001|Overall Study|Protocol Violation|1|||
156329222|NCT02124161|564305547|FG000|Overall Study|Withdrawal by Subject|1|||
156329223|NCT02124161|564305548|FG001|Overall Study|Withdrawal by Subject|2|||
156680792|NCT04662710|565577444|FG000|Overall Study|Death|14|||
156680793|NCT04662710|565577445|FG001|Overall Study|Death|331|||
156680794|NCT04662710|565577446|FG002|Overall Study|Death|367|||
156680795|NCT04662710|565577444|FG000|Overall Study|Ongoing|1|||
156680796|NCT04662710|565577445|FG001|Overall Study|Ongoing|109|||
156680797|NCT04662710|565577446|FG002|Overall Study|Ongoing|56|||
156680798|NCT04662710|565577444|FG000|Overall Study|Withdrawal by Subject|0|||
156680799|NCT04662710|565577445|FG001|Overall Study|Withdrawal by Subject|3|||
156680800|NCT04662710|565577446|FG002|Overall Study|Withdrawal by Subject|14|||
156680801|NCT02722616|565577447|FG000|Overall Study|Sponsor closed study after one month|2|||
156680802|NCT02722616|565577448|FG001|Overall Study|Sponsor closed study after one month|0|||
156680803|NCT02722616|565577449|FG002|Overall Study|Sponsor closed study after one month|0|||
156680804|NCT01705717|565577450|FG000|Overall Study|Adverse Event|2|||
156680805|NCT01705717|565577451|FG001|Overall Study|Adverse Event|2|||
156680806|NCT01705717|565577450|FG000|Overall Study|Lack of Efficacy|0|||
156680807|NCT01705717|565577451|FG001|Overall Study|Lack of Efficacy|1|||
156680808|NCT01705717|565577450|FG000|Overall Study|Other|0|||
156680809|NCT01705717|565577451|FG001|Overall Study|Other|2|||
156680810|NCT05480800|565577454|FG000|Overall Study|Withdrawal by Subject|0|||
156680811|NCT05480800|565577455|FG001|Overall Study|Withdrawal by Subject|0|||
156680812|NCT05480800|565577456|FG002|Overall Study|Withdrawal by Subject|2|||
156680813|NCT05480800|565577457|FG003|Overall Study|Withdrawal by Subject|1|||
156680814|NCT05480800|565577458|FG004|Overall Study|Withdrawal by Subject|0|||
156680815|NCT05480800|565577459|FG005|Overall Study|Withdrawal by Subject|0|||
156680816|NCT05480800|565577460|FG006|Overall Study|Withdrawal by Subject|1|||
156680817|NCT05480800|565577461|FG007|Overall Study|Withdrawal by Subject|0|||
156680818|NCT05480800|565577454|FG000|Overall Study|Other|0|||
156680819|NCT05480800|565577455|FG001|Overall Study|Other|0|||
156680820|NCT05480800|565577456|FG002|Overall Study|Other|0|||
156680821|NCT05480800|565577457|FG003|Overall Study|Other|0|||
156680822|NCT05480800|565577458|FG004|Overall Study|Other|0|||
156680823|NCT05480800|565577459|FG005|Overall Study|Other|0|||
156680824|NCT05480800|565577460|FG006|Overall Study|Other|1|||
156680825|NCT05480800|565577461|FG007|Overall Study|Other|0|||
156680826|NCT00676650|565577466|FG000|Overall Study|Death|45|||
156680827|NCT00676650|565577467|FG001|Overall Study|Death|14|||
156680828|NCT00676650|565577466|FG000|Overall Study|Adverse Event|159|||
156680829|NCT00676650|565577467|FG001|Overall Study|Adverse Event|21|||
156680830|NCT00676650|565577466|FG000|Overall Study|Global deterioration of health status|66|||
156680831|NCT00676650|565577467|FG001|Overall Study|Global deterioration of health status|31|||
156680832|NCT00676650|565577466|FG000|Overall Study|Lost to Follow-up|0|||
156680833|NCT00676650|565577467|FG001|Overall Study|Lost to Follow-up|1|||
156680834|NCT00676650|565577466|FG000|Overall Study|Objective progression or relapse|189|||
156435369|NCT04001829|564684911|FG001|Overall Study|Never start protocol therapy|5|||
156435370|NCT04001829|564684910|FG000|Overall Study|Adverse Event|11|||
156435371|NCT04001829|564684911|FG001|Overall Study|Adverse Event|7|||
156435372|NCT04001829|564684910|FG000|Overall Study|Alternative therapy|1|||
156435373|NCT04001829|564684911|FG001|Overall Study|Alternative therapy|2|||
156435374|NCT04001829|564684910|FG000|Overall Study|Disease progression/relapse|2|||
156435375|NCT04001829|564684911|FG001|Overall Study|Disease progression/relapse|1|||
156435376|NCT04001829|564684910|FG000|Overall Study|Other complicating disease|1|||
156783396|NCT03833167|565955483|FG000|Overall Study|Ongoing|186|||
156783397|NCT03833167|565955484|FG001|Overall Study|Ongoing|194|||
156783398|NCT03833167|565955483|FG000|Overall Study|Lost to Follow-up|1|||
156783399|NCT03833167|565955484|FG001|Overall Study|Lost to Follow-up|1|||
156783400|NCT03833167|565955483|FG000|Overall Study|Physician Decision|0|||
156783401|NCT03833167|565955484|FG001|Overall Study|Physician Decision|2|||
156783402|NCT03833167|565955483|FG000|Overall Study|Death|34|||
156783403|NCT03833167|565955484|FG001|Overall Study|Death|22|||
156783404|NCT03003962|565955485|FG000|Overall Study|Withdrawal by Subject|5|||
156783405|NCT03003962|565955486|FG001|Overall Study|Withdrawal by Subject|17|||
156783406|NCT03003962|565955485|FG000|Overall Study|Death|274|||
156783407|NCT03003962|565955486|FG001|Overall Study|Death|277|||
156783408|NCT03003962|565955485|FG000|Overall Study|Participants ongoing at DCO|55|||
156783409|NCT03003962|565955486|FG001|Overall Study|Participants ongoing at DCO|40|||
156783410|NCT01405911|565955487|FG000|Overall Study|Pre-treatment lab AE|0|||
156783411|NCT01405911|565955488|FG001|Overall Study|Pre-treatment lab AE|1|||
156783412|NCT01405911|565955489|FG002|Overall Study|Pre-treatment lab AE|0|||
156783413|NCT01405911|565955487|FG000|Overall Study|Lost to Follow-up|0|||
156783414|NCT01405911|565955488|FG001|Overall Study|Lost to Follow-up|1|||
156783415|NCT01405911|565955489|FG002|Overall Study|Lost to Follow-up|0|||
156783416|NCT01405911|565955487|FG000|Overall Study|Protocol Violation|1|||
156783417|NCT01405911|565955488|FG001|Overall Study|Protocol Violation|0|||
156783418|NCT01405911|565955489|FG002|Overall Study|Protocol Violation|0|||
156783419|NCT01405911|565955487|FG000|Overall Study|Withdrawal by Subject|3|||
156783420|NCT01405911|565955488|FG001|Overall Study|Withdrawal by Subject|1|||
156783421|NCT01405911|565955489|FG002|Overall Study|Withdrawal by Subject|1|||
156783422|NCT06375655|565955490|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
156783423|NCT06375655|565955491|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
156783424|NCT02530242|565955495|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
156783425|NCT02530242|565955496|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
156783426|NCT00283959|565955497|FG000|Extension Period|Low Compliance|1|||
156783427|NCT03514017|565955503|FG000|Overall Study|Death|1|||
156783428|NCT03514017|565955503|FG000|Overall Study|Adverse Event|1|||
156435377|NCT04001829|564684911|FG001|Overall Study|Other complicating disease|0|||
156783429|NCT03600350|565956326|FG000|Overall Study|Death|1|||
156783430|NCT03600350|565956326|FG000|Overall Study|On Follow Up|18|||
156783431|NCT02400736|565956329|FG000|Overall Study|Lost to Follow-up|6|||
156783432|NCT02400736|565956330|FG001|Overall Study|Lost to Follow-up|6|||
156783433|NCT02400736|565956329|FG000|Overall Study|Withdrawal by Subject|2|||
156783434|NCT02400736|565956330|FG001|Overall Study|Withdrawal by Subject|1|||
156783435|NCT02400736|565956329|FG000|Overall Study|Moved from the area|3|||
156783436|NCT02400736|565956330|FG001|Overall Study|Moved from the area|1|||
156783437|NCT01002105|565956331|FG000|Overall Study|Lost to Follow-up|10|||
156783438|NCT01002105|565956332|FG001|Overall Study|Lost to Follow-up|16|||
156783439|NCT01002105|565956331|FG000|Overall Study|non compliance|5|||
156783440|NCT01002105|565956332|FG001|Overall Study|non compliance|3|||
156783441|NCT01002105|565956331|FG000|Overall Study|condition worsened|4|||
156783442|NCT01002105|565956332|FG001|Overall Study|condition worsened|2|||
156783443|NCT00422461|565956333|FG000|Overall Study|Adverse Event|1|||
156783444|NCT00422461|565956334|FG001|Overall Study|Adverse Event|2|||
156783445|NCT00422461|565956335|FG002|Overall Study|Adverse Event|1|||
156783446|NCT00422461|565956336|FG003|Overall Study|Adverse Event|1|||
156783447|NCT00422461|565956333|FG000|Overall Study|Other|0|||
156783448|NCT00422461|565956334|FG001|Overall Study|Other|0|||
156783449|NCT00422461|565956335|FG002|Overall Study|Other|0|||
156783450|NCT00422461|565956336|FG003|Overall Study|Other|2|||
156783451|NCT00422461|565956333|FG000|Overall Study|Participants no longer willing to participate in study|1|||
156783452|NCT00422461|565956334|FG001|Overall Study|Participants no longer willing to participate in study|0|||
156783453|NCT00422461|565956335|FG002|Overall Study|Participants no longer willing to participate in study|0|||
156783454|NCT00422461|565956336|FG003|Overall Study|Participants no longer willing to participate in study|0|||
156783455|NCT00422461|565956333|FG000|Overall Study|Randomized but not treated|1|||
156783456|NCT00422461|565956334|FG001|Overall Study|Randomized but not treated|1|||
156783457|NCT00422461|565956335|FG002|Overall Study|Randomized but not treated|0|||
156783458|NCT00422461|565956336|FG003|Overall Study|Randomized but not treated|0|||
156783459|NCT01795937|565956338|FG000|Overall Study|Withdrawal by Subject|1|||
156783460|NCT01795937|565956339|FG001|Overall Study|Withdrawal by Subject|0|||
156783461|NCT01795937|565956340|FG002|Overall Study|Withdrawal by Subject|0|||
156783462|NCT01795937|565956338|FG000|Overall Study|Physician Decision|0|||
156783463|NCT01795937|565956339|FG001|Overall Study|Physician Decision|1|||
156783464|NCT01795937|565956340|FG002|Overall Study|Physician Decision|0|||
156783465|NCT01028053|565956341|FG000|Overall Study|Screen Failure|113|||
156783466|NCT01028053|565956341|FG000|Overall Study|Patient Request|11|||
156783467|NCT01028053|565956341|FG000|Overall Study|Protocol Violation|1|||
156783468|NCT01028053|565956341|FG000|Overall Study|Physician Decision|2|||
156783469|NCT01028053|565956341|FG000|Overall Study|Technical Problem|1|||
156783470|NCT01028053|565956341|FG000|Overall Study|Terminated by Sponsor|1|||
156783471|NCT01028053|565956341|FG000|Overall Study|Various reasons|4|||
156783472|NCT00845182|565956342|FG000|Overall Study|Lost to Follow-up|3|||
156783473|NCT00845182|565956343|FG001|Overall Study|Lost to Follow-up|3|||
156867445|NCT03847896|566275621|FG002|Overall Study|Condition under investigation worsened|0|||
156867446|NCT03847896|566275622|FG003|Overall Study|Condition under investigation worsened|1|||
156867447|NCT03847896|566275623|FG004|Overall Study|Condition under investigation worsened|1|||
156783474|NCT00845182|565956344|FG002|Overall Study|Lost to Follow-up|4|||
156783475|NCT00845182|565956342|FG000|Overall Study|Adverse Event|0|||
156783476|NCT00845182|565956343|FG001|Overall Study|Adverse Event|1|||
156783477|NCT00845182|565956344|FG002|Overall Study|Adverse Event|1|||
156783478|NCT00845182|565956342|FG000|Overall Study|Physician Decision|0|||
156783479|NCT00845182|565956343|FG001|Overall Study|Physician Decision|0|||
156783480|NCT00845182|565956344|FG002|Overall Study|Physician Decision|1|||
156783481|NCT04621760|565956345|FG000|Overall Study|Lost to Follow-up|2|||
156783482|NCT04621760|565956346|FG001|Overall Study|Lost to Follow-up|4|||
156783483|NCT04621760|565956345|FG000|Overall Study|Withdrawal by Subject|1|||
156783484|NCT04621760|565956346|FG001|Overall Study|Withdrawal by Subject|0|||
156783485|NCT02965716|565956348|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156783486|NCT02965716|565956349|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
156783487|NCT02965716|565956348|FG000|Overall Study|Progression/Relapse|8|||
156783488|NCT02965716|565956349|FG001|Overall Study|Progression/Relapse|16|||
156783489|NCT02965716|565956348|FG000|Overall Study|Death|1|||
156783490|NCT02965716|565956349|FG001|Overall Study|Death|0|||
156783491|NCT02965716|565956348|FG000|Overall Study|Not Protocol Specified|1|||
156783492|NCT02965716|565956349|FG001|Overall Study|Not Protocol Specified|3|||
156783493|NCT01336972|565956353|FG000|Overall Study|Adverse Event|1|||
156783494|NCT01336972|565956354|FG001|Overall Study|Adverse Event|1|||
156783495|NCT01336972|565956355|FG002|Overall Study|Adverse Event|0|||
156783496|NCT02441114|565956356|FG000|Washout2|Withdrawal by Subject|4|||
156783497|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
156783498|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
156783499|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
156783500|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
156783501|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
156783502|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
156783503|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
156783504|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
156783505|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
156783506|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
156783507|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
156783508|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
156783509|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
156783510|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
156783511|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
156867448|NCT03847896|566275619|FG000|Overall Study|Lack of Efficacy|0|||
156867449|NCT03847896|566275620|FG001|Overall Study|Lack of Efficacy|0|||
156867450|NCT03847896|566275621|FG002|Overall Study|Lack of Efficacy|0|||
156867451|NCT03847896|566275622|FG003|Overall Study|Lack of Efficacy|2|||
156867452|NCT03847896|566275623|FG004|Overall Study|Lack of Efficacy|2|||
156867453|NCT03847896|566275619|FG000|Overall Study|Other reasons|3|||
156867454|NCT03847896|566275620|FG001|Overall Study|Other reasons|3|||
156867455|NCT03847896|566275621|FG002|Overall Study|Other reasons|1|||
156867456|NCT03847896|566275622|FG003|Overall Study|Other reasons|2|||
156867457|NCT03847896|566275623|FG004|Overall Study|Other reasons|1|||
156867458|NCT02395471|566275624|FG000|Overall Study|Lost to Follow-up|2|||
156783512|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
156783513|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
156783514|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
156783515|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
156783516|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
156783517|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
156867459|NCT02395471|566275625|FG001|Overall Study|Lost to Follow-up|0|||
156867460|NCT02395471|566275624|FG000|Overall Study|Withdrawal by Subject|2|||
156867461|NCT02395471|566275625|FG001|Overall Study|Withdrawal by Subject|1|||
156867462|NCT02395471|566275624|FG000|Overall Study|Physician Decision|1|||
156867463|NCT02395471|566275625|FG001|Overall Study|Physician Decision|0|||
156783518|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
156783519|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
156783520|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
156783521|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
156783522|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
156783523|NCT02639559|565956365|FG000|Overall Study|Mobilization failure|0|||
156783524|NCT02639559|565956366|FG001|Overall Study|Mobilization failure|3|||
156783525|NCT02639559|565956365|FG000|Overall Study|Issues with vascular acess|1|||
156783526|NCT02639559|565956366|FG001|Overall Study|Issues with vascular acess|0|||
156783527|NCT04999020|565956367|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
156783528|NCT04999020|565956368|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
156783529|NCT04999020|565956369|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
156783530|NCT04999020|565956370|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
156783531|NCT04999020|565956367|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
156783532|NCT04999020|565956368|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
156783533|NCT04999020|565956369|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
156783534|NCT04999020|565956370|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
156783535|NCT04999020|565956367|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
156783536|NCT04999020|565956368|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
156783537|NCT04999020|565956369|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
156783538|NCT04999020|565956370|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
156783539|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156783540|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156783541|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
156783542|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
156783543|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
156783544|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
156783545|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
156783546|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
156783547|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
156783548|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
156783549|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
156783550|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
156783551|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156783552|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156783553|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
156783554|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156783555|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
156783556|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
156783557|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
156783558|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
156783559|NCT02691663|565956377|FG000|Overall Study|Screen failure after baseline|2|||
156783560|NCT02691663|565956378|FG001|Overall Study|Screen failure after baseline|2|||
156783561|NCT02691663|565956377|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
156783562|NCT02691663|565956378|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
156783563|NCT02691663|565956377|FG000|Overall Study|Withdrawn after Follow up 2|1|||
156783564|NCT02691663|565956378|FG001|Overall Study|Withdrawn after Follow up 2|1|||
156783565|NCT02691663|565956377|FG000|Overall Study|Lost to Follow-up|3|||
156783566|NCT02691663|565956378|FG001|Overall Study|Lost to Follow-up|2|||
156783567|NCT04828486|565956381|FG000|Overall Study|Adverse Event|2|||
156783568|NCT04828486|565956381|FG000|Overall Study|Death|1|||
156783569|NCT04828486|565956381|FG000|Overall Study|Disease Progression|8|||
156783570|NCT04828486|565956381|FG000|Overall Study|Other Complicating Disease|1|||
156783571|NCT04828486|565956381|FG000|Overall Study|Withdrawal by Subject|1|||
156783572|NCT03325439|565956382|FG000|Overall Study|Ineligibility|3|||
156783573|NCT00896233|565956383|FG000|Overall Study|Claustrophobia during MRI|1|||
156783574|NCT03674411|565956388|FG000|Overall Study|Non-treatment|4|||
156783575|NCT02227199|565956389|FG000|Overall Study|Physician Decision|0|||
156783576|NCT02227199|565956390|FG001|Overall Study|Physician Decision|0|||
156783577|NCT02227199|565956391|FG002|Overall Study|Physician Decision|1|||
156783578|NCT02227199|565956389|FG000|Overall Study|Adverse Event|0|||
156783579|NCT02227199|565956390|FG001|Overall Study|Adverse Event|0|||
156783580|NCT02227199|565956391|FG002|Overall Study|Adverse Event|3|||
156783581|NCT03573882|565956392|FG000|Overall Study|Study Terminated by Sponsor|22|||
156783582|NCT03573882|565956393|FG001|Overall Study|Study Terminated by Sponsor|17|||
156783583|NCT03573882|565956394|FG002|Overall Study|Study Terminated by Sponsor|18|||
156783584|NCT03573882|565956392|FG000|Overall Study|Withdrawal by Subject|6|||
156783585|NCT03573882|565956393|FG001|Overall Study|Withdrawal by Subject|11|||
156783586|NCT03573882|565956394|FG002|Overall Study|Withdrawal by Subject|7|||
156783587|NCT03573882|565956392|FG000|Overall Study|Adverse Event|7|||
156680835|NCT00676650|565577467|FG001|Overall Study|Objective progression or relapse|140|||
156680836|NCT00676650|565577466|FG000|Overall Study|Other|14|||
156680837|NCT00676650|565577467|FG001|Overall Study|Other|10|||
156680838|NCT00676650|565577466|FG000|Overall Study|Protocol Violation|3|||
156680839|NCT00676650|565577467|FG001|Overall Study|Protocol Violation|1|||
156680840|NCT00676650|565577466|FG000|Overall Study|Study terminated by sponsor|57|||
156680841|NCT00676650|565577467|FG001|Overall Study|Study terminated by sponsor|43|||
156680842|NCT00676650|565577466|FG000|Overall Study|Withdrawal by Subject|48|||
156680843|NCT00676650|565577467|FG001|Overall Study|Withdrawal by Subject|24|||
156680844|NCT00676650|565577466|FG000|Overall Study|Randomized but not treated|3|||
156680845|NCT00676650|565577467|FG001|Overall Study|Randomized but not treated|4|||
156680846|NCT02297841|565577471|FG000|Overall Study|Withdrawal by Subject|1|||
156680847|NCT02297841|565577471|FG000|Overall Study|Protocol Violation|7|||
156680848|NCT05061992|565577472|FG000|Overall Study|Excess bowel movements|1|||
156680849|NCT05061992|565577473|FG001|Overall Study|Excess bowel movements|0|||
156680850|NCT05061992|565577472|FG000|Overall Study|Complications of Medical Care|1|||
156680851|NCT05061992|565577473|FG001|Overall Study|Complications of Medical Care|0|||
156680852|NCT05061992|565577472|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
156680853|NCT05061992|565577473|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
156680854|NCT05061992|565577472|FG000|Overall Study|Withdrawal by Subject|0|||
156680855|NCT05061992|565577473|FG001|Overall Study|Withdrawal by Subject|1|||
156680856|NCT02246764|565577478|FG000|Overall Study|Adverse Event|15|||
156680857|NCT02246764|565577479|FG001|Overall Study|Adverse Event|29|||
156680858|NCT02246764|565577480|FG002|Overall Study|Adverse Event|1|||
156680859|NCT02246764|565577478|FG000|Overall Study|Withdrawal by Subject|0|||
156680860|NCT02246764|565577479|FG001|Overall Study|Withdrawal by Subject|0|||
156680861|NCT02246764|565577480|FG002|Overall Study|Withdrawal by Subject|1|||
156680862|NCT02246764|565577478|FG000|Overall Study|Disallowed Concomitant Medication|1|||
156680863|NCT02246764|565577479|FG001|Overall Study|Disallowed Concomitant Medication|0|||
156680864|NCT02246764|565577480|FG002|Overall Study|Disallowed Concomitant Medication|0|||
156680865|NCT02246764|565577478|FG000|Overall Study|Physician Decision|0|||
156680866|NCT02246764|565577479|FG001|Overall Study|Physician Decision|2|||
156680867|NCT02246764|565577480|FG002|Overall Study|Physician Decision|1|||
156680868|NCT02246764|565577478|FG000|Overall Study|Protocol Violation|2|||
156680869|NCT02246764|565577479|FG001|Overall Study|Protocol Violation|1|||
156680870|NCT02246764|565577480|FG002|Overall Study|Protocol Violation|1|||
156680871|NCT00413049|565577481|FG000|Overall Study|Adverse Event|10|||
156680872|NCT00413049|565577482|FG001|Overall Study|Adverse Event|8|||
156680873|NCT00413049|565577481|FG000|Overall Study|Withdrawal by Subject|7|||
156680874|NCT00413049|565577482|FG001|Overall Study|Withdrawal by Subject|5|||
156680875|NCT00413049|565577481|FG000|Overall Study|Lost to Follow-up|2|||
156680876|NCT00413049|565577482|FG001|Overall Study|Lost to Follow-up|3|||
156680877|NCT00413049|565577481|FG000|Overall Study|Protocol Violation|3|||
156680878|NCT00413049|565577482|FG001|Overall Study|Protocol Violation|1|||
156680879|NCT00413049|565577481|FG000|Overall Study|Subject no longer requires study drug|0|||
156680880|NCT00413049|565577482|FG001|Overall Study|Subject no longer requires study drug|1|||
156680881|NCT00413049|565577481|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156680882|NCT00413049|565577482|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156680883|NCT00413049|565577481|FG000|Overall Study|Lack of Efficacy|1|||
156680884|NCT00413049|565577482|FG001|Overall Study|Lack of Efficacy|0|||
156680885|NCT00487695|565577487|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
156680886|NCT00487695|565577488|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
156680887|NCT00487695|565577487|FG000|First Procedure|active wheezing (did not have procedure)|1|||
156680888|NCT00487695|565577488|FG001|First Procedure|active wheezing (did not have procedure)|0|||
156680889|NCT00487695|565577487|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
156680890|NCT00487695|565577488|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
156680891|NCT00487695|565577487|FG000|Second Procedure|active wheezing|0|||
156680892|NCT00487695|565577488|FG001|Second Procedure|active wheezing|1|||
156680893|NCT00487695|565577487|FG000|Second Procedure|Withdrawal by Subject|1|||
156680894|NCT00487695|565577488|FG001|Second Procedure|Withdrawal by Subject|2|||
156680895|NCT02104817|565577489|FG000|Overall Study|Death|363|||
156680896|NCT02104817|565577490|FG001|Overall Study|Death|330|||
156680897|NCT02104817|565577489|FG000|Overall Study|Lost to Follow-up|3|||
156680898|NCT02104817|565577490|FG001|Overall Study|Lost to Follow-up|2|||
156680899|NCT02104817|565577489|FG000|Overall Study|Protocol Violation|0|||
156680900|NCT02104817|565577490|FG001|Overall Study|Protocol Violation|1|||
156680901|NCT02104817|565577489|FG000|Overall Study|Study terminated by sponsor|5854|||
156680902|NCT02104817|565577490|FG001|Overall Study|Study terminated by sponsor|5901|||
156680903|NCT02104817|565577489|FG000|Overall Study|Withdrawal by Subject|111|||
156680904|NCT02104817|565577490|FG001|Overall Study|Withdrawal by Subject|78|||
156680905|NCT02104817|565577489|FG000|Overall Study|Other reasons|128|||
156680906|NCT02104817|565577490|FG001|Overall Study|Other reasons|135|||
156680907|NCT04633642|565577491|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
156680908|NCT04633642|565577492|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
156680909|NCT00611884|565577493|FG000|Overall Study|Adverse Event|1|||
156680910|NCT00611884|565577494|FG001|Overall Study|Adverse Event|0|||
156680911|NCT00611884|565577495|FG002|Overall Study|Adverse Event|0|||
156680912|NCT00611884|565577496|FG003|Overall Study|Adverse Event|1|||
156680913|NCT00611884|565577493|FG000|Overall Study|Non-Compliance|1|||
156680914|NCT00611884|565577494|FG001|Overall Study|Non-Compliance|4|||
156680915|NCT00611884|565577495|FG002|Overall Study|Non-Compliance|2|||
156680916|NCT00611884|565577496|FG003|Overall Study|Non-Compliance|2|||
156680917|NCT00611884|565577493|FG000|Overall Study|Lack of Efficacy|0|||
156680918|NCT00611884|565577494|FG001|Overall Study|Lack of Efficacy|1|||
156680919|NCT00611884|565577495|FG002|Overall Study|Lack of Efficacy|0|||
156680920|NCT00611884|565577496|FG003|Overall Study|Lack of Efficacy|0|||
156680921|NCT00611884|565577493|FG000|Overall Study|Unclassified|7|||
156680922|NCT00611884|565577494|FG001|Overall Study|Unclassified|4|||
156680923|NCT00611884|565577495|FG002|Overall Study|Unclassified|2|||
156680924|NCT00611884|565577496|FG003|Overall Study|Unclassified|3|||
156680925|NCT02858037|565577501|FG000|Overall Study|Death|1|||
156680926|NCT02858037|565577501|FG000|Overall Study|Withdrawal by Subject|18|||
156680927|NCT02858037|565577501|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
156680928|NCT02858037|565577501|FG000|Overall Study|Lost to Follow-up|3|||
156680929|NCT02858037|565577501|FG000|Overall Study|Other|4|||
156680930|NCT00283842|565577502|FG000|Overall Study|Adverse Event|8|||
156680931|NCT00283842|565577503|FG001|Overall Study|Adverse Event|7|||
156680932|NCT00283842|565577504|FG002|Overall Study|Adverse Event|21|||
156680933|NCT00283842|565577505|FG003|Overall Study|Adverse Event|21|||
156680934|NCT00283842|565577506|FG004|Overall Study|Adverse Event|5|||
156680935|NCT00283842|565577502|FG000|Overall Study|Protocol Violation|1|||
156680936|NCT00283842|565577503|FG001|Overall Study|Protocol Violation|5|||
156680937|NCT00283842|565577504|FG002|Overall Study|Protocol Violation|4|||
156680938|NCT00283842|565577505|FG003|Overall Study|Protocol Violation|0|||
156680939|NCT00283842|565577506|FG004|Overall Study|Protocol Violation|0|||
156680940|NCT00283842|565577502|FG000|Overall Study|Protocol deviation|0|||
156680941|NCT00283842|565577503|FG001|Overall Study|Protocol deviation|0|||
156867464|NCT02395471|566275624|FG000|Overall Study|Protocol Violation|0|||
156680942|NCT00283842|565577504|FG002|Overall Study|Protocol deviation|0|||
156680943|NCT00283842|565577505|FG003|Overall Study|Protocol deviation|0|||
156680944|NCT00283842|565577506|FG004|Overall Study|Protocol deviation|2|||
156680945|NCT00283842|565577502|FG000|Overall Study|Withdrawal by Subject|2|||
156680946|NCT00283842|565577503|FG001|Overall Study|Withdrawal by Subject|1|||
156680947|NCT00283842|565577504|FG002|Overall Study|Withdrawal by Subject|1|||
156680948|NCT00283842|565577505|FG003|Overall Study|Withdrawal by Subject|5|||
156680949|NCT00283842|565577506|FG004|Overall Study|Withdrawal by Subject|4|||
156867465|NCT02395471|566275625|FG001|Overall Study|Protocol Violation|1|||
156867466|NCT02395471|566275624|FG000|Overall Study|Failure to swollow sponge twice|1|||
156867467|NCT02395471|566275625|FG001|Overall Study|Failure to swollow sponge twice|0|||
156867468|NCT02395471|566275624|FG000|Overall Study|Patient did not return for procedure|0|||
156867469|NCT02395471|566275625|FG001|Overall Study|Patient did not return for procedure|1|||
156867470|NCT02395471|566275624|FG000|Overall Study|Subject not eligible|1|||
156867471|NCT02395471|566275625|FG001|Overall Study|Subject not eligible|0|||
156680950|NCT00283842|565577502|FG000|Overall Study|Lack of Efficacy|1|||
156680951|NCT00283842|565577503|FG001|Overall Study|Lack of Efficacy|3|||
156680952|NCT00283842|565577504|FG002|Overall Study|Lack of Efficacy|1|||
156680953|NCT00283842|565577505|FG003|Overall Study|Lack of Efficacy|0|||
156680954|NCT00283842|565577506|FG004|Overall Study|Lack of Efficacy|3|||
156680955|NCT00283842|565577502|FG000|Overall Study|Lost to Follow-up|0|||
156680956|NCT00283842|565577503|FG001|Overall Study|Lost to Follow-up|2|||
156680957|NCT00283842|565577504|FG002|Overall Study|Lost to Follow-up|4|||
156680958|NCT00283842|565577505|FG003|Overall Study|Lost to Follow-up|1|||
156680959|NCT00283842|565577506|FG004|Overall Study|Lost to Follow-up|1|||
156680960|NCT04768114|565577509|FG000|Overall Study|Lost to Follow-up|5|||
156680961|NCT04768114|565577510|FG001|Overall Study|Lost to Follow-up|10|||
156680962|NCT04768114|565577509|FG000|Overall Study|Withdrawal by Subject|0|||
156680963|NCT04768114|565577510|FG001|Overall Study|Withdrawal by Subject|1|||
156680964|NCT00715676|565577511|FG000|Overall Study|Adverse Event|3|||
156680965|NCT00715676|565577512|FG001|Overall Study|Adverse Event|5|||
156680966|NCT00715676|565577513|FG002|Overall Study|Adverse Event|21|||
156680967|NCT00715676|565577511|FG000|Overall Study|Withdrawal by Subject|1|||
156680968|NCT00715676|565577512|FG001|Overall Study|Withdrawal by Subject|3|||
156680969|NCT00715676|565577513|FG002|Overall Study|Withdrawal by Subject|8|||
156680970|NCT00715676|565577511|FG000|Overall Study|Lost to Follow-up|1|||
156680971|NCT00715676|565577512|FG001|Overall Study|Lost to Follow-up|2|||
156680972|NCT00715676|565577513|FG002|Overall Study|Lost to Follow-up|1|||
156680973|NCT00715676|565577511|FG000|Overall Study|Terminated by Sponsor|1|||
156867472|NCT00118417|566275626|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
156867473|NCT00118417|566275627|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
156867474|NCT00118417|566275626|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
156680974|NCT00715676|565577512|FG001|Overall Study|Terminated by Sponsor|0|||
156680975|NCT00715676|565577513|FG002|Overall Study|Terminated by Sponsor|0|||
156680976|NCT00715676|565577511|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
156867475|NCT00118417|566275627|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
156680977|NCT00715676|565577512|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
156680978|NCT00715676|565577513|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
156680979|NCT00715676|565577511|FG000|Overall Study|Use of Exclusionary Medication|0|||
156680980|NCT00715676|565577512|FG001|Overall Study|Use of Exclusionary Medication|0|||
156680981|NCT00715676|565577513|FG002|Overall Study|Use of Exclusionary Medication|1|||
156680982|NCT00715676|565577511|FG000|Overall Study|Elevated Blood Glucose|0|||
156680983|NCT00715676|565577512|FG001|Overall Study|Elevated Blood Glucose|1|||
156680984|NCT00715676|565577513|FG002|Overall Study|Elevated Blood Glucose|0|||
156680985|NCT01963260|565577514|FG000|Overall Study|Withdrawal by Subject|2|||
156680986|NCT01963260|565577515|FG001|Overall Study|Withdrawal by Subject|0|||
156680987|NCT01963260|565577516|FG002|Overall Study|Withdrawal by Subject|0|||
156680988|NCT01963260|565577517|FG003|Overall Study|Withdrawal by Subject|1|||
156680989|NCT01963260|565577518|FG004|Overall Study|Withdrawal by Subject|2|||
156680990|NCT01963260|565577519|FG005|Overall Study|Withdrawal by Subject|0|||
156680991|NCT01963260|565577520|FG006|Overall Study|Withdrawal by Subject|0|||
156680992|NCT01963260|565577521|FG007|Overall Study|Withdrawal by Subject|0|||
156680993|NCT01963260|565577522|FG008|Overall Study|Withdrawal by Subject|0|||
156680994|NCT01963260|565577523|FG009|Overall Study|Withdrawal by Subject|0|||
156680995|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
156680996|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
156680997|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
156680998|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
156680999|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
156681000|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
156681001|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
156681002|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
156681003|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
156681004|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
156681005|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
156681006|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
156681007|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
156681008|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
156681009|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
156681010|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
156681011|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
156681012|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
156681013|NCT01067521|565577524|FG000|Open-Label Period|Death|3|||
156681014|NCT01067521|565577525|FG001|Open-Label Period|Death|1|||
156681015|NCT01067521|565577524|FG000|Open-Label Period|Adverse Event|30|||
156681016|NCT01067521|565577525|FG001|Open-Label Period|Adverse Event|28|||
156681017|NCT01067521|565577524|FG000|Open-Label Period|Withdrawal by Subject|160|||
156681018|NCT01067521|565577525|FG001|Open-Label Period|Withdrawal by Subject|88|||
156681019|NCT01067521|565577524|FG000|Open-Label Period|Physician Decision|13|||
156681020|NCT01067521|565577525|FG001|Open-Label Period|Physician Decision|11|||
156681021|NCT01067521|565577524|FG000|Open-Label Period|Non-compliance with study drug|5|||
156681022|NCT01067521|565577525|FG001|Open-Label Period|Non-compliance with study drug|0|||
156681023|NCT01067521|565577524|FG000|Open-Label Period|Protocol Violation|3|||
156681024|NCT01067521|565577525|FG001|Open-Label Period|Protocol Violation|0|||
156681025|NCT01067521|565577524|FG000|Open-Label Period|Pregnancy|14|||
156681026|NCT01067521|565577525|FG001|Open-Label Period|Pregnancy|8|||
156681027|NCT01067521|565577524|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
156681028|NCT01067521|565577525|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
156681029|NCT01067521|565577524|FG000|Open-Label Period|Lost to Follow-up|21|||
156681030|NCT01067521|565577525|FG001|Open-Label Period|Lost to Follow-up|20|||
156681031|NCT01547728|565577529|FG000|Overall Study|Change in procedure and equipment|1|||
156681032|NCT01547728|565577529|FG000|Overall Study|Drug not ready for subject|1|||
156681033|NCT01547728|565577529|FG000|Overall Study|Screen failure|39|||
156681034|NCT03828539|565577530|FG000|Overall Study|Adverse Event|3|||
156783588|NCT03573882|565956393|FG001|Overall Study|Adverse Event|5|||
156783589|NCT03573882|565956394|FG002|Overall Study|Adverse Event|6|||
156783590|NCT03573882|565956392|FG000|Overall Study|Lost to Follow-up|2|||
156783591|NCT03573882|565956393|FG001|Overall Study|Lost to Follow-up|5|||
156783592|NCT03573882|565956394|FG002|Overall Study|Lost to Follow-up|3|||
156783593|NCT03573882|565956392|FG000|Overall Study|Physician Decision|4|||
156783594|NCT03573882|565956393|FG001|Overall Study|Physician Decision|3|||
156783595|NCT03573882|565956394|FG002|Overall Study|Physician Decision|2|||
156783596|NCT03573882|565956392|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
156783597|NCT03573882|565956393|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
156783598|NCT03573882|565956394|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
156329224|NCT02124161|564305547|FG000|Overall Study|Adverse Event|2|||
156681035|NCT03828539|565577531|FG001|Overall Study|Adverse Event|12|||
156783599|NCT03573882|565956392|FG000|Overall Study|Pregnancy|1|||
156783600|NCT03573882|565956393|FG001|Overall Study|Pregnancy|2|||
156867476|NCT00118417|566275626|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
156867477|NCT00118417|566275627|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
156867478|NCT00118417|566275626|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
156681036|NCT03828539|565577530|FG000|Overall Study|Patient's/guardian's decision|3|||
156681037|NCT03828539|565577531|FG001|Overall Study|Patient's/guardian's decision|5|||
156681038|NCT03828539|565577530|FG000|Overall Study|Lost to Follow-up|4|||
156681039|NCT03828539|565577531|FG001|Overall Study|Lost to Follow-up|2|||
156681040|NCT03828539|565577530|FG000|Overall Study|Protocol Violation|3|||
156681041|NCT03828539|565577531|FG001|Overall Study|Protocol Violation|2|||
156681042|NCT03828539|565577530|FG000|Overall Study|Withdrawal of informed consent|2|||
156681043|NCT03828539|565577531|FG001|Overall Study|Withdrawal of informed consent|1|||
156681044|NCT03828539|565577530|FG000|Overall Study|New therapy for study indication|1|||
156681045|NCT03828539|565577531|FG001|Overall Study|New therapy for study indication|0|||
156681046|NCT01341405|565577532|FG000|Overall Study|Adverse Event|0|||
156681047|NCT01341405|565577533|FG001|Overall Study|Adverse Event|1|||
156681048|NCT01341405|565577534|FG002|Overall Study|Adverse Event|1|||
156681049|NCT01341405|565577532|FG000|Overall Study|Withdrawal by Subject|3|||
156681050|NCT01341405|565577533|FG001|Overall Study|Withdrawal by Subject|2|||
156681051|NCT01341405|565577534|FG002|Overall Study|Withdrawal by Subject|1|||
156681052|NCT02760433|565577535|FG000|Overall Study|Lost to Follow-up|1|||
156681053|NCT02760433|565577536|FG001|Overall Study|Lost to Follow-up|0|||
156681054|NCT02760433|565577537|FG002|Overall Study|Lost to Follow-up|1|||
156681055|NCT02760433|565577538|FG003|Overall Study|Lost to Follow-up|0|||
156681056|NCT02760433|565577539|FG004|Overall Study|Lost to Follow-up|0|||
156681057|NCT02760433|565577535|FG000|Overall Study|Withdrawal by Subject|23|||
156681058|NCT02760433|565577536|FG001|Overall Study|Withdrawal by Subject|9|||
156681059|NCT02760433|565577537|FG002|Overall Study|Withdrawal by Subject|0|||
156681060|NCT02760433|565577538|FG003|Overall Study|Withdrawal by Subject|2|||
156783601|NCT03573882|565956394|FG002|Overall Study|Pregnancy|0|||
156783602|NCT03573882|565956392|FG000|Overall Study|Other|4|||
156783603|NCT03573882|565956393|FG001|Overall Study|Other|2|||
156783604|NCT03573882|565956394|FG002|Overall Study|Other|2|||
156783605|NCT02691572|565956395|FG000|Overall Study|Withdrawal by Subject|1|||
156783606|NCT02691572|565956396|FG001|Overall Study|Withdrawal by Subject|0|||
156783607|NCT02691572|565956395|FG000|Overall Study|Protocol Violation|0|||
156783608|NCT02691572|565956396|FG001|Overall Study|Protocol Violation|1|||
156783609|NCT04337021|565956400|FG000|Overall Study|Lost to Follow-up|54|||
156783610|NCT04337021|565956401|FG001|Overall Study|Lost to Follow-up|66|||
156783611|NCT06394323|565956404|FG000|Overall Study|Death|0|||
156783612|NCT06394323|565956405|FG001|Overall Study|Death|1|||
156783613|NCT06394323|565956406|FG002|Overall Study|Death|0|||
156783614|NCT06394323|565956407|FG003|Overall Study|Death|0|||
156783615|NCT06394323|565956404|FG000|Overall Study|Physician Decision|0|||
156783616|NCT06394323|565956405|FG001|Overall Study|Physician Decision|2|||
156783617|NCT06394323|565956406|FG002|Overall Study|Physician Decision|0|||
156783618|NCT06394323|565956407|FG003|Overall Study|Physician Decision|0|||
156783619|NCT06394323|565956404|FG000|Overall Study|Withdrawal by Subject|4|||
156783620|NCT06394323|565956405|FG001|Overall Study|Withdrawal by Subject|4|||
156783621|NCT06394323|565956406|FG002|Overall Study|Withdrawal by Subject|0|||
156783622|NCT06394323|565956407|FG003|Overall Study|Withdrawal by Subject|0|||
156783623|NCT03554473|565957482|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
156783624|NCT03554473|565957483|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
156783625|NCT03554473|565957484|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
156783626|NCT03554473|565957482|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
156783627|NCT03554473|565957483|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
156783628|NCT03554473|565957484|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
156783629|NCT03554473|565957482|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
156783630|NCT03554473|565957483|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
156783631|NCT03554473|565957484|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
156783632|NCT05206604|565957485|FG000|Overall Study|Non-compliance with study drug|0|||
156783633|NCT05206604|565957486|FG001|Overall Study|Non-compliance with study drug|0|||
156783634|NCT05206604|565957487|FG002|Overall Study|Non-compliance with study drug|0|||
156783635|NCT05206604|565957488|FG003|Overall Study|Non-compliance with study drug|0|||
156783636|NCT05206604|565957489|FG004|Overall Study|Non-compliance with study drug|0|||
156783637|NCT05206604|565957490|FG005|Overall Study|Non-compliance with study drug|1|||
156867479|NCT00118417|566275627|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
156681061|NCT02760433|565577539|FG004|Overall Study|Withdrawal by Subject|9|||
156681062|NCT02760433|565577535|FG000|Overall Study|Lack of Response At Week 14|0|||
156681063|NCT02760433|565577536|FG001|Overall Study|Lack of Response At Week 14|0|||
156681064|NCT02760433|565577537|FG002|Overall Study|Lack of Response At Week 14|0|||
156681065|NCT02760433|565577538|FG003|Overall Study|Lack of Response At Week 14|0|||
156681066|NCT02760433|565577539|FG004|Overall Study|Lack of Response At Week 14|1|||
156681067|NCT02760433|565577535|FG000|Overall Study|Subject refused to continue the study|1|||
156681068|NCT02760433|565577536|FG001|Overall Study|Subject refused to continue the study|0|||
156681069|NCT02760433|565577537|FG002|Overall Study|Subject refused to continue the study|0|||
156681070|NCT02760433|565577538|FG003|Overall Study|Subject refused to continue the study|0|||
156681071|NCT02760433|565577539|FG004|Overall Study|Subject refused to continue the study|0|||
156681072|NCT02760433|565577535|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
156681073|NCT02760433|565577536|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
156681074|NCT02760433|565577537|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
156681075|NCT02760433|565577538|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
156681076|NCT02760433|565577539|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
156681077|NCT02760433|565577535|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
156681078|NCT02760433|565577536|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
156681079|NCT02760433|565577537|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
156681080|NCT02760433|565577538|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
156681081|NCT02760433|565577539|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
156681082|NCT00766493|565577540|FG000|30 Days Post-Procedure|Discontinued|7|||
156681083|NCT00766493|565577540|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
156681084|NCT00766493|565577540|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
156681085|NCT01849458|565577542|FG000|Overall Study|Lost to Follow-up|4|||
156681086|NCT00024258|565577545|FG000|Overall Study|Withdrawal by Subject|1|||
156681087|NCT00024258|565577545|FG000|Overall Study|Disease Progression|8|||
156681088|NCT01863433|565577546|FG000|Overall Study|Protocol Violation|1|||
156681089|NCT03950674|565577547|FG000|Overall Study|Death|16|||
156681090|NCT03950674|565577548|FG001|Overall Study|Death|15|||
156681091|NCT03950674|565577547|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
156681092|NCT03950674|565577548|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
156681093|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
156681094|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
156681095|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
156681096|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
156681097|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
156681098|NCT01898598|565577550|FG000|Overall Study|Adverse Event|1|||
156681099|NCT01898598|565577551|FG001|Overall Study|Adverse Event|0|||
156681100|NCT01898598|565577550|FG000|Overall Study|Withdrawal by Subject|3|||
156681101|NCT01898598|565577551|FG001|Overall Study|Withdrawal by Subject|0|||
156435378|NCT04001829|564684910|FG000|Overall Study|Withdrawal by Subject|1|||
156681102|NCT01898598|565577550|FG000|Overall Study|Lost to Follow-up|0|||
156681103|NCT01898598|565577551|FG001|Overall Study|Lost to Follow-up|1|||
156681104|NCT01898598|565577550|FG000|Overall Study|Other|0|||
156681105|NCT01898598|565577551|FG001|Overall Study|Other|1|||
156681106|NCT03833427|565577552|FG000|Overall Study|Death|4|||
156681107|NCT03833427|565577553|FG001|Overall Study|Death|2|||
156681108|NCT03833427|565577554|FG002|Overall Study|Death|9|||
156681109|NCT03833427|565577555|FG003|Overall Study|Death|11|||
156681110|NCT03833427|565577556|FG004|Overall Study|Death|0|||
156681111|NCT03833427|565577557|FG005|Overall Study|Death|0|||
156681112|NCT03833427|565577558|FG006|Overall Study|Death|0|||
156681113|NCT03833427|565577552|FG000|Overall Study|Withdrawal by Subject|0|||
156681114|NCT03833427|565577553|FG001|Overall Study|Withdrawal by Subject|1|||
156681115|NCT03833427|565577554|FG002|Overall Study|Withdrawal by Subject|1|||
156681116|NCT03833427|565577555|FG003|Overall Study|Withdrawal by Subject|0|||
156681117|NCT03833427|565577556|FG004|Overall Study|Withdrawal by Subject|0|||
156681118|NCT03833427|565577557|FG005|Overall Study|Withdrawal by Subject|0|||
156681119|NCT03833427|565577558|FG006|Overall Study|Withdrawal by Subject|0|||
156681120|NCT03833427|565577552|FG000|Overall Study|Sponsor Decision|0|||
156681121|NCT03833427|565577553|FG001|Overall Study|Sponsor Decision|0|||
156681122|NCT03833427|565577554|FG002|Overall Study|Sponsor Decision|1|||
156681123|NCT03833427|565577555|FG003|Overall Study|Sponsor Decision|3|||
156681124|NCT03833427|565577556|FG004|Overall Study|Sponsor Decision|0|||
156681125|NCT03833427|565577557|FG005|Overall Study|Sponsor Decision|0|||
156681126|NCT03833427|565577558|FG006|Overall Study|Sponsor Decision|0|||
156681127|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
156681128|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
156783638|NCT05206604|565957491|FG006|Overall Study|Non-compliance with study drug|0|||
156681129|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
156681130|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
156681131|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
156681132|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
156681133|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
156681134|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
156681135|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
156681136|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
156681137|NCT05467540|565577568|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
156681138|NCT05467540|565577568|FG000|3-Month Follow-up|Lost to Follow-up|4|||
156681139|NCT05467540|565577568|FG000|3-Month Follow-up|Death|5|||
156681140|NCT05467540|565577568|FG000|12-Month Follow-up|Lost to Follow-up|6|||
156681141|NCT05467540|565577568|FG000|12-Month Follow-up|Death|8|||
156681142|NCT05467540|565577568|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
156681143|NCT03382041|565577592|FG000|Overall Study|Consent Form Lost|2|||
156681144|NCT03382041|565577593|FG001|Overall Study|Consent Form Lost|1|||
156681145|NCT03382041|565577592|FG000|Overall Study|Withdrawal by Subject|1|||
156681146|NCT03382041|565577593|FG001|Overall Study|Withdrawal by Subject|4|||
156681147|NCT03382041|565577592|FG000|Overall Study|Lost to Follow-up|1|||
156681148|NCT03382041|565577593|FG001|Overall Study|Lost to Follow-up|4|||
156681149|NCT01374451|565577596|FG000|Overall Study|Administrative problems|1|||
156681150|NCT01374451|565577597|FG001|Overall Study|Administrative problems|0|||
156681151|NCT00089973|565577598|FG000|Overall Study|Adverse Event|3|||
156681152|NCT00089973|565577598|FG000|Overall Study|Withdrawal by Subject|1|||
156681153|NCT00089973|565577598|FG000|Overall Study|Disease progression|45|||
156681154|NCT00089973|565577598|FG000|Overall Study|Death|1|||
156681155|NCT03493919|565577602|FG000|Overall Study|Other|2|||
156681156|NCT03493919|565577603|FG001|Overall Study|Other|0|||
156681157|NCT03493919|565577604|FG002|Overall Study|Other|1|||
156681158|NCT03493919|565577605|FG003|Overall Study|Other|0|||
156681159|NCT03493919|565577602|FG000|Overall Study|Withdrawal by Subject|9|||
156681160|NCT03493919|565577603|FG001|Overall Study|Withdrawal by Subject|3|||
156681161|NCT03493919|565577604|FG002|Overall Study|Withdrawal by Subject|1|||
156681162|NCT03493919|565577605|FG003|Overall Study|Withdrawal by Subject|1|||
156681163|NCT03493919|565577602|FG000|Overall Study|Lost to Follow-up|5|||
156681164|NCT03493919|565577603|FG001|Overall Study|Lost to Follow-up|0|||
156681165|NCT03493919|565577604|FG002|Overall Study|Lost to Follow-up|0|||
156681166|NCT03493919|565577605|FG003|Overall Study|Lost to Follow-up|3|||
156681167|NCT03493919|565577602|FG000|Overall Study|Adverse Event|0|||
156681168|NCT03493919|565577603|FG001|Overall Study|Adverse Event|1|||
156681169|NCT03493919|565577604|FG002|Overall Study|Adverse Event|0|||
156681170|NCT03493919|565577605|FG003|Overall Study|Adverse Event|0|||
156681171|NCT02129062|565578918|FG000|Overall Study|Death|1|||
156681172|NCT02129062|565578918|FG000|Overall Study|Disease Progression|2|||
156681173|NCT02031237|565578919|FG000|Overall Study|Death|1|||
156681174|NCT02031237|565578920|FG001|Overall Study|Death|5|||
156681175|NCT02031237|565578921|FG002|Overall Study|Death|0|||
156681176|NCT02031237|565578919|FG000|Overall Study|Physician Decision|0|||
156681177|NCT02031237|565578920|FG001|Overall Study|Physician Decision|1|||
156681178|NCT02031237|565578921|FG002|Overall Study|Physician Decision|0|||
156681179|NCT02031237|565578919|FG000|Overall Study|Withdrawal by Subject|2|||
156681180|NCT02031237|565578920|FG001|Overall Study|Withdrawal by Subject|2|||
156681181|NCT02031237|565578921|FG002|Overall Study|Withdrawal by Subject|0|||
156681182|NCT02031237|565578919|FG000|Overall Study|Protocol Violation|2|||
156681183|NCT02031237|565578920|FG001|Overall Study|Protocol Violation|6|||
156681184|NCT02031237|565578921|FG002|Overall Study|Protocol Violation|0|||
156681185|NCT02031237|565578919|FG000|Overall Study|Alternate Treatment Given|0|||
156681186|NCT02031237|565578920|FG001|Overall Study|Alternate Treatment Given|0|||
156681187|NCT02031237|565578921|FG002|Overall Study|Alternate Treatment Given|3|||
156681188|NCT00377156|565578927|FG000|Overall Study|Death|23|||
156681189|NCT00377156|565578928|FG001|Overall Study|Death|19|||
156681190|NCT00377156|565578927|FG000|Overall Study|Withdrawal by Subject|16|||
156681191|NCT00377156|565578928|FG001|Overall Study|Withdrawal by Subject|24|||
156681192|NCT00377156|565578927|FG000|Overall Study|Had follow-up <90 d|3|||
156681193|NCT00377156|565578928|FG001|Overall Study|Had follow-up <90 d|6|||
156681194|NCT00377156|565578927|FG000|Overall Study|Cancellation|1|||
156681195|NCT00377156|565578928|FG001|Overall Study|Cancellation|0|||
156681196|NCT00377156|565578927|FG000|Overall Study|Refused testing|0|||
156681197|NCT00377156|565578928|FG001|Overall Study|Refused testing|1|||
156681198|NCT00377156|565578927|FG000|Overall Study|Ineligible|0|||
156681199|NCT00377156|565578928|FG001|Overall Study|Ineligible|1|||
156681200|NCT00377156|565578927|FG000|Overall Study|Disability or language problem|0|||
156681201|NCT00377156|565578928|FG001|Overall Study|Disability or language problem|1|||
156681202|NCT00377156|565578927|FG000|Overall Study|Other|5|||
156783639|NCT05206604|565957492|FG007|Overall Study|Non-compliance with study drug|0|||
156681203|NCT00377156|565578928|FG001|Overall Study|Other|2|||
156681204|NCT01802216|565578929|FG000|4 Month Visit|Participant did not show to visit|3|||
156681205|NCT01802216|565578930|FG001|4 Month Visit|Participant did not show to visit|4|||
156681206|NCT01802216|565578929|FG000|8 Month Visit|Participant did not show to visit|3|||
156681207|NCT01802216|565578930|FG001|8 Month Visit|Participant did not show to visit|5|||
156681208|NCT01802216|565578929|FG000|12 Month Visit|Participant did not show to visit|3|||
156681209|NCT01802216|565578930|FG001|12 Month Visit|Participant did not show to visit|4|||
156681210|NCT00517192|565578935|FG000|Overall Study|Adverse Event|1|||
156681211|NCT00517192|565578936|FG001|Overall Study|Adverse Event|1|||
156681212|NCT00517192|565578935|FG000|Overall Study|Lost to Follow-up|1|||
156681213|NCT00517192|565578936|FG001|Overall Study|Lost to Follow-up|1|||
156681214|NCT00517192|565578935|FG000|Overall Study|Withdrawal by Subject|1|||
156681215|NCT00517192|565578936|FG001|Overall Study|Withdrawal by Subject|0|||
156681216|NCT00517192|565578935|FG000|Overall Study|Early termination of the trial|16|||
156681217|NCT00517192|565578936|FG001|Overall Study|Early termination of the trial|18|||
156681218|NCT05212948|565578942|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
156681219|NCT05212948|565578943|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
156681220|NCT05212948|565578942|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
156681221|NCT05212948|565578943|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
156681222|NCT05212948|565578942|FG000|Initial Vaccination Period|Pregnancy|20|||
156681223|NCT05212948|565578943|FG001|Initial Vaccination Period|Pregnancy|14|||
156681224|NCT05212948|565578942|FG000|Initial Vaccination Period|Physician Decision|686|||
156681225|NCT05212948|565578943|FG001|Initial Vaccination Period|Physician Decision|401|||
156681226|NCT05212948|565578942|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
156681227|NCT05212948|565578943|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
156681228|NCT05212948|565578942|FG000|Initial Vaccination Period|Death|23|||
156681229|NCT05212948|565578943|FG001|Initial Vaccination Period|Death|18|||
156681230|NCT05212948|565578942|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
156681231|NCT05212948|565578943|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
156681232|NCT05212948|565578942|FG000|Initial Vaccination Period|Adverse Event|36|||
156681233|NCT05212948|565578943|FG001|Initial Vaccination Period|Adverse Event|23|||
156681234|NCT05212948|565578942|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
156681235|NCT05212948|565578943|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
156681236|NCT05212948|565578942|FG000|Crossover Vaccination Period|Pregnancy|6|||
156681237|NCT05212948|565578943|FG001|Crossover Vaccination Period|Pregnancy|1|||
156435379|NCT04001829|564684911|FG001|Overall Study|Withdrawal by Subject|4|||
156681238|NCT05212948|565578942|FG000|Crossover Vaccination Period|Physician Decision|49|||
156681239|NCT05212948|565578943|FG001|Crossover Vaccination Period|Physician Decision|24|||
156681240|NCT05212948|565578942|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
156681241|NCT05212948|565578943|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
156681242|NCT05212948|565578942|FG000|Crossover Vaccination Period|Death|10|||
156681243|NCT05212948|565578943|FG001|Crossover Vaccination Period|Death|5|||
156681244|NCT05212948|565578942|FG000|Crossover Vaccination Period|Adverse Event|9|||
156783640|NCT00567580|565957493|FG000|Overall Study|Protocol Violation|28|||
156783641|NCT00567580|565957494|FG001|Overall Study|Protocol Violation|24|||
156783642|NCT00567580|565957495|FG002|Overall Study|Protocol Violation|24|||
156783643|NCT00552058|565957501|FG000|Overall Study|Adverse Event|8|||
156783644|NCT00552058|565957502|FG001|Overall Study|Adverse Event|7|||
156783645|NCT00552058|565957501|FG000|Overall Study|Lack of Efficacy|1|||
156783646|NCT00552058|565957502|FG001|Overall Study|Lack of Efficacy|5|||
156783647|NCT00552058|565957501|FG000|Overall Study|Lost to Follow-up|1|||
156783648|NCT00552058|565957502|FG001|Overall Study|Lost to Follow-up|0|||
156783649|NCT00552058|565957501|FG000|Overall Study|Withdrawal by Subject|4|||
156529345|NCT01794520|565032621|FG006|Overall Study|Withdrew consent|0|||
156529346|NCT01794520|565032615|FG000|Overall Study|Lost to Follow-up|0|||
156529347|NCT01794520|565032616|FG001|Overall Study|Lost to Follow-up|0|||
156435380|NCT04001829|564684910|FG000|Overall Study|Ineligible|2|||
156435381|NCT04001829|564684911|FG001|Overall Study|Ineligible|2|||
156435382|NCT04001829|564684910|FG000|Overall Study|Reason missing due to delinquent data|1|||
156681245|NCT05212948|565578943|FG001|Crossover Vaccination Period|Adverse Event|4|||
156681246|NCT05347693|565578944|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
156681247|NCT05347693|565578945|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
156681248|NCT05347693|565578946|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
156681249|NCT05347693|565578944|FG000|Inpatient Period|Withdrawal of consent|10|||
156681250|NCT05347693|565578945|FG001|Inpatient Period|Withdrawal of consent|0|||
156681251|NCT05347693|565578946|FG002|Inpatient Period|Withdrawal of consent|0|||
156681252|NCT05347693|565578944|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
156681253|NCT05347693|565578945|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
156435383|NCT04001829|564684911|FG001|Overall Study|Reason missing due to delinquent data|0|||
156435384|NCT04496960|564684912|FG000|Overall Study|Physician Decision|0|||
156435385|NCT04496960|564684913|FG001|Overall Study|Physician Decision|1|||
156681254|NCT05347693|565578946|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
156529348|NCT01794520|565032617|FG002|Overall Study|Lost to Follow-up|0|||
156529349|NCT01794520|565032618|FG003|Overall Study|Lost to Follow-up|0|||
156435386|NCT03175172|564684914|FG000|Overall Study|Death|3|||
156529350|NCT01794520|565032619|FG004|Overall Study|Lost to Follow-up|1|||
156681255|NCT05347693|565578944|FG000|Inpatient Period|Screening Failure|8|||
156681256|NCT05347693|565578945|FG001|Inpatient Period|Screening Failure|0|||
156783650|NCT00552058|565957502|FG001|Overall Study|Withdrawal by Subject|4|||
156783651|NCT00552058|565957501|FG000|Overall Study|Other: Protocol Violation|0|||
156529351|NCT01794520|565032620|FG005|Overall Study|Lost to Follow-up|0|||
156529352|NCT01794520|565032621|FG006|Overall Study|Lost to Follow-up|0|||
156529353|NCT01794520|565032615|FG000|Overall Study|Toxicity|0|||
156783652|NCT00552058|565957502|FG001|Overall Study|Other: Protocol Violation|1|||
156783653|NCT00552058|565957501|FG000|Overall Study|Other: Non Compliance|1|||
156783654|NCT00552058|565957502|FG001|Overall Study|Other: Non Compliance|2|||
156783655|NCT00552058|565957501|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
156783656|NCT00552058|565957502|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
156783657|NCT00552058|565957501|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
156783658|NCT00552058|565957502|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
156783659|NCT00552058|565957501|FG000|Overall Study|Other: Positive Stool Result|0|||
156783660|NCT00552058|565957502|FG001|Overall Study|Other: Positive Stool Result|1|||
156783661|NCT00552058|565957501|FG000|Overall Study|Other: Randomized in error|0|||
156783662|NCT00552058|565957502|FG001|Overall Study|Other: Randomized in error|1|||
156783663|NCT00552058|565957501|FG000|Overall Study|Other: Sponsors Decision|0|||
156783664|NCT00552058|565957502|FG001|Overall Study|Other: Sponsors Decision|1|||
156783665|NCT00552058|565957501|FG000|Overall Study|Other: Early Roll Over|1|||
156783666|NCT00552058|565957502|FG001|Overall Study|Other: Early Roll Over|0|||
156783667|NCT02609633|565957503|FG000|Overall Study|Consent Withdrawn|0|||
156783668|NCT02609633|565957504|FG001|Overall Study|Consent Withdrawn|1|||
156783669|NCT02609633|565957503|FG000|Overall Study|Protocol Deviation|1|||
156783670|NCT02609633|565957504|FG001|Overall Study|Protocol Deviation|0|||
156783671|NCT02609633|565957503|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
156783672|NCT02609633|565957504|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
156783673|NCT02609633|565957503|FG000|Overall Study|Reason not Specified|2|||
156783674|NCT02609633|565957504|FG001|Overall Study|Reason not Specified|1|||
156783675|NCT00471107|565957511|FG000|Overall Study|Technical problems/data loss|3|||
156783676|NCT00471107|565957512|FG001|Overall Study|Technical problems/data loss|1|||
156783677|NCT00471107|565957513|FG002|Overall Study|Technical problems/data loss|3|||
156783678|NCT00387127|565957515|FG000|Overall Study|Lost to Follow-up|0|||
156783679|NCT00387127|565957516|FG001|Overall Study|Lost to Follow-up|4|||
156783680|NCT00387127|565957515|FG000|Overall Study|Death|16|||
156783681|NCT00387127|565957516|FG001|Overall Study|Death|16|||
156783682|NCT00387127|565957515|FG000|Overall Study|Physician Decision|0|||
156783683|NCT00387127|565957516|FG001|Overall Study|Physician Decision|1|||
156783684|NCT00387127|565957515|FG000|Overall Study|Withdrawal by Subject|3|||
156783685|NCT00387127|565957516|FG001|Overall Study|Withdrawal by Subject|2|||
156783686|NCT00387127|565957515|FG000|Overall Study|Required by Protocol Amendment #4|12|||
156783687|NCT00387127|565957516|FG001|Overall Study|Required by Protocol Amendment #4|10|||
156783688|NCT00387127|565957515|FG000|Overall Study|Serious Adverse Event|1|||
156783689|NCT00387127|565957516|FG001|Overall Study|Serious Adverse Event|1|||
156783690|NCT00387127|565957515|FG000|Overall Study|Sponsor Unblinded|1|||
156783691|NCT00387127|565957516|FG001|Overall Study|Sponsor Unblinded|0|||
156783692|NCT02068599|565957522|FG000|Overall Study|Adverse Event|4|||
156783693|NCT02068599|565957523|FG001|Overall Study|Adverse Event|1|||
156783694|NCT02068599|565957524|FG002|Overall Study|Adverse Event|1|||
156783695|NCT02068599|565957522|FG000|Overall Study|Withdrawal by Subject|2|||
156783696|NCT02068599|565957523|FG001|Overall Study|Withdrawal by Subject|7|||
156783697|NCT02068599|565957524|FG002|Overall Study|Withdrawal by Subject|5|||
156783698|NCT02068599|565957522|FG000|Overall Study|Protocol Violation|4|||
156783699|NCT02068599|565957523|FG001|Overall Study|Protocol Violation|2|||
156783700|NCT02068599|565957524|FG002|Overall Study|Protocol Violation|3|||
156783701|NCT02068599|565957522|FG000|Overall Study|Lost to Follow-up|1|||
156783702|NCT02068599|565957523|FG001|Overall Study|Lost to Follow-up|0|||
156783703|NCT02068599|565957524|FG002|Overall Study|Lost to Follow-up|0|||
156783704|NCT02068599|565957522|FG000|Overall Study|Lack of Efficacy|0|||
156783705|NCT02068599|565957523|FG001|Overall Study|Lack of Efficacy|0|||
156783706|NCT02068599|565957524|FG002|Overall Study|Lack of Efficacy|3|||
156783707|NCT02068599|565957522|FG000|Overall Study|Noncompliance|0|||
156783708|NCT02068599|565957523|FG001|Overall Study|Noncompliance|0|||
156783709|NCT02068599|565957524|FG002|Overall Study|Noncompliance|1|||
156783710|NCT01263028|565957525|FG000|Overall Study|Withdrawal by Subject|1|||
156783711|NCT01263028|565957525|FG000|Overall Study|Adverse Event|1|||
156783712|NCT01263028|565957525|FG000|Overall Study|Study terminated due to low enrollment.|4|||
156783713|NCT06042855|565957526|FG000|Overall Study|No Receipt of Study Drug|48|||
156783714|NCT06042855|565957527|FG001|Overall Study|No Receipt of Study Drug|57|||
156783715|NCT06042855|565957526|FG000|Overall Study|Administratively Withdrawn|59|||
156529354|NCT01794520|565032616|FG001|Overall Study|Toxicity|2|||
156783716|NCT06042855|565957527|FG001|Overall Study|Administratively Withdrawn|59|||
156783717|NCT06038643|565957529|FG000|Overall Study|Withdrawal by Subject|9|||
156783718|NCT06038643|565957530|FG001|Overall Study|Withdrawal by Subject|4|||
156783719|NCT06038643|565957529|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
156783720|NCT06038643|565957530|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
156783721|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
156783722|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
156783723|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Death|28|||
156681257|NCT05347693|565578946|FG002|Inpatient Period|Screening Failure|0|||
156329225|NCT02124161|564305548|FG001|Overall Study|Adverse Event|0|||
156329226|NCT02124161|564305547|FG000|Overall Study|Does not meet entrance criteria|2|||
156329227|NCT02124161|564305548|FG001|Overall Study|Does not meet entrance criteria|3|||
156329228|NCT02124161|564305547|FG000|Overall Study|No longer meets eligibility criteria|5|||
156681258|NCT05347693|565578944|FG000|Inpatient Period|Death|2|||
156681259|NCT05347693|565578945|FG001|Inpatient Period|Death|0|||
156681260|NCT05347693|565578946|FG002|Inpatient Period|Death|0|||
156681261|NCT05347693|565578944|FG000|Inpatient Period|Physician Decision|5|||
156681262|NCT05347693|565578945|FG001|Inpatient Period|Physician Decision|0|||
156681263|NCT05347693|565578946|FG002|Inpatient Period|Physician Decision|0|||
156681264|NCT05347693|565578944|FG000|Inpatient Period|Adverse Event|3|||
156681265|NCT05347693|565578945|FG001|Inpatient Period|Adverse Event|0|||
156681266|NCT05347693|565578946|FG002|Inpatient Period|Adverse Event|0|||
156681267|NCT05347693|565578944|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
156681268|NCT05347693|565578945|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
156681269|NCT05347693|565578946|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
156681270|NCT05347693|565578944|FG000|Outpatient Period|Adverse Event|0|||
156681271|NCT05347693|565578945|FG001|Outpatient Period|Adverse Event|9|||
156681272|NCT05347693|565578946|FG002|Outpatient Period|Adverse Event|0|||
156681273|NCT05347693|565578944|FG000|Outpatient Period|Death|0|||
156681274|NCT05347693|565578945|FG001|Outpatient Period|Death|6|||
156681275|NCT05347693|565578946|FG002|Outpatient Period|Death|2|||
156681276|NCT05347693|565578944|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
156681277|NCT05347693|565578945|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
156681278|NCT05347693|565578946|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
156681279|NCT05347693|565578944|FG000|Outpatient Period|Lost to Follow-up|0|||
156681280|NCT05347693|565578945|FG001|Outpatient Period|Lost to Follow-up|0|||
156681281|NCT05347693|565578946|FG002|Outpatient Period|Lost to Follow-up|1|||
156681282|NCT05347693|565578944|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
156681283|NCT05347693|565578945|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
156681284|NCT05347693|565578946|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
156681285|NCT05347693|565578944|FG000|Outpatient Period|Scheduled hemodialysis|0|||
156681286|NCT05347693|565578945|FG001|Outpatient Period|Scheduled hemodialysis|1|||
156681287|NCT05347693|565578946|FG002|Outpatient Period|Scheduled hemodialysis|0|||
156681288|NCT05347693|565578944|FG000|Outpatient Period|Severe HK|0|||
156681289|NCT05347693|565578945|FG001|Outpatient Period|Severe HK|0|||
156681290|NCT05347693|565578946|FG002|Outpatient Period|Severe HK|1|||
156681291|NCT05347693|565578944|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
156681292|NCT05347693|565578945|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
156681293|NCT05347693|565578946|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
156681294|NCT05347693|565578944|FG000|Outpatient Period|Start of dialysis|0|||
156681295|NCT05347693|565578945|FG001|Outpatient Period|Start of dialysis|0|||
156681296|NCT05347693|565578946|FG002|Outpatient Period|Start of dialysis|1|||
156681297|NCT05347693|565578944|FG000|Outpatient Period|The participant entered hemodialysis|0|||
156681298|NCT05347693|565578945|FG001|Outpatient Period|The participant entered hemodialysis|0|||
156681299|NCT05347693|565578946|FG002|Outpatient Period|The participant entered hemodialysis|1|||
156681300|NCT05347693|565578944|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
156681301|NCT05347693|565578945|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
156681302|NCT05347693|565578946|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
156783724|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Death|29|||
156783725|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
156783726|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
156783727|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Other|30|||
156783728|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Other|20|||
156783729|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
156783730|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
156783731|NCT00699751|565957531|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
156783732|NCT00699751|565957532|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
156783733|NCT00699751|565957531|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
156783734|NCT00699751|565957532|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
156783735|NCT00699751|565957531|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
156783736|NCT00699751|565957532|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
156783737|NCT01947933|565957533|FG000|Overall Study|Withdrawal by Subject|0|||
156783738|NCT01947933|565957534|FG001|Overall Study|Withdrawal by Subject|0|||
156783739|NCT01947933|565957535|FG002|Overall Study|Withdrawal by Subject|1|||
156783740|NCT01947933|565957536|FG003|Overall Study|Withdrawal by Subject|0|||
156681303|NCT05347693|565578944|FG000|Outpatient Period|Withdrawal by Subject|0|||
156681304|NCT05347693|565578945|FG001|Outpatient Period|Withdrawal by Subject|8|||
156681305|NCT05347693|565578946|FG002|Outpatient Period|Withdrawal by Subject|5|||
156681306|NCT00695110|565578949|FG000|Treatment Period 1|Adverse Event|1|||
156681307|NCT00695110|565578949|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156681308|NCT00695110|565578949|FG000|Treatment Period 3|Withdrawal by Subject|1|||
156681309|NCT00695110|565578949|FG000|Treatment Period 4|Adverse Event|1|||
156681310|NCT04675775|565578953|FG000|Overall Study|Withdrawal by Subject|7|||
156681311|NCT04941768|565578957|FG000|Overall Study|Lost to Follow-up|10|||
156681312|NCT04941768|565578957|FG000|Overall Study|Death|24|||
156681313|NCT04941768|565578957|FG000|Overall Study|Progressive Disease|4|||
156681314|NCT04941768|565578957|FG000|Overall Study|Withdrawal by Subject|4|||
156681315|NCT04941768|565578957|FG000|Overall Study|Other|3|||
156681316|NCT04941768|565578957|FG000|Overall Study|Treatment ongoing|21|||
156681317|NCT04941768|565578957|FG000|Overall Study|Off treatment and in follow-up|21|||
156681318|NCT03302078|565578958|FG000|Washout Period|Adverse Event|0|||
156681319|NCT03302078|565578959|FG001|Washout Period|Adverse Event|1|||
156681320|NCT05148299|565578960|FG000|Treatment Period|Adverse Event|1|||
156681321|NCT05148299|565578960|FG000|Treatment Period|Physician Decision|1|||
156681322|NCT05148299|565578960|FG000|Treatment Period|Death|1|||
156681323|NCT05148299|565578960|FG000|Follow-up Period|Death|3|||
156681324|NCT02161549|565578961|FG000|Overall Study|Physician Decision|6|||
156681325|NCT02161549|565578962|FG001|Overall Study|Physician Decision|2|||
156681326|NCT02340780|565578963|FG000|Overall Study|Ineligible|1|||
156681327|NCT03433703|565578964|FG000|Overall Study|Study terminated by Sponsor|2|||
156681328|NCT01957150|565578965|FG000|Overall Study|Adverse Event|23|||
156681329|NCT01957150|565578966|FG001|Overall Study|Adverse Event|20|||
156681330|NCT01957150|565578965|FG000|Overall Study|Withdrawal by Subject|13|||
156681331|NCT01957150|565578966|FG001|Overall Study|Withdrawal by Subject|17|||
156681332|NCT01957150|565578965|FG000|Overall Study|Physician Decision|3|||
156681333|NCT01957150|565578966|FG001|Overall Study|Physician Decision|6|||
156681334|NCT01957150|565578965|FG000|Overall Study|Lost to Follow-up|4|||
156681335|NCT01957150|565578966|FG001|Overall Study|Lost to Follow-up|4|||
156329229|NCT02124161|564305548|FG001|Overall Study|No longer meets eligibility criteria|4|||
156329230|NCT02124161|564305547|FG000|Overall Study|Lost to Follow-up|3|||
156329231|NCT02124161|564305548|FG001|Overall Study|Lost to Follow-up|4|||
156329232|NCT05085730|564305554|FG000|Overall Study|Withdrawal by Subject|4|||
156329233|NCT05085730|564305554|FG000|Overall Study|Physician Decision|1|||
156329234|NCT04010539|564305555|FG000|Overall Study|Withdrawal by Subject|4|||
156329235|NCT04010539|564305556|FG001|Overall Study|Withdrawal by Subject|1|||
156329236|NCT04010539|564305555|FG000|Overall Study|Physician Decision|0|||
156329237|NCT04010539|564305556|FG001|Overall Study|Physician Decision|2|||
156329238|NCT04010539|564305555|FG000|Overall Study|Lost to Follow-up|10|||
156329239|NCT04010539|564305556|FG001|Overall Study|Lost to Follow-up|14|||
156329240|NCT04010539|564305555|FG000|Overall Study|Adverse Event|3|||
156329241|NCT04010539|564305556|FG001|Overall Study|Adverse Event|0|||
156329242|NCT04010539|564305555|FG000|Overall Study|Participant Did Not Receive IP|0|||
156329243|NCT04010539|564305556|FG001|Overall Study|Participant Did Not Receive IP|1|||
156329244|NCT04010539|564305555|FG000|Overall Study|Protocol Deviation|0|||
156329245|NCT04010539|564305556|FG001|Overall Study|Protocol Deviation|1|||
156329246|NCT04010539|564305555|FG000|Overall Study|Randomized in Error/ Mistake|2|||
156329247|NCT04010539|564305556|FG001|Overall Study|Randomized in Error/ Mistake|0|||
156329248|NCT04010539|564305555|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
156329249|NCT04010539|564305556|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
156329250|NCT00381381|564305564|FG000|Overall Study|Adverse Event|3|||
156329251|NCT00381381|564305564|FG000|Overall Study|Lost to Follow-up|52|||
156329252|NCT00381381|564305564|FG000|Overall Study|Withdrawal by Subject|9|||
156329253|NCT01484132|564305567|FG000|Overall Study|Lost to Follow-up|8|||
156329254|NCT01484132|564305567|FG000|Overall Study|Difficulty with time commitment|2|||
156329255|NCT01484132|564305567|FG000|Overall Study|Ineligible|1|||
156329256|NCT01484132|564305567|FG000|Overall Study|No pre-treatment urine sample collected|1|||
156329257|NCT01484132|564305567|FG000|Overall Study|No post-treatment urine sample collected|10|||
156329258|NCT01912963|564305568|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
156329259|NCT01912963|564305569|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
156329260|NCT01912963|564305570|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
156329261|NCT01912963|564305568|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
156329262|NCT01912963|564305569|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
156329263|NCT01912963|564305570|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
156329264|NCT01912963|564305568|FG000|Overall Study|Adverse Event|0|||
156329265|NCT01912963|564305569|FG001|Overall Study|Adverse Event|1|||
156329266|NCT01912963|564305570|FG002|Overall Study|Adverse Event|1|||
156329267|NCT01912963|564305568|FG000|Overall Study|Withdrawal by Subject|0|||
156681336|NCT01957150|565578965|FG000|Overall Study|Protocol Violation|1|||
156681337|NCT01957150|565578966|FG001|Overall Study|Protocol Violation|0|||
156681338|NCT01957150|565578965|FG000|Overall Study|Lack of Efficacy|11|||
156681339|NCT01957150|565578966|FG001|Overall Study|Lack of Efficacy|11|||
156681340|NCT03223909|565578967|FG000|Overall Study|Protocol Violation|48|||
156783741|NCT01947933|565957537|FG004|Overall Study|Withdrawal by Subject|0|||
156783742|NCT01947933|565957538|FG005|Overall Study|Withdrawal by Subject|0|||
156783743|NCT01947933|565957539|FG006|Overall Study|Withdrawal by Subject|0|||
156783744|NCT01947933|565957540|FG007|Overall Study|Withdrawal by Subject|0|||
156783745|NCT01947933|565957541|FG008|Overall Study|Withdrawal by Subject|0|||
156783746|NCT01947933|565957533|FG000|Overall Study|Lost to Follow-up|0|||
156783747|NCT01947933|565957534|FG001|Overall Study|Lost to Follow-up|0|||
156329268|NCT01912963|564305569|FG001|Overall Study|Withdrawal by Subject|1|||
156529355|NCT01794520|565032617|FG002|Overall Study|Toxicity|0|||
156529356|NCT01794520|565032618|FG003|Overall Study|Toxicity|0|||
156529357|NCT01794520|565032619|FG004|Overall Study|Toxicity|0|||
156529358|NCT01794520|565032620|FG005|Overall Study|Toxicity|0|||
156529359|NCT01794520|565032621|FG006|Overall Study|Toxicity|0|||
156529360|NCT01794520|565032615|FG000|Overall Study|Study terminated by sponsor|0|||
156529361|NCT01794520|565032616|FG001|Overall Study|Study terminated by sponsor|0|||
156529362|NCT01794520|565032617|FG002|Overall Study|Study terminated by sponsor|1|||
156529363|NCT01794520|565032618|FG003|Overall Study|Study terminated by sponsor|0|||
156529364|NCT01794520|565032619|FG004|Overall Study|Study terminated by sponsor|1|||
156529365|NCT01794520|565032620|FG005|Overall Study|Study terminated by sponsor|0|||
156529366|NCT01794520|565032621|FG006|Overall Study|Study terminated by sponsor|7|||
156529367|NCT01794520|565032615|FG000|Overall Study|Death|0|||
156529368|NCT01794520|565032616|FG001|Overall Study|Death|0|||
156529369|NCT01794520|565032617|FG002|Overall Study|Death|0|||
156529370|NCT01794520|565032618|FG003|Overall Study|Death|0|||
156529371|NCT01794520|565032619|FG004|Overall Study|Death|1|||
156529372|NCT01794520|565032620|FG005|Overall Study|Death|0|||
156329269|NCT01912963|564305570|FG002|Overall Study|Withdrawal by Subject|0|||
156329270|NCT01912963|564305568|FG000|Overall Study|Sought treatment locally|0|||
156329271|NCT01912963|564305569|FG001|Overall Study|Sought treatment locally|1|||
156329272|NCT01912963|564305570|FG002|Overall Study|Sought treatment locally|0|||
156329273|NCT02787551|564305572|FG000|Core Period: 26 Weeks|Adverse Event|10|||
156329274|NCT02787551|564305573|FG001|Core Period: 26 Weeks|Adverse Event|0|||
156329275|NCT02787551|564305572|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
156329276|NCT02787551|564305573|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
156329277|NCT02787551|564305572|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
156329278|NCT02787551|564305573|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
156329279|NCT02787551|564305572|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
156329280|NCT02787551|564305573|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
156329281|NCT02787551|564305572|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
156329282|NCT02787551|564305573|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
156329283|NCT02787551|564305572|FG000|Core Period: 26 Weeks|Other than specified|3|||
156329284|NCT02787551|564305573|FG001|Core Period: 26 Weeks|Other than specified|1|||
156329285|NCT02787551|564305572|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
156329286|NCT02787551|564305573|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
156329287|NCT02787551|564305572|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
156329288|NCT02787551|564305573|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
156329289|NCT02787551|564305572|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
156329290|NCT02787551|564305573|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
156329291|NCT03799211|564305574|FG000|Overall Study|Lost to Follow-up|2|||
156329292|NCT03799211|564305575|FG001|Overall Study|Lost to Follow-up|13|||
156329293|NCT03799211|564305574|FG000|Overall Study|Withdrawal by Subject|2|||
156329294|NCT03799211|564305575|FG001|Overall Study|Withdrawal by Subject|0|||
156329295|NCT00620464|564305576|FG000|Overall Study|Adverse Event|15|||
156329296|NCT00620464|564305577|FG001|Overall Study|Adverse Event|17|||
156329297|NCT00620464|564305576|FG000|Overall Study|Lost to Follow-up|1|||
156329298|NCT00620464|564305577|FG001|Overall Study|Lost to Follow-up|1|||
156329299|NCT00620464|564305576|FG000|Overall Study|Planning Pregnancy|1|||
156329300|NCT00620464|564305577|FG001|Overall Study|Planning Pregnancy|4|||
156329301|NCT00620464|564305576|FG000|Overall Study|Personal|2|||
156529373|NCT01794520|565032621|FG006|Overall Study|Death|22|||
156529374|NCT01794520|565032615|FG000|Overall Study|Other, not specified|0|||
156529375|NCT01794520|565032616|FG001|Overall Study|Other, not specified|0|||
156529376|NCT01794520|565032617|FG002|Overall Study|Other, not specified|1|||
156529377|NCT01794520|565032618|FG003|Overall Study|Other, not specified|1|||
156529378|NCT01794520|565032619|FG004|Overall Study|Other, not specified|4|||
156529379|NCT01794520|565032620|FG005|Overall Study|Other, not specified|1|||
156783748|NCT01947933|565957535|FG002|Overall Study|Lost to Follow-up|0|||
156783749|NCT01947933|565957536|FG003|Overall Study|Lost to Follow-up|0|||
156783750|NCT01947933|565957537|FG004|Overall Study|Lost to Follow-up|0|||
156783751|NCT01947933|565957538|FG005|Overall Study|Lost to Follow-up|0|||
156329302|NCT00620464|564305577|FG001|Overall Study|Personal|2|||
156329303|NCT00620464|564305576|FG000|Overall Study|Used prohibited medication|1|||
156329304|NCT00620464|564305577|FG001|Overall Study|Used prohibited medication|0|||
156529380|NCT01794520|565032621|FG006|Overall Study|Other, not specified|2|||
156529381|NCT04356183|565032622|FG000|Overall Study|Lost to Follow-up|1|||
156783752|NCT01947933|565957539|FG006|Overall Study|Lost to Follow-up|0|||
156783753|NCT01947933|565957540|FG007|Overall Study|Lost to Follow-up|0|||
156435387|NCT03175172|564684914|FG000|Overall Study|Withdrawal by Subject|3|||
156435388|NCT03175172|564684914|FG000|Overall Study|Lost to Follow-up|1|||
156435389|NCT03175172|564684914|FG000|Overall Study|Study Terminated by Sponsor|3|||
156435390|NCT02974634|564684915|FG000|Overall Study|Advanced disease|12|||
156435391|NCT02974634|564684916|FG001|Overall Study|Advanced disease|3|||
156435392|NCT02974634|564684915|FG000|Overall Study|Noncompliance|3|||
156435393|NCT02974634|564684916|FG001|Overall Study|Noncompliance|7|||
156435394|NCT02974634|564684915|FG000|Overall Study|intervention technology related issues|5|||
156435395|NCT02974634|564684916|FG001|Overall Study|intervention technology related issues|0|||
156435396|NCT02974634|564684915|FG000|Overall Study|Death|8|||
156435397|NCT02974634|564684916|FG001|Overall Study|Death|11|||
156435398|NCT02932410|564684917|FG000|Overall Study|Death|7|||
156435399|NCT02932410|564684918|FG001|Overall Study|Death|6|||
156435400|NCT02932410|564684919|FG002|Overall Study|Death|0|||
156435401|NCT02932410|564684920|FG003|Overall Study|Death|0|||
156435402|NCT02932410|564684917|FG000|Overall Study|Lost to Follow-up|1|||
156435403|NCT02932410|564684918|FG001|Overall Study|Lost to Follow-up|2|||
156435404|NCT02932410|564684919|FG002|Overall Study|Lost to Follow-up|0|||
156435405|NCT02932410|564684920|FG003|Overall Study|Lost to Follow-up|0|||
156435406|NCT02932410|564684917|FG000|Overall Study|Parent/Subjects decision|6|||
156435407|NCT02932410|564684918|FG001|Overall Study|Parent/Subjects decision|6|||
156435408|NCT02932410|564684919|FG002|Overall Study|Parent/Subjects decision|1|||
156435409|NCT02932410|564684920|FG003|Overall Study|Parent/Subjects decision|0|||
156435410|NCT02932410|564684917|FG000|Overall Study|Physician Decision|0|||
156435411|NCT02932410|564684918|FG001|Overall Study|Physician Decision|1|||
156435412|NCT02932410|564684919|FG002|Overall Study|Physician Decision|0|||
156435413|NCT02932410|564684920|FG003|Overall Study|Physician Decision|0|||
156435414|NCT05758415|564684924|FG000|Overall Study|Subject Decision|2|||
156435415|NCT05758415|564684925|FG001|Overall Study|Subject Decision|5|||
156435416|NCT05758415|564684924|FG000|Overall Study|Lost to Follow-up|0|||
156435417|NCT05758415|564684925|FG001|Overall Study|Lost to Follow-up|1|||
156435418|NCT03622593|564684926|FG000|Overall Study|Withdrawal by Subject|11|||
156435419|NCT03622593|564684927|FG001|Overall Study|Withdrawal by Subject|9|||
156435420|NCT03622593|564684928|FG002|Overall Study|Withdrawal by Subject|13|||
156435421|NCT03622593|564684926|FG000|Overall Study|Death|12|||
156435422|NCT03622593|564684927|FG001|Overall Study|Death|9|||
156435423|NCT03622593|564684928|FG002|Overall Study|Death|10|||
156435424|NCT03622593|564684926|FG000|Overall Study|Lost to Follow-up|11|||
156435425|NCT03622593|564684927|FG001|Overall Study|Lost to Follow-up|5|||
156435426|NCT03622593|564684928|FG002|Overall Study|Lost to Follow-up|8|||
156435427|NCT03622593|564684926|FG000|Overall Study|Adverse Event|4|||
156435428|NCT03622593|564684927|FG001|Overall Study|Adverse Event|5|||
156435429|NCT03622593|564684928|FG002|Overall Study|Adverse Event|6|||
156435430|NCT03622593|564684926|FG000|Overall Study|Physician Decision|2|||
156867480|NCT00118417|566275626|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
156867481|NCT00118417|566275627|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
156435431|NCT03622593|564684927|FG001|Overall Study|Physician Decision|1|||
156435432|NCT03622593|564684928|FG002|Overall Study|Physician Decision|6|||
156435433|NCT03622593|564684926|FG000|Overall Study|Other|2|||
156435434|NCT03622593|564684927|FG001|Overall Study|Other|2|||
156435435|NCT03622593|564684928|FG002|Overall Study|Other|3|||
156435436|NCT03622593|564684926|FG000|Overall Study|Protocol Violation|0|||
156435437|NCT03622593|564684927|FG001|Overall Study|Protocol Violation|0|||
156435438|NCT03622593|564684928|FG002|Overall Study|Protocol Violation|1|||
156435439|NCT03622593|564684926|FG000|Overall Study|Pregnancy|0|||
156435440|NCT03622593|564684927|FG001|Overall Study|Pregnancy|0|||
156435441|NCT03622593|564684928|FG002|Overall Study|Pregnancy|1|||
156435442|NCT01266265|564684931|FG000|Overall Study|Death|95|||
156435443|NCT01266265|564684932|FG001|Overall Study|Death|73|||
156435444|NCT01266265|564684931|FG000|Overall Study|Lost to Follow-up|23|||
156435445|NCT01266265|564684932|FG001|Overall Study|Lost to Follow-up|28|||
156435446|NCT01266265|564684931|FG000|Overall Study|Withdrawal by Subject|13|||
156435447|NCT01266265|564684932|FG001|Overall Study|Withdrawal by Subject|11|||
156435448|NCT01266265|564684931|FG000|Overall Study|Respiratory-related adverse event|2|||
156435449|NCT01266265|564684932|FG001|Overall Study|Respiratory-related adverse event|1|||
156435450|NCT01266265|564684931|FG000|Overall Study|Transferred care to another provider|22|||
156867482|NCT02978781|566275628|FG000|Part A|Adverse Event|1|||
156867483|NCT02978781|566275629|FG001|Part A|Adverse Event|1|||
156867484|NCT02978781|566275630|FG002|Part A|Adverse Event|0|||
156867485|NCT02978781|566275631|FG003|Part A|Adverse Event|0|||
156867486|NCT02978781|566275632|FG004|Part A|Adverse Event|0|||
156867487|NCT02978781|566275628|FG000|Part A|Withdrawal by Subject|0|||
156867488|NCT02978781|566275629|FG001|Part A|Withdrawal by Subject|1|||
156867489|NCT02978781|566275630|FG002|Part A|Withdrawal by Subject|0|||
156867490|NCT02978781|566275631|FG003|Part A|Withdrawal by Subject|0|||
156435451|NCT01266265|564684932|FG001|Overall Study|Transferred care to another provider|28|||
156435452|NCT01266265|564684931|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
156435453|NCT01266265|564684932|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
156435454|NCT01266265|564684931|FG000|Overall Study|Enrolled in another clinical study|15|||
156867491|NCT02978781|566275632|FG004|Part A|Withdrawal by Subject|0|||
156867492|NCT02978781|566275628|FG000|Part B|Withdrawal by Subject|0|||
156867493|NCT02978781|566275629|FG001|Part B|Withdrawal by Subject|0|||
156867494|NCT02978781|566275630|FG002|Part B|Withdrawal by Subject|0|||
156867495|NCT02978781|566275631|FG003|Part B|Withdrawal by Subject|1|||
156529382|NCT04356183|565032623|FG001|Overall Study|Lost to Follow-up|0|||
156529383|NCT04356183|565032622|FG000|Overall Study|Withdrawal by Subject|1|||
156529384|NCT04356183|565032623|FG001|Overall Study|Withdrawal by Subject|1|||
156529385|NCT01637623|565032624|FG000|Overall Study|Lost to Follow-up|0|||
156529386|NCT01637623|565032625|FG001|Overall Study|Lost to Follow-up|0|||
156529387|NCT01637623|565032626|FG002|Overall Study|Lost to Follow-up|2|||
156529388|NCT01637623|565032624|FG000|Overall Study|Physician Decision|1|||
156529389|NCT01637623|565032625|FG001|Overall Study|Physician Decision|0|||
156529390|NCT01637623|565032626|FG002|Overall Study|Physician Decision|1|||
156529391|NCT02824263|565032627|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
156529392|NCT02824263|565032628|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
156529393|NCT02824263|565032627|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
156529394|NCT02824263|565032628|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
156529395|NCT00568321|565032629|FG000|Overall Study|Adverse Event|1|||
156529396|NCT00568321|565032630|FG001|Overall Study|Adverse Event|0|||
156529397|NCT00568321|565032631|FG002|Overall Study|Adverse Event|0|||
156529398|NCT00568321|565032629|FG000|Overall Study|Lack of Efficacy|8|||
156529399|NCT00568321|565032630|FG001|Overall Study|Lack of Efficacy|5|||
156529400|NCT00568321|565032631|FG002|Overall Study|Lack of Efficacy|6|||
156529401|NCT00568321|565032629|FG000|Overall Study|Lost to Follow-up|0|||
156529402|NCT00568321|565032630|FG001|Overall Study|Lost to Follow-up|0|||
156529403|NCT00568321|565032631|FG002|Overall Study|Lost to Follow-up|1|||
156529404|NCT00568321|565032629|FG000|Overall Study|Withdrawal by Subject|2|||
156529405|NCT00568321|565032630|FG001|Overall Study|Withdrawal by Subject|0|||
156529406|NCT00568321|565032631|FG002|Overall Study|Withdrawal by Subject|0|||
156529407|NCT00568321|565032629|FG000|Overall Study|Protocol Violation|0|||
156529408|NCT00568321|565032630|FG001|Overall Study|Protocol Violation|0|||
156529409|NCT00568321|565032631|FG002|Overall Study|Protocol Violation|1|||
156529410|NCT00568321|565032629|FG000|Overall Study|Randomized, not treated|2|||
156529411|NCT00568321|565032630|FG001|Overall Study|Randomized, not treated|0|||
156529412|NCT00568321|565032631|FG002|Overall Study|Randomized, not treated|1|||
156529413|NCT04658186|565032633|FG000|Overall Study|Adverse Event|4|||
156529414|NCT04658186|565032634|FG001|Overall Study|Adverse Event|18|||
156529415|NCT04658186|565032635|FG002|Overall Study|Adverse Event|15|||
156529416|NCT04658186|565032633|FG000|Overall Study|Lack of Efficacy|1|||
156529417|NCT04658186|565032634|FG001|Overall Study|Lack of Efficacy|1|||
156529418|NCT04658186|565032635|FG002|Overall Study|Lack of Efficacy|0|||
156529419|NCT04658186|565032633|FG000|Overall Study|Protocol Violation|0|||
156529420|NCT04658186|565032634|FG001|Overall Study|Protocol Violation|0|||
156783754|NCT01947933|565957541|FG008|Overall Study|Lost to Follow-up|1|||
156783755|NCT00294398|565957542|FG000|Overall Study|Lost to Follow-up|21|||
156783756|NCT00294398|565957543|FG001|Overall Study|Lost to Follow-up|26|||
156783757|NCT01428128|565957547|FG000|Overall Study|Withdrawal by Subject|4|||
156783758|NCT01428128|565957547|FG000|Overall Study|Screen failure by p53|10|||
156783759|NCT01428128|565957547|FG000|Overall Study|Received Neulasta in one cycle|2|||
156783760|NCT01428128|565957547|FG000|Overall Study|Adverse Event|1|||
156867496|NCT02978781|566275632|FG004|Part B|Withdrawal by Subject|0|||
156867497|NCT02978781|566275628|FG000|Part C|Adverse Event|0|||
156867498|NCT02978781|566275629|FG001|Part C|Adverse Event|0|||
156867499|NCT02978781|566275630|FG002|Part C|Adverse Event|0|||
156867500|NCT02978781|566275631|FG003|Part C|Adverse Event|0|||
156529421|NCT04658186|565032635|FG002|Overall Study|Protocol Violation|1|||
156529422|NCT04658186|565032633|FG000|Overall Study|Lost to Follow-up|0|||
156529423|NCT04658186|565032634|FG001|Overall Study|Lost to Follow-up|0|||
156783761|NCT00250718|565957551|FG000|Overall Study|Death|1|||
156783762|NCT00250718|565957551|FG000|Overall Study|Adverse Event|1|||
156783763|NCT00250718|565957551|FG000|Overall Study|Withdrawal by Subject|1|||
156783764|NCT06100250|565957554|FG000|Overall Study|Lost to Follow-up|5|||
156783765|NCT00424008|565957556|FG000|Overall Study|Adverse Event|8|||
156783766|NCT00424008|565957557|FG001|Overall Study|Adverse Event|6|||
156783767|NCT00424008|565957556|FG000|Overall Study|Lack of Efficacy|40|||
156783768|NCT00424008|565957557|FG001|Overall Study|Lack of Efficacy|34|||
156783769|NCT00424008|565957556|FG000|Overall Study|Lost to Follow-up|1|||
156783770|NCT00424008|565957557|FG001|Overall Study|Lost to Follow-up|2|||
156783771|NCT00424008|565957556|FG000|Overall Study|Withdrawal by Subject|5|||
156783772|NCT00424008|565957557|FG001|Overall Study|Withdrawal by Subject|8|||
156783773|NCT00424008|565957556|FG000|Overall Study|Noncompliance with protocol|13|||
156783774|NCT00424008|565957557|FG001|Overall Study|Noncompliance with protocol|7|||
156529424|NCT04658186|565032635|FG002|Overall Study|Lost to Follow-up|2|||
156529425|NCT04658186|565032633|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
156529426|NCT04658186|565032634|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
156783775|NCT00424008|565957556|FG000|Overall Study|Did not meet protocol eligibility|16|||
156783776|NCT00424008|565957557|FG001|Overall Study|Did not meet protocol eligibility|21|||
156867501|NCT02978781|566275632|FG004|Part C|Adverse Event|2|||
156867502|NCT02978781|566275628|FG000|Part C|Withdrawal by Subject|0|||
156681341|NCT03223909|565578968|FG001|Overall Study|Protocol Violation|45|||
156681342|NCT03223909|565578969|FG002|Overall Study|Protocol Violation|16|||
156681343|NCT01856192|565578970|FG000|Overall Study|Adverse Event|12|||
156681344|NCT01856192|565578971|FG001|Overall Study|Adverse Event|4|||
156681345|NCT01856192|565578970|FG000|Overall Study|Alternative therapy|0|||
156783777|NCT00424008|565957556|FG000|Overall Study|Administrative|266|||
156783778|NCT00424008|565957557|FG001|Overall Study|Administrative|257|||
156783779|NCT02593864|565957558|FG000|Overall Study|Withdrawal by Subject|3|||
156783780|NCT02593864|565957558|FG000|Overall Study|Lost to Follow-up|3|||
156783781|NCT02114684|565957566|FG000|Overall Study|Death|6|||
156783782|NCT02114684|565957567|FG001|Overall Study|Death|4|||
156783783|NCT02114684|565957566|FG000|Overall Study|Lost to Follow-up|1|||
156783784|NCT02114684|565957567|FG001|Overall Study|Lost to Follow-up|2|||
156783785|NCT02114684|565957566|FG000|Overall Study|Withdrawal by Subject|1|||
156783786|NCT02114684|565957567|FG001|Overall Study|Withdrawal by Subject|2|||
156783787|NCT02114684|565957566|FG000|Overall Study|Relocation|3|||
156783788|NCT02114684|565957567|FG001|Overall Study|Relocation|1|||
156783789|NCT02114684|565957566|FG000|Overall Study|Rifampicin resistant on culture|0|||
156783790|NCT02114684|565957567|FG001|Overall Study|Rifampicin resistant on culture|1|||
156783791|NCT02114684|565957566|FG000|Overall Study|Patient Incarcerated|1|||
156783792|NCT02114684|565957567|FG001|Overall Study|Patient Incarcerated|0|||
156783793|NCT01397747|565957582|FG000|Overall Study|Multitarget DNA test excluded|689|||
156783794|NCT01397747|565957582|FG000|Overall Study|Colonoscopy excluded|304|||
156783795|NCT01397747|565957582|FG000|Overall Study|FIT excluded|34|||
156783796|NCT03828383|565957583|FG000|Overall Study|Lost to Follow-up|3|||
156783797|NCT03828383|565957584|FG001|Overall Study|Lost to Follow-up|2|||
156783798|NCT03828383|565957583|FG000|Overall Study|Withdrawal by Subject|4|||
156783799|NCT03828383|565957584|FG001|Overall Study|Withdrawal by Subject|5|||
156783800|NCT00504309|565957586|FG000|Overall Study|Death|0|||
156783801|NCT00504309|565957587|FG001|Overall Study|Death|0|||
156783802|NCT00504309|565957588|FG002|Overall Study|Death|0|||
156783803|NCT00504309|565957589|FG003|Overall Study|Death|0|||
156783804|NCT00504309|565957590|FG004|Overall Study|Death|1|||
156783805|NCT00504309|565957591|FG005|Overall Study|Death|0|||
156783806|NCT00504309|565957586|FG000|Overall Study|Withdrawal by Subject|0|||
156783807|NCT00504309|565957587|FG001|Overall Study|Withdrawal by Subject|0|||
156783808|NCT00504309|565957588|FG002|Overall Study|Withdrawal by Subject|1|||
156783809|NCT00504309|565957589|FG003|Overall Study|Withdrawal by Subject|0|||
156783810|NCT00504309|565957590|FG004|Overall Study|Withdrawal by Subject|0|||
156783811|NCT00504309|565957591|FG005|Overall Study|Withdrawal by Subject|0|||
156783812|NCT03345095|565957592|FG000|Overall Study|Lack of Efficacy|184|||
156783813|NCT03345095|565957593|FG001|Overall Study|Lack of Efficacy|156|||
156783814|NCT03345095|565957592|FG000|Overall Study|Adverse Event|36|||
156783815|NCT03345095|565957593|FG001|Overall Study|Adverse Event|118|||
156783816|NCT03345095|565957592|FG000|Overall Study|Withdrawal by Subject|22|||
156783817|NCT03345095|565957593|FG001|Overall Study|Withdrawal by Subject|59|||
156783818|NCT03345095|565957592|FG000|Overall Study|Physician Decision|3|||
156681346|NCT01856192|565578971|FG001|Overall Study|Alternative therapy|3|||
156681347|NCT01856192|565578970|FG000|Overall Study|Death|3|||
156681348|NCT01856192|565578971|FG001|Overall Study|Death|5|||
156681349|NCT01856192|565578970|FG000|Overall Study|Lack of Efficacy|0|||
156681350|NCT01856192|565578971|FG001|Overall Study|Lack of Efficacy|5|||
156681351|NCT01856192|565578970|FG000|Overall Study|Withdrawal by Subject|1|||
156681352|NCT01856192|565578971|FG001|Overall Study|Withdrawal by Subject|1|||
156681353|NCT01856192|565578970|FG000|Overall Study|Other diseases|1|||
156681354|NCT01856192|565578971|FG001|Overall Study|Other diseases|0|||
156681355|NCT01856192|565578970|FG000|Overall Study|Never started treatment|7|||
156681356|NCT01856192|565578971|FG001|Overall Study|Never started treatment|5|||
156681357|NCT01856192|565578970|FG000|Overall Study|Path ineligible|20|||
156681358|NCT01856192|565578971|FG001|Overall Study|Path ineligible|34|||
156783819|NCT03345095|565957593|FG001|Overall Study|Physician Decision|18|||
156783820|NCT03345095|565957592|FG000|Overall Study|Death|2|||
156783821|NCT03345095|565957593|FG001|Overall Study|Death|4|||
156783822|NCT03345095|565957592|FG000|Overall Study|Other reasons|2|||
156329305|NCT03139279|564305578|FG000|Overall Study|Physician Decision|2|||
156329306|NCT03139279|564305579|FG001|Overall Study|Physician Decision|0|||
156329307|NCT03139279|564305578|FG000|Overall Study|Protocol Violation|5|||
156329308|NCT03139279|564305579|FG001|Overall Study|Protocol Violation|4|||
156329309|NCT03139279|564305578|FG000|Overall Study|Withdrawal by Subject|0|||
156329310|NCT03139279|564305579|FG001|Overall Study|Withdrawal by Subject|2|||
156329311|NCT01336569|564305580|FG000|Overall Study|Lost to Follow-up|4|||
156329312|NCT02337738|564305581|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
156681359|NCT01856192|565578970|FG000|Overall Study|Non-path ineligible|2|||
156783823|NCT03345095|565957593|FG001|Overall Study|Other reasons|11|||
156783824|NCT03345095|565957592|FG000|Overall Study|Protocol Violation|0|||
156783825|NCT03345095|565957593|FG001|Overall Study|Protocol Violation|1|||
156783826|NCT02665455|565957594|FG000|Overall Study|Withdrawal by Subject|6|||
156681360|NCT01856192|565578971|FG001|Overall Study|Non-path ineligible|2|||
156681361|NCT01856192|565578970|FG000|Overall Study|Physician Decision|1|||
156681362|NCT01856192|565578971|FG001|Overall Study|Physician Decision|1|||
156867503|NCT02978781|566275629|FG001|Part C|Withdrawal by Subject|0|||
156867504|NCT02978781|566275630|FG002|Part C|Withdrawal by Subject|0|||
156867505|NCT02978781|566275631|FG003|Part C|Withdrawal by Subject|0|||
156867506|NCT02978781|566275632|FG004|Part C|Withdrawal by Subject|1|||
156867507|NCT02978781|566275628|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
156867508|NCT02978781|566275629|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
156867509|NCT02978781|566275630|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
156867510|NCT02978781|566275631|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
156867511|NCT02978781|566275632|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
156867512|NCT01039376|566275633|FG000|Overall Study|Lost to Follow-up|5|||
156867513|NCT01039376|566275634|FG001|Overall Study|Lost to Follow-up|12|||
156867514|NCT01039376|566275633|FG000|Overall Study|Physician Decision|15|||
156867515|NCT01039376|566275634|FG001|Overall Study|Physician Decision|10|||
156867516|NCT01039376|566275633|FG000|Overall Study|Withdrawal by Subject|20|||
156867517|NCT01039376|566275634|FG001|Overall Study|Withdrawal by Subject|32|||
156867518|NCT01039376|566275633|FG000|Overall Study|Study terminated by Sponsor|90|||
156867519|NCT01039376|566275634|FG001|Overall Study|Study terminated by Sponsor|72|||
156867520|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
156867521|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
156867522|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Adverse Event|31|||
156867523|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Adverse Event|21|||
156867524|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
156867525|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
156867526|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
156867527|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
156867528|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
156867529|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
156867530|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
156867531|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
156867532|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Administrative problems|3|||
156867533|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Administrative problems|3|||
156867534|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Death|5|||
156867535|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Death|8|||
156867536|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Disease progression|139|||
156867537|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Disease progression|119|||
156867538|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
156867539|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
156867540|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
156867541|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
156867542|NCT00785785|566275635|FG000|Optional Extension Phase|Adverse Event|4|||
156867543|NCT00785785|566275636|FG001|Optional Extension Phase|Adverse Event|5|||
156867544|NCT00785785|566275635|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
156867545|NCT00785785|566275636|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
156867546|NCT00785785|566275635|FG000|Optional Extension Phase|Lost to Follow-up|1|||
156867547|NCT00785785|566275636|FG001|Optional Extension Phase|Lost to Follow-up|0|||
156867548|NCT00785785|566275635|FG000|Optional Extension Phase|Administrative problems|2|||
156329313|NCT02337738|564305582|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
156329314|NCT02337738|564305583|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
156329315|NCT02337738|564305581|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156329316|NCT02337738|564305582|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
156329317|NCT02337738|564305583|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
156329318|NCT02337738|564305581|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
156329319|NCT02337738|564305582|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
156329320|NCT02337738|564305583|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
156329321|NCT02337738|564305581|FG000|Overall Study|Voluntary Withdrawal|10|||
156329322|NCT02337738|564305582|FG001|Overall Study|Voluntary Withdrawal|5|||
156329323|NCT02337738|564305583|FG002|Overall Study|Voluntary Withdrawal|2|||
156329324|NCT02337738|564305581|FG000|Overall Study|Lack of Efficacy|2|||
156329325|NCT02337738|564305582|FG001|Overall Study|Lack of Efficacy|4|||
156329326|NCT02337738|564305583|FG002|Overall Study|Lack of Efficacy|0|||
156329327|NCT02337738|564305581|FG000|Overall Study|Investigator's Judgment|1|||
156329328|NCT02337738|564305582|FG001|Overall Study|Investigator's Judgment|1|||
156329329|NCT02337738|564305583|FG002|Overall Study|Investigator's Judgment|3|||
156329330|NCT00406354|564305584|FG000|All Randomized Patients|Protocol Violation|0|||
156329331|NCT00406354|564305585|FG001|All Randomized Patients|Protocol Violation|0|||
156329332|NCT00406354|564305586|FG002|All Randomized Patients|Protocol Violation|1|||
156329333|NCT00406354|564305584|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
156329334|NCT00406354|564305585|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
156867549|NCT00785785|566275636|FG001|Optional Extension Phase|Administrative problems|0|||
156329335|NCT00406354|564305586|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
156329336|NCT00406354|564305584|FG000|All Randomized and Treated Patients|Adverse Event|6|||
156867550|NCT00785785|566275635|FG000|Optional Extension Phase|Death|1|||
156867551|NCT00785785|566275636|FG001|Optional Extension Phase|Death|5|||
156867552|NCT00785785|566275635|FG000|Optional Extension Phase|Disease progression|22|||
156867553|NCT00785785|566275636|FG001|Optional Extension Phase|Disease progression|70|||
156867554|NCT00785785|566275635|FG000|Optional Extension Phase|Protocol deviation|0|||
156867555|NCT00785785|566275636|FG001|Optional Extension Phase|Protocol deviation|2|||
156867556|NCT00785785|566275635|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
156867557|NCT00785785|566275636|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
156867558|NCT02453321|566275637|FG000|Overall Study|Weakness|1|||
156867559|NCT02453321|566275638|FG001|Overall Study|Weakness|1|||
156867560|NCT02453321|566275639|FG002|Overall Study|Weakness|2|||
156867561|NCT02453321|566275637|FG000|Overall Study|Deep Venous Thrombosis|0|||
156867562|NCT02453321|566275638|FG001|Overall Study|Deep Venous Thrombosis|1|||
156867563|NCT02453321|566275639|FG002|Overall Study|Deep Venous Thrombosis|0|||
156867564|NCT03252925|566275640|FG000|Overall Study|Withdrawal by Subject|1|||
156867565|NCT03252925|566275641|FG001|Overall Study|Withdrawal by Subject|0|||
156867566|NCT03252925|566275640|FG000|Overall Study|Protocol Violation|6|||
156867567|NCT03252925|566275641|FG001|Overall Study|Protocol Violation|0|||
156867568|NCT03252925|566275640|FG000|Overall Study|Adverse Event|1|||
156867569|NCT03252925|566275641|FG001|Overall Study|Adverse Event|0|||
156867570|NCT03252925|566275640|FG000|Overall Study|Lost to Follow-up|6|||
156867571|NCT03252925|566275641|FG001|Overall Study|Lost to Follow-up|6|||
156867572|NCT01244893|566275642|FG000|Baseline|Protocol Violation|0|||
156867573|NCT01244893|566275643|FG001|Baseline|Protocol Violation|1|||
156867574|NCT01244893|566275642|FG000|1-Week Follow Up|Lost to Follow-up|1|||
156867575|NCT01244893|566275643|FG001|1-Week Follow Up|Lost to Follow-up|0|||
156867576|NCT00357552|566275644|FG000|Screening|Did not meet eligibility criteria|84|||
156867577|NCT00357552|566275644|FG000|Weeks 0 to 24|Death|1|||
156867578|NCT00357552|566275644|FG000|Weeks 24 to 104|Death|3|||
156867579|NCT00357552|566275644|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
156867580|NCT00521404|566275645|FG000|Overall Study|Adverse Event|13|||
156867581|NCT00521404|566275645|FG000|Overall Study|Disease Progression|33|||
156867582|NCT00521404|566275645|FG000|Overall Study|Investigator decision|5|||
156867583|NCT00521404|566275645|FG000|Overall Study|Withdrawal of consent|3|||
156867584|NCT00521404|566275645|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
156867585|NCT00521404|566275645|FG000|Overall Study|Other|7|||
156867586|NCT04555616|566275646|FG000|Overall Study|Death|1|||
156867587|NCT04555616|566275647|FG001|Overall Study|Death|0|||
156867588|NCT04555616|566275648|FG002|Overall Study|Death|1|||
156867589|NCT04555616|566275646|FG000|Overall Study|Withdrawal by Subject|2|||
156867590|NCT04555616|566275647|FG001|Overall Study|Withdrawal by Subject|1|||
156867591|NCT04555616|566275648|FG002|Overall Study|Withdrawal by Subject|0|||
156867592|NCT00882557|566275651|FG000|Overall Study|Withdrawal by Subject|1|||
156867593|NCT00882557|566275652|FG001|Overall Study|Withdrawal by Subject|0|||
156867594|NCT00882557|566275651|FG000|Overall Study|Trouble with Vein Access|1|||
156867595|NCT00882557|566275652|FG001|Overall Study|Trouble with Vein Access|0|||
156867596|NCT00882557|566275651|FG000|Overall Study|Randomized Not Treated|0|||
156867597|NCT00882557|566275652|FG001|Overall Study|Randomized Not Treated|1|||
156867598|NCT01383356|566275653|FG000|Period 1|Adverse Event|5|||
156867599|NCT01383356|566275654|FG001|Period 1|Adverse Event|3|||
156867600|NCT01383356|566275653|FG000|Period 1|Non-compliance|3|||
156867601|NCT01383356|566275654|FG001|Period 1|Non-compliance|0|||
156867602|NCT01383356|566275653|FG000|Period 1|Out of Range Mid-study-Test|0|||
156867603|NCT01383356|566275654|FG001|Period 1|Out of Range Mid-study-Test|1|||
156867604|NCT01383356|566275653|FG000|Period 1|Personal|0|||
156867605|NCT01383356|566275654|FG001|Period 1|Personal|2|||
156867606|NCT02035267|566275655|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
156867607|NCT02035267|566275656|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
156867608|NCT02035267|566275657|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
156867609|NCT02035267|566275658|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
156867610|NCT02035267|566275655|FG000|Overall Study|Adverse Event|0|||
156867611|NCT02035267|566275656|FG001|Overall Study|Adverse Event|0|||
156867612|NCT02035267|566275657|FG002|Overall Study|Adverse Event|1|||
156867613|NCT02035267|566275658|FG003|Overall Study|Adverse Event|0|||
156867614|NCT02035267|566275655|FG000|Overall Study|Lost to Follow-up|0|||
156867615|NCT02035267|566275656|FG001|Overall Study|Lost to Follow-up|0|||
156867616|NCT02035267|566275657|FG002|Overall Study|Lost to Follow-up|0|||
156867617|NCT02035267|566275658|FG003|Overall Study|Lost to Follow-up|1|||
156867618|NCT02035267|566275655|FG000|Overall Study|Other unspecified|0|||
156867619|NCT02035267|566275656|FG001|Overall Study|Other unspecified|1|||
156867620|NCT02035267|566275657|FG002|Overall Study|Other unspecified|0|||
156867621|NCT02035267|566275658|FG003|Overall Study|Other unspecified|0|||
156867622|NCT03038880|566275665|FG000|Overall Study|Death|1|||
156867623|NCT03038880|566275666|FG001|Overall Study|Death|2|||
156867624|NCT03038880|566275667|FG002|Overall Study|Death|0|||
156867625|NCT03038880|566275665|FG000|Overall Study|Physician Decision|2|||
156867626|NCT03038880|566275666|FG001|Overall Study|Physician Decision|1|||
156867627|NCT03038880|566275667|FG002|Overall Study|Physician Decision|0|||
156867628|NCT03926611|566275668|FG000|Overall Study|Adverse Event|0|||
156867629|NCT03926611|566275669|FG001|Overall Study|Adverse Event|0|||
156867630|NCT03926611|566275670|FG002|Overall Study|Adverse Event|0|||
156867631|NCT03926611|566275671|FG003|Overall Study|Adverse Event|3|||
156867632|NCT03926611|566275672|FG004|Overall Study|Adverse Event|1|||
156867633|NCT03926611|566275673|FG005|Overall Study|Adverse Event|3|||
156867634|NCT03926611|566275674|FG006|Overall Study|Adverse Event|0|||
156867635|NCT03926611|566275668|FG000|Overall Study|Lack of Efficacy|1|||
156867636|NCT03926611|566275669|FG001|Overall Study|Lack of Efficacy|2|||
156867637|NCT03926611|566275670|FG002|Overall Study|Lack of Efficacy|0|||
156867638|NCT03926611|566275671|FG003|Overall Study|Lack of Efficacy|0|||
156867639|NCT03926611|566275672|FG004|Overall Study|Lack of Efficacy|1|||
156867640|NCT03926611|566275673|FG005|Overall Study|Lack of Efficacy|0|||
156867641|NCT03926611|566275674|FG006|Overall Study|Lack of Efficacy|1|||
156867642|NCT03926611|566275668|FG000|Overall Study|Physician Decision|0|||
156867643|NCT03926611|566275669|FG001|Overall Study|Physician Decision|0|||
156867644|NCT03926611|566275670|FG002|Overall Study|Physician Decision|0|||
156867645|NCT03926611|566275671|FG003|Overall Study|Physician Decision|0|||
156867646|NCT03926611|566275672|FG004|Overall Study|Physician Decision|0|||
156867647|NCT03926611|566275673|FG005|Overall Study|Physician Decision|1|||
156867648|NCT03926611|566275674|FG006|Overall Study|Physician Decision|0|||
156867649|NCT03926611|566275668|FG000|Overall Study|Protocol Violation|1|||
156867650|NCT03926611|566275669|FG001|Overall Study|Protocol Violation|0|||
156867651|NCT03926611|566275670|FG002|Overall Study|Protocol Violation|0|||
156867652|NCT03926611|566275671|FG003|Overall Study|Protocol Violation|1|||
156867653|NCT03926611|566275672|FG004|Overall Study|Protocol Violation|1|||
156867654|NCT03926611|566275673|FG005|Overall Study|Protocol Violation|1|||
156867655|NCT03926611|566275674|FG006|Overall Study|Protocol Violation|1|||
156867656|NCT03926611|566275668|FG000|Overall Study|Technical problems|0|||
156867657|NCT03926611|566275669|FG001|Overall Study|Technical problems|0|||
156867658|NCT03926611|566275670|FG002|Overall Study|Technical problems|0|||
156867659|NCT03926611|566275671|FG003|Overall Study|Technical problems|0|||
156867660|NCT03926611|566275672|FG004|Overall Study|Technical problems|0|||
156867661|NCT03926611|566275673|FG005|Overall Study|Technical problems|1|||
156867662|NCT03926611|566275674|FG006|Overall Study|Technical problems|0|||
156867663|NCT03926611|566275668|FG000|Overall Study|Withdrawal by Subject|1|||
156867664|NCT03926611|566275669|FG001|Overall Study|Withdrawal by Subject|1|||
156867665|NCT03926611|566275670|FG002|Overall Study|Withdrawal by Subject|1|||
156867666|NCT03926611|566275671|FG003|Overall Study|Withdrawal by Subject|0|||
156867667|NCT03926611|566275672|FG004|Overall Study|Withdrawal by Subject|0|||
156867668|NCT03926611|566275673|FG005|Overall Study|Withdrawal by Subject|1|||
156867669|NCT03926611|566275674|FG006|Overall Study|Withdrawal by Subject|3|||
156867670|NCT03926611|566275668|FG000|Overall Study|Covid-19 pandemic|0|||
156867671|NCT03926611|566275669|FG001|Overall Study|Covid-19 pandemic|0|||
156867672|NCT03926611|566275670|FG002|Overall Study|Covid-19 pandemic|1|||
156867673|NCT03926611|566275671|FG003|Overall Study|Covid-19 pandemic|0|||
156867674|NCT03926611|566275672|FG004|Overall Study|Covid-19 pandemic|1|||
156867675|NCT03926611|566275673|FG005|Overall Study|Covid-19 pandemic|2|||
156867676|NCT03926611|566275674|FG006|Overall Study|Covid-19 pandemic|0|||
156867677|NCT00956007|566275680|FG000|Overall Study|Protocol Violation|27|||
156867678|NCT00956007|566275681|FG001|Overall Study|Protocol Violation|23|||
156867679|NCT01750229|566275682|FG000|Randomized Crossover Phase|Adverse Event|1|||
156867680|NCT01750229|566275682|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
156867681|NCT01750229|566275682|FG000|Long-term Follow-up Phase|Adverse Event|2|||
156867682|NCT01750229|566275682|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
156867683|NCT02177032|566275683|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
156867684|NCT02177032|566275684|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
156867685|NCT02177032|566275685|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
156867686|NCT02177032|566275686|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
156867687|NCT02177032|566275683|FG000|Overall Study|Lost to Follow-up|0|||
156867688|NCT02177032|566275684|FG001|Overall Study|Lost to Follow-up|2|||
156867689|NCT02177032|566275685|FG002|Overall Study|Lost to Follow-up|0|||
156867690|NCT02177032|566275686|FG003|Overall Study|Lost to Follow-up|0|||
156867691|NCT02177032|566275683|FG000|Overall Study|OTHER|2|||
156867692|NCT02177032|566275684|FG001|Overall Study|OTHER|0|||
156435455|NCT01266265|564684932|FG001|Overall Study|Enrolled in another clinical study|26|||
156867693|NCT02177032|566275685|FG002|Overall Study|OTHER|1|||
156867694|NCT02177032|566275686|FG003|Overall Study|OTHER|0|||
156867695|NCT02177032|566275683|FG000|Overall Study|Withdrawal by Subject|1|||
156867696|NCT02177032|566275684|FG001|Overall Study|Withdrawal by Subject|0|||
156867697|NCT02177032|566275685|FG002|Overall Study|Withdrawal by Subject|1|||
156867698|NCT02177032|566275686|FG003|Overall Study|Withdrawal by Subject|0|||
156867699|NCT01134055|566275687|FG000|Overall Study|Adverse Event|5|||
156867700|NCT01134055|566275688|FG001|Overall Study|Adverse Event|2|||
156867701|NCT01134055|566275689|FG002|Overall Study|Adverse Event|2|||
156867702|NCT01134055|566275690|FG003|Overall Study|Adverse Event|2|||
156867703|NCT01134055|566275691|FG004|Overall Study|Adverse Event|5|||
156867704|NCT01134055|566275692|FG005|Overall Study|Adverse Event|7|||
156867705|NCT01134055|566275693|FG006|Overall Study|Adverse Event|2|||
156867706|NCT01134055|566275687|FG000|Overall Study|Lost to Follow-up|0|||
156867707|NCT01134055|566275688|FG001|Overall Study|Lost to Follow-up|1|||
156867708|NCT01134055|566275689|FG002|Overall Study|Lost to Follow-up|0|||
156867709|NCT01134055|566275690|FG003|Overall Study|Lost to Follow-up|1|||
156867710|NCT01134055|566275691|FG004|Overall Study|Lost to Follow-up|0|||
156867711|NCT01134055|566275692|FG005|Overall Study|Lost to Follow-up|0|||
156867712|NCT01134055|566275693|FG006|Overall Study|Lost to Follow-up|0|||
156867713|NCT01134055|566275687|FG000|Overall Study|Withdrawal by Subject|3|||
156867714|NCT01134055|566275688|FG001|Overall Study|Withdrawal by Subject|3|||
156867715|NCT01134055|566275689|FG002|Overall Study|Withdrawal by Subject|1|||
156867716|NCT01134055|566275690|FG003|Overall Study|Withdrawal by Subject|2|||
156867717|NCT01134055|566275691|FG004|Overall Study|Withdrawal by Subject|0|||
156867718|NCT01134055|566275692|FG005|Overall Study|Withdrawal by Subject|0|||
156867719|NCT01134055|566275693|FG006|Overall Study|Withdrawal by Subject|8|||
156867720|NCT01134055|566275687|FG000|Overall Study|Protocol Violation|0|||
156867721|NCT01134055|566275688|FG001|Overall Study|Protocol Violation|0|||
156867722|NCT01134055|566275689|FG002|Overall Study|Protocol Violation|0|||
156867723|NCT01134055|566275690|FG003|Overall Study|Protocol Violation|1|||
156867724|NCT01134055|566275691|FG004|Overall Study|Protocol Violation|1|||
156867725|NCT01134055|566275692|FG005|Overall Study|Protocol Violation|0|||
156867726|NCT01134055|566275693|FG006|Overall Study|Protocol Violation|0|||
156867727|NCT01134055|566275687|FG000|Overall Study|Physician Decision|0|||
156867728|NCT01134055|566275688|FG001|Overall Study|Physician Decision|0|||
156867729|NCT01134055|566275689|FG002|Overall Study|Physician Decision|0|||
156867730|NCT01134055|566275690|FG003|Overall Study|Physician Decision|0|||
156867731|NCT01134055|566275691|FG004|Overall Study|Physician Decision|0|||
156867732|NCT01134055|566275692|FG005|Overall Study|Physician Decision|0|||
156867733|NCT01134055|566275693|FG006|Overall Study|Physician Decision|1|||
156867734|NCT04798196|566275695|FG000|Overall Study|Lost to Follow-up|3|||
156867735|NCT04798196|566275696|FG001|Overall Study|Lost to Follow-up|1|||
156867736|NCT04798196|566275697|FG002|Overall Study|Lost to Follow-up|3|||
156867737|NCT00734539|566275710|FG000|Main Study|Death|33|||
156867738|NCT00734539|566275711|FG001|Main Study|Death|32|||
156867739|NCT00734539|566275710|FG000|Main Study|Physician Decision|2|||
156867740|NCT00734539|566275711|FG001|Main Study|Physician Decision|0|||
156867741|NCT00734539|566275710|FG000|Main Study|Withdrawal by Subject|1|||
156867742|NCT00734539|566275711|FG001|Main Study|Withdrawal by Subject|3|||
156867743|NCT00734539|566275710|FG000|Main Study|Enrolled in error; ineligible|1|||
156867744|NCT00734539|566275711|FG001|Main Study|Enrolled in error; ineligible|0|||
156867745|NCT00705016|566275714|FG000|Overall Study|Adverse Event|6|||
156867746|NCT00705016|566275715|FG001|Overall Study|Adverse Event|11|||
156867747|NCT00705016|566275716|FG002|Overall Study|Adverse Event|10|||
156867748|NCT00705016|566275714|FG000|Overall Study|Death|5|||
156867749|NCT00705016|566275715|FG001|Overall Study|Death|7|||
156867750|NCT00705016|566275716|FG002|Overall Study|Death|5|||
156329337|NCT00406354|564305585|FG001|All Randomized and Treated Patients|Adverse Event|2|||
156329338|NCT00406354|564305586|FG002|All Randomized and Treated Patients|Adverse Event|1|||
156329339|NCT00406354|564305584|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
156329340|NCT00406354|564305585|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
156329341|NCT00406354|564305586|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
156329342|NCT00406354|564305584|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
156329343|NCT00406354|564305585|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
156329344|NCT00406354|564305586|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
156329345|NCT00406354|564305584|FG000|All Randomized and Treated Patients|Physician Decision|0|||
156329346|NCT00406354|564305585|FG001|All Randomized and Treated Patients|Physician Decision|0|||
156329347|NCT00406354|564305586|FG002|All Randomized and Treated Patients|Physician Decision|1|||
156329348|NCT01565642|564305589|FG000|Overall Study|Withdrawal by Subject|2|||
156329349|NCT01565642|564305590|FG001|Overall Study|Withdrawal by Subject|1|||
156329350|NCT01631812|564305591|FG000|Overall Study|Adverse Event|25|||
156329351|NCT01631812|564305591|FG000|Overall Study|Lack of Efficacy|5|||
156329352|NCT01631812|564305591|FG000|Overall Study|Withdrawal by Subject|4|||
156329353|NCT01631812|564305591|FG000|Overall Study|Physician Decision|3|||
156329354|NCT02130024|564305602|FG000|Overall Study|Adverse Event|10|||
156435456|NCT01266265|564684931|FG000|Overall Study|Non-compliance|8|||
156867751|NCT00705016|566275714|FG000|Overall Study|Protocol Violation|0|||
156867752|NCT00705016|566275715|FG001|Overall Study|Protocol Violation|1|||
156867753|NCT00705016|566275716|FG002|Overall Study|Protocol Violation|1|||
156867754|NCT00705016|566275714|FG000|Overall Study|Withdrawal by Subject|4|||
156867755|NCT00705016|566275715|FG001|Overall Study|Withdrawal by Subject|3|||
156867756|NCT00705016|566275716|FG002|Overall Study|Withdrawal by Subject|2|||
156867757|NCT00705016|566275714|FG000|Overall Study|Progressive Disease|33|||
156867758|NCT00705016|566275715|FG001|Overall Study|Progressive Disease|29|||
156867759|NCT00705016|566275716|FG002|Overall Study|Progressive Disease|33|||
156867760|NCT00705016|566275714|FG000|Overall Study|Symptomatic Deterioration|3|||
156867761|NCT00705016|566275715|FG001|Overall Study|Symptomatic Deterioration|1|||
156329355|NCT02130024|564305603|FG001|Overall Study|Adverse Event|11|||
156435457|NCT01266265|564684932|FG001|Overall Study|Non-compliance|5|||
156867762|NCT00705016|566275716|FG002|Overall Study|Symptomatic Deterioration|1|||
156867763|NCT00705016|566275714|FG000|Overall Study|Other|9|||
156867764|NCT00705016|566275715|FG001|Overall Study|Other|6|||
156329356|NCT02130024|564305602|FG000|Overall Study|Death|2|||
156783827|NCT02665455|565957594|FG000|Overall Study|Lost to Follow-up|1|||
156783828|NCT02665455|565957594|FG000|Overall Study|Adverse Event|1|||
156783829|NCT02665455|565957594|FG000|Overall Study|Protocol Violation|1|||
156783830|NCT01039675|565957596|FG000|Overall Study|Adverse Event|0|||
156783831|NCT01039675|565957597|FG001|Overall Study|Adverse Event|2|||
156783832|NCT01039675|565957596|FG000|Overall Study|Lack of Efficacy|0|||
156783833|NCT01039675|565957597|FG001|Overall Study|Lack of Efficacy|2|||
156783834|NCT01039675|565957596|FG000|Overall Study|Withdrawal by Subject|0|||
156783835|NCT01039675|565957597|FG001|Overall Study|Withdrawal by Subject|1|||
156783836|NCT01039675|565957596|FG000|Overall Study|Lost to Follow-up|0|||
156783837|NCT01039675|565957597|FG001|Overall Study|Lost to Follow-up|1|||
156783838|NCT01039675|565957596|FG000|Overall Study|Physician Decision|0|||
156783839|NCT01039675|565957597|FG001|Overall Study|Physician Decision|1|||
156783840|NCT05865886|565957598|FG000|Overall Study|Serious adverse event|0|||
156783841|NCT05865886|565957599|FG001|Overall Study|Serious adverse event|1|||
156783842|NCT01671059|565957600|FG000|Overall Study|Adverse Event|4|||
156783843|NCT01671059|565957600|FG000|Overall Study|Lack of Efficacy|1|||
156783844|NCT02564978|565957601|FG000|Overall Study|Adverse Event|8|||
156783845|NCT02564978|565957601|FG000|Overall Study|Death|1|||
156783846|NCT02564978|565957601|FG000|Overall Study|Lost to Follow-up|1|||
156783847|NCT02564978|565957601|FG000|Overall Study|Withdrawal by Subject|15|||
156783848|NCT02564978|565957601|FG000|Overall Study|Early Study Closure|2|||
156783849|NCT02564978|565957601|FG000|Overall Study|Other Reason|5|||
156783850|NCT04971837|565958867|FG000|Overall Study|Long Term Illness|1|||
156783851|NCT04971837|565958867|FG000|Overall Study|BMI too low|9|||
156783852|NCT04971837|565958867|FG000|Overall Study|geographic location|1|||
156783853|NCT04971837|565958867|FG000|Overall Study|Discontinued scheduling conflict|1|||
156783854|NCT03787212|565958871|FG000|Period 1|Study Termination|2|||
156783855|NCT03787212|565958872|FG001|Period 1|Study Termination|2|||
156783856|NCT04289298|565958875|FG000|Overall Study|Lost to Follow-up|5|||
156783857|NCT04289298|565958876|FG001|Overall Study|Lost to Follow-up|0|||
156783858|NCT04289298|565958875|FG000|Overall Study|Withdrawal by Subject|2|||
156783859|NCT04289298|565958876|FG001|Overall Study|Withdrawal by Subject|0|||
156783860|NCT01778985|565958878|FG000|Overall Study|Lost to Follow-up|1|||
156783861|NCT01778985|565958879|FG001|Overall Study|Lost to Follow-up|0|||
156783862|NCT01778985|565958878|FG000|Overall Study|Physician Decision|2|||
156783863|NCT01778985|565958879|FG001|Overall Study|Physician Decision|2|||
156783864|NCT01778985|565958878|FG000|Overall Study|Protocol Violation|4|||
156783865|NCT01778985|565958879|FG001|Overall Study|Protocol Violation|1|||
156783866|NCT00504231|565958880|FG000|Overall Study|Discrepant chart documentation re route|0|||
156329357|NCT02130024|564305603|FG001|Overall Study|Death|2|||
156329358|NCT02130024|564305602|FG000|Overall Study|Lost to Follow-up|1|||
156329359|NCT02130024|564305603|FG001|Overall Study|Lost to Follow-up|1|||
156329360|NCT02130024|564305602|FG000|Overall Study|Physician Decision|1|||
156329361|NCT02130024|564305603|FG001|Overall Study|Physician Decision|3|||
156681363|NCT01856192|565578970|FG000|Overall Study|Suspicion of progressive disease|1|||
156681364|NCT01856192|565578971|FG001|Overall Study|Suspicion of progressive disease|0|||
156681365|NCT01856192|565578970|FG000|Overall Study|Non-compliance|1|||
156681366|NCT01856192|565578971|FG001|Overall Study|Non-compliance|0|||
156681367|NCT00098475|565578972|FG000|Step 1|Progressive disease|33|||
156681368|NCT00098475|565578973|FG001|Step 1|Progressive disease|35|||
156681369|NCT00098475|565578974|FG002|Step 1|Progressive disease|2|||
156681370|NCT00098475|565578975|FG003|Step 1|Progressive disease|1|||
156681371|NCT00098475|565578972|FG000|Step 1|Adverse Event|56|||
156681372|NCT00098475|565578973|FG001|Step 1|Adverse Event|37|||
156681373|NCT00098475|565578974|FG002|Step 1|Adverse Event|0|||
156681374|NCT00098475|565578975|FG003|Step 1|Adverse Event|1|||
156681375|NCT00098475|565578972|FG000|Step 1|Death|8|||
156329362|NCT02130024|564305602|FG000|Overall Study|Protocol Deviation|4|||
156329363|NCT02130024|564305603|FG001|Overall Study|Protocol Deviation|0|||
156329364|NCT02130024|564305602|FG000|Overall Study|Site Administration Problems|1|||
156329365|NCT02130024|564305603|FG001|Overall Study|Site Administration Problems|0|||
156329366|NCT02130024|564305602|FG000|Overall Study|Subject Withdrew Consent|6|||
156435458|NCT01266265|564684931|FG000|Overall Study|Lung transplant|6|||
156681376|NCT00098475|565578973|FG001|Step 1|Death|5|||
156681377|NCT00098475|565578974|FG002|Step 1|Death|0|||
156681378|NCT00098475|565578975|FG003|Step 1|Death|1|||
156783867|NCT00504231|565958881|FG001|Overall Study|Discrepant chart documentation re route|0|||
156783868|NCT00504231|565958882|FG002|Overall Study|Discrepant chart documentation re route|1|||
156783869|NCT00504231|565958883|FG003|Overall Study|Discrepant chart documentation re route|0|||
156783870|NCT01629563|565958884|FG000|Overall Study|Adverse Event|16|||
156783871|NCT01629563|565958885|FG001|Overall Study|Adverse Event|16|||
156783872|NCT01629563|565958884|FG000|Overall Study|Death|2|||
156329367|NCT02130024|564305603|FG001|Overall Study|Subject Withdrew Consent|14|||
156329368|NCT02024555|564305604|FG000|Overall Study|Lost to Follow-up|1|||
156681379|NCT00098475|565578972|FG000|Step 1|Withdrawal by Subject|14|||
156681380|NCT00098475|565578973|FG001|Step 1|Withdrawal by Subject|11|||
156783873|NCT01629563|565958885|FG001|Overall Study|Death|0|||
156329369|NCT02024555|564305605|FG001|Overall Study|Lost to Follow-up|1|||
156783874|NCT01629563|565958884|FG000|Overall Study|Lack of Efficacy|2|||
156783875|NCT01629563|565958885|FG001|Overall Study|Lack of Efficacy|3|||
156783876|NCT01629563|565958884|FG000|Overall Study|Lost to Follow-up|1|||
156783877|NCT01629563|565958885|FG001|Overall Study|Lost to Follow-up|0|||
156783878|NCT01629563|565958884|FG000|Overall Study|Pregnancy|1|||
156783879|NCT01629563|565958885|FG001|Overall Study|Pregnancy|2|||
156783880|NCT01629563|565958884|FG000|Overall Study|Protocol Violation|0|||
156783881|NCT01629563|565958885|FG001|Overall Study|Protocol Violation|1|||
156783882|NCT01629563|565958884|FG000|Overall Study|Withdrawal by Subject|27|||
156783883|NCT01629563|565958885|FG001|Overall Study|Withdrawal by Subject|20|||
156783884|NCT01629563|565958884|FG000|Overall Study|surgery|0|||
156783885|NCT01629563|565958885|FG001|Overall Study|surgery|3|||
156783886|NCT01629563|565958884|FG000|Overall Study|Lack of return of menses|12|||
156783887|NCT01629563|565958885|FG001|Overall Study|Lack of return of menses|7|||
156783888|NCT01629563|565958884|FG000|Overall Study|Protocol Violation|0|||
156783889|NCT01629563|565958885|FG001|Overall Study|Protocol Violation|1|||
156783890|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
156783891|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Adverse Event|1|||
156783892|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
156783893|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Physician Decision|1|||
156783894|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
156783895|NCT00088881|565958886|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
156783896|NCT00088881|565958886|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
156783897|NCT01129284|565958888|FG000|Overall Study|Adverse Event|2|||
156783898|NCT01129284|565958889|FG001|Overall Study|Adverse Event|0|||
156783899|NCT01129284|565958890|FG002|Overall Study|Adverse Event|1|||
156783900|NCT02082483|565958891|FG000|Overall Study|Lost to Follow-up|1|||
156783901|NCT02082483|565958892|FG001|Overall Study|Lost to Follow-up|1|||
156783902|NCT02082483|565958891|FG000|Overall Study|Withdrawal by Subject|2|||
156783903|NCT02082483|565958892|FG001|Overall Study|Withdrawal by Subject|1|||
156783904|NCT02082483|565958891|FG000|Overall Study|Physician Decision|1|||
156783905|NCT02082483|565958892|FG001|Overall Study|Physician Decision|1|||
156783906|NCT02082483|565958891|FG000|Overall Study|Death|2|||
156783907|NCT02082483|565958892|FG001|Overall Study|Death|3|||
156783908|NCT01028560|565958895|FG000|Overall Study|Lack of Efficacy|3|||
156783909|NCT01028560|565958896|FG001|Overall Study|Lack of Efficacy|6|||
156783910|NCT01028560|565958895|FG000|Overall Study|Withdrawal by Subject|7|||
156783911|NCT01028560|565958896|FG001|Overall Study|Withdrawal by Subject|12|||
156783912|NCT01060111|565958897|FG000|Overall Study|Adverse Event|9|||
156783913|NCT01060111|565958898|FG001|Overall Study|Adverse Event|5|||
156783914|NCT01060111|565958899|FG002|Overall Study|Adverse Event|18|||
156783915|NCT01060111|565958897|FG000|Overall Study|Lack of Efficacy|2|||
156783916|NCT01060111|565958898|FG001|Overall Study|Lack of Efficacy|1|||
156783917|NCT01060111|565958899|FG002|Overall Study|Lack of Efficacy|0|||
156783918|NCT01060111|565958897|FG000|Overall Study|Inappropriate participant|5|||
156783919|NCT01060111|565958898|FG001|Overall Study|Inappropriate participant|4|||
156783920|NCT01060111|565958899|FG002|Overall Study|Inappropriate participant|5|||
156783921|NCT01060111|565958897|FG000|Overall Study|Participants' evasion for hospital visit|0|||
156783922|NCT01060111|565958898|FG001|Overall Study|Participants' evasion for hospital visit|3|||
156783923|NCT01060111|565958899|FG002|Overall Study|Participants' evasion for hospital visit|2|||
156783924|NCT01060111|565958897|FG000|Overall Study|Participants' non-cooperation|8|||
156783925|NCT01060111|565958898|FG001|Overall Study|Participants' non-cooperation|6|||
156783926|NCT01060111|565958899|FG002|Overall Study|Participants' non-cooperation|6|||
156783927|NCT01060111|565958897|FG000|Overall Study|Adverse event and insufficient effect|0|||
156783928|NCT01060111|565958898|FG001|Overall Study|Adverse event and insufficient effect|1|||
156783929|NCT01060111|565958899|FG002|Overall Study|Adverse event and insufficient effect|0|||
156783930|NCT01060111|565958897|FG000|Overall Study|Participants' non-cooperation|1|||
156783931|NCT01060111|565958898|FG001|Overall Study|Participants' non-cooperation|0|||
156783932|NCT01060111|565958899|FG002|Overall Study|Participants' non-cooperation|0|||
156783933|NCT01060111|565958897|FG000|Overall Study|Other|2|||
156783934|NCT01060111|565958898|FG001|Overall Study|Other|3|||
156783935|NCT01060111|565958899|FG002|Overall Study|Other|4|||
156783936|NCT05278065|565958900|FG000|Overall Study|Withdrawal by Subject|1|||
156783937|NCT05278065|565958901|FG001|Overall Study|Withdrawal by Subject|0|||
156783938|NCT02070991|565958902|FG000|Overall Study|Death|2|||
156783939|NCT02070991|565958903|FG001|Overall Study|Death|0|||
156783940|NCT02070991|565958902|FG000|Overall Study|Withdrawal by Subject|1|||
156783941|NCT02070991|565958903|FG001|Overall Study|Withdrawal by Subject|0|||
156783942|NCT03670628|565958906|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
156783943|NCT03670628|565958907|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
156783944|NCT03670628|565958906|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
156783945|NCT03670628|565958907|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
156783946|NCT03123588|565958908|FG000|Overall Study|Study Terminated by Sponsor|2|||
156783947|NCT03123588|565958909|FG001|Overall Study|Study Terminated by Sponsor|5|||
156329370|NCT02024555|564305604|FG000|Overall Study|Withdrawal by Subject|5|||
156329371|NCT02024555|564305605|FG001|Overall Study|Withdrawal by Subject|1|||
156329372|NCT02718300|564305606|FG000|Overall Study|Death|4|||
156329373|NCT02718300|564305607|FG001|Overall Study|Death|5|||
156329374|NCT02718300|564305608|FG002|Overall Study|Death|17|||
156329375|NCT02718300|564305606|FG000|Overall Study|Lost to Follow-up|1|||
156329376|NCT02718300|564305607|FG001|Overall Study|Lost to Follow-up|0|||
156329377|NCT02718300|564305608|FG002|Overall Study|Lost to Follow-up|2|||
156329378|NCT02718300|564305606|FG000|Overall Study|Physician Decision|1|||
156329379|NCT02718300|564305607|FG001|Overall Study|Physician Decision|0|||
156329380|NCT02718300|564305608|FG002|Overall Study|Physician Decision|2|||
156329381|NCT02718300|564305606|FG000|Overall Study|Study Terminated by Sponsor|6|||
156329382|NCT02718300|564305607|FG001|Overall Study|Study Terminated by Sponsor|3|||
156435459|NCT01266265|564684932|FG001|Overall Study|Lung transplant|5|||
156435460|NCT01266265|564684931|FG000|Overall Study|Site closed early|4|||
156681381|NCT00098475|565578974|FG002|Step 1|Withdrawal by Subject|0|||
156681382|NCT00098475|565578975|FG003|Step 1|Withdrawal by Subject|0|||
156867765|NCT00705016|566275716|FG002|Overall Study|Other|6|||
156867766|NCT00942604|566275719|FG000|Overall Study|Protocol Violation|1|||
156867767|NCT00942604|566275720|FG001|Overall Study|Protocol Violation|1|||
156867768|NCT00942604|566275719|FG000|Overall Study|Adverse Event|0|||
156867769|NCT00942604|566275720|FG001|Overall Study|Adverse Event|1|||
156867770|NCT00942604|566275719|FG000|Overall Study|Withdrawal by Subject|0|||
156867771|NCT00942604|566275720|FG001|Overall Study|Withdrawal by Subject|1|||
156867772|NCT00942604|566275719|FG000|Overall Study|Patient relocation|1|||
156867773|NCT00942604|566275720|FG001|Overall Study|Patient relocation|1|||
156867774|NCT01656408|566275721|FG000|Overall Study|Adverse Event|0|||
156867775|NCT01656408|566275722|FG001|Overall Study|Adverse Event|0|||
156867776|NCT01656408|566275723|FG002|Overall Study|Adverse Event|1|||
156867777|NCT01656408|566275724|FG003|Overall Study|Adverse Event|0|||
156867778|NCT01656408|566275725|FG004|Overall Study|Adverse Event|0|||
156867779|NCT01656408|566275726|FG005|Overall Study|Adverse Event|1|||
156867780|NCT01656408|566275727|FG006|Overall Study|Adverse Event|1|||
156867781|NCT01656408|566275728|FG007|Overall Study|Adverse Event|0|||
156867782|NCT01656408|566275729|FG008|Overall Study|Adverse Event|1|||
156867783|NCT01656408|566275730|FG009|Overall Study|Adverse Event|0|||
156867784|NCT01656408|566275721|FG000|Overall Study|Physician Decision|1|||
156867785|NCT01656408|566275722|FG001|Overall Study|Physician Decision|0|||
156867786|NCT01656408|566275723|FG002|Overall Study|Physician Decision|1|||
156867787|NCT01656408|566275724|FG003|Overall Study|Physician Decision|0|||
156867788|NCT01656408|566275725|FG004|Overall Study|Physician Decision|1|||
156867789|NCT01656408|566275726|FG005|Overall Study|Physician Decision|1|||
156867790|NCT01656408|566275727|FG006|Overall Study|Physician Decision|0|||
156867791|NCT01656408|566275728|FG007|Overall Study|Physician Decision|1|||
156867792|NCT01656408|566275729|FG008|Overall Study|Physician Decision|1|||
156867793|NCT01656408|566275730|FG009|Overall Study|Physician Decision|3|||
156867794|NCT00904982|566275736|FG000|Overall Study|Withdrawal by Subject|2|||
156867795|NCT00904982|566275737|FG001|Overall Study|Withdrawal by Subject|0|||
156867796|NCT00904982|566275738|FG002|Overall Study|Withdrawal by Subject|0|||
156867797|NCT00904982|566275739|FG003|Overall Study|Withdrawal by Subject|0|||
156867798|NCT01318915|566275743|FG000|Overall Study|Lost to Follow-up|1|||
156867799|NCT04119414|566275744|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
156867800|NCT01929317|566275750|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
156867801|NCT01929317|566275751|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
156867802|NCT01929317|566275750|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
156867803|NCT01929317|566275751|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
156867804|NCT01929317|566275750|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
156867805|NCT01929317|566275751|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
156867806|NCT01929317|566275750|FG000|Long-term Phase|Adverse Event|5|||
156867807|NCT01929317|566275751|FG001|Long-term Phase|Adverse Event|1|||
156867808|NCT01929317|566275750|FG000|Long-term Phase|Physician Decision|3|||
156867809|NCT01929317|566275751|FG001|Long-term Phase|Physician Decision|0|||
156867810|NCT01929317|566275750|FG000|Long-term Phase|Withdrawal by Subject|4|||
156867811|NCT01929317|566275751|FG001|Long-term Phase|Withdrawal by Subject|0|||
156867812|NCT01929317|566275750|FG000|Long-term Phase|Protocol Violation|1|||
156867813|NCT01929317|566275751|FG001|Long-term Phase|Protocol Violation|0|||
156681383|NCT00098475|565578972|FG000|Step 1|Physician Decision|5|||
156867814|NCT01929317|566275750|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
156867815|NCT01929317|566275751|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
156329383|NCT02718300|564305608|FG002|Overall Study|Study Terminated by Sponsor|4|||
156329384|NCT02718300|564305606|FG000|Overall Study|Withdrawal by Subject|0|||
156329385|NCT02718300|564305607|FG001|Overall Study|Withdrawal by Subject|4|||
156329386|NCT02718300|564305608|FG002|Overall Study|Withdrawal by Subject|3|||
156681384|NCT00098475|565578973|FG001|Step 1|Physician Decision|2|||
156681385|NCT00098475|565578974|FG002|Step 1|Physician Decision|0|||
156867816|NCT01929317|566275750|FG000|Long-term Phase|Study Closed/Terminated|5|||
156867817|NCT01929317|566275751|FG001|Long-term Phase|Study Closed/Terminated|3|||
156867818|NCT03815929|566275754|FG000|Overall Study|Lost to Follow-up|2|||
156867819|NCT03815929|566275755|FG001|Overall Study|Lost to Follow-up|1|||
156867820|NCT03815929|566275756|FG002|Overall Study|Lost to Follow-up|0|||
156867821|NCT03815929|566275754|FG000|Overall Study|Physician Decision|2|||
156867822|NCT03815929|566275755|FG001|Overall Study|Physician Decision|2|||
156867823|NCT03815929|566275756|FG002|Overall Study|Physician Decision|0|||
156867824|NCT03815929|566275754|FG000|Overall Study|Withdrawal by Subject|0|||
156867825|NCT03815929|566275755|FG001|Overall Study|Withdrawal by Subject|0|||
156867826|NCT03815929|566275756|FG002|Overall Study|Withdrawal by Subject|1|||
156867827|NCT02205736|566275757|FG000|Overall Study|Lost to Follow-up|106|||
156867828|NCT01198977|566275761|FG000|Overall Study|Lost to Follow-up|1|||
156867829|NCT01198977|566275762|FG001|Overall Study|Lost to Follow-up|0|||
156867830|NCT01588522|566275768|FG000|Overall Study|Withdrawal by Subject|1|||
156867831|NCT01588522|566275769|FG001|Overall Study|Withdrawal by Subject|5|||
156867832|NCT01588522|566275770|FG002|Overall Study|Withdrawal by Subject|3|||
156867833|NCT01588522|566275771|FG003|Overall Study|Withdrawal by Subject|1|||
156867834|NCT01588522|566275772|FG004|Overall Study|Withdrawal by Subject|2|||
156867835|NCT01588522|566275773|FG005|Overall Study|Withdrawal by Subject|0|||
156867836|NCT01588522|566275768|FG000|Overall Study|Lack of Efficacy|0|||
156867837|NCT01588522|566275769|FG001|Overall Study|Lack of Efficacy|0|||
156867838|NCT01588522|566275770|FG002|Overall Study|Lack of Efficacy|0|||
156867839|NCT01588522|566275771|FG003|Overall Study|Lack of Efficacy|0|||
156867840|NCT01588522|566275772|FG004|Overall Study|Lack of Efficacy|1|||
156867841|NCT01588522|566275773|FG005|Overall Study|Lack of Efficacy|0|||
156867842|NCT01588522|566275768|FG000|Overall Study|Adverse Event|0|||
156867843|NCT01588522|566275769|FG001|Overall Study|Adverse Event|0|||
156867844|NCT01588522|566275770|FG002|Overall Study|Adverse Event|0|||
156867845|NCT01588522|566275771|FG003|Overall Study|Adverse Event|1|||
156867846|NCT01588522|566275772|FG004|Overall Study|Adverse Event|0|||
156867847|NCT01588522|566275773|FG005|Overall Study|Adverse Event|0|||
156867848|NCT01588522|566275768|FG000|Overall Study|Grade 2 alopecia|1|||
156867849|NCT01588522|566275769|FG001|Overall Study|Grade 2 alopecia|0|||
156867850|NCT01588522|566275770|FG002|Overall Study|Grade 2 alopecia|0|||
156681386|NCT00098475|565578975|FG003|Step 1|Physician Decision|0|||
156867851|NCT01588522|566275771|FG003|Overall Study|Grade 2 alopecia|0|||
156435461|NCT01266265|564684932|FG001|Overall Study|Site closed early|3|||
156435462|NCT01266265|564684931|FG000|Overall Study|Clinical worsening|1|||
156435463|NCT01266265|564684932|FG001|Overall Study|Clinical worsening|1|||
156435464|NCT00423098|564684933|FG000|Overall Study|Adverse Event|1|||
156435465|NCT00423098|564684934|FG001|Overall Study|Adverse Event|2|||
156681387|NCT00098475|565578972|FG000|Step 1|Alternative therapy|31|||
156681388|NCT00098475|565578973|FG001|Step 1|Alternative therapy|43|||
156681389|NCT00098475|565578974|FG002|Step 1|Alternative therapy|1|||
156435466|NCT00423098|564684933|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156435467|NCT00423098|564684934|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156435468|NCT00423098|564684933|FG000|Overall Study|Administrative problems|0|||
156681390|NCT00098475|565578975|FG003|Step 1|Alternative therapy|0|||
156681391|NCT00098475|565578972|FG000|Step 1|Other disease|2|||
156681392|NCT00098475|565578973|FG001|Step 1|Other disease|1|||
156681393|NCT00098475|565578974|FG002|Step 1|Other disease|1|||
156681394|NCT00098475|565578975|FG003|Step 1|Other disease|0|||
156681395|NCT00098475|565578972|FG000|Step 1|Never started treatment|0|||
156681396|NCT00098475|565578973|FG001|Step 1|Never started treatment|2|||
156681397|NCT00098475|565578974|FG002|Step 1|Never started treatment|0|||
156681398|NCT00098475|565578975|FG003|Step 1|Never started treatment|0|||
156681399|NCT00098475|565578972|FG000|Step 1|Still on treatment as of this analysis|14|||
156681400|NCT00098475|565578973|FG001|Step 1|Still on treatment as of this analysis|27|||
156681401|NCT00098475|565578974|FG002|Step 1|Still on treatment as of this analysis|0|||
156681402|NCT00098475|565578975|FG003|Step 1|Still on treatment as of this analysis|0|||
156681403|NCT00098475|565578972|FG000|Step 1|Knee surgery|1|||
156681404|NCT00098475|565578973|FG001|Step 1|Knee surgery|0|||
156681405|NCT00098475|565578974|FG002|Step 1|Knee surgery|0|||
156435469|NCT00423098|564684934|FG001|Overall Study|Administrative problems|1|||
156435470|NCT00423098|564684933|FG000|Overall Study|Death|2|||
156435471|NCT00423098|564684934|FG001|Overall Study|Death|0|||
156681406|NCT00098475|565578975|FG003|Step 1|Knee surgery|0|||
156681407|NCT00098475|565578972|FG000|Step 1|Complications|1|||
156681408|NCT00098475|565578973|FG001|Step 1|Complications|0|||
156681409|NCT00098475|565578974|FG002|Step 1|Complications|0|||
156681410|NCT00098475|565578975|FG003|Step 1|Complications|0|||
156681411|NCT00098475|565578972|FG000|Step 1|Cannot comply due to other tx|0|||
156681412|NCT00098475|565578973|FG001|Step 1|Cannot comply due to other tx|1|||
156681413|NCT00098475|565578974|FG002|Step 1|Cannot comply due to other tx|0|||
156681414|NCT00098475|565578975|FG003|Step 1|Cannot comply due to other tx|0|||
156681415|NCT00098475|565578972|FG000|Step 1|Both patient and physician's decision|2|||
156681416|NCT00098475|565578973|FG001|Step 1|Both patient and physician's decision|1|||
156681417|NCT00098475|565578974|FG002|Step 1|Both patient and physician's decision|0|||
156867852|NCT01588522|566275772|FG004|Overall Study|Grade 2 alopecia|0|||
156867853|NCT01588522|566275773|FG005|Overall Study|Grade 2 alopecia|0|||
156867854|NCT01588522|566275768|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
156867855|NCT01588522|566275769|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
156867856|NCT01588522|566275770|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
156867857|NCT01588522|566275771|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
156867858|NCT01588522|566275772|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
156867859|NCT01588522|566275773|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
156867860|NCT01588522|566275768|FG000|Overall Study|Taken off taxane-based regimen|0|||
156867861|NCT01588522|566275769|FG001|Overall Study|Taken off taxane-based regimen|0|||
156867862|NCT01588522|566275770|FG002|Overall Study|Taken off taxane-based regimen|0|||
156867863|NCT01588522|566275771|FG003|Overall Study|Taken off taxane-based regimen|1|||
156867864|NCT01588522|566275772|FG004|Overall Study|Taken off taxane-based regimen|0|||
156867865|NCT01588522|566275773|FG005|Overall Study|Taken off taxane-based regimen|0|||
156867866|NCT01588522|566275768|FG000|Overall Study|Did not initiate chemotherapy|0|||
156329387|NCT02718300|564305606|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
156329388|NCT02718300|564305607|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
156329389|NCT02718300|564305608|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
156329390|NCT02742441|564306926|FG000|Overall Study|Lost to Follow-up|4|||
156329391|NCT02742441|564306927|FG001|Overall Study|Lost to Follow-up|4|||
156329392|NCT02742441|564306926|FG000|Overall Study|Withdrawal by Subject|2|||
156329393|NCT02742441|564306927|FG001|Overall Study|Withdrawal by Subject|2|||
156329394|NCT02742441|564306926|FG000|Overall Study|Adverse Event|0|||
156329395|NCT02742441|564306927|FG001|Overall Study|Adverse Event|2|||
156329396|NCT02202837|564306928|FG000|Overall Study|Enbrel treatment discontinued|36|||
156329397|NCT02202837|564306929|FG001|Overall Study|Enbrel treatment discontinued|4|||
156329398|NCT02202837|564306928|FG000|Overall Study|Other|10|||
156329399|NCT02202837|564306929|FG001|Overall Study|Other|0|||
156329400|NCT02202837|564306928|FG000|Overall Study|Lost to Follow-up|7|||
156329401|NCT02202837|564306929|FG001|Overall Study|Lost to Follow-up|1|||
156329402|NCT00231842|564306933|FG000|Overall Study|Withdrawal by Subject|3|||
156329403|NCT00231842|564306933|FG000|Overall Study|Did not complete the last 3 cycle|8|||
156329404|NCT02422303|564306934|FG000|Overall Study|Lost to Follow-up|1|||
156329405|NCT02422303|564306935|FG001|Overall Study|Lost to Follow-up|1|||
156329406|NCT00850343|564306936|FG000|Overall Study|Withdrawal by Subject|11|||
156329407|NCT00850343|564306937|FG001|Overall Study|Withdrawal by Subject|0|||
156329408|NCT00850343|564306938|FG002|Overall Study|Withdrawal by Subject|3|||
156329409|NCT00850343|564306939|FG003|Overall Study|Withdrawal by Subject|2|||
156329410|NCT00850343|564306936|FG000|Overall Study|Adverse Event|15|||
156329411|NCT00850343|564306937|FG001|Overall Study|Adverse Event|2|||
156329412|NCT00850343|564306938|FG002|Overall Study|Adverse Event|6|||
156329413|NCT00850343|564306939|FG003|Overall Study|Adverse Event|6|||
156329414|NCT00850343|564306936|FG000|Overall Study|Pregnancy|0|||
156329415|NCT00850343|564306937|FG001|Overall Study|Pregnancy|0|||
156329416|NCT00850343|564306938|FG002|Overall Study|Pregnancy|0|||
156329417|NCT00850343|564306939|FG003|Overall Study|Pregnancy|1|||
156329418|NCT00850343|564306936|FG000|Overall Study|Lack of Efficacy|17|||
156329419|NCT00850343|564306937|FG001|Overall Study|Lack of Efficacy|0|||
156329420|NCT00850343|564306938|FG002|Overall Study|Lack of Efficacy|3|||
156329421|NCT00850343|564306939|FG003|Overall Study|Lack of Efficacy|2|||
156329422|NCT00850343|564306936|FG000|Overall Study|Non-compliance with Study Procedures|1|||
156329423|NCT00850343|564306937|FG001|Overall Study|Non-compliance with Study Procedures|0|||
156329424|NCT00850343|564306938|FG002|Overall Study|Non-compliance with Study Procedures|1|||
156329425|NCT00850343|564306939|FG003|Overall Study|Non-compliance with Study Procedures|1|||
156329426|NCT00850343|564306936|FG000|Overall Study|Physician Decision|2|||
156329427|NCT00850343|564306937|FG001|Overall Study|Physician Decision|1|||
156329428|NCT00850343|564306938|FG002|Overall Study|Physician Decision|1|||
156329429|NCT00850343|564306939|FG003|Overall Study|Physician Decision|1|||
156329430|NCT00371826|564306940|FG000|Core Phase (12 Months)|Adverse Event|15|||
156329431|NCT00371826|564306941|FG001|Core Phase (12 Months)|Adverse Event|4|||
156329432|NCT00371826|564306942|FG002|Core Phase (12 Months)|Adverse Event|9|||
156329433|NCT00371826|564306940|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
156329434|NCT00371826|564306941|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
156329435|NCT00371826|564306942|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
156329436|NCT00371826|564306940|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
156329437|NCT00371826|564306941|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
156329438|NCT00371826|564306942|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
156329439|NCT00371826|564306940|FG000|Core Phase (12 Months)|Protocol Violation|1|||
156329440|NCT00371826|564306941|FG001|Core Phase (12 Months)|Protocol Violation|0|||
156329441|NCT00371826|564306942|FG002|Core Phase (12 Months)|Protocol Violation|1|||
156329442|NCT00371826|564306940|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
156329443|NCT00371826|564306941|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
156329444|NCT00371826|564306942|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
156329445|NCT00371826|564306940|FG000|Core Phase (12 Months)|Administrative problems|1|||
156329446|NCT00371826|564306941|FG001|Core Phase (12 Months)|Administrative problems|0|||
156329447|NCT00371826|564306942|FG002|Core Phase (12 Months)|Administrative problems|8|||
156329448|NCT00371826|564306940|FG000|Core Phase (12 Months)|Graft Loss|0|||
156329449|NCT00371826|564306941|FG001|Core Phase (12 Months)|Graft Loss|1|||
156329450|NCT00371826|564306942|FG002|Core Phase (12 Months)|Graft Loss|0|||
156329451|NCT00371826|564306940|FG000|Extension Phase (24 Months)|Adverse Event|4|||
156329452|NCT00371826|564306941|FG001|Extension Phase (24 Months)|Adverse Event|5|||
156329453|NCT00371826|564306942|FG002|Extension Phase (24 Months)|Adverse Event|0|||
156329454|NCT00371826|564306940|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
156329455|NCT00371826|564306941|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
156329456|NCT00371826|564306942|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
156329457|NCT00371826|564306940|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
156329458|NCT00371826|564306941|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
156329459|NCT00371826|564306942|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
156329460|NCT00371826|564306940|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
156329461|NCT00371826|564306941|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
156329462|NCT00371826|564306942|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
156329463|NCT00371826|564306940|FG000|Extension Phase (24 Months)|Administrative problems|0|||
156329464|NCT00371826|564306941|FG001|Extension Phase (24 Months)|Administrative problems|0|||
156329465|NCT00371826|564306942|FG002|Extension Phase (24 Months)|Administrative problems|2|||
156329466|NCT01031706|564306952|FG000|Overall Study|Adverse Event|1|||
156329467|NCT01031706|564306953|FG001|Overall Study|Adverse Event|0|||
156329468|NCT01031706|564306952|FG000|Overall Study|Withdrawal by Subject|1|||
156329469|NCT01031706|564306953|FG001|Overall Study|Withdrawal by Subject|1|||
156329470|NCT02517866|564306954|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156329471|NCT02517866|564306955|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
156329472|NCT02517866|564306956|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156329473|NCT02517866|564306954|FG000|Overall Study|Significant Protocol Deviation|4|||
156329474|NCT02517866|564306955|FG001|Overall Study|Significant Protocol Deviation|1|||
156329475|NCT02517866|564306956|FG002|Overall Study|Significant Protocol Deviation|0|||
156329476|NCT02517866|564306954|FG000|Overall Study|Lost to Follow-up|1|||
156783948|NCT03123588|565958908|FG000|Overall Study|Withdrawal by Subject|1|||
156783949|NCT03123588|565958909|FG001|Overall Study|Withdrawal by Subject|0|||
156783950|NCT03123588|565958908|FG000|Overall Study|Adverse Event|1|||
156783951|NCT03123588|565958909|FG001|Overall Study|Adverse Event|0|||
156783952|NCT03123588|565958908|FG000|Overall Study|Physician Decision|2|||
156783953|NCT03123588|565958909|FG001|Overall Study|Physician Decision|1|||
156783954|NCT00997126|565958911|FG000|Overall Study|Physician Decision|7|||
156783955|NCT00997126|565958912|FG001|Overall Study|Physician Decision|11|||
156783956|NCT01769443|565958914|FG000|Overall Study|Study closure|1|||
156783957|NCT01769443|565958915|FG001|Overall Study|Study closure|0|||
156783958|NCT00866320|565958918|FG000|Overall Study|Withdrawal by Subject|4|||
156783959|NCT00866320|565958918|FG000|Overall Study|Death|2|||
156783960|NCT02063724|565958919|FG000|Overall Study|Disease progression|1|||
156867867|NCT01588522|566275769|FG001|Overall Study|Did not initiate chemotherapy|0|||
156867868|NCT01588522|566275770|FG002|Overall Study|Did not initiate chemotherapy|0|||
156867869|NCT01588522|566275771|FG003|Overall Study|Did not initiate chemotherapy|0|||
156867870|NCT01588522|566275772|FG004|Overall Study|Did not initiate chemotherapy|1|||
156867871|NCT01588522|566275773|FG005|Overall Study|Did not initiate chemotherapy|0|||
156867872|NCT02855125|566275776|FG000|Overall Study|Withdrawal by Subject|2|||
156867873|NCT02855125|566275777|FG001|Overall Study|Withdrawal by Subject|2|||
156867874|NCT02855125|566275776|FG000|Overall Study|Clinical Disease Progression|5|||
156867875|NCT02855125|566275777|FG001|Overall Study|Clinical Disease Progression|4|||
156867876|NCT02855125|566275776|FG000|Overall Study|Radiologic Disease Progression|36|||
156867877|NCT02855125|566275777|FG001|Overall Study|Radiologic Disease Progression|39|||
156867878|NCT02855125|566275776|FG000|Overall Study|Adverse Event|11|||
156867879|NCT02855125|566275777|FG001|Overall Study|Adverse Event|7|||
156867880|NCT02855125|566275776|FG000|Overall Study|Physician Decision|1|||
156867881|NCT02855125|566275777|FG001|Overall Study|Physician Decision|0|||
156867882|NCT02855125|566275776|FG000|Overall Study|On Treatment|9|||
156867883|NCT02855125|566275777|FG001|Overall Study|On Treatment|11|||
156867884|NCT02855125|566275776|FG000|Overall Study|Randomized but not treated|0|||
156867885|NCT02855125|566275777|FG001|Overall Study|Randomized but not treated|1|||
156867886|NCT04467905|566275778|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
156329477|NCT02517866|564306955|FG001|Overall Study|Lost to Follow-up|0|||
156329478|NCT02517866|564306956|FG002|Overall Study|Lost to Follow-up|0|||
156329479|NCT02517866|564306954|FG000|Overall Study|Voluntary Withdrawal|2|||
156329480|NCT02517866|564306955|FG001|Overall Study|Voluntary Withdrawal|2|||
156783961|NCT02315625|565958920|FG000|First Intervention|Disease Progression|1|||
156783962|NCT02315625|565958921|FG001|First Intervention|Disease Progression|0|||
156867887|NCT04467905|566275779|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
156329481|NCT02517866|564306956|FG002|Overall Study|Voluntary Withdrawal|0|||
156329482|NCT02517866|564306954|FG000|Overall Study|Investigator Decision|2|||
156329483|NCT02517866|564306955|FG001|Overall Study|Investigator Decision|1|||
156783963|NCT02315625|565958920|FG000|Second Intervention|Physician Decision|2|||
156529427|NCT04658186|565032635|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
156681418|NCT00098475|565578975|FG003|Step 1|Both patient and physician's decision|0|||
156681419|NCT00098475|565578972|FG000|Step 1|Incorrect disease assessment|2|||
156681420|NCT00098475|565578973|FG001|Step 1|Incorrect disease assessment|0|||
156681421|NCT00098475|565578974|FG002|Step 1|Incorrect disease assessment|0|||
156681422|NCT00098475|565578975|FG003|Step 1|Incorrect disease assessment|0|||
156681423|NCT00098475|565578972|FG000|Step 1|Off treatment for > specified timeframe|1|||
156681424|NCT00098475|565578973|FG001|Step 1|Off treatment for > specified timeframe|1|||
156681425|NCT00098475|565578974|FG002|Step 1|Off treatment for > specified timeframe|0|||
156681426|NCT00098475|565578975|FG003|Step 1|Off treatment for > specified timeframe|0|||
156681427|NCT00098475|565578972|FG000|Step 1|Declining performance status|0|||
156681428|NCT00098475|565578973|FG001|Step 1|Declining performance status|1|||
156681429|NCT00098475|565578974|FG002|Step 1|Declining performance status|0|||
156681430|NCT00098475|565578975|FG003|Step 1|Declining performance status|0|||
156681431|NCT00098475|565578972|FG000|Step 1|Insurance issue|0|||
156681432|NCT00098475|565578973|FG001|Step 1|Insurance issue|1|||
156681433|NCT00098475|565578974|FG002|Step 1|Insurance issue|0|||
156681434|NCT00098475|565578975|FG003|Step 1|Insurance issue|0|||
156681435|NCT00098475|565578972|FG000|Step 1|Rising paraprotein|0|||
156681436|NCT00098475|565578973|FG001|Step 1|Rising paraprotein|1|||
156681437|NCT00098475|565578974|FG002|Step 1|Rising paraprotein|0|||
156681438|NCT00098475|565578975|FG003|Step 1|Rising paraprotein|0|||
156681439|NCT00098475|565578972|FG000|Step 1|Referred to other physicians|0|||
156681440|NCT00098475|565578973|FG001|Step 1|Referred to other physicians|1|||
156681441|NCT00098475|565578974|FG002|Step 1|Referred to other physicians|0|||
156681442|NCT00098475|565578975|FG003|Step 1|Referred to other physicians|0|||
156681443|NCT00098475|565578972|FG000|Step 1|Criteria to continue treatment not met|0|||
156529428|NCT04658186|565032633|FG000|Overall Study|Participant is Moving in Another Province|0|||
156529429|NCT04658186|565032634|FG001|Overall Study|Participant is Moving in Another Province|1|||
156529430|NCT04658186|565032635|FG002|Overall Study|Participant is Moving in Another Province|0|||
156529431|NCT04658186|565032633|FG000|Overall Study|Non-Compliance|0|||
156681444|NCT00098475|565578973|FG001|Step 1|Criteria to continue treatment not met|1|||
156681445|NCT00098475|565578974|FG002|Step 1|Criteria to continue treatment not met|0|||
156681446|NCT00098475|565578975|FG003|Step 1|Criteria to continue treatment not met|0|||
156681447|NCT00098475|565578972|FG000|Step 1|Misinterpretation of lab data|0|||
156681448|NCT00098475|565578973|FG001|Step 1|Misinterpretation of lab data|1|||
156681449|NCT00098475|565578974|FG002|Step 1|Misinterpretation of lab data|0|||
156681450|NCT00098475|565578975|FG003|Step 1|Misinterpretation of lab data|0|||
156681451|NCT00098475|565578972|FG000|Step 1|Patient fell with fracture|1|||
156681452|NCT00098475|565578973|FG001|Step 1|Patient fell with fracture|0|||
156681453|NCT00098475|565578974|FG002|Step 1|Patient fell with fracture|0|||
156681454|NCT00098475|565578975|FG003|Step 1|Patient fell with fracture|0|||
156681455|NCT00098475|565578972|FG000|Step 1|Not documented|0|||
156681456|NCT00098475|565578973|FG001|Step 1|Not documented|1|||
156681457|NCT00098475|565578974|FG002|Step 1|Not documented|0|||
156681458|NCT00098475|565578975|FG003|Step 1|Not documented|0|||
156681459|NCT00098475|565578972|FG000|Step 2|Disease progression|1|||
156681460|NCT00098475|565578973|FG001|Step 2|Disease progression|4|||
156681461|NCT00098475|565578974|FG002|Step 2|Disease progression|0|||
156681462|NCT00098475|565578975|FG003|Step 2|Disease progression|0|||
156681463|NCT00098475|565578972|FG000|Step 2|Adverse Event|2|||
156681464|NCT00098475|565578973|FG001|Step 2|Adverse Event|0|||
156681465|NCT00098475|565578974|FG002|Step 2|Adverse Event|0|||
156681466|NCT00098475|565578975|FG003|Step 2|Adverse Event|0|||
156681467|NCT00098475|565578972|FG000|Step 2|Withdrawal by Subject|0|||
156681468|NCT00098475|565578973|FG001|Step 2|Withdrawal by Subject|2|||
156681469|NCT00098475|565578974|FG002|Step 2|Withdrawal by Subject|0|||
156681470|NCT00098475|565578975|FG003|Step 2|Withdrawal by Subject|0|||
156681471|NCT00098475|565578972|FG000|Step 2|Physician Decision|0|||
156681472|NCT00098475|565578973|FG001|Step 2|Physician Decision|1|||
156681473|NCT00098475|565578974|FG002|Step 2|Physician Decision|0|||
156681474|NCT00098475|565578975|FG003|Step 2|Physician Decision|0|||
156681475|NCT00098475|565578972|FG000|Step 2|Alternative therapy|1|||
156681476|NCT00098475|565578973|FG001|Step 2|Alternative therapy|2|||
156681477|NCT00098475|565578974|FG002|Step 2|Alternative therapy|0|||
156681478|NCT00098475|565578975|FG003|Step 2|Alternative therapy|0|||
156681479|NCT00098475|565578972|FG000|Step 2|Never started treatment|1|||
156681480|NCT00098475|565578973|FG001|Step 2|Never started treatment|1|||
156681481|NCT00098475|565578974|FG002|Step 2|Never started treatment|0|||
156681482|NCT00098475|565578975|FG003|Step 2|Never started treatment|0|||
156681483|NCT01583530|565578977|FG000|Overall Study|Adverse Event|0|||
156681484|NCT01583530|565578978|FG001|Overall Study|Adverse Event|0|||
156681485|NCT01583530|565578979|FG002|Overall Study|Adverse Event|0|||
156529432|NCT04658186|565032634|FG001|Overall Study|Non-Compliance|1|||
156681486|NCT01583530|565578980|FG003|Overall Study|Adverse Event|0|||
156681487|NCT01583530|565578981|FG004|Overall Study|Adverse Event|0|||
156681488|NCT01583530|565578982|FG005|Overall Study|Adverse Event|1|||
156681489|NCT01583530|565578977|FG000|Overall Study|Withdrawal by Subject|0|||
156529433|NCT04658186|565032635|FG002|Overall Study|Non-Compliance|1|||
156681490|NCT01583530|565578978|FG001|Overall Study|Withdrawal by Subject|3|||
156681491|NCT01583530|565578979|FG002|Overall Study|Withdrawal by Subject|0|||
156681492|NCT01583530|565578980|FG003|Overall Study|Withdrawal by Subject|1|||
156681493|NCT01583530|565578981|FG004|Overall Study|Withdrawal by Subject|1|||
156681494|NCT01583530|565578982|FG005|Overall Study|Withdrawal by Subject|2|||
156681495|NCT01583530|565578977|FG000|Overall Study|Lost to Follow-up|0|||
156681496|NCT01583530|565578978|FG001|Overall Study|Lost to Follow-up|0|||
156681497|NCT01583530|565578979|FG002|Overall Study|Lost to Follow-up|0|||
156681498|NCT01583530|565578980|FG003|Overall Study|Lost to Follow-up|0|||
156681499|NCT01583530|565578981|FG004|Overall Study|Lost to Follow-up|3|||
156681500|NCT01583530|565578982|FG005|Overall Study|Lost to Follow-up|0|||
156681501|NCT01583530|565578977|FG000|Overall Study|Lack of compliance|0|||
156681502|NCT01583530|565578978|FG001|Overall Study|Lack of compliance|0|||
156681503|NCT01583530|565578979|FG002|Overall Study|Lack of compliance|0|||
156681504|NCT01583530|565578980|FG003|Overall Study|Lack of compliance|0|||
156681505|NCT01583530|565578981|FG004|Overall Study|Lack of compliance|1|||
156783964|NCT02315625|565958921|FG001|Second Intervention|Physician Decision|1|||
156783965|NCT02315625|565958920|FG000|Second Intervention|Study closure|1|||
156783966|NCT02315625|565958921|FG001|Second Intervention|Study closure|0|||
156783967|NCT02315625|565958920|FG000|Second Intervention|Disease Progression|1|||
156783968|NCT02315625|565958921|FG001|Second Intervention|Disease Progression|0|||
156783969|NCT02697422|565958922|FG000|Overall Study|Declined exit survey|9|||
156783970|NCT02697422|565958923|FG001|Overall Study|Declined exit survey|2|||
156783971|NCT02697422|565958922|FG000|Overall Study|Lost to Follow-up|13|||
156783972|NCT02697422|565958923|FG001|Overall Study|Lost to Follow-up|8|||
156783973|NCT02697422|565958922|FG000|Overall Study|Death|2|||
156783974|NCT02697422|565958923|FG001|Overall Study|Death|1|||
156783975|NCT02697422|565958922|FG000|Overall Study|Withdrawal by Subject|0|||
156783976|NCT02697422|565958923|FG001|Overall Study|Withdrawal by Subject|1|||
156783977|NCT02697422|565958922|FG000|Overall Study|Physician Decision|1|||
156783978|NCT02697422|565958923|FG001|Overall Study|Physician Decision|1|||
156783979|NCT02697422|565958922|FG000|Overall Study|Exit survey data lost|1|||
156783980|NCT02697422|565958923|FG001|Overall Study|Exit survey data lost|0|||
156783981|NCT04149353|565958924|FG000|Overall Study|Study terminated|1|||
156783982|NCT01871727|565958925|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
156783983|NCT01871727|565958926|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
156783984|NCT01871727|565958927|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
156783985|NCT01871727|565958928|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
156783986|NCT01871727|565958929|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
156783987|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
156783988|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
156783989|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
156783990|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
156783991|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
156783992|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
156783993|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
156783994|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
156783995|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
156783996|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
156783997|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
156783998|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
156681506|NCT01583530|565578982|FG005|Overall Study|Lack of compliance|0|||
156783999|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
156784000|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
156784001|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
156784002|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
156784003|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
156784004|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
156867888|NCT04467905|566275780|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
156681507|NCT02416180|565578983|FG000|Overall Study|Withdrawal by Subject|1|||
156867889|NCT04467905|566275778|FG000|Overall Study|Conversion to SR|0|||
156867890|NCT04467905|566275779|FG001|Overall Study|Conversion to SR|0|||
156867891|NCT04467905|566275780|FG002|Overall Study|Conversion to SR|3|||
156867892|NCT04467905|566275778|FG000|Overall Study|Technical issue with Holter ECG|0|||
156681508|NCT00640926|565578984|FG000|Overall Study|Adverse Event|2|||
156681509|NCT00640926|565578985|FG001|Overall Study|Adverse Event|3|||
156681510|NCT00640926|565578986|FG002|Overall Study|Adverse Event|2|||
156681511|NCT00640926|565578984|FG000|Overall Study|Lack of Efficacy|0|||
156681512|NCT00640926|565578985|FG001|Overall Study|Lack of Efficacy|2|||
156681513|NCT00640926|565578986|FG002|Overall Study|Lack of Efficacy|1|||
156681514|NCT00640926|565578984|FG000|Overall Study|Protocol Violation|2|||
156784005|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
156681515|NCT00640926|565578985|FG001|Overall Study|Protocol Violation|0|||
156784006|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
156681516|NCT00640926|565578986|FG002|Overall Study|Protocol Violation|2|||
156681517|NCT00640926|565578984|FG000|Overall Study|Lost to Follow-up|3|||
156681518|NCT00640926|565578985|FG001|Overall Study|Lost to Follow-up|1|||
156681519|NCT00640926|565578986|FG002|Overall Study|Lost to Follow-up|2|||
156681520|NCT00640926|565578984|FG000|Overall Study|Withdrawal by Subject|1|||
156681521|NCT00640926|565578985|FG001|Overall Study|Withdrawal by Subject|0|||
156681522|NCT00640926|565578986|FG002|Overall Study|Withdrawal by Subject|1|||
156681523|NCT01841073|565578987|FG000|Overall Study|Adverse Event|1|||
156681524|NCT01841073|565578988|FG001|Overall Study|Adverse Event|1|||
156681525|NCT01841073|565578987|FG000|Overall Study|Physician Decision|1|||
156681526|NCT01841073|565578988|FG001|Overall Study|Physician Decision|0|||
156681527|NCT01841073|565578987|FG000|Overall Study|Lost to Follow-up|0|||
156681528|NCT01841073|565578988|FG001|Overall Study|Lost to Follow-up|2|||
156681529|NCT00550147|565578989|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
156681530|NCT00550147|565578989|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
156681531|NCT00550147|565578989|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
156681532|NCT00550147|565578989|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
156681533|NCT00550147|565578989|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
156681534|NCT04320745|565578990|FG000|Overall Study|Adverse Event|26|||
156681535|NCT04320745|565578990|FG000|Overall Study|Withdrawal by Subject|4|||
156681536|NCT04320745|565578990|FG000|Overall Study|Lost to Follow-up|12|||
156681537|NCT04320745|565578990|FG000|Overall Study|Protocol Deviation|2|||
156681538|NCT04320745|565578990|FG000|Overall Study|Non-compliance With Study Drug|2|||
156681539|NCT04320745|565578990|FG000|Overall Study|Reason Not Specified|1|||
156681540|NCT00046839|565578991|FG000|Overall Study|Ineligible / No protocol treatment|0|||
156681541|NCT00046839|565578992|FG001|Overall Study|Ineligible / No protocol treatment|2|||
156681542|NCT00046839|565578991|FG000|Overall Study|Withdrawal of consent|1|||
156681543|NCT00046839|565578992|FG001|Overall Study|Withdrawal of consent|0|||
156681544|NCT02472639|565578994|FG000|Overall Study|Physician Decision|4|||
156681545|NCT02472639|565578995|FG001|Overall Study|Physician Decision|3|||
156329484|NCT02517866|564306956|FG002|Overall Study|Investigator Decision|0|||
156681546|NCT00751023|565578996|FG000|Overall Study|Lost to Follow-up|11|||
156681547|NCT00751023|565578997|FG001|Overall Study|Lost to Follow-up|7|||
156681548|NCT02050321|565578998|FG000|Overall Study|Withdrawal by Subject|1|||
156681549|NCT02050321|565578998|FG000|Overall Study|Adverse Event|1|||
156681550|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
156681551|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
156681552|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
156681553|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
156681554|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
156681555|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
156681556|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
156681557|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
156681558|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
156681559|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
156681560|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
156681561|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
156681562|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
156681563|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
156681564|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
156681565|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
156681566|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
156681567|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
156681568|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
156681569|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
156681570|NCT02151149|565579014|FG000|Treatment Period|Death|2|||
156681571|NCT02151149|565579015|FG001|Treatment Period|Death|3|||
156681572|NCT02151149|565579014|FG000|Treatment Period|Adverse Event|17|||
156681573|NCT02151149|565579015|FG001|Treatment Period|Adverse Event|14|||
156681574|NCT02151149|565579014|FG000|Treatment Period|Progressive Disease|25|||
156681575|NCT02151149|565579015|FG001|Treatment Period|Progressive Disease|24|||
156681576|NCT02151149|565579014|FG000|Treatment Period|Symptomatic Deterioration|2|||
156681577|NCT02151149|565579015|FG001|Treatment Period|Symptomatic Deterioration|10|||
156784007|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
156784008|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
156329485|NCT02517866|564306954|FG000|Overall Study|Reason not specified|2|||
156681578|NCT02151149|565579014|FG000|Treatment Period|Withdrawal by Subject|13|||
156681579|NCT02151149|565579015|FG001|Treatment Period|Withdrawal by Subject|11|||
156681580|NCT02151149|565579014|FG000|Treatment Period|Miscellaneous|8|||
156681581|NCT02151149|565579015|FG001|Treatment Period|Miscellaneous|7|||
156681582|NCT02151149|565579014|FG000|Treatment Period|Participants randomized but not treated|3|||
156784009|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
156329486|NCT02517866|564306955|FG001|Overall Study|Reason not specified|0|||
156867893|NCT04467905|566275779|FG001|Overall Study|Technical issue with Holter ECG|0|||
156867894|NCT04467905|566275780|FG002|Overall Study|Technical issue with Holter ECG|3|||
156867895|NCT04467905|566275778|FG000|Overall Study|Hemodynamic instability|0|||
156867896|NCT04467905|566275779|FG001|Overall Study|Hemodynamic instability|0|||
156867897|NCT04467905|566275780|FG002|Overall Study|Hemodynamic instability|1|||
156867898|NCT04467905|566275778|FG000|Overall Study|Site misinterpretation of protocol|0|||
156867899|NCT04467905|566275779|FG001|Overall Study|Site misinterpretation of protocol|0|||
156867900|NCT04467905|566275780|FG002|Overall Study|Site misinterpretation of protocol|1|||
156867901|NCT02514083|566275781|FG000|Overall Study|Adverse Event|1|||
156867902|NCT01899040|566275782|FG000|Overall Study|Randomized in error|0|||
156867903|NCT01899040|566275783|FG001|Overall Study|Randomized in error|1|||
156867904|NCT01899040|566275784|FG002|Overall Study|Randomized in error|1|||
156867905|NCT01899040|566275782|FG000|Overall Study|Adverse Event|3|||
156435472|NCT02013830|564684936|FG000|Overall Study|Adverse Event|3|||
156435473|NCT02013830|564684936|FG000|Overall Study|Death|1|||
156867906|NCT01899040|566275783|FG001|Overall Study|Adverse Event|1|||
156867907|NCT01899040|566275784|FG002|Overall Study|Adverse Event|2|||
156867908|NCT01899040|566275782|FG000|Overall Study|Unspecified reasons|4|||
156784010|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
156784011|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
156784012|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
156784013|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
156867909|NCT01899040|566275783|FG001|Overall Study|Unspecified reasons|4|||
156867910|NCT01899040|566275784|FG002|Overall Study|Unspecified reasons|0|||
156867911|NCT01899040|566275782|FG000|Overall Study|Compliance issues|1|||
156867912|NCT01899040|566275783|FG001|Overall Study|Compliance issues|2|||
156867913|NCT01899040|566275784|FG002|Overall Study|Compliance issues|0|||
156867914|NCT04586205|566275792|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
156867915|NCT04586205|566275793|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
156867916|NCT01590888|566277244|FG000|Overall Study|Adverse Event|3|||
156784014|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
156784015|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
156784016|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
156784017|NCT03019588|565958930|FG000|Overall Study|Death|44|||
156784018|NCT03019588|565958931|FG001|Overall Study|Death|46|||
156784019|NCT03019588|565958930|FG000|Overall Study|Study terminated by Sponsor|3|||
156784020|NCT03019588|565958931|FG001|Overall Study|Study terminated by Sponsor|1|||
156784021|NCT00366535|565958934|FG000|First Phase: 12 Weeks|Adverse Event|1|||
156784022|NCT00366535|565958935|FG001|First Phase: 12 Weeks|Adverse Event|3|||
156784023|NCT00366535|565958934|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
156784024|NCT00366535|565958935|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
156784025|NCT00366535|565958934|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
156784026|NCT00366535|565958935|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
156784027|NCT00366535|565958934|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
156784028|NCT00366535|565958935|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
156784029|NCT02958527|565958940|FG000|Overall Study|Not collected CRFs|12|||
156784030|NCT02939781|565958942|FG000|Overall Study|Protocol Violation|8|||
156784031|NCT02939781|565958942|FG000|Overall Study|Withdrawal by Subject|1|||
156784032|NCT05259033|565958943|FG000|Overall Study|Withdrawal by Subject|10|||
156784033|NCT05259033|565958944|FG001|Overall Study|Withdrawal by Subject|5|||
156784034|NCT05259033|565958943|FG000|Overall Study|Lost to Follow-up|1|||
156784035|NCT05259033|565958944|FG001|Overall Study|Lost to Follow-up|0|||
156784036|NCT05259033|565958943|FG000|Overall Study|Death|2|||
156784037|NCT05259033|565958944|FG001|Overall Study|Death|0|||
156784038|NCT01068249|565958948|FG000|Overall Study|Death|1|||
156784039|NCT01068249|565958948|FG000|Overall Study|Withdrawal by Subject|3|||
156867917|NCT01590888|566277245|FG001|Overall Study|Adverse Event|0|||
156867918|NCT01590888|566277246|FG002|Overall Study|Adverse Event|1|||
156867919|NCT01590888|566277244|FG000|Overall Study|Lost to Follow-up|1|||
156867920|NCT01590888|566277245|FG001|Overall Study|Lost to Follow-up|0|||
156867921|NCT01590888|566277246|FG002|Overall Study|Lost to Follow-up|0|||
156867922|NCT02141295|566277250|FG000|Overall Study|Adverse Event|1|||
156867923|NCT02141295|566277251|FG001|Overall Study|Adverse Event|18|||
156867924|NCT02141295|566277252|FG002|Overall Study|Adverse Event|11|||
156784040|NCT05537571|565958949|FG000|Overall Study|Withdrawal by Subject|1|||
156784041|NCT05537571|565958950|FG001|Overall Study|Withdrawal by Subject|1|||
156784042|NCT05537571|565958951|FG002|Overall Study|Withdrawal by Subject|0|||
156867925|NCT02141295|566277250|FG000|Overall Study|Physician Decision|2|||
156435474|NCT02013830|564684936|FG000|Overall Study|Insufficient therapeutic response|25|||
156784043|NCT05537571|565958952|FG003|Overall Study|Withdrawal by Subject|0|||
156867926|NCT02141295|566277251|FG001|Overall Study|Physician Decision|19|||
156867927|NCT02141295|566277252|FG002|Overall Study|Physician Decision|14|||
156784044|NCT05537571|565958953|FG004|Overall Study|Withdrawal by Subject|0|||
156784045|NCT05537571|565958949|FG000|Overall Study|Adverse Event|2|||
156867928|NCT02141295|566277250|FG000|Overall Study|Study terminated by sponsor|0|||
156867929|NCT02141295|566277251|FG001|Overall Study|Study terminated by sponsor|6|||
156681583|NCT02151149|565579015|FG001|Treatment Period|Participants randomized but not treated|2|||
156681584|NCT02151149|565579014|FG000|Follow-Up Period|Lost to Follow-up|2|||
156681585|NCT02151149|565579015|FG001|Follow-Up Period|Lost to Follow-up|3|||
156681586|NCT02151149|565579014|FG000|Follow-Up Period|Death|37|||
156681587|NCT02151149|565579015|FG001|Follow-Up Period|Death|34|||
156681588|NCT00057941|565579016|FG000|Overall Study|Death|1|||
156681589|NCT00057941|565579017|FG001|Overall Study|Death|2|||
156681590|NCT00057941|565579016|FG000|Overall Study|Adverse Event|7|||
156681591|NCT00057941|565579017|FG001|Overall Study|Adverse Event|9|||
156681592|NCT00057941|565579016|FG000|Overall Study|Lack of Efficacy|54|||
156681593|NCT00057941|565579017|FG001|Overall Study|Lack of Efficacy|53|||
156681594|NCT00057941|565579016|FG000|Overall Study|Withdrawal by Subject|6|||
156681595|NCT00057941|565579017|FG001|Overall Study|Withdrawal by Subject|1|||
156681596|NCT00057941|565579016|FG000|Overall Study|still on treatment|3|||
156681597|NCT00057941|565579017|FG001|Overall Study|still on treatment|1|||
156435475|NCT02013830|564684936|FG000|Overall Study|Refused treatment|1|||
156681598|NCT00057941|565579016|FG000|Overall Study|insurance, symptomatic deterioration|1|||
156681599|NCT00057941|565579017|FG001|Overall Study|insurance, symptomatic deterioration|3|||
156681600|NCT00057941|565579016|FG000|Overall Study|Ineligible|2|||
156681601|NCT00057941|565579017|FG001|Overall Study|Ineligible|5|||
156681602|NCT03419962|565579018|FG000|Overall Study|Change to other medication|1|||
156681603|NCT03419962|565579018|FG000|Overall Study|Refusal of continuing with trial drug|1|||
156681604|NCT03419962|565579018|FG000|Overall Study|Lost to Follow-up|3|||
156681605|NCT03419962|565579018|FG000|Overall Study|Difficulty in inhaling the doses|1|||
156681606|NCT03419962|565579018|FG000|Overall Study|Missing completion data|31|||
156681607|NCT04142658|565579021|FG000|Overall Study|Death|2|||
156681608|NCT04142658|565579022|FG001|Overall Study|Death|1|||
156681609|NCT04142658|565579021|FG000|Overall Study|Lost to Follow-up|4|||
156681610|NCT04142658|565579022|FG001|Overall Study|Lost to Follow-up|13|||
156681611|NCT04142658|565579021|FG000|Overall Study|Withdrawal by Subject|9|||
156681612|NCT04142658|565579022|FG001|Overall Study|Withdrawal by Subject|16|||
156681613|NCT01781234|565579023|FG000|Overall Study|Adverse Event|2|||
156681614|NCT01781234|565579024|FG001|Overall Study|Adverse Event|0|||
156681615|NCT01781234|565579023|FG000|Overall Study|Protocol Violation|3|||
156681616|NCT01781234|565579024|FG001|Overall Study|Protocol Violation|0|||
156681617|NCT01781234|565579023|FG000|Overall Study|Withdrawal by Subject|4|||
156681618|NCT01781234|565579024|FG001|Overall Study|Withdrawal by Subject|3|||
156681619|NCT03439085|565579025|FG000|Overall Study|Death|2|||
156681620|NCT03439085|565579025|FG000|Overall Study|Screen Failure|20|||
156681621|NCT01499160|565579029|FG000|Overall Study|Adverse Event|1|||
156681622|NCT01499160|565579029|FG000|Overall Study|Withdrawal by Subject|1|||
156681623|NCT01438476|565579033|FG000|Overall Study|Protocol Violation|1|||
156681624|NCT01438476|565579034|FG001|Overall Study|Protocol Violation|0|||
156681625|NCT01438476|565579033|FG000|Overall Study|Withdrawal by Subject|1|||
156681626|NCT01438476|565579034|FG001|Overall Study|Withdrawal by Subject|0|||
156681627|NCT01438476|565579033|FG000|Overall Study|No Surgery- Disease|8|||
156681628|NCT01438476|565579034|FG001|Overall Study|No Surgery- Disease|10|||
156681629|NCT01438476|565579033|FG000|Overall Study|Communication barrier|0|||
156681630|NCT01438476|565579034|FG001|Overall Study|Communication barrier|1|||
156681631|NCT03294317|565579037|FG000|Overall Study|Physician Decision|1|||
156681632|NCT03294317|565579037|FG000|Overall Study|Withdrawal by Subject|6|||
156681633|NCT03294317|565579037|FG000|Overall Study|Lost to Follow-up|1|||
156681634|NCT03294317|565579037|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
156681635|NCT03294317|565579037|FG000|Overall Study|Failed HB lead implant|8|||
156681636|NCT03294317|565579037|FG000|Overall Study|Received CRT instead|1|||
156681637|NCT03294317|565579037|FG000|Overall Study|Exited after lead revision|2|||
156681638|NCT00860262|565579038|FG000|Overall Study|Adverse Event|9|||
156681639|NCT00860262|565579039|FG001|Overall Study|Adverse Event|6|||
156681640|NCT00860262|565579040|FG002|Overall Study|Adverse Event|7|||
156681641|NCT00860262|565579038|FG000|Overall Study|Protocol Violation|0|||
156681642|NCT00860262|565579039|FG001|Overall Study|Protocol Violation|1|||
156681643|NCT00860262|565579040|FG002|Overall Study|Protocol Violation|0|||
156681644|NCT00860262|565579038|FG000|Overall Study|Lost to Follow-up|2|||
156681645|NCT00860262|565579039|FG001|Overall Study|Lost to Follow-up|0|||
156681646|NCT00860262|565579040|FG002|Overall Study|Lost to Follow-up|1|||
156681647|NCT00860262|565579038|FG000|Overall Study|Withdrawal by Subject|4|||
156681648|NCT00860262|565579039|FG001|Overall Study|Withdrawal by Subject|8|||
156681649|NCT00860262|565579040|FG002|Overall Study|Withdrawal by Subject|6|||
156681650|NCT00860262|565579038|FG000|Overall Study|Lack of Efficacy|0|||
156681651|NCT00860262|565579039|FG001|Overall Study|Lack of Efficacy|4|||
156681652|NCT00860262|565579040|FG002|Overall Study|Lack of Efficacy|3|||
156681653|NCT00860262|565579038|FG000|Overall Study|Other|5|||
156681654|NCT00860262|565579039|FG001|Overall Study|Other|3|||
156681655|NCT00860262|565579040|FG002|Overall Study|Other|1|||
156681656|NCT00857818|565579041|FG000|Overall Study|Lack of Efficacy|1|||
156681657|NCT00857818|565579042|FG001|Overall Study|Lack of Efficacy|0|||
156681658|NCT00857818|565579041|FG000|Overall Study|Adverse Event|3|||
156681659|NCT00857818|565579042|FG001|Overall Study|Adverse Event|0|||
156681660|NCT00857818|565579041|FG000|Overall Study|Withdrawal by Subject|0|||
156329487|NCT02517866|564306956|FG002|Overall Study|Reason not specified|0|||
156329488|NCT03114488|564306957|FG000|Time Period 2|Withdrawal by Subject|1|||
156329489|NCT03114488|564306958|FG001|Time Period 2|Withdrawal by Subject|3|||
156329490|NCT03711266|564306959|FG000|Overall Study|Lost to Follow-up|10|||
156329491|NCT03387683|564306960|FG000|Overall Study|In receipt of disallowed medication|1|||
156329492|NCT03387683|564306961|FG001|Overall Study|In receipt of disallowed medication|0|||
156329493|NCT03387683|564306960|FG000|Overall Study|Did not receive treatment|1|||
156329494|NCT03387683|564306961|FG001|Overall Study|Did not receive treatment|0|||
156329495|NCT01646073|564306962|FG000|Period A (12 Weeks)|Adverse Event|0|||
156329496|NCT01646073|564306963|FG001|Period A (12 Weeks)|Adverse Event|2|||
156329497|NCT01646073|564306962|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
156329498|NCT01646073|564306963|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
156329499|NCT01646073|564306962|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
156329500|NCT01646073|564306963|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
156329501|NCT01646073|564306962|FG000|Period A (12 Weeks)|Protocol Violation|0|||
156329502|NCT01646073|564306963|FG001|Period A (12 Weeks)|Protocol Violation|1|||
156329503|NCT01646073|564306962|FG000|Period A (12 Weeks)|Other|0|||
156329504|NCT01646073|564306963|FG001|Period A (12 Weeks)|Other|1|||
156329505|NCT01646073|564306962|FG000|Period B (12 Weeks)|Adverse Event|0|||
156329506|NCT01646073|564306963|FG001|Period B (12 Weeks)|Adverse Event|7|||
156329507|NCT01646073|564306962|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
156329508|NCT01646073|564306963|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
156329509|NCT01646073|564306962|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
156329510|NCT01646073|564306963|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
156329511|NCT01393301|564306964|FG000|Overall Study|Lost to Follow-up|5|||
156329512|NCT01393301|564306965|FG001|Overall Study|Lost to Follow-up|3|||
156329513|NCT01393301|564306964|FG000|Overall Study|Withdrawal by Subject|2|||
156329514|NCT01393301|564306965|FG001|Overall Study|Withdrawal by Subject|0|||
156329515|NCT01393301|564306964|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
156329516|NCT01393301|564306965|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
156329517|NCT00853073|564306966|FG000|Overall Study|Withdrawal by Subject|3|||
156329518|NCT00853073|564306967|FG001|Overall Study|Withdrawal by Subject|2|||
156329519|NCT01999114|564306968|FG000|Overall Study|Adverse Event|8|||
156329520|NCT01999114|564306969|FG001|Overall Study|Adverse Event|7|||
156329521|NCT01999114|564306970|FG002|Overall Study|Adverse Event|2|||
156329522|NCT01999114|564306971|FG003|Overall Study|Adverse Event|2|||
156329523|NCT01999114|564306972|FG004|Overall Study|Adverse Event|1|||
156329524|NCT01999114|564306968|FG000|Overall Study|Withdrawal by Subject|0|||
156329525|NCT01999114|564306969|FG001|Overall Study|Withdrawal by Subject|0|||
156329526|NCT01999114|564306970|FG002|Overall Study|Withdrawal by Subject|1|||
156329527|NCT01999114|564306971|FG003|Overall Study|Withdrawal by Subject|0|||
156329528|NCT01999114|564306972|FG004|Overall Study|Withdrawal by Subject|1|||
156329529|NCT01999114|564306968|FG000|Overall Study|Lost to Follow-up|0|||
156329530|NCT01999114|564306969|FG001|Overall Study|Lost to Follow-up|0|||
156329531|NCT01999114|564306970|FG002|Overall Study|Lost to Follow-up|1|||
156329532|NCT01999114|564306971|FG003|Overall Study|Lost to Follow-up|0|||
156329533|NCT01999114|564306972|FG004|Overall Study|Lost to Follow-up|0|||
156329534|NCT01999114|564306968|FG000|Overall Study|Administrative|0|||
156329535|NCT01999114|564306969|FG001|Overall Study|Administrative|0|||
156329536|NCT01999114|564306970|FG002|Overall Study|Administrative|1|||
156329537|NCT01999114|564306971|FG003|Overall Study|Administrative|1|||
156329538|NCT01999114|564306972|FG004|Overall Study|Administrative|2|||
156329539|NCT03342963|564306973|FG000|Overall Study|Adverse Event|1|||
156329540|NCT03342963|564306974|FG001|Overall Study|Adverse Event|2|||
156329541|NCT03342963|564306975|FG002|Overall Study|Adverse Event|0|||
156329542|NCT03342963|564306976|FG003|Overall Study|Adverse Event|0|||
156329543|NCT03342963|564306973|FG000|Overall Study|Withdrawal by Subject|1|||
156329544|NCT03342963|564306974|FG001|Overall Study|Withdrawal by Subject|0|||
156329545|NCT03342963|564306975|FG002|Overall Study|Withdrawal by Subject|0|||
156329546|NCT03342963|564306976|FG003|Overall Study|Withdrawal by Subject|0|||
156329547|NCT01008150|564306977|FG000|Overall Study|did not receive study drug|1|||
156329548|NCT01008150|564306978|FG001|Overall Study|did not receive study drug|1|||
156329549|NCT01008150|564306979|FG002|Overall Study|did not receive study drug|1|||
156329550|NCT01008150|564306980|FG003|Overall Study|did not receive study drug|0|||
156329551|NCT01309165|564306981|FG000|Overall Study|Lost to Follow-up|4|||
156329552|NCT01309165|564306982|FG001|Overall Study|Lost to Follow-up|3|||
156329553|NCT01309165|564306981|FG000|Overall Study|Return to work|1|||
156329554|NCT01309165|564306982|FG001|Overall Study|Return to work|2|||
156329555|NCT01309165|564306981|FG000|Overall Study|Left country|0|||
156329556|NCT01309165|564306982|FG001|Overall Study|Left country|1|||
156329557|NCT01309165|564306981|FG000|Overall Study|No transportation|0|||
156329558|NCT01309165|564306982|FG001|Overall Study|No transportation|1|||
156329559|NCT01309165|564306981|FG000|Overall Study|Admitted to hospital for second stroke|1|||
156329560|NCT01309165|564306982|FG001|Overall Study|Admitted to hospital for second stroke|0|||
156329561|NCT01497275|564306983|FG000|Overall Study|Death|1|||
156329562|NCT01497275|564306983|FG000|Overall Study|Adverse Event|1|||
156329563|NCT01950169|564306984|FG000|Overall Study|Withdrawal by Subject|2|||
156784046|NCT05537571|565958950|FG001|Overall Study|Adverse Event|0|||
156867930|NCT02141295|566277252|FG002|Overall Study|Study terminated by sponsor|6|||
156867931|NCT02141295|566277250|FG000|Overall Study|Non-compliance|0|||
156867932|NCT02141295|566277251|FG001|Overall Study|Non-compliance|1|||
156867933|NCT02141295|566277252|FG002|Overall Study|Non-compliance|0|||
156867934|NCT02141295|566277250|FG000|Overall Study|Progressive disease|3|||
156867935|NCT02141295|566277251|FG001|Overall Study|Progressive disease|32|||
156867936|NCT02141295|566277252|FG002|Overall Study|Progressive disease|50|||
156867937|NCT02141295|566277250|FG000|Overall Study|Reason not specified|0|||
156867938|NCT02141295|566277251|FG001|Overall Study|Reason not specified|9|||
156867939|NCT02141295|566277252|FG002|Overall Study|Reason not specified|10|||
156867940|NCT02141295|566277250|FG000|Overall Study|Withdrawal by Subject|0|||
156867941|NCT02141295|566277251|FG001|Overall Study|Withdrawal by Subject|9|||
156867942|NCT02141295|566277252|FG002|Overall Study|Withdrawal by Subject|4|||
156867943|NCT01432730|566277259|FG000|Period 1|Adverse Event|2|||
156867944|NCT01432730|566277260|FG001|Period 1|Adverse Event|0|||
156867945|NCT01432730|566277259|FG000|Period 2|Adverse Event|0|||
156867946|NCT01432730|566277260|FG001|Period 2|Adverse Event|4|||
156867947|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
156867948|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
156867949|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
156867950|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
156867951|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
156867952|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
156867953|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
156867954|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
156867955|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
156867956|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
156867957|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
156867958|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
156867959|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
156867960|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
156867961|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
156867962|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
156867963|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
156867964|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
156867965|NCT01235741|566277261|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
156867966|NCT01235741|566277262|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
156867967|NCT01235741|566277263|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
156867968|NCT01235741|566277261|FG000|Randomized to Treatment|Adverse Event|0|||
156867969|NCT01235741|566277262|FG001|Randomized to Treatment|Adverse Event|1|||
156867970|NCT01235741|566277263|FG002|Randomized to Treatment|Adverse Event|1|||
156867971|NCT01235741|566277261|FG000|Randomized to Treatment|Sponsor terminated study|0|||
156867972|NCT01235741|566277262|FG001|Randomized to Treatment|Sponsor terminated study|35|||
156867973|NCT01235741|566277263|FG002|Randomized to Treatment|Sponsor terminated study|34|||
156867974|NCT01235741|566277261|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
156867975|NCT01235741|566277262|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
156867976|NCT01235741|566277263|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
156867977|NCT01235741|566277261|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
156867978|NCT01235741|566277262|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
156867979|NCT01235741|566277263|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
156867980|NCT01235741|566277261|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
156867981|NCT01235741|566277262|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
156867982|NCT01235741|566277263|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
156867983|NCT01705509|566277267|FG000|Inclusion CPET|Screen Failure|5|||
156867984|NCT01705509|566277267|FG000|Inclusion CPET|Withdrawal by Subject|2|||
156867985|NCT01705509|566277267|FG000|CPET w/ Ranexa|Screen Failure|2|||
156867986|NCT00904033|566277268|FG000|Overall Study|Withdrawal by Subject|1|||
156867987|NCT00904033|566277269|FG001|Overall Study|Withdrawal by Subject|1|||
156867988|NCT00904033|566277270|FG002|Overall Study|Withdrawal by Subject|0|||
156867989|NCT00904033|566277271|FG003|Overall Study|Withdrawal by Subject|0|||
156529434|NCT04658186|565032633|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
156529435|NCT04658186|565032634|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
156867990|NCT00904033|566277268|FG000|Overall Study|Physician Decision|0|||
156867991|NCT00904033|566277269|FG001|Overall Study|Physician Decision|0|||
156867992|NCT00904033|566277270|FG002|Overall Study|Physician Decision|1|||
156867993|NCT00904033|566277271|FG003|Overall Study|Physician Decision|0|||
156867994|NCT00904033|566277268|FG000|Overall Study|Unable to obtain final blood draw|0|||
156867995|NCT00904033|566277269|FG001|Overall Study|Unable to obtain final blood draw|0|||
156867996|NCT00904033|566277270|FG002|Overall Study|Unable to obtain final blood draw|0|||
156867997|NCT00904033|566277271|FG003|Overall Study|Unable to obtain final blood draw|2|||
156681661|NCT00857818|565579042|FG001|Overall Study|Withdrawal by Subject|4|||
156681662|NCT00857818|565579041|FG000|Overall Study|Sponsor terminated study|6|||
156681663|NCT00857818|565579042|FG001|Overall Study|Sponsor terminated study|4|||
156681664|NCT00857818|565579041|FG000|Overall Study|Investigator decision|1|||
156681665|NCT00857818|565579042|FG001|Overall Study|Investigator decision|0|||
156681666|NCT01049581|565579043|FG000|Overall Study|Lost to Follow-up|2|||
156681667|NCT01049581|565579044|FG001|Overall Study|Lost to Follow-up|1|||
156681668|NCT02459418|565580700|FG000|Overall Study|Exclusion Criteria|4|||
156681669|NCT02459418|565580701|FG001|Overall Study|Exclusion Criteria|0|||
156681670|NCT02459418|565580700|FG000|Overall Study|Protocol Violation|0|||
156681671|NCT02459418|565580701|FG001|Overall Study|Protocol Violation|2|||
156681672|NCT02459418|565580700|FG000|Overall Study|Physician Decision|0|||
156681673|NCT02459418|565580701|FG001|Overall Study|Physician Decision|2|||
156681674|NCT02459418|565580700|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
156681675|NCT02459418|565580701|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
156681676|NCT02459418|565580700|FG000|Overall Study|Adverse Event|0|||
156681677|NCT02459418|565580701|FG001|Overall Study|Adverse Event|1|||
156681678|NCT02459418|565580700|FG000|Overall Study|Withdrawal by Subject|1|||
156681679|NCT02459418|565580701|FG001|Overall Study|Withdrawal by Subject|1|||
156681680|NCT02459418|565580700|FG000|Overall Study|Elevated Creatine Kinase|1|||
156681681|NCT02459418|565580701|FG001|Overall Study|Elevated Creatine Kinase|0|||
156681682|NCT02459418|565580700|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
156681683|NCT02459418|565580701|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
156681684|NCT02697617|565580702|FG000|Overall Study|Withdrawal by Subject|0|||
156681685|NCT02697617|565580703|FG001|Overall Study|Withdrawal by Subject|2|||
156681686|NCT02697617|565580702|FG000|Overall Study|Pregnancy|1|||
156681687|NCT02697617|565580703|FG001|Overall Study|Pregnancy|0|||
156681688|NCT03303417|565580704|FG000|Overall Study|Withdrawal by Subject|1|||
156681689|NCT03303417|565580705|FG001|Overall Study|Withdrawal by Subject|1|||
156681690|NCT00381849|565580709|FG000|Wash Out|Withdrawal by Subject|0|||
156681691|NCT00381849|565580710|FG001|Wash Out|Withdrawal by Subject|1|||
156681692|NCT01765270|565580712|FG000|Overall Study|Physician Decision|1|||
156681693|NCT01765270|565580713|FG001|Overall Study|Physician Decision|0|||
156681694|NCT01765270|565580712|FG000|Overall Study|Withdrawal by Subject|0|||
156681695|NCT01765270|565580713|FG001|Overall Study|Withdrawal by Subject|1|||
156681696|NCT00329160|565580714|FG000|Overall Study|Adverse Event|27|||
156681697|NCT00329160|565580714|FG000|Overall Study|Withdrawal by Subject|13|||
156681698|NCT00329160|565580714|FG000|Overall Study|Protocol Violation|2|||
156681699|NCT00329160|565580714|FG000|Overall Study|Did not Receive Study Drug|1|||
156867998|NCT02736890|566277272|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
156867999|NCT02736890|566277273|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
156868000|NCT02736890|566277272|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
156868001|NCT02736890|566277273|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
156868002|NCT03077412|566277275|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
156868003|NCT03077412|566277276|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
156329564|NCT01950169|564306985|FG001|Overall Study|Withdrawal by Subject|8|||
156329565|NCT01950169|564306986|FG002|Overall Study|Withdrawal by Subject|1|||
156329566|NCT01950169|564306984|FG000|Overall Study|Death|1|||
156329567|NCT01950169|564306985|FG001|Overall Study|Death|0|||
156329568|NCT01950169|564306986|FG002|Overall Study|Death|0|||
156329569|NCT01938573|564306987|FG000|Overall Study|Lack of Efficacy|1|||
156329570|NCT01938573|564306988|FG001|Overall Study|Lack of Efficacy|0|||
156329571|NCT01938573|564306987|FG000|Overall Study|Operation at other hospital|1|||
156329572|NCT01938573|564306988|FG001|Overall Study|Operation at other hospital|0|||
156329573|NCT01739309|564306993|FG000|Overall Study|Adverse Event|1|||
156329574|NCT01739309|564306993|FG000|Overall Study|Withdrawal by Subject|1|||
156681700|NCT00329160|565580714|FG000|Overall Study|Incomplete IVUS|45|||
156681701|NCT01755975|565580720|FG000|Overall Study|Adverse Event|0|||
156329575|NCT05447897|564306994|FG000|Overall Study|Did not participate in survey|2|||
156329576|NCT04553679|564306995|FG000|Overall Study|Withdrawal by Subject|2|||
156681702|NCT01755975|565580721|FG001|Overall Study|Adverse Event|0|||
156681703|NCT01755975|565580722|FG002|Overall Study|Adverse Event|1|||
156681704|NCT01755975|565580723|FG003|Overall Study|Adverse Event|0|||
156329577|NCT04553679|564306996|FG001|Overall Study|Withdrawal by Subject|0|||
156329578|NCT04553679|564306995|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
156681705|NCT01755975|565580724|FG004|Overall Study|Adverse Event|2|||
156681706|NCT03653026|565580725|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
156681707|NCT03653026|565580726|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
156681708|NCT03653026|565580727|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
156681709|NCT03653026|565580728|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
156681710|NCT03653026|565580725|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
156681711|NCT03653026|565580726|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
156329579|NCT04553679|564306996|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
156329580|NCT00178633|564306997|FG000|Overall Study|Lost to Follow-up|6|||
156681712|NCT03653026|565580727|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156681713|NCT03653026|565580728|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156681714|NCT03653026|565580725|FG000|Part 1: Placebo-controlled Period|Other|0|||
156681715|NCT03653026|565580726|FG001|Part 1: Placebo-controlled Period|Other|3|||
156681716|NCT03653026|565580727|FG002|Part 1: Placebo-controlled Period|Other|0|||
156681717|NCT03653026|565580728|FG003|Part 1: Placebo-controlled Period|Other|0|||
156681718|NCT03653026|565580725|FG000|Part 2: Open-label Extension|Adverse Event|0|||
156681719|NCT03653026|565580726|FG001|Part 2: Open-label Extension|Adverse Event|0|||
156681720|NCT03653026|565580727|FG002|Part 2: Open-label Extension|Adverse Event|1|||
156681721|NCT03653026|565580728|FG003|Part 2: Open-label Extension|Adverse Event|1|||
156681722|NCT03653026|565580725|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
156681723|NCT03653026|565580726|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
156681724|NCT03653026|565580727|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
156681725|NCT03653026|565580728|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
156681726|NCT03653026|565580725|FG000|Part 2: Open-label Extension|Other|0|||
156681727|NCT03653026|565580726|FG001|Part 2: Open-label Extension|Other|0|||
156681728|NCT03653026|565580727|FG002|Part 2: Open-label Extension|Other|1|||
156681729|NCT03653026|565580728|FG003|Part 2: Open-label Extension|Other|2|||
156681730|NCT01933919|565580731|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
156681731|NCT01933919|565580732|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
156681732|NCT01933919|565580731|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
156681733|NCT01933919|565580732|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
156681734|NCT01933919|565580731|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
156784047|NCT05537571|565958951|FG002|Overall Study|Adverse Event|0|||
156784048|NCT05537571|565958952|FG003|Overall Study|Adverse Event|0|||
156681735|NCT01933919|565580732|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
156681736|NCT01933919|565580731|FG000|Open-label Long-term Phase|Adverse Event|2|||
156681737|NCT01933919|565580732|FG001|Open-label Long-term Phase|Adverse Event|0|||
156681738|NCT01933919|565580731|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
156681739|NCT01933919|565580732|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
156784049|NCT05537571|565958953|FG004|Overall Study|Adverse Event|0|||
156784050|NCT05537571|565958949|FG000|Overall Study|Hepatitis A screening result|2|||
156784051|NCT05537571|565958950|FG001|Overall Study|Hepatitis A screening result|0|||
156784052|NCT05537571|565958951|FG002|Overall Study|Hepatitis A screening result|0|||
156784053|NCT05537571|565958952|FG003|Overall Study|Hepatitis A screening result|0|||
156784054|NCT05537571|565958953|FG004|Overall Study|Hepatitis A screening result|0|||
156784055|NCT05537571|565958949|FG000|Overall Study|Lost to Follow-up|0|||
156784056|NCT05537571|565958950|FG001|Overall Study|Lost to Follow-up|0|||
156784057|NCT05537571|565958951|FG002|Overall Study|Lost to Follow-up|1|||
156784058|NCT05537571|565958952|FG003|Overall Study|Lost to Follow-up|0|||
156784059|NCT05537571|565958953|FG004|Overall Study|Lost to Follow-up|1|||
156784060|NCT04439123|565958956|FG000|Overall Study|Adverse Event|11|||
156784061|NCT04439123|565958956|FG000|Overall Study|Death|1|||
156784062|NCT04439123|565958956|FG000|Overall Study|Disease progression|19|||
156784063|NCT04439123|565958956|FG000|Overall Study|Withdrawal by Subject|2|||
156784064|NCT04439123|565958956|FG000|Overall Study|Still on treatment|2|||
156784065|NCT03022630|565961083|FG000|Overall Study|Death|9|||
156784066|NCT03022630|565961084|FG001|Overall Study|Death|7|||
156784067|NCT03022630|565961083|FG000|Overall Study|Withdrawal by Subject|0|||
156784068|NCT03022630|565961084|FG001|Overall Study|Withdrawal by Subject|5|||
156784069|NCT00884949|565961085|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
156784070|NCT00884949|565961085|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
156784071|NCT00382070|565961086|FG000|Overall Study|No follow up data mapped to Other|17|||
156784072|NCT00382070|565961087|FG001|Overall Study|No follow up data mapped to Other|19|||
156784073|NCT00382070|565961086|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
156784074|NCT00382070|565961087|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
156784075|NCT00382070|565961086|FG000|Overall Study|No clinical assessment|9|||
156784076|NCT00382070|565961087|FG001|Overall Study|No clinical assessment|11|||
156784077|NCT01734928|565961088|FG000|Randomization|Physician Decision|0|||
156784078|NCT01734928|565961089|FG001|Randomization|Physician Decision|1|||
156868004|NCT03077412|566277277|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
156784079|NCT01734928|565961088|FG000|Randomization|clinical progression|0|||
156681740|NCT01933919|565580731|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
156681741|NCT01933919|565580732|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
156681742|NCT01933919|565580731|FG000|Open-label Long-term Phase|Other|1|||
156784080|NCT01734928|565961089|FG001|Randomization|clinical progression|1|||
156784081|NCT01734928|565961088|FG000|Randomization|progressive disease|0|||
156784082|NCT01734928|565961089|FG001|Randomization|progressive disease|2|||
156784083|NCT01734928|565961088|FG000|Randomization|Withdrew informed consent|0|||
156784084|NCT01734928|565961089|FG001|Randomization|Withdrew informed consent|4|||
156784085|NCT01734928|565961088|FG000|Randomization|Death|1|||
156784086|NCT01734928|565961089|FG001|Randomization|Death|0|||
156784087|NCT01734928|565961088|FG000|Randomization|Randomization error|1|||
156681743|NCT01933919|565580732|FG001|Open-label Long-term Phase|Other|2|||
156681744|NCT00852917|565580733|FG000|Overall Study|Adverse Event|13|||
156784088|NCT01734928|565961089|FG001|Randomization|Randomization error|0|||
156784089|NCT01734928|565961088|FG000|Randomization|Lost to Follow-up|1|||
156784090|NCT01734928|565961089|FG001|Randomization|Lost to Follow-up|0|||
156784091|NCT01734928|565961088|FG000|Treatment Period|Lost to Follow-up|0|||
156784092|NCT01734928|565961089|FG001|Treatment Period|Lost to Follow-up|2|||
156784093|NCT01734928|565961088|FG000|Treatment Period|Progressive Disease|167|||
156784094|NCT01734928|565961089|FG001|Treatment Period|Progressive Disease|165|||
156784095|NCT01734928|565961088|FG000|Treatment Period|Adverse Event|39|||
156784096|NCT01734928|565961089|FG001|Treatment Period|Adverse Event|52|||
156784097|NCT01734928|565961088|FG000|Treatment Period|Withdrawal of Consent|25|||
156784098|NCT01734928|565961089|FG001|Treatment Period|Withdrawal of Consent|22|||
156784099|NCT01734928|565961088|FG000|Treatment Period|Death|20|||
156784100|NCT01734928|565961089|FG001|Treatment Period|Death|9|||
156784101|NCT01734928|565961088|FG000|Treatment Period|Other Reasons|27|||
156784102|NCT01734928|565961089|FG001|Treatment Period|Other Reasons|19|||
156784103|NCT01734928|565961088|FG000|Treatment Period|Pregnancy|0|||
156784104|NCT01734928|565961089|FG001|Treatment Period|Pregnancy|1|||
156784105|NCT00620035|565961090|FG000|Overall Study|Adverse Event|106|||
156784106|NCT00620035|565961090|FG000|Overall Study|Withdrawal of Informed Consent|1|||
156784107|NCT00620035|565961090|FG000|Overall Study|Other Reason|38|||
156784108|NCT03684057|565961092|FG000|Overall Study|Withdrawal by Subject|4|||
156681745|NCT00852917|565580734|FG001|Overall Study|Adverse Event|20|||
156681746|NCT00852917|565580735|FG002|Overall Study|Adverse Event|35|||
156681747|NCT00852917|565580736|FG003|Overall Study|Adverse Event|17|||
156681748|NCT00852917|565580733|FG000|Overall Study|Lack of Efficacy|21|||
156681749|NCT00852917|565580734|FG001|Overall Study|Lack of Efficacy|11|||
156681750|NCT00852917|565580735|FG002|Overall Study|Lack of Efficacy|11|||
156681751|NCT00852917|565580736|FG003|Overall Study|Lack of Efficacy|47|||
156681752|NCT00852917|565580733|FG000|Overall Study|Withdrawal by Subject|4|||
156681753|NCT00852917|565580734|FG001|Overall Study|Withdrawal by Subject|8|||
156681754|NCT00852917|565580735|FG002|Overall Study|Withdrawal by Subject|10|||
156681755|NCT00852917|565580736|FG003|Overall Study|Withdrawal by Subject|9|||
156681756|NCT00852917|565580733|FG000|Overall Study|Physician Decision|6|||
156681757|NCT00852917|565580734|FG001|Overall Study|Physician Decision|7|||
156681758|NCT00852917|565580735|FG002|Overall Study|Physician Decision|2|||
156681759|NCT00852917|565580736|FG003|Overall Study|Physician Decision|19|||
156681760|NCT00852917|565580733|FG000|Overall Study|Death|0|||
156681761|NCT00852917|565580734|FG001|Overall Study|Death|0|||
156681762|NCT00852917|565580735|FG002|Overall Study|Death|0|||
156681763|NCT00852917|565580736|FG003|Overall Study|Death|1|||
156681764|NCT02575339|565580737|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
156681765|NCT02575339|565580738|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
156681766|NCT02575339|565580739|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
156681767|NCT02575339|565580737|FG000|Study Treatment|Disease Progression|5|||
156681768|NCT02575339|565580738|FG001|Study Treatment|Disease Progression|2|||
156681769|NCT02575339|565580739|FG002|Study Treatment|Disease Progression|0|||
156681770|NCT02575339|565580737|FG000|Study Treatment|Adverse Event|1|||
156681771|NCT02575339|565580738|FG001|Study Treatment|Adverse Event|2|||
156681772|NCT02575339|565580739|FG002|Study Treatment|Adverse Event|0|||
156681773|NCT02575339|565580737|FG000|Follow up|Death|6|||
156681774|NCT02575339|565580738|FG001|Follow up|Death|2|||
156681775|NCT02575339|565580739|FG002|Follow up|Death|0|||
156681776|NCT02575339|565580737|FG000|Follow up|Study Terminated|0|||
156681777|NCT02575339|565580738|FG001|Follow up|Study Terminated|2|||
156681778|NCT02575339|565580739|FG002|Follow up|Study Terminated|0|||
156681779|NCT02575339|565580737|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
156681780|NCT02575339|565580738|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
156681781|NCT02575339|565580739|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
156681782|NCT01358877|565580740|FG000|Overall Study|Withdrawal by Subject|475|||
156681783|NCT01358877|565580741|FG001|Overall Study|Withdrawal by Subject|466|||
156784109|NCT03684057|565961093|FG001|Overall Study|Withdrawal by Subject|5|||
156784110|NCT00456612|565961095|FG000|Overall Study|Withdrawal by Subject|3|||
156784111|NCT02316613|565961096|FG000|Overall Study|Death|63|||
156681784|NCT01358877|565580740|FG000|Overall Study|Recurrence of disease|181|||
156681785|NCT01358877|565580741|FG001|Overall Study|Recurrence of disease|269|||
156784112|NCT02316613|565961096|FG000|Overall Study|Lost to Follow-up|9|||
156784113|NCT02316613|565961096|FG000|Overall Study|Lymphoma transformation|2|||
156784114|NCT02316613|565961096|FG000|Overall Study|Participant moved/changed medical team|11|||
156681786|NCT01358877|565580740|FG000|Overall Study|Lost to Follow-up|181|||
156681787|NCT01358877|565580741|FG001|Overall Study|Lost to Follow-up|176|||
156681788|NCT01358877|565580740|FG000|Overall Study|Death|41|||
156681789|NCT01358877|565580741|FG001|Overall Study|Death|46|||
156681790|NCT01358877|565580740|FG000|Overall Study|Adverse Event|39|||
156681791|NCT01358877|565580741|FG001|Overall Study|Adverse Event|42|||
156681792|NCT01358877|565580740|FG000|Overall Study|Physician Decision|43|||
156784115|NCT02316613|565961096|FG000|Overall Study|No data and duplicate cases|5|||
156681793|NCT01358877|565580741|FG001|Overall Study|Physician Decision|32|||
156681794|NCT01358877|565580740|FG000|Overall Study|Contralateral breast cancer|42|||
156681795|NCT01358877|565580741|FG001|Overall Study|Contralateral breast cancer|28|||
156681796|NCT01358877|565580740|FG000|Overall Study|Reason not specified|37|||
156681797|NCT01358877|565580741|FG001|Overall Study|Reason not specified|29|||
156681798|NCT02510261|565580742|FG000|Overall Study|Adverse Event|5|||
156681799|NCT02510261|565580743|FG001|Overall Study|Adverse Event|8|||
156681800|NCT02510261|565580744|FG002|Overall Study|Adverse Event|0|||
156681801|NCT02510261|565580742|FG000|Overall Study|Physician Decision|1|||
156681802|NCT02510261|565580743|FG001|Overall Study|Physician Decision|5|||
156681803|NCT02510261|565580744|FG002|Overall Study|Physician Decision|0|||
156681804|NCT02510261|565580742|FG000|Overall Study|Death|19|||
156681805|NCT02510261|565580743|FG001|Overall Study|Death|19|||
156681806|NCT02510261|565580744|FG002|Overall Study|Death|0|||
156681807|NCT02510261|565580742|FG000|Overall Study|Withdrawal by Subject|3|||
156681808|NCT02510261|565580743|FG001|Overall Study|Withdrawal by Subject|10|||
156681809|NCT02510261|565580744|FG002|Overall Study|Withdrawal by Subject|3|||
156681810|NCT01597479|565580748|FG000|Overall Study|Protocol Violation|1|||
156681811|NCT01597479|565580749|FG001|Overall Study|Protocol Violation|0|||
156681812|NCT01597479|565580748|FG000|Overall Study|Lost to Follow-up|1|||
156681813|NCT01597479|565580749|FG001|Overall Study|Lost to Follow-up|0|||
156681814|NCT02003222|565580750|FG000|Induction|Never started treatment|0|||
156681815|NCT02003222|565580751|FG001|Induction|Never started treatment|0|||
156681816|NCT02003222|565580752|FG002|Induction|Never started treatment|0|||
156681817|NCT02003222|565580753|FG003|Induction|Never started treatment|0|||
156681818|NCT02003222|565580754|FG004|Induction|Never started treatment|8|||
156681819|NCT02003222|565580750|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
156681820|NCT02003222|565580751|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
156681821|NCT02003222|565580752|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
156681822|NCT02003222|565580753|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
156681823|NCT02003222|565580754|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
156681824|NCT02003222|565580750|FG000|Induction|Adverse Event|0|||
156681825|NCT02003222|565580751|FG001|Induction|Adverse Event|0|||
156681826|NCT02003222|565580752|FG002|Induction|Adverse Event|0|||
156681827|NCT02003222|565580753|FG003|Induction|Adverse Event|0|||
156681828|NCT02003222|565580754|FG004|Induction|Adverse Event|13|||
156681829|NCT02003222|565580750|FG000|Induction|Alternative therapy|0|||
156681830|NCT02003222|565580751|FG001|Induction|Alternative therapy|0|||
156681831|NCT02003222|565580752|FG002|Induction|Alternative therapy|0|||
156681832|NCT02003222|565580753|FG003|Induction|Alternative therapy|0|||
156681833|NCT02003222|565580754|FG004|Induction|Alternative therapy|12|||
156681834|NCT02003222|565580750|FG000|Induction|Disease progression|0|||
156681835|NCT02003222|565580751|FG001|Induction|Disease progression|0|||
156681836|NCT02003222|565580752|FG002|Induction|Disease progression|0|||
156681837|NCT02003222|565580753|FG003|Induction|Disease progression|0|||
156681838|NCT02003222|565580754|FG004|Induction|Disease progression|22|||
156681839|NCT02003222|565580750|FG000|Induction|Death|0|||
156681840|NCT02003222|565580751|FG001|Induction|Death|0|||
156681841|NCT02003222|565580752|FG002|Induction|Death|0|||
156681842|NCT02003222|565580753|FG003|Induction|Death|0|||
156681843|NCT02003222|565580754|FG004|Induction|Death|3|||
156681844|NCT02003222|565580750|FG000|Induction|Withdrawal by Subject|0|||
156681845|NCT02003222|565580751|FG001|Induction|Withdrawal by Subject|0|||
156681846|NCT02003222|565580752|FG002|Induction|Withdrawal by Subject|0|||
156681847|NCT02003222|565580753|FG003|Induction|Withdrawal by Subject|0|||
156681848|NCT02003222|565580754|FG004|Induction|Withdrawal by Subject|8|||
156681849|NCT02003222|565580750|FG000|Induction|Other reasons|0|||
156681850|NCT02003222|565580751|FG001|Induction|Other reasons|0|||
156681851|NCT02003222|565580752|FG002|Induction|Other reasons|0|||
156681852|NCT02003222|565580753|FG003|Induction|Other reasons|0|||
156681853|NCT02003222|565580754|FG004|Induction|Other reasons|22|||
156681854|NCT02003222|565580750|FG000|Intensification|Never started treatment|0|||
156681855|NCT02003222|565580751|FG001|Intensification|Never started treatment|0|||
156681856|NCT02003222|565580752|FG002|Intensification|Never started treatment|0|||
156681857|NCT02003222|565580753|FG003|Intensification|Never started treatment|0|||
156681858|NCT02003222|565580754|FG004|Intensification|Never started treatment|2|||
156681859|NCT02003222|565580750|FG000|Intensification|Adverse Event|0|||
156681860|NCT02003222|565580751|FG001|Intensification|Adverse Event|0|||
156681861|NCT02003222|565580752|FG002|Intensification|Adverse Event|0|||
156681862|NCT02003222|565580753|FG003|Intensification|Adverse Event|0|||
156681863|NCT02003222|565580754|FG004|Intensification|Adverse Event|6|||
156681864|NCT02003222|565580750|FG000|Intensification|Alternative therapy|0|||
156681865|NCT02003222|565580751|FG001|Intensification|Alternative therapy|0|||
156681866|NCT02003222|565580752|FG002|Intensification|Alternative therapy|0|||
156681867|NCT02003222|565580753|FG003|Intensification|Alternative therapy|0|||
156681868|NCT02003222|565580754|FG004|Intensification|Alternative therapy|8|||
156681869|NCT02003222|565580750|FG000|Intensification|Disease progression|0|||
156681870|NCT02003222|565580751|FG001|Intensification|Disease progression|0|||
156681871|NCT02003222|565580752|FG002|Intensification|Disease progression|0|||
156681872|NCT02003222|565580753|FG003|Intensification|Disease progression|0|||
156681873|NCT02003222|565580754|FG004|Intensification|Disease progression|18|||
156681874|NCT02003222|565580750|FG000|Intensification|Withdrawal by Subject|0|||
156681875|NCT02003222|565580751|FG001|Intensification|Withdrawal by Subject|0|||
156681876|NCT02003222|565580752|FG002|Intensification|Withdrawal by Subject|0|||
156681877|NCT02003222|565580753|FG003|Intensification|Withdrawal by Subject|0|||
156681878|NCT02003222|565580754|FG004|Intensification|Withdrawal by Subject|5|||
156681879|NCT02003222|565580750|FG000|Intensification|Other reasons|0|||
156681880|NCT02003222|565580751|FG001|Intensification|Other reasons|0|||
156681881|NCT02003222|565580752|FG002|Intensification|Other reasons|0|||
156681882|NCT02003222|565580753|FG003|Intensification|Other reasons|0|||
156681883|NCT02003222|565580754|FG004|Intensification|Other reasons|8|||
156681884|NCT01886872|565580760|FG000|Overall Study|Ineligible|7|||
156681885|NCT01886872|565580761|FG001|Overall Study|Ineligible|4|||
156681886|NCT01886872|565580762|FG002|Overall Study|Ineligible|12|||
156681887|NCT02167594|565580763|FG000|Overall Study|Withdrawal by Subject|2|||
156681888|NCT02167594|565580764|FG001|Overall Study|Withdrawal by Subject|0|||
156681889|NCT02167594|565580765|FG002|Overall Study|Withdrawal by Subject|0|||
156681890|NCT02167594|565580763|FG000|Overall Study|Death|0|||
156681891|NCT02167594|565580764|FG001|Overall Study|Death|1|||
156681892|NCT02167594|565580765|FG002|Overall Study|Death|0|||
156681893|NCT02340962|565580770|FG000|Overall Study|Lost to Follow-up|1|||
156681894|NCT02340962|565580771|FG001|Overall Study|Lost to Follow-up|0|||
156681895|NCT04994431|565580772|FG000|Overall Study|Adverse Event|1|||
156681896|NCT04994431|565580773|FG001|Overall Study|Adverse Event|0|||
156681897|NCT02911935|565580774|FG000|Overall Study|Lost to Follow-up|5|||
156681898|NCT02911935|565580775|FG001|Overall Study|Lost to Follow-up|7|||
156681899|NCT00603512|565580776|FG000|Overall Study|Adverse Event|0|||
156681900|NCT00603512|565580777|FG001|Overall Study|Adverse Event|2|||
156681901|NCT00603512|565580778|FG002|Overall Study|Adverse Event|4|||
156681902|NCT00603512|565580779|FG003|Overall Study|Adverse Event|4|||
156681903|NCT00603512|565580780|FG004|Overall Study|Adverse Event|2|||
156681904|NCT00603512|565580776|FG000|Overall Study|Lack of Efficacy|0|||
156681905|NCT00603512|565580777|FG001|Overall Study|Lack of Efficacy|1|||
156681906|NCT00603512|565580778|FG002|Overall Study|Lack of Efficacy|0|||
156681907|NCT00603512|565580779|FG003|Overall Study|Lack of Efficacy|0|||
156681908|NCT00603512|565580780|FG004|Overall Study|Lack of Efficacy|1|||
156681909|NCT00603512|565580776|FG000|Overall Study|Other|2|||
156681910|NCT00603512|565580777|FG001|Overall Study|Other|1|||
156681911|NCT00603512|565580778|FG002|Overall Study|Other|0|||
156681912|NCT00603512|565580779|FG003|Overall Study|Other|1|||
156681913|NCT00603512|565580780|FG004|Overall Study|Other|1|||
156681914|NCT00603512|565580776|FG000|Overall Study|Withdrawal by Subject|0|||
156681915|NCT00603512|565580777|FG001|Overall Study|Withdrawal by Subject|0|||
156681916|NCT00603512|565580778|FG002|Overall Study|Withdrawal by Subject|0|||
156681917|NCT00603512|565580779|FG003|Overall Study|Withdrawal by Subject|0|||
156681918|NCT00603512|565580780|FG004|Overall Study|Withdrawal by Subject|1|||
156681919|NCT00603512|565580776|FG000|Overall Study|Randomized but not treated|0|||
156681920|NCT00603512|565580777|FG001|Overall Study|Randomized but not treated|1|||
156681921|NCT00603512|565580778|FG002|Overall Study|Randomized but not treated|1|||
156681922|NCT00603512|565580779|FG003|Overall Study|Randomized but not treated|2|||
156681923|NCT00603512|565580780|FG004|Overall Study|Randomized but not treated|0|||
156681924|NCT04979858|565580781|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
156681925|NCT04979858|565580782|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
156681926|NCT04253236|565580783|FG000|Overall Study|Adverse Event|1|||
156681927|NCT04253236|565580784|FG001|Overall Study|Adverse Event|0|||
156681928|NCT04253236|565580783|FG000|Overall Study|Safety Concerns|1|||
156681929|NCT04253236|565580784|FG001|Overall Study|Safety Concerns|0|||
156681930|NCT04253236|565580783|FG000|Overall Study|Study Terminated by Sponsor|1|||
156681931|NCT04253236|565580784|FG001|Overall Study|Study Terminated by Sponsor|0|||
156681932|NCT03259789|565580785|FG000|Overall Study|Adverse Event|3|||
156681933|NCT03259789|565580786|FG001|Overall Study|Adverse Event|2|||
156681934|NCT03259789|565580787|FG002|Overall Study|Adverse Event|1|||
156681935|NCT03259789|565580785|FG000|Overall Study|Withdrawal by Subject|9|||
156681936|NCT03259789|565580786|FG001|Overall Study|Withdrawal by Subject|5|||
156681937|NCT03259789|565580787|FG002|Overall Study|Withdrawal by Subject|1|||
156681938|NCT03259789|565580785|FG000|Overall Study|Lost to Follow-up|5|||
156681939|NCT03259789|565580786|FG001|Overall Study|Lost to Follow-up|9|||
156681940|NCT03259789|565580787|FG002|Overall Study|Lost to Follow-up|4|||
156681941|NCT03259789|565580785|FG000|Overall Study|Physician Decision|0|||
156681942|NCT03259789|565580786|FG001|Overall Study|Physician Decision|1|||
156681943|NCT03259789|565580787|FG002|Overall Study|Physician Decision|0|||
156681944|NCT02063217|565580788|FG000|Overall Study|Withdrawal by Subject|1|||
156681945|NCT02063217|565580789|FG001|Overall Study|Withdrawal by Subject|0|||
156681946|NCT02063217|565580790|FG002|Overall Study|Withdrawal by Subject|0|||
156681947|NCT00889252|565580791|FG000|Overall Study|Adverse Event|2|||
156681948|NCT00889252|565580792|FG001|Overall Study|Adverse Event|4|||
156681949|NCT00889252|565580791|FG000|Overall Study|Withdrawal by Subject|3|||
156681950|NCT00889252|565580792|FG001|Overall Study|Withdrawal by Subject|0|||
156681951|NCT00889252|565580791|FG000|Overall Study|Protocol Violation|2|||
156681952|NCT00889252|565580792|FG001|Overall Study|Protocol Violation|0|||
156681953|NCT04291508|565580793|FG000|Overall Study|Withdrawal by Subject|1|||
156681954|NCT04291508|565580794|FG001|Overall Study|Withdrawal by Subject|0|||
156681955|NCT04291508|565580795|FG002|Overall Study|Withdrawal by Subject|1|||
156681956|NCT04291508|565580796|FG003|Overall Study|Withdrawal by Subject|0|||
156681957|NCT04291508|565580793|FG000|Overall Study|lost to follow up|4|||
156681958|NCT04291508|565580794|FG001|Overall Study|lost to follow up|0|||
156681959|NCT04291508|565580795|FG002|Overall Study|lost to follow up|1|||
156681960|NCT04291508|565580796|FG003|Overall Study|lost to follow up|0|||
156681961|NCT03566238|565580797|FG000|Overall Study|Adverse Event|0|||
156681962|NCT03566238|565580798|FG001|Overall Study|Adverse Event|0|||
156681963|NCT03566238|565580799|FG002|Overall Study|Adverse Event|1|||
156681964|NCT03566238|565580797|FG000|Overall Study|Lack of Efficacy|5|||
156681965|NCT03566238|565580798|FG001|Overall Study|Lack of Efficacy|4|||
156681966|NCT03566238|565580799|FG002|Overall Study|Lack of Efficacy|2|||
156681967|NCT03566238|565580797|FG000|Overall Study|Other|0|||
156681968|NCT03566238|565580798|FG001|Overall Study|Other|1|||
156681969|NCT03566238|565580799|FG002|Overall Study|Other|0|||
156681970|NCT01833169|565580812|FG000|Overall Study|Disease Progression|99|||
156681971|NCT01833169|565580812|FG000|Overall Study|Adverse Event|33|||
156784116|NCT02316613|565961096|FG000|Overall Study|Did not met selection criteria|14|||
156784117|NCT03422718|565961106|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
156784118|NCT03422718|565961107|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
156784119|NCT03422718|565961108|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
156784120|NCT03422718|565961109|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
156784121|NCT03422718|565961110|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
156784122|NCT03422718|565961111|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
156784123|NCT03422718|565961112|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
156784124|NCT03422718|565961113|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
156784125|NCT03422718|565961106|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
156784126|NCT03422718|565961107|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
156784127|NCT03422718|565961108|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
156784128|NCT03422718|565961109|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
156784129|NCT03422718|565961110|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
156784130|NCT03422718|565961111|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
156784131|NCT03422718|565961112|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
156784132|NCT03422718|565961113|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
156784133|NCT03422718|565961106|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
156784134|NCT03422718|565961107|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
156784135|NCT03422718|565961108|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
156784136|NCT03422718|565961109|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
156784137|NCT03422718|565961110|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
156784138|NCT03422718|565961111|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
156784139|NCT03422718|565961112|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
156784140|NCT03422718|565961113|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
156784141|NCT03422718|565961106|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156784142|NCT03422718|565961107|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
156868005|NCT03077412|566277275|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
156868006|NCT03077412|566277276|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
156868007|NCT03077412|566277277|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
156784143|NCT03422718|565961108|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156868008|NCT03077412|566277275|FG000|Overall Study|Adverse Event|1|||
156868009|NCT03077412|566277276|FG001|Overall Study|Adverse Event|2|||
156681972|NCT01833169|565580812|FG000|Overall Study|Withdrawal by Subject|9|||
156681973|NCT01833169|565580812|FG000|Overall Study|Death|3|||
156681974|NCT01833169|565580812|FG000|Overall Study|Physician Decision|2|||
156681975|NCT02169336|565580817|FG000|Overall Study|Lack of Efficacy|1|||
156681976|NCT02169336|565580818|FG001|Overall Study|Lack of Efficacy|1|||
156681977|NCT02169336|565580819|FG002|Overall Study|Lack of Efficacy|0|||
156681978|NCT02169336|565580817|FG000|Overall Study|Adverse Event|2|||
156681979|NCT02169336|565580818|FG001|Overall Study|Adverse Event|3|||
156681980|NCT02169336|565580819|FG002|Overall Study|Adverse Event|1|||
156681981|NCT02169336|565580817|FG000|Overall Study|Withdrawal by Subject|1|||
156681982|NCT02169336|565580818|FG001|Overall Study|Withdrawal by Subject|0|||
156681983|NCT02169336|565580819|FG002|Overall Study|Withdrawal by Subject|0|||
156681984|NCT02169336|565580817|FG000|Overall Study|Physician Decision|0|||
156681985|NCT02169336|565580818|FG001|Overall Study|Physician Decision|0|||
156681986|NCT02169336|565580819|FG002|Overall Study|Physician Decision|1|||
156681987|NCT02169336|565580817|FG000|Overall Study|Subject declined to continue dosing|0|||
156681988|NCT02169336|565580818|FG001|Overall Study|Subject declined to continue dosing|0|||
156681989|NCT02169336|565580819|FG002|Overall Study|Subject declined to continue dosing|1|||
156681990|NCT04718129|565580820|FG000|Overall Study|Lost to Follow-up|6|||
156681991|NCT04718129|565580821|FG001|Overall Study|Lost to Follow-up|7|||
156681992|NCT01598896|565580822|FG000|Overall Study|Withdrawal by Subject|0|||
156681993|NCT01598896|565580823|FG001|Overall Study|Withdrawal by Subject|1|||
156681994|NCT01598896|565580822|FG000|Overall Study|Lack of Efficacy|0|||
156681995|NCT01598896|565580823|FG001|Overall Study|Lack of Efficacy|1|||
156681996|NCT00420095|565580824|FG000|Overall Study|Adverse Event|1|||
156681997|NCT00420095|565580825|FG001|Overall Study|Adverse Event|0|||
156681998|NCT00420095|565580824|FG000|Overall Study|Protocol Violation|1|||
156681999|NCT00420095|565580825|FG001|Overall Study|Protocol Violation|1|||
156682000|NCT00420095|565580824|FG000|Overall Study|Lost to Follow-up|1|||
156682001|NCT00420095|565580825|FG001|Overall Study|Lost to Follow-up|0|||
156682002|NCT00393705|565580826|FG000|Overall Study|Adverse Event|0|||
156682003|NCT00393705|565580827|FG001|Overall Study|Adverse Event|2|||
156682004|NCT00393705|565580826|FG000|Overall Study|Death|0|||
156682005|NCT00393705|565580827|FG001|Overall Study|Death|1|||
156682006|NCT00393705|565580826|FG000|Overall Study|Lost to Follow-up|2|||
156682007|NCT00393705|565580827|FG001|Overall Study|Lost to Follow-up|2|||
156682008|NCT00393705|565580826|FG000|Overall Study|Entry Criteria Not Met|10|||
156682009|NCT00393705|565580827|FG001|Overall Study|Entry Criteria Not Met|10|||
156682010|NCT00393705|565580826|FG000|Overall Study|Protocol Violation|4|||
156682011|NCT00393705|565580827|FG001|Overall Study|Protocol Violation|3|||
156682012|NCT00393705|565580826|FG000|Overall Study|Withdrawal by Subject|5|||
156682013|NCT00393705|565580827|FG001|Overall Study|Withdrawal by Subject|3|||
156682014|NCT00393705|565580826|FG000|Overall Study|Physician Decision|2|||
156682015|NCT00393705|565580827|FG001|Overall Study|Physician Decision|2|||
156682016|NCT01120691|565580830|FG000|Overall Study|Adverse Event|59|||
156682017|NCT01120691|565580831|FG001|Overall Study|Adverse Event|67|||
156682018|NCT01120691|565580832|FG002|Overall Study|Adverse Event|47|||
156682019|NCT01120691|565580830|FG000|Overall Study|Subject withdrew consent|33|||
156682020|NCT01120691|565580831|FG001|Overall Study|Subject withdrew consent|50|||
156682021|NCT01120691|565580832|FG002|Overall Study|Subject withdrew consent|44|||
156682022|NCT01120691|565580830|FG000|Overall Study|Death|21|||
156682023|NCT01120691|565580831|FG001|Overall Study|Death|22|||
156682024|NCT01120691|565580832|FG002|Overall Study|Death|24|||
156682025|NCT01120691|565580830|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
156682026|NCT01120691|565580831|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
156682027|NCT01120691|565580832|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
156682028|NCT01120691|565580830|FG000|Overall Study|Administrative problems|15|||
156682029|NCT01120691|565580831|FG001|Overall Study|Administrative problems|8|||
156682030|NCT01120691|565580832|FG002|Overall Study|Administrative problems|9|||
156682031|NCT01120691|565580830|FG000|Overall Study|Protocol deviation|13|||
156682032|NCT01120691|565580831|FG001|Overall Study|Protocol deviation|12|||
156682033|NCT01120691|565580832|FG002|Overall Study|Protocol deviation|12|||
156682034|NCT01120691|565580830|FG000|Overall Study|Lost to Follow-up|5|||
156682035|NCT01120691|565580831|FG001|Overall Study|Lost to Follow-up|6|||
156682036|NCT01120691|565580832|FG002|Overall Study|Lost to Follow-up|4|||
156784144|NCT03422718|565961109|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156784145|NCT03422718|565961110|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
156329581|NCT03845543|564306998|FG000|Overall Study|Death|25|||
156682037|NCT01120691|565580830|FG000|Overall Study|Abnormal test procedure result(s)|3|||
156784146|NCT03422718|565961111|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
156868010|NCT03077412|566277277|FG002|Overall Study|Adverse Event|2|||
156329582|NCT03845543|564306998|FG000|Overall Study|Withdrawal by Subject|2|||
156329583|NCT03845543|564306998|FG000|Overall Study|Lost to Follow-up|12|||
156329584|NCT03845543|564306998|FG000|Overall Study|Adverse Event|17|||
156329585|NCT02028871|564307004|FG000|Overall Study|Positive urine drug screen|1|||
156329586|NCT02028871|564307005|FG001|Overall Study|Positive urine drug screen|1|||
156329587|NCT02028871|564307004|FG000|Overall Study|Withdrawal by Subject|1|||
156329588|NCT02028871|564307005|FG001|Overall Study|Withdrawal by Subject|2|||
156329589|NCT02028871|564307004|FG000|Overall Study|IV placement difficulty|1|||
156329590|NCT02028871|564307005|FG001|Overall Study|IV placement difficulty|0|||
156682038|NCT01120691|565580831|FG001|Overall Study|Abnormal test procedure result(s)|2|||
156682039|NCT01120691|565580832|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156682040|NCT01120691|565580830|FG000|Overall Study|Patient's inability to use the device|3|||
156682041|NCT01120691|565580831|FG001|Overall Study|Patient's inability to use the device|1|||
156682042|NCT01120691|565580832|FG002|Overall Study|Patient's inability to use the device|0|||
156682043|NCT01120691|565580830|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156682044|NCT01120691|565580831|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156682045|NCT01120691|565580832|FG002|Overall Study|Abnormal laboratory value(s)|4|||
156682046|NCT03370510|565580836|FG000|Overall Study|COVID-19|2|||
156682047|NCT03370510|565580837|FG001|Overall Study|COVID-19|0|||
156682048|NCT00772148|565580838|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
156682049|NCT00772148|565580839|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
156682050|NCT00772148|565580838|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
156329591|NCT02028871|564307004|FG000|Overall Study|Current Illness|1|||
156329592|NCT02028871|564307005|FG001|Overall Study|Current Illness|0|||
156329593|NCT02633501|564307008|FG000|Overall Study|Adverse Event|0|||
156329594|NCT02633501|564307009|FG001|Overall Study|Adverse Event|0|||
156329595|NCT02633501|564307010|FG002|Overall Study|Adverse Event|1|||
156682051|NCT00772148|565580839|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
156682052|NCT00772148|565580838|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
156682053|NCT00772148|565580839|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
156682054|NCT00772148|565580838|FG000|Maintenance Phase (Week 52)|Death|2|||
156682055|NCT00772148|565580839|FG001|Maintenance Phase (Week 52)|Death|2|||
156682056|NCT00772148|565580838|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
156682057|NCT00772148|565580839|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
156682058|NCT00772148|565580838|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
156682059|NCT00772148|565580839|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
156682060|NCT00772148|565580838|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
156682061|NCT00772148|565580839|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
156682062|NCT00688844|565580840|FG000|Overall Study|Lost to Follow-up|10|||
156682063|NCT01223027|565580843|FG000|Overall Study|Adverse Event|20|||
156682064|NCT01223027|565580844|FG001|Overall Study|Adverse Event|10|||
156682065|NCT01223027|565580843|FG000|Overall Study|Death|42|||
156682066|NCT01223027|565580844|FG001|Overall Study|Death|42|||
156682067|NCT01223027|565580843|FG000|Overall Study|Lost to Follow-up|2|||
156682068|NCT01223027|565580844|FG001|Overall Study|Lost to Follow-up|1|||
156682069|NCT01223027|565580843|FG000|Overall Study|Physician Decision|4|||
156682070|NCT01223027|565580844|FG001|Overall Study|Physician Decision|8|||
156682071|NCT01223027|565580843|FG000|Overall Study|Progressive Disease|167|||
156682072|NCT01223027|565580844|FG001|Overall Study|Progressive Disease|183|||
156682073|NCT01223027|565580843|FG000|Overall Study|Protocol Violation|2|||
156682074|NCT01223027|565580844|FG001|Overall Study|Protocol Violation|1|||
156682075|NCT01223027|565580843|FG000|Overall Study|Subject/guardian decicion|18|||
156682076|NCT01223027|565580844|FG001|Overall Study|Subject/guardian decicion|16|||
156682077|NCT01223027|565580843|FG000|Overall Study|New therapy for study indication|17|||
156329596|NCT02633501|564307011|FG003|Overall Study|Adverse Event|0|||
156329597|NCT02633501|564307012|FG004|Overall Study|Adverse Event|1|||
156329598|NCT02633501|564307013|FG005|Overall Study|Adverse Event|1|||
156682078|NCT01223027|565580844|FG001|Overall Study|New therapy for study indication|8|||
156682079|NCT01223027|565580843|FG000|Overall Study|Study terminated by sponsor|2|||
156682080|NCT01223027|565580844|FG001|Overall Study|Study terminated by sponsor|8|||
156682081|NCT01475487|565580845|FG000|Overall Study|had to leave early for personal reasons|2|||
156682082|NCT01475487|565580846|FG001|Overall Study|had to leave early for personal reasons|1|||
156682083|NCT04428645|565580849|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
156682084|NCT01321697|565580850|FG000|Overall Study|Study Terminated|7|||
156682085|NCT02061280|565580851|FG000|Overall Study|Protocol Violation|12|||
156682086|NCT02061280|565580852|FG001|Overall Study|Protocol Violation|8|||
156682087|NCT02061280|565580851|FG000|Overall Study|moved out of state|0|||
156682088|NCT02061280|565580852|FG001|Overall Study|moved out of state|1|||
156682089|NCT02061280|565580851|FG000|Overall Study|Withdrawal by Subject|1|||
156682090|NCT02061280|565580852|FG001|Overall Study|Withdrawal by Subject|2|||
156682091|NCT02061280|565580851|FG000|Overall Study|Lost to Follow-up|5|||
156682092|NCT02061280|565580852|FG001|Overall Study|Lost to Follow-up|1|||
156682093|NCT01977456|565580853|FG000|Overall Study|Death|5|||
156682094|NCT00559637|565582520|FG000|Overall Study|Adverse Event|22|||
156682095|NCT00559637|565582520|FG000|Overall Study|Withdrawal by Subject|4|||
156682096|NCT00559637|565582520|FG000|Overall Study|Protocol Violation|6|||
156682097|NCT00559637|565582520|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
156682098|NCT00559637|565582520|FG000|Overall Study|Failure to return|6|||
156682099|NCT00559637|565582520|FG000|Overall Study|Insufficient response|3|||
156682100|NCT00559637|565582520|FG000|Overall Study|Started requiring dialysis after month 7|2|||
156682101|NCT00559637|565582520|FG000|Overall Study|Suspected lung cancer|1|||
156682102|NCT00559637|565582520|FG000|Overall Study|Participation in another study|1|||
156682103|NCT00559637|565582520|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
156682104|NCT00559637|565582520|FG000|Overall Study|Change of center|1|||
156682105|NCT00559637|565582520|FG000|Overall Study|Change of home|1|||
156682106|NCT00559637|565582520|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
156682107|NCT00653159|565582521|FG000|Overall Study|Adverse Event|4|||
156682108|NCT00653159|565582522|FG001|Overall Study|Adverse Event|1|||
156682109|NCT00653159|565582521|FG000|Overall Study|Lost to Follow-up|1|||
156682110|NCT00653159|565582522|FG001|Overall Study|Lost to Follow-up|2|||
156682111|NCT01872715|565582523|FG000|Overall Study|Adverse Event|1|||
156682112|NCT01872715|565582523|FG000|Overall Study|Protocol Violation|1|||
156329599|NCT02633501|564307008|FG000|Overall Study|Withdrawal by Subject|2|||
156329600|NCT02633501|564307009|FG001|Overall Study|Withdrawal by Subject|1|||
156682113|NCT01872715|565582523|FG000|Overall Study|Withdrawal by Subject|2|||
156682114|NCT00683592|565582524|FG000|Overall Study|Adverse Event|12|||
156682115|NCT00683592|565582525|FG001|Overall Study|Adverse Event|4|||
156682116|NCT00683592|565582524|FG000|Overall Study|Withdrawal by Subject|11|||
156682117|NCT00683592|565582525|FG001|Overall Study|Withdrawal by Subject|11|||
156784147|NCT03422718|565961112|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156784148|NCT03422718|565961113|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156784149|NCT03422718|565961106|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
156784150|NCT03422718|565961107|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
156784151|NCT03422718|565961108|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
156784152|NCT03422718|565961109|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
156784153|NCT03422718|565961110|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
156784154|NCT03422718|565961111|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
156868011|NCT03077412|566277275|FG000|Overall Study|Investigator's Discretion|0|||
156868012|NCT03077412|566277276|FG001|Overall Study|Investigator's Discretion|1|||
156868013|NCT03077412|566277277|FG002|Overall Study|Investigator's Discretion|1|||
156868014|NCT03077412|566277275|FG000|Overall Study|Withdrew Consent|0|||
156868015|NCT03077412|566277276|FG001|Overall Study|Withdrew Consent|2|||
156529436|NCT04658186|565032635|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
156529437|NCT04658186|565032633|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
156529438|NCT04658186|565032634|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
156529439|NCT04658186|565032635|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
156529440|NCT04658186|565032633|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
156529441|NCT04658186|565032634|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
156529442|NCT04658186|565032635|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
156529443|NCT04658186|565032633|FG000|Overall Study|PI Decision due to Participant Safety|0|||
156529444|NCT04658186|565032634|FG001|Overall Study|PI Decision due to Participant Safety|0|||
156529445|NCT04658186|565032635|FG002|Overall Study|PI Decision due to Participant Safety|1|||
156529446|NCT04658186|565032633|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
156529447|NCT04658186|565032634|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
156529448|NCT04658186|565032635|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
156529449|NCT04098068|565032636|FG000|Overall Study|Disease Progression|7|||
156529450|NCT04098068|565032636|FG000|Overall Study|Withdrawal by Subject|2|||
156529451|NCT04098068|565032636|FG000|Overall Study|New Cancer Diagnosis|1|||
156529452|NCT03871829|565032637|FG000|Overall Study|Lost to Follow-up|0|||
156529453|NCT03871829|565032638|FG001|Overall Study|Lost to Follow-up|1|||
156529454|NCT03871829|565032637|FG000|Overall Study|Withdrawal by Subject|1|||
156529455|NCT03871829|565032638|FG001|Overall Study|Withdrawal by Subject|1|||
156529456|NCT03871829|565032637|FG000|Overall Study|Death|12|||
156529457|NCT03871829|565032638|FG001|Overall Study|Death|8|||
156529458|NCT03871829|565032637|FG000|Overall Study|Study terminated by sponsor|31|||
156529459|NCT03871829|565032638|FG001|Overall Study|Study terminated by sponsor|34|||
156529460|NCT02993523|565032639|FG000|Overall Study|Withdrew Consent|0|||
156529461|NCT02993523|565032640|FG001|Overall Study|Withdrew Consent|0|||
156784155|NCT03422718|565961112|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
156784156|NCT03422718|565961113|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
156784157|NCT03422718|565961106|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
156868016|NCT03077412|566277277|FG002|Overall Study|Withdrew Consent|0|||
156868017|NCT05097963|566277278|FG000|Overall Study|Protocol Violation|13|||
156868018|NCT05097963|566277278|FG000|Overall Study|Withdrawal by Subject|21|||
156868019|NCT01417377|566277279|FG000|Overall Study|Lost to Follow-up|12|||
156868020|NCT01417377|566277279|FG000|Overall Study|Enrolled, but not treated|1|||
156868021|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
156868022|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
156868023|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
156868024|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
156868025|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
156868026|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
156868027|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
156868028|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
156868029|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
156868030|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
156868031|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
156868032|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
156435476|NCT01111526|564684937|FG000|Overall Study|GVHD Disease Progression|0|||
156435477|NCT01111526|564684938|FG001|Overall Study|GVHD Disease Progression|1|||
156435478|NCT01111526|564684939|FG002|Overall Study|GVHD Disease Progression|2|||
156435479|NCT02015546|564684940|FG000|Overall Study|Withdrawal by Subject|1|||
156435480|NCT02015546|564684941|FG001|Overall Study|Withdrawal by Subject|1|||
156435481|NCT02015546|564684942|FG002|Overall Study|Withdrawal by Subject|1|||
156435482|NCT02015546|564684940|FG000|Overall Study|Screem Failure|2|||
156435483|NCT02015546|564684941|FG001|Overall Study|Screem Failure|1|||
156435484|NCT02015546|564684942|FG002|Overall Study|Screem Failure|3|||
156435485|NCT04424641|564684943|FG000|Overall Study|Death|1|||
156529462|NCT02993523|565032641|FG002|Overall Study|Withdrew Consent|2|||
156529463|NCT02993523|565032642|FG003|Overall Study|Withdrew Consent|9|||
156868033|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
156868034|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
156682118|NCT00683592|565582524|FG000|Overall Study|Lost to Follow-up|17|||
156682119|NCT00683592|565582525|FG001|Overall Study|Lost to Follow-up|17|||
156682120|NCT00683592|565582524|FG000|Overall Study|Lack of Efficacy|3|||
156682121|NCT00683592|565582525|FG001|Overall Study|Lack of Efficacy|7|||
156868035|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
156868036|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
156868037|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
156868038|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
156868039|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
156868040|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
156868041|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
156868042|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
156868043|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
156868044|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
156868045|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
156868046|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
156868047|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
156868048|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
156868049|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868050|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868051|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868052|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868053|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868054|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868055|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
156868056|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868057|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868058|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868059|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156682122|NCT00683592|565582524|FG000|Overall Study|Physician Decision|0|||
156682123|NCT00683592|565582525|FG001|Overall Study|Physician Decision|1|||
156682124|NCT00683592|565582524|FG000|Overall Study|Non-compliance|3|||
156682125|NCT00683592|565582525|FG001|Overall Study|Non-compliance|5|||
156682126|NCT00683592|565582524|FG000|Overall Study|Other|1|||
156682127|NCT00683592|565582525|FG001|Overall Study|Other|1|||
156682128|NCT02419573|565582535|FG000|Overall Study|Lost to Follow-up|3|||
156682129|NCT02419573|565582536|FG001|Overall Study|Lost to Follow-up|0|||
156682130|NCT02419573|565582535|FG000|Overall Study|Withdrawal by Subject|1|||
156682131|NCT02419573|565582536|FG001|Overall Study|Withdrawal by Subject|0|||
156868060|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868061|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868062|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868063|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Transplant|0|||
156868064|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Transplant|1|||
156868065|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Transplant|0|||
156868066|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Transplant|0|||
156868067|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Transplant|0|||
156868068|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Transplant|1|||
156682132|NCT00493792|565582537|FG000|Overall Study|Death|55|||
156682133|NCT00493792|565582538|FG001|Overall Study|Death|50|||
156682134|NCT00493792|565582537|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
156682135|NCT00493792|565582538|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
156682136|NCT04501094|565582539|FG000|Overall Study|Death (unrelated to research)|1|||
156682137|NCT04501094|565582540|FG001|Overall Study|Death (unrelated to research)|0|||
156682138|NCT02426541|565582541|FG000|Overall Study|Protocol Violation|1|||
156682139|NCT02426541|565582542|FG001|Overall Study|Protocol Violation|0|||
156682140|NCT02674633|565582547|FG000|Overall Study|Lost to Follow-up|3|||
156682141|NCT02674633|565582548|FG001|Overall Study|Lost to Follow-up|2|||
156682142|NCT02674633|565582547|FG000|Overall Study|Physician Decision|1|||
156682143|NCT02674633|565582548|FG001|Overall Study|Physician Decision|0|||
156682144|NCT02674633|565582547|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156682145|NCT02674633|565582548|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156682146|NCT04167618|565582549|FG000|Overall Study|Trial terminated by sponsor|1|||
156868069|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Transplant|0|||
156868070|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Transplant|0|||
156329601|NCT02633501|564307010|FG002|Overall Study|Withdrawal by Subject|2|||
156329602|NCT02633501|564307011|FG003|Overall Study|Withdrawal by Subject|2|||
156329603|NCT02633501|564307012|FG004|Overall Study|Withdrawal by Subject|1|||
156682147|NCT04167618|565582550|FG001|Overall Study|Trial terminated by sponsor|1|||
156682148|NCT02994394|565582551|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
156329604|NCT02633501|564307013|FG005|Overall Study|Withdrawal by Subject|3|||
156682149|NCT02994394|565582552|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682150|NCT02994394|565582553|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
156682151|NCT02994394|565582554|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682152|NCT02994394|565582555|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682153|NCT02994394|565582556|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682154|NCT02994394|565582551|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
156682155|NCT02994394|565582552|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
156682156|NCT02994394|565582553|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
156682157|NCT02994394|565582554|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
156682158|NCT02994394|565582555|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
156682159|NCT02994394|565582556|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
156682160|NCT05693805|565582557|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
156682161|NCT05693805|565582558|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
156682162|NCT04982445|565582562|FG000|Overall Study|Protocol Violation|1|||
156682163|NCT04982445|565582562|FG000|Overall Study|Withdrawal by Subject|4|||
156682164|NCT04982445|565582562|FG000|Overall Study|Lost to Follow-up|1|||
156682165|NCT02152982|565582563|FG000|Overall Study|Withdrawal by Subject|17|||
156682166|NCT02152982|565582564|FG001|Overall Study|Withdrawal by Subject|16|||
156682167|NCT02152982|565582563|FG000|Overall Study|Did not start treatment|11|||
156682168|NCT02152982|565582564|FG001|Overall Study|Did not start treatment|5|||
156682169|NCT02152982|565582563|FG000|Overall Study|Disease progression|41|||
156682170|NCT02152982|565582564|FG001|Overall Study|Disease progression|52|||
156682171|NCT02152982|565582563|FG000|Overall Study|Adverse Event|7|||
156682172|NCT02152982|565582564|FG001|Overall Study|Adverse Event|12|||
156682173|NCT02152982|565582563|FG000|Overall Study|Complicating disease|1|||
156682174|NCT02152982|565582564|FG001|Overall Study|Complicating disease|1|||
156682175|NCT02152982|565582563|FG000|Overall Study|Death|0|||
156682176|NCT02152982|565582564|FG001|Overall Study|Death|3|||
156682177|NCT02152982|565582563|FG000|Overall Study|Physician Decision|3|||
156682178|NCT02152982|565582564|FG001|Overall Study|Physician Decision|0|||
156682179|NCT03230487|565582567|FG000|Overall Study|Adverse Event|0|||
156682180|NCT03230487|565582568|FG001|Overall Study|Adverse Event|0|||
156682181|NCT03230487|565582569|FG002|Overall Study|Adverse Event|0|||
156682182|NCT03230487|565582570|FG003|Overall Study|Adverse Event|1|||
156682183|NCT03230487|565582571|FG004|Overall Study|Adverse Event|0|||
156682184|NCT03230487|565582572|FG005|Overall Study|Adverse Event|0|||
156682185|NCT00835796|565582575|FG000|First Intervention|Withdrawal by Subject|0|||
156682186|NCT00835796|565582576|FG001|First Intervention|Withdrawal by Subject|1|||
156682187|NCT00348816|565582577|FG000|Overall Study|Noncompliance with radiation treatment|1|||
156682188|NCT06128525|565582578|FG000|Overall Study|Patient withdrew consent|1|||
156682189|NCT05070754|565582579|FG000|Overall Study|Withdrawal by Subject|0|||
156682190|NCT05070754|565582580|FG001|Overall Study|Withdrawal by Subject|0|||
156682191|NCT05070754|565582581|FG002|Overall Study|Withdrawal by Subject|0|||
156682192|NCT05070754|565582582|FG003|Overall Study|Withdrawal by Subject|1|||
156682193|NCT05070754|565582579|FG000|Overall Study|Protocol Violation|0|||
156682194|NCT05070754|565582580|FG001|Overall Study|Protocol Violation|0|||
156682195|NCT05070754|565582581|FG002|Overall Study|Protocol Violation|0|||
156682196|NCT05070754|565582582|FG003|Overall Study|Protocol Violation|1|||
156784158|NCT03422718|565961107|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
156784159|NCT03422718|565961108|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
156784160|NCT03422718|565961109|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
156784161|NCT03422718|565961110|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
156784162|NCT03422718|565961111|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
156784163|NCT03422718|565961112|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
156784164|NCT03422718|565961113|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
156784165|NCT03309605|565961114|FG000|Overall Study|Adverse Event|0|||
156784166|NCT03309605|565961115|FG001|Overall Study|Adverse Event|0|||
156784167|NCT03309605|565961116|FG002|Overall Study|Adverse Event|0|||
156329605|NCT02633501|564307008|FG000|Overall Study|Various other reasons|0|||
156682197|NCT01398787|565582583|FG000|Overall Study|Adverse Event|1|||
156682198|NCT03414034|565582584|FG000|Overall Study|Adverse Event|6|||
156682199|NCT03414034|565582585|FG001|Overall Study|Adverse Event|1|||
156682200|NCT03414034|565582586|FG002|Overall Study|Adverse Event|1|||
156682201|NCT03414034|565582584|FG000|Overall Study|Death|0|||
156682202|NCT03414034|565582585|FG001|Overall Study|Death|0|||
156784168|NCT03309605|565961117|FG003|Overall Study|Adverse Event|1|||
156329606|NCT02633501|564307009|FG001|Overall Study|Various other reasons|2|||
156329607|NCT02633501|564307010|FG002|Overall Study|Various other reasons|4|||
156329608|NCT02633501|564307011|FG003|Overall Study|Various other reasons|1|||
156329609|NCT02633501|564307012|FG004|Overall Study|Various other reasons|7|||
156329610|NCT02633501|564307013|FG005|Overall Study|Various other reasons|11|||
156784169|NCT03309605|565961118|FG004|Overall Study|Adverse Event|0|||
156784170|NCT03309605|565961119|FG005|Overall Study|Adverse Event|0|||
156682203|NCT03414034|565582586|FG002|Overall Study|Death|1|||
156682204|NCT03414034|565582584|FG000|Overall Study|Non-compliance With Study Drug|0|||
156682205|NCT03414034|565582585|FG001|Overall Study|Non-compliance With Study Drug|0|||
156682206|NCT03414034|565582586|FG002|Overall Study|Non-compliance With Study Drug|1|||
156682207|NCT03414034|565582584|FG000|Overall Study|Physician Decision|1|||
156682208|NCT03414034|565582585|FG001|Overall Study|Physician Decision|3|||
156682209|NCT03414034|565582586|FG002|Overall Study|Physician Decision|2|||
156682210|NCT03414034|565582584|FG000|Overall Study|Withdrawal of Informed Consent|2|||
156682211|NCT03414034|565582585|FG001|Overall Study|Withdrawal of Informed Consent|1|||
156682212|NCT03414034|565582586|FG002|Overall Study|Withdrawal of Informed Consent|4|||
156682213|NCT03414034|565582584|FG000|Overall Study|Progressive Disease|15|||
156682214|NCT03414034|565582585|FG001|Overall Study|Progressive Disease|15|||
156682215|NCT03414034|565582586|FG002|Overall Study|Progressive Disease|17|||
156682216|NCT03414034|565582584|FG000|Overall Study|Miscellaneous|0|||
156682217|NCT03414034|565582585|FG001|Overall Study|Miscellaneous|0|||
156682218|NCT03414034|565582586|FG002|Overall Study|Miscellaneous|2|||
156682219|NCT04010227|565582587|FG000|Overall Study|Death|1|||
156682220|NCT04010227|565582588|FG001|Overall Study|Death|2|||
156682221|NCT04010227|565582587|FG000|Overall Study|Medical Reasons|4|||
156682222|NCT04010227|565582588|FG001|Overall Study|Medical Reasons|3|||
156682223|NCT04010227|565582587|FG000|Overall Study|Withdrawal by Subject|2|||
156682224|NCT04010227|565582588|FG001|Overall Study|Withdrawal by Subject|0|||
156682225|NCT04010227|565582587|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
156682226|NCT04010227|565582588|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
156682227|NCT00194792|565582589|FG000|Overall Study|Withdrawal by Subject|1|||
156682228|NCT02448563|565582590|FG000|Overall Study|Lost to Follow-up|16|||
156682229|NCT02448563|565582591|FG001|Overall Study|Lost to Follow-up|10|||
156682230|NCT02448563|565582590|FG000|Overall Study|Withdrawal by Subject|0|||
156682231|NCT02448563|565582591|FG001|Overall Study|Withdrawal by Subject|1|||
156682232|NCT00702507|565582592|FG000|Initial Treatment Phase|Adverse Event|2|||
156682233|NCT00702507|565582592|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
156682234|NCT00702507|565582592|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
156682235|NCT00702507|565582592|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
156682236|NCT00702507|565582592|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
156682237|NCT00702507|565582592|FG000|Follow-up Phase|Protocol Violation|2|||
156682238|NCT00702507|565582592|FG000|Follow-up Phase|Lost to Follow-up|23|||
156682239|NCT00702507|565582592|FG000|Follow-up Phase|Late Enrollment|1|||
156682240|NCT02308696|565582593|FG000|Overall Study|Lost to Follow-up|28|||
156682241|NCT02308696|565582594|FG001|Overall Study|Lost to Follow-up|21|||
156682242|NCT02308696|565582593|FG000|Overall Study|Death|8|||
156682243|NCT02308696|565582594|FG001|Overall Study|Death|4|||
156682244|NCT02308696|565582593|FG000|Overall Study|Moved to a Higher Level of Care|17|||
156682245|NCT02308696|565582594|FG001|Overall Study|Moved to a Higher Level of Care|6|||
156682246|NCT00113919|565582595|FG000|Overall Study|Physician Decision|8|||
156682247|NCT00113919|565582595|FG000|Overall Study|Death|6|||
156682248|NCT04194008|565582600|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
156682249|NCT04194008|565582600|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
156682250|NCT04194008|565582600|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
156682251|NCT04194008|565582600|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
156682252|NCT04194008|565582600|FG000|Treatment Phase With Nerivio|Missing data|4|||
156682253|NCT04194008|565582600|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
156682254|NCT01785615|565582601|FG000|Dietary Phase|Lost to Follow-up|0|||
156682255|NCT01785615|565582602|FG001|Dietary Phase|Lost to Follow-up|0|||
156682256|NCT01785615|565582603|FG002|Dietary Phase|Lost to Follow-up|0|||
156682257|NCT01785615|565582604|FG003|Dietary Phase|Lost to Follow-up|24|||
156682258|NCT01881737|565582605|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
156682259|NCT01881737|565582605|FG000|Overall Study|Withdrawal by Subject|1|||
156682260|NCT01881737|565582605|FG000|Overall Study|Worsening of baseline behavior|1|||
156682261|NCT02522780|565582606|FG000|Overall Study|Consent withdrawn by subject|5|||
156682262|NCT02522780|565582607|FG001|Overall Study|Consent withdrawn by subject|7|||
156682263|NCT02522780|565582606|FG000|Overall Study|Protocol deviation|1|||
156682264|NCT02522780|565582607|FG001|Overall Study|Protocol deviation|3|||
156682265|NCT02522780|565582606|FG000|Overall Study|Subject refused endoscopic procedure|0|||
156682266|NCT02522780|565582607|FG001|Overall Study|Subject refused endoscopic procedure|1|||
156682267|NCT02522780|565582606|FG000|Overall Study|Adverse event, non-fatal|11|||
156682268|NCT02522780|565582607|FG001|Overall Study|Adverse event, non-fatal|16|||
156682269|NCT02260635|565582608|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
156682270|NCT02260635|565582609|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
156682271|NCT02260635|565582608|FG000|Open-Label Extension|Study Termination|25|||
156682272|NCT02260635|565582609|FG001|Open-Label Extension|Study Termination|25|||
156682273|NCT02260635|565582608|FG000|Open-Label Extension|Withdrawal by Subject|1|||
156682274|NCT02260635|565582609|FG001|Open-Label Extension|Withdrawal by Subject|0|||
156682275|NCT04106817|565582610|FG000|Overall Study|Lost to Follow-up|1|||
156682276|NCT04106817|565582611|FG001|Overall Study|Lost to Follow-up|0|||
156682277|NCT04106817|565582612|FG002|Overall Study|Lost to Follow-up|0|||
156682278|NCT00926367|565582616|FG000|Overall Study|Withdrawal by Subject|0|||
156682279|NCT00926367|565582617|FG001|Overall Study|Withdrawal by Subject|1|||
156682280|NCT00926367|565582616|FG000|Overall Study|Lost to Follow-up|1|||
156682281|NCT00926367|565582617|FG001|Overall Study|Lost to Follow-up|0|||
156682282|NCT00926367|565582616|FG000|Overall Study|Skin Irritation|1|||
156682283|NCT00926367|565582617|FG001|Overall Study|Skin Irritation|2|||
156329611|NCT02633501|564307008|FG000|Overall Study|Lost to Follow-up|0|||
156329612|NCT02633501|564307009|FG001|Overall Study|Lost to Follow-up|0|||
156435486|NCT04424641|564684944|FG001|Overall Study|Death|2|||
156435487|NCT04424641|564684945|FG002|Overall Study|Death|3|||
156435488|NCT04424641|564684946|FG003|Overall Study|Death|0|||
156435489|NCT04424641|564684947|FG004|Overall Study|Death|3|||
156435490|NCT04424641|564684948|FG005|Overall Study|Death|0|||
156435491|NCT04424641|564684949|FG006|Overall Study|Death|1|||
156435492|NCT04424641|564684950|FG007|Overall Study|Death|2|||
156435493|NCT04424641|564684943|FG000|Overall Study|Sponsor decision|0|||
156435494|NCT04424641|564684944|FG001|Overall Study|Sponsor decision|2|||
156435495|NCT04424641|564684945|FG002|Overall Study|Sponsor decision|3|||
156329613|NCT02633501|564307010|FG002|Overall Study|Lost to Follow-up|0|||
156435496|NCT04424641|564684946|FG003|Overall Study|Sponsor decision|7|||
156435497|NCT04424641|564684947|FG004|Overall Study|Sponsor decision|2|||
156435498|NCT04424641|564684948|FG005|Overall Study|Sponsor decision|2|||
156784171|NCT03309605|565961120|FG006|Overall Study|Adverse Event|2|||
156784172|NCT03309605|565961121|FG007|Overall Study|Adverse Event|1|||
156784173|NCT03309605|565961114|FG000|Overall Study|Withdrawal by Subject|0|||
156784174|NCT03309605|565961115|FG001|Overall Study|Withdrawal by Subject|0|||
156784175|NCT03309605|565961116|FG002|Overall Study|Withdrawal by Subject|0|||
156784176|NCT03309605|565961117|FG003|Overall Study|Withdrawal by Subject|0|||
156784177|NCT03309605|565961118|FG004|Overall Study|Withdrawal by Subject|1|||
156784178|NCT03309605|565961119|FG005|Overall Study|Withdrawal by Subject|0|||
156784179|NCT03309605|565961120|FG006|Overall Study|Withdrawal by Subject|1|||
156784180|NCT03309605|565961121|FG007|Overall Study|Withdrawal by Subject|1|||
156784181|NCT05788328|565961122|FG000|Treatment Period 4 (5 Days)|Other|1|||
156329614|NCT02633501|564307011|FG003|Overall Study|Lost to Follow-up|1|||
156329615|NCT02633501|564307012|FG004|Overall Study|Lost to Follow-up|2|||
156329616|NCT02633501|564307013|FG005|Overall Study|Lost to Follow-up|0|||
156329617|NCT01104155|564307018|FG000|Overall Study|Adverse Event|15|||
156329618|NCT01104155|564307019|FG001|Overall Study|Adverse Event|8|||
156329619|NCT01104155|564307018|FG000|Overall Study|Participant choice|6|||
156329620|NCT01104155|564307019|FG001|Overall Study|Participant choice|5|||
156329621|NCT01104155|564307018|FG000|Overall Study|Withdrawal of consent|1|||
156329622|NCT01104155|564307019|FG001|Overall Study|Withdrawal of consent|1|||
156329623|NCT01104155|564307018|FG000|Overall Study|Other|3|||
156329624|NCT01104155|564307019|FG001|Overall Study|Other|4|||
156329625|NCT02963935|564307026|FG000|Overall Study|Adverse Event|12|||
156329626|NCT02963935|564307027|FG001|Overall Study|Adverse Event|6|||
156329627|NCT02963935|564307026|FG000|Overall Study|Protocol Violation|2|||
156329628|NCT02963935|564307027|FG001|Overall Study|Protocol Violation|1|||
156329629|NCT02963935|564307026|FG000|Overall Study|Lack of Efficacy|0|||
156329630|NCT02963935|564307027|FG001|Overall Study|Lack of Efficacy|2|||
156329631|NCT02963935|564307026|FG000|Overall Study|Lost to Follow-up|1|||
156329632|NCT02963935|564307027|FG001|Overall Study|Lost to Follow-up|6|||
156329633|NCT02963935|564307026|FG000|Overall Study|Unclassified|13|||
156329634|NCT02963935|564307027|FG001|Overall Study|Unclassified|22|||
156329635|NCT03911154|564307028|FG000|Overall Study|Withdrawal by Subject|1|||
156329636|NCT00292318|564307035|FG000|Overall Study|Study terminated by officials|2|||
156329637|NCT00292318|564307036|FG001|Overall Study|Study terminated by officials|1|||
156329638|NCT01822496|564307037|FG000|Overall Study|Protocol Violation|2|||
156329639|NCT01822496|564307038|FG001|Overall Study|Protocol Violation|2|||
156329640|NCT01822496|564307039|FG002|Overall Study|Protocol Violation|0|||
156329641|NCT01822496|564307040|FG003|Overall Study|Protocol Violation|1|||
156329642|NCT01822496|564307037|FG000|Overall Study|Withdrawal by Subject|0|||
156329643|NCT01822496|564307038|FG001|Overall Study|Withdrawal by Subject|0|||
156329644|NCT01822496|564307039|FG002|Overall Study|Withdrawal by Subject|0|||
156329645|NCT01822496|564307040|FG003|Overall Study|Withdrawal by Subject|3|||
156329646|NCT02906332|564307045|FG000|Overall Study|Withdrawal by Subject|1|||
156329647|NCT03945266|564307046|FG000|Overall Study|Withdrawal by Subject|1|||
156329648|NCT03945266|564307047|FG001|Overall Study|Withdrawal by Subject|0|||
156329649|NCT03945266|564307046|FG000|Overall Study|Miscarriage|0|||
156329650|NCT03945266|564307047|FG001|Overall Study|Miscarriage|2|||
156329651|NCT03945266|564307046|FG000|Overall Study|Lost to Follow-up|1|||
156435499|NCT04424641|564684949|FG006|Overall Study|Sponsor decision|3|||
156435500|NCT04424641|564684950|FG007|Overall Study|Sponsor decision|4|||
156784182|NCT05788328|565961122|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
156329652|NCT03945266|564307047|FG001|Overall Study|Lost to Follow-up|0|||
156329653|NCT05736224|564307050|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
156329654|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
156329655|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156329656|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156329657|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156329658|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156435501|NCT04424641|564684943|FG000|Overall Study|Withdrawal by Subject|0|||
156435502|NCT04424641|564684944|FG001|Overall Study|Withdrawal by Subject|0|||
156682284|NCT01517867|565582618|FG000|Overall Study|never started treatment|29|||
156682285|NCT01517867|565582619|FG001|Overall Study|never started treatment|32|||
156682286|NCT01517867|565582618|FG000|Overall Study|Withdrawal by Subject|34|||
156682287|NCT01517867|565582619|FG001|Overall Study|Withdrawal by Subject|30|||
156682288|NCT01517867|565582618|FG000|Overall Study|Still in treatment at study end|0|||
156682289|NCT01517867|565582619|FG001|Overall Study|Still in treatment at study end|3|||
156784183|NCT02181621|565961123|FG000|Overall Study|Adverse Event|1|||
156784184|NCT02181621|565961124|FG001|Overall Study|Adverse Event|0|||
156784185|NCT02181621|565961123|FG000|Overall Study|Previously Enrolled|0|||
156784186|NCT02181621|565961124|FG001|Overall Study|Previously Enrolled|1|||
156784187|NCT02181621|565961123|FG000|Overall Study|Enrollment Hold|1|||
156784188|NCT02181621|565961124|FG001|Overall Study|Enrollment Hold|1|||
156784189|NCT00145327|565961125|FG000|Overall Study|Withdrawal by Subject|77|||
156784190|NCT00145327|565961126|FG001|Overall Study|Withdrawal by Subject|72|||
156784191|NCT00145327|565961127|FG002|Overall Study|Withdrawal by Subject|164|||
156784192|NCT00145327|565961125|FG000|Overall Study|Death|26|||
156784193|NCT00145327|565961126|FG001|Overall Study|Death|18|||
156784194|NCT00145327|565961127|FG002|Overall Study|Death|30|||
156784195|NCT00145327|565961125|FG000|Overall Study|Adverse Event|14|||
156784196|NCT00145327|565961126|FG001|Overall Study|Adverse Event|11|||
156784197|NCT00145327|565961127|FG002|Overall Study|Adverse Event|22|||
156784198|NCT00145327|565961125|FG000|Overall Study|Lost to Follow-up|9|||
156784199|NCT00145327|565961126|FG001|Overall Study|Lost to Follow-up|14|||
156784200|NCT00145327|565961127|FG002|Overall Study|Lost to Follow-up|14|||
156784201|NCT00145327|565961125|FG000|Overall Study|Administrative problems|12|||
156784202|NCT00145327|565961126|FG001|Overall Study|Administrative problems|9|||
156784203|NCT00145327|565961127|FG002|Overall Study|Administrative problems|13|||
156784204|NCT00145327|565961125|FG000|Overall Study|Protocol Violation|2|||
156784205|NCT00145327|565961126|FG001|Overall Study|Protocol Violation|0|||
156784206|NCT00145327|565961127|FG002|Overall Study|Protocol Violation|2|||
156784207|NCT00145327|565961125|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156784208|NCT00145327|565961126|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156784209|NCT00145327|565961127|FG002|Overall Study|Abnormal laboratory value(s)|2|||
156784210|NCT00145327|565961125|FG000|Overall Study|Missing - not stated|1|||
156784211|NCT00145327|565961126|FG001|Overall Study|Missing - not stated|0|||
156784212|NCT00145327|565961127|FG002|Overall Study|Missing - not stated|1|||
156784213|NCT00864513|565961129|FG000|Overall Study|Withdrawal by Subject|3|||
156784214|NCT00762788|565961130|FG000|Overall Study|Lost to Follow-up|26|||
156784215|NCT00762788|565961131|FG001|Overall Study|Lost to Follow-up|37|||
156784216|NCT00762788|565961132|FG002|Overall Study|Lost to Follow-up|21|||
156784217|NCT00762788|565961133|FG003|Overall Study|Lost to Follow-up|26|||
156784218|NCT00762788|565961134|FG004|Overall Study|Lost to Follow-up|13|||
156784219|NCT00762788|565961135|FG005|Overall Study|Lost to Follow-up|21|||
156784220|NCT03073109|565961137|FG000|Overall Study|Adverse Event|0|||
156784221|NCT03073109|565961138|FG001|Overall Study|Adverse Event|1|||
156784222|NCT03073109|565961137|FG000|Overall Study|Other|2|||
156784223|NCT03073109|565961138|FG001|Overall Study|Other|0|||
156784224|NCT03073109|565961137|FG000|Overall Study|Lost to Follow-up|8|||
156784225|NCT03073109|565961138|FG001|Overall Study|Lost to Follow-up|1|||
156784226|NCT05938010|565961139|FG000|Overall Study|Lost to Follow-up|2|||
156784227|NCT00985192|565961140|FG000|Overall Study|Withdrawal by Subject|1|||
156784228|NCT00985192|565961140|FG000|Overall Study|Disease Progression|1|||
156784229|NCT00985192|565961140|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
156784230|NCT01875237|565961141|FG000|Overall Study|GVDH before DLI|1|||
156784231|NCT01875237|565961142|FG001|Overall Study|GVDH before DLI|0|||
156784232|NCT01875237|565961141|FG000|Overall Study|DLI cells could not be produced|1|||
156784233|NCT01875237|565961142|FG001|Overall Study|DLI cells could not be produced|0|||
156784234|NCT00983957|565961145|FG000|Overall Study|Adverse Event|1|||
156784235|NCT00983957|565961145|FG000|Overall Study|Personal Reasons|1|||
156784236|NCT03055195|565961146|FG000|Overall Study|Lack of Efficacy|1|||
156784237|NCT03055195|565961147|FG001|Overall Study|Lack of Efficacy|0|||
156784238|NCT03055195|565961146|FG000|Overall Study|Withdrawal by Subject|6|||
156329659|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156529464|NCT02993523|565032643|FG004|Overall Study|Withdrew Consent|0|||
156682290|NCT03847974|565582620|FG000|Overall Study|relocated out of region|3|||
156682291|NCT03847974|565582620|FG000|Overall Study|Withdrawal by Subject|2|||
156682292|NCT03847974|565582620|FG000|Overall Study|Adverse Event|1|||
156682293|NCT01685216|565582623|FG000|Overall Study|Did not receive study drug|1|||
156682294|NCT01294449|565582624|FG000|Overall Study|Death|11|||
156784239|NCT03055195|565961147|FG001|Overall Study|Withdrawal by Subject|7|||
156784240|NCT03055195|565961146|FG000|Overall Study|Study Terminated by Sponsor|2|||
156784241|NCT03055195|565961147|FG001|Overall Study|Study Terminated by Sponsor|6|||
156784242|NCT03055195|565961146|FG000|Overall Study|Protocol Violation|2|||
156784243|NCT03055195|565961147|FG001|Overall Study|Protocol Violation|1|||
156784244|NCT03055195|565961146|FG000|Overall Study|Physician Decision|1|||
156784245|NCT03055195|565961147|FG001|Overall Study|Physician Decision|0|||
156784246|NCT00986232|565961148|FG000|Overall Study|Adverse Event|1|||
156784247|NCT00986232|565961149|FG001|Overall Study|Adverse Event|2|||
156784248|NCT00986232|565961150|FG002|Overall Study|Adverse Event|3|||
156784249|NCT00986232|565961151|FG003|Overall Study|Adverse Event|0|||
156784250|NCT00986232|565961148|FG000|Overall Study|Lost to Follow-up|19|||
156784251|NCT00986232|565961149|FG001|Overall Study|Lost to Follow-up|12|||
156784252|NCT00986232|565961150|FG002|Overall Study|Lost to Follow-up|12|||
156784253|NCT00986232|565961151|FG003|Overall Study|Lost to Follow-up|7|||
156784254|NCT00986232|565961148|FG000|Overall Study|Protocol Violation|2|||
156784255|NCT00986232|565961149|FG001|Overall Study|Protocol Violation|3|||
156784256|NCT00986232|565961150|FG002|Overall Study|Protocol Violation|0|||
156784257|NCT00986232|565961151|FG003|Overall Study|Protocol Violation|1|||
156784258|NCT00986232|565961148|FG000|Overall Study|Withdrawal by Subject|13|||
156784259|NCT00986232|565961149|FG001|Overall Study|Withdrawal by Subject|16|||
156784260|NCT00986232|565961150|FG002|Overall Study|Withdrawal by Subject|12|||
156784261|NCT00986232|565961151|FG003|Overall Study|Withdrawal by Subject|3|||
156784262|NCT00986232|565961148|FG000|Overall Study|Missed one or more bleeds|13|||
156784263|NCT00986232|565961149|FG001|Overall Study|Missed one or more bleeds|10|||
156784264|NCT00986232|565961150|FG002|Overall Study|Missed one or more bleeds|6|||
156784265|NCT00986232|565961151|FG003|Overall Study|Missed one or more bleeds|7|||
156784266|NCT00986232|565961148|FG000|Overall Study|Incomplete safety follow-up|3|||
156784267|NCT00986232|565961149|FG001|Overall Study|Incomplete safety follow-up|7|||
156784268|NCT00986232|565961150|FG002|Overall Study|Incomplete safety follow-up|2|||
156784269|NCT00986232|565961151|FG003|Overall Study|Incomplete safety follow-up|2|||
156784270|NCT02568423|565961152|FG000|Overall Study|Lost to Follow-up|0|||
156784271|NCT02568423|565961153|FG001|Overall Study|Lost to Follow-up|2|||
156784272|NCT02568423|565961154|FG002|Overall Study|Lost to Follow-up|0|||
156784273|NCT02568423|565961155|FG003|Overall Study|Lost to Follow-up|0|||
156784274|NCT02568423|565961156|FG004|Overall Study|Lost to Follow-up|0|||
156784275|NCT02568423|565961157|FG005|Overall Study|Lost to Follow-up|0|||
156784276|NCT02568423|565961158|FG006|Overall Study|Lost to Follow-up|0|||
156784277|NCT02568423|565961159|FG007|Overall Study|Lost to Follow-up|0|||
156784278|NCT02568423|565961152|FG000|Overall Study|Physician Decision|0|||
156784279|NCT02568423|565961153|FG001|Overall Study|Physician Decision|0|||
156784280|NCT02568423|565961154|FG002|Overall Study|Physician Decision|0|||
156784281|NCT02568423|565961155|FG003|Overall Study|Physician Decision|0|||
156784282|NCT02568423|565961156|FG004|Overall Study|Physician Decision|0|||
156784283|NCT02568423|565961157|FG005|Overall Study|Physician Decision|1|||
156784284|NCT02568423|565961158|FG006|Overall Study|Physician Decision|0|||
156784285|NCT02568423|565961159|FG007|Overall Study|Physician Decision|0|||
156784286|NCT00790933|565961160|FG000|Overall Study|Adverse Event|94|||
156784287|NCT00790933|565961161|FG001|Overall Study|Adverse Event|119|||
156784288|NCT00790933|565961162|FG002|Overall Study|Adverse Event|65|||
156784289|NCT00790933|565961163|FG003|Overall Study|Adverse Event|5|||
156784290|NCT00790933|565961164|FG004|Overall Study|Adverse Event|69|||
156784291|NCT00790933|565961160|FG000|Overall Study|Protocol Violation(s)|8|||
156784292|NCT00790933|565961161|FG001|Overall Study|Protocol Violation(s)|18|||
156784293|NCT00790933|565961162|FG002|Overall Study|Protocol Violation(s)|7|||
156784294|NCT00790933|565961163|FG003|Overall Study|Protocol Violation(s)|0|||
156784295|NCT00790933|565961164|FG004|Overall Study|Protocol Violation(s)|12|||
156784296|NCT00790933|565961160|FG000|Overall Study|Lack of Efficacy|192|||
156784297|NCT00790933|565961161|FG001|Overall Study|Lack of Efficacy|176|||
156784298|NCT00790933|565961162|FG002|Overall Study|Lack of Efficacy|130|||
156784299|NCT00790933|565961163|FG003|Overall Study|Lack of Efficacy|1|||
156784300|NCT00790933|565961164|FG004|Overall Study|Lack of Efficacy|121|||
156784301|NCT00790933|565961160|FG000|Overall Study|Study Terminated by Sponsor|0|||
156784302|NCT00790933|565961161|FG001|Overall Study|Study Terminated by Sponsor|0|||
156784303|NCT00790933|565961162|FG002|Overall Study|Study Terminated by Sponsor|1|||
156784304|NCT00790933|565961163|FG003|Overall Study|Study Terminated by Sponsor|0|||
156784305|NCT00790933|565961164|FG004|Overall Study|Study Terminated by Sponsor|0|||
156529465|NCT02993523|565032639|FG000|Overall Study|Lost to Follow-up|0|||
156529466|NCT02993523|565032640|FG001|Overall Study|Lost to Follow-up|0|||
156529467|NCT02993523|565032641|FG002|Overall Study|Lost to Follow-up|3|||
156529468|NCT02993523|565032642|FG003|Overall Study|Lost to Follow-up|6|||
156529469|NCT02993523|565032643|FG004|Overall Study|Lost to Follow-up|0|||
156529470|NCT02993523|565032639|FG000|Overall Study|Death|1|||
156529471|NCT02993523|565032640|FG001|Overall Study|Death|1|||
156529472|NCT02993523|565032641|FG002|Overall Study|Death|138|||
156529473|NCT02993523|565032642|FG003|Overall Study|Death|222|||
156529474|NCT02993523|565032643|FG004|Overall Study|Death|6|||
156529475|NCT02993523|565032639|FG000|Overall Study|Reason not Specified|0|||
156529476|NCT02993523|565032640|FG001|Overall Study|Reason not Specified|0|||
156529477|NCT02993523|565032641|FG002|Overall Study|Reason not Specified|1|||
156784306|NCT00790933|565961160|FG000|Overall Study|Withdrawal by Subject|123|||
156784307|NCT00790933|565961161|FG001|Overall Study|Withdrawal by Subject|120|||
156784308|NCT00790933|565961162|FG002|Overall Study|Withdrawal by Subject|52|||
156784309|NCT00790933|565961163|FG003|Overall Study|Withdrawal by Subject|6|||
156784310|NCT00790933|565961164|FG004|Overall Study|Withdrawal by Subject|50|||
156784311|NCT00790933|565961160|FG000|Overall Study|Lost to Follow-up|13|||
156784312|NCT00790933|565961161|FG001|Overall Study|Lost to Follow-up|31|||
156784313|NCT00790933|565961162|FG002|Overall Study|Lost to Follow-up|10|||
156682295|NCT01294449|565582625|FG001|Overall Study|Death|12|||
156682296|NCT01294449|565582624|FG000|Overall Study|Withdrawal by Subject|1|||
156682297|NCT01294449|565582625|FG001|Overall Study|Withdrawal by Subject|3|||
156682298|NCT02654015|565582626|FG000|Overall Study|Death|12|||
156682299|NCT02654015|565582626|FG000|Overall Study|Lost to Follow-up|3|||
156682300|NCT01896505|565582629|FG000|Overall Study|Adverse Event|1|||
156682301|NCT01896505|565582630|FG001|Overall Study|Adverse Event|0|||
156682302|NCT01896505|565582631|FG002|Overall Study|Adverse Event|2|||
156682303|NCT01896505|565582632|FG003|Overall Study|Adverse Event|1|||
156682304|NCT01896505|565582633|FG004|Overall Study|Adverse Event|1|||
156682305|NCT01896505|565582634|FG005|Overall Study|Adverse Event|0|||
156682306|NCT01896505|565582629|FG000|Overall Study|Physician Decision|1|||
156682307|NCT01896505|565582630|FG001|Overall Study|Physician Decision|3|||
156682308|NCT01896505|565582631|FG002|Overall Study|Physician Decision|2|||
156682309|NCT01896505|565582632|FG003|Overall Study|Physician Decision|0|||
156682310|NCT01896505|565582633|FG004|Overall Study|Physician Decision|0|||
156682311|NCT01896505|565582634|FG005|Overall Study|Physician Decision|1|||
156682312|NCT01896505|565582629|FG000|Overall Study|Withdrawal by Subject|1|||
156682313|NCT01896505|565582630|FG001|Overall Study|Withdrawal by Subject|0|||
156682314|NCT01896505|565582631|FG002|Overall Study|Withdrawal by Subject|3|||
156682315|NCT01896505|565582632|FG003|Overall Study|Withdrawal by Subject|1|||
156682316|NCT01896505|565582633|FG004|Overall Study|Withdrawal by Subject|0|||
156682317|NCT01896505|565582634|FG005|Overall Study|Withdrawal by Subject|0|||
156682318|NCT01896505|565582629|FG000|Overall Study|Disease Progression|7|||
156682319|NCT01896505|565582630|FG001|Overall Study|Disease Progression|5|||
156682320|NCT01896505|565582631|FG002|Overall Study|Disease Progression|8|||
156682321|NCT01896505|565582632|FG003|Overall Study|Disease Progression|4|||
156682322|NCT01896505|565582633|FG004|Overall Study|Disease Progression|4|||
156682323|NCT01896505|565582634|FG005|Overall Study|Disease Progression|4|||
156682324|NCT01896505|565582629|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
156682325|NCT01896505|565582630|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
156682326|NCT01896505|565582631|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
156682327|NCT01896505|565582632|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
156682328|NCT01896505|565582633|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
156682329|NCT01896505|565582634|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
156682330|NCT01896505|565582629|FG000|Overall Study|Intercurrent illness|0|||
156682331|NCT01896505|565582630|FG001|Overall Study|Intercurrent illness|1|||
156682332|NCT01896505|565582631|FG002|Overall Study|Intercurrent illness|0|||
156682333|NCT01896505|565582632|FG003|Overall Study|Intercurrent illness|0|||
156682334|NCT01896505|565582633|FG004|Overall Study|Intercurrent illness|0|||
156682335|NCT01896505|565582634|FG005|Overall Study|Intercurrent illness|0|||
156682336|NCT01896505|565582629|FG000|Overall Study|Death|0|||
156682337|NCT01896505|565582630|FG001|Overall Study|Death|0|||
156682338|NCT01896505|565582631|FG002|Overall Study|Death|1|||
156682339|NCT01896505|565582632|FG003|Overall Study|Death|1|||
156682340|NCT01896505|565582633|FG004|Overall Study|Death|0|||
156682341|NCT01896505|565582634|FG005|Overall Study|Death|1|||
156682342|NCT02466386|565582637|FG000|Overall Study|Adverse Event|5|||
156682343|NCT02466386|565582637|FG000|Overall Study|Protocol Violation|2|||
156682344|NCT02466386|565582637|FG000|Overall Study|Withdrawal by Subject|14|||
156682345|NCT02466386|565582637|FG000|Overall Study|Lost to Follow-up|5|||
156682346|NCT02466386|565582637|FG000|Overall Study|Lack of Efficacy|8|||
156682347|NCT02466386|565582637|FG000|Overall Study|Other|10|||
156682348|NCT05317195|565582638|FG000|Randomization|Withdrawal by Subject|1|||
156784314|NCT00790933|565961163|FG003|Overall Study|Lost to Follow-up|1|||
156784315|NCT00790933|565961164|FG004|Overall Study|Lost to Follow-up|15|||
156435503|NCT04424641|564684945|FG002|Overall Study|Withdrawal by Subject|0|||
156435504|NCT04424641|564684946|FG003|Overall Study|Withdrawal by Subject|0|||
156435505|NCT04424641|564684947|FG004|Overall Study|Withdrawal by Subject|1|||
156435506|NCT04424641|564684948|FG005|Overall Study|Withdrawal by Subject|0|||
156784316|NCT00790933|565961160|FG000|Overall Study|Reason Not Specified|8|||
156784317|NCT00790933|565961161|FG001|Overall Study|Reason Not Specified|16|||
156435507|NCT04424641|564684949|FG006|Overall Study|Withdrawal by Subject|0|||
156435508|NCT04424641|564684950|FG007|Overall Study|Withdrawal by Subject|0|||
156682349|NCT05317195|565582638|FG000|Randomization|Discontinued|6|||
156682350|NCT05317195|565582638|FG000|Admission|Withdrawal by Subject|2|||
156682351|NCT00593827|565582639|FG000|Overall Study|On Active Treatment/Pending|0|||
156682352|NCT00593827|565582640|FG001|Overall Study|On Active Treatment/Pending|2|||
156682353|NCT01183884|565582641|FG000|Overall Study|Progressive Disease|26|||
156682354|NCT01183884|565582641|FG000|Overall Study|Adverse Event|3|||
156784318|NCT00790933|565961162|FG002|Overall Study|Reason Not Specified|4|||
156435509|NCT04424641|564684943|FG000|Overall Study|Other|0|||
156682355|NCT01183884|565582641|FG000|Overall Study|Withdrawal by Subject|1|||
156682356|NCT01183884|565582641|FG000|Overall Study|Other Complicating Disease|3|||
156682357|NCT01183884|565582641|FG000|Overall Study|Not Treated|1|||
156682358|NCT01183884|565582641|FG000|Overall Study|Other|4|||
156682359|NCT02212457|565582642|FG000|Overall Study|Adverse Event|1|||
156682360|NCT02212457|565582643|FG001|Overall Study|Adverse Event|2|||
156682361|NCT02212457|565582644|FG002|Overall Study|Adverse Event|2|||
156682362|NCT02212457|565582645|FG003|Overall Study|Adverse Event|2|||
156682363|NCT02212457|565582646|FG004|Overall Study|Adverse Event|0|||
156682364|NCT02212457|565582647|FG005|Overall Study|Adverse Event|1|||
156682365|NCT02212457|565582642|FG000|Overall Study|Withdrawal by Subject|8|||
156682366|NCT02212457|565582643|FG001|Overall Study|Withdrawal by Subject|10|||
156682367|NCT02212457|565582644|FG002|Overall Study|Withdrawal by Subject|8|||
156682368|NCT02212457|565582645|FG003|Overall Study|Withdrawal by Subject|6|||
156682369|NCT02212457|565582646|FG004|Overall Study|Withdrawal by Subject|5|||
156682370|NCT02212457|565582647|FG005|Overall Study|Withdrawal by Subject|4|||
156682371|NCT02212457|565582642|FG000|Overall Study|Lost to Follow-up|6|||
156682372|NCT02212457|565582643|FG001|Overall Study|Lost to Follow-up|7|||
156682373|NCT02212457|565582644|FG002|Overall Study|Lost to Follow-up|4|||
156682374|NCT02212457|565582645|FG003|Overall Study|Lost to Follow-up|1|||
156682375|NCT02212457|565582646|FG004|Overall Study|Lost to Follow-up|8|||
156682376|NCT02212457|565582647|FG005|Overall Study|Lost to Follow-up|4|||
156682377|NCT02212457|565582642|FG000|Overall Study|Protocol Violation|2|||
156682378|NCT02212457|565582643|FG001|Overall Study|Protocol Violation|1|||
156682379|NCT02212457|565582644|FG002|Overall Study|Protocol Violation|0|||
156682380|NCT02212457|565582645|FG003|Overall Study|Protocol Violation|1|||
156682381|NCT02212457|565582646|FG004|Overall Study|Protocol Violation|2|||
156682382|NCT02212457|565582647|FG005|Overall Study|Protocol Violation|3|||
156682383|NCT02212457|565582642|FG000|Overall Study|Other|2|||
156682384|NCT02212457|565582643|FG001|Overall Study|Other|1|||
156682385|NCT02212457|565582644|FG002|Overall Study|Other|2|||
156682386|NCT02212457|565582645|FG003|Overall Study|Other|1|||
156682387|NCT02212457|565582646|FG004|Overall Study|Other|0|||
156682388|NCT02212457|565582647|FG005|Overall Study|Other|1|||
156682389|NCT04553406|565582648|FG000|Overall Study|Study Discontinuation|0|||
156682390|NCT04553406|565582649|FG001|Overall Study|Study Discontinuation|1|||
156682391|NCT01214239|565582650|FG000|Overall Study|Adverse Event|3|||
156682392|NCT01214239|565582651|FG001|Overall Study|Adverse Event|4|||
156682393|NCT01214239|565582650|FG000|Overall Study|Protocol Violation|2|||
156682394|NCT01214239|565582651|FG001|Overall Study|Protocol Violation|1|||
156682395|NCT01214239|565582650|FG000|Overall Study|Lost to Follow-up|1|||
156682396|NCT01214239|565582651|FG001|Overall Study|Lost to Follow-up|1|||
156682397|NCT01214239|565582650|FG000|Overall Study|Withdrawal by Subject|4|||
156682398|NCT01214239|565582651|FG001|Overall Study|Withdrawal by Subject|9|||
156682399|NCT01214239|565582650|FG000|Overall Study|Lack of Efficacy|1|||
156682400|NCT01214239|565582651|FG001|Overall Study|Lack of Efficacy|2|||
156682401|NCT01214239|565582650|FG000|Overall Study|patient's private reason|1|||
156682402|NCT01214239|565582651|FG001|Overall Study|patient's private reason|1|||
156682403|NCT01841060|565584767|FG000|Overall Study|Protocol Violation|10|||
156682404|NCT01848210|565584768|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
156682405|NCT01848210|565584769|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
156682406|NCT01848210|565584768|FG000|Overall Study|Lost to Follow-up|24|||
156682407|NCT01848210|565584769|FG001|Overall Study|Lost to Follow-up|12|||
156682408|NCT01848210|565584768|FG000|Overall Study|Protocol Violation|3|||
156682409|NCT01848210|565584769|FG001|Overall Study|Protocol Violation|5|||
156682410|NCT01848210|565584768|FG000|Overall Study|Use of Forbidden Drugs|9|||
156682411|NCT01848210|565584769|FG001|Overall Study|Use of Forbidden Drugs|10|||
156682412|NCT01848210|565584768|FG000|Overall Study|Impedition Condition|5|||
156682413|NCT01848210|565584769|FG001|Overall Study|Impedition Condition|9|||
156682414|NCT01848210|565584768|FG000|Overall Study|Adverse Event|7|||
156682415|NCT01848210|565584769|FG001|Overall Study|Adverse Event|9|||
156682416|NCT01848210|565584768|FG000|Overall Study|Discontinuation Criterion|5|||
156682417|NCT01848210|565584769|FG001|Overall Study|Discontinuation Criterion|7|||
156682418|NCT01848210|565584768|FG000|Overall Study|Hypesensitivity|1|||
156682419|NCT01848210|565584769|FG001|Overall Study|Hypesensitivity|0|||
156682420|NCT01848210|565584768|FG000|Overall Study|Hepatic Function Alteration|4|||
156682421|NCT01848210|565584769|FG001|Overall Study|Hepatic Function Alteration|0|||
156682422|NCT01848210|565584768|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
156682423|NCT01848210|565584769|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
156682424|NCT01848210|565584768|FG000|Overall Study|Administrative|1|||
156682425|NCT01848210|565584769|FG001|Overall Study|Administrative|0|||
156682426|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
156682427|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
156682428|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
156682429|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
156682430|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
156682431|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
156682432|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
156682433|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
156682434|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
156682435|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
156682436|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
156682437|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
156682438|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
156682439|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
156682440|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
156682441|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
156682442|NCT04592419|565584770|FG000|Open-Label Extension Period|Adverse Event|1|||
156682443|NCT04592419|565584771|FG001|Open-Label Extension Period|Adverse Event|2|||
156682444|NCT04592419|565584770|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
156682445|NCT04592419|565584771|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
156682446|NCT04592419|565584770|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
156682447|NCT04592419|565584771|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
156682448|NCT04592419|565584770|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
156682449|NCT04592419|565584771|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
156682450|NCT04592419|565584770|FG000|Open-Label Extension Period|Sponsor Request|73|||
156682451|NCT04592419|565584771|FG001|Open-Label Extension Period|Sponsor Request|84|||
156682452|NCT00685035|565584776|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
156682453|NCT00685035|565584777|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
156682454|NCT00784979|565584783|FG000|Overall Study|incomplete data|6|||
156682455|NCT00894933|565584787|FG000|Overall Study|Lost to Follow-up|2|||
156682456|NCT00894933|565584787|FG000|Overall Study|Cancelled Procedure|1|||
156682457|NCT00894933|565584787|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
156682458|NCT04241133|565584789|FG000|Overall Study|COVID19 Precautions|14|||
156682459|NCT04241133|565584790|FG001|Overall Study|COVID19 Precautions|34|||
156682460|NCT00631007|565584792|FG000|Overall Study|Adverse Event|0|||
156682461|NCT00631007|565584793|FG001|Overall Study|Adverse Event|2|||
156682462|NCT00631007|565584794|FG002|Overall Study|Adverse Event|0|||
156682463|NCT00631007|565584795|FG003|Overall Study|Adverse Event|2|||
156682464|NCT00631007|565584796|FG004|Overall Study|Adverse Event|3|||
156682465|NCT00631007|565584797|FG005|Overall Study|Adverse Event|2|||
156682466|NCT00631007|565584792|FG000|Overall Study|Lost to Follow-up|2|||
156682467|NCT00631007|565584793|FG001|Overall Study|Lost to Follow-up|1|||
156682468|NCT00631007|565584794|FG002|Overall Study|Lost to Follow-up|2|||
156682469|NCT00631007|565584795|FG003|Overall Study|Lost to Follow-up|4|||
156682470|NCT00631007|565584796|FG004|Overall Study|Lost to Follow-up|5|||
156682471|NCT00631007|565584797|FG005|Overall Study|Lost to Follow-up|3|||
156682472|NCT00631007|565584792|FG000|Overall Study|Physician Decision|1|||
156682473|NCT00631007|565584793|FG001|Overall Study|Physician Decision|0|||
156682474|NCT00631007|565584794|FG002|Overall Study|Physician Decision|1|||
156682475|NCT00631007|565584795|FG003|Overall Study|Physician Decision|0|||
156682476|NCT00631007|565584796|FG004|Overall Study|Physician Decision|0|||
156682477|NCT00631007|565584797|FG005|Overall Study|Physician Decision|2|||
156682478|NCT00631007|565584792|FG000|Overall Study|Persistent Hyperglycemia|2|||
156682479|NCT00631007|565584793|FG001|Overall Study|Persistent Hyperglycemia|2|||
156682480|NCT00631007|565584794|FG002|Overall Study|Persistent Hyperglycemia|5|||
156682481|NCT00631007|565584795|FG003|Overall Study|Persistent Hyperglycemia|1|||
156682482|NCT00631007|565584796|FG004|Overall Study|Persistent Hyperglycemia|2|||
156682483|NCT00631007|565584797|FG005|Overall Study|Persistent Hyperglycemia|5|||
156682484|NCT00631007|565584792|FG000|Overall Study|Withdrawal by Subject|4|||
156682485|NCT00631007|565584793|FG001|Overall Study|Withdrawal by Subject|5|||
156784319|NCT00790933|565961163|FG003|Overall Study|Reason Not Specified|1|||
156784320|NCT00790933|565961164|FG004|Overall Study|Reason Not Specified|9|||
156784321|NCT00720083|565961167|FG000|Overall Study|Ineligible|1|||
156784322|NCT00720083|565961168|FG001|Overall Study|Ineligible|2|||
156784323|NCT00245570|565961170|FG000|Washout Between Periods III and IV|Adverse Event|0|||
156784324|NCT00245570|565961171|FG001|Washout Between Periods III and IV|Adverse Event|1|||
156784325|NCT00245570|565961172|FG002|Washout Between Periods III and IV|Adverse Event|0|||
156784326|NCT00245570|565961173|FG003|Washout Between Periods III and IV|Adverse Event|0|||
156329660|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156329661|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
156329662|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156329663|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156329664|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156329665|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156338244|NCT05248867|564336592|FG000|Open-label Period|Withdrawal by Subject|0|||
156682486|NCT00631007|565584794|FG002|Overall Study|Withdrawal by Subject|2|||
156682487|NCT00631007|565584795|FG003|Overall Study|Withdrawal by Subject|2|||
156682488|NCT00631007|565584796|FG004|Overall Study|Withdrawal by Subject|1|||
156682489|NCT00631007|565584797|FG005|Overall Study|Withdrawal by Subject|3|||
156682490|NCT00631007|565584792|FG000|Overall Study|Other|2|||
156682491|NCT00631007|565584793|FG001|Overall Study|Other|1|||
156682492|NCT00631007|565584794|FG002|Overall Study|Other|0|||
156682493|NCT00631007|565584795|FG003|Overall Study|Other|0|||
156682494|NCT00631007|565584796|FG004|Overall Study|Other|1|||
156682495|NCT00631007|565584797|FG005|Overall Study|Other|0|||
156682496|NCT00683787|565584798|FG000|Overall Study|Progression|3|||
156682497|NCT00683787|565584799|FG001|Overall Study|Progression|3|||
156682498|NCT00683787|565584800|FG002|Overall Study|Progression|0|||
156682499|NCT00683787|565584798|FG000|Overall Study|Adverse Event|0|||
156682500|NCT00683787|565584799|FG001|Overall Study|Adverse Event|0|||
156682501|NCT00683787|565584800|FG002|Overall Study|Adverse Event|2|||
156682502|NCT00460109|565584801|FG000|Overall Study|Death|1|||
156682503|NCT01235715|565584802|FG000|Overall Study|Physician Decision|0|||
156682504|NCT01235715|565584803|FG001|Overall Study|Physician Decision|2|||
156682505|NCT03619876|565584804|FG000|Overall Study|Withdrawal by Subject|1|||
156682506|NCT03619876|565584805|FG001|Overall Study|Withdrawal by Subject|2|||
156682507|NCT03619876|565584804|FG000|Overall Study|Withdrawal due to incidental finding|0|||
156682508|NCT03619876|565584805|FG001|Overall Study|Withdrawal due to incidental finding|2|||
156682509|NCT02344745|565584806|FG000|Overall Study|Data collection sheets were lost|2|||
156682510|NCT02344745|565584807|FG001|Overall Study|Data collection sheets were lost|0|||
156682511|NCT02788513|565584808|FG000|Overall Study|Withdrawal by Subject|3|||
156682512|NCT02788513|565584809|FG001|Overall Study|Withdrawal by Subject|0|||
156682513|NCT02788513|565584810|FG002|Overall Study|Withdrawal by Subject|2|||
156682514|NCT02788513|565584811|FG003|Overall Study|Withdrawal by Subject|3|||
156682515|NCT02788513|565584812|FG004|Overall Study|Withdrawal by Subject|1|||
156682516|NCT02788513|565584808|FG000|Overall Study|Lost to Follow-up|1|||
156682517|NCT02788513|565584809|FG001|Overall Study|Lost to Follow-up|0|||
156682518|NCT02788513|565584810|FG002|Overall Study|Lost to Follow-up|0|||
156682519|NCT02788513|565584811|FG003|Overall Study|Lost to Follow-up|0|||
156682520|NCT02788513|565584812|FG004|Overall Study|Lost to Follow-up|1|||
156682521|NCT02788513|565584808|FG000|Overall Study|Adverse Event|5|||
156682522|NCT02788513|565584809|FG001|Overall Study|Adverse Event|8|||
156682523|NCT02788513|565584810|FG002|Overall Study|Adverse Event|4|||
156682524|NCT02788513|565584811|FG003|Overall Study|Adverse Event|2|||
156682525|NCT02788513|565584812|FG004|Overall Study|Adverse Event|2|||
156682526|NCT02788513|565584808|FG000|Overall Study|Protocol Violation|0|||
156682527|NCT02788513|565584809|FG001|Overall Study|Protocol Violation|0|||
156682528|NCT02788513|565584810|FG002|Overall Study|Protocol Violation|1|||
156784327|NCT00245570|565961174|FG004|Washout Between Periods III and IV|Adverse Event|0|||
156784328|NCT00245570|565961175|FG005|Washout Between Periods III and IV|Adverse Event|0|||
156784329|NCT01913470|565961176|FG000|Overall Study|Lost to Follow-up|0|||
156784330|NCT01913470|565961177|FG001|Overall Study|Lost to Follow-up|1|||
156784331|NCT01913470|565961176|FG000|Overall Study|Physician Decision|0|||
156784332|NCT01913470|565961177|FG001|Overall Study|Physician Decision|1|||
156784333|NCT01913470|565961176|FG000|Overall Study|Withdrawal by Subject|0|||
156784334|NCT01913470|565961177|FG001|Overall Study|Withdrawal by Subject|1|||
156784335|NCT01829165|565961189|FG000|Overall Study|Did not complete intervention|2|||
156784336|NCT01829165|565961190|FG001|Overall Study|Did not complete intervention|0|||
156784337|NCT02573467|565961191|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
156784338|NCT02573467|565961192|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
156784339|NCT02573467|565961193|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
156784340|NCT02573467|565961194|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
156784341|NCT02573467|565961191|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
156784342|NCT02573467|565961192|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
156784343|NCT02573467|565961193|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
156784344|NCT02573467|565961194|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
156784345|NCT02573467|565961191|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
156784346|NCT02573467|565961192|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
156784347|NCT02573467|565961193|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
156784348|NCT02573467|565961194|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
156435510|NCT04424641|564684944|FG001|Overall Study|Other|0|||
156435511|NCT04424641|564684945|FG002|Overall Study|Other|1|||
156784349|NCT02573467|565961191|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
156784350|NCT02573467|565961192|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
156435512|NCT04424641|564684946|FG003|Overall Study|Other|0|||
156435513|NCT04424641|564684947|FG004|Overall Study|Other|0|||
156682529|NCT02788513|565584811|FG003|Overall Study|Protocol Violation|1|||
156682530|NCT02788513|565584812|FG004|Overall Study|Protocol Violation|0|||
156682531|NCT02788513|565584808|FG000|Overall Study|Subject decided to stop taking treatment|0|||
156784351|NCT02573467|565961193|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
156784352|NCT02573467|565961194|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
156784353|NCT02573467|565961191|FG000|Post-treatment Follow up Epoch|Death|1|||
156784354|NCT02573467|565961192|FG001|Post-treatment Follow up Epoch|Death|1|||
156784355|NCT02573467|565961193|FG002|Post-treatment Follow up Epoch|Death|0|||
156784356|NCT02573467|565961194|FG003|Post-treatment Follow up Epoch|Death|1|||
156682532|NCT02788513|565584809|FG001|Overall Study|Subject decided to stop taking treatment|0|||
156682533|NCT02788513|565584810|FG002|Overall Study|Subject decided to stop taking treatment|1|||
156682534|NCT02788513|565584811|FG003|Overall Study|Subject decided to stop taking treatment|0|||
156868071|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Transplant|0|||
156868072|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Transplant|0|||
156868073|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Transplant|0|||
156868074|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Transplant|0|||
156868075|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Transplant|0|||
156868076|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Transplant|0|||
156868077|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
156868078|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
156868079|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
156868080|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
156868081|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
156868082|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
156868083|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
156868084|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
156868085|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
156868086|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
156868087|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
156868088|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
156868089|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
156868090|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
156868091|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
156868092|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
156868093|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
156868094|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
156868095|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
156868096|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
156868097|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
156868098|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
156868099|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
156868100|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
156868101|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
156868102|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
156868103|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
156868104|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
156868105|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
156868106|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
156868107|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
156868108|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
156868109|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
156868110|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
156868111|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
156868112|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
156868113|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
156868114|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
156868115|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
156868116|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
156868117|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
156868118|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
156868119|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
156868120|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
156868121|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
156868122|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
156868123|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
156868124|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
156868125|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
156868126|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
156868127|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
156868128|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
156868129|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
156868130|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
156868131|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
156868132|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
156868133|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868134|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868135|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868136|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868137|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868138|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868139|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868140|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
156868141|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868142|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
156682535|NCT02788513|565584812|FG004|Overall Study|Subject decided to stop taking treatment|0|||
156682536|NCT02788513|565584808|FG000|Overall Study|Decision by the study team|0|||
156682537|NCT02788513|565584809|FG001|Overall Study|Decision by the study team|0|||
156682538|NCT02788513|565584810|FG002|Overall Study|Decision by the study team|0|||
156682539|NCT02788513|565584811|FG003|Overall Study|Decision by the study team|0|||
156682540|NCT02788513|565584812|FG004|Overall Study|Decision by the study team|1|||
156682541|NCT02943993|565584813|FG000|Overall Study|Withdrawal by Subject|52|||
156682542|NCT02943993|565584813|FG000|Overall Study|Transfer to another institution|6|||
156682543|NCT02943993|565584813|FG000|Overall Study|Lost to Follow-up|135|||
156682544|NCT02943993|565584813|FG000|Overall Study|Death|98|||
156682545|NCT02943993|565584813|FG000|Overall Study|Other reason for premature termination|32|||
156682546|NCT02943993|565584813|FG000|Overall Study|Missing reason for termination|7|||
156682547|NCT04968925|565584819|FG000|Phase I- Period 1|COVID-19 related|0|||
156529478|NCT02993523|565032642|FG003|Overall Study|Reason not Specified|1|||
156529479|NCT02993523|565032643|FG004|Overall Study|Reason not Specified|0|||
156529480|NCT03694418|565032644|FG000|Overall Study|Lost to Follow-up|115|||
156529481|NCT03694418|565032645|FG001|Overall Study|Lost to Follow-up|23|||
156529482|NCT03694418|565032646|FG002|Overall Study|Lost to Follow-up|12|||
156529483|NCT03694418|565032647|FG003|Overall Study|Lost to Follow-up|12|||
156529484|NCT03694418|565032648|FG004|Overall Study|Lost to Follow-up|13|||
156529485|NCT04288778|565032665|FG000|Overall Study|Withdrawal by Subject|2|||
156529486|NCT04288778|565032665|FG000|Overall Study|Adverse Event|5|||
156529487|NCT04288778|565032665|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156529488|NCT04288778|565032665|FG000|Overall Study|Other|1|||
156529489|NCT04288778|565032665|FG000|Overall Study|Started but not treated|2|||
156529490|NCT04485104|565032666|FG000|Overall Study|Physician Decision|2|||
156529491|NCT04485104|565032667|FG001|Overall Study|Physician Decision|0|||
156529492|NCT04485104|565032666|FG000|Overall Study|Decision by sponsor|0|||
156529493|NCT04485104|565032667|FG001|Overall Study|Decision by sponsor|1|||
156784357|NCT02573467|565961191|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
156784358|NCT02573467|565961192|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
156784359|NCT02573467|565961193|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
156784360|NCT02573467|565961194|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
156784361|NCT02573467|565961191|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
156784362|NCT02573467|565961192|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
156784363|NCT02573467|565961193|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
156784364|NCT02573467|565961194|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
156784365|NCT00710970|565961195|FG000|Overall Study|Never took drug|3|||
156784366|NCT01960842|565961200|FG000|Overall Study|Adverse Event|1|||
156784367|NCT01960842|565961200|FG000|Overall Study|Withdrawal by Subject|2|||
156784368|NCT01158404|565961205|FG000|Overall Study|Withdrawal by Subject|0|||
156784369|NCT01158404|565961206|FG001|Overall Study|Withdrawal by Subject|1|||
156784370|NCT01158404|565961207|FG002|Overall Study|Withdrawal by Subject|0|||
156784371|NCT01158404|565961208|FG003|Overall Study|Withdrawal by Subject|0|||
156784372|NCT01158404|565961209|FG004|Overall Study|Withdrawal by Subject|3|||
156784373|NCT01158404|565961210|FG005|Overall Study|Withdrawal by Subject|1|||
156784374|NCT01158404|565961211|FG006|Overall Study|Withdrawal by Subject|0|||
156784375|NCT01158404|565961212|FG007|Overall Study|Withdrawal by Subject|1|||
156784376|NCT01158404|565961205|FG000|Overall Study|Physician Decision|0|||
156784377|NCT01158404|565961206|FG001|Overall Study|Physician Decision|0|||
156784378|NCT01158404|565961207|FG002|Overall Study|Physician Decision|0|||
156784379|NCT01158404|565961208|FG003|Overall Study|Physician Decision|0|||
156784380|NCT01158404|565961209|FG004|Overall Study|Physician Decision|0|||
156784381|NCT01158404|565961210|FG005|Overall Study|Physician Decision|0|||
156784382|NCT01158404|565961211|FG006|Overall Study|Physician Decision|0|||
156784383|NCT01158404|565961212|FG007|Overall Study|Physician Decision|1|||
156784384|NCT01158404|565961205|FG000|Overall Study|Progressive Disease|0|||
156784385|NCT01158404|565961206|FG001|Overall Study|Progressive Disease|0|||
156784386|NCT01158404|565961207|FG002|Overall Study|Progressive Disease|0|||
156784387|NCT01158404|565961208|FG003|Overall Study|Progressive Disease|0|||
156784388|NCT01158404|565961209|FG004|Overall Study|Progressive Disease|0|||
156784389|NCT01158404|565961210|FG005|Overall Study|Progressive Disease|0|||
156784390|NCT01158404|565961211|FG006|Overall Study|Progressive Disease|1|||
156784391|NCT01158404|565961212|FG007|Overall Study|Progressive Disease|0|||
156784392|NCT02056288|565961213|FG000|In-Hospital Data|Surgery cancelled|1|||
156784393|NCT02056288|565961214|FG001|In-Hospital Data|Surgery cancelled|0|||
156329666|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156329667|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156529494|NCT04442737|565032668|FG000|Overall Study|Lost to Follow-up|1|||
156529495|NCT04442737|565032669|FG001|Overall Study|Lost to Follow-up|3|||
156784394|NCT02056288|565961213|FG000|In-Hospital Data|Protocol Violation|3|||
156529496|NCT04442737|565032668|FG000|Overall Study|Withdrawal by Subject|3|||
156529497|NCT04442737|565032669|FG001|Overall Study|Withdrawal by Subject|2|||
156529498|NCT04442737|565032668|FG000|Overall Study|Adverse Event|3|||
156784395|NCT02056288|565961214|FG001|In-Hospital Data|Protocol Violation|0|||
156682548|NCT04968925|565584820|FG001|Phase I- Period 1|COVID-19 related|1|||
156682549|NCT04968925|565584821|FG002|Phase I- Period 1|COVID-19 related|0|||
156682550|NCT04968925|565584822|FG003|Phase I- Period 1|COVID-19 related|0|||
156682551|NCT04968925|565584819|FG000|Phase I- Period 1|Subject enrolled in error|1|||
156682552|NCT04968925|565584820|FG001|Phase I- Period 1|Subject enrolled in error|1|||
156682553|NCT04968925|565584821|FG002|Phase I- Period 1|Subject enrolled in error|0|||
156682554|NCT04968925|565584822|FG003|Phase I- Period 1|Subject enrolled in error|0|||
156682555|NCT04968925|565584819|FG000|Phase II- Period 1|COVID-19 Related|0|||
156682556|NCT04968925|565584820|FG001|Phase II- Period 1|COVID-19 Related|0|||
156682557|NCT04968925|565584821|FG002|Phase II- Period 1|COVID-19 Related|6|||
156682558|NCT04968925|565584822|FG003|Phase II- Period 1|COVID-19 Related|6|||
156682559|NCT04968925|565584819|FG000|Phase II- Period 1|Subject enrolled in error|0|||
156682560|NCT04968925|565584820|FG001|Phase II- Period 1|Subject enrolled in error|0|||
156682561|NCT04968925|565584821|FG002|Phase II- Period 1|Subject enrolled in error|1|||
156682562|NCT04968925|565584822|FG003|Phase II- Period 1|Subject enrolled in error|0|||
156682563|NCT04968925|565584819|FG000|Phase II -Period 2|COVID-19 related|0|||
156682564|NCT04968925|565584820|FG001|Phase II -Period 2|COVID-19 related|0|||
156682565|NCT04968925|565584821|FG002|Phase II -Period 2|COVID-19 related|4|||
156682566|NCT04968925|565584822|FG003|Phase II -Period 2|COVID-19 related|3|||
156682567|NCT04968925|565584819|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
156682568|NCT04968925|565584820|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
156682569|NCT04968925|565584821|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
156682570|NCT04968925|565584822|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
156682571|NCT00396630|565584824|FG000|Overall Study|Lost to Follow-up|1|||
156682572|NCT00396630|565584825|FG001|Overall Study|Lost to Follow-up|1|||
156682573|NCT00396630|565584824|FG000|Overall Study|Withdrawal by Subject|1|||
156682574|NCT00396630|565584825|FG001|Overall Study|Withdrawal by Subject|1|||
156682575|NCT00396630|565584824|FG000|Overall Study|Not vaccinated at Visit 3|3|||
156682576|NCT00396630|565584825|FG001|Overall Study|Not vaccinated at Visit 3|3|||
156682577|NCT00876265|565584826|FG000|Overall Study|Miscellaneous reasons|4|||
156682578|NCT00876265|565584826|FG000|Overall Study|Lost to Follow-up|6|||
156682579|NCT00876265|565584826|FG000|Overall Study|Withdrawal by Subject|2|||
156682580|NCT02327325|565584827|FG000|Overall Study|Withdrawal by Subject|1|||
156682581|NCT02327325|565584828|FG001|Overall Study|Withdrawal by Subject|4|||
156682582|NCT02327325|565584829|FG002|Overall Study|Withdrawal by Subject|4|||
156682583|NCT02327325|565584827|FG000|Overall Study|Excluded by Study Team|0|||
156682584|NCT02327325|565584828|FG001|Overall Study|Excluded by Study Team|0|||
156682585|NCT02327325|565584829|FG002|Overall Study|Excluded by Study Team|1|||
156682586|NCT00651183|565584832|FG000|Overall Study|Lack of Efficacy|1|||
156682587|NCT00651183|565584833|FG001|Overall Study|Lack of Efficacy|0|||
156682588|NCT00651183|565584832|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
156682589|NCT00651183|565584833|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
156682590|NCT00651183|565584832|FG000|Overall Study|Tolerability insufficient|5|||
156682591|NCT00651183|565584833|FG001|Overall Study|Tolerability insufficient|2|||
156682592|NCT00651183|565584832|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
156435514|NCT04424641|564684948|FG005|Overall Study|Other|0|||
156435515|NCT04424641|564684949|FG006|Overall Study|Other|0|||
156435516|NCT04424641|564684950|FG007|Overall Study|Other|0|||
156435517|NCT05855655|564684953|FG000|Overall Study|Withdrawal by Subject|0|||
156435518|NCT05855655|564684954|FG001|Overall Study|Withdrawal by Subject|1|||
156435519|NCT05855655|564684953|FG000|Overall Study|Lost to Follow-up|4|||
156435520|NCT05855655|564684954|FG001|Overall Study|Lost to Follow-up|0|||
156682593|NCT00651183|565584833|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
156682594|NCT00651183|565584832|FG000|Overall Study|Withdrawal by Subject|6|||
156682595|NCT00651183|565584833|FG001|Overall Study|Withdrawal by Subject|3|||
156682596|NCT00651183|565584832|FG000|Overall Study|Lost to Follow-up|3|||
156682597|NCT00651183|565584833|FG001|Overall Study|Lost to Follow-up|1|||
156784396|NCT02056288|565961213|FG000|In-Hospital Data|Physician Decision|1|||
156784397|NCT02056288|565961214|FG001|In-Hospital Data|Physician Decision|0|||
156435521|NCT01426269|564684955|FG000|Period 1: 12 Weeks|Adverse Event|5|||
156435522|NCT01426269|564684956|FG001|Period 1: 12 Weeks|Adverse Event|0|||
156435523|NCT01426269|564684957|FG002|Period 1: 12 Weeks|Adverse Event|0|||
156435524|NCT01426269|564684955|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
156435525|NCT01426269|564684956|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
156435526|NCT01426269|564684957|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
156435527|NCT01426269|564684955|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
156435528|NCT01426269|564684956|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
156435529|NCT01426269|564684957|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
156435530|NCT01426269|564684955|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
156435531|NCT01426269|564684956|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
156435532|NCT01426269|564684957|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
156435533|NCT01426269|564684955|FG000|Period 1: 12 Weeks|Pregnancy|1|||
156435534|NCT01426269|564684956|FG001|Period 1: 12 Weeks|Pregnancy|0|||
156435535|NCT01426269|564684957|FG002|Period 1: 12 Weeks|Pregnancy|0|||
156435536|NCT01426269|564684955|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
156682598|NCT00651183|565584832|FG000|Overall Study|Other reasons|4|||
156682599|NCT00651183|565584833|FG001|Overall Study|Other reasons|2|||
156682600|NCT00651183|565584832|FG000|Overall Study|missing|1|||
156682601|NCT00651183|565584833|FG001|Overall Study|missing|0|||
156682602|NCT00996437|565584840|FG000|Overall Study|Death|1|||
156682603|NCT00996437|565584841|FG001|Overall Study|Death|0|||
156682604|NCT00996437|565584840|FG000|Overall Study|Dropped|2|||
156682605|NCT00996437|565584841|FG001|Overall Study|Dropped|2|||
156682606|NCT00996437|565584840|FG000|Overall Study|Missed|2|||
156682607|NCT00996437|565584841|FG001|Overall Study|Missed|5|||
156682608|NCT01091103|565584842|FG000|Overall Study|Adverse Event|1|||
156682609|NCT01091103|565584842|FG000|Overall Study|Progressive Disease|3|||
156682610|NCT01270620|565584843|FG000|Overall Study|Withdrawal by Subject|1|||
156682611|NCT01270620|565584844|FG001|Overall Study|Withdrawal by Subject|3|||
156682612|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
156682613|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
156682614|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
156682615|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
156682616|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
156682617|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
156682618|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
156682619|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
156682620|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
156682621|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
156682622|NCT01045707|565584846|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
156682623|NCT01045707|565584847|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
156682624|NCT01045707|565584846|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
156682625|NCT01045707|565584847|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
156682626|NCT01045707|565584846|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
156682627|NCT01045707|565584847|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
156682628|NCT01045707|565584846|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
156682629|NCT01045707|565584847|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
156682630|NCT00809965|565584848|FG000|Overall Study|Death|194|||
156682631|NCT00809965|565584849|FG001|Overall Study|Death|147|||
156682632|NCT00809965|565584850|FG002|Overall Study|Death|196|||
156682633|NCT00809965|565584848|FG000|Overall Study|Lost to Follow-up|17|||
156682634|NCT00809965|565584849|FG001|Overall Study|Lost to Follow-up|10|||
156682635|NCT00809965|565584850|FG002|Overall Study|Lost to Follow-up|18|||
156682636|NCT00809965|565584848|FG000|Overall Study|Withdrawal by Subject|405|||
156682637|NCT00809965|565584849|FG001|Overall Study|Withdrawal by Subject|448|||
156682638|NCT00809965|565584850|FG002|Overall Study|Withdrawal by Subject|441|||
156682639|NCT00809965|565584848|FG000|Overall Study|Other Reason|167|||
156682640|NCT00809965|565584849|FG001|Overall Study|Other Reason|170|||
156682641|NCT00809965|565584850|FG002|Overall Study|Other Reason|189|||
156682642|NCT02780167|565584851|FG000|Overall Study|Adverse Event|9|||
156682643|NCT02780167|565584852|FG001|Overall Study|Adverse Event|8|||
156682644|NCT02780167|565584853|FG002|Overall Study|Adverse Event|8|||
156682645|NCT02780167|565584854|FG003|Overall Study|Adverse Event|12|||
156682646|NCT02780167|565584855|FG004|Overall Study|Adverse Event|8|||
156682647|NCT02780167|565584851|FG000|Overall Study|Lack of Efficacy|6|||
156682648|NCT02780167|565584852|FG001|Overall Study|Lack of Efficacy|5|||
156682649|NCT02780167|565584853|FG002|Overall Study|Lack of Efficacy|6|||
156682650|NCT02780167|565584854|FG003|Overall Study|Lack of Efficacy|1|||
156682651|NCT02780167|565584855|FG004|Overall Study|Lack of Efficacy|0|||
156682652|NCT02780167|565584851|FG000|Overall Study|Lost to Follow-up|2|||
156682653|NCT02780167|565584852|FG001|Overall Study|Lost to Follow-up|0|||
156682654|NCT02780167|565584853|FG002|Overall Study|Lost to Follow-up|1|||
156784398|NCT02056288|565961213|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
156784399|NCT02056288|565961214|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
156784400|NCT02384460|565961217|FG000|Overall Study|Protocol Violation|0|||
156784401|NCT02384460|565961218|FG001|Overall Study|Protocol Violation|1|||
156784402|NCT02384460|565961217|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
156784403|NCT02384460|565961218|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
156784404|NCT02384460|565961217|FG000|Overall Study|Adverse Event|5|||
156784405|NCT02384460|565961218|FG001|Overall Study|Adverse Event|2|||
156682655|NCT02780167|565584854|FG003|Overall Study|Lost to Follow-up|0|||
156682656|NCT02780167|565584855|FG004|Overall Study|Lost to Follow-up|0|||
156682657|NCT02780167|565584851|FG000|Overall Study|Does not meet entrance criteria|0|||
156682658|NCT02780167|565584852|FG001|Overall Study|Does not meet entrance criteria|0|||
156682659|NCT02780167|565584853|FG002|Overall Study|Does not meet entrance criteria|1|||
156682660|NCT02780167|565584854|FG003|Overall Study|Does not meet entrance criteria|0|||
156682661|NCT02780167|565584855|FG004|Overall Study|Does not meet entrance criteria|0|||
156682662|NCT02780167|565584851|FG000|Overall Study|No longer meets eligibility criteria|0|||
156784406|NCT02384460|565961217|FG000|Overall Study|Withdrawal by Subject|0|||
156784407|NCT02384460|565961218|FG001|Overall Study|Withdrawal by Subject|3|||
156784408|NCT02384460|565961217|FG000|Overall Study|Elective medical treatment|1|||
156435537|NCT01426269|564684956|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
156435538|NCT01426269|564684957|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
156435539|NCT01426269|564684955|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
156435540|NCT01426269|564684956|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
156435541|NCT01426269|564684957|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
156435542|NCT01426269|564684955|FG000|Period 2: 40 Weeks|Adverse Event|0|||
156435543|NCT01426269|564684956|FG001|Period 2: 40 Weeks|Adverse Event|1|||
156435544|NCT01426269|564684957|FG002|Period 2: 40 Weeks|Adverse Event|2|||
156435545|NCT01426269|564684955|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
156435546|NCT01426269|564684956|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
156435547|NCT01426269|564684957|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
156435548|NCT01426269|564684955|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
156435549|NCT01426269|564684956|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
156435550|NCT01426269|564684957|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
156435551|NCT01426269|564684955|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
156435552|NCT01426269|564684956|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
156435553|NCT01426269|564684957|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
156435554|NCT01426269|564684955|FG000|Period 2: 40 Weeks|Site closed|0|||
156435555|NCT01426269|564684956|FG001|Period 2: 40 Weeks|Site closed|6|||
156435556|NCT01426269|564684957|FG002|Period 2: 40 Weeks|Site closed|5|||
156435557|NCT01426269|564684955|FG000|Period 2: 40 Weeks|Relapsed|0|||
156435558|NCT01426269|564684956|FG001|Period 2: 40 Weeks|Relapsed|9|||
156435559|NCT01426269|564684957|FG002|Period 2: 40 Weeks|Relapsed|18|||
156435560|NCT01171625|564684958|FG000|Overall Study|On-Protocol|67|||
156435561|NCT01171625|564684958|FG000|Overall Study|Death|38|||
156435562|NCT01171625|564684958|FG000|Overall Study|Withdrawal by Subject|31|||
156435563|NCT01171625|564684958|FG000|Overall Study|Explanted|10|||
156435564|NCT01171625|564684958|FG000|Overall Study|Lost to Follow-up|5|||
156435565|NCT01171625|564684958|FG000|Overall Study|Patient received valve-in-valve|3|||
156435566|NCT01171625|564684958|FG000|Overall Study|Other|1|||
156435567|NCT01171625|564684958|FG000|Overall Study|Consented but did not receive device|25|||
156435568|NCT02296424|564684961|FG000|Part 1|New therapy for study indication|0|||
156435569|NCT02296424|564684962|FG001|Part 1|New therapy for study indication|1|||
156435570|NCT02296424|564684963|FG002|Part 1|New therapy for study indication|0|||
156435571|NCT02296424|564684964|FG003|Part 1|New therapy for study indication|0|||
156435572|NCT02296424|564684961|FG000|Part 1|Protocol Violation|0|||
156435573|NCT02296424|564684962|FG001|Part 1|Protocol Violation|1|||
156435574|NCT02296424|564684963|FG002|Part 1|Protocol Violation|0|||
156435575|NCT02296424|564684964|FG003|Part 1|Protocol Violation|0|||
156435576|NCT02296424|564684961|FG000|Part 1|Withdrawal by Subject|0|||
156435577|NCT02296424|564684962|FG001|Part 1|Withdrawal by Subject|2|||
156435578|NCT02296424|564684963|FG002|Part 1|Withdrawal by Subject|0|||
156435579|NCT02296424|564684964|FG003|Part 1|Withdrawal by Subject|0|||
156435580|NCT02296424|564684961|FG000|Part 1|Study terminated by sponsor|0|||
156435581|NCT02296424|564684962|FG001|Part 1|Study terminated by sponsor|1|||
156435582|NCT02296424|564684963|FG002|Part 1|Study terminated by sponsor|0|||
156435583|NCT02296424|564684964|FG003|Part 1|Study terminated by sponsor|0|||
156784409|NCT02384460|565961218|FG001|Overall Study|Elective medical treatment|0|||
156784410|NCT02384460|565961217|FG000|Overall Study|Non-compliance|1|||
156784411|NCT02384460|565961218|FG001|Overall Study|Non-compliance|0|||
156784412|NCT02400580|565961219|FG000|Overall Study|Withdrawal by Subject|1|||
156784413|NCT02400580|565961220|FG001|Overall Study|Withdrawal by Subject|1|||
156435584|NCT02296424|564684961|FG000|Part 1|Adverse Event|2|||
156435585|NCT02296424|564684962|FG001|Part 1|Adverse Event|11|||
156435586|NCT02296424|564684963|FG002|Part 1|Adverse Event|0|||
156435587|NCT02296424|564684964|FG003|Part 1|Adverse Event|0|||
156435588|NCT02296424|564684961|FG000|Part 1|Lack of Efficacy|5|||
156435589|NCT02296424|564684962|FG001|Part 1|Lack of Efficacy|17|||
156435590|NCT02296424|564684963|FG002|Part 1|Lack of Efficacy|0|||
156435591|NCT02296424|564684964|FG003|Part 1|Lack of Efficacy|0|||
156784414|NCT02400580|565961219|FG000|Overall Study|Adverse Event|1|||
156784415|NCT02400580|565961220|FG001|Overall Study|Adverse Event|0|||
156784416|NCT04233580|565961223|FG000|Overall Study|Adverse Event|3|||
156435592|NCT02296424|564684961|FG000|Part 1|16 directly started part II|16|||
156435593|NCT02296424|564684962|FG001|Part 1|16 directly started part II|0|||
156435594|NCT02296424|564684963|FG002|Part 1|16 directly started part II|0|||
156784417|NCT04233580|565961224|FG001|Overall Study|Adverse Event|3|||
156784418|NCT04233580|565961223|FG000|Overall Study|Withdrawal by Subject|2|||
156784419|NCT04233580|565961224|FG001|Overall Study|Withdrawal by Subject|1|||
156435595|NCT02296424|564684964|FG003|Part 1|16 directly started part II|0|||
156784420|NCT02029443|565961225|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
156784421|NCT02029443|565961226|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
156435596|NCT02296424|564684961|FG000|Part 2|Lack of Efficacy|0|||
156435597|NCT02296424|564684962|FG001|Part 2|Lack of Efficacy|0|||
156435598|NCT02296424|564684963|FG002|Part 2|Lack of Efficacy|1|||
156435599|NCT02296424|564684964|FG003|Part 2|Lack of Efficacy|0|||
156435600|NCT02296424|564684961|FG000|Part 2|Adverse Event|0|||
156435601|NCT02296424|564684962|FG001|Part 2|Adverse Event|0|||
156784422|NCT02029443|565961227|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
156784423|NCT02029443|565961228|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
156784424|NCT02029443|565961229|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
156784425|NCT02029443|565961225|FG000|Overall Study|Death|13|||
156784426|NCT02029443|565961226|FG001|Overall Study|Death|2|||
156784427|NCT02029443|565961227|FG002|Overall Study|Death|2|||
156784428|NCT02029443|565961228|FG003|Overall Study|Death|11|||
156784429|NCT02029443|565961229|FG004|Overall Study|Death|2|||
156784430|NCT02029443|565961225|FG000|Overall Study|Lost to Follow-up|1|||
156784431|NCT02029443|565961226|FG001|Overall Study|Lost to Follow-up|0|||
156784432|NCT02029443|565961227|FG002|Overall Study|Lost to Follow-up|1|||
156784433|NCT02029443|565961228|FG003|Overall Study|Lost to Follow-up|1|||
156784434|NCT02029443|565961229|FG004|Overall Study|Lost to Follow-up|0|||
156784435|NCT02029443|565961225|FG000|Overall Study|Started other anti-cancer therapy|17|||
156784436|NCT02029443|565961226|FG001|Overall Study|Started other anti-cancer therapy|4|||
156784437|NCT02029443|565961227|FG002|Overall Study|Started other anti-cancer therapy|7|||
156784438|NCT02029443|565961228|FG003|Overall Study|Started other anti-cancer therapy|9|||
156784439|NCT02029443|565961229|FG004|Overall Study|Started other anti-cancer therapy|3|||
156784440|NCT02029443|565961225|FG000|Overall Study|Withdrawal by Subject|3|||
156784441|NCT02029443|565961226|FG001|Overall Study|Withdrawal by Subject|1|||
156784442|NCT02029443|565961227|FG002|Overall Study|Withdrawal by Subject|1|||
156784443|NCT02029443|565961228|FG003|Overall Study|Withdrawal by Subject|1|||
156784444|NCT02029443|565961229|FG004|Overall Study|Withdrawal by Subject|0|||
156784445|NCT02029443|565961225|FG000|Overall Study|Other|6|||
156784446|NCT02029443|565961226|FG001|Overall Study|Other|6|||
156435602|NCT02296424|564684963|FG002|Part 2|Adverse Event|1|||
156784447|NCT02029443|565961227|FG002|Overall Study|Other|4|||
156784448|NCT02029443|565961228|FG003|Overall Study|Other|2|||
156784449|NCT02029443|565961229|FG004|Overall Study|Other|0|||
156784450|NCT00625378|565961230|FG000|Overall Study|Adverse Event|22|||
156784451|NCT00625378|565961231|FG001|Overall Study|Adverse Event|0|||
156784452|NCT00625378|565961230|FG000|Overall Study|Withdrawal by Subject|16|||
156435603|NCT02296424|564684964|FG003|Part 2|Adverse Event|0|||
156435604|NCT02296424|564684961|FG000|Part 2|Lost to Follow-up|0|||
156435605|NCT02296424|564684962|FG001|Part 2|Lost to Follow-up|0|||
156435606|NCT02296424|564684963|FG002|Part 2|Lost to Follow-up|1|||
156435607|NCT02296424|564684964|FG003|Part 2|Lost to Follow-up|0|||
156435608|NCT01337635|564684971|FG000|Overall Study|Lost to Follow-up|0|||
156435609|NCT01337635|564684972|FG001|Overall Study|Lost to Follow-up|1|||
156435610|NCT01113931|564684973|FG000|Overall Study|Adverse Event|2|||
156435611|NCT01113931|564684974|FG001|Overall Study|Adverse Event|2|||
156435612|NCT01113931|564684973|FG000|Overall Study|Physician Decision|0|||
156435613|NCT01113931|564684974|FG001|Overall Study|Physician Decision|2|||
156435614|NCT01113931|564684973|FG000|Overall Study|Lost to Follow-up|12|||
156435615|NCT01113931|564684974|FG001|Overall Study|Lost to Follow-up|9|||
156435616|NCT01113931|564684973|FG000|Overall Study|Various|2|||
156435617|NCT01113931|564684974|FG001|Overall Study|Various|4|||
156435618|NCT01113931|564684973|FG000|Overall Study|Withdrawal by Subject|3|||
156435619|NCT01113931|564684974|FG001|Overall Study|Withdrawal by Subject|0|||
156435620|NCT02537522|564684983|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
156435621|NCT02537522|564684984|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
156435622|NCT02537522|564684985|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
156435623|NCT02537522|564684986|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
156435624|NCT02537522|564684983|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
156435625|NCT02537522|564684984|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
156435626|NCT02537522|564684985|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
156435627|NCT02537522|564684986|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
156435628|NCT02537522|564684983|FG000|Phase I - Contralateral|incorrect randomization|0|||
156435629|NCT02537522|564684984|FG001|Phase I - Contralateral|incorrect randomization|1|||
156435630|NCT02537522|564684985|FG002|Phase I - Contralateral|incorrect randomization|0|||
156435631|NCT02537522|564684986|FG003|Phase I - Contralateral|incorrect randomization|0|||
156435632|NCT02537522|564684983|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
156435633|NCT02537522|564684984|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
156435634|NCT02537522|564684985|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
156435635|NCT02537522|564684986|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
156435636|NCT02537522|564684983|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
156435637|NCT02537522|564684984|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
156435638|NCT02537522|564684985|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
156435639|NCT02537522|564684986|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
156435640|NCT03920215|564684988|FG000|Overall Study|Lost to Follow-up|1|||
156435641|NCT03920215|564684989|FG001|Overall Study|Lost to Follow-up|2|||
156435642|NCT03920215|564684990|FG002|Overall Study|Lost to Follow-up|0|||
156435643|NCT03920215|564684991|FG003|Overall Study|Lost to Follow-up|0|||
156435644|NCT03920215|564684988|FG000|Overall Study|Death|0|||
156784453|NCT00625378|565961231|FG001|Overall Study|Withdrawal by Subject|0|||
156784454|NCT00625378|565961230|FG000|Overall Study|Death|38|||
156784455|NCT00625378|565961231|FG001|Overall Study|Death|0|||
156435645|NCT03920215|564684989|FG001|Overall Study|Death|0|||
156435646|NCT03920215|564684990|FG002|Overall Study|Death|0|||
156435647|NCT03920215|564684991|FG003|Overall Study|Death|1|||
156435648|NCT02425111|564684994|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
156435649|NCT02425111|564684994|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
156435650|NCT02425111|564684994|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
156435651|NCT02425111|564684994|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
156435652|NCT02425111|564684994|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
156435653|NCT02425111|564684994|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
156435654|NCT00585533|564684995|FG000|Overall Study|objective or symptomatic progression|9|||
156435655|NCT02798835|564684996|FG000|Overall Study|Protocol Violation|0|||
156435656|NCT02798835|564684997|FG001|Overall Study|Protocol Violation|0|||
156435657|NCT02798835|564684998|FG002|Overall Study|Protocol Violation|3|||
156435658|NCT03024606|564685003|FG000|Overall Study|Withdrawal by Subject|9|||
156435659|NCT03024606|564685004|FG001|Overall Study|Withdrawal by Subject|10|||
156435660|NCT02547922|564685014|FG000|Overall Study|Withdrawal by Subject|9|||
156435661|NCT02547922|564685015|FG001|Overall Study|Withdrawal by Subject|6|||
156682663|NCT02780167|565584852|FG001|Overall Study|No longer meets eligibility criteria|0|||
156682664|NCT02780167|565584853|FG002|Overall Study|No longer meets eligibility criteria|0|||
156682665|NCT02780167|565584854|FG003|Overall Study|No longer meets eligibility criteria|1|||
156682666|NCT02780167|565584855|FG004|Overall Study|No longer meets eligibility criteria|1|||
156682667|NCT02780167|565584851|FG000|Overall Study|Protocol Violation|5|||
156682668|NCT02780167|565584852|FG001|Overall Study|Protocol Violation|5|||
156682669|NCT02780167|565584853|FG002|Overall Study|Protocol Violation|1|||
156682670|NCT02780167|565584854|FG003|Overall Study|Protocol Violation|1|||
156682671|NCT02780167|565584855|FG004|Overall Study|Protocol Violation|2|||
156682672|NCT02780167|565584851|FG000|Overall Study|Withdrawal by Subject|6|||
156682673|NCT02780167|565584852|FG001|Overall Study|Withdrawal by Subject|4|||
156682674|NCT02780167|565584853|FG002|Overall Study|Withdrawal by Subject|4|||
156682675|NCT02780167|565584854|FG003|Overall Study|Withdrawal by Subject|3|||
156682676|NCT02780167|565584855|FG004|Overall Study|Withdrawal by Subject|4|||
156682677|NCT02780167|565584851|FG000|Overall Study|Other|0|||
156682678|NCT02780167|565584852|FG001|Overall Study|Other|0|||
156682679|NCT02780167|565584853|FG002|Overall Study|Other|3|||
156682680|NCT02780167|565584854|FG003|Overall Study|Other|1|||
156682681|NCT02780167|565584855|FG004|Overall Study|Other|2|||
156435662|NCT02547922|564685016|FG002|Overall Study|Withdrawal by Subject|10|||
156435663|NCT02547922|564685014|FG000|Overall Study|Adverse Event|3|||
156435664|NCT02547922|564685015|FG001|Overall Study|Adverse Event|1|||
156435665|NCT02547922|564685016|FG002|Overall Study|Adverse Event|2|||
156682682|NCT05552261|565584857|FG000|Overall Study|Withdrawal by Subject|1|||
156682683|NCT05552261|565584857|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
156682684|NCT02315066|565584858|FG000|Overall Study|Lost to Follow-up|0|||
156682685|NCT02315066|565584859|FG001|Overall Study|Lost to Follow-up|1|||
156682686|NCT02315066|565584860|FG002|Overall Study|Lost to Follow-up|1|||
156682687|NCT02315066|565584861|FG003|Overall Study|Lost to Follow-up|0|||
156682688|NCT02315066|565584862|FG004|Overall Study|Lost to Follow-up|1|||
156682689|NCT02315066|565584863|FG005|Overall Study|Lost to Follow-up|0|||
156435666|NCT02547922|564685014|FG000|Overall Study|Lost to Follow-up|1|||
156682690|NCT02315066|565584864|FG006|Overall Study|Lost to Follow-up|2|||
156682691|NCT02315066|565584865|FG007|Overall Study|Lost to Follow-up|1|||
156682692|NCT02315066|565584866|FG008|Overall Study|Lost to Follow-up|0|||
156682693|NCT02315066|565584867|FG009|Overall Study|Lost to Follow-up|0|||
156682694|NCT02315066|565584868|FG010|Overall Study|Lost to Follow-up|1|||
156682695|NCT02315066|565584869|FG011|Overall Study|Lost to Follow-up|2|||
156682696|NCT02315066|565584870|FG012|Overall Study|Lost to Follow-up|0|||
156682697|NCT02315066|565584871|FG013|Overall Study|Lost to Follow-up|4|||
156682698|NCT02315066|565584858|FG000|Overall Study|Death|2|||
156682699|NCT02315066|565584859|FG001|Overall Study|Death|7|||
156682700|NCT02315066|565584860|FG002|Overall Study|Death|6|||
156682701|NCT02315066|565584861|FG003|Overall Study|Death|11|||
156682702|NCT02315066|565584862|FG004|Overall Study|Death|10|||
156682703|NCT02315066|565584863|FG005|Overall Study|Death|3|||
156682704|NCT02315066|565584864|FG006|Overall Study|Death|9|||
156435667|NCT02547922|564685015|FG001|Overall Study|Lost to Follow-up|0|||
156435668|NCT02547922|564685016|FG002|Overall Study|Lost to Follow-up|0|||
156435669|NCT02547922|564685014|FG000|Overall Study|Lack of Efficacy|5|||
156682705|NCT02315066|565584865|FG007|Overall Study|Death|9|||
156682706|NCT02315066|565584866|FG008|Overall Study|Death|10|||
156682707|NCT02315066|565584867|FG009|Overall Study|Death|8|||
156435670|NCT02547922|564685015|FG001|Overall Study|Lack of Efficacy|7|||
156435671|NCT02547922|564685016|FG002|Overall Study|Lack of Efficacy|4|||
156435672|NCT02547922|564685014|FG000|Overall Study|Death|1|||
156682708|NCT02315066|565584868|FG010|Overall Study|Death|10|||
156682709|NCT02315066|565584869|FG011|Overall Study|Death|7|||
156682710|NCT02315066|565584870|FG012|Overall Study|Death|8|||
156682711|NCT02315066|565584871|FG013|Overall Study|Death|21|||
156682712|NCT02315066|565584858|FG000|Overall Study|Other|0|||
156682713|NCT02315066|565584859|FG001|Overall Study|Other|0|||
156435673|NCT02547922|564685015|FG001|Overall Study|Death|0|||
156435674|NCT02547922|564685016|FG002|Overall Study|Death|0|||
156435675|NCT02547922|564685014|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
156435676|NCT02547922|564685015|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
156435677|NCT02547922|564685016|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
156529499|NCT04442737|565032669|FG001|Overall Study|Adverse Event|2|||
156529500|NCT04442737|565032668|FG000|Overall Study|Death|0|||
156529501|NCT04442737|565032669|FG001|Overall Study|Death|1|||
156529502|NCT04442737|565032668|FG000|Overall Study|Protocol Violation|0|||
156529503|NCT04442737|565032669|FG001|Overall Study|Protocol Violation|2|||
156529504|NCT04442737|565032668|FG000|Overall Study|Other|1|||
156529505|NCT04442737|565032669|FG001|Overall Study|Other|1|||
156529506|NCT00744523|565032670|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
156529507|NCT00744523|565032671|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
156529508|NCT01139021|565032672|FG000|Overall Study|Adverse Event|0|||
156529509|NCT01139021|565032673|FG001|Overall Study|Adverse Event|0|||
156435678|NCT02547922|564685014|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
156435679|NCT02547922|564685015|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
156435680|NCT02547922|564685016|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
156435681|NCT02547922|564685014|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
156529510|NCT01139021|565032674|FG002|Overall Study|Adverse Event|0|||
156682714|NCT02315066|565584860|FG002|Overall Study|Other|0|||
156682715|NCT02315066|565584861|FG003|Overall Study|Other|0|||
156682716|NCT02315066|565584862|FG004|Overall Study|Other|0|||
156682717|NCT02315066|565584863|FG005|Overall Study|Other|0|||
156682718|NCT02315066|565584864|FG006|Overall Study|Other|0|||
156682719|NCT02315066|565584865|FG007|Overall Study|Other|1|||
156682720|NCT02315066|565584866|FG008|Overall Study|Other|1|||
156682721|NCT02315066|565584867|FG009|Overall Study|Other|2|||
156682722|NCT02315066|565584868|FG010|Overall Study|Other|0|||
156682723|NCT02315066|565584869|FG011|Overall Study|Other|0|||
156682724|NCT02315066|565584870|FG012|Overall Study|Other|0|||
156682725|NCT02315066|565584871|FG013|Overall Study|Other|0|||
156682726|NCT02315066|565584858|FG000|Overall Study|Subject refused further follow-up|0|||
156682727|NCT02315066|565584859|FG001|Overall Study|Subject refused further follow-up|2|||
156682728|NCT02315066|565584860|FG002|Overall Study|Subject refused further follow-up|2|||
156682729|NCT02315066|565584861|FG003|Overall Study|Subject refused further follow-up|0|||
156682730|NCT02315066|565584862|FG004|Overall Study|Subject refused further follow-up|0|||
156682731|NCT02315066|565584863|FG005|Overall Study|Subject refused further follow-up|0|||
156682732|NCT02315066|565584864|FG006|Overall Study|Subject refused further follow-up|2|||
156682733|NCT02315066|565584865|FG007|Overall Study|Subject refused further follow-up|3|||
156682734|NCT02315066|565584866|FG008|Overall Study|Subject refused further follow-up|0|||
156682735|NCT02315066|565584867|FG009|Overall Study|Subject refused further follow-up|1|||
156682736|NCT02315066|565584868|FG010|Overall Study|Subject refused further follow-up|1|||
156682737|NCT02315066|565584869|FG011|Overall Study|Subject refused further follow-up|2|||
156682738|NCT02315066|565584870|FG012|Overall Study|Subject refused further follow-up|2|||
156682739|NCT02315066|565584871|FG013|Overall Study|Subject refused further follow-up|4|||
156682740|NCT02315066|565584858|FG000|Overall Study|Study ongoing at date of cut-off|0|||
156682741|NCT02315066|565584859|FG001|Overall Study|Study ongoing at date of cut-off|0|||
156682742|NCT02315066|565584860|FG002|Overall Study|Study ongoing at date of cut-off|0|||
156682743|NCT02315066|565584861|FG003|Overall Study|Study ongoing at date of cut-off|0|||
156682744|NCT02315066|565584862|FG004|Overall Study|Study ongoing at date of cut-off|0|||
156682745|NCT02315066|565584863|FG005|Overall Study|Study ongoing at date of cut-off|0|||
156682746|NCT02315066|565584864|FG006|Overall Study|Study ongoing at date of cut-off|0|||
156682747|NCT02315066|565584865|FG007|Overall Study|Study ongoing at date of cut-off|0|||
156682748|NCT02315066|565584866|FG008|Overall Study|Study ongoing at date of cut-off|0|||
156682749|NCT02315066|565584867|FG009|Overall Study|Study ongoing at date of cut-off|0|||
156682750|NCT02315066|565584868|FG010|Overall Study|Study ongoing at date of cut-off|0|||
156682751|NCT02315066|565584869|FG011|Overall Study|Study ongoing at date of cut-off|0|||
156682752|NCT02315066|565584870|FG012|Overall Study|Study ongoing at date of cut-off|0|||
156682753|NCT02315066|565584871|FG013|Overall Study|Study ongoing at date of cut-off|1|||
156682754|NCT02916693|565584872|FG000|Overall Study|Lost to Follow-up|7|||
156529511|NCT01139021|565032675|FG003|Overall Study|Adverse Event|0|||
156682755|NCT01190930|565584873|FG000|Induction|Adverse Event|17|||
156682756|NCT01190930|565584874|FG001|Induction|Adverse Event|0|||
156682757|NCT01190930|565584875|FG002|Induction|Adverse Event|0|||
156682758|NCT01190930|565584876|FG003|Induction|Adverse Event|0|||
156682759|NCT01190930|565584877|FG004|Induction|Adverse Event|0|||
156682760|NCT01190930|565584878|FG005|Induction|Adverse Event|0|||
156682761|NCT01190930|565584879|FG006|Induction|Adverse Event|0|||
156682762|NCT01190930|565584880|FG007|Induction|Adverse Event|0|||
156682763|NCT01190930|565584881|FG008|Induction|Adverse Event|0|||
156682764|NCT01190930|565584882|FG009|Induction|Adverse Event|0|||
156529512|NCT01139021|565032676|FG004|Overall Study|Adverse Event|1|||
156529513|NCT01139021|565032677|FG005|Overall Study|Adverse Event|0|||
156529514|NCT01139021|565032672|FG000|Overall Study|Lost to Follow-up|0|||
156435682|NCT02547922|564685015|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
156435683|NCT02547922|564685016|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
156435684|NCT02547922|564685014|FG000|Overall Study|Physician Decision|2|||
156435685|NCT02547922|564685015|FG001|Overall Study|Physician Decision|1|||
156435686|NCT02547922|564685016|FG002|Overall Study|Physician Decision|2|||
156868143|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
156868144|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868145|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868146|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868147|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868148|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868149|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868150|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868151|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868152|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868153|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868154|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
156868155|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868156|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
156868157|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868158|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868159|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868160|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868161|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868162|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156435687|NCT02547922|564685014|FG000|Overall Study|Patients did not receive IP|1|||
156435688|NCT02547922|564685015|FG001|Overall Study|Patients did not receive IP|1|||
156435689|NCT02547922|564685016|FG002|Overall Study|Patients did not receive IP|0|||
156868163|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868164|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868165|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868166|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868167|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868168|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
156868169|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868170|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868171|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868172|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868173|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868174|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868175|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Transplant|0|||
156868176|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Transplant|0|||
156868177|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Transplant|0|||
156868178|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Transplant|0|||
156868179|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Transplant|0|||
156868180|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Transplant|0|||
156868181|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Transplant|0|||
156868182|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Transplant|0|||
156868183|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Transplant|0|||
156868184|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Transplant|4|||
156868185|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Transplant|2|||
156868186|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Transplant|0|||
156868187|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Transplant|0|||
156868188|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Transplant|0|||
156868189|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
156868190|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
156435690|NCT03482011|564685021|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
156435691|NCT03482011|564685022|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
156435692|NCT03482011|564685023|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
156435693|NCT03482011|564685024|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
156435694|NCT03482011|564685025|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
156435695|NCT03482011|564685026|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
156435696|NCT03482011|564685027|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
156435697|NCT03482011|564685028|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
156868191|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
156682765|NCT01190930|565584873|FG000|Induction|Death|34|||
156868192|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
156868193|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
156868194|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
156868195|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
156868196|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
156435698|NCT03482011|564685021|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
156682766|NCT01190930|565584874|FG001|Induction|Death|0|||
156868197|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
156868198|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
156868199|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
156868200|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
156868201|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
156868202|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
156868203|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
156868204|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
156868205|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
156868206|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
156868207|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
156868208|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
156868209|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
156868210|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
156868211|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
156868212|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
156868213|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
156868214|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
156868215|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
156868216|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
156868217|NCT02113982|566277280|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868218|NCT02113982|566277281|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868219|NCT02113982|566277282|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868220|NCT02113982|566277283|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868221|NCT02113982|566277284|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868222|NCT02113982|566277285|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868223|NCT02113982|566277286|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868224|NCT02113982|566277287|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868225|NCT02113982|566277288|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868226|NCT02113982|566277289|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868227|NCT02113982|566277290|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868228|NCT02113982|566277291|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
156868229|NCT02113982|566277292|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868230|NCT02113982|566277293|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868231|NCT02113982|566277280|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868232|NCT02113982|566277281|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868233|NCT02113982|566277282|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868234|NCT02113982|566277283|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868235|NCT02113982|566277284|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868236|NCT02113982|566277285|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868237|NCT02113982|566277286|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868238|NCT02113982|566277287|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868239|NCT02113982|566277288|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868240|NCT02113982|566277289|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868241|NCT02113982|566277290|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868242|NCT02113982|566277291|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
156868243|NCT02113982|566277292|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868244|NCT02113982|566277293|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868245|NCT02113982|566277280|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868246|NCT02113982|566277281|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868247|NCT02113982|566277282|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868248|NCT02113982|566277283|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868249|NCT02113982|566277284|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868250|NCT02113982|566277285|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868251|NCT02113982|566277286|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868252|NCT02113982|566277287|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868253|NCT02113982|566277288|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868254|NCT02113982|566277289|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156435699|NCT03482011|564685022|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
156435700|NCT03482011|564685023|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156435701|NCT03482011|564685024|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156435702|NCT03482011|564685025|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156435703|NCT03482011|564685026|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156435704|NCT03482011|564685027|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156868255|NCT02113982|566277290|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868256|NCT02113982|566277291|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
156868257|NCT02113982|566277292|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868258|NCT02113982|566277293|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868259|NCT02113982|566277280|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
156868260|NCT02113982|566277281|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
156868261|NCT02113982|566277282|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
156435705|NCT03482011|564685028|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156682767|NCT01190930|565584875|FG002|Induction|Death|0|||
156682768|NCT01190930|565584876|FG003|Induction|Death|0|||
156682769|NCT01190930|565584877|FG004|Induction|Death|0|||
156682770|NCT01190930|565584878|FG005|Induction|Death|0|||
156682771|NCT01190930|565584879|FG006|Induction|Death|0|||
156682772|NCT01190930|565584880|FG007|Induction|Death|0|||
156682773|NCT01190930|565584881|FG008|Induction|Death|0|||
156682774|NCT01190930|565584882|FG009|Induction|Death|0|||
156682775|NCT01190930|565584873|FG000|Induction|Lost to Follow-up|1|||
156682776|NCT01190930|565584874|FG001|Induction|Lost to Follow-up|0|||
156682777|NCT01190930|565584875|FG002|Induction|Lost to Follow-up|0|||
156682778|NCT01190930|565584876|FG003|Induction|Lost to Follow-up|0|||
156682779|NCT01190930|565584877|FG004|Induction|Lost to Follow-up|0|||
156682780|NCT01190930|565584878|FG005|Induction|Lost to Follow-up|0|||
156682781|NCT01190930|565584879|FG006|Induction|Lost to Follow-up|0|||
156682782|NCT01190930|565584880|FG007|Induction|Lost to Follow-up|0|||
156682783|NCT01190930|565584881|FG008|Induction|Lost to Follow-up|0|||
156682784|NCT01190930|565584882|FG009|Induction|Lost to Follow-up|0|||
156682785|NCT01190930|565584873|FG000|Induction|Physician Decision|125|||
156682786|NCT01190930|565584874|FG001|Induction|Physician Decision|3|||
156682787|NCT01190930|565584875|FG002|Induction|Physician Decision|0|||
156682788|NCT01190930|565584876|FG003|Induction|Physician Decision|0|||
156682789|NCT01190930|565584877|FG004|Induction|Physician Decision|0|||
156682790|NCT01190930|565584878|FG005|Induction|Physician Decision|0|||
156682791|NCT01190930|565584879|FG006|Induction|Physician Decision|0|||
156682792|NCT01190930|565584880|FG007|Induction|Physician Decision|0|||
156682793|NCT01190930|565584881|FG008|Induction|Physician Decision|0|||
156682794|NCT01190930|565584882|FG009|Induction|Physician Decision|0|||
156682795|NCT01190930|565584873|FG000|Induction|Withdrawal by Subject|9|||
156682796|NCT01190930|565584874|FG001|Induction|Withdrawal by Subject|0|||
156682797|NCT01190930|565584875|FG002|Induction|Withdrawal by Subject|0|||
156682798|NCT01190930|565584876|FG003|Induction|Withdrawal by Subject|0|||
156682799|NCT01190930|565584877|FG004|Induction|Withdrawal by Subject|0|||
156682800|NCT01190930|565584878|FG005|Induction|Withdrawal by Subject|0|||
156682801|NCT01190930|565584879|FG006|Induction|Withdrawal by Subject|0|||
156682802|NCT01190930|565584880|FG007|Induction|Withdrawal by Subject|0|||
156682803|NCT01190930|565584881|FG008|Induction|Withdrawal by Subject|0|||
156682804|NCT01190930|565584882|FG009|Induction|Withdrawal by Subject|0|||
156682805|NCT01190930|565584873|FG000|Induction|Refusal|235|||
156682806|NCT01190930|565584874|FG001|Induction|Refusal|0|||
156682807|NCT01190930|565584875|FG002|Induction|Refusal|0|||
156682808|NCT01190930|565584876|FG003|Induction|Refusal|0|||
156682809|NCT01190930|565584877|FG004|Induction|Refusal|0|||
156682810|NCT01190930|565584878|FG005|Induction|Refusal|0|||
156682811|NCT01190930|565584879|FG006|Induction|Refusal|0|||
156682812|NCT01190930|565584880|FG007|Induction|Refusal|0|||
156682813|NCT01190930|565584881|FG008|Induction|Refusal|0|||
156682814|NCT01190930|565584882|FG009|Induction|Refusal|0|||
156682815|NCT01190930|565584873|FG000|Induction|Inevaluable|23|||
156682816|NCT01190930|565584874|FG001|Induction|Inevaluable|1|||
156682817|NCT01190930|565584875|FG002|Induction|Inevaluable|0|||
156682818|NCT01190930|565584876|FG003|Induction|Inevaluable|0|||
156682819|NCT01190930|565584877|FG004|Induction|Inevaluable|0|||
156682820|NCT01190930|565584878|FG005|Induction|Inevaluable|0|||
156682821|NCT01190930|565584879|FG006|Induction|Inevaluable|0|||
156682822|NCT01190930|565584880|FG007|Induction|Inevaluable|0|||
156682823|NCT01190930|565584881|FG008|Induction|Inevaluable|0|||
156682824|NCT01190930|565584882|FG009|Induction|Inevaluable|0|||
156682825|NCT01190930|565584873|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
156682826|NCT01190930|565584874|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682827|NCT01190930|565584875|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156784456|NCT00625378|565961230|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
156784457|NCT00625378|565961231|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
156784458|NCT00625378|565961230|FG000|Overall Study|Lost to Follow-up|17|||
156784459|NCT00625378|565961231|FG001|Overall Study|Lost to Follow-up|0|||
156682828|NCT01190930|565584876|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156784460|NCT00625378|565961230|FG000|Overall Study|Non-compliant with study medication|3|||
156784461|NCT00625378|565961231|FG001|Overall Study|Non-compliant with study medication|0|||
156682829|NCT01190930|565584877|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682830|NCT01190930|565584878|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682831|NCT01190930|565584879|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682832|NCT01190930|565584880|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682833|NCT01190930|565584881|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682834|NCT01190930|565584882|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682835|NCT01190930|565584873|FG000|Induction|High Risk Downs|80|||
156682836|NCT01190930|565584874|FG001|Induction|High Risk Downs|0|||
156682837|NCT01190930|565584875|FG002|Induction|High Risk Downs|0|||
156682838|NCT01190930|565584876|FG003|Induction|High Risk Downs|0|||
156682839|NCT01190930|565584877|FG004|Induction|High Risk Downs|0|||
156682840|NCT01190930|565584878|FG005|Induction|High Risk Downs|0|||
156682841|NCT01190930|565584879|FG006|Induction|High Risk Downs|0|||
156682842|NCT01190930|565584880|FG007|Induction|High Risk Downs|0|||
156682843|NCT01190930|565584881|FG008|Induction|High Risk Downs|0|||
156682844|NCT01190930|565584882|FG009|Induction|High Risk Downs|0|||
156682845|NCT01190930|565584873|FG000|Induction|Enrollment onto another COG Protocol|1|||
156682846|NCT01190930|565584874|FG001|Induction|Enrollment onto another COG Protocol|0|||
156682847|NCT01190930|565584875|FG002|Induction|Enrollment onto another COG Protocol|0|||
156784462|NCT00625378|565961230|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
156784463|NCT00625378|565961231|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
156784464|NCT00625378|565961230|FG000|Overall Study|Medical decision|1|||
156784465|NCT00625378|565961231|FG001|Overall Study|Medical decision|0|||
156784466|NCT00625378|565961230|FG000|Overall Study|Multiple toxicities|1|||
156784467|NCT00625378|565961231|FG001|Overall Study|Multiple toxicities|0|||
156784468|NCT00625378|565961230|FG000|Overall Study|New cancer|1|||
156784469|NCT00625378|565961231|FG001|Overall Study|New cancer|0|||
156784470|NCT00625378|565961230|FG000|Overall Study|PTA program|2|||
156784471|NCT00625378|565961231|FG001|Overall Study|PTA program|0|||
156784472|NCT00625378|565961230|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
156784473|NCT00625378|565961231|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
156784474|NCT00625378|565961230|FG000|Overall Study|Sponsor decision|1|||
156784475|NCT00625378|565961231|FG001|Overall Study|Sponsor decision|0|||
156784476|NCT00625378|565961230|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
156784477|NCT00625378|565961231|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
156784478|NCT00625378|565961230|FG000|Overall Study|Switch to commercial drug|6|||
156784479|NCT00625378|565961231|FG001|Overall Study|Switch to commercial drug|1|||
156784480|NCT00625378|565961230|FG000|Overall Study|Missing|2|||
156784481|NCT00625378|565961231|FG001|Overall Study|Missing|0|||
156868262|NCT02113982|566277283|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
156868263|NCT02113982|566277284|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
156868264|NCT02113982|566277285|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
156682848|NCT01190930|565584876|FG003|Induction|Enrollment onto another COG Protocol|0|||
156682849|NCT01190930|565584877|FG004|Induction|Enrollment onto another COG Protocol|0|||
156682850|NCT01190930|565584878|FG005|Induction|Enrollment onto another COG Protocol|0|||
156682851|NCT01190930|565584879|FG006|Induction|Enrollment onto another COG Protocol|0|||
156682852|NCT01190930|565584880|FG007|Induction|Enrollment onto another COG Protocol|0|||
156682853|NCT01190930|565584881|FG008|Induction|Enrollment onto another COG Protocol|0|||
156682854|NCT01190930|565584882|FG009|Induction|Enrollment onto another COG Protocol|0|||
156682855|NCT01190930|565584873|FG000|Induction|Average Risk|1847|||
156682856|NCT01190930|565584874|FG001|Induction|Average Risk|0|||
156682857|NCT01190930|565584875|FG002|Induction|Average Risk|0|||
156682858|NCT01190930|565584876|FG003|Induction|Average Risk|0|||
156682859|NCT01190930|565584877|FG004|Induction|Average Risk|0|||
156682860|NCT01190930|565584878|FG005|Induction|Average Risk|0|||
156682861|NCT01190930|565584879|FG006|Induction|Average Risk|0|||
156682862|NCT01190930|565584880|FG007|Induction|Average Risk|0|||
156682863|NCT01190930|565584881|FG008|Induction|Average Risk|0|||
156682864|NCT01190930|565584882|FG009|Induction|Average Risk|0|||
156682865|NCT01190930|565584873|FG000|Induction|High Risk|1227|||
156682866|NCT01190930|565584874|FG001|Induction|High Risk|0|||
156682867|NCT01190930|565584875|FG002|Induction|High Risk|0|||
156682868|NCT01190930|565584876|FG003|Induction|High Risk|0|||
156682869|NCT01190930|565584877|FG004|Induction|High Risk|0|||
156682870|NCT01190930|565584878|FG005|Induction|High Risk|0|||
156682871|NCT01190930|565584879|FG006|Induction|High Risk|0|||
156682872|NCT01190930|565584880|FG007|Induction|High Risk|0|||
156682873|NCT01190930|565584881|FG008|Induction|High Risk|0|||
156682874|NCT01190930|565584882|FG009|Induction|High Risk|0|||
156682875|NCT01190930|565584873|FG000|Induction|Low Risk|443|||
156682876|NCT01190930|565584874|FG001|Induction|Low Risk|0|||
156682877|NCT01190930|565584875|FG002|Induction|Low Risk|0|||
156682878|NCT01190930|565584876|FG003|Induction|Low Risk|0|||
156682879|NCT01190930|565584877|FG004|Induction|Low Risk|0|||
156682880|NCT01190930|565584878|FG005|Induction|Low Risk|0|||
156682881|NCT01190930|565584879|FG006|Induction|Low Risk|0|||
156682882|NCT01190930|565584880|FG007|Induction|Low Risk|0|||
156682883|NCT01190930|565584881|FG008|Induction|Low Risk|0|||
156682884|NCT01190930|565584882|FG009|Induction|Low Risk|0|||
156682885|NCT01190930|565584873|FG000|Induction|Very High Risk|1012|||
156784482|NCT00625378|565961230|FG000|Overall Study|End of treatment not available|2|||
156784483|NCT00625378|565961231|FG001|Overall Study|End of treatment not available|0|||
156784484|NCT00625378|565961230|FG000|Overall Study|Never treated|2|||
156784485|NCT00625378|565961231|FG001|Overall Study|Never treated|0|||
156784486|NCT03753542|565961233|FG000|Overall Study|Lost to Follow-up|9|||
156682886|NCT01190930|565584874|FG001|Induction|Very High Risk|0|||
156682887|NCT01190930|565584875|FG002|Induction|Very High Risk|0|||
156682888|NCT01190930|565584876|FG003|Induction|Very High Risk|0|||
156682889|NCT01190930|565584877|FG004|Induction|Very High Risk|0|||
156682890|NCT01190930|565584878|FG005|Induction|Very High Risk|0|||
156682891|NCT01190930|565584879|FG006|Induction|Very High Risk|0|||
156682892|NCT01190930|565584880|FG007|Induction|Very High Risk|0|||
156682893|NCT01190930|565584881|FG008|Induction|Very High Risk|0|||
156682894|NCT01190930|565584882|FG009|Induction|Very High Risk|0|||
156682895|NCT01190930|565584873|FG000|Induction|Philadelphia chromosome-positive|99|||
156682896|NCT01190930|565584874|FG001|Induction|Philadelphia chromosome-positive|0|||
156682897|NCT01190930|565584875|FG002|Induction|Philadelphia chromosome-positive|0|||
156682898|NCT01190930|565584876|FG003|Induction|Philadelphia chromosome-positive|0|||
156435706|NCT03482011|564685021|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
156435707|NCT03482011|564685022|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
156435708|NCT03482011|564685023|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
156435709|NCT03482011|564685024|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
156435710|NCT03482011|564685025|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
156682899|NCT01190930|565584877|FG004|Induction|Philadelphia chromosome-positive|0|||
156682900|NCT01190930|565584878|FG005|Induction|Philadelphia chromosome-positive|0|||
156682901|NCT01190930|565584879|FG006|Induction|Philadelphia chromosome-positive|0|||
156682902|NCT01190930|565584880|FG007|Induction|Philadelphia chromosome-positive|0|||
156682903|NCT01190930|565584881|FG008|Induction|Philadelphia chromosome-positive|0|||
156682904|NCT01190930|565584882|FG009|Induction|Philadelphia chromosome-positive|0|||
156682905|NCT01190930|565584873|FG000|Induction|Incomplete Induction data|63|||
156682906|NCT01190930|565584874|FG001|Induction|Incomplete Induction data|0|||
156682907|NCT01190930|565584875|FG002|Induction|Incomplete Induction data|0|||
156682908|NCT01190930|565584876|FG003|Induction|Incomplete Induction data|0|||
156682909|NCT01190930|565584877|FG004|Induction|Incomplete Induction data|0|||
156682910|NCT01190930|565584878|FG005|Induction|Incomplete Induction data|0|||
156682911|NCT01190930|565584879|FG006|Induction|Incomplete Induction data|0|||
156682912|NCT01190930|565584880|FG007|Induction|Incomplete Induction data|0|||
156682913|NCT01190930|565584881|FG008|Induction|Incomplete Induction data|0|||
156682914|NCT01190930|565584882|FG009|Induction|Incomplete Induction data|0|||
156682915|NCT01190930|565584873|FG000|Induction|Progressive disease|0|||
156682916|NCT01190930|565584874|FG001|Induction|Progressive disease|1|||
156682917|NCT01190930|565584875|FG002|Induction|Progressive disease|0|||
156682918|NCT01190930|565584876|FG003|Induction|Progressive disease|0|||
156682919|NCT01190930|565584877|FG004|Induction|Progressive disease|0|||
156682920|NCT01190930|565584878|FG005|Induction|Progressive disease|0|||
156682921|NCT01190930|565584879|FG006|Induction|Progressive disease|0|||
156682922|NCT01190930|565584880|FG007|Induction|Progressive disease|0|||
156682923|NCT01190930|565584881|FG008|Induction|Progressive disease|0|||
156682924|NCT01190930|565584882|FG009|Induction|Progressive disease|0|||
156682925|NCT01190930|565584873|FG000|Induction|No treatment|3|||
156682926|NCT01190930|565584874|FG001|Induction|No treatment|0|||
156682927|NCT01190930|565584875|FG002|Induction|No treatment|0|||
156682928|NCT01190930|565584876|FG003|Induction|No treatment|0|||
156682929|NCT01190930|565584877|FG004|Induction|No treatment|0|||
156682930|NCT01190930|565584878|FG005|Induction|No treatment|0|||
156682931|NCT01190930|565584879|FG006|Induction|No treatment|0|||
156682932|NCT01190930|565584880|FG007|Induction|No treatment|0|||
156682933|NCT01190930|565584881|FG008|Induction|No treatment|0|||
156682934|NCT01190930|565584882|FG009|Induction|No treatment|0|||
156682935|NCT01190930|565584873|FG000|Induction|Ineligible|69|||
156682936|NCT01190930|565584874|FG001|Induction|Ineligible|4|||
156682937|NCT01190930|565584875|FG002|Induction|Ineligible|0|||
156682938|NCT01190930|565584876|FG003|Induction|Ineligible|0|||
156682939|NCT01190930|565584877|FG004|Induction|Ineligible|0|||
156682940|NCT01190930|565584878|FG005|Induction|Ineligible|0|||
156682941|NCT01190930|565584879|FG006|Induction|Ineligible|0|||
156682942|NCT01190930|565584880|FG007|Induction|Ineligible|0|||
156682943|NCT01190930|565584881|FG008|Induction|Ineligible|0|||
156682944|NCT01190930|565584882|FG009|Induction|Ineligible|0|||
156682945|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
156682946|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
156682947|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
156682948|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
156682949|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
156682950|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
156682951|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
156682952|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
156682953|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
156682954|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
156682955|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Death|0|||
156682956|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Death|0|||
156682957|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Death|8|||
156682958|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Death|4|||
156682959|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Death|0|||
156682960|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Death|0|||
156682961|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Death|0|||
156682962|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Death|0|||
156784487|NCT03753542|565961234|FG001|Overall Study|Lost to Follow-up|14|||
156682963|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Death|0|||
156682964|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Death|0|||
156682965|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
156682966|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
156682967|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
156868265|NCT02113982|566277286|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
156868266|NCT02113982|566277287|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
156868267|NCT02113982|566277288|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
156868268|NCT02113982|566277289|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
156868269|NCT02113982|566277290|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
156868270|NCT02113982|566277291|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
156868271|NCT02113982|566277292|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
156868272|NCT02113982|566277293|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
156868273|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868274|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868275|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868276|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868277|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868278|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868279|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868280|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868281|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868282|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868283|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868284|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868285|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
156868286|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868287|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868288|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868289|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868290|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868291|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868292|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868293|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868294|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868295|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868296|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868297|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868298|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868299|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
156868300|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
156868301|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868302|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868303|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868304|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868305|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868306|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868307|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868308|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868309|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868310|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868311|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868312|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868313|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
156868314|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
156868315|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868316|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868317|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868318|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868319|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868320|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868321|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868322|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868323|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868324|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868325|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868326|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868327|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
156868328|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
156868329|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868330|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156529515|NCT01139021|565032673|FG001|Overall Study|Lost to Follow-up|0|||
156682968|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
156682969|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
156682970|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
156682971|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
156682972|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
156682973|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
156682974|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
156682975|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682976|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
156682977|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
156682978|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
156682979|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682980|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682981|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682982|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682983|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682984|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682985|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Refusal|0|||
156682986|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Refusal|2|||
156682987|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Refusal|694|||
156682988|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Refusal|4|||
156682989|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Refusal|0|||
156682990|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Refusal|3|||
156682991|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Refusal|0|||
156682992|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Refusal|0|||
156682993|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Refusal|0|||
156682994|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Refusal|0|||
156682995|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
156682996|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
156682997|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
156682998|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
156682999|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
156683000|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
156683001|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
156683002|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
156683003|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
156683004|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
156683005|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683006|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
156683007|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683008|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683009|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683010|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683011|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683012|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683013|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683014|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683015|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
156683016|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
156683017|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
156683018|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
156683019|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
156683020|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
156683021|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
156683022|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
156683023|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
156683024|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
156683025|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Relapse|0|||
156683026|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Relapse|0|||
156683027|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Relapse|1|||
156683028|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Relapse|0|||
156683029|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Relapse|0|||
156683030|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Relapse|0|||
156683031|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Relapse|0|||
156683032|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Relapse|0|||
156683033|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Relapse|0|||
156683034|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Relapse|0|||
156683035|NCT01190930|565584873|FG000|Maintenance|Adverse Event|0|||
156683036|NCT01190930|565584874|FG001|Maintenance|Adverse Event|0|||
156683037|NCT01190930|565584875|FG002|Maintenance|Adverse Event|0|||
156683038|NCT01190930|565584876|FG003|Maintenance|Adverse Event|0|||
156683039|NCT01190930|565584877|FG004|Maintenance|Adverse Event|0|||
156683040|NCT01190930|565584878|FG005|Maintenance|Adverse Event|1|||
156683041|NCT01190930|565584879|FG006|Maintenance|Adverse Event|1|||
156683042|NCT01190930|565584880|FG007|Maintenance|Adverse Event|3|||
156683043|NCT01190930|565584881|FG008|Maintenance|Adverse Event|3|||
156683044|NCT01190930|565584882|FG009|Maintenance|Adverse Event|0|||
156683045|NCT01190930|565584873|FG000|Maintenance|Death|0|||
156683046|NCT01190930|565584874|FG001|Maintenance|Death|0|||
156683047|NCT01190930|565584875|FG002|Maintenance|Death|0|||
156683048|NCT01190930|565584876|FG003|Maintenance|Death|1|||
156683049|NCT01190930|565584877|FG004|Maintenance|Death|0|||
156683050|NCT01190930|565584878|FG005|Maintenance|Death|0|||
156683051|NCT01190930|565584879|FG006|Maintenance|Death|2|||
156683052|NCT01190930|565584880|FG007|Maintenance|Death|2|||
156683053|NCT01190930|565584881|FG008|Maintenance|Death|2|||
156683054|NCT01190930|565584882|FG009|Maintenance|Death|2|||
156683055|NCT01190930|565584873|FG000|Maintenance|Lost to Follow-up|0|||
156683056|NCT01190930|565584874|FG001|Maintenance|Lost to Follow-up|0|||
156683057|NCT01190930|565584875|FG002|Maintenance|Lost to Follow-up|0|||
156683058|NCT01190930|565584876|FG003|Maintenance|Lost to Follow-up|0|||
156683059|NCT01190930|565584877|FG004|Maintenance|Lost to Follow-up|0|||
156683060|NCT01190930|565584878|FG005|Maintenance|Lost to Follow-up|0|||
156683061|NCT01190930|565584879|FG006|Maintenance|Lost to Follow-up|1|||
156683062|NCT01190930|565584880|FG007|Maintenance|Lost to Follow-up|1|||
156683063|NCT01190930|565584881|FG008|Maintenance|Lost to Follow-up|1|||
156683064|NCT01190930|565584882|FG009|Maintenance|Lost to Follow-up|0|||
156683065|NCT01190930|565584873|FG000|Maintenance|Physician Decision|0|||
156683066|NCT01190930|565584874|FG001|Maintenance|Physician Decision|1|||
156683067|NCT01190930|565584875|FG002|Maintenance|Physician Decision|0|||
156683068|NCT01190930|565584876|FG003|Maintenance|Physician Decision|5|||
156683069|NCT01190930|565584877|FG004|Maintenance|Physician Decision|9|||
156683070|NCT01190930|565584878|FG005|Maintenance|Physician Decision|4|||
156683071|NCT01190930|565584879|FG006|Maintenance|Physician Decision|8|||
156683072|NCT01190930|565584880|FG007|Maintenance|Physician Decision|8|||
156683073|NCT01190930|565584881|FG008|Maintenance|Physician Decision|10|||
156683074|NCT01190930|565584882|FG009|Maintenance|Physician Decision|17|||
156683075|NCT01190930|565584873|FG000|Maintenance|Withdrawal by Subject|0|||
156683076|NCT01190930|565584874|FG001|Maintenance|Withdrawal by Subject|0|||
156683077|NCT01190930|565584875|FG002|Maintenance|Withdrawal by Subject|0|||
156683078|NCT01190930|565584876|FG003|Maintenance|Withdrawal by Subject|0|||
156683079|NCT01190930|565584877|FG004|Maintenance|Withdrawal by Subject|0|||
156683080|NCT01190930|565584878|FG005|Maintenance|Withdrawal by Subject|0|||
156683081|NCT01190930|565584879|FG006|Maintenance|Withdrawal by Subject|2|||
156683082|NCT01190930|565584880|FG007|Maintenance|Withdrawal by Subject|1|||
156683083|NCT01190930|565584881|FG008|Maintenance|Withdrawal by Subject|4|||
156683084|NCT01190930|565584882|FG009|Maintenance|Withdrawal by Subject|1|||
156683085|NCT01190930|565584873|FG000|Maintenance|Refusal|0|||
156683086|NCT01190930|565584874|FG001|Maintenance|Refusal|1|||
156683087|NCT01190930|565584875|FG002|Maintenance|Refusal|0|||
156683088|NCT01190930|565584876|FG003|Maintenance|Refusal|2|||
156683089|NCT01190930|565584877|FG004|Maintenance|Refusal|0|||
156683090|NCT01190930|565584878|FG005|Maintenance|Refusal|4|||
156683091|NCT01190930|565584879|FG006|Maintenance|Refusal|5|||
156683092|NCT01190930|565584880|FG007|Maintenance|Refusal|17|||
156683093|NCT01190930|565584881|FG008|Maintenance|Refusal|13|||
156683094|NCT01190930|565584882|FG009|Maintenance|Refusal|6|||
156683095|NCT01190930|565584873|FG000|Maintenance|second malignant neoplasm|0|||
156683096|NCT01190930|565584874|FG001|Maintenance|second malignant neoplasm|0|||
156683097|NCT01190930|565584875|FG002|Maintenance|second malignant neoplasm|0|||
156683098|NCT01190930|565584876|FG003|Maintenance|second malignant neoplasm|1|||
156683099|NCT01190930|565584877|FG004|Maintenance|second malignant neoplasm|0|||
156683100|NCT01190930|565584878|FG005|Maintenance|second malignant neoplasm|1|||
156683101|NCT01190930|565584879|FG006|Maintenance|second malignant neoplasm|0|||
156683102|NCT01190930|565584880|FG007|Maintenance|second malignant neoplasm|0|||
156683103|NCT01190930|565584881|FG008|Maintenance|second malignant neoplasm|1|||
156683104|NCT01190930|565584882|FG009|Maintenance|second malignant neoplasm|0|||
156683105|NCT01190930|565584873|FG000|Maintenance|Inevaluable|0|||
156683106|NCT01190930|565584874|FG001|Maintenance|Inevaluable|0|||
156683107|NCT01190930|565584875|FG002|Maintenance|Inevaluable|0|||
156683108|NCT01190930|565584876|FG003|Maintenance|Inevaluable|0|||
156683109|NCT01190930|565584877|FG004|Maintenance|Inevaluable|0|||
156683110|NCT01190930|565584878|FG005|Maintenance|Inevaluable|1|||
156683111|NCT01190930|565584879|FG006|Maintenance|Inevaluable|1|||
156683112|NCT01190930|565584880|FG007|Maintenance|Inevaluable|1|||
156683113|NCT01190930|565584881|FG008|Maintenance|Inevaluable|0|||
156683114|NCT01190930|565584882|FG009|Maintenance|Inevaluable|0|||
156683115|NCT01190930|565584873|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
156683116|NCT01190930|565584874|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
156683117|NCT01190930|565584875|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
156683118|NCT01190930|565584876|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
156683119|NCT01190930|565584877|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
156683120|NCT01190930|565584878|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
156683121|NCT01190930|565584879|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
156683122|NCT01190930|565584880|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
156683123|NCT01190930|565584881|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
156683124|NCT01190930|565584882|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
156683125|NCT01190930|565584873|FG000|Maintenance|Relapse|0|||
156683126|NCT01190930|565584874|FG001|Maintenance|Relapse|0|||
156683127|NCT01190930|565584875|FG002|Maintenance|Relapse|0|||
156683128|NCT01190930|565584876|FG003|Maintenance|Relapse|2|||
156683129|NCT01190930|565584877|FG004|Maintenance|Relapse|0|||
156683130|NCT01190930|565584878|FG005|Maintenance|Relapse|1|||
156683131|NCT01190930|565584879|FG006|Maintenance|Relapse|6|||
156683132|NCT01190930|565584880|FG007|Maintenance|Relapse|13|||
156683133|NCT01190930|565584881|FG008|Maintenance|Relapse|11|||
156683134|NCT01190930|565584882|FG009|Maintenance|Relapse|11|||
156683135|NCT01190930|565584873|FG000|Maintenance|Still on therapy|0|||
156683136|NCT01190930|565584874|FG001|Maintenance|Still on therapy|8|||
156683137|NCT01190930|565584875|FG002|Maintenance|Still on therapy|0|||
156683138|NCT01190930|565584876|FG003|Maintenance|Still on therapy|29|||
156683139|NCT01190930|565584877|FG004|Maintenance|Still on therapy|0|||
156683140|NCT01190930|565584878|FG005|Maintenance|Still on therapy|0|||
156683141|NCT01190930|565584879|FG006|Maintenance|Still on therapy|0|||
156529516|NCT01139021|565032674|FG002|Overall Study|Lost to Follow-up|0|||
156683142|NCT01190930|565584880|FG007|Maintenance|Still on therapy|0|||
156683143|NCT01190930|565584881|FG008|Maintenance|Still on therapy|0|||
156683144|NCT01190930|565584882|FG009|Maintenance|Still on therapy|0|||
156683145|NCT00979212|565584886|FG000|Overall Study|Protocol Violation|1|||
156683146|NCT00979212|565584887|FG001|Overall Study|Protocol Violation|8|||
156683147|NCT00979212|565584886|FG000|Overall Study|No protocol therapy received|1|||
156683148|NCT00979212|565584887|FG001|Overall Study|No protocol therapy received|0|||
156683149|NCT00035555|565584888|FG000|Overall Study|Adverse Event|5|||
156683150|NCT00035555|565584889|FG001|Overall Study|Adverse Event|8|||
156683151|NCT00035555|565584890|FG002|Overall Study|Adverse Event|9|||
156683152|NCT00035555|565584888|FG000|Overall Study|Allograft loss|1|||
156683153|NCT00035555|565584889|FG001|Overall Study|Allograft loss|1|||
156683154|NCT00035555|565584890|FG002|Overall Study|Allograft loss|2|||
156683155|NCT00035555|565584888|FG000|Overall Study|Death|0|||
156683156|NCT00035555|565584889|FG001|Overall Study|Death|0|||
156683157|NCT00035555|565584890|FG002|Overall Study|Death|2|||
156683158|NCT00035555|565584888|FG000|Overall Study|Lost to Follow-up|0|||
156683159|NCT00035555|565584889|FG001|Overall Study|Lost to Follow-up|0|||
156683160|NCT00035555|565584890|FG002|Overall Study|Lost to Follow-up|1|||
156683161|NCT00035555|565584888|FG000|Overall Study|Noncompliance|0|||
156683162|NCT00035555|565584889|FG001|Overall Study|Noncompliance|1|||
156683163|NCT00035555|565584890|FG002|Overall Study|Noncompliance|1|||
156683164|NCT00035555|565584888|FG000|Overall Study|Prohibited medication|1|||
156683165|NCT00035555|565584889|FG001|Overall Study|Prohibited medication|1|||
156683166|NCT00035555|565584890|FG002|Overall Study|Prohibited medication|0|||
156683167|NCT00035555|565584888|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
156683168|NCT00035555|565584889|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
156683169|NCT00035555|565584890|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
156529517|NCT01139021|565032675|FG003|Overall Study|Lost to Follow-up|0|||
156683170|NCT00035555|565584888|FG000|Overall Study|Withdrawal by Subject|2|||
156683171|NCT00035555|565584889|FG001|Overall Study|Withdrawal by Subject|0|||
156683172|NCT00035555|565584890|FG002|Overall Study|Withdrawal by Subject|2|||
156683173|NCT00035555|565584888|FG000|Overall Study|Investigator deemed not a good candidate|0|||
156683174|NCT00035555|565584889|FG001|Overall Study|Investigator deemed not a good candidate|0|||
156683175|NCT00035555|565584890|FG002|Overall Study|Investigator deemed not a good candidate|1|||
156784488|NCT04210375|565961236|FG000|Overall Study|Death|0|||
156784489|NCT04210375|565961237|FG001|Overall Study|Death|1|||
156784490|NCT04210375|565961238|FG002|Overall Study|Death|0|||
156784491|NCT04210375|565961239|FG003|Overall Study|Death|0|||
156784492|NCT05752487|565961240|FG000|Overall Study|Enrolled, not treated|9|||
156683176|NCT00035555|565584888|FG000|Overall Study|Received cyclosporin in error|0|||
156683177|NCT00035555|565584889|FG001|Overall Study|Received cyclosporin in error|0|||
156683178|NCT00035555|565584890|FG002|Overall Study|Received cyclosporin in error|1|||
156529518|NCT01139021|565032676|FG004|Overall Study|Lost to Follow-up|2|||
156683179|NCT00337428|565584891|FG000|Overall Study|Withdrawal by Subject|1|||
156683180|NCT00337428|565584892|FG001|Overall Study|Withdrawal by Subject|2|||
156784493|NCT05752487|565961240|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
156683181|NCT00337428|565584891|FG000|Overall Study|Lack of Time|1|||
156683182|NCT00337428|565584892|FG001|Overall Study|Lack of Time|1|||
156683183|NCT00337428|565584891|FG000|Overall Study|Unwilling to Continue|1|||
156683184|NCT00337428|565584892|FG001|Overall Study|Unwilling to Continue|0|||
156529519|NCT01139021|565032677|FG005|Overall Study|Lost to Follow-up|0|||
156683185|NCT00337428|565584891|FG000|Overall Study|Anorexia|1|||
156683186|NCT00337428|565584892|FG001|Overall Study|Anorexia|0|||
156683187|NCT02618382|565584893|FG000|Overall Study|Physician Decision|1|||
156683188|NCT02618382|565584893|FG000|Overall Study|Withdrawal by Subject|1|||
156683189|NCT02618382|565584893|FG000|Overall Study|Protocol Violation|1|||
156683190|NCT04886063|565584900|FG000|Overall Study|Adverse Event|50|||
156683191|NCT04886063|565584900|FG000|Overall Study|Lack of Efficacy|31|||
156683192|NCT04886063|565584900|FG000|Overall Study|Withdrawal by Subject|45|||
156683193|NCT04886063|565584900|FG000|Overall Study|Physician Decision|3|||
156683194|NCT04886063|565584900|FG000|Overall Study|Protocol Violation|3|||
156683195|NCT04886063|565584900|FG000|Overall Study|Site closure|4|||
156683196|NCT04886063|565584900|FG000|Overall Study|Nursing home replacement|3|||
156683197|NCT04886063|565584900|FG000|Overall Study|Lost to Follow-up|5|||
156683198|NCT04886063|565584900|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
156683199|NCT04886063|565584900|FG000|Overall Study|>1 reason|20|||
156683200|NCT01628549|565584901|FG000|Overall Study|Adverse Event|1|||
156683201|NCT01628549|565584902|FG001|Overall Study|Adverse Event|1|||
156683202|NCT01628549|565584903|FG002|Overall Study|Adverse Event|0|||
156435711|NCT03482011|564685026|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
156435712|NCT03482011|564685027|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
156435713|NCT03482011|564685028|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
156435714|NCT03482011|564685021|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
156435715|NCT03482011|564685022|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
156435716|NCT03482011|564685023|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
156435717|NCT03482011|564685024|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
156435718|NCT03482011|564685025|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
156435719|NCT03482011|564685026|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
156435720|NCT03482011|564685027|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
156435721|NCT03482011|564685028|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
156435722|NCT03482011|564685021|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
156435723|NCT03482011|564685022|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
156435724|NCT03482011|564685023|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156435725|NCT03482011|564685024|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156435726|NCT03482011|564685025|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156435727|NCT03482011|564685026|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156435728|NCT03482011|564685027|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156435729|NCT03482011|564685028|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156435730|NCT03482011|564685021|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
156435731|NCT03482011|564685022|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
156435732|NCT03482011|564685023|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
156435733|NCT03482011|564685024|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
156435734|NCT03482011|564685025|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
156435735|NCT03482011|564685026|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
156435736|NCT03482011|564685027|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
156435737|NCT03482011|564685028|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
156435738|NCT03482011|564685021|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
156435739|NCT03482011|564685022|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
156435740|NCT03482011|564685023|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
156435741|NCT03482011|564685024|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
156435742|NCT03482011|564685025|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
156435743|NCT03482011|564685026|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
156435744|NCT03482011|564685027|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
156435745|NCT03482011|564685028|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
156435746|NCT03482011|564685021|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156435747|NCT03482011|564685022|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156435748|NCT03482011|564685023|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156435749|NCT03482011|564685024|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156435750|NCT03482011|564685025|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
156435751|NCT03482011|564685026|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156784494|NCT05752487|565961240|FG000|Overall Study|Withdrawal by Subject|2|||
156784495|NCT04124965|565961242|FG000|Overall Study|Adverse event, non-fatal|3|||
156435752|NCT03482011|564685027|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156435753|NCT03482011|564685028|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
156435754|NCT03482011|564685021|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
156435755|NCT03482011|564685022|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
156435756|NCT03482011|564685023|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
156435757|NCT03482011|564685024|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
156435758|NCT03482011|564685025|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
156435759|NCT03482011|564685026|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
156435760|NCT03482011|564685027|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
156529520|NCT01139021|565032672|FG000|Overall Study|Protocol Violation|1|||
156683203|NCT01628549|565584904|FG003|Overall Study|Adverse Event|4|||
156683204|NCT01628549|565584901|FG000|Overall Study|Lost to Follow-up|3|||
156683205|NCT01628549|565584902|FG001|Overall Study|Lost to Follow-up|4|||
156683206|NCT01628549|565584903|FG002|Overall Study|Lost to Follow-up|3|||
156683207|NCT01628549|565584904|FG003|Overall Study|Lost to Follow-up|3|||
156683208|NCT01628549|565584901|FG000|Overall Study|Withdrawal by Subject|3|||
156683209|NCT01628549|565584902|FG001|Overall Study|Withdrawal by Subject|4|||
156683210|NCT01628549|565584903|FG002|Overall Study|Withdrawal by Subject|4|||
156683211|NCT01628549|565584904|FG003|Overall Study|Withdrawal by Subject|1|||
156683212|NCT01628549|565584901|FG000|Overall Study|Protocol Violation|2|||
156683213|NCT01628549|565584902|FG001|Overall Study|Protocol Violation|1|||
156683214|NCT01628549|565584903|FG002|Overall Study|Protocol Violation|1|||
156683215|NCT01628549|565584904|FG003|Overall Study|Protocol Violation|0|||
156683216|NCT01628549|565584901|FG000|Overall Study|withdrawn for noncompliance|0|||
156784496|NCT04124965|565961243|FG001|Overall Study|Adverse event, non-fatal|1|||
156784497|NCT04124965|565961242|FG000|Overall Study|Withdrawal by Subject|1|||
156784498|NCT04124965|565961243|FG001|Overall Study|Withdrawal by Subject|1|||
156784499|NCT04124965|565961242|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
156784500|NCT04124965|565961243|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
156784501|NCT04124965|565961242|FG000|Overall Study|Pregnancy|1|||
156784502|NCT04124965|565961243|FG001|Overall Study|Pregnancy|0|||
156784503|NCT04124965|565961242|FG000|Overall Study|Sponsor and participant decision|0|||
156784504|NCT04124965|565961243|FG001|Overall Study|Sponsor and participant decision|1|||
156529521|NCT01139021|565032673|FG001|Overall Study|Protocol Violation|0|||
156529522|NCT01139021|565032674|FG002|Overall Study|Protocol Violation|0|||
156529523|NCT01139021|565032675|FG003|Overall Study|Protocol Violation|0|||
156529524|NCT01139021|565032676|FG004|Overall Study|Protocol Violation|2|||
156529525|NCT01139021|565032677|FG005|Overall Study|Protocol Violation|0|||
156529526|NCT01139021|565032672|FG000|Overall Study|Withdrawal by Subject|0|||
156529527|NCT01139021|565032673|FG001|Overall Study|Withdrawal by Subject|0|||
156529528|NCT01139021|565032674|FG002|Overall Study|Withdrawal by Subject|0|||
156529529|NCT01139021|565032675|FG003|Overall Study|Withdrawal by Subject|1|||
156529530|NCT01139021|565032676|FG004|Overall Study|Withdrawal by Subject|4|||
156529531|NCT01139021|565032677|FG005|Overall Study|Withdrawal by Subject|0|||
156529532|NCT00784693|565032682|FG000|Overall Study|Lost to Follow-up|0|||
156529533|NCT00784693|565032683|FG001|Overall Study|Lost to Follow-up|1|||
156529534|NCT00784693|565032682|FG000|Overall Study|Lack of Efficacy|1|||
156529535|NCT00784693|565032683|FG001|Overall Study|Lack of Efficacy|1|||
156529536|NCT00784693|565032682|FG000|Overall Study|Withdrawal by Subject|0|||
156529537|NCT00784693|565032683|FG001|Overall Study|Withdrawal by Subject|4|||
156529538|NCT00784693|565032682|FG000|Overall Study|Randomized but not Treated|1|||
156529539|NCT00784693|565032683|FG001|Overall Study|Randomized but not Treated|0|||
156529540|NCT00784693|565032682|FG000|Overall Study|Other|1|||
156529541|NCT00784693|565032683|FG001|Overall Study|Other|0|||
156529542|NCT05458479|565032684|FG000|Overall Study|Lost to Follow-up|1|||
156529543|NCT01176773|565032686|FG000|Overall Study|Screen Failure|2|||
156529544|NCT01176773|565032686|FG000|Overall Study|Withdrew consent|1|||
156529545|NCT01498289|565032691|FG000|Overall Study|Adverse Event|16|||
156529546|NCT01498289|565032692|FG001|Overall Study|Adverse Event|18|||
156529547|NCT01498289|565032691|FG000|Overall Study|Death|6|||
156529548|NCT01498289|565032692|FG001|Overall Study|Death|8|||
156529549|NCT01498289|565032691|FG000|Overall Study|Withdrawal unrelated to AE|16|||
156529550|NCT01498289|565032692|FG001|Overall Study|Withdrawal unrelated to AE|16|||
156529551|NCT01498289|565032691|FG000|Overall Study|Progression/relapse|53|||
156529552|NCT01498289|565032692|FG001|Overall Study|Progression/relapse|59|||
156529553|NCT01498289|565032691|FG000|Overall Study|Not protocol specified|7|||
156529554|NCT01498289|565032692|FG001|Overall Study|Not protocol specified|2|||
156529555|NCT01498289|565032691|FG000|Overall Study|Reason under review|0|||
156529556|NCT01498289|565032692|FG001|Overall Study|Reason under review|1|||
156529557|NCT01423253|565032693|FG000|Overall Study|Adverse Event|2|||
156529558|NCT01423253|565032693|FG000|Overall Study|Lack of Efficacy|2|||
156529559|NCT01423253|565032693|FG000|Overall Study|Lost to Follow-up|1|||
156529560|NCT01423253|565032693|FG000|Overall Study|Protocol Violation|2|||
156529561|NCT01423253|565032693|FG000|Overall Study|Withdrawal by Subject|2|||
156529562|NCT02804178|565032697|FG000|Overall Study|Adverse Event|1|||
156529563|NCT02513745|565032702|FG000|Overall Study|Criteria at time of surgery not met.|3|||
156529564|NCT02513745|565032703|FG001|Overall Study|Criteria at time of surgery not met.|3|||
156529565|NCT01116882|565032704|FG000|30-day|Lost to Follow-up|50|||
156529566|NCT01116882|565032705|FG001|30-day|Lost to Follow-up|21|||
156529567|NCT01116882|565032704|FG000|30-day|Withdrawal by Subject|2|||
156683217|NCT01628549|565584902|FG001|Overall Study|withdrawn for noncompliance|2|||
156683218|NCT01628549|565584903|FG002|Overall Study|withdrawn for noncompliance|1|||
156529568|NCT01116882|565032705|FG001|30-day|Withdrawal by Subject|4|||
156529569|NCT01116882|565032704|FG000|30-day|Other Reasons|16|||
156529570|NCT01116882|565032705|FG001|30-day|Other Reasons|6|||
156529571|NCT01116882|565032704|FG000|12-month|Lost to Follow-up|111|||
156529572|NCT01116882|565032705|FG001|12-month|Lost to Follow-up|42|||
156529573|NCT01116882|565032704|FG000|12-month|Other Reasons|151|||
156784505|NCT04124965|565961242|FG000|Overall Study|Personal surgery|0|||
156784506|NCT04124965|565961243|FG001|Overall Study|Personal surgery|1|||
156529574|NCT01116882|565032705|FG001|12-month|Other Reasons|49|||
156529575|NCT01116882|565032704|FG000|12-month|Withdrawal by Subject|5|||
156529576|NCT01116882|565032705|FG001|12-month|Withdrawal by Subject|8|||
156529577|NCT00547365|565032706|FG000|Overall Study|Physician Decision|1|||
156784507|NCT04124965|565961242|FG000|Overall Study|Physician Decision|0|||
156529578|NCT00547365|565032706|FG000|Overall Study|Lost to Follow-up|1|||
156529579|NCT00547365|565032706|FG000|Overall Study|Protocol Violation|2|||
156529580|NCT00547365|565032706|FG000|Overall Study|death (not related to study)|4|||
156529581|NCT00504881|565032709|FG000|Overall Study|Lack of Efficacy|1|||
156529582|NCT00504881|565032710|FG001|Overall Study|Lack of Efficacy|5|||
156529583|NCT00504881|565032709|FG000|Overall Study|Lost to Follow-up|0|||
156529584|NCT00504881|565032710|FG001|Overall Study|Lost to Follow-up|2|||
156529585|NCT00504881|565032709|FG000|Overall Study|Withdrawal by Subject|1|||
156529586|NCT00504881|565032710|FG001|Overall Study|Withdrawal by Subject|4|||
156529587|NCT00504881|565032709|FG000|Overall Study|Non-Compliance|1|||
156529588|NCT00504881|565032710|FG001|Overall Study|Non-Compliance|0|||
156529589|NCT00504881|565032709|FG000|Overall Study|No Birth Control|0|||
156529590|NCT00504881|565032710|FG001|Overall Study|No Birth Control|1|||
156529591|NCT00504881|565032709|FG000|Overall Study|Safety Visit not performed|0|||
156529592|NCT00504881|565032710|FG001|Overall Study|Safety Visit not performed|1|||
156529593|NCT00504881|565032709|FG000|Overall Study|AE, serious fatal|0|||
156529594|NCT00504881|565032710|FG001|Overall Study|AE, serious fatal|1|||
156529595|NCT00504881|565032709|FG000|Overall Study|SAE, non-fatal|2|||
156529596|NCT00504881|565032710|FG001|Overall Study|SAE, non-fatal|6|||
156529597|NCT00504881|565032709|FG000|Overall Study|AE, non-serious non-fatal|4|||
156529598|NCT00504881|565032710|FG001|Overall Study|AE, non-serious non-fatal|14|||
156529599|NCT00504881|565032709|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156529600|NCT00504881|565032710|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
156529601|NCT00504881|565032709|FG000|Overall Study|AE of unknown type|1|||
156529602|NCT00504881|565032710|FG001|Overall Study|AE of unknown type|0|||
156529603|NCT01777269|565032711|FG000|Overall Study|Adverse Event|24|||
156529604|NCT01777269|565032712|FG001|Overall Study|Adverse Event|33|||
156529605|NCT01777269|565032711|FG000|Overall Study|Lack of Efficacy|8|||
156529606|NCT01777269|565032712|FG001|Overall Study|Lack of Efficacy|10|||
156529607|NCT01777269|565032711|FG000|Overall Study|Protocol Violation|4|||
156529608|NCT01777269|565032712|FG001|Overall Study|Protocol Violation|4|||
156529609|NCT01777269|565032711|FG000|Overall Study|Participants reached stopping criteria|1|||
156529610|NCT01777269|565032712|FG001|Overall Study|Participants reached stopping criteria|1|||
156529611|NCT01777269|565032711|FG000|Overall Study|Lost to Follow-up|4|||
156529612|NCT01777269|565032712|FG001|Overall Study|Lost to Follow-up|0|||
156529613|NCT01777269|565032711|FG000|Overall Study|Physician Decision|5|||
156529614|NCT01777269|565032712|FG001|Overall Study|Physician Decision|2|||
156529615|NCT01777269|565032711|FG000|Overall Study|Withdrawal by Subject|9|||
156529616|NCT01777269|565032712|FG001|Overall Study|Withdrawal by Subject|9|||
156529617|NCT00753272|565032720|FG000|Overall Study|Adverse Event|878|||
156529618|NCT00753272|565032721|FG001|Overall Study|Adverse Event|869|||
156529619|NCT00753272|565032720|FG000|Overall Study|Protocol Violation|28|||
156529620|NCT00753272|565032721|FG001|Overall Study|Protocol Violation|46|||
156529621|NCT00753272|565032720|FG000|Overall Study|Withdrawal by Subject|2481|||
156529622|NCT00753272|565032721|FG001|Overall Study|Withdrawal by Subject|2407|||
156529623|NCT00753272|565032720|FG000|Overall Study|Lost to Follow-up|491|||
156529624|NCT00753272|565032721|FG001|Overall Study|Lost to Follow-up|497|||
156529625|NCT00753272|565032720|FG000|Overall Study|Other|1104|||
156529626|NCT00753272|565032721|FG001|Overall Study|Other|1088|||
156529627|NCT01193920|565032722|FG000|Overall Study|Withdrawal by Subject|1|||
156529628|NCT01193920|565032723|FG001|Overall Study|Withdrawal by Subject|0|||
156529629|NCT01193920|565032724|FG002|Overall Study|Withdrawal by Subject|5|||
156529630|NCT01193920|565032725|FG003|Overall Study|Withdrawal by Subject|1|||
156529631|NCT01193920|565032726|FG004|Overall Study|Withdrawal by Subject|3|||
156529632|NCT01193920|565032727|FG005|Overall Study|Withdrawal by Subject|1|||
156529633|NCT01193920|565032728|FG006|Overall Study|Withdrawal by Subject|3|||
156529634|NCT01193920|565032729|FG007|Overall Study|Withdrawal by Subject|0|||
156529635|NCT01193920|565032730|FG008|Overall Study|Withdrawal by Subject|1|||
156529636|NCT01193920|565032731|FG009|Overall Study|Withdrawal by Subject|0|||
156529637|NCT01193920|565032722|FG000|Overall Study|Lost to Follow-up|1|||
156784508|NCT04124965|565961243|FG001|Overall Study|Physician Decision|1|||
156784509|NCT00002874|565961244|FG000|Overall Study|Withdrawal by Subject|1|||
156529638|NCT01193920|565032723|FG001|Overall Study|Lost to Follow-up|0|||
156529639|NCT01193920|565032724|FG002|Overall Study|Lost to Follow-up|1|||
156529640|NCT01193920|565032725|FG003|Overall Study|Lost to Follow-up|1|||
156529641|NCT01193920|565032726|FG004|Overall Study|Lost to Follow-up|3|||
156529642|NCT01193920|565032727|FG005|Overall Study|Lost to Follow-up|3|||
156529643|NCT01193920|565032728|FG006|Overall Study|Lost to Follow-up|1|||
156529644|NCT01193920|565032729|FG007|Overall Study|Lost to Follow-up|0|||
156529645|NCT01193920|565032730|FG008|Overall Study|Lost to Follow-up|2|||
156529646|NCT01193920|565032731|FG009|Overall Study|Lost to Follow-up|3|||
156529647|NCT01193920|565032722|FG000|Overall Study|Protocol Violation|1|||
156529648|NCT01193920|565032723|FG001|Overall Study|Protocol Violation|0|||
156529649|NCT01193920|565032724|FG002|Overall Study|Protocol Violation|0|||
156529650|NCT01193920|565032725|FG003|Overall Study|Protocol Violation|0|||
156529651|NCT01193920|565032726|FG004|Overall Study|Protocol Violation|0|||
156529652|NCT01193920|565032727|FG005|Overall Study|Protocol Violation|0|||
156683219|NCT01628549|565584904|FG003|Overall Study|withdrawn for noncompliance|0|||
156683220|NCT01628549|565584901|FG000|Overall Study|abnormal laboratory test results|0|||
156683221|NCT01628549|565584902|FG001|Overall Study|abnormal laboratory test results|0|||
156683222|NCT01628549|565584903|FG002|Overall Study|abnormal laboratory test results|1|||
156683223|NCT01628549|565584904|FG003|Overall Study|abnormal laboratory test results|0|||
156683224|NCT01628549|565584901|FG000|Overall Study|positive pregnancy test|0|||
156683225|NCT01628549|565584902|FG001|Overall Study|positive pregnancy test|0|||
156683226|NCT01628549|565584903|FG002|Overall Study|positive pregnancy test|0|||
156683227|NCT01628549|565584904|FG003|Overall Study|positive pregnancy test|1|||
156683228|NCT00177164|565584912|FG000|Overall Study|Protocol Violation|0|||
156683229|NCT00177164|565584913|FG001|Overall Study|Protocol Violation|7|||
156683230|NCT00177164|565584912|FG000|Overall Study|Lost to Follow-up|4|||
156683231|NCT00177164|565584913|FG001|Overall Study|Lost to Follow-up|5|||
156683232|NCT00177164|565584912|FG000|Overall Study|increase in alcohol and drug use|1|||
156683233|NCT00177164|565584913|FG001|Overall Study|increase in alcohol and drug use|2|||
156683234|NCT00177164|565584912|FG000|Overall Study|Adverse Event|1|||
156683235|NCT00177164|565584913|FG001|Overall Study|Adverse Event|0|||
156683236|NCT00177164|565584912|FG000|Overall Study|discharge from hospital|1|||
156683237|NCT00177164|565584913|FG001|Overall Study|discharge from hospital|0|||
156683238|NCT00177164|565584912|FG000|Overall Study|Lack of Efficacy|2|||
156683239|NCT00177164|565584913|FG001|Overall Study|Lack of Efficacy|1|||
156683240|NCT00177164|565584912|FG000|Overall Study|Pregnancy|0|||
156683241|NCT00177164|565584913|FG001|Overall Study|Pregnancy|1|||
156683242|NCT00965757|565584916|FG000|Double-blind Phase|Progression of concomitant disease|1|||
156683243|NCT00965757|565584917|FG001|Double-blind Phase|Progression of concomitant disease|2|||
156683244|NCT00965757|565584918|FG002|Double-blind Phase|Progression of concomitant disease|0|||
156683245|NCT00965757|565584919|FG003|Double-blind Phase|Progression of concomitant disease|0|||
156683246|NCT00965757|565584916|FG000|Double-blind Phase|Adverse drug reaction|2|||
156683247|NCT00965757|565584917|FG001|Double-blind Phase|Adverse drug reaction|1|||
156683248|NCT00965757|565584918|FG002|Double-blind Phase|Adverse drug reaction|0|||
156683249|NCT00965757|565584919|FG003|Double-blind Phase|Adverse drug reaction|0|||
156683250|NCT00965757|565584916|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
156683251|NCT00965757|565584917|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
156683252|NCT00965757|565584918|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
156683253|NCT00965757|565584919|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
156683254|NCT00965757|565584916|FG000|Double-blind Phase|Lack of Efficacy|7|||
156683255|NCT00965757|565584917|FG001|Double-blind Phase|Lack of Efficacy|11|||
156683256|NCT00965757|565584918|FG002|Double-blind Phase|Lack of Efficacy|0|||
156683257|NCT00965757|565584919|FG003|Double-blind Phase|Lack of Efficacy|0|||
156683258|NCT00965757|565584916|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
156683259|NCT00965757|565584917|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
156683260|NCT00965757|565584918|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
156683261|NCT00965757|565584919|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
156683262|NCT00965757|565584916|FG000|Double-blind Phase|Lost to Follow-up|0|||
156683263|NCT00965757|565584917|FG001|Double-blind Phase|Lost to Follow-up|1|||
156683264|NCT00965757|565584918|FG002|Double-blind Phase|Lost to Follow-up|0|||
156683265|NCT00965757|565584919|FG003|Double-blind Phase|Lost to Follow-up|0|||
156683266|NCT00965757|565584916|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
156683267|NCT00965757|565584917|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
156683268|NCT00965757|565584918|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
156683269|NCT00965757|565584919|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
156683270|NCT00965757|565584916|FG000|Double-blind Phase|Other|1|||
156683271|NCT00965757|565584917|FG001|Double-blind Phase|Other|0|||
156683272|NCT00965757|565584918|FG002|Double-blind Phase|Other|0|||
156683273|NCT00965757|565584919|FG003|Double-blind Phase|Other|0|||
156683274|NCT00965757|565584916|FG000|Extension Phase|Progression of concomitant disease|0|||
156683275|NCT00965757|565584917|FG001|Extension Phase|Progression of concomitant disease|0|||
156683276|NCT00965757|565584918|FG002|Extension Phase|Progression of concomitant disease|4|||
156683277|NCT00965757|565584919|FG003|Extension Phase|Progression of concomitant disease|2|||
156683278|NCT00965757|565584916|FG000|Extension Phase|Adverse drug reaction|0|||
156683279|NCT00965757|565584917|FG001|Extension Phase|Adverse drug reaction|0|||
156683280|NCT00965757|565584918|FG002|Extension Phase|Adverse drug reaction|6|||
156683281|NCT00965757|565584919|FG003|Extension Phase|Adverse drug reaction|3|||
156683282|NCT00965757|565584916|FG000|Extension Phase|Abnormal Laboratory Value|0|||
156683283|NCT00965757|565584917|FG001|Extension Phase|Abnormal Laboratory Value|0|||
156683284|NCT00965757|565584918|FG002|Extension Phase|Abnormal Laboratory Value|6|||
156683285|NCT00965757|565584919|FG003|Extension Phase|Abnormal Laboratory Value|1|||
156683286|NCT00965757|565584916|FG000|Extension Phase|Lack of Efficacy|0|||
156683287|NCT00965757|565584917|FG001|Extension Phase|Lack of Efficacy|0|||
156683288|NCT00965757|565584918|FG002|Extension Phase|Lack of Efficacy|8|||
156784510|NCT00002874|565961245|FG001|Overall Study|Withdrawal by Subject|1|||
156784511|NCT00002874|565961244|FG000|Overall Study|Protocol Violation|44|||
156683289|NCT00965757|565584919|FG003|Extension Phase|Lack of Efficacy|12|||
156683290|NCT00965757|565584916|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
156683291|NCT00965757|565584917|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
156683292|NCT00965757|565584918|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
156683293|NCT00965757|565584919|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
156683294|NCT00965757|565584916|FG000|Extension Phase|Lost to Follow-up|0|||
156683295|NCT00965757|565584917|FG001|Extension Phase|Lost to Follow-up|0|||
156683296|NCT00965757|565584918|FG002|Extension Phase|Lost to Follow-up|0|||
156683297|NCT00965757|565584919|FG003|Extension Phase|Lost to Follow-up|1|||
156683298|NCT00965757|565584916|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
156683299|NCT00965757|565584917|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
156683300|NCT00965757|565584918|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
156683301|NCT00965757|565584919|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
156683302|NCT00965757|565584916|FG000|Extension Phase|Protocol Violation|0|||
156683303|NCT00965757|565584917|FG001|Extension Phase|Protocol Violation|0|||
156683304|NCT00965757|565584918|FG002|Extension Phase|Protocol Violation|0|||
156683305|NCT00965757|565584919|FG003|Extension Phase|Protocol Violation|1|||
156683306|NCT00965757|565584916|FG000|Extension Phase|Other|0|||
156683307|NCT00965757|565584917|FG001|Extension Phase|Other|0|||
156683308|NCT00965757|565584918|FG002|Extension Phase|Other|2|||
156683309|NCT00965757|565584919|FG003|Extension Phase|Other|1|||
156683310|NCT03807440|565584920|FG000|Overall Study|No documentation of index date 2|320|||
156683311|NCT03807440|565584920|FG000|Overall Study|No informed consent for index date 2|117|||
156683312|NCT02451358|565584921|FG000|Overall Study|Withdrawal by Subject|1|||
156683313|NCT02451358|565584922|FG001|Overall Study|Withdrawal by Subject|1|||
156683314|NCT02451358|565584923|FG002|Overall Study|Withdrawal by Subject|0|||
156683315|NCT02451358|565584924|FG003|Overall Study|Withdrawal by Subject|0|||
156683316|NCT02451358|565584921|FG000|Overall Study|Protocol Violation|0|||
156683317|NCT02451358|565584922|FG001|Overall Study|Protocol Violation|1|||
156683318|NCT02451358|565584923|FG002|Overall Study|Protocol Violation|1|||
156683319|NCT02451358|565584924|FG003|Overall Study|Protocol Violation|0|||
156683320|NCT01344018|565584932|FG000|Overall Study|Death|22|||
156683321|NCT01344018|565584933|FG001|Overall Study|Death|25|||
156683322|NCT01344018|565584932|FG000|Overall Study|Lost to Follow-up|4|||
156683323|NCT01344018|565584933|FG001|Overall Study|Lost to Follow-up|7|||
156683324|NCT01332968|565584935|FG000|Induction Period|Adverse Event|23|||
156683325|NCT01332968|565584936|FG001|Induction Period|Adverse Event|26|||
156683326|NCT01332968|565584937|FG002|Induction Period|Adverse Event|0|||
156683327|NCT01332968|565584938|FG003|Induction Period|Adverse Event|0|||
156683328|NCT01332968|565584939|FG004|Induction Period|Adverse Event|0|||
156683329|NCT01332968|565584940|FG005|Induction Period|Adverse Event|0|||
156683330|NCT01332968|565584941|FG006|Induction Period|Adverse Event|0|||
156683331|NCT01332968|565584942|FG007|Induction Period|Adverse Event|0|||
156683332|NCT01332968|565584935|FG000|Induction Period|Death|1|||
156683333|NCT01332968|565584936|FG001|Induction Period|Death|4|||
156683334|NCT01332968|565584937|FG002|Induction Period|Death|0|||
156683335|NCT01332968|565584938|FG003|Induction Period|Death|0|||
156683336|NCT01332968|565584939|FG004|Induction Period|Death|0|||
156683337|NCT01332968|565584940|FG005|Induction Period|Death|0|||
156683338|NCT01332968|565584941|FG006|Induction Period|Death|0|||
156683339|NCT01332968|565584942|FG007|Induction Period|Death|0|||
156683340|NCT01332968|565584935|FG000|Induction Period|Non-compliance|1|||
156683341|NCT01332968|565584936|FG001|Induction Period|Non-compliance|0|||
156683342|NCT01332968|565584937|FG002|Induction Period|Non-compliance|0|||
156683343|NCT01332968|565584938|FG003|Induction Period|Non-compliance|0|||
156683344|NCT01332968|565584939|FG004|Induction Period|Non-compliance|0|||
156683345|NCT01332968|565584940|FG005|Induction Period|Non-compliance|0|||
156683346|NCT01332968|565584941|FG006|Induction Period|Non-compliance|0|||
156683347|NCT01332968|565584942|FG007|Induction Period|Non-compliance|0|||
156683348|NCT01332968|565584935|FG000|Induction Period|Other|2|||
156683349|NCT01332968|565584936|FG001|Induction Period|Other|2|||
156683350|NCT01332968|565584937|FG002|Induction Period|Other|0|||
156683351|NCT01332968|565584938|FG003|Induction Period|Other|0|||
156683352|NCT01332968|565584939|FG004|Induction Period|Other|0|||
156683353|NCT01332968|565584940|FG005|Induction Period|Other|0|||
156784512|NCT00002874|565961245|FG001|Overall Study|Protocol Violation|34|||
156784513|NCT01214720|565961248|FG000|Overall Study|Alive and still on treatment|34|||
156784514|NCT01214720|565961249|FG001|Overall Study|Alive and still on treatment|18|||
156784515|NCT01214720|565961248|FG000|Overall Study|Alive and in follow-up|45|||
156683354|NCT01332968|565584941|FG006|Induction Period|Other|0|||
156683355|NCT01332968|565584942|FG007|Induction Period|Other|0|||
156683356|NCT01332968|565584935|FG000|Induction Period|Physician Decision|6|||
156683357|NCT01332968|565584936|FG001|Induction Period|Physician Decision|1|||
156683358|NCT01332968|565584937|FG002|Induction Period|Physician Decision|0|||
156683359|NCT01332968|565584938|FG003|Induction Period|Physician Decision|0|||
156683360|NCT01332968|565584939|FG004|Induction Period|Physician Decision|0|||
156683361|NCT01332968|565584940|FG005|Induction Period|Physician Decision|0|||
156683362|NCT01332968|565584941|FG006|Induction Period|Physician Decision|0|||
156683363|NCT01332968|565584942|FG007|Induction Period|Physician Decision|0|||
156683364|NCT01332968|565584935|FG000|Induction Period|Progressive Disease|15|||
156683365|NCT01332968|565584936|FG001|Induction Period|Progressive Disease|7|||
156683366|NCT01332968|565584937|FG002|Induction Period|Progressive Disease|0|||
156683367|NCT01332968|565584938|FG003|Induction Period|Progressive Disease|0|||
156683368|NCT01332968|565584939|FG004|Induction Period|Progressive Disease|0|||
156683369|NCT01332968|565584940|FG005|Induction Period|Progressive Disease|0|||
156683370|NCT01332968|565584941|FG006|Induction Period|Progressive Disease|0|||
156683371|NCT01332968|565584942|FG007|Induction Period|Progressive Disease|0|||
156683372|NCT01332968|565584935|FG000|Induction Period|Protocol Violation|3|||
156683373|NCT01332968|565584936|FG001|Induction Period|Protocol Violation|4|||
156683374|NCT01332968|565584937|FG002|Induction Period|Protocol Violation|0|||
156683375|NCT01332968|565584938|FG003|Induction Period|Protocol Violation|0|||
156683376|NCT01332968|565584939|FG004|Induction Period|Protocol Violation|0|||
156683377|NCT01332968|565584940|FG005|Induction Period|Protocol Violation|0|||
156683378|NCT01332968|565584941|FG006|Induction Period|Protocol Violation|0|||
156683379|NCT01332968|565584942|FG007|Induction Period|Protocol Violation|0|||
156683380|NCT01332968|565584935|FG000|Induction Period|Withdrawal by Subject|3|||
156683381|NCT01332968|565584936|FG001|Induction Period|Withdrawal by Subject|5|||
156683382|NCT01332968|565584937|FG002|Induction Period|Withdrawal by Subject|0|||
156683383|NCT01332968|565584938|FG003|Induction Period|Withdrawal by Subject|0|||
156683384|NCT01332968|565584939|FG004|Induction Period|Withdrawal by Subject|0|||
156683385|NCT01332968|565584940|FG005|Induction Period|Withdrawal by Subject|0|||
156683386|NCT01332968|565584941|FG006|Induction Period|Withdrawal by Subject|0|||
156683387|NCT01332968|565584942|FG007|Induction Period|Withdrawal by Subject|0|||
156683388|NCT01332968|565584935|FG000|Induction Period|Randomised but not treated|4|||
156683389|NCT01332968|565584936|FG001|Induction Period|Randomised but not treated|7|||
156683390|NCT01332968|565584937|FG002|Induction Period|Randomised but not treated|0|||
156683391|NCT01332968|565584938|FG003|Induction Period|Randomised but not treated|0|||
156683392|NCT01332968|565584939|FG004|Induction Period|Randomised but not treated|0|||
156683393|NCT01332968|565584940|FG005|Induction Period|Randomised but not treated|0|||
156683394|NCT01332968|565584941|FG006|Induction Period|Randomised but not treated|0|||
156683395|NCT01332968|565584942|FG007|Induction Period|Randomised but not treated|0|||
156683396|NCT01332968|565584935|FG000|Maintenance/Observation Period|Adverse Event|0|||
156683397|NCT01332968|565584936|FG001|Maintenance/Observation Period|Adverse Event|0|||
156683398|NCT01332968|565584937|FG002|Maintenance/Observation Period|Adverse Event|53|||
156683399|NCT01332968|565584938|FG003|Maintenance/Observation Period|Adverse Event|66|||
156683400|NCT01332968|565584939|FG004|Maintenance/Observation Period|Adverse Event|0|||
156683401|NCT01332968|565584940|FG005|Maintenance/Observation Period|Adverse Event|0|||
156683402|NCT01332968|565584941|FG006|Maintenance/Observation Period|Adverse Event|0|||
156683403|NCT01332968|565584942|FG007|Maintenance/Observation Period|Adverse Event|0|||
156683404|NCT01332968|565584935|FG000|Maintenance/Observation Period|Death|0|||
156683405|NCT01332968|565584936|FG001|Maintenance/Observation Period|Death|0|||
156683406|NCT01332968|565584937|FG002|Maintenance/Observation Period|Death|5|||
156683407|NCT01332968|565584938|FG003|Maintenance/Observation Period|Death|6|||
156683408|NCT01332968|565584939|FG004|Maintenance/Observation Period|Death|0|||
156683409|NCT01332968|565584940|FG005|Maintenance/Observation Period|Death|0|||
156683410|NCT01332968|565584941|FG006|Maintenance/Observation Period|Death|0|||
156683411|NCT01332968|565584942|FG007|Maintenance/Observation Period|Death|0|||
156683412|NCT01332968|565584935|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
156683413|NCT01332968|565584936|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
156683414|NCT01332968|565584937|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
156683415|NCT01332968|565584938|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
156683416|NCT01332968|565584939|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
156683417|NCT01332968|565584940|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
156683418|NCT01332968|565584941|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
156683419|NCT01332968|565584942|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
156683420|NCT01332968|565584935|FG000|Maintenance/Observation Period|Non-compliance|0|||
156683421|NCT01332968|565584936|FG001|Maintenance/Observation Period|Non-compliance|0|||
156683422|NCT01332968|565584937|FG002|Maintenance/Observation Period|Non-compliance|4|||
156683423|NCT01332968|565584938|FG003|Maintenance/Observation Period|Non-compliance|3|||
156683424|NCT01332968|565584939|FG004|Maintenance/Observation Period|Non-compliance|0|||
156683425|NCT01332968|565584940|FG005|Maintenance/Observation Period|Non-compliance|0|||
156683426|NCT01332968|565584941|FG006|Maintenance/Observation Period|Non-compliance|0|||
156683427|NCT01332968|565584942|FG007|Maintenance/Observation Period|Non-compliance|0|||
156683428|NCT01332968|565584935|FG000|Maintenance/Observation Period|Other|0|||
156683429|NCT01332968|565584936|FG001|Maintenance/Observation Period|Other|0|||
156683430|NCT01332968|565584937|FG002|Maintenance/Observation Period|Other|4|||
156529653|NCT01193920|565032728|FG006|Overall Study|Protocol Violation|0|||
156529654|NCT01193920|565032729|FG007|Overall Study|Protocol Violation|0|||
156683431|NCT01332968|565584938|FG003|Maintenance/Observation Period|Other|7|||
156683432|NCT01332968|565584939|FG004|Maintenance/Observation Period|Other|0|||
156683433|NCT01332968|565584940|FG005|Maintenance/Observation Period|Other|0|||
156683434|NCT01332968|565584941|FG006|Maintenance/Observation Period|Other|0|||
156683435|NCT01332968|565584942|FG007|Maintenance/Observation Period|Other|0|||
156683436|NCT01332968|565584935|FG000|Maintenance/Observation Period|Physician Decision|0|||
156868331|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868332|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868333|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868334|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156329668|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
156529655|NCT01193920|565032730|FG008|Overall Study|Protocol Violation|0|||
156529656|NCT01193920|565032731|FG009|Overall Study|Protocol Violation|0|||
156529657|NCT01193920|565032722|FG000|Overall Study|Death|0|||
156529658|NCT01193920|565032723|FG001|Overall Study|Death|0|||
156529659|NCT01193920|565032724|FG002|Overall Study|Death|0|||
156529660|NCT01193920|565032725|FG003|Overall Study|Death|1|||
156529661|NCT01193920|565032726|FG004|Overall Study|Death|0|||
156529662|NCT01193920|565032727|FG005|Overall Study|Death|0|||
156529663|NCT01193920|565032728|FG006|Overall Study|Death|2|||
156529664|NCT01193920|565032729|FG007|Overall Study|Death|3|||
156529665|NCT01193920|565032730|FG008|Overall Study|Death|2|||
156529666|NCT01193920|565032731|FG009|Overall Study|Death|4|||
156529667|NCT01193920|565032722|FG000|Overall Study|Unable to classify|0|||
156529668|NCT01193920|565032723|FG001|Overall Study|Unable to classify|0|||
156529669|NCT01193920|565032724|FG002|Overall Study|Unable to classify|0|||
156529670|NCT01193920|565032725|FG003|Overall Study|Unable to classify|1|||
156529671|NCT01193920|565032726|FG004|Overall Study|Unable to classify|0|||
156529672|NCT01193920|565032727|FG005|Overall Study|Unable to classify|0|||
156529673|NCT01193920|565032728|FG006|Overall Study|Unable to classify|0|||
156529674|NCT01193920|565032729|FG007|Overall Study|Unable to classify|1|||
156529675|NCT01193920|565032730|FG008|Overall Study|Unable to classify|0|||
156529676|NCT01193920|565032731|FG009|Overall Study|Unable to classify|0|||
156529677|NCT01335009|565032734|FG000|Overall Study|Too ill to travel to study sites|1|||
156529678|NCT01335009|565032735|FG001|Overall Study|Too ill to travel to study sites|0|||
156529679|NCT01335009|565032734|FG000|Overall Study|Death|28|||
156529680|NCT01335009|565032735|FG001|Overall Study|Death|32|||
156529681|NCT01335009|565032734|FG000|Overall Study|Withdrawal by Subject|1|||
156529682|NCT01335009|565032735|FG001|Overall Study|Withdrawal by Subject|1|||
156529683|NCT01335009|565032734|FG000|Overall Study|Lost to Follow-up|1|||
156529684|NCT01335009|565032735|FG001|Overall Study|Lost to Follow-up|0|||
156529685|NCT04824521|565032736|FG000|Overall Study|Lost to Follow-up|1|||
156529686|NCT01598311|565032737|FG000|Overall Study|Physician Decision|4|||
156529687|NCT01598311|565032738|FG001|Overall Study|Physician Decision|5|||
156529688|NCT01598311|565032737|FG000|Overall Study|Adverse Event|9|||
156529689|NCT01598311|565032738|FG001|Overall Study|Adverse Event|13|||
156529690|NCT01598311|565032737|FG000|Overall Study|Lost to Follow-up|7|||
156529691|NCT01598311|565032738|FG001|Overall Study|Lost to Follow-up|12|||
156529692|NCT01598311|565032737|FG000|Overall Study|Withdrawal by Subject|9|||
156529693|NCT01598311|565032738|FG001|Overall Study|Withdrawal by Subject|13|||
156529694|NCT01598311|565032737|FG000|Overall Study|No reason provided.|0|||
156529695|NCT01598311|565032738|FG001|Overall Study|No reason provided.|5|||
156529696|NCT01598311|565032737|FG000|Overall Study|Randomized but never treated|8|||
156529697|NCT01598311|565032738|FG001|Overall Study|Randomized but never treated|5|||
156529698|NCT01598311|565032737|FG000|Overall Study|Treated but no confirmed CDAD|9|||
156529699|NCT01598311|565032738|FG001|Overall Study|Treated but no confirmed CDAD|8|||
156529700|NCT01598311|565032737|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
156529701|NCT01598311|565032738|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
156529702|NCT00688103|565032739|FG000|Overall Study|Adverse Event|4|||
156529703|NCT00688103|565032740|FG001|Overall Study|Adverse Event|1|||
156529704|NCT00688103|565032739|FG000|Overall Study|Lack of Efficacy|11|||
156529705|NCT00688103|565032740|FG001|Overall Study|Lack of Efficacy|1|||
156529706|NCT00688103|565032739|FG000|Overall Study|Withdrawal by Subject|4|||
156529707|NCT00688103|565032740|FG001|Overall Study|Withdrawal by Subject|2|||
156529708|NCT00688103|565032739|FG000|Overall Study|complex reasons|11|||
156529709|NCT00688103|565032740|FG001|Overall Study|complex reasons|9|||
156529710|NCT03144804|565032741|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
156529711|NCT04223856|565032742|FG000|Overall Study|Progressive disease|153|||
156529712|NCT04223856|565032743|FG001|Overall Study|Progressive disease|73|||
156529713|NCT04223856|565032742|FG000|Overall Study|Adverse Event|97|||
156529714|NCT04223856|565032743|FG001|Overall Study|Adverse Event|62|||
156529715|NCT04223856|565032742|FG000|Overall Study|Physician Decision|9|||
156529716|NCT04223856|565032743|FG001|Overall Study|Physician Decision|28|||
156529717|NCT04223856|565032742|FG000|Overall Study|Withdrawal by Subject|22|||
156529718|NCT04223856|565032743|FG001|Overall Study|Withdrawal by Subject|24|||
156529719|NCT04223856|565032742|FG000|Overall Study|Other|7|||
156529720|NCT04223856|565032743|FG001|Overall Study|Other|2|||
156529721|NCT04223856|565032742|FG000|Overall Study|Randomized but not treated|2|||
156529722|NCT04223856|565032743|FG001|Overall Study|Randomized but not treated|11|||
156529723|NCT04223856|565032742|FG000|Overall Study|On-treatment|144|||
156529724|NCT04223856|565032743|FG001|Overall Study|On-treatment|0|||
156529725|NCT03078907|565034690|FG000|Overall Study|Adverse Event|2|||
156529726|NCT03078907|565034691|FG001|Overall Study|Adverse Event|0|||
156435761|NCT03482011|564685028|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
156435762|NCT03482011|564685021|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156435763|NCT03482011|564685022|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156435764|NCT03482011|564685023|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156683437|NCT01332968|565584936|FG001|Maintenance/Observation Period|Physician Decision|0|||
156435765|NCT03482011|564685024|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
156435766|NCT03482011|564685025|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
156435767|NCT03482011|564685026|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
156435768|NCT03482011|564685027|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
156435769|NCT03482011|564685028|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
156435770|NCT03482011|564685021|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156435771|NCT03482011|564685022|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156435772|NCT03482011|564685023|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156435773|NCT03482011|564685024|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
156435774|NCT03482011|564685025|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156435775|NCT03482011|564685026|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
156435776|NCT03482011|564685027|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
156435777|NCT03482011|564685028|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
156435778|NCT03482011|564685021|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
156435779|NCT03482011|564685022|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
156435780|NCT03482011|564685023|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
156435781|NCT03482011|564685024|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
156435782|NCT03482011|564685025|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
156435783|NCT03482011|564685026|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
156435784|NCT03482011|564685027|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
156435785|NCT03482011|564685028|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
156435786|NCT03482011|564685021|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
156435787|NCT03482011|564685022|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
156435788|NCT03482011|564685023|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
156435789|NCT03482011|564685024|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
156435790|NCT03482011|564685025|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
156435791|NCT03482011|564685026|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
156435792|NCT03482011|564685027|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
156435793|NCT03482011|564685028|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
156435794|NCT03482011|564685021|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
156435795|NCT03482011|564685022|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
156435796|NCT03482011|564685023|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
156435797|NCT03482011|564685024|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
156435798|NCT03482011|564685025|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
156435799|NCT03482011|564685026|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
156435800|NCT03482011|564685027|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
156435801|NCT03482011|564685028|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
156435802|NCT03482011|564685021|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
156435803|NCT03482011|564685022|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
156435804|NCT03482011|564685023|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
156435805|NCT03482011|564685024|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
156435806|NCT03482011|564685025|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
156435807|NCT03482011|564685026|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
156435808|NCT03482011|564685027|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
156435809|NCT03482011|564685028|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
156435810|NCT00468052|564685029|FG000|Overall Study|Protocol Violation|7|||
156435811|NCT00468052|564685030|FG001|Overall Study|Protocol Violation|8|||
156435812|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
156435813|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
156435814|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
156435815|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
156435816|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
156435817|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
156435818|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
156435819|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
156435820|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
156435821|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
156435822|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
156435823|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
156435824|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
156435825|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
156435826|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
156435827|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
156784516|NCT01214720|565961249|FG001|Overall Study|Alive and in follow-up|48|||
156784517|NCT01214720|565961248|FG000|Overall Study|Lost to Follow-up|6|||
156683438|NCT01332968|565584937|FG002|Maintenance/Observation Period|Physician Decision|14|||
156683439|NCT01332968|565584938|FG003|Maintenance/Observation Period|Physician Decision|19|||
156683440|NCT01332968|565584939|FG004|Maintenance/Observation Period|Physician Decision|0|||
156683441|NCT01332968|565584940|FG005|Maintenance/Observation Period|Physician Decision|1|||
156683442|NCT01332968|565584941|FG006|Maintenance/Observation Period|Physician Decision|0|||
156683443|NCT01332968|565584942|FG007|Maintenance/Observation Period|Physician Decision|0|||
156683444|NCT01332968|565584935|FG000|Maintenance/Observation Period|Progressive Disease|0|||
156683445|NCT01332968|565584936|FG001|Maintenance/Observation Period|Progressive Disease|0|||
156683446|NCT01332968|565584937|FG002|Maintenance/Observation Period|Progressive Disease|72|||
156683447|NCT01332968|565584938|FG003|Maintenance/Observation Period|Progressive Disease|40|||
156683448|NCT01332968|565584939|FG004|Maintenance/Observation Period|Progressive Disease|0|||
156683449|NCT01332968|565584940|FG005|Maintenance/Observation Period|Progressive Disease|0|||
156683450|NCT01332968|565584941|FG006|Maintenance/Observation Period|Progressive Disease|0|||
156683451|NCT01332968|565584942|FG007|Maintenance/Observation Period|Progressive Disease|0|||
156683452|NCT01332968|565584935|FG000|Maintenance/Observation Period|Protocol Violation|0|||
156683453|NCT01332968|565584936|FG001|Maintenance/Observation Period|Protocol Violation|0|||
156683454|NCT01332968|565584937|FG002|Maintenance/Observation Period|Protocol Violation|1|||
156683455|NCT01332968|565584938|FG003|Maintenance/Observation Period|Protocol Violation|1|||
156683456|NCT01332968|565584939|FG004|Maintenance/Observation Period|Protocol Violation|0|||
156683457|NCT01332968|565584940|FG005|Maintenance/Observation Period|Protocol Violation|0|||
156683458|NCT01332968|565584941|FG006|Maintenance/Observation Period|Protocol Violation|0|||
156683459|NCT01332968|565584942|FG007|Maintenance/Observation Period|Protocol Violation|0|||
156683460|NCT01332968|565584935|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683461|NCT01332968|565584936|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683462|NCT01332968|565584937|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
156683463|NCT01332968|565584938|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
156683464|NCT01332968|565584939|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683465|NCT01332968|565584940|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683466|NCT01332968|565584941|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683467|NCT01332968|565584942|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683468|NCT01332968|565584935|FG000|Follow-Up Period|Adverse Event|0|||
156683469|NCT01332968|565584936|FG001|Follow-Up Period|Adverse Event|0|||
156683470|NCT01332968|565584937|FG002|Follow-Up Period|Adverse Event|0|||
156683471|NCT01332968|565584938|FG003|Follow-Up Period|Adverse Event|0|||
156683472|NCT01332968|565584939|FG004|Follow-Up Period|Adverse Event|0|||
156683473|NCT01332968|565584940|FG005|Follow-Up Period|Adverse Event|0|||
156683474|NCT01332968|565584941|FG006|Follow-Up Period|Adverse Event|0|||
156683475|NCT01332968|565584942|FG007|Follow-Up Period|Adverse Event|4|||
156683476|NCT01332968|565584935|FG000|Follow-Up Period|Death|0|||
156683477|NCT01332968|565584936|FG001|Follow-Up Period|Death|0|||
156683478|NCT01332968|565584937|FG002|Follow-Up Period|Death|0|||
156784518|NCT01214720|565961249|FG001|Overall Study|Lost to Follow-up|2|||
156784519|NCT03166631|565963177|FG000|Overall Study|Progressive disease|2|||
156784520|NCT03166631|565963178|FG001|Overall Study|Progressive disease|1|||
156784521|NCT03166631|565963179|FG002|Overall Study|Progressive disease|3|||
156784522|NCT03166631|565963180|FG003|Overall Study|Progressive disease|4|||
156784523|NCT03166631|565963181|FG004|Overall Study|Progressive disease|2|||
156784524|NCT03166631|565963182|FG005|Overall Study|Progressive disease|2|||
156784525|NCT03166631|565963183|FG006|Overall Study|Progressive disease|5|||
156784526|NCT03166631|565963184|FG007|Overall Study|Progressive disease|6|||
156784527|NCT03166631|565963185|FG008|Overall Study|Progressive disease|11|||
156784528|NCT03166631|565963186|FG009|Overall Study|Progressive disease|5|||
156784529|NCT03166631|565963187|FG010|Overall Study|Progressive disease|7|||
156784530|NCT03166631|565963177|FG000|Overall Study|Physician Decision|0|||
156784531|NCT03166631|565963178|FG001|Overall Study|Physician Decision|0|||
156784532|NCT03166631|565963179|FG002|Overall Study|Physician Decision|0|||
156784533|NCT03166631|565963180|FG003|Overall Study|Physician Decision|0|||
156784534|NCT03166631|565963181|FG004|Overall Study|Physician Decision|0|||
156784535|NCT03166631|565963182|FG005|Overall Study|Physician Decision|0|||
156784536|NCT03166631|565963183|FG006|Overall Study|Physician Decision|1|||
156784537|NCT03166631|565963184|FG007|Overall Study|Physician Decision|0|||
156784538|NCT03166631|565963185|FG008|Overall Study|Physician Decision|1|||
156784539|NCT03166631|565963186|FG009|Overall Study|Physician Decision|0|||
156868335|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156784540|NCT03166631|565963187|FG010|Overall Study|Physician Decision|1|||
156868336|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868337|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156683479|NCT01332968|565584938|FG003|Follow-Up Period|Death|0|||
156683480|NCT01332968|565584939|FG004|Follow-Up Period|Death|0|||
156683481|NCT01332968|565584940|FG005|Follow-Up Period|Death|0|||
156683482|NCT01332968|565584941|FG006|Follow-Up Period|Death|27|||
156784541|NCT03166631|565963177|FG000|Overall Study|Death|0|||
156784542|NCT03166631|565963178|FG001|Overall Study|Death|0|||
156784543|NCT03166631|565963179|FG002|Overall Study|Death|0|||
156784544|NCT03166631|565963180|FG003|Overall Study|Death|0|||
156784545|NCT03166631|565963181|FG004|Overall Study|Death|1|||
156784546|NCT03166631|565963182|FG005|Overall Study|Death|0|||
156784547|NCT03166631|565963183|FG006|Overall Study|Death|1|||
156784548|NCT03166631|565963184|FG007|Overall Study|Death|0|||
156784549|NCT03166631|565963185|FG008|Overall Study|Death|0|||
156784550|NCT03166631|565963186|FG009|Overall Study|Death|0|||
156784551|NCT03166631|565963187|FG010|Overall Study|Death|0|||
156784552|NCT03166631|565963177|FG000|Overall Study|Adverse Event|1|||
156784553|NCT03166631|565963178|FG001|Overall Study|Adverse Event|0|||
156784554|NCT03166631|565963179|FG002|Overall Study|Adverse Event|0|||
156784555|NCT03166631|565963180|FG003|Overall Study|Adverse Event|0|||
156784556|NCT03166631|565963181|FG004|Overall Study|Adverse Event|0|||
156784557|NCT03166631|565963182|FG005|Overall Study|Adverse Event|1|||
156784558|NCT03166631|565963183|FG006|Overall Study|Adverse Event|1|||
156784559|NCT03166631|565963184|FG007|Overall Study|Adverse Event|0|||
156784560|NCT03166631|565963185|FG008|Overall Study|Adverse Event|1|||
156784561|NCT03166631|565963186|FG009|Overall Study|Adverse Event|2|||
156784562|NCT03166631|565963187|FG010|Overall Study|Adverse Event|1|||
156784563|NCT03166631|565963177|FG000|Overall Study|Withdrawal by Subject|0|||
156784564|NCT03166631|565963178|FG001|Overall Study|Withdrawal by Subject|0|||
156784565|NCT03166631|565963179|FG002|Overall Study|Withdrawal by Subject|0|||
156784566|NCT03166631|565963180|FG003|Overall Study|Withdrawal by Subject|0|||
156784567|NCT03166631|565963181|FG004|Overall Study|Withdrawal by Subject|0|||
156784568|NCT03166631|565963182|FG005|Overall Study|Withdrawal by Subject|0|||
156784569|NCT03166631|565963183|FG006|Overall Study|Withdrawal by Subject|0|||
156784570|NCT03166631|565963184|FG007|Overall Study|Withdrawal by Subject|0|||
156784571|NCT03166631|565963185|FG008|Overall Study|Withdrawal by Subject|1|||
156784572|NCT03166631|565963186|FG009|Overall Study|Withdrawal by Subject|1|||
156529727|NCT03078907|565034690|FG000|Overall Study|Other|1|||
156529728|NCT03078907|565034691|FG001|Overall Study|Other|0|||
156529729|NCT03078907|565034690|FG000|Overall Study|Protocol Violation|0|||
156529730|NCT03078907|565034691|FG001|Overall Study|Protocol Violation|1|||
156529731|NCT01955122|565034692|FG000|Overall Study|Physician Decision|5|||
156529732|NCT01955122|565034693|FG001|Overall Study|Physician Decision|5|||
156784573|NCT03166631|565963187|FG010|Overall Study|Withdrawal by Subject|0|||
156784574|NCT02370394|565963197|FG000|Overall Study|Lost to Follow-up|2|||
156784575|NCT02370394|565963198|FG001|Overall Study|Lost to Follow-up|1|||
156784576|NCT02370394|565963197|FG000|Overall Study|Withdrawal by Subject|0|||
156784577|NCT02370394|565963198|FG001|Overall Study|Withdrawal by Subject|1|||
156784578|NCT01108796|565963201|FG000|Overall Study|Adverse Event|0|||
156784579|NCT01108796|565963202|FG001|Overall Study|Adverse Event|1|||
156329669|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156329670|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156329671|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156329672|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156529733|NCT01672788|565034694|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
156529734|NCT01672788|565034695|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
156529735|NCT01672788|565034696|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
156529736|NCT01672788|565034697|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
156529737|NCT03329196|565034700|FG000|Overall Study|Adverse Event|10|||
156529738|NCT03329196|565034701|FG001|Overall Study|Adverse Event|5|||
156529739|NCT03329196|565034700|FG000|Overall Study|Physician Decision|2|||
156529740|NCT03329196|565034701|FG001|Overall Study|Physician Decision|2|||
156529741|NCT03329196|565034700|FG000|Overall Study|Withdrawal by Subject|11|||
156529742|NCT03329196|565034701|FG001|Overall Study|Withdrawal by Subject|3|||
156529743|NCT03329196|565034700|FG000|Overall Study|Hepatic function abnormalities|0|||
156529744|NCT03329196|565034701|FG001|Overall Study|Hepatic function abnormalities|1|||
156529745|NCT03329196|565034700|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
156784580|NCT01108796|565963201|FG000|Overall Study|Lost to Follow-up|7|||
156784581|NCT01108796|565963202|FG001|Overall Study|Lost to Follow-up|6|||
156329673|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156329674|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156529746|NCT03329196|565034701|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
156529747|NCT03329196|565034700|FG000|Overall Study|Difficult to control Hb|2|||
156529748|NCT03329196|565034701|FG001|Overall Study|Difficult to control Hb|3|||
156529749|NCT03329196|565034700|FG000|Overall Study|Dialysis or renal transplant|13|||
156529750|NCT03329196|565034701|FG001|Overall Study|Dialysis or renal transplant|15|||
156784582|NCT00758043|565963203|FG000|Overall Study|Adverse Event|1|||
156784583|NCT00758043|565963204|FG001|Overall Study|Adverse Event|20|||
156784584|NCT00758043|565963205|FG002|Overall Study|Adverse Event|12|||
156784585|NCT00758043|565963206|FG003|Overall Study|Adverse Event|62|||
156784586|NCT00758043|565963203|FG000|Overall Study|Lack of Efficacy|0|||
156784587|NCT00758043|565963204|FG001|Overall Study|Lack of Efficacy|6|||
156784588|NCT00758043|565963205|FG002|Overall Study|Lack of Efficacy|18|||
156683483|NCT01332968|565584942|FG007|Follow-Up Period|Death|30|||
156683484|NCT01332968|565584935|FG000|Follow-Up Period|Lost to Follow-up|0|||
156683485|NCT01332968|565584936|FG001|Follow-Up Period|Lost to Follow-up|0|||
156683486|NCT01332968|565584937|FG002|Follow-Up Period|Lost to Follow-up|0|||
156683487|NCT01332968|565584938|FG003|Follow-Up Period|Lost to Follow-up|0|||
156683488|NCT01332968|565584939|FG004|Follow-Up Period|Lost to Follow-up|0|||
156683489|NCT01332968|565584940|FG005|Follow-Up Period|Lost to Follow-up|0|||
156683490|NCT01332968|565584941|FG006|Follow-Up Period|Lost to Follow-up|11|||
156683491|NCT01332968|565584942|FG007|Follow-Up Period|Lost to Follow-up|15|||
156683492|NCT01332968|565584935|FG000|Follow-Up Period|Non-compliance|0|||
156683493|NCT01332968|565584936|FG001|Follow-Up Period|Non-compliance|0|||
156683494|NCT01332968|565584937|FG002|Follow-Up Period|Non-compliance|0|||
156784589|NCT00758043|565963206|FG003|Overall Study|Lack of Efficacy|12|||
156784590|NCT00758043|565963203|FG000|Overall Study|Refused Further Treatment|0|||
156784591|NCT00758043|565963204|FG001|Overall Study|Refused Further Treatment|11|||
156784592|NCT00758043|565963205|FG002|Overall Study|Refused Further Treatment|5|||
156784593|NCT00758043|565963206|FG003|Overall Study|Refused Further Treatment|8|||
156784594|NCT00758043|565963203|FG000|Overall Study|Lost to Follow-up|0|||
156435828|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
156435829|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
156435830|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
156435831|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
156435832|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
156435833|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
156435834|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
156435835|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
156435836|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
156435837|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
156435838|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
156435839|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
156435840|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
156435841|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
156435842|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
156435843|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
156435844|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
156435845|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
156435846|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
156435847|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
156435848|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
156435849|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
156435850|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
156435851|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
156435852|NCT02709655|564685031|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
156435853|NCT02709655|564685032|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
156435854|NCT02709655|564685033|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
156435855|NCT02709655|564685034|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
156435856|NCT02709655|564685035|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
156435857|NCT02709655|564685031|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
156435858|NCT02709655|564685032|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
156435859|NCT02709655|564685033|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
156435860|NCT02709655|564685034|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
156435861|NCT02709655|564685035|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
156435862|NCT02709655|564685031|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
156435863|NCT02709655|564685032|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
156435864|NCT02709655|564685033|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
156435865|NCT02709655|564685034|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
156435866|NCT02709655|564685035|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
156435867|NCT02709655|564685031|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
156435868|NCT02709655|564685032|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
156435869|NCT02709655|564685033|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
156435870|NCT02709655|564685034|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
156435871|NCT02709655|564685035|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
156435872|NCT02709655|564685031|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
156435873|NCT02709655|564685032|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
156435874|NCT02709655|564685033|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
156683495|NCT01332968|565584938|FG003|Follow-Up Period|Non-compliance|0|||
156683496|NCT01332968|565584939|FG004|Follow-Up Period|Non-compliance|0|||
156683497|NCT01332968|565584940|FG005|Follow-Up Period|Non-compliance|0|||
156683498|NCT01332968|565584941|FG006|Follow-Up Period|Non-compliance|4|||
156784595|NCT00758043|565963204|FG001|Overall Study|Lost to Follow-up|2|||
156683499|NCT01332968|565584942|FG007|Follow-Up Period|Non-compliance|9|||
156683500|NCT01332968|565584935|FG000|Follow-Up Period|Other|0|||
156683501|NCT01332968|565584936|FG001|Follow-Up Period|Other|0|||
156683502|NCT01332968|565584937|FG002|Follow-Up Period|Other|0|||
156683503|NCT01332968|565584938|FG003|Follow-Up Period|Other|0|||
156683504|NCT01332968|565584939|FG004|Follow-Up Period|Other|0|||
156683505|NCT01332968|565584940|FG005|Follow-Up Period|Other|0|||
156683506|NCT01332968|565584941|FG006|Follow-Up Period|Other|18|||
156683507|NCT01332968|565584942|FG007|Follow-Up Period|Other|21|||
156683508|NCT01332968|565584935|FG000|Follow-Up Period|Physician Decision|0|||
156683509|NCT01332968|565584936|FG001|Follow-Up Period|Physician Decision|0|||
156683510|NCT01332968|565584937|FG002|Follow-Up Period|Physician Decision|0|||
156683511|NCT01332968|565584938|FG003|Follow-Up Period|Physician Decision|0|||
156435875|NCT02709655|564685034|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
156683512|NCT01332968|565584939|FG004|Follow-Up Period|Physician Decision|0|||
156683513|NCT01332968|565584940|FG005|Follow-Up Period|Physician Decision|0|||
156683514|NCT01332968|565584941|FG006|Follow-Up Period|Physician Decision|12|||
156683515|NCT01332968|565584942|FG007|Follow-Up Period|Physician Decision|15|||
156683516|NCT01332968|565584935|FG000|Follow-Up Period|Progressive Disease|0|||
156683517|NCT01332968|565584936|FG001|Follow-Up Period|Progressive Disease|0|||
156683518|NCT01332968|565584937|FG002|Follow-Up Period|Progressive Disease|0|||
156683519|NCT01332968|565584938|FG003|Follow-Up Period|Progressive Disease|0|||
156683520|NCT01332968|565584939|FG004|Follow-Up Period|Progressive Disease|0|||
156683521|NCT01332968|565584940|FG005|Follow-Up Period|Progressive Disease|0|||
156683522|NCT01332968|565584941|FG006|Follow-Up Period|Progressive Disease|126|||
156683523|NCT01332968|565584942|FG007|Follow-Up Period|Progressive Disease|106|||
156683524|NCT01332968|565584935|FG000|Follow-Up Period|Protocol Violation|0|||
156683525|NCT01332968|565584936|FG001|Follow-Up Period|Protocol Violation|0|||
156683526|NCT01332968|565584937|FG002|Follow-Up Period|Protocol Violation|0|||
156683527|NCT01332968|565584938|FG003|Follow-Up Period|Protocol Violation|0|||
156683528|NCT01332968|565584939|FG004|Follow-Up Period|Protocol Violation|0|||
156683529|NCT01332968|565584940|FG005|Follow-Up Period|Protocol Violation|0|||
156683530|NCT01332968|565584941|FG006|Follow-Up Period|Protocol Violation|1|||
156683531|NCT01332968|565584942|FG007|Follow-Up Period|Protocol Violation|0|||
156683532|NCT01332968|565584935|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156683533|NCT01332968|565584936|FG001|Follow-Up Period|Withdrawal by Subject|0|||
156683534|NCT01332968|565584937|FG002|Follow-Up Period|Withdrawal by Subject|0|||
156683535|NCT01332968|565584938|FG003|Follow-Up Period|Withdrawal by Subject|0|||
156683536|NCT01332968|565584939|FG004|Follow-Up Period|Withdrawal by Subject|0|||
156683537|NCT01332968|565584940|FG005|Follow-Up Period|Withdrawal by Subject|0|||
156683538|NCT01332968|565584941|FG006|Follow-Up Period|Withdrawal by Subject|29|||
156683539|NCT01332968|565584942|FG007|Follow-Up Period|Withdrawal by Subject|32|||
156683540|NCT01332968|565584935|FG000|Follow-Up Period|No reason provided|0|||
156683541|NCT01332968|565584936|FG001|Follow-Up Period|No reason provided|0|||
156683542|NCT01332968|565584937|FG002|Follow-Up Period|No reason provided|0|||
156683543|NCT01332968|565584938|FG003|Follow-Up Period|No reason provided|0|||
156683544|NCT01332968|565584939|FG004|Follow-Up Period|No reason provided|0|||
156683545|NCT01332968|565584940|FG005|Follow-Up Period|No reason provided|0|||
156683546|NCT01332968|565584941|FG006|Follow-Up Period|No reason provided|2|||
156683547|NCT01332968|565584942|FG007|Follow-Up Period|No reason provided|3|||
156683548|NCT02351167|565584943|FG000|Overall Study|Withdrawal by Subject|19|||
156683549|NCT02351167|565584944|FG001|Overall Study|Withdrawal by Subject|18|||
156683550|NCT02351167|565584945|FG002|Overall Study|Withdrawal by Subject|21|||
156683551|NCT02914457|565584949|FG000|Overall Study|Withdrawal by Subject|1|||
156683552|NCT02914457|565584949|FG000|Overall Study|Physician Decision|1|||
156435876|NCT02709655|564685035|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
156683553|NCT02914457|565584949|FG000|Overall Study|No veins available for lead placement|1|||
156683554|NCT02914457|565584949|FG000|Overall Study|Electrical instability of patient|1|||
156683555|NCT02914457|565584949|FG000|Overall Study|ECG acquisition error due to sweating|1|||
156683556|NCT02914457|565584949|FG000|Overall Study|Protocol Violation|1|||
156683557|NCT02014441|565586998|FG000|Overall Study|Withdrawal by Subject|12|||
156683558|NCT02576717|565586999|FG000|Overall Study|Other Reasons|16|||
156683559|NCT02576717|565587000|FG001|Overall Study|Other Reasons|18|||
156683560|NCT02576717|565587001|FG002|Overall Study|Other Reasons|15|||
156683561|NCT02576717|565586999|FG000|Overall Study|Covid-19 Pandemic|0|||
156683562|NCT02576717|565587000|FG001|Overall Study|Covid-19 Pandemic|1|||
156435877|NCT02709655|564685031|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
156683563|NCT02576717|565587001|FG002|Overall Study|Covid-19 Pandemic|1|||
156683564|NCT02576717|565586999|FG000|Overall Study|Sponsor Decision|0|||
156683565|NCT02576717|565587000|FG001|Overall Study|Sponsor Decision|0|||
156683566|NCT02576717|565587001|FG002|Overall Study|Sponsor Decision|1|||
156683567|NCT02576717|565586999|FG000|Overall Study|Physician Decision|3|||
156683568|NCT02576717|565587000|FG001|Overall Study|Physician Decision|8|||
156683569|NCT02576717|565587001|FG002|Overall Study|Physician Decision|9|||
156683570|NCT02576717|565586999|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
156683571|NCT02576717|565587000|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
156784596|NCT00758043|565963205|FG002|Overall Study|Lost to Follow-up|2|||
156683572|NCT02576717|565587001|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
156683573|NCT02576717|565586999|FG000|Overall Study|Death|3|||
156683574|NCT02576717|565587000|FG001|Overall Study|Death|5|||
156683575|NCT02576717|565587001|FG002|Overall Study|Death|3|||
156683576|NCT02576717|565586999|FG000|Overall Study|Lost to Follow-up|9|||
156683577|NCT02576717|565587000|FG001|Overall Study|Lost to Follow-up|10|||
156683578|NCT02576717|565587001|FG002|Overall Study|Lost to Follow-up|19|||
156683579|NCT02576717|565586999|FG000|Overall Study|Protocol Violation|4|||
156683580|NCT02576717|565587000|FG001|Overall Study|Protocol Violation|0|||
156683581|NCT02576717|565587001|FG002|Overall Study|Protocol Violation|5|||
156683582|NCT02576717|565586999|FG000|Overall Study|Lack of Efficacy|24|||
156683583|NCT02576717|565587000|FG001|Overall Study|Lack of Efficacy|28|||
156683584|NCT02576717|565587001|FG002|Overall Study|Lack of Efficacy|20|||
156683585|NCT02576717|565586999|FG000|Overall Study|Adverse Event|26|||
156683586|NCT02576717|565587000|FG001|Overall Study|Adverse Event|32|||
156683587|NCT02576717|565587001|FG002|Overall Study|Adverse Event|26|||
156683588|NCT01363011|565587002|FG000|Main Study|Adverse Event|2|||
156683589|NCT01363011|565587003|FG001|Main Study|Adverse Event|3|||
156683590|NCT01363011|565587002|FG000|Main Study|Investigator's Discretion|1|||
156683591|NCT01363011|565587003|FG001|Main Study|Investigator's Discretion|1|||
156683592|NCT01363011|565587002|FG000|Main Study|Withdrew Consent|1|||
156683593|NCT01363011|565587003|FG001|Main Study|Withdrew Consent|4|||
156683594|NCT01363011|565587002|FG000|Main Study|Protocol Violation|0|||
156683595|NCT01363011|565587003|FG001|Main Study|Protocol Violation|1|||
156683596|NCT01363011|565587002|FG000|Extension Phase|Adverse Event|1|||
156683597|NCT01363011|565587003|FG001|Extension Phase|Adverse Event|1|||
156683598|NCT01363011|565587002|FG000|Extension Phase|Lack of Efficacy|0|||
156683599|NCT01363011|565587003|FG001|Extension Phase|Lack of Efficacy|1|||
156683600|NCT01363011|565587002|FG000|Extension Phase|Investigator's Discretion|2|||
156683601|NCT01363011|565587003|FG001|Extension Phase|Investigator's Discretion|2|||
156683602|NCT01363011|565587002|FG000|Extension Phase|Withdrew Consent|0|||
156683603|NCT01363011|565587003|FG001|Extension Phase|Withdrew Consent|1|||
156683604|NCT01363011|565587002|FG000|Extension Phase|Lost to Follow-up|0|||
156683605|NCT01363011|565587003|FG001|Extension Phase|Lost to Follow-up|2|||
156683606|NCT01363011|565587002|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
156683607|NCT01363011|565587003|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
156683608|NCT02457819|565587007|FG000|Overall Study|reason not given|8|||
156683609|NCT02457819|565587007|FG000|Overall Study|Withdrawal by Subject|24|||
156683610|NCT02457819|565587007|FG000|Overall Study|Protocol Violation|1|||
156683611|NCT02457819|565587007|FG000|Overall Study|non compliance with study drug|4|||
156683612|NCT02457819|565587007|FG000|Overall Study|Lost to Follow-up|10|||
156683613|NCT02457819|565587007|FG000|Overall Study|Lack of Efficacy|19|||
156683614|NCT02457819|565587007|FG000|Overall Study|Adverse Event|33|||
156683615|NCT03330236|565587010|FG000|Overall Study|Death|2|||
156683616|NCT03330236|565587011|FG001|Overall Study|Death|1|||
156683617|NCT03330236|565587010|FG000|Overall Study|Withdrawal by Subject|2|||
156683618|NCT03330236|565587011|FG001|Overall Study|Withdrawal by Subject|4|||
156683619|NCT03330236|565587010|FG000|Overall Study|Lost to Follow-up|0|||
156683620|NCT03330236|565587011|FG001|Overall Study|Lost to Follow-up|2|||
156683621|NCT03330236|565587010|FG000|Overall Study|Physician Decision|2|||
156683622|NCT03330236|565587011|FG001|Overall Study|Physician Decision|0|||
156683623|NCT03330236|565587010|FG000|Overall Study|Protocol Violation|4|||
156683624|NCT03330236|565587011|FG001|Overall Study|Protocol Violation|3|||
156683625|NCT03330236|565587010|FG000|Overall Study|SedLine malfunction/blinding|19|||
156683626|NCT03330236|565587011|FG001|Overall Study|SedLine malfunction/blinding|14|||
156683627|NCT03330236|565587010|FG000|Overall Study|Volatile anesthetics used|11|||
156683628|NCT03330236|565587011|FG001|Overall Study|Volatile anesthetics used|8|||
156683629|NCT03330236|565587010|FG000|Overall Study|Surgery aborted/converted to open|60|||
156683630|NCT03330236|565587011|FG001|Overall Study|Surgery aborted/converted to open|52|||
156683631|NCT01961882|565587015|FG000|Overall Study|Adverse Event|3|||
156329675|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
156329676|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156329677|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156329678|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156338245|NCT05248867|564336593|FG001|Open-label Period|Withdrawal by Subject|0|||
156683632|NCT01961882|565587016|FG001|Overall Study|Adverse Event|2|||
156683633|NCT01961882|565587015|FG000|Overall Study|Physician Decision|1|||
156683634|NCT01961882|565587016|FG001|Overall Study|Physician Decision|0|||
156683635|NCT01961882|565587015|FG000|Overall Study|Withdrawal by Subject|4|||
156683636|NCT01961882|565587016|FG001|Overall Study|Withdrawal by Subject|1|||
156683637|NCT01961882|565587015|FG000|Overall Study|Relapse of AML|39|||
156683638|NCT01961882|565587016|FG001|Overall Study|Relapse of AML|37|||
156683639|NCT01961882|565587015|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
156683640|NCT01961882|565587016|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
156683641|NCT01961882|565587015|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
156784597|NCT00758043|565963206|FG003|Overall Study|Lost to Follow-up|5|||
156683642|NCT01961882|565587016|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
156683643|NCT01901848|565587017|FG000|Randomized and Treated|Lost to Follow-up|3|||
156683644|NCT01901848|565587018|FG001|Randomized and Treated|Lost to Follow-up|6|||
156683645|NCT01901848|565587017|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
156683646|NCT01901848|565587018|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
156683647|NCT00763555|565587019|FG000|Overall Study|Adverse Event|2|||
156683648|NCT00763555|565587020|FG001|Overall Study|Adverse Event|1|||
156683649|NCT00763555|565587019|FG000|Overall Study|Withdrawal by Subject|2|||
156683650|NCT00763555|565587020|FG001|Overall Study|Withdrawal by Subject|6|||
156683651|NCT00763555|565587019|FG000|Overall Study|Lost to Follow-up|0|||
156683652|NCT00763555|565587020|FG001|Overall Study|Lost to Follow-up|3|||
156683653|NCT01729026|565587021|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
156683654|NCT01729026|565587022|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
156683655|NCT01729026|565587021|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
156683656|NCT01729026|565587022|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
156683657|NCT00407745|565587024|FG000|Overall Study|Lack of Efficacy|1|||
156683658|NCT00407745|565587025|FG001|Overall Study|Lack of Efficacy|2|||
156683659|NCT00407745|565587024|FG000|Overall Study|Withdrawal by Subject|3|||
156683660|NCT00407745|565587025|FG001|Overall Study|Withdrawal by Subject|3|||
156683661|NCT00407745|565587024|FG000|Overall Study|Protocol Violation|5|||
156683662|NCT00407745|565587025|FG001|Overall Study|Protocol Violation|3|||
156683663|NCT00407745|565587024|FG000|Overall Study|Adverse Event|8|||
156683664|NCT00407745|565587025|FG001|Overall Study|Adverse Event|8|||
156683665|NCT00407745|565587024|FG000|Overall Study|Other|2|||
156683666|NCT00407745|565587025|FG001|Overall Study|Other|0|||
156683667|NCT00407745|565587024|FG000|Overall Study|Randomized, unknown if treated|0|||
156683668|NCT00407745|565587025|FG001|Overall Study|Randomized, unknown if treated|1|||
156683669|NCT00108082|565587028|FG000|Overall Study|Adverse Event|14|||
156683670|NCT00108082|565587029|FG001|Overall Study|Adverse Event|12|||
156683671|NCT00108082|565587030|FG002|Overall Study|Adverse Event|17|||
156683672|NCT00108082|565587028|FG000|Overall Study|Lost to Follow-up|6|||
156683673|NCT00108082|565587029|FG001|Overall Study|Lost to Follow-up|3|||
156683674|NCT00108082|565587030|FG002|Overall Study|Lost to Follow-up|7|||
156683675|NCT00108082|565587028|FG000|Overall Study|Consent Withdrawn|3|||
156683676|NCT00108082|565587029|FG001|Overall Study|Consent Withdrawn|3|||
156683677|NCT00108082|565587030|FG002|Overall Study|Consent Withdrawn|5|||
156683678|NCT00108082|565587028|FG000|Overall Study|Protocol Violation|1|||
156683679|NCT00108082|565587029|FG001|Overall Study|Protocol Violation|2|||
156683680|NCT00108082|565587030|FG002|Overall Study|Protocol Violation|0|||
156683681|NCT00108082|565587028|FG000|Overall Study|Lack of Efficacy|3|||
156683682|NCT00108082|565587029|FG001|Overall Study|Lack of Efficacy|1|||
156683683|NCT00108082|565587030|FG002|Overall Study|Lack of Efficacy|2|||
156683684|NCT00108082|565587028|FG000|Overall Study|Amendment 4: > Month 12|5|||
156683685|NCT00108082|565587029|FG001|Overall Study|Amendment 4: > Month 12|7|||
156683686|NCT00108082|565587030|FG002|Overall Study|Amendment 4: > Month 12|5|||
156683687|NCT00108082|565587028|FG000|Overall Study|Woman of Child-bearing Potential|2|||
156683688|NCT00108082|565587029|FG001|Overall Study|Woman of Child-bearing Potential|0|||
156683689|NCT00108082|565587030|FG002|Overall Study|Woman of Child-bearing Potential|2|||
156683690|NCT00108082|565587028|FG000|Overall Study|Incorrectly Randomized|0|||
156683691|NCT00108082|565587029|FG001|Overall Study|Incorrectly Randomized|0|||
156683692|NCT00108082|565587030|FG002|Overall Study|Incorrectly Randomized|2|||
156683693|NCT00108082|565587028|FG000|Overall Study|Non-compliance|1|||
156683694|NCT00108082|565587029|FG001|Overall Study|Non-compliance|0|||
156683695|NCT00108082|565587030|FG002|Overall Study|Non-compliance|2|||
156683696|NCT00108082|565587028|FG000|Overall Study|Stopped Study Medication|0|||
156683697|NCT00108082|565587029|FG001|Overall Study|Stopped Study Medication|0|||
156683698|NCT00108082|565587030|FG002|Overall Study|Stopped Study Medication|1|||
156868338|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868339|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868340|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156683699|NCT00108082|565587028|FG000|Overall Study|Site Closed Study|0|||
156683700|NCT00108082|565587029|FG001|Overall Study|Site Closed Study|2|||
156683701|NCT00108082|565587030|FG002|Overall Study|Site Closed Study|0|||
156683702|NCT00108082|565587028|FG000|Overall Study|Protocol Amendment|0|||
156683703|NCT00108082|565587029|FG001|Overall Study|Protocol Amendment|1|||
156683704|NCT00108082|565587030|FG002|Overall Study|Protocol Amendment|0|||
156683705|NCT00108082|565587028|FG000|Overall Study|Study Medication Not Tapered|0|||
156683706|NCT00108082|565587029|FG001|Overall Study|Study Medication Not Tapered|1|||
156683707|NCT00108082|565587030|FG002|Overall Study|Study Medication Not Tapered|0|||
156683708|NCT00108082|565587028|FG000|Overall Study|Subject Left Site Location|1|||
156683709|NCT00108082|565587029|FG001|Overall Study|Subject Left Site Location|0|||
156683710|NCT00108082|565587030|FG002|Overall Study|Subject Left Site Location|0|||
156868341|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
156683711|NCT00108082|565587028|FG000|Overall Study|Investigator Not at Site|1|||
156683712|NCT00108082|565587029|FG001|Overall Study|Investigator Not at Site|0|||
156683713|NCT00108082|565587030|FG002|Overall Study|Investigator Not at Site|0|||
156683714|NCT00108082|565587028|FG000|Overall Study|Blood Pressure Not Controlled|1|||
156683715|NCT00108082|565587029|FG001|Overall Study|Blood Pressure Not Controlled|0|||
156683716|NCT00108082|565587030|FG002|Overall Study|Blood Pressure Not Controlled|0|||
156683717|NCT02940730|565587034|FG000|Intervention 2|Physician Decision|7|||
156683718|NCT02940730|565587035|FG001|Intervention 2|Physician Decision|0|||
156683719|NCT00298740|565587039|FG000|Overall Study|Lack of Efficacy|6|||
156683720|NCT00298740|565587039|FG000|Overall Study|Withdrawal by Subject|3|||
156683721|NCT01064531|565587040|FG000|Overall Study|Lost to Follow-up|0|||
156683722|NCT01064531|565587041|FG001|Overall Study|Lost to Follow-up|2|||
156683723|NCT01064531|565587040|FG000|Overall Study|Physician Decision|0|||
156683724|NCT01064531|565587041|FG001|Overall Study|Physician Decision|1|||
156683725|NCT01064531|565587040|FG000|Overall Study|Withdrawal by Subject|2|||
156683726|NCT01064531|565587041|FG001|Overall Study|Withdrawal by Subject|2|||
156683727|NCT01064531|565587040|FG000|Overall Study|Revision due to femoral stem loosening|1|||
156683728|NCT01064531|565587041|FG001|Overall Study|Revision due to femoral stem loosening|0|||
156683729|NCT01064531|565587040|FG000|Overall Study|Revision due to dislocation|0|||
156683730|NCT01064531|565587041|FG001|Overall Study|Revision due to dislocation|1|||
156784598|NCT00758043|565963203|FG000|Overall Study|Withdrawal by Subject|0|||
156784599|NCT00758043|565963204|FG001|Overall Study|Withdrawal by Subject|1|||
156784600|NCT00758043|565963205|FG002|Overall Study|Withdrawal by Subject|1|||
156784601|NCT00758043|565963206|FG003|Overall Study|Withdrawal by Subject|4|||
156784602|NCT00758043|565963203|FG000|Overall Study|Required Prohibited Medication|0|||
156784603|NCT00758043|565963204|FG001|Overall Study|Required Prohibited Medication|0|||
156784604|NCT00758043|565963205|FG002|Overall Study|Required Prohibited Medication|1|||
156784605|NCT00758043|565963206|FG003|Overall Study|Required Prohibited Medication|3|||
156784606|NCT00758043|565963203|FG000|Overall Study|Non-Compliant With study Drug|0|||
156784607|NCT00758043|565963204|FG001|Overall Study|Non-Compliant With study Drug|0|||
156784608|NCT00758043|565963205|FG002|Overall Study|Non-Compliant With study Drug|0|||
156784609|NCT00758043|565963206|FG003|Overall Study|Non-Compliant With study Drug|1|||
156784610|NCT00758043|565963203|FG000|Overall Study|Other Reasons|0|||
156784611|NCT00758043|565963204|FG001|Overall Study|Other Reasons|1|||
156784612|NCT00758043|565963205|FG002|Overall Study|Other Reasons|0|||
156784613|NCT00758043|565963206|FG003|Overall Study|Other Reasons|5|||
156784614|NCT02545127|565963213|FG000|Overall Study|Lost to Follow-up|1|||
156784615|NCT02545127|565963214|FG001|Overall Study|Lost to Follow-up|0|||
156784616|NCT03197935|565963215|FG000|Overall Study|Death due to any cause|26|||
156784617|NCT03197935|565963216|FG001|Overall Study|Death due to any cause|15|||
156784618|NCT03197935|565963215|FG000|Overall Study|Lost to Follow-up|3|||
156784619|NCT03197935|565963216|FG001|Overall Study|Lost to Follow-up|5|||
156784620|NCT03197935|565963215|FG000|Overall Study|Physician Decision|2|||
156784621|NCT03197935|565963216|FG001|Overall Study|Physician Decision|1|||
156784622|NCT03197935|565963215|FG000|Overall Study|Withdrawal by Subject|16|||
156784623|NCT03197935|565963216|FG001|Overall Study|Withdrawal by Subject|8|||
156784624|NCT04027946|565963217|FG000|Overall Study|Screen failures|3|||
156784625|NCT01562444|565963224|FG000|Overall Study|Did not meet entry criteria|2|||
156784626|NCT01562444|565963225|FG001|Overall Study|Did not meet entry criteria|0|||
156784627|NCT01562444|565963226|FG002|Overall Study|Did not meet entry criteria|3|||
156784628|NCT01562444|565963224|FG000|Overall Study|Did not comply with blood draw schedule|1|||
156784629|NCT01562444|565963225|FG001|Overall Study|Did not comply with blood draw schedule|0|||
156784630|NCT01562444|565963226|FG002|Overall Study|Did not comply with blood draw schedule|1|||
156784631|NCT01562444|565963224|FG000|Overall Study|Unavailable serological results|0|||
156784632|NCT01562444|565963225|FG001|Overall Study|Unavailable serological results|2|||
156784633|NCT01562444|565963226|FG002|Overall Study|Unavailable serological results|2|||
156784634|NCT01562444|565963224|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
156784635|NCT01562444|565963225|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
156784636|NCT01562444|565963226|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
156784637|NCT01562444|565963224|FG000|Overall Study|Protocol forbidden medication|1|||
156784638|NCT01562444|565963225|FG001|Overall Study|Protocol forbidden medication|0|||
156784639|NCT01562444|565963226|FG002|Overall Study|Protocol forbidden medication|0|||
156784640|NCT03794544|565963236|FG000|Overall Study|Withdrawal by Subject|1|||
156784641|NCT03794544|565963237|FG001|Overall Study|Withdrawal by Subject|1|||
156784642|NCT03794544|565963238|FG002|Overall Study|Withdrawal by Subject|0|||
156784643|NCT03794544|565963239|FG003|Overall Study|Withdrawal by Subject|0|||
156784644|NCT03794544|565963236|FG000|Overall Study|Death|0|||
156784645|NCT03794544|565963237|FG001|Overall Study|Death|0|||
156784646|NCT03794544|565963238|FG002|Overall Study|Death|0|||
156329679|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156683731|NCT01064531|565587040|FG000|Overall Study|Death|0|||
156683732|NCT01064531|565587041|FG001|Overall Study|Death|1|||
156683733|NCT03449199|565587045|FG000|Overall Study|Lost to Follow-up|1|||
156683734|NCT03449199|565587046|FG001|Overall Study|Lost to Follow-up|1|||
156683735|NCT03449199|565587047|FG002|Overall Study|Lost to Follow-up|0|||
156683736|NCT03449199|565587045|FG000|Overall Study|Protocol Deviation|0|||
156683737|NCT03449199|565587046|FG001|Overall Study|Protocol Deviation|0|||
156683738|NCT03449199|565587047|FG002|Overall Study|Protocol Deviation|1|||
156683739|NCT03449199|565587045|FG000|Overall Study|Withdrawal by Subject|0|||
156683740|NCT03449199|565587046|FG001|Overall Study|Withdrawal by Subject|0|||
156683741|NCT03449199|565587047|FG002|Overall Study|Withdrawal by Subject|1|||
156683742|NCT00684567|565587048|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
156683743|NCT00684567|565587048|FG000|Monotherapy Period|Adverse Event|2|||
156683744|NCT00684567|565587048|FG000|Monotherapy Period|Death|1|||
156683745|NCT00684567|565587048|FG000|Monotherapy Period|Progression of primary disease|11|||
156683746|NCT03136406|565587049|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
156683747|NCT01201759|565587050|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
156683748|NCT01201759|565587051|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
156683749|NCT01201759|565587050|FG000|Visit 3 - Washout|Adverse Event|0|||
156683750|NCT01201759|565587051|FG001|Visit 3 - Washout|Adverse Event|3|||
156683751|NCT01201759|565587050|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
156683752|NCT01201759|565587051|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
156683753|NCT01201759|565587050|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
156683754|NCT01201759|565587051|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
156683755|NCT00906373|565587052|FG000|Overall Study|Withdrawal by Subject|0|||
156683756|NCT00906373|565587053|FG001|Overall Study|Withdrawal by Subject|5|||
156683757|NCT00906373|565587052|FG000|Overall Study|Other|0|||
156683758|NCT00906373|565587053|FG001|Overall Study|Other|1|||
156683759|NCT00906373|565587052|FG000|Overall Study|Still on treatment at cutoff date|0|||
156683760|NCT00906373|565587053|FG001|Overall Study|Still on treatment at cutoff date|2|||
156683761|NCT00848042|565587054|FG000|Overall Study|Death|1|||
156683762|NCT00848042|565587055|FG001|Overall Study|Death|2|||
156683763|NCT00848042|565587056|FG002|Overall Study|Death|0|||
156683764|NCT00848042|565587054|FG000|Overall Study|Other Therapy|3|||
156683765|NCT00848042|565587055|FG001|Overall Study|Other Therapy|0|||
156683766|NCT00848042|565587056|FG002|Overall Study|Other Therapy|0|||
156683767|NCT02744755|565587057|FG000|Study Period 1|Protocol Violation|2|||
156683768|NCT02744755|565587058|FG001|Study Period 1|Protocol Violation|1|||
156683769|NCT02744755|565587057|FG000|Study Period 1|not defined|0|||
156683770|NCT02744755|565587058|FG001|Study Period 1|not defined|1|||
156683771|NCT02744755|565587057|FG000|Study Period 1|Pregnancy|1|||
156683772|NCT02744755|565587058|FG001|Study Period 1|Pregnancy|0|||
156683773|NCT02744755|565587057|FG000|Study Period 1|Adverse Event|1|||
156683774|NCT02744755|565587058|FG001|Study Period 1|Adverse Event|1|||
156683775|NCT02744755|565587057|FG000|Study Period 1|Lost to Follow-up|1|||
156683776|NCT02744755|565587058|FG001|Study Period 1|Lost to Follow-up|1|||
156683777|NCT02744755|565587057|FG000|Study Period 1|Lack of Efficacy|1|||
156683778|NCT02744755|565587058|FG001|Study Period 1|Lack of Efficacy|0|||
156683779|NCT02744755|565587057|FG000|Study Period 1|Withdrawal by Subject|8|||
156683780|NCT02744755|565587058|FG001|Study Period 1|Withdrawal by Subject|4|||
156683781|NCT02744755|565587057|FG000|Study Period 2|Adverse Event|5|||
156683782|NCT02744755|565587058|FG001|Study Period 2|Adverse Event|0|||
156683783|NCT02744755|565587057|FG000|Study Period 2|Protocol Violation|1|||
156683784|NCT02744755|565587058|FG001|Study Period 2|Protocol Violation|0|||
156868342|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868343|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868344|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868345|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868346|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868347|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868348|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868349|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868350|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868351|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868352|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868353|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868354|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868355|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
156868356|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156435878|NCT02709655|564685032|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
156435879|NCT02709655|564685033|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
156683785|NCT02744755|565587057|FG000|Study Period 2|not defined|3|||
156683786|NCT02744755|565587058|FG001|Study Period 2|not defined|2|||
156683787|NCT02744755|565587057|FG000|Study Period 2|Lost to Follow-up|0|||
156683788|NCT02744755|565587058|FG001|Study Period 2|Lost to Follow-up|2|||
156683789|NCT02744755|565587057|FG000|Study Period 2|Withdrawal by Subject|2|||
156683790|NCT02744755|565587058|FG001|Study Period 2|Withdrawal by Subject|2|||
156683791|NCT02744755|565587057|FG000|Study Period 2|Lack of Efficacy|3|||
156683792|NCT02744755|565587058|FG001|Study Period 2|Lack of Efficacy|2|||
156683795|NCT00112294|565587060|FG000|Overall Study|Still on study|5|||
156683796|NCT00112294|565587061|FG001|Overall Study|Still on study|0|||
156683797|NCT03843125|565587064|FG000|Overall Study|Adverse Event|17|||
156683798|NCT03843125|565587065|FG001|Overall Study|Adverse Event|13|||
156683799|NCT03843125|565587066|FG002|Overall Study|Adverse Event|5|||
156683800|NCT03843125|565587067|FG003|Overall Study|Adverse Event|9|||
156683801|NCT03843125|565587064|FG000|Overall Study|Death|0|||
156683802|NCT03843125|565587065|FG001|Overall Study|Death|6|||
156683803|NCT03843125|565587066|FG002|Overall Study|Death|2|||
156683804|NCT03843125|565587067|FG003|Overall Study|Death|0|||
156683805|NCT03843125|565587064|FG000|Overall Study|Lack of Efficacy|14|||
156683806|NCT03843125|565587065|FG001|Overall Study|Lack of Efficacy|11|||
156683807|NCT03843125|565587066|FG002|Overall Study|Lack of Efficacy|9|||
156683808|NCT03843125|565587067|FG003|Overall Study|Lack of Efficacy|4|||
156683809|NCT03843125|565587064|FG000|Overall Study|Lost to Follow-up|3|||
156683810|NCT03843125|565587065|FG001|Overall Study|Lost to Follow-up|4|||
156683811|NCT03843125|565587066|FG002|Overall Study|Lost to Follow-up|0|||
156683812|NCT03843125|565587067|FG003|Overall Study|Lost to Follow-up|2|||
156683813|NCT03843125|565587064|FG000|Overall Study|Other|12|||
156683814|NCT03843125|565587065|FG001|Overall Study|Other|14|||
156683815|NCT03843125|565587066|FG002|Overall Study|Other|3|||
156683816|NCT03843125|565587067|FG003|Overall Study|Other|4|||
156683817|NCT03843125|565587064|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
156683818|NCT03843125|565587065|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
156683819|NCT03843125|565587066|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
156683820|NCT03843125|565587067|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
156683821|NCT03843125|565587064|FG000|Overall Study|Study Terminated by Sponsor|318|||
156683822|NCT03843125|565587065|FG001|Overall Study|Study Terminated by Sponsor|318|||
156683823|NCT03843125|565587066|FG002|Overall Study|Study Terminated by Sponsor|163|||
156683824|NCT03843125|565587067|FG003|Overall Study|Study Terminated by Sponsor|163|||
156683825|NCT03843125|565587064|FG000|Overall Study|Withdrawal by Subject|23|||
156683826|NCT03843125|565587065|FG001|Overall Study|Withdrawal by Subject|12|||
156683827|NCT03843125|565587066|FG002|Overall Study|Withdrawal by Subject|6|||
156683828|NCT03843125|565587067|FG003|Overall Study|Withdrawal by Subject|9|||
156683829|NCT03843125|565587064|FG000|Overall Study|Missing data|0|||
156683830|NCT03843125|565587065|FG001|Overall Study|Missing data|1|||
156683831|NCT03843125|565587066|FG002|Overall Study|Missing data|1|||
156683832|NCT03843125|565587067|FG003|Overall Study|Missing data|0|||
156683833|NCT00721955|565587068|FG000|Overall Study|Adverse Event|0|||
156683834|NCT00721955|565587069|FG001|Overall Study|Adverse Event|0|||
156683835|NCT00721955|565587070|FG002|Overall Study|Adverse Event|2|||
156683836|NCT01292837|565587071|FG000|Overall Study|Adverse Event|1|||
156683837|NCT01292837|565587071|FG000|Overall Study|Further treatment determined|1|||
156683838|NCT02174276|565587072|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
156683839|NCT02174276|565587073|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
156683840|NCT02174276|565587074|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
156683841|NCT02174276|565587075|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
156683842|NCT02174276|565587072|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
156683843|NCT02174276|565587073|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
156683844|NCT02174276|565587074|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
156683845|NCT02174276|565587075|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
156683846|NCT02174276|565587072|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
156683847|NCT02174276|565587073|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
156683848|NCT02174276|565587074|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
156683849|NCT02174276|565587075|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
156683850|NCT02174276|565587072|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
156683851|NCT02174276|565587073|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
156683852|NCT02174276|565587074|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
156683853|NCT02174276|565587075|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
156683854|NCT02174276|565587072|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
156683855|NCT02174276|565587073|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
156683856|NCT02174276|565587074|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
156683857|NCT02174276|565587075|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
156683858|NCT02174276|565587072|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
156868357|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156683859|NCT02174276|565587073|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
156683860|NCT02174276|565587074|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
156683861|NCT02174276|565587075|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
156683862|NCT01206439|565587078|FG000|Overall Study|subject did not meet inclusion criteria|1|||
156683863|NCT01055886|565587080|FG000|Overall Study|Withdrawal by Subject|4|||
156683864|NCT01055886|565587081|FG001|Overall Study|Withdrawal by Subject|9|||
156683865|NCT01055886|565587080|FG000|Overall Study|Lost to Follow-up|1|||
156683866|NCT01055886|565587081|FG001|Overall Study|Lost to Follow-up|1|||
156683867|NCT01055886|565587080|FG000|Overall Study|Withdrawal by PI|0|||
156683868|NCT01055886|565587081|FG001|Overall Study|Withdrawal by PI|1|||
156683869|NCT04254809|565587084|FG000|Overall Study|Lost to Follow-up|5|||
156683870|NCT04254809|565587085|FG001|Overall Study|Lost to Follow-up|10|||
156683871|NCT02972515|565587086|FG000|Overall Study|Lost to Follow-up|78|||
156683872|NCT01928615|565587087|FG000|Overall Study|Study Terminated by Sponsor|2|||
156683873|NCT00609154|565587088|FG000|Overall Study|Protocol Violation|1|||
156683874|NCT00609154|565587089|FG001|Overall Study|Protocol Violation|2|||
156683875|NCT00609154|565587088|FG000|Overall Study|Unable to establish IV access|0|||
156683876|NCT00609154|565587089|FG001|Overall Study|Unable to establish IV access|4|||
156683877|NCT00609154|565587088|FG000|Overall Study|Adverse Event|0|||
156683878|NCT00609154|565587089|FG001|Overall Study|Adverse Event|2|||
156683879|NCT04531527|565587090|FG000|Overall Study|Found to be Ineligible|3|||
156683880|NCT01077258|565587098|FG000|Overall Study|Lost to Follow-up|1390|||
156683881|NCT01077258|565587098|FG000|Overall Study|Adverse drug reaction|218|||
156683882|NCT01077258|565587098|FG000|Overall Study|Lack of Efficacy|663|||
156683883|NCT01077258|565587098|FG000|Overall Study|Clinical remission|37|||
156683884|NCT01077258|565587098|FG000|Overall Study|Other reasons|260|||
156683885|NCT00434837|565587099|FG000|Overall Study|Lost to Follow-up|20|||
156683886|NCT00434837|565587100|FG001|Overall Study|Lost to Follow-up|23|||
156683887|NCT00434837|565587101|FG002|Overall Study|Lost to Follow-up|30|||
156683888|NCT00726895|565587103|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156683889|NCT00726895|565587104|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156683890|NCT03310619|565587108|FG000|Pre-Treatment Period|Death|1|||
156683891|NCT03310619|565587109|FG001|Pre-Treatment Period|Death|0|||
156683892|NCT03310619|565587110|FG002|Pre-Treatment Period|Death|0|||
156683893|NCT03310619|565587111|FG003|Pre-Treatment Period|Death|0|||
156683894|NCT03310619|565587112|FG004|Pre-Treatment Period|Death|1|||
156683895|NCT03310619|565587113|FG005|Pre-Treatment Period|Death|0|||
156683896|NCT03310619|565587114|FG006|Pre-Treatment Period|Death|0|||
156683897|NCT03310619|565587115|FG007|Pre-Treatment Period|Death|0|||
156683898|NCT03310619|565587108|FG000|Pre-Treatment Period|Other reasons|2|||
156683899|NCT03310619|565587109|FG001|Pre-Treatment Period|Other reasons|1|||
156683900|NCT03310619|565587110|FG002|Pre-Treatment Period|Other reasons|2|||
156683901|NCT03310619|565587111|FG003|Pre-Treatment Period|Other reasons|0|||
156683902|NCT03310619|565587112|FG004|Pre-Treatment Period|Other reasons|0|||
156683903|NCT03310619|565587113|FG005|Pre-Treatment Period|Other reasons|0|||
156683904|NCT03310619|565587114|FG006|Pre-Treatment Period|Other reasons|2|||
156683905|NCT03310619|565587115|FG007|Pre-Treatment Period|Other reasons|0|||
156683906|NCT03310619|565587108|FG000|Treatment Period|Death|1|||
156683907|NCT03310619|565587109|FG001|Treatment Period|Death|2|||
156683908|NCT03310619|565587110|FG002|Treatment Period|Death|0|||
156683909|NCT03310619|565587111|FG003|Treatment Period|Death|0|||
156683910|NCT03310619|565587112|FG004|Treatment Period|Death|1|||
156683911|NCT03310619|565587113|FG005|Treatment Period|Death|0|||
156683912|NCT03310619|565587114|FG006|Treatment Period|Death|2|||
156683913|NCT03310619|565587115|FG007|Treatment Period|Death|0|||
156683914|NCT03310619|565587108|FG000|Treatment Period|Adverse Event|0|||
156683915|NCT03310619|565587109|FG001|Treatment Period|Adverse Event|1|||
156683916|NCT03310619|565587110|FG002|Treatment Period|Adverse Event|4|||
156683917|NCT03310619|565587111|FG003|Treatment Period|Adverse Event|1|||
156683918|NCT03310619|565587112|FG004|Treatment Period|Adverse Event|0|||
156683919|NCT03310619|565587113|FG005|Treatment Period|Adverse Event|0|||
156683920|NCT03310619|565587114|FG006|Treatment Period|Adverse Event|0|||
156683921|NCT03310619|565587115|FG007|Treatment Period|Adverse Event|0|||
156683922|NCT03310619|565587108|FG000|Treatment Period|Withdrawal by participant|0|||
156329680|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156683923|NCT03310619|565587109|FG001|Treatment Period|Withdrawal by participant|0|||
156683924|NCT03310619|565587110|FG002|Treatment Period|Withdrawal by participant|1|||
156683925|NCT03310619|565587111|FG003|Treatment Period|Withdrawal by participant|0|||
156683926|NCT03310619|565587112|FG004|Treatment Period|Withdrawal by participant|0|||
156683927|NCT03310619|565587113|FG005|Treatment Period|Withdrawal by participant|0|||
156683928|NCT03310619|565587114|FG006|Treatment Period|Withdrawal by participant|0|||
156683929|NCT03310619|565587115|FG007|Treatment Period|Withdrawal by participant|0|||
156683930|NCT03310619|565587108|FG000|Treatment Period|Lost to Follow-up|0|||
156683931|NCT03310619|565587109|FG001|Treatment Period|Lost to Follow-up|0|||
156329681|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156329682|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
156329683|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156683932|NCT03310619|565587110|FG002|Treatment Period|Lost to Follow-up|0|||
156683933|NCT03310619|565587111|FG003|Treatment Period|Lost to Follow-up|0|||
156683934|NCT03310619|565587112|FG004|Treatment Period|Lost to Follow-up|0|||
156683935|NCT03310619|565587113|FG005|Treatment Period|Lost to Follow-up|0|||
156683936|NCT03310619|565587114|FG006|Treatment Period|Lost to Follow-up|0|||
156683937|NCT03310619|565587115|FG007|Treatment Period|Lost to Follow-up|1|||
156683938|NCT03310619|565587108|FG000|Treatment Period|Study terminated by sponsor|0|||
156683939|NCT03310619|565587109|FG001|Treatment Period|Study terminated by sponsor|0|||
156683940|NCT03310619|565587110|FG002|Treatment Period|Study terminated by sponsor|0|||
156683941|NCT03310619|565587111|FG003|Treatment Period|Study terminated by sponsor|0|||
156683942|NCT03310619|565587112|FG004|Treatment Period|Study terminated by sponsor|0|||
156683943|NCT03310619|565587113|FG005|Treatment Period|Study terminated by sponsor|0|||
156683944|NCT03310619|565587114|FG006|Treatment Period|Study terminated by sponsor|0|||
156683945|NCT03310619|565587115|FG007|Treatment Period|Study terminated by sponsor|1|||
156683946|NCT03310619|565587108|FG000|Treatment Period|Physician Decision|0|||
156683947|NCT03310619|565587109|FG001|Treatment Period|Physician Decision|0|||
156683948|NCT03310619|565587110|FG002|Treatment Period|Physician Decision|0|||
156683949|NCT03310619|565587111|FG003|Treatment Period|Physician Decision|0|||
156683950|NCT03310619|565587112|FG004|Treatment Period|Physician Decision|3|||
156683951|NCT03310619|565587113|FG005|Treatment Period|Physician Decision|0|||
156683952|NCT03310619|565587114|FG006|Treatment Period|Physician Decision|0|||
156683953|NCT03310619|565587115|FG007|Treatment Period|Physician Decision|0|||
156683954|NCT03310619|565587108|FG000|Treatment Period|Other reasons|1|||
156683955|NCT03310619|565587109|FG001|Treatment Period|Other reasons|0|||
156683956|NCT03310619|565587110|FG002|Treatment Period|Other reasons|2|||
156683957|NCT03310619|565587111|FG003|Treatment Period|Other reasons|0|||
156683958|NCT03310619|565587112|FG004|Treatment Period|Other reasons|0|||
156683959|NCT03310619|565587113|FG005|Treatment Period|Other reasons|0|||
156683960|NCT03310619|565587114|FG006|Treatment Period|Other reasons|0|||
156683961|NCT03310619|565587115|FG007|Treatment Period|Other reasons|0|||
156683962|NCT01266603|565587118|FG000|Overall Study|Adverse Event|1|||
156683963|NCT01266603|565587118|FG000|Overall Study|Lack of Efficacy|14|||
156683964|NCT01266603|565587118|FG000|Overall Study|Withdrawal by Subject|1|||
156683965|NCT01266603|565587118|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
156683966|NCT04307849|565587119|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
156683967|NCT04307849|565587120|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
156683968|NCT04307849|565587121|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
156683969|NCT04307849|565587122|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
156683970|NCT04307849|565587123|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
156683971|NCT04307849|565587124|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
156683972|NCT04307849|565587119|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683973|NCT04307849|565587120|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683974|NCT04307849|565587121|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
156683975|NCT04307849|565587122|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683976|NCT04307849|565587123|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683977|NCT04307849|565587124|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683978|NCT04307849|565587119|FG000|Overall Study|Family member did not want them to continue|0|||
156683979|NCT04307849|565587120|FG001|Overall Study|Family member did not want them to continue|0|||
156683980|NCT04307849|565587121|FG002|Overall Study|Family member did not want them to continue|1|||
156683981|NCT04307849|565587122|FG003|Overall Study|Family member did not want them to continue|0|||
156683982|NCT04307849|565587123|FG004|Overall Study|Family member did not want them to continue|0|||
156683983|NCT04307849|565587124|FG005|Overall Study|Family member did not want them to continue|0|||
156683984|NCT04307849|565587119|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
156683985|NCT04307849|565587120|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
156683986|NCT04307849|565587121|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
156683987|NCT04307849|565587122|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
156683988|NCT04307849|565587123|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
156683989|NCT04307849|565587124|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
156683990|NCT00756717|565587125|FG000|Overall Study|Withdrawal by Subject|2|||
156683991|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
156683992|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
156529751|NCT02464228|565034702|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
156529752|NCT02464228|565034703|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
156529753|NCT02464228|565034704|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
156529754|NCT02464228|565034705|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
156529755|NCT02464228|565034702|FG000|Overall Study|Physician Decision|2|||
156529756|NCT02464228|565034703|FG001|Overall Study|Physician Decision|0|||
156529757|NCT02464228|565034704|FG002|Overall Study|Physician Decision|1|||
156529758|NCT02464228|565034705|FG003|Overall Study|Physician Decision|0|||
156529759|NCT02464228|565034702|FG000|Overall Study|Miscellaneous|1|||
156529760|NCT02464228|565034703|FG001|Overall Study|Miscellaneous|0|||
156683993|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
156683994|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
156683995|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
156683996|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
156683997|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
156784647|NCT03794544|565963239|FG003|Overall Study|Death|1|||
156529761|NCT02464228|565034704|FG002|Overall Study|Miscellaneous|1|||
156683998|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
156683999|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
156684000|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
156684001|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
156684002|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
156684003|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
156684004|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
156684005|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
156684006|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
156684007|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
156684008|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
156684009|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
156684010|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
156684011|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
156684012|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
156684013|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
156684014|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
156684015|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
156684016|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
156684017|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
156684018|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
156684019|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
156684020|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
156684021|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
156684022|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
156684023|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
156684024|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
156684025|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
156684026|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
156684027|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
156684028|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
156684029|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
156684030|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
156684031|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
156684032|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
156684033|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
156684034|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
156684035|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
156684036|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
156684037|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
156684038|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
156684039|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
156684040|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
156684041|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
156684042|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
156684043|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
156684044|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
156684045|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
156684046|NCT02762994|565587131|FG000|Overall Study|Withdrawal by Subject|0|||
156684047|NCT02762994|565587132|FG001|Overall Study|Withdrawal by Subject|1|||
156684048|NCT02762994|565587133|FG002|Overall Study|Withdrawal by Subject|2|||
156684049|NCT02762994|565587134|FG003|Overall Study|Withdrawal by Subject|0|||
156684050|NCT02762994|565587131|FG000|Overall Study|Protocol Violation|1|||
156684051|NCT02762994|565587132|FG001|Overall Study|Protocol Violation|0|||
156435880|NCT02709655|564685034|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
156435881|NCT02709655|564685035|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
156435882|NCT02709655|564685031|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
156435883|NCT02709655|564685032|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
156435884|NCT02709655|564685033|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
156435885|NCT02709655|564685034|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
156435886|NCT02709655|564685035|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
156435887|NCT02709655|564685031|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
156435888|NCT02709655|564685032|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
156435889|NCT02709655|564685033|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
156435890|NCT02709655|564685034|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
156684052|NCT02762994|565587133|FG002|Overall Study|Protocol Violation|0|||
156684053|NCT02762994|565587134|FG003|Overall Study|Protocol Violation|2|||
156684054|NCT03507686|565587145|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
156684055|NCT03507686|565587146|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
156684056|NCT03507686|565587145|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
156684057|NCT03507686|565587146|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
156684058|NCT03507686|565587145|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
156684059|NCT03507686|565587146|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
156684060|NCT03507686|565587145|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
156684061|NCT03507686|565587146|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
156684062|NCT03507686|565587145|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
156684063|NCT03507686|565587146|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
156684064|NCT03507686|565587145|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
156684065|NCT03507686|565587146|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
156684066|NCT00585312|565587147|FG000|Overall Study|Adverse Event|3|||
156684067|NCT00585312|565587148|FG001|Overall Study|Adverse Event|0|||
156684068|NCT00585312|565587147|FG000|Overall Study|Lack of Efficacy|6|||
156684069|NCT00585312|565587148|FG001|Overall Study|Lack of Efficacy|11|||
156684070|NCT00585312|565587147|FG000|Overall Study|Lost to Follow-up|1|||
156684071|NCT00585312|565587148|FG001|Overall Study|Lost to Follow-up|1|||
156684072|NCT00585312|565587147|FG000|Overall Study|Reason not specified|2|||
156684073|NCT00585312|565587148|FG001|Overall Study|Reason not specified|0|||
156684074|NCT00585312|565587147|FG000|Overall Study|Withdrawal by Subject|5|||
156684075|NCT00585312|565587148|FG001|Overall Study|Withdrawal by Subject|1|||
156684076|NCT00585312|565587147|FG000|Overall Study|Study terminated by the sponsor|34|||
156684077|NCT00585312|565587148|FG001|Overall Study|Study terminated by the sponsor|31|||
156684078|NCT02387762|565587149|FG000|Overall Study|Withdrawal by Subject|1|||
156684079|NCT02387762|565587150|FG001|Overall Study|Withdrawal by Subject|0|||
156684080|NCT04203667|565587151|FG000|Overall Study|Withdrawal by Subject|1|||
156684081|NCT04203667|565587151|FG000|Overall Study|Lost to Follow-up|1|||
156684082|NCT04203667|565587151|FG000|Overall Study|Death|1|||
156684083|NCT04203667|565587151|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
156684084|NCT01160640|565587152|FG000|Overall Study|Physician Decision|3|||
156684085|NCT01160640|565587153|FG001|Overall Study|Physician Decision|3|||
156684086|NCT01160640|565587152|FG000|Overall Study|Incarceration|1|||
156684087|NCT01160640|565587153|FG001|Overall Study|Incarceration|0|||
156684088|NCT01160640|565587152|FG000|Overall Study|Withdrawal by Subject|0|||
156684089|NCT01160640|565587153|FG001|Overall Study|Withdrawal by Subject|3|||
156684090|NCT00642811|565587155|FG000|Overall Study|Adverse Event|2|||
156684091|NCT00642811|565587156|FG001|Overall Study|Adverse Event|3|||
156684092|NCT00642811|565587157|FG002|Overall Study|Adverse Event|0|||
156684093|NCT00642811|565587158|FG003|Overall Study|Adverse Event|0|||
156684094|NCT00642811|565587159|FG004|Overall Study|Adverse Event|0|||
156684095|NCT00642811|565587160|FG005|Overall Study|Adverse Event|1|||
156329684|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156684096|NCT00642811|565587155|FG000|Overall Study|Developement of discontinuation criteria|0|||
156684097|NCT00642811|565587156|FG001|Overall Study|Developement of discontinuation criteria|0|||
156684098|NCT00642811|565587157|FG002|Overall Study|Developement of discontinuation criteria|0|||
156684099|NCT00642811|565587158|FG003|Overall Study|Developement of discontinuation criteria|0|||
156684100|NCT00642811|565587159|FG004|Overall Study|Developement of discontinuation criteria|1|||
156684101|NCT00642811|565587160|FG005|Overall Study|Developement of discontinuation criteria|0|||
156684102|NCT00642811|565587155|FG000|Overall Study|Severe Non-compliance to protocol|1|||
156684103|NCT00642811|565587156|FG001|Overall Study|Severe Non-compliance to protocol|0|||
156684104|NCT00642811|565587157|FG002|Overall Study|Severe Non-compliance to protocol|0|||
156684105|NCT00642811|565587158|FG003|Overall Study|Severe Non-compliance to protocol|0|||
156684106|NCT00642811|565587159|FG004|Overall Study|Severe Non-compliance to protocol|0|||
156329685|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156329686|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156329687|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156329688|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156329689|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
156329690|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156329691|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156338246|NCT05248867|564336594|FG002|Open-label Period|Withdrawal by Subject|3|||
156338247|NCT05248867|564336595|FG003|Open-label Period|Withdrawal by Subject|1|||
156684107|NCT00642811|565587160|FG005|Overall Study|Severe Non-compliance to protocol|0|||
156684108|NCT00642811|565587155|FG000|Overall Study|Other|0|||
156684109|NCT00642811|565587156|FG001|Overall Study|Other|1|||
156684110|NCT00642811|565587157|FG002|Overall Study|Other|0|||
156684111|NCT00642811|565587158|FG003|Overall Study|Other|1|||
156684112|NCT00642811|565587159|FG004|Overall Study|Other|0|||
156684113|NCT00642811|565587160|FG005|Overall Study|Other|0|||
156684114|NCT02614898|565587161|FG000|Overall Study|Participated until study termination|10|||
156784648|NCT03794544|565963236|FG000|Overall Study|Lost to Follow-up|0|||
156684115|NCT02614898|565587162|FG001|Overall Study|Participated until study termination|26|||
156684116|NCT02614898|565587161|FG000|Overall Study|Lost to Follow-up|0|||
156684117|NCT02614898|565587162|FG001|Overall Study|Lost to Follow-up|2|||
156684118|NCT02614898|565587161|FG000|Overall Study|Physician Decision|1|||
156684119|NCT02614898|565587162|FG001|Overall Study|Physician Decision|8|||
156684120|NCT02614898|565587161|FG000|Overall Study|Study Terminated by Sponsor|3|||
156684121|NCT02614898|565587162|FG001|Overall Study|Study Terminated by Sponsor|0|||
156684122|NCT02614898|565587161|FG000|Overall Study|Withdrawal by Subject|0|||
156684123|NCT02614898|565587162|FG001|Overall Study|Withdrawal by Subject|2|||
156684124|NCT02614898|565587161|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156684125|NCT02614898|565587162|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156684126|NCT02614898|565587161|FG000|Overall Study|Other-Additional Information Unavailable|0|||
156684127|NCT02614898|565587162|FG001|Overall Study|Other-Additional Information Unavailable|11|||
156684128|NCT02614898|565587161|FG000|Overall Study|Missing|0|||
156684129|NCT02614898|565587162|FG001|Overall Study|Missing|1|||
156684130|NCT03168906|565587163|FG000|Overall Study|Lack of Efficacy|6|||
156684131|NCT03168906|565587164|FG001|Overall Study|Lack of Efficacy|6|||
156684132|NCT05258630|565589137|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
156684133|NCT05258630|565589138|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
156684134|NCT05258630|565589137|FG000|Overall Study|Lost to Follow-up|0|||
156684135|NCT05258630|565589138|FG001|Overall Study|Lost to Follow-up|2|||
156684136|NCT03431337|565589139|FG000|Overall Study|Lost to Follow-up|21|||
156684137|NCT03431337|565589140|FG001|Overall Study|Lost to Follow-up|19|||
156684138|NCT03431337|565589139|FG000|Overall Study|Withdrawal by Subject|8|||
156684139|NCT03431337|565589140|FG001|Overall Study|Withdrawal by Subject|3|||
156684140|NCT00401245|565589141|FG000|Double Blind Titration Phase|Adverse Event|3|||
156684141|NCT00401245|565589142|FG001|Double Blind Titration Phase|Adverse Event|2|||
156684142|NCT00401245|565589143|FG002|Double Blind Titration Phase|Adverse Event|5|||
156684143|NCT00401245|565589144|FG003|Double Blind Titration Phase|Adverse Event|12|||
156684144|NCT00401245|565589145|FG004|Double Blind Titration Phase|Adverse Event|0|||
156684145|NCT00401245|565589146|FG005|Double Blind Titration Phase|Adverse Event|0|||
156684146|NCT00401245|565589147|FG006|Double Blind Titration Phase|Adverse Event|0|||
156684147|NCT00401245|565589148|FG007|Double Blind Titration Phase|Adverse Event|0|||
156684148|NCT00401245|565589141|FG000|Double Blind Titration Phase|Other|0|||
156684149|NCT00401245|565589142|FG001|Double Blind Titration Phase|Other|0|||
156684150|NCT00401245|565589143|FG002|Double Blind Titration Phase|Other|1|||
156684151|NCT00401245|565589144|FG003|Double Blind Titration Phase|Other|0|||
156684152|NCT00401245|565589145|FG004|Double Blind Titration Phase|Other|0|||
156684153|NCT00401245|565589146|FG005|Double Blind Titration Phase|Other|0|||
156684154|NCT00401245|565589147|FG006|Double Blind Titration Phase|Other|0|||
156684155|NCT00401245|565589148|FG007|Double Blind Titration Phase|Other|0|||
156529762|NCT02464228|565034705|FG003|Overall Study|Miscellaneous|0|||
156529763|NCT02464228|565034702|FG000|Overall Study|Adverse Event|9|||
156529764|NCT02464228|565034703|FG001|Overall Study|Adverse Event|0|||
156529765|NCT02464228|565034704|FG002|Overall Study|Adverse Event|3|||
156529766|NCT02464228|565034705|FG003|Overall Study|Adverse Event|0|||
156529767|NCT02464228|565034702|FG000|Overall Study|Withdrawal by Subject|1|||
156684156|NCT00401245|565589141|FG000|Double Blind Titration Phase|Protocol Violation|0|||
156684157|NCT00401245|565589142|FG001|Double Blind Titration Phase|Protocol Violation|0|||
156684158|NCT00401245|565589143|FG002|Double Blind Titration Phase|Protocol Violation|0|||
156684159|NCT00401245|565589144|FG003|Double Blind Titration Phase|Protocol Violation|1|||
156684160|NCT00401245|565589145|FG004|Double Blind Titration Phase|Protocol Violation|0|||
156684161|NCT00401245|565589146|FG005|Double Blind Titration Phase|Protocol Violation|0|||
156684162|NCT00401245|565589147|FG006|Double Blind Titration Phase|Protocol Violation|0|||
156684163|NCT00401245|565589148|FG007|Double Blind Titration Phase|Protocol Violation|0|||
156684164|NCT00401245|565589141|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
156684165|NCT00401245|565589142|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
156684166|NCT00401245|565589143|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
156684167|NCT00401245|565589144|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
156684168|NCT00401245|565589145|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
156784649|NCT03794544|565963237|FG001|Overall Study|Lost to Follow-up|1|||
156329692|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156329693|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156329694|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156329695|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156529768|NCT02464228|565034703|FG001|Overall Study|Withdrawal by Subject|1|||
156529769|NCT02464228|565034704|FG002|Overall Study|Withdrawal by Subject|1|||
156684169|NCT00401245|565589146|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
156684170|NCT00401245|565589147|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
156684171|NCT00401245|565589148|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
156684172|NCT00401245|565589141|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684173|NCT00401245|565589142|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
156684174|NCT00401245|565589143|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684175|NCT00401245|565589144|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
156684176|NCT00401245|565589145|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684177|NCT00401245|565589146|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684178|NCT00401245|565589147|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684179|NCT00401245|565589148|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684180|NCT00401245|565589141|FG000|Open Label Phase|Adverse Event|5|||
156684181|NCT00401245|565589142|FG001|Open Label Phase|Adverse Event|14|||
156684182|NCT00401245|565589143|FG002|Open Label Phase|Adverse Event|6|||
156684183|NCT00401245|565589144|FG003|Open Label Phase|Adverse Event|7|||
156684184|NCT00401245|565589145|FG004|Open Label Phase|Adverse Event|0|||
156684185|NCT00401245|565589146|FG005|Open Label Phase|Adverse Event|0|||
156684186|NCT00401245|565589147|FG006|Open Label Phase|Adverse Event|0|||
156684187|NCT00401245|565589148|FG007|Open Label Phase|Adverse Event|0|||
156684188|NCT00401245|565589141|FG000|Open Label Phase|Lost to Follow-up|5|||
156684189|NCT00401245|565589142|FG001|Open Label Phase|Lost to Follow-up|7|||
156684190|NCT00401245|565589143|FG002|Open Label Phase|Lost to Follow-up|5|||
156684191|NCT00401245|565589144|FG003|Open Label Phase|Lost to Follow-up|4|||
156684192|NCT00401245|565589145|FG004|Open Label Phase|Lost to Follow-up|0|||
156684193|NCT00401245|565589146|FG005|Open Label Phase|Lost to Follow-up|0|||
156684194|NCT00401245|565589147|FG006|Open Label Phase|Lost to Follow-up|0|||
156684195|NCT00401245|565589148|FG007|Open Label Phase|Lost to Follow-up|0|||
156684196|NCT00401245|565589141|FG000|Open Label Phase|Other|4|||
156684197|NCT00401245|565589142|FG001|Open Label Phase|Other|8|||
156684198|NCT00401245|565589143|FG002|Open Label Phase|Other|7|||
156684199|NCT00401245|565589144|FG003|Open Label Phase|Other|8|||
156684200|NCT00401245|565589145|FG004|Open Label Phase|Other|0|||
156684201|NCT00401245|565589146|FG005|Open Label Phase|Other|0|||
156684202|NCT00401245|565589147|FG006|Open Label Phase|Other|0|||
156684203|NCT00401245|565589148|FG007|Open Label Phase|Other|0|||
156684204|NCT00401245|565589141|FG000|Open Label Phase|Protocol Violation|0|||
156684205|NCT00401245|565589142|FG001|Open Label Phase|Protocol Violation|1|||
156435891|NCT02709655|564685035|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
156684206|NCT00401245|565589143|FG002|Open Label Phase|Protocol Violation|0|||
156684207|NCT00401245|565589144|FG003|Open Label Phase|Protocol Violation|1|||
156435892|NCT00102063|564685036|FG000|Overall Study|Lack of Efficacy|5|||
156435893|NCT00102063|564685037|FG001|Overall Study|Lack of Efficacy|1|||
156684208|NCT00401245|565589145|FG004|Open Label Phase|Protocol Violation|0|||
156684209|NCT00401245|565589146|FG005|Open Label Phase|Protocol Violation|0|||
156684210|NCT00401245|565589147|FG006|Open Label Phase|Protocol Violation|0|||
156684211|NCT00401245|565589148|FG007|Open Label Phase|Protocol Violation|0|||
156684212|NCT00401245|565589141|FG000|Open Label Phase|Withdrawal by Subject|3|||
156435894|NCT00102063|564685038|FG002|Overall Study|Lack of Efficacy|1|||
156435895|NCT00102063|564685036|FG000|Overall Study|Adverse Event|7|||
156435896|NCT00102063|564685037|FG001|Overall Study|Adverse Event|4|||
156435897|NCT00102063|564685038|FG002|Overall Study|Adverse Event|2|||
156435898|NCT00102063|564685036|FG000|Overall Study|Withdrawal by Subject|4|||
156684213|NCT00401245|565589142|FG001|Open Label Phase|Withdrawal by Subject|3|||
156684214|NCT00401245|565589143|FG002|Open Label Phase|Withdrawal by Subject|2|||
156684215|NCT00401245|565589144|FG003|Open Label Phase|Withdrawal by Subject|1|||
156684216|NCT00401245|565589145|FG004|Open Label Phase|Withdrawal by Subject|0|||
156684217|NCT00401245|565589146|FG005|Open Label Phase|Withdrawal by Subject|0|||
156684218|NCT00401245|565589147|FG006|Open Label Phase|Withdrawal by Subject|0|||
156684219|NCT00401245|565589148|FG007|Open Label Phase|Withdrawal by Subject|0|||
156684220|NCT00401245|565589141|FG000|Open Label Phase|Lack of Efficacy|4|||
156684221|NCT00401245|565589142|FG001|Open Label Phase|Lack of Efficacy|2|||
156684222|NCT00401245|565589143|FG002|Open Label Phase|Lack of Efficacy|3|||
156684223|NCT00401245|565589144|FG003|Open Label Phase|Lack of Efficacy|0|||
156684224|NCT00401245|565589145|FG004|Open Label Phase|Lack of Efficacy|0|||
156684225|NCT00401245|565589146|FG005|Open Label Phase|Lack of Efficacy|0|||
156684226|NCT00401245|565589147|FG006|Open Label Phase|Lack of Efficacy|0|||
156684227|NCT00401245|565589148|FG007|Open Label Phase|Lack of Efficacy|0|||
156684228|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Adverse Event|0|||
156435899|NCT00102063|564685037|FG001|Overall Study|Withdrawal by Subject|12|||
156435900|NCT00102063|564685038|FG002|Overall Study|Withdrawal by Subject|5|||
156435901|NCT00102063|564685036|FG000|Overall Study|Lost to Follow-up|0|||
156435902|NCT00102063|564685037|FG001|Overall Study|Lost to Follow-up|0|||
156684229|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Adverse Event|0|||
156684230|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Adverse Event|0|||
156684231|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Adverse Event|0|||
156684232|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Adverse Event|1|||
156684233|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Adverse Event|1|||
156684234|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Adverse Event|2|||
156684235|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Adverse Event|4|||
156684236|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Investigator request|0|||
156684237|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Investigator request|0|||
156684238|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Investigator request|0|||
156684239|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Investigator request|0|||
156684240|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Investigator request|0|||
156684241|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Investigator request|0|||
156684242|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Investigator request|0|||
156684243|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Investigator request|1|||
156684244|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Other|0|||
156684245|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Other|0|||
156684246|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Other|0|||
156684247|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Other|0|||
156684248|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Other|1|||
156684249|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Other|0|||
156684250|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Other|2|||
156684251|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Other|2|||
156684252|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156684253|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156868358|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156684254|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156684255|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156684256|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
156684257|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
156868359|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868360|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868361|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868362|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868363|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868364|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868365|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868366|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156435903|NCT00102063|564685038|FG002|Overall Study|Lost to Follow-up|1|||
156684258|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
156684259|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156684260|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684261|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684262|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684263|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684264|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684265|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
156684266|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684267|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684268|NCT04412057|565589149|FG000|Overall Study|Death|3|||
156684269|NCT04412057|565589150|FG001|Overall Study|Death|7|||
156684270|NCT04412057|565589149|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
156684271|NCT04412057|565589150|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
156684272|NCT05889039|565589152|FG000|Overall Study|error in completing survey|0|||
156684273|NCT05889039|565589153|FG001|Overall Study|error in completing survey|2|||
156684274|NCT05889039|565589154|FG002|Overall Study|error in completing survey|0|||
156684275|NCT05889039|565589155|FG003|Overall Study|error in completing survey|0|||
156684276|NCT05889039|565589152|FG000|Overall Study|Lost to Follow-up|4|||
156684277|NCT05889039|565589153|FG001|Overall Study|Lost to Follow-up|0|||
156684278|NCT05889039|565589154|FG002|Overall Study|Lost to Follow-up|0|||
156684279|NCT05889039|565589155|FG003|Overall Study|Lost to Follow-up|0|||
156684280|NCT03023137|565589156|FG000|Overall Study|Multiple pregnancy|2|||
156684281|NCT03023137|565589157|FG001|Overall Study|Multiple pregnancy|4|||
156868367|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868368|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156435904|NCT00102063|564685036|FG000|Overall Study|Protocol Violation|0|||
156435905|NCT00102063|564685037|FG001|Overall Study|Protocol Violation|1|||
156435906|NCT00102063|564685038|FG002|Overall Study|Protocol Violation|1|||
156435907|NCT00857649|564685039|FG000|Overall Study|Adverse Event|15|||
156435908|NCT00857649|564685040|FG001|Overall Study|Adverse Event|10|||
156435909|NCT00857649|564685039|FG000|Overall Study|Non-compliance|1|||
156435910|NCT00857649|564685040|FG001|Overall Study|Non-compliance|1|||
156435911|NCT00857649|564685039|FG000|Overall Study|Protocol Violation|2|||
156435912|NCT00857649|564685040|FG001|Overall Study|Protocol Violation|2|||
156684282|NCT03023137|565589156|FG000|Overall Study|Lost to Follow-up|1|||
156684283|NCT03023137|565589157|FG001|Overall Study|Lost to Follow-up|1|||
156684284|NCT03023137|565589156|FG000|Overall Study|Protocol Violation|0|||
156684285|NCT03023137|565589157|FG001|Overall Study|Protocol Violation|4|||
156684286|NCT03023137|565589156|FG000|Overall Study|Lost the baby in a car accident|1|||
156684287|NCT03023137|565589157|FG001|Overall Study|Lost the baby in a car accident|0|||
156684288|NCT01450800|565589166|FG000|Overall Study|Protocol Violation|1|||
156684289|NCT01450800|565589167|FG001|Overall Study|Protocol Violation|3|||
156684290|NCT03496298|565589170|FG000|Overall Study|Adverse Event|49|||
156684291|NCT03496298|565589171|FG001|Overall Study|Adverse Event|68|||
156684292|NCT03496298|565589172|FG002|Overall Study|Adverse Event|79|||
156684293|NCT03496298|565589170|FG000|Overall Study|Study terminated by Sponsor|1050|||
156684294|NCT03496298|565589171|FG001|Overall Study|Study terminated by Sponsor|1063|||
156684295|NCT03496298|565589172|FG002|Overall Study|Study terminated by Sponsor|1071|||
156684296|NCT03496298|565589170|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
156684297|NCT03496298|565589171|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
156684298|NCT03496298|565589172|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
156684299|NCT03496298|565589170|FG000|Overall Study|Withdrawal by Subject|176|||
156684300|NCT03496298|565589171|FG001|Overall Study|Withdrawal by Subject|154|||
156684301|NCT03496298|565589172|FG002|Overall Study|Withdrawal by Subject|151|||
156684302|NCT03496298|565589170|FG000|Overall Study|Other|29|||
156684303|NCT03496298|565589171|FG001|Overall Study|Other|20|||
156684304|NCT03496298|565589172|FG002|Overall Study|Other|23|||
156684305|NCT03496298|565589170|FG000|Overall Study|Randomized and not treated|1|||
156684306|NCT03496298|565589171|FG001|Overall Study|Randomized and not treated|1|||
156684307|NCT03496298|565589172|FG002|Overall Study|Randomized and not treated|1|||
156684308|NCT02608476|565589178|FG000|Overall Study|Withdrawal by Subject|30|||
156684309|NCT02608476|565589179|FG001|Overall Study|Withdrawal by Subject|37|||
156684310|NCT02608476|565589178|FG000|Overall Study|Lost to Follow-up|24|||
156684311|NCT02608476|565589179|FG001|Overall Study|Lost to Follow-up|24|||
156684312|NCT02608476|565589178|FG000|Overall Study|Adverse Event|2|||
156684313|NCT02608476|565589179|FG001|Overall Study|Adverse Event|8|||
156684314|NCT02608476|565589178|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
156684315|NCT02608476|565589179|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
156684316|NCT02608476|565589178|FG000|Overall Study|Noncompliance with treatment|1|||
156684317|NCT02608476|565589179|FG001|Overall Study|Noncompliance with treatment|5|||
156684318|NCT02608476|565589178|FG000|Overall Study|Lack of Efficacy|3|||
156684319|NCT02608476|565589179|FG001|Overall Study|Lack of Efficacy|1|||
156684320|NCT02608476|565589178|FG000|Overall Study|Other|0|||
156684321|NCT02608476|565589179|FG001|Overall Study|Other|1|||
156684322|NCT02608476|565589178|FG000|Overall Study|Physician Decision|1|||
156684323|NCT02608476|565589179|FG001|Overall Study|Physician Decision|0|||
156684324|NCT02608476|565589178|FG000|Overall Study|Pregnancy|0|||
156684325|NCT02608476|565589179|FG001|Overall Study|Pregnancy|1|||
156684326|NCT02608476|565589178|FG000|Overall Study|Progressive disease|1|||
156684327|NCT02608476|565589179|FG001|Overall Study|Progressive disease|0|||
156684328|NCT00676494|565589180|FG000|Overall Study|Missed Visit|8|||
156684329|NCT00676494|565589180|FG000|Overall Study|Withdrawal by Subject|6|||
156684330|NCT02795676|565589181|FG000|Overall Study|Adverse Event|2|||
156684331|NCT02795676|565589182|FG001|Overall Study|Adverse Event|0|||
156684332|NCT02795676|565589181|FG000|Overall Study|Withdrawal by Subject|3|||
156684333|NCT02795676|565589182|FG001|Overall Study|Withdrawal by Subject|1|||
156684334|NCT02058160|565589188|FG000|Overall Study|Randomized but not treated|2|||
156684335|NCT02058160|565589189|FG001|Overall Study|Randomized but not treated|4|||
156684336|NCT02058160|565589188|FG000|Overall Study|Poor compliance to protocol|4|||
156684337|NCT02058160|565589189|FG001|Overall Study|Poor compliance to protocol|1|||
156684338|NCT02058160|565589188|FG000|Overall Study|Adverse Event|12|||
156684339|NCT02058160|565589189|FG001|Overall Study|Adverse Event|3|||
156684340|NCT02058160|565589188|FG000|Overall Study|Lost to Follow-up|1|||
156684341|NCT02058160|565589189|FG001|Overall Study|Lost to Follow-up|0|||
156684342|NCT02058160|565589188|FG000|Overall Study|Other than specified above|12|||
156684343|NCT02058160|565589189|FG001|Overall Study|Other than specified above|6|||
156684344|NCT01203917|565589190|FG000|Overall Study|Death|29|||
156684345|NCT01203917|565589190|FG000|Overall Study|Lost to Follow-up|2|||
156684346|NCT01203917|565589190|FG000|Overall Study|Withdrawal by Subject|3|||
156684347|NCT01203917|565589190|FG000|Overall Study|Due to objective disease progression|1|||
156684348|NCT01203917|565589190|FG000|Overall Study|Due to EGFR M+I patient|1|||
156784650|NCT03794544|565963238|FG002|Overall Study|Lost to Follow-up|1|||
156329696|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
156329697|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156684349|NCT00152516|565589195|FG000|Overall Study|Adverse Event|18|||
156684350|NCT00152516|565589195|FG000|Overall Study|Lack and Loss of Efficacy|30|||
156684351|NCT00152516|565589195|FG000|Overall Study|Lost to Follow-up|5|||
156684352|NCT00152516|565589195|FG000|Overall Study|Withdrawal by Subject|8|||
156684353|NCT00152516|565589195|FG000|Overall Study|Protocol Violation|3|||
156684354|NCT00152516|565589195|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
156684355|NCT00152516|565589195|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
156684356|NCT00152516|565589195|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
156684357|NCT00152516|565589195|FG000|Overall Study|Other: Non-Compliance|2|||
156684358|NCT00152516|565589195|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
156684359|NCT00152516|565589195|FG000|Overall Study|Other: Moved Out Of State|1|||
156684360|NCT00152516|565589195|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
156684361|NCT00152516|565589195|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
156684362|NCT04660032|565589198|FG000|Overall Study|Protocol Violation|1|||
156684363|NCT04660032|565589199|FG001|Overall Study|Protocol Violation|1|||
156684364|NCT01086969|565589202|FG000|Overall Study|Withdrawal by Subject|1|||
156684365|NCT01086969|565589203|FG001|Overall Study|Withdrawal by Subject|2|||
156684366|NCT01086969|565589204|FG002|Overall Study|Withdrawal by Subject|0|||
156684367|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
156684368|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
156684369|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
156684370|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
156684371|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
156684372|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
156684373|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
156684374|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
156684375|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
156684376|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Other|1|||
156684377|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Other|4|||
156684378|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Other|5|||
156684379|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
156684380|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
156684381|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
156684382|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
156684383|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
156684384|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
156684385|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
156684386|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
156684387|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
156684388|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
156684389|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
156684390|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
156684391|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
156684392|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
156684393|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
156684394|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Other|1|||
156684395|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Other|4|||
156684396|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Other|2|||
156684397|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
156684398|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
156684399|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
156684400|NCT00819767|565589212|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156684401|NCT00819767|565589213|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156684402|NCT00250705|565589214|FG000|Overall Study|Lack of Efficacy|2|||
156684403|NCT00761176|565589217|FG000|Overall Study|Death|1|||
156684404|NCT00761176|565589218|FG001|Overall Study|Death|0|||
156684405|NCT00761176|565589217|FG000|Overall Study|Withdrawal by Subject|1|||
156684406|NCT00761176|565589218|FG001|Overall Study|Withdrawal by Subject|1|||
156684407|NCT05103657|565589219|FG000|Overall Study|Other reasons than listed|9|||
156684408|NCT05103657|565589220|FG001|Overall Study|Other reasons than listed|8|||
156684409|NCT05103657|565589219|FG000|Overall Study|Protocol deviation|2|||
156684410|NCT05103657|565589220|FG001|Overall Study|Protocol deviation|2|||
156684411|NCT05103657|565589219|FG000|Overall Study|No reason available|5|||
156684412|NCT05103657|565589220|FG001|Overall Study|No reason available|4|||
156684413|NCT05103657|565589219|FG000|Overall Study|Burden of study procedures|3|||
156684414|NCT05103657|565589220|FG001|Overall Study|Burden of study procedures|1|||
156684415|NCT05103657|565589219|FG000|Overall Study|Perceived lack of efficacy|1|||
156684416|NCT05103657|565589220|FG001|Overall Study|Perceived lack of efficacy|1|||
156684417|NCT05103657|565589219|FG000|Overall Study|Adverse Event|6|||
156684418|NCT05103657|565589220|FG001|Overall Study|Adverse Event|14|||
156684419|NCT05103657|565589219|FG000|Overall Study|Not Treated|1|||
156529770|NCT02464228|565034705|FG003|Overall Study|Withdrawal by Subject|0|||
156529771|NCT02464228|565034702|FG000|Overall Study|Disease Progression|22|||
156529772|NCT02464228|565034703|FG001|Overall Study|Disease Progression|12|||
156529773|NCT02464228|565034704|FG002|Overall Study|Disease Progression|5|||
156529774|NCT02464228|565034705|FG003|Overall Study|Disease Progression|2|||
156529775|NCT01180998|565034711|FG000|Overall Study|Poor Vision|0|||
156684420|NCT05103657|565589220|FG001|Overall Study|Not Treated|1|||
156684421|NCT02020967|565589221|FG000|Overall Study|Withdrawal by Subject|51|||
156684422|NCT00129116|565589222|FG000|Primary Phase|Lost to Follow-up|1|||
156684423|NCT00129116|565589223|FG001|Primary Phase|Lost to Follow-up|1|||
156684424|NCT00129116|565589224|FG002|Primary Phase|Lost to Follow-up|0|||
156684425|NCT00129116|565589225|FG003|Primary Phase|Lost to Follow-up|1|||
156684426|NCT00129116|565589226|FG004|Primary Phase|Lost to Follow-up|1|||
156684427|NCT00129116|565589222|FG000|Primary Phase|Protocol Violation|0|||
156684428|NCT00129116|565589223|FG001|Primary Phase|Protocol Violation|1|||
156684429|NCT00129116|565589224|FG002|Primary Phase|Protocol Violation|0|||
156529776|NCT01180998|565034712|FG001|Overall Study|Poor Vision|2|||
156684430|NCT00129116|565589225|FG003|Primary Phase|Protocol Violation|0|||
156684431|NCT00129116|565589226|FG004|Primary Phase|Protocol Violation|0|||
156684432|NCT00129116|565589222|FG000|Primary Phase|Adverse Event|1|||
156684433|NCT00129116|565589223|FG001|Primary Phase|Adverse Event|1|||
156684434|NCT00129116|565589224|FG002|Primary Phase|Adverse Event|0|||
156684435|NCT00129116|565589225|FG003|Primary Phase|Adverse Event|0|||
156684436|NCT00129116|565589226|FG004|Primary Phase|Adverse Event|0|||
156684437|NCT00129116|565589222|FG000|Primary Phase|Withdrawal by Subject|0|||
156684438|NCT00129116|565589223|FG001|Primary Phase|Withdrawal by Subject|1|||
156684439|NCT00129116|565589224|FG002|Primary Phase|Withdrawal by Subject|0|||
156684440|NCT00129116|565589225|FG003|Primary Phase|Withdrawal by Subject|0|||
156684441|NCT00129116|565589226|FG004|Primary Phase|Withdrawal by Subject|0|||
156684442|NCT00129116|565589222|FG000|Primary Phase|Other|0|||
156684443|NCT00129116|565589223|FG001|Primary Phase|Other|0|||
156684444|NCT00129116|565589224|FG002|Primary Phase|Other|1|||
156684445|NCT00129116|565589225|FG003|Primary Phase|Other|0|||
156684446|NCT00129116|565589226|FG004|Primary Phase|Other|0|||
156684447|NCT00129116|565589222|FG000|Booster Phase|Lost to Follow-up|2|||
156684448|NCT00129116|565589223|FG001|Booster Phase|Lost to Follow-up|0|||
156684449|NCT00129116|565589224|FG002|Booster Phase|Lost to Follow-up|0|||
156684450|NCT00129116|565589225|FG003|Booster Phase|Lost to Follow-up|0|||
156684451|NCT00129116|565589226|FG004|Booster Phase|Lost to Follow-up|1|||
156684452|NCT02539368|565589229|FG000|Overall Study|Death|4|||
156684453|NCT02539368|565589230|FG001|Overall Study|Death|2|||
156684454|NCT02539368|565589231|FG002|Overall Study|Death|1|||
156684455|NCT02539368|565589232|FG003|Overall Study|Death|0|||
156684456|NCT02539368|565589233|FG004|Overall Study|Death|0|||
156684457|NCT02539368|565589229|FG000|Overall Study|Withdrawal by Subject|44|||
156684458|NCT02539368|565589230|FG001|Overall Study|Withdrawal by Subject|35|||
156684459|NCT02539368|565589231|FG002|Overall Study|Withdrawal by Subject|9|||
156684460|NCT02539368|565589232|FG003|Overall Study|Withdrawal by Subject|1|||
156435913|NCT00857649|564685039|FG000|Overall Study|Withdrawal of Consent|10|||
156435914|NCT00857649|564685040|FG001|Overall Study|Withdrawal of Consent|7|||
156435915|NCT00857649|564685039|FG000|Overall Study|Nursing Home Placement|2|||
156435916|NCT00857649|564685040|FG001|Overall Study|Nursing Home Placement|9|||
156435917|NCT00857649|564685039|FG000|Overall Study|Other Reasons|1|||
156435918|NCT00857649|564685040|FG001|Overall Study|Other Reasons|3|||
156435919|NCT02248480|564685042|FG000|Overall Study|Lack of Efficacy|4|||
156435920|NCT02248480|564685043|FG001|Overall Study|Lack of Efficacy|6|||
156435921|NCT02248480|564685042|FG000|Overall Study|Adverse Event|11|||
156684461|NCT02539368|565589233|FG004|Overall Study|Withdrawal by Subject|3|||
156684462|NCT02539368|565589229|FG000|Overall Study|Physician Decision|49|||
156684463|NCT02539368|565589230|FG001|Overall Study|Physician Decision|15|||
156684464|NCT02539368|565589231|FG002|Overall Study|Physician Decision|7|||
156684465|NCT02539368|565589232|FG003|Overall Study|Physician Decision|0|||
156684466|NCT02539368|565589233|FG004|Overall Study|Physician Decision|2|||
156684467|NCT02539368|565589229|FG000|Overall Study|Lost to Follow-up|96|||
156684468|NCT02539368|565589230|FG001|Overall Study|Lost to Follow-up|21|||
156684469|NCT02539368|565589231|FG002|Overall Study|Lost to Follow-up|16|||
156684470|NCT02539368|565589232|FG003|Overall Study|Lost to Follow-up|4|||
156684471|NCT02539368|565589233|FG004|Overall Study|Lost to Follow-up|3|||
156684472|NCT02539368|565589229|FG000|Overall Study|Adverse Event|44|||
156684473|NCT02539368|565589230|FG001|Overall Study|Adverse Event|5|||
156684474|NCT02539368|565589231|FG002|Overall Study|Adverse Event|9|||
156684475|NCT02539368|565589232|FG003|Overall Study|Adverse Event|0|||
156684476|NCT02539368|565589233|FG004|Overall Study|Adverse Event|3|||
156684477|NCT02539368|565589229|FG000|Overall Study|Participant Non-compliant|13|||
156684478|NCT02539368|565589230|FG001|Overall Study|Participant Non-compliant|2|||
156684479|NCT02539368|565589231|FG002|Overall Study|Participant Non-compliant|1|||
156684480|NCT02539368|565589232|FG003|Overall Study|Participant Non-compliant|1|||
156684481|NCT02539368|565589233|FG004|Overall Study|Participant Non-compliant|0|||
156684482|NCT02539368|565589229|FG000|Overall Study|Other|145|||
156684483|NCT02539368|565589230|FG001|Overall Study|Other|18|||
156684484|NCT02539368|565589231|FG002|Overall Study|Other|24|||
156684485|NCT02539368|565589232|FG003|Overall Study|Other|1|||
156684486|NCT02539368|565589233|FG004|Overall Study|Other|3|||
156684487|NCT02539368|565589229|FG000|Overall Study|Missing|10|||
156684488|NCT02539368|565589230|FG001|Overall Study|Missing|3|||
156684489|NCT02539368|565589231|FG002|Overall Study|Missing|0|||
156435922|NCT02248480|564685043|FG001|Overall Study|Adverse Event|2|||
156435923|NCT02248480|564685042|FG000|Overall Study|Withdrawal by Subject|2|||
156529777|NCT01180998|565034713|FG002|Overall Study|Poor Vision|2|||
156684490|NCT02539368|565589232|FG003|Overall Study|Missing|0|||
156684491|NCT02539368|565589233|FG004|Overall Study|Missing|0|||
156684492|NCT00398073|565589235|FG000|Overall Study|Withdrawal by Subject|1|||
156684493|NCT00398073|565589236|FG001|Overall Study|Withdrawal by Subject|0|||
156684494|NCT01263561|565589237|FG000|Overall Study|Death|1|||
156435924|NCT02248480|564685043|FG001|Overall Study|Withdrawal by Subject|4|||
156529778|NCT01180998|565034711|FG000|Overall Study|Lost to Follow-up|0|||
156684495|NCT01263561|565589238|FG001|Overall Study|Death|2|||
156684496|NCT00879684|565589239|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
156684497|NCT00879684|565589240|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
156684498|NCT00879684|565589241|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
156684499|NCT00879684|565589242|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
156684500|NCT00879684|565589243|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
156684501|NCT00879684|565589244|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
156684502|NCT00879684|565589245|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
156684503|NCT00879684|565589239|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
156684504|NCT00879684|565589240|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
156684505|NCT00879684|565589241|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
156684506|NCT00879684|565589242|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
156684507|NCT00879684|565589243|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
156684508|NCT00879684|565589244|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
156684509|NCT00879684|565589245|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
156684510|NCT00879684|565589239|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684511|NCT00879684|565589240|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684512|NCT00879684|565589241|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
156684513|NCT00879684|565589242|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
156684514|NCT00879684|565589243|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684515|NCT00879684|565589244|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684516|NCT00879684|565589245|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684517|NCT00879684|565589239|FG000|Stage 1: Dose Escalation|Death|0|||
156684518|NCT00879684|565589240|FG001|Stage 1: Dose Escalation|Death|0|||
156684519|NCT00879684|565589241|FG002|Stage 1: Dose Escalation|Death|1|||
156684520|NCT00879684|565589242|FG003|Stage 1: Dose Escalation|Death|0|||
156684521|NCT00879684|565589243|FG004|Stage 1: Dose Escalation|Death|0|||
156684522|NCT00879684|565589244|FG005|Stage 1: Dose Escalation|Death|0|||
156684523|NCT00879684|565589245|FG006|Stage 1: Dose Escalation|Death|0|||
156684524|NCT00879684|565589239|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684525|NCT00879684|565589240|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684526|NCT00879684|565589241|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684527|NCT00879684|565589242|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684528|NCT00879684|565589243|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684529|NCT00879684|565589244|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684530|NCT00879684|565589245|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
156684531|NCT00879684|565589239|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
156329698|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156329699|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156329700|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156329701|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156329702|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156329703|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
156329704|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156329705|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156329706|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156329707|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156329708|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156329709|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156329710|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
156329711|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156329712|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156329713|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156329714|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156329715|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156329716|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156329717|NCT04526509|564307051|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
156329718|NCT04526509|564307052|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156329719|NCT04526509|564307053|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156684532|NCT00879684|565589240|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684533|NCT00879684|565589241|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684534|NCT00879684|565589242|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684535|NCT00879684|565589243|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684536|NCT00879684|565589244|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684537|NCT00879684|565589245|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
156684538|NCT00879684|565589239|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684539|NCT00879684|565589240|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684540|NCT00879684|565589241|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684541|NCT00879684|565589242|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684542|NCT00879684|565589243|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684543|NCT00879684|565589244|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684544|NCT00879684|565589245|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
156684545|NCT00708682|565589246|FG000|Infant Series|Adverse Event|1|||
156684546|NCT00708682|565589246|FG000|Infant Series|Lost to Follow-up|4|||
156684547|NCT00708682|565589246|FG000|Infant Series|Protocol Violation|1|||
156684548|NCT00708682|565589246|FG000|Infant Series|Parent/legal guardian request|6|||
156684549|NCT00708682|565589246|FG000|Infant Series|Failed to return|2|||
156684550|NCT00708682|565589246|FG000|Infant Series|Other|19|||
156684551|NCT00708682|565589246|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
156684552|NCT00708682|565589246|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
156684553|NCT00708682|565589246|FG000|Toddler Dose|Lost to Follow-up|3|||
156684554|NCT00708682|565589246|FG000|Toddler Dose|Failed to Return|4|||
156684555|NCT03185741|565589252|FG000|Baseline|Withdrawal by Subject|1|||
156684556|NCT03185741|565589253|FG001|Baseline|Withdrawal by Subject|3|||
156684557|NCT03185741|565589254|FG002|Baseline|Withdrawal by Subject|2|||
156684558|NCT03185741|565589252|FG000|Baseline|Lost to Follow-up|1|||
156684559|NCT03185741|565589253|FG001|Baseline|Lost to Follow-up|2|||
156684560|NCT03185741|565589254|FG002|Baseline|Lost to Follow-up|3|||
156684561|NCT03185741|565589252|FG000|3Month|Death|1|||
156684562|NCT03185741|565589253|FG001|3Month|Death|1|||
156684563|NCT03185741|565589254|FG002|3Month|Death|2|||
156684564|NCT03185741|565589252|FG000|3Month|Withdrawal by Subject|1|||
156684565|NCT03185741|565589253|FG001|3Month|Withdrawal by Subject|5|||
156684566|NCT03185741|565589254|FG002|3Month|Withdrawal by Subject|1|||
156684567|NCT03185741|565589252|FG000|3Month|Lost to Follow-up|7|||
156684568|NCT03185741|565589253|FG001|3Month|Lost to Follow-up|9|||
156684569|NCT03185741|565589254|FG002|3Month|Lost to Follow-up|8|||
156684570|NCT03185741|565589252|FG000|3Month|Unavailable for 3Month|11|||
156684571|NCT03185741|565589253|FG001|3Month|Unavailable for 3Month|10|||
156684572|NCT03185741|565589254|FG002|3Month|Unavailable for 3Month|11|||
156684573|NCT03185741|565589252|FG000|3Month|Protocol Violation|0|||
156684574|NCT03185741|565589253|FG001|3Month|Protocol Violation|0|||
156684575|NCT03185741|565589254|FG002|3Month|Protocol Violation|3|||
156684576|NCT03185741|565589252|FG000|6Month|Death|1|||
156684577|NCT03185741|565589253|FG001|6Month|Death|1|||
156684578|NCT03185741|565589254|FG002|6Month|Death|2|||
156684579|NCT03185741|565589252|FG000|6Month|Withdrawal by Subject|2|||
156684580|NCT03185741|565589253|FG001|6Month|Withdrawal by Subject|3|||
156784651|NCT03794544|565963239|FG003|Overall Study|Lost to Follow-up|0|||
156784652|NCT03794544|565963236|FG000|Overall Study|Other|0|||
156329720|NCT04526509|564307054|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156329721|NCT04526509|564307055|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156329722|NCT04526509|564307056|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156329723|NCT04526509|564307057|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156329724|NCT04526509|564307051|FG000|Enrolled|Study Terminated by Sponsor|0|||
156329725|NCT04526509|564307052|FG001|Enrolled|Study Terminated by Sponsor|0|||
156329726|NCT04526509|564307053|FG002|Enrolled|Study Terminated by Sponsor|0|||
156329727|NCT04526509|564307054|FG003|Enrolled|Study Terminated by Sponsor|0|||
156329728|NCT04526509|564307055|FG004|Enrolled|Study Terminated by Sponsor|0|||
156329729|NCT04526509|564307056|FG005|Enrolled|Study Terminated by Sponsor|0|||
156329730|NCT04526509|564307057|FG006|Enrolled|Study Terminated by Sponsor|1|||
156329731|NCT04526509|564307051|FG000|Enrolled|Death prior to lymphodepletion|0|||
156329732|NCT04526509|564307052|FG001|Enrolled|Death prior to lymphodepletion|0|||
156329733|NCT04526509|564307053|FG002|Enrolled|Death prior to lymphodepletion|0|||
156329734|NCT04526509|564307054|FG003|Enrolled|Death prior to lymphodepletion|1|||
156329735|NCT04526509|564307055|FG004|Enrolled|Death prior to lymphodepletion|0|||
156329736|NCT04526509|564307056|FG005|Enrolled|Death prior to lymphodepletion|0|||
156329737|NCT04526509|564307057|FG006|Enrolled|Death prior to lymphodepletion|0|||
156435925|NCT02248480|564685042|FG000|Overall Study|Entry Criteria Not Met|0|||
156684581|NCT03185741|565589254|FG002|6Month|Withdrawal by Subject|1|||
156329738|NCT04526509|564307051|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156684582|NCT03185741|565589252|FG000|6Month|Lost to Follow-up|16|||
156684583|NCT03185741|565589253|FG001|6Month|Lost to Follow-up|15|||
156435926|NCT02248480|564685043|FG001|Overall Study|Entry Criteria Not Met|1|||
156435927|NCT02248480|564685042|FG000|Overall Study|Other:Physician Decision|0|||
156784653|NCT03794544|565963237|FG001|Overall Study|Other|1|||
156784654|NCT03794544|565963238|FG002|Overall Study|Other|0|||
156784655|NCT03794544|565963239|FG003|Overall Study|Other|0|||
156784656|NCT00421733|565963241|FG000|Overall Study|Adverse Event|4|||
156784657|NCT00421733|565963242|FG001|Overall Study|Adverse Event|9|||
156784658|NCT00421733|565963243|FG002|Overall Study|Adverse Event|2|||
156784659|NCT00421733|565963241|FG000|Overall Study|Lost to Follow-up|1|||
156784660|NCT00421733|565963242|FG001|Overall Study|Lost to Follow-up|2|||
156784661|NCT00421733|565963243|FG002|Overall Study|Lost to Follow-up|4|||
156784662|NCT00421733|565963241|FG000|Overall Study|Withdrawal by Subject|1|||
156784663|NCT00421733|565963242|FG001|Overall Study|Withdrawal by Subject|2|||
156784664|NCT00421733|565963243|FG002|Overall Study|Withdrawal by Subject|7|||
156784665|NCT00421733|565963241|FG000|Overall Study|Death|0|||
156784666|NCT00421733|565963242|FG001|Overall Study|Death|3|||
156784667|NCT00421733|565963243|FG002|Overall Study|Death|0|||
156784668|NCT00421733|565963241|FG000|Overall Study|Required dialysis|1|||
156784669|NCT00421733|565963242|FG001|Overall Study|Required dialysis|0|||
156784670|NCT00421733|565963243|FG002|Overall Study|Required dialysis|0|||
156784671|NCT00421733|565963241|FG000|Overall Study|Administrative|2|||
156784672|NCT00421733|565963242|FG001|Overall Study|Administrative|0|||
156784673|NCT00421733|565963243|FG002|Overall Study|Administrative|0|||
156784674|NCT00421733|565963241|FG000|Overall Study|Did not satisfy entry criteria|1|||
156784675|NCT00421733|565963242|FG001|Overall Study|Did not satisfy entry criteria|3|||
156784676|NCT00421733|565963243|FG002|Overall Study|Did not satisfy entry criteria|2|||
156784677|NCT00421733|565963241|FG000|Overall Study|Sponsor request|1|||
156784678|NCT00421733|565963242|FG001|Overall Study|Sponsor request|0|||
156784679|NCT00421733|565963243|FG002|Overall Study|Sponsor request|3|||
156784680|NCT00421733|565963241|FG000|Overall Study|Protocol deviation|4|||
156784681|NCT00421733|565963242|FG001|Overall Study|Protocol deviation|7|||
156784682|NCT00421733|565963243|FG002|Overall Study|Protocol deviation|2|||
156784683|NCT00894647|565963244|FG000|Overall Study|Adverse Event|5|||
156784684|NCT00894647|565963245|FG001|Overall Study|Adverse Event|4|||
156784685|NCT00894647|565963244|FG000|Overall Study|Withdrawal by Subject|4|||
156784686|NCT00894647|565963245|FG001|Overall Study|Withdrawal by Subject|4|||
156784687|NCT00894647|565963244|FG000|Overall Study|Lost to Follow-up|0|||
156784688|NCT00894647|565963245|FG001|Overall Study|Lost to Follow-up|2|||
156784689|NCT00894647|565963244|FG000|Overall Study|Non-compliance with study procedures|0|||
156784690|NCT00894647|565963245|FG001|Overall Study|Non-compliance with study procedures|2|||
156784691|NCT00894647|565963244|FG000|Overall Study|Other, not due to AE|1|||
156784692|NCT00894647|565963245|FG001|Overall Study|Other, not due to AE|2|||
156784693|NCT00397930|565963252|FG000|Overall Study|Personal reasons|14|||
156784694|NCT00397930|565963253|FG001|Overall Study|Personal reasons|8|||
156784695|NCT00397930|565963252|FG000|Overall Study|Other medical|9|||
156784696|NCT00397930|565963253|FG001|Overall Study|Other medical|4|||
156784697|NCT00397930|565963252|FG000|Overall Study|Unknown reasons|9|||
156784698|NCT00397930|565963253|FG001|Overall Study|Unknown reasons|14|||
156784699|NCT00397930|565963252|FG000|Overall Study|Noncompliant|3|||
156784700|NCT00397930|565963253|FG001|Overall Study|Noncompliant|2|||
156784701|NCT00397930|565963252|FG000|Overall Study|Too time-consuming|2|||
156784702|NCT00397930|565963253|FG001|Overall Study|Too time-consuming|9|||
156784703|NCT00397930|565963252|FG000|Overall Study|Started own yoga program|1|||
156784704|NCT00397930|565963253|FG001|Overall Study|Started own yoga program|1|||
156784705|NCT00397930|565963252|FG000|Overall Study|Did not want to be in control group|0|||
156784706|NCT00397930|565963253|FG001|Overall Study|Did not want to be in control group|1|||
156784707|NCT00397930|565963252|FG000|Overall Study|Withdrawal by Subject|0|||
156784708|NCT00397930|565963253|FG001|Overall Study|Withdrawal by Subject|8|||
156435928|NCT02248480|564685043|FG001|Overall Study|Other:Physician Decision|1|||
156435929|NCT00630786|564685044|FG000|Overall Study|Physician Decision|0|||
156435930|NCT00630786|564685045|FG001|Overall Study|Physician Decision|0|||
156435931|NCT00630786|564685046|FG002|Overall Study|Physician Decision|1|||
156435932|NCT00630786|564685044|FG000|Overall Study|Withdrawal by Subject|0|||
156435933|NCT00630786|564685045|FG001|Overall Study|Withdrawal by Subject|1|||
156435934|NCT00630786|564685046|FG002|Overall Study|Withdrawal by Subject|1|||
156435935|NCT00630786|564685044|FG000|Overall Study|Lost to Follow-up|0|||
156435936|NCT00630786|564685045|FG001|Overall Study|Lost to Follow-up|1|||
156435937|NCT00630786|564685046|FG002|Overall Study|Lost to Follow-up|0|||
156435938|NCT00630786|564685044|FG000|Overall Study|Other|1|||
156435939|NCT00630786|564685045|FG001|Overall Study|Other|0|||
156435940|NCT00630786|564685046|FG002|Overall Study|Other|0|||
156435941|NCT03070483|564685049|FG000|Overall Study|Lost to Follow-up|2|||
156784709|NCT00397930|565963252|FG000|Overall Study|Missing data|0|||
156784710|NCT00397930|565963253|FG001|Overall Study|Missing data|4|||
156784711|NCT01433978|565963256|FG000|Core Study|Adverse Event, Non-Fatal|0|||
156435942|NCT06269640|564686703|FG000|Overall Study|Death|1|||
156435943|NCT03979365|564686704|FG000|Overall Study|Death|1|||
156435944|NCT03979365|564686705|FG001|Overall Study|Death|3|||
156435945|NCT03979365|564686704|FG000|Overall Study|Withdrawal by Subject|0|||
156784712|NCT01433978|565963257|FG001|Core Study|Adverse Event, Non-Fatal|1|||
156784713|NCT01433978|565963258|FG002|Core Study|Adverse Event, Non-Fatal|0|||
156784714|NCT01433978|565963256|FG000|Core Study|Lack of Efficacy|5|||
156784715|NCT01433978|565963257|FG001|Core Study|Lack of Efficacy|1|||
156784716|NCT01433978|565963258|FG002|Core Study|Lack of Efficacy|0|||
156784717|NCT01433978|565963256|FG000|Core Study|Study Terminated by Sponsor|6|||
156784718|NCT01433978|565963257|FG001|Core Study|Study Terminated by Sponsor|9|||
156784719|NCT01433978|565963258|FG002|Core Study|Study Terminated by Sponsor|0|||
156784720|NCT01433978|565963256|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
156784721|NCT01433978|565963257|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
156784722|NCT01433978|565963258|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
156784723|NCT01433978|565963256|FG000|Extension Phase|Lack of Efficacy|0|||
156784724|NCT01433978|565963257|FG001|Extension Phase|Lack of Efficacy|0|||
156784725|NCT01433978|565963258|FG002|Extension Phase|Lack of Efficacy|1|||
156784726|NCT01433978|565963256|FG000|Extension Phase|Study Terminated by Sponsor|0|||
156784727|NCT01433978|565963257|FG001|Extension Phase|Study Terminated by Sponsor|0|||
156529779|NCT01180998|565034712|FG001|Overall Study|Lost to Follow-up|0|||
156529780|NCT01180998|565034713|FG002|Overall Study|Lost to Follow-up|1|||
156529781|NCT01180998|565034711|FG000|Overall Study|Protocol Violation|1|||
156529782|NCT01180998|565034712|FG001|Overall Study|Protocol Violation|2|||
156529783|NCT01180998|565034713|FG002|Overall Study|Protocol Violation|0|||
156684584|NCT03185741|565589254|FG002|6Month|Lost to Follow-up|16|||
156684585|NCT03573336|565589257|FG000|Overall Study|Study terminated|2|||
156684586|NCT03573336|565589258|FG001|Overall Study|Study terminated|4|||
156684587|NCT03573336|565589259|FG002|Overall Study|Study terminated|2|||
156684588|NCT01525628|565589260|FG000|Overall Study|Adverse Event|1|||
156684589|NCT01525628|565589261|FG001|Overall Study|Adverse Event|1|||
156684590|NCT01525628|565589262|FG002|Overall Study|Adverse Event|2|||
156684591|NCT01525628|565589263|FG003|Overall Study|Adverse Event|0|||
156684592|NCT01525628|565589264|FG004|Overall Study|Adverse Event|1|||
156684593|NCT01525628|565589260|FG000|Overall Study|Lack of Efficacy|0|||
156684594|NCT01525628|565589261|FG001|Overall Study|Lack of Efficacy|2|||
156684595|NCT01525628|565589262|FG002|Overall Study|Lack of Efficacy|2|||
156684596|NCT01525628|565589263|FG003|Overall Study|Lack of Efficacy|1|||
156684597|NCT01525628|565589264|FG004|Overall Study|Lack of Efficacy|2|||
156684598|NCT01525628|565589260|FG000|Overall Study|Protocol Violation|0|||
156684599|NCT01525628|565589261|FG001|Overall Study|Protocol Violation|0|||
156684600|NCT01525628|565589262|FG002|Overall Study|Protocol Violation|1|||
156684601|NCT01525628|565589263|FG003|Overall Study|Protocol Violation|0|||
156684602|NCT01525628|565589264|FG004|Overall Study|Protocol Violation|0|||
156684603|NCT01525628|565589260|FG000|Overall Study|Lost to Follow-up|1|||
156684604|NCT01525628|565589261|FG001|Overall Study|Lost to Follow-up|1|||
156684605|NCT01525628|565589262|FG002|Overall Study|Lost to Follow-up|0|||
156684606|NCT01525628|565589263|FG003|Overall Study|Lost to Follow-up|0|||
156684607|NCT01525628|565589264|FG004|Overall Study|Lost to Follow-up|0|||
156684608|NCT01525628|565589260|FG000|Overall Study|Withdrawal by Subject|0|||
156684609|NCT01525628|565589261|FG001|Overall Study|Withdrawal by Subject|1|||
156684610|NCT01525628|565589262|FG002|Overall Study|Withdrawal by Subject|0|||
156684611|NCT01525628|565589263|FG003|Overall Study|Withdrawal by Subject|0|||
156684612|NCT01525628|565589264|FG004|Overall Study|Withdrawal by Subject|0|||
156684613|NCT01525628|565589260|FG000|Overall Study|Other reason not defined above|0|||
156684614|NCT01525628|565589261|FG001|Overall Study|Other reason not defined above|0|||
156684615|NCT01525628|565589262|FG002|Overall Study|Other reason not defined above|0|||
156684616|NCT01525628|565589263|FG003|Overall Study|Other reason not defined above|3|||
156684617|NCT01525628|565589264|FG004|Overall Study|Other reason not defined above|0|||
156684618|NCT00239005|565589265|FG000|Overall Study|Adverse Event|6|||
156684619|NCT00239005|565589266|FG001|Overall Study|Adverse Event|6|||
156684620|NCT00239005|565589265|FG000|Overall Study|Withdrawal by Subject|3|||
156684621|NCT00239005|565589266|FG001|Overall Study|Withdrawal by Subject|4|||
156684622|NCT00239005|565589265|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
156684623|NCT00239005|565589266|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
156684624|NCT00239005|565589265|FG000|Overall Study|Protocol Violation|1|||
156684625|NCT00239005|565589266|FG001|Overall Study|Protocol Violation|0|||
156684626|NCT00239005|565589265|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
156684627|NCT00239005|565589266|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
156684628|NCT00239005|565589265|FG000|Overall Study|Lost to Follow-up|0|||
156684629|NCT00239005|565589266|FG001|Overall Study|Lost to Follow-up|1|||
156684630|NCT03108820|565589267|FG000|Overall Study|Lost to Follow-up|30|||
156684631|NCT03108820|565589268|FG001|Overall Study|Lost to Follow-up|28|||
156684632|NCT03108820|565589267|FG000|Overall Study|Withdrawal by Subject|32|||
156784728|NCT01433978|565963258|FG002|Extension Phase|Study Terminated by Sponsor|4|||
156529784|NCT01180998|565034711|FG000|Overall Study|Withdrawal by Subject|0|||
156684633|NCT03108820|565589268|FG001|Overall Study|Withdrawal by Subject|24|||
156684634|NCT03108820|565589267|FG000|Overall Study|Death|6|||
156684635|NCT03108820|565589268|FG001|Overall Study|Death|11|||
156529785|NCT01180998|565034712|FG001|Overall Study|Withdrawal by Subject|0|||
156684636|NCT00787605|565589269|FG000|Overall Study|Administrative Problems|3|||
156784729|NCT01773889|565963259|FG000|Overall Study|lack of funding|2|||
156529786|NCT01180998|565034713|FG002|Overall Study|Withdrawal by Subject|1|||
156529787|NCT01180998|565034711|FG000|Overall Study|Poor comfort|3|||
156529788|NCT01180998|565034712|FG001|Overall Study|Poor comfort|0|||
156784730|NCT03954938|565963260|FG000|Overall Study|Withdrawal by Subject|2|||
156784731|NCT03954938|565963260|FG000|Overall Study|Adverse Event|1|||
156784732|NCT01371565|565963261|FG000|Overall Study|Withdrawal by Subject|1|||
156784733|NCT01371565|565963261|FG000|Overall Study|Death|1|||
156784734|NCT01371565|565963261|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
156784735|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
156784736|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
156784737|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
156784738|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
156784739|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
156784740|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
156784741|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
156784742|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
156784743|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
156784744|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
156784745|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
156784746|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
156784747|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
156784748|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
156784749|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
156784750|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
156784751|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
156784752|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
156784753|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
156529789|NCT01180998|565034713|FG002|Overall Study|Poor comfort|4|||
156784754|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
156784755|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
156329739|NCT04526509|564307052|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156329740|NCT04526509|564307053|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156529790|NCT01180998|565034711|FG000|Overall Study|Poor lens handling|0|||
156529791|NCT01180998|565034712|FG001|Overall Study|Poor lens handling|0|||
156529792|NCT01180998|565034713|FG002|Overall Study|Poor lens handling|2|||
156529793|NCT01176968|565034714|FG000|Overall Study|Adverse Event|10|||
156529794|NCT01176968|565034715|FG001|Overall Study|Adverse Event|11|||
156529795|NCT01176968|565034714|FG000|Overall Study|Death|2|||
156529796|NCT01176968|565034715|FG001|Overall Study|Death|3|||
156529797|NCT01176968|565034714|FG000|Overall Study|Lack of Efficacy|0|||
156529798|NCT01176968|565034715|FG001|Overall Study|Lack of Efficacy|1|||
156529799|NCT01176968|565034714|FG000|Overall Study|Lost to Follow-up|16|||
156529800|NCT01176968|565034715|FG001|Overall Study|Lost to Follow-up|14|||
156529801|NCT01176968|565034714|FG000|Overall Study|Withdrawal by Subject|48|||
156529802|NCT01176968|565034715|FG001|Overall Study|Withdrawal by Subject|48|||
156529803|NCT01176968|565034714|FG000|Overall Study|Protocol Violation|2|||
156529804|NCT01176968|565034715|FG001|Overall Study|Protocol Violation|1|||
156529805|NCT01176968|565034714|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
156529806|NCT01176968|565034715|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
156529807|NCT01176968|565034714|FG000|Overall Study|Study terminated by sponsor|0|||
156529808|NCT01176968|565034715|FG001|Overall Study|Study terminated by sponsor|1|||
156529809|NCT01176968|565034714|FG000|Overall Study|Reason not defined|5|||
156529810|NCT01176968|565034715|FG001|Overall Study|Reason not defined|3|||
156529811|NCT05057247|565034716|FG000|Overall Study|Death|4|||
156529812|NCT05057247|565034716|FG000|Overall Study|Physician Decision|3|||
156529813|NCT05057247|565034716|FG000|Overall Study|Progressive Disease|7|||
156529814|NCT05057247|565034716|FG000|Overall Study|Withdrawal by Subject|3|||
156529815|NCT05057247|565034716|FG000|Overall Study|Adverse Event|6|||
156529816|NCT05057247|565034716|FG000|Overall Study|Subject Non-Compliance|1|||
156529817|NCT05057247|565034716|FG000|Overall Study|On treatment|2|||
156529818|NCT03588728|565034720|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
156529819|NCT03588728|565034721|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
156529820|NCT03588728|565034722|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
156529821|NCT03588728|565034723|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
156529822|NCT03588728|565034720|FG000|Overall Study|Lab shut down due to COVID-19|0|||
156529823|NCT03588728|565034721|FG001|Overall Study|Lab shut down due to COVID-19|0|||
156529824|NCT03588728|565034722|FG002|Overall Study|Lab shut down due to COVID-19|0|||
156529825|NCT03588728|565034723|FG003|Overall Study|Lab shut down due to COVID-19|1|||
156529826|NCT03588728|565034720|FG000|Overall Study|multiple technical issues|1|||
156784756|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
156529827|NCT03588728|565034721|FG001|Overall Study|multiple technical issues|0|||
156529828|NCT03588728|565034722|FG002|Overall Study|multiple technical issues|0|||
156529829|NCT03588728|565034723|FG003|Overall Study|multiple technical issues|0|||
156784757|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
156784758|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
156435946|NCT03979365|564686705|FG001|Overall Study|Withdrawal by Subject|1|||
156435947|NCT03979365|564686704|FG000|Overall Study|Drug Conversion|0|||
156435948|NCT03979365|564686705|FG001|Overall Study|Drug Conversion|3|||
156435949|NCT01580293|564686706|FG000|Part A_Main Trial|Adverse Event|0|||
156435950|NCT01580293|564686707|FG001|Part A_Main Trial|Adverse Event|2|||
156435951|NCT01580293|564686708|FG002|Part A_Main Trial|Adverse Event|0|||
156435952|NCT01580293|564686706|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
156435953|NCT01580293|564686707|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
156435954|NCT01580293|564686708|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
156435955|NCT01580293|564686706|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
156435956|NCT01580293|564686707|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
156435957|NCT01580293|564686708|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
156435958|NCT01580293|564686706|FG000|Part A_Extension|Adverse Event|0|||
156435959|NCT01580293|564686707|FG001|Part A_Extension|Adverse Event|2|||
156435960|NCT01580293|564686708|FG002|Part A_Extension|Adverse Event|0|||
156435961|NCT01580293|564686706|FG000|Part A_Extension|Withdrawal by Subject|0|||
156435962|NCT01580293|564686707|FG001|Part A_Extension|Withdrawal by Subject|3|||
156435963|NCT01580293|564686708|FG002|Part A_Extension|Withdrawal by Subject|0|||
156435964|NCT01580293|564686706|FG000|Part A_Extension|Lost to Follow-up|0|||
156435965|NCT01580293|564686707|FG001|Part A_Extension|Lost to Follow-up|1|||
156435966|NCT01580293|564686708|FG002|Part A_Extension|Lost to Follow-up|0|||
156435967|NCT01580293|564686706|FG000|Part A_Extension|Other Reason|0|||
156435968|NCT01580293|564686707|FG001|Part A_Extension|Other Reason|1|||
156435969|NCT01580293|564686708|FG002|Part A_Extension|Other Reason|0|||
156435970|NCT01580293|564686706|FG000|Part A_Extension|Completed Japan only|0|||
156435971|NCT01580293|564686707|FG001|Part A_Extension|Completed Japan only|5|||
156435972|NCT01580293|564686708|FG002|Part A_Extension|Completed Japan only|0|||
156435973|NCT01580293|564686706|FG000|Part B|Withdrawal by Subject|0|||
156435974|NCT01580293|564686707|FG001|Part B|Withdrawal by Subject|0|||
156435975|NCT01580293|564686708|FG002|Part B|Withdrawal by Subject|1|||
156435976|NCT01580293|564686706|FG000|Part B|Other reason|0|||
156435977|NCT01580293|564686707|FG001|Part B|Other reason|0|||
156435978|NCT01580293|564686708|FG002|Part B|Other reason|1|||
156435979|NCT01134562|564686709|FG000|Overall Study|Adverse Event|0|||
156435980|NCT01134562|564686710|FG001|Overall Study|Adverse Event|1|||
156435981|NCT01134562|564686711|FG002|Overall Study|Adverse Event|0|||
156435982|NCT01134562|564686712|FG003|Overall Study|Adverse Event|0|||
156435983|NCT01134562|564686713|FG004|Overall Study|Adverse Event|0|||
156435984|NCT00711958|564686714|FG000|Overall Study|Withdrawal by Subject|6|||
156435985|NCT00711958|564686715|FG001|Overall Study|Withdrawal by Subject|8|||
156435986|NCT00711958|564686714|FG000|Overall Study|Lack of Efficacy|3|||
156435987|NCT00711958|564686715|FG001|Overall Study|Lack of Efficacy|1|||
156435988|NCT00711958|564686714|FG000|Overall Study|Clinical deterioration|1|||
156435989|NCT00711958|564686715|FG001|Overall Study|Clinical deterioration|0|||
156435990|NCT00711958|564686714|FG000|Overall Study|Adverse Event|9|||
156435991|NCT00711958|564686715|FG001|Overall Study|Adverse Event|7|||
156435992|NCT00711958|564686714|FG000|Overall Study|Protocol Violation|1|||
156435993|NCT00711958|564686715|FG001|Overall Study|Protocol Violation|0|||
156435994|NCT00711958|564686714|FG000|Overall Study|Lost to Follow-up|2|||
156435995|NCT00711958|564686715|FG001|Overall Study|Lost to Follow-up|2|||
156435996|NCT00711958|564686714|FG000|Overall Study|Death|10|||
156435997|NCT00711958|564686715|FG001|Overall Study|Death|5|||
156435998|NCT00711958|564686714|FG000|Overall Study|Progression of disease|1|||
156435999|NCT00711958|564686715|FG001|Overall Study|Progression of disease|0|||
156436000|NCT02383472|564686716|FG000|Overall Study|Withdrawal by Subject|1|||
156436001|NCT02383472|564686717|FG001|Overall Study|Withdrawal by Subject|1|||
156436002|NCT00854906|564686720|FG000|Overall Study|One person had no ocular history|1|||
156436003|NCT00071799|564686721|FG000|Overall Study|Adverse Event|19|||
156436004|NCT00071799|564686722|FG001|Overall Study|Adverse Event|10|||
156436005|NCT00071799|564686721|FG000|Overall Study|Protocol Violation|1|||
156436006|NCT00071799|564686722|FG001|Overall Study|Protocol Violation|7|||
156436007|NCT00071799|564686721|FG000|Overall Study|Lost to Follow-up|1|||
156436008|NCT00071799|564686722|FG001|Overall Study|Lost to Follow-up|1|||
156436009|NCT00071799|564686721|FG000|Overall Study|Withdrawal by Subject|15|||
156436010|NCT00071799|564686722|FG001|Overall Study|Withdrawal by Subject|37|||
156436011|NCT00071799|564686721|FG000|Overall Study|Physician Decision|0|||
156436012|NCT00071799|564686722|FG001|Overall Study|Physician Decision|2|||
156436013|NCT00071799|564686721|FG000|Overall Study|Lack of Efficacy|11|||
156436014|NCT00071799|564686722|FG001|Overall Study|Lack of Efficacy|18|||
156436015|NCT00071799|564686721|FG000|Overall Study|Disease Progression|23|||
156436016|NCT00071799|564686722|FG001|Overall Study|Disease Progression|20|||
156436017|NCT00071799|564686721|FG000|Overall Study|Different Central+Local Pathology Review|0|||
156436018|NCT00071799|564686722|FG001|Overall Study|Different Central+Local Pathology Review|1|||
156436019|NCT00071799|564686721|FG000|Overall Study|Not Documented|0|||
156436020|NCT00071799|564686722|FG001|Overall Study|Not Documented|2|||
156436021|NCT05526248|564686725|FG000|Overall Study|Lost to Follow-up|1|||
156436022|NCT05526248|564686725|FG000|Overall Study|Adverse Event|2|||
156436023|NCT05526248|564686725|FG000|Overall Study|Withdrawal by Subject|1|||
156436024|NCT04527549|564686726|FG000|Overall Study|Withdrawal by Subject|1|||
156436025|NCT04527549|564686727|FG001|Overall Study|Withdrawal by Subject|1|||
156436026|NCT00814346|564686730|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
156436027|NCT00814346|564686731|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
156436028|NCT00814346|564686730|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
156436029|NCT00814346|564686731|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
156436030|NCT00814346|564686730|FG000|Open Phase (17 Months)|Adverse Event|5|||
156436031|NCT00814346|564686731|FG001|Open Phase (17 Months)|Adverse Event|0|||
156436032|NCT00814346|564686730|FG000|Open Phase (17 Months)|Consent|2|||
156436033|NCT00814346|564686731|FG001|Open Phase (17 Months)|Consent|0|||
156436034|NCT00814346|564686730|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
156436035|NCT00814346|564686731|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
156436036|NCT00814346|564686730|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
156436037|NCT00814346|564686731|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
156436038|NCT05136443|564686733|FG000|Overall Study|Lost to Follow-up|2|||
156684637|NCT00787605|565589270|FG001|Overall Study|Administrative Problems|0|||
156684638|NCT00787605|565589269|FG000|Overall Study|Adverse Event|14|||
156684639|NCT00787605|565589270|FG001|Overall Study|Adverse Event|25|||
156684640|NCT00787605|565589269|FG000|Overall Study|Lost to Follow-up|3|||
156684641|NCT00787605|565589270|FG001|Overall Study|Lost to Follow-up|6|||
156684642|NCT00787605|565589269|FG000|Overall Study|Protocol Violation|7|||
156684643|NCT00787605|565589270|FG001|Overall Study|Protocol Violation|3|||
156684644|NCT00787605|565589269|FG000|Overall Study|Withdrawal by Subject|6|||
156684645|NCT00787605|565589270|FG001|Overall Study|Withdrawal by Subject|13|||
156684646|NCT00787605|565589269|FG000|Overall Study|Lack of Efficacy|13|||
156684647|NCT00787605|565589270|FG001|Overall Study|Lack of Efficacy|9|||
156684648|NCT01488448|565589276|FG000|Overall Study|Withdrawal by Subject|3|||
156684649|NCT01488448|565589277|FG001|Overall Study|Withdrawal by Subject|1|||
156684650|NCT01488448|565589276|FG000|Overall Study|Adverse Event|9|||
156684651|NCT01488448|565589277|FG001|Overall Study|Adverse Event|4|||
156684652|NCT01488448|565589276|FG000|Overall Study|Physician Decision|4|||
156684653|NCT01488448|565589277|FG001|Overall Study|Physician Decision|9|||
156684654|NCT01488448|565589276|FG000|Overall Study|Protocol Violation|4|||
156684655|NCT01488448|565589277|FG001|Overall Study|Protocol Violation|3|||
156684656|NCT00654641|565589278|FG000|Overall Study|Lost to Follow-up|2|||
156684657|NCT00654641|565589279|FG001|Overall Study|Lost to Follow-up|3|||
156436039|NCT05136443|564686733|FG000|Overall Study|Adverse Event|2|||
156436040|NCT05764161|564686734|FG000|12-week DBVC Period|Lack of Efficacy|2|||
156436041|NCT05764161|564686735|FG001|12-week DBVC Period|Lack of Efficacy|1|||
156436042|NCT05764161|564686734|FG000|12-week DBVC Period|Lost to Follow-up|0|||
156684658|NCT01992094|565589280|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
156684659|NCT01992094|565589281|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
156684660|NCT01992094|565589282|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
156684661|NCT01992094|565589280|FG000|Overall Study|Adverse Event|1|||
156684662|NCT01992094|565589281|FG001|Overall Study|Adverse Event|0|||
156684663|NCT01992094|565589282|FG002|Overall Study|Adverse Event|0|||
156684664|NCT01992094|565589280|FG000|Overall Study|Death|5|||
156436043|NCT05764161|564686735|FG001|12-week DBVC Period|Lost to Follow-up|2|||
156684665|NCT01992094|565589281|FG001|Overall Study|Death|5|||
156684666|NCT01992094|565589282|FG002|Overall Study|Death|2|||
156684667|NCT01992094|565589280|FG000|Overall Study|Lost to Follow-up|26|||
156684668|NCT01992094|565589281|FG001|Overall Study|Lost to Follow-up|9|||
156684669|NCT01992094|565589282|FG002|Overall Study|Lost to Follow-up|13|||
156684670|NCT01992094|565589280|FG000|Overall Study|OTHER|4|||
156684671|NCT01992094|565589281|FG001|Overall Study|OTHER|0|||
156684672|NCT01992094|565589282|FG002|Overall Study|OTHER|0|||
156684673|NCT01992094|565589280|FG000|Overall Study|Protocol Violation|1|||
156684674|NCT01992094|565589281|FG001|Overall Study|Protocol Violation|0|||
156684675|NCT01992094|565589282|FG002|Overall Study|Protocol Violation|1|||
156436044|NCT05764161|564686734|FG000|12-week DBVC Period|Protocol Violation|2|||
156684676|NCT01992094|565589280|FG000|Overall Study|Withdrawal by Subject|7|||
156684677|NCT01992094|565589281|FG001|Overall Study|Withdrawal by Subject|3|||
156684678|NCT01992094|565589282|FG002|Overall Study|Withdrawal by Subject|4|||
156684679|NCT00810602|565589285|FG000|Overall Study|Withdrawal by Subject|8|||
156684680|NCT00810602|565589286|FG001|Overall Study|Withdrawal by Subject|3|||
156684681|NCT03840382|565589287|FG000|Overall Study|Lost to Follow-up|11|||
156684682|NCT02625974|565589288|FG000|Part 1|Lost to Follow-up|9|||
156436045|NCT05764161|564686735|FG001|12-week DBVC Period|Protocol Violation|4|||
156436046|NCT05764161|564686734|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
156436047|NCT05764161|564686735|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
156436048|NCT05764161|564686734|FG000|40-week OLE Period|Lack of Efficacy|0|||
156436049|NCT05764161|564686735|FG001|40-week OLE Period|Lack of Efficacy|1|||
156684683|NCT02625974|565589289|FG001|Part 1|Lost to Follow-up|3|||
156684684|NCT02625974|565589288|FG000|Part 2|Lost to Follow-up|4|||
156684685|NCT02625974|565589289|FG001|Part 2|Lost to Follow-up|6|||
156684686|NCT02625974|565589288|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
156436050|NCT05764161|564686734|FG000|40-week OLE Period|Lost to Follow-up|1|||
156436051|NCT05764161|564686735|FG001|40-week OLE Period|Lost to Follow-up|4|||
156684687|NCT02625974|565589289|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
156684688|NCT01142661|565589290|FG000|Overall Study|Adverse Event|2|||
156684689|NCT01142661|565589290|FG000|Overall Study|Withdrawal by Subject|1|||
156684690|NCT01142661|565589290|FG000|Overall Study|Physician Decision|1|||
156684691|NCT00434590|565589291|FG000|Overall Study|Administrative problems|5|||
156684692|NCT00434590|565589292|FG001|Overall Study|Administrative problems|5|||
156684693|NCT00965731|565589295|FG000|Overall Study|Death|0|||
156684694|NCT00965731|565589296|FG001|Overall Study|Death|4|||
156684695|NCT00965731|565589295|FG000|Overall Study|Withdrawal by Subject|0|||
156684696|NCT00965731|565589296|FG001|Overall Study|Withdrawal by Subject|1|||
156684697|NCT00965731|565589295|FG000|Overall Study|Other|7|||
156684698|NCT00965731|565589296|FG001|Overall Study|Other|15|||
156684699|NCT03429049|565590629|FG000|Overall Study|Adverse Event|2|||
156684700|NCT03429049|565590630|FG001|Overall Study|Adverse Event|3|||
156684701|NCT03429049|565590629|FG000|Overall Study|Death|0|||
156684702|NCT03429049|565590630|FG001|Overall Study|Death|1|||
156684703|NCT03429049|565590629|FG000|Overall Study|Lack of Efficacy|4|||
156684704|NCT03429049|565590630|FG001|Overall Study|Lack of Efficacy|2|||
156684705|NCT03429049|565590629|FG000|Overall Study|Lost to Follow-up|9|||
156684706|NCT03429049|565590630|FG001|Overall Study|Lost to Follow-up|8|||
156784759|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
156784760|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
156684707|NCT03429049|565590629|FG000|Overall Study|Physician Decision|1|||
156684708|NCT03429049|565590630|FG001|Overall Study|Physician Decision|0|||
156784761|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
156436052|NCT05764161|564686734|FG000|40-week OLE Period|Withdrawal by Subject|2|||
156436053|NCT05764161|564686735|FG001|40-week OLE Period|Withdrawal by Subject|7|||
156436054|NCT05764161|564686734|FG000|40-week OLE Period|Extended Travel|0|||
156436055|NCT05764161|564686735|FG001|40-week OLE Period|Extended Travel|1|||
156436056|NCT05764161|564686734|FG000|40-week OLE Period|Ongoing|66|||
156436057|NCT05764161|564686735|FG001|40-week OLE Period|Ongoing|59|||
156436058|NCT00507689|564686742|FG000|Pre-Randomization Period|Adverse Event|1|||
156436059|NCT00507689|564686743|FG001|Pre-Randomization Period|Adverse Event|0|||
156436060|NCT00507689|564686742|FG000|Pre-Randomization Period|Physician Decision|1|||
156436061|NCT00507689|564686743|FG001|Pre-Randomization Period|Physician Decision|0|||
156436062|NCT00507689|564686742|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
156436063|NCT00507689|564686743|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
156436064|NCT00507689|564686742|FG000|Randomized Period|Adverse Event|1|||
156436065|NCT00507689|564686743|FG001|Randomized Period|Adverse Event|1|||
156436066|NCT00507689|564686742|FG000|Randomized Period|Withdrawal by Subject|0|||
156436067|NCT00507689|564686743|FG001|Randomized Period|Withdrawal by Subject|1|||
156436068|NCT01145885|564686749|FG000|Overall Study|Progressive Disease|7|||
156436069|NCT05299606|564686750|FG000|Overall Study|Death|1|||
156436070|NCT03460756|564686752|FG000|Overall Study|Adverse Event|0|||
156436071|NCT03460756|564686753|FG001|Overall Study|Adverse Event|0|||
156436072|NCT03460756|564686754|FG002|Overall Study|Adverse Event|0|||
156436073|NCT03460756|564686755|FG003|Overall Study|Adverse Event|1|||
156436074|NCT03460756|564686752|FG000|Overall Study|Lack of Efficacy|0|||
156436075|NCT03460756|564686753|FG001|Overall Study|Lack of Efficacy|0|||
156436076|NCT03460756|564686754|FG002|Overall Study|Lack of Efficacy|0|||
156436077|NCT03460756|564686755|FG003|Overall Study|Lack of Efficacy|2|||
156436078|NCT03460756|564686752|FG000|Overall Study|Lost to Follow-up|0|||
156436079|NCT03460756|564686753|FG001|Overall Study|Lost to Follow-up|1|||
156436080|NCT03460756|564686754|FG002|Overall Study|Lost to Follow-up|2|||
156436081|NCT03460756|564686755|FG003|Overall Study|Lost to Follow-up|1|||
156436082|NCT03460756|564686752|FG000|Overall Study|Pregnancy|0|||
156436083|NCT03460756|564686753|FG001|Overall Study|Pregnancy|0|||
156436084|NCT03460756|564686754|FG002|Overall Study|Pregnancy|0|||
156436085|NCT03460756|564686755|FG003|Overall Study|Pregnancy|1|||
156436086|NCT03460756|564686752|FG000|Overall Study|Protocol Violation|0|||
156436087|NCT03460756|564686753|FG001|Overall Study|Protocol Violation|0|||
156436088|NCT03460756|564686754|FG002|Overall Study|Protocol Violation|0|||
156436089|NCT03460756|564686755|FG003|Overall Study|Protocol Violation|1|||
156436090|NCT03460756|564686752|FG000|Overall Study|Withdrawal by Subject|0|||
156436091|NCT03460756|564686753|FG001|Overall Study|Withdrawal by Subject|4|||
156684709|NCT03429049|565590629|FG000|Overall Study|Protocol Violation|3|||
156684710|NCT03429049|565590630|FG001|Overall Study|Protocol Violation|0|||
156684711|NCT03429049|565590629|FG000|Overall Study|Sponsor Decision|2|||
156684712|NCT03429049|565590630|FG001|Overall Study|Sponsor Decision|0|||
156784762|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
156436092|NCT03460756|564686754|FG002|Overall Study|Withdrawal by Subject|7|||
156436093|NCT03460756|564686755|FG003|Overall Study|Withdrawal by Subject|3|||
156436094|NCT00723450|564686757|FG000|Open-Label Phase|Adverse Event|26|||
156436095|NCT00723450|564686758|FG001|Open-Label Phase|Adverse Event|0|||
156436096|NCT00723450|564686759|FG002|Open-Label Phase|Adverse Event|0|||
156436097|NCT00723450|564686757|FG000|Open-Label Phase|Lack of Efficacy|18|||
156436098|NCT00723450|564686758|FG001|Open-Label Phase|Lack of Efficacy|0|||
156436099|NCT00723450|564686759|FG002|Open-Label Phase|Lack of Efficacy|0|||
156684713|NCT03429049|565590629|FG000|Overall Study|Withdrawal by Subject|4|||
156684714|NCT03429049|565590630|FG001|Overall Study|Withdrawal by Subject|20|||
156684715|NCT03429049|565590629|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
156684716|NCT03429049|565590630|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
156684717|NCT04703855|565590631|FG000|Overall Study|Heart Transplant|1|||
156684718|NCT01560819|565590633|FG000|Overall Study|Physician Decision|1|||
156684719|NCT01560819|565590634|FG001|Overall Study|Physician Decision|0|||
156684720|NCT00399893|565590637|FG000|Overall Study|Withdrawal by Subject|1|||
156684721|NCT00399893|565590638|FG001|Overall Study|Withdrawal by Subject|0|||
156868369|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
156868370|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868371|NCT02085161|566277294|FG000|Overall Study|Not Treated|1|||
156868372|NCT02085161|566277295|FG001|Overall Study|Not Treated|0|||
156868373|NCT02085161|566277296|FG002|Overall Study|Not Treated|0|||
156868374|NCT02085161|566277297|FG003|Overall Study|Not Treated|0|||
156868375|NCT02085161|566277294|FG000|Overall Study|Adverse Event|8|||
156868376|NCT02085161|566277295|FG001|Overall Study|Adverse Event|5|||
156868377|NCT02085161|566277296|FG002|Overall Study|Adverse Event|4|||
156868378|NCT02085161|566277297|FG003|Overall Study|Adverse Event|5|||
156868379|NCT02085161|566277294|FG000|Overall Study|Protocol Violation|0|||
156868380|NCT02085161|566277295|FG001|Overall Study|Protocol Violation|1|||
156868381|NCT02085161|566277296|FG002|Overall Study|Protocol Violation|0|||
156868382|NCT02085161|566277297|FG003|Overall Study|Protocol Violation|1|||
156868383|NCT02085161|566277294|FG000|Overall Study|Withdrawal by Subject|2|||
156868384|NCT02085161|566277295|FG001|Overall Study|Withdrawal by Subject|4|||
156868385|NCT02085161|566277296|FG002|Overall Study|Withdrawal by Subject|0|||
156868386|NCT02085161|566277297|FG003|Overall Study|Withdrawal by Subject|3|||
156868387|NCT02085161|566277294|FG000|Overall Study|Other Reason|1|||
156868388|NCT02085161|566277295|FG001|Overall Study|Other Reason|0|||
156868389|NCT02085161|566277296|FG002|Overall Study|Other Reason|1|||
156868390|NCT02085161|566277297|FG003|Overall Study|Other Reason|1|||
156868391|NCT00068692|566277308|FG000|Step 1: Registration|Disese progression/relapse|5|||
156868392|NCT00068692|566277309|FG001|Step 1: Registration|Disese progression/relapse|0|||
156868393|NCT00068692|566277310|FG002|Step 1: Registration|Disese progression/relapse|0|||
156868394|NCT00068692|566277311|FG003|Step 1: Registration|Disese progression/relapse|0|||
156868395|NCT00068692|566277312|FG004|Step 1: Registration|Disese progression/relapse|0|||
156868396|NCT00068692|566277313|FG005|Step 1: Registration|Disese progression/relapse|0|||
156529830|NCT03588728|565034720|FG000|Overall Study|Hospitalized for COVID|1|||
156529831|NCT03588728|565034721|FG001|Overall Study|Hospitalized for COVID|0|||
156529832|NCT03588728|565034722|FG002|Overall Study|Hospitalized for COVID|0|||
156529833|NCT03588728|565034723|FG003|Overall Study|Hospitalized for COVID|0|||
156529834|NCT03588728|565034720|FG000|Overall Study|Schedule change unable to attend sessions|1|||
156529835|NCT03588728|565034721|FG001|Overall Study|Schedule change unable to attend sessions|0|||
156529836|NCT03588728|565034722|FG002|Overall Study|Schedule change unable to attend sessions|0|||
156868397|NCT00068692|566277314|FG006|Step 1: Registration|Disese progression/relapse|0|||
156868398|NCT00068692|566277315|FG007|Step 1: Registration|Disese progression/relapse|0|||
156868399|NCT00068692|566277308|FG000|Step 1: Registration|Adverse Event|7|||
156868400|NCT00068692|566277309|FG001|Step 1: Registration|Adverse Event|0|||
156868401|NCT00068692|566277310|FG002|Step 1: Registration|Adverse Event|0|||
156868402|NCT00068692|566277311|FG003|Step 1: Registration|Adverse Event|0|||
156868403|NCT00068692|566277312|FG004|Step 1: Registration|Adverse Event|0|||
156868404|NCT00068692|566277313|FG005|Step 1: Registration|Adverse Event|0|||
156868405|NCT00068692|566277314|FG006|Step 1: Registration|Adverse Event|0|||
156868406|NCT00068692|566277315|FG007|Step 1: Registration|Adverse Event|0|||
156868407|NCT00068692|566277308|FG000|Step 1: Registration|Death|1|||
156868408|NCT00068692|566277309|FG001|Step 1: Registration|Death|0|||
156868409|NCT00068692|566277310|FG002|Step 1: Registration|Death|0|||
156868410|NCT00068692|566277311|FG003|Step 1: Registration|Death|0|||
156529837|NCT03588728|565034723|FG003|Overall Study|Schedule change unable to attend sessions|0|||
156529838|NCT01388790|565034724|FG000|Overall Study|Ongoing at data cut-off date|8|||
156529839|NCT00908232|565034725|FG000|Cycle 1 to 4|Death|5|||
156684722|NCT00114231|565590639|FG000|Overall Study|No consent|2|||
156684723|NCT00114231|565590640|FG001|Overall Study|No consent|0|||
156684724|NCT00114231|565590639|FG000|Overall Study|QARC requirement not met|1|||
156684725|NCT00114231|565590640|FG001|Overall Study|QARC requirement not met|0|||
156684726|NCT00114231|565590639|FG000|Overall Study|Suspected metastatic disease|1|||
156684727|NCT00114231|565590640|FG001|Overall Study|Suspected metastatic disease|0|||
156868411|NCT00068692|566277312|FG004|Step 1: Registration|Death|0|||
156868412|NCT00068692|566277313|FG005|Step 1: Registration|Death|0|||
156868413|NCT00068692|566277314|FG006|Step 1: Registration|Death|0|||
156868414|NCT00068692|566277315|FG007|Step 1: Registration|Death|0|||
156868415|NCT00068692|566277308|FG000|Step 1: Registration|Withdrawal by Subject|11|||
156868416|NCT00068692|566277309|FG001|Step 1: Registration|Withdrawal by Subject|0|||
156868417|NCT00068692|566277310|FG002|Step 1: Registration|Withdrawal by Subject|0|||
156868418|NCT00068692|566277311|FG003|Step 1: Registration|Withdrawal by Subject|0|||
156529840|NCT00908232|565034726|FG001|Cycle 1 to 4|Death|0|||
156529841|NCT00908232|565034727|FG002|Cycle 1 to 4|Death|0|||
156529842|NCT00908232|565034728|FG003|Cycle 1 to 4|Death|0|||
156529843|NCT00908232|565034725|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
156529844|NCT00908232|565034726|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
156529845|NCT00908232|565034727|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
156529846|NCT00908232|565034728|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
156529847|NCT00908232|565034725|FG000|Cycle 1 to 4|Progressive Disease|6|||
156529848|NCT00908232|565034726|FG001|Cycle 1 to 4|Progressive Disease|0|||
156529849|NCT00908232|565034727|FG002|Cycle 1 to 4|Progressive Disease|0|||
156529850|NCT00908232|565034728|FG003|Cycle 1 to 4|Progressive Disease|0|||
156529851|NCT00908232|565034725|FG000|Cycle 1 to 4|Adverse Event|12|||
156529852|NCT00908232|565034726|FG001|Cycle 1 to 4|Adverse Event|0|||
156529853|NCT00908232|565034727|FG002|Cycle 1 to 4|Adverse Event|0|||
156529854|NCT00908232|565034728|FG003|Cycle 1 to 4|Adverse Event|0|||
156529855|NCT00908232|565034725|FG000|Cycle 1 to 4|Other|1|||
156529856|NCT00908232|565034726|FG001|Cycle 1 to 4|Other|0|||
156529857|NCT00908232|565034727|FG002|Cycle 1 to 4|Other|0|||
156529858|NCT00908232|565034728|FG003|Cycle 1 to 4|Other|0|||
156529859|NCT00908232|565034725|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
156529860|NCT00908232|565034726|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
156529861|NCT00908232|565034727|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
156784763|NCT00617903|565963264|FG000|Overall Study|Withdrawal by Subject|2|||
156784764|NCT00617903|565963265|FG001|Overall Study|Withdrawal by Subject|3|||
156784765|NCT00617903|565963264|FG000|Overall Study|Lost to Follow-up|1|||
156784766|NCT00617903|565963265|FG001|Overall Study|Lost to Follow-up|1|||
156784767|NCT00617903|565963264|FG000|Overall Study|Lack of Efficacy|0|||
156784768|NCT00617903|565963265|FG001|Overall Study|Lack of Efficacy|1|||
156784769|NCT00617903|565963264|FG000|Overall Study|Adverse Event|0|||
156784770|NCT00617903|565963265|FG001|Overall Study|Adverse Event|1|||
156784771|NCT00617903|565963264|FG000|Overall Study|noncompliance|0|||
156784772|NCT00617903|565963265|FG001|Overall Study|noncompliance|1|||
156784773|NCT02565186|565963266|FG000|Overall Study|Adverse Event|113|||
156784774|NCT02565186|565963267|FG001|Overall Study|Adverse Event|148|||
156784775|NCT02565186|565963266|FG000|Overall Study|Lost to Follow-up|102|||
156784776|NCT02565186|565963267|FG001|Overall Study|Lost to Follow-up|93|||
156784777|NCT02565186|565963266|FG000|Overall Study|Non-Compliance|57|||
156784778|NCT02565186|565963267|FG001|Overall Study|Non-Compliance|55|||
156784779|NCT02565186|565963266|FG000|Overall Study|Withdrawal by Subject|229|||
156784780|NCT02565186|565963267|FG001|Overall Study|Withdrawal by Subject|214|||
156784781|NCT02565186|565963266|FG000|Overall Study|Physician Decision|18|||
156784782|NCT02565186|565963267|FG001|Overall Study|Physician Decision|16|||
156784783|NCT02565186|565963266|FG000|Overall Study|Sponsor Request|5|||
156784784|NCT02565186|565963267|FG001|Overall Study|Sponsor Request|9|||
156784785|NCT02565186|565963266|FG000|Overall Study|Missing|1|||
156784786|NCT02565186|565963267|FG001|Overall Study|Missing|0|||
156529862|NCT00908232|565034728|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
156529863|NCT00908232|565034725|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
156529864|NCT00908232|565034726|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
156529865|NCT00908232|565034727|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
156529866|NCT00908232|565034728|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
156436100|NCT00723450|564686757|FG000|Open-Label Phase|Protocol Violation|35|||
156436101|NCT00723450|564686758|FG001|Open-Label Phase|Protocol Violation|0|||
156436102|NCT00723450|564686759|FG002|Open-Label Phase|Protocol Violation|0|||
156436103|NCT00723450|564686757|FG000|Open-Label Phase|Lost to Follow-up|7|||
156436104|NCT00723450|564686758|FG001|Open-Label Phase|Lost to Follow-up|0|||
156436105|NCT00723450|564686759|FG002|Open-Label Phase|Lost to Follow-up|0|||
156436106|NCT00723450|564686757|FG000|Open-Label Phase|Physician Decision|2|||
156436107|NCT00723450|564686758|FG001|Open-Label Phase|Physician Decision|0|||
156436108|NCT00723450|564686759|FG002|Open-Label Phase|Physician Decision|0|||
156436109|NCT00723450|564686757|FG000|Open-Label Phase|Withdrawal by Subject|37|||
156436110|NCT00723450|564686758|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156436111|NCT00723450|564686759|FG002|Open-Label Phase|Withdrawal by Subject|0|||
156436112|NCT00723450|564686757|FG000|Randomized Phase|Adverse Event|0|||
156436113|NCT00723450|564686758|FG001|Randomized Phase|Adverse Event|26|||
156436114|NCT00723450|564686759|FG002|Randomized Phase|Adverse Event|17|||
156784787|NCT02565186|565963266|FG000|Overall Study|Did Not Receive Study Drug|55|||
156436115|NCT00723450|564686757|FG000|Randomized Phase|Lack of Efficacy|0|||
156436116|NCT00723450|564686758|FG001|Randomized Phase|Lack of Efficacy|11|||
156529867|NCT00908232|565034725|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
156529868|NCT00908232|565034726|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
156529869|NCT00908232|565034727|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
156784788|NCT02565186|565963267|FG001|Overall Study|Did Not Receive Study Drug|86|||
156784789|NCT02217982|565963268|FG000|Overall Study|Trial discontinued|1|||
156784790|NCT02217982|565963269|FG001|Overall Study|Trial discontinued|0|||
156784791|NCT02217982|565963268|FG000|Overall Study|Adverse Event|0|||
156784792|NCT02217982|565963269|FG001|Overall Study|Adverse Event|1|||
156784793|NCT04676646|565963270|FG000|Open-label Run-in Phase|Adverse Event|3|||
156684728|NCT00114231|565590639|FG000|Overall Study|No adenocarcinoma|1|||
156684729|NCT00114231|565590640|FG001|Overall Study|No adenocarcinoma|0|||
156784794|NCT04676646|565963271|FG001|Open-label Run-in Phase|Adverse Event|0|||
156784795|NCT04676646|565963272|FG002|Open-label Run-in Phase|Adverse Event|0|||
156784796|NCT04676646|565963270|FG000|Open-label Run-in Phase|Death|3|||
156784797|NCT04676646|565963271|FG001|Open-label Run-in Phase|Death|0|||
156784798|NCT04676646|565963272|FG002|Open-label Run-in Phase|Death|0|||
156784799|NCT04676646|565963270|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
156784800|NCT04676646|565963271|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
156784801|NCT04676646|565963272|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
156784802|NCT04676646|565963270|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
156784803|NCT04676646|565963271|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
156784804|NCT04676646|565963272|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
156684730|NCT00114231|565590639|FG000|Overall Study|Low creatinine clearance|0|||
156684731|NCT00114231|565590640|FG001|Overall Study|Low creatinine clearance|1|||
156684732|NCT00114231|565590639|FG000|Overall Study|Tumor size > 4cm|1|||
156684733|NCT00114231|565590640|FG001|Overall Study|Tumor size > 4cm|0|||
156684734|NCT00114231|565590639|FG000|Overall Study|Tumor fixed on digital exam|0|||
156684735|NCT00114231|565590640|FG001|Overall Study|Tumor fixed on digital exam|1|||
156684736|NCT00114231|565590639|FG000|Overall Study|No Absolute Neutrophil Count|2|||
156684737|NCT00114231|565590640|FG001|Overall Study|No Absolute Neutrophil Count|0|||
156784805|NCT04676646|565963270|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
156784806|NCT04676646|565963271|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
156784807|NCT04676646|565963272|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
156784808|NCT04676646|565963270|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
156784809|NCT04676646|565963271|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
156784810|NCT04676646|565963272|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
156436117|NCT00723450|564686759|FG002|Randomized Phase|Lack of Efficacy|11|||
156684738|NCT00114231|565590639|FG000|Overall Study|Biopsy done after registration|1|||
156684739|NCT00114231|565590640|FG001|Overall Study|Biopsy done after registration|0|||
156684740|NCT02668822|565590650|FG000|Overall Study|Protocol Violation|2|||
156684741|NCT02668822|565590651|FG001|Overall Study|Protocol Violation|0|||
156684742|NCT02668822|565590650|FG000|Overall Study|Study Terminated by Sponsor|7|||
156684743|NCT02668822|565590651|FG001|Overall Study|Study Terminated by Sponsor|9|||
156684744|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
156684745|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
156684746|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
156684747|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
156684748|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
156684749|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
156684750|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
156684751|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
156684752|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
156684753|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
156684754|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
156684755|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
156684756|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
156684757|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
156684758|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
156684759|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
156684760|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
156684761|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
156684762|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
156684763|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
156684764|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
156684765|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
156684766|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
156684767|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
156684768|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
156684769|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
156784811|NCT04676646|565963270|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
156436118|NCT00723450|564686757|FG000|Randomized Phase|Protocol Violation|0|||
156436119|NCT00723450|564686758|FG001|Randomized Phase|Protocol Violation|9|||
156436120|NCT00723450|564686759|FG002|Randomized Phase|Protocol Violation|13|||
156436121|NCT00723450|564686757|FG000|Randomized Phase|Lost to Follow-up|0|||
156436122|NCT00723450|564686758|FG001|Randomized Phase|Lost to Follow-up|2|||
156436123|NCT00723450|564686759|FG002|Randomized Phase|Lost to Follow-up|3|||
156436124|NCT00723450|564686757|FG000|Randomized Phase|Physician Decision|0|||
156529870|NCT00908232|565034728|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
156784812|NCT04676646|565963271|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
156784813|NCT04676646|565963272|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
156784814|NCT04676646|565963270|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
156784815|NCT04676646|565963271|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
156784816|NCT04676646|565963272|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
156529871|NCT00908232|565034725|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
156529872|NCT00908232|565034726|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
156529873|NCT00908232|565034727|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
156529874|NCT00908232|565034728|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
156529875|NCT00908232|565034725|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
156529876|NCT00908232|565034726|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
156529877|NCT00908232|565034727|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
156529878|NCT00908232|565034728|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
156529879|NCT00908232|565034725|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
156529880|NCT00908232|565034726|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
156529881|NCT00908232|565034727|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
156529882|NCT00908232|565034728|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
156529883|NCT00908232|565034725|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
156529884|NCT00908232|565034726|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
156529885|NCT00908232|565034727|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
156529886|NCT00908232|565034728|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
156529887|NCT00908232|565034725|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
156529888|NCT00908232|565034726|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
156529889|NCT00908232|565034727|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
156529890|NCT00908232|565034728|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
156529891|NCT03153137|565034729|FG000|Overall Study|Lost to Follow-up|1|||
156529892|NCT03153137|565034730|FG001|Overall Study|Lost to Follow-up|0|||
156529893|NCT03153137|565034729|FG000|Overall Study|Withdrawal by Subject|2|||
156529894|NCT03153137|565034730|FG001|Overall Study|Withdrawal by Subject|1|||
156529895|NCT03153137|565034729|FG000|Overall Study|Physician Decision|0|||
156529896|NCT03153137|565034730|FG001|Overall Study|Physician Decision|3|||
156529897|NCT00195507|565034734|FG000|Overall Study|Adverse Event|24|||
156529898|NCT00195507|565034735|FG001|Overall Study|Adverse Event|13|||
156529899|NCT00195507|565034734|FG000|Overall Study|Death|0|||
156529900|NCT00195507|565034735|FG001|Overall Study|Death|1|||
156529901|NCT00195507|565034734|FG000|Overall Study|Failed to Return|4|||
156529902|NCT00195507|565034735|FG001|Overall Study|Failed to Return|3|||
156529903|NCT00195507|565034734|FG000|Overall Study|Physician Decision|1|||
156529904|NCT00195507|565034735|FG001|Overall Study|Physician Decision|2|||
156529905|NCT00195507|565034734|FG000|Overall Study|Lost to Follow-up|3|||
156529906|NCT00195507|565034735|FG001|Overall Study|Lost to Follow-up|2|||
156529907|NCT00195507|565034734|FG000|Overall Study|Protocol Violation|5|||
156529908|NCT00195507|565034735|FG001|Overall Study|Protocol Violation|4|||
156529909|NCT00195507|565034734|FG000|Overall Study|Lack of Efficacy|40|||
156529910|NCT00195507|565034735|FG001|Overall Study|Lack of Efficacy|67|||
156529911|NCT00195507|565034734|FG000|Overall Study|Withdrawal by Subject|16|||
156529912|NCT00195507|565034735|FG001|Overall Study|Withdrawal by Subject|23|||
156529913|NCT00195507|565034734|FG000|Overall Study|Protocol Deviation|6|||
156529914|NCT00195507|565034735|FG001|Overall Study|Protocol Deviation|3|||
156529915|NCT00528866|565034736|FG000|Overall Study|Protocol Violation|6|||
156529916|NCT00993915|565034740|FG000|Overall Study|Insufficient clinical response|3|||
156529917|NCT00993915|565034740|FG000|Overall Study|Withdrawal by Subject|2|||
156529918|NCT00993915|565034740|FG000|Overall Study|Other|1|||
156529919|NCT00993915|565034740|FG000|Overall Study|Ongoing|3|||
156529920|NCT01386658|565034741|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
156529921|NCT01386658|565034742|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
156529922|NCT01386658|565034741|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
156529923|NCT01386658|565034742|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
156529924|NCT02465463|565034748|FG000|Overall Study|Lost to Follow-up|2|||
156529925|NCT02465463|565034749|FG001|Overall Study|Lost to Follow-up|1|||
156529926|NCT02465463|565034748|FG000|Overall Study|Death|1|||
156529927|NCT02465463|565034749|FG001|Overall Study|Death|0|||
156529928|NCT02465463|565034748|FG000|Overall Study|Protocol Violation|1|||
156529929|NCT02465463|565034749|FG001|Overall Study|Protocol Violation|0|||
156529930|NCT01067326|565034754|FG000|Overall Study|Adverse Event|0|||
156529931|NCT01067326|565034755|FG001|Overall Study|Adverse Event|2|||
156529932|NCT01067326|565034754|FG000|Overall Study|Withdrawal by Subject|1|||
156529933|NCT01067326|565034755|FG001|Overall Study|Withdrawal by Subject|0|||
156529934|NCT01067326|565034754|FG000|Overall Study|Early Study Termination|1|||
156529935|NCT01067326|565034755|FG001|Overall Study|Early Study Termination|1|||
156529936|NCT01230788|565034760|FG000|Overall Study|Prescribed exclusion drug|1|||
156529937|NCT00323297|565034761|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
156529938|NCT00323297|565034762|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
156529939|NCT00323297|565034761|FG000|Part A (Double Blind Randomized)|Death|0|||
156529940|NCT00323297|565034762|FG001|Part A (Double Blind Randomized)|Death|1|||
156529941|NCT00323297|565034761|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
156529942|NCT00323297|565034762|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
156529943|NCT00323297|565034761|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
156529944|NCT00323297|565034762|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
156529945|NCT00323297|565034761|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
156529946|NCT00323297|565034762|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
156529947|NCT00323297|565034761|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
156529948|NCT00323297|565034762|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
156529949|NCT00323297|565034761|FG000|Part B (Open-label)|Death|0|||
156529950|NCT00323297|565034762|FG001|Part B (Open-label)|Death|1|||
156529951|NCT00323297|565034761|FG000|Part B (Open-label)|Reason unspecified|0|||
156529952|NCT00323297|565034762|FG001|Part B (Open-label)|Reason unspecified|1|||
156529953|NCT00323297|565034761|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
156529954|NCT00323297|565034762|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
156529955|NCT00323297|565034761|FG000|Part B (Open-label)|Lack of Efficacy|3|||
156529956|NCT00323297|565034762|FG001|Part B (Open-label)|Lack of Efficacy|1|||
156529957|NCT00323297|565034761|FG000|Part B (Open-label)|Adverse Event|5|||
156529958|NCT00323297|565034762|FG001|Part B (Open-label)|Adverse Event|5|||
156529959|NCT00323297|565034761|FG000|Part B (Open-label)|Protocol Violation|0|||
156529960|NCT00323297|565034762|FG001|Part B (Open-label)|Protocol Violation|1|||
156529961|NCT00564018|565034764|FG000|Overall Study|Withdrawal by Subject|2|||
156529962|NCT00564018|565034765|FG001|Overall Study|Withdrawal by Subject|3|||
156529963|NCT00564018|565034766|FG002|Overall Study|Withdrawal by Subject|1|||
156529964|NCT00986440|565034767|FG000|Overall Study|Progressive disease|27|||
156529965|NCT00986440|565034768|FG001|Overall Study|Progressive disease|37|||
156529966|NCT00986440|565034767|FG000|Overall Study|Serious adverse event or adverse event|9|||
156529967|NCT00986440|565034768|FG001|Overall Study|Serious adverse event or adverse event|2|||
156529968|NCT00986440|565034767|FG000|Overall Study|Withdrawal by Subject|1|||
156529969|NCT00986440|565034768|FG001|Overall Study|Withdrawal by Subject|2|||
156529970|NCT00986440|565034767|FG000|Overall Study|Screen failure (not dosed)|4|||
156529971|NCT00986440|565034768|FG001|Overall Study|Screen failure (not dosed)|2|||
156529972|NCT00954421|565034776|FG000|Screening|screen failures|3|||
156529973|NCT00954421|565034776|FG000|6 Months of DBS|Withdrawal by Subject|1|||
156529974|NCT00954421|565034776|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
156529975|NCT00458341|565034787|FG000|Cycle 1|Adverse Event|1|||
156529976|NCT00458341|565034788|FG001|Cycle 1|Adverse Event|0|||
156529977|NCT05461794|565034789|FG000|Overall Study|Withdrawal by Subject|1|||
156529978|NCT05461794|565034790|FG001|Overall Study|Withdrawal by Subject|1|||
156529979|NCT05461794|565034791|FG002|Overall Study|Withdrawal by Subject|3|||
156529980|NCT05461794|565034789|FG000|Overall Study|Study Terminated By Sponsor|18|||
156529981|NCT05461794|565034790|FG001|Overall Study|Study Terminated By Sponsor|13|||
156529982|NCT05461794|565034791|FG002|Overall Study|Study Terminated By Sponsor|16|||
156684770|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
156684771|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
156684772|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
156684773|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
156684774|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
156684775|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
156684776|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
156684777|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
156684778|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
156684779|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
156684780|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
156684781|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
156684782|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
156684783|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
156684784|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
156684785|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
156684786|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
156684787|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
156529983|NCT05461794|565034789|FG000|Overall Study|Death|20|||
156529984|NCT05461794|565034790|FG001|Overall Study|Death|5|||
156529985|NCT05461794|565034791|FG002|Overall Study|Death|19|||
156529986|NCT02730598|565034792|FG000|Overall Study|Withdrawal by Subject|3|||
156529987|NCT02730598|565034793|FG001|Overall Study|Withdrawal by Subject|3|||
156529988|NCT02730598|565034792|FG000|Overall Study|Protocol Violation|0|||
156529989|NCT02730598|565034793|FG001|Overall Study|Protocol Violation|1|||
156529990|NCT02730598|565034792|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
156436125|NCT00723450|564686758|FG001|Randomized Phase|Physician Decision|3|||
156436126|NCT00723450|564686759|FG002|Randomized Phase|Physician Decision|1|||
156436127|NCT00723450|564686757|FG000|Randomized Phase|Withdrawal by Subject|0|||
156436128|NCT00723450|564686758|FG001|Randomized Phase|Withdrawal by Subject|14|||
156436129|NCT00723450|564686759|FG002|Randomized Phase|Withdrawal by Subject|22|||
156436130|NCT03946670|564686762|FG000|Overall Study|Progressive Disease|34|||
156436131|NCT03946670|564686763|FG001|Overall Study|Progressive Disease|27|||
156436132|NCT03946670|564686762|FG000|Overall Study|Adverse Event|7|||
156436133|NCT03946670|564686763|FG001|Overall Study|Adverse Event|10|||
156436134|NCT03946670|564686762|FG000|Overall Study|Physician Decision|6|||
156436135|NCT03946670|564686763|FG001|Overall Study|Physician Decision|5|||
156436136|NCT03946670|564686762|FG000|Overall Study|Death|5|||
156436137|NCT03946670|564686763|FG001|Overall Study|Death|8|||
156436138|NCT03946670|564686762|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
156436139|NCT03946670|564686763|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
156436140|NCT03946670|564686762|FG000|Overall Study|Subject Decision|4|||
156436141|NCT03946670|564686763|FG001|Overall Study|Subject Decision|5|||
156436142|NCT03946670|564686762|FG000|Overall Study|Study Terminated By Sponsor|2|||
156436143|NCT03946670|564686763|FG001|Overall Study|Study Terminated By Sponsor|0|||
156436144|NCT03946670|564686762|FG000|Overall Study|New Therapy For Study Indication|1|||
156436145|NCT03946670|564686763|FG001|Overall Study|New Therapy For Study Indication|0|||
156436146|NCT03946670|564686762|FG000|Overall Study|Not Treated|1|||
156436147|NCT03946670|564686763|FG001|Overall Study|Not Treated|1|||
156436148|NCT01135511|564686767|FG000|Overall Study|Adverse Event|0|||
156436149|NCT01135511|564686768|FG001|Overall Study|Adverse Event|1|||
156436150|NCT01135511|564686769|FG002|Overall Study|Adverse Event|2|||
156436151|NCT01135511|564686770|FG003|Overall Study|Adverse Event|0|||
156436152|NCT01135511|564686771|FG004|Overall Study|Adverse Event|0|||
156436153|NCT01135511|564686772|FG005|Overall Study|Adverse Event|1|||
156436154|NCT01135511|564686773|FG006|Overall Study|Adverse Event|0|||
156436155|NCT01135511|564686774|FG007|Overall Study|Adverse Event|1|||
156436156|NCT01135511|564686775|FG008|Overall Study|Adverse Event|0|||
156436157|NCT01135511|564686767|FG000|Overall Study|Lack of Efficacy|0|||
156436158|NCT01135511|564686768|FG001|Overall Study|Lack of Efficacy|1|||
156436159|NCT01135511|564686769|FG002|Overall Study|Lack of Efficacy|1|||
156436160|NCT01135511|564686770|FG003|Overall Study|Lack of Efficacy|2|||
156436161|NCT01135511|564686771|FG004|Overall Study|Lack of Efficacy|0|||
156436162|NCT01135511|564686772|FG005|Overall Study|Lack of Efficacy|0|||
156436163|NCT01135511|564686773|FG006|Overall Study|Lack of Efficacy|0|||
156436164|NCT01135511|564686774|FG007|Overall Study|Lack of Efficacy|0|||
156436165|NCT01135511|564686775|FG008|Overall Study|Lack of Efficacy|0|||
156784817|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
156784818|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
156784819|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
156784820|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Death|0|||
156784821|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Death|1|||
156784822|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Death|2|||
156784823|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
156784824|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
156436166|NCT01135511|564686767|FG000|Overall Study|Protocol Violation|0|||
156436167|NCT01135511|564686768|FG001|Overall Study|Protocol Violation|0|||
156436168|NCT01135511|564686769|FG002|Overall Study|Protocol Violation|3|||
156436169|NCT01135511|564686770|FG003|Overall Study|Protocol Violation|0|||
156436170|NCT01135511|564686771|FG004|Overall Study|Protocol Violation|0|||
156436171|NCT01135511|564686772|FG005|Overall Study|Protocol Violation|0|||
156436172|NCT01135511|564686773|FG006|Overall Study|Protocol Violation|0|||
156436173|NCT01135511|564686774|FG007|Overall Study|Protocol Violation|0|||
156436174|NCT01135511|564686775|FG008|Overall Study|Protocol Violation|0|||
156436175|NCT01135511|564686767|FG000|Overall Study|Pregnancy|0|||
156436176|NCT01135511|564686768|FG001|Overall Study|Pregnancy|0|||
156436177|NCT01135511|564686769|FG002|Overall Study|Pregnancy|0|||
156436178|NCT01135511|564686770|FG003|Overall Study|Pregnancy|1|||
156436179|NCT01135511|564686771|FG004|Overall Study|Pregnancy|0|||
156436180|NCT01135511|564686772|FG005|Overall Study|Pregnancy|0|||
156436181|NCT01135511|564686773|FG006|Overall Study|Pregnancy|0|||
156436182|NCT01135511|564686774|FG007|Overall Study|Pregnancy|0|||
156436183|NCT01135511|564686775|FG008|Overall Study|Pregnancy|0|||
156436184|NCT01135511|564686767|FG000|Overall Study|could not visit the clinic|0|||
156436185|NCT01135511|564686768|FG001|Overall Study|could not visit the clinic|1|||
156436186|NCT01135511|564686769|FG002|Overall Study|could not visit the clinic|2|||
156436187|NCT01135511|564686770|FG003|Overall Study|could not visit the clinic|0|||
156436188|NCT01135511|564686771|FG004|Overall Study|could not visit the clinic|0|||
156436189|NCT01135511|564686772|FG005|Overall Study|could not visit the clinic|0|||
156436190|NCT01135511|564686773|FG006|Overall Study|could not visit the clinic|0|||
156436191|NCT01135511|564686774|FG007|Overall Study|could not visit the clinic|0|||
156436192|NCT01135511|564686775|FG008|Overall Study|could not visit the clinic|0|||
156436193|NCT01135511|564686767|FG000|Overall Study|noncompliance with study drug taken|0|||
156436194|NCT01135511|564686768|FG001|Overall Study|noncompliance with study drug taken|0|||
156329741|NCT04526509|564307054|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
156784825|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
156784826|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
156784827|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
156784828|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
156784829|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
156784830|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
156784831|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
156784832|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
156784833|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
156784834|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
156784835|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
156784836|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
156784837|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
156784838|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
156784839|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
156784840|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
156784841|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
156784842|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
156784843|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
156784844|NCT04270760|565963273|FG000|Overall Study|Withdrawal by Subject|0|||
156784845|NCT04270760|565963274|FG001|Overall Study|Withdrawal by Subject|1|||
156784846|NCT04270760|565963275|FG002|Overall Study|Withdrawal by Subject|3|||
156784847|NCT04270760|565963276|FG003|Overall Study|Withdrawal by Subject|0|||
156784848|NCT04270760|565963277|FG004|Overall Study|Withdrawal by Subject|0|||
156784849|NCT04270760|565963273|FG000|Overall Study|Lost to Follow-up|1|||
156784850|NCT04270760|565963274|FG001|Overall Study|Lost to Follow-up|2|||
156784851|NCT04270760|565963275|FG002|Overall Study|Lost to Follow-up|1|||
156784852|NCT04270760|565963276|FG003|Overall Study|Lost to Follow-up|0|||
156784853|NCT04270760|565963277|FG004|Overall Study|Lost to Follow-up|0|||
156784854|NCT04270760|565963273|FG000|Overall Study|Death|0|||
156784855|NCT04270760|565963274|FG001|Overall Study|Death|0|||
156784856|NCT04270760|565963275|FG002|Overall Study|Death|0|||
156784857|NCT04270760|565963276|FG003|Overall Study|Death|0|||
156784858|NCT04270760|565963277|FG004|Overall Study|Death|1|||
156784859|NCT05156125|565963278|FG000|Overall Study|Lack of Efficacy|1|||
156784860|NCT05156125|565963279|FG001|Overall Study|Lack of Efficacy|1|||
156784861|NCT05156125|565963280|FG002|Overall Study|Lack of Efficacy|1|||
156784862|NCT05156125|565963278|FG000|Overall Study|Physician Decision|0|||
156784863|NCT05156125|565963279|FG001|Overall Study|Physician Decision|0|||
156784864|NCT05156125|565963280|FG002|Overall Study|Physician Decision|1|||
156784865|NCT05156125|565963278|FG000|Overall Study|Non-compliance|0|||
156784866|NCT05156125|565963279|FG001|Overall Study|Non-compliance|1|||
156784867|NCT05156125|565963280|FG002|Overall Study|Non-compliance|1|||
156784868|NCT05156125|565963278|FG000|Overall Study|Withdrawal by Subject|0|||
156784869|NCT05156125|565963279|FG001|Overall Study|Withdrawal by Subject|0|||
156784870|NCT05156125|565963280|FG002|Overall Study|Withdrawal by Subject|1|||
156784871|NCT05156125|565963278|FG000|Overall Study|Adverse Event|2|||
156784872|NCT05156125|565963279|FG001|Overall Study|Adverse Event|1|||
156784873|NCT05156125|565963280|FG002|Overall Study|Adverse Event|0|||
156784874|NCT01623752|565963283|FG000|Phase 1 (78 Weeks)|No Data|249|||
156784875|NCT01623752|565963284|FG001|Phase 1 (78 Weeks)|No Data|66|||
156784876|NCT01623752|565963285|FG002|Phase 1 (78 Weeks)|No Data|2|||
156784877|NCT01623752|565963283|FG000|Phase 1 (78 Weeks)|Other|33|||
156784878|NCT01623752|565963284|FG001|Phase 1 (78 Weeks)|Other|20|||
156784879|NCT01623752|565963285|FG002|Phase 1 (78 Weeks)|Other|0|||
156784880|NCT01623752|565963283|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
156784881|NCT01623752|565963284|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
156784882|NCT01623752|565963285|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
156784883|NCT01623752|565963283|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
156329742|NCT04526509|564307055|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156329743|NCT04526509|564307056|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156329744|NCT04526509|564307057|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156329745|NCT04526509|564307051|FG000|Enrolled|Physician Decision|0|||
156784884|NCT01623752|565963284|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
156329746|NCT04526509|564307052|FG001|Enrolled|Physician Decision|1|||
156329747|NCT04526509|564307053|FG002|Enrolled|Physician Decision|0|||
156329748|NCT04526509|564307054|FG003|Enrolled|Physician Decision|0|||
156329749|NCT04526509|564307055|FG004|Enrolled|Physician Decision|0|||
156329750|NCT04526509|564307056|FG005|Enrolled|Physician Decision|0|||
156329751|NCT04526509|564307057|FG006|Enrolled|Physician Decision|0|||
156684788|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
156684789|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
156684790|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
156684791|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
156684792|NCT01522950|565590656|FG000|Overall Study|Withdrawal by Subject|3|||
156684793|NCT01522950|565590657|FG001|Overall Study|Withdrawal by Subject|2|||
156684794|NCT01522950|565590658|FG002|Overall Study|Withdrawal by Subject|1|||
156684795|NCT01522950|565590656|FG000|Overall Study|Adverse Event|3|||
156684796|NCT01522950|565590657|FG001|Overall Study|Adverse Event|1|||
156684797|NCT01522950|565590658|FG002|Overall Study|Adverse Event|1|||
156684798|NCT01522950|565590656|FG000|Overall Study|Protocol Violation|0|||
156684799|NCT01522950|565590657|FG001|Overall Study|Protocol Violation|0|||
156684800|NCT01522950|565590658|FG002|Overall Study|Protocol Violation|2|||
156684801|NCT01522950|565590656|FG000|Overall Study|Death|0|||
156684802|NCT01522950|565590657|FG001|Overall Study|Death|1|||
156684803|NCT01522950|565590658|FG002|Overall Study|Death|1|||
156684804|NCT01522950|565590656|FG000|Overall Study|Study Medication Sensitivity|0|||
156684805|NCT01522950|565590657|FG001|Overall Study|Study Medication Sensitivity|1|||
156684806|NCT01522950|565590658|FG002|Overall Study|Study Medication Sensitivity|0|||
156684807|NCT03036839|565590661|FG000|Overall Study|Adverse Event|0|||
156684808|NCT03036839|565590662|FG001|Overall Study|Adverse Event|0|||
156684809|NCT03036839|565590663|FG002|Overall Study|Adverse Event|1|||
156684810|NCT03036839|565590661|FG000|Overall Study|Death|3|||
156684811|NCT03036839|565590662|FG001|Overall Study|Death|0|||
156684812|NCT03036839|565590663|FG002|Overall Study|Death|3|||
156684813|NCT03036839|565590661|FG000|Overall Study|Withdrew Consent|0|||
156684814|NCT03036839|565590662|FG001|Overall Study|Withdrew Consent|0|||
156684815|NCT03036839|565590663|FG002|Overall Study|Withdrew Consent|1|||
156684816|NCT00412737|565590665|FG000|Overall Study|Death|1|||
156684817|NCT00412737|565590666|FG001|Overall Study|Death|0|||
156684818|NCT00412737|565590665|FG000|Overall Study|Adverse Event|3|||
156684819|NCT00412737|565590666|FG001|Overall Study|Adverse Event|2|||
156684820|NCT00412737|565590665|FG000|Overall Study|Refused Treatment|6|||
156684821|NCT00412737|565590666|FG001|Overall Study|Refused Treatment|2|||
156684822|NCT00412737|565590665|FG000|Overall Study|Failure to Return|6|||
156684823|NCT00412737|565590666|FG001|Overall Study|Failure to Return|2|||
156684824|NCT01652729|565590672|FG000|Overall Study|Withdrawal by Subject|14|||
156684825|NCT01652729|565590673|FG001|Overall Study|Withdrawal by Subject|7|||
156684826|NCT01652729|565590674|FG002|Overall Study|Withdrawal by Subject|7|||
156684827|NCT01652729|565590672|FG000|Overall Study|Adverse Event|4|||
156684828|NCT01652729|565590673|FG001|Overall Study|Adverse Event|0|||
156684829|NCT01652729|565590674|FG002|Overall Study|Adverse Event|3|||
156684830|NCT01652729|565590672|FG000|Overall Study|Physician Decision|1|||
156684831|NCT01652729|565590673|FG001|Overall Study|Physician Decision|0|||
156684832|NCT01652729|565590674|FG002|Overall Study|Physician Decision|1|||
156684833|NCT01652729|565590672|FG000|Overall Study|Protocol Violation|1|||
156684834|NCT01652729|565590673|FG001|Overall Study|Protocol Violation|0|||
156684835|NCT01652729|565590674|FG002|Overall Study|Protocol Violation|0|||
156684836|NCT01652729|565590672|FG000|Overall Study|Lost to Follow-up|6|||
156684837|NCT01652729|565590673|FG001|Overall Study|Lost to Follow-up|6|||
156684838|NCT01652729|565590674|FG002|Overall Study|Lost to Follow-up|3|||
156684839|NCT01652729|565590672|FG000|Overall Study|Administrative|1|||
156684840|NCT01652729|565590673|FG001|Overall Study|Administrative|0|||
156684841|NCT01652729|565590674|FG002|Overall Study|Administrative|0|||
156684842|NCT00483548|565590675|FG000|Overall Study|Randomized; not treated with study drug|1|||
156684843|NCT00483548|565590676|FG001|Overall Study|Randomized; not treated with study drug|3|||
156684844|NCT00483548|565590675|FG000|Overall Study|Adverse Event|25|||
156684845|NCT00483548|565590676|FG001|Overall Study|Adverse Event|14|||
156684846|NCT00483548|565590675|FG000|Overall Study|Laboratory abnormality|1|||
156684847|NCT00483548|565590676|FG001|Overall Study|Laboratory abnormality|2|||
156684848|NCT00483548|565590675|FG000|Overall Study|Lack of Efficacy|4|||
156684849|NCT00483548|565590676|FG001|Overall Study|Lack of Efficacy|8|||
156684850|NCT00483548|565590675|FG000|Overall Study|Protocol Violation|11|||
156329752|NCT01896050|564308683|FG000|Overall Study|Adverse Event|37|||
156684851|NCT00483548|565590676|FG001|Overall Study|Protocol Violation|7|||
156684852|NCT00483548|565590675|FG000|Overall Study|Pregnancy|1|||
156684853|NCT00483548|565590676|FG001|Overall Study|Pregnancy|0|||
156684854|NCT00483548|565590675|FG000|Overall Study|Protocol required discontinuation|6|||
156684855|NCT00483548|565590676|FG001|Overall Study|Protocol required discontinuation|6|||
156684856|NCT00483548|565590675|FG000|Overall Study|Unable to comply with protocol schedule|1|||
156684857|NCT00483548|565590676|FG001|Overall Study|Unable to comply with protocol schedule|0|||
156684858|NCT00483548|565590675|FG000|Overall Study|Non-compliance with medication|2|||
156684859|NCT00483548|565590676|FG001|Overall Study|Non-compliance with medication|0|||
156684860|NCT00483548|565590675|FG000|Overall Study|Lost to Follow-up|3|||
156684861|NCT00483548|565590676|FG001|Overall Study|Lost to Follow-up|4|||
156684862|NCT00483548|565590675|FG000|Overall Study|Withdrawal by Subject|5|||
156784885|NCT01623752|565963285|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
156784886|NCT01623752|565963283|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
156784887|NCT01623752|565963284|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
156784888|NCT01623752|565963285|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
156784889|NCT01623752|565963283|FG000|Phase 2 (78 Weeks)|Other|5|||
156784890|NCT01623752|565963284|FG001|Phase 2 (78 Weeks)|Other|1|||
156784891|NCT01623752|565963285|FG002|Phase 2 (78 Weeks)|Other|0|||
156784892|NCT01623752|565963283|FG000|Phase 2 (78 Weeks)|No Data|43|||
156784893|NCT01623752|565963284|FG001|Phase 2 (78 Weeks)|No Data|11|||
156784894|NCT01623752|565963285|FG002|Phase 2 (78 Weeks)|No Data|0|||
156784895|NCT01623752|565963283|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
156784896|NCT01623752|565963284|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
156784897|NCT01623752|565963285|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
156784898|NCT01755637|565963287|FG000|Period 1|Adverse Event|0|||
156784899|NCT01755637|565963288|FG001|Period 1|Adverse Event|1|||
156784900|NCT01814332|565963289|FG000|Overall Study|Adverse Event|8|||
156784901|NCT01814332|565963290|FG001|Overall Study|Adverse Event|3|||
156784902|NCT01814332|565963289|FG000|Overall Study|Withdrawal by Subject|3|||
156784903|NCT01814332|565963290|FG001|Overall Study|Withdrawal by Subject|8|||
156784904|NCT01814332|565963289|FG000|Overall Study|Protocol Violation|0|||
156784905|NCT01814332|565963290|FG001|Overall Study|Protocol Violation|4|||
156784906|NCT01814332|565963289|FG000|Overall Study|Lost to Follow-up|5|||
156784907|NCT01814332|565963290|FG001|Overall Study|Lost to Follow-up|1|||
156784908|NCT04389671|565963291|FG000|Overall Study|Death|7|||
156784909|NCT03338023|565963292|FG000|Overall Study|Withdrawal by Subject|3|||
156784910|NCT03338023|565963293|FG001|Overall Study|Withdrawal by Subject|4|||
156784911|NCT03338023|565963292|FG000|Overall Study|Protocol Violation|3|||
156784912|NCT03338023|565963293|FG001|Overall Study|Protocol Violation|3|||
156784913|NCT03338023|565963292|FG000|Overall Study|Lost to Follow-up|2|||
156784914|NCT03338023|565963293|FG001|Overall Study|Lost to Follow-up|1|||
156784915|NCT03338023|565963292|FG000|Overall Study|Physician Decision|1|||
156784916|NCT03338023|565963293|FG001|Overall Study|Physician Decision|2|||
156784917|NCT04996264|565963294|FG000|Overall Study|Lost to Follow-up|0|||
156784918|NCT04996264|565963295|FG001|Overall Study|Lost to Follow-up|1|||
156784919|NCT04996264|565963294|FG000|Overall Study|Withdrawal by Subject|4|||
156784920|NCT04996264|565963295|FG001|Overall Study|Withdrawal by Subject|3|||
156784921|NCT04996264|565963294|FG000|Overall Study|1 left AMA|0|||
156784922|NCT04996264|565963295|FG001|Overall Study|1 left AMA|1|||
156784923|NCT04996264|565963294|FG000|Overall Study|Subject changed hospitals|0|||
156784924|NCT04996264|565963295|FG001|Overall Study|Subject changed hospitals|1|||
156784925|NCT04996264|565963294|FG000|Overall Study|unable to complete due to work|0|||
156784926|NCT04996264|565963295|FG001|Overall Study|unable to complete due to work|1|||
156784927|NCT00685698|565963296|FG000|Overall Study|Withdrawal by Subject|1|||
156784928|NCT00685698|565963296|FG000|Overall Study|Protocol Violation|6|||
156784929|NCT00685698|565963296|FG000|Overall Study|Adverse Event|3|||
156784930|NCT00685698|565963296|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
156784931|NCT00685698|565963296|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
156784932|NCT00685698|565963296|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
156784933|NCT02030418|565963297|FG000|Overall Study|Death|78|||
156784934|NCT02030418|565963297|FG000|Overall Study|Missed 12-Month Visit|9|||
156784935|NCT02030418|565963297|FG000|Overall Study|Withdrawn|57|||
156784936|NCT03412890|565963308|FG000|Overall Study|Adverse Event|5|||
156784937|NCT03412890|565963309|FG001|Overall Study|Adverse Event|5|||
156784938|NCT03412890|565963310|FG002|Overall Study|Adverse Event|9|||
156784939|NCT03412890|565963308|FG000|Overall Study|Protocol deviation|2|||
156784940|NCT03412890|565963309|FG001|Overall Study|Protocol deviation|1|||
156784941|NCT03412890|565963310|FG002|Overall Study|Protocol deviation|2|||
156784942|NCT03412890|565963308|FG000|Overall Study|Lost to Follow-up|7|||
156784943|NCT03412890|565963309|FG001|Overall Study|Lost to Follow-up|10|||
156784944|NCT03412890|565963310|FG002|Overall Study|Lost to Follow-up|10|||
156784945|NCT03412890|565963308|FG000|Overall Study|Withdrawal by Subject|9|||
156784946|NCT03412890|565963309|FG001|Overall Study|Withdrawal by Subject|12|||
156784947|NCT03412890|565963310|FG002|Overall Study|Withdrawal by Subject|11|||
156784948|NCT03412890|565963308|FG000|Overall Study|Lack of Efficacy|2|||
156784949|NCT03412890|565963309|FG001|Overall Study|Lack of Efficacy|7|||
156784950|NCT03412890|565963310|FG002|Overall Study|Lack of Efficacy|5|||
156784951|NCT03412890|565963308|FG000|Overall Study|Other|5|||
156784952|NCT03412890|565963309|FG001|Overall Study|Other|6|||
156784953|NCT03412890|565963310|FG002|Overall Study|Other|5|||
156784954|NCT03412890|565963308|FG000|Overall Study|Participants who did not receive any study drug|0|||
156784955|NCT03412890|565963309|FG001|Overall Study|Participants who did not receive any study drug|1|||
156784956|NCT03412890|565963310|FG002|Overall Study|Participants who did not receive any study drug|0|||
156784957|NCT02583477|565963312|FG000|Overall Study|Adverse Event|0|||
156784958|NCT02583477|565963313|FG001|Overall Study|Adverse Event|2|||
156784959|NCT02583477|565963312|FG000|Overall Study|Death|1|||
156784960|NCT02583477|565963313|FG001|Overall Study|Death|16|||
156784961|NCT02583477|565963312|FG000|Overall Study|Study terminated|2|||
156784962|NCT02583477|565963313|FG001|Overall Study|Study terminated|2|||
156784963|NCT05507450|565963314|FG000|Overall Study|Death|0|||
156784964|NCT05507450|565963315|FG001|Overall Study|Death|0|||
156784965|NCT05507450|565963316|FG002|Overall Study|Death|1|||
156784966|NCT05507450|565963317|FG003|Overall Study|Death|0|||
156784967|NCT05507450|565963314|FG000|Overall Study|Lost to Follow-up|22|||
156784968|NCT05507450|565963315|FG001|Overall Study|Lost to Follow-up|20|||
156784969|NCT05507450|565963316|FG002|Overall Study|Lost to Follow-up|20|||
156784970|NCT05507450|565963317|FG003|Overall Study|Lost to Follow-up|7|||
156784971|NCT05507450|565963314|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156784972|NCT05507450|565963315|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
156784973|NCT05507450|565963316|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156784974|NCT05507450|565963317|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156784975|NCT05507450|565963314|FG000|Overall Study|Withdrawal by Subject|4|||
156784976|NCT05507450|565963315|FG001|Overall Study|Withdrawal by Subject|11|||
156784977|NCT05507450|565963316|FG002|Overall Study|Withdrawal by Subject|7|||
156784978|NCT05507450|565963317|FG003|Overall Study|Withdrawal by Subject|3|||
156784979|NCT05507450|565963314|FG000|Overall Study|Participant left the country|0|||
156784980|NCT05507450|565963315|FG001|Overall Study|Participant left the country|0|||
156784981|NCT05507450|565963316|FG002|Overall Study|Participant left the country|1|||
156784982|NCT05507450|565963317|FG003|Overall Study|Participant left the country|0|||
156784983|NCT05436288|565963319|FG000|Overall Study|Lost to Follow-up|1|||
156784984|NCT05436288|565963319|FG000|Overall Study|Adverse Event|1|||
156784985|NCT03767894|565963325|FG000|Overall Study|Withdrawal by Subject|1|||
156784986|NCT01436500|565963328|FG000|Overall Study|Death|1|||
156784987|NCT01436500|565963329|FG001|Overall Study|Death|0|||
156784988|NCT01436500|565963330|FG002|Overall Study|Death|0|||
156784989|NCT01436500|565963331|FG003|Overall Study|Death|0|||
156784990|NCT01436500|565963332|FG004|Overall Study|Death|0|||
156784991|NCT01436500|565963328|FG000|Overall Study|Adverse Event|0|||
156784992|NCT01436500|565963329|FG001|Overall Study|Adverse Event|2|||
156784993|NCT01436500|565963330|FG002|Overall Study|Adverse Event|2|||
156784994|NCT01436500|565963331|FG003|Overall Study|Adverse Event|0|||
156784995|NCT01436500|565963332|FG004|Overall Study|Adverse Event|1|||
156784996|NCT01436500|565963328|FG000|Overall Study|Withdrawal by Subject|0|||
156784997|NCT01436500|565963329|FG001|Overall Study|Withdrawal by Subject|0|||
156784998|NCT01436500|565963330|FG002|Overall Study|Withdrawal by Subject|2|||
156784999|NCT01436500|565963331|FG003|Overall Study|Withdrawal by Subject|0|||
156785000|NCT01436500|565963332|FG004|Overall Study|Withdrawal by Subject|2|||
156785001|NCT01436500|565963328|FG000|Overall Study|Physician Decision|0|||
156785002|NCT01436500|565963329|FG001|Overall Study|Physician Decision|0|||
156785003|NCT01436500|565963330|FG002|Overall Study|Physician Decision|1|||
156785004|NCT01436500|565963331|FG003|Overall Study|Physician Decision|0|||
156785005|NCT01436500|565963332|FG004|Overall Study|Physician Decision|0|||
156785006|NCT01436500|565963328|FG000|Overall Study|liver transplant|1|||
156785007|NCT01436500|565963329|FG001|Overall Study|liver transplant|0|||
156785008|NCT01436500|565963330|FG002|Overall Study|liver transplant|0|||
156785009|NCT01436500|565963331|FG003|Overall Study|liver transplant|0|||
156785010|NCT01436500|565963332|FG004|Overall Study|liver transplant|0|||
156785011|NCT01436500|565963328|FG000|Overall Study|initiation of dialysis|0|||
156436195|NCT01135511|564686769|FG002|Overall Study|noncompliance with study drug taken|0|||
156436196|NCT01135511|564686770|FG003|Overall Study|noncompliance with study drug taken|0|||
156436197|NCT01135511|564686771|FG004|Overall Study|noncompliance with study drug taken|1|||
156436198|NCT01135511|564686772|FG005|Overall Study|noncompliance with study drug taken|0|||
156436199|NCT01135511|564686773|FG006|Overall Study|noncompliance with study drug taken|0|||
156436200|NCT01135511|564686774|FG007|Overall Study|noncompliance with study drug taken|0|||
156436201|NCT01135511|564686775|FG008|Overall Study|noncompliance with study drug taken|0|||
156436202|NCT01135511|564686767|FG000|Overall Study|Withdrawal by Subject|0|||
156436203|NCT01135511|564686768|FG001|Overall Study|Withdrawal by Subject|0|||
156436204|NCT01135511|564686769|FG002|Overall Study|Withdrawal by Subject|0|||
156436205|NCT01135511|564686770|FG003|Overall Study|Withdrawal by Subject|0|||
156436206|NCT01135511|564686771|FG004|Overall Study|Withdrawal by Subject|0|||
156436207|NCT01135511|564686772|FG005|Overall Study|Withdrawal by Subject|0|||
156436208|NCT01135511|564686773|FG006|Overall Study|Withdrawal by Subject|1|||
156436209|NCT01135511|564686774|FG007|Overall Study|Withdrawal by Subject|0|||
156436210|NCT01135511|564686775|FG008|Overall Study|Withdrawal by Subject|1|||
156436211|NCT04707313|564686782|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
156436212|NCT04707313|564686783|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
156436213|NCT04707313|564686784|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
156436214|NCT04707313|564686785|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
156785012|NCT01436500|565963329|FG001|Overall Study|initiation of dialysis|0|||
156785013|NCT01436500|565963330|FG002|Overall Study|initiation of dialysis|0|||
156785014|NCT01436500|565963331|FG003|Overall Study|initiation of dialysis|0|||
156785015|NCT01436500|565963332|FG004|Overall Study|initiation of dialysis|1|||
156785016|NCT01436500|565963328|FG000|Overall Study|discontinued study drug|1|||
156436215|NCT04707313|564686786|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
156785017|NCT01436500|565963329|FG001|Overall Study|discontinued study drug|0|||
156785018|NCT01436500|565963330|FG002|Overall Study|discontinued study drug|0|||
156785019|NCT01436500|565963331|FG003|Overall Study|discontinued study drug|0|||
156868419|NCT00068692|566277312|FG004|Step 1: Registration|Withdrawal by Subject|0|||
156868420|NCT00068692|566277313|FG005|Step 1: Registration|Withdrawal by Subject|0|||
156868421|NCT00068692|566277314|FG006|Step 1: Registration|Withdrawal by Subject|0|||
156868422|NCT00068692|566277315|FG007|Step 1: Registration|Withdrawal by Subject|0|||
156868423|NCT00068692|566277308|FG000|Step 1: Registration|Alternative therapy|2|||
156868424|NCT00068692|566277309|FG001|Step 1: Registration|Alternative therapy|0|||
156868425|NCT00068692|566277310|FG002|Step 1: Registration|Alternative therapy|0|||
156868426|NCT00068692|566277311|FG003|Step 1: Registration|Alternative therapy|0|||
156868427|NCT00068692|566277312|FG004|Step 1: Registration|Alternative therapy|0|||
156868428|NCT00068692|566277313|FG005|Step 1: Registration|Alternative therapy|0|||
156868429|NCT00068692|566277314|FG006|Step 1: Registration|Alternative therapy|0|||
156868430|NCT00068692|566277315|FG007|Step 1: Registration|Alternative therapy|0|||
156868431|NCT00068692|566277308|FG000|Step 1: Registration|Complicating disease|2|||
156868432|NCT00068692|566277309|FG001|Step 1: Registration|Complicating disease|0|||
156868433|NCT00068692|566277310|FG002|Step 1: Registration|Complicating disease|0|||
156868434|NCT00068692|566277311|FG003|Step 1: Registration|Complicating disease|0|||
156868435|NCT00068692|566277312|FG004|Step 1: Registration|Complicating disease|0|||
156868436|NCT00068692|566277313|FG005|Step 1: Registration|Complicating disease|0|||
156868437|NCT00068692|566277314|FG006|Step 1: Registration|Complicating disease|0|||
156868438|NCT00068692|566277315|FG007|Step 1: Registration|Complicating disease|0|||
156868439|NCT00068692|566277308|FG000|Step 1: Registration|Protocol Violation|1|||
156868440|NCT00068692|566277309|FG001|Step 1: Registration|Protocol Violation|0|||
156868441|NCT00068692|566277310|FG002|Step 1: Registration|Protocol Violation|0|||
156868442|NCT00068692|566277311|FG003|Step 1: Registration|Protocol Violation|0|||
156868443|NCT00068692|566277312|FG004|Step 1: Registration|Protocol Violation|0|||
156868444|NCT00068692|566277313|FG005|Step 1: Registration|Protocol Violation|0|||
156868445|NCT00068692|566277314|FG006|Step 1: Registration|Protocol Violation|0|||
156868446|NCT00068692|566277315|FG007|Step 1: Registration|Protocol Violation|0|||
156868447|NCT00068692|566277308|FG000|Step 1: Registration|Not eligible|6|||
156868448|NCT00068692|566277309|FG001|Step 1: Registration|Not eligible|0|||
156868449|NCT00068692|566277310|FG002|Step 1: Registration|Not eligible|0|||
156868450|NCT00068692|566277311|FG003|Step 1: Registration|Not eligible|0|||
156868451|NCT00068692|566277312|FG004|Step 1: Registration|Not eligible|0|||
156868452|NCT00068692|566277313|FG005|Step 1: Registration|Not eligible|0|||
156868453|NCT00068692|566277314|FG006|Step 1: Registration|Not eligible|0|||
156868454|NCT00068692|566277315|FG007|Step 1: Registration|Not eligible|0|||
156868455|NCT00068692|566277308|FG000|Step 1: Registration|Other|2|||
156868456|NCT00068692|566277309|FG001|Step 1: Registration|Other|0|||
156868457|NCT00068692|566277310|FG002|Step 1: Registration|Other|0|||
156868458|NCT00068692|566277311|FG003|Step 1: Registration|Other|0|||
156868459|NCT00068692|566277312|FG004|Step 1: Registration|Other|0|||
156868460|NCT00068692|566277313|FG005|Step 1: Registration|Other|0|||
156868461|NCT00068692|566277314|FG006|Step 1: Registration|Other|0|||
156868462|NCT00068692|566277315|FG007|Step 1: Registration|Other|0|||
156868463|NCT00068692|566277308|FG000|Step 1: Registration|Not start protocol therapy|3|||
156868464|NCT00068692|566277309|FG001|Step 1: Registration|Not start protocol therapy|0|||
156868465|NCT00068692|566277310|FG002|Step 1: Registration|Not start protocol therapy|0|||
156868466|NCT00068692|566277311|FG003|Step 1: Registration|Not start protocol therapy|0|||
156868467|NCT00068692|566277312|FG004|Step 1: Registration|Not start protocol therapy|0|||
156868468|NCT00068692|566277313|FG005|Step 1: Registration|Not start protocol therapy|0|||
156868469|NCT00068692|566277314|FG006|Step 1: Registration|Not start protocol therapy|0|||
156868470|NCT00068692|566277315|FG007|Step 1: Registration|Not start protocol therapy|0|||
156868471|NCT00068692|566277308|FG000|Step 1: Registration|Registered but not randomized|0|||
156868472|NCT00068692|566277309|FG001|Step 1: Registration|Registered but not randomized|1|||
156868473|NCT00068692|566277310|FG002|Step 1: Registration|Registered but not randomized|0|||
156868474|NCT00068692|566277311|FG003|Step 1: Registration|Registered but not randomized|0|||
156868475|NCT00068692|566277312|FG004|Step 1: Registration|Registered but not randomized|0|||
156868476|NCT00068692|566277313|FG005|Step 1: Registration|Registered but not randomized|0|||
156868477|NCT00068692|566277314|FG006|Step 1: Registration|Registered but not randomized|0|||
156436216|NCT04707313|564686787|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
156436217|NCT04707313|564686788|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
156436218|NCT04707313|564686789|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
156436219|NCT04707313|564686790|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
156436220|NCT04707313|564686791|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
156436221|NCT04707313|564686792|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
156868478|NCT00068692|566277315|FG007|Step 1: Registration|Registered but not randomized|0|||
156868479|NCT00068692|566277308|FG000|Step 2: Randomization|Disesae progression/replase|0|||
156868480|NCT00068692|566277309|FG001|Step 2: Randomization|Disesae progression/replase|0|||
156868481|NCT00068692|566277310|FG002|Step 2: Randomization|Disesae progression/replase|1|||
156868482|NCT00068692|566277311|FG003|Step 2: Randomization|Disesae progression/replase|1|||
156868483|NCT00068692|566277312|FG004|Step 2: Randomization|Disesae progression/replase|0|||
156868484|NCT00068692|566277313|FG005|Step 2: Randomization|Disesae progression/replase|0|||
156436222|NCT04707313|564686793|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
156684863|NCT00483548|565590676|FG001|Overall Study|Withdrawal by Subject|2|||
156684864|NCT04364737|565590680|FG000|Overall Study|Withdrawal by Subject|4|||
156684865|NCT04364737|565590681|FG001|Overall Study|Withdrawal by Subject|9|||
156684866|NCT04364737|565590680|FG000|Overall Study|Lost to Follow-up|1|||
156684867|NCT04364737|565590681|FG001|Overall Study|Lost to Follow-up|1|||
156684868|NCT00868296|565590683|FG000|Overall Study|Adverse Event|0|||
156684869|NCT00868296|565590684|FG001|Overall Study|Adverse Event|2|||
156684870|NCT00868296|565590683|FG000|Overall Study|Withdrawal by Subject|0|||
156684871|NCT00868296|565590684|FG001|Overall Study|Withdrawal by Subject|1|||
156684872|NCT04205162|565590698|FG000|Overall Study|Lost to Follow-up|1|||
156684873|NCT04205162|565590699|FG001|Overall Study|Lost to Follow-up|0|||
156684874|NCT04205162|565590698|FG000|Overall Study|Withdrawal by Subject|2|||
156684875|NCT04205162|565590699|FG001|Overall Study|Withdrawal by Subject|0|||
156684876|NCT04205162|565590698|FG000|Overall Study|University closure due to COVID-19|1|||
156684877|NCT04205162|565590699|FG001|Overall Study|University closure due to COVID-19|0|||
156684878|NCT01999894|565590700|FG000|Overall Study|Adverse Event|9|||
156684879|NCT01999894|565590700|FG000|Overall Study|Lack of Efficacy|5|||
156684880|NCT01999894|565590700|FG000|Overall Study|Protocol Violation|1|||
156684881|NCT01999894|565590700|FG000|Overall Study|Withdrawal by Subject|7|||
156684882|NCT01999894|565590700|FG000|Overall Study|Lost to Follow-up|10|||
156684883|NCT01999894|565590700|FG000|Overall Study|Other Reason|3|||
156684884|NCT01999894|565590700|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
156684885|NCT00372996|565590702|FG000|Overall Study|Death|11|||
156684886|NCT00372996|565590703|FG001|Overall Study|Death|4|||
156684887|NCT00372996|565590704|FG002|Overall Study|Death|8|||
156684888|NCT00372996|565590705|FG003|Overall Study|Death|7|||
156684889|NCT00372996|565590702|FG000|Overall Study|Lost to Follow-up|0|||
156684890|NCT00372996|565590703|FG001|Overall Study|Lost to Follow-up|2|||
156684891|NCT00372996|565590704|FG002|Overall Study|Lost to Follow-up|0|||
156684892|NCT00372996|565590705|FG003|Overall Study|Lost to Follow-up|1|||
156684893|NCT00372996|565590702|FG000|Overall Study|Withdrawal by Subject|12|||
156684894|NCT00372996|565590703|FG001|Overall Study|Withdrawal by Subject|6|||
156684895|NCT00372996|565590704|FG002|Overall Study|Withdrawal by Subject|9|||
156684896|NCT00372996|565590705|FG003|Overall Study|Withdrawal by Subject|5|||
156684897|NCT00372996|565590702|FG000|Overall Study|Study Terminated by Sponsor|4|||
156684898|NCT00372996|565590703|FG001|Overall Study|Study Terminated by Sponsor|0|||
156684899|NCT00372996|565590704|FG002|Overall Study|Study Terminated by Sponsor|4|||
156684900|NCT00372996|565590705|FG003|Overall Study|Study Terminated by Sponsor|0|||
156684901|NCT00372996|565590702|FG000|Overall Study|Other|10|||
156684902|NCT00372996|565590703|FG001|Overall Study|Other|2|||
156684903|NCT00372996|565590704|FG002|Overall Study|Other|7|||
156684904|NCT00372996|565590705|FG003|Overall Study|Other|7|||
156684905|NCT01186016|565590706|FG000|Overall Study|Withdrawal by Subject|46|||
156684906|NCT01186016|565590707|FG001|Overall Study|Withdrawal by Subject|29|||
156684907|NCT03750695|565590709|FG000|Overall Study|Lost to Follow-up|0|||
156684908|NCT03750695|565590710|FG001|Overall Study|Lost to Follow-up|1|||
156684909|NCT01098539|565590711|FG000|Overall Study|Adverse Event|26|||
156684910|NCT01098539|565590712|FG001|Overall Study|Adverse Event|26|||
156684911|NCT01098539|565590711|FG000|Overall Study|Protocol Violation|1|||
156684912|NCT01098539|565590712|FG001|Overall Study|Protocol Violation|4|||
156684913|NCT01098539|565590711|FG000|Overall Study|Noncompliance|3|||
156684914|NCT01098539|565590712|FG001|Overall Study|Noncompliance|5|||
156684915|NCT01098539|565590711|FG000|Overall Study|Lost to Follow-up|4|||
156684916|NCT01098539|565590712|FG001|Overall Study|Lost to Follow-up|4|||
156684917|NCT01098539|565590711|FG000|Overall Study|Withdrawal by Subject|12|||
156684918|NCT01098539|565590712|FG001|Overall Study|Withdrawal by Subject|26|||
156684919|NCT01098539|565590711|FG000|Overall Study|Physician Decision|5|||
156684920|NCT01098539|565590712|FG001|Overall Study|Physician Decision|3|||
156684921|NCT03173560|565590713|FG000|Overall Study|Death|70|||
156684922|NCT03173560|565590714|FG001|Overall Study|Death|60|||
156684923|NCT03173560|565590713|FG000|Overall Study|Lost to Follow-up|1|||
156684924|NCT03173560|565590714|FG001|Overall Study|Lost to Follow-up|4|||
156684925|NCT03173560|565590713|FG000|Overall Study|Withdrawal by Subject|10|||
156684926|NCT03173560|565590714|FG001|Overall Study|Withdrawal by Subject|5|||
156684927|NCT03173560|565590713|FG000|Overall Study|Other|0|||
156684928|NCT03173560|565590714|FG001|Overall Study|Other|1|||
156684929|NCT02661022|565590715|FG000|Overall Study|Withdrawal by Subject|3|||
156684930|NCT02661022|565590716|FG001|Overall Study|Withdrawal by Subject|0|||
156684931|NCT02661022|565590715|FG000|Overall Study|Adverse Event|1|||
156684932|NCT02661022|565590716|FG001|Overall Study|Adverse Event|1|||
156684933|NCT02661022|565590715|FG000|Overall Study|Physician Decision|1|||
156684934|NCT02661022|565590716|FG001|Overall Study|Physician Decision|0|||
156785020|NCT01436500|565963332|FG004|Overall Study|discontinued study drug|0|||
156684935|NCT02661022|565590715|FG000|Overall Study|Progressive Disease|2|||
156684936|NCT02661022|565590716|FG001|Overall Study|Progressive Disease|1|||
156684937|NCT00732160|565590717|FG000|Overall Study|Adverse Event|1|||
156684938|NCT00732160|565590718|FG001|Overall Study|Adverse Event|0|||
156684939|NCT00732160|565590719|FG002|Overall Study|Adverse Event|1|||
156684940|NCT00732160|565590720|FG003|Overall Study|Adverse Event|1|||
156785021|NCT01436500|565963328|FG000|Overall Study|Other|0|||
156529991|NCT02730598|565034793|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
156529992|NCT00810394|565034794|FG000|Overall Study|Withdrawal by Subject|3|||
156529993|NCT03254485|565034797|FG000|Overall Study|Adverse Event|3|||
156529994|NCT03254485|565034798|FG001|Overall Study|Adverse Event|0|||
156529995|NCT03254485|565034799|FG002|Overall Study|Adverse Event|0|||
156529996|NCT03254485|565034800|FG003|Overall Study|Adverse Event|6|||
156529997|NCT03254485|565034797|FG000|Overall Study|Protocol Violation|6|||
156684941|NCT00732160|565590717|FG000|Overall Study|scheduling|4|||
156684942|NCT00732160|565590718|FG001|Overall Study|scheduling|4|||
156684943|NCT00732160|565590719|FG002|Overall Study|scheduling|2|||
156684944|NCT00732160|565590720|FG003|Overall Study|scheduling|1|||
156684945|NCT00090753|565590721|FG000|First Treatment Period|Adverse Event|20|||
156684946|NCT00090753|565590722|FG001|First Treatment Period|Adverse Event|8|||
156684947|NCT00090753|565590721|FG000|First Treatment Period|Death|88|||
156684948|NCT00090753|565590722|FG001|First Treatment Period|Death|62|||
156684949|NCT00090753|565590721|FG000|First Treatment Period|Lack of Efficacy|2|||
156684950|NCT00090753|565590722|FG001|First Treatment Period|Lack of Efficacy|1|||
156684951|NCT00090753|565590721|FG000|First Treatment Period|Refused Treatment|32|||
156684952|NCT00090753|565590722|FG001|First Treatment Period|Refused Treatment|25|||
156684953|NCT00090753|565590721|FG000|First Treatment Period|Lost to Follow-up|4|||
156684954|NCT00090753|565590722|FG001|First Treatment Period|Lost to Follow-up|4|||
156684955|NCT00090753|565590721|FG000|First Treatment Period|Renal Transplant|70|||
156684956|NCT00090753|565590722|FG001|First Treatment Period|Renal Transplant|50|||
156684957|NCT00090753|565590721|FG000|First Treatment Period|Mircera Commercialization|1|||
156684958|NCT00090753|565590722|FG001|First Treatment Period|Mircera Commercialization|0|||
156684959|NCT00090753|565590721|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
156684960|NCT00090753|565590722|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
156684961|NCT00090753|565590721|FG000|Extended Treatment Period|Adverse Event|11|||
156684962|NCT00090753|565590722|FG001|Extended Treatment Period|Adverse Event|0|||
156684963|NCT00090753|565590721|FG000|Extended Treatment Period|Death|58|||
156684964|NCT00090753|565590722|FG001|Extended Treatment Period|Death|30|||
156684965|NCT00090753|565590721|FG000|Extended Treatment Period|Lack of Efficacy|1|||
156684966|NCT00090753|565590722|FG001|Extended Treatment Period|Lack of Efficacy|0|||
156684967|NCT00090753|565590721|FG000|Extended Treatment Period|Refused Treatment|18|||
156684968|NCT00090753|565590722|FG001|Extended Treatment Period|Refused Treatment|12|||
156684969|NCT00090753|565590721|FG000|Extended Treatment Period|Lost to Follow-up|3|||
156684970|NCT00090753|565590722|FG001|Extended Treatment Period|Lost to Follow-up|1|||
156684971|NCT00090753|565590721|FG000|Extended Treatment Period|Renal Transplant|15|||
156684972|NCT00090753|565590722|FG001|Extended Treatment Period|Renal Transplant|12|||
156684973|NCT00090753|565590721|FG000|Extended Treatment Period|Mircera Commercialization|188|||
156684974|NCT00090753|565590722|FG001|Extended Treatment Period|Mircera Commercialization|93|||
156684975|NCT00090753|565590721|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
156684976|NCT00090753|565590722|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
156684977|NCT01466036|565590729|FG000|Overall Study|Death|1|||
156684978|NCT01466036|565590730|FG001|Overall Study|Death|1|||
156684979|NCT01466036|565590729|FG000|Overall Study|Physician Decision|0|||
156684980|NCT01466036|565590730|FG001|Overall Study|Physician Decision|4|||
156684981|NCT01466036|565590729|FG000|Overall Study|Adverse Event|2|||
156684982|NCT01466036|565590730|FG001|Overall Study|Adverse Event|6|||
156684983|NCT01466036|565590729|FG000|Overall Study|Withdrawal by Subject|2|||
156684984|NCT01466036|565590730|FG001|Overall Study|Withdrawal by Subject|8|||
156684985|NCT01466036|565590729|FG000|Overall Study|progression/relapse|14|||
156684986|NCT01466036|565590730|FG001|Overall Study|progression/relapse|21|||
156684987|NCT01466036|565590729|FG000|Overall Study|prolonged treatment delay|1|||
156684988|NCT01466036|565590730|FG001|Overall Study|prolonged treatment delay|1|||
156684989|NCT01609582|565590731|FG000|Overall Study|Adverse Event|20|||
156684990|NCT01609582|565590732|FG001|Overall Study|Adverse Event|18|||
156684991|NCT01609582|565590731|FG000|Overall Study|Lost to Follow-up|10|||
156684992|NCT01609582|565590732|FG001|Overall Study|Lost to Follow-up|10|||
156684993|NCT01609582|565590731|FG000|Overall Study|Withdrawal by Subject|21|||
156684994|NCT01609582|565590732|FG001|Overall Study|Withdrawal by Subject|15|||
156684995|NCT01609582|565590731|FG000|Overall Study|Study Terminated by Sponsor|1543|||
156684996|NCT01609582|565590732|FG001|Overall Study|Study Terminated by Sponsor|1548|||
156529998|NCT03254485|565034798|FG001|Overall Study|Protocol Violation|0|||
156684997|NCT01609582|565590731|FG000|Overall Study|Other|9|||
156684998|NCT01609582|565590732|FG001|Overall Study|Other|10|||
156684999|NCT01609582|565590731|FG000|Overall Study|Randomized, but not treated|0|||
156685000|NCT01609582|565590732|FG001|Overall Study|Randomized, but not treated|3|||
156685001|NCT00685750|565590733|FG000|Overall Study|Tumor sampling failure|0|||
156685002|NCT00685750|565590734|FG001|Overall Study|Tumor sampling failure|0|||
156685003|NCT00685750|565590735|FG002|Overall Study|Tumor sampling failure|1|||
156685004|NCT00685750|565590736|FG003|Overall Study|Tumor sampling failure|0|||
156529999|NCT03254485|565034799|FG002|Overall Study|Protocol Violation|0|||
156530000|NCT03254485|565034800|FG003|Overall Study|Protocol Violation|2|||
156685005|NCT00685750|565590737|FG004|Overall Study|Tumor sampling failure|0|||
156685006|NCT00685750|565590738|FG005|Overall Study|Tumor sampling failure|0|||
156785022|NCT01436500|565963329|FG001|Overall Study|Other|1|||
156785023|NCT01436500|565963330|FG002|Overall Study|Other|0|||
156530001|NCT03254485|565034797|FG000|Overall Study|Withdrawal by Subject|1|||
156530002|NCT03254485|565034798|FG001|Overall Study|Withdrawal by Subject|0|||
156530003|NCT03254485|565034799|FG002|Overall Study|Withdrawal by Subject|0|||
156530004|NCT03254485|565034800|FG003|Overall Study|Withdrawal by Subject|4|||
156530005|NCT03254485|565034797|FG000|Overall Study|Death|0|||
156530006|NCT03254485|565034798|FG001|Overall Study|Death|0|||
156530007|NCT03254485|565034799|FG002|Overall Study|Death|0|||
156530008|NCT03254485|565034800|FG003|Overall Study|Death|1|||
156530009|NCT03254485|565034797|FG000|Overall Study|Lost to Follow-up|1|||
156530010|NCT03254485|565034798|FG001|Overall Study|Lost to Follow-up|0|||
156530011|NCT03254485|565034799|FG002|Overall Study|Lost to Follow-up|0|||
156530012|NCT03254485|565034800|FG003|Overall Study|Lost to Follow-up|0|||
156530013|NCT03254485|565034797|FG000|Overall Study|Other|1|||
156530014|NCT03254485|565034798|FG001|Overall Study|Other|0|||
156530015|NCT03254485|565034799|FG002|Overall Study|Other|0|||
156530016|NCT03254485|565034800|FG003|Overall Study|Other|2|||
156530017|NCT00467285|565034801|FG000|Overall Study|Lost to Follow-up|4|||
156530018|NCT00467285|565034802|FG001|Overall Study|Lost to Follow-up|4|||
156530019|NCT03891524|565034803|FG000|Overall Study|Death|0|||
156530020|NCT03891524|565034804|FG001|Overall Study|Death|0|||
156530021|NCT03891524|565034805|FG002|Overall Study|Death|0|||
156530022|NCT03891524|565034806|FG003|Overall Study|Death|0|||
156530023|NCT03891524|565034807|FG004|Overall Study|Death|0|||
156530024|NCT03891524|565034808|FG005|Overall Study|Death|0|||
156530025|NCT03891524|565034809|FG006|Overall Study|Death|0|||
156530026|NCT03891524|565034810|FG007|Overall Study|Death|1|||
156530027|NCT03891524|565034803|FG000|Overall Study|Withdrawal by Subject|0|||
156530028|NCT03891524|565034804|FG001|Overall Study|Withdrawal by Subject|1|||
156530029|NCT03891524|565034805|FG002|Overall Study|Withdrawal by Subject|2|||
156530030|NCT03891524|565034806|FG003|Overall Study|Withdrawal by Subject|1|||
156530031|NCT03891524|565034807|FG004|Overall Study|Withdrawal by Subject|2|||
156530032|NCT03891524|565034808|FG005|Overall Study|Withdrawal by Subject|2|||
156530033|NCT03891524|565034809|FG006|Overall Study|Withdrawal by Subject|2|||
156530034|NCT03891524|565034810|FG007|Overall Study|Withdrawal by Subject|1|||
156530035|NCT02958267|565034812|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
156530036|NCT02958267|565034813|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
156530037|NCT02958267|565034812|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
156530038|NCT02958267|565034813|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
156530039|NCT02958267|565034812|FG000|Follow-up Visits|Additional treatment pursued|2|||
156530040|NCT02958267|565034813|FG001|Follow-up Visits|Additional treatment pursued|1|||
156530041|NCT00475033|565034814|FG000|Infant Series|Failed to return|3|||
156530042|NCT00475033|565034815|FG001|Infant Series|Failed to return|4|||
156530043|NCT00475033|565034814|FG000|Infant Series|Parent or legal guardian request|1|||
156530044|NCT00475033|565034815|FG001|Infant Series|Parent or legal guardian request|5|||
156530045|NCT00475033|565034814|FG000|Infant Series|Protocol Violation|1|||
156530046|NCT00475033|565034815|FG001|Infant Series|Protocol Violation|2|||
156530047|NCT00475033|565034814|FG000|Infant Series|Lost to Follow-up|2|||
156530048|NCT00475033|565034815|FG001|Infant Series|Lost to Follow-up|0|||
156530049|NCT00475033|565034814|FG000|Infant Series|Adverse Event|0|||
156530050|NCT00475033|565034815|FG001|Infant Series|Adverse Event|2|||
156530051|NCT00475033|565034814|FG000|After the Infant Series|Adverse Event|0|||
156785024|NCT01436500|565963331|FG003|Overall Study|Other|1|||
156785025|NCT01436500|565963332|FG004|Overall Study|Other|0|||
156785026|NCT03983109|565963333|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
156785027|NCT03983109|565963334|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
156530052|NCT00475033|565034815|FG001|After the Infant Series|Adverse Event|4|||
156530053|NCT00475033|565034814|FG000|After the Infant Series|Parent or legal guardian request|2|||
156530054|NCT00475033|565034815|FG001|After the Infant Series|Parent or legal guardian request|2|||
156785028|NCT00887588|565963335|FG000|Core Period|Death|1|||
156329753|NCT01896050|564308684|FG001|Overall Study|Adverse Event|2|||
156329754|NCT01896050|564308683|FG000|Overall Study|Death|1|||
156329755|NCT01896050|564308684|FG001|Overall Study|Death|0|||
156329756|NCT00392015|564308685|FG000|Overall Study|Lost to Follow-up|2|||
156329757|NCT00392015|564308686|FG001|Overall Study|Lost to Follow-up|0|||
156329758|NCT00392015|564308687|FG002|Overall Study|Lost to Follow-up|2|||
156530055|NCT00475033|565034814|FG000|After the Infant Series|Failed to return|2|||
156530056|NCT00475033|565034815|FG001|After the Infant Series|Failed to return|1|||
156530057|NCT00475033|565034814|FG000|After the Infant Series|Protocol Violation|1|||
156530058|NCT00475033|565034815|FG001|After the Infant Series|Protocol Violation|0|||
156530059|NCT00475033|565034814|FG000|After the Infant Series|Lost to Follow-up|1|||
156530060|NCT00475033|565034815|FG001|After the Infant Series|Lost to Follow-up|0|||
156530061|NCT00475033|565034814|FG000|After the Infant Series|Other|0|||
156530062|NCT00475033|565034815|FG001|After the Infant Series|Other|1|||
156530063|NCT00475033|565034814|FG000|Toddler Dose|Parent or legal guardian request|2|||
156530064|NCT00475033|565034815|FG001|Toddler Dose|Parent or legal guardian request|0|||
156530065|NCT00475033|565034814|FG000|Toddler Dose|Failed to return|1|||
156530066|NCT00475033|565034815|FG001|Toddler Dose|Failed to return|0|||
156530067|NCT00475033|565034814|FG000|Toddler Dose|Lost to Follow-up|1|||
156530068|NCT00475033|565034815|FG001|Toddler Dose|Lost to Follow-up|0|||
156530069|NCT01696942|565034820|FG000|Overall Study|Withdrawal by Subject|1|||
156530070|NCT01696942|565034821|FG001|Overall Study|Withdrawal by Subject|0|||
156530071|NCT01696942|565034820|FG000|Overall Study|Protocol Violation|1|||
156530072|NCT01696942|565034821|FG001|Overall Study|Protocol Violation|2|||
156530073|NCT01696942|565034820|FG000|Overall Study|screen failure|0|||
156530074|NCT01696942|565034821|FG001|Overall Study|screen failure|1|||
156530075|NCT03231943|565034822|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530076|NCT03231943|565034823|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
156530077|NCT03231943|565034824|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
156530078|NCT03231943|565034825|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530079|NCT03231943|565034826|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530080|NCT03231943|565034827|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530081|NCT03231943|565034828|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530082|NCT03231943|565034829|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530083|NCT03231943|565034830|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156785029|NCT00887588|565963336|FG001|Core Period|Death|1|||
156785030|NCT00887588|565963335|FG000|Core Period|Lost to Follow-up|3|||
156785031|NCT00887588|565963336|FG001|Core Period|Lost to Follow-up|1|||
156785032|NCT00887588|565963335|FG000|Core Period|Withdrawal by Subject|6|||
156530084|NCT03231943|565034831|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530085|NCT03231943|565034832|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530086|NCT03231943|565034833|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530087|NCT03231943|565034834|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
156530088|NCT03231943|565034822|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530089|NCT03231943|565034823|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
156530090|NCT03231943|565034824|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530091|NCT03231943|565034825|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530092|NCT03231943|565034826|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530093|NCT03231943|565034827|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530094|NCT03231943|565034828|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530095|NCT03231943|565034829|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530096|NCT03231943|565034830|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156785033|NCT00887588|565963336|FG001|Core Period|Withdrawal by Subject|8|||
156785034|NCT00887588|565963335|FG000|Core Period|Adverse Event|9|||
156785035|NCT00887588|565963336|FG001|Core Period|Adverse Event|11|||
156785036|NCT00887588|565963335|FG000|Extension Period|Adverse Event|4|||
156785037|NCT00887588|565963336|FG001|Extension Period|Adverse Event|4|||
156785038|NCT00887588|565963335|FG000|Extension Period|Death|0|||
156785039|NCT00887588|565963336|FG001|Extension Period|Death|1|||
156785040|NCT00887588|565963335|FG000|Extension Period|Protocol deviation|1|||
156785041|NCT00887588|565963336|FG001|Extension Period|Protocol deviation|0|||
156785042|NCT00887588|565963335|FG000|Extension Period|Lost to Follow-up|1|||
156785043|NCT00887588|565963336|FG001|Extension Period|Lost to Follow-up|0|||
156785044|NCT02184156|565963340|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
156785045|NCT02184156|565963341|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
156785046|NCT02184156|565963340|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
156785047|NCT02184156|565963341|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
156785048|NCT03158311|565963345|FG000|Overall Study|Subject/Guardian Decision|10|||
156785049|NCT03158311|565963346|FG001|Overall Study|Subject/Guardian Decision|6|||
156785050|NCT03158311|565963347|FG002|Overall Study|Subject/Guardian Decision|11|||
156785051|NCT03158311|565963345|FG000|Overall Study|Adverse Event|5|||
156785052|NCT03158311|565963346|FG001|Overall Study|Adverse Event|3|||
156785053|NCT03158311|565963347|FG002|Overall Study|Adverse Event|3|||
156329759|NCT00392015|564308688|FG003|Overall Study|Lost to Follow-up|1|||
156329760|NCT00392015|564308689|FG004|Overall Study|Lost to Follow-up|1|||
156329761|NCT00392015|564308690|FG005|Overall Study|Lost to Follow-up|0|||
156329762|NCT00392015|564308685|FG000|Overall Study|Withdrawal by Subject|0|||
156329763|NCT00392015|564308686|FG001|Overall Study|Withdrawal by Subject|0|||
156329764|NCT00392015|564308687|FG002|Overall Study|Withdrawal by Subject|2|||
156329765|NCT00392015|564308688|FG003|Overall Study|Withdrawal by Subject|0|||
156329766|NCT00392015|564308689|FG004|Overall Study|Withdrawal by Subject|0|||
156329767|NCT00392015|564308690|FG005|Overall Study|Withdrawal by Subject|0|||
156329768|NCT00392015|564308685|FG000|Overall Study|Adverse Event|0|||
156530097|NCT03231943|565034831|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530098|NCT03231943|565034832|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530099|NCT03231943|565034833|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156785054|NCT03158311|565963345|FG000|Overall Study|Techinical Problems|3|||
156329769|NCT00392015|564308686|FG001|Overall Study|Adverse Event|0|||
156329770|NCT00392015|564308687|FG002|Overall Study|Adverse Event|0|||
156329771|NCT00392015|564308688|FG003|Overall Study|Adverse Event|0|||
156785055|NCT03158311|565963346|FG001|Overall Study|Techinical Problems|1|||
156785056|NCT03158311|565963347|FG002|Overall Study|Techinical Problems|5|||
156436223|NCT04707313|564686794|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
156436224|NCT04707313|564686782|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
156436225|NCT04707313|564686783|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
156436226|NCT04707313|564686784|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156436227|NCT04707313|564686785|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156436228|NCT04707313|564686786|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
156436229|NCT04707313|564686787|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156436230|NCT04707313|564686788|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156785057|NCT03158311|565963345|FG000|Overall Study|Physician Decision|2|||
156785058|NCT03158311|565963346|FG001|Overall Study|Physician Decision|3|||
156785059|NCT03158311|565963347|FG002|Overall Study|Physician Decision|7|||
156785060|NCT03158311|565963345|FG000|Overall Study|Lost to Follow-up|1|||
156530100|NCT03231943|565034834|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
156530101|NCT03231943|565034822|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
156530102|NCT03231943|565034823|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530103|NCT03231943|565034824|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530104|NCT03231943|565034825|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530105|NCT03231943|565034826|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530106|NCT03231943|565034827|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530107|NCT03231943|565034828|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156785061|NCT03158311|565963346|FG001|Overall Study|Lost to Follow-up|1|||
156785062|NCT03158311|565963347|FG002|Overall Study|Lost to Follow-up|1|||
156785063|NCT03158311|565963345|FG000|Overall Study|Sponsor decision|1|||
156785064|NCT03158311|565963346|FG001|Overall Study|Sponsor decision|0|||
156785065|NCT03158311|565963347|FG002|Overall Study|Sponsor decision|0|||
156785066|NCT03158311|565963345|FG000|Overall Study|Pregnancy|0|||
156530108|NCT03231943|565034829|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530109|NCT03231943|565034830|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530110|NCT03231943|565034831|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530111|NCT03231943|565034832|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530112|NCT03231943|565034833|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530113|NCT03231943|565034834|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156530114|NCT03231943|565034822|FG000|Part 2|Adverse Event|0|||
156530115|NCT03231943|565034823|FG001|Part 2|Adverse Event|0|||
156530116|NCT03231943|565034824|FG002|Part 2|Adverse Event|0|||
156530117|NCT03231943|565034825|FG003|Part 2|Adverse Event|0|||
156530118|NCT03231943|565034826|FG004|Part 2|Adverse Event|0|||
156530119|NCT03231943|565034827|FG005|Part 2|Adverse Event|0|||
156530120|NCT03231943|565034828|FG006|Part 2|Adverse Event|0|||
156530121|NCT03231943|565034829|FG007|Part 2|Adverse Event|0|||
156530122|NCT03231943|565034830|FG008|Part 2|Adverse Event|0|||
156530123|NCT03231943|565034831|FG009|Part 2|Adverse Event|0|||
156530124|NCT03231943|565034832|FG010|Part 2|Adverse Event|1|||
156785067|NCT03158311|565963346|FG001|Overall Study|Pregnancy|2|||
156785068|NCT03158311|565963347|FG002|Overall Study|Pregnancy|0|||
156785069|NCT03158311|565963345|FG000|Overall Study|Randomized in error|0|||
156785070|NCT03158311|565963346|FG001|Overall Study|Randomized in error|0|||
156785071|NCT03158311|565963347|FG002|Overall Study|Randomized in error|1|||
156785072|NCT01033071|565963348|FG000|Overall Study|Adverse Event|28|||
156785073|NCT01033071|565963349|FG001|Overall Study|Adverse Event|51|||
156785074|NCT01033071|565963350|FG002|Overall Study|Adverse Event|26|||
156785075|NCT01033071|565963348|FG000|Overall Study|Protocol Violation|0|||
156785076|NCT01033071|565963349|FG001|Overall Study|Protocol Violation|2|||
156785077|NCT01033071|565963350|FG002|Overall Study|Protocol Violation|1|||
156785078|NCT01033071|565963348|FG000|Overall Study|Lost to Follow-up|4|||
156785079|NCT01033071|565963349|FG001|Overall Study|Lost to Follow-up|5|||
156785080|NCT01033071|565963350|FG002|Overall Study|Lost to Follow-up|5|||
156785081|NCT01033071|565963348|FG000|Overall Study|Withdrawal by Subject|17|||
156785082|NCT01033071|565963349|FG001|Overall Study|Withdrawal by Subject|14|||
156785083|NCT01033071|565963350|FG002|Overall Study|Withdrawal by Subject|11|||
156785084|NCT01033071|565963348|FG000|Overall Study|Lack of Efficacy|0|||
156785085|NCT01033071|565963349|FG001|Overall Study|Lack of Efficacy|1|||
156785086|NCT01033071|565963350|FG002|Overall Study|Lack of Efficacy|1|||
156785087|NCT01033071|565963348|FG000|Overall Study|Other|6|||
156785088|NCT01033071|565963349|FG001|Overall Study|Other|4|||
156436231|NCT04707313|564686789|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156530125|NCT03231943|565034833|FG011|Part 2|Adverse Event|0|||
156785089|NCT01033071|565963350|FG002|Overall Study|Other|3|||
156785090|NCT04073407|565963353|FG000|Part 1|Withdrawal by Subject|1|||
156785091|NCT04073407|565963354|FG001|Part 1|Withdrawal by Subject|0|||
156530126|NCT03231943|565034834|FG012|Part 2|Adverse Event|0|||
156530127|NCT03231943|565034822|FG000|Part 2|Withdrawal by Subject|0|||
156530128|NCT03231943|565034823|FG001|Part 2|Withdrawal by Subject|0|||
156530129|NCT03231943|565034824|FG002|Part 2|Withdrawal by Subject|0|||
156808724|NCT02595879|566054443|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
156808725|NCT02595879|566054444|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
156808726|NCT01396187|566054445|FG000|Overall Study|Adverse Event|0|||
156785092|NCT04073407|565963353|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
156785093|NCT04073407|565963354|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
156785094|NCT04073407|565963353|FG000|Part 2|Withdrawal by Subject|0|||
156785095|NCT04073407|565963354|FG001|Part 2|Withdrawal by Subject|1|||
156785096|NCT00960856|565964816|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156785097|NCT00960856|565964817|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
156785098|NCT00960856|565964818|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
156785099|NCT00960856|565964819|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
156785100|NCT00960856|565964816|FG000|Washout Period of 7 Days|Adverse Event|0|||
156785101|NCT00960856|565964817|FG001|Washout Period of 7 Days|Adverse Event|0|||
156785102|NCT00960856|565964818|FG002|Washout Period of 7 Days|Adverse Event|1|||
156785103|NCT00960856|565964819|FG003|Washout Period of 7 Days|Adverse Event|0|||
156785104|NCT03315689|565964824|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
156785105|NCT03315689|565964825|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
156785106|NCT03315689|565964824|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
156785107|NCT03315689|565964825|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
156785108|NCT03315689|565964824|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
156785109|NCT03315689|565964825|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
156785110|NCT01297244|565964826|FG000|Overall Study|Progressive disease|22|||
156785111|NCT01297244|565964827|FG001|Overall Study|Progressive disease|3|||
156785112|NCT01297244|565964826|FG000|Overall Study|Adverse Event|9|||
156785113|NCT01297244|565964827|FG001|Overall Study|Adverse Event|1|||
156785114|NCT01297244|565964826|FG000|Overall Study|Death|1|||
156785115|NCT01297244|565964827|FG001|Overall Study|Death|1|||
156785116|NCT01297244|565964826|FG000|Overall Study|Clinical progression|1|||
156785117|NCT01297244|565964827|FG001|Overall Study|Clinical progression|1|||
156785118|NCT01297244|565964826|FG000|Overall Study|Withdrawal by Subject|2|||
156785119|NCT01297244|565964827|FG001|Overall Study|Withdrawal by Subject|0|||
156785120|NCT01348698|565964828|FG000|Overall Study|Does not meet lesion size criteria|1|||
156785121|NCT01348698|565964828|FG000|Overall Study|Death|3|||
156785122|NCT01348698|565964828|FG000|Overall Study|PI decision to close study|68|||
156785123|NCT02595749|565964829|FG000|Overall Study|Withdrawal by Subject|12|||
156785124|NCT02595749|565964830|FG001|Overall Study|Withdrawal by Subject|7|||
156785125|NCT00669331|565964831|FG000|Randomisation to First Dose|Adverse Event|1|||
156785126|NCT00669331|565964832|FG001|Randomisation to First Dose|Adverse Event|0|||
156785127|NCT00669331|565964831|FG000|Randomisation to First Dose|Protocol Violation|1|||
156785128|NCT00669331|565964832|FG001|Randomisation to First Dose|Protocol Violation|0|||
156785129|NCT00669331|565964831|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
156785130|NCT00669331|565964832|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
156785131|NCT00669331|565964831|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
156785132|NCT00669331|565964832|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
156785133|NCT00669331|565964831|FG000|Randomisation to First Dose|Death|1|||
156785134|NCT00669331|565964832|FG001|Randomisation to First Dose|Death|0|||
156785135|NCT00669331|565964831|FG000|Randomisation to First Dose|Sponsor decision|0|||
156785136|NCT00669331|565964832|FG001|Randomisation to First Dose|Sponsor decision|1|||
156785137|NCT00669331|565964831|FG000|Randomisation to First Dose|Randomised in error|3|||
156785138|NCT00669331|565964832|FG001|Randomisation to First Dose|Randomised in error|10|||
156785139|NCT00669331|565964831|FG000|Blinded Treatment Period|Adverse Event|16|||
156785140|NCT00669331|565964832|FG001|Blinded Treatment Period|Adverse Event|10|||
156785141|NCT00669331|565964831|FG000|Blinded Treatment Period|Protocol Violation|1|||
156785142|NCT00669331|565964832|FG001|Blinded Treatment Period|Protocol Violation|1|||
156785143|NCT00669331|565964831|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
156785144|NCT00669331|565964832|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
156785145|NCT00669331|565964831|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
156785146|NCT00669331|565964832|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
156785147|NCT00669331|565964831|FG000|Blinded Treatment Period|Death|0|||
156785148|NCT00669331|565964832|FG001|Blinded Treatment Period|Death|2|||
156785149|NCT00669331|565964831|FG000|Blinded Treatment Period|Physician Decision|3|||
156785150|NCT00669331|565964832|FG001|Blinded Treatment Period|Physician Decision|3|||
156868485|NCT00068692|566277314|FG006|Step 2: Randomization|Disesae progression/replase|0|||
156868486|NCT00068692|566277315|FG007|Step 2: Randomization|Disesae progression/replase|0|||
156868487|NCT00068692|566277308|FG000|Step 2: Randomization|Adverse Event|0|||
156329772|NCT00392015|564308689|FG004|Overall Study|Adverse Event|1|||
156530130|NCT03231943|565034825|FG003|Part 2|Withdrawal by Subject|0|||
156785151|NCT00669331|565964831|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
156785152|NCT00669331|565964832|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
156785153|NCT01454063|565964833|FG000|Randomized|Adverse Event|1|||
156785154|NCT01454063|565964834|FG001|Randomized|Adverse Event|1|||
156785155|NCT01454063|565964833|FG000|Randomized|Protocol Violation|0|||
156785156|NCT01454063|565964834|FG001|Randomized|Protocol Violation|1|||
156785157|NCT03387046|565964835|FG000|Overall Study|Adverse Event|1|||
156785158|NCT03387046|565964836|FG001|Overall Study|Adverse Event|1|||
156329773|NCT00392015|564308690|FG005|Overall Study|Adverse Event|0|||
156530131|NCT03231943|565034826|FG004|Part 2|Withdrawal by Subject|0|||
156530132|NCT03231943|565034827|FG005|Part 2|Withdrawal by Subject|0|||
156530133|NCT03231943|565034828|FG006|Part 2|Withdrawal by Subject|0|||
156685007|NCT00685750|565590739|FG006|Overall Study|Tumor sampling failure|0|||
156685008|NCT00685750|565590733|FG000|Overall Study|Patient didn't receive the treatment|0|||
156685009|NCT00685750|565590734|FG001|Overall Study|Patient didn't receive the treatment|0|||
156685010|NCT00685750|565590735|FG002|Overall Study|Patient didn't receive the treatment|0|||
156685011|NCT00685750|565590736|FG003|Overall Study|Patient didn't receive the treatment|0|||
156685012|NCT00685750|565590737|FG004|Overall Study|Patient didn't receive the treatment|0|||
156685013|NCT00685750|565590738|FG005|Overall Study|Patient didn't receive the treatment|0|||
156685014|NCT00685750|565590739|FG006|Overall Study|Patient didn't receive the treatment|1|||
156685015|NCT00685750|565590733|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156685016|NCT00685750|565590734|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156685017|NCT00685750|565590735|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156685018|NCT00685750|565590736|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
156685019|NCT00685750|565590737|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
156685020|NCT00685750|565590738|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
156685021|NCT00685750|565590739|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
156685022|NCT04974580|565590742|FG000|Overall Study|Lost to Follow-up|33|||
156685023|NCT04974580|565590743|FG001|Overall Study|Lost to Follow-up|39|||
156685024|NCT04974580|565590744|FG002|Overall Study|Lost to Follow-up|30|||
156685025|NCT04974580|565590745|FG003|Overall Study|Lost to Follow-up|29|||
156685026|NCT00587431|565590746|FG000|Overall Study|Adverse Event|1|||
156685027|NCT00587431|565590747|FG001|Overall Study|Adverse Event|0|||
156685028|NCT00587431|565590746|FG000|Overall Study|Withdrawal by Subject|0|||
156685029|NCT00587431|565590747|FG001|Overall Study|Withdrawal by Subject|1|||
156685030|NCT05467982|565590748|FG000|Overall Study|Death|0|||
156685031|NCT05467982|565590749|FG001|Overall Study|Death|1|||
156685032|NCT05467982|565590748|FG000|Overall Study|Lost to Follow-up|3|||
156685033|NCT05467982|565590749|FG001|Overall Study|Lost to Follow-up|1|||
156685034|NCT02941523|565590753|FG000|Monotherapy|Withdrawal by Subject|0|||
156685035|NCT02941523|565590754|FG001|Monotherapy|Withdrawal by Subject|1|||
156685036|NCT02941523|565590753|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
156685037|NCT02941523|565590754|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
156685038|NCT02941523|565590753|FG000|Carboplatin Combination Therapy|Death|1|||
156685039|NCT02941523|565590754|FG001|Carboplatin Combination Therapy|Death|2|||
156685040|NCT02941523|565590753|FG000|Carboplatin Combination Therapy|Disease progression|2|||
156685041|NCT02941523|565590754|FG001|Carboplatin Combination Therapy|Disease progression|0|||
156685042|NCT02941523|565590753|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
156685043|NCT02941523|565590754|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
156685044|NCT04330157|565590755|FG000|Overall Study|Protocol Violation|4|||
156685045|NCT04330157|565590755|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
156685046|NCT00869440|565590757|FG000|Overall Study|Withdrawal by Subject|1|||
156685047|NCT00869440|565590758|FG001|Overall Study|Withdrawal by Subject|0|||
156685048|NCT00869440|565590759|FG002|Overall Study|Withdrawal by Subject|0|||
156785159|NCT03558672|565964837|FG000|Overall Study|Study Early Termination|10|||
156785160|NCT00509600|565964838|FG000|Overall Study|Adverse Event|1|||
156785161|NCT01027416|565964840|FG000|Overall Study|Withdrawal by Subject|0|||
156785162|NCT01027416|565964841|FG001|Overall Study|Withdrawal by Subject|1|||
156785163|NCT01027416|565964840|FG000|Overall Study|Physician Decision|1|||
156785164|NCT01027416|565964841|FG001|Overall Study|Physician Decision|4|||
156785165|NCT01428713|565964842|FG000|Overall Study|Non-compliance|2|||
156785166|NCT01428713|565964843|FG001|Overall Study|Non-compliance|2|||
156785167|NCT01428713|565964842|FG000|Overall Study|Withdrawal by Subject|1|||
156785168|NCT01428713|565964843|FG001|Overall Study|Withdrawal by Subject|1|||
156785169|NCT01428713|565964842|FG000|Overall Study|Adverse Event|0|||
156785170|NCT01428713|565964843|FG001|Overall Study|Adverse Event|2|||
156530134|NCT03231943|565034829|FG007|Part 2|Withdrawal by Subject|0|||
156785171|NCT00875667|565964846|FG000|Overall Study|Adverse Event|29|||
156785172|NCT00875667|565964847|FG001|Overall Study|Adverse Event|10|||
156785173|NCT00875667|565964846|FG000|Overall Study|Withdrawal by Subject|17|||
156785174|NCT00875667|565964847|FG001|Overall Study|Withdrawal by Subject|5|||
156785175|NCT00875667|565964846|FG000|Overall Study|Death|7|||
156685049|NCT00869440|565590760|FG003|Overall Study|Withdrawal by Subject|0|||
156685050|NCT00869440|565590757|FG000|Overall Study|Physician Decision|1|||
156685051|NCT00869440|565590758|FG001|Overall Study|Physician Decision|1|||
156685052|NCT00869440|565590759|FG002|Overall Study|Physician Decision|0|||
156685053|NCT00869440|565590760|FG003|Overall Study|Physician Decision|0|||
156685054|NCT03558139|565590761|FG000|Overall Study|Consent Withdrawn|1|||
156685055|NCT03558139|565590762|FG001|Overall Study|Consent Withdrawn|1|||
156685056|NCT03558139|565590763|FG002|Overall Study|Consent Withdrawn|4|||
156685057|NCT03558139|565590761|FG000|Overall Study|Death|5|||
156685058|NCT03558139|565590762|FG001|Overall Study|Death|3|||
156685059|NCT03558139|565590763|FG002|Overall Study|Death|8|||
156685060|NCT03558139|565590761|FG000|Overall Study|Lost to Follow-up|0|||
156685061|NCT03558139|565590762|FG001|Overall Study|Lost to Follow-up|0|||
156685062|NCT03558139|565590763|FG002|Overall Study|Lost to Follow-up|3|||
156685063|NCT03558139|565590761|FG000|Overall Study|Study Ended Per Protocol|0|||
156685064|NCT03558139|565590762|FG001|Overall Study|Study Ended Per Protocol|3|||
156685065|NCT03558139|565590763|FG002|Overall Study|Study Ended Per Protocol|6|||
156685066|NCT00251316|565590764|FG000|Overall Study|Physician Decision|2|||
156685067|NCT00251316|565590765|FG001|Overall Study|Physician Decision|3|||
156685068|NCT00569777|565590768|FG000|Overall Study|Withdrawal by Subject|4|||
156685069|NCT00569777|565590769|FG001|Overall Study|Withdrawal by Subject|0|||
156685070|NCT00569777|565590768|FG000|Overall Study|Adverse Event|3|||
156685071|NCT00569777|565590769|FG001|Overall Study|Adverse Event|0|||
156685072|NCT00569777|565590768|FG000|Overall Study|Lost to Follow-up|1|||
156685073|NCT00569777|565590769|FG001|Overall Study|Lost to Follow-up|0|||
156685074|NCT00569777|565590768|FG000|Overall Study|scheduled eye surgery|0|||
156685075|NCT00569777|565590769|FG001|Overall Study|scheduled eye surgery|1|||
156685076|NCT00569777|565590768|FG000|Overall Study|did not meet exclusion criteria|1|||
156685077|NCT00569777|565590769|FG001|Overall Study|did not meet exclusion criteria|2|||
156685078|NCT00569777|565590768|FG000|Overall Study|pregnant|1|||
156685079|NCT00569777|565590769|FG001|Overall Study|pregnant|0|||
156685080|NCT02030535|565590771|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
156685081|NCT04773600|565590777|FG000|Overall Study|Withdrawal by Subject|15|||
156685082|NCT04773600|565590778|FG001|Overall Study|Withdrawal by Subject|9|||
156685083|NCT04773600|565590777|FG000|Overall Study|Lost to Follow-up|10|||
156685084|NCT04773600|565590778|FG001|Overall Study|Lost to Follow-up|6|||
156685085|NCT04773600|565590777|FG000|Overall Study|Adverse Event|8|||
156685086|NCT04773600|565590778|FG001|Overall Study|Adverse Event|2|||
156685087|NCT04773600|565590777|FG000|Overall Study|Lack of Efficacy|2|||
156685088|NCT04773600|565590778|FG001|Overall Study|Lack of Efficacy|3|||
156685089|NCT04773600|565590777|FG000|Overall Study|Noncompliance|2|||
156685090|NCT04773600|565590778|FG001|Overall Study|Noncompliance|0|||
156685091|NCT04773600|565590777|FG000|Overall Study|Protocol Violation|2|||
156685092|NCT04773600|565590778|FG001|Overall Study|Protocol Violation|0|||
156685093|NCT04773600|565590777|FG000|Overall Study|Physician Decision|0|||
156685094|NCT04773600|565590778|FG001|Overall Study|Physician Decision|1|||
156685095|NCT04773600|565590777|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
156685096|NCT04773600|565590778|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
156685097|NCT04773600|565590777|FG000|Overall Study|Emergency Travel Out of Country|1|||
156685098|NCT04773600|565590778|FG001|Overall Study|Emergency Travel Out of Country|0|||
156685099|NCT01923311|565592056|FG000|Overall Study|Pregnancy|1|||
156436232|NCT04707313|564686790|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156685100|NCT01923311|565592057|FG001|Overall Study|Pregnancy|0|||
156685101|NCT01923311|565592056|FG000|Overall Study|Investigator's Discretion|1|||
156685102|NCT01923311|565592057|FG001|Overall Study|Investigator's Discretion|0|||
156685103|NCT01923311|565592056|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156685104|NCT01923311|565592057|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156685105|NCT01923311|565592056|FG000|Overall Study|Withdrew Consent|1|||
156685106|NCT01923311|565592057|FG001|Overall Study|Withdrew Consent|0|||
156685107|NCT01923311|565592056|FG000|Overall Study|Study Terminated by Sponsor|12|||
156685108|NCT01923311|565592057|FG001|Overall Study|Study Terminated by Sponsor|0|||
156685109|NCT03180528|565592063|FG000|Overall Study|Adverse Event|1|||
156685110|NCT03180528|565592063|FG000|Overall Study|Withdrawal by Subject|1|||
156685111|NCT03180528|565592063|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
156685112|NCT02839798|565592064|FG000|Overall Study|Withdrawal by Subject|2|||
156685113|NCT04129944|565592065|FG000|Overall Study|Death|0|||
156685114|NCT04129944|565592066|FG001|Overall Study|Death|0|||
156685115|NCT04129944|565592067|FG002|Overall Study|Death|0|||
156685116|NCT04129944|565592068|FG003|Overall Study|Death|1|||
156685117|NCT04129944|565592065|FG000|Overall Study|Lost to Follow-up|1|||
156685118|NCT04129944|565592066|FG001|Overall Study|Lost to Follow-up|0|||
156685119|NCT04129944|565592067|FG002|Overall Study|Lost to Follow-up|0|||
156685120|NCT04129944|565592068|FG003|Overall Study|Lost to Follow-up|0|||
156785176|NCT00875667|565964847|FG001|Overall Study|Death|2|||
156785177|NCT00875667|565964846|FG000|Overall Study|Protocol Violation|2|||
156436233|NCT04707313|564686791|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156530135|NCT03231943|565034830|FG008|Part 2|Withdrawal by Subject|0|||
156685121|NCT04129944|565592065|FG000|Overall Study|Withdrawal by Subject|1|||
156685122|NCT04129944|565592066|FG001|Overall Study|Withdrawal by Subject|0|||
156685123|NCT04129944|565592067|FG002|Overall Study|Withdrawal by Subject|1|||
156685124|NCT04129944|565592068|FG003|Overall Study|Withdrawal by Subject|2|||
156685125|NCT03710590|565592069|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
156685126|NCT03710590|565592070|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
156685127|NCT02488824|565592071|FG000|Overall Study|Adverse Event|1|||
156685128|NCT02488824|565592072|FG001|Overall Study|Adverse Event|1|||
156685129|NCT02356211|565592073|FG000|Overall Study|Withdrawal by Subject|2|||
156685130|NCT02356211|565592074|FG001|Overall Study|Withdrawal by Subject|2|||
156685131|NCT02356211|565592073|FG000|Overall Study|ineligible|1|||
156685132|NCT02356211|565592074|FG001|Overall Study|ineligible|8|||
156685133|NCT01124695|565592079|FG000|Overall Study|Disease progression|77|||
156685134|NCT01124695|565592079|FG000|Overall Study|Adverse Event|11|||
156685135|NCT01124695|565592079|FG000|Overall Study|Death|1|||
156685136|NCT01124695|565592079|FG000|Overall Study|Withdrawal by Subject|7|||
156685137|NCT01124695|565592079|FG000|Overall Study|Physician Decision|3|||
156685138|NCT01124695|565592079|FG000|Overall Study|Alternative therapy|9|||
156685139|NCT01124695|565592079|FG000|Overall Study|No documentation that patient went off treatment|4|||
156685140|NCT01124695|565592079|FG000|Overall Study|Ineligible|9|||
156685141|NCT01124695|565592079|FG000|Overall Study|Ineligible and never start treatment|2|||
156685142|NCT02695719|565592090|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
156685143|NCT02695719|565592091|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
156685144|NCT02695719|565592090|FG000|Overall Study|Significant Protocol Deviation|0|||
156685145|NCT02695719|565592091|FG001|Overall Study|Significant Protocol Deviation|1|||
156685146|NCT02695719|565592090|FG000|Overall Study|Voluntary Withdrawal|1|||
156685147|NCT02695719|565592091|FG001|Overall Study|Voluntary Withdrawal|0|||
156685148|NCT03180801|565592092|FG000|Overall Study|Physician Decision|3|||
156685149|NCT03180801|565592093|FG001|Overall Study|Physician Decision|3|||
156685150|NCT03180801|565592094|FG002|Overall Study|Physician Decision|1|||
156436234|NCT04707313|564686792|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156685151|NCT03180801|565592092|FG000|Overall Study|Non-compliance|1|||
156685152|NCT03180801|565592093|FG001|Overall Study|Non-compliance|4|||
156685153|NCT03180801|565592094|FG002|Overall Study|Non-compliance|0|||
156685154|NCT03180801|565592092|FG000|Overall Study|Inoculation Target Reached|1|||
156685155|NCT03180801|565592093|FG001|Overall Study|Inoculation Target Reached|1|||
156685156|NCT03180801|565592094|FG002|Overall Study|Inoculation Target Reached|3|||
156685157|NCT03180801|565592092|FG000|Overall Study|Adverse Event|1|||
156685158|NCT03180801|565592093|FG001|Overall Study|Adverse Event|0|||
156685159|NCT03180801|565592094|FG002|Overall Study|Adverse Event|2|||
156685160|NCT03180801|565592092|FG000|Overall Study|Withdrawal by Subject|2|||
156685161|NCT03180801|565592093|FG001|Overall Study|Withdrawal by Subject|2|||
156685162|NCT03180801|565592094|FG002|Overall Study|Withdrawal by Subject|1|||
156685163|NCT03180801|565592092|FG000|Overall Study|Lost to Follow-up|0|||
156685164|NCT03180801|565592093|FG001|Overall Study|Lost to Follow-up|2|||
156685165|NCT03180801|565592094|FG002|Overall Study|Lost to Follow-up|3|||
156685166|NCT01220609|565592095|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
156685167|NCT01220609|565592095|FG000|Overall Study|Ineligible- Wrong cell type|1|||
156685168|NCT01220609|565592095|FG000|Overall Study|Ineligible-Never treated|1|||
156685169|NCT01142908|565592097|FG000|Overall Study|Lost to Follow-up|19|||
156685170|NCT01142908|565592098|FG001|Overall Study|Lost to Follow-up|13|||
156685171|NCT01142908|565592097|FG000|Overall Study|Death|1|||
156685172|NCT01142908|565592098|FG001|Overall Study|Death|4|||
156685173|NCT01142908|565592097|FG000|Overall Study|Excluded - did not meet criteria|9|||
156685174|NCT01142908|565592098|FG001|Overall Study|Excluded - did not meet criteria|5|||
156685175|NCT01142908|565592097|FG000|Overall Study|Withdrawal by Subject|3|||
156685176|NCT01142908|565592098|FG001|Overall Study|Withdrawal by Subject|0|||
156685177|NCT00529217|565592114|FG000|Overall Study|Lack of Efficacy|2|||
156685178|NCT00529217|565592114|FG000|Overall Study|Unable to adhere to study schedule|2|||
156685179|NCT01546519|565592115|FG000|Overall Study|Adverse Event|0|||
156685180|NCT01546519|565592116|FG001|Overall Study|Adverse Event|0|||
156685181|NCT01546519|565592117|FG002|Overall Study|Adverse Event|1|||
156685182|NCT01546519|565592118|FG003|Overall Study|Adverse Event|1|||
156685183|NCT01546519|565592115|FG000|Overall Study|Death|0|||
156685184|NCT01546519|565592116|FG001|Overall Study|Death|1|||
156685185|NCT01546519|565592117|FG002|Overall Study|Death|3|||
156685186|NCT01546519|565592118|FG003|Overall Study|Death|1|||
156685187|NCT01546519|565592115|FG000|Overall Study|related to disease progression|2|||
156685188|NCT01546519|565592116|FG001|Overall Study|related to disease progression|2|||
156685189|NCT01546519|565592117|FG002|Overall Study|related to disease progression|2|||
156685190|NCT01546519|565592118|FG003|Overall Study|related to disease progression|1|||
156685191|NCT01546519|565592115|FG000|Overall Study|Physician Decision|6|||
156685192|NCT01546519|565592116|FG001|Overall Study|Physician Decision|5|||
156685193|NCT01546519|565592117|FG002|Overall Study|Physician Decision|2|||
156685194|NCT01546519|565592118|FG003|Overall Study|Physician Decision|3|||
156685195|NCT01546519|565592115|FG000|Overall Study|Withdrawal by Subject|1|||
156685196|NCT01546519|565592116|FG001|Overall Study|Withdrawal by Subject|0|||
156685197|NCT01546519|565592117|FG002|Overall Study|Withdrawal by Subject|0|||
156685198|NCT01546519|565592118|FG003|Overall Study|Withdrawal by Subject|0|||
156685199|NCT01519947|565592119|FG000|Overall Study|Death|0|||
156685200|NCT01519947|565592120|FG001|Overall Study|Death|0|||
156685201|NCT01519947|565592121|FG002|Overall Study|Death|0|||
156685202|NCT01519947|565592122|FG003|Overall Study|Death|1|||
156685203|NCT01519947|565592119|FG000|Overall Study|Protocol Violation|0|||
156436235|NCT04707313|564686793|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156685204|NCT01519947|565592120|FG001|Overall Study|Protocol Violation|0|||
156685205|NCT01519947|565592121|FG002|Overall Study|Protocol Violation|2|||
156685206|NCT01519947|565592122|FG003|Overall Study|Protocol Violation|1|||
156685207|NCT01519947|565592119|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
156685208|NCT01519947|565592120|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
156685209|NCT01519947|565592121|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
156868488|NCT00068692|566277309|FG001|Step 2: Randomization|Adverse Event|0|||
156868489|NCT00068692|566277310|FG002|Step 2: Randomization|Adverse Event|4|||
156868490|NCT00068692|566277311|FG003|Step 2: Randomization|Adverse Event|2|||
156868491|NCT00068692|566277312|FG004|Step 2: Randomization|Adverse Event|2|||
156868492|NCT00068692|566277313|FG005|Step 2: Randomization|Adverse Event|3|||
156868493|NCT00068692|566277314|FG006|Step 2: Randomization|Adverse Event|4|||
156868494|NCT00068692|566277315|FG007|Step 2: Randomization|Adverse Event|4|||
156868495|NCT00068692|566277308|FG000|Step 2: Randomization|Death|0|||
156868496|NCT00068692|566277309|FG001|Step 2: Randomization|Death|0|||
156868497|NCT00068692|566277310|FG002|Step 2: Randomization|Death|0|||
156868498|NCT00068692|566277311|FG003|Step 2: Randomization|Death|0|||
156868499|NCT00068692|566277312|FG004|Step 2: Randomization|Death|1|||
156868500|NCT00068692|566277313|FG005|Step 2: Randomization|Death|0|||
156868501|NCT00068692|566277314|FG006|Step 2: Randomization|Death|0|||
156868502|NCT00068692|566277315|FG007|Step 2: Randomization|Death|1|||
156868503|NCT00068692|566277308|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
156868504|NCT00068692|566277309|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
156868505|NCT00068692|566277310|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
156868506|NCT00068692|566277311|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
156868507|NCT00068692|566277312|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
156868508|NCT00068692|566277313|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
156868509|NCT00068692|566277314|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
156868510|NCT00068692|566277315|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
156868511|NCT00068692|566277308|FG000|Step 2: Randomization|alternative therapy|0|||
156868512|NCT00068692|566277309|FG001|Step 2: Randomization|alternative therapy|0|||
156868513|NCT00068692|566277310|FG002|Step 2: Randomization|alternative therapy|0|||
156868514|NCT00068692|566277311|FG003|Step 2: Randomization|alternative therapy|1|||
156868515|NCT00068692|566277312|FG004|Step 2: Randomization|alternative therapy|1|||
156868516|NCT00068692|566277313|FG005|Step 2: Randomization|alternative therapy|0|||
156868517|NCT00068692|566277314|FG006|Step 2: Randomization|alternative therapy|0|||
156868518|NCT00068692|566277315|FG007|Step 2: Randomization|alternative therapy|0|||
156868519|NCT00068692|566277308|FG000|Step 2: Randomization|Physician Decision|0|||
156868520|NCT00068692|566277309|FG001|Step 2: Randomization|Physician Decision|0|||
156868521|NCT00068692|566277310|FG002|Step 2: Randomization|Physician Decision|0|||
156868522|NCT00068692|566277311|FG003|Step 2: Randomization|Physician Decision|1|||
156868523|NCT00068692|566277312|FG004|Step 2: Randomization|Physician Decision|1|||
156868524|NCT00068692|566277313|FG005|Step 2: Randomization|Physician Decision|0|||
156868525|NCT00068692|566277314|FG006|Step 2: Randomization|Physician Decision|0|||
156868526|NCT00068692|566277315|FG007|Step 2: Randomization|Physician Decision|0|||
156685210|NCT01519947|565592122|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
156685211|NCT01519947|565592119|FG000|Overall Study|Development of Anemia|0|||
156685212|NCT01519947|565592120|FG001|Overall Study|Development of Anemia|1|||
156685213|NCT01519947|565592121|FG002|Overall Study|Development of Anemia|0|||
156685214|NCT01519947|565592122|FG003|Overall Study|Development of Anemia|1|||
156785178|NCT00875667|565964847|FG001|Overall Study|Protocol Violation|0|||
156785179|NCT00875667|565964846|FG000|Overall Study|Disease Progression|100|||
156785180|NCT00875667|565964847|FG001|Overall Study|Disease Progression|49|||
156868527|NCT00068692|566277308|FG000|Step 2: Randomization|Other|0|||
156868528|NCT00068692|566277309|FG001|Step 2: Randomization|Other|0|||
156868529|NCT00068692|566277310|FG002|Step 2: Randomization|Other|0|||
156685215|NCT01519947|565592119|FG000|Overall Study|Blood Transfusion|0|||
156685216|NCT01519947|565592120|FG001|Overall Study|Blood Transfusion|1|||
156685217|NCT01519947|565592121|FG002|Overall Study|Blood Transfusion|1|||
156785181|NCT00875667|565964846|FG000|Overall Study|Miscellaneous|12|||
156785182|NCT00875667|565964847|FG001|Overall Study|Miscellaneous|6|||
156785183|NCT00875667|565964846|FG000|Overall Study|Randomized but no Study Drug Given|3|||
156785184|NCT00875667|565964847|FG001|Overall Study|Randomized but no Study Drug Given|1|||
156785185|NCT00120250|565964848|FG000|Overall Study|Lost to Follow-up|1|||
156785186|NCT00120250|565964849|FG001|Overall Study|Lost to Follow-up|1|||
156785187|NCT00120250|565964848|FG000|Overall Study|Protocol Violation|0|||
156685218|NCT01519947|565592122|FG003|Overall Study|Blood Transfusion|0|||
156785188|NCT00120250|565964849|FG001|Overall Study|Protocol Violation|1|||
156785189|NCT01967277|565964853|FG000|Overall Study|Lost to Follow-up|1|||
156785190|NCT01967277|565964854|FG001|Overall Study|Lost to Follow-up|2|||
156785191|NCT01967277|565964853|FG000|Overall Study|Unrelated illness|0|||
156785192|NCT01967277|565964854|FG001|Overall Study|Unrelated illness|1|||
156685219|NCT01519947|565592119|FG000|Overall Study|Withdrawal by Subject|0|||
156868530|NCT00068692|566277311|FG003|Step 2: Randomization|Other|1|||
156868531|NCT00068692|566277312|FG004|Step 2: Randomization|Other|0|||
156868532|NCT00068692|566277313|FG005|Step 2: Randomization|Other|1|||
156868533|NCT00068692|566277314|FG006|Step 2: Randomization|Other|0|||
156868534|NCT00068692|566277315|FG007|Step 2: Randomization|Other|0|||
156868535|NCT00068692|566277308|FG000|Step 2: Randomization|never start protocol therapy|0|||
156868536|NCT00068692|566277309|FG001|Step 2: Randomization|never start protocol therapy|0|||
156685220|NCT01519947|565592120|FG001|Overall Study|Withdrawal by Subject|1|||
156785193|NCT01524705|565964857|FG000|Overall Study|Adverse Event|2|||
156685221|NCT01519947|565592121|FG002|Overall Study|Withdrawal by Subject|0|||
156685222|NCT01519947|565592122|FG003|Overall Study|Withdrawal by Subject|1|||
156685223|NCT01519947|565592119|FG000|Overall Study|Lost to Follow-up|0|||
156685224|NCT01519947|565592120|FG001|Overall Study|Lost to Follow-up|0|||
156685225|NCT01519947|565592121|FG002|Overall Study|Lost to Follow-up|3|||
156685226|NCT01519947|565592122|FG003|Overall Study|Lost to Follow-up|2|||
156685227|NCT01519947|565592119|FG000|Overall Study|Poor Response|1|||
156685228|NCT01519947|565592120|FG001|Overall Study|Poor Response|0|||
156685229|NCT01519947|565592121|FG002|Overall Study|Poor Response|0|||
156685230|NCT01519947|565592122|FG003|Overall Study|Poor Response|1|||
156685231|NCT01519947|565592119|FG000|Overall Study|Adverse Event|1|||
156685232|NCT01519947|565592120|FG001|Overall Study|Adverse Event|0|||
156685233|NCT01519947|565592121|FG002|Overall Study|Adverse Event|1|||
156685234|NCT01519947|565592122|FG003|Overall Study|Adverse Event|1|||
156685235|NCT01386125|565592125|FG000|Overall Study|Lost to Follow-up|3|||
156685236|NCT01386125|565592126|FG001|Overall Study|Lost to Follow-up|9|||
156685237|NCT01386125|565592125|FG000|Overall Study|Physician Decision|0|||
156685238|NCT01386125|565592126|FG001|Overall Study|Physician Decision|1|||
156685239|NCT01386125|565592125|FG000|Overall Study|Protocol Violation|5|||
156685240|NCT01386125|565592126|FG001|Overall Study|Protocol Violation|7|||
156685241|NCT01386125|565592125|FG000|Overall Study|Disease Progress|1|||
156685242|NCT01386125|565592126|FG001|Overall Study|Disease Progress|2|||
156685243|NCT01386125|565592125|FG000|Overall Study|Withdrawal by Subject|13|||
156685244|NCT01386125|565592126|FG001|Overall Study|Withdrawal by Subject|12|||
156685245|NCT01386125|565592125|FG000|Overall Study|Adverse Event|2|||
156685246|NCT01386125|565592126|FG001|Overall Study|Adverse Event|5|||
156685247|NCT01386125|565592125|FG000|Overall Study|Lack of Efficacy|0|||
156685248|NCT01386125|565592126|FG001|Overall Study|Lack of Efficacy|1|||
156685249|NCT01386125|565592125|FG000|Overall Study|Participant Leaving Country|1|||
156685250|NCT01386125|565592126|FG001|Overall Study|Participant Leaving Country|0|||
156685251|NCT02359864|565592128|FG000|Overall Study|Withdrawal by Subject|1|||
156685252|NCT02359864|565592129|FG001|Overall Study|Withdrawal by Subject|0|||
156685253|NCT00725764|565592130|FG000|Overall Study|Withdrawal by Subject|2|||
156685254|NCT00725764|565592130|FG000|Overall Study|Physician Decision|1|||
156685255|NCT00725764|565592130|FG000|Overall Study|Progressive Disease|7|||
156685256|NCT00725764|565592130|FG000|Overall Study|Lost to Follow-up|1|||
156685257|NCT00725764|565592130|FG000|Overall Study|Death|1|||
156685258|NCT00725764|565592130|FG000|Overall Study|Participant non compliant with protocol|1|||
156685259|NCT00725764|565592130|FG000|Overall Study|Decline in performance status|1|||
156685260|NCT04480307|565592132|FG000|Overall Study|Withdrawal by Subject|0|||
156685261|NCT04480307|565592133|FG001|Overall Study|Withdrawal by Subject|1|||
156685262|NCT04480307|565592134|FG002|Overall Study|Withdrawal by Subject|0|||
156685263|NCT04480307|565592135|FG003|Overall Study|Withdrawal by Subject|0|||
156685264|NCT04480307|565592132|FG000|Overall Study|Adverse Event|0|||
156685265|NCT04480307|565592133|FG001|Overall Study|Adverse Event|0|||
156685266|NCT04480307|565592134|FG002|Overall Study|Adverse Event|0|||
156685267|NCT04480307|565592135|FG003|Overall Study|Adverse Event|1|||
156685268|NCT00515216|565592140|FG000|Overall Study|Withdrawal by Subject|1|||
156685269|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
156685270|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
156436236|NCT04707313|564686794|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156436237|NCT04707313|564686782|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
156685271|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
156685272|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
156685273|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
156685274|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
156685275|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
156685276|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
156685277|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
156685278|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
156685279|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
156685280|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
156685281|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
156436238|NCT04707313|564686783|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
156685282|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
156685283|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
156685284|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
156685285|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
156685286|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
156685287|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
156685288|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
156685289|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
156685290|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
156785194|NCT01524705|565964858|FG001|Overall Study|Adverse Event|0|||
156785195|NCT01524705|565964857|FG000|Overall Study|Death|1|||
156785196|NCT01524705|565964858|FG001|Overall Study|Death|0|||
156785197|NCT01524705|565964857|FG000|Overall Study|Lost to Follow-up|0|||
156785198|NCT01524705|565964858|FG001|Overall Study|Lost to Follow-up|1|||
156785199|NCT01524705|565964857|FG000|Overall Study|Withdrawal by Subject|0|||
156785200|NCT01524705|565964858|FG001|Overall Study|Withdrawal by Subject|1|||
156785201|NCT01524705|565964857|FG000|Overall Study|Pancreatic Cancer|0|||
156785202|NCT01524705|565964858|FG001|Overall Study|Pancreatic Cancer|1|||
156785203|NCT00103506|565964859|FG000|Overall Study|Study closed by sponsor|34|||
156785204|NCT00103506|565964860|FG001|Overall Study|Study closed by sponsor|37|||
156785205|NCT00103506|565964859|FG000|Overall Study|Death|257|||
156785206|NCT00103506|565964860|FG001|Overall Study|Death|253|||
156785207|NCT00103506|565964859|FG000|Overall Study|Lost to Follow-up|13|||
156785208|NCT00103506|565964860|FG001|Overall Study|Lost to Follow-up|13|||
156785209|NCT00103506|565964859|FG000|Overall Study|Withdrawal by Subject|18|||
156785210|NCT00103506|565964860|FG001|Overall Study|Withdrawal by Subject|21|||
156785211|NCT00585585|565964861|FG000|Overall Study|Adverse Event|1|||
156785212|NCT02153827|565964862|FG000|Overall Study|Lost to Follow-up|3|||
156785213|NCT02153827|565964863|FG001|Overall Study|Lost to Follow-up|9|||
156785214|NCT00965094|565964870|FG000|Overall Study|Adverse Event|5|||
156785215|NCT00965094|565964871|FG001|Overall Study|Adverse Event|0|||
156785216|NCT00965094|565964870|FG000|Overall Study|Lost to Follow-up|0|||
156785217|NCT00965094|565964871|FG001|Overall Study|Lost to Follow-up|1|||
156785218|NCT01179516|565964873|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
156785219|NCT01179516|565964874|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
156785220|NCT01179516|565964875|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
156785221|NCT01179516|565964873|FG000|Overall Study|Lack of Efficacy|4|||
156785222|NCT01179516|565964874|FG001|Overall Study|Lack of Efficacy|2|||
156785223|NCT01179516|565964875|FG002|Overall Study|Lack of Efficacy|0|||
156785224|NCT01179516|565964873|FG000|Overall Study|Noncompliance with Study Drug|2|||
156785225|NCT01179516|565964874|FG001|Overall Study|Noncompliance with Study Drug|0|||
156785226|NCT01179516|565964875|FG002|Overall Study|Noncompliance with Study Drug|1|||
156785227|NCT01179516|565964873|FG000|Overall Study|Protocol Deviations|4|||
156785228|NCT01179516|565964874|FG001|Overall Study|Protocol Deviations|3|||
156785229|NCT01179516|565964875|FG002|Overall Study|Protocol Deviations|3|||
156785230|NCT01179516|565964873|FG000|Overall Study|Withdrawal of Consent|2|||
156785231|NCT01179516|565964874|FG001|Overall Study|Withdrawal of Consent|6|||
156785232|NCT01179516|565964875|FG002|Overall Study|Withdrawal of Consent|10|||
156785233|NCT01179516|565964873|FG000|Overall Study|Lost to Follow-up|7|||
156785234|NCT01179516|565964874|FG001|Overall Study|Lost to Follow-up|7|||
156785235|NCT01179516|565964875|FG002|Overall Study|Lost to Follow-up|3|||
156785236|NCT01179516|565964873|FG000|Overall Study|Other|2|||
156785237|NCT01179516|565964874|FG001|Overall Study|Other|0|||
156785238|NCT01179516|565964875|FG002|Overall Study|Other|2|||
156785239|NCT05064800|565964880|FG000|Period 3|Withdrawal by Subject|0|||
156785240|NCT05064800|565964881|FG001|Period 3|Withdrawal by Subject|0|||
156785241|NCT05064800|565964882|FG002|Period 3|Withdrawal by Subject|0|||
156785242|NCT05064800|565964883|FG003|Period 3|Withdrawal by Subject|0|||
156785243|NCT05064800|565964884|FG004|Period 3|Withdrawal by Subject|1|||
156785244|NCT05064800|565964885|FG005|Period 3|Withdrawal by Subject|0|||
156785245|NCT00183391|565964886|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
156785246|NCT00183391|565964887|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
156785247|NCT00183391|565964886|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
156785248|NCT00183391|565964887|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
156436239|NCT04707313|564686784|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
156436240|NCT04707313|564686785|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
156436241|NCT04707313|564686786|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
156436242|NCT04707313|564686787|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
156436243|NCT04707313|564686788|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
156436244|NCT04707313|564686789|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
156436245|NCT04707313|564686790|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
156436246|NCT04707313|564686791|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
156436247|NCT04707313|564686792|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
156785249|NCT00395512|565964888|FG000|Overall Study|Adverse Event|3|||
156785250|NCT00395512|565964889|FG001|Overall Study|Adverse Event|8|||
156785251|NCT00395512|565964890|FG002|Overall Study|Adverse Event|6|||
156785252|NCT00395512|565964891|FG003|Overall Study|Adverse Event|6|||
156436248|NCT04707313|564686793|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
156436249|NCT04707313|564686794|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
156785253|NCT00395512|565964888|FG000|Overall Study|Protocol Violation|2|||
156785254|NCT00395512|565964889|FG001|Overall Study|Protocol Violation|3|||
156785255|NCT00395512|565964890|FG002|Overall Study|Protocol Violation|6|||
156785256|NCT00395512|565964891|FG003|Overall Study|Protocol Violation|7|||
156785257|NCT00395512|565964888|FG000|Overall Study|Lost to Follow-up|2|||
156785258|NCT00395512|565964889|FG001|Overall Study|Lost to Follow-up|6|||
156785259|NCT00395512|565964890|FG002|Overall Study|Lost to Follow-up|5|||
156685291|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
156685292|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
156685293|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
156685294|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
156685295|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
156685296|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
156685297|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
156685298|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
156685299|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
156685300|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
156685301|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
156685302|NCT02250651|565592141|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
156685303|NCT02250651|565592142|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
156685304|NCT02250651|565592143|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
156685305|NCT02250651|565592141|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
156685306|NCT02250651|565592142|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
156685307|NCT02250651|565592143|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
156685308|NCT02250651|565592141|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
156685309|NCT02250651|565592142|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
156685310|NCT02250651|565592143|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
156685311|NCT02250651|565592141|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
156685312|NCT02250651|565592142|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
156685313|NCT02250651|565592143|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
156685314|NCT01264835|565592144|FG000|Overall Study|Lost to Follow-up|1|||
156685315|NCT02427399|565592148|FG000|Overall Study|Protocol Violation|14|||
156685316|NCT02427399|565592149|FG001|Overall Study|Protocol Violation|16|||
156785260|NCT00395512|565964891|FG003|Overall Study|Lost to Follow-up|5|||
156785261|NCT00395512|565964888|FG000|Overall Study|Withdrawal by Subject|6|||
156785262|NCT00395512|565964889|FG001|Overall Study|Withdrawal by Subject|5|||
156785263|NCT00395512|565964890|FG002|Overall Study|Withdrawal by Subject|5|||
156785264|NCT00395512|565964891|FG003|Overall Study|Withdrawal by Subject|12|||
156685317|NCT02427399|565592150|FG002|Overall Study|Protocol Violation|12|||
156685318|NCT02427399|565592151|FG003|Overall Study|Protocol Violation|18|||
156685319|NCT02427399|565592152|FG004|Overall Study|Protocol Violation|15|||
156685320|NCT01115933|565592153|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
156685321|NCT00605176|565592154|FG000|Overall Study|Adverse Event|2|||
156685322|NCT00605176|565592155|FG001|Overall Study|Adverse Event|1|||
156685323|NCT00605176|565592156|FG002|Overall Study|Adverse Event|3|||
156685324|NCT00605176|565592154|FG000|Overall Study|Withdrawal by Subject|4|||
156685325|NCT00605176|565592155|FG001|Overall Study|Withdrawal by Subject|2|||
156685326|NCT00605176|565592156|FG002|Overall Study|Withdrawal by Subject|4|||
156685327|NCT00605176|565592154|FG000|Overall Study|Lost to Follow-up|2|||
156685328|NCT00605176|565592155|FG001|Overall Study|Lost to Follow-up|2|||
156685329|NCT00605176|565592156|FG002|Overall Study|Lost to Follow-up|1|||
156685330|NCT00605176|565592154|FG000|Overall Study|Non-complicance with study procedures|1|||
156685331|NCT00605176|565592155|FG001|Overall Study|Non-complicance with study procedures|0|||
156685332|NCT00605176|565592156|FG002|Overall Study|Non-complicance with study procedures|0|||
156685333|NCT00605176|565592154|FG000|Overall Study|Use of concomitant therapy|1|||
156685334|NCT00605176|565592155|FG001|Overall Study|Use of concomitant therapy|0|||
156685335|NCT00605176|565592156|FG002|Overall Study|Use of concomitant therapy|1|||
156685336|NCT00605176|565592154|FG000|Overall Study|Other (not due to AE)|1|||
156685337|NCT00605176|565592155|FG001|Overall Study|Other (not due to AE)|1|||
156685338|NCT00605176|565592156|FG002|Overall Study|Other (not due to AE)|0|||
156685339|NCT01557920|565592159|FG000|Overall Study|Withdrawal by Subject|2|||
156685340|NCT01557920|565592160|FG001|Overall Study|Withdrawal by Subject|3|||
156685341|NCT01557920|565592159|FG000|Overall Study|Lack of Efficacy|1|||
156685342|NCT01557920|565592160|FG001|Overall Study|Lack of Efficacy|0|||
156685343|NCT01808248|565592169|FG000|Overall Study|Lack of Efficacy|3|||
156685344|NCT01808248|565592169|FG000|Overall Study|Withdrawal by Subject|1|||
156685345|NCT01808248|565592169|FG000|Overall Study|Lost to Follow-up|1|||
156685346|NCT03689894|565592175|FG000|Overall Study|Adverse Event|1|||
156685347|NCT01610063|565592176|FG000|Overall Study|Lost to Follow-up|42|||
156685348|NCT01610063|565592177|FG001|Overall Study|Lost to Follow-up|20|||
156685349|NCT01378962|565592182|FG000|Overall Study|Death|14|||
156685350|NCT01378962|565592182|FG000|Overall Study|Lost to Follow-up|1|||
156785265|NCT00395512|565964888|FG000|Overall Study|Physician Decision|6|||
156785266|NCT00395512|565964889|FG001|Overall Study|Physician Decision|4|||
156785267|NCT00395512|565964890|FG002|Overall Study|Physician Decision|2|||
156785268|NCT00395512|565964891|FG003|Overall Study|Physician Decision|2|||
156868537|NCT00068692|566277310|FG002|Step 2: Randomization|never start protocol therapy|1|||
156685351|NCT01378962|565592182|FG000|Overall Study|Other|2|||
156685352|NCT02056652|565592183|FG000|Overall Study|Withdrawal by Subject|1|||
156785269|NCT00395512|565964888|FG000|Overall Study|Other|1|||
156685353|NCT02056652|565592184|FG001|Overall Study|Withdrawal by Subject|0|||
156685354|NCT02056652|565592183|FG000|Overall Study|Lost to Follow-up|0|||
156685355|NCT02056652|565592184|FG001|Overall Study|Lost to Follow-up|3|||
156685356|NCT00987831|565592185|FG000|Overall Study|Never flared in 12 months|1|||
156685357|NCT00987831|565592186|FG001|Overall Study|Never flared in 12 months|0|||
156685358|NCT00987831|565592187|FG002|Overall Study|Never flared in 12 months|0|||
156685359|NCT00987831|565592185|FG000|Overall Study|Lost to Follow-up|0|||
156685360|NCT00987831|565592186|FG001|Overall Study|Lost to Follow-up|3|||
156685361|NCT00987831|565592187|FG002|Overall Study|Lost to Follow-up|0|||
156685362|NCT03253094|565592188|FG000|Overall Study|Adverse Event|2|||
156685363|NCT03253094|565592189|FG001|Overall Study|Adverse Event|0|||
156685364|NCT03253094|565592190|FG002|Overall Study|Adverse Event|0|||
156685365|NCT03253094|565592191|FG003|Overall Study|Adverse Event|0|||
156685366|NCT03253094|565592192|FG004|Overall Study|Adverse Event|0|||
156685367|NCT03253094|565592193|FG005|Overall Study|Adverse Event|0|||
156685368|NCT03253094|565592188|FG000|Overall Study|Lack of Efficacy|0|||
156685369|NCT03253094|565592189|FG001|Overall Study|Lack of Efficacy|0|||
156685370|NCT03253094|565592190|FG002|Overall Study|Lack of Efficacy|2|||
156685371|NCT03253094|565592191|FG003|Overall Study|Lack of Efficacy|1|||
156685372|NCT03253094|565592192|FG004|Overall Study|Lack of Efficacy|2|||
156685373|NCT03253094|565592193|FG005|Overall Study|Lack of Efficacy|1|||
156685374|NCT03253094|565592188|FG000|Overall Study|Lost to Follow-up|0|||
156685375|NCT03253094|565592189|FG001|Overall Study|Lost to Follow-up|0|||
156685376|NCT03253094|565592190|FG002|Overall Study|Lost to Follow-up|1|||
156685377|NCT03253094|565592191|FG003|Overall Study|Lost to Follow-up|1|||
156685378|NCT03253094|565592192|FG004|Overall Study|Lost to Follow-up|0|||
156685379|NCT03253094|565592193|FG005|Overall Study|Lost to Follow-up|1|||
156685380|NCT03253094|565592188|FG000|Overall Study|Physician Decision|1|||
156685381|NCT03253094|565592189|FG001|Overall Study|Physician Decision|0|||
156685382|NCT03253094|565592190|FG002|Overall Study|Physician Decision|0|||
156685383|NCT03253094|565592191|FG003|Overall Study|Physician Decision|1|||
156685384|NCT03253094|565592192|FG004|Overall Study|Physician Decision|0|||
156685385|NCT03253094|565592193|FG005|Overall Study|Physician Decision|2|||
156685386|NCT03253094|565592188|FG000|Overall Study|Withdrawal by Subject|1|||
156685387|NCT03253094|565592189|FG001|Overall Study|Withdrawal by Subject|2|||
156685388|NCT03253094|565592190|FG002|Overall Study|Withdrawal by Subject|1|||
156685389|NCT03253094|565592191|FG003|Overall Study|Withdrawal by Subject|0|||
156685390|NCT03253094|565592192|FG004|Overall Study|Withdrawal by Subject|3|||
156685391|NCT03253094|565592193|FG005|Overall Study|Withdrawal by Subject|0|||
156685392|NCT03253094|565592188|FG000|Overall Study|Other|0|||
156685393|NCT03253094|565592189|FG001|Overall Study|Other|1|||
156685394|NCT03253094|565592190|FG002|Overall Study|Other|2|||
156685395|NCT03253094|565592191|FG003|Overall Study|Other|1|||
156685396|NCT03253094|565592192|FG004|Overall Study|Other|0|||
156685397|NCT03253094|565592193|FG005|Overall Study|Other|0|||
156685398|NCT02219308|565592194|FG000|Overall Study|Withdrawal by Subject|1|||
156685399|NCT02219308|565592195|FG001|Overall Study|Withdrawal by Subject|2|||
156685400|NCT04149535|565592198|FG000|Overall Study|Death|11|||
156685401|NCT04149535|565592199|FG001|Overall Study|Death|7|||
156685402|NCT04149535|565592198|FG000|Overall Study|Physician Decision|10|||
156685403|NCT04149535|565592199|FG001|Overall Study|Physician Decision|4|||
156685404|NCT04149535|565592198|FG000|Overall Study|Withdrawal by Subject|6|||
156685405|NCT04149535|565592199|FG001|Overall Study|Withdrawal by Subject|7|||
156685406|NCT04149535|565592198|FG000|Overall Study|Not described|2|||
156685407|NCT04149535|565592199|FG001|Overall Study|Not described|0|||
156685408|NCT02175368|565592200|FG000|Overall Study|Lost to Follow-up|1|||
156685409|NCT02875028|565592201|FG000|Washout Period|Withdrawal by Subject|0|||
156685410|NCT02875028|565592202|FG001|Washout Period|Withdrawal by Subject|1|||
156436250|NCT04707313|564686782|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436251|NCT04707313|564686783|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
156436252|NCT04707313|564686784|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
156436253|NCT04707313|564686785|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436254|NCT04707313|564686786|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
156685411|NCT05068284|565592203|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
156685412|NCT05068284|565592204|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
156685413|NCT05068284|565592205|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685414|NCT05068284|565592206|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685415|NCT05068284|565592207|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685416|NCT05068284|565592208|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685417|NCT05068284|565592209|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685418|NCT05068284|565592210|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685419|NCT05068284|565592203|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685420|NCT05068284|565592204|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685421|NCT05068284|565592205|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
156685422|NCT05068284|565592206|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685423|NCT05068284|565592207|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685424|NCT05068284|565592208|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685425|NCT05068284|565592209|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685426|NCT05068284|565592210|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685427|NCT05068284|565592203|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
156685428|NCT05068284|565592204|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
156685429|NCT05068284|565592205|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
156685430|NCT05068284|565592206|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
156685431|NCT05068284|565592207|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
156685432|NCT05068284|565592208|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
156685433|NCT05068284|565592209|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
156685434|NCT05068284|565592210|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
156685435|NCT05068284|565592203|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685436|NCT05068284|565592204|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685437|NCT05068284|565592205|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
156685438|NCT05068284|565592206|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685439|NCT05068284|565592207|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
156685440|NCT05068284|565592208|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685441|NCT05068284|565592209|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685442|NCT05068284|565592210|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685443|NCT05068284|565592203|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685444|NCT05068284|565592204|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685445|NCT05068284|565592205|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685446|NCT05068284|565592206|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
156685447|NCT05068284|565592207|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685448|NCT05068284|565592208|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685449|NCT05068284|565592209|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685450|NCT05068284|565592210|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685451|NCT05068284|565592203|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685452|NCT05068284|565592204|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685453|NCT05068284|565592205|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
156685454|NCT05068284|565592206|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
156685455|NCT05068284|565592207|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685456|NCT05068284|565592208|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685457|NCT05068284|565592209|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685458|NCT05068284|565592210|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685459|NCT05068284|565592203|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685460|NCT05068284|565592204|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685461|NCT05068284|565592205|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
156685462|NCT05068284|565592206|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685463|NCT05068284|565592207|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685464|NCT05068284|565592208|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685465|NCT05068284|565592209|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685466|NCT05068284|565592210|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685467|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
156685468|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685469|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685470|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685471|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685472|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685473|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685474|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685475|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
156685476|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685477|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685478|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685479|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685480|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
156685481|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
156685482|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685483|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
156329774|NCT00392015|564308685|FG000|Overall Study|Previous trial recipient|0|||
156685484|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685485|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685486|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685487|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685488|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685489|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
156685490|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685491|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
156685492|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685493|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685494|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685495|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685496|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685497|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685498|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685499|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
156685500|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685501|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685502|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685503|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156868538|NCT00068692|566277311|FG003|Step 2: Randomization|never start protocol therapy|0|||
156868539|NCT00068692|566277312|FG004|Step 2: Randomization|never start protocol therapy|1|||
156868540|NCT00068692|566277313|FG005|Step 2: Randomization|never start protocol therapy|0|||
156868541|NCT00068692|566277314|FG006|Step 2: Randomization|never start protocol therapy|0|||
156868542|NCT00068692|566277315|FG007|Step 2: Randomization|never start protocol therapy|0|||
156868543|NCT01600716|566277317|FG000|Overall Study|Other Reasons|3|||
156868544|NCT01600716|566277318|FG001|Overall Study|Other Reasons|1|||
156868545|NCT01600716|566277317|FG000|Overall Study|Personal Reasons|0|||
156436255|NCT04707313|564686787|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436256|NCT04707313|564686788|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436257|NCT04707313|564686789|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436258|NCT04707313|564686790|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436259|NCT04707313|564686791|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436260|NCT04707313|564686792|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436261|NCT04707313|564686793|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436262|NCT04707313|564686794|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
156436263|NCT04707313|564686782|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
156868546|NCT01600716|566277318|FG001|Overall Study|Personal Reasons|2|||
156868547|NCT01600716|566277317|FG000|Overall Study|Lost to Follow-up|0|||
156868548|NCT01600716|566277318|FG001|Overall Study|Lost to Follow-up|2|||
156868549|NCT01600716|566277317|FG000|Overall Study|Pregnancy|1|||
156868550|NCT01600716|566277318|FG001|Overall Study|Pregnancy|0|||
156868551|NCT01600716|566277317|FG000|Overall Study|Lack of Efficacy|2|||
156868552|NCT01600716|566277318|FG001|Overall Study|Lack of Efficacy|1|||
156868553|NCT01600716|566277317|FG000|Overall Study|Adverse Event|1|||
156868554|NCT01600716|566277318|FG001|Overall Study|Adverse Event|1|||
156868555|NCT03557034|566277321|FG000|Overall Study|Withdrawal by Subject|1|||
156868556|NCT03557034|566277322|FG001|Overall Study|Withdrawal by Subject|0|||
156436264|NCT04707313|564686783|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
156436265|NCT04707313|564686784|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
156436266|NCT04707313|564686785|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
156436267|NCT04707313|564686786|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
156436268|NCT04707313|564686787|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
156685504|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685505|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685506|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685507|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
156685508|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
156868557|NCT03349034|566277325|FG000|Overall Study|catheters dislodged during transport|2|||
156868558|NCT03349034|566277326|FG001|Overall Study|catheters dislodged during transport|0|||
156868559|NCT03349034|566277325|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
156436269|NCT04707313|564686788|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
156436270|NCT04707313|564686789|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
156436271|NCT04707313|564686790|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
156436272|NCT04707313|564686791|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
156436273|NCT04707313|564686792|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
156436274|NCT04707313|564686793|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
156436275|NCT04707313|564686794|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
156436276|NCT04707313|564686782|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
156436277|NCT04707313|564686783|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436278|NCT04707313|564686784|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436279|NCT04707313|564686785|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436280|NCT04707313|564686786|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436281|NCT04707313|564686787|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
156436282|NCT04707313|564686788|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
156436283|NCT04707313|564686789|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
156436284|NCT04707313|564686790|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436285|NCT04707313|564686791|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436286|NCT04707313|564686792|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436287|NCT04707313|564686793|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436288|NCT04707313|564686794|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
156436289|NCT04707313|564686782|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
156436290|NCT04707313|564686783|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
156436291|NCT04707313|564686784|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
156436292|NCT04707313|564686785|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
156436293|NCT04707313|564686786|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
156436294|NCT04707313|564686787|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
156436295|NCT04707313|564686788|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
156436296|NCT04707313|564686789|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
156436297|NCT04707313|564686790|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
156436298|NCT04707313|564686791|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
156436299|NCT04707313|564686792|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
156436300|NCT04707313|564686793|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
156530136|NCT03231943|565034831|FG009|Part 2|Withdrawal by Subject|0|||
156530137|NCT03231943|565034832|FG010|Part 2|Withdrawal by Subject|0|||
156785270|NCT00395512|565964889|FG001|Overall Study|Other|1|||
156785271|NCT00395512|565964890|FG002|Overall Study|Other|0|||
156785272|NCT00395512|565964891|FG003|Overall Study|Other|0|||
156785273|NCT00395512|565964888|FG000|Overall Study|Hyperglycemic Rescue|18|||
156785274|NCT00395512|565964889|FG001|Overall Study|Hyperglycemic Rescue|10|||
156785275|NCT00395512|565964890|FG002|Overall Study|Hyperglycemic Rescue|4|||
156785276|NCT00395512|565964891|FG003|Overall Study|Hyperglycemic Rescue|6|||
156785277|NCT04584554|565964896|FG000|Overall Study|Withdrawal by Subject|2|||
156785278|NCT04584554|565964897|FG001|Overall Study|Withdrawal by Subject|2|||
156785279|NCT04625972|565964901|FG000|Overall Study|Death|3|||
156785280|NCT04625972|565964902|FG001|Overall Study|Death|2|||
156785281|NCT04625972|565964901|FG000|Overall Study|Lost to Follow-up|82|||
156785282|NCT04625972|565964902|FG001|Overall Study|Lost to Follow-up|38|||
156785283|NCT04625972|565964901|FG000|Overall Study|Physician Decision|2|||
156785284|NCT04625972|565964902|FG001|Overall Study|Physician Decision|0|||
156785285|NCT04625972|565964901|FG000|Overall Study|Protocol Violation|0|||
156785286|NCT04625972|565964902|FG001|Overall Study|Protocol Violation|1|||
156785287|NCT04625972|565964901|FG000|Overall Study|Withdrawal by Subject|37|||
156785288|NCT04625972|565964902|FG001|Overall Study|Withdrawal by Subject|24|||
156785289|NCT04625972|565964901|FG000|Overall Study|Not specified elsewhere|8|||
156785290|NCT04625972|565964902|FG001|Overall Study|Not specified elsewhere|6|||
156785291|NCT05591755|565964903|FG000|Overall Study|Screen Failure|1|||
156785292|NCT05591755|565964904|FG001|Overall Study|Screen Failure|0|||
156785293|NCT05591755|565964905|FG002|Overall Study|Screen Failure|0|||
156785294|NCT05591755|565964906|FG003|Overall Study|Screen Failure|0|||
156785295|NCT05591755|565964903|FG000|Overall Study|Protocol Violation|0|||
156785296|NCT05591755|565964904|FG001|Overall Study|Protocol Violation|0|||
156785297|NCT05591755|565964905|FG002|Overall Study|Protocol Violation|2|||
156785298|NCT05591755|565964906|FG003|Overall Study|Protocol Violation|0|||
156785299|NCT05591755|565964903|FG000|Overall Study|Withdrawal by Subject|0|||
156785300|NCT05591755|565964904|FG001|Overall Study|Withdrawal by Subject|1|||
156785301|NCT05591755|565964905|FG002|Overall Study|Withdrawal by Subject|0|||
156785302|NCT05591755|565964906|FG003|Overall Study|Withdrawal by Subject|0|||
156785303|NCT00433290|565964907|FG000|Overall Study|Adverse Event|24|||
156785304|NCT00433290|565964908|FG001|Overall Study|Adverse Event|7|||
156785305|NCT00433290|565964907|FG000|Overall Study|Lack of Efficacy|1|||
156785306|NCT00433290|565964908|FG001|Overall Study|Lack of Efficacy|5|||
156785307|NCT00433290|565964907|FG000|Overall Study|Withdrawal by Subject|4|||
156785308|NCT00433290|565964908|FG001|Overall Study|Withdrawal by Subject|2|||
156785309|NCT00433290|565964907|FG000|Overall Study|Protocol Violation|3|||
156785310|NCT00433290|565964908|FG001|Overall Study|Protocol Violation|2|||
156785311|NCT00433290|565964907|FG000|Overall Study|Physician Decision|2|||
156436301|NCT04707313|564686794|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
156436302|NCT04707313|564686782|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436303|NCT04707313|564686783|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436304|NCT04707313|564686784|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
156436305|NCT04707313|564686785|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436306|NCT04707313|564686786|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436307|NCT04707313|564686787|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436308|NCT04707313|564686788|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436309|NCT04707313|564686789|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
156436310|NCT04707313|564686790|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436311|NCT04707313|564686791|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436312|NCT04707313|564686792|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436313|NCT04707313|564686793|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436314|NCT04707313|564686794|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
156436315|NCT04707313|564686782|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436316|NCT04707313|564686783|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436317|NCT04707313|564686784|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436318|NCT04707313|564686785|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436319|NCT04707313|564686786|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436320|NCT04707313|564686787|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436321|NCT04707313|564686788|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436322|NCT04707313|564686789|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436323|NCT04707313|564686790|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436324|NCT04707313|564686791|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
156436325|NCT04707313|564686792|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
156436326|NCT04707313|564686793|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
156436327|NCT04707313|564686794|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
156436328|NCT04707313|564686782|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436329|NCT04707313|564686783|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436330|NCT04707313|564686784|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156685509|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
156685510|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
156685511|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
156685512|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
156685513|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
156685514|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
156685515|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685516|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685517|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685518|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685519|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685520|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685521|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685522|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
156685523|NCT02447887|565593866|FG000|Overall Study|Study was terminated|3|||
156685524|NCT03941834|565593867|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
156685525|NCT03941834|565593868|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
156329775|NCT00392015|564308686|FG001|Overall Study|Previous trial recipient|0|||
156329776|NCT00392015|564308687|FG002|Overall Study|Previous trial recipient|0|||
156329777|NCT00392015|564308688|FG003|Overall Study|Previous trial recipient|0|||
156329778|NCT00392015|564308689|FG004|Overall Study|Previous trial recipient|1|||
156329779|NCT00392015|564308690|FG005|Overall Study|Previous trial recipient|0|||
156329780|NCT01858376|564308691|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
156329781|NCT03894046|564308695|FG000|Overall Study|Protocol Violation|1|||
156329782|NCT03894046|564308696|FG001|Overall Study|Protocol Violation|0|||
156329783|NCT03894046|564308697|FG002|Overall Study|Protocol Violation|0|||
156329784|NCT03894046|564308695|FG000|Overall Study|Adverse Event|0|||
156329785|NCT03894046|564308696|FG001|Overall Study|Adverse Event|1|||
156329786|NCT03894046|564308697|FG002|Overall Study|Adverse Event|0|||
156329787|NCT03894046|564308695|FG000|Overall Study|Withdrawal by Subject|2|||
156329788|NCT03894046|564308696|FG001|Overall Study|Withdrawal by Subject|3|||
156785312|NCT00433290|565964908|FG001|Overall Study|Physician Decision|0|||
156785313|NCT00433290|565964907|FG000|Overall Study|Entry Criteria Not Met|0|||
156785314|NCT00433290|565964908|FG001|Overall Study|Entry Criteria Not Met|1|||
156785315|NCT00433290|565964907|FG000|Overall Study|Lost to Follow-up|1|||
156785316|NCT00433290|565964908|FG001|Overall Study|Lost to Follow-up|0|||
156329789|NCT03894046|564308697|FG002|Overall Study|Withdrawal by Subject|1|||
156329790|NCT03894046|564308695|FG000|Overall Study|Death|15|||
156329791|NCT03894046|564308696|FG001|Overall Study|Death|21|||
156436331|NCT04707313|564686785|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436332|NCT04707313|564686786|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436333|NCT04707313|564686787|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436334|NCT04707313|564686788|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436335|NCT04707313|564686789|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436336|NCT04707313|564686790|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436337|NCT04707313|564686791|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
156436338|NCT04707313|564686792|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
156436339|NCT04707313|564686793|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
156436340|NCT04707313|564686794|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
156436341|NCT04707313|564686782|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436342|NCT04707313|564686783|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436343|NCT04707313|564686784|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436344|NCT04707313|564686785|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436345|NCT04707313|564686786|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436346|NCT04707313|564686787|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436347|NCT04707313|564686788|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436348|NCT04707313|564686789|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436349|NCT04707313|564686790|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
156436350|NCT04707313|564686791|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
156436351|NCT04707313|564686792|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
156436352|NCT04707313|564686793|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
156436353|NCT04707313|564686794|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
156530138|NCT03231943|565034833|FG011|Part 2|Withdrawal by Subject|1|||
156530139|NCT03231943|565034834|FG012|Part 2|Withdrawal by Subject|0|||
156530140|NCT00047320|565034835|FG000|Overall Study|Lack of Efficacy|8|||
156530141|NCT00047320|565034835|FG000|Overall Study|Lost to Follow-up|1|||
156530142|NCT00047320|565034835|FG000|Overall Study|Physician Decision|8|||
156530143|NCT00047320|565034835|FG000|Overall Study|Withdrawal by Subject|9|||
156530144|NCT00047320|565034835|FG000|Overall Study|Ineligible|2|||
156530145|NCT04821869|565034836|FG000|Overall Study|Adverse Event|4|||
156530146|NCT04821869|565034836|FG000|Overall Study|Withdrawal by Subject|2|||
156530147|NCT04821869|565034836|FG000|Overall Study|Did not meet FEV1 criteria|1|||
156530148|NCT00658684|565034837|FG000|Overall Study|Adverse Event|10|||
156530149|NCT00658684|565034838|FG001|Overall Study|Adverse Event|8|||
156530150|NCT00658684|565034839|FG002|Overall Study|Adverse Event|2|||
156530151|NCT00658684|565034840|FG003|Overall Study|Adverse Event|0|||
156530152|NCT00658684|565034837|FG000|Overall Study|Withdrawal by Subject|6|||
156530153|NCT00658684|565034838|FG001|Overall Study|Withdrawal by Subject|4|||
156530154|NCT00658684|565034839|FG002|Overall Study|Withdrawal by Subject|1|||
156530155|NCT00658684|565034840|FG003|Overall Study|Withdrawal by Subject|1|||
156530156|NCT00658684|565034837|FG000|Overall Study|Lack of Efficacy|1|||
156530157|NCT00658684|565034838|FG001|Overall Study|Lack of Efficacy|1|||
156530158|NCT00658684|565034839|FG002|Overall Study|Lack of Efficacy|0|||
156530159|NCT00658684|565034840|FG003|Overall Study|Lack of Efficacy|0|||
156530160|NCT00658684|565034837|FG000|Overall Study|Protocol Violation|1|||
156530161|NCT00658684|565034838|FG001|Overall Study|Protocol Violation|1|||
156530162|NCT00658684|565034839|FG002|Overall Study|Protocol Violation|0|||
156530163|NCT00658684|565034840|FG003|Overall Study|Protocol Violation|0|||
156530164|NCT00658684|565034837|FG000|Overall Study|Pregnancy|1|||
156530165|NCT00658684|565034838|FG001|Overall Study|Pregnancy|1|||
156530166|NCT00658684|565034839|FG002|Overall Study|Pregnancy|0|||
156530167|NCT00658684|565034840|FG003|Overall Study|Pregnancy|0|||
156530168|NCT03226275|565034843|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
156530169|NCT03226275|565034844|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
156530170|NCT03226275|565034845|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
156530171|NCT03226275|565034846|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
156530172|NCT03226275|565034843|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
156530173|NCT03226275|565034844|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
156530174|NCT03226275|565034845|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
156785317|NCT02547935|565964909|FG000|Overall Study|Other|0|||
156785318|NCT02547935|565964910|FG001|Overall Study|Other|1|||
156785319|NCT02547935|565964911|FG002|Overall Study|Other|0|||
156785320|NCT02547935|565964909|FG000|Overall Study|Withdrawal by Subject|2|||
156785321|NCT02547935|565964910|FG001|Overall Study|Withdrawal by Subject|3|||
156785322|NCT02547935|565964911|FG002|Overall Study|Withdrawal by Subject|4|||
156785323|NCT02547935|565964909|FG000|Overall Study|Screen Failure|2|||
156785324|NCT02547935|565964910|FG001|Overall Study|Screen Failure|0|||
156785325|NCT02547935|565964911|FG002|Overall Study|Screen Failure|0|||
156785326|NCT02547935|565964909|FG000|Overall Study|Physician Decision|0|||
156785327|NCT02547935|565964910|FG001|Overall Study|Physician Decision|1|||
156785328|NCT02547935|565964911|FG002|Overall Study|Physician Decision|0|||
156785329|NCT02547935|565964909|FG000|Overall Study|Lost to Follow-up|0|||
156785330|NCT02547935|565964910|FG001|Overall Study|Lost to Follow-up|2|||
156785331|NCT02547935|565964911|FG002|Overall Study|Lost to Follow-up|1|||
156329792|NCT03894046|564308697|FG002|Overall Study|Death|4|||
156785332|NCT02547935|565964909|FG000|Overall Study|Death|1|||
156785333|NCT02547935|565964910|FG001|Overall Study|Death|1|||
156785334|NCT02547935|565964911|FG002|Overall Study|Death|0|||
156785335|NCT00086307|565964912|FG000|Overall Study|Lack of Efficacy|1|||
156329793|NCT03894046|564308695|FG000|Overall Study|No growth of ABC|2|||
156785336|NCT00086307|565964913|FG001|Overall Study|Lack of Efficacy|1|||
156785337|NCT00086307|565964914|FG002|Overall Study|Lack of Efficacy|2|||
156785338|NCT00086307|565964912|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
156785339|NCT00086307|565964913|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
156785340|NCT00086307|565964914|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
156785341|NCT00086307|565964912|FG000|Overall Study|Nausea and headaches|0|||
156785342|NCT00086307|565964913|FG001|Overall Study|Nausea and headaches|0|||
156785343|NCT00086307|565964914|FG002|Overall Study|Nausea and headaches|1|||
156785344|NCT00086307|565964912|FG000|Overall Study|Constipation and sleepiness|0|||
156329794|NCT03894046|564308696|FG001|Overall Study|No growth of ABC|1|||
156329795|NCT03894046|564308697|FG002|Overall Study|No growth of ABC|0|||
156329796|NCT03894046|564308695|FG000|Overall Study|Physician Decision|1|||
156329797|NCT03894046|564308696|FG001|Overall Study|Physician Decision|1|||
156329798|NCT03894046|564308697|FG002|Overall Study|Physician Decision|1|||
156329799|NCT03894046|564308695|FG000|Overall Study|Prohibited concomitant medication|1|||
156329800|NCT03894046|564308696|FG001|Overall Study|Prohibited concomitant medication|0|||
156329801|NCT03894046|564308697|FG002|Overall Study|Prohibited concomitant medication|0|||
156329802|NCT03894046|564308695|FG000|Overall Study|Transferred to other arm/group|1|||
156329803|NCT03894046|564308696|FG001|Overall Study|Transferred to other arm/group|1|||
156329804|NCT03894046|564308697|FG002|Overall Study|Transferred to other arm/group|0|||
156329805|NCT02486302|564308706|FG000|Overall Study|Discontinued prematurely|410|||
156329806|NCT02486302|564308706|FG000|Overall Study|Documentation not completed|255|||
156329807|NCT02486302|564308706|FG000|Overall Study|Excluded due to legal reasons|8|||
156329808|NCT02486302|564308706|FG000|Overall Study|Not treated|3|||
156329809|NCT01871142|564308707|FG000|Overall Study|Adverse Event|1|||
156329810|NCT00734474|564308710|FG000|Overall Study|Entry Criteria Not Met|0|||
156329811|NCT00734474|564308711|FG001|Overall Study|Entry Criteria Not Met|0|||
156329812|NCT00734474|564308712|FG002|Overall Study|Entry Criteria Not Met|5|||
156329813|NCT00734474|564308713|FG003|Overall Study|Entry Criteria Not Met|0|||
156329814|NCT00734474|564308714|FG004|Overall Study|Entry Criteria Not Met|3|||
156329815|NCT00734474|564308715|FG005|Overall Study|Entry Criteria Not Met|1|||
156329816|NCT00734474|564308716|FG006|Overall Study|Entry Criteria Not Met|0|||
156329817|NCT00734474|564308717|FG007|Overall Study|Entry Criteria Not Met|1|||
156329818|NCT00734474|564308718|FG008|Overall Study|Entry Criteria Not Met|1|||
156329819|NCT00734474|564308710|FG000|Overall Study|Lost to Follow-up|1|||
156329820|NCT00734474|564308711|FG001|Overall Study|Lost to Follow-up|0|||
156329821|NCT00734474|564308712|FG002|Overall Study|Lost to Follow-up|13|||
156329822|NCT00734474|564308713|FG003|Overall Study|Lost to Follow-up|0|||
156329823|NCT00734474|564308714|FG004|Overall Study|Lost to Follow-up|11|||
156329824|NCT00734474|564308715|FG005|Overall Study|Lost to Follow-up|1|||
156329825|NCT00734474|564308716|FG006|Overall Study|Lost to Follow-up|0|||
156329826|NCT00734474|564308717|FG007|Overall Study|Lost to Follow-up|9|||
156329827|NCT00734474|564308718|FG008|Overall Study|Lost to Follow-up|4|||
156329828|NCT00734474|564308710|FG000|Overall Study|Withdrawal by Subject|2|||
156329829|NCT00734474|564308711|FG001|Overall Study|Withdrawal by Subject|1|||
156329830|NCT00734474|564308712|FG002|Overall Study|Withdrawal by Subject|18|||
156329831|NCT00734474|564308713|FG003|Overall Study|Withdrawal by Subject|0|||
156329832|NCT00734474|564308714|FG004|Overall Study|Withdrawal by Subject|24|||
156329833|NCT00734474|564308715|FG005|Overall Study|Withdrawal by Subject|2|||
156329834|NCT00734474|564308716|FG006|Overall Study|Withdrawal by Subject|0|||
156329835|NCT00734474|564308717|FG007|Overall Study|Withdrawal by Subject|36|||
156329836|NCT00734474|564308718|FG008|Overall Study|Withdrawal by Subject|21|||
156329837|NCT00734474|564308710|FG000|Overall Study|Physician Decision|0|||
156329838|NCT00734474|564308711|FG001|Overall Study|Physician Decision|0|||
156329839|NCT00734474|564308712|FG002|Overall Study|Physician Decision|4|||
156329840|NCT00734474|564308713|FG003|Overall Study|Physician Decision|1|||
156329841|NCT00734474|564308714|FG004|Overall Study|Physician Decision|11|||
156436354|NCT04707313|564686782|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
156329842|NCT00734474|564308715|FG005|Overall Study|Physician Decision|0|||
156329843|NCT00734474|564308716|FG006|Overall Study|Physician Decision|0|||
156329844|NCT00734474|564308717|FG007|Overall Study|Physician Decision|9|||
156329845|NCT00734474|564308718|FG008|Overall Study|Physician Decision|9|||
156329846|NCT00734474|564308710|FG000|Overall Study|Adverse Event|4|||
156329847|NCT00734474|564308711|FG001|Overall Study|Adverse Event|4|||
156329848|NCT00734474|564308712|FG002|Overall Study|Adverse Event|63|||
156785345|NCT00086307|565964913|FG001|Overall Study|Constipation and sleepiness|0|||
156329849|NCT00734474|564308713|FG003|Overall Study|Adverse Event|1|||
156329850|NCT00734474|564308714|FG004|Overall Study|Adverse Event|64|||
156329851|NCT00734474|564308715|FG005|Overall Study|Adverse Event|0|||
156329852|NCT00734474|564308716|FG006|Overall Study|Adverse Event|1|||
156329853|NCT00734474|564308717|FG007|Overall Study|Adverse Event|65|||
156329854|NCT00734474|564308718|FG008|Overall Study|Adverse Event|39|||
156436355|NCT04707313|564686783|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436356|NCT04707313|564686784|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436357|NCT04707313|564686785|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436358|NCT04707313|564686786|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436359|NCT04707313|564686787|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436360|NCT04707313|564686788|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436361|NCT04707313|564686789|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436362|NCT04707313|564686790|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436363|NCT04707313|564686791|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
156436364|NCT04707313|564686792|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
156436365|NCT04707313|564686793|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
156685526|NCT03941834|565593869|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
156685527|NCT03941834|565593867|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
156530175|NCT03226275|565034846|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
156785346|NCT00086307|565964914|FG002|Overall Study|Constipation and sleepiness|1|||
156785347|NCT00086307|565964912|FG000|Overall Study|Suicidal ideation|0|||
156785348|NCT00086307|565964913|FG001|Overall Study|Suicidal ideation|0|||
156785349|NCT00086307|565964914|FG002|Overall Study|Suicidal ideation|1|||
156785350|NCT00086307|565964912|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
156785351|NCT00086307|565964913|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
156785352|NCT00086307|565964914|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
156785353|NCT00086307|565964912|FG000|Overall Study|Withdrawal by Subject|0|||
156785354|NCT00086307|565964913|FG001|Overall Study|Withdrawal by Subject|0|||
156785355|NCT00086307|565964914|FG002|Overall Study|Withdrawal by Subject|2|||
156785356|NCT01018953|565964915|FG000|Overall Study|Adverse Event|2|||
156785357|NCT01018953|565964915|FG000|Overall Study|Withdrawal by Subject|1|||
156785358|NCT01018953|565964915|FG000|Overall Study|Study termination by sponsor|5|||
156785359|NCT00724503|565964916|FG000|Overall Study|Lost to Follow-up|4|||
156785360|NCT00724503|565964917|FG001|Overall Study|Lost to Follow-up|8|||
156785361|NCT00724503|565964916|FG000|Overall Study|Withdrawal by Subject|11|||
156785362|NCT00724503|565964917|FG001|Overall Study|Withdrawal by Subject|23|||
156785363|NCT00724503|565964916|FG000|Overall Study|Death|190|||
156785364|NCT00724503|565964917|FG001|Overall Study|Death|182|||
156785365|NCT00724503|565964916|FG000|Overall Study|Adverse Event|1|||
156785366|NCT00724503|565964917|FG001|Overall Study|Adverse Event|0|||
156785367|NCT00724503|565964916|FG000|Overall Study|Not otherwise specified|4|||
156785368|NCT00724503|565964917|FG001|Overall Study|Not otherwise specified|7|||
156785369|NCT01186419|565964918|FG000|Overall Study|Withdrawal by Subject|5|||
156785370|NCT01186419|565964919|FG001|Overall Study|Withdrawal by Subject|3|||
156785371|NCT01186419|565964918|FG000|Overall Study|Adverse Event|1|||
156785372|NCT01186419|565964919|FG001|Overall Study|Adverse Event|2|||
156785373|NCT01186419|565964918|FG000|Overall Study|Physician Decision|0|||
156530176|NCT03442114|565034847|FG000|Overall Study|Lost to Follow-up|13|||
156685528|NCT03941834|565593868|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
156685529|NCT03941834|565593869|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
156685530|NCT03941834|565593867|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
156685531|NCT03941834|565593868|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
156685532|NCT03941834|565593869|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
156685533|NCT03941834|565593867|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
156685534|NCT03941834|565593868|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
156685535|NCT03941834|565593869|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
156685536|NCT03941834|565593867|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
156685537|NCT03941834|565593868|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
156685538|NCT03941834|565593869|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
156685539|NCT03941834|565593867|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
156685540|NCT03941834|565593868|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
156685541|NCT03941834|565593869|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
156685542|NCT02012452|565593870|FG000|Overall Study|Lost to Follow-up|2|||
156685543|NCT02012452|565593871|FG001|Overall Study|Lost to Follow-up|1|||
156685544|NCT02012452|565593870|FG000|Overall Study|Withdrawal by Subject|4|||
156685545|NCT02012452|565593871|FG001|Overall Study|Withdrawal by Subject|0|||
156685546|NCT04403399|565593872|FG000|Period 2|Physician Decision|0|||
156785374|NCT01186419|565964919|FG001|Overall Study|Physician Decision|3|||
156785375|NCT01186419|565964918|FG000|Overall Study|Other|1|||
156785376|NCT01186419|565964919|FG001|Overall Study|Other|1|||
156785377|NCT01928771|565964925|FG000|Overall Study|Adverse Event|6|||
156785378|NCT01928771|565964926|FG001|Overall Study|Adverse Event|5|||
156436366|NCT04707313|564686794|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
156436367|NCT04707313|564686782|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156685547|NCT04403399|565593873|FG001|Period 2|Physician Decision|1|||
156685548|NCT01606228|565593874|FG000|Overall Study|Lost to Follow-up|20|||
156685549|NCT01606228|565593874|FG000|Overall Study|Withdrawal by Subject|3|||
156685550|NCT01606228|565593874|FG000|Overall Study|Non-compliant|3|||
156785379|NCT01928771|565964927|FG002|Overall Study|Adverse Event|1|||
156785380|NCT01928771|565964925|FG000|Overall Study|Death|2|||
156785381|NCT01928771|565964926|FG001|Overall Study|Death|2|||
156436368|NCT04707313|564686783|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436369|NCT04707313|564686784|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436370|NCT04707313|564686785|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436371|NCT04707313|564686786|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436372|NCT04707313|564686787|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436373|NCT04707313|564686788|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436374|NCT04707313|564686789|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436375|NCT04707313|564686790|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436376|NCT04707313|564686791|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
156436377|NCT04707313|564686792|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
156436378|NCT04707313|564686793|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436379|NCT04707313|564686794|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156436380|NCT04707313|564686782|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436381|NCT04707313|564686783|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436382|NCT04707313|564686784|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436383|NCT04707313|564686785|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436384|NCT04707313|564686786|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436385|NCT04707313|564686787|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436386|NCT04707313|564686788|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436387|NCT04707313|564686789|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436388|NCT04707313|564686790|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156436389|NCT04707313|564686791|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
156436390|NCT04707313|564686792|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
156436391|NCT04707313|564686793|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
156436392|NCT04707313|564686794|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
156436393|NCT02459899|564686795|FG000|Overall Study|Adverse Event|1|||
156436394|NCT02459899|564686796|FG001|Overall Study|Adverse Event|1|||
156436395|NCT02459899|564686797|FG002|Overall Study|Adverse Event|0|||
156436396|NCT02459899|564686798|FG003|Overall Study|Adverse Event|0|||
156436397|NCT02459899|564686795|FG000|Overall Study|Lost to Follow-up|1|||
156436398|NCT02459899|564686796|FG001|Overall Study|Lost to Follow-up|2|||
156436399|NCT02459899|564686797|FG002|Overall Study|Lost to Follow-up|0|||
156436400|NCT02459899|564686798|FG003|Overall Study|Lost to Follow-up|1|||
156436401|NCT02459899|564686795|FG000|Overall Study|Non-compliance with the treatment|0|||
156436402|NCT02459899|564686796|FG001|Overall Study|Non-compliance with the treatment|0|||
156436403|NCT02459899|564686797|FG002|Overall Study|Non-compliance with the treatment|0|||
156785382|NCT01928771|565964927|FG002|Overall Study|Death|2|||
156785383|NCT01928771|565964925|FG000|Overall Study|Lost to Follow-up|5|||
156785384|NCT01928771|565964926|FG001|Overall Study|Lost to Follow-up|6|||
156785385|NCT01928771|565964927|FG002|Overall Study|Lost to Follow-up|3|||
156785386|NCT01928771|565964925|FG000|Overall Study|Withdrawal by Subject|20|||
156785387|NCT01928771|565964926|FG001|Overall Study|Withdrawal by Subject|15|||
156785388|NCT01928771|565964927|FG002|Overall Study|Withdrawal by Subject|17|||
156785389|NCT01928771|565964925|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
156785390|NCT01928771|565964926|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
156785391|NCT01928771|565964927|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
156785392|NCT01928771|565964925|FG000|Overall Study|Other Reasons|9|||
156785393|NCT01928771|565964926|FG001|Overall Study|Other Reasons|9|||
156785394|NCT01928771|565964927|FG002|Overall Study|Other Reasons|14|||
156785395|NCT01928771|565964925|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
156785396|NCT01928771|565964926|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
156785397|NCT01928771|565964927|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
156785398|NCT01407367|565964932|FG000|Overall Study|Death|24|||
156785399|NCT01407367|565964933|FG001|Overall Study|Death|32|||
156785400|NCT01407367|565964932|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
156785401|NCT01407367|565964933|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
156785402|NCT01407367|565964932|FG000|Overall Study|Withdrawal by Subject|4|||
156785403|NCT01407367|565964933|FG001|Overall Study|Withdrawal by Subject|15|||
156785404|NCT01407367|565964932|FG000|Overall Study|Lost to Follow-up|0|||
156785405|NCT01407367|565964933|FG001|Overall Study|Lost to Follow-up|2|||
156436404|NCT02459899|564686798|FG003|Overall Study|Non-compliance with the treatment|1|||
156436405|NCT02459899|564686795|FG000|Overall Study|Withdrawal by Subject|1|||
156436406|NCT02459899|564686796|FG001|Overall Study|Withdrawal by Subject|3|||
156436407|NCT02459899|564686797|FG002|Overall Study|Withdrawal by Subject|0|||
156436408|NCT02459899|564686798|FG003|Overall Study|Withdrawal by Subject|0|||
156436409|NCT02739035|564686801|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
156436410|NCT02739035|564686802|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
156530177|NCT03442114|565034848|FG001|Overall Study|Lost to Follow-up|13|||
156436411|NCT02739035|564686801|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
156436412|NCT02739035|564686802|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
156530178|NCT03442114|565034847|FG000|Overall Study|Physician Decision|2|||
156785406|NCT01560416|565964937|FG000|Randomized Phase|Crossover Participants|7|||
156785407|NCT01560416|565964938|FG001|Randomized Phase|Crossover Participants|0|||
156436413|NCT02739035|564686801|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
156436414|NCT02739035|564686802|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
156436415|NCT02739035|564686801|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
156685551|NCT01606228|565593874|FG000|Overall Study|Lack of Efficacy|2|||
156685552|NCT01606228|565593874|FG000|Overall Study|Adverse Event|1|||
156868560|NCT03349034|566277326|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
156868561|NCT03349034|566277325|FG000|Overall Study|soft tissue flap used|1|||
156868562|NCT03349034|566277326|FG001|Overall Study|soft tissue flap used|0|||
156868563|NCT03349034|566277325|FG000|Overall Study|Other|0|||
156868564|NCT03349034|566277326|FG001|Overall Study|Other|1|||
156868565|NCT01759446|566277327|FG000|Overall Study|Protocol Violation|1|||
156868566|NCT01759446|566277328|FG001|Overall Study|Protocol Violation|0|||
156868567|NCT01759446|566277329|FG002|Overall Study|Protocol Violation|1|||
156868568|NCT01759446|566277330|FG003|Overall Study|Protocol Violation|0|||
156868569|NCT01759446|566277331|FG004|Overall Study|Protocol Violation|0|||
156868570|NCT01759446|566277327|FG000|Overall Study|Withdrawal by Subject|0|||
156685553|NCT04100096|565593875|FG000|Overall Study|Adverse Event|19|||
156685554|NCT04100096|565593876|FG001|Overall Study|Adverse Event|7|||
156685555|NCT04100096|565593875|FG000|Overall Study|Lack of Efficacy|0|||
156685556|NCT04100096|565593876|FG001|Overall Study|Lack of Efficacy|1|||
156685557|NCT04100096|565593875|FG000|Overall Study|Lost to Follow-up|13|||
156868571|NCT01759446|566277328|FG001|Overall Study|Withdrawal by Subject|1|||
156868572|NCT01759446|566277329|FG002|Overall Study|Withdrawal by Subject|0|||
156868573|NCT01759446|566277330|FG003|Overall Study|Withdrawal by Subject|1|||
156436416|NCT02739035|564686802|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
156436417|NCT04177394|564686812|FG000|Overall Study|Death|16|||
156436418|NCT04177394|564686812|FG000|Overall Study|Withdrawal by Subject|19|||
156436419|NCT04177394|564686812|FG000|Overall Study|Missed visits|61|||
156436420|NCT04177394|564686812|FG000|Overall Study|Expected Visits|15|||
156436421|NCT00843882|564686813|FG000|Step 1|Lack of Efficacy|14|||
156436422|NCT00843882|564686814|FG001|Step 1|Lack of Efficacy|10|||
156436423|NCT00843882|564686815|FG002|Step 1|Lack of Efficacy|21|||
156436424|NCT00843882|564686813|FG000|Step 1|Adverse Event|8|||
156436425|NCT00843882|564686814|FG001|Step 1|Adverse Event|17|||
156436426|NCT00843882|564686815|FG002|Step 1|Adverse Event|20|||
156436427|NCT00843882|564686813|FG000|Step 1|Death|1|||
156436428|NCT00843882|564686814|FG001|Step 1|Death|2|||
156436429|NCT00843882|564686815|FG002|Step 1|Death|4|||
156436430|NCT00843882|564686813|FG000|Step 1|Withdrawal by Subject|6|||
156436431|NCT00843882|564686814|FG001|Step 1|Withdrawal by Subject|12|||
156436432|NCT00843882|564686815|FG002|Step 1|Withdrawal by Subject|9|||
156436433|NCT00843882|564686813|FG000|Step 1|Physician Decision|0|||
156436434|NCT00843882|564686814|FG001|Step 1|Physician Decision|5|||
156436435|NCT00843882|564686815|FG002|Step 1|Physician Decision|1|||
156436436|NCT00843882|564686813|FG000|Step 1|Patient and physician's decision|0|||
156436437|NCT00843882|564686814|FG001|Step 1|Patient and physician's decision|0|||
156436438|NCT00843882|564686815|FG002|Step 1|Patient and physician's decision|1|||
156436439|NCT00843882|564686813|FG000|Step 1|Other complicating disease|1|||
156436440|NCT00843882|564686814|FG001|Step 1|Other complicating disease|3|||
156436441|NCT00843882|564686815|FG002|Step 1|Other complicating disease|4|||
156436442|NCT00843882|564686813|FG000|Step 1|Alternative therapy|0|||
156436443|NCT00843882|564686814|FG001|Step 1|Alternative therapy|1|||
156436444|NCT00843882|564686815|FG002|Step 1|Alternative therapy|1|||
156436445|NCT00843882|564686813|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
156436446|NCT00843882|564686814|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
156436447|NCT00843882|564686815|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
156436448|NCT00843882|564686813|FG000|Step 1|Off treatment reason unknown|0|||
156436449|NCT00843882|564686814|FG001|Step 1|Off treatment reason unknown|1|||
156436450|NCT00843882|564686815|FG002|Step 1|Off treatment reason unknown|4|||
156436451|NCT00843882|564686813|FG000|Step 1|Never started treatment|2|||
156436452|NCT00843882|564686814|FG001|Step 1|Never started treatment|0|||
156436453|NCT00843882|564686815|FG002|Step 1|Never started treatment|0|||
156436454|NCT00843882|564686813|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
156436455|NCT00843882|564686814|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
156436456|NCT00843882|564686815|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
156436457|NCT00843882|564686813|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
156436458|NCT00843882|564686814|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
156436459|NCT00843882|564686815|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
156436460|NCT00843882|564686813|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
156436461|NCT00843882|564686814|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
156436462|NCT00843882|564686815|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
156436463|NCT00843882|564686813|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
156436464|NCT00843882|564686814|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
156436465|NCT00843882|564686815|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
156436466|NCT00843882|564686813|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
156436467|NCT00843882|564686814|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
156436468|NCT00843882|564686815|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
156436469|NCT00843882|564686813|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
156436470|NCT00843882|564686814|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
156436471|NCT00843882|564686815|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
156436472|NCT00843882|564686813|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
156436473|NCT00843882|564686814|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
156436474|NCT00843882|564686815|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
156436475|NCT01582269|564686816|FG000|Overall Study|Withdrawal by Subject|1|||
156436476|NCT01582269|564686817|FG001|Overall Study|Withdrawal by Subject|0|||
156436477|NCT01582269|564686818|FG002|Overall Study|Withdrawal by Subject|0|||
156436478|NCT06218251|564686819|FG000|Overall Study|Lost to Follow-up|4|||
156436479|NCT02031471|564686820|FG000|24 Week Treatment Period|Adverse Event|6|||
156436480|NCT02031471|564686820|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
156436481|NCT02031471|564686820|FG000|24 Week Treatment Period|Protocol Violation|1|||
156436482|NCT02031471|564686820|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
156436483|NCT02031471|564686820|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
156436484|NCT02031471|564686820|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
156685558|NCT04100096|565593876|FG001|Overall Study|Lost to Follow-up|11|||
156685559|NCT04100096|565593875|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156685560|NCT04100096|565593876|FG001|Overall Study|Non-Compliance With Study Drug|3|||
156685561|NCT04100096|565593875|FG000|Overall Study|Protocol Deviation|1|||
156685562|NCT04100096|565593876|FG001|Overall Study|Protocol Deviation|1|||
156685563|NCT04100096|565593875|FG000|Overall Study|Withdrawal by Participant|13|||
156685564|NCT04100096|565593876|FG001|Overall Study|Withdrawal by Participant|15|||
156685565|NCT00991510|565593879|FG000|Period I (Days 1-14)|Adverse Event|1|||
156685566|NCT00991510|565593880|FG001|Period I (Days 1-14)|Adverse Event|0|||
156685567|NCT00991510|565593879|FG000|Period III (Days 29-112)|Adverse Event|1|||
156685568|NCT00991510|565593880|FG001|Period III (Days 29-112)|Adverse Event|1|||
156685569|NCT01976728|565593881|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
156685570|NCT01976728|565593882|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
156685571|NCT01976728|565593883|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
156685572|NCT01976728|565593884|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
156685573|NCT01563237|565593885|FG000|Overall Study|Lost to Follow-up|6|||
156685574|NCT01563237|565593886|FG001|Overall Study|Lost to Follow-up|0|||
156685575|NCT01563237|565593885|FG000|Overall Study|Withdrawal by Subject|1|||
156685576|NCT01563237|565593886|FG001|Overall Study|Withdrawal by Subject|0|||
156685577|NCT01563237|565593885|FG000|Overall Study|Adverse Event|1|||
156685578|NCT01563237|565593886|FG001|Overall Study|Adverse Event|0|||
156685579|NCT01563237|565593885|FG000|Overall Study|Medical Reasons|1|||
156685580|NCT01563237|565593886|FG001|Overall Study|Medical Reasons|0|||
156685581|NCT01563237|565593885|FG000|Overall Study|Death|1|||
156685582|NCT01563237|565593886|FG001|Overall Study|Death|0|||
156685583|NCT01049412|565593889|FG000|Period I|Withdrawal by Subject|4|||
156685584|NCT01049412|565593890|FG001|Period I|Withdrawal by Subject|6|||
156685585|NCT01049412|565593889|FG000|Period I|Lost to Follow-up|2|||
156685586|NCT01049412|565593890|FG001|Period I|Lost to Follow-up|2|||
156685587|NCT01049412|565593889|FG000|Period I|Physician Decision|0|||
156685588|NCT01049412|565593890|FG001|Period I|Physician Decision|3|||
156685589|NCT01049412|565593889|FG000|Period I|Protocol Violation|1|||
156685590|NCT01049412|565593890|FG001|Period I|Protocol Violation|2|||
156685591|NCT01049412|565593889|FG000|Period I|Adverse Event|1|||
156685592|NCT01049412|565593890|FG001|Period I|Adverse Event|0|||
156685593|NCT01049412|565593889|FG000|Period II|Withdrawal by Subject|2|||
156685594|NCT01049412|565593890|FG001|Period II|Withdrawal by Subject|3|||
156685595|NCT01049412|565593889|FG000|Period II|Adverse Event|1|||
156685596|NCT01049412|565593890|FG001|Period II|Adverse Event|0|||
156685597|NCT01049412|565593889|FG000|Period II|Lost to Follow-up|1|||
156685598|NCT01049412|565593890|FG001|Period II|Lost to Follow-up|0|||
156685599|NCT05966090|565593891|FG000|Overall Study|Lost to Follow-up|6|||
156685600|NCT05966090|565593892|FG001|Overall Study|Lost to Follow-up|6|||
156436485|NCT02031471|564686820|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
156436486|NCT05076266|564686821|FG000|Overall Study|Survey not complete - Participant refusal|2|||
156436487|NCT05076266|564686822|FG001|Overall Study|Survey not complete - Participant refusal|0|||
156436488|NCT05797155|564686823|FG000|Overall Study|Lost to Follow-up|33|||
156436489|NCT05797155|564686824|FG001|Overall Study|Lost to Follow-up|12|||
156436490|NCT00617201|564686825|FG000|Overall Study|Lost to Follow-up|9|||
156436491|NCT00617201|564686826|FG001|Overall Study|Lost to Follow-up|13|||
156685601|NCT05966090|565593891|FG000|Overall Study|Adverse Event|1|||
156685602|NCT05966090|565593892|FG001|Overall Study|Adverse Event|1|||
156685603|NCT05966090|565593891|FG000|Overall Study|Withdrawal by Subject|1|||
156685604|NCT05966090|565593892|FG001|Overall Study|Withdrawal by Subject|1|||
156685605|NCT05966090|565593891|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156685606|NCT05966090|565593892|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156685607|NCT05966090|565593891|FG000|Overall Study|Other|1|||
156685608|NCT05966090|565593892|FG001|Overall Study|Other|1|||
156685609|NCT00804141|565593893|FG000|Overall Study|Adverse Event|157|||
156685610|NCT00804141|565593893|FG000|Overall Study|Death|4|||
156685611|NCT00804141|565593893|FG000|Overall Study|Failed to return|96|||
156685612|NCT00804141|565593893|FG000|Overall Study|Investigator request|8|||
156685613|NCT00804141|565593893|FG000|Overall Study|Protocol Violation|85|||
156436492|NCT03723616|564688553|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
156436493|NCT03723616|564688554|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
156436494|NCT03723616|564688555|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
156436495|NCT03723616|564688556|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
156436496|NCT03723616|564688557|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
156436497|NCT03723616|564688558|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
156436498|NCT06001177|564688561|FG000|Treatment Phase|Adverse Event|1|||
156436499|NCT06001177|564688562|FG001|Treatment Phase|Adverse Event|0|||
156436500|NCT06001177|564688561|FG000|Treatment Phase|Withdrawal by Subject|1|||
156436501|NCT06001177|564688562|FG001|Treatment Phase|Withdrawal by Subject|0|||
156436502|NCT06001177|564688561|FG000|Observation Phase|Adverse Event|1|||
156436503|NCT06001177|564688562|FG001|Observation Phase|Adverse Event|1|||
156436504|NCT06001177|564688561|FG000|Observation Phase|Withdrawal by Subject|0|||
156436505|NCT06001177|564688562|FG001|Observation Phase|Withdrawal by Subject|1|||
156436506|NCT00799396|564688565|FG000|Clopidogrel Treatment|Adverse Event|6|||
156436507|NCT00799396|564688565|FG000|Clopidogrel Treatment|Physician Decision|5|||
156436508|NCT00799396|564688565|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
156436509|NCT00799396|564688565|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
156436510|NCT00799396|564688565|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
156436511|NCT01307267|564688566|FG000|Overall Study|Death|4|||
156436512|NCT01307267|564688567|FG001|Overall Study|Death|3|||
156436513|NCT01307267|564688568|FG002|Overall Study|Death|5|||
156436514|NCT01307267|564688569|FG003|Overall Study|Death|3|||
156436515|NCT01307267|564688570|FG004|Overall Study|Death|1|||
156436516|NCT01307267|564688571|FG005|Overall Study|Death|26|||
156436517|NCT01307267|564688572|FG006|Overall Study|Death|2|||
156436518|NCT01307267|564688573|FG007|Overall Study|Death|2|||
156436519|NCT01307267|564688574|FG008|Overall Study|Death|21|||
156436520|NCT01307267|564688575|FG009|Overall Study|Death|2|||
156436521|NCT01307267|564688576|FG010|Overall Study|Death|3|||
156436522|NCT01307267|564688577|FG011|Overall Study|Death|9|||
156436523|NCT01307267|564688578|FG012|Overall Study|Death|0|||
156436524|NCT01307267|564688579|FG013|Overall Study|Death|0|||
156436525|NCT01307267|564688580|FG014|Overall Study|Death|0|||
156436526|NCT01307267|564688581|FG015|Overall Study|Death|0|||
156436527|NCT01307267|564688582|FG016|Overall Study|Death|1|||
156436528|NCT01307267|564688583|FG017|Overall Study|Death|1|||
156436529|NCT01307267|564688584|FG018|Overall Study|Death|2|||
156436530|NCT01307267|564688585|FG019|Overall Study|Death|8|||
156436531|NCT01307267|564688586|FG020|Overall Study|Death|1|||
156436532|NCT01307267|564688587|FG021|Overall Study|Death|2|||
156436533|NCT01307267|564688588|FG022|Overall Study|Death|2|||
156436534|NCT01307267|564688566|FG000|Overall Study|Lost to Follow-up|0|||
156436535|NCT01307267|564688567|FG001|Overall Study|Lost to Follow-up|0|||
156436536|NCT01307267|564688568|FG002|Overall Study|Lost to Follow-up|0|||
156436537|NCT01307267|564688569|FG003|Overall Study|Lost to Follow-up|0|||
156436538|NCT01307267|564688570|FG004|Overall Study|Lost to Follow-up|0|||
156436539|NCT01307267|564688571|FG005|Overall Study|Lost to Follow-up|7|||
156436540|NCT01307267|564688572|FG006|Overall Study|Lost to Follow-up|0|||
156436541|NCT01307267|564688573|FG007|Overall Study|Lost to Follow-up|0|||
156436542|NCT01307267|564688574|FG008|Overall Study|Lost to Follow-up|1|||
156436543|NCT01307267|564688575|FG009|Overall Study|Lost to Follow-up|2|||
156436544|NCT01307267|564688576|FG010|Overall Study|Lost to Follow-up|1|||
156436545|NCT01307267|564688577|FG011|Overall Study|Lost to Follow-up|0|||
156436546|NCT01307267|564688578|FG012|Overall Study|Lost to Follow-up|0|||
156436547|NCT01307267|564688579|FG013|Overall Study|Lost to Follow-up|0|||
156436548|NCT01307267|564688580|FG014|Overall Study|Lost to Follow-up|0|||
156436549|NCT01307267|564688581|FG015|Overall Study|Lost to Follow-up|0|||
156436550|NCT01307267|564688582|FG016|Overall Study|Lost to Follow-up|0|||
156436551|NCT01307267|564688583|FG017|Overall Study|Lost to Follow-up|0|||
156436552|NCT01307267|564688584|FG018|Overall Study|Lost to Follow-up|0|||
156436553|NCT01307267|564688585|FG019|Overall Study|Lost to Follow-up|2|||
156436554|NCT01307267|564688586|FG020|Overall Study|Lost to Follow-up|0|||
156436555|NCT01307267|564688587|FG021|Overall Study|Lost to Follow-up|0|||
156436556|NCT01307267|564688588|FG022|Overall Study|Lost to Follow-up|0|||
156436557|NCT01307267|564688566|FG000|Overall Study|Withdrawal by Subject|0|||
156436558|NCT01307267|564688567|FG001|Overall Study|Withdrawal by Subject|0|||
156436559|NCT01307267|564688568|FG002|Overall Study|Withdrawal by Subject|0|||
156436560|NCT01307267|564688569|FG003|Overall Study|Withdrawal by Subject|0|||
156436561|NCT01307267|564688570|FG004|Overall Study|Withdrawal by Subject|0|||
156436562|NCT01307267|564688571|FG005|Overall Study|Withdrawal by Subject|1|||
156685614|NCT00804141|565593893|FG000|Overall Study|Withdrawal by Subject|131|||
156685615|NCT00804141|565593893|FG000|Overall Study|Lack of Efficacy|46|||
156436563|NCT01307267|564688572|FG006|Overall Study|Withdrawal by Subject|0|||
156436564|NCT01307267|564688573|FG007|Overall Study|Withdrawal by Subject|1|||
156436565|NCT01307267|564688574|FG008|Overall Study|Withdrawal by Subject|5|||
156436566|NCT01307267|564688575|FG009|Overall Study|Withdrawal by Subject|1|||
156436567|NCT01307267|564688576|FG010|Overall Study|Withdrawal by Subject|1|||
156436568|NCT01307267|564688577|FG011|Overall Study|Withdrawal by Subject|1|||
156436569|NCT01307267|564688578|FG012|Overall Study|Withdrawal by Subject|0|||
156685616|NCT00804141|565593893|FG000|Overall Study|Other than specified|30|||
156685617|NCT00804141|565593893|FG000|Overall Study|Enrolled but not treated|6|||
156685618|NCT02418455|565593895|FG000|48-Week Treatment Period|Other- Not Specified|1|||
156685619|NCT02418455|565593895|FG000|Continuation Period|Sponsor Decision|7|||
156685620|NCT03235479|565593898|FG000|Overall Study|Lost to Follow-up|8|||
156685621|NCT03235479|565593899|FG001|Overall Study|Lost to Follow-up|11|||
156685622|NCT03235479|565593898|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
156685623|NCT03235479|565593899|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
156436570|NCT01307267|564688579|FG013|Overall Study|Withdrawal by Subject|0|||
156436571|NCT01307267|564688580|FG014|Overall Study|Withdrawal by Subject|0|||
156436572|NCT01307267|564688581|FG015|Overall Study|Withdrawal by Subject|0|||
156436573|NCT01307267|564688582|FG016|Overall Study|Withdrawal by Subject|0|||
156436574|NCT01307267|564688583|FG017|Overall Study|Withdrawal by Subject|0|||
156436575|NCT01307267|564688584|FG018|Overall Study|Withdrawal by Subject|0|||
156436576|NCT01307267|564688585|FG019|Overall Study|Withdrawal by Subject|3|||
156436577|NCT01307267|564688586|FG020|Overall Study|Withdrawal by Subject|0|||
156436578|NCT01307267|564688587|FG021|Overall Study|Withdrawal by Subject|0|||
156436579|NCT01307267|564688588|FG022|Overall Study|Withdrawal by Subject|0|||
156436580|NCT01307267|564688566|FG000|Overall Study|Other|0|||
156436581|NCT01307267|564688567|FG001|Overall Study|Other|0|||
156436582|NCT01307267|564688568|FG002|Overall Study|Other|0|||
156436583|NCT01307267|564688569|FG003|Overall Study|Other|0|||
156436584|NCT01307267|564688570|FG004|Overall Study|Other|0|||
156436585|NCT01307267|564688571|FG005|Overall Study|Other|7|||
156685624|NCT03235479|565593898|FG000|Overall Study|Pregnancy|1|||
156685625|NCT03235479|565593899|FG001|Overall Study|Pregnancy|0|||
156685626|NCT03235479|565593898|FG000|Overall Study|Protocol Deviation|1|||
156685627|NCT03235479|565593899|FG001|Overall Study|Protocol Deviation|3|||
156685628|NCT03235479|565593898|FG000|Overall Study|Technical Problems|3|||
156685629|NCT03235479|565593899|FG001|Overall Study|Technical Problems|2|||
156685630|NCT03235479|565593898|FG000|Overall Study|Withdrawal by Subject|2|||
156685631|NCT03235479|565593899|FG001|Overall Study|Withdrawal by Subject|2|||
156685632|NCT03235479|565593898|FG000|Overall Study|Other Reasons|3|||
156685633|NCT03235479|565593899|FG001|Overall Study|Other Reasons|5|||
156685634|NCT02001051|565593900|FG000|Overall Study|Deemed not eligible following enrollment|0|||
156685635|NCT02001051|565593901|FG001|Overall Study|Deemed not eligible following enrollment|1|||
156685636|NCT00779402|565593902|FG000|Treatment Phase 1|Disease Progression|1|||
156685637|NCT00779402|565593903|FG001|Treatment Phase 1|Disease Progression|0|||
156685638|NCT00779402|565593902|FG000|Treatment Phase 1|Adverse Event|2|||
156685639|NCT00779402|565593903|FG001|Treatment Phase 1|Adverse Event|0|||
156685640|NCT00779402|565593902|FG000|Treatment Phase 1|Protocol Violation|1|||
156685641|NCT00779402|565593903|FG001|Treatment Phase 1|Protocol Violation|0|||
156685642|NCT00779402|565593902|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
156685643|NCT00779402|565593903|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
156785408|NCT01695772|565964940|FG000|Overall Study|Withdrawal by Subject|18|||
156785409|NCT01695772|565964940|FG000|Overall Study|Progressive Disease|8|||
156785410|NCT01695772|565964940|FG000|Overall Study|Investigator Decision|5|||
156436586|NCT01307267|564688572|FG006|Overall Study|Other|0|||
156436587|NCT01307267|564688573|FG007|Overall Study|Other|1|||
156785411|NCT01695772|565964940|FG000|Overall Study|Lost to Follow-up|4|||
156785412|NCT01695772|565964940|FG000|Overall Study|Protocol Violation|2|||
156785413|NCT01695772|565964940|FG000|Overall Study|Unspecified Reason|1|||
156785414|NCT00004859|565964943|FG000|Overall Study|Lack of Efficacy|43|||
156785415|NCT00004859|565964944|FG001|Overall Study|Lack of Efficacy|113|||
156685644|NCT00779402|565593902|FG000|Treatment Phase 1|Lost to Follow-up|0|||
156785416|NCT00004859|565964943|FG000|Overall Study|Adverse Event|31|||
156785417|NCT00004859|565964944|FG001|Overall Study|Adverse Event|93|||
156785418|NCT00004859|565964943|FG000|Overall Study|Death|5|||
156436588|NCT01307267|564688574|FG008|Overall Study|Other|3|||
156785419|NCT00004859|565964944|FG001|Overall Study|Death|5|||
156436589|NCT01307267|564688575|FG009|Overall Study|Other|0|||
156436590|NCT01307267|564688576|FG010|Overall Study|Other|1|||
156436591|NCT01307267|564688577|FG011|Overall Study|Other|1|||
156436592|NCT01307267|564688578|FG012|Overall Study|Other|1|||
156436593|NCT01307267|564688579|FG013|Overall Study|Other|0|||
156436594|NCT01307267|564688580|FG014|Overall Study|Other|2|||
156436595|NCT01307267|564688581|FG015|Overall Study|Other|1|||
156685645|NCT00779402|565593903|FG001|Treatment Phase 1|Lost to Follow-up|1|||
156685646|NCT00779402|565593902|FG000|Treatment Phase 1|Death|0|||
156685647|NCT00779402|565593903|FG001|Treatment Phase 1|Death|1|||
156685648|NCT00779402|565593902|FG000|Treatment Phase 1|Intercurrent Illness|1|||
156785420|NCT00004859|565964943|FG000|Overall Study|Withdrawal by Subject|7|||
156685649|NCT00779402|565593903|FG001|Treatment Phase 1|Intercurrent Illness|1|||
156685650|NCT00779402|565593902|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
156685651|NCT00779402|565593903|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
156436596|NCT01307267|564688582|FG016|Overall Study|Other|0|||
156436597|NCT01307267|564688583|FG017|Overall Study|Other|0|||
156436598|NCT01307267|564688584|FG018|Overall Study|Other|0|||
156436599|NCT01307267|564688585|FG019|Overall Study|Other|19|||
156436600|NCT01307267|564688586|FG020|Overall Study|Other|2|||
156436601|NCT01307267|564688587|FG021|Overall Study|Other|3|||
156436602|NCT01307267|564688588|FG022|Overall Study|Other|2|||
156436603|NCT04956575|564688589|FG000|Overall Study|Death|1|||
156436604|NCT04956575|564688590|FG001|Overall Study|Death|0|||
156436605|NCT04956575|564688591|FG002|Overall Study|Death|0|||
156685652|NCT00779402|565593902|FG000|Treatment Phase 1|Other|4|||
156436606|NCT04956575|564688592|FG003|Overall Study|Death|0|||
156436607|NCT04956575|564688593|FG004|Overall Study|Death|0|||
156685653|NCT00779402|565593903|FG001|Treatment Phase 1|Other|2|||
156685654|NCT00779402|565593902|FG000|Treatment Phase 1|Closure of Study|3|||
156685655|NCT00779402|565593903|FG001|Treatment Phase 1|Closure of Study|2|||
156685656|NCT00779402|565593902|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
156685657|NCT00779402|565593903|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
156685658|NCT00779402|565593902|FG000|Surveillance Phase|Protocol Violation|0|||
156685659|NCT00779402|565593903|FG001|Surveillance Phase|Protocol Violation|1|||
156436608|NCT04956575|564688594|FG005|Overall Study|Death|0|||
156436609|NCT04956575|564688595|FG006|Overall Study|Death|0|||
156436610|NCT04956575|564688596|FG007|Overall Study|Death|1|||
156436611|NCT04956575|564688597|FG008|Overall Study|Death|0|||
156436612|NCT04956575|564688598|FG009|Overall Study|Death|1|||
156436613|NCT04956575|564688599|FG010|Overall Study|Death|0|||
156530179|NCT03442114|565034848|FG001|Overall Study|Physician Decision|2|||
156530180|NCT03442114|565034847|FG000|Overall Study|Protocol Violation|0|||
156530181|NCT03442114|565034848|FG001|Overall Study|Protocol Violation|2|||
156530182|NCT03442114|565034847|FG000|Overall Study|Withdrawal by Subject|1|||
156530183|NCT03442114|565034848|FG001|Overall Study|Withdrawal by Subject|3|||
156530184|NCT03442114|565034847|FG000|Overall Study|Guardianship Change|0|||
156530185|NCT03442114|565034848|FG001|Overall Study|Guardianship Change|1|||
156530186|NCT01128361|565036297|FG000|Overall Study|Lost to Follow-up|0|||
156530187|NCT01128361|565036298|FG001|Overall Study|Lost to Follow-up|1|||
156530188|NCT01128361|565036297|FG000|Overall Study|Withdrawal by Subject|5|||
156530189|NCT01128361|565036298|FG001|Overall Study|Withdrawal by Subject|2|||
156530190|NCT05736211|565036311|FG000|Overall Study|Lost to Follow-up|6|||
156530191|NCT05736211|565036312|FG001|Overall Study|Lost to Follow-up|0|||
156530192|NCT02634346|565036315|FG000|Overall Study|Withdrawal by Subject|8|||
156530193|NCT02634346|565036316|FG001|Overall Study|Withdrawal by Subject|9|||
156685660|NCT00779402|565593902|FG000|Surveillance Phase|Patient refused to continue|22|||
156685661|NCT00779402|565593903|FG001|Surveillance Phase|Patient refused to continue|14|||
156785421|NCT00004859|565964944|FG001|Overall Study|Withdrawal by Subject|33|||
156785422|NCT00004859|565964943|FG000|Overall Study|Protocol Violation|2|||
156785423|NCT00004859|565964944|FG001|Overall Study|Protocol Violation|2|||
156785424|NCT00004859|565964943|FG000|Overall Study|other disease|0|||
156785425|NCT00004859|565964944|FG001|Overall Study|other disease|3|||
156785426|NCT00004859|565964943|FG000|Overall Study|error|3|||
156785427|NCT00004859|565964944|FG001|Overall Study|error|1|||
156785428|NCT00004859|565964943|FG000|Overall Study|missing data|14|||
156785429|NCT00004859|565964944|FG001|Overall Study|missing data|11|||
156785430|NCT00004859|565964943|FG000|Overall Study|Other|13|||
156785431|NCT00004859|565964944|FG001|Overall Study|Other|21|||
156436614|NCT04956575|564688600|FG011|Overall Study|Death|0|||
156436615|NCT04956575|564688589|FG000|Overall Study|Lost to Follow-up|3|||
156436616|NCT04956575|564688590|FG001|Overall Study|Lost to Follow-up|4|||
156530194|NCT02634346|565036317|FG002|Overall Study|Withdrawal by Subject|8|||
156685662|NCT00779402|565593902|FG000|Surveillance Phase|Lost to Follow-up|2|||
156785432|NCT00585169|565966344|FG000|Overall Study|Withdrawal by Subject|1|||
156436617|NCT04956575|564688591|FG002|Overall Study|Lost to Follow-up|2|||
156436618|NCT04956575|564688592|FG003|Overall Study|Lost to Follow-up|3|||
156436619|NCT04956575|564688593|FG004|Overall Study|Lost to Follow-up|1|||
156436620|NCT04956575|564688594|FG005|Overall Study|Lost to Follow-up|10|||
156436621|NCT04956575|564688595|FG006|Overall Study|Lost to Follow-up|11|||
156530195|NCT02634346|565036315|FG000|Overall Study|Adverse Event|2|||
156785433|NCT03055221|565966345|FG000|Overall Study|Adverse Event|2|||
156785434|NCT03055221|565966345|FG000|Overall Study|Withdrawal by Subject|4|||
156785435|NCT03055221|565966345|FG000|Overall Study|Death|6|||
156785436|NCT03055221|565966345|FG000|Overall Study|Physician Decision|1|||
156785437|NCT03055221|565966345|FG000|Overall Study|Study terminated by Sponsor|3|||
156785438|NCT03055221|565966345|FG000|Overall Study|Lost to Follow-up|4|||
156436622|NCT04956575|564688596|FG007|Overall Study|Lost to Follow-up|7|||
156436623|NCT04956575|564688597|FG008|Overall Study|Lost to Follow-up|4|||
156436624|NCT04956575|564688598|FG009|Overall Study|Lost to Follow-up|2|||
156530196|NCT02634346|565036316|FG001|Overall Study|Adverse Event|2|||
156685663|NCT00779402|565593903|FG001|Surveillance Phase|Lost to Follow-up|1|||
156685664|NCT00779402|565593902|FG000|Surveillance Phase|Death|0|||
156685665|NCT00779402|565593903|FG001|Surveillance Phase|Death|1|||
156685666|NCT00779402|565593902|FG000|Surveillance Phase|Intercurrent Illness|2|||
156685667|NCT00779402|565593903|FG001|Surveillance Phase|Intercurrent Illness|0|||
156685668|NCT00779402|565593902|FG000|Surveillance Phase|Other|5|||
156685669|NCT00779402|565593903|FG001|Surveillance Phase|Other|5|||
156685670|NCT00779402|565593902|FG000|Surveillance Phase|Withdrawal by Subject|4|||
156685671|NCT00779402|565593903|FG001|Surveillance Phase|Withdrawal by Subject|1|||
156685672|NCT00779402|565593902|FG000|Surveillance Phase|Closure of study|5|||
156685673|NCT00779402|565593903|FG001|Surveillance Phase|Closure of study|6|||
156685674|NCT00779402|565593902|FG000|Surveillance Phase|Completed Protocol Visits|3|||
156685675|NCT00779402|565593903|FG001|Surveillance Phase|Completed Protocol Visits|2|||
156685676|NCT00779402|565593902|FG000|Long-term Follow-up|Patient refused to continue|2|||
156785439|NCT01964560|565966346|FG000|Overall Study|Adverse Event|23|||
156785440|NCT01964560|565966346|FG000|Overall Study|Lack of Efficacy|46|||
156785441|NCT01964560|565966346|FG000|Overall Study|Protocol deviation|2|||
156785442|NCT01964560|565966346|FG000|Overall Study|Lost to Follow-up|4|||
156785443|NCT01964560|565966346|FG000|Overall Study|Withdrawal by Subject|64|||
156785444|NCT01964560|565966346|FG000|Overall Study|Surgery-hemispherotomy|1|||
156785445|NCT01964560|565966346|FG000|Overall Study|Surgery|1|||
156785446|NCT01964560|565966346|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
156785447|NCT01964560|565966346|FG000|Overall Study|Patient and Investigator choice|1|||
156436625|NCT04956575|564688599|FG010|Overall Study|Lost to Follow-up|3|||
156436626|NCT04956575|564688600|FG011|Overall Study|Lost to Follow-up|8|||
156436627|NCT04956575|564688589|FG000|Overall Study|Withdrawal by Subject|1|||
156436628|NCT04956575|564688590|FG001|Overall Study|Withdrawal by Subject|2|||
156436629|NCT04956575|564688591|FG002|Overall Study|Withdrawal by Subject|1|||
156436630|NCT04956575|564688592|FG003|Overall Study|Withdrawal by Subject|4|||
156436631|NCT04956575|564688593|FG004|Overall Study|Withdrawal by Subject|2|||
156436632|NCT04956575|564688594|FG005|Overall Study|Withdrawal by Subject|8|||
156436633|NCT04956575|564688595|FG006|Overall Study|Withdrawal by Subject|5|||
156436634|NCT04956575|564688596|FG007|Overall Study|Withdrawal by Subject|1|||
156436635|NCT04956575|564688597|FG008|Overall Study|Withdrawal by Subject|1|||
156436636|NCT04956575|564688598|FG009|Overall Study|Withdrawal by Subject|0|||
156436637|NCT04956575|564688599|FG010|Overall Study|Withdrawal by Subject|3|||
156785448|NCT01964560|565966346|FG000|Overall Study|Patient was prescribed CBD|1|||
156785449|NCT01964560|565966346|FG000|Overall Study|Participant moved to another country|1|||
156785450|NCT02391584|565966347|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
156785451|NCT02391584|565966348|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
156785452|NCT02391584|565966347|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
156785453|NCT02391584|565966348|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
156785454|NCT02391584|565966347|FG000|3 Month|Lost to Follow-up|1|||
156785455|NCT02391584|565966348|FG001|3 Month|Lost to Follow-up|0|||
156785456|NCT02391584|565966347|FG000|6 Month|Withdrawal by Subject|1|||
156785457|NCT02391584|565966348|FG001|6 Month|Withdrawal by Subject|0|||
156785458|NCT02391584|565966347|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
156785459|NCT02391584|565966348|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
156785460|NCT01441414|565966361|FG000|Overall Study|Participant died|9|||
156785461|NCT01441414|565966361|FG000|Overall Study|Other reasons|3|||
156785462|NCT01441414|565966361|FG000|Overall Study|Study terminated by sponsor|2|||
156436638|NCT04956575|564688600|FG011|Overall Study|Withdrawal by Subject|1|||
156436639|NCT03593876|564688601|FG000|Overall Study|Withdrawal by Subject|1|||
156436640|NCT03593876|564688601|FG000|Overall Study|Discharged home before intervention completion|2|||
156436641|NCT06119113|564688602|FG000|Overall Study|Lost to Follow-up|15|||
156436642|NCT06119113|564688603|FG001|Overall Study|Lost to Follow-up|13|||
156436643|NCT06119113|564688604|FG002|Overall Study|Lost to Follow-up|21|||
156436644|NCT05309668|564688605|FG000|Overall Study|Ongoing at data cut-off|14|||
156436645|NCT05309668|564688606|FG001|Overall Study|Ongoing at data cut-off|17|||
156436646|NCT05309668|564688607|FG002|Overall Study|Ongoing at data cut-off|4|||
156436647|NCT02696707|564688608|FG000|Per Protocol Population|Physician Decision|2|||
156436648|NCT02696707|564688609|FG001|Per Protocol Population|Physician Decision|1|||
156436649|NCT02696707|564688608|FG000|Per Protocol Population|Participant Decision|0|||
156436650|NCT02696707|564688609|FG001|Per Protocol Population|Participant Decision|2|||
156436651|NCT02696707|564688608|FG000|Completed Study as Planned|Reason = LVEF|2|||
156785463|NCT01441414|565966361|FG000|Overall Study|Subject refused further follow-up|1|||
156785464|NCT01058005|565966373|FG000|Overall Study|Adverse Event|0|||
156785465|NCT01058005|565966374|FG001|Overall Study|Adverse Event|2|||
156785466|NCT01058005|565966375|FG002|Overall Study|Adverse Event|1|||
156785467|NCT01058005|565966373|FG000|Overall Study|Physician Decision|2|||
156785468|NCT01058005|565966374|FG001|Overall Study|Physician Decision|2|||
156785469|NCT01058005|565966375|FG002|Overall Study|Physician Decision|0|||
156785470|NCT01058005|565966373|FG000|Overall Study|Withdrawal by Subject|4|||
156785471|NCT01058005|565966374|FG001|Overall Study|Withdrawal by Subject|5|||
156785472|NCT01058005|565966375|FG002|Overall Study|Withdrawal by Subject|11|||
156785473|NCT01058005|565966373|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
156808727|NCT01396187|566054446|FG001|Overall Study|Adverse Event|1|||
156685677|NCT00779402|565593903|FG001|Long-term Follow-up|Patient refused to continue|0|||
156530197|NCT02634346|565036317|FG002|Overall Study|Adverse Event|7|||
156530198|NCT02634346|565036315|FG000|Overall Study|Lack of Efficacy|1|||
156530199|NCT02634346|565036316|FG001|Overall Study|Lack of Efficacy|2|||
156530200|NCT02634346|565036317|FG002|Overall Study|Lack of Efficacy|8|||
156530201|NCT02634346|565036315|FG000|Overall Study|Lost to Follow-up|1|||
156530202|NCT02634346|565036316|FG001|Overall Study|Lost to Follow-up|0|||
156530203|NCT02634346|565036317|FG002|Overall Study|Lost to Follow-up|0|||
156530204|NCT02634346|565036315|FG000|Overall Study|Protocol Violation|0|||
156530205|NCT02634346|565036316|FG001|Overall Study|Protocol Violation|1|||
156530206|NCT02634346|565036317|FG002|Overall Study|Protocol Violation|0|||
156530207|NCT00992511|565036318|FG000|Overall Study|Migrated/moved from study area|1|||
156530208|NCT00992511|565036319|FG001|Overall Study|Migrated/moved from study area|0|||
156530209|NCT00992511|565036320|FG002|Overall Study|Migrated/moved from study area|1|||
156530210|NCT00992511|565036321|FG003|Overall Study|Migrated/moved from study area|2|||
156530211|NCT00992511|565036318|FG000|Overall Study|Lost to Follow-up|1|||
156530212|NCT00992511|565036319|FG001|Overall Study|Lost to Follow-up|0|||
156530213|NCT00992511|565036320|FG002|Overall Study|Lost to Follow-up|0|||
156530214|NCT00992511|565036321|FG003|Overall Study|Lost to Follow-up|2|||
156530215|NCT00992511|565036318|FG000|Overall Study|Withdrawal by Subject|0|||
156530216|NCT00992511|565036319|FG001|Overall Study|Withdrawal by Subject|0|||
156530217|NCT00992511|565036320|FG002|Overall Study|Withdrawal by Subject|1|||
156530218|NCT00992511|565036321|FG003|Overall Study|Withdrawal by Subject|1|||
156530219|NCT02076113|565036324|FG000|Overall Study|Lost to Follow-up|4|||
156530220|NCT02076113|565036325|FG001|Overall Study|Lost to Follow-up|1|||
156530221|NCT02076113|565036324|FG000|Overall Study|Withdrawal by Subject|2|||
156530222|NCT02076113|565036325|FG001|Overall Study|Withdrawal by Subject|3|||
156530223|NCT02076113|565036324|FG000|Overall Study|Death|1|||
156530224|NCT02076113|565036325|FG001|Overall Study|Death|3|||
156530225|NCT00769860|565036331|FG000|Overall Study|Withdrawal by Subject|2|||
156530226|NCT00769860|565036332|FG001|Overall Study|Withdrawal by Subject|0|||
156530227|NCT00448435|565036335|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
156530228|NCT00448435|565036336|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
156530229|NCT00412971|565036341|FG000|Overall Study|Lost to Follow-up|17|||
156530230|NCT00412971|565036342|FG001|Overall Study|Lost to Follow-up|9|||
156530231|NCT00412971|565036341|FG000|Overall Study|Protocol Violation|13|||
156530232|NCT00412971|565036342|FG001|Overall Study|Protocol Violation|1|||
156530233|NCT01774084|565036345|FG000|Overall Study|Personal reasons|1|||
156530234|NCT01774084|565036346|FG001|Overall Study|Personal reasons|0|||
156530235|NCT01106404|565036347|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
156530236|NCT01106404|565036348|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
156868574|NCT01759446|566277331|FG004|Overall Study|Withdrawal by Subject|0|||
156868575|NCT00865566|566277332|FG000|Overall Study|Death|1|||
156868576|NCT00865566|566277333|FG001|Overall Study|Death|11|||
156436652|NCT02696707|564688609|FG001|Completed Study as Planned|Reason = LVEF|2|||
156436653|NCT02696707|564688608|FG000|Completed Study as Planned|Protocol Violation|2|||
156436654|NCT02696707|564688609|FG001|Completed Study as Planned|Protocol Violation|6|||
156436655|NCT02696707|564688608|FG000|Completed Study as Planned|Metastatic disease|3|||
156436656|NCT02696707|564688609|FG001|Completed Study as Planned|Metastatic disease|0|||
156436657|NCT02696707|564688608|FG000|Completed Study as Planned|Location|1|||
156436658|NCT02696707|564688609|FG001|Completed Study as Planned|Location|1|||
156436659|NCT01786564|564688614|FG000|Overall Study|Lost to Follow-up|47|||
156436660|NCT01786564|564688614|FG000|Overall Study|Ineligible|17|||
156436661|NCT03034915|564688615|FG000|Overall Study|Adverse Event|29|||
156436662|NCT03034915|564688616|FG001|Overall Study|Adverse Event|32|||
156436663|NCT03034915|564688617|FG002|Overall Study|Adverse Event|22|||
156436664|NCT03034915|564688615|FG000|Overall Study|Lost to Follow-up|5|||
156436665|NCT03034915|564688616|FG001|Overall Study|Lost to Follow-up|13|||
156436666|NCT03034915|564688617|FG002|Overall Study|Lost to Follow-up|3|||
156436667|NCT03034915|564688615|FG000|Overall Study|Withdrawal by Subject|29|||
156436668|NCT03034915|564688616|FG001|Overall Study|Withdrawal by Subject|46|||
156436669|NCT03034915|564688617|FG002|Overall Study|Withdrawal by Subject|41|||
156436670|NCT03034915|564688615|FG000|Overall Study|Protocol Deviation|2|||
156436671|NCT03034915|564688616|FG001|Overall Study|Protocol Deviation|14|||
156436672|NCT03034915|564688617|FG002|Overall Study|Protocol Deviation|7|||
156436673|NCT03034915|564688615|FG000|Overall Study|Lack of Efficacy|8|||
156436674|NCT03034915|564688616|FG001|Overall Study|Lack of Efficacy|16|||
156436675|NCT03034915|564688617|FG002|Overall Study|Lack of Efficacy|18|||
156530237|NCT01106404|565036347|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
156530238|NCT01106404|565036348|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
156530239|NCT01106404|565036347|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
156530240|NCT01106404|565036348|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
156530241|NCT01106404|565036347|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
156530242|NCT01106404|565036348|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
156530243|NCT01387230|565036349|FG000|Overall Study|Adverse Event|0|||
156530244|NCT01387230|565036350|FG001|Overall Study|Adverse Event|1|||
156530245|NCT01387230|565036351|FG002|Overall Study|Adverse Event|3|||
156530246|NCT01387230|565036349|FG000|Overall Study|Lack of Efficacy|8|||
156530247|NCT01387230|565036350|FG001|Overall Study|Lack of Efficacy|5|||
156436676|NCT03034915|564688615|FG000|Overall Study|Site closed|2|||
156436677|NCT03034915|564688616|FG001|Overall Study|Site closed|2|||
156436678|NCT03034915|564688617|FG002|Overall Study|Site closed|4|||
156436679|NCT03034915|564688615|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
156436680|NCT03034915|564688616|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
156436681|NCT03034915|564688617|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
156436682|NCT03034915|564688615|FG000|Overall Study|Physician Decision|1|||
156436683|NCT03034915|564688616|FG001|Overall Study|Physician Decision|5|||
156436684|NCT03034915|564688617|FG002|Overall Study|Physician Decision|2|||
156436685|NCT03861767|564688620|FG000|Overall Study|Withdrawal by Subject|2|||
156530248|NCT01387230|565036351|FG002|Overall Study|Lack of Efficacy|4|||
156685678|NCT00779402|565593902|FG000|Long-term Follow-up|Other|5|||
156685679|NCT00779402|565593903|FG001|Long-term Follow-up|Other|0|||
156685680|NCT00779402|565593902|FG000|Long-term Follow-up|Closure of Study|8|||
156685681|NCT00779402|565593903|FG001|Long-term Follow-up|Closure of Study|4|||
156685682|NCT00779402|565593902|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
156685683|NCT00779402|565593903|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
156685684|NCT00693225|565593908|FG000|Overall Study|Lost to Follow-up|1|||
156685685|NCT00693225|565593909|FG001|Overall Study|Lost to Follow-up|2|||
156685686|NCT00693225|565593908|FG000|Overall Study|Adverse Event|1|||
156685687|NCT00693225|565593909|FG001|Overall Study|Adverse Event|3|||
156685688|NCT01315028|565593910|FG000|Overall Study|Lost to Follow-up|1|||
156685689|NCT01315028|565593911|FG001|Overall Study|Lost to Follow-up|0|||
156685690|NCT01315028|565593910|FG000|Overall Study|Death|0|||
156685691|NCT01315028|565593911|FG001|Overall Study|Death|1|||
156685692|NCT03585959|565593916|FG000|Overall Study|Physician Decision|1|||
156685693|NCT03585959|565593916|FG000|Overall Study|Unsuccessful Procedure|2|||
156685694|NCT02531594|565593917|FG000|Overall Study|Withdrawal by Subject|7|||
156685695|NCT02531594|565593918|FG001|Overall Study|Withdrawal by Subject|8|||
156685696|NCT00220727|565593948|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
156685697|NCT00220727|565593949|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
156685698|NCT01175473|565593950|FG000|Overall Study|Adverse Event|2|||
156685699|NCT01175473|565593951|FG001|Overall Study|Adverse Event|2|||
156685700|NCT02508116|565593954|FG000|Overall Study|Lost to Follow-up|2|||
156685701|NCT02508116|565593955|FG001|Overall Study|Lost to Follow-up|3|||
156685702|NCT02508116|565593954|FG000|Overall Study|Withdrawal by Subject|3|||
156685703|NCT02508116|565593955|FG001|Overall Study|Withdrawal by Subject|2|||
156685704|NCT02508116|565593954|FG000|Overall Study|Protocol Violation|1|||
156685705|NCT02508116|565593955|FG001|Overall Study|Protocol Violation|2|||
156685706|NCT02508116|565593954|FG000|Overall Study|Physician Decision|2|||
156685707|NCT02508116|565593955|FG001|Overall Study|Physician Decision|0|||
156685708|NCT00109850|565593961|FG000|Overall Study|Adverse Event|1|||
156685709|NCT00109850|565593961|FG000|Overall Study|Death|2|||
156685710|NCT00109850|565593961|FG000|Overall Study|Ineligible|1|||
156685711|NCT04234464|565593962|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
156685712|NCT04234464|565593963|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
156685713|NCT00476593|565593964|FG000|Overall Study|Lost to Follow-up|10|||
156685714|NCT00476593|565593965|FG001|Overall Study|Lost to Follow-up|2|||
156685715|NCT00476593|565593966|FG002|Overall Study|Lost to Follow-up|8|||
156685716|NCT00476593|565593967|FG003|Overall Study|Lost to Follow-up|22|||
156685717|NCT00983528|565593968|FG000|Overall Study|Death|4|||
156685718|NCT00983528|565593968|FG000|Overall Study|Lost to Follow-up|1|||
156685719|NCT00983528|565593968|FG000|Overall Study|Study Terminated|1|||
156685720|NCT03430011|565593970|FG000|Pre-Treatment|Death|1|||
156685721|NCT03430011|565593971|FG001|Pre-Treatment|Death|0|||
156685722|NCT03430011|565593972|FG002|Pre-Treatment|Death|0|||
156685723|NCT03430011|565593973|FG003|Pre-Treatment|Death|0|||
156685724|NCT03430011|565593974|FG004|Pre-Treatment|Death|1|||
156685725|NCT03430011|565593975|FG005|Pre-Treatment|Death|0|||
156685726|NCT03430011|565593976|FG006|Pre-Treatment|Death|1|||
156685727|NCT03430011|565593977|FG007|Pre-Treatment|Death|0|||
156685728|NCT03430011|565593970|FG000|Pre-Treatment|Screen Fail|0|||
156685729|NCT03430011|565593971|FG001|Pre-Treatment|Screen Fail|0|||
156685730|NCT03430011|565593972|FG002|Pre-Treatment|Screen Fail|0|||
156685731|NCT03430011|565593973|FG003|Pre-Treatment|Screen Fail|0|||
156530249|NCT01387230|565036349|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
156685732|NCT03430011|565593974|FG004|Pre-Treatment|Screen Fail|1|||
156785474|NCT01058005|565966374|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
156530250|NCT01387230|565036350|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
156685733|NCT03430011|565593975|FG005|Pre-Treatment|Screen Fail|0|||
156685734|NCT03430011|565593976|FG006|Pre-Treatment|Screen Fail|0|||
156685735|NCT03430011|565593977|FG007|Pre-Treatment|Screen Fail|0|||
156685736|NCT03430011|565593970|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685737|NCT03430011|565593971|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685738|NCT03430011|565593972|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
156685739|NCT03430011|565593973|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685740|NCT03430011|565593974|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
156530251|NCT01387230|565036351|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
156530252|NCT01387230|565036349|FG000|Overall Study|Lost to Follow-up|0|||
156530253|NCT01387230|565036350|FG001|Overall Study|Lost to Follow-up|0|||
156530254|NCT01387230|565036351|FG002|Overall Study|Lost to Follow-up|1|||
156530255|NCT01387230|565036349|FG000|Overall Study|Withdrawal by Subject|4|||
156530256|NCT01387230|565036350|FG001|Overall Study|Withdrawal by Subject|1|||
156530257|NCT01387230|565036351|FG002|Overall Study|Withdrawal by Subject|0|||
156530258|NCT03026127|565036355|FG000|CRISP R61|Adverse Event|5|||
156530259|NCT03026127|565036356|FG001|CRISP R61|Adverse Event|0|||
156530260|NCT03026127|565036357|FG002|CRISP R61|Adverse Event|0|||
156685741|NCT03430011|565593975|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
156530261|NCT03026127|565036355|FG000|CRISP R61|Lost to Follow-up|2|||
156530262|NCT03026127|565036356|FG001|CRISP R61|Lost to Follow-up|0|||
156530263|NCT03026127|565036357|FG002|CRISP R61|Lost to Follow-up|0|||
156530264|NCT03026127|565036355|FG000|CRISP R61|Dropped before therapy|5|||
156685742|NCT03430011|565593976|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685743|NCT03430011|565593977|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685744|NCT03430011|565593970|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
156685745|NCT03430011|565593971|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
156685746|NCT03430011|565593972|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
156685747|NCT03430011|565593973|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
156685748|NCT03430011|565593974|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
156685749|NCT03430011|565593975|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
156685750|NCT03430011|565593976|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
156685751|NCT03430011|565593977|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
156685752|NCT03430011|565593970|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
156685753|NCT03430011|565593971|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
156685754|NCT03430011|565593972|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
156685755|NCT03430011|565593973|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
156685756|NCT03430011|565593974|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
156685757|NCT03430011|565593975|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
156685758|NCT03430011|565593976|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
156685759|NCT03430011|565593977|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
156685760|NCT03430011|565593970|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
156685761|NCT03430011|565593971|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
156685762|NCT03430011|565593972|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
156685763|NCT03430011|565593973|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
156685764|NCT03430011|565593974|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
156685765|NCT03430011|565593975|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
156685766|NCT03430011|565593976|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
156685767|NCT03430011|565593977|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
156685768|NCT03430011|565593970|FG000|JCARH125 Treatment|Death|4|||
156685769|NCT03430011|565593971|FG001|JCARH125 Treatment|Death|19|||
156685770|NCT03430011|565593972|FG002|JCARH125 Treatment|Death|10|||
156685771|NCT03430011|565593973|FG003|JCARH125 Treatment|Death|8|||
156685772|NCT03430011|565593974|FG004|JCARH125 Treatment|Death|5|||
156685773|NCT03430011|565593975|FG005|JCARH125 Treatment|Death|3|||
156685774|NCT03430011|565593976|FG006|JCARH125 Treatment|Death|4|||
156685775|NCT03430011|565593977|FG007|JCARH125 Treatment|Death|2|||
156685776|NCT03430011|565593970|FG000|JCARH125 Treatment|Other reasons|1|||
156685777|NCT03430011|565593971|FG001|JCARH125 Treatment|Other reasons|0|||
156685778|NCT03430011|565593972|FG002|JCARH125 Treatment|Other reasons|4|||
156685779|NCT03430011|565593973|FG003|JCARH125 Treatment|Other reasons|2|||
156685780|NCT03430011|565593974|FG004|JCARH125 Treatment|Other reasons|2|||
156685781|NCT03430011|565593975|FG005|JCARH125 Treatment|Other reasons|1|||
156685782|NCT03430011|565593976|FG006|JCARH125 Treatment|Other reasons|3|||
156685783|NCT03430011|565593977|FG007|JCARH125 Treatment|Other reasons|2|||
156685784|NCT00559364|565593979|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
156685785|NCT00559364|565593980|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
156685786|NCT04126343|565593981|FG000|Overall Study|Adverse Event|0|||
156685787|NCT04126343|565593982|FG001|Overall Study|Adverse Event|0|||
156685788|NCT04126343|565593983|FG002|Overall Study|Adverse Event|0|||
156685789|NCT04126343|565593984|FG003|Overall Study|Adverse Event|0|||
156685790|NCT04126343|565593985|FG004|Overall Study|Adverse Event|0|||
156685791|NCT04126343|565593986|FG005|Overall Study|Adverse Event|1|||
156685792|NCT04126343|565593981|FG000|Overall Study|Withdrawal by Subject|0|||
156685793|NCT04126343|565593982|FG001|Overall Study|Withdrawal by Subject|0|||
156685794|NCT04126343|565593983|FG002|Overall Study|Withdrawal by Subject|0|||
156685795|NCT04126343|565593984|FG003|Overall Study|Withdrawal by Subject|1|||
156530265|NCT03026127|565036356|FG001|CRISP R61|Dropped before therapy|0|||
156685796|NCT04126343|565593985|FG004|Overall Study|Withdrawal by Subject|0|||
156685797|NCT04126343|565593986|FG005|Overall Study|Withdrawal by Subject|0|||
156685798|NCT04126343|565593981|FG000|Overall Study|Related to COVID-19 pandemic|3|||
156685799|NCT04126343|565593982|FG001|Overall Study|Related to COVID-19 pandemic|4|||
156685800|NCT04126343|565593983|FG002|Overall Study|Related to COVID-19 pandemic|3|||
156685801|NCT04126343|565593984|FG003|Overall Study|Related to COVID-19 pandemic|3|||
156436686|NCT03861767|564688621|FG001|Overall Study|Withdrawal by Subject|1|||
156436687|NCT03861767|564688622|FG002|Overall Study|Withdrawal by Subject|0|||
156436688|NCT03861767|564688623|FG003|Overall Study|Withdrawal by Subject|5|||
156436689|NCT03861767|564688624|FG004|Overall Study|Withdrawal by Subject|2|||
156436690|NCT03861767|564688625|FG005|Overall Study|Withdrawal by Subject|1|||
156436691|NCT03861767|564688626|FG006|Overall Study|Withdrawal by Subject|3|||
156436692|NCT03861767|564688627|FG007|Overall Study|Withdrawal by Subject|1|||
156436693|NCT03861767|564688628|FG008|Overall Study|Withdrawal by Subject|0|||
156436694|NCT03861767|564688629|FG009|Overall Study|Withdrawal by Subject|5|||
156436695|NCT00346333|564688630|FG000|Overall Study|Death|1|||
156436696|NCT00346333|564688631|FG001|Overall Study|Death|0|||
156436697|NCT00346333|564688630|FG000|Overall Study|unwilling or unable to continue|4|||
156436698|NCT00346333|564688631|FG001|Overall Study|unwilling or unable to continue|8|||
156436699|NCT00117286|564688632|FG000|Overall Study|Adverse Event|12|||
156436700|NCT00117286|564688633|FG001|Overall Study|Adverse Event|6|||
156436701|NCT00117286|564688632|FG000|Overall Study|Lost to Follow-up|2|||
156436702|NCT00117286|564688633|FG001|Overall Study|Lost to Follow-up|0|||
156436703|NCT00117286|564688632|FG000|Overall Study|Protocol Violation|3|||
156436704|NCT00117286|564688633|FG001|Overall Study|Protocol Violation|3|||
156436705|NCT00117286|564688632|FG000|Overall Study|Withdrawal by Subject|6|||
156436706|NCT00117286|564688633|FG001|Overall Study|Withdrawal by Subject|2|||
156436707|NCT00117286|564688632|FG000|Overall Study|Physician Decision|3|||
156436708|NCT00117286|564688633|FG001|Overall Study|Physician Decision|7|||
156436709|NCT00117286|564688632|FG000|Overall Study|Lack of Efficacy|2|||
156436710|NCT00117286|564688633|FG001|Overall Study|Lack of Efficacy|1|||
156436711|NCT00117286|564688632|FG000|Overall Study|Research site closing|0|||
156436712|NCT00117286|564688633|FG001|Overall Study|Research site closing|2|||
156436713|NCT00189202|564688634|FG000|Overall Study|Physician Decision|5|||
156436714|NCT04446117|564688637|FG000|Overall Study|No Study Treatment Given|4|||
156436715|NCT04446117|564688638|FG001|Overall Study|No Study Treatment Given|3|||
156436716|NCT04446117|564688637|FG000|Overall Study|Radiographic Disease Progression|132|||
156436717|NCT04446117|564688638|FG001|Overall Study|Radiographic Disease Progression|158|||
156436718|NCT04446117|564688637|FG000|Overall Study|Adverse Event|79|||
156436719|NCT04446117|564688638|FG001|Overall Study|Adverse Event|43|||
156436720|NCT04446117|564688637|FG000|Overall Study|Lack of Clinical Benefit|1|||
156436721|NCT04446117|564688638|FG001|Overall Study|Lack of Clinical Benefit|1|||
156436722|NCT04446117|564688637|FG000|Overall Study|Withdrawal by Subject|24|||
156436723|NCT04446117|564688638|FG001|Overall Study|Withdrawal by Subject|22|||
156436724|NCT04446117|564688637|FG000|Overall Study|Lost to Follow-up|0|||
156436725|NCT04446117|564688638|FG001|Overall Study|Lost to Follow-up|3|||
156436726|NCT04446117|564688637|FG000|Overall Study|Miscellaneous|26|||
156436727|NCT04446117|564688638|FG001|Overall Study|Miscellaneous|36|||
156436728|NCT04446117|564688637|FG000|Overall Study|Missing Data/Data not yet Received|1|||
156436729|NCT04446117|564688638|FG001|Overall Study|Missing Data/Data not yet Received|0|||
156436730|NCT03654768|564688639|FG000|Overall Study|Adverse Event|1|||
156436731|NCT03654768|564688640|FG001|Overall Study|Adverse Event|6|||
156436732|NCT03654768|564688639|FG000|Overall Study|Loss of response|2|||
156685802|NCT04126343|565593985|FG004|Overall Study|Related to COVID-19 pandemic|3|||
156436733|NCT03654768|564688640|FG001|Overall Study|Loss of response|2|||
156436734|NCT03654768|564688639|FG000|Overall Study|Non-compliance|0|||
156436735|NCT03654768|564688640|FG001|Overall Study|Non-compliance|1|||
156436736|NCT03654768|564688639|FG000|Overall Study|Refusal not related to toxicity|1|||
156436737|NCT03654768|564688640|FG001|Overall Study|Refusal not related to toxicity|5|||
156436738|NCT03654768|564688639|FG000|Overall Study|Did not receive protocol therapy|1|||
156436739|NCT03654768|564688640|FG001|Overall Study|Did not receive protocol therapy|1|||
156436740|NCT00588770|564688641|FG000|Overall Study|Disease progression|85|||
156436741|NCT00588770|564688642|FG001|Overall Study|Disease progression|68|||
156436742|NCT00588770|564688641|FG000|Overall Study|Adverse Event|29|||
156436743|NCT00588770|564688642|FG001|Overall Study|Adverse Event|58|||
156436744|NCT00588770|564688641|FG000|Overall Study|Death|13|||
156436745|NCT00588770|564688642|FG001|Overall Study|Death|22|||
156685803|NCT04126343|565593986|FG005|Overall Study|Related to COVID-19 pandemic|3|||
156685804|NCT00330460|565593995|FG000|Overall Study|Physician Decision|1|||
156685805|NCT00330460|565593996|FG001|Overall Study|Physician Decision|0|||
156685806|NCT00330460|565593995|FG000|Overall Study|Adverse Event|10|||
156436746|NCT00588770|564688641|FG000|Overall Study|Withdrawal by Subject|15|||
156436747|NCT00588770|564688642|FG001|Overall Study|Withdrawal by Subject|25|||
156436748|NCT00588770|564688641|FG000|Overall Study|Alternative therapy|2|||
156436749|NCT00588770|564688642|FG001|Overall Study|Alternative therapy|4|||
156436750|NCT00588770|564688641|FG000|Overall Study|Other complicating disease|3|||
156436751|NCT00588770|564688642|FG001|Overall Study|Other complicating disease|2|||
156436752|NCT00588770|564688641|FG000|Overall Study|Not start protocol therapy|0|||
156436753|NCT00588770|564688642|FG001|Overall Study|Not start protocol therapy|9|||
156436754|NCT00588770|564688641|FG000|Overall Study|Lack of Efficacy|8|||
156436755|NCT00588770|564688642|FG001|Overall Study|Lack of Efficacy|10|||
156436756|NCT00588770|564688641|FG000|Overall Study|Physician discretion|2|||
156436757|NCT00588770|564688642|FG001|Overall Study|Physician discretion|0|||
156685807|NCT00330460|565593996|FG001|Overall Study|Adverse Event|8|||
156685808|NCT00330460|565593995|FG000|Overall Study|Withdrawal by Subject|18|||
156685809|NCT00330460|565593996|FG001|Overall Study|Withdrawal by Subject|17|||
156685810|NCT00330460|565593995|FG000|Overall Study|Death|1|||
156685811|NCT00330460|565593996|FG001|Overall Study|Death|1|||
156685812|NCT00330460|565593995|FG000|Overall Study|Ineligibility determined|1|||
156685813|NCT00330460|565593996|FG001|Overall Study|Ineligibility determined|3|||
156685814|NCT00330460|565593995|FG000|Overall Study|Lost to Follow-up|8|||
156685815|NCT00330460|565593996|FG001|Overall Study|Lost to Follow-up|3|||
156685816|NCT00330460|565593995|FG000|Overall Study|Noncompliance|2|||
156685817|NCT00330460|565593996|FG001|Overall Study|Noncompliance|1|||
156685818|NCT00330460|565593995|FG000|Overall Study|Other|1|||
156685819|NCT00330460|565593996|FG001|Overall Study|Other|0|||
156685820|NCT03712124|565593997|FG000|Overall Study|Protocol Violation|1|||
156685821|NCT03712124|565593998|FG001|Overall Study|Protocol Violation|0|||
156685822|NCT00388037|565594000|FG000|Overall Study|Protocol Violation|1|||
156685823|NCT00602537|565594003|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
156685824|NCT00602537|565594004|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
156685825|NCT00602537|565594003|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
156685826|NCT00602537|565594004|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
156685827|NCT00602537|565594003|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
156685828|NCT00602537|565594004|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
156685829|NCT00602537|565594003|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
156685830|NCT00602537|565594004|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
156685831|NCT00602537|565594003|FG000|Follow Up Study Comparison|Adverse Event|1|||
156685832|NCT00602537|565594004|FG001|Follow Up Study Comparison|Adverse Event|0|||
156685833|NCT00602537|565594003|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
156685834|NCT00602537|565594004|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
156685835|NCT00602537|565594003|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
156685836|NCT00602537|565594004|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
156685837|NCT04314843|565594005|FG000|Overall Study|Death|2|||
156685838|NCT04314843|565594006|FG001|Overall Study|Death|2|||
156685839|NCT04314843|565594005|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
156685840|NCT04314843|565594006|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
156785475|NCT01058005|565966375|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
156785476|NCT01058005|565966373|FG000|Overall Study|Reason Missing|5|||
156785477|NCT01058005|565966374|FG001|Overall Study|Reason Missing|3|||
156785478|NCT01058005|565966375|FG002|Overall Study|Reason Missing|1|||
156785479|NCT01717859|565966376|FG000|Overall Study|Adverse Event|5|||
156785480|NCT01717859|565966376|FG000|Overall Study|Moved out of state|1|||
156329855|NCT00734474|564308710|FG000|Overall Study|Protocol Violation|0|||
156329856|NCT00734474|564308711|FG001|Overall Study|Protocol Violation|0|||
156329857|NCT00734474|564308712|FG002|Overall Study|Protocol Violation|4|||
156329858|NCT00734474|564308713|FG003|Overall Study|Protocol Violation|0|||
156329859|NCT00734474|564308714|FG004|Overall Study|Protocol Violation|3|||
156329860|NCT00734474|564308715|FG005|Overall Study|Protocol Violation|0|||
156329861|NCT00734474|564308716|FG006|Overall Study|Protocol Violation|0|||
156329862|NCT00734474|564308717|FG007|Overall Study|Protocol Violation|3|||
156329863|NCT00734474|564308718|FG008|Overall Study|Protocol Violation|1|||
156329864|NCT00734474|564308710|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
156329865|NCT00734474|564308711|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
156329866|NCT00734474|564308712|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
156329867|NCT00734474|564308713|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
156329868|NCT00734474|564308714|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
156329869|NCT00734474|564308715|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
156329870|NCT00734474|564308716|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
156329871|NCT00734474|564308717|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
156329872|NCT00734474|564308718|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
156329873|NCT00734474|564308710|FG000|Overall Study|Sponsor Decision|0|||
156329874|NCT00734474|564308711|FG001|Overall Study|Sponsor Decision|0|||
156329875|NCT00734474|564308712|FG002|Overall Study|Sponsor Decision|0|||
156329876|NCT00734474|564308713|FG003|Overall Study|Sponsor Decision|0|||
156685841|NCT01899326|565594007|FG000|Overall Study|Withdrawal by Subject|1|||
156685842|NCT01899326|565594007|FG000|Overall Study|Adverse Event|2|||
156685843|NCT01899326|565594007|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
156685844|NCT00373425|565594008|FG000|Overall Study|Relapse of NSCLC|116|||
156685845|NCT00373425|565594009|FG001|Overall Study|Relapse of NSCLC|104|||
156785481|NCT01717859|565966376|FG000|Overall Study|Patient concerned about mental health|1|||
156785482|NCT01717859|565966376|FG000|Overall Study|Lost to Follow-up|1|||
156329877|NCT00734474|564308714|FG004|Overall Study|Sponsor Decision|2|||
156329878|NCT00734474|564308715|FG005|Overall Study|Sponsor Decision|0|||
156329879|NCT00734474|564308716|FG006|Overall Study|Sponsor Decision|0|||
156436758|NCT00588770|564688641|FG000|Overall Study|Patient non-compliance|2|||
156685846|NCT00373425|565594010|FG002|Overall Study|Relapse of NSCLC|19|||
156808728|NCT01396187|566054447|FG002|Overall Study|Adverse Event|0|||
156808729|NCT01396187|566054448|FG003|Overall Study|Adverse Event|0|||
156685847|NCT00373425|565594011|FG003|Overall Study|Relapse of NSCLC|2|||
156685848|NCT00373425|565594012|FG004|Overall Study|Relapse of NSCLC|26|||
156685849|NCT00373425|565594008|FG000|Overall Study|Adverse Event|191|||
156685850|NCT00373425|565594009|FG001|Overall Study|Adverse Event|22|||
156685851|NCT00373425|565594010|FG002|Overall Study|Adverse Event|59|||
156685852|NCT00373425|565594011|FG003|Overall Study|Adverse Event|0|||
156685853|NCT00373425|565594012|FG004|Overall Study|Adverse Event|34|||
156685854|NCT00373425|565594008|FG000|Overall Study|Patient request|35|||
156685855|NCT00373425|565594009|FG001|Overall Study|Patient request|18|||
156685856|NCT00373425|565594010|FG002|Overall Study|Patient request|43|||
156685857|NCT00373425|565594011|FG003|Overall Study|Patient request|6|||
156685858|NCT00373425|565594012|FG004|Overall Study|Patient request|7|||
156685859|NCT00373425|565594008|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
156685860|NCT00373425|565594009|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
156685861|NCT00373425|565594010|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
156685862|NCT00373425|565594011|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
156685863|NCT00373425|565594012|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
156685864|NCT00373425|565594008|FG000|Overall Study|Death|7|||
156685865|NCT00373425|565594009|FG001|Overall Study|Death|0|||
156685866|NCT00373425|565594010|FG002|Overall Study|Death|3|||
156685867|NCT00373425|565594011|FG003|Overall Study|Death|1|||
156685868|NCT00373425|565594012|FG004|Overall Study|Death|0|||
156685869|NCT02752802|565594013|FG000|Overall Study|Contrast Volume Not Collected|1|||
156685870|NCT02752802|565594014|FG001|Overall Study|Contrast Volume Not Collected|0|||
156685871|NCT02808819|565594015|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
156685872|NCT02808819|565594016|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
156685873|NCT02808819|565594015|FG000|Overall Study|Withdrawal by Subject|10|||
156685874|NCT02808819|565594016|FG001|Overall Study|Withdrawal by Subject|13|||
156685875|NCT02808819|565594015|FG000|Overall Study|Site terminated by sponsor|2|||
156685876|NCT02808819|565594016|FG001|Overall Study|Site terminated by sponsor|0|||
156685877|NCT02808819|565594015|FG000|Overall Study|Pregnancy|1|||
156685878|NCT02808819|565594016|FG001|Overall Study|Pregnancy|0|||
156685879|NCT02808819|565594015|FG000|Overall Study|Lost to Follow-up|1|||
156685880|NCT02808819|565594016|FG001|Overall Study|Lost to Follow-up|6|||
156685881|NCT02808819|565594015|FG000|Overall Study|Protocol Violation|0|||
156685882|NCT02808819|565594016|FG001|Overall Study|Protocol Violation|1|||
156685883|NCT02808819|565594015|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
156685884|NCT02808819|565594016|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
156685885|NCT02808819|565594015|FG000|Overall Study|Death|1|||
156685886|NCT02808819|565594016|FG001|Overall Study|Death|0|||
156685887|NCT02808819|565594015|FG000|Overall Study|Adverse Event|3|||
156685888|NCT02808819|565594016|FG001|Overall Study|Adverse Event|4|||
156685889|NCT02692482|565594017|FG000|Overall Study|Death|2|||
156685890|NCT02692482|565594018|FG001|Overall Study|Death|2|||
156685891|NCT02692482|565594017|FG000|Overall Study|Withdrawal by Subject|1|||
156685892|NCT02692482|565594018|FG001|Overall Study|Withdrawal by Subject|2|||
156685893|NCT04405739|565594023|FG000|Overall Study|Adverse Event|0|||
156685894|NCT04405739|565594024|FG001|Overall Study|Adverse Event|1|||
156685895|NCT04405739|565594025|FG002|Overall Study|Adverse Event|0|||
156685896|NCT04405739|565594026|FG003|Overall Study|Adverse Event|0|||
156685897|NCT04405739|565594023|FG000|Overall Study|Lost to Follow-up|0|||
156685898|NCT04405739|565594024|FG001|Overall Study|Lost to Follow-up|2|||
156685899|NCT04405739|565594025|FG002|Overall Study|Lost to Follow-up|1|||
156685900|NCT04405739|565594026|FG003|Overall Study|Lost to Follow-up|3|||
156685901|NCT04405739|565594023|FG000|Overall Study|Withdrawal by Subject|0|||
156685902|NCT04405739|565594024|FG001|Overall Study|Withdrawal by Subject|2|||
156685903|NCT04405739|565594025|FG002|Overall Study|Withdrawal by Subject|1|||
156685904|NCT04405739|565594026|FG003|Overall Study|Withdrawal by Subject|1|||
156685905|NCT04405739|565594023|FG000|Overall Study|Death|0|||
156685906|NCT04405739|565594024|FG001|Overall Study|Death|0|||
156685907|NCT04405739|565594025|FG002|Overall Study|Death|1|||
156685908|NCT04405739|565594026|FG003|Overall Study|Death|0|||
156685909|NCT04405739|565594023|FG000|Overall Study|Transferred to rehab|0|||
156685910|NCT04405739|565594024|FG001|Overall Study|Transferred to rehab|0|||
156685911|NCT04405739|565594025|FG002|Overall Study|Transferred to rehab|0|||
156685912|NCT04405739|565594026|FG003|Overall Study|Transferred to rehab|1|||
156685913|NCT04405739|565594023|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
156685914|NCT04405739|565594024|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
156685915|NCT04405739|565594025|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
156685916|NCT04405739|565594026|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
156685917|NCT01835548|565594029|FG000|Dose Optimization Period|Adverse Event|0|||
156685918|NCT01835548|565594030|FG001|Dose Optimization Period|Adverse Event|0|||
156685919|NCT01835548|565594031|FG002|Dose Optimization Period|Adverse Event|1|||
156685920|NCT01835548|565594029|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
156685921|NCT01835548|565594030|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
156685922|NCT01835548|565594031|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
156685923|NCT01835548|565594029|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156808730|NCT01396187|566054449|FG004|Overall Study|Adverse Event|0|||
156685924|NCT01835548|565594030|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156685925|NCT01835548|565594031|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156685926|NCT01835548|565594029|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156685927|NCT01835548|565594030|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156685928|NCT01835548|565594031|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156685929|NCT00576303|565594032|FG000|Dose Titration Period|Early withdrawal|17|||
156685930|NCT00576303|565594032|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
156685931|NCT00576303|565594032|FG000|Long Term Safety Period|Early withdrawal|16|||
156685932|NCT00824369|565594033|FG000|Overall Study|Nolonger willing to participate in study|1|||
156685933|NCT00824369|565594034|FG001|Overall Study|Nolonger willing to participate in study|0|||
156685934|NCT00824369|565594035|FG002|Overall Study|Nolonger willing to participate in study|1|||
156685935|NCT00824369|565594036|FG003|Overall Study|Nolonger willing to participate in study|2|||
156685936|NCT00824369|565594037|FG004|Overall Study|Nolonger willing to participate in study|0|||
156685937|NCT00824369|565594038|FG005|Overall Study|Nolonger willing to participate in study|1|||
156685938|NCT00824369|565594033|FG000|Overall Study|Lost to Follow-up|0|||
156685939|NCT00824369|565594034|FG001|Overall Study|Lost to Follow-up|0|||
156685940|NCT00824369|565594035|FG002|Overall Study|Lost to Follow-up|0|||
156685941|NCT00824369|565594036|FG003|Overall Study|Lost to Follow-up|0|||
156685942|NCT00824369|565594037|FG004|Overall Study|Lost to Follow-up|1|||
156685943|NCT00824369|565594038|FG005|Overall Study|Lost to Follow-up|0|||
156685944|NCT00442546|565594039|FG000|Overall Study|Adverse Event|11|||
156685945|NCT00442546|565594040|FG001|Overall Study|Adverse Event|17|||
156685946|NCT00442546|565594041|FG002|Overall Study|Adverse Event|13|||
156685947|NCT00442546|565594039|FG000|Overall Study|Lost to Follow-up|1|||
156685948|NCT00442546|565594040|FG001|Overall Study|Lost to Follow-up|2|||
156685949|NCT00442546|565594041|FG002|Overall Study|Lost to Follow-up|1|||
156685950|NCT00442546|565594039|FG000|Overall Study|Other|4|||
156685951|NCT00442546|565594040|FG001|Overall Study|Other|9|||
156685952|NCT00442546|565594041|FG002|Overall Study|Other|6|||
156685953|NCT00442546|565594039|FG000|Overall Study|Withdrawal by Subject|5|||
156785483|NCT01717859|565966376|FG000|Overall Study|Withdrawal by Subject|2|||
156785484|NCT02287025|565966378|FG000|Overall Study|Not treated|2|||
156785485|NCT02287025|565966379|FG001|Overall Study|Not treated|0|||
156785486|NCT02287025|565966378|FG000|Overall Study|Progression of disease|3|||
156785487|NCT02287025|565966379|FG001|Overall Study|Progression of disease|2|||
156785488|NCT02287025|565966378|FG000|Overall Study|Adverse Event|2|||
156785489|NCT02287025|565966379|FG001|Overall Study|Adverse Event|4|||
156785490|NCT02287025|565966378|FG000|Overall Study|Withdrawal by Subject|2|||
156785491|NCT02287025|565966379|FG001|Overall Study|Withdrawal by Subject|2|||
156785492|NCT02287025|565966378|FG000|Overall Study|Screening failed|1|||
156785493|NCT02287025|565966379|FG001|Overall Study|Screening failed|1|||
156785494|NCT00899847|565966380|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
156785495|NCT05987540|565966381|FG000|Overall Study|Withdrawal by Subject|2|||
156785496|NCT05987540|565966381|FG000|Overall Study|Death|1|||
156785497|NCT05987540|565966381|FG000|Overall Study|Study Termination|1|||
156785498|NCT05987540|565966381|FG000|Overall Study|Adverse Event|2|||
156785499|NCT04053452|565966382|FG000|Overall Study|Withdrawal by Subject|1|||
156785500|NCT04053452|565966383|FG001|Overall Study|Withdrawal by Subject|0|||
156785501|NCT04053452|565966382|FG000|Overall Study|Time restraint due to inpatient needs|1|||
156785502|NCT04053452|565966383|FG001|Overall Study|Time restraint due to inpatient needs|2|||
156785503|NCT01421134|565966384|FG000|Overall Study|Adverse Event|3|||
156785504|NCT01421134|565966385|FG001|Overall Study|Adverse Event|5|||
156785505|NCT01421134|565966384|FG000|Overall Study|Lack of Efficacy|2|||
156785506|NCT01421134|565966385|FG001|Overall Study|Lack of Efficacy|4|||
156785507|NCT01421134|565966384|FG000|Overall Study|Protocol Violation|0|||
156785508|NCT01421134|565966385|FG001|Overall Study|Protocol Violation|3|||
156785509|NCT01421134|565966384|FG000|Overall Study|Withdrawal by Subject|1|||
156785510|NCT01421134|565966385|FG001|Overall Study|Withdrawal by Subject|1|||
156785511|NCT01421134|565966384|FG000|Overall Study|Administrative|0|||
156436759|NCT00588770|564688642|FG001|Overall Study|Patient non-compliance|2|||
156436760|NCT04697628|564688643|FG000|Overall Study|Withdrawal by Subject|17|||
156436761|NCT04697628|564688644|FG001|Overall Study|Withdrawal by Subject|23|||
156436762|NCT04697628|564688643|FG000|Overall Study|Lost to Follow-up|0|||
156685954|NCT00442546|565594040|FG001|Overall Study|Withdrawal by Subject|5|||
156685955|NCT00442546|565594041|FG002|Overall Study|Withdrawal by Subject|7|||
156685956|NCT00442546|565594039|FG000|Overall Study|Randomized But Not Treated|5|||
156685957|NCT00442546|565594040|FG001|Overall Study|Randomized But Not Treated|4|||
156685958|NCT00442546|565594041|FG002|Overall Study|Randomized But Not Treated|6|||
156685959|NCT01557582|565594046|FG000|Overall Study|Protocol Violation|4|||
156685960|NCT01557582|565594046|FG000|Overall Study|Operator error|2|||
156685961|NCT02843659|565594047|FG000|Overall Study|Subject Withdrew Consent|0|||
156785512|NCT01421134|565966385|FG001|Overall Study|Administrative|1|||
156785513|NCT01421134|565966384|FG000|Overall Study|Lost to Follow-up|1|||
156785514|NCT01421134|565966385|FG001|Overall Study|Lost to Follow-up|1|||
156785515|NCT02959892|565966386|FG000|Overall Study|PET tracer synthesis failure|1|||
156785516|NCT02959892|565966387|FG001|Overall Study|PET tracer synthesis failure|0|||
156685962|NCT02843659|565594048|FG001|Overall Study|Subject Withdrew Consent|0|||
156685963|NCT02843659|565594049|FG002|Overall Study|Subject Withdrew Consent|1|||
156685964|NCT02843659|565594047|FG000|Overall Study|Administrative Reason by Sponsor|4|||
156685965|NCT02843659|565594048|FG001|Overall Study|Administrative Reason by Sponsor|5|||
156685966|NCT02843659|565594049|FG002|Overall Study|Administrative Reason by Sponsor|4|||
156685967|NCT02843659|565594047|FG000|Overall Study|Adverse Event|0|||
156685968|NCT02843659|565594048|FG001|Overall Study|Adverse Event|1|||
156685969|NCT02843659|565594049|FG002|Overall Study|Adverse Event|0|||
156685970|NCT03203642|565594050|FG000|Overall Study|Adverse Event|3|||
156685971|NCT03203642|565594051|FG001|Overall Study|Adverse Event|1|||
156685972|NCT03203642|565594050|FG000|Overall Study|Withdrawal by Subject|6|||
156436763|NCT04697628|564688644|FG001|Overall Study|Lost to Follow-up|4|||
156436764|NCT04697628|564688643|FG000|Overall Study|On-going in study|122|||
156436765|NCT04697628|564688644|FG001|Overall Study|On-going in study|91|||
156436766|NCT03388632|564688645|FG000|Triplet C|Clinical progression|0|||
156436767|NCT03388632|564688646|FG001|Triplet C|Clinical progression|0|||
156436768|NCT03388632|564688647|FG002|Triplet C|Clinical progression|0|||
156436769|NCT03388632|564688648|FG003|Triplet C|Clinical progression|0|||
156436770|NCT03388632|564688649|FG004|Triplet C|Clinical progression|1|||
156436771|NCT03388632|564688650|FG005|Triplet C|Clinical progression|0|||
156436772|NCT03388632|564688651|FG006|Triplet C|Clinical progression|0|||
156436773|NCT03388632|564688652|FG007|Triplet C|Clinical progression|0|||
156436774|NCT03388632|564688653|FG008|Triplet C|Clinical progression|0|||
156436775|NCT03388632|564688645|FG000|Triplet C|42-day lapse in tx|0|||
156436776|NCT03388632|564688646|FG001|Triplet C|42-day lapse in tx|0|||
156436777|NCT03388632|564688647|FG002|Triplet C|42-day lapse in tx|0|||
156436778|NCT03388632|564688648|FG003|Triplet C|42-day lapse in tx|0|||
156685973|NCT03203642|565594051|FG001|Overall Study|Withdrawal by Subject|6|||
156685974|NCT03203642|565594050|FG000|Overall Study|Lost to Follow-up|2|||
156685975|NCT03203642|565594051|FG001|Overall Study|Lost to Follow-up|1|||
156685976|NCT03203642|565594050|FG000|Overall Study|Termination of the study by sponsor|1|||
156685977|NCT03203642|565594051|FG001|Overall Study|Termination of the study by sponsor|1|||
156436779|NCT03388632|564688649|FG004|Triplet C|42-day lapse in tx|1|||
156436780|NCT03388632|564688650|FG005|Triplet C|42-day lapse in tx|0|||
156436781|NCT03388632|564688651|FG006|Triplet C|42-day lapse in tx|0|||
156436782|NCT03388632|564688652|FG007|Triplet C|42-day lapse in tx|0|||
156436783|NCT03388632|564688653|FG008|Triplet C|42-day lapse in tx|0|||
156436784|NCT03388632|564688645|FG000|Triplet C|Adverse Event|0|||
156436785|NCT03388632|564688646|FG001|Triplet C|Adverse Event|0|||
156436786|NCT03388632|564688647|FG002|Triplet C|Adverse Event|0|||
156436787|NCT03388632|564688648|FG003|Triplet C|Adverse Event|0|||
156436788|NCT03388632|564688649|FG004|Triplet C|Adverse Event|0|||
156436789|NCT03388632|564688650|FG005|Triplet C|Adverse Event|0|||
156436790|NCT03388632|564688651|FG006|Triplet C|Adverse Event|0|||
156436791|NCT03388632|564688652|FG007|Triplet C|Adverse Event|0|||
156436792|NCT03388632|564688653|FG008|Triplet C|Adverse Event|1|||
156436793|NCT03388632|564688645|FG000|Triplet C|Switched to alternative treatment|0|||
156436794|NCT03388632|564688646|FG001|Triplet C|Switched to alternative treatment|0|||
156436795|NCT03388632|564688647|FG002|Triplet C|Switched to alternative treatment|0|||
156436796|NCT03388632|564688648|FG003|Triplet C|Switched to alternative treatment|0|||
156436797|NCT03388632|564688649|FG004|Triplet C|Switched to alternative treatment|0|||
156436798|NCT03388632|564688650|FG005|Triplet C|Switched to alternative treatment|0|||
156436799|NCT03388632|564688651|FG006|Triplet C|Switched to alternative treatment|0|||
156436800|NCT03388632|564688652|FG007|Triplet C|Switched to alternative treatment|1|||
156436801|NCT03388632|564688653|FG008|Triplet C|Switched to alternative treatment|0|||
156436802|NCT03388632|564688645|FG000|Triplet C|Participant choice|0|||
156785517|NCT02959892|565966386|FG000|Overall Study|Study termination|0|||
156785518|NCT02959892|565966387|FG001|Overall Study|Study termination|1|||
156785519|NCT00122187|565966388|FG000|Overall Study|Withdrew because of resource limitations|2|||
156436803|NCT03388632|564688646|FG001|Triplet C|Participant choice|0|||
156785520|NCT00122187|565966389|FG001|Overall Study|Withdrew because of resource limitations|2|||
156785521|NCT02061592|565966393|FG000|Period 1|Withdrawal by Subject|1|||
156785522|NCT02061592|565966394|FG001|Period 1|Withdrawal by Subject|0|||
156785523|NCT02061592|565966393|FG000|Period 1|Protocol Violation|1|||
156436804|NCT03388632|564688647|FG002|Triplet C|Participant choice|0|||
156436805|NCT03388632|564688648|FG003|Triplet C|Participant choice|0|||
156436806|NCT03388632|564688649|FG004|Triplet C|Participant choice|0|||
156685978|NCT03203642|565594050|FG000|Overall Study|Participant moved|0|||
156685979|NCT03203642|565594051|FG001|Overall Study|Participant moved|1|||
156685980|NCT03203642|565594050|FG000|Overall Study|Investigator's decision|3|||
156685981|NCT03203642|565594051|FG001|Overall Study|Investigator's decision|0|||
156685982|NCT03203642|565594050|FG000|Overall Study|Other than above specified|0|||
156685983|NCT03203642|565594051|FG001|Overall Study|Other than above specified|1|||
156785524|NCT02061592|565966394|FG001|Period 1|Protocol Violation|0|||
156436807|NCT03388632|564688650|FG005|Triplet C|Participant choice|1|||
156436808|NCT03388632|564688651|FG006|Triplet C|Participant choice|0|||
156436809|NCT03388632|564688652|FG007|Triplet C|Participant choice|0|||
156436810|NCT03388632|564688653|FG008|Triplet C|Participant choice|0|||
156785525|NCT02061592|565966393|FG000|Period 2|Lost to Follow-up|0|||
156436811|NCT04108208|564688654|FG000|Overall Study|Withdrawal by Subject|2|||
156436812|NCT04108208|564688655|FG001|Overall Study|Withdrawal by Subject|6|||
156436813|NCT04108208|564688654|FG000|Overall Study|other-ongoing|20|||
156685984|NCT02413294|565594052|FG000|Overall Study|Withdrawal by Subject|1|||
156685985|NCT02688387|565596316|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685986|NCT02688387|565596317|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685987|NCT02688387|565596318|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
156685988|NCT02688387|565596319|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685989|NCT02688387|565596320|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685990|NCT02688387|565596321|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685991|NCT02688387|565596322|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685992|NCT02688387|565596323|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685993|NCT02688387|565596324|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685994|NCT02688387|565596325|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685995|NCT02688387|565596326|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685996|NCT02688387|565596327|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685997|NCT02688387|565596328|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685998|NCT02688387|565596329|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685999|NCT02688387|565596330|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686000|NCT02688387|565596331|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686001|NCT02688387|565596332|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686002|NCT02688387|565596333|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686003|NCT02688387|565596334|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686004|NCT02688387|565596335|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686005|NCT02688387|565596336|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686006|NCT02688387|565596337|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156785526|NCT02061592|565966394|FG001|Period 2|Lost to Follow-up|1|||
156785527|NCT04433975|565966395|FG000|1-month Follow Up|Withdrawal by Subject|1|||
156785528|NCT04433975|565966396|FG001|1-month Follow Up|Withdrawal by Subject|1|||
156785529|NCT04433975|565966395|FG000|1-month Follow Up|Lost to Follow-up|21|||
156785530|NCT04433975|565966396|FG001|1-month Follow Up|Lost to Follow-up|25|||
156329880|NCT00734474|564308717|FG007|Overall Study|Sponsor Decision|0|||
156329881|NCT00734474|564308718|FG008|Overall Study|Sponsor Decision|0|||
156329882|NCT00734474|564308710|FG000|Overall Study|Death|0|||
156329883|NCT00734474|564308711|FG001|Overall Study|Death|0|||
156329884|NCT00734474|564308712|FG002|Overall Study|Death|1|||
156329885|NCT00734474|564308713|FG003|Overall Study|Death|0|||
156329886|NCT00734474|564308714|FG004|Overall Study|Death|0|||
156329887|NCT00734474|564308715|FG005|Overall Study|Death|0|||
156329888|NCT00734474|564308716|FG006|Overall Study|Death|0|||
156329889|NCT00734474|564308717|FG007|Overall Study|Death|2|||
156329890|NCT00734474|564308718|FG008|Overall Study|Death|1|||
156329891|NCT00734474|564308710|FG000|Overall Study|Lack of Efficacy|0|||
156329892|NCT00734474|564308711|FG001|Overall Study|Lack of Efficacy|0|||
156329893|NCT00734474|564308712|FG002|Overall Study|Lack of Efficacy|4|||
156329894|NCT00734474|564308713|FG003|Overall Study|Lack of Efficacy|0|||
156329895|NCT00734474|564308714|FG004|Overall Study|Lack of Efficacy|0|||
156329896|NCT00734474|564308715|FG005|Overall Study|Lack of Efficacy|0|||
156329897|NCT00734474|564308716|FG006|Overall Study|Lack of Efficacy|0|||
156329898|NCT00734474|564308717|FG007|Overall Study|Lack of Efficacy|4|||
156329899|NCT00734474|564308718|FG008|Overall Study|Lack of Efficacy|6|||
156329900|NCT02104752|564308721|FG000|Overall Study|Withdrawal by Subject|1|||
156329901|NCT02104752|564308722|FG001|Overall Study|Withdrawal by Subject|0|||
156329902|NCT02104752|564308721|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
156329903|NCT02104752|564308722|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
156329904|NCT02899299|564308723|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
156329905|NCT02899299|564308724|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
156329906|NCT02899299|564308723|FG000|Pre-treatment|Participant withdrew consent|1|||
156329907|NCT02899299|564308724|FG001|Pre-treatment|Participant withdrew consent|11|||
156329908|NCT02899299|564308723|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
156329909|NCT02899299|564308724|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
156329910|NCT02899299|564308723|FG000|Pre-treatment|Not reported|0|||
156329911|NCT02899299|564308724|FG001|Pre-treatment|Not reported|1|||
156329912|NCT02899299|564308723|FG000|Treatment|Disease Progression|182|||
156329913|NCT02899299|564308724|FG001|Treatment|Disease Progression|43|||
156329914|NCT02899299|564308723|FG000|Treatment|Study Drug Toxicity|60|||
156329915|NCT02899299|564308724|FG001|Treatment|Study Drug Toxicity|24|||
156329916|NCT02899299|564308723|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
156436814|NCT04108208|564688655|FG001|Overall Study|other-ongoing|40|||
156329917|NCT02899299|564308724|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
156329918|NCT02899299|564308723|FG000|Treatment|Participant request to discontinue Study treatment|4|||
156329919|NCT02899299|564308724|FG001|Treatment|Participant request to discontinue Study treatment|10|||
156329920|NCT02899299|564308723|FG000|Treatment|Participant withdrew consent|6|||
156329921|NCT02899299|564308724|FG001|Treatment|Participant withdrew consent|3|||
156329922|NCT02899299|564308723|FG000|Treatment|Lost to Follow-up|0|||
156436815|NCT04108208|564688654|FG000|Overall Study|Death|1|||
156436816|NCT04108208|564688655|FG001|Overall Study|Death|4|||
156436817|NCT04108208|564688654|FG000|Overall Study|Lost to Follow-up|2|||
156436818|NCT04108208|564688655|FG001|Overall Study|Lost to Follow-up|0|||
156436819|NCT00997386|564688657|FG000|Overall Study|Death|7|||
156436820|NCT01350804|564688660|FG000|Core Study|Withdrawal by Subject|11|||
156436821|NCT01350804|564688661|FG001|Core Study|Withdrawal by Subject|17|||
156436822|NCT01350804|564688662|FG002|Core Study|Withdrawal by Subject|16|||
156436823|NCT01350804|564688663|FG003|Core Study|Withdrawal by Subject|7|||
156436824|NCT01350804|564688660|FG000|Core Study|Study terminated by Sponsor|0|||
156436825|NCT01350804|564688661|FG001|Core Study|Study terminated by Sponsor|0|||
156436826|NCT01350804|564688662|FG002|Core Study|Study terminated by Sponsor|0|||
156436827|NCT01350804|564688663|FG003|Core Study|Study terminated by Sponsor|2|||
156436828|NCT01350804|564688660|FG000|Core Study|Protocol deviation|1|||
156436829|NCT01350804|564688661|FG001|Core Study|Protocol deviation|0|||
156436830|NCT01350804|564688662|FG002|Core Study|Protocol deviation|1|||
156436831|NCT01350804|564688663|FG003|Core Study|Protocol deviation|0|||
156436832|NCT01350804|564688660|FG000|Core Study|Physician Decision|1|||
156436833|NCT01350804|564688661|FG001|Core Study|Physician Decision|0|||
156436834|NCT01350804|564688662|FG002|Core Study|Physician Decision|1|||
156436835|NCT01350804|564688663|FG003|Core Study|Physician Decision|3|||
156436836|NCT01350804|564688660|FG000|Core Study|Lost to Follow-up|3|||
156436837|NCT01350804|564688661|FG001|Core Study|Lost to Follow-up|0|||
156436838|NCT01350804|564688662|FG002|Core Study|Lost to Follow-up|2|||
156436839|NCT01350804|564688663|FG003|Core Study|Lost to Follow-up|1|||
156436840|NCT01350804|564688660|FG000|Core Study|Lack of Efficacy|16|||
156436841|NCT01350804|564688661|FG001|Core Study|Lack of Efficacy|19|||
156436842|NCT01350804|564688662|FG002|Core Study|Lack of Efficacy|18|||
156436843|NCT01350804|564688663|FG003|Core Study|Lack of Efficacy|5|||
156436844|NCT01350804|564688660|FG000|Core Study|Death|1|||
156436845|NCT01350804|564688661|FG001|Core Study|Death|1|||
156436846|NCT01350804|564688662|FG002|Core Study|Death|1|||
156436847|NCT01350804|564688663|FG003|Core Study|Death|0|||
156436848|NCT01350804|564688660|FG000|Core Study|Adverse Event|8|||
156436849|NCT01350804|564688661|FG001|Core Study|Adverse Event|10|||
156436850|NCT01350804|564688662|FG002|Core Study|Adverse Event|8|||
156436851|NCT01350804|564688663|FG003|Core Study|Adverse Event|8|||
156436852|NCT01350804|564688660|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
156436853|NCT01350804|564688661|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
156436854|NCT01350804|564688662|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
156686007|NCT02688387|565596316|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686008|NCT02688387|565596317|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686009|NCT02688387|565596318|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686010|NCT02688387|565596319|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
156686011|NCT02688387|565596320|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686012|NCT02688387|565596321|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686013|NCT02688387|565596322|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686014|NCT02688387|565596323|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686015|NCT02688387|565596324|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686016|NCT02688387|565596325|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686017|NCT02688387|565596326|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686018|NCT02688387|565596327|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686019|NCT02688387|565596328|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686020|NCT02688387|565596329|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686021|NCT02688387|565596330|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686022|NCT02688387|565596331|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686023|NCT02688387|565596332|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686024|NCT02688387|565596333|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686025|NCT02688387|565596334|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686026|NCT02688387|565596335|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156868577|NCT00865566|566277332|FG000|Overall Study|Lost to Follow-up|314|||
156868578|NCT00865566|566277333|FG001|Overall Study|Lost to Follow-up|315|||
156436855|NCT01350804|564688663|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
156436856|NCT01350804|564688660|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
156436857|NCT01350804|564688661|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
156436858|NCT01350804|564688662|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
156436859|NCT01350804|564688663|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
156436860|NCT01350804|564688660|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
156436861|NCT01350804|564688661|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
156436862|NCT01350804|564688662|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
156436863|NCT01350804|564688663|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
156436864|NCT01350804|564688660|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
156436865|NCT01350804|564688661|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
156436866|NCT01350804|564688662|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
156530266|NCT03026127|565036357|FG002|CRISP R61|Dropped before therapy|0|||
156530267|NCT03026127|565036355|FG000|CRISP R33|Lost to Follow-up|0|||
156530268|NCT03026127|565036356|FG001|CRISP R33|Lost to Follow-up|5|||
156530269|NCT03026127|565036357|FG002|CRISP R33|Lost to Follow-up|4|||
156530270|NCT03026127|565036355|FG000|CRISP R33|Adverse Event|0|||
156530271|NCT03026127|565036356|FG001|CRISP R33|Adverse Event|9|||
156530272|NCT03026127|565036357|FG002|CRISP R33|Adverse Event|5|||
156530273|NCT03026127|565036355|FG000|CRISP R33|Withdrawal by Subject|0|||
156530274|NCT03026127|565036356|FG001|CRISP R33|Withdrawal by Subject|9|||
156530275|NCT03026127|565036357|FG002|CRISP R33|Withdrawal by Subject|1|||
156530276|NCT03026127|565036355|FG000|CRISP R33|Lack of Efficacy|0|||
156530277|NCT03026127|565036356|FG001|CRISP R33|Lack of Efficacy|3|||
156530278|NCT03026127|565036357|FG002|CRISP R33|Lack of Efficacy|2|||
156530279|NCT03026127|565036355|FG000|CRISP R33|Physician Decision|0|||
156530280|NCT03026127|565036356|FG001|CRISP R33|Physician Decision|3|||
156785531|NCT04433975|565966395|FG000|3-month Follow Up|Lost to Follow-up|20|||
156785532|NCT04433975|565966396|FG001|3-month Follow Up|Lost to Follow-up|24|||
156785533|NCT04433975|565966395|FG000|3-month Follow Up|Death|1|||
156785534|NCT04433975|565966396|FG001|3-month Follow Up|Death|0|||
156785535|NCT04433975|565966395|FG000|3-month Follow Up|Withdrawal by Subject|2|||
156785536|NCT04433975|565966396|FG001|3-month Follow Up|Withdrawal by Subject|0|||
156785537|NCT04433975|565966395|FG000|6-month Follow Up|Lost to Follow-up|23|||
156785538|NCT04433975|565966396|FG001|6-month Follow Up|Lost to Follow-up|28|||
156785539|NCT04433975|565966395|FG000|6-month Follow Up|Withdrawal by Subject|1|||
156785540|NCT04433975|565966396|FG001|6-month Follow Up|Withdrawal by Subject|1|||
156785541|NCT04433975|565966395|FG000|9-month Follow Up|Lost to Follow-up|27|||
156785542|NCT04433975|565966396|FG001|9-month Follow Up|Lost to Follow-up|36|||
156785543|NCT04433975|565966395|FG000|9-month Follow Up|Death|0|||
156785544|NCT04433975|565966396|FG001|9-month Follow Up|Death|1|||
156785545|NCT04433975|565966395|FG000|12-month Follow Up|Lost to Follow-up|27|||
156329923|NCT02899299|564308724|FG001|Treatment|Lost to Follow-up|2|||
156329924|NCT02899299|564308723|FG000|Treatment|Maximum Clinical Benefit|11|||
156329925|NCT02899299|564308724|FG001|Treatment|Maximum Clinical Benefit|2|||
156329926|NCT02899299|564308723|FG000|Treatment|Poor/Non-compliance|1|||
156329927|NCT02899299|564308724|FG001|Treatment|Poor/Non-compliance|0|||
156329928|NCT02899299|564308723|FG000|Treatment|Participant no longer meets Study criteria|4|||
156329929|NCT02899299|564308724|FG001|Treatment|Participant no longer meets Study criteria|0|||
156329930|NCT02899299|564308723|FG000|Treatment|Administrative reason by Sponsor|2|||
156329931|NCT02899299|564308724|FG001|Treatment|Administrative reason by Sponsor|0|||
156329932|NCT02899299|564308723|FG000|Treatment|Other reasons|12|||
156329933|NCT02899299|564308724|FG001|Treatment|Other reasons|2|||
156329934|NCT02899299|564308723|FG000|Treatment|Not reported|7|||
156329935|NCT02899299|564308724|FG001|Treatment|Not reported|0|||
156329936|NCT00428792|564308725|FG000|Overall Study|Lack of Efficacy|1|||
156329937|NCT00428792|564308726|FG001|Overall Study|Lack of Efficacy|3|||
156329938|NCT00428792|564308725|FG000|Overall Study|Lost to Follow-up|0|||
156329939|NCT00428792|564308726|FG001|Overall Study|Lost to Follow-up|1|||
156329940|NCT04612790|564308727|FG000|DB Period (Up to 36 Weeks)|Death|1|||
156329941|NCT04612790|564308728|FG001|DB Period (Up to 36 Weeks)|Death|1|||
156329942|NCT04612790|564308729|FG002|DB Period (Up to 36 Weeks)|Death|0|||
156329943|NCT04612790|564308730|FG003|DB Period (Up to 36 Weeks)|Death|0|||
156329944|NCT04612790|564308727|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
156329945|NCT04612790|564308728|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
156329946|NCT04612790|564308729|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
156329947|NCT04612790|564308730|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
156329948|NCT04612790|564308727|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
156329949|NCT04612790|564308728|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
156329950|NCT04612790|564308729|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
156329951|NCT04612790|564308730|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
156329952|NCT04612790|564308727|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
156329953|NCT04612790|564308728|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
156329954|NCT04612790|564308729|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
156329955|NCT04612790|564308730|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
156329956|NCT04612790|564308727|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
156329957|NCT04612790|564308728|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
156329958|NCT04612790|564308729|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
156329959|NCT04612790|564308730|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
156329960|NCT04612790|564308727|FG000|DB Period (Up to 36 Weeks)|Other|1|||
156329961|NCT04612790|564308728|FG001|DB Period (Up to 36 Weeks)|Other|0|||
156329962|NCT04612790|564308729|FG002|DB Period (Up to 36 Weeks)|Other|0|||
156329963|NCT04612790|564308730|FG003|DB Period (Up to 36 Weeks)|Other|0|||
156530281|NCT03026127|565036357|FG002|CRISP R33|Physician Decision|1|||
156329964|NCT04612790|564308727|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
156785546|NCT04433975|565966396|FG001|12-month Follow Up|Lost to Follow-up|31|||
156785547|NCT04392635|565966401|FG000|Overall Study|Lost to Follow-up|0|||
156785548|NCT04392635|565966402|FG001|Overall Study|Lost to Follow-up|1|||
156785549|NCT00724893|565966407|FG000|Overall Study|Adverse Event|76|||
156436867|NCT01350804|564688663|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
156436868|NCT01350804|564688660|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
156436869|NCT01350804|564688661|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
156436870|NCT01350804|564688662|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
156436871|NCT01350804|564688663|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
156436872|NCT01350804|564688660|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
156436873|NCT01350804|564688661|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
156436874|NCT01350804|564688662|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
156436875|NCT01350804|564688663|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
156436876|NCT01241292|564689148|FG000|Overall Study|Administrative Reason by Sponsor|1|||
156436877|NCT01241292|564689149|FG001|Overall Study|Administrative Reason by Sponsor|0|||
156436878|NCT01241292|564689148|FG000|Overall Study|Disease Progression|2|||
156436879|NCT01241292|564689149|FG001|Overall Study|Disease Progression|0|||
156436880|NCT01241292|564689148|FG000|Overall Study|Study Drug Toxicity|0|||
156686027|NCT02688387|565596336|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686028|NCT02688387|565596337|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686029|NCT02688387|565596316|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686030|NCT02688387|565596317|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
156686031|NCT02688387|565596318|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686032|NCT02688387|565596319|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686033|NCT02688387|565596320|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156868579|NCT00865566|566277332|FG000|Overall Study|Withdrawal by Subject|45|||
156868580|NCT00865566|566277333|FG001|Overall Study|Withdrawal by Subject|65|||
156868581|NCT00865566|566277332|FG000|Overall Study|Physician Decision|0|||
156868582|NCT00865566|566277333|FG001|Overall Study|Physician Decision|1|||
156868583|NCT00865566|566277332|FG000|Overall Study|Participant relocated|78|||
156868584|NCT00865566|566277333|FG001|Overall Study|Participant relocated|107|||
156868585|NCT00865566|566277332|FG000|Overall Study|Participant unable to adhere|27|||
156868586|NCT00865566|566277333|FG001|Overall Study|Participant unable to adhere|42|||
156868587|NCT00865566|566277332|FG000|Overall Study|Other; N=245 due to early study closure|154|||
156868588|NCT00865566|566277333|FG001|Overall Study|Other; N=245 due to early study closure|139|||
156868589|NCT00865566|566277332|FG000|Overall Study|HIV infection|5|||
156868590|NCT00865566|566277333|FG001|Overall Study|HIV infection|7|||
156868591|NCT02054104|566277338|FG000|Overall Study|Did not want to continue due to college classes|1|||
156868592|NCT02054104|566277339|FG001|Overall Study|Did not want to continue due to college classes|0|||
156868593|NCT02054104|566277338|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
156868594|NCT02054104|566277339|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
156868595|NCT02054104|566277338|FG000|Overall Study|No evidence of immunologic response|2|||
156868596|NCT02054104|566277339|FG001|Overall Study|No evidence of immunologic response|2|||
156868597|NCT02054104|566277338|FG000|Overall Study|Disease Progression On Study|4|||
156436881|NCT01241292|564689149|FG001|Overall Study|Study Drug Toxicity|1|||
156686034|NCT02688387|565596321|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686035|NCT02688387|565596322|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156785550|NCT00724893|565966408|FG001|Overall Study|Adverse Event|142|||
156785551|NCT00724893|565966407|FG000|Overall Study|Withdrawal by Subject|0|||
156785552|NCT00724893|565966408|FG001|Overall Study|Withdrawal by Subject|1|||
156785553|NCT00724893|565966407|FG000|Overall Study|Lack of virologic response|94|||
156785554|NCT00724893|565966408|FG001|Overall Study|Lack of virologic response|202|||
156785555|NCT00724893|565966407|FG000|Overall Study|Reason not specified|193|||
156785556|NCT00724893|565966408|FG001|Overall Study|Reason not specified|7|||
156785557|NCT00724893|565966407|FG000|Overall Study|Patient choice|0|||
156785558|NCT00724893|565966408|FG001|Overall Study|Patient choice|26|||
156785559|NCT00724893|565966407|FG000|Overall Study|Geographic reasons|0|||
156785560|NCT00724893|565966408|FG001|Overall Study|Geographic reasons|11|||
156785561|NCT00724893|565966407|FG000|Overall Study|Incarceration|0|||
156785562|NCT00724893|565966408|FG001|Overall Study|Incarceration|9|||
156785563|NCT00724893|565966407|FG000|Overall Study|Substance abuse|0|||
156785564|NCT00724893|565966408|FG001|Overall Study|Substance abuse|3|||
156785565|NCT00724893|565966407|FG000|Overall Study|Financial reasons|0|||
156785566|NCT00724893|565966408|FG001|Overall Study|Financial reasons|2|||
156785567|NCT00724893|565966407|FG000|Overall Study|Assigned shorter treatment|0|||
156785568|NCT00724893|565966408|FG001|Overall Study|Assigned shorter treatment|2|||
156785569|NCT00724893|565966407|FG000|Overall Study|Lost to Follow-up|0|||
156436882|NCT01241292|564689148|FG000|Overall Study|Participant Discontinued Treatment|0|||
156530282|NCT03026127|565036355|FG000|CRISP R33|Transportation|0|||
156785570|NCT00724893|565966408|FG001|Overall Study|Lost to Follow-up|52|||
156868598|NCT02054104|566277339|FG001|Overall Study|Disease Progression On Study|5|||
156436883|NCT01241292|564689149|FG001|Overall Study|Participant Discontinued Treatment|2|||
156530283|NCT03026127|565036356|FG001|CRISP R33|Transportation|2|||
156785571|NCT00724893|565966407|FG000|Overall Study|Unknown, missing data|1|||
156785572|NCT00724893|565966408|FG001|Overall Study|Unknown, missing data|1|||
156785573|NCT01290731|565966411|FG000|Overall Study|Withdrawal by Subject|1|||
156686036|NCT02688387|565596323|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686037|NCT02688387|565596324|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686038|NCT02688387|565596325|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686039|NCT02688387|565596326|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686040|NCT02688387|565596327|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686041|NCT02688387|565596328|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686042|NCT02688387|565596329|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686043|NCT02688387|565596330|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686044|NCT02688387|565596331|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686045|NCT02688387|565596332|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686046|NCT02688387|565596333|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156785574|NCT01279200|565966416|FG000|Overall Study|Withdrawal by Subject|1|||
156785575|NCT01279200|565966417|FG001|Overall Study|Withdrawal by Subject|3|||
156785576|NCT01279200|565966416|FG000|Overall Study|Patient withdrawal due to high cost|0|||
156785577|NCT01279200|565966417|FG001|Overall Study|Patient withdrawal due to high cost|1|||
156785578|NCT01279200|565966416|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
156785579|NCT01279200|565966417|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
156785580|NCT01279200|565966416|FG000|Overall Study|ultrasound screening failure|0|||
156785581|NCT01279200|565966417|FG001|Overall Study|ultrasound screening failure|1|||
156785582|NCT01279200|565966416|FG000|Overall Study|Lost to Follow-up|0|||
156785583|NCT01279200|565966417|FG001|Overall Study|Lost to Follow-up|1|||
156785584|NCT01279200|565966416|FG000|Overall Study|Adverse Event|1|||
156785585|NCT01279200|565966417|FG001|Overall Study|Adverse Event|0|||
156785586|NCT01399099|565966418|FG000|Overall Study|Lost to Follow-up|14|||
156785587|NCT01399099|565966418|FG000|Overall Study|Physician Decision|1|||
156785588|NCT01399099|565966418|FG000|Overall Study|Protocol Violation|1|||
156785589|NCT01399099|565966418|FG000|Overall Study|Skin Irritation|13|||
156785590|NCT01399099|565966418|FG000|Overall Study|Infection|1|||
156785591|NCT01399099|565966418|FG000|Overall Study|Miscellaneous|4|||
156785592|NCT02181738|565966419|FG000|Overall Study|Participant Withdrew Consent|2|||
156785593|NCT02181738|565966420|FG001|Overall Study|Participant Withdrew Consent|1|||
156785594|NCT02181738|565966421|FG002|Overall Study|Participant Withdrew Consent|1|||
156785595|NCT02181738|565966422|FG003|Overall Study|Participant Withdrew Consent|1|||
156785596|NCT02181738|565966419|FG000|Overall Study|Lost to Follow-up|1|||
156785597|NCT02181738|565966420|FG001|Overall Study|Lost to Follow-up|2|||
156785598|NCT02181738|565966421|FG002|Overall Study|Lost to Follow-up|1|||
156785599|NCT02181738|565966422|FG003|Overall Study|Lost to Follow-up|1|||
156785600|NCT02181738|565966419|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
156785601|NCT02181738|565966420|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
156785602|NCT02181738|565966421|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
156785603|NCT02181738|565966422|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
156785604|NCT02181738|565966419|FG000|Overall Study|Poor/Non-Compliance|1|||
156785605|NCT02181738|565966420|FG001|Overall Study|Poor/Non-Compliance|0|||
156785606|NCT02181738|565966421|FG002|Overall Study|Poor/Non-Compliance|2|||
156785607|NCT02181738|565966422|FG003|Overall Study|Poor/Non-Compliance|1|||
156785608|NCT02181738|565966419|FG000|Overall Study|Disease Progression|28|||
156785609|NCT02181738|565966420|FG001|Overall Study|Disease Progression|35|||
156785610|NCT02181738|565966421|FG002|Overall Study|Disease Progression|40|||
156785611|NCT02181738|565966422|FG003|Overall Study|Disease Progression|0|||
156785612|NCT02181738|565966419|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
156785613|NCT02181738|565966420|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
156785614|NCT02181738|565966421|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
156785615|NCT02181738|565966422|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
156785616|NCT02181738|565966419|FG000|Overall Study|Study Drug Toxicity|6|||
156785617|NCT02181738|565966420|FG001|Overall Study|Study Drug Toxicity|11|||
156785618|NCT02181738|565966421|FG002|Overall Study|Study Drug Toxicity|8|||
156785619|NCT02181738|565966422|FG003|Overall Study|Study Drug Toxicity|1|||
156785620|NCT02181738|565966419|FG000|Overall Study|Other Reasons|14|||
156785621|NCT02181738|565966420|FG001|Overall Study|Other Reasons|16|||
156785622|NCT02181738|565966421|FG002|Overall Study|Other Reasons|28|||
156785623|NCT02181738|565966422|FG003|Overall Study|Other Reasons|0|||
156785624|NCT02181738|565966419|FG000|Overall Study|Maximum Clinical Benefit|3|||
156785625|NCT02181738|565966420|FG001|Overall Study|Maximum Clinical Benefit|0|||
156785626|NCT02181738|565966421|FG002|Overall Study|Maximum Clinical Benefit|1|||
156785627|NCT02181738|565966422|FG003|Overall Study|Maximum Clinical Benefit|0|||
156785628|NCT02181738|565966419|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
156785629|NCT02181738|565966420|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
156785630|NCT02181738|565966421|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
156785631|NCT02181738|565966422|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156785632|NCT01668537|565966423|FG000|Overall Study|Request to Discontinue Prematurely|1|||
156785633|NCT01668537|565966424|FG001|Overall Study|Request to Discontinue Prematurely|1|||
156868599|NCT02054104|566277338|FG000|Overall Study|Diagnosis of lymphoma|0|||
156868600|NCT02054104|566277339|FG001|Overall Study|Diagnosis of lymphoma|1|||
156868601|NCT02054104|566277338|FG000|Overall Study|Inconclusive response|0|||
156868602|NCT02054104|566277339|FG001|Overall Study|Inconclusive response|1|||
156868603|NCT02404025|566277340|FG000|Overall Study|Adverse Event|1|||
156686047|NCT02688387|565596334|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686048|NCT02688387|565596335|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686049|NCT02688387|565596336|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686050|NCT02688387|565596337|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686051|NCT02688387|565596316|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686052|NCT02688387|565596317|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686053|NCT02688387|565596318|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
156686054|NCT02688387|565596319|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686055|NCT02688387|565596320|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
156686056|NCT02688387|565596321|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686057|NCT02688387|565596322|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686058|NCT02688387|565596323|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686059|NCT02688387|565596324|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686060|NCT02688387|565596325|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686061|NCT02688387|565596326|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686062|NCT02688387|565596327|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686063|NCT02688387|565596328|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686064|NCT02688387|565596329|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686065|NCT02688387|565596330|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686066|NCT02688387|565596331|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686067|NCT02688387|565596332|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686068|NCT02688387|565596333|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686069|NCT02688387|565596334|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686070|NCT02688387|565596335|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156868604|NCT02404025|566277340|FG000|Overall Study|Lack of Efficacy|3|||
156868605|NCT00098813|566277341|FG000|Overall Study|Death|8|||
156868606|NCT00098813|566277341|FG000|Overall Study|Protocol Violation|1|||
156868607|NCT00098813|566277341|FG000|Overall Study|Withdrawal by Subject|7|||
156868608|NCT00098813|566277341|FG000|Overall Study|Progression of Disease|1|||
156868609|NCT00098813|566277341|FG000|Overall Study|Other complicating disease|1|||
156868610|NCT00098813|566277341|FG000|Overall Study|Reversal of RAI resistance|1|||
156868611|NCT02230670|566277342|FG000|Overall Study|Adverse Event|1|||
156868612|NCT02230670|566277343|FG001|Overall Study|Adverse Event|2|||
156868613|NCT02230670|566277342|FG000|Overall Study|Withdrawal by Subject|2|||
156868614|NCT02230670|566277343|FG001|Overall Study|Withdrawal by Subject|2|||
156868615|NCT02230670|566277342|FG000|Overall Study|Physician Decision|0|||
156868616|NCT02230670|566277343|FG001|Overall Study|Physician Decision|1|||
156868617|NCT02230670|566277342|FG000|Overall Study|Protocol Violation|0|||
156868618|NCT02230670|566277343|FG001|Overall Study|Protocol Violation|1|||
156868619|NCT02230670|566277342|FG000|Overall Study|Progression to Child-Pugh C|1|||
156868620|NCT02230670|566277343|FG001|Overall Study|Progression to Child-Pugh C|2|||
156868621|NCT01907854|566277348|FG000|Overall Study|Protocol Violation|1|||
156686071|NCT02688387|565596336|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686072|NCT02688387|565596337|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686073|NCT02688387|565596316|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
156686074|NCT02688387|565596317|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686075|NCT02688387|565596318|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686076|NCT02688387|565596319|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686077|NCT02688387|565596320|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686078|NCT02688387|565596321|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686079|NCT02688387|565596322|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686080|NCT02688387|565596323|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156868622|NCT01907854|566277349|FG001|Overall Study|Protocol Violation|1|||
156868623|NCT01907854|566277348|FG000|Overall Study|Withdrawal by Subject|9|||
156530284|NCT03026127|565036357|FG002|CRISP R33|Transportation|1|||
156868624|NCT01907854|566277349|FG001|Overall Study|Withdrawal by Subject|7|||
156868625|NCT01907854|566277348|FG000|Overall Study|Lost to Follow-up|2|||
156868626|NCT01907854|566277349|FG001|Overall Study|Lost to Follow-up|2|||
156868627|NCT01907854|566277348|FG000|Overall Study|Unclassified|4|||
156868628|NCT01907854|566277349|FG001|Overall Study|Unclassified|3|||
156868629|NCT00892099|566277350|FG000|Overall Study|Death|1|||
156868630|NCT00892099|566277351|FG001|Overall Study|Death|0|||
156868631|NCT00892099|566277352|FG002|Overall Study|Death|1|||
156785634|NCT01668537|565966423|FG000|Overall Study|Subject unwilling/unable to comply|5|||
156785635|NCT01668537|565966424|FG001|Overall Study|Subject unwilling/unable to comply|0|||
156785636|NCT01668537|565966423|FG000|Overall Study|Reason Precludes Participation|1|||
156785637|NCT01668537|565966424|FG001|Overall Study|Reason Precludes Participation|0|||
156785638|NCT01668537|565966423|FG000|Overall Study|Lost to Follow-up|13|||
156785639|NCT01668537|565966424|FG001|Overall Study|Lost to Follow-up|6|||
156785640|NCT01668537|565966423|FG000|Overall Study|Other|2|||
156785641|NCT01668537|565966424|FG001|Overall Study|Other|3|||
156785642|NCT01149538|565966425|FG000|Overall Study|Lost to Follow-up|0|||
156785643|NCT01149538|565966426|FG001|Overall Study|Lost to Follow-up|1|||
156785644|NCT01149538|565966425|FG000|Overall Study|Withdrawal by Subject|5|||
156785645|NCT01149538|565966426|FG001|Overall Study|Withdrawal by Subject|3|||
156785646|NCT00888849|565966427|FG000|Overall Study|Death|4|||
156785647|NCT00888849|565966428|FG001|Overall Study|Death|7|||
156785648|NCT00888849|565966427|FG000|Overall Study|Lost to Follow-up|1|||
156785649|NCT00888849|565966428|FG001|Overall Study|Lost to Follow-up|2|||
156785650|NCT00629239|565966429|FG000|Overall Study|Adverse Event|7|||
156785651|NCT00629239|565966430|FG001|Overall Study|Adverse Event|4|||
156785652|NCT00629239|565966429|FG000|Overall Study|Physician Decision|1|||
156785653|NCT00629239|565966430|FG001|Overall Study|Physician Decision|0|||
156785654|NCT01851369|565966431|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785655|NCT01851369|565966432|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785656|NCT01851369|565966433|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785657|NCT01851369|565966434|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785658|NCT01851369|565966435|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785659|NCT01851369|565966436|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
156785660|NCT01851369|565966437|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785661|NCT01851369|565966438|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785662|NCT01851369|565966439|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785663|NCT01851369|565966440|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785664|NCT01851369|565966441|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785665|NCT01851369|565966442|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785666|NCT01851369|565966443|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785667|NCT00567112|565966451|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
156785668|NCT00567112|565966452|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
156785669|NCT00567112|565966453|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
156785670|NCT00567112|565966451|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
156785671|NCT00567112|565966452|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
156785672|NCT00567112|565966453|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
156785673|NCT00567112|565966451|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
156785674|NCT00567112|565966452|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
156785675|NCT00567112|565966453|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
156785676|NCT01740427|565966454|FG000|Overall Study|Objective Progression or Relapse|286|||
156785677|NCT01740427|565966455|FG001|Overall Study|Objective Progression or Relapse|172|||
156785678|NCT01740427|565966454|FG000|Overall Study|Adverse Event|32|||
156785679|NCT01740427|565966455|FG001|Overall Study|Adverse Event|9|||
156785680|NCT01740427|565966454|FG000|Overall Study|Global Deterioration of Health Status|28|||
156785681|NCT01740427|565966455|FG001|Overall Study|Global Deterioration of Health Status|12|||
156785682|NCT01740427|565966454|FG000|Overall Study|Participant Refused Continued Treatment|27|||
156785683|NCT01740427|565966455|FG001|Overall Study|Participant Refused Continued Treatment|15|||
156785684|NCT01740427|565966454|FG000|Overall Study|Unspecified reasons|52|||
156785685|NCT01740427|565966455|FG001|Overall Study|Unspecified reasons|8|||
156785686|NCT01740427|565966454|FG000|Overall Study|Death|10|||
156785687|NCT01740427|565966455|FG001|Overall Study|Death|3|||
156785688|NCT01740427|565966454|FG000|Overall Study|Protocol Violation|5|||
156785689|NCT01740427|565966455|FG001|Overall Study|Protocol Violation|3|||
156785690|NCT01740427|565966454|FG000|Overall Study|Lost to Follow-up|3|||
156785691|NCT01740427|565966455|FG001|Overall Study|Lost to Follow-up|0|||
156785692|NCT01740427|565966454|FG000|Overall Study|Site Terminated by Sponsor|1|||
156785693|NCT01740427|565966455|FG001|Overall Study|Site Terminated by Sponsor|0|||
156785694|NCT04796207|565966458|FG000|Overall Study|Lost to Follow-up|7|||
156785695|NCT04796207|565966459|FG001|Overall Study|Lost to Follow-up|2|||
156785696|NCT01860989|565966462|FG000|Overall Study|Unsatisfactory therapeutic|5|||
156785697|NCT04739709|565966465|FG000|Overall Study|Physician Decision|1|||
156785698|NCT04739709|565966466|FG001|Overall Study|Physician Decision|0|||
156785699|NCT03003468|565966467|FG000|Overall Study|Withdrawal by Subject|0|||
156785700|NCT03003468|565966468|FG001|Overall Study|Withdrawal by Subject|0|||
156785701|NCT03003468|565966469|FG002|Overall Study|Withdrawal by Subject|1|||
156785702|NCT03003468|565966467|FG000|Overall Study|No measurable lesions|0|||
156785703|NCT03003468|565966468|FG001|Overall Study|No measurable lesions|0|||
156785704|NCT03003468|565966469|FG002|Overall Study|No measurable lesions|1|||
156686081|NCT02688387|565596324|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686082|NCT02688387|565596325|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686083|NCT02688387|565596326|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686084|NCT02688387|565596327|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156868632|NCT00892099|566277350|FG000|Overall Study|Adverse Event|1|||
156868633|NCT00892099|566277351|FG001|Overall Study|Adverse Event|0|||
156868634|NCT00892099|566277352|FG002|Overall Study|Adverse Event|0|||
156868635|NCT00892099|566277350|FG000|Overall Study|replocated|1|||
156868636|NCT00892099|566277351|FG001|Overall Study|replocated|0|||
156868637|NCT00892099|566277352|FG002|Overall Study|replocated|2|||
156868638|NCT00892099|566277350|FG000|Overall Study|Prolonged hospitalization|1|||
156868639|NCT00892099|566277351|FG001|Overall Study|Prolonged hospitalization|0|||
156868640|NCT00892099|566277352|FG002|Overall Study|Prolonged hospitalization|1|||
156868641|NCT00892099|566277350|FG000|Overall Study|no further details|1|||
156868642|NCT00892099|566277351|FG001|Overall Study|no further details|0|||
156868643|NCT00892099|566277352|FG002|Overall Study|no further details|1|||
156868644|NCT00892099|566277350|FG000|Overall Study|kidney function recovered|0|||
156868645|NCT00892099|566277351|FG001|Overall Study|kidney function recovered|1|||
156868646|NCT00892099|566277352|FG002|Overall Study|kidney function recovered|0|||
156868647|NCT00892099|566277350|FG000|Overall Study|investigator decision|0|||
156868648|NCT00892099|566277351|FG001|Overall Study|investigator decision|0|||
156868649|NCT00892099|566277352|FG002|Overall Study|investigator decision|1|||
156868650|NCT00892099|566277350|FG000|Overall Study|Lost to Follow-up|0|||
156868651|NCT00892099|566277351|FG001|Overall Study|Lost to Follow-up|0|||
156868652|NCT00892099|566277352|FG002|Overall Study|Lost to Follow-up|1|||
156868653|NCT02346721|566277353|FG000|Overall Study|Withdrew Consent|3|||
156868654|NCT02346721|566277353|FG000|Overall Study|Lack of Efficacy|1|||
156868655|NCT04455815|566277354|FG000|Randomisation Phase|Adverse Event|1|||
156868656|NCT04455815|566277355|FG001|Randomisation Phase|Adverse Event|0|||
156868657|NCT04455815|566277354|FG000|Treatment Phase|Adverse Event|0|||
156868658|NCT04455815|566277355|FG001|Treatment Phase|Adverse Event|1|||
156868659|NCT04455815|566277354|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
156868660|NCT04455815|566277355|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
156868661|NCT04455815|566277354|FG000|Treatment Phase|Withdrawal by Subject|1|||
156868662|NCT04455815|566277355|FG001|Treatment Phase|Withdrawal by Subject|1|||
156868663|NCT03594110|566277359|FG000|Interventional Part|Participant concerned about study treatment|23|||
156868664|NCT03594110|566277360|FG001|Interventional Part|Participant concerned about study treatment|28|||
156868665|NCT03594110|566277359|FG000|Interventional Part|Doctor advice|38|||
156868666|NCT03594110|566277360|FG001|Interventional Part|Doctor advice|40|||
156868667|NCT03594110|566277359|FG000|Interventional Part|Participants' wish|89|||
156868668|NCT03594110|566277360|FG001|Interventional Part|Participants' wish|68|||
156868669|NCT03594110|566277359|FG000|Interventional Part|Adverse event-non-fatal events|119|||
156868670|NCT03594110|566277360|FG001|Interventional Part|Adverse event-non-fatal events|116|||
156868671|NCT03594110|566277359|FG000|Interventional Part|Study drug stopped, reason missing|336|||
156868672|NCT03594110|566277360|FG001|Interventional Part|Study drug stopped, reason missing|294|||
156868673|NCT03594110|566277359|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
156868674|NCT03594110|566277360|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
156868675|NCT03594110|566277359|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
156868676|NCT03594110|566277360|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
156868677|NCT03594110|566277359|FG000|Interventional Part|Contraindicated drug started|32|||
156868678|NCT03594110|566277360|FG001|Interventional Part|Contraindicated drug started|18|||
156868679|NCT03594110|566277359|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
156868680|NCT03594110|566277360|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
156868681|NCT03594110|566277359|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
156868682|NCT03594110|566277360|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
156868683|NCT03594110|566277359|FG000|Non-interventional Part|Withdrawal by Subject|3|||
156868684|NCT03594110|566277360|FG001|Non-interventional Part|Withdrawal by Subject|4|||
156868685|NCT03594110|566277359|FG000|Non-interventional Part|Lost to Follow-up|45|||
156868686|NCT03594110|566277360|FG001|Non-interventional Part|Lost to Follow-up|41|||
156329965|NCT04612790|564308728|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
156329966|NCT04612790|564308729|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
156686085|NCT02688387|565596328|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686086|NCT02688387|565596329|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686087|NCT02688387|565596330|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686088|NCT02688387|565596331|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686089|NCT02688387|565596332|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686090|NCT02688387|565596333|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686091|NCT02688387|565596334|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686092|NCT02688387|565596335|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686093|NCT02688387|565596336|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686094|NCT02688387|565596337|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686095|NCT02688387|565596316|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686096|NCT02688387|565596317|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686097|NCT02688387|565596318|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686098|NCT02688387|565596319|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686099|NCT02688387|565596320|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686100|NCT02688387|565596321|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686101|NCT02688387|565596322|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686102|NCT02688387|565596323|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686103|NCT02688387|565596324|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686104|NCT02688387|565596325|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686105|NCT02688387|565596326|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
156686106|NCT02688387|565596327|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686107|NCT02688387|565596328|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686108|NCT02688387|565596329|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686109|NCT02688387|565596330|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686110|NCT02688387|565596331|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686111|NCT02688387|565596332|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686112|NCT02688387|565596333|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686113|NCT02688387|565596334|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686114|NCT02688387|565596335|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686115|NCT02688387|565596336|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686116|NCT02688387|565596337|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686117|NCT02688387|565596316|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686118|NCT02688387|565596317|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686119|NCT02688387|565596318|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686120|NCT02688387|565596319|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686121|NCT02688387|565596320|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686122|NCT02688387|565596321|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686123|NCT02688387|565596322|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686124|NCT02688387|565596323|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686125|NCT02688387|565596324|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686126|NCT02688387|565596325|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686127|NCT02688387|565596326|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686128|NCT02688387|565596327|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686129|NCT02688387|565596328|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686130|NCT02688387|565596329|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686131|NCT02688387|565596330|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
156686132|NCT02688387|565596331|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686133|NCT02688387|565596332|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686134|NCT02688387|565596333|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686135|NCT02688387|565596334|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686136|NCT02688387|565596335|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686137|NCT02688387|565596336|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686138|NCT02688387|565596337|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686139|NCT02688387|565596316|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156785705|NCT00421993|565966470|FG000|Overall Study|Withdrawal by Subject|22|||
156785706|NCT00421993|565966471|FG001|Overall Study|Withdrawal by Subject|23|||
156785707|NCT00421993|565966472|FG002|Overall Study|Withdrawal by Subject|23|||
156785708|NCT00421993|565966473|FG003|Overall Study|Withdrawal by Subject|24|||
156785709|NCT00421993|565966470|FG000|Overall Study|Lost to Follow-up|18|||
156785710|NCT00421993|565966471|FG001|Overall Study|Lost to Follow-up|19|||
156785711|NCT00421993|565966472|FG002|Overall Study|Lost to Follow-up|22|||
156785712|NCT00421993|565966473|FG003|Overall Study|Lost to Follow-up|20|||
156785713|NCT00421993|565966470|FG000|Overall Study|Adverse Event|11|||
156785714|NCT00421993|565966471|FG001|Overall Study|Adverse Event|1|||
156785715|NCT00421993|565966472|FG002|Overall Study|Adverse Event|6|||
156785716|NCT00421993|565966473|FG003|Overall Study|Adverse Event|4|||
156785717|NCT00421993|565966470|FG000|Overall Study|Protocol Violation|2|||
156785718|NCT00421993|565966471|FG001|Overall Study|Protocol Violation|2|||
156785719|NCT00421993|565966472|FG002|Overall Study|Protocol Violation|0|||
156785720|NCT00421993|565966473|FG003|Overall Study|Protocol Violation|1|||
156785721|NCT00421993|565966470|FG000|Overall Study|Lack of Efficacy|0|||
156785722|NCT00421993|565966471|FG001|Overall Study|Lack of Efficacy|3|||
156785723|NCT00421993|565966472|FG002|Overall Study|Lack of Efficacy|0|||
156785724|NCT00421993|565966473|FG003|Overall Study|Lack of Efficacy|5|||
156785725|NCT00421993|565966470|FG000|Overall Study|Pregnancy|0|||
156785726|NCT00421993|565966471|FG001|Overall Study|Pregnancy|1|||
156785727|NCT00421993|565966472|FG002|Overall Study|Pregnancy|1|||
156785728|NCT00421993|565966473|FG003|Overall Study|Pregnancy|2|||
156785729|NCT00421993|565966470|FG000|Overall Study|Subject transportation issues|0|||
156785730|NCT00421993|565966471|FG001|Overall Study|Subject transportation issues|0|||
156329967|NCT04612790|564308730|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
156329968|NCT04612790|564308727|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
156530285|NCT03027557|565036358|FG000|Overall Study|Adverse Event|1|||
156686140|NCT02688387|565596317|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686141|NCT02688387|565596318|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686142|NCT02688387|565596319|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686143|NCT02688387|565596320|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686144|NCT02688387|565596321|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686145|NCT02688387|565596322|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686146|NCT02688387|565596323|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686147|NCT02688387|565596324|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156785731|NCT00421993|565966472|FG002|Overall Study|Subject transportation issues|0|||
156785732|NCT00421993|565966473|FG003|Overall Study|Subject transportation issues|1|||
156785733|NCT02405962|565966474|FG000|Overall Study|Lost to Follow-up|1|||
156785734|NCT02405962|565966475|FG001|Overall Study|Lost to Follow-up|4|||
156785735|NCT02405962|565966474|FG000|Overall Study|A participant has moved to another place|0|||
156785736|NCT02405962|565966475|FG001|Overall Study|A participant has moved to another place|1|||
156785737|NCT01980888|565966476|FG000|Overall Study|Study Terminated by Sponsor|116|||
156785738|NCT01980888|565966477|FG001|Overall Study|Study Terminated by Sponsor|122|||
156785739|NCT01980888|565966476|FG000|Overall Study|Withdrew Consent|17|||
156785740|NCT01980888|565966477|FG001|Overall Study|Withdrew Consent|6|||
156785741|NCT01980888|565966476|FG000|Overall Study|Investigator's Discretion|8|||
156785742|NCT01980888|565966477|FG001|Overall Study|Investigator's Discretion|3|||
156785743|NCT01980888|565966476|FG000|Overall Study|Non-Compliance with Study Drug|3|||
156785744|NCT01980888|565966477|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156785745|NCT00165698|565966479|FG000|Overall Study|Adverse Event|2|||
156785746|NCT00165698|565966480|FG001|Overall Study|Adverse Event|10|||
156785747|NCT00165698|565966479|FG000|Overall Study|Lost to Follow-up|2|||
156785748|NCT00165698|565966480|FG001|Overall Study|Lost to Follow-up|2|||
156785749|NCT00165698|565966479|FG000|Overall Study|Withdrawal by Subject|2|||
156785750|NCT00165698|565966480|FG001|Overall Study|Withdrawal by Subject|1|||
156785751|NCT00165698|565966479|FG000|Overall Study|Protocol Violation|1|||
156785752|NCT00165698|565966480|FG001|Overall Study|Protocol Violation|0|||
156785753|NCT00165698|565966479|FG000|Overall Study|Not Taken/Lost the medicine|1|||
156785754|NCT00165698|565966480|FG001|Overall Study|Not Taken/Lost the medicine|2|||
156785755|NCT01483651|565966481|FG000|Overall Study|Withdrawal by Subject|0|||
156785756|NCT01483651|565966482|FG001|Overall Study|Withdrawal by Subject|1|||
156785757|NCT01483651|565966483|FG002|Overall Study|Withdrawal by Subject|1|||
156785758|NCT01483651|565966484|FG003|Overall Study|Withdrawal by Subject|0|||
156785759|NCT01483651|565966485|FG004|Overall Study|Withdrawal by Subject|0|||
156785760|NCT01483651|565966486|FG005|Overall Study|Withdrawal by Subject|1|||
156785761|NCT01184118|565966494|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
156785762|NCT01184118|565966494|FG000|Overall Study|No physiologic confirmation of asthma|8|||
156785763|NCT01184118|565966494|FG000|Overall Study|FEV1 <60% predicted|2|||
156785764|NCT01184118|565966494|FG000|Overall Study|Exclusionary medical condition|2|||
156785765|NCT01184118|565966494|FG000|Overall Study|Withdrawal by Subject|5|||
156785766|NCT01937117|565966495|FG000|Overall Study|Disease Progression|7|||
156785767|NCT01937117|565966495|FG000|Overall Study|Physician Decision|4|||
156785768|NCT01937117|565966495|FG000|Overall Study|Adverse Event|2|||
156785769|NCT02186171|565966497|FG000|Overall Study|Withdrawal by Subject|1|||
156785770|NCT02186171|565966498|FG001|Overall Study|Withdrawal by Subject|9|||
156785771|NCT02186171|565966497|FG000|Overall Study|Lost to Follow-up|2|||
156785772|NCT02186171|565966498|FG001|Overall Study|Lost to Follow-up|2|||
156785773|NCT02186171|565966497|FG000|Overall Study|Death|1|||
156785774|NCT02186171|565966498|FG001|Overall Study|Death|2|||
156785775|NCT02186171|565966497|FG000|Overall Study|Protocol-specified Criteria|0|||
156785776|NCT02186171|565966498|FG001|Overall Study|Protocol-specified Criteria|2|||
156785777|NCT01245062|565966499|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
156785778|NCT01245062|565966500|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
156785779|NCT01245062|565966501|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
156785780|NCT01245062|565966499|FG000|Randomization and Crossover Phase|Physician Decision|2|||
156785781|NCT01245062|565966500|FG001|Randomization and Crossover Phase|Physician Decision|4|||
156785782|NCT01245062|565966501|FG002|Randomization and Crossover Phase|Physician Decision|0|||
156785783|NCT01245062|565966499|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
156785784|NCT01245062|565966500|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
156785785|NCT01245062|565966501|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
156785786|NCT01245062|565966499|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
156785787|NCT01245062|565966500|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
156785788|NCT01245062|565966501|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
156785789|NCT01245062|565966499|FG000|Cross-over Phase|Lost to Follow-up|0|||
156785790|NCT01245062|565966500|FG001|Cross-over Phase|Lost to Follow-up|0|||
156785791|NCT01245062|565966501|FG002|Cross-over Phase|Lost to Follow-up|1|||
156868687|NCT00419952|566277364|FG000|Overall Study|Adverse Event|8|||
156868688|NCT00419952|566277365|FG001|Overall Study|Adverse Event|10|||
156868689|NCT00419952|566277364|FG000|Overall Study|Withdrawal by Subject|44|||
156868690|NCT00419952|566277365|FG001|Overall Study|Withdrawal by Subject|43|||
156868691|NCT00419952|566277364|FG000|Overall Study|Lost to Follow-up|43|||
156868692|NCT00419952|566277365|FG001|Overall Study|Lost to Follow-up|34|||
156868693|NCT00419952|566277364|FG000|Overall Study|Protocol Violation|32|||
156868694|NCT00419952|566277365|FG001|Overall Study|Protocol Violation|24|||
156868695|NCT00419952|566277364|FG000|Overall Study|Pregnancy|4|||
156868696|NCT00419952|566277365|FG001|Overall Study|Pregnancy|2|||
156868697|NCT00419952|566277364|FG000|Overall Study|Physician Decision|1|||
156868698|NCT00419952|566277365|FG001|Overall Study|Physician Decision|3|||
156868699|NCT00419952|566277364|FG000|Overall Study|Incorrectly enrolled|10|||
156868700|NCT00419952|566277365|FG001|Overall Study|Incorrectly enrolled|3|||
156868701|NCT00419952|566277364|FG000|Overall Study|Intake of prohibited medication|2|||
156868702|NCT00419952|566277365|FG001|Overall Study|Intake of prohibited medication|2|||
156868703|NCT00419952|566277364|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
156868704|NCT00419952|566277365|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
156868705|NCT00419952|566277364|FG000|Overall Study|Diary or medication non-compliance|2|||
156785792|NCT01245062|565966499|FG000|Cross-over Phase|Physician Decision|0|||
156785793|NCT01245062|565966500|FG001|Cross-over Phase|Physician Decision|0|||
156785794|NCT01245062|565966501|FG002|Cross-over Phase|Physician Decision|1|||
156785795|NCT01245062|565966499|FG000|Cross-over Phase|Withdrew Consent|0|||
156785796|NCT01245062|565966500|FG001|Cross-over Phase|Withdrew Consent|0|||
156785797|NCT01245062|565966501|FG002|Cross-over Phase|Withdrew Consent|4|||
156785798|NCT01245062|565966499|FG000|Cross-over Phase|Study closed/ terminated|0|||
156785799|NCT01245062|565966500|FG001|Cross-over Phase|Study closed/ terminated|0|||
156785800|NCT01245062|565966501|FG002|Cross-over Phase|Study closed/ terminated|11|||
156785801|NCT05762744|565966503|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
156785802|NCT05762744|565966504|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
156785803|NCT05762744|565966503|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
156785804|NCT05762744|565966504|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
156785805|NCT03882801|565968150|FG000|Period 1|Adverse Event|0|||
156785806|NCT03882801|565968151|FG001|Period 1|Adverse Event|1|||
156785807|NCT03882801|565968150|FG000|Period 1|Non-compliance with study drug|1|||
156785808|NCT03882801|565968151|FG001|Period 1|Non-compliance with study drug|1|||
156785809|NCT03882801|565968150|FG000|Period 1|Never treated with study drug|1|||
156785810|NCT03882801|565968151|FG001|Period 1|Never treated with study drug|0|||
156785811|NCT03882801|565968150|FG000|Washout Period|Physician Decision|0|||
156785812|NCT03882801|565968151|FG001|Washout Period|Physician Decision|1|||
156785813|NCT03882801|565968150|FG000|Period 2|Non-compliance with study drug|0|||
156785814|NCT03882801|565968151|FG001|Period 2|Non-compliance with study drug|1|||
156785815|NCT01793129|565968152|FG000|Overall Study|Lost to Follow-up|3|||
156785816|NCT01793129|565968153|FG001|Overall Study|Lost to Follow-up|7|||
156785817|NCT01793129|565968152|FG000|Overall Study|Withdrawal by Subject|0|||
156785818|NCT01793129|565968153|FG001|Overall Study|Withdrawal by Subject|2|||
156785819|NCT04193176|565968156|FG000|Overall Study|Withdrawal by Subject|6|||
156785820|NCT04193176|565968157|FG001|Overall Study|Withdrawal by Subject|10|||
156785821|NCT00944645|565968158|FG000|Period 2|Adverse Event|1|||
156785822|NCT00944645|565968159|FG001|Period 2|Adverse Event|0|||
156785823|NCT00944645|565968158|FG000|Period 2|Lost to Follow-up|0|||
156785824|NCT00944645|565968159|FG001|Period 2|Lost to Follow-up|3|||
156785825|NCT00944645|565968158|FG000|Period 2|Withdrawal by Subject|7|||
156785826|NCT00944645|565968159|FG001|Period 2|Withdrawal by Subject|6|||
156785827|NCT00454142|565968160|FG000|Overall Study|Withdrawal by Subject|1|||
156785828|NCT01245751|565968164|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
156785829|NCT01245751|565968165|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
156868706|NCT00419952|566277365|FG001|Overall Study|Diary or medication non-compliance|4|||
156868707|NCT00419952|566277364|FG000|Overall Study|Abnormal ECG|1|||
156868708|NCT00419952|566277365|FG001|Overall Study|Abnormal ECG|0|||
156868709|NCT02085460|566277366|FG000|Overall Study|Adverse Event|2|||
156868710|NCT02085460|566277367|FG001|Overall Study|Adverse Event|2|||
156436884|NCT02115282|564689154|FG000|Overall Study|Disease progression during treatment|216|||
156785830|NCT01245751|565968166|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
156785831|NCT01245751|565968167|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
156785832|NCT01245751|565968164|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
156785833|NCT01245751|565968165|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
156785834|NCT01245751|565968166|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
156785835|NCT01245751|565968167|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
156785836|NCT01245751|565968164|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
156785837|NCT01245751|565968165|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
156785838|NCT01245751|565968166|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
156785839|NCT01245751|565968167|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
156785840|NCT01783015|565968170|FG000|Blinded Treatment|Adverse Event|0|||
156785841|NCT01783015|565968171|FG001|Blinded Treatment|Adverse Event|1|||
156785842|NCT01783015|565968172|FG002|Blinded Treatment|Adverse Event|0|||
156868711|NCT02085460|566277368|FG002|Overall Study|Adverse Event|1|||
156868712|NCT02085460|566277366|FG000|Overall Study|Physician Decision|1|||
156868713|NCT02085460|566277367|FG001|Overall Study|Physician Decision|1|||
156868714|NCT02085460|566277368|FG002|Overall Study|Physician Decision|2|||
156868715|NCT02085460|566277366|FG000|Overall Study|Withdrawal by Subject|11|||
156868716|NCT02085460|566277367|FG001|Overall Study|Withdrawal by Subject|5|||
156868717|NCT02085460|566277368|FG002|Overall Study|Withdrawal by Subject|7|||
156868718|NCT02158546|566277376|FG000|Overall Study|Physician Decision|0|||
156868719|NCT02158546|566277377|FG001|Overall Study|Physician Decision|1|||
156868720|NCT02158546|566277378|FG002|Overall Study|Physician Decision|0|||
156868721|NCT02158546|566277379|FG003|Overall Study|Physician Decision|0|||
156868722|NCT02158546|566277376|FG000|Overall Study|Non-compliance|0|||
156868723|NCT02158546|566277377|FG001|Overall Study|Non-compliance|1|||
156868724|NCT02158546|566277378|FG002|Overall Study|Non-compliance|0|||
156868725|NCT02158546|566277379|FG003|Overall Study|Non-compliance|1|||
156868726|NCT02158546|566277376|FG000|Overall Study|Failure to meet eligibility criteria|0|||
156868727|NCT02158546|566277377|FG001|Overall Study|Failure to meet eligibility criteria|1|||
156868728|NCT02158546|566277378|FG002|Overall Study|Failure to meet eligibility criteria|0|||
156868729|NCT02158546|566277379|FG003|Overall Study|Failure to meet eligibility criteria|0|||
156868730|NCT02158546|566277376|FG000|Overall Study|Lack of Efficacy|1|||
156868731|NCT02158546|566277377|FG001|Overall Study|Lack of Efficacy|1|||
156868732|NCT02158546|566277378|FG002|Overall Study|Lack of Efficacy|0|||
156868733|NCT02158546|566277379|FG003|Overall Study|Lack of Efficacy|0|||
156868734|NCT02158546|566277376|FG000|Overall Study|Adverse Event|2|||
156868735|NCT02158546|566277377|FG001|Overall Study|Adverse Event|2|||
156868736|NCT02158546|566277378|FG002|Overall Study|Adverse Event|0|||
156868737|NCT02158546|566277379|FG003|Overall Study|Adverse Event|0|||
156868738|NCT02158546|566277376|FG000|Overall Study|Withdrawal by Subject|6|||
156868739|NCT02158546|566277377|FG001|Overall Study|Withdrawal by Subject|2|||
156868740|NCT02158546|566277378|FG002|Overall Study|Withdrawal by Subject|1|||
156868741|NCT02158546|566277379|FG003|Overall Study|Withdrawal by Subject|0|||
156868742|NCT02158546|566277376|FG000|Overall Study|Lost to Follow-up|5|||
156868743|NCT02158546|566277377|FG001|Overall Study|Lost to Follow-up|4|||
156868744|NCT02158546|566277378|FG002|Overall Study|Lost to Follow-up|0|||
156868745|NCT02158546|566277379|FG003|Overall Study|Lost to Follow-up|1|||
156868746|NCT02158546|566277376|FG000|Overall Study|Site Excluded|5|||
156868747|NCT02158546|566277377|FG001|Overall Study|Site Excluded|5|||
156868748|NCT02158546|566277378|FG002|Overall Study|Site Excluded|3|||
156868749|NCT02158546|566277379|FG003|Overall Study|Site Excluded|4|||
156868750|NCT02351817|566277381|FG000|Period 1|Adverse Event|1|||
156868751|NCT02351817|566277382|FG001|Period 1|Adverse Event|2|||
156868752|NCT02351817|566277381|FG000|Period 1|Lack of Efficacy|0|||
156868753|NCT02351817|566277382|FG001|Period 1|Lack of Efficacy|1|||
156868754|NCT02351817|566277381|FG000|Period 2|Adverse Event|0|||
156868755|NCT02351817|566277382|FG001|Period 2|Adverse Event|2|||
156868756|NCT02351817|566277381|FG000|Period 2|Protocol Violation|1|||
156868757|NCT02351817|566277382|FG001|Period 2|Protocol Violation|0|||
156868758|NCT02488915|566277385|FG000|Overall Study|Death|21|||
156868759|NCT02488915|566277385|FG000|Overall Study|Lost to Follow-up|4|||
156868760|NCT02488915|566277385|FG000|Overall Study|Withdrawal by Subject|1|||
156868761|NCT00891904|566277392|FG000|Overall Study|Death|1|||
156868762|NCT00891904|566277392|FG000|Overall Study|Adverse Event|1|||
156868763|NCT01046396|566277393|FG000|Overall Study|Withdrawal by Subject|5|||
156868764|NCT01208207|566277394|FG000|Part I|Adverse Event|19|||
156868765|NCT01208207|566277395|FG001|Part I|Adverse Event|2|||
156868766|NCT01208207|566277396|FG002|Part I|Adverse Event|6|||
156868767|NCT01208207|566277397|FG003|Part I|Adverse Event|0|||
156868768|NCT01208207|566277398|FG004|Part I|Adverse Event|0|||
156868769|NCT01208207|566277399|FG005|Part I|Adverse Event|0|||
156868770|NCT01208207|566277400|FG006|Part I|Adverse Event|0|||
156868771|NCT01208207|566277394|FG000|Part I|Lack of Efficacy|21|||
156329969|NCT04612790|564308728|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
156329970|NCT04612790|564308729|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
156868772|NCT01208207|566277395|FG001|Part I|Lack of Efficacy|3|||
156868773|NCT01208207|566277396|FG002|Part I|Lack of Efficacy|2|||
156868774|NCT01208207|566277397|FG003|Part I|Lack of Efficacy|0|||
156868775|NCT01208207|566277398|FG004|Part I|Lack of Efficacy|0|||
156868776|NCT01208207|566277399|FG005|Part I|Lack of Efficacy|0|||
156868777|NCT01208207|566277400|FG006|Part I|Lack of Efficacy|0|||
156868778|NCT01208207|566277394|FG000|Part I|Lost to Follow-up|6|||
156868779|NCT01208207|566277395|FG001|Part I|Lost to Follow-up|1|||
156868780|NCT01208207|566277396|FG002|Part I|Lost to Follow-up|0|||
156868781|NCT01208207|566277397|FG003|Part I|Lost to Follow-up|0|||
156868782|NCT01208207|566277398|FG004|Part I|Lost to Follow-up|0|||
156868783|NCT01208207|566277399|FG005|Part I|Lost to Follow-up|0|||
156868784|NCT01208207|566277400|FG006|Part I|Lost to Follow-up|0|||
156868785|NCT01208207|566277394|FG000|Part I|Non-Compliance With Study Drug|1|||
156868786|NCT01208207|566277395|FG001|Part I|Non-Compliance With Study Drug|0|||
156868787|NCT01208207|566277396|FG002|Part I|Non-Compliance With Study Drug|1|||
156868788|NCT01208207|566277397|FG003|Part I|Non-Compliance With Study Drug|0|||
156868789|NCT01208207|566277398|FG004|Part I|Non-Compliance With Study Drug|0|||
156868790|NCT01208207|566277399|FG005|Part I|Non-Compliance With Study Drug|0|||
156868791|NCT01208207|566277400|FG006|Part I|Non-Compliance With Study Drug|0|||
156868792|NCT01208207|566277394|FG000|Part I|Physician Decision|0|||
156868793|NCT01208207|566277395|FG001|Part I|Physician Decision|1|||
156868794|NCT01208207|566277396|FG002|Part I|Physician Decision|0|||
156868795|NCT01208207|566277397|FG003|Part I|Physician Decision|0|||
156868796|NCT01208207|566277398|FG004|Part I|Physician Decision|0|||
156868797|NCT01208207|566277399|FG005|Part I|Physician Decision|0|||
156868798|NCT01208207|566277400|FG006|Part I|Physician Decision|0|||
156868799|NCT01208207|566277394|FG000|Part I|Progressive Disease|1|||
156868800|NCT01208207|566277395|FG001|Part I|Progressive Disease|0|||
156868801|NCT01208207|566277396|FG002|Part I|Progressive Disease|0|||
156868802|NCT01208207|566277397|FG003|Part I|Progressive Disease|0|||
156868803|NCT01208207|566277398|FG004|Part I|Progressive Disease|0|||
156868804|NCT01208207|566277399|FG005|Part I|Progressive Disease|0|||
156868805|NCT01208207|566277400|FG006|Part I|Progressive Disease|0|||
156868806|NCT01208207|566277394|FG000|Part I|Protocol Violation|8|||
156868807|NCT01208207|566277395|FG001|Part I|Protocol Violation|0|||
156868808|NCT01208207|566277396|FG002|Part I|Protocol Violation|2|||
156868809|NCT01208207|566277397|FG003|Part I|Protocol Violation|0|||
156868810|NCT01208207|566277398|FG004|Part I|Protocol Violation|0|||
156868811|NCT01208207|566277399|FG005|Part I|Protocol Violation|0|||
156868812|NCT01208207|566277400|FG006|Part I|Protocol Violation|0|||
156868813|NCT01208207|566277394|FG000|Part I|Withdrawal by Subject|14|||
156868814|NCT01208207|566277395|FG001|Part I|Withdrawal by Subject|4|||
156868815|NCT01208207|566277396|FG002|Part I|Withdrawal by Subject|4|||
156868816|NCT01208207|566277397|FG003|Part I|Withdrawal by Subject|0|||
156868817|NCT01208207|566277398|FG004|Part I|Withdrawal by Subject|0|||
156868818|NCT01208207|566277399|FG005|Part I|Withdrawal by Subject|0|||
156868819|NCT01208207|566277400|FG006|Part I|Withdrawal by Subject|0|||
156868820|NCT01208207|566277394|FG000|Part II|Withdrawal by Subject|0|||
156868821|NCT01208207|566277395|FG001|Part II|Withdrawal by Subject|0|||
156868822|NCT01208207|566277396|FG002|Part II|Withdrawal by Subject|0|||
156868823|NCT01208207|566277397|FG003|Part II|Withdrawal by Subject|10|||
156868824|NCT01208207|566277398|FG004|Part II|Withdrawal by Subject|9|||
156868825|NCT01208207|566277399|FG005|Part II|Withdrawal by Subject|3|||
156868826|NCT01208207|566277400|FG006|Part II|Withdrawal by Subject|5|||
156868827|NCT01208207|566277394|FG000|Part II|Adverse Event|0|||
156868828|NCT01208207|566277395|FG001|Part II|Adverse Event|0|||
156686148|NCT02688387|565596325|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686149|NCT02688387|565596326|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686150|NCT02688387|565596327|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686151|NCT02688387|565596328|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686152|NCT02688387|565596329|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686153|NCT02688387|565596330|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686154|NCT02688387|565596331|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686155|NCT02688387|565596332|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686156|NCT02688387|565596333|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686157|NCT02688387|565596334|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686158|NCT02688387|565596335|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686159|NCT02688387|565596336|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
156686160|NCT02688387|565596337|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686161|NCT02688387|565596316|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686162|NCT02688387|565596317|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686163|NCT02688387|565596318|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156785843|NCT01783015|565968170|FG000|Blinded Treatment|Protocol Violation|0|||
156785844|NCT01783015|565968171|FG001|Blinded Treatment|Protocol Violation|1|||
156785845|NCT01783015|565968172|FG002|Blinded Treatment|Protocol Violation|0|||
156785846|NCT01783015|565968170|FG000|Blinded Treatment|Withdrawal by Subject|0|||
156785847|NCT01783015|565968171|FG001|Blinded Treatment|Withdrawal by Subject|1|||
156785848|NCT01783015|565968172|FG002|Blinded Treatment|Withdrawal by Subject|0|||
156785849|NCT01783015|565968170|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
156785850|NCT01783015|565968171|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
156785851|NCT01783015|565968172|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
156785852|NCT01783015|565968170|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
156868829|NCT01208207|566277396|FG002|Part II|Adverse Event|0|||
156868830|NCT01208207|566277397|FG003|Part II|Adverse Event|5|||
156868831|NCT01208207|566277398|FG004|Part II|Adverse Event|9|||
156868832|NCT01208207|566277399|FG005|Part II|Adverse Event|4|||
156868833|NCT01208207|566277400|FG006|Part II|Adverse Event|2|||
156868834|NCT01208207|566277394|FG000|Part II|Lack of Efficacy|0|||
156868835|NCT01208207|566277395|FG001|Part II|Lack of Efficacy|0|||
156868836|NCT01208207|566277396|FG002|Part II|Lack of Efficacy|0|||
156785853|NCT01783015|565968171|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
156868837|NCT01208207|566277397|FG003|Part II|Lack of Efficacy|6|||
156868838|NCT01208207|566277398|FG004|Part II|Lack of Efficacy|4|||
156868839|NCT01208207|566277399|FG005|Part II|Lack of Efficacy|3|||
156868840|NCT01208207|566277400|FG006|Part II|Lack of Efficacy|3|||
156868841|NCT01208207|566277394|FG000|Part II|Lost to Follow-up|0|||
156868842|NCT01208207|566277395|FG001|Part II|Lost to Follow-up|0|||
156868843|NCT01208207|566277396|FG002|Part II|Lost to Follow-up|0|||
156868844|NCT01208207|566277397|FG003|Part II|Lost to Follow-up|4|||
156868845|NCT01208207|566277398|FG004|Part II|Lost to Follow-up|0|||
156868846|NCT01208207|566277399|FG005|Part II|Lost to Follow-up|2|||
156868847|NCT01208207|566277400|FG006|Part II|Lost to Follow-up|1|||
156868848|NCT01208207|566277394|FG000|Part II|Non-Compliance With Study Drug|0|||
156868849|NCT01208207|566277395|FG001|Part II|Non-Compliance With Study Drug|0|||
156868850|NCT01208207|566277396|FG002|Part II|Non-Compliance With Study Drug|0|||
156868851|NCT01208207|566277397|FG003|Part II|Non-Compliance With Study Drug|4|||
156868852|NCT01208207|566277398|FG004|Part II|Non-Compliance With Study Drug|1|||
156868853|NCT01208207|566277399|FG005|Part II|Non-Compliance With Study Drug|1|||
156868854|NCT01208207|566277400|FG006|Part II|Non-Compliance With Study Drug|0|||
156868855|NCT01208207|566277394|FG000|Part II|Physician Decision|0|||
156868856|NCT01208207|566277395|FG001|Part II|Physician Decision|0|||
156868857|NCT01208207|566277396|FG002|Part II|Physician Decision|0|||
156868858|NCT01208207|566277397|FG003|Part II|Physician Decision|1|||
156868859|NCT01208207|566277398|FG004|Part II|Physician Decision|0|||
156868860|NCT01208207|566277399|FG005|Part II|Physician Decision|2|||
156868861|NCT01208207|566277400|FG006|Part II|Physician Decision|0|||
156868862|NCT01208207|566277394|FG000|Part II|Protocol Violation|0|||
156868863|NCT01208207|566277395|FG001|Part II|Protocol Violation|0|||
156868864|NCT01208207|566277396|FG002|Part II|Protocol Violation|0|||
156868865|NCT01208207|566277397|FG003|Part II|Protocol Violation|1|||
156868866|NCT01208207|566277398|FG004|Part II|Protocol Violation|0|||
156868867|NCT01208207|566277399|FG005|Part II|Protocol Violation|0|||
156868868|NCT01208207|566277400|FG006|Part II|Protocol Violation|0|||
156868869|NCT01208207|566277394|FG000|Part II|Technical Problems|0|||
156868870|NCT01208207|566277395|FG001|Part II|Technical Problems|0|||
156868871|NCT01208207|566277396|FG002|Part II|Technical Problems|0|||
156868872|NCT01208207|566277397|FG003|Part II|Technical Problems|1|||
156868873|NCT01208207|566277398|FG004|Part II|Technical Problems|0|||
156868874|NCT01208207|566277399|FG005|Part II|Technical Problems|1|||
156868875|NCT01208207|566277400|FG006|Part II|Technical Problems|0|||
156868876|NCT01605799|566277406|FG000|Overall Study|Withdrawal by Subject|2|||
156868877|NCT01605799|566277407|FG001|Overall Study|Withdrawal by Subject|1|||
156868878|NCT00686712|566277408|FG000|Overall Study|Protocol Violation|8|||
156868879|NCT00686712|566277409|FG001|Overall Study|Protocol Violation|8|||
156868880|NCT00686712|566277410|FG002|Overall Study|Protocol Violation|10|||
156868881|NCT00686712|566277408|FG000|Overall Study|Lost to Follow-up|1|||
156868882|NCT00686712|566277409|FG001|Overall Study|Lost to Follow-up|2|||
156868883|NCT00686712|566277410|FG002|Overall Study|Lost to Follow-up|3|||
156868884|NCT00686712|566277408|FG000|Overall Study|Adverse Event|1|||
156868885|NCT00686712|566277409|FG001|Overall Study|Adverse Event|1|||
156868886|NCT00686712|566277410|FG002|Overall Study|Adverse Event|0|||
156868887|NCT00926237|566277413|FG000|Overall Study|Withdrawal by Subject|2|||
156868888|NCT00926237|566277414|FG001|Overall Study|Withdrawal by Subject|1|||
156868889|NCT03313037|566277425|FG000|Overall Study|Protocol Violation|4|||
156868890|NCT03313037|566277426|FG001|Overall Study|Protocol Violation|1|||
156868891|NCT03313037|566277425|FG000|Overall Study|Other|1|||
156868892|NCT03313037|566277426|FG001|Overall Study|Other|1|||
156868893|NCT03313037|566277425|FG000|Overall Study|Withdrawal by Subject|4|||
156868894|NCT03313037|566277426|FG001|Overall Study|Withdrawal by Subject|3|||
156868895|NCT03313037|566277425|FG000|Overall Study|No longer meets eligibility criteria|1|||
156868896|NCT03313037|566277426|FG001|Overall Study|No longer meets eligibility criteria|7|||
156868897|NCT03313037|566277425|FG000|Overall Study|Lost to Follow-up|9|||
156868898|NCT03313037|566277426|FG001|Overall Study|Lost to Follow-up|8|||
156868899|NCT03313037|566277425|FG000|Overall Study|Randomized but not treated|1|||
156868900|NCT03313037|566277426|FG001|Overall Study|Randomized but not treated|0|||
156868901|NCT02760498|566277427|FG000|Overall Study|Adverse Event|3|||
156868902|NCT02760498|566277428|FG001|Overall Study|Adverse Event|3|||
156868903|NCT02760498|566277429|FG002|Overall Study|Adverse Event|1|||
156868904|NCT02760498|566277430|FG003|Overall Study|Adverse Event|1|||
156329971|NCT04612790|564308730|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
156329972|NCT04612790|564308727|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
156329973|NCT04612790|564308728|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
156329974|NCT04612790|564308729|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
156868905|NCT02760498|566277431|FG004|Overall Study|Adverse Event|0|||
156868906|NCT02760498|566277432|FG005|Overall Study|Adverse Event|6|||
156868907|NCT02760498|566277427|FG000|Overall Study|Death|7|||
156868908|NCT02760498|566277428|FG001|Overall Study|Death|5|||
156868909|NCT02760498|566277429|FG002|Overall Study|Death|5|||
156868910|NCT02760498|566277430|FG003|Overall Study|Death|7|||
156868911|NCT02760498|566277431|FG004|Overall Study|Death|0|||
156868912|NCT02760498|566277432|FG005|Overall Study|Death|23|||
156868913|NCT02760498|566277427|FG000|Overall Study|Lost to Follow-up|0|||
156868914|NCT02760498|566277428|FG001|Overall Study|Lost to Follow-up|0|||
156868915|NCT02760498|566277429|FG002|Overall Study|Lost to Follow-up|0|||
156868916|NCT02760498|566277430|FG003|Overall Study|Lost to Follow-up|0|||
156686164|NCT02688387|565596319|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686165|NCT02688387|565596320|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686166|NCT02688387|565596321|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686167|NCT02688387|565596322|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686168|NCT02688387|565596323|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686169|NCT02688387|565596324|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686170|NCT02688387|565596325|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686171|NCT02688387|565596326|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686172|NCT02688387|565596327|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686173|NCT02688387|565596328|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686174|NCT02688387|565596329|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686175|NCT02688387|565596330|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686176|NCT02688387|565596331|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686177|NCT02688387|565596332|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686178|NCT02688387|565596333|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686179|NCT02688387|565596334|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
156686180|NCT02688387|565596335|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686181|NCT02688387|565596336|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
156785854|NCT01783015|565968172|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
156785855|NCT00504556|565968173|FG000|Overall Study|Adverse Event|11|||
156785856|NCT00504556|565968174|FG001|Overall Study|Adverse Event|11|||
156785857|NCT00504556|565968175|FG002|Overall Study|Adverse Event|14|||
156785858|NCT00504556|565968176|FG003|Overall Study|Adverse Event|13|||
156785859|NCT00504556|565968177|FG004|Overall Study|Adverse Event|5|||
156785860|NCT00504556|565968173|FG000|Overall Study|Death|3|||
156785861|NCT00504556|565968174|FG001|Overall Study|Death|3|||
156785862|NCT00504556|565968175|FG002|Overall Study|Death|1|||
156785863|NCT00504556|565968176|FG003|Overall Study|Death|0|||
156785864|NCT00504556|565968177|FG004|Overall Study|Death|2|||
156785865|NCT00504556|565968173|FG000|Overall Study|Protocol Violation|1|||
156785866|NCT00504556|565968174|FG001|Overall Study|Protocol Violation|3|||
156785867|NCT00504556|565968175|FG002|Overall Study|Protocol Violation|2|||
156785868|NCT00504556|565968176|FG003|Overall Study|Protocol Violation|1|||
156785869|NCT00504556|565968177|FG004|Overall Study|Protocol Violation|2|||
156785870|NCT00504556|565968173|FG000|Overall Study|Lost to Follow-up|0|||
156785871|NCT00504556|565968174|FG001|Overall Study|Lost to Follow-up|0|||
156785872|NCT00504556|565968175|FG002|Overall Study|Lost to Follow-up|1|||
156785873|NCT00504556|565968176|FG003|Overall Study|Lost to Follow-up|1|||
156785874|NCT00504556|565968177|FG004|Overall Study|Lost to Follow-up|1|||
156785875|NCT00504556|565968173|FG000|Overall Study|Withdrawal by Subject|16|||
156785876|NCT00504556|565968174|FG001|Overall Study|Withdrawal by Subject|16|||
156785877|NCT00504556|565968175|FG002|Overall Study|Withdrawal by Subject|7|||
156785878|NCT00504556|565968176|FG003|Overall Study|Withdrawal by Subject|8|||
156785879|NCT00504556|565968177|FG004|Overall Study|Withdrawal by Subject|12|||
156785880|NCT00504556|565968173|FG000|Overall Study|administrative reasons|0|||
156785881|NCT00504556|565968174|FG001|Overall Study|administrative reasons|2|||
156785882|NCT00504556|565968175|FG002|Overall Study|administrative reasons|2|||
156785883|NCT00504556|565968176|FG003|Overall Study|administrative reasons|1|||
156785884|NCT00504556|565968177|FG004|Overall Study|administrative reasons|2|||
156785885|NCT00504556|565968173|FG000|Overall Study|did not meet entry criteria|2|||
156785886|NCT00504556|565968174|FG001|Overall Study|did not meet entry criteria|0|||
156785887|NCT00504556|565968175|FG002|Overall Study|did not meet entry criteria|1|||
156785888|NCT00504556|565968176|FG003|Overall Study|did not meet entry criteria|1|||
156785889|NCT00504556|565968177|FG004|Overall Study|did not meet entry criteria|0|||
156785890|NCT00504556|565968173|FG000|Overall Study|data monitor committee decision|0|||
156785891|NCT00504556|565968174|FG001|Overall Study|data monitor committee decision|0|||
156785892|NCT00504556|565968175|FG002|Overall Study|data monitor committee decision|0|||
156785893|NCT00504556|565968176|FG003|Overall Study|data monitor committee decision|100|||
156785894|NCT00504556|565968177|FG004|Overall Study|data monitor committee decision|0|||
156785895|NCT00504556|565968173|FG000|Overall Study|Other|2|||
156785896|NCT00504556|565968174|FG001|Overall Study|Other|2|||
156785897|NCT00504556|565968175|FG002|Overall Study|Other|2|||
156785898|NCT00504556|565968176|FG003|Overall Study|Other|3|||
156785899|NCT00504556|565968177|FG004|Overall Study|Other|0|||
156868917|NCT02760498|566277431|FG004|Overall Study|Lost to Follow-up|0|||
156686182|NCT02688387|565596337|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686183|NCT02688387|565596316|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156785900|NCT00504556|565968173|FG000|Overall Study|not in safety analysis set|0|||
156785901|NCT00504556|565968174|FG001|Overall Study|not in safety analysis set|1|||
156785902|NCT00504556|565968175|FG002|Overall Study|not in safety analysis set|1|||
156785903|NCT00504556|565968176|FG003|Overall Study|not in safety analysis set|0|||
156785904|NCT00504556|565968177|FG004|Overall Study|not in safety analysis set|1|||
156785905|NCT03607695|565968178|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
156785906|NCT03607695|565968178|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
156785907|NCT02741193|565968179|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
156868918|NCT02760498|566277432|FG005|Overall Study|Lost to Follow-up|3|||
156868919|NCT02760498|566277427|FG000|Overall Study|Non-compliance with study drug|0|||
156868920|NCT02760498|566277428|FG001|Overall Study|Non-compliance with study drug|2|||
156868921|NCT02760498|566277429|FG002|Overall Study|Non-compliance with study drug|0|||
156868922|NCT02760498|566277430|FG003|Overall Study|Non-compliance with study drug|0|||
156868923|NCT02760498|566277431|FG004|Overall Study|Non-compliance with study drug|0|||
156868924|NCT02760498|566277432|FG005|Overall Study|Non-compliance with study drug|0|||
156868925|NCT02760498|566277427|FG000|Overall Study|Participant decision|1|||
156868926|NCT02760498|566277428|FG001|Overall Study|Participant decision|4|||
156868927|NCT02760498|566277429|FG002|Overall Study|Participant decision|2|||
156868928|NCT02760498|566277430|FG003|Overall Study|Participant decision|2|||
156868929|NCT02760498|566277431|FG004|Overall Study|Participant decision|1|||
156868930|NCT02760498|566277432|FG005|Overall Study|Participant decision|6|||
156868931|NCT02760498|566277427|FG000|Overall Study|Sponsor decision|0|||
156868932|NCT02760498|566277428|FG001|Overall Study|Sponsor decision|0|||
156868933|NCT02760498|566277429|FG002|Overall Study|Sponsor decision|0|||
156868934|NCT02760498|566277430|FG003|Overall Study|Sponsor decision|3|||
156868935|NCT02760498|566277431|FG004|Overall Study|Sponsor decision|0|||
156868936|NCT02760498|566277432|FG005|Overall Study|Sponsor decision|0|||
156868937|NCT02760498|566277427|FG000|Overall Study|Physician Decision|3|||
156868938|NCT02760498|566277428|FG001|Overall Study|Physician Decision|4|||
156868939|NCT02760498|566277429|FG002|Overall Study|Physician Decision|1|||
156868940|NCT02760498|566277430|FG003|Overall Study|Physician Decision|4|||
156868941|NCT02760498|566277431|FG004|Overall Study|Physician Decision|0|||
156868942|NCT02760498|566277432|FG005|Overall Study|Physician Decision|2|||
156868943|NCT02760498|566277427|FG000|Overall Study|Disease progression|21|||
156868944|NCT02760498|566277428|FG001|Overall Study|Disease progression|19|||
156868945|NCT02760498|566277429|FG002|Overall Study|Disease progression|20|||
156868946|NCT02760498|566277430|FG003|Overall Study|Disease progression|18|||
156868947|NCT02760498|566277431|FG004|Overall Study|Disease progression|4|||
156868948|NCT02760498|566277432|FG005|Overall Study|Disease progression|55|||
156868949|NCT02760498|566277427|FG000|Overall Study|Withdrawal by Subject|4|||
156868950|NCT02760498|566277428|FG001|Overall Study|Withdrawal by Subject|7|||
156868951|NCT02760498|566277429|FG002|Overall Study|Withdrawal by Subject|5|||
156868952|NCT02760498|566277430|FG003|Overall Study|Withdrawal by Subject|1|||
156868953|NCT02760498|566277431|FG004|Overall Study|Withdrawal by Subject|0|||
156868954|NCT02760498|566277432|FG005|Overall Study|Withdrawal by Subject|6|||
156868955|NCT02760498|566277427|FG000|Overall Study|Other than specified|1|||
156868956|NCT02760498|566277428|FG001|Overall Study|Other than specified|6|||
156530286|NCT03027557|565036359|FG001|Overall Study|Adverse Event|0|||
156530287|NCT03027557|565036360|FG002|Overall Study|Adverse Event|0|||
156530288|NCT02430051|565036363|FG000|Overall Study|Withdrawal by Subject|6|||
156530289|NCT02430051|565036364|FG001|Overall Study|Withdrawal by Subject|3|||
156530290|NCT02430051|565036363|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
156530291|NCT02430051|565036364|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
156530292|NCT02430051|565036363|FG000|Overall Study|Protocol Violation|1|||
156530293|NCT02430051|565036364|FG001|Overall Study|Protocol Violation|0|||
156530294|NCT02030405|565036370|FG000|Overall Study|Withdrawal by Subject|1|||
156530295|NCT02030405|565036370|FG000|Overall Study|Lost to Follow-up|1|||
156530296|NCT00132496|565036371|FG000|Overall Study|Withdrawal by Subject|1|||
156530297|NCT00132496|565036372|FG001|Overall Study|Withdrawal by Subject|2|||
156530298|NCT00132496|565036371|FG000|Overall Study|Physician Decision|1|||
156530299|NCT00132496|565036372|FG001|Overall Study|Physician Decision|0|||
156530300|NCT00388154|565036375|FG000|Overall Study|Withdrawal by Subject|1|||
156530301|NCT04526197|565036381|FG000|Period 1|Adverse Event|0|||
156530302|NCT04526197|565036382|FG001|Period 1|Adverse Event|1|||
156530303|NCT04526197|565036381|FG000|Period 1|Withdrawal by Subject|1|||
156530304|NCT04526197|565036382|FG001|Period 1|Withdrawal by Subject|0|||
156686184|NCT02688387|565596317|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156868957|NCT02760498|566277429|FG002|Overall Study|Other than specified|0|||
156868958|NCT02760498|566277430|FG003|Overall Study|Other than specified|3|||
156868959|NCT02760498|566277431|FG004|Overall Study|Other than specified|1|||
156530305|NCT04526197|565036381|FG000|Period 2|Adverse Event|0|||
156530306|NCT04526197|565036382|FG001|Period 2|Adverse Event|1|||
156530307|NCT04526197|565036381|FG000|Period 2|Withdrawal by Subject|0|||
156530308|NCT04526197|565036382|FG001|Period 2|Withdrawal by Subject|1|||
156530309|NCT01209143|565036383|FG000|Overall Study|Adverse Event|2|||
156530310|NCT01209143|565036384|FG001|Overall Study|Adverse Event|1|||
156530311|NCT01209143|565036383|FG000|Overall Study|Death|0|||
156868960|NCT02760498|566277432|FG005|Overall Study|Other than specified|0|||
156868961|NCT02760498|566277427|FG000|Overall Study|Not treated|0|||
156868962|NCT02760498|566277428|FG001|Overall Study|Not treated|0|||
156868963|NCT02760498|566277429|FG002|Overall Study|Not treated|0|||
156868964|NCT02760498|566277430|FG003|Overall Study|Not treated|0|||
156868965|NCT02760498|566277431|FG004|Overall Study|Not treated|0|||
156868966|NCT02760498|566277432|FG005|Overall Study|Not treated|2|||
156868967|NCT02202759|566278955|FG000|Overall Study|Study Terminated by Sponsor|3|||
156530312|NCT01209143|565036384|FG001|Overall Study|Death|1|||
156785908|NCT02741193|565968179|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
156785909|NCT02502383|565968182|FG000|Overall Study|Lost to Follow-up|130|||
156785910|NCT02502383|565968183|FG001|Overall Study|Lost to Follow-up|131|||
156785911|NCT02502383|565968182|FG000|Overall Study|Withdrawal by Subject|31|||
156785912|NCT02502383|565968183|FG001|Overall Study|Withdrawal by Subject|24|||
156785913|NCT00289978|565968184|FG000|Overall Study|Withdrawal by Subject|31|||
156785914|NCT00289978|565968185|FG001|Overall Study|Withdrawal by Subject|17|||
156785915|NCT00289978|565968186|FG002|Overall Study|Withdrawal by Subject|28|||
156785916|NCT00289978|565968184|FG000|Overall Study|Adverse Event|22|||
156785917|NCT00289978|565968185|FG001|Overall Study|Adverse Event|13|||
156785918|NCT00289978|565968186|FG002|Overall Study|Adverse Event|18|||
156785919|NCT00289978|565968184|FG000|Overall Study|Lack of Efficacy|13|||
156785920|NCT00289978|565968185|FG001|Overall Study|Lack of Efficacy|6|||
156785921|NCT00289978|565968186|FG002|Overall Study|Lack of Efficacy|25|||
156785922|NCT00289978|565968184|FG000|Overall Study|Abnormal laboratory value(s)|20|||
156785923|NCT00289978|565968185|FG001|Overall Study|Abnormal laboratory value(s)|9|||
156785924|NCT00289978|565968186|FG002|Overall Study|Abnormal laboratory value(s)|1|||
156785925|NCT00289978|565968184|FG000|Overall Study|Lost to Follow-up|3|||
156785926|NCT00289978|565968185|FG001|Overall Study|Lost to Follow-up|5|||
156785927|NCT00289978|565968186|FG002|Overall Study|Lost to Follow-up|7|||
156785928|NCT00289978|565968184|FG000|Overall Study|Protocol Violation|5|||
156785929|NCT00289978|565968185|FG001|Overall Study|Protocol Violation|5|||
156785930|NCT00289978|565968186|FG002|Overall Study|Protocol Violation|4|||
156785931|NCT00289978|565968184|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156785932|NCT00289978|565968185|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156785933|NCT00289978|565968186|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156785934|NCT00289978|565968184|FG000|Overall Study|Death|1|||
156785935|NCT00289978|565968185|FG001|Overall Study|Death|0|||
156785936|NCT00289978|565968186|FG002|Overall Study|Death|2|||
156785937|NCT00903344|565968187|FG000|Overall Study|Pregnancy|2|||
156785938|NCT00903344|565968188|FG001|Overall Study|Pregnancy|3|||
156785939|NCT00903344|565968187|FG000|Overall Study|Lost to Follow-up|3|||
156785940|NCT00903344|565968188|FG001|Overall Study|Lost to Follow-up|0|||
156785941|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
156785942|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
156785943|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
156785944|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
156785945|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
156785946|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
156785947|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
156785948|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
156785949|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
156785950|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
156785951|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
156785952|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
156785953|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
156785954|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
156785955|NCT01243424|565968191|FG000|Discontinuation From Treatment|Not treated|5|||
156785956|NCT01243424|565968192|FG001|Discontinuation From Treatment|Not treated|4|||
156785957|NCT01243424|565968191|FG000|Discontinuation From Treatment|Adverse Event|457|||
156785958|NCT01243424|565968192|FG001|Discontinuation From Treatment|Adverse Event|523|||
156785959|NCT01243424|565968191|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
156785960|NCT01243424|565968192|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
156785961|NCT01243424|565968191|FG000|Discontinuation From Treatment|Protocol Violation|46|||
156785962|NCT01243424|565968192|FG001|Discontinuation From Treatment|Protocol Violation|47|||
156785963|NCT01243424|565968191|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
156785964|NCT01243424|565968192|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
156785965|NCT01243424|565968191|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
156785966|NCT01243424|565968192|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
156785967|NCT01243424|565968191|FG000|Discontinuation From Treatment|Other than listed above|230|||
156785968|NCT01243424|565968192|FG001|Discontinuation From Treatment|Other than listed above|211|||
156785969|NCT01093885|565968212|FG000|Overall Study|Adverse Event|4|||
156785970|NCT01093885|565968212|FG000|Overall Study|Lost to Follow-up|1|||
156329975|NCT04612790|564308730|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
156329976|NCT04612790|564308727|FG000|OLE Period (Up to 1 Year)|Other|0|||
156785971|NCT01301001|565968213|FG000|First Intervention|Lost to Follow-up|4|||
156785972|NCT01301001|565968214|FG001|First Intervention|Lost to Follow-up|4|||
156785973|NCT01301001|565968213|FG000|First Intervention|Withdrawal by Subject|1|||
156785974|NCT01301001|565968214|FG001|First Intervention|Withdrawal by Subject|4|||
156785975|NCT01301001|565968213|FG000|First Intervention|Adverse Event|5|||
156785976|NCT01301001|565968214|FG001|First Intervention|Adverse Event|0|||
156868968|NCT02202759|566278956|FG001|Overall Study|Study Terminated by Sponsor|3|||
156868969|NCT02202759|566278957|FG002|Overall Study|Study Terminated by Sponsor|3|||
156868970|NCT02202759|566278955|FG000|Overall Study|Withdrawal by Subject|2|||
156868971|NCT02202759|566278956|FG001|Overall Study|Withdrawal by Subject|1|||
156868972|NCT02202759|566278957|FG002|Overall Study|Withdrawal by Subject|1|||
156868973|NCT02202759|566278955|FG000|Overall Study|Reason not Specified|4|||
156868974|NCT02202759|566278956|FG001|Overall Study|Reason not Specified|11|||
156868975|NCT02202759|566278957|FG002|Overall Study|Reason not Specified|10|||
156868976|NCT01987453|566278958|FG000|Overall Study|Death|0|||
156868977|NCT01987453|566278959|FG001|Overall Study|Death|0|||
156868978|NCT01987453|566278960|FG002|Overall Study|Death|1|||
156868979|NCT01987453|566278958|FG000|Overall Study|Lack of Efficacy|1|||
156868980|NCT01987453|566278959|FG001|Overall Study|Lack of Efficacy|12|||
156868981|NCT01987453|566278960|FG002|Overall Study|Lack of Efficacy|0|||
156868982|NCT04953728|566278961|FG000|Overall Study|Withdrawal by Subject|3|||
156868983|NCT04953728|566278961|FG000|Overall Study|Physician Decision|1|||
156868984|NCT02904954|566278966|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
156868985|NCT02904954|566278967|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
156868986|NCT02904954|566278966|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
156868987|NCT02904954|566278967|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
156868988|NCT02904954|566278966|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
156868989|NCT02904954|566278967|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
156868990|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Recurrence|2|||
156868991|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Recurrence|0|||
156868992|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Adverse Event|2|||
156868993|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Adverse Event|6|||
156868994|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Participant wishes|12|||
156868995|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Participant wishes|7|||
156868996|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Physician Decision|2|||
156868997|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Physician Decision|1|||
156868998|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
156686185|NCT02688387|565596318|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686186|NCT02688387|565596319|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686187|NCT02688387|565596320|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686188|NCT02688387|565596321|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686189|NCT02688387|565596322|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686190|NCT02688387|565596323|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686191|NCT02688387|565596324|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686192|NCT02688387|565596325|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686193|NCT02688387|565596326|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686194|NCT02688387|565596327|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686195|NCT02688387|565596328|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686196|NCT02688387|565596329|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686197|NCT02688387|565596330|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686198|NCT02688387|565596331|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686199|NCT02688387|565596332|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686200|NCT02688387|565596333|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686201|NCT02688387|565596334|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686202|NCT02688387|565596335|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
156686203|NCT02688387|565596336|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686204|NCT02688387|565596337|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686205|NCT02190279|565596338|FG000|Overall Study|Withdrawal consent|1|||
156686206|NCT02190279|565596339|FG001|Overall Study|Withdrawal consent|0|||
156686207|NCT02190279|565596340|FG002|Overall Study|Withdrawal consent|1|||
156686208|NCT02190279|565596338|FG000|Overall Study|Lost to Follow-up|2|||
156686209|NCT02190279|565596339|FG001|Overall Study|Lost to Follow-up|0|||
156686210|NCT02190279|565596340|FG002|Overall Study|Lost to Follow-up|0|||
156686211|NCT02190279|565596338|FG000|Overall Study|Refused further treatment|0|||
156686212|NCT02190279|565596339|FG001|Overall Study|Refused further treatment|0|||
156686213|NCT02190279|565596340|FG002|Overall Study|Refused further treatment|1|||
156686214|NCT02190279|565596338|FG000|Overall Study|Screening failure|0|||
156686215|NCT02190279|565596339|FG001|Overall Study|Screening failure|0|||
156686216|NCT02190279|565596340|FG002|Overall Study|Screening failure|1|||
156686217|NCT00802178|565596341|FG000|Overall Study|Lack of Efficacy|36|||
156686218|NCT00802178|565596341|FG000|Overall Study|Insufficient tolerability (IT)|17|||
156686219|NCT00802178|565596341|FG000|Overall Study|Withdrawal by Subject|18|||
156868999|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
156869000|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Death|0|||
156869001|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Death|1|||
156869002|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
156869003|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
156869004|NCT00753506|566278968|FG000|Overall Study|Withdrawal by Subject|4|||
156530313|NCT01209143|565036383|FG000|Overall Study|Physician Decision|3|||
156686220|NCT00802178|565596341|FG000|Overall Study|Other|32|||
156686221|NCT00802178|565596341|FG000|Overall Study|Lack of efficacy and patient wish|1|||
156686222|NCT00802178|565596341|FG000|Overall Study|IT and patient wish|8|||
156686223|NCT00802178|565596341|FG000|Overall Study|Patients wish and other reason|1|||
156686224|NCT00831233|565596342|FG000|Overall Study|Adverse Event|0|||
156686225|NCT00831233|565596343|FG001|Overall Study|Adverse Event|1|||
156686226|NCT00831233|565596342|FG000|Overall Study|Protocol Violation|1|||
156686227|NCT00831233|565596343|FG001|Overall Study|Protocol Violation|0|||
156686228|NCT00831233|565596342|FG000|Overall Study|Selection Criteria Not Met|2|||
156686229|NCT00831233|565596343|FG001|Overall Study|Selection Criteria Not Met|0|||
156785977|NCT01301001|565968213|FG000|First Intervention|Protocol Violation|0|||
156785978|NCT01301001|565968214|FG001|First Intervention|Protocol Violation|1|||
156785979|NCT01301001|565968213|FG000|Second Intervention|Adverse Event|2|||
156785980|NCT01301001|565968214|FG001|Second Intervention|Adverse Event|0|||
156785981|NCT01301001|565968213|FG000|Second Intervention|Withdrawal by Subject|2|||
156785982|NCT01301001|565968214|FG001|Second Intervention|Withdrawal by Subject|0|||
156785983|NCT04535362|565968215|FG000|Overall Study|Lost to Follow-up|3|||
156785984|NCT04535362|565968216|FG001|Overall Study|Lost to Follow-up|1|||
156785985|NCT03791060|565968217|FG000|Overall Study|Withdrawal by Subject|1|||
156785986|NCT02852434|565968218|FG000|Overall Study|Withdrawal by Subject|0|||
156785987|NCT02852434|565968219|FG001|Overall Study|Withdrawal by Subject|1|||
156785988|NCT02852434|565968218|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
156785989|NCT02852434|565968219|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
156785990|NCT02018887|565968222|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
156785991|NCT02018887|565968223|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785992|NCT02018887|565968224|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785993|NCT02018887|565968225|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785994|NCT02018887|565968226|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785995|NCT02018887|565968227|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785996|NCT02018887|565968228|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785997|NCT02018887|565968229|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785998|NCT02018887|565968230|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785999|NCT02018887|565968231|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156786000|NCT02018887|565968232|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156786001|NCT02018887|565968222|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786002|NCT02018887|565968223|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786003|NCT02018887|565968224|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786004|NCT02018887|565968225|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786005|NCT02018887|565968226|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
156786006|NCT02018887|565968227|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786007|NCT02018887|565968228|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
156786008|NCT02018887|565968229|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
156786009|NCT02018887|565968230|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786010|NCT02018887|565968231|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786011|NCT02018887|565968232|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786012|NCT02018887|565968222|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
156786013|NCT02018887|565968223|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
156786014|NCT02018887|565968224|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
156786015|NCT02018887|565968225|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
156786016|NCT02018887|565968226|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
156786017|NCT02018887|565968227|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
156786018|NCT02018887|565968228|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
156786019|NCT02018887|565968229|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
156786020|NCT02018887|565968230|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
156786021|NCT02018887|565968231|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
156786022|NCT02018887|565968232|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
156786023|NCT02018887|565968222|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
156530314|NCT01209143|565036384|FG001|Overall Study|Physician Decision|1|||
156786024|NCT02018887|565968223|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
156786025|NCT02018887|565968224|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
156786026|NCT02018887|565968225|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
156786027|NCT02018887|565968226|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
156786028|NCT02018887|565968227|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
156786029|NCT02018887|565968228|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
156786030|NCT02018887|565968229|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
156786031|NCT02018887|565968230|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
156786032|NCT02018887|565968231|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
156786033|NCT02018887|565968232|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
156786034|NCT01145222|565968233|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
156786035|NCT01145222|565968234|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
156786036|NCT01145222|565968235|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
156786037|NCT01145222|565968236|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
156786038|NCT01145222|565968233|FG000|Overall Study|Poor bowel preparation|0|||
156786039|NCT01145222|565968234|FG001|Overall Study|Poor bowel preparation|0|||
156686230|NCT00784134|565596344|FG000|Overall Study|Lost to Follow-up|3|||
156686231|NCT00784134|565596345|FG001|Overall Study|Lost to Follow-up|6|||
156686232|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
156869005|NCT00753506|566278969|FG001|Overall Study|Withdrawal by Subject|1|||
156869006|NCT00753506|566278968|FG000|Overall Study|Lost to Follow-up|2|||
156869007|NCT00753506|566278969|FG001|Overall Study|Lost to Follow-up|0|||
156869008|NCT00753506|566278968|FG000|Overall Study|Other reason|1|||
156869009|NCT00753506|566278969|FG001|Overall Study|Other reason|1|||
156869010|NCT04226742|566278970|FG000|Overall Study|Lost to Follow-up|16|||
156869011|NCT04226742|566278971|FG001|Overall Study|Lost to Follow-up|13|||
156869012|NCT04226742|566278970|FG000|Overall Study|Withdrawal by Subject|5|||
156869013|NCT04226742|566278971|FG001|Overall Study|Withdrawal by Subject|3|||
156869014|NCT00123422|566278977|FG000|Overall Study|Physician Decision|2|||
156869015|NCT00123422|566278978|FG001|Overall Study|Physician Decision|2|||
156869016|NCT00123422|566278979|FG002|Overall Study|Physician Decision|6|||
156869017|NCT00123422|566278977|FG000|Overall Study|Withdrawal by Subject|1|||
156869018|NCT00123422|566278978|FG001|Overall Study|Withdrawal by Subject|2|||
156869019|NCT00123422|566278979|FG002|Overall Study|Withdrawal by Subject|2|||
156869020|NCT00123422|566278977|FG000|Overall Study|Lost to Follow-up|1|||
156869021|NCT00123422|566278978|FG001|Overall Study|Lost to Follow-up|2|||
156869022|NCT00123422|566278979|FG002|Overall Study|Lost to Follow-up|2|||
156869023|NCT04646044|566278980|FG000|Overall Study|Lost to Follow-up|0|||
156869024|NCT04646044|566278981|FG001|Overall Study|Lost to Follow-up|0|||
156869025|NCT04646044|566278982|FG002|Overall Study|Lost to Follow-up|1|||
156869026|NCT04646044|566278983|FG003|Overall Study|Lost to Follow-up|0|||
156686233|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
156686234|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
156686235|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
156686236|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
156686237|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
156686238|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
156686239|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
156686240|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
156686241|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
156686242|NCT03785145|565596346|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
156686243|NCT03785145|565596347|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
156686244|NCT03785145|565596346|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
156686245|NCT03785145|565596347|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
156686246|NCT03785145|565596346|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
156686247|NCT03785145|565596347|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
156686248|NCT03785145|565596346|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
156686249|NCT03785145|565596347|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
156686250|NCT03785145|565596346|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
156686251|NCT03785145|565596347|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
156686252|NCT03785145|565596346|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
156686253|NCT03785145|565596347|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
156686254|NCT02211014|565596348|FG000|Overall Study|Adverse Event|0|||
156686255|NCT02211014|565596349|FG001|Overall Study|Adverse Event|2|||
156686256|NCT02211014|565596348|FG000|Overall Study|Physician Decision|1|||
156686257|NCT02211014|565596349|FG001|Overall Study|Physician Decision|2|||
156686258|NCT02211014|565596348|FG000|Overall Study|Started another cancer therapy|1|||
156686259|NCT02211014|565596349|FG001|Overall Study|Started another cancer therapy|0|||
156686260|NCT02211014|565596348|FG000|Overall Study|Withdrawal by Subject|0|||
156686261|NCT02211014|565596349|FG001|Overall Study|Withdrawal by Subject|1|||
156686262|NCT02211014|565596348|FG000|Overall Study|In agreement with patient, no benefit|0|||
156686263|NCT02211014|565596349|FG001|Overall Study|In agreement with patient, no benefit|1|||
156686264|NCT00097786|565596350|FG000|Overall Study|lost to follow-up for all-cause death|296|||
156686265|NCT00097786|565596351|FG001|Overall Study|lost to follow-up for all-cause death|292|||
156686266|NCT00097786|565596352|FG002|Overall Study|lost to follow-up for all-cause death|313|||
156686267|NCT00097786|565596353|FG003|Overall Study|lost to follow-up for all-cause death|310|||
156686268|NCT02443324|565596355|FG000|Overall Study|Death|4|||
156686269|NCT02443324|565596356|FG001|Overall Study|Death|1|||
156686270|NCT02443324|565596357|FG002|Overall Study|Death|0|||
156686271|NCT02443324|565596358|FG003|Overall Study|Death|3|||
156686272|NCT02443324|565596359|FG004|Overall Study|Death|1|||
156686273|NCT02443324|565596360|FG005|Overall Study|Death|3|||
156869027|NCT04646044|566278980|FG000|Overall Study|Withdrawal by Subject|0|||
156869028|NCT04646044|566278981|FG001|Overall Study|Withdrawal by Subject|1|||
156869029|NCT04646044|566278982|FG002|Overall Study|Withdrawal by Subject|0|||
156869030|NCT04646044|566278983|FG003|Overall Study|Withdrawal by Subject|0|||
156869031|NCT01908803|566278984|FG000|Overall Study|Adverse Event|1|||
156869032|NCT01908803|566278985|FG001|Overall Study|Adverse Event|0|||
156686274|NCT02443324|565596361|FG006|Overall Study|Death|2|||
156686275|NCT02443324|565596355|FG000|Overall Study|Lost to Follow-up|0|||
156686276|NCT02443324|565596356|FG001|Overall Study|Lost to Follow-up|0|||
156686277|NCT02443324|565596357|FG002|Overall Study|Lost to Follow-up|0|||
156686278|NCT02443324|565596358|FG003|Overall Study|Lost to Follow-up|1|||
156686279|NCT02443324|565596359|FG004|Overall Study|Lost to Follow-up|0|||
156686280|NCT02443324|565596360|FG005|Overall Study|Lost to Follow-up|1|||
156686281|NCT02443324|565596361|FG006|Overall Study|Lost to Follow-up|0|||
156686282|NCT02443324|565596355|FG000|Overall Study|Physician Decision|0|||
156686283|NCT02443324|565596356|FG001|Overall Study|Physician Decision|3|||
156686284|NCT02443324|565596357|FG002|Overall Study|Physician Decision|5|||
156869033|NCT01908803|566278984|FG000|Overall Study|Physician Decision|0|||
156530315|NCT01209143|565036383|FG000|Overall Study|Lost to Follow-up|1|||
156530316|NCT01209143|565036384|FG001|Overall Study|Lost to Follow-up|0|||
156686285|NCT02443324|565596358|FG003|Overall Study|Physician Decision|1|||
156686286|NCT02443324|565596359|FG004|Overall Study|Physician Decision|1|||
156686287|NCT02443324|565596360|FG005|Overall Study|Physician Decision|0|||
156686288|NCT02443324|565596361|FG006|Overall Study|Physician Decision|2|||
156686289|NCT02443324|565596355|FG000|Overall Study|Progressive Disease|20|||
156686290|NCT02443324|565596356|FG001|Overall Study|Progressive Disease|20|||
156686291|NCT02443324|565596357|FG002|Overall Study|Progressive Disease|13|||
156686292|NCT02443324|565596358|FG003|Overall Study|Progressive Disease|10|||
156686293|NCT02443324|565596359|FG004|Overall Study|Progressive Disease|13|||
156686294|NCT02443324|565596360|FG005|Overall Study|Progressive Disease|17|||
156686295|NCT02443324|565596361|FG006|Overall Study|Progressive Disease|10|||
156686296|NCT02443324|565596355|FG000|Overall Study|Withdrawal by Subject|0|||
156686297|NCT02443324|565596356|FG001|Overall Study|Withdrawal by Subject|0|||
156686298|NCT02443324|565596357|FG002|Overall Study|Withdrawal by Subject|3|||
156686299|NCT02443324|565596358|FG003|Overall Study|Withdrawal by Subject|1|||
156686300|NCT02443324|565596359|FG004|Overall Study|Withdrawal by Subject|1|||
156686301|NCT02443324|565596360|FG005|Overall Study|Withdrawal by Subject|0|||
156686302|NCT02443324|565596361|FG006|Overall Study|Withdrawal by Subject|1|||
156686303|NCT02443324|565596355|FG000|Overall Study|Adverse Event|0|||
156686304|NCT02443324|565596356|FG001|Overall Study|Adverse Event|1|||
156686305|NCT02443324|565596357|FG002|Overall Study|Adverse Event|3|||
156686306|NCT02443324|565596358|FG003|Overall Study|Adverse Event|0|||
156686307|NCT02443324|565596359|FG004|Overall Study|Adverse Event|4|||
156686308|NCT02443324|565596360|FG005|Overall Study|Adverse Event|3|||
156686309|NCT02443324|565596361|FG006|Overall Study|Adverse Event|3|||
156686310|NCT02443324|565596355|FG000|Overall Study|Enrolled but Never Treated|0|||
156686311|NCT02443324|565596356|FG001|Overall Study|Enrolled but Never Treated|0|||
156686312|NCT02443324|565596357|FG002|Overall Study|Enrolled but Never Treated|1|||
156686313|NCT02443324|565596358|FG003|Overall Study|Enrolled but Never Treated|0|||
156686314|NCT02443324|565596359|FG004|Overall Study|Enrolled but Never Treated|1|||
156686315|NCT02443324|565596360|FG005|Overall Study|Enrolled but Never Treated|0|||
156686316|NCT02443324|565596361|FG006|Overall Study|Enrolled but Never Treated|1|||
156686317|NCT01647711|565596362|FG000|Overall Study|Progressive disease|6|||
156686318|NCT01647711|565596363|FG001|Overall Study|Progressive disease|2|||
156686319|NCT01647711|565596364|FG002|Overall Study|Progressive disease|6|||
156686320|NCT01647711|565596365|FG003|Overall Study|Progressive disease|8|||
156686321|NCT01647711|565596366|FG004|Overall Study|Progressive disease|2|||
156686322|NCT01647711|565596362|FG000|Overall Study|Other adverse event|0|||
156686323|NCT01647711|565596363|FG001|Overall Study|Other adverse event|0|||
156686324|NCT01647711|565596364|FG002|Overall Study|Other adverse event|2|||
156686325|NCT01647711|565596365|FG003|Overall Study|Other adverse event|0|||
156686326|NCT01647711|565596366|FG004|Overall Study|Other adverse event|2|||
156530317|NCT01209143|565036383|FG000|Overall Study|Withdrawal by Subject|2|||
156530318|NCT01209143|565036384|FG001|Overall Study|Withdrawal by Subject|1|||
156686327|NCT01647711|565596362|FG000|Overall Study|Protocol Violation|0|||
156686328|NCT01647711|565596363|FG001|Overall Study|Protocol Violation|0|||
156686329|NCT01647711|565596364|FG002|Overall Study|Protocol Violation|0|||
156686330|NCT01647711|565596365|FG003|Overall Study|Protocol Violation|0|||
156686331|NCT01647711|565596366|FG004|Overall Study|Protocol Violation|1|||
156686332|NCT01647711|565596362|FG000|Overall Study|Refused to continue taking medication|0|||
156686333|NCT01647711|565596363|FG001|Overall Study|Refused to continue taking medication|0|||
156686334|NCT01647711|565596364|FG002|Overall Study|Refused to continue taking medication|0|||
156686335|NCT01647711|565596365|FG003|Overall Study|Refused to continue taking medication|2|||
156686336|NCT01647711|565596366|FG004|Overall Study|Refused to continue taking medication|1|||
156686337|NCT01647711|565596362|FG000|Overall Study|Other reason not defined|0|||
156686338|NCT01647711|565596363|FG001|Overall Study|Other reason not defined|1|||
156686339|NCT01647711|565596364|FG002|Overall Study|Other reason not defined|1|||
156686340|NCT01647711|565596365|FG003|Overall Study|Other reason not defined|1|||
156686341|NCT01647711|565596366|FG004|Overall Study|Other reason not defined|0|||
156686342|NCT01316419|565596367|FG000|Overall Study|Not treated|103|||
156686343|NCT01316419|565596367|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
156686344|NCT01316419|565596367|FG000|Overall Study|Lost to Follow-up|19|||
156686345|NCT01345318|565596368|FG000|Overall Study|Adverse Event|16|||
156686346|NCT01345318|565596368|FG000|Overall Study|Lack of Efficacy|17|||
156869034|NCT01908803|566278985|FG001|Overall Study|Physician Decision|1|||
156869035|NCT01908803|566278984|FG000|Overall Study|Withdrawal by Subject|1|||
156869036|NCT01908803|566278985|FG001|Overall Study|Withdrawal by Subject|0|||
156869037|NCT01908803|566278984|FG000|Overall Study|Randomization Error|1|||
156869038|NCT01908803|566278985|FG001|Overall Study|Randomization Error|0|||
156869039|NCT01908803|566278984|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
156869040|NCT01908803|566278985|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
156869041|NCT00823615|566278986|FG000|Period 2|Lost to Follow-up|2|||
156869042|NCT00823615|566278987|FG001|Period 2|Lost to Follow-up|0|||
156869043|NCT00823615|566278986|FG000|Period 2|Time/Job Conflict|1|||
156869044|NCT00823615|566278987|FG001|Period 2|Time/Job Conflict|2|||
156869045|NCT02215252|566278989|FG000|Overall Study|Adverse Event|1|||
156869046|NCT02215252|566278990|FG001|Overall Study|Adverse Event|5|||
156869047|NCT02215252|566278991|FG002|Overall Study|Adverse Event|2|||
156869048|NCT02215252|566278989|FG000|Overall Study|Lost to Follow-up|0|||
156869049|NCT02215252|566278990|FG001|Overall Study|Lost to Follow-up|0|||
156869050|NCT02215252|566278991|FG002|Overall Study|Lost to Follow-up|1|||
156869051|NCT02215252|566278989|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
156869052|NCT02215252|566278990|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
156869053|NCT02215252|566278991|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
156869054|NCT02215252|566278989|FG000|Overall Study|Protocol Violation|0|||
156869055|NCT02215252|566278990|FG001|Overall Study|Protocol Violation|1|||
156869056|NCT02215252|566278991|FG002|Overall Study|Protocol Violation|0|||
156869057|NCT02215252|566278989|FG000|Overall Study|Withdrawal by Subject|1|||
156869058|NCT02215252|566278990|FG001|Overall Study|Withdrawal by Subject|0|||
156869059|NCT02215252|566278991|FG002|Overall Study|Withdrawal by Subject|0|||
156869060|NCT02215252|566278989|FG000|Overall Study|Other|0|||
156869061|NCT02215252|566278990|FG001|Overall Study|Other|1|||
156869062|NCT02215252|566278991|FG002|Overall Study|Other|1|||
156869063|NCT02118961|566278992|FG000|Overall Study|Withdrawal by Subject|1|||
156869064|NCT02118961|566278993|FG001|Overall Study|Withdrawal by Subject|0|||
156869065|NCT01657019|566278995|FG000|Overall Study|Withdrawal by Subject|65|||
156869066|NCT01657019|566278995|FG000|Overall Study|Adverse Event|55|||
156869067|NCT01657019|566278995|FG000|Overall Study|Lost to Follow-up|48|||
156869068|NCT01657019|566278995|FG000|Overall Study|Protocol Violation|6|||
156869069|NCT01657019|566278995|FG000|Overall Study|Lack of Efficacy|3|||
156869070|NCT01657019|566278995|FG000|Overall Study|Other|58|||
156869071|NCT03910244|566278996|FG000|Overall Study|Adverse Event|14|||
156869072|NCT03910244|566278997|FG001|Overall Study|Adverse Event|0|||
156869073|NCT03910244|566278996|FG000|Overall Study|Death|1|||
156869074|NCT03910244|566278997|FG001|Overall Study|Death|0|||
156869075|NCT03910244|566278996|FG000|Overall Study|Lost to Follow-up|0|||
156869076|NCT03910244|566278997|FG001|Overall Study|Lost to Follow-up|2|||
156869077|NCT03910244|566278996|FG000|Overall Study|Joint withdrawal decision|1|||
156869078|NCT03910244|566278997|FG001|Overall Study|Joint withdrawal decision|0|||
156786040|NCT01145222|565968235|FG002|Overall Study|Poor bowel preparation|0|||
156786041|NCT01145222|565968236|FG003|Overall Study|Poor bowel preparation|1|||
156786042|NCT01011283|565968237|FG000|Overall Study|Adverse Event|4|||
156786043|NCT01011283|565968238|FG001|Overall Study|Adverse Event|2|||
156786044|NCT01011283|565968237|FG000|Overall Study|Progressive Disease|0|||
156786045|NCT01011283|565968238|FG001|Overall Study|Progressive Disease|2|||
156786046|NCT01011283|565968237|FG000|Overall Study|Terminated by Sponsor|5|||
156786047|NCT01011283|565968238|FG001|Overall Study|Terminated by Sponsor|5|||
156786048|NCT01011283|565968237|FG000|Overall Study|Other|2|||
156786049|NCT01011283|565968238|FG001|Overall Study|Other|2|||
156786050|NCT04689009|565968239|FG000|Overall Study|Adverse Event|1|||
156786051|NCT04689009|565968240|FG001|Overall Study|Adverse Event|0|||
156786052|NCT04689009|565968239|FG000|Overall Study|Lost to Follow-up|1|||
156786053|NCT04689009|565968240|FG001|Overall Study|Lost to Follow-up|2|||
156786054|NCT04689009|565968239|FG000|Overall Study|Withdrawal by Subject|4|||
156786055|NCT04689009|565968240|FG001|Overall Study|Withdrawal by Subject|3|||
156786056|NCT04689009|565968239|FG000|Overall Study|Protocol Violation|1|||
156786057|NCT04689009|565968240|FG001|Overall Study|Protocol Violation|0|||
156786058|NCT00985790|565968241|FG000|Overall Study|Withdrawal by Subject|1|||
156786059|NCT00985790|565968242|FG001|Overall Study|Withdrawal by Subject|1|||
156786060|NCT00985790|565968241|FG000|Overall Study|Lost to Follow-up|6|||
156786061|NCT00985790|565968242|FG001|Overall Study|Lost to Follow-up|7|||
156869079|NCT03910244|566278996|FG000|Overall Study|Study Terminated by Sponsor|7|||
156786062|NCT01666314|565968243|FG000|Overall Study|Adverse Event|3|||
156869080|NCT03910244|566278997|FG001|Overall Study|Study Terminated by Sponsor|4|||
156869081|NCT03910244|566278996|FG000|Overall Study|Physician Decision|1|||
156869082|NCT03910244|566278997|FG001|Overall Study|Physician Decision|0|||
156869083|NCT03910244|566278996|FG000|Overall Study|Protocol Violation|1|||
156869084|NCT03910244|566278997|FG001|Overall Study|Protocol Violation|0|||
156869085|NCT03910244|566278996|FG000|Overall Study|Withdrawal by Subject|7|||
156869086|NCT03910244|566278997|FG001|Overall Study|Withdrawal by Subject|2|||
156786063|NCT01666314|565968244|FG001|Overall Study|Adverse Event|13|||
156786064|NCT01666314|565968245|FG002|Overall Study|Adverse Event|7|||
156786065|NCT01666314|565968246|FG003|Overall Study|Adverse Event|7|||
156786066|NCT01666314|565968243|FG000|Overall Study|Progressive Disease|11|||
156786067|NCT01666314|565968244|FG001|Overall Study|Progressive Disease|9|||
156786068|NCT01666314|565968245|FG002|Overall Study|Progressive Disease|19|||
156786069|NCT01666314|565968246|FG003|Overall Study|Progressive Disease|20|||
156786070|NCT01666314|565968243|FG000|Overall Study|Symptomatic Deterioration|1|||
156786071|NCT01666314|565968244|FG001|Overall Study|Symptomatic Deterioration|0|||
156786072|NCT01666314|565968245|FG002|Overall Study|Symptomatic Deterioration|2|||
156786073|NCT01666314|565968246|FG003|Overall Study|Symptomatic Deterioration|0|||
156786074|NCT01666314|565968243|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
156786075|NCT01666314|565968244|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
156786076|NCT01666314|565968245|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
156786077|NCT01666314|565968246|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
156786078|NCT01666314|565968243|FG000|Overall Study|Withdrawal by Subject|1|||
156786079|NCT01666314|565968244|FG001|Overall Study|Withdrawal by Subject|1|||
156786080|NCT01666314|565968245|FG002|Overall Study|Withdrawal by Subject|2|||
156786081|NCT01666314|565968246|FG003|Overall Study|Withdrawal by Subject|3|||
156786082|NCT01666314|565968243|FG000|Overall Study|Reason not Specified|10|||
156786083|NCT01666314|565968244|FG001|Overall Study|Reason not Specified|7|||
156786084|NCT01666314|565968245|FG002|Overall Study|Reason not Specified|5|||
156786085|NCT01666314|565968246|FG003|Overall Study|Reason not Specified|5|||
156786086|NCT05089357|565968253|FG000|Overall Study|Withdrawal by Subject|23|||
156786087|NCT05089357|565968253|FG000|Overall Study|Lost to Follow-up|6|||
156786088|NCT05089357|565968253|FG000|Overall Study|Medical reason|1|||
156786089|NCT05089357|565968253|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
156786090|NCT05089357|565968253|FG000|Overall Study|Pregnancy|2|||
156786091|NCT02021318|565968254|FG000|Overall Study|Adverse Event|2|||
156786092|NCT02021318|565968255|FG001|Overall Study|Adverse Event|1|||
156786093|NCT02021318|565968254|FG000|Overall Study|Death|33|||
156786094|NCT02021318|565968255|FG001|Overall Study|Death|34|||
156786095|NCT02021318|565968254|FG000|Overall Study|Lost to Follow-up|3|||
156786096|NCT02021318|565968255|FG001|Overall Study|Lost to Follow-up|3|||
156786097|NCT02021318|565968254|FG000|Overall Study|Progressive Disease|0|||
156786098|NCT02021318|565968255|FG001|Overall Study|Progressive Disease|1|||
156786099|NCT02021318|565968254|FG000|Overall Study|Withdrawal by Subject|30|||
156786100|NCT02021318|565968255|FG001|Overall Study|Withdrawal by Subject|18|||
156786101|NCT02021318|565968254|FG000|Overall Study|Physician Decision|3|||
156786102|NCT02021318|565968255|FG001|Overall Study|Physician Decision|3|||
156786103|NCT02021318|565968254|FG000|Overall Study|Miscellaneous|2|||
156786104|NCT02021318|565968255|FG001|Overall Study|Miscellaneous|3|||
156786105|NCT00689052|565968256|FG000|Overall Study|Adverse Event|4|||
156786106|NCT00689052|565968257|FG001|Overall Study|Adverse Event|6|||
156786107|NCT00689052|565968256|FG000|Overall Study|Protocol Violation|1|||
156786108|NCT00689052|565968257|FG001|Overall Study|Protocol Violation|0|||
156786109|NCT00689052|565968256|FG000|Overall Study|Lost to Follow-up|2|||
156786110|NCT00689052|565968257|FG001|Overall Study|Lost to Follow-up|0|||
156786111|NCT00689052|565968256|FG000|Overall Study|Withdrawal by Subject|2|||
156786112|NCT00689052|565968257|FG001|Overall Study|Withdrawal by Subject|0|||
156786113|NCT00689052|565968256|FG000|Overall Study|Early termination of the trial|22|||
156786114|NCT00689052|565968257|FG001|Overall Study|Early termination of the trial|24|||
156786115|NCT04180696|565968258|FG000|Overall Study|Death|5|||
156786116|NCT04180696|565968259|FG001|Overall Study|Death|6|||
156786117|NCT04180696|565968258|FG000|Overall Study|Lost to Follow-up|1|||
156786118|NCT04180696|565968259|FG001|Overall Study|Lost to Follow-up|0|||
156786119|NCT04180696|565968258|FG000|Overall Study|Withdrawal by Subject|0|||
156786120|NCT04180696|565968259|FG001|Overall Study|Withdrawal by Subject|1|||
156786121|NCT01727154|565968267|FG000|Overall Study|Death|17|||
156786122|NCT01727154|565968267|FG000|Overall Study|Withdrawal by Subject|14|||
156786123|NCT01727154|565968267|FG000|Overall Study|Subject Withdrew Consent|18|||
156786124|NCT01727154|565968267|FG000|Overall Study|Study Terminated|6|||
156786125|NCT01727154|565968267|FG000|Overall Study|No Discontinuation Documentation|4|||
156786126|NCT00003474|565968268|FG000|Overall Study|Not Evaluable|14|||
156786127|NCT03020888|565968269|FG000|Overall Study|Physician Decision|4|||
156786128|NCT03020888|565968269|FG000|Overall Study|Withdrawal by Subject|6|||
156786129|NCT03020888|565968269|FG000|Overall Study|Insurance coverage|2|||
156786130|NCT03020888|565968269|FG000|Overall Study|Lost to Follow-up|1|||
156786131|NCT01198548|565968275|FG000|Overall Study|Disease Progression|9|||
156786132|NCT01198548|565968275|FG000|Overall Study|Administrative Decision|1|||
156786133|NCT02015104|565968276|FG000|Overall Study|Withdrew consent after first dose drug|1|||
156786134|NCT02015104|565968277|FG001|Overall Study|Withdrew consent after first dose drug|0|||
156786135|NCT02015104|565968276|FG000|Overall Study|Withdrew consent prior to treatment|0|||
156786136|NCT02015104|565968277|FG001|Overall Study|Withdrew consent prior to treatment|1|||
156786137|NCT06025695|565968278|FG000|Overall Study|Adverse Event|5|||
156786138|NCT06025695|565968279|FG001|Overall Study|Adverse Event|6|||
156786139|NCT06025695|565968278|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
156786140|NCT06025695|565968279|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
156786141|NCT06025695|565968278|FG000|Overall Study|Other|23|||
156786142|NCT06025695|565968279|FG001|Overall Study|Other|19|||
156786143|NCT06025695|565968278|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
156786144|NCT06025695|565968279|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
156786145|NCT01452347|565968280|FG000|Overall Study|Adverse Event|2|||
156786146|NCT01452347|565968281|FG001|Overall Study|Adverse Event|1|||
156786147|NCT01452347|565968280|FG000|Overall Study|Non compliance protocol|2|||
156786148|NCT01452347|565968281|FG001|Overall Study|Non compliance protocol|0|||
156786149|NCT01452347|565968280|FG000|Overall Study|Lost to Follow-up|2|||
156786150|NCT01452347|565968281|FG001|Overall Study|Lost to Follow-up|0|||
156786151|NCT01452347|565968280|FG000|Overall Study|Withdrawal by Subject|3|||
156786152|NCT01452347|565968281|FG001|Overall Study|Withdrawal by Subject|3|||
156786153|NCT01452347|565968280|FG000|Overall Study|Not treated|6|||
156786154|NCT01452347|565968281|FG001|Overall Study|Not treated|3|||
156786155|NCT01452347|565968280|FG000|Overall Study|Other reason not defined above|2|||
156786156|NCT01452347|565968281|FG001|Overall Study|Other reason not defined above|0|||
156786157|NCT01030900|565968282|FG000|Overall Study|Not treated due to congestive heart failure|1|||
156786158|NCT01030900|565968282|FG000|Overall Study|Not treated due to rapid disease|1|||
156786159|NCT00441896|565968283|FG000|Overall Study|Withdrawal by Subject|0|||
156786160|NCT00441896|565968284|FG001|Overall Study|Withdrawal by Subject|0|||
156786161|NCT00441896|565968285|FG002|Overall Study|Withdrawal by Subject|0|||
156786162|NCT00441896|565968286|FG003|Overall Study|Withdrawal by Subject|1|||
156786163|NCT00441896|565968287|FG004|Overall Study|Withdrawal by Subject|0|||
156786164|NCT00441896|565968288|FG005|Overall Study|Withdrawal by Subject|0|||
156786165|NCT00441896|565968289|FG006|Overall Study|Withdrawal by Subject|0|||
156786166|NCT00441896|565968290|FG007|Overall Study|Withdrawal by Subject|0|||
156786167|NCT00441896|565968291|FG008|Overall Study|Withdrawal by Subject|0|||
156786168|NCT00441896|565968292|FG009|Overall Study|Withdrawal by Subject|0|||
156786169|NCT00441896|565968283|FG000|Overall Study|Other|0|||
156786170|NCT00441896|565968284|FG001|Overall Study|Other|0|||
156786171|NCT00441896|565968285|FG002|Overall Study|Other|0|||
156786172|NCT00441896|565968286|FG003|Overall Study|Other|0|||
156786173|NCT00441896|565968287|FG004|Overall Study|Other|1|||
156786174|NCT00441896|565968288|FG005|Overall Study|Other|0|||
156786175|NCT00441896|565968289|FG006|Overall Study|Other|0|||
156786176|NCT00441896|565968290|FG007|Overall Study|Other|0|||
156786177|NCT00441896|565968291|FG008|Overall Study|Other|0|||
156786178|NCT00441896|565968292|FG009|Overall Study|Other|0|||
156786179|NCT01301092|565968293|FG000|Overall Study|Lost to Follow-up|0|||
156786180|NCT01301092|565968294|FG001|Overall Study|Lost to Follow-up|0|||
156786181|NCT01301092|565968295|FG002|Overall Study|Lost to Follow-up|1|||
156786182|NCT03334175|565968296|FG000|Overall Study|Lost to Follow-up|0|||
156786183|NCT03334175|565968297|FG001|Overall Study|Lost to Follow-up|1|||
156786184|NCT01350973|565968301|FG000|Overall Study|Adverse Event|4|||
156786185|NCT01350973|565968302|FG001|Overall Study|Adverse Event|7|||
156786186|NCT01350973|565968303|FG002|Overall Study|Adverse Event|7|||
156786187|NCT01350973|565968301|FG000|Overall Study|Voluntary Withdrawal|2|||
156786188|NCT01350973|565968302|FG001|Overall Study|Voluntary Withdrawal|1|||
156786189|NCT01350973|565968303|FG002|Overall Study|Voluntary Withdrawal|1|||
156786190|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
156786191|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
156786192|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
156786193|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
156786194|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
156786195|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156786196|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
156786197|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
156786198|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
156786199|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
156786200|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
156786201|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
156786202|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
156786203|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
156786204|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
156786205|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
156786206|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
156786207|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
156786208|NCT03738215|565968304|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
156786209|NCT03738215|565968305|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
156786210|NCT03738215|565968306|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
156786211|NCT03738215|565968304|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
156786212|NCT03738215|565968305|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
156530319|NCT01209143|565036383|FG000|Overall Study|Disease progression|11|||
156786213|NCT03738215|565968306|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
156786214|NCT03738215|565968304|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
156869087|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
156869088|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
156869089|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
156869090|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
156869091|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
156869092|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
156869093|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
156869094|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
156869095|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
156869096|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
156869097|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
156869098|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
156869099|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
156869100|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
156869101|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
156869102|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156869103|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
156869104|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156869105|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
156869106|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156869107|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156869108|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
156869109|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156869110|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156869111|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Other|10|||
156869112|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Other|2|||
156869113|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Other|6|||
156869114|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156869115|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156869116|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156869117|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156869118|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156869119|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156869120|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156869121|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156869122|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156869123|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
156869124|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
156869125|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
156869126|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156869127|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156869128|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156869129|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Other|8|||
156869130|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Other|3|||
156869131|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Other|4|||
156869132|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
156869133|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156869134|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156869135|NCT02106390|566279001|FG000|Overall Study|Withdrawal by Subject|15|||
156869136|NCT02106390|566279002|FG001|Overall Study|Withdrawal by Subject|16|||
156869137|NCT02106390|566279003|FG002|Overall Study|Withdrawal by Subject|15|||
156869138|NCT02106390|566279001|FG000|Overall Study|Lost to Follow-up|25|||
156869139|NCT02106390|566279002|FG001|Overall Study|Lost to Follow-up|20|||
156869140|NCT02106390|566279003|FG002|Overall Study|Lost to Follow-up|13|||
156869141|NCT02106390|566279001|FG000|Overall Study|Other: Administrative Reason|8|||
156869142|NCT02106390|566279002|FG001|Overall Study|Other: Administrative Reason|5|||
156869143|NCT02106390|566279003|FG002|Overall Study|Other: Administrative Reason|12|||
156869144|NCT02106390|566279001|FG000|Overall Study|Other: Unspecified|1|||
156869145|NCT02106390|566279002|FG001|Overall Study|Other: Unspecified|4|||
156869146|NCT02106390|566279003|FG002|Overall Study|Other: Unspecified|2|||
156869147|NCT02106390|566279001|FG000|Overall Study|Adverse Event|0|||
156869148|NCT02106390|566279002|FG001|Overall Study|Adverse Event|2|||
156869149|NCT02106390|566279003|FG002|Overall Study|Adverse Event|1|||
156869150|NCT02106390|566279001|FG000|Overall Study|Protocol Violation|0|||
156869151|NCT02106390|566279002|FG001|Overall Study|Protocol Violation|1|||
156869152|NCT02106390|566279003|FG002|Overall Study|Protocol Violation|0|||
156869153|NCT03219528|566279004|FG000|Overall Study|Lost to Follow-up|5|||
156786215|NCT03738215|565968305|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
156786216|NCT03738215|565968306|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
156786217|NCT03738215|565968304|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
156786218|NCT03738215|565968305|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
156786219|NCT03738215|565968306|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
156786220|NCT00853047|565968307|FG000|Core Phase|Participant Request|0|||
156786221|NCT00853047|565968308|FG001|Core Phase|Participant Request|0|||
156786222|NCT00853047|565968309|FG002|Core Phase|Participant Request|0|||
156786223|NCT00853047|565968310|FG003|Core Phase|Participant Request|1|||
156786224|NCT00853047|565968311|FG004|Core Phase|Participant Request|0|||
156786225|NCT00853047|565968312|FG005|Core Phase|Participant Request|0|||
156786226|NCT00853047|565968307|FG000|Open-Label Extension Phase|Participant Request|0|||
156786227|NCT00853047|565968308|FG001|Open-Label Extension Phase|Participant Request|0|||
156786228|NCT00853047|565968309|FG002|Open-Label Extension Phase|Participant Request|0|||
156786229|NCT00853047|565968310|FG003|Open-Label Extension Phase|Participant Request|0|||
156786230|NCT00853047|565968311|FG004|Open-Label Extension Phase|Participant Request|0|||
156786231|NCT00853047|565968312|FG005|Open-Label Extension Phase|Participant Request|7|||
156786232|NCT00853047|565968307|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
156786233|NCT00853047|565968308|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
156786234|NCT00853047|565968309|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
156786235|NCT00853047|565968310|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
156786236|NCT00853047|565968311|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
156786237|NCT00853047|565968312|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
156786238|NCT00853047|565968307|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786239|NCT00853047|565968308|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786240|NCT00853047|565968309|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786241|NCT00853047|565968310|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786242|NCT00853047|565968311|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786243|NCT00853047|565968312|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
156786244|NCT00853047|565968307|FG000|Open-Label Extension Phase|Investigator Decision|0|||
156786245|NCT00853047|565968308|FG001|Open-Label Extension Phase|Investigator Decision|0|||
156786246|NCT00853047|565968309|FG002|Open-Label Extension Phase|Investigator Decision|0|||
156786247|NCT00853047|565968310|FG003|Open-Label Extension Phase|Investigator Decision|0|||
156786248|NCT00853047|565968311|FG004|Open-Label Extension Phase|Investigator Decision|0|||
156786249|NCT00853047|565968312|FG005|Open-Label Extension Phase|Investigator Decision|1|||
156786250|NCT00853047|565968307|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
156786251|NCT00853047|565968308|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
156786252|NCT00853047|565968309|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
156786253|NCT00853047|565968310|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
156786254|NCT00853047|565968311|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
156786255|NCT00853047|565968312|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
156786256|NCT02638493|565968313|FG000|Overall Study|Inability to provide semen samples|2|||
156786257|NCT02638493|565968314|FG001|Overall Study|Inability to provide semen samples|0|||
156786258|NCT02638493|565968315|FG002|Overall Study|Inability to provide semen samples|0|||
156786259|NCT01567085|565970313|FG000|Overall Study|Death|6|||
156786260|NCT01567085|565970313|FG000|Overall Study|Adverse Event|6|||
156786261|NCT01567085|565970313|FG000|Overall Study|Lost to Follow-up|3|||
156786262|NCT01567085|565970313|FG000|Overall Study|Graft loss|2|||
156786263|NCT01567085|565970313|FG000|Overall Study|Renal transplantectomy|1|||
156786264|NCT01567085|565970313|FG000|Overall Study|Returned to chronic dialysis|1|||
156786265|NCT01567085|565970313|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
156786266|NCT03537729|565970324|FG000|Overall Study|Death|2|||
156786267|NCT03537729|565970325|FG001|Overall Study|Death|2|||
156786268|NCT03537729|565970326|FG002|Overall Study|Death|7|||
156786269|NCT03537729|565970324|FG000|Overall Study|Withdrawal by Subject|3|||
156786270|NCT03537729|565970325|FG001|Overall Study|Withdrawal by Subject|3|||
156786271|NCT03537729|565970326|FG002|Overall Study|Withdrawal by Subject|0|||
156786272|NCT03537729|565970324|FG000|Overall Study|Subject Moved|8|||
156786273|NCT03537729|565970325|FG001|Overall Study|Subject Moved|5|||
156786274|NCT03537729|565970326|FG002|Overall Study|Subject Moved|4|||
156786275|NCT03537729|565970324|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
156786276|NCT03537729|565970325|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
156786277|NCT03537729|565970326|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
156786278|NCT03537729|565970324|FG000|Overall Study|COVID-19 Site Restrictions|11|||
156786279|NCT03537729|565970325|FG001|Overall Study|COVID-19 Site Restrictions|15|||
156786280|NCT03537729|565970326|FG002|Overall Study|COVID-19 Site Restrictions|18|||
156786281|NCT03537729|565970324|FG000|Overall Study|Decline in Health|5|||
156786282|NCT03537729|565970325|FG001|Overall Study|Decline in Health|9|||
156786283|NCT03537729|565970326|FG002|Overall Study|Decline in Health|4|||
156786284|NCT03537729|565970324|FG000|Overall Study|Determined Ineligible|0|||
156786285|NCT03537729|565970325|FG001|Overall Study|Determined Ineligible|0|||
156786286|NCT03537729|565970326|FG002|Overall Study|Determined Ineligible|1|||
156530320|NCT01209143|565036384|FG001|Overall Study|Disease progression|16|||
156686347|NCT01345318|565596368|FG000|Overall Study|Lost to Follow-up|2|||
156686348|NCT01345318|565596368|FG000|Overall Study|Protocol Violation|1|||
156686349|NCT01345318|565596368|FG000|Overall Study|Withdrawal by Subject|41|||
156686350|NCT01345318|565596368|FG000|Overall Study|Other|3|||
156686351|NCT01685073|565596369|FG000|Overall Study|Lost to Follow-up|6|||
156686352|NCT01685073|565596370|FG001|Overall Study|Lost to Follow-up|8|||
156686353|NCT01685073|565596369|FG000|Overall Study|Withdrawal by Subject|24|||
156686354|NCT01685073|565596370|FG001|Overall Study|Withdrawal by Subject|24|||
156686355|NCT01239472|565596371|FG000|Overall Study|Withdrawal by Subject|5|||
156686356|NCT01239472|565596372|FG001|Overall Study|Withdrawal by Subject|1|||
156686357|NCT01239472|565596371|FG000|Overall Study|Adverse Event|0|||
156686358|NCT01239472|565596372|FG001|Overall Study|Adverse Event|1|||
156686359|NCT01239472|565596371|FG000|Overall Study|Lack of Efficacy|0|||
156686360|NCT01239472|565596372|FG001|Overall Study|Lack of Efficacy|1|||
156686361|NCT00418522|565596376|FG000|Overall Study|Adverse Event|7|||
156686362|NCT00418522|565596377|FG001|Overall Study|Adverse Event|1|||
156686363|NCT00418522|565596376|FG000|Overall Study|Lack of Efficacy|1|||
156686364|NCT00418522|565596377|FG001|Overall Study|Lack of Efficacy|3|||
156686365|NCT00418522|565596376|FG000|Overall Study|Lost to Follow-up|10|||
156686366|NCT00418522|565596377|FG001|Overall Study|Lost to Follow-up|4|||
156686367|NCT00418522|565596376|FG000|Overall Study|Withdrawal by Subject|31|||
156686368|NCT00418522|565596377|FG001|Overall Study|Withdrawal by Subject|7|||
156686369|NCT00418522|565596376|FG000|Overall Study|Other|27|||
156686370|NCT00418522|565596377|FG001|Overall Study|Other|23|||
156686371|NCT00418522|565596376|FG000|Overall Study|Randomized but did not receive treatment|7|||
156686372|NCT00418522|565596377|FG001|Overall Study|Randomized but did not receive treatment|4|||
156686373|NCT01005329|565596378|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
156786287|NCT00284934|565970331|FG000|Overall Study|Adverse Event|1|||
156786288|NCT00284934|565970332|FG001|Overall Study|Adverse Event|2|||
156786289|NCT00284934|565970331|FG000|Overall Study|Other reasons|3|||
156786290|NCT00284934|565970332|FG001|Overall Study|Other reasons|1|||
156786291|NCT01560988|565970333|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
156786292|NCT01560988|565970334|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
156786293|NCT01560988|565970333|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
156786294|NCT01560988|565970334|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
156786295|NCT01560988|565970333|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
156786296|NCT01560988|565970334|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
156786297|NCT01160744|565970335|FG000|Overall Study|Withdrawal by Subject|11|||
156786298|NCT01160744|565970336|FG001|Overall Study|Withdrawal by Subject|5|||
156786299|NCT01160744|565970337|FG002|Overall Study|Withdrawal by Subject|6|||
156786300|NCT01160744|565970338|FG003|Overall Study|Withdrawal by Subject|4|||
156786301|NCT01160744|565970335|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
156786302|NCT01160744|565970336|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
156786303|NCT01160744|565970337|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
156786304|NCT01160744|565970338|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
156786305|NCT02301429|565970343|FG000|Overall Study|not acceptable vascular anatomy|3|||
156786306|NCT00500110|565970344|FG000|Overall Study|Withdrawal by Subject|3|||
156786307|NCT01502072|565970345|FG000|Overall Study|Withdrawal by Subject|1|||
156786308|NCT01502072|565970346|FG001|Overall Study|Withdrawal by Subject|0|||
156786309|NCT01502072|565970347|FG002|Overall Study|Withdrawal by Subject|0|||
156786310|NCT01502072|565970345|FG000|Overall Study|Death|0|||
156786311|NCT01502072|565970346|FG001|Overall Study|Death|1|||
156786312|NCT01502072|565970347|FG002|Overall Study|Death|0|||
156786313|NCT04821245|565970348|FG000|Overall Study|Withdrawal by Subject|3|||
156786314|NCT04821245|565970348|FG000|Overall Study|Physician Decision|1|||
156786315|NCT04821245|565970348|FG000|Overall Study|Protocol Violation|5|||
156786316|NCT00605657|565970349|FG000|Overall Study|Adverse Event|1|||
156786317|NCT00605657|565970349|FG000|Overall Study|Protocol Violation|1|||
156786318|NCT00397046|565970357|FG000|Overall Study|Disease Progression|3|||
156786319|NCT00397046|565970358|FG001|Overall Study|Disease Progression|3|||
156786320|NCT00397046|565970359|FG002|Overall Study|Disease Progression|10|||
156786321|NCT00397046|565970360|FG003|Overall Study|Disease Progression|5|||
156786322|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
156786323|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
156786324|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
156786325|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
156786326|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
156786327|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
156786328|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
156686374|NCT00573170|565596381|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
156686375|NCT00573170|565596382|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
156686376|NCT00573170|565596383|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
156686377|NCT00573170|565596384|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
156686378|NCT00573170|565596385|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
156869154|NCT03219528|566279005|FG001|Overall Study|Lost to Follow-up|4|||
156869155|NCT03219528|566279004|FG000|Overall Study|Withdrawal by Subject|4|||
156869156|NCT03219528|566279005|FG001|Overall Study|Withdrawal by Subject|4|||
156869157|NCT00790842|566279006|FG000|Dose Level 1|Adverse Event|1|||
156869158|NCT00790842|566279007|FG001|Dose Level 1|Adverse Event|0|||
156869159|NCT00790842|566279008|FG002|Dose Level 1|Adverse Event|0|||
156869160|NCT00790842|566279009|FG003|Dose Level 1|Adverse Event|2|||
156869161|NCT00790842|566279010|FG004|Dose Level 1|Adverse Event|0|||
156869162|NCT00790842|566279011|FG005|Dose Level 1|Adverse Event|0|||
156869163|NCT00790842|566279012|FG006|Dose Level 1|Adverse Event|0|||
156869164|NCT00790842|566279013|FG007|Dose Level 1|Adverse Event|1|||
156869165|NCT00790842|566279014|FG008|Dose Level 1|Adverse Event|0|||
156869166|NCT00790842|566279015|FG009|Dose Level 1|Adverse Event|0|||
156869167|NCT00790842|566279016|FG010|Dose Level 1|Adverse Event|0|||
156869168|NCT00790842|566279006|FG000|Dose Level 1|Physician Decision|1|||
156869169|NCT00790842|566279007|FG001|Dose Level 1|Physician Decision|0|||
156869170|NCT00790842|566279008|FG002|Dose Level 1|Physician Decision|0|||
156869171|NCT00790842|566279009|FG003|Dose Level 1|Physician Decision|0|||
156869172|NCT00790842|566279010|FG004|Dose Level 1|Physician Decision|0|||
156869173|NCT00790842|566279011|FG005|Dose Level 1|Physician Decision|0|||
156869174|NCT00790842|566279012|FG006|Dose Level 1|Physician Decision|0|||
156869175|NCT00790842|566279013|FG007|Dose Level 1|Physician Decision|1|||
156869176|NCT00790842|566279014|FG008|Dose Level 1|Physician Decision|0|||
156869177|NCT00790842|566279015|FG009|Dose Level 1|Physician Decision|0|||
156869178|NCT00790842|566279016|FG010|Dose Level 1|Physician Decision|0|||
156869179|NCT00790842|566279006|FG000|Dose Level 1|Withdrawal by Subject|1|||
156869180|NCT00790842|566279007|FG001|Dose Level 1|Withdrawal by Subject|0|||
156869181|NCT00790842|566279008|FG002|Dose Level 1|Withdrawal by Subject|0|||
156869182|NCT00790842|566279009|FG003|Dose Level 1|Withdrawal by Subject|0|||
156869183|NCT00790842|566279010|FG004|Dose Level 1|Withdrawal by Subject|0|||
156869184|NCT00790842|566279011|FG005|Dose Level 1|Withdrawal by Subject|0|||
156329977|NCT04612790|564308728|FG001|OLE Period (Up to 1 Year)|Other|0|||
156329978|NCT04612790|564308729|FG002|OLE Period (Up to 1 Year)|Other|0|||
156329979|NCT04612790|564308730|FG003|OLE Period (Up to 1 Year)|Other|1|||
156530321|NCT00381303|565036385|FG000|Overall Study|Lost to Follow-up|25|||
156530322|NCT00381303|565036386|FG001|Overall Study|Lost to Follow-up|9|||
156530323|NCT00381303|565036385|FG000|Overall Study|AE/HIV-related event|22|||
156530324|NCT00381303|565036386|FG001|Overall Study|AE/HIV-related event|6|||
156530325|NCT00381303|565036385|FG000|Overall Study|Non-Adherence|13|||
156530326|NCT00381303|565036386|FG001|Overall Study|Non-Adherence|6|||
156530327|NCT00381303|565036385|FG000|Overall Study|Withdrawal by Subject|13|||
156530328|NCT00381303|565036386|FG001|Overall Study|Withdrawal by Subject|6|||
156530329|NCT00381303|565036385|FG000|Overall Study|Virologic failure|6|||
156686379|NCT00573170|565596386|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
156686380|NCT00573170|565596381|FG000|First Washout Period|Adverse Event|1|||
156686381|NCT00573170|565596382|FG001|First Washout Period|Adverse Event|1|||
156686382|NCT00573170|565596383|FG002|First Washout Period|Adverse Event|0|||
156686383|NCT00573170|565596384|FG003|First Washout Period|Adverse Event|0|||
156686384|NCT00573170|565596385|FG004|First Washout Period|Adverse Event|0|||
156686385|NCT00573170|565596386|FG005|First Washout Period|Adverse Event|1|||
156686386|NCT00573170|565596381|FG000|First Washout Period|Lack of Efficacy|0|||
156686387|NCT00573170|565596382|FG001|First Washout Period|Lack of Efficacy|0|||
156686388|NCT00573170|565596383|FG002|First Washout Period|Lack of Efficacy|0|||
156686389|NCT00573170|565596384|FG003|First Washout Period|Lack of Efficacy|0|||
156686390|NCT00573170|565596385|FG004|First Washout Period|Lack of Efficacy|0|||
156686391|NCT00573170|565596386|FG005|First Washout Period|Lack of Efficacy|1|||
156686392|NCT00573170|565596381|FG000|First Washout Period|Lost to Follow-up|1|||
156786329|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
156786330|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
156786331|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
156786332|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
156786333|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
156786334|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Other|6|||
156786335|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Other|3|||
156786336|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Other|0|||
156786337|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
156786338|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156786339|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156786340|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
156869185|NCT00790842|566279012|FG006|Dose Level 1|Withdrawal by Subject|0|||
156869186|NCT00790842|566279013|FG007|Dose Level 1|Withdrawal by Subject|0|||
156869187|NCT00790842|566279014|FG008|Dose Level 1|Withdrawal by Subject|0|||
156530330|NCT00381303|565036386|FG001|Overall Study|Virologic failure|4|||
156686393|NCT00573170|565596382|FG001|First Washout Period|Lost to Follow-up|1|||
156686394|NCT00573170|565596383|FG002|First Washout Period|Lost to Follow-up|0|||
156686395|NCT00573170|565596384|FG003|First Washout Period|Lost to Follow-up|2|||
156869188|NCT00790842|566279015|FG009|Dose Level 1|Withdrawal by Subject|0|||
156869189|NCT00790842|566279016|FG010|Dose Level 1|Withdrawal by Subject|0|||
156869190|NCT00790842|566279006|FG000|Dose Level 2|Death|0|||
156869191|NCT00790842|566279007|FG001|Dose Level 2|Death|1|||
156869192|NCT00790842|566279008|FG002|Dose Level 2|Death|0|||
156869193|NCT00790842|566279009|FG003|Dose Level 2|Death|0|||
156869194|NCT00790842|566279010|FG004|Dose Level 2|Death|1|||
156869195|NCT00790842|566279011|FG005|Dose Level 2|Death|0|||
156869196|NCT00790842|566279012|FG006|Dose Level 2|Death|0|||
156869197|NCT00790842|566279013|FG007|Dose Level 2|Death|0|||
156869198|NCT00790842|566279014|FG008|Dose Level 2|Death|0|||
156869199|NCT00790842|566279015|FG009|Dose Level 2|Death|0|||
156869200|NCT00790842|566279016|FG010|Dose Level 2|Death|0|||
156869201|NCT00790842|566279006|FG000|Dose Level 2|Physician Decision|0|||
156869202|NCT00790842|566279007|FG001|Dose Level 2|Physician Decision|1|||
156869203|NCT00790842|566279008|FG002|Dose Level 2|Physician Decision|0|||
156869204|NCT00790842|566279009|FG003|Dose Level 2|Physician Decision|0|||
156869205|NCT00790842|566279010|FG004|Dose Level 2|Physician Decision|0|||
156869206|NCT00790842|566279011|FG005|Dose Level 2|Physician Decision|0|||
156869207|NCT00790842|566279012|FG006|Dose Level 2|Physician Decision|0|||
156869208|NCT00790842|566279013|FG007|Dose Level 2|Physician Decision|0|||
156869209|NCT00790842|566279014|FG008|Dose Level 2|Physician Decision|0|||
156869210|NCT00790842|566279015|FG009|Dose Level 2|Physician Decision|0|||
156869211|NCT00790842|566279016|FG010|Dose Level 2|Physician Decision|0|||
156869212|NCT00790842|566279006|FG000|Dose Level 2|Withdrawal by Subject|0|||
156869213|NCT00790842|566279007|FG001|Dose Level 2|Withdrawal by Subject|1|||
156869214|NCT00790842|566279008|FG002|Dose Level 2|Withdrawal by Subject|0|||
156869215|NCT00790842|566279009|FG003|Dose Level 2|Withdrawal by Subject|0|||
156869216|NCT00790842|566279010|FG004|Dose Level 2|Withdrawal by Subject|0|||
156869217|NCT00790842|566279011|FG005|Dose Level 2|Withdrawal by Subject|0|||
156869218|NCT00790842|566279012|FG006|Dose Level 2|Withdrawal by Subject|0|||
156869219|NCT00790842|566279013|FG007|Dose Level 2|Withdrawal by Subject|0|||
156869220|NCT00790842|566279014|FG008|Dose Level 2|Withdrawal by Subject|0|||
156869221|NCT00790842|566279015|FG009|Dose Level 2|Withdrawal by Subject|0|||
156686396|NCT00573170|565596385|FG004|First Washout Period|Lost to Follow-up|0|||
156686397|NCT00573170|565596386|FG005|First Washout Period|Lost to Follow-up|2|||
156686398|NCT00573170|565596381|FG000|First Washout Period|Withdrawal by Subject|2|||
156686399|NCT00573170|565596382|FG001|First Washout Period|Withdrawal by Subject|0|||
156686400|NCT00573170|565596383|FG002|First Washout Period|Withdrawal by Subject|0|||
156686401|NCT00573170|565596384|FG003|First Washout Period|Withdrawal by Subject|2|||
156686402|NCT00573170|565596385|FG004|First Washout Period|Withdrawal by Subject|3|||
156686403|NCT00573170|565596386|FG005|First Washout Period|Withdrawal by Subject|3|||
156686404|NCT00573170|565596381|FG000|First Washout Period|Other|4|||
156686405|NCT00573170|565596382|FG001|First Washout Period|Other|0|||
156686406|NCT00573170|565596383|FG002|First Washout Period|Other|1|||
156686407|NCT00573170|565596384|FG003|First Washout Period|Other|1|||
156686408|NCT00573170|565596385|FG004|First Washout Period|Other|0|||
156686409|NCT00573170|565596386|FG005|First Washout Period|Other|0|||
156686410|NCT00573170|565596381|FG000|Second Washout Period|Adverse Event|1|||
156686411|NCT00573170|565596382|FG001|Second Washout Period|Adverse Event|0|||
156686412|NCT00573170|565596383|FG002|Second Washout Period|Adverse Event|0|||
156686413|NCT00573170|565596384|FG003|Second Washout Period|Adverse Event|0|||
156686414|NCT00573170|565596385|FG004|Second Washout Period|Adverse Event|1|||
156686415|NCT00573170|565596386|FG005|Second Washout Period|Adverse Event|0|||
156686416|NCT00573170|565596381|FG000|Second Washout Period|Protocol Violation|2|||
156686417|NCT00573170|565596382|FG001|Second Washout Period|Protocol Violation|1|||
156686418|NCT00573170|565596383|FG002|Second Washout Period|Protocol Violation|1|||
156686419|NCT00573170|565596384|FG003|Second Washout Period|Protocol Violation|0|||
156686420|NCT00573170|565596385|FG004|Second Washout Period|Protocol Violation|0|||
156869222|NCT00790842|566279016|FG010|Dose Level 2|Withdrawal by Subject|0|||
156869223|NCT00790842|566279006|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869224|NCT00790842|566279007|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869225|NCT00790842|566279008|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869226|NCT00790842|566279009|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869227|NCT00790842|566279010|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869228|NCT00790842|566279011|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869229|NCT00790842|566279012|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869230|NCT00790842|566279013|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156686421|NCT00573170|565596386|FG005|Second Washout Period|Protocol Violation|0|||
156686422|NCT00573170|565596381|FG000|Second Washout Period|Withdrawal by Subject|1|||
156869231|NCT00790842|566279014|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
156436885|NCT02115282|564689155|FG001|Overall Study|Disease progression during treatment|229|||
156686423|NCT00573170|565596382|FG001|Second Washout Period|Withdrawal by Subject|1|||
156686424|NCT00573170|565596383|FG002|Second Washout Period|Withdrawal by Subject|2|||
156686425|NCT00573170|565596384|FG003|Second Washout Period|Withdrawal by Subject|0|||
156869232|NCT00790842|566279015|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156786341|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
156786342|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
156786343|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Adverse Event|0|||
156786344|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Adverse Event|0|||
156786345|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Adverse Event|21|||
156786346|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
156786347|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
156329980|NCT03615326|564308734|FG000|Overall Study|Death|266|||
156329981|NCT03615326|564308735|FG001|Overall Study|Death|286|||
156786348|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
156786349|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
156786350|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
156786351|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
156786352|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
156786353|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
156786354|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
156786355|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Administrative|0|||
156786356|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Administrative|0|||
156786357|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Administrative|36|||
156786358|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Other|0|||
156786359|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Other|0|||
156786360|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Other|9|||
156786361|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
156786362|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
156786363|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
156786364|NCT01975285|565970376|FG000|Overall Study|Failed Block and follow up|2|||
156786365|NCT01975285|565970377|FG001|Overall Study|Failed Block and follow up|2|||
156786366|NCT00604383|565970380|FG000|Overall Study|Withdrawal by Subject|33|||
156786367|NCT00604383|565970381|FG001|Overall Study|Withdrawal by Subject|31|||
156786368|NCT00604383|565970380|FG000|Overall Study|Lost to Follow-up|24|||
156786369|NCT00604383|565970381|FG001|Overall Study|Lost to Follow-up|19|||
156786370|NCT00604383|565970380|FG000|Overall Study|Death|14|||
156786371|NCT00604383|565970381|FG001|Overall Study|Death|22|||
156786372|NCT00604383|565970380|FG000|Overall Study|Adverse Event|16|||
156786373|NCT00604383|565970381|FG001|Overall Study|Adverse Event|9|||
156786374|NCT00604383|565970380|FG000|Overall Study|Physician Decision|0|||
156786375|NCT00604383|565970381|FG001|Overall Study|Physician Decision|3|||
156786376|NCT01698008|565970382|FG000|Overall Study|Withdrawal by Subject|1|||
156786377|NCT01698008|565970383|FG001|Overall Study|Withdrawal by Subject|2|||
156786378|NCT02619812|565970390|FG000|Overall Study|Withdrawal by Subject|0|||
156786379|NCT02619812|565970391|FG001|Overall Study|Withdrawal by Subject|0|||
156786380|NCT02619812|565970392|FG002|Overall Study|Withdrawal by Subject|1|||
156786381|NCT02619812|565970393|FG003|Overall Study|Withdrawal by Subject|2|||
156786382|NCT04098302|565970396|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
156786383|NCT04098302|565970397|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
156786384|NCT04098302|565970398|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
156786385|NCT04098302|565970399|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
156786386|NCT04098302|565970396|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
156786387|NCT04098302|565970397|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
156786388|NCT04098302|565970398|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
156786389|NCT04098302|565970399|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
156786390|NCT04098302|565970396|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
156786391|NCT04098302|565970397|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
156786392|NCT04098302|565970398|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
156786393|NCT04098302|565970399|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
156786394|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
156786395|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
156786396|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
156786397|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
156786398|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
156786399|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
156786400|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
156786401|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
156786402|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
156786403|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
156786404|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
156786405|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
156786406|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
156786407|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
156329982|NCT03615326|564308736|FG002|Overall Study|Death|14|||
156869233|NCT00790842|566279016|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869234|NCT00790842|566279006|FG000|Dose Level 3|Adverse Event|0|||
156869235|NCT00790842|566279007|FG001|Dose Level 3|Adverse Event|0|||
156869236|NCT00790842|566279008|FG002|Dose Level 3|Adverse Event|1|||
156869237|NCT00790842|566279009|FG003|Dose Level 3|Adverse Event|0|||
156869238|NCT00790842|566279010|FG004|Dose Level 3|Adverse Event|0|||
156869239|NCT00790842|566279011|FG005|Dose Level 3|Adverse Event|0|||
156869240|NCT00790842|566279012|FG006|Dose Level 3|Adverse Event|0|||
156869241|NCT00790842|566279013|FG007|Dose Level 3|Adverse Event|0|||
156869242|NCT00790842|566279014|FG008|Dose Level 3|Adverse Event|0|||
156869243|NCT00790842|566279015|FG009|Dose Level 3|Adverse Event|0|||
156869244|NCT00790842|566279016|FG010|Dose Level 3|Adverse Event|0|||
156869245|NCT00790842|566279006|FG000|Dose Level 3|Withdrawal by Subject|0|||
156869246|NCT00790842|566279007|FG001|Dose Level 3|Withdrawal by Subject|0|||
156869247|NCT00790842|566279008|FG002|Dose Level 3|Withdrawal by Subject|3|||
156869248|NCT00790842|566279009|FG003|Dose Level 3|Withdrawal by Subject|0|||
156869249|NCT00790842|566279010|FG004|Dose Level 3|Withdrawal by Subject|0|||
156869250|NCT00790842|566279011|FG005|Dose Level 3|Withdrawal by Subject|0|||
156869251|NCT00790842|566279012|FG006|Dose Level 3|Withdrawal by Subject|0|||
156869252|NCT00790842|566279013|FG007|Dose Level 3|Withdrawal by Subject|0|||
156869253|NCT00790842|566279014|FG008|Dose Level 3|Withdrawal by Subject|0|||
156869254|NCT00790842|566279015|FG009|Dose Level 3|Withdrawal by Subject|2|||
156869255|NCT00790842|566279016|FG010|Dose Level 3|Withdrawal by Subject|0|||
156869256|NCT00790842|566279006|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869257|NCT00790842|566279007|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869258|NCT00790842|566279008|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869259|NCT00790842|566279009|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869260|NCT00790842|566279010|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869261|NCT00790842|566279011|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
156869262|NCT00790842|566279012|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869263|NCT00790842|566279013|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869264|NCT00790842|566279014|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869265|NCT00790842|566279015|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869266|NCT00790842|566279016|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869267|NCT00790842|566279006|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869268|NCT00790842|566279007|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156686426|NCT00573170|565596385|FG004|Second Washout Period|Withdrawal by Subject|1|||
156686427|NCT00573170|565596386|FG005|Second Washout Period|Withdrawal by Subject|0|||
156686428|NCT00573170|565596381|FG000|Second Washout Period|Lost to Follow-up|0|||
156686429|NCT00573170|565596382|FG001|Second Washout Period|Lost to Follow-up|0|||
156686430|NCT00573170|565596383|FG002|Second Washout Period|Lost to Follow-up|0|||
156686431|NCT00573170|565596384|FG003|Second Washout Period|Lost to Follow-up|1|||
156686432|NCT00573170|565596385|FG004|Second Washout Period|Lost to Follow-up|0|||
156686433|NCT00573170|565596386|FG005|Second Washout Period|Lost to Follow-up|0|||
156686434|NCT00573170|565596381|FG000|Second Washout Period|Other|1|||
156686435|NCT00573170|565596382|FG001|Second Washout Period|Other|2|||
156686436|NCT00573170|565596383|FG002|Second Washout Period|Other|1|||
156686437|NCT00573170|565596384|FG003|Second Washout Period|Other|4|||
156686438|NCT00573170|565596385|FG004|Second Washout Period|Other|6|||
156686439|NCT00573170|565596386|FG005|Second Washout Period|Other|2|||
156686440|NCT00573170|565596381|FG000|Third Treatment Period|Withdrawal by Subject|1|||
156686441|NCT00573170|565596382|FG001|Third Treatment Period|Withdrawal by Subject|0|||
156686442|NCT00573170|565596383|FG002|Third Treatment Period|Withdrawal by Subject|0|||
156686443|NCT00573170|565596384|FG003|Third Treatment Period|Withdrawal by Subject|0|||
156686444|NCT00573170|565596385|FG004|Third Treatment Period|Withdrawal by Subject|0|||
156686445|NCT00573170|565596386|FG005|Third Treatment Period|Withdrawal by Subject|0|||
156686446|NCT00573170|565596381|FG000|Third Treatment Period|Lost to Follow-up|0|||
156686447|NCT00573170|565596382|FG001|Third Treatment Period|Lost to Follow-up|0|||
156686448|NCT00573170|565596383|FG002|Third Treatment Period|Lost to Follow-up|0|||
156686449|NCT00573170|565596384|FG003|Third Treatment Period|Lost to Follow-up|0|||
156686450|NCT00573170|565596385|FG004|Third Treatment Period|Lost to Follow-up|0|||
156686451|NCT00573170|565596386|FG005|Third Treatment Period|Lost to Follow-up|2|||
156686452|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
156686453|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
156686454|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
156686455|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
156686456|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
156869269|NCT00790842|566279008|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
156869270|NCT00790842|566279009|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869271|NCT00790842|566279010|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869272|NCT00790842|566279011|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156329983|NCT03615326|564308737|FG003|Overall Study|Death|17|||
156329984|NCT03615326|564308734|FG000|Overall Study|Lost to Follow-up|0|||
156869273|NCT00790842|566279012|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869274|NCT00790842|566279013|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869275|NCT00790842|566279014|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869276|NCT00790842|566279015|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869277|NCT00790842|566279016|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869278|NCT00790842|566279006|FG000|Dose Level 4|Adverse Event|0|||
156869279|NCT00790842|566279007|FG001|Dose Level 4|Adverse Event|0|||
156869280|NCT00790842|566279008|FG002|Dose Level 4|Adverse Event|0|||
156869281|NCT00790842|566279009|FG003|Dose Level 4|Adverse Event|0|||
156869282|NCT00790842|566279010|FG004|Dose Level 4|Adverse Event|0|||
156869283|NCT00790842|566279011|FG005|Dose Level 4|Adverse Event|0|||
156869284|NCT00790842|566279012|FG006|Dose Level 4|Adverse Event|1|||
156869285|NCT00790842|566279013|FG007|Dose Level 4|Adverse Event|0|||
156869286|NCT00790842|566279014|FG008|Dose Level 4|Adverse Event|0|||
156869287|NCT00790842|566279015|FG009|Dose Level 4|Adverse Event|0|||
156869288|NCT00790842|566279016|FG010|Dose Level 4|Adverse Event|0|||
156869289|NCT00790842|566279006|FG000|Dose Level 4|Physician Decision|0|||
156869290|NCT00790842|566279007|FG001|Dose Level 4|Physician Decision|0|||
156869291|NCT00790842|566279008|FG002|Dose Level 4|Physician Decision|0|||
156869292|NCT00790842|566279009|FG003|Dose Level 4|Physician Decision|0|||
156869293|NCT00790842|566279010|FG004|Dose Level 4|Physician Decision|0|||
156869294|NCT00790842|566279011|FG005|Dose Level 4|Physician Decision|0|||
156869295|NCT00790842|566279012|FG006|Dose Level 4|Physician Decision|1|||
156869296|NCT00790842|566279013|FG007|Dose Level 4|Physician Decision|0|||
156869297|NCT00790842|566279014|FG008|Dose Level 4|Physician Decision|0|||
156869298|NCT00790842|566279015|FG009|Dose Level 4|Physician Decision|0|||
156869299|NCT00790842|566279016|FG010|Dose Level 4|Physician Decision|1|||
156869300|NCT00790842|566279006|FG000|Dose Level 4|Withdrawal by Subject|0|||
156869301|NCT00790842|566279007|FG001|Dose Level 4|Withdrawal by Subject|0|||
156869302|NCT00790842|566279008|FG002|Dose Level 4|Withdrawal by Subject|0|||
156869303|NCT00790842|566279009|FG003|Dose Level 4|Withdrawal by Subject|0|||
156869304|NCT00790842|566279010|FG004|Dose Level 4|Withdrawal by Subject|0|||
156869305|NCT00790842|566279011|FG005|Dose Level 4|Withdrawal by Subject|0|||
156869306|NCT00790842|566279012|FG006|Dose Level 4|Withdrawal by Subject|0|||
156869307|NCT00790842|566279013|FG007|Dose Level 4|Withdrawal by Subject|0|||
156869308|NCT00790842|566279014|FG008|Dose Level 4|Withdrawal by Subject|0|||
156869309|NCT00790842|566279015|FG009|Dose Level 4|Withdrawal by Subject|0|||
156869310|NCT00790842|566279016|FG010|Dose Level 4|Withdrawal by Subject|1|||
156869311|NCT00790842|566279006|FG000|Expansion Cohort|Adverse Event|0|||
156869312|NCT00790842|566279007|FG001|Expansion Cohort|Adverse Event|0|||
156869313|NCT00790842|566279008|FG002|Expansion Cohort|Adverse Event|0|||
156869314|NCT00790842|566279009|FG003|Expansion Cohort|Adverse Event|0|||
156869315|NCT00790842|566279010|FG004|Expansion Cohort|Adverse Event|0|||
156869316|NCT00790842|566279011|FG005|Expansion Cohort|Adverse Event|0|||
156869317|NCT00790842|566279012|FG006|Expansion Cohort|Adverse Event|1|||
156869318|NCT00790842|566279013|FG007|Expansion Cohort|Adverse Event|0|||
156869319|NCT00790842|566279014|FG008|Expansion Cohort|Adverse Event|0|||
156869320|NCT00790842|566279015|FG009|Expansion Cohort|Adverse Event|0|||
156869321|NCT00790842|566279016|FG010|Expansion Cohort|Adverse Event|0|||
156869322|NCT00790842|566279006|FG000|Expansion Cohort|Death|0|||
156869323|NCT00790842|566279007|FG001|Expansion Cohort|Death|0|||
156869324|NCT00790842|566279008|FG002|Expansion Cohort|Death|2|||
156869325|NCT00790842|566279009|FG003|Expansion Cohort|Death|0|||
156869326|NCT00790842|566279010|FG004|Expansion Cohort|Death|0|||
156869327|NCT00790842|566279011|FG005|Expansion Cohort|Death|0|||
156869328|NCT00790842|566279012|FG006|Expansion Cohort|Death|0|||
156869329|NCT00790842|566279013|FG007|Expansion Cohort|Death|0|||
156869330|NCT00790842|566279014|FG008|Expansion Cohort|Death|0|||
156869331|NCT00790842|566279015|FG009|Expansion Cohort|Death|0|||
156329985|NCT03615326|564308735|FG001|Overall Study|Lost to Follow-up|1|||
156869332|NCT00790842|566279016|FG010|Expansion Cohort|Death|0|||
156869333|NCT00790842|566279006|FG000|Expansion Cohort|Physician Decision|0|||
156869334|NCT00790842|566279007|FG001|Expansion Cohort|Physician Decision|0|||
156869335|NCT00790842|566279008|FG002|Expansion Cohort|Physician Decision|1|||
156869336|NCT00790842|566279009|FG003|Expansion Cohort|Physician Decision|0|||
156869337|NCT00790842|566279010|FG004|Expansion Cohort|Physician Decision|0|||
156869338|NCT00790842|566279011|FG005|Expansion Cohort|Physician Decision|0|||
156869339|NCT00790842|566279012|FG006|Expansion Cohort|Physician Decision|0|||
156329986|NCT03615326|564308736|FG002|Overall Study|Lost to Follow-up|0|||
156869340|NCT00790842|566279013|FG007|Expansion Cohort|Physician Decision|0|||
156869341|NCT00790842|566279014|FG008|Expansion Cohort|Physician Decision|0|||
156869342|NCT00790842|566279015|FG009|Expansion Cohort|Physician Decision|0|||
156869343|NCT00790842|566279016|FG010|Expansion Cohort|Physician Decision|0|||
156869344|NCT00790842|566279006|FG000|Expansion Cohort|Withdrawal by Subject|0|||
156869345|NCT00790842|566279007|FG001|Expansion Cohort|Withdrawal by Subject|0|||
156869346|NCT00790842|566279008|FG002|Expansion Cohort|Withdrawal by Subject|3|||
156869347|NCT00790842|566279009|FG003|Expansion Cohort|Withdrawal by Subject|0|||
156869348|NCT00790842|566279010|FG004|Expansion Cohort|Withdrawal by Subject|0|||
156869349|NCT00790842|566279011|FG005|Expansion Cohort|Withdrawal by Subject|0|||
156786408|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
156786409|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
156786410|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
156786411|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
156786412|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
156786413|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
156786414|NCT05061706|565970400|FG000|Overall Study|Adverse Event|29|||
156786415|NCT05061706|565970401|FG001|Overall Study|Adverse Event|1|||
156786416|NCT05061706|565970400|FG000|Overall Study|Lack of Efficacy|0|||
156786417|NCT05061706|565970401|FG001|Overall Study|Lack of Efficacy|1|||
156786418|NCT05061706|565970400|FG000|Overall Study|Lost to Follow-up|2|||
156786419|NCT05061706|565970401|FG001|Overall Study|Lost to Follow-up|2|||
156786420|NCT05061706|565970400|FG000|Overall Study|Protocol Violation|3|||
156786421|NCT05061706|565970401|FG001|Overall Study|Protocol Violation|1|||
156786422|NCT05061706|565970400|FG000|Overall Study|Withdrawal by Subject|3|||
156786423|NCT05061706|565970401|FG001|Overall Study|Withdrawal by Subject|9|||
156786424|NCT00601107|565970402|FG000|Overall Study|Adverse Event|0|||
156786425|NCT00601107|565970403|FG001|Overall Study|Adverse Event|1|||
156786426|NCT00601107|565970404|FG002|Overall Study|Adverse Event|3|||
156786427|NCT00601107|565970405|FG003|Overall Study|Adverse Event|0|||
156786428|NCT00601107|565970402|FG000|Overall Study|Withdrawal by Subject|5|||
156786429|NCT00601107|565970403|FG001|Overall Study|Withdrawal by Subject|4|||
156786430|NCT00601107|565970404|FG002|Overall Study|Withdrawal by Subject|7|||
156786431|NCT00601107|565970405|FG003|Overall Study|Withdrawal by Subject|4|||
156786432|NCT00601107|565970402|FG000|Overall Study|Lost to Follow-up|3|||
156786433|NCT00601107|565970403|FG001|Overall Study|Lost to Follow-up|3|||
156786434|NCT00601107|565970404|FG002|Overall Study|Lost to Follow-up|0|||
156786435|NCT00601107|565970405|FG003|Overall Study|Lost to Follow-up|3|||
156786436|NCT00601107|565970402|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
156786437|NCT00601107|565970403|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
156786438|NCT00601107|565970404|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
156786439|NCT00601107|565970405|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
156786440|NCT00601107|565970402|FG000|Overall Study|Worsening of Psoriasis|4|||
156786441|NCT00601107|565970403|FG001|Overall Study|Worsening of Psoriasis|1|||
156786442|NCT00601107|565970404|FG002|Overall Study|Worsening of Psoriasis|1|||
156786443|NCT00601107|565970405|FG003|Overall Study|Worsening of Psoriasis|4|||
156786444|NCT00601107|565970402|FG000|Overall Study|Undefined|1|||
156786445|NCT00601107|565970403|FG001|Overall Study|Undefined|0|||
156786446|NCT00601107|565970404|FG002|Overall Study|Undefined|1|||
156786447|NCT00601107|565970405|FG003|Overall Study|Undefined|0|||
156786448|NCT03892915|565970406|FG000|Overall Study|Lost to Follow-up|6|||
156786449|NCT03892915|565970407|FG001|Overall Study|Lost to Follow-up|12|||
156786450|NCT03892915|565970406|FG000|Overall Study|Death|0|||
156786451|NCT03892915|565970407|FG001|Overall Study|Death|2|||
156786452|NCT03892915|565970406|FG000|Overall Study|Withdrawal by Subject|1|||
156786453|NCT03892915|565970407|FG001|Overall Study|Withdrawal by Subject|1|||
156786454|NCT03892915|565970406|FG000|Overall Study|unsuccessful delivery|13|||
156786455|NCT03892915|565970407|FG001|Overall Study|unsuccessful delivery|18|||
156786456|NCT00191152|565970408|FG000|Initial Treatment|Adverse Event|43|||
156786457|NCT00191152|565970409|FG001|Initial Treatment|Adverse Event|67|||
156786458|NCT00191152|565970408|FG000|Initial Treatment|Physician Decision|40|||
156786459|NCT00191152|565970409|FG001|Initial Treatment|Physician Decision|31|||
156786460|NCT00191152|565970408|FG000|Initial Treatment|Withdrawal by Subject|40|||
156786461|NCT00191152|565970409|FG001|Initial Treatment|Withdrawal by Subject|28|||
156786462|NCT00191152|565970408|FG000|Initial Treatment|Lost to Follow-up|0|||
156786463|NCT00191152|565970409|FG001|Initial Treatment|Lost to Follow-up|6|||
156786464|NCT00191152|565970408|FG000|Initial Treatment|Other|18|||
156786465|NCT00191152|565970409|FG001|Initial Treatment|Other|21|||
156786466|NCT00191152|565970408|FG000|Crossover Treatment|Adverse Event|8|||
156786467|NCT00191152|565970409|FG001|Crossover Treatment|Adverse Event|8|||
156786468|NCT00191152|565970408|FG000|Crossover Treatment|Physician Decision|7|||
156329987|NCT03615326|564308737|FG003|Overall Study|Lost to Follow-up|0|||
156786469|NCT00191152|565970409|FG001|Crossover Treatment|Physician Decision|7|||
156786470|NCT00191152|565970408|FG000|Crossover Treatment|Withdrawal by Subject|6|||
156786471|NCT00191152|565970409|FG001|Crossover Treatment|Withdrawal by Subject|9|||
156786472|NCT00191152|565970408|FG000|Crossover Treatment|Lost to Follow-up|2|||
156786473|NCT00191152|565970409|FG001|Crossover Treatment|Lost to Follow-up|1|||
156329988|NCT03615326|564308734|FG000|Overall Study|Withdrawal by Subject|1|||
156786474|NCT00191152|565970408|FG000|Crossover Treatment|Other|4|||
156786475|NCT00191152|565970409|FG001|Crossover Treatment|Other|3|||
156786476|NCT00114777|565970410|FG000|Randomization to Month 36|Death|10|||
156786477|NCT00114777|565970411|FG001|Randomization to Month 36|Death|4|||
156329989|NCT03615326|564308735|FG001|Overall Study|Withdrawal by Subject|3|||
156786478|NCT00114777|565970412|FG002|Randomization to Month 36|Death|3|||
156786479|NCT00114777|565970410|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
156786480|NCT00114777|565970411|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
156786481|NCT00114777|565970412|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
156786482|NCT00114777|565970410|FG000|Randomization to Month 36|Lack of Efficacy|19|||
156786483|NCT00114777|565970411|FG001|Randomization to Month 36|Lack of Efficacy|15|||
156786484|NCT00114777|565970412|FG002|Randomization to Month 36|Lack of Efficacy|17|||
156786485|NCT00114777|565970410|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
156786486|NCT00114777|565970411|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
156786487|NCT00114777|565970412|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
156786488|NCT00114777|565970410|FG000|Randomization to Month 36|Adverse Event|34|||
156786489|NCT00114777|565970411|FG001|Randomization to Month 36|Adverse Event|35|||
156786490|NCT00114777|565970412|FG002|Randomization to Month 36|Adverse Event|44|||
156786491|NCT00114777|565970410|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
156786492|NCT00114777|565970411|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
156786493|NCT00114777|565970412|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
156786494|NCT00114777|565970410|FG000|Randomization to Month 36|Other|9|||
156786495|NCT00114777|565970411|FG001|Randomization to Month 36|Other|3|||
156786496|NCT00114777|565970412|FG002|Randomization to Month 36|Other|12|||
156786497|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Death|8|||
156786498|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Death|13|||
156786499|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Death|7|||
156786500|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
156786501|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
156786502|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
156786503|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
156786504|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
156786505|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
156786506|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
156786507|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
156786508|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
156786509|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
156786510|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
156786511|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
156786512|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
156786513|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
156786514|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
156786515|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
156786516|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
156786517|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
156786518|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
156786519|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
156786520|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
156786521|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Other|2|||
156786522|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Other|0|||
156786523|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Other|2|||
156786524|NCT01181128|565970416|FG000|Overall Study|Withdrawal by Subject|2|||
156786525|NCT01181128|565970417|FG001|Overall Study|Withdrawal by Subject|2|||
156786526|NCT01181128|565970418|FG002|Overall Study|Withdrawal by Subject|0|||
156786527|NCT01181128|565970416|FG000|Overall Study|Death|1|||
156786528|NCT01181128|565970417|FG001|Overall Study|Death|0|||
156786529|NCT01181128|565970418|FG002|Overall Study|Death|0|||
156786530|NCT01181128|565970416|FG000|Overall Study|Physician Decision|2|||
156786531|NCT01181128|565970417|FG001|Overall Study|Physician Decision|0|||
156786532|NCT01181128|565970418|FG002|Overall Study|Physician Decision|0|||
156786533|NCT01181128|565970416|FG000|Overall Study|Adverse Event|0|||
156786534|NCT01181128|565970417|FG001|Overall Study|Adverse Event|2|||
156786535|NCT01181128|565970418|FG002|Overall Study|Adverse Event|0|||
156786536|NCT01181128|565970416|FG000|Overall Study|Other|1|||
156786537|NCT01181128|565970417|FG001|Overall Study|Other|1|||
156786538|NCT01181128|565970418|FG002|Overall Study|Other|1|||
156786539|NCT04477486|565970421|FG000|Overall Study|Death|2|||
156786540|NCT04477486|565970421|FG000|Overall Study|Ongoing at Time of Analysis|11|||
156786541|NCT02336503|565970424|FG000|Overall Study|Lost to Follow-up|0|||
156786542|NCT02336503|565970425|FG001|Overall Study|Lost to Follow-up|3|||
156786543|NCT02336503|565970426|FG002|Overall Study|Lost to Follow-up|0|||
156786544|NCT02336503|565970427|FG003|Overall Study|Lost to Follow-up|2|||
156786545|NCT02336503|565970424|FG000|Overall Study|Withdrawal by Subject|2|||
156786546|NCT02336503|565970425|FG001|Overall Study|Withdrawal by Subject|0|||
156786547|NCT02336503|565970426|FG002|Overall Study|Withdrawal by Subject|0|||
156786548|NCT02336503|565970427|FG003|Overall Study|Withdrawal by Subject|4|||
156786549|NCT02336503|565970424|FG000|Overall Study|Adverse Event|0|||
156786550|NCT02336503|565970425|FG001|Overall Study|Adverse Event|0|||
156786551|NCT02336503|565970426|FG002|Overall Study|Adverse Event|1|||
156786552|NCT02336503|565970427|FG003|Overall Study|Adverse Event|0|||
156786553|NCT01543503|565970428|FG000|Overall Study|Lost to Follow-up|32|||
156786554|NCT01543503|565970429|FG001|Overall Study|Lost to Follow-up|36|||
156786555|NCT01543503|565970428|FG000|Overall Study|Adverse Event|9|||
156686457|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
156686458|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156686459|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156686460|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
156686461|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
156686462|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
156686463|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
156686464|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
156686465|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
156686466|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
156686467|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
156686468|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Death|2|||
156686469|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Death|1|||
156686470|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Death|0|||
156686471|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Death|0|||
156686472|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
156686473|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
156686474|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
156686475|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
156686476|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
156686477|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
156686478|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
156686479|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
156686480|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
156686481|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
156686482|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
156686483|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
156686484|NCT03110380|565596390|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
156686485|NCT03110380|565596391|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
156686486|NCT03110380|565596392|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
156686487|NCT03110380|565596393|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
156686488|NCT03110380|565596390|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
156686489|NCT03110380|565596391|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
156686490|NCT03110380|565596392|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
156686491|NCT03110380|565596393|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
156686492|NCT03110380|565596390|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
156686493|NCT03110380|565596391|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
156686494|NCT03110380|565596392|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
156686495|NCT03110380|565596393|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
156686496|NCT02147587|565596394|FG000|Overall Study|Adverse Event|9|||
156686497|NCT02147587|565596395|FG001|Overall Study|Adverse Event|4|||
156686498|NCT02147587|565596394|FG000|Overall Study|Lack of Efficacy|2|||
156686499|NCT02147587|565596395|FG001|Overall Study|Lack of Efficacy|1|||
156686500|NCT01714739|565596396|FG000|Overall Study|Disease progression|3|||
156686501|NCT01714739|565596397|FG001|Overall Study|Disease progression|5|||
156686502|NCT01714739|565596398|FG002|Overall Study|Disease progression|5|||
156686503|NCT01714739|565596399|FG003|Overall Study|Disease progression|204|||
156686504|NCT01714739|565596400|FG004|Overall Study|Disease progression|1|||
156686505|NCT01714739|565596401|FG005|Overall Study|Disease progression|3|||
156686506|NCT01714739|565596402|FG006|Overall Study|Disease progression|5|||
156686507|NCT01714739|565596396|FG000|Overall Study|Study drug toxicity|1|||
156686508|NCT01714739|565596397|FG001|Overall Study|Study drug toxicity|1|||
156686509|NCT01714739|565596398|FG002|Overall Study|Study drug toxicity|1|||
156686510|NCT01714739|565596399|FG003|Overall Study|Study drug toxicity|15|||
156686511|NCT01714739|565596400|FG004|Overall Study|Study drug toxicity|0|||
156686512|NCT01714739|565596401|FG005|Overall Study|Study drug toxicity|0|||
156686513|NCT01714739|565596402|FG006|Overall Study|Study drug toxicity|5|||
156686514|NCT01714739|565596396|FG000|Overall Study|Death|0|||
156686515|NCT01714739|565596397|FG001|Overall Study|Death|0|||
156686516|NCT01714739|565596398|FG002|Overall Study|Death|0|||
156686517|NCT01714739|565596399|FG003|Overall Study|Death|1|||
156686518|NCT01714739|565596400|FG004|Overall Study|Death|0|||
156686519|NCT01714739|565596401|FG005|Overall Study|Death|0|||
156686520|NCT01714739|565596402|FG006|Overall Study|Death|0|||
156686521|NCT01714739|565596396|FG000|Overall Study|Adverse Event unrelated to drug|0|||
156686522|NCT01714739|565596397|FG001|Overall Study|Adverse Event unrelated to drug|0|||
156686523|NCT01714739|565596398|FG002|Overall Study|Adverse Event unrelated to drug|3|||
156686524|NCT01714739|565596399|FG003|Overall Study|Adverse Event unrelated to drug|21|||
156686525|NCT01714739|565596400|FG004|Overall Study|Adverse Event unrelated to drug|0|||
156686526|NCT01714739|565596401|FG005|Overall Study|Adverse Event unrelated to drug|0|||
156786556|NCT01543503|565970429|FG001|Overall Study|Adverse Event|13|||
156686527|NCT01714739|565596402|FG006|Overall Study|Adverse Event unrelated to drug|0|||
156786557|NCT01543503|565970428|FG000|Overall Study|Lack of Efficacy|4|||
156530331|NCT00381303|565036385|FG000|Overall Study|Ineligible to continue the trial|2|||
156530332|NCT00381303|565036386|FG001|Overall Study|Ineligible to continue the trial|1|||
156869350|NCT00790842|566279012|FG006|Expansion Cohort|Withdrawal by Subject|0|||
156530333|NCT00381303|565036385|FG000|Overall Study|Pregnancy|2|||
156530334|NCT00381303|565036386|FG001|Overall Study|Pregnancy|0|||
156530335|NCT00381303|565036385|FG000|Overall Study|Physician Decision|1|||
156530336|NCT00381303|565036386|FG001|Overall Study|Physician Decision|0|||
156530337|NCT00381303|565036385|FG000|Overall Study|Physician's decision to close the site|3|||
156530338|NCT00381303|565036386|FG001|Overall Study|Physician's decision to close the site|1|||
156530339|NCT00381303|565036385|FG000|Overall Study|Subject moved out of state|2|||
156530340|NCT00381303|565036386|FG001|Overall Study|Subject moved out of state|0|||
156530341|NCT00381303|565036385|FG000|Overall Study|Subject taking too many different meds|1|||
156530342|NCT00381303|565036386|FG001|Overall Study|Subject taking too many different meds|0|||
156530343|NCT00381303|565036385|FG000|Overall Study|No virologic response by week 12|1|||
156530344|NCT00381303|565036386|FG001|Overall Study|No virologic response by week 12|0|||
156530345|NCT00381303|565036385|FG000|Overall Study|Subject was too busy for appointments|1|||
156530346|NCT00381303|565036386|FG001|Overall Study|Subject was too busy for appointments|0|||
156530347|NCT00381303|565036385|FG000|Overall Study|Subject did not continue visits|1|||
156530348|NCT00381303|565036386|FG001|Overall Study|Subject did not continue visits|0|||
156530349|NCT00381303|565036385|FG000|Overall Study|Subject primary physician's decision|1|||
156530350|NCT00381303|565036386|FG001|Overall Study|Subject primary physician's decision|0|||
156530351|NCT01136811|565036389|FG000|Overall Study|Physician Decision|11|||
156530352|NCT01211522|565036390|FG000|Overall Study|Withdrawal by Subject|3|||
156530353|NCT01211522|565036391|FG001|Overall Study|Withdrawal by Subject|7|||
156530354|NCT01211522|565036392|FG002|Overall Study|Withdrawal by Subject|5|||
156530355|NCT01145755|565036394|FG000|Overall Study|Adverse Event|2|||
156530356|NCT01145755|565036395|FG001|Overall Study|Adverse Event|4|||
156530357|NCT01145755|565036396|FG002|Overall Study|Adverse Event|2|||
156530358|NCT01145755|565036394|FG000|Overall Study|Withdrawal by Subject|2|||
156530359|NCT01145755|565036395|FG001|Overall Study|Withdrawal by Subject|2|||
156530360|NCT01145755|565036396|FG002|Overall Study|Withdrawal by Subject|2|||
156530361|NCT01145755|565036394|FG000|Overall Study|Lost to Follow-up|2|||
156530362|NCT01145755|565036395|FG001|Overall Study|Lost to Follow-up|3|||
156530363|NCT01145755|565036396|FG002|Overall Study|Lost to Follow-up|1|||
156530364|NCT01145755|565036394|FG000|Overall Study|Protocol Violation|0|||
156530365|NCT01145755|565036395|FG001|Overall Study|Protocol Violation|3|||
156530366|NCT01145755|565036396|FG002|Overall Study|Protocol Violation|1|||
156530367|NCT01145755|565036394|FG000|Overall Study|Study Closure|14|||
156530368|NCT01145755|565036395|FG001|Overall Study|Study Closure|14|||
156530369|NCT01145755|565036396|FG002|Overall Study|Study Closure|17|||
156530370|NCT01145755|565036394|FG000|Overall Study|Lack of Efficacy|0|||
156530371|NCT01145755|565036395|FG001|Overall Study|Lack of Efficacy|1|||
156530372|NCT01145755|565036396|FG002|Overall Study|Lack of Efficacy|0|||
156530373|NCT01145755|565036394|FG000|Overall Study|Patient could not swollow medication|0|||
156530374|NCT01145755|565036395|FG001|Overall Study|Patient could not swollow medication|0|||
156530375|NCT01145755|565036396|FG002|Overall Study|Patient could not swollow medication|1|||
156869351|NCT00790842|566279013|FG007|Expansion Cohort|Withdrawal by Subject|0|||
156869352|NCT00790842|566279014|FG008|Expansion Cohort|Withdrawal by Subject|0|||
156869353|NCT00790842|566279015|FG009|Expansion Cohort|Withdrawal by Subject|0|||
156869354|NCT00790842|566279016|FG010|Expansion Cohort|Withdrawal by Subject|0|||
156869355|NCT00790842|566279006|FG000|Expansion Cohort|Study Closure|0|||
156869356|NCT00790842|566279007|FG001|Expansion Cohort|Study Closure|0|||
156869357|NCT00790842|566279008|FG002|Expansion Cohort|Study Closure|1|||
156869358|NCT00790842|566279009|FG003|Expansion Cohort|Study Closure|0|||
156869359|NCT00790842|566279010|FG004|Expansion Cohort|Study Closure|0|||
156869360|NCT00790842|566279011|FG005|Expansion Cohort|Study Closure|0|||
156869361|NCT00790842|566279012|FG006|Expansion Cohort|Study Closure|0|||
156869362|NCT00790842|566279013|FG007|Expansion Cohort|Study Closure|0|||
156530376|NCT01145755|565036394|FG000|Overall Study|Withdrawal by Subject|0|||
156530377|NCT01145755|565036395|FG001|Overall Study|Withdrawal by Subject|0|||
156530378|NCT01145755|565036396|FG002|Overall Study|Withdrawal by Subject|1|||
156530379|NCT01145755|565036394|FG000|Overall Study|Positive urine ethanol|0|||
156530380|NCT01145755|565036395|FG001|Overall Study|Positive urine ethanol|1|||
156530381|NCT01145755|565036396|FG002|Overall Study|Positive urine ethanol|0|||
156869363|NCT00790842|566279014|FG008|Expansion Cohort|Study Closure|0|||
156530382|NCT00372385|565036402|FG000|Overall Study|Adverse Event|6|||
156530383|NCT00372385|565036403|FG001|Overall Study|Adverse Event|11|||
156530384|NCT00372385|565036404|FG002|Overall Study|Adverse Event|9|||
156530385|NCT00372385|565036405|FG003|Overall Study|Adverse Event|7|||
156530386|NCT00372385|565036402|FG000|Overall Study|Noncompliance|0|||
156530387|NCT00372385|565036403|FG001|Overall Study|Noncompliance|1|||
156530388|NCT00372385|565036404|FG002|Overall Study|Noncompliance|1|||
156530389|NCT00372385|565036405|FG003|Overall Study|Noncompliance|1|||
156869364|NCT00790842|566279015|FG009|Expansion Cohort|Study Closure|0|||
156869365|NCT00790842|566279016|FG010|Expansion Cohort|Study Closure|0|||
156869366|NCT02968004|566279017|FG000|Main Study Phase|Adverse Event|1|||
156686528|NCT01714739|565596396|FG000|Overall Study|Participant request to stop therapy|0|||
156686529|NCT01714739|565596397|FG001|Overall Study|Participant request to stop therapy|1|||
156686530|NCT01714739|565596398|FG002|Overall Study|Participant request to stop therapy|0|||
156686531|NCT01714739|565596399|FG003|Overall Study|Participant request to stop therapy|6|||
156686532|NCT01714739|565596400|FG004|Overall Study|Participant request to stop therapy|0|||
156686533|NCT01714739|565596401|FG005|Overall Study|Participant request to stop therapy|0|||
156686534|NCT01714739|565596402|FG006|Overall Study|Participant request to stop therapy|0|||
156686535|NCT01714739|565596396|FG000|Overall Study|Participant withdrew consent|0|||
156686536|NCT01714739|565596397|FG001|Overall Study|Participant withdrew consent|1|||
156686537|NCT01714739|565596398|FG002|Overall Study|Participant withdrew consent|0|||
156686538|NCT01714739|565596399|FG003|Overall Study|Participant withdrew consent|8|||
156686539|NCT01714739|565596400|FG004|Overall Study|Participant withdrew consent|0|||
156686540|NCT01714739|565596401|FG005|Overall Study|Participant withdrew consent|0|||
156686541|NCT01714739|565596402|FG006|Overall Study|Participant withdrew consent|0|||
156686542|NCT01714739|565596396|FG000|Overall Study|Lost to Follow-up|0|||
156686543|NCT01714739|565596397|FG001|Overall Study|Lost to Follow-up|0|||
156686544|NCT01714739|565596398|FG002|Overall Study|Lost to Follow-up|0|||
156686545|NCT01714739|565596399|FG003|Overall Study|Lost to Follow-up|1|||
156686546|NCT01714739|565596400|FG004|Overall Study|Lost to Follow-up|0|||
156686547|NCT01714739|565596401|FG005|Overall Study|Lost to Follow-up|0|||
156686548|NCT01714739|565596402|FG006|Overall Study|Lost to Follow-up|0|||
156686549|NCT01714739|565596396|FG000|Overall Study|Maximum clinical benefit|0|||
156686550|NCT01714739|565596397|FG001|Overall Study|Maximum clinical benefit|1|||
156686551|NCT01714739|565596398|FG002|Overall Study|Maximum clinical benefit|1|||
156686552|NCT01714739|565596399|FG003|Overall Study|Maximum clinical benefit|3|||
156686553|NCT01714739|565596400|FG004|Overall Study|Maximum clinical benefit|0|||
156686554|NCT01714739|565596401|FG005|Overall Study|Maximum clinical benefit|0|||
156686555|NCT01714739|565596402|FG006|Overall Study|Maximum clinical benefit|0|||
156686556|NCT01714739|565596396|FG000|Overall Study|Poor/non-comliance|0|||
156686557|NCT01714739|565596397|FG001|Overall Study|Poor/non-comliance|1|||
156686558|NCT01714739|565596398|FG002|Overall Study|Poor/non-comliance|0|||
156686559|NCT01714739|565596399|FG003|Overall Study|Poor/non-comliance|1|||
156686560|NCT01714739|565596400|FG004|Overall Study|Poor/non-comliance|0|||
156686561|NCT01714739|565596401|FG005|Overall Study|Poor/non-comliance|0|||
156686562|NCT01714739|565596402|FG006|Overall Study|Poor/non-comliance|0|||
156686563|NCT01714739|565596396|FG000|Overall Study|No longer meets study criteria|0|||
156686564|NCT01714739|565596397|FG001|Overall Study|No longer meets study criteria|0|||
156686565|NCT01714739|565596398|FG002|Overall Study|No longer meets study criteria|0|||
156686566|NCT01714739|565596399|FG003|Overall Study|No longer meets study criteria|1|||
156686567|NCT01714739|565596400|FG004|Overall Study|No longer meets study criteria|0|||
156686568|NCT01714739|565596401|FG005|Overall Study|No longer meets study criteria|0|||
156686569|NCT01714739|565596402|FG006|Overall Study|No longer meets study criteria|0|||
156686570|NCT01714739|565596396|FG000|Overall Study|Other reason|0|||
156686571|NCT01714739|565596397|FG001|Overall Study|Other reason|0|||
156686572|NCT01714739|565596398|FG002|Overall Study|Other reason|0|||
156686573|NCT01714739|565596399|FG003|Overall Study|Other reason|3|||
156686574|NCT01714739|565596400|FG004|Overall Study|Other reason|1|||
156686575|NCT01714739|565596401|FG005|Overall Study|Other reason|0|||
156686576|NCT01714739|565596402|FG006|Overall Study|Other reason|0|||
156686577|NCT03170869|565596413|FG000|Overall Study|Protocol Violation|5|||
156686578|NCT03170869|565596413|FG000|Overall Study|Early study termination|3|||
156686579|NCT03635983|565596416|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
156686580|NCT03635983|565596417|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
156686581|NCT03635983|565596416|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156686582|NCT03635983|565596417|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156686583|NCT03635983|565596416|FG000|Pre-Treatment Period|Other reasons|0|||
156686584|NCT03635983|565596417|FG001|Pre-Treatment Period|Other reasons|1|||
156686585|NCT03635983|565596416|FG000|Pre-Treatment Period|Disease Progression|0|||
156686586|NCT03635983|565596417|FG001|Pre-Treatment Period|Disease Progression|1|||
156686587|NCT03635983|565596416|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
156686588|NCT03635983|565596417|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
156686589|NCT03635983|565596416|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
156686590|NCT03635983|565596417|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
156686591|NCT03635983|565596416|FG000|Treatment Period|Withdrawal by Subject|3|||
156786558|NCT01543503|565970429|FG001|Overall Study|Lack of Efficacy|16|||
156786559|NCT01543503|565970428|FG000|Overall Study|Participant withdrew informed consent|8|||
156686592|NCT03635983|565596417|FG001|Treatment Period|Withdrawal by Subject|5|||
156786560|NCT01543503|565970429|FG001|Overall Study|Participant withdrew informed consent|10|||
156786561|NCT01543503|565970428|FG000|Overall Study|Change of jobs|0|||
156786562|NCT01543503|565970429|FG001|Overall Study|Change of jobs|1|||
156786563|NCT01543503|565970428|FG000|Overall Study|Intolerance to the biologic treatment|0|||
156869367|NCT02968004|566279018|FG001|Main Study Phase|Adverse Event|0|||
156686593|NCT03635983|565596416|FG000|Treatment Period|Death|3|||
156686594|NCT03635983|565596417|FG001|Treatment Period|Death|5|||
156686595|NCT03635983|565596416|FG000|Treatment Period|Poor/Non-compliance|2|||
156686596|NCT03635983|565596417|FG001|Treatment Period|Poor/Non-compliance|1|||
156686597|NCT03635983|565596416|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
156686598|NCT03635983|565596417|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
156686599|NCT03635983|565596416|FG000|Treatment Period|Other reasons|7|||
156686600|NCT03635983|565596417|FG001|Treatment Period|Other reasons|4|||
156686601|NCT03635983|565596416|FG000|Treatment Period|Disease progression|230|||
156686602|NCT03635983|565596417|FG001|Treatment Period|Disease progression|201|||
156686603|NCT03635983|565596416|FG000|Treatment Period|Study drug toxicity|35|||
156686604|NCT03635983|565596417|FG001|Treatment Period|Study drug toxicity|36|||
156686605|NCT03635983|565596416|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
156686606|NCT03635983|565596417|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
156686607|NCT03635983|565596416|FG000|Treatment Period|Maximum clinical benefit|3|||
156686608|NCT03635983|565596417|FG001|Treatment Period|Maximum clinical benefit|5|||
156686609|NCT03635983|565596416|FG000|Treatment Period|Administrative reason by the sponsor|1|||
156686610|NCT03635983|565596417|FG001|Treatment Period|Administrative reason by the sponsor|2|||
156686611|NCT03635983|565596416|FG000|Treatment Period|Lost to Follow-up|0|||
156686612|NCT03635983|565596417|FG001|Treatment Period|Lost to Follow-up|1|||
156686613|NCT01235442|565596418|FG000|Overall Study|Lost to Follow-up|12|||
156686614|NCT01235442|565596419|FG001|Overall Study|Lost to Follow-up|10|||
156686615|NCT01235442|565596418|FG000|Overall Study|Death|0|||
156686616|NCT01235442|565596419|FG001|Overall Study|Death|2|||
156686617|NCT01235442|565596418|FG000|Overall Study|Pregnancy|1|||
156686618|NCT01235442|565596419|FG001|Overall Study|Pregnancy|1|||
156686619|NCT01235442|565596418|FG000|Overall Study|Ineligibility determined|5|||
156686620|NCT01235442|565596419|FG001|Overall Study|Ineligibility determined|4|||
156686621|NCT01235442|565596418|FG000|Overall Study|Protocol Violation|3|||
156686622|NCT01235442|565596419|FG001|Overall Study|Protocol Violation|3|||
156686623|NCT01235442|565596418|FG000|Overall Study|Adverse Event|4|||
156686624|NCT01235442|565596419|FG001|Overall Study|Adverse Event|6|||
156686625|NCT01235442|565596418|FG000|Overall Study|Withdrawal by Subject|15|||
156686626|NCT01235442|565596419|FG001|Overall Study|Withdrawal by Subject|9|||
156686627|NCT01235442|565596418|FG000|Overall Study|Lack of Efficacy|1|||
156686628|NCT01235442|565596419|FG001|Overall Study|Lack of Efficacy|3|||
156686629|NCT01235442|565596418|FG000|Overall Study|Noncompliance|1|||
156686630|NCT01235442|565596419|FG001|Overall Study|Noncompliance|2|||
156686631|NCT01235442|565596418|FG000|Overall Study|Administrative decision|1|||
156686632|NCT01235442|565596419|FG001|Overall Study|Administrative decision|2|||
156686633|NCT01235442|565596418|FG000|Overall Study|Other unspecified|1|||
156786564|NCT01543503|565970429|FG001|Overall Study|Intolerance to the biologic treatment|1|||
156786565|NCT01543503|565970428|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
156786566|NCT01543503|565970429|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
156786567|NCT01543503|565970428|FG000|Overall Study|Participant did not complete last visit|0|||
156786568|NCT01543503|565970429|FG001|Overall Study|Participant did not complete last visit|2|||
156786569|NCT01543503|565970428|FG000|Overall Study|Refused to continue treatment|7|||
156786570|NCT01543503|565970429|FG001|Overall Study|Refused to continue treatment|0|||
156786571|NCT01543503|565970428|FG000|Overall Study|Incorrect medication received|1|||
156786572|NCT01543503|565970429|FG001|Overall Study|Incorrect medication received|0|||
156786573|NCT01543503|565970428|FG000|Overall Study|Participant moved to another city|2|||
156786574|NCT01543503|565970429|FG001|Overall Study|Participant moved to another city|0|||
156786575|NCT01543503|565970428|FG000|Overall Study|Participant will not return for visits|0|||
156786576|NCT01543503|565970429|FG001|Overall Study|Participant will not return for visits|2|||
156786577|NCT01543503|565970428|FG000|Overall Study|Participant transferred to another city|1|||
156786578|NCT01543503|565970429|FG001|Overall Study|Participant transferred to another city|0|||
156786579|NCT01543503|565970428|FG000|Overall Study|Participant moved to Scotland|1|||
156786580|NCT01543503|565970429|FG001|Overall Study|Participant moved to Scotland|0|||
156786581|NCT01543503|565970428|FG000|Overall Study|Participant decision to stop treatment|1|||
156786582|NCT01543503|565970429|FG001|Overall Study|Participant decision to stop treatment|0|||
156786583|NCT01543503|565970428|FG000|Overall Study|Investigator did not wish to participate|1|||
156786584|NCT01543503|565970429|FG001|Overall Study|Investigator did not wish to participate|1|||
156786585|NCT01543503|565970428|FG000|Overall Study|Participant recruited after closing date|0|||
156786586|NCT01543503|565970429|FG001|Overall Study|Participant recruited after closing date|1|||
156869368|NCT02968004|566279017|FG000|Main Study Phase|Withdrawal by Subject|0|||
156869369|NCT02968004|566279018|FG001|Main Study Phase|Withdrawal by Subject|1|||
156869370|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
156869371|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
156686634|NCT01235442|565596419|FG001|Overall Study|Other unspecified|2|||
156686635|NCT01857973|565596420|FG000|Overall Study|Subject did not meet required BG range|3|||
156686636|NCT01857973|565596420|FG000|Overall Study|drop out after 3 failed attempts|1|||
156686637|NCT01857973|565596420|FG000|Overall Study|Physician Decision|1|||
156686638|NCT02663882|565596421|FG000|Overall Study|Lost to Follow-up|4|||
156686639|NCT02663882|565596422|FG001|Overall Study|Lost to Follow-up|2|||
156686640|NCT01701973|565596423|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156869372|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
156869373|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
156869374|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
156869375|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
156869376|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
156869377|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
156869378|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
156869379|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
156869380|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
156869381|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
156869382|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
156869383|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
156869384|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
156869385|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
156869386|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
156869387|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
156869388|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
156869389|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
156869390|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
156869391|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
156869392|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
156869393|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
156869394|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
156869395|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
156869396|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
156869397|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
156869398|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
156869399|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
156869400|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
156869401|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
156869402|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
156869403|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
156869404|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
156869405|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
156869406|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
156869407|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
156869408|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
156869409|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
156869410|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
156869411|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
156869412|NCT05029362|566279019|FG000|Overall Study|Lost to Follow-up|9|||
156869413|NCT00561925|566279020|FG000|14 Day Lead-In Period|Adverse Event|38|||
156869414|NCT00561925|566279021|FG001|14 Day Lead-In Period|Adverse Event|0|||
156869415|NCT00561925|566279022|FG002|14 Day Lead-In Period|Adverse Event|0|||
156869416|NCT00561925|566279023|FG003|14 Day Lead-In Period|Adverse Event|0|||
156869417|NCT00561925|566279024|FG004|14 Day Lead-In Period|Adverse Event|0|||
156869418|NCT00561925|566279020|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
156869419|NCT00561925|566279021|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
156869420|NCT00561925|566279022|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
156869421|NCT00561925|566279023|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
156869422|NCT00561925|566279024|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
156869423|NCT00561925|566279020|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
156869424|NCT00561925|566279021|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
156869425|NCT00561925|566279022|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
156869426|NCT00561925|566279023|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
156869427|NCT00561925|566279024|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
156869428|NCT00561925|566279020|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
156869429|NCT00561925|566279021|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
156869430|NCT00561925|566279022|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
156869431|NCT00561925|566279023|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
156869432|NCT00561925|566279024|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
156869433|NCT00561925|566279020|FG000|14 Day Lead-In Period|Other|5|||
156869434|NCT00561925|566279021|FG001|14 Day Lead-In Period|Other|0|||
156869435|NCT00561925|566279022|FG002|14 Day Lead-In Period|Other|0|||
156869436|NCT00561925|566279023|FG003|14 Day Lead-In Period|Other|0|||
156869437|NCT00561925|566279024|FG004|14 Day Lead-In Period|Other|0|||
156869438|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
156869439|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
156869440|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
156686641|NCT01701973|565596424|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
156686642|NCT01701973|565596425|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686643|NCT01701973|565596426|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686644|NCT01701973|565596427|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686645|NCT01701973|565596428|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686646|NCT01701973|565596429|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686647|NCT01701973|565596430|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686648|NCT02412722|565596437|FG000|Overall Study|Adverse Event|0|||
156686649|NCT02412722|565596438|FG001|Overall Study|Adverse Event|2|||
156686650|NCT02412722|565596439|FG002|Overall Study|Adverse Event|0|||
156686651|NCT02412722|565596440|FG003|Overall Study|Adverse Event|3|||
156686652|NCT02412722|565596441|FG004|Overall Study|Adverse Event|0|||
156686653|NCT02412722|565596442|FG005|Overall Study|Adverse Event|3|||
156686654|NCT02412722|565596437|FG000|Overall Study|Progressive Disease|6|||
156686655|NCT02412722|565596438|FG001|Overall Study|Progressive Disease|4|||
156686656|NCT02412722|565596439|FG002|Overall Study|Progressive Disease|4|||
156686657|NCT02412722|565596440|FG003|Overall Study|Progressive Disease|9|||
156686658|NCT02412722|565596441|FG004|Overall Study|Progressive Disease|3|||
156686659|NCT02412722|565596442|FG005|Overall Study|Progressive Disease|3|||
156686660|NCT02412722|565596437|FG000|Overall Study|Withdrawal by Subject|2|||
156686661|NCT02412722|565596438|FG001|Overall Study|Withdrawal by Subject|0|||
156686662|NCT02412722|565596439|FG002|Overall Study|Withdrawal by Subject|1|||
156686663|NCT02412722|565596440|FG003|Overall Study|Withdrawal by Subject|2|||
156686664|NCT02412722|565596441|FG004|Overall Study|Withdrawal by Subject|1|||
156686665|NCT02412722|565596442|FG005|Overall Study|Withdrawal by Subject|1|||
156686666|NCT02412722|565596437|FG000|Overall Study|Lost to Follow-up|0|||
156686667|NCT02412722|565596438|FG001|Overall Study|Lost to Follow-up|0|||
156686668|NCT02412722|565596439|FG002|Overall Study|Lost to Follow-up|0|||
156686669|NCT02412722|565596440|FG003|Overall Study|Lost to Follow-up|0|||
156686670|NCT02412722|565596441|FG004|Overall Study|Lost to Follow-up|1|||
156686671|NCT02412722|565596442|FG005|Overall Study|Lost to Follow-up|0|||
156686672|NCT02412722|565596437|FG000|Overall Study|Received drug in run-in and discontinued|0|||
156686673|NCT02412722|565596438|FG001|Overall Study|Received drug in run-in and discontinued|2|||
156686674|NCT02412722|565596439|FG002|Overall Study|Received drug in run-in and discontinued|0|||
156686675|NCT02412722|565596440|FG003|Overall Study|Received drug in run-in and discontinued|0|||
156686676|NCT02412722|565596441|FG004|Overall Study|Received drug in run-in and discontinued|0|||
156686677|NCT02412722|565596442|FG005|Overall Study|Received drug in run-in and discontinued|0|||
156686678|NCT02412722|565596437|FG000|Overall Study|Reason not Specified|3|||
156686679|NCT02412722|565596438|FG001|Overall Study|Reason not Specified|0|||
156686680|NCT02412722|565596439|FG002|Overall Study|Reason not Specified|2|||
156686681|NCT02412722|565596440|FG003|Overall Study|Reason not Specified|1|||
156686682|NCT02412722|565596441|FG004|Overall Study|Reason not Specified|2|||
156686683|NCT02412722|565596442|FG005|Overall Study|Reason not Specified|6|||
156686684|NCT04449341|565596445|FG000|Overall Study|Protocol Violation|1|||
156686685|NCT04449341|565596446|FG001|Overall Study|Protocol Violation|0|||
156686686|NCT01020526|565596448|FG000|Overall Study|Withdrawal by Subject|5|||
156686687|NCT01020526|565596448|FG000|Overall Study|Other reasons|3|||
156686688|NCT01020526|565596448|FG000|Overall Study|Insufficient clinical response|3|||
156686689|NCT01020526|565596448|FG000|Overall Study|Lost to Follow-up|1|||
156686690|NCT01020526|565596448|FG000|Overall Study|Adverse Event|2|||
156686691|NCT00551616|565596451|FG000|Overall Study|Lost to Follow-up|48|||
156686692|NCT00551616|565596452|FG001|Overall Study|Lost to Follow-up|40|||
156686693|NCT03546647|565596453|FG000|Overall Study|Adverse Event|1|||
156686694|NCT03546647|565596454|FG001|Overall Study|Adverse Event|0|||
156686695|NCT03297294|565596455|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
156686696|NCT03297294|565596456|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
156686697|NCT03297294|565596457|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156686698|NCT03297294|565596458|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156686699|NCT03297294|565596459|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156686700|NCT03297294|565596455|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
156686701|NCT03297294|565596456|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
156686702|NCT03297294|565596457|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156686703|NCT03297294|565596458|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156686704|NCT03297294|565596459|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156686705|NCT03297294|565596455|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
156686706|NCT03297294|565596456|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
156686707|NCT03297294|565596457|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156786587|NCT01543503|565970428|FG000|Overall Study|Site stopped participation|5|||
156436886|NCT02115282|564689154|FG000|Overall Study|Adverse Event|49|||
156686708|NCT03297294|565596458|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156686709|NCT03297294|565596459|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156686710|NCT03297294|565596455|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
156686711|NCT03297294|565596456|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
156686712|NCT03297294|565596457|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156686713|NCT03297294|565596458|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156686714|NCT03297294|565596459|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156686715|NCT03297294|565596455|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
156686716|NCT03297294|565596456|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
156686717|NCT03297294|565596457|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
156686718|NCT03297294|565596458|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
156686719|NCT03297294|565596459|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
156686720|NCT01435031|565596460|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
156686721|NCT01435031|565596460|FG000|ITT at 1 Month|Death|1|||
156686722|NCT01435031|565596460|FG000|ITT at 1 Month|Lost to Follow-up|4|||
156686723|NCT01435031|565596460|FG000|ITT at 6 Months|Death|2|||
156686724|NCT01435031|565596460|FG000|ITT at 6 Months|Lost to Follow-up|3|||
156686725|NCT01435031|565596460|FG000|ITT at 1 Year|Death|1|||
156686726|NCT01435031|565596460|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
156686727|NCT01435031|565596460|FG000|ITT at 1 Year|Lost to Follow-up|6|||
156686728|NCT01435031|565596460|FG000|ITT at 2 Years|Death|7|||
156686729|NCT01435031|565596460|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
156686730|NCT01435031|565596460|FG000|ITT at 2 Years|Lost to Follow-up|4|||
156686731|NCT01435031|565596460|FG000|ITT at 3 Years|Death|5|||
156686732|NCT01435031|565596460|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
156686733|NCT01435031|565596460|FG000|ITT at 3 Years|Lost to Follow-up|4|||
156686734|NCT01435031|565596460|FG000|ITT at 4 Years|Death|4|||
156686735|NCT01435031|565596460|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
156686736|NCT01435031|565596460|FG000|ITT at 4 Years|Lost to Follow-up|1|||
156686737|NCT00105157|565596461|FG000|Double-Blind (DB)|Never Treated|1|||
156686738|NCT00105157|565596462|FG001|Double-Blind (DB)|Never Treated|0|||
156686739|NCT00105157|565596463|FG002|Double-Blind (DB)|Never Treated|0|||
156686740|NCT00105157|565596464|FG003|Double-Blind (DB)|Never Treated|0|||
156686741|NCT00105157|565596461|FG000|Double-Blind (DB)|Adverse Event|2|||
156686742|NCT00105157|565596462|FG001|Double-Blind (DB)|Adverse Event|0|||
156686743|NCT00105157|565596463|FG002|Double-Blind (DB)|Adverse Event|1|||
156686744|NCT00105157|565596464|FG003|Double-Blind (DB)|Adverse Event|1|||
156686745|NCT00105157|565596461|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
156686746|NCT00105157|565596462|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
156686747|NCT00105157|565596463|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
156686748|NCT00105157|565596464|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
156686749|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Adverse Event|3|||
156686750|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Adverse Event|1|||
156686751|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Adverse Event|0|||
156686752|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Adverse Event|0|||
156686753|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
156686754|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
156686755|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
156686756|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
156686757|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
156686758|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
156686759|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
156686760|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
156686761|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
156686762|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
156686763|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
156686764|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
156686765|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
156686766|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
156686767|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
156686768|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
156686769|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
156686770|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
156686771|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
156686772|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
156686773|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
156686774|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
156686775|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
156686776|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
156686777|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
156686778|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
156686779|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
156686780|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
156686781|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
156786588|NCT01543503|565970429|FG001|Overall Study|Site stopped participation|1|||
156786589|NCT01543503|565970428|FG000|Overall Study|Participant did not attend a visit|1|||
156786590|NCT01543503|565970429|FG001|Overall Study|Participant did not attend a visit|0|||
156786591|NCT01543503|565970428|FG000|Overall Study|Moved to other rheumatologic site|0|||
156530390|NCT00372385|565036402|FG000|Overall Study|Physician Decision|1|||
156530391|NCT00372385|565036403|FG001|Overall Study|Physician Decision|0|||
156530392|NCT00372385|565036404|FG002|Overall Study|Physician Decision|0|||
156530393|NCT00372385|565036405|FG003|Overall Study|Physician Decision|0|||
156786592|NCT01543503|565970429|FG001|Overall Study|Moved to other rheumatologic site|1|||
156786593|NCT01543503|565970428|FG000|Overall Study|Participant consented to another study|0|||
156530394|NCT00372385|565036402|FG000|Overall Study|Lost to Follow-up|2|||
156530395|NCT00372385|565036403|FG001|Overall Study|Lost to Follow-up|0|||
156530396|NCT00372385|565036404|FG002|Overall Study|Lost to Follow-up|0|||
156530397|NCT00372385|565036405|FG003|Overall Study|Lost to Follow-up|0|||
156530398|NCT00372385|565036402|FG000|Overall Study|Withdrawal by Subject|2|||
156530399|NCT00372385|565036403|FG001|Overall Study|Withdrawal by Subject|1|||
156530400|NCT00372385|565036404|FG002|Overall Study|Withdrawal by Subject|0|||
156530401|NCT00372385|565036405|FG003|Overall Study|Withdrawal by Subject|0|||
156530402|NCT00372385|565036402|FG000|Overall Study|Refusal of Treatment|3|||
156530403|NCT00372385|565036403|FG001|Overall Study|Refusal of Treatment|6|||
156530404|NCT00372385|565036404|FG002|Overall Study|Refusal of Treatment|0|||
156530405|NCT00372385|565036405|FG003|Overall Study|Refusal of Treatment|0|||
156530406|NCT00372385|565036402|FG000|Overall Study|No Response|1|||
156530407|NCT00372385|565036403|FG001|Overall Study|No Response|1|||
156530408|NCT00372385|565036404|FG002|Overall Study|No Response|0|||
156530409|NCT00372385|565036405|FG003|Overall Study|No Response|0|||
156530410|NCT00372385|565036402|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
156530411|NCT00372385|565036403|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
156530412|NCT00372385|565036404|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
156530413|NCT00372385|565036405|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
156530414|NCT00372385|565036402|FG000|Overall Study|Virologic Stopping Rule|17|||
156530415|NCT00372385|565036403|FG001|Overall Study|Virologic Stopping Rule|0|||
156530416|NCT00372385|565036404|FG002|Overall Study|Virologic Stopping Rule|0|||
156530417|NCT00372385|565036405|FG003|Overall Study|Virologic Stopping Rule|0|||
156530418|NCT01966471|565036406|FG000|Overall Study|Death|44|||
156530419|NCT01966471|565036407|FG001|Overall Study|Death|56|||
156530420|NCT01966471|565036406|FG000|Overall Study|Lost to Follow-up|46|||
156530421|NCT01966471|565036407|FG001|Overall Study|Lost to Follow-up|39|||
156786594|NCT01543503|565970429|FG001|Overall Study|Participant consented to another study|2|||
156436887|NCT02115282|564689155|FG001|Overall Study|Adverse Event|23|||
156436888|NCT02115282|564689154|FG000|Overall Study|Death|1|||
156436889|NCT02115282|564689155|FG001|Overall Study|Death|3|||
156436890|NCT02115282|564689154|FG000|Overall Study|Alternative therapy|1|||
156436891|NCT02115282|564689155|FG001|Overall Study|Alternative therapy|1|||
156436892|NCT02115282|564689154|FG000|Overall Study|Complicating disease|0|||
156436893|NCT02115282|564689155|FG001|Overall Study|Complicating disease|3|||
156436894|NCT02115282|564689154|FG000|Overall Study|Withdrawal by Subject|12|||
156436895|NCT02115282|564689155|FG001|Overall Study|Withdrawal by Subject|10|||
156436896|NCT02115282|564689154|FG000|Overall Study|Symptomatic progression/deterioration|7|||
156436897|NCT02115282|564689155|FG001|Overall Study|Symptomatic progression/deterioration|18|||
156436898|NCT02115282|564689154|FG000|Overall Study|Non-compliance|5|||
156436899|NCT02115282|564689155|FG001|Overall Study|Non-compliance|1|||
156436900|NCT02115282|564689154|FG000|Overall Study|Protocol Violation|2|||
156436901|NCT02115282|564689155|FG001|Overall Study|Protocol Violation|2|||
156436902|NCT02115282|564689154|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
156436903|NCT02115282|564689155|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
156436904|NCT02115282|564689154|FG000|Overall Study|Not start protocol therapy|9|||
156436905|NCT02115282|564689155|FG001|Overall Study|Not start protocol therapy|10|||
156436906|NCT04795752|564689156|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
156436907|NCT04795752|564689157|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
156436908|NCT04795752|564689156|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
156436909|NCT04795752|564689157|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
156436910|NCT04795752|564689156|FG000|Primary Endpoint Phase|Physician Decision|2|||
156436911|NCT04795752|564689157|FG001|Primary Endpoint Phase|Physician Decision|0|||
156436912|NCT04795752|564689156|FG000|Primary Endpoint Phase|Other|4|||
156436913|NCT04795752|564689157|FG001|Primary Endpoint Phase|Other|1|||
156436914|NCT04795752|564689156|FG000|Primary Endpoint Phase|Protocol Violation|1|||
156436915|NCT04795752|564689157|FG001|Primary Endpoint Phase|Protocol Violation|0|||
156436916|NCT04795752|564689156|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
156436917|NCT04795752|564689157|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
156436918|NCT04795752|564689156|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
156436919|NCT04795752|564689157|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
156436920|NCT04795752|564689156|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
156686782|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
156686783|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
156686784|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
156686785|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
156686786|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
156686787|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
156686788|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
156686789|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
156686790|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
156686791|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
156686792|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
156686793|NCT01396421|565596465|FG000|Overall Study|Lost to Follow-up|0|||
156786595|NCT01543503|565970428|FG000|Overall Study|Participant went to United States|1|||
156786596|NCT01543503|565970429|FG001|Overall Study|Participant went to United States|0|||
156786597|NCT01543503|565970428|FG000|Overall Study|Screen failure|1|||
156786598|NCT01543503|565970429|FG001|Overall Study|Screen failure|0|||
156786599|NCT02460380|565970430|FG000|Overall Study|Withdrawal by Subject|10|||
156786600|NCT02460380|565970431|FG001|Overall Study|Withdrawal by Subject|5|||
156786601|NCT01478087|565970434|FG000|Overall Study|due to sponsor closing study|1|||
156786602|NCT03566550|565970436|FG000|Overall Study|Withdrawal by Subject|0|||
156686794|NCT01396421|565596466|FG001|Overall Study|Lost to Follow-up|0|||
156686795|NCT01396421|565596467|FG002|Overall Study|Lost to Follow-up|0|||
156686796|NCT01396421|565596468|FG003|Overall Study|Lost to Follow-up|1|||
156686797|NCT01396421|565596465|FG000|Overall Study|Adverse Event|17|||
156686798|NCT01396421|565596466|FG001|Overall Study|Adverse Event|15|||
156686799|NCT01396421|565596467|FG002|Overall Study|Adverse Event|12|||
156686800|NCT01396421|565596468|FG003|Overall Study|Adverse Event|32|||
156686801|NCT01396421|565596465|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
156686802|NCT01396421|565596466|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
156686803|NCT01396421|565596467|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
156686804|NCT01396421|565596468|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
156686805|NCT01396421|565596465|FG000|Overall Study|Physician Decision|1|||
156686806|NCT01396421|565596466|FG001|Overall Study|Physician Decision|1|||
156686807|NCT01396421|565596467|FG002|Overall Study|Physician Decision|0|||
156686808|NCT01396421|565596468|FG003|Overall Study|Physician Decision|3|||
156686809|NCT01396421|565596465|FG000|Overall Study|Withdrawal by Subject|31|||
156686810|NCT01396421|565596466|FG001|Overall Study|Withdrawal by Subject|24|||
156686811|NCT01396421|565596467|FG002|Overall Study|Withdrawal by Subject|13|||
156686812|NCT01396421|565596468|FG003|Overall Study|Withdrawal by Subject|21|||
156686813|NCT01396421|565596465|FG000|Overall Study|Protocol Deviation|2|||
156869441|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
156869442|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
156686814|NCT01396421|565596466|FG001|Overall Study|Protocol Deviation|1|||
156686815|NCT01396421|565596467|FG002|Overall Study|Protocol Deviation|1|||
156686816|NCT01396421|565596468|FG003|Overall Study|Protocol Deviation|0|||
156786603|NCT03566550|565970437|FG001|Overall Study|Withdrawal by Subject|1|||
156786604|NCT04576949|565970439|FG000|Overall Study|Adverse Event|1|||
156786605|NCT04576949|565970440|FG001|Overall Study|Adverse Event|3|||
156786606|NCT04576949|565970441|FG002|Overall Study|Adverse Event|2|||
156786607|NCT04576949|565970439|FG000|Overall Study|Withdrawal by Subject|41|||
156786608|NCT04576949|565970440|FG001|Overall Study|Withdrawal by Subject|26|||
156786609|NCT04576949|565970441|FG002|Overall Study|Withdrawal by Subject|18|||
156786610|NCT04576949|565970439|FG000|Overall Study|Physician Decision|3|||
156786611|NCT04576949|565970440|FG001|Overall Study|Physician Decision|0|||
156786612|NCT04576949|565970441|FG002|Overall Study|Physician Decision|0|||
156786613|NCT04576949|565970439|FG000|Overall Study|Death|0|||
156786614|NCT04576949|565970440|FG001|Overall Study|Death|1|||
156786615|NCT04576949|565970441|FG002|Overall Study|Death|0|||
156786616|NCT04576949|565970439|FG000|Overall Study|Lost to Follow-up|29|||
156786617|NCT04576949|565970440|FG001|Overall Study|Lost to Follow-up|37|||
156786618|NCT04576949|565970441|FG002|Overall Study|Lost to Follow-up|24|||
156869443|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
156869444|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
156686817|NCT01396421|565596465|FG000|Overall Study|Lack of Efficacy|7|||
156786619|NCT04576949|565970439|FG000|Overall Study|Other, Not Specified|2|||
156686818|NCT01396421|565596466|FG001|Overall Study|Lack of Efficacy|17|||
156686819|NCT01396421|565596467|FG002|Overall Study|Lack of Efficacy|7|||
156686820|NCT01396421|565596468|FG003|Overall Study|Lack of Efficacy|18|||
156686821|NCT00104247|565596473|FG000|Overall Study|Withdrawal by Subject|1|||
156686822|NCT00104247|565596474|FG001|Overall Study|Withdrawal by Subject|0|||
156686823|NCT00104247|565596473|FG000|Overall Study|Noncompliant with dosing|0|||
156786620|NCT04576949|565970440|FG001|Overall Study|Other, Not Specified|3|||
156786621|NCT04576949|565970441|FG002|Overall Study|Other, Not Specified|1|||
156786622|NCT04576949|565970439|FG000|Overall Study|Other|1|||
156786623|NCT04576949|565970440|FG001|Overall Study|Other|0|||
156786624|NCT04576949|565970441|FG002|Overall Study|Other|0|||
156786625|NCT00052715|565970445|FG000|Overall Study|wrong histology|1|||
156786626|NCT01936974|565970446|FG000|Overall Study|Physician Decision|2|||
156786627|NCT01936974|565970447|FG001|Overall Study|Physician Decision|5|||
156786628|NCT00063999|565970450|FG000|Overall Study|Withdrawal by Subject|1|||
156530422|NCT01966471|565036406|FG000|Overall Study|Various reasons|4|||
156530423|NCT01966471|565036407|FG001|Overall Study|Various reasons|4|||
156530424|NCT01966471|565036406|FG000|Overall Study|Physician Decision|7|||
156530425|NCT01966471|565036407|FG001|Overall Study|Physician Decision|5|||
156530426|NCT01966471|565036406|FG000|Overall Study|Study Terminated By Sponsor|758|||
156530427|NCT01966471|565036407|FG001|Overall Study|Study Terminated By Sponsor|773|||
156530428|NCT01966471|565036406|FG000|Overall Study|Withdrawal by Subject|59|||
156530429|NCT01966471|565036407|FG001|Overall Study|Withdrawal by Subject|51|||
156530430|NCT01030198|565036412|FG000|Overall Study|Could not measure efficacy accurately|0|||
156530431|NCT01030198|565036413|FG001|Overall Study|Could not measure efficacy accurately|7|||
156530432|NCT02279862|565036414|FG000|Overall Study|Study drug toxicity|3|||
156530433|NCT02279862|565036415|FG001|Overall Study|Study drug toxicity|6|||
156530434|NCT02279862|565036414|FG000|Overall Study|No longer meets criteria|0|||
156530435|NCT02279862|565036415|FG001|Overall Study|No longer meets criteria|1|||
156530436|NCT02279862|565036414|FG000|Overall Study|Administrative reason by sponsor|0|||
156530437|NCT02279862|565036415|FG001|Overall Study|Administrative reason by sponsor|1|||
156530438|NCT02279862|565036414|FG000|Overall Study|Disease progression|5|||
156530439|NCT02279862|565036415|FG001|Overall Study|Disease progression|2|||
156530440|NCT02279862|565036414|FG000|Overall Study|Study closed by sponsor|16|||
156530441|NCT02279862|565036415|FG001|Overall Study|Study closed by sponsor|13|||
156530442|NCT02279862|565036414|FG000|Overall Study|Other|1|||
156530443|NCT02279862|565036415|FG001|Overall Study|Other|2|||
156530444|NCT02279862|565036414|FG000|Overall Study|Withdrawal by Subject|1|||
156530445|NCT02279862|565036415|FG001|Overall Study|Withdrawal by Subject|0|||
156530446|NCT03431857|565036416|FG000|Overall Study|Death|6|||
156530447|NCT03431857|565036416|FG000|Overall Study|Lost to Follow-up|41|||
156530448|NCT03431857|565036416|FG000|Overall Study|Adverse Event|6|||
156530449|NCT03431857|565036416|FG000|Overall Study|Withdrawal by Subject|1|||
156530450|NCT01323621|565036417|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
156530451|NCT01323621|565036418|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
156530452|NCT01323621|565036419|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
156530453|NCT01323621|565036417|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
156530454|NCT01323621|565036418|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
156530455|NCT01323621|565036419|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
156530456|NCT01323621|565036417|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
156530457|NCT01323621|565036418|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
156530458|NCT01323621|565036419|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
156530459|NCT01323621|565036417|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
156530460|NCT01323621|565036418|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
156530461|NCT01323621|565036419|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
156530462|NCT01323621|565036417|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
156530463|NCT01323621|565036418|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
156530464|NCT01323621|565036419|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
156530465|NCT01323621|565036417|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
156530466|NCT01323621|565036418|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
156530467|NCT01323621|565036419|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
156530468|NCT01323621|565036417|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
156530469|NCT01323621|565036418|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
156530470|NCT01323621|565036419|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
156530471|NCT01323621|565036417|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
156530472|NCT01323621|565036418|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
156530473|NCT01323621|565036419|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
156530474|NCT01323621|565036417|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
156530475|NCT01323621|565036418|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
156530476|NCT01323621|565036419|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
156530477|NCT01323621|565036417|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156530478|NCT01323621|565036418|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
156530479|NCT01323621|565036419|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156530480|NCT01323621|565036417|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
156530481|NCT01323621|565036418|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
156530482|NCT01323621|565036419|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
156786629|NCT00063999|565970451|FG001|Overall Study|Withdrawal by Subject|0|||
156786630|NCT00063999|565970450|FG000|Overall Study|Ineligible|44|||
156786631|NCT00063999|565970451|FG001|Overall Study|Ineligible|24|||
156786632|NCT01078545|565970455|FG000|Overall Study|Lost to Follow-up|13|||
156869445|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
156869446|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
156869447|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
156869448|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
156869449|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
156869450|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
156869451|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
156869452|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
156869453|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
156869454|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
156869455|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
156786633|NCT01078545|565970455|FG000|Overall Study|Physician Decision|6|||
156786634|NCT01078545|565970455|FG000|Overall Study|Withdrawal by Subject|3|||
156786635|NCT01078545|565970455|FG000|Overall Study|Death|3|||
156786636|NCT01078545|565970455|FG000|Overall Study|Participant moved to another physician|1|||
156786637|NCT02497755|565970456|FG000|Overall Study|Protocol Violation|1|||
156786638|NCT02497755|565970457|FG001|Overall Study|Protocol Violation|0|||
156786639|NCT01774370|565970460|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
156786640|NCT01774370|565970460|FG000|Overall Study|Administered prior to the contract date|4|||
156786641|NCT01774370|565970460|FG000|Overall Study|Subjects of contraindications|34|||
156786642|NCT01774370|565970460|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
156786643|NCT01774370|565970460|FG000|Overall Study|Follow-up failure|34|||
156786644|NCT00514917|565970463|FG000|Overall Study|Death|4|||
156786645|NCT00514917|565970464|FG001|Overall Study|Death|10|||
156786646|NCT00514917|565970463|FG000|Overall Study|Protocol Violation|1|||
156786647|NCT00514917|565970464|FG001|Overall Study|Protocol Violation|0|||
156786648|NCT00514917|565970463|FG000|Overall Study|Lost to Follow-up|4|||
156786649|NCT00514917|565970464|FG001|Overall Study|Lost to Follow-up|3|||
156786650|NCT00514917|565970463|FG000|Overall Study|Withdrawal by Subject|18|||
156786651|NCT00514917|565970464|FG001|Overall Study|Withdrawal by Subject|16|||
156786652|NCT00514917|565970463|FG000|Overall Study|Discontinued due to study closure|88|||
156786653|NCT00514917|565970464|FG001|Overall Study|Discontinued due to study closure|81|||
156786654|NCT00514917|565970463|FG000|Overall Study|Undefined|11|||
156786655|NCT00514917|565970464|FG001|Overall Study|Undefined|5|||
156786656|NCT04243837|565970468|FG000|Overall Study|Adverse Event|2|||
156786657|NCT04243837|565970469|FG001|Overall Study|Adverse Event|1|||
156786658|NCT04243837|565970468|FG000|Overall Study|Withdrawal by Subject|4|||
156786659|NCT04243837|565970469|FG001|Overall Study|Withdrawal by Subject|2|||
156786660|NCT04243837|565970468|FG000|Overall Study|Covid-19 lock down|1|||
156786661|NCT04243837|565970469|FG001|Overall Study|Covid-19 lock down|0|||
156786662|NCT04243837|565970468|FG000|Overall Study|Study Terminated by Sponsor|11|||
156786663|NCT04243837|565970469|FG001|Overall Study|Study Terminated by Sponsor|12|||
156786664|NCT02280499|565970470|FG000|Overall Study|Death|14|||
156786665|NCT02280499|565970470|FG000|Overall Study|Lost to Follow-up|42|||
156786666|NCT02280499|565970470|FG000|Overall Study|Adverse Event|5|||
156786667|NCT03511066|565970484|FG000|Overall Study|Withdrawal by Subject|1|||
156786668|NCT03511066|565970485|FG001|Overall Study|Withdrawal by Subject|2|||
156786669|NCT03511066|565970486|FG002|Overall Study|Withdrawal by Subject|3|||
156786670|NCT03511066|565970484|FG000|Overall Study|Lost to Follow-up|2|||
156786671|NCT03511066|565970485|FG001|Overall Study|Lost to Follow-up|3|||
156786672|NCT03511066|565970486|FG002|Overall Study|Lost to Follow-up|0|||
156786673|NCT04560309|565970487|FG000|Overall Study|Meet drop out criteria|1|||
156786674|NCT04560309|565970488|FG001|Overall Study|Meet drop out criteria|1|||
156786675|NCT04146909|565970489|FG000|Overall Study|Withdrawal by Subject|3|||
156786676|NCT04146909|565970489|FG000|Overall Study|Did not qualify after consented|1|||
156786677|NCT05085405|565970490|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
156786678|NCT05085405|565970491|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
156786679|NCT05085405|565970492|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
156786680|NCT05085405|565970493|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
156786681|NCT05085405|565970494|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
156786682|NCT05085405|565970495|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
156786683|NCT05085405|565970490|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786684|NCT05085405|565970491|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786685|NCT05085405|565970492|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786686|NCT05085405|565970493|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
156786687|NCT05085405|565970494|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786688|NCT05085405|565970495|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786689|NCT01860404|565970496|FG000|Overall Study|Lost to Follow-up|3|||
156786690|NCT01860404|565970497|FG001|Overall Study|Lost to Follow-up|4|||
156786691|NCT01860404|565970498|FG002|Overall Study|Lost to Follow-up|1|||
156786692|NCT01860404|565970499|FG003|Overall Study|Lost to Follow-up|6|||
156686824|NCT00104247|565596474|FG001|Overall Study|Noncompliant with dosing|1|||
156686825|NCT03314662|565596476|FG000|Overall Study|Withdrawal by Subject|1|||
156686826|NCT03314662|565596477|FG001|Overall Study|Withdrawal by Subject|1|||
156686827|NCT03314662|565596478|FG002|Overall Study|Withdrawal by Subject|1|||
156686828|NCT03314662|565596476|FG000|Overall Study|Lost to Follow-up|5|||
156686829|NCT03314662|565596477|FG001|Overall Study|Lost to Follow-up|4|||
156686830|NCT03314662|565596478|FG002|Overall Study|Lost to Follow-up|4|||
156686831|NCT03314662|565596476|FG000|Overall Study|Death|2|||
156686832|NCT03314662|565596477|FG001|Overall Study|Death|0|||
156686833|NCT03314662|565596478|FG002|Overall Study|Death|0|||
156686834|NCT01634854|565596479|FG000|Overall Study|Cesarean delivery|2|||
156686835|NCT01634854|565596480|FG001|Overall Study|Cesarean delivery|7|||
156686836|NCT01169038|565596481|FG000|Overall Study|Death|1|||
156686837|NCT01169038|565596481|FG000|Overall Study|Adverse Event|5|||
156686838|NCT01169038|565596481|FG000|Overall Study|Required antibiotic administration|1|||
156686839|NCT02490800|565596482|FG000|Overall Study|Adverse Event|0|||
156686840|NCT02490800|565596483|FG001|Overall Study|Adverse Event|0|||
156686841|NCT02490800|565596484|FG002|Overall Study|Adverse Event|0|||
156686842|NCT02490800|565596485|FG003|Overall Study|Adverse Event|2|||
156686843|NCT02490800|565596486|FG004|Overall Study|Adverse Event|3|||
156686844|NCT02490800|565596487|FG005|Overall Study|Adverse Event|2|||
156686845|NCT02490800|565596488|FG006|Overall Study|Adverse Event|0|||
156686846|NCT02490800|565596489|FG007|Overall Study|Adverse Event|0|||
156686847|NCT02490800|565596490|FG008|Overall Study|Adverse Event|0|||
156686848|NCT02490800|565596491|FG009|Overall Study|Adverse Event|0|||
156686849|NCT02490800|565596492|FG010|Overall Study|Adverse Event|0|||
156686850|NCT02490800|565596493|FG011|Overall Study|Adverse Event|2|||
156686851|NCT02490800|565596494|FG012|Overall Study|Adverse Event|2|||
156686852|NCT02490800|565596482|FG000|Overall Study|Withdrawal by Subject|0|||
156686853|NCT02490800|565596483|FG001|Overall Study|Withdrawal by Subject|0|||
156686854|NCT02490800|565596484|FG002|Overall Study|Withdrawal by Subject|0|||
156686855|NCT02490800|565596485|FG003|Overall Study|Withdrawal by Subject|1|||
156686856|NCT02490800|565596486|FG004|Overall Study|Withdrawal by Subject|0|||
156686857|NCT02490800|565596487|FG005|Overall Study|Withdrawal by Subject|0|||
156686858|NCT02490800|565596488|FG006|Overall Study|Withdrawal by Subject|0|||
156686859|NCT02490800|565596489|FG007|Overall Study|Withdrawal by Subject|0|||
156686860|NCT02490800|565596490|FG008|Overall Study|Withdrawal by Subject|1|||
156686861|NCT02490800|565596491|FG009|Overall Study|Withdrawal by Subject|0|||
156786693|NCT01860404|565970500|FG004|Overall Study|Lost to Follow-up|4|||
156786694|NCT01860404|565970496|FG000|Overall Study|Withdrawal by Subject|0|||
156786695|NCT01860404|565970497|FG001|Overall Study|Withdrawal by Subject|0|||
156786696|NCT01860404|565970498|FG002|Overall Study|Withdrawal by Subject|4|||
156786697|NCT01860404|565970499|FG003|Overall Study|Withdrawal by Subject|0|||
156786698|NCT01860404|565970500|FG004|Overall Study|Withdrawal by Subject|0|||
156786699|NCT00356421|565970502|FG000|Overall Study|Lack of Efficacy|3|||
156786700|NCT00356421|565970503|FG001|Overall Study|Lack of Efficacy|0|||
156786701|NCT00356421|565970502|FG000|Overall Study|Withdrawal by Subject|9|||
156786702|NCT00356421|565970503|FG001|Overall Study|Withdrawal by Subject|2|||
156786703|NCT00356421|565970502|FG000|Overall Study|Related to study drug|15|||
156786704|NCT00356421|565970503|FG001|Overall Study|Related to study drug|12|||
156786705|NCT00356421|565970502|FG000|Overall Study|Not related to study drug|5|||
156786706|NCT00356421|565970503|FG001|Overall Study|Not related to study drug|3|||
156786707|NCT00663351|565970504|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
156786708|NCT00663351|565970505|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
156786709|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
156786710|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
156786711|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
156786712|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
156786713|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
156786714|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
156786715|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
156786716|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
156786717|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
156786718|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
156786719|NCT03336866|565970506|FG000|Overall Study|Lost to Follow-up|2|||
156786720|NCT03336866|565970507|FG001|Overall Study|Lost to Follow-up|0|||
156686862|NCT02490800|565596492|FG010|Overall Study|Withdrawal by Subject|0|||
156686863|NCT02490800|565596493|FG011|Overall Study|Withdrawal by Subject|0|||
156686864|NCT02490800|565596494|FG012|Overall Study|Withdrawal by Subject|0|||
156686865|NCT02490800|565596482|FG000|Overall Study|Progressive disease|3|||
156686866|NCT02490800|565596483|FG001|Overall Study|Progressive disease|3|||
156686867|NCT02490800|565596484|FG002|Overall Study|Progressive disease|3|||
156786721|NCT03336866|565970508|FG002|Overall Study|Lost to Follow-up|3|||
156686868|NCT02490800|565596485|FG003|Overall Study|Progressive disease|4|||
156686869|NCT02490800|565596486|FG004|Overall Study|Progressive disease|4|||
156686870|NCT02490800|565596487|FG005|Overall Study|Progressive disease|1|||
156686871|NCT02490800|565596488|FG006|Overall Study|Progressive disease|4|||
156686872|NCT02490800|565596489|FG007|Overall Study|Progressive disease|3|||
156686873|NCT02490800|565596490|FG008|Overall Study|Progressive disease|6|||
156686874|NCT02490800|565596491|FG009|Overall Study|Progressive disease|2|||
156686875|NCT02490800|565596492|FG010|Overall Study|Progressive disease|7|||
156686876|NCT02490800|565596493|FG011|Overall Study|Progressive disease|1|||
156686877|NCT02490800|565596494|FG012|Overall Study|Progressive disease|10|||
156686878|NCT02490800|565596482|FG000|Overall Study|Patient enrolled in post-trial access|0|||
156686879|NCT02490800|565596483|FG001|Overall Study|Patient enrolled in post-trial access|0|||
156686880|NCT02490800|565596484|FG002|Overall Study|Patient enrolled in post-trial access|0|||
156686881|NCT02490800|565596485|FG003|Overall Study|Patient enrolled in post-trial access|0|||
156686882|NCT02490800|565596486|FG004|Overall Study|Patient enrolled in post-trial access|0|||
156686883|NCT02490800|565596487|FG005|Overall Study|Patient enrolled in post-trial access|0|||
156686884|NCT02490800|565596488|FG006|Overall Study|Patient enrolled in post-trial access|0|||
156686885|NCT02490800|565596489|FG007|Overall Study|Patient enrolled in post-trial access|0|||
156686886|NCT02490800|565596490|FG008|Overall Study|Patient enrolled in post-trial access|0|||
156686887|NCT02490800|565596491|FG009|Overall Study|Patient enrolled in post-trial access|1|||
156686888|NCT02490800|565596492|FG010|Overall Study|Patient enrolled in post-trial access|1|||
156686889|NCT02490800|565596493|FG011|Overall Study|Patient enrolled in post-trial access|0|||
156686890|NCT02490800|565596494|FG012|Overall Study|Patient enrolled in post-trial access|6|||
156686891|NCT03257254|565596495|FG000|Overall Study|Withdrawal by Subject|7|||
156686892|NCT03257254|565596495|FG000|Overall Study|Lost to Follow-up|9|||
156686893|NCT03257254|565596495|FG000|Overall Study|Study discontinued by sponsor|5|||
156686894|NCT03365791|565596496|FG000|Overall Study|Adverse Event|5|||
156686895|NCT03365791|565596496|FG000|Overall Study|Death|1|||
156686896|NCT03365791|565596496|FG000|Overall Study|Lost to Follow-up|1|||
156686897|NCT03365791|565596496|FG000|Overall Study|Physician Decision|9|||
156686898|NCT03365791|565596496|FG000|Overall Study|Progressive disease|51|||
156686899|NCT03365791|565596496|FG000|Overall Study|Subject/guardian decision|5|||
156686900|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
156686901|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686902|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686903|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156786722|NCT03336866|565970506|FG000|Overall Study|Withdrawal by Subject|1|||
156786723|NCT03336866|565970507|FG001|Overall Study|Withdrawal by Subject|1|||
156786724|NCT03336866|565970508|FG002|Overall Study|Withdrawal by Subject|0|||
156786725|NCT03336866|565970506|FG000|Overall Study|Noncompliance with clinic house rules|0|||
156786726|NCT03336866|565970507|FG001|Overall Study|Noncompliance with clinic house rules|0|||
156786727|NCT03336866|565970508|FG002|Overall Study|Noncompliance with clinic house rules|1|||
156786728|NCT03462563|565970509|FG000|Overall Study|Death|1|||
156786729|NCT03462563|565970510|FG001|Overall Study|Death|1|||
156869456|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
156869457|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
156869458|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
156869459|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
156869460|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
156869461|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
156869462|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
156869463|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
156869464|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
156869465|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
156869466|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
156869467|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
156869468|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Death|0|||
156869469|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Death|6|||
156869470|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Death|3|||
156869471|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Death|0|||
156869472|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Death|0|||
156869473|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
156869474|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
156869475|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
156686904|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686905|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686906|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686907|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686908|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686909|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
156686910|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686911|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156786730|NCT03462563|565970509|FG000|Overall Study|Termination of study|2|||
156686912|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686913|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686914|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686915|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686916|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686917|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686918|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
156686919|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686920|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686921|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156786731|NCT03462563|565970510|FG001|Overall Study|Termination of study|1|||
156786732|NCT03462563|565970509|FG000|Overall Study|Adverse Event|1|||
156786733|NCT03462563|565970510|FG001|Overall Study|Adverse Event|3|||
156786734|NCT03462563|565970509|FG000|Overall Study|Unspecified reason|10|||
156786735|NCT03462563|565970510|FG001|Overall Study|Unspecified reason|12|||
156786736|NCT03462563|565970509|FG000|Overall Study|Physician Decision|1|||
156786737|NCT03462563|565970510|FG001|Overall Study|Physician Decision|0|||
156786738|NCT01751685|565970513|FG000|6-mo Followup|Missed study visit|1|||
156786739|NCT01751685|565970514|FG001|6-mo Followup|Missed study visit|0|||
156786740|NCT01751685|565970513|FG000|6-mo Followup|Withdrawal by Subject|2|||
156786741|NCT01751685|565970514|FG001|6-mo Followup|Withdrawal by Subject|2|||
156786742|NCT01751685|565970513|FG000|6-mo Followup|Lost to Follow-up|0|||
156786743|NCT01751685|565970514|FG001|6-mo Followup|Lost to Follow-up|1|||
156786744|NCT01751685|565970513|FG000|12-mo Followup|Lost to Follow-up|5|||
156786745|NCT01751685|565970514|FG001|12-mo Followup|Lost to Follow-up|0|||
156786746|NCT03011372|565970515|FG000|Overall Study|Death|16|||
156786747|NCT03011372|565970515|FG000|Overall Study|Lost to Follow-up|2|||
156786748|NCT03011372|565970515|FG000|Overall Study|Sponsor Decision|17|||
156786749|NCT03011372|565970515|FG000|Overall Study|Withdrawal by Subject|7|||
156786750|NCT03011372|565970515|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
156786751|NCT03011372|565970515|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
156786752|NCT03011372|565970515|FG000|Overall Study|Sponsor's Decision|2|||
156786753|NCT01179399|565970516|FG000|Overall Study|Adverse Event|1|||
156786754|NCT01179399|565970516|FG000|Overall Study|Lack of Efficacy|30|||
156786755|NCT01179399|565970516|FG000|Overall Study|Withdrawal by Subject|1|||
156786756|NCT03572218|565970517|FG000|Overall Study|Lost to Follow-up|3|||
156786757|NCT03572218|565970518|FG001|Overall Study|Lost to Follow-up|2|||
156786758|NCT03572218|565970517|FG000|Overall Study|No longer available for study visits|2|||
156786759|NCT03572218|565970518|FG001|Overall Study|No longer available for study visits|1|||
156786760|NCT03572218|565970517|FG000|Overall Study|No longer interested|1|||
156786761|NCT03572218|565970518|FG001|Overall Study|No longer interested|2|||
156786762|NCT02724644|565972723|FG000|Overall Study|Adverse Event|7|||
156786763|NCT02724644|565972724|FG001|Overall Study|Adverse Event|1|||
156786764|NCT02724644|565972723|FG000|Overall Study|Lost to Follow-up|6|||
156786765|NCT02724644|565972724|FG001|Overall Study|Lost to Follow-up|2|||
156786766|NCT02724644|565972723|FG000|Overall Study|Withdrawal by Subject|7|||
156786767|NCT02724644|565972724|FG001|Overall Study|Withdrawal by Subject|1|||
156786768|NCT02724644|565972723|FG000|Overall Study|Administrative|1|||
156786769|NCT02724644|565972724|FG001|Overall Study|Administrative|0|||
156786770|NCT00676052|565972728|FG000|Overall Study|Adverse Event|0|||
156786771|NCT00676052|565972729|FG001|Overall Study|Adverse Event|1|||
156786772|NCT00676052|565972730|FG002|Overall Study|Adverse Event|1|||
156786773|NCT00676052|565972731|FG003|Overall Study|Adverse Event|2|||
156786774|NCT00676052|565972732|FG004|Overall Study|Adverse Event|2|||
156786775|NCT00676052|565972733|FG005|Overall Study|Adverse Event|2|||
156786776|NCT00676052|565972728|FG000|Overall Study|Lack of Efficacy|2|||
156786777|NCT00676052|565972729|FG001|Overall Study|Lack of Efficacy|2|||
156786778|NCT00676052|565972730|FG002|Overall Study|Lack of Efficacy|1|||
156786779|NCT00676052|565972731|FG003|Overall Study|Lack of Efficacy|1|||
156786780|NCT00676052|565972732|FG004|Overall Study|Lack of Efficacy|2|||
156786781|NCT00676052|565972733|FG005|Overall Study|Lack of Efficacy|1|||
156786782|NCT00676052|565972728|FG000|Overall Study|Protocol Violation|5|||
156786783|NCT00676052|565972729|FG001|Overall Study|Protocol Violation|3|||
156786784|NCT00676052|565972730|FG002|Overall Study|Protocol Violation|2|||
156786785|NCT00676052|565972731|FG003|Overall Study|Protocol Violation|2|||
156786786|NCT00676052|565972732|FG004|Overall Study|Protocol Violation|1|||
156786787|NCT00676052|565972733|FG005|Overall Study|Protocol Violation|2|||
156786788|NCT00676052|565972728|FG000|Overall Study|Lost to Follow-up|0|||
156786789|NCT00676052|565972729|FG001|Overall Study|Lost to Follow-up|0|||
156786790|NCT00676052|565972730|FG002|Overall Study|Lost to Follow-up|0|||
156786791|NCT00676052|565972731|FG003|Overall Study|Lost to Follow-up|0|||
156786792|NCT00676052|565972732|FG004|Overall Study|Lost to Follow-up|1|||
156786793|NCT00676052|565972733|FG005|Overall Study|Lost to Follow-up|0|||
156786794|NCT00676052|565972728|FG000|Overall Study|Physician Decision|1|||
156786795|NCT00676052|565972729|FG001|Overall Study|Physician Decision|1|||
156786796|NCT00676052|565972730|FG002|Overall Study|Physician Decision|1|||
156686922|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686923|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686924|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686925|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686926|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686927|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
156686928|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686929|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686930|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686931|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686932|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686933|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686934|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686935|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686936|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
156686937|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686938|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686939|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686940|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686941|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686942|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686943|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686944|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686945|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
156686946|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686947|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686948|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686949|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686950|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686951|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686952|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686953|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686954|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
156686955|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686956|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156869476|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
156869477|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
156869478|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Other|0|||
156869479|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Other|8|||
156869480|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Other|11|||
156869481|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Other|0|||
156869482|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Other|0|||
156869483|NCT00561925|566279020|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
156869484|NCT00561925|566279021|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
156869485|NCT00561925|566279022|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
156869486|NCT00561925|566279023|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
156869487|NCT00561925|566279024|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
156869488|NCT04041414|566279027|FG000|Overall Study|Lost to Follow-up|1|||
156869489|NCT04041414|566279028|FG001|Overall Study|Lost to Follow-up|2|||
156869490|NCT00665652|566279029|FG000|Overall Study|Adverse Event|4|||
156869491|NCT00665652|566279029|FG000|Overall Study|Death|1|||
156869492|NCT00665652|566279029|FG000|Overall Study|No longer met inclusion criteria.|1|||
156869493|NCT02161016|566279030|FG000|Overall Study|withdrawn by IRB|1|||
156869494|NCT00380367|566279036|FG000|Overall Study|Lost to Follow-up|1|||
156869495|NCT00380367|566279036|FG000|Overall Study|Withdrawal by Subject|1|||
156869496|NCT02504151|566279041|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
156869497|NCT02504151|566279042|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
156869498|NCT02504151|566279041|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
156869499|NCT02504151|566279042|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
156869500|NCT02504151|566279041|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156869501|NCT02504151|566279042|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156869502|NCT02504151|566279041|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
156869503|NCT02504151|566279042|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
156869504|NCT05038982|566279043|FG000|Overall Study|Withdrawal by Subject|0|||
156329990|NCT03615326|564308736|FG002|Overall Study|Withdrawal by Subject|0|||
156329991|NCT03615326|564308737|FG003|Overall Study|Withdrawal by Subject|0|||
156686957|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686958|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686959|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686960|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686961|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686962|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686963|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
156686964|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
156686965|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
156686966|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
156686967|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
156686968|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
156686969|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
156686970|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
156686971|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
156686972|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686973|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686974|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686975|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686976|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
156686977|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686978|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686979|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
156686980|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686981|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
156686982|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
156686983|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686984|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686985|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686986|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686987|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686988|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686989|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686990|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
156686991|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
156686992|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
156686993|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
156686994|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
156686995|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
156686996|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
156686997|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
156686998|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
156686999|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687000|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687001|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
156687002|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687003|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687004|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687005|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687006|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687007|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156786797|NCT00676052|565972731|FG003|Overall Study|Physician Decision|0|||
156786798|NCT00676052|565972732|FG004|Overall Study|Physician Decision|0|||
156786799|NCT00676052|565972733|FG005|Overall Study|Physician Decision|1|||
156786800|NCT00676052|565972728|FG000|Overall Study|Withdrawal by Subject|1|||
156786801|NCT00676052|565972729|FG001|Overall Study|Withdrawal by Subject|0|||
156786802|NCT00676052|565972730|FG002|Overall Study|Withdrawal by Subject|1|||
156786803|NCT00676052|565972731|FG003|Overall Study|Withdrawal by Subject|0|||
156786804|NCT00676052|565972732|FG004|Overall Study|Withdrawal by Subject|0|||
156786805|NCT00676052|565972733|FG005|Overall Study|Withdrawal by Subject|0|||
156786806|NCT02930941|565972734|FG000|Overall Study|Lost to Follow-up|1|||
156687008|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687009|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
156687010|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687011|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
156687012|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687013|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687014|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
156687015|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
156687016|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687017|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
156687018|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
156687019|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
156329992|NCT03615326|564308734|FG000|Overall Study|Participants Ongoing|83|||
156687020|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
156687021|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
156687022|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
156786807|NCT02930941|565972735|FG001|Overall Study|Lost to Follow-up|2|||
156786808|NCT00527748|565972748|FG000|Overall Study|Other|3|||
156786809|NCT00710554|565972749|FG000|Overall Study|Adverse Event|24|||
156786810|NCT00710554|565972750|FG001|Overall Study|Adverse Event|7|||
156786811|NCT00710554|565972749|FG000|Overall Study|Withdrawal by Subject|7|||
156786812|NCT00710554|565972750|FG001|Overall Study|Withdrawal by Subject|3|||
156786813|NCT00710554|565972749|FG000|Overall Study|Lost to Follow-up|7|||
156786814|NCT00710554|565972750|FG001|Overall Study|Lost to Follow-up|1|||
156786815|NCT00710554|565972749|FG000|Overall Study|Lack of Efficacy|11|||
156786816|NCT00710554|565972750|FG001|Overall Study|Lack of Efficacy|12|||
156786817|NCT00710554|565972749|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
156786818|NCT00710554|565972750|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
156786819|NCT00292370|565972751|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
156786820|NCT00292370|565972752|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
156786821|NCT00292370|565972753|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
156786822|NCT00292370|565972751|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
156786823|NCT00292370|565972752|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
156786824|NCT00292370|565972753|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
156786825|NCT00292370|565972751|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
156786826|NCT00292370|565972752|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
156786827|NCT00292370|565972753|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
156786828|NCT00292370|565972751|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
156786829|NCT00292370|565972752|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
156786830|NCT00292370|565972753|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
156786831|NCT00292370|565972751|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
156786832|NCT00292370|565972752|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
156786833|NCT00292370|565972753|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
156786834|NCT00292370|565972751|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
156786835|NCT00292370|565972752|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
156786836|NCT00292370|565972753|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
156786837|NCT01346709|565972754|FG000|Overall Study|Protocol Violation|35|||
156786838|NCT01346709|565972754|FG000|Overall Study|Lost to Follow-up|31|||
156786839|NCT01346709|565972754|FG000|Overall Study|Missing data in candidate risk factor|285|||
156786840|NCT02365064|565972763|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
156786841|NCT02365064|565972764|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
156786842|NCT02365064|565972763|FG000|Overall Study|Withdrawal by Subject|6|||
156786843|NCT02365064|565972764|FG001|Overall Study|Withdrawal by Subject|9|||
156786844|NCT02365064|565972763|FG000|Overall Study|Treatment intolerance|2|||
156786845|NCT02365064|565972764|FG001|Overall Study|Treatment intolerance|4|||
156786846|NCT02773537|565972773|FG000|Overall Study|Lost to Follow-up|0|||
156786847|NCT02773537|565972774|FG001|Overall Study|Lost to Follow-up|1|||
156786848|NCT02773537|565972775|FG002|Overall Study|Lost to Follow-up|4|||
156786849|NCT01840163|565972776|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
156786850|NCT01840163|565972777|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
156786851|NCT01840163|565972776|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
156786852|NCT01840163|565972777|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
156786853|NCT01840163|565972776|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
156786854|NCT01840163|565972777|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
156786855|NCT00662038|565972778|FG000|Overall Study|Reason not specified|3|||
156786856|NCT00662038|565972778|FG000|Overall Study|Withdrawn consent|22|||
156786857|NCT00662038|565972778|FG000|Overall Study|Withdrawal by Subject|83|||
156786858|NCT00662038|565972778|FG000|Overall Study|Sponsor decision|1|||
156869505|NCT05038982|566279044|FG001|Overall Study|Withdrawal by Subject|2|||
156869506|NCT01454102|566279048|FG000|Overall Study|Continuing in the treatment period|0|||
156869507|NCT01454102|566279049|FG001|Overall Study|Continuing in the treatment period|0|||
156869508|NCT01454102|566279050|FG002|Overall Study|Continuing in the treatment period|0|||
156869509|NCT01454102|566279051|FG003|Overall Study|Continuing in the treatment period|0|||
156869510|NCT01454102|566279052|FG004|Overall Study|Continuing in the treatment period|3|||
156869511|NCT01454102|566279053|FG005|Overall Study|Continuing in the treatment period|3|||
156869512|NCT01454102|566279054|FG006|Overall Study|Continuing in the treatment period|2|||
156869513|NCT01454102|566279055|FG007|Overall Study|Continuing in the treatment period|0|||
156869514|NCT01454102|566279056|FG008|Overall Study|Continuing in the treatment period|1|||
156869515|NCT01454102|566279057|FG009|Overall Study|Continuing in the treatment period|0|||
156869516|NCT01454102|566279058|FG010|Overall Study|Continuing in the treatment period|0|||
156869517|NCT01454102|566279059|FG011|Overall Study|Continuing in the treatment period|4|||
156869518|NCT01454102|566279060|FG012|Overall Study|Continuing in the treatment period|7|||
156869519|NCT01454102|566279061|FG013|Overall Study|Continuing in the treatment period|4|||
156869520|NCT01454102|566279062|FG014|Overall Study|Continuing in the treatment period|3|||
156869521|NCT01454102|566279063|FG015|Overall Study|Continuing in the treatment period|1|||
156869522|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
156869523|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
156869524|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
156869525|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
156869526|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156869527|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
156869528|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
156869529|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
156869530|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
156869531|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
156869532|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
156869533|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
156869534|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
156869535|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
156869536|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
156869537|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
156869538|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
156869539|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
156869540|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
156869541|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
156869542|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
156869543|NCT03739203|566279066|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
156869544|NCT03739203|566279067|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
156869545|NCT03739203|566279068|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
156869546|NCT03739203|566279066|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
156869547|NCT03739203|566279067|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
156869548|NCT03739203|566279068|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
156869549|NCT03739203|566279066|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
156869550|NCT03739203|566279067|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
156869551|NCT03739203|566279068|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
156869552|NCT03739203|566279066|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
156869553|NCT03739203|566279067|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
156869554|NCT03739203|566279068|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
156869555|NCT01782378|566279069|FG000|First Series|Lost to Follow-up|7|||
156869556|NCT01782378|566279070|FG001|First Series|Lost to Follow-up|8|||
156869557|NCT01782378|566279069|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
156869558|NCT01782378|566279070|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
156869559|NCT01782378|566279069|FG000|Second Series|Lost to Follow-up|8|||
156869560|NCT01782378|566279070|FG001|Second Series|Lost to Follow-up|7|||
156869561|NCT01782378|566279069|FG000|Second Series|Did not choose to complete S2 Optional|18|||
156329993|NCT03615326|564308735|FG001|Overall Study|Participants Ongoing|58|||
156687023|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
156687024|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
156687025|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
156687026|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687027|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687028|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687029|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156869562|NCT01782378|566279070|FG001|Second Series|Did not choose to complete S2 Optional|0|||
156869563|NCT00830440|566279071|FG000|Overall Study|Protocol Violation|1|||
156687030|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687031|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687032|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
156687033|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687034|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687035|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
156687036|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
156687037|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
156687038|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
156687039|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
156786859|NCT00662038|565972778|FG000|Overall Study|Physician Decision|19|||
156786860|NCT00662038|565972778|FG000|Overall Study|Lung transplantation|44|||
156786861|NCT00662038|565972778|FG000|Overall Study|Lost to Follow-up|1|||
156786862|NCT00662038|565972778|FG000|Overall Study|Death|95|||
156786863|NCT00662038|565972778|FG000|Overall Study|Adverse Event|358|||
156786864|NCT00662038|565972778|FG000|Overall Study|Continued treatment|5|||
156786865|NCT02421510|565972780|FG000|Overall Study|Other|4|||
156786866|NCT02421510|565972781|FG001|Overall Study|Other|2|||
156786867|NCT02421510|565972782|FG002|Overall Study|Other|3|||
156786868|NCT02421510|565972780|FG000|Overall Study|Protocol Violation|1|||
156786869|NCT02421510|565972781|FG001|Overall Study|Protocol Violation|2|||
156786870|NCT02421510|565972782|FG002|Overall Study|Protocol Violation|0|||
156786871|NCT02421510|565972780|FG000|Overall Study|Death|1|||
156786872|NCT02421510|565972781|FG001|Overall Study|Death|0|||
156786873|NCT02421510|565972782|FG002|Overall Study|Death|0|||
156786874|NCT02421510|565972780|FG000|Overall Study|Noncompliance with study drug|1|||
156786875|NCT02421510|565972781|FG001|Overall Study|Noncompliance with study drug|0|||
156786876|NCT02421510|565972782|FG002|Overall Study|Noncompliance with study drug|0|||
156786877|NCT02421510|565972780|FG000|Overall Study|Physician Decision|1|||
156786878|NCT02421510|565972781|FG001|Overall Study|Physician Decision|1|||
156786879|NCT02421510|565972782|FG002|Overall Study|Physician Decision|3|||
156786880|NCT02421510|565972780|FG000|Overall Study|Adverse Event|9|||
156786881|NCT02421510|565972781|FG001|Overall Study|Adverse Event|10|||
156786882|NCT02421510|565972782|FG002|Overall Study|Adverse Event|18|||
156786883|NCT02421510|565972780|FG000|Overall Study|Pregnancy|1|||
156786884|NCT02421510|565972781|FG001|Overall Study|Pregnancy|1|||
156786885|NCT02421510|565972782|FG002|Overall Study|Pregnancy|0|||
156786886|NCT02421510|565972780|FG000|Overall Study|Withdrawal by Subject|14|||
156786887|NCT02421510|565972781|FG001|Overall Study|Withdrawal by Subject|18|||
156786888|NCT02421510|565972782|FG002|Overall Study|Withdrawal by Subject|12|||
156786889|NCT02421510|565972780|FG000|Overall Study|Lost to Follow-up|1|||
156786890|NCT02421510|565972781|FG001|Overall Study|Lost to Follow-up|1|||
156786891|NCT02421510|565972782|FG002|Overall Study|Lost to Follow-up|0|||
156786892|NCT03774810|565972783|FG000|Phase 1|Lack of Efficacy|21|||
156786893|NCT03774810|565972784|FG001|Phase 1|Lack of Efficacy|0|||
156786894|NCT03774810|565972785|FG002|Phase 1|Lack of Efficacy|0|||
156786895|NCT03774810|565972786|FG003|Phase 1|Lack of Efficacy|0|||
156786896|NCT03774810|565972787|FG004|Phase 1|Lack of Efficacy|0|||
156786897|NCT03774810|565972783|FG000|Phase 1|Withdrawal by Subject|9|||
156786898|NCT03774810|565972784|FG001|Phase 1|Withdrawal by Subject|0|||
156786899|NCT03774810|565972785|FG002|Phase 1|Withdrawal by Subject|0|||
156786900|NCT03774810|565972786|FG003|Phase 1|Withdrawal by Subject|0|||
156786901|NCT03774810|565972787|FG004|Phase 1|Withdrawal by Subject|0|||
156786902|NCT03774810|565972783|FG000|Phase 1|Lost to Follow-up|2|||
156786903|NCT03774810|565972784|FG001|Phase 1|Lost to Follow-up|0|||
156786904|NCT03774810|565972785|FG002|Phase 1|Lost to Follow-up|0|||
156786905|NCT03774810|565972786|FG003|Phase 1|Lost to Follow-up|0|||
156786906|NCT03774810|565972787|FG004|Phase 1|Lost to Follow-up|0|||
156786907|NCT03774810|565972783|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
156786908|NCT03774810|565972784|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
156786909|NCT03774810|565972785|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
156786910|NCT03774810|565972786|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
156786911|NCT03774810|565972787|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
156687040|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
156786912|NCT03774810|565972783|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
156786913|NCT03774810|565972784|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
156530483|NCT01323621|565036417|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156786914|NCT03774810|565972785|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
156786915|NCT03774810|565972786|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
156786916|NCT03774810|565972787|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
156786917|NCT03774810|565972783|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
156786918|NCT03774810|565972784|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
156786919|NCT03774810|565972785|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
156786920|NCT03774810|565972786|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
156786921|NCT03774810|565972787|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
156786922|NCT03774810|565972783|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
156869564|NCT00830440|566279072|FG001|Overall Study|Protocol Violation|0|||
156329994|NCT03615326|564308736|FG002|Overall Study|Participants Ongoing|6|||
156687041|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
156687042|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
156687043|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
156687044|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687045|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
156687046|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687047|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687048|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687049|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687050|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
156687051|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687052|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687053|NCT00109837|565599206|FG000|Overall Study|Adverse Event|2|||
156687054|NCT00109837|565599206|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
156687055|NCT00109837|565599206|FG000|Overall Study|Death|1|||
156687056|NCT00109837|565599206|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
156687057|NCT00109837|565599206|FG000|Overall Study|Not treated|1|||
156687058|NCT00109837|565599206|FG000|Overall Study|Ineligible|1|||
156687059|NCT01989676|565599207|FG000|Overall Study|Death|52|||
156687060|NCT01989676|565599208|FG001|Overall Study|Death|60|||
156687061|NCT01989676|565599207|FG000|Overall Study|Protocol Violation|2|||
156687062|NCT01989676|565599208|FG001|Overall Study|Protocol Violation|1|||
156687063|NCT01989676|565599207|FG000|Overall Study|Lost to Follow-up|8|||
156687064|NCT01989676|565599208|FG001|Overall Study|Lost to Follow-up|18|||
156687065|NCT01989676|565599207|FG000|Overall Study|No longer willing to participate in study|26|||
156687066|NCT01989676|565599208|FG001|Overall Study|No longer willing to participate in study|26|||
156687067|NCT01989676|565599207|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
156687068|NCT01989676|565599208|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
156687069|NCT01989676|565599207|FG000|Overall Study|Other|4|||
156786923|NCT03774810|565972784|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
156786924|NCT03774810|565972785|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
156786925|NCT03774810|565972786|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
156786926|NCT03774810|565972787|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
156786927|NCT03774810|565972783|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
156786928|NCT03774810|565972784|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
156786929|NCT03774810|565972785|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
156786930|NCT03774810|565972786|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
156786931|NCT03774810|565972787|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
156786932|NCT03774810|565972783|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
156786933|NCT03774810|565972784|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
156786934|NCT03774810|565972785|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
156786935|NCT03774810|565972786|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
156786936|NCT03774810|565972787|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
156786937|NCT00927186|565972790|FG000|12 Months Primary Study|Adverse Event|5|||
156786938|NCT00927186|565972791|FG001|12 Months Primary Study|Adverse Event|2|||
156786939|NCT00927186|565972790|FG000|12 Months Primary Study|Lost to Follow-up|1|||
156786940|NCT00927186|565972791|FG001|12 Months Primary Study|Lost to Follow-up|0|||
156786941|NCT00927186|565972790|FG000|12 Months Primary Study|Protocol Violation|0|||
156786942|NCT00927186|565972791|FG001|12 Months Primary Study|Protocol Violation|1|||
156786943|NCT00927186|565972790|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
156786944|NCT00927186|565972791|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
156786945|NCT04641975|565972797|FG000|Overall Study|Protocol Violation|1|||
156786946|NCT04641975|565972798|FG001|Overall Study|Protocol Violation|2|||
156786947|NCT04641975|565972799|FG002|Overall Study|Protocol Violation|0|||
156786948|NCT04641975|565972800|FG003|Overall Study|Protocol Violation|0|||
156786949|NCT04641975|565972797|FG000|Overall Study|Adverse Event|0|||
156687070|NCT01989676|565599208|FG001|Overall Study|Other|3|||
156687071|NCT01619579|565599209|FG000|Overall Study|Withdrawal by Subject|0|||
156687072|NCT01619579|565599210|FG001|Overall Study|Withdrawal by Subject|3|||
156786950|NCT04641975|565972798|FG001|Overall Study|Adverse Event|0|||
156786951|NCT04641975|565972799|FG002|Overall Study|Adverse Event|1|||
156329995|NCT03615326|564308737|FG003|Overall Study|Participants Ongoing|3|||
156786952|NCT04641975|565972800|FG003|Overall Study|Adverse Event|1|||
156687073|NCT02938442|565599212|FG000|Overall Study|Death|0|||
156687074|NCT02938442|565599213|FG001|Overall Study|Death|1|||
156329996|NCT02651467|564308742|FG000|Overall Study|Withdrawal by Subject|0|||
156329997|NCT02651467|564308743|FG001|Overall Study|Withdrawal by Subject|0|||
156687075|NCT02938442|565599212|FG000|Overall Study|Lost to Follow-up|0|||
156687076|NCT02938442|565599213|FG001|Overall Study|Lost to Follow-up|1|||
156687077|NCT02938442|565599212|FG000|Overall Study|Physician Decision|0|||
156687078|NCT02938442|565599213|FG001|Overall Study|Physician Decision|1|||
156869565|NCT00830440|566279071|FG000|Overall Study|Withdrawal by Subject|1|||
156687079|NCT02938442|565599212|FG000|Overall Study|Withdrawal by Subject|2|||
156687080|NCT02938442|565599213|FG001|Overall Study|Withdrawal by Subject|0|||
156687081|NCT01115855|565599214|FG000|Overall Study|Adverse Event|16|||
156687082|NCT01115855|565599215|FG001|Overall Study|Adverse Event|18|||
156687083|NCT01115855|565599214|FG000|Overall Study|Death|6|||
156687084|NCT01115855|565599215|FG001|Overall Study|Death|5|||
156687085|NCT01115855|565599214|FG000|Overall Study|Lab Abnormality|1|||
156687086|NCT01115855|565599215|FG001|Overall Study|Lab Abnormality|1|||
156687087|NCT01115855|565599214|FG000|Overall Study|Protocol Violation|0|||
156687088|NCT01115855|565599215|FG001|Overall Study|Protocol Violation|1|||
156687089|NCT01115855|565599214|FG000|Overall Study|Withdrawal by Subject|5|||
156687090|NCT01115855|565599215|FG001|Overall Study|Withdrawal by Subject|5|||
156687091|NCT01115855|565599214|FG000|Overall Study|Other|8|||
156687092|NCT01115855|565599215|FG001|Overall Study|Other|6|||
156687093|NCT01684215|565599216|FG000|Phase 1, Part 1|Adverse Event|1|||
156687094|NCT01684215|565599217|FG001|Phase 1, Part 1|Adverse Event|0|||
156687095|NCT01684215|565599218|FG002|Phase 1, Part 1|Adverse Event|0|||
156687096|NCT01684215|565599219|FG003|Phase 1, Part 1|Adverse Event|0|||
156687097|NCT01684215|565599216|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
156687098|NCT01684215|565599217|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
156687099|NCT01684215|565599218|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
156687100|NCT01684215|565599219|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
156687101|NCT01684215|565599216|FG000|Phase 1, Part 2|Adverse Event|0|||
156687102|NCT01684215|565599217|FG001|Phase 1, Part 2|Adverse Event|0|||
156687103|NCT01684215|565599218|FG002|Phase 1, Part 2|Adverse Event|1|||
156687104|NCT01684215|565599219|FG003|Phase 1, Part 2|Adverse Event|0|||
156687105|NCT01684215|565599216|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
156687106|NCT01684215|565599217|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
156687107|NCT01684215|565599218|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
156687108|NCT01684215|565599219|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
156687109|NCT01684215|565599216|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
156687110|NCT01684215|565599217|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
156687111|NCT01684215|565599218|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
156687112|NCT01684215|565599219|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
156687113|NCT01684215|565599216|FG000|Phase 2|Death|0|||
156687114|NCT01684215|565599217|FG001|Phase 2|Death|0|||
156869566|NCT00830440|566279072|FG001|Overall Study|Withdrawal by Subject|0|||
156687115|NCT01684215|565599218|FG002|Phase 2|Death|0|||
156869567|NCT00830440|566279071|FG000|Overall Study|unsuccessful procedure|4|||
156869568|NCT00830440|566279072|FG001|Overall Study|unsuccessful procedure|0|||
156869569|NCT00830440|566279071|FG000|Overall Study|Adverse Event|2|||
156869570|NCT00830440|566279072|FG001|Overall Study|Adverse Event|0|||
156687116|NCT01684215|565599219|FG003|Phase 2|Death|8|||
156687117|NCT01684215|565599216|FG000|Phase 2|Study terminated by sponsor|0|||
156687118|NCT01684215|565599217|FG001|Phase 2|Study terminated by sponsor|0|||
156687119|NCT01684215|565599218|FG002|Phase 2|Study terminated by sponsor|0|||
156687120|NCT01684215|565599219|FG003|Phase 2|Study terminated by sponsor|30|||
156687121|NCT01684215|565599216|FG000|Phase 2|Enrolled but not treated|0|||
156687122|NCT01684215|565599217|FG001|Phase 2|Enrolled but not treated|0|||
156687123|NCT01684215|565599218|FG002|Phase 2|Enrolled but not treated|0|||
156687124|NCT01684215|565599219|FG003|Phase 2|Enrolled but not treated|1|||
156687125|NCT01684215|565599216|FG000|Phase 2|Lost to Follow-up|0|||
156687126|NCT01684215|565599217|FG001|Phase 2|Lost to Follow-up|0|||
156687127|NCT01684215|565599218|FG002|Phase 2|Lost to Follow-up|0|||
156687128|NCT01684215|565599219|FG003|Phase 2|Lost to Follow-up|4|||
156687129|NCT00480324|565599220|FG000|Overall Study|Adverse Event|1|||
156687130|NCT00480324|565599221|FG001|Overall Study|Adverse Event|1|||
156687131|NCT00480324|565599220|FG000|Overall Study|Protocol Violation|0|||
156687132|NCT00480324|565599221|FG001|Overall Study|Protocol Violation|1|||
156687133|NCT00480324|565599220|FG000|Overall Study|Withdrawal by Subject|14|||
156687134|NCT00480324|565599221|FG001|Overall Study|Withdrawal by Subject|5|||
156687135|NCT00480324|565599220|FG000|Overall Study|Lost to Follow-up|17|||
156687136|NCT00480324|565599221|FG001|Overall Study|Lost to Follow-up|8|||
156687137|NCT00480324|565599220|FG000|Overall Study|Subject's mother pregnant|0|||
156687138|NCT00480324|565599221|FG001|Overall Study|Subject's mother pregnant|1|||
156687139|NCT00966381|565599222|FG000|Overall Study|Withdrawal by Subject|2|||
156687140|NCT00966381|565599223|FG001|Overall Study|Withdrawal by Subject|2|||
156687141|NCT01915940|565599224|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
156687142|NCT01915940|565599225|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
156687143|NCT01915940|565599226|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
156687144|NCT01915940|565599224|FG000|Treatment Period|Decision of Participant|0|||
156687145|NCT01915940|565599225|FG001|Treatment Period|Decision of Participant|1|||
156687146|NCT01915940|565599226|FG002|Treatment Period|Decision of Participant|3|||
156869571|NCT02592798|566279073|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
156687147|NCT01915940|565599224|FG000|Treatment Period|Adverse Event|0|||
156687148|NCT01915940|565599225|FG001|Treatment Period|Adverse Event|9|||
156687149|NCT01915940|565599226|FG002|Treatment Period|Adverse Event|1|||
156687150|NCT01915940|565599224|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
156687151|NCT01915940|565599225|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
156687152|NCT01915940|565599226|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
156869572|NCT02592798|566279074|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
156869573|NCT02592798|566279073|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
156869574|NCT02592798|566279074|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
156869575|NCT02592798|566279073|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
156869576|NCT02592798|566279074|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
156869577|NCT02592798|566279073|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
156687153|NCT03686150|565599227|FG000|Overall Study|Withdrawal by Subject|1|||
156687154|NCT03686150|565599228|FG001|Overall Study|Withdrawal by Subject|1|||
156687155|NCT03686150|565599229|FG002|Overall Study|Withdrawal by Subject|1|||
156687156|NCT03686150|565599230|FG003|Overall Study|Withdrawal by Subject|0|||
156687157|NCT03686150|565599231|FG004|Overall Study|Withdrawal by Subject|1|||
156687158|NCT03686150|565599232|FG005|Overall Study|Withdrawal by Subject|2|||
156687159|NCT03686150|565599227|FG000|Overall Study|Physician Decision|1|||
156687160|NCT03686150|565599228|FG001|Overall Study|Physician Decision|0|||
156687161|NCT03686150|565599229|FG002|Overall Study|Physician Decision|0|||
156687162|NCT03686150|565599230|FG003|Overall Study|Physician Decision|0|||
156687163|NCT03686150|565599231|FG004|Overall Study|Physician Decision|0|||
156687164|NCT03686150|565599232|FG005|Overall Study|Physician Decision|1|||
156687165|NCT03686150|565599227|FG000|Overall Study|Lost to Follow-up|0|||
156687166|NCT03686150|565599228|FG001|Overall Study|Lost to Follow-up|1|||
156786953|NCT04641975|565972797|FG000|Overall Study|Withdrawal by Subject|1|||
156786954|NCT04641975|565972798|FG001|Overall Study|Withdrawal by Subject|0|||
156786955|NCT04641975|565972799|FG002|Overall Study|Withdrawal by Subject|0|||
156786956|NCT04641975|565972800|FG003|Overall Study|Withdrawal by Subject|0|||
156786957|NCT02264821|565972802|FG000|Overall Study|Protocol Violation|1|||
156786958|NCT02264821|565972803|FG001|Overall Study|Protocol Violation|3|||
156786959|NCT02264821|565972804|FG002|Overall Study|Protocol Violation|6|||
156786960|NCT03142334|565972806|FG000|Overall Study|Death|18|||
156786961|NCT03142334|565972807|FG001|Overall Study|Death|33|||
156786962|NCT03142334|565972806|FG000|Overall Study|Withdrawal by Subject|15|||
156786963|NCT03142334|565972807|FG001|Overall Study|Withdrawal by Subject|11|||
156786964|NCT03142334|565972806|FG000|Overall Study|Ongoing on trial follow up|463|||
156786965|NCT03142334|565972807|FG001|Overall Study|Ongoing on trial follow up|454|||
156786966|NCT04865978|565972808|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
156786967|NCT04865978|565972809|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
156786968|NCT05587998|565972810|FG000|Overall Study|Withdrawal by Subject|1|||
156786969|NCT05587998|565972811|FG001|Overall Study|Withdrawal by Subject|1|||
156786970|NCT05587998|565972810|FG000|Overall Study|Not treated|3|||
156786971|NCT05587998|565972811|FG001|Overall Study|Not treated|1|||
156786972|NCT05587998|565972810|FG000|Overall Study|Non-compliance with study procedures|0|||
156786973|NCT05587998|565972811|FG001|Overall Study|Non-compliance with study procedures|1|||
156786974|NCT03528577|565972814|FG000|Sequence 1|Failed Spirometry|1|||
156786975|NCT03528577|565972814|FG000|Sequence 1|Restricted medication|1|||
156786976|NCT03528577|565972814|FG000|Sequence 2|Adverse Event|1|||
156786977|NCT03528577|565972814|FG000|Sequence 2|Withdrawal by Subject|1|||
156786978|NCT03528577|565972814|FG000|Sequence 2|Failed Spirometry|1|||
156786979|NCT03528577|565972814|FG000|Sequence 3|Failed Spirometry|1|||
156786980|NCT03528577|565972814|FG000|Sequence 4|Failed Spirometry|2|||
156786981|NCT03528577|565972814|FG000|Sequence 4|Adverse Event|1|||
156786982|NCT04882215|565972815|FG000|Overall Study|Withdrawal by Subject|5|||
156786983|NCT04882215|565972816|FG001|Overall Study|Withdrawal by Subject|0|||
156786984|NCT03835117|565972817|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
156786985|NCT03835117|565972818|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
156786986|NCT04263532|565972819|FG000|Overall Study|Withdrawal by Subject|2|||
156786987|NCT04263532|565972820|FG001|Overall Study|Withdrawal by Subject|0|||
156786988|NCT06083493|565972821|FG000|Overall Study|Technical issues with the interventional device|2|||
156869578|NCT02592798|566279074|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
156687167|NCT03686150|565599229|FG002|Overall Study|Lost to Follow-up|0|||
156869579|NCT02592798|566279073|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
156530484|NCT01323621|565036418|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
156687168|NCT03686150|565599230|FG003|Overall Study|Lost to Follow-up|0|||
156786989|NCT06083493|565972822|FG001|Overall Study|Technical issues with the interventional device|2|||
156687169|NCT03686150|565599231|FG004|Overall Study|Lost to Follow-up|0|||
156786990|NCT06083493|565972821|FG000|Overall Study|Performed incorrect visual task|1|||
156786991|NCT06083493|565972822|FG001|Overall Study|Performed incorrect visual task|0|||
156786992|NCT06083493|565972821|FG000|Overall Study|Insufficient baseline performance|0|||
156786993|NCT06083493|565972822|FG001|Overall Study|Insufficient baseline performance|1|||
156786994|NCT03225989|565972826|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
156687170|NCT03686150|565599232|FG005|Overall Study|Lost to Follow-up|0|||
156786995|NCT03225989|565972827|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
156786996|NCT03225989|565972828|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
156786997|NCT03225989|565972826|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
156786998|NCT03225989|565972827|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
156786999|NCT03225989|565972828|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
156787000|NCT03225989|565972826|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
156787001|NCT03225989|565972827|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
156787002|NCT03225989|565972828|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
156787003|NCT03225989|565972826|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
156787004|NCT03225989|565972827|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
156787005|NCT03225989|565972828|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
156787006|NCT03225989|565972826|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
156787007|NCT03225989|565972827|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
156787008|NCT03225989|565972828|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
156787009|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
156787010|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
156787011|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
156787012|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
156787013|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
156787014|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
156787015|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
156787016|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
156787017|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
156787018|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
156687171|NCT00983918|565599235|FG000|Overall Study|conversion to open cholecystectomy|0|||
156687172|NCT00983918|565599236|FG001|Overall Study|conversion to open cholecystectomy|2|||
156687173|NCT00983918|565599237|FG002|Overall Study|conversion to open cholecystectomy|2|||
156687174|NCT00983918|565599238|FG003|Overall Study|conversion to open cholecystectomy|2|||
156687175|NCT00988208|565599254|FG000|Overall Study|Adverse Event|71|||
156687176|NCT00988208|565599255|FG001|Overall Study|Adverse Event|122|||
156687177|NCT00988208|565599254|FG000|Overall Study|Disease Progression|103|||
156687178|NCT00988208|565599255|FG001|Overall Study|Disease Progression|89|||
156687179|NCT00988208|565599254|FG000|Overall Study|Withdrawal by Subject|50|||
156687180|NCT00988208|565599255|FG001|Overall Study|Withdrawal by Subject|57|||
156687181|NCT00988208|565599254|FG000|Overall Study|Death|9|||
156687182|NCT00988208|565599255|FG001|Overall Study|Death|15|||
156687183|NCT00988208|565599254|FG000|Overall Study|Lost to Follow-up|2|||
156687184|NCT00988208|565599255|FG001|Overall Study|Lost to Follow-up|3|||
156687185|NCT00988208|565599254|FG000|Overall Study|Protocol Violation|9|||
156687186|NCT00988208|565599255|FG001|Overall Study|Protocol Violation|2|||
156687187|NCT00988208|565599254|FG000|Overall Study|Sponsor Decision|102|||
156687188|NCT00988208|565599255|FG001|Overall Study|Sponsor Decision|78|||
156687189|NCT00988208|565599254|FG000|Overall Study|Clinical Progression|17|||
156687190|NCT00988208|565599255|FG001|Overall Study|Clinical Progression|16|||
156687191|NCT00988208|565599254|FG000|Overall Study|Biochemical Progression|21|||
156687192|NCT00988208|565599255|FG001|Overall Study|Biochemical Progression|7|||
156687193|NCT00988208|565599254|FG000|Overall Study|Clinical Deterioration|7|||
156687194|NCT00988208|565599255|FG001|Overall Study|Clinical Deterioration|14|||
156687195|NCT00988208|565599254|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
156687196|NCT00988208|565599255|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
156687197|NCT00988208|565599254|FG000|Overall Study|Other|8|||
156687198|NCT00988208|565599255|FG001|Overall Study|Other|3|||
156687199|NCT01796964|565599256|FG000|Overall Study|Adverse Event|1|||
156687200|NCT01796964|565599257|FG001|Overall Study|Adverse Event|1|||
156687201|NCT01796964|565599256|FG000|Overall Study|Death|1|||
156687202|NCT01796964|565599257|FG001|Overall Study|Death|0|||
156687203|NCT01796964|565599256|FG000|Overall Study|Protocol Violation|0|||
156687204|NCT01796964|565599257|FG001|Overall Study|Protocol Violation|1|||
156687205|NCT01796964|565599256|FG000|Overall Study|Withdrawal by Subject|1|||
156687206|NCT01796964|565599257|FG001|Overall Study|Withdrawal by Subject|1|||
156787019|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
156687207|NCT04025684|565599258|FG000|Overall Study|Withdrawal by Subject|1|||
156687208|NCT04025684|565599259|FG001|Overall Study|Withdrawal by Subject|1|||
156687209|NCT04025684|565599260|FG002|Overall Study|Withdrawal by Subject|0|||
156687210|NCT04025684|565599261|FG003|Overall Study|Withdrawal by Subject|0|||
156687211|NCT04025684|565599258|FG000|Overall Study|Multiple reasons|1|||
156687212|NCT04025684|565599259|FG001|Overall Study|Multiple reasons|3|||
156687213|NCT04025684|565599260|FG002|Overall Study|Multiple reasons|0|||
156687214|NCT04025684|565599261|FG003|Overall Study|Multiple reasons|1|||
156687215|NCT01844531|565599262|FG000|Overall Study|Withdrawal by Subject|0|||
156687216|NCT01844531|565599263|FG001|Overall Study|Withdrawal by Subject|1|||
156687217|NCT01844531|565599264|FG002|Overall Study|Withdrawal by Subject|0|||
156687218|NCT01844531|565599265|FG003|Overall Study|Withdrawal by Subject|0|||
156687219|NCT01546922|565599274|FG000|First Period of 10 Weeks|Protocol Violation|3|||
156687220|NCT01546922|565599275|FG001|First Period of 10 Weeks|Protocol Violation|1|||
156687221|NCT01546922|565599274|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
156687222|NCT01546922|565599275|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
156787020|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
156787021|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
156787022|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
156687223|NCT01546922|565599274|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
156687224|NCT01546922|565599275|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
156687225|NCT01546922|565599274|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
156687226|NCT01546922|565599275|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
156687227|NCT01546922|565599274|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
156687228|NCT01546922|565599275|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
156687229|NCT01613378|565599283|FG000|Overall Study|Lack of Efficacy|13|||
156687230|NCT01613378|565599283|FG000|Overall Study|Adverse Event|11|||
156687231|NCT01613378|565599283|FG000|Overall Study|Withdrawal by Subject|8|||
156687232|NCT01613378|565599283|FG000|Overall Study|Death|2|||
156687233|NCT01613378|565599283|FG000|Overall Study|Lost to Follow-up|1|||
156687234|NCT01613378|565599283|FG000|Overall Study|Other Reason|4|||
156687235|NCT02000531|565599284|FG000|Overall Study|Lost to Follow-up|1|||
156687236|NCT02000531|565599285|FG001|Overall Study|Lost to Follow-up|0|||
156687237|NCT02000531|565599284|FG000|Overall Study|Discontinued due to data cut-off|3|||
156687238|NCT02000531|565599285|FG001|Overall Study|Discontinued due to data cut-off|8|||
156687239|NCT00794417|565599286|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
156687240|NCT00794417|565599287|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
156687241|NCT00794417|565599288|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
156687242|NCT00794417|565599289|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
156687243|NCT00794417|565599286|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
156687244|NCT00794417|565599287|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
156687245|NCT00794417|565599288|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
156687246|NCT00794417|565599289|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
156687247|NCT00794417|565599286|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
156687248|NCT00794417|565599287|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
156687249|NCT00794417|565599288|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
156687250|NCT00794417|565599289|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
156687251|NCT00794417|565599286|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
156687252|NCT00794417|565599287|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
156687253|NCT00794417|565599288|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
156687254|NCT00794417|565599289|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
156687255|NCT00794417|565599286|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
156687256|NCT00794417|565599287|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
156687257|NCT00794417|565599288|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
156687258|NCT00794417|565599289|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
156687259|NCT00794417|565599286|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
156687260|NCT00794417|565599287|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
156687261|NCT00794417|565599288|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
156687262|NCT00794417|565599289|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
156687263|NCT00317642|565599295|FG000|Overall Study|Not Received Either Study Drug|1|||
156687264|NCT00317642|565599296|FG001|Overall Study|Not Received Either Study Drug|3|||
156687265|NCT00317642|565599295|FG000|Overall Study|Physician Decision|15|||
156687266|NCT00317642|565599296|FG001|Overall Study|Physician Decision|7|||
156687267|NCT00317642|565599295|FG000|Overall Study|Participant declined treatment|14|||
156687268|NCT00317642|565599296|FG001|Overall Study|Participant declined treatment|3|||
156687269|NCT00317642|565599295|FG000|Overall Study|Adverse Event|17|||
156687270|NCT00317642|565599296|FG001|Overall Study|Adverse Event|5|||
156687271|NCT00317642|565599295|FG000|Overall Study|Treatment Failure|56|||
156687272|NCT00317642|565599296|FG001|Overall Study|Treatment Failure|102|||
156687273|NCT00317642|565599295|FG000|Overall Study|Disease Recurrence|1|||
156687274|NCT00317642|565599296|FG001|Overall Study|Disease Recurrence|2|||
156687275|NCT00317642|565599295|FG000|Overall Study|Death|14|||
156687276|NCT00317642|565599296|FG001|Overall Study|Death|7|||
156687277|NCT00317642|565599295|FG000|Overall Study|Not Continue to Consolidation|2|||
156687278|NCT00317642|565599296|FG001|Overall Study|Not Continue to Consolidation|0|||
156687279|NCT00317642|565599295|FG000|Overall Study|Withdrawal by Subject|0|||
156687280|NCT00317642|565599296|FG001|Overall Study|Withdrawal by Subject|1|||
156687281|NCT00317642|565599295|FG000|Overall Study|Referred For Transplantation|1|||
156687282|NCT00317642|565599296|FG001|Overall Study|Referred For Transplantation|0|||
156687283|NCT00317642|565599295|FG000|Overall Study|AML Not Centrally Confirmed|1|||
156687284|NCT00317642|565599296|FG001|Overall Study|AML Not Centrally Confirmed|5|||
156687285|NCT00255151|565599297|FG000|Overall Study|Adverse Event|10|||
156787023|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
156787024|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
156787025|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
156787026|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
156787027|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
156787028|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
156787029|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
156787030|NCT03093870|565972832|FG000|Overall Study|Withdrawal by Subject|2|||
156787031|NCT03093870|565972833|FG001|Overall Study|Withdrawal by Subject|6|||
156787032|NCT03093870|565972834|FG002|Overall Study|Withdrawal by Subject|5|||
156787033|NCT03093870|565972832|FG000|Overall Study|Death|1|||
156787034|NCT03093870|565972833|FG001|Overall Study|Death|35|||
156787035|NCT03093870|565972834|FG002|Overall Study|Death|35|||
156787036|NCT03093870|565972832|FG000|Overall Study|Radiographic disease progression|10|||
156787037|NCT03093870|565972833|FG001|Overall Study|Radiographic disease progression|0|||
156787038|NCT03093870|565972834|FG002|Overall Study|Radiographic disease progression|0|||
156787039|NCT03093870|565972832|FG000|Overall Study|Clinical disease progression|1|||
156787040|NCT03093870|565972833|FG001|Overall Study|Clinical disease progression|0|||
156787041|NCT03093870|565972834|FG002|Overall Study|Clinical disease progression|0|||
156787042|NCT03093870|565972832|FG000|Overall Study|Physician Decision|2|||
156787043|NCT03093870|565972833|FG001|Overall Study|Physician Decision|0|||
156787044|NCT03093870|565972834|FG002|Overall Study|Physician Decision|0|||
156787045|NCT03093870|565972832|FG000|Overall Study|Adverse Event|7|||
156787046|NCT03093870|565972833|FG001|Overall Study|Adverse Event|0|||
156787047|NCT03093870|565972834|FG002|Overall Study|Adverse Event|0|||
156787048|NCT03093870|565972832|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
156787049|NCT03093870|565972833|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
156787050|NCT03093870|565972834|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
156787051|NCT03093870|565972832|FG000|Overall Study|Lost to Follow-up|0|||
156787052|NCT03093870|565972833|FG001|Overall Study|Lost to Follow-up|0|||
156787053|NCT03093870|565972834|FG002|Overall Study|Lost to Follow-up|1|||
156787054|NCT01986751|565972840|FG000|Overall Study|improperly consented|10|||
156787055|NCT01986751|565972841|FG001|Overall Study|improperly consented|2|||
156787056|NCT03501277|565972845|FG000|Intervention Period 1 (4 Days)|Other|0|||
156787057|NCT03501277|565972846|FG001|Intervention Period 1 (4 Days)|Other|0|||
156787058|NCT03501277|565972847|FG002|Intervention Period 1 (4 Days)|Other|1|||
156787059|NCT03501277|565972848|FG003|Intervention Period 1 (4 Days)|Other|0|||
156787060|NCT03501277|565972845|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
156787061|NCT03501277|565972846|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
156787062|NCT03501277|565972847|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
156787063|NCT03501277|565972848|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
156787064|NCT03501277|565972845|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
156787065|NCT03501277|565972846|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
156787066|NCT03501277|565972847|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
156787067|NCT03501277|565972848|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
156787068|NCT03501277|565972845|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
156787069|NCT03501277|565972846|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
156787070|NCT03501277|565972847|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
156787071|NCT03501277|565972848|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
156787072|NCT01873833|565972850|FG000|Overall Study|Withdrawal by Subject|1|||
156787073|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Adverse Event|14|||
156787074|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Adverse Event|27|||
156787075|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Adverse Event|60|||
156787076|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Adverse Event|0|||
156787077|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Adverse Event|0|||
156787078|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Pregnancy|0|||
156787079|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Pregnancy|7|||
156787080|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Pregnancy|9|||
156787081|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Pregnancy|0|||
156787082|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Pregnancy|0|||
156787083|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
156787084|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
156787085|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
156787086|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
156787087|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
156787088|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
156787089|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
156787090|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
156787091|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
156787092|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
156787093|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Death|1|||
156329998|NCT02651467|564308744|FG002|Overall Study|Withdrawal by Subject|2|||
156869580|NCT02592798|566279074|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
156869581|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
156869582|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
156869583|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
156869584|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
156869585|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
156869586|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
156869587|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
156869588|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
156869589|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
156869590|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
156869591|NCT02592798|566279073|FG000|Transition From DB2 to OLE|Other reasons|1|||
156869592|NCT02592798|566279074|FG001|Transition From DB2 to OLE|Other reasons|0|||
156869593|NCT02592798|566279073|FG000|Open Label Period (OLE)|Other reasons|0|||
156869594|NCT02592798|566279074|FG001|Open Label Period (OLE)|Other reasons|2|||
156869595|NCT02592798|566279073|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
156869596|NCT02592798|566279074|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
156869597|NCT02592798|566279073|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
156869598|NCT02592798|566279074|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
156869599|NCT02592798|566279073|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
156869600|NCT02592798|566279074|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
156869601|NCT02592798|566279073|FG000|Open Label Period (OLE)|Adverse Event|0|||
156869602|NCT02592798|566279074|FG001|Open Label Period (OLE)|Adverse Event|1|||
156869603|NCT01188343|566279075|FG000|Overall Study|Not vaccinated|0|||
156869604|NCT01188343|566279076|FG001|Overall Study|Not vaccinated|2|||
156869605|NCT01188343|566279077|FG002|Overall Study|Not vaccinated|1|||
156869606|NCT01188343|566279075|FG000|Overall Study|Withdrawal by Subject|1|||
156869607|NCT01188343|566279076|FG001|Overall Study|Withdrawal by Subject|24|||
156869608|NCT01188343|566279077|FG002|Overall Study|Withdrawal by Subject|0|||
156869609|NCT01143246|566279078|FG000|Overall Study|Adverse Event|24|||
156869610|NCT01143246|566279079|FG001|Overall Study|Adverse Event|28|||
156869611|NCT01143246|566279078|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
156869612|NCT01143246|566279079|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
156869613|NCT01143246|566279078|FG000|Overall Study|Lost to Follow-up|0|||
156869614|NCT01143246|566279079|FG001|Overall Study|Lost to Follow-up|1|||
156869615|NCT01143246|566279078|FG000|Overall Study|Death|16|||
156869616|NCT01143246|566279079|FG001|Overall Study|Death|15|||
156869617|NCT01143246|566279078|FG000|Overall Study|Reason not Specified|3|||
156869618|NCT01143246|566279079|FG001|Overall Study|Reason not Specified|5|||
156869619|NCT01663103|566279080|FG000|Overall Study|Withdrawal by Subject|1|||
156869620|NCT01663103|566279081|FG001|Overall Study|Withdrawal by Subject|2|||
156869621|NCT01663103|566279080|FG000|Overall Study|Adverse Event|1|||
156869622|NCT01663103|566279081|FG001|Overall Study|Adverse Event|0|||
156869623|NCT01663103|566279080|FG000|Overall Study|dog bite|1|||
156869624|NCT01663103|566279081|FG001|Overall Study|dog bite|0|||
156869625|NCT00363480|566279082|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
156869626|NCT00363480|566279082|FG000|Overall Study|Adverse Event|4|||
156869627|NCT00363480|566279082|FG000|Overall Study|Lost to Follow-up|5|||
156869628|NCT00363480|566279082|FG000|Overall Study|Withdrawal by Subject|5|||
156869629|NCT00363480|566279082|FG000|Overall Study|Non-compliance of subject|1|||
156869630|NCT00363480|566279082|FG000|Overall Study|Participant discontinued on its own|1|||
156869631|NCT04634253|566279085|FG000|Overall Study|Adverse Event|1|||
156869632|NCT04634253|566279086|FG001|Overall Study|Adverse Event|1|||
156869633|NCT04634253|566279087|FG002|Overall Study|Adverse Event|0|||
156869634|NCT04634253|566279085|FG000|Overall Study|Physician Decision|0|||
156869635|NCT04634253|566279086|FG001|Overall Study|Physician Decision|1|||
156869636|NCT04634253|566279087|FG002|Overall Study|Physician Decision|0|||
156869637|NCT04634253|566279085|FG000|Overall Study|Withdrawal by Subject|1|||
156869638|NCT04634253|566279086|FG001|Overall Study|Withdrawal by Subject|0|||
156869639|NCT04634253|566279087|FG002|Overall Study|Withdrawal by Subject|3|||
156869640|NCT01457703|566279094|FG000|Overall Study|Screen Failure|5|||
156869641|NCT01457703|566279095|FG001|Overall Study|Screen Failure|7|||
156869642|NCT01457703|566279094|FG000|Overall Study|Withdrawal by Subject|1|||
156869643|NCT01457703|566279095|FG001|Overall Study|Withdrawal by Subject|4|||
156869644|NCT01658436|566279096|FG000|Overall Study|Adverse Event|6|||
156869645|NCT01658436|566279097|FG001|Overall Study|Adverse Event|5|||
156869646|NCT01658436|566279096|FG000|Overall Study|Physician Decision|1|||
156869647|NCT01658436|566279097|FG001|Overall Study|Physician Decision|0|||
156869648|NCT01658436|566279096|FG000|Overall Study|Progressive disease|12|||
156869649|NCT01658436|566279097|FG001|Overall Study|Progressive disease|4|||
156869650|NCT01658436|566279096|FG000|Overall Study|Study terminated by sponsor|0|||
156869651|NCT01658436|566279097|FG001|Overall Study|Study terminated by sponsor|1|||
156329999|NCT02651467|564308742|FG000|Overall Study|Other (Not specified)|1|||
156530485|NCT01323621|565036419|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
156869652|NCT01658436|566279096|FG000|Overall Study|Subject/guardian decision|0|||
156869653|NCT01658436|566279097|FG001|Overall Study|Subject/guardian decision|1|||
156869654|NCT01658436|566279096|FG000|Overall Study|Death|1|||
156869655|NCT01658436|566279097|FG001|Overall Study|Death|0|||
156869656|NCT03987503|566279098|FG000|Overall Study|Lost to Follow-up|20|||
156869657|NCT03987503|566279098|FG000|Overall Study|Withdrawal by Subject|2|||
156869658|NCT00888940|566279102|FG000|Overall Study|Adverse Event|12|||
156869659|NCT00888940|566279103|FG001|Overall Study|Adverse Event|3|||
156869660|NCT00888940|566279102|FG000|Overall Study|Lost to Follow-up|5|||
156869661|NCT00888940|566279103|FG001|Overall Study|Lost to Follow-up|5|||
156869662|NCT00888940|566279102|FG000|Overall Study|Randomized Not Treated|11|||
156869663|NCT00888940|566279103|FG001|Overall Study|Randomized Not Treated|13|||
156869664|NCT01646125|566280982|FG000|Overall Study|Untreated|2|||
156869665|NCT01646125|566280983|FG001|Overall Study|Untreated|5|||
156869666|NCT01646125|566280982|FG000|Overall Study|Adverse Event|2|||
156869667|NCT01646125|566280983|FG001|Overall Study|Adverse Event|1|||
156869668|NCT01646125|566280982|FG000|Overall Study|Death|1|||
156869669|NCT01646125|566280983|FG001|Overall Study|Death|1|||
156869670|NCT01646125|566280982|FG000|Overall Study|Physician Decision|1|||
156869671|NCT01646125|566280983|FG001|Overall Study|Physician Decision|3|||
156869672|NCT01646125|566280982|FG000|Overall Study|Progressive disease|22|||
156869673|NCT01646125|566280983|FG001|Overall Study|Progressive disease|16|||
156869674|NCT01646125|566280982|FG000|Overall Study|Study terminated by sponsor|2|||
156869675|NCT01646125|566280983|FG001|Overall Study|Study terminated by sponsor|1|||
156869676|NCT01646125|566280982|FG000|Overall Study|Subject/Guardian decision|1|||
156869677|NCT01646125|566280983|FG001|Overall Study|Subject/Guardian decision|1|||
156869678|NCT02105662|566280984|FG000|Overall Study|Lost to Follow-up|5|||
156869679|NCT02105662|566280984|FG000|Overall Study|Withdrawal by Subject|1|||
156869680|NCT02331277|566280985|FG000|Overall Study|Withdrawal by Subject|1|||
156869681|NCT02331277|566280986|FG001|Overall Study|Withdrawal by Subject|0|||
156869682|NCT01376804|566280988|FG000|Treatment Period|Withdrawal by Subject|1|||
156869683|NCT01376804|566280988|FG000|Treatment Period|Adverse Event|6|||
156869684|NCT01376804|566280988|FG000|Treatment Period|Patient did not receive study drug|1|||
156869685|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
156869686|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
156869687|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Patient requirement|20|||
156869688|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Death|5|||
156869689|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Change of therapy|6|||
156869690|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
156869691|NCT01071798|566280989|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
156869692|NCT01071798|566280989|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
156869693|NCT01071798|566280989|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
156869694|NCT01071798|566280989|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
156869695|NCT01528969|566280991|FG000|Overall Study|absent from the school at baseline|2|||
156869696|NCT01528969|566280992|FG001|Overall Study|absent from the school at baseline|0|||
156869697|NCT03584789|566280997|FG000|Overall Study|refused EHR permission|19|||
156869698|NCT03584789|566280998|FG001|Overall Study|refused EHR permission|28|||
156869699|NCT03584789|566280999|FG002|Overall Study|refused EHR permission|23|||
156869700|NCT03584789|566280997|FG000|Overall Study|patients tied to a provider who retired|0|||
156869701|NCT03584789|566280998|FG001|Overall Study|patients tied to a provider who retired|0|||
156869702|NCT03584789|566280999|FG002|Overall Study|patients tied to a provider who retired|3|||
156869703|NCT00602472|566281001|FG000|Overall Study|Adverse Event|5|||
156869704|NCT00602472|566281002|FG001|Overall Study|Adverse Event|23|||
156869705|NCT00602472|566281001|FG000|Overall Study|Protocol Violation|4|||
156869706|NCT00602472|566281002|FG001|Overall Study|Protocol Violation|19|||
156869707|NCT00602472|566281001|FG000|Overall Study|Withdrawal by Subject|8|||
156869708|NCT00602472|566281002|FG001|Overall Study|Withdrawal by Subject|14|||
156869709|NCT00602472|566281001|FG000|Overall Study|Other incl. lack of efficacy|4|||
156869710|NCT00602472|566281002|FG001|Overall Study|Other incl. lack of efficacy|2|||
156869711|NCT01938716|566281003|FG000|Overall Study|Physician Decision|2|||
156869712|NCT01938716|566281003|FG000|Overall Study|Withdrawal by Subject|2|||
156869713|NCT02803580|566281004|FG000|Overall Study|Death|13|||
156869714|NCT02803580|566281004|FG000|Overall Study|Lost to Follow-up|19|||
156869715|NCT02803580|566281004|FG000|Overall Study|Withdrawal by Subject|3|||
156869716|NCT02803580|566281004|FG000|Overall Study|Inclusion in clinical trial|1|||
156869717|NCT03126591|566281005|FG000|Overall Study|Death|6|||
156869718|NCT03126591|566281006|FG001|Overall Study|Death|3|||
156869719|NCT03126591|566281007|FG002|Overall Study|Death|17|||
156869720|NCT03126591|566281005|FG000|Overall Study|Progressive Disease|0|||
156869721|NCT03126591|566281006|FG001|Overall Study|Progressive Disease|1|||
156330000|NCT02651467|564308743|FG001|Overall Study|Other (Not specified)|0|||
156869722|NCT03126591|566281007|FG002|Overall Study|Progressive Disease|2|||
156869723|NCT03126591|566281005|FG000|Overall Study|Terminated by Sponsor|0|||
156869724|NCT03126591|566281006|FG001|Overall Study|Terminated by Sponsor|1|||
156869725|NCT03126591|566281007|FG002|Overall Study|Terminated by Sponsor|4|||
156869726|NCT03126591|566281005|FG000|Overall Study|Withdrawal by Subject|1|||
156869727|NCT03126591|566281006|FG001|Overall Study|Withdrawal by Subject|1|||
156869728|NCT03126591|566281007|FG002|Overall Study|Withdrawal by Subject|4|||
156869729|NCT03722238|566281010|FG000|Overall Study|Protocol Violation|1|||
156869730|NCT03722238|566281011|FG001|Overall Study|Protocol Violation|0|||
156869731|NCT03722238|566281010|FG000|Overall Study|Physician Decision|1|||
156687286|NCT00255151|565599298|FG001|Overall Study|Adverse Event|6|||
156687287|NCT00255151|565599299|FG002|Overall Study|Adverse Event|9|||
156687288|NCT00255151|565599297|FG000|Overall Study|Lost to Follow-up|4|||
156687289|NCT00255151|565599298|FG001|Overall Study|Lost to Follow-up|3|||
156687290|NCT00255151|565599299|FG002|Overall Study|Lost to Follow-up|4|||
156687291|NCT00255151|565599297|FG000|Overall Study|Withdrawal by Subject|18|||
156869732|NCT03722238|566281011|FG001|Overall Study|Physician Decision|0|||
156869733|NCT03722238|566281010|FG000|Overall Study|Death|1|||
156687292|NCT00255151|565599298|FG001|Overall Study|Withdrawal by Subject|17|||
156687293|NCT00255151|565599299|FG002|Overall Study|Withdrawal by Subject|8|||
156687294|NCT00255151|565599297|FG000|Overall Study|Noncompliance|0|||
156687295|NCT00255151|565599298|FG001|Overall Study|Noncompliance|1|||
156687296|NCT00255151|565599299|FG002|Overall Study|Noncompliance|2|||
156687297|NCT00255151|565599297|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
156687298|NCT00255151|565599298|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
156869734|NCT03722238|566281011|FG001|Overall Study|Death|0|||
156869735|NCT03722238|566281010|FG000|Overall Study|Lost to Follow-up|6|||
156869736|NCT03722238|566281011|FG001|Overall Study|Lost to Follow-up|0|||
156869737|NCT03722238|566281010|FG000|Overall Study|Partial missing data|44|||
156869738|NCT03722238|566281011|FG001|Overall Study|Partial missing data|1|||
156869739|NCT03722238|566281010|FG000|Overall Study|Withdrawal by Subject|2|||
156869740|NCT03722238|566281011|FG001|Overall Study|Withdrawal by Subject|0|||
156869741|NCT03722238|566281010|FG000|Overall Study|Other|4|||
156869742|NCT03722238|566281011|FG001|Overall Study|Other|0|||
156869743|NCT03722238|566281010|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
156869744|NCT03722238|566281011|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
156869745|NCT03722238|566281010|FG000|Overall Study|Did not meet risk classification group criteria|90|||
156869746|NCT03722238|566281011|FG001|Overall Study|Did not meet risk classification group criteria|0|||
156869747|NCT03722238|566281010|FG000|Overall Study|Did not sign consent|17|||
156869748|NCT03722238|566281011|FG001|Overall Study|Did not sign consent|0|||
156869749|NCT03722238|566281010|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
156869750|NCT03722238|566281011|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
156687299|NCT00255151|565599299|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
156687300|NCT00255151|565599297|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
156687301|NCT00255151|565599298|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
156687302|NCT00255151|565599299|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
156687303|NCT00255151|565599297|FG000|Overall Study|Possible Barrett's Esophagus|1|||
156687304|NCT00255151|565599298|FG001|Overall Study|Possible Barrett's Esophagus|3|||
156687305|NCT00255151|565599299|FG002|Overall Study|Possible Barrett's Esophagus|8|||
156869751|NCT03722238|566281010|FG000|Overall Study|Not willing to purchase study medication|142|||
156869752|NCT03722238|566281011|FG001|Overall Study|Not willing to purchase study medication|0|||
156869753|NCT03722238|566281010|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
156869754|NCT03722238|566281011|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
156869755|NCT01285323|566281012|FG000|Overall Study|Adverse Event|9|||
156869756|NCT01285323|566281013|FG001|Overall Study|Adverse Event|8|||
156869757|NCT01285323|566281012|FG000|Overall Study|Lack of Efficacy|4|||
156869758|NCT01285323|566281013|FG001|Overall Study|Lack of Efficacy|2|||
156869759|NCT01285323|566281012|FG000|Overall Study|Withdrawal by Subject|15|||
156869760|NCT01285323|566281013|FG001|Overall Study|Withdrawal by Subject|11|||
156869761|NCT01285323|566281012|FG000|Overall Study|Protocol Violation|1|||
156869762|NCT01285323|566281013|FG001|Overall Study|Protocol Violation|2|||
156869763|NCT01285323|566281012|FG000|Overall Study|Non-compliance with study procedures|2|||
156869764|NCT01285323|566281013|FG001|Overall Study|Non-compliance with study procedures|3|||
156687306|NCT00255151|565599297|FG000|Overall Study|Esophageal Stricture|0|||
156869765|NCT01285323|566281012|FG000|Overall Study|Lost to Follow-up|1|||
156869766|NCT01285323|566281013|FG001|Overall Study|Lost to Follow-up|1|||
156869767|NCT01285323|566281012|FG000|Overall Study|Other|1|||
156869768|NCT01285323|566281013|FG001|Overall Study|Other|3|||
156869769|NCT02606643|566281014|FG000|Overall Study|did not meet inclusion criteria|1|||
156330001|NCT02651467|564308744|FG002|Overall Study|Other (Not specified)|2|||
156330002|NCT00004635|564308745|FG000|Period One|refused|2|||
156687307|NCT00255151|565599298|FG001|Overall Study|Esophageal Stricture|0|||
156869770|NCT02606643|566281015|FG001|Overall Study|did not meet inclusion criteria|3|||
156869771|NCT00885170|566281018|FG000|Overall Study|Adverse Event|12|||
156869772|NCT00885170|566281019|FG001|Overall Study|Adverse Event|4|||
156869773|NCT00885170|566281018|FG000|Overall Study|Excessive bone loss|6|||
156330003|NCT00004635|564308746|FG001|Period One|refused|1|||
156869774|NCT00885170|566281019|FG001|Overall Study|Excessive bone loss|3|||
156869775|NCT00885170|566281018|FG000|Overall Study|Lost to Follow-up|2|||
156869776|NCT00885170|566281019|FG001|Overall Study|Lost to Follow-up|1|||
156687308|NCT00255151|565599299|FG002|Overall Study|Esophageal Stricture|1|||
156687309|NCT00255151|565599297|FG000|Overall Study|Therapeutic Failure|11|||
156687310|NCT00255151|565599298|FG001|Overall Study|Therapeutic Failure|2|||
156687311|NCT00255151|565599299|FG002|Overall Study|Therapeutic Failure|3|||
156687312|NCT00792623|565599301|FG000|Overall Study|Adverse Event|2|||
156687313|NCT00792623|565599301|FG000|Overall Study|Withdrawal by Subject|5|||
156687314|NCT00880087|565599305|FG000|Overall Study|Lost to Follow-up|0|||
156687315|NCT00880087|565599306|FG001|Overall Study|Lost to Follow-up|2|||
156687316|NCT00743509|565599307|FG000|Overall Study|Withdrawal by Subject|2|||
156687317|NCT00931463|565599308|FG000|Overall Study|Death|8|||
156687318|NCT00931463|565599309|FG001|Overall Study|Death|4|||
156687319|NCT00931463|565599308|FG000|Overall Study|Withdrawal by Subject|5|||
156687320|NCT00931463|565599309|FG001|Overall Study|Withdrawal by Subject|0|||
156687321|NCT00931463|565599308|FG000|Overall Study|Lost to Follow-up|4|||
156687322|NCT00931463|565599309|FG001|Overall Study|Lost to Follow-up|1|||
156687323|NCT00808509|565599310|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
156687324|NCT00808509|565599311|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
156687325|NCT00808509|565599310|FG000|Randomized Phase|Reduced methotrexate dose|1|||
156687326|NCT00808509|565599311|FG001|Randomized Phase|Reduced methotrexate dose|2|||
156687327|NCT00808509|565599310|FG000|Randomized Phase|Patient refused rescue therapy|0|||
156687328|NCT00808509|565599311|FG001|Randomized Phase|Patient refused rescue therapy|3|||
156687329|NCT00575380|565599315|FG000|Overall Study|Withdrawal by Subject|1|||
156687330|NCT00575380|565599316|FG001|Overall Study|Withdrawal by Subject|0|||
156687331|NCT00575380|565599315|FG000|Overall Study|Adverse Event|0|||
156687332|NCT00575380|565599316|FG001|Overall Study|Adverse Event|1|||
156687333|NCT00575380|565599315|FG000|Overall Study|Various|0|||
156687334|NCT00575380|565599316|FG001|Overall Study|Various|2|||
156687335|NCT04019054|565599317|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
156687336|NCT04019054|565599318|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
156687337|NCT04019054|565599317|FG000|Overall Study|Withdrawal by Subject|3|||
156687338|NCT04019054|565599318|FG001|Overall Study|Withdrawal by Subject|1|||
156687339|NCT01040793|565599319|FG000|Overall Study|Adverse Event|5|||
156687340|NCT01040793|565599320|FG001|Overall Study|Adverse Event|3|||
156687341|NCT01040793|565599321|FG002|Overall Study|Adverse Event|0|||
156687342|NCT01040793|565599322|FG003|Overall Study|Adverse Event|2|||
156687343|NCT01040793|565599323|FG004|Overall Study|Adverse Event|2|||
156687344|NCT01040793|565599324|FG005|Overall Study|Adverse Event|1|||
156687345|NCT01040793|565599319|FG000|Overall Study|Protocol Violation|1|||
156687346|NCT01040793|565599320|FG001|Overall Study|Protocol Violation|1|||
156687347|NCT01040793|565599321|FG002|Overall Study|Protocol Violation|1|||
156687348|NCT01040793|565599322|FG003|Overall Study|Protocol Violation|0|||
156869777|NCT00885170|566281018|FG000|Overall Study|Physician Decision|2|||
156869778|NCT00885170|566281019|FG001|Overall Study|Physician Decision|1|||
156687349|NCT01040793|565599323|FG004|Overall Study|Protocol Violation|1|||
156687350|NCT01040793|565599324|FG005|Overall Study|Protocol Violation|0|||
156687351|NCT01040793|565599319|FG000|Overall Study|Lost to Follow-up|0|||
156687352|NCT01040793|565599320|FG001|Overall Study|Lost to Follow-up|1|||
156687353|NCT01040793|565599321|FG002|Overall Study|Lost to Follow-up|1|||
156687354|NCT01040793|565599322|FG003|Overall Study|Lost to Follow-up|0|||
156687355|NCT01040793|565599323|FG004|Overall Study|Lost to Follow-up|0|||
156687356|NCT01040793|565599324|FG005|Overall Study|Lost to Follow-up|0|||
156687357|NCT01040793|565599319|FG000|Overall Study|Withdrawal by Subject|0|||
156687358|NCT01040793|565599320|FG001|Overall Study|Withdrawal by Subject|0|||
156687359|NCT01040793|565599321|FG002|Overall Study|Withdrawal by Subject|0|||
156687360|NCT01040793|565599322|FG003|Overall Study|Withdrawal by Subject|2|||
156687361|NCT01040793|565599323|FG004|Overall Study|Withdrawal by Subject|0|||
156687362|NCT01040793|565599324|FG005|Overall Study|Withdrawal by Subject|0|||
156687363|NCT01040793|565599319|FG000|Overall Study|Other reasons not listed above|0|||
156687364|NCT01040793|565599320|FG001|Overall Study|Other reasons not listed above|0|||
156687365|NCT01040793|565599321|FG002|Overall Study|Other reasons not listed above|1|||
156687366|NCT01040793|565599322|FG003|Overall Study|Other reasons not listed above|0|||
156687367|NCT01040793|565599323|FG004|Overall Study|Other reasons not listed above|1|||
156687368|NCT01040793|565599324|FG005|Overall Study|Other reasons not listed above|0|||
156687369|NCT04499482|565599325|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
156687370|NCT00124462|565599326|FG000|Overall Study|Lost to Follow-up|3|||
156687371|NCT00124462|565599327|FG001|Overall Study|Lost to Follow-up|3|||
156687372|NCT00124462|565599326|FG000|Overall Study|Physician Decision|3|||
156687373|NCT00124462|565599327|FG001|Overall Study|Physician Decision|4|||
156687374|NCT00124462|565599326|FG000|Overall Study|Withdrawal by Subject|4|||
156687375|NCT00124462|565599327|FG001|Overall Study|Withdrawal by Subject|5|||
156687376|NCT00124462|565599326|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
156687377|NCT00124462|565599327|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
156687378|NCT01684878|565599331|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
156869779|NCT00885170|566281018|FG000|Overall Study|Protocol Violation|3|||
156330004|NCT00004635|564308745|FG000|Period One|Withdrawal by Subject|1|||
156869780|NCT00885170|566281019|FG001|Overall Study|Protocol Violation|1|||
156869781|NCT00885170|566281018|FG000|Overall Study|Withdrawal by Subject|13|||
156869782|NCT00885170|566281019|FG001|Overall Study|Withdrawal by Subject|13|||
156869783|NCT03771664|566281020|FG000|Overall Study|Adverse Event|1|||
156869784|NCT03771664|566281021|FG001|Overall Study|Adverse Event|0|||
156869785|NCT03771664|566281020|FG000|Overall Study|Lost to Follow-up|1|||
156869786|NCT03771664|566281021|FG001|Overall Study|Lost to Follow-up|0|||
156869787|NCT03771664|566281020|FG000|Overall Study|Withdrawal by Participant|1|||
156869788|NCT03771664|566281021|FG001|Overall Study|Withdrawal by Participant|4|||
156869789|NCT03771664|566281020|FG000|Overall Study|Randomized but not Treated|0|||
156869790|NCT03771664|566281021|FG001|Overall Study|Randomized but not Treated|1|||
156869791|NCT02120898|566281022|FG000|Overall Study|Withdrawal by Subject|4|||
156869792|NCT02120898|566281023|FG001|Overall Study|Withdrawal by Subject|2|||
156869793|NCT02120898|566281024|FG002|Overall Study|Withdrawal by Subject|2|||
156869794|NCT02120898|566281022|FG000|Overall Study|Non-compliance with study drug|3|||
156869795|NCT02120898|566281023|FG001|Overall Study|Non-compliance with study drug|0|||
156687379|NCT01684878|565599332|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
156687380|NCT01684878|565599333|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
156687381|NCT01684878|565599334|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
156687382|NCT01684878|565599331|FG000|Part 1: Safety Run in Phase|Death|15|||
156687383|NCT01684878|565599332|FG001|Part 1: Safety Run in Phase|Death|20|||
156687384|NCT01684878|565599333|FG002|Part 1: Safety Run in Phase|Death|0|||
156687385|NCT01684878|565599334|FG003|Part 1: Safety Run in Phase|Death|0|||
156687386|NCT01684878|565599331|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
156687387|NCT01684878|565599332|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
156687388|NCT01684878|565599333|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
156687389|NCT01684878|565599334|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
156687390|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
156687391|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
156687392|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
156687393|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
156687394|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
156687395|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
156687396|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
156687397|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
156687398|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Death|0|||
156687399|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Death|0|||
156687400|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Death|62|||
156687401|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Death|68|||
156687402|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
156687403|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
156687404|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
156687405|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
156687406|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
156687407|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
156687408|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
156687409|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
156687410|NCT03942211|565599337|FG000|Overall Study|Death|1|||
156869796|NCT02120898|566281024|FG002|Overall Study|Non-compliance with study drug|0|||
156869797|NCT02120898|566281022|FG000|Overall Study|Adverse Event|1|||
156869798|NCT02120898|566281023|FG001|Overall Study|Adverse Event|2|||
156869799|NCT02120898|566281024|FG002|Overall Study|Adverse Event|1|||
156687411|NCT03942211|565599338|FG001|Overall Study|Death|0|||
156687412|NCT03942211|565599337|FG000|Overall Study|Study terminated by sponsor|5|||
156687413|NCT03942211|565599338|FG001|Overall Study|Study terminated by sponsor|3|||
156687414|NCT03942211|565599337|FG000|Overall Study|Adverse Event|0|||
156687415|NCT03942211|565599338|FG001|Overall Study|Adverse Event|1|||
156687416|NCT00127166|565599339|FG000|Period I|Protocol Violation|0|||
156687417|NCT00127166|565599340|FG001|Period I|Protocol Violation|2|||
156687418|NCT00127166|565599339|FG000|Period I|Withdrawal by Subject|2|||
156687419|NCT00127166|565599340|FG001|Period I|Withdrawal by Subject|0|||
156687420|NCT00127166|565599339|FG000|Period I|Patient did not meet inclusion criteria|1|||
156869800|NCT02120898|566281022|FG000|Overall Study|Protocol Violation|1|||
156869801|NCT02120898|566281023|FG001|Overall Study|Protocol Violation|2|||
156869802|NCT02120898|566281024|FG002|Overall Study|Protocol Violation|0|||
156687421|NCT00127166|565599340|FG001|Period I|Patient did not meet inclusion criteria|0|||
156687422|NCT00127166|565599339|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
156687423|NCT00127166|565599340|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
156687424|NCT00127166|565599339|FG000|Period II|Withdrawal by Subject|2|||
156687425|NCT00127166|565599340|FG001|Period II|Withdrawal by Subject|0|||
156869803|NCT02120898|566281022|FG000|Overall Study|Lost to Follow-up|0|||
156869804|NCT02120898|566281023|FG001|Overall Study|Lost to Follow-up|0|||
156869805|NCT02120898|566281024|FG002|Overall Study|Lost to Follow-up|1|||
156869806|NCT00684021|566281025|FG000|Overall Study|MRI Contraindicated|1|||
156687426|NCT00127166|565599339|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
156687427|NCT00127166|565599340|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
156687428|NCT01148225|565599341|FG000|Overall Study|Other|185|||
156687429|NCT00605917|565599344|FG000|Overall Study|Protocol Violation|79|||
156687430|NCT01506908|565599345|FG000|Overall Study|Adverse Event|1|||
156687431|NCT01506908|565599346|FG001|Overall Study|Adverse Event|0|||
156687432|NCT00925301|565599355|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
156687433|NCT00925301|565599356|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
156687434|NCT00925301|565599357|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
156687435|NCT00925301|565599358|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
156687436|NCT00925301|565599355|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
156687437|NCT00925301|565599356|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
156687438|NCT00925301|565599357|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
156687439|NCT00925301|565599358|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
156687440|NCT00925301|565599355|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
156687441|NCT00925301|565599356|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
156687442|NCT00925301|565599357|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
156687443|NCT00925301|565599358|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
156687444|NCT00925301|565599355|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
156687445|NCT00925301|565599356|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
156687446|NCT00925301|565599357|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
156687447|NCT00925301|565599358|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
156687448|NCT00925301|565599355|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
156687449|NCT00925301|565599356|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
156687450|NCT00925301|565599357|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
156687451|NCT00925301|565599358|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
156687452|NCT00925301|565599355|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
156687453|NCT00925301|565599356|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
156687454|NCT00925301|565599357|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
156687455|NCT00925301|565599358|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
156687456|NCT00925301|565599355|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
156687457|NCT00925301|565599356|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
156687458|NCT00925301|565599357|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
156687459|NCT00925301|565599358|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
156687460|NCT03043560|565599359|FG000|Overall Study|Discontinued Intervention|1|||
156687461|NCT03043560|565599360|FG001|Overall Study|Discontinued Intervention|2|||
156687462|NCT03043560|565599359|FG000|Overall Study|Lost to Follow-up|0|||
156687463|NCT03043560|565599360|FG001|Overall Study|Lost to Follow-up|1|||
156687464|NCT01117766|565599361|FG000|First Intervention|Adverse Event|0|||
156687465|NCT01117766|565599362|FG001|First Intervention|Adverse Event|1|||
156687466|NCT01117766|565599361|FG000|First Intervention|Protocol Violation|1|||
156687467|NCT01117766|565599362|FG001|First Intervention|Protocol Violation|0|||
156687468|NCT01117766|565599361|FG000|Washout Period|Protocol Violation|0|||
156687469|NCT01117766|565599362|FG001|Washout Period|Protocol Violation|2|||
156687470|NCT01117766|565599361|FG000|Second Intervention|Lost to Follow-up|1|||
156687471|NCT01117766|565599362|FG001|Second Intervention|Lost to Follow-up|0|||
156687472|NCT01117766|565599361|FG000|Second Intervention|Other|1|||
156687473|NCT01117766|565599362|FG001|Second Intervention|Other|2|||
156687474|NCT01117766|565599361|FG000|Second Intervention|Adverse Event|0|||
156687475|NCT01117766|565599362|FG001|Second Intervention|Adverse Event|2|||
156687476|NCT01117766|565599361|FG000|Second Intervention|Withdrawal by Subject|0|||
156687477|NCT01117766|565599362|FG001|Second Intervention|Withdrawal by Subject|1|||
156687478|NCT05766787|565599363|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
156869807|NCT00684021|566281026|FG001|Overall Study|MRI Contraindicated|1|||
156869808|NCT00684021|566281027|FG002|Overall Study|MRI Contraindicated|1|||
156869809|NCT00684021|566281028|FG003|Overall Study|MRI Contraindicated|0|||
156869810|NCT00684021|566281025|FG000|Overall Study|MRI not performed|0|||
156869811|NCT00684021|566281026|FG001|Overall Study|MRI not performed|1|||
156687479|NCT05766787|565599364|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
156687480|NCT05766787|565599363|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
156687481|NCT05766787|565599364|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
156687482|NCT05766787|565599363|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
156687483|NCT05766787|565599364|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
156687484|NCT00438659|565599365|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
156687485|NCT00438659|565599366|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
156687486|NCT00438659|565599365|FG000|Overall Study|Cancel|5|||
156687487|NCT00438659|565599366|FG001|Overall Study|Cancel|2|||
156687488|NCT03718117|565599367|FG000|Overall Study|Death|12|||
156330005|NCT00004635|564308746|FG001|Period One|Withdrawal by Subject|1|||
156687489|NCT03718117|565599368|FG001|Overall Study|Death|11|||
156687490|NCT03718117|565599369|FG002|Overall Study|Death|0|||
156687491|NCT03718117|565599367|FG000|Overall Study|Other|0|||
156687492|NCT03718117|565599368|FG001|Overall Study|Other|1|||
156687493|NCT03718117|565599369|FG002|Overall Study|Other|0|||
156687494|NCT03718117|565599367|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
156687495|NCT03718117|565599368|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
156687496|NCT03718117|565599369|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
156687497|NCT03718117|565599367|FG000|Overall Study|Participant not met eligibility criteria|0|||
156687498|NCT03718117|565599368|FG001|Overall Study|Participant not met eligibility criteria|0|||
156687499|NCT03718117|565599369|FG002|Overall Study|Participant not met eligibility criteria|2|||
156687500|NCT01867606|565599370|FG000|Overall Study|Withdrawal by Subject|10|||
156687501|NCT01867606|565599371|FG001|Overall Study|Withdrawal by Subject|14|||
156687502|NCT01867606|565599370|FG000|Overall Study|Protocol Violation|0|||
156687503|NCT01867606|565599371|FG001|Overall Study|Protocol Violation|1|||
156687504|NCT00206102|565599372|FG000|Overall Study|Adverse Event|119|||
156687505|NCT00206102|565599373|FG001|Overall Study|Adverse Event|82|||
156687506|NCT00206102|565599372|FG000|Overall Study|Protocol Violation|0|||
156687507|NCT00206102|565599373|FG001|Overall Study|Protocol Violation|2|||
156687508|NCT00206102|565599372|FG000|Overall Study|Lack of therapeutic response|16|||
156687509|NCT00206102|565599373|FG001|Overall Study|Lack of therapeutic response|11|||
156687510|NCT00206102|565599372|FG000|Overall Study|Lost to Follow-up|95|||
156687511|NCT00206102|565599373|FG001|Overall Study|Lost to Follow-up|66|||
156687512|NCT00206102|565599372|FG000|Overall Study|Withdrawal by Subject|118|||
156687513|NCT00206102|565599373|FG001|Overall Study|Withdrawal by Subject|101|||
156687514|NCT00206102|565599372|FG000|Overall Study|Study-specific discontinuation criteria|18|||
156687515|NCT00206102|565599373|FG001|Overall Study|Study-specific discontinuation criteria|17|||
156687516|NCT00206102|565599372|FG000|Overall Study|None of those categories|42|||
156687517|NCT00206102|565599373|FG001|Overall Study|None of those categories|36|||
156687518|NCT01917968|565599374|FG000|Overall Study|Death|3|||
156687519|NCT01917968|565599375|FG001|Overall Study|Death|2|||
156687520|NCT01917968|565599374|FG000|Overall Study|Lost to Follow-up|21|||
156687521|NCT01917968|565599375|FG001|Overall Study|Lost to Follow-up|39|||
156687522|NCT01917968|565599374|FG000|Overall Study|Physician Decision|1|||
156687523|NCT01917968|565599375|FG001|Overall Study|Physician Decision|2|||
156869812|NCT00684021|566281027|FG002|Overall Study|MRI not performed|1|||
156869813|NCT00684021|566281028|FG003|Overall Study|MRI not performed|2|||
156330006|NCT00004635|564308745|FG000|Period One|Protocol Violation|1|||
156687524|NCT01917968|565599374|FG000|Overall Study|Withdrawal by Subject|20|||
156687525|NCT01917968|565599375|FG001|Overall Study|Withdrawal by Subject|35|||
156687526|NCT01917968|565599374|FG000|Overall Study|Subject Relocation|5|||
156687527|NCT01917968|565599375|FG001|Overall Study|Subject Relocation|1|||
156687528|NCT01917968|565599374|FG000|Overall Study|36M Missed Visit|3|||
156687529|NCT01917968|565599375|FG001|Overall Study|36M Missed Visit|2|||
156687530|NCT01917968|565599374|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
156687531|NCT01917968|565599375|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
156687532|NCT01917968|565599374|FG000|Overall Study|Change in Family Circumstances|0|||
156687533|NCT01917968|565599375|FG001|Overall Study|Change in Family Circumstances|1|||
156687534|NCT01917968|565599374|FG000|Overall Study|No Data Available|0|||
156687535|NCT01917968|565599375|FG001|Overall Study|No Data Available|2|||
156687536|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
156687537|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
156687538|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
156687539|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
156687540|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
156687541|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
156687542|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
156687543|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
156687544|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
156687545|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
156687546|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
156687547|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
156687548|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
156687549|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
156687550|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
156687551|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
156687552|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
156687553|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
156687554|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
156687555|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
156687556|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
156687557|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
156687558|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
156687559|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
156687560|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
156687561|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
156687562|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
156687563|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
156687564|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
156687565|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
156687566|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
156687567|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
156687568|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
156687569|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
156687570|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
156687571|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
156687572|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
156687573|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
156687574|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
156687575|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
156687576|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
156687577|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
156687578|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
156687579|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
156687580|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
156687581|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
156687582|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
156687583|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
156687584|NCT01588548|565599381|FG000|Overall Study|Withdrawal by Subject|0|||
156687585|NCT01588548|565599382|FG001|Overall Study|Withdrawal by Subject|1|||
156687586|NCT01588548|565599383|FG002|Overall Study|Withdrawal by Subject|1|||
156687587|NCT01588548|565599384|FG003|Overall Study|Withdrawal by Subject|1|||
156687588|NCT01588548|565599385|FG004|Overall Study|Withdrawal by Subject|2|||
156687589|NCT01588548|565599386|FG005|Overall Study|Withdrawal by Subject|3|||
156687590|NCT01588548|565599381|FG000|Overall Study|Adverse Event|0|||
156687591|NCT01588548|565599382|FG001|Overall Study|Adverse Event|0|||
156687592|NCT01588548|565599383|FG002|Overall Study|Adverse Event|1|||
156687593|NCT01588548|565599384|FG003|Overall Study|Adverse Event|2|||
156687594|NCT01588548|565599385|FG004|Overall Study|Adverse Event|1|||
156687595|NCT01588548|565599386|FG005|Overall Study|Adverse Event|0|||
156687596|NCT01588548|565599381|FG000|Overall Study|Condition Under Investigation Worsened|3|||
156687597|NCT01588548|565599382|FG001|Overall Study|Condition Under Investigation Worsened|6|||
156687598|NCT01588548|565599383|FG002|Overall Study|Condition Under Investigation Worsened|4|||
156687599|NCT01588548|565599384|FG003|Overall Study|Condition Under Investigation Worsened|4|||
156687600|NCT01588548|565599385|FG004|Overall Study|Condition Under Investigation Worsened|3|||
156687601|NCT01588548|565599386|FG005|Overall Study|Condition Under Investigation Worsened|3|||
156687602|NCT00292227|565599389|FG000|Patch Period|Adverse Event|1|||
156687603|NCT00292227|565599390|FG001|Patch Period|Adverse Event|0|||
156687604|NCT00292227|565599391|FG002|Patch Period|Adverse Event|2|||
156687605|NCT00292227|565599389|FG000|Patch Period|Withdrawal by Subject|0|||
156687606|NCT00292227|565599390|FG001|Patch Period|Withdrawal by Subject|0|||
156687607|NCT00292227|565599391|FG002|Patch Period|Withdrawal by Subject|1|||
156687608|NCT00537017|565599394|FG000|Treatment Phase|Adverse Event|19|||
156687609|NCT00537017|565599394|FG000|Treatment Phase|Withdrawal by Subject|13|||
156687610|NCT00537017|565599394|FG000|Treatment Phase|Protocol Violation|2|||
156687611|NCT00537017|565599394|FG000|Follow-up Phase|Withdrawal by Subject|9|||
156687612|NCT02329431|565599396|FG000|Overall Study|Lost to Follow-up|20|||
156687613|NCT02329431|565599397|FG001|Overall Study|Lost to Follow-up|13|||
156687614|NCT03581188|565601202|FG000|Overall Study|Inclusion criteria not met|3|||
156687615|NCT03581188|565601203|FG001|Overall Study|Inclusion criteria not met|2|||
156687616|NCT03581188|565601202|FG000|Overall Study|Lost to Follow-up|5|||
156687617|NCT03581188|565601203|FG001|Overall Study|Lost to Follow-up|5|||
156687618|NCT03581188|565601202|FG000|Overall Study|Discontinued intervention|11|||
156687619|NCT03581188|565601203|FG001|Overall Study|Discontinued intervention|8|||
156687620|NCT01280617|565601209|FG000|Overall Study|Adverse Event|0|||
156687621|NCT01280617|565601210|FG001|Overall Study|Adverse Event|1|||
156687622|NCT01311557|565601211|FG000|Overall Study|Serious adverse event|0|||
156687623|NCT01311557|565601212|FG001|Overall Study|Serious adverse event|1|||
156687624|NCT01311557|565601211|FG000|Overall Study|Protocol Violation|4|||
156687625|NCT01311557|565601212|FG001|Overall Study|Protocol Violation|2|||
156687626|NCT01311557|565601211|FG000|Overall Study|Lost to Follow-up|0|||
156687627|NCT01311557|565601212|FG001|Overall Study|Lost to Follow-up|1|||
156687628|NCT01311557|565601211|FG000|Overall Study|Withdrawal by Subject|1|||
156687629|NCT01311557|565601212|FG001|Overall Study|Withdrawal by Subject|2|||
156687630|NCT00608517|565601213|FG000|Overall Study|Death|1|||
156687631|NCT00608517|565601214|FG001|Overall Study|Death|0|||
156687632|NCT00608517|565601215|FG002|Overall Study|Death|0|||
156687633|NCT00572039|565601216|FG000|Overall Study|Withdrawal by Subject|9|||
156530486|NCT04226833|565036420|FG000|Overall Study|Death|0|||
156530487|NCT04226833|565036421|FG001|Overall Study|Death|0|||
156530488|NCT04226833|565036422|FG002|Overall Study|Death|1|||
156530489|NCT04226833|565036423|FG003|Overall Study|Death|0|||
156530490|NCT01163721|565036426|FG000|Overall Study|Adverse Event|5|||
156530491|NCT01163721|565036427|FG001|Overall Study|Adverse Event|6|||
156530492|NCT01163721|565036426|FG000|Overall Study|Withdrawal by Subject|3|||
156530493|NCT01163721|565036427|FG001|Overall Study|Withdrawal by Subject|4|||
156530494|NCT01163721|565036426|FG000|Overall Study|Lost to Follow-up|0|||
156530495|NCT01163721|565036427|FG001|Overall Study|Lost to Follow-up|1|||
156530496|NCT01163721|565036426|FG000|Overall Study|Physician Decision|0|||
156530497|NCT01163721|565036427|FG001|Overall Study|Physician Decision|1|||
156530498|NCT00364156|565036430|FG000|Overall Study|Withdrawal by Subject|73|||
156530499|NCT00364156|565036431|FG001|Overall Study|Withdrawal by Subject|80|||
156530500|NCT00364156|565036430|FG000|Overall Study|Protocol Violation|6|||
156530501|NCT00364156|565036431|FG001|Overall Study|Protocol Violation|1|||
156530502|NCT01050205|565036432|FG000|Overall Study|Lost to Follow-up|7|||
156530503|NCT01050205|565036433|FG001|Overall Study|Lost to Follow-up|1|||
156530504|NCT01050205|565036432|FG000|Overall Study|Withdrawal by Subject|1|||
156530505|NCT01050205|565036433|FG001|Overall Study|Withdrawal by Subject|1|||
156530506|NCT01050205|565036432|FG000|Overall Study|Relocated from area|1|||
156530507|NCT01050205|565036433|FG001|Overall Study|Relocated from area|2|||
156530508|NCT01050205|565036432|FG000|Overall Study|Discontinued Intervention|2|||
156530509|NCT01050205|565036433|FG001|Overall Study|Discontinued Intervention|0|||
156530510|NCT01119001|565036439|FG000|Overall Study|Withdrawal by Subject|2|||
156530511|NCT00403754|565036440|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
156530512|NCT00403754|565036441|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
156530513|NCT00403754|565036442|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
156530514|NCT00403754|565036443|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
156530515|NCT00403754|565036440|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
156530516|NCT00403754|565036441|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
156530517|NCT00403754|565036442|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
156530518|NCT00403754|565036443|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
156530519|NCT04343248|565036444|FG000|Overall Study|Withdrawal by Subject|5|||
156530520|NCT04343248|565036445|FG001|Overall Study|Withdrawal by Subject|6|||
156530521|NCT04343248|565036444|FG000|Overall Study|Death|1|||
156530522|NCT04343248|565036445|FG001|Overall Study|Death|2|||
156530523|NCT04343248|565036444|FG000|Overall Study|Lost to Follow-up|9|||
156530524|NCT04343248|565036445|FG001|Overall Study|Lost to Follow-up|6|||
156530525|NCT04343248|565036444|FG000|Overall Study|Physician Decision|0|||
156530526|NCT04343248|565036445|FG001|Overall Study|Physician Decision|1|||
156530527|NCT04343248|565036444|FG000|Overall Study|Adverse Event|1|||
156530528|NCT04343248|565036445|FG001|Overall Study|Adverse Event|0|||
156530529|NCT02708095|565036446|FG000|Overall Study|Adverse Event|4|||
156530530|NCT02708095|565036447|FG001|Overall Study|Adverse Event|10|||
156530531|NCT02708095|565036448|FG002|Overall Study|Adverse Event|11|||
156530532|NCT02708095|565036446|FG000|Overall Study|Lack of Efficacy|9|||
156530533|NCT02708095|565036447|FG001|Overall Study|Lack of Efficacy|3|||
156530534|NCT02708095|565036448|FG002|Overall Study|Lack of Efficacy|0|||
156530535|NCT02708095|565036446|FG000|Overall Study|Lost to Follow-up|2|||
156530536|NCT02708095|565036447|FG001|Overall Study|Lost to Follow-up|0|||
156530537|NCT02708095|565036448|FG002|Overall Study|Lost to Follow-up|0|||
156530538|NCT02708095|565036446|FG000|Overall Study|Physician Decision|2|||
156530539|NCT02708095|565036447|FG001|Overall Study|Physician Decision|3|||
156530540|NCT02708095|565036448|FG002|Overall Study|Physician Decision|2|||
156530541|NCT02708095|565036446|FG000|Overall Study|Protocol Violation|0|||
156530542|NCT02708095|565036447|FG001|Overall Study|Protocol Violation|0|||
156530543|NCT02708095|565036448|FG002|Overall Study|Protocol Violation|1|||
156530544|NCT02708095|565036446|FG000|Overall Study|Withdrawal by Subject|5|||
156530545|NCT02708095|565036447|FG001|Overall Study|Withdrawal by Subject|3|||
156530546|NCT02708095|565036448|FG002|Overall Study|Withdrawal by Subject|4|||
156530547|NCT05245097|565036449|FG000|Overall Study|Adverse Event|13|||
156530548|NCT05245097|565036450|FG001|Overall Study|Adverse Event|2|||
156530549|NCT05245097|565036449|FG000|Overall Study|Protocol Violation|8|||
156530550|NCT05245097|565036450|FG001|Overall Study|Protocol Violation|6|||
156530551|NCT05245097|565036449|FG000|Overall Study|Withdrawal by Subject|18|||
156530552|NCT05245097|565036450|FG001|Overall Study|Withdrawal by Subject|0|||
156530553|NCT05245097|565036449|FG000|Overall Study|Death|6|||
156530554|NCT05245097|565036450|FG001|Overall Study|Death|7|||
156530555|NCT05245097|565036449|FG000|Overall Study|Physician Decision|6|||
156530556|NCT05245097|565036450|FG001|Overall Study|Physician Decision|0|||
156530557|NCT05245097|565036449|FG000|Overall Study|Relocation|4|||
156530558|NCT05245097|565036450|FG001|Overall Study|Relocation|3|||
156530559|NCT03604523|565036451|FG000|Overall Study|Physician Decision|1|||
156530560|NCT03604523|565036452|FG001|Overall Study|Physician Decision|0|||
156530561|NCT01422850|565036459|FG000|Overall Study|Physician Decision|3|||
156687634|NCT00572039|565601217|FG001|Overall Study|Withdrawal by Subject|6|||
156687635|NCT00572039|565601216|FG000|Overall Study|Death|2|||
156687636|NCT00572039|565601217|FG001|Overall Study|Death|3|||
156687637|NCT00572039|565601216|FG000|Overall Study|Ill|5|||
156530562|NCT04484831|565036460|FG000|Overall Study|Withdrawal by Subject|1|||
156530563|NCT04484831|565036461|FG001|Overall Study|Withdrawal by Subject|0|||
156687638|NCT00572039|565601217|FG001|Overall Study|Ill|1|||
156687639|NCT01470417|565601220|FG000|Overall Study|Disease progression|0|||
156687640|NCT01470417|565601221|FG001|Overall Study|Disease progression|2|||
156687641|NCT02973321|565601224|FG000|Overall Study|Other than specified|0|||
156687642|NCT02973321|565601225|FG001|Overall Study|Other than specified|5|||
156687643|NCT02973321|565601226|FG002|Overall Study|Other than specified|3|||
156687644|NCT02973321|565601227|FG003|Overall Study|Other than specified|3|||
156687645|NCT02973321|565601228|FG004|Overall Study|Other than specified|1|||
156687646|NCT02973321|565601224|FG000|Overall Study|Lack of Efficacy|0|||
156687647|NCT02973321|565601225|FG001|Overall Study|Lack of Efficacy|0|||
156687648|NCT02973321|565601226|FG002|Overall Study|Lack of Efficacy|0|||
156687649|NCT02973321|565601227|FG003|Overall Study|Lack of Efficacy|0|||
156687650|NCT02973321|565601228|FG004|Overall Study|Lack of Efficacy|1|||
156687651|NCT02973321|565601224|FG000|Overall Study|Adverse Event|1|||
156687652|NCT02973321|565601225|FG001|Overall Study|Adverse Event|10|||
156687653|NCT02973321|565601226|FG002|Overall Study|Adverse Event|11|||
156687654|NCT02973321|565601227|FG003|Overall Study|Adverse Event|13|||
156687655|NCT02973321|565601228|FG004|Overall Study|Adverse Event|3|||
156687656|NCT01098110|565601233|FG000|Overall Study|Withdrawal by Subject|14|||
156687657|NCT01098110|565601234|FG001|Overall Study|Withdrawal by Subject|24|||
156687658|NCT01098110|565601235|FG002|Overall Study|Withdrawal by Subject|19|||
156687659|NCT01098110|565601233|FG000|Overall Study|Adverse Event|30|||
156787094|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Death|2|||
156787095|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Death|2|||
156787096|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Death|0|||
156787097|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Death|0|||
156787098|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
156787099|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
156787100|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
156787101|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
156787102|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
156787103|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
156787104|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
156787105|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
156787106|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
156787107|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
156787108|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
156787109|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
156787110|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
156787111|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
156787112|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
156787113|NCT00098293|565972851|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
156787114|NCT00098293|565972852|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
156787115|NCT00098293|565972853|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
156787116|NCT00098293|565972854|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
156787117|NCT00098293|565972855|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
156787118|NCT00098293|565972851|FG000|Open-label (OL) Phase|Adverse Event|0|||
156787119|NCT00098293|565972852|FG001|Open-label (OL) Phase|Adverse Event|3|||
156787120|NCT00098293|565972853|FG002|Open-label (OL) Phase|Adverse Event|7|||
156787121|NCT00098293|565972854|FG003|Open-label (OL) Phase|Adverse Event|6|||
156787122|NCT00098293|565972855|FG004|Open-label (OL) Phase|Adverse Event|0|||
156787123|NCT00098293|565972851|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
156787124|NCT00098293|565972852|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
156787125|NCT00098293|565972853|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
156787126|NCT00098293|565972854|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
156787127|NCT00098293|565972855|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
156787128|NCT00098293|565972851|FG000|Open-label (OL) Phase|Pregnancy|0|||
156787129|NCT00098293|565972852|FG001|Open-label (OL) Phase|Pregnancy|1|||
156787130|NCT00098293|565972853|FG002|Open-label (OL) Phase|Pregnancy|0|||
156787131|NCT00098293|565972854|FG003|Open-label (OL) Phase|Pregnancy|3|||
156787132|NCT00098293|565972855|FG004|Open-label (OL) Phase|Pregnancy|0|||
156787133|NCT00098293|565972851|FG000|Open-label (OL) Phase|Protocol Violation|0|||
156787134|NCT00098293|565972852|FG001|Open-label (OL) Phase|Protocol Violation|6|||
156530564|NCT02244996|565036463|FG000|Overall Study|Lack of Efficacy|2|||
156530565|NCT02244996|565036464|FG001|Overall Study|Lack of Efficacy|6|||
156687660|NCT01098110|565601234|FG001|Overall Study|Adverse Event|32|||
156687661|NCT01098110|565601235|FG002|Overall Study|Adverse Event|43|||
156687662|NCT01098110|565601233|FG000|Overall Study|Lack of Efficacy|13|||
156787135|NCT00098293|565972853|FG002|Open-label (OL) Phase|Protocol Violation|13|||
156787136|NCT00098293|565972854|FG003|Open-label (OL) Phase|Protocol Violation|16|||
156787137|NCT00098293|565972855|FG004|Open-label (OL) Phase|Protocol Violation|0|||
156787138|NCT00098293|565972851|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
156687663|NCT01098110|565601234|FG001|Overall Study|Lack of Efficacy|9|||
156687664|NCT01098110|565601235|FG002|Overall Study|Lack of Efficacy|27|||
156687665|NCT01098110|565601233|FG000|Overall Study|Other|4|||
156687666|NCT01098110|565601234|FG001|Overall Study|Other|7|||
156687667|NCT01098110|565601235|FG002|Overall Study|Other|5|||
156687668|NCT01098110|565601233|FG000|Overall Study|Untreated|1|||
156687669|NCT01098110|565601234|FG001|Overall Study|Untreated|1|||
156687670|NCT01098110|565601235|FG002|Overall Study|Untreated|0|||
156687671|NCT00707434|565601238|FG000|Overall Study|Adverse Event|1|||
156687672|NCT01011556|565601239|FG000|Overall Study|Adverse Event|1|||
156687673|NCT01011556|565601240|FG001|Overall Study|Adverse Event|3|||
156687674|NCT01011556|565601241|FG002|Overall Study|Adverse Event|2|||
156687675|NCT01011556|565601242|FG003|Overall Study|Adverse Event|1|||
156530566|NCT03471871|565036465|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
156530567|NCT03471871|565036466|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
156687676|NCT01011556|565601239|FG000|Overall Study|Lost to Follow-up|1|||
156687677|NCT01011556|565601240|FG001|Overall Study|Lost to Follow-up|0|||
156687678|NCT01011556|565601241|FG002|Overall Study|Lost to Follow-up|0|||
156687679|NCT01011556|565601242|FG003|Overall Study|Lost to Follow-up|0|||
156687680|NCT01011556|565601239|FG000|Overall Study|Physician Decision|1|||
156687681|NCT01011556|565601240|FG001|Overall Study|Physician Decision|0|||
156687682|NCT01011556|565601241|FG002|Overall Study|Physician Decision|0|||
156687683|NCT01011556|565601242|FG003|Overall Study|Physician Decision|1|||
156687684|NCT01011556|565601239|FG000|Overall Study|Protocol Violation|0|||
156687685|NCT01011556|565601240|FG001|Overall Study|Protocol Violation|1|||
156687686|NCT01011556|565601241|FG002|Overall Study|Protocol Violation|0|||
156687687|NCT01011556|565601242|FG003|Overall Study|Protocol Violation|0|||
156687688|NCT01011556|565601239|FG000|Overall Study|Withdrawal by Subject|1|||
156687689|NCT01011556|565601240|FG001|Overall Study|Withdrawal by Subject|2|||
156687690|NCT01011556|565601241|FG002|Overall Study|Withdrawal by Subject|4|||
156687691|NCT01011556|565601242|FG003|Overall Study|Withdrawal by Subject|4|||
156687692|NCT01011556|565601239|FG000|Overall Study|Sponsor decision|0|||
156687693|NCT01011556|565601240|FG001|Overall Study|Sponsor decision|1|||
156687694|NCT01011556|565601241|FG002|Overall Study|Sponsor decision|1|||
156687695|NCT01011556|565601242|FG003|Overall Study|Sponsor decision|2|||
156687696|NCT01011556|565601239|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
156687697|NCT01011556|565601240|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
156687698|NCT01011556|565601241|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
156687699|NCT01011556|565601242|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
156687700|NCT00614822|565601243|FG000|Overall Study|Adverse Event|3|||
156687701|NCT03649412|565601244|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
156687702|NCT03649412|565601245|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
156687703|NCT03649412|565601244|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
156787139|NCT00098293|565972852|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
156787140|NCT00098293|565972853|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
156787141|NCT00098293|565972854|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
156787142|NCT00098293|565972855|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
156787143|NCT00098293|565972851|FG000|Open-label (OL) Phase|Death|0|||
156787144|NCT00098293|565972852|FG001|Open-label (OL) Phase|Death|2|||
156787145|NCT00098293|565972853|FG002|Open-label (OL) Phase|Death|3|||
156787146|NCT00098293|565972854|FG003|Open-label (OL) Phase|Death|0|||
156787147|NCT00098293|565972855|FG004|Open-label (OL) Phase|Death|0|||
156787148|NCT00098293|565972851|FG000|Supplemental Phase (SP)|Death|0|||
156787149|NCT00098293|565972852|FG001|Supplemental Phase (SP)|Death|0|||
156787150|NCT00098293|565972853|FG002|Supplemental Phase (SP)|Death|0|||
156787151|NCT00098293|565972854|FG003|Supplemental Phase (SP)|Death|0|||
156787152|NCT00098293|565972855|FG004|Supplemental Phase (SP)|Death|1|||
156787153|NCT00098293|565972851|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
156787154|NCT00098293|565972852|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
156787155|NCT00098293|565972853|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
156787156|NCT00098293|565972854|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
156787157|NCT00098293|565972855|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
156787158|NCT00098293|565972851|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
156787159|NCT00098293|565972852|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
156687704|NCT03649412|565601245|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
156687705|NCT03649412|565601244|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
156687706|NCT03649412|565601245|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156687707|NCT03649412|565601244|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
156687708|NCT03649412|565601245|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
156787160|NCT00098293|565972853|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
156787161|NCT00098293|565972854|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
156787162|NCT00098293|565972855|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
156787163|NCT00098293|565972851|FG000|Supplemental Phase (SP)|Other|0|||
156687709|NCT03649412|565601244|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
156687710|NCT03649412|565601245|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
156687711|NCT03649412|565601244|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
156330007|NCT00004635|564308746|FG001|Period One|Protocol Violation|0|||
156687712|NCT03649412|565601245|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
156687713|NCT00530348|565601246|FG000|Overall Study|Adverse Event|5|||
156687714|NCT00530348|565601247|FG001|Overall Study|Adverse Event|1|||
156687715|NCT00530348|565601246|FG000|Overall Study|Death|0|||
156687716|NCT00530348|565601247|FG001|Overall Study|Death|1|||
156687717|NCT00530348|565601246|FG000|Overall Study|Lack of Efficacy|2|||
156687718|NCT00530348|565601247|FG001|Overall Study|Lack of Efficacy|0|||
156687719|NCT00530348|565601246|FG000|Overall Study|Lost to Follow-up|0|||
156687720|NCT00530348|565601247|FG001|Overall Study|Lost to Follow-up|2|||
156687721|NCT00530348|565601246|FG000|Overall Study|Physician Decision|1|||
156687722|NCT00530348|565601247|FG001|Overall Study|Physician Decision|2|||
156687723|NCT00530348|565601246|FG000|Overall Study|Pregnancy|1|||
156687724|NCT00530348|565601247|FG001|Overall Study|Pregnancy|0|||
156687725|NCT00530348|565601246|FG000|Overall Study|Withdrawal by Subject|12|||
156687726|NCT00530348|565601247|FG001|Overall Study|Withdrawal by Subject|12|||
156687727|NCT00530348|565601246|FG000|Overall Study|Randomised in error|1|||
156687728|NCT00530348|565601247|FG001|Overall Study|Randomised in error|0|||
156687729|NCT00530348|565601246|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
156687730|NCT00530348|565601247|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
156687731|NCT04364763|565601248|FG000|Overall Study|Death|1|||
156687732|NCT04364763|565601249|FG001|Overall Study|Death|2|||
156687733|NCT04364763|565601248|FG000|Overall Study|Lost to Follow-up|1|||
156687734|NCT04364763|565601249|FG001|Overall Study|Lost to Follow-up|0|||
156687735|NCT01256060|565601251|FG000|Overall Study|Lost to Follow-up|0|||
156687736|NCT01256060|565601252|FG001|Overall Study|Lost to Follow-up|1|||
156687737|NCT01256060|565601253|FG002|Overall Study|Lost to Follow-up|0|||
156687738|NCT01256060|565601254|FG003|Overall Study|Lost to Follow-up|0|||
156687739|NCT00089076|565601259|FG000|Overall Study|Alternate Therapy|1|||
156687740|NCT00089076|565601259|FG000|Overall Study|Withdrawal by Subject|2|||
156687741|NCT00089076|565601259|FG000|Overall Study|Progression|7|||
156687742|NCT01009515|565601261|FG000|Overall Study|Withdrawal by Subject|3|||
156687743|NCT01501110|565601263|FG000|Overall Study|Death|0|||
156687744|NCT01501110|565601264|FG001|Overall Study|Death|1|||
156687745|NCT00983476|565601265|FG000|Overall Study|Did not receive intervention|17|||
156687746|NCT00983476|565601266|FG001|Overall Study|Did not receive intervention|22|||
156687747|NCT00983476|565601267|FG002|Overall Study|Did not receive intervention|0|||
156787164|NCT00098293|565972852|FG001|Supplemental Phase (SP)|Other|0|||
156787165|NCT00098293|565972853|FG002|Supplemental Phase (SP)|Other|0|||
156787166|NCT00098293|565972854|FG003|Supplemental Phase (SP)|Other|0|||
156787167|NCT00098293|565972855|FG004|Supplemental Phase (SP)|Other|22|||
156787168|NCT01968785|565972856|FG000|Overall Study|Withdrawal by Subject|1|||
156787169|NCT01968785|565972857|FG001|Overall Study|Withdrawal by Subject|0|||
156787170|NCT02829957|565972859|FG000|Overall Study|Lost to Follow-up|2|||
156787171|NCT02829957|565972860|FG001|Overall Study|Lost to Follow-up|1|||
156787172|NCT04193527|565972865|FG000|Overall Study|Other|1|||
156787173|NCT04193527|565972866|FG001|Overall Study|Other|1|||
156787174|NCT04193527|565972867|FG002|Overall Study|Other|0|||
156787175|NCT03808909|565972868|FG000|Overall Study|Lost to Follow-up|3|||
156787176|NCT03808909|565972869|FG001|Overall Study|Lost to Follow-up|0|||
156787177|NCT00676689|565972872|FG000|Overall Study|Screen Failure|2|||
156787178|NCT00676689|565972872|FG000|Overall Study|Death|2|||
156787179|NCT00676689|565972872|FG000|Overall Study|Lost to Follow-up|4|||
156787180|NCT00676689|565972872|FG000|Overall Study|Physician Decision|1|||
156787181|NCT00676689|565972872|FG000|Overall Study|Withdrawal by Subject|3|||
156787182|NCT00676689|565972872|FG000|Overall Study|Continuing FU|49|||
156787183|NCT01827943|565972873|FG000|Overall Study|Protocol Violation|8|||
156787184|NCT01827943|565972873|FG000|Overall Study|Never treated because of an rapid progression|1|||
156787185|NCT01487161|565972874|FG000|Overall Study|Adverse Event|1|||
156787186|NCT01487161|565972875|FG001|Overall Study|Adverse Event|0|||
156687748|NCT01439724|565601269|FG000|Overall Study|missing consultation|9|||
156687749|NCT01439724|565601270|FG001|Overall Study|missing consultation|8|||
156687750|NCT01483625|565601277|FG000|Overall Study|Adverse Event|1|||
156687751|NCT01483625|565601278|FG001|Overall Study|Adverse Event|1|||
156687752|NCT01483625|565601277|FG000|Overall Study|Refused to continue medication|2|||
156687753|NCT01483625|565601278|FG001|Overall Study|Refused to continue medication|1|||
156687754|NCT01483625|565601277|FG000|Overall Study|Due to other reason|1|||
156687755|NCT01483625|565601278|FG001|Overall Study|Due to other reason|0|||
156787187|NCT01487161|565972876|FG002|Overall Study|Adverse Event|0|||
156787188|NCT01487161|565972877|FG003|Overall Study|Adverse Event|0|||
156787189|NCT01487161|565972874|FG000|Overall Study|Withdrawal by Subject|1|||
156787190|NCT01487161|565972875|FG001|Overall Study|Withdrawal by Subject|1|||
156787191|NCT01487161|565972876|FG002|Overall Study|Withdrawal by Subject|1|||
156787192|NCT01487161|565972877|FG003|Overall Study|Withdrawal by Subject|2|||
156687756|NCT00084799|565601279|FG000|Overall Study|Disease Progression|1|||
156687757|NCT00084799|565601280|FG001|Overall Study|Disease Progression|0|||
156687758|NCT01083680|565601292|FG000|Overall Study|Lost to Follow-up|2758|||
156687759|NCT01083680|565601292|FG000|Overall Study|Withdrawal by Subject|1086|||
156787193|NCT01487161|565972874|FG000|Overall Study|missing data|0|||
156787194|NCT01487161|565972875|FG001|Overall Study|missing data|1|||
156687760|NCT03877926|565601293|FG000|Overall Study|Adverse Event|1|||
156687761|NCT03877926|565601294|FG001|Overall Study|Adverse Event|0|||
156687762|NCT03877926|565601295|FG002|Overall Study|Adverse Event|0|||
156687763|NCT03877926|565601296|FG003|Overall Study|Adverse Event|0|||
156687764|NCT03877926|565601293|FG000|Overall Study|Death|2|||
156687765|NCT03877926|565601294|FG001|Overall Study|Death|2|||
156687766|NCT03877926|565601295|FG002|Overall Study|Death|2|||
156687767|NCT03877926|565601296|FG003|Overall Study|Death|0|||
156687768|NCT03877926|565601293|FG000|Overall Study|Lost to Follow-up|41|||
156687769|NCT03877926|565601294|FG001|Overall Study|Lost to Follow-up|52|||
156687770|NCT03877926|565601295|FG002|Overall Study|Lost to Follow-up|45|||
156687771|NCT03877926|565601296|FG003|Overall Study|Lost to Follow-up|17|||
156687772|NCT03877926|565601293|FG000|Overall Study|Physician Decision|2|||
156687773|NCT03877926|565601294|FG001|Overall Study|Physician Decision|0|||
156687774|NCT03877926|565601295|FG002|Overall Study|Physician Decision|2|||
156687775|NCT03877926|565601296|FG003|Overall Study|Physician Decision|0|||
156687776|NCT03877926|565601293|FG000|Overall Study|Withdrawal by Subject|18|||
156687777|NCT03877926|565601294|FG001|Overall Study|Withdrawal by Subject|21|||
156687778|NCT03877926|565601295|FG002|Overall Study|Withdrawal by Subject|12|||
156687779|NCT03877926|565601296|FG003|Overall Study|Withdrawal by Subject|4|||
156687780|NCT03877926|565601293|FG000|Overall Study|Other - Various|4|||
156687781|NCT03877926|565601294|FG001|Overall Study|Other - Various|1|||
156687782|NCT03877926|565601295|FG002|Overall Study|Other - Various|1|||
156687783|NCT03877926|565601296|FG003|Overall Study|Other - Various|0|||
156687784|NCT03877926|565601293|FG000|Overall Study|Not Treated|3|||
156687785|NCT03877926|565601294|FG001|Overall Study|Not Treated|1|||
156687786|NCT03877926|565601295|FG002|Overall Study|Not Treated|1|||
156687787|NCT03877926|565601296|FG003|Overall Study|Not Treated|0|||
156687788|NCT02400476|565601297|FG000|Overall Study|Adverse Event|57|||
156687789|NCT02400476|565601298|FG001|Overall Study|Adverse Event|10|||
156687790|NCT02400476|565601299|FG002|Overall Study|Adverse Event|22|||
156687791|NCT02400476|565601300|FG003|Overall Study|Adverse Event|19|||
156687792|NCT02400476|565601301|FG004|Overall Study|Adverse Event|5|||
156687793|NCT02400476|565601302|FG005|Overall Study|Adverse Event|8|||
156687794|NCT02400476|565601297|FG000|Overall Study|Withdrawal by Subject|4|||
156687795|NCT02400476|565601298|FG001|Overall Study|Withdrawal by Subject|1|||
156687796|NCT02400476|565601299|FG002|Overall Study|Withdrawal by Subject|12|||
156687797|NCT02400476|565601300|FG003|Overall Study|Withdrawal by Subject|7|||
156687798|NCT02400476|565601301|FG004|Overall Study|Withdrawal by Subject|5|||
156687799|NCT02400476|565601302|FG005|Overall Study|Withdrawal by Subject|5|||
156687800|NCT02400476|565601297|FG000|Overall Study|Lost to Follow-up|0|||
156687801|NCT02400476|565601298|FG001|Overall Study|Lost to Follow-up|0|||
156687802|NCT02400476|565601299|FG002|Overall Study|Lost to Follow-up|0|||
156687803|NCT02400476|565601300|FG003|Overall Study|Lost to Follow-up|1|||
156687804|NCT02400476|565601301|FG004|Overall Study|Lost to Follow-up|3|||
156687805|NCT02400476|565601302|FG005|Overall Study|Lost to Follow-up|1|||
156687806|NCT02400476|565601297|FG000|Overall Study|Physician Decision|0|||
156687807|NCT02400476|565601298|FG001|Overall Study|Physician Decision|0|||
156687808|NCT02400476|565601299|FG002|Overall Study|Physician Decision|1|||
156687809|NCT02400476|565601300|FG003|Overall Study|Physician Decision|1|||
156787195|NCT01487161|565972876|FG002|Overall Study|missing data|0|||
156787196|NCT01487161|565972877|FG003|Overall Study|missing data|0|||
156787197|NCT03113136|565972878|FG000|Overall Study|Lost to Follow-up|22|||
156787198|NCT03113136|565972879|FG001|Overall Study|Lost to Follow-up|47|||
156787199|NCT03113136|565972880|FG002|Overall Study|Lost to Follow-up|54|||
156787200|NCT03113136|565972878|FG000|Overall Study|Withdrawal by Subject|4|||
156787201|NCT03113136|565972879|FG001|Overall Study|Withdrawal by Subject|13|||
156787202|NCT03113136|565972880|FG002|Overall Study|Withdrawal by Subject|14|||
156787203|NCT03113136|565972878|FG000|Overall Study|Ineligible|0|||
156787204|NCT03113136|565972879|FG001|Overall Study|Ineligible|2|||
156537832|NCT05111041|565062870|FG001|Overall Study|Withdrawal by Subject|0|||
156687810|NCT02400476|565601301|FG004|Overall Study|Physician Decision|0|||
156687811|NCT02400476|565601302|FG005|Overall Study|Physician Decision|1|||
156687812|NCT02400476|565601297|FG000|Overall Study|Other, Disease Progression|0|||
156687813|NCT02400476|565601298|FG001|Overall Study|Other, Disease Progression|1|||
156687814|NCT02400476|565601299|FG002|Overall Study|Other, Disease Progression|2|||
156687815|NCT02400476|565601300|FG003|Overall Study|Other, Disease Progression|1|||
156687816|NCT02400476|565601301|FG004|Overall Study|Other, Disease Progression|2|||
156787205|NCT03113136|565972880|FG002|Overall Study|Ineligible|1|||
156787206|NCT03113136|565972878|FG000|Overall Study|Study Team Decision|1|||
156787207|NCT03113136|565972879|FG001|Overall Study|Study Team Decision|4|||
156687817|NCT02400476|565601302|FG005|Overall Study|Other, Disease Progression|1|||
156687818|NCT02400476|565601297|FG000|Overall Study|Other, Decreased Quality of Life|0|||
156787208|NCT03113136|565972880|FG002|Overall Study|Study Team Decision|0|||
156787209|NCT00977561|565972882|FG000|Overall Study|Death|3|||
156687819|NCT02400476|565601298|FG001|Overall Study|Other, Decreased Quality of Life|0|||
156687820|NCT02400476|565601299|FG002|Overall Study|Other, Decreased Quality of Life|2|||
156687821|NCT02400476|565601300|FG003|Overall Study|Other, Decreased Quality of Life|0|||
156687822|NCT02400476|565601301|FG004|Overall Study|Other, Decreased Quality of Life|0|||
156787210|NCT00977561|565972883|FG001|Overall Study|Death|2|||
156687823|NCT02400476|565601302|FG005|Overall Study|Other, Decreased Quality of Life|0|||
156687824|NCT02400476|565601297|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
156687825|NCT02400476|565601298|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
156687826|NCT02400476|565601299|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
156687827|NCT02400476|565601300|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
156687828|NCT02400476|565601301|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
156687829|NCT02400476|565601302|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
156687830|NCT02487082|565601303|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
156687831|NCT02487082|565601304|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
156687832|NCT02487082|565601303|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
156687833|NCT02487082|565601304|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
156687834|NCT00003531|565601305|FG000|Overall Study|Not evaluable|10|||
156687835|NCT00588731|565601306|FG000|Overall Study|Withdrawal by Subject|3|||
156687836|NCT00588731|565601307|FG001|Overall Study|Withdrawal by Subject|2|||
156687837|NCT00346164|565601308|FG000|Overall Study|Adverse Event|0|||
156687838|NCT00346164|565601309|FG001|Overall Study|Adverse Event|0|||
156687839|NCT00346164|565601310|FG002|Overall Study|Adverse Event|0|||
156687840|NCT00346164|565601311|FG003|Overall Study|Adverse Event|1|||
156687841|NCT00346164|565601308|FG000|Overall Study|Lack of Efficacy|0|||
156687842|NCT00346164|565601309|FG001|Overall Study|Lack of Efficacy|1|||
156687843|NCT00346164|565601310|FG002|Overall Study|Lack of Efficacy|7|||
156687844|NCT00346164|565601311|FG003|Overall Study|Lack of Efficacy|25|||
156687845|NCT00346164|565601308|FG000|Overall Study|Physician Decision|0|||
156687846|NCT00346164|565601309|FG001|Overall Study|Physician Decision|1|||
156687847|NCT00346164|565601310|FG002|Overall Study|Physician Decision|2|||
156687848|NCT00346164|565601311|FG003|Overall Study|Physician Decision|27|||
156687849|NCT00346164|565601308|FG000|Overall Study|Protocol Violation|6|||
156687850|NCT00346164|565601309|FG001|Overall Study|Protocol Violation|2|||
156687851|NCT00346164|565601310|FG002|Overall Study|Protocol Violation|10|||
156687852|NCT00346164|565601311|FG003|Overall Study|Protocol Violation|4|||
156687853|NCT00346164|565601308|FG000|Overall Study|Withdrawal by Subject|0|||
156687854|NCT00346164|565601309|FG001|Overall Study|Withdrawal by Subject|0|||
156687855|NCT00346164|565601310|FG002|Overall Study|Withdrawal by Subject|2|||
156687856|NCT00346164|565601311|FG003|Overall Study|Withdrawal by Subject|0|||
156687857|NCT00346164|565601308|FG000|Overall Study|Ineligible|11|||
156687858|NCT00346164|565601309|FG001|Overall Study|Ineligible|2|||
156687859|NCT00346164|565601310|FG002|Overall Study|Ineligible|2|||
156687860|NCT00346164|565601311|FG003|Overall Study|Ineligible|23|||
156687861|NCT00346164|565601308|FG000|Overall Study|Refusal of further protocol therapy|0|||
156687862|NCT00346164|565601309|FG001|Overall Study|Refusal of further protocol therapy|1|||
156687863|NCT00346164|565601310|FG002|Overall Study|Refusal of further protocol therapy|3|||
156687864|NCT00346164|565601311|FG003|Overall Study|Refusal of further protocol therapy|15|||
156687865|NCT00346164|565601308|FG000|Overall Study|Inability to start week 16 tx on time|0|||
156687866|NCT00346164|565601309|FG001|Overall Study|Inability to start week 16 tx on time|0|||
156687867|NCT00346164|565601310|FG002|Overall Study|Inability to start week 16 tx on time|0|||
156687868|NCT00346164|565601311|FG003|Overall Study|Inability to start week 16 tx on time|11|||
156687869|NCT03139240|565601313|FG000|Overall Study|Lost to Follow-up|0|||
156687870|NCT03139240|565601314|FG001|Overall Study|Lost to Follow-up|1|||
156687871|NCT03139240|565601315|FG002|Overall Study|Lost to Follow-up|1|||
156687872|NCT03139240|565601316|FG003|Overall Study|Lost to Follow-up|0|||
156687873|NCT04569786|565601325|FG000|Overall Study|Lost to Follow-up|1|||
156687874|NCT04569786|565601326|FG001|Overall Study|Lost to Follow-up|0|||
156687875|NCT04569786|565601327|FG002|Overall Study|Lost to Follow-up|4|||
156687876|NCT04569786|565601328|FG003|Overall Study|Lost to Follow-up|1|||
156687877|NCT04569786|565601329|FG004|Overall Study|Lost to Follow-up|0|||
156687878|NCT04569786|565601325|FG000|Overall Study|Withdrawal by Subject|0|||
156687879|NCT04569786|565601326|FG001|Overall Study|Withdrawal by Subject|0|||
156687880|NCT04569786|565601327|FG002|Overall Study|Withdrawal by Subject|0|||
156687881|NCT04569786|565601328|FG003|Overall Study|Withdrawal by Subject|5|||
156687882|NCT04569786|565601329|FG004|Overall Study|Withdrawal by Subject|1|||
156687883|NCT04569786|565601325|FG000|Overall Study|Physician Decision|0|||
156687884|NCT04569786|565601326|FG001|Overall Study|Physician Decision|0|||
156687885|NCT04569786|565601327|FG002|Overall Study|Physician Decision|0|||
156687886|NCT04569786|565601328|FG003|Overall Study|Physician Decision|1|||
156687887|NCT04569786|565601329|FG004|Overall Study|Physician Decision|0|||
156687888|NCT01955044|565601330|FG000|Overall Study|Death|1|||
156687889|NCT01955044|565601331|FG001|Overall Study|Death|1|||
156687890|NCT01955044|565601332|FG002|Overall Study|Death|0|||
156687891|NCT02260258|565601336|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
156687892|NCT02260258|565601337|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
156687893|NCT04232540|565601339|FG000|Overall Study|Lost to Follow-up|1|||
156687894|NCT04232540|565601340|FG001|Overall Study|Lost to Follow-up|0|||
156687895|NCT03234608|565601341|FG000|Overall Study|Lost to Follow-up|23|||
156687896|NCT03234608|565601342|FG001|Overall Study|Lost to Follow-up|21|||
156687897|NCT02105701|565601343|FG000|Overall Study|Lost to Follow-up|1|||
156687898|NCT02105701|565601344|FG001|Overall Study|Lost to Follow-up|0|||
156687899|NCT02105701|565601345|FG002|Overall Study|Lost to Follow-up|2|||
156687900|NCT02105701|565601346|FG003|Overall Study|Lost to Follow-up|1|||
156687901|NCT02105701|565601343|FG000|Overall Study|Protocol Violation|0|||
156687902|NCT02105701|565601344|FG001|Overall Study|Protocol Violation|0|||
156687903|NCT02105701|565601345|FG002|Overall Study|Protocol Violation|1|||
156687904|NCT02105701|565601346|FG003|Overall Study|Protocol Violation|0|||
156687905|NCT02105701|565601343|FG000|Overall Study|Withdrawal by Subject|2|||
156687906|NCT02105701|565601344|FG001|Overall Study|Withdrawal by Subject|1|||
156687907|NCT02105701|565601345|FG002|Overall Study|Withdrawal by Subject|0|||
156687908|NCT02105701|565601346|FG003|Overall Study|Withdrawal by Subject|1|||
156687909|NCT02105701|565601343|FG000|Overall Study|Death|1|||
156687910|NCT02105701|565601344|FG001|Overall Study|Death|0|||
156687911|NCT02105701|565601345|FG002|Overall Study|Death|0|||
156687912|NCT02105701|565601346|FG003|Overall Study|Death|0|||
156687913|NCT01362296|565601347|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
156687914|NCT01362296|565601348|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
156687915|NCT01362296|565601349|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
156687916|NCT01362296|565601350|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
156687917|NCT01362296|565601347|FG000|Randomized Phase (RP)|Physician Decision|1|||
156687918|NCT01362296|565601348|FG001|Randomized Phase (RP)|Physician Decision|9|||
156687919|NCT01362296|565601349|FG002|Randomized Phase (RP)|Physician Decision|0|||
156687920|NCT01362296|565601350|FG003|Randomized Phase (RP)|Physician Decision|0|||
156687921|NCT01362296|565601347|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
156687922|NCT01362296|565601348|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
156687923|NCT01362296|565601349|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
156687924|NCT01362296|565601350|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
156687925|NCT01362296|565601347|FG000|Randomized Phase (RP)|Adverse Event|20|||
156687926|NCT01362296|565601348|FG001|Randomized Phase (RP)|Adverse Event|4|||
156687927|NCT01362296|565601349|FG002|Randomized Phase (RP)|Adverse Event|0|||
156687928|NCT01362296|565601350|FG003|Randomized Phase (RP)|Adverse Event|0|||
156687929|NCT01362296|565601347|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
156687930|NCT01362296|565601348|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
156687931|NCT01362296|565601349|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
156687932|NCT01362296|565601350|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
156869814|NCT00684021|566281025|FG000|Overall Study|Death|1|||
156869815|NCT00684021|566281026|FG001|Overall Study|Death|0|||
156869816|NCT00684021|566281027|FG002|Overall Study|Death|0|||
156869817|NCT00684021|566281028|FG003|Overall Study|Death|0|||
156869818|NCT02556177|566281029|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
156869819|NCT02556177|566281030|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
156869820|NCT03818321|566281032|FG000|Overall Study|Withdrawal by Subject|1|||
156869821|NCT03818321|566281033|FG001|Overall Study|Withdrawal by Subject|2|||
156869822|NCT01721044|566281036|FG000|Treatment Period|Adverse Event|7|||
156869823|NCT01721044|566281037|FG001|Treatment Period|Adverse Event|7|||
156687933|NCT01362296|565601347|FG000|Crossover Phase|PD including Death due to PD|0|||
156687934|NCT01362296|565601348|FG001|Crossover Phase|PD including Death due to PD|0|||
156869824|NCT01721044|566281038|FG002|Treatment Period|Adverse Event|10|||
156869825|NCT01721044|566281036|FG000|Treatment Period|Death|0|||
156869826|NCT01721044|566281037|FG001|Treatment Period|Death|0|||
156869827|NCT01721044|566281038|FG002|Treatment Period|Death|1|||
156869828|NCT01721044|566281036|FG000|Treatment Period|Lack of Efficacy|16|||
156869829|NCT01721044|566281037|FG001|Treatment Period|Lack of Efficacy|4|||
156687935|NCT01362296|565601349|FG002|Crossover Phase|PD including Death due to PD|16|||
156687936|NCT01362296|565601350|FG003|Crossover Phase|PD including Death due to PD|1|||
156687937|NCT01362296|565601347|FG000|Crossover Phase|Withdrawal by Subject|0|||
156687938|NCT01362296|565601348|FG001|Crossover Phase|Withdrawal by Subject|0|||
156687939|NCT01362296|565601349|FG002|Crossover Phase|Withdrawal by Subject|2|||
156687940|NCT01362296|565601350|FG003|Crossover Phase|Withdrawal by Subject|1|||
156687941|NCT01362296|565601347|FG000|Crossover Phase|Adverse Event|0|||
156869830|NCT01721044|566281038|FG002|Treatment Period|Lack of Efficacy|4|||
156869831|NCT01721044|566281036|FG000|Treatment Period|Lost to Follow-up|0|||
156330008|NCT00004635|564308745|FG000|Period One|PSA did not go <5 ng/mL|1|||
156330009|NCT00004635|564308746|FG001|Period One|PSA did not go <5 ng/mL|0|||
156330010|NCT00004635|564308745|FG000|Period One|second malignancy|1|||
156687942|NCT01362296|565601348|FG001|Crossover Phase|Adverse Event|0|||
156687943|NCT01362296|565601349|FG002|Crossover Phase|Adverse Event|4|||
156687944|NCT01362296|565601350|FG003|Crossover Phase|Adverse Event|0|||
156687945|NCT01362296|565601347|FG000|Crossover Phase|Study Closed/Terminated|0|||
156687946|NCT01362296|565601348|FG001|Crossover Phase|Study Closed/Terminated|0|||
156687947|NCT01362296|565601349|FG002|Crossover Phase|Study Closed/Terminated|1|||
156687948|NCT01362296|565601350|FG003|Crossover Phase|Study Closed/Terminated|0|||
156869832|NCT01721044|566281037|FG001|Treatment Period|Lost to Follow-up|0|||
156869833|NCT01721044|566281038|FG002|Treatment Period|Lost to Follow-up|1|||
156330011|NCT00004635|564308746|FG001|Period One|second malignancy|0|||
156330012|NCT00004635|564308745|FG000|Period One|progressed|0|||
156869834|NCT01721044|566281036|FG000|Treatment Period|Physician Decision|1|||
156687949|NCT03693950|565601351|FG000|Overall Study|Withdrawal by Subject|1|||
156687950|NCT03693950|565601352|FG001|Overall Study|Withdrawal by Subject|0|||
156687951|NCT04230876|565601354|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
156687952|NCT04230876|565601355|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
156687953|NCT01662362|565601356|FG000|Overall Study|Lost to Follow-up|38|||
156687954|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
156687955|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
156687956|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
156687957|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
156687958|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
156869835|NCT01721044|566281037|FG001|Treatment Period|Physician Decision|0|||
156869836|NCT01721044|566281038|FG002|Treatment Period|Physician Decision|2|||
156869837|NCT01721044|566281036|FG000|Treatment Period|Protocol Violation|1|||
156869838|NCT01721044|566281037|FG001|Treatment Period|Protocol Violation|0|||
156869839|NCT01721044|566281038|FG002|Treatment Period|Protocol Violation|0|||
156869840|NCT01721044|566281036|FG000|Treatment Period|Withdrawal by Subject|7|||
156869841|NCT01721044|566281037|FG001|Treatment Period|Withdrawal by Subject|6|||
156869842|NCT01721044|566281038|FG002|Treatment Period|Withdrawal by Subject|1|||
156869843|NCT01499355|566281039|FG000|Run-In Period|Study Termination|15|||
156869844|NCT01499355|566281040|FG001|Run-In Period|Study Termination|0|||
156869845|NCT01499355|566281041|FG002|Run-In Period|Study Termination|0|||
156869846|NCT01499355|566281042|FG003|Run-In Period|Study Termination|0|||
156869847|NCT01499355|566281039|FG000|Run-In Period|Other|3|||
156869848|NCT01499355|566281040|FG001|Run-In Period|Other|0|||
156869849|NCT01499355|566281041|FG002|Run-In Period|Other|0|||
156869850|NCT01499355|566281042|FG003|Run-In Period|Other|0|||
156869851|NCT01499355|566281039|FG000|Run-In Period|Death|2|||
156869852|NCT01499355|566281040|FG001|Run-In Period|Death|0|||
156869853|NCT01499355|566281041|FG002|Run-In Period|Death|0|||
156537833|NCT01011439|565062871|FG000|Overall Study|Death|37|||
156787211|NCT00977561|565972882|FG000|Overall Study|Study terminated|0|||
156787212|NCT00977561|565972883|FG001|Overall Study|Study terminated|2|||
156787213|NCT00977561|565972882|FG000|Overall Study|Other|2|||
156787214|NCT00977561|565972883|FG001|Overall Study|Other|0|||
156787215|NCT02187055|565972884|FG000|Overall Study|Lack of Efficacy|10|||
156787216|NCT02187055|565972885|FG001|Overall Study|Lack of Efficacy|3|||
156787217|NCT02187055|565972886|FG002|Overall Study|Lack of Efficacy|7|||
156787218|NCT02187055|565972884|FG000|Overall Study|Lost to Follow-up|2|||
156787219|NCT02187055|565972885|FG001|Overall Study|Lost to Follow-up|7|||
156787220|NCT02187055|565972886|FG002|Overall Study|Lost to Follow-up|3|||
156787221|NCT02187055|565972884|FG000|Overall Study|No longer meets eligibility criteria|0|||
156787222|NCT02187055|565972885|FG001|Overall Study|No longer meets eligibility criteria|2|||
156787223|NCT02187055|565972886|FG002|Overall Study|No longer meets eligibility criteria|0|||
156787224|NCT02187055|565972884|FG000|Overall Study|No longer willing to participate|6|||
156787225|NCT02187055|565972885|FG001|Overall Study|No longer willing to participate|8|||
156787226|NCT02187055|565972886|FG002|Overall Study|No longer willing to participate|10|||
156787227|NCT02187055|565972884|FG000|Overall Study|Other|5|||
156787228|NCT02187055|565972885|FG001|Overall Study|Other|6|||
156787229|NCT02187055|565972886|FG002|Overall Study|Other|3|||
156787230|NCT02187055|565972884|FG000|Overall Study|Protocol Violation|9|||
156787231|NCT02187055|565972885|FG001|Overall Study|Protocol Violation|9|||
156787232|NCT02187055|565972886|FG002|Overall Study|Protocol Violation|4|||
156787233|NCT02187055|565972884|FG000|Overall Study|Pregnancy|3|||
156787234|NCT02187055|565972885|FG001|Overall Study|Pregnancy|1|||
156787235|NCT02187055|565972886|FG002|Overall Study|Pregnancy|0|||
156787236|NCT02187055|565972884|FG000|Overall Study|Withdrawal by Subject|11|||
156787237|NCT02187055|565972885|FG001|Overall Study|Withdrawal by Subject|11|||
156787238|NCT02187055|565972886|FG002|Overall Study|Withdrawal by Subject|11|||
156787239|NCT02187055|565972884|FG000|Overall Study|Adverse Event|21|||
156787240|NCT02187055|565972885|FG001|Overall Study|Adverse Event|26|||
156787241|NCT02187055|565972886|FG002|Overall Study|Adverse Event|36|||
156787242|NCT02187055|565972884|FG000|Overall Study|Death|2|||
156787243|NCT02187055|565972885|FG001|Overall Study|Death|0|||
156787244|NCT02187055|565972886|FG002|Overall Study|Death|0|||
156787245|NCT01107457|565972889|FG000|Part A|Adverse Event|1|||
156787246|NCT01107457|565972890|FG001|Part A|Adverse Event|2|||
156787247|NCT01107457|565972891|FG002|Part A|Adverse Event|1|||
156787248|NCT01107457|565972892|FG003|Part A|Adverse Event|0|||
156787249|NCT01107457|565972893|FG004|Part A|Adverse Event|0|||
156787250|NCT01107457|565972894|FG005|Part A|Adverse Event|0|||
156787251|NCT01107457|565972889|FG000|Part A|Withdrawal by Subject|3|||
156787252|NCT01107457|565972890|FG001|Part A|Withdrawal by Subject|3|||
156787253|NCT01107457|565972891|FG002|Part A|Withdrawal by Subject|0|||
156787254|NCT01107457|565972892|FG003|Part A|Withdrawal by Subject|3|||
156787255|NCT01107457|565972893|FG004|Part A|Withdrawal by Subject|1|||
156869854|NCT01499355|566281042|FG003|Run-In Period|Death|0|||
156869855|NCT01499355|566281039|FG000|Run-In Period|Investigator Decision|2|||
156869856|NCT01499355|566281040|FG001|Run-In Period|Investigator Decision|0|||
156869857|NCT01499355|566281041|FG002|Run-In Period|Investigator Decision|0|||
156687959|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
156687960|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
156687961|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
156687962|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
156687963|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
156687964|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
156687965|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
156687966|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Death|0|||
156687967|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Death|1|||
156687968|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Death|0|||
156687969|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Death|0|||
156687970|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
156687971|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
156687972|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
156687973|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
156687974|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
156687975|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
156687976|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
156687977|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
156687978|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
156687979|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
156687980|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
156687981|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
156687982|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Disease Progression|3|||
156687983|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Disease Progression|3|||
156687984|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Disease Progression|0|||
156687985|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Disease Progression|7|||
156687986|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
156687987|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
156687988|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
156687989|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
156687990|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
156687991|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
156687992|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
156687993|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
156687994|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Adverse Event|0|||
156687995|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Adverse Event|3|||
156687996|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Adverse Event|2|||
156687997|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Adverse Event|2|||
156687998|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
156687999|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
156688000|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
156688001|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
156688002|NCT00545688|565601358|FG000|Follow-Up Period|Death|4|||
156688003|NCT00545688|565601359|FG001|Follow-Up Period|Death|2|||
156688004|NCT00545688|565601360|FG002|Follow-Up Period|Death|2|||
156688005|NCT00545688|565601361|FG003|Follow-Up Period|Death|6|||
156688006|NCT00545688|565601358|FG000|Follow-Up Period|Disease Progression|6|||
156688007|NCT00545688|565601359|FG001|Follow-Up Period|Disease Progression|5|||
156688008|NCT00545688|565601360|FG002|Follow-Up Period|Disease Progression|9|||
156688009|NCT00545688|565601361|FG003|Follow-Up Period|Disease Progression|9|||
156688010|NCT00545688|565601358|FG000|Follow-Up Period|Refused Treatment|6|||
156688011|NCT00545688|565601359|FG001|Follow-Up Period|Refused Treatment|2|||
156688012|NCT00545688|565601360|FG002|Follow-Up Period|Refused Treatment|0|||
156688013|NCT00545688|565601361|FG003|Follow-Up Period|Refused Treatment|2|||
156688014|NCT00545688|565601358|FG000|Follow-Up Period|Lost to Follow-up|3|||
156688015|NCT00545688|565601359|FG001|Follow-Up Period|Lost to Follow-up|3|||
156688016|NCT00545688|565601360|FG002|Follow-Up Period|Lost to Follow-up|3|||
156688017|NCT00545688|565601361|FG003|Follow-Up Period|Lost to Follow-up|1|||
156787256|NCT01107457|565972894|FG005|Part A|Withdrawal by Subject|0|||
156787257|NCT01107457|565972889|FG000|Part A|Lost to Follow-up|0|||
156787258|NCT01107457|565972890|FG001|Part A|Lost to Follow-up|1|||
156787259|NCT01107457|565972891|FG002|Part A|Lost to Follow-up|0|||
156330013|NCT00004635|564308746|FG001|Period One|progressed|2|||
156688018|NCT00545688|565601358|FG000|Follow-Up Period|Unspecified Reason|2|||
156688019|NCT00545688|565601359|FG001|Follow-Up Period|Unspecified Reason|5|||
156688020|NCT00545688|565601360|FG002|Follow-Up Period|Unspecified Reason|6|||
156688021|NCT00545688|565601361|FG003|Follow-Up Period|Unspecified Reason|8|||
156688022|NCT00545688|565601358|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
156688023|NCT00545688|565601359|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
156688024|NCT00545688|565601360|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
156688025|NCT00545688|565601361|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
156787260|NCT01107457|565972892|FG003|Part A|Lost to Follow-up|0|||
156787261|NCT01107457|565972893|FG004|Part A|Lost to Follow-up|0|||
156537834|NCT01011439|565062871|FG000|Overall Study|Lost to Follow-up|4|||
156688026|NCT02339090|565601362|FG000|Overall Study|Adverse Event|1|||
156688027|NCT02339090|565601363|FG001|Overall Study|Adverse Event|0|||
156688028|NCT02339090|565601362|FG000|Overall Study|Lost to Follow-up|0|||
156688029|NCT02339090|565601363|FG001|Overall Study|Lost to Follow-up|1|||
156688030|NCT02339090|565601362|FG000|Overall Study|Non-compliance With Study Drug|0|||
156688031|NCT02339090|565601363|FG001|Overall Study|Non-compliance With Study Drug|1|||
156688032|NCT02339090|565601362|FG000|Overall Study|Withdrawal by Subject|2|||
156688033|NCT02339090|565601363|FG001|Overall Study|Withdrawal by Subject|1|||
156688034|NCT02339090|565601362|FG000|Overall Study|Poor Growth|3|||
156688035|NCT02339090|565601363|FG001|Overall Study|Poor Growth|0|||
156688036|NCT02339090|565601362|FG000|Overall Study|Randomized but not treated|0|||
156688037|NCT02339090|565601363|FG001|Overall Study|Randomized but not treated|2|||
156688038|NCT00248170|565601367|FG000|Overall Study|Withdrawal by Subject|71|||
156688039|NCT00248170|565601368|FG001|Overall Study|Withdrawal by Subject|79|||
156688040|NCT00248170|565601367|FG000|Overall Study|Protocol Violation|35|||
156688041|NCT00248170|565601368|FG001|Overall Study|Protocol Violation|30|||
156688042|NCT00248170|565601367|FG000|Overall Study|Lost to Follow-up|28|||
156688043|NCT00248170|565601368|FG001|Overall Study|Lost to Follow-up|35|||
156688044|NCT00248170|565601367|FG000|Overall Study|Disease progression|196|||
156688045|NCT00248170|565601368|FG001|Overall Study|Disease progression|216|||
156688046|NCT00248170|565601367|FG000|Overall Study|Death|28|||
156688047|NCT00248170|565601368|FG001|Overall Study|Death|47|||
156688048|NCT00248170|565601367|FG000|Overall Study|Adverse Event|311|||
156688049|NCT00248170|565601368|FG001|Overall Study|Adverse Event|296|||
156688050|NCT00248170|565601367|FG000|Overall Study|Administrative problems|22|||
156688051|NCT00248170|565601368|FG001|Overall Study|Administrative problems|25|||
156688052|NCT00248170|565601367|FG000|Overall Study|Abnormal test procedure(s) result|49|||
156688053|NCT00248170|565601368|FG001|Overall Study|Abnormal test procedure(s) result|61|||
156688054|NCT00248170|565601367|FG000|Overall Study|Abnormal laboratory values|4|||
156688055|NCT00248170|565601368|FG001|Overall Study|Abnormal laboratory values|0|||
156688056|NCT00248170|565601367|FG000|Overall Study|Protocol deviation|17|||
156688057|NCT00248170|565601368|FG001|Overall Study|Protocol deviation|19|||
156688058|NCT04039919|565602713|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156787262|NCT01107457|565972894|FG005|Part A|Lost to Follow-up|0|||
156787263|NCT01107457|565972889|FG000|Part A|Lack of Efficacy|1|||
156787264|NCT01107457|565972890|FG001|Part A|Lack of Efficacy|0|||
156688059|NCT04039919|565602714|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156688060|NCT04039919|565602715|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156688061|NCT04039919|565602716|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156688062|NCT04039919|565602717|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156688063|NCT04039919|565602713|FG000|Treatment Period 1|Sponsor's decision|0|||
156688064|NCT04039919|565602714|FG001|Treatment Period 1|Sponsor's decision|0|||
156688065|NCT04039919|565602715|FG002|Treatment Period 1|Sponsor's decision|0|||
156787265|NCT01107457|565972891|FG002|Part A|Lack of Efficacy|0|||
156787266|NCT01107457|565972892|FG003|Part A|Lack of Efficacy|0|||
156688066|NCT04039919|565602716|FG003|Treatment Period 1|Sponsor's decision|0|||
156688067|NCT04039919|565602717|FG004|Treatment Period 1|Sponsor's decision|16|||
156688068|NCT04039919|565602713|FG000|Treatment Period 5|Withdrawal by Subject|1|||
156688069|NCT04039919|565602714|FG001|Treatment Period 5|Withdrawal by Subject|0|||
156688070|NCT04039919|565602715|FG002|Treatment Period 5|Withdrawal by Subject|0|||
156787267|NCT01107457|565972893|FG004|Part A|Lack of Efficacy|0|||
156787268|NCT01107457|565972894|FG005|Part A|Lack of Efficacy|0|||
156787269|NCT01107457|565972889|FG000|Part A|Protocol Violation|0|||
156787270|NCT01107457|565972890|FG001|Part A|Protocol Violation|1|||
156787271|NCT01107457|565972891|FG002|Part A|Protocol Violation|0|||
156787272|NCT01107457|565972892|FG003|Part A|Protocol Violation|0|||
156787273|NCT01107457|565972893|FG004|Part A|Protocol Violation|0|||
156787274|NCT01107457|565972894|FG005|Part A|Protocol Violation|0|||
156787275|NCT01107457|565972889|FG000|Part B and C|Adverse Event|0|||
156787276|NCT01107457|565972890|FG001|Part B and C|Adverse Event|0|||
156787277|NCT01107457|565972891|FG002|Part B and C|Adverse Event|0|||
156787278|NCT01107457|565972892|FG003|Part B and C|Adverse Event|0|||
156688071|NCT04039919|565602716|FG003|Treatment Period 5|Withdrawal by Subject|0|||
156688072|NCT04039919|565602717|FG004|Treatment Period 5|Withdrawal by Subject|0|||
156688073|NCT03250299|565602722|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
156688074|NCT03250299|565602723|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
156688075|NCT03250299|565602724|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
156688076|NCT03250299|565602725|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
156688077|NCT03250299|565602726|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
156688078|NCT03250299|565602722|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
156688079|NCT03250299|565602723|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
156787279|NCT01107457|565972893|FG004|Part B and C|Adverse Event|0|||
156688080|NCT03250299|565602724|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
156688081|NCT03250299|565602725|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
156787280|NCT01107457|565972894|FG005|Part B and C|Adverse Event|12|||
156787281|NCT01107457|565972889|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156787282|NCT01107457|565972890|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156787283|NCT01107457|565972891|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156688082|NCT03250299|565602726|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
156688083|NCT03250299|565602722|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
156688084|NCT03250299|565602723|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
156688085|NCT03250299|565602724|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
156688086|NCT03250299|565602725|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
156688087|NCT03250299|565602726|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
156688088|NCT03250299|565602722|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
156688089|NCT03250299|565602723|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
156688090|NCT03250299|565602724|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
156688091|NCT03250299|565602725|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
156688092|NCT03250299|565602726|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
156688093|NCT03346070|565602727|FG000|Overall Study|Death|0|||
156688094|NCT03346070|565602728|FG001|Overall Study|Death|0|||
156688095|NCT03346070|565602729|FG002|Overall Study|Death|0|||
156688096|NCT03346070|565602730|FG003|Overall Study|Death|0|||
156688097|NCT03346070|565602731|FG004|Overall Study|Death|1|||
156688098|NCT03346070|565602727|FG000|Overall Study|Lost to Follow-up|0|||
156688099|NCT03346070|565602728|FG001|Overall Study|Lost to Follow-up|1|||
156688100|NCT03346070|565602729|FG002|Overall Study|Lost to Follow-up|2|||
156688101|NCT03346070|565602730|FG003|Overall Study|Lost to Follow-up|0|||
156688102|NCT03346070|565602731|FG004|Overall Study|Lost to Follow-up|0|||
156688103|NCT03346070|565602727|FG000|Overall Study|Physician Decision|0|||
156688104|NCT03346070|565602728|FG001|Overall Study|Physician Decision|0|||
156688105|NCT03346070|565602729|FG002|Overall Study|Physician Decision|0|||
156688106|NCT03346070|565602730|FG003|Overall Study|Physician Decision|1|||
156787284|NCT01107457|565972892|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156787285|NCT01107457|565972893|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156787286|NCT01107457|565972894|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
156787287|NCT01107457|565972889|FG000|Part B and C|Physician Decision|0|||
156787288|NCT01107457|565972890|FG001|Part B and C|Physician Decision|0|||
156787289|NCT01107457|565972891|FG002|Part B and C|Physician Decision|0|||
156787290|NCT01107457|565972892|FG003|Part B and C|Physician Decision|0|||
156787291|NCT01107457|565972893|FG004|Part B and C|Physician Decision|0|||
156787292|NCT01107457|565972894|FG005|Part B and C|Physician Decision|3|||
156787293|NCT01107457|565972889|FG000|Part B and C|Lack of Efficacy|0|||
156787294|NCT01107457|565972890|FG001|Part B and C|Lack of Efficacy|0|||
156787295|NCT01107457|565972891|FG002|Part B and C|Lack of Efficacy|0|||
156787296|NCT01107457|565972892|FG003|Part B and C|Lack of Efficacy|0|||
156787297|NCT01107457|565972893|FG004|Part B and C|Lack of Efficacy|0|||
156787298|NCT01107457|565972894|FG005|Part B and C|Lack of Efficacy|7|||
156787299|NCT01107457|565972889|FG000|Part B and C|Lost to Follow-up|0|||
156787300|NCT01107457|565972890|FG001|Part B and C|Lost to Follow-up|0|||
156787301|NCT01107457|565972891|FG002|Part B and C|Lost to Follow-up|0|||
156787302|NCT01107457|565972892|FG003|Part B and C|Lost to Follow-up|0|||
156787303|NCT01107457|565972893|FG004|Part B and C|Lost to Follow-up|0|||
156787304|NCT01107457|565972894|FG005|Part B and C|Lost to Follow-up|10|||
156787305|NCT01107457|565972889|FG000|Part B and C|Protocol Violation|0|||
156787306|NCT01107457|565972890|FG001|Part B and C|Protocol Violation|0|||
156787307|NCT01107457|565972891|FG002|Part B and C|Protocol Violation|0|||
156787308|NCT01107457|565972892|FG003|Part B and C|Protocol Violation|0|||
156787309|NCT01107457|565972893|FG004|Part B and C|Protocol Violation|0|||
156787310|NCT01107457|565972894|FG005|Part B and C|Protocol Violation|1|||
156787311|NCT01107457|565972889|FG000|Part B and C|Sponsor Decision|0|||
156787312|NCT01107457|565972890|FG001|Part B and C|Sponsor Decision|0|||
156787313|NCT01107457|565972891|FG002|Part B and C|Sponsor Decision|0|||
156787314|NCT01107457|565972892|FG003|Part B and C|Sponsor Decision|0|||
156787315|NCT01107457|565972893|FG004|Part B and C|Sponsor Decision|0|||
156787316|NCT01107457|565972894|FG005|Part B and C|Sponsor Decision|66|||
156787317|NCT01107457|565972889|FG000|Part B and C|Withdrawal by Subject|0|||
156787318|NCT01107457|565972890|FG001|Part B and C|Withdrawal by Subject|0|||
156787319|NCT01107457|565972891|FG002|Part B and C|Withdrawal by Subject|0|||
156787320|NCT01107457|565972892|FG003|Part B and C|Withdrawal by Subject|0|||
156688107|NCT03346070|565602731|FG004|Overall Study|Physician Decision|1|||
156688108|NCT03346070|565602727|FG000|Overall Study|Withdrawal by Subject|1|||
156787321|NCT01107457|565972893|FG004|Part B and C|Withdrawal by Subject|0|||
156787322|NCT01107457|565972894|FG005|Part B and C|Withdrawal by Subject|16|||
156787323|NCT01107457|565972889|FG000|Part B and C|Clinical Relapse|0|||
156688109|NCT03346070|565602728|FG001|Overall Study|Withdrawal by Subject|0|||
156688110|NCT03346070|565602729|FG002|Overall Study|Withdrawal by Subject|0|||
156688111|NCT03346070|565602730|FG003|Overall Study|Withdrawal by Subject|1|||
156688112|NCT03346070|565602731|FG004|Overall Study|Withdrawal by Subject|0|||
156787324|NCT01107457|565972890|FG001|Part B and C|Clinical Relapse|0|||
156787325|NCT01107457|565972891|FG002|Part B and C|Clinical Relapse|0|||
156787326|NCT01107457|565972892|FG003|Part B and C|Clinical Relapse|0|||
156787327|NCT01107457|565972893|FG004|Part B and C|Clinical Relapse|0|||
156787328|NCT01107457|565972894|FG005|Part B and C|Clinical Relapse|4|||
156787329|NCT00694161|565972895|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
156787330|NCT00694161|565972895|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
156869858|NCT01499355|566281042|FG003|Run-In Period|Investigator Decision|0|||
156869859|NCT01499355|566281039|FG000|Run-In Period|Consent Withdrawn|1|||
156869860|NCT01499355|566281040|FG001|Run-In Period|Consent Withdrawn|0|||
156869861|NCT01499355|566281041|FG002|Run-In Period|Consent Withdrawn|0|||
156869862|NCT01499355|566281042|FG003|Run-In Period|Consent Withdrawn|0|||
156869863|NCT01499355|566281039|FG000|Run-In Period|Adverse Event|8|||
156869864|NCT01499355|566281040|FG001|Run-In Period|Adverse Event|0|||
156869865|NCT01499355|566281041|FG002|Run-In Period|Adverse Event|0|||
156869866|NCT01499355|566281042|FG003|Run-In Period|Adverse Event|0|||
156869867|NCT01499355|566281039|FG000|Double-Blind Period|Adverse Event|0|||
156869868|NCT01499355|566281040|FG001|Double-Blind Period|Adverse Event|2|||
156869869|NCT01499355|566281041|FG002|Double-Blind Period|Adverse Event|3|||
156688113|NCT03346070|565602727|FG000|Overall Study|Study medication not received as planned|2|||
156688114|NCT03346070|565602728|FG001|Overall Study|Study medication not received as planned|3|||
156688115|NCT03346070|565602729|FG002|Overall Study|Study medication not received as planned|2|||
156688116|NCT03346070|565602730|FG003|Overall Study|Study medication not received as planned|3|||
156688117|NCT03346070|565602731|FG004|Overall Study|Study medication not received as planned|2|||
156688118|NCT03346070|565602727|FG000|Overall Study|Screen Failure|0|||
156688119|NCT03346070|565602728|FG001|Overall Study|Screen Failure|0|||
156688120|NCT03346070|565602729|FG002|Overall Study|Screen Failure|0|||
156688121|NCT03346070|565602730|FG003|Overall Study|Screen Failure|1|||
156688122|NCT03346070|565602731|FG004|Overall Study|Screen Failure|1|||
156688123|NCT00977548|565602732|FG000|Overall Study|Ineligible|4|||
156688124|NCT00977548|565602732|FG000|Overall Study|Adverse Event|8|||
156688125|NCT00977548|565602732|FG000|Overall Study|Withdrawal by Subject|1|||
156688126|NCT02070757|565602735|FG000|Overall Study|Adverse Event|107|||
156688127|NCT02070757|565602736|FG001|Overall Study|Adverse Event|99|||
156688128|NCT02070757|565602735|FG000|Overall Study|Lost to Follow-up|7|||
156688129|NCT02070757|565602736|FG001|Overall Study|Lost to Follow-up|4|||
156688130|NCT02070757|565602735|FG000|Overall Study|Protocol Violation|0|||
156688131|NCT02070757|565602736|FG001|Overall Study|Protocol Violation|4|||
156688132|NCT02070757|565602735|FG000|Overall Study|Withdrawal by Subject|1|||
156688133|NCT02070757|565602736|FG001|Overall Study|Withdrawal by Subject|3|||
156688134|NCT02070757|565602735|FG000|Overall Study|Investigator Decision|0|||
156688135|NCT02070757|565602736|FG001|Overall Study|Investigator Decision|2|||
156688136|NCT02070757|565602735|FG000|Overall Study|Discharged from Study Hospital|2|||
156869870|NCT01499355|566281042|FG003|Double-Blind Period|Adverse Event|2|||
156869871|NCT01499355|566281039|FG000|Double-Blind Period|Study Termination|0|||
156869872|NCT01499355|566281040|FG001|Double-Blind Period|Study Termination|18|||
156688137|NCT02070757|565602736|FG001|Overall Study|Discharged from Study Hospital|2|||
156688138|NCT04086641|565602739|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
156688139|NCT04086641|565602740|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
156688140|NCT01546142|565602741|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
156688141|NCT01546142|565602742|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
156688142|NCT01546142|565602741|FG000|Overall Study|Subject Noncompliance|1|||
156688143|NCT01546142|565602742|FG001|Overall Study|Subject Noncompliance|1|||
156688144|NCT01546142|565602741|FG000|Overall Study|Adverse Event|6|||
156688145|NCT01546142|565602742|FG001|Overall Study|Adverse Event|3|||
156688146|NCT01546142|565602741|FG000|Overall Study|Lost to Follow-up|20|||
156688147|NCT01546142|565602742|FG001|Overall Study|Lost to Follow-up|15|||
156688148|NCT01546142|565602741|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
156688149|NCT01546142|565602742|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
156688150|NCT01546142|565602741|FG000|Overall Study|Subject Randomized but Not Treated|1|||
156688151|NCT01546142|565602742|FG001|Overall Study|Subject Randomized but Not Treated|0|||
156688152|NCT01213836|565602743|FG000|Period 1, First Intervention|Adverse Event|2|||
156688153|NCT01213836|565602744|FG001|Period 1, First Intervention|Adverse Event|1|||
156688154|NCT01213836|565602743|FG000|Period 1, First Intervention|Protocol Violation|0|||
156688155|NCT01213836|565602744|FG001|Period 1, First Intervention|Protocol Violation|1|||
156688156|NCT01213836|565602743|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
156688157|NCT01213836|565602744|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
156688158|NCT00706095|565602750|FG000|Overall Study|Progressive Disease|4|||
156688159|NCT00706095|565602751|FG001|Overall Study|Progressive Disease|5|||
156688160|NCT00706095|565602752|FG002|Overall Study|Progressive Disease|3|||
156688161|NCT00706095|565602750|FG000|Overall Study|Clinical Progression|1|||
156688162|NCT00706095|565602751|FG001|Overall Study|Clinical Progression|2|||
156688163|NCT00706095|565602752|FG002|Overall Study|Clinical Progression|2|||
156688164|NCT00706095|565602750|FG000|Overall Study|Withdrawal by Subject|1|||
156688165|NCT00706095|565602751|FG001|Overall Study|Withdrawal by Subject|0|||
156688166|NCT00706095|565602752|FG002|Overall Study|Withdrawal by Subject|0|||
156688167|NCT00126126|565602762|FG000|Overall Study|Lost to Follow-up|0|||
156688168|NCT00126126|565602763|FG001|Overall Study|Lost to Follow-up|2|||
156688169|NCT00892281|565602764|FG000|Overall Study|Adverse Event|65|||
156688170|NCT00892281|565602765|FG001|Overall Study|Adverse Event|8|||
156869873|NCT01499355|566281041|FG002|Double-Blind Period|Study Termination|16|||
156869874|NCT01499355|566281042|FG003|Double-Blind Period|Study Termination|14|||
156869875|NCT01499355|566281039|FG000|Double-Blind Period|Other|0|||
156787331|NCT00694161|565972895|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
156787332|NCT03601052|565972896|FG000|Overall Study|Lost to Follow-up|2|||
156787333|NCT00694122|565972897|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
156787334|NCT00694122|565972898|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
156787335|NCT00694122|565972897|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
156787336|NCT00694122|565972898|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
156787337|NCT00694122|565972897|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
156787338|NCT00694122|565972898|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
156787339|NCT00105508|565972899|FG000|Overall Study|Prephase Dropout|1|||
156787340|NCT00105508|565972900|FG001|Overall Study|Prephase Dropout|0|||
156787341|NCT00105508|565972899|FG000|Overall Study|Adverse Event|16|||
156787342|NCT00105508|565972900|FG001|Overall Study|Adverse Event|19|||
156787343|NCT00105508|565972899|FG000|Overall Study|Insufficient Efficacy|1|||
156787344|NCT00105508|565972900|FG001|Overall Study|Insufficient Efficacy|0|||
156787345|NCT00105508|565972899|FG000|Overall Study|Withdrawal by Subject|10|||
156787346|NCT00105508|565972900|FG001|Overall Study|Withdrawal by Subject|6|||
156787347|NCT00105508|565972899|FG000|Overall Study|Lost to Follow-up|3|||
156787348|NCT00105508|565972900|FG001|Overall Study|Lost to Follow-up|0|||
156787349|NCT00105508|565972899|FG000|Overall Study|Protocol Violation|1|||
156787350|NCT00105508|565972900|FG001|Overall Study|Protocol Violation|2|||
156787351|NCT00105508|565972899|FG000|Overall Study|Other|8|||
156787352|NCT00105508|565972900|FG001|Overall Study|Other|9|||
156787353|NCT00683384|565972901|FG000|Overall Study|Death|1|||
156787354|NCT00683384|565972901|FG000|Overall Study|Adverse Event|1|||
156787355|NCT00120874|565972902|FG000|Overall Study|Death|0|||
156787356|NCT00120874|565972903|FG001|Overall Study|Death|1|||
156787357|NCT01348490|565972912|FG000|Overall Study|Death|1|||
156787358|NCT01348490|565972912|FG000|Overall Study|Adverse Event|3|||
156787359|NCT01348490|565972912|FG000|Overall Study|Consent withdrawn|7|||
156787360|NCT01348490|565972912|FG000|Overall Study|Disease progression|3|||
156787361|NCT01348490|565972912|FG000|Overall Study|Lost to Follow-up|1|||
156787362|NCT01348490|565972912|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
156787363|NCT01348490|565972912|FG000|Overall Study|Other Unspecified|8|||
156787364|NCT03632720|565972913|FG000|Overall Study|Adverse Event|2|||
156787365|NCT03632720|565972914|FG001|Overall Study|Adverse Event|0|||
156787366|NCT03632720|565972915|FG002|Overall Study|Adverse Event|0|||
156787367|NCT03632720|565972913|FG000|Overall Study|Lost to Follow-up|0|||
156787368|NCT03632720|565972914|FG001|Overall Study|Lost to Follow-up|1|||
156787369|NCT03632720|565972915|FG002|Overall Study|Lost to Follow-up|0|||
156787370|NCT03632720|565972913|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
156787371|NCT03632720|565972914|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
156787372|NCT03632720|565972915|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
156787373|NCT03632720|565972913|FG000|Overall Study|Screen failure|0|||
156787374|NCT03632720|565972914|FG001|Overall Study|Screen failure|1|||
156787375|NCT03632720|565972915|FG002|Overall Study|Screen failure|0|||
156787376|NCT01049828|565972916|FG000|Overall Study|Claustrophibia and Frustration|2|||
156787377|NCT00520572|565974712|FG000|Overall Study|Adverse Event|9|||
156787378|NCT00520572|565974713|FG001|Overall Study|Adverse Event|3|||
156787379|NCT00520572|565974714|FG002|Overall Study|Adverse Event|6|||
156787380|NCT00520572|565974715|FG003|Overall Study|Adverse Event|9|||
156787381|NCT00520572|565974716|FG004|Overall Study|Adverse Event|7|||
156787382|NCT00520572|565974717|FG005|Overall Study|Adverse Event|2|||
156787383|NCT00520572|565974712|FG000|Overall Study|Withdrawal by Subject|0|||
156787384|NCT00520572|565974713|FG001|Overall Study|Withdrawal by Subject|9|||
156787385|NCT00520572|565974714|FG002|Overall Study|Withdrawal by Subject|5|||
156787386|NCT00520572|565974715|FG003|Overall Study|Withdrawal by Subject|2|||
156787387|NCT00520572|565974716|FG004|Overall Study|Withdrawal by Subject|2|||
156787388|NCT00520572|565974717|FG005|Overall Study|Withdrawal by Subject|0|||
156869876|NCT01499355|566281040|FG001|Double-Blind Period|Other|1|||
156869877|NCT01499355|566281041|FG002|Double-Blind Period|Other|2|||
156869878|NCT01499355|566281042|FG003|Double-Blind Period|Other|2|||
156787389|NCT00520572|565974712|FG000|Overall Study|Protocol Violation|0|||
156787390|NCT00520572|565974713|FG001|Overall Study|Protocol Violation|0|||
156787391|NCT00520572|565974714|FG002|Overall Study|Protocol Violation|1|||
156787392|NCT00520572|565974715|FG003|Overall Study|Protocol Violation|0|||
156787393|NCT00520572|565974716|FG004|Overall Study|Protocol Violation|0|||
156787394|NCT00520572|565974717|FG005|Overall Study|Protocol Violation|0|||
156787395|NCT00520572|565974712|FG000|Overall Study|Lack of Efficacy|1|||
156787396|NCT00520572|565974713|FG001|Overall Study|Lack of Efficacy|1|||
156787397|NCT00520572|565974714|FG002|Overall Study|Lack of Efficacy|1|||
156787398|NCT00520572|565974715|FG003|Overall Study|Lack of Efficacy|2|||
156787399|NCT00520572|565974716|FG004|Overall Study|Lack of Efficacy|1|||
156787400|NCT00520572|565974717|FG005|Overall Study|Lack of Efficacy|0|||
156787401|NCT00520572|565974712|FG000|Overall Study|Lost to Follow-up|0|||
156787402|NCT00520572|565974713|FG001|Overall Study|Lost to Follow-up|0|||
156787403|NCT00520572|565974714|FG002|Overall Study|Lost to Follow-up|0|||
156787404|NCT00520572|565974715|FG003|Overall Study|Lost to Follow-up|0|||
156869879|NCT01499355|566281039|FG000|Double-Blind Period|Death|0|||
156688171|NCT00892281|565602764|FG000|Overall Study|Lost to Follow-up|81|||
156688172|NCT00892281|565602765|FG001|Overall Study|Lost to Follow-up|8|||
156688173|NCT00892281|565602764|FG000|Overall Study|Pregnancy|1|||
156688174|NCT00892281|565602765|FG001|Overall Study|Pregnancy|0|||
156688175|NCT00892281|565602764|FG000|Overall Study|Protocol Violation|7|||
156688176|NCT00892281|565602765|FG001|Overall Study|Protocol Violation|2|||
156688177|NCT00892281|565602764|FG000|Overall Study|Withdrawal by Subject|86|||
156688178|NCT00892281|565602765|FG001|Overall Study|Withdrawal by Subject|14|||
156688179|NCT00892281|565602764|FG000|Overall Study|Subject failed to return for final visit|2|||
156688180|NCT00892281|565602765|FG001|Overall Study|Subject failed to return for final visit|0|||
156688181|NCT00892281|565602764|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
156688182|NCT00892281|565602765|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
156688183|NCT00892281|565602764|FG000|Overall Study|Final visit completed 4 weeks late|0|||
156688184|NCT00892281|565602765|FG001|Overall Study|Final visit completed 4 weeks late|1|||
156688185|NCT00892281|565602764|FG000|Overall Study|Subject completed day after study closed|1|||
156688186|NCT00892281|565602765|FG001|Overall Study|Subject completed day after study closed|0|||
156688187|NCT00892281|565602764|FG000|Overall Study|Family emergency|1|||
156688188|NCT00892281|565602765|FG001|Overall Study|Family emergency|0|||
156688189|NCT00892281|565602764|FG000|Overall Study|Last visit not done - death in family|1|||
156688190|NCT00892281|565602765|FG001|Overall Study|Last visit not done - death in family|0|||
156688191|NCT00892281|565602764|FG000|Overall Study|Did not meet incl/excl criteria|1|||
156688192|NCT00892281|565602765|FG001|Overall Study|Did not meet incl/excl criteria|0|||
156330014|NCT00004635|564308745|FG000|Period One|health problem|0|||
156688193|NCT00892281|565602764|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
156688194|NCT00892281|565602765|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
156688195|NCT00892281|565602764|FG000|Overall Study|Unable to redeem the drug voucher|1|||
156688196|NCT00892281|565602765|FG001|Overall Study|Unable to redeem the drug voucher|0|||
156688197|NCT00892281|565602764|FG000|Overall Study|Subject not good candidate for study|1|||
156688198|NCT00892281|565602765|FG001|Overall Study|Subject not good candidate for study|0|||
156688199|NCT00892281|565602764|FG000|Overall Study|Subject did not return for any visits|1|||
156688200|NCT00892281|565602765|FG001|Overall Study|Subject did not return for any visits|0|||
156688201|NCT00892281|565602764|FG000|Overall Study|Subject missed several visits/lost meds|1|||
156688202|NCT00892281|565602765|FG001|Overall Study|Subject missed several visits/lost meds|0|||
156688203|NCT00892281|565602764|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
156688204|NCT00892281|565602765|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
156688205|NCT00892281|565602764|FG000|Overall Study|Scheduled for knee replacement|0|||
156688206|NCT00892281|565602765|FG001|Overall Study|Scheduled for knee replacement|1|||
156688207|NCT00892281|565602764|FG000|Overall Study|PI complained of inadequate compensation|3|||
156688208|NCT00892281|565602765|FG001|Overall Study|PI complained of inadequate compensation|0|||
156688209|NCT00892281|565602764|FG000|Overall Study|Subject lost interest in program|0|||
156688210|NCT00892281|565602765|FG001|Overall Study|Subject lost interest in program|1|||
156688211|NCT00892281|565602764|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
156688212|NCT00892281|565602765|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
156688213|NCT00892281|565602764|FG000|Overall Study|Death in family|1|||
156688214|NCT00892281|565602765|FG001|Overall Study|Death in family|0|||
156688215|NCT00892281|565602764|FG000|Overall Study|Lack of efficacy of study product|2|||
156688216|NCT00892281|565602765|FG001|Overall Study|Lack of efficacy of study product|0|||
156688217|NCT00892281|565602764|FG000|Overall Study|Subject not seen by PI at final visit|1|||
156688218|NCT00892281|565602765|FG001|Overall Study|Subject not seen by PI at final visit|0|||
156688219|NCT00892281|565602764|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
156688220|NCT00892281|565602765|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
156787405|NCT00520572|565974716|FG004|Overall Study|Lost to Follow-up|1|||
156787406|NCT00520572|565974717|FG005|Overall Study|Lost to Follow-up|0|||
156787407|NCT00520572|565974712|FG000|Overall Study|Incorrect enrollment|1|||
156787408|NCT00520572|565974713|FG001|Overall Study|Incorrect enrollment|0|||
156787409|NCT00520572|565974714|FG002|Overall Study|Incorrect enrollment|1|||
156787410|NCT00520572|565974715|FG003|Overall Study|Incorrect enrollment|0|||
156787411|NCT00520572|565974716|FG004|Overall Study|Incorrect enrollment|1|||
156787412|NCT00520572|565974717|FG005|Overall Study|Incorrect enrollment|0|||
156787413|NCT00520572|565974712|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787414|NCT00520572|565974713|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
156787415|NCT00520572|565974714|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787416|NCT00520572|565974715|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787417|NCT00520572|565974716|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787418|NCT00520572|565974717|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787419|NCT00520572|565974712|FG000|Overall Study|Long break in taking Medication|0|||
156787420|NCT00520572|565974713|FG001|Overall Study|Long break in taking Medication|0|||
156869880|NCT01499355|566281040|FG001|Double-Blind Period|Death|1|||
156688221|NCT00892281|565602764|FG000|Overall Study|Missed multiple visits|1|||
156688222|NCT00892281|565602765|FG001|Overall Study|Missed multiple visits|0|||
156688223|NCT00892281|565602764|FG000|Overall Study|Missed visits rescheduled out of window|1|||
156688224|NCT00892281|565602765|FG001|Overall Study|Missed visits rescheduled out of window|0|||
156688225|NCT00892281|565602764|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
156688226|NCT00892281|565602765|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
156688227|NCT00892281|565602764|FG000|Overall Study|Subject had history of drug abuse|1|||
156688228|NCT00892281|565602765|FG001|Overall Study|Subject had history of drug abuse|0|||
156688229|NCT00892281|565602764|FG000|Overall Study|Rash on hand|1|||
156688230|NCT00892281|565602765|FG001|Overall Study|Rash on hand|0|||
156688231|NCT00892281|565602764|FG000|Overall Study|Visit 4 date out of window|1|||
156688232|NCT00892281|565602765|FG001|Overall Study|Visit 4 date out of window|0|||
156688233|NCT01534078|565602766|FG000|Overall Study|Death|1|||
156688234|NCT01534078|565602766|FG000|Overall Study|Withdrawal by Subject|1|||
156688235|NCT00986570|565602767|FG000|Overall Study|Lost to Follow-up|6|||
156688236|NCT00986570|565602767|FG000|Overall Study|Potential bias for objective assessment|1|||
156688237|NCT02225665|565602768|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
156688238|NCT02225665|565602769|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
156688239|NCT02225665|565602768|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
156688240|NCT02225665|565602769|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
156688241|NCT01355302|565602770|FG000|Phase 1b|Death|4|||
156688242|NCT01355302|565602771|FG001|Phase 1b|Death|0|||
156688243|NCT01355302|565602772|FG002|Phase 1b|Death|0|||
156688244|NCT01355302|565602770|FG000|Phase 1b|Study terminated by sponsor|2|||
156688245|NCT01355302|565602771|FG001|Phase 1b|Study terminated by sponsor|0|||
156688246|NCT01355302|565602772|FG002|Phase 1b|Study terminated by sponsor|0|||
156688247|NCT00263887|565602773|FG000|Overall Study|Withdrawal by Subject|1|||
156688248|NCT00263887|565602774|FG001|Overall Study|Withdrawal by Subject|1|||
156688249|NCT00263887|565602773|FG000|Overall Study|Lung transplantation|1|||
156688250|NCT00263887|565602774|FG001|Overall Study|Lung transplantation|2|||
156688251|NCT00263887|565602773|FG000|Overall Study|Too ill to attend visit|1|||
156688252|NCT00263887|565602774|FG001|Overall Study|Too ill to attend visit|0|||
156688253|NCT00263887|565602773|FG000|Overall Study|Adverse Event|0|||
156688254|NCT00263887|565602774|FG001|Overall Study|Adverse Event|2|||
156688255|NCT00263887|565602773|FG000|Overall Study|Disease progression|0|||
156688256|NCT00263887|565602774|FG001|Overall Study|Disease progression|1|||
156688257|NCT00263887|565602773|FG000|Overall Study|Lack of Efficacy|0|||
156688258|NCT00263887|565602774|FG001|Overall Study|Lack of Efficacy|1|||
156688259|NCT02274948|565602775|FG000|Overall Study|Lost to Follow-up|28|||
156688260|NCT02274948|565602776|FG001|Overall Study|Lost to Follow-up|25|||
156688261|NCT02274948|565602775|FG000|Overall Study|Withdrawal by Subject|64|||
156688262|NCT02274948|565602776|FG001|Overall Study|Withdrawal by Subject|58|||
156688263|NCT02274948|565602775|FG000|Overall Study|Stopped on family Practitioner advice|2|||
156688264|NCT02274948|565602776|FG001|Overall Study|Stopped on family Practitioner advice|5|||
156688265|NCT02274948|565602775|FG000|Overall Study|Left the area|4|||
156688266|NCT02274948|565602776|FG001|Overall Study|Left the area|3|||
156688267|NCT02502734|565602777|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
156688268|NCT02502734|565602778|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
156688269|NCT02502734|565602777|FG000|Washout Period|Adverse Event|1|||
156688270|NCT02502734|565602778|FG001|Washout Period|Adverse Event|0|||
156688271|NCT00865514|565602787|FG000|Overall Study|Infusion cost exceeded funding|2|||
156688272|NCT03095118|565602788|FG000|Overall Study|Adverse Event|1|||
156688273|NCT03095118|565602788|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
156688274|NCT02865395|565602789|FG000|Overall Study|Physician Decision|6|||
156688275|NCT02865395|565602790|FG001|Overall Study|Physician Decision|10|||
156688276|NCT02865395|565602791|FG002|Overall Study|Physician Decision|7|||
156688277|NCT03920280|565602792|FG000|Overall Study|Adverse Event|2|||
156688278|NCT03920280|565602793|FG001|Overall Study|Adverse Event|3|||
156688279|NCT03920280|565602792|FG000|Overall Study|Lost to Follow-up|0|||
156688280|NCT03920280|565602793|FG001|Overall Study|Lost to Follow-up|1|||
156688281|NCT03920280|565602792|FG000|Overall Study|Withdrawal by Subject|1|||
156688282|NCT03920280|565602793|FG001|Overall Study|Withdrawal by Subject|1|||
156688283|NCT03920280|565602792|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
156688284|NCT03920280|565602793|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
156688285|NCT00985231|565602796|FG000|Overall Study|ineligible|1|||
156688286|NCT00985231|565602797|FG001|Overall Study|ineligible|0|||
156688287|NCT00985231|565602796|FG000|Overall Study|Protocol Violation|1|||
156688288|NCT00985231|565602797|FG001|Overall Study|Protocol Violation|0|||
156688289|NCT00985231|565602796|FG000|Overall Study|Withdrawal by Subject|1|||
156688290|NCT00985231|565602797|FG001|Overall Study|Withdrawal by Subject|0|||
156688291|NCT00985231|565602796|FG000|Overall Study|Lost to Follow-up|0|||
156688292|NCT00985231|565602797|FG001|Overall Study|Lost to Follow-up|1|||
156688293|NCT00985231|565602796|FG000|Overall Study|Study related symptoms & complaints|0|||
156688294|NCT00985231|565602797|FG001|Overall Study|Study related symptoms & complaints|2|||
156688295|NCT04220775|565602800|FG000|Overall Study|Adverse Event|1|||
156688296|NCT04220775|565602801|FG001|Overall Study|Adverse Event|0|||
156688297|NCT04220775|565602800|FG000|Overall Study|Disease Progression|1|||
156688298|NCT04220775|565602801|FG001|Overall Study|Disease Progression|0|||
156869881|NCT01499355|566281041|FG002|Double-Blind Period|Death|0|||
156688299|NCT00436917|565602802|FG000|Overall Study|Withdrawal by Subject|13|||
156688300|NCT00436917|565602802|FG000|Overall Study|Adverse Event|2|||
156688301|NCT00436917|565602802|FG000|Overall Study|Physician Decision|1|||
156688302|NCT00436917|565602802|FG000|Overall Study|Death|1|||
156688303|NCT00436917|565602802|FG000|Overall Study|Lost to Follow-up|1|||
156688304|NCT00436917|565602802|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
156688305|NCT00436917|565602802|FG000|Overall Study|Increased creatinine|1|||
156688306|NCT00436917|565602802|FG000|Overall Study|Personal conflicts of patient|1|||
156688307|NCT02169791|565602803|FG000|Overall Study|Death|6|||
156688308|NCT02169791|565602803|FG000|Overall Study|patient withdrew consent|1|||
156688309|NCT02075606|565602807|FG000|Overall Study|Adverse Event|5|||
156688310|NCT02075606|565602807|FG000|Overall Study|Withdrawal by Subject|1|||
156688311|NCT02075606|565602807|FG000|Overall Study|Death|1|||
156688312|NCT02075606|565602807|FG000|Overall Study|Investigator's decision|1|||
156688313|NCT02075606|565602807|FG000|Overall Study|Symptom management|1|||
156688314|NCT02075606|565602807|FG000|Overall Study|Increasing Symptoms|1|||
156688315|NCT01857206|565602809|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
156688316|NCT01857206|565602810|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
156688317|NCT01857206|565602809|FG000|Overall Study|Lost to Follow-up|9|||
156688318|NCT01857206|565602810|FG001|Overall Study|Lost to Follow-up|6|||
156688319|NCT01857206|565602809|FG000|Overall Study|Unclassified|3|||
156688320|NCT01857206|565602810|FG001|Overall Study|Unclassified|3|||
156688321|NCT01857206|565602809|FG000|Overall Study|Withdrawal by Subject|1|||
156688322|NCT01857206|565602810|FG001|Overall Study|Withdrawal by Subject|0|||
156688323|NCT00271024|565602811|FG000|Overall Study|Lost Interest|3|||
156688324|NCT00271024|565602812|FG001|Overall Study|Lost Interest|4|||
156688325|NCT00271024|565602813|FG002|Overall Study|Lost Interest|2|||
156688326|NCT00271024|565602814|FG003|Overall Study|Lost Interest|3|||
156688327|NCT00271024|565602811|FG000|Overall Study|Unknown/Unspecified|11|||
156688328|NCT00271024|565602812|FG001|Overall Study|Unknown/Unspecified|11|||
156688329|NCT00271024|565602813|FG002|Overall Study|Unknown/Unspecified|8|||
156688330|NCT00271024|565602814|FG003|Overall Study|Unknown/Unspecified|4|||
156688331|NCT00271024|565602811|FG000|Overall Study|Protocol Violation|1|||
156688332|NCT00271024|565602812|FG001|Overall Study|Protocol Violation|6|||
156688333|NCT00271024|565602813|FG002|Overall Study|Protocol Violation|5|||
156688334|NCT00271024|565602814|FG003|Overall Study|Protocol Violation|11|||
156688335|NCT00271024|565602811|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
156688336|NCT00271024|565602812|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
156688337|NCT00271024|565602813|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
156688338|NCT00271024|565602814|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
156688339|NCT00271024|565602811|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
156688340|NCT00271024|565602812|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
156688341|NCT00271024|565602813|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
156688342|NCT00271024|565602814|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
156688343|NCT01261624|565602815|FG000|Week 0 to Week 12|Disease Progression|1|||
156688344|NCT01261624|565602816|FG001|Week 0 to Week 12|Disease Progression|1|||
156688345|NCT01261624|565602815|FG000|Week 0 to Week 12|Insufficient Response|0|||
156688346|NCT01261624|565602816|FG001|Week 0 to Week 12|Insufficient Response|2|||
156688347|NCT01261624|565602815|FG000|Week 13 to Week 24|Insufficient Response|0|||
156688348|NCT01261624|565602816|FG001|Week 13 to Week 24|Insufficient Response|1|||
156688349|NCT02094261|565602820|FG000|Overall Study|Death|24|||
156688350|NCT02094261|565602820|FG000|Overall Study|Lost to Follow-up|1|||
156688351|NCT02094261|565602820|FG000|Overall Study|Withdrawal by Subject|4|||
156688352|NCT02094261|565602820|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
156688353|NCT00860743|565602825|FG000|Overall Study|Withdrawal by Subject|3|||
156688354|NCT00860743|565602826|FG001|Overall Study|Withdrawal by Subject|0|||
156688355|NCT02776553|565602827|FG000|Overall Study|Lost to Follow-up|1|||
156688356|NCT02776553|565602828|FG001|Overall Study|Lost to Follow-up|0|||
156688357|NCT02776553|565602827|FG000|Overall Study|got liver transplant|1|||
156688358|NCT02776553|565602828|FG001|Overall Study|got liver transplant|2|||
156688359|NCT02776553|565602827|FG000|Overall Study|had other surgery|1|||
156688360|NCT02776553|565602828|FG001|Overall Study|had other surgery|0|||
156688361|NCT02776553|565602827|FG000|Overall Study|Protocol Violation|0|||
156688362|NCT02776553|565602828|FG001|Overall Study|Protocol Violation|1|||
156688363|NCT00268892|565602830|FG000|Overall Study|Adverse Event|14|||
156688364|NCT00268892|565602831|FG001|Overall Study|Adverse Event|17|||
156688365|NCT00268892|565602832|FG002|Overall Study|Adverse Event|20|||
156688366|NCT00268892|565602830|FG000|Overall Study|Lack of Efficacy|1|||
156688367|NCT00268892|565602831|FG001|Overall Study|Lack of Efficacy|3|||
156688368|NCT00268892|565602832|FG002|Overall Study|Lack of Efficacy|0|||
156688369|NCT00268892|565602830|FG000|Overall Study|Withdrawal by Subject|14|||
156688370|NCT00268892|565602831|FG001|Overall Study|Withdrawal by Subject|15|||
156688371|NCT00268892|565602832|FG002|Overall Study|Withdrawal by Subject|13|||
156688372|NCT00268892|565602830|FG000|Overall Study|Physician Decision|0|||
156688373|NCT00268892|565602831|FG001|Overall Study|Physician Decision|1|||
156688374|NCT00268892|565602832|FG002|Overall Study|Physician Decision|0|||
156688375|NCT00268892|565602830|FG000|Overall Study|Lost to Follow-up|5|||
156688376|NCT00268892|565602831|FG001|Overall Study|Lost to Follow-up|2|||
156688377|NCT00268892|565602832|FG002|Overall Study|Lost to Follow-up|4|||
156688378|NCT00268892|565602830|FG000|Overall Study|Protocol Violation|0|||
156688379|NCT00268892|565602831|FG001|Overall Study|Protocol Violation|1|||
156688380|NCT00268892|565602832|FG002|Overall Study|Protocol Violation|0|||
156688381|NCT00268892|565602830|FG000|Overall Study|Disease Progression|1|||
156688382|NCT00268892|565602831|FG001|Overall Study|Disease Progression|1|||
156688383|NCT00268892|565602832|FG002|Overall Study|Disease Progression|0|||
156688384|NCT00268892|565602830|FG000|Overall Study|Trial Site Closed|4|||
156688385|NCT00268892|565602831|FG001|Overall Study|Trial Site Closed|2|||
156688386|NCT00268892|565602832|FG002|Overall Study|Trial Site Closed|2|||
156688387|NCT01640184|565602833|FG000|Overall Study|Death|1|||
156688388|NCT01640184|565602834|FG001|Overall Study|Death|0|||
156688389|NCT01640184|565602835|FG002|Overall Study|Death|0|||
156688390|NCT01640184|565602833|FG000|Overall Study|Lost to Follow-up|4|||
156688391|NCT01640184|565602834|FG001|Overall Study|Lost to Follow-up|1|||
156688392|NCT01640184|565602835|FG002|Overall Study|Lost to Follow-up|0|||
156688393|NCT01640184|565602833|FG000|Overall Study|Physician Decision|3|||
156688394|NCT01640184|565602834|FG001|Overall Study|Physician Decision|0|||
156688395|NCT01640184|565602835|FG002|Overall Study|Physician Decision|0|||
156688396|NCT01640184|565602833|FG000|Overall Study|Withdrawal by Subject|0|||
156688397|NCT01640184|565602834|FG001|Overall Study|Withdrawal by Subject|1|||
156688398|NCT01640184|565602835|FG002|Overall Study|Withdrawal by Subject|1|||
156688399|NCT01640184|565602833|FG000|Overall Study|Protocol Violation|0|||
156688400|NCT01640184|565602834|FG001|Overall Study|Protocol Violation|0|||
156688401|NCT01640184|565602835|FG002|Overall Study|Protocol Violation|1|||
156688402|NCT02087176|565602836|FG000|Overall Study|Withdrawal by Subject|1|||
156688403|NCT02087176|565602836|FG000|Overall Study|Death|10|||
156688404|NCT02087176|565602836|FG000|Overall Study|Censored|19|||
156688405|NCT02087176|565602836|FG000|Overall Study|Study Terminated by Sponsor|2|||
156688406|NCT02927834|565602837|FG000|Overall Study|Lost to Follow-up|1|||
156688407|NCT02927834|565602838|FG001|Overall Study|Lost to Follow-up|2|||
156688408|NCT02927834|565602839|FG002|Overall Study|Lost to Follow-up|2|||
156688409|NCT03812991|565602841|FG000|Overall Study|Lost to Follow-up|3|||
156688410|NCT03812991|565602842|FG001|Overall Study|Lost to Follow-up|1|||
156688411|NCT01644149|565602843|FG000|Overall Study|Withdrawal by Subject|1|||
156688412|NCT01644149|565602844|FG001|Overall Study|Withdrawal by Subject|0|||
156688413|NCT01644149|565602843|FG000|Overall Study|Lost to Follow-up|3|||
156688414|NCT01644149|565602844|FG001|Overall Study|Lost to Follow-up|1|||
156688415|NCT04798482|565602845|FG000|Overall Study|Physician Decision|1|||
156688416|NCT04798482|565602845|FG000|Overall Study|Lost eligibility|1|||
156688417|NCT00690482|565602846|FG000|Overall Study|Adverse Event|2|||
156688418|NCT00690482|565602847|FG001|Overall Study|Adverse Event|1|||
156688419|NCT00690482|565602846|FG000|Overall Study|Incorrect enrolment|0|||
156688420|NCT00690482|565602847|FG001|Overall Study|Incorrect enrolment|1|||
156688421|NCT00690482|565602846|FG000|Overall Study|Study-specific discontinuation criteria|1|||
156688422|NCT00690482|565602847|FG001|Overall Study|Study-specific discontinuation criteria|0|||
156688423|NCT00690482|565602846|FG000|Overall Study|Intake of prohibited medicine|1|||
156688424|NCT00690482|565602847|FG001|Overall Study|Intake of prohibited medicine|0|||
156688425|NCT00690482|565602846|FG000|Overall Study|withdrew consent at rand.day|0|||
156688426|NCT00690482|565602847|FG001|Overall Study|withdrew consent at rand.day|1|||
156688427|NCT01253317|565602858|FG000|Overall Study|Adverse Event|2|||
156688428|NCT00749411|565602863|FG000|Overall Study|Adverse Event|0|||
156688429|NCT00749411|565602864|FG001|Overall Study|Adverse Event|2|||
156688430|NCT00749411|565602863|FG000|Overall Study|Lack of Efficacy|0|||
156688431|NCT00749411|565602864|FG001|Overall Study|Lack of Efficacy|1|||
156688432|NCT00749411|565602863|FG000|Overall Study|Protocol Violation|1|||
156688433|NCT00749411|565602864|FG001|Overall Study|Protocol Violation|1|||
156688434|NCT00749411|565602863|FG000|Overall Study|Protocol-defined stopping criteria|0|||
156688435|NCT00749411|565602864|FG001|Overall Study|Protocol-defined stopping criteria|1|||
156688436|NCT01507090|565602867|FG000|Overall Study|incomplete dataset|18|||
156688437|NCT01301482|565604339|FG000|Overall Study|Withdrawal by Subject|1|||
156688438|NCT05212883|565604352|FG000|Overall Study|Invalid test result|125|||
156688439|NCT02363439|565604353|FG000|Overall Study|Lack of Efficacy|4|||
156688440|NCT03573817|565604358|FG000|Overall Study|Adverse Event|0|||
156688441|NCT03573817|565604359|FG001|Overall Study|Adverse Event|2|||
156869882|NCT01499355|566281042|FG003|Double-Blind Period|Death|0|||
156869883|NCT01499355|566281039|FG000|Double-Blind Period|Investigator Decision|0|||
156688442|NCT03573817|565604358|FG000|Overall Study|Protocol Violation|0|||
156688443|NCT03573817|565604359|FG001|Overall Study|Protocol Violation|1|||
156688444|NCT03573817|565604358|FG000|Overall Study|Withdrawal by Subject|1|||
156688445|NCT03573817|565604359|FG001|Overall Study|Withdrawal by Subject|1|||
156688446|NCT01719562|565604362|FG000|Overall Study|Lost to Follow-up|1|||
156688447|NCT01719562|565604363|FG001|Overall Study|Lost to Follow-up|0|||
156688448|NCT01719562|565604362|FG000|Overall Study|Death|1|||
156688449|NCT01719562|565604363|FG001|Overall Study|Death|0|||
156688450|NCT01719562|565604362|FG000|Overall Study|New cancer diagnosis|1|||
156688451|NCT01719562|565604363|FG001|Overall Study|New cancer diagnosis|0|||
156688452|NCT00508027|565604364|FG000|Dose Level 1|Lost to Follow-up|4|||
156688453|NCT00508027|565604364|FG000|Dose Level 1|Withdrawal by Subject|2|||
156688454|NCT00508027|565604364|FG000|Dose Level 1|Physician Decision|2|||
156688455|NCT00508027|565604364|FG000|Dose Level 2|Lost to Follow-up|2|||
156688456|NCT00508027|565604364|FG000|Dose Level 2|Withdrawal by Subject|2|||
156688457|NCT02013531|565604367|FG000|Overall Study|Lost to Follow-up|3|||
156688458|NCT02013531|565604367|FG000|Overall Study|Met Withdrawal Criteria|1|||
156688459|NCT02013531|565604367|FG000|Overall Study|Withdrawal by Subject|1|||
156688460|NCT03554317|565604369|FG000|Overall Study|Withdrawal by Subject|1|||
156688461|NCT03554317|565604369|FG000|Overall Study|PSA Progression|3|||
156688462|NCT03554317|565604369|FG000|Overall Study|Radiographic Progression|4|||
156688463|NCT00939627|565604374|FG000|Overall Study|Disease Progression|16|||
156688464|NCT00939627|565604375|FG001|Overall Study|Disease Progression|12|||
156688465|NCT00939627|565604376|FG002|Overall Study|Disease Progression|0|||
156688466|NCT00939627|565604374|FG000|Overall Study|Adverse Event|6|||
156688467|NCT00939627|565604375|FG001|Overall Study|Adverse Event|7|||
156688468|NCT00939627|565604376|FG002|Overall Study|Adverse Event|0|||
156688469|NCT00939627|565604374|FG000|Overall Study|Death|0|||
156688470|NCT00939627|565604375|FG001|Overall Study|Death|2|||
156688471|NCT00939627|565604376|FG002|Overall Study|Death|0|||
156688472|NCT00939627|565604374|FG000|Overall Study|Withdrawal by Subject|2|||
156688473|NCT00939627|565604375|FG001|Overall Study|Withdrawal by Subject|4|||
156688474|NCT00939627|565604376|FG002|Overall Study|Withdrawal by Subject|0|||
156688475|NCT00939627|565604374|FG000|Overall Study|Other complicating disease|1|||
156688476|NCT00939627|565604375|FG001|Overall Study|Other complicating disease|1|||
156688477|NCT00939627|565604376|FG002|Overall Study|Other complicating disease|0|||
156688478|NCT00939627|565604374|FG000|Overall Study|Not compliant|2|||
156688479|NCT00939627|565604375|FG001|Overall Study|Not compliant|0|||
156688480|NCT00939627|565604376|FG002|Overall Study|Not compliant|0|||
156688481|NCT00939627|565604374|FG000|Overall Study|No off-tx reason given|0|||
156688482|NCT00939627|565604375|FG001|Overall Study|No off-tx reason given|2|||
156688483|NCT00939627|565604376|FG002|Overall Study|No off-tx reason given|0|||
156688484|NCT00537199|565604381|FG000|Overall Study|Study Terminated|1|||
156688485|NCT00467831|565604384|FG000|Overall Study|Death|2|||
156688486|NCT00467831|565604384|FG000|Overall Study|Withdrawal by Subject|1|||
156688487|NCT01832402|565604387|FG000|Overall Study|Lost to Follow-up|2|||
156688488|NCT01832402|565604388|FG001|Overall Study|Lost to Follow-up|0|||
156688489|NCT01832402|565604387|FG000|Overall Study|Withdrawal by Subject|3|||
156688490|NCT01832402|565604388|FG001|Overall Study|Withdrawal by Subject|3|||
156688491|NCT01832402|565604387|FG000|Overall Study|Declining Performance status|2|||
156688492|NCT01832402|565604388|FG001|Overall Study|Declining Performance status|1|||
156688493|NCT00612677|565604389|FG000|Overall Study|study closed before treatment started|1|||
156688494|NCT01198873|565604390|FG000|Overall Study|Adverse Event|4|||
156688495|NCT01198873|565604391|FG001|Overall Study|Adverse Event|7|||
156688496|NCT01198873|565604390|FG000|Overall Study|Study closure|29|||
156688497|NCT01198873|565604391|FG001|Overall Study|Study closure|23|||
156869884|NCT01499355|566281040|FG001|Double-Blind Period|Investigator Decision|0|||
156869885|NCT01499355|566281041|FG002|Double-Blind Period|Investigator Decision|3|||
156869886|NCT01499355|566281042|FG003|Double-Blind Period|Investigator Decision|3|||
156869887|NCT01499355|566281039|FG000|Double-Blind Period|Consent Withdrawn|0|||
156869888|NCT01499355|566281040|FG001|Double-Blind Period|Consent Withdrawn|0|||
156869889|NCT01499355|566281041|FG002|Double-Blind Period|Consent Withdrawn|1|||
156869890|NCT01499355|566281042|FG003|Double-Blind Period|Consent Withdrawn|2|||
156869891|NCT01499355|566281039|FG000|Double-Blind Period|Lost to Follow-up|0|||
156869892|NCT01499355|566281040|FG001|Double-Blind Period|Lost to Follow-up|1|||
156869893|NCT01499355|566281041|FG002|Double-Blind Period|Lost to Follow-up|0|||
156869894|NCT01499355|566281042|FG003|Double-Blind Period|Lost to Follow-up|0|||
156869895|NCT02420821|566281044|FG000|Overall Study|Lost to Follow-up|6|||
156869896|NCT02420821|566281045|FG001|Overall Study|Lost to Follow-up|6|||
156869897|NCT02420821|566281044|FG000|Overall Study|Non-compliance|0|||
156869898|NCT02420821|566281045|FG001|Overall Study|Non-compliance|2|||
156869899|NCT02420821|566281044|FG000|Overall Study|Physician Decision|6|||
156869900|NCT02420821|566281045|FG001|Overall Study|Physician Decision|2|||
156869901|NCT02420821|566281044|FG000|Overall Study|Withdrawal by Subject|32|||
156869902|NCT02420821|566281045|FG001|Overall Study|Withdrawal by Subject|25|||
156688498|NCT01198873|565604390|FG000|Overall Study|Other than above|4|||
156869903|NCT02420821|566281044|FG000|Overall Study|Death|270|||
156688499|NCT01198873|565604391|FG001|Overall Study|Other than above|2|||
156688500|NCT03827018|565604393|FG000|Overall Study|Adverse Event|1|||
156688501|NCT03827018|565604394|FG001|Overall Study|Adverse Event|0|||
156869904|NCT02420821|566281045|FG001|Overall Study|Death|263|||
156688502|NCT03827018|565604393|FG000|Overall Study|Withdrawal by Subject|2|||
156688503|NCT03827018|565604394|FG001|Overall Study|Withdrawal by Subject|2|||
156688504|NCT03827018|565604393|FG000|Overall Study|Lack of Efficacy|0|||
156688505|NCT03827018|565604394|FG001|Overall Study|Lack of Efficacy|1|||
156688506|NCT01998243|565604395|FG000|Overall Study|Pregnancy|0|||
156688507|NCT01998243|565604396|FG001|Overall Study|Pregnancy|1|||
156688508|NCT01998243|565604395|FG000|Overall Study|Protocol Violation|5|||
156869905|NCT02420821|566281044|FG000|Overall Study|Study Terminated By Sponsor|145|||
156869906|NCT02420821|566281045|FG001|Overall Study|Study Terminated By Sponsor|149|||
156688509|NCT01998243|565604396|FG001|Overall Study|Protocol Violation|2|||
156688510|NCT01998243|565604395|FG000|Overall Study|Withdrawal by Subject|3|||
156688511|NCT01998243|565604396|FG001|Overall Study|Withdrawal by Subject|4|||
156688512|NCT02492841|565604404|FG000|Overall Study|Lost to Follow-up|34|||
156688513|NCT02492841|565604405|FG001|Overall Study|Lost to Follow-up|31|||
156688514|NCT02492841|565604406|FG002|Overall Study|Lost to Follow-up|35|||
156688515|NCT00479388|565604407|FG000|Overall Study|Adverse Event|90|||
156688516|NCT00479388|565604408|FG001|Overall Study|Adverse Event|45|||
156688517|NCT00479388|565604407|FG000|Overall Study|Lost to Follow-up|0|||
156688518|NCT00479388|565604408|FG001|Overall Study|Lost to Follow-up|2|||
156688519|NCT00479388|565604407|FG000|Overall Study|Protocol Violation|10|||
156688520|NCT00479388|565604408|FG001|Overall Study|Protocol Violation|9|||
156688521|NCT00479388|565604407|FG000|Overall Study|Withdrawal by Subject|32|||
156688522|NCT00479388|565604408|FG001|Overall Study|Withdrawal by Subject|17|||
156688523|NCT01876368|565604409|FG000|Overall Study|Adverse Event|2|||
156688524|NCT01876368|565604410|FG001|Overall Study|Adverse Event|5|||
156688525|NCT01876368|565604409|FG000|Overall Study|Lack of Efficacy|1|||
156688526|NCT01876368|565604410|FG001|Overall Study|Lack of Efficacy|0|||
156688527|NCT01876368|565604409|FG000|Overall Study|Lost to Follow-up|0|||
156688528|NCT01876368|565604410|FG001|Overall Study|Lost to Follow-up|1|||
156688529|NCT01876368|565604409|FG000|Overall Study|Non-compliance with study treatment|0|||
156688530|NCT01876368|565604410|FG001|Overall Study|Non-compliance with study treatment|1|||
156688531|NCT01876368|565604409|FG000|Overall Study|Physician Decision|0|||
156688532|NCT01876368|565604410|FG001|Overall Study|Physician Decision|2|||
156688533|NCT01876368|565604409|FG000|Overall Study|Protocol deviation|3|||
156688534|NCT01876368|565604410|FG001|Overall Study|Protocol deviation|3|||
156688535|NCT01876368|565604409|FG000|Overall Study|Subject/guardian decision|3|||
156688536|NCT01876368|565604410|FG001|Overall Study|Subject/guardian decision|1|||
156688537|NCT02563769|565604411|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
156688538|NCT02563769|565604412|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
156688539|NCT02563769|565604413|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
156688540|NCT01192399|565604417|FG000|Overall Study|Lack of Efficacy|2|||
156688541|NCT01930175|565604418|FG000|Core Study|Lost to Follow-up|0|||
156688542|NCT01930175|565604419|FG001|Core Study|Lost to Follow-up|1|||
156688543|NCT01930175|565604420|FG002|Core Study|Lost to Follow-up|0|||
156688544|NCT01930175|565604418|FG000|Core Study|Adverse Event|0|||
156688545|NCT01930175|565604419|FG001|Core Study|Adverse Event|0|||
156688546|NCT01930175|565604420|FG002|Core Study|Adverse Event|1|||
156688547|NCT02820740|565604421|FG000|Overall Study|Did not have procedure|2|||
156688548|NCT00890552|565604422|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
156688549|NCT00890552|565604422|FG000|On-treatment|Early prog disease/ death|10|||
156688550|NCT03903159|565604423|FG000|Overall Study|Discharged with Staff Approval|2|||
156688551|NCT03903159|565604423|FG000|Overall Study|Discharged at Staff Request|2|||
156688552|NCT03903159|565604423|FG000|Overall Study|Discharged Against Staff Advice|1|||
156688553|NCT02244424|565604428|FG000|Overall Study|Lost to Follow-up|20|||
156688554|NCT02244424|565604429|FG001|Overall Study|Lost to Follow-up|10|||
156688555|NCT04117945|565604430|FG000|Overall Study|Death|1|||
156688556|NCT04117945|565604431|FG001|Overall Study|Death|0|||
156688557|NCT04117945|565604430|FG000|Overall Study|Withdrawal by Subject|3|||
156688558|NCT04117945|565604431|FG001|Overall Study|Withdrawal by Subject|1|||
156787421|NCT00520572|565974714|FG002|Overall Study|Long break in taking Medication|0|||
156787422|NCT00520572|565974715|FG003|Overall Study|Long break in taking Medication|1|||
156787423|NCT00520572|565974716|FG004|Overall Study|Long break in taking Medication|0|||
156787424|NCT00520572|565974717|FG005|Overall Study|Long break in taking Medication|0|||
156787425|NCT00520572|565974712|FG000|Overall Study|Did not receive Treatment|1|||
156688559|NCT04117945|565604430|FG000|Overall Study|Disease Progression|0|||
156688560|NCT04117945|565604431|FG001|Overall Study|Disease Progression|2|||
156688561|NCT04117945|565604430|FG000|Overall Study|Ineligible|8|||
156688562|NCT04117945|565604431|FG001|Overall Study|Ineligible|7|||
156787426|NCT00520572|565974713|FG001|Overall Study|Did not receive Treatment|0|||
156787427|NCT00520572|565974714|FG002|Overall Study|Did not receive Treatment|1|||
156787428|NCT00520572|565974715|FG003|Overall Study|Did not receive Treatment|0|||
156688563|NCT00562120|565604435|FG000|First Intervention Period|Adverse Event|1|||
156688564|NCT00562120|565604436|FG001|First Intervention Period|Adverse Event|0|||
156688565|NCT00562120|565604437|FG002|First Intervention Period|Adverse Event|0|||
156688566|NCT00562120|565604438|FG003|First Intervention Period|Adverse Event|0|||
156688567|NCT00562120|565604435|FG000|First Intervention Period|Randomized but not Treated|1|||
156688568|NCT00562120|565604436|FG001|First Intervention Period|Randomized but not Treated|0|||
156688569|NCT00562120|565604437|FG002|First Intervention Period|Randomized but not Treated|0|||
156787429|NCT00520572|565974716|FG004|Overall Study|Did not receive Treatment|0|||
156787430|NCT00520572|565974717|FG005|Overall Study|Did not receive Treatment|0|||
156787431|NCT03548415|565974720|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
156688570|NCT00562120|565604438|FG003|First Intervention Period|Randomized but not Treated|0|||
156688571|NCT02148445|565604439|FG000|Overall Study|Death|1|||
156688572|NCT02148445|565604440|FG001|Overall Study|Death|3|||
156688573|NCT03450629|565604441|FG000|Overall Study|Adverse Event|15|||
156688574|NCT03450629|565604442|FG001|Overall Study|Adverse Event|14|||
156688575|NCT03450629|565604441|FG000|Overall Study|Physician Decision|2|||
156688576|NCT03450629|565604442|FG001|Overall Study|Physician Decision|2|||
156869907|NCT02420821|566281044|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
156869908|NCT02420821|566281045|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
156688577|NCT03450629|565604441|FG000|Overall Study|Lack of Efficacy|2|||
156688578|NCT03450629|565604442|FG001|Overall Study|Lack of Efficacy|0|||
156688579|NCT03450629|565604441|FG000|Overall Study|Lost to Follow-up|4|||
156869909|NCT02420821|566281044|FG000|Overall Study|Adverse Event|0|||
156869910|NCT02420821|566281045|FG001|Overall Study|Adverse Event|1|||
156869911|NCT02420821|566281044|FG000|Overall Study|Protinuria|0|||
156869912|NCT02420821|566281045|FG001|Overall Study|Protinuria|1|||
156869913|NCT02420821|566281044|FG000|Overall Study|Progressive Disease|1|||
156869914|NCT02420821|566281045|FG001|Overall Study|Progressive Disease|1|||
156869915|NCT02420821|566281044|FG000|Overall Study|Disease Progression|0|||
156869916|NCT02420821|566281045|FG001|Overall Study|Disease Progression|1|||
156869917|NCT02420821|566281044|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
156869918|NCT02420821|566281045|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
156869919|NCT02745119|566281054|FG000|Overall Study|Adverse Event|1|||
156869920|NCT02745119|566281055|FG001|Overall Study|Adverse Event|0|||
156688580|NCT03450629|565604442|FG001|Overall Study|Lost to Follow-up|2|||
156688581|NCT03450629|565604441|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156688582|NCT03450629|565604442|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
156688583|NCT03450629|565604441|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156688584|NCT03450629|565604442|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156688585|NCT03450629|565604441|FG000|Overall Study|Protocol Violation|11|||
156688586|NCT03450629|565604442|FG001|Overall Study|Protocol Violation|8|||
156688587|NCT03450629|565604441|FG000|Overall Study|Withdrawal by Subject|12|||
156688588|NCT03450629|565604442|FG001|Overall Study|Withdrawal by Subject|6|||
156688589|NCT03366194|565604443|FG000|Overall Study|Lost to Follow-up|2|||
156688590|NCT02093923|565604444|FG000|Overall Study|Lost to Follow-up|0|||
156688591|NCT02093923|565604445|FG001|Overall Study|Lost to Follow-up|0|||
156688592|NCT02093923|565604446|FG002|Overall Study|Lost to Follow-up|0|||
156688593|NCT02093923|565604447|FG003|Overall Study|Lost to Follow-up|1|||
156688594|NCT02093923|565604448|FG004|Overall Study|Lost to Follow-up|0|||
156869921|NCT02745119|566281056|FG002|Overall Study|Adverse Event|1|||
156869922|NCT02745119|566281057|FG003|Overall Study|Adverse Event|3|||
156869923|NCT02745119|566281054|FG000|Overall Study|Death|3|||
156869924|NCT02745119|566281055|FG001|Overall Study|Death|3|||
156869925|NCT02745119|566281056|FG002|Overall Study|Death|0|||
156869926|NCT02745119|566281057|FG003|Overall Study|Death|4|||
156869927|NCT02745119|566281054|FG000|Overall Study|Lost to Follow-up|0|||
156869928|NCT02745119|566281055|FG001|Overall Study|Lost to Follow-up|0|||
156869929|NCT02745119|566281056|FG002|Overall Study|Lost to Follow-up|0|||
156869930|NCT02745119|566281057|FG003|Overall Study|Lost to Follow-up|1|||
156688595|NCT02093923|565604444|FG000|Overall Study|Screen failure after randomization|0|||
156688596|NCT02093923|565604445|FG001|Overall Study|Screen failure after randomization|0|||
156688597|NCT02093923|565604446|FG002|Overall Study|Screen failure after randomization|0|||
156688598|NCT02093923|565604447|FG003|Overall Study|Screen failure after randomization|1|||
156688599|NCT02093923|565604448|FG004|Overall Study|Screen failure after randomization|0|||
156688600|NCT03438006|565604449|FG000|Overall Study|Adverse Event|1|||
156688601|NCT03438006|565604449|FG000|Overall Study|Lost to Follow-up|67|||
156688602|NCT03438006|565604449|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
156688603|NCT03438006|565604449|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
156688604|NCT01181531|565604450|FG000|Overall Study|Other|17|||
156688605|NCT01181531|565604451|FG001|Overall Study|Other|12|||
156688606|NCT01181531|565604450|FG000|Overall Study|Partial consent by subject withdrawn|0|||
156688607|NCT01181531|565604451|FG001|Overall Study|Partial consent by subject withdrawn|1|||
156688608|NCT01181531|565604450|FG000|Overall Study|Physician Decision|3|||
156688609|NCT01181531|565604451|FG001|Overall Study|Physician Decision|1|||
156688610|NCT01181531|565604450|FG000|Overall Study|Noncompliance|2|||
156688611|NCT01181531|565604451|FG001|Overall Study|Noncompliance|2|||
156869931|NCT02745119|566281054|FG000|Overall Study|Protocol Deviation|0|||
156869932|NCT02745119|566281055|FG001|Overall Study|Protocol Deviation|0|||
156869933|NCT02745119|566281056|FG002|Overall Study|Protocol Deviation|0|||
156869934|NCT02745119|566281057|FG003|Overall Study|Protocol Deviation|1|||
156869935|NCT02745119|566281054|FG000|Overall Study|Withdrawal by Subject|7|||
156330015|NCT00004635|564308746|FG001|Period One|health problem|1|||
156688612|NCT01181531|565604450|FG000|Overall Study|Ineligibility determined|1|||
156688613|NCT01181531|565604451|FG001|Overall Study|Ineligibility determined|2|||
156688614|NCT01181531|565604450|FG000|Overall Study|Protocol Specified Criteria|15|||
156688615|NCT01181531|565604451|FG001|Overall Study|Protocol Specified Criteria|8|||
156688616|NCT01181531|565604450|FG000|Overall Study|Pregnancy|0|||
156688617|NCT01181531|565604451|FG001|Overall Study|Pregnancy|1|||
156869936|NCT02745119|566281055|FG001|Overall Study|Withdrawal by Subject|15|||
156869937|NCT02745119|566281056|FG002|Overall Study|Withdrawal by Subject|8|||
156869938|NCT02745119|566281057|FG003|Overall Study|Withdrawal by Subject|14|||
156869939|NCT02745119|566281054|FG000|Overall Study|Study Terminated by Sponsor|134|||
156688618|NCT01181531|565604450|FG000|Overall Study|Withdrawal by Subject|8|||
156688619|NCT01181531|565604451|FG001|Overall Study|Withdrawal by Subject|7|||
156688620|NCT01181531|565604450|FG000|Overall Study|Protocol Violation|6|||
156688621|NCT01181531|565604451|FG001|Overall Study|Protocol Violation|6|||
156688622|NCT01181531|565604450|FG000|Overall Study|Death|9|||
156688623|NCT01181531|565604451|FG001|Overall Study|Death|12|||
156688624|NCT01181531|565604450|FG000|Overall Study|Adverse Event|0|||
156688625|NCT01181531|565604451|FG001|Overall Study|Adverse Event|1|||
156688626|NCT02737592|565604452|FG000|Overall Study|Withdrawal by Subject|1|||
156688627|NCT02792218|565604453|FG000|Overall Study|Patient/guardian decision|15|||
156688628|NCT02792218|565604454|FG001|Overall Study|Patient/guardian decision|42|||
156688629|NCT02792218|565604453|FG000|Overall Study|Adverse Event|15|||
156688630|NCT02792218|565604454|FG001|Overall Study|Adverse Event|14|||
156688631|NCT02792218|565604453|FG000|Overall Study|Lost to Follow-up|10|||
156688632|NCT02792218|565604454|FG001|Overall Study|Lost to Follow-up|5|||
156688633|NCT02792218|565604453|FG000|Overall Study|Lack of Efficacy|1|||
156688634|NCT02792218|565604454|FG001|Overall Study|Lack of Efficacy|12|||
156688635|NCT02792218|565604453|FG000|Overall Study|Physician Decision|4|||
156688636|NCT02792218|565604454|FG001|Overall Study|Physician Decision|4|||
156688637|NCT02792218|565604453|FG000|Overall Study|Protocol deviation|3|||
156688638|NCT02792218|565604454|FG001|Overall Study|Protocol deviation|2|||
156688639|NCT02792218|565604453|FG000|Overall Study|New therapy for study indication|0|||
156688640|NCT02792218|565604454|FG001|Overall Study|New therapy for study indication|1|||
156688641|NCT02792218|565604453|FG000|Overall Study|Non-compliance with study treatment|0|||
156688642|NCT02792218|565604454|FG001|Overall Study|Non-compliance with study treatment|1|||
156688643|NCT02792218|565604453|FG000|Overall Study|Pregnancy|1|||
156688644|NCT02792218|565604454|FG001|Overall Study|Pregnancy|0|||
156688645|NCT03123783|565604455|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688646|NCT03123783|565604456|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
156688647|NCT03123783|565604457|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688648|NCT03123783|565604458|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688649|NCT03123783|565604459|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688650|NCT03123783|565604460|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688651|NCT03123783|565604461|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688652|NCT03123783|565604455|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
156688653|NCT03123783|565604456|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
156688654|NCT03123783|565604457|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
156688655|NCT03123783|565604458|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
156688656|NCT03123783|565604459|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
156688657|NCT03123783|565604460|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
156688658|NCT03123783|565604461|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
156688659|NCT03123783|565604455|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
156688660|NCT03123783|565604456|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
156688661|NCT03123783|565604457|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
156688662|NCT03123783|565604458|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
156688663|NCT03123783|565604459|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
156688664|NCT03123783|565604460|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
156688665|NCT03123783|565604461|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
156688666|NCT03123783|565604455|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688667|NCT03123783|565604456|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688668|NCT03123783|565604457|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688669|NCT03123783|565604458|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688670|NCT03123783|565604459|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
156688671|NCT03123783|565604460|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688672|NCT03123783|565604461|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688673|NCT00955721|565604464|FG000|Overall Study|Physician Decision|1|||
156688674|NCT00955721|565604465|FG001|Overall Study|Physician Decision|0|||
156688675|NCT00955721|565604464|FG000|Overall Study|Death|1|||
156688676|NCT00955721|565604465|FG001|Overall Study|Death|0|||
156688677|NCT00955721|565604464|FG000|Overall Study|Withdrawal by Subject|1|||
156688678|NCT00955721|565604465|FG001|Overall Study|Withdrawal by Subject|0|||
156688679|NCT03183141|565604467|FG000|Overall Study|Withdrawal by Subject|2|||
156688680|NCT03183141|565604468|FG001|Overall Study|Withdrawal by Subject|4|||
156688681|NCT03183141|565604467|FG000|Overall Study|Death|0|||
156688682|NCT03183141|565604468|FG001|Overall Study|Death|8|||
156688683|NCT02953678|565604470|FG000|Overall Study|Adverse Event|20|||
156688684|NCT02953678|565604470|FG000|Overall Study|Death|7|||
156688685|NCT02953678|565604470|FG000|Overall Study|Physician Decision|23|||
156688686|NCT02953678|565604470|FG000|Overall Study|Progressive Disease of GVHD|7|||
156688687|NCT02953678|565604470|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
156688688|NCT02953678|565604470|FG000|Overall Study|Withdrawal by participant|3|||
156688689|NCT02953678|565604470|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
156688690|NCT02953678|565604470|FG000|Overall Study|Participants were transferred to commercial product.|3|||
156688691|NCT04034355|565604473|FG000|Overall Study|Study terminated by Sponsor|10|||
156688692|NCT04034355|565604474|FG001|Overall Study|Study terminated by Sponsor|17|||
156688693|NCT04034355|565604473|FG000|Overall Study|Withdrawal by Subject|12|||
156688694|NCT04034355|565604474|FG001|Overall Study|Withdrawal by Subject|11|||
156688695|NCT04034355|565604473|FG000|Overall Study|Site terminated by Sponsor|4|||
156688696|NCT04034355|565604474|FG001|Overall Study|Site terminated by Sponsor|5|||
156688697|NCT04034355|565604473|FG000|Overall Study|Adverse Event|2|||
156688698|NCT04034355|565604474|FG001|Overall Study|Adverse Event|0|||
156688699|NCT04034355|565604473|FG000|Overall Study|Death|1|||
156688700|NCT04034355|565604474|FG001|Overall Study|Death|1|||
156688701|NCT04034355|565604473|FG000|Overall Study|Not reported|2|||
156688702|NCT04034355|565604474|FG001|Overall Study|Not reported|0|||
156688703|NCT04034355|565604473|FG000|Overall Study|Lost to Follow-up|1|||
156688704|NCT04034355|565604474|FG001|Overall Study|Lost to Follow-up|0|||
156688705|NCT04034355|565604473|FG000|Overall Study|Physician Decision|1|||
156688706|NCT04034355|565604474|FG001|Overall Study|Physician Decision|0|||
156688707|NCT04034355|565604473|FG000|Overall Study|Protocol Violation|0|||
156688708|NCT04034355|565604474|FG001|Overall Study|Protocol Violation|1|||
156688709|NCT04034355|565604473|FG000|Overall Study|Progressive disease|1|||
156787432|NCT03548415|565974721|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
156787433|NCT03548415|565974722|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
156787434|NCT03548415|565974723|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
156787435|NCT03548415|565974724|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
156787436|NCT04605588|565974726|FG000|Overall Study|Withdrawal by Subject|1|||
156787437|NCT04605588|565974727|FG001|Overall Study|Withdrawal by Subject|0|||
156787438|NCT01230814|565974728|FG000|Overall Study|Lost to Follow-up|11|||
156787439|NCT01230814|565974729|FG001|Overall Study|Lost to Follow-up|3|||
156787440|NCT01230814|565974728|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
156787441|NCT01230814|565974729|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
156688710|NCT04034355|565604474|FG001|Overall Study|Progressive disease|0|||
156688711|NCT02284347|565606049|FG000|Overall Study|Lost to Follow-up|2|||
156688712|NCT02284347|565606049|FG000|Overall Study|Withdrawn prior to treatment|1|||
156688713|NCT00544817|565606052|FG000|Combined Modality|Lack of Efficacy|2|||
156688714|NCT00544817|565606052|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
156688715|NCT00544817|565606052|FG000|Combined Modality|Adverse Event|2|||
156688716|NCT00544817|565606052|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
156688717|NCT00544817|565606052|FG000|No Treatment Interval|Lack of Efficacy|8|||
156688718|NCT00544817|565606052|FG000|No Treatment Interval|Physician Decision|3|||
156688719|NCT00544817|565606052|FG000|No Treatment Interval|Adverse Event|1|||
156688720|NCT00544817|565606052|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
156688721|NCT00544817|565606052|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
156688722|NCT00544817|565606052|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
156688723|NCT02999984|565606053|FG000|Overall Study|Treatment Failure|1|||
156787442|NCT01803737|565974732|FG000|Overall Study|Lack of Time|1|||
156787443|NCT01803737|565974733|FG001|Overall Study|Lack of Time|0|||
156787444|NCT01803737|565974732|FG000|Overall Study|Medical Reason|0|||
156787445|NCT01803737|565974733|FG001|Overall Study|Medical Reason|1|||
156688724|NCT00754013|565606056|FG000|Overall Study|Lost to Follow-up|1|||
156688725|NCT00754013|565606057|FG001|Overall Study|Lost to Follow-up|1|||
156688726|NCT00754013|565606056|FG000|Overall Study|didn't return after study termed|3|||
156688727|NCT00754013|565606057|FG001|Overall Study|didn't return after study termed|4|||
156688728|NCT02813421|565606058|FG000|Overall Study|Withdrawal by Subject|1|||
156787446|NCT01803737|565974732|FG000|Overall Study|Lost to Follow-up|0|||
156869940|NCT02745119|566281055|FG001|Overall Study|Study Terminated by Sponsor|252|||
156869941|NCT02745119|566281056|FG002|Overall Study|Study Terminated by Sponsor|135|||
156869942|NCT02745119|566281057|FG003|Overall Study|Study Terminated by Sponsor|251|||
156869943|NCT02745119|566281054|FG000|Overall Study|Physician Decision|0|||
156688729|NCT02813421|565606059|FG001|Overall Study|Withdrawal by Subject|2|||
156688730|NCT02813421|565606058|FG000|Overall Study|Lost to Follow-up|1|||
156688731|NCT02813421|565606059|FG001|Overall Study|Lost to Follow-up|1|||
156787447|NCT01803737|565974733|FG001|Overall Study|Lost to Follow-up|2|||
156787448|NCT01748552|565974734|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
156787449|NCT01748552|565974735|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
156787450|NCT01748552|565974736|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
156869944|NCT02745119|566281055|FG001|Overall Study|Physician Decision|2|||
156688732|NCT04213209|565606066|FG000|Overall Study|Protocol Violation|1|||
156688733|NCT04213209|565606067|FG001|Overall Study|Protocol Violation|0|||
156688734|NCT04213209|565606068|FG002|Overall Study|Protocol Violation|0|||
156688735|NCT04213209|565606069|FG003|Overall Study|Protocol Violation|0|||
156688736|NCT04213209|565606070|FG004|Overall Study|Protocol Violation|0|||
156688737|NCT04213209|565606071|FG005|Overall Study|Protocol Violation|0|||
156688738|NCT02129647|565606081|FG000|Overall Study|Adverse Event|2|||
156688739|NCT02129647|565606081|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
156688740|NCT01570283|565606083|FG000|Cohort 1: Dose Level 1|Death|0|||
156688741|NCT01570283|565606084|FG001|Cohort 1: Dose Level 1|Death|1|||
156688742|NCT01570283|565606085|FG002|Cohort 1: Dose Level 1|Death|0|||
156688743|NCT01570283|565606086|FG003|Cohort 1: Dose Level 1|Death|0|||
156688744|NCT01570283|565606087|FG004|Cohort 1: Dose Level 1|Death|0|||
156688745|NCT01570283|565606088|FG005|Cohort 1: Dose Level 1|Death|0|||
156688746|NCT01570283|565606083|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688747|NCT01570283|565606084|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
156688748|NCT01570283|565606085|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688749|NCT01570283|565606086|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688750|NCT01570283|565606087|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688751|NCT01570283|565606088|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688752|NCT01570283|565606083|FG000|Cohort 2: Dose Level 2|Death|0|||
156688753|NCT01570283|565606084|FG001|Cohort 2: Dose Level 2|Death|0|||
156688754|NCT01570283|565606085|FG002|Cohort 2: Dose Level 2|Death|1|||
156688755|NCT01570283|565606086|FG003|Cohort 2: Dose Level 2|Death|0|||
156688756|NCT01570283|565606087|FG004|Cohort 2: Dose Level 2|Death|0|||
156688757|NCT01570283|565606088|FG005|Cohort 2: Dose Level 2|Death|0|||
156688758|NCT01570283|565606083|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688759|NCT01570283|565606084|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688760|NCT01570283|565606085|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688761|NCT01570283|565606086|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
156688762|NCT01570283|565606087|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688763|NCT01570283|565606088|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688764|NCT01570283|565606083|FG000|Cohort 3: Dose Level 3|Death|0|||
156688765|NCT01570283|565606084|FG001|Cohort 3: Dose Level 3|Death|0|||
156688766|NCT01570283|565606085|FG002|Cohort 3: Dose Level 3|Death|0|||
156688767|NCT01570283|565606086|FG003|Cohort 3: Dose Level 3|Death|0|||
156688768|NCT01570283|565606087|FG004|Cohort 3: Dose Level 3|Death|0|||
156688769|NCT01570283|565606088|FG005|Cohort 3: Dose Level 3|Death|1|||
156688770|NCT01570283|565606083|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688771|NCT01570283|565606084|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688772|NCT01570283|565606085|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688773|NCT01570283|565606086|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688774|NCT01570283|565606087|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688775|NCT01570283|565606088|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
156688776|NCT02017860|565606089|FG000|Overall Study|Adverse Event|1|||
156688777|NCT02017860|565606089|FG000|Overall Study|Withdrawal by Subject|1|||
156688778|NCT03756883|565606090|FG000|Overall Study|Adverse Event|2|||
156688779|NCT03756883|565606091|FG001|Overall Study|Adverse Event|2|||
156688780|NCT03756883|565606092|FG002|Overall Study|Adverse Event|2|||
156688781|NCT03756883|565606090|FG000|Overall Study|Lack of Efficacy|0|||
156688782|NCT03756883|565606091|FG001|Overall Study|Lack of Efficacy|1|||
156688783|NCT03756883|565606092|FG002|Overall Study|Lack of Efficacy|2|||
156688784|NCT03756883|565606090|FG000|Overall Study|Lost to Follow-up|3|||
156688785|NCT03756883|565606091|FG001|Overall Study|Lost to Follow-up|3|||
156688786|NCT03756883|565606092|FG002|Overall Study|Lost to Follow-up|0|||
156688787|NCT03756883|565606090|FG000|Overall Study|Protocol Violation|2|||
156688788|NCT03756883|565606091|FG001|Overall Study|Protocol Violation|0|||
156688789|NCT03756883|565606092|FG002|Overall Study|Protocol Violation|1|||
156688790|NCT03756883|565606090|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
156688791|NCT03756883|565606091|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
156688792|NCT03756883|565606092|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
156688793|NCT03756883|565606090|FG000|Overall Study|Withdrawal by Subject|4|||
156688794|NCT03756883|565606091|FG001|Overall Study|Withdrawal by Subject|1|||
156688795|NCT03756883|565606092|FG002|Overall Study|Withdrawal by Subject|0|||
156688796|NCT03756883|565606090|FG000|Overall Study|Other Reasons|2|||
156688797|NCT03756883|565606091|FG001|Overall Study|Other Reasons|4|||
156787451|NCT01748552|565974737|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
156787452|NCT01748552|565974738|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
156787453|NCT01748552|565974739|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
156787454|NCT01748552|565974740|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
156787455|NCT01748552|565974741|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
156688798|NCT03756883|565606092|FG002|Overall Study|Other Reasons|0|||
156688799|NCT00685802|565606095|FG000|Washout Period of 7 Days|Protocol Violation|2|||
156787456|NCT01748552|565974742|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
156787457|NCT01748552|565974743|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
156787458|NCT01748552|565974744|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
156688800|NCT00685802|565606096|FG001|Washout Period of 7 Days|Protocol Violation|0|||
156688801|NCT00685802|565606095|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156688802|NCT00685802|565606096|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156688803|NCT01333072|565606097|FG000|Overall Study|Lost to Follow-up|3|||
156688804|NCT01333072|565606098|FG001|Overall Study|Lost to Follow-up|0|||
156688805|NCT01333072|565606097|FG000|Overall Study|Adverse Event|2|||
156688806|NCT01333072|565606098|FG001|Overall Study|Adverse Event|4|||
156688807|NCT01333072|565606097|FG000|Overall Study|Physician Decision|1|||
156688808|NCT01333072|565606098|FG001|Overall Study|Physician Decision|0|||
156688809|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
156688810|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
156688811|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
156688812|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
156688813|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
156688814|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
156688815|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
156688816|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
156688817|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
156688818|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
156688819|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
156688820|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
156688821|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
156688822|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
156688823|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
156688824|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
156688825|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
156688826|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
156688827|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
156688828|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
156688829|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
156688830|NCT00384293|565606099|FG000|Post-randomization Period|Adverse Event|0|||
156688831|NCT00384293|565606100|FG001|Post-randomization Period|Adverse Event|23|||
156688832|NCT00384293|565606101|FG002|Post-randomization Period|Adverse Event|7|||
156688833|NCT00384293|565606099|FG000|Post-randomization Period|Lost to Follow-up|0|||
156688834|NCT00384293|565606100|FG001|Post-randomization Period|Lost to Follow-up|2|||
156688835|NCT00384293|565606101|FG002|Post-randomization Period|Lost to Follow-up|1|||
156688836|NCT00384293|565606099|FG000|Post-randomization Period|Protocol Violation|0|||
156688837|NCT00384293|565606100|FG001|Post-randomization Period|Protocol Violation|1|||
156688838|NCT00384293|565606101|FG002|Post-randomization Period|Protocol Violation|0|||
156688839|NCT00384293|565606099|FG000|Post-randomization Period|Withdrawal by Subject|0|||
156688840|NCT00384293|565606100|FG001|Post-randomization Period|Withdrawal by Subject|8|||
156688841|NCT00384293|565606101|FG002|Post-randomization Period|Withdrawal by Subject|6|||
156688842|NCT00384293|565606099|FG000|Post-randomization Period|Trial Termination|0|||
156787459|NCT01748552|565974745|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
156787460|NCT01748552|565974734|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787461|NCT01748552|565974735|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787462|NCT01748552|565974736|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156869945|NCT02745119|566281056|FG002|Overall Study|Physician Decision|2|||
156869946|NCT02745119|566281057|FG003|Overall Study|Physician Decision|2|||
156869947|NCT02745119|566281054|FG000|Overall Study|Reason Not Specified|0|||
156869948|NCT02745119|566281055|FG001|Overall Study|Reason Not Specified|2|||
156869949|NCT02745119|566281056|FG002|Overall Study|Reason Not Specified|0|||
156787463|NCT01748552|565974737|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787464|NCT01748552|565974738|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787465|NCT01748552|565974739|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787466|NCT01748552|565974740|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
156787467|NCT01748552|565974741|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
156787468|NCT01748552|565974742|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
156787469|NCT01748552|565974743|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787470|NCT01748552|565974744|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787471|NCT01748552|565974745|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787472|NCT01386645|565974746|FG000|Overall Study|Physician Decision|0|||
156787473|NCT01386645|565974747|FG001|Overall Study|Physician Decision|0|||
156787474|NCT01386645|565974748|FG002|Overall Study|Physician Decision|1|||
156787475|NCT01386645|565974746|FG000|Overall Study|Withdrawal by Subject|0|||
156787476|NCT01386645|565974747|FG001|Overall Study|Withdrawal by Subject|1|||
156787477|NCT01386645|565974748|FG002|Overall Study|Withdrawal by Subject|1|||
156787478|NCT01530256|565974749|FG000|Overall Study|Death|2|||
156869950|NCT02745119|566281057|FG003|Overall Study|Reason Not Specified|1|||
156869951|NCT00960999|566281058|FG000|Overall Study|Withdrawal by Subject|1|||
156688843|NCT00384293|565606100|FG001|Post-randomization Period|Trial Termination|180|||
156688844|NCT00384293|565606101|FG002|Post-randomization Period|Trial Termination|204|||
156688845|NCT00384293|565606099|FG000|Post-randomization Period|Patient Randomized in Error|0|||
156688846|NCT00384293|565606100|FG001|Post-randomization Period|Patient Randomized in Error|0|||
156688847|NCT00384293|565606101|FG002|Post-randomization Period|Patient Randomized in Error|1|||
156688848|NCT00619359|565606106|FG000|Overall Study|Adverse Event|32|||
156688849|NCT00619359|565606107|FG001|Overall Study|Adverse Event|36|||
156688850|NCT00619359|565606106|FG000|Overall Study|Lost to Follow-up|12|||
156688851|NCT00619359|565606107|FG001|Overall Study|Lost to Follow-up|16|||
156688852|NCT00619359|565606106|FG000|Overall Study|Physician Decision|0|||
156688853|NCT00619359|565606107|FG001|Overall Study|Physician Decision|7|||
156688854|NCT00619359|565606106|FG000|Overall Study|Protocol Violation|1|||
156688855|NCT00619359|565606107|FG001|Overall Study|Protocol Violation|1|||
156688856|NCT00619359|565606106|FG000|Overall Study|Withdrawal by Subject|19|||
156688857|NCT00619359|565606107|FG001|Overall Study|Withdrawal by Subject|20|||
156688858|NCT00619359|565606106|FG000|Overall Study|Progressive Disease|3|||
156688859|NCT00619359|565606107|FG001|Overall Study|Progressive Disease|1|||
156688860|NCT00493454|565606112|FG000|Overall Study|Withdrawal by Subject|1|||
156688861|NCT00103038|565606114|FG000|Overall Study|Withdrawal by Subject|8|||
156688862|NCT00103038|565606114|FG000|Overall Study|Screen failure|3|||
156688863|NCT00103038|565606114|FG000|Overall Study|Death|1|||
156688864|NCT00103038|565606114|FG000|Overall Study|Physician Decision|1|||
156688865|NCT01463982|565606115|FG000|Overall Study|Withdrawal by Subject|0|||
156688866|NCT01463982|565606116|FG001|Overall Study|Withdrawal by Subject|1|||
156688867|NCT01463982|565606117|FG002|Overall Study|Withdrawal by Subject|1|||
156688868|NCT01463982|565606118|FG003|Overall Study|Withdrawal by Subject|0|||
156688869|NCT01463982|565606115|FG000|Overall Study|Treatment delay over 5 week|0|||
156688870|NCT01463982|565606116|FG001|Overall Study|Treatment delay over 5 week|0|||
156688871|NCT01463982|565606117|FG002|Overall Study|Treatment delay over 5 week|1|||
156688872|NCT01463982|565606118|FG003|Overall Study|Treatment delay over 5 week|0|||
156688873|NCT02462486|565606119|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
156688874|NCT02462486|565606120|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
156688875|NCT02462486|565606121|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
156688876|NCT02462486|565606119|FG000|Overall Study|Adverse Event|53|||
156688877|NCT02462486|565606120|FG001|Overall Study|Adverse Event|48|||
156688878|NCT02462486|565606121|FG002|Overall Study|Adverse Event|21|||
156688879|NCT02462486|565606119|FG000|Overall Study|Lack of Efficacy|6|||
156688880|NCT02462486|565606120|FG001|Overall Study|Lack of Efficacy|12|||
156688881|NCT02462486|565606121|FG002|Overall Study|Lack of Efficacy|3|||
156688882|NCT02462486|565606119|FG000|Overall Study|Lost to Follow-up|3|||
156688883|NCT02462486|565606120|FG001|Overall Study|Lost to Follow-up|4|||
156688884|NCT02462486|565606121|FG002|Overall Study|Lost to Follow-up|2|||
156688885|NCT02462486|565606119|FG000|Overall Study|Withdrawal by Subject|25|||
156688886|NCT02462486|565606120|FG001|Overall Study|Withdrawal by Subject|22|||
156688887|NCT02462486|565606121|FG002|Overall Study|Withdrawal by Subject|19|||
156688888|NCT02462486|565606119|FG000|Overall Study|Protocol Violation|3|||
156688889|NCT02462486|565606120|FG001|Overall Study|Protocol Violation|1|||
156688890|NCT02462486|565606121|FG002|Overall Study|Protocol Violation|1|||
156688891|NCT02462486|565606119|FG000|Overall Study|Reason not Specified|3|||
156688892|NCT02462486|565606120|FG001|Overall Study|Reason not Specified|4|||
156688893|NCT02462486|565606121|FG002|Overall Study|Reason not Specified|3|||
156688894|NCT02310763|565606122|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
156688895|NCT02310763|565606123|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
156688896|NCT02310763|565606124|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
156688897|NCT02310763|565606122|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
156688898|NCT02310763|565606123|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
156688899|NCT02310763|565606124|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
156688900|NCT02310763|565606122|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
156688901|NCT02310763|565606123|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
156787479|NCT04621786|565974750|FG000|Overall Study|Lost to Follow-up|9|||
156787480|NCT04621786|565974750|FG000|Overall Study|Protocol Violation|3|||
156787481|NCT02533674|565974751|FG000|Dose Level I|Progressive disease|1|||
156787482|NCT02533674|565974752|FG001|Dose Level I|Progressive disease|0|||
156787483|NCT02533674|565974753|FG002|Dose Level I|Progressive disease|0|||
156787484|NCT02533674|565974754|FG003|Dose Level I|Progressive disease|0|||
156436921|NCT04795752|564689157|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
156688902|NCT02310763|565606124|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
156436922|NCT04795752|564689156|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
156688903|NCT02310763|565606122|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
156688904|NCT02310763|565606123|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
156688905|NCT02310763|565606124|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
156688906|NCT02310763|565606122|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
156787485|NCT02533674|565974755|FG004|Dose Level I|Progressive disease|0|||
156787486|NCT02533674|565974756|FG005|Dose Level I|Progressive disease|0|||
156787487|NCT02533674|565974757|FG006|Dose Level I|Progressive disease|0|||
156688907|NCT02310763|565606123|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
156688908|NCT02310763|565606124|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
156688909|NCT01731886|565606126|FG000|Overall Study|Death|1|||
156688910|NCT01731886|565606127|FG001|Overall Study|Death|0|||
156688911|NCT01731886|565606126|FG000|Overall Study|Never started treatment|0|||
156688912|NCT01731886|565606127|FG001|Overall Study|Never started treatment|1|||
156688913|NCT01731886|565606126|FG000|Overall Study|Non-compliant|1|||
156688914|NCT01731886|565606127|FG001|Overall Study|Non-compliant|0|||
156688915|NCT02280187|565606128|FG000|Overall Study|Lost to Follow-up|218|||
156688916|NCT04668274|565606129|FG000|Part 1 Study Period 1|Adverse Event|3|||
156688917|NCT04668274|565606130|FG001|Part 1 Study Period 1|Adverse Event|0|||
156688918|NCT04668274|565606131|FG002|Part 1 Study Period 1|Adverse Event|0|||
156688919|NCT04668274|565606132|FG003|Part 1 Study Period 1|Adverse Event|0|||
156688920|NCT04668274|565606129|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
156688921|NCT04668274|565606130|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
156688922|NCT04668274|565606131|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
156688923|NCT04668274|565606132|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
156688924|NCT04668274|565606129|FG000|Part 1 Study Period 2|Other|0|||
156688925|NCT04668274|565606130|FG001|Part 1 Study Period 2|Other|1|||
156688926|NCT04668274|565606131|FG002|Part 1 Study Period 2|Other|0|||
156688927|NCT04668274|565606132|FG003|Part 1 Study Period 2|Other|0|||
156688928|NCT04668274|565606129|FG000|Part 1 Study Period 3|Adverse Event|0|||
156688929|NCT04668274|565606130|FG001|Part 1 Study Period 3|Adverse Event|0|||
156688930|NCT04668274|565606131|FG002|Part 1 Study Period 3|Adverse Event|1|||
156688931|NCT04668274|565606132|FG003|Part 1 Study Period 3|Adverse Event|0|||
156688932|NCT04668274|565606129|FG000|Part 1 Study Period 3|Other|0|||
156688933|NCT04668274|565606130|FG001|Part 1 Study Period 3|Other|0|||
156688934|NCT04668274|565606131|FG002|Part 1 Study Period 3|Other|2|||
156688935|NCT04668274|565606132|FG003|Part 1 Study Period 3|Other|0|||
156688936|NCT04668274|565606129|FG000|Part 2 Study Period 4|Other|0|||
156688937|NCT04668274|565606130|FG001|Part 2 Study Period 4|Other|0|||
156688938|NCT04668274|565606131|FG002|Part 2 Study Period 4|Other|0|||
156688939|NCT04668274|565606132|FG003|Part 2 Study Period 4|Other|1|||
156688940|NCT02010255|565606133|FG000|Overall Study|Death|0|||
156688941|NCT02010255|565606134|FG001|Overall Study|Death|1|||
156688942|NCT02010255|565606135|FG002|Overall Study|Death|4|||
156688943|NCT02010255|565606136|FG003|Overall Study|Death|4|||
156688944|NCT02010255|565606137|FG004|Overall Study|Death|2|||
156688945|NCT02010255|565606138|FG005|Overall Study|Death|0|||
156688946|NCT02010255|565606139|FG006|Overall Study|Death|1|||
156688947|NCT02010255|565606140|FG007|Overall Study|Death|1|||
156688948|NCT02010255|565606141|FG008|Overall Study|Death|1|||
156688949|NCT02010255|565606142|FG009|Overall Study|Death|0|||
156688950|NCT02010255|565606143|FG010|Overall Study|Death|1|||
156688951|NCT02010255|565606144|FG011|Overall Study|Death|1|||
156787488|NCT02533674|565974758|FG007|Dose Level I|Progressive disease|0|||
156787489|NCT02533674|565974751|FG000|Dose Level I|Withdrawal by Subject|1|||
156787490|NCT02533674|565974752|FG001|Dose Level I|Withdrawal by Subject|0|||
156787491|NCT02533674|565974753|FG002|Dose Level I|Withdrawal by Subject|0|||
156787492|NCT02533674|565974754|FG003|Dose Level I|Withdrawal by Subject|0|||
156787493|NCT02533674|565974755|FG004|Dose Level I|Withdrawal by Subject|0|||
156787494|NCT02533674|565974756|FG005|Dose Level I|Withdrawal by Subject|0|||
156787495|NCT02533674|565974757|FG006|Dose Level I|Withdrawal by Subject|0|||
156787496|NCT02533674|565974758|FG007|Dose Level I|Withdrawal by Subject|0|||
156787497|NCT02533674|565974751|FG000|Dose Level I|Physician Decision|1|||
156787498|NCT02533674|565974752|FG001|Dose Level I|Physician Decision|0|||
156787499|NCT02533674|565974753|FG002|Dose Level I|Physician Decision|0|||
156787500|NCT02533674|565974754|FG003|Dose Level I|Physician Decision|0|||
156787501|NCT02533674|565974755|FG004|Dose Level I|Physician Decision|0|||
156787502|NCT02533674|565974756|FG005|Dose Level I|Physician Decision|0|||
156787503|NCT02533674|565974757|FG006|Dose Level I|Physician Decision|0|||
156787504|NCT02533674|565974758|FG007|Dose Level I|Physician Decision|0|||
156787505|NCT02533674|565974751|FG000|Dose Level I|Death|1|||
156330016|NCT00004635|564308745|FG000|Period One|discrepancy in data entry|0|||
156787506|NCT02533674|565974752|FG001|Dose Level I|Death|0|||
156537835|NCT01011439|565062871|FG000|Overall Study|Withdrawal by Subject|1|||
156688952|NCT02010255|565606145|FG012|Overall Study|Death|0|||
156688953|NCT02010255|565606146|FG013|Overall Study|Death|0|||
156688954|NCT02010255|565606133|FG000|Overall Study|Lack of Efficacy|4|||
156787507|NCT02533674|565974753|FG002|Dose Level I|Death|0|||
156787508|NCT02533674|565974754|FG003|Dose Level I|Death|0|||
156688955|NCT02010255|565606134|FG001|Overall Study|Lack of Efficacy|1|||
156688956|NCT02010255|565606135|FG002|Overall Study|Lack of Efficacy|2|||
156688957|NCT02010255|565606136|FG003|Overall Study|Lack of Efficacy|1|||
156688958|NCT02010255|565606137|FG004|Overall Study|Lack of Efficacy|1|||
156688959|NCT02010255|565606138|FG005|Overall Study|Lack of Efficacy|0|||
156688960|NCT02010255|565606139|FG006|Overall Study|Lack of Efficacy|0|||
156787509|NCT02533674|565974755|FG004|Dose Level I|Death|0|||
156688961|NCT02010255|565606140|FG007|Overall Study|Lack of Efficacy|0|||
156688962|NCT02010255|565606141|FG008|Overall Study|Lack of Efficacy|0|||
156688963|NCT02010255|565606142|FG009|Overall Study|Lack of Efficacy|0|||
156688964|NCT02010255|565606143|FG010|Overall Study|Lack of Efficacy|1|||
156688965|NCT02010255|565606144|FG011|Overall Study|Lack of Efficacy|0|||
156688966|NCT02010255|565606145|FG012|Overall Study|Lack of Efficacy|0|||
156688967|NCT02010255|565606146|FG013|Overall Study|Lack of Efficacy|0|||
156688968|NCT02010255|565606133|FG000|Overall Study|Withdrew Consent|1|||
156688969|NCT02010255|565606134|FG001|Overall Study|Withdrew Consent|0|||
156688970|NCT02010255|565606135|FG002|Overall Study|Withdrew Consent|0|||
156688971|NCT02010255|565606136|FG003|Overall Study|Withdrew Consent|1|||
156688972|NCT02010255|565606137|FG004|Overall Study|Withdrew Consent|0|||
156688973|NCT02010255|565606138|FG005|Overall Study|Withdrew Consent|0|||
156688974|NCT02010255|565606139|FG006|Overall Study|Withdrew Consent|0|||
156688975|NCT02010255|565606140|FG007|Overall Study|Withdrew Consent|0|||
156688976|NCT02010255|565606141|FG008|Overall Study|Withdrew Consent|0|||
156688977|NCT02010255|565606142|FG009|Overall Study|Withdrew Consent|0|||
156688978|NCT02010255|565606143|FG010|Overall Study|Withdrew Consent|0|||
156688979|NCT02010255|565606144|FG011|Overall Study|Withdrew Consent|0|||
156688980|NCT02010255|565606145|FG012|Overall Study|Withdrew Consent|0|||
156688981|NCT02010255|565606146|FG013|Overall Study|Withdrew Consent|0|||
156688982|NCT02010255|565606133|FG000|Overall Study|Adverse Event|1|||
156688983|NCT02010255|565606134|FG001|Overall Study|Adverse Event|0|||
156688984|NCT02010255|565606135|FG002|Overall Study|Adverse Event|0|||
156688985|NCT02010255|565606136|FG003|Overall Study|Adverse Event|0|||
156688986|NCT02010255|565606137|FG004|Overall Study|Adverse Event|0|||
156688987|NCT02010255|565606138|FG005|Overall Study|Adverse Event|0|||
156688988|NCT02010255|565606139|FG006|Overall Study|Adverse Event|0|||
156688989|NCT02010255|565606140|FG007|Overall Study|Adverse Event|0|||
156688990|NCT02010255|565606141|FG008|Overall Study|Adverse Event|0|||
156688991|NCT02010255|565606142|FG009|Overall Study|Adverse Event|0|||
156688992|NCT02010255|565606143|FG010|Overall Study|Adverse Event|0|||
156688993|NCT02010255|565606144|FG011|Overall Study|Adverse Event|0|||
156688994|NCT02010255|565606145|FG012|Overall Study|Adverse Event|0|||
156688995|NCT02010255|565606146|FG013|Overall Study|Adverse Event|0|||
156688996|NCT02010255|565606133|FG000|Overall Study|Lost to Follow-up|0|||
156688997|NCT02010255|565606134|FG001|Overall Study|Lost to Follow-up|0|||
156688998|NCT02010255|565606135|FG002|Overall Study|Lost to Follow-up|1|||
156688999|NCT02010255|565606136|FG003|Overall Study|Lost to Follow-up|0|||
156689000|NCT02010255|565606137|FG004|Overall Study|Lost to Follow-up|1|||
156689001|NCT02010255|565606138|FG005|Overall Study|Lost to Follow-up|0|||
156689002|NCT02010255|565606139|FG006|Overall Study|Lost to Follow-up|0|||
156689003|NCT02010255|565606140|FG007|Overall Study|Lost to Follow-up|0|||
156689004|NCT02010255|565606141|FG008|Overall Study|Lost to Follow-up|0|||
156689005|NCT02010255|565606142|FG009|Overall Study|Lost to Follow-up|0|||
156689006|NCT02010255|565606143|FG010|Overall Study|Lost to Follow-up|0|||
156689007|NCT02010255|565606144|FG011|Overall Study|Lost to Follow-up|0|||
156689008|NCT02010255|565606145|FG012|Overall Study|Lost to Follow-up|0|||
156689009|NCT02010255|565606146|FG013|Overall Study|Lost to Follow-up|0|||
156689010|NCT02010255|565606133|FG000|Overall Study|Randomized but Not Treated|0|||
156689011|NCT02010255|565606134|FG001|Overall Study|Randomized but Not Treated|0|||
156689012|NCT02010255|565606135|FG002|Overall Study|Randomized but Not Treated|0|||
156689013|NCT02010255|565606136|FG003|Overall Study|Randomized but Not Treated|0|||
156689014|NCT02010255|565606137|FG004|Overall Study|Randomized but Not Treated|0|||
156689015|NCT02010255|565606138|FG005|Overall Study|Randomized but Not Treated|0|||
156689016|NCT02010255|565606139|FG006|Overall Study|Randomized but Not Treated|0|||
156689017|NCT02010255|565606140|FG007|Overall Study|Randomized but Not Treated|0|||
156689018|NCT02010255|565606141|FG008|Overall Study|Randomized but Not Treated|0|||
156689019|NCT02010255|565606142|FG009|Overall Study|Randomized but Not Treated|0|||
156689020|NCT02010255|565606143|FG010|Overall Study|Randomized but Not Treated|0|||
156689021|NCT02010255|565606144|FG011|Overall Study|Randomized but Not Treated|0|||
156689022|NCT02010255|565606145|FG012|Overall Study|Randomized but Not Treated|0|||
156689023|NCT02010255|565606146|FG013|Overall Study|Randomized but Not Treated|1|||
156689024|NCT02039063|565606147|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
156689025|NCT02039063|565606148|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
156689026|NCT02039063|565606149|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
156689027|NCT02039063|565606150|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
156787510|NCT02533674|565974756|FG005|Dose Level I|Death|0|||
156689028|NCT02039063|565606147|FG000|Treatment Phase|Progression of disease|0|||
156689029|NCT02039063|565606148|FG001|Treatment Phase|Progression of disease|0|||
156689030|NCT02039063|565606149|FG002|Treatment Phase|Progression of disease|1|||
156689031|NCT02039063|565606150|FG003|Treatment Phase|Progression of disease|1|||
156689032|NCT02039063|565606147|FG000|Extension Phase|Inadequate therapeutic effect|0|||
156689033|NCT02039063|565606148|FG001|Extension Phase|Inadequate therapeutic effect|1|||
156689034|NCT02039063|565606149|FG002|Extension Phase|Inadequate therapeutic effect|2|||
156689035|NCT02039063|565606150|FG003|Extension Phase|Inadequate therapeutic effect|0|||
156689036|NCT02039063|565606147|FG000|Extension Phase|Progression of disease|0|||
156689037|NCT02039063|565606148|FG001|Extension Phase|Progression of disease|0|||
156689038|NCT02039063|565606149|FG002|Extension Phase|Progression of disease|0|||
156689039|NCT02039063|565606150|FG003|Extension Phase|Progression of disease|1|||
156869952|NCT00960999|566281059|FG001|Overall Study|Withdrawal by Subject|0|||
156869953|NCT00960999|566281058|FG000|Overall Study|Protocol Violation|5|||
156869954|NCT00960999|566281059|FG001|Overall Study|Protocol Violation|2|||
156869955|NCT00960999|566281058|FG000|Overall Study|RT dose constraints not met|2|||
156869956|NCT00960999|566281059|FG001|Overall Study|RT dose constraints not met|0|||
156869957|NCT00432172|566281060|FG000|Overall Study|Physician Decision|0|||
156869958|NCT00432172|566281061|FG001|Overall Study|Physician Decision|0|||
156869959|NCT00432172|566281062|FG002|Overall Study|Physician Decision|2|||
156869960|NCT00432172|566281063|FG003|Overall Study|Physician Decision|0|||
156869961|NCT00432172|566281060|FG000|Overall Study|Adverse Event|4|||
156869962|NCT00432172|566281061|FG001|Overall Study|Adverse Event|2|||
156869963|NCT00432172|566281062|FG002|Overall Study|Adverse Event|4|||
156869964|NCT00432172|566281063|FG003|Overall Study|Adverse Event|3|||
156869965|NCT00432172|566281060|FG000|Overall Study|Disease progression|0|||
156869966|NCT00432172|566281061|FG001|Overall Study|Disease progression|2|||
156869967|NCT00432172|566281062|FG002|Overall Study|Disease progression|5|||
156869968|NCT00432172|566281063|FG003|Overall Study|Disease progression|1|||
156869969|NCT00432172|566281060|FG000|Overall Study|Withdrawal by Subject|0|||
156869970|NCT00432172|566281061|FG001|Overall Study|Withdrawal by Subject|1|||
156869971|NCT00432172|566281062|FG002|Overall Study|Withdrawal by Subject|0|||
156869972|NCT00432172|566281063|FG003|Overall Study|Withdrawal by Subject|2|||
156869973|NCT00432172|566281060|FG000|Overall Study|No treatment received|2|||
156869974|NCT00432172|566281061|FG001|Overall Study|No treatment received|2|||
156869975|NCT00432172|566281062|FG002|Overall Study|No treatment received|0|||
156869976|NCT00432172|566281063|FG003|Overall Study|No treatment received|1|||
156869977|NCT02536963|566281064|FG000|Overall Study|Withdrawal by Subject|18|||
156869978|NCT02668393|566281065|FG000|Overall Study|Progressive disease|6|||
156869979|NCT02668393|566281066|FG001|Overall Study|Progressive disease|3|||
156869980|NCT02668393|566281065|FG000|Overall Study|Adverse Event|0|||
156869981|NCT02668393|566281066|FG001|Overall Study|Adverse Event|2|||
156869982|NCT02668393|566281065|FG000|Overall Study|Withdrawal from the trial|0|||
156869983|NCT02668393|566281066|FG001|Overall Study|Withdrawal from the trial|1|||
156869984|NCT02668393|566281065|FG000|Overall Study|Lack of benefit and side effects|1|||
156869985|NCT02668393|566281066|FG001|Overall Study|Lack of benefit and side effects|0|||
156869986|NCT02141204|566281067|FG000|Overall Study|Lost to Follow-up|2|||
156869987|NCT02141204|566281068|FG001|Overall Study|Lost to Follow-up|1|||
156869988|NCT02141204|566281067|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
156869989|NCT02141204|566281068|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
156869990|NCT02141204|566281067|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
156869991|NCT02141204|566281068|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
156869992|NCT02141204|566281067|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
156869993|NCT02141204|566281068|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
156869994|NCT00515619|566281071|FG000|Overall Study|Adverse Event|34|||
156869995|NCT00515619|566281071|FG000|Overall Study|Lack of Efficacy|92|||
156869996|NCT00515619|566281071|FG000|Overall Study|Withdrawal by Subject|66|||
156869997|NCT00515619|566281071|FG000|Overall Study|Protocol Violation|3|||
156869998|NCT00515619|566281071|FG000|Overall Study|Lost to Follow-up|4|||
156869999|NCT00515619|566281071|FG000|Overall Study|Unsatisfactory compliance|6|||
156870000|NCT00515619|566281071|FG000|Overall Study|Other: Site discontinuing trials|2|||
156870001|NCT00515619|566281071|FG000|Overall Study|Other: Subject cannot attend visits|2|||
156870002|NCT00515619|566281071|FG000|Overall Study|Other: Subject required surgery|1|||
156870003|NCT00515619|566281071|FG000|Overall Study|Other: Subject moved to another country|1|||
156870004|NCT00515619|566281071|FG000|Overall Study|Other: Investigator decision|1|||
156870005|NCT00515619|566281071|FG000|Overall Study|Other: Subject became pregnant|1|||
156870006|NCT00515619|566281071|FG000|Overall Study|Other: Request from sponsor|1|||
156870007|NCT00515619|566281071|FG000|Overall Study|Other: Drug available on license|1|||
156870008|NCT00515619|566281071|FG000|Overall Study|Other: Subject interested in other AED|1|||
156870009|NCT02379091|566281072|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156870010|NCT02379091|566281073|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
156870011|NCT02379091|566281074|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156870012|NCT02379091|566281075|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
156870013|NCT02379091|566281072|FG000|Overall Study|Principal Investigator Discretion|0|||
156870014|NCT02379091|566281073|FG001|Overall Study|Principal Investigator Discretion|1|||
156870015|NCT02379091|566281074|FG002|Overall Study|Principal Investigator Discretion|0|||
156689040|NCT02039063|565606147|FG000|Extension Phase|Adverse Event|0|||
156689041|NCT02039063|565606148|FG001|Extension Phase|Adverse Event|0|||
156870016|NCT02379091|566281075|FG003|Overall Study|Principal Investigator Discretion|0|||
156870017|NCT02379091|566281072|FG000|Overall Study|Lost to Follow-up|0|||
156870018|NCT02379091|566281073|FG001|Overall Study|Lost to Follow-up|0|||
156870019|NCT02379091|566281074|FG002|Overall Study|Lost to Follow-up|0|||
156870020|NCT02379091|566281075|FG003|Overall Study|Lost to Follow-up|1|||
156870021|NCT02379091|566281072|FG000|Overall Study|Voluntary Withdrawal|2|||
156870022|NCT02379091|566281073|FG001|Overall Study|Voluntary Withdrawal|5|||
156870023|NCT02379091|566281074|FG002|Overall Study|Voluntary Withdrawal|2|||
156870024|NCT02379091|566281075|FG003|Overall Study|Voluntary Withdrawal|4|||
156689042|NCT02039063|565606149|FG002|Extension Phase|Adverse Event|1|||
156689043|NCT02039063|565606150|FG003|Extension Phase|Adverse Event|0|||
156689044|NCT03417830|565606151|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
156689045|NCT03417830|565606152|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
156689046|NCT00823199|565606156|FG000|Overall Study|Withdrawal by Subject|2|||
156689047|NCT00941720|565606157|FG000|Overall Study|Withdrawal by Subject|1|||
156689048|NCT00941720|565606157|FG000|Overall Study|Insurance denied participation|11|||
156689049|NCT00941720|565606157|FG000|Overall Study|ineligible|2|||
156689050|NCT00171340|565606158|FG000|Overall Study|Adverse Event|46|||
156689051|NCT00171340|565606159|FG001|Overall Study|Adverse Event|42|||
156689052|NCT00171340|565606158|FG000|Overall Study|Lack of Efficacy|29|||
156689053|NCT00171340|565606159|FG001|Overall Study|Lack of Efficacy|41|||
156689054|NCT00171340|565606158|FG000|Overall Study|Protocol Violation|7|||
156689055|NCT00171340|565606159|FG001|Overall Study|Protocol Violation|8|||
156689056|NCT00171340|565606158|FG000|Overall Study|Withdrawal by Subject|22|||
156689057|NCT00171340|565606159|FG001|Overall Study|Withdrawal by Subject|19|||
156689058|NCT00171340|565606158|FG000|Overall Study|Lost to Follow-up|0|||
156689059|NCT00171340|565606159|FG001|Overall Study|Lost to Follow-up|5|||
156689060|NCT00171340|565606158|FG000|Overall Study|Abnormal Laboratory Results|2|||
156689061|NCT00171340|565606159|FG001|Overall Study|Abnormal Laboratory Results|0|||
156689062|NCT00171340|565606158|FG000|Overall Study|Abnormal Test Procedure Results|6|||
156689063|NCT00171340|565606159|FG001|Overall Study|Abnormal Test Procedure Results|11|||
156689064|NCT00171340|565606158|FG000|Overall Study|No Longer Required Study Drug|1|||
156689065|NCT00171340|565606159|FG001|Overall Study|No Longer Required Study Drug|1|||
156689066|NCT00171340|565606158|FG000|Overall Study|Administrative Problems|5|||
156689067|NCT00171340|565606159|FG001|Overall Study|Administrative Problems|2|||
156689068|NCT00171340|565606158|FG000|Overall Study|Death|6|||
156689069|NCT00171340|565606159|FG001|Overall Study|Death|6|||
156689070|NCT00680186|565606162|FG000|Overall Study|Adverse Event|47|||
156689071|NCT00680186|565606163|FG001|Overall Study|Adverse Event|44|||
156689072|NCT00680186|565606162|FG000|Overall Study|Protocol Violation|31|||
156689073|NCT00680186|565606163|FG001|Overall Study|Protocol Violation|26|||
156689074|NCT00680186|565606162|FG000|Overall Study|Lost to Follow-up|11|||
156689075|NCT00680186|565606163|FG001|Overall Study|Lost to Follow-up|6|||
156689076|NCT00680186|565606162|FG000|Overall Study|Withdrawal by Subject|32|||
156689077|NCT00680186|565606163|FG001|Overall Study|Withdrawal by Subject|39|||
156689078|NCT00680186|565606162|FG000|Overall Study|Other|4|||
156689079|NCT00680186|565606163|FG001|Overall Study|Other|1|||
156689080|NCT00613730|565606166|FG000|Overall Study|Disease progression|2|||
156689081|NCT00613730|565606166|FG000|Overall Study|Administrative decision|1|||
156689082|NCT04965389|565606172|FG000|Overall Study|Other reasons|1|||
156689083|NCT04965389|565606173|FG001|Overall Study|Other reasons|0|||
156689084|NCT04965389|565606174|FG002|Overall Study|Other reasons|0|||
156689085|NCT04965389|565606175|FG003|Overall Study|Other reasons|0|||
156689086|NCT04965389|565606172|FG000|Overall Study|Participant withdrew consent|0|||
156689087|NCT04965389|565606173|FG001|Overall Study|Participant withdrew consent|1|||
156689088|NCT04965389|565606174|FG002|Overall Study|Participant withdrew consent|0|||
156689089|NCT04965389|565606175|FG003|Overall Study|Participant withdrew consent|0|||
156689090|NCT04965389|565606172|FG000|Overall Study|Poor/Non-compliance|0|||
156689091|NCT04965389|565606173|FG001|Overall Study|Poor/Non-compliance|1|||
156689092|NCT04965389|565606174|FG002|Overall Study|Poor/Non-compliance|0|||
156689093|NCT04965389|565606175|FG003|Overall Study|Poor/Non-compliance|0|||
156787511|NCT02533674|565974757|FG006|Dose Level I|Death|0|||
156787512|NCT02533674|565974758|FG007|Dose Level I|Death|0|||
156787513|NCT02533674|565974751|FG000|Dose Level I|Never Treated|1|||
156787514|NCT02533674|565974752|FG001|Dose Level I|Never Treated|0|||
156787515|NCT02533674|565974753|FG002|Dose Level I|Never Treated|0|||
156787516|NCT02533674|565974754|FG003|Dose Level I|Never Treated|0|||
156787517|NCT02533674|565974755|FG004|Dose Level I|Never Treated|0|||
156689094|NCT00724373|565606178|FG000|Overall Study|Adverse Event|41|||
156787518|NCT02533674|565974756|FG005|Dose Level I|Never Treated|0|||
156787519|NCT02533674|565974757|FG006|Dose Level I|Never Treated|0|||
156787520|NCT02533674|565974758|FG007|Dose Level I|Never Treated|0|||
156787521|NCT02533674|565974751|FG000|Dose Level II|Progressive disease|0|||
156787522|NCT02533674|565974752|FG001|Dose Level II|Progressive disease|3|||
156787523|NCT02533674|565974753|FG002|Dose Level II|Progressive disease|0|||
156689095|NCT00724373|565606178|FG000|Overall Study|Lack of Efficacy|82|||
156689096|NCT00724373|565606178|FG000|Overall Study|Lost to Follow-up|7|||
156689097|NCT00724373|565606178|FG000|Overall Study|Non-compliance|2|||
156689098|NCT00724373|565606178|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
156689099|NCT00724373|565606178|FG000|Overall Study|Participant moved away|1|||
156689100|NCT00724373|565606178|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
156689101|NCT00724373|565606178|FG000|Overall Study|Only to have 24 week regimen|1|||
156689102|NCT00724373|565606178|FG000|Overall Study|Viral Relapse|1|||
156689103|NCT00724373|565606178|FG000|Overall Study|Acute HCV infection|1|||
156787524|NCT02533674|565974754|FG003|Dose Level II|Progressive disease|0|||
156787525|NCT02533674|565974755|FG004|Dose Level II|Progressive disease|0|||
156787526|NCT02533674|565974756|FG005|Dose Level II|Progressive disease|0|||
156689104|NCT00724373|565606178|FG000|Overall Study|Drug Relapse|1|||
156689105|NCT00724373|565606178|FG000|Overall Study|Tolerability|23|||
156689106|NCT01436643|565606179|FG000|2-week Pre-treatment|Abnormal test result|0|||
156689107|NCT01436643|565606180|FG001|2-week Pre-treatment|Abnormal test result|0|||
156689108|NCT01436643|565606181|FG002|2-week Pre-treatment|Abnormal test result|0|||
156689109|NCT01436643|565606182|FG003|2-week Pre-treatment|Abnormal test result|1|||
156689110|NCT01436643|565606179|FG000|2-week Pre-treatment|Adverse Event|0|||
156689111|NCT01436643|565606180|FG001|2-week Pre-treatment|Adverse Event|0|||
156689112|NCT01436643|565606181|FG002|2-week Pre-treatment|Adverse Event|0|||
156689113|NCT01436643|565606182|FG003|2-week Pre-treatment|Adverse Event|5|||
156689114|NCT01436643|565606179|FG000|2-week Pre-treatment|Protocol Violation|0|||
156689115|NCT01436643|565606180|FG001|2-week Pre-treatment|Protocol Violation|0|||
156689116|NCT01436643|565606181|FG002|2-week Pre-treatment|Protocol Violation|0|||
156689117|NCT01436643|565606182|FG003|2-week Pre-treatment|Protocol Violation|4|||
156689118|NCT01436643|565606179|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
156689119|NCT01436643|565606180|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
156689120|NCT01436643|565606181|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
156689121|NCT01436643|565606182|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
156689122|NCT01436643|565606179|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
156689123|NCT01436643|565606180|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
156689124|NCT01436643|565606181|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
156689125|NCT01436643|565606182|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
156689126|NCT01436643|565606179|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
156689127|NCT01436643|565606180|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
156689128|NCT01436643|565606181|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
156689129|NCT01436643|565606182|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
156689130|NCT01382251|565606183|FG000|Overall Study|Surgeries cancelled or delayed|16|||
156689131|NCT01382251|565606184|FG001|Overall Study|Surgeries cancelled or delayed|16|||
156689132|NCT01382251|565606183|FG000|Overall Study|Lost to Follow-up|4|||
156689133|NCT01382251|565606184|FG001|Overall Study|Lost to Follow-up|4|||
156689134|NCT01382251|565606183|FG000|Overall Study|Contacted after study closed|1|||
156689135|NCT01382251|565606184|FG001|Overall Study|Contacted after study closed|1|||
156689136|NCT01117987|565606185|FG000|Overall Study|Protocol deviation|0|||
156689137|NCT01117987|565606186|FG001|Overall Study|Protocol deviation|1|||
156689138|NCT01117987|565606185|FG000|Overall Study|Subject no longer requires study drug|1|||
156689139|NCT01117987|565606186|FG001|Overall Study|Subject no longer requires study drug|0|||
156689140|NCT01117987|565606185|FG000|Overall Study|Lost to Follow-up|1|||
156689141|NCT01117987|565606186|FG001|Overall Study|Lost to Follow-up|1|||
156689142|NCT01117987|565606185|FG000|Overall Study|Abnormal test procedure result|2|||
156689143|NCT01117987|565606186|FG001|Overall Study|Abnormal test procedure result|0|||
156689144|NCT01117987|565606185|FG000|Overall Study|Lack of Efficacy|3|||
156689145|NCT01117987|565606186|FG001|Overall Study|Lack of Efficacy|4|||
156689146|NCT01117987|565606185|FG000|Overall Study|Death|5|||
156689147|NCT01117987|565606186|FG001|Overall Study|Death|10|||
156689148|NCT01117987|565606185|FG000|Overall Study|Withdrawal by Subject|5|||
156689149|NCT01117987|565606186|FG001|Overall Study|Withdrawal by Subject|10|||
156689150|NCT01117987|565606185|FG000|Overall Study|Adverse Event|19|||
156689151|NCT01117987|565606186|FG001|Overall Study|Adverse Event|26|||
156689152|NCT01117987|565606185|FG000|Overall Study|Administrative problems|25|||
156689153|NCT01117987|565606186|FG001|Overall Study|Administrative problems|22|||
156689154|NCT02377063|565606187|FG000|Overall Study|Non-compliance|5|||
156870025|NCT02379091|566281072|FG000|Overall Study|Study Termination|7|||
156870026|NCT02379091|566281073|FG001|Overall Study|Study Termination|2|||
156689155|NCT01524913|565606188|FG000|Overall Study|Lost to Follow-up|4|||
156689156|NCT01524913|565606189|FG001|Overall Study|Lost to Follow-up|0|||
156689157|NCT01524913|565606190|FG002|Overall Study|Lost to Follow-up|0|||
156689158|NCT00702208|565606191|FG000|Overall Study|Lost to Follow-up|28|||
156689159|NCT00702208|565606191|FG000|Overall Study|Did not self-lavage|1|||
156689160|NCT00702208|565606191|FG000|Overall Study|Unsatisfactory colposcopy|2|||
156689161|NCT04678817|565607542|FG000|Overall Study|Lost to Follow-up|28|||
156689162|NCT04678817|565607543|FG001|Overall Study|Lost to Follow-up|0|||
156689163|NCT04678817|565607544|FG002|Overall Study|Lost to Follow-up|0|||
156689164|NCT02124902|565607552|FG000|Overall Study|Adverse Event|7|||
156689165|NCT02124902|565607553|FG001|Overall Study|Adverse Event|2|||
156689166|NCT02124902|565607552|FG000|Overall Study|Went to alternative treatment|4|||
156689167|NCT02124902|565607553|FG001|Overall Study|Went to alternative treatment|0|||
156689168|NCT02124902|565607552|FG000|Overall Study|Withdrawal by Subject|2|||
156689169|NCT02124902|565607553|FG001|Overall Study|Withdrawal by Subject|1|||
156689170|NCT02124902|565607552|FG000|Overall Study|Physician Decision|2|||
156689171|NCT02124902|565607553|FG001|Overall Study|Physician Decision|0|||
156689172|NCT02124902|565607552|FG000|Overall Study|Not eligible|1|||
156689173|NCT02124902|565607553|FG001|Overall Study|Not eligible|0|||
156689174|NCT02124902|565607552|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
156689175|NCT02124902|565607553|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
156689176|NCT01937351|565607554|FG000|Overall Study|Withdrawal by Subject|4|||
156689177|NCT01937351|565607555|FG001|Overall Study|Withdrawal by Subject|2|||
156689178|NCT01937351|565607554|FG000|Overall Study|Death|1|||
156689179|NCT01937351|565607555|FG001|Overall Study|Death|0|||
156689180|NCT01937351|565607554|FG000|Overall Study|Not treated w device, per protocol fail|4|||
156689181|NCT01937351|565607555|FG001|Overall Study|Not treated w device, per protocol fail|0|||
156689182|NCT01961687|565607556|FG000|Overall Study|Lost to Follow-up|19|||
156689183|NCT01961687|565607556|FG000|Overall Study|Re-operation|17|||
156689184|NCT01961687|565607556|FG000|Overall Study|Death|7|||
156689185|NCT01961687|565607556|FG000|Overall Study|Withdrawal by Subject|6|||
156689186|NCT01961687|565607556|FG000|Overall Study|Adverse Event|6|||
156689187|NCT01961687|565607556|FG000|Overall Study|Moved to area without study site|2|||
156689188|NCT01961687|565607556|FG000|Overall Study|Sponsor decision|2|||
156689189|NCT01961687|565607556|FG000|Overall Study|Physician Decision|1|||
156689190|NCT01961687|565607556|FG000|Overall Study|Unable to meet follow-up requirements|1|||
156689191|NCT00546910|565607559|FG000|Overall Study|Adverse Event|2|||
156689192|NCT00546910|565607560|FG001|Overall Study|Adverse Event|3|||
156689193|NCT00546910|565607559|FG000|Overall Study|Lack of Efficacy|5|||
156787527|NCT02533674|565974757|FG006|Dose Level II|Progressive disease|0|||
156787528|NCT02533674|565974758|FG007|Dose Level II|Progressive disease|0|||
156787529|NCT02533674|565974751|FG000|Dose Level II|Withdrawal by Subject|0|||
156787530|NCT02533674|565974752|FG001|Dose Level II|Withdrawal by Subject|1|||
156787531|NCT02533674|565974753|FG002|Dose Level II|Withdrawal by Subject|0|||
156787532|NCT02533674|565974754|FG003|Dose Level II|Withdrawal by Subject|0|||
156787533|NCT02533674|565974755|FG004|Dose Level II|Withdrawal by Subject|0|||
156787534|NCT02533674|565974756|FG005|Dose Level II|Withdrawal by Subject|0|||
156787535|NCT02533674|565974757|FG006|Dose Level II|Withdrawal by Subject|0|||
156787536|NCT02533674|565974758|FG007|Dose Level II|Withdrawal by Subject|0|||
156787537|NCT02533674|565974751|FG000|Dose Level II|Treatment-related AE|0|||
156787538|NCT02533674|565974752|FG001|Dose Level II|Treatment-related AE|1|||
156787539|NCT02533674|565974753|FG002|Dose Level II|Treatment-related AE|0|||
156787540|NCT02533674|565974754|FG003|Dose Level II|Treatment-related AE|0|||
156787541|NCT02533674|565974755|FG004|Dose Level II|Treatment-related AE|0|||
156787542|NCT02533674|565974756|FG005|Dose Level II|Treatment-related AE|0|||
156787543|NCT02533674|565974757|FG006|Dose Level II|Treatment-related AE|0|||
156787544|NCT02533674|565974758|FG007|Dose Level II|Treatment-related AE|0|||
156787545|NCT02533674|565974751|FG000|Dose Level II|Physician Decision|0|||
156787546|NCT02533674|565974752|FG001|Dose Level II|Physician Decision|1|||
156787547|NCT02533674|565974753|FG002|Dose Level II|Physician Decision|0|||
156787548|NCT02533674|565974754|FG003|Dose Level II|Physician Decision|0|||
156787549|NCT02533674|565974755|FG004|Dose Level II|Physician Decision|0|||
156787550|NCT02533674|565974756|FG005|Dose Level II|Physician Decision|0|||
156787551|NCT02533674|565974757|FG006|Dose Level II|Physician Decision|0|||
156787552|NCT02533674|565974758|FG007|Dose Level II|Physician Decision|0|||
156787553|NCT02533674|565974751|FG000|Dose Level II|Non-treatment-related AE|0|||
156787554|NCT02533674|565974752|FG001|Dose Level II|Non-treatment-related AE|1|||
156787555|NCT02533674|565974753|FG002|Dose Level II|Non-treatment-related AE|0|||
156787556|NCT02533674|565974754|FG003|Dose Level II|Non-treatment-related AE|0|||
156787557|NCT02533674|565974755|FG004|Dose Level II|Non-treatment-related AE|0|||
156787558|NCT02533674|565974756|FG005|Dose Level II|Non-treatment-related AE|0|||
156787559|NCT02533674|565974757|FG006|Dose Level II|Non-treatment-related AE|0|||
156787560|NCT02533674|565974758|FG007|Dose Level II|Non-treatment-related AE|0|||
156787561|NCT02533674|565974751|FG000|Dose Level III|Progressive disease|0|||
156787562|NCT02533674|565974752|FG001|Dose Level III|Progressive disease|0|||
156787563|NCT02533674|565974753|FG002|Dose Level III|Progressive disease|2|||
156787564|NCT02533674|565974754|FG003|Dose Level III|Progressive disease|0|||
156787565|NCT02533674|565974755|FG004|Dose Level III|Progressive disease|0|||
156787566|NCT02533674|565974756|FG005|Dose Level III|Progressive disease|0|||
156787567|NCT02533674|565974757|FG006|Dose Level III|Progressive disease|0|||
156787568|NCT02533674|565974758|FG007|Dose Level III|Progressive disease|0|||
156787569|NCT02533674|565974751|FG000|Dose Level III|Withdrawal by Subject|0|||
156787570|NCT02533674|565974752|FG001|Dose Level III|Withdrawal by Subject|0|||
156787571|NCT02533674|565974753|FG002|Dose Level III|Withdrawal by Subject|1|||
156787572|NCT02533674|565974754|FG003|Dose Level III|Withdrawal by Subject|0|||
156787573|NCT02533674|565974755|FG004|Dose Level III|Withdrawal by Subject|0|||
156787574|NCT02533674|565974756|FG005|Dose Level III|Withdrawal by Subject|0|||
156787575|NCT02533674|565974757|FG006|Dose Level III|Withdrawal by Subject|0|||
156330017|NCT00004635|564308746|FG001|Period One|discrepancy in data entry|1|||
156330018|NCT00004635|564308745|FG000|Period Two|progression|2|||
156330019|NCT00004635|564308746|FG001|Period Two|progression|3|||
156689194|NCT00546910|565607560|FG001|Overall Study|Lack of Efficacy|7|||
156689195|NCT00546910|565607559|FG000|Overall Study|Physician Decision|0|||
156689196|NCT00546910|565607560|FG001|Overall Study|Physician Decision|1|||
156689197|NCT00546910|565607559|FG000|Overall Study|Withdrawal by Subject|2|||
156689198|NCT00546910|565607560|FG001|Overall Study|Withdrawal by Subject|0|||
156787576|NCT02533674|565974758|FG007|Dose Level III|Withdrawal by Subject|0|||
156787577|NCT02533674|565974751|FG000|Dose Level III|Treatment-related AE|0|||
156787578|NCT02533674|565974752|FG001|Dose Level III|Treatment-related AE|0|||
156787579|NCT02533674|565974753|FG002|Dose Level III|Treatment-related AE|1|||
156689199|NCT01467479|565607561|FG000|Overall Study|No Study Medication|1|||
156689200|NCT01467479|565607562|FG001|Overall Study|No Study Medication|0|||
156689201|NCT01467479|565607563|FG002|Overall Study|No Study Medication|2|||
156689202|NCT01467479|565607561|FG000|Overall Study|Adverse Event|1|||
156689203|NCT01467479|565607562|FG001|Overall Study|Adverse Event|2|||
156689204|NCT01467479|565607563|FG002|Overall Study|Adverse Event|0|||
156436923|NCT04795752|564689157|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
156689205|NCT01467479|565607561|FG000|Overall Study|Death|0|||
156689206|NCT01467479|565607562|FG001|Overall Study|Death|0|||
156689207|NCT01467479|565607563|FG002|Overall Study|Death|1|||
156689208|NCT01467479|565607561|FG000|Overall Study|Lost to Follow-up|2|||
156689209|NCT01467479|565607562|FG001|Overall Study|Lost to Follow-up|5|||
156689210|NCT01467479|565607563|FG002|Overall Study|Lost to Follow-up|3|||
156689211|NCT01467479|565607561|FG000|Overall Study|Withdrawal of Consent|3|||
156689212|NCT01467479|565607562|FG001|Overall Study|Withdrawal of Consent|7|||
156689213|NCT01467479|565607563|FG002|Overall Study|Withdrawal of Consent|7|||
156689214|NCT01467479|565607561|FG000|Overall Study|Study Terminated by Sponsor|1|||
156689215|NCT01467479|565607562|FG001|Overall Study|Study Terminated by Sponsor|3|||
156689216|NCT01467479|565607563|FG002|Overall Study|Study Terminated by Sponsor|3|||
156689217|NCT01467479|565607561|FG000|Overall Study|Other|1|||
156689218|NCT01467479|565607562|FG001|Overall Study|Other|0|||
156689219|NCT01467479|565607563|FG002|Overall Study|Other|0|||
156689220|NCT01730040|565607573|FG000|Overall Study|Randomized but not treated|0|||
156689221|NCT01730040|565607574|FG001|Overall Study|Randomized but not treated|0|||
156689222|NCT01730040|565607575|FG002|Overall Study|Randomized but not treated|0|||
156689223|NCT01730040|565607576|FG003|Overall Study|Randomized but not treated|0|||
156689224|NCT01730040|565607577|FG004|Overall Study|Randomized but not treated|0|||
156689225|NCT01730040|565607578|FG005|Overall Study|Randomized but not treated|1|||
156689226|NCT01730040|565607579|FG006|Overall Study|Randomized but not treated|0|||
156689227|NCT01730040|565607573|FG000|Overall Study|Subject moved|0|||
156689228|NCT01730040|565607574|FG001|Overall Study|Subject moved|0|||
156689229|NCT01730040|565607575|FG002|Overall Study|Subject moved|1|||
156689230|NCT01730040|565607576|FG003|Overall Study|Subject moved|0|||
156689231|NCT01730040|565607577|FG004|Overall Study|Subject moved|0|||
156689232|NCT01730040|565607578|FG005|Overall Study|Subject moved|0|||
156689233|NCT01730040|565607579|FG006|Overall Study|Subject moved|1|||
156689234|NCT01730040|565607573|FG000|Overall Study|Physician Decision|0|||
156689235|NCT01730040|565607574|FG001|Overall Study|Physician Decision|0|||
156689236|NCT01730040|565607575|FG002|Overall Study|Physician Decision|0|||
156689237|NCT01730040|565607576|FG003|Overall Study|Physician Decision|0|||
156689238|NCT01730040|565607577|FG004|Overall Study|Physician Decision|0|||
156689239|NCT01730040|565607578|FG005|Overall Study|Physician Decision|1|||
156689240|NCT01730040|565607579|FG006|Overall Study|Physician Decision|1|||
156689241|NCT01730040|565607573|FG000|Overall Study|Other than specified|7|||
156689242|NCT01730040|565607574|FG001|Overall Study|Other than specified|8|||
156689243|NCT01730040|565607575|FG002|Overall Study|Other than specified|5|||
156689244|NCT01730040|565607576|FG003|Overall Study|Other than specified|5|||
156689245|NCT01730040|565607577|FG004|Overall Study|Other than specified|5|||
156689246|NCT01730040|565607578|FG005|Overall Study|Other than specified|4|||
156689247|NCT01730040|565607579|FG006|Overall Study|Other than specified|4|||
156689248|NCT01730040|565607573|FG000|Overall Study|Adverse Event|4|||
156689249|NCT01730040|565607574|FG001|Overall Study|Adverse Event|3|||
156689250|NCT01730040|565607575|FG002|Overall Study|Adverse Event|5|||
156689251|NCT01730040|565607576|FG003|Overall Study|Adverse Event|3|||
156689252|NCT01730040|565607577|FG004|Overall Study|Adverse Event|1|||
156689253|NCT01730040|565607578|FG005|Overall Study|Adverse Event|1|||
156689254|NCT01730040|565607579|FG006|Overall Study|Adverse Event|2|||
156787580|NCT02533674|565974754|FG003|Dose Level III|Treatment-related AE|0|||
156787581|NCT02533674|565974755|FG004|Dose Level III|Treatment-related AE|0|||
156787582|NCT02533674|565974756|FG005|Dose Level III|Treatment-related AE|0|||
156787583|NCT02533674|565974757|FG006|Dose Level III|Treatment-related AE|0|||
156787584|NCT02533674|565974758|FG007|Dose Level III|Treatment-related AE|0|||
156787585|NCT02533674|565974751|FG000|Dose Level IV|Progressive disease|0|||
156787586|NCT02533674|565974752|FG001|Dose Level IV|Progressive disease|0|||
156787587|NCT02533674|565974753|FG002|Dose Level IV|Progressive disease|0|||
156787588|NCT02533674|565974754|FG003|Dose Level IV|Progressive disease|3|||
156787589|NCT02533674|565974755|FG004|Dose Level IV|Progressive disease|0|||
156436924|NCT04795752|564689156|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
156689255|NCT01730040|565607573|FG000|Overall Study|Poor compliance to protocol|2|||
156689256|NCT01730040|565607574|FG001|Overall Study|Poor compliance to protocol|4|||
156689257|NCT01730040|565607575|FG002|Overall Study|Poor compliance to protocol|0|||
156689258|NCT01730040|565607576|FG003|Overall Study|Poor compliance to protocol|0|||
156689259|NCT01730040|565607577|FG004|Overall Study|Poor compliance to protocol|0|||
156689260|NCT01730040|565607578|FG005|Overall Study|Poor compliance to protocol|0|||
156689261|NCT01730040|565607579|FG006|Overall Study|Poor compliance to protocol|1|||
156689262|NCT01552369|565607583|FG000|Overall Study|Did not consent to extended follow up|8|||
156689263|NCT01552369|565607584|FG001|Overall Study|Did not consent to extended follow up|9|||
156689264|NCT00614926|565607585|FG000|Overall Study|Burden of travel|1|||
156689265|NCT00614926|565607586|FG001|Overall Study|Burden of travel|0|||
156689266|NCT00614926|565607585|FG000|Overall Study|Adverse Event|3|||
156689267|NCT00614926|565607586|FG001|Overall Study|Adverse Event|0|||
156689268|NCT02310789|565607591|FG000|Overall Study|Adverse Event|1|||
156689269|NCT01197417|565607592|FG000|Overall Study|Physician Decision|3|||
156689270|NCT01197417|565607593|FG001|Overall Study|Physician Decision|2|||
156689271|NCT01197417|565607592|FG000|Overall Study|Withdrawal by Subject|2|||
156689272|NCT01197417|565607593|FG001|Overall Study|Withdrawal by Subject|4|||
156689273|NCT01197417|565607592|FG000|Overall Study|Site miscommunication|0|||
156689274|NCT01197417|565607593|FG001|Overall Study|Site miscommunication|1|||
156689275|NCT01197417|565607592|FG000|Overall Study|Subject transferred to intensive care|0|||
156689276|NCT01197417|565607593|FG001|Overall Study|Subject transferred to intensive care|1|||
156689277|NCT01197417|565607592|FG000|Overall Study|Not consented in time to receive drug|0|||
156689278|NCT01197417|565607593|FG001|Overall Study|Not consented in time to receive drug|1|||
156689279|NCT01197417|565607592|FG000|Overall Study|Hypotension|1|||
156689280|NCT01197417|565607593|FG001|Overall Study|Hypotension|2|||
156689281|NCT01197417|565607592|FG000|Overall Study|Found to be ineligible|2|||
156689282|NCT01197417|565607593|FG001|Overall Study|Found to be ineligible|5|||
156689283|NCT01197417|565607592|FG000|Overall Study|No 25-hour magnesium level|0|||
156689284|NCT01197417|565607593|FG001|Overall Study|No 25-hour magnesium level|2|||
156689285|NCT02065713|565607594|FG000|Overall Study|Adverse Event|0|||
156689286|NCT02065713|565607595|FG001|Overall Study|Adverse Event|1|||
156689287|NCT02065713|565607594|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156689288|NCT02065713|565607595|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156689289|NCT01833533|565607598|FG000|Overall Study|Adverse Event|0|||
156689290|NCT01833533|565607599|FG001|Overall Study|Adverse Event|1|||
156689291|NCT01833533|565607598|FG000|Overall Study|Lost to Follow-up|4|||
156689292|NCT01833533|565607599|FG001|Overall Study|Lost to Follow-up|9|||
156689293|NCT01833533|565607598|FG000|Overall Study|To Enter an Extension Study|0|||
156689294|NCT01833533|565607599|FG001|Overall Study|To Enter an Extension Study|4|||
156689295|NCT01833533|565607598|FG000|Overall Study|Other|2|||
156689296|NCT01833533|565607599|FG001|Overall Study|Other|7|||
156689297|NCT02772562|565607601|FG000|Overall Study|Withdrawal by Subject|1|||
156689298|NCT02772562|565607601|FG000|Overall Study|Protocol Violation|1|||
156689299|NCT01048502|565607604|FG000|Overall Study|Lost to Follow-up|2|||
156689300|NCT01048502|565607605|FG001|Overall Study|Lost to Follow-up|0|||
156689301|NCT01048502|565607606|FG002|Overall Study|Lost to Follow-up|0|||
156689302|NCT01048502|565607607|FG003|Overall Study|Lost to Follow-up|0|||
156689303|NCT01048502|565607604|FG000|Overall Study|Adverse Event|1|||
156689304|NCT01048502|565607605|FG001|Overall Study|Adverse Event|0|||
156689305|NCT01048502|565607606|FG002|Overall Study|Adverse Event|0|||
156689306|NCT01048502|565607607|FG003|Overall Study|Adverse Event|0|||
156689307|NCT01048502|565607604|FG000|Overall Study|Withdrawal by Subject|1|||
156689308|NCT01048502|565607605|FG001|Overall Study|Withdrawal by Subject|4|||
156689309|NCT01048502|565607606|FG002|Overall Study|Withdrawal by Subject|5|||
156689310|NCT01048502|565607607|FG003|Overall Study|Withdrawal by Subject|3|||
156689311|NCT01048502|565607604|FG000|Overall Study|Physician Decision|0|||
156689312|NCT01048502|565607605|FG001|Overall Study|Physician Decision|3|||
156689313|NCT01048502|565607606|FG002|Overall Study|Physician Decision|0|||
156689314|NCT01048502|565607607|FG003|Overall Study|Physician Decision|1|||
156689315|NCT03336242|565607608|FG000|Overall Study|Adverse Event|0|||
156689316|NCT03336242|565607609|FG001|Overall Study|Adverse Event|1|||
156689317|NCT02457611|565607611|FG000|Overall Study|Lost to Follow-up|3|||
156689318|NCT03005067|565607612|FG000|Overall Study|Withdrawal by Subject|3|||
156689319|NCT03005067|565607613|FG001|Overall Study|Withdrawal by Subject|2|||
156689320|NCT03005067|565607612|FG000|Overall Study|Adverse Event|4|||
156689321|NCT03005067|565607613|FG001|Overall Study|Adverse Event|3|||
156689322|NCT03005067|565607612|FG000|Overall Study|Other (reason not specified)|3|||
156689323|NCT03005067|565607613|FG001|Overall Study|Other (reason not specified)|1|||
156689324|NCT03005067|565607612|FG000|Overall Study|Protocol Violation|0|||
156689325|NCT03005067|565607613|FG001|Overall Study|Protocol Violation|1|||
156689326|NCT00296491|565607614|FG000|Overall Study|Low Pollen Counts|18|||
156689327|NCT00296491|565607615|FG001|Overall Study|Low Pollen Counts|26|||
156689328|NCT00296491|565607616|FG002|Overall Study|Low Pollen Counts|25|||
156689329|NCT00296491|565607617|FG003|Overall Study|Low Pollen Counts|16|||
156689330|NCT00296491|565607614|FG000|Overall Study|Protocol Violation|4|||
156689331|NCT00296491|565607615|FG001|Overall Study|Protocol Violation|6|||
156689332|NCT00296491|565607616|FG002|Overall Study|Protocol Violation|2|||
156689333|NCT00296491|565607617|FG003|Overall Study|Protocol Violation|3|||
156689334|NCT00296491|565607614|FG000|Overall Study|Adverse Event|1|||
156689335|NCT00296491|565607615|FG001|Overall Study|Adverse Event|3|||
156689336|NCT00296491|565607616|FG002|Overall Study|Adverse Event|1|||
156689337|NCT00296491|565607617|FG003|Overall Study|Adverse Event|4|||
156689338|NCT00296491|565607614|FG000|Overall Study|Withdrawn due to Asthma|0|||
156689339|NCT00296491|565607615|FG001|Overall Study|Withdrawn due to Asthma|0|||
156689340|NCT00296491|565607616|FG002|Overall Study|Withdrawn due to Asthma|0|||
156689341|NCT00296491|565607617|FG003|Overall Study|Withdrawn due to Asthma|4|||
156689342|NCT00296491|565607614|FG000|Overall Study|Withdrawal by Subject|7|||
156689343|NCT00296491|565607615|FG001|Overall Study|Withdrawal by Subject|3|||
156689344|NCT00296491|565607616|FG002|Overall Study|Withdrawal by Subject|3|||
156689345|NCT00296491|565607617|FG003|Overall Study|Withdrawal by Subject|2|||
156689346|NCT00296491|565607614|FG000|Overall Study|Non-Compliance|12|||
156689347|NCT00296491|565607615|FG001|Overall Study|Non-Compliance|13|||
156689348|NCT00296491|565607616|FG002|Overall Study|Non-Compliance|10|||
156689349|NCT00296491|565607617|FG003|Overall Study|Non-Compliance|14|||
156689350|NCT00296491|565607614|FG000|Overall Study|Lost to Follow-up|0|||
156689351|NCT00296491|565607615|FG001|Overall Study|Lost to Follow-up|2|||
156689352|NCT00296491|565607616|FG002|Overall Study|Lost to Follow-up|2|||
156689353|NCT00296491|565607617|FG003|Overall Study|Lost to Follow-up|0|||
156689354|NCT05575063|565607620|FG000|Overall Study|Withdrawal by Subject|1|||
156689355|NCT01740791|565607623|FG000|Overall Study|Randomized but never treated|5|||
156689356|NCT01740791|565607624|FG001|Overall Study|Randomized but never treated|3|||
156689357|NCT01740791|565607625|FG002|Overall Study|Randomized but never treated|2|||
156689358|NCT01740791|565607626|FG003|Overall Study|Randomized but never treated|2|||
156689359|NCT01740791|565607627|FG004|Overall Study|Randomized but never treated|1|||
156689360|NCT01740791|565607628|FG005|Overall Study|Randomized but never treated|3|||
156689361|NCT01740791|565607623|FG000|Overall Study|Lost to Follow-up|2|||
156689362|NCT01740791|565607624|FG001|Overall Study|Lost to Follow-up|0|||
156689363|NCT01740791|565607625|FG002|Overall Study|Lost to Follow-up|2|||
156689364|NCT01740791|565607626|FG003|Overall Study|Lost to Follow-up|3|||
156689365|NCT01740791|565607627|FG004|Overall Study|Lost to Follow-up|2|||
156689366|NCT01740791|565607628|FG005|Overall Study|Lost to Follow-up|3|||
156689367|NCT01740791|565607623|FG000|Overall Study|Withdrew Consent|4|||
156689368|NCT01740791|565607624|FG001|Overall Study|Withdrew Consent|0|||
156689369|NCT01740791|565607625|FG002|Overall Study|Withdrew Consent|1|||
156689370|NCT01740791|565607626|FG003|Overall Study|Withdrew Consent|2|||
156689371|NCT01740791|565607627|FG004|Overall Study|Withdrew Consent|0|||
156689372|NCT01740791|565607628|FG005|Overall Study|Withdrew Consent|3|||
156689373|NCT01740791|565607623|FG000|Overall Study|Investigator's discretion|1|||
156689374|NCT01740791|565607624|FG001|Overall Study|Investigator's discretion|0|||
156689375|NCT01740791|565607625|FG002|Overall Study|Investigator's discretion|1|||
156689376|NCT01740791|565607626|FG003|Overall Study|Investigator's discretion|0|||
156689377|NCT01740791|565607627|FG004|Overall Study|Investigator's discretion|0|||
156689378|NCT01740791|565607628|FG005|Overall Study|Investigator's discretion|1|||
156689379|NCT01740791|565607623|FG000|Overall Study|Adverse Event|0|||
156689380|NCT01740791|565607624|FG001|Overall Study|Adverse Event|0|||
156689381|NCT01740791|565607625|FG002|Overall Study|Adverse Event|0|||
156689382|NCT01740791|565607626|FG003|Overall Study|Adverse Event|0|||
156689383|NCT01740791|565607627|FG004|Overall Study|Adverse Event|0|||
156689384|NCT01740791|565607628|FG005|Overall Study|Adverse Event|1|||
156689385|NCT01351350|565607635|FG000|Overall Study|Disease Progression|5|||
156689386|NCT01351350|565607636|FG001|Overall Study|Disease Progression|13|||
156689387|NCT01351350|565607637|FG002|Overall Study|Disease Progression|6|||
156689388|NCT01351350|565607638|FG003|Overall Study|Disease Progression|8|||
156689389|NCT01351350|565607639|FG004|Overall Study|Disease Progression|5|||
156689390|NCT01351350|565607635|FG000|Overall Study|Adverse Event|1|||
156689391|NCT01351350|565607636|FG001|Overall Study|Adverse Event|10|||
156689392|NCT01351350|565607637|FG002|Overall Study|Adverse Event|1|||
156689393|NCT01351350|565607638|FG003|Overall Study|Adverse Event|2|||
156689394|NCT01351350|565607639|FG004|Overall Study|Adverse Event|0|||
156689395|NCT01351350|565607635|FG000|Overall Study|Participant Decision|2|||
156689396|NCT01351350|565607636|FG001|Overall Study|Participant Decision|6|||
156689397|NCT01351350|565607637|FG002|Overall Study|Participant Decision|3|||
156689398|NCT01351350|565607638|FG003|Overall Study|Participant Decision|3|||
156689399|NCT01351350|565607639|FG004|Overall Study|Participant Decision|2|||
156689400|NCT01351350|565607635|FG000|Overall Study|Enrolled but not Treated|0|||
156689401|NCT01351350|565607636|FG001|Overall Study|Enrolled but not Treated|0|||
156689402|NCT01351350|565607637|FG002|Overall Study|Enrolled but not Treated|1|||
156689403|NCT01351350|565607638|FG003|Overall Study|Enrolled but not Treated|0|||
156689404|NCT01351350|565607639|FG004|Overall Study|Enrolled but not Treated|0|||
156689405|NCT04647383|565607640|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
156689406|NCT04647383|565607641|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
156689407|NCT04647383|565607642|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
156689408|NCT04647383|565607643|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
156689409|NCT00775528|565607644|FG000|Overall Study|Protocol Violation|1|||
156689410|NCT02083926|565607649|FG000|Overall Study|Withdrawal by Subject|1|||
156689411|NCT02083926|565607650|FG001|Overall Study|Withdrawal by Subject|0|||
156689412|NCT02610816|565607651|FG000|Phase 1|Withdrawal by Subject|2|||
156689413|NCT02610816|565607652|FG001|Phase 1|Withdrawal by Subject|6|||
156689414|NCT02610816|565607653|FG002|Phase 1|Withdrawal by Subject|0|||
156689415|NCT02610816|565607654|FG003|Phase 1|Withdrawal by Subject|0|||
156689416|NCT02610816|565607651|FG000|Phase 1|Lost to Follow-up|2|||
156689417|NCT02610816|565607652|FG001|Phase 1|Lost to Follow-up|1|||
156689418|NCT02610816|565607653|FG002|Phase 1|Lost to Follow-up|0|||
156689419|NCT02610816|565607654|FG003|Phase 1|Lost to Follow-up|0|||
156689420|NCT02610816|565607651|FG000|Phase 1|Physician Decision|0|||
156689421|NCT02610816|565607652|FG001|Phase 1|Physician Decision|1|||
156689422|NCT02610816|565607653|FG002|Phase 1|Physician Decision|0|||
156689423|NCT02610816|565607654|FG003|Phase 1|Physician Decision|0|||
156530568|NCT03471871|565036467|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
156530569|NCT03471871|565036468|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
156689424|NCT02610816|565607651|FG000|Phase 2|Withdrawal by Subject|0|||
156689425|NCT02610816|565607652|FG001|Phase 2|Withdrawal by Subject|0|||
156689426|NCT02610816|565607653|FG002|Phase 2|Withdrawal by Subject|9|||
156689427|NCT02610816|565607654|FG003|Phase 2|Withdrawal by Subject|3|||
156689428|NCT02610816|565607651|FG000|Phase 2|Lost to Follow-up|0|||
156689429|NCT02610816|565607652|FG001|Phase 2|Lost to Follow-up|0|||
156689430|NCT02610816|565607653|FG002|Phase 2|Lost to Follow-up|2|||
156689431|NCT02610816|565607654|FG003|Phase 2|Lost to Follow-up|0|||
156689432|NCT02610816|565607651|FG000|Phase 2|Physician Decision|0|||
156689433|NCT02610816|565607652|FG001|Phase 2|Physician Decision|0|||
156689434|NCT02610816|565607653|FG002|Phase 2|Physician Decision|0|||
156689435|NCT02610816|565607654|FG003|Phase 2|Physician Decision|2|||
156689436|NCT02610816|565607651|FG000|Phase 2|Pregnancy|0|||
156689437|NCT02610816|565607652|FG001|Phase 2|Pregnancy|0|||
156689438|NCT02610816|565607653|FG002|Phase 2|Pregnancy|0|||
156689439|NCT02610816|565607654|FG003|Phase 2|Pregnancy|1|||
156689440|NCT00384176|565607657|FG000|Overall Study|Death|239|||
156689441|NCT00384176|565607658|FG001|Overall Study|Death|247|||
156689442|NCT00384176|565607659|FG002|Overall Study|Death|105|||
156689443|NCT00384176|565607657|FG000|Overall Study|Withdrawal by Subject|52|||
156689444|NCT00384176|565607658|FG001|Overall Study|Withdrawal by Subject|48|||
156689445|NCT00384176|565607659|FG002|Overall Study|Withdrawal by Subject|22|||
156689446|NCT00384176|565607657|FG000|Overall Study|Lost to Follow-up|16|||
156689447|NCT00384176|565607658|FG001|Overall Study|Lost to Follow-up|18|||
156689448|NCT00384176|565607659|FG002|Overall Study|Lost to Follow-up|4|||
156689449|NCT00384176|565607657|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
156689450|NCT00384176|565607658|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
156689451|NCT00384176|565607659|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
156689452|NCT00384176|565607657|FG000|Overall Study|Longer QTC as Visit 1|1|||
156689453|NCT00384176|565607658|FG001|Overall Study|Longer QTC as Visit 1|0|||
156436925|NCT04795752|564689157|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
156436926|NCT00792948|564689158|FG000|Overall Study|Adverse Event|6|||
156436927|NCT00792948|564689158|FG000|Overall Study|Death|4|||
156436928|NCT00792948|564689158|FG000|Overall Study|Withdrawal by Subject|3|||
156436929|NCT00792948|564689158|FG000|Overall Study|Ineligible|2|||
156436930|NCT00792948|564689158|FG000|Overall Study|Insurance denial - not treated|1|||
156436931|NCT00792948|564689158|FG000|Overall Study|Physician Decision|11|||
156436932|NCT00792948|564689158|FG000|Overall Study|Protocol Violation|1|||
156436933|NCT06129045|564689159|FG000|Overall Study|Lost to Follow-up|1|||
156689454|NCT00384176|565607659|FG002|Overall Study|Longer QTC as Visit 1|0|||
156689455|NCT00384176|565607657|FG000|Overall Study|Toxicity of treatment|1|||
156689456|NCT00384176|565607658|FG001|Overall Study|Toxicity of treatment|0|||
156689457|NCT00384176|565607659|FG002|Overall Study|Toxicity of treatment|0|||
156436934|NCT06129045|564689160|FG001|Overall Study|Lost to Follow-up|1|||
156436935|NCT06129045|564689161|FG002|Overall Study|Lost to Follow-up|4|||
156436936|NCT01390402|564689166|FG000|Overall Study|Death|1|||
156436937|NCT01390402|564689166|FG000|Overall Study|Disease Progression|4|||
156436938|NCT03492177|564689167|FG000|Overall Study|Adverse Event|1|||
156436939|NCT03492177|564689168|FG001|Overall Study|Adverse Event|0|||
156436940|NCT03492177|564689169|FG002|Overall Study|Adverse Event|0|||
156436941|NCT03492177|564689167|FG000|Overall Study|Death|3|||
156436942|NCT03492177|564689168|FG001|Overall Study|Death|0|||
156436943|NCT03492177|564689169|FG002|Overall Study|Death|3|||
156436944|NCT03492177|564689167|FG000|Overall Study|Lack of Efficacy|1|||
156436945|NCT03492177|564689168|FG001|Overall Study|Lack of Efficacy|2|||
156436946|NCT03492177|564689169|FG002|Overall Study|Lack of Efficacy|0|||
156436947|NCT03492177|564689167|FG000|Overall Study|Other|1|||
156436948|NCT03492177|564689168|FG001|Overall Study|Other|0|||
156689458|NCT00384176|565607657|FG000|Overall Study|Did not receive study treatment|0|||
156689459|NCT00384176|565607658|FG001|Overall Study|Did not receive study treatment|1|||
156689460|NCT00384176|565607659|FG002|Overall Study|Did not receive study treatment|1|||
156689461|NCT00384176|565607657|FG000|Overall Study|Physician Decision|0|||
156436949|NCT03492177|564689169|FG002|Overall Study|Other|0|||
156436950|NCT03492177|564689167|FG000|Overall Study|Ongoing|16|||
156436951|NCT03492177|564689168|FG001|Overall Study|Ongoing|19|||
156436952|NCT03492177|564689169|FG002|Overall Study|Ongoing|17|||
156436953|NCT02445391|564689172|FG000|Overall Study|No active protocol treatment|3|||
156436954|NCT02445391|564689173|FG001|Overall Study|No active protocol treatment|0|||
156436955|NCT02445391|564689174|FG002|Overall Study|No active protocol treatment|0|||
156436956|NCT02445391|564689172|FG000|Overall Study|Adverse Event|0|||
156436957|NCT02445391|564689173|FG001|Overall Study|Adverse Event|21|||
156689462|NCT00384176|565607658|FG001|Overall Study|Physician Decision|2|||
156689463|NCT00384176|565607659|FG002|Overall Study|Physician Decision|0|||
156689464|NCT00384176|565607657|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
156787590|NCT02533674|565974756|FG005|Dose Level IV|Progressive disease|0|||
156689465|NCT00384176|565607658|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
156689466|NCT00384176|565607659|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
156689467|NCT00842530|565607660|FG000|Overall Study|Serious adverse event|0|||
156689468|NCT00842530|565607661|FG001|Overall Study|Serious adverse event|6|||
156689469|NCT00842530|565607660|FG000|Overall Study|Other adverse event|6|||
156689470|NCT00842530|565607661|FG001|Overall Study|Other adverse event|1|||
156689471|NCT00842530|565607660|FG000|Overall Study|Protocol Violation|32|||
156689472|NCT00842530|565607661|FG001|Overall Study|Protocol Violation|14|||
156689473|NCT00842530|565607660|FG000|Overall Study|Lost to Follow-up|6|||
156689474|NCT00842530|565607661|FG001|Overall Study|Lost to Follow-up|8|||
156689475|NCT00842530|565607660|FG000|Overall Study|Withdrawal by Subject|73|||
156689476|NCT00842530|565607661|FG001|Overall Study|Withdrawal by Subject|28|||
156689477|NCT02939950|565607662|FG000|Overall Study|Lost to Follow-up|13|||
156689478|NCT02939950|565607663|FG001|Overall Study|Lost to Follow-up|16|||
156689479|NCT02939950|565607662|FG000|Overall Study|Positive slit lamp findings|0|||
156689480|NCT02939950|565607663|FG001|Overall Study|Positive slit lamp findings|1|||
156689481|NCT02939950|565607662|FG000|Overall Study|Chalazion upper lid|0|||
156689482|NCT02939950|565607663|FG001|Overall Study|Chalazion upper lid|1|||
156689483|NCT02939950|565607662|FG000|Overall Study|Lack of motivation|0|||
156689484|NCT02939950|565607663|FG001|Overall Study|Lack of motivation|2|||
156689485|NCT02939950|565607662|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
156689486|NCT02939950|565607663|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
156689487|NCT02939950|565607662|FG000|Overall Study|Military orders|1|||
156689488|NCT02939950|565607663|FG001|Overall Study|Military orders|0|||
156689489|NCT02939950|565607662|FG000|Overall Study|Participant Relocated|5|||
156689490|NCT02939950|565607663|FG001|Overall Study|Participant Relocated|3|||
156689491|NCT02939950|565607662|FG000|Overall Study|Study related symptoms|8|||
156689492|NCT02939950|565607663|FG001|Overall Study|Study related symptoms|8|||
156689493|NCT02939950|565607662|FG000|Overall Study|Unacceptable lens movement|2|||
156689494|NCT02939950|565607663|FG001|Overall Study|Unacceptable lens movement|0|||
156689495|NCT02939950|565607662|FG000|Overall Study|Protocol Violation|6|||
156689496|NCT02939950|565607663|FG001|Overall Study|Protocol Violation|3|||
156689497|NCT02939950|565607662|FG000|Overall Study|Physician Decision|2|||
156689498|NCT02939950|565607663|FG001|Overall Study|Physician Decision|0|||
156689499|NCT02939950|565607662|FG000|Overall Study|Pregnancy|6|||
156689500|NCT02939950|565607663|FG001|Overall Study|Pregnancy|7|||
156689501|NCT02939950|565607662|FG000|Overall Study|Withdrawal by Subject|12|||
156689502|NCT02939950|565607663|FG001|Overall Study|Withdrawal by Subject|28|||
156689503|NCT02939950|565607662|FG000|Overall Study|Adverse Event|7|||
156689504|NCT02939950|565607663|FG001|Overall Study|Adverse Event|3|||
156689505|NCT02939950|565607662|FG000|Overall Study|Randomized, not dispensed|1|||
156689506|NCT02939950|565607663|FG001|Overall Study|Randomized, not dispensed|0|||
156689507|NCT02939950|565607662|FG000|Overall Study|Ineligible at Baseline|2|||
156689508|NCT02939950|565607663|FG001|Overall Study|Ineligible at Baseline|8|||
156689509|NCT00402025|565607665|FG000|Overall Study|Adverse Event|0|||
156689510|NCT00402025|565607666|FG001|Overall Study|Adverse Event|0|||
156689511|NCT00402025|565607667|FG002|Overall Study|Adverse Event|2|||
156689512|NCT00402025|565607665|FG000|Overall Study|Death|0|||
156689513|NCT00402025|565607666|FG001|Overall Study|Death|1|||
156689514|NCT00402025|565607667|FG002|Overall Study|Death|5|||
156689515|NCT00402025|565607665|FG000|Overall Study|Disease Progression|1|||
156689516|NCT00402025|565607666|FG001|Overall Study|Disease Progression|1|||
156689517|NCT00402025|565607667|FG002|Overall Study|Disease Progression|2|||
156689518|NCT00402025|565607665|FG000|Overall Study|Physician Decision|1|||
156689519|NCT00402025|565607666|FG001|Overall Study|Physician Decision|1|||
156689520|NCT00402025|565607667|FG002|Overall Study|Physician Decision|0|||
156689521|NCT00402025|565607665|FG000|Overall Study|Participant Decision|0|||
156787591|NCT02533674|565974757|FG006|Dose Level IV|Progressive disease|0|||
156787592|NCT02533674|565974758|FG007|Dose Level IV|Progressive disease|0|||
156787593|NCT02533674|565974751|FG000|Dose Level IV|Withdrawal by Subject|0|||
156787594|NCT02533674|565974752|FG001|Dose Level IV|Withdrawal by Subject|0|||
156787595|NCT02533674|565974753|FG002|Dose Level IV|Withdrawal by Subject|0|||
156787596|NCT02533674|565974754|FG003|Dose Level IV|Withdrawal by Subject|1|||
156787597|NCT02533674|565974755|FG004|Dose Level IV|Withdrawal by Subject|0|||
156787598|NCT02533674|565974756|FG005|Dose Level IV|Withdrawal by Subject|0|||
156330020|NCT00004635|564308745|FG000|Period Two|Adverse Event|1|||
156330021|NCT00004635|564308746|FG001|Period Two|Adverse Event|0|||
156689522|NCT00402025|565607666|FG001|Overall Study|Participant Decision|0|||
156689523|NCT00402025|565607667|FG002|Overall Study|Participant Decision|1|||
156689524|NCT01314118|565608916|FG000|Overall Study|Adverse Event|10|||
156689525|NCT01314118|565608916|FG000|Overall Study|Progressive disease|3|||
156689526|NCT01314118|565608916|FG000|Overall Study|Death|8|||
156689527|NCT01314118|565608916|FG000|Overall Study|Physician Decision|13|||
156689528|NCT01314118|565608916|FG000|Overall Study|Sponsor Decision|1|||
156689529|NCT01314118|565608916|FG000|Overall Study|Protocol Violation|2|||
156689530|NCT01314118|565608916|FG000|Overall Study|Withdrawal by Subject|26|||
156689531|NCT01314118|565608916|FG000|Overall Study|Other|21|||
156689532|NCT00655850|565608917|FG000|Overall Study|Death|2|||
156787599|NCT02533674|565974757|FG006|Dose Level IV|Withdrawal by Subject|0|||
156689533|NCT00655850|565608917|FG000|Overall Study|Withdrawal by Subject|1|||
156689534|NCT02459665|565608918|FG000|Overall Study|Withdrawal by Subject|0|||
156689535|NCT02459665|565608919|FG001|Overall Study|Withdrawal by Subject|1|||
156689536|NCT02459665|565608920|FG002|Overall Study|Withdrawal by Subject|1|||
156689537|NCT02459665|565608921|FG003|Overall Study|Withdrawal by Subject|2|||
156689538|NCT00865098|565608923|FG000|Overall Study|Progressive disease|1|||
156689539|NCT01014624|565608924|FG000|Overall Study|Adverse Event|0|||
156689540|NCT01014624|565608925|FG001|Overall Study|Adverse Event|1|||
156689541|NCT01014624|565608924|FG000|Overall Study|Protocol Violation|1|||
156689542|NCT01014624|565608925|FG001|Overall Study|Protocol Violation|0|||
156689543|NCT01014624|565608924|FG000|Overall Study|Withdrawal by Subject|1|||
156689544|NCT01014624|565608925|FG001|Overall Study|Withdrawal by Subject|0|||
156689545|NCT01715896|565608926|FG000|Overall Study|Lost to Follow-up|0|||
156689546|NCT01715896|565608927|FG001|Overall Study|Lost to Follow-up|2|||
156689547|NCT01715896|565608926|FG000|Overall Study|Withdrawal by Subject|1|||
156689548|NCT01715896|565608927|FG001|Overall Study|Withdrawal by Subject|4|||
156689549|NCT01715896|565608926|FG000|Overall Study|Other|2|||
156689550|NCT01715896|565608927|FG001|Overall Study|Other|5|||
156689551|NCT01117337|565608929|FG000|Overall Study|Lost to Follow-up|4|||
156689552|NCT01117337|565608930|FG001|Overall Study|Lost to Follow-up|0|||
156689553|NCT01045993|565608931|FG000|Overall Study|Treated-later found eligibility not met|0|||
156689554|NCT01045993|565608932|FG001|Overall Study|Treated-later found eligibility not met|1|||
156689555|NCT01045993|565608933|FG002|Overall Study|Treated-later found eligibility not met|0|||
156689556|NCT01045993|565608934|FG003|Overall Study|Treated-later found eligibility not met|0|||
156689557|NCT00949988|565608940|FG000|Overall Study|Withdrawal by Subject|3|||
156689558|NCT01929395|565608941|FG000|Overall Study|Did not complete - non-related toxicity|1|||
156689559|NCT01929395|565608942|FG001|Overall Study|Did not complete - non-related toxicity|0|||
156689560|NCT01929395|565608943|FG002|Overall Study|Did not complete - non-related toxicity|0|||
156689561|NCT01929395|565608941|FG000|Overall Study|Withdrawal by Subject|0|||
156689562|NCT01929395|565608942|FG001|Overall Study|Withdrawal by Subject|1|||
156689563|NCT01929395|565608943|FG002|Overall Study|Withdrawal by Subject|0|||
156689564|NCT01929395|565608941|FG000|Overall Study|Screen Fail|0|||
156689565|NCT01929395|565608942|FG001|Overall Study|Screen Fail|0|||
156689566|NCT01929395|565608943|FG002|Overall Study|Screen Fail|1|||
156689567|NCT03604341|565608945|FG000|Overall Study|Withdrawal by Subject|1|||
156689568|NCT03604341|565608946|FG001|Overall Study|Withdrawal by Subject|1|||
156689569|NCT03604341|565608945|FG000|Overall Study|Adverse Event|1|||
156689570|NCT03604341|565608946|FG001|Overall Study|Adverse Event|0|||
156689571|NCT03604341|565608945|FG000|Overall Study|Protocol Violation|0|||
156689572|NCT03604341|565608946|FG001|Overall Study|Protocol Violation|1|||
156689573|NCT00484419|565608947|FG000|Overall Study|Adverse Event|3|||
156689574|NCT00484419|565608948|FG001|Overall Study|Adverse Event|0|||
156689575|NCT00484419|565608949|FG002|Overall Study|Adverse Event|0|||
156689576|NCT00484419|565608947|FG000|Overall Study|Lost to Follow-up|1|||
156689577|NCT00484419|565608948|FG001|Overall Study|Lost to Follow-up|0|||
156689578|NCT00484419|565608949|FG002|Overall Study|Lost to Follow-up|2|||
156689579|NCT00484419|565608947|FG000|Overall Study|Withdrawal by Subject|3|||
156689580|NCT00484419|565608948|FG001|Overall Study|Withdrawal by Subject|1|||
156689581|NCT00484419|565608949|FG002|Overall Study|Withdrawal by Subject|1|||
156689582|NCT00484419|565608947|FG000|Overall Study|subject met discontinuation criteria|2|||
156689583|NCT00484419|565608948|FG001|Overall Study|subject met discontinuation criteria|2|||
156689584|NCT00484419|565608949|FG002|Overall Study|subject met discontinuation criteria|4|||
156689585|NCT00484419|565608947|FG000|Overall Study|required restricted medication|1|||
156689586|NCT00484419|565608948|FG001|Overall Study|required restricted medication|0|||
156689587|NCT00484419|565608949|FG002|Overall Study|required restricted medication|1|||
156689588|NCT00484419|565608947|FG000|Overall Study|Physician Decision|1|||
156689589|NCT00484419|565608948|FG001|Overall Study|Physician Decision|1|||
156689590|NCT00484419|565608949|FG002|Overall Study|Physician Decision|1|||
156689591|NCT00484419|565608947|FG000|Overall Study|subject unable to receive medication|1|||
156689592|NCT00484419|565608948|FG001|Overall Study|subject unable to receive medication|0|||
156689593|NCT00484419|565608949|FG002|Overall Study|subject unable to receive medication|0|||
156689594|NCT00484419|565608947|FG000|Overall Study|subject relocated|0|||
156689595|NCT00484419|565608948|FG001|Overall Study|subject relocated|1|||
156689596|NCT00484419|565608949|FG002|Overall Study|subject relocated|0|||
156689597|NCT00484419|565608947|FG000|Overall Study|sponsor decision, randomized in error|0|||
156689598|NCT00484419|565608948|FG001|Overall Study|sponsor decision, randomized in error|0|||
156689599|NCT00484419|565608949|FG002|Overall Study|sponsor decision, randomized in error|2|||
156689600|NCT00355472|565608952|FG000|Overall Study|Physician Decision|1|||
156689601|NCT05445843|565608953|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
156689602|NCT05445843|565608954|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
156689603|NCT05445843|565608953|FG000|Overall Study|Progressive disease|17|||
156689604|NCT05445843|565608954|FG001|Overall Study|Progressive disease|9|||
156689605|NCT05445843|565608953|FG000|Overall Study|Physician Decision|16|||
156689606|NCT05445843|565608954|FG001|Overall Study|Physician Decision|4|||
156870027|NCT02379091|566281074|FG002|Overall Study|Study Termination|5|||
156689607|NCT05445843|565608953|FG000|Overall Study|Death|6|||
156689608|NCT05445843|565608954|FG001|Overall Study|Death|3|||
156689609|NCT05445843|565608953|FG000|Overall Study|Subject decision|6|||
156689610|NCT05445843|565608954|FG001|Overall Study|Subject decision|2|||
156689611|NCT05445843|565608953|FG000|Overall Study|Adverse Event|2|||
156689612|NCT05445843|565608954|FG001|Overall Study|Adverse Event|0|||
156689613|NCT05307679|565608959|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
156689614|NCT05307679|565608960|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
156436958|NCT02445391|564689174|FG002|Overall Study|Adverse Event|12|||
156689615|NCT02674386|565608963|FG000|Overall Study|Lost to Follow-up|0|||
156689616|NCT02674386|565608964|FG001|Overall Study|Lost to Follow-up|1|||
156689617|NCT02674386|565608965|FG002|Overall Study|Lost to Follow-up|1|||
156689618|NCT02674386|565608963|FG000|Overall Study|Withdrawal by Subject|0|||
156689619|NCT02674386|565608964|FG001|Overall Study|Withdrawal by Subject|4|||
156689620|NCT02674386|565608965|FG002|Overall Study|Withdrawal by Subject|0|||
156689621|NCT02674386|565608963|FG000|Overall Study|Other|0|||
156689622|NCT02674386|565608964|FG001|Overall Study|Other|1|||
156689623|NCT02674386|565608965|FG002|Overall Study|Other|0|||
156689624|NCT02674386|565608963|FG000|Overall Study|Enrolled but not evaluated|0|||
156689625|NCT02674386|565608964|FG001|Overall Study|Enrolled but not evaluated|4|||
156689626|NCT02674386|565608965|FG002|Overall Study|Enrolled but not evaluated|0|||
156689627|NCT00396331|565608970|FG000|Overall Study|Failed to mobilize - no transplant|8|||
156689628|NCT00396331|565608970|FG000|Overall Study|Did not go on to transplant|5|||
156689629|NCT00396331|565608970|FG000|Overall Study|Lost to Follow-up|3|||
156689630|NCT00396331|565608970|FG000|Overall Study|Death|16|||
156689631|NCT00873119|565608981|FG000|Overall Study|Patient request|4|||
156689632|NCT00873119|565608982|FG001|Overall Study|Patient request|2|||
156689633|NCT00873119|565608981|FG000|Overall Study|Adverse Event|8|||
156689634|NCT00873119|565608982|FG001|Overall Study|Adverse Event|0|||
156689635|NCT00873119|565608981|FG000|Overall Study|Progressive disease|26|||
156689636|NCT00873119|565608982|FG001|Overall Study|Progressive disease|18|||
156689637|NCT00873119|565608981|FG000|Overall Study|Death|2|||
156689638|NCT00873119|565608982|FG001|Overall Study|Death|1|||
156689639|NCT00873119|565608981|FG000|Overall Study|Other|2|||
156689640|NCT00873119|565608982|FG001|Overall Study|Other|5|||
156689641|NCT00873119|565608981|FG000|Overall Study|Not treated|2|||
156689642|NCT00873119|565608982|FG001|Overall Study|Not treated|0|||
156689643|NCT03648879|565608983|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
156689644|NCT00285584|565608984|FG000|Month 3|Lost to Follow-up|3|||
156689645|NCT00285584|565608985|FG001|Month 3|Lost to Follow-up|3|||
156689646|NCT00285584|565608984|FG000|Month 3|Withdrawal by Subject|1|||
156689647|NCT00285584|565608985|FG001|Month 3|Withdrawal by Subject|0|||
156689648|NCT00285584|565608984|FG000|Month 6|Lost to Follow-up|0|||
156689649|NCT00285584|565608985|FG001|Month 6|Lost to Follow-up|1|||
156689650|NCT01884688|565608988|FG000|Overall Study|Screen Failure|2|||
156689651|NCT04099641|565608992|FG000|Overall Study|Death|46|||
156689652|NCT04099641|565608993|FG001|Overall Study|Death|12|||
156436959|NCT02445391|564689172|FG000|Overall Study|Alternative therapy|0|||
156436960|NCT02445391|564689173|FG001|Overall Study|Alternative therapy|0|||
156436961|NCT02445391|564689174|FG002|Overall Study|Alternative therapy|1|||
156436962|NCT02445391|564689172|FG000|Overall Study|Disease progression|0|||
156436963|NCT02445391|564689173|FG001|Overall Study|Disease progression|7|||
156436964|NCT02445391|564689174|FG002|Overall Study|Disease progression|22|||
156436965|NCT02445391|564689172|FG000|Overall Study|Complicating disease|0|||
156436966|NCT02445391|564689173|FG001|Overall Study|Complicating disease|2|||
156436967|NCT02445391|564689174|FG002|Overall Study|Complicating disease|1|||
156436968|NCT02445391|564689172|FG000|Overall Study|Withdrawal by Subject|0|||
156436969|NCT02445391|564689173|FG001|Overall Study|Withdrawal by Subject|4|||
156436970|NCT02445391|564689174|FG002|Overall Study|Withdrawal by Subject|9|||
156436971|NCT02445391|564689172|FG000|Overall Study|Financial issue|0|||
156436972|NCT02445391|564689173|FG001|Overall Study|Financial issue|0|||
156436973|NCT02445391|564689174|FG002|Overall Study|Financial issue|2|||
156436974|NCT02445391|564689172|FG000|Overall Study|Still on treatment|0|||
156436975|NCT02445391|564689173|FG001|Overall Study|Still on treatment|7|||
156436976|NCT02445391|564689174|FG002|Overall Study|Still on treatment|16|||
156537836|NCT01011439|565062871|FG000|Overall Study|Sponsor's decision|15|||
156436977|NCT02445391|564689172|FG000|Overall Study|Not start protocol therapy|0|||
156436978|NCT02445391|564689173|FG001|Overall Study|Not start protocol therapy|12|||
156436979|NCT02445391|564689174|FG002|Overall Study|Not start protocol therapy|9|||
156436980|NCT02611037|564689175|FG000|Overall Study|Withdrawal prior to treatment|2|||
156436981|NCT02611037|564689176|FG001|Overall Study|Withdrawal prior to treatment|0|||
156436982|NCT05850520|564689177|FG000|Overall Study|Withdrawal by Subject|8|||
156689653|NCT04099641|565608992|FG000|Overall Study|Lost to Follow-up|1|||
156689654|NCT04099641|565608993|FG001|Overall Study|Lost to Follow-up|0|||
156689655|NCT04099641|565608992|FG000|Overall Study|Withdrawal by Subject|2|||
156689656|NCT04099641|565608993|FG001|Overall Study|Withdrawal by Subject|0|||
156689657|NCT00895037|565608994|FG000|Overall Study|Death|0|||
156689658|NCT00895037|565608995|FG001|Overall Study|Death|2|||
156689659|NCT00895037|565608996|FG002|Overall Study|Death|1|||
156689660|NCT02470091|565609005|FG000|Overall Study|Withdrawal by Subject|1|||
156787600|NCT02533674|565974758|FG007|Dose Level IV|Withdrawal by Subject|0|||
156787601|NCT02533674|565974751|FG000|Dose Level IV|Physician Decision|0|||
156787602|NCT02533674|565974752|FG001|Dose Level IV|Physician Decision|0|||
156787603|NCT02533674|565974753|FG002|Dose Level IV|Physician Decision|0|||
156787604|NCT02533674|565974754|FG003|Dose Level IV|Physician Decision|1|||
156787605|NCT02533674|565974755|FG004|Dose Level IV|Physician Decision|0|||
156787606|NCT02533674|565974756|FG005|Dose Level IV|Physician Decision|0|||
156787607|NCT02533674|565974757|FG006|Dose Level IV|Physician Decision|0|||
156787608|NCT02533674|565974758|FG007|Dose Level IV|Physician Decision|0|||
156787609|NCT02533674|565974751|FG000|Dose Level V|Progressive disease|0|||
156787610|NCT02533674|565974752|FG001|Dose Level V|Progressive disease|0|||
156787611|NCT02533674|565974753|FG002|Dose Level V|Progressive disease|0|||
156787612|NCT02533674|565974754|FG003|Dose Level V|Progressive disease|0|||
156787613|NCT02533674|565974755|FG004|Dose Level V|Progressive disease|3|||
156787614|NCT02533674|565974756|FG005|Dose Level V|Progressive disease|0|||
156787615|NCT02533674|565974757|FG006|Dose Level V|Progressive disease|0|||
156787616|NCT02533674|565974758|FG007|Dose Level V|Progressive disease|0|||
156787617|NCT02533674|565974751|FG000|Dose Level V|Withdrawal by Subject|0|||
156787618|NCT02533674|565974752|FG001|Dose Level V|Withdrawal by Subject|0|||
156787619|NCT02533674|565974753|FG002|Dose Level V|Withdrawal by Subject|0|||
156787620|NCT02533674|565974754|FG003|Dose Level V|Withdrawal by Subject|0|||
156787621|NCT02533674|565974755|FG004|Dose Level V|Withdrawal by Subject|1|||
156787622|NCT02533674|565974756|FG005|Dose Level V|Withdrawal by Subject|0|||
156787623|NCT02533674|565974757|FG006|Dose Level V|Withdrawal by Subject|0|||
156537837|NCT01236573|565062874|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
156689661|NCT02470091|565609006|FG001|Overall Study|Withdrawal by Subject|0|||
156689662|NCT02470091|565609005|FG000|Overall Study|Ineligible|0|||
156689663|NCT02470091|565609006|FG001|Overall Study|Ineligible|2|||
156689664|NCT00303667|565609017|FG000|Overall Study|Death|0|||
156689665|NCT00303667|565609018|FG001|Overall Study|Death|4|||
156689666|NCT01029392|565609020|FG000|Overall Study|Withdrawal by Subject|18|||
156689667|NCT01029392|565609021|FG001|Overall Study|Withdrawal by Subject|11|||
156689668|NCT01029392|565609020|FG000|Overall Study|Physician Decision|2|||
156689669|NCT01029392|565609021|FG001|Overall Study|Physician Decision|0|||
156689670|NCT01103479|565609022|FG000|Overall Study|Up to date with CRC screening|1|||
156689671|NCT01103479|565609023|FG001|Overall Study|Up to date with CRC screening|9|||
156689672|NCT01103479|565609024|FG002|Overall Study|Up to date with CRC screening|12|||
156689673|NCT01103479|565609022|FG000|Overall Study|Family history of CRC|1|||
156689674|NCT01103479|565609023|FG001|Overall Study|Family history of CRC|0|||
156689675|NCT01103479|565609024|FG002|Overall Study|Family history of CRC|2|||
156689676|NCT01103479|565609022|FG000|Overall Study|Active cancer|1|||
156689677|NCT01103479|565609023|FG001|Overall Study|Active cancer|0|||
156689678|NCT01103479|565609024|FG002|Overall Study|Active cancer|0|||
156689679|NCT01103479|565609022|FG000|Overall Study|Saw non-study physician|2|||
156689680|NCT01103479|565609023|FG001|Overall Study|Saw non-study physician|0|||
156689681|NCT01103479|565609024|FG002|Overall Study|Saw non-study physician|0|||
156689682|NCT00834899|565609025|FG000|Overall Study|Withdrawal by Subject|1|||
156689683|NCT00834899|565609026|FG001|Overall Study|Withdrawal by Subject|1|||
156689684|NCT01534637|565609027|FG000|Overall Study|Physician Decision|3|||
156689685|NCT01534637|565609027|FG000|Overall Study|Lack of Efficacy|3|||
156689686|NCT01534637|565609027|FG000|Overall Study|Withdrawal by Subject|1|||
156689687|NCT01534637|565609027|FG000|Overall Study|Adverse Event|1|||
156689688|NCT01534637|565609027|FG000|Overall Study|Liver Mets before treatment|1|||
156689689|NCT01523587|565609028|FG000|Overall Study|Other than listed|5|||
156689690|NCT01523587|565609029|FG001|Overall Study|Other than listed|5|||
156689691|NCT01523587|565609028|FG000|Overall Study|Worsening of underlying cancer disease|19|||
156787624|NCT02533674|565974758|FG007|Dose Level V|Withdrawal by Subject|0|||
156787625|NCT02533674|565974751|FG000|Dose Level V|Physician Decision|0|||
156787626|NCT02533674|565974752|FG001|Dose Level V|Physician Decision|0|||
156787627|NCT02533674|565974753|FG002|Dose Level V|Physician Decision|0|||
156787628|NCT02533674|565974754|FG003|Dose Level V|Physician Decision|0|||
156787629|NCT02533674|565974755|FG004|Dose Level V|Physician Decision|1|||
156787630|NCT02533674|565974756|FG005|Dose Level V|Physician Decision|0|||
156787631|NCT02533674|565974757|FG006|Dose Level V|Physician Decision|0|||
156787632|NCT02533674|565974758|FG007|Dose Level V|Physician Decision|0|||
156870028|NCT02379091|566281075|FG003|Overall Study|Study Termination|8|||
156689692|NCT01523587|565609029|FG001|Overall Study|Worsening of underlying cancer disease|34|||
156689693|NCT01523587|565609028|FG000|Overall Study|Adverse Event|68|||
156689694|NCT01523587|565609029|FG001|Overall Study|Adverse Event|52|||
156689695|NCT01523587|565609028|FG000|Overall Study|Protocol Violation|5|||
156689696|NCT01523587|565609029|FG001|Overall Study|Protocol Violation|3|||
156689697|NCT01523587|565609028|FG000|Overall Study|Lost to Follow-up|2|||
156787633|NCT02533674|565974751|FG000|Dose Level VI|Progressive disease|0|||
156787634|NCT02533674|565974752|FG001|Dose Level VI|Progressive disease|0|||
156787635|NCT02533674|565974753|FG002|Dose Level VI|Progressive disease|0|||
156787636|NCT02533674|565974754|FG003|Dose Level VI|Progressive disease|0|||
156787637|NCT02533674|565974755|FG004|Dose Level VI|Progressive disease|0|||
156787638|NCT02533674|565974756|FG005|Dose Level VI|Progressive disease|7|||
156689698|NCT01523587|565609029|FG001|Overall Study|Lost to Follow-up|2|||
156689699|NCT01523587|565609028|FG000|Overall Study|Withdrawal by Subject|28|||
156689700|NCT01523587|565609029|FG001|Overall Study|Withdrawal by Subject|20|||
156689701|NCT01523587|565609028|FG000|Overall Study|Withdrew due to Progressive disease|265|||
156689702|NCT01523587|565609029|FG001|Overall Study|Withdrew due to Progressive disease|279|||
156689703|NCT01523587|565609028|FG000|Overall Study|Randomised but bot treated|6|||
156689704|NCT01523587|565609029|FG001|Overall Study|Randomised but bot treated|2|||
156689705|NCT01298778|565609030|FG000|Overall Study|Lost to Follow-up|2|||
156689706|NCT01298778|565609031|FG001|Overall Study|Lost to Follow-up|3|||
156689707|NCT01298778|565609030|FG000|Overall Study|Incorrect use of VAS|1|||
156689708|NCT01298778|565609031|FG001|Overall Study|Incorrect use of VAS|0|||
156689709|NCT01298778|565609030|FG000|Overall Study|Withdrawal by Subject|0|||
156689710|NCT01298778|565609031|FG001|Overall Study|Withdrawal by Subject|1|||
156689711|NCT01298778|565609030|FG000|Overall Study|Protocol Violation|0|||
156689712|NCT01298778|565609031|FG001|Overall Study|Protocol Violation|1|||
156689713|NCT01298778|565609030|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
156689714|NCT01298778|565609031|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
156689715|NCT00536484|565609035|FG000|Overall Study|Adverse Event|21|||
156689716|NCT00536484|565609036|FG001|Overall Study|Adverse Event|34|||
156689717|NCT00536484|565609035|FG000|Overall Study|Withdrawal by Subject|11|||
156689718|NCT00536484|565609036|FG001|Overall Study|Withdrawal by Subject|11|||
156689719|NCT00536484|565609035|FG000|Overall Study|Lost to Follow-up|8|||
156689720|NCT00536484|565609036|FG001|Overall Study|Lost to Follow-up|6|||
156689721|NCT00536484|565609035|FG000|Overall Study|Lack of Efficacy|16|||
156689722|NCT00536484|565609036|FG001|Overall Study|Lack of Efficacy|5|||
156689723|NCT00536484|565609035|FG000|Overall Study|Other|4|||
156530570|NCT03471871|565036469|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
156530571|NCT03471871|565036465|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
156530572|NCT03471871|565036466|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
156530573|NCT03471871|565036467|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
156530574|NCT03471871|565036468|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
156530575|NCT03471871|565036469|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
156530576|NCT03471871|565036465|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
156530577|NCT03471871|565036466|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
156530578|NCT03471871|565036467|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
156530579|NCT03471871|565036468|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
156530580|NCT03471871|565036469|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
156530581|NCT03471871|565036465|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
156530582|NCT03471871|565036466|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
156530583|NCT03471871|565036467|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
156530584|NCT03471871|565036468|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
156530585|NCT03471871|565036469|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
156530586|NCT03471871|565036465|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
156530587|NCT03471871|565036466|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
156530588|NCT03471871|565036467|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
156689724|NCT00536484|565609036|FG001|Overall Study|Other|0|||
156689725|NCT02549573|565609039|FG000|Overall Study|Withdrawal by Subject|0|||
156689726|NCT02549573|565609040|FG001|Overall Study|Withdrawal by Subject|2|||
156689727|NCT02549573|565609039|FG000|Overall Study|Protocol Violation|0|||
156689728|NCT02549573|565609040|FG001|Overall Study|Protocol Violation|1|||
156689729|NCT03064438|565610665|FG000|Overall Study|Lost to Follow-up|1|||
156689730|NCT03064438|565610666|FG001|Overall Study|Lost to Follow-up|0|||
156689731|NCT03064438|565610665|FG000|Overall Study|Withdrawal by Subject|0|||
156689732|NCT03064438|565610666|FG001|Overall Study|Withdrawal by Subject|1|||
156787639|NCT02533674|565974757|FG006|Dose Level VI|Progressive disease|0|||
156787640|NCT02533674|565974758|FG007|Dose Level VI|Progressive disease|0|||
156787641|NCT02533674|565974751|FG000|Dose Level VI|Withdrawal by Subject|0|||
156787642|NCT02533674|565974752|FG001|Dose Level VI|Withdrawal by Subject|0|||
156787643|NCT02533674|565974753|FG002|Dose Level VI|Withdrawal by Subject|0|||
156787644|NCT02533674|565974754|FG003|Dose Level VI|Withdrawal by Subject|0|||
156787645|NCT02533674|565974755|FG004|Dose Level VI|Withdrawal by Subject|0|||
156787646|NCT02533674|565974756|FG005|Dose Level VI|Withdrawal by Subject|1|||
156689733|NCT04266301|565610667|FG000|Overall Study|Progressive Disease|111|||
156689734|NCT04266301|565610668|FG001|Overall Study|Progressive Disease|92|||
156787647|NCT02533674|565974757|FG006|Dose Level VI|Withdrawal by Subject|0|||
156530589|NCT03471871|565036468|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
156530590|NCT03471871|565036469|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
156689735|NCT04266301|565610667|FG000|Overall Study|Adverse Event|41|||
156689736|NCT04266301|565610668|FG001|Overall Study|Adverse Event|43|||
156787648|NCT02533674|565974758|FG007|Dose Level VI|Withdrawal by Subject|0|||
156787649|NCT02533674|565974751|FG000|Dose Level VI|Treatment-related AE|0|||
156787650|NCT02533674|565974752|FG001|Dose Level VI|Treatment-related AE|0|||
156689737|NCT04266301|565610667|FG000|Overall Study|Death|26|||
156689738|NCT04266301|565610668|FG001|Overall Study|Death|35|||
156689739|NCT04266301|565610667|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
156689740|NCT04266301|565610668|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
156689741|NCT04266301|565610667|FG000|Overall Study|Study Terminated by Sponsor|22|||
156689742|NCT04266301|565610668|FG001|Overall Study|Study Terminated by Sponsor|27|||
156689743|NCT04266301|565610667|FG000|Overall Study|Participant Decision|22|||
156689744|NCT04266301|565610668|FG001|Overall Study|Participant Decision|28|||
156689745|NCT04266301|565610667|FG000|Overall Study|Physician Decision|14|||
156689746|NCT04266301|565610668|FG001|Overall Study|Physician Decision|9|||
156689747|NCT04266301|565610667|FG000|Overall Study|New Therapy for Study Indication|2|||
156689748|NCT04266301|565610668|FG001|Overall Study|New Therapy for Study Indication|4|||
156689749|NCT04266301|565610667|FG000|Overall Study|Protocol Deviation|2|||
156689750|NCT04266301|565610668|FG001|Overall Study|Protocol Deviation|4|||
156689751|NCT04266301|565610667|FG000|Overall Study|Guardian Decision|1|||
156689752|NCT04266301|565610668|FG001|Overall Study|Guardian Decision|0|||
156689753|NCT04266301|565610667|FG000|Overall Study|Lost to Follow-up|1|||
156689754|NCT04266301|565610668|FG001|Overall Study|Lost to Follow-up|0|||
156689755|NCT04266301|565610667|FG000|Overall Study|Participants Not Treated|1|||
156689756|NCT04266301|565610668|FG001|Overall Study|Participants Not Treated|1|||
156689757|NCT04079712|565610669|FG000|Overall Study|Disease progression before starting treatment|1|||
156689758|NCT01432574|565610671|FG000|Overall Study|Moved|2|||
156689759|NCT01432574|565610671|FG000|Overall Study|Not interested|1|||
156689760|NCT04373551|565610672|FG000|Overall Study|Lost to Follow-up|15|||
156689761|NCT04373551|565610672|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
156689762|NCT01042535|565610673|FG000|Overall Study|disease progression prior to treatment|3|||
156689763|NCT01042535|565610673|FG000|Overall Study|disease progression during treatment|3|||
156689764|NCT01042535|565610673|FG000|Overall Study|complications from other disease|2|||
156689765|NCT03438539|565610674|FG000|Overall Study|Lost to Follow-up|8|||
156689766|NCT03438539|565610675|FG001|Overall Study|Lost to Follow-up|4|||
156689767|NCT03438539|565610676|FG002|Overall Study|Lost to Follow-up|10|||
156689768|NCT03438539|565610677|FG003|Overall Study|Lost to Follow-up|9|||
156689769|NCT03438539|565610678|FG004|Overall Study|Lost to Follow-up|3|||
156689770|NCT03438539|565610679|FG005|Overall Study|Lost to Follow-up|8|||
156689771|NCT00440466|565610681|FG000|Overall Study|Death|3|||
156689772|NCT00440466|565610682|FG001|Overall Study|Death|2|||
156689773|NCT00440466|565610683|FG002|Overall Study|Death|9|||
156689774|NCT00440466|565610681|FG000|Overall Study|Adverse Event|3|||
156689775|NCT00440466|565610682|FG001|Overall Study|Adverse Event|4|||
156689776|NCT00440466|565610683|FG002|Overall Study|Adverse Event|11|||
156689777|NCT00440466|565610681|FG000|Overall Study|Lost to Follow-up|1|||
156689778|NCT00440466|565610682|FG001|Overall Study|Lost to Follow-up|0|||
156689779|NCT00440466|565610683|FG002|Overall Study|Lost to Follow-up|2|||
156689780|NCT00440466|565610681|FG000|Overall Study|Physician Decision|2|||
156689781|NCT00440466|565610682|FG001|Overall Study|Physician Decision|0|||
156689782|NCT00440466|565610683|FG002|Overall Study|Physician Decision|1|||
156689783|NCT00440466|565610681|FG000|Overall Study|Protocol Violation|2|||
156689784|NCT00440466|565610682|FG001|Overall Study|Protocol Violation|0|||
156689785|NCT00440466|565610683|FG002|Overall Study|Protocol Violation|4|||
156689786|NCT00440466|565610681|FG000|Overall Study|Withdrawal by Subject|2|||
156689787|NCT00440466|565610682|FG001|Overall Study|Withdrawal by Subject|5|||
156689788|NCT00440466|565610683|FG002|Overall Study|Withdrawal by Subject|9|||
156689789|NCT00440466|565610681|FG000|Overall Study|Began Dialysis|0|||
156689790|NCT00440466|565610682|FG001|Overall Study|Began Dialysis|0|||
156689791|NCT00440466|565610683|FG002|Overall Study|Began Dialysis|1|||
156689792|NCT00440466|565610681|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
156689793|NCT00440466|565610682|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
156689794|NCT00440466|565610683|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
156689795|NCT00140413|565610692|FG000|Overall Study|Lost to Follow-up|1|||
156689796|NCT00140413|565610693|FG001|Overall Study|Lost to Follow-up|0|||
156689797|NCT00140413|565610692|FG000|Overall Study|Withdrawal by Subject|2|||
156689798|NCT00140413|565610693|FG001|Overall Study|Withdrawal by Subject|0|||
156689799|NCT00918463|565610696|FG000|Overall Study|Death|1|||
156689800|NCT00918463|565610696|FG000|Overall Study|Lack of Efficacy|1|||
156689801|NCT01659736|565610697|FG000|Treatment Period|Adverse Event|1|||
156689802|NCT01659736|565610698|FG001|Treatment Period|Adverse Event|1|||
156689803|NCT01659736|565610697|FG000|Treatment Period|Protocol Violation|3|||
156689804|NCT01659736|565610698|FG001|Treatment Period|Protocol Violation|1|||
156689805|NCT01659736|565610697|FG000|Treatment Period|Withdrawal by Subject|1|||
156689806|NCT01659736|565610698|FG001|Treatment Period|Withdrawal by Subject|0|||
156689807|NCT01659736|565610697|FG000|3-month Follow-up|Lost to Follow-up|0|||
156787651|NCT02533674|565974753|FG002|Dose Level VI|Treatment-related AE|0|||
156787652|NCT02533674|565974754|FG003|Dose Level VI|Treatment-related AE|0|||
156689808|NCT01659736|565610698|FG001|3-month Follow-up|Lost to Follow-up|1|||
156689809|NCT05444556|565610699|FG000|Overall Study|Withdrawal by Subject|0|||
156689810|NCT05444556|565610700|FG001|Overall Study|Withdrawal by Subject|0|||
156689811|NCT05444556|565610701|FG002|Overall Study|Withdrawal by Subject|2|||
156689812|NCT05444556|565610702|FG003|Overall Study|Withdrawal by Subject|1|||
156689813|NCT02791893|565610704|FG000|Blinded Phase|Lost to Follow-up|2|||
156689814|NCT02791893|565610705|FG001|Blinded Phase|Lost to Follow-up|2|||
156689815|NCT02791893|565610704|FG000|Blinded Phase|Withdrawal by Subject|1|||
156689816|NCT02791893|565610705|FG001|Blinded Phase|Withdrawal by Subject|2|||
156689817|NCT02791893|565610704|FG000|Open Label Phase|Lost to Follow-up|3|||
156689818|NCT02791893|565610705|FG001|Open Label Phase|Lost to Follow-up|0|||
156689819|NCT02791893|565610704|FG000|Open Label Phase|Withdrawal by Subject|0|||
156689820|NCT02791893|565610705|FG001|Open Label Phase|Withdrawal by Subject|2|||
156689821|NCT04319159|565610709|FG000|Overall Study|Screening failure|13|||
156689822|NCT04319159|565610709|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
156689823|NCT04319159|565610709|FG000|Overall Study|Withdrawal by Subject|1|||
156689824|NCT04976621|565610717|FG000|Overall Study|Lost to Follow-up|2|||
156689825|NCT04976621|565610718|FG001|Overall Study|Lost to Follow-up|2|||
156689826|NCT04976621|565610717|FG000|Overall Study|Withdrawal by Subject|1|||
156689827|NCT04976621|565610718|FG001|Overall Study|Withdrawal by Subject|1|||
156689828|NCT00754442|565610719|FG000|Overall Study|Withdrawal by Subject|5|||
156689829|NCT00754442|565610720|FG001|Overall Study|Withdrawal by Subject|3|||
156689830|NCT01557842|565610721|FG000|Overall Study|Lost to Follow-up|0|||
156689831|NCT01557842|565610722|FG001|Overall Study|Lost to Follow-up|1|||
156689832|NCT01557842|565610721|FG000|Overall Study|Death|1|||
156689833|NCT01557842|565610722|FG001|Overall Study|Death|0|||
156689834|NCT01557842|565610721|FG000|Overall Study|Lack of Efficacy|0|||
156689835|NCT01557842|565610722|FG001|Overall Study|Lack of Efficacy|1|||
156689836|NCT01557842|565610721|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
156689837|NCT01557842|565610722|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
156689838|NCT01557842|565610721|FG000|Overall Study|Study Terminated by Sponsor|3|||
156689839|NCT01557842|565610722|FG001|Overall Study|Study Terminated by Sponsor|4|||
156689840|NCT01557842|565610721|FG000|Overall Study|Not Ablated|2|||
156689841|NCT01557842|565610722|FG001|Overall Study|Not Ablated|0|||
156689842|NCT05560763|565610723|FG000|Overall Study|Withdrawal by Subject|4|||
156689843|NCT01829113|565610724|FG000|Overall Study|Disease Progression|37|||
156689844|NCT01829113|565610725|FG001|Overall Study|Disease Progression|48|||
156689845|NCT01829113|565610724|FG000|Overall Study|Adverse Event|14|||
156689846|NCT01829113|565610725|FG001|Overall Study|Adverse Event|10|||
156689847|NCT01829113|565610724|FG000|Overall Study|Withdrawal by Subject|17|||
156689848|NCT01829113|565610725|FG001|Overall Study|Withdrawal by Subject|10|||
156689849|NCT01829113|565610724|FG000|Overall Study|Death|4|||
156689850|NCT01829113|565610725|FG001|Overall Study|Death|6|||
156689851|NCT01829113|565610724|FG000|Overall Study|Sponsor Decision|1|||
156689852|NCT01829113|565610725|FG001|Overall Study|Sponsor Decision|1|||
156689853|NCT01829113|565610724|FG000|Overall Study|No Study Treatment Received|3|||
156689854|NCT01829113|565610725|FG001|Overall Study|No Study Treatment Received|2|||
156689855|NCT01829113|565610724|FG000|Overall Study|Physician Decision|1|||
156689856|NCT01829113|565610725|FG001|Overall Study|Physician Decision|1|||
156689857|NCT06279871|565610726|FG000|Overall Study|Death|0|||
156689858|NCT06279871|565610727|FG001|Overall Study|Death|0|||
156870029|NCT02379091|566281072|FG000|Overall Study|Lack of Efficacy|3|||
156870030|NCT02379091|566281073|FG001|Overall Study|Lack of Efficacy|0|||
156870031|NCT02379091|566281074|FG002|Overall Study|Lack of Efficacy|0|||
156870032|NCT02379091|566281075|FG003|Overall Study|Lack of Efficacy|0|||
156689859|NCT06279871|565610728|FG002|Overall Study|Death|0|||
156689860|NCT06279871|565610729|FG003|Overall Study|Death|0|||
156689861|NCT06279871|565610730|FG004|Overall Study|Death|0|||
156689862|NCT06279871|565610731|FG005|Overall Study|Death|1|||
156689863|NCT06279871|565610732|FG006|Overall Study|Death|0|||
156689864|NCT06279871|565610726|FG000|Overall Study|Other than Specified|1|||
156689865|NCT06279871|565610727|FG001|Overall Study|Other than Specified|0|||
156689866|NCT06279871|565610728|FG002|Overall Study|Other than Specified|4|||
156689867|NCT06279871|565610729|FG003|Overall Study|Other than Specified|0|||
156689868|NCT06279871|565610730|FG004|Overall Study|Other than Specified|0|||
156689869|NCT06279871|565610731|FG005|Overall Study|Other than Specified|0|||
156689870|NCT06279871|565610732|FG006|Overall Study|Other than Specified|0|||
156870033|NCT03326713|566281077|FG000|Overall Study|Death|2|||
156870034|NCT03326713|566281078|FG001|Overall Study|Death|1|||
156870035|NCT03326713|566281079|FG002|Overall Study|Death|0|||
156689871|NCT06279871|565610726|FG000|Overall Study|Withdrawal by Subject|4|||
156870036|NCT03326713|566281077|FG000|Overall Study|Lost to Follow-up|20|||
156689872|NCT06279871|565610727|FG001|Overall Study|Withdrawal by Subject|8|||
156870037|NCT03326713|566281078|FG001|Overall Study|Lost to Follow-up|21|||
156870038|NCT03326713|566281079|FG002|Overall Study|Lost to Follow-up|33|||
156870039|NCT03326713|566281077|FG000|Overall Study|Withdrawal by Subject|1|||
156870040|NCT03326713|566281078|FG001|Overall Study|Withdrawal by Subject|2|||
156689873|NCT06279871|565610728|FG002|Overall Study|Withdrawal by Subject|4|||
156689874|NCT06279871|565610729|FG003|Overall Study|Withdrawal by Subject|2|||
156689875|NCT06279871|565610730|FG004|Overall Study|Withdrawal by Subject|0|||
156689876|NCT06279871|565610731|FG005|Overall Study|Withdrawal by Subject|0|||
156689877|NCT06279871|565610732|FG006|Overall Study|Withdrawal by Subject|0|||
156689878|NCT06279871|565610726|FG000|Overall Study|Lost to Follow-up|11|||
156689879|NCT06279871|565610727|FG001|Overall Study|Lost to Follow-up|10|||
156689880|NCT06279871|565610728|FG002|Overall Study|Lost to Follow-up|8|||
156689881|NCT06279871|565610729|FG003|Overall Study|Lost to Follow-up|0|||
156689882|NCT06279871|565610730|FG004|Overall Study|Lost to Follow-up|0|||
156689883|NCT06279871|565610731|FG005|Overall Study|Lost to Follow-up|0|||
156689884|NCT06279871|565610732|FG006|Overall Study|Lost to Follow-up|0|||
156689885|NCT06279871|565610726|FG000|Overall Study|Adverse Event|0|||
156689886|NCT06279871|565610727|FG001|Overall Study|Adverse Event|1|||
156689887|NCT06279871|565610728|FG002|Overall Study|Adverse Event|0|||
156689888|NCT06279871|565610729|FG003|Overall Study|Adverse Event|0|||
156689889|NCT06279871|565610730|FG004|Overall Study|Adverse Event|0|||
156689890|NCT06279871|565610731|FG005|Overall Study|Adverse Event|0|||
156330022|NCT00004635|564308745|FG000|Period Two|refused|0|||
156330023|NCT00004635|564308746|FG001|Period Two|refused|2|||
156689891|NCT06279871|565610732|FG006|Overall Study|Adverse Event|0|||
156689892|NCT04706507|565610733|FG000|Overall Study|Death|45|||
156689893|NCT04706507|565610734|FG001|Overall Study|Death|22|||
156689894|NCT04706507|565610733|FG000|Overall Study|Unable to adhere|0|||
156689895|NCT04706507|565610734|FG001|Overall Study|Unable to adhere|2|||
156689896|NCT04706507|565610733|FG000|Overall Study|Lost to Follow-up|13|||
156689897|NCT04706507|565610734|FG001|Overall Study|Lost to Follow-up|12|||
156689898|NCT04706507|565610733|FG000|Overall Study|Withdrawal of consent|1|||
156689899|NCT04706507|565610734|FG001|Overall Study|Withdrawal of consent|1|||
156689900|NCT04706507|565610733|FG000|Overall Study|Patient or LAR refuses further participation|0|||
156689901|NCT04706507|565610734|FG001|Overall Study|Patient or LAR refuses further participation|3|||
156689902|NCT02709486|565610735|FG000|Overall Study|Adverse Event|2|||
156689903|NCT02709486|565610736|FG001|Overall Study|Adverse Event|5|||
156689904|NCT02709486|565610737|FG002|Overall Study|Adverse Event|3|||
156689905|NCT02709486|565610735|FG000|Overall Study|Death|0|||
156689906|NCT02709486|565610736|FG001|Overall Study|Death|0|||
156689907|NCT02709486|565610737|FG002|Overall Study|Death|2|||
156689908|NCT02709486|565610735|FG000|Overall Study|Insufficient clinical response|7|||
156689909|NCT02709486|565610736|FG001|Overall Study|Insufficient clinical response|3|||
156689910|NCT02709486|565610737|FG002|Overall Study|Insufficient clinical response|3|||
156689911|NCT02709486|565610735|FG000|Overall Study|Lost to Follow-up|3|||
156689912|NCT02709486|565610736|FG001|Overall Study|Lost to Follow-up|2|||
156689913|NCT02709486|565610737|FG002|Overall Study|Lost to Follow-up|2|||
156689914|NCT02709486|565610735|FG000|Overall Study|Other|0|||
156689915|NCT02709486|565610736|FG001|Overall Study|Other|2|||
156689916|NCT02709486|565610737|FG002|Overall Study|Other|3|||
156689917|NCT02709486|565610735|FG000|Overall Study|Withdrawal by Subject|32|||
156689918|NCT02709486|565610736|FG001|Overall Study|Withdrawal by Subject|22|||
156689919|NCT02709486|565610737|FG002|Overall Study|Withdrawal by Subject|32|||
156689920|NCT00706355|565610742|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
156689921|NCT00706355|565610743|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
156689922|NCT00706355|565610744|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
156689923|NCT00706355|565610745|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
156689924|NCT00706355|565610742|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
156689925|NCT00706355|565610743|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
156689926|NCT00706355|565610744|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
156689927|NCT00706355|565610745|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
156689928|NCT00706355|565610742|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
156689929|NCT00706355|565610743|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
156689930|NCT00706355|565610744|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
156689931|NCT00706355|565610745|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
156689932|NCT00706355|565610742|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
156689933|NCT00706355|565610743|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
156689934|NCT00706355|565610744|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
156689935|NCT00706355|565610745|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
156689936|NCT00706355|565610742|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
156689937|NCT00706355|565610743|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
156689938|NCT00706355|565610744|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
156689939|NCT00706355|565610745|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
156689940|NCT00706355|565610742|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
156689941|NCT00706355|565610743|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
156689942|NCT00706355|565610744|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
156689943|NCT00706355|565610745|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
156689944|NCT00706355|565610742|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
156330024|NCT00004635|564308745|FG000|Period Two|health problem|1|||
156689945|NCT00706355|565610743|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
156689946|NCT00706355|565610744|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
156689947|NCT00706355|565610745|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
156689948|NCT00706355|565610742|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
156689949|NCT00706355|565610743|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
156689950|NCT00706355|565610744|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
156689951|NCT00706355|565610745|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
156689952|NCT00706355|565610742|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
156689953|NCT00706355|565610743|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
156689954|NCT00706355|565610744|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
156689955|NCT00706355|565610745|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
156689956|NCT02691741|565610748|FG000|Overall Study|Adverse Event|0|||
156689957|NCT02691741|565610749|FG001|Overall Study|Adverse Event|2|||
156689958|NCT02691741|565610748|FG000|Overall Study|Lost to Follow-up|1|||
156689959|NCT02691741|565610749|FG001|Overall Study|Lost to Follow-up|0|||
156689960|NCT02691741|565610748|FG000|Overall Study|Physician Decision|0|||
156689961|NCT02691741|565610749|FG001|Overall Study|Physician Decision|1|||
156689962|NCT02691741|565610748|FG000|Overall Study|Withdrawal by Subject|0|||
156689963|NCT02691741|565610749|FG001|Overall Study|Withdrawal by Subject|4|||
156689964|NCT02139124|565610750|FG000|Overall Study|Adverse Event|2|||
156689965|NCT02139124|565610751|FG001|Overall Study|Adverse Event|0|||
156689966|NCT02139124|565610752|FG002|Overall Study|Adverse Event|1|||
156689967|NCT02139124|565610753|FG003|Overall Study|Adverse Event|2|||
156689968|NCT02139124|565610754|FG004|Overall Study|Adverse Event|5|||
156689969|NCT02139124|565610750|FG000|Overall Study|Withdrawal by Subject|2|||
156530591|NCT01306890|565038073|FG000|Overall Study|Adverse Event|2|||
156530592|NCT01306890|565038073|FG000|Overall Study|Death|1223|||
156530593|NCT01306890|565038073|FG000|Overall Study|Lost to Follow-up|58|||
156689970|NCT02139124|565610751|FG001|Overall Study|Withdrawal by Subject|2|||
156689971|NCT02139124|565610752|FG002|Overall Study|Withdrawal by Subject|2|||
156689972|NCT02139124|565610753|FG003|Overall Study|Withdrawal by Subject|2|||
156689973|NCT02139124|565610754|FG004|Overall Study|Withdrawal by Subject|3|||
156689974|NCT02139124|565610750|FG000|Overall Study|Protocol Violation|0|||
156689975|NCT02139124|565610751|FG001|Overall Study|Protocol Violation|0|||
156689976|NCT02139124|565610752|FG002|Overall Study|Protocol Violation|0|||
156689977|NCT02139124|565610753|FG003|Overall Study|Protocol Violation|1|||
156689978|NCT02139124|565610754|FG004|Overall Study|Protocol Violation|1|||
156689979|NCT02139124|565610750|FG000|Overall Study|non-compliant|1|||
156689980|NCT02139124|565610751|FG001|Overall Study|non-compliant|0|||
156689981|NCT02139124|565610752|FG002|Overall Study|non-compliant|0|||
156689982|NCT02139124|565610753|FG003|Overall Study|non-compliant|2|||
156689983|NCT02139124|565610754|FG004|Overall Study|non-compliant|0|||
156689984|NCT02139124|565610750|FG000|Overall Study|incarceration|0|||
156689985|NCT02139124|565610751|FG001|Overall Study|incarceration|0|||
156689986|NCT02139124|565610752|FG002|Overall Study|incarceration|1|||
156689987|NCT02139124|565610753|FG003|Overall Study|incarceration|0|||
156689988|NCT02139124|565610754|FG004|Overall Study|incarceration|0|||
156689989|NCT02139124|565610750|FG000|Overall Study|subject moved|1|||
156689990|NCT02139124|565610751|FG001|Overall Study|subject moved|0|||
156689991|NCT02139124|565610752|FG002|Overall Study|subject moved|0|||
156689992|NCT02139124|565610753|FG003|Overall Study|subject moved|0|||
156689993|NCT02139124|565610754|FG004|Overall Study|subject moved|0|||
156330025|NCT00004635|564308746|FG001|Period Two|health problem|1|||
156689994|NCT02139124|565610750|FG000|Overall Study|Lost to Follow-up|3|||
156689995|NCT02139124|565610751|FG001|Overall Study|Lost to Follow-up|2|||
156689996|NCT02139124|565610752|FG002|Overall Study|Lost to Follow-up|0|||
156689997|NCT02139124|565610753|FG003|Overall Study|Lost to Follow-up|5|||
156689998|NCT02139124|565610754|FG004|Overall Study|Lost to Follow-up|4|||
156689999|NCT03465436|565610755|FG000|Period 1|Protocol Violation|0|||
156690000|NCT03465436|565610756|FG001|Period 1|Protocol Violation|0|||
156690001|NCT03465436|565610757|FG002|Period 1|Protocol Violation|1|||
156690002|NCT03465436|565610758|FG003|Period 1|Protocol Violation|0|||
156690003|NCT03465436|565610755|FG000|Period 2|Protocol Violation|0|||
156690004|NCT03465436|565610756|FG001|Period 2|Protocol Violation|1|||
156690005|NCT03465436|565610757|FG002|Period 2|Protocol Violation|0|||
156690006|NCT03465436|565610758|FG003|Period 2|Protocol Violation|0|||
156690007|NCT03465436|565610755|FG000|Period 3|Protocol Violation|1|||
156690008|NCT03465436|565610756|FG001|Period 3|Protocol Violation|1|||
156690009|NCT03465436|565610757|FG002|Period 3|Protocol Violation|0|||
156690010|NCT03465436|565610758|FG003|Period 3|Protocol Violation|0|||
156690011|NCT03465436|565610755|FG000|Period 4|Protocol Violation|0|||
156690012|NCT03465436|565610756|FG001|Period 4|Protocol Violation|0|||
156690013|NCT03465436|565610757|FG002|Period 4|Protocol Violation|1|||
156690014|NCT03465436|565610758|FG003|Period 4|Protocol Violation|0|||
156330026|NCT00004635|564308745|FG000|Period Two|travel issues|0|||
156530594|NCT01306890|565038073|FG000|Overall Study|Withdrawal by Subject|88|||
156690015|NCT01425528|565610759|FG000|Overall Study|Withdrawal by Subject|1|||
156690016|NCT01425528|565610760|FG001|Overall Study|Withdrawal by Subject|1|||
156690017|NCT02697773|565610761|FG000|Overall Study|Adverse Event|2|||
156690018|NCT02697773|565610762|FG001|Overall Study|Adverse Event|1|||
156690019|NCT02697773|565610763|FG002|Overall Study|Adverse Event|2|||
156690020|NCT02697773|565610761|FG000|Overall Study|Death|0|||
156690021|NCT02697773|565610762|FG001|Overall Study|Death|0|||
156690022|NCT02697773|565610763|FG002|Overall Study|Death|2|||
156690023|NCT02697773|565610761|FG000|Overall Study|Lack of Efficacy|4|||
156690024|NCT02697773|565610762|FG001|Overall Study|Lack of Efficacy|6|||
156690025|NCT02697773|565610763|FG002|Overall Study|Lack of Efficacy|6|||
156690026|NCT02697773|565610761|FG000|Overall Study|Lost to Follow-up|5|||
156690027|NCT02697773|565610762|FG001|Overall Study|Lost to Follow-up|5|||
156690028|NCT02697773|565610763|FG002|Overall Study|Lost to Follow-up|7|||
156690029|NCT02697773|565610761|FG000|Overall Study|Other|15|||
156690030|NCT02697773|565610762|FG001|Overall Study|Other|11|||
156690031|NCT02697773|565610763|FG002|Overall Study|Other|10|||
156690032|NCT02697773|565610761|FG000|Overall Study|Protocol Violation|1|||
156690033|NCT02697773|565610762|FG001|Overall Study|Protocol Violation|1|||
156690034|NCT02697773|565610763|FG002|Overall Study|Protocol Violation|0|||
156690035|NCT02697773|565610761|FG000|Overall Study|Withdrawal by Subject|10|||
156690036|NCT02697773|565610762|FG001|Overall Study|Withdrawal by Subject|13|||
156690037|NCT02697773|565610763|FG002|Overall Study|Withdrawal by Subject|13|||
156690038|NCT02697773|565610761|FG000|Overall Study|Randomized but not treated|1|||
156690039|NCT02697773|565610762|FG001|Overall Study|Randomized but not treated|1|||
156690040|NCT02697773|565610763|FG002|Overall Study|Randomized but not treated|0|||
156690041|NCT02243293|565610764|FG000|Overall Study|Adverse Event|1|||
156690042|NCT02243293|565610765|FG001|Overall Study|Adverse Event|0|||
156690043|NCT02243293|565610766|FG002|Overall Study|Adverse Event|0|||
156690044|NCT02243293|565610767|FG003|Overall Study|Adverse Event|0|||
156690045|NCT02243293|565610768|FG004|Overall Study|Adverse Event|0|||
156690046|NCT02243293|565610769|FG005|Overall Study|Adverse Event|0|||
156690047|NCT02243293|565610770|FG006|Overall Study|Adverse Event|0|||
156690048|NCT02243293|565610771|FG007|Overall Study|Adverse Event|0|||
156690049|NCT02243293|565610772|FG008|Overall Study|Adverse Event|0|||
156690050|NCT02243293|565610773|FG009|Overall Study|Adverse Event|0|||
156690051|NCT02243293|565610774|FG010|Overall Study|Adverse Event|0|||
156690052|NCT02243293|565610775|FG011|Overall Study|Adverse Event|0|||
156690053|NCT02243293|565610776|FG012|Overall Study|Adverse Event|0|||
156690054|NCT02243293|565610777|FG013|Overall Study|Adverse Event|0|||
156690055|NCT02243293|565610778|FG014|Overall Study|Adverse Event|0|||
156690056|NCT02243293|565610779|FG015|Overall Study|Adverse Event|1|||
156690057|NCT02243293|565610780|FG016|Overall Study|Adverse Event|0|||
156690058|NCT02243293|565610781|FG017|Overall Study|Adverse Event|0|||
156690059|NCT02243293|565610782|FG018|Overall Study|Adverse Event|0|||
156690060|NCT02243293|565610783|FG019|Overall Study|Adverse Event|0|||
156690061|NCT02243293|565610784|FG020|Overall Study|Adverse Event|1|||
156690062|NCT02243293|565610785|FG021|Overall Study|Adverse Event|0|||
156690063|NCT02243293|565610764|FG000|Overall Study|Withdrawal by Subject|1|||
156690064|NCT02243293|565610765|FG001|Overall Study|Withdrawal by Subject|0|||
156690065|NCT02243293|565610766|FG002|Overall Study|Withdrawal by Subject|0|||
156690066|NCT02243293|565610767|FG003|Overall Study|Withdrawal by Subject|0|||
156690067|NCT02243293|565610768|FG004|Overall Study|Withdrawal by Subject|0|||
156690068|NCT02243293|565610769|FG005|Overall Study|Withdrawal by Subject|0|||
156690069|NCT02243293|565610770|FG006|Overall Study|Withdrawal by Subject|0|||
156690070|NCT02243293|565610771|FG007|Overall Study|Withdrawal by Subject|0|||
156690071|NCT02243293|565610772|FG008|Overall Study|Withdrawal by Subject|0|||
156690072|NCT02243293|565610773|FG009|Overall Study|Withdrawal by Subject|1|||
156690073|NCT02243293|565610774|FG010|Overall Study|Withdrawal by Subject|0|||
156787653|NCT02533674|565974755|FG004|Dose Level VI|Treatment-related AE|0|||
156787654|NCT02533674|565974756|FG005|Dose Level VI|Treatment-related AE|1|||
156787655|NCT02533674|565974757|FG006|Dose Level VI|Treatment-related AE|0|||
156787656|NCT02533674|565974758|FG007|Dose Level VI|Treatment-related AE|0|||
156787657|NCT02533674|565974751|FG000|Dose Level VII|Progressive disease|0|||
156787658|NCT02533674|565974752|FG001|Dose Level VII|Progressive disease|0|||
156787659|NCT02533674|565974753|FG002|Dose Level VII|Progressive disease|0|||
156787660|NCT02533674|565974754|FG003|Dose Level VII|Progressive disease|0|||
156870041|NCT03326713|566281079|FG002|Overall Study|Withdrawal by Subject|11|||
156870042|NCT03326713|566281077|FG000|Overall Study|Found Ineligible|11|||
156870043|NCT03326713|566281078|FG001|Overall Study|Found Ineligible|11|||
156436983|NCT05850520|564689178|FG001|Overall Study|Withdrawal by Subject|8|||
156690074|NCT02243293|565610775|FG011|Overall Study|Withdrawal by Subject|1|||
156690075|NCT02243293|565610776|FG012|Overall Study|Withdrawal by Subject|0|||
156690076|NCT02243293|565610777|FG013|Overall Study|Withdrawal by Subject|0|||
156690077|NCT02243293|565610778|FG014|Overall Study|Withdrawal by Subject|0|||
156690078|NCT02243293|565610779|FG015|Overall Study|Withdrawal by Subject|0|||
156690079|NCT02243293|565610780|FG016|Overall Study|Withdrawal by Subject|0|||
156690080|NCT02243293|565610781|FG017|Overall Study|Withdrawal by Subject|0|||
156690081|NCT02243293|565610782|FG018|Overall Study|Withdrawal by Subject|0|||
156787661|NCT02533674|565974755|FG004|Dose Level VII|Progressive disease|0|||
156870044|NCT03326713|566281079|FG002|Overall Study|Found Ineligible|8|||
156690082|NCT02243293|565610783|FG019|Overall Study|Withdrawal by Subject|0|||
156690083|NCT02243293|565610784|FG020|Overall Study|Withdrawal by Subject|0|||
156690084|NCT02243293|565610785|FG021|Overall Study|Withdrawal by Subject|1|||
156690085|NCT02243293|565610764|FG000|Overall Study|Lost to Follow-up|0|||
156690086|NCT02243293|565610765|FG001|Overall Study|Lost to Follow-up|1|||
156870045|NCT00771758|566281080|FG000|Overall Study|Adverse Event|2|||
156870046|NCT00771758|566281081|FG001|Overall Study|Adverse Event|8|||
156870047|NCT00771758|566281082|FG002|Overall Study|Adverse Event|1|||
156870048|NCT00771758|566281080|FG000|Overall Study|Lack of Efficacy|0|||
156870049|NCT00771758|566281081|FG001|Overall Study|Lack of Efficacy|2|||
156870050|NCT00771758|566281082|FG002|Overall Study|Lack of Efficacy|1|||
156870051|NCT00771758|566281080|FG000|Overall Study|Lost to Follow-up|1|||
156870052|NCT00771758|566281081|FG001|Overall Study|Lost to Follow-up|0|||
156870053|NCT00771758|566281082|FG002|Overall Study|Lost to Follow-up|0|||
156870054|NCT00771758|566281080|FG000|Overall Study|Protocol Violation|1|||
156870055|NCT00771758|566281081|FG001|Overall Study|Protocol Violation|0|||
156870056|NCT00771758|566281082|FG002|Overall Study|Protocol Violation|0|||
156870057|NCT00771758|566281080|FG000|Overall Study|Withdrawal by Subject|1|||
156870058|NCT00771758|566281081|FG001|Overall Study|Withdrawal by Subject|0|||
156870059|NCT00771758|566281082|FG002|Overall Study|Withdrawal by Subject|0|||
156870060|NCT00771758|566281080|FG000|Overall Study|Other|3|||
156870061|NCT00771758|566281081|FG001|Overall Study|Other|2|||
156870062|NCT00771758|566281082|FG002|Overall Study|Other|0|||
156870063|NCT03067077|566281083|FG000|Overall Study|Did not receive surgery|4|||
156870064|NCT03067077|566281084|FG001|Overall Study|Did not receive surgery|5|||
156870065|NCT03067077|566281083|FG000|Overall Study|Lost to Follow-up|3|||
156870066|NCT03067077|566281084|FG001|Overall Study|Lost to Follow-up|2|||
156870067|NCT00935584|566281085|FG000|Overall Study|Withdrawal by Subject|9|||
156870068|NCT00935584|566281086|FG001|Overall Study|Withdrawal by Subject|0|||
156870069|NCT00935584|566281085|FG000|Overall Study|Death|3|||
156870070|NCT00935584|566281086|FG001|Overall Study|Death|0|||
156870071|NCT00935584|566281085|FG000|Overall Study|Lost to Follow-up|8|||
156870072|NCT00935584|566281086|FG001|Overall Study|Lost to Follow-up|0|||
156870073|NCT00935584|566281085|FG000|Overall Study|No show|9|||
156870074|NCT00935584|566281086|FG001|Overall Study|No show|0|||
156870075|NCT00935584|566281085|FG000|Overall Study|Relocated|3|||
156870076|NCT00935584|566281086|FG001|Overall Study|Relocated|0|||
156870077|NCT00935584|566281085|FG000|Overall Study|Patient changed provider|3|||
156870078|NCT00935584|566281086|FG001|Overall Study|Patient changed provider|0|||
156870079|NCT00935584|566281085|FG000|Overall Study|Provider dropped out of study|14|||
156870080|NCT00935584|566281086|FG001|Overall Study|Provider dropped out of study|4|||
156870081|NCT01394016|566281087|FG000|Overall Study|Progressive Disease|2|||
156870082|NCT01394016|566281088|FG001|Overall Study|Progressive Disease|0|||
156870083|NCT01394016|566281089|FG002|Overall Study|Progressive Disease|0|||
156870084|NCT01394016|566281090|FG003|Overall Study|Progressive Disease|0|||
156870085|NCT01394016|566281091|FG004|Overall Study|Progressive Disease|0|||
156870086|NCT01394016|566281092|FG005|Overall Study|Progressive Disease|0|||
156870087|NCT01394016|566281093|FG006|Overall Study|Progressive Disease|0|||
156870088|NCT01394016|566281094|FG007|Overall Study|Progressive Disease|0|||
156870089|NCT01394016|566281095|FG008|Overall Study|Progressive Disease|0|||
156870090|NCT01394016|566281096|FG009|Overall Study|Progressive Disease|0|||
156870091|NCT01394016|566281097|FG010|Overall Study|Progressive Disease|0|||
156870092|NCT01394016|566281098|FG011|Overall Study|Progressive Disease|0|||
156870093|NCT01394016|566281099|FG012|Overall Study|Progressive Disease|0|||
156870094|NCT01394016|566281100|FG013|Overall Study|Progressive Disease|0|||
156870095|NCT01394016|566281101|FG014|Overall Study|Progressive Disease|0|||
156870096|NCT01394016|566281102|FG015|Overall Study|Progressive Disease|0|||
156870097|NCT01394016|566281103|FG016|Overall Study|Progressive Disease|0|||
156870098|NCT01394016|566281104|FG017|Overall Study|Progressive Disease|0|||
156870099|NCT01394016|566281105|FG018|Overall Study|Progressive Disease|0|||
156870100|NCT01394016|566281087|FG000|Overall Study|Withdrawal by Subject|0|||
156870101|NCT01394016|566281088|FG001|Overall Study|Withdrawal by Subject|0|||
156870102|NCT01394016|566281089|FG002|Overall Study|Withdrawal by Subject|0|||
156870103|NCT01394016|566281090|FG003|Overall Study|Withdrawal by Subject|0|||
156870104|NCT01394016|566281091|FG004|Overall Study|Withdrawal by Subject|0|||
156870105|NCT01394016|566281092|FG005|Overall Study|Withdrawal by Subject|0|||
156870106|NCT01394016|566281093|FG006|Overall Study|Withdrawal by Subject|0|||
156870107|NCT01394016|566281094|FG007|Overall Study|Withdrawal by Subject|1|||
156870108|NCT01394016|566281095|FG008|Overall Study|Withdrawal by Subject|1|||
156870109|NCT01394016|566281096|FG009|Overall Study|Withdrawal by Subject|1|||
156870110|NCT01394016|566281097|FG010|Overall Study|Withdrawal by Subject|4|||
156870111|NCT01394016|566281098|FG011|Overall Study|Withdrawal by Subject|0|||
156330027|NCT00004635|564308746|FG001|Period Two|travel issues|1|||
156330028|NCT00004635|564308745|FG000|Period Two|secondary malignancy|1|||
156870112|NCT01394016|566281099|FG012|Overall Study|Withdrawal by Subject|0|||
156870113|NCT01394016|566281100|FG013|Overall Study|Withdrawal by Subject|3|||
156870114|NCT01394016|566281101|FG014|Overall Study|Withdrawal by Subject|1|||
156870115|NCT01394016|566281102|FG015|Overall Study|Withdrawal by Subject|3|||
156870116|NCT01394016|566281103|FG016|Overall Study|Withdrawal by Subject|1|||
156330029|NCT00004635|564308746|FG001|Period Two|secondary malignancy|1|||
156870117|NCT01394016|566281104|FG017|Overall Study|Withdrawal by Subject|1|||
156870118|NCT01394016|566281105|FG018|Overall Study|Withdrawal by Subject|2|||
156870119|NCT01394016|566281087|FG000|Overall Study|Adverse Event|0|||
156870120|NCT01394016|566281088|FG001|Overall Study|Adverse Event|0|||
156690087|NCT02243293|565610766|FG002|Overall Study|Lost to Follow-up|1|||
156690088|NCT02243293|565610767|FG003|Overall Study|Lost to Follow-up|1|||
156690089|NCT02243293|565610768|FG004|Overall Study|Lost to Follow-up|0|||
156690090|NCT02243293|565610769|FG005|Overall Study|Lost to Follow-up|0|||
156690091|NCT02243293|565610770|FG006|Overall Study|Lost to Follow-up|3|||
156690092|NCT02243293|565610771|FG007|Overall Study|Lost to Follow-up|0|||
156787662|NCT02533674|565974756|FG005|Dose Level VII|Progressive disease|0|||
156787663|NCT02533674|565974757|FG006|Dose Level VII|Progressive disease|10|||
156787664|NCT02533674|565974758|FG007|Dose Level VII|Progressive disease|0|||
156787665|NCT02533674|565974751|FG000|Dose Level VII|Withdrawal by Subject|0|||
156787666|NCT02533674|565974752|FG001|Dose Level VII|Withdrawal by Subject|0|||
156787667|NCT02533674|565974753|FG002|Dose Level VII|Withdrawal by Subject|0|||
156787668|NCT02533674|565974754|FG003|Dose Level VII|Withdrawal by Subject|0|||
156787669|NCT02533674|565974755|FG004|Dose Level VII|Withdrawal by Subject|0|||
156787670|NCT02533674|565974756|FG005|Dose Level VII|Withdrawal by Subject|0|||
156330030|NCT00004635|564308745|FG000|Period Two|Lost to Follow-up|1|||
156690093|NCT02243293|565610772|FG008|Overall Study|Lost to Follow-up|0|||
156690094|NCT02243293|565610773|FG009|Overall Study|Lost to Follow-up|0|||
156690095|NCT02243293|565610774|FG010|Overall Study|Lost to Follow-up|0|||
156690096|NCT02243293|565610775|FG011|Overall Study|Lost to Follow-up|2|||
156690097|NCT02243293|565610776|FG012|Overall Study|Lost to Follow-up|0|||
156690098|NCT02243293|565610777|FG013|Overall Study|Lost to Follow-up|0|||
156690099|NCT02243293|565610778|FG014|Overall Study|Lost to Follow-up|0|||
156690100|NCT02243293|565610779|FG015|Overall Study|Lost to Follow-up|0|||
156690101|NCT02243293|565610780|FG016|Overall Study|Lost to Follow-up|3|||
156690102|NCT02243293|565610781|FG017|Overall Study|Lost to Follow-up|1|||
156690103|NCT02243293|565610782|FG018|Overall Study|Lost to Follow-up|0|||
156690104|NCT02243293|565610783|FG019|Overall Study|Lost to Follow-up|0|||
156690105|NCT02243293|565610784|FG020|Overall Study|Lost to Follow-up|1|||
156690106|NCT02243293|565610785|FG021|Overall Study|Lost to Follow-up|2|||
156690107|NCT02243293|565610764|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
156787671|NCT02533674|565974757|FG006|Dose Level VII|Withdrawal by Subject|3|||
156787672|NCT02533674|565974758|FG007|Dose Level VII|Withdrawal by Subject|0|||
156787673|NCT02533674|565974751|FG000|Dose Level VII|Treatment-related AE|0|||
156787674|NCT02533674|565974752|FG001|Dose Level VII|Treatment-related AE|0|||
156787675|NCT02533674|565974753|FG002|Dose Level VII|Treatment-related AE|0|||
156787676|NCT02533674|565974754|FG003|Dose Level VII|Treatment-related AE|0|||
156787677|NCT02533674|565974755|FG004|Dose Level VII|Treatment-related AE|0|||
156787678|NCT02533674|565974756|FG005|Dose Level VII|Treatment-related AE|0|||
156787679|NCT02533674|565974757|FG006|Dose Level VII|Treatment-related AE|1|||
156787680|NCT02533674|565974758|FG007|Dose Level VII|Treatment-related AE|0|||
156787681|NCT02533674|565974751|FG000|Dose Level VII|Death|0|||
156787682|NCT02533674|565974752|FG001|Dose Level VII|Death|0|||
156787683|NCT02533674|565974753|FG002|Dose Level VII|Death|0|||
156787684|NCT02533674|565974754|FG003|Dose Level VII|Death|0|||
156787685|NCT02533674|565974755|FG004|Dose Level VII|Death|0|||
156787686|NCT02533674|565974756|FG005|Dose Level VII|Death|0|||
156787687|NCT02533674|565974757|FG006|Dose Level VII|Death|2|||
156787688|NCT02533674|565974758|FG007|Dose Level VII|Death|0|||
156787689|NCT02533674|565974751|FG000|Dose Level VIII|Progressive disease|0|||
156787690|NCT02533674|565974752|FG001|Dose Level VIII|Progressive disease|0|||
156787691|NCT02533674|565974753|FG002|Dose Level VIII|Progressive disease|0|||
156787692|NCT02533674|565974754|FG003|Dose Level VIII|Progressive disease|0|||
156787693|NCT02533674|565974755|FG004|Dose Level VIII|Progressive disease|0|||
156787694|NCT02533674|565974756|FG005|Dose Level VIII|Progressive disease|0|||
156787695|NCT02533674|565974757|FG006|Dose Level VIII|Progressive disease|0|||
156787696|NCT02533674|565974758|FG007|Dose Level VIII|Progressive disease|3|||
156787697|NCT02533674|565974751|FG000|Dose Level VIII|Withdrawal by Subject|0|||
156787698|NCT02533674|565974752|FG001|Dose Level VIII|Withdrawal by Subject|0|||
156787699|NCT02533674|565974753|FG002|Dose Level VIII|Withdrawal by Subject|0|||
156787700|NCT02533674|565974754|FG003|Dose Level VIII|Withdrawal by Subject|0|||
156787701|NCT02533674|565974755|FG004|Dose Level VIII|Withdrawal by Subject|0|||
156787702|NCT02533674|565974756|FG005|Dose Level VIII|Withdrawal by Subject|0|||
156787703|NCT02533674|565974757|FG006|Dose Level VIII|Withdrawal by Subject|0|||
156787704|NCT02533674|565974758|FG007|Dose Level VIII|Withdrawal by Subject|1|||
156787705|NCT02533674|565974751|FG000|Dose Level VIII|Treatment-related AE|0|||
156787706|NCT02533674|565974752|FG001|Dose Level VIII|Treatment-related AE|0|||
156787707|NCT02533674|565974753|FG002|Dose Level VIII|Treatment-related AE|0|||
156330031|NCT00004635|564308746|FG001|Period Two|Lost to Follow-up|0|||
156690108|NCT02243293|565610765|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
156787708|NCT02533674|565974754|FG003|Dose Level VIII|Treatment-related AE|0|||
156690109|NCT02243293|565610766|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
156690110|NCT02243293|565610767|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
156690111|NCT02243293|565610768|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
156787709|NCT02533674|565974755|FG004|Dose Level VIII|Treatment-related AE|0|||
156787710|NCT02533674|565974756|FG005|Dose Level VIII|Treatment-related AE|0|||
156690112|NCT02243293|565610769|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
156787711|NCT02533674|565974757|FG006|Dose Level VIII|Treatment-related AE|0|||
156690113|NCT02243293|565610770|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
156690114|NCT02243293|565610771|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
156690115|NCT02243293|565610772|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
156690116|NCT02243293|565610773|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
156690117|NCT02243293|565610774|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
156690118|NCT02243293|565610775|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
156690119|NCT02243293|565610776|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
156690120|NCT02243293|565610777|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
156690121|NCT02243293|565610778|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
156690122|NCT02243293|565610779|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
156690123|NCT02243293|565610780|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
156690124|NCT02243293|565610781|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
156690125|NCT02243293|565610782|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
156690126|NCT02243293|565610783|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
156690127|NCT02243293|565610784|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
156690128|NCT02243293|565610785|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
156690129|NCT02243293|565610764|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
156690130|NCT02243293|565610765|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
156690131|NCT02243293|565610766|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
156690132|NCT02243293|565610767|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
156690133|NCT02243293|565610768|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
156690134|NCT02243293|565610769|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
156690135|NCT02243293|565610770|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
156690136|NCT02243293|565610771|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
156690137|NCT02243293|565610772|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
156690138|NCT02243293|565610773|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
156690139|NCT02243293|565610774|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
156690140|NCT02243293|565610775|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
156690141|NCT02243293|565610776|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
156690142|NCT02243293|565610777|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
156690143|NCT02243293|565610778|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
156690144|NCT02243293|565610779|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
156690145|NCT02243293|565610780|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
156690146|NCT02243293|565610781|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
156690147|NCT02243293|565610782|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
156690148|NCT02243293|565610783|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
156690149|NCT02243293|565610784|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
156690150|NCT02243293|565610785|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
156690151|NCT00440115|565610786|FG000|Overall Study|Death|7|||
156690152|NCT00440115|565610787|FG001|Overall Study|Death|9|||
156690153|NCT00440115|565610788|FG002|Overall Study|Death|5|||
156690154|NCT00440115|565610786|FG000|Overall Study|Incarceration|0|||
156690155|NCT00440115|565610787|FG001|Overall Study|Incarceration|2|||
156690156|NCT00440115|565610788|FG002|Overall Study|Incarceration|1|||
156690157|NCT03069417|565610789|FG000|Overall Study|Lost to Follow-up|2|||
156690158|NCT03069417|565610790|FG001|Overall Study|Lost to Follow-up|0|||
156690159|NCT03069417|565610789|FG000|Overall Study|Reason Unknown|4|||
156690160|NCT03069417|565610790|FG001|Overall Study|Reason Unknown|7|||
156690161|NCT03078478|565610794|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
156690162|NCT03078478|565610795|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
156690163|NCT03078478|565610794|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
156690164|NCT03078478|565610795|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
156690165|NCT03078478|565610794|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
156690166|NCT03078478|565610795|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
156690167|NCT03078478|565610794|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
156690168|NCT03078478|565610795|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
156690169|NCT03078478|565610794|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
156690170|NCT03078478|565610795|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
156690171|NCT03078478|565610794|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
156690172|NCT03078478|565610795|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
156690173|NCT03078478|565610794|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
156690174|NCT03078478|565610795|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
156690175|NCT03078478|565610794|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
156787712|NCT02533674|565974758|FG007|Dose Level VIII|Treatment-related AE|1|||
156787713|NCT02533674|565974751|FG000|Dose Level VIII|Never treated|0|||
156690176|NCT03078478|565610795|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
156690177|NCT01172821|565610798|FG000|Overall Study|Adverse Event|5|||
156690178|NCT01172821|565610799|FG001|Overall Study|Adverse Event|2|||
156690179|NCT01172821|565610800|FG002|Overall Study|Adverse Event|2|||
156690180|NCT01172821|565610801|FG003|Overall Study|Adverse Event|7|||
156690181|NCT01172821|565610798|FG000|Overall Study|Protocol Violation|0|||
156690182|NCT01172821|565610799|FG001|Overall Study|Protocol Violation|2|||
156690183|NCT01172821|565610800|FG002|Overall Study|Protocol Violation|1|||
156690184|NCT01172821|565610801|FG003|Overall Study|Protocol Violation|2|||
156690185|NCT01172821|565610798|FG000|Overall Study|Lost to Follow-up|4|||
156690186|NCT01172821|565610799|FG001|Overall Study|Lost to Follow-up|1|||
156690187|NCT01172821|565610800|FG002|Overall Study|Lost to Follow-up|2|||
156690188|NCT01172821|565610801|FG003|Overall Study|Lost to Follow-up|2|||
156690189|NCT01172821|565610798|FG000|Overall Study|Withdrawal by Subject|2|||
156690190|NCT01172821|565610799|FG001|Overall Study|Withdrawal by Subject|3|||
156690191|NCT01172821|565610800|FG002|Overall Study|Withdrawal by Subject|3|||
156690192|NCT01172821|565610801|FG003|Overall Study|Withdrawal by Subject|3|||
156690193|NCT01172821|565610798|FG000|Overall Study|Other|3|||
156690194|NCT01172821|565610799|FG001|Overall Study|Other|4|||
156690195|NCT01172821|565610800|FG002|Overall Study|Other|5|||
156690196|NCT01172821|565610801|FG003|Overall Study|Other|3|||
156690197|NCT02756637|565610804|FG000|Overall Study|Not eligible for initial SWOG study|10|||
156690198|NCT02756637|565610805|FG001|Overall Study|Not eligible for initial SWOG study|10|||
156690199|NCT02756637|565610804|FG000|Overall Study|No available NLR value|44|||
156690200|NCT02756637|565610805|FG001|Overall Study|No available NLR value|44|||
156690201|NCT02756637|565610804|FG000|Overall Study|Did not complete curative therapy|33|||
156690202|NCT02756637|565610805|FG001|Overall Study|Did not complete curative therapy|0|||
156690203|NCT02985879|565610808|FG000|Overall Study|Adverse Event|7|||
156690204|NCT02985879|565610809|FG001|Overall Study|Adverse Event|9|||
156690205|NCT02985879|565610810|FG002|Overall Study|Adverse Event|7|||
156690206|NCT02985879|565610808|FG000|Overall Study|Withdrew consent|6|||
156690207|NCT02985879|565610809|FG001|Overall Study|Withdrew consent|8|||
156690208|NCT02985879|565610810|FG002|Overall Study|Withdrew consent|10|||
156690209|NCT02985879|565610808|FG000|Overall Study|Lost to Follow-up|1|||
156690210|NCT02985879|565610809|FG001|Overall Study|Lost to Follow-up|0|||
156690211|NCT02985879|565610810|FG002|Overall Study|Lost to Follow-up|2|||
156690212|NCT02985879|565610808|FG000|Overall Study|Other, not specified|62|||
156690213|NCT02985879|565610809|FG001|Overall Study|Other, not specified|58|||
156690214|NCT02985879|565610810|FG002|Overall Study|Other, not specified|58|||
156690215|NCT02723773|565612311|FG000|Overall Study|Adverse Event|934|||
156690216|NCT02723773|565612312|FG001|Overall Study|Adverse Event|3|||
156690217|NCT02723773|565612313|FG002|Overall Study|Adverse Event|1|||
156690218|NCT02723773|565612314|FG003|Overall Study|Adverse Event|9|||
156690219|NCT02723773|565612311|FG000|Overall Study|Protocol Violation|1|||
156690220|NCT02723773|565612312|FG001|Overall Study|Protocol Violation|0|||
156690221|NCT02723773|565612313|FG002|Overall Study|Protocol Violation|0|||
156690222|NCT02723773|565612314|FG003|Overall Study|Protocol Violation|0|||
156690223|NCT02723773|565612311|FG000|Overall Study|Withdrawal by Subject|360|||
156690224|NCT02723773|565612312|FG001|Overall Study|Withdrawal by Subject|5|||
156690225|NCT02723773|565612313|FG002|Overall Study|Withdrawal by Subject|6|||
156690226|NCT02723773|565612314|FG003|Overall Study|Withdrawal by Subject|10|||
156690227|NCT02723773|565612311|FG000|Overall Study|Migrated/moved from study area|37|||
156690228|NCT02723773|565612312|FG001|Overall Study|Migrated/moved from study area|0|||
156690229|NCT02723773|565612313|FG002|Overall Study|Migrated/moved from study area|0|||
156690230|NCT02723773|565612314|FG003|Overall Study|Migrated/moved from study area|1|||
156690231|NCT02723773|565612311|FG000|Overall Study|Lost to Follow-up|198|||
156690232|NCT02723773|565612312|FG001|Overall Study|Lost to Follow-up|0|||
156690233|NCT02723773|565612313|FG002|Overall Study|Lost to Follow-up|0|||
156690234|NCT02723773|565612314|FG003|Overall Study|Lost to Follow-up|0|||
156690235|NCT02723773|565612311|FG000|Overall Study|Other|189|||
156690236|NCT02723773|565612312|FG001|Overall Study|Other|1|||
156690237|NCT02723773|565612313|FG002|Overall Study|Other|2|||
156690238|NCT02723773|565612314|FG003|Overall Study|Other|2|||
156690239|NCT05168774|565612315|FG000|Overall Study|Lack of Efficacy|1|||
156690240|NCT05168774|565612316|FG001|Overall Study|Lack of Efficacy|2|||
156690241|NCT05168774|565612315|FG000|Overall Study|Withdrawal by Subject|1|||
156690242|NCT05168774|565612316|FG001|Overall Study|Withdrawal by Subject|2|||
156690243|NCT05168774|565612315|FG000|Overall Study|Adverse Event|2|||
156690244|NCT05168774|565612316|FG001|Overall Study|Adverse Event|0|||
156690245|NCT03940703|565612317|FG000|Overall Study|Still under treatment|31|||
156787714|NCT02533674|565974752|FG001|Dose Level VIII|Never treated|0|||
156690246|NCT03940703|565612318|FG001|Overall Study|Still under treatment|0|||
156690247|NCT03310957|565612319|FG000|Overall Study|Withdrawal by Subject|1|||
156690248|NCT03310957|565612320|FG001|Overall Study|Withdrawal by Subject|1|||
156690249|NCT03310957|565612321|FG002|Overall Study|Withdrawal by Subject|1|||
156690250|NCT03310957|565612322|FG003|Overall Study|Withdrawal by Subject|5|||
156690251|NCT03310957|565612323|FG004|Overall Study|Withdrawal by Subject|0|||
156690252|NCT03310957|565612324|FG005|Overall Study|Withdrawal by Subject|4|||
156690253|NCT03310957|565612325|FG006|Overall Study|Withdrawal by Subject|3|||
156690254|NCT03310957|565612319|FG000|Overall Study|Site Terminated|0|||
156690255|NCT03310957|565612320|FG001|Overall Study|Site Terminated|1|||
156690256|NCT03310957|565612321|FG002|Overall Study|Site Terminated|1|||
156690257|NCT03310957|565612322|FG003|Overall Study|Site Terminated|1|||
156690258|NCT03310957|565612323|FG004|Overall Study|Site Terminated|0|||
156787715|NCT02533674|565974753|FG002|Dose Level VIII|Never treated|0|||
156787716|NCT02533674|565974754|FG003|Dose Level VIII|Never treated|0|||
156787717|NCT02533674|565974755|FG004|Dose Level VIII|Never treated|0|||
156787718|NCT02533674|565974756|FG005|Dose Level VIII|Never treated|0|||
156787719|NCT02533674|565974757|FG006|Dose Level VIII|Never treated|0|||
156787720|NCT02533674|565974758|FG007|Dose Level VIII|Never treated|1|||
156787721|NCT03021005|565974759|FG000|Overall Study|Lost to Follow-up|39|||
156787722|NCT03021005|565974760|FG001|Overall Study|Lost to Follow-up|26|||
156787723|NCT03188705|565974761|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
156787724|NCT03188705|565974761|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
156787725|NCT01174459|565974765|FG000|Overall Study|case report form (CRF) not collected|5|||
156787726|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
156787727|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
156787728|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
156787729|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
156787730|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
156787731|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
156787732|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
156787733|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
156787734|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
156787735|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
156787736|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
156787737|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
156787738|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
156787739|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
156787740|NCT00290758|565974766|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
156787741|NCT00290758|565974767|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
156787742|NCT03994120|565974769|FG000|Overall Study|Lost to Follow-up|3|||
156787743|NCT03994120|565974770|FG001|Overall Study|Lost to Follow-up|1|||
156787744|NCT00474968|565974771|FG000|Overall Study|Withdrawal by Subject|8|||
156787745|NCT00474968|565974772|FG001|Overall Study|Withdrawal by Subject|7|||
156787746|NCT00474968|565974771|FG000|Overall Study|Protocol Violation|9|||
156787747|NCT00474968|565974772|FG001|Overall Study|Protocol Violation|8|||
156787748|NCT00474968|565974771|FG000|Overall Study|Sample not collected|1|||
156787749|NCT00474968|565974772|FG001|Overall Study|Sample not collected|1|||
156787750|NCT00215553|565974773|FG000|Overall Study|Adverse Event|0|||
156787751|NCT00215553|565974774|FG001|Overall Study|Adverse Event|1|||
156787752|NCT00215553|565974775|FG002|Overall Study|Adverse Event|2|||
156787753|NCT00215553|565974776|FG003|Overall Study|Adverse Event|1|||
156787754|NCT00215553|565974777|FG004|Overall Study|Adverse Event|2|||
156787755|NCT00215553|565974778|FG005|Overall Study|Adverse Event|6|||
156787756|NCT00215553|565974779|FG006|Overall Study|Adverse Event|0|||
156787757|NCT01111292|565974780|FG000|Treatment|Physician Decision|1|||
156787758|NCT01111292|565974781|FG001|Treatment|Physician Decision|1|||
156787759|NCT04914000|565974782|FG000|Overall Study|Lost to Follow-up|8|||
156787760|NCT04914000|565974782|FG000|Overall Study|Withdrawal by Subject|1|||
156787761|NCT01429623|565974783|FG000|Overall Study|Death|1|||
156787762|NCT01429623|565974784|FG001|Overall Study|Death|0|||
156787763|NCT01429623|565974783|FG000|Overall Study|Adverse Event|7|||
156787764|NCT01429623|565974784|FG001|Overall Study|Adverse Event|14|||
156787765|NCT01429623|565974783|FG000|Overall Study|Withdrawal by Subject|19|||
156787766|NCT01429623|565974784|FG001|Overall Study|Withdrawal by Subject|13|||
156787767|NCT01429623|565974783|FG000|Overall Study|Physician Decision|2|||
156787768|NCT01429623|565974784|FG001|Overall Study|Physician Decision|3|||
156787769|NCT01429623|565974783|FG000|Overall Study|Protocol Violation|3|||
156787770|NCT01429623|565974784|FG001|Overall Study|Protocol Violation|2|||
156787771|NCT01429623|565974783|FG000|Overall Study|Assorted|1|||
156787772|NCT01429623|565974784|FG001|Overall Study|Assorted|2|||
156787773|NCT01429623|565974783|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
156787774|NCT01429623|565974784|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
156787775|NCT01429623|565974783|FG000|Overall Study|No post baseline data|4|||
156787776|NCT01429623|565974784|FG001|Overall Study|No post baseline data|4|||
156787777|NCT00981175|565974785|FG000|Primary Dose Vaccination|Adverse Event|1|||
156787778|NCT00981175|565974786|FG001|Primary Dose Vaccination|Adverse Event|0|||
156787779|NCT00981175|565974785|FG000|Primary Dose Vaccination|Protocol Violation|0|||
156787780|NCT00981175|565974786|FG001|Primary Dose Vaccination|Protocol Violation|1|||
156787781|NCT00981175|565974785|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
156787782|NCT00981175|565974786|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
156787783|NCT00981175|565974785|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
156787784|NCT00981175|565974786|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
156787785|NCT01096186|565974787|FG000|Overall Study|Adverse Event|16|||
156787786|NCT01096186|565974787|FG000|Overall Study|Death|4|||
156787787|NCT01096186|565974787|FG000|Overall Study|Lack of Efficacy|4|||
156787788|NCT01096186|565974787|FG000|Overall Study|Lost to Follow-up|2|||
156787789|NCT01096186|565974787|FG000|Overall Study|Withdrawal by Subject|22|||
156690259|NCT03310957|565612324|FG005|Overall Study|Site Terminated|2|||
156690260|NCT03310957|565612325|FG006|Overall Study|Site Terminated|8|||
156690261|NCT03310957|565612319|FG000|Overall Study|Lost to Follow-up|1|||
156870121|NCT01394016|566281089|FG002|Overall Study|Adverse Event|0|||
156870122|NCT01394016|566281090|FG003|Overall Study|Adverse Event|0|||
156690262|NCT03310957|565612320|FG001|Overall Study|Lost to Follow-up|1|||
156870123|NCT01394016|566281091|FG004|Overall Study|Adverse Event|0|||
156690263|NCT03310957|565612321|FG002|Overall Study|Lost to Follow-up|1|||
156690264|NCT03310957|565612322|FG003|Overall Study|Lost to Follow-up|4|||
156690265|NCT03310957|565612323|FG004|Overall Study|Lost to Follow-up|0|||
156690266|NCT03310957|565612324|FG005|Overall Study|Lost to Follow-up|4|||
156690267|NCT03310957|565612325|FG006|Overall Study|Lost to Follow-up|2|||
156690268|NCT03310957|565612319|FG000|Overall Study|Death|5|||
156787790|NCT01096186|565974787|FG000|Overall Study|Physician Decision|1|||
156787791|NCT01096186|565974787|FG000|Overall Study|Noncompliance with study drug|1|||
156787792|NCT03156621|565974792|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
156787793|NCT03156621|565974793|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
156787794|NCT03156621|565974792|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156787795|NCT03156621|565974793|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
156787796|NCT00799864|565974794|FG000|Overall Study|Participant reached a virologic endpoint|9|||
156787797|NCT00799864|565974795|FG001|Overall Study|Participant reached a virologic endpoint|2|||
156787798|NCT00799864|565974796|FG002|Overall Study|Participant reached a virologic endpoint|2|||
156787799|NCT00799864|565974797|FG003|Overall Study|Participant reached a virologic endpoint|0|||
156787800|NCT00799864|565974798|FG004|Overall Study|Participant reached a virologic endpoint|0|||
156787801|NCT00799864|565974794|FG000|Overall Study|Other|2|||
156787802|NCT00799864|565974795|FG001|Overall Study|Other|1|||
156787803|NCT00799864|565974796|FG002|Overall Study|Other|0|||
156787804|NCT00799864|565974797|FG003|Overall Study|Other|0|||
156787805|NCT00799864|565974798|FG004|Overall Study|Other|0|||
156787806|NCT00079781|565974799|FG000|Pre-implant Period|Withdrawal by Subject|2|||
156787807|NCT00079781|565974800|FG001|Pre-implant Period|Withdrawal by Subject|0|||
156787808|NCT00079781|565974801|FG002|Pre-implant Period|Withdrawal by Subject|0|||
156787809|NCT00079781|565974799|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
156787810|NCT00079781|565974800|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
156787811|NCT00079781|565974801|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
156787812|NCT00079781|565974799|FG000|Follow-up Period|Withdrawal by Subject|3|||
156787813|NCT00079781|565974800|FG001|Follow-up Period|Withdrawal by Subject|0|||
156787814|NCT00079781|565974801|FG002|Follow-up Period|Withdrawal by Subject|1|||
156787815|NCT00079781|565974799|FG000|Follow-up Period|Lost to Follow-up|1|||
156787816|NCT00079781|565974800|FG001|Follow-up Period|Lost to Follow-up|0|||
156787817|NCT00079781|565974801|FG002|Follow-up Period|Lost to Follow-up|0|||
156787818|NCT00079781|565974799|FG000|Follow-up Period|Death|0|||
156787819|NCT00079781|565974800|FG001|Follow-up Period|Death|0|||
156787820|NCT00079781|565974801|FG002|Follow-up Period|Death|1|||
156787821|NCT00576407|565974802|FG000|Overall Study|Death|7|||
156787822|NCT00576407|565974802|FG000|Overall Study|Physician Decision|1|||
156787823|NCT00225758|565974803|FG000|Overall Study|Adverse Event|4|||
156787824|NCT00621322|565974804|FG000|Overall Study|Lost to Follow-up|0|||
156787825|NCT00621322|565974805|FG001|Overall Study|Lost to Follow-up|0|||
156787826|NCT00621322|565974806|FG002|Overall Study|Lost to Follow-up|0|||
156870124|NCT01394016|566281092|FG005|Overall Study|Adverse Event|0|||
156870125|NCT01394016|566281093|FG006|Overall Study|Adverse Event|0|||
156787827|NCT00621322|565974807|FG003|Overall Study|Lost to Follow-up|0|||
156787828|NCT00621322|565974808|FG004|Overall Study|Lost to Follow-up|1|||
156787829|NCT00621322|565974809|FG005|Overall Study|Lost to Follow-up|0|||
156787830|NCT00621322|565974804|FG000|Overall Study|Physician Decision|0|||
156787831|NCT00621322|565974805|FG001|Overall Study|Physician Decision|0|||
156787832|NCT00621322|565974806|FG002|Overall Study|Physician Decision|1|||
156787833|NCT00621322|565974807|FG003|Overall Study|Physician Decision|1|||
156787834|NCT00621322|565974808|FG004|Overall Study|Physician Decision|0|||
156787835|NCT00621322|565974809|FG005|Overall Study|Physician Decision|0|||
156870126|NCT01394016|566281094|FG007|Overall Study|Adverse Event|0|||
156690269|NCT03310957|565612320|FG001|Overall Study|Death|8|||
156787836|NCT00621322|565974804|FG000|Overall Study|Withdrawal by Subject|0|||
156787837|NCT00621322|565974805|FG001|Overall Study|Withdrawal by Subject|0|||
156787838|NCT00621322|565974806|FG002|Overall Study|Withdrawal by Subject|0|||
156787839|NCT00621322|565974807|FG003|Overall Study|Withdrawal by Subject|1|||
156787840|NCT00621322|565974808|FG004|Overall Study|Withdrawal by Subject|0|||
156787841|NCT00621322|565974809|FG005|Overall Study|Withdrawal by Subject|2|||
156787842|NCT00621322|565974804|FG000|Overall Study|Migrated/moved from study area|1|||
156787843|NCT00621322|565974805|FG001|Overall Study|Migrated/moved from study area|0|||
156690270|NCT03310957|565612321|FG002|Overall Study|Death|18|||
156690271|NCT03310957|565612322|FG003|Overall Study|Death|31|||
156690272|NCT03310957|565612323|FG004|Overall Study|Death|1|||
156787844|NCT00621322|565974806|FG002|Overall Study|Migrated/moved from study area|1|||
156787845|NCT00621322|565974807|FG003|Overall Study|Migrated/moved from study area|1|||
156787846|NCT00621322|565974808|FG004|Overall Study|Migrated/moved from study area|0|||
156870127|NCT01394016|566281095|FG008|Overall Study|Adverse Event|0|||
156690273|NCT03310957|565612324|FG005|Overall Study|Death|29|||
156690274|NCT03310957|565612325|FG006|Overall Study|Death|7|||
156690275|NCT03310957|565612319|FG000|Overall Study|Discontinuation per sponsor|0|||
156690276|NCT03310957|565612320|FG001|Overall Study|Discontinuation per sponsor|1|||
156690277|NCT03310957|565612321|FG002|Overall Study|Discontinuation per sponsor|2|||
156690278|NCT03310957|565612322|FG003|Overall Study|Discontinuation per sponsor|4|||
156690279|NCT03310957|565612323|FG004|Overall Study|Discontinuation per sponsor|1|||
156690280|NCT03310957|565612324|FG005|Overall Study|Discontinuation per sponsor|9|||
156690281|NCT03310957|565612325|FG006|Overall Study|Discontinuation per sponsor|12|||
156690282|NCT03310957|565612319|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
156690283|NCT03310957|565612320|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
156690284|NCT03310957|565612321|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
156690285|NCT03310957|565612322|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
156690286|NCT03310957|565612323|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
156690287|NCT03310957|565612324|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
156690288|NCT03310957|565612325|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
156690289|NCT03310957|565612319|FG000|Overall Study|Treatment landscape|0|||
156690290|NCT03310957|565612320|FG001|Overall Study|Treatment landscape|0|||
156690291|NCT03310957|565612321|FG002|Overall Study|Treatment landscape|1|||
156690292|NCT03310957|565612322|FG003|Overall Study|Treatment landscape|1|||
156690293|NCT03310957|565612323|FG004|Overall Study|Treatment landscape|0|||
156690294|NCT03310957|565612324|FG005|Overall Study|Treatment landscape|1|||
156690295|NCT03310957|565612325|FG006|Overall Study|Treatment landscape|0|||
156690296|NCT03310957|565612319|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690297|NCT03310957|565612320|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690298|NCT03310957|565612321|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690299|NCT03310957|565612322|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690300|NCT03310957|565612323|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
156690301|NCT03310957|565612324|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690302|NCT03310957|565612325|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690303|NCT03310957|565612319|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690304|NCT03310957|565612320|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690305|NCT03310957|565612321|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
156690306|NCT03310957|565612322|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690307|NCT03310957|565612323|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690308|NCT03310957|565612324|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690309|NCT03310957|565612325|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690310|NCT03310957|565612319|FG000|Overall Study|Hospice|0|||
156690311|NCT03310957|565612320|FG001|Overall Study|Hospice|0|||
156690312|NCT03310957|565612321|FG002|Overall Study|Hospice|0|||
156690313|NCT03310957|565612322|FG003|Overall Study|Hospice|0|||
156690314|NCT03310957|565612323|FG004|Overall Study|Hospice|0|||
156690315|NCT03310957|565612324|FG005|Overall Study|Hospice|1|||
156690316|NCT03310957|565612325|FG006|Overall Study|Hospice|0|||
156690317|NCT03310957|565612319|FG000|Overall Study|Progressive|0|||
156690318|NCT03310957|565612320|FG001|Overall Study|Progressive|0|||
156690319|NCT03310957|565612321|FG002|Overall Study|Progressive|1|||
156690320|NCT03310957|565612322|FG003|Overall Study|Progressive|0|||
156690321|NCT03310957|565612323|FG004|Overall Study|Progressive|0|||
156690322|NCT03310957|565612324|FG005|Overall Study|Progressive|0|||
156690323|NCT03310957|565612325|FG006|Overall Study|Progressive|0|||
156690324|NCT02658487|565612331|FG000|Overall Study|Death|2|||
156690325|NCT02658487|565612331|FG000|Overall Study|Disease progression|10|||
156690326|NCT02658487|565612331|FG000|Overall Study|Alternative therapy|1|||
156690327|NCT02658487|565612331|FG000|Overall Study|Adverse Event|1|||
156690328|NCT02658487|565612331|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
156690329|NCT02658487|565612331|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
156690330|NCT01475253|565612345|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
156690331|NCT01475253|565612346|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
156690332|NCT01475253|565612347|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
156690333|NCT01475253|565612348|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
156690334|NCT01475253|565612345|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
156690335|NCT01475253|565612346|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
156787847|NCT00621322|565974809|FG005|Overall Study|Migrated/moved from study area|2|||
156690336|NCT01475253|565612347|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
156690337|NCT01475253|565612348|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
156690338|NCT03135899|565612349|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690339|NCT03135899|565612350|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690340|NCT03135899|565612351|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690341|NCT03135899|565612352|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690342|NCT03135899|565612353|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690343|NCT03135899|565612354|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690344|NCT03135899|565612355|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
156870128|NCT01394016|566281096|FG009|Overall Study|Adverse Event|1|||
156690345|NCT03135899|565612356|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690346|NCT03135899|565612349|FG000|Overall Study|Withdrawal by Subject|0|||
156690347|NCT03135899|565612350|FG001|Overall Study|Withdrawal by Subject|0|||
156690348|NCT03135899|565612351|FG002|Overall Study|Withdrawal by Subject|0|||
156690349|NCT03135899|565612352|FG003|Overall Study|Withdrawal by Subject|0|||
156690350|NCT03135899|565612353|FG004|Overall Study|Withdrawal by Subject|0|||
156690351|NCT03135899|565612354|FG005|Overall Study|Withdrawal by Subject|2|||
156690352|NCT03135899|565612355|FG006|Overall Study|Withdrawal by Subject|0|||
156690353|NCT03135899|565612356|FG007|Overall Study|Withdrawal by Subject|0|||
156870129|NCT01394016|566281097|FG010|Overall Study|Adverse Event|0|||
156870130|NCT01394016|566281098|FG011|Overall Study|Adverse Event|0|||
156690354|NCT04146363|565612357|FG000|Induction Period|Adverse Event|1|||
156690355|NCT04146363|565612358|FG001|Induction Period|Adverse Event|2|||
156690356|NCT04146363|565612359|FG002|Induction Period|Adverse Event|0|||
156690357|NCT04146363|565612360|FG003|Induction Period|Adverse Event|0|||
156690358|NCT04146363|565612361|FG004|Induction Period|Adverse Event|0|||
156690359|NCT04146363|565612362|FG005|Induction Period|Adverse Event|0|||
156690360|NCT04146363|565612363|FG006|Induction Period|Adverse Event|0|||
156690361|NCT04146363|565612364|FG007|Induction Period|Adverse Event|0|||
156690362|NCT04146363|565612365|FG008|Induction Period|Adverse Event|0|||
156690363|NCT04146363|565612366|FG009|Induction Period|Adverse Event|0|||
156690364|NCT04146363|565612367|FG010|Induction Period|Adverse Event|0|||
156690365|NCT04146363|565612357|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
156690366|NCT04146363|565612358|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
156690367|NCT04146363|565612359|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
156690368|NCT04146363|565612360|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
156690369|NCT04146363|565612361|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
156690370|NCT04146363|565612362|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
156690371|NCT04146363|565612363|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
156690372|NCT04146363|565612364|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
156690373|NCT04146363|565612365|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
156690374|NCT04146363|565612366|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
156690375|NCT04146363|565612367|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
156690376|NCT04146363|565612357|FG000|Induction Period|Lack of Efficacy|7|||
156690377|NCT04146363|565612358|FG001|Induction Period|Lack of Efficacy|2|||
156690378|NCT04146363|565612359|FG002|Induction Period|Lack of Efficacy|0|||
156690379|NCT04146363|565612360|FG003|Induction Period|Lack of Efficacy|0|||
156690380|NCT04146363|565612361|FG004|Induction Period|Lack of Efficacy|0|||
156690381|NCT04146363|565612362|FG005|Induction Period|Lack of Efficacy|0|||
156690382|NCT04146363|565612363|FG006|Induction Period|Lack of Efficacy|0|||
156690383|NCT04146363|565612364|FG007|Induction Period|Lack of Efficacy|0|||
156690384|NCT04146363|565612365|FG008|Induction Period|Lack of Efficacy|0|||
156690385|NCT04146363|565612366|FG009|Induction Period|Lack of Efficacy|0|||
156690386|NCT04146363|565612367|FG010|Induction Period|Lack of Efficacy|0|||
156690387|NCT04146363|565612357|FG000|Induction Period|Lost to Follow-up|1|||
156690388|NCT04146363|565612358|FG001|Induction Period|Lost to Follow-up|4|||
156690389|NCT04146363|565612359|FG002|Induction Period|Lost to Follow-up|0|||
156690390|NCT04146363|565612360|FG003|Induction Period|Lost to Follow-up|0|||
156690391|NCT04146363|565612361|FG004|Induction Period|Lost to Follow-up|0|||
156690392|NCT04146363|565612362|FG005|Induction Period|Lost to Follow-up|0|||
156690393|NCT04146363|565612363|FG006|Induction Period|Lost to Follow-up|0|||
156690394|NCT04146363|565612364|FG007|Induction Period|Lost to Follow-up|0|||
156690395|NCT04146363|565612365|FG008|Induction Period|Lost to Follow-up|0|||
156690396|NCT04146363|565612366|FG009|Induction Period|Lost to Follow-up|0|||
156787848|NCT01259024|565974813|FG000|Overall Study|Physician Decision|1|||
156787849|NCT01657500|565974814|FG000|Overall Study|set impropperly matched|3|||
156787850|NCT01657500|565974815|FG001|Overall Study|set impropperly matched|3|||
156787851|NCT01657500|565974814|FG000|Overall Study|Lost to Follow-up|2|||
156787852|NCT01657500|565974815|FG001|Overall Study|Lost to Follow-up|2|||
156787853|NCT00756444|565974818|FG000|Overall Study|Adverse Event|1|||
156787854|NCT00756444|565974819|FG001|Overall Study|Adverse Event|1|||
156787855|NCT00756444|565974818|FG000|Overall Study|Withdrawal by Subject|6|||
156787856|NCT00756444|565974819|FG001|Overall Study|Withdrawal by Subject|8|||
156787857|NCT00756444|565974818|FG000|Overall Study|Lost to Follow-up|0|||
156787858|NCT00756444|565974819|FG001|Overall Study|Lost to Follow-up|1|||
156787859|NCT00756444|565974818|FG000|Overall Study|Death|5|||
156787860|NCT00756444|565974819|FG001|Overall Study|Death|4|||
156690397|NCT04146363|565612367|FG010|Induction Period|Lost to Follow-up|0|||
156690398|NCT04146363|565612357|FG000|Induction Period|Positive quantiferon test|0|||
156787861|NCT00756444|565974818|FG000|Overall Study|Disease Progression|2|||
156787862|NCT00756444|565974819|FG001|Overall Study|Disease Progression|7|||
156690399|NCT04146363|565612358|FG001|Induction Period|Positive quantiferon test|1|||
156690400|NCT04146363|565612359|FG002|Induction Period|Positive quantiferon test|0|||
156690401|NCT04146363|565612360|FG003|Induction Period|Positive quantiferon test|0|||
156690402|NCT04146363|565612361|FG004|Induction Period|Positive quantiferon test|0|||
156690403|NCT04146363|565612362|FG005|Induction Period|Positive quantiferon test|0|||
156690404|NCT04146363|565612363|FG006|Induction Period|Positive quantiferon test|0|||
156690405|NCT04146363|565612364|FG007|Induction Period|Positive quantiferon test|0|||
156690406|NCT04146363|565612365|FG008|Induction Period|Positive quantiferon test|0|||
156690407|NCT04146363|565612366|FG009|Induction Period|Positive quantiferon test|0|||
156690408|NCT04146363|565612367|FG010|Induction Period|Positive quantiferon test|0|||
156690409|NCT04146363|565612357|FG000|Induction Period|Protocol Deviation|5|||
156690410|NCT04146363|565612358|FG001|Induction Period|Protocol Deviation|6|||
156690411|NCT04146363|565612359|FG002|Induction Period|Protocol Deviation|0|||
156690412|NCT04146363|565612360|FG003|Induction Period|Protocol Deviation|0|||
156690413|NCT04146363|565612361|FG004|Induction Period|Protocol Deviation|0|||
156690414|NCT04146363|565612362|FG005|Induction Period|Protocol Deviation|0|||
156690415|NCT04146363|565612363|FG006|Induction Period|Protocol Deviation|0|||
156690416|NCT04146363|565612364|FG007|Induction Period|Protocol Deviation|0|||
156690417|NCT04146363|565612365|FG008|Induction Period|Protocol Deviation|0|||
156690418|NCT04146363|565612366|FG009|Induction Period|Protocol Deviation|0|||
156690419|NCT04146363|565612367|FG010|Induction Period|Protocol Deviation|0|||
156690420|NCT04146363|565612357|FG000|Induction Period|Withdrawal by Subject|6|||
156690421|NCT04146363|565612358|FG001|Induction Period|Withdrawal by Subject|3|||
156690422|NCT04146363|565612359|FG002|Induction Period|Withdrawal by Subject|0|||
156690423|NCT04146363|565612360|FG003|Induction Period|Withdrawal by Subject|0|||
156690424|NCT04146363|565612361|FG004|Induction Period|Withdrawal by Subject|0|||
156690425|NCT04146363|565612362|FG005|Induction Period|Withdrawal by Subject|0|||
156690426|NCT04146363|565612363|FG006|Induction Period|Withdrawal by Subject|0|||
156690427|NCT04146363|565612364|FG007|Induction Period|Withdrawal by Subject|0|||
156690428|NCT04146363|565612365|FG008|Induction Period|Withdrawal by Subject|0|||
156690429|NCT04146363|565612366|FG009|Induction Period|Withdrawal by Subject|0|||
156690430|NCT04146363|565612367|FG010|Induction Period|Withdrawal by Subject|0|||
156690431|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690432|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690433|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690434|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690435|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690436|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690437|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
156690438|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
156690439|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690440|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690441|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690442|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690443|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690444|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690445|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690446|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690447|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690448|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690449|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
156690450|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690451|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690452|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690453|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690454|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690455|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690456|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690457|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690458|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690459|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
156690460|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
156690461|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690462|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690463|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690464|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
156787863|NCT00756444|565974818|FG000|Overall Study|Ineligibility Determined|1|||
156787864|NCT00756444|565974819|FG001|Overall Study|Ineligibility Determined|0|||
156787865|NCT00564070|565974820|FG000|Overall Study|Lost to Follow-up|9|||
156690465|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690466|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
156690467|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690468|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
156787866|NCT00564070|565974821|FG001|Overall Study|Lost to Follow-up|7|||
156690469|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
156690470|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690471|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690472|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690473|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690474|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690475|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690476|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690477|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690478|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690479|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
156787867|NCT00564070|565974820|FG000|Overall Study|Worsening depression, referred to care|3|||
156870131|NCT01394016|566281099|FG012|Overall Study|Adverse Event|0|||
156870132|NCT01394016|566281100|FG013|Overall Study|Adverse Event|0|||
156787868|NCT00564070|565974821|FG001|Overall Study|Worsening depression, referred to care|0|||
156787869|NCT02346370|565974822|FG000|Overall Study|Not treated|1|||
156787870|NCT02346370|565974823|FG001|Overall Study|Not treated|0|||
156787871|NCT02346370|565974824|FG002|Overall Study|Not treated|0|||
156787872|NCT02346370|565974822|FG000|Overall Study|Withdrawal of consent|1|||
156787873|NCT02346370|565974823|FG001|Overall Study|Withdrawal of consent|0|||
156787874|NCT02346370|565974824|FG002|Overall Study|Withdrawal of consent|0|||
156787875|NCT02346370|565974822|FG000|Overall Study|Death|1|||
156787876|NCT02346370|565974823|FG001|Overall Study|Death|3|||
156787877|NCT02346370|565974824|FG002|Overall Study|Death|1|||
156787878|NCT02346370|565974822|FG000|Overall Study|Sponsor discontinued study|5|||
156787879|NCT02346370|565974823|FG001|Overall Study|Sponsor discontinued study|0|||
156787880|NCT02346370|565974824|FG002|Overall Study|Sponsor discontinued study|2|||
156787881|NCT02346370|565974822|FG000|Overall Study|Radiologic progression|0|||
156787882|NCT02346370|565974823|FG001|Overall Study|Radiologic progression|0|||
156787883|NCT02346370|565974824|FG002|Overall Study|Radiologic progression|1|||
156787884|NCT02346370|565974822|FG000|Overall Study|Physician Decision|0|||
156787885|NCT02346370|565974823|FG001|Overall Study|Physician Decision|1|||
156787886|NCT02346370|565974824|FG002|Overall Study|Physician Decision|0|||
156787887|NCT01217047|565974825|FG000|Overall Study|Lost to Follow-up|0|||
156787888|NCT01217047|565974826|FG001|Overall Study|Lost to Follow-up|1|||
156787889|NCT01217047|565974827|FG002|Overall Study|Lost to Follow-up|0|||
156787890|NCT02318277|565974828|FG000|Overall Study|Physician Decision|0|||
156787891|NCT02318277|565974829|FG001|Overall Study|Physician Decision|0|||
156787892|NCT02318277|565974830|FG002|Overall Study|Physician Decision|0|||
156787893|NCT02318277|565974831|FG003|Overall Study|Physician Decision|0|||
156787894|NCT02318277|565974832|FG004|Overall Study|Physician Decision|0|||
156787895|NCT02318277|565974833|FG005|Overall Study|Physician Decision|0|||
156787896|NCT02318277|565974834|FG006|Overall Study|Physician Decision|0|||
156787897|NCT02318277|565974835|FG007|Overall Study|Physician Decision|1|||
156787898|NCT02318277|565974828|FG000|Overall Study|Other|0|||
156787899|NCT02318277|565974829|FG001|Overall Study|Other|0|||
156787900|NCT02318277|565974830|FG002|Overall Study|Other|0|||
156787901|NCT02318277|565974831|FG003|Overall Study|Other|0|||
156787902|NCT02318277|565974832|FG004|Overall Study|Other|0|||
156787903|NCT02318277|565974833|FG005|Overall Study|Other|0|||
156787904|NCT02318277|565974834|FG006|Overall Study|Other|1|||
156787905|NCT02318277|565974835|FG007|Overall Study|Other|0|||
156787906|NCT02318277|565974828|FG000|Overall Study|Withdrawal by Subject|0|||
156787907|NCT02318277|565974829|FG001|Overall Study|Withdrawal by Subject|0|||
156787908|NCT02318277|565974830|FG002|Overall Study|Withdrawal by Subject|1|||
156787909|NCT02318277|565974831|FG003|Overall Study|Withdrawal by Subject|0|||
156787910|NCT02318277|565974832|FG004|Overall Study|Withdrawal by Subject|1|||
156787911|NCT02318277|565974833|FG005|Overall Study|Withdrawal by Subject|1|||
156787912|NCT02318277|565974834|FG006|Overall Study|Withdrawal by Subject|6|||
156787913|NCT02318277|565974835|FG007|Overall Study|Withdrawal by Subject|14|||
156787914|NCT02318277|565974828|FG000|Overall Study|Participant trial terminated by sponsor|0|||
156787915|NCT02318277|565974829|FG001|Overall Study|Participant trial terminated by sponsor|0|||
156787916|NCT02318277|565974830|FG002|Overall Study|Participant trial terminated by sponsor|1|||
156787917|NCT02318277|565974831|FG003|Overall Study|Participant trial terminated by sponsor|0|||
156787918|NCT02318277|565974832|FG004|Overall Study|Participant trial terminated by sponsor|1|||
156787919|NCT02318277|565974833|FG005|Overall Study|Participant trial terminated by sponsor|2|||
156787920|NCT02318277|565974834|FG006|Overall Study|Participant trial terminated by sponsor|5|||
156787921|NCT02318277|565974835|FG007|Overall Study|Participant trial terminated by sponsor|16|||
156787922|NCT02318277|565974828|FG000|Overall Study|Lost to Follow-up|1|||
156787923|NCT02318277|565974829|FG001|Overall Study|Lost to Follow-up|0|||
156787924|NCT02318277|565974830|FG002|Overall Study|Lost to Follow-up|1|||
156787925|NCT02318277|565974831|FG003|Overall Study|Lost to Follow-up|0|||
156787926|NCT02318277|565974832|FG004|Overall Study|Lost to Follow-up|0|||
156787927|NCT02318277|565974833|FG005|Overall Study|Lost to Follow-up|0|||
156787928|NCT02318277|565974834|FG006|Overall Study|Lost to Follow-up|3|||
156870133|NCT01394016|566281101|FG014|Overall Study|Adverse Event|0|||
156690480|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
156690481|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
156690482|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
156690483|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690484|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690485|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690486|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690487|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690488|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
156690489|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690490|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690491|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
156690492|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
156690493|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
156690494|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690495|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690496|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690497|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690498|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690499|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690500|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690501|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690502|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690503|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690504|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690505|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
156690506|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
156690507|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690508|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690509|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690510|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690511|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690512|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690513|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690514|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690515|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690516|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
156690517|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
156690518|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
156690519|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690520|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690521|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690522|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690523|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690524|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690525|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690526|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690527|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
156690528|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
156690529|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690530|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690531|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690532|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690533|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690534|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690535|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690536|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690537|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690538|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
156690539|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
156690540|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690541|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156530595|NCT01306890|565038073|FG000|Overall Study|Unspecified reasons|104|||
156530596|NCT01306890|565038073|FG000|Overall Study|Study Termination|3|||
156690542|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690543|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156870134|NCT01394016|566281102|FG015|Overall Study|Adverse Event|0|||
156870135|NCT01394016|566281103|FG016|Overall Study|Adverse Event|1|||
156870136|NCT01394016|566281104|FG017|Overall Study|Adverse Event|1|||
156690544|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690545|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690546|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690547|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690548|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690549|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
156690550|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
156690551|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
156690552|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690553|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690554|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690555|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690556|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690557|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690558|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690559|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690560|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690561|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
156690562|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690563|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690564|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690565|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690566|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690567|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156787929|NCT02318277|565974835|FG007|Overall Study|Lost to Follow-up|4|||
156787930|NCT02318277|565974828|FG000|Overall Study|Death|5|||
156787931|NCT02318277|565974829|FG001|Overall Study|Death|3|||
156787932|NCT02318277|565974830|FG002|Overall Study|Death|1|||
156787933|NCT02318277|565974831|FG003|Overall Study|Death|4|||
156870137|NCT01394016|566281105|FG018|Overall Study|Adverse Event|0|||
156870138|NCT01394016|566281087|FG000|Overall Study|Sponsor Decision|0|||
156870139|NCT01394016|566281088|FG001|Overall Study|Sponsor Decision|0|||
156870140|NCT01394016|566281089|FG002|Overall Study|Sponsor Decision|0|||
156870141|NCT01394016|566281090|FG003|Overall Study|Sponsor Decision|0|||
156870142|NCT01394016|566281091|FG004|Overall Study|Sponsor Decision|0|||
156870143|NCT01394016|566281092|FG005|Overall Study|Sponsor Decision|0|||
156870144|NCT01394016|566281093|FG006|Overall Study|Sponsor Decision|0|||
156870145|NCT01394016|566281094|FG007|Overall Study|Sponsor Decision|0|||
156870146|NCT01394016|566281095|FG008|Overall Study|Sponsor Decision|0|||
156870147|NCT01394016|566281096|FG009|Overall Study|Sponsor Decision|0|||
156870148|NCT01394016|566281097|FG010|Overall Study|Sponsor Decision|0|||
156870149|NCT01394016|566281098|FG011|Overall Study|Sponsor Decision|0|||
156870150|NCT01394016|566281099|FG012|Overall Study|Sponsor Decision|1|||
156870151|NCT01394016|566281100|FG013|Overall Study|Sponsor Decision|0|||
156870152|NCT01394016|566281101|FG014|Overall Study|Sponsor Decision|0|||
156870153|NCT01394016|566281102|FG015|Overall Study|Sponsor Decision|0|||
156870154|NCT01394016|566281103|FG016|Overall Study|Sponsor Decision|0|||
156870155|NCT01394016|566281104|FG017|Overall Study|Sponsor Decision|0|||
156870156|NCT01394016|566281105|FG018|Overall Study|Sponsor Decision|0|||
156870157|NCT01394016|566281087|FG000|Overall Study|Lost to Follow-up|0|||
156870158|NCT01394016|566281088|FG001|Overall Study|Lost to Follow-up|0|||
156870159|NCT01394016|566281089|FG002|Overall Study|Lost to Follow-up|0|||
156870160|NCT01394016|566281090|FG003|Overall Study|Lost to Follow-up|0|||
156870161|NCT01394016|566281091|FG004|Overall Study|Lost to Follow-up|0|||
156787934|NCT02318277|565974832|FG004|Overall Study|Death|6|||
156787935|NCT02318277|565974833|FG005|Overall Study|Death|5|||
156787936|NCT02318277|565974834|FG006|Overall Study|Death|34|||
156787937|NCT02318277|565974835|FG007|Overall Study|Death|58|||
156690568|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690569|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690570|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156787938|NCT02318277|565974828|FG000|Overall Study|Transitioned to Hospice|0|||
156787939|NCT02318277|565974829|FG001|Overall Study|Transitioned to Hospice|0|||
156787940|NCT02318277|565974830|FG002|Overall Study|Transitioned to Hospice|0|||
156787941|NCT02318277|565974831|FG003|Overall Study|Transitioned to Hospice|0|||
156787942|NCT02318277|565974832|FG004|Overall Study|Transitioned to Hospice|0|||
156787943|NCT02318277|565974833|FG005|Overall Study|Transitioned to Hospice|1|||
156787944|NCT02318277|565974834|FG006|Overall Study|Transitioned to Hospice|0|||
156870162|NCT01394016|566281092|FG005|Overall Study|Lost to Follow-up|0|||
156870163|NCT01394016|566281093|FG006|Overall Study|Lost to Follow-up|0|||
156870164|NCT01394016|566281094|FG007|Overall Study|Lost to Follow-up|0|||
156870165|NCT01394016|566281095|FG008|Overall Study|Lost to Follow-up|0|||
156870166|NCT01394016|566281096|FG009|Overall Study|Lost to Follow-up|0|||
156530597|NCT01306890|565038073|FG000|Overall Study|No discontinuation documentation|41|||
156690571|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690572|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
156690573|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690574|NCT02914236|565612372|FG000|Overall Study|Lost to Follow-up|1|||
156690575|NCT00380692|565612375|FG000|Study Period II - Double Blind|Adverse Event|1|||
156690576|NCT00380692|565612376|FG001|Study Period II - Double Blind|Adverse Event|0|||
156690577|NCT00380692|565612375|FG000|Study Period II - Double Blind|Protocol Violation|2|||
156690578|NCT00380692|565612376|FG001|Study Period II - Double Blind|Protocol Violation|2|||
156690579|NCT00380692|565612375|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
156690580|NCT00380692|565612376|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
156690581|NCT00380692|565612375|FG000|Study Period II - Double Blind|Physician Decision|0|||
156690582|NCT00380692|565612376|FG001|Study Period II - Double Blind|Physician Decision|1|||
156690583|NCT00380692|565612375|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
156690584|NCT00380692|565612376|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
156690585|NCT00380692|565612375|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
156690586|NCT00380692|565612376|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
156690587|NCT00380692|565612375|FG000|Study Period III - Open Label|Adverse Event|5|||
156690588|NCT00380692|565612376|FG001|Study Period III - Open Label|Adverse Event|3|||
156690589|NCT00380692|565612375|FG000|Study Period III - Open Label|Protocol Violation|0|||
156690590|NCT00380692|565612376|FG001|Study Period III - Open Label|Protocol Violation|0|||
156690591|NCT00380692|565612375|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
156690592|NCT00380692|565612376|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
156690593|NCT00380692|565612375|FG000|Study Period III - Open Label|Physician Decision|0|||
156690594|NCT00380692|565612376|FG001|Study Period III - Open Label|Physician Decision|3|||
156690595|NCT00380692|565612375|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
156690596|NCT00380692|565612376|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
156690597|NCT00380692|565612375|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
156690598|NCT00380692|565612376|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
156690599|NCT02676284|565612377|FG000|Overall Study|Withdrawal by Subject|1|||
156690600|NCT00107042|565612378|FG000|Overall Study|Lost to Follow-up|9|||
156690601|NCT00107042|565612379|FG001|Overall Study|Lost to Follow-up|7|||
156690602|NCT00107042|565612378|FG000|Overall Study|Withdrawal by Subject|6|||
156690603|NCT00107042|565612379|FG001|Overall Study|Withdrawal by Subject|1|||
156690604|NCT00107042|565612378|FG000|Overall Study|Moved out of area|5|||
156690605|NCT00107042|565612379|FG001|Overall Study|Moved out of area|3|||
156690606|NCT00107042|565612378|FG000|Overall Study|Pregnancy|1|||
156690607|NCT00107042|565612379|FG001|Overall Study|Pregnancy|1|||
156690608|NCT00107042|565612378|FG000|Overall Study|Inadvertent enrollment|0|||
156690609|NCT00107042|565612379|FG001|Overall Study|Inadvertent enrollment|1|||
156690610|NCT00107042|565612378|FG000|Overall Study|vaccinated outside window|1|||
156690611|NCT00107042|565612379|FG001|Overall Study|vaccinated outside window|1|||
156690612|NCT00107042|565612378|FG000|Overall Study|Disallowed medications|0|||
156690613|NCT00107042|565612379|FG001|Overall Study|Disallowed medications|2|||
156690614|NCT03919448|565612381|FG000|Overall Study|Withdrawal by Subject|1|||
156690615|NCT03919448|565612382|FG001|Overall Study|Withdrawal by Subject|0|||
156690616|NCT03919448|565612383|FG002|Overall Study|Withdrawal by Subject|0|||
156690617|NCT01221090|565612385|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
156690618|NCT01221090|565612386|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
156690619|NCT01221090|565612387|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
156690620|NCT01221090|565612388|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
156690621|NCT01221090|565612385|FG000|Overall Study|Withdrawal by Subject|0|||
156690622|NCT01221090|565612386|FG001|Overall Study|Withdrawal by Subject|22|||
156690623|NCT01221090|565612387|FG002|Overall Study|Withdrawal by Subject|27|||
156690624|NCT01221090|565612388|FG003|Overall Study|Withdrawal by Subject|2|||
156690625|NCT04507126|565612389|FG000|Overall Study|Withdrawal by Subject|3|||
156690626|NCT04507126|565612389|FG000|Overall Study|Protocol Violation|4|||
156690627|NCT00708708|565612390|FG000|Overall Study|Another therapy instead of Enbrel|141|||
156690628|NCT00708708|565612390|FG000|Overall Study|Lost to Follow-up|52|||
156690629|NCT00708708|565612390|FG000|Overall Study|Withdrawal by Subject|51|||
156690630|NCT00708708|565612390|FG000|Overall Study|Intolerance|42|||
156690631|NCT00708708|565612390|FG000|Overall Study|Another therapy along with Enbrel|15|||
156690632|NCT00708708|565612390|FG000|Overall Study|Other unspecified|11|||
156690633|NCT00708708|565612390|FG000|Overall Study|Good effectiveness|9|||
156690634|NCT00708708|565612390|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
156690635|NCT00708708|565612390|FG000|Overall Study|Administrative reasons|7|||
156690636|NCT00708708|565612390|FG000|Overall Study|Lack of effectiveness|4|||
156690637|NCT00708708|565612390|FG000|Overall Study|Lack of compliance|3|||
156690638|NCT00708708|565612390|FG000|Overall Study|Pregnancy|3|||
156690639|NCT00708708|565612390|FG000|Overall Study|Adverse Event|3|||
156690640|NCT00708708|565612390|FG000|Overall Study|Missing values|392|||
156690641|NCT01287039|565612392|FG000|Overall Study|Noncompliance with study procedures|0|||
156690642|NCT01287039|565612393|FG001|Overall Study|Noncompliance with study procedures|1|||
156690643|NCT01287039|565612392|FG000|Overall Study|Change of location/residence|0|||
156690644|NCT01287039|565612393|FG001|Overall Study|Change of location/residence|3|||
156690645|NCT01287039|565612392|FG000|Overall Study|Elective surgery|0|||
156690646|NCT01287039|565612393|FG001|Overall Study|Elective surgery|1|||
156690647|NCT01287039|565612392|FG000|Overall Study|Protocol Violation|2|||
156690648|NCT01287039|565612393|FG001|Overall Study|Protocol Violation|3|||
156690649|NCT01287039|565612392|FG000|Overall Study|Excluded medication taken|1|||
156690650|NCT01287039|565612393|FG001|Overall Study|Excluded medication taken|0|||
156787945|NCT02318277|565974835|FG007|Overall Study|Transitioned to Hospice|0|||
156787946|NCT03364686|565974836|FG000|Overall Study|Physician Decision|2|||
156787947|NCT00501085|565974837|FG000|Overall Study|Lost to Follow-up|195|||
156787948|NCT00501085|565974837|FG000|Overall Study|Withdrawal by Subject|34|||
156787949|NCT00501085|565974837|FG000|Overall Study|Subject Decision|1|||
156787950|NCT00501085|565974837|FG000|Overall Study|Revision Surgery|7|||
156787951|NCT00501085|565974837|FG000|Overall Study|Explantation Surgery|26|||
156787952|NCT00501085|565974837|FG000|Overall Study|Adverse Event|4|||
156787953|NCT00501085|565974837|FG000|Overall Study|Non-Compliance|24|||
156787954|NCT00501085|565974837|FG000|Overall Study|Study closed by sponsor|109|||
156787955|NCT00501085|565974837|FG000|Overall Study|Other loss to follow-up|32|||
156787956|NCT02362412|565974841|FG000|Treatment Period III|Lost to Follow-up|0|||
156787957|NCT02362412|565974842|FG001|Treatment Period III|Lost to Follow-up|1|||
156787958|NCT02675452|565974844|FG000|Overall Study|Sponsor decision|0|||
156787959|NCT02675452|565974845|FG001|Overall Study|Sponsor decision|0|||
156787960|NCT02675452|565974846|FG002|Overall Study|Sponsor decision|0|||
156787961|NCT02675452|565974847|FG003|Overall Study|Sponsor decision|0|||
156787962|NCT02675452|565974848|FG004|Overall Study|Sponsor decision|0|||
156787963|NCT02675452|565974849|FG005|Overall Study|Sponsor decision|0|||
156787964|NCT02675452|565974850|FG006|Overall Study|Sponsor decision|0|||
156787965|NCT02675452|565974851|FG007|Overall Study|Sponsor decision|0|||
156787966|NCT02675452|565974852|FG008|Overall Study|Sponsor decision|0|||
156787967|NCT02675452|565974853|FG009|Overall Study|Sponsor decision|1|||
156787968|NCT02675452|565974854|FG010|Overall Study|Sponsor decision|0|||
156787969|NCT02675452|565974855|FG011|Overall Study|Sponsor decision|0|||
156787970|NCT02675452|565974856|FG012|Overall Study|Sponsor decision|0|||
156787971|NCT02675452|565974857|FG013|Overall Study|Sponsor decision|2|||
156787972|NCT02675452|565974858|FG014|Overall Study|Sponsor decision|1|||
156787973|NCT02675452|565974859|FG015|Overall Study|Sponsor decision|0|||
156787974|NCT02675452|565974860|FG016|Overall Study|Sponsor decision|1|||
156787975|NCT02675452|565974861|FG017|Overall Study|Sponsor decision|0|||
156787976|NCT02675452|565974862|FG018|Overall Study|Sponsor decision|0|||
156787977|NCT02675452|565974863|FG019|Overall Study|Sponsor decision|0|||
156787978|NCT02675452|565974864|FG020|Overall Study|Sponsor decision|0|||
156787979|NCT02675452|565974865|FG021|Overall Study|Sponsor decision|0|||
156787980|NCT02675452|565974866|FG022|Overall Study|Sponsor decision|0|||
156787981|NCT02675452|565974867|FG023|Overall Study|Sponsor decision|0|||
156787982|NCT02675452|565974868|FG024|Overall Study|Sponsor decision|0|||
156787983|NCT02675452|565974869|FG025|Overall Study|Sponsor decision|0|||
156787984|NCT02675452|565974870|FG026|Overall Study|Sponsor decision|2|||
156787985|NCT02675452|565974871|FG027|Overall Study|Sponsor decision|0|||
156787986|NCT02675452|565974872|FG028|Overall Study|Sponsor decision|0|||
156436984|NCT05850520|564689179|FG002|Overall Study|Withdrawal by Subject|16|||
156436985|NCT05850520|564689177|FG000|Overall Study|Lost to Follow-up|2|||
156436986|NCT05850520|564689178|FG001|Overall Study|Lost to Follow-up|2|||
156787987|NCT02675452|565974844|FG000|Overall Study|Withdrawal by Subject|0|||
156787988|NCT02675452|565974845|FG001|Overall Study|Withdrawal by Subject|0|||
156787989|NCT02675452|565974846|FG002|Overall Study|Withdrawal by Subject|0|||
156787990|NCT02675452|565974847|FG003|Overall Study|Withdrawal by Subject|0|||
156787991|NCT02675452|565974848|FG004|Overall Study|Withdrawal by Subject|0|||
156787992|NCT02675452|565974849|FG005|Overall Study|Withdrawal by Subject|0|||
156787993|NCT02675452|565974850|FG006|Overall Study|Withdrawal by Subject|0|||
156787994|NCT02675452|565974851|FG007|Overall Study|Withdrawal by Subject|0|||
156787995|NCT02675452|565974852|FG008|Overall Study|Withdrawal by Subject|0|||
156787996|NCT02675452|565974853|FG009|Overall Study|Withdrawal by Subject|1|||
156787997|NCT02675452|565974854|FG010|Overall Study|Withdrawal by Subject|0|||
156787998|NCT02675452|565974855|FG011|Overall Study|Withdrawal by Subject|1|||
156787999|NCT02675452|565974856|FG012|Overall Study|Withdrawal by Subject|0|||
156788000|NCT02675452|565974857|FG013|Overall Study|Withdrawal by Subject|1|||
156788001|NCT02675452|565974858|FG014|Overall Study|Withdrawal by Subject|1|||
156788002|NCT02675452|565974859|FG015|Overall Study|Withdrawal by Subject|0|||
156788003|NCT02675452|565974860|FG016|Overall Study|Withdrawal by Subject|2|||
156788004|NCT02675452|565974861|FG017|Overall Study|Withdrawal by Subject|0|||
156788005|NCT02675452|565974862|FG018|Overall Study|Withdrawal by Subject|0|||
156788006|NCT02675452|565974863|FG019|Overall Study|Withdrawal by Subject|0|||
156788007|NCT02675452|565974864|FG020|Overall Study|Withdrawal by Subject|0|||
156436987|NCT05850520|564689179|FG002|Overall Study|Lost to Follow-up|2|||
156436988|NCT05850520|564689177|FG000|Overall Study|Death|2|||
156788008|NCT02675452|565974865|FG021|Overall Study|Withdrawal by Subject|0|||
156436989|NCT05850520|564689178|FG001|Overall Study|Death|2|||
156690651|NCT01287039|565612392|FG000|Overall Study|Noncompliance with study medication|0|||
156690652|NCT01287039|565612393|FG001|Overall Study|Noncompliance with study medication|1|||
156690653|NCT01287039|565612392|FG000|Overall Study|Problem with travel|0|||
156690654|NCT01287039|565612393|FG001|Overall Study|Problem with travel|1|||
156690655|NCT01287039|565612392|FG000|Overall Study|Death|1|||
156690656|NCT01287039|565612393|FG001|Overall Study|Death|0|||
156690657|NCT01287039|565612392|FG000|Overall Study|Change of residence|1|||
156690658|NCT01287039|565612393|FG001|Overall Study|Change of residence|0|||
156690659|NCT01287039|565612392|FG000|Overall Study|Adverse Event|7|||
156690660|NCT01287039|565612393|FG001|Overall Study|Adverse Event|4|||
156690661|NCT01287039|565612392|FG000|Overall Study|Withdrawal by Subject|14|||
156690662|NCT01287039|565612393|FG001|Overall Study|Withdrawal by Subject|11|||
156690663|NCT01287039|565612392|FG000|Overall Study|Lost to Follow-up|3|||
156690664|NCT01287039|565612393|FG001|Overall Study|Lost to Follow-up|2|||
156690665|NCT01223235|565612394|FG000|Overall Study|Withdrawal by Subject|1|||
156690666|NCT06972251|565612413|FG000|Overall Study|Withdrawal by Subject|1|||
156690667|NCT06972251|565612414|FG001|Overall Study|Withdrawal by Subject|0|||
156690668|NCT06972251|565612413|FG000|Overall Study|Lost to Follow-up|10|||
156690669|NCT06972251|565612414|FG001|Overall Study|Lost to Follow-up|2|||
156690670|NCT05224544|565612418|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
156690671|NCT05224544|565612419|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
156690672|NCT00351351|565612425|FG000|Overall Study|surgical access pbs; device issues|9|||
156690673|NCT00351351|565612426|FG001|Overall Study|surgical access pbs; device issues|4|||
156690674|NCT01341587|565612427|FG000|Overall Study|Lost to Follow-up|2|||
156690675|NCT01341587|565612428|FG001|Overall Study|Lost to Follow-up|0|||
156690676|NCT01341587|565612427|FG000|Overall Study|stopped using the meters|2|||
156690677|NCT01341587|565612428|FG001|Overall Study|stopped using the meters|10|||
156690678|NCT03891329|565612430|FG000|Overall Study|Death|5|||
156690679|NCT03891329|565612430|FG000|Overall Study|Lost to Follow-up|4|||
156690680|NCT03891329|565612430|FG000|Overall Study|Physician Decision|4|||
156690681|NCT03891329|565612430|FG000|Overall Study|Device explanted|3|||
156690682|NCT03891329|565612430|FG000|Overall Study|No study device implanted|3|||
156690683|NCT03176784|565612431|FG000|Overall Study|Lost to Follow-up|77|||
156690684|NCT03176784|565612432|FG001|Overall Study|Lost to Follow-up|79|||
156690685|NCT03176784|565612433|FG002|Overall Study|Lost to Follow-up|79|||
156690686|NCT03176784|565612434|FG003|Overall Study|Lost to Follow-up|49|||
156690687|NCT03176784|565612431|FG000|Overall Study|Withdrawal by Subject|28|||
156690688|NCT03176784|565612432|FG001|Overall Study|Withdrawal by Subject|34|||
156690689|NCT03176784|565612433|FG002|Overall Study|Withdrawal by Subject|34|||
156690690|NCT03176784|565612434|FG003|Overall Study|Withdrawal by Subject|21|||
156690691|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
156690692|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
156690693|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
156690694|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
156690695|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
156690696|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
156690697|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
156690698|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
156690699|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
156690700|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
156690701|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
156690702|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
156690703|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690704|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690705|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
156690706|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
156690707|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
156690708|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
156690709|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
156690710|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
156690711|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
156690712|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
156690713|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
156690714|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
156690715|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
156690716|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
156690717|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
156690718|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
156690719|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Death|0|||
156690720|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Death|1|||
156690721|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Death|0|||
156690722|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Death|0|||
156690723|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
156690724|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
156870167|NCT01394016|566281097|FG010|Overall Study|Lost to Follow-up|0|||
156690725|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
156436990|NCT05850520|564689179|FG002|Overall Study|Death|3|||
156690726|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
156690727|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
156690728|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
156690729|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
156690730|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
156690731|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Other|1|||
156690732|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Other|3|||
156690733|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Other|0|||
156690734|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Other|0|||
156690735|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
156690736|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
156690737|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
156690738|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
156690739|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Death|1|||
156690740|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Death|0|||
156690741|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Death|0|||
156690742|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Death|0|||
156690743|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
156690744|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
156690745|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
156690746|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
156690747|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
156690748|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
156690749|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
156690750|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
156690751|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
156690752|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
156690753|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
156690754|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
156690755|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
156690756|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
156690757|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
156690758|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
156690759|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690760|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
156690761|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
156690762|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
156690763|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
156690764|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
156690765|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
156690766|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
156690767|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
156690768|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
156690769|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
156690770|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
156690771|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
156690772|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
156690773|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
156690774|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
156690775|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
156690776|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
156690777|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
156690778|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
156788009|NCT02675452|565974866|FG022|Overall Study|Withdrawal by Subject|3|||
156788010|NCT02675452|565974867|FG023|Overall Study|Withdrawal by Subject|0|||
156788011|NCT02675452|565974868|FG024|Overall Study|Withdrawal by Subject|1|||
156788012|NCT02675452|565974869|FG025|Overall Study|Withdrawal by Subject|0|||
156788013|NCT02675452|565974870|FG026|Overall Study|Withdrawal by Subject|1|||
156788014|NCT02675452|565974871|FG027|Overall Study|Withdrawal by Subject|3|||
156788015|NCT02675452|565974872|FG028|Overall Study|Withdrawal by Subject|4|||
156788016|NCT02675452|565974844|FG000|Overall Study|Death|0|||
156788017|NCT02675452|565974845|FG001|Overall Study|Death|0|||
156788018|NCT02675452|565974846|FG002|Overall Study|Death|1|||
156870168|NCT01394016|566281098|FG011|Overall Study|Lost to Follow-up|0|||
156690779|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Other|3|||
156690780|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Other|0|||
156690781|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Other|4|||
156690782|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Other|1|||
156690783|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
156690784|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
156788019|NCT02675452|565974847|FG003|Overall Study|Death|0|||
156690785|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
156690786|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
156690787|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
156690788|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
156690789|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
156690790|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
156690791|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
156690792|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
156690793|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
156690794|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
156690795|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690796|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
156690797|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690798|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690799|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
156690800|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
156690801|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
156690802|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
156690803|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
156690804|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
156690805|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
156690806|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
156690807|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
156690808|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
156690809|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
156690810|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
156690811|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
156690812|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
156690813|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
156690814|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
156690815|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
156690816|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
156690817|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
156690818|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
156690819|NCT02654587|565612439|FG000|Overall Study|patient alive at end of study|22|||
156690820|NCT02654587|565612440|FG001|Overall Study|patient alive at end of study|8|||
156690821|NCT02654587|565612439|FG000|Overall Study|Withdrawal by Subject|1|||
156690822|NCT02654587|565612440|FG001|Overall Study|Withdrawal by Subject|7|||
156690823|NCT01825837|565612441|FG000|PART I|Withdrawal by Subject|0|||
156690824|NCT01825837|565612442|FG001|PART I|Withdrawal by Subject|0|||
156690825|NCT01825837|565612443|FG002|PART I|Withdrawal by Subject|0|||
156690826|NCT01825837|565612444|FG003|PART I|Withdrawal by Subject|6|||
156690827|NCT01825837|565612441|FG000|PART I|Patient non-compliance|0|||
156690828|NCT01825837|565612442|FG001|PART I|Patient non-compliance|0|||
156690829|NCT01825837|565612443|FG002|PART I|Patient non-compliance|0|||
156690830|NCT01825837|565612444|FG003|PART I|Patient non-compliance|1|||
156690831|NCT01825837|565612441|FG000|PART I|Treatment failure|0|||
156690832|NCT01825837|565612442|FG001|PART I|Treatment failure|0|||
156788020|NCT02675452|565974848|FG004|Overall Study|Death|0|||
156530598|NCT02217436|565038074|FG000|Overall Study|Protocol Violation|1|||
156530599|NCT02217436|565038075|FG001|Overall Study|Protocol Violation|1|||
156788021|NCT02675452|565974849|FG005|Overall Study|Death|1|||
156788022|NCT02675452|565974850|FG006|Overall Study|Death|0|||
156788023|NCT02675452|565974851|FG007|Overall Study|Death|0|||
156788024|NCT02675452|565974852|FG008|Overall Study|Death|1|||
156788025|NCT02675452|565974853|FG009|Overall Study|Death|0|||
156788026|NCT02675452|565974854|FG010|Overall Study|Death|0|||
156788027|NCT02675452|565974855|FG011|Overall Study|Death|0|||
156788028|NCT02675452|565974856|FG012|Overall Study|Death|1|||
156788029|NCT02675452|565974857|FG013|Overall Study|Death|0|||
156788030|NCT02675452|565974858|FG014|Overall Study|Death|0|||
156788031|NCT02675452|565974859|FG015|Overall Study|Death|2|||
156788032|NCT02675452|565974860|FG016|Overall Study|Death|0|||
156788033|NCT02675452|565974861|FG017|Overall Study|Death|0|||
156788034|NCT02675452|565974862|FG018|Overall Study|Death|4|||
156788035|NCT02675452|565974863|FG019|Overall Study|Death|3|||
156530600|NCT02217436|565038074|FG000|Overall Study|Incomplete data|0|||
156788036|NCT02675452|565974864|FG020|Overall Study|Death|3|||
156788037|NCT02675452|565974865|FG021|Overall Study|Death|3|||
156788038|NCT02675452|565974866|FG022|Overall Study|Death|7|||
156788039|NCT02675452|565974867|FG023|Overall Study|Death|5|||
156788040|NCT02675452|565974868|FG024|Overall Study|Death|3|||
156690833|NCT01825837|565612443|FG002|PART I|Treatment failure|0|||
156690834|NCT01825837|565612444|FG003|PART I|Treatment failure|7|||
156690835|NCT01825837|565612441|FG000|PART I|reason unspecified|0|||
156690836|NCT01825837|565612442|FG001|PART I|reason unspecified|0|||
156690837|NCT01825837|565612443|FG002|PART I|reason unspecified|0|||
156690838|NCT01825837|565612444|FG003|PART I|reason unspecified|3|||
156690839|NCT01825837|565612441|FG000|PART II|Withdrawal by Subject|3|||
156690840|NCT01825837|565612442|FG001|PART II|Withdrawal by Subject|3|||
156690841|NCT01825837|565612443|FG002|PART II|Withdrawal by Subject|7|||
156690842|NCT01825837|565612444|FG003|PART II|Withdrawal by Subject|0|||
156690843|NCT01825837|565612441|FG000|PART II|Patient non-compliance|5|||
156690844|NCT01825837|565612442|FG001|PART II|Patient non-compliance|2|||
156690845|NCT01825837|565612443|FG002|PART II|Patient non-compliance|4|||
156690846|NCT01825837|565612444|FG003|PART II|Patient non-compliance|0|||
156690847|NCT01825837|565612441|FG000|PART II|Adverse Event|3|||
156690848|NCT01825837|565612442|FG001|PART II|Adverse Event|3|||
156690849|NCT01825837|565612443|FG002|PART II|Adverse Event|1|||
156690850|NCT01825837|565612444|FG003|PART II|Adverse Event|0|||
156690851|NCT01825837|565612441|FG000|PART II|Treatment failure|6|||
156690852|NCT01825837|565612442|FG001|PART II|Treatment failure|4|||
156690853|NCT01825837|565612443|FG002|PART II|Treatment failure|5|||
156690854|NCT01825837|565612444|FG003|PART II|Treatment failure|0|||
156690855|NCT01825837|565612441|FG000|PART II|reason unspecified|2|||
156690856|NCT01825837|565612442|FG001|PART II|reason unspecified|2|||
156690857|NCT01825837|565612443|FG002|PART II|reason unspecified|2|||
156690858|NCT01825837|565612444|FG003|PART II|reason unspecified|0|||
156690859|NCT00904748|565612447|FG000|Overall Study|Withdrawal by Subject|1|||
156690860|NCT00904748|565612448|FG001|Overall Study|Withdrawal by Subject|1|||
156690861|NCT00904748|565612449|FG002|Overall Study|Withdrawal by Subject|1|||
156690862|NCT00904748|565612450|FG003|Overall Study|Withdrawal by Subject|2|||
156690863|NCT00904748|565612451|FG004|Overall Study|Withdrawal by Subject|0|||
156690864|NCT00904748|565612452|FG005|Overall Study|Withdrawal by Subject|0|||
156690865|NCT00904748|565612447|FG000|Overall Study|Adverse Event|0|||
156690866|NCT00904748|565612448|FG001|Overall Study|Adverse Event|0|||
156690867|NCT00904748|565612449|FG002|Overall Study|Adverse Event|0|||
156690868|NCT00904748|565612450|FG003|Overall Study|Adverse Event|0|||
156690869|NCT00904748|565612451|FG004|Overall Study|Adverse Event|1|||
156690870|NCT00904748|565612452|FG005|Overall Study|Adverse Event|0|||
156690871|NCT01682148|565612453|FG000|Overall Study|Withdrawal by Subject|2|||
156690872|NCT01682148|565612454|FG001|Overall Study|Withdrawal by Subject|0|||
156690873|NCT01682148|565612453|FG000|Overall Study|Lost to Follow-up|1|||
156690874|NCT01682148|565612454|FG001|Overall Study|Lost to Follow-up|2|||
156690875|NCT01682148|565612453|FG000|Overall Study|Protocol Violation|1|||
156690876|NCT01682148|565612454|FG001|Overall Study|Protocol Violation|1|||
156690877|NCT01056640|565612455|FG000|Overall Study|Withdrawal by Subject|11|||
156690878|NCT01056640|565612456|FG001|Overall Study|Withdrawal by Subject|8|||
156690879|NCT01056640|565612455|FG000|Overall Study|Death|15|||
156690880|NCT01056640|565612456|FG001|Overall Study|Death|4|||
156690881|NCT01803269|565612457|FG000|Overall Study|Withdrawal by Subject|3|||
156690882|NCT01803269|565612458|FG001|Overall Study|Withdrawal by Subject|0|||
156690883|NCT01803269|565612459|FG002|Overall Study|Withdrawal by Subject|0|||
156690884|NCT01202877|565612460|FG000|Overall Study|Disease Progression|0|||
156690885|NCT01202877|565612461|FG001|Overall Study|Disease Progression|1|||
156690886|NCT01202877|565612462|FG002|Overall Study|Disease Progression|2|||
156690887|NCT01202877|565612460|FG000|Overall Study|Adverse Event|0|||
156690888|NCT01202877|565612461|FG001|Overall Study|Adverse Event|0|||
156690889|NCT01202877|565612462|FG002|Overall Study|Adverse Event|2|||
156690890|NCT01202877|565612460|FG000|Overall Study|Withdrawal by Subject|0|||
156690891|NCT01202877|565612461|FG001|Overall Study|Withdrawal by Subject|0|||
156690892|NCT01202877|565612462|FG002|Overall Study|Withdrawal by Subject|1|||
156690893|NCT01202877|565612460|FG000|Overall Study|Death|0|||
156690894|NCT01202877|565612461|FG001|Overall Study|Death|0|||
156788041|NCT02675452|565974869|FG025|Overall Study|Death|4|||
156788042|NCT02675452|565974870|FG026|Overall Study|Death|7|||
156788043|NCT02675452|565974871|FG027|Overall Study|Death|6|||
156788044|NCT02675452|565974872|FG028|Overall Study|Death|9|||
156788045|NCT02675452|565974844|FG000|Overall Study|Lost to Follow-up|0|||
156788046|NCT02675452|565974845|FG001|Overall Study|Lost to Follow-up|1|||
156788047|NCT02675452|565974846|FG002|Overall Study|Lost to Follow-up|0|||
156788048|NCT02675452|565974847|FG003|Overall Study|Lost to Follow-up|0|||
156788049|NCT02675452|565974848|FG004|Overall Study|Lost to Follow-up|0|||
156788050|NCT02675452|565974849|FG005|Overall Study|Lost to Follow-up|0|||
156870169|NCT01394016|566281099|FG012|Overall Study|Lost to Follow-up|0|||
156690895|NCT01202877|565612462|FG002|Overall Study|Death|1|||
156690896|NCT04403763|565612463|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
156690897|NCT04403763|565612464|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
156690898|NCT04403763|565612465|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
156690899|NCT04403763|565612466|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
156690900|NCT04403763|565612467|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
156788051|NCT02675452|565974850|FG006|Overall Study|Lost to Follow-up|0|||
156870170|NCT01394016|566281100|FG013|Overall Study|Lost to Follow-up|0|||
156690901|NCT04403763|565612468|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
156690902|NCT04403763|565612469|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
156690903|NCT04403763|565612463|FG000|Stage 1|Early termination due to PK tube failure|0|||
156690904|NCT04403763|565612464|FG001|Stage 1|Early termination due to PK tube failure|0|||
156690905|NCT04403763|565612465|FG002|Stage 1|Early termination due to PK tube failure|1|||
156690906|NCT04403763|565612466|FG003|Stage 1|Early termination due to PK tube failure|0|||
156690907|NCT04403763|565612467|FG004|Stage 1|Early termination due to PK tube failure|0|||
156690908|NCT04403763|565612468|FG005|Stage 1|Early termination due to PK tube failure|0|||
156690909|NCT04403763|565612469|FG006|Stage 1|Early termination due to PK tube failure|0|||
156690910|NCT04403763|565612463|FG000|Stage 2A|Adverse Event|0|||
156690911|NCT04403763|565612464|FG001|Stage 2A|Adverse Event|0|||
156690912|NCT04403763|565612465|FG002|Stage 2A|Adverse Event|0|||
156690913|NCT04403763|565612466|FG003|Stage 2A|Adverse Event|0|||
156690914|NCT04403763|565612467|FG004|Stage 2A|Adverse Event|0|||
156690915|NCT04403763|565612468|FG005|Stage 2A|Adverse Event|0|||
156690916|NCT04403763|565612469|FG006|Stage 2A|Adverse Event|1|||
156690917|NCT01885182|565614339|FG000|Overall Study|Adverse Event|11|||
156690918|NCT01885182|565614340|FG001|Overall Study|Adverse Event|13|||
156690919|NCT01885182|565614339|FG000|Overall Study|Withdrawal by Subject|13|||
156690920|NCT01885182|565614340|FG001|Overall Study|Withdrawal by Subject|6|||
156690921|NCT01885182|565614339|FG000|Overall Study|Lost to Follow-up|2|||
156690922|NCT01885182|565614340|FG001|Overall Study|Lost to Follow-up|2|||
156690923|NCT01885182|565614339|FG000|Overall Study|Lack of Efficacy|8|||
156690924|NCT01885182|565614340|FG001|Overall Study|Lack of Efficacy|1|||
156690925|NCT04776746|565614341|FG000|Overall Study|Study terminated by sponsor|61|||
156690926|NCT04776746|565614341|FG000|Overall Study|Adverse Event|5|||
156690927|NCT04776746|565614341|FG000|Overall Study|Death|4|||
156690928|NCT04776746|565614341|FG000|Overall Study|Lack of Efficacy|3|||
156690929|NCT04776746|565614341|FG000|Overall Study|Noncompliance with study drug|2|||
156690930|NCT04776746|565614341|FG000|Overall Study|Not related to COVID-19|2|||
156690931|NCT00856830|565614344|FG000|Irinotecan & Bendamustine|Death|0|||
156690932|NCT00856830|565614345|FG001|Irinotecan & Bendamustine|Death|0|||
156690933|NCT00856830|565614346|FG002|Irinotecan & Bendamustine|Death|0|||
156690934|NCT00856830|565614347|FG003|Irinotecan & Bendamustine|Death|2|||
156690935|NCT00856830|565614344|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
156690936|NCT00856830|565614345|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
156690937|NCT00856830|565614346|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
156690938|NCT00856830|565614347|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
156690939|NCT03768726|565614348|FG000|Treatment Phase|Adverse Event|2|||
156690940|NCT03768726|565614349|FG001|Treatment Phase|Adverse Event|2|||
156690941|NCT03768726|565614348|FG000|Treatment Phase|Lost to Follow-up|1|||
156690942|NCT03768726|565614349|FG001|Treatment Phase|Lost to Follow-up|0|||
156690943|NCT03768726|565614348|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
156690944|NCT03768726|565614349|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
156690945|NCT03768726|565614348|FG000|Treatment Phase|Withdrawal by Subject|3|||
156690946|NCT03768726|565614349|FG001|Treatment Phase|Withdrawal by Subject|1|||
156690947|NCT03768726|565614348|FG000|Follow-Up|Adverse Event|2|||
156690948|NCT03768726|565614349|FG001|Follow-Up|Adverse Event|2|||
156690949|NCT03768726|565614348|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
156690950|NCT03768726|565614349|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
156690951|NCT03768726|565614348|FG000|Follow-Up|Withdrawal by Subject|2|||
156690952|NCT03768726|565614349|FG001|Follow-Up|Withdrawal by Subject|0|||
156690953|NCT03768726|565614348|FG000|Follow-Up|Other|1|||
156690954|NCT03768726|565614349|FG001|Follow-Up|Other|0|||
156690955|NCT01286558|565614350|FG000|Overall Study|Adverse Event|1|||
156330032|NCT00004635|564308745|FG000|Period Two|discrepancy in data entry|0|||
156330033|NCT00004635|564308746|FG001|Period Two|discrepancy in data entry|1|||
156690956|NCT01286558|565614351|FG001|Overall Study|Adverse Event|1|||
156690957|NCT01286558|565614350|FG000|Overall Study|Withdrawal by Subject|0|||
156690958|NCT01286558|565614351|FG001|Overall Study|Withdrawal by Subject|1|||
156690959|NCT01787279|565614352|FG000|Overall Study|Lost to Follow-up|2|||
156690960|NCT01787279|565614352|FG000|Overall Study|Lack of Efficacy|1|||
156690961|NCT02148913|565614354|FG000|Overall Study|Death|0|||
156690962|NCT02148913|565614355|FG001|Overall Study|Death|1|||
156690963|NCT02148913|565614356|FG002|Overall Study|Death|0|||
156690964|NCT02148913|565614357|FG003|Overall Study|Death|0|||
156690965|NCT01567826|565614359|FG000|Overall Study|Lost to Follow-up|3|||
156690966|NCT01567826|565614360|FG001|Overall Study|Lost to Follow-up|2|||
156690967|NCT03265288|565614367|FG000|Overall Study|Adverse Event|0|||
156690968|NCT03265288|565614368|FG001|Overall Study|Adverse Event|1|||
156690969|NCT03265288|565614367|FG000|Overall Study|Withdrawal by Subject|13|||
156330034|NCT00191906|564308747|FG000|Study Period II|Adverse Event|0|||
156330035|NCT00191906|564308748|FG001|Study Period II|Adverse Event|1|||
156330036|NCT00191906|564308749|FG002|Study Period II|Adverse Event|0|||
156690970|NCT03265288|565614368|FG001|Overall Study|Withdrawal by Subject|5|||
156690971|NCT03265288|565614367|FG000|Overall Study|Drug Withdrawn|3|||
156690972|NCT03265288|565614368|FG001|Overall Study|Drug Withdrawn|3|||
156690973|NCT03265288|565614367|FG000|Overall Study|Any Other Reason|7|||
156690974|NCT03265288|565614368|FG001|Overall Study|Any Other Reason|3|||
156690975|NCT00099268|565614372|FG000|Overall Study|Withdrawal by Subject|46|||
156690976|NCT00099268|565614373|FG001|Overall Study|Withdrawal by Subject|28|||
156690977|NCT00099268|565614372|FG000|Overall Study|Adverse Event|19|||
156690978|NCT00099268|565614373|FG001|Overall Study|Adverse Event|19|||
156690979|NCT00099268|565614372|FG000|Overall Study|Protocol Violation|9|||
156690980|NCT00099268|565614373|FG001|Overall Study|Protocol Violation|8|||
156690981|NCT00099268|565614372|FG000|Overall Study|Lost to Follow-up|6|||
156690982|NCT00099268|565614373|FG001|Overall Study|Lost to Follow-up|4|||
156690983|NCT00099268|565614372|FG000|Overall Study|Lack of Efficacy|5|||
156690984|NCT00099268|565614373|FG001|Overall Study|Lack of Efficacy|18|||
156690985|NCT00099268|565614372|FG000|Overall Study|Administrative problems|4|||
156690986|NCT00099268|565614373|FG001|Overall Study|Administrative problems|4|||
156690987|NCT00099268|565614372|FG000|Overall Study|Death|3|||
156690988|NCT00099268|565614373|FG001|Overall Study|Death|1|||
156690989|NCT01360866|565614374|FG000|Overall Study|Lost to Follow-up|11|||
156690990|NCT01360866|565614375|FG001|Overall Study|Lost to Follow-up|28|||
156690991|NCT01360866|565614376|FG002|Overall Study|Lost to Follow-up|41|||
156690992|NCT01360866|565614377|FG003|Overall Study|Lost to Follow-up|0|||
156690993|NCT01360866|565614374|FG000|Overall Study|Adverse Event|56|||
156690994|NCT01360866|565614375|FG001|Overall Study|Adverse Event|61|||
156690995|NCT01360866|565614376|FG002|Overall Study|Adverse Event|134|||
156690996|NCT01360866|565614377|FG003|Overall Study|Adverse Event|6|||
156690997|NCT01360866|565614374|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
156690998|NCT01360866|565614375|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
156690999|NCT01360866|565614376|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
156691000|NCT01360866|565614377|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
156691001|NCT01360866|565614374|FG000|Overall Study|Withdrawn by Investigator|9|||
156691002|NCT01360866|565614375|FG001|Overall Study|Withdrawn by Investigator|8|||
156691003|NCT01360866|565614376|FG002|Overall Study|Withdrawn by Investigator|31|||
156691004|NCT01360866|565614377|FG003|Overall Study|Withdrawn by Investigator|2|||
156691005|NCT01360866|565614374|FG000|Overall Study|Withdrawal by participant|79|||
156691006|NCT01360866|565614375|FG001|Overall Study|Withdrawal by participant|89|||
156691007|NCT01360866|565614376|FG002|Overall Study|Withdrawal by participant|168|||
156691008|NCT01360866|565614377|FG003|Overall Study|Withdrawal by participant|8|||
156691009|NCT01360866|565614374|FG000|Overall Study|Protocol Deviation|25|||
156691010|NCT01360866|565614375|FG001|Overall Study|Protocol Deviation|33|||
156691011|NCT01360866|565614376|FG002|Overall Study|Protocol Deviation|61|||
156691012|NCT01360866|565614377|FG003|Overall Study|Protocol Deviation|2|||
156691013|NCT01360866|565614374|FG000|Overall Study|Lack of Efficacy|30|||
156691014|NCT01360866|565614375|FG001|Overall Study|Lack of Efficacy|40|||
156691015|NCT01360866|565614376|FG002|Overall Study|Lack of Efficacy|30|||
156691016|NCT01360866|565614377|FG003|Overall Study|Lack of Efficacy|4|||
156691017|NCT03702049|565614378|FG000|Overall Study|Lost to Follow-up|4|||
156691018|NCT03702049|565614378|FG000|Overall Study|Physician Decision|1|||
156691019|NCT05016622|565614379|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
156691020|NCT05016622|565614379|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
156691021|NCT03575871|565614391|FG000|Overall Study|Adverse Event|5|||
156691022|NCT03575871|565614392|FG001|Overall Study|Adverse Event|5|||
156691023|NCT03575871|565614393|FG002|Overall Study|Adverse Event|8|||
156691024|NCT03575871|565614391|FG000|Overall Study|Death|1|||
156691025|NCT03575871|565614392|FG001|Overall Study|Death|0|||
156691026|NCT03575871|565614393|FG002|Overall Study|Death|0|||
156691027|NCT03575871|565614391|FG000|Overall Study|Lack of Efficacy|5|||
156691028|NCT03575871|565614392|FG001|Overall Study|Lack of Efficacy|4|||
156691029|NCT03575871|565614393|FG002|Overall Study|Lack of Efficacy|7|||
156691030|NCT03575871|565614391|FG000|Overall Study|Lost to Follow-up|1|||
156691031|NCT03575871|565614392|FG001|Overall Study|Lost to Follow-up|1|||
156691032|NCT03575871|565614393|FG002|Overall Study|Lost to Follow-up|1|||
156691033|NCT03575871|565614391|FG000|Overall Study|Protocol Deviation|1|||
156691034|NCT03575871|565614392|FG001|Overall Study|Protocol Deviation|1|||
156691035|NCT03575871|565614393|FG002|Overall Study|Protocol Deviation|1|||
156691036|NCT03575871|565614391|FG000|Overall Study|Withdrawal by Subject|6|||
156691037|NCT03575871|565614392|FG001|Overall Study|Withdrawal by Subject|1|||
156691038|NCT03575871|565614393|FG002|Overall Study|Withdrawal by Subject|9|||
156691039|NCT03575871|565614391|FG000|Overall Study|Other than specified|2|||
156691040|NCT03575871|565614392|FG001|Overall Study|Other than specified|2|||
156530601|NCT02217436|565038075|FG001|Overall Study|Incomplete data|1|||
156691041|NCT03575871|565614393|FG002|Overall Study|Other than specified|0|||
156691042|NCT05506358|565614394|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
156691043|NCT05506358|565614395|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
156691044|NCT05506358|565614396|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
156691045|NCT05506358|565614397|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
156691046|NCT05506358|565614398|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
156691047|NCT05506358|565614394|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
156691048|NCT05506358|565614395|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
156788052|NCT02675452|565974851|FG007|Overall Study|Lost to Follow-up|0|||
156691049|NCT05506358|565614396|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
156691050|NCT05506358|565614397|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
156691051|NCT05506358|565614398|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
156691052|NCT05506358|565614394|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
156691053|NCT05506358|565614395|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
156691054|NCT05506358|565614396|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
156691055|NCT05506358|565614397|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
156691056|NCT05506358|565614398|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
156691057|NCT05506358|565614394|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
156691058|NCT05506358|565614395|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
156691059|NCT05506358|565614396|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
156691060|NCT05506358|565614397|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
156691061|NCT05506358|565614398|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
156691062|NCT05506358|565614394|FG000|Overall Study|HbE trait|0|||
156691063|NCT05506358|565614395|FG001|Overall Study|HbE trait|0|||
156691064|NCT05506358|565614396|FG002|Overall Study|HbE trait|0|||
156691065|NCT05506358|565614397|FG003|Overall Study|HbE trait|1|||
156691066|NCT05506358|565614398|FG004|Overall Study|HbE trait|0|||
156691067|NCT00584844|565614406|FG000|Overall Study|Withdrawal by Subject|59|||
156691068|NCT00584844|565614406|FG000|Overall Study|Screen Failure|20|||
156691069|NCT00171301|565614407|FG000|Overall Study|Death|1|||
156691070|NCT00171301|565614408|FG001|Overall Study|Death|2|||
156691071|NCT00171301|565614407|FG000|Overall Study|Adverse Event|1|||
156691072|NCT00171301|565614408|FG001|Overall Study|Adverse Event|2|||
156691073|NCT00171301|565614407|FG000|Overall Study|Lost to Follow-up|6|||
156691074|NCT00171301|565614408|FG001|Overall Study|Lost to Follow-up|2|||
156691075|NCT00171301|565614407|FG000|Overall Study|Protocol Violation|0|||
156691076|NCT00171301|565614408|FG001|Overall Study|Protocol Violation|2|||
156691077|NCT00171301|565614407|FG000|Overall Study|Withdrawal by Subject|0|||
156691078|NCT00171301|565614408|FG001|Overall Study|Withdrawal by Subject|1|||
156691079|NCT02100319|565614411|FG000|Overall Study|Case Report Forms Uncollected|11|||
156691080|NCT02100319|565614411|FG000|Overall Study|Protocol Deviation|5|||
156691081|NCT02566993|565614412|FG000|Overall Study|Randomized but not treated|5|||
156691082|NCT02566993|565614413|FG001|Overall Study|Randomized but not treated|16|||
156691083|NCT02566993|565614412|FG000|Overall Study|Progressive disease|213|||
156691084|NCT02566993|565614413|FG001|Overall Study|Progressive disease|152|||
156691085|NCT02566993|565614412|FG000|Overall Study|Withdrawal by Subject|12|||
156691086|NCT02566993|565614413|FG001|Overall Study|Withdrawal by Subject|28|||
156691087|NCT02566993|565614412|FG000|Overall Study|Death|17|||
156691088|NCT02566993|565614413|FG001|Overall Study|Death|23|||
156691089|NCT02566993|565614412|FG000|Overall Study|Physician Decision|10|||
156691090|NCT02566993|565614413|FG001|Overall Study|Physician Decision|17|||
156691091|NCT02566993|565614412|FG000|Overall Study|Study drug-related adverse event|20|||
156691092|NCT02566993|565614413|FG001|Overall Study|Study drug-related adverse event|41|||
156691093|NCT02566993|565614412|FG000|Overall Study|Non study drug-related adverse event|9|||
156691094|NCT02566993|565614413|FG001|Overall Study|Non study drug-related adverse event|9|||
156691095|NCT02566993|565614412|FG000|Overall Study|Symptomatic deterioration|9|||
156691096|NCT02566993|565614413|FG001|Overall Study|Symptomatic deterioration|16|||
156691097|NCT02566993|565614412|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
156691098|NCT02566993|565614413|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
156691099|NCT02566993|565614412|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
156691100|NCT02566993|565614413|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
156691101|NCT02566993|565614412|FG000|Overall Study|Screening failure|2|||
156691102|NCT02566993|565614413|FG001|Overall Study|Screening failure|0|||
156691103|NCT02566993|565614412|FG000|Overall Study|Lost to Follow-up|0|||
156788053|NCT02675452|565974852|FG008|Overall Study|Lost to Follow-up|0|||
156788054|NCT02675452|565974853|FG009|Overall Study|Lost to Follow-up|0|||
156691104|NCT02566993|565614413|FG001|Overall Study|Lost to Follow-up|1|||
156691105|NCT02566993|565614412|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
156691106|NCT02566993|565614413|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
156788055|NCT02675452|565974854|FG010|Overall Study|Lost to Follow-up|0|||
156788056|NCT02675452|565974855|FG011|Overall Study|Lost to Follow-up|0|||
156788057|NCT02675452|565974856|FG012|Overall Study|Lost to Follow-up|1|||
156788058|NCT02675452|565974857|FG013|Overall Study|Lost to Follow-up|0|||
156788059|NCT02675452|565974858|FG014|Overall Study|Lost to Follow-up|0|||
156788060|NCT02675452|565974859|FG015|Overall Study|Lost to Follow-up|0|||
156788061|NCT02675452|565974860|FG016|Overall Study|Lost to Follow-up|0|||
156788062|NCT02675452|565974861|FG017|Overall Study|Lost to Follow-up|0|||
156788063|NCT02675452|565974862|FG018|Overall Study|Lost to Follow-up|0|||
156788064|NCT02675452|565974863|FG019|Overall Study|Lost to Follow-up|0|||
156788065|NCT02675452|565974864|FG020|Overall Study|Lost to Follow-up|0|||
156691107|NCT05206448|565614414|FG000|Overall Study|Lost to Follow-up|2|||
156691108|NCT05206448|565614415|FG001|Overall Study|Lost to Follow-up|2|||
156691109|NCT05206448|565614414|FG000|Overall Study|Withdrawal by Subject|2|||
156870171|NCT01394016|566281101|FG014|Overall Study|Lost to Follow-up|0|||
156870172|NCT01394016|566281102|FG015|Overall Study|Lost to Follow-up|0|||
156691110|NCT05206448|565614415|FG001|Overall Study|Withdrawal by Subject|0|||
156691111|NCT05206448|565614414|FG000|Overall Study|found ineligible after randomization|1|||
156691112|NCT05206448|565614415|FG001|Overall Study|found ineligible after randomization|1|||
156691113|NCT05206448|565614414|FG000|Overall Study|unable to complete study due to personal constraints|1|||
156691114|NCT05206448|565614415|FG001|Overall Study|unable to complete study due to personal constraints|0|||
156691115|NCT05206448|565614414|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
156691116|NCT05206448|565614415|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
156691117|NCT02589522|565614416|FG000|Overall Study|Physician Decision|1|||
156691118|NCT02589522|565614417|FG001|Overall Study|Physician Decision|2|||
156691119|NCT02589522|565614418|FG002|Overall Study|Physician Decision|0|||
156691120|NCT02589522|565614416|FG000|Overall Study|Did not start treatment|1|||
156691121|NCT02589522|565614417|FG001|Overall Study|Did not start treatment|0|||
156691122|NCT02589522|565614418|FG002|Overall Study|Did not start treatment|0|||
156691123|NCT01478828|565614419|FG000|Overall Study|Adverse Event|1|||
156691124|NCT05611996|565614420|FG000|Overall Study|Ineligible|1|||
156691125|NCT05611996|565614420|FG000|Overall Study|Withdrawal by Subject|9|||
156691126|NCT04479475|565614424|FG000|Overall Study|Withdrawal by Subject|7|||
156691127|NCT01134627|565614425|FG000|Overall Study|Adverse Event|47|||
156691128|NCT01134627|565614426|FG001|Overall Study|Adverse Event|31|||
156691129|NCT01134627|565614425|FG000|Overall Study|Lost to Follow-up|1|||
156691130|NCT01134627|565614426|FG001|Overall Study|Lost to Follow-up|2|||
156870173|NCT01394016|566281103|FG016|Overall Study|Lost to Follow-up|0|||
156870174|NCT01394016|566281104|FG017|Overall Study|Lost to Follow-up|0|||
156691131|NCT01134627|565614425|FG000|Overall Study|Protocol Violation|3|||
156691132|NCT01134627|565614426|FG001|Overall Study|Protocol Violation|5|||
156691133|NCT01134627|565614425|FG000|Overall Study|Lack of Efficacy|2|||
156691134|NCT01134627|565614426|FG001|Overall Study|Lack of Efficacy|12|||
156691135|NCT01134627|565614425|FG000|Overall Study|Withdrawal by Subject|4|||
156691136|NCT01134627|565614426|FG001|Overall Study|Withdrawal by Subject|3|||
156691137|NCT01134627|565614425|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
156691138|NCT01134627|565614426|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
156691139|NCT01134627|565614425|FG000|Overall Study|Other|11|||
156691140|NCT01134627|565614426|FG001|Overall Study|Other|14|||
156691141|NCT00466726|565614429|FG000|Overall Study|Not evaluable for response|14|||
156870175|NCT01394016|566281105|FG018|Overall Study|Lost to Follow-up|1|||
156870176|NCT03534804|566281106|FG000|Overall Study|Withdrawal by Subject|1|||
156691142|NCT00350402|565614430|FG000|Overall Study|Lost to Follow-up|1|||
156691143|NCT00350402|565614431|FG001|Overall Study|Lost to Follow-up|1|||
156691144|NCT01376310|565614432|FG000|Overall Study|Study closed/terminated|1|||
156691145|NCT01376310|565614433|FG001|Overall Study|Study closed/terminated|2|||
156691146|NCT01376310|565614432|FG000|Overall Study|Withdrawal by Subject|8|||
156691147|NCT01376310|565614433|FG001|Overall Study|Withdrawal by Subject|2|||
156691148|NCT01376310|565614432|FG000|Overall Study|Physician Decision|26|||
156691149|NCT01376310|565614433|FG001|Overall Study|Physician Decision|7|||
156691150|NCT01376310|565614432|FG000|Overall Study|Lost to Follow-up|1|||
156691151|NCT01376310|565614433|FG001|Overall Study|Lost to Follow-up|0|||
156691152|NCT02339740|565614436|FG000|Overall Study|Death|1|||
156691153|NCT02339740|565614437|FG001|Overall Study|Death|0|||
156691154|NCT02339740|565614436|FG000|Overall Study|Physician Decision|0|||
156691155|NCT02339740|565614437|FG001|Overall Study|Physician Decision|2|||
156870177|NCT00174187|566281110|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
156870178|NCT00174187|566281111|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
156870179|NCT00174187|566281112|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
156870180|NCT00174187|566281110|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
156436991|NCT05850520|564689177|FG000|Overall Study|Adverse Event|2|||
156436992|NCT05850520|564689178|FG001|Overall Study|Adverse Event|0|||
156691156|NCT02339740|565614436|FG000|Overall Study|Withdrawal by Subject|5|||
156691157|NCT02339740|565614437|FG001|Overall Study|Withdrawal by Subject|1|||
156691158|NCT02339740|565614436|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
156691159|NCT02339740|565614437|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
156691160|NCT00645944|565614438|FG000|Randomized|Withdrawal by Subject|1|||
156691161|NCT00645944|565614439|FG001|Randomized|Withdrawal by Subject|2|||
156691162|NCT00645944|565614438|FG000|Received Medication|Adverse Event|2|||
156691163|NCT00645944|565614439|FG001|Received Medication|Adverse Event|1|||
156870181|NCT00174187|566281111|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
156436993|NCT05850520|564689179|FG002|Overall Study|Adverse Event|1|||
156436994|NCT05850520|564689177|FG000|Overall Study|Physician Decision|0|||
156691164|NCT00645944|565614438|FG000|Received Medication|Withdrawal by Subject|1|||
156691165|NCT00645944|565614439|FG001|Received Medication|Withdrawal by Subject|1|||
156691166|NCT00645944|565614438|FG000|Received Medication|Lost to Follow-up|1|||
156691167|NCT00645944|565614439|FG001|Received Medication|Lost to Follow-up|0|||
156691168|NCT00645944|565614438|FG000|Received Medication|Protocol Violation|2|||
156691169|NCT00645944|565614439|FG001|Received Medication|Protocol Violation|1|||
156691170|NCT01807117|565614441|FG000|Overall Study|Physician Decision|2|||
156691171|NCT01807117|565614441|FG000|Overall Study|Disease diagnosis not a study disease|1|||
156691172|NCT00606502|565614449|FG000|Randomization|Randomized but not treated|3|||
156691173|NCT00606502|565614450|FG001|Randomization|Randomized but not treated|0|||
156691174|NCT00606502|565614449|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
156691175|NCT00606502|565614450|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
156691176|NCT02377921|565614453|FG000|Overall Study|Subject non-compliance|1|||
156691177|NCT02377921|565614454|FG001|Overall Study|Subject non-compliance|1|||
156691178|NCT02443545|565614455|FG000|Overall Study|Adverse Event|1|||
156691179|NCT02443545|565614456|FG001|Overall Study|Adverse Event|1|||
156691180|NCT02443545|565614455|FG000|Overall Study|Lost to Follow-up|0|||
156691181|NCT02443545|565614456|FG001|Overall Study|Lost to Follow-up|2|||
156436995|NCT05850520|564689178|FG001|Overall Study|Physician Decision|1|||
156436996|NCT05850520|564689179|FG002|Overall Study|Physician Decision|0|||
156436997|NCT05850520|564689177|FG000|Overall Study|Protocol deviation|0|||
156436998|NCT05850520|564689178|FG001|Overall Study|Protocol deviation|0|||
156436999|NCT05850520|564689179|FG002|Overall Study|Protocol deviation|1|||
156437000|NCT05850520|564689177|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
156437001|NCT05850520|564689178|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
156437002|NCT05850520|564689179|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
156437003|NCT03889925|564689913|FG000|Overall Study|Lost to Follow-up|11|||
156437004|NCT03889925|564689914|FG001|Overall Study|Lost to Follow-up|10|||
156437005|NCT02320123|564689919|FG000|Overall Study|Lost to Follow-up|4|||
156691182|NCT02443545|565614455|FG000|Overall Study|Physician Decision|3|||
156691183|NCT02443545|565614456|FG001|Overall Study|Physician Decision|0|||
156691184|NCT02443545|565614455|FG000|Overall Study|Protocol Violation|8|||
156788066|NCT02675452|565974865|FG021|Overall Study|Lost to Follow-up|0|||
156788067|NCT02675452|565974866|FG022|Overall Study|Lost to Follow-up|0|||
156788068|NCT02675452|565974867|FG023|Overall Study|Lost to Follow-up|0|||
156788069|NCT02675452|565974868|FG024|Overall Study|Lost to Follow-up|0|||
156788070|NCT02675452|565974869|FG025|Overall Study|Lost to Follow-up|0|||
156788071|NCT02675452|565974870|FG026|Overall Study|Lost to Follow-up|1|||
156788072|NCT02675452|565974871|FG027|Overall Study|Lost to Follow-up|0|||
156788073|NCT02675452|565974872|FG028|Overall Study|Lost to Follow-up|0|||
156788074|NCT02675452|565974844|FG000|Overall Study|Other|0|||
156788075|NCT02675452|565974845|FG001|Overall Study|Other|0|||
156788076|NCT02675452|565974846|FG002|Overall Study|Other|0|||
156788077|NCT02675452|565974847|FG003|Overall Study|Other|0|||
156788078|NCT02675452|565974848|FG004|Overall Study|Other|0|||
156788079|NCT02675452|565974849|FG005|Overall Study|Other|0|||
156788080|NCT02675452|565974850|FG006|Overall Study|Other|0|||
156788081|NCT02675452|565974851|FG007|Overall Study|Other|0|||
156788082|NCT02675452|565974852|FG008|Overall Study|Other|0|||
156788083|NCT02675452|565974853|FG009|Overall Study|Other|0|||
156788084|NCT02675452|565974854|FG010|Overall Study|Other|0|||
156788085|NCT02675452|565974855|FG011|Overall Study|Other|0|||
156788086|NCT02675452|565974856|FG012|Overall Study|Other|0|||
156788087|NCT02675452|565974857|FG013|Overall Study|Other|0|||
156788088|NCT02675452|565974858|FG014|Overall Study|Other|0|||
156788089|NCT02675452|565974859|FG015|Overall Study|Other|0|||
156788090|NCT02675452|565974860|FG016|Overall Study|Other|0|||
156788091|NCT02675452|565974861|FG017|Overall Study|Other|0|||
156788092|NCT02675452|565974862|FG018|Overall Study|Other|0|||
156788093|NCT02675452|565974863|FG019|Overall Study|Other|0|||
156788094|NCT02675452|565974864|FG020|Overall Study|Other|0|||
156788095|NCT02675452|565974865|FG021|Overall Study|Other|0|||
156788096|NCT02675452|565974866|FG022|Overall Study|Other|0|||
156788097|NCT02675452|565974867|FG023|Overall Study|Other|0|||
156788098|NCT02675452|565974868|FG024|Overall Study|Other|0|||
156788099|NCT02675452|565974869|FG025|Overall Study|Other|0|||
156788100|NCT02675452|565974870|FG026|Overall Study|Other|1|||
156788101|NCT02675452|565974871|FG027|Overall Study|Other|0|||
156788102|NCT02675452|565974872|FG028|Overall Study|Other|0|||
156788103|NCT00545948|565974873|FG000|Overall Study|Not Treated|1|||
156437006|NCT02320123|564689920|FG001|Overall Study|Lost to Follow-up|6|||
156437007|NCT02320123|564689919|FG000|Overall Study|Death|6|||
156437008|NCT02320123|564689920|FG001|Overall Study|Death|5|||
156437009|NCT01765543|564689925|FG000|Overall Study|Death|1|||
156691185|NCT02443545|565614456|FG001|Overall Study|Protocol Violation|1|||
156691186|NCT02443545|565614455|FG000|Overall Study|Pregnancy|1|||
156691187|NCT02443545|565614456|FG001|Overall Study|Pregnancy|1|||
156788104|NCT00545948|565974874|FG001|Overall Study|Not Treated|1|||
156788105|NCT00545948|565974875|FG002|Overall Study|Not Treated|7|||
156788106|NCT03467945|565974876|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156788107|NCT03467945|565974877|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156788108|NCT03467945|565974878|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156788109|NCT03467945|565974879|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156788110|NCT03467945|565974876|FG000|Treatment Period 3|Withdrawal by Subject|1|||
156788111|NCT03467945|565974877|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156691188|NCT02443545|565614455|FG000|Overall Study|Withdrawal by Subject|6|||
156691189|NCT02443545|565614456|FG001|Overall Study|Withdrawal by Subject|3|||
156691190|NCT02443545|565614455|FG000|Overall Study|Termination of study|20|||
156691191|NCT02443545|565614456|FG001|Overall Study|Termination of study|11|||
156691192|NCT04179019|565614457|FG000|Overall Study|Lost to Follow-up|2|||
156691193|NCT04179019|565614457|FG000|Overall Study|Physician Decision|2|||
156691194|NCT04179019|565614457|FG000|Overall Study|Withdrawal by Subject|5|||
156691195|NCT04179019|565614457|FG000|Overall Study|Adverse Event|4|||
156691196|NCT01855048|565614461|FG000|Overall Study|Withdrawal by Subject|0|||
156691197|NCT01855048|565614462|FG001|Overall Study|Withdrawal by Subject|1|||
156691198|NCT01855048|565614463|FG002|Overall Study|Withdrawal by Subject|0|||
156691199|NCT01855048|565614464|FG003|Overall Study|Withdrawal by Subject|0|||
156691200|NCT01855048|565614465|FG004|Overall Study|Withdrawal by Subject|1|||
156691201|NCT01855048|565614466|FG005|Overall Study|Withdrawal by Subject|0|||
156691202|NCT01813071|565614467|FG000|Overall Study|Protocol Violation|0|||
156691203|NCT01813071|565614468|FG001|Overall Study|Protocol Violation|0|||
156691204|NCT01813071|565614469|FG002|Overall Study|Protocol Violation|0|||
156691205|NCT01813071|565614470|FG003|Overall Study|Protocol Violation|0|||
156691206|NCT01813071|565614471|FG004|Overall Study|Protocol Violation|1|||
156691207|NCT01813071|565614472|FG005|Overall Study|Protocol Violation|4|||
156691208|NCT01813071|565614473|FG006|Overall Study|Protocol Violation|2|||
156691209|NCT01813071|565614474|FG007|Overall Study|Protocol Violation|4|||
156691210|NCT01813071|565614475|FG008|Overall Study|Protocol Violation|2|||
156691211|NCT01813071|565614467|FG000|Overall Study|Withdrawal by Subject|0|||
156691212|NCT01813071|565614468|FG001|Overall Study|Withdrawal by Subject|0|||
156691213|NCT01813071|565614469|FG002|Overall Study|Withdrawal by Subject|0|||
156691214|NCT01813071|565614470|FG003|Overall Study|Withdrawal by Subject|0|||
156691215|NCT01813071|565614471|FG004|Overall Study|Withdrawal by Subject|0|||
156691216|NCT01813071|565614472|FG005|Overall Study|Withdrawal by Subject|1|||
156691217|NCT01813071|565614473|FG006|Overall Study|Withdrawal by Subject|0|||
156691218|NCT01813071|565614474|FG007|Overall Study|Withdrawal by Subject|0|||
156691219|NCT01813071|565614475|FG008|Overall Study|Withdrawal by Subject|0|||
156691220|NCT01813071|565614467|FG000|Overall Study|Adverse Event|0|||
156691221|NCT01813071|565614468|FG001|Overall Study|Adverse Event|0|||
156691222|NCT01813071|565614469|FG002|Overall Study|Adverse Event|0|||
156691223|NCT01813071|565614470|FG003|Overall Study|Adverse Event|0|||
156691224|NCT01813071|565614471|FG004|Overall Study|Adverse Event|0|||
156691225|NCT01813071|565614472|FG005|Overall Study|Adverse Event|1|||
156691226|NCT01813071|565614473|FG006|Overall Study|Adverse Event|0|||
156691227|NCT01813071|565614474|FG007|Overall Study|Adverse Event|0|||
156691228|NCT01813071|565614475|FG008|Overall Study|Adverse Event|0|||
156691229|NCT01813071|565614467|FG000|Overall Study|Physician Decision|0|||
156691230|NCT01813071|565614468|FG001|Overall Study|Physician Decision|0|||
156691231|NCT01813071|565614469|FG002|Overall Study|Physician Decision|0|||
156691232|NCT01813071|565614470|FG003|Overall Study|Physician Decision|0|||
156691233|NCT01813071|565614471|FG004|Overall Study|Physician Decision|0|||
156870182|NCT00174187|566281112|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
156870183|NCT00174187|566281110|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
156870184|NCT00174187|566281111|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
156870185|NCT00174187|566281112|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
156870186|NCT00174187|566281110|FG000|Period 1 (up to 3 Years)|Other|0|||
156870187|NCT00174187|566281111|FG001|Period 1 (up to 3 Years)|Other|1|||
156870188|NCT00174187|566281112|FG002|Period 1 (up to 3 Years)|Other|0|||
156870189|NCT00174187|566281110|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
156870190|NCT00174187|566281111|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
156870191|NCT00174187|566281112|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
156870192|NCT00174187|566281110|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
156870193|NCT00174187|566281111|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
156870194|NCT00174187|566281112|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
156870195|NCT00174187|566281110|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
156870196|NCT00174187|566281111|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
156691234|NCT01813071|565614472|FG005|Overall Study|Physician Decision|0|||
156691235|NCT01813071|565614473|FG006|Overall Study|Physician Decision|1|||
156691236|NCT01813071|565614474|FG007|Overall Study|Physician Decision|0|||
156691237|NCT01813071|565614475|FG008|Overall Study|Physician Decision|0|||
156691238|NCT01813071|565614467|FG000|Overall Study|Met inc/exc criteria|0|||
156691239|NCT01813071|565614468|FG001|Overall Study|Met inc/exc criteria|0|||
156691240|NCT01813071|565614469|FG002|Overall Study|Met inc/exc criteria|0|||
156691241|NCT01813071|565614470|FG003|Overall Study|Met inc/exc criteria|0|||
156691242|NCT01813071|565614471|FG004|Overall Study|Met inc/exc criteria|0|||
156691243|NCT01813071|565614472|FG005|Overall Study|Met inc/exc criteria|1|||
156691244|NCT01813071|565614473|FG006|Overall Study|Met inc/exc criteria|0|||
156691245|NCT01813071|565614474|FG007|Overall Study|Met inc/exc criteria|1|||
156691246|NCT01813071|565614475|FG008|Overall Study|Met inc/exc criteria|1|||
156691247|NCT05486065|565614476|FG000|Overall Study|Withdrawal by Subject|1|||
156691248|NCT05486065|565614477|FG001|Overall Study|Withdrawal by Subject|5|||
156691249|NCT05486065|565614478|FG002|Overall Study|Withdrawal by Subject|4|||
156691250|NCT05486065|565614479|FG003|Overall Study|Withdrawal by Subject|3|||
156691251|NCT05486065|565614476|FG000|Overall Study|Lost to Follow-up|4|||
156691252|NCT05486065|565614477|FG001|Overall Study|Lost to Follow-up|2|||
156691253|NCT05486065|565614478|FG002|Overall Study|Lost to Follow-up|2|||
156691254|NCT05486065|565614479|FG003|Overall Study|Lost to Follow-up|2|||
156691255|NCT05486065|565614476|FG000|Overall Study|Physician Decision|0|||
156691256|NCT05486065|565614477|FG001|Overall Study|Physician Decision|1|||
156691257|NCT05486065|565614478|FG002|Overall Study|Physician Decision|1|||
156691258|NCT05486065|565614479|FG003|Overall Study|Physician Decision|0|||
156691259|NCT05486065|565614476|FG000|Overall Study|Failure to meet randomization criteria|0|||
156691260|NCT05486065|565614477|FG001|Overall Study|Failure to meet randomization criteria|0|||
156691261|NCT05486065|565614478|FG002|Overall Study|Failure to meet randomization criteria|0|||
156691262|NCT05486065|565614479|FG003|Overall Study|Failure to meet randomization criteria|1|||
156691263|NCT00307931|565614480|FG000|Overall Study|Adverse Event|1|||
156691264|NCT00613834|565614483|FG000|Overall Study|Withdrawal by Subject|0|||
156691265|NCT00613834|565614484|FG001|Overall Study|Withdrawal by Subject|3|||
156691266|NCT00560937|565614488|FG000|Overall Study|Withdrawal by Subject|0|||
156691267|NCT00560937|565614489|FG001|Overall Study|Withdrawal by Subject|1|||
156691268|NCT00560937|565614488|FG000|Overall Study|Physician Decision|1|||
156691269|NCT00560937|565614489|FG001|Overall Study|Physician Decision|1|||
156691270|NCT03919162|565614492|FG000|Overall Study|Adverse Event|3|||
156691271|NCT03919162|565614493|FG001|Overall Study|Adverse Event|2|||
156691272|NCT03919162|565614492|FG000|Overall Study|Death|2|||
156691273|NCT03919162|565614493|FG001|Overall Study|Death|0|||
156691274|NCT03919162|565614492|FG000|Overall Study|Lost to Follow-up|1|||
156691275|NCT03919162|565614493|FG001|Overall Study|Lost to Follow-up|0|||
156691276|NCT03919162|565614492|FG000|Overall Study|Withdrawal by Subject|12|||
156691277|NCT03919162|565614493|FG001|Overall Study|Withdrawal by Subject|12|||
156691278|NCT03919162|565614492|FG000|Overall Study|Study terminated by Sponsor|20|||
156691279|NCT03919162|565614493|FG001|Overall Study|Study terminated by Sponsor|24|||
156691280|NCT03919162|565614492|FG000|Overall Study|Screen failure|1|||
156691281|NCT03919162|565614493|FG001|Overall Study|Screen failure|0|||
156691282|NCT03919162|565614492|FG000|Overall Study|Missing|1|||
156691283|NCT03919162|565614493|FG001|Overall Study|Missing|1|||
156691284|NCT04846881|565614495|FG000|Overall Study|Adverse Event|14|||
156691285|NCT04846881|565614496|FG001|Overall Study|Adverse Event|15|||
156691286|NCT04846881|565614495|FG000|Overall Study|Burden of study procedures|7|||
156691287|NCT04846881|565614496|FG001|Overall Study|Burden of study procedures|3|||
156691288|NCT04846881|565614495|FG000|Overall Study|Protocol deviation|6|||
156691289|NCT04846881|565614496|FG001|Overall Study|Protocol deviation|4|||
156691290|NCT04846881|565614495|FG000|Overall Study|Perceived lack of efficacy|5|||
156691291|NCT04846881|565614496|FG001|Overall Study|Perceived lack of efficacy|2|||
156691292|NCT04846881|565614495|FG000|Overall Study|Change of residence|2|||
156691293|NCT04846881|565614496|FG001|Overall Study|Change of residence|0|||
156691294|NCT04846881|565614495|FG000|Overall Study|Technical problems|0|||
156691295|NCT04846881|565614496|FG001|Overall Study|Technical problems|1|||
156691296|NCT04846881|565614495|FG000|Overall Study|Other than listed|3|||
156691297|NCT04846881|565614496|FG001|Overall Study|Other than listed|10|||
156691298|NCT04846881|565614495|FG000|Overall Study|No reason available|1|||
156691299|NCT04846881|565614496|FG001|Overall Study|No reason available|3|||
156691300|NCT04846881|565614495|FG000|Overall Study|Patient randomised in error|1|||
156691301|NCT04846881|565614496|FG001|Overall Study|Patient randomised in error|0|||
156691302|NCT03341000|565615636|FG000|Overall Study|Adverse Event|1|||
156691303|NCT02516410|565615639|FG000|Overall Study|Adverse Event|0|||
156691304|NCT02516410|565615640|FG001|Overall Study|Adverse Event|1|||
156691305|NCT02516410|565615639|FG000|Overall Study|Withdrawal by Subject|0|||
156691306|NCT02516410|565615640|FG001|Overall Study|Withdrawal by Subject|1|||
156691307|NCT02694549|565615643|FG000|Overall Study|screen failures|2|||
156691308|NCT03438396|565615646|FG000|Overall Study|Reason Not Specified|9|||
156691309|NCT03438396|565615646|FG000|Overall Study|Withdrawal by Subject|5|||
156691310|NCT03438396|565615646|FG000|Overall Study|Lost to Follow-up|2|||
156691311|NCT03438396|565615646|FG000|Overall Study|Death|85|||
156691312|NCT03438396|565615646|FG000|Overall Study|Not treated|1|||
156691313|NCT01173471|565615647|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156691314|NCT01173471|565615648|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156691315|NCT01173471|565615649|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156691316|NCT01173471|565615650|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156691317|NCT01173471|565615647|FG000|Overall Study|Condition under investigation worsened|2|||
156788112|NCT03467945|565974878|FG002|Treatment Period 3|Withdrawal by Subject|2|||
156788113|NCT03467945|565974879|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156788114|NCT04595370|565974884|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
156788115|NCT04595370|565974885|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156788116|NCT04595370|565974886|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156788117|NCT04595370|565974887|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156870197|NCT00174187|566281112|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
156870198|NCT00174187|566281110|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
156870199|NCT00174187|566281111|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
156870200|NCT00174187|566281112|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
156870201|NCT00174187|566281110|FG000|Period 2 (After 3 Years)|Other|0|||
156870202|NCT00174187|566281111|FG001|Period 2 (After 3 Years)|Other|0|||
156870203|NCT00174187|566281112|FG002|Period 2 (After 3 Years)|Other|5|||
156691318|NCT01173471|565615648|FG001|Overall Study|Condition under investigation worsened|0|||
156691319|NCT01173471|565615649|FG002|Overall Study|Condition under investigation worsened|0|||
156691320|NCT01173471|565615650|FG003|Overall Study|Condition under investigation worsened|0|||
156691321|NCT01173471|565615647|FG000|Overall Study|Lost to Follow-up|0|||
156691322|NCT01173471|565615648|FG001|Overall Study|Lost to Follow-up|0|||
156691323|NCT01173471|565615649|FG002|Overall Study|Lost to Follow-up|1|||
156691324|NCT01173471|565615650|FG003|Overall Study|Lost to Follow-up|0|||
156691325|NCT01173471|565615647|FG000|Overall Study|Reason given as Other|0|||
156691326|NCT01173471|565615648|FG001|Overall Study|Reason given as Other|0|||
156691327|NCT01173471|565615649|FG002|Overall Study|Reason given as Other|1|||
156691328|NCT01173471|565615650|FG003|Overall Study|Reason given as Other|0|||
156691329|NCT02370914|565615651|FG000|Overall Study|Protocol Violation|2|||
156691330|NCT00252174|565615653|FG000|Overall Study|Withdrawal by Subject|0|||
156691331|NCT00252174|565615654|FG001|Overall Study|Withdrawal by Subject|1|||
156691332|NCT00252174|565615655|FG002|Overall Study|Withdrawal by Subject|0|||
156691333|NCT02224573|565615656|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
156691334|NCT02224573|565615657|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
156691335|NCT02224573|565615656|FG000|Treatment Phase|Started on Other IMP|1|||
156691336|NCT02224573|565615657|FG001|Treatment Phase|Started on Other IMP|0|||
156691337|NCT02224573|565615656|FG000|Treatment Phase|Participant Discontinued IMP|0|||
156691338|NCT02224573|565615657|FG001|Treatment Phase|Participant Discontinued IMP|1|||
156691339|NCT02224573|565615656|FG000|Treatment Phase|Lack of Efficacy|15|||
156691340|NCT02224573|565615657|FG001|Treatment Phase|Lack of Efficacy|8|||
156691341|NCT02224573|565615656|FG000|Treatment Phase|Began Commercial Product|1|||
156691342|NCT02224573|565615657|FG001|Treatment Phase|Began Commercial Product|0|||
156691343|NCT02224573|565615656|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
156691344|NCT02224573|565615657|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
156691345|NCT02224573|565615656|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
156691346|NCT02224573|565615657|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
156691347|NCT02224573|565615656|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
156691348|NCT02224573|565615657|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
156870204|NCT04161157|566281113|FG000|Overall Study|Lost to Follow-up|4|||
156870205|NCT04161157|566281113|FG000|Overall Study|Death|3|||
156870206|NCT04161157|566281113|FG000|Overall Study|Ineligible|2|||
156870207|NCT04161157|566281113|FG000|Overall Study|Withdrawal by Subject|4|||
156870208|NCT01285557|566281118|FG000|Overall Study|Death|173|||
156870209|NCT01285557|566281119|FG001|Overall Study|Death|90|||
156870210|NCT01285557|566281118|FG000|Overall Study|Lost to Follow-up|6|||
156870211|NCT01285557|566281119|FG001|Overall Study|Lost to Follow-up|2|||
156870212|NCT01285557|566281118|FG000|Overall Study|Withdrew Consent|6|||
156870213|NCT01285557|566281119|FG001|Overall Study|Withdrew Consent|1|||
156870214|NCT01285557|566281118|FG000|Overall Study|Sponsor Study Termination|23|||
156870215|NCT01285557|566281119|FG001|Overall Study|Sponsor Study Termination|13|||
156870216|NCT01285557|566281118|FG000|Overall Study|Randomized but not treated|1|||
156870217|NCT01285557|566281119|FG001|Overall Study|Randomized but not treated|1|||
156870218|NCT01285557|566281118|FG000|Overall Study|Study follow-up ongoing|28|||
156870219|NCT01285557|566281119|FG001|Overall Study|Study follow-up ongoing|14|||
156870220|NCT01285557|566281118|FG000|Overall Study|Sponsor Decision|2|||
156870221|NCT01285557|566281119|FG001|Overall Study|Sponsor Decision|1|||
156870222|NCT02991768|566281124|FG000|Overall Study|Physician Decision|4|||
156870223|NCT05786651|566281127|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
156870224|NCT04922216|566281129|FG000|Overall Study|Withdrawal by Subject|0|||
156870225|NCT04922216|566281130|FG001|Overall Study|Withdrawal by Subject|1|||
156870226|NCT04922216|566281131|FG002|Overall Study|Withdrawal by Subject|0|||
156330037|NCT00191906|564308750|FG003|Study Period II|Adverse Event|0|||
156691349|NCT02224573|565615656|FG000|Treatment Phase|Continued Compassionate Use|1|||
156691350|NCT02224573|565615657|FG001|Treatment Phase|Continued Compassionate Use|0|||
156691351|NCT02224573|565615656|FG000|Treatment Phase|Lack of Efficiency|2|||
156691352|NCT02224573|565615657|FG001|Treatment Phase|Lack of Efficiency|1|||
156691353|NCT02224573|565615656|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
156870227|NCT04922216|566281132|FG003|Overall Study|Withdrawal by Subject|0|||
156870228|NCT04922216|566281133|FG004|Overall Study|Withdrawal by Subject|0|||
156870229|NCT04922216|566281134|FG005|Overall Study|Withdrawal by Subject|0|||
156870230|NCT04922216|566281135|FG006|Overall Study|Withdrawal by Subject|0|||
156870231|NCT04922216|566281136|FG007|Overall Study|Withdrawal by Subject|2|||
156870232|NCT04922216|566281137|FG008|Overall Study|Withdrawal by Subject|0|||
156870233|NCT04922216|566281138|FG009|Overall Study|Withdrawal by Subject|0|||
156330038|NCT00191906|564308747|FG000|Study Period II|Withdrawal by Subject|0|||
156691354|NCT02224573|565615657|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
156691355|NCT02224573|565615656|FG000|Treatment Phase|Participant Moved|2|||
156691356|NCT02224573|565615657|FG001|Treatment Phase|Participant Moved|0|||
156691357|NCT02224573|565615656|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
156691358|NCT02224573|565615657|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
156691359|NCT02224573|565615656|FG000|Treatment Phase|Refused Medication|1|||
156691360|NCT02224573|565615657|FG001|Treatment Phase|Refused Medication|1|||
156691361|NCT02224573|565615656|FG000|Treatment Phase|Adverse Event|26|||
156691362|NCT02224573|565615657|FG001|Treatment Phase|Adverse Event|38|||
156691363|NCT02224573|565615656|FG000|Treatment Phase|Placed in Group Home|0|||
156691364|NCT02224573|565615657|FG001|Treatment Phase|Placed in Group Home|1|||
156691365|NCT02224573|565615656|FG000|Treatment Phase|Pursued Other Trials|1|||
156691366|NCT02224573|565615657|FG001|Treatment Phase|Pursued Other Trials|0|||
156691367|NCT02224573|565615656|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
156691368|NCT02224573|565615657|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
156691369|NCT02224573|565615656|FG000|Treatment Phase|Lost to Follow-up|2|||
156691370|NCT02224573|565615657|FG001|Treatment Phase|Lost to Follow-up|1|||
156691371|NCT02224573|565615656|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
156691372|NCT02224573|565615657|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
156691373|NCT02224573|565615656|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
156330039|NCT00191906|564308748|FG001|Study Period II|Withdrawal by Subject|3|||
156330040|NCT00191906|564308749|FG002|Study Period II|Withdrawal by Subject|0|||
156330041|NCT00191906|564308750|FG003|Study Period II|Withdrawal by Subject|0|||
156330042|NCT00191906|564308747|FG000|Study Period II|Parent/Caregiver Decision|0|||
156330043|NCT00191906|564308748|FG001|Study Period II|Parent/Caregiver Decision|1|||
156330044|NCT00191906|564308749|FG002|Study Period II|Parent/Caregiver Decision|0|||
156330045|NCT00191906|564308750|FG003|Study Period II|Parent/Caregiver Decision|0|||
156330046|NCT00191906|564308747|FG000|Study Period II|Entry Criteria Exclusion|0|||
156330047|NCT00191906|564308748|FG001|Study Period II|Entry Criteria Exclusion|0|||
156330048|NCT00191906|564308749|FG002|Study Period II|Entry Criteria Exclusion|1|||
156330049|NCT00191906|564308750|FG003|Study Period II|Entry Criteria Exclusion|0|||
156330050|NCT00191906|564308747|FG000|Study Period III|Adverse Event|1|||
156330051|NCT00191906|564308748|FG001|Study Period III|Adverse Event|0|||
156330052|NCT00191906|564308749|FG002|Study Period III|Adverse Event|0|||
156330053|NCT00191906|564308750|FG003|Study Period III|Adverse Event|0|||
156330054|NCT00191906|564308747|FG000|Study Period III|Lost to Follow-up|0|||
156330055|NCT00191906|564308748|FG001|Study Period III|Lost to Follow-up|1|||
156330056|NCT00191906|564308749|FG002|Study Period III|Lost to Follow-up|0|||
156691374|NCT02224573|565615657|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
156437010|NCT01765543|564689925|FG000|Overall Study|Withdrawal by Subject|2|||
156437011|NCT01190007|564689926|FG000|Overall Study|Withdrawal by Subject|4|||
156437012|NCT01190007|564689926|FG000|Overall Study|Adverse Event|8|||
156437013|NCT01190007|564689926|FG000|Overall Study|Difficulty of visit for complications|1|||
156437014|NCT01190007|564689926|FG000|Overall Study|Participant was arrested|1|||
156437015|NCT03401112|564689934|FG000|Overall Study|Adverse Event|1|||
156437016|NCT03401112|564689935|FG001|Overall Study|Adverse Event|2|||
156437017|NCT03401112|564689936|FG002|Overall Study|Adverse Event|3|||
156437018|NCT03401112|564689937|FG003|Overall Study|Adverse Event|2|||
156437019|NCT03401112|564689938|FG004|Overall Study|Adverse Event|0|||
156437020|NCT03401112|564689934|FG000|Overall Study|Lost to Follow-up|1|||
156437021|NCT03401112|564689935|FG001|Overall Study|Lost to Follow-up|0|||
156437022|NCT03401112|564689936|FG002|Overall Study|Lost to Follow-up|0|||
156437023|NCT03401112|564689937|FG003|Overall Study|Lost to Follow-up|0|||
156437024|NCT03401112|564689938|FG004|Overall Study|Lost to Follow-up|0|||
156437025|NCT03401112|564689934|FG000|Overall Study|Noncompliance|1|||
156437026|NCT03401112|564689935|FG001|Overall Study|Noncompliance|2|||
156437027|NCT03401112|564689936|FG002|Overall Study|Noncompliance|3|||
156437028|NCT03401112|564689937|FG003|Overall Study|Noncompliance|0|||
156691375|NCT02224573|565615656|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
156691376|NCT02224573|565615657|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
156691377|NCT02224573|565615656|FG000|Taper Phase|Adverse Event|1|||
156691378|NCT02224573|565615657|FG001|Taper Phase|Adverse Event|1|||
156691379|NCT02546362|565615658|FG000|4-week Treatment Period|Lost to Follow-up|1|||
156691380|NCT02546362|565615658|FG000|4-week Treatment Period|Change in medication|2|||
156330057|NCT00191906|564308750|FG003|Study Period III|Lost to Follow-up|0|||
156330058|NCT00191906|564308747|FG000|Study Period III|Parent/Caregiver Decision|1|||
156437029|NCT03401112|564689938|FG004|Overall Study|Noncompliance|0|||
156437030|NCT03401112|564689934|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
156437031|NCT03401112|564689935|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
156437032|NCT03401112|564689936|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
156437033|NCT03401112|564689937|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
156437034|NCT03401112|564689938|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
156437035|NCT03401112|564689934|FG000|Overall Study|Withdrawal by Subject|0|||
156437036|NCT03401112|564689935|FG001|Overall Study|Withdrawal by Subject|3|||
156691381|NCT02546362|565615658|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
156691382|NCT02546362|565615658|FG000|12-week Treatment Period|Lost to Follow-up|2|||
156691383|NCT02546362|565615658|FG000|12-week Treatment Period|Change in medication|1|||
156691384|NCT01138826|565615659|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
156691385|NCT01138826|565615660|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
156691386|NCT01138826|565615661|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
156691387|NCT01138826|565615662|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
156691388|NCT01138826|565615663|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
156691389|NCT01138826|565615664|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
156691390|NCT02025010|565615669|FG000|Overall Study|Symptomatic or radiographic progression|36|||
156691391|NCT02025010|565615669|FG000|Overall Study|Adverse Event|6|||
156691392|NCT02025010|565615669|FG000|Overall Study|Physician Decision|7|||
156691393|NCT02025010|565615669|FG000|Overall Study|Withdrawal by Subject|3|||
156691394|NCT02025010|565615669|FG000|Overall Study|Intercurrent illness|3|||
156691395|NCT02025010|565615669|FG000|Overall Study|Patients still on treatment|3|||
156691396|NCT02025010|565615669|FG000|Overall Study|Never initiate the treatment|2|||
156691397|NCT04440449|565615670|FG000|Overall Study|Lost to Follow-up|2|||
156691398|NCT04440449|565615671|FG001|Overall Study|Lost to Follow-up|0|||
156691399|NCT01949116|565615673|FG000|Overall Study|Death|2|||
156691400|NCT01949116|565615674|FG001|Overall Study|Death|0|||
156691401|NCT01949116|565615673|FG000|Overall Study|Lost to Follow-up|1|||
156691402|NCT01949116|565615674|FG001|Overall Study|Lost to Follow-up|3|||
156691403|NCT01949116|565615673|FG000|Overall Study|Withdrawal by Subject|5|||
156691404|NCT01949116|565615674|FG001|Overall Study|Withdrawal by Subject|3|||
156691405|NCT03832738|565615675|FG000|Overall Study|Withdrawal by Subject|6|||
156691406|NCT03832738|565615676|FG001|Overall Study|Withdrawal by Subject|7|||
156691407|NCT03832738|565615677|FG002|Overall Study|Withdrawal by Subject|16|||
156691408|NCT03832738|565615675|FG000|Overall Study|Physician Decision|0|||
156691409|NCT03832738|565615676|FG001|Overall Study|Physician Decision|1|||
156691410|NCT03832738|565615677|FG002|Overall Study|Physician Decision|2|||
156691411|NCT03832738|565615675|FG000|Overall Study|Adverse Event|2|||
156691412|NCT03832738|565615676|FG001|Overall Study|Adverse Event|3|||
156691413|NCT03832738|565615677|FG002|Overall Study|Adverse Event|1|||
156691414|NCT03832738|565615675|FG000|Overall Study|Pregnancy|0|||
156691415|NCT03832738|565615676|FG001|Overall Study|Pregnancy|1|||
156691416|NCT03832738|565615677|FG002|Overall Study|Pregnancy|0|||
156691417|NCT02442271|565615678|FG000|Overall Study|Adverse Event|1|||
156691418|NCT02442271|565615678|FG000|Overall Study|Withdrew Consent|1|||
156691419|NCT02442271|565615678|FG000|Overall Study|Lost to Follow-up|1|||
156691420|NCT02442271|565615678|FG000|Overall Study|Other|1|||
156691421|NCT00831623|565615679|FG000|Overall Study|Withdrawal by Subject|9|||
156691422|NCT00831623|565615679|FG000|Overall Study|Lost to Follow-up|1|||
156691423|NCT00831623|565615679|FG000|Overall Study|Not 2 years post-treatment|12|||
156691424|NCT02080832|565615688|FG000|Overall Study|Excluded from analysis by MRI|9|||
156691425|NCT02080832|565615689|FG001|Overall Study|Excluded from analysis by MRI|10|||
156691426|NCT02080832|565615690|FG002|Overall Study|Excluded from analysis by MRI|14|||
156691427|NCT02080832|565615688|FG000|Overall Study|Lost to Follow-up|0|||
156691428|NCT02080832|565615689|FG001|Overall Study|Lost to Follow-up|2|||
156691429|NCT02080832|565615690|FG002|Overall Study|Lost to Follow-up|2|||
156691430|NCT01560507|565615691|FG000|Overall Study|Lost to Follow-up|3|||
156691431|NCT01560507|565615692|FG001|Overall Study|Lost to Follow-up|1|||
156691432|NCT01560507|565615693|FG002|Overall Study|Lost to Follow-up|2|||
156691433|NCT01560507|565615691|FG000|Overall Study|Withdrawal by Subject|1|||
156691434|NCT01560507|565615692|FG001|Overall Study|Withdrawal by Subject|1|||
156691435|NCT01560507|565615693|FG002|Overall Study|Withdrawal by Subject|0|||
156691436|NCT01660022|565615694|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
156691437|NCT01660022|565615695|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
156691438|NCT01660022|565615696|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
156691439|NCT01660022|565615697|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
156691440|NCT01660022|565615698|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
156691441|NCT01660022|565615699|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
156691442|NCT01660022|565615694|FG000|First Sequence (7 Days)|Adverse Event|0|||
156691443|NCT01660022|565615695|FG001|First Sequence (7 Days)|Adverse Event|0|||
156691444|NCT01660022|565615696|FG002|First Sequence (7 Days)|Adverse Event|0|||
156691445|NCT01660022|565615697|FG003|First Sequence (7 Days)|Adverse Event|0|||
156691446|NCT01660022|565615698|FG004|First Sequence (7 Days)|Adverse Event|1|||
156691447|NCT01660022|565615699|FG005|First Sequence (7 Days)|Adverse Event|3|||
156691448|NCT01660022|565615694|FG000|First Sequence (7 Days)|Protocol Violation|0|||
156691449|NCT01660022|565615695|FG001|First Sequence (7 Days)|Protocol Violation|0|||
156691450|NCT01660022|565615696|FG002|First Sequence (7 Days)|Protocol Violation|0|||
156691451|NCT01660022|565615697|FG003|First Sequence (7 Days)|Protocol Violation|0|||
156691452|NCT01660022|565615698|FG004|First Sequence (7 Days)|Protocol Violation|0|||
156691453|NCT01660022|565615699|FG005|First Sequence (7 Days)|Protocol Violation|1|||
156691454|NCT03545191|565615701|FG000|Overall Study|Death|1|||
156691455|NCT03545191|565615702|FG001|Overall Study|Death|0|||
156691456|NCT03545191|565615703|FG002|Overall Study|Death|0|||
156530602|NCT04641299|565038088|FG000|Overall Study|Adverse Event|0|||
156530603|NCT04641299|565038089|FG001|Overall Study|Adverse Event|0|||
156530604|NCT04641299|565038090|FG002|Overall Study|Adverse Event|2|||
156530605|NCT04641299|565038091|FG003|Overall Study|Adverse Event|0|||
156530606|NCT04641299|565038088|FG000|Overall Study|Lost to Follow-up|0|||
156691457|NCT03545191|565615701|FG000|Overall Study|Adverse Event|4|||
156691458|NCT03545191|565615702|FG001|Overall Study|Adverse Event|2|||
156691459|NCT03545191|565615703|FG002|Overall Study|Adverse Event|7|||
156691460|NCT03545191|565615701|FG000|Overall Study|Other reasons|3|||
156691461|NCT03545191|565615702|FG001|Overall Study|Other reasons|11|||
156691462|NCT03545191|565615703|FG002|Overall Study|Other reasons|8|||
156691463|NCT03545191|565615701|FG000|Overall Study|Withdrawal by Subject|13|||
156691464|NCT03545191|565615702|FG001|Overall Study|Withdrawal by Subject|10|||
156691465|NCT03545191|565615703|FG002|Overall Study|Withdrawal by Subject|12|||
156691466|NCT03545191|565615701|FG000|Overall Study|Lost to Follow-up|1|||
156691467|NCT03545191|565615702|FG001|Overall Study|Lost to Follow-up|2|||
156691468|NCT03545191|565615703|FG002|Overall Study|Lost to Follow-up|3|||
156691469|NCT01277718|565615707|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
156691470|NCT01277718|565615708|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
156691471|NCT01277718|565615707|FG000|Period 2 - Second Intervention|Physician Decision|0|||
156691472|NCT01277718|565615708|FG001|Period 2 - Second Intervention|Physician Decision|2|||
156691473|NCT02746627|565615712|FG000|Overall Study|Withdrawal by Subject|1|||
156691474|NCT02746627|565615713|FG001|Overall Study|Withdrawal by Subject|1|||
156691475|NCT02746627|565615714|FG002|Overall Study|Withdrawal by Subject|1|||
156691476|NCT02858726|565615715|FG000|Overall Study|Adverse Event|4|||
156691477|NCT02858726|565615716|FG001|Overall Study|Adverse Event|4|||
156691478|NCT02858726|565615717|FG002|Overall Study|Adverse Event|9|||
156691479|NCT02858726|565615718|FG003|Overall Study|Adverse Event|1|||
156691480|NCT02858726|565615715|FG000|Overall Study|Physician Decision|0|||
156691481|NCT02858726|565615716|FG001|Overall Study|Physician Decision|0|||
156691482|NCT02858726|565615717|FG002|Overall Study|Physician Decision|1|||
156691483|NCT02858726|565615718|FG003|Overall Study|Physician Decision|0|||
156691484|NCT02858726|565615715|FG000|Overall Study|Protocol Violation|0|||
156691485|NCT02858726|565615716|FG001|Overall Study|Protocol Violation|0|||
156691486|NCT02858726|565615717|FG002|Overall Study|Protocol Violation|0|||
156691487|NCT02858726|565615718|FG003|Overall Study|Protocol Violation|1|||
156788118|NCT04595370|565974888|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156788119|NCT04595370|565974889|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156788120|NCT04595370|565974884|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788121|NCT04595370|565974885|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788122|NCT04595370|565974886|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
156788123|NCT04595370|565974887|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788124|NCT04595370|565974888|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788125|NCT04595370|565974889|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788126|NCT04595370|565974884|FG000|Overall Study|Adverse Event|0|||
156788127|NCT04595370|565974885|FG001|Overall Study|Adverse Event|4|||
156788128|NCT04595370|565974886|FG002|Overall Study|Adverse Event|3|||
156788129|NCT04595370|565974887|FG003|Overall Study|Adverse Event|1|||
156788130|NCT04595370|565974888|FG004|Overall Study|Adverse Event|1|||
156788131|NCT04595370|565974889|FG005|Overall Study|Adverse Event|1|||
156788132|NCT04595370|565974884|FG000|Overall Study|Withdrawal of Consent|1|||
156788133|NCT04595370|565974885|FG001|Overall Study|Withdrawal of Consent|1|||
156788134|NCT04595370|565974886|FG002|Overall Study|Withdrawal of Consent|1|||
156788135|NCT04595370|565974887|FG003|Overall Study|Withdrawal of Consent|0|||
156788136|NCT04595370|565974888|FG004|Overall Study|Withdrawal of Consent|0|||
156788137|NCT04595370|565974889|FG005|Overall Study|Withdrawal of Consent|0|||
156788138|NCT04595370|565974884|FG000|Overall Study|Death|0|||
156788139|NCT04595370|565974885|FG001|Overall Study|Death|1|||
156788140|NCT04595370|565974886|FG002|Overall Study|Death|0|||
156788141|NCT04595370|565974887|FG003|Overall Study|Death|0|||
156788142|NCT04595370|565974888|FG004|Overall Study|Death|1|||
156788143|NCT04595370|565974889|FG005|Overall Study|Death|0|||
156788144|NCT04595370|565974884|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156788145|NCT04595370|565974885|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156788146|NCT04595370|565974886|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156788147|NCT04595370|565974887|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156788148|NCT04595370|565974888|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156530607|NCT04641299|565038089|FG001|Overall Study|Lost to Follow-up|1|||
156530608|NCT04641299|565038090|FG002|Overall Study|Lost to Follow-up|0|||
156691488|NCT02858726|565615715|FG000|Overall Study|Study Terminated by Sponsor|0|||
156691489|NCT02858726|565615716|FG001|Overall Study|Study Terminated by Sponsor|0|||
156691490|NCT02858726|565615717|FG002|Overall Study|Study Terminated by Sponsor|0|||
156691491|NCT02858726|565615718|FG003|Overall Study|Study Terminated by Sponsor|1|||
156788149|NCT04595370|565974889|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156788150|NCT04595370|565974884|FG000|Overall Study|Withdrawal by Subject|0|||
156691492|NCT02858726|565615715|FG000|Overall Study|Withdrawal by Subject|1|||
156691493|NCT02858726|565615716|FG001|Overall Study|Withdrawal by Subject|2|||
156691494|NCT02858726|565615717|FG002|Overall Study|Withdrawal by Subject|1|||
156691495|NCT02858726|565615718|FG003|Overall Study|Withdrawal by Subject|0|||
156691496|NCT02858726|565615715|FG000|Overall Study|Noncompliance|0|||
156691497|NCT02858726|565615716|FG001|Overall Study|Noncompliance|1|||
156691498|NCT02858726|565615717|FG002|Overall Study|Noncompliance|0|||
156691499|NCT02858726|565615718|FG003|Overall Study|Noncompliance|0|||
156691500|NCT00233987|565615723|FG000|Overall Study|Withdrawal by Subject|1|||
156691501|NCT00233987|565615723|FG000|Overall Study|Lack of Efficacy|2|||
156691502|NCT00233987|565615723|FG000|Overall Study|Reason Under Review|1|||
156691503|NCT00233987|565615723|FG000|Overall Study|Other - Not Protocol Specified|5|||
156691504|NCT00233987|565615723|FG000|Overall Study|Eligible but No Treatment Received|2|||
156691505|NCT00233987|565615723|FG000|Overall Study|Ineligible|4|||
156691506|NCT01688726|565615726|FG000|Overall Study|Adverse Event|1|||
156691507|NCT01688726|565615727|FG001|Overall Study|Adverse Event|0|||
156691508|NCT01688726|565615726|FG000|Overall Study|Relocated abroad|0|||
156691509|NCT01688726|565615727|FG001|Overall Study|Relocated abroad|1|||
156788151|NCT04595370|565974885|FG001|Overall Study|Withdrawal by Subject|0|||
156788152|NCT04595370|565974886|FG002|Overall Study|Withdrawal by Subject|1|||
156788153|NCT04595370|565974887|FG003|Overall Study|Withdrawal by Subject|0|||
156691510|NCT04553913|565615728|FG000|Overall Study|patient's block resolved prior to PACU|1|||
156691511|NCT04553913|565615728|FG000|Overall Study|did not use the device properly|5|||
156691512|NCT01481324|565615729|FG000|Overall Study|Missing Data|0|||
156691513|NCT01481324|565615730|FG001|Overall Study|Missing Data|2|||
156691514|NCT01481324|565615731|FG002|Overall Study|Missing Data|2|||
156691515|NCT00710749|565615735|FG000|First Intervention|Withdrawal by Subject|1|||
156691516|NCT00710749|565615736|FG001|First Intervention|Withdrawal by Subject|0|||
156691517|NCT05478252|565615737|FG000|Overall Study|Withdrawal by Subject|2|||
156691518|NCT05478252|565615738|FG001|Overall Study|Withdrawal by Subject|3|||
156691519|NCT05478252|565615737|FG000|Overall Study|Lost to Follow-up|4|||
156691520|NCT05478252|565615738|FG001|Overall Study|Lost to Follow-up|2|||
156691521|NCT05478252|565615737|FG000|Overall Study|Physician Decision|1|||
156691522|NCT05478252|565615738|FG001|Overall Study|Physician Decision|1|||
156691523|NCT05478252|565615737|FG000|Overall Study|Death|1|||
156691524|NCT05478252|565615738|FG001|Overall Study|Death|0|||
156691525|NCT04560998|565615739|FG000|Overall Study|Withdrawal by Subject|18|||
156691526|NCT04560998|565615740|FG001|Overall Study|Withdrawal by Subject|12|||
156691527|NCT04560998|565615739|FG000|Overall Study|Lost to Follow-up|8|||
156691528|NCT04560998|565615740|FG001|Overall Study|Lost to Follow-up|5|||
156691529|NCT04560998|565615739|FG000|Overall Study|Physician Decision|4|||
156691530|NCT04560998|565615740|FG001|Overall Study|Physician Decision|0|||
156691531|NCT03821272|565617978|FG000|Overall Study|Death|1|||
156691532|NCT03821272|565617979|FG001|Overall Study|Death|0|||
156691533|NCT03821272|565617978|FG000|Overall Study|Physician Decision|1|||
156691534|NCT03821272|565617979|FG001|Overall Study|Physician Decision|0|||
156691535|NCT03821272|565617978|FG000|Overall Study|Withdrawal by Subject|1|||
156691536|NCT03821272|565617979|FG001|Overall Study|Withdrawal by Subject|0|||
156691537|NCT05904769|565617980|FG000|Overall Study|Physician Decision|0|||
156691538|NCT05904769|565617981|FG001|Overall Study|Physician Decision|6|||
156691539|NCT05626803|565617982|FG000|Overall Study|Lost to Follow-up|0|||
156691540|NCT05626803|565617983|FG001|Overall Study|Lost to Follow-up|1|||
156691541|NCT05626803|565617984|FG002|Overall Study|Lost to Follow-up|0|||
156691542|NCT05626803|565617985|FG003|Overall Study|Lost to Follow-up|0|||
156691543|NCT04974619|565617986|FG000|Overall Study|Lost to Follow-up|0|||
156691544|NCT04974619|565617987|FG001|Overall Study|Lost to Follow-up|0|||
156691545|NCT04974619|565617988|FG002|Overall Study|Lost to Follow-up|1|||
156691546|NCT04974619|565617986|FG000|Overall Study|Withdrawal by Subject|0|||
156691547|NCT04974619|565617987|FG001|Overall Study|Withdrawal by Subject|0|||
156691548|NCT04974619|565617988|FG002|Overall Study|Withdrawal by Subject|1|||
156691549|NCT04974619|565617986|FG000|Overall Study|Protocol Violation|0|||
156691550|NCT04974619|565617987|FG001|Overall Study|Protocol Violation|1|||
156691551|NCT04974619|565617988|FG002|Overall Study|Protocol Violation|0|||
156691552|NCT01688466|565617990|FG000|Overall Study|Withdrawal by Subject|2|||
156691553|NCT01688466|565617991|FG001|Overall Study|Withdrawal by Subject|1|||
156691554|NCT01688466|565617990|FG000|Overall Study|Death|0|||
156691555|NCT01688466|565617991|FG001|Overall Study|Death|1|||
156691556|NCT01688466|565617990|FG000|Overall Study|Adverse Event|0|||
156788154|NCT04595370|565974888|FG004|Overall Study|Withdrawal by Subject|2|||
156788155|NCT04595370|565974889|FG005|Overall Study|Withdrawal by Subject|0|||
156788156|NCT04595370|565974884|FG000|Overall Study|Lost to Follow-up|0|||
156437037|NCT03401112|564689936|FG002|Overall Study|Withdrawal by Subject|2|||
156691557|NCT01688466|565617991|FG001|Overall Study|Adverse Event|4|||
156691558|NCT01688466|565617990|FG000|Overall Study|Not evaluable|0|||
156691559|NCT01688466|565617991|FG001|Overall Study|Not evaluable|1|||
156691560|NCT01000610|565617992|FG000|Overall Study|Adverse Event|1|||
156691561|NCT01000610|565617992|FG000|Overall Study|Lost to Follow-up|4|||
156691562|NCT01000610|565617992|FG000|Overall Study|Treatment failure|1|||
156691563|NCT04495283|565617995|FG000|Overall Study|Physician Decision|0|||
156691564|NCT04495283|565617996|FG001|Overall Study|Physician Decision|0|||
156691565|NCT04495283|565617997|FG002|Overall Study|Physician Decision|1|||
156691566|NCT04495283|565617995|FG000|Overall Study|Withdrawal by Subject|0|||
156691567|NCT04495283|565617996|FG001|Overall Study|Withdrawal by Subject|1|||
156691568|NCT04495283|565617997|FG002|Overall Study|Withdrawal by Subject|1|||
156691569|NCT04495283|565617995|FG000|Overall Study|Other|1|||
156691570|NCT04495283|565617996|FG001|Overall Study|Other|0|||
156691571|NCT04495283|565617997|FG002|Overall Study|Other|1|||
156691572|NCT01647958|565618011|FG000|Initial Study|Lost to Follow-up|2|||
156691573|NCT01647958|565618012|FG001|Initial Study|Lost to Follow-up|3|||
156788157|NCT04595370|565974885|FG001|Overall Study|Lost to Follow-up|0|||
156788158|NCT04595370|565974886|FG002|Overall Study|Lost to Follow-up|0|||
156437038|NCT03401112|564689937|FG003|Overall Study|Withdrawal by Subject|1|||
156437039|NCT03401112|564689938|FG004|Overall Study|Withdrawal by Subject|0|||
156437040|NCT03401112|564689934|FG000|Overall Study|Physician Decision|0|||
156788159|NCT04595370|565974887|FG003|Overall Study|Lost to Follow-up|0|||
156788160|NCT04595370|565974888|FG004|Overall Study|Lost to Follow-up|1|||
156788161|NCT04595370|565974889|FG005|Overall Study|Lost to Follow-up|0|||
156788162|NCT04595370|565974884|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
156788163|NCT04595370|565974885|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
156788164|NCT04595370|565974886|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
156788165|NCT04595370|565974887|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
156788166|NCT04595370|565974888|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
156788167|NCT04595370|565974889|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
156788168|NCT00541775|565974890|FG000|Overall Study|Adverse Event|3|||
156788169|NCT00541775|565974891|FG001|Overall Study|Adverse Event|2|||
156788170|NCT00541775|565974892|FG002|Overall Study|Adverse Event|1|||
156788171|NCT00541775|565974890|FG000|Overall Study|Lack of Efficacy|0|||
156788172|NCT00541775|565974891|FG001|Overall Study|Lack of Efficacy|0|||
156788173|NCT00541775|565974892|FG002|Overall Study|Lack of Efficacy|3|||
156788174|NCT00541775|565974890|FG000|Overall Study|Lost to Follow-up|0|||
156788175|NCT00541775|565974891|FG001|Overall Study|Lost to Follow-up|0|||
156788176|NCT00541775|565974892|FG002|Overall Study|Lost to Follow-up|2|||
156788177|NCT00541775|565974890|FG000|Overall Study|Protocol Violation|1|||
156788178|NCT00541775|565974891|FG001|Overall Study|Protocol Violation|0|||
156788179|NCT00541775|565974892|FG002|Overall Study|Protocol Violation|0|||
156788180|NCT00541775|565974890|FG000|Overall Study|Withdrawal by Subject and Other|5|||
156788181|NCT00541775|565974891|FG001|Overall Study|Withdrawal by Subject and Other|0|||
156788182|NCT00541775|565974892|FG002|Overall Study|Withdrawal by Subject and Other|2|||
156788183|NCT01945242|565974893|FG000|Overall Study|Physician Decision|3|||
156788184|NCT01945242|565974894|FG001|Overall Study|Physician Decision|3|||
156788185|NCT02975700|565974895|FG000|Overall Study|Adverse Event|1|||
156788186|NCT02975700|565974895|FG000|Overall Study|Progressive disease|3|||
156788187|NCT02975700|565974895|FG000|Overall Study|Failed screening criteria|2|||
156788188|NCT01541254|565974898|FG000|Overall Study|Withdrawal by Subject|1|||
156788189|NCT01541254|565974898|FG000|Overall Study|excluded - metal allergy|1|||
156788190|NCT01541254|565974898|FG000|Overall Study|enrolled after study closed|1|||
156788191|NCT01541254|565974898|FG000|Overall Study|GI bleed prior to procedure|1|||
156788192|NCT01541254|565974898|FG000|Overall Study|stent not required|1|||
156788193|NCT01541254|565974898|FG000|Overall Study|alternate stent used|1|||
156788194|NCT05660538|565974899|FG000|Overall Study|Adverse Event|0|||
156788195|NCT05660538|565974900|FG001|Overall Study|Adverse Event|0|||
156788196|NCT05660538|565974901|FG002|Overall Study|Adverse Event|1|||
156788197|NCT05660538|565974902|FG003|Overall Study|Adverse Event|0|||
156788198|NCT05660538|565974899|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156788199|NCT05660538|565974900|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
156788200|NCT05660538|565974901|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
156788201|NCT05660538|565974902|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
156788202|NCT05660538|565974899|FG000|Overall Study|Lost to Follow-up|0|||
156788203|NCT05660538|565974900|FG001|Overall Study|Lost to Follow-up|0|||
156788204|NCT05660538|565974901|FG002|Overall Study|Lost to Follow-up|1|||
156788205|NCT05660538|565974902|FG003|Overall Study|Lost to Follow-up|1|||
156437041|NCT03401112|564689935|FG001|Overall Study|Physician Decision|0|||
156437042|NCT03401112|564689936|FG002|Overall Study|Physician Decision|0|||
156437043|NCT03401112|564689937|FG003|Overall Study|Physician Decision|2|||
156691574|NCT01647958|565618011|FG000|Continuation Phase|treatment received during Overall Study|39|||
156788206|NCT05660538|565974899|FG000|Overall Study|Death|0|||
156788207|NCT05660538|565974900|FG001|Overall Study|Death|0|||
156788208|NCT05660538|565974901|FG002|Overall Study|Death|1|||
156788209|NCT05660538|565974902|FG003|Overall Study|Death|0|||
156788210|NCT05660538|565974899|FG000|Overall Study|Physician Decision|0|||
156788211|NCT05660538|565974900|FG001|Overall Study|Physician Decision|0|||
156788212|NCT05660538|565974901|FG002|Overall Study|Physician Decision|0|||
156788213|NCT05660538|565974902|FG003|Overall Study|Physician Decision|1|||
156788214|NCT05660538|565974899|FG000|Overall Study|Sponsor Decision|1|||
156788215|NCT05660538|565974900|FG001|Overall Study|Sponsor Decision|0|||
156691575|NCT01647958|565618012|FG001|Continuation Phase|treatment received during Overall Study|0|||
156691576|NCT01647958|565618011|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
156691577|NCT01647958|565618012|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
156691578|NCT01131299|565618013|FG000|Overall Study|Withdrawal by Subject|4|||
156691579|NCT01131299|565618014|FG001|Overall Study|Withdrawal by Subject|7|||
156691580|NCT01207440|565618022|FG000|Overall Study|Adverse Event|46|||
156691581|NCT01207440|565618023|FG001|Overall Study|Adverse Event|11|||
156691582|NCT01207440|565618024|FG002|Overall Study|Adverse Event|7|||
156691583|NCT01207440|565618025|FG003|Overall Study|Adverse Event|2|||
156691584|NCT01207440|565618026|FG004|Overall Study|Adverse Event|6|||
156691585|NCT01207440|565618027|FG005|Overall Study|Adverse Event|6|||
156691586|NCT01207440|565618028|FG006|Overall Study|Adverse Event|2|||
156691587|NCT01207440|565618022|FG000|Overall Study|Death|6|||
156691588|NCT01207440|565618023|FG001|Overall Study|Death|3|||
156691589|NCT01207440|565618024|FG002|Overall Study|Death|2|||
156691590|NCT01207440|565618025|FG003|Overall Study|Death|2|||
156691591|NCT01207440|565618026|FG004|Overall Study|Death|7|||
156691592|NCT01207440|565618027|FG005|Overall Study|Death|5|||
156691593|NCT01207440|565618028|FG006|Overall Study|Death|1|||
156691594|NCT01207440|565618022|FG000|Overall Study|Lack of Efficacy|13|||
156691595|NCT01207440|565618023|FG001|Overall Study|Lack of Efficacy|2|||
156691596|NCT01207440|565618024|FG002|Overall Study|Lack of Efficacy|5|||
156691597|NCT01207440|565618025|FG003|Overall Study|Lack of Efficacy|1|||
156691598|NCT01207440|565618026|FG004|Overall Study|Lack of Efficacy|2|||
156691599|NCT01207440|565618027|FG005|Overall Study|Lack of Efficacy|3|||
156691600|NCT01207440|565618028|FG006|Overall Study|Lack of Efficacy|0|||
156691601|NCT01207440|565618022|FG000|Overall Study|Lost to Follow-up|0|||
156691602|NCT01207440|565618023|FG001|Overall Study|Lost to Follow-up|0|||
156691603|NCT01207440|565618024|FG002|Overall Study|Lost to Follow-up|2|||
156691604|NCT01207440|565618025|FG003|Overall Study|Lost to Follow-up|1|||
156691605|NCT01207440|565618026|FG004|Overall Study|Lost to Follow-up|0|||
156691606|NCT01207440|565618027|FG005|Overall Study|Lost to Follow-up|0|||
156691607|NCT01207440|565618028|FG006|Overall Study|Lost to Follow-up|0|||
156691608|NCT01207440|565618022|FG000|Overall Study|Non-compliance with Study Drug|3|||
156691609|NCT01207440|565618023|FG001|Overall Study|Non-compliance with Study Drug|0|||
156691610|NCT01207440|565618024|FG002|Overall Study|Non-compliance with Study Drug|1|||
156691611|NCT01207440|565618025|FG003|Overall Study|Non-compliance with Study Drug|0|||
156691612|NCT01207440|565618026|FG004|Overall Study|Non-compliance with Study Drug|0|||
156691613|NCT01207440|565618027|FG005|Overall Study|Non-compliance with Study Drug|0|||
156691614|NCT01207440|565618028|FG006|Overall Study|Non-compliance with Study Drug|0|||
156691615|NCT01207440|565618022|FG000|Overall Study|Physician Decision|6|||
156691616|NCT01207440|565618023|FG001|Overall Study|Physician Decision|5|||
156691617|NCT01207440|565618024|FG002|Overall Study|Physician Decision|5|||
156691618|NCT01207440|565618025|FG003|Overall Study|Physician Decision|0|||
156691619|NCT01207440|565618026|FG004|Overall Study|Physician Decision|1|||
156691620|NCT01207440|565618027|FG005|Overall Study|Physician Decision|0|||
156788216|NCT05660538|565974901|FG002|Overall Study|Sponsor Decision|0|||
156788217|NCT05660538|565974902|FG003|Overall Study|Sponsor Decision|0|||
156788218|NCT05660538|565974899|FG000|Overall Study|Other|1|||
156788219|NCT05660538|565974900|FG001|Overall Study|Other|0|||
156691621|NCT01207440|565618028|FG006|Overall Study|Physician Decision|0|||
156691622|NCT01207440|565618022|FG000|Overall Study|Progressive Disease|19|||
156691623|NCT01207440|565618023|FG001|Overall Study|Progressive Disease|10|||
156691624|NCT01207440|565618024|FG002|Overall Study|Progressive Disease|19|||
156691625|NCT01207440|565618025|FG003|Overall Study|Progressive Disease|7|||
156691626|NCT01207440|565618026|FG004|Overall Study|Progressive Disease|23|||
156691627|NCT01207440|565618027|FG005|Overall Study|Progressive Disease|27|||
156691628|NCT01207440|565618028|FG006|Overall Study|Progressive Disease|0|||
156691629|NCT01207440|565618022|FG000|Overall Study|Protocol Violation|2|||
156691630|NCT01207440|565618023|FG001|Overall Study|Protocol Violation|0|||
156691631|NCT01207440|565618024|FG002|Overall Study|Protocol Violation|0|||
156691632|NCT01207440|565618025|FG003|Overall Study|Protocol Violation|0|||
156691633|NCT01207440|565618026|FG004|Overall Study|Protocol Violation|0|||
156788220|NCT05660538|565974901|FG002|Overall Study|Other|0|||
156788221|NCT05660538|565974902|FG003|Overall Study|Other|1|||
156788222|NCT05660538|565974899|FG000|Overall Study|Randomized but did not receive study drug|1|||
156788223|NCT05660538|565974900|FG001|Overall Study|Randomized but did not receive study drug|0|||
156788224|NCT05660538|565974901|FG002|Overall Study|Randomized but did not receive study drug|0|||
156691634|NCT01207440|565618027|FG005|Overall Study|Protocol Violation|0|||
156691635|NCT01207440|565618028|FG006|Overall Study|Protocol Violation|0|||
156691636|NCT01207440|565618022|FG000|Overall Study|Site Terminated by Sponsor|69|||
156691637|NCT01207440|565618023|FG001|Overall Study|Site Terminated by Sponsor|19|||
156691638|NCT01207440|565618024|FG002|Overall Study|Site Terminated by Sponsor|12|||
156691639|NCT01207440|565618025|FG003|Overall Study|Site Terminated by Sponsor|2|||
156691640|NCT01207440|565618026|FG004|Overall Study|Site Terminated by Sponsor|3|||
156691641|NCT01207440|565618027|FG005|Overall Study|Site Terminated by Sponsor|0|||
156788225|NCT05660538|565974902|FG003|Overall Study|Randomized but did not receive study drug|1|||
156788226|NCT05660538|565974899|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
156330059|NCT00191906|564308748|FG001|Study Period III|Parent/Caregiver Decision|0|||
156330060|NCT00191906|564308749|FG002|Study Period III|Parent/Caregiver Decision|0|||
156330061|NCT00191906|564308750|FG003|Study Period III|Parent/Caregiver Decision|0|||
156330062|NCT00191906|564308747|FG000|Study Period III|Lack of Efficacy|3|||
156330063|NCT00191906|564308748|FG001|Study Period III|Lack of Efficacy|3|||
156330064|NCT00191906|564308749|FG002|Study Period III|Lack of Efficacy|0|||
156330065|NCT00191906|564308750|FG003|Study Period III|Lack of Efficacy|0|||
156330066|NCT00573937|564308751|FG000|Overall Study|Study Terminated|0|||
156330067|NCT00573937|564308752|FG001|Overall Study|Study Terminated|1|||
156330068|NCT00333801|564308753|FG000|Overall Study|Moved to another state|5|||
156330069|NCT00333801|564308754|FG001|Overall Study|Moved to another state|3|||
156330070|NCT00333801|564308753|FG000|Overall Study|Lost to Follow-up|2|||
156330071|NCT00333801|564308754|FG001|Overall Study|Lost to Follow-up|0|||
156330072|NCT00333801|564308753|FG000|Overall Study|Incarcerated|1|||
156330073|NCT00333801|564308754|FG001|Overall Study|Incarcerated|2|||
156330074|NCT00333801|564308753|FG000|Overall Study|Withdrawal by Subject|0|||
156330075|NCT00333801|564308754|FG001|Overall Study|Withdrawal by Subject|1|||
156330076|NCT00777205|564308755|FG000|Overall Study|Lost to Follow-up|25|||
156330077|NCT00777205|564308756|FG001|Overall Study|Lost to Follow-up|9|||
156330078|NCT00777205|564308755|FG000|Overall Study|Withdrawal by Subject|6|||
156330079|NCT00777205|564308756|FG001|Overall Study|Withdrawal by Subject|4|||
156330080|NCT00777205|564308755|FG000|Overall Study|Death|0|||
156330081|NCT00777205|564308756|FG001|Overall Study|Death|2|||
156330082|NCT00777205|564308755|FG000|Overall Study|Protocol Violation|0|||
156330083|NCT00777205|564308756|FG001|Overall Study|Protocol Violation|56|||
156330084|NCT00631696|564308757|FG000|Overall Study|Entered, not randomized to treatment|1|||
156330085|NCT00631696|564308758|FG001|Overall Study|Entered, not randomized to treatment|1|||
156330086|NCT00631696|564308757|FG000|Overall Study|Discontinued after database release date|1|||
156330087|NCT00631696|564308758|FG001|Overall Study|Discontinued after database release date|0|||
156330088|NCT00631696|564308757|FG000|Overall Study|Follow up after database release date|1|||
156330089|NCT00631696|564308758|FG001|Overall Study|Follow up after database release date|0|||
156330090|NCT00631696|564308757|FG000|Overall Study|Lost to Follow-up|7|||
156330091|NCT00631696|564308758|FG001|Overall Study|Lost to Follow-up|10|||
156330092|NCT00631696|564308757|FG000|Overall Study|Withdrawal by Subject|2|||
156330093|NCT00631696|564308758|FG001|Overall Study|Withdrawal by Subject|9|||
156330094|NCT00631696|564308757|FG000|Overall Study|Other|8|||
156330095|NCT00631696|564308758|FG001|Overall Study|Other|8|||
156330096|NCT00631696|564308757|FG000|Overall Study|Protocol Violation|9|||
156330097|NCT00631696|564308758|FG001|Overall Study|Protocol Violation|9|||
156330098|NCT00631696|564308757|FG000|Overall Study|Study terminated by sponsor|3|||
156330099|NCT00631696|564308758|FG001|Overall Study|Study terminated by sponsor|3|||
156330100|NCT00631696|564308757|FG000|Overall Study|Adverse Event|5|||
156330101|NCT00631696|564308758|FG001|Overall Study|Adverse Event|0|||
156330102|NCT01134731|564308761|FG000|Overall Study|Adverse Event|3|||
156330103|NCT01134731|564308762|FG001|Overall Study|Adverse Event|2|||
156330104|NCT01134731|564308763|FG002|Overall Study|Adverse Event|1|||
156330105|NCT01134731|564308761|FG000|Overall Study|Physician Decision|2|||
156330106|NCT01134731|564308762|FG001|Overall Study|Physician Decision|2|||
156330107|NCT01134731|564308763|FG002|Overall Study|Physician Decision|2|||
156330108|NCT01134731|564308761|FG000|Overall Study|Lack of Efficacy|0|||
156330109|NCT01134731|564308762|FG001|Overall Study|Lack of Efficacy|0|||
156330110|NCT01134731|564308763|FG002|Overall Study|Lack of Efficacy|1|||
156330111|NCT01134731|564308761|FG000|Overall Study|Withdrawal by Subject|3|||
156330112|NCT01134731|564308762|FG001|Overall Study|Withdrawal by Subject|3|||
156330113|NCT01134731|564308763|FG002|Overall Study|Withdrawal by Subject|1|||
156330114|NCT01134731|564308761|FG000|Overall Study|Lost to Follow-up|5|||
156330115|NCT01134731|564308762|FG001|Overall Study|Lost to Follow-up|4|||
156330116|NCT01134731|564308763|FG002|Overall Study|Lost to Follow-up|3|||
156330117|NCT05095454|564308764|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
156530609|NCT04641299|565038091|FG003|Overall Study|Lost to Follow-up|0|||
156691642|NCT01207440|565618028|FG006|Overall Study|Site Terminated by Sponsor|2|||
156691643|NCT01207440|565618022|FG000|Overall Study|Withdrawal by Subject|29|||
156330118|NCT05095454|564308765|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
156330119|NCT00679055|564308766|FG000|Overall Study|Adverse Event|0|||
156330120|NCT00679055|564308767|FG001|Overall Study|Adverse Event|1|||
156330121|NCT00679055|564308766|FG000|Overall Study|Other|0|||
156330122|NCT00679055|564308767|FG001|Overall Study|Other|3|||
156330123|NCT00679055|564308766|FG000|Overall Study|Study Terminated|2|||
156330124|NCT00679055|564308767|FG001|Overall Study|Study Terminated|1|||
156330125|NCT00629772|564308768|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
156330126|NCT00629772|564308769|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
156330127|NCT00629772|564308768|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
156330128|NCT00629772|564308769|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
156330129|NCT03840174|564308770|FG000|Overall Study|Withdrawal by Subject|1|||
156330130|NCT03840174|564308771|FG001|Overall Study|Withdrawal by Subject|0|||
156330131|NCT03840174|564308772|FG002|Overall Study|Withdrawal by Subject|0|||
156330132|NCT03840174|564308773|FG003|Overall Study|Withdrawal by Subject|0|||
156330133|NCT02410551|564308774|FG000|Overall Study|Adverse Event|1|||
156330134|NCT02410551|564308774|FG000|Overall Study|Withdrawal by Subject|1|||
156330135|NCT02410551|564308774|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
156330136|NCT05469113|564308775|FG000|Period 2|Adverse Event|0|||
156330137|NCT05469113|564308776|FG001|Period 2|Adverse Event|3|||
156330138|NCT01986140|564308780|FG000|Overall Study|Withdrawal by Subject|31|||
156330139|NCT01986140|564308781|FG001|Overall Study|Withdrawal by Subject|25|||
156330140|NCT01986140|564308780|FG000|Overall Study|alternative treatment|1|||
156330141|NCT01986140|564308781|FG001|Overall Study|alternative treatment|1|||
156330142|NCT01986140|564308780|FG000|Overall Study|found not eligible|3|||
156330143|NCT01986140|564308781|FG001|Overall Study|found not eligible|0|||
156330144|NCT01986140|564308780|FG000|Overall Study|Adverse Event|0|||
156330145|NCT01986140|564308781|FG001|Overall Study|Adverse Event|1|||
156330146|NCT01986140|564308780|FG000|Overall Study|progression disease|0|||
156330147|NCT01986140|564308781|FG001|Overall Study|progression disease|1|||
156330148|NCT01069627|564308789|FG000|Overall Study|Disease progression|7|||
156330149|NCT01069627|564308789|FG000|Overall Study|Adverse Event|12|||
156330150|NCT01069627|564308789|FG000|Overall Study|Protocol Violation|1|||
156330151|NCT00464269|564308794|FG000|Overall Study|Lack of Efficacy|1|||
156330152|NCT00464269|564308795|FG001|Overall Study|Lack of Efficacy|0|||
156330153|NCT00464269|564308796|FG002|Overall Study|Lack of Efficacy|0|||
156330154|NCT00464269|564308797|FG003|Overall Study|Lack of Efficacy|0|||
156330155|NCT00464269|564308794|FG000|Overall Study|Lost to Follow-up|0|||
156330156|NCT00464269|564308795|FG001|Overall Study|Lost to Follow-up|4|||
156330157|NCT00464269|564308796|FG002|Overall Study|Lost to Follow-up|0|||
156330158|NCT00464269|564308797|FG003|Overall Study|Lost to Follow-up|1|||
156691644|NCT01207440|565618023|FG001|Overall Study|Withdrawal by Subject|4|||
156691645|NCT01207440|565618024|FG002|Overall Study|Withdrawal by Subject|5|||
156691646|NCT01207440|565618025|FG003|Overall Study|Withdrawal by Subject|3|||
156691647|NCT01207440|565618026|FG004|Overall Study|Withdrawal by Subject|2|||
156691648|NCT01207440|565618027|FG005|Overall Study|Withdrawal by Subject|2|||
156691649|NCT01207440|565618028|FG006|Overall Study|Withdrawal by Subject|0|||
156691650|NCT01207440|565618022|FG000|Overall Study|Reason Not Specified|10|||
156691651|NCT01207440|565618023|FG001|Overall Study|Reason Not Specified|10|||
156691652|NCT01207440|565618024|FG002|Overall Study|Reason Not Specified|7|||
156691653|NCT01207440|565618025|FG003|Overall Study|Reason Not Specified|0|||
156691654|NCT01207440|565618026|FG004|Overall Study|Reason Not Specified|4|||
156870234|NCT04922216|566281139|FG010|Overall Study|Withdrawal by Subject|0|||
156870235|NCT04922216|566281140|FG011|Overall Study|Withdrawal by Subject|0|||
156870236|NCT04922216|566281141|FG012|Overall Study|Withdrawal by Subject|1|||
156870237|NCT04922216|566281142|FG013|Overall Study|Withdrawal by Subject|1|||
156870238|NCT04922216|566281143|FG014|Overall Study|Withdrawal by Subject|1|||
156870239|NCT04922216|566281144|FG015|Overall Study|Withdrawal by Subject|0|||
156330159|NCT00464269|564308794|FG000|Overall Study|Withdrawal by Subject|0|||
156330160|NCT00464269|564308795|FG001|Overall Study|Withdrawal by Subject|2|||
156330161|NCT00464269|564308796|FG002|Overall Study|Withdrawal by Subject|1|||
156330162|NCT00464269|564308797|FG003|Overall Study|Withdrawal by Subject|1|||
156691655|NCT01207440|565618027|FG005|Overall Study|Reason Not Specified|3|||
156691656|NCT01207440|565618028|FG006|Overall Study|Reason Not Specified|0|||
156691657|NCT01592721|565618029|FG000|Long-term Follow-up|Death|1|||
156691658|NCT04718194|565618030|FG000|Overall Study|Withdrawal by Subject|3|||
156691659|NCT04718194|565618031|FG001|Overall Study|Withdrawal by Subject|0|||
156691660|NCT04718194|565618030|FG000|Overall Study|Lost to Follow-up|3|||
156691661|NCT04718194|565618031|FG001|Overall Study|Lost to Follow-up|0|||
156691662|NCT00821873|565618032|FG000|Overall Study|Lost to Follow-up|4|||
156691663|NCT02698865|565618033|FG000|Overall Study|Other|11|||
156330163|NCT00464269|564308794|FG000|Overall Study|Other reason|3|||
156330164|NCT00464269|564308795|FG001|Overall Study|Other reason|3|||
156330165|NCT00464269|564308796|FG002|Overall Study|Other reason|1|||
156691664|NCT02698865|565618034|FG001|Overall Study|Other|11|||
156691665|NCT02698865|565618033|FG000|Overall Study|Withdrawal by Subject|20|||
156870240|NCT04922216|566281145|FG016|Overall Study|Withdrawal by Subject|0|||
156330166|NCT00464269|564308797|FG003|Overall Study|Other reason|1|||
156691666|NCT02698865|565618034|FG001|Overall Study|Withdrawal by Subject|16|||
156691667|NCT02698865|565618033|FG000|Overall Study|Physician Decision|0|||
156691668|NCT02698865|565618034|FG001|Overall Study|Physician Decision|4|||
156691669|NCT02698865|565618033|FG000|Overall Study|Lost to Follow-up|4|||
156691670|NCT02698865|565618034|FG001|Overall Study|Lost to Follow-up|2|||
156691671|NCT03861481|565618036|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
156870241|NCT04922216|566281146|FG017|Overall Study|Withdrawal by Subject|1|||
156330167|NCT00464269|564308794|FG000|Overall Study|AE, serious fatal|0|||
156330168|NCT00464269|564308795|FG001|Overall Study|AE, serious fatal|0|||
156330169|NCT00464269|564308796|FG002|Overall Study|AE, serious fatal|1|||
156330170|NCT00464269|564308797|FG003|Overall Study|AE, serious fatal|1|||
156330171|NCT00464269|564308794|FG000|Overall Study|SAE, non-fatal|0|||
156330172|NCT00464269|564308795|FG001|Overall Study|SAE, non-fatal|0|||
156691672|NCT03861481|565618037|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
156330173|NCT00464269|564308796|FG002|Overall Study|SAE, non-fatal|0|||
156330174|NCT00464269|564308797|FG003|Overall Study|SAE, non-fatal|1|||
156330175|NCT00464269|564308794|FG000|Overall Study|AE, non-serious non-fatal|2|||
156691673|NCT03861481|565618036|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
156691674|NCT03861481|565618037|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
156691675|NCT03861481|565618036|FG000|Overall Study|Relapse|1|||
156691676|NCT03861481|565618037|FG001|Overall Study|Relapse|0|||
156691677|NCT03861481|565618036|FG000|Overall Study|Withdrawal by Subject|0|||
156691678|NCT03861481|565618037|FG001|Overall Study|Withdrawal by Subject|1|||
156691679|NCT03861481|565618036|FG000|Overall Study|Lack of Efficacy|4|||
156691680|NCT03861481|565618037|FG001|Overall Study|Lack of Efficacy|5|||
156691681|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
156691682|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
156691683|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
156691684|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
156691685|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
156788227|NCT05660538|565974900|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
156788228|NCT05660538|565974901|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
156788229|NCT05660538|565974902|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
156788230|NCT05737745|565974903|FG000|Overall Study|Withdrawal by Subject|0|||
156788231|NCT05737745|565974904|FG001|Overall Study|Withdrawal by Subject|6|||
156788232|NCT05737745|565974905|FG002|Overall Study|Withdrawal by Subject|1|||
156788233|NCT02218268|565974906|FG000|24 Hour Washout|Physician Decision|11|||
156788234|NCT02218268|565974907|FG001|24 Hour Washout|Physician Decision|9|||
156788235|NCT02569242|565974908|FG000|Overall Study|Death|1|||
156788236|NCT02569242|565974909|FG001|Overall Study|Death|0|||
156788237|NCT02569242|565974908|FG000|Overall Study|Withdrawal by Subject|0|||
156788238|NCT02569242|565974909|FG001|Overall Study|Withdrawal by Subject|1|||
156788239|NCT03651336|565974910|FG000|Overall Study|Withdrawal by Subject|4|||
156788240|NCT01125748|565974912|FG000|Overall Study|Adverse Event|0|||
156788241|NCT01125748|565974913|FG001|Overall Study|Adverse Event|2|||
156788242|NCT01125748|565974912|FG000|Overall Study|Lost to Follow-up|0|||
156788243|NCT01125748|565974913|FG001|Overall Study|Lost to Follow-up|1|||
156788244|NCT01125748|565974912|FG000|Overall Study|Physician Decision|8|||
156788245|NCT01125748|565974913|FG001|Overall Study|Physician Decision|7|||
156788246|NCT01125748|565974912|FG000|Overall Study|Patient Decision to Withdraw|2|||
156788247|NCT01125748|565974913|FG001|Overall Study|Patient Decision to Withdraw|4|||
156788248|NCT01028391|565974914|FG000|Overall Study|Adverse Event|4|||
156788249|NCT01028391|565974915|FG001|Overall Study|Adverse Event|0|||
156788250|NCT01028391|565974914|FG000|Overall Study|Lack of Efficacy|0|||
156788251|NCT01028391|565974915|FG001|Overall Study|Lack of Efficacy|2|||
156788252|NCT01028391|565974914|FG000|Overall Study|Lost to Follow-up|3|||
156788253|NCT01028391|565974915|FG001|Overall Study|Lost to Follow-up|4|||
156788254|NCT01028391|565974914|FG000|Overall Study|Physician Decision|0|||
156788255|NCT01028391|565974915|FG001|Overall Study|Physician Decision|1|||
156788256|NCT01028391|565974914|FG000|Overall Study|Withdrawal by Subject|6|||
156788257|NCT01028391|565974915|FG001|Overall Study|Withdrawal by Subject|3|||
156788258|NCT01028391|565974914|FG000|Overall Study|Needed excluded medication|1|||
156788259|NCT01028391|565974915|FG001|Overall Study|Needed excluded medication|1|||
156788260|NCT00837330|565974916|FG000|Overall Study|Lost to Follow-up|1|||
156788261|NCT00837330|565974917|FG001|Overall Study|Lost to Follow-up|3|||
156788262|NCT01227395|565974918|FG000|Overall Study|Protocol Violation|0|||
156788263|NCT01227395|565974919|FG001|Overall Study|Protocol Violation|1|||
156788264|NCT03259308|565974924|FG000|Overall Study|Adverse Event|5|||
156788265|NCT03259308|565974925|FG001|Overall Study|Adverse Event|4|||
156788266|NCT03259308|565974926|FG002|Overall Study|Adverse Event|1|||
156788267|NCT03259308|565974924|FG000|Overall Study|Withdrawal by Subject|2|||
156788268|NCT03259308|565974925|FG001|Overall Study|Withdrawal by Subject|1|||
156788269|NCT03259308|565974926|FG002|Overall Study|Withdrawal by Subject|3|||
156788270|NCT03259308|565974924|FG000|Overall Study|Lost to Follow-up|0|||
156788271|NCT03259308|565974925|FG001|Overall Study|Lost to Follow-up|0|||
156788272|NCT03259308|565974926|FG002|Overall Study|Lost to Follow-up|1|||
156788273|NCT03259308|565974924|FG000|Overall Study|Pregnancy|0|||
156788274|NCT03259308|565974925|FG001|Overall Study|Pregnancy|0|||
156330176|NCT00464269|564308795|FG001|Overall Study|AE, non-serious non-fatal|8|||
156530610|NCT04641299|565038088|FG000|Overall Study|Withdrawal by Subject|1|||
156691686|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
156691687|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
156691688|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
156788275|NCT03259308|565974926|FG002|Overall Study|Pregnancy|1|||
156788276|NCT03259308|565974924|FG000|Overall Study|Protocol Deviation|0|||
156788277|NCT03259308|565974925|FG001|Overall Study|Protocol Deviation|3|||
156788278|NCT03259308|565974926|FG002|Overall Study|Protocol Deviation|0|||
156788279|NCT03259308|565974924|FG000|Overall Study|Lack of Efficacy|0|||
156788280|NCT03259308|565974925|FG001|Overall Study|Lack of Efficacy|0|||
156691689|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
156691690|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
156691691|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
156691692|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
156691693|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
156691694|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
156691695|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
156691696|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
156691697|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
156691698|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
156691699|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
156691700|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691701|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691702|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691703|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691704|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691705|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
156691706|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
156691707|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
156691708|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
156691709|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
156691710|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
156691711|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
156691712|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
156691713|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
156691714|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
156691715|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
156691716|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
156691717|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
156691718|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
156691719|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
156691720|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
156691721|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
156691722|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
156691723|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
156691724|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
156691725|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
156691726|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
156691727|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
156691728|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
156691729|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
156691730|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
156691731|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
156691732|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
156691733|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
156530611|NCT04641299|565038089|FG001|Overall Study|Withdrawal by Subject|0|||
156691734|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
156691735|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
156691736|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
156691737|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
156691738|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
156691739|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
156691740|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
156691741|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
156691742|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
156691743|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
156691744|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
156691745|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
156691746|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
156788281|NCT03259308|565974926|FG002|Overall Study|Lack of Efficacy|1|||
156788282|NCT00300495|565974927|FG000|Overall Study|Protocol Violation|4|||
156788283|NCT00300495|565974928|FG001|Overall Study|Protocol Violation|1|||
156788284|NCT03004183|565977142|FG000|Overall Study|Adverse Event|7|||
156788285|NCT03004183|565977142|FG000|Overall Study|Lost to Follow-up|1|||
156788286|NCT03004183|565977142|FG000|Overall Study|Physician Decision|40|||
156788287|NCT03004183|565977142|FG000|Overall Study|Withdrawal by Subject|1|||
156691747|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
156691748|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
156691749|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
156691750|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
156691751|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
156691752|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
156691753|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
156691754|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
156691755|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
156691756|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
156691757|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
156691758|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
156691759|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
156691760|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
156691761|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
156691762|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
156691763|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
156691764|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
156691765|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
156691766|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
156691767|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
156691768|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
156691769|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
156691770|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
156691771|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
156691772|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
156691773|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
156691774|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
156691775|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
156691776|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
156691777|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
156691778|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
156691779|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
156691780|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
156691781|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
156691782|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
156691783|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Other|0|||
156691784|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Other|0|||
156691785|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Other|1|||
156691786|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Other|2|||
156691787|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Other|0|||
156691788|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Other|1|||
156691789|NCT00773734|565618038|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156691790|NCT00773734|565618039|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156691791|NCT00773734|565618040|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156691792|NCT00773734|565618041|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
156691793|NCT00773734|565618042|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156788288|NCT03004183|565977142|FG000|Overall Study|COVID-19|1|||
156788289|NCT03312114|565977145|FG000|Overall Study|All the five enrolled dropped out of the|5|||
156788290|NCT02469961|565977151|FG000|Overall Study|Physician Decision|4|||
156788291|NCT02469961|565977152|FG001|Overall Study|Physician Decision|1|||
156788292|NCT02123511|565977154|FG000|Overall Study|Cancelled treatment|1|||
156788293|NCT02123511|565977155|FG001|Overall Study|Cancelled treatment|0|||
156788294|NCT02123511|565977154|FG000|Overall Study|Incomplete data|1|||
156788295|NCT02123511|565977155|FG001|Overall Study|Incomplete data|3|||
156788296|NCT02123511|565977154|FG000|Overall Study|Ineligible|0|||
156788297|NCT02123511|565977155|FG001|Overall Study|Ineligible|1|||
156788298|NCT01423084|565977156|FG000|Overall Study|Adverse Event|0|||
156788299|NCT01423084|565977157|FG001|Overall Study|Adverse Event|1|||
156788300|NCT01423084|565977156|FG000|Overall Study|Withdrawal by Subject|2|||
156788301|NCT01423084|565977157|FG001|Overall Study|Withdrawal by Subject|3|||
156788302|NCT01133977|565977161|FG000|Overall Study|Adverse Event|0|||
156788303|NCT01133977|565977162|FG001|Overall Study|Adverse Event|0|||
156788304|NCT01133977|565977163|FG002|Overall Study|Adverse Event|1|||
156788305|NCT01133977|565977164|FG003|Overall Study|Adverse Event|0|||
156788306|NCT01133977|565977165|FG004|Overall Study|Adverse Event|0|||
156788307|NCT01133977|565977161|FG000|Overall Study|Death|1|||
156788308|NCT01133977|565977162|FG001|Overall Study|Death|1|||
156788309|NCT01133977|565977163|FG002|Overall Study|Death|1|||
156788310|NCT01133977|565977164|FG003|Overall Study|Death|7|||
156788311|NCT01133977|565977165|FG004|Overall Study|Death|3|||
156691794|NCT00773734|565618043|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156691795|NCT00773734|565618038|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
156691796|NCT00773734|565618039|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
156691797|NCT00773734|565618040|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
156691798|NCT00773734|565618041|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
156691799|NCT00773734|565618042|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
156691800|NCT00773734|565618043|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
156691801|NCT00773734|565618038|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
156691802|NCT00773734|565618039|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
156437044|NCT03401112|564689938|FG004|Overall Study|Physician Decision|0|||
156437045|NCT03401112|564689934|FG000|Overall Study|Study was Terminated by Sponsor|0|||
156437046|NCT03401112|564689935|FG001|Overall Study|Study was Terminated by Sponsor|0|||
156691803|NCT00773734|565618040|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
156691804|NCT00773734|565618041|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
156691805|NCT00773734|565618042|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
156691806|NCT00773734|565618043|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
156691807|NCT00773734|565618038|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
156691808|NCT00773734|565618039|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
156788312|NCT01133977|565977161|FG000|Overall Study|Started a New Line of Therapy|2|||
156788313|NCT01133977|565977162|FG001|Overall Study|Started a New Line of Therapy|6|||
156691809|NCT00773734|565618040|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
156788314|NCT01133977|565977163|FG002|Overall Study|Started a New Line of Therapy|4|||
156788315|NCT01133977|565977164|FG003|Overall Study|Started a New Line of Therapy|25|||
156788316|NCT01133977|565977165|FG004|Overall Study|Started a New Line of Therapy|33|||
156788317|NCT01133977|565977161|FG000|Overall Study|Lost to Follow-up|0|||
156788318|NCT01133977|565977162|FG001|Overall Study|Lost to Follow-up|0|||
156788319|NCT01133977|565977163|FG002|Overall Study|Lost to Follow-up|0|||
156788320|NCT01133977|565977164|FG003|Overall Study|Lost to Follow-up|2|||
156788321|NCT01133977|565977165|FG004|Overall Study|Lost to Follow-up|1|||
156788322|NCT01133977|565977161|FG000|Overall Study|Withdrawal by Subject|0|||
156788323|NCT01133977|565977162|FG001|Overall Study|Withdrawal by Subject|0|||
156788324|NCT01133977|565977163|FG002|Overall Study|Withdrawal by Subject|0|||
156788325|NCT01133977|565977164|FG003|Overall Study|Withdrawal by Subject|5|||
156788326|NCT01133977|565977165|FG004|Overall Study|Withdrawal by Subject|1|||
156788327|NCT02462057|565977166|FG000|Overall Study|Left Vitality|32|||
156788328|NCT02462057|565977167|FG001|Overall Study|Left Vitality|27|||
156788329|NCT02462057|565977168|FG002|Overall Study|Left Vitality|23|||
156788330|NCT02462057|565977169|FG003|Overall Study|Left Vitality|35|||
156788331|NCT02462057|565977170|FG004|Overall Study|Left Vitality|33|||
156788332|NCT02462057|565977166|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
156788333|NCT02462057|565977167|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
156788334|NCT02462057|565977168|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
156788335|NCT02462057|565977169|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
156788336|NCT02462057|565977170|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
156788337|NCT01908699|565977177|FG000|Overall Study|Adverse Event|8|||
156788338|NCT01908699|565977178|FG001|Overall Study|Adverse Event|12|||
156788339|NCT01908699|565977177|FG000|Overall Study|Lack of Efficacy|2|||
156788340|NCT01908699|565977178|FG001|Overall Study|Lack of Efficacy|2|||
156788341|NCT01908699|565977177|FG000|Overall Study|Lost to Follow-up|2|||
156788342|NCT01908699|565977178|FG001|Overall Study|Lost to Follow-up|4|||
156788343|NCT01908699|565977177|FG000|Overall Study|Physician Decision|8|||
156788344|NCT01908699|565977178|FG001|Overall Study|Physician Decision|8|||
156788345|NCT01908699|565977177|FG000|Overall Study|Withdrawal by Subject|15|||
156788346|NCT01908699|565977178|FG001|Overall Study|Withdrawal by Subject|10|||
156788347|NCT01908699|565977177|FG000|Overall Study|Pregnancy|0|||
156788348|NCT01908699|565977178|FG001|Overall Study|Pregnancy|1|||
156788349|NCT01908699|565977177|FG000|Overall Study|Randomized in Error|1|||
156788350|NCT01908699|565977178|FG001|Overall Study|Randomized in Error|0|||
156788351|NCT01908699|565977177|FG000|Overall Study|Death|9|||
156691810|NCT00773734|565618041|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
156691811|NCT00773734|565618042|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
156691812|NCT00773734|565618043|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
156788352|NCT01908699|565977178|FG001|Overall Study|Death|12|||
156788353|NCT01908699|565977177|FG000|Overall Study|Progressive Disease|30|||
156788354|NCT01908699|565977178|FG001|Overall Study|Progressive Disease|29|||
156788355|NCT02105012|565977179|FG000|Overall Study|Withdrawal by Subject|11|||
156788356|NCT02105012|565977179|FG000|Overall Study|Protocol Specified Criteria|9|||
156788357|NCT02105012|565977179|FG000|Overall Study|Lost to Follow-up|4|||
156788358|NCT02105012|565977179|FG000|Overall Study|Protocol Violation|4|||
156437047|NCT03401112|564689936|FG002|Overall Study|Study was Terminated by Sponsor|0|||
156788359|NCT02105012|565977179|FG000|Overall Study|Physician Decision|3|||
156788360|NCT02105012|565977179|FG000|Overall Study|Adverse Event|1|||
156788361|NCT02105012|565977179|FG000|Overall Study|Lack of Efficacy|1|||
156788362|NCT00493285|565977180|FG000|Overall Study|Lost to Follow-up|0|||
156788363|NCT00493285|565977181|FG001|Overall Study|Lost to Follow-up|0|||
156691813|NCT01220297|565618047|FG000|Overall Study|Death|2|||
156691814|NCT01220297|565618047|FG000|Overall Study|Lost to Follow-up|1|||
156691815|NCT02119286|565618049|FG000|Overall Study|Adverse Event|9|||
156691816|NCT02119286|565618050|FG001|Overall Study|Adverse Event|7|||
156691817|NCT02119286|565618051|FG002|Overall Study|Adverse Event|2|||
156691818|NCT02119286|565618049|FG000|Overall Study|Lack of Efficacy|11|||
156691819|NCT02119286|565618050|FG001|Overall Study|Lack of Efficacy|3|||
156691820|NCT02119286|565618051|FG002|Overall Study|Lack of Efficacy|4|||
156691821|NCT02119286|565618049|FG000|Overall Study|Lost to Follow-up|2|||
156691822|NCT02119286|565618050|FG001|Overall Study|Lost to Follow-up|0|||
156691823|NCT02119286|565618051|FG002|Overall Study|Lost to Follow-up|1|||
156691824|NCT02119286|565618049|FG000|Overall Study|Withdrawal by Subject|4|||
156691825|NCT02119286|565618050|FG001|Overall Study|Withdrawal by Subject|1|||
156691826|NCT02119286|565618051|FG002|Overall Study|Withdrawal by Subject|0|||
156691827|NCT04109313|565618052|FG000|Overall Study|Pregnancy|1|||
156691828|NCT04109313|565618052|FG000|Overall Study|Adverse Event|11|||
156691829|NCT04109313|565618052|FG000|Overall Study|Lack of Efficacy|11|||
156691830|NCT04109313|565618052|FG000|Overall Study|Lost to Follow-up|1|||
156691831|NCT04109313|565618052|FG000|Overall Study|Physician Decision|2|||
156691832|NCT04109313|565618052|FG000|Overall Study|Subject Decision|13|||
156691833|NCT04109313|565618052|FG000|Overall Study|Covid-19 situation|2|||
156691834|NCT01272921|565618053|FG000|Overall Study|Protocol Violation|2|||
156691835|NCT01272921|565618054|FG001|Overall Study|Protocol Violation|1|||
156691836|NCT01132664|565618055|FG000|Phase lb|Adverse Event|0|||
156691837|NCT01132664|565618056|FG001|Phase lb|Adverse Event|1|||
156691838|NCT01132664|565618057|FG002|Phase lb|Adverse Event|0|||
156691839|NCT01132664|565618058|FG003|Phase lb|Adverse Event|0|||
156691840|NCT01132664|565618059|FG004|Phase lb|Adverse Event|0|||
156691841|NCT01132664|565618055|FG000|Phase lb|Withdrawal by Subject|1|||
156691842|NCT01132664|565618056|FG001|Phase lb|Withdrawal by Subject|2|||
156691843|NCT01132664|565618057|FG002|Phase lb|Withdrawal by Subject|0|||
156691844|NCT01132664|565618058|FG003|Phase lb|Withdrawal by Subject|0|||
156691845|NCT01132664|565618059|FG004|Phase lb|Withdrawal by Subject|0|||
156691846|NCT01132664|565618055|FG000|Phase lb|Disease Progression|4|||
156691847|NCT01132664|565618056|FG001|Phase lb|Disease Progression|9|||
156691848|NCT01132664|565618057|FG002|Phase lb|Disease Progression|0|||
156691849|NCT01132664|565618058|FG003|Phase lb|Disease Progression|0|||
156691850|NCT01132664|565618059|FG004|Phase lb|Disease Progression|0|||
156691851|NCT01132664|565618055|FG000|Phase ll|Death|0|||
156691852|NCT01132664|565618056|FG001|Phase ll|Death|0|||
156691853|NCT01132664|565618057|FG002|Phase ll|Death|2|||
156691854|NCT01132664|565618058|FG003|Phase ll|Death|0|||
156691855|NCT01132664|565618059|FG004|Phase ll|Death|0|||
156691856|NCT01132664|565618055|FG000|Phase ll|Adverse Event|0|||
156691857|NCT01132664|565618056|FG001|Phase ll|Adverse Event|0|||
156691858|NCT01132664|565618057|FG002|Phase ll|Adverse Event|10|||
156691859|NCT01132664|565618058|FG003|Phase ll|Adverse Event|0|||
156691860|NCT01132664|565618059|FG004|Phase ll|Adverse Event|0|||
156691861|NCT01132664|565618055|FG000|Phase ll|Withdrawal by Subject|0|||
156691862|NCT01132664|565618056|FG001|Phase ll|Withdrawal by Subject|0|||
156691863|NCT01132664|565618057|FG002|Phase ll|Withdrawal by Subject|3|||
156691864|NCT01132664|565618058|FG003|Phase ll|Withdrawal by Subject|0|||
156691865|NCT01132664|565618059|FG004|Phase ll|Withdrawal by Subject|0|||
156691866|NCT01132664|565618055|FG000|Phase ll|Disease progression|0|||
156691867|NCT01132664|565618056|FG001|Phase ll|Disease progression|0|||
156691868|NCT01132664|565618057|FG002|Phase ll|Disease progression|35|||
156691869|NCT01132664|565618058|FG003|Phase ll|Disease progression|0|||
156691870|NCT01132664|565618059|FG004|Phase ll|Disease progression|0|||
156691871|NCT01132664|565618055|FG000|BM Cohort|Disease progression|0|||
156691872|NCT01132664|565618056|FG001|BM Cohort|Disease progression|0|||
156691873|NCT01132664|565618057|FG002|BM Cohort|Disease progression|0|||
156691874|NCT01132664|565618058|FG003|BM Cohort|Disease progression|3|||
156691875|NCT01132664|565618059|FG004|BM Cohort|Disease progression|4|||
156691876|NCT01132664|565618055|FG000|BM Cohort|Adverse Event|0|||
156691877|NCT01132664|565618056|FG001|BM Cohort|Adverse Event|0|||
156691878|NCT01132664|565618057|FG002|BM Cohort|Adverse Event|0|||
156691879|NCT01132664|565618058|FG003|BM Cohort|Adverse Event|0|||
156691880|NCT01132664|565618059|FG004|BM Cohort|Adverse Event|1|||
156691881|NCT01132664|565618055|FG000|BM Cohort|Withdrawal by Subject|0|||
156691882|NCT01132664|565618056|FG001|BM Cohort|Withdrawal by Subject|0|||
156691883|NCT01132664|565618057|FG002|BM Cohort|Withdrawal by Subject|0|||
156691884|NCT01132664|565618058|FG003|BM Cohort|Withdrawal by Subject|0|||
156691885|NCT01132664|565618059|FG004|BM Cohort|Withdrawal by Subject|1|||
156691886|NCT01996332|565618061|FG000|Overall Study|Adverse Event|117|||
156691887|NCT01996332|565618061|FG000|Overall Study|Lack of Efficacy|1245|||
156691888|NCT01996332|565618061|FG000|Overall Study|Death|264|||
156691889|NCT01996332|565618061|FG000|Overall Study|Protocol Violation|9|||
156691890|NCT01996332|565618061|FG000|Overall Study|Withdrawal by Subject|71|||
156691891|NCT01996332|565618061|FG000|Overall Study|Other|20|||
156691892|NCT01996332|565618061|FG000|Overall Study|Clinical Deterioration|28|||
156691893|NCT01996332|565618061|FG000|Overall Study|Physician Decision|17|||
156691894|NCT01996332|565618061|FG000|Overall Study|Lost to Follow-up|34|||
156691895|NCT02113189|565618062|FG000|Overall Study|Lost to follow up|2|||
156691896|NCT02113189|565618063|FG001|Overall Study|Lost to follow up|1|||
156691897|NCT02113189|565618064|FG002|Overall Study|Lost to follow up|3|||
156691898|NCT02954159|565618065|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
156691899|NCT02954159|565618066|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
156691900|NCT02954159|565618065|FG000|Overall Study|Withdrawal by Subject|0|||
156691901|NCT02954159|565618066|FG001|Overall Study|Withdrawal by Subject|1|||
156691902|NCT01744093|565618067|FG000|Overall Study|Withdrawal by Subject|6|||
156691903|NCT01744093|565618068|FG001|Overall Study|Withdrawal by Subject|1|||
156691904|NCT02006628|565618069|FG000|Overall Study|Adverse Event|1|||
156691905|NCT02006628|565618070|FG001|Overall Study|Adverse Event|1|||
156691906|NCT02006628|565618069|FG000|Overall Study|Withdrawal by Subject|2|||
156691907|NCT02006628|565618070|FG001|Overall Study|Withdrawal by Subject|1|||
156691908|NCT00262041|565618071|FG000|Overall Study|Withdrawal by Subject|0|||
156691909|NCT00262041|565618072|FG001|Overall Study|Withdrawal by Subject|3|||
156691910|NCT00262041|565618073|FG002|Overall Study|Withdrawal by Subject|1|||
156691911|NCT00262041|565618071|FG000|Overall Study|Lost to Follow-up|1|||
156691912|NCT00262041|565618072|FG001|Overall Study|Lost to Follow-up|1|||
156691913|NCT00262041|565618073|FG002|Overall Study|Lost to Follow-up|5|||
156691914|NCT00262041|565618071|FG000|Overall Study|Unable to classify|1|||
156691915|NCT00262041|565618072|FG001|Overall Study|Unable to classify|0|||
156691916|NCT00262041|565618073|FG002|Overall Study|Unable to classify|0|||
156691917|NCT03578237|565618076|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
156691918|NCT03578237|565618077|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
156691919|NCT04132336|565618078|FG000|Overall Study|Investigator Decision|0|||
156691920|NCT04132336|565618079|FG001|Overall Study|Investigator Decision|1|||
156691921|NCT04132336|565618080|FG002|Overall Study|Investigator Decision|0|||
156691922|NCT04132336|565618081|FG003|Overall Study|Investigator Decision|0|||
156691923|NCT04132336|565618082|FG004|Overall Study|Investigator Decision|0|||
156691924|NCT04132336|565618083|FG005|Overall Study|Investigator Decision|0|||
156691925|NCT04132336|565618084|FG006|Overall Study|Investigator Decision|0|||
156691926|NCT02488330|565618085|FG000|Overall Study|Adverse Event|1|||
156691927|NCT02488330|565618085|FG000|Overall Study|Physician Decision|2|||
156691928|NCT02488330|565618085|FG000|Overall Study|Death|2|||
156691929|NCT02488330|565618085|FG000|Overall Study|Disease Progression|3|||
156691930|NCT02488330|565618085|FG000|Overall Study|Study Termination by Sponsor|4|||
156691931|NCT02384941|565618090|FG000|Overall Study|Adverse Event|11|||
156691932|NCT02384941|565618091|FG001|Overall Study|Adverse Event|13|||
156691933|NCT02384941|565618092|FG002|Overall Study|Adverse Event|17|||
156691934|NCT02384941|565618090|FG000|Overall Study|Lost to Follow-up|3|||
156691935|NCT02384941|565618091|FG001|Overall Study|Lost to Follow-up|2|||
156691936|NCT02384941|565618092|FG002|Overall Study|Lost to Follow-up|1|||
156691937|NCT02384941|565618090|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156691938|NCT02384941|565618091|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156691939|NCT02384941|565618092|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156691940|NCT02384941|565618090|FG000|Overall Study|Physician Decision|1|||
156691941|NCT02384941|565618091|FG001|Overall Study|Physician Decision|1|||
156691942|NCT02384941|565618092|FG002|Overall Study|Physician Decision|0|||
156691943|NCT02384941|565618090|FG000|Overall Study|Protocol Violation|3|||
156691944|NCT02384941|565618091|FG001|Overall Study|Protocol Violation|0|||
156691945|NCT02384941|565618092|FG002|Overall Study|Protocol Violation|0|||
156691946|NCT02384941|565618090|FG000|Overall Study|Withdrawal by Subject|26|||
156691947|NCT02384941|565618091|FG001|Overall Study|Withdrawal by Subject|19|||
156691948|NCT02384941|565618092|FG002|Overall Study|Withdrawal by Subject|20|||
156788364|NCT00493285|565977182|FG002|Overall Study|Lost to Follow-up|0|||
156788365|NCT00493285|565977183|FG003|Overall Study|Lost to Follow-up|0|||
156788366|NCT00493285|565977184|FG004|Overall Study|Lost to Follow-up|1|||
156788367|NCT00493285|565977185|FG005|Overall Study|Lost to Follow-up|0|||
156788368|NCT05345405|565977187|FG000|Overall Study|Withdrawal by Subject|2|||
156788369|NCT05345405|565977188|FG001|Overall Study|Withdrawal by Subject|0|||
156788370|NCT05345405|565977189|FG002|Overall Study|Withdrawal by Subject|0|||
156691949|NCT02384941|565618090|FG000|Overall Study|Pregnancy|0|||
156691950|NCT02384941|565618091|FG001|Overall Study|Pregnancy|0|||
156691951|NCT02384941|565618092|FG002|Overall Study|Pregnancy|1|||
156691952|NCT02384941|565618090|FG000|Overall Study|Other than specified above|4|||
156691953|NCT02384941|565618091|FG001|Overall Study|Other than specified above|0|||
156691954|NCT02384941|565618092|FG002|Overall Study|Other than specified above|1|||
156788371|NCT05345405|565977187|FG000|Overall Study|Did not meet eligibility criteria|0|||
156788372|NCT05345405|565977188|FG001|Overall Study|Did not meet eligibility criteria|2|||
156788373|NCT05345405|565977189|FG002|Overall Study|Did not meet eligibility criteria|0|||
156691955|NCT02493777|565618093|FG000|Overall Study|Lost to Follow-up|0|||
156691956|NCT02493777|565618094|FG001|Overall Study|Lost to Follow-up|1|||
156691957|NCT00468728|565618095|FG000|Treatment|criteria for mITT population|4|||
156691958|NCT00468728|565618096|FG001|Treatment|criteria for mITT population|11|||
156691959|NCT00468728|565618095|FG000|Follow-up|mITT failure|34|||
156691960|NCT00468728|565618096|FG001|Follow-up|mITT failure|31|||
156788374|NCT05345405|565977187|FG000|Overall Study|Lost to Follow-up|0|||
156691961|NCT01642914|565618097|FG000|Overall Study|Adverse Event|11|||
156691962|NCT01642914|565618098|FG001|Overall Study|Adverse Event|7|||
156691963|NCT01642914|565618099|FG002|Overall Study|Adverse Event|15|||
156691964|NCT01642914|565618097|FG000|Overall Study|Lack of Efficacy|9|||
156691965|NCT01642914|565618098|FG001|Overall Study|Lack of Efficacy|4|||
156691966|NCT01642914|565618099|FG002|Overall Study|Lack of Efficacy|2|||
156691967|NCT01642914|565618097|FG000|Overall Study|Protocol Violation|15|||
156691968|NCT01642914|565618098|FG001|Overall Study|Protocol Violation|13|||
156691969|NCT01642914|565618099|FG002|Overall Study|Protocol Violation|6|||
156691970|NCT01642914|565618097|FG000|Overall Study|Withdrawal by Subject|5|||
156691971|NCT01642914|565618098|FG001|Overall Study|Withdrawal by Subject|5|||
156691972|NCT01642914|565618099|FG002|Overall Study|Withdrawal by Subject|10|||
156691973|NCT01642914|565618097|FG000|Overall Study|Lost to Follow-up|5|||
156691974|NCT01642914|565618098|FG001|Overall Study|Lost to Follow-up|3|||
156691975|NCT01642914|565618099|FG002|Overall Study|Lost to Follow-up|7|||
156691976|NCT01642914|565618097|FG000|Overall Study|Other Reason|1|||
156691977|NCT01642914|565618098|FG001|Overall Study|Other Reason|0|||
156691978|NCT01642914|565618099|FG002|Overall Study|Other Reason|0|||
156691979|NCT01705236|565618100|FG000|Overall Study|Lost to Follow-up|1|||
156691980|NCT01705236|565618100|FG000|Overall Study|Administrative problems|2|||
156691981|NCT01705236|565618100|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156691982|NCT01705236|565618100|FG000|Overall Study|Protocol Violation|3|||
156691983|NCT01705236|565618100|FG000|Overall Study|Abnormal test procedure result(s)|4|||
156691984|NCT01705236|565618100|FG000|Overall Study|Abnormal laboratory value(s)|4|||
156691985|NCT01705236|565618100|FG000|Overall Study|Withdrawal by Subject|5|||
156691986|NCT01705236|565618100|FG000|Overall Study|Adverse Event|5|||
156691987|NCT03028740|565618101|FG000|Overall Study|Did not Receive Study Drug|4|||
156691988|NCT03028740|565618102|FG001|Overall Study|Did not Receive Study Drug|5|||
156691989|NCT03028740|565618101|FG000|Overall Study|Adverse Event|8|||
156691990|NCT03028740|565618102|FG001|Overall Study|Adverse Event|26|||
156691991|NCT03028740|565618101|FG000|Overall Study|Lack of Efficacy|0|||
156691992|NCT03028740|565618102|FG001|Overall Study|Lack of Efficacy|1|||
156691993|NCT03028740|565618101|FG000|Overall Study|Withdrawal by Subject|48|||
156691994|NCT03028740|565618102|FG001|Overall Study|Withdrawal by Subject|101|||
156691995|NCT03028740|565618101|FG000|Overall Study|Lost to Follow-up|30|||
156691996|NCT03028740|565618102|FG001|Overall Study|Lost to Follow-up|54|||
156691997|NCT03028740|565618101|FG000|Overall Study|Physician Decision|4|||
156691998|NCT03028740|565618102|FG001|Overall Study|Physician Decision|11|||
156691999|NCT03028740|565618101|FG000|Overall Study|Protocol Violation|4|||
156692000|NCT03028740|565618102|FG001|Overall Study|Protocol Violation|8|||
156692001|NCT03028740|565618101|FG000|Overall Study|Non-compliance with Study Drug|0|||
156692002|NCT03028740|565618102|FG001|Overall Study|Non-compliance with Study Drug|2|||
156692003|NCT03028740|565618101|FG000|Overall Study|Study Terminated by Sponsor|467|||
156692004|NCT03028740|565618102|FG001|Overall Study|Study Terminated by Sponsor|917|||
156692005|NCT03028740|565618101|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
156692006|NCT03028740|565618102|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
156692007|NCT03028740|565618101|FG000|Overall Study|Reason not Specified|1|||
156692008|NCT03028740|565618102|FG001|Overall Study|Reason not Specified|5|||
156692009|NCT06005597|565618103|FG000|Overall Study|Lost to Follow-up|1|||
156692010|NCT06005597|565618104|FG001|Overall Study|Lost to Follow-up|2|||
156692011|NCT06005597|565618105|FG002|Overall Study|Lost to Follow-up|1|||
156692012|NCT06005597|565618106|FG003|Overall Study|Lost to Follow-up|2|||
156692013|NCT06005597|565618103|FG000|Overall Study|Death|1|||
156788375|NCT05345405|565977188|FG001|Overall Study|Lost to Follow-up|0|||
156788376|NCT05345405|565977189|FG002|Overall Study|Lost to Follow-up|1|||
156788377|NCT01750281|565977190|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
156788378|NCT01750281|565977191|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
156788379|NCT01750281|565977192|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
156788380|NCT01750281|565977190|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
156788381|NCT01750281|565977191|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
156788382|NCT01750281|565977192|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
156788383|NCT01750281|565977190|FG000|Overall Study|Did not receive treatment|0|||
156692014|NCT06005597|565618104|FG001|Overall Study|Death|1|||
156788384|NCT01750281|565977191|FG001|Overall Study|Did not receive treatment|1|||
156692015|NCT06005597|565618105|FG002|Overall Study|Death|1|||
156692016|NCT06005597|565618106|FG003|Overall Study|Death|0|||
156692017|NCT04572243|565618108|FG000|Core Study: 14 Weeks|Adverse Event|1|||
156788385|NCT01750281|565977192|FG002|Overall Study|Did not receive treatment|0|||
156788386|NCT04189588|565977193|FG000|Overall Study|Death|0|||
156692018|NCT04572243|565618109|FG001|Core Study: 14 Weeks|Adverse Event|2|||
156692019|NCT04572243|565618110|FG002|Core Study: 14 Weeks|Adverse Event|0|||
156692020|NCT04572243|565618111|FG003|Core Study: 14 Weeks|Adverse Event|0|||
156692021|NCT04572243|565618108|FG000|Core Study: 14 Weeks|Subject choice|0|||
156692022|NCT04572243|565618109|FG001|Core Study: 14 Weeks|Subject choice|2|||
156692023|NCT04572243|565618110|FG002|Core Study: 14 Weeks|Subject choice|0|||
156692024|NCT04572243|565618111|FG003|Core Study: 14 Weeks|Subject choice|0|||
156788387|NCT04189588|565977194|FG001|Overall Study|Death|1|||
156692025|NCT04572243|565618108|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
156692026|NCT04572243|565618109|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
156692027|NCT04572243|565618110|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
156692028|NCT04572243|565618111|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
156692029|NCT04572243|565618108|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
156692030|NCT04572243|565618109|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
156692031|NCT04572243|565618110|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
156692032|NCT04572243|565618111|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
156692033|NCT01661881|565618112|FG000|Overall Study|Disease Progression|1|||
156692034|NCT01231373|565618113|FG000|Overall Study|Withdrew consent prior to randomization|2|||
156692035|NCT01231373|565618114|FG001|Overall Study|Withdrew consent prior to randomization|1|||
156692036|NCT01231373|565618115|FG002|Overall Study|Withdrew consent prior to randomization|0|||
156692037|NCT01231373|565618116|FG003|Overall Study|Withdrew consent prior to randomization|0|||
156692038|NCT01231373|565618113|FG000|Overall Study|Lost to Follow-up|0|||
156692039|NCT01231373|565618114|FG001|Overall Study|Lost to Follow-up|0|||
156692040|NCT01231373|565618115|FG002|Overall Study|Lost to Follow-up|0|||
156692041|NCT01231373|565618116|FG003|Overall Study|Lost to Follow-up|1|||
156692042|NCT01231373|565618113|FG000|Overall Study|Withdrew Consent|1|||
156692043|NCT01231373|565618114|FG001|Overall Study|Withdrew Consent|0|||
156692044|NCT01231373|565618115|FG002|Overall Study|Withdrew Consent|0|||
156692045|NCT01231373|565618116|FG003|Overall Study|Withdrew Consent|0|||
156692046|NCT01790113|565618117|FG000|Overall Study|Adverse Event|2|||
156692047|NCT01790113|565618118|FG001|Overall Study|Adverse Event|7|||
156692048|NCT01790113|565618117|FG000|Overall Study|Study ended due to FDA clearance|1|||
156692049|NCT01790113|565618118|FG001|Overall Study|Study ended due to FDA clearance|68|||
156692050|NCT03451006|565618119|FG000|Overall Study|Withdrawal by Subject|2|||
156692051|NCT03451006|565618120|FG001|Overall Study|Withdrawal by Subject|2|||
156692052|NCT00775606|565618125|FG000|Overall Study|Study sponsor terminated funding|3|||
156530612|NCT04641299|565038090|FG002|Overall Study|Withdrawal by Subject|0|||
156530613|NCT04641299|565038091|FG003|Overall Study|Withdrawal by Subject|0|||
156530614|NCT04641299|565038088|FG000|Overall Study|Reason not given|1|||
156530615|NCT04641299|565038089|FG001|Overall Study|Reason not given|0|||
156692053|NCT00775606|565618126|FG001|Overall Study|Study sponsor terminated funding|0|||
156530616|NCT04641299|565038090|FG002|Overall Study|Reason not given|0|||
156530617|NCT04641299|565038091|FG003|Overall Study|Reason not given|0|||
156692054|NCT02278718|565618127|FG000|Overall Study|Adverse Event|1|||
156692055|NCT02278718|565618128|FG001|Overall Study|Adverse Event|0|||
156692056|NCT02278718|565618127|FG000|Overall Study|Lost to Follow-up|2|||
156692057|NCT02278718|565618128|FG001|Overall Study|Lost to Follow-up|4|||
156692058|NCT02278718|565618127|FG000|Overall Study|Withdrawal by Subject|1|||
156692059|NCT02278718|565618128|FG001|Overall Study|Withdrawal by Subject|4|||
156692060|NCT02278718|565618127|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
156692061|NCT02278718|565618128|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
156692062|NCT02278718|565618127|FG000|Overall Study|Missing|0|||
156692063|NCT02278718|565618128|FG001|Overall Study|Missing|1|||
156692064|NCT03212794|565618129|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
156692065|NCT03212794|565618130|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
156692066|NCT03212794|565618129|FG000|Overall Study|Lost to Follow-up|5|||
156692067|NCT03212794|565618130|FG001|Overall Study|Lost to Follow-up|6|||
156692068|NCT03212794|565618129|FG000|Overall Study|Incarcerated; unable to participate|2|||
156692069|NCT03212794|565618130|FG001|Overall Study|Incarcerated; unable to participate|0|||
156692070|NCT03212794|565618129|FG000|Overall Study|Withdrawal by Subject|1|||
156692071|NCT03212794|565618130|FG001|Overall Study|Withdrawal by Subject|0|||
156692072|NCT03212794|565618129|FG000|Overall Study|Death|0|||
156692073|NCT03212794|565618130|FG001|Overall Study|Death|1|||
156692074|NCT03212794|565618129|FG000|Overall Study|Found to be ineligible after allocation|0|||
156788388|NCT04189588|565977193|FG000|Overall Study|Lost to Follow-up|0|||
156788389|NCT04189588|565977194|FG001|Overall Study|Lost to Follow-up|1|||
156788390|NCT01658735|565977204|FG000|Overall Study|Lack of Efficacy|1|||
156788391|NCT01658735|565977205|FG001|Overall Study|Lack of Efficacy|0|||
156788392|NCT01658735|565977206|FG002|Overall Study|Lack of Efficacy|1|||
156788393|NCT01658735|565977204|FG000|Overall Study|Lost to Follow-up|1|||
156788394|NCT01658735|565977205|FG001|Overall Study|Lost to Follow-up|1|||
156788395|NCT01658735|565977206|FG002|Overall Study|Lost to Follow-up|0|||
156788396|NCT01658735|565977204|FG000|Overall Study|Protocol Violation|0|||
156788397|NCT01658735|565977205|FG001|Overall Study|Protocol Violation|1|||
156788398|NCT01658735|565977206|FG002|Overall Study|Protocol Violation|0|||
156788399|NCT01658735|565977204|FG000|Overall Study|Withdrawal by Subject|3|||
156788400|NCT01658735|565977205|FG001|Overall Study|Withdrawal by Subject|5|||
156788401|NCT01658735|565977206|FG002|Overall Study|Withdrawal by Subject|3|||
156788402|NCT03302936|565977207|FG000|Overall Study|Protocol Violation|3|||
156788403|NCT03302936|565977208|FG001|Overall Study|Protocol Violation|4|||
156788404|NCT01379937|565977209|FG000|Overall Study|Protocol Violation|0|||
156788405|NCT01379937|565977210|FG001|Overall Study|Protocol Violation|0|||
156788406|NCT01379937|565977211|FG002|Overall Study|Protocol Violation|0|||
156870242|NCT04922216|566281147|FG018|Overall Study|Withdrawal by Subject|1|||
156870243|NCT04922216|566281148|FG019|Overall Study|Withdrawal by Subject|1|||
156870244|NCT04922216|566281149|FG020|Overall Study|Withdrawal by Subject|1|||
156870245|NCT04922216|566281150|FG021|Overall Study|Withdrawal by Subject|0|||
156870246|NCT04922216|566281151|FG022|Overall Study|Withdrawal by Subject|0|||
156870247|NCT04922216|566281152|FG023|Overall Study|Withdrawal by Subject|2|||
156870248|NCT04922216|566281153|FG024|Overall Study|Withdrawal by Subject|0|||
156870249|NCT04922216|566281154|FG025|Overall Study|Withdrawal by Subject|0|||
156870250|NCT04922216|566281155|FG026|Overall Study|Withdrawal by Subject|1|||
156870251|NCT04922216|566281156|FG027|Overall Study|Withdrawal by Subject|0|||
156870252|NCT04922216|566281157|FG028|Overall Study|Withdrawal by Subject|0|||
156330177|NCT00464269|564308796|FG002|Overall Study|AE, non-serious non-fatal|3|||
156330178|NCT00464269|564308797|FG003|Overall Study|AE, non-serious non-fatal|4|||
156692075|NCT03212794|565618130|FG001|Overall Study|Found to be ineligible after allocation|1|||
156692076|NCT03212794|565618129|FG000|Overall Study|Relocated out of area|2|||
156692077|NCT03212794|565618130|FG001|Overall Study|Relocated out of area|0|||
156692078|NCT02547766|565618131|FG000|Overall Study|Withdrawal by Subject|1|||
156692079|NCT03253744|565618138|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
156692080|NCT03253744|565618139|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
156692081|NCT03253744|565618140|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
156692082|NCT03253744|565618141|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
156692083|NCT03847194|565618142|FG000|Overall Study|Lost to Follow-up|2|||
156692084|NCT03847194|565618143|FG001|Overall Study|Lost to Follow-up|5|||
156692085|NCT03847194|565618142|FG000|Overall Study|Withdrawal by Subject|1|||
156692086|NCT03847194|565618143|FG001|Overall Study|Withdrawal by Subject|2|||
156692087|NCT03847194|565618142|FG000|Overall Study|Death|0|||
156692088|NCT03847194|565618143|FG001|Overall Study|Death|1|||
156692089|NCT01010750|565618145|FG000|Second Intervention|Adverse Event|0|||
156692090|NCT01010750|565618146|FG001|Second Intervention|Adverse Event|1|||
156692091|NCT01010750|565618147|FG002|Second Intervention|Adverse Event|0|||
156692092|NCT01010750|565618148|FG003|Second Intervention|Adverse Event|0|||
156692093|NCT01010750|565618149|FG004|Second Intervention|Adverse Event|0|||
156692094|NCT01010750|565618150|FG005|Second Intervention|Adverse Event|0|||
156692095|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
156692096|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
156692097|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
156692098|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
156692099|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
156692100|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
156692101|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
156692102|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
156692103|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
156692104|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
156692105|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
156692106|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
156692107|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
156692108|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
156692109|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
156692110|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
156692111|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
156692112|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
156692113|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
156692114|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
156692115|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
156692116|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
156692117|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
156692118|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
156692119|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
156692120|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
156692121|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
156692122|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
156692123|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
156692124|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
156330179|NCT00464269|564308794|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156330180|NCT00464269|564308795|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156692125|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
156692126|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
156692127|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
156692128|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
156692129|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
156870253|NCT04922216|566281158|FG029|Overall Study|Withdrawal by Subject|0|||
156870254|NCT04922216|566281159|FG030|Overall Study|Withdrawal by Subject|1|||
156330181|NCT00464269|564308796|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
156330182|NCT00464269|564308797|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156330183|NCT05055128|564308798|FG000|Overall Study|Adverse Event|0|||
156330184|NCT05055128|564308799|FG001|Overall Study|Adverse Event|0|||
156330185|NCT05055128|564308800|FG002|Overall Study|Adverse Event|0|||
156330186|NCT05055128|564308801|FG003|Overall Study|Adverse Event|1|||
156692130|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
156692131|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
156692132|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
156692133|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
156692134|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
156692135|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
156692136|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
156692137|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
156692138|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
156692139|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
156692140|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
156692141|NCT02510014|565618158|FG000|Treatment Period|Adverse Event|11|||
156692142|NCT02510014|565618159|FG001|Treatment Period|Adverse Event|4|||
156692143|NCT02510014|565618158|FG000|Treatment Period|Withdrawal symptoms|3|||
156692144|NCT02510014|565618159|FG001|Treatment Period|Withdrawal symptoms|0|||
156692145|NCT02510014|565618158|FG000|Treatment Period|Lost to Follow-up|80|||
156692146|NCT02510014|565618159|FG001|Treatment Period|Lost to Follow-up|19|||
156692147|NCT02510014|565618158|FG000|Treatment Period|Physician Decision|5|||
156692148|NCT02510014|565618159|FG001|Treatment Period|Physician Decision|0|||
156692149|NCT02510014|565618158|FG000|Treatment Period|Withdrawal by Subject|67|||
156692150|NCT02510014|565618159|FG001|Treatment Period|Withdrawal by Subject|24|||
156692151|NCT02510014|565618158|FG000|Treatment Period|Withdrawn by the investigator|7|||
156692152|NCT02510014|565618159|FG001|Treatment Period|Withdrawn by the investigator|1|||
156692153|NCT02510014|565618158|FG000|Treatment Period|Protocol Violation|4|||
156692154|NCT02510014|565618159|FG001|Treatment Period|Protocol Violation|4|||
156692155|NCT02510014|565618158|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
156692156|NCT02510014|565618159|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
156692157|NCT03438227|565618160|FG000|Overall Study|Withdrawal by Subject|10|||
156692158|NCT03438227|565618161|FG001|Overall Study|Withdrawal by Subject|5|||
156692159|NCT02972502|565618166|FG000|Overall Study|Lost to Follow-up|3|||
156692160|NCT02972502|565618167|FG001|Overall Study|Lost to Follow-up|1|||
156692161|NCT02972502|565618166|FG000|Overall Study|Withdrawal by Subject|1|||
156692162|NCT02972502|565618167|FG001|Overall Study|Withdrawal by Subject|1|||
156692163|NCT03852459|565618168|FG000|Overall Study|Adverse Event|2|||
156692164|NCT03852459|565618169|FG001|Overall Study|Adverse Event|2|||
156692165|NCT03852459|565618168|FG000|Overall Study|Withdrawal by Subject|1|||
156692166|NCT03852459|565618169|FG001|Overall Study|Withdrawal by Subject|1|||
156692167|NCT00049842|565618170|FG000|Treatment Phase|Adverse Event|47|||
156692168|NCT00049842|565618171|FG001|Treatment Phase|Adverse Event|12|||
156692169|NCT00049842|565618170|FG000|Treatment Phase|Withdrawal by Subject|35|||
156692170|NCT00049842|565618171|FG001|Treatment Phase|Withdrawal by Subject|46|||
156692171|NCT00049842|565618170|FG000|Treatment Phase|Non-compliance with protocol|7|||
156692172|NCT00049842|565618171|FG001|Treatment Phase|Non-compliance with protocol|8|||
156692173|NCT00049842|565618170|FG000|Treatment Phase|Lost to Follow-up|4|||
156692174|NCT00049842|565618171|FG001|Treatment Phase|Lost to Follow-up|8|||
156692175|NCT00049842|565618170|FG000|Treatment Phase|Administrative|0|||
156692176|NCT00049842|565618171|FG001|Treatment Phase|Administrative|3|||
156692177|NCT00049842|565618170|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
156692178|NCT00049842|565618171|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
156330187|NCT05055128|564308802|FG004|Overall Study|Adverse Event|1|||
156330188|NCT05055128|564308798|FG000|Overall Study|Protocol Violation|0|||
156330189|NCT05055128|564308799|FG001|Overall Study|Protocol Violation|0|||
156330190|NCT05055128|564308800|FG002|Overall Study|Protocol Violation|0|||
156330191|NCT05055128|564308801|FG003|Overall Study|Protocol Violation|1|||
156330192|NCT05055128|564308802|FG004|Overall Study|Protocol Violation|0|||
156330193|NCT05055128|564308798|FG000|Overall Study|Withdrawal by Subject|5|||
156330194|NCT05055128|564308799|FG001|Overall Study|Withdrawal by Subject|2|||
156692179|NCT00049842|565618170|FG000|Follow-up Phase|Adverse Event|6|||
156692180|NCT00049842|565618171|FG001|Follow-up Phase|Adverse Event|1|||
156692181|NCT00049842|565618170|FG000|Follow-up Phase|Other|1|||
156870255|NCT04922216|566281160|FG031|Overall Study|Withdrawal by Subject|0|||
156870256|NCT04922216|566281129|FG000|Overall Study|Lost to Follow-up|1|||
156870257|NCT04922216|566281130|FG001|Overall Study|Lost to Follow-up|0|||
156692182|NCT00049842|565618171|FG001|Follow-up Phase|Other|4|||
156330195|NCT05055128|564308800|FG002|Overall Study|Withdrawal by Subject|2|||
156330196|NCT05055128|564308801|FG003|Overall Study|Withdrawal by Subject|4|||
156330197|NCT05055128|564308802|FG004|Overall Study|Withdrawal by Subject|2|||
156330198|NCT05055128|564308798|FG000|Overall Study|Randomized By Mistake|0|||
156870258|NCT04922216|566281131|FG002|Overall Study|Lost to Follow-up|2|||
156692183|NCT01138111|565618177|FG000|Overall Study|Withdrawal by Subject|5|||
156692184|NCT01138111|565618177|FG000|Overall Study|Adverse Event|1|||
156692185|NCT01138111|565618177|FG000|Overall Study|Death|1|||
156692186|NCT01138111|565618177|FG000|Overall Study|Lost to Follow-up|2|||
156788407|NCT01379937|565977212|FG003|Overall Study|Protocol Violation|1|||
156788408|NCT01379937|565977209|FG000|Overall Study|Consent withdrawal|0|||
156692187|NCT01118117|565618178|FG000|Overall Study|Death|8|||
156788409|NCT01379937|565977210|FG001|Overall Study|Consent withdrawal|1|||
156788410|NCT01379937|565977211|FG002|Overall Study|Consent withdrawal|0|||
156788411|NCT01379937|565977212|FG003|Overall Study|Consent withdrawal|0|||
156788412|NCT01379937|565977209|FG000|Overall Study|Lost to Follow-up|1|||
156788413|NCT01379937|565977210|FG001|Overall Study|Lost to Follow-up|2|||
156788414|NCT01379937|565977211|FG002|Overall Study|Lost to Follow-up|2|||
156788415|NCT01379937|565977212|FG003|Overall Study|Lost to Follow-up|0|||
156788416|NCT01122680|565977213|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
156788417|NCT01122680|565977214|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
156788418|NCT01122680|565977215|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
156788419|NCT01122680|565977216|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
156788420|NCT01122680|565977213|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
156788421|NCT01122680|565977214|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
156788422|NCT01122680|565977215|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
156788423|NCT01122680|565977216|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
156788424|NCT01122680|565977213|FG000|Period 1 (4 Weeks)|Other|1|||
156788425|NCT01122680|565977214|FG001|Period 1 (4 Weeks)|Other|1|||
156788426|NCT01122680|565977215|FG002|Period 1 (4 Weeks)|Other|0|||
156788427|NCT01122680|565977216|FG003|Period 1 (4 Weeks)|Other|0|||
156788428|NCT01122680|565977213|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
156788429|NCT01122680|565977214|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
156788430|NCT01122680|565977215|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
156788431|NCT01122680|565977216|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
156788432|NCT01122680|565977213|FG000|Period 2 (4 Weeks)|Other|1|||
156788433|NCT01122680|565977214|FG001|Period 2 (4 Weeks)|Other|0|||
156788434|NCT01122680|565977215|FG002|Period 2 (4 Weeks)|Other|0|||
156788435|NCT01122680|565977216|FG003|Period 2 (4 Weeks)|Other|0|||
156788436|NCT01122680|565977213|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
156788437|NCT01122680|565977214|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
156788438|NCT01122680|565977215|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
156788439|NCT01122680|565977216|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
156788440|NCT01122680|565977213|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156788441|NCT01122680|565977214|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
156788442|NCT01122680|565977215|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156788443|NCT01122680|565977216|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156788444|NCT04985682|565977217|FG000|Overall Study|Withdrawal by Subject|1|||
156788445|NCT03016403|565977224|FG000|Baseline|Death|5|||
156788446|NCT03016403|565977225|FG001|Baseline|Death|8|||
156788447|NCT03016403|565977226|FG002|Baseline|Death|1|||
156788448|NCT03016403|565977227|FG003|Baseline|Death|0|||
156788449|NCT03016403|565977224|FG000|Baseline|Withdrawal by Subject|2|||
156788450|NCT03016403|565977225|FG001|Baseline|Withdrawal by Subject|8|||
156788451|NCT03016403|565977226|FG002|Baseline|Withdrawal by Subject|4|||
156788452|NCT03016403|565977227|FG003|Baseline|Withdrawal by Subject|10|||
156788453|NCT03016403|565977224|FG000|Baseline|Lost to Follow-up|9|||
156788454|NCT03016403|565977225|FG001|Baseline|Lost to Follow-up|11|||
156788455|NCT03016403|565977226|FG002|Baseline|Lost to Follow-up|6|||
156788456|NCT03016403|565977227|FG003|Baseline|Lost to Follow-up|24|||
156788457|NCT03016403|565977224|FG000|6-week Follow-up|Death|1|||
156788458|NCT03016403|565977225|FG001|6-week Follow-up|Death|4|||
156788459|NCT03016403|565977226|FG002|6-week Follow-up|Death|0|||
156788460|NCT03016403|565977227|FG003|6-week Follow-up|Death|0|||
156788461|NCT03016403|565977224|FG000|6-week Follow-up|Lost to Follow-up|2|||
156788462|NCT03016403|565977225|FG001|6-week Follow-up|Lost to Follow-up|7|||
156788463|NCT03016403|565977226|FG002|6-week Follow-up|Lost to Follow-up|4|||
156788464|NCT03016403|565977227|FG003|6-week Follow-up|Lost to Follow-up|8|||
156870259|NCT04922216|566281132|FG003|Overall Study|Lost to Follow-up|0|||
156692188|NCT01118117|565618179|FG001|Overall Study|Death|0|||
156692189|NCT01118117|565618178|FG000|Overall Study|Lost to Follow-up|6|||
156692190|NCT01118117|565618179|FG001|Overall Study|Lost to Follow-up|0|||
156692191|NCT01118117|565618178|FG000|Overall Study|Missed 12 Month Visit|7|||
156692192|NCT01118117|565618179|FG001|Overall Study|Missed 12 Month Visit|0|||
156692193|NCT00706992|565618180|FG000|Overall Study|Study termination|5|||
156692194|NCT00706992|565618181|FG001|Overall Study|Study termination|5|||
156788465|NCT03016403|565977224|FG000|6-week Follow-up|Withdrawal by Subject|0|||
156788466|NCT03016403|565977225|FG001|6-week Follow-up|Withdrawal by Subject|2|||
156788467|NCT03016403|565977226|FG002|6-week Follow-up|Withdrawal by Subject|0|||
156788468|NCT03016403|565977227|FG003|6-week Follow-up|Withdrawal by Subject|1|||
156788469|NCT03016403|565977224|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
156788470|NCT03016403|565977225|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
156788471|NCT03016403|565977226|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
156788472|NCT03016403|565977227|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
156788473|NCT03016403|565977224|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
156692195|NCT00706992|565618182|FG002|Overall Study|Study termination|6|||
156692196|NCT00706992|565618183|FG003|Overall Study|Study termination|2|||
156692197|NCT00706992|565618184|FG004|Overall Study|Study termination|3|||
156692198|NCT00706992|565618185|FG005|Overall Study|Study termination|2|||
156692199|NCT00706992|565618186|FG006|Overall Study|Study termination|3|||
156692200|NCT00706992|565618180|FG000|Overall Study|Disease progression before treatment|0|||
156692201|NCT00706992|565618181|FG001|Overall Study|Disease progression before treatment|0|||
156692202|NCT00706992|565618182|FG002|Overall Study|Disease progression before treatment|0|||
156692203|NCT00706992|565618183|FG003|Overall Study|Disease progression before treatment|0|||
156692204|NCT00706992|565618184|FG004|Overall Study|Disease progression before treatment|1|||
156692205|NCT00706992|565618185|FG005|Overall Study|Disease progression before treatment|0|||
156692206|NCT00706992|565618186|FG006|Overall Study|Disease progression before treatment|0|||
156692207|NCT03959527|565620141|FG000|Overall Study|Withdrawal by Subject|8|||
156692208|NCT03959527|565620142|FG001|Overall Study|Withdrawal by Subject|3|||
156692209|NCT03959527|565620141|FG000|Overall Study|Lost to Follow-up|31|||
156692210|NCT03959527|565620142|FG001|Overall Study|Lost to Follow-up|15|||
156692211|NCT03959527|565620141|FG000|Overall Study|Did not meet eligibility criteria|1|||
156692212|NCT03959527|565620142|FG001|Overall Study|Did not meet eligibility criteria|1|||
156692213|NCT03959527|565620141|FG000|Overall Study|Protocol Violation|10|||
156788474|NCT03016403|565977225|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
156788475|NCT03016403|565977226|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
156788476|NCT03016403|565977227|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
156788477|NCT03016403|565977224|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
156788478|NCT03016403|565977225|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
156788479|NCT03016403|565977226|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
156788480|NCT03016403|565977227|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
156788481|NCT05463705|565977228|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
156788482|NCT05463705|565977229|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
156788483|NCT05463705|565977230|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
156788484|NCT05463705|565977231|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
156788485|NCT05463705|565977232|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
156788486|NCT05463705|565977233|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
156788487|NCT00552279|565977235|FG000|Overall Study|Adverse Event|0|||
156788488|NCT00552279|565977236|FG001|Overall Study|Adverse Event|1|||
156788489|NCT00552279|565977235|FG000|Overall Study|Withdrawal by Subject|12|||
156788490|NCT00552279|565977236|FG001|Overall Study|Withdrawal by Subject|1|||
156788491|NCT00552279|565977235|FG000|Overall Study|Lost to Follow-up|1|||
156788492|NCT00552279|565977236|FG001|Overall Study|Lost to Follow-up|0|||
156788493|NCT00552279|565977235|FG000|Overall Study|Other|1|||
156788494|NCT00552279|565977236|FG001|Overall Study|Other|1|||
156788495|NCT01655069|565977237|FG000|Overall Study|Physician Decision|0|||
156788496|NCT01655069|565977238|FG001|Overall Study|Physician Decision|0|||
156788497|NCT01655069|565977239|FG002|Overall Study|Physician Decision|0|||
156788498|NCT01655069|565977240|FG003|Overall Study|Physician Decision|1|||
156788499|NCT01655069|565977237|FG000|Overall Study|Adverse Event|6|||
156788500|NCT01655069|565977238|FG001|Overall Study|Adverse Event|7|||
156788501|NCT01655069|565977239|FG002|Overall Study|Adverse Event|2|||
156788502|NCT01655069|565977240|FG003|Overall Study|Adverse Event|3|||
156788503|NCT01655069|565977237|FG000|Overall Study|Lack of Efficacy|0|||
156788504|NCT01655069|565977238|FG001|Overall Study|Lack of Efficacy|1|||
156788505|NCT01655069|565977239|FG002|Overall Study|Lack of Efficacy|0|||
156788506|NCT01655069|565977240|FG003|Overall Study|Lack of Efficacy|0|||
156788507|NCT01655069|565977237|FG000|Overall Study|No Treatment Needed|0|||
156788508|NCT01655069|565977238|FG001|Overall Study|No Treatment Needed|1|||
156788509|NCT01655069|565977239|FG002|Overall Study|No Treatment Needed|0|||
156788510|NCT01655069|565977240|FG003|Overall Study|No Treatment Needed|0|||
156788511|NCT01655069|565977237|FG000|Overall Study|Withdrawal by Subject|2|||
156788512|NCT01655069|565977238|FG001|Overall Study|Withdrawal by Subject|3|||
156788513|NCT01655069|565977239|FG002|Overall Study|Withdrawal by Subject|0|||
156788514|NCT01655069|565977240|FG003|Overall Study|Withdrawal by Subject|0|||
156788515|NCT01530997|565977241|FG000|Overall Study|Physician Decision|1|||
156788516|NCT01530997|565977241|FG000|Overall Study|Withdrawal by Subject|1|||
156788517|NCT02453191|565977244|FG000|Overall Study|Withdrawal by Subject|1|||
156788518|NCT01520714|565977245|FG000|Overall Study|Protocol Violation|0|||
156788519|NCT01520714|565977246|FG001|Overall Study|Protocol Violation|3|||
156788520|NCT01520714|565977245|FG000|Overall Study|Adverse Event|0|||
156788521|NCT01520714|565977246|FG001|Overall Study|Adverse Event|2|||
156788522|NCT01520714|565977245|FG000|Overall Study|Lack of Efficacy|0|||
156788523|NCT01520714|565977246|FG001|Overall Study|Lack of Efficacy|1|||
156788524|NCT01210443|565977249|FG000|Overall Study|Study terminated by sponsor|2|||
156692214|NCT03959527|565620142|FG001|Overall Study|Protocol Violation|5|||
156692215|NCT06029959|565620143|FG000|Overall Study|Physician Decision|6|||
156788525|NCT02807181|565977252|FG000|Overall Study|Death|28|||
156530618|NCT01890148|565038095|FG000|Overall Study|Adverse Event|1|||
156692216|NCT01010126|565620148|FG000|Overall Study|Withdrawal by Subject|1|||
156692217|NCT01010126|565620149|FG001|Overall Study|Withdrawal by Subject|0|||
156692218|NCT01010126|565620150|FG002|Overall Study|Withdrawal by Subject|1|||
156692219|NCT01010126|565620151|FG003|Overall Study|Withdrawal by Subject|0|||
156692220|NCT01010126|565620152|FG004|Overall Study|Withdrawal by Subject|3|||
156692221|NCT01010126|565620153|FG005|Overall Study|Withdrawal by Subject|0|||
156692222|NCT00493246|565620154|FG000|Overall Study|Withdrawal by Subject|0|||
156692223|NCT00493246|565620155|FG001|Overall Study|Withdrawal by Subject|0|||
156692224|NCT00493246|565620156|FG002|Overall Study|Withdrawal by Subject|0|||
156692225|NCT00493246|565620157|FG003|Overall Study|Withdrawal by Subject|0|||
156692226|NCT00493246|565620158|FG004|Overall Study|Withdrawal by Subject|1|||
156692227|NCT00493246|565620159|FG005|Overall Study|Withdrawal by Subject|0|||
156692228|NCT00493246|565620160|FG006|Overall Study|Withdrawal by Subject|0|||
156692229|NCT00493246|565620161|FG007|Overall Study|Withdrawal by Subject|0|||
156692230|NCT00493246|565620154|FG000|Overall Study|No access to draw blood|0|||
156692231|NCT00493246|565620155|FG001|Overall Study|No access to draw blood|0|||
156692232|NCT00493246|565620156|FG002|Overall Study|No access to draw blood|0|||
156692233|NCT00493246|565620157|FG003|Overall Study|No access to draw blood|0|||
156692234|NCT00493246|565620158|FG004|Overall Study|No access to draw blood|0|||
156870260|NCT04922216|566281133|FG004|Overall Study|Lost to Follow-up|0|||
156870261|NCT04922216|566281134|FG005|Overall Study|Lost to Follow-up|2|||
156870262|NCT04922216|566281135|FG006|Overall Study|Lost to Follow-up|0|||
156870263|NCT04922216|566281136|FG007|Overall Study|Lost to Follow-up|1|||
156692235|NCT00493246|565620159|FG005|Overall Study|No access to draw blood|1|||
156788526|NCT02807181|565977253|FG001|Overall Study|Death|24|||
156788527|NCT02807181|565977252|FG000|Overall Study|Withdrawal by Subject|1|||
156788528|NCT02807181|565977253|FG001|Overall Study|Withdrawal by Subject|1|||
156788529|NCT02807181|565977252|FG000|Overall Study|Lost to Follow-up|0|||
156788530|NCT02807181|565977253|FG001|Overall Study|Lost to Follow-up|2|||
156788531|NCT02807181|565977252|FG000|Overall Study|Subject decision|1|||
156788532|NCT02807181|565977253|FG001|Overall Study|Subject decision|0|||
156788533|NCT02807181|565977252|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
156788534|NCT02807181|565977253|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
156788535|NCT02807181|565977252|FG000|Overall Study|In Study|3|||
156788536|NCT02807181|565977253|FG001|Overall Study|In Study|3|||
156788537|NCT02807181|565977252|FG000|Overall Study|Post Progression|3|||
156788538|NCT02807181|565977253|FG001|Overall Study|Post Progression|2|||
156788539|NCT01489358|565977254|FG000|Overall Study|Lost to Follow-up|0|||
156788540|NCT01489358|565977255|FG001|Overall Study|Lost to Follow-up|0|||
156788541|NCT01489358|565977256|FG002|Overall Study|Lost to Follow-up|2|||
156788542|NCT03518203|565977259|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
156788543|NCT03518203|565977259|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
156788544|NCT00345592|565977261|FG000|Overall Study|Death|14|||
156788545|NCT00345592|565977262|FG001|Overall Study|Death|16|||
156788546|NCT00345592|565977261|FG000|Overall Study|Withdrawal by Subject|11|||
156788547|NCT00345592|565977262|FG001|Overall Study|Withdrawal by Subject|8|||
156788548|NCT01663987|565977263|FG000|Overall Study|Adverse Event|7|||
156788549|NCT01663987|565977264|FG001|Overall Study|Adverse Event|2|||
156788550|NCT01663987|565977263|FG000|Overall Study|Lost to Follow-up|1|||
156788551|NCT01663987|565977264|FG001|Overall Study|Lost to Follow-up|1|||
156788552|NCT01663987|565977263|FG000|Overall Study|Withdrawal by Subject|2|||
156788553|NCT01663987|565977264|FG001|Overall Study|Withdrawal by Subject|3|||
156788554|NCT01663987|565977263|FG000|Overall Study|Other reason not defined above|3|||
156788555|NCT01663987|565977264|FG001|Overall Study|Other reason not defined above|0|||
156788556|NCT01084135|565977266|FG000|20 Week|Physician Decision|0|||
156788557|NCT01084135|565977267|FG001|20 Week|Physician Decision|1|||
156788558|NCT02366130|565977268|FG000|Overall Study|Withdrawal by Subject|3|||
156788559|NCT02366130|565977268|FG000|Overall Study|Ineligible|6|||
156788560|NCT01065766|565977269|FG000|Overall Study|Assessed before the contracted date|1|||
156788561|NCT01065766|565977269|FG000|Overall Study|Contraindication to administration|6|||
156788562|NCT01065766|565977269|FG000|Overall Study|Violated dosage/administration|25|||
156788563|NCT03520387|565977273|FG000|Pre-Randomization|Withdrawal by Subject|1|||
156692236|NCT00493246|565620160|FG006|Overall Study|No access to draw blood|0|||
156692237|NCT00493246|565620161|FG007|Overall Study|No access to draw blood|0|||
156692238|NCT00493246|565620154|FG000|Overall Study|Lost to Follow-up|0|||
156788564|NCT03520387|565977274|FG001|Pre-Randomization|Withdrawal by Subject|0|||
156788565|NCT03520387|565977275|FG002|Pre-Randomization|Withdrawal by Subject|0|||
156788566|NCT03520387|565977276|FG003|Pre-Randomization|Withdrawal by Subject|0|||
156788567|NCT03520387|565977277|FG004|Pre-Randomization|Withdrawal by Subject|0|||
156692239|NCT00493246|565620155|FG001|Overall Study|Lost to Follow-up|0|||
156692240|NCT00493246|565620156|FG002|Overall Study|Lost to Follow-up|0|||
156788568|NCT03520387|565977273|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
156788569|NCT03520387|565977274|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
156788570|NCT03520387|565977275|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
156870264|NCT04922216|566281137|FG008|Overall Study|Lost to Follow-up|1|||
156692241|NCT00493246|565620157|FG003|Overall Study|Lost to Follow-up|0|||
156692242|NCT00493246|565620158|FG004|Overall Study|Lost to Follow-up|0|||
156692243|NCT00493246|565620159|FG005|Overall Study|Lost to Follow-up|0|||
156692244|NCT00493246|565620160|FG006|Overall Study|Lost to Follow-up|1|||
156692245|NCT00493246|565620161|FG007|Overall Study|Lost to Follow-up|0|||
156692246|NCT00595335|565620162|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
156692247|NCT00595335|565620163|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
156692248|NCT00595335|565620162|FG000|Baseline to Six Months|Disease Progression|1|||
156692249|NCT00595335|565620163|FG001|Baseline to Six Months|Disease Progression|1|||
156692250|NCT00595335|565620162|FG000|Baseline to Six Months|Adverse Event|1|||
156692251|NCT00595335|565620163|FG001|Baseline to Six Months|Adverse Event|0|||
156692252|NCT00595335|565620162|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
156692253|NCT00595335|565620163|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
156692254|NCT00595335|565620162|FG000|Six Months to Twelve Months|Disease Progression|1|||
156692255|NCT00595335|565620163|FG001|Six Months to Twelve Months|Disease Progression|0|||
156692256|NCT00493779|565620166|FG000|Overall Study|Logistical issue at site|1|||
156692257|NCT01215513|565620171|FG000|Overall Study|Not completed CS42|9|||
156692258|NCT01215513|565620171|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
156692259|NCT01215513|565620171|FG000|Overall Study|Adverse event (CS42A)|2|||
156692260|NCT01215513|565620171|FG000|Overall Study|Physician decision (CS42A)|6|||
156692261|NCT01215513|565620171|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
156788571|NCT03520387|565977276|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
156788572|NCT03520387|565977277|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
156788573|NCT04913675|565977278|FG000|Main Study (Up to Week 36)|Death|0|||
156788574|NCT04913675|565977279|FG001|Main Study (Up to Week 36)|Death|2|||
156788575|NCT04913675|565977280|FG002|Main Study (Up to Week 36)|Death|2|||
156788576|NCT04913675|565977281|FG003|Main Study (Up to Week 36)|Death|0|||
156788577|NCT04913675|565977278|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
156788578|NCT04913675|565977279|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
156788579|NCT04913675|565977280|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
156788580|NCT04913675|565977281|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
156788581|NCT04913675|565977278|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
156788582|NCT04913675|565977279|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
156788583|NCT04913675|565977280|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
156788584|NCT04913675|565977281|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
156788585|NCT04913675|565977278|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
156788586|NCT04913675|565977279|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
156788587|NCT04913675|565977280|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
156788588|NCT04913675|565977281|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
156788589|NCT04913675|565977278|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
156788590|NCT04913675|565977279|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
156788591|NCT04913675|565977280|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
156788592|NCT04913675|565977281|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
156788593|NCT04518410|565977282|FG000|Overall Study|Lost to Follow-up|1|||
156788594|NCT04518410|565977283|FG001|Overall Study|Lost to Follow-up|1|||
156788595|NCT04518410|565977284|FG002|Overall Study|Lost to Follow-up|8|||
156788596|NCT04518410|565977285|FG003|Overall Study|Lost to Follow-up|5|||
156788597|NCT04518410|565977286|FG004|Overall Study|Lost to Follow-up|92|||
156788598|NCT04518410|565977287|FG005|Overall Study|Lost to Follow-up|25|||
156788599|NCT04518410|565977288|FG006|Overall Study|Lost to Follow-up|25|||
156788600|NCT04518410|565977289|FG007|Overall Study|Lost to Follow-up|3|||
156788601|NCT04518410|565977290|FG008|Overall Study|Lost to Follow-up|2|||
156788602|NCT04518410|565977291|FG009|Overall Study|Lost to Follow-up|13|||
156692262|NCT01215513|565620171|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
156692263|NCT01763918|565620181|FG000|Overall Study|Withdrawal by Subject|2|||
156692264|NCT01763918|565620182|FG001|Overall Study|Withdrawal by Subject|1|||
156692265|NCT01763918|565620183|FG002|Overall Study|Withdrawal by Subject|1|||
156692266|NCT01763918|565620184|FG003|Overall Study|Withdrawal by Subject|2|||
156692267|NCT01763918|565620181|FG000|Overall Study|Sponsor Decision|4|||
156692268|NCT01763918|565620182|FG001|Overall Study|Sponsor Decision|0|||
156692269|NCT01763918|565620183|FG002|Overall Study|Sponsor Decision|9|||
156692270|NCT01763918|565620184|FG003|Overall Study|Sponsor Decision|0|||
156692271|NCT00897949|565620185|FG000|Overall Study|Adverse Event|1|||
156788603|NCT04518410|565977292|FG010|Overall Study|Lost to Follow-up|9|||
156692272|NCT00897949|565620186|FG001|Overall Study|Adverse Event|1|||
156692273|NCT00897949|565620187|FG002|Overall Study|Adverse Event|0|||
156788604|NCT04518410|565977293|FG011|Overall Study|Lost to Follow-up|13|||
156788605|NCT04518410|565977294|FG012|Overall Study|Lost to Follow-up|9|||
156788606|NCT04518410|565977295|FG013|Overall Study|Lost to Follow-up|13|||
156788607|NCT04518410|565977296|FG014|Overall Study|Lost to Follow-up|8|||
156788608|NCT04518410|565977297|FG015|Overall Study|Lost to Follow-up|10|||
156788609|NCT04518410|565977298|FG016|Overall Study|Lost to Follow-up|6|||
156788610|NCT04518410|565977299|FG017|Overall Study|Lost to Follow-up|13|||
156788611|NCT04518410|565977300|FG018|Overall Study|Lost to Follow-up|21|||
156788612|NCT04518410|565977301|FG019|Overall Study|Lost to Follow-up|6|||
156330199|NCT05055128|564308799|FG001|Overall Study|Randomized By Mistake|1|||
156330200|NCT05055128|564308800|FG002|Overall Study|Randomized By Mistake|0|||
156330201|NCT05055128|564308801|FG003|Overall Study|Randomized By Mistake|0|||
156330202|NCT05055128|564308802|FG004|Overall Study|Randomized By Mistake|0|||
156692274|NCT00897949|565620185|FG000|Overall Study|Lost to Follow-up|0|||
156692275|NCT00897949|565620186|FG001|Overall Study|Lost to Follow-up|2|||
156692276|NCT00897949|565620187|FG002|Overall Study|Lost to Follow-up|1|||
156692277|NCT00897949|565620185|FG000|Overall Study|Protocol Violation|6|||
156692278|NCT00897949|565620186|FG001|Overall Study|Protocol Violation|3|||
156692279|NCT00897949|565620187|FG002|Overall Study|Protocol Violation|1|||
156330203|NCT05055128|564308798|FG000|Overall Study|Other|1|||
156330204|NCT05055128|564308799|FG001|Overall Study|Other|0|||
156330205|NCT05055128|564308800|FG002|Overall Study|Other|0|||
156330206|NCT05055128|564308801|FG003|Overall Study|Other|0|||
156330207|NCT05055128|564308802|FG004|Overall Study|Other|0|||
156330208|NCT02955797|564308809|FG000|Overall Study|Protocol Violation|1|||
156330209|NCT02955797|564308810|FG001|Overall Study|Protocol Violation|0|||
156330210|NCT02955797|564308811|FG002|Overall Study|Protocol Violation|0|||
156330211|NCT02955797|564308812|FG003|Overall Study|Protocol Violation|1|||
156330212|NCT02955797|564308809|FG000|Overall Study|Withdrawal by Subject|2|||
156330213|NCT02955797|564308810|FG001|Overall Study|Withdrawal by Subject|2|||
156330214|NCT02955797|564308811|FG002|Overall Study|Withdrawal by Subject|0|||
156330215|NCT02955797|564308812|FG003|Overall Study|Withdrawal by Subject|1|||
156330216|NCT02955797|564308809|FG000|Overall Study|Lost to Follow-up|0|||
156330217|NCT02955797|564308810|FG001|Overall Study|Lost to Follow-up|1|||
156330218|NCT02955797|564308811|FG002|Overall Study|Lost to Follow-up|0|||
156330219|NCT02955797|564308812|FG003|Overall Study|Lost to Follow-up|0|||
156330220|NCT00543543|564308813|FG000|Base Study|Adverse Event|1|||
156330221|NCT00543543|564308814|FG001|Base Study|Adverse Event|11|||
156330222|NCT00543543|564308815|FG002|Base Study|Adverse Event|0|||
156330223|NCT00543543|564308816|FG003|Base Study|Adverse Event|5|||
156330224|NCT00543543|564308813|FG000|Base Study|Lost to Follow-up|12|||
156330225|NCT00543543|564308814|FG001|Base Study|Lost to Follow-up|749|||
156437048|NCT03401112|564689937|FG003|Overall Study|Study was Terminated by Sponsor|1|||
156437049|NCT03401112|564689938|FG004|Overall Study|Study was Terminated by Sponsor|0|||
156437050|NCT03401112|564689934|FG000|Overall Study|Day 1 Assessment not Done|1|||
156437051|NCT03401112|564689935|FG001|Overall Study|Day 1 Assessment not Done|0|||
156692280|NCT00897949|565620185|FG000|Overall Study|Withdrawal by Subject|1|||
156692281|NCT00897949|565620186|FG001|Overall Study|Withdrawal by Subject|2|||
156692282|NCT00897949|565620187|FG002|Overall Study|Withdrawal by Subject|0|||
156692283|NCT00897949|565620185|FG000|Overall Study|Patient Uncoorperative|0|||
156692284|NCT00897949|565620186|FG001|Overall Study|Patient Uncoorperative|2|||
156692285|NCT00897949|565620187|FG002|Overall Study|Patient Uncoorperative|1|||
156692286|NCT00897949|565620185|FG000|Overall Study|Lost to Follow-up|30|||
156692287|NCT00897949|565620186|FG001|Overall Study|Lost to Follow-up|23|||
156692288|NCT00897949|565620187|FG002|Overall Study|Lost to Follow-up|17|||
156788613|NCT04518410|565977302|FG020|Overall Study|Lost to Follow-up|7|||
156788614|NCT04518410|565977303|FG021|Overall Study|Lost to Follow-up|21|||
156788615|NCT04518410|565977304|FG022|Overall Study|Lost to Follow-up|1|||
156788616|NCT04518410|565977305|FG023|Overall Study|Lost to Follow-up|7|||
156788617|NCT04518410|565977306|FG024|Overall Study|Lost to Follow-up|6|||
156788618|NCT04518410|565977282|FG000|Overall Study|Withdrawal by Subject|1|||
156788619|NCT04518410|565977283|FG001|Overall Study|Withdrawal by Subject|2|||
156788620|NCT04518410|565977284|FG002|Overall Study|Withdrawal by Subject|2|||
156788621|NCT04518410|565977285|FG003|Overall Study|Withdrawal by Subject|3|||
156788622|NCT04518410|565977286|FG004|Overall Study|Withdrawal by Subject|20|||
156788623|NCT04518410|565977287|FG005|Overall Study|Withdrawal by Subject|20|||
156788624|NCT04518410|565977288|FG006|Overall Study|Withdrawal by Subject|25|||
156788625|NCT04518410|565977289|FG007|Overall Study|Withdrawal by Subject|6|||
156788626|NCT04518410|565977290|FG008|Overall Study|Withdrawal by Subject|1|||
156788627|NCT04518410|565977291|FG009|Overall Study|Withdrawal by Subject|12|||
156788628|NCT04518410|565977292|FG010|Overall Study|Withdrawal by Subject|5|||
156788629|NCT04518410|565977293|FG011|Overall Study|Withdrawal by Subject|7|||
156330226|NCT00543543|564308815|FG002|Base Study|Lost to Follow-up|9|||
156330227|NCT00543543|564308816|FG003|Base Study|Lost to Follow-up|701|||
156330228|NCT00543543|564308813|FG000|Base Study|Physician Decision|0|||
156330229|NCT00543543|564308814|FG001|Base Study|Physician Decision|4|||
156330230|NCT00543543|564308815|FG002|Base Study|Physician Decision|0|||
156330231|NCT00543543|564308816|FG003|Base Study|Physician Decision|7|||
156692289|NCT00897949|565620185|FG000|Overall Study|Withdrawal by Subject|24|||
156692290|NCT00897949|565620186|FG001|Overall Study|Withdrawal by Subject|31|||
156692291|NCT00897949|565620187|FG002|Overall Study|Withdrawal by Subject|17|||
156692292|NCT00897949|565620185|FG000|Overall Study|Abnormal Prestudy Labs|2|||
156330232|NCT00543543|564308813|FG000|Base Study|Protocol Violation|0|||
156330233|NCT00543543|564308814|FG001|Base Study|Protocol Violation|6|||
156788630|NCT04518410|565977294|FG012|Overall Study|Withdrawal by Subject|2|||
156788631|NCT04518410|565977295|FG013|Overall Study|Withdrawal by Subject|13|||
156788632|NCT04518410|565977296|FG014|Overall Study|Withdrawal by Subject|4|||
156788633|NCT04518410|565977297|FG015|Overall Study|Withdrawal by Subject|9|||
156692293|NCT00897949|565620186|FG001|Overall Study|Abnormal Prestudy Labs|3|||
156692294|NCT00897949|565620187|FG002|Overall Study|Abnormal Prestudy Labs|4|||
156692295|NCT00897949|565620185|FG000|Overall Study|Abnormal Baseline ECG|2|||
156692296|NCT00897949|565620186|FG001|Overall Study|Abnormal Baseline ECG|2|||
156692297|NCT00897949|565620187|FG002|Overall Study|Abnormal Baseline ECG|4|||
156692298|NCT00897949|565620185|FG000|Overall Study|Need for Concom. Med.|0|||
156692299|NCT00897949|565620186|FG001|Overall Study|Need for Concom. Med.|1|||
156692300|NCT00897949|565620187|FG002|Overall Study|Need for Concom. Med.|1|||
156692301|NCT00897949|565620185|FG000|Overall Study|Lack of Migraine Attack|29|||
156692302|NCT00897949|565620186|FG001|Overall Study|Lack of Migraine Attack|30|||
156692303|NCT00897949|565620187|FG002|Overall Study|Lack of Migraine Attack|19|||
156692304|NCT00897949|565620185|FG000|Overall Study|Did not take study drug|9|||
156692305|NCT00897949|565620186|FG001|Overall Study|Did not take study drug|3|||
156692306|NCT00897949|565620187|FG002|Overall Study|Did not take study drug|4|||
156692307|NCT01553747|565620188|FG000|Overall Study|Protocol Violation|0|||
156692308|NCT01553747|565620189|FG001|Overall Study|Protocol Violation|2|||
156692309|NCT01553747|565620190|FG002|Overall Study|Protocol Violation|0|||
156692310|NCT01553747|565620188|FG000|Overall Study|Voluntarily withdrew|70|||
156692311|NCT01553747|565620189|FG001|Overall Study|Voluntarily withdrew|66|||
156692312|NCT01553747|565620190|FG002|Overall Study|Voluntarily withdrew|74|||
156692313|NCT01553747|565620188|FG000|Overall Study|Adverse event or SAE|32|||
156692314|NCT01553747|565620189|FG001|Overall Study|Adverse event or SAE|28|||
156692315|NCT01553747|565620190|FG002|Overall Study|Adverse event or SAE|19|||
156692316|NCT01553747|565620188|FG000|Overall Study|Physician decision: other|10|||
156692317|NCT01553747|565620189|FG001|Overall Study|Physician decision: other|8|||
156692318|NCT01553747|565620190|FG002|Overall Study|Physician decision: other|7|||
156692319|NCT01553747|565620188|FG000|Overall Study|Lost to Follow-up|11|||
156692320|NCT01553747|565620189|FG001|Overall Study|Lost to Follow-up|5|||
156692321|NCT01553747|565620190|FG002|Overall Study|Lost to Follow-up|6|||
156692322|NCT01553747|565620188|FG000|Overall Study|Sponsor decision, specify|7|||
156692323|NCT01553747|565620189|FG001|Overall Study|Sponsor decision, specify|5|||
156692324|NCT01553747|565620190|FG002|Overall Study|Sponsor decision, specify|0|||
156692325|NCT01553747|565620188|FG000|Overall Study|Physician decision: lack of efficacy|1|||
156692326|NCT01553747|565620189|FG001|Overall Study|Physician decision: lack of efficacy|5|||
156692327|NCT01553747|565620190|FG002|Overall Study|Physician decision: lack of efficacy|3|||
156692328|NCT00102687|565620191|FG000|Initial Period|Withdrawal by Subject|6|||
156692329|NCT00102687|565620192|FG001|Initial Period|Withdrawal by Subject|3|||
156692330|NCT00102687|565620193|FG002|Initial Period|Withdrawal by Subject|5|||
156692331|NCT00102687|565620194|FG003|Initial Period|Withdrawal by Subject|0|||
156692332|NCT00102687|565620195|FG004|Initial Period|Withdrawal by Subject|0|||
156692333|NCT00102687|565620191|FG000|Initial Period|Adverse Event|4|||
156692334|NCT00102687|565620192|FG001|Initial Period|Adverse Event|7|||
156692335|NCT00102687|565620193|FG002|Initial Period|Adverse Event|9|||
156692336|NCT00102687|565620194|FG003|Initial Period|Adverse Event|0|||
156692337|NCT00102687|565620195|FG004|Initial Period|Adverse Event|0|||
156692338|NCT00102687|565620191|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
156692339|NCT00102687|565620192|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
156692340|NCT00102687|565620193|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
156692341|NCT00102687|565620194|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
156692342|NCT00102687|565620195|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
156692343|NCT00102687|565620191|FG000|Initial Period|Protocol Violation|0|||
156692344|NCT00102687|565620192|FG001|Initial Period|Protocol Violation|0|||
156692345|NCT00102687|565620193|FG002|Initial Period|Protocol Violation|2|||
156692346|NCT00102687|565620194|FG003|Initial Period|Protocol Violation|0|||
156692347|NCT00102687|565620195|FG004|Initial Period|Protocol Violation|0|||
156692348|NCT00102687|565620191|FG000|Initial Period|Physician Decision|2|||
156692349|NCT00102687|565620192|FG001|Initial Period|Physician Decision|9|||
156692350|NCT00102687|565620193|FG002|Initial Period|Physician Decision|6|||
156692351|NCT00102687|565620194|FG003|Initial Period|Physician Decision|0|||
156692352|NCT00102687|565620195|FG004|Initial Period|Physician Decision|0|||
156692353|NCT00102687|565620191|FG000|Initial Period|Sponsor's decision|0|||
156692354|NCT00102687|565620192|FG001|Initial Period|Sponsor's decision|1|||
156692355|NCT00102687|565620193|FG002|Initial Period|Sponsor's decision|1|||
156692356|NCT00102687|565620194|FG003|Initial Period|Sponsor's decision|0|||
156692357|NCT00102687|565620195|FG004|Initial Period|Sponsor's decision|0|||
156692358|NCT00102687|565620191|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
156692359|NCT00102687|565620192|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
156692360|NCT00102687|565620193|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
156692361|NCT00102687|565620194|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
156692362|NCT00102687|565620195|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
156692363|NCT00102687|565620191|FG000|Initial Period|Death|1|||
156692364|NCT00102687|565620192|FG001|Initial Period|Death|1|||
156692365|NCT00102687|565620193|FG002|Initial Period|Death|1|||
156692366|NCT00102687|565620194|FG003|Initial Period|Death|0|||
156692367|NCT00102687|565620195|FG004|Initial Period|Death|0|||
156692368|NCT00102687|565620191|FG000|Maintenance Period|Withdrawal by Subject|4|||
156692369|NCT00102687|565620192|FG001|Maintenance Period|Withdrawal by Subject|0|||
156692370|NCT00102687|565620193|FG002|Maintenance Period|Withdrawal by Subject|2|||
156692371|NCT00102687|565620194|FG003|Maintenance Period|Withdrawal by Subject|3|||
156692372|NCT00102687|565620195|FG004|Maintenance Period|Withdrawal by Subject|1|||
156692373|NCT00102687|565620191|FG000|Maintenance Period|Adverse Event|1|||
156692374|NCT00102687|565620192|FG001|Maintenance Period|Adverse Event|0|||
156692375|NCT00102687|565620193|FG002|Maintenance Period|Adverse Event|0|||
156692376|NCT00102687|565620194|FG003|Maintenance Period|Adverse Event|1|||
156692377|NCT00102687|565620195|FG004|Maintenance Period|Adverse Event|3|||
156692378|NCT00102687|565620191|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
156692379|NCT00102687|565620192|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
156692380|NCT00102687|565620193|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
156692381|NCT00102687|565620194|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
156692382|NCT00102687|565620195|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
156692383|NCT00102687|565620191|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
156692384|NCT00102687|565620192|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
156692385|NCT00102687|565620193|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
156692386|NCT00102687|565620194|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
156692387|NCT00102687|565620195|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
156692388|NCT00102687|565620191|FG000|Maintenance Period|Death|0|||
156692389|NCT00102687|565620192|FG001|Maintenance Period|Death|0|||
156692390|NCT00102687|565620193|FG002|Maintenance Period|Death|0|||
156692391|NCT00102687|565620194|FG003|Maintenance Period|Death|1|||
156692392|NCT00102687|565620195|FG004|Maintenance Period|Death|1|||
156692393|NCT00102687|565620191|FG000|Maintenance Period|Physician Decision|1|||
156692394|NCT00102687|565620192|FG001|Maintenance Period|Physician Decision|2|||
156692395|NCT00102687|565620193|FG002|Maintenance Period|Physician Decision|3|||
156692396|NCT00102687|565620194|FG003|Maintenance Period|Physician Decision|0|||
156692397|NCT00102687|565620195|FG004|Maintenance Period|Physician Decision|4|||
156692398|NCT01144403|565620200|FG000|Overall Study|Lost to Follow-up|3|||
156692399|NCT01144403|565620200|FG000|Overall Study|Death|1|||
156692400|NCT01144403|565620200|FG000|Overall Study|Adverse Event|1|||
156692401|NCT00977431|565620201|FG000|Overall Study|Other than listed|1|||
156692402|NCT00977431|565620202|FG001|Overall Study|Other than listed|0|||
156692403|NCT00977431|565620203|FG002|Overall Study|Other than listed|0|||
156692404|NCT00977431|565620204|FG003|Overall Study|Other than listed|0|||
156692405|NCT00977431|565620205|FG004|Overall Study|Other than listed|2|||
156692406|NCT00977431|565620201|FG000|Overall Study|Protocol Violation|0|||
156692407|NCT00977431|565620202|FG001|Overall Study|Protocol Violation|0|||
156692408|NCT00977431|565620203|FG002|Overall Study|Protocol Violation|1|||
156692409|NCT00977431|565620204|FG003|Overall Study|Protocol Violation|0|||
156692410|NCT00977431|565620205|FG004|Overall Study|Protocol Violation|0|||
156692411|NCT00977431|565620201|FG000|Overall Study|Adverse Event|3|||
156692412|NCT00977431|565620202|FG001|Overall Study|Adverse Event|0|||
156692413|NCT00977431|565620203|FG002|Overall Study|Adverse Event|4|||
156692414|NCT00977431|565620204|FG003|Overall Study|Adverse Event|0|||
156692415|NCT00977431|565620205|FG004|Overall Study|Adverse Event|6|||
156330234|NCT00543543|564308815|FG002|Base Study|Protocol Violation|0|||
156330235|NCT00543543|564308816|FG003|Base Study|Protocol Violation|6|||
156692416|NCT00977431|565620201|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
156692417|NCT00977431|565620202|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
156692418|NCT00977431|565620203|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
156692419|NCT00977431|565620204|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
156692420|NCT00977431|565620205|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
156692421|NCT00977431|565620201|FG000|Overall Study|Progressive disease|2|||
156692422|NCT00977431|565620202|FG001|Overall Study|Progressive disease|6|||
156692423|NCT00977431|565620203|FG002|Overall Study|Progressive disease|1|||
156692424|NCT00977431|565620204|FG003|Overall Study|Progressive disease|3|||
156692425|NCT00977431|565620205|FG004|Overall Study|Progressive disease|5|||
156692426|NCT03739138|565620212|FG000|Overall Study|Death|0|||
156692427|NCT03739138|565620213|FG001|Overall Study|Death|7|||
156692428|NCT03739138|565620214|FG002|Overall Study|Death|4|||
156692429|NCT03739138|565620215|FG003|Overall Study|Death|13|||
156692430|NCT03739138|565620216|FG004|Overall Study|Death|0|||
156692431|NCT03739138|565620212|FG000|Overall Study|Lost to Follow-up|0|||
156330236|NCT00543543|564308813|FG000|Base Study|Withdrawal by Subject|7|||
156330237|NCT00543543|564308814|FG001|Base Study|Withdrawal by Subject|482|||
156692432|NCT03739138|565620213|FG001|Overall Study|Lost to Follow-up|0|||
156692433|NCT03739138|565620214|FG002|Overall Study|Lost to Follow-up|1|||
156692434|NCT03739138|565620215|FG003|Overall Study|Lost to Follow-up|0|||
156692435|NCT03739138|565620216|FG004|Overall Study|Lost to Follow-up|0|||
156692436|NCT03739138|565620212|FG000|Overall Study|Study Terminated By Sponsor|0|||
156692437|NCT03739138|565620213|FG001|Overall Study|Study Terminated By Sponsor|0|||
156692438|NCT03739138|565620214|FG002|Overall Study|Study Terminated By Sponsor|0|||
156330238|NCT00543543|564308815|FG002|Base Study|Withdrawal by Subject|5|||
156692439|NCT03739138|565620215|FG003|Overall Study|Study Terminated By Sponsor|4|||
156692440|NCT03739138|565620216|FG004|Overall Study|Study Terminated By Sponsor|0|||
156692441|NCT03739138|565620212|FG000|Overall Study|Withdrawal by Subject|0|||
156692442|NCT03739138|565620213|FG001|Overall Study|Withdrawal by Subject|0|||
156692443|NCT03739138|565620214|FG002|Overall Study|Withdrawal by Subject|0|||
156692444|NCT03739138|565620215|FG003|Overall Study|Withdrawal by Subject|1|||
156692445|NCT03739138|565620216|FG004|Overall Study|Withdrawal by Subject|0|||
156692446|NCT00597116|565620220|FG000|Overall Study|Adverse Event|2|||
156692447|NCT00597116|565620221|FG001|Overall Study|Adverse Event|1|||
156692448|NCT00597116|565620220|FG000|Overall Study|Withdrawal by Subject|0|||
156692449|NCT00597116|565620221|FG001|Overall Study|Withdrawal by Subject|2|||
156692450|NCT00597116|565620220|FG000|Overall Study|Physician Decision|0|||
156692451|NCT00597116|565620221|FG001|Overall Study|Physician Decision|1|||
156692452|NCT00597116|565620220|FG000|Overall Study|Death|0|||
156692453|NCT00597116|565620221|FG001|Overall Study|Death|1|||
156692454|NCT00597116|565620220|FG000|Overall Study|Lost to Follow-up|1|||
156692455|NCT00597116|565620221|FG001|Overall Study|Lost to Follow-up|0|||
156692456|NCT00597116|565620220|FG000|Overall Study|Progressive disease|11|||
156692457|NCT00597116|565620221|FG001|Overall Study|Progressive disease|6|||
156692458|NCT02096588|565620222|FG000|Overall Study|Lack of Efficacy|2|||
156692459|NCT02096588|565620223|FG001|Overall Study|Lack of Efficacy|0|||
156692460|NCT02096588|565620222|FG000|Overall Study|Withdrawal by Subject|0|||
156692461|NCT02096588|565620223|FG001|Overall Study|Withdrawal by Subject|1|||
156692462|NCT01258101|565620224|FG000|Overall Study|Adverse Event|5|||
156692463|NCT01258101|565620225|FG001|Overall Study|Adverse Event|6|||
156692464|NCT01258101|565620226|FG002|Overall Study|Adverse Event|0|||
156692465|NCT01258101|565620227|FG003|Overall Study|Adverse Event|0|||
156692466|NCT01258101|565620224|FG000|Overall Study|Extra exclusion criterion amended|2|||
156692467|NCT01258101|565620225|FG001|Overall Study|Extra exclusion criterion amended|1|||
156692468|NCT01258101|565620226|FG002|Overall Study|Extra exclusion criterion amended|1|||
156692469|NCT01258101|565620227|FG003|Overall Study|Extra exclusion criterion amended|1|||
156692470|NCT01258101|565620224|FG000|Overall Study|Informed consent has been withdrawn|2|||
156692471|NCT01258101|565620225|FG001|Overall Study|Informed consent has been withdrawn|2|||
156692472|NCT01258101|565620226|FG002|Overall Study|Informed consent has been withdrawn|1|||
156692473|NCT01258101|565620227|FG003|Overall Study|Informed consent has been withdrawn|1|||
156692474|NCT01258101|565620224|FG000|Overall Study|Patient is not able to attend visits|8|||
156692475|NCT01258101|565620225|FG001|Overall Study|Patient is not able to attend visits|9|||
156692476|NCT01258101|565620226|FG002|Overall Study|Patient is not able to attend visits|7|||
156692477|NCT01258101|565620227|FG003|Overall Study|Patient is not able to attend visits|6|||
156692478|NCT01258101|565620224|FG000|Overall Study|Patient´s compliance|4|||
156692479|NCT01258101|565620225|FG001|Overall Study|Patient´s compliance|3|||
156692480|NCT01258101|565620226|FG002|Overall Study|Patient´s compliance|1|||
156692481|NCT01258101|565620227|FG003|Overall Study|Patient´s compliance|2|||
156692482|NCT01258101|565620224|FG000|Overall Study|Lost to Follow-up|5|||
156692483|NCT01258101|565620225|FG001|Overall Study|Lost to Follow-up|5|||
156692484|NCT01258101|565620226|FG002|Overall Study|Lost to Follow-up|0|||
156692485|NCT01258101|565620227|FG003|Overall Study|Lost to Follow-up|6|||
156788634|NCT04518410|565977298|FG016|Overall Study|Withdrawal by Subject|0|||
156788635|NCT04518410|565977299|FG017|Overall Study|Withdrawal by Subject|15|||
156788636|NCT04518410|565977300|FG018|Overall Study|Withdrawal by Subject|12|||
156788637|NCT04518410|565977301|FG019|Overall Study|Withdrawal by Subject|9|||
156788638|NCT04518410|565977302|FG020|Overall Study|Withdrawal by Subject|14|||
156788639|NCT04518410|565977303|FG021|Overall Study|Withdrawal by Subject|3|||
156788640|NCT04518410|565977304|FG022|Overall Study|Withdrawal by Subject|2|||
156788641|NCT04518410|565977305|FG023|Overall Study|Withdrawal by Subject|9|||
156788642|NCT04518410|565977306|FG024|Overall Study|Withdrawal by Subject|8|||
156788643|NCT04518410|565977282|FG000|Overall Study|Other|1|||
156788644|NCT04518410|565977283|FG001|Overall Study|Other|0|||
156788645|NCT04518410|565977284|FG002|Overall Study|Other|0|||
156788646|NCT04518410|565977285|FG003|Overall Study|Other|1|||
156788647|NCT04518410|565977286|FG004|Overall Study|Other|6|||
156788648|NCT04518410|565977287|FG005|Overall Study|Other|6|||
156788649|NCT04518410|565977288|FG006|Overall Study|Other|5|||
156788650|NCT04518410|565977289|FG007|Overall Study|Other|2|||
156788651|NCT04518410|565977290|FG008|Overall Study|Other|0|||
156692486|NCT01258101|565620224|FG000|Overall Study|PCR positive at week 24|0|||
156692487|NCT01258101|565620225|FG001|Overall Study|PCR positive at week 24|0|||
156692488|NCT01258101|565620226|FG002|Overall Study|PCR positive at week 24|0|||
156692489|NCT01258101|565620227|FG003|Overall Study|PCR positive at week 24|1|||
156692490|NCT01258101|565620224|FG000|Overall Study|Other reason|7|||
156692491|NCT01258101|565620225|FG001|Overall Study|Other reason|8|||
156692492|NCT01258101|565620226|FG002|Overall Study|Other reason|1|||
156692493|NCT01258101|565620227|FG003|Overall Study|Other reason|8|||
156692494|NCT00063882|565620230|FG000|Overall Study|Protocol Violation|3|||
156692495|NCT00063882|565620231|FG001|Overall Study|Protocol Violation|3|||
156788652|NCT04518410|565977291|FG009|Overall Study|Other|1|||
156788653|NCT04518410|565977292|FG010|Overall Study|Other|0|||
156788654|NCT04518410|565977293|FG011|Overall Study|Other|2|||
156788655|NCT04518410|565977294|FG012|Overall Study|Other|0|||
156788656|NCT04518410|565977295|FG013|Overall Study|Other|0|||
156692496|NCT00063882|565620230|FG000|Overall Study|Withdrawal by Subject|2|||
156692497|NCT00063882|565620231|FG001|Overall Study|Withdrawal by Subject|1|||
156692498|NCT02903238|565620232|FG000|Overall Study|Lost to Follow-up|4|||
156692499|NCT02777918|565620234|FG000|Overall Study|Medical reasons|1|||
156692500|NCT02777918|565620235|FG001|Overall Study|Medical reasons|2|||
156692501|NCT02777918|565620234|FG000|Overall Study|Too busy / stressed|1|||
156692502|NCT02777918|565620235|FG001|Overall Study|Too busy / stressed|1|||
156692503|NCT02777918|565620234|FG000|Overall Study|Withdrawal by Subject|1|||
156692504|NCT02777918|565620235|FG001|Overall Study|Withdrawal by Subject|1|||
156692505|NCT00733369|565620242|FG000|Overall Study|Lost to Follow-up|2|||
156692506|NCT00733369|565620243|FG001|Overall Study|Lost to Follow-up|1|||
156692507|NCT00733369|565620242|FG000|Overall Study|Adverse Event|4|||
156692508|NCT00733369|565620243|FG001|Overall Study|Adverse Event|4|||
156692509|NCT00733369|565620242|FG000|Overall Study|Protocol Violation|4|||
156692510|NCT00733369|565620243|FG001|Overall Study|Protocol Violation|4|||
156692511|NCT01020799|565620244|FG000|Overall Study|Adverse Event|4|||
156692512|NCT01020799|565620245|FG001|Overall Study|Adverse Event|3|||
156692513|NCT01020799|565620246|FG002|Overall Study|Adverse Event|2|||
156692514|NCT01020799|565620244|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
156692515|NCT01020799|565620245|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
156692516|NCT01020799|565620246|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
156692517|NCT01020799|565620244|FG000|Overall Study|Protocol Violation|3|||
156692518|NCT01020799|565620245|FG001|Overall Study|Protocol Violation|2|||
156692519|NCT01020799|565620246|FG002|Overall Study|Protocol Violation|0|||
156692520|NCT01020799|565620244|FG000|Overall Study|Withdrawal by Subject|2|||
156692521|NCT01020799|565620245|FG001|Overall Study|Withdrawal by Subject|2|||
156692522|NCT01020799|565620246|FG002|Overall Study|Withdrawal by Subject|3|||
156692523|NCT01020799|565620244|FG000|Overall Study|Lost to Follow-up|6|||
156692524|NCT01020799|565620245|FG001|Overall Study|Lost to Follow-up|4|||
156692525|NCT01020799|565620246|FG002|Overall Study|Lost to Follow-up|2|||
156692526|NCT02556307|565620256|FG000|Overall Study|Premature treatment interruption|11|||
156692527|NCT02556307|565620256|FG000|Overall Study|Lost to Follow-up|36|||
156692528|NCT02556307|565620256|FG000|Overall Study|Change to triple therapy|4|||
156692529|NCT02556307|565620256|FG000|Overall Study|Enrolled but not treated|2|||
156692530|NCT00653991|565620258|FG000|3 Month Follow-up|Participant would not respond|150|||
156788657|NCT04518410|565977296|FG014|Overall Study|Other|0|||
156788658|NCT04518410|565977297|FG015|Overall Study|Other|3|||
156788659|NCT04518410|565977298|FG016|Overall Study|Other|1|||
156788660|NCT04518410|565977299|FG017|Overall Study|Other|1|||
156788661|NCT04518410|565977300|FG018|Overall Study|Other|1|||
156788662|NCT04518410|565977301|FG019|Overall Study|Other|0|||
156788663|NCT04518410|565977302|FG020|Overall Study|Other|1|||
156788664|NCT04518410|565977303|FG021|Overall Study|Other|0|||
156788665|NCT04518410|565977304|FG022|Overall Study|Other|1|||
156788666|NCT04518410|565977305|FG023|Overall Study|Other|2|||
156788667|NCT04518410|565977306|FG024|Overall Study|Other|2|||
156788668|NCT04518410|565977282|FG000|Overall Study|Protocol Violation|0|||
156788669|NCT04518410|565977283|FG001|Overall Study|Protocol Violation|0|||
156788670|NCT04518410|565977284|FG002|Overall Study|Protocol Violation|0|||
156692531|NCT00653991|565620259|FG001|3 Month Follow-up|Participant would not respond|157|||
156692532|NCT00653991|565620258|FG000|6 Month Follow-up|Participant would not respond|133|||
156692533|NCT00653991|565620259|FG001|6 Month Follow-up|Participant would not respond|141|||
156692534|NCT02149121|565620260|FG000|Main Study Period|Lack of Efficacy|2|||
156692535|NCT02149121|565620261|FG001|Main Study Period|Lack of Efficacy|2|||
156692536|NCT02149121|565620262|FG002|Main Study Period|Lack of Efficacy|1|||
156692537|NCT02149121|565620263|FG003|Main Study Period|Lack of Efficacy|0|||
156692538|NCT02149121|565620264|FG004|Main Study Period|Lack of Efficacy|0|||
156692539|NCT02149121|565620265|FG005|Main Study Period|Lack of Efficacy|0|||
156692540|NCT02149121|565620266|FG006|Main Study Period|Lack of Efficacy|0|||
156692541|NCT02149121|565620260|FG000|Main Study Period|Withdrawal by Subject|9|||
156692542|NCT02149121|565620261|FG001|Main Study Period|Withdrawal by Subject|5|||
156692543|NCT02149121|565620262|FG002|Main Study Period|Withdrawal by Subject|1|||
156788671|NCT04518410|565977285|FG003|Overall Study|Protocol Violation|2|||
156788672|NCT04518410|565977286|FG004|Overall Study|Protocol Violation|17|||
156788673|NCT04518410|565977287|FG005|Overall Study|Protocol Violation|1|||
156692544|NCT02149121|565620263|FG003|Main Study Period|Withdrawal by Subject|0|||
156692545|NCT02149121|565620264|FG004|Main Study Period|Withdrawal by Subject|0|||
156692546|NCT02149121|565620265|FG005|Main Study Period|Withdrawal by Subject|0|||
156788674|NCT04518410|565977288|FG006|Overall Study|Protocol Violation|2|||
156788675|NCT04518410|565977289|FG007|Overall Study|Protocol Violation|1|||
156692547|NCT02149121|565620266|FG006|Main Study Period|Withdrawal by Subject|0|||
156788676|NCT04518410|565977290|FG008|Overall Study|Protocol Violation|0|||
156788677|NCT04518410|565977291|FG009|Overall Study|Protocol Violation|0|||
156692548|NCT02149121|565620260|FG000|Main Study Period|Adverse Event|2|||
156788678|NCT04518410|565977292|FG010|Overall Study|Protocol Violation|0|||
156788679|NCT04518410|565977293|FG011|Overall Study|Protocol Violation|0|||
156788680|NCT04518410|565977294|FG012|Overall Study|Protocol Violation|0|||
156788681|NCT04518410|565977295|FG013|Overall Study|Protocol Violation|0|||
156788682|NCT04518410|565977296|FG014|Overall Study|Protocol Violation|0|||
156692549|NCT02149121|565620261|FG001|Main Study Period|Adverse Event|5|||
156692550|NCT02149121|565620262|FG002|Main Study Period|Adverse Event|1|||
156692551|NCT02149121|565620263|FG003|Main Study Period|Adverse Event|0|||
156692552|NCT02149121|565620264|FG004|Main Study Period|Adverse Event|0|||
156692553|NCT02149121|565620265|FG005|Main Study Period|Adverse Event|0|||
156692554|NCT02149121|565620266|FG006|Main Study Period|Adverse Event|0|||
156692555|NCT02149121|565620260|FG000|Main Study Period|Protocol Violation|2|||
156692556|NCT02149121|565620261|FG001|Main Study Period|Protocol Violation|0|||
156692557|NCT02149121|565620262|FG002|Main Study Period|Protocol Violation|0|||
156692558|NCT02149121|565620263|FG003|Main Study Period|Protocol Violation|0|||
156692559|NCT02149121|565620264|FG004|Main Study Period|Protocol Violation|0|||
156692560|NCT02149121|565620265|FG005|Main Study Period|Protocol Violation|0|||
156692561|NCT02149121|565620266|FG006|Main Study Period|Protocol Violation|0|||
156692562|NCT02149121|565620260|FG000|Main Study Period|Lost to Follow-up|2|||
156692563|NCT02149121|565620261|FG001|Main Study Period|Lost to Follow-up|1|||
156692564|NCT02149121|565620262|FG002|Main Study Period|Lost to Follow-up|0|||
156692565|NCT02149121|565620263|FG003|Main Study Period|Lost to Follow-up|0|||
156692566|NCT02149121|565620264|FG004|Main Study Period|Lost to Follow-up|0|||
156692567|NCT02149121|565620265|FG005|Main Study Period|Lost to Follow-up|0|||
156692568|NCT02149121|565620266|FG006|Main Study Period|Lost to Follow-up|0|||
156692569|NCT02149121|565620260|FG000|Main Study Period|Death|1|||
156692570|NCT02149121|565620261|FG001|Main Study Period|Death|0|||
156692571|NCT02149121|565620262|FG002|Main Study Period|Death|0|||
156692572|NCT02149121|565620263|FG003|Main Study Period|Death|0|||
156692573|NCT02149121|565620264|FG004|Main Study Period|Death|0|||
156692574|NCT02149121|565620265|FG005|Main Study Period|Death|0|||
156692575|NCT02149121|565620266|FG006|Main Study Period|Death|0|||
156692576|NCT02149121|565620260|FG000|Main Study Period|Physician Decision|1|||
156692577|NCT02149121|565620261|FG001|Main Study Period|Physician Decision|0|||
156692578|NCT02149121|565620262|FG002|Main Study Period|Physician Decision|0|||
156692579|NCT02149121|565620263|FG003|Main Study Period|Physician Decision|0|||
156692580|NCT02149121|565620264|FG004|Main Study Period|Physician Decision|0|||
156692581|NCT02149121|565620265|FG005|Main Study Period|Physician Decision|0|||
156692582|NCT02149121|565620266|FG006|Main Study Period|Physician Decision|0|||
156692583|NCT02149121|565620260|FG000|Main Study Period|Developed any malignancy|0|||
156692584|NCT02149121|565620261|FG001|Main Study Period|Developed any malignancy|1|||
156692585|NCT02149121|565620262|FG002|Main Study Period|Developed any malignancy|1|||
156692586|NCT02149121|565620263|FG003|Main Study Period|Developed any malignancy|0|||
156692587|NCT02149121|565620264|FG004|Main Study Period|Developed any malignancy|0|||
156692588|NCT02149121|565620265|FG005|Main Study Period|Developed any malignancy|0|||
156692589|NCT02149121|565620266|FG006|Main Study Period|Developed any malignancy|0|||
156692590|NCT02149121|565620260|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
156692591|NCT02149121|565620261|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
156692592|NCT02149121|565620262|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
156692593|NCT02149121|565620263|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
156692594|NCT02149121|565620264|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
156692595|NCT02149121|565620265|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
156692596|NCT02149121|565620266|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
156692597|NCT02149121|565620260|FG000|Main Study Period|Disease progression|0|||
156692598|NCT02149121|565620261|FG001|Main Study Period|Disease progression|1|||
156692599|NCT02149121|565620262|FG002|Main Study Period|Disease progression|0|||
156692600|NCT02149121|565620263|FG003|Main Study Period|Disease progression|0|||
156692601|NCT02149121|565620264|FG004|Main Study Period|Disease progression|0|||
156692602|NCT02149121|565620265|FG005|Main Study Period|Disease progression|0|||
156692603|NCT02149121|565620266|FG006|Main Study Period|Disease progression|0|||
156870265|NCT04922216|566281138|FG009|Overall Study|Lost to Follow-up|2|||
156870266|NCT04922216|566281139|FG010|Overall Study|Lost to Follow-up|2|||
156870267|NCT04922216|566281140|FG011|Overall Study|Lost to Follow-up|1|||
156870268|NCT04922216|566281141|FG012|Overall Study|Lost to Follow-up|1|||
156330239|NCT00543543|564308816|FG003|Base Study|Withdrawal by Subject|503|||
156692604|NCT02149121|565620260|FG000|Extension Study Period|Withdrawal by Subject|0|||
156330240|NCT00543543|564308813|FG000|Extension Study|Adverse Event|0|||
156692605|NCT02149121|565620261|FG001|Extension Study Period|Withdrawal by Subject|0|||
156692606|NCT02149121|565620262|FG002|Extension Study Period|Withdrawal by Subject|0|||
156692607|NCT02149121|565620263|FG003|Extension Study Period|Withdrawal by Subject|1|||
156692608|NCT02149121|565620264|FG004|Extension Study Period|Withdrawal by Subject|0|||
156692609|NCT02149121|565620265|FG005|Extension Study Period|Withdrawal by Subject|2|||
156692610|NCT02149121|565620266|FG006|Extension Study Period|Withdrawal by Subject|0|||
156692611|NCT01244061|565620275|FG000|Overall Study|Death|1|||
156692612|NCT01244061|565620276|FG001|Overall Study|Death|0|||
156692613|NCT01244061|565620275|FG000|Overall Study|Did not meet entrance criteria|1|||
156692614|NCT01244061|565620276|FG001|Overall Study|Did not meet entrance criteria|0|||
156692615|NCT01244061|565620275|FG000|Overall Study|Lack of Efficacy|1|||
156692616|NCT01244061|565620276|FG001|Overall Study|Lack of Efficacy|3|||
156870269|NCT04922216|566281142|FG013|Overall Study|Lost to Follow-up|0|||
156788683|NCT04518410|565977297|FG015|Overall Study|Protocol Violation|0|||
156788684|NCT04518410|565977298|FG016|Overall Study|Protocol Violation|1|||
156330241|NCT00543543|564308814|FG001|Extension Study|Adverse Event|0|||
156330242|NCT00543543|564308815|FG002|Extension Study|Adverse Event|0|||
156330243|NCT00543543|564308816|FG003|Extension Study|Adverse Event|5|||
156330244|NCT00543543|564308813|FG000|Extension Study|Lost to Follow-up|0|||
156330245|NCT00543543|564308814|FG001|Extension Study|Lost to Follow-up|0|||
156330246|NCT00543543|564308815|FG002|Extension Study|Lost to Follow-up|0|||
156330247|NCT00543543|564308816|FG003|Extension Study|Lost to Follow-up|77|||
156330248|NCT00543543|564308813|FG000|Extension Study|Physician Decision|0|||
156330249|NCT00543543|564308814|FG001|Extension Study|Physician Decision|0|||
156330250|NCT00543543|564308815|FG002|Extension Study|Physician Decision|0|||
156788685|NCT04518410|565977299|FG017|Overall Study|Protocol Violation|1|||
156788686|NCT04518410|565977300|FG018|Overall Study|Protocol Violation|0|||
156788687|NCT04518410|565977301|FG019|Overall Study|Protocol Violation|0|||
156788688|NCT04518410|565977302|FG020|Overall Study|Protocol Violation|1|||
156788689|NCT04518410|565977303|FG021|Overall Study|Protocol Violation|2|||
156788690|NCT04518410|565977304|FG022|Overall Study|Protocol Violation|0|||
156788691|NCT04518410|565977305|FG023|Overall Study|Protocol Violation|3|||
156788692|NCT04518410|565977306|FG024|Overall Study|Protocol Violation|0|||
156788693|NCT04518410|565977282|FG000|Overall Study|Death|0|||
156330251|NCT00543543|564308816|FG003|Extension Study|Physician Decision|7|||
156330252|NCT00543543|564308813|FG000|Extension Study|Pregnancy|0|||
156788694|NCT04518410|565977283|FG001|Overall Study|Death|0|||
156870270|NCT04922216|566281143|FG014|Overall Study|Lost to Follow-up|1|||
156870271|NCT04922216|566281144|FG015|Overall Study|Lost to Follow-up|0|||
156330253|NCT00543543|564308814|FG001|Extension Study|Pregnancy|0|||
156870272|NCT04922216|566281145|FG016|Overall Study|Lost to Follow-up|0|||
156870273|NCT04922216|566281146|FG017|Overall Study|Lost to Follow-up|2|||
156870274|NCT04922216|566281147|FG018|Overall Study|Lost to Follow-up|1|||
156330254|NCT00543543|564308815|FG002|Extension Study|Pregnancy|0|||
156330255|NCT00543543|564308816|FG003|Extension Study|Pregnancy|6|||
156330256|NCT00543543|564308813|FG000|Extension Study|Protocol Violation|0|||
156330257|NCT00543543|564308814|FG001|Extension Study|Protocol Violation|0|||
156330258|NCT00543543|564308815|FG002|Extension Study|Protocol Violation|0|||
156330259|NCT00543543|564308816|FG003|Extension Study|Protocol Violation|11|||
156330260|NCT00543543|564308813|FG000|Extension Study|Withdrawal by Subject|0|||
156330261|NCT00543543|564308814|FG001|Extension Study|Withdrawal by Subject|0|||
156330262|NCT00543543|564308815|FG002|Extension Study|Withdrawal by Subject|0|||
156788695|NCT04518410|565977284|FG002|Overall Study|Death|0|||
156870275|NCT04922216|566281148|FG019|Overall Study|Lost to Follow-up|0|||
156870276|NCT04922216|566281149|FG020|Overall Study|Lost to Follow-up|1|||
156870277|NCT04922216|566281150|FG021|Overall Study|Lost to Follow-up|0|||
156870278|NCT04922216|566281151|FG022|Overall Study|Lost to Follow-up|2|||
156870279|NCT04922216|566281152|FG023|Overall Study|Lost to Follow-up|1|||
156870280|NCT04922216|566281153|FG024|Overall Study|Lost to Follow-up|0|||
156870281|NCT04922216|566281154|FG025|Overall Study|Lost to Follow-up|2|||
156870282|NCT04922216|566281155|FG026|Overall Study|Lost to Follow-up|0|||
156870283|NCT04922216|566281156|FG027|Overall Study|Lost to Follow-up|0|||
156870284|NCT04922216|566281157|FG028|Overall Study|Lost to Follow-up|1|||
156870285|NCT04922216|566281158|FG029|Overall Study|Lost to Follow-up|0|||
156870286|NCT04922216|566281159|FG030|Overall Study|Lost to Follow-up|2|||
156870287|NCT04922216|566281160|FG031|Overall Study|Lost to Follow-up|1|||
156870288|NCT03278249|566281161|FG000|Overall Study|Withdrawal by Subject|2|||
156870289|NCT03278249|566281161|FG000|Overall Study|Lost to Follow-up|1|||
156870290|NCT02017405|566281162|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156330263|NCT00543543|564308816|FG003|Extension Study|Withdrawal by Subject|120|||
156330264|NCT00945555|564308817|FG000|Overall Study|Referred to another hospital|5|||
156788696|NCT04518410|565977285|FG003|Overall Study|Death|0|||
156788697|NCT04518410|565977286|FG004|Overall Study|Death|12|||
156330265|NCT00945555|564308817|FG000|Overall Study|Worsening condition, intensive care unit|1|||
156330266|NCT00945555|564308817|FG000|Overall Study|Withdrawal by Subject|2|||
156330267|NCT00945555|564308817|FG000|Overall Study|Participant continued treatment at home|1|||
156330268|NCT00945555|564308817|FG000|Overall Study|Death|18|||
156330269|NCT00945555|564308817|FG000|Overall Study|Other|1|||
156330270|NCT04502979|564308819|FG000|Overall Study|Lost to Follow-up|1|||
156330271|NCT04502979|564308820|FG001|Overall Study|Lost to Follow-up|3|||
156330272|NCT04502979|564308819|FG000|Overall Study|Withdrawal by Subject|2|||
156330273|NCT04502979|564308820|FG001|Overall Study|Withdrawal by Subject|1|||
156788698|NCT04518410|565977287|FG005|Overall Study|Death|2|||
156788699|NCT04518410|565977288|FG006|Overall Study|Death|11|||
156788700|NCT04518410|565977289|FG007|Overall Study|Death|0|||
156788701|NCT04518410|565977290|FG008|Overall Study|Death|1|||
156788702|NCT04518410|565977291|FG009|Overall Study|Death|0|||
156788703|NCT04518410|565977292|FG010|Overall Study|Death|0|||
156870291|NCT02017405|566281163|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156870292|NCT02017405|566281164|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156870293|NCT02017405|566281165|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156870294|NCT02017405|566281166|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156788704|NCT04518410|565977293|FG011|Overall Study|Death|0|||
156788705|NCT04518410|565977294|FG012|Overall Study|Death|0|||
156788706|NCT04518410|565977295|FG013|Overall Study|Death|1|||
156788707|NCT04518410|565977296|FG014|Overall Study|Death|1|||
156788708|NCT04518410|565977297|FG015|Overall Study|Death|0|||
156788709|NCT04518410|565977298|FG016|Overall Study|Death|0|||
156788710|NCT04518410|565977299|FG017|Overall Study|Death|1|||
156788711|NCT04518410|565977300|FG018|Overall Study|Death|4|||
156788712|NCT04518410|565977301|FG019|Overall Study|Death|4|||
156788713|NCT04518410|565977302|FG020|Overall Study|Death|1|||
156788714|NCT04518410|565977303|FG021|Overall Study|Death|0|||
156788715|NCT04518410|565977304|FG022|Overall Study|Death|0|||
156788716|NCT04518410|565977305|FG023|Overall Study|Death|0|||
156788717|NCT04518410|565977306|FG024|Overall Study|Death|0|||
156788718|NCT04518410|565977282|FG000|Overall Study|Requirement to start alternative therapy|0|||
156788719|NCT04518410|565977283|FG001|Overall Study|Requirement to start alternative therapy|0|||
156788720|NCT04518410|565977284|FG002|Overall Study|Requirement to start alternative therapy|1|||
156788721|NCT04518410|565977285|FG003|Overall Study|Requirement to start alternative therapy|0|||
156788722|NCT04518410|565977286|FG004|Overall Study|Requirement to start alternative therapy|0|||
156788723|NCT04518410|565977287|FG005|Overall Study|Requirement to start alternative therapy|0|||
156788724|NCT04518410|565977288|FG006|Overall Study|Requirement to start alternative therapy|0|||
156788725|NCT04518410|565977289|FG007|Overall Study|Requirement to start alternative therapy|0|||
156788726|NCT04518410|565977290|FG008|Overall Study|Requirement to start alternative therapy|0|||
156437052|NCT03401112|564689936|FG002|Overall Study|Day 1 Assessment not Done|0|||
156437053|NCT03401112|564689937|FG003|Overall Study|Day 1 Assessment not Done|0|||
156437054|NCT03401112|564689938|FG004|Overall Study|Day 1 Assessment not Done|0|||
156692617|NCT01244061|565620275|FG000|Overall Study|Lost to Follow-up|34|||
156692618|NCT01244061|565620276|FG001|Overall Study|Lost to Follow-up|30|||
156692619|NCT01244061|565620275|FG000|Overall Study|Withdrawal by Subject|29|||
156692620|NCT01244061|565620276|FG001|Overall Study|Withdrawal by Subject|46|||
156692621|NCT01244061|565620275|FG000|Overall Study|Other|8|||
156692622|NCT01244061|565620276|FG001|Overall Study|Other|19|||
156692623|NCT01244061|565620275|FG000|Overall Study|Protocol Violation|1|||
156692624|NCT01244061|565620276|FG001|Overall Study|Protocol Violation|1|||
156692625|NCT01244061|565620275|FG000|Overall Study|Adverse Event|5|||
156692626|NCT01244061|565620276|FG001|Overall Study|Adverse Event|2|||
156692627|NCT01244061|565620275|FG000|Overall Study|Randomized but not treated|2|||
156692628|NCT01244061|565620276|FG001|Overall Study|Randomized but not treated|2|||
156692629|NCT03166124|565620277|FG000|Treatment Period 1|Adverse Event|0|||
156692630|NCT03166124|565620278|FG001|Treatment Period 1|Adverse Event|0|||
156692631|NCT03166124|565620279|FG002|Treatment Period 1|Adverse Event|1|||
156692632|NCT03166124|565620280|FG003|Treatment Period 1|Adverse Event|0|||
156692633|NCT03166124|565620277|FG000|Wash-out Period|Withdrawal by Subject|0|||
156692634|NCT03166124|565620278|FG001|Wash-out Period|Withdrawal by Subject|1|||
156692635|NCT03166124|565620279|FG002|Wash-out Period|Withdrawal by Subject|0|||
156692636|NCT03166124|565620280|FG003|Wash-out Period|Withdrawal by Subject|1|||
156692637|NCT03166124|565620277|FG000|Wash-out Period|Adverse Event|0|||
156692638|NCT03166124|565620278|FG001|Wash-out Period|Adverse Event|1|||
156692639|NCT03166124|565620279|FG002|Wash-out Period|Adverse Event|1|||
156692640|NCT03166124|565620280|FG003|Wash-out Period|Adverse Event|0|||
156692641|NCT00788593|565620283|FG000|Placebo Run-in Phase|Adverse Event|2|||
156692642|NCT00788593|565620284|FG001|Placebo Run-in Phase|Adverse Event|0|||
156692643|NCT00788593|565620285|FG002|Placebo Run-in Phase|Adverse Event|0|||
156692644|NCT00788593|565620283|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
156692645|NCT00788593|565620284|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
156692646|NCT00788593|565620285|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
156692647|NCT00788593|565620283|FG000|Placebo Run-in Phase|Protocol Violation|2|||
156692648|NCT00788593|565620284|FG001|Placebo Run-in Phase|Protocol Violation|0|||
156692649|NCT00788593|565620285|FG002|Placebo Run-in Phase|Protocol Violation|0|||
156692650|NCT00788593|565620283|FG000|First Intervention Period|Adverse Event|0|||
156692651|NCT00788593|565620284|FG001|First Intervention Period|Adverse Event|1|||
156692652|NCT00788593|565620285|FG002|First Intervention Period|Adverse Event|0|||
156692653|NCT00788593|565620283|FG000|Second Intervention Period|Lost to Follow-up|0|||
156692654|NCT00788593|565620284|FG001|Second Intervention Period|Lost to Follow-up|1|||
156788727|NCT04518410|565977291|FG009|Overall Study|Requirement to start alternative therapy|0|||
156788728|NCT04518410|565977292|FG010|Overall Study|Requirement to start alternative therapy|0|||
156788729|NCT04518410|565977293|FG011|Overall Study|Requirement to start alternative therapy|0|||
156788730|NCT04518410|565977294|FG012|Overall Study|Requirement to start alternative therapy|0|||
156788731|NCT04518410|565977295|FG013|Overall Study|Requirement to start alternative therapy|0|||
156788732|NCT04518410|565977296|FG014|Overall Study|Requirement to start alternative therapy|0|||
156788733|NCT04518410|565977297|FG015|Overall Study|Requirement to start alternative therapy|0|||
156692655|NCT00788593|565620285|FG002|Second Intervention Period|Lost to Follow-up|0|||
156788734|NCT04518410|565977298|FG016|Overall Study|Requirement to start alternative therapy|0|||
156788735|NCT04518410|565977299|FG017|Overall Study|Requirement to start alternative therapy|0|||
156788736|NCT04518410|565977300|FG018|Overall Study|Requirement to start alternative therapy|0|||
156692656|NCT00788593|565620283|FG000|Second Intervention Period|Other|0|||
156692657|NCT00788593|565620284|FG001|Second Intervention Period|Other|0|||
156692658|NCT00788593|565620285|FG002|Second Intervention Period|Other|1|||
156692659|NCT00515034|565620286|FG000|Overall Study|Adverse Event|2|||
156692660|NCT00515034|565620287|FG001|Overall Study|Adverse Event|0|||
156692661|NCT00515034|565620288|FG002|Overall Study|Adverse Event|1|||
156692662|NCT00515034|565620289|FG003|Overall Study|Adverse Event|0|||
156692663|NCT00515034|565620286|FG000|Overall Study|Death|4|||
156692664|NCT00515034|565620287|FG001|Overall Study|Death|2|||
156692665|NCT00515034|565620288|FG002|Overall Study|Death|1|||
156692666|NCT00515034|565620289|FG003|Overall Study|Death|3|||
156692667|NCT00515034|565620286|FG000|Overall Study|Withdrawal by Subject|1|||
156692668|NCT00515034|565620287|FG001|Overall Study|Withdrawal by Subject|0|||
156692669|NCT00515034|565620288|FG002|Overall Study|Withdrawal by Subject|3|||
156692670|NCT00515034|565620289|FG003|Overall Study|Withdrawal by Subject|0|||
156692671|NCT00515034|565620286|FG000|Overall Study|Physician Decision|0|||
156692672|NCT00515034|565620287|FG001|Overall Study|Physician Decision|0|||
156692673|NCT00515034|565620288|FG002|Overall Study|Physician Decision|1|||
156692674|NCT00515034|565620289|FG003|Overall Study|Physician Decision|1|||
156692675|NCT00515034|565620286|FG000|Overall Study|Other|1|||
156692676|NCT00515034|565620287|FG001|Overall Study|Other|0|||
156692677|NCT00515034|565620288|FG002|Overall Study|Other|2|||
156692678|NCT00515034|565620289|FG003|Overall Study|Other|1|||
156692679|NCT01392326|565620292|FG000|Overall Study|Death|2|||
156692680|NCT01392326|565620293|FG001|Overall Study|Death|0|||
156692681|NCT01392326|565620294|FG002|Overall Study|Death|0|||
156692682|NCT01392326|565620292|FG000|Overall Study|Withdrawal by Subject|12|||
156692683|NCT01392326|565620293|FG001|Overall Study|Withdrawal by Subject|11|||
156692684|NCT01392326|565620294|FG002|Overall Study|Withdrawal by Subject|15|||
156692685|NCT01392326|565620292|FG000|Overall Study|Protocol Violation|2|||
156692686|NCT01392326|565620293|FG001|Overall Study|Protocol Violation|0|||
156692687|NCT01392326|565620294|FG002|Overall Study|Protocol Violation|0|||
156692688|NCT01392326|565620292|FG000|Overall Study|Pregnancy|0|||
156692689|NCT01392326|565620293|FG001|Overall Study|Pregnancy|0|||
156692690|NCT01392326|565620294|FG002|Overall Study|Pregnancy|1|||
156692691|NCT01392326|565620292|FG000|Overall Study|Physician Decision|7|||
156692692|NCT01392326|565620293|FG001|Overall Study|Physician Decision|5|||
156692693|NCT01392326|565620294|FG002|Overall Study|Physician Decision|2|||
156692694|NCT01392326|565620292|FG000|Overall Study|Lost to Follow-up|1|||
156692695|NCT01392326|565620293|FG001|Overall Study|Lost to Follow-up|3|||
156692696|NCT01392326|565620294|FG002|Overall Study|Lost to Follow-up|4|||
156692697|NCT01392326|565620292|FG000|Overall Study|Lack of Efficacy|14|||
156692698|NCT01392326|565620293|FG001|Overall Study|Lack of Efficacy|10|||
156692699|NCT01392326|565620294|FG002|Overall Study|Lack of Efficacy|15|||
156692700|NCT01392326|565620292|FG000|Overall Study|Adverse Event|9|||
156692701|NCT01392326|565620293|FG001|Overall Study|Adverse Event|6|||
156692702|NCT01392326|565620294|FG002|Overall Study|Adverse Event|11|||
156692703|NCT00518622|565620297|FG000|Overall Study|Lost to Follow-up|0|||
156692704|NCT00518622|565620298|FG001|Overall Study|Lost to Follow-up|0|||
156692705|NCT00518622|565620299|FG002|Overall Study|Lost to Follow-up|1|||
156692706|NCT00518622|565620300|FG003|Overall Study|Lost to Follow-up|0|||
156692707|NCT00518622|565620301|FG004|Overall Study|Lost to Follow-up|0|||
156870295|NCT02017405|566281167|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
156870296|NCT02017405|566281162|FG000|Open-label Phase|Adverse Event|1|||
156870297|NCT02017405|566281163|FG001|Open-label Phase|Adverse Event|1|||
156870298|NCT02017405|566281164|FG002|Open-label Phase|Adverse Event|0|||
156870299|NCT02017405|566281165|FG003|Open-label Phase|Adverse Event|0|||
156870300|NCT02017405|566281166|FG004|Open-label Phase|Adverse Event|0|||
156870301|NCT02017405|566281167|FG005|Open-label Phase|Adverse Event|0|||
156870302|NCT03207763|566282483|FG000|Overall Study|Lost to Follow-up|1|||
156870303|NCT03207763|566282484|FG001|Overall Study|Lost to Follow-up|0|||
156870304|NCT00990704|566282485|FG000|Overall Study|Adverse Event|1|||
156870305|NCT00990704|566282486|FG001|Overall Study|Adverse Event|1|||
156330274|NCT02734433|564308827|FG000|Overall Study|Disease progression|1|||
156330275|NCT02734433|564308828|FG001|Overall Study|Disease progression|5|||
156330276|NCT02734433|564308827|FG000|Overall Study|Clinical progression|0|||
156692708|NCT00518622|565620302|FG005|Overall Study|Lost to Follow-up|0|||
156692709|NCT00518622|565620303|FG006|Overall Study|Lost to Follow-up|0|||
156692710|NCT00518622|565620304|FG007|Overall Study|Lost to Follow-up|0|||
156692711|NCT00518622|565620297|FG000|Overall Study|Study medication taken incorrectly|0|||
156692712|NCT00518622|565620298|FG001|Overall Study|Study medication taken incorrectly|1|||
156692713|NCT00518622|565620299|FG002|Overall Study|Study medication taken incorrectly|0|||
156692714|NCT00518622|565620300|FG003|Overall Study|Study medication taken incorrectly|0|||
156692715|NCT00518622|565620301|FG004|Overall Study|Study medication taken incorrectly|0|||
156692716|NCT00518622|565620302|FG005|Overall Study|Study medication taken incorrectly|0|||
156692717|NCT00518622|565620303|FG006|Overall Study|Study medication taken incorrectly|0|||
156692718|NCT00518622|565620304|FG007|Overall Study|Study medication taken incorrectly|0|||
156692719|NCT03487848|565620305|FG000|Overall Study|Lost to Follow-up|1|||
156692720|NCT03499119|565620306|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
156870306|NCT00990704|566282485|FG000|Overall Study|Physician Decision|0|||
156692721|NCT03499119|565620307|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
156692722|NCT03499119|565620308|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
156692723|NCT03499119|565620309|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
156692724|NCT03499119|565620306|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
156692725|NCT03499119|565620307|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
156692726|NCT03499119|565620308|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
156692727|NCT03499119|565620309|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
156692728|NCT03499119|565620306|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
156692729|NCT03499119|565620307|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
156692730|NCT03499119|565620308|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
156692731|NCT03499119|565620309|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
156692732|NCT03499119|565620306|FG000|Optional Extension Phase|Lost to Follow-up|0|||
156692733|NCT03499119|565620307|FG001|Optional Extension Phase|Lost to Follow-up|0|||
156692734|NCT03499119|565620308|FG002|Optional Extension Phase|Lost to Follow-up|0|||
156692735|NCT03499119|565620309|FG003|Optional Extension Phase|Lost to Follow-up|1|||
156692736|NCT03499119|565620306|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
156692737|NCT03499119|565620307|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
156692738|NCT03499119|565620308|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
156692739|NCT03499119|565620309|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
156692740|NCT03499119|565620306|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
156692741|NCT03499119|565620307|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
156692742|NCT03499119|565620308|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
156692743|NCT03499119|565620309|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
156692744|NCT00094094|565620310|FG000|Overall Study|Death|2|||
156692745|NCT00094094|565620310|FG000|Overall Study|Lack of Efficacy|23|||
156692746|NCT00094094|565620310|FG000|Overall Study|Adverse Event|7|||
156692747|NCT02655016|565620313|FG000|Overall Study|Disease progression|6|||
156692748|NCT02655016|565620314|FG001|Overall Study|Disease progression|4|||
156692749|NCT02655016|565620313|FG000|Overall Study|Site closed|0|||
156692750|NCT02655016|565620314|FG001|Overall Study|Site closed|1|||
156692751|NCT02655016|565620313|FG000|Overall Study|Death|30|||
156692752|NCT02655016|565620314|FG001|Overall Study|Death|48|||
156692753|NCT02655016|565620313|FG000|Overall Study|Lost to Follow-up|1|||
156692754|NCT02655016|565620314|FG001|Overall Study|Lost to Follow-up|1|||
156692755|NCT02655016|565620313|FG000|Overall Study|Withdrawal by Subject|18|||
156692756|NCT02655016|565620314|FG001|Overall Study|Withdrawal by Subject|36|||
156692757|NCT04459715|565620317|FG000|Overall Study|Adverse Event|3|||
156788737|NCT04518410|565977301|FG019|Overall Study|Requirement to start alternative therapy|0|||
156788738|NCT04518410|565977302|FG020|Overall Study|Requirement to start alternative therapy|0|||
156788739|NCT04518410|565977303|FG021|Overall Study|Requirement to start alternative therapy|0|||
156788740|NCT04518410|565977304|FG022|Overall Study|Requirement to start alternative therapy|0|||
156788741|NCT04518410|565977305|FG023|Overall Study|Requirement to start alternative therapy|0|||
156788742|NCT04518410|565977306|FG024|Overall Study|Requirement to start alternative therapy|0|||
156788743|NCT04518410|565977282|FG000|Overall Study|Randomized but not treated|0|||
156788744|NCT04518410|565977283|FG001|Overall Study|Randomized but not treated|0|||
156788745|NCT04518410|565977284|FG002|Overall Study|Randomized but not treated|0|||
156788746|NCT04518410|565977285|FG003|Overall Study|Randomized but not treated|2|||
156788747|NCT04518410|565977286|FG004|Overall Study|Randomized but not treated|6|||
156788748|NCT04518410|565977287|FG005|Overall Study|Randomized but not treated|4|||
156788749|NCT04518410|565977288|FG006|Overall Study|Randomized but not treated|3|||
156788750|NCT04518410|565977289|FG007|Overall Study|Randomized but not treated|3|||
156788751|NCT04518410|565977290|FG008|Overall Study|Randomized but not treated|0|||
156788752|NCT04518410|565977291|FG009|Overall Study|Randomized but not treated|4|||
156788753|NCT04518410|565977292|FG010|Overall Study|Randomized but not treated|0|||
156788754|NCT04518410|565977293|FG011|Overall Study|Randomized but not treated|0|||
156788755|NCT04518410|565977294|FG012|Overall Study|Randomized but not treated|1|||
156788756|NCT04518410|565977295|FG013|Overall Study|Randomized but not treated|3|||
156788757|NCT04518410|565977296|FG014|Overall Study|Randomized but not treated|3|||
156788758|NCT04518410|565977297|FG015|Overall Study|Randomized but not treated|3|||
156788759|NCT04518410|565977298|FG016|Overall Study|Randomized but not treated|4|||
156788760|NCT04518410|565977299|FG017|Overall Study|Randomized but not treated|5|||
156870307|NCT00990704|566282486|FG001|Overall Study|Physician Decision|1|||
156692758|NCT04459715|565620318|FG001|Overall Study|Adverse Event|3|||
156692759|NCT04459715|565620317|FG000|Overall Study|Death|111|||
156692760|NCT04459715|565620318|FG001|Overall Study|Death|93|||
156692761|NCT04459715|565620317|FG000|Overall Study|Lost to Follow-up|10|||
156692762|NCT04459715|565620318|FG001|Overall Study|Lost to Follow-up|9|||
156788761|NCT04518410|565977300|FG018|Overall Study|Randomized but not treated|4|||
156692763|NCT04459715|565620317|FG000|Overall Study|Other Reasons|4|||
156692764|NCT04459715|565620318|FG001|Overall Study|Other Reasons|5|||
156692765|NCT04459715|565620317|FG000|Overall Study|PROTOCOL DEVIATION|0|||
156692766|NCT04459715|565620318|FG001|Overall Study|PROTOCOL DEVIATION|1|||
156692767|NCT04459715|565620317|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
156788762|NCT04518410|565977301|FG019|Overall Study|Randomized but not treated|0|||
156437055|NCT03401112|564689934|FG000|Overall Study|Not Dosed|0|||
156437056|NCT03401112|564689935|FG001|Overall Study|Not Dosed|0|||
156437057|NCT03401112|564689936|FG002|Overall Study|Not Dosed|1|||
156437058|NCT03401112|564689937|FG003|Overall Study|Not Dosed|0|||
156437059|NCT03401112|564689938|FG004|Overall Study|Not Dosed|0|||
156437060|NCT03401112|564689934|FG000|Overall Study|Missed Clinical Visit|0|||
156437061|NCT03401112|564689935|FG001|Overall Study|Missed Clinical Visit|0|||
156437062|NCT03401112|564689936|FG002|Overall Study|Missed Clinical Visit|1|||
156437063|NCT03401112|564689937|FG003|Overall Study|Missed Clinical Visit|0|||
156437064|NCT03401112|564689938|FG004|Overall Study|Missed Clinical Visit|0|||
156437065|NCT03401112|564689934|FG000|Overall Study|Missed Doses|0|||
156437066|NCT03401112|564689935|FG001|Overall Study|Missed Doses|0|||
156437067|NCT03401112|564689936|FG002|Overall Study|Missed Doses|1|||
156437068|NCT03401112|564689937|FG003|Overall Study|Missed Doses|0|||
156437069|NCT03401112|564689938|FG004|Overall Study|Missed Doses|0|||
156437070|NCT01264679|564689939|FG000|Overall Study|Participation in Another Clinical Trial|1|||
156437071|NCT01264679|564689939|FG000|Overall Study|Physician Decision|1|||
156437072|NCT01264679|564689939|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
156437073|NCT01264679|564689939|FG000|Overall Study|Withdrawal by Subject|1|||
156437074|NCT03475316|564689940|FG000|6 Month Intervention|Adverse Event|2|||
156437075|NCT03475316|564689941|FG001|6 Month Intervention|Adverse Event|1|||
156437076|NCT03475316|564689940|FG000|6 Month Intervention|Withdrawal by Subject|2|||
156437077|NCT03475316|564689941|FG001|6 Month Intervention|Withdrawal by Subject|0|||
156437078|NCT03475316|564689940|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
156437079|NCT03475316|564689941|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
156437080|NCT03475316|564689940|FG000|9 Months|Study stopped due to COVID pandemic|3|||
156437081|NCT03475316|564689941|FG001|9 Months|Study stopped due to COVID pandemic|4|||
156437082|NCT01595061|564689942|FG000|Overall Study|Never Treated|3|||
156437083|NCT01595061|564689942|FG000|Overall Study|Inadequate Pathology|1|||
156437084|NCT03194958|564689945|FG000|Overall Study|Death|0|||
156437085|NCT03194958|564689946|FG001|Overall Study|Death|1|||
156437086|NCT03194958|564689947|FG002|Overall Study|Death|1|||
156437087|NCT03194958|564689948|FG003|Overall Study|Death|1|||
156437088|NCT03194958|564689945|FG000|Overall Study|Withdrawal by Subject|24|||
156437089|NCT03194958|564689946|FG001|Overall Study|Withdrawal by Subject|27|||
156437090|NCT03194958|564689947|FG002|Overall Study|Withdrawal by Subject|7|||
156437091|NCT03194958|564689948|FG003|Overall Study|Withdrawal by Subject|22|||
156437092|NCT03194958|564689945|FG000|Overall Study|Lost to Follow-up|168|||
156437093|NCT03194958|564689946|FG001|Overall Study|Lost to Follow-up|196|||
156437094|NCT03194958|564689947|FG002|Overall Study|Lost to Follow-up|174|||
156437095|NCT03194958|564689948|FG003|Overall Study|Lost to Follow-up|186|||
156437096|NCT01179334|564689951|FG000|Treatment Period|Adverse Event|1|||
156437097|NCT01179334|564689952|FG001|Treatment Period|Adverse Event|0|||
156437098|NCT01179334|564689951|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
156437099|NCT01179334|564689952|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
156437100|NCT01179334|564689951|FG000|Long-term Extension (LTE) Period|Death|3|||
156437101|NCT01179334|564689952|FG001|Long-term Extension (LTE) Period|Death|0|||
156437102|NCT01179334|564689951|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
156437103|NCT01179334|564689952|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
156437104|NCT00256243|564689953|FG000|Overall Study|Lost to Follow-up|2|||
156437105|NCT00256243|564689953|FG000|Overall Study|Death|7|||
156437106|NCT00256243|564689953|FG000|Overall Study|Not treated|1|||
156437107|NCT01152190|564689954|FG000|Overall Study|Adverse Event|2|||
156530619|NCT00234494|565038096|FG000|Overall Study|Protocol Violation|2|||
156530620|NCT05104476|565038101|FG000|Overall Study|Randomized But Not Treated|1|||
156530621|NCT05104476|565038102|FG001|Overall Study|Randomized But Not Treated|2|||
156530622|NCT05104476|565038101|FG000|Overall Study|Adverse Event|2|||
156530623|NCT05104476|565038102|FG001|Overall Study|Adverse Event|2|||
156530624|NCT05104476|565038101|FG000|Overall Study|Withdrawal by Subject|3|||
156530625|NCT05104476|565038102|FG001|Overall Study|Withdrawal by Subject|3|||
156437108|NCT01152190|564689955|FG001|Overall Study|Adverse Event|4|||
156437109|NCT01152190|564689954|FG000|Overall Study|Death|1|||
156437110|NCT01152190|564689955|FG001|Overall Study|Death|0|||
156437111|NCT01152190|564689954|FG000|Overall Study|Protocol Violation|1|||
156437112|NCT01152190|564689955|FG001|Overall Study|Protocol Violation|1|||
156437113|NCT01152190|564689954|FG000|Overall Study|Withdrawal by Subject|1|||
156437114|NCT01152190|564689955|FG001|Overall Study|Withdrawal by Subject|3|||
156437115|NCT01595321|564689958|FG000|Overall Study|Adverse Event|1|||
156437116|NCT01595321|564689959|FG001|Overall Study|Adverse Event|1|||
156437117|NCT01595321|564689960|FG002|Overall Study|Adverse Event|1|||
156437118|NCT01595321|564689958|FG000|Overall Study|Lack of Efficacy|0|||
156437119|NCT01595321|564689959|FG001|Overall Study|Lack of Efficacy|0|||
156437120|NCT01595321|564689960|FG002|Overall Study|Lack of Efficacy|4|||
156437121|NCT00834834|564689961|FG000|Overall Study|Withdrawal by Subject|4|||
156437122|NCT00834834|564689962|FG001|Overall Study|Withdrawal by Subject|3|||
156437123|NCT00373529|564689963|FG000|Overall Study|Physician Decision|19|||
156437124|NCT00373529|564689963|FG000|Overall Study|Withdrawal by Subject|7|||
156437125|NCT00373529|564689963|FG000|Overall Study|Adverse Event|7|||
156437126|NCT00373529|564689963|FG000|Overall Study|Treatment failure|36|||
156437127|NCT00373529|564689963|FG000|Overall Study|Disease recurrence|10|||
156788763|NCT04518410|565977302|FG020|Overall Study|Randomized but not treated|0|||
156788764|NCT04518410|565977303|FG021|Overall Study|Randomized but not treated|5|||
156788765|NCT04518410|565977304|FG022|Overall Study|Randomized but not treated|0|||
156788766|NCT04518410|565977305|FG023|Overall Study|Randomized but not treated|3|||
156788767|NCT04518410|565977306|FG024|Overall Study|Randomized but not treated|1|||
156788768|NCT04518410|565977282|FG000|Overall Study|Screen Fail but Randomized|0|||
156788769|NCT04518410|565977283|FG001|Overall Study|Screen Fail but Randomized|0|||
156788770|NCT04518410|565977284|FG002|Overall Study|Screen Fail but Randomized|0|||
156788771|NCT04518410|565977285|FG003|Overall Study|Screen Fail but Randomized|0|||
156788772|NCT04518410|565977286|FG004|Overall Study|Screen Fail but Randomized|2|||
156788773|NCT04518410|565977287|FG005|Overall Study|Screen Fail but Randomized|0|||
156788774|NCT04518410|565977288|FG006|Overall Study|Screen Fail but Randomized|0|||
156788775|NCT04518410|565977289|FG007|Overall Study|Screen Fail but Randomized|0|||
156788776|NCT04518410|565977290|FG008|Overall Study|Screen Fail but Randomized|0|||
156788777|NCT04518410|565977291|FG009|Overall Study|Screen Fail but Randomized|0|||
156330277|NCT02734433|564308828|FG001|Overall Study|Clinical progression|1|||
156330278|NCT02734433|564308827|FG000|Overall Study|Withdrawal by Subject|1|||
156330279|NCT02734433|564308828|FG001|Overall Study|Withdrawal by Subject|2|||
156330280|NCT03698331|564308831|FG000|Overall Study|Adverse Event|2|||
156330281|NCT03698331|564308832|FG001|Overall Study|Adverse Event|3|||
156330282|NCT03698331|564308831|FG000|Overall Study|Withdrawal by Subject|1|||
156330283|NCT03698331|564308832|FG001|Overall Study|Withdrawal by Subject|1|||
156330284|NCT03698331|564308831|FG000|Overall Study|Lost to Follow-up|0|||
156330285|NCT03698331|564308832|FG001|Overall Study|Lost to Follow-up|2|||
156330286|NCT03698331|564308831|FG000|Overall Study|Non-compliance with study drug|1|||
156330287|NCT03698331|564308832|FG001|Overall Study|Non-compliance with study drug|0|||
156330288|NCT04916769|564308835|FG000|Period 1|Physician Decision|0|||
156330289|NCT04916769|564308836|FG001|Period 1|Physician Decision|0|||
156330290|NCT04916769|564308837|FG002|Period 1|Physician Decision|0|||
156330291|NCT04916769|564308838|FG003|Period 1|Physician Decision|0|||
156330292|NCT04916769|564308839|FG004|Period 1|Physician Decision|0|||
156330293|NCT04916769|564308840|FG005|Period 1|Physician Decision|1|||
156330294|NCT04916769|564308835|FG000|Period 2|Physician Decision|0|||
156330295|NCT04916769|564308836|FG001|Period 2|Physician Decision|1|||
156330296|NCT04916769|564308837|FG002|Period 2|Physician Decision|0|||
156330297|NCT04916769|564308838|FG003|Period 2|Physician Decision|0|||
156330298|NCT04916769|564308839|FG004|Period 2|Physician Decision|0|||
156330299|NCT04916769|564308840|FG005|Period 2|Physician Decision|0|||
156330300|NCT05628103|564308856|FG000|Overall Study|Adverse Event|7|||
156330301|NCT05628103|564308856|FG000|Overall Study|Withdrawal by Subject|3|||
156330302|NCT05628103|564308856|FG000|Overall Study|Lost to Follow-up|3|||
156330303|NCT05628103|564308856|FG000|Overall Study|Lack of Efficacy|1|||
156330304|NCT05628103|564308856|FG000|Overall Study|Non-Compliance With Study Drug|4|||
156330305|NCT04840888|564308857|FG000|Period 1|Withdrawal by Subject|0|||
156330306|NCT04840888|564308858|FG001|Period 1|Withdrawal by Subject|0|||
156330307|NCT04840888|564308859|FG002|Period 1|Withdrawal by Subject|0|||
156330308|NCT04840888|564308860|FG003|Period 1|Withdrawal by Subject|0|||
156330309|NCT04840888|564308861|FG004|Period 1|Withdrawal by Subject|1|||
156330310|NCT04840888|564308862|FG005|Period 1|Withdrawal by Subject|0|||
156330311|NCT04840888|564308857|FG000|Period 1|Adverse Event|0|||
156330312|NCT04840888|564308858|FG001|Period 1|Adverse Event|0|||
156330313|NCT04840888|564308859|FG002|Period 1|Adverse Event|1|||
156330314|NCT04840888|564308860|FG003|Period 1|Adverse Event|1|||
156330315|NCT04840888|564308861|FG004|Period 1|Adverse Event|10|||
156330316|NCT04840888|564308862|FG005|Period 1|Adverse Event|1|||
156330317|NCT02719327|564308865|FG000|Overall Study|Withdrawal by Subject|11|||
156330318|NCT02719327|564308866|FG001|Overall Study|Withdrawal by Subject|8|||
156330319|NCT04340193|564308867|FG000|Overall Study|Other reason|0|||
156330320|NCT04340193|564308868|FG001|Overall Study|Other reason|0|||
156330321|NCT04340193|564308869|FG002|Overall Study|Other reason|1|||
156330322|NCT04340193|564308867|FG000|Overall Study|Disease recurrence|0|||
156330323|NCT04340193|564308868|FG001|Overall Study|Disease recurrence|1|||
156330324|NCT04340193|564308869|FG002|Overall Study|Disease recurrence|0|||
156330325|NCT04340193|564308867|FG000|Overall Study|Study drug toxicity|1|||
156330326|NCT04340193|564308868|FG001|Overall Study|Study drug toxicity|0|||
156788778|NCT04518410|565977292|FG010|Overall Study|Screen Fail but Randomized|0|||
156330327|NCT04340193|564308869|FG002|Overall Study|Study drug toxicity|0|||
156330328|NCT04340193|564308867|FG000|Overall Study|Disease progression|1|||
156330329|NCT04340193|564308868|FG001|Overall Study|Disease progression|2|||
156330330|NCT04340193|564308869|FG002|Overall Study|Disease progression|3|||
156330331|NCT04340193|564308867|FG000|Overall Study|Administrative reasons by sponsor|0|||
156330332|NCT04340193|564308868|FG001|Overall Study|Administrative reasons by sponsor|1|||
156330333|NCT04340193|564308869|FG002|Overall Study|Administrative reasons by sponsor|0|||
156330334|NCT04340193|564308867|FG000|Overall Study|Adverse Event|1|||
156437128|NCT00373529|564689963|FG000|Overall Study|Death|16|||
156788779|NCT04518410|565977293|FG011|Overall Study|Screen Fail but Randomized|0|||
156788780|NCT04518410|565977294|FG012|Overall Study|Screen Fail but Randomized|0|||
156788781|NCT04518410|565977295|FG013|Overall Study|Screen Fail but Randomized|0|||
156788782|NCT04518410|565977296|FG014|Overall Study|Screen Fail but Randomized|0|||
156788783|NCT04518410|565977297|FG015|Overall Study|Screen Fail but Randomized|0|||
156788784|NCT04518410|565977298|FG016|Overall Study|Screen Fail but Randomized|0|||
156788785|NCT04518410|565977299|FG017|Overall Study|Screen Fail but Randomized|0|||
156788786|NCT04518410|565977300|FG018|Overall Study|Screen Fail but Randomized|0|||
156788787|NCT04518410|565977301|FG019|Overall Study|Screen Fail but Randomized|0|||
156788788|NCT04518410|565977302|FG020|Overall Study|Screen Fail but Randomized|0|||
156788789|NCT04518410|565977303|FG021|Overall Study|Screen Fail but Randomized|0|||
156330335|NCT04340193|564308868|FG001|Overall Study|Adverse Event|1|||
156788790|NCT04518410|565977304|FG022|Overall Study|Screen Fail but Randomized|0|||
156788791|NCT04518410|565977305|FG023|Overall Study|Screen Fail but Randomized|0|||
156788792|NCT04518410|565977306|FG024|Overall Study|Screen Fail but Randomized|0|||
156788793|NCT04518410|565977282|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788794|NCT04518410|565977283|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788795|NCT04518410|565977284|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788796|NCT04518410|565977285|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788797|NCT04518410|565977286|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
156788798|NCT04518410|565977287|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
156788799|NCT04518410|565977288|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
156788800|NCT04518410|565977289|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
156788801|NCT04518410|565977290|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
156330336|NCT04340193|564308869|FG002|Overall Study|Adverse Event|0|||
156330337|NCT04246372|564310417|FG000|Overall Study|Adverse Event|1|||
156330338|NCT04246372|564310417|FG000|Overall Study|Withdrawal by Subject|1|||
156330339|NCT04246372|564310417|FG000|Overall Study|Protocol Violation|2|||
156330340|NCT04246372|564310417|FG000|Overall Study|Physician Decision|1|||
156330341|NCT04063384|564310420|FG000|Overall Study|placebo manipulation issue|1|||
156330342|NCT04063384|564310421|FG001|Overall Study|placebo manipulation issue|2|||
156330343|NCT04063384|564310422|FG002|Overall Study|placebo manipulation issue|1|||
156330344|NCT04063384|564310423|FG003|Overall Study|placebo manipulation issue|1|||
156330345|NCT01824342|564310424|FG000|Overall Study|Withdrawal by Subject|0|||
156330346|NCT01824342|564310425|FG001|Overall Study|Withdrawal by Subject|3|||
156330347|NCT01824342|564310424|FG000|Overall Study|Adverse Event|1|||
156330348|NCT01824342|564310425|FG001|Overall Study|Adverse Event|1|||
156330349|NCT01824342|564310424|FG000|Overall Study|Disease Progression|1|||
156330350|NCT01824342|564310425|FG001|Overall Study|Disease Progression|1|||
156330351|NCT01824342|564310424|FG000|Overall Study|Physician Decision|5|||
156330352|NCT01824342|564310425|FG001|Overall Study|Physician Decision|0|||
156330353|NCT01824342|564310424|FG000|Overall Study|Death|2|||
156330354|NCT01824342|564310425|FG001|Overall Study|Death|0|||
156330355|NCT04195906|564310426|FG000|Part 1|Adverse Event|3|||
156330356|NCT04195906|564310427|FG001|Part 1|Adverse Event|7|||
156330357|NCT04195906|564310426|FG000|Part 1|Withdrawal by Subject|0|||
156330358|NCT04195906|564310427|FG001|Part 1|Withdrawal by Subject|1|||
156330359|NCT04195906|564310426|FG000|Part 2|Adverse Event|1|||
156330360|NCT04195906|564310427|FG001|Part 2|Adverse Event|1|||
156330361|NCT04195906|564310426|FG000|Part 2|Withdrawal by Subject|0|||
156330362|NCT04195906|564310427|FG001|Part 2|Withdrawal by Subject|3|||
156330363|NCT04195906|564310426|FG000|Part 2|Other|1|||
156330364|NCT04195906|564310427|FG001|Part 2|Other|3|||
156330365|NCT00313300|564310431|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
156330366|NCT00313300|564310432|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
156330367|NCT00313300|564310433|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
156330368|NCT00313300|564310434|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
156330369|NCT00313300|564310435|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
156330370|NCT00313300|564310431|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
156330371|NCT00313300|564310432|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
156330372|NCT00313300|564310433|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
156330373|NCT00313300|564310434|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
156330374|NCT00313300|564310435|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
156330375|NCT00313300|564310431|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
156330376|NCT00313300|564310432|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
156330377|NCT00313300|564310433|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
156330378|NCT00313300|564310434|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
156330379|NCT00313300|564310435|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
156330380|NCT00313300|564310431|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
156330381|NCT00313300|564310432|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
156330382|NCT00313300|564310433|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
156330383|NCT00313300|564310434|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
156437129|NCT00373529|564689963|FG000|Overall Study|Need for treatment prohibited by study|1|||
156437130|NCT00373529|564689963|FG000|Overall Study|Other|8|||
156437131|NCT00373529|564689963|FG000|Overall Study|Failed independent confirmation of AML|3|||
156437132|NCT00373529|564689963|FG000|Overall Study|Consent violation|1|||
156437133|NCT01585558|564689972|FG000|Overall Study|Withdrawal by Subject|4|||
156437134|NCT01585558|564689973|FG001|Overall Study|Withdrawal by Subject|5|||
156437135|NCT01585558|564689974|FG002|Overall Study|Withdrawal by Subject|8|||
156437136|NCT01585558|564689972|FG000|Overall Study|Lost to Follow-up|2|||
156437137|NCT01585558|564689973|FG001|Overall Study|Lost to Follow-up|0|||
156437138|NCT01585558|564689974|FG002|Overall Study|Lost to Follow-up|3|||
156437139|NCT01585558|564689972|FG000|Overall Study|Adverse Event|3|||
156437140|NCT01585558|564689973|FG001|Overall Study|Adverse Event|4|||
156437141|NCT01585558|564689974|FG002|Overall Study|Adverse Event|1|||
156437142|NCT01585558|564689972|FG000|Overall Study|Protocol Violation|4|||
156437143|NCT01585558|564689973|FG001|Overall Study|Protocol Violation|3|||
156437144|NCT01585558|564689974|FG002|Overall Study|Protocol Violation|2|||
156437145|NCT01585558|564689972|FG000|Overall Study|Lack of Efficacy|0|||
156788802|NCT04518410|565977291|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
156788803|NCT04518410|565977292|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
156788804|NCT04518410|565977293|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788805|NCT04518410|565977294|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788806|NCT04518410|565977295|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
156788807|NCT04518410|565977296|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788808|NCT04518410|565977297|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
156788809|NCT04518410|565977298|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
156437146|NCT01585558|564689973|FG001|Overall Study|Lack of Efficacy|0|||
156437147|NCT01585558|564689974|FG002|Overall Study|Lack of Efficacy|1|||
156437148|NCT01810263|564689988|FG000|Overall Study|Lost to Follow-up|8|||
156437149|NCT01810263|564689989|FG001|Overall Study|Lost to Follow-up|7|||
156437150|NCT00026312|564689990|FG000|Overall Study|Adverse Event|0|||
156437151|NCT00026312|564689991|FG001|Overall Study|Adverse Event|32|||
156437152|NCT00026312|564689990|FG000|Overall Study|Death|1|||
156437153|NCT00026312|564689991|FG001|Overall Study|Death|7|||
156437154|NCT00026312|564689990|FG000|Overall Study|Lack of Efficacy|19|||
156692768|NCT04459715|565620318|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
156692769|NCT04459715|565620317|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
156692770|NCT04459715|565620318|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
156692771|NCT04459715|565620317|FG000|Overall Study|Withdrawal by Subject|22|||
156692772|NCT04459715|565620318|FG001|Overall Study|Withdrawal by Subject|22|||
156692773|NCT02631876|565621712|FG000|Overall Study|Death|96|||
156692774|NCT02631876|565621713|FG001|Overall Study|Death|50|||
156692775|NCT02631876|565621712|FG000|Overall Study|Investigator's discretion|1|||
156692776|NCT02631876|565621713|FG001|Overall Study|Investigator's discretion|0|||
156692777|NCT02631876|565621712|FG000|Overall Study|Lost to Follow-up|2|||
156692778|NCT02631876|565621713|FG001|Overall Study|Lost to Follow-up|0|||
156692779|NCT02631876|565621712|FG000|Overall Study|Withdrawal by Subject|16|||
156788810|NCT04518410|565977299|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
156808731|NCT01396187|566054445|FG000|Overall Study|Withdrawal by Subject|0|||
156808732|NCT01396187|566054446|FG001|Overall Study|Withdrawal by Subject|1|||
156808733|NCT01396187|566054447|FG002|Overall Study|Withdrawal by Subject|1|||
156808734|NCT01396187|566054448|FG003|Overall Study|Withdrawal by Subject|0|||
156808735|NCT01396187|566054449|FG004|Overall Study|Withdrawal by Subject|0|||
156808736|NCT01396187|566054445|FG000|Overall Study|Other|1|||
156437155|NCT00026312|564689991|FG001|Overall Study|Lack of Efficacy|114|||
156437156|NCT00026312|564689990|FG000|Overall Study|Lost to Follow-up|0|||
156692780|NCT02631876|565621713|FG001|Overall Study|Withdrawal by Subject|9|||
156692781|NCT02631876|565621712|FG000|Overall Study|Other than specified|4|||
156692782|NCT02631876|565621713|FG001|Overall Study|Other than specified|4|||
156808737|NCT01396187|566054446|FG001|Overall Study|Other|1|||
156437157|NCT00026312|564689991|FG001|Overall Study|Lost to Follow-up|5|||
156437158|NCT00026312|564689990|FG000|Overall Study|Physician Decision|1|||
156437159|NCT00026312|564689991|FG001|Overall Study|Physician Decision|37|||
156808738|NCT01396187|566054447|FG002|Overall Study|Other|0|||
156808739|NCT01396187|566054448|FG003|Overall Study|Other|0|||
156808740|NCT01396187|566054449|FG004|Overall Study|Other|1|||
156808741|NCT01898286|566054450|FG000|Overall Study|Withdrawal by Subject|1|||
156808742|NCT01898286|566054450|FG000|Overall Study|Protocol Violation|1|||
156808743|NCT01898286|566054450|FG000|Overall Study|Lost to Follow-up|1|||
156808744|NCT05554146|566054451|FG000|Overall Study|Adverse Event|0|||
156808745|NCT05554146|566054452|FG001|Overall Study|Adverse Event|1|||
156808746|NCT05554146|566054453|FG002|Overall Study|Adverse Event|0|||
156808747|NCT05554146|566054454|FG003|Overall Study|Adverse Event|0|||
156437160|NCT00026312|564689990|FG000|Overall Study|Protocol Violation|0|||
156437161|NCT00026312|564689991|FG001|Overall Study|Protocol Violation|3|||
156437162|NCT00026312|564689990|FG000|Overall Study|Withdrawal by Subject|1|||
156437163|NCT00026312|564689991|FG001|Overall Study|Withdrawal by Subject|6|||
156437164|NCT00026312|564689990|FG000|Overall Study|Ineligible|4|||
156437165|NCT00026312|564689991|FG001|Overall Study|Ineligible|5|||
156437166|NCT00026312|564689990|FG000|Overall Study|Entry onto another COG study|0|||
156437167|NCT00026312|564689991|FG001|Overall Study|Entry onto another COG study|1|||
156437168|NCT00026312|564689990|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
156437169|NCT00026312|564689991|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
156437170|NCT03785782|564691106|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
156437171|NCT03785782|564691107|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
156437172|NCT03785782|564691106|FG000|Overall Study|Withdrawal by Subject|1|||
156437173|NCT03785782|564691107|FG001|Overall Study|Withdrawal by Subject|1|||
156437174|NCT03785782|564691106|FG000|Overall Study|insufficient image quality.|3|||
156437175|NCT03785782|564691107|FG001|Overall Study|insufficient image quality.|0|||
156437176|NCT05777785|564691108|FG000|Overall Study|Withdrawal by Subject|5|||
156437177|NCT05777785|564691108|FG000|Overall Study|Lost to Follow-up|1|||
156437178|NCT05644444|564691109|FG000|Tolerance Phase|Adverse Event|0|||
156437179|NCT05644444|564691110|FG001|Tolerance Phase|Adverse Event|2|||
156437180|NCT05644444|564691109|FG000|Treatment Phase|Adverse Event|0|||
156437181|NCT05644444|564691110|FG001|Treatment Phase|Adverse Event|2|||
156437182|NCT00493649|564691112|FG000|Overall Study|Adverse Event|44|||
156437183|NCT00493649|564691112|FG000|Overall Study|Patient Request|21|||
156437184|NCT00493649|564691112|FG000|Overall Study|Investigator Request|2|||
156437185|NCT00493649|564691112|FG000|Overall Study|Disease Progression|1|||
156437186|NCT00493649|564691112|FG000|Overall Study|Lost to Follow-up|1|||
156437187|NCT00493649|564691112|FG000|Overall Study|Other|13|||
156437188|NCT00925899|564691115|FG000|Part 1|Death|1|||
156437189|NCT00925899|564691116|FG001|Part 1|Death|2|||
156437190|NCT00925899|564691115|FG000|Part 1|Withdrawal by Subject|10|||
156437191|NCT00925899|564691116|FG001|Part 1|Withdrawal by Subject|9|||
156437192|NCT01823536|564691119|FG000|Overall Study|Lost to Follow-up|1|||
156437193|NCT01823536|564691120|FG001|Overall Study|Lost to Follow-up|0|||
156437194|NCT01823536|564691121|FG002|Overall Study|Lost to Follow-up|0|||
156437195|NCT01823536|564691122|FG003|Overall Study|Lost to Follow-up|1|||
156437196|NCT01823536|564691123|FG004|Overall Study|Lost to Follow-up|1|||
156437197|NCT01823536|564691124|FG005|Overall Study|Lost to Follow-up|0|||
156437198|NCT01823536|564691119|FG000|Overall Study|Protocol Violation|0|||
156437199|NCT01823536|564691120|FG001|Overall Study|Protocol Violation|1|||
156437200|NCT01823536|564691121|FG002|Overall Study|Protocol Violation|0|||
156437201|NCT01823536|564691122|FG003|Overall Study|Protocol Violation|0|||
156437202|NCT01823536|564691123|FG004|Overall Study|Protocol Violation|0|||
156437203|NCT01823536|564691124|FG005|Overall Study|Protocol Violation|0|||
156437204|NCT01823536|564691119|FG000|Overall Study|Withdrawal by Subject|1|||
156437205|NCT01823536|564691120|FG001|Overall Study|Withdrawal by Subject|1|||
156437206|NCT01823536|564691121|FG002|Overall Study|Withdrawal by Subject|0|||
156437207|NCT01823536|564691122|FG003|Overall Study|Withdrawal by Subject|0|||
156437208|NCT01823536|564691123|FG004|Overall Study|Withdrawal by Subject|0|||
156870308|NCT01399372|566282487|FG000|Overall Study|Protocol Violation|3|||
156870309|NCT01399372|566282488|FG001|Overall Study|Protocol Violation|1|||
156870310|NCT01177397|566282492|FG000|Overall Study|Protocol Violation|0|||
156870311|NCT01177397|566282493|FG001|Overall Study|Protocol Violation|0|||
156870312|NCT01177397|566282494|FG002|Overall Study|Protocol Violation|0|||
156870313|NCT01177397|566282495|FG003|Overall Study|Protocol Violation|0|||
156870314|NCT01177397|566282496|FG004|Overall Study|Protocol Violation|0|||
156870315|NCT01177397|566282497|FG005|Overall Study|Protocol Violation|1|||
156870316|NCT01177397|566282498|FG006|Overall Study|Protocol Violation|0|||
156870317|NCT01177397|566282499|FG007|Overall Study|Protocol Violation|0|||
156870318|NCT01177397|566282500|FG008|Overall Study|Protocol Violation|0|||
156870319|NCT01177397|566282501|FG009|Overall Study|Protocol Violation|0|||
156437209|NCT01823536|564691124|FG005|Overall Study|Withdrawal by Subject|0|||
156437210|NCT01823536|564691119|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
156437211|NCT01823536|564691120|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
156437212|NCT01823536|564691121|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
156437213|NCT01823536|564691122|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
156437214|NCT01823536|564691123|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
156437215|NCT01823536|564691124|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
156437216|NCT01823536|564691119|FG000|Overall Study|Met exclusion criterion No 6|0|||
156437217|NCT01823536|564691120|FG001|Overall Study|Met exclusion criterion No 6|0|||
156437218|NCT01823536|564691121|FG002|Overall Study|Met exclusion criterion No 6|0|||
156437219|NCT01823536|564691122|FG003|Overall Study|Met exclusion criterion No 6|1|||
156437220|NCT01823536|564691123|FG004|Overall Study|Met exclusion criterion No 6|0|||
156437221|NCT01823536|564691124|FG005|Overall Study|Met exclusion criterion No 6|0|||
156870320|NCT01177397|566282502|FG010|Overall Study|Protocol Violation|0|||
156870321|NCT01177397|566282503|FG011|Overall Study|Protocol Violation|0|||
156870322|NCT01177397|566282492|FG000|Overall Study|Lost to Follow-up|0|||
156437222|NCT01823536|564691119|FG000|Overall Study|Subject moved out of the state|0|||
156437223|NCT01823536|564691120|FG001|Overall Study|Subject moved out of the state|0|||
156437224|NCT01823536|564691121|FG002|Overall Study|Subject moved out of the state|0|||
156437225|NCT01823536|564691122|FG003|Overall Study|Subject moved out of the state|0|||
156437226|NCT01823536|564691123|FG004|Overall Study|Subject moved out of the state|1|||
156437227|NCT01823536|564691124|FG005|Overall Study|Subject moved out of the state|0|||
156437228|NCT03648762|564691125|FG000|Overall Study|Lost to Follow-up|1|||
156437229|NCT03648762|564691126|FG001|Overall Study|Lost to Follow-up|2|||
156437230|NCT03648762|564691127|FG002|Overall Study|Lost to Follow-up|0|||
156437231|NCT03648762|564691125|FG000|Overall Study|Withdrawal by Subject|5|||
156437232|NCT03648762|564691126|FG001|Overall Study|Withdrawal by Subject|2|||
156437233|NCT03648762|564691127|FG002|Overall Study|Withdrawal by Subject|1|||
156437234|NCT00768664|564691135|FG000|Overall Study|Death|57|||
156437235|NCT00768664|564691135|FG000|Overall Study|Lost to Follow-up|2|||
156437236|NCT00768664|564691135|FG000|Overall Study|Other|9|||
156437237|NCT00768664|564691135|FG000|Overall Study|Participant refused|1|||
156437238|NCT02544152|564691136|FG000|Overall Study|Adverse Event|0|||
156437239|NCT02544152|564691137|FG001|Overall Study|Adverse Event|4|||
156437240|NCT02544152|564691136|FG000|Overall Study|Withdrawal by Subject|0|||
156437241|NCT02544152|564691137|FG001|Overall Study|Withdrawal by Subject|3|||
156437242|NCT02544152|564691136|FG000|Overall Study|Other|1|||
156437243|NCT02544152|564691137|FG001|Overall Study|Other|0|||
156437244|NCT04480827|564691138|FG000|Overall Study|Adverse Event|0|||
156437245|NCT04480827|564691139|FG001|Overall Study|Adverse Event|0|||
156437246|NCT04480827|564691140|FG002|Overall Study|Adverse Event|0|||
156437247|NCT04480827|564691141|FG003|Overall Study|Adverse Event|0|||
156437248|NCT04480827|564691142|FG004|Overall Study|Adverse Event|0|||
156437249|NCT04480827|564691143|FG005|Overall Study|Adverse Event|1|||
156437250|NCT04480827|564691144|FG006|Overall Study|Adverse Event|0|||
156437251|NCT00465816|564691145|FG000|Overall Study|Lost to Follow-up|0|||
156437252|NCT00465816|564691146|FG001|Overall Study|Lost to Follow-up|0|||
156437253|NCT00465816|564691147|FG002|Overall Study|Lost to Follow-up|2|||
156437254|NCT02139046|564691148|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156437255|NCT02139046|564691149|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
156437256|NCT02139046|564691150|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
156437257|NCT02139046|564691151|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
156437258|NCT02139046|564691152|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
156437259|NCT02139046|564691148|FG000|Overall Study|Major Protocol Deviation|9|||
156437260|NCT02139046|564691149|FG001|Overall Study|Major Protocol Deviation|10|||
156437261|NCT02139046|564691150|FG002|Overall Study|Major Protocol Deviation|16|||
156437262|NCT02139046|564691151|FG003|Overall Study|Major Protocol Deviation|12|||
156437263|NCT02139046|564691152|FG004|Overall Study|Major Protocol Deviation|6|||
156437264|NCT02139046|564691148|FG000|Overall Study|Lost to Follow-up|13|||
156437265|NCT02139046|564691149|FG001|Overall Study|Lost to Follow-up|16|||
156437266|NCT02139046|564691150|FG002|Overall Study|Lost to Follow-up|16|||
156437267|NCT02139046|564691151|FG003|Overall Study|Lost to Follow-up|18|||
156437268|NCT02139046|564691152|FG004|Overall Study|Lost to Follow-up|13|||
156437269|NCT02139046|564691148|FG000|Overall Study|Voluntary Withdrawal|20|||
156437270|NCT02139046|564691149|FG001|Overall Study|Voluntary Withdrawal|8|||
156437271|NCT02139046|564691150|FG002|Overall Study|Voluntary Withdrawal|10|||
156437272|NCT02139046|564691151|FG003|Overall Study|Voluntary Withdrawal|15|||
156437273|NCT02139046|564691152|FG004|Overall Study|Voluntary Withdrawal|16|||
156437274|NCT02139046|564691148|FG000|Overall Study|Lack of Efficacy|0|||
156437275|NCT02139046|564691149|FG001|Overall Study|Lack of Efficacy|1|||
156437276|NCT02139046|564691150|FG002|Overall Study|Lack of Efficacy|2|||
156437277|NCT02139046|564691151|FG003|Overall Study|Lack of Efficacy|1|||
156437278|NCT02139046|564691152|FG004|Overall Study|Lack of Efficacy|2|||
156530626|NCT05104476|565038101|FG000|Overall Study|Other Than Specified|0|||
156530627|NCT05104476|565038102|FG001|Overall Study|Other Than Specified|3|||
156788811|NCT04518410|565977300|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
156788812|NCT04518410|565977301|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
156788813|NCT04518410|565977302|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
156437279|NCT02139046|564691148|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
156437280|NCT02139046|564691149|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
156437281|NCT02139046|564691150|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
156437282|NCT02139046|564691151|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
156437283|NCT02139046|564691152|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
156437284|NCT02139046|564691148|FG000|Overall Study|Other Miscellaneous Reasons|10|||
156437285|NCT02139046|564691149|FG001|Overall Study|Other Miscellaneous Reasons|9|||
156437286|NCT02139046|564691150|FG002|Overall Study|Other Miscellaneous Reasons|4|||
156530628|NCT02170389|565038105|FG000|Overall Study|Study terminated prior to start of treat|1|||
156788814|NCT04518410|565977303|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
156437287|NCT02139046|564691151|FG003|Overall Study|Other Miscellaneous Reasons|9|||
156530629|NCT04614662|565038108|FG000|Overall Study|Withdrawal by Subject|0|||
156437288|NCT02139046|564691152|FG004|Overall Study|Other Miscellaneous Reasons|12|||
156437289|NCT00818454|564691155|FG000|Treatment Period 1|Adverse Event|0|||
156437290|NCT00818454|564691156|FG001|Treatment Period 1|Adverse Event|1|||
156437291|NCT00818454|564691157|FG002|Treatment Period 1|Adverse Event|0|||
156437292|NCT00818454|564691158|FG003|Treatment Period 1|Adverse Event|0|||
156437293|NCT00818454|564691155|FG000|Treatment Period 1|Other|3|||
156437294|NCT00818454|564691156|FG001|Treatment Period 1|Other|0|||
156437295|NCT00818454|564691157|FG002|Treatment Period 1|Other|0|||
156437296|NCT00818454|564691158|FG003|Treatment Period 1|Other|0|||
156437297|NCT00818454|564691155|FG000|Washout Period of 1 Week|Adverse Event|1|||
156437298|NCT00818454|564691156|FG001|Washout Period of 1 Week|Adverse Event|1|||
156437299|NCT00818454|564691157|FG002|Washout Period of 1 Week|Adverse Event|0|||
156437300|NCT00818454|564691158|FG003|Washout Period of 1 Week|Adverse Event|0|||
156437301|NCT00818454|564691155|FG000|Washout Period of 1 Week|Protocol Violation|2|||
156437302|NCT00818454|564691156|FG001|Washout Period of 1 Week|Protocol Violation|0|||
156437303|NCT00818454|564691157|FG002|Washout Period of 1 Week|Protocol Violation|0|||
156437304|NCT00818454|564691158|FG003|Washout Period of 1 Week|Protocol Violation|0|||
156437305|NCT00818454|564691155|FG000|Washout Period of 1 Week|Other|1|||
156437306|NCT00818454|564691156|FG001|Washout Period of 1 Week|Other|2|||
156437307|NCT00818454|564691157|FG002|Washout Period of 1 Week|Other|0|||
156437308|NCT00818454|564691158|FG003|Washout Period of 1 Week|Other|0|||
156437309|NCT00818454|564691155|FG000|Treatment Period 2|Other|2|||
156437310|NCT00818454|564691156|FG001|Treatment Period 2|Other|1|||
156437311|NCT00818454|564691157|FG002|Treatment Period 2|Other|0|||
156437312|NCT00818454|564691158|FG003|Treatment Period 2|Other|0|||
156437313|NCT00818454|564691155|FG000|Treatment Period 3|Adverse Event|0|||
156437314|NCT00818454|564691156|FG001|Treatment Period 3|Adverse Event|0|||
156437315|NCT00818454|564691157|FG002|Treatment Period 3|Adverse Event|0|||
156437316|NCT00818454|564691158|FG003|Treatment Period 3|Adverse Event|1|||
156437317|NCT03454529|564691161|FG000|Overall Study|Did not receive treatment|6|||
156437318|NCT03454529|564691161|FG000|Overall Study|Received < 80% doses|1|||
156437319|NCT01582100|564691165|FG000|Overall Study|Adverse Event|1|||
156437320|NCT01582100|564691165|FG000|Overall Study|Withdrawal by Subject|1|||
156437321|NCT01040689|564691167|FG000|Overall Study|Adverse Event|0|||
156437322|NCT01040689|564691168|FG001|Overall Study|Adverse Event|0|||
156437323|NCT01040689|564691169|FG002|Overall Study|Adverse Event|2|||
156437324|NCT01040689|564691170|FG003|Overall Study|Adverse Event|4|||
156437325|NCT01040689|564691167|FG000|Overall Study|Lack of Efficacy|0|||
156437326|NCT01040689|564691168|FG001|Overall Study|Lack of Efficacy|0|||
156437327|NCT01040689|564691169|FG002|Overall Study|Lack of Efficacy|1|||
156437328|NCT01040689|564691170|FG003|Overall Study|Lack of Efficacy|0|||
156437329|NCT01040689|564691167|FG000|Overall Study|Lost to Follow-up|1|||
156437330|NCT01040689|564691168|FG001|Overall Study|Lost to Follow-up|0|||
156437331|NCT01040689|564691169|FG002|Overall Study|Lost to Follow-up|0|||
156437332|NCT01040689|564691170|FG003|Overall Study|Lost to Follow-up|0|||
156437333|NCT01040689|564691167|FG000|Overall Study|Withdrawal by Subject|2|||
156437334|NCT01040689|564691168|FG001|Overall Study|Withdrawal by Subject|1|||
156437335|NCT01040689|564691169|FG002|Overall Study|Withdrawal by Subject|1|||
156437336|NCT01040689|564691170|FG003|Overall Study|Withdrawal by Subject|0|||
156437337|NCT01040689|564691167|FG000|Overall Study|Other reasons not listed above|0|||
156437338|NCT01040689|564691168|FG001|Overall Study|Other reasons not listed above|1|||
156437339|NCT01040689|564691169|FG002|Overall Study|Other reasons not listed above|0|||
156437340|NCT01040689|564691170|FG003|Overall Study|Other reasons not listed above|0|||
156437341|NCT03718767|564691177|FG000|Overall Study|Declined to participate (before treatment started)|0|||
156437342|NCT03718767|564691178|FG001|Overall Study|Declined to participate (before treatment started)|0|||
156437343|NCT03718767|564691179|FG002|Overall Study|Declined to participate (before treatment started)|7|||
156437344|NCT03718767|564691177|FG000|Overall Study|Ineligible|0|||
156437345|NCT03718767|564691178|FG001|Overall Study|Ineligible|0|||
156437346|NCT03718767|564691179|FG002|Overall Study|Ineligible|17|||
156788815|NCT04518410|565977304|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
156437347|NCT00494442|564691180|FG000|Overall Study|Death|1|||
156437348|NCT00494442|564691181|FG001|Overall Study|Death|1|||
156437349|NCT00494442|564691180|FG000|Overall Study|Lack of Efficacy|16|||
156437350|NCT00494442|564691181|FG001|Overall Study|Lack of Efficacy|10|||
156437351|NCT00494442|564691180|FG000|Overall Study|Adverse Event|0|||
156437352|NCT00494442|564691181|FG001|Overall Study|Adverse Event|2|||
156437353|NCT00494442|564691180|FG000|Overall Study|Physician Decision|0|||
156437354|NCT00494442|564691181|FG001|Overall Study|Physician Decision|1|||
156437355|NCT00494442|564691180|FG000|Overall Study|Non-compliance|0|||
156437356|NCT00494442|564691181|FG001|Overall Study|Non-compliance|1|||
156437357|NCT00494442|564691180|FG000|Overall Study|Intercurrent illness|0|||
156437358|NCT00494442|564691181|FG001|Overall Study|Intercurrent illness|1|||
156437359|NCT03184558|564691184|FG000|Overall Study|Withdrawal by Subject|2|||
156437360|NCT03184558|564691184|FG000|Overall Study|Death|16|||
156437361|NCT03184558|564691184|FG000|Overall Study|Lost to Follow-up|2|||
156437362|NCT03184558|564691184|FG000|Overall Study|Other|9|||
156437363|NCT01254019|564691185|FG000|Overall Study|Adverse Event|0|||
156437364|NCT01254019|564691186|FG001|Overall Study|Adverse Event|2|||
156530630|NCT04614662|565038109|FG001|Overall Study|Withdrawal by Subject|1|||
156530631|NCT01603082|565038110|FG000|Overall Study|Adverse Event|0|||
156530632|NCT01603082|565038111|FG001|Overall Study|Adverse Event|1|||
156530633|NCT01603082|565038110|FG000|Overall Study|Withdrawal by Subject|1|||
156530634|NCT01603082|565038111|FG001|Overall Study|Withdrawal by Subject|0|||
156530635|NCT01603082|565038110|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
156530636|NCT01603082|565038111|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
156530637|NCT01862640|565038120|FG000|Overall Study|Adverse Event|4|||
156437365|NCT01254019|564691185|FG000|Overall Study|Protocol Violation|1|||
156437366|NCT01254019|564691186|FG001|Overall Study|Protocol Violation|0|||
156437367|NCT01254019|564691185|FG000|Overall Study|Withdrawal by Subject|0|||
156437368|NCT01254019|564691186|FG001|Overall Study|Withdrawal by Subject|2|||
156437369|NCT03061474|564691187|FG000|Overall Study|Adverse Event|2|||
156437370|NCT03061474|564691188|FG001|Overall Study|Adverse Event|0|||
156437371|NCT03061474|564691187|FG000|Overall Study|Safety Risk|0|||
156437372|NCT03061474|564691188|FG001|Overall Study|Safety Risk|1|||
156437373|NCT03061474|564691187|FG000|Overall Study|Participant unwilling or unable to participate|0|||
156437374|NCT03061474|564691188|FG001|Overall Study|Participant unwilling or unable to participate|2|||
156437375|NCT03061474|564691187|FG000|Overall Study|Lost to Follow-up|0|||
156437376|NCT03061474|564691188|FG001|Overall Study|Lost to Follow-up|1|||
156437377|NCT03520413|564691197|FG000|Overall Study|Lost to Follow-up|1|||
156530638|NCT01862640|565038121|FG001|Overall Study|Adverse Event|10|||
156530639|NCT01862640|565038122|FG002|Overall Study|Adverse Event|6|||
156437378|NCT03520413|564691198|FG001|Overall Study|Lost to Follow-up|1|||
156437379|NCT03520413|564691197|FG000|Overall Study|Withdrawal by Subject|1|||
156437380|NCT03520413|564691198|FG001|Overall Study|Withdrawal by Subject|2|||
156437381|NCT03520413|564691197|FG000|Overall Study|Death|0|||
156437382|NCT03520413|564691198|FG001|Overall Study|Death|1|||
156437383|NCT03520413|564691197|FG000|Overall Study|Physician Decision|3|||
156530640|NCT01862640|565038123|FG003|Overall Study|Adverse Event|8|||
156530641|NCT01862640|565038120|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
156530642|NCT01862640|565038121|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
156437384|NCT03520413|564691198|FG001|Overall Study|Physician Decision|3|||
156530643|NCT01862640|565038122|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
156530644|NCT01862640|565038123|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
156530645|NCT01862640|565038120|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
156530646|NCT01862640|565038121|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
156437385|NCT03520413|564691197|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
156437386|NCT03520413|564691198|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
156437387|NCT00638963|564691199|FG000|Overall Study|Withdrawal by Subject|1|||
156437388|NCT00638963|564691200|FG001|Overall Study|Withdrawal by Subject|0|||
156437389|NCT00360698|564691202|FG000|Run-In|Physician Decision|0|||
156437390|NCT00360698|564691203|FG001|Run-In|Physician Decision|1|||
156530647|NCT01862640|565038122|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
156530648|NCT01862640|565038123|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
156530649|NCT01862640|565038120|FG000|Overall Study|Withdrawal by Subject|2|||
156530650|NCT01862640|565038121|FG001|Overall Study|Withdrawal by Subject|4|||
156530651|NCT01862640|565038122|FG002|Overall Study|Withdrawal by Subject|8|||
156530652|NCT01862640|565038123|FG003|Overall Study|Withdrawal by Subject|5|||
156530653|NCT01862640|565038120|FG000|Overall Study|Protocol Deviation|0|||
156530654|NCT01862640|565038121|FG001|Overall Study|Protocol Deviation|0|||
156530655|NCT01862640|565038122|FG002|Overall Study|Protocol Deviation|1|||
156530656|NCT01862640|565038123|FG003|Overall Study|Protocol Deviation|0|||
156530657|NCT05085665|565038124|FG000|Overall Study|Physician Decision|2|||
156530658|NCT01717768|565038125|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156530659|NCT01717768|565038126|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
156530660|NCT01717768|565038127|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156530661|NCT01717768|565038128|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156530662|NCT01717768|565038129|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156530663|NCT01717768|565038130|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156530664|NCT01717768|565038131|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156530665|NCT01717768|565038132|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156530666|NCT01717768|565038133|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156692783|NCT01013649|565621716|FG000|First Step|Withdrawal by Subject|36|||
156692784|NCT01013649|565621717|FG001|First Step|Withdrawal by Subject|19|||
156437391|NCT00360698|564691202|FG000|Run-In|Withdrawal by Subject|0|||
156437392|NCT00360698|564691203|FG001|Run-In|Withdrawal by Subject|2|||
156437393|NCT00360698|564691202|FG000|Run-In|Non compliance with treatment procedure|0|||
156437394|NCT00360698|564691203|FG001|Run-In|Non compliance with treatment procedure|1|||
156692785|NCT01013649|565621718|FG002|First Step|Withdrawal by Subject|0|||
156692786|NCT01013649|565621719|FG003|First Step|Withdrawal by Subject|0|||
156692787|NCT01013649|565621716|FG000|First Step|Progression|58|||
156692788|NCT01013649|565621717|FG001|First Step|Progression|23|||
156692789|NCT01013649|565621718|FG002|First Step|Progression|0|||
156692790|NCT01013649|565621719|FG003|First Step|Progression|0|||
156692791|NCT01013649|565621716|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
156692792|NCT01013649|565621717|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
156692793|NCT01013649|565621718|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
156692794|NCT01013649|565621719|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
156692795|NCT01013649|565621716|FG000|First Step|Death|3|||
156788816|NCT04518410|565977305|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
156788817|NCT04518410|565977306|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
156788818|NCT04518410|565977282|FG000|Overall Study|Dual Enrolled Subject|0|||
156788819|NCT04518410|565977283|FG001|Overall Study|Dual Enrolled Subject|0|||
156437395|NCT00360698|564691202|FG000|Run-In|Sponsor request|0|||
156437396|NCT00360698|564691203|FG001|Run-In|Sponsor request|2|||
156437397|NCT00360698|564691202|FG000|Run-In|Patient did not meet inclusion criteria|0|||
156437398|NCT00360698|564691203|FG001|Run-In|Patient did not meet inclusion criteria|1|||
156437399|NCT00360698|564691202|FG000|Run-In|Patient personal reasons|0|||
156437400|NCT00360698|564691203|FG001|Run-In|Patient personal reasons|2|||
156437401|NCT00360698|564691202|FG000|Run-In|Need of insulin with meals|0|||
156437402|NCT00360698|564691203|FG001|Run-In|Need of insulin with meals|1|||
156437403|NCT00360698|564691202|FG000|Treatment Period|Non compliance with treatment procedure|1|||
156437404|NCT00360698|564691203|FG001|Treatment Period|Non compliance with treatment procedure|0|||
156437405|NCT00360698|564691202|FG000|Treatment Period|Early termination by error|0|||
156437406|NCT00360698|564691203|FG001|Treatment Period|Early termination by error|1|||
156437407|NCT02755116|564691205|FG000|Overall Study|surgery converted to open, pt admitted|3|||
156437408|NCT02755116|564691206|FG001|Overall Study|surgery converted to open, pt admitted|1|||
156437409|NCT02200770|564691207|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
156437410|NCT02200770|564691208|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
156437411|NCT02200770|564691207|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
156437412|NCT02200770|564691208|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
156437413|NCT02200770|564691207|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
156788820|NCT04518410|565977284|FG002|Overall Study|Dual Enrolled Subject|0|||
156788821|NCT04518410|565977285|FG003|Overall Study|Dual Enrolled Subject|0|||
156788822|NCT04518410|565977286|FG004|Overall Study|Dual Enrolled Subject|0|||
156788823|NCT04518410|565977287|FG005|Overall Study|Dual Enrolled Subject|0|||
156788824|NCT04518410|565977288|FG006|Overall Study|Dual Enrolled Subject|0|||
156788825|NCT04518410|565977289|FG007|Overall Study|Dual Enrolled Subject|0|||
156788826|NCT04518410|565977290|FG008|Overall Study|Dual Enrolled Subject|0|||
156788827|NCT04518410|565977291|FG009|Overall Study|Dual Enrolled Subject|0|||
156788828|NCT04518410|565977292|FG010|Overall Study|Dual Enrolled Subject|0|||
156788829|NCT04518410|565977293|FG011|Overall Study|Dual Enrolled Subject|0|||
156788830|NCT04518410|565977294|FG012|Overall Study|Dual Enrolled Subject|0|||
156788831|NCT04518410|565977295|FG013|Overall Study|Dual Enrolled Subject|0|||
156788832|NCT04518410|565977296|FG014|Overall Study|Dual Enrolled Subject|0|||
156788833|NCT04518410|565977297|FG015|Overall Study|Dual Enrolled Subject|0|||
156788834|NCT04518410|565977298|FG016|Overall Study|Dual Enrolled Subject|0|||
156788835|NCT04518410|565977299|FG017|Overall Study|Dual Enrolled Subject|1|||
156788836|NCT04518410|565977300|FG018|Overall Study|Dual Enrolled Subject|0|||
156788837|NCT04518410|565977301|FG019|Overall Study|Dual Enrolled Subject|0|||
156788838|NCT04518410|565977302|FG020|Overall Study|Dual Enrolled Subject|0|||
156788839|NCT04518410|565977303|FG021|Overall Study|Dual Enrolled Subject|0|||
156788840|NCT04518410|565977304|FG022|Overall Study|Dual Enrolled Subject|0|||
156788841|NCT04518410|565977305|FG023|Overall Study|Dual Enrolled Subject|0|||
156788842|NCT04518410|565977306|FG024|Overall Study|Dual Enrolled Subject|0|||
156788843|NCT01341990|565977307|FG000|Overall Study|Adverse Event|0|||
156788844|NCT01341990|565977308|FG001|Overall Study|Adverse Event|1|||
156788845|NCT01341990|565977307|FG000|Overall Study|Torn Study Lens|1|||
156788846|NCT01341990|565977308|FG001|Overall Study|Torn Study Lens|0|||
156437414|NCT02200770|564691208|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
156437415|NCT02200770|564691207|FG000|Randomized-controlled Period (RCP)|Other|1|||
156437416|NCT02200770|564691208|FG001|Randomized-controlled Period (RCP)|Other|2|||
156437417|NCT02200770|564691207|FG000|Open-label Period (OLP)|Adverse Event|1|||
156437418|NCT02200770|564691208|FG001|Open-label Period (OLP)|Adverse Event|2|||
156437419|NCT02200770|564691207|FG000|Open-label Period (OLP)|Death|1|||
156437420|NCT02200770|564691208|FG001|Open-label Period (OLP)|Death|2|||
156437421|NCT02200770|564691207|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
156437422|NCT02200770|564691208|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
156692796|NCT01013649|565621717|FG001|First Step|Death|4|||
156692797|NCT01013649|565621718|FG002|First Step|Death|0|||
156692798|NCT01013649|565621719|FG003|First Step|Death|0|||
156788847|NCT01341990|565977307|FG000|Overall Study|Withdrawal by Subject|2|||
156788848|NCT01341990|565977308|FG001|Overall Study|Withdrawal by Subject|0|||
156437423|NCT02200770|564691207|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
156437424|NCT02200770|564691208|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
156530667|NCT01717768|565038134|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156788849|NCT00290238|565977309|FG000|Overall Study|Study terminated|27|||
156437425|NCT02200770|564691207|FG000|Open-label Period (OLP)|Other|6|||
156437426|NCT02200770|564691208|FG001|Open-label Period (OLP)|Other|15|||
156437427|NCT05283395|564691213|FG000|Overall Study|Adverse Event|4|||
156437428|NCT05283395|564691214|FG001|Overall Study|Adverse Event|4|||
156437429|NCT05283395|564691215|FG002|Overall Study|Adverse Event|0|||
156437430|NCT05283395|564691213|FG000|Overall Study|Patient Lost to Follow-Up|0|||
156437431|NCT05283395|564691214|FG001|Overall Study|Patient Lost to Follow-Up|0|||
156437432|NCT05283395|564691215|FG002|Overall Study|Patient Lost to Follow-Up|1|||
156437433|NCT05283395|564691213|FG000|Overall Study|Patient Withdrawal|2|||
156437434|NCT05283395|564691214|FG001|Overall Study|Patient Withdrawal|4|||
156437435|NCT05283395|564691215|FG002|Overall Study|Patient Withdrawal|2|||
156437436|NCT05283395|564691213|FG000|Overall Study|Investigator Decision|1|||
156437437|NCT05283395|564691214|FG001|Overall Study|Investigator Decision|0|||
156437438|NCT05283395|564691215|FG002|Overall Study|Investigator Decision|1|||
156437439|NCT05283395|564691213|FG000|Overall Study|Enrolled in error|0|||
156437440|NCT05283395|564691214|FG001|Overall Study|Enrolled in error|0|||
156437441|NCT05283395|564691215|FG002|Overall Study|Enrolled in error|1|||
156437442|NCT00712335|564691217|FG000|Overall Study|Withdrawal by Subject|0|||
156437443|NCT00712335|564691218|FG001|Overall Study|Withdrawal by Subject|7|||
156437444|NCT00712335|564691219|FG002|Overall Study|Withdrawal by Subject|2|||
156437445|NCT00712335|564691220|FG003|Overall Study|Withdrawal by Subject|3|||
156437446|NCT00712335|564691221|FG004|Overall Study|Withdrawal by Subject|0|||
156437447|NCT00712335|564691217|FG000|Overall Study|Lost to Follow-up|2|||
156437448|NCT00712335|564691218|FG001|Overall Study|Lost to Follow-up|5|||
156437449|NCT00712335|564691219|FG002|Overall Study|Lost to Follow-up|0|||
156437450|NCT00712335|564691220|FG003|Overall Study|Lost to Follow-up|1|||
156437451|NCT00712335|564691221|FG004|Overall Study|Lost to Follow-up|0|||
156437452|NCT00712335|564691217|FG000|Overall Study|Protocol Violation|1|||
156437453|NCT00712335|564691218|FG001|Overall Study|Protocol Violation|2|||
156437454|NCT00712335|564691219|FG002|Overall Study|Protocol Violation|1|||
156437455|NCT00712335|564691220|FG003|Overall Study|Protocol Violation|0|||
156437456|NCT00712335|564691221|FG004|Overall Study|Protocol Violation|0|||
156437457|NCT00712335|564691217|FG000|Overall Study|Lack of Efficacy|0|||
156437458|NCT00712335|564691218|FG001|Overall Study|Lack of Efficacy|0|||
156437459|NCT00712335|564691219|FG002|Overall Study|Lack of Efficacy|1|||
156437460|NCT00712335|564691220|FG003|Overall Study|Lack of Efficacy|1|||
156437461|NCT00712335|564691221|FG004|Overall Study|Lack of Efficacy|0|||
156437462|NCT00712335|564691217|FG000|Overall Study|Other Reason|0|||
156437463|NCT00712335|564691218|FG001|Overall Study|Other Reason|3|||
156437464|NCT00712335|564691219|FG002|Overall Study|Other Reason|1|||
156437465|NCT00712335|564691220|FG003|Overall Study|Other Reason|0|||
156437466|NCT00712335|564691221|FG004|Overall Study|Other Reason|0|||
156437467|NCT00424645|564691222|FG000|Overall Study|Death|1|||
156437468|NCT00424645|564691223|FG001|Overall Study|Death|0|||
156437469|NCT00356265|564691225|FG000|Overall Study|Withdrawal by Subject|0|||
156437470|NCT00356265|564691226|FG001|Overall Study|Withdrawal by Subject|0|||
156437471|NCT00356265|564691227|FG002|Overall Study|Withdrawal by Subject|1|||
156437472|NCT01170026|564692322|FG000|Overall Study|Lost to Follow-up|4|||
156437473|NCT01170026|564692323|FG001|Overall Study|Lost to Follow-up|2|||
156437474|NCT04817670|564692324|FG000|Overall Study|Withdrawal by Subject|1|||
156437475|NCT04817670|564692325|FG001|Overall Study|Withdrawal by Subject|0|||
156437476|NCT04817670|564692326|FG002|Overall Study|Withdrawal by Subject|0|||
156437477|NCT04817670|564692327|FG003|Overall Study|Withdrawal by Subject|0|||
156437478|NCT04817670|564692328|FG004|Overall Study|Withdrawal by Subject|0|||
156437479|NCT04817670|564692324|FG000|Overall Study|Lost to Follow-up|0|||
156437480|NCT04817670|564692325|FG001|Overall Study|Lost to Follow-up|0|||
156437481|NCT04817670|564692326|FG002|Overall Study|Lost to Follow-up|1|||
156437482|NCT04817670|564692327|FG003|Overall Study|Lost to Follow-up|0|||
156437483|NCT04817670|564692328|FG004|Overall Study|Lost to Follow-up|0|||
156437484|NCT00304031|564692329|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
156437485|NCT00304031|564692330|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
156437486|NCT00304031|564692331|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
156437487|NCT00304031|564692329|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
156437488|NCT00304031|564692330|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
156437489|NCT00304031|564692331|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
156437490|NCT00304031|564692329|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
156437491|NCT00304031|564692330|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
156437492|NCT00304031|564692331|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
156437493|NCT00304031|564692329|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
156437494|NCT00304031|564692330|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
156437495|NCT00304031|564692331|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
156437496|NCT00304031|564692329|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
156692799|NCT01013649|565621716|FG000|First Step|Adverse Event|9|||
156437497|NCT00304031|564692330|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
156530668|NCT01717768|565038135|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156692800|NCT01013649|565621717|FG001|First Step|Adverse Event|5|||
156692801|NCT01013649|565621718|FG002|First Step|Adverse Event|0|||
156692802|NCT01013649|565621719|FG003|First Step|Adverse Event|0|||
156692803|NCT01013649|565621716|FG000|First Step|Other|4|||
156692804|NCT01013649|565621717|FG001|First Step|Other|6|||
156692805|NCT01013649|565621718|FG002|First Step|Other|0|||
156692806|NCT01013649|565621719|FG003|First Step|Other|0|||
156692807|NCT04285567|565621720|FG000|Overall Study|Death|3|||
156692808|NCT04285567|565621721|FG001|Overall Study|Death|3|||
156692809|NCT04285567|565621720|FG000|Overall Study|Lost to Follow-up|1|||
156692810|NCT04285567|565621721|FG001|Overall Study|Lost to Follow-up|1|||
156692811|NCT04285567|565621720|FG000|Overall Study|Reason Not Specified|1|||
156692812|NCT04285567|565621721|FG001|Overall Study|Reason Not Specified|1|||
156788850|NCT00290238|565977310|FG001|Overall Study|Study terminated|27|||
156788851|NCT00290238|565977309|FG000|Overall Study|Lost to Follow-up|0|||
156788852|NCT00290238|565977310|FG001|Overall Study|Lost to Follow-up|1|||
156788853|NCT00290238|565977309|FG000|Overall Study|Withdrawal by Subject|15|||
156788854|NCT00290238|565977310|FG001|Overall Study|Withdrawal by Subject|13|||
156788855|NCT03834883|565977311|FG000|Second Treatment|Withdrawal by Subject|1|||
156330384|NCT00313300|564310435|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
156330385|NCT00313300|564310431|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
156330386|NCT00313300|564310432|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
156330387|NCT00313300|564310433|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
156330388|NCT00313300|564310434|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
156330389|NCT00313300|564310435|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
156330390|NCT00313300|564310431|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
156330391|NCT00313300|564310432|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
156330392|NCT00313300|564310433|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
156330393|NCT00313300|564310434|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
156330394|NCT00313300|564310435|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
156330395|NCT00313300|564310431|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
156330396|NCT00313300|564310432|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
156330397|NCT00313300|564310433|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
156330398|NCT00313300|564310434|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
156330399|NCT00313300|564310435|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
156330400|NCT00313300|564310431|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
156330401|NCT00313300|564310432|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
156330402|NCT00313300|564310433|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
156330403|NCT00313300|564310434|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
156330404|NCT00313300|564310435|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
156330405|NCT00313300|564310431|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
156330406|NCT00313300|564310432|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
156330407|NCT00313300|564310433|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
156330408|NCT00313300|564310434|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
156330409|NCT00313300|564310435|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
156330410|NCT00313300|564310431|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
156330411|NCT00313300|564310432|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
156330412|NCT00313300|564310433|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
156330413|NCT00313300|564310434|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
156330414|NCT00313300|564310435|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
156330415|NCT00313300|564310431|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
156330416|NCT00313300|564310432|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
156330417|NCT00313300|564310433|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
156330418|NCT00313300|564310434|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
156330419|NCT00313300|564310435|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
156330420|NCT00313300|564310431|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
156330421|NCT00313300|564310432|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
156330422|NCT00313300|564310433|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
156330423|NCT00313300|564310434|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
156330424|NCT00313300|564310435|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
156692813|NCT04285567|565621720|FG000|Overall Study|Physician Decision|2|||
156788856|NCT03834883|565977312|FG001|Second Treatment|Withdrawal by Subject|0|||
156788857|NCT03834883|565977313|FG002|Second Treatment|Withdrawal by Subject|0|||
156330425|NCT00313300|564310431|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
156330426|NCT00313300|564310432|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
156330427|NCT00313300|564310433|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
156330428|NCT00313300|564310434|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
156330429|NCT00313300|564310435|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
156692814|NCT04285567|565621721|FG001|Overall Study|Physician Decision|1|||
156692815|NCT04285567|565621720|FG000|Overall Study|Withdrawal by Subject|2|||
156692816|NCT04285567|565621721|FG001|Overall Study|Withdrawal by Subject|6|||
156788858|NCT03834883|565977314|FG003|Second Treatment|Withdrawal by Subject|0|||
156530669|NCT01717768|565038136|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
156530670|NCT01717768|565038125|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156692817|NCT04285567|565621720|FG000|Overall Study|Adverse Event|1|||
156692818|NCT04285567|565621721|FG001|Overall Study|Adverse Event|0|||
156692819|NCT04285567|565621720|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
156692820|NCT04285567|565621721|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
156692821|NCT01408563|565621722|FG000|Overall Study|Ineligible after consent/ registration|2|||
156692822|NCT02246439|565621726|FG000|Overall Study|Adverse Event|3|||
156692823|NCT02246439|565621727|FG001|Overall Study|Adverse Event|0|||
156692824|NCT02246439|565621726|FG000|Overall Study|Lost to Follow-up|7|||
156692825|NCT02246439|565621727|FG001|Overall Study|Lost to Follow-up|5|||
156692826|NCT02246439|565621726|FG000|Overall Study|Protocol Violation|0|||
156692827|NCT02246439|565621727|FG001|Overall Study|Protocol Violation|2|||
156692828|NCT02246439|565621726|FG000|Overall Study|Physician Decision|0|||
156692829|NCT02246439|565621727|FG001|Overall Study|Physician Decision|1|||
156692830|NCT02246439|565621726|FG000|Overall Study|Unkonwn|1|||
156330430|NCT00313300|564310431|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
156330431|NCT00313300|564310432|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
156330432|NCT00313300|564310433|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
156330433|NCT00313300|564310434|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
156330434|NCT00313300|564310435|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
156330435|NCT00313300|564310431|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
156330436|NCT00313300|564310432|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
156330437|NCT00313300|564310433|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
156330438|NCT00313300|564310434|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
156330439|NCT00313300|564310435|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
156330440|NCT00313300|564310431|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
156330441|NCT00313300|564310432|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
156330442|NCT00313300|564310433|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
156330443|NCT00313300|564310434|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
156330444|NCT00313300|564310435|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
156330445|NCT00313300|564310431|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
156330446|NCT00313300|564310432|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
156330447|NCT00313300|564310433|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
156330448|NCT00313300|564310434|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
156330449|NCT00313300|564310435|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
156330450|NCT00313300|564310431|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
156330451|NCT00313300|564310432|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
156330452|NCT00313300|564310433|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
156330453|NCT00313300|564310434|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
156330454|NCT00313300|564310435|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
156330455|NCT00313300|564310431|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
156330456|NCT00313300|564310432|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
156330457|NCT00313300|564310433|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
156330458|NCT00313300|564310434|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
156330459|NCT00313300|564310435|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
156330460|NCT00313300|564310431|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
156330461|NCT00313300|564310432|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
156330462|NCT00313300|564310433|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
156330463|NCT00313300|564310434|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
156330464|NCT00313300|564310435|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
156330465|NCT00313300|564310431|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
156330466|NCT00313300|564310432|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
156330467|NCT00313300|564310433|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
156330468|NCT00313300|564310434|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
156330469|NCT00313300|564310435|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
156330470|NCT01926015|564310437|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156330471|NCT01926015|564310438|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156330472|NCT01926015|564310437|FG000|Overall Study|Randomized not treated|2|||
156330473|NCT01926015|564310438|FG001|Overall Study|Randomized not treated|0|||
156330474|NCT01364649|564310439|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
156330475|NCT01364649|564310440|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
156330476|NCT01364649|564310439|FG000|Overall Study|Lack of Efficacy|6|||
156330477|NCT01364649|564310440|FG001|Overall Study|Lack of Efficacy|0|||
156330478|NCT01364649|564310439|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
156530671|NCT01717768|565038126|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156692831|NCT02246439|565621727|FG001|Overall Study|Unkonwn|3|||
156788859|NCT03834883|565977311|FG000|Second Treatment|COVID-19 pandemic|1|||
156692832|NCT02246439|565621726|FG000|Overall Study|Withdrawal by Subject|1|||
156870323|NCT01177397|566282493|FG001|Overall Study|Lost to Follow-up|0|||
156870324|NCT01177397|566282494|FG002|Overall Study|Lost to Follow-up|0|||
156870325|NCT01177397|566282495|FG003|Overall Study|Lost to Follow-up|0|||
156870326|NCT01177397|566282496|FG004|Overall Study|Lost to Follow-up|1|||
156870327|NCT01177397|566282497|FG005|Overall Study|Lost to Follow-up|0|||
156437498|NCT00304031|564692331|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
156437499|NCT00304031|564692329|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
156437500|NCT00304031|564692330|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
156437501|NCT00304031|564692331|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
156437502|NCT00304031|564692329|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
156437503|NCT00304031|564692330|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
156437504|NCT00304031|564692331|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
156437505|NCT00304031|564692329|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
156437506|NCT00304031|564692330|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
156437507|NCT00304031|564692331|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
156437508|NCT00304031|564692329|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
156437509|NCT00304031|564692330|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
156437510|NCT00304031|564692331|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
156437511|NCT01188655|564692332|FG000|Overall Study|Lack of Efficacy|1|||
156437512|NCT01188655|564692332|FG000|Overall Study|Lost to Follow-up|1|||
156437513|NCT01188655|564692332|FG000|Overall Study|Other|11|||
156437514|NCT00683696|564692333|FG000|Overall Study|Withdrawn due to study closure|337|||
156437515|NCT00683696|564692334|FG001|Overall Study|Withdrawn due to study closure|338|||
156437516|NCT00683696|564692333|FG000|Overall Study|Withdrawn prior to study closure|13|||
156437517|NCT00683696|564692334|FG001|Overall Study|Withdrawn prior to study closure|28|||
156437518|NCT00683696|564692333|FG000|Overall Study|Lost to Follow-up|5|||
156437519|NCT00683696|564692334|FG001|Overall Study|Lost to Follow-up|6|||
156437520|NCT00683696|564692333|FG000|Overall Study|Vital status follow-up only|3|||
156437521|NCT00683696|564692334|FG001|Overall Study|Vital status follow-up only|3|||
156870328|NCT01177397|566282498|FG006|Overall Study|Lost to Follow-up|0|||
156870329|NCT01177397|566282499|FG007|Overall Study|Lost to Follow-up|2|||
156437522|NCT00683696|564692333|FG000|Overall Study|Death|46|||
156437523|NCT00683696|564692334|FG001|Overall Study|Death|30|||
156437524|NCT00089544|564692335|FG000|Overall Study|Ineligible|1|||
156437525|NCT00089544|564692336|FG001|Overall Study|Ineligible|0|||
156437526|NCT02396316|564692337|FG000|Overall Study|Physician Decision|1|||
156692833|NCT02246439|565621727|FG001|Overall Study|Withdrawal by Subject|0|||
156692834|NCT03439852|565621728|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
156692835|NCT03439852|565621729|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
156692836|NCT03439852|565621728|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
156692837|NCT03439852|565621729|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
156692838|NCT03439852|565621728|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
156692839|NCT03439852|565621729|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
156692840|NCT04271735|565621734|FG000|Overall Study|Physician Decision|2|||
156692841|NCT04271735|565621735|FG001|Overall Study|Physician Decision|0|||
156692842|NCT00922272|565621736|FG000|Open-label Phase|Adverse Event|5|||
156692843|NCT00922272|565621737|FG001|Open-label Phase|Adverse Event|0|||
156692844|NCT00922272|565621736|FG000|Open-label Phase|Protocol Violation|1|||
156692845|NCT00922272|565621737|FG001|Open-label Phase|Protocol Violation|0|||
156692846|NCT00922272|565621736|FG000|Open-label Phase|Withdrawal by Subject|11|||
156692847|NCT00922272|565621737|FG001|Open-label Phase|Withdrawal by Subject|0|||
156692848|NCT00922272|565621736|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
156692849|NCT00922272|565621737|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
156692850|NCT00922272|565621736|FG000|Open-label Phase|Withdrawal criteria met|5|||
156692851|NCT00922272|565621737|FG001|Open-label Phase|Withdrawal criteria met|0|||
156692852|NCT00922272|565621736|FG000|Double-blind Phase|Adverse Event|1|||
156692853|NCT00922272|565621737|FG001|Double-blind Phase|Adverse Event|1|||
156692854|NCT00922272|565621736|FG000|Double-blind Phase|Withdrawal by Subject|1|||
156692855|NCT00922272|565621737|FG001|Double-blind Phase|Withdrawal by Subject|1|||
156692856|NCT00922272|565621736|FG000|Double-blind Phase|Lost to Follow-up|2|||
156692857|NCT00922272|565621737|FG001|Double-blind Phase|Lost to Follow-up|1|||
156692858|NCT00922272|565621736|FG000|Double-blind Phase|Withdrawal criteria met|1|||
156692859|NCT00922272|565621737|FG001|Double-blind Phase|Withdrawal criteria met|1|||
156692860|NCT00922272|565621736|FG000|Double-blind Phase|Noncompliance|1|||
156692861|NCT00922272|565621737|FG001|Double-blind Phase|Noncompliance|1|||
156692862|NCT00922272|565621736|FG000|Double-blind Phase|Positive urine drug screen|1|||
156692863|NCT00922272|565621737|FG001|Double-blind Phase|Positive urine drug screen|1|||
156870330|NCT01177397|566282500|FG008|Overall Study|Lost to Follow-up|0|||
156437527|NCT02396316|564692338|FG001|Overall Study|Physician Decision|0|||
156692864|NCT03197558|565621738|FG000|Overall Study|Tubes not placed|1|||
156870331|NCT01177397|566282501|FG009|Overall Study|Lost to Follow-up|0|||
156870332|NCT01177397|566282502|FG010|Overall Study|Lost to Follow-up|0|||
156437528|NCT02396316|564692337|FG000|Overall Study|Progressive disease|6|||
156437529|NCT02396316|564692338|FG001|Overall Study|Progressive disease|3|||
156437530|NCT02396316|564692337|FG000|Overall Study|Protocol Violation|0|||
156437531|NCT02396316|564692338|FG001|Overall Study|Protocol Violation|1|||
156437532|NCT02396316|564692337|FG000|Overall Study|Treatment unblinded|0|||
156437533|NCT02396316|564692338|FG001|Overall Study|Treatment unblinded|1|||
156437534|NCT01662336|564692344|FG000|Overall Study|Adverse Event|1|||
156437535|NCT01662336|564692344|FG000|Overall Study|No longer on LPV/r|30|||
156437536|NCT01662336|564692344|FG000|Overall Study|Other|29|||
156437537|NCT01662336|564692344|FG000|Overall Study|Withdrawal by Subject|6|||
156437538|NCT02189252|564692345|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
156437539|NCT02189252|564692346|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
156437540|NCT02189252|564692347|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
156808748|NCT05554146|566054451|FG000|Overall Study|Protocol Violation|0|||
156437541|NCT02189252|564692348|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
156437542|NCT02189252|564692345|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
156437543|NCT02189252|564692346|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
156437544|NCT02189252|564692347|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
156437545|NCT02189252|564692348|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
156437546|NCT00566735|564692349|FG000|Overall Study|Withdrawal by Subject|0|||
156437547|NCT00566735|564692350|FG001|Overall Study|Withdrawal by Subject|1|||
156437548|NCT00566735|564692349|FG000|Overall Study|Refused neuropsychological testing|2|||
156437549|NCT00566735|564692350|FG001|Overall Study|Refused neuropsychological testing|5|||
156437550|NCT00566735|564692349|FG000|Overall Study|Switched into a manic episode|0|||
156437551|NCT00566735|564692350|FG001|Overall Study|Switched into a manic episode|1|||
156437552|NCT05876949|564692351|FG000|Overall Study|Withdrawal by Subject|1|||
156437553|NCT05876949|564692352|FG001|Overall Study|Withdrawal by Subject|3|||
156437554|NCT05876949|564692351|FG000|Overall Study|Physician Decision|0|||
156437555|NCT05876949|564692352|FG001|Overall Study|Physician Decision|2|||
156437556|NCT05876949|564692351|FG000|Overall Study|Death|0|||
156437557|NCT05876949|564692352|FG001|Overall Study|Death|1|||
156437558|NCT00508924|564692353|FG000|Overall Study|Protocol Violation|0|||
156437559|NCT00508924|564692354|FG001|Overall Study|Protocol Violation|0|||
156437560|NCT00508924|564692355|FG002|Overall Study|Protocol Violation|1|||
156437561|NCT00508924|564692356|FG003|Overall Study|Protocol Violation|1|||
156437562|NCT02755805|564692357|FG000|Overall Study|Lost to Follow-up|1|||
156437563|NCT02755805|564692358|FG001|Overall Study|Lost to Follow-up|2|||
156437564|NCT02755805|564692357|FG000|Overall Study|Refused assessments|1|||
156437565|NCT02755805|564692358|FG001|Overall Study|Refused assessments|0|||
156437566|NCT02755805|564692357|FG000|Overall Study|Withdrawal by Subject|0|||
156437567|NCT02755805|564692358|FG001|Overall Study|Withdrawal by Subject|2|||
156437568|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
156437569|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
156437570|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
156437571|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
156437572|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
156437573|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
156437574|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
156437575|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
156437576|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
156437577|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
156437578|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
156437579|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
156437580|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
156437581|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
156437582|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
156437583|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
156437584|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
156437585|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
156437586|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
156437587|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
156437588|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
156437589|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
156437590|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
156437591|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
156437592|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
156437593|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
156437594|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
156437595|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
156692865|NCT01304693|565621747|FG000|Overall Study|Adverse Event|0|||
156692866|NCT01304693|565621748|FG001|Overall Study|Adverse Event|0|||
156692867|NCT01304693|565621749|FG002|Overall Study|Adverse Event|0|||
156692868|NCT01304693|565621750|FG003|Overall Study|Adverse Event|0|||
156692869|NCT01304693|565621751|FG004|Overall Study|Adverse Event|1|||
156437596|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
156437597|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
156437598|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
156437599|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
156437600|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
156437601|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
156437602|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
156437603|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
156437604|NCT03593213|564692362|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
156437605|NCT03593213|564692363|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
156437606|NCT03593213|564692364|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
156437607|NCT03593213|564692365|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
156437608|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
156437609|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
156437610|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
156437611|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
156437612|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
156437613|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
156437614|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
156437615|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
156437616|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
156437617|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
156437618|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
156437619|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
156437620|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
156437621|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
156437622|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
156437623|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
156437624|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
156808749|NCT05554146|566054452|FG001|Overall Study|Protocol Violation|1|||
156808750|NCT05554146|566054453|FG002|Overall Study|Protocol Violation|0|||
156330479|NCT01364649|564310440|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
156330480|NCT01364649|564310439|FG000|Overall Study|Protocol Deviations|4|||
156330481|NCT01364649|564310440|FG001|Overall Study|Protocol Deviations|8|||
156330482|NCT01364649|564310439|FG000|Overall Study|Withdrawal of Consent|9|||
156330483|NCT01364649|564310440|FG001|Overall Study|Withdrawal of Consent|7|||
156330484|NCT01364649|564310439|FG000|Overall Study|Lost to Follow-up|12|||
156330485|NCT01364649|564310440|FG001|Overall Study|Lost to Follow-up|13|||
156330486|NCT01364649|564310439|FG000|Overall Study|Other|4|||
156330487|NCT01364649|564310440|FG001|Overall Study|Other|1|||
156330488|NCT02468232|564310443|FG000|Core Part of Study|Adverse Event|0|||
156330489|NCT02468232|564310444|FG001|Core Part of Study|Adverse Event|1|||
156330490|NCT02468232|564310445|FG002|Core Part of Study|Adverse Event|0|||
156330491|NCT02468232|564310446|FG003|Core Part of Study|Adverse Event|0|||
156330492|NCT02468232|564310443|FG000|Core Part of Study|Death|20|||
156330493|NCT02468232|564310444|FG001|Core Part of Study|Death|17|||
156330494|NCT02468232|564310445|FG002|Core Part of Study|Death|0|||
156330495|NCT02468232|564310446|FG003|Core Part of Study|Death|0|||
156330496|NCT02468232|564310443|FG000|Core Part of Study|Technical Problems|1|||
156330497|NCT02468232|564310444|FG001|Core Part of Study|Technical Problems|1|||
156330498|NCT02468232|564310445|FG002|Core Part of Study|Technical Problems|0|||
156330499|NCT02468232|564310446|FG003|Core Part of Study|Technical Problems|0|||
156330500|NCT02468232|564310443|FG000|OLE Part of Study|Adverse Event|0|||
156330501|NCT02468232|564310444|FG001|OLE Part of Study|Adverse Event|0|||
156330502|NCT02468232|564310445|FG002|OLE Part of Study|Adverse Event|4|||
156808751|NCT05554146|566054454|FG003|Overall Study|Protocol Violation|0|||
156808752|NCT05554146|566054451|FG000|Overall Study|No longer interested in participating|0|||
156808753|NCT05554146|566054452|FG001|Overall Study|No longer interested in participating|0|||
156330503|NCT02468232|564310446|FG003|OLE Part of Study|Adverse Event|5|||
156330504|NCT02468232|564310443|FG000|OLE Part of Study|Death|0|||
156330505|NCT02468232|564310444|FG001|OLE Part of Study|Death|0|||
156330506|NCT02468232|564310445|FG002|OLE Part of Study|Death|4|||
156330507|NCT02468232|564310446|FG003|OLE Part of Study|Death|2|||
156330508|NCT02468232|564310443|FG000|OLE Part of Study|Physician Decision|0|||
156808754|NCT05554146|566054453|FG002|Overall Study|No longer interested in participating|1|||
156808755|NCT05554146|566054454|FG003|Overall Study|No longer interested in participating|0|||
156808756|NCT05554146|566054451|FG000|Overall Study|Lost to Follow-up|1|||
156808757|NCT05554146|566054452|FG001|Overall Study|Lost to Follow-up|0|||
156808758|NCT05554146|566054453|FG002|Overall Study|Lost to Follow-up|0|||
156692870|NCT01304693|565621747|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
156692871|NCT01304693|565621748|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
156692872|NCT01304693|565621749|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
156692873|NCT01304693|565621750|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
156692874|NCT01304693|565621751|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
156692875|NCT02581163|565621752|FG000|Overall Study|Failure to return|15|||
156692876|NCT02581163|565621752|FG000|Overall Study|Insufficient virological response|3|||
156692877|NCT02581163|565621752|FG000|Overall Study|Withdrew consent|1|||
156692878|NCT02581163|565621752|FG000|Overall Study|Death|1|||
156692879|NCT02581163|565621752|FG000|Overall Study|Other, not specified|9|||
156692880|NCT00931268|565621753|FG000|Overall Study|Lost to Follow-up|6|||
156692881|NCT02072148|565621759|FG000|Overall Study|withdrew prior to surgery|23|||
156692882|NCT02072148|565621760|FG001|Overall Study|withdrew prior to surgery|0|||
156692883|NCT02072148|565621761|FG002|Overall Study|withdrew prior to surgery|0|||
156692884|NCT02072148|565621759|FG000|Overall Study|Death|0|||
156692885|NCT02072148|565621760|FG001|Overall Study|Death|0|||
156692886|NCT02072148|565621761|FG002|Overall Study|Death|1|||
156692887|NCT02072148|565621759|FG000|Overall Study|Withdrawal by Subject|0|||
156692888|NCT02072148|565621760|FG001|Overall Study|Withdrawal by Subject|13|||
156692889|NCT02072148|565621761|FG002|Overall Study|Withdrawal by Subject|12|||
156692890|NCT00430495|565621763|FG000|Overall Study|Adverse Event|2|||
156692891|NCT00430495|565621764|FG001|Overall Study|Adverse Event|3|||
156692892|NCT00430495|565621765|FG002|Overall Study|Adverse Event|2|||
156692893|NCT00430495|565621766|FG003|Overall Study|Adverse Event|0|||
156692894|NCT00430495|565621763|FG000|Overall Study|Death|0|||
156788860|NCT03834883|565977312|FG001|Second Treatment|COVID-19 pandemic|0|||
156788861|NCT03834883|565977313|FG002|Second Treatment|COVID-19 pandemic|1|||
156788862|NCT03834883|565977314|FG003|Second Treatment|COVID-19 pandemic|1|||
156788863|NCT01569763|565979056|FG000|Overall Study|Lack of Efficacy|2|||
156788864|NCT01569763|565979057|FG001|Overall Study|Lack of Efficacy|7|||
156437625|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
156437626|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
156437627|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
156437628|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
156437629|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
156437630|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
156437631|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
156437632|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
156437633|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
156437634|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
156437635|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
156437636|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
156437637|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
156692895|NCT00430495|565621764|FG001|Overall Study|Death|0|||
156692896|NCT00430495|565621765|FG002|Overall Study|Death|1|||
156692897|NCT00430495|565621766|FG003|Overall Study|Death|0|||
156692898|NCT00430495|565621763|FG000|Overall Study|Lost to Follow-up|0|||
156788865|NCT01569763|565979056|FG000|Overall Study|Adverse Event|1|||
156788866|NCT01569763|565979057|FG001|Overall Study|Adverse Event|0|||
156788867|NCT01926509|565979058|FG000|Overall Study|vital sign met discontinuation criteria|1|||
156788868|NCT01926509|565979059|FG001|Overall Study|vital sign met discontinuation criteria|0|||
156330509|NCT02468232|564310444|FG001|OLE Part of Study|Physician Decision|0|||
156330510|NCT02468232|564310445|FG002|OLE Part of Study|Physician Decision|4|||
156330511|NCT02468232|564310446|FG003|OLE Part of Study|Physician Decision|0|||
156330512|NCT02468232|564310443|FG000|OLE Part of Study|Subject/Guardian decision|0|||
156330513|NCT02468232|564310444|FG001|OLE Part of Study|Subject/Guardian decision|0|||
156330514|NCT02468232|564310445|FG002|OLE Part of Study|Subject/Guardian decision|2|||
156330515|NCT02468232|564310446|FG003|OLE Part of Study|Subject/Guardian decision|5|||
156330516|NCT01826604|564310447|FG000|Overall Study|Lost to Follow-up|8|||
156330517|NCT01826604|564310448|FG001|Overall Study|Lost to Follow-up|9|||
156330518|NCT04540497|564310451|FG000|Overall Study|Adverse Event|0|||
156330519|NCT04540497|564310452|FG001|Overall Study|Adverse Event|2|||
156330520|NCT04540497|564310451|FG000|Overall Study|Lost to Follow-up|1|||
156330521|NCT04540497|564310452|FG001|Overall Study|Lost to Follow-up|0|||
156330522|NCT04540497|564310451|FG000|Overall Study|Withdrawal by Subject|1|||
156330523|NCT04540497|564310452|FG001|Overall Study|Withdrawal by Subject|1|||
156330524|NCT04540497|564310451|FG000|Overall Study|Miscellaneous|2|||
156330525|NCT04540497|564310452|FG001|Overall Study|Miscellaneous|1|||
156692899|NCT00430495|565621764|FG001|Overall Study|Lost to Follow-up|1|||
156692900|NCT00430495|565621765|FG002|Overall Study|Lost to Follow-up|4|||
156692901|NCT00430495|565621766|FG003|Overall Study|Lost to Follow-up|0|||
156692902|NCT00430495|565621763|FG000|Overall Study|Protocol Violation|1|||
156330526|NCT05274815|564310453|FG000|Overall Study|Adverse Event|1|||
156808759|NCT05554146|566054454|FG003|Overall Study|Lost to Follow-up|0|||
156870333|NCT01177397|566282503|FG011|Overall Study|Lost to Follow-up|0|||
156870334|NCT01177397|566282492|FG000|Overall Study|Death|0|||
156870335|NCT01177397|566282493|FG001|Overall Study|Death|0|||
156870336|NCT01177397|566282494|FG002|Overall Study|Death|1|||
156870337|NCT01177397|566282495|FG003|Overall Study|Death|1|||
156692903|NCT00430495|565621764|FG001|Overall Study|Protocol Violation|0|||
156692904|NCT00430495|565621765|FG002|Overall Study|Protocol Violation|1|||
156692905|NCT00430495|565621766|FG003|Overall Study|Protocol Violation|0|||
156692906|NCT00430495|565621763|FG000|Overall Study|Disease Progression|1|||
156692907|NCT00430495|565621764|FG001|Overall Study|Disease Progression|1|||
156692908|NCT00430495|565621765|FG002|Overall Study|Disease Progression|0|||
156870338|NCT01177397|566282496|FG004|Overall Study|Death|0|||
156692909|NCT00430495|565621766|FG003|Overall Study|Disease Progression|0|||
156692910|NCT00430495|565621763|FG000|Overall Study|Other|8|||
156692911|NCT00430495|565621764|FG001|Overall Study|Other|2|||
156692912|NCT00430495|565621765|FG002|Overall Study|Other|5|||
156692913|NCT00430495|565621766|FG003|Overall Study|Other|4|||
156692914|NCT00430495|565621763|FG000|Overall Study|Randomized but not Treated|2|||
156692915|NCT00430495|565621764|FG001|Overall Study|Randomized but not Treated|0|||
156692916|NCT00430495|565621765|FG002|Overall Study|Randomized but not Treated|0|||
156692917|NCT00430495|565621766|FG003|Overall Study|Randomized but not Treated|0|||
156788869|NCT01926509|565979060|FG002|Overall Study|vital sign met discontinuation criteria|0|||
156788870|NCT01926509|565979061|FG003|Overall Study|vital sign met discontinuation criteria|0|||
156788871|NCT02730169|565979062|FG000|Overall Study|Protocol Violation|1|||
156788872|NCT02730169|565979063|FG001|Overall Study|Protocol Violation|0|||
156788873|NCT02730169|565979064|FG002|Overall Study|Protocol Violation|0|||
156788874|NCT02730169|565979065|FG003|Overall Study|Protocol Violation|1|||
156788875|NCT02730169|565979062|FG000|Overall Study|Adverse Event|2|||
156788876|NCT02730169|565979063|FG001|Overall Study|Adverse Event|3|||
156788877|NCT02730169|565979064|FG002|Overall Study|Adverse Event|3|||
156788878|NCT02730169|565979065|FG003|Overall Study|Adverse Event|0|||
156870339|NCT01177397|566282497|FG005|Overall Study|Death|0|||
156870340|NCT01177397|566282498|FG006|Overall Study|Death|0|||
156870341|NCT01177397|566282499|FG007|Overall Study|Death|5|||
156870342|NCT01177397|566282500|FG008|Overall Study|Death|2|||
156870343|NCT01177397|566282501|FG009|Overall Study|Death|1|||
156870344|NCT01177397|566282502|FG010|Overall Study|Death|0|||
156870345|NCT01177397|566282503|FG011|Overall Study|Death|0|||
156870346|NCT01177397|566282492|FG000|Overall Study|Withdrawal by Subject|0|||
156870347|NCT01177397|566282493|FG001|Overall Study|Withdrawal by Subject|0|||
156870348|NCT01177397|566282494|FG002|Overall Study|Withdrawal by Subject|1|||
156870349|NCT01177397|566282495|FG003|Overall Study|Withdrawal by Subject|1|||
156870350|NCT01177397|566282496|FG004|Overall Study|Withdrawal by Subject|1|||
156870351|NCT01177397|566282497|FG005|Overall Study|Withdrawal by Subject|2|||
156870352|NCT01177397|566282498|FG006|Overall Study|Withdrawal by Subject|0|||
156870353|NCT01177397|566282499|FG007|Overall Study|Withdrawal by Subject|5|||
156330527|NCT05274815|564310453|FG000|Overall Study|Death|2|||
156330528|NCT05274815|564310453|FG000|Overall Study|Lost to Follow-up|4|||
156330529|NCT05274815|564310453|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
156330530|NCT05274815|564310453|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
156330531|NCT05274815|564310453|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
156330532|NCT05274815|564310453|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
156330533|NCT05274815|564310453|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
156330534|NCT05274815|564310453|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
156330535|NCT05274815|564310453|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
156330536|NCT05274815|564310453|FG000|Overall Study|Withdrawal by Subject|11|||
156330537|NCT06132659|564310454|FG000|Overall Study|Lost to Follow-up|0|||
156330538|NCT06132659|564310455|FG001|Overall Study|Lost to Follow-up|1|||
156330539|NCT06132659|564310456|FG002|Overall Study|Lost to Follow-up|0|||
156330540|NCT03914326|564310457|FG000|Overall Study|Withdrawal by Subject|27|||
156330541|NCT03914326|564310458|FG001|Overall Study|Withdrawal by Subject|34|||
156330542|NCT03914326|564310457|FG000|Overall Study|Lost to Follow-up|43|||
156692918|NCT00158756|565621767|FG000|Overall Study|Withdrawal by Subject|5|||
156692919|NCT00158756|565621768|FG001|Overall Study|Withdrawal by Subject|0|||
156692920|NCT00158756|565621769|FG002|Overall Study|Withdrawal by Subject|6|||
156692921|NCT00158756|565621770|FG003|Overall Study|Withdrawal by Subject|1|||
156870354|NCT01177397|566282500|FG008|Overall Study|Withdrawal by Subject|9|||
156870355|NCT01177397|566282501|FG009|Overall Study|Withdrawal by Subject|1|||
156870356|NCT01177397|566282502|FG010|Overall Study|Withdrawal by Subject|1|||
156870357|NCT01177397|566282503|FG011|Overall Study|Withdrawal by Subject|0|||
156692922|NCT00158756|565621771|FG004|Overall Study|Withdrawal by Subject|3|||
156788879|NCT02730169|565979062|FG000|Overall Study|Adverse Event of Special Interest|0|||
156788880|NCT02730169|565979063|FG001|Overall Study|Adverse Event of Special Interest|1|||
156788881|NCT02730169|565979064|FG002|Overall Study|Adverse Event of Special Interest|2|||
156788882|NCT02730169|565979065|FG003|Overall Study|Adverse Event of Special Interest|0|||
156788883|NCT02730169|565979062|FG000|Overall Study|Withdrawal by Subject|6|||
156870358|NCT01177397|566282492|FG000|Overall Study|Adverse Event|0|||
156870359|NCT01177397|566282493|FG001|Overall Study|Adverse Event|0|||
156870360|NCT01177397|566282494|FG002|Overall Study|Adverse Event|1|||
156870361|NCT01177397|566282495|FG003|Overall Study|Adverse Event|2|||
156870362|NCT01177397|566282496|FG004|Overall Study|Adverse Event|0|||
156870363|NCT01177397|566282497|FG005|Overall Study|Adverse Event|12|||
156437638|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
156437639|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
156437640|NCT03593213|564692362|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
156437641|NCT03593213|564692363|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
156437642|NCT03593213|564692364|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
156437643|NCT03593213|564692365|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
156437644|NCT01831791|564692368|FG000|Overall Study|Withdrawal by Subject|10|||
156437645|NCT00494780|564692369|FG000|Overall Study|Adverse Event|1|||
156437646|NCT00494780|564692370|FG001|Overall Study|Adverse Event|0|||
156437647|NCT00494780|564692369|FG000|Overall Study|Withdrew before Dosed|0|||
156437648|NCT00494780|564692370|FG001|Overall Study|Withdrew before Dosed|1|||
156437649|NCT00494780|564692369|FG000|Overall Study|Progression of Study Disease|7|||
156437650|NCT00494780|564692370|FG001|Overall Study|Progression of Study Disease|8|||
156437651|NCT00494780|564692369|FG000|Overall Study|New Treatment|2|||
156437652|NCT00494780|564692370|FG001|Overall Study|New Treatment|2|||
156437653|NCT00494780|564692369|FG000|Overall Study|Non-compliance|1|||
156437654|NCT00494780|564692370|FG001|Overall Study|Non-compliance|0|||
156437655|NCT00494780|564692369|FG000|Overall Study|Residual Tumour Mass|0|||
156437656|NCT00494780|564692370|FG001|Overall Study|Residual Tumour Mass|1|||
156437657|NCT00494780|564692369|FG000|Overall Study|Insurance Issues|0|||
156437658|NCT00494780|564692370|FG001|Overall Study|Insurance Issues|1|||
156437659|NCT01391130|564692377|FG000|Overall Study|Withdrawal by Subject|3|||
156437660|NCT01391130|564692378|FG001|Overall Study|Withdrawal by Subject|2|||
156437661|NCT01391130|564692377|FG000|Overall Study|Physician Decision|2|||
156437662|NCT01391130|564692378|FG001|Overall Study|Physician Decision|3|||
156437663|NCT01391130|564692377|FG000|Overall Study|Did not Receive Drug|1|||
156437664|NCT01391130|564692378|FG001|Overall Study|Did not Receive Drug|1|||
156437665|NCT03260140|564692379|FG000|Overall Study|Death|4|||
156437666|NCT03260140|564692380|FG001|Overall Study|Death|1|||
156437667|NCT03260140|564692379|FG000|Overall Study|Withdrawal by Subject|1|||
156437668|NCT03260140|564692380|FG001|Overall Study|Withdrawal by Subject|4|||
156437669|NCT00463788|564692381|FG000|Overall Study|Progressive Disease|86|||
156437670|NCT00463788|564692382|FG001|Overall Study|Progressive Disease|42|||
156437671|NCT00463788|564692381|FG000|Overall Study|Adverse Event|6|||
156437672|NCT00463788|564692382|FG001|Overall Study|Adverse Event|2|||
156437673|NCT00463788|564692381|FG000|Overall Study|Withdrawal by Subject|6|||
156437674|NCT00463788|564692382|FG001|Overall Study|Withdrawal by Subject|2|||
156437675|NCT00463788|564692381|FG000|Overall Study|Death|4|||
156437676|NCT00463788|564692382|FG001|Overall Study|Death|3|||
156437677|NCT00463788|564692381|FG000|Overall Study|Symptomatic Deterioration|2|||
156437678|NCT00463788|564692382|FG001|Overall Study|Symptomatic Deterioration|3|||
156437679|NCT00463788|564692381|FG000|Overall Study|Lost to Follow-up|1|||
156437680|NCT00463788|564692382|FG001|Overall Study|Lost to Follow-up|0|||
156437681|NCT00463788|564692381|FG000|Overall Study|Protocol Violation|0|||
156437682|NCT00463788|564692382|FG001|Overall Study|Protocol Violation|1|||
156437683|NCT00463788|564692381|FG000|Overall Study|Other|3|||
156437684|NCT00463788|564692382|FG001|Overall Study|Other|0|||
156437685|NCT00463788|564692381|FG000|Overall Study|Randomized but not treated|1|||
156437686|NCT00463788|564692382|FG001|Overall Study|Randomized but not treated|1|||
156437687|NCT01692938|564692383|FG000|Overall Study|Protocol Deviation|1|||
156437688|NCT01692938|564692384|FG001|Overall Study|Protocol Deviation|1|||
156437689|NCT01692938|564692383|FG000|Overall Study|Study completed prior to site completion|3|||
156437690|NCT01692938|564692384|FG001|Overall Study|Study completed prior to site completion|3|||
156437691|NCT02423291|564692388|FG000|Overall Study|Lack of Efficacy|14|||
156437692|NCT02423291|564692388|FG000|Overall Study|Adverse Event|1|||
156437693|NCT00566527|564692389|FG000|Overall Study|Reason not provided|3|||
156437694|NCT00566527|564692390|FG001|Overall Study|Reason not provided|11|||
156437695|NCT00566527|564692391|FG002|Overall Study|Reason not provided|10|||
156437696|NCT00566527|564692389|FG000|Overall Study|Adverse Event|2|||
156437697|NCT00566527|564692390|FG001|Overall Study|Adverse Event|0|||
156437698|NCT00566527|564692391|FG002|Overall Study|Adverse Event|1|||
156437699|NCT00566527|564692389|FG000|Overall Study|Physician Decision|3|||
156437700|NCT00566527|564692390|FG001|Overall Study|Physician Decision|8|||
156437701|NCT00566527|564692391|FG002|Overall Study|Physician Decision|20|||
156437702|NCT00566527|564692389|FG000|Overall Study|Lost to Follow-up|3|||
156437703|NCT00566527|564692390|FG001|Overall Study|Lost to Follow-up|4|||
156437704|NCT00566527|564692391|FG002|Overall Study|Lost to Follow-up|4|||
156530672|NCT01717768|565038127|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156437705|NCT00566527|564692389|FG000|Overall Study|Withdrawal by Subject|6|||
156437706|NCT00566527|564692390|FG001|Overall Study|Withdrawal by Subject|43|||
156870364|NCT01177397|566282498|FG006|Overall Study|Adverse Event|1|||
156692923|NCT00158756|565621767|FG000|Overall Study|Adverse Event|0|||
156692924|NCT00158756|565621768|FG001|Overall Study|Adverse Event|0|||
156692925|NCT00158756|565621769|FG002|Overall Study|Adverse Event|1|||
156692926|NCT00158756|565621770|FG003|Overall Study|Adverse Event|0|||
156692927|NCT00158756|565621771|FG004|Overall Study|Adverse Event|0|||
156692928|NCT00158756|565621767|FG000|Overall Study|Serious adverse event|0|||
156692929|NCT00158756|565621768|FG001|Overall Study|Serious adverse event|0|||
156692930|NCT00158756|565621769|FG002|Overall Study|Serious adverse event|1|||
156692931|NCT00158756|565621770|FG003|Overall Study|Serious adverse event|0|||
156692932|NCT00158756|565621771|FG004|Overall Study|Serious adverse event|0|||
156692933|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
156692934|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
156692935|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
156692936|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
156692937|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
156692938|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
156692939|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
156692940|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
156692941|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
156692942|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
156692943|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
156692944|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
156692945|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
156692946|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
156692947|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
156692948|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
156692949|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
156692950|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
156692951|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
156692952|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
156692953|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
156692954|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
156692955|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
156692956|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
156692957|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
156692958|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
156692959|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
156692960|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
156692961|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
156692962|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
156692963|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
156692964|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
156692965|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
156692966|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
156692967|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
156692968|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
156692969|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
156692970|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
156692971|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
156692972|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
156692973|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
156692974|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
156692975|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
156692976|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
156692977|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
156692978|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
156692979|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
156692980|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
156692981|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
156692982|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
156692983|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
156692984|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
156692985|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
156788884|NCT02730169|565979063|FG001|Overall Study|Withdrawal by Subject|11|||
156788885|NCT02730169|565979064|FG002|Overall Study|Withdrawal by Subject|6|||
156788886|NCT02730169|565979065|FG003|Overall Study|Withdrawal by Subject|8|||
156692986|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
156692987|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
156692988|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
156692989|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
156692990|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
156692991|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
156692992|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
156692993|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
156692994|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
156692995|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
156692996|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
156692997|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
156692998|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
156692999|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
156693000|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
156693001|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
156693002|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
156693003|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
156693004|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
156693005|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
156693006|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
156693007|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
156693008|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
156693009|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
156693010|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
156693011|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
156693012|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
156693013|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
156693014|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
156693015|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
156693016|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
156693017|NCT03656874|565621777|FG000|Overall Study|Lost to Follow-up|3|||
156693018|NCT03656874|565621778|FG001|Overall Study|Lost to Follow-up|17|||
156693019|NCT01206816|565621779|FG000|Overall Study|Protocol Violation|0|||
156693020|NCT01206816|565621780|FG001|Overall Study|Protocol Violation|0|||
156693021|NCT01206816|565621781|FG002|Overall Study|Protocol Violation|1|||
156693022|NCT01206816|565621782|FG003|Overall Study|Protocol Violation|0|||
156693023|NCT01206816|565621783|FG004|Overall Study|Protocol Violation|0|||
156693024|NCT01206816|565621784|FG005|Overall Study|Protocol Violation|0|||
156693025|NCT01206816|565621785|FG006|Overall Study|Protocol Violation|0|||
156693026|NCT01206816|565621779|FG000|Overall Study|Withdrawal by Subject|0|||
156693027|NCT01206816|565621780|FG001|Overall Study|Withdrawal by Subject|0|||
156693028|NCT01206816|565621781|FG002|Overall Study|Withdrawal by Subject|1|||
156693029|NCT01206816|565621782|FG003|Overall Study|Withdrawal by Subject|0|||
156788887|NCT02730169|565979062|FG000|Overall Study|Lost to Follow-up|5|||
156788888|NCT02730169|565979063|FG001|Overall Study|Lost to Follow-up|6|||
156788889|NCT02730169|565979064|FG002|Overall Study|Lost to Follow-up|5|||
156788890|NCT02730169|565979065|FG003|Overall Study|Lost to Follow-up|6|||
156788891|NCT02730169|565979062|FG000|Overall Study|Other|0|||
156788892|NCT02730169|565979063|FG001|Overall Study|Other|0|||
156788893|NCT02730169|565979064|FG002|Overall Study|Other|1|||
156788894|NCT02730169|565979065|FG003|Overall Study|Other|1|||
156788895|NCT03681093|565979066|FG000|Overall Study|Subject decision|0|||
156788896|NCT03681093|565979067|FG001|Overall Study|Subject decision|2|||
156788897|NCT03681093|565979068|FG002|Overall Study|Subject decision|1|||
156788898|NCT01213251|565979070|FG000|Overall Study|Death|2|||
156788899|NCT01213251|565979071|FG001|Overall Study|Death|1|||
156788900|NCT01213251|565979072|FG002|Overall Study|Death|2|||
156870365|NCT01177397|566282499|FG007|Overall Study|Adverse Event|14|||
156437707|NCT00566527|564692391|FG002|Overall Study|Withdrawal by Subject|43|||
156437708|NCT00959946|564692392|FG000|Overall Study|Adverse Event|0|||
156437709|NCT00959946|564692393|FG001|Overall Study|Adverse Event|0|||
156437710|NCT00959946|564692394|FG002|Overall Study|Adverse Event|2|||
156437711|NCT00959946|564692395|FG003|Overall Study|Adverse Event|1|||
156437712|NCT00959946|564692396|FG004|Overall Study|Adverse Event|0|||
156437713|NCT00959946|564692397|FG005|Overall Study|Adverse Event|1|||
156437714|NCT00959946|564692398|FG006|Overall Study|Adverse Event|0|||
156693030|NCT01206816|565621783|FG004|Overall Study|Withdrawal by Subject|0|||
156693031|NCT01206816|565621784|FG005|Overall Study|Withdrawal by Subject|0|||
156788901|NCT01213251|565979070|FG000|Overall Study|Exit|3|||
156788902|NCT01213251|565979071|FG001|Overall Study|Exit|2|||
156788903|NCT01213251|565979072|FG002|Overall Study|Exit|8|||
156788904|NCT01213251|565979070|FG000|Overall Study|Protocol Violation|1|||
156870366|NCT01177397|566282500|FG008|Overall Study|Adverse Event|8|||
156693032|NCT01206816|565621785|FG006|Overall Study|Withdrawal by Subject|0|||
156693033|NCT01206816|565621779|FG000|Overall Study|Progressive disease|3|||
156693034|NCT01206816|565621780|FG001|Overall Study|Progressive disease|3|||
156693035|NCT01206816|565621781|FG002|Overall Study|Progressive disease|13|||
156693036|NCT01206816|565621782|FG003|Overall Study|Progressive disease|3|||
156693037|NCT01206816|565621783|FG004|Overall Study|Progressive disease|3|||
156693038|NCT01206816|565621784|FG005|Overall Study|Progressive disease|16|||
156693039|NCT01206816|565621785|FG006|Overall Study|Progressive disease|3|||
156693040|NCT01206816|565621779|FG000|Overall Study|Other AE|0|||
156693041|NCT01206816|565621780|FG001|Overall Study|Other AE|0|||
156693042|NCT01206816|565621781|FG002|Overall Study|Other AE|4|||
156693043|NCT01206816|565621782|FG003|Overall Study|Other AE|0|||
156693044|NCT01206816|565621783|FG004|Overall Study|Other AE|0|||
156693045|NCT01206816|565621784|FG005|Overall Study|Other AE|3|||
156693046|NCT01206816|565621785|FG006|Overall Study|Other AE|2|||
156693047|NCT01206816|565621779|FG000|Overall Study|other than stated above|0|||
156693048|NCT01206816|565621780|FG001|Overall Study|other than stated above|0|||
156693049|NCT01206816|565621781|FG002|Overall Study|other than stated above|1|||
156693050|NCT01206816|565621782|FG003|Overall Study|other than stated above|0|||
156693051|NCT01206816|565621783|FG004|Overall Study|other than stated above|0|||
156693052|NCT01206816|565621784|FG005|Overall Study|other than stated above|0|||
156693053|NCT01206816|565621785|FG006|Overall Study|other than stated above|1|||
156693054|NCT01939496|565621787|FG000|Overall Study|Adverse Event|2|||
156693055|NCT01939496|565621788|FG001|Overall Study|Adverse Event|0|||
156693056|NCT01939496|565621789|FG002|Overall Study|Adverse Event|0|||
156693057|NCT01939496|565621787|FG000|Overall Study|Lost to Follow-up|1|||
156693058|NCT01939496|565621788|FG001|Overall Study|Lost to Follow-up|1|||
156693059|NCT01939496|565621789|FG002|Overall Study|Lost to Follow-up|0|||
156693060|NCT01939496|565621787|FG000|Overall Study|Physician Decision|1|||
156693061|NCT01939496|565621788|FG001|Overall Study|Physician Decision|0|||
156693062|NCT01939496|565621789|FG002|Overall Study|Physician Decision|0|||
156693063|NCT01939496|565621787|FG000|Overall Study|Protocol Violation|3|||
156693064|NCT01939496|565621788|FG001|Overall Study|Protocol Violation|0|||
156693065|NCT01939496|565621789|FG002|Overall Study|Protocol Violation|0|||
156693066|NCT01939496|565621787|FG000|Overall Study|Withdrawal by Subject|0|||
156693067|NCT01939496|565621788|FG001|Overall Study|Withdrawal by Subject|1|||
156693068|NCT01939496|565621789|FG002|Overall Study|Withdrawal by Subject|1|||
156693069|NCT01939496|565621787|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
156693070|NCT01939496|565621788|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
156693071|NCT01939496|565621789|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
156693072|NCT01939496|565621787|FG000|Overall Study|Other|2|||
156693073|NCT01939496|565621788|FG001|Overall Study|Other|0|||
156693074|NCT01939496|565621789|FG002|Overall Study|Other|1|||
156693075|NCT03463993|565621793|FG000|Overall Study|Lost to Follow-up|7|||
156693076|NCT03463993|565621794|FG001|Overall Study|Lost to Follow-up|8|||
156693077|NCT03463993|565621793|FG000|Overall Study|Withdrawal by Subject|2|||
156693078|NCT03463993|565621794|FG001|Overall Study|Withdrawal by Subject|0|||
156693079|NCT03463993|565621793|FG000|Overall Study|Protocol Violation|4|||
156693080|NCT03463993|565621794|FG001|Overall Study|Protocol Violation|1|||
156693081|NCT03463993|565621793|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
156693082|NCT03463993|565621794|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
156693083|NCT03463993|565621793|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
156330543|NCT03914326|564310458|FG001|Overall Study|Lost to Follow-up|51|||
156330544|NCT03914326|564310457|FG000|Overall Study|Randomised more than once|0|||
156330545|NCT03914326|564310458|FG001|Overall Study|Randomised more than once|1|||
156330546|NCT03323502|564310459|FG000|Overall Study|Resident could not be linked to CMS data|594|||
156330547|NCT03323502|564310460|FG001|Overall Study|Resident could not be linked to CMS data|435|||
156330548|NCT03323502|564310459|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
156330549|NCT03323502|564310460|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
156330550|NCT03323502|564310459|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
156330551|NCT03323502|564310460|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
156330552|NCT03323502|564310459|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
156330553|NCT03323502|564310460|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
156330554|NCT03323502|564310459|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
156330555|NCT03323502|564310460|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
156330556|NCT04798781|564310461|FG000|Overall Study|Withdrawal by Subject|1|||
156330557|NCT02607930|564310464|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
156330558|NCT02607930|564310465|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
156330559|NCT02607930|564310466|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
156330560|NCT02607930|564310467|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
156330561|NCT02607930|564310464|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
156437715|NCT00959946|564692399|FG007|Overall Study|Adverse Event|0|||
156693084|NCT03463993|565621794|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
156693085|NCT01300052|565621795|FG000|Overall Study|Adverse Event|3|||
156693086|NCT01300052|565621796|FG001|Overall Study|Adverse Event|0|||
156693087|NCT01300052|565621795|FG000|Overall Study|Withdrawal by Subject|2|||
156693088|NCT01300052|565621796|FG001|Overall Study|Withdrawal by Subject|2|||
156693089|NCT01300052|565621795|FG000|Overall Study|Protocol Violation|1|||
156693090|NCT01300052|565621796|FG001|Overall Study|Protocol Violation|1|||
156693091|NCT05444543|565621797|FG000|Overall Study|Withdrawal by Subject|1|||
156693092|NCT05444543|565621798|FG001|Overall Study|Withdrawal by Subject|0|||
156693093|NCT05444543|565621797|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
156693094|NCT05444543|565621798|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
156693095|NCT05444543|565621797|FG000|Overall Study|Adverse Event|0|||
156693096|NCT05444543|565621798|FG001|Overall Study|Adverse Event|1|||
156693097|NCT05444543|565621797|FG000|Overall Study|Family relocating at a distance from study site|0|||
156693098|NCT05444543|565621798|FG001|Overall Study|Family relocating at a distance from study site|1|||
156693099|NCT02408120|565621799|FG000|Overall Study|Withdrawal by Subject|0|||
156693100|NCT02408120|565621800|FG001|Overall Study|Withdrawal by Subject|1|||
156693101|NCT02408120|565621799|FG000|Overall Study|Treatment Refusal|1|||
156693102|NCT02408120|565621800|FG001|Overall Study|Treatment Refusal|0|||
156693103|NCT02408120|565621799|FG000|Overall Study|Received Steroids|1|||
156693104|NCT02408120|565621800|FG001|Overall Study|Received Steroids|1|||
156693105|NCT02408120|565621799|FG000|Overall Study|Discharged same day|1|||
156693106|NCT02408120|565621800|FG001|Overall Study|Discharged same day|1|||
156693107|NCT02408120|565621799|FG000|Overall Study|Did not receive insulin|1|||
156693108|NCT02408120|565621800|FG001|Overall Study|Did not receive insulin|2|||
156693109|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
156693110|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
156693111|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
156693112|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
156693113|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
156693114|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
156693115|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
156693116|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
156693117|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
156693118|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
156693119|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Subject decision|1|||
156693120|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Subject decision|1|||
156693121|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
156693122|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
156693123|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
156693124|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
156693125|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
156693126|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
156330562|NCT02607930|564310465|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
156330563|NCT02607930|564310466|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
156330564|NCT02607930|564310467|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
156330565|NCT02607930|564310464|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
156330566|NCT02607930|564310465|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
156330567|NCT02607930|564310466|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
156330568|NCT02607930|564310467|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
156330569|NCT02607930|564310464|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
156330570|NCT02607930|564310465|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
156330571|NCT02607930|564310466|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
156330572|NCT02607930|564310467|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
156330573|NCT02607930|564310464|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
156330574|NCT02607930|564310465|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
156330575|NCT02607930|564310466|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
156330576|NCT02607930|564310467|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
156330577|NCT02607930|564310464|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
156330578|NCT02607930|564310465|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
156330579|NCT02607930|564310466|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
156330580|NCT02607930|564310467|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
156330581|NCT02607930|564310464|FG000|Double-Blinded Treatment Phase|Death|2|||
156330582|NCT02607930|564310465|FG001|Double-Blinded Treatment Phase|Death|1|||
156330583|NCT02607930|564310466|FG002|Double-Blinded Treatment Phase|Death|0|||
156330584|NCT02607930|564310467|FG003|Double-Blinded Treatment Phase|Death|0|||
156330585|NCT02607930|564310464|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
156330586|NCT02607930|564310465|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
156330587|NCT02607930|564310466|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
156693127|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
156693128|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
156330588|NCT02607930|564310467|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
156693129|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
156693130|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
156693131|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
156693132|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
156693133|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
156693134|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
156693135|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
156693136|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
156693137|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
156693138|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
156693139|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
156693140|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
156693141|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
156693142|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
156693143|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
156437716|NCT00959946|564692392|FG000|Overall Study|Death|0|||
156437717|NCT00959946|564692393|FG001|Overall Study|Death|0|||
156437718|NCT00959946|564692394|FG002|Overall Study|Death|0|||
156437719|NCT00959946|564692395|FG003|Overall Study|Death|0|||
156437720|NCT00959946|564692396|FG004|Overall Study|Death|0|||
156437721|NCT00959946|564692397|FG005|Overall Study|Death|1|||
156437722|NCT00959946|564692398|FG006|Overall Study|Death|0|||
156437723|NCT00959946|564692399|FG007|Overall Study|Death|0|||
156437724|NCT00959946|564692392|FG000|Overall Study|Disease Progression|2|||
156437725|NCT00959946|564692393|FG001|Overall Study|Disease Progression|4|||
156437726|NCT00959946|564692394|FG002|Overall Study|Disease Progression|2|||
156437727|NCT00959946|564692395|FG003|Overall Study|Disease Progression|4|||
156437728|NCT00959946|564692396|FG004|Overall Study|Disease Progression|4|||
156437729|NCT00959946|564692397|FG005|Overall Study|Disease Progression|6|||
156437730|NCT00959946|564692398|FG006|Overall Study|Disease Progression|2|||
156437731|NCT00959946|564692399|FG007|Overall Study|Disease Progression|2|||
156437732|NCT00959946|564692392|FG000|Overall Study|Withdrawal by Subject|0|||
156437733|NCT00959946|564692393|FG001|Overall Study|Withdrawal by Subject|0|||
156437734|NCT00959946|564692394|FG002|Overall Study|Withdrawal by Subject|0|||
156437735|NCT00959946|564692395|FG003|Overall Study|Withdrawal by Subject|0|||
156437736|NCT00959946|564692396|FG004|Overall Study|Withdrawal by Subject|0|||
156437737|NCT00959946|564692397|FG005|Overall Study|Withdrawal by Subject|1|||
156437738|NCT00959946|564692398|FG006|Overall Study|Withdrawal by Subject|0|||
156437739|NCT00959946|564692399|FG007|Overall Study|Withdrawal by Subject|0|||
156437740|NCT01837966|564692400|FG000|Overall Study|Withdrawal by Subject|2|||
156437741|NCT01837966|564692401|FG001|Overall Study|Withdrawal by Subject|1|||
156437742|NCT04975308|564692405|FG000|Overall Study|Withdrawal by Subject|6|||
156437743|NCT04975308|564692406|FG001|Overall Study|Withdrawal by Subject|16|||
156437744|NCT04975308|564692407|FG002|Overall Study|Withdrawal by Subject|6|||
156437745|NCT04975308|564692405|FG000|Overall Study|Physician Decision|0|||
156437746|NCT04975308|564692406|FG001|Overall Study|Physician Decision|3|||
156437747|NCT04975308|564692407|FG002|Overall Study|Physician Decision|1|||
156437748|NCT04975308|564692405|FG000|Overall Study|Adverse Event|10|||
156437749|NCT04975308|564692406|FG001|Overall Study|Adverse Event|1|||
156437750|NCT04975308|564692407|FG002|Overall Study|Adverse Event|12|||
156437751|NCT04975308|564692405|FG000|Overall Study|On study treatment (Ongoing)|65|||
156437752|NCT04975308|564692406|FG001|Overall Study|On study treatment (Ongoing)|43|||
156437753|NCT04975308|564692407|FG002|Overall Study|On study treatment (Ongoing)|75|||
156437754|NCT04975308|564692405|FG000|Overall Study|Protocol Deviation|4|||
156437755|NCT04975308|564692406|FG001|Overall Study|Protocol Deviation|3|||
156437756|NCT04975308|564692407|FG002|Overall Study|Protocol Deviation|2|||
156437757|NCT02115139|564692410|FG000|Overall Study|Protocol Violation|1|||
156437758|NCT02115139|564692410|FG000|Overall Study|treatment discontinuation|6|||
156437759|NCT00258895|564692411|FG000|Overall Study|Lost to Follow-up|3|||
156437760|NCT00258895|564692412|FG001|Overall Study|Lost to Follow-up|1|||
156437761|NCT00258895|564692411|FG000|Overall Study|Protocol Violation|6|||
156437762|NCT00258895|564692412|FG001|Overall Study|Protocol Violation|2|||
156693144|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
156693145|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
156693146|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
156693147|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
156693148|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
156693149|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
156437763|NCT00258895|564692411|FG000|Overall Study|Withdrawal by Subject|1|||
156437764|NCT00258895|564692412|FG001|Overall Study|Withdrawal by Subject|0|||
156437765|NCT00841035|564692413|FG000|Phase 1 Overall Study|Physician Decision|13|||
156437766|NCT00433199|564692418|FG000|Double-Blind Period|Adverse Event|0|||
156437767|NCT00433199|564692419|FG001|Double-Blind Period|Adverse Event|25|||
156437768|NCT00433199|564692418|FG000|Double-Blind Period|Lack of Efficacy|0|||
156437769|NCT00433199|564692419|FG001|Double-Blind Period|Lack of Efficacy|2|||
156437770|NCT00433199|564692418|FG000|Double-Blind Period|Lost to Follow-up|2|||
156437771|NCT00433199|564692419|FG001|Double-Blind Period|Lost to Follow-up|5|||
156437772|NCT00433199|564692418|FG000|Double-Blind Period|Withdrawal by Subject|8|||
156437773|NCT00433199|564692419|FG001|Double-Blind Period|Withdrawal by Subject|19|||
156437774|NCT00433199|564692418|FG000|Double-Blind Period|Protocol Violation|1|||
156437775|NCT00433199|564692419|FG001|Double-Blind Period|Protocol Violation|10|||
156437776|NCT00433199|564692418|FG000|Double-Blind Period|Administrative|1|||
156437777|NCT00433199|564692419|FG001|Double-Blind Period|Administrative|5|||
156437778|NCT00433199|564692418|FG000|Open-Label Period|Adverse Event|0|||
156437779|NCT00433199|564692419|FG001|Open-Label Period|Adverse Event|19|||
156437780|NCT00433199|564692418|FG000|Open-Label Period|Lack of Efficacy|0|||
156437781|NCT00433199|564692419|FG001|Open-Label Period|Lack of Efficacy|2|||
156437782|NCT00433199|564692418|FG000|Open-Label Period|Lost to Follow-up|0|||
156437783|NCT00433199|564692419|FG001|Open-Label Period|Lost to Follow-up|3|||
156437784|NCT00433199|564692418|FG000|Open-Label Period|Withdrawal by Subject|0|||
156437785|NCT00433199|564692419|FG001|Open-Label Period|Withdrawal by Subject|7|||
156437786|NCT00433199|564692418|FG000|Open-Label Period|Protocol Violation|0|||
156437787|NCT00433199|564692419|FG001|Open-Label Period|Protocol Violation|2|||
156437788|NCT00433199|564692418|FG000|Open-Label Period|Administrative|0|||
156437789|NCT00433199|564692419|FG001|Open-Label Period|Administrative|1|||
156437790|NCT00357097|564692420|FG000|Overall Study|Did not meet inclusion criteria|5|||
156437791|NCT00357097|564692421|FG001|Overall Study|Did not meet inclusion criteria|3|||
156437792|NCT00357097|564692420|FG000|Overall Study|Adverse Event|34|||
156437793|NCT00357097|564692421|FG001|Overall Study|Adverse Event|6|||
156693150|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
156693151|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
156693152|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
156693153|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
156693154|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
156693155|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
156693156|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
156693157|NCT02696031|565621803|FG000|Up to Week 24|Adverse Event|2|||
156693158|NCT02696031|565621804|FG001|Up to Week 24|Adverse Event|4|||
156693159|NCT02696031|565621805|FG002|Up to Week 24|Adverse Event|2|||
156693160|NCT02696031|565621806|FG003|Up to Week 24|Adverse Event|0|||
156693161|NCT02696031|565621807|FG004|Up to Week 24|Adverse Event|0|||
156693162|NCT02696031|565621808|FG005|Up to Week 24|Adverse Event|0|||
156693163|NCT02696031|565621803|FG000|Up to Week 24|Lack of Efficacy|2|||
156693164|NCT02696031|565621804|FG001|Up to Week 24|Lack of Efficacy|1|||
156693165|NCT02696031|565621805|FG002|Up to Week 24|Lack of Efficacy|2|||
156693166|NCT02696031|565621806|FG003|Up to Week 24|Lack of Efficacy|0|||
156693167|NCT02696031|565621807|FG004|Up to Week 24|Lack of Efficacy|0|||
156693168|NCT02696031|565621808|FG005|Up to Week 24|Lack of Efficacy|0|||
156693169|NCT02696031|565621803|FG000|Up to Week 24|Lost to Follow-up|0|||
156693170|NCT02696031|565621804|FG001|Up to Week 24|Lost to Follow-up|1|||
156693171|NCT02696031|565621805|FG002|Up to Week 24|Lost to Follow-up|1|||
156693172|NCT02696031|565621806|FG003|Up to Week 24|Lost to Follow-up|0|||
156693173|NCT02696031|565621807|FG004|Up to Week 24|Lost to Follow-up|0|||
156693174|NCT02696031|565621808|FG005|Up to Week 24|Lost to Follow-up|0|||
156693175|NCT02696031|565621803|FG000|Up to Week 24|Physician Decision|1|||
156693176|NCT02696031|565621804|FG001|Up to Week 24|Physician Decision|0|||
156693177|NCT02696031|565621805|FG002|Up to Week 24|Physician Decision|1|||
156693178|NCT02696031|565621806|FG003|Up to Week 24|Physician Decision|0|||
156693179|NCT02696031|565621807|FG004|Up to Week 24|Physician Decision|0|||
156693180|NCT02696031|565621808|FG005|Up to Week 24|Physician Decision|0|||
156693181|NCT02696031|565621803|FG000|Up to Week 24|Protocol Violation|1|||
156693182|NCT02696031|565621804|FG001|Up to Week 24|Protocol Violation|0|||
156693183|NCT02696031|565621805|FG002|Up to Week 24|Protocol Violation|0|||
156437794|NCT00357097|564692420|FG000|Overall Study|Withdrawal by Subject|8|||
156693184|NCT02696031|565621806|FG003|Up to Week 24|Protocol Violation|0|||
156693185|NCT02696031|565621807|FG004|Up to Week 24|Protocol Violation|0|||
156693186|NCT02696031|565621808|FG005|Up to Week 24|Protocol Violation|0|||
156437795|NCT00357097|564692421|FG001|Overall Study|Withdrawal by Subject|7|||
156437796|NCT00357097|564692420|FG000|Overall Study|Non-compliance|1|||
156437797|NCT00357097|564692421|FG001|Overall Study|Non-compliance|2|||
156437798|NCT00357097|564692420|FG000|Overall Study|Lack of Efficacy|2|||
156530673|NCT01717768|565038128|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156788905|NCT01213251|565979071|FG001|Overall Study|Protocol Violation|1|||
156788906|NCT01213251|565979072|FG002|Overall Study|Protocol Violation|0|||
156788907|NCT01213251|565979070|FG000|Overall Study|Missed 18-Month Follow-up|0|||
156437799|NCT00357097|564692421|FG001|Overall Study|Lack of Efficacy|8|||
156437800|NCT00357097|564692420|FG000|Overall Study|Met Exclusion Criteria|3|||
156437801|NCT00357097|564692421|FG001|Overall Study|Met Exclusion Criteria|1|||
156437802|NCT00357097|564692420|FG000|Overall Study|Other|1|||
156693187|NCT02696031|565621803|FG000|Up to Week 24|Withdrawal by Subject|4|||
156693188|NCT02696031|565621804|FG001|Up to Week 24|Withdrawal by Subject|1|||
156788908|NCT01213251|565979071|FG001|Overall Study|Missed 18-Month Follow-up|0|||
156693189|NCT02696031|565621805|FG002|Up to Week 24|Withdrawal by Subject|5|||
156693190|NCT02696031|565621806|FG003|Up to Week 24|Withdrawal by Subject|0|||
156693191|NCT02696031|565621807|FG004|Up to Week 24|Withdrawal by Subject|0|||
156693192|NCT02696031|565621808|FG005|Up to Week 24|Withdrawal by Subject|0|||
156693193|NCT02696031|565621803|FG000|Up to Week 52|Adverse Event|4|||
156693194|NCT02696031|565621804|FG001|Up to Week 52|Adverse Event|5|||
156693195|NCT02696031|565621805|FG002|Up to Week 52|Adverse Event|3|||
156693196|NCT02696031|565621806|FG003|Up to Week 52|Adverse Event|0|||
156693197|NCT02696031|565621807|FG004|Up to Week 52|Adverse Event|0|||
156693198|NCT02696031|565621808|FG005|Up to Week 52|Adverse Event|0|||
156693199|NCT02696031|565621803|FG000|Up to Week 52|Lack of Efficacy|10|||
156693200|NCT02696031|565621804|FG001|Up to Week 52|Lack of Efficacy|7|||
156693201|NCT02696031|565621805|FG002|Up to Week 52|Lack of Efficacy|11|||
156693202|NCT02696031|565621806|FG003|Up to Week 52|Lack of Efficacy|0|||
156693203|NCT02696031|565621807|FG004|Up to Week 52|Lack of Efficacy|0|||
156693204|NCT02696031|565621808|FG005|Up to Week 52|Lack of Efficacy|0|||
156693205|NCT02696031|565621803|FG000|Up to Week 52|Lost to Follow-up|1|||
156693206|NCT02696031|565621804|FG001|Up to Week 52|Lost to Follow-up|1|||
156693207|NCT02696031|565621805|FG002|Up to Week 52|Lost to Follow-up|1|||
156693208|NCT02696031|565621806|FG003|Up to Week 52|Lost to Follow-up|0|||
156693209|NCT02696031|565621807|FG004|Up to Week 52|Lost to Follow-up|0|||
156693210|NCT02696031|565621808|FG005|Up to Week 52|Lost to Follow-up|0|||
156693211|NCT02696031|565621803|FG000|Up to Week 52|Physician Decision|1|||
156693212|NCT02696031|565621804|FG001|Up to Week 52|Physician Decision|1|||
156693213|NCT02696031|565621805|FG002|Up to Week 52|Physician Decision|2|||
156693214|NCT02696031|565621806|FG003|Up to Week 52|Physician Decision|0|||
156693215|NCT02696031|565621807|FG004|Up to Week 52|Physician Decision|0|||
156693216|NCT02696031|565621808|FG005|Up to Week 52|Physician Decision|0|||
156693217|NCT02696031|565621803|FG000|Up to Week 52|Pregnancy|0|||
156693218|NCT02696031|565621804|FG001|Up to Week 52|Pregnancy|2|||
156693219|NCT02696031|565621805|FG002|Up to Week 52|Pregnancy|0|||
156693220|NCT02696031|565621806|FG003|Up to Week 52|Pregnancy|0|||
156693221|NCT02696031|565621807|FG004|Up to Week 52|Pregnancy|0|||
156693222|NCT02696031|565621808|FG005|Up to Week 52|Pregnancy|0|||
156693223|NCT02696031|565621803|FG000|Up to Week 52|Protocol Violation|1|||
156693224|NCT02696031|565621804|FG001|Up to Week 52|Protocol Violation|0|||
156693225|NCT02696031|565621805|FG002|Up to Week 52|Protocol Violation|0|||
156693226|NCT02696031|565621806|FG003|Up to Week 52|Protocol Violation|0|||
156693227|NCT02696031|565621807|FG004|Up to Week 52|Protocol Violation|0|||
156693228|NCT02696031|565621808|FG005|Up to Week 52|Protocol Violation|0|||
156693229|NCT02696031|565621803|FG000|Up to Week 52|Withdrawal by Subject|12|||
156693230|NCT02696031|565621804|FG001|Up to Week 52|Withdrawal by Subject|3|||
156693231|NCT02696031|565621805|FG002|Up to Week 52|Withdrawal by Subject|9|||
156693232|NCT02696031|565621806|FG003|Up to Week 52|Withdrawal by Subject|0|||
156693233|NCT02696031|565621807|FG004|Up to Week 52|Withdrawal by Subject|0|||
156693234|NCT02696031|565621808|FG005|Up to Week 52|Withdrawal by Subject|0|||
156693235|NCT02696031|565621803|FG000|Up to Week 104|Pregnancy|0|||
156693236|NCT02696031|565621804|FG001|Up to Week 104|Pregnancy|2|||
156693237|NCT02696031|565621805|FG002|Up to Week 104|Pregnancy|1|||
156788909|NCT01213251|565979072|FG002|Overall Study|Missed 18-Month Follow-up|1|||
156788910|NCT02698787|565979073|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
156788911|NCT02698787|565979074|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
156788912|NCT01882829|565979076|FG000|Overall Study|Adverse Event|4|||
156788913|NCT01882829|565979076|FG000|Overall Study|Protocol Violation|1|||
156788914|NCT01882829|565979076|FG000|Overall Study|Withdrawal by Subject|1|||
156788915|NCT00326495|565979084|FG000|Overall Study|Switched to alternative treatment|1|||
156788916|NCT00326495|565979084|FG000|Overall Study|Disease progression before treatment|1|||
156788917|NCT00326495|565979084|FG000|Overall Study|Refused further treatment|2|||
156788918|NCT00326495|565979084|FG000|Overall Study|Subject off study before assessment|1|||
156788919|NCT02802865|565979085|FG000|Overall Study|Pregnancy|1|||
156788920|NCT02802865|565979086|FG001|Overall Study|Pregnancy|1|||
156693238|NCT02696031|565621806|FG003|Up to Week 104|Pregnancy|0|||
156693239|NCT02696031|565621807|FG004|Up to Week 104|Pregnancy|0|||
156693240|NCT02696031|565621808|FG005|Up to Week 104|Pregnancy|0|||
156693241|NCT02696031|565621803|FG000|Up to Week 104|Withdrawal by Subject|15|||
156693242|NCT02696031|565621804|FG001|Up to Week 104|Withdrawal by Subject|10|||
156693243|NCT02696031|565621805|FG002|Up to Week 104|Withdrawal by Subject|16|||
156693244|NCT02696031|565621806|FG003|Up to Week 104|Withdrawal by Subject|0|||
156788921|NCT02802865|565979085|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
156530674|NCT01717768|565038129|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156693245|NCT02696031|565621807|FG004|Up to Week 104|Withdrawal by Subject|0|||
156693246|NCT02696031|565621808|FG005|Up to Week 104|Withdrawal by Subject|0|||
156693247|NCT02696031|565621803|FG000|Up to Week 104|Protocol Violation|1|||
156693248|NCT02696031|565621804|FG001|Up to Week 104|Protocol Violation|0|||
156693249|NCT02696031|565621805|FG002|Up to Week 104|Protocol Violation|0|||
156693250|NCT02696031|565621806|FG003|Up to Week 104|Protocol Violation|0|||
156693251|NCT02696031|565621807|FG004|Up to Week 104|Protocol Violation|0|||
156788922|NCT02802865|565979086|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
156788923|NCT01862029|565979087|FG000|Overall Study|Physician Decision|1|||
156693252|NCT02696031|565621808|FG005|Up to Week 104|Protocol Violation|0|||
156693253|NCT02696031|565621803|FG000|Up to Week 104|Physician Decision|1|||
156693254|NCT02696031|565621804|FG001|Up to Week 104|Physician Decision|2|||
156693255|NCT02696031|565621805|FG002|Up to Week 104|Physician Decision|3|||
156693256|NCT02696031|565621806|FG003|Up to Week 104|Physician Decision|0|||
156693257|NCT02696031|565621807|FG004|Up to Week 104|Physician Decision|0|||
156693258|NCT02696031|565621808|FG005|Up to Week 104|Physician Decision|0|||
156437803|NCT00357097|564692421|FG001|Overall Study|Other|1|||
156437804|NCT00357097|564692420|FG000|Overall Study|Increase of RLS Symptoms|0|||
156437805|NCT00357097|564692421|FG001|Overall Study|Increase of RLS Symptoms|1|||
156437806|NCT00658996|564692422|FG000|First Intervention|Positive slit lamp finding|1|||
156437807|NCT00658996|564692423|FG001|First Intervention|Positive slit lamp finding|0|||
156437808|NCT00658996|564692422|FG000|First Intervention|Lack of lenses|0|||
156437809|NCT00658996|564692423|FG001|First Intervention|Lack of lenses|1|||
156437810|NCT00658996|564692422|FG000|Crossover Period|Physician Decision|1|||
156437811|NCT00658996|564692423|FG001|Crossover Period|Physician Decision|0|||
156437812|NCT00658996|564692422|FG000|Crossover Period|Ineligible|1|||
156437813|NCT00658996|564692423|FG001|Crossover Period|Ineligible|1|||
156437814|NCT00658996|564692422|FG000|Second Intervention|Developed a stye on upper lid|1|||
156437815|NCT00658996|564692423|FG001|Second Intervention|Developed a stye on upper lid|0|||
156437816|NCT00658996|564692422|FG000|Second Intervention|Positive slit lamp finding|0|||
156437817|NCT00658996|564692423|FG001|Second Intervention|Positive slit lamp finding|1|||
156437818|NCT02994654|564692425|FG000|Overall Study|Lost to Follow-up|1|||
156437819|NCT03603717|564692428|FG000|Overall Study|Lost to Follow-up|20|||
156437820|NCT03603717|564692429|FG001|Overall Study|Lost to Follow-up|20|||
156437821|NCT03603717|564692428|FG000|Overall Study|Withdrawal by Subject|16|||
156437822|NCT03603717|564692429|FG001|Overall Study|Withdrawal by Subject|10|||
156437823|NCT00732381|564692432|FG000|Overall Study|Adverse Event|1|||
156437824|NCT00732381|564692433|FG001|Overall Study|Adverse Event|0|||
156437825|NCT00732381|564692432|FG000|Overall Study|Treatment Failure|1|||
156437826|NCT00732381|564692433|FG001|Overall Study|Treatment Failure|1|||
156437827|NCT04603924|564693428|FG000|Overall Study|Not Dosed|2|||
156437828|NCT04603924|564693429|FG001|Overall Study|Not Dosed|1|||
156437829|NCT04603924|564693428|FG000|Overall Study|Withdrawal by Subject|6|||
156437830|NCT04603924|564693429|FG001|Overall Study|Withdrawal by Subject|6|||
156437831|NCT04603924|564693428|FG000|Overall Study|Adverse Event|2|||
156437832|NCT04603924|564693429|FG001|Overall Study|Adverse Event|2|||
156437833|NCT03762668|564693432|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
156437834|NCT03762668|564693433|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
156693259|NCT02696031|565621803|FG000|Up to Week 104|Lost to Follow-up|2|||
156437835|NCT00686855|564693437|FG000|Overall Study|Lost to Follow-up|1|||
156788924|NCT03931785|565979088|FG000|Overall Study|Lost to Follow-up|4|||
156788925|NCT03931785|565979089|FG001|Overall Study|Lost to Follow-up|1|||
156788926|NCT03931785|565979090|FG002|Overall Study|Lost to Follow-up|4|||
156788927|NCT03931785|565979091|FG003|Overall Study|Lost to Follow-up|3|||
156788928|NCT03931785|565979088|FG000|Overall Study|Adverse Event|1|||
156788929|NCT03931785|565979089|FG001|Overall Study|Adverse Event|0|||
156788930|NCT03931785|565979090|FG002|Overall Study|Adverse Event|3|||
156788931|NCT03931785|565979091|FG003|Overall Study|Adverse Event|4|||
156788932|NCT03931785|565979088|FG000|Overall Study|Protocol Violation|0|||
156788933|NCT03931785|565979089|FG001|Overall Study|Protocol Violation|1|||
156788934|NCT03931785|565979090|FG002|Overall Study|Protocol Violation|0|||
156788935|NCT03931785|565979091|FG003|Overall Study|Protocol Violation|0|||
156788936|NCT03931785|565979088|FG000|Overall Study|Noncompliance With Study drug|0|||
156788937|NCT03931785|565979089|FG001|Overall Study|Noncompliance With Study drug|1|||
156788938|NCT03931785|565979090|FG002|Overall Study|Noncompliance With Study drug|0|||
156788939|NCT03931785|565979091|FG003|Overall Study|Noncompliance With Study drug|0|||
156788940|NCT03931785|565979088|FG000|Overall Study|Other Not specified|0|||
156788941|NCT03931785|565979089|FG001|Overall Study|Other Not specified|2|||
156788942|NCT03931785|565979090|FG002|Overall Study|Other Not specified|2|||
156788943|NCT03931785|565979091|FG003|Overall Study|Other Not specified|2|||
156788944|NCT03931785|565979088|FG000|Overall Study|Withdrawal by Subject|0|||
156788945|NCT03931785|565979089|FG001|Overall Study|Withdrawal by Subject|2|||
156788946|NCT03931785|565979090|FG002|Overall Study|Withdrawal by Subject|4|||
156788947|NCT03931785|565979091|FG003|Overall Study|Withdrawal by Subject|1|||
156788948|NCT03931785|565979088|FG000|Overall Study|Pregnancy|0|||
156437836|NCT00686855|564693438|FG001|Overall Study|Lost to Follow-up|0|||
156437837|NCT00686855|564693437|FG000|Overall Study|Progressive GVHD|0|||
156437838|NCT00686855|564693438|FG001|Overall Study|Progressive GVHD|1|||
156693260|NCT02696031|565621804|FG001|Up to Week 104|Lost to Follow-up|3|||
156437839|NCT02731755|564693441|FG000|First Intervention|Withdrawal by Subject|0|||
156437840|NCT02731755|564693442|FG001|First Intervention|Withdrawal by Subject|2|||
156437841|NCT01460446|564693443|FG000|Overall Study|Non-compliance|2|||
156437842|NCT01460446|564693444|FG001|Overall Study|Non-compliance|9|||
156437843|NCT01460446|564693443|FG000|Overall Study|Consent Withdrawn|0|||
156788949|NCT03931785|565979089|FG001|Overall Study|Pregnancy|0|||
156788950|NCT03931785|565979090|FG002|Overall Study|Pregnancy|0|||
156788951|NCT03931785|565979091|FG003|Overall Study|Pregnancy|1|||
156788952|NCT03211858|565979092|FG000|Overall Study|Adverse Event|8|||
156437844|NCT01460446|564693444|FG001|Overall Study|Consent Withdrawn|4|||
156437845|NCT01460446|564693443|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
156437846|NCT01460446|564693444|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
156437847|NCT01460446|564693443|FG000|Overall Study|Surgery/Illness|1|||
156437848|NCT01460446|564693444|FG001|Overall Study|Surgery/Illness|1|||
156437849|NCT01460446|564693443|FG000|Overall Study|Pregnancy|1|||
156437850|NCT01460446|564693444|FG001|Overall Study|Pregnancy|0|||
156437851|NCT01460446|564693443|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
156437852|NCT01460446|564693444|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
156437853|NCT00714714|564693445|FG000|Overall Study|Adverse Event|1|||
156437854|NCT02616900|564693446|FG000|Overall Study|Lack of Efficacy|7|||
156437855|NCT02616900|564693446|FG000|Overall Study|Lost to Follow-up|2|||
156437856|NCT02616900|564693446|FG000|Overall Study|Protocol Violation|5|||
156437857|NCT02616900|564693446|FG000|Overall Study|Withdrawal by Subject|3|||
156437858|NCT02616900|564693446|FG000|Overall Study|Incomplete data|6|||
156437859|NCT02613871|564693449|FG000|Overall Study|Death|2|||
156437860|NCT02613871|564693449|FG000|Overall Study|Withdrew Consent|1|||
156437861|NCT00845832|564693450|FG000|Treatment Period|Adverse Event|0|||
156437862|NCT00845832|564693451|FG001|Treatment Period|Adverse Event|2|||
156437863|NCT00845832|564693452|FG002|Treatment Period|Adverse Event|0|||
156437864|NCT00845832|564693450|FG000|Treatment Period|Protocol Violation|1|||
156437865|NCT00845832|564693451|FG001|Treatment Period|Protocol Violation|1|||
156437866|NCT00845832|564693452|FG002|Treatment Period|Protocol Violation|0|||
156437867|NCT00845832|564693450|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
156437868|NCT00845832|564693451|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
156437869|NCT00845832|564693452|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
156437870|NCT00845832|564693450|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
156437871|NCT00845832|564693451|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
156437872|NCT00845832|564693452|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
156437873|NCT00869323|564693453|FG000|Maintenance Therapy|concurrent illness|1|||
156437874|NCT02880241|564693454|FG000|Overall Study|Lack of Efficacy|1|||
156437875|NCT02880241|564693455|FG001|Overall Study|Lack of Efficacy|0|||
156437876|NCT02880241|564693456|FG002|Overall Study|Lack of Efficacy|0|||
156437877|NCT02880241|564693457|FG003|Overall Study|Lack of Efficacy|0|||
156437878|NCT02880241|564693458|FG004|Overall Study|Lack of Efficacy|0|||
156437879|NCT02880241|564693459|FG005|Overall Study|Lack of Efficacy|0|||
156437880|NCT03737240|564693460|FG000|Overall Study|Lost to Follow-up|16|||
156437881|NCT03737240|564693461|FG001|Overall Study|Lost to Follow-up|15|||
156437882|NCT00891930|564693462|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
156437883|NCT00891930|564693462|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
156437884|NCT00891930|564693462|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
156437885|NCT00891930|564693462|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
156870367|NCT01177397|566282501|FG009|Overall Study|Adverse Event|6|||
156870368|NCT01177397|566282502|FG010|Overall Study|Adverse Event|3|||
156870369|NCT01177397|566282503|FG011|Overall Study|Adverse Event|7|||
156870370|NCT01177397|566282492|FG000|Overall Study|Disease progression|1|||
156870371|NCT01177397|566282493|FG001|Overall Study|Disease progression|2|||
156870372|NCT01177397|566282494|FG002|Overall Study|Disease progression|5|||
156870373|NCT01177397|566282495|FG003|Overall Study|Disease progression|5|||
156870374|NCT01177397|566282496|FG004|Overall Study|Disease progression|4|||
156870375|NCT01177397|566282497|FG005|Overall Study|Disease progression|10|||
156870376|NCT01177397|566282498|FG006|Overall Study|Disease progression|10|||
156870377|NCT01177397|566282499|FG007|Overall Study|Disease progression|21|||
156788953|NCT03211858|565979093|FG001|Overall Study|Adverse Event|6|||
156788954|NCT03211858|565979092|FG000|Overall Study|Lack of Efficacy|0|||
156788955|NCT03211858|565979093|FG001|Overall Study|Lack of Efficacy|4|||
156788956|NCT03211858|565979092|FG000|Overall Study|Poor compliance to protocol|6|||
156788957|NCT03211858|565979093|FG001|Overall Study|Poor compliance to protocol|2|||
156788958|NCT03211858|565979092|FG000|Overall Study|Non-serious Hypoglycemia|1|||
156788959|NCT03211858|565979093|FG001|Overall Study|Non-serious Hypoglycemia|0|||
156788960|NCT03211858|565979092|FG000|Overall Study|Other than specified above|22|||
156788961|NCT03211858|565979093|FG001|Overall Study|Other than specified above|21|||
156788962|NCT01529112|565979096|FG000|Overall Study|Adverse Event|2|||
156788963|NCT01529112|565979097|FG001|Overall Study|Adverse Event|0|||
156788964|NCT01529112|565979096|FG000|Overall Study|Death|59|||
156788965|NCT01529112|565979097|FG001|Overall Study|Death|38|||
156788966|NCT01529112|565979096|FG000|Overall Study|Protocol Violation|1|||
156788967|NCT01529112|565979097|FG001|Overall Study|Protocol Violation|0|||
156788968|NCT01529112|565979096|FG000|Overall Study|Withdrawal by Subject|7|||
156788969|NCT01529112|565979097|FG001|Overall Study|Withdrawal by Subject|3|||
156788970|NCT04034056|565979102|FG000|Overall Study|Withdrawal by Subject|2|||
156788971|NCT04034056|565979102|FG000|Overall Study|Reason Not Specified|13|||
156870378|NCT01177397|566282500|FG008|Overall Study|Disease progression|18|||
156870379|NCT01177397|566282501|FG009|Overall Study|Disease progression|12|||
156437886|NCT00891930|564693462|FG000|Part 2 Panitumumab + AMG479|Death|30|||
156788972|NCT04034056|565979102|FG000|Overall Study|Adverse Event|56|||
156788973|NCT04135352|565979104|FG000|Overall Study|Not treated-randomization error|0|||
156870380|NCT01177397|566282502|FG010|Overall Study|Disease progression|10|||
156870381|NCT01177397|566282503|FG011|Overall Study|Disease progression|8|||
156870382|NCT01177397|566282492|FG000|Overall Study|Other reasons|0|||
156870383|NCT01177397|566282493|FG001|Overall Study|Other reasons|0|||
156870384|NCT01177397|566282494|FG002|Overall Study|Other reasons|1|||
156870385|NCT01177397|566282495|FG003|Overall Study|Other reasons|0|||
156330589|NCT02607930|564310464|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
156330590|NCT02607930|564310465|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
156330591|NCT02607930|564310466|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
156330592|NCT02607930|564310467|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
156330593|NCT02607930|564310464|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
156330594|NCT02607930|564310465|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
156330595|NCT02607930|564310466|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
156330596|NCT02607930|564310467|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
156330597|NCT02607930|564310464|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
156330598|NCT02607930|564310465|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
156330599|NCT02607930|564310466|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
156330600|NCT02607930|564310467|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
156330601|NCT02607930|564310464|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
156330602|NCT02607930|564310465|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
156330603|NCT02607930|564310466|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
156330604|NCT02607930|564310467|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
156330605|NCT02607930|564310464|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
156330606|NCT02607930|564310465|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
156330607|NCT02607930|564310466|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
156330608|NCT02607930|564310467|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
156330609|NCT02607930|564310464|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
156330610|NCT02607930|564310465|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
156330611|NCT02607930|564310466|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
156330612|NCT02607930|564310467|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
156330613|NCT02607930|564310464|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
156330614|NCT02607930|564310465|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
156330615|NCT02607930|564310466|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
156330616|NCT02607930|564310467|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
156330617|NCT02607930|564310464|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
156330618|NCT02607930|564310465|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
156330619|NCT02607930|564310466|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
156330620|NCT02607930|564310467|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
156330621|NCT03198078|564310468|FG000|Overall Study|Adverse Event|0|||
156330622|NCT03198078|564310469|FG001|Overall Study|Adverse Event|1|||
156330623|NCT03198078|564310470|FG002|Overall Study|Adverse Event|2|||
156330624|NCT03198078|564310468|FG000|Overall Study|Lack of Efficacy|0|||
156330625|NCT03198078|564310469|FG001|Overall Study|Lack of Efficacy|0|||
156330626|NCT03198078|564310470|FG002|Overall Study|Lack of Efficacy|3|||
156330627|NCT03198078|564310468|FG000|Overall Study|Lost to Follow-up|1|||
156330628|NCT03198078|564310469|FG001|Overall Study|Lost to Follow-up|0|||
156330629|NCT03198078|564310470|FG002|Overall Study|Lost to Follow-up|0|||
156330630|NCT03198078|564310468|FG000|Overall Study|Pregnancy|0|||
156330631|NCT03198078|564310469|FG001|Overall Study|Pregnancy|1|||
156330632|NCT03198078|564310470|FG002|Overall Study|Pregnancy|0|||
156330633|NCT03198078|564310468|FG000|Overall Study|Withdrawal by Subject|1|||
156330634|NCT03198078|564310469|FG001|Overall Study|Withdrawal by Subject|0|||
156330635|NCT03198078|564310470|FG002|Overall Study|Withdrawal by Subject|2|||
156330636|NCT03198078|564310468|FG000|Overall Study|Withdrawal by Caregiver|1|||
156330637|NCT03198078|564310469|FG001|Overall Study|Withdrawal by Caregiver|3|||
156330638|NCT03198078|564310470|FG002|Overall Study|Withdrawal by Caregiver|5|||
156330639|NCT01676727|564310473|FG000|Overall Study|Death|18|||
156330640|NCT01676727|564310473|FG000|Overall Study|Withdrawal by Subject|6|||
156330641|NCT01676727|564310473|FG000|Overall Study|Screening failure|5|||
156330642|NCT01676727|564310473|FG000|Overall Study|Not willing to attend 1-year visit|2|||
156330643|NCT01676727|564310473|FG000|Overall Study|Valve explanted|1|||
156330644|NCT00722423|564310479|FG000|Overall Study|Protocol Violation|0|||
156330645|NCT00722423|564310480|FG001|Overall Study|Protocol Violation|1|||
156330646|NCT00737438|564310483|FG000|Overall Study|Withdrawal by Subject|2|||
156330647|NCT00737438|564310483|FG000|Overall Study|Patient ineligible|1|||
156330648|NCT04810481|564310485|FG000|Overall Study|Disqualified data sets|10|||
156330649|NCT04810481|564310486|FG001|Overall Study|Disqualified data sets|28|||
156330650|NCT04102098|564310489|FG000|Main Study Period|Ongoing in study|302|||
156330651|NCT04102098|564310490|FG001|Main Study Period|Ongoing in study|291|||
156870386|NCT01177397|566282496|FG004|Overall Study|Other reasons|1|||
156330652|NCT04102098|564310489|FG000|Main Study Period|Death|20|||
156330653|NCT04102098|564310490|FG001|Main Study Period|Death|27|||
156330654|NCT04102098|564310489|FG000|Main Study Period|Lost to Follow-up|1|||
156330655|NCT04102098|564310490|FG001|Main Study Period|Lost to Follow-up|1|||
156693261|NCT02696031|565621805|FG002|Up to Week 104|Lost to Follow-up|1|||
156693262|NCT02696031|565621806|FG003|Up to Week 104|Lost to Follow-up|0|||
156693263|NCT02696031|565621807|FG004|Up to Week 104|Lost to Follow-up|0|||
156693264|NCT02696031|565621808|FG005|Up to Week 104|Lost to Follow-up|0|||
156693265|NCT02696031|565621803|FG000|Up to Week 104|Lack of Efficacy|13|||
156693266|NCT02696031|565621804|FG001|Up to Week 104|Lack of Efficacy|12|||
156693267|NCT02696031|565621805|FG002|Up to Week 104|Lack of Efficacy|11|||
156693268|NCT02696031|565621806|FG003|Up to Week 104|Lack of Efficacy|0|||
156693269|NCT02696031|565621807|FG004|Up to Week 104|Lack of Efficacy|0|||
156693270|NCT02696031|565621808|FG005|Up to Week 104|Lack of Efficacy|0|||
156693271|NCT02696031|565621803|FG000|Up to Week 104|Adverse Event|7|||
156693272|NCT02696031|565621804|FG001|Up to Week 104|Adverse Event|11|||
156693273|NCT02696031|565621805|FG002|Up to Week 104|Adverse Event|5|||
156788974|NCT04135352|565979105|FG001|Overall Study|Not treated-randomization error|0|||
156788975|NCT04135352|565979106|FG002|Overall Study|Not treated-randomization error|1|||
156693274|NCT02696031|565621806|FG003|Up to Week 104|Adverse Event|0|||
156693275|NCT02696031|565621807|FG004|Up to Week 104|Adverse Event|0|||
156693276|NCT02696031|565621808|FG005|Up to Week 104|Adverse Event|0|||
156788976|NCT04135352|565979107|FG003|Overall Study|Not treated-randomization error|0|||
156788977|NCT04135352|565979108|FG004|Overall Study|Not treated-randomization error|0|||
156788978|NCT04135352|565979109|FG005|Overall Study|Not treated-randomization error|0|||
156788979|NCT04135352|565979110|FG006|Overall Study|Not treated-randomization error|0|||
156788980|NCT04135352|565979111|FG007|Overall Study|Not treated-randomization error|0|||
156788981|NCT04135352|565979104|FG000|Overall Study|Withdrawal by Subject|0|||
156788982|NCT04135352|565979105|FG001|Overall Study|Withdrawal by Subject|0|||
156788983|NCT04135352|565979106|FG002|Overall Study|Withdrawal by Subject|2|||
156788984|NCT04135352|565979107|FG003|Overall Study|Withdrawal by Subject|0|||
156788985|NCT04135352|565979108|FG004|Overall Study|Withdrawal by Subject|0|||
156788986|NCT04135352|565979109|FG005|Overall Study|Withdrawal by Subject|0|||
156788987|NCT04135352|565979110|FG006|Overall Study|Withdrawal by Subject|0|||
156788988|NCT04135352|565979111|FG007|Overall Study|Withdrawal by Subject|0|||
156788989|NCT04135352|565979104|FG000|Overall Study|Sponsor Decision|0|||
156788990|NCT04135352|565979105|FG001|Overall Study|Sponsor Decision|0|||
156788991|NCT04135352|565979106|FG002|Overall Study|Sponsor Decision|2|||
156788992|NCT04135352|565979107|FG003|Overall Study|Sponsor Decision|5|||
156788993|NCT04135352|565979108|FG004|Overall Study|Sponsor Decision|1|||
156788994|NCT04135352|565979109|FG005|Overall Study|Sponsor Decision|4|||
156788995|NCT04135352|565979110|FG006|Overall Study|Sponsor Decision|0|||
156788996|NCT04135352|565979111|FG007|Overall Study|Sponsor Decision|0|||
156788997|NCT04135352|565979104|FG000|Overall Study|Physician Decision|0|||
156788998|NCT04135352|565979105|FG001|Overall Study|Physician Decision|0|||
156788999|NCT04135352|565979106|FG002|Overall Study|Physician Decision|1|||
156789000|NCT04135352|565979107|FG003|Overall Study|Physician Decision|0|||
156789001|NCT04135352|565979108|FG004|Overall Study|Physician Decision|1|||
156789002|NCT04135352|565979109|FG005|Overall Study|Physician Decision|0|||
156789003|NCT04135352|565979110|FG006|Overall Study|Physician Decision|0|||
156789004|NCT04135352|565979111|FG007|Overall Study|Physician Decision|0|||
156789005|NCT04135352|565979104|FG000|Overall Study|Death|3|||
156789006|NCT04135352|565979105|FG001|Overall Study|Death|4|||
156789007|NCT04135352|565979106|FG002|Overall Study|Death|7|||
156789008|NCT04135352|565979107|FG003|Overall Study|Death|0|||
156789009|NCT04135352|565979108|FG004|Overall Study|Death|3|||
156789010|NCT04135352|565979109|FG005|Overall Study|Death|1|||
156789011|NCT04135352|565979110|FG006|Overall Study|Death|0|||
156789012|NCT04135352|565979111|FG007|Overall Study|Death|0|||
156789013|NCT00609973|565979112|FG000|Overall Study|Adverse Event|2|||
156789014|NCT00609973|565979113|FG001|Overall Study|Adverse Event|1|||
156789015|NCT00609973|565979112|FG000|Overall Study|Protocol Violation|4|||
156789016|NCT00609973|565979113|FG001|Overall Study|Protocol Violation|3|||
156789017|NCT00609973|565979112|FG000|Overall Study|Lost to Follow-up|2|||
156789018|NCT00609973|565979113|FG001|Overall Study|Lost to Follow-up|1|||
156789019|NCT00609973|565979112|FG000|Overall Study|Withdrawal by Subject|0|||
156789020|NCT00609973|565979113|FG001|Overall Study|Withdrawal by Subject|1|||
156789021|NCT01362270|565979114|FG000|Overall Study|Withdrawal by Subject|1|||
156789022|NCT01362270|565979115|FG001|Overall Study|Withdrawal by Subject|0|||
156789023|NCT01362270|565979114|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
156789024|NCT01362270|565979115|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
156789025|NCT01362270|565979114|FG000|Overall Study|Met excl. criteria before 1st session|1|||
156789026|NCT01362270|565979115|FG001|Overall Study|Met excl. criteria before 1st session|1|||
156789027|NCT01691482|565979118|FG000|Treatment Period 2|Adverse Event|0|||
156789028|NCT01691482|565979119|FG001|Treatment Period 2|Adverse Event|1|||
156789029|NCT01691482|565979118|FG000|Treatment Period 2|Protocol Violation|1|||
156789030|NCT01691482|565979119|FG001|Treatment Period 2|Protocol Violation|1|||
156789031|NCT01392495|565979120|FG000|Overall Study|Death|3|||
156789032|NCT01392495|565979120|FG000|Overall Study|Administrative problems|8|||
156789033|NCT01392495|565979120|FG000|Overall Study|Withdrawal by Subject|2|||
156870387|NCT01177397|566282497|FG005|Overall Study|Other reasons|1|||
156870388|NCT01177397|566282498|FG006|Overall Study|Other reasons|2|||
156870389|NCT01177397|566282499|FG007|Overall Study|Other reasons|6|||
156870390|NCT01177397|566282500|FG008|Overall Study|Other reasons|10|||
156870391|NCT01177397|566282501|FG009|Overall Study|Other reasons|8|||
156870392|NCT01177397|566282502|FG010|Overall Study|Other reasons|0|||
156870393|NCT01177397|566282503|FG011|Overall Study|Other reasons|2|||
156870394|NCT01358721|566282506|FG000|Overall Study|Withdrawal by Subject|0|||
156870395|NCT01358721|566282507|FG001|Overall Study|Withdrawal by Subject|0|||
156870396|NCT01358721|566282508|FG002|Overall Study|Withdrawal by Subject|0|||
156870397|NCT01358721|566282509|FG003|Overall Study|Withdrawal by Subject|1|||
156437887|NCT05001945|564693468|FG000|Overall Study|Adverse Event|0|||
156437888|NCT05001945|564693469|FG001|Overall Study|Adverse Event|0|||
156437889|NCT05001945|564693470|FG002|Overall Study|Adverse Event|0|||
156437890|NCT05001945|564693471|FG003|Overall Study|Adverse Event|1|||
156437891|NCT05001945|564693472|FG004|Overall Study|Adverse Event|0|||
156437892|NCT05001945|564693473|FG005|Overall Study|Adverse Event|0|||
156437893|NCT05001945|564693474|FG006|Overall Study|Adverse Event|0|||
156437894|NCT05001945|564693475|FG007|Overall Study|Adverse Event|0|||
156437895|NCT05001945|564693468|FG000|Overall Study|Lost to Follow-up|0|||
156437896|NCT05001945|564693469|FG001|Overall Study|Lost to Follow-up|1|||
156437897|NCT05001945|564693470|FG002|Overall Study|Lost to Follow-up|1|||
156437898|NCT05001945|564693471|FG003|Overall Study|Lost to Follow-up|2|||
156437899|NCT05001945|564693472|FG004|Overall Study|Lost to Follow-up|0|||
156437900|NCT05001945|564693473|FG005|Overall Study|Lost to Follow-up|1|||
156437901|NCT05001945|564693474|FG006|Overall Study|Lost to Follow-up|0|||
156437902|NCT05001945|564693475|FG007|Overall Study|Lost to Follow-up|0|||
156437903|NCT05001945|564693468|FG000|Overall Study|Protocol Violation|1|||
156437904|NCT05001945|564693469|FG001|Overall Study|Protocol Violation|0|||
156437905|NCT05001945|564693470|FG002|Overall Study|Protocol Violation|1|||
156437906|NCT05001945|564693471|FG003|Overall Study|Protocol Violation|1|||
156437907|NCT05001945|564693472|FG004|Overall Study|Protocol Violation|0|||
156437908|NCT05001945|564693473|FG005|Overall Study|Protocol Violation|1|||
156437909|NCT05001945|564693474|FG006|Overall Study|Protocol Violation|0|||
156437910|NCT05001945|564693475|FG007|Overall Study|Protocol Violation|0|||
156437911|NCT05001945|564693468|FG000|Overall Study|Withdrawal by Subject|0|||
156437912|NCT05001945|564693469|FG001|Overall Study|Withdrawal by Subject|0|||
156437913|NCT05001945|564693470|FG002|Overall Study|Withdrawal by Subject|0|||
156437914|NCT05001945|564693471|FG003|Overall Study|Withdrawal by Subject|1|||
156437915|NCT05001945|564693472|FG004|Overall Study|Withdrawal by Subject|1|||
156437916|NCT05001945|564693473|FG005|Overall Study|Withdrawal by Subject|1|||
156437917|NCT05001945|564693474|FG006|Overall Study|Withdrawal by Subject|0|||
156437918|NCT05001945|564693475|FG007|Overall Study|Withdrawal by Subject|1|||
156437919|NCT05001945|564693468|FG000|Overall Study|Not specified by Investigator|0|||
156437920|NCT05001945|564693469|FG001|Overall Study|Not specified by Investigator|3|||
156437921|NCT05001945|564693470|FG002|Overall Study|Not specified by Investigator|0|||
156437922|NCT05001945|564693471|FG003|Overall Study|Not specified by Investigator|0|||
156437923|NCT05001945|564693472|FG004|Overall Study|Not specified by Investigator|1|||
156437924|NCT05001945|564693473|FG005|Overall Study|Not specified by Investigator|0|||
156437925|NCT05001945|564693474|FG006|Overall Study|Not specified by Investigator|0|||
156437926|NCT05001945|564693475|FG007|Overall Study|Not specified by Investigator|0|||
156437927|NCT02570711|564693476|FG000|Overall Study|Death|1|||
156437928|NCT02570711|564693477|FG001|Overall Study|Death|0|||
156437929|NCT02570711|564693476|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
156437930|NCT02570711|564693477|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
156437931|NCT02448446|564693478|FG000|Overall Study|Withdrawal by Subject|1|||
156437932|NCT02448446|564693479|FG001|Overall Study|Withdrawal by Subject|0|||
156437933|NCT00545077|564693481|FG000|Overall Study|Treatment not received|5|||
156437934|NCT00545077|564693482|FG001|Overall Study|Treatment not received|1|||
156437935|NCT00545077|564693481|FG000|Overall Study|Disease Progression|131|||
156437936|NCT00545077|564693482|FG001|Overall Study|Disease Progression|98|||
156437937|NCT00545077|564693481|FG000|Overall Study|Withdrawal by Subject|3|||
156437938|NCT00545077|564693482|FG001|Overall Study|Withdrawal by Subject|14|||
156437939|NCT00545077|564693481|FG000|Overall Study|Physician Decision|6|||
156437940|NCT00545077|564693482|FG001|Overall Study|Physician Decision|3|||
156437941|NCT00545077|564693481|FG000|Overall Study|Lost to Follow-up|2|||
156437942|NCT00545077|564693482|FG001|Overall Study|Lost to Follow-up|0|||
156437943|NCT00545077|564693481|FG000|Overall Study|Protocol Violation|1|||
156437944|NCT00545077|564693482|FG001|Overall Study|Protocol Violation|0|||
156437945|NCT00545077|564693481|FG000|Overall Study|Adverse Event|0|||
156437946|NCT00545077|564693482|FG001|Overall Study|Adverse Event|31|||
156437947|NCT00545077|564693481|FG000|Overall Study|Death|0|||
156437948|NCT00545077|564693482|FG001|Overall Study|Death|8|||
156870398|NCT01358721|566282506|FG000|Overall Study|Death|0|||
156870399|NCT01358721|566282507|FG001|Overall Study|Death|2|||
156437949|NCT02957136|564693487|FG000|Overall Study|Withdrawal by Subject|2|||
156870400|NCT01358721|566282508|FG002|Overall Study|Death|0|||
156870401|NCT01358721|566282509|FG003|Overall Study|Death|0|||
156870402|NCT01358721|566282506|FG000|Overall Study|Study Drug Toxicity|1|||
156870403|NCT01358721|566282507|FG001|Overall Study|Study Drug Toxicity|3|||
156870404|NCT01358721|566282508|FG002|Overall Study|Study Drug Toxicity|4|||
156870405|NCT01358721|566282509|FG003|Overall Study|Study Drug Toxicity|5|||
156870406|NCT01358721|566282506|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
156870407|NCT01358721|566282507|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
156870408|NCT01358721|566282508|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
156870409|NCT01358721|566282509|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
156870410|NCT01358721|566282506|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
156870411|NCT01358721|566282507|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
156870412|NCT01358721|566282508|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
156870413|NCT01358721|566282509|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
156870414|NCT01358721|566282506|FG000|Overall Study|Adverse Event related to study drug|1|||
156870415|NCT01358721|566282507|FG001|Overall Study|Adverse Event related to study drug|0|||
156870416|NCT01358721|566282508|FG002|Overall Study|Adverse Event related to study drug|0|||
156870417|NCT01358721|566282509|FG003|Overall Study|Adverse Event related to study drug|1|||
156870418|NCT01358721|566282506|FG000|Overall Study|Disease Progression|19|||
156870419|NCT01358721|566282507|FG001|Overall Study|Disease Progression|15|||
156870420|NCT01358721|566282508|FG002|Overall Study|Disease Progression|17|||
156870421|NCT01358721|566282509|FG003|Overall Study|Disease Progression|15|||
156870422|NCT01358721|566282506|FG000|Overall Study|Out of State/Unmet Criteria|0|||
156870423|NCT01358721|566282507|FG001|Overall Study|Out of State/Unmet Criteria|0|||
156870424|NCT01358721|566282508|FG002|Overall Study|Out of State/Unmet Criteria|1|||
156870425|NCT01358721|566282509|FG003|Overall Study|Out of State/Unmet Criteria|0|||
156870426|NCT01002339|566282510|FG000|Overall Study|Withdrawal by Subject|0|||
156870427|NCT01002339|566282511|FG001|Overall Study|Withdrawal by Subject|1|||
156870428|NCT01002339|566282512|FG002|Overall Study|Withdrawal by Subject|0|||
156870429|NCT01002339|566282510|FG000|Overall Study|Incorrect treatment assignment|0|||
156870430|NCT01002339|566282511|FG001|Overall Study|Incorrect treatment assignment|0|||
156870431|NCT01002339|566282512|FG002|Overall Study|Incorrect treatment assignment|1|||
156870432|NCT01002339|566282510|FG000|Overall Study|Protocol Violation|0|||
156870433|NCT01002339|566282511|FG001|Overall Study|Protocol Violation|0|||
156870434|NCT01002339|566282512|FG002|Overall Study|Protocol Violation|2|||
156870435|NCT01002339|566282510|FG000|Overall Study|Lung cancer detected before transplant|0|||
156870436|NCT01002339|566282511|FG001|Overall Study|Lung cancer detected before transplant|0|||
156870437|NCT01002339|566282512|FG002|Overall Study|Lung cancer detected before transplant|1|||
156870438|NCT01002339|566282510|FG000|Overall Study|Randomized. Not transplanted|0|||
156870439|NCT01002339|566282511|FG001|Overall Study|Randomized. Not transplanted|0|||
156870440|NCT01002339|566282512|FG002|Overall Study|Randomized. Not transplanted|1|||
156870441|NCT00433004|566282513|FG000|Overall Study|Lost to Follow-up|5|||
156870442|NCT00433004|566282514|FG001|Overall Study|Lost to Follow-up|7|||
156870443|NCT00742235|566282515|FG000|Overall Study|Lost to Follow-up|0|||
156870444|NCT00742235|566282516|FG001|Overall Study|Lost to Follow-up|31|||
156870445|NCT05661409|566282518|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
156870446|NCT05661409|566282519|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
156870447|NCT05661409|566282520|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
156870448|NCT05661409|566282521|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
156870449|NCT05661409|566282522|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
156870450|NCT05661409|566282523|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
156870451|NCT05661409|566282518|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
156870452|NCT05661409|566282519|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
156870453|NCT05661409|566282520|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
156870454|NCT05661409|566282521|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
156870455|NCT05661409|566282522|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
156870456|NCT05661409|566282523|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
156870457|NCT05661409|566282518|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
156693277|NCT02696031|565621803|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693278|NCT02696031|565621804|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
156693279|NCT02696031|565621805|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693280|NCT02696031|565621806|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693281|NCT02696031|565621807|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693282|NCT02696031|565621808|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693283|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
156693284|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
156693285|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
156693286|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
156693287|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
156870458|NCT05661409|566282519|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
156870459|NCT05661409|566282520|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
156870460|NCT05661409|566282521|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
156870461|NCT05661409|566282522|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
156870462|NCT05661409|566282523|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
156870463|NCT05661409|566282518|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870464|NCT05661409|566282519|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870465|NCT05661409|566282520|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870466|NCT05661409|566282521|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870467|NCT05661409|566282522|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870468|NCT05661409|566282523|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
156870469|NCT05661409|566282518|FG000|Overall Study|Miscommu-nication about administration|0|||
156870470|NCT05661409|566282519|FG001|Overall Study|Miscommu-nication about administration|0|||
156870471|NCT05661409|566282520|FG002|Overall Study|Miscommu-nication about administration|0|||
156870472|NCT05661409|566282521|FG003|Overall Study|Miscommu-nication about administration|0|||
156870473|NCT05661409|566282522|FG004|Overall Study|Miscommu-nication about administration|0|||
156870474|NCT05661409|566282523|FG005|Overall Study|Miscommu-nication about administration|1|||
156870475|NCT00831181|566282530|FG000|Overall Study|Adverse Event|12|||
156870476|NCT04313244|566282531|FG000|Overall Study|Withdrawal of Consent|3|||
156870477|NCT04313244|566282532|FG001|Overall Study|Withdrawal of Consent|3|||
156870478|NCT04313244|566282531|FG000|Overall Study|Met Exclusion Criteria|1|||
156870479|NCT04313244|566282532|FG001|Overall Study|Met Exclusion Criteria|0|||
156870480|NCT04313244|566282531|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
156870481|NCT04313244|566282532|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
156870482|NCT00927953|566282533|FG000|Overall Study|Death|2|||
156870483|NCT00927953|566282534|FG001|Overall Study|Death|1|||
156870484|NCT02976038|566282535|FG000|Overall Study|Physician Decision|22|||
156870485|NCT02976038|566282535|FG000|Overall Study|Withdrawal by Subject|3|||
156870486|NCT02976038|566282535|FG000|Overall Study|Lost to Follow-up|2|||
156870487|NCT02976038|566282535|FG000|Overall Study|Adverse Event|1|||
156870488|NCT00724698|566282536|FG000|Overall Study|Adverse Event|9|||
156870489|NCT00724698|566282536|FG000|Overall Study|Failure of Therapy|4|||
156870490|NCT00724698|566282536|FG000|Overall Study|Poor Compliance|16|||
156870491|NCT00724698|566282536|FG000|Overall Study|Lost to Follow-up|36|||
156870492|NCT00724698|566282536|FG000|Overall Study|No Info|25|||
156870493|NCT05021978|566282539|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
156870494|NCT05021978|566282540|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
156870495|NCT05021978|566282541|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
156870496|NCT05021978|566282542|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
156870497|NCT05021978|566282539|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
156870498|NCT05021978|566282540|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
156870499|NCT05021978|566282541|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
156870500|NCT05021978|566282542|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
156870501|NCT00196313|566282543|FG000|Overall Study|Protocol Violation|2|||
156870502|NCT00196313|566282544|FG001|Overall Study|Protocol Violation|3|||
156870503|NCT00196313|566282543|FG000|Overall Study|Withdrawal by Subject|3|||
156870504|NCT00196313|566282544|FG001|Overall Study|Withdrawal by Subject|1|||
156870505|NCT00196313|566282543|FG000|Overall Study|Adverse Event|3|||
156870506|NCT00196313|566282544|FG001|Overall Study|Adverse Event|1|||
156870507|NCT00196313|566282543|FG000|Overall Study|Subject Pregnant|1|||
156870508|NCT00196313|566282544|FG001|Overall Study|Subject Pregnant|1|||
156870509|NCT00196313|566282543|FG000|Overall Study|Lost to Follow-up|2|||
156870510|NCT00196313|566282544|FG001|Overall Study|Lost to Follow-up|2|||
156870511|NCT00043979|566282545|FG000|Period 1|recipient with progressive disease|7|||
156870512|NCT00043979|566282546|FG001|Period 1|recipient with progressive disease|4|||
156870513|NCT00043979|566282547|FG002|Period 1|recipient with progressive disease|3|||
156870514|NCT03096288|566282549|FG000|Overall Study|Withdrawal by Subject|0|||
156870515|NCT03096288|566282550|FG001|Overall Study|Withdrawal by Subject|1|||
156870516|NCT03096288|566282551|FG002|Overall Study|Withdrawal by Subject|0|||
156870517|NCT03096288|566282552|FG003|Overall Study|Withdrawal by Subject|1|||
156870518|NCT01411891|566282558|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
156870519|NCT01411891|566282559|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
156870520|NCT01995838|566282560|FG000|Overall Study|Lost to Follow-up|0|||
156870521|NCT01995838|566282561|FG001|Overall Study|Lost to Follow-up|1|||
156870522|NCT01995838|566282562|FG002|Overall Study|Lost to Follow-up|0|||
156870523|NCT01995838|566282563|FG003|Overall Study|Lost to Follow-up|0|||
156870524|NCT01995838|566282564|FG004|Overall Study|Lost to Follow-up|0|||
156870525|NCT01995838|566282565|FG005|Overall Study|Lost to Follow-up|0|||
156870526|NCT01995838|566282566|FG006|Overall Study|Lost to Follow-up|1|||
156870527|NCT01995838|566282560|FG000|Overall Study|Participant choice|2|||
156870528|NCT01995838|566282561|FG001|Overall Study|Participant choice|0|||
156870529|NCT01995838|566282562|FG002|Overall Study|Participant choice|0|||
156870530|NCT01995838|566282563|FG003|Overall Study|Participant choice|0|||
156870531|NCT01995838|566282564|FG004|Overall Study|Participant choice|0|||
156870532|NCT01995838|566282565|FG005|Overall Study|Participant choice|1|||
156870533|NCT01995838|566282566|FG006|Overall Study|Participant choice|1|||
156870534|NCT01995838|566282560|FG000|Overall Study|Adverse Event|0|||
156693288|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
156693289|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
156693290|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
156693291|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
156693292|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
156693293|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
156693294|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
156693295|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693296|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693297|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693298|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
156693299|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693300|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693301|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693302|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693303|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693304|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693305|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
156789034|NCT01392495|565979120|FG000|Overall Study|Adverse Event|3|||
156789035|NCT02571244|565979121|FG000|Overall Study|Lost to Follow-up|0|||
156789036|NCT02571244|565979122|FG001|Overall Study|Lost to Follow-up|1|||
156789037|NCT02571244|565979121|FG000|Overall Study|Unable to reach out post discharge|3|||
156789038|NCT02571244|565979122|FG001|Overall Study|Unable to reach out post discharge|0|||
156789039|NCT01696214|565979123|FG000|Overall Study|Lost to Follow-up|1|||
156789040|NCT01696214|565979124|FG001|Overall Study|Lost to Follow-up|0|||
156789041|NCT01696214|565979125|FG002|Overall Study|Lost to Follow-up|0|||
156789042|NCT01696214|565979126|FG003|Overall Study|Lost to Follow-up|0|||
156789043|NCT02134028|565979127|FG000|Overall Study|Lack of Efficacy|1|||
156789044|NCT02134028|565979128|FG001|Overall Study|Lack of Efficacy|0|||
156789045|NCT02134028|565979129|FG002|Overall Study|Lack of Efficacy|3|||
156789046|NCT02134028|565979130|FG003|Overall Study|Lack of Efficacy|2|||
156789047|NCT02134028|565979131|FG004|Overall Study|Lack of Efficacy|1|||
156789048|NCT02134028|565979132|FG005|Overall Study|Lack of Efficacy|2|||
156789049|NCT02134028|565979133|FG006|Overall Study|Lack of Efficacy|1|||
156789050|NCT02134028|565979134|FG007|Overall Study|Lack of Efficacy|0|||
156789051|NCT02134028|565979127|FG000|Overall Study|Poor compliance to protocol|1|||
156789052|NCT02134028|565979128|FG001|Overall Study|Poor compliance to protocol|1|||
156789053|NCT02134028|565979129|FG002|Overall Study|Poor compliance to protocol|3|||
156789054|NCT02134028|565979130|FG003|Overall Study|Poor compliance to protocol|7|||
156789055|NCT02134028|565979131|FG004|Overall Study|Poor compliance to protocol|1|||
156789056|NCT02134028|565979132|FG005|Overall Study|Poor compliance to protocol|1|||
156789057|NCT02134028|565979133|FG006|Overall Study|Poor compliance to protocol|0|||
156789058|NCT02134028|565979134|FG007|Overall Study|Poor compliance to protocol|0|||
156789059|NCT02134028|565979127|FG000|Overall Study|Other unspecified|4|||
156789060|NCT02134028|565979128|FG001|Overall Study|Other unspecified|22|||
156789061|NCT02134028|565979129|FG002|Overall Study|Other unspecified|33|||
156789062|NCT02134028|565979130|FG003|Overall Study|Other unspecified|64|||
156789063|NCT02134028|565979131|FG004|Overall Study|Other unspecified|8|||
156789064|NCT02134028|565979132|FG005|Overall Study|Other unspecified|6|||
156789065|NCT02134028|565979133|FG006|Overall Study|Other unspecified|2|||
156789066|NCT02134028|565979134|FG007|Overall Study|Other unspecified|1|||
156789067|NCT02134028|565979127|FG000|Overall Study|Adverse Event|3|||
156789068|NCT02134028|565979128|FG001|Overall Study|Adverse Event|19|||
156789069|NCT02134028|565979129|FG002|Overall Study|Adverse Event|13|||
156789070|NCT02134028|565979130|FG003|Overall Study|Adverse Event|32|||
156789071|NCT02134028|565979131|FG004|Overall Study|Adverse Event|4|||
156789072|NCT02134028|565979132|FG005|Overall Study|Adverse Event|5|||
156789073|NCT02134028|565979133|FG006|Overall Study|Adverse Event|1|||
156789074|NCT02134028|565979134|FG007|Overall Study|Adverse Event|2|||
156789075|NCT01309100|565979137|FG000|Overall Study|Protocol Violation|1|||
156789076|NCT01309100|565979137|FG000|Overall Study|Positive Slit lamp finding|1|||
156789077|NCT01452789|565979140|FG000|Overall Study|Withdrawal by Subject|3|||
156789078|NCT01452789|565979141|FG001|Overall Study|Withdrawal by Subject|2|||
156789079|NCT00066170|565979142|FG000|Overall Study|Adverse Event|2|||
156789080|NCT00066170|565979143|FG001|Overall Study|Adverse Event|4|||
156789081|NCT00066170|565979144|FG002|Overall Study|Adverse Event|1|||
156789082|NCT00066170|565979145|FG003|Overall Study|Adverse Event|7|||
156789083|NCT00066170|565979142|FG000|Overall Study|Serious Adverse Event|0|||
156789084|NCT00066170|565979143|FG001|Overall Study|Serious Adverse Event|0|||
156789085|NCT00066170|565979144|FG002|Overall Study|Serious Adverse Event|1|||
156789086|NCT00066170|565979145|FG003|Overall Study|Serious Adverse Event|1|||
156789087|NCT00066170|565979142|FG000|Overall Study|Lost to Follow-up|0|||
156693306|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693307|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
156693308|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
156693309|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
156693310|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
156693311|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
156693312|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
156693313|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
156693314|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
156693315|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
156693316|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
156693317|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
156693318|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
156693319|NCT00058214|565621809|FG000|Overall Study|Adverse Event|1|||
156870535|NCT01995838|566282561|FG001|Overall Study|Adverse Event|0|||
156870536|NCT01995838|566282562|FG002|Overall Study|Adverse Event|0|||
156870537|NCT01995838|566282563|FG003|Overall Study|Adverse Event|0|||
156870538|NCT01995838|566282564|FG004|Overall Study|Adverse Event|0|||
156870539|NCT01995838|566282565|FG005|Overall Study|Adverse Event|0|||
156870540|NCT01995838|566282566|FG006|Overall Study|Adverse Event|1|||
156870541|NCT01995838|566282560|FG000|Overall Study|Withdrawal by Subject|0|||
156870542|NCT01995838|566282561|FG001|Overall Study|Withdrawal by Subject|0|||
156870543|NCT01995838|566282562|FG002|Overall Study|Withdrawal by Subject|0|||
156870544|NCT01995838|566282563|FG003|Overall Study|Withdrawal by Subject|0|||
156870545|NCT01995838|566282564|FG004|Overall Study|Withdrawal by Subject|1|||
156870546|NCT01995838|566282565|FG005|Overall Study|Withdrawal by Subject|0|||
156870547|NCT01995838|566282566|FG006|Overall Study|Withdrawal by Subject|0|||
156870548|NCT01995838|566282560|FG000|Overall Study|Other|3|||
156870549|NCT01995838|566282561|FG001|Overall Study|Other|1|||
156870550|NCT01995838|566282562|FG002|Overall Study|Other|0|||
156870551|NCT01995838|566282563|FG003|Overall Study|Other|2|||
156693320|NCT00958126|565621816|FG000|Overall Study|Serious Adverse Event|0|||
156693321|NCT00958126|565621817|FG001|Overall Study|Serious Adverse Event|2|||
156693322|NCT00958126|565621818|FG002|Overall Study|Serious Adverse Event|0|||
156789088|NCT00066170|565979143|FG001|Overall Study|Lost to Follow-up|1|||
156693323|NCT00958126|565621819|FG003|Overall Study|Serious Adverse Event|0|||
156789089|NCT00066170|565979144|FG002|Overall Study|Lost to Follow-up|0|||
156789090|NCT00066170|565979145|FG003|Overall Study|Lost to Follow-up|0|||
156789091|NCT00066170|565979142|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
156789092|NCT00066170|565979143|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
156789093|NCT00066170|565979144|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
156789094|NCT00066170|565979145|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
156789095|NCT00066170|565979142|FG000|Overall Study|Protocol Violation|3|||
156789096|NCT00066170|565979143|FG001|Overall Study|Protocol Violation|0|||
156789097|NCT00066170|565979144|FG002|Overall Study|Protocol Violation|0|||
156789098|NCT00066170|565979145|FG003|Overall Study|Protocol Violation|0|||
156789099|NCT00066170|565979142|FG000|Overall Study|Other|1|||
156789100|NCT00066170|565979143|FG001|Overall Study|Other|5|||
156789101|NCT00066170|565979144|FG002|Overall Study|Other|2|||
156870552|NCT01995838|566282564|FG004|Overall Study|Other|1|||
156870553|NCT01995838|566282565|FG005|Overall Study|Other|1|||
156870554|NCT01995838|566282566|FG006|Overall Study|Other|2|||
156870555|NCT03196349|566282567|FG000|Overall Study|Did not receive study drug|0|||
156530675|NCT01717768|565038130|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156693324|NCT00958126|565621820|FG004|Overall Study|Serious Adverse Event|0|||
156789102|NCT00066170|565979145|FG003|Overall Study|Other|0|||
156789103|NCT03722030|565979146|FG000|Overall Study|Withdrawal by Subject|1|||
156789104|NCT03722030|565979147|FG001|Overall Study|Withdrawal by Subject|0|||
156789105|NCT00754559|565979150|FG000|Overall Study|Adverse Event|15|||
156789106|NCT00754559|565979150|FG000|Overall Study|Protocol Violation|11|||
156789107|NCT00754559|565979150|FG000|Overall Study|Lack of Efficacy|10|||
156789108|NCT00754559|565979150|FG000|Overall Study|Lost to Follow-up|2|||
156789109|NCT00754559|565979150|FG000|Overall Study|Administrative reason|1|||
156789110|NCT00754559|565979150|FG000|Overall Study|Other|5|||
156789111|NCT00754559|565979150|FG000|Overall Study|Withdrawal by Subject|3|||
156789112|NCT04000724|565979154|FG000|Overall Study|Withdrawal by Subject|5|||
156789113|NCT04000724|565979155|FG001|Overall Study|Withdrawal by Subject|3|||
156789114|NCT04000724|565979156|FG002|Overall Study|Withdrawal by Subject|4|||
156789115|NCT04000724|565979154|FG000|Overall Study|Lost to Follow-up|11|||
156789116|NCT04000724|565979155|FG001|Overall Study|Lost to Follow-up|7|||
156789117|NCT04000724|565979156|FG002|Overall Study|Lost to Follow-up|13|||
156789118|NCT00455455|565979157|FG000|Washout|Withdrawal by Subject|0|||
156789119|NCT00455455|565979158|FG001|Washout|Withdrawal by Subject|1|||
156789120|NCT00455455|565979157|FG000|Washout|Withdrawal by Subject|1|||
156789121|NCT00455455|565979158|FG001|Washout|Withdrawal by Subject|0|||
156789122|NCT01370538|565979159|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
156789123|NCT01370538|565979160|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
156789124|NCT01370538|565979159|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156789125|NCT01370538|565979160|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156789126|NCT01370538|565979159|FG000|Overall Study|Adverse Event|1|||
156789127|NCT01370538|565979160|FG001|Overall Study|Adverse Event|0|||
156789128|NCT01370538|565979159|FG000|Overall Study|Protocol Violation|8|||
156789129|NCT01370538|565979160|FG001|Overall Study|Protocol Violation|5|||
156789130|NCT01370538|565979159|FG000|Overall Study|Development of study specific withdrawal|1|||
156789131|NCT01370538|565979160|FG001|Overall Study|Development of study specific withdrawal|1|||
156789132|NCT01370538|565979159|FG000|Overall Study|Lost to follow up|6|||
156789133|NCT01370538|565979160|FG001|Overall Study|Lost to follow up|10|||
156789134|NCT02945046|565979162|FG000|Overall Study|Adverse Event|1|||
156789135|NCT02945046|565979163|FG001|Overall Study|Adverse Event|0|||
156789136|NCT02945046|565979164|FG002|Overall Study|Adverse Event|2|||
156789137|NCT02945046|565979162|FG000|Overall Study|Withdrawal by Subject|3|||
156789138|NCT02945046|565979163|FG001|Overall Study|Withdrawal by Subject|3|||
156789139|NCT02945046|565979164|FG002|Overall Study|Withdrawal by Subject|3|||
156789140|NCT02945046|565979162|FG000|Overall Study|Protocol Violation|2|||
156330656|NCT04102098|564310489|FG000|Main Study Period|Physician Decision|0|||
156330657|NCT04102098|564310490|FG001|Main Study Period|Physician Decision|1|||
156330658|NCT04102098|564310489|FG000|Main Study Period|Withdrawal by Subject|11|||
156330659|NCT04102098|564310490|FG001|Main Study Period|Withdrawal by Subject|14|||
156330660|NCT04102098|564310489|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
156330661|NCT04102098|564310490|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
156330662|NCT04102098|564310489|FG000|Crossover: AS Who Crossed Over|Death|11|||
156330663|NCT04102098|564310490|FG001|Crossover: AS Who Crossed Over|Death|0|||
156330664|NCT04102098|564310489|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
156330665|NCT04102098|564310490|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
156330666|NCT03755791|564310493|FG000|Overall Study|Did not receive any study treatment|3|||
156330667|NCT03755791|564310494|FG001|Overall Study|Did not receive any study treatment|0|||
156330668|NCT03755791|564310495|FG002|Overall Study|Did not receive any study treatment|10|||
156330669|NCT03755791|564310493|FG000|Overall Study|Radiographic progression|204|||
156330670|NCT03755791|564310494|FG001|Overall Study|Radiographic progression|92|||
156330671|NCT03755791|564310495|FG002|Overall Study|Radiographic progression|115|||
156330672|NCT03755791|564310493|FG000|Overall Study|Adverse Event|140|||
156330673|NCT03755791|564310494|FG001|Overall Study|Adverse Event|60|||
156330674|NCT03755791|564310495|FG002|Overall Study|Adverse Event|51|||
156330675|NCT03755791|564310493|FG000|Overall Study|Lack of Efficacy|12|||
156330676|NCT03755791|564310494|FG001|Overall Study|Lack of Efficacy|6|||
156330677|NCT03755791|564310495|FG002|Overall Study|Lack of Efficacy|6|||
156330678|NCT03755791|564310493|FG000|Overall Study|Withdrawal by Subject|26|||
156330679|NCT03755791|564310494|FG001|Overall Study|Withdrawal by Subject|23|||
156330680|NCT03755791|564310495|FG002|Overall Study|Withdrawal by Subject|24|||
156330681|NCT03755791|564310493|FG000|Overall Study|Sponsor decision,|41|||
156330682|NCT03755791|564310494|FG001|Overall Study|Sponsor decision,|5|||
156330683|NCT03755791|564310495|FG002|Overall Study|Sponsor decision,|7|||
156330684|NCT03755791|564310493|FG000|Overall Study|Lost to Follow-up|1|||
156330685|NCT03755791|564310494|FG001|Overall Study|Lost to Follow-up|0|||
156330686|NCT03755791|564310495|FG002|Overall Study|Lost to Follow-up|2|||
156330687|NCT03755791|564310493|FG000|Overall Study|Protocol Violation|0|||
156330688|NCT03755791|564310494|FG001|Overall Study|Protocol Violation|0|||
156330689|NCT03755791|564310495|FG002|Overall Study|Protocol Violation|2|||
156330690|NCT03755791|564310493|FG000|Overall Study|Other than specified|5|||
156330691|NCT03755791|564310494|FG001|Overall Study|Other than specified|2|||
156330692|NCT03755791|564310495|FG002|Overall Study|Other than specified|0|||
156330693|NCT02905149|564310496|FG000|Overall Study|Lost to Follow-up|2|||
156330694|NCT02905149|564310497|FG001|Overall Study|Lost to Follow-up|0|||
156330695|NCT03277690|564310498|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
156330696|NCT03277690|564310499|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
156330697|NCT03277690|564310498|FG000|Dose Titration and Maintenance|Physician Decision|1|||
156330698|NCT03277690|564310499|FG001|Dose Titration and Maintenance|Physician Decision|0|||
156330699|NCT03277690|564310498|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
156330700|NCT03277690|564310499|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
156330701|NCT03277690|564310498|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
156330702|NCT03277690|564310499|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
156330703|NCT03277690|564310498|FG000|Dose Titration and Maintenance|Adverse Event|15|||
156330704|NCT03277690|564310499|FG001|Dose Titration and Maintenance|Adverse Event|0|||
156330705|NCT03277690|564310498|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
156330706|NCT03277690|564310499|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
156330707|NCT03277690|564310498|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
156330708|NCT03277690|564310499|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
156330709|NCT00747812|564310500|FG000|Overall Study|Research Site Staff Relocation|5|||
156330710|NCT00747812|564310501|FG001|Overall Study|Research Site Staff Relocation|3|||
156330711|NCT03109847|564310502|FG000|Overall Study|Withdrawal by Subject|1|||
156870556|NCT03196349|566282568|FG001|Overall Study|Did not receive study drug|1|||
156870557|NCT03196349|566282569|FG002|Overall Study|Did not receive study drug|2|||
156870558|NCT03196349|566282567|FG000|Overall Study|No data entered|2|||
156870559|NCT03196349|566282568|FG001|Overall Study|No data entered|4|||
156870560|NCT03196349|566282569|FG002|Overall Study|No data entered|0|||
156870561|NCT03196349|566282567|FG000|Overall Study|Study Terminated early|15|||
156870562|NCT03196349|566282568|FG001|Overall Study|Study Terminated early|9|||
156870563|NCT03196349|566282569|FG002|Overall Study|Study Terminated early|11|||
156870564|NCT02819804|566282570|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
156870565|NCT03967444|566282571|FG000|Overall Study|Lost to Follow-up|1|||
156870566|NCT03967444|566282572|FG001|Overall Study|Lost to Follow-up|2|||
156870567|NCT01821118|566282579|FG000|Overall Study|Death|0|||
156870568|NCT01821118|566282580|FG001|Overall Study|Death|1|||
156870569|NCT01519921|566282589|FG000|Overall Study|Adverse Event|10|||
156870570|NCT01519921|566282590|FG001|Overall Study|Adverse Event|9|||
156870571|NCT01519921|566282589|FG000|Overall Study|Lack of Efficacy|4|||
156870572|NCT01519921|566282590|FG001|Overall Study|Lack of Efficacy|3|||
156870573|NCT01519921|566282589|FG000|Overall Study|Withdrawal by Subject|3|||
156870574|NCT01519921|566282590|FG001|Overall Study|Withdrawal by Subject|0|||
156870575|NCT01519921|566282589|FG000|Overall Study|Lost to Follow-up|2|||
156870576|NCT01519921|566282590|FG001|Overall Study|Lost to Follow-up|1|||
156870577|NCT01519921|566282589|FG000|Overall Study|Treatment refusal|2|||
156870578|NCT01519921|566282590|FG001|Overall Study|Treatment refusal|1|||
156870579|NCT01519921|566282589|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
156870580|NCT01519921|566282590|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
156870581|NCT03133793|566282593|FG000|Overall Study|Withdrawal by Subject|0|||
156870582|NCT03133793|566282594|FG001|Overall Study|Withdrawal by Subject|4|||
156870583|NCT03133793|566282595|FG002|Overall Study|Withdrawal by Subject|2|||
156870584|NCT03133793|566282596|FG003|Overall Study|Withdrawal by Subject|4|||
156870585|NCT03133793|566282593|FG000|Overall Study|Lost to Follow-up|1|||
156870586|NCT03133793|566282594|FG001|Overall Study|Lost to Follow-up|0|||
156870587|NCT03133793|566282595|FG002|Overall Study|Lost to Follow-up|2|||
156870588|NCT03133793|566282596|FG003|Overall Study|Lost to Follow-up|0|||
156870589|NCT03133793|566282593|FG000|Overall Study|Death|0|||
156870590|NCT03133793|566282594|FG001|Overall Study|Death|0|||
156870591|NCT03133793|566282595|FG002|Overall Study|Death|0|||
156870592|NCT03133793|566282596|FG003|Overall Study|Death|1|||
156870593|NCT03486834|566282597|FG000|Overall Study|Withdrawal by Subject|46|||
156870594|NCT03486834|566282598|FG001|Overall Study|Withdrawal by Subject|46|||
156870595|NCT03486834|566282599|FG002|Overall Study|Withdrawal by Subject|52|||
156870596|NCT03486834|566282597|FG000|Overall Study|Adverse Event|8|||
156870597|NCT03486834|566282598|FG001|Overall Study|Adverse Event|7|||
156870598|NCT03486834|566282599|FG002|Overall Study|Adverse Event|0|||
156870599|NCT03486834|566282597|FG000|Overall Study|Lost to Follow-up|41|||
156870600|NCT03486834|566282598|FG001|Overall Study|Lost to Follow-up|24|||
156693325|NCT00958126|565621821|FG005|Overall Study|Serious Adverse Event|0|||
156693326|NCT00958126|565621822|FG006|Overall Study|Serious Adverse Event|1|||
156693327|NCT00958126|565621823|FG007|Overall Study|Serious Adverse Event|0|||
156693328|NCT00958126|565621816|FG000|Overall Study|Withdrawal by Subject|0|||
156693329|NCT00958126|565621817|FG001|Overall Study|Withdrawal by Subject|2|||
156693330|NCT00958126|565621818|FG002|Overall Study|Withdrawal by Subject|0|||
156693331|NCT00958126|565621819|FG003|Overall Study|Withdrawal by Subject|0|||
156693332|NCT00958126|565621820|FG004|Overall Study|Withdrawal by Subject|0|||
156693333|NCT00958126|565621821|FG005|Overall Study|Withdrawal by Subject|0|||
156693334|NCT00958126|565621822|FG006|Overall Study|Withdrawal by Subject|0|||
156693335|NCT00958126|565621823|FG007|Overall Study|Withdrawal by Subject|0|||
156693336|NCT00958126|565621816|FG000|Overall Study|Moved away from study area|0|||
156693337|NCT00958126|565621817|FG001|Overall Study|Moved away from study area|0|||
156693338|NCT00958126|565621818|FG002|Overall Study|Moved away from study area|1|||
156693339|NCT00958126|565621819|FG003|Overall Study|Moved away from study area|1|||
156693340|NCT00958126|565621820|FG004|Overall Study|Moved away from study area|0|||
156693341|NCT00958126|565621821|FG005|Overall Study|Moved away from study area|0|||
156693342|NCT00958126|565621822|FG006|Overall Study|Moved away from study area|0|||
156693343|NCT00958126|565621823|FG007|Overall Study|Moved away from study area|0|||
156693344|NCT00958126|565621816|FG000|Overall Study|Lost to Follow-up|1|||
156870601|NCT03486834|566282599|FG002|Overall Study|Lost to Follow-up|39|||
156870602|NCT03486834|566282597|FG000|Overall Study|Non-compliance with Study Drug|2|||
156870603|NCT03486834|566282598|FG001|Overall Study|Non-compliance with Study Drug|2|||
156870604|NCT03486834|566282599|FG002|Overall Study|Non-compliance with Study Drug|0|||
156870605|NCT03486834|566282597|FG000|Overall Study|Physician Decision|5|||
156870606|NCT03486834|566282598|FG001|Overall Study|Physician Decision|2|||
156870607|NCT03486834|566282599|FG002|Overall Study|Physician Decision|3|||
156870608|NCT03486834|566282597|FG000|Overall Study|Pregnancy|10|||
156870609|NCT03486834|566282598|FG001|Overall Study|Pregnancy|12|||
156870610|NCT03486834|566282599|FG002|Overall Study|Pregnancy|12|||
156870611|NCT03486834|566282597|FG000|Overall Study|Protocol Deviation|2|||
156870612|NCT03486834|566282598|FG001|Overall Study|Protocol Deviation|3|||
156870613|NCT03486834|566282599|FG002|Overall Study|Protocol Deviation|3|||
156693345|NCT00958126|565621817|FG001|Overall Study|Lost to Follow-up|5|||
156693346|NCT00958126|565621818|FG002|Overall Study|Lost to Follow-up|9|||
156693347|NCT00958126|565621819|FG003|Overall Study|Lost to Follow-up|8|||
156693348|NCT00958126|565621820|FG004|Overall Study|Lost to Follow-up|0|||
156693349|NCT00958126|565621821|FG005|Overall Study|Lost to Follow-up|0|||
156693350|NCT00958126|565621822|FG006|Overall Study|Lost to Follow-up|0|||
156693351|NCT00958126|565621823|FG007|Overall Study|Lost to Follow-up|0|||
156693352|NCT00958126|565621816|FG000|Overall Study|Sponsor/Investigator decision|0|||
156693353|NCT00958126|565621817|FG001|Overall Study|Sponsor/Investigator decision|0|||
156693354|NCT00958126|565621818|FG002|Overall Study|Sponsor/Investigator decision|0|||
156693355|NCT00958126|565621819|FG003|Overall Study|Sponsor/Investigator decision|1|||
156693356|NCT00958126|565621820|FG004|Overall Study|Sponsor/Investigator decision|0|||
156870614|NCT03486834|566282597|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156870615|NCT03486834|566282598|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156870616|NCT03486834|566282599|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156870617|NCT03486834|566282597|FG000|Overall Study|Randomized but not treated|4|||
156870618|NCT03486834|566282598|FG001|Overall Study|Randomized but not treated|4|||
156870619|NCT03486834|566282599|FG002|Overall Study|Randomized but not treated|1|||
156870620|NCT00687193|566282601|FG000|Overall Study|Adverse Event|0|||
156870621|NCT00687193|566282602|FG001|Overall Study|Adverse Event|1|||
156870622|NCT00687193|566282603|FG002|Overall Study|Adverse Event|2|||
156870623|NCT00687193|566282604|FG003|Overall Study|Adverse Event|3|||
156870624|NCT00687193|566282605|FG004|Overall Study|Adverse Event|0|||
156870625|NCT00687193|566282606|FG005|Overall Study|Adverse Event|2|||
156870626|NCT00687193|566282601|FG000|Overall Study|Lack of Efficacy|1|||
156870627|NCT00687193|566282602|FG001|Overall Study|Lack of Efficacy|1|||
156870628|NCT00687193|566282603|FG002|Overall Study|Lack of Efficacy|0|||
156870629|NCT00687193|566282604|FG003|Overall Study|Lack of Efficacy|0|||
156870630|NCT00687193|566282605|FG004|Overall Study|Lack of Efficacy|0|||
156870631|NCT00687193|566282606|FG005|Overall Study|Lack of Efficacy|2|||
156870632|NCT00687193|566282601|FG000|Overall Study|Protocol Violation|1|||
156870633|NCT00687193|566282602|FG001|Overall Study|Protocol Violation|2|||
156870634|NCT00687193|566282603|FG002|Overall Study|Protocol Violation|0|||
156870635|NCT00687193|566282604|FG003|Overall Study|Protocol Violation|1|||
156870636|NCT00687193|566282605|FG004|Overall Study|Protocol Violation|2|||
156870637|NCT00687193|566282606|FG005|Overall Study|Protocol Violation|0|||
156870638|NCT02129699|566282607|FG000|Overall Study|Did not start treatment|3|||
156870639|NCT02129699|566282608|FG001|Overall Study|Did not start treatment|2|||
156870640|NCT02446899|566284228|FG000|Overall Study|Adverse Event|4|||
156870641|NCT02446899|566284229|FG001|Overall Study|Adverse Event|7|||
156870642|NCT02446899|566284228|FG000|Overall Study|Condition Under Investigation Worsened|1|||
156870643|NCT02446899|566284229|FG001|Overall Study|Condition Under Investigation Worsened|4|||
156870644|NCT02446899|566284228|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
156870645|NCT02446899|566284229|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
156693357|NCT00958126|565621821|FG005|Overall Study|Sponsor/Investigator decision|0|||
156693358|NCT00958126|565621822|FG006|Overall Study|Sponsor/Investigator decision|0|||
156693359|NCT00958126|565621823|FG007|Overall Study|Sponsor/Investigator decision|0|||
156693360|NCT00958126|565621816|FG000|Overall Study|Other Reason|0|||
156693361|NCT00958126|565621817|FG001|Overall Study|Other Reason|0|||
156870646|NCT02446899|566284228|FG000|Overall Study|Lack of Efficacy|2|||
156870647|NCT02446899|566284229|FG001|Overall Study|Lack of Efficacy|8|||
156870648|NCT02446899|566284228|FG000|Overall Study|Lost to Follow-up|1|||
156870649|NCT02446899|566284229|FG001|Overall Study|Lost to Follow-up|3|||
156870650|NCT02446899|566284228|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
156870651|NCT02446899|566284229|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
156870652|NCT02446899|566284228|FG000|Overall Study|Withdrawal by Subject|11|||
156870653|NCT02446899|566284229|FG001|Overall Study|Withdrawal by Subject|19|||
156870654|NCT02446899|566284228|FG000|Overall Study|Miscellaneous|5|||
156870655|NCT02446899|566284229|FG001|Overall Study|Miscellaneous|4|||
156870656|NCT02446899|566284228|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
156870657|NCT02446899|566284229|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
156870658|NCT01554241|566284230|FG000|Overall Study|Death|3|||
156870659|NCT01554241|566284231|FG001|Overall Study|Death|1|||
156870660|NCT01554241|566284232|FG002|Overall Study|Death|1|||
156870661|NCT01554241|566284233|FG003|Overall Study|Death|0|||
156530676|NCT01717768|565038131|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156693362|NCT00958126|565621818|FG002|Overall Study|Other Reason|0|||
156693363|NCT00958126|565621819|FG003|Overall Study|Other Reason|1|||
156693364|NCT00958126|565621820|FG004|Overall Study|Other Reason|0|||
156693365|NCT00958126|565621821|FG005|Overall Study|Other Reason|1|||
156870662|NCT01554241|566284230|FG000|Overall Study|protocol specified renal stone|0|||
156870663|NCT01554241|566284231|FG001|Overall Study|protocol specified renal stone|0|||
156870664|NCT01554241|566284232|FG002|Overall Study|protocol specified renal stone|0|||
156870665|NCT01554241|566284233|FG003|Overall Study|protocol specified renal stone|1|||
156870666|NCT01554241|566284230|FG000|Overall Study|protocol specified change in eGFR|0|||
156693366|NCT00958126|565621822|FG006|Overall Study|Other Reason|0|||
156530677|NCT01717768|565038132|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156693367|NCT00958126|565621823|FG007|Overall Study|Other Reason|0|||
156693368|NCT03078582|565621824|FG000|Overall Study|Adverse Event|0|||
156693369|NCT03078582|565621825|FG001|Overall Study|Adverse Event|8|||
156693370|NCT00430950|565621826|FG000|Overall Study|Adverse Event|7|||
156693371|NCT00430950|565621827|FG001|Overall Study|Adverse Event|6|||
156693372|NCT00430950|565621826|FG000|Overall Study|Withdrawal by Subject|1|||
156693373|NCT00430950|565621827|FG001|Overall Study|Withdrawal by Subject|0|||
156693374|NCT00430950|565621826|FG000|Overall Study|concomitant medication,etc.|5|||
156693375|NCT00430950|565621827|FG001|Overall Study|concomitant medication,etc.|7|||
156693376|NCT00293202|565621830|FG000|Overall Study|Withdrawal by Subject|1|||
156693377|NCT00293202|565621831|FG001|Overall Study|Withdrawal by Subject|2|||
156693378|NCT00293202|565621830|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
156693379|NCT00293202|565621831|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
156693380|NCT00293202|565621830|FG000|Overall Study|on-hold due to fistula maturation time|1|||
156693381|NCT00293202|565621831|FG001|Overall Study|on-hold due to fistula maturation time|0|||
156693382|NCT00123955|565621833|FG000|Overall Study|Adverse Event|1|||
156693383|NCT00123955|565621834|FG001|Overall Study|Adverse Event|0|||
156693384|NCT00123955|565621833|FG000|Overall Study|Withdrawal by Subject|4|||
156693385|NCT00123955|565621834|FG001|Overall Study|Withdrawal by Subject|3|||
156693386|NCT00123955|565621833|FG000|Overall Study|Death|0|||
156693387|NCT00123955|565621834|FG001|Overall Study|Death|1|||
156693388|NCT01558297|565621835|FG000|Overall Study|Withdrawal by Subject|2|||
156693389|NCT01558297|565621836|FG001|Overall Study|Withdrawal by Subject|2|||
156693390|NCT01558297|565621837|FG002|Overall Study|Withdrawal by Subject|1|||
156693391|NCT02427984|565621838|FG000|Overall Study|Lost to Follow-up|13|||
156693392|NCT02427984|565621839|FG001|Overall Study|Lost to Follow-up|5|||
156693393|NCT02427984|565621840|FG002|Overall Study|Lost to Follow-up|18|||
156693394|NCT02054130|565624002|FG000|Overall Study|Withdrawal by Subject|4|||
156693395|NCT02054130|565624003|FG001|Overall Study|Withdrawal by Subject|4|||
156330712|NCT03109847|564310503|FG001|Overall Study|Withdrawal by Subject|0|||
156330713|NCT04209348|564310504|FG000|Overall Study|Lost to Follow-up|1|||
156330714|NCT04209348|564310505|FG001|Overall Study|Lost to Follow-up|0|||
156330715|NCT00747461|564310506|FG000|Overall Study|study terminated by sponsor|5|||
156330716|NCT02149875|564310507|FG000|Overall Study|Lost to Follow-up|3|||
156330717|NCT02149875|564310508|FG001|Overall Study|Lost to Follow-up|4|||
156330718|NCT02149875|564310509|FG002|Overall Study|Lost to Follow-up|5|||
156330719|NCT02149875|564310507|FG000|Overall Study|Withdrawal by Subject|3|||
156330720|NCT02149875|564310508|FG001|Overall Study|Withdrawal by Subject|2|||
156330721|NCT02149875|564310509|FG002|Overall Study|Withdrawal by Subject|2|||
156330722|NCT02149875|564310507|FG000|Overall Study|Physician Decision|1|||
156330723|NCT02149875|564310508|FG001|Overall Study|Physician Decision|2|||
156330724|NCT02149875|564310509|FG002|Overall Study|Physician Decision|2|||
156330725|NCT00771316|564310511|FG000|Overall Study|Adverse Event|0|||
156330726|NCT00771316|564310512|FG001|Overall Study|Adverse Event|1|||
156330727|NCT00771316|564310511|FG000|Overall Study|Patient withdrew consent|1|||
156330728|NCT00771316|564310512|FG001|Overall Study|Patient withdrew consent|0|||
156330729|NCT00771316|564310511|FG000|Overall Study|Discontinued due to early termination|1|||
156330730|NCT00771316|564310512|FG001|Overall Study|Discontinued due to early termination|0|||
156330731|NCT03131453|564310513|FG000|Overall Study|Study terminated by Sponsor|424|||
156330732|NCT03131453|564310514|FG001|Overall Study|Study terminated by Sponsor|222|||
156330733|NCT03131453|564310515|FG002|Overall Study|Study terminated by Sponsor|438|||
156330734|NCT03131453|564310513|FG000|Overall Study|Withdrawal by Subject|18|||
156330735|NCT03131453|564310514|FG001|Overall Study|Withdrawal by Subject|7|||
156330736|NCT03131453|564310515|FG002|Overall Study|Withdrawal by Subject|13|||
156330737|NCT03131453|564310513|FG000|Overall Study|Adverse Event|10|||
156330738|NCT03131453|564310514|FG001|Overall Study|Adverse Event|3|||
156330739|NCT03131453|564310515|FG002|Overall Study|Adverse Event|3|||
156330740|NCT03131453|564310513|FG000|Overall Study|Lost to Follow-up|1|||
156330741|NCT03131453|564310514|FG001|Overall Study|Lost to Follow-up|0|||
156330742|NCT03131453|564310515|FG002|Overall Study|Lost to Follow-up|1|||
156330743|NCT03131453|564310513|FG000|Overall Study|Physician Decision|1|||
156330744|NCT03131453|564310514|FG001|Overall Study|Physician Decision|0|||
156330745|NCT03131453|564310515|FG002|Overall Study|Physician Decision|1|||
156330746|NCT03131453|564310513|FG000|Overall Study|Non-compliance with study treatment|1|||
156330747|NCT03131453|564310514|FG001|Overall Study|Non-compliance with study treatment|0|||
156330748|NCT03131453|564310515|FG002|Overall Study|Non-compliance with study treatment|0|||
156330749|NCT03131453|564310513|FG000|Overall Study|Technical problems|1|||
156330750|NCT03131453|564310514|FG001|Overall Study|Technical problems|0|||
156330751|NCT03131453|564310515|FG002|Overall Study|Technical problems|0|||
156330752|NCT03131453|564310513|FG000|Overall Study|Protocol deviation|0|||
156330753|NCT03131453|564310514|FG001|Overall Study|Protocol deviation|1|||
156330754|NCT03131453|564310515|FG002|Overall Study|Protocol deviation|0|||
156330755|NCT02081183|564310516|FG000|Overall Study|Lost to Follow-up|0|||
156330756|NCT02081183|564310517|FG001|Overall Study|Lost to Follow-up|1|||
156330757|NCT02081183|564310516|FG000|Overall Study|Protocol Violation|1|||
156330758|NCT02081183|564310517|FG001|Overall Study|Protocol Violation|0|||
156693396|NCT02054130|565624004|FG002|Overall Study|Withdrawal by Subject|7|||
156693397|NCT02054130|565624005|FG003|Overall Study|Withdrawal by Subject|10|||
156693398|NCT02054130|565624002|FG000|Overall Study|Death|0|||
156693399|NCT02054130|565624003|FG001|Overall Study|Death|1|||
156693400|NCT02054130|565624004|FG002|Overall Study|Death|0|||
156693401|NCT02054130|565624005|FG003|Overall Study|Death|0|||
156693402|NCT02054130|565624002|FG000|Overall Study|Lost to Follow-up|0|||
156693403|NCT02054130|565624003|FG001|Overall Study|Lost to Follow-up|0|||
156693404|NCT02054130|565624004|FG002|Overall Study|Lost to Follow-up|1|||
156693405|NCT02054130|565624005|FG003|Overall Study|Lost to Follow-up|2|||
156693406|NCT02054130|565624002|FG000|Overall Study|Missed dose|4|||
156693407|NCT02054130|565624003|FG001|Overall Study|Missed dose|6|||
156693408|NCT02054130|565624004|FG002|Overall Study|Missed dose|7|||
156693409|NCT02054130|565624005|FG003|Overall Study|Missed dose|10|||
156693410|NCT01386684|565624006|FG000|Overall Study|Lost to Follow-up|51|||
156693411|NCT01386684|565624006|FG000|Overall Study|Other|51|||
156693412|NCT01386684|565624006|FG000|Overall Study|Death|47|||
156693413|NCT01386684|565624006|FG000|Overall Study|Withdrawal of Consent|44|||
156693414|NCT01386684|565624006|FG000|Overall Study|Alternative Therapy Required|37|||
156693415|NCT01386684|565624006|FG000|Overall Study|Disease Progression|28|||
156693416|NCT01386684|565624006|FG000|Overall Study|Adverse Event|20|||
156693417|NCT01386684|565624006|FG000|Overall Study|Noncompliance|8|||
156693418|NCT01386684|565624006|FG000|Overall Study|Protocol Violation|4|||
156693419|NCT01386684|565624006|FG000|Overall Study|Missing|3|||
156693420|NCT04268316|565624008|FG000|Overall Study|Withdrawal by Subject|2|||
156870667|NCT01554241|566284231|FG001|Overall Study|protocol specified change in eGFR|0|||
156870668|NCT01554241|566284232|FG002|Overall Study|protocol specified change in eGFR|1|||
156870669|NCT01554241|566284233|FG003|Overall Study|protocol specified change in eGFR|0|||
156870670|NCT01554241|566284230|FG000|Overall Study|Withdrawal by Subject|0|||
156870671|NCT01554241|566284231|FG001|Overall Study|Withdrawal by Subject|0|||
156870672|NCT01554241|566284232|FG002|Overall Study|Withdrawal by Subject|2|||
156870673|NCT01554241|566284233|FG003|Overall Study|Withdrawal by Subject|0|||
156870674|NCT04730271|566284234|FG000|Overall Study|Adverse Event|0|||
156870675|NCT04730271|566284235|FG001|Overall Study|Adverse Event|2|||
156870676|NCT04730271|566284234|FG000|Overall Study|Withdrawal by Subject|1|||
156870677|NCT04730271|566284235|FG001|Overall Study|Withdrawal by Subject|1|||
156870678|NCT04730271|566284234|FG000|Overall Study|Protocol Violation|7|||
156870679|NCT04730271|566284235|FG001|Overall Study|Protocol Violation|13|||
156870680|NCT04730271|566284234|FG000|Overall Study|Lost to Follow-up|3|||
156870681|NCT04730271|566284235|FG001|Overall Study|Lost to Follow-up|3|||
156870682|NCT04730271|566284234|FG000|Overall Study|Death|1|||
156870683|NCT04730271|566284235|FG001|Overall Study|Death|0|||
156870684|NCT00998296|566284236|FG000|Overall Study|Progressive disease|0|||
156870685|NCT00998296|566284237|FG001|Overall Study|Progressive disease|1|||
156870686|NCT00998296|566284238|FG002|Overall Study|Progressive disease|0|||
156870687|NCT00998296|566284239|FG003|Overall Study|Progressive disease|0|||
156870688|NCT00998296|566284240|FG004|Overall Study|Progressive disease|0|||
156870689|NCT00998296|566284241|FG005|Overall Study|Progressive disease|0|||
156870690|NCT00998296|566284242|FG006|Overall Study|Progressive disease|1|||
156870691|NCT00998296|566284243|FG007|Overall Study|Progressive disease|0|||
156870692|NCT00998296|566284244|FG008|Overall Study|Progressive disease|0|||
156870693|NCT00998296|566284245|FG009|Overall Study|Progressive disease|14|||
156870694|NCT00998296|566284246|FG010|Overall Study|Progressive disease|5|||
156870695|NCT00998296|566284236|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870696|NCT00998296|566284237|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870697|NCT00998296|566284238|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870698|NCT00998296|566284239|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870699|NCT00998296|566284240|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
156870700|NCT00998296|566284241|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870701|NCT00998296|566284242|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870702|NCT00998296|566284243|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
156870703|NCT00998296|566284244|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
156870704|NCT00998296|566284245|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870705|NCT00998296|566284246|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
156530678|NCT01717768|565038133|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156693421|NCT04268316|565624009|FG001|Overall Study|Withdrawal by Subject|1|||
156870706|NCT00998296|566284236|FG000|Overall Study|Other adverse event|0|||
156330759|NCT02081183|564310516|FG000|Overall Study|Other|3|||
156693422|NCT04268316|565624010|FG002|Overall Study|Withdrawal by Subject|0|||
156330760|NCT02081183|564310517|FG001|Overall Study|Other|3|||
156330761|NCT04308304|564310518|FG000|Overall Study|Withdrawal by Subject|4|||
156693423|NCT02040779|565624012|FG000|Overall Study|Adverse Event|1|||
156693424|NCT02040779|565624013|FG001|Overall Study|Adverse Event|0|||
156693425|NCT02040779|565624014|FG002|Overall Study|Adverse Event|0|||
156330762|NCT04308304|564310519|FG001|Overall Study|Withdrawal by Subject|0|||
156870707|NCT00998296|566284237|FG001|Overall Study|Other adverse event|0|||
156870708|NCT00998296|566284238|FG002|Overall Study|Other adverse event|0|||
156330763|NCT04308304|564310518|FG000|Overall Study|Protocol Violation|1|||
156693426|NCT02040779|565624012|FG000|Overall Study|Withdrawal by Subject|4|||
156693427|NCT02040779|565624013|FG001|Overall Study|Withdrawal by Subject|1|||
156693428|NCT02040779|565624014|FG002|Overall Study|Withdrawal by Subject|3|||
156693429|NCT02040779|565624012|FG000|Overall Study|Non-compliance|0|||
156693430|NCT02040779|565624013|FG001|Overall Study|Non-compliance|1|||
156693431|NCT02040779|565624014|FG002|Overall Study|Non-compliance|0|||
156693432|NCT02040779|565624012|FG000|Overall Study|Protocol Violation|2|||
156693433|NCT02040779|565624013|FG001|Overall Study|Protocol Violation|1|||
156693434|NCT02040779|565624014|FG002|Overall Study|Protocol Violation|0|||
156693435|NCT02040779|565624012|FG000|Overall Study|Lost to Follow-up|1|||
156693436|NCT02040779|565624013|FG001|Overall Study|Lost to Follow-up|2|||
156693437|NCT02040779|565624014|FG002|Overall Study|Lost to Follow-up|1|||
156693438|NCT02040779|565624012|FG000|Overall Study|Lack of Efficacy|4|||
156693439|NCT02040779|565624013|FG001|Overall Study|Lack of Efficacy|2|||
156693440|NCT02040779|565624014|FG002|Overall Study|Lack of Efficacy|0|||
156693441|NCT02132637|565624015|FG000|Study Period 1|Withdrawal by Subject|0|||
156693442|NCT02132637|565624016|FG001|Study Period 1|Withdrawal by Subject|4|||
156693443|NCT02132637|565624015|FG000|Study Period 1|Physician Decision|1|||
156693444|NCT02132637|565624016|FG001|Study Period 1|Physician Decision|0|||
156693445|NCT02132637|565624015|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
156693446|NCT02132637|565624016|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
156693447|NCT02132637|565624015|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
156693448|NCT02132637|565624016|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
156693449|NCT00866658|565624025|FG000|Overall Study|Adverse Event|5|||
156693450|NCT00866658|565624026|FG001|Overall Study|Adverse Event|14|||
156693451|NCT00866658|565624025|FG000|Overall Study|Lack of Efficacy|2|||
156693452|NCT00866658|565624026|FG001|Overall Study|Lack of Efficacy|1|||
156693453|NCT00866658|565624025|FG000|Overall Study|Withdrawal by Subject|1|||
156693454|NCT00866658|565624026|FG001|Overall Study|Withdrawal by Subject|0|||
156693455|NCT00866658|565624025|FG000|Overall Study|Protocol Violation|1|||
156693456|NCT00866658|565624026|FG001|Overall Study|Protocol Violation|1|||
156693457|NCT00866658|565624025|FG000|Overall Study|Familial and Personal Reasons|4|||
156693458|NCT00866658|565624026|FG001|Overall Study|Familial and Personal Reasons|5|||
156693459|NCT02528123|565624027|FG000|Overall Study|Lost to Follow-up|1|||
156693460|NCT04505293|565624030|FG000|Overall Study|Lost to Follow-up|2|||
156693461|NCT04505293|565624030|FG000|Overall Study|Withdrawal by Subject|6|||
156693462|NCT04505293|565624030|FG000|Overall Study|CT scan unreadable|277|||
156693463|NCT00506129|565624031|FG000|Overall Study|Disease Progression/Relapse|15|||
156693464|NCT00506129|565624031|FG000|Overall Study|Death|7|||
156693465|NCT04295135|565624032|FG000|Overall Study|Withdrawal by Subject|2|||
156693466|NCT04295135|565624033|FG001|Overall Study|Withdrawal by Subject|1|||
156693467|NCT04295135|565624032|FG000|Overall Study|Subject left organization|8|||
156693468|NCT04295135|565624033|FG001|Overall Study|Subject left organization|4|||
156693469|NCT02923674|565624034|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
156693470|NCT02923674|565624035|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
156693471|NCT02923674|565624036|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
156693472|NCT02923674|565624034|FG000|Overall Study|Lost to Follow-up|7|||
156693473|NCT02923674|565624035|FG001|Overall Study|Lost to Follow-up|12|||
156693474|NCT02923674|565624036|FG002|Overall Study|Lost to Follow-up|7|||
156693475|NCT02923674|565624034|FG000|Overall Study|Problem with intervention|2|||
156693476|NCT02923674|565624035|FG001|Overall Study|Problem with intervention|2|||
156693477|NCT02923674|565624036|FG002|Overall Study|Problem with intervention|1|||
156693478|NCT02923674|565624034|FG000|Overall Study|Adverse Event|3|||
156693479|NCT02923674|565624035|FG001|Overall Study|Adverse Event|1|||
156693480|NCT02923674|565624036|FG002|Overall Study|Adverse Event|1|||
156693481|NCT02923674|565624034|FG000|Overall Study|Withdrawal by Subject|2|||
156693482|NCT02923674|565624035|FG001|Overall Study|Withdrawal by Subject|2|||
156693483|NCT02923674|565624036|FG002|Overall Study|Withdrawal by Subject|2|||
156789141|NCT02945046|565979163|FG001|Overall Study|Protocol Violation|3|||
156789142|NCT02945046|565979164|FG002|Overall Study|Protocol Violation|2|||
156789143|NCT02945046|565979162|FG000|Overall Study|Lost to Follow-up|1|||
156789144|NCT02945046|565979163|FG001|Overall Study|Lost to Follow-up|1|||
156789145|NCT02945046|565979164|FG002|Overall Study|Lost to Follow-up|0|||
156693484|NCT02712333|565624037|FG000|First Period|Withdrawal by Subject|3|||
156789146|NCT02945046|565979162|FG000|Overall Study|Lack of Efficacy|1|||
156789147|NCT02945046|565979163|FG001|Overall Study|Lack of Efficacy|2|||
156693485|NCT02712333|565624038|FG001|First Period|Withdrawal by Subject|2|||
156693486|NCT01546649|565624043|FG000|Overall Study|Adverse Event|4|||
156693487|NCT01546649|565624044|FG001|Overall Study|Adverse Event|5|||
156693488|NCT01546649|565624043|FG000|Overall Study|Protocol Violation|1|||
156693489|NCT01546649|565624044|FG001|Overall Study|Protocol Violation|0|||
156693490|NCT01546649|565624043|FG000|Overall Study|Lack of Efficacy|1|||
156693491|NCT01546649|565624044|FG001|Overall Study|Lack of Efficacy|0|||
156693492|NCT01546649|565624043|FG000|Overall Study|Recurrence|1|||
156693493|NCT01546649|565624044|FG001|Overall Study|Recurrence|1|||
156693494|NCT01546649|565624043|FG000|Overall Study|Discovery of secondary cancer|0|||
156789148|NCT02945046|565979164|FG002|Overall Study|Lack of Efficacy|1|||
156789149|NCT02945046|565979162|FG000|Overall Study|Other than specified|5|||
156693495|NCT01546649|565624044|FG001|Overall Study|Discovery of secondary cancer|1|||
156693496|NCT01546649|565624043|FG000|Overall Study|Withdrawal by Subject|1|||
156693497|NCT01546649|565624044|FG001|Overall Study|Withdrawal by Subject|2|||
156693498|NCT01621191|565624046|FG000|Overall Study|Adverse Event|9|||
156693499|NCT01621191|565624046|FG000|Overall Study|Withdrawal by Subject|8|||
156693500|NCT01621191|565624046|FG000|Overall Study|Lack of Efficacy|6|||
156693501|NCT01621191|565624046|FG000|Overall Study|Lost to Follow-up|1|||
156693502|NCT01621191|565624046|FG000|Overall Study|Site Removed From Study|1|||
156693503|NCT00706381|565624050|FG000|Overall Study|Lost to Follow-up|0|||
156693504|NCT00706381|565624051|FG001|Overall Study|Lost to Follow-up|1|||
156693505|NCT00706381|565624052|FG002|Overall Study|Lost to Follow-up|1|||
156693506|NCT00706381|565624053|FG003|Overall Study|Lost to Follow-up|0|||
156693507|NCT04355663|565624054|FG000|Overall Study|Physician Decision|2|||
156693508|NCT04355663|565624055|FG001|Overall Study|Physician Decision|7|||
156693509|NCT04355663|565624056|FG002|Overall Study|Physician Decision|0|||
156693510|NCT04355663|565624054|FG000|Overall Study|Adverse Event|0|||
156693511|NCT04355663|565624055|FG001|Overall Study|Adverse Event|0|||
156693512|NCT04355663|565624056|FG002|Overall Study|Adverse Event|1|||
156693513|NCT04355663|565624054|FG000|Overall Study|Withdrawal by Subject|0|||
156693514|NCT04355663|565624055|FG001|Overall Study|Withdrawal by Subject|8|||
156693515|NCT04355663|565624056|FG002|Overall Study|Withdrawal by Subject|3|||
156693516|NCT05420012|565624062|FG000|Overall Study|Lost to Follow-up|0|||
156693517|NCT05420012|565624063|FG001|Overall Study|Lost to Follow-up|1|||
156693518|NCT01782482|565624066|FG000|Overall Study|Adverse Event|2|||
156693519|NCT01782482|565624067|FG001|Overall Study|Adverse Event|1|||
156693520|NCT01782482|565624066|FG000|Overall Study|Lost to Follow-up|2|||
156693521|NCT01782482|565624067|FG001|Overall Study|Lost to Follow-up|3|||
156870709|NCT00998296|566284239|FG003|Overall Study|Other adverse event|0|||
156870710|NCT00998296|566284240|FG004|Overall Study|Other adverse event|1|||
156870711|NCT00998296|566284241|FG005|Overall Study|Other adverse event|0|||
156693522|NCT01782482|565624066|FG000|Overall Study|Physician Decision|1|||
156693523|NCT01782482|565624067|FG001|Overall Study|Physician Decision|0|||
156693524|NCT01782482|565624066|FG000|Overall Study|Protocol Violation|1|||
156693525|NCT01782482|565624067|FG001|Overall Study|Protocol Violation|0|||
156693526|NCT01782482|565624066|FG000|Overall Study|Withdrawal by Subject|2|||
156693527|NCT01782482|565624067|FG001|Overall Study|Withdrawal by Subject|3|||
156693528|NCT01782482|565624066|FG000|Overall Study|Randomized in Error|2|||
156693529|NCT01782482|565624067|FG001|Overall Study|Randomized in Error|2|||
156693530|NCT01782482|565624066|FG000|Overall Study|Habitually wearing toric lens OS|0|||
156693531|NCT01782482|565624067|FG001|Overall Study|Habitually wearing toric lens OS|1|||
156693532|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
156693533|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
156693534|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
156693535|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
156693536|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
156693537|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
156693538|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
156693539|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
156693540|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
156693541|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
156693542|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
156693543|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
156693544|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
156789150|NCT02945046|565979163|FG001|Overall Study|Other than specified|4|||
156789151|NCT02945046|565979164|FG002|Overall Study|Other than specified|7|||
156789152|NCT01608308|565979166|FG000|Overall Study|pretreatment medical and billing reasons|0|||
156789153|NCT01608308|565979167|FG001|Overall Study|pretreatment medical and billing reasons|2|||
156789154|NCT00032487|565979179|FG000|Overall Study|Withdrawal by Subject|67|||
156789155|NCT00032487|565979180|FG001|Overall Study|Withdrawal by Subject|43|||
156789156|NCT00032487|565979179|FG000|Overall Study|Adverse Event|3|||
156789157|NCT00032487|565979180|FG001|Overall Study|Adverse Event|7|||
156789158|NCT00032487|565979179|FG000|Overall Study|Lost to Follow-up|57|||
156789159|NCT00032487|565979180|FG001|Overall Study|Lost to Follow-up|58|||
156789160|NCT00032487|565979179|FG000|Overall Study|Had other reason|12|||
156789161|NCT00032487|565979180|FG001|Overall Study|Had other reason|12|||
156789162|NCT04648241|565979182|FG000|Overall Study|Lost to Follow-up|1|||
156693545|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
156693546|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
156693547|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
156693548|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
156693549|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
156693550|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
156693551|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
156693552|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Unclassified|14|||
156789163|NCT04648241|565979183|FG001|Overall Study|Lost to Follow-up|0|||
156789164|NCT02057666|565979184|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
156870712|NCT00998296|566284242|FG006|Overall Study|Other adverse event|0|||
156870713|NCT00998296|566284243|FG007|Overall Study|Other adverse event|0|||
156870714|NCT00998296|566284244|FG008|Overall Study|Other adverse event|0|||
156870715|NCT00998296|566284245|FG009|Overall Study|Other adverse event|1|||
156870716|NCT00998296|566284246|FG010|Overall Study|Other adverse event|2|||
156870717|NCT00998296|566284236|FG000|Overall Study|Refused to continue taking trial med.|0|||
156870718|NCT00998296|566284237|FG001|Overall Study|Refused to continue taking trial med.|0|||
156870719|NCT00998296|566284238|FG002|Overall Study|Refused to continue taking trial med.|0|||
156870720|NCT00998296|566284239|FG003|Overall Study|Refused to continue taking trial med.|0|||
156870721|NCT00998296|566284240|FG004|Overall Study|Refused to continue taking trial med.|0|||
156870722|NCT00998296|566284241|FG005|Overall Study|Refused to continue taking trial med.|0|||
156870723|NCT00998296|566284242|FG006|Overall Study|Refused to continue taking trial med.|0|||
156870724|NCT00998296|566284243|FG007|Overall Study|Refused to continue taking trial med.|0|||
156870725|NCT00998296|566284244|FG008|Overall Study|Refused to continue taking trial med.|0|||
156870726|NCT00998296|566284245|FG009|Overall Study|Refused to continue taking trial med.|2|||
156870727|NCT00998296|566284246|FG010|Overall Study|Refused to continue taking trial med.|0|||
156870728|NCT00998296|566284236|FG000|Overall Study|Reason other than those specified above|0|||
156870729|NCT00998296|566284237|FG001|Overall Study|Reason other than those specified above|0|||
156870730|NCT00998296|566284238|FG002|Overall Study|Reason other than those specified above|0|||
156870731|NCT00998296|566284239|FG003|Overall Study|Reason other than those specified above|0|||
156870732|NCT00998296|566284240|FG004|Overall Study|Reason other than those specified above|0|||
156530679|NCT01717768|565038134|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156530680|NCT01717768|565038135|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
156530681|NCT01717768|565038136|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
156530682|NCT01717768|565038125|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156530683|NCT01717768|565038126|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156530684|NCT01717768|565038127|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156870733|NCT00998296|566284241|FG005|Overall Study|Reason other than those specified above|0|||
156870734|NCT00998296|566284242|FG006|Overall Study|Reason other than those specified above|0|||
156870735|NCT00998296|566284243|FG007|Overall Study|Reason other than those specified above|0|||
156870736|NCT00998296|566284244|FG008|Overall Study|Reason other than those specified above|0|||
156870737|NCT00998296|566284245|FG009|Overall Study|Reason other than those specified above|1|||
156870738|NCT00998296|566284246|FG010|Overall Study|Reason other than those specified above|0|||
156870739|NCT04396639|566284247|FG000|Overall Study|Withdrawal by Subject|1|||
156870740|NCT04396639|566284247|FG000|Overall Study|Other|1|||
156870741|NCT01544335|566284248|FG000|Overall Study|Lost to Follow-up|27|||
156870742|NCT01544335|566284248|FG000|Overall Study|Death|4|||
156870743|NCT01544335|566284248|FG000|Overall Study|Disease progression|3|||
156870744|NCT01544335|566284248|FG000|Overall Study|Baseline Measurements not Available|19|||
156870745|NCT02223858|566284251|FG000|Overall Study|Death|1|||
156870746|NCT02223858|566284252|FG001|Overall Study|Death|1|||
156870747|NCT02223858|566284251|FG000|Overall Study|Lost to Follow-up|6|||
156870748|NCT02223858|566284252|FG001|Overall Study|Lost to Follow-up|11|||
156870749|NCT02223858|566284251|FG000|Overall Study|Withdrawal by Subject|8|||
156870750|NCT02223858|566284252|FG001|Overall Study|Withdrawal by Subject|5|||
156870751|NCT02223858|566284251|FG000|Overall Study|Refused|9|||
156870752|NCT02223858|566284252|FG001|Overall Study|Refused|9|||
156870753|NCT03198507|566284253|FG000|Overall Study|Withdrawal by Subject|1|||
156870754|NCT03198507|566284254|FG001|Overall Study|Withdrawal by Subject|0|||
156870755|NCT00241839|566284261|FG000|Overall Study|Withdrawal by Subject|18|||
156870756|NCT00241839|566284262|FG001|Overall Study|Withdrawal by Subject|17|||
156437950|NCT02957136|564693488|FG001|Overall Study|Withdrawal by Subject|1|||
156437951|NCT02214160|564693489|FG000|Overall Study|Withdrawal by Subject|1|||
156437952|NCT02214160|564693490|FG001|Overall Study|Withdrawal by Subject|0|||
156437953|NCT02214160|564693491|FG002|Overall Study|Withdrawal by Subject|6|||
156437954|NCT02214160|564693489|FG000|Overall Study|Death|2|||
156437955|NCT02214160|564693490|FG001|Overall Study|Death|2|||
156437956|NCT02214160|564693491|FG002|Overall Study|Death|1|||
156437957|NCT02214160|564693489|FG000|Overall Study|Subject Non-Compliance|0|||
156437958|NCT02214160|564693490|FG001|Overall Study|Subject Non-Compliance|3|||
156437959|NCT02214160|564693491|FG002|Overall Study|Subject Non-Compliance|1|||
156437960|NCT02214160|564693489|FG000|Overall Study|Adverse Event|0|||
156437961|NCT02214160|564693490|FG001|Overall Study|Adverse Event|1|||
156437962|NCT02214160|564693491|FG002|Overall Study|Adverse Event|1|||
156437963|NCT02214160|564693489|FG000|Overall Study|Sponsor Decision|0|||
156437964|NCT02214160|564693490|FG001|Overall Study|Sponsor Decision|2|||
156437965|NCT02214160|564693491|FG002|Overall Study|Sponsor Decision|0|||
156437966|NCT02214160|564693489|FG000|Overall Study|Protocol Violation|1|||
156437967|NCT02214160|564693490|FG001|Overall Study|Protocol Violation|0|||
156437968|NCT02214160|564693491|FG002|Overall Study|Protocol Violation|0|||
156870757|NCT00241839|566284261|FG000|Overall Study|Adverse Event|1|||
156870758|NCT00241839|566284262|FG001|Overall Study|Adverse Event|1|||
156870759|NCT03809104|566284263|FG000|Overall Study|Withdrawal by Subject|3|||
156437969|NCT02214160|564693489|FG000|Overall Study|Physician Decision|0|||
156437970|NCT02214160|564693490|FG001|Overall Study|Physician Decision|0|||
156437971|NCT02214160|564693491|FG002|Overall Study|Physician Decision|1|||
156437972|NCT01063972|564693492|FG000|Overall Study|Death|12|||
156870760|NCT01532986|566284268|FG000|Overall Study|Death|9|||
156870761|NCT01532986|566284269|FG001|Overall Study|Death|9|||
156870762|NCT01532986|566284268|FG000|Overall Study|Withdrawal by Subject|7|||
156870763|NCT01532986|566284269|FG001|Overall Study|Withdrawal by Subject|10|||
156870764|NCT01532986|566284268|FG000|Overall Study|Physician Decision|7|||
156870765|NCT01532986|566284269|FG001|Overall Study|Physician Decision|5|||
156870766|NCT04614974|566284270|FG000|Overall Study|Lost to Follow-up|14|||
156437973|NCT01063972|564693493|FG001|Overall Study|Death|11|||
156437974|NCT01063972|564693492|FG000|Overall Study|Incarcerated|2|||
156437975|NCT01063972|564693493|FG001|Overall Study|Incarcerated|1|||
156437976|NCT01510717|564693494|FG000|Overall Study|Adverse Event|1|||
156437977|NCT01510717|564693495|FG001|Overall Study|Adverse Event|2|||
156437978|NCT01510717|564693494|FG000|Overall Study|Death|1|||
156437979|NCT01510717|564693495|FG001|Overall Study|Death|0|||
156437980|NCT01510717|564693494|FG000|Overall Study|Lost to Follow-up|0|||
156437981|NCT01510717|564693495|FG001|Overall Study|Lost to Follow-up|1|||
156437982|NCT01510717|564693494|FG000|Overall Study|Withdrawal by Subject|0|||
156437983|NCT01510717|564693495|FG001|Overall Study|Withdrawal by Subject|2|||
156437984|NCT02555215|564693501|FG000|Overall Study|Other|1|||
156437985|NCT02555215|564693501|FG000|Overall Study|Investigator Decision|2|||
156437986|NCT00529789|564693502|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
156437987|NCT00529789|564693502|FG000|Study Period II/III|Adverse Event|3|||
156437988|NCT00529789|564693502|FG000|Study Period II/III|Lack of Efficacy|2|||
156437989|NCT00529789|564693502|FG000|Study Period II/III|Withdrawal by Subject|1|||
156437990|NCT00529789|564693502|FG000|Study Period II/III|Protocol Violation|3|||
156437991|NCT00529789|564693502|FG000|Study Period II/III|Physician Decision|3|||
156437992|NCT00529789|564693502|FG000|Study Period II/III|Lost to Follow-up|3|||
156437993|NCT00529789|564693502|FG000|Study Period IV|Parent/Caregiver Decision|1|||
156437994|NCT00529789|564693502|FG000|Study Period IV|Adverse Event|1|||
156437995|NCT00529789|564693502|FG000|Study Period IV|Lack of Efficacy|1|||
156437996|NCT00529789|564693502|FG000|Study Period IV|Lost to Follow-up|3|||
156437997|NCT01968226|564693503|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
156437998|NCT00457743|564693507|FG000|Overall Study|Adverse Event|0|||
156437999|NCT00457743|564693508|FG001|Overall Study|Adverse Event|4|||
156438000|NCT00457743|564693509|FG002|Overall Study|Adverse Event|0|||
156438001|NCT00457743|564693507|FG000|Overall Study|Lack of Efficacy|3|||
156438002|NCT00457743|564693508|FG001|Overall Study|Lack of Efficacy|23|||
156438003|NCT00457743|564693509|FG002|Overall Study|Lack of Efficacy|3|||
156438004|NCT00468910|564693510|FG000|Overall Study|Lost to Follow-up|2|||
156438005|NCT00468910|564693511|FG001|Overall Study|Lost to Follow-up|1|||
156438006|NCT00468910|564693510|FG000|Overall Study|Withdrawal by Subject|2|||
156438007|NCT00468910|564693511|FG001|Overall Study|Withdrawal by Subject|1|||
156438008|NCT00468910|564693510|FG000|Overall Study|Medical Contraindication|0|||
156438009|NCT00468910|564693511|FG001|Overall Study|Medical Contraindication|1|||
156438010|NCT01909778|564693512|FG000|Overall Study|failed screening|1|||
156438011|NCT05323734|564693514|FG000|Overall Study|Adverse Event|5|||
156438012|NCT05323734|564693515|FG001|Overall Study|Adverse Event|2|||
156438013|NCT05323734|564693514|FG000|Overall Study|Physician Decision|1|||
156438014|NCT05323734|564693515|FG001|Overall Study|Physician Decision|0|||
156438015|NCT05323734|564693514|FG000|Overall Study|Lack of Efficacy|1|||
156438016|NCT05323734|564693515|FG001|Overall Study|Lack of Efficacy|2|||
156438017|NCT05323734|564693514|FG000|Overall Study|Withdrawal by Subject|2|||
156438018|NCT05323734|564693515|FG001|Overall Study|Withdrawal by Subject|0|||
156438019|NCT05323734|564693514|FG000|Overall Study|Participant Withdrawn Due|0|||
156438020|NCT05323734|564693515|FG001|Overall Study|Participant Withdrawn Due|1|||
156438021|NCT00547118|564693516|FG000|Overall Study|Did not qualify prior to starting drug|1|||
156438022|NCT00547118|564693517|FG001|Overall Study|Did not qualify prior to starting drug|1|||
156438023|NCT00547118|564693516|FG000|Overall Study|Study suspended|7|||
156438024|NCT00547118|564693517|FG001|Overall Study|Study suspended|8|||
156438025|NCT00457691|564693532|FG000|Overall Study|Adverse Event|4|||
156438026|NCT00457691|564693533|FG001|Overall Study|Adverse Event|1|||
156438027|NCT00457691|564693532|FG000|Overall Study|Death|163|||
156438028|NCT00457691|564693533|FG001|Overall Study|Death|148|||
156438029|NCT00457691|564693532|FG000|Overall Study|Protocol Violation|1|||
156438030|NCT00457691|564693533|FG001|Overall Study|Protocol Violation|3|||
156438031|NCT00457691|564693532|FG000|Overall Study|Lost to Follow-up|23|||
156438032|NCT00457691|564693533|FG001|Overall Study|Lost to Follow-up|14|||
156438033|NCT00457691|564693532|FG000|Overall Study|Study terminated by Sponsor|1|||
156438034|NCT00457691|564693533|FG001|Overall Study|Study terminated by Sponsor|1|||
156438035|NCT00457691|564693532|FG000|Overall Study|Subject refused (reason other than AE)|14|||
156438036|NCT00457691|564693533|FG001|Overall Study|Subject refused (reason other than AE)|19|||
156438037|NCT00457691|564693532|FG000|Overall Study|Disease progression, study terminated|180|||
156693553|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Unclassified|4|||
156693554|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Unclassified|8|||
156693555|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Unclassified|0|||
156693556|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Unclassified|0|||
156693557|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
156693558|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
156693559|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
156693560|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
156693561|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
156693562|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
156693563|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
156693564|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
156693565|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
156693566|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
156693567|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
156693568|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
156693569|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
156693570|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
156693571|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
156693572|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
156693573|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
156693574|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
156693575|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
156693576|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
156693577|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
156693578|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
156693579|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
156693580|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
156693581|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
156693582|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
156693583|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
156693584|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
156693585|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
156693586|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
156693587|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
156693588|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
156693589|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
156693590|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
156693591|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
156693592|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
156693593|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
156693594|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
156693595|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
156693596|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
156693597|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
156693598|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
156693599|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
156693600|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
156693601|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
156693602|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
156693603|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
156693604|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
156693605|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
156693606|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
156693607|NCT00767520|565624079|FG000|Overall Study|Participants still on treatment|11|||
156693608|NCT00767520|565624080|FG001|Overall Study|Participants still on treatment|15|||
156693609|NCT00767520|565624079|FG000|Overall Study|Randomized in error and Never treated|0|||
156693610|NCT00767520|565624080|FG001|Overall Study|Randomized in error and Never treated|2|||
156693611|NCT00720226|565624081|FG000|Overall Study|Withdrawal by Subject|7|||
156693612|NCT00720226|565624082|FG001|Overall Study|Withdrawal by Subject|4|||
156693613|NCT03401073|565624083|FG000|Overall Study|Lost to Follow-up|1|||
156693614|NCT03401073|565624084|FG001|Overall Study|Lost to Follow-up|2|||
156693615|NCT01470612|565624085|FG000|Overall Study|Adverse Event|20|||
156693616|NCT01470612|565624086|FG001|Overall Study|Adverse Event|80|||
156693617|NCT01470612|565624085|FG000|Overall Study|Death|0|||
156693618|NCT01470612|565624086|FG001|Overall Study|Death|1|||
156693619|NCT01470612|565624085|FG000|Overall Study|Lack of Efficacy|20|||
156693620|NCT01470612|565624086|FG001|Overall Study|Lack of Efficacy|326|||
156693621|NCT01470612|565624085|FG000|Overall Study|Lost to Follow-up|2|||
156693622|NCT01470612|565624086|FG001|Overall Study|Lost to Follow-up|5|||
156693623|NCT01470612|565624085|FG000|Overall Study|Did not meet entrance criteria|0|||
156693624|NCT01470612|565624086|FG001|Overall Study|Did not meet entrance criteria|1|||
156693625|NCT01470612|565624085|FG000|Overall Study|Pregnancy|2|||
156693626|NCT01470612|565624086|FG001|Overall Study|Pregnancy|10|||
156693627|NCT01470612|565624085|FG000|Overall Study|Protocol Violation|2|||
156693628|NCT01470612|565624086|FG001|Overall Study|Protocol Violation|7|||
156693629|NCT01470612|565624085|FG000|Overall Study|Withdrawal by Subject|24|||
156693630|NCT01470612|565624086|FG001|Overall Study|Withdrawal by Subject|79|||
156693631|NCT01470612|565624085|FG000|Overall Study|Other|14|||
156693632|NCT01470612|565624086|FG001|Overall Study|Other|156|||
156693633|NCT02039414|565624088|FG000|Overall Study|Delivered|1|||
156693634|NCT02039414|565624089|FG001|Overall Study|Delivered|1|||
156693635|NCT02039414|565624088|FG000|Overall Study|Lost to Follow-up|2|||
156693636|NCT02039414|565624089|FG001|Overall Study|Lost to Follow-up|0|||
156693637|NCT02039414|565624088|FG000|Overall Study|Protocol Violation|3|||
156693638|NCT02039414|565624089|FG001|Overall Study|Protocol Violation|1|||
156693639|NCT01347866|565624090|FG000|Overall Study|Death|0|||
156693640|NCT01347866|565624091|FG001|Overall Study|Death|0|||
156693641|NCT01347866|565624092|FG002|Overall Study|Death|0|||
156693642|NCT01347866|565624093|FG003|Overall Study|Death|1|||
156693643|NCT01347866|565624094|FG004|Overall Study|Death|2|||
156693644|NCT01347866|565624095|FG005|Overall Study|Death|2|||
156693645|NCT01347866|565624096|FG006|Overall Study|Death|1|||
156693646|NCT01347866|565624097|FG007|Overall Study|Death|0|||
156693647|NCT01347866|565624098|FG008|Overall Study|Death|4|||
156693648|NCT01347866|565624099|FG009|Overall Study|Death|1|||
156693649|NCT01347866|565624100|FG010|Overall Study|Death|3|||
156693650|NCT01347866|565624101|FG011|Overall Study|Death|1|||
156693651|NCT01347866|565624102|FG012|Overall Study|Death|2|||
156693652|NCT01347866|565624103|FG013|Overall Study|Death|0|||
156693653|NCT01347866|565624104|FG014|Overall Study|Death|0|||
156693654|NCT01347866|565624105|FG015|Overall Study|Death|1|||
156693655|NCT01347866|565624106|FG016|Overall Study|Death|0|||
156693656|NCT01347866|565624090|FG000|Overall Study|Lost to Follow-up|0|||
156693657|NCT01347866|565624091|FG001|Overall Study|Lost to Follow-up|0|||
156693658|NCT01347866|565624092|FG002|Overall Study|Lost to Follow-up|0|||
156870767|NCT04614974|566284271|FG001|Overall Study|Lost to Follow-up|11|||
156870768|NCT01635153|566284272|FG000|Overall Study|Lost to Follow-up|40|||
156693659|NCT01347866|565624093|FG003|Overall Study|Lost to Follow-up|0|||
156693660|NCT01347866|565624094|FG004|Overall Study|Lost to Follow-up|0|||
156693661|NCT01347866|565624095|FG005|Overall Study|Lost to Follow-up|0|||
156693662|NCT01347866|565624096|FG006|Overall Study|Lost to Follow-up|0|||
156693663|NCT01347866|565624097|FG007|Overall Study|Lost to Follow-up|1|||
156693664|NCT01347866|565624098|FG008|Overall Study|Lost to Follow-up|1|||
156693665|NCT01347866|565624099|FG009|Overall Study|Lost to Follow-up|0|||
156693666|NCT01347866|565624100|FG010|Overall Study|Lost to Follow-up|0|||
156693667|NCT01347866|565624101|FG011|Overall Study|Lost to Follow-up|0|||
156693668|NCT01347866|565624102|FG012|Overall Study|Lost to Follow-up|0|||
156693669|NCT01347866|565624103|FG013|Overall Study|Lost to Follow-up|0|||
156693670|NCT01347866|565624104|FG014|Overall Study|Lost to Follow-up|0|||
156693671|NCT01347866|565624105|FG015|Overall Study|Lost to Follow-up|0|||
156693672|NCT01347866|565624106|FG016|Overall Study|Lost to Follow-up|0|||
156693673|NCT01347866|565624090|FG000|Overall Study|Other|3|||
156693674|NCT01347866|565624091|FG001|Overall Study|Other|1|||
156693675|NCT01347866|565624092|FG002|Overall Study|Other|1|||
156693676|NCT01347866|565624093|FG003|Overall Study|Other|4|||
156693677|NCT01347866|565624094|FG004|Overall Study|Other|5|||
156693678|NCT01347866|565624095|FG005|Overall Study|Other|0|||
156693679|NCT01347866|565624096|FG006|Overall Study|Other|5|||
156693680|NCT01347866|565624097|FG007|Overall Study|Other|3|||
156693681|NCT01347866|565624098|FG008|Overall Study|Other|22|||
156693682|NCT01347866|565624099|FG009|Overall Study|Other|5|||
156693683|NCT01347866|565624100|FG010|Overall Study|Other|0|||
156693684|NCT01347866|565624101|FG011|Overall Study|Other|3|||
156693685|NCT01347866|565624102|FG012|Overall Study|Other|4|||
156693686|NCT01347866|565624103|FG013|Overall Study|Other|4|||
156870769|NCT01635153|566284273|FG001|Overall Study|Lost to Follow-up|43|||
156870770|NCT00658359|566284275|FG000|Overall Study|Death|3|||
156693687|NCT01347866|565624104|FG014|Overall Study|Other|2|||
156693688|NCT01347866|565624105|FG015|Overall Study|Other|3|||
156693689|NCT01347866|565624106|FG016|Overall Study|Other|0|||
156693690|NCT01347866|565624090|FG000|Overall Study|Subject refused further follow-up|2|||
156693691|NCT01347866|565624091|FG001|Overall Study|Subject refused further follow-up|0|||
156693692|NCT01347866|565624092|FG002|Overall Study|Subject refused further follow-up|0|||
156693693|NCT01347866|565624093|FG003|Overall Study|Subject refused further follow-up|2|||
156693694|NCT01347866|565624094|FG004|Overall Study|Subject refused further follow-up|0|||
156693695|NCT01347866|565624095|FG005|Overall Study|Subject refused further follow-up|1|||
156693696|NCT01347866|565624096|FG006|Overall Study|Subject refused further follow-up|0|||
156693697|NCT01347866|565624097|FG007|Overall Study|Subject refused further follow-up|0|||
156693698|NCT01347866|565624098|FG008|Overall Study|Subject refused further follow-up|4|||
156693699|NCT01347866|565624099|FG009|Overall Study|Subject refused further follow-up|1|||
156693700|NCT01347866|565624100|FG010|Overall Study|Subject refused further follow-up|0|||
156870771|NCT00658359|566284276|FG001|Overall Study|Death|1|||
156870772|NCT00658359|566284277|FG002|Overall Study|Death|2|||
156693701|NCT01347866|565624101|FG011|Overall Study|Subject refused further follow-up|0|||
156693702|NCT01347866|565624102|FG012|Overall Study|Subject refused further follow-up|1|||
156693703|NCT01347866|565624103|FG013|Overall Study|Subject refused further follow-up|3|||
156693704|NCT01347866|565624104|FG014|Overall Study|Subject refused further follow-up|1|||
156693705|NCT01347866|565624105|FG015|Overall Study|Subject refused further follow-up|0|||
156693706|NCT01347866|565624106|FG016|Overall Study|Subject refused further follow-up|2|||
156693707|NCT02429934|565624107|FG000|Overall Study|Withdrawal by Subject|0|||
156693708|NCT02429934|565624108|FG001|Overall Study|Withdrawal by Subject|2|||
156693709|NCT02429934|565624107|FG000|Overall Study|Adverse Event|2|||
156693710|NCT02429934|565624108|FG001|Overall Study|Adverse Event|0|||
156693711|NCT02429934|565624107|FG000|Overall Study|Lost to Follow-up|1|||
156693712|NCT02429934|565624108|FG001|Overall Study|Lost to Follow-up|1|||
156693713|NCT02429934|565624107|FG000|Overall Study|Physician Decision|1|||
156693714|NCT02429934|565624108|FG001|Overall Study|Physician Decision|0|||
156693715|NCT00869024|565624109|FG000|Overall Study|Death|2|||
156693716|NCT00869024|565624110|FG001|Overall Study|Death|3|||
156693717|NCT00869024|565624109|FG000|Overall Study|Lost to Follow-up|0|||
156693718|NCT00869024|565624110|FG001|Overall Study|Lost to Follow-up|1|||
156693719|NCT00869024|565624109|FG000|Overall Study|Protocol Violation|0|||
156693720|NCT00869024|565624110|FG001|Overall Study|Protocol Violation|1|||
156693721|NCT01564459|565624111|FG000|Run-In|Adverse Event|7|||
156693722|NCT01564459|565624112|FG001|Run-In|Adverse Event|0|||
156693723|NCT01564459|565624113|FG002|Run-In|Adverse Event|0|||
156693724|NCT01564459|565624111|FG000|Run-In|Lost to Follow-up|1|||
156693725|NCT01564459|565624112|FG001|Run-In|Lost to Follow-up|0|||
156693726|NCT01564459|565624113|FG002|Run-In|Lost to Follow-up|0|||
156693727|NCT01564459|565624111|FG000|Run-In|Non-compliance with study drug|2|||
156693728|NCT01564459|565624112|FG001|Run-In|Non-compliance with study drug|0|||
156693729|NCT01564459|565624113|FG002|Run-In|Non-compliance with study drug|0|||
156693730|NCT01564459|565624111|FG000|Run-In|Protocol Violation|1|||
156693731|NCT01564459|565624112|FG001|Run-In|Protocol Violation|0|||
156693732|NCT01564459|565624113|FG002|Run-In|Protocol Violation|0|||
156693733|NCT01564459|565624111|FG000|Run-In|Withdrawal by Subject|1|||
156693734|NCT01564459|565624112|FG001|Run-In|Withdrawal by Subject|0|||
156693735|NCT01564459|565624113|FG002|Run-In|Withdrawal by Subject|0|||
156693736|NCT01564459|565624111|FG000|Double-blind Treatment|Adverse Event|0|||
156693737|NCT01564459|565624112|FG001|Double-blind Treatment|Adverse Event|0|||
156693738|NCT01564459|565624113|FG002|Double-blind Treatment|Adverse Event|1|||
156693739|NCT02025751|565624123|FG000|Overall Study|Lost to Follow-up|1|||
156693740|NCT02025751|565624124|FG001|Overall Study|Lost to Follow-up|0|||
156693741|NCT02025751|565624123|FG000|Overall Study|Adverse Event|0|||
156693742|NCT02025751|565624124|FG001|Overall Study|Adverse Event|1|||
156693743|NCT02025751|565624123|FG000|Overall Study|Physician Decision|0|||
156693744|NCT02025751|565624124|FG001|Overall Study|Physician Decision|1|||
156693745|NCT02025751|565624123|FG000|Overall Study|Withdrawal by Subject|0|||
156693746|NCT02025751|565624124|FG001|Overall Study|Withdrawal by Subject|1|||
156693747|NCT02687360|565624127|FG000|Overall Study|Withdrawal by Subject|3|||
156693748|NCT02687360|565624128|FG001|Overall Study|Withdrawal by Subject|0|||
156693749|NCT02181296|565624130|FG000|Overall Study|Lost to Follow-up|7|||
156693750|NCT02181296|565624131|FG001|Overall Study|Lost to Follow-up|6|||
156693751|NCT02939014|565624132|FG000|Overall Study|Lost to Follow-up|1|||
156693752|NCT02939014|565624133|FG001|Overall Study|Lost to Follow-up|0|||
156693753|NCT02939014|565624132|FG000|Overall Study|Death|4|||
156693754|NCT02939014|565624133|FG001|Overall Study|Death|3|||
156330764|NCT04308304|564310519|FG001|Overall Study|Protocol Violation|0|||
156330765|NCT00165984|564310520|FG000|Overall Study|Death|15|||
156870773|NCT00658359|566284275|FG000|Overall Study|Adverse Event|13|||
156693755|NCT01568866|565624134|FG000|Overall Study|Disease Progression|208|||
156693756|NCT01568866|565624135|FG001|Overall Study|Disease Progression|183|||
156693757|NCT01568866|565624134|FG000|Overall Study|Adverse Event|94|||
156693758|NCT01568866|565624135|FG001|Overall Study|Adverse Event|96|||
156693759|NCT01568866|565624134|FG000|Overall Study|Patient Request|55|||
156693760|NCT01568866|565624135|FG001|Overall Study|Patient Request|71|||
156693761|NCT01568866|565624134|FG000|Overall Study|Physician Decision|40|||
156693762|NCT01568866|565624135|FG001|Overall Study|Physician Decision|32|||
156693763|NCT01568866|565624134|FG000|Overall Study|Withdrawal by Subject|19|||
156693764|NCT01568866|565624135|FG001|Overall Study|Withdrawal by Subject|11|||
156870774|NCT00658359|566284276|FG001|Overall Study|Adverse Event|6|||
156870775|NCT00658359|566284277|FG002|Overall Study|Adverse Event|9|||
156330766|NCT01686828|564310521|FG000|Overall Study|Physician Decision|1|||
156693765|NCT01568866|565624134|FG000|Overall Study|Death|10|||
156693766|NCT01568866|565624135|FG001|Overall Study|Death|18|||
156693767|NCT01568866|565624134|FG000|Overall Study|Protocol Non-compliance|2|||
156693768|NCT01568866|565624135|FG001|Overall Study|Protocol Non-compliance|4|||
156693769|NCT01568866|565624134|FG000|Overall Study|Lost to Follow-up|1|||
156693770|NCT01568866|565624135|FG001|Overall Study|Lost to Follow-up|0|||
156693771|NCT01568866|565624134|FG000|Overall Study|Randomized but Not Dosed|9|||
156693772|NCT01568866|565624135|FG001|Overall Study|Randomized but Not Dosed|1|||
156693773|NCT03864042|565624136|FG000|DDI Phase|Adverse Event|2|||
156693774|NCT03864042|565624137|FG001|DDI Phase|Adverse Event|0|||
156693775|NCT03864042|565624138|FG002|DDI Phase|Adverse Event|0|||
156693776|NCT03864042|565624136|FG000|DDI Phase|Physician Decision|1|||
156693777|NCT03864042|565624137|FG001|DDI Phase|Physician Decision|0|||
156693778|NCT03864042|565624138|FG002|DDI Phase|Physician Decision|0|||
156693779|NCT03864042|565624136|FG000|DDI Phase|Progressive Disease|1|||
156693780|NCT03864042|565624137|FG001|DDI Phase|Progressive Disease|0|||
156693781|NCT03864042|565624138|FG002|DDI Phase|Progressive Disease|0|||
156693782|NCT03864042|565624136|FG000|Post-DDI Phase|Adverse Event|5|||
156693783|NCT03864042|565624137|FG001|Post-DDI Phase|Adverse Event|3|||
156693784|NCT03864042|565624138|FG002|Post-DDI Phase|Adverse Event|2|||
156693785|NCT03864042|565624136|FG000|Post-DDI Phase|Progressive Disease|11|||
156693786|NCT03864042|565624137|FG001|Post-DDI Phase|Progressive Disease|6|||
156693787|NCT03864042|565624138|FG002|Post-DDI Phase|Progressive Disease|13|||
156693788|NCT03864042|565624136|FG000|Post-DDI Phase|Discretion of investigator|1|||
156693789|NCT03864042|565624137|FG001|Post-DDI Phase|Discretion of investigator|1|||
156693790|NCT03864042|565624138|FG002|Post-DDI Phase|Discretion of investigator|0|||
156693791|NCT03864042|565624136|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
156693792|NCT03864042|565624137|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
156693793|NCT03864042|565624138|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
156693794|NCT03864042|565624136|FG000|Post-DDI Phase|Withdrawal of consent|1|||
156693795|NCT03864042|565624137|FG001|Post-DDI Phase|Withdrawal of consent|2|||
156693796|NCT03864042|565624138|FG002|Post-DDI Phase|Withdrawal of consent|0|||
156693797|NCT01698775|565624139|FG000|Phase A|Adverse Event|2|||
156693798|NCT01698775|565624140|FG001|Phase A|Adverse Event|1|||
156693799|NCT01698775|565624139|FG000|Phase A|Death|1|||
156693800|NCT01698775|565624140|FG001|Phase A|Death|1|||
156693801|NCT01698775|565624139|FG000|Phase A|Lack of Efficacy|1|||
156693802|NCT01698775|565624140|FG001|Phase A|Lack of Efficacy|0|||
156693803|NCT01698775|565624139|FG000|Phase A|Lost to Follow-up|1|||
156693804|NCT01698775|565624140|FG001|Phase A|Lost to Follow-up|2|||
156693805|NCT01698775|565624139|FG000|Phase A|Protocol Violation|1|||
156693806|NCT01698775|565624140|FG001|Phase A|Protocol Violation|0|||
156693807|NCT01698775|565624139|FG000|Phase A|Withdrawal by Subject|3|||
156693808|NCT01698775|565624140|FG001|Phase A|Withdrawal by Subject|4|||
156693809|NCT01698775|565624139|FG000|Phase A|Kidney [transplant]|0|||
156693810|NCT01698775|565624140|FG001|Phase A|Kidney [transplant]|1|||
156693811|NCT01698775|565624139|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
156693812|NCT01698775|565624140|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
156693813|NCT01698775|565624139|FG000|Phase B|Adverse Event|6|||
156693814|NCT01698775|565624140|FG001|Phase B|Adverse Event|3|||
156789165|NCT02057666|565979185|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
156789166|NCT02057666|565979184|FG000|Double Blind Treatment Period|Poor tolerability|7|||
156693815|NCT01698775|565624139|FG000|Phase B|Death|0|||
156789167|NCT02057666|565979185|FG001|Double Blind Treatment Period|Poor tolerability|2|||
156789168|NCT02057666|565979184|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
156789169|NCT02057666|565979185|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
156789170|NCT02057666|565979184|FG000|Double Blind Treatment Period|Physician Decision|1|||
156789171|NCT02057666|565979185|FG001|Double Blind Treatment Period|Physician Decision|0|||
156789172|NCT02057666|565979184|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
156789173|NCT02057666|565979185|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
156789174|NCT02057666|565979184|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
156789175|NCT02057666|565979185|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
156789176|NCT02057666|565979184|FG000|Double Blind Treatment Period|Sponsor's request|70|||
156789177|NCT02057666|565979185|FG001|Double Blind Treatment Period|Sponsor's request|34|||
156789178|NCT02057666|565979184|FG000|Open-Label Treatment Period|Poor tolerability|0|||
156789179|NCT02057666|565979185|FG001|Open-Label Treatment Period|Poor tolerability|1|||
156330767|NCT01686828|564310522|FG001|Overall Study|Physician Decision|0|||
156330768|NCT01686828|564310523|FG002|Overall Study|Physician Decision|0|||
156330769|NCT01686828|564310524|FG003|Overall Study|Physician Decision|0|||
156330770|NCT01686828|564310521|FG000|Overall Study|New Job|0|||
156330771|NCT01686828|564310522|FG001|Overall Study|New Job|1|||
156330772|NCT01686828|564310523|FG002|Overall Study|New Job|0|||
156530685|NCT01717768|565038128|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156693816|NCT01698775|565624140|FG001|Phase B|Death|1|||
156693817|NCT01698775|565624139|FG000|Phase B|Lack of Efficacy|0|||
156693818|NCT01698775|565624140|FG001|Phase B|Lack of Efficacy|1|||
156330773|NCT01686828|564310524|FG003|Overall Study|New Job|0|||
156330774|NCT01686828|564310521|FG000|Overall Study|Weight Loss|0|||
156330775|NCT01686828|564310522|FG001|Overall Study|Weight Loss|0|||
156693819|NCT01698775|565624139|FG000|Phase B|Lost to Follow-up|0|||
156693820|NCT01698775|565624140|FG001|Phase B|Lost to Follow-up|1|||
156693821|NCT01698775|565624139|FG000|Phase B|Physician Decision|1|||
156693822|NCT01698775|565624140|FG001|Phase B|Physician Decision|1|||
156693823|NCT01698775|565624139|FG000|Phase B|Protocol Violation|1|||
156693824|NCT01698775|565624140|FG001|Phase B|Protocol Violation|1|||
156693825|NCT01698775|565624139|FG000|Phase B|Withdrawal by Subject|6|||
156693826|NCT01698775|565624140|FG001|Phase B|Withdrawal by Subject|2|||
156693827|NCT02143583|565624147|FG000|Overall Study|Withdrawal by Subject|1|||
156693828|NCT02143583|565624148|FG001|Overall Study|Withdrawal by Subject|0|||
156693829|NCT02143583|565624149|FG002|Overall Study|Withdrawal by Subject|1|||
156693830|NCT02143583|565624147|FG000|Overall Study|husband illness|0|||
156693831|NCT02143583|565624148|FG001|Overall Study|husband illness|0|||
156693832|NCT02143583|565624149|FG002|Overall Study|husband illness|1|||
156693833|NCT00766831|565624150|FG000|Overall Study|Withdrawal by Subject|4|||
156693834|NCT00766831|565624150|FG000|Overall Study|Lost to Follow-up|3|||
156693835|NCT00766831|565624150|FG000|Overall Study|Adverse Event|20|||
156693836|NCT00766831|565624150|FG000|Overall Study|Protocol Violation|15|||
156693837|NCT00766831|565624150|FG000|Overall Study|Physician Decision|5|||
156693838|NCT00766831|565624150|FG000|Overall Study|Withdrawal of consent|26|||
156693839|NCT00766831|565624150|FG000|Overall Study|Non cooperation by participants|14|||
156693840|NCT00766831|565624150|FG000|Overall Study|Other|28|||
156693841|NCT02333487|565624153|FG000|Overall Study|Adverse Event|0|||
156693842|NCT02333487|565624154|FG001|Overall Study|Adverse Event|2|||
156693843|NCT02333487|565624155|FG002|Overall Study|Adverse Event|0|||
156789180|NCT02057666|565979184|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
156789181|NCT02057666|565979185|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
156789182|NCT02057666|565979184|FG000|Open-Label Treatment Period|Sponsor's request|0|||
156789183|NCT02057666|565979185|FG001|Open-Label Treatment Period|Sponsor's request|4|||
156789184|NCT05661734|565979186|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
156789185|NCT05661734|565979186|FG000|Overall Study|Lost to Follow-up|13|||
156789186|NCT05661734|565979186|FG000|Overall Study|Enrolled but not dosed|2|||
156789187|NCT02489045|565979189|FG000|Overall Study|unable to collect usable data|53|||
156789188|NCT02489045|565979189|FG000|Follow-up|Lost to Follow-up|10|||
156789189|NCT01108055|565979196|FG000|Overall Study|Ineligible|11|||
156789190|NCT01108055|565979196|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
156789191|NCT03339453|565979198|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
156789192|NCT03339453|565979199|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
156789193|NCT01117350|565979211|FG000|Comparative Period|Not Treated|5|||
156789194|NCT01117350|565979212|FG001|Comparative Period|Not Treated|8|||
156789195|NCT01117350|565979211|FG000|Comparative Period|Adverse Event|6|||
156789196|NCT01117350|565979212|FG001|Comparative Period|Adverse Event|33|||
156789197|NCT01117350|565979211|FG000|Comparative Period|Lost to Follow-up|11|||
156789198|NCT01117350|565979212|FG001|Comparative Period|Lost to Follow-up|7|||
156789199|NCT01117350|565979211|FG000|Comparative Period|Withdrawal by Subject|9|||
156789200|NCT01117350|565979212|FG001|Comparative Period|Withdrawal by Subject|13|||
156789201|NCT01117350|565979211|FG000|Comparative Period|Protocol Violation|8|||
156789202|NCT01117350|565979212|FG001|Comparative Period|Protocol Violation|12|||
156789203|NCT01117350|565979211|FG000|Comparative Period|Lack of Efficacy|1|||
156789204|NCT01117350|565979212|FG001|Comparative Period|Lack of Efficacy|0|||
156789205|NCT01117350|565979211|FG000|Comparative Period|Physician Decision|0|||
156789206|NCT01117350|565979212|FG001|Comparative Period|Physician Decision|1|||
156789207|NCT01117350|565979211|FG000|Comparative Period|Move to another city/country|2|||
156789208|NCT01117350|565979212|FG001|Comparative Period|Move to another city/country|1|||
156789209|NCT01117350|565979211|FG000|Extension Period|Not included in extension, not treated|0|||
156789210|NCT01117350|565979212|FG001|Extension Period|Not included in extension, not treated|50|||
156789211|NCT01117350|565979211|FG000|Extension Period|Adverse Event|0|||
156789212|NCT01117350|565979212|FG001|Extension Period|Adverse Event|2|||
156789213|NCT01117350|565979211|FG000|Extension Period|Protocol Violation|0|||
156789214|NCT01117350|565979212|FG001|Extension Period|Protocol Violation|2|||
156789215|NCT01117350|565979211|FG000|Extension Period|Lost to Follow-up|0|||
156789216|NCT01117350|565979212|FG001|Extension Period|Lost to Follow-up|2|||
156870776|NCT00658359|566284275|FG000|Overall Study|Protocol Violation|1|||
156870777|NCT00658359|566284276|FG001|Overall Study|Protocol Violation|0|||
156870778|NCT00658359|566284277|FG002|Overall Study|Protocol Violation|0|||
156870779|NCT00658359|566284275|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
156789217|NCT01117350|565979211|FG000|Extension Period|Withdrawal by Subject|0|||
156789218|NCT01117350|565979212|FG001|Extension Period|Withdrawal by Subject|3|||
156789219|NCT01117350|565979211|FG000|Extension Period|Lack of Efficacy|0|||
156789220|NCT01117350|565979212|FG001|Extension Period|Lack of Efficacy|2|||
156789221|NCT01117350|565979211|FG000|Extension Period|Inclusion criteria not respected|0|||
156789222|NCT01117350|565979212|FG001|Extension Period|Inclusion criteria not respected|1|||
156789223|NCT01117350|565979211|FG000|Extension Period|Prohibited medication|0|||
156789224|NCT01117350|565979212|FG001|Extension Period|Prohibited medication|1|||
156789225|NCT02487199|565979218|FG000|Overall Study|Withdrew Consent|0|||
156789226|NCT02487199|565979219|FG001|Overall Study|Withdrew Consent|1|||
156789227|NCT00286455|565979220|FG000|Overall Study|Hyperglycemia rescue|19|||
156789228|NCT00286455|565979221|FG001|Overall Study|Hyperglycemia rescue|13|||
156789229|NCT00286455|565979222|FG002|Overall Study|Hyperglycemia rescue|10|||
156789230|NCT00286455|565979220|FG000|Overall Study|Adverse Event|1|||
156789231|NCT00286455|565979221|FG001|Overall Study|Adverse Event|3|||
156789232|NCT00286455|565979222|FG002|Overall Study|Adverse Event|2|||
156693844|NCT04189445|565625615|FG000|Overall Study|Withdrawal of consent|8|||
156693845|NCT04189445|565625616|FG001|Overall Study|Withdrawal of consent|1|||
156693846|NCT04189445|565625617|FG002|Overall Study|Withdrawal of consent|0|||
156693847|NCT04189445|565625615|FG000|Overall Study|Study Terminated by Sponsor|25|||
156693848|NCT04189445|565625616|FG001|Overall Study|Study Terminated by Sponsor|3|||
156693849|NCT04189445|565625617|FG002|Overall Study|Study Terminated by Sponsor|0|||
156693850|NCT04189445|565625615|FG000|Overall Study|Death|54|||
156693851|NCT04189445|565625616|FG001|Overall Study|Death|24|||
156693852|NCT04189445|565625617|FG002|Overall Study|Death|0|||
156693853|NCT02960893|565625619|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
156693854|NCT02960893|565625620|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
156693855|NCT02960893|565625621|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
156693856|NCT02960893|565625622|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
156693857|NCT02960893|565625619|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
156693858|NCT02960893|565625620|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
156693859|NCT02960893|565625621|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
156693860|NCT02960893|565625622|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
156693861|NCT02960893|565625619|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
156693862|NCT02960893|565625620|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
156693863|NCT02960893|565625621|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
156693864|NCT02960893|565625622|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
156693865|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
156693866|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
156693867|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
156693868|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
156693869|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
156693870|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
156693871|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
156693872|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
156693873|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
156693874|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
156693875|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
156693876|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
156693877|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
156693878|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
156693879|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
156693880|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
156693881|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
156693882|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
156693883|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
156693884|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
156693885|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
156693886|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
156693887|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
156693888|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
156693889|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
156693890|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
156693891|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
156693892|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
156693893|NCT02091141|565625623|FG000|Overall Study|Death|280|||
156693894|NCT02091141|565625624|FG001|Overall Study|Death|118|||
156693895|NCT02091141|565625625|FG002|Overall Study|Death|46|||
156693896|NCT02091141|565625626|FG003|Overall Study|Death|13|||
156693897|NCT02091141|565625627|FG004|Overall Study|Death|31|||
156693898|NCT02091141|565625628|FG005|Overall Study|Death|16|||
156693899|NCT02091141|565625629|FG006|Overall Study|Death|12|||
156693900|NCT02091141|565625623|FG000|Overall Study|Withdrawal by Subject|21|||
156693901|NCT02091141|565625624|FG001|Overall Study|Withdrawal by Subject|13|||
156693902|NCT02091141|565625625|FG002|Overall Study|Withdrawal by Subject|3|||
156693903|NCT02091141|565625626|FG003|Overall Study|Withdrawal by Subject|2|||
156789233|NCT00286455|565979220|FG000|Overall Study|Lost to Follow-up|0|||
156789234|NCT00286455|565979221|FG001|Overall Study|Lost to Follow-up|3|||
156789235|NCT00286455|565979222|FG002|Overall Study|Lost to Follow-up|3|||
156789236|NCT00286455|565979220|FG000|Overall Study|Physician Decision|3|||
156789237|NCT00286455|565979221|FG001|Overall Study|Physician Decision|0|||
156789238|NCT00286455|565979222|FG002|Overall Study|Physician Decision|2|||
156789239|NCT00286455|565979220|FG000|Overall Study|Protocol Violation|1|||
156693904|NCT02091141|565625627|FG004|Overall Study|Withdrawal by Subject|2|||
156693905|NCT02091141|565625628|FG005|Overall Study|Withdrawal by Subject|3|||
156789240|NCT00286455|565979221|FG001|Overall Study|Protocol Violation|1|||
156789241|NCT00286455|565979222|FG002|Overall Study|Protocol Violation|0|||
156789242|NCT00286455|565979220|FG000|Overall Study|Participant Non-compliance|1|||
156870780|NCT00658359|566284276|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
156870781|NCT00658359|566284277|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
156438038|NCT00457691|564693533|FG001|Overall Study|Disease progression, study terminated|196|||
156438039|NCT01121549|564693534|FG000|Overall Study|Adverse Event|10|||
156438040|NCT01121549|564693534|FG000|Overall Study|Lack of Efficacy|11|||
156438041|NCT01121549|564693534|FG000|Overall Study|Lost to Follow-up|12|||
156438042|NCT01121549|564693534|FG000|Overall Study|Did not meet entrance criteria|9|||
156438043|NCT01121549|564693534|FG000|Overall Study|Study terminated by sponsor|197|||
156438044|NCT01121549|564693534|FG000|Overall Study|Pregnancy|1|||
156438045|NCT01121549|564693534|FG000|Overall Study|Protocol Violation|33|||
156870782|NCT00658359|566284275|FG000|Overall Study|Withdrawal by Subject|7|||
156438046|NCT01121549|564693534|FG000|Overall Study|Withdrawal by Subject|16|||
156438047|NCT01121549|564693534|FG000|Overall Study|Other|58|||
156438048|NCT03073941|564695342|FG000|Overall Study|Received non-study device intraoperatively|0|||
156693906|NCT02091141|565625629|FG006|Overall Study|Withdrawal by Subject|0|||
156693907|NCT02091141|565625623|FG000|Overall Study|Lost to Follow-up|21|||
156693908|NCT02091141|565625624|FG001|Overall Study|Lost to Follow-up|5|||
156693909|NCT02091141|565625625|FG002|Overall Study|Lost to Follow-up|1|||
156693910|NCT02091141|565625626|FG003|Overall Study|Lost to Follow-up|0|||
156693911|NCT02091141|565625627|FG004|Overall Study|Lost to Follow-up|1|||
156693912|NCT02091141|565625628|FG005|Overall Study|Lost to Follow-up|2|||
156693913|NCT02091141|565625629|FG006|Overall Study|Lost to Follow-up|0|||
156693914|NCT02091141|565625623|FG000|Overall Study|Reason Not Specified|6|||
156693915|NCT02091141|565625624|FG001|Overall Study|Reason Not Specified|5|||
156530686|NCT01717768|565038129|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156530687|NCT01717768|565038130|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156693916|NCT02091141|565625625|FG002|Overall Study|Reason Not Specified|2|||
156693917|NCT02091141|565625626|FG003|Overall Study|Reason Not Specified|0|||
156693918|NCT02091141|565625627|FG004|Overall Study|Reason Not Specified|0|||
156693919|NCT02091141|565625628|FG005|Overall Study|Reason Not Specified|0|||
156693920|NCT02091141|565625629|FG006|Overall Study|Reason Not Specified|1|||
156693921|NCT02091141|565625623|FG000|Overall Study|Study Ended by Sponsor|1|||
156693922|NCT02091141|565625624|FG001|Overall Study|Study Ended by Sponsor|9|||
156693923|NCT02091141|565625625|FG002|Overall Study|Study Ended by Sponsor|0|||
156693924|NCT02091141|565625626|FG003|Overall Study|Study Ended by Sponsor|0|||
156693925|NCT02091141|565625627|FG004|Overall Study|Study Ended by Sponsor|0|||
156693926|NCT02091141|565625628|FG005|Overall Study|Study Ended by Sponsor|0|||
156693927|NCT02091141|565625629|FG006|Overall Study|Study Ended by Sponsor|0|||
156693928|NCT02091141|565625623|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693929|NCT02091141|565625624|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
156693930|NCT02091141|565625625|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693931|NCT02091141|565625626|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693932|NCT02091141|565625627|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693933|NCT02091141|565625628|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693934|NCT02091141|565625629|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693935|NCT04551911|565625630|FG000|Overall Study|Lost to Follow-up|2|||
156693936|NCT04551911|565625631|FG001|Overall Study|Lost to Follow-up|1|||
156693937|NCT04551911|565625630|FG000|Overall Study|Withdrawal by Subject|10|||
156693938|NCT04551911|565625631|FG001|Overall Study|Withdrawal by Subject|10|||
156693939|NCT04551911|565625630|FG000|Overall Study|Did not receive the study drug|3|||
156693940|NCT04551911|565625631|FG001|Overall Study|Did not receive the study drug|4|||
156693941|NCT02177136|565625633|FG000|DB Phase|Withdrawal by Subject|2|||
156693942|NCT02177136|565625634|FG001|DB Phase|Withdrawal by Subject|0|||
156693943|NCT02177136|565625635|FG002|DB Phase|Withdrawal by Subject|0|||
156693944|NCT02177136|565625636|FG003|DB Phase|Withdrawal by Subject|0|||
156693945|NCT02177136|565625633|FG000|DB Phase|Discontinued Due to Pruritus|1|||
156693946|NCT02177136|565625634|FG001|DB Phase|Discontinued Due to Pruritus|3|||
156693947|NCT02177136|565625635|FG002|DB Phase|Discontinued Due to Pruritus|0|||
156693948|NCT02177136|565625636|FG003|DB Phase|Discontinued Due to Pruritus|0|||
156693949|NCT02177136|565625633|FG000|DB Phase|Adverse Event|3|||
156693950|NCT02177136|565625634|FG001|DB Phase|Adverse Event|2|||
156693951|NCT02177136|565625635|FG002|DB Phase|Adverse Event|3|||
156693952|NCT02177136|565625636|FG003|DB Phase|Adverse Event|0|||
156693953|NCT02177136|565625633|FG000|DB Phase|Protocol Violation|0|||
156693954|NCT02177136|565625634|FG001|DB Phase|Protocol Violation|0|||
156693955|NCT02177136|565625635|FG002|DB Phase|Protocol Violation|1|||
156438049|NCT03073941|564695343|FG001|Overall Study|Received non-study device intraoperatively|2|||
156438050|NCT03073941|564695342|FG000|Overall Study|Death|1|||
156438051|NCT03073941|564695343|FG001|Overall Study|Death|0|||
156438052|NCT03073941|564695342|FG000|Overall Study|Withdrawal by Subject|1|||
156438053|NCT03073941|564695343|FG001|Overall Study|Withdrawal by Subject|3|||
156438054|NCT03073941|564695342|FG000|Overall Study|Lost to Follow-up|5|||
156693956|NCT02177136|565625636|FG003|DB Phase|Protocol Violation|0|||
156693957|NCT02177136|565625633|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
156693958|NCT02177136|565625634|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
156693959|NCT02177136|565625635|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
156693960|NCT02177136|565625636|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
156693961|NCT02177136|565625633|FG000|LTSE Phase|Withdrawal by Subject|0|||
156693962|NCT02177136|565625634|FG001|LTSE Phase|Withdrawal by Subject|0|||
156693963|NCT02177136|565625635|FG002|LTSE Phase|Withdrawal by Subject|0|||
156693964|NCT02177136|565625636|FG003|LTSE Phase|Withdrawal by Subject|6|||
156693965|NCT02177136|565625633|FG000|LTSE Phase|Adverse Event|0|||
156693966|NCT02177136|565625634|FG001|LTSE Phase|Adverse Event|0|||
156693967|NCT02177136|565625635|FG002|LTSE Phase|Adverse Event|0|||
156693968|NCT02177136|565625636|FG003|LTSE Phase|Adverse Event|10|||
156693969|NCT02177136|565625633|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
156693970|NCT02177136|565625634|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
156693971|NCT02177136|565625635|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
156693972|NCT02177136|565625636|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
156693973|NCT02177136|565625633|FG000|LTSE Phase|Physician Decision|0|||
156693974|NCT02177136|565625634|FG001|LTSE Phase|Physician Decision|0|||
156693975|NCT02177136|565625635|FG002|LTSE Phase|Physician Decision|0|||
156693976|NCT02177136|565625636|FG003|LTSE Phase|Physician Decision|2|||
156693977|NCT02177136|565625633|FG000|LTSE Phase|Lost to Follow-up|0|||
156693978|NCT02177136|565625634|FG001|LTSE Phase|Lost to Follow-up|0|||
156693979|NCT02177136|565625635|FG002|LTSE Phase|Lost to Follow-up|0|||
156693980|NCT02177136|565625636|FG003|LTSE Phase|Lost to Follow-up|1|||
156693981|NCT02177136|565625633|FG000|LTSE Phase|Participant Moved|0|||
156693982|NCT02177136|565625634|FG001|LTSE Phase|Participant Moved|0|||
156693983|NCT02177136|565625635|FG002|LTSE Phase|Participant Moved|0|||
156693984|NCT02177136|565625636|FG003|LTSE Phase|Participant Moved|1|||
156693985|NCT00094458|565625639|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
156693986|NCT00094458|565625640|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
156693987|NCT00094458|565625641|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
156693988|NCT00094458|565625642|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
156693989|NCT00094458|565625643|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
156693990|NCT00094458|565625644|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
156693991|NCT00094458|565625639|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
156693992|NCT00094458|565625640|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
156693993|NCT00094458|565625641|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
156693994|NCT00094458|565625642|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
156693995|NCT00094458|565625643|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
156693996|NCT00094458|565625644|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
156693997|NCT00094458|565625639|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
156693998|NCT00094458|565625640|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
156693999|NCT00094458|565625641|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
156694000|NCT00094458|565625642|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
156694001|NCT00094458|565625643|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
156694002|NCT00094458|565625644|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
156694003|NCT00094458|565625639|FG000|Main Study: Through Week 30|Adverse Event|38|||
156694004|NCT00094458|565625640|FG001|Main Study: Through Week 30|Adverse Event|20|||
156694005|NCT00094458|565625641|FG002|Main Study: Through Week 30|Adverse Event|28|||
156694006|NCT00094458|565625642|FG003|Main Study: Through Week 30|Adverse Event|0|||
156694007|NCT00094458|565625643|FG004|Main Study: Through Week 30|Adverse Event|0|||
156694008|NCT00094458|565625644|FG005|Main Study: Through Week 30|Adverse Event|0|||
156694009|NCT00094458|565625639|FG000|Main Study: Through Week 30|Death|1|||
156694010|NCT00094458|565625640|FG001|Main Study: Through Week 30|Death|0|||
156694011|NCT00094458|565625641|FG002|Main Study: Through Week 30|Death|0|||
156694012|NCT00094458|565625642|FG003|Main Study: Through Week 30|Death|0|||
156694013|NCT00094458|565625643|FG004|Main Study: Through Week 30|Death|0|||
156694014|NCT00094458|565625644|FG005|Main Study: Through Week 30|Death|0|||
156694015|NCT00094458|565625639|FG000|Main Study: Through Week 30|Other|19|||
156694016|NCT00094458|565625640|FG001|Main Study: Through Week 30|Other|16|||
156694017|NCT00094458|565625641|FG002|Main Study: Through Week 30|Other|9|||
156694018|NCT00094458|565625642|FG003|Main Study: Through Week 30|Other|0|||
156694019|NCT00094458|565625643|FG004|Main Study: Through Week 30|Other|0|||
156694020|NCT00094458|565625644|FG005|Main Study: Through Week 30|Other|0|||
156694021|NCT00094458|565625639|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
156694022|NCT00094458|565625640|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
156694023|NCT00094458|565625641|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
156694024|NCT00094458|565625642|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
156694025|NCT00094458|565625643|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
156694026|NCT00094458|565625644|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
156694027|NCT00094458|565625639|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
156870783|NCT00658359|566284276|FG001|Overall Study|Withdrawal by Subject|4|||
156694028|NCT00094458|565625640|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
156694029|NCT00094458|565625641|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
156694030|NCT00094458|565625642|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
156330776|NCT01686828|564310523|FG002|Overall Study|Weight Loss|1|||
156330777|NCT01686828|564310524|FG003|Overall Study|Weight Loss|0|||
156330778|NCT01736124|564310525|FG000|Post-intervention Assessment|Death|2|||
156330779|NCT01736124|564310526|FG001|Post-intervention Assessment|Death|2|||
156330780|NCT01736124|564310525|FG000|Post-intervention Assessment|lost computer access|1|||
156330781|NCT01736124|564310526|FG001|Post-intervention Assessment|lost computer access|1|||
156330782|NCT01736124|564310525|FG000|Post-intervention Assessment|Moved away|3|||
156330783|NCT01736124|564310526|FG001|Post-intervention Assessment|Moved away|1|||
156330784|NCT01736124|564310525|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
156330785|NCT01736124|564310526|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
156330786|NCT01736124|564310525|FG000|Post-intervention Assessment|Illness|3|||
156330787|NCT01736124|564310526|FG001|Post-intervention Assessment|Illness|2|||
156330788|NCT01736124|564310525|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
156330789|NCT01736124|564310526|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
156330790|NCT01736124|564310525|FG000|Post-intervention Assessment|Temporarily away|3|||
156330791|NCT01736124|564310526|FG001|Post-intervention Assessment|Temporarily away|1|||
156330792|NCT01736124|564310525|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
156330793|NCT01736124|564310526|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
156330794|NCT01736124|564310525|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
156330795|NCT01736124|564310526|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
156330796|NCT01736124|564310525|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
156330797|NCT01736124|564310526|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
156330798|NCT01736124|564310525|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
156330799|NCT01736124|564310526|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
156330800|NCT01736124|564310525|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
156330801|NCT01736124|564310526|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
156330802|NCT01736124|564310525|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
156330803|NCT01736124|564310526|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
156330804|NCT01736124|564310525|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
156330805|NCT01736124|564310526|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
156330806|NCT01736124|564310525|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
156330807|NCT01736124|564310526|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
156330808|NCT01736124|564310525|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
156330809|NCT01736124|564310526|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
156330810|NCT04176705|564310527|FG000|Overall Study|Withdrawal by Subject|4|||
156330811|NCT04176705|564310528|FG001|Overall Study|Withdrawal by Subject|4|||
156330812|NCT04176705|564310527|FG000|Overall Study|Death|1|||
156330813|NCT04176705|564310528|FG001|Overall Study|Death|1|||
156330814|NCT04176705|564310527|FG000|Overall Study|Lost to Follow-up|3|||
156330815|NCT04176705|564310528|FG001|Overall Study|Lost to Follow-up|3|||
156330816|NCT04026711|564310529|FG000|Overall Study|Withdrawal by Subject|1|||
156330817|NCT04026711|564310530|FG001|Overall Study|Withdrawal by Subject|0|||
156330818|NCT04026711|564310529|FG000|Overall Study|mental health crisis|1|||
156330819|NCT04026711|564310530|FG001|Overall Study|mental health crisis|0|||
156330820|NCT05741528|564310531|FG000|Overall Study|Withdrawal by Subject|11|||
156330821|NCT05741528|564310531|FG000|Overall Study|Lost to Follow-up|3|||
156330822|NCT05741528|564310531|FG000|Overall Study|Adverse Event|2|||
156330823|NCT05741528|564310531|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156330824|NCT05741528|564310531|FG000|Overall Study|Reason Not Specified|1|||
156694031|NCT00094458|565625643|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
156694032|NCT00094458|565625644|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
156694033|NCT00094458|565625639|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
156694034|NCT00094458|565625640|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
156870784|NCT00658359|566284277|FG002|Overall Study|Withdrawal by Subject|2|||
156870785|NCT00658359|566284275|FG000|Overall Study|Lost to Follow-up|2|||
156870786|NCT00658359|566284276|FG001|Overall Study|Lost to Follow-up|2|||
156870787|NCT00658359|566284277|FG002|Overall Study|Lost to Follow-up|4|||
156870788|NCT00658359|566284275|FG000|Overall Study|Lack of Efficacy|0|||
156870789|NCT00658359|566284276|FG001|Overall Study|Lack of Efficacy|1|||
156870790|NCT00658359|566284277|FG002|Overall Study|Lack of Efficacy|0|||
156870791|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Adverse Event|9|||
156870792|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Adverse Event|3|||
156870793|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Death|7|||
156870794|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Death|7|||
156330825|NCT04823650|564310532|FG000|Overall Study|Withdrawal by Subject|0|||
156330826|NCT04823650|564310533|FG001|Overall Study|Withdrawal by Subject|0|||
156330827|NCT04823650|564310534|FG002|Overall Study|Withdrawal by Subject|0|||
156330828|NCT04823650|564310535|FG003|Overall Study|Withdrawal by Subject|0|||
156870795|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
156870796|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
156870797|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Physician Decision|1|||
156438055|NCT03073941|564695343|FG001|Overall Study|Lost to Follow-up|4|||
156438056|NCT03073941|564695342|FG000|Overall Study|Adverse Event|4|||
156530688|NCT01717768|565038131|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156530689|NCT01717768|565038132|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
156330829|NCT04823650|564310536|FG004|Overall Study|Withdrawal by Subject|1|||
156330830|NCT04823650|564310537|FG005|Overall Study|Withdrawal by Subject|0|||
156330831|NCT03794583|564311863|FG000|Overall Study|Death|8|||
156330832|NCT03794583|564311863|FG000|Overall Study|Study Terminated by Sponsor|24|||
156330833|NCT03794583|564311863|FG000|Overall Study|Withdrawal by Subject|9|||
156330834|NCT02497612|564311864|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
156330835|NCT02497612|564311865|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
156330836|NCT02497612|564311866|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
156330837|NCT02497612|564311867|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
156330838|NCT02497612|564311864|FG000|Overall Study|Participant's request|2|||
156330839|NCT02497612|564311865|FG001|Overall Study|Participant's request|3|||
156330840|NCT02497612|564311866|FG002|Overall Study|Participant's request|4|||
156330841|NCT02497612|564311867|FG003|Overall Study|Participant's request|1|||
156330842|NCT02497612|564311864|FG000|Overall Study|Investigator's judgement|1|||
156330843|NCT02497612|564311865|FG001|Overall Study|Investigator's judgement|0|||
156330844|NCT02497612|564311866|FG002|Overall Study|Investigator's judgement|0|||
156330845|NCT02497612|564311867|FG003|Overall Study|Investigator's judgement|2|||
156330846|NCT02497612|564311864|FG000|Overall Study|Adverse Event|3|||
156330847|NCT02497612|564311865|FG001|Overall Study|Adverse Event|1|||
156330848|NCT02497612|564311866|FG002|Overall Study|Adverse Event|4|||
156330849|NCT02497612|564311867|FG003|Overall Study|Adverse Event|1|||
156330850|NCT02497612|564311864|FG000|Overall Study|Lost to Follow-up|1|||
156330851|NCT02497612|564311865|FG001|Overall Study|Lost to Follow-up|1|||
156330852|NCT02497612|564311866|FG002|Overall Study|Lost to Follow-up|0|||
156330853|NCT02497612|564311867|FG003|Overall Study|Lost to Follow-up|1|||
156330854|NCT02497612|564311864|FG000|Overall Study|Other unspecified|1|||
156330855|NCT02497612|564311865|FG001|Overall Study|Other unspecified|1|||
156330856|NCT02497612|564311866|FG002|Overall Study|Other unspecified|2|||
156330857|NCT02497612|564311867|FG003|Overall Study|Other unspecified|0|||
156330858|NCT02497612|564311864|FG000|Overall Study|Not eligible|1|||
156330859|NCT02497612|564311865|FG001|Overall Study|Not eligible|0|||
156330860|NCT02497612|564311866|FG002|Overall Study|Not eligible|0|||
156330861|NCT02497612|564311867|FG003|Overall Study|Not eligible|1|||
156330862|NCT00902668|564311868|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
156330863|NCT01914757|564311869|FG000|Overall Study|Severe non-compliance to protocol|3|||
156330864|NCT01914757|564311870|FG001|Overall Study|Severe non-compliance to protocol|1|||
156330865|NCT01914757|564311871|FG002|Overall Study|Severe non-compliance to protocol|2|||
156330866|NCT01914757|564311869|FG000|Overall Study|Lost to Follow-up|5|||
156330867|NCT01914757|564311870|FG001|Overall Study|Lost to Follow-up|8|||
156330868|NCT01914757|564311871|FG002|Overall Study|Lost to Follow-up|6|||
156330869|NCT01914757|564311869|FG000|Overall Study|Withdrawal by Subject|15|||
156330870|NCT01914757|564311870|FG001|Overall Study|Withdrawal by Subject|27|||
156330871|NCT01914757|564311871|FG002|Overall Study|Withdrawal by Subject|19|||
156330872|NCT01914757|564311869|FG000|Overall Study|Death|2|||
156530690|NCT01717768|565038133|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156530691|NCT01717768|565038134|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156530692|NCT01717768|565038135|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156530693|NCT01717768|565038136|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
156530694|NCT01717768|565038125|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156530695|NCT01717768|565038126|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156330873|NCT01914757|564311870|FG001|Overall Study|Death|2|||
156330874|NCT01914757|564311871|FG002|Overall Study|Death|1|||
156330875|NCT01914757|564311869|FG000|Overall Study|Adverse Event|4|||
156330876|NCT01914757|564311870|FG001|Overall Study|Adverse Event|3|||
156330877|NCT01914757|564311871|FG002|Overall Study|Adverse Event|4|||
156330878|NCT01914757|564311869|FG000|Overall Study|Study specific withdrawal criteria|0|||
156330879|NCT01914757|564311870|FG001|Overall Study|Study specific withdrawal criteria|1|||
156330880|NCT01914757|564311871|FG002|Overall Study|Study specific withdrawal criteria|0|||
156330881|NCT01914757|564311869|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156330882|NCT01914757|564311870|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156330883|NCT01914757|564311871|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
156330884|NCT01914757|564311869|FG000|Overall Study|Other reasons|5|||
156330885|NCT01914757|564311870|FG001|Overall Study|Other reasons|9|||
156330886|NCT01914757|564311871|FG002|Overall Study|Other reasons|4|||
156330887|NCT02083081|564311883|FG000|Overall Study|Lost to Follow-up|31|||
156330888|NCT02083081|564311884|FG001|Overall Study|Lost to Follow-up|9|||
156330889|NCT01230710|564311889|FG000|Overall Study|Disease Progression|41|||
156330890|NCT01230710|564311889|FG000|Overall Study|Lost to Follow-up|3|||
156330891|NCT01230710|564311889|FG000|Overall Study|Death|4|||
156330892|NCT01230710|564311889|FG000|Overall Study|Withdrawal of Consent|1|||
156330893|NCT02853344|564311891|FG000|Overall Study|Lost to Follow-up|1|||
156330894|NCT02853344|564311892|FG001|Overall Study|Lost to Follow-up|1|||
156330895|NCT02853344|564311891|FG000|Overall Study|Withdrawal by Subject|2|||
156694035|NCT00094458|565625641|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
156694036|NCT00094458|565625642|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
156694037|NCT00094458|565625643|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
156694038|NCT00094458|565625644|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
156694039|NCT00094458|565625639|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
156694040|NCT00094458|565625640|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
156694041|NCT00094458|565625641|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
156694042|NCT00094458|565625642|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
156694043|NCT00094458|565625643|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
156694044|NCT00094458|565625644|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
156694045|NCT00094458|565625639|FG000|OLE: Open-Label Extension|Adverse Event|0|||
156694046|NCT00094458|565625640|FG001|OLE: Open-Label Extension|Adverse Event|0|||
156694047|NCT00094458|565625641|FG002|OLE: Open-Label Extension|Adverse Event|0|||
156694048|NCT00094458|565625642|FG003|OLE: Open-Label Extension|Adverse Event|0|||
156694049|NCT00094458|565625643|FG004|OLE: Open-Label Extension|Adverse Event|3|||
156694050|NCT00094458|565625644|FG005|OLE: Open-Label Extension|Adverse Event|4|||
156694051|NCT00094458|565625639|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
156694052|NCT00094458|565625640|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
156694053|NCT00094458|565625641|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
156694054|NCT00094458|565625642|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
156694055|NCT00094458|565625643|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
156694056|NCT00094458|565625644|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
156694057|NCT00094458|565625639|FG000|OLE: Open-Label Extension|Patient decision|0|||
156694058|NCT00094458|565625640|FG001|OLE: Open-Label Extension|Patient decision|0|||
156438057|NCT03073941|564695343|FG001|Overall Study|Adverse Event|2|||
156438058|NCT03073941|564695342|FG000|Overall Study|Met an exclusion criterion|0|||
156438059|NCT03073941|564695343|FG001|Overall Study|Met an exclusion criterion|1|||
156438060|NCT04250883|564695344|FG000|Overall Study|Lost to Follow-up|1|||
156438061|NCT04250883|564695345|FG001|Overall Study|Lost to Follow-up|0|||
156438062|NCT03936660|564695347|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
156438063|NCT03936660|564695348|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
156694059|NCT00094458|565625641|FG002|OLE: Open-Label Extension|Patient decision|0|||
156694060|NCT00094458|565625642|FG003|OLE: Open-Label Extension|Patient decision|0|||
156694061|NCT00094458|565625643|FG004|OLE: Open-Label Extension|Patient decision|1|||
156694062|NCT00094458|565625644|FG005|OLE: Open-Label Extension|Patient decision|0|||
156694063|NCT00619112|565625651|FG000|Overall Study|Adverse Event|1|||
156694064|NCT00619112|565625652|FG001|Overall Study|Adverse Event|2|||
156694065|NCT00729248|565625653|FG000|Overall Study|Physician Decision|2|||
156694066|NCT03573505|565625656|FG000|Overall Study|Adverse Event|1|||
156694067|NCT03573505|565625657|FG001|Overall Study|Adverse Event|1|||
156694068|NCT03573505|565625656|FG000|Overall Study|Consent withdrawn|0|||
156694069|NCT03573505|565625657|FG001|Overall Study|Consent withdrawn|1|||
156694070|NCT03573505|565625656|FG000|Overall Study|Disease progression|0|||
156694071|NCT03573505|565625657|FG001|Overall Study|Disease progression|1|||
156694072|NCT03573505|565625656|FG000|Overall Study|Site Terminated by Sponsor|1|||
156694073|NCT03573505|565625657|FG001|Overall Study|Site Terminated by Sponsor|1|||
156694074|NCT03573505|565625656|FG000|Overall Study|Study terminated by sponsor|50|||
156694075|NCT03573505|565625657|FG001|Overall Study|Study terminated by sponsor|45|||
156694076|NCT03573505|565625656|FG000|Overall Study|Reason not specified|0|||
156694077|NCT03573505|565625657|FG001|Overall Study|Reason not specified|1|||
156694078|NCT03573505|565625656|FG000|Overall Study|Death|0|||
156694079|NCT03573505|565625657|FG001|Overall Study|Death|4|||
156694080|NCT00652028|565625660|FG000|Overall Study|Adverse Event|1|||
156694081|NCT00652028|565625661|FG001|Overall Study|Adverse Event|0|||
156694082|NCT00652028|565625662|FG002|Overall Study|Adverse Event|0|||
156694083|NCT00652028|565625663|FG003|Overall Study|Adverse Event|0|||
156694084|NCT00652028|565625660|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
156694085|NCT00652028|565625661|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
156694086|NCT00652028|565625662|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
156694087|NCT00652028|565625663|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
156694088|NCT00652028|565625660|FG000|Overall Study|Physician Decision|0|||
156694089|NCT00652028|565625661|FG001|Overall Study|Physician Decision|0|||
156694090|NCT00652028|565625662|FG002|Overall Study|Physician Decision|1|||
156694091|NCT00652028|565625663|FG003|Overall Study|Physician Decision|0|||
156694092|NCT03835325|565625665|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
156694093|NCT03835325|565625665|FG000|Overall Study|Selection failure|1|||
156789243|NCT00286455|565979221|FG001|Overall Study|Participant Non-compliance|0|||
156789244|NCT00286455|565979222|FG002|Overall Study|Participant Non-compliance|0|||
156789245|NCT00286455|565979220|FG000|Overall Study|Withdrawal by Subject|0|||
156438064|NCT01391832|564695349|FG000|Overall Study|Withdrawal by Subject|21|||
156789246|NCT00286455|565979221|FG001|Overall Study|Withdrawal by Subject|8|||
156694094|NCT02787408|565625666|FG000|Overall Study|Death|16|||
156694095|NCT02787408|565625666|FG000|Overall Study|Withdrawal by Subject|1|||
156789247|NCT00286455|565979222|FG002|Overall Study|Withdrawal by Subject|7|||
156694096|NCT02787408|565625666|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
156694097|NCT03395639|565625669|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
156694098|NCT03395639|565625670|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
156694099|NCT03395639|565625671|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
156694100|NCT03395639|565625669|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
156694101|NCT03395639|565625670|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
156694102|NCT03395639|565625671|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
156694103|NCT03395639|565625669|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
156694104|NCT03395639|565625670|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
156694105|NCT03395639|565625671|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
156694106|NCT03395639|565625669|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
156694107|NCT03395639|565625670|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
156694108|NCT03395639|565625671|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
156694109|NCT03395639|565625669|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
156694110|NCT03395639|565625670|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
156694111|NCT03395639|565625671|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
156694112|NCT00942331|565625672|FG000|Overall Study|Did not start treatment|15|||
156694113|NCT00942331|565625673|FG001|Overall Study|Did not start treatment|22|||
156694114|NCT00567476|565625675|FG000|Overall Study|Adverse Event|2|||
156694115|NCT00567476|565625676|FG001|Overall Study|Adverse Event|0|||
156694116|NCT00567476|565625675|FG000|Overall Study|Pregnancy|1|||
156694117|NCT00567476|565625676|FG001|Overall Study|Pregnancy|0|||
156694118|NCT00567476|565625675|FG000|Overall Study|Protocol Violation|4|||
156694119|NCT00567476|565625676|FG001|Overall Study|Protocol Violation|1|||
156694120|NCT00567476|565625675|FG000|Overall Study|Lost to Follow-up|0|||
156694121|NCT00567476|565625676|FG001|Overall Study|Lost to Follow-up|1|||
156694122|NCT00567476|565625675|FG000|Overall Study|Administrative issues|1|||
156694123|NCT00567476|565625676|FG001|Overall Study|Administrative issues|0|||
156694124|NCT00567476|565625675|FG000|Overall Study|Medical Decision|0|||
156694125|NCT00567476|565625676|FG001|Overall Study|Medical Decision|1|||
156694126|NCT00567476|565625675|FG000|Overall Study|Non-adherence to protocol|0|||
156694127|NCT00567476|565625676|FG001|Overall Study|Non-adherence to protocol|1|||
156694128|NCT00995085|565625677|FG000|Overall Study|Withdrawal by Subject|5|||
156694129|NCT01194973|565625681|FG000|Screening Period|Screen Failure|3|||
156694130|NCT01194973|565625681|FG000|26 Week Treatment Period|Adverse Event|1|||
156694131|NCT01194973|565625681|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
156694132|NCT01194973|565625681|FG000|26 Week Treatment Period|Pregnancy|1|||
156694133|NCT00757848|565625684|FG000|Overall Study|Voluntary discontinuation|1|||
156694134|NCT00757848|565625685|FG001|Overall Study|Voluntary discontinuation|0|||
156694135|NCT00757848|565625684|FG000|Overall Study|Adverse Event|1|||
156694136|NCT00757848|565625685|FG001|Overall Study|Adverse Event|2|||
156694137|NCT00757848|565625684|FG000|Overall Study|Incorrect enrolment|1|||
156694138|NCT00757848|565625685|FG001|Overall Study|Incorrect enrolment|0|||
156694139|NCT01338987|565625686|FG000|Overall Study|enrolled on new protocol|0|||
156694140|NCT01338987|565625687|FG001|Overall Study|enrolled on new protocol|0|||
156694141|NCT01338987|565625688|FG002|Overall Study|enrolled on new protocol|1|||
156694142|NCT01338987|565625689|FG003|Overall Study|enrolled on new protocol|0|||
156694143|NCT01338987|565625690|FG004|Overall Study|enrolled on new protocol|0|||
156694144|NCT01338987|565625686|FG000|Overall Study|Disease progression on study|2|||
156694145|NCT01338987|565625687|FG001|Overall Study|Disease progression on study|1|||
156694146|NCT01338987|565625688|FG002|Overall Study|Disease progression on study|1|||
156694147|NCT01338987|565625689|FG003|Overall Study|Disease progression on study|0|||
156694148|NCT01338987|565625690|FG004|Overall Study|Disease progression on study|0|||
156694149|NCT03856593|565625698|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
156694150|NCT03856593|565625699|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
156694151|NCT01901874|565625703|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
156694152|NCT01901874|565625703|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
156694153|NCT01901874|565625703|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
156694154|NCT01901874|565625703|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
156694155|NCT01901874|565625703|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
156694156|NCT01901874|565625703|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
156694157|NCT02595008|565625704|FG000|Overall Study|Enrolled In Error|1|||
156694158|NCT02595008|565625705|FG001|Overall Study|Enrolled In Error|0|||
156694159|NCT03407118|565625706|FG000|Period 2|Withdrawal by Subject|1|||
156694160|NCT03407118|565625707|FG001|Period 2|Withdrawal by Subject|0|||
156694161|NCT03977701|565625720|FG000|Overall Study|COVID-19 pandemic|0|||
156870798|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Physician Decision|0|||
156870799|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
156694162|NCT03977701|565625721|FG001|Overall Study|COVID-19 pandemic|0|||
156694163|NCT03977701|565625722|FG002|Overall Study|COVID-19 pandemic|0|||
156330896|NCT02853344|564311892|FG001|Overall Study|Withdrawal by Subject|4|||
156330897|NCT02853344|564311891|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
156330898|NCT02853344|564311892|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
156330899|NCT02853344|564311891|FG000|Overall Study|Death|70|||
156330900|NCT02853344|564311892|FG001|Overall Study|Death|112|||
156330901|NCT00299182|564311893|FG000|Overall Study|Withdrawal by Subject|0|||
156330902|NCT00299182|564311894|FG001|Overall Study|Withdrawal by Subject|0|||
156330903|NCT00299182|564311895|FG002|Overall Study|Withdrawal by Subject|1|||
156330904|NCT00299182|564311896|FG003|Overall Study|Withdrawal by Subject|0|||
156330905|NCT00299182|564311897|FG004|Overall Study|Withdrawal by Subject|1|||
156330906|NCT00299182|564311898|FG005|Overall Study|Withdrawal by Subject|2|||
156330907|NCT00299182|564311899|FG006|Overall Study|Withdrawal by Subject|0|||
156330908|NCT00299182|564311893|FG000|Overall Study|Chemotherapy Changed|0|||
156330909|NCT00299182|564311894|FG001|Overall Study|Chemotherapy Changed|0|||
156330910|NCT00299182|564311895|FG002|Overall Study|Chemotherapy Changed|1|||
156330911|NCT00299182|564311896|FG003|Overall Study|Chemotherapy Changed|0|||
156330912|NCT00299182|564311897|FG004|Overall Study|Chemotherapy Changed|1|||
156330913|NCT00299182|564311898|FG005|Overall Study|Chemotherapy Changed|0|||
156694164|NCT03977701|565625723|FG003|Overall Study|COVID-19 pandemic|0|||
156694165|NCT03977701|565625724|FG004|Overall Study|COVID-19 pandemic|0|||
156694166|NCT03977701|565625725|FG005|Overall Study|COVID-19 pandemic|1|||
156694167|NCT03977701|565625726|FG006|Overall Study|COVID-19 pandemic|0|||
156694168|NCT03977701|565625727|FG007|Overall Study|COVID-19 pandemic|1|||
156694169|NCT03977701|565625728|FG008|Overall Study|COVID-19 pandemic|0|||
156694170|NCT03977701|565625729|FG009|Overall Study|COVID-19 pandemic|0|||
156694171|NCT02340221|565625734|FG000|Overall Study|Death|100|||
156694172|NCT02340221|565625735|FG001|Overall Study|Death|197|||
156694173|NCT02340221|565625734|FG000|Overall Study|Withdrawal by Participant|24|||
156694174|NCT02340221|565625735|FG001|Overall Study|Withdrawal by Participant|37|||
156694175|NCT02340221|565625734|FG000|Overall Study|Lost to Follow-up|4|||
156694176|NCT02340221|565625735|FG001|Overall Study|Lost to Follow-up|15|||
156694177|NCT02340221|565625734|FG000|Overall Study|Reason Not Specified|85|||
156694178|NCT02340221|565625735|FG001|Overall Study|Reason Not Specified|165|||
156694179|NCT02340221|565625734|FG000|Overall Study|Study Terminated by Sponsor|1|||
156694180|NCT02340221|565625735|FG001|Overall Study|Study Terminated by Sponsor|3|||
156694181|NCT01583218|565625736|FG000|Overall Study|Withdrawal by Subject|43|||
156694182|NCT01583218|565625737|FG001|Overall Study|Withdrawal by Subject|29|||
156694183|NCT01583218|565625736|FG000|Overall Study|Death|206|||
156694184|NCT01583218|565625737|FG001|Overall Study|Death|211|||
156694185|NCT01583218|565625736|FG000|Overall Study|Lost to Follow-up|11|||
156694186|NCT01583218|565625737|FG001|Overall Study|Lost to Follow-up|17|||
156694187|NCT01583218|565625736|FG000|Overall Study|Adverse event or serious adverse event|3|||
156694188|NCT01583218|565625737|FG001|Overall Study|Adverse event or serious adverse event|3|||
156694189|NCT01583218|565625736|FG000|Overall Study|Patient /Family decision|3|||
156694190|NCT01583218|565625737|FG001|Overall Study|Patient /Family decision|0|||
156694191|NCT01583218|565625736|FG000|Overall Study|Cannot contact patient directly|1|||
156694192|NCT01583218|565625737|FG001|Overall Study|Cannot contact patient directly|2|||
156694193|NCT01583218|565625736|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
156694194|NCT01583218|565625737|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
156694195|NCT01583218|565625736|FG000|Overall Study|Patient did not wish to attend visits|0|||
156694196|NCT01583218|565625737|FG001|Overall Study|Patient did not wish to attend visits|1|||
156694197|NCT01583218|565625736|FG000|Overall Study|Patient randomized but not dosed|17|||
156694198|NCT01583218|565625737|FG001|Overall Study|Patient randomized but not dosed|16|||
156694199|NCT01583218|565625736|FG000|Overall Study|Patient was assessed via phone in person|1|||
156694200|NCT01583218|565625737|FG001|Overall Study|Patient was assessed via phone in person|0|||
156694201|NCT01583218|565625736|FG000|Overall Study|Patient deemed ineligible after random|2|||
156694202|NCT01583218|565625737|FG001|Overall Study|Patient deemed ineligible after random|0|||
156694203|NCT01583218|565625736|FG000|Overall Study|Patient was early terminated from study|0|||
156694204|NCT01583218|565625737|FG001|Overall Study|Patient was early terminated from study|1|||
156694205|NCT01583218|565625736|FG000|Overall Study|Patient was randomized due to mistake|1|||
156694206|NCT01583218|565625737|FG001|Overall Study|Patient was randomized due to mistake|0|||
156694207|NCT01583218|565625736|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
156694208|NCT01583218|565625737|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
156870800|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
156330914|NCT00299182|564311899|FG006|Overall Study|Chemotherapy Changed|1|||
156330915|NCT00299182|564311893|FG000|Overall Study|Adverse Event|0|||
156330916|NCT00299182|564311894|FG001|Overall Study|Adverse Event|0|||
156330917|NCT00299182|564311895|FG002|Overall Study|Adverse Event|0|||
156330918|NCT00299182|564311896|FG003|Overall Study|Adverse Event|0|||
156330919|NCT00299182|564311897|FG004|Overall Study|Adverse Event|0|||
156330920|NCT00299182|564311898|FG005|Overall Study|Adverse Event|1|||
156694209|NCT01583218|565625736|FG000|Overall Study|Withdraw of consent on day of random|1|||
156694210|NCT01583218|565625737|FG001|Overall Study|Withdraw of consent on day of random|0|||
156694211|NCT00952276|565625740|FG000|Overall Study|Withdrawal by Subject|1|||
156694212|NCT00952276|565625741|FG001|Overall Study|Withdrawal by Subject|0|||
156694213|NCT00952276|565625742|FG002|Overall Study|Withdrawal by Subject|0|||
156694214|NCT00952276|565625743|FG003|Overall Study|Withdrawal by Subject|1|||
156694215|NCT00952276|565625744|FG004|Overall Study|Withdrawal by Subject|0|||
156694216|NCT00003138|565627684|FG000|Step 1|Reasons off treatment not documented|60|||
156694217|NCT00003138|565627685|FG001|Step 1|Reasons off treatment not documented|57|||
156694218|NCT00003138|565627684|FG000|Step 1|Never started treatment|1|||
156694219|NCT00003138|565627685|FG001|Step 1|Never started treatment|0|||
156694220|NCT00003138|565627684|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
156694221|NCT00003138|565627685|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
156694222|NCT00003138|565627684|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
156694223|NCT00003138|565627685|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
156694224|NCT00003138|565627684|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
156694225|NCT00003138|565627685|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
156694226|NCT00003138|565627684|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
156694227|NCT00003138|565627685|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
156694228|NCT03340064|565627686|FG000|First Period|Adverse Event, non-fatal|2|||
156694229|NCT03340064|565627687|FG001|First Period|Adverse Event, non-fatal|0|||
156694230|NCT03340064|565627686|FG000|First Period|Lack of Efficacy|3|||
156694231|NCT03340064|565627687|FG001|First Period|Lack of Efficacy|0|||
156694232|NCT03340064|565627686|FG000|Second Period|Adverse Event, non-fatal|1|||
156694233|NCT03340064|565627687|FG001|Second Period|Adverse Event, non-fatal|1|||
156694234|NCT03340064|565627686|FG000|Second Period|Lack of Efficacy|11|||
156694235|NCT03340064|565627687|FG001|Second Period|Lack of Efficacy|0|||
156438065|NCT01391832|564695350|FG001|Overall Study|Withdrawal by Subject|22|||
156438066|NCT01391832|564695349|FG000|Overall Study|Lost to Follow-up|0|||
156438067|NCT01391832|564695350|FG001|Overall Study|Lost to Follow-up|1|||
156438068|NCT00722046|564695353|FG000|Overall Study|Adverse Event|0|||
156438069|NCT00722046|564695354|FG001|Overall Study|Adverse Event|1|||
156438070|NCT00722046|564695355|FG002|Overall Study|Adverse Event|2|||
156438071|NCT00722046|564695356|FG003|Overall Study|Adverse Event|1|||
156438072|NCT00722046|564695357|FG004|Overall Study|Adverse Event|2|||
156438073|NCT00722046|564695358|FG005|Overall Study|Adverse Event|1|||
156438074|NCT00722046|564695359|FG006|Overall Study|Adverse Event|0|||
156438075|NCT00722046|564695353|FG000|Overall Study|Death|0|||
156438076|NCT00722046|564695354|FG001|Overall Study|Death|1|||
156438077|NCT00722046|564695355|FG002|Overall Study|Death|0|||
156438078|NCT00722046|564695356|FG003|Overall Study|Death|0|||
156438079|NCT00722046|564695357|FG004|Overall Study|Death|0|||
156438080|NCT00722046|564695358|FG005|Overall Study|Death|0|||
156694236|NCT03340064|565627686|FG000|Second Period|Physician Decision|3|||
156694237|NCT03340064|565627687|FG001|Second Period|Physician Decision|0|||
156694238|NCT03340064|565627686|FG000|Second Period|Withdrawal by Subject|2|||
156694239|NCT03340064|565627687|FG001|Second Period|Withdrawal by Subject|1|||
156789248|NCT00394472|565981202|FG000|Overall Study|Protocol Violation|1|||
156789249|NCT00394472|565981203|FG001|Overall Study|Protocol Violation|3|||
156789250|NCT00394472|565981202|FG000|Overall Study|incorrect enrolment|4|||
156438081|NCT00722046|564695359|FG006|Overall Study|Death|2|||
156438082|NCT00722046|564695353|FG000|Overall Study|Protocol Violation|1|||
156789251|NCT00394472|565981203|FG001|Overall Study|incorrect enrolment|2|||
156789252|NCT00394472|565981202|FG000|Overall Study|Adverse Event|4|||
156789253|NCT00394472|565981203|FG001|Overall Study|Adverse Event|2|||
156789254|NCT00394472|565981202|FG000|Overall Study|Withdrawal by Subject|0|||
156789255|NCT00394472|565981203|FG001|Overall Study|Withdrawal by Subject|2|||
156789256|NCT00394472|565981202|FG000|Overall Study|Physician Decision|0|||
156789257|NCT00394472|565981203|FG001|Overall Study|Physician Decision|1|||
156789258|NCT00394472|565981202|FG000|Overall Study|Lost to Follow-up|0|||
156789259|NCT00394472|565981203|FG001|Overall Study|Lost to Follow-up|1|||
156789260|NCT01654250|565981204|FG000|Overall Study|Lost to Follow-up|1|||
156789261|NCT01654250|565981205|FG001|Overall Study|Lost to Follow-up|0|||
156789262|NCT01013870|565981206|FG000|Overall Study|Lost to Follow-up|1|||
156789263|NCT01013870|565981207|FG001|Overall Study|Lost to Follow-up|3|||
156789264|NCT00862277|565981210|FG000|Overall Study|Protocol Violation|1|||
156789265|NCT00862277|565981211|FG001|Overall Study|Protocol Violation|2|||
156789266|NCT00862277|565981212|FG002|Overall Study|Protocol Violation|5|||
156789267|NCT02168439|565981213|FG000|Overall Study|Protocol Violation|0|||
156789268|NCT02168439|565981214|FG001|Overall Study|Protocol Violation|2|||
156789269|NCT02004275|565981215|FG000|Phase 1|Ineligible|0|||
156789270|NCT02004275|565981216|FG001|Phase 1|Ineligible|0|||
156789271|NCT02004275|565981217|FG002|Phase 1|Ineligible|0|||
156789272|NCT02004275|565981218|FG003|Phase 1|Ineligible|1|||
156789273|NCT02004275|565981219|FG004|Phase 1|Ineligible|1|||
156789274|NCT02004275|565981220|FG005|Phase 1|Ineligible|0|||
156789275|NCT02004275|565981215|FG000|Phase 1|Protocol Violation|0|||
156789276|NCT02004275|565981216|FG001|Phase 1|Protocol Violation|0|||
156789277|NCT02004275|565981217|FG002|Phase 1|Protocol Violation|0|||
156789278|NCT02004275|565981218|FG003|Phase 1|Protocol Violation|1|||
156694240|NCT03340064|565627686|FG000|Second Period|Approved Drug Available For Indication|1|||
156694241|NCT03340064|565627687|FG001|Second Period|Approved Drug Available For Indication|0|||
156694242|NCT03340064|565627686|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
156694243|NCT03340064|565627687|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
156694244|NCT01045421|565627688|FG000|Phase 1|Progressive Disease|0|||
156694245|NCT01045421|565627689|FG001|Phase 1|Progressive Disease|0|||
156694246|NCT01045421|565627690|FG002|Phase 1|Progressive Disease|0|||
156694247|NCT01045421|565627691|FG003|Phase 1|Progressive Disease|0|||
156694248|NCT01045421|565627692|FG004|Phase 1|Progressive Disease|1|||
156694249|NCT01045421|565627693|FG005|Phase 1|Progressive Disease|0|||
156694250|NCT01045421|565627694|FG006|Phase 1|Progressive Disease|0|||
156694251|NCT01045421|565627695|FG007|Phase 1|Progressive Disease|0|||
156694252|NCT01045421|565627696|FG008|Phase 1|Progressive Disease|0|||
156694253|NCT01045421|565627697|FG009|Phase 1|Progressive Disease|0|||
156694254|NCT01045421|565627698|FG010|Phase 1|Progressive Disease|0|||
156694255|NCT01045421|565627688|FG000|Phase 1|Withdrawal by Subject|0|||
156694256|NCT01045421|565627689|FG001|Phase 1|Withdrawal by Subject|0|||
156694257|NCT01045421|565627690|FG002|Phase 1|Withdrawal by Subject|0|||
156694258|NCT01045421|565627691|FG003|Phase 1|Withdrawal by Subject|1|||
156694259|NCT01045421|565627692|FG004|Phase 1|Withdrawal by Subject|0|||
156694260|NCT01045421|565627693|FG005|Phase 1|Withdrawal by Subject|0|||
156694261|NCT01045421|565627694|FG006|Phase 1|Withdrawal by Subject|0|||
156694262|NCT01045421|565627695|FG007|Phase 1|Withdrawal by Subject|0|||
156694263|NCT01045421|565627696|FG008|Phase 1|Withdrawal by Subject|0|||
156694264|NCT01045421|565627697|FG009|Phase 1|Withdrawal by Subject|0|||
156694265|NCT01045421|565627698|FG010|Phase 1|Withdrawal by Subject|0|||
156694266|NCT01045421|565627688|FG000|Phase 2|Progressive Disease|0|||
156694267|NCT01045421|565627689|FG001|Phase 2|Progressive Disease|0|||
156694268|NCT01045421|565627690|FG002|Phase 2|Progressive Disease|0|||
156694269|NCT01045421|565627691|FG003|Phase 2|Progressive Disease|0|||
156694270|NCT01045421|565627692|FG004|Phase 2|Progressive Disease|0|||
156694271|NCT01045421|565627693|FG005|Phase 2|Progressive Disease|0|||
156694272|NCT01045421|565627694|FG006|Phase 2|Progressive Disease|0|||
156694273|NCT01045421|565627695|FG007|Phase 2|Progressive Disease|1|||
156694274|NCT01045421|565627696|FG008|Phase 2|Progressive Disease|1|||
156694275|NCT01045421|565627697|FG009|Phase 2|Progressive Disease|1|||
156694276|NCT01045421|565627698|FG010|Phase 2|Progressive Disease|1|||
156694277|NCT01045421|565627688|FG000|Phase 2|Death|0|||
156694278|NCT01045421|565627689|FG001|Phase 2|Death|0|||
156694279|NCT01045421|565627690|FG002|Phase 2|Death|0|||
156694280|NCT01045421|565627691|FG003|Phase 2|Death|0|||
156694281|NCT01045421|565627692|FG004|Phase 2|Death|0|||
156694282|NCT01045421|565627693|FG005|Phase 2|Death|0|||
156694283|NCT01045421|565627694|FG006|Phase 2|Death|0|||
156694284|NCT01045421|565627695|FG007|Phase 2|Death|1|||
156694285|NCT01045421|565627696|FG008|Phase 2|Death|1|||
156694286|NCT01045421|565627697|FG009|Phase 2|Death|2|||
156694287|NCT01045421|565627698|FG010|Phase 2|Death|0|||
156694288|NCT01045421|565627688|FG000|Phase 2|Other|0|||
156694289|NCT01045421|565627689|FG001|Phase 2|Other|0|||
156694290|NCT01045421|565627690|FG002|Phase 2|Other|0|||
156694291|NCT01045421|565627691|FG003|Phase 2|Other|0|||
156694292|NCT01045421|565627692|FG004|Phase 2|Other|0|||
156694293|NCT01045421|565627693|FG005|Phase 2|Other|0|||
156694294|NCT01045421|565627694|FG006|Phase 2|Other|0|||
156694295|NCT01045421|565627695|FG007|Phase 2|Other|3|||
156694296|NCT01045421|565627696|FG008|Phase 2|Other|0|||
156694297|NCT01045421|565627697|FG009|Phase 2|Other|0|||
156694298|NCT01045421|565627698|FG010|Phase 2|Other|1|||
156694299|NCT02522403|565627699|FG000|Overall Study|Lost to Follow-up|2|||
156694300|NCT02522403|565627700|FG001|Overall Study|Lost to Follow-up|2|||
156789279|NCT02004275|565981219|FG004|Phase 1|Protocol Violation|0|||
156789280|NCT02004275|565981220|FG005|Phase 1|Protocol Violation|5|||
156694301|NCT02522403|565627699|FG000|Overall Study|Withdrawal by Subject|2|||
156789281|NCT02004275|565981215|FG000|Phase 2 Part 1|Ineligible|6|||
156694302|NCT02522403|565627700|FG001|Overall Study|Withdrawal by Subject|4|||
156694303|NCT05142566|565627701|FG000|Overall Study|Protocol Violation|1|||
156694304|NCT01553279|565627702|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
156694305|NCT01553279|565627703|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
156694306|NCT01553279|565627702|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
156694307|NCT01553279|565627703|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
156694308|NCT01553279|565627702|FG000|Interim Period|Withdrawal by Subject|2|||
156694309|NCT01553279|565627703|FG001|Interim Period|Withdrawal by Subject|2|||
156694310|NCT01553279|565627702|FG000|Interim Period|Lost to Follow-up|1|||
156694311|NCT01553279|565627703|FG001|Interim Period|Lost to Follow-up|0|||
156694312|NCT01553279|565627702|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
156694313|NCT01553279|565627703|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
156694314|NCT01553279|565627702|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
156694315|NCT01553279|565627703|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
156694316|NCT00605865|565627704|FG000|Overall Study|Protocol Violation|115|||
156694317|NCT01884311|565627709|FG000|Overall Study|Withdrawal by Subject|3|||
156789282|NCT02004275|565981216|FG001|Phase 2 Part 1|Ineligible|9|||
156694318|NCT01884311|565627709|FG000|Overall Study|withdrew consent due to AEs|1|||
156694319|NCT01884311|565627709|FG000|Overall Study|Precautionary measure|1|||
156694320|NCT01995266|565627710|FG000|Overall Study|Death|1|||
156694321|NCT01995266|565627710|FG000|Overall Study|Lack of Efficacy|6|||
156694322|NCT01995266|565627710|FG000|Overall Study|Adverse Event|2|||
156694323|NCT03247517|565627711|FG000|Overall Study|Adverse Event|0|||
156694324|NCT03247517|565627712|FG001|Overall Study|Adverse Event|4|||
156694325|NCT03247517|565627713|FG002|Overall Study|Adverse Event|2|||
156694326|NCT03247517|565627711|FG000|Overall Study|Lost to Follow-up|2|||
156694327|NCT03247517|565627712|FG001|Overall Study|Lost to Follow-up|6|||
156694328|NCT03247517|565627713|FG002|Overall Study|Lost to Follow-up|4|||
156694329|NCT03247517|565627711|FG000|Overall Study|Consent withdrawn by caregiver|1|||
156694330|NCT03247517|565627712|FG001|Overall Study|Consent withdrawn by caregiver|4|||
156694331|NCT03247517|565627713|FG002|Overall Study|Consent withdrawn by caregiver|7|||
156694332|NCT03247517|565627711|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
156694333|NCT03247517|565627712|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
156694334|NCT03247517|565627713|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
156694335|NCT03247517|565627711|FG000|Overall Study|Protocol Violation|0|||
156694336|NCT03247517|565627712|FG001|Overall Study|Protocol Violation|2|||
156694337|NCT03247517|565627713|FG002|Overall Study|Protocol Violation|0|||
156694338|NCT03247517|565627711|FG000|Overall Study|Multiple reasons|3|||
156694339|NCT03247517|565627712|FG001|Overall Study|Multiple reasons|1|||
156694340|NCT03247517|565627713|FG002|Overall Study|Multiple reasons|0|||
156694341|NCT03310411|565627714|FG000|Period 1|Adverse Event|0|||
156694342|NCT03310411|565627715|FG001|Period 1|Adverse Event|0|||
156694343|NCT03310411|565627716|FG002|Period 1|Adverse Event|0|||
156694344|NCT03310411|565627717|FG003|Period 1|Adverse Event|1|||
156694345|NCT02751359|565627718|FG000|Overall Study|Lost to Follow-up|1|||
156694346|NCT02400671|565627719|FG000|Overall Study|Death|5|||
156694347|NCT02400671|565627720|FG001|Overall Study|Death|3|||
156694348|NCT02400671|565627721|FG002|Overall Study|Death|4|||
156694349|NCT02400671|565627719|FG000|Overall Study|Lost to Follow-up|20|||
156694350|NCT02400671|565627720|FG001|Overall Study|Lost to Follow-up|27|||
156694351|NCT02400671|565627721|FG002|Overall Study|Lost to Follow-up|24|||
156694352|NCT02400671|565627719|FG000|Overall Study|Withdrawal by Subject|2|||
156694353|NCT02400671|565627720|FG001|Overall Study|Withdrawal by Subject|2|||
156694354|NCT02400671|565627721|FG002|Overall Study|Withdrawal by Subject|0|||
156694355|NCT02145026|565627725|FG000|Overall Study|Adverse Event|2|||
156694356|NCT02145026|565627725|FG000|Overall Study|Death|4|||
156694357|NCT02145026|565627725|FG000|Overall Study|Withdrawal by Subject|2|||
156694358|NCT02145026|565627725|FG000|Overall Study|Physician Decision|4|||
156694359|NCT00127036|565627726|FG000|Overall Study|Insufficient Data for Analysis|6|||
156694360|NCT00127036|565627727|FG001|Overall Study|Insufficient Data for Analysis|11|||
156694361|NCT00127036|565627726|FG000|Overall Study|Screen Failure|2|||
156694362|NCT00127036|565627727|FG001|Overall Study|Screen Failure|0|||
156694363|NCT01797835|565627734|FG000|Overall Study|Lost to Follow-up|31|||
156694364|NCT01797835|565627735|FG001|Overall Study|Lost to Follow-up|27|||
156694365|NCT01403064|565627736|FG000|Overall Study|Death|0|||
156694366|NCT01403064|565627737|FG001|Overall Study|Death|0|||
156694367|NCT01403064|565627738|FG002|Overall Study|Death|1|||
156694368|NCT01403064|565627739|FG003|Overall Study|Death|1|||
156694369|NCT01403064|565627736|FG000|Overall Study|Withdrawal by Subject|0|||
156694370|NCT01403064|565627737|FG001|Overall Study|Withdrawal by Subject|0|||
156694371|NCT01403064|565627738|FG002|Overall Study|Withdrawal by Subject|1|||
156694372|NCT01403064|565627739|FG003|Overall Study|Withdrawal by Subject|1|||
156694373|NCT01403064|565627736|FG000|Overall Study|Other|1|||
156694374|NCT01403064|565627737|FG001|Overall Study|Other|0|||
156694375|NCT01403064|565627738|FG002|Overall Study|Other|2|||
156694376|NCT01403064|565627739|FG003|Overall Study|Other|1|||
156694377|NCT03052322|565627740|FG000|Overall Study|Other un-specified|1|||
156694378|NCT03052322|565627741|FG001|Overall Study|Other un-specified|2|||
156694379|NCT03052322|565627740|FG000|Overall Study|Withdrawal by Subject|10|||
156694380|NCT03052322|565627741|FG001|Overall Study|Withdrawal by Subject|9|||
156694381|NCT03052322|565627740|FG000|Overall Study|Death|0|||
156694382|NCT03052322|565627741|FG001|Overall Study|Death|2|||
156694383|NCT03052322|565627740|FG000|Overall Study|Lack of Efficacy|1|||
156694384|NCT03052322|565627741|FG001|Overall Study|Lack of Efficacy|2|||
156694385|NCT03052322|565627740|FG000|Overall Study|Protocol Violation|1|||
156694386|NCT03052322|565627741|FG001|Overall Study|Protocol Violation|0|||
156694387|NCT03052322|565627740|FG000|Overall Study|Lost to Follow-up|2|||
156694388|NCT03052322|565627741|FG001|Overall Study|Lost to Follow-up|4|||
156694389|NCT03052322|565627740|FG000|Overall Study|Adverse Event|6|||
156694390|NCT03052322|565627741|FG001|Overall Study|Adverse Event|13|||
156694391|NCT00973765|565627742|FG000|Overall Study|Lost to Follow-up|8|||
156694392|NCT00973765|565627743|FG001|Overall Study|Lost to Follow-up|14|||
156694393|NCT04920916|565627744|FG000|Phase IIa 60 Day Study|Death|2|||
156694394|NCT04920916|565627745|FG001|Phase IIa 60 Day Study|Death|5|||
156694395|NCT04920916|565627744|FG000|1 Year Follow up (Phone Call)|Death|1|||
156694396|NCT04920916|565627745|FG001|1 Year Follow up (Phone Call)|Death|3|||
156694397|NCT04920916|565627744|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
156870801|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
156870802|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
156870803|NCT02558296|566284278|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
156870804|NCT02558296|566284279|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
156870805|NCT02558296|566284278|FG000|Completed the Study|Adverse Event|14|||
156870806|NCT02558296|566284279|FG001|Completed the Study|Adverse Event|5|||
156870807|NCT02558296|566284278|FG000|Completed the Study|Death|39|||
156870808|NCT02558296|566284279|FG001|Completed the Study|Death|25|||
156438083|NCT00722046|564695354|FG001|Overall Study|Protocol Violation|0|||
156438084|NCT00722046|564695355|FG002|Overall Study|Protocol Violation|0|||
156870809|NCT02558296|566284278|FG000|Completed the Study|Lost to Follow-up|31|||
156870810|NCT02558296|566284279|FG001|Completed the Study|Lost to Follow-up|23|||
156870811|NCT02558296|566284278|FG000|Completed the Study|Physician Decision|6|||
156870812|NCT02558296|566284279|FG001|Completed the Study|Physician Decision|0|||
156870813|NCT02558296|566284278|FG000|Completed the Study|Protocol Violation|2|||
156870814|NCT02558296|566284279|FG001|Completed the Study|Protocol Violation|1|||
156870815|NCT02558296|566284278|FG000|Completed the Study|Withdrawal by Subject|53|||
156870816|NCT02558296|566284279|FG001|Completed the Study|Withdrawal by Subject|31|||
156870817|NCT02558296|566284278|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
156870818|NCT02558296|566284279|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
156870819|NCT02754440|566284280|FG000|Overall Study|Protocol Violation|3|||
156870820|NCT02754440|566284281|FG001|Overall Study|Protocol Violation|2|||
156870821|NCT02754440|566284282|FG002|Overall Study|Protocol Violation|2|||
156870822|NCT02754440|566284283|FG003|Overall Study|Protocol Violation|6|||
156870823|NCT02754440|566284280|FG000|Overall Study|Adverse Event|3|||
156694398|NCT04920916|565627745|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
156694399|NCT02011113|565627746|FG000|Overall Study|Adverse Event|4|||
156694400|NCT02011113|565627746|FG000|Overall Study|Disease Progression (DP)|16|||
156694401|NCT02011113|565627746|FG000|Overall Study|Death|1|||
156694402|NCT02011113|565627746|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
156694403|NCT02011113|565627746|FG000|Overall Study|Investigator's judgement- DP|3|||
156694404|NCT02011113|565627746|FG000|Overall Study|Study terminated by sponsor|11|||
156694405|NCT02669940|565627749|FG000|Overall Study|Failure to return|0|||
156694406|NCT02669940|565627750|FG001|Overall Study|Failure to return|3|||
156694407|NCT02669940|565627749|FG000|Overall Study|Insufficient follow-up data|1|||
156694408|NCT02669940|565627750|FG001|Overall Study|Insufficient follow-up data|0|||
156694409|NCT01892657|565627751|FG000|Overall Study|Withdrawal by Subject|6|||
156694410|NCT01892657|565627751|FG000|Overall Study|Protocol Violation|12|||
156694411|NCT05065983|565627760|FG000|Overall Study|Lost to Follow-up|2|||
156694412|NCT00986180|565627761|FG000|Overall Study|Adverse Event|21|||
156694413|NCT00986180|565627762|FG001|Overall Study|Adverse Event|23|||
156694414|NCT00986180|565627761|FG000|Overall Study|Lack of Efficacy|4|||
156694415|NCT00986180|565627762|FG001|Overall Study|Lack of Efficacy|3|||
156438085|NCT00722046|564695356|FG003|Overall Study|Protocol Violation|0|||
156438086|NCT00722046|564695357|FG004|Overall Study|Protocol Violation|0|||
156438087|NCT00722046|564695358|FG005|Overall Study|Protocol Violation|1|||
156438088|NCT00722046|564695359|FG006|Overall Study|Protocol Violation|0|||
156438089|NCT00722046|564695353|FG000|Overall Study|Withdrawal by Subject|3|||
156438090|NCT00722046|564695354|FG001|Overall Study|Withdrawal by Subject|3|||
156438091|NCT00722046|564695355|FG002|Overall Study|Withdrawal by Subject|4|||
156438092|NCT00722046|564695356|FG003|Overall Study|Withdrawal by Subject|4|||
156694416|NCT00986180|565627761|FG000|Overall Study|Lost to Follow-up|5|||
156694417|NCT00986180|565627762|FG001|Overall Study|Lost to Follow-up|7|||
156694418|NCT00986180|565627761|FG000|Overall Study|Physician Decision|1|||
156694419|NCT00986180|565627762|FG001|Overall Study|Physician Decision|3|||
156694420|NCT00986180|565627761|FG000|Overall Study|Protocol Violation|2|||
156694421|NCT00986180|565627762|FG001|Overall Study|Protocol Violation|0|||
156694422|NCT00986180|565627761|FG000|Overall Study|Withdrawal by Subject|1|||
156694423|NCT00986180|565627762|FG001|Overall Study|Withdrawal by Subject|9|||
156694424|NCT00986180|565627761|FG000|Overall Study|Miscellanies|10|||
156694425|NCT00986180|565627762|FG001|Overall Study|Miscellanies|11|||
156694426|NCT03251963|565627765|FG000|Overall Study|inappropriate Xa level timing|6|||
156694427|NCT03251963|565627766|FG001|Overall Study|inappropriate Xa level timing|3|||
156694428|NCT03251963|565627765|FG000|Overall Study|no peak Xa level drawn|2|||
156694429|NCT03251963|565627766|FG001|Overall Study|no peak Xa level drawn|0|||
156694430|NCT03251963|565627765|FG000|Overall Study|bled prior to Xa level|1|||
156694431|NCT03251963|565627766|FG001|Overall Study|bled prior to Xa level|2|||
156694432|NCT00003875|565627767|FG000|Overall Study|Screen Failed|1|||
156694433|NCT03127644|565627768|FG000|Overall Study|Study-specific withdrawal criteria|0|||
156694434|NCT03127644|565627769|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156694435|NCT03127644|565627770|FG002|Overall Study|Study-specific withdrawal criteria|2|||
156694436|NCT05070546|565627771|FG000|Overall Study|Death|0|||
156694437|NCT05070546|565627772|FG001|Overall Study|Death|0|||
156694438|NCT05070546|565627773|FG002|Overall Study|Death|0|||
156694439|NCT05070546|565627774|FG003|Overall Study|Death|0|||
156694440|NCT05070546|565627775|FG004|Overall Study|Death|0|||
156694441|NCT05070546|565627776|FG005|Overall Study|Death|1|||
156694442|NCT05070546|565627771|FG000|Overall Study|Lost to Follow-up|8|||
156694443|NCT05070546|565627772|FG001|Overall Study|Lost to Follow-up|2|||
156694444|NCT05070546|565627773|FG002|Overall Study|Lost to Follow-up|7|||
156694445|NCT05070546|565627774|FG003|Overall Study|Lost to Follow-up|1|||
156694446|NCT05070546|565627775|FG004|Overall Study|Lost to Follow-up|2|||
156694447|NCT05070546|565627776|FG005|Overall Study|Lost to Follow-up|0|||
156694448|NCT05070546|565627771|FG000|Overall Study|Withdrawal by Subject|1|||
156694449|NCT05070546|565627772|FG001|Overall Study|Withdrawal by Subject|1|||
156694450|NCT05070546|565627773|FG002|Overall Study|Withdrawal by Subject|3|||
156694451|NCT05070546|565627774|FG003|Overall Study|Withdrawal by Subject|0|||
156694452|NCT05070546|565627775|FG004|Overall Study|Withdrawal by Subject|0|||
156694453|NCT05070546|565627776|FG005|Overall Study|Withdrawal by Subject|0|||
156694454|NCT05070546|565627771|FG000|Overall Study|Other|0|||
156694455|NCT05070546|565627772|FG001|Overall Study|Other|0|||
156694456|NCT05070546|565627773|FG002|Overall Study|Other|0|||
156694457|NCT05070546|565627774|FG003|Overall Study|Other|0|||
156694458|NCT05070546|565627775|FG004|Overall Study|Other|3|||
156694459|NCT05070546|565627776|FG005|Overall Study|Other|0|||
156694460|NCT05070546|565627771|FG000|Overall Study|Randomized but not vaccinated|1|||
156694461|NCT05070546|565627772|FG001|Overall Study|Randomized but not vaccinated|0|||
156694462|NCT05070546|565627773|FG002|Overall Study|Randomized but not vaccinated|1|||
156694463|NCT05070546|565627774|FG003|Overall Study|Randomized but not vaccinated|1|||
156694464|NCT05070546|565627775|FG004|Overall Study|Randomized but not vaccinated|3|||
156694465|NCT05070546|565627776|FG005|Overall Study|Randomized but not vaccinated|0|||
156694466|NCT01370213|565627779|FG000|Overall Study|Early Death|1|||
156694467|NCT01370213|565627780|FG001|Overall Study|Early Death|0|||
156694468|NCT01370213|565627781|FG002|Overall Study|Early Death|0|||
156694469|NCT01370213|565627779|FG000|Overall Study|Not evaluable|0|||
156694470|NCT01370213|565627780|FG001|Overall Study|Not evaluable|2|||
156694471|NCT01370213|565627781|FG002|Overall Study|Not evaluable|0|||
156694472|NCT01550744|565627787|FG000|Open-Label|Lost to Follow-up|7|||
156694473|NCT01550744|565627788|FG001|Open-Label|Lost to Follow-up|0|||
156694474|NCT01550744|565627789|FG002|Open-Label|Lost to Follow-up|0|||
156694475|NCT01550744|565627787|FG000|Open-Label|Withdrawal by Subject|13|||
156694476|NCT01550744|565627788|FG001|Open-Label|Withdrawal by Subject|0|||
156694477|NCT01550744|565627789|FG002|Open-Label|Withdrawal by Subject|0|||
156694478|NCT01550744|565627787|FG000|Open-Label|Adverse Event|11|||
156694479|NCT01550744|565627788|FG001|Open-Label|Adverse Event|0|||
156694480|NCT01550744|565627789|FG002|Open-Label|Adverse Event|0|||
156694481|NCT01550744|565627787|FG000|Open-Label|Lack of Efficacy|4|||
156694482|NCT01550744|565627788|FG001|Open-Label|Lack of Efficacy|0|||
156694483|NCT01550744|565627789|FG002|Open-Label|Lack of Efficacy|0|||
156694484|NCT01550744|565627787|FG000|Open-Label|Protocol Violation|4|||
156694485|NCT01550744|565627788|FG001|Open-Label|Protocol Violation|0|||
156694486|NCT01550744|565627789|FG002|Open-Label|Protocol Violation|0|||
156694487|NCT01550744|565627787|FG000|Open-Label|Not all 3 study drug injections received|2|||
156694488|NCT01550744|565627788|FG001|Open-Label|Not all 3 study drug injections received|0|||
156694489|NCT01550744|565627789|FG002|Open-Label|Not all 3 study drug injections received|0|||
156694490|NCT01550744|565627787|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
156694491|NCT01550744|565627788|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
156694492|NCT01550744|565627789|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
156694493|NCT01550744|565627787|FG000|Open-Label|Other|1|||
156694494|NCT01550744|565627788|FG001|Open-Label|Other|0|||
156694495|NCT01550744|565627789|FG002|Open-Label|Other|0|||
156694496|NCT01550744|565627787|FG000|Double-Blind|Lost to Follow-up|0|||
156694497|NCT01550744|565627788|FG001|Double-Blind|Lost to Follow-up|6|||
156694498|NCT01550744|565627789|FG002|Double-Blind|Lost to Follow-up|12|||
156694499|NCT01550744|565627787|FG000|Double-Blind|Withdrawal by Subject|0|||
156694500|NCT01550744|565627788|FG001|Double-Blind|Withdrawal by Subject|2|||
156694501|NCT01550744|565627789|FG002|Double-Blind|Withdrawal by Subject|15|||
156694502|NCT01550744|565627787|FG000|Double-Blind|Adverse Event|0|||
156694503|NCT01550744|565627788|FG001|Double-Blind|Adverse Event|4|||
156694504|NCT01550744|565627789|FG002|Double-Blind|Adverse Event|15|||
156694505|NCT01550744|565627787|FG000|Double-Blind|Death|0|||
156694506|NCT01550744|565627788|FG001|Double-Blind|Death|1|||
156694507|NCT01550744|565627789|FG002|Double-Blind|Death|0|||
156694508|NCT01550744|565627787|FG000|Double-Blind|Lack of Efficacy|0|||
156694509|NCT01550744|565627788|FG001|Double-Blind|Lack of Efficacy|2|||
156694510|NCT01550744|565627789|FG002|Double-Blind|Lack of Efficacy|8|||
156694511|NCT01550744|565627787|FG000|Double-Blind|Protocol Violation|0|||
156694512|NCT01550744|565627788|FG001|Double-Blind|Protocol Violation|0|||
156694513|NCT01550744|565627789|FG002|Double-Blind|Protocol Violation|4|||
156694514|NCT01550744|565627787|FG000|Double-Blind|Pregnancy|0|||
156694515|NCT01550744|565627788|FG001|Double-Blind|Pregnancy|0|||
156694516|NCT01550744|565627789|FG002|Double-Blind|Pregnancy|3|||
156694517|NCT01550744|565627787|FG000|Double-Blind|Other|0|||
156694518|NCT01550744|565627788|FG001|Double-Blind|Other|2|||
156694519|NCT01550744|565627789|FG002|Double-Blind|Other|10|||
156694520|NCT00038649|565627791|FG000|Overall Study|Adverse Event|9|||
156694521|NCT03096847|565627792|FG000|Overall Study|Other|2|||
156694522|NCT03096847|565627793|FG001|Overall Study|Other|1|||
156694523|NCT03096847|565627794|FG002|Overall Study|Other|2|||
156694524|NCT03096847|565627792|FG000|Overall Study|Lost to Follow-up|1|||
156694525|NCT03096847|565627793|FG001|Overall Study|Lost to Follow-up|0|||
156694526|NCT03096847|565627794|FG002|Overall Study|Lost to Follow-up|1|||
156694527|NCT03096847|565627792|FG000|Overall Study|Death|6|||
156694528|NCT03096847|565627793|FG001|Overall Study|Death|0|||
156694529|NCT03096847|565627794|FG002|Overall Study|Death|2|||
156694530|NCT03096847|565627792|FG000|Overall Study|Protocol Violation|3|||
156694531|NCT03096847|565627793|FG001|Overall Study|Protocol Violation|0|||
156694532|NCT03096847|565627794|FG002|Overall Study|Protocol Violation|6|||
156694533|NCT03096847|565627792|FG000|Overall Study|Physician Decision|12|||
156694534|NCT03096847|565627793|FG001|Overall Study|Physician Decision|2|||
156694535|NCT03096847|565627794|FG002|Overall Study|Physician Decision|8|||
156694536|NCT03096847|565627792|FG000|Overall Study|Withdrawal by Subject|24|||
156694537|NCT03096847|565627793|FG001|Overall Study|Withdrawal by Subject|1|||
156694538|NCT03096847|565627794|FG002|Overall Study|Withdrawal by Subject|12|||
156694539|NCT03096847|565627792|FG000|Overall Study|Adverse Event|72|||
156694540|NCT03096847|565627793|FG001|Overall Study|Adverse Event|6|||
156694541|NCT03096847|565627794|FG002|Overall Study|Adverse Event|28|||
156694542|NCT03096847|565627792|FG000|Overall Study|Progressive disease|97|||
156694543|NCT03096847|565627793|FG001|Overall Study|Progressive disease|10|||
156694544|NCT03096847|565627794|FG002|Overall Study|Progressive disease|78|||
156694545|NCT03096847|565627792|FG000|Overall Study|Non-compliance with study medication|1|||
156694546|NCT03096847|565627793|FG001|Overall Study|Non-compliance with study medication|0|||
156694547|NCT03096847|565627794|FG002|Overall Study|Non-compliance with study medication|0|||
156694548|NCT03096847|565627792|FG000|Overall Study|New therapy for study indication|1|||
156694549|NCT03096847|565627793|FG001|Overall Study|New therapy for study indication|0|||
156694550|NCT03096847|565627794|FG002|Overall Study|New therapy for study indication|1|||
156694551|NCT00359632|565627795|FG000|Overall Study|Death|2|||
156694552|NCT00359632|565627796|FG001|Overall Study|Death|0|||
156694553|NCT00359632|565627795|FG000|Overall Study|Adverse Event|1|||
156694554|NCT00359632|565627796|FG001|Overall Study|Adverse Event|0|||
156694555|NCT00359632|565627795|FG000|Overall Study|Non-compliance with visit schedule|1|||
156694556|NCT00359632|565627796|FG001|Overall Study|Non-compliance with visit schedule|0|||
156694557|NCT03978091|565627797|FG000|Overall Study|Lost to Follow-up|0|||
156694558|NCT03978091|565627798|FG001|Overall Study|Lost to Follow-up|0|||
156694559|NCT03978091|565627799|FG002|Overall Study|Lost to Follow-up|1|||
156694560|NCT03978091|565627800|FG003|Overall Study|Lost to Follow-up|0|||
156694561|NCT03978091|565627801|FG004|Overall Study|Lost to Follow-up|0|||
156694562|NCT03978091|565627802|FG005|Overall Study|Lost to Follow-up|0|||
156694563|NCT03978091|565627797|FG000|Overall Study|Withdrawal by Subject|0|||
156694564|NCT03978091|565627798|FG001|Overall Study|Withdrawal by Subject|0|||
156694565|NCT03978091|565627799|FG002|Overall Study|Withdrawal by Subject|0|||
156694566|NCT03978091|565627800|FG003|Overall Study|Withdrawal by Subject|1|||
156694567|NCT03978091|565627801|FG004|Overall Study|Withdrawal by Subject|1|||
156694568|NCT03978091|565627802|FG005|Overall Study|Withdrawal by Subject|0|||
156694569|NCT01491035|565627820|FG000|Overall Study|Lost to Follow-up|0|||
156694570|NCT01491035|565627821|FG001|Overall Study|Lost to Follow-up|0|||
156694571|NCT01491035|565627822|FG002|Overall Study|Lost to Follow-up|0|||
156694572|NCT01491035|565627823|FG003|Overall Study|Lost to Follow-up|0|||
156694573|NCT01491035|565627824|FG004|Overall Study|Lost to Follow-up|1|||
156694574|NCT01491035|565627825|FG005|Overall Study|Lost to Follow-up|0|||
156694575|NCT01491035|565627826|FG006|Overall Study|Lost to Follow-up|0|||
156694576|NCT01491035|565627827|FG007|Overall Study|Lost to Follow-up|0|||
156694577|NCT02999477|565627828|FG000|Overall Study|found ineligible after first dose|0|||
156694578|NCT02999477|565627829|FG001|Overall Study|found ineligible after first dose|1|||
156694579|NCT02999477|565627828|FG000|Overall Study|Withdrawal by Subject|1|||
156694580|NCT02999477|565627829|FG001|Overall Study|Withdrawal by Subject|1|||
156694581|NCT01846273|565627830|FG000|Overall Study|Adverse Event|9|||
156694582|NCT01846273|565627831|FG001|Overall Study|Adverse Event|7|||
156694583|NCT01846273|565627832|FG002|Overall Study|Adverse Event|0|||
156694584|NCT01846273|565627830|FG000|Overall Study|Subject withdrew consent|5|||
156694585|NCT01846273|565627831|FG001|Overall Study|Subject withdrew consent|8|||
156694586|NCT01846273|565627832|FG002|Overall Study|Subject withdrew consent|0|||
156694587|NCT01846273|565627830|FG000|Overall Study|Lost to Follow-up|2|||
156694588|NCT01846273|565627831|FG001|Overall Study|Lost to Follow-up|1|||
156694589|NCT01846273|565627832|FG002|Overall Study|Lost to Follow-up|0|||
156694590|NCT01846273|565627830|FG000|Overall Study|Administrative problems|1|||
156694591|NCT01846273|565627831|FG001|Overall Study|Administrative problems|0|||
156694592|NCT01846273|565627832|FG002|Overall Study|Administrative problems|0|||
156694593|NCT01846273|565627830|FG000|Overall Study|Death|2|||
156694594|NCT01846273|565627831|FG001|Overall Study|Death|1|||
156694595|NCT01846273|565627832|FG002|Overall Study|Death|0|||
156694596|NCT01846273|565627830|FG000|Overall Study|Disease Progression|0|||
156694597|NCT01846273|565627831|FG001|Overall Study|Disease Progression|4|||
156694598|NCT01846273|565627832|FG002|Overall Study|Disease Progression|0|||
156694599|NCT01846273|565627830|FG000|Overall Study|Protocol Deviation|2|||
156694600|NCT01846273|565627831|FG001|Overall Study|Protocol Deviation|3|||
156694601|NCT01846273|565627832|FG002|Overall Study|Protocol Deviation|0|||
156694602|NCT01846273|565627830|FG000|Overall Study|Physician Decision|1|||
156694603|NCT01846273|565627831|FG001|Overall Study|Physician Decision|2|||
156694604|NCT01846273|565627832|FG002|Overall Study|Physician Decision|0|||
156694605|NCT00891839|565627833|FG000|Overall Study|Adverse Event|2|||
156694606|NCT00891839|565627833|FG000|Overall Study|Withdrawal by Subject|2|||
156694607|NCT00891839|565627833|FG000|Overall Study|Disease progression|3|||
156694608|NCT01641133|565627834|FG000|Overall Study|Protocol Violation|0|||
156694609|NCT01641133|565627835|FG001|Overall Study|Protocol Violation|1|||
156694610|NCT01641133|565627836|FG002|Overall Study|Protocol Violation|1|||
156694611|NCT01641133|565627834|FG000|Overall Study|Migrated/moved from study area|5|||
156694612|NCT01641133|565627835|FG001|Overall Study|Migrated/moved from study area|3|||
156789283|NCT02004275|565981217|FG002|Phase 2 Part 1|Ineligible|0|||
156789284|NCT02004275|565981218|FG003|Phase 2 Part 1|Ineligible|0|||
156789285|NCT02004275|565981219|FG004|Phase 2 Part 1|Ineligible|0|||
156789286|NCT02004275|565981220|FG005|Phase 2 Part 1|Ineligible|0|||
156789287|NCT02004275|565981215|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
156789288|NCT02004275|565981216|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
156789289|NCT02004275|565981217|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
156789290|NCT02004275|565981218|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
156789291|NCT02004275|565981219|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
156789292|NCT02004275|565981220|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
156789293|NCT04432298|565981221|FG000|Overall Study|Other than specified|1|||
156789294|NCT04432298|565981222|FG001|Overall Study|Other than specified|0|||
156789295|NCT04432298|565981221|FG000|Overall Study|Lost to Follow-up|0|||
156789296|NCT04432298|565981222|FG001|Overall Study|Lost to Follow-up|1|||
156789297|NCT04432298|565981221|FG000|Overall Study|Death|3|||
156789298|NCT04432298|565981222|FG001|Overall Study|Death|2|||
156789299|NCT04432298|565981221|FG000|Overall Study|Withdrawal by Subject|2|||
156789300|NCT04432298|565981222|FG001|Overall Study|Withdrawal by Subject|0|||
156789301|NCT00348374|565981223|FG000|Overall Study|Adverse Event|1|||
156789302|NCT00348374|565981224|FG001|Overall Study|Adverse Event|4|||
156789303|NCT00348374|565981223|FG000|Overall Study|Lost to Follow-up|1|||
156789304|NCT00348374|565981224|FG001|Overall Study|Lost to Follow-up|3|||
156789305|NCT00348374|565981223|FG000|Overall Study|Withdrawal by Subject|5|||
156789306|NCT00348374|565981224|FG001|Overall Study|Withdrawal by Subject|5|||
156789307|NCT00348374|565981223|FG000|Overall Study|Other|11|||
156789308|NCT00348374|565981224|FG001|Overall Study|Other|12|||
156789309|NCT00348374|565981223|FG000|Overall Study|ongoing at date of cutoff|1|||
156789310|NCT00348374|565981224|FG001|Overall Study|ongoing at date of cutoff|1|||
156789311|NCT00348374|565981223|FG000|Overall Study|randomized but did not receive treatment|0|||
156789312|NCT00348374|565981224|FG001|Overall Study|randomized but did not receive treatment|7|||
156789313|NCT00458705|565981228|FG000|Overall Study|Adverse Event|4|||
156789314|NCT00458705|565981228|FG000|Overall Study|Not Treated|1|||
156789315|NCT02180672|565981229|FG000|Overall Study|Lost to Follow-up|5|||
156789316|NCT02180672|565981230|FG001|Overall Study|Lost to Follow-up|7|||
156789317|NCT00378560|565981234|FG000|Overall Study|Adverse Event|1|||
156789318|NCT00378560|565981235|FG001|Overall Study|Adverse Event|0|||
156789319|NCT00378560|565981234|FG000|Overall Study|Lost to Follow-up|24|||
156789320|NCT00378560|565981235|FG001|Overall Study|Lost to Follow-up|29|||
156789321|NCT00378560|565981234|FG000|Overall Study|Protocol Violation|2|||
156789322|NCT00378560|565981235|FG001|Overall Study|Protocol Violation|0|||
156789323|NCT00378560|565981234|FG000|Overall Study|Withdrawal by Subject|17|||
156789324|NCT00378560|565981235|FG001|Overall Study|Withdrawal by Subject|21|||
156789325|NCT00378560|565981234|FG000|Overall Study|Moved|4|||
156789326|NCT00378560|565981235|FG001|Overall Study|Moved|3|||
156789327|NCT00378560|565981234|FG000|Overall Study|Pregnancy|7|||
156789328|NCT00378560|565981235|FG001|Overall Study|Pregnancy|5|||
156789329|NCT00378560|565981234|FG000|Overall Study|Laboratory test values abnormal|1|||
156789330|NCT00378560|565981235|FG001|Overall Study|Laboratory test values abnormal|0|||
156789331|NCT02070380|565981236|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
156789332|NCT02070380|565981237|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
156694613|NCT01641133|565627836|FG002|Overall Study|Migrated/moved from study area|1|||
156789333|NCT02070380|565981238|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
156789334|NCT02070380|565981239|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
156789335|NCT02070380|565981236|FG000|Second Injection|Image sets missing or technically inadeq|0|||
156789336|NCT02070380|565981237|FG001|Second Injection|Image sets missing or technically inadeq|1|||
156789337|NCT02070380|565981238|FG002|Second Injection|Image sets missing or technically inadeq|0|||
156789338|NCT02070380|565981239|FG003|Second Injection|Image sets missing or technically inadeq|0|||
156789339|NCT02070380|565981236|FG000|Second Injection|Protocol Violation|0|||
156694614|NCT01641133|565627834|FG000|Overall Study|Adverse Event|0|||
156694615|NCT01641133|565627835|FG001|Overall Study|Adverse Event|0|||
156789340|NCT02070380|565981237|FG001|Second Injection|Protocol Violation|1|||
156789341|NCT02070380|565981238|FG002|Second Injection|Protocol Violation|1|||
156789342|NCT02070380|565981239|FG003|Second Injection|Protocol Violation|5|||
156789343|NCT01682603|565981250|FG000|Overall Study|Lost to Follow-up|3|||
156789344|NCT01791205|565981251|FG000|Phase II|Lack of Efficacy|6|||
156789345|NCT01791205|565981252|FG001|Phase II|Lack of Efficacy|0|||
156789346|NCT01791205|565981251|FG000|Phase II|Adverse Event|2|||
156789347|NCT01791205|565981252|FG001|Phase II|Adverse Event|0|||
156789348|NCT01791205|565981251|FG000|Phase II|Safety|1|||
156789349|NCT01791205|565981252|FG001|Phase II|Safety|0|||
156789350|NCT01791205|565981251|FG000|Phase II|Lost to Follow-up|1|||
156789351|NCT01791205|565981252|FG001|Phase II|Lost to Follow-up|0|||
156789352|NCT01791205|565981251|FG000|Phase II|Remission of disease|1|||
156789353|NCT01791205|565981252|FG001|Phase II|Remission of disease|0|||
156789354|NCT01791205|565981251|FG000|Phase II|Physician's decision|1|||
156789355|NCT01791205|565981252|FG001|Phase II|Physician's decision|0|||
156789356|NCT01697501|565981254|FG000|Overall Study|Protocol Violation|2|||
156789357|NCT02242903|565981255|FG000|Overall Study|Withdrawal by Subject|1|||
156789358|NCT02242903|565981256|FG001|Overall Study|Withdrawal by Subject|0|||
156789359|NCT02242903|565981257|FG002|Overall Study|Withdrawal by Subject|0|||
156789360|NCT02242903|565981258|FG003|Overall Study|Withdrawal by Subject|0|||
156789361|NCT02242903|565981259|FG004|Overall Study|Withdrawal by Subject|0|||
156789362|NCT02242903|565981260|FG005|Overall Study|Withdrawal by Subject|0|||
156789363|NCT02242903|565981261|FG006|Overall Study|Withdrawal by Subject|0|||
156789364|NCT00779909|565981270|FG000|Overall Study|Lost to Follow-up|1|||
156789365|NCT00779909|565981271|FG001|Overall Study|Lost to Follow-up|0|||
156789366|NCT00779909|565981272|FG002|Overall Study|Lost to Follow-up|0|||
156789367|NCT00779909|565981273|FG003|Overall Study|Lost to Follow-up|1|||
156789368|NCT00779909|565981270|FG000|Overall Study|Withdrawal by Subject|0|||
156789369|NCT00779909|565981271|FG001|Overall Study|Withdrawal by Subject|1|||
156789370|NCT00779909|565981272|FG002|Overall Study|Withdrawal by Subject|0|||
156789371|NCT00779909|565981273|FG003|Overall Study|Withdrawal by Subject|0|||
156789372|NCT00337194|565981274|FG000|Overall Study|Adverse Event|5|||
156789373|NCT00337194|565981275|FG001|Overall Study|Adverse Event|1|||
156789374|NCT00337194|565981274|FG000|Overall Study|Death|2|||
156789375|NCT00337194|565981275|FG001|Overall Study|Death|0|||
156789376|NCT00337194|565981274|FG000|Overall Study|Withdrawal by Subject|1|||
156789377|NCT00337194|565981275|FG001|Overall Study|Withdrawal by Subject|0|||
156789378|NCT00337194|565981274|FG000|Overall Study|Disease progression|1|||
156789379|NCT00337194|565981275|FG001|Overall Study|Disease progression|2|||
156789380|NCT00337194|565981274|FG000|Overall Study|Subsequent non-protocol therapy|3|||
156789381|NCT00337194|565981275|FG001|Overall Study|Subsequent non-protocol therapy|1|||
156789382|NCT01896986|565981284|FG000|Overall Study|samples lost|14|||
156789383|NCT01896986|565981285|FG001|Overall Study|samples lost|23|||
156789384|NCT03757715|565981288|FG000|Overall Study|Lost to Follow-up|4|||
156789385|NCT03757715|565981289|FG001|Overall Study|Lost to Follow-up|9|||
156789386|NCT03757715|565981288|FG000|Overall Study|Withdrawal by Subject|1|||
156789387|NCT03757715|565981289|FG001|Overall Study|Withdrawal by Subject|1|||
156789388|NCT00281580|565981290|FG000|Overall Study|Adverse Event|2|||
156789389|NCT00281580|565981291|FG001|Overall Study|Adverse Event|0|||
156789390|NCT00281580|565981292|FG002|Overall Study|Adverse Event|2|||
156789391|NCT00281580|565981293|FG003|Overall Study|Adverse Event|4|||
156789392|NCT00281580|565981294|FG004|Overall Study|Adverse Event|1|||
156789393|NCT00281580|565981295|FG005|Overall Study|Adverse Event|0|||
156789394|NCT00281580|565981296|FG006|Overall Study|Adverse Event|1|||
156789395|NCT00281580|565981297|FG007|Overall Study|Adverse Event|0|||
156789396|NCT00281580|565981298|FG008|Overall Study|Adverse Event|1|||
156789397|NCT00281580|565981299|FG009|Overall Study|Adverse Event|6|||
156789398|NCT00281580|565981300|FG010|Overall Study|Adverse Event|0|||
156789399|NCT00281580|565981301|FG011|Overall Study|Adverse Event|5|||
156789400|NCT00281580|565981302|FG012|Overall Study|Adverse Event|8|||
156789401|NCT00281580|565981303|FG013|Overall Study|Adverse Event|2|||
156789402|NCT00281580|565981304|FG014|Overall Study|Adverse Event|3|||
156789403|NCT00281580|565981305|FG015|Overall Study|Adverse Event|3|||
156330921|NCT00299182|564311899|FG006|Overall Study|Adverse Event|0|||
156789404|NCT00281580|565981290|FG000|Overall Study|Protocol Violation|0|||
156789405|NCT00281580|565981291|FG001|Overall Study|Protocol Violation|0|||
156789406|NCT00281580|565981292|FG002|Overall Study|Protocol Violation|1|||
156870824|NCT02754440|566284281|FG001|Overall Study|Adverse Event|1|||
156330922|NCT00299182|564311893|FG000|Overall Study|Not Eligible|0|||
156330923|NCT00299182|564311894|FG001|Overall Study|Not Eligible|0|||
156330924|NCT00299182|564311895|FG002|Overall Study|Not Eligible|0|||
156789407|NCT00281580|565981293|FG003|Overall Study|Protocol Violation|1|||
156789408|NCT00281580|565981294|FG004|Overall Study|Protocol Violation|0|||
156789409|NCT00281580|565981295|FG005|Overall Study|Protocol Violation|0|||
156789410|NCT00281580|565981296|FG006|Overall Study|Protocol Violation|1|||
156789411|NCT00281580|565981297|FG007|Overall Study|Protocol Violation|0|||
156789412|NCT00281580|565981298|FG008|Overall Study|Protocol Violation|2|||
156789413|NCT00281580|565981299|FG009|Overall Study|Protocol Violation|0|||
156789414|NCT00281580|565981300|FG010|Overall Study|Protocol Violation|1|||
156789415|NCT00281580|565981301|FG011|Overall Study|Protocol Violation|2|||
156789416|NCT00281580|565981302|FG012|Overall Study|Protocol Violation|0|||
156789417|NCT00281580|565981303|FG013|Overall Study|Protocol Violation|1|||
156870825|NCT02754440|566284282|FG002|Overall Study|Adverse Event|0|||
156870826|NCT02754440|566284283|FG003|Overall Study|Adverse Event|9|||
156870827|NCT02754440|566284280|FG000|Overall Study|Withdrawal by Subject|0|||
156870828|NCT02754440|566284281|FG001|Overall Study|Withdrawal by Subject|0|||
156870829|NCT02754440|566284282|FG002|Overall Study|Withdrawal by Subject|0|||
156870830|NCT02754440|566284283|FG003|Overall Study|Withdrawal by Subject|1|||
156870831|NCT02754440|566284280|FG000|Overall Study|Equipment failure|0|||
156870832|NCT02754440|566284281|FG001|Overall Study|Equipment failure|5|||
156870833|NCT02754440|566284282|FG002|Overall Study|Equipment failure|5|||
156870834|NCT02754440|566284283|FG003|Overall Study|Equipment failure|7|||
156870835|NCT02754440|566284280|FG000|Overall Study|Subject issues not resulting in AE|0|||
156870836|NCT02754440|566284281|FG001|Overall Study|Subject issues not resulting in AE|0|||
156870837|NCT02754440|566284282|FG002|Overall Study|Subject issues not resulting in AE|0|||
156870838|NCT02754440|566284283|FG003|Overall Study|Subject issues not resulting in AE|12|||
156870839|NCT02919995|566284286|FG000|Overall Study|Adverse Event|0|||
156870840|NCT02919995|566284287|FG001|Overall Study|Adverse Event|0|||
156870841|NCT02919995|566284288|FG002|Overall Study|Adverse Event|0|||
156870842|NCT02919995|566284289|FG003|Overall Study|Adverse Event|0|||
156870843|NCT02919995|566284290|FG004|Overall Study|Adverse Event|0|||
156870844|NCT02919995|566284291|FG005|Overall Study|Adverse Event|1|||
156870845|NCT00275509|566284292|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
156870846|NCT00275509|566284293|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
156870847|NCT03388164|566284298|FG000|Overall Study|Withdrawal by Subject|3|||
156870848|NCT03388164|566284299|FG001|Overall Study|Withdrawal by Subject|1|||
156870849|NCT00345358|566284300|FG000|Primary Vaccination Phase|Other|0|||
156870850|NCT00345358|566284301|FG001|Primary Vaccination Phase|Other|1|||
156870851|NCT00345358|566284302|FG002|Primary Vaccination Phase|Other|1|||
156870852|NCT00345358|566284303|FG003|Primary Vaccination Phase|Other|0|||
156870853|NCT00345358|566284300|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
156870854|NCT00345358|566284301|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
156870855|NCT00345358|566284302|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
156870856|NCT00345358|566284303|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
156870857|NCT00345358|566284300|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
156870858|NCT00345358|566284301|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
156870859|NCT00345358|566284302|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
156870860|NCT00345358|566284303|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
156870861|NCT00345358|566284300|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
156870862|NCT00345358|566284301|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
156870863|NCT00345358|566284302|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
156870864|NCT00345358|566284303|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
156870865|NCT00345358|566284300|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
156870866|NCT00345358|566284301|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
156870867|NCT00345358|566284302|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
156870868|NCT00345358|566284303|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
156870869|NCT00345358|566284300|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
156870870|NCT00345358|566284301|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
156870871|NCT00345358|566284302|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
156870872|NCT00345358|566284303|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
156870873|NCT00346697|566284305|FG000|Overall Study|Lost to Follow-up|0|||
156870874|NCT00346697|566284306|FG001|Overall Study|Lost to Follow-up|1|||
156870875|NCT00499083|566284307|FG000|Overall Study|Not evaluable|3|||
156870876|NCT00686686|566284308|FG000|Overall Study|Non-compliance|1|||
156870877|NCT00686686|566284308|FG000|Overall Study|Adverse Event|2|||
156870878|NCT00686686|566284308|FG000|Overall Study|Lost to Follow-up|3|||
156870879|NCT01012440|566284309|FG000|Overall Study|Withdrawal by Subject|2|||
156870880|NCT00477386|566284310|FG000|Overall Study|Adverse Event|4|||
156870881|NCT00477386|566284311|FG001|Overall Study|Adverse Event|8|||
156870882|NCT00477386|566284310|FG000|Overall Study|Disease progression, relapse|3|||
156870883|NCT00477386|566284311|FG001|Overall Study|Disease progression, relapse|4|||
156870884|NCT00477386|566284310|FG000|Overall Study|Disease progression, refractory|1|||
156870885|NCT00477386|566284311|FG001|Overall Study|Disease progression, refractory|3|||
156870886|NCT00477386|566284310|FG000|Overall Study|Other|1|||
156870887|NCT00477386|566284311|FG001|Overall Study|Other|2|||
156870888|NCT00477386|566284310|FG000|Overall Study|Physician Decision|1|||
156870889|NCT00477386|566284311|FG001|Overall Study|Physician Decision|0|||
156870890|NCT00477386|566284310|FG000|Overall Study|Withdrawal by Subject|1|||
156870891|NCT00477386|566284311|FG001|Overall Study|Withdrawal by Subject|0|||
156870892|NCT01254422|566284312|FG000|Overall Study|Protocol Violation|1|||
156870893|NCT01254422|566284313|FG001|Overall Study|Protocol Violation|0|||
156870894|NCT01254422|566284312|FG000|Overall Study|Adverse Event|1|||
156870895|NCT01254422|566284313|FG001|Overall Study|Adverse Event|0|||
156870896|NCT01254422|566284312|FG000|Overall Study|Serious adverse event|0|||
156870897|NCT01254422|566284313|FG001|Overall Study|Serious adverse event|1|||
156870898|NCT01254422|566284312|FG000|Overall Study|Lost to Follow-up|1|||
156330925|NCT00299182|564311896|FG003|Overall Study|Not Eligible|0|||
156789418|NCT00281580|565981304|FG014|Overall Study|Protocol Violation|1|||
156789419|NCT00281580|565981305|FG015|Overall Study|Protocol Violation|3|||
156789420|NCT00281580|565981290|FG000|Overall Study|Withdrawal by Subject|3|||
156789421|NCT00281580|565981291|FG001|Overall Study|Withdrawal by Subject|0|||
156789422|NCT00281580|565981292|FG002|Overall Study|Withdrawal by Subject|1|||
156789423|NCT00281580|565981293|FG003|Overall Study|Withdrawal by Subject|1|||
156789424|NCT00281580|565981294|FG004|Overall Study|Withdrawal by Subject|1|||
156789425|NCT00281580|565981295|FG005|Overall Study|Withdrawal by Subject|2|||
156789426|NCT00281580|565981296|FG006|Overall Study|Withdrawal by Subject|2|||
156789427|NCT00281580|565981297|FG007|Overall Study|Withdrawal by Subject|0|||
156789428|NCT00281580|565981298|FG008|Overall Study|Withdrawal by Subject|1|||
156789429|NCT00281580|565981299|FG009|Overall Study|Withdrawal by Subject|4|||
156789430|NCT00281580|565981300|FG010|Overall Study|Withdrawal by Subject|1|||
156789431|NCT00281580|565981301|FG011|Overall Study|Withdrawal by Subject|1|||
156789432|NCT00281580|565981302|FG012|Overall Study|Withdrawal by Subject|2|||
156789433|NCT00281580|565981303|FG013|Overall Study|Withdrawal by Subject|2|||
156789434|NCT00281580|565981304|FG014|Overall Study|Withdrawal by Subject|1|||
156789435|NCT00281580|565981305|FG015|Overall Study|Withdrawal by Subject|5|||
156789436|NCT00281580|565981290|FG000|Overall Study|Lack of Efficacy|2|||
156789437|NCT00281580|565981291|FG001|Overall Study|Lack of Efficacy|1|||
156789438|NCT00281580|565981292|FG002|Overall Study|Lack of Efficacy|1|||
156789439|NCT00281580|565981293|FG003|Overall Study|Lack of Efficacy|6|||
156789440|NCT00281580|565981294|FG004|Overall Study|Lack of Efficacy|2|||
156789441|NCT00281580|565981295|FG005|Overall Study|Lack of Efficacy|0|||
156789442|NCT00281580|565981296|FG006|Overall Study|Lack of Efficacy|0|||
156789443|NCT00281580|565981297|FG007|Overall Study|Lack of Efficacy|0|||
156789444|NCT00281580|565981298|FG008|Overall Study|Lack of Efficacy|0|||
156789445|NCT00281580|565981299|FG009|Overall Study|Lack of Efficacy|0|||
156789446|NCT00281580|565981300|FG010|Overall Study|Lack of Efficacy|0|||
156789447|NCT00281580|565981301|FG011|Overall Study|Lack of Efficacy|1|||
156789448|NCT00281580|565981302|FG012|Overall Study|Lack of Efficacy|0|||
156789449|NCT00281580|565981303|FG013|Overall Study|Lack of Efficacy|2|||
156789450|NCT00281580|565981304|FG014|Overall Study|Lack of Efficacy|1|||
156789451|NCT00281580|565981305|FG015|Overall Study|Lack of Efficacy|0|||
156789452|NCT00281580|565981290|FG000|Overall Study|Lost to Follow-up|0|||
156789453|NCT00281580|565981291|FG001|Overall Study|Lost to Follow-up|0|||
156789454|NCT00281580|565981292|FG002|Overall Study|Lost to Follow-up|0|||
156789455|NCT00281580|565981293|FG003|Overall Study|Lost to Follow-up|3|||
156789456|NCT00281580|565981294|FG004|Overall Study|Lost to Follow-up|0|||
156789457|NCT00281580|565981295|FG005|Overall Study|Lost to Follow-up|1|||
156789458|NCT00281580|565981296|FG006|Overall Study|Lost to Follow-up|0|||
156789459|NCT00281580|565981297|FG007|Overall Study|Lost to Follow-up|1|||
156789460|NCT00281580|565981298|FG008|Overall Study|Lost to Follow-up|2|||
156789461|NCT00281580|565981299|FG009|Overall Study|Lost to Follow-up|1|||
156789462|NCT00281580|565981300|FG010|Overall Study|Lost to Follow-up|1|||
156789463|NCT00281580|565981301|FG011|Overall Study|Lost to Follow-up|0|||
156789464|NCT00281580|565981302|FG012|Overall Study|Lost to Follow-up|1|||
156789465|NCT00281580|565981303|FG013|Overall Study|Lost to Follow-up|0|||
156789466|NCT00281580|565981304|FG014|Overall Study|Lost to Follow-up|0|||
156789467|NCT00281580|565981305|FG015|Overall Study|Lost to Follow-up|0|||
156789468|NCT00281580|565981290|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
156789469|NCT00281580|565981291|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
156789470|NCT00281580|565981292|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
156789471|NCT00281580|565981293|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
156789472|NCT00281580|565981294|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
156789473|NCT00281580|565981295|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
156789474|NCT00281580|565981296|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
156789475|NCT00281580|565981297|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
156870899|NCT01254422|566284313|FG001|Overall Study|Lost to Follow-up|0|||
156870900|NCT00643162|566284314|FG000|Overall Study|Withdrawal by Subject|1|||
156870901|NCT00643162|566284315|FG001|Overall Study|Withdrawal by Subject|1|||
156870902|NCT00318643|566284316|FG000|Overall Study|Adverse Event|0|||
156870903|NCT00318643|566284317|FG001|Overall Study|Adverse Event|0|||
156870904|NCT00318643|566284318|FG002|Overall Study|Adverse Event|0|||
156870905|NCT00318643|566284319|FG003|Overall Study|Adverse Event|0|||
156870906|NCT00318643|566284320|FG004|Overall Study|Adverse Event|1|||
156789476|NCT00281580|565981298|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
156789477|NCT00281580|565981299|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
156789478|NCT00281580|565981300|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
156789479|NCT00281580|565981301|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
156789480|NCT00281580|565981302|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
156789481|NCT00281580|565981303|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
156789482|NCT00281580|565981304|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
156870907|NCT00318643|566284316|FG000|Overall Study|Participant's Decision|0|||
156870908|NCT00318643|566284317|FG001|Overall Study|Participant's Decision|0|||
156870909|NCT00318643|566284318|FG002|Overall Study|Participant's Decision|0|||
156438093|NCT00722046|564695357|FG004|Overall Study|Withdrawal by Subject|4|||
156438094|NCT00722046|564695358|FG005|Overall Study|Withdrawal by Subject|7|||
156438095|NCT00722046|564695359|FG006|Overall Study|Withdrawal by Subject|3|||
156438096|NCT00722046|564695353|FG000|Overall Study|Randomized, but not treated|1|||
156438097|NCT00722046|564695354|FG001|Overall Study|Randomized, but not treated|1|||
156438098|NCT00722046|564695355|FG002|Overall Study|Randomized, but not treated|0|||
156438099|NCT00722046|564695356|FG003|Overall Study|Randomized, but not treated|2|||
156438100|NCT00722046|564695357|FG004|Overall Study|Randomized, but not treated|0|||
156438101|NCT00722046|564695358|FG005|Overall Study|Randomized, but not treated|0|||
156789483|NCT00281580|565981305|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
156789484|NCT00276380|565981309|FG000|Overall Study|Adverse Event|5|||
156789485|NCT00276380|565981310|FG001|Overall Study|Adverse Event|3|||
156789486|NCT00276380|565981309|FG000|Overall Study|Lost to Follow-up|1|||
156789487|NCT00276380|565981310|FG001|Overall Study|Lost to Follow-up|1|||
156789488|NCT00276380|565981309|FG000|Overall Study|Withdrawal by Subject|3|||
156789489|NCT00276380|565981310|FG001|Overall Study|Withdrawal by Subject|6|||
156789490|NCT00276380|565981309|FG000|Overall Study|Death|5|||
156789491|NCT00276380|565981310|FG001|Overall Study|Death|3|||
156789492|NCT00276380|565981309|FG000|Overall Study|Abnormal aPPT Levels|0|||
156789493|NCT00276380|565981310|FG001|Overall Study|Abnormal aPPT Levels|1|||
156789494|NCT03071965|565981311|FG000|Overall Study|Adverse Event|0|||
156789495|NCT03071965|565981312|FG001|Overall Study|Adverse Event|0|||
156789496|NCT03071965|565981313|FG002|Overall Study|Adverse Event|1|||
156789497|NCT03071965|565981314|FG003|Overall Study|Adverse Event|0|||
156789498|NCT03071965|565981311|FG000|Overall Study|Death|0|||
156789499|NCT03071965|565981312|FG001|Overall Study|Death|0|||
156789500|NCT03071965|565981313|FG002|Overall Study|Death|1|||
156789501|NCT03071965|565981314|FG003|Overall Study|Death|1|||
156789502|NCT03071965|565981311|FG000|Overall Study|COVID-19|0|||
156789503|NCT03071965|565981312|FG001|Overall Study|COVID-19|1|||
156789504|NCT03071965|565981313|FG002|Overall Study|COVID-19|0|||
156789505|NCT03071965|565981314|FG003|Overall Study|COVID-19|1|||
156789506|NCT03071965|565981311|FG000|Overall Study|Other Health Reason|0|||
156789507|NCT03071965|565981312|FG001|Overall Study|Other Health Reason|0|||
156789508|NCT03071965|565981313|FG002|Overall Study|Other Health Reason|0|||
156789509|NCT03071965|565981314|FG003|Overall Study|Other Health Reason|1|||
156789510|NCT04829214|565981315|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
156789511|NCT04829214|565981316|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
156789512|NCT04829214|565981315|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
156789513|NCT04829214|565981316|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
156694616|NCT01641133|565627836|FG002|Overall Study|Adverse Event|1|||
156694617|NCT01641133|565627834|FG000|Overall Study|Withdrawal by Subject|5|||
156694618|NCT01641133|565627835|FG001|Overall Study|Withdrawal by Subject|3|||
156694619|NCT01641133|565627836|FG002|Overall Study|Withdrawal by Subject|3|||
156694620|NCT01641133|565627834|FG000|Overall Study|Lost to Follow-up|0|||
156694621|NCT01641133|565627835|FG001|Overall Study|Lost to Follow-up|2|||
156694622|NCT01641133|565627836|FG002|Overall Study|Lost to Follow-up|2|||
156694623|NCT02220725|565627837|FG000|Overall Study|Lost to Follow-up|0|||
156694624|NCT02220725|565627838|FG001|Overall Study|Lost to Follow-up|0|||
156694625|NCT02220725|565627839|FG002|Overall Study|Lost to Follow-up|0|||
156694626|NCT02220725|565627840|FG003|Overall Study|Lost to Follow-up|1|||
156694627|NCT02220725|565627837|FG000|Overall Study|Withdrawal by Subject|0|||
156694628|NCT02220725|565627838|FG001|Overall Study|Withdrawal by Subject|0|||
156694629|NCT02220725|565627839|FG002|Overall Study|Withdrawal by Subject|0|||
156694630|NCT02220725|565627840|FG003|Overall Study|Withdrawal by Subject|1|||
156694631|NCT00712985|565627841|FG000|Overall Study|1 withdrew prior to start of drug|1|||
156694632|NCT00712985|565627841|FG000|Overall Study|1 patient moved out of state|1|||
156694633|NCT00712985|565627841|FG000|Overall Study|Lack of Efficacy|3|||
156694634|NCT02674061|565627842|FG000|Overall Study|Death|229|||
156694635|NCT02674061|565627843|FG001|Overall Study|Death|77|||
156694636|NCT02674061|565627842|FG000|Overall Study|Lost to Follow-up|3|||
156694637|NCT02674061|565627843|FG001|Overall Study|Lost to Follow-up|3|||
156694638|NCT02674061|565627842|FG000|Overall Study|Withdrawal by Subject|9|||
156694639|NCT02674061|565627843|FG001|Overall Study|Withdrawal by Subject|1|||
156694640|NCT02674061|565627842|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
156694641|NCT02674061|565627843|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
156694642|NCT03334721|565627846|FG000|Overall Study|Withdrawal by Subject|1|||
156694643|NCT03334721|565627847|FG001|Overall Study|Withdrawal by Subject|0|||
156694644|NCT03334721|565627846|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
156694645|NCT03334721|565627847|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
156694646|NCT01663727|565627848|FG000|Overall Study|Death|161|||
156694647|NCT01663727|565627849|FG001|Overall Study|Death|155|||
156694648|NCT01663727|565627848|FG000|Overall Study|Lost to Follow-up|10|||
156694649|NCT01663727|565627849|FG001|Overall Study|Lost to Follow-up|8|||
156694650|NCT01663727|565627848|FG000|Overall Study|Withdrawal by Subject|18|||
156694651|NCT01663727|565627849|FG001|Overall Study|Withdrawal by Subject|25|||
156870910|NCT00318643|566284319|FG003|Overall Study|Participant's Decision|0|||
156870911|NCT00318643|566284320|FG004|Overall Study|Participant's Decision|1|||
156530696|NCT01717768|565038127|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156530697|NCT01717768|565038128|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156530698|NCT01717768|565038129|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156530699|NCT01717768|565038130|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156530700|NCT01717768|565038131|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156530701|NCT01717768|565038132|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156530702|NCT01717768|565038133|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156694652|NCT01663727|565627848|FG000|Overall Study|Study Terminated|51|||
156330926|NCT00299182|564311897|FG004|Overall Study|Not Eligible|1|||
156330927|NCT00299182|564311898|FG005|Overall Study|Not Eligible|0|||
156694653|NCT01663727|565627849|FG001|Overall Study|Study Terminated|50|||
156694654|NCT01663727|565627848|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
156694655|NCT01663727|565627849|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
156694656|NCT01663727|565627848|FG000|Overall Study|Withdrawal prior to dosing.|1|||
156694657|NCT01663727|565627849|FG001|Overall Study|Withdrawal prior to dosing.|0|||
156694658|NCT01902628|565627850|FG000|Overall Study|Withdrawal of participant's consent|7|||
156694659|NCT01902628|565627850|FG000|Overall Study|Adverse Event|41|||
156694660|NCT01902628|565627850|FG000|Overall Study|Lost to Follow-up|35|||
156694661|NCT01232491|565627851|FG000|Overall Study|Adverse Event|13|||
156694662|NCT01232491|565627852|FG001|Overall Study|Adverse Event|8|||
156694663|NCT01232491|565627851|FG000|Overall Study|Lack of Efficacy|1|||
156694664|NCT01232491|565627852|FG001|Overall Study|Lack of Efficacy|5|||
156694665|NCT01232491|565627851|FG000|Overall Study|Protocol Violation|13|||
156694666|NCT01232491|565627852|FG001|Overall Study|Protocol Violation|11|||
156694667|NCT01232491|565627851|FG000|Overall Study|Withdrawal Criteria|12|||
156694668|NCT01232491|565627852|FG001|Overall Study|Withdrawal Criteria|21|||
156694669|NCT01232491|565627851|FG000|Overall Study|Other|21|||
156694670|NCT01232491|565627852|FG001|Overall Study|Other|18|||
156694671|NCT02932228|565627855|FG000|Overall Study|Death|8|||
156694672|NCT02932228|565627856|FG001|Overall Study|Death|23|||
156694673|NCT02932228|565627855|FG000|Overall Study|not eligible upon chart review|2|||
156694674|NCT02932228|565627856|FG001|Overall Study|not eligible upon chart review|5|||
156694675|NCT03303625|565629520|FG000|Overall Study|Withdrawal by Subject|2|||
156694676|NCT03303625|565629521|FG001|Overall Study|Withdrawal by Subject|0|||
156694677|NCT03303625|565629522|FG002|Overall Study|Withdrawal by Subject|0|||
156694678|NCT03303625|565629523|FG003|Overall Study|Withdrawal by Subject|0|||
156694679|NCT02221037|565629525|FG000|Overall Study|Physician Decision|0|||
156694680|NCT02221037|565629526|FG001|Overall Study|Physician Decision|0|||
156694681|NCT02221037|565629527|FG002|Overall Study|Physician Decision|1|||
156694682|NCT02221037|565629528|FG003|Overall Study|Physician Decision|0|||
156694683|NCT00856973|565629529|FG000|Overall Study|Adverse Event|5|||
156694684|NCT00856973|565629530|FG001|Overall Study|Adverse Event|5|||
156694685|NCT00856973|565629531|FG002|Overall Study|Adverse Event|3|||
156694686|NCT00856973|565629529|FG000|Overall Study|Lost to Follow-up|6|||
156694687|NCT00856973|565629530|FG001|Overall Study|Lost to Follow-up|3|||
156694688|NCT00856973|565629531|FG002|Overall Study|Lost to Follow-up|5|||
156694689|NCT00856973|565629529|FG000|Overall Study|Physician Decision|0|||
156694690|NCT00856973|565629530|FG001|Overall Study|Physician Decision|3|||
156694691|NCT00856973|565629531|FG002|Overall Study|Physician Decision|1|||
156694692|NCT00856973|565629529|FG000|Overall Study|Protocol Violation|1|||
156694693|NCT00856973|565629530|FG001|Overall Study|Protocol Violation|2|||
156694694|NCT00856973|565629531|FG002|Overall Study|Protocol Violation|1|||
156694695|NCT00856973|565629529|FG000|Overall Study|Withdrawal by Subject|13|||
156694696|NCT00856973|565629530|FG001|Overall Study|Withdrawal by Subject|16|||
156694697|NCT00856973|565629531|FG002|Overall Study|Withdrawal by Subject|15|||
156694698|NCT00856973|565629529|FG000|Overall Study|Other|11|||
156694699|NCT00856973|565629530|FG001|Overall Study|Other|12|||
156694700|NCT00856973|565629531|FG002|Overall Study|Other|13|||
156694701|NCT04556552|565629534|FG000|Overall Study|Lost to Follow-up|1|||
156694702|NCT04556552|565629535|FG001|Overall Study|Lost to Follow-up|0|||
156694703|NCT04556552|565629534|FG000|Overall Study|Claustrophobia|0|||
156694704|NCT04556552|565629535|FG001|Overall Study|Claustrophobia|1|||
156694705|NCT04556552|565629534|FG000|Overall Study|Inability to continue|0|||
156694706|NCT04556552|565629535|FG001|Overall Study|Inability to continue|1|||
156694707|NCT03955471|565629536|FG000|Overall Study|Death|22|||
156694708|NCT03955471|565629536|FG000|Overall Study|Lost to Follow-up|1|||
156694709|NCT03955471|565629536|FG000|Overall Study|Withdrawal by Subject|6|||
156694710|NCT03955471|565629536|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
156694711|NCT01030341|565629537|FG000|Overall Study|Withdrawal by Subject|1|||
156694712|NCT01030341|565629537|FG000|Overall Study|Lost to Follow-up|2|||
156694713|NCT02307266|565629540|FG000|Overall Study|Adverse Event|3|||
156694714|NCT02307266|565629541|FG001|Overall Study|Adverse Event|1|||
156694715|NCT02307266|565629542|FG002|Overall Study|Adverse Event|5|||
156789514|NCT06399471|565981317|FG000|Overall Study|Withdrawal by Subject|1|||
156789515|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
156789516|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
156789517|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
156789518|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
156789519|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
156789520|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
156789521|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
156789522|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
156789523|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
156789524|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
156789525|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
156789526|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
156789527|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
156789528|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
156789529|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
156789530|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
156789531|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
156789532|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
156789533|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
156789534|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
156789535|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
156789536|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
156789537|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
156789538|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
156789539|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
156789540|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
156789541|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
156789542|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
156789543|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
156789544|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
156789545|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
156789546|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
156789547|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
156789548|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
156789549|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
156789550|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
156789551|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
156789552|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
156789553|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
156789554|NCT01370642|565981323|FG000|Overall Study|Adverse Event|2|||
156789555|NCT01370642|565981324|FG001|Overall Study|Adverse Event|1|||
156789556|NCT01370642|565981325|FG002|Overall Study|Adverse Event|1|||
156789557|NCT01370642|565981323|FG000|Overall Study|Detectable HCV RNA|0|||
156789558|NCT01370642|565981324|FG001|Overall Study|Detectable HCV RNA|0|||
156789559|NCT01370642|565981325|FG002|Overall Study|Detectable HCV RNA|22|||
156789560|NCT01370642|565981323|FG000|Overall Study|Lost to Follow-up|0|||
156789561|NCT01370642|565981324|FG001|Overall Study|Lost to Follow-up|0|||
156789562|NCT01370642|565981325|FG002|Overall Study|Lost to Follow-up|1|||
156789563|NCT01370642|565981323|FG000|Overall Study|Physician Decision|4|||
156789564|NCT01370642|565981324|FG001|Overall Study|Physician Decision|1|||
156789565|NCT01370642|565981325|FG002|Overall Study|Physician Decision|2|||
156789566|NCT01370642|565981323|FG000|Overall Study|Withdrawal by Subject|2|||
156789567|NCT01370642|565981324|FG001|Overall Study|Withdrawal by Subject|4|||
156789568|NCT01370642|565981325|FG002|Overall Study|Withdrawal by Subject|3|||
156789569|NCT00147537|565981332|FG000|Phase 1b|Death|0|||
156789570|NCT00147537|565981333|FG001|Phase 1b|Death|1|||
156789571|NCT00147537|565981334|FG002|Phase 1b|Death|2|||
156789572|NCT00147537|565981335|FG003|Phase 1b|Death|1|||
156789573|NCT00147537|565981336|FG004|Phase 1b|Death|2|||
156789574|NCT00147537|565981337|FG005|Phase 1b|Death|2|||
156789575|NCT00147537|565981338|FG006|Phase 1b|Death|1|||
156789576|NCT00147537|565981339|FG007|Phase 1b|Death|3|||
156789577|NCT00147537|565981340|FG008|Phase 1b|Death|9|||
156789578|NCT00147537|565981341|FG009|Phase 1b|Death|0|||
156789579|NCT00147537|565981342|FG010|Phase 1b|Death|0|||
156789580|NCT00147537|565981332|FG000|Phase 1b|Lost to Follow-up|2|||
156789581|NCT00147537|565981333|FG001|Phase 1b|Lost to Follow-up|1|||
156789582|NCT00147537|565981334|FG002|Phase 1b|Lost to Follow-up|0|||
156789583|NCT00147537|565981335|FG003|Phase 1b|Lost to Follow-up|0|||
156789584|NCT00147537|565981336|FG004|Phase 1b|Lost to Follow-up|0|||
156789585|NCT00147537|565981337|FG005|Phase 1b|Lost to Follow-up|0|||
156789586|NCT00147537|565981338|FG006|Phase 1b|Lost to Follow-up|2|||
156789587|NCT00147537|565981339|FG007|Phase 1b|Lost to Follow-up|0|||
156789588|NCT00147537|565981340|FG008|Phase 1b|Lost to Follow-up|1|||
156789589|NCT00147537|565981341|FG009|Phase 1b|Lost to Follow-up|0|||
156789590|NCT00147537|565981342|FG010|Phase 1b|Lost to Follow-up|0|||
156789591|NCT00147537|565981332|FG000|Phase 1b|Other|0|||
156789592|NCT00147537|565981333|FG001|Phase 1b|Other|0|||
156789593|NCT00147537|565981334|FG002|Phase 1b|Other|2|||
156789594|NCT00147537|565981335|FG003|Phase 1b|Other|1|||
156789595|NCT00147537|565981336|FG004|Phase 1b|Other|1|||
156789596|NCT00147537|565981337|FG005|Phase 1b|Other|1|||
156789597|NCT00147537|565981338|FG006|Phase 1b|Other|14|||
156789598|NCT00147537|565981339|FG007|Phase 1b|Other|4|||
156789599|NCT00147537|565981340|FG008|Phase 1b|Other|4|||
156789600|NCT00147537|565981341|FG009|Phase 1b|Other|0|||
156789601|NCT00147537|565981342|FG010|Phase 1b|Other|0|||
156789602|NCT00147537|565981332|FG000|Phase 1b|Withdrawal by Subject|0|||
156789603|NCT00147537|565981333|FG001|Phase 1b|Withdrawal by Subject|0|||
156789604|NCT00147537|565981334|FG002|Phase 1b|Withdrawal by Subject|0|||
156789605|NCT00147537|565981335|FG003|Phase 1b|Withdrawal by Subject|0|||
156789606|NCT00147537|565981336|FG004|Phase 1b|Withdrawal by Subject|0|||
156789607|NCT00147537|565981337|FG005|Phase 1b|Withdrawal by Subject|0|||
156789608|NCT00147537|565981338|FG006|Phase 1b|Withdrawal by Subject|0|||
156789609|NCT00147537|565981339|FG007|Phase 1b|Withdrawal by Subject|0|||
156789610|NCT00147537|565981340|FG008|Phase 1b|Withdrawal by Subject|2|||
156789611|NCT00147537|565981341|FG009|Phase 1b|Withdrawal by Subject|0|||
156789612|NCT00147537|565981342|FG010|Phase 1b|Withdrawal by Subject|0|||
156789613|NCT00147537|565981332|FG000|Phase 1b|Randomized but not treated|0|||
156789614|NCT00147537|565981333|FG001|Phase 1b|Randomized but not treated|0|||
156789615|NCT00147537|565981334|FG002|Phase 1b|Randomized but not treated|0|||
156789616|NCT00147537|565981335|FG003|Phase 1b|Randomized but not treated|0|||
156789617|NCT00147537|565981336|FG004|Phase 1b|Randomized but not treated|0|||
156789618|NCT00147537|565981337|FG005|Phase 1b|Randomized but not treated|0|||
156789619|NCT00147537|565981338|FG006|Phase 1b|Randomized but not treated|1|||
156789620|NCT00147537|565981339|FG007|Phase 1b|Randomized but not treated|0|||
156789621|NCT00147537|565981340|FG008|Phase 1b|Randomized but not treated|1|||
156789622|NCT00147537|565981341|FG009|Phase 1b|Randomized but not treated|0|||
156789623|NCT00147537|565981342|FG010|Phase 1b|Randomized but not treated|0|||
156789624|NCT00147537|565981332|FG000|Phase 2|Death|0|||
156789625|NCT00147537|565981333|FG001|Phase 2|Death|0|||
156789626|NCT00147537|565981334|FG002|Phase 2|Death|0|||
156789627|NCT00147537|565981335|FG003|Phase 2|Death|0|||
156789628|NCT00147537|565981336|FG004|Phase 2|Death|0|||
156789629|NCT00147537|565981337|FG005|Phase 2|Death|0|||
156789630|NCT00147537|565981338|FG006|Phase 2|Death|0|||
156789631|NCT00147537|565981339|FG007|Phase 2|Death|0|||
156789632|NCT00147537|565981340|FG008|Phase 2|Death|0|||
156789633|NCT00147537|565981341|FG009|Phase 2|Death|85|||
156789634|NCT00147537|565981342|FG010|Phase 2|Death|31|||
156789635|NCT00147537|565981332|FG000|Phase 2|Lost to Follow-up|0|||
156789636|NCT00147537|565981333|FG001|Phase 2|Lost to Follow-up|0|||
156789637|NCT00147537|565981334|FG002|Phase 2|Lost to Follow-up|0|||
156789638|NCT00147537|565981335|FG003|Phase 2|Lost to Follow-up|0|||
156789639|NCT00147537|565981336|FG004|Phase 2|Lost to Follow-up|0|||
156789640|NCT00147537|565981337|FG005|Phase 2|Lost to Follow-up|0|||
156789641|NCT00147537|565981338|FG006|Phase 2|Lost to Follow-up|0|||
156789642|NCT00147537|565981339|FG007|Phase 2|Lost to Follow-up|0|||
156789643|NCT00147537|565981340|FG008|Phase 2|Lost to Follow-up|0|||
156789644|NCT00147537|565981341|FG009|Phase 2|Lost to Follow-up|12|||
156789645|NCT00147537|565981342|FG010|Phase 2|Lost to Follow-up|4|||
156789646|NCT00147537|565981332|FG000|Phase 2|Other|0|||
156789647|NCT00147537|565981333|FG001|Phase 2|Other|0|||
156789648|NCT00147537|565981334|FG002|Phase 2|Other|0|||
156789649|NCT00147537|565981335|FG003|Phase 2|Other|0|||
156789650|NCT00147537|565981336|FG004|Phase 2|Other|0|||
156789651|NCT00147537|565981337|FG005|Phase 2|Other|0|||
156789652|NCT00147537|565981338|FG006|Phase 2|Other|0|||
156789653|NCT00147537|565981339|FG007|Phase 2|Other|0|||
156789654|NCT00147537|565981340|FG008|Phase 2|Other|0|||
156789655|NCT00147537|565981341|FG009|Phase 2|Other|47|||
156789656|NCT00147537|565981342|FG010|Phase 2|Other|12|||
156789657|NCT00147537|565981332|FG000|Phase 2|Withdrawal by Subject|0|||
156789658|NCT00147537|565981333|FG001|Phase 2|Withdrawal by Subject|0|||
156789659|NCT00147537|565981334|FG002|Phase 2|Withdrawal by Subject|0|||
156789660|NCT00147537|565981335|FG003|Phase 2|Withdrawal by Subject|0|||
156789661|NCT00147537|565981336|FG004|Phase 2|Withdrawal by Subject|0|||
156789662|NCT00147537|565981337|FG005|Phase 2|Withdrawal by Subject|0|||
156789663|NCT00147537|565981338|FG006|Phase 2|Withdrawal by Subject|0|||
156789664|NCT00147537|565981339|FG007|Phase 2|Withdrawal by Subject|0|||
156789665|NCT00147537|565981340|FG008|Phase 2|Withdrawal by Subject|0|||
156789666|NCT00147537|565981341|FG009|Phase 2|Withdrawal by Subject|16|||
156789667|NCT00147537|565981342|FG010|Phase 2|Withdrawal by Subject|4|||
156789668|NCT00147537|565981332|FG000|Phase 2|Randomized but not treated|0|||
156789669|NCT00147537|565981333|FG001|Phase 2|Randomized but not treated|0|||
156789670|NCT00147537|565981334|FG002|Phase 2|Randomized but not treated|0|||
156789671|NCT00147537|565981335|FG003|Phase 2|Randomized but not treated|0|||
156789672|NCT00147537|565981336|FG004|Phase 2|Randomized but not treated|0|||
156789673|NCT00147537|565981337|FG005|Phase 2|Randomized but not treated|0|||
156789674|NCT00147537|565981338|FG006|Phase 2|Randomized but not treated|0|||
156789675|NCT00147537|565981339|FG007|Phase 2|Randomized but not treated|0|||
156789676|NCT00147537|565981340|FG008|Phase 2|Randomized but not treated|0|||
156789677|NCT00147537|565981341|FG009|Phase 2|Randomized but not treated|1|||
156789678|NCT00147537|565981342|FG010|Phase 2|Randomized but not treated|1|||
156789679|NCT00987935|565981343|FG000|Overall Study|Progressive disease|3|||
156789680|NCT00987935|565981344|FG001|Overall Study|Progressive disease|2|||
156789681|NCT00987935|565981345|FG002|Overall Study|Progressive disease|3|||
156789682|NCT00987935|565981346|FG003|Overall Study|Progressive disease|2|||
156789683|NCT00987935|565981347|FG004|Overall Study|Progressive disease|5|||
156789684|NCT00987935|565981348|FG005|Overall Study|Progressive disease|3|||
156789685|NCT00987935|565981349|FG006|Overall Study|Progressive disease|9|||
156789686|NCT00987935|565981350|FG007|Overall Study|Progressive disease|48|||
156789687|NCT00987935|565981351|FG008|Overall Study|Progressive disease|23|||
156789688|NCT00987935|565981343|FG000|Overall Study|Adverse Event|0|||
156789689|NCT00987935|565981344|FG001|Overall Study|Adverse Event|1|||
156789690|NCT00987935|565981345|FG002|Overall Study|Adverse Event|0|||
156789691|NCT00987935|565981346|FG003|Overall Study|Adverse Event|1|||
156789692|NCT00987935|565981347|FG004|Overall Study|Adverse Event|1|||
156789693|NCT00987935|565981348|FG005|Overall Study|Adverse Event|0|||
156789694|NCT00987935|565981349|FG006|Overall Study|Adverse Event|2|||
156789695|NCT00987935|565981350|FG007|Overall Study|Adverse Event|10|||
156789696|NCT00987935|565981351|FG008|Overall Study|Adverse Event|6|||
156789697|NCT00987935|565981343|FG000|Overall Study|Refused to continue taking trial med.|1|||
156789698|NCT00987935|565981344|FG001|Overall Study|Refused to continue taking trial med.|0|||
156789699|NCT00987935|565981345|FG002|Overall Study|Refused to continue taking trial med.|0|||
156789700|NCT00987935|565981346|FG003|Overall Study|Refused to continue taking trial med.|0|||
156789701|NCT00987935|565981347|FG004|Overall Study|Refused to continue taking trial med.|1|||
156789702|NCT00987935|565981348|FG005|Overall Study|Refused to continue taking trial med.|0|||
156789703|NCT00987935|565981349|FG006|Overall Study|Refused to continue taking trial med.|4|||
156789704|NCT00987935|565981350|FG007|Overall Study|Refused to continue taking trial med.|4|||
156789705|NCT00987935|565981351|FG008|Overall Study|Refused to continue taking trial med.|2|||
156789706|NCT00987935|565981343|FG000|Overall Study|Reason other than those specified above|0|||
156789707|NCT00987935|565981344|FG001|Overall Study|Reason other than those specified above|0|||
156789708|NCT00987935|565981345|FG002|Overall Study|Reason other than those specified above|0|||
156789709|NCT00987935|565981346|FG003|Overall Study|Reason other than those specified above|0|||
156789710|NCT00987935|565981347|FG004|Overall Study|Reason other than those specified above|0|||
156789711|NCT00987935|565981348|FG005|Overall Study|Reason other than those specified above|0|||
156789712|NCT00987935|565981349|FG006|Overall Study|Reason other than those specified above|0|||
156789713|NCT00987935|565981350|FG007|Overall Study|Reason other than those specified above|0|||
156789714|NCT00987935|565981351|FG008|Overall Study|Reason other than those specified above|1|||
156789715|NCT01089543|565981352|FG000|Overall Study|Withdrawal by Subject|2|||
156789716|NCT01089543|565981353|FG001|Overall Study|Withdrawal by Subject|3|||
156789717|NCT01089543|565981354|FG002|Overall Study|Withdrawal by Subject|3|||
156789718|NCT01089543|565981355|FG003|Overall Study|Withdrawal by Subject|1|||
156789719|NCT01089543|565981352|FG000|Overall Study|Physician Decision|1|||
156789720|NCT01089543|565981353|FG001|Overall Study|Physician Decision|0|||
156789721|NCT01089543|565981354|FG002|Overall Study|Physician Decision|0|||
156789722|NCT01089543|565981355|FG003|Overall Study|Physician Decision|1|||
156789723|NCT01089543|565981352|FG000|Overall Study|Adverse Event|0|||
156789724|NCT01089543|565981353|FG001|Overall Study|Adverse Event|1|||
156789725|NCT01089543|565981354|FG002|Overall Study|Adverse Event|0|||
156789726|NCT01089543|565981355|FG003|Overall Study|Adverse Event|0|||
156789727|NCT00468546|565981356|FG000|Week 24 Analysis|Lack of Efficacy|83|||
156789728|NCT00468546|565981357|FG001|Week 24 Analysis|Lack of Efficacy|37|||
156789729|NCT00468546|565981356|FG000|Week 24 Analysis|Refused treatment|5|||
156789730|NCT00468546|565981357|FG001|Week 24 Analysis|Refused treatment|5|||
156789731|NCT00468546|565981356|FG000|Week 24 Analysis|Adverse Event|1|||
156789732|NCT00468546|565981357|FG001|Week 24 Analysis|Adverse Event|8|||
156789733|NCT00468546|565981356|FG000|Week 24 Analysis|Failure to return|3|||
156789734|NCT00468546|565981357|FG001|Week 24 Analysis|Failure to return|4|||
156789735|NCT00468546|565981356|FG000|Week 24 Analysis|Rescue therapy|2|||
156789736|NCT00468546|565981357|FG001|Week 24 Analysis|Rescue therapy|0|||
156789737|NCT00468546|565981356|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
156789738|NCT00468546|565981357|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
156870912|NCT00318643|566284316|FG000|Overall Study|Investigator's Decision|0|||
156330928|NCT00299182|564311899|FG006|Overall Study|Not Eligible|0|||
156789739|NCT00468546|565981356|FG000|Week 24 Analysis|Due to clinical hold|1|||
156789740|NCT00468546|565981357|FG001|Week 24 Analysis|Due to clinical hold|0|||
156789741|NCT00468546|565981356|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
156789742|NCT00468546|565981357|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
156789743|NCT00468546|565981356|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
156789744|NCT00468546|565981357|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
156789745|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
156789746|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
156330929|NCT04043728|564311906|FG000|Overall Study|Lost to Follow-up|1|||
156330930|NCT04043728|564311907|FG001|Overall Study|Lost to Follow-up|2|||
156330931|NCT04043728|564311908|FG002|Overall Study|Lost to Follow-up|0|||
156330932|NCT03841448|564311909|FG000|Double-blind Treatment (DBT) Period|Death|1|||
156330933|NCT03841448|564311910|FG001|Double-blind Treatment (DBT) Period|Death|1|||
156330934|NCT03841448|564311911|FG002|Double-blind Treatment (DBT) Period|Death|0|||
156789747|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Death|1|||
156789748|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Death|0|||
156330935|NCT03841448|564311912|FG003|Double-blind Treatment (DBT) Period|Death|0|||
156789749|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
156789750|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
156789751|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
156789752|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
156789753|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
156789754|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
156789755|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
156789756|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
156789757|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
156789758|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
156789759|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Other|17|||
156789760|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Other|14|||
156789761|NCT00309244|565981358|FG000|Overall Study|Adverse Event|29|||
156789762|NCT00309244|565981359|FG001|Overall Study|Adverse Event|12|||
156789763|NCT00309244|565981358|FG000|Overall Study|Lost to Follow-up|6|||
156789764|NCT00309244|565981359|FG001|Overall Study|Lost to Follow-up|22|||
156789765|NCT00309244|565981358|FG000|Overall Study|Physician Decision|5|||
156789766|NCT00309244|565981359|FG001|Overall Study|Physician Decision|8|||
156789767|NCT00309244|565981358|FG000|Overall Study|Protocol Violation|6|||
156789768|NCT00309244|565981359|FG001|Overall Study|Protocol Violation|3|||
156789769|NCT00309244|565981358|FG000|Overall Study|Withdrawal by Subject|50|||
156789770|NCT00309244|565981359|FG001|Overall Study|Withdrawal by Subject|32|||
156789771|NCT00309244|565981358|FG000|Overall Study|Various|7|||
156789772|NCT00309244|565981359|FG001|Overall Study|Various|7|||
156789773|NCT00309244|565981358|FG000|Overall Study|Randomized but not dosed|11|||
156789774|NCT00309244|565981359|FG001|Overall Study|Randomized but not dosed|12|||
156789775|NCT00309244|565981358|FG000|Overall Study|Death|4|||
156789776|NCT00309244|565981359|FG001|Overall Study|Death|1|||
156789777|NCT03438656|565981360|FG000|Overall Study|Lost to Follow-up|2|||
156789778|NCT03335566|565981361|FG000|Overall Study|Adverse Event|0|||
156789779|NCT03335566|565981362|FG001|Overall Study|Adverse Event|1|||
156789780|NCT03335566|565981361|FG000|Overall Study|Lost to Follow-up|1|||
156789781|NCT03335566|565981362|FG001|Overall Study|Lost to Follow-up|0|||
156789782|NCT03335566|565981361|FG000|Overall Study|Technical Problems|1|||
156789783|NCT03335566|565981362|FG001|Overall Study|Technical Problems|0|||
156789784|NCT03335566|565981361|FG000|Overall Study|Protocol Violation|1|||
156789785|NCT03335566|565981362|FG001|Overall Study|Protocol Violation|0|||
156789786|NCT03335566|565981361|FG000|Overall Study|Other than specified above|1|||
156789787|NCT03335566|565981362|FG001|Overall Study|Other than specified above|2|||
156789788|NCT04223687|565981363|FG000|Overall Study|Missing primary outcome|1|||
156789789|NCT04223687|565981364|FG001|Overall Study|Missing primary outcome|0|||
156789790|NCT04128228|565981368|FG000|Overall Study|Withdrawal by Subject|3|||
156789791|NCT04128228|565981369|FG001|Overall Study|Withdrawal by Subject|3|||
156789792|NCT04128228|565981370|FG002|Overall Study|Withdrawal by Subject|0|||
156789793|NCT04128228|565981371|FG003|Overall Study|Withdrawal by Subject|0|||
156789794|NCT04128228|565981368|FG000|Overall Study|noncompliance|2|||
156789795|NCT04128228|565981369|FG001|Overall Study|noncompliance|2|||
156789796|NCT04128228|565981370|FG002|Overall Study|noncompliance|0|||
156789797|NCT04128228|565981371|FG003|Overall Study|noncompliance|0|||
156789798|NCT03163264|565981372|FG000|Overall Study|Withdrawal by Subject|13|||
156789799|NCT03163264|565981373|FG001|Overall Study|Withdrawal by Subject|3|||
156789800|NCT03163264|565981374|FG002|Overall Study|Withdrawal by Subject|4|||
156789801|NCT03163264|565981375|FG003|Overall Study|Withdrawal by Subject|2|||
156789802|NCT03163264|565981372|FG000|Overall Study|Lost to Follow-up|17|||
156789803|NCT03163264|565981373|FG001|Overall Study|Lost to Follow-up|20|||
156789804|NCT03163264|565981374|FG002|Overall Study|Lost to Follow-up|0|||
156789805|NCT03163264|565981375|FG003|Overall Study|Lost to Follow-up|0|||
156789806|NCT03163264|565981372|FG000|Overall Study|Death|0|||
156789807|NCT03163264|565981373|FG001|Overall Study|Death|2|||
156789808|NCT03163264|565981374|FG002|Overall Study|Death|0|||
156789809|NCT03163264|565981375|FG003|Overall Study|Death|0|||
156330936|NCT03841448|564311909|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
156330937|NCT03841448|564311910|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
156789810|NCT02774278|565981376|FG000|Overall Study|Lack of Efficacy|199|||
156789811|NCT02774278|565981376|FG000|Overall Study|Death|29|||
156789812|NCT02774278|565981376|FG000|Overall Study|Adverse event/intercurrent illness|16|||
156789813|NCT02774278|565981376|FG000|Overall Study|Refused treatment/did not cooperate|9|||
156789814|NCT02774278|565981376|FG000|Overall Study|Administrative reasons|6|||
156789815|NCT02774278|565981376|FG000|Overall Study|Withdrawal by Subject|3|||
156789816|NCT02774278|565981376|FG000|Overall Study|Protocol Violation|2|||
156789817|NCT00236197|565981379|FG000|Overall Study|Withdrawal by Subject|3|||
156789818|NCT00236197|565981380|FG001|Overall Study|Withdrawal by Subject|2|||
156789819|NCT00236197|565981379|FG000|Overall Study|Lost to Follow-up|1|||
156789820|NCT00236197|565981380|FG001|Overall Study|Lost to Follow-up|5|||
156789821|NCT00236197|565981379|FG000|Overall Study|Protocol Violation|0|||
156789822|NCT00236197|565981380|FG001|Overall Study|Protocol Violation|3|||
156789823|NCT00236197|565981379|FG000|Overall Study|Medication non-compliance|1|||
156789824|NCT00236197|565981380|FG001|Overall Study|Medication non-compliance|2|||
156789825|NCT00236197|565981379|FG000|Overall Study|Other|0|||
156789826|NCT00236197|565981380|FG001|Overall Study|Other|2|||
156789827|NCT03760666|565981383|FG000|Overall Study|Adverse Event|2|||
156789828|NCT03760666|565981384|FG001|Overall Study|Adverse Event|4|||
156789829|NCT03760666|565981385|FG002|Overall Study|Adverse Event|1|||
156789830|NCT03760666|565981383|FG000|Overall Study|AML Disease Progression|3|||
156789831|NCT03760666|565981384|FG001|Overall Study|AML Disease Progression|3|||
156789832|NCT03760666|565981385|FG002|Overall Study|AML Disease Progression|0|||
156789833|NCT03760666|565981383|FG000|Overall Study|Physician Decision|0|||
156789834|NCT03760666|565981384|FG001|Overall Study|Physician Decision|3|||
156789835|NCT03760666|565981385|FG002|Overall Study|Physician Decision|0|||
156789836|NCT03760666|565981383|FG000|Overall Study|Withdrawal by Subject|0|||
156789837|NCT03760666|565981384|FG001|Overall Study|Withdrawal by Subject|1|||
156789838|NCT03760666|565981385|FG002|Overall Study|Withdrawal by Subject|0|||
156694716|NCT02307266|565629540|FG000|Overall Study|Withdrawal by Subject|2|||
156694717|NCT02307266|565629541|FG001|Overall Study|Withdrawal by Subject|0|||
156694718|NCT02307266|565629542|FG002|Overall Study|Withdrawal by Subject|1|||
156694719|NCT02307266|565629540|FG000|Overall Study|Lost to Follow-up|3|||
156694720|NCT02307266|565629541|FG001|Overall Study|Lost to Follow-up|0|||
156694721|NCT02307266|565629542|FG002|Overall Study|Lost to Follow-up|0|||
156694722|NCT02856880|565629544|FG000|Overall Study|Withdrawal of consent|1|||
156694723|NCT00793780|565629545|FG000|Overall Study|Withdrawal by Subject|2|||
156694724|NCT00793780|565629546|FG001|Overall Study|Withdrawal by Subject|1|||
156694725|NCT02858492|565629547|FG000|Overall Study|Withdrawal by Subject|0|||
156694726|NCT02858492|565629548|FG001|Overall Study|Withdrawal by Subject|1|||
156694727|NCT02858492|565629549|FG002|Overall Study|Withdrawal by Subject|0|||
156789839|NCT01800058|565981390|FG000|Overall Study|Lost to Follow-up|1|||
156789840|NCT06868667|565981391|FG000|Overall Study|Death|0|||
156789841|NCT06868667|565981392|FG001|Overall Study|Death|4|||
156789842|NCT06868667|565981391|FG000|Overall Study|Lost to Follow-up|0|||
156789843|NCT06868667|565981392|FG001|Overall Study|Lost to Follow-up|1|||
156789844|NCT06868667|565981391|FG000|Overall Study|Withdrawal by Subject|1|||
156789845|NCT06868667|565981392|FG001|Overall Study|Withdrawal by Subject|0|||
156789846|NCT06868667|565981391|FG000|Overall Study|Ongoing|9|||
156789847|NCT06868667|565981392|FG001|Overall Study|Ongoing|9|||
156694728|NCT02858492|565629550|FG003|Overall Study|Withdrawal by Subject|1|||
156694729|NCT02858492|565629547|FG000|Overall Study|Adverse Event|0|||
156694730|NCT02858492|565629548|FG001|Overall Study|Adverse Event|0|||
156789848|NCT05330429|565981393|FG000|Overall Study|Study Terminated by Sponsor|4|||
156789849|NCT05330429|565981394|FG001|Overall Study|Study Terminated by Sponsor|33|||
156789850|NCT05330429|565981395|FG002|Overall Study|Study Terminated by Sponsor|12|||
156789851|NCT05330429|565981393|FG000|Overall Study|Death|5|||
156789852|NCT05330429|565981394|FG001|Overall Study|Death|2|||
156789853|NCT05330429|565981395|FG002|Overall Study|Death|4|||
156789854|NCT05330429|565981393|FG000|Overall Study|Withdrew Consent|0|||
156789855|NCT05330429|565981394|FG001|Overall Study|Withdrew Consent|5|||
156789856|NCT05330429|565981395|FG002|Overall Study|Withdrew Consent|4|||
156789857|NCT05330429|565981393|FG000|Overall Study|Investigator's Discretion|0|||
156789858|NCT05330429|565981394|FG001|Overall Study|Investigator's Discretion|1|||
156789859|NCT05330429|565981395|FG002|Overall Study|Investigator's Discretion|3|||
156789860|NCT05330429|565981393|FG000|Overall Study|Subject Decision|1|||
156789861|NCT05330429|565981394|FG001|Overall Study|Subject Decision|2|||
156789862|NCT05330429|565981395|FG002|Overall Study|Subject Decision|0|||
156789863|NCT05330429|565981393|FG000|Overall Study|Lost to Follow-up|0|||
156789864|NCT05330429|565981394|FG001|Overall Study|Lost to Follow-up|1|||
156789865|NCT05330429|565981395|FG002|Overall Study|Lost to Follow-up|0|||
156789866|NCT06097273|565981399|FG000|Overall Study|Death|2|||
156789867|NCT06097273|565981400|FG001|Overall Study|Death|1|||
156789868|NCT06097273|565981401|FG002|Overall Study|Death|2|||
156789869|NCT06097273|565981402|FG003|Overall Study|Death|2|||
156694731|NCT02858492|565629549|FG002|Overall Study|Adverse Event|0|||
156694732|NCT02858492|565629550|FG003|Overall Study|Adverse Event|3|||
156694733|NCT02858492|565629547|FG000|Overall Study|Lack of Efficacy|0|||
156789870|NCT06097273|565981399|FG000|Overall Study|Lost to Follow-up|27|||
156330938|NCT03841448|564311911|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
156789871|NCT06097273|565981400|FG001|Overall Study|Lost to Follow-up|18|||
156789872|NCT06097273|565981401|FG002|Overall Study|Lost to Follow-up|36|||
156789873|NCT06097273|565981402|FG003|Overall Study|Lost to Follow-up|31|||
156789874|NCT06097273|565981399|FG000|Overall Study|Physician Decision|0|||
156789875|NCT06097273|565981400|FG001|Overall Study|Physician Decision|1|||
156694734|NCT02858492|565629548|FG001|Overall Study|Lack of Efficacy|0|||
156694735|NCT02858492|565629549|FG002|Overall Study|Lack of Efficacy|0|||
156694736|NCT02858492|565629550|FG003|Overall Study|Lack of Efficacy|1|||
156694737|NCT02858492|565629547|FG000|Overall Study|Protocol defined stopping criteria|0|||
156694738|NCT02858492|565629548|FG001|Overall Study|Protocol defined stopping criteria|0|||
156694739|NCT02858492|565629549|FG002|Overall Study|Protocol defined stopping criteria|0|||
156694740|NCT02858492|565629550|FG003|Overall Study|Protocol defined stopping criteria|1|||
156694741|NCT02944383|565629551|FG000|Overall Study|Lost to Follow-up|0|||
156694742|NCT02944383|565629552|FG001|Overall Study|Lost to Follow-up|0|||
156694743|NCT02944383|565629553|FG002|Overall Study|Lost to Follow-up|1|||
156694744|NCT02944383|565629551|FG000|Overall Study|Withdrawal by Subject|1|||
156694745|NCT02944383|565629552|FG001|Overall Study|Withdrawal by Subject|0|||
156694746|NCT02944383|565629553|FG002|Overall Study|Withdrawal by Subject|0|||
156694747|NCT03623386|565629556|FG000|Overall Study|Protocol Violation|3|||
156330939|NCT03841448|564311912|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
156694748|NCT03623386|565629557|FG001|Overall Study|Protocol Violation|2|||
156694749|NCT03623386|565629558|FG002|Overall Study|Protocol Violation|0|||
156694750|NCT03623386|565629556|FG000|Overall Study|Physician Decision|1|||
156330940|NCT03841448|564311909|FG000|Open-Label Extension (OLE) Period|Death|0|||
156330941|NCT03841448|564311910|FG001|Open-Label Extension (OLE) Period|Death|0|||
156330942|NCT03841448|564311911|FG002|Open-Label Extension (OLE) Period|Death|0|||
156694751|NCT03623386|565629557|FG001|Overall Study|Physician Decision|1|||
156694752|NCT03623386|565629558|FG002|Overall Study|Physician Decision|0|||
156694753|NCT03623386|565629556|FG000|Overall Study|Lost to Follow-up|0|||
156694754|NCT03623386|565629557|FG001|Overall Study|Lost to Follow-up|2|||
156694755|NCT03623386|565629558|FG002|Overall Study|Lost to Follow-up|0|||
156694756|NCT03623386|565629556|FG000|Overall Study|COVID-19|0|||
156694757|NCT03623386|565629557|FG001|Overall Study|COVID-19|1|||
156694758|NCT03623386|565629558|FG002|Overall Study|COVID-19|0|||
156694759|NCT00515541|565629559|FG000|Overall Study|Physician Decision|0|||
156694760|NCT00515541|565629560|FG001|Overall Study|Physician Decision|2|||
156694761|NCT00515541|565629561|FG002|Overall Study|Physician Decision|0|||
156694762|NCT00515541|565629562|FG003|Overall Study|Physician Decision|1|||
156694763|NCT00515541|565629559|FG000|Overall Study|No show for appointments|0|||
156694764|NCT00515541|565629560|FG001|Overall Study|No show for appointments|1|||
156694765|NCT00515541|565629561|FG002|Overall Study|No show for appointments|0|||
156694766|NCT00515541|565629562|FG003|Overall Study|No show for appointments|2|||
156694767|NCT00515541|565629559|FG000|Overall Study|Withdrawal by Subject|0|||
156694768|NCT00515541|565629560|FG001|Overall Study|Withdrawal by Subject|2|||
156694769|NCT00515541|565629561|FG002|Overall Study|Withdrawal by Subject|0|||
156694770|NCT00515541|565629562|FG003|Overall Study|Withdrawal by Subject|2|||
156694771|NCT02588950|565629563|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
156694772|NCT02588950|565629564|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
156694773|NCT02588950|565629565|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
156694774|NCT02588950|565629566|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
156694775|NCT02588950|565629563|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
156694776|NCT02588950|565629564|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
156694777|NCT02588950|565629565|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
156694778|NCT02588950|565629566|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
156694779|NCT02072824|565629567|FG000|Overall Study|Insufficient clinical response|1|||
156694780|NCT02072824|565629568|FG001|Overall Study|Insufficient clinical response|0|||
156694781|NCT02072824|565629569|FG002|Overall Study|Insufficient clinical response|1|||
156694782|NCT02072824|565629567|FG000|Overall Study|No longer willing to participate|1|||
156694783|NCT02072824|565629568|FG001|Overall Study|No longer willing to participate|0|||
156789876|NCT06097273|565981401|FG002|Overall Study|Physician Decision|0|||
156789877|NCT06097273|565981402|FG003|Overall Study|Physician Decision|3|||
156789878|NCT06097273|565981399|FG000|Overall Study|Protocol Violation|1|||
156789879|NCT06097273|565981400|FG001|Overall Study|Protocol Violation|1|||
156330943|NCT03841448|564311912|FG003|Open-Label Extension (OLE) Period|Death|1|||
156330944|NCT03841448|564311909|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
156330945|NCT03841448|564311910|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
156330946|NCT03841448|564311911|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
156330947|NCT03841448|564311912|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
156694784|NCT02072824|565629569|FG002|Overall Study|No longer willing to participate|1|||
156694785|NCT02072824|565629567|FG000|Overall Study|Medication error|0|||
156694786|NCT02072824|565629568|FG001|Overall Study|Medication error|1|||
156694787|NCT02072824|565629569|FG002|Overall Study|Medication error|0|||
156694788|NCT02072824|565629567|FG000|Overall Study|Adverse Event|0|||
156694789|NCT02072824|565629568|FG001|Overall Study|Adverse Event|0|||
156789880|NCT06097273|565981401|FG002|Overall Study|Protocol Violation|2|||
156789881|NCT06097273|565981402|FG003|Overall Study|Protocol Violation|1|||
156330948|NCT03841448|564311909|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
156330949|NCT03841448|564311910|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
156330950|NCT03841448|564311911|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
156694790|NCT02072824|565629569|FG002|Overall Study|Adverse Event|1|||
156694791|NCT00841906|565629572|FG000|Overall Study|Withdrawal by Subject|2|||
156694792|NCT00841906|565629573|FG001|Overall Study|Withdrawal by Subject|0|||
156694793|NCT03921151|565629574|FG000|Overall Study|Withdrawal by Subject|11|||
156694794|NCT03921151|565629575|FG001|Overall Study|Withdrawal by Subject|16|||
156694795|NCT00857792|565629577|FG000|Overall Study|inadequate image quality for analysis|12|||
156694796|NCT03001219|565629581|FG000|Proof of Concept|Study Termination by Sponsor|0|||
156694797|NCT03001219|565629582|FG001|Proof of Concept|Study Termination by Sponsor|1|||
156694798|NCT03001219|565629581|FG000|Proof of Concept|Withdrawal by Subject|0|||
156694799|NCT03001219|565629582|FG001|Proof of Concept|Withdrawal by Subject|4|||
156694800|NCT03001219|565629581|FG000|Proof of Concept|Protocol Deviation|0|||
156694801|NCT03001219|565629582|FG001|Proof of Concept|Protocol Deviation|1|||
156694802|NCT03001219|565629581|FG000|Proof of Concept|Adverse Event|1|||
156694803|NCT03001219|565629582|FG001|Proof of Concept|Adverse Event|1|||
156694804|NCT03001219|565629581|FG000|Proof of Concept|Physician Decision|1|||
156694805|NCT03001219|565629582|FG001|Proof of Concept|Physician Decision|0|||
156694806|NCT03001219|565629581|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
156694807|NCT03001219|565629582|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
156694808|NCT03001219|565629581|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
156694809|NCT03001219|565629582|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
156694810|NCT03001219|565629581|FG000|Extension Period Analysis|Physician Decision|0|||
156694811|NCT03001219|565629582|FG001|Extension Period Analysis|Physician Decision|1|||
156694812|NCT03001219|565629581|FG000|Extension Period Analysis|Adverse Event|1|||
156694813|NCT03001219|565629582|FG001|Extension Period Analysis|Adverse Event|1|||
156694814|NCT03001219|565629581|FG000|Extension Period Analysis|Protocol Deviation|0|||
156694815|NCT03001219|565629582|FG001|Extension Period Analysis|Protocol Deviation|1|||
156694816|NCT03001219|565629581|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
156694817|NCT03001219|565629582|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
156694818|NCT03760250|565629584|FG000|Overall Study|Withdrawal by Subject|1|||
156694819|NCT03760250|565629584|FG000|Overall Study|Physician Decision|1|||
156694820|NCT03733210|565629585|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
156694821|NCT03733210|565629586|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
156694822|NCT04421586|565629587|FG000|Overall Study|Death|0|||
156694823|NCT04421586|565629588|FG001|Overall Study|Death|1|||
156694824|NCT04421586|565629587|FG000|Overall Study|Lost to Follow-up|2|||
156694825|NCT04421586|565629588|FG001|Overall Study|Lost to Follow-up|2|||
156694826|NCT04421586|565629587|FG000|Overall Study|Withdrawn by PI|1|||
156694827|NCT04421586|565629588|FG001|Overall Study|Withdrawn by PI|0|||
156694828|NCT04421586|565629587|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
156694829|NCT04421586|565629588|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
156694830|NCT02963441|565629589|FG000|Overall Study|Protocol violation or withdrawn|8|||
156694831|NCT02963441|565629589|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
156694832|NCT02963441|565629589|FG000|Overall Study|IDx-DR insufficient quality|33|||
156694833|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Adverse Event|9|||
156694834|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Adverse Event|4|||
156694835|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Adverse Event|5|||
156694836|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Adverse Event|9|||
156694837|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Adverse Event|8|||
156694838|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Adverse Event|0|||
156694839|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Adverse Event|0|||
156694840|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
156694841|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
156694842|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
156694843|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
156694844|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
156694845|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
156694846|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
156694847|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Death|1|||
156694848|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Death|1|||
156694849|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Death|1|||
156694850|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Death|1|||
156694851|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Death|0|||
156694852|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Death|0|||
156694853|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Death|0|||
156694854|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
156789882|NCT06097273|565981399|FG000|Overall Study|Withdrawal by Subject|14|||
156694855|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
156694856|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
156694857|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
156694858|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
156694859|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
156438102|NCT00722046|564695359|FG006|Overall Study|Randomized, but not treated|0|||
156694860|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
156789883|NCT06097273|565981400|FG001|Overall Study|Withdrawal by Subject|11|||
156438103|NCT00722046|564695353|FG000|Overall Study|Other|0|||
156694861|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694862|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694863|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
156694864|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694865|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694866|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694867|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694868|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
156694869|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
156694870|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
156694871|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
156694872|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
156694873|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
156694874|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
156694875|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Other|2|||
156694876|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Other|9|||
156694877|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Other|9|||
156694878|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Other|3|||
156694879|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Other|2|||
156694880|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Other|0|||
156694881|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Other|0|||
156694882|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
156694883|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
156694884|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
156694885|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
156694886|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
156694887|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
156694888|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
156694889|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
156694890|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
156694891|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
156694892|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
156694893|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
156694894|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
156694895|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
156694896|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
156694897|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
156694898|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
156694899|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
156694900|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
156694901|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
156694902|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
156694903|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Death|0|||
156694904|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Death|0|||
156694905|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Death|0|||
156694906|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Death|0|||
156694907|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Death|0|||
156694908|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Death|0|||
156694909|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Death|1|||
156694910|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
156694911|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
156694912|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
156694913|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
156694914|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
156694915|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
156694916|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
156694917|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Other|1|||
156694918|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Other|0|||
156694919|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Other|0|||
156694920|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Other|1|||
156694921|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Other|0|||
156789884|NCT06097273|565981401|FG002|Overall Study|Withdrawal by Subject|14|||
156789885|NCT06097273|565981402|FG003|Overall Study|Withdrawal by Subject|15|||
156694922|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Other|1|||
156694923|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Other|2|||
156694924|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156694925|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156694926|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
156694927|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156694928|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156694929|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156789886|NCT06097273|565981399|FG000|Overall Study|Other Than Specified|7|||
156694930|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
156694931|NCT01765582|565629599|FG000|Overall Study|Other|3|||
156694932|NCT01765582|565629600|FG001|Overall Study|Other|6|||
156694933|NCT01765582|565629601|FG002|Overall Study|Other|9|||
156694934|NCT01765582|565629599|FG000|Overall Study|Lost to Follow-up|2|||
156438104|NCT00722046|564695354|FG001|Overall Study|Other|0|||
156438105|NCT00722046|564695355|FG002|Overall Study|Other|1|||
156438106|NCT00722046|564695356|FG003|Overall Study|Other|1|||
156438107|NCT00722046|564695357|FG004|Overall Study|Other|3|||
156438108|NCT00722046|564695358|FG005|Overall Study|Other|2|||
156438109|NCT00722046|564695359|FG006|Overall Study|Other|1|||
156438110|NCT00516321|564695367|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
156438111|NCT00516321|564695368|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
156438112|NCT00516321|564695369|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
156438113|NCT00516321|564695367|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
156438114|NCT00516321|564695368|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
156438115|NCT00516321|564695369|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
156438116|NCT00516321|564695367|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
156438117|NCT00516321|564695368|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
156438118|NCT00516321|564695369|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
156438119|NCT00516321|564695367|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
156438120|NCT00516321|564695368|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
156438121|NCT00516321|564695369|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
156438122|NCT00516321|564695367|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
156438123|NCT00516321|564695368|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
156438124|NCT00516321|564695369|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
156438125|NCT00516321|564695367|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
156438126|NCT00516321|564695368|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
156438127|NCT00516321|564695369|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
156438128|NCT00516321|564695367|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
156438129|NCT00516321|564695368|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
156438130|NCT00516321|564695369|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
156438131|NCT00516321|564695367|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
156438132|NCT00516321|564695368|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
156438133|NCT00516321|564695369|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
156438134|NCT00516321|564695367|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
156438135|NCT00516321|564695368|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
156438136|NCT00516321|564695369|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
156438137|NCT00516321|564695367|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
156438138|NCT00516321|564695368|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
156438139|NCT00516321|564695369|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
156438140|NCT00516321|564695367|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
156438141|NCT00516321|564695368|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
156438142|NCT00516321|564695369|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
156438143|NCT01599104|564695374|FG000|Overall Study|Withdrawal by Subject|1|||
156438144|NCT01599104|564695375|FG001|Overall Study|Withdrawal by Subject|1|||
156438145|NCT01599104|564695376|FG002|Overall Study|Withdrawal by Subject|2|||
156438146|NCT01599104|564695374|FG000|Overall Study|Technical Problems|1|||
156438147|NCT01599104|564695375|FG001|Overall Study|Technical Problems|0|||
156438148|NCT01599104|564695376|FG002|Overall Study|Technical Problems|0|||
156438149|NCT01599104|564695374|FG000|Overall Study|Physician Decision|3|||
156438150|NCT01599104|564695375|FG001|Overall Study|Physician Decision|2|||
156438151|NCT01599104|564695376|FG002|Overall Study|Physician Decision|2|||
156438152|NCT01599104|564695374|FG000|Overall Study|Non-compliance with study treatment|0|||
156438153|NCT01599104|564695375|FG001|Overall Study|Non-compliance with study treatment|1|||
156438154|NCT01599104|564695376|FG002|Overall Study|Non-compliance with study treatment|0|||
156438155|NCT01599104|564695374|FG000|Overall Study|Lack of Efficacy|4|||
156438156|NCT01599104|564695375|FG001|Overall Study|Lack of Efficacy|4|||
156438157|NCT01599104|564695376|FG002|Overall Study|Lack of Efficacy|10|||
156438158|NCT01599104|564695374|FG000|Overall Study|Adverse Event|7|||
156438159|NCT01599104|564695375|FG001|Overall Study|Adverse Event|6|||
156438160|NCT01599104|564695376|FG002|Overall Study|Adverse Event|12|||
156438161|NCT02271854|564695379|FG000|Overall Study|Withdrawal by Subject|2|||
156438162|NCT02271854|564695379|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
156438163|NCT02271854|564695379|FG000|Overall Study|Lost to Follow-up|1|||
156438164|NCT01185561|564695382|FG000|Overall Study|Lost to Follow-up|0|||
156438165|NCT01185561|564695383|FG001|Overall Study|Lost to Follow-up|4|||
156438166|NCT01185561|564695382|FG000|Overall Study|Withdrawal by Subject|2|||
156438167|NCT01185561|564695383|FG001|Overall Study|Withdrawal by Subject|8|||
156694935|NCT01765582|565629600|FG001|Overall Study|Lost to Follow-up|2|||
156694936|NCT01765582|565629601|FG002|Overall Study|Lost to Follow-up|1|||
156694937|NCT01765582|565629599|FG000|Overall Study|Death|31|||
156694938|NCT01765582|565629600|FG001|Overall Study|Death|36|||
156694939|NCT01765582|565629601|FG002|Overall Study|Death|33|||
156694940|NCT01765582|565629599|FG000|Overall Study|Sponsor Decision|46|||
156694941|NCT01765582|565629600|FG001|Overall Study|Sponsor Decision|42|||
156694942|NCT01765582|565629601|FG002|Overall Study|Sponsor Decision|42|||
156694943|NCT01765582|565629599|FG000|Overall Study|Withdrawal of Consent|11|||
156694944|NCT01765582|565629600|FG001|Overall Study|Withdrawal of Consent|6|||
156694945|NCT01765582|565629601|FG002|Overall Study|Withdrawal of Consent|10|||
156694946|NCT00714493|565629604|FG000|Overall Study|Adverse Event|11|||
156694947|NCT00714493|565629604|FG000|Overall Study|Death|3|||
156694948|NCT00714493|565629604|FG000|Overall Study|Lack of Efficacy|10|||
156694949|NCT00714493|565629604|FG000|Overall Study|Lost to Follow-up|3|||
156694950|NCT00714493|565629604|FG000|Overall Study|Protocol Violation|12|||
156694951|NCT00714493|565629604|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
156694952|NCT00714493|565629604|FG000|Overall Study|OTHER|2|||
156694953|NCT01070771|565629605|FG000|Overall Study|Adverse Event|2|||
156694954|NCT01070771|565629605|FG000|Overall Study|Protocol Violation|1|||
156694955|NCT00136318|565629606|FG000|Overall Study|Adverse Event|5|||
156694956|NCT00136318|565629607|FG001|Overall Study|Adverse Event|5|||
156694957|NCT00136318|565629606|FG000|Overall Study|Withdrawal by Subject|2|||
156694958|NCT00136318|565629607|FG001|Overall Study|Withdrawal by Subject|2|||
156694959|NCT00725621|565629614|FG000|Overall Study|Adverse Event|25|||
156694960|NCT00725621|565629614|FG000|Overall Study|Lack of Efficacy|46|||
156694961|NCT00725621|565629614|FG000|Overall Study|Withdrawal by Subject|57|||
156694962|NCT00725621|565629614|FG000|Overall Study|Physician Decision|19|||
156789887|NCT06097273|565981400|FG001|Overall Study|Other Than Specified|3|||
156789888|NCT06097273|565981401|FG002|Overall Study|Other Than Specified|11|||
156870913|NCT00318643|566284317|FG001|Overall Study|Investigator's Decision|0|||
156870914|NCT00318643|566284318|FG002|Overall Study|Investigator's Decision|0|||
156870915|NCT00318643|566284319|FG003|Overall Study|Investigator's Decision|0|||
156870916|NCT00318643|566284320|FG004|Overall Study|Investigator's Decision|1|||
156870917|NCT02691507|566284323|FG000|Overall Study|Missed Visit 3|0|||
156870918|NCT02691507|566284324|FG001|Overall Study|Missed Visit 3|1|||
156870919|NCT01812252|566284325|FG000|Overall Study|Persistent Disease|1|||
156870920|NCT01812252|566284326|FG001|Overall Study|Persistent Disease|0|||
156870921|NCT01812252|566284325|FG000|Overall Study|Not transplanted|11|||
156870922|NCT01812252|566284326|FG001|Overall Study|Not transplanted|11|||
156789889|NCT06097273|565981402|FG003|Overall Study|Other Than Specified|6|||
156789890|NCT01027754|565983650|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
156789891|NCT01027754|565983651|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
156789892|NCT01027754|565983650|FG000|Overall Study|Withdrawal by Subject|0|||
156789893|NCT01027754|565983651|FG001|Overall Study|Withdrawal by Subject|5|||
156789894|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
156789895|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789896|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789897|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789898|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789899|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
156789900|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789901|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
156789902|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789903|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
156789904|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789905|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789906|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789907|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789908|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
156789909|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156789910|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156870923|NCT01812252|566284325|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
156330951|NCT03841448|564311912|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
156330952|NCT03841448|564311909|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
156694963|NCT00725621|565629614|FG000|Overall Study|Lost to Follow-up|52|||
156694964|NCT00725621|565629614|FG000|Overall Study|Non-compliance|8|||
156694965|NCT00725621|565629614|FG000|Overall Study|Continued treatment by other physician|6|||
156789911|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156870924|NCT01812252|566284326|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
156870925|NCT01812252|566284325|FG000|Overall Study|Withdrawal by Subject|1|||
156330953|NCT03841448|564311910|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
156530703|NCT01717768|565038134|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
156870926|NCT01812252|566284326|FG001|Overall Study|Withdrawal by Subject|1|||
156870927|NCT01812252|566284325|FG000|Overall Study|Screen Failure|1|||
156870928|NCT01812252|566284326|FG001|Overall Study|Screen Failure|0|||
156870929|NCT02557139|566284327|FG000|Overall Study|Significant liver elevation|1|||
156870930|NCT02557139|566284328|FG001|Overall Study|Significant liver elevation|0|||
156870931|NCT02557139|566284329|FG002|Overall Study|Significant liver elevation|1|||
156870932|NCT02557139|566284327|FG000|Overall Study|Withdrawal by Subject|1|||
156870933|NCT02557139|566284328|FG001|Overall Study|Withdrawal by Subject|0|||
156870934|NCT02557139|566284329|FG002|Overall Study|Withdrawal by Subject|0|||
156870935|NCT02557139|566284327|FG000|Overall Study|Illness of prohibited medication|0|||
156870936|NCT02557139|566284328|FG001|Overall Study|Illness of prohibited medication|0|||
156870937|NCT02557139|566284329|FG002|Overall Study|Illness of prohibited medication|1|||
156870938|NCT03023397|566284331|FG000|Run-In|Failed screening allergen challenge|1|||
156870939|NCT03023397|566284332|FG001|Run-In|Failed screening allergen challenge|0|||
156870940|NCT03023397|566284333|FG002|Run-In|Failed screening allergen challenge|0|||
156870941|NCT03023397|566284331|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
156870942|NCT03023397|566284332|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
156870943|NCT03023397|566284333|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
156870944|NCT01216189|566284337|FG000|Overall Study|Lost to Follow-up|21|||
156870945|NCT01216189|566284338|FG001|Overall Study|Lost to Follow-up|3|||
156870946|NCT01216189|566284337|FG000|Overall Study|Death|4|||
156870947|NCT01216189|566284338|FG001|Overall Study|Death|2|||
156870948|NCT01146795|566284339|FG000|Overall Study|Withdrawal by Subject|4|||
156870949|NCT01146795|566284339|FG000|Overall Study|Adverse Event|6|||
156870950|NCT01146795|566284339|FG000|Overall Study|Still in treatment at study closure|10|||
156870951|NCT05375760|566284340|FG000|Overall Study|Adverse Event|1|||
156870952|NCT05375760|566284341|FG001|Overall Study|Adverse Event|0|||
156870953|NCT05375760|566284340|FG000|Overall Study|Death|0|||
156870954|NCT05375760|566284341|FG001|Overall Study|Death|1|||
156870955|NCT05375760|566284340|FG000|Overall Study|Lost to Follow-up|6|||
156870956|NCT05375760|566284341|FG001|Overall Study|Lost to Follow-up|6|||
156870957|NCT05375760|566284340|FG000|Overall Study|Withdrawal by Subject|17|||
156870958|NCT05375760|566284341|FG001|Overall Study|Withdrawal by Subject|19|||
156870959|NCT05375760|566284340|FG000|Overall Study|Dosing halted by FDA|96|||
156870960|NCT05375760|566284341|FG001|Overall Study|Dosing halted by FDA|100|||
156870961|NCT05375760|566284340|FG000|Overall Study|Not compliant with study visit|2|||
156870962|NCT05375760|566284341|FG001|Overall Study|Not compliant with study visit|0|||
156870963|NCT05375760|566284340|FG000|Overall Study|Physician Decision|1|||
156870964|NCT05375760|566284341|FG001|Overall Study|Physician Decision|0|||
156870965|NCT05375760|566284340|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
156870966|NCT05375760|566284341|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
156530704|NCT01717768|565038135|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156789912|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156789913|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156789914|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156789915|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
156789916|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789917|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789918|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789919|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789920|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
156789921|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789922|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789923|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
156789924|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789925|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789926|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789927|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789928|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789929|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156870967|NCT05375760|566284340|FG000|Overall Study|Participant moved|1|||
156870968|NCT05375760|566284341|FG001|Overall Study|Participant moved|0|||
156870969|NCT03853109|566284342|FG000|Overall Study|Withdrawal by Subject|0|||
156870970|NCT03853109|566284343|FG001|Overall Study|Withdrawal by Subject|0|||
156870971|NCT03853109|566284344|FG002|Overall Study|Withdrawal by Subject|1|||
156870972|NCT03853109|566284345|FG003|Overall Study|Withdrawal by Subject|2|||
156870973|NCT03853109|566284346|FG004|Overall Study|Withdrawal by Subject|1|||
156694966|NCT00725621|565629614|FG000|Overall Study|Switched to other study|1|||
156694967|NCT00725621|565629614|FG000|Overall Study|Switched to other drug|1|||
156694968|NCT00725621|565629614|FG000|Overall Study|Prepared for elective surgery|1|||
156694969|NCT00725621|565629614|FG000|Overall Study|Reason not specified|55|||
156694970|NCT01189500|565629615|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
156694971|NCT01189500|565629615|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
156694972|NCT00851643|565629620|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
156694973|NCT00851643|565629621|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694974|NCT00851643|565629622|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694975|NCT00851643|565629623|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694976|NCT00851643|565629624|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694977|NCT00851643|565629625|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694978|NCT00851643|565629620|FG000|Base Study (Up to 12 Months)|Other|0|||
156694979|NCT00851643|565629621|FG001|Base Study (Up to 12 Months)|Other|0|||
156694980|NCT00851643|565629622|FG002|Base Study (Up to 12 Months)|Other|0|||
156694981|NCT00851643|565629623|FG003|Base Study (Up to 12 Months)|Other|0|||
156694982|NCT00851643|565629624|FG004|Base Study (Up to 12 Months)|Other|0|||
156694983|NCT00851643|565629625|FG005|Base Study (Up to 12 Months)|Other|1|||
156694984|NCT00851643|565629620|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
156694985|NCT00851643|565629621|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
156694986|NCT00851643|565629622|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
156694987|NCT00851643|565629623|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
156694988|NCT00851643|565629624|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
156694989|NCT00851643|565629625|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
156694990|NCT00851643|565629620|FG000|Extension Study (Up to 36 Months)|Moved|0|||
156694991|NCT00851643|565629621|FG001|Extension Study (Up to 36 Months)|Moved|2|||
156694992|NCT00851643|565629622|FG002|Extension Study (Up to 36 Months)|Moved|1|||
156694993|NCT00851643|565629623|FG003|Extension Study (Up to 36 Months)|Moved|1|||
156694994|NCT00851643|565629624|FG004|Extension Study (Up to 36 Months)|Moved|0|||
156694995|NCT00851643|565629625|FG005|Extension Study (Up to 36 Months)|Moved|1|||
156694996|NCT00359788|565629626|FG000|Overall Study|Adverse Event|11|||
156694997|NCT00359788|565629627|FG001|Overall Study|Adverse Event|10|||
156694998|NCT00359788|565629626|FG000|Overall Study|Lack of Efficacy|1|||
156694999|NCT00359788|565629627|FG001|Overall Study|Lack of Efficacy|2|||
156695000|NCT00359788|565629626|FG000|Overall Study|Lost to Follow-up|3|||
156695001|NCT00359788|565629627|FG001|Overall Study|Lost to Follow-up|2|||
156695002|NCT00359788|565629626|FG000|Overall Study|Withdrawal by Subject|4|||
156695003|NCT00359788|565629627|FG001|Overall Study|Withdrawal by Subject|1|||
156695004|NCT00359788|565629626|FG000|Overall Study|Protocol Violation|4|||
156695005|NCT00359788|565629627|FG001|Overall Study|Protocol Violation|2|||
156695006|NCT03351231|565629630|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
156695007|NCT03351231|565629630|FG000|Combination Therapy Period|Disease progression|2|||
156695008|NCT03351231|565629630|FG000|Combination Therapy Period|Study drug toxicity|1|||
156695009|NCT03351231|565629630|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
156695010|NCT03351231|565629630|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
156695011|NCT03351231|565629630|FG000|Safety Follow-Up Period|Other reason|2|||
156695012|NCT01673698|565629631|FG000|Overall Study|Lost to Follow-up|51|||
156695013|NCT01673698|565629632|FG001|Overall Study|Lost to Follow-up|13|||
156695014|NCT01297322|565629633|FG000|Overall Study|Lost to Follow-up|1|||
156695015|NCT01297322|565629634|FG001|Overall Study|Lost to Follow-up|0|||
156695016|NCT01297322|565629633|FG000|Overall Study|Withdrawal by Subject|0|||
156695017|NCT01297322|565629634|FG001|Overall Study|Withdrawal by Subject|1|||
156695018|NCT01297322|565629633|FG000|Overall Study|Protocol Violation|0|||
156695019|NCT01297322|565629634|FG001|Overall Study|Protocol Violation|3|||
156695020|NCT01111019|565629635|FG000|Overall Study|Withdrew Prematurely|2|||
156695021|NCT01111019|565629635|FG000|Overall Study|Other|1|||
156695022|NCT02013375|565629636|FG000|Overall Study|Did not engraft|1|||
156330954|NCT03841448|564311911|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
156330955|NCT03841448|564311912|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
156330956|NCT04068610|564311913|FG000|Overall Study|Death|4|||
156330957|NCT04068610|564311914|FG001|Overall Study|Death|8|||
156330958|NCT04068610|564311915|FG002|Overall Study|Death|13|||
156695023|NCT02013375|565629636|FG000|Overall Study|Did not engraft|1|||
156695024|NCT04062448|565631085|FG000|Overall Study|Lost to Follow-up|1|||
156695025|NCT04062448|565631085|FG000|Overall Study|Withdrawal by Subject|2|||
156695026|NCT04319718|565631089|FG000|Overall Study|Adverse Event|0|||
156695027|NCT04319718|565631090|FG001|Overall Study|Adverse Event|2|||
156695028|NCT04319718|565631089|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
156695029|NCT04319718|565631090|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
156695030|NCT00321828|565631091|FG000|Overall Study|Ineligible|3|||
156695031|NCT00321828|565631091|FG000|Overall Study|No follow up data|1|||
156330959|NCT04068610|564311913|FG000|Overall Study|Lost to Follow-up|0|||
156695032|NCT00858143|565631094|FG000|Overall Study|Adverse Event|16|||
156695033|NCT00858143|565631094|FG000|Overall Study|Lack of Efficacy|4|||
156695034|NCT00858143|565631094|FG000|Overall Study|Death|7|||
156695035|NCT00858143|565631094|FG000|Overall Study|Other|23|||
156695036|NCT03853148|565631099|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
156695037|NCT03853148|565631100|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
156695038|NCT03853148|565631101|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
156695039|NCT03853148|565631102|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
156695040|NCT00090610|565631103|FG000|Overall Study|Withdrawal by Subject|1|||
156695041|NCT00090610|565631104|FG001|Overall Study|Withdrawal by Subject|1|||
156695042|NCT00599521|565631107|FG000|Overall Study|Lack of Efficacy|4|||
156695043|NCT00599521|565631108|FG001|Overall Study|Lack of Efficacy|8|||
156695044|NCT00599521|565631107|FG000|Overall Study|Adverse Event|4|||
156695045|NCT00599521|565631108|FG001|Overall Study|Adverse Event|1|||
156695046|NCT00599521|565631107|FG000|Overall Study|Withdrawal by Subject|28|||
156695047|NCT00599521|565631108|FG001|Overall Study|Withdrawal by Subject|34|||
156695048|NCT00599521|565631107|FG000|Overall Study|Protocol Violation|1|||
156695049|NCT00599521|565631108|FG001|Overall Study|Protocol Violation|1|||
156695050|NCT00599521|565631107|FG000|Overall Study|Lost to Follow-up|23|||
156695051|NCT00599521|565631108|FG001|Overall Study|Lost to Follow-up|23|||
156695052|NCT00599521|565631107|FG000|Overall Study|Pregnancy|0|||
156695053|NCT00599521|565631108|FG001|Overall Study|Pregnancy|2|||
156695054|NCT05855616|565631111|FG000|Overall Study|Lost to Follow-up|1|||
156695055|NCT05855616|565631112|FG001|Overall Study|Lost to Follow-up|2|||
156695056|NCT01248013|565631115|FG000|Overall Study|Withdrawal by Subject|14|||
156695057|NCT01859130|565631116|FG000|Overall Study|Death|4|||
156695058|NCT01859130|565631116|FG000|Overall Study|Lost to Follow-up|16|||
156695059|NCT01859130|565631116|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
156695060|NCT01859130|565631116|FG000|Overall Study|Physician Decision|6|||
156695061|NCT01859130|565631116|FG000|Overall Study|Withdrawal by Subject|17|||
156695062|NCT01859130|565631116|FG000|Overall Study|Adverse Event|11|||
156695063|NCT01388166|565631117|FG000|Overall Study|Adverse Event|16|||
156695064|NCT01388166|565631117|FG000|Overall Study|Lost to Follow-up|30|||
156695065|NCT01388166|565631117|FG000|Overall Study|Others than specified above|13|||
156695066|NCT04325204|565631118|FG000|Overall Study|Death|0|||
156695067|NCT04325204|565631119|FG001|Overall Study|Death|1|||
156695068|NCT04325204|565631118|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
156695069|NCT04325204|565631119|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
156695070|NCT04325204|565631118|FG000|Overall Study|Lost to Follow-up|8|||
156695071|NCT04325204|565631119|FG001|Overall Study|Lost to Follow-up|8|||
156695072|NCT04325204|565631118|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
156695073|NCT04325204|565631119|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
156695074|NCT01196078|565631125|FG000|Overall Study|Withdrawal by Subject|3|||
156695075|NCT01196078|565631126|FG001|Overall Study|Withdrawal by Subject|5|||
156695076|NCT01196078|565631125|FG000|Overall Study|Adverse Event|4|||
156695077|NCT01196078|565631126|FG001|Overall Study|Adverse Event|4|||
156695078|NCT01196078|565631125|FG000|Overall Study|Protocol Violation|2|||
156695079|NCT01196078|565631126|FG001|Overall Study|Protocol Violation|1|||
156695080|NCT01196078|565631125|FG000|Overall Study|Lack of Efficacy|17|||
156695081|NCT01196078|565631126|FG001|Overall Study|Lack of Efficacy|23|||
156695082|NCT01196078|565631125|FG000|Overall Study|Lost to Follow-up|1|||
156695083|NCT01196078|565631126|FG001|Overall Study|Lost to Follow-up|0|||
156695084|NCT01196078|565631125|FG000|Overall Study|Death|6|||
156695085|NCT01196078|565631126|FG001|Overall Study|Death|4|||
156695086|NCT02667288|565631127|FG000|Overall Study|Protocol Violation|5|||
156695087|NCT02667288|565631127|FG000|Overall Study|Lost to Follow-up|3|||
156695088|NCT02667288|565631127|FG000|Overall Study|Withdrawal by Subject|5|||
156695089|NCT01429051|565631128|FG000|Titration Phase|Death|1|||
156695090|NCT01429051|565631128|FG000|Titration Phase|Withdrawal by Subject|7|||
156695091|NCT01429051|565631128|FG000|Titration Phase|Physician Decision|1|||
156695092|NCT01429051|565631128|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
156695093|NCT01429051|565631128|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
156695094|NCT01429051|565631128|FG000|Efficacy Phase|Adverse Event|1|||
156695095|NCT01429051|565631128|FG000|Efficacy Phase|Death|1|||
156695096|NCT01429051|565631128|FG000|Tolerability Phase|Death|5|||
156695097|NCT01429051|565631128|FG000|Tolerability Phase|Adverse Event|2|||
156695098|NCT01429051|565631128|FG000|Tolerability Phase|Withdrawal by Subject|5|||
156695099|NCT01429051|565631128|FG000|Tolerability Phase|Physician Decision|1|||
156695100|NCT01429051|565631128|FG000|Tolerability Phase|Other|2|||
156695101|NCT04688931|565631137|FG000|Overall Study|Adverse Event|4|||
156695102|NCT04688931|565631138|FG001|Overall Study|Adverse Event|1|||
156695103|NCT04688931|565631137|FG000|Overall Study|Withdrawal by Subject|5|||
156695104|NCT04688931|565631138|FG001|Overall Study|Withdrawal by Subject|16|||
156695105|NCT04688931|565631137|FG000|Overall Study|Physician Decision|3|||
156695106|NCT04688931|565631138|FG001|Overall Study|Physician Decision|5|||
156438168|NCT01078116|564695384|FG000|Overall Study|Lost to Follow-up|17|||
156695107|NCT04688931|565631137|FG000|Overall Study|Noncompliance|0|||
156695108|NCT04688931|565631138|FG001|Overall Study|Noncompliance|1|||
156695109|NCT04688931|565631137|FG000|Overall Study|Lost to Follow-up|1|||
156695110|NCT04688931|565631138|FG001|Overall Study|Lost to Follow-up|3|||
156695111|NCT04688931|565631137|FG000|Overall Study|Randomization Error|3|||
156695112|NCT04688931|565631138|FG001|Overall Study|Randomization Error|0|||
156695113|NCT04688931|565631137|FG000|Overall Study|Not Eligible|1|||
156695114|NCT04688931|565631138|FG001|Overall Study|Not Eligible|3|||
156695115|NCT04688931|565631137|FG000|Overall Study|Disease Progression|0|||
156695116|NCT04688931|565631138|FG001|Overall Study|Disease Progression|2|||
156695117|NCT04688931|565631137|FG000|Overall Study|Sponsor Requirement|1|||
156695118|NCT04688931|565631138|FG001|Overall Study|Sponsor Requirement|1|||
156695119|NCT04688931|565631137|FG000|Overall Study|Other Reason|1|||
156695120|NCT04688931|565631138|FG001|Overall Study|Other Reason|2|||
156695121|NCT00616941|565631139|FG000|Overall Study|Progressive Disease|1|||
156695122|NCT00616941|565631140|FG001|Overall Study|Progressive Disease|2|||
156695123|NCT00616941|565631141|FG002|Overall Study|Progressive Disease|1|||
156695124|NCT00616941|565631139|FG000|Overall Study|Adverse Event|0|||
156695125|NCT00616941|565631140|FG001|Overall Study|Adverse Event|1|||
156695126|NCT00616941|565631141|FG002|Overall Study|Adverse Event|1|||
156695127|NCT00616941|565631139|FG000|Overall Study|Subject Non-compliance|0|||
156695128|NCT00616941|565631140|FG001|Overall Study|Subject Non-compliance|0|||
156695129|NCT00616941|565631141|FG002|Overall Study|Subject Non-compliance|1|||
156695130|NCT00616941|565631139|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
156695131|NCT00616941|565631140|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
156695132|NCT00616941|565631141|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
156695133|NCT00616941|565631139|FG000|Overall Study|Vaccination Suspended|0|||
156695134|NCT00616941|565631140|FG001|Overall Study|Vaccination Suspended|0|||
156695135|NCT00616941|565631141|FG002|Overall Study|Vaccination Suspended|3|||
156695136|NCT00076804|565631149|FG000|Overall Study|Death|9|||
156695137|NCT00076804|565631150|FG001|Overall Study|Death|20|||
156695138|NCT00076804|565631149|FG000|Overall Study|Lost to Follow-up|9|||
156695139|NCT00076804|565631150|FG001|Overall Study|Lost to Follow-up|9|||
156695140|NCT00076804|565631149|FG000|Overall Study|Withdrawal by Subject|10|||
156695141|NCT00076804|565631150|FG001|Overall Study|Withdrawal by Subject|8|||
156695142|NCT00076804|565631149|FG000|Overall Study|Early study Closure|32|||
156695143|NCT00076804|565631150|FG001|Overall Study|Early study Closure|32|||
156695144|NCT00354341|565631153|FG000|Overall Study|Adverse Event|1|||
156695145|NCT00354341|565631154|FG001|Overall Study|Adverse Event|0|||
156695146|NCT00354341|565631153|FG000|Overall Study|Death|0|||
156695147|NCT00354341|565631154|FG001|Overall Study|Death|2|||
156695148|NCT00354341|565631153|FG000|Overall Study|Refused treatment|1|||
156695149|NCT00354341|565631154|FG001|Overall Study|Refused treatment|2|||
156695150|NCT00354341|565631153|FG000|Overall Study|Failure to return|0|||
156695151|NCT00354341|565631154|FG001|Overall Study|Failure to return|1|||
156695152|NCT00354341|565631153|FG000|Overall Study|Other|1|||
156695153|NCT00354341|565631154|FG001|Overall Study|Other|2|||
156695154|NCT00251719|565631155|FG000|Overall Study|Adverse Event|14|||
156695155|NCT00251719|565631156|FG001|Overall Study|Adverse Event|8|||
156695156|NCT00251719|565631157|FG002|Overall Study|Adverse Event|7|||
156695157|NCT00251719|565631155|FG000|Overall Study|Protocol Violation|1|||
156695158|NCT00251719|565631156|FG001|Overall Study|Protocol Violation|1|||
156695159|NCT00251719|565631157|FG002|Overall Study|Protocol Violation|1|||
156695160|NCT00251719|565631155|FG000|Overall Study|Lost to Follow-up|5|||
156695161|NCT00251719|565631156|FG001|Overall Study|Lost to Follow-up|11|||
156695162|NCT00251719|565631157|FG002|Overall Study|Lost to Follow-up|8|||
156695163|NCT00251719|565631155|FG000|Overall Study|Withdrawal by Subject|14|||
156695164|NCT00251719|565631156|FG001|Overall Study|Withdrawal by Subject|12|||
156438169|NCT01078116|564695384|FG000|Overall Study|Adverse Event|5|||
156438170|NCT01078116|564695384|FG000|Overall Study|Withdrawal by Subject|8|||
156438171|NCT01078116|564695384|FG000|Overall Study|Lack of effectiveness|15|||
156438172|NCT01078116|564695384|FG000|Overall Study|Case report form not completed|3|||
156438173|NCT02499159|564695385|FG000|Randomization|Protocol Violation|1|||
156695165|NCT00251719|565631157|FG002|Overall Study|Withdrawal by Subject|11|||
156695166|NCT00251719|565631155|FG000|Overall Study|Lack of Efficacy|2|||
156438174|NCT02499159|564695386|FG001|Randomization|Protocol Violation|1|||
156438175|NCT02499159|564695385|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
156695167|NCT00251719|565631156|FG001|Overall Study|Lack of Efficacy|1|||
156695168|NCT00251719|565631157|FG002|Overall Study|Lack of Efficacy|0|||
156695169|NCT00251719|565631155|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
156695170|NCT00251719|565631156|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
156695171|NCT00251719|565631157|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
156695172|NCT00251719|565631155|FG000|Overall Study|Investigator decision|1|||
156695173|NCT00251719|565631156|FG001|Overall Study|Investigator decision|1|||
156695174|NCT00251719|565631157|FG002|Overall Study|Investigator decision|0|||
156695175|NCT00251719|565631155|FG000|Overall Study|Noncompliance|2|||
156438176|NCT02499159|564695386|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
156330960|NCT04068610|564311914|FG001|Overall Study|Lost to Follow-up|2|||
156330961|NCT04068610|564311915|FG002|Overall Study|Lost to Follow-up|0|||
156695176|NCT00251719|565631156|FG001|Overall Study|Noncompliance|3|||
156695177|NCT00251719|565631157|FG002|Overall Study|Noncompliance|1|||
156695178|NCT00251719|565631155|FG000|Overall Study|Barrett's esophagus|2|||
156695179|NCT00251719|565631156|FG001|Overall Study|Barrett's esophagus|2|||
156695180|NCT00251719|565631157|FG002|Overall Study|Barrett's esophagus|0|||
156695181|NCT01449279|565631158|FG000|Overall Study|Lack of Efficacy|5|||
156695182|NCT01449279|565631158|FG000|Overall Study|Toxicity|2|||
156695183|NCT01732874|565631160|FG000|Overall Study|Withdrawal by Subject|5|||
156695184|NCT01732874|565631161|FG001|Overall Study|Withdrawal by Subject|1|||
156695185|NCT01732874|565631160|FG000|Overall Study|Death of Infant|3|||
156695186|NCT01732874|565631161|FG001|Overall Study|Death of Infant|2|||
156695187|NCT00688376|565631164|FG000|Double-Blind Phase|Adverse Event|4|||
156695188|NCT00688376|565631165|FG001|Double-Blind Phase|Adverse Event|4|||
156695189|NCT00688376|565631164|FG000|Double-Blind Phase|Protocol Violation|1|||
156695190|NCT00688376|565631165|FG001|Double-Blind Phase|Protocol Violation|2|||
156695191|NCT00688376|565631164|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
156695192|NCT00688376|565631165|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
156695193|NCT00688376|565631164|FG000|Double-Blind Phase|Not treated|0|||
156695194|NCT00688376|565631165|FG001|Double-Blind Phase|Not treated|1|||
156695195|NCT00688376|565631164|FG000|Blinded Extension Phase|Adverse Event|3|||
156695196|NCT00688376|565631165|FG001|Blinded Extension Phase|Adverse Event|4|||
156695197|NCT00688376|565631164|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
156695198|NCT00688376|565631165|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
156695199|NCT00688376|565631164|FG000|Blinded Extension Phase|Physician Decision|1|||
156695200|NCT00688376|565631165|FG001|Blinded Extension Phase|Physician Decision|0|||
156695201|NCT00688376|565631164|FG000|Blinded Extension Phase|Other|1|||
156695202|NCT00688376|565631165|FG001|Blinded Extension Phase|Other|0|||
156695203|NCT00557076|565631166|FG000|Overall Study|Unblinding|0|||
156695204|NCT00557076|565631167|FG001|Overall Study|Unblinding|1|||
156695205|NCT02792959|565631169|FG000|Overall Study|Protocol Violation|1|||
156695206|NCT03201250|565631170|FG000|Overall Study|screen failures|3|||
156695207|NCT03201250|565631171|FG001|Overall Study|screen failures|0|||
156695208|NCT03201250|565631172|FG002|Overall Study|screen failures|0|||
156695209|NCT03484117|565631173|FG000|Overall Study|Lost to Follow-up|1|||
156695210|NCT03484117|565631174|FG001|Overall Study|Lost to Follow-up|3|||
156695211|NCT03484117|565631173|FG000|Overall Study|Declined participation in exit assess|1|||
156695212|NCT03484117|565631174|FG001|Overall Study|Declined participation in exit assess|1|||
156695213|NCT03551496|565631178|FG000|Overall Study|Death|11|||
156695214|NCT03551496|565631179|FG001|Overall Study|Death|7|||
156695215|NCT03551496|565631178|FG000|Overall Study|Withdrawal by Subject|4|||
156695216|NCT03551496|565631179|FG001|Overall Study|Withdrawal by Subject|3|||
156695217|NCT03551496|565631178|FG000|Overall Study|Other Reasons|1|||
156695218|NCT03551496|565631179|FG001|Overall Study|Other Reasons|0|||
156695219|NCT01780987|565631182|FG000|Overall Study|Adverse Event|0|||
156695220|NCT01780987|565631183|FG001|Overall Study|Adverse Event|4|||
156695221|NCT01780987|565631182|FG000|Overall Study|Withdrawal by Subject|2|||
156695222|NCT01780987|565631183|FG001|Overall Study|Withdrawal by Subject|0|||
156695223|NCT01780987|565631182|FG000|Overall Study|Request of Changing Hospital|0|||
156695224|NCT01780987|565631183|FG001|Overall Study|Request of Changing Hospital|1|||
156695225|NCT01780987|565631182|FG000|Overall Study|Changing Residence|1|||
156695226|NCT01780987|565631183|FG001|Overall Study|Changing Residence|0|||
156695227|NCT01780987|565631182|FG000|Overall Study|Not Receiving any Study Medication|0|||
156695228|NCT01780987|565631183|FG001|Overall Study|Not Receiving any Study Medication|1|||
156695229|NCT02303041|565631184|FG000|Overall Study|Adverse Event|1|||
156695230|NCT02303041|565631185|FG001|Overall Study|Adverse Event|2|||
156695231|NCT00886288|565631186|FG000|Overall Study|no respect of the 12 weeks period|657|||
156695232|NCT00886288|565631187|FG001|Overall Study|no respect of the 12 weeks period|227|||
156695233|NCT00886288|565631186|FG000|Overall Study|Lost to Follow-up|86|||
156695234|NCT00886288|565631187|FG001|Overall Study|Lost to Follow-up|0|||
156695235|NCT02335983|565631188|FG000|Overall Study|Sponsor Decision|0|||
156330962|NCT04068610|564311913|FG000|Overall Study|Withdrawal by Subject|0|||
156330963|NCT04068610|564311914|FG001|Overall Study|Withdrawal by Subject|4|||
156330964|NCT04068610|564311915|FG002|Overall Study|Withdrawal by Subject|2|||
156330965|NCT04068610|564311913|FG000|Overall Study|Other|3|||
156330966|NCT04068610|564311914|FG001|Overall Study|Other|12|||
156695236|NCT02335983|565631189|FG001|Overall Study|Sponsor Decision|0|||
156695237|NCT02335983|565631190|FG002|Overall Study|Sponsor Decision|1|||
156695238|NCT02335983|565631191|FG003|Overall Study|Sponsor Decision|1|||
156695239|NCT02335983|565631192|FG004|Overall Study|Sponsor Decision|0|||
156695240|NCT02335983|565631193|FG005|Overall Study|Sponsor Decision|1|||
156695241|NCT02335983|565631188|FG000|Overall Study|Withdrawal by Subject|3|||
156695242|NCT02335983|565631189|FG001|Overall Study|Withdrawal by Subject|2|||
156695243|NCT02335983|565631190|FG002|Overall Study|Withdrawal by Subject|2|||
156695244|NCT02335983|565631191|FG003|Overall Study|Withdrawal by Subject|1|||
156330967|NCT04068610|564311915|FG002|Overall Study|Other|11|||
156330968|NCT05535972|564311916|FG000|Overall Study|Withdrawal by Subject|31|||
156695245|NCT02335983|565631192|FG004|Overall Study|Withdrawal by Subject|3|||
156695246|NCT02335983|565631193|FG005|Overall Study|Withdrawal by Subject|9|||
156695247|NCT02335983|565631188|FG000|Overall Study|Death|0|||
156695248|NCT02335983|565631189|FG001|Overall Study|Death|0|||
156695249|NCT02335983|565631190|FG002|Overall Study|Death|2|||
156695250|NCT02335983|565631191|FG003|Overall Study|Death|0|||
156695251|NCT02335983|565631192|FG004|Overall Study|Death|0|||
156695252|NCT02335983|565631193|FG005|Overall Study|Death|0|||
156695253|NCT02335983|565631188|FG000|Overall Study|Lost to Follow-up|0|||
156695254|NCT02335983|565631189|FG001|Overall Study|Lost to Follow-up|0|||
156695255|NCT02335983|565631190|FG002|Overall Study|Lost to Follow-up|0|||
156695256|NCT02335983|565631191|FG003|Overall Study|Lost to Follow-up|0|||
156695257|NCT02335983|565631192|FG004|Overall Study|Lost to Follow-up|0|||
156695258|NCT02335983|565631193|FG005|Overall Study|Lost to Follow-up|1|||
156695259|NCT02335983|565631188|FG000|Overall Study|Protocol Specified Criteria|5|||
156695260|NCT02335983|565631189|FG001|Overall Study|Protocol Specified Criteria|7|||
156695261|NCT02335983|565631190|FG002|Overall Study|Protocol Specified Criteria|27|||
156695262|NCT02335983|565631191|FG003|Overall Study|Protocol Specified Criteria|7|||
156695263|NCT02335983|565631192|FG004|Overall Study|Protocol Specified Criteria|5|||
156695264|NCT02335983|565631193|FG005|Overall Study|Protocol Specified Criteria|21|||
156695265|NCT00289874|565631194|FG000|Overall Study|Adverse Event|1|||
156695266|NCT00289874|565631195|FG001|Overall Study|Adverse Event|5|||
156695267|NCT00289874|565631194|FG000|Overall Study|Lost to Follow-up|1|||
156695268|NCT00289874|565631195|FG001|Overall Study|Lost to Follow-up|1|||
156695269|NCT00289874|565631194|FG000|Overall Study|Protocol Violation|3|||
156695270|NCT00289874|565631195|FG001|Overall Study|Protocol Violation|2|||
156695271|NCT00289874|565631194|FG000|Overall Study|Did not meet eligibility|1|||
156695272|NCT00289874|565631195|FG001|Overall Study|Did not meet eligibility|0|||
156695273|NCT04700280|565631201|FG000|Overall Study|Adverse Event|4|||
156695274|NCT04700280|565631202|FG001|Overall Study|Adverse Event|0|||
156695275|NCT04700280|565631201|FG000|Overall Study|Lack of Efficacy|1|||
156695276|NCT04700280|565631202|FG001|Overall Study|Lack of Efficacy|0|||
156695277|NCT04700280|565631201|FG000|Overall Study|Study terminated by sponsor|5|||
156695278|NCT04700280|565631202|FG001|Overall Study|Study terminated by sponsor|3|||
156695279|NCT04700280|565631201|FG000|Overall Study|Other than specified|1|||
156695280|NCT04700280|565631202|FG001|Overall Study|Other than specified|0|||
156695281|NCT01843348|565631203|FG000|Overall Study|Withdrawal by Subject|4|||
156330969|NCT05535972|564311916|FG000|Overall Study|Lost to Follow-up|5|||
156330970|NCT05535972|564311916|FG000|Overall Study|Adverse Event|6|||
156330971|NCT05535972|564311916|FG000|Overall Study|Protocol Deviation|2|||
156330972|NCT00586625|564311917|FG000|Overall Study|Adverse Event|6|||
156330973|NCT00586625|564311918|FG001|Overall Study|Adverse Event|6|||
156330974|NCT00586625|564311917|FG000|Overall Study|Protocol Violation|3|||
156438177|NCT02499159|564695385|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
156438178|NCT02499159|564695386|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
156438179|NCT02499159|564695385|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
156695282|NCT01843348|565631204|FG001|Overall Study|Withdrawal by Subject|16|||
156695283|NCT01843348|565631205|FG002|Overall Study|Withdrawal by Subject|18|||
156695284|NCT01843348|565631203|FG000|Overall Study|Lost to Follow-up|5|||
156695285|NCT01843348|565631204|FG001|Overall Study|Lost to Follow-up|4|||
156695286|NCT01843348|565631205|FG002|Overall Study|Lost to Follow-up|2|||
156695287|NCT01843348|565631203|FG000|Overall Study|Death|5|||
156695288|NCT01843348|565631204|FG001|Overall Study|Death|3|||
156695289|NCT01843348|565631205|FG002|Overall Study|Death|4|||
156695290|NCT01843348|565631203|FG000|Overall Study|Graft loss/retransplantation|5|||
156695291|NCT01843348|565631204|FG001|Overall Study|Graft loss/retransplantation|8|||
156695292|NCT01843348|565631205|FG002|Overall Study|Graft loss/retransplantation|11|||
156695293|NCT01843348|565631203|FG000|Overall Study|Various reasons|4|||
156695294|NCT01843348|565631204|FG001|Overall Study|Various reasons|9|||
156330975|NCT00586625|564311918|FG001|Overall Study|Protocol Violation|0|||
156438180|NCT02499159|564695386|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
156438181|NCT02499159|564695385|FG000|30-Day Follow-Up Phone Call|Other|1|||
156438182|NCT02499159|564695386|FG001|30-Day Follow-Up Phone Call|Other|0|||
156695295|NCT01843348|565631205|FG002|Overall Study|Various reasons|6|||
156695296|NCT00251641|565631206|FG000|Overall Study|Adverse Event|80|||
156695297|NCT00251641|565631207|FG001|Overall Study|Adverse Event|8|||
156695298|NCT00251641|565631206|FG000|Overall Study|Lack of Efficacy|2|||
156695299|NCT00251641|565631207|FG001|Overall Study|Lack of Efficacy|1|||
156695300|NCT00251641|565631206|FG000|Overall Study|Progression of Disease|0|||
156695301|NCT00251641|565631207|FG001|Overall Study|Progression of Disease|2|||
156695302|NCT00251641|565631206|FG000|Overall Study|Lost to Follow-up|3|||
156695303|NCT00251641|565631207|FG001|Overall Study|Lost to Follow-up|3|||
156695304|NCT00251641|565631206|FG000|Overall Study|Withdrawal by Subject|6|||
156695305|NCT00251641|565631207|FG001|Overall Study|Withdrawal by Subject|8|||
156695306|NCT00251641|565631206|FG000|Overall Study|Protocol Violation|10|||
156695307|NCT00251641|565631207|FG001|Overall Study|Protocol Violation|2|||
156330976|NCT00586625|564311917|FG000|Overall Study|Withdrawal by Subject|32|||
156330977|NCT00586625|564311918|FG001|Overall Study|Withdrawal by Subject|10|||
156695308|NCT00251641|565631206|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
156695309|NCT00251641|565631207|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
156695310|NCT00251641|565631206|FG000|Overall Study|Switched Treatment|9|||
156695311|NCT00251641|565631207|FG001|Overall Study|Switched Treatment|63|||
156695312|NCT02093221|565631208|FG000|Overall Study|Adverse Event|1|||
156695313|NCT02093221|565631209|FG001|Overall Study|Adverse Event|0|||
156695314|NCT02093221|565631210|FG002|Overall Study|Adverse Event|0|||
156695315|NCT02093221|565631211|FG003|Overall Study|Adverse Event|0|||
156695316|NCT02093221|565631212|FG004|Overall Study|Adverse Event|0|||
156695317|NCT02093221|565631208|FG000|Overall Study|Withdrawal by Subject|1|||
156695318|NCT02093221|565631209|FG001|Overall Study|Withdrawal by Subject|1|||
156695319|NCT02093221|565631210|FG002|Overall Study|Withdrawal by Subject|4|||
156695320|NCT02093221|565631211|FG003|Overall Study|Withdrawal by Subject|1|||
156695321|NCT02093221|565631212|FG004|Overall Study|Withdrawal by Subject|1|||
156695322|NCT02093221|565631208|FG000|Overall Study|Lost to Follow-up|2|||
156695323|NCT02093221|565631209|FG001|Overall Study|Lost to Follow-up|0|||
156695324|NCT02093221|565631210|FG002|Overall Study|Lost to Follow-up|1|||
156695325|NCT02093221|565631211|FG003|Overall Study|Lost to Follow-up|1|||
156695326|NCT02093221|565631212|FG004|Overall Study|Lost to Follow-up|0|||
156695327|NCT02093221|565631208|FG000|Overall Study|Death|0|||
156695328|NCT02093221|565631209|FG001|Overall Study|Death|1|||
156695329|NCT02093221|565631210|FG002|Overall Study|Death|0|||
156695330|NCT02093221|565631211|FG003|Overall Study|Death|0|||
156695331|NCT02093221|565631212|FG004|Overall Study|Death|0|||
156695332|NCT02093221|565631208|FG000|Overall Study|Protocol Violation|0|||
156695333|NCT02093221|565631209|FG001|Overall Study|Protocol Violation|1|||
156695334|NCT02093221|565631210|FG002|Overall Study|Protocol Violation|0|||
156695335|NCT02093221|565631211|FG003|Overall Study|Protocol Violation|0|||
156695336|NCT02093221|565631212|FG004|Overall Study|Protocol Violation|0|||
156695337|NCT02093221|565631208|FG000|Overall Study|Study termination|6|||
156695338|NCT02093221|565631209|FG001|Overall Study|Study termination|5|||
156695339|NCT02093221|565631210|FG002|Overall Study|Study termination|4|||
156695340|NCT02093221|565631211|FG003|Overall Study|Study termination|6|||
156695341|NCT02093221|565631212|FG004|Overall Study|Study termination|7|||
156695342|NCT05069155|565631213|FG000|Overall Study|Withdrawal by Subject|1|||
156695343|NCT05069155|565631214|FG001|Overall Study|Withdrawal by Subject|3|||
156695344|NCT01929031|565631215|FG000|Overall Study|Adverse Event|3|||
156695345|NCT01929031|565631216|FG001|Overall Study|Adverse Event|1|||
156695346|NCT01929031|565631217|FG002|Overall Study|Adverse Event|1|||
156695347|NCT01929031|565631218|FG003|Overall Study|Adverse Event|0|||
156695348|NCT01929031|565631219|FG004|Overall Study|Adverse Event|0|||
156695349|NCT01929031|565631220|FG005|Overall Study|Adverse Event|0|||
156695350|NCT01929031|565631215|FG000|Overall Study|Protocol Violation|1|||
156695351|NCT01929031|565631216|FG001|Overall Study|Protocol Violation|0|||
156695352|NCT01929031|565631217|FG002|Overall Study|Protocol Violation|0|||
156695353|NCT01929031|565631218|FG003|Overall Study|Protocol Violation|0|||
156695354|NCT01929031|565631219|FG004|Overall Study|Protocol Violation|0|||
156695355|NCT01929031|565631220|FG005|Overall Study|Protocol Violation|1|||
156695356|NCT01929031|565631215|FG000|Overall Study|Reason other than specified above|0|||
156695357|NCT01929031|565631216|FG001|Overall Study|Reason other than specified above|1|||
156438183|NCT02242487|564695387|FG000|Overall Study|Adverse Event|13|||
156438184|NCT02242487|564695388|FG001|Overall Study|Adverse Event|15|||
156438185|NCT02242487|564695387|FG000|Overall Study|Lack of Efficacy|4|||
156438186|NCT02242487|564695388|FG001|Overall Study|Lack of Efficacy|6|||
156438187|NCT02242487|564695387|FG000|Overall Study|Protocol Violation|2|||
156438188|NCT02242487|564695388|FG001|Overall Study|Protocol Violation|0|||
156695358|NCT01929031|565631217|FG002|Overall Study|Reason other than specified above|0|||
156695359|NCT01929031|565631218|FG003|Overall Study|Reason other than specified above|0|||
156695360|NCT01929031|565631219|FG004|Overall Study|Reason other than specified above|1|||
156695361|NCT01929031|565631220|FG005|Overall Study|Reason other than specified above|0|||
156695362|NCT01366443|565631221|FG000|Overall Study|Lost to Follow-up|2|||
156870974|NCT03853109|566284347|FG005|Overall Study|Withdrawal by Subject|4|||
156438189|NCT02242487|564695387|FG000|Overall Study|Lost to Follow-up|2|||
156695363|NCT01366443|565631221|FG000|Overall Study|Under 18 yo|1|||
156695364|NCT05816200|565631222|FG000|Overall Study|Lost to Follow-up|2|||
156695365|NCT05816200|565631223|FG001|Overall Study|Lost to Follow-up|1|||
156695366|NCT02394730|565631224|FG000|Overall Study|Lost to Follow-up|1|||
156695367|NCT02394730|565631225|FG001|Overall Study|Lost to Follow-up|0|||
156695368|NCT02394730|565631224|FG000|Overall Study|Withdrawal by Subject|0|||
156695369|NCT02394730|565631225|FG001|Overall Study|Withdrawal by Subject|1|||
156695370|NCT00731549|565631226|FG000|Overall Study|Lost to Follow-up|19|||
156695371|NCT00731549|565631226|FG000|Overall Study|Met withdrawal criteria|24|||
156695372|NCT00731549|565631226|FG000|Overall Study|Physician Decision|16|||
156695373|NCT00731549|565631226|FG000|Overall Study|Withdrawal by Subject|89|||
156695374|NCT00731549|565631226|FG000|Overall Study|Protocol deviation|1|||
156438190|NCT02242487|564695388|FG001|Overall Study|Lost to Follow-up|1|||
156695375|NCT00731549|565631226|FG000|Overall Study|Adverse Event|31|||
156695376|NCT00731549|565631226|FG000|Overall Study|Lack of efficacy with AE|37|||
156695377|NCT00731549|565631226|FG000|Overall Study|Lack of efficacy without AE|6|||
156530705|NCT01717768|565038136|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
156530706|NCT01699789|565038137|FG000|Overall Study|Withdrawal by Subject|18|||
156530707|NCT01699789|565038138|FG001|Overall Study|Withdrawal by Subject|23|||
156530708|NCT01699789|565038137|FG000|Overall Study|Death|1|||
156530709|NCT01699789|565038138|FG001|Overall Study|Death|2|||
156530710|NCT01699789|565038137|FG000|Overall Study|Lost to Follow-up|83|||
156530711|NCT01699789|565038138|FG001|Overall Study|Lost to Follow-up|101|||
156530712|NCT01009554|565038139|FG000|Overall Study|Adverse Event|1|||
156530713|NCT01009554|565038140|FG001|Overall Study|Adverse Event|1|||
156530714|NCT01009554|565038139|FG000|Overall Study|Withdrawal by Subject|1|||
156530715|NCT01009554|565038140|FG001|Overall Study|Withdrawal by Subject|3|||
156530716|NCT01009554|565038139|FG000|Overall Study|Noncompliant with Study Product|0|||
156530717|NCT01009554|565038140|FG001|Overall Study|Noncompliant with Study Product|3|||
156530718|NCT02973048|565038143|FG000|Overall Study|Epidural catheter insertion failure|1|||
156530719|NCT02973048|565038144|FG001|Overall Study|Epidural catheter insertion failure|0|||
156530720|NCT02973048|565038143|FG000|Overall Study|Withdrawal by Subject|0|||
156530721|NCT02973048|565038144|FG001|Overall Study|Withdrawal by Subject|3|||
156530722|NCT04427501|565038147|FG000|Overall Study|Death|0|||
156530723|NCT04427501|565038148|FG001|Overall Study|Death|0|||
156530724|NCT04427501|565038149|FG002|Overall Study|Death|0|||
156530725|NCT04427501|565038150|FG003|Overall Study|Death|0|||
156530726|NCT04427501|565038151|FG004|Overall Study|Death|0|||
156530727|NCT04427501|565038152|FG005|Overall Study|Death|15|||
156530728|NCT04427501|565038153|FG006|Overall Study|Death|0|||
156530729|NCT04427501|565038154|FG007|Overall Study|Death|0|||
156530730|NCT04427501|565038155|FG008|Overall Study|Death|0|||
156530731|NCT04427501|565038156|FG009|Overall Study|Death|0|||
156530732|NCT04427501|565038157|FG010|Overall Study|Death|0|||
156530733|NCT04427501|565038158|FG011|Overall Study|Death|0|||
156530734|NCT04427501|565038147|FG000|Overall Study|Lost to Follow-up|5|||
156530735|NCT04427501|565038148|FG001|Overall Study|Lost to Follow-up|1|||
156530736|NCT04427501|565038149|FG002|Overall Study|Lost to Follow-up|2|||
156530737|NCT04427501|565038150|FG003|Overall Study|Lost to Follow-up|0|||
156530738|NCT04427501|565038151|FG004|Overall Study|Lost to Follow-up|2|||
156530739|NCT04427501|565038152|FG005|Overall Study|Lost to Follow-up|11|||
156530740|NCT04427501|565038153|FG006|Overall Study|Lost to Follow-up|10|||
156530741|NCT04427501|565038154|FG007|Overall Study|Lost to Follow-up|10|||
156530742|NCT04427501|565038155|FG008|Overall Study|Lost to Follow-up|2|||
156530743|NCT04427501|565038156|FG009|Overall Study|Lost to Follow-up|5|||
156530744|NCT04427501|565038157|FG010|Overall Study|Lost to Follow-up|2|||
156530745|NCT04427501|565038158|FG011|Overall Study|Lost to Follow-up|0|||
156530746|NCT04427501|565038147|FG000|Overall Study|Physician Decision|0|||
156530747|NCT04427501|565038148|FG001|Overall Study|Physician Decision|3|||
156530748|NCT04427501|565038149|FG002|Overall Study|Physician Decision|0|||
156530749|NCT04427501|565038150|FG003|Overall Study|Physician Decision|0|||
156530750|NCT04427501|565038151|FG004|Overall Study|Physician Decision|0|||
156530751|NCT04427501|565038152|FG005|Overall Study|Physician Decision|0|||
156530752|NCT04427501|565038153|FG006|Overall Study|Physician Decision|2|||
156530753|NCT04427501|565038154|FG007|Overall Study|Physician Decision|0|||
156530754|NCT04427501|565038155|FG008|Overall Study|Physician Decision|0|||
156530755|NCT04427501|565038156|FG009|Overall Study|Physician Decision|0|||
156530756|NCT04427501|565038157|FG010|Overall Study|Physician Decision|0|||
156530757|NCT04427501|565038158|FG011|Overall Study|Physician Decision|0|||
156530758|NCT04427501|565038147|FG000|Overall Study|Withdrawal by Subject|9|||
156530759|NCT04427501|565038148|FG001|Overall Study|Withdrawal by Subject|2|||
156530760|NCT04427501|565038149|FG002|Overall Study|Withdrawal by Subject|2|||
156530761|NCT04427501|565038150|FG003|Overall Study|Withdrawal by Subject|3|||
156530762|NCT04427501|565038151|FG004|Overall Study|Withdrawal by Subject|7|||
156530763|NCT04427501|565038152|FG005|Overall Study|Withdrawal by Subject|25|||
156530764|NCT04427501|565038153|FG006|Overall Study|Withdrawal by Subject|15|||
156530765|NCT04427501|565038154|FG007|Overall Study|Withdrawal by Subject|7|||
156530766|NCT04427501|565038155|FG008|Overall Study|Withdrawal by Subject|4|||
156530767|NCT04427501|565038156|FG009|Overall Study|Withdrawal by Subject|1|||
156530768|NCT04427501|565038157|FG010|Overall Study|Withdrawal by Subject|4|||
156530769|NCT04427501|565038158|FG011|Overall Study|Withdrawal by Subject|0|||
156530770|NCT04427501|565038147|FG000|Overall Study|Other - as reported by the investigator|1|||
156530771|NCT04427501|565038148|FG001|Overall Study|Other - as reported by the investigator|0|||
156530772|NCT04427501|565038149|FG002|Overall Study|Other - as reported by the investigator|0|||
156530773|NCT04427501|565038150|FG003|Overall Study|Other - as reported by the investigator|0|||
156530774|NCT04427501|565038151|FG004|Overall Study|Other - as reported by the investigator|0|||
156530775|NCT04427501|565038152|FG005|Overall Study|Other - as reported by the investigator|6|||
156530776|NCT04427501|565038153|FG006|Overall Study|Other - as reported by the investigator|6|||
156789930|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156789931|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156530777|NCT04427501|565038154|FG007|Overall Study|Other - as reported by the investigator|0|||
156530778|NCT04427501|565038155|FG008|Overall Study|Other - as reported by the investigator|0|||
156530779|NCT04427501|565038156|FG009|Overall Study|Other - as reported by the investigator|0|||
156695378|NCT00588640|565631227|FG000|Overall Study|Physician Decision|1|||
156695379|NCT00588640|565631227|FG000|Overall Study|Ineligible Patient|1|||
156695380|NCT01393730|565631228|FG000|Overall Study|Withdrawal by Subject|3|||
156695381|NCT01393730|565631228|FG000|Overall Study|Other|2|||
156695382|NCT01393730|565631228|FG000|Overall Study|Adverse Event|1|||
156695383|NCT00103402|565631229|FG000|Overall Study|Adverse Event|3|||
156695384|NCT00103402|565631230|FG001|Overall Study|Adverse Event|4|||
156695385|NCT00103402|565631229|FG000|Overall Study|Lost to Follow-up|8|||
156695386|NCT00103402|565631230|FG001|Overall Study|Lost to Follow-up|7|||
156695387|NCT00103402|565631229|FG000|Overall Study|Dissatisfied/No longer interested|6|||
156695388|NCT00103402|565631230|FG001|Overall Study|Dissatisfied/No longer interested|6|||
156695389|NCT00103402|565631229|FG000|Overall Study|Personal constraints/Other|5|||
156695390|NCT00103402|565631230|FG001|Overall Study|Personal constraints/Other|0|||
156695391|NCT02384850|565631231|FG000|Overall Study|Withdrawal by Subject|2|||
156695392|NCT02384850|565631232|FG001|Overall Study|Withdrawal by Subject|2|||
156695393|NCT00507546|565631233|FG000|Overall Study|Withdrawal by Subject|1|||
156695394|NCT00507546|565631234|FG001|Overall Study|Withdrawal by Subject|0|||
156695395|NCT00507546|565631233|FG000|Overall Study|Protocol Violation|1|||
156695396|NCT00507546|565631234|FG001|Overall Study|Protocol Violation|0|||
156695397|NCT00507546|565631233|FG000|Overall Study|Physician Decision|0|||
156695398|NCT00507546|565631234|FG001|Overall Study|Physician Decision|1|||
156695399|NCT03510182|565631239|FG000|Overall Study|Withdrawal by Subject|2|||
156695400|NCT04385277|565632928|FG000|Overall Study|Physician Decision|2|||
156695401|NCT04385277|565632928|FG000|Overall Study|Ineligible|1|||
156695402|NCT04385277|565632928|FG000|Overall Study|Patient/Parent Refusal|2|||
156695403|NCT04905290|565632929|FG000|Overall Study|Adverse Event|4|||
156695404|NCT04905290|565632929|FG000|Overall Study|Death|2|||
156695405|NCT04905290|565632929|FG000|Overall Study|Withdrawal by Subject|4|||
156695406|NCT04905290|565632929|FG000|Overall Study|Physician Decision|2|||
156695407|NCT04905290|565632929|FG000|Overall Study|Lost to Follow-up|2|||
156695408|NCT04905290|565632929|FG000|Overall Study|Screen Failure|2|||
156695409|NCT04905290|565632929|FG000|Overall Study|Unsuccessful Procedure|2|||
156695410|NCT03295318|565632930|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
156695411|NCT03295318|565632931|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
156695412|NCT03295318|565632932|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
156695413|NCT03295318|565632930|FG000|Overall Study|Death|1|||
156695414|NCT03295318|565632931|FG001|Overall Study|Death|1|||
156695415|NCT03295318|565632932|FG002|Overall Study|Death|1|||
156695416|NCT03295318|565632930|FG000|Overall Study|Protocol Violation|4|||
156695417|NCT03295318|565632931|FG001|Overall Study|Protocol Violation|3|||
156695418|NCT03295318|565632932|FG002|Overall Study|Protocol Violation|3|||
156695419|NCT03295318|565632930|FG000|Overall Study|Withdrawal by Subject|0|||
156695420|NCT03295318|565632931|FG001|Overall Study|Withdrawal by Subject|0|||
156695421|NCT03295318|565632932|FG002|Overall Study|Withdrawal by Subject|1|||
156695422|NCT03295318|565632930|FG000|Overall Study|Subject discontinued due to travel|0|||
156695423|NCT03295318|565632931|FG001|Overall Study|Subject discontinued due to travel|1|||
156695424|NCT03295318|565632932|FG002|Overall Study|Subject discontinued due to travel|0|||
156695425|NCT03747601|565632933|FG000|Overall Study|COVID halt to visits|4|||
156695426|NCT00573157|565632934|FG000|Overall Study|Adverse Event|3|||
156695427|NCT00573157|565632935|FG001|Overall Study|Adverse Event|1|||
156695428|NCT00573157|565632934|FG000|Overall Study|Other|1|||
156695429|NCT00573157|565632935|FG001|Overall Study|Other|1|||
156695430|NCT01032018|565632936|FG000|Overall Study|Lost to Follow-up|6|||
156695431|NCT01032018|565632937|FG001|Overall Study|Lost to Follow-up|5|||
156695432|NCT01032018|565632936|FG000|Overall Study|Death|0|||
156695433|NCT01032018|565632937|FG001|Overall Study|Death|1|||
156695434|NCT01293539|565632942|FG000|Overall Study|Physician Decision|1|||
156695435|NCT00609518|565632943|FG000|Overall Study|Death from Study Disease|32|||
156695436|NCT00609518|565632944|FG001|Overall Study|Death from Study Disease|32|||
156695437|NCT00609518|565632943|FG000|Overall Study|Withdrawal by Subject|5|||
156438191|NCT02242487|564695387|FG000|Overall Study|Other - Miscellaneous|4|||
156438192|NCT02242487|564695388|FG001|Overall Study|Other - Miscellaneous|6|||
156438193|NCT02242487|564695387|FG000|Overall Study|Withdrawal by Subject|37|||
156695438|NCT00609518|565632944|FG001|Overall Study|Withdrawal by Subject|3|||
156695439|NCT00609518|565632943|FG000|Overall Study|Lost to Follow-up|3|||
156695440|NCT00609518|565632944|FG001|Overall Study|Lost to Follow-up|0|||
156695441|NCT00609518|565632943|FG000|Overall Study|Physician Decision|1|||
156695442|NCT00609518|565632944|FG001|Overall Study|Physician Decision|3|||
156695443|NCT00609518|565632943|FG000|Overall Study|Death from Adverse Event|2|||
156695444|NCT00609518|565632944|FG001|Overall Study|Death from Adverse Event|2|||
156695445|NCT04032158|565632945|FG000|Overall Study|Study Termination|2|||
156695446|NCT04032158|565632946|FG001|Overall Study|Study Termination|1|||
156695447|NCT00059787|565632947|FG000|Overall Study|Adverse Event|13|||
156695448|NCT00059787|565632947|FG000|Overall Study|disease progression|2|||
156695449|NCT00059787|565632947|FG000|Overall Study|ineligible|1|||
156695450|NCT00059787|565632947|FG000|Overall Study|Other|4|||
156695451|NCT04710979|565632950|FG000|Overall Study|Lost to Follow-up|2|||
156695452|NCT04710979|565632951|FG001|Overall Study|Lost to Follow-up|4|||
156438194|NCT02242487|564695388|FG001|Overall Study|Withdrawal by Subject|19|||
156438195|NCT03644849|564695389|FG000|Overall Study|Lost to Follow-up|1|||
156438196|NCT03644849|564695390|FG001|Overall Study|Lost to Follow-up|3|||
156438197|NCT02564744|564695391|FG000|Overall Study|Investigator decision|0|||
156438198|NCT02564744|564695392|FG001|Overall Study|Investigator decision|0|||
156438199|NCT02564744|564695393|FG002|Overall Study|Investigator decision|0|||
156438200|NCT02564744|564695394|FG003|Overall Study|Investigator decision|0|||
156438201|NCT02564744|564695395|FG004|Overall Study|Investigator decision|1|||
156438202|NCT02564744|564695391|FG000|Overall Study|Death|10|||
156438203|NCT02564744|564695392|FG001|Overall Study|Death|5|||
156438204|NCT02564744|564695393|FG002|Overall Study|Death|4|||
156438205|NCT02564744|564695394|FG003|Overall Study|Death|16|||
156438206|NCT02564744|564695395|FG004|Overall Study|Death|16|||
156438207|NCT02564744|564695391|FG000|Overall Study|End of study Page Missing|0|||
156438208|NCT02564744|564695392|FG001|Overall Study|End of study Page Missing|0|||
156438209|NCT02564744|564695393|FG002|Overall Study|End of study Page Missing|3|||
156438210|NCT02564744|564695394|FG003|Overall Study|End of study Page Missing|3|||
156438211|NCT02564744|564695395|FG004|Overall Study|End of study Page Missing|0|||
156438212|NCT02564744|564695391|FG000|Overall Study|Subject Withdrew Consent|1|||
156438213|NCT02564744|564695392|FG001|Overall Study|Subject Withdrew Consent|1|||
156438214|NCT02564744|564695393|FG002|Overall Study|Subject Withdrew Consent|1|||
156438215|NCT02564744|564695394|FG003|Overall Study|Subject Withdrew Consent|0|||
156438216|NCT02564744|564695395|FG004|Overall Study|Subject Withdrew Consent|2|||
156438217|NCT02564744|564695391|FG000|Overall Study|Lost to Follow-up|0|||
156438218|NCT02564744|564695392|FG001|Overall Study|Lost to Follow-up|1|||
156438219|NCT02564744|564695393|FG002|Overall Study|Lost to Follow-up|0|||
156438220|NCT02564744|564695394|FG003|Overall Study|Lost to Follow-up|0|||
156438221|NCT02564744|564695395|FG004|Overall Study|Lost to Follow-up|1|||
156438222|NCT02564744|564695391|FG000|Overall Study|Reason not specified|1|||
156438223|NCT02564744|564695392|FG001|Overall Study|Reason not specified|0|||
156438224|NCT02564744|564695393|FG002|Overall Study|Reason not specified|0|||
156870975|NCT03853109|566284348|FG006|Overall Study|Withdrawal by Subject|5|||
156870976|NCT03853109|566284349|FG007|Overall Study|Withdrawal by Subject|3|||
156870977|NCT03853109|566284342|FG000|Overall Study|Decision by Sponsor|0|||
156870978|NCT03853109|566284343|FG001|Overall Study|Decision by Sponsor|0|||
156695453|NCT04710979|565632950|FG000|Overall Study|Withdrawal by Subject|1|||
156695454|NCT04710979|565632951|FG001|Overall Study|Withdrawal by Subject|0|||
156695455|NCT04397445|565632954|FG000|Overall Study|Withdrawal by Subject|1|||
156695456|NCT04397445|565632955|FG001|Overall Study|Withdrawal by Subject|0|||
156695457|NCT04397445|565632956|FG002|Overall Study|Withdrawal by Subject|0|||
156695458|NCT04397445|565632957|FG003|Overall Study|Withdrawal by Subject|0|||
156695459|NCT00891371|565632958|FG000|Pre-assignment|Inclusion/exclusion|5|||
156695460|NCT00891371|565632958|FG000|Pre-assignment|Consent withdrawal|1|||
156695461|NCT00891371|565632958|FG000|Treatment|Lack of Efficacy|5|||
156789932|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156789933|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156438225|NCT02564744|564695394|FG003|Overall Study|Reason not specified|0|||
156695462|NCT00891371|565632958|FG000|Treatment|Adverse Event|2|||
156695463|NCT00891371|565632958|FG000|Treatment|Death|1|||
156789934|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
156438226|NCT02564744|564695395|FG004|Overall Study|Reason not specified|0|||
156438227|NCT02252042|564695397|FG000|Overall Study|Adverse Event|9|||
156438228|NCT02252042|564695398|FG001|Overall Study|Adverse Event|6|||
156789935|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
156789936|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
156789937|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
156789938|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
156789939|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
156789940|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
156789941|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
156789942|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
156789943|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
156789944|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789945|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
156789946|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789947|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789948|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789949|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789950|NCT01557244|565983655|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
156789951|NCT01557244|565983656|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
156789952|NCT01557244|565983657|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
156789953|NCT01557244|565983658|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
156695464|NCT00891371|565632958|FG000|Treatment|Lost to Follow-up|1|||
156695465|NCT00307034|565632959|FG000|Overall Study|Adverse Event|1|||
156695466|NCT00307034|565632960|FG001|Overall Study|Adverse Event|2|||
156695467|NCT00307034|565632959|FG000|Overall Study|Withdrawal by Subject|1|||
156695468|NCT00307034|565632960|FG001|Overall Study|Withdrawal by Subject|2|||
156695469|NCT00307034|565632959|FG000|Overall Study|Lost to Follow-up|0|||
156695470|NCT00307034|565632960|FG001|Overall Study|Lost to Follow-up|3|||
156695471|NCT02034058|565632961|FG000|Overall Study|Death|3|||
156695472|NCT03709823|565632972|FG000|Overall Study|Adverse Event|0|||
156695473|NCT03709823|565632973|FG001|Overall Study|Adverse Event|0|||
156695474|NCT03709823|565632974|FG002|Overall Study|Adverse Event|1|||
156695475|NCT03709823|565632975|FG003|Overall Study|Adverse Event|0|||
156695476|NCT03709823|565632976|FG004|Overall Study|Adverse Event|0|||
156695477|NCT03709823|565632977|FG005|Overall Study|Adverse Event|0|||
156695478|NCT03709823|565632972|FG000|Overall Study|Lost to Follow-up|2|||
156695479|NCT03709823|565632973|FG001|Overall Study|Lost to Follow-up|2|||
156695480|NCT03709823|565632974|FG002|Overall Study|Lost to Follow-up|2|||
156695481|NCT03709823|565632975|FG003|Overall Study|Lost to Follow-up|1|||
156695482|NCT03709823|565632976|FG004|Overall Study|Lost to Follow-up|1|||
156695483|NCT03709823|565632977|FG005|Overall Study|Lost to Follow-up|0|||
156695484|NCT03709823|565632972|FG000|Overall Study|Withdrawal by Subject|1|||
156695485|NCT03709823|565632973|FG001|Overall Study|Withdrawal by Subject|3|||
156695486|NCT03709823|565632974|FG002|Overall Study|Withdrawal by Subject|0|||
156695487|NCT03709823|565632975|FG003|Overall Study|Withdrawal by Subject|0|||
156695488|NCT03709823|565632976|FG004|Overall Study|Withdrawal by Subject|0|||
156695489|NCT03709823|565632977|FG005|Overall Study|Withdrawal by Subject|0|||
156695490|NCT03709823|565632972|FG000|Overall Study|Other, Not Specified|0|||
156695491|NCT03709823|565632973|FG001|Overall Study|Other, Not Specified|0|||
156695492|NCT03709823|565632974|FG002|Overall Study|Other, Not Specified|0|||
156695493|NCT03709823|565632975|FG003|Overall Study|Other, Not Specified|1|||
156695494|NCT03709823|565632976|FG004|Overall Study|Other, Not Specified|0|||
156695495|NCT03709823|565632977|FG005|Overall Study|Other, Not Specified|0|||
156695496|NCT00846521|565632978|FG000|Overall Study|Withdrawal by Subject|5|||
156695497|NCT00846521|565632978|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
156695498|NCT00846521|565632978|FG000|Overall Study|Protocol Violation|1|||
156695499|NCT04392583|565632979|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
156695500|NCT02575911|565632982|FG000|Overall Study|Lost to Follow-up|1|||
156695501|NCT01249365|565632983|FG000|Overall Study|Lost to Follow-up|1|||
156695502|NCT03579966|565632984|FG000|Overall Study|Adverse Event|6|||
156695503|NCT03579966|565632984|FG000|Overall Study|Lost to Follow-up|4|||
156695504|NCT03579966|565632984|FG000|Overall Study|Physician Decision|10|||
156695505|NCT03579966|565632984|FG000|Overall Study|Pregnancy|1|||
156695506|NCT03579966|565632984|FG000|Overall Study|Withdrawal by Subject|16|||
156695507|NCT03579966|565632984|FG000|Overall Study|Study terminated by Sponsor|22|||
156695508|NCT03579966|565632984|FG000|Overall Study|Protocol Violation|1|||
156695509|NCT02408068|565632987|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695510|NCT02408068|565632988|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695511|NCT02408068|565632989|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
156695512|NCT02408068|565632990|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695513|NCT02408068|565632991|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695514|NCT02408068|565632992|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695515|NCT01340768|565632993|FG000|Overall Study|Lost to Follow-up|10|||
156695516|NCT01340768|565632994|FG001|Overall Study|Lost to Follow-up|4|||
156695517|NCT01340768|565632993|FG000|Overall Study|Withdrawal by Subject|5|||
156695518|NCT01340768|565632994|FG001|Overall Study|Withdrawal by Subject|1|||
156695519|NCT01340768|565632993|FG000|Overall Study|Other|2|||
156695520|NCT01340768|565632994|FG001|Overall Study|Other|0|||
156695521|NCT03052959|565632997|FG000|Overall Study|Lost to Follow-up|4|||
156695522|NCT03052959|565632998|FG001|Overall Study|Lost to Follow-up|5|||
156695523|NCT02397408|565632999|FG000|Overall Study|Physician Decision|4|||
156695524|NCT02397408|565632999|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
156438229|NCT02252042|564695397|FG000|Overall Study|Death|209|||
156695525|NCT01524679|565633000|FG000|Overall Study|Lost to Follow-up|1|||
156695526|NCT01524679|565633001|FG001|Overall Study|Lost to Follow-up|4|||
156695527|NCT01524679|565633000|FG000|Overall Study|Withdrawal by Subject|4|||
156695528|NCT01524679|565633001|FG001|Overall Study|Withdrawal by Subject|4|||
156695529|NCT01524679|565633000|FG000|Overall Study|Adverse Event|9|||
156695530|NCT01524679|565633001|FG001|Overall Study|Adverse Event|0|||
156695531|NCT01524679|565633000|FG000|Overall Study|Protocol Violation|1|||
156695532|NCT01524679|565633001|FG001|Overall Study|Protocol Violation|0|||
156695533|NCT01524679|565633000|FG000|Overall Study|Lack of Efficacy|2|||
156695534|NCT01524679|565633001|FG001|Overall Study|Lack of Efficacy|0|||
156695535|NCT01524679|565633000|FG000|Overall Study|e.g.wish for children, relocation|6|||
156695536|NCT01524679|565633001|FG001|Overall Study|e.g.wish for children, relocation|1|||
156695537|NCT03321630|565633006|FG000|Overall Study|Adverse Event|1|||
156695538|NCT03321630|565633006|FG000|Overall Study|Investigator Discretion|2|||
156695539|NCT03321630|565633006|FG000|Overall Study|Withdrawal by Subject|1|||
156695540|NCT00140426|565633007|FG000|Overall Study|Withdrawal by Subject|0|||
156530780|NCT04427501|565038157|FG010|Overall Study|Other - as reported by the investigator|0|||
156530781|NCT04427501|565038158|FG011|Overall Study|Other - as reported by the investigator|0|||
156530782|NCT04427501|565038147|FG000|Overall Study|Other|0|||
156530783|NCT04427501|565038148|FG001|Overall Study|Other|0|||
156530784|NCT04427501|565038149|FG002|Overall Study|Other|0|||
156530785|NCT04427501|565038150|FG003|Overall Study|Other|0|||
156530786|NCT04427501|565038151|FG004|Overall Study|Other|0|||
156530787|NCT04427501|565038152|FG005|Overall Study|Other|0|||
156530788|NCT04427501|565038153|FG006|Overall Study|Other|0|||
156530789|NCT04427501|565038154|FG007|Overall Study|Other|0|||
156530790|NCT04427501|565038155|FG008|Overall Study|Other|0|||
156530791|NCT04427501|565038156|FG009|Overall Study|Other|0|||
156530792|NCT04427501|565038157|FG010|Overall Study|Other|0|||
156530793|NCT04427501|565038158|FG011|Overall Study|Other|1|||
156530794|NCT03170154|565038159|FG000|Overall Study|Lost to Follow-up|4|||
156530795|NCT03170154|565038159|FG000|Overall Study|Death|2|||
156530796|NCT03170154|565038159|FG000|Overall Study|Withdrawal by Subject|2|||
156530797|NCT01906346|565038162|FG000|Overall Study|AEs|1|||
156530798|NCT01891721|565038167|FG000|Overall Study|Lost to Follow-up|10|||
156530799|NCT01891721|565038168|FG001|Overall Study|Lost to Follow-up|5|||
156530800|NCT01891721|565038169|FG002|Overall Study|Lost to Follow-up|1|||
156530801|NCT00633061|565038170|FG000|Overall Study|Study closed|86|||
156530802|NCT00633061|565038171|FG001|Overall Study|Study closed|0|||
156530803|NCT02000427|565038172|FG000|Overall Study|Death|22|||
156530804|NCT05125679|565038173|FG000|Overall Study|Study Terminated by Sponsor|2|||
156530805|NCT05125679|565038174|FG001|Overall Study|Study Terminated by Sponsor|5|||
156530806|NCT03829319|565038187|FG000|Overall Study|Sponsor's Decision|4|||
156695541|NCT00140426|565633008|FG001|Overall Study|Withdrawal by Subject|3|||
156695542|NCT02149108|565633009|FG000|Overall Study|Not treated|1|||
156695543|NCT02149108|565633010|FG001|Overall Study|Not treated|2|||
156695544|NCT02149108|565633009|FG000|Overall Study|Progressive Disease (PD)|324|||
156695545|NCT02149108|565633010|FG001|Overall Study|Progressive Disease (PD)|318|||
156695546|NCT02149108|565633009|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
156695547|NCT02149108|565633010|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
156695548|NCT02149108|565633009|FG000|Overall Study|Other Adverse Event (AE)|8|||
156695549|NCT02149108|565633010|FG001|Overall Study|Other Adverse Event (AE)|18|||
156695550|NCT02149108|565633009|FG000|Overall Study|Other not defined above|0|||
156695551|NCT02149108|565633010|FG001|Overall Study|Other not defined above|2|||
156695552|NCT02149108|565633009|FG000|Overall Study|Refusal to continue trial medication|15|||
156695553|NCT02149108|565633010|FG001|Overall Study|Refusal to continue trial medication|11|||
156695554|NCT02149108|565633009|FG000|Overall Study|Lost to Follow-up|1|||
156695555|NCT02149108|565633010|FG001|Overall Study|Lost to Follow-up|0|||
156695556|NCT00950963|565633011|FG000|Overall Study|Lost to Follow-up|29|||
156695557|NCT00950963|565633012|FG001|Overall Study|Lost to Follow-up|24|||
156695558|NCT04168190|565633013|FG000|Overall Study|Lost to Follow-up|0|||
156695559|NCT04168190|565633014|FG001|Overall Study|Lost to Follow-up|1|||
156695560|NCT04168190|565633015|FG002|Overall Study|Lost to Follow-up|0|||
156695561|NCT04168190|565633016|FG003|Overall Study|Lost to Follow-up|7|||
156695562|NCT04168190|565633017|FG004|Overall Study|Lost to Follow-up|5|||
156695563|NCT04168190|565633013|FG000|Overall Study|Withdrawal by Subject|1|||
156695564|NCT04168190|565633014|FG001|Overall Study|Withdrawal by Subject|0|||
156695565|NCT04168190|565633015|FG002|Overall Study|Withdrawal by Subject|0|||
156695566|NCT04168190|565633016|FG003|Overall Study|Withdrawal by Subject|2|||
156695567|NCT04168190|565633017|FG004|Overall Study|Withdrawal by Subject|4|||
156695568|NCT04168190|565633013|FG000|Overall Study|Death|0|||
156695569|NCT04168190|565633014|FG001|Overall Study|Death|0|||
156695570|NCT04168190|565633015|FG002|Overall Study|Death|0|||
156789954|NCT01557244|565983659|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
156789955|NCT01557244|565983660|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
156789956|NCT01557244|565983661|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
156789957|NCT01557244|565983655|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
156530807|NCT03829319|565038188|FG001|Overall Study|Sponsor's Decision|90|||
156530808|NCT03829319|565038189|FG002|Overall Study|Sponsor's Decision|102|||
156530809|NCT03829319|565038187|FG000|Overall Study|Withdrawal by Subject|1|||
156530810|NCT03829319|565038188|FG001|Overall Study|Withdrawal by Subject|5|||
156530811|NCT03829319|565038189|FG002|Overall Study|Withdrawal by Subject|4|||
156530812|NCT03829319|565038187|FG000|Overall Study|Physician Decision|0|||
156530813|NCT03829319|565038188|FG001|Overall Study|Physician Decision|3|||
156695571|NCT04168190|565633016|FG003|Overall Study|Death|1|||
156695572|NCT04168190|565633017|FG004|Overall Study|Death|0|||
156695573|NCT02325518|565633018|FG000|Overall Study|Adverse Event|4|||
156695574|NCT02325518|565633019|FG001|Overall Study|Adverse Event|1|||
156695575|NCT02325518|565633018|FG000|Overall Study|Physician Decision|0|||
156530814|NCT03829319|565038189|FG002|Overall Study|Physician Decision|0|||
156695576|NCT02325518|565633019|FG001|Overall Study|Physician Decision|1|||
156695577|NCT02325518|565633018|FG000|Overall Study|Withdrawal by Subject|0|||
156695578|NCT02325518|565633019|FG001|Overall Study|Withdrawal by Subject|1|||
156530815|NCT03829319|565038187|FG000|Overall Study|Lost to Follow-up|0|||
156530816|NCT03829319|565038188|FG001|Overall Study|Lost to Follow-up|0|||
156870979|NCT03853109|566284344|FG002|Overall Study|Decision by Sponsor|1|||
156870980|NCT03853109|566284345|FG003|Overall Study|Decision by Sponsor|0|||
156870981|NCT03853109|566284346|FG004|Overall Study|Decision by Sponsor|1|||
156870982|NCT03853109|566284347|FG005|Overall Study|Decision by Sponsor|1|||
156870983|NCT03853109|566284348|FG006|Overall Study|Decision by Sponsor|10|||
156870984|NCT03853109|566284349|FG007|Overall Study|Decision by Sponsor|2|||
156870985|NCT03853109|566284342|FG000|Overall Study|Lost to Follow-up|0|||
156870986|NCT03853109|566284343|FG001|Overall Study|Lost to Follow-up|0|||
156870987|NCT03853109|566284344|FG002|Overall Study|Lost to Follow-up|0|||
156870988|NCT03853109|566284345|FG003|Overall Study|Lost to Follow-up|0|||
156870989|NCT03853109|566284346|FG004|Overall Study|Lost to Follow-up|1|||
156870990|NCT03853109|566284347|FG005|Overall Study|Lost to Follow-up|3|||
156870991|NCT03853109|566284348|FG006|Overall Study|Lost to Follow-up|0|||
156870992|NCT03853109|566284349|FG007|Overall Study|Lost to Follow-up|0|||
156870993|NCT03853109|566284342|FG000|Overall Study|Death|2|||
156870994|NCT03853109|566284343|FG001|Overall Study|Death|5|||
156870995|NCT03853109|566284344|FG002|Overall Study|Death|8|||
156870996|NCT03853109|566284345|FG003|Overall Study|Death|10|||
156870997|NCT03853109|566284346|FG004|Overall Study|Death|3|||
156870998|NCT03853109|566284347|FG005|Overall Study|Death|20|||
156870999|NCT03853109|566284348|FG006|Overall Study|Death|10|||
156871000|NCT03853109|566284349|FG007|Overall Study|Death|5|||
156871001|NCT04032093|566284350|FG000|Overall Study|Lost to Follow-up|7|||
156871002|NCT04032093|566284351|FG001|Overall Study|Lost to Follow-up|7|||
156871003|NCT04032093|566284352|FG002|Overall Study|Lost to Follow-up|6|||
156871004|NCT04032093|566284353|FG003|Overall Study|Lost to Follow-up|10|||
156871005|NCT04032093|566284354|FG004|Overall Study|Lost to Follow-up|13|||
156871006|NCT04032093|566284355|FG005|Overall Study|Lost to Follow-up|7|||
156871007|NCT04032093|566284356|FG006|Overall Study|Lost to Follow-up|7|||
156871008|NCT04032093|566284357|FG007|Overall Study|Lost to Follow-up|5|||
156871009|NCT04032093|566284358|FG008|Overall Study|Lost to Follow-up|9|||
156871010|NCT04032093|566284359|FG009|Overall Study|Lost to Follow-up|12|||
156871011|NCT04032093|566284350|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871012|NCT04032093|566284351|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871013|NCT04032093|566284352|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871014|NCT04032093|566284353|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
156871015|NCT04032093|566284354|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
156871016|NCT04032093|566284355|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871017|NCT04032093|566284356|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871018|NCT04032093|566284357|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871019|NCT04032093|566284358|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
156871020|NCT04032093|566284359|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
156871021|NCT04032093|566284350|FG000|Overall Study|Other|1|||
156871022|NCT04032093|566284351|FG001|Overall Study|Other|0|||
156695579|NCT01675661|565633020|FG000|Overall Study|Lost to Follow-up|22|||
156695580|NCT01675661|565633021|FG001|Overall Study|Lost to Follow-up|23|||
156695581|NCT01675661|565633020|FG000|Overall Study|Practical problems|9|||
156695582|NCT01675661|565633021|FG001|Overall Study|Practical problems|5|||
156871023|NCT04032093|566284352|FG002|Overall Study|Other|0|||
156871024|NCT04032093|566284353|FG003|Overall Study|Other|1|||
156871025|NCT04032093|566284354|FG004|Overall Study|Other|1|||
156871026|NCT04032093|566284355|FG005|Overall Study|Other|0|||
156871027|NCT04032093|566284356|FG006|Overall Study|Other|0|||
156871028|NCT04032093|566284357|FG007|Overall Study|Other|0|||
156871029|NCT04032093|566284358|FG008|Overall Study|Other|0|||
156871030|NCT04032093|566284359|FG009|Overall Study|Other|1|||
156330978|NCT00586625|564311917|FG000|Overall Study|Subject non-compliance|0|||
156330979|NCT00586625|564311918|FG001|Overall Study|Subject non-compliance|1|||
156530817|NCT03829319|565038189|FG002|Overall Study|Lost to Follow-up|1|||
156695583|NCT01675661|565633020|FG000|Overall Study|Moved away|5|||
156871031|NCT04032093|566284350|FG000|Overall Study|Withdrawal by Subject|1|||
156871032|NCT04032093|566284351|FG001|Overall Study|Withdrawal by Subject|3|||
156871033|NCT04032093|566284352|FG002|Overall Study|Withdrawal by Subject|2|||
156871034|NCT04032093|566284353|FG003|Overall Study|Withdrawal by Subject|2|||
156871035|NCT04032093|566284354|FG004|Overall Study|Withdrawal by Subject|3|||
156871036|NCT04032093|566284355|FG005|Overall Study|Withdrawal by Subject|0|||
156530818|NCT03829319|565038187|FG000|Overall Study|Death|8|||
156695584|NCT01675661|565633021|FG001|Overall Study|Moved away|6|||
156871037|NCT04032093|566284356|FG006|Overall Study|Withdrawal by Subject|0|||
156871038|NCT04032093|566284357|FG007|Overall Study|Withdrawal by Subject|0|||
156871039|NCT04032093|566284358|FG008|Overall Study|Withdrawal by Subject|0|||
156871040|NCT04032093|566284359|FG009|Overall Study|Withdrawal by Subject|0|||
156871041|NCT04032093|566284350|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156871042|NCT04032093|566284351|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156871043|NCT04032093|566284352|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156871044|NCT04032093|566284353|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156871045|NCT04032093|566284354|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156871046|NCT04032093|566284355|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156530819|NCT03829319|565038188|FG001|Overall Study|Death|277|||
156695585|NCT01675661|565633020|FG000|Overall Study|Withdrawal by Subject|3|||
156695586|NCT01675661|565633021|FG001|Overall Study|Withdrawal by Subject|7|||
156695587|NCT01675661|565633020|FG000|Overall Study|Physician Decision|0|||
156695588|NCT01675661|565633021|FG001|Overall Study|Physician Decision|2|||
156695589|NCT01675661|565633020|FG000|Overall Study|Death|0|||
156695590|NCT01675661|565633021|FG001|Overall Study|Death|1|||
156695591|NCT01675661|565633020|FG000|Overall Study|Other reason|1|||
156695592|NCT01675661|565633021|FG001|Overall Study|Other reason|2|||
156695593|NCT04765384|565633022|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
156695594|NCT04765384|565633023|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
156695595|NCT04765384|565633024|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
156695596|NCT04765384|565633025|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
156695597|NCT04765384|565633026|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
156695598|NCT04765384|565633027|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
156695599|NCT04765384|565633022|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
156695600|NCT04765384|565633023|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
156695601|NCT04765384|565633024|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
156695602|NCT04765384|565633025|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
156695603|NCT04765384|565633026|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
156695604|NCT04765384|565633027|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
156695605|NCT04765384|565633022|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695606|NCT04765384|565633023|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695607|NCT04765384|565633024|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695608|NCT04765384|565633025|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695609|NCT04765384|565633026|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695610|NCT04765384|565633027|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
156695611|NCT04765384|565633022|FG000|Post-natal: Neonates and Infants|Death|0|||
156695612|NCT04765384|565633023|FG001|Post-natal: Neonates and Infants|Death|0|||
156695613|NCT04765384|565633024|FG002|Post-natal: Neonates and Infants|Death|0|||
156695614|NCT04765384|565633025|FG003|Post-natal: Neonates and Infants|Death|1|||
156695615|NCT04765384|565633026|FG004|Post-natal: Neonates and Infants|Death|0|||
156695616|NCT04765384|565633027|FG005|Post-natal: Neonates and Infants|Death|0|||
156695617|NCT04765384|565633022|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695618|NCT04765384|565633023|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695619|NCT04765384|565633024|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695620|NCT04765384|565633025|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695621|NCT04765384|565633026|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695622|NCT04765384|565633027|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
156695623|NCT00987389|565633028|FG000|Overall Study|Ineligible|0|||
156695624|NCT00987389|565633029|FG001|Overall Study|Ineligible|3|||
156695625|NCT00987389|565633030|FG002|Overall Study|Ineligible|0|||
156695626|NCT00987389|565633031|FG003|Overall Study|Ineligible|0|||
156695627|NCT00987389|565633028|FG000|Overall Study|Lost to Follow-up|4|||
156695628|NCT00987389|565633029|FG001|Overall Study|Lost to Follow-up|1|||
156695629|NCT00987389|565633030|FG002|Overall Study|Lost to Follow-up|3|||
156695630|NCT00987389|565633031|FG003|Overall Study|Lost to Follow-up|1|||
156695631|NCT00987389|565633028|FG000|Overall Study|Withdrawal by Subject|4|||
156695632|NCT00987389|565633029|FG001|Overall Study|Withdrawal by Subject|3|||
156695633|NCT00987389|565633030|FG002|Overall Study|Withdrawal by Subject|2|||
156695634|NCT00987389|565633031|FG003|Overall Study|Withdrawal by Subject|1|||
156695635|NCT00987389|565633028|FG000|Overall Study|Withdrawn from Treatment|0|||
156695636|NCT00987389|565633029|FG001|Overall Study|Withdrawn from Treatment|1|||
156695637|NCT00987389|565633030|FG002|Overall Study|Withdrawn from Treatment|0|||
156695638|NCT00987389|565633031|FG003|Overall Study|Withdrawn from Treatment|0|||
156695639|NCT00987389|565633028|FG000|Overall Study|Multiple different reasons|1|||
156695640|NCT00987389|565633029|FG001|Overall Study|Multiple different reasons|0|||
156695641|NCT00987389|565633030|FG002|Overall Study|Multiple different reasons|3|||
156695642|NCT00987389|565633031|FG003|Overall Study|Multiple different reasons|1|||
156695643|NCT02992418|565633034|FG000|Overall Study|Withdrawal by Subject|11|||
156695644|NCT02992418|565633035|FG001|Overall Study|Withdrawal by Subject|12|||
156695645|NCT02992418|565633034|FG000|Overall Study|Non-compliance with the protocol|308|||
156695646|NCT02992418|565633035|FG001|Overall Study|Non-compliance with the protocol|308|||
156695647|NCT02992418|565633034|FG000|Overall Study|Lost to Follow-up|27|||
156695648|NCT02992418|565633035|FG001|Overall Study|Lost to Follow-up|22|||
156695649|NCT00289536|565633036|FG000|Period 3|Lost to Follow-up|0|||
156695650|NCT00289536|565633037|FG001|Period 3|Lost to Follow-up|0|||
156695651|NCT00289536|565633038|FG002|Period 3|Lost to Follow-up|1|||
156695652|NCT03246126|565633043|FG000|Overall Study|Withdrawal by Subject|0|||
156438230|NCT02252042|564695398|FG001|Overall Study|Death|217|||
156695653|NCT03246126|565633044|FG001|Overall Study|Withdrawal by Subject|1|||
156695654|NCT00629265|565633047|FG000|Overall Study|Lost to Follow-up|4|||
156695655|NCT00629265|565633048|FG001|Overall Study|Lost to Follow-up|5|||
156695656|NCT00629265|565633047|FG000|Overall Study|Withdrawal by Subject|11|||
156695657|NCT00629265|565633048|FG001|Overall Study|Withdrawal by Subject|8|||
156695658|NCT00629265|565633047|FG000|Overall Study|Death|1|||
156695659|NCT00629265|565633048|FG001|Overall Study|Death|0|||
156695660|NCT00629265|565633047|FG000|Overall Study|Adverse Event|2|||
156695661|NCT00629265|565633048|FG001|Overall Study|Adverse Event|0|||
156695662|NCT00629265|565633047|FG000|Overall Study|HNC Recurrence|4|||
156695663|NCT00629265|565633048|FG001|Overall Study|HNC Recurrence|0|||
156695664|NCT00629265|565633047|FG000|Overall Study|Other CA Requiring Treatment|1|||
156695665|NCT00629265|565633048|FG001|Overall Study|Other CA Requiring Treatment|3|||
156695666|NCT00629265|565633047|FG000|Overall Study|Needed Esophageal Dilation|4|||
156695667|NCT00629265|565633048|FG001|Overall Study|Needed Esophageal Dilation|1|||
156695668|NCT00629265|565633047|FG000|Overall Study|Unrelated Medical Complications|3|||
156695669|NCT00629265|565633048|FG001|Overall Study|Unrelated Medical Complications|1|||
156695670|NCT00629265|565633047|FG000|Overall Study|Unknown Reason|2|||
156695671|NCT00629265|565633048|FG001|Overall Study|Unknown Reason|2|||
156695672|NCT04465630|565633049|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
156695673|NCT04465630|565633049|FG000|Overall Study|Screen failure|8|||
156695674|NCT04465630|565633049|FG000|Overall Study|Baseline failure|16|||
156695675|NCT01006135|565633050|FG000|Overall Study|Adverse Event|22|||
156695676|NCT01006135|565633050|FG000|Overall Study|Protocol Violation|14|||
156695677|NCT01006135|565633050|FG000|Overall Study|Lost to Follow-up|32|||
156695678|NCT01006135|565633050|FG000|Overall Study|Other|72|||
156695679|NCT01732484|565633054|FG000|Overall Study|Death|7|||
156695680|NCT01732484|565633054|FG000|Overall Study|Lost to Follow-up|14|||
156695681|NCT01732484|565633054|FG000|Overall Study|chronical illness|5|||
156695682|NCT05297578|565633055|FG000|Overall Study|Lost to Follow-up|1|||
156695683|NCT05297578|565633056|FG001|Overall Study|Lost to Follow-up|1|||
156695684|NCT05297578|565633057|FG002|Overall Study|Lost to Follow-up|2|||
156695685|NCT05297578|565633058|FG003|Overall Study|Lost to Follow-up|1|||
156871047|NCT04032093|566284356|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
156871048|NCT04032093|566284357|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
156871049|NCT04032093|566284358|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
156871050|NCT04032093|566284359|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
156871051|NCT04032093|566284350|FG000|Overall Study|Adverse Event|0|||
156871052|NCT04032093|566284351|FG001|Overall Study|Adverse Event|0|||
156871053|NCT04032093|566284352|FG002|Overall Study|Adverse Event|0|||
156871054|NCT04032093|566284353|FG003|Overall Study|Adverse Event|0|||
156871055|NCT04032093|566284354|FG004|Overall Study|Adverse Event|0|||
156871056|NCT04032093|566284355|FG005|Overall Study|Adverse Event|0|||
156871057|NCT04032093|566284356|FG006|Overall Study|Adverse Event|0|||
156871058|NCT04032093|566284357|FG007|Overall Study|Adverse Event|0|||
156871059|NCT04032093|566284358|FG008|Overall Study|Adverse Event|0|||
156871060|NCT04032093|566284359|FG009|Overall Study|Adverse Event|1|||
156871061|NCT04032093|566284350|FG000|Overall Study|Physician Decision|0|||
156871062|NCT04032093|566284351|FG001|Overall Study|Physician Decision|0|||
156871063|NCT04032093|566284352|FG002|Overall Study|Physician Decision|0|||
156871064|NCT04032093|566284353|FG003|Overall Study|Physician Decision|0|||
156871065|NCT04032093|566284354|FG004|Overall Study|Physician Decision|0|||
156871066|NCT04032093|566284355|FG005|Overall Study|Physician Decision|1|||
156871067|NCT04032093|566284356|FG006|Overall Study|Physician Decision|0|||
156871068|NCT04032093|566284357|FG007|Overall Study|Physician Decision|0|||
156871069|NCT04032093|566284358|FG008|Overall Study|Physician Decision|0|||
156871070|NCT04032093|566284359|FG009|Overall Study|Physician Decision|0|||
156871071|NCT02377817|566284360|FG000|Overall Study|Transportation/childcare barriers.|2|||
156871072|NCT02377817|566284361|FG001|Overall Study|Transportation/childcare barriers.|0|||
156695686|NCT05297578|565633055|FG000|Overall Study|Death|0|||
156695687|NCT05297578|565633056|FG001|Overall Study|Death|1|||
156695688|NCT05297578|565633057|FG002|Overall Study|Death|0|||
156871073|NCT02377817|566284360|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
156871074|NCT02377817|566284361|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
156871075|NCT01696188|566284379|FG000|Overall Study|Protocol Violation|1|||
156871076|NCT01696188|566284380|FG001|Overall Study|Protocol Violation|1|||
156871077|NCT01185080|566284381|FG000|Overall Study|Adverse Event|1|||
156871078|NCT01185080|566284382|FG001|Overall Study|Adverse Event|1|||
156438231|NCT02252042|564695397|FG000|Overall Study|Physician Decision|0|||
156438232|NCT02252042|564695398|FG001|Overall Study|Physician Decision|2|||
156438233|NCT02252042|564695397|FG000|Overall Study|Transferred to Extension Study|7|||
156695689|NCT05297578|565633058|FG003|Overall Study|Death|0|||
156438234|NCT02252042|564695398|FG001|Overall Study|Transferred to Extension Study|1|||
156438235|NCT02252042|564695397|FG000|Overall Study|Did Not Continue on Extension Study|7|||
156695690|NCT05297578|565633055|FG000|Overall Study|Withdrawal by Subject|0|||
156695691|NCT05297578|565633056|FG001|Overall Study|Withdrawal by Subject|0|||
156695692|NCT05297578|565633057|FG002|Overall Study|Withdrawal by Subject|1|||
156695693|NCT05297578|565633058|FG003|Overall Study|Withdrawal by Subject|0|||
156871079|NCT01185080|566284383|FG002|Overall Study|Adverse Event|0|||
156871080|NCT01185080|566284381|FG000|Overall Study|Personal reasons|0|||
156871081|NCT01185080|566284382|FG001|Overall Study|Personal reasons|0|||
156871082|NCT01185080|566284383|FG002|Overall Study|Personal reasons|1|||
156871083|NCT02876601|566284384|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
156438236|NCT02252042|564695398|FG001|Overall Study|Did Not Continue on Extension Study|2|||
156695694|NCT01087489|565633059|FG000|Overall Study|enrolled in another VA study|0|||
156695695|NCT01087489|565633060|FG001|Overall Study|enrolled in another VA study|1|||
156695696|NCT01087489|565633059|FG000|Overall Study|Death|0|||
156695697|NCT01087489|565633060|FG001|Overall Study|Death|1|||
156695698|NCT01087489|565633059|FG000|Overall Study|unable to survey by telephone|0|||
156695699|NCT01087489|565633060|FG001|Overall Study|unable to survey by telephone|1|||
156695700|NCT02032706|565633068|FG000|Overall Study|Did not qualify|5|||
156695701|NCT02032706|565633068|FG000|Overall Study|Protocol Violation|1|||
156695702|NCT00893737|565633069|FG000|Overall Study|Adverse Event|4|||
156695703|NCT00893737|565633069|FG000|Overall Study|Withdrawal by Subject|2|||
156695704|NCT00893737|565633069|FG000|Overall Study|Lost to Follow-up|6|||
156695705|NCT00928707|565633070|FG000|Overall Study|Protocol Violation|1|||
156695706|NCT00928707|565633071|FG001|Overall Study|Protocol Violation|0|||
156695707|NCT00132028|565633072|FG000|Overall Study|Adverse Event|7|||
156695708|NCT00132028|565633072|FG000|Overall Study|Death|2|||
156695709|NCT00132028|565633072|FG000|Overall Study|Lack of Efficacy|11|||
156695710|NCT00132028|565633072|FG000|Overall Study|Withdrawal by Subject|2|||
156695711|NCT00132028|565633072|FG000|Overall Study|not eligible|2|||
156695712|NCT00132028|565633072|FG000|Overall Study|Physician Decision|3|||
156695713|NCT02140411|565633073|FG000|Overall Study|Adverse Event|1|||
156695714|NCT03981419|565633076|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
156695715|NCT03981419|565633077|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
156695716|NCT01330459|565633082|FG000|Overall Study|Physician Decision|0|||
156695717|NCT01330459|565633083|FG001|Overall Study|Physician Decision|2|||
156695718|NCT01437943|565633085|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
156695719|NCT01437943|565633086|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
156695720|NCT01437943|565633085|FG000|Overall Study|Subject expressed pregnancy plans|1|||
156695721|NCT01437943|565633086|FG001|Overall Study|Subject expressed pregnancy plans|0|||
156695722|NCT01437943|565633085|FG000|Overall Study|Adverse Event|2|||
156695723|NCT01437943|565633086|FG001|Overall Study|Adverse Event|0|||
156695724|NCT02005887|565633088|FG000|Overall Study|Protocol Violation|0|||
156695725|NCT02005887|565633089|FG001|Overall Study|Protocol Violation|2|||
156695726|NCT01615263|565633098|FG000|Overall Study|Post-randomization exclusion|0|||
156695727|NCT01615263|565633099|FG001|Overall Study|Post-randomization exclusion|2|||
156695728|NCT00160641|565633100|FG000|Overall Study|Adverse Event|102|||
156695729|NCT00160641|565633100|FG000|Overall Study|Withdrawal by Subject|87|||
156695730|NCT00160641|565633100|FG000|Overall Study|Lost to Follow-up|8|||
156695731|NCT00160641|565633100|FG000|Overall Study|Lack of Efficacy|12|||
156695732|NCT00160641|565633100|FG000|Overall Study|Protocol Violation|3|||
156695733|NCT00160641|565633100|FG000|Overall Study|Other|9|||
156695734|NCT03097588|565633102|FG000|Overall Study|Adverse Event|1|||
156695735|NCT01144364|565633103|FG000|Induction Phase|Disease progression|14|||
156695736|NCT01144364|565633104|FG001|Induction Phase|Disease progression|0|||
156871084|NCT02876601|566284385|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
156438237|NCT02252042|564695397|FG000|Overall Study|Withdrawal by Subject|15|||
156438238|NCT02252042|564695398|FG001|Overall Study|Withdrawal by Subject|20|||
156438239|NCT01177670|564695400|FG000|Overall Study|Study Terminated|115|||
156438240|NCT01177670|564695400|FG000|Overall Study|Physician Decision|50|||
156438241|NCT01177670|564695400|FG000|Overall Study|Withdrawal by Subject|4|||
156438242|NCT00979992|564695401|FG000|Overall Study|Ineligible - inadequate pathology|1|||
156438243|NCT00979992|564695401|FG000|Overall Study|Ineligible - wrong cell type|2|||
156438244|NCT00979992|564695401|FG000|Overall Study|Refused - Never Treated|2|||
156438245|NCT03691428|564695407|FG000|Overall Study|Withdrawal by Subject|6|||
156438246|NCT03691428|564695408|FG001|Overall Study|Withdrawal by Subject|8|||
156438247|NCT01460290|564695409|FG000|Overall Study|Adverse Event|3|||
156438248|NCT01460290|564695409|FG000|Overall Study|Elevated liver function|1|||
156438249|NCT02527148|564695410|FG000|Overall Study|Did not receive study intervention|1|||
156438250|NCT02527148|564695411|FG001|Overall Study|Did not receive study intervention|0|||
156438251|NCT00309907|564695412|FG000|Overall Study|Death|4|||
156438252|NCT00309907|564695412|FG000|Overall Study|Physician Decision|1|||
156438253|NCT00309907|564695412|FG000|Overall Study|Ineligible|11|||
156438254|NCT00309907|564695412|FG000|Overall Study|Major infectious event|4|||
156438255|NCT00980330|564695413|FG000|Overall Study|Adverse Event|0|||
156438256|NCT00980330|564695414|FG001|Overall Study|Adverse Event|0|||
156438257|NCT00980330|564695415|FG002|Overall Study|Adverse Event|0|||
156438258|NCT00980330|564695416|FG003|Overall Study|Adverse Event|1|||
156438259|NCT00980330|564695417|FG004|Overall Study|Adverse Event|0|||
156438260|NCT00980330|564695418|FG005|Overall Study|Adverse Event|0|||
156438261|NCT00980330|564695419|FG006|Overall Study|Adverse Event|0|||
156438262|NCT00980330|564695413|FG000|Overall Study|Lost to Follow-up|1|||
156438263|NCT00980330|564695414|FG001|Overall Study|Lost to Follow-up|1|||
156438264|NCT00980330|564695415|FG002|Overall Study|Lost to Follow-up|4|||
156438265|NCT00980330|564695416|FG003|Overall Study|Lost to Follow-up|2|||
156695737|NCT01144364|565633105|FG002|Induction Phase|Disease progression|0|||
156695738|NCT01144364|565633103|FG000|Induction Phase|Adverse Event|9|||
156695739|NCT01144364|565633104|FG001|Induction Phase|Adverse Event|0|||
156695740|NCT01144364|565633105|FG002|Induction Phase|Adverse Event|0|||
156695741|NCT01144364|565633103|FG000|Induction Phase|Death|1|||
156695742|NCT01144364|565633104|FG001|Induction Phase|Death|0|||
156695743|NCT01144364|565633105|FG002|Induction Phase|Death|0|||
156695744|NCT01144364|565633103|FG000|Induction Phase|Withdrawal by Subject|1|||
156695745|NCT01144364|565633104|FG001|Induction Phase|Withdrawal by Subject|0|||
156695746|NCT01144364|565633105|FG002|Induction Phase|Withdrawal by Subject|0|||
156695747|NCT01144364|565633103|FG000|Induction Phase|Lost to Follow-up|2|||
156695748|NCT01144364|565633104|FG001|Induction Phase|Lost to Follow-up|0|||
156695749|NCT01144364|565633105|FG002|Induction Phase|Lost to Follow-up|0|||
156695750|NCT01144364|565633103|FG000|Induction Phase|Physician Decision|1|||
156695751|NCT01144364|565633104|FG001|Induction Phase|Physician Decision|0|||
156695752|NCT01144364|565633105|FG002|Induction Phase|Physician Decision|0|||
156695753|NCT01144364|565633103|FG000|Induction Phase|Stable disease|2|||
156695754|NCT01144364|565633104|FG001|Induction Phase|Stable disease|0|||
156695755|NCT01144364|565633105|FG002|Induction Phase|Stable disease|0|||
156695756|NCT01144364|565633103|FG000|Induction Phase|Secondary neoplasia|1|||
156695757|NCT01144364|565633104|FG001|Induction Phase|Secondary neoplasia|0|||
156695758|NCT01144364|565633105|FG002|Induction Phase|Secondary neoplasia|0|||
156695759|NCT01144364|565633103|FG000|Induction Phase|Protocol Violation|1|||
156695760|NCT01144364|565633104|FG001|Induction Phase|Protocol Violation|0|||
156695761|NCT01144364|565633105|FG002|Induction Phase|Protocol Violation|0|||
156695762|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
156695763|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
156695764|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
156695765|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
156695766|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
156695767|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
156695768|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Death|0|||
156695769|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Death|2|||
156695770|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Death|0|||
156695771|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
156695772|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
156695773|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
156695774|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
156695775|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
156695776|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
156695777|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
156695778|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
156695779|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
156695780|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
156695781|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
156695782|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
156695783|NCT00673933|565633106|FG000|Overall Study|Withdrawal by Subject|2|||
156695784|NCT00673933|565633106|FG000|Overall Study|Lost to Follow-up|1|||
156438266|NCT00980330|564695417|FG004|Overall Study|Lost to Follow-up|1|||
156438267|NCT00980330|564695418|FG005|Overall Study|Lost to Follow-up|1|||
156438268|NCT00980330|564695419|FG006|Overall Study|Lost to Follow-up|2|||
156438269|NCT00980330|564695413|FG000|Overall Study|Withdrawal by Subject|2|||
156438270|NCT00980330|564695414|FG001|Overall Study|Withdrawal by Subject|4|||
156438271|NCT00980330|564695415|FG002|Overall Study|Withdrawal by Subject|4|||
156438272|NCT00980330|564695416|FG003|Overall Study|Withdrawal by Subject|1|||
156438273|NCT00980330|564695417|FG004|Overall Study|Withdrawal by Subject|3|||
156438274|NCT00980330|564695418|FG005|Overall Study|Withdrawal by Subject|2|||
156438275|NCT00980330|564695419|FG006|Overall Study|Withdrawal by Subject|5|||
156438276|NCT00980330|564695413|FG000|Overall Study|(not specified)|2|||
156438277|NCT00980330|564695414|FG001|Overall Study|(not specified)|0|||
156438278|NCT00980330|564695415|FG002|Overall Study|(not specified)|0|||
156438279|NCT00980330|564695416|FG003|Overall Study|(not specified)|1|||
156438280|NCT00980330|564695417|FG004|Overall Study|(not specified)|1|||
156695785|NCT04932941|565633107|FG000|Overall Study|Lost to Follow-up|3|||
156695786|NCT04932941|565633108|FG001|Overall Study|Lost to Follow-up|1|||
156695787|NCT04932941|565633107|FG000|Overall Study|Withdrawal by Subject|7|||
156695788|NCT04932941|565633108|FG001|Overall Study|Withdrawal by Subject|4|||
156695789|NCT04932941|565633107|FG000|Overall Study|Other|4|||
156438281|NCT00980330|564695418|FG005|Overall Study|(not specified)|1|||
156438282|NCT00980330|564695419|FG006|Overall Study|(not specified)|0|||
156438283|NCT01039688|564695420|FG000|Overall Study|Adverse Event|38|||
156438284|NCT01039688|564695421|FG001|Overall Study|Adverse Event|39|||
156438285|NCT01039688|564695422|FG002|Overall Study|Adverse Event|24|||
156695790|NCT04932941|565633108|FG001|Overall Study|Other|2|||
156695791|NCT02206620|565633109|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
156695792|NCT02206620|565633110|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
156695793|NCT02206620|565633109|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
156695794|NCT02206620|565633110|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
156695795|NCT00375492|565633112|FG000|Overall Study|Adverse Event|4|||
156695796|NCT00375492|565633113|FG001|Overall Study|Adverse Event|5|||
156695797|NCT00375492|565633112|FG000|Overall Study|Entry Criteria Not Met|0|||
156695798|NCT00375492|565633113|FG001|Overall Study|Entry Criteria Not Met|1|||
156695799|NCT00375492|565633112|FG000|Overall Study|Loss of Glucose Control|0|||
156695800|NCT00375492|565633113|FG001|Overall Study|Loss of Glucose Control|1|||
156695801|NCT00375492|565633112|FG000|Overall Study|Lost to Follow-up|10|||
156695802|NCT00375492|565633113|FG001|Overall Study|Lost to Follow-up|5|||
156695803|NCT00375492|565633112|FG000|Overall Study|Physician Decision|0|||
156695804|NCT00375492|565633113|FG001|Overall Study|Physician Decision|4|||
156695805|NCT00375492|565633112|FG000|Overall Study|Protocol Violation|6|||
156695806|NCT00375492|565633113|FG001|Overall Study|Protocol Violation|3|||
156695807|NCT00375492|565633112|FG000|Overall Study|Sponsor Decision|0|||
156695808|NCT00375492|565633113|FG001|Overall Study|Sponsor Decision|1|||
156695809|NCT00375492|565633112|FG000|Overall Study|Withdrawal by Subject|6|||
156695810|NCT00375492|565633113|FG001|Overall Study|Withdrawal by Subject|6|||
156695811|NCT00912093|565634263|FG000|The Controlled Phase|Death|0|||
156695812|NCT00912093|565634264|FG001|The Controlled Phase|Death|1|||
156695813|NCT00912093|565634265|FG002|The Controlled Phase|Death|0|||
156695814|NCT00912093|565634266|FG003|The Controlled Phase|Death|0|||
156695815|NCT00912093|565634267|FG004|The Controlled Phase|Death|0|||
156695816|NCT00912093|565634263|FG000|The Controlled Phase|Medical Condition|0|||
156695817|NCT00912093|565634264|FG001|The Controlled Phase|Medical Condition|1|||
156695818|NCT00912093|565634265|FG002|The Controlled Phase|Medical Condition|0|||
156695819|NCT00912093|565634266|FG003|The Controlled Phase|Medical Condition|0|||
156695820|NCT00912093|565634267|FG004|The Controlled Phase|Medical Condition|0|||
156695821|NCT00912093|565634263|FG000|The Controlled Phase|Lost to Follow-up|0|||
156695822|NCT00912093|565634264|FG001|The Controlled Phase|Lost to Follow-up|0|||
156695823|NCT00912093|565634265|FG002|The Controlled Phase|Lost to Follow-up|0|||
156695824|NCT00912093|565634266|FG003|The Controlled Phase|Lost to Follow-up|0|||
156695825|NCT00912093|565634267|FG004|The Controlled Phase|Lost to Follow-up|1|||
156695826|NCT00103311|565634268|FG000|Overall Study|Lost to Follow-up|1|||
156695827|NCT00103311|565634269|FG001|Overall Study|Lost to Follow-up|0|||
156695828|NCT00103311|565634268|FG000|Overall Study|Withdrawal by Subject|2|||
156695829|NCT00103311|565634269|FG001|Overall Study|Withdrawal by Subject|1|||
156695830|NCT00103311|565634268|FG000|Overall Study|Adverse Event|1|||
156695831|NCT00103311|565634269|FG001|Overall Study|Adverse Event|0|||
156695832|NCT02621034|565634270|FG000|Overall Study|Lost to Follow-up|3|||
156695833|NCT02621034|565634271|FG001|Overall Study|Lost to Follow-up|2|||
156695834|NCT02621034|565634272|FG002|Overall Study|Lost to Follow-up|5|||
156695835|NCT02372071|565634273|FG000|Overall Study|Protocol Violation|18|||
156695836|NCT01968694|565634274|FG000|Washout (1 Month)|Lost to Follow-up|0|||
156695837|NCT01968694|565634275|FG001|Washout (1 Month)|Lost to Follow-up|1|||
156695838|NCT02836496|565634276|FG000|Overall Study|Adverse Event|2|||
156438286|NCT01039688|564695420|FG000|Overall Study|Lack of Efficacy|20|||
156695839|NCT02836496|565634277|FG001|Overall Study|Adverse Event|1|||
156695840|NCT02836496|565634276|FG000|Overall Study|Withdrawal by Subject|0|||
156695841|NCT02836496|565634277|FG001|Overall Study|Withdrawal by Subject|1|||
156695842|NCT01400919|565634278|FG000|Overall Study|Withdrawal by Subject|4|||
156695843|NCT01400919|565634278|FG000|Overall Study|Lost to Follow-up|2|||
156695844|NCT01400919|565634278|FG000|Overall Study|Missed visit|2|||
156695845|NCT01246011|565634279|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
156695846|NCT01246011|565634280|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
156695847|NCT01246011|565634281|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
156695848|NCT01246011|565634279|FG000|Overall Study|Withdrawal by Subject|0|||
156695849|NCT01246011|565634280|FG001|Overall Study|Withdrawal by Subject|0|||
156695850|NCT01246011|565634281|FG002|Overall Study|Withdrawal by Subject|1|||
156695851|NCT00415194|565634291|FG000|Overall Study|Adverse Event|37|||
156695852|NCT00415194|565634292|FG001|Overall Study|Adverse Event|32|||
156695853|NCT00415194|565634291|FG000|Overall Study|Entry Criteria Not Met|4|||
156695854|NCT00415194|565634292|FG001|Overall Study|Entry Criteria Not Met|8|||
156789958|NCT01557244|565983656|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
156789959|NCT01557244|565983657|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789960|NCT01557244|565983658|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789961|NCT01557244|565983659|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789962|NCT01557244|565983660|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789963|NCT01557244|565983661|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789964|NCT01557244|565983655|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789965|NCT01557244|565983656|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156695855|NCT00415194|565634291|FG000|Overall Study|Lost to Follow-up|1|||
156695856|NCT00415194|565634292|FG001|Overall Study|Lost to Follow-up|0|||
156695857|NCT00415194|565634291|FG000|Overall Study|Physician Decision|10|||
156695858|NCT00415194|565634292|FG001|Overall Study|Physician Decision|16|||
156695859|NCT00415194|565634291|FG000|Overall Study|Progressive Disease|180|||
156695860|NCT00415194|565634292|FG001|Overall Study|Progressive Disease|217|||
156695861|NCT00415194|565634291|FG000|Overall Study|Protocol Violation|4|||
156695862|NCT00415194|565634292|FG001|Overall Study|Protocol Violation|2|||
156695863|NCT00415194|565634291|FG000|Overall Study|Withdrawal by Subject|28|||
156695864|NCT00415194|565634292|FG001|Overall Study|Withdrawal by Subject|21|||
156695865|NCT00415194|565634291|FG000|Overall Study|Death Due to Study Disease|26|||
156695866|NCT00415194|565634292|FG001|Overall Study|Death Due to Study Disease|29|||
156695867|NCT00415194|565634291|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
156695868|NCT00415194|565634292|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
156695869|NCT00415194|565634291|FG000|Overall Study|Death Due to Procedural Related AE|0|||
156695870|NCT00415194|565634292|FG001|Overall Study|Death Due to Procedural Related AE|1|||
156695871|NCT00415194|565634291|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
156695872|NCT00415194|565634292|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
156695873|NCT01297465|565634293|FG000|Overall Study|Lack of Ovarian Response|1|||
156695874|NCT01297465|565634294|FG001|Overall Study|Lack of Ovarian Response|1|||
156695875|NCT01297465|565634293|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
156695876|NCT01297465|565634294|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
156695877|NCT01297465|565634293|FG000|Overall Study|No Oocytes Retrieved|1|||
156695878|NCT01297465|565634294|FG001|Overall Study|No Oocytes Retrieved|1|||
156695879|NCT01297465|565634293|FG000|Overall Study|Poor oocyte quality|0|||
156695880|NCT01297465|565634294|FG001|Overall Study|Poor oocyte quality|1|||
156695881|NCT01297465|565634293|FG000|Overall Study|No Fertilization|6|||
156695882|NCT01297465|565634294|FG001|Overall Study|No Fertilization|4|||
156695883|NCT01297465|565634293|FG000|Overall Study|All Embryos Discarded|0|||
156695884|NCT01297465|565634294|FG001|Overall Study|All Embryos Discarded|1|||
156695885|NCT01297465|565634293|FG000|Overall Study|Intention to Freeze all Embryos|0|||
156695886|NCT01297465|565634294|FG001|Overall Study|Intention to Freeze all Embryos|1|||
156695887|NCT00969540|565634295|FG000|Overall Study|Lost to Follow-up|1|||
156330980|NCT00586625|564311917|FG000|Overall Study|Subject unable to return for visit|2|||
156871085|NCT02876601|566284386|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
156871086|NCT02876601|566284387|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
156871087|NCT06083506|566284389|FG000|Overall Study|Physician Decision|2|||
156871088|NCT06083506|566284389|FG000|Overall Study|Lack of Efficacy|1|||
156871089|NCT01648751|566284401|FG000|Overall Study|Withdrawal by Subject|2|||
156330981|NCT00586625|564311918|FG001|Overall Study|Subject unable to return for visit|0|||
156330982|NCT02649894|564311920|FG000|Overall Study|Adverse Event|1|||
156530820|NCT03829319|565038189|FG002|Overall Study|Death|266|||
156695888|NCT00969540|565634296|FG001|Overall Study|Lost to Follow-up|1|||
156695889|NCT01683838|565634297|FG000|Overall Study|Adverse Event|12|||
156695890|NCT01683838|565634298|FG001|Overall Study|Adverse Event|2|||
156789966|NCT01557244|565983657|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789967|NCT01557244|565983658|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
156789968|NCT01557244|565983659|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789969|NCT01557244|565983660|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789970|NCT01557244|565983661|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789971|NCT01557244|565983655|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
156789972|NCT01557244|565983656|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
156789973|NCT01557244|565983657|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789974|NCT01557244|565983658|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789975|NCT01557244|565983659|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789976|NCT01557244|565983660|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789977|NCT01557244|565983661|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789978|NCT01313676|565983662|FG000|Overall Study|Adverse Event|395|||
156789979|NCT01313676|565983663|FG001|Overall Study|Adverse Event|365|||
156789980|NCT01313676|565983664|FG002|Overall Study|Adverse Event|372|||
156789981|NCT01313676|565983665|FG003|Overall Study|Adverse Event|333|||
156789982|NCT01313676|565983662|FG000|Overall Study|Lack of Efficacy|98|||
156789983|NCT01313676|565983663|FG001|Overall Study|Lack of Efficacy|90|||
156789984|NCT01313676|565983664|FG002|Overall Study|Lack of Efficacy|65|||
156789985|NCT01313676|565983665|FG003|Overall Study|Lack of Efficacy|46|||
156789986|NCT01313676|565983662|FG000|Overall Study|Protocol Violation|37|||
156330983|NCT02649894|564311921|FG001|Overall Study|Adverse Event|0|||
156330984|NCT02649894|564311920|FG000|Overall Study|Physician Decision|0|||
156330985|NCT02649894|564311921|FG001|Overall Study|Physician Decision|1|||
156330986|NCT02649894|564311920|FG000|Overall Study|Withdrawal by Subject|5|||
156330987|NCT02649894|564311921|FG001|Overall Study|Withdrawal by Subject|2|||
156330988|NCT02649894|564311920|FG000|Overall Study|Lost to Follow-up|2|||
156330989|NCT02649894|564311921|FG001|Overall Study|Lost to Follow-up|1|||
156330990|NCT02649894|564311920|FG000|Overall Study|Death|30|||
156695891|NCT01683838|565634297|FG000|Overall Study|Protocol Violation|3|||
156695892|NCT01683838|565634298|FG001|Overall Study|Protocol Violation|1|||
156789987|NCT01313676|565983663|FG001|Overall Study|Protocol Violation|44|||
156789988|NCT01313676|565983664|FG002|Overall Study|Protocol Violation|46|||
156871090|NCT01648751|566284402|FG001|Overall Study|Withdrawal by Subject|3|||
156330991|NCT02649894|564311921|FG001|Overall Study|Death|7|||
156330992|NCT02649894|564311920|FG000|Overall Study|Other, not specified|6|||
156695893|NCT01683838|565634297|FG000|Overall Study|Withdrawal by Subject|6|||
156695894|NCT01683838|565634298|FG001|Overall Study|Withdrawal by Subject|5|||
156695895|NCT01683838|565634297|FG000|Overall Study|Lost to Follow-up|1|||
156695896|NCT01683838|565634298|FG001|Overall Study|Lost to Follow-up|1|||
156695897|NCT01683838|565634297|FG000|Overall Study|Other|4|||
156695898|NCT01683838|565634298|FG001|Overall Study|Other|3|||
156695899|NCT01646138|565634299|FG000|Overall Study|Lost to Follow-up|0|||
156695900|NCT01646138|565634300|FG001|Overall Study|Lost to Follow-up|0|||
156695901|NCT01646138|565634301|FG002|Overall Study|Lost to Follow-up|0|||
156695902|NCT01646138|565634302|FG003|Overall Study|Lost to Follow-up|0|||
156695903|NCT01646138|565634303|FG004|Overall Study|Lost to Follow-up|2|||
156695904|NCT04049617|565634304|FG000|Overall Study|Adverse Event|0|||
156695905|NCT04049617|565634305|FG001|Overall Study|Adverse Event|0|||
156695906|NCT04049617|565634306|FG002|Overall Study|Adverse Event|0|||
156695907|NCT04049617|565634307|FG003|Overall Study|Adverse Event|1|||
156695908|NCT04049617|565634308|FG004|Overall Study|Adverse Event|0|||
156695909|NCT04049617|565634309|FG005|Overall Study|Adverse Event|0|||
156695910|NCT04049617|565634304|FG000|Overall Study|Death|0|||
156695911|NCT04049617|565634305|FG001|Overall Study|Death|0|||
156695912|NCT04049617|565634306|FG002|Overall Study|Death|0|||
156695913|NCT04049617|565634307|FG003|Overall Study|Death|0|||
156695914|NCT04049617|565634308|FG004|Overall Study|Death|0|||
156695915|NCT04049617|565634309|FG005|Overall Study|Death|1|||
156438287|NCT01039688|564695421|FG001|Overall Study|Lack of Efficacy|11|||
156695916|NCT04049617|565634304|FG000|Overall Study|Lost to Follow-up|0|||
156695917|NCT04049617|565634305|FG001|Overall Study|Lost to Follow-up|0|||
156695918|NCT04049617|565634306|FG002|Overall Study|Lost to Follow-up|0|||
156695919|NCT04049617|565634307|FG003|Overall Study|Lost to Follow-up|1|||
156695920|NCT04049617|565634308|FG004|Overall Study|Lost to Follow-up|0|||
156695921|NCT04049617|565634309|FG005|Overall Study|Lost to Follow-up|0|||
156695922|NCT04049617|565634304|FG000|Overall Study|Withdrew consent|0|||
156695923|NCT04049617|565634305|FG001|Overall Study|Withdrew consent|0|||
156695924|NCT04049617|565634306|FG002|Overall Study|Withdrew consent|1|||
156695925|NCT04049617|565634307|FG003|Overall Study|Withdrew consent|0|||
156695926|NCT04049617|565634308|FG004|Overall Study|Withdrew consent|0|||
156438288|NCT01039688|564695422|FG002|Overall Study|Lack of Efficacy|26|||
156438289|NCT01039688|564695420|FG000|Overall Study|Lost to Follow-up|11|||
156871091|NCT03467750|566284404|FG000|Overall Study|Surgery canceled|1|||
156871092|NCT03467750|566284405|FG001|Overall Study|Surgery canceled|0|||
156438290|NCT01039688|564695421|FG001|Overall Study|Lost to Follow-up|9|||
156695927|NCT04049617|565634309|FG005|Overall Study|Withdrew consent|0|||
156695928|NCT00801099|565634310|FG000|Overall Study|Lost to Follow-up|101|||
156695929|NCT04078126|565634311|FG000|Washout|Study put on hold due to COVID-19|0|||
156695930|NCT04078126|565634312|FG001|Washout|Study put on hold due to COVID-19|2|||
156695931|NCT04078126|565634311|FG000|Period 2|Study put on hold due to COVID-19|1|||
156871093|NCT03467750|566284404|FG000|Overall Study|Protocol Violation|1|||
156871094|NCT03467750|566284405|FG001|Overall Study|Protocol Violation|1|||
156871095|NCT03467750|566284404|FG000|Overall Study|Withdrawal by Subject|0|||
156438291|NCT01039688|564695422|FG002|Overall Study|Lost to Follow-up|5|||
156438292|NCT01039688|564695420|FG000|Overall Study|Other|13|||
156438293|NCT01039688|564695421|FG001|Overall Study|Other|25|||
156438294|NCT01039688|564695422|FG002|Overall Study|Other|12|||
156438295|NCT01039688|564695420|FG000|Overall Study|Withdrawal by Subject|23|||
156871096|NCT03467750|566284405|FG001|Overall Study|Withdrawal by Subject|1|||
156330993|NCT02649894|564311921|FG001|Overall Study|Other, not specified|0|||
156330994|NCT04590963|564311922|FG000|Overall Study|Death|118|||
156330995|NCT04590963|564311923|FG001|Overall Study|Death|59|||
156330996|NCT04590963|564311922|FG000|Overall Study|Lost to Follow-up|1|||
156330997|NCT04590963|564311923|FG001|Overall Study|Lost to Follow-up|1|||
156330998|NCT04590963|564311922|FG000|Overall Study|Progressive disease|0|||
156330999|NCT04590963|564311923|FG001|Overall Study|Progressive disease|1|||
156331000|NCT04590963|564311922|FG000|Overall Study|Study terminated by sponsor|103|||
156331001|NCT04590963|564311923|FG001|Overall Study|Study terminated by sponsor|50|||
156331002|NCT04590963|564311922|FG000|Overall Study|Withdrawal by Subject|15|||
156331003|NCT04590963|564311923|FG001|Overall Study|Withdrawal by Subject|8|||
156331004|NCT04590963|564311922|FG000|Overall Study|Ongoing at data cut-off|9|||
156331005|NCT04590963|564311923|FG001|Overall Study|Ongoing at data cut-off|4|||
156331006|NCT04590963|564311922|FG000|Overall Study|Screen failure|1|||
156331007|NCT04590963|564311923|FG001|Overall Study|Screen failure|0|||
156438296|NCT01039688|564695421|FG001|Overall Study|Withdrawal by Subject|27|||
156695932|NCT04078126|565634312|FG001|Period 2|Study put on hold due to COVID-19|1|||
156695933|NCT01169532|565634313|FG000|Overall Study|Withdrawal by Subject|1|||
156695934|NCT01156142|565634317|FG000|Overall Study|Withdrawal by Subject|8|||
156695935|NCT01156142|565634318|FG001|Overall Study|Withdrawal by Subject|6|||
156695936|NCT01156142|565634317|FG000|Overall Study|Ineligible|0|||
156695937|NCT01156142|565634318|FG001|Overall Study|Ineligible|1|||
156871097|NCT05673876|566284406|FG000|Overall Study|Death|3|||
156871098|NCT05673876|566284407|FG001|Overall Study|Death|1|||
156331008|NCT04430738|564311926|FG000|Phase 1: Dose Escalation|Death|1|||
156695938|NCT02643355|565634319|FG000|Overall Study|Withdrawal by Subject|1|||
156871099|NCT05673876|566284406|FG000|Overall Study|Study Terminated by Sponsor|0|||
156871100|NCT05673876|566284407|FG001|Overall Study|Study Terminated by Sponsor|1|||
156871101|NCT05673876|566284406|FG000|Overall Study|Physician Decision|0|||
156871102|NCT05673876|566284407|FG001|Overall Study|Physician Decision|1|||
156871103|NCT03529422|566284408|FG000|Overall Study|Withdrawal by Subject|1|||
156871104|NCT03529422|566284408|FG000|Overall Study|Protocol Violation|1|||
156871105|NCT03529422|566284408|FG000|Overall Study|Disease progression|2|||
156871106|NCT05006573|566284411|FG000|Double-blind Treatment Period|Physician Decision|2|||
156871107|NCT05006573|566284412|FG001|Double-blind Treatment Period|Physician Decision|0|||
156530821|NCT01210118|565038192|FG000|Overall Study|Lost to Follow-up|1|||
156530822|NCT01210118|565038193|FG001|Overall Study|Lost to Follow-up|1|||
156530823|NCT01210118|565038192|FG000|Overall Study|Protocol Violation|1|||
156530824|NCT01210118|565038193|FG001|Overall Study|Protocol Violation|1|||
156530825|NCT01210118|565038192|FG000|Overall Study|Spontaneous abortion|1|||
156530826|NCT01210118|565038193|FG001|Overall Study|Spontaneous abortion|3|||
156530827|NCT00777946|565038194|FG000|Overall Study|Adverse Event|11|||
156530828|NCT00777946|565038195|FG001|Overall Study|Adverse Event|1|||
156530829|NCT00777946|565038196|FG002|Overall Study|Adverse Event|3|||
156530830|NCT00777946|565038194|FG000|Overall Study|Lack of Efficacy|0|||
156530831|NCT00777946|565038195|FG001|Overall Study|Lack of Efficacy|0|||
156530832|NCT00777946|565038196|FG002|Overall Study|Lack of Efficacy|9|||
156530833|NCT00777946|565038194|FG000|Overall Study|Condition no longer required study drug|1|||
156530834|NCT00777946|565038195|FG001|Overall Study|Condition no longer required study drug|0|||
156530835|NCT00777946|565038196|FG002|Overall Study|Condition no longer required study drug|0|||
156530836|NCT00777946|565038194|FG000|Overall Study|Patient withdrew consent|3|||
156530837|NCT00777946|565038195|FG001|Overall Study|Patient withdrew consent|2|||
156530838|NCT00777946|565038196|FG002|Overall Study|Patient withdrew consent|3|||
156530839|NCT00777946|565038194|FG000|Overall Study|Lost to Follow-up|3|||
156530840|NCT00777946|565038195|FG001|Overall Study|Lost to Follow-up|1|||
156530841|NCT00777946|565038196|FG002|Overall Study|Lost to Follow-up|0|||
156530842|NCT00777946|565038194|FG000|Overall Study|Protocol deviation|2|||
156530843|NCT00777946|565038195|FG001|Overall Study|Protocol deviation|1|||
156530844|NCT00777946|565038196|FG002|Overall Study|Protocol deviation|1|||
156530845|NCT00777946|565038194|FG000|Overall Study|Randomized in error|1|||
156530846|NCT00777946|565038195|FG001|Overall Study|Randomized in error|1|||
156530847|NCT00777946|565038196|FG002|Overall Study|Randomized in error|0|||
156530848|NCT01079130|565038197|FG000|Overall Study|Adverse Event|1|||
156530849|NCT01079130|565038198|FG001|Overall Study|Adverse Event|1|||
156530850|NCT01079130|565038199|FG002|Overall Study|Adverse Event|0|||
156530851|NCT01079130|565038200|FG003|Overall Study|Adverse Event|1|||
156530852|NCT01079130|565038201|FG004|Overall Study|Adverse Event|5|||
156530853|NCT01079130|565038202|FG005|Overall Study|Adverse Event|1|||
156530854|NCT01079130|565038197|FG000|Overall Study|Administrative problems|1|||
156530855|NCT01079130|565038198|FG001|Overall Study|Administrative problems|3|||
156530856|NCT01079130|565038199|FG002|Overall Study|Administrative problems|0|||
156530857|NCT01079130|565038200|FG003|Overall Study|Administrative problems|0|||
156530858|NCT01079130|565038201|FG004|Overall Study|Administrative problems|0|||
156530859|NCT01079130|565038202|FG005|Overall Study|Administrative problems|1|||
156530860|NCT01079130|565038197|FG000|Overall Study|Withdrawal by Subject|0|||
156530861|NCT01079130|565038198|FG001|Overall Study|Withdrawal by Subject|1|||
156530862|NCT01079130|565038199|FG002|Overall Study|Withdrawal by Subject|0|||
156530863|NCT01079130|565038200|FG003|Overall Study|Withdrawal by Subject|0|||
156530864|NCT01079130|565038201|FG004|Overall Study|Withdrawal by Subject|1|||
156530865|NCT01079130|565038202|FG005|Overall Study|Withdrawal by Subject|3|||
156530866|NCT01079130|565038197|FG000|Overall Study|Protocol deviation|0|||
156530867|NCT01079130|565038198|FG001|Overall Study|Protocol deviation|2|||
156530868|NCT01079130|565038199|FG002|Overall Study|Protocol deviation|1|||
156530869|NCT01079130|565038200|FG003|Overall Study|Protocol deviation|2|||
156530870|NCT01079130|565038201|FG004|Overall Study|Protocol deviation|0|||
156530871|NCT01079130|565038202|FG005|Overall Study|Protocol deviation|0|||
156530872|NCT01079130|565038197|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156530873|NCT01079130|565038198|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156530874|NCT01079130|565038199|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156530875|NCT01079130|565038200|FG003|Overall Study|Abnormal test procedure result(s)|0|||
156530876|NCT01079130|565038201|FG004|Overall Study|Abnormal test procedure result(s)|1|||
156530877|NCT01079130|565038202|FG005|Overall Study|Abnormal test procedure result(s)|0|||
156530878|NCT01079130|565038197|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156530879|NCT01079130|565038198|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156530880|NCT01079130|565038199|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156871108|NCT05006573|566284411|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
156530881|NCT01079130|565038200|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
156530882|NCT01079130|565038201|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
156530883|NCT01079130|565038202|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
156530884|NCT01079130|565038197|FG000|Overall Study|Lost to Follow-up|0|||
156530885|NCT01079130|565038198|FG001|Overall Study|Lost to Follow-up|0|||
156530886|NCT01079130|565038199|FG002|Overall Study|Lost to Follow-up|0|||
156530887|NCT01079130|565038200|FG003|Overall Study|Lost to Follow-up|0|||
156438297|NCT01039688|564695422|FG002|Overall Study|Withdrawal by Subject|13|||
156695939|NCT02643355|565634320|FG001|Overall Study|Withdrawal by Subject|3|||
156695940|NCT02643355|565634319|FG000|Overall Study|Protocol Violation|0|||
156695941|NCT02643355|565634320|FG001|Overall Study|Protocol Violation|2|||
156695942|NCT00857259|565634324|FG000|Overall Study|Protocol Violation|1|||
156695943|NCT00857259|565634325|FG001|Overall Study|Protocol Violation|0|||
156695944|NCT00857259|565634326|FG002|Overall Study|Protocol Violation|1|||
156695945|NCT02701413|565634327|FG000|Overall Study|Withdrawal by Subject|7|||
156695946|NCT02701413|565634328|FG001|Overall Study|Withdrawal by Subject|11|||
156695947|NCT02138136|565634329|FG000|Overall Study|Protocol Violation|4|||
156695948|NCT02138136|565634329|FG000|Overall Study|Physician Decision|7|||
156695949|NCT02138136|565634329|FG000|Overall Study|Lack of Efficacy|35|||
156695950|NCT02138136|565634329|FG000|Overall Study|Pregnancy|2|||
156695951|NCT02138136|565634329|FG000|Overall Study|Adverse Event|18|||
156695952|NCT02138136|565634329|FG000|Overall Study|Withdrawal by Subject|36|||
156695953|NCT02138136|565634329|FG000|Overall Study|Lost to Follow-up|32|||
156695954|NCT02138136|565634329|FG000|Overall Study|Withdrawn by Sponsor|5|||
156695955|NCT01660334|565634334|FG000|Overall Study|Lost to Follow-up|1|||
156695956|NCT00988065|565634335|FG000|Overall Study|Adverse Event|4|||
156695957|NCT00988065|565634336|FG001|Overall Study|Adverse Event|10|||
156695958|NCT00988065|565634337|FG002|Overall Study|Adverse Event|2|||
156695959|NCT00988065|565634335|FG000|Overall Study|Lost to Follow-up|1|||
156695960|NCT00988065|565634336|FG001|Overall Study|Lost to Follow-up|2|||
156695961|NCT00988065|565634337|FG002|Overall Study|Lost to Follow-up|2|||
156695962|NCT00988065|565634335|FG000|Overall Study|Subject withdrew consent|3|||
156695963|NCT00988065|565634336|FG001|Overall Study|Subject withdrew consent|5|||
156695964|NCT00988065|565634337|FG002|Overall Study|Subject withdrew consent|2|||
156695965|NCT00988065|565634335|FG000|Overall Study|Noncompliance with protocol|5|||
156695966|NCT00988065|565634336|FG001|Overall Study|Noncompliance with protocol|6|||
156695967|NCT00988065|565634337|FG002|Overall Study|Noncompliance with protocol|9|||
156695968|NCT00985712|565634340|FG000|Overall Study|Adverse Event|0|||
156695969|NCT00985712|565634341|FG001|Overall Study|Adverse Event|1|||
156695970|NCT00985712|565634340|FG000|Overall Study|Lost to Follow-up|2|||
156695971|NCT00985712|565634341|FG001|Overall Study|Lost to Follow-up|2|||
156695972|NCT00985712|565634340|FG000|Overall Study|Protocol Violation|0|||
156695973|NCT00985712|565634341|FG001|Overall Study|Protocol Violation|1|||
156695974|NCT00985712|565634340|FG000|Overall Study|Withdrawal by Subject|4|||
156695975|NCT00985712|565634341|FG001|Overall Study|Withdrawal by Subject|1|||
156695976|NCT00985712|565634340|FG000|Overall Study|Sponsor decision|0|||
156695977|NCT00985712|565634341|FG001|Overall Study|Sponsor decision|2|||
156695978|NCT01875471|565634342|FG000|Overall Study|Adverse Event|0|||
156695979|NCT01875471|565634343|FG001|Overall Study|Adverse Event|1|||
156695980|NCT01875471|565634342|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
156695981|NCT01875471|565634343|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
156695982|NCT01321008|565634344|FG000|Overall Study|Early Study Termination|1|||
156695983|NCT00257920|565634347|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
156695984|NCT00257920|565634348|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
156695985|NCT00257920|565634347|FG000|Period: Second Intervention|Other|2|||
156695986|NCT00257920|565634348|FG001|Period: Second Intervention|Other|1|||
156695987|NCT00770692|565634349|FG000|Overall Study|Withdrawal by Subject|7|||
156695988|NCT00770692|565634350|FG001|Overall Study|Withdrawal by Subject|9|||
156695989|NCT00770692|565634351|FG002|Overall Study|Withdrawal by Subject|9|||
156695990|NCT00770692|565634352|FG003|Overall Study|Withdrawal by Subject|6|||
156695991|NCT00770692|565634349|FG000|Overall Study|Adverse Event|3|||
156695992|NCT00770692|565634350|FG001|Overall Study|Adverse Event|0|||
156695993|NCT00770692|565634351|FG002|Overall Study|Adverse Event|4|||
156695994|NCT00770692|565634352|FG003|Overall Study|Adverse Event|4|||
156695995|NCT00770692|565634349|FG000|Overall Study|Investigator judgment|2|||
156695996|NCT00770692|565634350|FG001|Overall Study|Investigator judgment|0|||
156695997|NCT00770692|565634351|FG002|Overall Study|Investigator judgment|1|||
156695998|NCT00770692|565634352|FG003|Overall Study|Investigator judgment|1|||
156695999|NCT01230892|565634353|FG000|Overall Study|Withdrawal by Subject|1|||
156331009|NCT04430738|564311927|FG001|Phase 1: Dose Escalation|Death|4|||
156331010|NCT04430738|564311928|FG002|Phase 1: Dose Escalation|Death|4|||
156331011|NCT04430738|564311929|FG003|Phase 1: Dose Escalation|Death|1|||
156331012|NCT04430738|564311930|FG004|Phase 1: Dose Escalation|Death|6|||
156331013|NCT04430738|564311931|FG005|Phase 1: Dose Escalation|Death|0|||
156696000|NCT01230892|565634354|FG001|Overall Study|Withdrawal by Subject|1|||
156696001|NCT01230892|565634353|FG000|Overall Study|Lost to Follow-up|2|||
156696002|NCT01230892|565634354|FG001|Overall Study|Lost to Follow-up|0|||
156696003|NCT00679913|565634355|FG000|Overall Study|Protocol Violation|18|||
156696004|NCT00679913|565634356|FG001|Overall Study|Protocol Violation|13|||
156696005|NCT01000493|565634359|FG000|Overall Study|Adverse Event|3|||
156696006|NCT01000493|565634360|FG001|Overall Study|Adverse Event|6|||
156696007|NCT01000493|565634359|FG000|Overall Study|Lack of Efficacy|1|||
156696008|NCT01000493|565634360|FG001|Overall Study|Lack of Efficacy|1|||
156696009|NCT01000493|565634359|FG000|Overall Study|Protocol Violation|1|||
156696010|NCT01000493|565634360|FG001|Overall Study|Protocol Violation|8|||
156696011|NCT01000493|565634359|FG000|Overall Study|Study closed/terminated|25|||
156696012|NCT01000493|565634360|FG001|Overall Study|Study closed/terminated|23|||
156696013|NCT01000493|565634359|FG000|Overall Study|Lost to Follow-up|5|||
156696014|NCT01000493|565634360|FG001|Overall Study|Lost to Follow-up|9|||
156696015|NCT01000493|565634359|FG000|Overall Study|Physician Decision|1|||
156696016|NCT01000493|565634360|FG001|Overall Study|Physician Decision|1|||
156696017|NCT01000493|565634359|FG000|Overall Study|Withdrawal by Subject|3|||
156696018|NCT01000493|565634360|FG001|Overall Study|Withdrawal by Subject|7|||
156696019|NCT00062751|565634361|FG000|Overall Study|Disease progression|24|||
156696020|NCT00062751|565634362|FG001|Overall Study|Disease progression|17|||
156696021|NCT00062751|565634363|FG002|Overall Study|Disease progression|24|||
156696022|NCT00062751|565634364|FG003|Overall Study|Disease progression|2|||
156696023|NCT00062751|565634365|FG004|Overall Study|Disease progression|2|||
156696024|NCT00062751|565634361|FG000|Overall Study|Adverse Event|4|||
156696025|NCT00062751|565634362|FG001|Overall Study|Adverse Event|7|||
156871109|NCT05006573|566284412|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
156871110|NCT05006573|566284411|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
156871111|NCT05006573|566284412|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
156871112|NCT05006573|566284411|FG000|Double-blind Treatment Period|Protocol Violation|2|||
156871113|NCT05006573|566284412|FG001|Double-blind Treatment Period|Protocol Violation|0|||
156871114|NCT05006573|566284411|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
156871115|NCT05006573|566284412|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
156438298|NCT01039688|564695420|FG000|Overall Study|Death|2|||
156696026|NCT00062751|565634363|FG002|Overall Study|Adverse Event|2|||
156696027|NCT00062751|565634364|FG003|Overall Study|Adverse Event|2|||
156696028|NCT00062751|565634365|FG004|Overall Study|Adverse Event|2|||
156696029|NCT00062751|565634361|FG000|Overall Study|Other|2|||
156696030|NCT00062751|565634362|FG001|Overall Study|Other|3|||
156696031|NCT00062751|565634363|FG002|Overall Study|Other|1|||
156696032|NCT00062751|565634364|FG003|Overall Study|Other|0|||
156696033|NCT00062751|565634365|FG004|Overall Study|Other|1|||
156696034|NCT00062751|565634361|FG000|Overall Study|Withdrawal by Subject|1|||
156696035|NCT00062751|565634362|FG001|Overall Study|Withdrawal by Subject|2|||
156696036|NCT00062751|565634363|FG002|Overall Study|Withdrawal by Subject|2|||
156696037|NCT00062751|565634364|FG003|Overall Study|Withdrawal by Subject|1|||
156696038|NCT00062751|565634365|FG004|Overall Study|Withdrawal by Subject|0|||
156696039|NCT00062751|565634361|FG000|Overall Study|Symptomatic deterioration|1|||
156696040|NCT00062751|565634362|FG001|Overall Study|Symptomatic deterioration|1|||
156696041|NCT00062751|565634363|FG002|Overall Study|Symptomatic deterioration|0|||
156696042|NCT00062751|565634364|FG003|Overall Study|Symptomatic deterioration|0|||
156696043|NCT00062751|565634365|FG004|Overall Study|Symptomatic deterioration|1|||
156696044|NCT00062751|565634361|FG000|Overall Study|Death|1|||
156696045|NCT00062751|565634362|FG001|Overall Study|Death|0|||
156696046|NCT00062751|565634363|FG002|Overall Study|Death|1|||
156696047|NCT00062751|565634364|FG003|Overall Study|Death|0|||
156696048|NCT00062751|565634365|FG004|Overall Study|Death|0|||
156696049|NCT03629028|565634366|FG000|Overall Study|Lost to Follow-up|26|||
156696050|NCT03629028|565634367|FG001|Overall Study|Lost to Follow-up|23|||
156696051|NCT03629028|565634366|FG000|Overall Study|Pregnancy|4|||
156696052|NCT03629028|565634367|FG001|Overall Study|Pregnancy|2|||
156696053|NCT03629028|565634366|FG000|Overall Study|intolerance to examination|2|||
156696054|NCT03629028|565634367|FG001|Overall Study|intolerance to examination|0|||
156696055|NCT03828448|565634376|FG000|Overall Study|Sponsor's Discretion|34|||
156696056|NCT02037165|565634377|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
156696057|NCT02037165|565634378|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
156789989|NCT01313676|565983665|FG003|Overall Study|Protocol Violation|44|||
156789990|NCT01313676|565983662|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
156789991|NCT01313676|565983663|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
156789992|NCT01313676|565983664|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
156789993|NCT01313676|565983665|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
156789994|NCT01313676|565983662|FG000|Overall Study|Study Closed/terminated|7|||
156789995|NCT01313676|565983663|FG001|Overall Study|Study Closed/terminated|6|||
156789996|NCT01313676|565983664|FG002|Overall Study|Study Closed/terminated|9|||
156789997|NCT01313676|565983665|FG003|Overall Study|Study Closed/terminated|9|||
156789998|NCT01313676|565983662|FG000|Overall Study|Lost to Follow-up|0|||
156789999|NCT01313676|565983663|FG001|Overall Study|Lost to Follow-up|0|||
156790000|NCT01313676|565983664|FG002|Overall Study|Lost to Follow-up|1|||
156790001|NCT01313676|565983665|FG003|Overall Study|Lost to Follow-up|0|||
156790002|NCT01313676|565983662|FG000|Overall Study|Physician Decision|53|||
156790003|NCT01313676|565983663|FG001|Overall Study|Physician Decision|64|||
156790004|NCT01313676|565983664|FG002|Overall Study|Physician Decision|62|||
156696058|NCT02037165|565634379|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
156696059|NCT02037165|565634380|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
156696060|NCT02037165|565634381|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
156871116|NCT05006573|566284411|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
156696061|NCT02192164|565634385|FG000|Overall Study|Other|8|||
156696062|NCT02192164|565634385|FG000|Overall Study|Withdrawal by Subject|1|||
156790005|NCT01313676|565983665|FG003|Overall Study|Physician Decision|48|||
156331014|NCT04430738|564311926|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
156331015|NCT04430738|564311927|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
156331016|NCT04430738|564311928|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
156331017|NCT04430738|564311929|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
156696063|NCT02192164|565634385|FG000|Overall Study|Physician Decision|4|||
156331018|NCT04430738|564311930|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
156696064|NCT02192164|565634385|FG000|Overall Study|Did not meet the exclusion criteria|1|||
156696065|NCT01346774|565634386|FG000|Overall Study|Did not take a single dose|6|||
156696066|NCT01346774|565634387|FG001|Overall Study|Did not take a single dose|4|||
156696067|NCT01346774|565634386|FG000|Overall Study|Lost to Follow-up|3|||
156696068|NCT01346774|565634387|FG001|Overall Study|Lost to Follow-up|4|||
156696069|NCT01346774|565634386|FG000|Overall Study|Withdrawal by Subject|1|||
156696070|NCT01346774|565634387|FG001|Overall Study|Withdrawal by Subject|4|||
156696071|NCT01346774|565634386|FG000|Overall Study|Protocol Violation|2|||
156696072|NCT01346774|565634387|FG001|Overall Study|Protocol Violation|3|||
156696073|NCT01346774|565634386|FG000|Overall Study|Adverse Event|1|||
156331019|NCT04430738|564311931|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
156331020|NCT04430738|564311926|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
156331021|NCT04430738|564311927|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
156331022|NCT04430738|564311928|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
156331023|NCT04430738|564311929|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
156331024|NCT04430738|564311930|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
156331025|NCT04430738|564311931|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
156331026|NCT04430738|564311926|FG000|Phase 1: Dose Escalation|Other|1|||
156331027|NCT04430738|564311927|FG001|Phase 1: Dose Escalation|Other|0|||
156331028|NCT04430738|564311928|FG002|Phase 1: Dose Escalation|Other|0|||
156331029|NCT04430738|564311929|FG003|Phase 1: Dose Escalation|Other|0|||
156331030|NCT04430738|564311930|FG004|Phase 1: Dose Escalation|Other|0|||
156331031|NCT04430738|564311931|FG005|Phase 1: Dose Escalation|Other|0|||
156331032|NCT04430738|564311926|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
156331033|NCT04430738|564311927|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
156331034|NCT04430738|564311928|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
156331035|NCT04430738|564311929|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
156331036|NCT04430738|564311930|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
156438299|NCT01039688|564695421|FG001|Overall Study|Death|0|||
156438300|NCT01039688|564695422|FG002|Overall Study|Death|0|||
156438301|NCT00346151|564695423|FG000|Overall Study|Withdrawal by Subject|3|||
156438302|NCT04054635|564695428|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
156438303|NCT04054635|564695429|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
156696074|NCT01346774|565634387|FG001|Overall Study|Adverse Event|2|||
156696075|NCT00609466|565634397|FG000|Overall Study|Withdrawal by Subject|0|||
156696076|NCT00609466|565634398|FG001|Overall Study|Withdrawal by Subject|1|||
156696077|NCT00609466|565634399|FG002|Overall Study|Withdrawal by Subject|1|||
156696078|NCT00609466|565634397|FG000|Overall Study|Adverse Event|2|||
156696079|NCT00609466|565634398|FG001|Overall Study|Adverse Event|3|||
156696080|NCT00609466|565634399|FG002|Overall Study|Adverse Event|1|||
156696081|NCT00609466|565634397|FG000|Overall Study|Lack of Efficacy|0|||
156696082|NCT00609466|565634398|FG001|Overall Study|Lack of Efficacy|2|||
156331037|NCT04430738|564311931|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
156331038|NCT04430738|564311926|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156331039|NCT04430738|564311927|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156331040|NCT04430738|564311928|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156696083|NCT00609466|565634399|FG002|Overall Study|Lack of Efficacy|2|||
156696084|NCT03512262|565634400|FG000|Overall Study|Adverse Event|8|||
156331041|NCT04430738|564311929|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156331042|NCT04430738|564311930|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156331043|NCT04430738|564311931|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
156331044|NCT02628769|564311933|FG000|First Intervention|Adverse Event|1|||
156331045|NCT02628769|564311934|FG001|First Intervention|Adverse Event|0|||
156331046|NCT02628769|564311933|FG000|First Intervention|Withdrawal by Subject|0|||
156331047|NCT02628769|564311934|FG001|First Intervention|Withdrawal by Subject|1|||
156331048|NCT02628769|564311933|FG000|Second Intervention|Adverse Event|2|||
156331049|NCT02628769|564311934|FG001|Second Intervention|Adverse Event|0|||
156696085|NCT03512262|565634401|FG001|Overall Study|Adverse Event|3|||
156331050|NCT02628769|564311933|FG000|Second Intervention|Physician Decision|0|||
156438304|NCT04054635|564695430|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
156696086|NCT03512262|565634400|FG000|Overall Study|Death (non-treatment emergent)|1|||
156438305|NCT04054635|564695428|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
156696087|NCT03512262|565634401|FG001|Overall Study|Death (non-treatment emergent)|0|||
156696088|NCT03512262|565634400|FG000|Overall Study|Withdrawal by Subject|17|||
156696089|NCT03512262|565634401|FG001|Overall Study|Withdrawal by Subject|9|||
156696090|NCT03512262|565634400|FG000|Overall Study|Lost to Follow-up|7|||
156696091|NCT03512262|565634401|FG001|Overall Study|Lost to Follow-up|1|||
156696092|NCT03512262|565634400|FG000|Overall Study|Other than Specified|2|||
156696093|NCT03512262|565634401|FG001|Overall Study|Other than Specified|2|||
156696094|NCT01299805|565634402|FG000|Overall Study|Adverse Event|2|||
156696095|NCT01299805|565634403|FG001|Overall Study|Adverse Event|0|||
156696096|NCT04221789|565635984|FG000|Overall Study|deviation from protoco|22|||
156696097|NCT04221789|565635985|FG001|Overall Study|deviation from protoco|8|||
156696098|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
156696099|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
156696100|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
156696101|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
156696102|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
156696103|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
156696104|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
156696105|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
156696106|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
156696107|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
156696108|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
156696109|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
156696110|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
156696111|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
156696112|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
156696113|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
156696114|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
156696115|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
156696116|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
156696117|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
156696118|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
156696119|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
156696120|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
156696121|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
156696122|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
156696123|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
156696124|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
156696125|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
156696126|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
156696127|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
156696128|NCT02935686|565635986|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
156696129|NCT02935686|565635987|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
156696130|NCT02935686|565635988|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
156696131|NCT02935686|565635989|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
156696132|NCT02935686|565635990|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
156696133|NCT02935686|565635986|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
156696134|NCT02935686|565635987|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
156696135|NCT02935686|565635988|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
156696136|NCT02935686|565635989|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
156696137|NCT02935686|565635990|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
156696138|NCT02935686|565635986|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
156696139|NCT02935686|565635987|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
156696140|NCT02935686|565635988|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
156696141|NCT02935686|565635989|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
156696142|NCT02935686|565635990|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
156696143|NCT02935686|565635986|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
156696144|NCT02935686|565635987|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
156696145|NCT02935686|565635988|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
156696146|NCT02935686|565635989|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
156696147|NCT02935686|565635990|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
156696148|NCT02935686|565635986|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
156696149|NCT02935686|565635987|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
156696150|NCT02935686|565635988|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
156696151|NCT02935686|565635989|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
156696152|NCT02935686|565635990|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
156696153|NCT01183221|565635991|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
156696154|NCT01183221|565635992|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
156696155|NCT00678041|565636002|FG000|Overall Study|Physician Decision|5|||
156696156|NCT00678041|565636003|FG001|Overall Study|Physician Decision|5|||
156696157|NCT02358343|565636004|FG000|Screening Intervention|Death|0|||
156696158|NCT02358343|565636005|FG001|Screening Intervention|Death|2|||
156696159|NCT02358343|565636006|FG002|Screening Intervention|Death|0|||
156696160|NCT02358343|565636007|FG003|Screening Intervention|Death|0|||
156696161|NCT02358343|565636008|FG004|Screening Intervention|Death|0|||
156696162|NCT02358343|565636004|FG000|Screening Intervention|Withdrawal by Subject|1|||
156696163|NCT02358343|565636005|FG001|Screening Intervention|Withdrawal by Subject|0|||
156696164|NCT02358343|565636006|FG002|Screening Intervention|Withdrawal by Subject|0|||
156696165|NCT02358343|565636007|FG003|Screening Intervention|Withdrawal by Subject|0|||
156696166|NCT02358343|565636008|FG004|Screening Intervention|Withdrawal by Subject|0|||
156696167|NCT02358343|565636004|FG000|Screening Intervention|Determined Ineligible|5|||
156696168|NCT02358343|565636005|FG001|Screening Intervention|Determined Ineligible|6|||
156696169|NCT02358343|565636006|FG002|Screening Intervention|Determined Ineligible|0|||
156696170|NCT02358343|565636007|FG003|Screening Intervention|Determined Ineligible|0|||
156696171|NCT02358343|565636008|FG004|Screening Intervention|Determined Ineligible|0|||
156696172|NCT02358343|565636004|FG000|Comparative Efficacy Trial / Observation|Death|0|||
156696173|NCT02358343|565636005|FG001|Comparative Efficacy Trial / Observation|Death|0|||
156696174|NCT02358343|565636006|FG002|Comparative Efficacy Trial / Observation|Death|2|||
156696175|NCT02358343|565636007|FG003|Comparative Efficacy Trial / Observation|Death|0|||
156696176|NCT02358343|565636008|FG004|Comparative Efficacy Trial / Observation|Death|0|||
156696177|NCT02358343|565636004|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
156696178|NCT02358343|565636005|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
156696179|NCT02358343|565636006|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
156696180|NCT02358343|565636007|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
156696181|NCT02358343|565636008|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
156696182|NCT02358343|565636004|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
156696183|NCT02358343|565636005|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
156696184|NCT02358343|565636006|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
156696185|NCT02358343|565636007|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
156696186|NCT02358343|565636008|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
156696187|NCT02518919|565636012|FG000|Overall Study|Protocol Violation|1|||
156696188|NCT02518919|565636013|FG001|Overall Study|Protocol Violation|1|||
156696189|NCT02518919|565636014|FG002|Overall Study|Protocol Violation|2|||
156696190|NCT04498403|565636015|FG000|Overall Study|Adverse Event|1|||
156696191|NCT04498403|565636016|FG001|Overall Study|Adverse Event|0|||
156696192|NCT04498403|565636015|FG000|Overall Study|Study Terminated By Sponsor|29|||
156530888|NCT01079130|565038201|FG004|Overall Study|Lost to Follow-up|1|||
156530889|NCT01079130|565038202|FG005|Overall Study|Lost to Follow-up|0|||
156530890|NCT00174265|565038220|FG000|Overall Study|Adverse Event|7|||
156530891|NCT00174265|565038221|FG001|Overall Study|Adverse Event|4|||
156530892|NCT00174265|565038220|FG000|Overall Study|Lack of Efficacy|2|||
156530893|NCT00174265|565038221|FG001|Overall Study|Lack of Efficacy|2|||
156530894|NCT00174265|565038220|FG000|Overall Study|Withdrawal by Subject|3|||
156530895|NCT00174265|565038221|FG001|Overall Study|Withdrawal by Subject|5|||
156530896|NCT00174265|565038220|FG000|Overall Study|Lost to Follow-up|1|||
156696193|NCT04498403|565636016|FG001|Overall Study|Study Terminated By Sponsor|10|||
156696194|NCT01951885|565636017|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
156696195|NCT01951885|565636018|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
156696196|NCT01951885|565636017|FG000|Overall Study|Adverse Event|1|||
156696197|NCT01951885|565636018|FG001|Overall Study|Adverse Event|0|||
156696198|NCT01951885|565636017|FG000|Overall Study|Withdrawal by Subject|0|||
156696199|NCT01951885|565636018|FG001|Overall Study|Withdrawal by Subject|1|||
156696200|NCT01951885|565636017|FG000|Overall Study|ineligible due to a change in donor|0|||
156696201|NCT01951885|565636018|FG001|Overall Study|ineligible due to a change in donor|1|||
156696202|NCT01951885|565636017|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
156696203|NCT01951885|565636018|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
156696204|NCT00577395|565636019|FG000|Overall Study|Study was terminated early by Sponsor|7|||
156696205|NCT00577395|565636020|FG001|Overall Study|Study was terminated early by Sponsor|6|||
156696206|NCT01700049|565636027|FG000|Overall Study|Withdrawal by Subject|1|||
156696207|NCT03084367|565636031|FG000|Overall Study|Lost to Follow-up|32|||
156696208|NCT03084367|565636031|FG000|Overall Study|Withdrawal by Subject|4|||
156696209|NCT03084367|565636031|FG000|Overall Study|Other|1|||
156696210|NCT01206101|565636032|FG000|Overall Study|Adverse Event|1|||
156696211|NCT01206101|565636033|FG001|Overall Study|Adverse Event|0|||
156696212|NCT01206101|565636032|FG000|Overall Study|Physician Decision|0|||
156696213|NCT01206101|565636033|FG001|Overall Study|Physician Decision|1|||
156696214|NCT01206101|565636032|FG000|Overall Study|Unclassified|1|||
156696215|NCT01206101|565636033|FG001|Overall Study|Unclassified|0|||
156696216|NCT00368979|565636039|FG000|Overall Study|Adverse Event|9|||
156696217|NCT00368979|565636040|FG001|Overall Study|Adverse Event|16|||
156696218|NCT00368979|565636039|FG000|Overall Study|Lack of Efficacy|5|||
156696219|NCT00368979|565636040|FG001|Overall Study|Lack of Efficacy|3|||
156696220|NCT00368979|565636039|FG000|Overall Study|Other|3|||
156530897|NCT00174265|565038221|FG001|Overall Study|Lost to Follow-up|0|||
156530898|NCT00174265|565038220|FG000|Overall Study|Other (Not specified)|16|||
156696221|NCT00368979|565636040|FG001|Overall Study|Other|1|||
156696222|NCT00368979|565636039|FG000|Overall Study|Lost to Follow-up|1|||
156696223|NCT00368979|565636040|FG001|Overall Study|Lost to Follow-up|0|||
156696224|NCT00368979|565636039|FG000|Overall Study|Protocol Violation|2|||
156696225|NCT00368979|565636040|FG001|Overall Study|Protocol Violation|1|||
156696226|NCT00368979|565636039|FG000|Overall Study|Withdrawal by Subject|5|||
156696227|NCT00368979|565636040|FG001|Overall Study|Withdrawal by Subject|9|||
156696228|NCT00394524|565636041|FG000|Overall Study|Protocol Violation|2|||
156696229|NCT00394524|565636042|FG001|Overall Study|Protocol Violation|3|||
156696230|NCT00394524|565636041|FG000|Overall Study|Death|1|||
156696231|NCT00394524|565636042|FG001|Overall Study|Death|0|||
156696232|NCT00394524|565636041|FG000|Overall Study|Withdrawal by Subject|0|||
156696233|NCT00394524|565636042|FG001|Overall Study|Withdrawal by Subject|1|||
156696234|NCT01462318|565636045|FG000|Main Study / TP-DI Study|Other|2|||
156696235|NCT01462318|565636046|FG001|Main Study / TP-DI Study|Other|0|||
156696236|NCT01462318|565636047|FG002|Main Study / TP-DI Study|Other|0|||
156696237|NCT01462318|565636045|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
156696238|NCT01462318|565636046|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
156696239|NCT01462318|565636047|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
156696240|NCT01462318|565636045|FG000|Main Study / TP-DI Study|Adverse Event|4|||
156696241|NCT01462318|565636046|FG001|Main Study / TP-DI Study|Adverse Event|0|||
156696242|NCT01462318|565636047|FG002|Main Study / TP-DI Study|Adverse Event|0|||
156696243|NCT01462318|565636045|FG000|Extension Phase|Lost to Follow-up|0|||
156696244|NCT01462318|565636046|FG001|Extension Phase|Lost to Follow-up|0|||
156696245|NCT01462318|565636047|FG002|Extension Phase|Lost to Follow-up|1|||
156696246|NCT01462318|565636045|FG000|Extension Phase|Other|0|||
156696247|NCT01462318|565636046|FG001|Extension Phase|Other|0|||
156696248|NCT01462318|565636047|FG002|Extension Phase|Other|1|||
156696249|NCT01462318|565636045|FG000|Extension Phase|Disease Progression|0|||
156696250|NCT01462318|565636046|FG001|Extension Phase|Disease Progression|0|||
156696251|NCT01462318|565636047|FG002|Extension Phase|Disease Progression|1|||
156696252|NCT01462318|565636045|FG000|Extension Phase|Withdrawal by Subject|0|||
156696253|NCT01462318|565636046|FG001|Extension Phase|Withdrawal by Subject|0|||
156696254|NCT01462318|565636047|FG002|Extension Phase|Withdrawal by Subject|15|||
156696255|NCT01462318|565636045|FG000|Extension Phase|Investigator Decision|0|||
156696256|NCT01462318|565636046|FG001|Extension Phase|Investigator Decision|0|||
156696257|NCT01462318|565636047|FG002|Extension Phase|Investigator Decision|5|||
156696258|NCT01462318|565636045|FG000|Extension Phase|Adverse Event|0|||
156696259|NCT01462318|565636046|FG001|Extension Phase|Adverse Event|0|||
156790006|NCT01313676|565983662|FG000|Overall Study|Decision by Participant or Proxy|643|||
156790007|NCT01313676|565983663|FG001|Overall Study|Decision by Participant or Proxy|527|||
156790008|NCT01313676|565983664|FG002|Overall Study|Decision by Participant or Proxy|515|||
156696260|NCT01462318|565636047|FG002|Extension Phase|Adverse Event|22|||
156696261|NCT03827564|565636048|FG000|Overall Study|Discontinued due to Study Termination|1|||
156696262|NCT03827564|565636049|FG001|Overall Study|Discontinued due to Study Termination|0|||
156696263|NCT02238626|565636052|FG000|Overall Study|Adverse Event|3|||
156696264|NCT02238626|565636053|FG001|Overall Study|Adverse Event|5|||
156696265|NCT02238626|565636054|FG002|Overall Study|Adverse Event|0|||
156790009|NCT01313676|565983665|FG003|Overall Study|Decision by Participant or Proxy|492|||
156790010|NCT01313676|565983662|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
156790011|NCT01313676|565983663|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
156331051|NCT02628769|564311934|FG001|Second Intervention|Physician Decision|1|||
156331052|NCT01467583|564311935|FG000|Overall Study|Death|1|||
156331053|NCT01467583|564311936|FG001|Overall Study|Death|1|||
156331054|NCT01467583|564311937|FG002|Overall Study|Death|0|||
156331055|NCT01467583|564311935|FG000|Overall Study|Withdrawal by Subject|1|||
156331056|NCT01467583|564311936|FG001|Overall Study|Withdrawal by Subject|0|||
156331057|NCT01467583|564311937|FG002|Overall Study|Withdrawal by Subject|0|||
156331058|NCT01467583|564311935|FG000|Overall Study|Protocol Violation|0|||
156331059|NCT01467583|564311936|FG001|Overall Study|Protocol Violation|0|||
156331060|NCT01467583|564311937|FG002|Overall Study|Protocol Violation|2|||
156331061|NCT00309985|564311939|FG000|Overall Study|Disease progression|12|||
156331062|NCT00309985|564311940|FG001|Overall Study|Disease progression|0|||
156331063|NCT00309985|564311939|FG000|Overall Study|Adverse Event|30|||
156331064|NCT00309985|564311940|FG001|Overall Study|Adverse Event|0|||
156696266|NCT02238626|565636055|FG003|Overall Study|Adverse Event|3|||
156696267|NCT02238626|565636052|FG000|Overall Study|Lost to Follow-up|2|||
156696268|NCT02238626|565636053|FG001|Overall Study|Lost to Follow-up|4|||
156696269|NCT02238626|565636054|FG002|Overall Study|Lost to Follow-up|2|||
156331065|NCT00309985|564311939|FG000|Overall Study|Death|2|||
156331066|NCT00309985|564311940|FG001|Overall Study|Death|0|||
156331067|NCT00309985|564311939|FG000|Overall Study|Withdrawal by Subject|5|||
156696270|NCT02238626|565636055|FG003|Overall Study|Lost to Follow-up|2|||
156696271|NCT02238626|565636052|FG000|Overall Study|Withdrawal by Subject|0|||
156696272|NCT02238626|565636053|FG001|Overall Study|Withdrawal by Subject|3|||
156696273|NCT02238626|565636054|FG002|Overall Study|Withdrawal by Subject|0|||
156331068|NCT00309985|564311940|FG001|Overall Study|Withdrawal by Subject|1|||
156696274|NCT02238626|565636055|FG003|Overall Study|Withdrawal by Subject|1|||
156696275|NCT02238626|565636052|FG000|Overall Study|Death|0|||
156696276|NCT02238626|565636053|FG001|Overall Study|Death|0|||
156696277|NCT02238626|565636054|FG002|Overall Study|Death|1|||
156696278|NCT02238626|565636055|FG003|Overall Study|Death|1|||
156696279|NCT02238626|565636052|FG000|Overall Study|Other|0|||
156696280|NCT02238626|565636053|FG001|Overall Study|Other|2|||
156696281|NCT02238626|565636054|FG002|Overall Study|Other|0|||
156696282|NCT02238626|565636055|FG003|Overall Study|Other|0|||
156696283|NCT00270257|565636056|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
156696284|NCT00270257|565636057|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
156696285|NCT01195103|565636061|FG000|Overall Study|Withdrawal by Subject|1|||
156696286|NCT01195103|565636062|FG001|Overall Study|Withdrawal by Subject|0|||
156696287|NCT01195103|565636063|FG002|Overall Study|Withdrawal by Subject|0|||
156696288|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
156696289|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
156696290|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
156696291|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
156696292|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
156696293|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
156696294|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
156696295|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
156696296|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Various|0|||
156696297|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Various|9|||
156696298|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Adverse Event|23|||
156696299|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Adverse Event|0|||
156696300|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Death|2|||
156696301|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Death|0|||
156696302|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
156696303|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
156696304|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
156696305|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
156696306|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Various|3|||
156530899|NCT00174265|565038221|FG001|Overall Study|Other (Not specified)|10|||
156530900|NCT03040622|565038222|FG000|Overall Study|unable to implant device|3|||
156530901|NCT02818920|565038223|FG000|Overall Study|Unresectable|4|||
156530902|NCT02818920|565038223|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
156530903|NCT02818920|565038223|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
156530904|NCT02818920|565038223|FG000|Overall Study|Adverse Event|3|||
156530905|NCT02818920|565038223|FG000|Overall Study|Developed Other Disease|1|||
156530906|NCT02818920|565038223|FG000|Overall Study|Refused Further Treatment|1|||
156530907|NCT00445068|565038224|FG000|Overall Study|Disease progression|26|||
156530908|NCT00445068|565038224|FG000|Overall Study|Adverse Event|5|||
156530909|NCT00445068|565038224|FG000|Overall Study|Abnormal laboratory value|2|||
156530910|NCT00445068|565038224|FG000|Overall Study|Withdrawal by Subject|2|||
156530911|NCT00445068|565038224|FG000|Overall Study|Death|1|||
156530912|NCT02673619|565038225|FG000|Overall Study|Lost to Follow-up|1|||
156530913|NCT02673619|565038226|FG001|Overall Study|Lost to Follow-up|0|||
156530914|NCT02673619|565038227|FG002|Overall Study|Lost to Follow-up|0|||
156530915|NCT02673619|565038228|FG003|Overall Study|Lost to Follow-up|0|||
156530916|NCT02673619|565038225|FG000|Overall Study|Withdrawal by Subject|1|||
156530917|NCT02673619|565038226|FG001|Overall Study|Withdrawal by Subject|1|||
156530918|NCT02673619|565038227|FG002|Overall Study|Withdrawal by Subject|1|||
156530919|NCT02673619|565038228|FG003|Overall Study|Withdrawal by Subject|0|||
156530920|NCT02673619|565038225|FG000|Overall Study|Adverse Event|0|||
156530921|NCT02673619|565038226|FG001|Overall Study|Adverse Event|0|||
156696307|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Various|0|||
156696308|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
156696309|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
156696310|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
156696311|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
156696312|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
156331069|NCT00309985|564311939|FG000|Overall Study|Physician Decision|3|||
156696313|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
156696314|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
156696315|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
156696316|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
156696317|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
156696318|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
156696319|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
156530922|NCT02673619|565038227|FG002|Overall Study|Adverse Event|1|||
156530923|NCT02673619|565038228|FG003|Overall Study|Adverse Event|0|||
156530924|NCT02673619|565038225|FG000|Overall Study|Lack of Efficacy|0|||
156530925|NCT02673619|565038226|FG001|Overall Study|Lack of Efficacy|0|||
156530926|NCT02673619|565038227|FG002|Overall Study|Lack of Efficacy|1|||
156530927|NCT02673619|565038228|FG003|Overall Study|Lack of Efficacy|0|||
156696320|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
156696321|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
156696322|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Various|4|||
156696323|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Various|0|||
156696324|NCT01959035|565636080|FG000|Overall Study|Adverse Event|5|||
156696325|NCT01959035|565636080|FG000|Overall Study|Withdrawal by Subject|4|||
156696326|NCT01959035|565636080|FG000|Overall Study|Lost to Follow-up|1|||
156696327|NCT01959035|565636080|FG000|Overall Study|Other (no primary reason given)|1|||
156696328|NCT03254602|565636081|FG000|Overall Study|Lost to Follow-up|4|||
156696329|NCT01691820|565636082|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
156696330|NCT01691820|565636083|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
156696331|NCT01691820|565636082|FG000|Overall Study|Migrated/moved from study area|7|||
156696332|NCT01691820|565636083|FG001|Overall Study|Migrated/moved from study area|4|||
156696333|NCT01691820|565636082|FG000|Overall Study|Lost to Follow-up|6|||
156790012|NCT01313676|565983664|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
156790013|NCT01313676|565983665|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
156790014|NCT01313676|565983662|FG000|Overall Study|Investigator Site Closed|12|||
156790015|NCT01313676|565983663|FG001|Overall Study|Investigator Site Closed|11|||
156790016|NCT01313676|565983664|FG002|Overall Study|Investigator Site Closed|15|||
156790017|NCT01313676|565983665|FG003|Overall Study|Investigator Site Closed|10|||
156790018|NCT01313676|565983662|FG000|Overall Study|Missing|1|||
156790019|NCT01313676|565983663|FG001|Overall Study|Missing|1|||
156790020|NCT01313676|565983664|FG002|Overall Study|Missing|1|||
156790021|NCT01313676|565983665|FG003|Overall Study|Missing|0|||
156790022|NCT02562040|565983666|FG000|Overall Study|Lost to Follow-up|20|||
156790023|NCT02562040|565983667|FG001|Overall Study|Lost to Follow-up|28|||
156790024|NCT02562040|565983666|FG000|Overall Study|Withdrawal by Subject|8|||
156790025|NCT02562040|565983667|FG001|Overall Study|Withdrawal by Subject|7|||
156790026|NCT02562040|565983666|FG000|Overall Study|Adverse Event|1|||
156790027|NCT02562040|565983667|FG001|Overall Study|Adverse Event|0|||
156790028|NCT00368849|565983671|FG000|Overall Study|Withdrawal by Subject|0|||
156790029|NCT00368849|565983672|FG001|Overall Study|Withdrawal by Subject|1|||
156790030|NCT00368849|565983671|FG000|Overall Study|Physician Decision|0|||
156790031|NCT00368849|565983672|FG001|Overall Study|Physician Decision|1|||
156790032|NCT01902303|565983674|FG000|Overall Study|Adverse Event|0|||
156790033|NCT01902303|565983675|FG001|Overall Study|Adverse Event|1|||
156790034|NCT01902303|565983674|FG000|Overall Study|Lost to Follow-up|0|||
156790035|NCT01902303|565983675|FG001|Overall Study|Lost to Follow-up|1|||
156790036|NCT01902303|565983674|FG000|Overall Study|Protocol Violation|2|||
156790037|NCT01902303|565983675|FG001|Overall Study|Protocol Violation|2|||
156790038|NCT01902303|565983674|FG000|Overall Study|subject lost investigational product|0|||
156790039|NCT01902303|565983675|FG001|Overall Study|subject lost investigational product|1|||
156790040|NCT01902303|565983674|FG000|Overall Study|Did not develop a cold sore|21|||
156790041|NCT01902303|565983675|FG001|Overall Study|Did not develop a cold sore|19|||
156790042|NCT01699685|565983676|FG000|Period 1|Adverse Event|1|||
156790043|NCT01699685|565983677|FG001|Period 1|Adverse Event|1|||
156790044|NCT01699685|565983676|FG000|Period 1|Medical or ethical, noncompliance|2|||
156790045|NCT01699685|565983677|FG001|Period 1|Medical or ethical, noncompliance|0|||
156790046|NCT01699685|565983676|FG000|Period 1|Other|0|||
156790047|NCT01699685|565983677|FG001|Period 1|Other|1|||
156790048|NCT01699685|565983676|FG000|Period 1|Patient request|0|||
156790049|NCT01699685|565983677|FG001|Period 1|Patient request|1|||
156790050|NCT01699685|565983676|FG000|Period 2|Lost to Follow-up|1|||
156790051|NCT01699685|565983677|FG001|Period 2|Lost to Follow-up|0|||
156790052|NCT03635996|565983678|FG000|Overall Study|Study terminated by Sponsor|94|||
156790053|NCT03635996|565983678|FG000|Overall Study|Withdrawal by Subject|20|||
156790054|NCT03635996|565983678|FG000|Overall Study|Ablation|26|||
156790055|NCT03635996|565983678|FG000|Overall Study|Adverse Event|7|||
156790056|NCT03635996|565983678|FG000|Overall Study|Physician Decision|3|||
156790057|NCT03635996|565983678|FG000|Overall Study|Prohibited medication|5|||
156790058|NCT03635996|565983678|FG000|Overall Study|Did not meet eligibility criteria|5|||
156790059|NCT03635996|565983678|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
156790060|NCT03635996|565983678|FG000|Overall Study|Protocol Violation|1|||
156790061|NCT03635996|565983678|FG000|Overall Study|Lost to Follow-up|1|||
156790062|NCT05058456|565983679|FG000|Overall Study|Death|1|||
156790063|NCT05058456|565983679|FG000|Overall Study|End of Study data not yet due for release|34|||
156790064|NCT02933151|565983680|FG000|Overall Study|Lost to Follow-up|19|||
156790065|NCT02933151|565983681|FG001|Overall Study|Lost to Follow-up|18|||
156790066|NCT02933151|565983680|FG000|Overall Study|Death|1732|||
156790067|NCT02933151|565983681|FG001|Overall Study|Death|1827|||
156790068|NCT02933151|565983680|FG000|Overall Study|Transplant|210|||
156790069|NCT02933151|565983681|FG001|Overall Study|Transplant|278|||
156790070|NCT02933151|565983680|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
156790071|NCT02933151|565983681|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
156790072|NCT02933151|565983680|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
156790073|NCT02933151|565983681|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
156696334|NCT01691820|565636083|FG001|Overall Study|Lost to Follow-up|17|||
156696335|NCT01691820|565636082|FG000|Overall Study|Other (unspecified)|4|||
156696336|NCT01691820|565636083|FG001|Overall Study|Other (unspecified)|1|||
156696337|NCT03347422|565636084|FG000|Part A (26 Weeks)|Adverse Event|3|||
156696338|NCT03347422|565636085|FG001|Part A (26 Weeks)|Adverse Event|0|||
156696339|NCT03347422|565636084|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
156696340|NCT03347422|565636085|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
156696341|NCT03347422|565636084|FG000|Part B (149 Weeks)|Adverse Event|0|||
156696342|NCT03347422|565636085|FG001|Part B (149 Weeks)|Adverse Event|1|||
156696343|NCT03347422|565636084|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
156696344|NCT03347422|565636085|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
156696345|NCT03347422|565636084|FG000|Part B (149 Weeks)|Other|1|||
156696346|NCT03347422|565636085|FG001|Part B (149 Weeks)|Other|0|||
156696347|NCT03914950|565636092|FG000|Overall Study|Physician Decision|54|||
156696348|NCT01155024|565636093|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
156696349|NCT01155024|565636094|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
156696350|NCT01155024|565636093|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
156696351|NCT01155024|565636094|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
156696352|NCT01155024|565636093|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
156696353|NCT01155024|565636094|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
156696354|NCT02272634|565636102|FG000|Overall Study|Adverse Event|1|||
156696355|NCT02272634|565636103|FG001|Overall Study|Adverse Event|0|||
156696356|NCT02272634|565636104|FG002|Overall Study|Adverse Event|0|||
156696357|NCT02272634|565636102|FG000|Overall Study|Protocol Violation|0|||
156696358|NCT02272634|565636103|FG001|Overall Study|Protocol Violation|0|||
156696359|NCT02272634|565636104|FG002|Overall Study|Protocol Violation|1|||
156696360|NCT02272634|565636102|FG000|Overall Study|Withdrawal by Subject|0|||
156696361|NCT02272634|565636103|FG001|Overall Study|Withdrawal by Subject|1|||
156696362|NCT02272634|565636104|FG002|Overall Study|Withdrawal by Subject|0|||
156696363|NCT04647721|565636105|FG000|Overall Study|Withdrawal by Subject|0|||
156696364|NCT04647721|565636106|FG001|Overall Study|Withdrawal by Subject|2|||
156696365|NCT04647721|565636105|FG000|Overall Study|Lost to Follow-up|2|||
156696366|NCT04647721|565636106|FG001|Overall Study|Lost to Follow-up|0|||
156530928|NCT03444324|565038229|FG000|Overall Study|Withdrawal by Subject|0|||
156530929|NCT03444324|565038230|FG001|Overall Study|Withdrawal by Subject|1|||
156530930|NCT03444324|565038229|FG000|Overall Study|Lost to Follow-up|4|||
156530931|NCT03444324|565038230|FG001|Overall Study|Lost to Follow-up|2|||
156530932|NCT03444324|565038229|FG000|Overall Study|Protocol Violation|0|||
156530933|NCT03444324|565038230|FG001|Overall Study|Protocol Violation|1|||
156530934|NCT03444324|565038229|FG000|Overall Study|Lack of Trial Compliance|1|||
156530935|NCT03444324|565038230|FG001|Overall Study|Lack of Trial Compliance|1|||
156530936|NCT03444324|565038229|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
156530937|NCT03444324|565038230|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
156530938|NCT06071754|565038234|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
156530939|NCT01215175|565039793|FG000|Overall Study|Lost to Follow-up|0|||
156530940|NCT01215175|565039794|FG001|Overall Study|Lost to Follow-up|1|||
156530941|NCT01215175|565039795|FG002|Overall Study|Lost to Follow-up|0|||
156530942|NCT01215175|565039796|FG003|Overall Study|Lost to Follow-up|1|||
156530943|NCT01215175|565039797|FG004|Overall Study|Lost to Follow-up|0|||
156530944|NCT00293722|565039798|FG000|Overall Study|Other|427|||
156530945|NCT04498169|565039800|FG000|Study Completion|Adverse Event|1|||
156530946|NCT04498169|565039801|FG001|Study Completion|Adverse Event|1|||
156530947|NCT06069778|565039802|FG000|Overall Study|Withdrawal by Subject|1|||
156530948|NCT03801902|565039803|FG000|Overall Study|Did not receive protocol treatment.|1|||
156696367|NCT01974440|565636109|FG000|Overall Study|Lost to Follow-up|7|||
156696368|NCT01974440|565636110|FG001|Overall Study|Lost to Follow-up|7|||
156696369|NCT01974440|565636109|FG000|Overall Study|Withdrawal by Subject|24|||
156696370|NCT01974440|565636110|FG001|Overall Study|Withdrawal by Subject|20|||
156696371|NCT01974440|565636109|FG000|Overall Study|Sponsor decision|109|||
156696372|NCT01974440|565636110|FG001|Overall Study|Sponsor decision|110|||
156696373|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
156696374|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
156696375|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
156696376|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
156696377|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
156696378|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
156790074|NCT02933151|565983680|FG000|Overall Study|Recovered Kidney Function|47|||
156530949|NCT03801902|565039804|FG001|Overall Study|Did not receive protocol treatment.|0|||
156530950|NCT03801902|565039805|FG002|Overall Study|Did not receive protocol treatment.|0|||
156530951|NCT03801902|565039806|FG003|Overall Study|Did not receive protocol treatment.|0|||
156696379|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
156696380|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
156696381|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
156696382|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
156696383|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
156696384|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
156696385|NCT04771403|565636111|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
156696386|NCT04771403|565636112|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
156696387|NCT04771403|565636111|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
156696388|NCT04771403|565636112|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
156696389|NCT01640873|565636113|FG000|Overall Study|Protocol Violation|2|||
156696390|NCT01640873|565636114|FG001|Overall Study|Protocol Violation|1|||
156696391|NCT02749292|565636115|FG000|Overall Study|Physician Decision|1|||
156696392|NCT02749292|565636116|FG001|Overall Study|Physician Decision|0|||
156696393|NCT02749292|565636115|FG000|Overall Study|Withdrawal by Subject|5|||
156696394|NCT02749292|565636116|FG001|Overall Study|Withdrawal by Subject|7|||
156696395|NCT02749292|565636115|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
156696396|NCT02749292|565636116|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
156696397|NCT02749292|565636115|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
156696398|NCT02749292|565636116|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
156696399|NCT02749292|565636115|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
156696400|NCT02749292|565636116|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
156696401|NCT02749292|565636115|FG000|Overall Study|Adverse Event|4|||
156696402|NCT02749292|565636116|FG001|Overall Study|Adverse Event|1|||
156696403|NCT02749292|565636115|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
156696404|NCT02749292|565636116|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
156696405|NCT02749292|565636115|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
156696406|NCT02749292|565636116|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
156696407|NCT02749292|565636115|FG000|Overall Study|Requiring glucocorticoids|0|||
156696408|NCT02749292|565636116|FG001|Overall Study|Requiring glucocorticoids|3|||
156696409|NCT02749292|565636115|FG000|Overall Study|Cancer|1|||
156696410|NCT02749292|565636116|FG001|Overall Study|Cancer|0|||
156696411|NCT02458092|565636117|FG000|Overall Study|Withdrawal by Subject|1|||
156696412|NCT02458092|565636118|FG001|Overall Study|Withdrawal by Subject|0|||
156696413|NCT00876018|565636119|FG000|Overall Study|Lost to Follow-up|0|||
156696414|NCT00876018|565636120|FG001|Overall Study|Lost to Follow-up|1|||
156696415|NCT00876018|565636121|FG002|Overall Study|Lost to Follow-up|1|||
156696416|NCT00876018|565636119|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
156696417|NCT00876018|565636120|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
156696418|NCT00876018|565636121|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
156696419|NCT01301508|565636122|FG000|Overall Study|Withdrawal by Subject|1|||
156696420|NCT01301508|565636123|FG001|Overall Study|Withdrawal by Subject|2|||
156696421|NCT01301508|565636122|FG000|Overall Study|Lost to Follow-up|0|||
156696422|NCT01301508|565636123|FG001|Overall Study|Lost to Follow-up|1|||
156696423|NCT01300923|565636124|FG000|Overall Study|Physician Decision|0|||
156696424|NCT01300923|565636125|FG001|Overall Study|Physician Decision|2|||
156696425|NCT02707861|565636128|FG000|Overall Study|Went onto commercial drug|30|||
156696426|NCT02707861|565636129|FG001|Overall Study|Went onto commercial drug|23|||
156696427|NCT02707861|565636128|FG000|Overall Study|Adverse Event|2|||
156696428|NCT02707861|565636129|FG001|Overall Study|Adverse Event|3|||
156696429|NCT02707861|565636128|FG000|Overall Study|Death|5|||
156696430|NCT02707861|565636129|FG001|Overall Study|Death|2|||
156696431|NCT02707861|565636128|FG000|Overall Study|Lack of Efficacy|0|||
156696432|NCT02707861|565636129|FG001|Overall Study|Lack of Efficacy|2|||
156696433|NCT02707861|565636128|FG000|Overall Study|Physician Decision|1|||
156696434|NCT02707861|565636129|FG001|Overall Study|Physician Decision|4|||
156696435|NCT02707861|565636128|FG000|Overall Study|Withdrawal by Subject|2|||
156696436|NCT02707861|565636129|FG001|Overall Study|Withdrawal by Subject|1|||
156790075|NCT02933151|565983681|FG001|Overall Study|Recovered Kidney Function|29|||
156790076|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
156790077|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
156790078|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
156696437|NCT02707861|565636128|FG000|Overall Study|Lost to Follow-up|1|||
156696438|NCT02707861|565636129|FG001|Overall Study|Lost to Follow-up|3|||
156696439|NCT00369382|565636132|FG000|Overall Study|Death|0|||
156696440|NCT00369382|565636133|FG001|Overall Study|Death|2|||
156696441|NCT00369382|565636132|FG000|Overall Study|Physician Decision|2|||
156696442|NCT00369382|565636133|FG001|Overall Study|Physician Decision|1|||
156696443|NCT00369382|565636132|FG000|Overall Study|Withdrawal by Subject|5|||
156696444|NCT00369382|565636133|FG001|Overall Study|Withdrawal by Subject|0|||
156696445|NCT00369382|565636132|FG000|Overall Study|Randomized, not treated|2|||
156696446|NCT00369382|565636133|FG001|Overall Study|Randomized, not treated|0|||
156696447|NCT00369382|565636132|FG000|Overall Study|Other|1|||
156696448|NCT00369382|565636133|FG001|Overall Study|Other|0|||
156696449|NCT00448136|565636139|FG000|Overall Study|Death|3|||
156696450|NCT00448136|565636140|FG001|Overall Study|Death|8|||
156696451|NCT00448136|565636139|FG000|Overall Study|Investigator's decision (progression)|1|||
156696452|NCT00448136|565636140|FG001|Overall Study|Investigator's decision (progression)|0|||
156696453|NCT03407430|565636143|FG000|Washout|Protocol Violation|1|||
156696454|NCT03407430|565636144|FG001|Washout|Protocol Violation|0|||
156696455|NCT00922987|565636145|FG000|Overall Study|Insufficient clinical response|1|||
156696456|NCT00922987|565636145|FG000|Overall Study|Protocol Violation|2|||
156696457|NCT00922987|565636145|FG000|Overall Study|Adverse Event|1|||
156696458|NCT01334710|565636152|FG000|Overall Study|Trial was terminated|3|||
156696459|NCT05011123|565638061|FG000|Overall Study|Withdrawal by Subject|4|||
156696460|NCT05011123|565638062|FG001|Overall Study|Withdrawal by Subject|2|||
156696461|NCT05011123|565638061|FG000|Overall Study|Lost to Follow-up|7|||
156696462|NCT05011123|565638062|FG001|Overall Study|Lost to Follow-up|6|||
156696463|NCT05011123|565638061|FG000|Overall Study|Ongoing at the time of DBL date|36|||
156696464|NCT05011123|565638062|FG001|Overall Study|Ongoing at the time of DBL date|10|||
156696465|NCT05011123|565638061|FG000|Overall Study|Randomized but did not receive vaccination|1|||
156696466|NCT05011123|565638062|FG001|Overall Study|Randomized but did not receive vaccination|0|||
156696467|NCT01687478|565638065|FG000|Overall Study|Adverse Event|3|||
156696468|NCT01687478|565638066|FG001|Overall Study|Adverse Event|10|||
156696469|NCT01687478|565638065|FG000|Overall Study|Lost to Follow-up|1|||
156696470|NCT01687478|565638066|FG001|Overall Study|Lost to Follow-up|3|||
156696471|NCT01687478|565638065|FG000|Overall Study|Protocol Violation|0|||
156696472|NCT01687478|565638066|FG001|Overall Study|Protocol Violation|2|||
156696473|NCT01687478|565638065|FG000|Overall Study|Withdrawal by Subject|21|||
156696474|NCT01687478|565638066|FG001|Overall Study|Withdrawal by Subject|19|||
156696475|NCT01687478|565638065|FG000|Overall Study|Physician Decision|1|||
156696476|NCT01687478|565638066|FG001|Overall Study|Physician Decision|3|||
156696477|NCT01687478|565638065|FG000|Overall Study|Entry Criteria Not Met|6|||
156696478|NCT01687478|565638066|FG001|Overall Study|Entry Criteria Not Met|2|||
156696479|NCT03188718|565638067|FG000|Overall Study|Participant noncompliance|4|||
156696480|NCT03188718|565638067|FG000|Overall Study|Withdrawal by Subject|1|||
156696481|NCT03188718|565638067|FG000|Overall Study|Device failure|3|||
156696482|NCT04322149|565638068|FG000|Overall Study|Adverse Event|1|||
156696483|NCT04322149|565638069|FG001|Overall Study|Adverse Event|1|||
156696484|NCT04322149|565638070|FG002|Overall Study|Adverse Event|0|||
156696485|NCT04322149|565638071|FG003|Overall Study|Adverse Event|0|||
156696486|NCT04322149|565638068|FG000|Overall Study|Withdrawal by Subject|0|||
156696487|NCT04322149|565638069|FG001|Overall Study|Withdrawal by Subject|0|||
156696488|NCT04322149|565638070|FG002|Overall Study|Withdrawal by Subject|0|||
156696489|NCT04322149|565638071|FG003|Overall Study|Withdrawal by Subject|2|||
156696490|NCT04322149|565638068|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
156696491|NCT04322149|565638069|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
156696492|NCT04322149|565638070|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
156696493|NCT04322149|565638071|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
156696494|NCT00450619|565638072|FG000|Overall Study|refused treatment after randomization|2|||
156696495|NCT00450619|565638073|FG001|Overall Study|refused treatment after randomization|0|||
156696496|NCT00450619|565638072|FG000|Overall Study|did not progress; refused further trmt|1|||
156696497|NCT00450619|565638073|FG001|Overall Study|did not progress; refused further trmt|1|||
156696498|NCT00450619|565638072|FG000|Overall Study|Adverse Event|1|||
156696499|NCT00450619|565638073|FG001|Overall Study|Adverse Event|0|||
156696500|NCT02963311|565638076|FG000|Overall Study|Withdrawal by Subject|1|||
156696501|NCT02963311|565638076|FG000|Overall Study|Screen Failure|4|||
156696502|NCT04442490|565638079|FG000|Overall Study|Withdrawal by Subject|18|||
156696503|NCT04442490|565638080|FG001|Overall Study|Withdrawal by Subject|10|||
156696504|NCT04442490|565638079|FG000|Overall Study|Lost to Follow-up|7|||
156696505|NCT04442490|565638080|FG001|Overall Study|Lost to Follow-up|7|||
156696506|NCT04442490|565638079|FG000|Overall Study|Adverse Event|2|||
156696507|NCT04442490|565638080|FG001|Overall Study|Adverse Event|6|||
156696508|NCT04442490|565638079|FG000|Overall Study|Noncompliance|3|||
156696509|NCT04442490|565638080|FG001|Overall Study|Noncompliance|1|||
156696510|NCT04442490|565638079|FG000|Overall Study|Physician Decision|2|||
156696511|NCT04442490|565638080|FG001|Overall Study|Physician Decision|1|||
156696512|NCT04442490|565638079|FG000|Overall Study|Reason not Specified|2|||
156696513|NCT04442490|565638080|FG001|Overall Study|Reason not Specified|1|||
156696514|NCT04442490|565638079|FG000|Overall Study|Randomized but not Treated|3|||
156696515|NCT04442490|565638080|FG001|Overall Study|Randomized but not Treated|3|||
156696516|NCT02227147|565638082|FG000|Controlled Treatment Period|Adverse Event|4|||
156696517|NCT02227147|565638083|FG001|Controlled Treatment Period|Adverse Event|3|||
156696518|NCT02227147|565638082|FG000|Controlled Treatment Period|Other|2|||
156696519|NCT02227147|565638083|FG001|Controlled Treatment Period|Other|0|||
156696520|NCT02227147|565638082|FG000|Follow-up Period|Other|3|||
156696521|NCT02227147|565638083|FG001|Follow-up Period|Other|5|||
156696522|NCT00158600|565638089|FG000|Overall Study|unable to commit time to study|0|||
156696523|NCT00158600|565638090|FG001|Overall Study|unable to commit time to study|1|||
156696524|NCT00158600|565638089|FG000|Overall Study|Adverse Event|2|||
156696525|NCT00158600|565638090|FG001|Overall Study|Adverse Event|1|||
156696526|NCT00158600|565638089|FG000|Overall Study|Death|1|||
156696527|NCT00158600|565638090|FG001|Overall Study|Death|0|||
156696528|NCT00158600|565638089|FG000|Overall Study|Withdrawal by Subject|2|||
156696529|NCT00158600|565638090|FG001|Overall Study|Withdrawal by Subject|2|||
156696530|NCT02038907|565638091|FG000|Overall Study|Protocol Violation|0|||
156696531|NCT02038907|565638092|FG001|Overall Study|Protocol Violation|0|||
156696532|NCT02038907|565638093|FG002|Overall Study|Protocol Violation|0|||
156696533|NCT02038907|565638094|FG003|Overall Study|Protocol Violation|0|||
156696534|NCT02038907|565638095|FG004|Overall Study|Protocol Violation|0|||
156696535|NCT02038907|565638096|FG005|Overall Study|Protocol Violation|0|||
156696536|NCT02038907|565638097|FG006|Overall Study|Protocol Violation|0|||
156696537|NCT02038907|565638098|FG007|Overall Study|Protocol Violation|0|||
156696538|NCT02038907|565638099|FG008|Overall Study|Protocol Violation|0|||
156696539|NCT02038907|565638100|FG009|Overall Study|Protocol Violation|0|||
156696540|NCT02038907|565638101|FG010|Overall Study|Protocol Violation|1|||
156696541|NCT02038907|565638102|FG011|Overall Study|Protocol Violation|0|||
156696542|NCT02038907|565638103|FG012|Overall Study|Protocol Violation|0|||
156696543|NCT02038907|565638104|FG013|Overall Study|Protocol Violation|0|||
156696544|NCT02038907|565638091|FG000|Overall Study|Withdrawal by Subject|0|||
156696545|NCT02038907|565638092|FG001|Overall Study|Withdrawal by Subject|0|||
156696546|NCT02038907|565638093|FG002|Overall Study|Withdrawal by Subject|0|||
156696547|NCT02038907|565638094|FG003|Overall Study|Withdrawal by Subject|0|||
156696548|NCT02038907|565638095|FG004|Overall Study|Withdrawal by Subject|0|||
156696549|NCT02038907|565638096|FG005|Overall Study|Withdrawal by Subject|0|||
156696550|NCT02038907|565638097|FG006|Overall Study|Withdrawal by Subject|0|||
156696551|NCT02038907|565638098|FG007|Overall Study|Withdrawal by Subject|0|||
156696552|NCT02038907|565638099|FG008|Overall Study|Withdrawal by Subject|0|||
156696553|NCT02038907|565638100|FG009|Overall Study|Withdrawal by Subject|0|||
156696554|NCT02038907|565638101|FG010|Overall Study|Withdrawal by Subject|1|||
156696555|NCT02038907|565638102|FG011|Overall Study|Withdrawal by Subject|0|||
156696556|NCT02038907|565638103|FG012|Overall Study|Withdrawal by Subject|0|||
156696557|NCT02038907|565638104|FG013|Overall Study|Withdrawal by Subject|0|||
156696558|NCT00622466|565638109|FG000|Overall Study|Death|1|||
156696559|NCT00622466|565638109|FG000|Overall Study|Adverse Event|1|||
156696560|NCT00622466|565638109|FG000|Overall Study|Withdrawal by Subject|2|||
156696561|NCT02618408|565638110|FG000|Overall Study|Withdrawal by Subject|1|||
156696562|NCT02618408|565638111|FG001|Overall Study|Withdrawal by Subject|0|||
156696563|NCT02618408|565638112|FG002|Overall Study|Withdrawal by Subject|4|||
156696564|NCT02618408|565638110|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
156696565|NCT02618408|565638111|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
156696566|NCT02618408|565638112|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
156696567|NCT02618408|565638110|FG000|Overall Study|Lost to Follow-up|4|||
156696568|NCT02618408|565638111|FG001|Overall Study|Lost to Follow-up|2|||
156696569|NCT02618408|565638112|FG002|Overall Study|Lost to Follow-up|6|||
156696570|NCT02618408|565638110|FG000|Overall Study|Adverse Event|4|||
156696571|NCT02618408|565638111|FG001|Overall Study|Adverse Event|0|||
156871117|NCT05006573|566284412|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
156871118|NCT02605122|566285963|FG000|Overall Study|Withdrawal by Subject|4|||
156871119|NCT02605122|566285964|FG001|Overall Study|Withdrawal by Subject|1|||
156871120|NCT02605122|566285963|FG000|Overall Study|Lost to Follow-up|1|||
156871121|NCT02605122|566285964|FG001|Overall Study|Lost to Follow-up|1|||
156871122|NCT02873702|566285968|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
156871123|NCT02873702|566285969|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
156871124|NCT02873702|566285970|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
156871125|NCT02873702|566285971|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
156331070|NCT00309985|564311940|FG001|Overall Study|Physician Decision|0|||
156696572|NCT02618408|565638112|FG002|Overall Study|Adverse Event|10|||
156696573|NCT02618408|565638110|FG000|Overall Study|Physician Decision|1|||
156696574|NCT02618408|565638111|FG001|Overall Study|Physician Decision|1|||
156696575|NCT02618408|565638112|FG002|Overall Study|Physician Decision|2|||
156696576|NCT02618408|565638110|FG000|Overall Study|Protocol Violation|1|||
156696577|NCT02618408|565638111|FG001|Overall Study|Protocol Violation|1|||
156696578|NCT02618408|565638112|FG002|Overall Study|Protocol Violation|2|||
156696579|NCT02618408|565638110|FG000|Overall Study|Other, Multiple Categories|0|||
156696580|NCT02618408|565638111|FG001|Overall Study|Other, Multiple Categories|0|||
156871126|NCT02873702|566285968|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
156696581|NCT02618408|565638112|FG002|Overall Study|Other, Multiple Categories|4|||
156696582|NCT05183217|565638113|FG000|Overall Study|Withdrawal by Subject|1|||
156696583|NCT05183217|565638114|FG001|Overall Study|Withdrawal by Subject|1|||
156696584|NCT01593696|565638115|FG000|Dose Escalation|Progressive Disease|2|||
156696585|NCT01593696|565638116|FG001|Dose Escalation|Progressive Disease|0|||
156696586|NCT01593696|565638117|FG002|Dose Escalation|Progressive Disease|0|||
156696587|NCT01593696|565638118|FG003|Dose Escalation|Progressive Disease|0|||
156696588|NCT01593696|565638115|FG000|Dose Expansion|Fungal infection|0|||
156696589|NCT01593696|565638116|FG001|Dose Expansion|Fungal infection|0|||
156696590|NCT01593696|565638117|FG002|Dose Expansion|Fungal infection|1|||
156696591|NCT01593696|565638118|FG003|Dose Expansion|Fungal infection|0|||
156696592|NCT01936623|565638119|FG000|Overall Study|Lost to Follow-up|0|||
156696593|NCT01936623|565638120|FG001|Overall Study|Lost to Follow-up|5|||
156696594|NCT00369655|565638124|FG000|Overall Study|Refusal of further treatment|2|||
156696595|NCT02455050|565638125|FG000|Treatment Period 1|Lost to Follow-up|1|||
156696596|NCT02455050|565638126|FG001|Treatment Period 1|Lost to Follow-up|1|||
156696597|NCT02455050|565638127|FG002|Treatment Period 1|Lost to Follow-up|1|||
156696598|NCT02455050|565638128|FG003|Treatment Period 1|Lost to Follow-up|2|||
156696599|NCT02455050|565638125|FG000|Treatment Period 2|Lost to Follow-up|1|||
156696600|NCT02455050|565638126|FG001|Treatment Period 2|Lost to Follow-up|0|||
156696601|NCT02455050|565638127|FG002|Treatment Period 2|Lost to Follow-up|2|||
156696602|NCT02455050|565638128|FG003|Treatment Period 2|Lost to Follow-up|1|||
156696603|NCT03402750|565638129|FG000|Overall Study|Lost to Follow-up|2|||
156696604|NCT03402750|565638130|FG001|Overall Study|Lost to Follow-up|1|||
156696605|NCT02981303|565638131|FG000|Overall Study|Progressive Disease|17|||
156696606|NCT02981303|565638132|FG001|Overall Study|Progressive Disease|37|||
156696607|NCT02981303|565638131|FG000|Overall Study|Adverse Event|1|||
156696608|NCT02981303|565638132|FG001|Overall Study|Adverse Event|4|||
156696609|NCT02981303|565638131|FG000|Overall Study|Withdrawal by Subject|0|||
156696610|NCT02981303|565638132|FG001|Overall Study|Withdrawal by Subject|1|||
156696611|NCT01831765|565638133|FG000|Overall Study|Lack of Efficacy|1|||
156696612|NCT01831765|565638134|FG001|Overall Study|Lack of Efficacy|0|||
156696613|NCT01831765|565638135|FG002|Overall Study|Lack of Efficacy|0|||
156696614|NCT01831765|565638133|FG000|Overall Study|Other, sponsor withdrew subject|0|||
156696615|NCT01831765|565638134|FG001|Overall Study|Other, sponsor withdrew subject|1|||
156696616|NCT01831765|565638135|FG002|Overall Study|Other, sponsor withdrew subject|0|||
156696617|NCT01831765|565638133|FG000|Overall Study|Pregnancy|1|||
156696618|NCT01831765|565638134|FG001|Overall Study|Pregnancy|1|||
156696619|NCT01831765|565638135|FG002|Overall Study|Pregnancy|2|||
156696620|NCT01831765|565638133|FG000|Overall Study|Death|0|||
156696621|NCT01831765|565638134|FG001|Overall Study|Death|1|||
156696622|NCT01831765|565638135|FG002|Overall Study|Death|1|||
156696623|NCT01831765|565638133|FG000|Overall Study|Other, site closed|1|||
156696624|NCT01831765|565638134|FG001|Overall Study|Other, site closed|1|||
156696625|NCT01831765|565638135|FG002|Overall Study|Other, site closed|0|||
156696626|NCT01831765|565638133|FG000|Overall Study|Adverse Event|5|||
156696627|NCT01831765|565638134|FG001|Overall Study|Adverse Event|3|||
156696628|NCT01831765|565638135|FG002|Overall Study|Adverse Event|3|||
156696629|NCT01831765|565638133|FG000|Overall Study|Withdrawal by Subject|22|||
156696630|NCT01831765|565638134|FG001|Overall Study|Withdrawal by Subject|7|||
156696631|NCT01831765|565638135|FG002|Overall Study|Withdrawal by Subject|17|||
156696632|NCT01831765|565638133|FG000|Overall Study|Withdrawal criteria|12|||
156696633|NCT01831765|565638134|FG001|Overall Study|Withdrawal criteria|10|||
156696634|NCT01831765|565638135|FG002|Overall Study|Withdrawal criteria|16|||
156696635|NCT01831765|565638133|FG000|Overall Study|Lost to Follow-up|2|||
156696636|NCT01831765|565638134|FG001|Overall Study|Lost to Follow-up|3|||
156696637|NCT01831765|565638135|FG002|Overall Study|Lost to Follow-up|3|||
156696638|NCT00706511|565638142|FG000|Overall Study|Withdrawal by Subject|1|||
156696639|NCT00706511|565638143|FG001|Overall Study|Withdrawal by Subject|0|||
156696640|NCT00706511|565638144|FG002|Overall Study|Withdrawal by Subject|0|||
156696641|NCT00706511|565638145|FG003|Overall Study|Withdrawal by Subject|0|||
156696642|NCT02116608|565638151|FG000|Overall Study|Lost to Follow-up|0|||
156696643|NCT02116608|565638152|FG001|Overall Study|Lost to Follow-up|0|||
156696644|NCT02116608|565638153|FG002|Overall Study|Lost to Follow-up|1|||
156696645|NCT02116608|565638151|FG000|Overall Study|Physician Decision|0|||
156696646|NCT02116608|565638152|FG001|Overall Study|Physician Decision|1|||
156696647|NCT02116608|565638153|FG002|Overall Study|Physician Decision|0|||
156696648|NCT02116608|565638151|FG000|Overall Study|Death|0|||
156696649|NCT02116608|565638152|FG001|Overall Study|Death|1|||
156696650|NCT02116608|565638153|FG002|Overall Study|Death|0|||
156696651|NCT00988442|565638154|FG000|Overall Study|Death|1|||
156696652|NCT00988442|565638155|FG001|Overall Study|Death|2|||
156696653|NCT00988442|565638154|FG000|Overall Study|Lost to Follow-up|0|||
156696654|NCT00988442|565638155|FG001|Overall Study|Lost to Follow-up|1|||
156696655|NCT00988442|565638154|FG000|Overall Study|Early Study Closure|29|||
156696656|NCT00988442|565638155|FG001|Overall Study|Early Study Closure|25|||
156696657|NCT00117325|565638156|FG000|Overall Study|Adverse Event|3|||
156696658|NCT00117325|565638157|FG001|Overall Study|Adverse Event|3|||
156696659|NCT00117325|565638156|FG000|Overall Study|Lost to Follow-up|1|||
156696660|NCT00117325|565638157|FG001|Overall Study|Lost to Follow-up|1|||
156696661|NCT00117325|565638156|FG000|Overall Study|Protocol Violation|2|||
156696662|NCT00117325|565638157|FG001|Overall Study|Protocol Violation|3|||
156696663|NCT00117325|565638156|FG000|Overall Study|Withdrawal by Subject|3|||
156696664|NCT00117325|565638157|FG001|Overall Study|Withdrawal by Subject|2|||
156696665|NCT00117325|565638156|FG000|Overall Study|Lack of Efficacy|1|||
156696666|NCT00117325|565638157|FG001|Overall Study|Lack of Efficacy|0|||
156696667|NCT00117325|565638156|FG000|Overall Study|Use of prohibited medicine|1|||
156696668|NCT00117325|565638157|FG001|Overall Study|Use of prohibited medicine|2|||
156696669|NCT00117325|565638156|FG000|Overall Study|Early termination|1|||
156696670|NCT00117325|565638157|FG001|Overall Study|Early termination|1|||
156696671|NCT00117325|565638156|FG000|Overall Study|Admisnitrative|1|||
156696672|NCT00117325|565638157|FG001|Overall Study|Admisnitrative|0|||
156696673|NCT01468818|565638161|FG000|Overall Study|Death during treatment|2|||
156696674|NCT02266134|565638162|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
156696675|NCT02266134|565638163|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
156331071|NCT00309985|564311939|FG000|Overall Study|Never started treatment|7|||
156331072|NCT00309985|564311940|FG001|Overall Study|Never started treatment|0|||
156331073|NCT00309985|564311939|FG000|Overall Study|Complicating disease|1|||
156331074|NCT00309985|564311940|FG001|Overall Study|Complicating disease|0|||
156696676|NCT02266134|565638164|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
156696677|NCT02266134|565638165|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
156696678|NCT02266134|565638162|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
156696679|NCT02266134|565638163|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
156331075|NCT00309985|564311939|FG000|Overall Study|Non-compliance|1|||
156331076|NCT00309985|564311940|FG001|Overall Study|Non-compliance|0|||
156331077|NCT00309985|564311939|FG000|Overall Study|Chemotherapy discontinued only|1|||
156331078|NCT00309985|564311940|FG001|Overall Study|Chemotherapy discontinued only|0|||
156331079|NCT03659916|564311941|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
156331080|NCT03659916|564311942|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
156331081|NCT03659916|564311943|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
156331082|NCT03659916|564311941|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
156331083|NCT03659916|564311942|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
156331084|NCT03659916|564311943|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
156331085|NCT03659916|564311941|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
156331086|NCT03659916|564311942|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
156331087|NCT03659916|564311943|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
156331088|NCT03659916|564311941|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
156331089|NCT03659916|564311942|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
156331090|NCT03659916|564311943|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
156331091|NCT03659916|564311941|FG000|Treatment Period (72 Weeks)|Other|1|||
156331092|NCT03659916|564311942|FG001|Treatment Period (72 Weeks)|Other|3|||
156331093|NCT03659916|564311943|FG002|Treatment Period (72 Weeks)|Other|9|||
156331094|NCT03659916|564311941|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
156331095|NCT03659916|564311942|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
156331096|NCT03659916|564311943|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
156331097|NCT03659916|564311941|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
156331098|NCT03659916|564311942|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
156331099|NCT03659916|564311943|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
156331100|NCT03659916|564311941|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
156331101|NCT03659916|564311942|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
156331102|NCT03659916|564311943|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
156331103|NCT03659916|564311941|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
156331104|NCT03659916|564311942|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
156331105|NCT03659916|564311943|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
156331106|NCT03659916|564311941|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
156331107|NCT03659916|564311942|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
156331108|NCT03659916|564311943|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
156331109|NCT03659916|564311941|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
156331110|NCT03659916|564311942|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
156331111|NCT03659916|564311943|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
156438306|NCT04054635|564695429|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
156696680|NCT02266134|565638164|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
156696681|NCT02266134|565638165|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
156696682|NCT02266134|565638162|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
156438307|NCT04054635|564695430|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
156438308|NCT01254188|564695431|FG000|Overall Study|Disease Progression|6|||
156438309|NCT01254188|564695431|FG000|Overall Study|Protocol Violation|6|||
156696683|NCT02266134|565638163|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
156696684|NCT02266134|565638164|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
156438310|NCT01254188|564695431|FG000|Overall Study|Pregnancy|2|||
156438311|NCT01254188|564695431|FG000|Overall Study|Death|4|||
156696685|NCT02266134|565638165|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
156696686|NCT02266134|565638162|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
156696687|NCT02266134|565638163|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
156696688|NCT02266134|565638164|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
156696689|NCT02266134|565638165|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
156696690|NCT02266134|565638162|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
156696691|NCT02266134|565638163|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
156696692|NCT02266134|565638164|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
156696693|NCT02266134|565638165|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
156696694|NCT02266134|565638162|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
156696695|NCT02266134|565638163|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
156696696|NCT02266134|565638164|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
156696697|NCT02266134|565638165|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
156696698|NCT04620135|565638166|FG000|Study Completion|Adverse Event|2|||
156696699|NCT04620135|565638167|FG001|Study Completion|Adverse Event|3|||
156696700|NCT04620135|565638166|FG000|Study Completion|Withdrawal by Subject|2|||
156696701|NCT04620135|565638167|FG001|Study Completion|Withdrawal by Subject|0|||
156696702|NCT01442688|565638169|FG000|First Intervention|Withdrawal by Subject|1|||
156696703|NCT01442688|565638170|FG001|First Intervention|Withdrawal by Subject|0|||
156438312|NCT01254188|564695431|FG000|Overall Study|Lost to Follow-up|5|||
156438313|NCT01254188|564695431|FG000|Overall Study|Withdrawal by Subject|7|||
156438314|NCT01254188|564695431|FG000|Overall Study|Adverse Event|43|||
156438315|NCT01254188|564695431|FG000|Overall Study|per investigator discretion|20|||
156438316|NCT00535145|564695432|FG000|Phase I|Adverse Event|3|||
156696704|NCT01442688|565638169|FG000|First Intervention|subject incarcerated|1|||
156696705|NCT01442688|565638170|FG001|First Intervention|subject incarcerated|0|||
156696706|NCT01442688|565638169|FG000|Second Intervention|Adverse Event|1|||
156438317|NCT00535145|564695432|FG000|Phase I|Lost to Follow-up|7|||
156696707|NCT01442688|565638170|FG001|Second Intervention|Adverse Event|0|||
156696708|NCT00762437|565638171|FG000|Overall Study|Lost to Follow-up|7|||
156696709|NCT00762437|565638171|FG000|Overall Study|Missed final study visit|11|||
156696710|NCT00762437|565638171|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
156696711|NCT00302081|565638172|FG000|Overall Study|Adverse Event|6|||
156696712|NCT00302081|565638173|FG001|Overall Study|Adverse Event|5|||
156696713|NCT00302081|565638174|FG002|Overall Study|Adverse Event|4|||
156696714|NCT00302081|565638172|FG000|Overall Study|Lost to Follow-up|21|||
156438318|NCT00535145|564695432|FG000|Phase I|Withdrawal by Subject|6|||
156696715|NCT00302081|565638173|FG001|Overall Study|Lost to Follow-up|18|||
156696716|NCT00302081|565638174|FG002|Overall Study|Lost to Follow-up|28|||
156696717|NCT00302081|565638172|FG000|Overall Study|Withdrawal by Subject|8|||
156696718|NCT00302081|565638173|FG001|Overall Study|Withdrawal by Subject|12|||
156696719|NCT00302081|565638174|FG002|Overall Study|Withdrawal by Subject|8|||
156696720|NCT00302081|565638172|FG000|Overall Study|Protocol Violation|5|||
156696721|NCT00302081|565638173|FG001|Overall Study|Protocol Violation|1|||
156696722|NCT00302081|565638174|FG002|Overall Study|Protocol Violation|2|||
156696723|NCT00302081|565638172|FG000|Overall Study|Lack of Efficacy|1|||
156696724|NCT00302081|565638173|FG001|Overall Study|Lack of Efficacy|0|||
156696725|NCT00302081|565638174|FG002|Overall Study|Lack of Efficacy|5|||
156696726|NCT00302081|565638172|FG000|Overall Study|Death|2|||
156696727|NCT00302081|565638173|FG001|Overall Study|Death|1|||
156696728|NCT00302081|565638174|FG002|Overall Study|Death|0|||
156696729|NCT00302081|565638172|FG000|Overall Study|Other|13|||
156696730|NCT00302081|565638173|FG001|Overall Study|Other|6|||
156696731|NCT00302081|565638174|FG002|Overall Study|Other|5|||
156696732|NCT01359644|565638175|FG000|Treatment Period|Lack of Efficacy|0|||
156696733|NCT01359644|565638176|FG001|Treatment Period|Lack of Efficacy|1|||
156696734|NCT01359644|565638177|FG002|Treatment Period|Lack of Efficacy|0|||
156696735|NCT01359644|565638178|FG003|Treatment Period|Lack of Efficacy|0|||
156696736|NCT01359644|565638179|FG004|Treatment Period|Lack of Efficacy|0|||
156696737|NCT01359644|565638180|FG005|Treatment Period|Lack of Efficacy|0|||
156696738|NCT01359644|565638181|FG006|Treatment Period|Lack of Efficacy|0|||
156696739|NCT01359644|565638182|FG007|Treatment Period|Lack of Efficacy|0|||
156696740|NCT01359644|565638183|FG008|Treatment Period|Lack of Efficacy|0|||
156696741|NCT01359644|565638184|FG009|Treatment Period|Lack of Efficacy|0|||
156696742|NCT01359644|565638175|FG000|Treatment Period|Adverse Event|0|||
156696743|NCT01359644|565638176|FG001|Treatment Period|Adverse Event|0|||
156696744|NCT01359644|565638177|FG002|Treatment Period|Adverse Event|1|||
156696745|NCT01359644|565638178|FG003|Treatment Period|Adverse Event|0|||
156696746|NCT01359644|565638179|FG004|Treatment Period|Adverse Event|0|||
156696747|NCT01359644|565638180|FG005|Treatment Period|Adverse Event|1|||
156696748|NCT01359644|565638181|FG006|Treatment Period|Adverse Event|0|||
156696749|NCT01359644|565638182|FG007|Treatment Period|Adverse Event|0|||
156696750|NCT01359644|565638183|FG008|Treatment Period|Adverse Event|0|||
156696751|NCT01359644|565638184|FG009|Treatment Period|Adverse Event|0|||
156696752|NCT01359644|565638175|FG000|Treatment Period|Lost to Follow-up|0|||
156696753|NCT01359644|565638176|FG001|Treatment Period|Lost to Follow-up|0|||
156696754|NCT01359644|565638177|FG002|Treatment Period|Lost to Follow-up|0|||
156331112|NCT04941456|564311944|FG000|Overall Study|Withdrawal by Subject|1|||
156331113|NCT04941456|564311945|FG001|Overall Study|Withdrawal by Subject|0|||
156331114|NCT04941456|564311944|FG000|Overall Study|Protocol Violation|1|||
156331115|NCT04941456|564311945|FG001|Overall Study|Protocol Violation|0|||
156331116|NCT02296684|564311946|FG000|Overall Study|Withdrawal by Subject|0|||
156331117|NCT02296684|564311947|FG001|Overall Study|Withdrawal by Subject|1|||
156331118|NCT02296684|564311948|FG002|Overall Study|Withdrawal by Subject|1|||
156331119|NCT02296684|564311946|FG000|Overall Study|Death|2|||
156331120|NCT02296684|564311947|FG001|Overall Study|Death|0|||
156331121|NCT02296684|564311948|FG002|Overall Study|Death|0|||
156438319|NCT00535145|564695432|FG000|Phase I|(eligibility)|8|||
156438320|NCT00535145|564695432|FG000|Phase I|(protocol violation)|1|||
156696755|NCT01359644|565638178|FG003|Treatment Period|Lost to Follow-up|0|||
156696756|NCT01359644|565638179|FG004|Treatment Period|Lost to Follow-up|0|||
156696757|NCT01359644|565638180|FG005|Treatment Period|Lost to Follow-up|1|||
156696758|NCT01359644|565638181|FG006|Treatment Period|Lost to Follow-up|0|||
156696759|NCT01359644|565638182|FG007|Treatment Period|Lost to Follow-up|0|||
156696760|NCT01359644|565638183|FG008|Treatment Period|Lost to Follow-up|0|||
156696761|NCT01359644|565638184|FG009|Treatment Period|Lost to Follow-up|0|||
156696762|NCT01359644|565638175|FG000|Follow-up Period|Withdrawal by Subject|0|||
156696763|NCT01359644|565638176|FG001|Follow-up Period|Withdrawal by Subject|0|||
156696764|NCT01359644|565638177|FG002|Follow-up Period|Withdrawal by Subject|0|||
156696765|NCT01359644|565638178|FG003|Follow-up Period|Withdrawal by Subject|0|||
156696766|NCT01359644|565638179|FG004|Follow-up Period|Withdrawal by Subject|0|||
156696767|NCT01359644|565638180|FG005|Follow-up Period|Withdrawal by Subject|1|||
156696768|NCT01359644|565638181|FG006|Follow-up Period|Withdrawal by Subject|0|||
156696769|NCT01359644|565638182|FG007|Follow-up Period|Withdrawal by Subject|0|||
156696770|NCT01359644|565638183|FG008|Follow-up Period|Withdrawal by Subject|0|||
156696771|NCT01359644|565638184|FG009|Follow-up Period|Withdrawal by Subject|0|||
156696772|NCT01359644|565638175|FG000|Follow-up Period|Lost to Follow-up|0|||
156696773|NCT01359644|565638176|FG001|Follow-up Period|Lost to Follow-up|0|||
156696774|NCT01359644|565638177|FG002|Follow-up Period|Lost to Follow-up|0|||
156696775|NCT01359644|565638178|FG003|Follow-up Period|Lost to Follow-up|0|||
156696776|NCT01359644|565638179|FG004|Follow-up Period|Lost to Follow-up|0|||
156696777|NCT01359644|565638180|FG005|Follow-up Period|Lost to Follow-up|0|||
156696778|NCT01359644|565638181|FG006|Follow-up Period|Lost to Follow-up|1|||
156696779|NCT01359644|565638182|FG007|Follow-up Period|Lost to Follow-up|2|||
156696780|NCT01359644|565638183|FG008|Follow-up Period|Lost to Follow-up|0|||
156696781|NCT01359644|565638184|FG009|Follow-up Period|Lost to Follow-up|0|||
156696782|NCT00311311|565638186|FG000|Overall Study|Adverse Event|3|||
156696783|NCT00311311|565638187|FG001|Overall Study|Adverse Event|2|||
156696784|NCT00311311|565638186|FG000|Overall Study|Withdrawal by Subject|1|||
156696785|NCT00311311|565638187|FG001|Overall Study|Withdrawal by Subject|1|||
156696786|NCT00311311|565638186|FG000|Overall Study|Noncompliance|0|||
156696787|NCT00311311|565638187|FG001|Overall Study|Noncompliance|1|||
156696788|NCT00311311|565638186|FG000|Overall Study|Study Termination by Sponsor|3|||
156696789|NCT00311311|565638187|FG001|Overall Study|Study Termination by Sponsor|4|||
156696790|NCT00311311|565638186|FG000|Overall Study|Death|1|||
156696791|NCT00311311|565638187|FG001|Overall Study|Death|0|||
156696792|NCT00311311|565638186|FG000|Overall Study|Lack of ancillary assistance|0|||
156696793|NCT00311311|565638187|FG001|Overall Study|Lack of ancillary assistance|1|||
156696794|NCT03979820|565638188|FG000|Overall Study|Protocol Violation|1|||
156696795|NCT03979820|565638189|FG001|Overall Study|Protocol Violation|0|||
156696796|NCT03979820|565638190|FG002|Overall Study|Protocol Violation|0|||
156696797|NCT03979820|565638191|FG003|Overall Study|Protocol Violation|0|||
156696798|NCT03979820|565638188|FG000|Overall Study|Withdrawal by Subject|0|||
156696799|NCT03979820|565638189|FG001|Overall Study|Withdrawal by Subject|0|||
156696800|NCT03979820|565638190|FG002|Overall Study|Withdrawal by Subject|1|||
156696801|NCT03979820|565638191|FG003|Overall Study|Withdrawal by Subject|0|||
156696802|NCT03979820|565638188|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
156696803|NCT03979820|565638189|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
156331122|NCT03805646|564311949|FG000|Overall Study|Death|40|||
156438321|NCT00535145|564695432|FG000|Phase I|(PI decision)|1|||
156438322|NCT00535145|564695432|FG000|Phase I|(diagnosis)|3|||
156438323|NCT00535145|564695432|FG000|Phase II|Adverse Event|2|||
156696804|NCT03979820|565638190|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
156438324|NCT00535145|564695432|FG000|Phase II|Lack of Efficacy|1|||
156696805|NCT03979820|565638191|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
156696806|NCT01229735|565638192|FG000|Overall Study|Lack of Efficacy|8|||
156696807|NCT01229735|565638193|FG001|Overall Study|Lack of Efficacy|8|||
156696808|NCT01229735|565638192|FG000|Overall Study|Protocol Violation|13|||
156331123|NCT03805646|564311950|FG001|Overall Study|Death|49|||
156331124|NCT03805646|564311949|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
156438325|NCT00535145|564695432|FG000|Phase II|Lost to Follow-up|5|||
156438326|NCT00535145|564695432|FG000|Phase II|Withdrawal by Subject|5|||
156438327|NCT00535145|564695432|FG000|Phase II|Subject non-compliance|2|||
156696809|NCT01229735|565638193|FG001|Overall Study|Protocol Violation|8|||
156696810|NCT01229735|565638192|FG000|Overall Study|Lost to Follow-up|0|||
156696811|NCT01229735|565638193|FG001|Overall Study|Lost to Follow-up|2|||
156696812|NCT01229735|565638192|FG000|Overall Study|Withdrawal by Subject|18|||
156696813|NCT01229735|565638193|FG001|Overall Study|Withdrawal by Subject|17|||
156696814|NCT01229735|565638192|FG000|Overall Study|Other Reason|13|||
156696815|NCT01229735|565638193|FG001|Overall Study|Other Reason|10|||
156696816|NCT01229735|565638192|FG000|Overall Study|SAE, non-fatal|0|||
156696817|NCT01229735|565638193|FG001|Overall Study|SAE, non-fatal|4|||
156696818|NCT01229735|565638192|FG000|Overall Study|AE, non-serious non-fatal|13|||
156696819|NCT01229735|565638193|FG001|Overall Study|AE, non-serious non-fatal|17|||
156696820|NCT01229735|565638192|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156696821|NCT01229735|565638193|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156696822|NCT02130882|565638194|FG000|Overall Study|Withdrawal by Subject|0|||
156696823|NCT02130882|565638195|FG001|Overall Study|Withdrawal by Subject|1|||
156696824|NCT00536263|565638198|FG000|Overall Study|Adverse Event|5|||
156696825|NCT00536263|565638199|FG001|Overall Study|Adverse Event|5|||
156696826|NCT00536263|565638200|FG002|Overall Study|Adverse Event|7|||
156696827|NCT00536263|565638198|FG000|Overall Study|Lost to Follow-up|3|||
156696828|NCT00536263|565638199|FG001|Overall Study|Lost to Follow-up|4|||
156696829|NCT00536263|565638200|FG002|Overall Study|Lost to Follow-up|4|||
156696830|NCT00536263|565638198|FG000|Overall Study|Subject withdrew - not treatment related|2|||
156696831|NCT00536263|565638199|FG001|Overall Study|Subject withdrew - not treatment related|0|||
156696832|NCT00536263|565638200|FG002|Overall Study|Subject withdrew - not treatment related|5|||
156696833|NCT00536263|565638198|FG000|Overall Study|Subject withdrew - treatment related|0|||
156696834|NCT00536263|565638199|FG001|Overall Study|Subject withdrew - treatment related|3|||
156696835|NCT00536263|565638200|FG002|Overall Study|Subject withdrew - treatment related|2|||
156696836|NCT00536263|565638198|FG000|Overall Study|Noncompliance with protocol|0|||
156696837|NCT00536263|565638199|FG001|Overall Study|Noncompliance with protocol|0|||
156696838|NCT00536263|565638200|FG002|Overall Study|Noncompliance with protocol|1|||
156696839|NCT00536263|565638198|FG000|Overall Study|Did not meet protocol eligibility|1|||
156696840|NCT00536263|565638199|FG001|Overall Study|Did not meet protocol eligibility|2|||
156696841|NCT00536263|565638200|FG002|Overall Study|Did not meet protocol eligibility|2|||
156696842|NCT00826449|565638205|FG000|Overall Study|Disease Progression|4|||
156696843|NCT00826449|565638205|FG000|Overall Study|Withdrawal by Subject|1|||
156696844|NCT02331368|565638206|FG000|Overall Study|Withdrawal by Subject|3|||
156696845|NCT02302859|565638219|FG000|Overall Study|Lost Phone|1|||
156696846|NCT02302859|565638220|FG001|Overall Study|Lost Phone|1|||
156696847|NCT02302859|565638219|FG000|Overall Study|Withdrawal by Subject|0|||
156696848|NCT02302859|565638220|FG001|Overall Study|Withdrawal by Subject|1|||
156696849|NCT04453202|565638227|FG000|Overall Study|Adverse Event|0|||
156696850|NCT04453202|565638228|FG001|Overall Study|Adverse Event|0|||
156696851|NCT04453202|565638229|FG002|Overall Study|Adverse Event|0|||
156696852|NCT04453202|565638230|FG003|Overall Study|Adverse Event|0|||
156696853|NCT04453202|565638231|FG004|Overall Study|Adverse Event|0|||
156696854|NCT04453202|565638232|FG005|Overall Study|Adverse Event|0|||
156696855|NCT04453202|565638233|FG006|Overall Study|Adverse Event|1|||
156696856|NCT04453202|565638234|FG007|Overall Study|Adverse Event|0|||
156696857|NCT04453202|565638235|FG008|Overall Study|Adverse Event|0|||
156696858|NCT04453202|565638236|FG009|Overall Study|Adverse Event|0|||
156696859|NCT04453202|565638237|FG010|Overall Study|Adverse Event|0|||
156696860|NCT04453202|565638227|FG000|Overall Study|Death|0|||
156696861|NCT04453202|565638228|FG001|Overall Study|Death|0|||
156696862|NCT04453202|565638229|FG002|Overall Study|Death|0|||
156696863|NCT04453202|565638230|FG003|Overall Study|Death|0|||
156696864|NCT04453202|565638231|FG004|Overall Study|Death|0|||
156696865|NCT04453202|565638232|FG005|Overall Study|Death|0|||
156331125|NCT03805646|564311950|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
156696866|NCT04453202|565638233|FG006|Overall Study|Death|0|||
156696867|NCT04453202|565638234|FG007|Overall Study|Death|0|||
156696868|NCT04453202|565638235|FG008|Overall Study|Death|0|||
156696869|NCT04453202|565638236|FG009|Overall Study|Death|1|||
156696870|NCT04453202|565638237|FG010|Overall Study|Death|0|||
156696871|NCT04453202|565638227|FG000|Overall Study|Lost to Follow-up|0|||
156331126|NCT05171777|564311951|FG000|Treatment Crossover Period|Adverse Event|9|||
156331127|NCT05171777|564311952|FG001|Treatment Crossover Period|Adverse Event|6|||
156331128|NCT05171777|564311953|FG002|Treatment Crossover Period|Adverse Event|0|||
156331129|NCT05171777|564311954|FG003|Treatment Crossover Period|Adverse Event|0|||
156331130|NCT05171777|564311951|FG000|Treatment Crossover Period|Death|5|||
156331131|NCT05171777|564311952|FG001|Treatment Crossover Period|Death|5|||
156331132|NCT05171777|564311953|FG002|Treatment Crossover Period|Death|0|||
156331133|NCT05171777|564311954|FG003|Treatment Crossover Period|Death|0|||
156331134|NCT05171777|564311951|FG000|Treatment Crossover Period|Disease Relapse|1|||
156331135|NCT05171777|564311952|FG001|Treatment Crossover Period|Disease Relapse|0|||
156331136|NCT05171777|564311953|FG002|Treatment Crossover Period|Disease Relapse|0|||
156331137|NCT05171777|564311954|FG003|Treatment Crossover Period|Disease Relapse|0|||
156696872|NCT04453202|565638228|FG001|Overall Study|Lost to Follow-up|1|||
156696873|NCT04453202|565638229|FG002|Overall Study|Lost to Follow-up|0|||
156696874|NCT04453202|565638230|FG003|Overall Study|Lost to Follow-up|1|||
156696875|NCT04453202|565638231|FG004|Overall Study|Lost to Follow-up|0|||
156696876|NCT04453202|565638232|FG005|Overall Study|Lost to Follow-up|0|||
156696877|NCT04453202|565638233|FG006|Overall Study|Lost to Follow-up|0|||
156696878|NCT04453202|565638234|FG007|Overall Study|Lost to Follow-up|0|||
156696879|NCT04453202|565638235|FG008|Overall Study|Lost to Follow-up|0|||
156696880|NCT04453202|565638236|FG009|Overall Study|Lost to Follow-up|1|||
156696881|NCT04453202|565638237|FG010|Overall Study|Lost to Follow-up|1|||
156696882|NCT04453202|565638227|FG000|Overall Study|Withdrawal by Subject|1|||
156696883|NCT04453202|565638228|FG001|Overall Study|Withdrawal by Subject|2|||
156696884|NCT04453202|565638229|FG002|Overall Study|Withdrawal by Subject|1|||
156696885|NCT04453202|565638230|FG003|Overall Study|Withdrawal by Subject|2|||
156696886|NCT04453202|565638231|FG004|Overall Study|Withdrawal by Subject|1|||
156696887|NCT04453202|565638232|FG005|Overall Study|Withdrawal by Subject|1|||
156696888|NCT04453202|565638233|FG006|Overall Study|Withdrawal by Subject|0|||
156696889|NCT04453202|565638234|FG007|Overall Study|Withdrawal by Subject|0|||
156696890|NCT04453202|565638235|FG008|Overall Study|Withdrawal by Subject|0|||
156696891|NCT04453202|565638236|FG009|Overall Study|Withdrawal by Subject|1|||
156696892|NCT04453202|565638237|FG010|Overall Study|Withdrawal by Subject|0|||
156696893|NCT04453202|565638227|FG000|Overall Study|Adverse Event|0|||
156696894|NCT04453202|565638228|FG001|Overall Study|Adverse Event|0|||
156871127|NCT02873702|566285969|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
156438328|NCT00439569|564695436|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
156438329|NCT00439569|564695436|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
156438330|NCT00439569|564695436|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
156438331|NCT02423798|564695437|FG000|Overall Study|Withdrawal by Subject|3|||
156438332|NCT01430611|564695441|FG000|Overall Study|Adverse Event|0|||
156438333|NCT01430611|564695442|FG001|Overall Study|Adverse Event|1|||
156438334|NCT01430611|564695441|FG000|Overall Study|Protocol Violation|1|||
156438335|NCT01430611|564695442|FG001|Overall Study|Protocol Violation|0|||
156438336|NCT01430611|564695441|FG000|Overall Study|Lost to Follow-up|1|||
156438337|NCT01430611|564695442|FG001|Overall Study|Lost to Follow-up|0|||
156438338|NCT01430611|564695441|FG000|Overall Study|Withdrawal by Subject|15|||
156438339|NCT01430611|564695442|FG001|Overall Study|Withdrawal by Subject|14|||
156438340|NCT01202955|564695443|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
156871128|NCT02873702|566285970|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
156871129|NCT02873702|566285971|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
156871130|NCT02873702|566285968|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
156871131|NCT02873702|566285969|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
156871132|NCT02873702|566285970|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
156871133|NCT02873702|566285971|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
156871134|NCT02873702|566285968|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
156871135|NCT02873702|566285969|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
156871136|NCT02873702|566285970|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
156871137|NCT02873702|566285971|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
156871138|NCT02873702|566285968|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
156871139|NCT02873702|566285969|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
156871140|NCT02873702|566285970|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
156871141|NCT02873702|566285971|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
156871142|NCT01229267|566285976|FG000|Overall Study|Adverse Event|4|||
156871143|NCT01229267|566285977|FG001|Overall Study|Adverse Event|6|||
156871144|NCT01229267|566285978|FG002|Overall Study|Adverse Event|3|||
156871145|NCT01229267|566285979|FG003|Overall Study|Adverse Event|2|||
156871146|NCT01229267|566285980|FG004|Overall Study|Adverse Event|10|||
156871147|NCT01229267|566285976|FG000|Overall Study|Death|40|||
156871148|NCT01229267|566285977|FG001|Overall Study|Death|37|||
156871149|NCT01229267|566285978|FG002|Overall Study|Death|35|||
156871150|NCT01229267|566285979|FG003|Overall Study|Death|13|||
156871151|NCT01229267|566285980|FG004|Overall Study|Death|103|||
156871152|NCT01229267|566285976|FG000|Overall Study|Withdrawal by Subject|23|||
156871153|NCT01229267|566285977|FG001|Overall Study|Withdrawal by Subject|22|||
156871154|NCT01229267|566285978|FG002|Overall Study|Withdrawal by Subject|32|||
156438341|NCT01202955|564695444|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
156696895|NCT04453202|565638229|FG002|Overall Study|Adverse Event|0|||
156696896|NCT04453202|565638230|FG003|Overall Study|Adverse Event|0|||
156696897|NCT04453202|565638231|FG004|Overall Study|Adverse Event|0|||
156438342|NCT02928224|564695445|FG000|Overall Study|Lost to Follow-up|1|||
156438343|NCT02928224|564695446|FG001|Overall Study|Lost to Follow-up|1|||
156696898|NCT04453202|565638232|FG005|Overall Study|Adverse Event|1|||
156696899|NCT04453202|565638233|FG006|Overall Study|Adverse Event|0|||
156696900|NCT04453202|565638234|FG007|Overall Study|Adverse Event|0|||
156696901|NCT04453202|565638235|FG008|Overall Study|Adverse Event|0|||
156871155|NCT01229267|566285979|FG003|Overall Study|Withdrawal by Subject|14|||
156871156|NCT01229267|566285980|FG004|Overall Study|Withdrawal by Subject|59|||
156696902|NCT04453202|565638236|FG009|Overall Study|Adverse Event|0|||
156790079|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
156790080|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
156790081|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
156790082|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
156790083|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
156790084|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
156790085|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
156790086|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
156790087|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
156790088|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
156790089|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
156790090|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
156790091|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
156790092|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
156790093|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
156790094|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
156438344|NCT02928224|564695447|FG002|Overall Study|Lost to Follow-up|3|||
156438345|NCT02928224|564695448|FG003|Overall Study|Lost to Follow-up|0|||
156438346|NCT02928224|564695445|FG000|Overall Study|Death|30|||
156438347|NCT02928224|564695446|FG001|Overall Study|Death|209|||
156438348|NCT02928224|564695447|FG002|Overall Study|Death|193|||
156438349|NCT02928224|564695448|FG003|Overall Study|Death|198|||
156438350|NCT02928224|564695445|FG000|Overall Study|Withdrawal by Subject|0|||
156438351|NCT02928224|564695446|FG001|Overall Study|Withdrawal by Subject|3|||
156438352|NCT02928224|564695447|FG002|Overall Study|Withdrawal by Subject|7|||
156438353|NCT02928224|564695448|FG003|Overall Study|Withdrawal by Subject|20|||
156438354|NCT02928224|564695445|FG000|Overall Study|Study participation terminated by sponsor|3|||
156438355|NCT02928224|564695446|FG001|Overall Study|Study participation terminated by sponsor|8|||
156438356|NCT02928224|564695447|FG002|Overall Study|Study participation terminated by sponsor|12|||
156438357|NCT02928224|564695448|FG003|Overall Study|Study participation terminated by sponsor|3|||
156438358|NCT02928224|564695445|FG000|Overall Study|Other|3|||
156438359|NCT02928224|564695446|FG001|Overall Study|Other|3|||
156438360|NCT02928224|564695447|FG002|Overall Study|Other|5|||
156438361|NCT02928224|564695448|FG003|Overall Study|Other|0|||
156438362|NCT01278394|564695449|FG000|Overall Study|Lost to Follow-up|1|||
156438363|NCT01943916|564695450|FG000|Overall Study|Technically invalid images|10|||
156438364|NCT01943916|564695450|FG000|Overall Study|Enrollment Failure|23|||
156438365|NCT01943916|564695450|FG000|Overall Study|Pilot Phase exclusion|100|||
156438366|NCT01943916|564695450|FG000|Overall Study|Quality Assurance Reader Fail|130|||
156438367|NCT01943916|564695450|FG000|Overall Study|Technical Failure|39|||
156530952|NCT02260882|565039807|FG000|Overall Study|Protocol Violation|0|||
156790095|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
156871157|NCT01229267|566285976|FG000|Overall Study|Protocol Violation|0|||
156871158|NCT01229267|566285977|FG001|Overall Study|Protocol Violation|1|||
156871159|NCT01229267|566285978|FG002|Overall Study|Protocol Violation|0|||
156871160|NCT01229267|566285979|FG003|Overall Study|Protocol Violation|0|||
156871161|NCT01229267|566285980|FG004|Overall Study|Protocol Violation|0|||
156871162|NCT01229267|566285976|FG000|Overall Study|Progressive disease|0|||
156871163|NCT01229267|566285977|FG001|Overall Study|Progressive disease|0|||
156871164|NCT01229267|566285978|FG002|Overall Study|Progressive disease|0|||
156871165|NCT01229267|566285979|FG003|Overall Study|Progressive disease|0|||
156790096|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
156790097|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
156790098|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
156790099|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
156790100|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
156790101|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
156790102|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
156871166|NCT01229267|566285980|FG004|Overall Study|Progressive disease|1|||
156871167|NCT01229267|566285976|FG000|Overall Study|Physician Decision|8|||
156871168|NCT01229267|566285977|FG001|Overall Study|Physician Decision|11|||
156871169|NCT01229267|566285978|FG002|Overall Study|Physician Decision|8|||
156871170|NCT01229267|566285979|FG003|Overall Study|Physician Decision|3|||
156871171|NCT01229267|566285980|FG004|Overall Study|Physician Decision|25|||
156871172|NCT01229267|566285976|FG000|Overall Study|Lost to Follow-up|6|||
156871173|NCT01229267|566285977|FG001|Overall Study|Lost to Follow-up|5|||
156871174|NCT01229267|566285978|FG002|Overall Study|Lost to Follow-up|8|||
156438368|NCT01943916|564695450|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
156438369|NCT01943916|564695450|FG000|Overall Study|No Truth Panel Review|38|||
156438370|NCT01943916|564695450|FG000|Overall Study|Protocol Deviation|1|||
156438371|NCT00919763|564695451|FG000|Overall Study|Adverse Event|7|||
156790103|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
156871175|NCT01229267|566285979|FG003|Overall Study|Lost to Follow-up|3|||
156871176|NCT01229267|566285980|FG004|Overall Study|Lost to Follow-up|22|||
156696903|NCT04453202|565638237|FG010|Overall Study|Adverse Event|0|||
156696904|NCT02615171|565638238|FG000|Overall Study|Lost to Follow-up|2|||
156696905|NCT02615171|565638239|FG001|Overall Study|Lost to Follow-up|1|||
156696906|NCT00456495|565638243|FG000|Overall Study|Physician Decision|2|||
156696907|NCT01940497|565638244|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
156696908|NCT01940497|565638245|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
156696909|NCT01940497|565638244|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
156696910|NCT01940497|565638245|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
156696911|NCT01940497|565638244|FG000|Overall Study|Violation of Entry Criteria|1|||
156696912|NCT01940497|565638245|FG001|Overall Study|Violation of Entry Criteria|1|||
156331138|NCT05171777|564311951|FG000|Treatment Crossover Period|Reason not Specified|1|||
156331139|NCT05171777|564311952|FG001|Treatment Crossover Period|Reason not Specified|1|||
156331140|NCT05171777|564311953|FG002|Treatment Crossover Period|Reason not Specified|0|||
156331141|NCT05171777|564311954|FG003|Treatment Crossover Period|Reason not Specified|0|||
156331142|NCT05171777|564311951|FG000|Treatment Crossover Period|Physician Decision|0|||
156331143|NCT05171777|564311952|FG001|Treatment Crossover Period|Physician Decision|1|||
156331144|NCT05171777|564311953|FG002|Treatment Crossover Period|Physician Decision|0|||
156331145|NCT05171777|564311954|FG003|Treatment Crossover Period|Physician Decision|0|||
156331146|NCT05171777|564311951|FG000|Treatment Crossover Period|Progressive Disease|14|||
156331147|NCT05171777|564311952|FG001|Treatment Crossover Period|Progressive Disease|10|||
156331148|NCT05171777|564311953|FG002|Treatment Crossover Period|Progressive Disease|0|||
156331149|NCT05171777|564311954|FG003|Treatment Crossover Period|Progressive Disease|0|||
156331150|NCT05171777|564311951|FG000|Treatment Crossover Period|Protocol Violation|0|||
156331151|NCT05171777|564311952|FG001|Treatment Crossover Period|Protocol Violation|2|||
156331152|NCT05171777|564311953|FG002|Treatment Crossover Period|Protocol Violation|0|||
156331153|NCT05171777|564311954|FG003|Treatment Crossover Period|Protocol Violation|0|||
156331154|NCT05171777|564311951|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
156331155|NCT05171777|564311952|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
156331156|NCT05171777|564311953|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
156438372|NCT00919763|564695452|FG001|Overall Study|Adverse Event|1|||
156438373|NCT00919763|564695451|FG000|Overall Study|Lost to Follow-up|1|||
156696913|NCT01940497|565638244|FG000|Overall Study|Refused Treatment|1|||
156696914|NCT01940497|565638245|FG001|Overall Study|Refused Treatment|3|||
156696915|NCT01940497|565638244|FG000|Overall Study|Withdrew Consent|6|||
156696916|NCT01940497|565638245|FG001|Overall Study|Withdrew Consent|2|||
156790104|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
156790105|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
156790106|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
156790107|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
156790108|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
156790109|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
156790110|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
156790111|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
156790112|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
156790113|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
156790114|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
156790115|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
156790116|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
156790117|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
156790118|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
156790119|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
156790120|NCT03280615|565983686|FG000|Overall Study|Lost to Follow-up|1|||
156790121|NCT03280615|565983687|FG001|Overall Study|Lost to Follow-up|2|||
156790122|NCT03280615|565983686|FG000|Overall Study|Adverse Event|1|||
156790123|NCT03280615|565983687|FG001|Overall Study|Adverse Event|1|||
156790124|NCT03280615|565983686|FG000|Overall Study|Withdrawal by Subject|2|||
156790125|NCT03280615|565983687|FG001|Overall Study|Withdrawal by Subject|2|||
156790126|NCT00004228|565983692|FG000|Overall Study|Adverse Event|0|||
156790127|NCT00004228|565983693|FG001|Overall Study|Adverse Event|1|||
156790128|NCT00004228|565983694|FG002|Overall Study|Adverse Event|0|||
156790129|NCT00004228|565983695|FG003|Overall Study|Adverse Event|0|||
156790130|NCT00004228|565983696|FG004|Overall Study|Adverse Event|1|||
156790131|NCT00004228|565983697|FG005|Overall Study|Adverse Event|0|||
156790132|NCT00004228|565983698|FG006|Overall Study|Adverse Event|0|||
156790133|NCT00004228|565983692|FG000|Overall Study|Death|0|||
156790134|NCT00004228|565983693|FG001|Overall Study|Death|1|||
156790135|NCT00004228|565983694|FG002|Overall Study|Death|2|||
156790136|NCT00004228|565983695|FG003|Overall Study|Death|0|||
156790137|NCT00004228|565983696|FG004|Overall Study|Death|1|||
156790138|NCT00004228|565983697|FG005|Overall Study|Death|0|||
156790139|NCT00004228|565983698|FG006|Overall Study|Death|0|||
156790140|NCT00004228|565983692|FG000|Overall Study|Lack of Efficacy|1|||
156790141|NCT00004228|565983693|FG001|Overall Study|Lack of Efficacy|6|||
156438374|NCT00919763|564695452|FG001|Overall Study|Lost to Follow-up|0|||
156438375|NCT00919763|564695451|FG000|Overall Study|Protocol Violation|1|||
156438376|NCT00919763|564695452|FG001|Overall Study|Protocol Violation|1|||
156438377|NCT00919763|564695451|FG000|Overall Study|Withdrawal by Subject|3|||
156438378|NCT00919763|564695452|FG001|Overall Study|Withdrawal by Subject|1|||
156438379|NCT00919763|564695451|FG000|Overall Study|Non-compliance|0|||
156438380|NCT00919763|564695452|FG001|Overall Study|Non-compliance|1|||
156438381|NCT04740164|564695453|FG000|Overall Study|Lack of Efficacy|4|||
156438382|NCT04740164|564695454|FG001|Overall Study|Lack of Efficacy|0|||
156438383|NCT04740164|564695453|FG000|Overall Study|Physician Decision|3|||
156438384|NCT04740164|564695454|FG001|Overall Study|Physician Decision|3|||
156438385|NCT00442117|564695458|FG000|Overall Study|Adverse Event|3|||
156438386|NCT00442117|564695459|FG001|Overall Study|Adverse Event|2|||
156438387|NCT00442117|564695458|FG000|Overall Study|Lack of Efficacy|2|||
156438388|NCT00442117|564695459|FG001|Overall Study|Lack of Efficacy|6|||
156438389|NCT00442117|564695458|FG000|Overall Study|Lost to Follow-up|1|||
156438390|NCT00442117|564695459|FG001|Overall Study|Lost to Follow-up|2|||
156438391|NCT00442117|564695458|FG000|Overall Study|Withdrawal by Subject|2|||
156438392|NCT00442117|564695459|FG001|Overall Study|Withdrawal by Subject|2|||
156438393|NCT00442117|564695458|FG000|Overall Study|Major Deviation|25|||
156438394|NCT00442117|564695459|FG001|Overall Study|Major Deviation|20|||
156438395|NCT00442117|564695458|FG000|Overall Study|Non compliance with protocol|3|||
156438396|NCT00442117|564695459|FG001|Overall Study|Non compliance with protocol|5|||
156438397|NCT00442117|564695458|FG000|Overall Study|Met Withdrawal Criteria|2|||
156438398|NCT00442117|564695459|FG001|Overall Study|Met Withdrawal Criteria|1|||
156438399|NCT00206375|564695460|FG000|Overall Study|Lost to Follow-up|1|||
156438400|NCT00206375|564695461|FG001|Overall Study|Lost to Follow-up|0|||
156438401|NCT00206375|564695462|FG002|Overall Study|Lost to Follow-up|0|||
156438402|NCT00206375|564695460|FG000|Overall Study|Withdrawal by Subject|2|||
156438403|NCT00206375|564695461|FG001|Overall Study|Withdrawal by Subject|1|||
156438404|NCT00206375|564695462|FG002|Overall Study|Withdrawal by Subject|3|||
156438405|NCT00206375|564695460|FG000|Overall Study|Study terminated due to lack of funds|0|||
156438406|NCT00206375|564695461|FG001|Overall Study|Study terminated due to lack of funds|1|||
156438407|NCT00206375|564695462|FG002|Overall Study|Study terminated due to lack of funds|1|||
156438408|NCT01353963|564695463|FG000|Overall Study|Adverse Event|2|||
156438409|NCT04789408|564695464|FG000|Overall Study|Death|4|||
156438410|NCT04789408|564695465|FG001|Overall Study|Death|3|||
156438411|NCT04789408|564695466|FG002|Overall Study|Death|6|||
156438412|NCT04789408|564695464|FG000|Overall Study|Did not meet eligibility criteria|1|||
156438413|NCT04789408|564695465|FG001|Overall Study|Did not meet eligibility criteria|0|||
156438414|NCT04789408|564695466|FG002|Overall Study|Did not meet eligibility criteria|0|||
156438415|NCT04789408|564695464|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
156438416|NCT04789408|564695465|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
156438417|NCT04789408|564695466|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
156438418|NCT01420549|564695467|FG000|Overall Study|Adverse Event|1|||
156438419|NCT01420549|564695468|FG001|Overall Study|Adverse Event|1|||
156438420|NCT01420549|564695467|FG000|Overall Study|Lost to Follow-up|2|||
156438421|NCT01420549|564695468|FG001|Overall Study|Lost to Follow-up|2|||
156438422|NCT01420549|564695467|FG000|Overall Study|Protocol Violation|0|||
156438423|NCT01420549|564695468|FG001|Overall Study|Protocol Violation|1|||
156438424|NCT01420549|564695467|FG000|Overall Study|Non-adherence to medication|4|||
156438425|NCT01420549|564695468|FG001|Overall Study|Non-adherence to medication|1|||
156438426|NCT02763319|564696976|FG000|Overall Study|Adverse Event|12|||
156438427|NCT02763319|564696977|FG001|Overall Study|Adverse Event|3|||
156438428|NCT02763319|564696976|FG000|Overall Study|Death|123|||
156438429|NCT02763319|564696977|FG001|Overall Study|Death|123|||
156438430|NCT02763319|564696976|FG000|Overall Study|Lost to Follow-up|6|||
156438431|NCT02763319|564696977|FG001|Overall Study|Lost to Follow-up|7|||
156438432|NCT02763319|564696976|FG000|Overall Study|Noncompliance with Study Drug|2|||
156438433|NCT02763319|564696977|FG001|Overall Study|Noncompliance with Study Drug|0|||
156438434|NCT02763319|564696976|FG000|Overall Study|"Captured as Other in Database"|29|||
156438435|NCT02763319|564696977|FG001|Overall Study|"Captured as Other in Database"|34|||
156438436|NCT02763319|564696976|FG000|Overall Study|Physician Decision|1|||
156438437|NCT02763319|564696977|FG001|Overall Study|Physician Decision|7|||
156438438|NCT02763319|564696976|FG000|Overall Study|Progressive Disease|24|||
156438439|NCT02763319|564696977|FG001|Overall Study|Progressive Disease|27|||
156438440|NCT02763319|564696976|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
156438441|NCT02763319|564696977|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
156438442|NCT02763319|564696976|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
156438443|NCT02763319|564696977|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
156438444|NCT02763319|564696976|FG000|Overall Study|Withdrawal by Subject|26|||
156438445|NCT02763319|564696977|FG001|Overall Study|Withdrawal by Subject|25|||
156438446|NCT00840177|564696980|FG000|Overall Study|Adverse Event|5|||
156438447|NCT00840177|564696981|FG001|Overall Study|Adverse Event|1|||
156438448|NCT00840177|564696982|FG002|Overall Study|Adverse Event|1|||
156696917|NCT01940497|565638244|FG000|Overall Study|Administrative/Other|1|||
156696918|NCT01940497|565638245|FG001|Overall Study|Administrative/Other|1|||
156696919|NCT03123861|565638246|FG000|Overall Study|Protocol Violation|1|||
156696920|NCT03123861|565638247|FG001|Overall Study|Protocol Violation|1|||
156696921|NCT03123861|565638246|FG000|Overall Study|Withdrawal by Subject|2|||
156696922|NCT03123861|565638247|FG001|Overall Study|Withdrawal by Subject|2|||
156696923|NCT06218823|565640797|FG000|Overall Study|Death|3|||
156438449|NCT00840177|564696980|FG000|Overall Study|Refusal unrelated to adverse events|1|||
156696924|NCT06218823|565640798|FG001|Overall Study|Death|0|||
156696925|NCT06218823|565640797|FG000|Overall Study|Lost to Follow-up|0|||
156696926|NCT06218823|565640798|FG001|Overall Study|Lost to Follow-up|2|||
156696927|NCT06077487|565640799|FG000|Overall Study|Withdrawal by Subject|0|||
156696928|NCT06077487|565640800|FG001|Overall Study|Withdrawal by Subject|1|||
156696929|NCT05101486|565640801|FG000|Overall Study|Death|1|||
156696930|NCT05101486|565640802|FG001|Overall Study|Death|0|||
156696931|NCT05101486|565640803|FG002|Overall Study|Death|1|||
156696932|NCT05101486|565640801|FG000|Overall Study|Lost to Follow-up|12|||
156696933|NCT05101486|565640802|FG001|Overall Study|Lost to Follow-up|8|||
156696934|NCT05101486|565640803|FG002|Overall Study|Lost to Follow-up|17|||
156696935|NCT05101486|565640801|FG000|Overall Study|Physician Decision|1|||
156696936|NCT05101486|565640802|FG001|Overall Study|Physician Decision|0|||
156696937|NCT05101486|565640803|FG002|Overall Study|Physician Decision|0|||
156696938|NCT05101486|565640801|FG000|Overall Study|Protocol Violation|0|||
156696939|NCT05101486|565640802|FG001|Overall Study|Protocol Violation|0|||
156696940|NCT05101486|565640803|FG002|Overall Study|Protocol Violation|1|||
156696941|NCT05101486|565640801|FG000|Overall Study|Withdrawal by Subject|5|||
156696942|NCT05101486|565640802|FG001|Overall Study|Withdrawal by Subject|2|||
156696943|NCT05101486|565640803|FG002|Overall Study|Withdrawal by Subject|4|||
156696944|NCT05101486|565640801|FG000|Overall Study|Randomized but not vaccinated|1|||
156696945|NCT05101486|565640802|FG001|Overall Study|Randomized but not vaccinated|1|||
156696946|NCT05101486|565640803|FG002|Overall Study|Randomized but not vaccinated|1|||
156696947|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
156696948|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
156696949|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
156696950|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
156696951|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
156696952|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
156696953|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
156696954|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
156696955|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
156696956|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
156696957|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
156696958|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
156696959|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
156696960|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
156696961|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
156696962|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Other|3|||
156696963|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Other|0|||
156696964|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Other|0|||
156696965|NCT02788045|565640804|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
156696966|NCT02788045|565640805|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
156696967|NCT02788045|565640806|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
156696968|NCT02788045|565640804|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
156696969|NCT02788045|565640805|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
156696970|NCT02788045|565640806|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
156696971|NCT02788045|565640804|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
156696972|NCT02788045|565640805|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
156696973|NCT02788045|565640806|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
156696974|NCT04394351|565640807|FG000|Part A (16 Weeks)|Adverse Event|1|||
156696975|NCT04394351|565640808|FG001|Part A (16 Weeks)|Adverse Event|0|||
156696976|NCT04394351|565640809|FG002|Part A (16 Weeks)|Adverse Event|0|||
156696977|NCT04394351|565640810|FG003|Part A (16 Weeks)|Adverse Event|0|||
156696978|NCT04394351|565640811|FG004|Part A (16 Weeks)|Adverse Event|0|||
156696979|NCT04394351|565640812|FG005|Part A (16 Weeks)|Adverse Event|0|||
156696980|NCT04394351|565640813|FG006|Part A (16 Weeks)|Adverse Event|0|||
156696981|NCT04394351|565640814|FG007|Part A (16 Weeks)|Adverse Event|0|||
156696982|NCT04394351|565640807|FG000|Part A (16 Weeks)|Physician Decision|0|||
156696983|NCT04394351|565640808|FG001|Part A (16 Weeks)|Physician Decision|1|||
156696984|NCT04394351|565640809|FG002|Part A (16 Weeks)|Physician Decision|0|||
156696985|NCT04394351|565640810|FG003|Part A (16 Weeks)|Physician Decision|0|||
156696986|NCT04394351|565640811|FG004|Part A (16 Weeks)|Physician Decision|0|||
156696987|NCT04394351|565640812|FG005|Part A (16 Weeks)|Physician Decision|0|||
156696988|NCT04394351|565640813|FG006|Part A (16 Weeks)|Physician Decision|0|||
156696989|NCT04394351|565640814|FG007|Part A (16 Weeks)|Physician Decision|0|||
156696990|NCT04394351|565640807|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696991|NCT04394351|565640808|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
156696992|NCT04394351|565640809|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696993|NCT04394351|565640810|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696994|NCT04394351|565640811|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696995|NCT04394351|565640812|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696996|NCT04394351|565640813|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
156790142|NCT00004228|565983694|FG002|Overall Study|Lack of Efficacy|5|||
156790143|NCT00004228|565983695|FG003|Overall Study|Lack of Efficacy|3|||
156790144|NCT00004228|565983696|FG004|Overall Study|Lack of Efficacy|9|||
156438450|NCT00840177|564696981|FG001|Overall Study|Refusal unrelated to adverse events|0|||
156438451|NCT00840177|564696982|FG002|Overall Study|Refusal unrelated to adverse events|1|||
156438452|NCT00840177|564696980|FG000|Overall Study|Progression/relapse|2|||
156438453|NCT00840177|564696981|FG001|Overall Study|Progression/relapse|0|||
156438454|NCT00840177|564696982|FG002|Overall Study|Progression/relapse|0|||
156438455|NCT00840177|564696980|FG000|Overall Study|Death|4|||
156438456|NCT00840177|564696981|FG001|Overall Study|Death|5|||
156438457|NCT00840177|564696982|FG002|Overall Study|Death|5|||
156438458|NCT00840177|564696980|FG000|Overall Study|not protocol specified|6|||
156438459|NCT00840177|564696981|FG001|Overall Study|not protocol specified|3|||
156438460|NCT00840177|564696982|FG002|Overall Study|not protocol specified|0|||
156438461|NCT00840177|564696980|FG000|Overall Study|Ineligible|0|||
156438462|NCT00840177|564696981|FG001|Overall Study|Ineligible|0|||
156438463|NCT00840177|564696982|FG002|Overall Study|Ineligible|3|||
156438464|NCT00840177|564696980|FG000|Overall Study|Did not start treatment|0|||
156438465|NCT00840177|564696981|FG001|Overall Study|Did not start treatment|0|||
156438466|NCT00840177|564696982|FG002|Overall Study|Did not start treatment|1|||
156438467|NCT03345901|564696986|FG000|Overall Study|The study was terminated|18|||
156438468|NCT00925587|564696987|FG000|Overall Study|Protocol Specified Criteria|6|||
156438469|NCT00925587|564696988|FG001|Overall Study|Protocol Specified Criteria|6|||
156438470|NCT00925587|564696987|FG000|Overall Study|Physician Decision|4|||
156438471|NCT00925587|564696988|FG001|Overall Study|Physician Decision|1|||
156438472|NCT00925587|564696987|FG000|Overall Study|Protocol Violation|6|||
156438473|NCT00925587|564696988|FG001|Overall Study|Protocol Violation|4|||
156438474|NCT00925587|564696987|FG000|Overall Study|Withdrawal by Subject|9|||
156438475|NCT00925587|564696988|FG001|Overall Study|Withdrawal by Subject|6|||
156438476|NCT00925587|564696987|FG000|Overall Study|Death|5|||
156438477|NCT00925587|564696988|FG001|Overall Study|Death|5|||
156438478|NCT00925587|564696987|FG000|Overall Study|Adverse Event|6|||
156438479|NCT00925587|564696988|FG001|Overall Study|Adverse Event|2|||
156438480|NCT00925587|564696987|FG000|Overall Study|Lost to Follow-up|0|||
156438481|NCT00925587|564696988|FG001|Overall Study|Lost to Follow-up|1|||
156438482|NCT00414544|564696989|FG000|Overall Study|Lost to Follow-up|14|||
156438483|NCT01318382|564696991|FG000|Overall Study|Physician Decision|2|||
156438484|NCT01318382|564696991|FG000|Overall Study|Device Malfunction|10|||
156438485|NCT01318382|564696991|FG000|Overall Study|Protocol Violation|1|||
156438486|NCT01308567|564696994|FG000|Overall Study|Lost to Follow-up|2|||
156438487|NCT01308567|564696995|FG001|Overall Study|Lost to Follow-up|4|||
156438488|NCT01308567|564696996|FG002|Overall Study|Lost to Follow-up|4|||
156438489|NCT01571596|564696999|FG000|Overall Study|Adverse Event|2|||
156438490|NCT01571596|564697000|FG001|Overall Study|Adverse Event|0|||
156438491|NCT01571596|564697001|FG002|Overall Study|Adverse Event|0|||
156438492|NCT01571596|564696999|FG000|Overall Study|Study Terminated by the Sponsor|0|||
156438493|NCT01571596|564697000|FG001|Overall Study|Study Terminated by the Sponsor|1|||
156438494|NCT01571596|564697001|FG002|Overall Study|Study Terminated by the Sponsor|1|||
156438495|NCT00585052|564697008|FG000|Overall Study|Withdrawal by Subject|1|||
156438496|NCT04425863|564697009|FG000|Overall Study|Death|0|||
156438497|NCT04425863|564697010|FG001|Overall Study|Death|0|||
156438498|NCT04425863|564697011|FG002|Overall Study|Death|1|||
156438499|NCT00277355|564697015|FG000|Overall Study|Withdrawal by Subject|3|||
156438500|NCT00277355|564697016|FG001|Overall Study|Withdrawal by Subject|3|||
156438501|NCT00277355|564697015|FG000|Overall Study|Lost to Follow-up|2|||
156438502|NCT00277355|564697016|FG001|Overall Study|Lost to Follow-up|2|||
156438503|NCT00277355|564697015|FG000|Overall Study|Adverse Event|5|||
156438504|NCT00277355|564697016|FG001|Overall Study|Adverse Event|0|||
156438505|NCT00277355|564697015|FG000|Overall Study|Death|3|||
156696997|NCT04394351|565640814|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696998|NCT04394351|565640807|FG000|Part B (36 Weeks)|Adverse Event|0|||
156438506|NCT00277355|564697016|FG001|Overall Study|Death|0|||
156438507|NCT00277355|564697015|FG000|Overall Study|Physician Decision|1|||
156438508|NCT00277355|564697016|FG001|Overall Study|Physician Decision|0|||
156438509|NCT02918279|564697029|FG000|Overall Study|Lost to Follow-up|3|||
156438510|NCT02918279|564697030|FG001|Overall Study|Lost to Follow-up|6|||
156438511|NCT02918279|564697029|FG000|Overall Study|Withdrawal by Subject|5|||
156438512|NCT02918279|564697030|FG001|Overall Study|Withdrawal by Subject|15|||
156438513|NCT02918279|564697029|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156438514|NCT02918279|564697030|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156438515|NCT02918279|564697029|FG000|Overall Study|Other|3|||
156696999|NCT04394351|565640808|FG001|Part B (36 Weeks)|Adverse Event|0|||
156697000|NCT04394351|565640809|FG002|Part B (36 Weeks)|Adverse Event|0|||
156697001|NCT04394351|565640810|FG003|Part B (36 Weeks)|Adverse Event|0|||
156697002|NCT04394351|565640811|FG004|Part B (36 Weeks)|Adverse Event|0|||
156697003|NCT04394351|565640812|FG005|Part B (36 Weeks)|Adverse Event|0|||
156697004|NCT04394351|565640813|FG006|Part B (36 Weeks)|Adverse Event|1|||
156697005|NCT04394351|565640814|FG007|Part B (36 Weeks)|Adverse Event|0|||
156697006|NCT04394351|565640807|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697007|NCT04394351|565640808|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697008|NCT04394351|565640809|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697009|NCT04394351|565640810|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697010|NCT04394351|565640811|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697011|NCT04394351|565640812|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697012|NCT04394351|565640813|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697013|NCT04394351|565640814|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
156697014|NCT04394351|565640807|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697015|NCT04394351|565640808|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697016|NCT04394351|565640809|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697017|NCT04394351|565640810|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697018|NCT04394351|565640811|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697019|NCT04394351|565640812|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697020|NCT04394351|565640813|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697021|NCT04394351|565640814|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
156697022|NCT04394351|565640807|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697023|NCT04394351|565640808|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697024|NCT04394351|565640809|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156438516|NCT02918279|564697030|FG001|Overall Study|Other|1|||
156697025|NCT04394351|565640810|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697026|NCT04394351|565640811|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697027|NCT04394351|565640812|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697028|NCT04394351|565640813|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697029|NCT04394351|565640814|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
156697030|NCT04394351|565640807|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697031|NCT04394351|565640808|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697032|NCT04394351|565640809|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697033|NCT04394351|565640810|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697034|NCT04394351|565640811|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697035|NCT04394351|565640812|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697036|NCT04394351|565640813|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697037|NCT04394351|565640814|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
156697038|NCT03653507|565640815|FG000|Overall Study|Miscellaneous|28|||
156438517|NCT00869258|564697031|FG000|Overall Study|Physician Decision|1|||
156438518|NCT02888080|564697032|FG000|Overall Study|Subject / Guardian decision|1|||
156697039|NCT03653507|565640816|FG001|Overall Study|Miscellaneous|19|||
156697040|NCT03653507|565640815|FG000|Overall Study|Withdrawal by Subject|37|||
156697041|NCT03653507|565640816|FG001|Overall Study|Withdrawal by Subject|22|||
156697042|NCT03653507|565640815|FG000|Overall Study|Protocol Deviation|2|||
156697043|NCT03653507|565640816|FG001|Overall Study|Protocol Deviation|1|||
156697044|NCT03653507|565640815|FG000|Overall Study|Progressive disease|117|||
156697045|NCT03653507|565640816|FG001|Overall Study|Progressive disease|168|||
156697046|NCT03653507|565640815|FG000|Overall Study|Lost to Follow-up|1|||
156697047|NCT03653507|565640816|FG001|Overall Study|Lost to Follow-up|1|||
156697048|NCT03653507|565640815|FG000|Overall Study|Death|25|||
156697049|NCT03653507|565640816|FG001|Overall Study|Death|22|||
156697050|NCT03653507|565640815|FG000|Overall Study|Adverse Event|35|||
156697051|NCT03653507|565640816|FG001|Overall Study|Adverse Event|14|||
156697052|NCT01288053|565640817|FG000|Overall Study|Death|1|||
156697053|NCT03188666|565640818|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
156697054|NCT03188666|565640819|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
156697055|NCT03188666|565640820|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
156697056|NCT03188666|565640821|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
156697057|NCT03188666|565640818|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
156438519|NCT02888080|564697033|FG001|Overall Study|Subject / Guardian decision|3|||
156697058|NCT03188666|565640819|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
156697059|NCT03188666|565640820|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
156697060|NCT03188666|565640821|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
156438520|NCT02888080|564697032|FG000|Overall Study|New Therapy for study indication|1|||
156438521|NCT02888080|564697033|FG001|Overall Study|New Therapy for study indication|0|||
156438522|NCT02888080|564697032|FG000|Overall Study|Lack of Efficacy|0|||
156697061|NCT03188666|565640818|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
156697062|NCT03188666|565640819|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
156697063|NCT03188666|565640820|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
156697064|NCT03188666|565640821|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
156697065|NCT03188666|565640818|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
156697066|NCT03188666|565640819|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
156697067|NCT03188666|565640820|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
156697068|NCT03188666|565640821|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
156697069|NCT00144781|565640822|FG000|Overall Study|Adverse Event|0|||
156438523|NCT02888080|564697033|FG001|Overall Study|Lack of Efficacy|1|||
156438524|NCT02888080|564697032|FG000|Overall Study|Adverse Event|0|||
156438525|NCT02888080|564697033|FG001|Overall Study|Adverse Event|1|||
156438526|NCT01641198|564697034|FG000|After 12 Months of Function|Lost to Follow-up|3|||
156438527|NCT01641198|564697035|FG001|After 12 Months of Function|Lost to Follow-up|2|||
156438528|NCT01641198|564697036|FG002|After 12 Months of Function|Lost to Follow-up|2|||
156438529|NCT01641198|564697034|FG000|After 12 Months of Function|Protocol Violation|1|||
156438530|NCT01641198|564697035|FG001|After 12 Months of Function|Protocol Violation|0|||
156438531|NCT01641198|564697036|FG002|After 12 Months of Function|Protocol Violation|0|||
156438532|NCT01641198|564697034|FG000|After 12 Months of Function|Adverse Event|0|||
156438533|NCT01641198|564697035|FG001|After 12 Months of Function|Adverse Event|1|||
156438534|NCT01641198|564697036|FG002|After 12 Months of Function|Adverse Event|0|||
156438535|NCT01641198|564697034|FG000|After 24 Months of Function|Lost to Follow-up|4|||
156438536|NCT01641198|564697035|FG001|After 24 Months of Function|Lost to Follow-up|9|||
156438537|NCT01641198|564697036|FG002|After 24 Months of Function|Lost to Follow-up|6|||
156530953|NCT02260882|565039808|FG001|Overall Study|Protocol Violation|1|||
156530954|NCT02119325|565039809|FG000|Washout Period 1|Adverse Event|0|||
156530955|NCT02119325|565039810|FG001|Washout Period 1|Adverse Event|1|||
156530956|NCT00954174|565039819|FG000|Overall Study|Adverse Event|28|||
156530957|NCT00954174|565039820|FG001|Overall Study|Adverse Event|23|||
156530958|NCT00954174|565039821|FG002|Overall Study|Adverse Event|4|||
156530959|NCT00954174|565039822|FG003|Overall Study|Adverse Event|9|||
156530960|NCT00954174|565039819|FG000|Overall Study|Death|4|||
156438538|NCT01641198|564697034|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
156438539|NCT01641198|564697035|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
156438540|NCT01641198|564697036|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
156438541|NCT01641198|564697034|FG000|At 15-20 Years of Function|Death|1|||
156438542|NCT01641198|564697035|FG001|At 15-20 Years of Function|Death|0|||
156438543|NCT01641198|564697036|FG002|At 15-20 Years of Function|Death|1|||
156438544|NCT03844269|564697043|FG000|Overall Study|Withdrawal pre-intervention|1|||
156438545|NCT03844269|564697043|FG000|Overall Study|Did not complete the intervention|2|||
156697070|NCT00144781|565640823|FG001|Overall Study|Adverse Event|1|||
156697071|NCT00144781|565640824|FG002|Overall Study|Adverse Event|0|||
156697072|NCT00144781|565640825|FG003|Overall Study|Adverse Event|0|||
156697073|NCT00144781|565640822|FG000|Overall Study|Non-compliant|0|||
156790145|NCT00004228|565983697|FG005|Overall Study|Lack of Efficacy|8|||
156790146|NCT00004228|565983698|FG006|Overall Study|Lack of Efficacy|4|||
156790147|NCT00004228|565983692|FG000|Overall Study|Lost to Follow-up|0|||
156790148|NCT00004228|565983693|FG001|Overall Study|Lost to Follow-up|0|||
156790149|NCT00004228|565983694|FG002|Overall Study|Lost to Follow-up|1|||
156790150|NCT00004228|565983695|FG003|Overall Study|Lost to Follow-up|0|||
156790151|NCT00004228|565983696|FG004|Overall Study|Lost to Follow-up|0|||
156790152|NCT00004228|565983697|FG005|Overall Study|Lost to Follow-up|0|||
156790153|NCT00004228|565983698|FG006|Overall Study|Lost to Follow-up|0|||
156790154|NCT00004228|565983692|FG000|Overall Study|Physician Decision|1|||
156790155|NCT00004228|565983693|FG001|Overall Study|Physician Decision|0|||
156790156|NCT00004228|565983694|FG002|Overall Study|Physician Decision|3|||
156790157|NCT00004228|565983695|FG003|Overall Study|Physician Decision|2|||
156790158|NCT00004228|565983696|FG004|Overall Study|Physician Decision|1|||
156790159|NCT00004228|565983697|FG005|Overall Study|Physician Decision|1|||
156790160|NCT00004228|565983698|FG006|Overall Study|Physician Decision|1|||
156790161|NCT00004228|565983692|FG000|Overall Study|Protocol Violation|0|||
156790162|NCT00004228|565983693|FG001|Overall Study|Protocol Violation|5|||
156790163|NCT00004228|565983694|FG002|Overall Study|Protocol Violation|2|||
156790164|NCT00004228|565983695|FG003|Overall Study|Protocol Violation|1|||
156790165|NCT00004228|565983696|FG004|Overall Study|Protocol Violation|1|||
156790166|NCT00004228|565983697|FG005|Overall Study|Protocol Violation|2|||
156790167|NCT00004228|565983698|FG006|Overall Study|Protocol Violation|0|||
156790168|NCT00004228|565983692|FG000|Overall Study|Withdrawal by Subject|3|||
156790169|NCT00004228|565983693|FG001|Overall Study|Withdrawal by Subject|0|||
156790170|NCT00004228|565983694|FG002|Overall Study|Withdrawal by Subject|1|||
156790171|NCT00004228|565983695|FG003|Overall Study|Withdrawal by Subject|0|||
156790172|NCT00004228|565983696|FG004|Overall Study|Withdrawal by Subject|2|||
156790173|NCT00004228|565983697|FG005|Overall Study|Withdrawal by Subject|1|||
156790174|NCT00004228|565983698|FG006|Overall Study|Withdrawal by Subject|2|||
156790175|NCT00004228|565983692|FG000|Overall Study|Other|0|||
156790176|NCT00004228|565983693|FG001|Overall Study|Other|0|||
156790177|NCT00004228|565983694|FG002|Overall Study|Other|1|||
156790178|NCT00004228|565983695|FG003|Overall Study|Other|0|||
156790179|NCT00004228|565983696|FG004|Overall Study|Other|0|||
156790180|NCT00004228|565983697|FG005|Overall Study|Other|0|||
156871177|NCT03085797|566285983|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
156790181|NCT00004228|565983698|FG006|Overall Study|Other|0|||
156790182|NCT00004228|565983692|FG000|Overall Study|ineligible|4|||
156790183|NCT00004228|565983693|FG001|Overall Study|ineligible|2|||
156790184|NCT00004228|565983694|FG002|Overall Study|ineligible|4|||
156790185|NCT00004228|565983695|FG003|Overall Study|ineligible|1|||
156790186|NCT00004228|565983696|FG004|Overall Study|ineligible|1|||
156790187|NCT00004228|565983697|FG005|Overall Study|ineligible|2|||
156790188|NCT00004228|565983698|FG006|Overall Study|ineligible|5|||
156790189|NCT02457546|565983703|FG000|Overall Study|Other reasons|4|||
156790190|NCT02457546|565983704|FG001|Overall Study|Other reasons|1|||
156790191|NCT02457546|565983703|FG000|Overall Study|Refused to complete study/procedures|1|||
156790192|NCT02457546|565983704|FG001|Overall Study|Refused to complete study/procedures|1|||
156790193|NCT02457546|565983703|FG000|Overall Study|Lost to Follow-up|4|||
156790194|NCT02457546|565983704|FG001|Overall Study|Lost to Follow-up|1|||
156790195|NCT02457546|565983703|FG000|Overall Study|Adverse Event|0|||
156790196|NCT02457546|565983704|FG001|Overall Study|Adverse Event|1|||
156790197|NCT01897896|565983705|FG000|Overall Study|Death|1|||
156790198|NCT01897896|565983706|FG001|Overall Study|Death|0|||
156790199|NCT01897896|565983705|FG000|Overall Study|Adverse Event|11|||
156790200|NCT01897896|565983706|FG001|Overall Study|Adverse Event|1|||
156790201|NCT01897896|565983705|FG000|Overall Study|Lost to Follow-up|1|||
156790202|NCT01897896|565983706|FG001|Overall Study|Lost to Follow-up|0|||
156790203|NCT01897896|565983705|FG000|Overall Study|Non-compliance with study drug dosing|1|||
156790204|NCT01897896|565983706|FG001|Overall Study|Non-compliance with study drug dosing|1|||
156790205|NCT01897896|565983705|FG000|Overall Study|Withdrawal by Subject|7|||
156790206|NCT01897896|565983706|FG001|Overall Study|Withdrawal by Subject|1|||
156790207|NCT01897896|565983705|FG000|Overall Study|Require drug that interfere with study|1|||
156790208|NCT01897896|565983706|FG001|Overall Study|Require drug that interfere with study|4|||
156790209|NCT01897896|565983705|FG000|Overall Study|Protocol Violation|1|||
156790210|NCT01897896|565983706|FG001|Overall Study|Protocol Violation|1|||
156790211|NCT01897896|565983705|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
156790212|NCT01897896|565983706|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
156790213|NCT01897896|565983705|FG000|Overall Study|Caregiver can no longer participate|0|||
156790214|NCT01897896|565983706|FG001|Overall Study|Caregiver can no longer participate|2|||
156790215|NCT01897896|565983705|FG000|Overall Study|Other than specified|2|||
156790216|NCT01897896|565983706|FG001|Overall Study|Other than specified|1|||
156790217|NCT00090402|565983716|FG000|Overall Study|Death|1|||
156790218|NCT00090402|565983717|FG001|Overall Study|Death|1|||
156790219|NCT00090402|565983718|FG002|Overall Study|Death|0|||
156790220|NCT00090402|565983716|FG000|Overall Study|subject moved|0|||
156790221|NCT00090402|565983717|FG001|Overall Study|subject moved|1|||
156790222|NCT00090402|565983718|FG002|Overall Study|subject moved|0|||
156790223|NCT00090402|565983716|FG000|Overall Study|stopped taking study medication|1|||
156790224|NCT00090402|565983717|FG001|Overall Study|stopped taking study medication|0|||
156790225|NCT00090402|565983718|FG002|Overall Study|stopped taking study medication|1|||
156790226|NCT01052428|565983721|FG000|Overall Study|Death|1|||
156790227|NCT01052428|565983722|FG001|Overall Study|Death|0|||
156790228|NCT01052428|565983721|FG000|Overall Study|Withdrawal by Subject|0|||
156790229|NCT01052428|565983722|FG001|Overall Study|Withdrawal by Subject|1|||
156790230|NCT01292473|565983723|FG000|Overall Study|Adverse Event|1|||
156790231|NCT01292473|565983724|FG001|Overall Study|Adverse Event|0|||
156790232|NCT01292473|565983725|FG002|Overall Study|Adverse Event|1|||
156790233|NCT01292473|565983726|FG003|Overall Study|Adverse Event|1|||
156790234|NCT01292473|565983723|FG000|Overall Study|Lost to Follow-up|1|||
156790235|NCT01292473|565983724|FG001|Overall Study|Lost to Follow-up|1|||
156790236|NCT01292473|565983725|FG002|Overall Study|Lost to Follow-up|2|||
156790237|NCT01292473|565983726|FG003|Overall Study|Lost to Follow-up|2|||
156790238|NCT01292473|565983723|FG000|Overall Study|Withdrawal by Subject|3|||
156790239|NCT01292473|565983724|FG001|Overall Study|Withdrawal by Subject|4|||
156790240|NCT01292473|565983725|FG002|Overall Study|Withdrawal by Subject|3|||
156790241|NCT01292473|565983726|FG003|Overall Study|Withdrawal by Subject|3|||
156790242|NCT01292473|565983723|FG000|Overall Study|Physician Decision|0|||
156790243|NCT01292473|565983724|FG001|Overall Study|Physician Decision|1|||
156790244|NCT01292473|565983725|FG002|Overall Study|Physician Decision|0|||
156790245|NCT01292473|565983726|FG003|Overall Study|Physician Decision|0|||
156790246|NCT01292473|565983723|FG000|Overall Study|Disease Progression|0|||
156790247|NCT01292473|565983724|FG001|Overall Study|Disease Progression|1|||
156790248|NCT01292473|565983725|FG002|Overall Study|Disease Progression|3|||
156790249|NCT01292473|565983726|FG003|Overall Study|Disease Progression|6|||
156790250|NCT02451007|565983727|FG000|Overall Study|Withdrawal by Subject|4|||
156790251|NCT02451007|565983727|FG000|Overall Study|Adverse Event|1|||
156790252|NCT02451007|565983727|FG000|Overall Study|Disease Progression|2|||
156790253|NCT01716559|565983728|FG000|Overall Study|Adverse Event|11|||
156790254|NCT01716559|565983728|FG000|Overall Study|Death|21|||
156790255|NCT01716559|565983728|FG000|Overall Study|Withdrawal by Subject|4|||
156790256|NCT01716559|565983728|FG000|Overall Study|Other withdrawal reason|75|||
156790257|NCT01651208|565983744|FG000|Overall Study|Lost to Follow-up|14|||
156697074|NCT00144781|565640823|FG001|Overall Study|Non-compliant|1|||
156697075|NCT00144781|565640824|FG002|Overall Study|Non-compliant|0|||
156697076|NCT00144781|565640825|FG003|Overall Study|Non-compliant|0|||
156697077|NCT03696953|565640826|FG000|Overall Study|Withdrawal by Subject|6|||
156697078|NCT03696953|565640827|FG001|Overall Study|Withdrawal by Subject|1|||
156697079|NCT03696953|565640826|FG000|Overall Study|missed GBS swabs|2|||
156697080|NCT03696953|565640827|FG001|Overall Study|missed GBS swabs|2|||
156697081|NCT03696953|565640826|FG000|Overall Study|lost study bottle containing capsules|2|||
156697082|NCT03696953|565640827|FG001|Overall Study|lost study bottle containing capsules|0|||
156697083|NCT03696953|565640826|FG000|Overall Study|Premature birth|1|||
156697084|NCT03696953|565640827|FG001|Overall Study|Premature birth|4|||
156697085|NCT03696953|565640826|FG000|Overall Study|Gestational hypertension|1|||
156697086|NCT03696953|565640827|FG001|Overall Study|Gestational hypertension|1|||
156697087|NCT03696953|565640826|FG000|Overall Study|Gestational diabetes|2|||
156697088|NCT03696953|565640827|FG001|Overall Study|Gestational diabetes|1|||
156697089|NCT03696953|565640826|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
156697090|NCT03696953|565640827|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
156697091|NCT03696953|565640826|FG000|Overall Study|Changed prenatal provider|1|||
156697092|NCT03696953|565640827|FG001|Overall Study|Changed prenatal provider|1|||
156697093|NCT02068092|565640828|FG000|Overall Study|Physician Decision|2|||
156697094|NCT02068092|565640828|FG000|Overall Study|Adverse Event|2|||
156697095|NCT02068092|565640828|FG000|Overall Study|Lost to Follow-up|4|||
156697096|NCT02068092|565640828|FG000|Overall Study|Withdrawal by Subject|2|||
156697097|NCT03502707|565640829|FG000|Overall Study|Adverse Event|0|||
156697098|NCT03502707|565640830|FG001|Overall Study|Adverse Event|0|||
156697099|NCT03502707|565640831|FG002|Overall Study|Adverse Event|0|||
156697100|NCT03502707|565640832|FG003|Overall Study|Adverse Event|0|||
156697101|NCT03502707|565640833|FG004|Overall Study|Adverse Event|0|||
156697102|NCT03502707|565640834|FG005|Overall Study|Adverse Event|0|||
156697103|NCT03502707|565640835|FG006|Overall Study|Adverse Event|0|||
156697104|NCT03502707|565640836|FG007|Overall Study|Adverse Event|0|||
156697105|NCT03502707|565640837|FG008|Overall Study|Adverse Event|0|||
156697106|NCT03502707|565640838|FG009|Overall Study|Adverse Event|0|||
156697107|NCT03502707|565640839|FG010|Overall Study|Adverse Event|0|||
156697108|NCT03502707|565640840|FG011|Overall Study|Adverse Event|0|||
156697109|NCT03502707|565640841|FG012|Overall Study|Adverse Event|0|||
156697110|NCT03502707|565640842|FG013|Overall Study|Adverse Event|0|||
156697111|NCT03502707|565640843|FG014|Overall Study|Adverse Event|0|||
156697112|NCT03502707|565640844|FG015|Overall Study|Adverse Event|1|||
156697113|NCT03502707|565640845|FG016|Overall Study|Adverse Event|5|||
156697114|NCT03502707|565640846|FG017|Overall Study|Adverse Event|0|||
156697115|NCT03502707|565640829|FG000|Overall Study|Death|0|||
156697116|NCT03502707|565640830|FG001|Overall Study|Death|0|||
156697117|NCT03502707|565640831|FG002|Overall Study|Death|0|||
156697118|NCT03502707|565640832|FG003|Overall Study|Death|1|||
156697119|NCT03502707|565640833|FG004|Overall Study|Death|0|||
156697120|NCT03502707|565640834|FG005|Overall Study|Death|0|||
156697121|NCT03502707|565640835|FG006|Overall Study|Death|0|||
156697122|NCT03502707|565640836|FG007|Overall Study|Death|0|||
156697123|NCT03502707|565640837|FG008|Overall Study|Death|1|||
156697124|NCT03502707|565640838|FG009|Overall Study|Death|1|||
156697125|NCT03502707|565640839|FG010|Overall Study|Death|0|||
156697126|NCT03502707|565640840|FG011|Overall Study|Death|0|||
156697127|NCT03502707|565640841|FG012|Overall Study|Death|1|||
156697128|NCT03502707|565640842|FG013|Overall Study|Death|0|||
156697129|NCT03502707|565640843|FG014|Overall Study|Death|0|||
156697130|NCT03502707|565640844|FG015|Overall Study|Death|1|||
156697131|NCT03502707|565640845|FG016|Overall Study|Death|0|||
156530961|NCT00954174|565039820|FG001|Overall Study|Death|2|||
156697132|NCT03502707|565640846|FG017|Overall Study|Death|0|||
156697133|NCT03502707|565640829|FG000|Overall Study|Lost to Follow-up|0|||
156697134|NCT03502707|565640830|FG001|Overall Study|Lost to Follow-up|0|||
156697135|NCT03502707|565640831|FG002|Overall Study|Lost to Follow-up|0|||
156697136|NCT03502707|565640832|FG003|Overall Study|Lost to Follow-up|0|||
156697137|NCT03502707|565640833|FG004|Overall Study|Lost to Follow-up|0|||
156697138|NCT03502707|565640834|FG005|Overall Study|Lost to Follow-up|0|||
156697139|NCT03502707|565640835|FG006|Overall Study|Lost to Follow-up|0|||
156697140|NCT03502707|565640836|FG007|Overall Study|Lost to Follow-up|5|||
156697141|NCT03502707|565640837|FG008|Overall Study|Lost to Follow-up|0|||
156697142|NCT03502707|565640838|FG009|Overall Study|Lost to Follow-up|2|||
156697143|NCT03502707|565640839|FG010|Overall Study|Lost to Follow-up|1|||
156697144|NCT03502707|565640840|FG011|Overall Study|Lost to Follow-up|2|||
156697145|NCT03502707|565640841|FG012|Overall Study|Lost to Follow-up|1|||
156697146|NCT03502707|565640842|FG013|Overall Study|Lost to Follow-up|1|||
156697147|NCT03502707|565640843|FG014|Overall Study|Lost to Follow-up|0|||
156697148|NCT03502707|565640844|FG015|Overall Study|Lost to Follow-up|4|||
156697149|NCT03502707|565640845|FG016|Overall Study|Lost to Follow-up|9|||
156697150|NCT03502707|565640846|FG017|Overall Study|Lost to Follow-up|2|||
156697151|NCT03502707|565640829|FG000|Overall Study|Physician Decision|0|||
156697152|NCT03502707|565640830|FG001|Overall Study|Physician Decision|0|||
156697153|NCT03502707|565640831|FG002|Overall Study|Physician Decision|0|||
156871178|NCT03085797|566285984|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
156871179|NCT03085797|566285983|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
156871180|NCT03085797|566285984|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
156871181|NCT03085797|566285983|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
156871182|NCT03085797|566285984|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
156871183|NCT04050202|566285985|FG000|Overall Study|Lost to Follow-up|2|||
156871184|NCT00001213|566285986|FG000|Overall Study|Death|18|||
156871185|NCT02636595|566285987|FG000|Overall Study|Lost to Follow-up|1|||
156871186|NCT02636595|566285987|FG000|Overall Study|Other|1|||
156871187|NCT05782179|566285991|FG000|Overall Study|Adverse Event|0|||
156871188|NCT05782179|566285992|FG001|Overall Study|Adverse Event|0|||
156871189|NCT05782179|566285993|FG002|Overall Study|Adverse Event|2|||
156871190|NCT05782179|566285994|FG003|Overall Study|Adverse Event|0|||
156697154|NCT03502707|565640832|FG003|Overall Study|Physician Decision|0|||
156697155|NCT03502707|565640833|FG004|Overall Study|Physician Decision|0|||
156697156|NCT03502707|565640834|FG005|Overall Study|Physician Decision|0|||
156697157|NCT03502707|565640835|FG006|Overall Study|Physician Decision|0|||
156697158|NCT03502707|565640836|FG007|Overall Study|Physician Decision|0|||
156697159|NCT03502707|565640837|FG008|Overall Study|Physician Decision|2|||
156697160|NCT03502707|565640838|FG009|Overall Study|Physician Decision|1|||
156697161|NCT03502707|565640839|FG010|Overall Study|Physician Decision|0|||
156697162|NCT03502707|565640840|FG011|Overall Study|Physician Decision|0|||
156697163|NCT03502707|565640841|FG012|Overall Study|Physician Decision|0|||
156697164|NCT03502707|565640842|FG013|Overall Study|Physician Decision|0|||
156697165|NCT03502707|565640843|FG014|Overall Study|Physician Decision|1|||
156697166|NCT03502707|565640844|FG015|Overall Study|Physician Decision|3|||
156697167|NCT03502707|565640845|FG016|Overall Study|Physician Decision|0|||
156697168|NCT03502707|565640846|FG017|Overall Study|Physician Decision|0|||
156697169|NCT03502707|565640829|FG000|Overall Study|Protocol Violation|0|||
156697170|NCT03502707|565640830|FG001|Overall Study|Protocol Violation|0|||
156697171|NCT03502707|565640831|FG002|Overall Study|Protocol Violation|0|||
156697172|NCT03502707|565640832|FG003|Overall Study|Protocol Violation|0|||
156697173|NCT03502707|565640833|FG004|Overall Study|Protocol Violation|0|||
156697174|NCT03502707|565640834|FG005|Overall Study|Protocol Violation|0|||
156697175|NCT03502707|565640835|FG006|Overall Study|Protocol Violation|0|||
156697176|NCT03502707|565640836|FG007|Overall Study|Protocol Violation|0|||
156697177|NCT03502707|565640837|FG008|Overall Study|Protocol Violation|0|||
156697178|NCT03502707|565640838|FG009|Overall Study|Protocol Violation|0|||
156697179|NCT03502707|565640839|FG010|Overall Study|Protocol Violation|0|||
156697180|NCT03502707|565640840|FG011|Overall Study|Protocol Violation|0|||
156697181|NCT03502707|565640841|FG012|Overall Study|Protocol Violation|0|||
156697182|NCT03502707|565640842|FG013|Overall Study|Protocol Violation|0|||
156697183|NCT03502707|565640843|FG014|Overall Study|Protocol Violation|0|||
156697184|NCT03502707|565640844|FG015|Overall Study|Protocol Violation|1|||
156697185|NCT03502707|565640845|FG016|Overall Study|Protocol Violation|0|||
156790258|NCT01651208|565983745|FG001|Overall Study|Lost to Follow-up|16|||
156790259|NCT02067156|565983746|FG000|Overall Study|Lost to Follow-up|4|||
156790260|NCT03596983|565983747|FG000|Overall Study|Withdrawal by Subject|3|||
156790261|NCT05287685|565983748|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
156790262|NCT05287685|565983749|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
156790263|NCT05287685|565983748|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
156790264|NCT05287685|565983749|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
156790265|NCT05529173|565983750|FG000|Overall Study|Physician Decision|3|||
156790266|NCT05529173|565983751|FG001|Overall Study|Physician Decision|6|||
156790267|NCT05529173|565983750|FG000|Overall Study|Sample shipment delay more than one day|4|||
156790268|NCT05529173|565983751|FG001|Overall Study|Sample shipment delay more than one day|0|||
156790269|NCT00835549|565983754|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
156790270|NCT00835549|565983755|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156871191|NCT05782179|566285995|FG004|Overall Study|Adverse Event|0|||
156871192|NCT05782179|566285996|FG005|Overall Study|Adverse Event|0|||
156871193|NCT06170242|566285997|FG000|Overall Study|Lost to Follow-up|0|||
156871194|NCT06170242|566285998|FG001|Overall Study|Lost to Follow-up|0|||
156871195|NCT06170242|566285999|FG002|Overall Study|Lost to Follow-up|1|||
156871196|NCT06170242|566286000|FG003|Overall Study|Lost to Follow-up|1|||
156871197|NCT02004093|566286001|FG000|Overall Study|Death|2|||
156871198|NCT02004093|566286002|FG001|Overall Study|Death|1|||
156697186|NCT03502707|565640846|FG017|Overall Study|Protocol Violation|0|||
156697187|NCT03502707|565640829|FG000|Overall Study|Withdrawal by Subject|1|||
156697188|NCT03502707|565640830|FG001|Overall Study|Withdrawal by Subject|1|||
156871199|NCT02004093|566286001|FG000|Overall Study|Lack of Efficacy|66|||
156697189|NCT03502707|565640831|FG002|Overall Study|Withdrawal by Subject|0|||
156697190|NCT03502707|565640832|FG003|Overall Study|Withdrawal by Subject|0|||
156697191|NCT03502707|565640833|FG004|Overall Study|Withdrawal by Subject|0|||
156697192|NCT03502707|565640834|FG005|Overall Study|Withdrawal by Subject|2|||
156790271|NCT03760081|565983769|FG000|Overall Study|Miscellaneous|0|||
156790272|NCT03760081|565983770|FG001|Overall Study|Miscellaneous|1|||
156871200|NCT02004093|566286002|FG001|Overall Study|Lack of Efficacy|62|||
156697193|NCT03502707|565640835|FG006|Overall Study|Withdrawal by Subject|0|||
156331157|NCT05171777|564311954|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
156331158|NCT05171777|564311951|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
156331159|NCT05171777|564311952|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
156331160|NCT05171777|564311953|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
156331161|NCT05171777|564311954|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
156331162|NCT05171777|564311951|FG000|Treatment Continuation Period|Adverse Event|0|||
156331163|NCT05171777|564311952|FG001|Treatment Continuation Period|Adverse Event|0|||
156331164|NCT05171777|564311953|FG002|Treatment Continuation Period|Adverse Event|3|||
156331165|NCT05171777|564311954|FG003|Treatment Continuation Period|Adverse Event|6|||
156331166|NCT05171777|564311951|FG000|Treatment Continuation Period|Death|0|||
156331167|NCT05171777|564311952|FG001|Treatment Continuation Period|Death|0|||
156331168|NCT05171777|564311953|FG002|Treatment Continuation Period|Death|1|||
156331169|NCT05171777|564311954|FG003|Treatment Continuation Period|Death|3|||
156331170|NCT05171777|564311951|FG000|Treatment Continuation Period|Disease Relapse|0|||
156530962|NCT00954174|565039821|FG002|Overall Study|Death|0|||
156530963|NCT00954174|565039822|FG003|Overall Study|Death|0|||
156697194|NCT03502707|565640836|FG007|Overall Study|Withdrawal by Subject|3|||
156697195|NCT03502707|565640837|FG008|Overall Study|Withdrawal by Subject|1|||
156697196|NCT03502707|565640838|FG009|Overall Study|Withdrawal by Subject|2|||
156697197|NCT03502707|565640839|FG010|Overall Study|Withdrawal by Subject|12|||
156697198|NCT03502707|565640840|FG011|Overall Study|Withdrawal by Subject|23|||
156697199|NCT03502707|565640841|FG012|Overall Study|Withdrawal by Subject|5|||
156697200|NCT03502707|565640842|FG013|Overall Study|Withdrawal by Subject|3|||
156697201|NCT03502707|565640843|FG014|Overall Study|Withdrawal by Subject|3|||
156697202|NCT03502707|565640844|FG015|Overall Study|Withdrawal by Subject|43|||
156697203|NCT03502707|565640845|FG016|Overall Study|Withdrawal by Subject|44|||
156697204|NCT03502707|565640846|FG017|Overall Study|Withdrawal by Subject|18|||
156697205|NCT03502707|565640829|FG000|Overall Study|Sponsor's Decision|1|||
156697206|NCT03502707|565640830|FG001|Overall Study|Sponsor's Decision|0|||
156697207|NCT03502707|565640831|FG002|Overall Study|Sponsor's Decision|0|||
156697208|NCT03502707|565640832|FG003|Overall Study|Sponsor's Decision|0|||
156697209|NCT03502707|565640833|FG004|Overall Study|Sponsor's Decision|0|||
156697210|NCT03502707|565640834|FG005|Overall Study|Sponsor's Decision|0|||
156697211|NCT03502707|565640835|FG006|Overall Study|Sponsor's Decision|0|||
156697212|NCT03502707|565640836|FG007|Overall Study|Sponsor's Decision|0|||
156697213|NCT03502707|565640837|FG008|Overall Study|Sponsor's Decision|0|||
156697214|NCT03502707|565640838|FG009|Overall Study|Sponsor's Decision|1|||
156697215|NCT03502707|565640839|FG010|Overall Study|Sponsor's Decision|0|||
156697216|NCT03502707|565640840|FG011|Overall Study|Sponsor's Decision|0|||
156697217|NCT03502707|565640841|FG012|Overall Study|Sponsor's Decision|0|||
156697218|NCT03502707|565640842|FG013|Overall Study|Sponsor's Decision|0|||
156697219|NCT03502707|565640843|FG014|Overall Study|Sponsor's Decision|0|||
156697220|NCT03502707|565640844|FG015|Overall Study|Sponsor's Decision|2|||
156697221|NCT03502707|565640845|FG016|Overall Study|Sponsor's Decision|1|||
156697222|NCT03502707|565640846|FG017|Overall Study|Sponsor's Decision|0|||
156697223|NCT03502707|565640829|FG000|Overall Study|Initiated Prohibited Medication|0|||
156697224|NCT03502707|565640830|FG001|Overall Study|Initiated Prohibited Medication|0|||
156697225|NCT03502707|565640831|FG002|Overall Study|Initiated Prohibited Medication|0|||
156697226|NCT03502707|565640832|FG003|Overall Study|Initiated Prohibited Medication|0|||
156697227|NCT03502707|565640833|FG004|Overall Study|Initiated Prohibited Medication|0|||
156697228|NCT03502707|565640834|FG005|Overall Study|Initiated Prohibited Medication|0|||
156697229|NCT03502707|565640835|FG006|Overall Study|Initiated Prohibited Medication|0|||
156697230|NCT03502707|565640836|FG007|Overall Study|Initiated Prohibited Medication|0|||
156697231|NCT03502707|565640837|FG008|Overall Study|Initiated Prohibited Medication|0|||
156697232|NCT03502707|565640838|FG009|Overall Study|Initiated Prohibited Medication|0|||
156697233|NCT03502707|565640839|FG010|Overall Study|Initiated Prohibited Medication|0|||
156697234|NCT03502707|565640840|FG011|Overall Study|Initiated Prohibited Medication|0|||
156697235|NCT03502707|565640841|FG012|Overall Study|Initiated Prohibited Medication|0|||
156697236|NCT03502707|565640842|FG013|Overall Study|Initiated Prohibited Medication|0|||
156697237|NCT03502707|565640843|FG014|Overall Study|Initiated Prohibited Medication|0|||
156697238|NCT03502707|565640844|FG015|Overall Study|Initiated Prohibited Medication|0|||
156697239|NCT03502707|565640845|FG016|Overall Study|Initiated Prohibited Medication|1|||
156697240|NCT03502707|565640846|FG017|Overall Study|Initiated Prohibited Medication|0|||
156697241|NCT03502707|565640829|FG000|Overall Study|Other|0|||
156697242|NCT03502707|565640830|FG001|Overall Study|Other|0|||
156697243|NCT03502707|565640831|FG002|Overall Study|Other|0|||
156697244|NCT03502707|565640832|FG003|Overall Study|Other|0|||
156697245|NCT03502707|565640833|FG004|Overall Study|Other|0|||
156697246|NCT03502707|565640834|FG005|Overall Study|Other|0|||
156697247|NCT03502707|565640835|FG006|Overall Study|Other|0|||
156697248|NCT03502707|565640836|FG007|Overall Study|Other|0|||
156697249|NCT03502707|565640837|FG008|Overall Study|Other|1|||
156697250|NCT03502707|565640838|FG009|Overall Study|Other|1|||
156697251|NCT03502707|565640839|FG010|Overall Study|Other|2|||
156331171|NCT05171777|564311952|FG001|Treatment Continuation Period|Disease Relapse|0|||
156331172|NCT05171777|564311953|FG002|Treatment Continuation Period|Disease Relapse|1|||
156871201|NCT02004093|566286001|FG000|Overall Study|Protocol Violation|0|||
156871202|NCT02004093|566286002|FG001|Overall Study|Protocol Violation|1|||
156871203|NCT02004093|566286001|FG000|Overall Study|Lost to Follow-up|0|||
156871204|NCT02004093|566286002|FG001|Overall Study|Lost to Follow-up|1|||
156871205|NCT02004093|566286001|FG000|Overall Study|Withdrawal by Subject|3|||
156871206|NCT02004093|566286002|FG001|Overall Study|Withdrawal by Subject|7|||
156871207|NCT02004093|566286001|FG000|Overall Study|Other|3|||
156871208|NCT02004093|566286002|FG001|Overall Study|Other|1|||
156871209|NCT04085289|566286003|FG000|Overall Study|Withdrawal by Subject|0|||
156697252|NCT03502707|565640840|FG011|Overall Study|Other|0|||
156871210|NCT04085289|566286004|FG001|Overall Study|Withdrawal by Subject|0|||
156871211|NCT04085289|566286005|FG002|Overall Study|Withdrawal by Subject|1|||
156871212|NCT00414596|566286006|FG000|Overall Study|Protocol Violation|2|||
156871213|NCT04639258|566286007|FG000|Overall Study|Screen failure|5|||
156871214|NCT04639258|566286007|FG000|Overall Study|Physician Decision|2|||
156871215|NCT04639258|566286007|FG000|Overall Study|Early study termination|3|||
156871216|NCT04639258|566286007|FG000|Overall Study|Withdrawal by Subject|1|||
156871217|NCT02560558|566286010|FG000|Overall Study|Adverse Event|1|||
156871218|NCT02560558|566286011|FG001|Overall Study|Adverse Event|0|||
156871219|NCT02560558|566286010|FG000|Overall Study|Death|0|||
156871220|NCT02560558|566286011|FG001|Overall Study|Death|2|||
156871221|NCT02560558|566286010|FG000|Overall Study|Lost to Follow-up|0|||
156871222|NCT02560558|566286011|FG001|Overall Study|Lost to Follow-up|4|||
156871223|NCT02560558|566286010|FG000|Overall Study|Protocol Violation|3|||
156871224|NCT02560558|566286011|FG001|Overall Study|Protocol Violation|0|||
156871225|NCT02560558|566286010|FG000|Overall Study|Withdrawal by Subject|3|||
156871226|NCT02560558|566286011|FG001|Overall Study|Withdrawal by Subject|0|||
156871227|NCT01263197|566286027|FG000|First Intervention (Period 1)|Adverse Event|0|||
156871228|NCT01263197|566286028|FG001|First Intervention (Period 1)|Adverse Event|0|||
156871229|NCT01263197|566286029|FG002|First Intervention (Period 1)|Adverse Event|0|||
156871230|NCT01263197|566286030|FG003|First Intervention (Period 1)|Adverse Event|0|||
156871231|NCT01263197|566286031|FG004|First Intervention (Period 1)|Adverse Event|0|||
156871232|NCT01263197|566286032|FG005|First Intervention (Period 1)|Adverse Event|1|||
156871233|NCT01263197|566286027|FG000|Washout Period 1|Protocol Violation|0|||
156871234|NCT01263197|566286028|FG001|Washout Period 1|Protocol Violation|0|||
156871235|NCT01263197|566286029|FG002|Washout Period 1|Protocol Violation|0|||
156871236|NCT01263197|566286030|FG003|Washout Period 1|Protocol Violation|0|||
156871237|NCT01263197|566286031|FG004|Washout Period 1|Protocol Violation|1|||
156871238|NCT01263197|566286032|FG005|Washout Period 1|Protocol Violation|0|||
156871239|NCT01263197|566286027|FG000|Washout Period 2|Physician Decision|0|||
156871240|NCT01263197|566286028|FG001|Washout Period 2|Physician Decision|0|||
156871241|NCT01263197|566286029|FG002|Washout Period 2|Physician Decision|0|||
156871242|NCT01263197|566286030|FG003|Washout Period 2|Physician Decision|0|||
156871243|NCT01263197|566286031|FG004|Washout Period 2|Physician Decision|0|||
156871244|NCT01263197|566286032|FG005|Washout Period 2|Physician Decision|1|||
156871245|NCT01263197|566286027|FG000|Washout Period 2|Protocol Violation|0|||
156697253|NCT03502707|565640841|FG012|Overall Study|Other|0|||
156697254|NCT03502707|565640842|FG013|Overall Study|Other|0|||
156697255|NCT03502707|565640843|FG014|Overall Study|Other|0|||
156697256|NCT03502707|565640844|FG015|Overall Study|Other|4|||
156697257|NCT03502707|565640845|FG016|Overall Study|Other|1|||
156697258|NCT03502707|565640846|FG017|Overall Study|Other|0|||
156697259|NCT03502707|565640829|FG000|Overall Study|Randomized but not vaccinated|0|||
156697260|NCT03502707|565640830|FG001|Overall Study|Randomized but not vaccinated|0|||
156697261|NCT03502707|565640831|FG002|Overall Study|Randomized but not vaccinated|0|||
156697262|NCT03502707|565640832|FG003|Overall Study|Randomized but not vaccinated|0|||
156871246|NCT01263197|566286028|FG001|Washout Period 2|Protocol Violation|0|||
156697263|NCT03502707|565640833|FG004|Overall Study|Randomized but not vaccinated|0|||
156697264|NCT03502707|565640834|FG005|Overall Study|Randomized but not vaccinated|0|||
156871247|NCT01263197|566286029|FG002|Washout Period 2|Protocol Violation|0|||
156871248|NCT01263197|566286030|FG003|Washout Period 2|Protocol Violation|1|||
156871249|NCT01263197|566286031|FG004|Washout Period 2|Protocol Violation|0|||
156871250|NCT01263197|566286032|FG005|Washout Period 2|Protocol Violation|0|||
156871251|NCT01263197|566286027|FG000|Third Intervention (Period 3)|Adverse Event|0|||
156871252|NCT01263197|566286028|FG001|Third Intervention (Period 3)|Adverse Event|1|||
156871253|NCT01263197|566286029|FG002|Third Intervention (Period 3)|Adverse Event|0|||
156871254|NCT01263197|566286030|FG003|Third Intervention (Period 3)|Adverse Event|0|||
156871255|NCT01263197|566286031|FG004|Third Intervention (Period 3)|Adverse Event|0|||
156871256|NCT01263197|566286032|FG005|Third Intervention (Period 3)|Adverse Event|0|||
156871257|NCT01967576|566286037|FG000|Overall Study|Withdrawal by Subject|3|||
156697265|NCT03502707|565640835|FG006|Overall Study|Randomized but not vaccinated|0|||
156697266|NCT03502707|565640836|FG007|Overall Study|Randomized but not vaccinated|0|||
156871258|NCT01967576|566286037|FG000|Overall Study|Progressed/Removed from treatment|1|||
156871259|NCT01967576|566286037|FG000|Overall Study|Study closing at site|1|||
156871260|NCT01967576|566286037|FG000|Overall Study|Adverse Event|1|||
156871261|NCT01967576|566286037|FG000|Overall Study|Refused further treatment|1|||
156871262|NCT02892448|566286040|FG000|Overall Study|Screening failure|2|||
156871263|NCT02892448|566286041|FG001|Overall Study|Screening failure|2|||
156871264|NCT02892448|566286042|FG002|Overall Study|Screening failure|1|||
156871265|NCT00131248|566286043|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
156871266|NCT00131248|566286044|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
156871267|NCT04269889|566286045|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
156871268|NCT01654302|566286050|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
156871269|NCT01654302|566286051|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
156871270|NCT02447003|566286056|FG000|Overall Study|Other|0|||
156871271|NCT02447003|566286057|FG001|Overall Study|Other|4|||
156871272|NCT02447003|566286056|FG000|Overall Study|Site discontinued|0|||
156871273|NCT02447003|566286057|FG001|Overall Study|Site discontinued|2|||
156871274|NCT02447003|566286056|FG000|Overall Study|Physician Decision|0|||
156871275|NCT02447003|566286057|FG001|Overall Study|Physician Decision|1|||
156871276|NCT02447003|566286056|FG000|Overall Study|Withdrawal by Subject|4|||
156871277|NCT02447003|566286057|FG001|Overall Study|Withdrawal by Subject|3|||
156871278|NCT02447003|566286056|FG000|Overall Study|Sponsor Decision|6|||
156871279|NCT02447003|566286057|FG001|Overall Study|Sponsor Decision|11|||
156871280|NCT02447003|566286056|FG000|Overall Study|Progressive Disease|1|||
156871281|NCT02447003|566286057|FG001|Overall Study|Progressive Disease|0|||
156871282|NCT02447003|566286056|FG000|Overall Study|Lost to Follow-up|5|||
156871283|NCT02447003|566286057|FG001|Overall Study|Lost to Follow-up|0|||
156871284|NCT02447003|566286056|FG000|Overall Study|Death|154|||
156871285|NCT02447003|566286057|FG001|Overall Study|Death|63|||
156871286|NCT03848728|566286058|FG000|Overall Study|Death|16|||
156871287|NCT03848728|566286059|FG001|Overall Study|Death|13|||
156871288|NCT03848728|566286058|FG000|Overall Study|Outmigrated to non-study community|98|||
156871289|NCT03848728|566286059|FG001|Overall Study|Outmigrated to non-study community|106|||
156871290|NCT03848728|566286058|FG000|Overall Study|Transfered to non-study clinic|32|||
156697267|NCT03502707|565640837|FG008|Overall Study|Randomized but not vaccinated|0|||
156697268|NCT03502707|565640838|FG009|Overall Study|Randomized but not vaccinated|0|||
156697269|NCT03502707|565640839|FG010|Overall Study|Randomized but not vaccinated|0|||
156697270|NCT03502707|565640840|FG011|Overall Study|Randomized but not vaccinated|1|||
156697271|NCT03502707|565640841|FG012|Overall Study|Randomized but not vaccinated|0|||
156697272|NCT03502707|565640842|FG013|Overall Study|Randomized but not vaccinated|0|||
156697273|NCT03502707|565640843|FG014|Overall Study|Randomized but not vaccinated|0|||
156697274|NCT03502707|565640844|FG015|Overall Study|Randomized but not vaccinated|0|||
156697275|NCT03502707|565640845|FG016|Overall Study|Randomized but not vaccinated|0|||
156697276|NCT03502707|565640846|FG017|Overall Study|Randomized but not vaccinated|1|||
156697277|NCT00461253|565640847|FG000|Overall Study|Death|985|||
156697278|NCT00461253|565640848|FG001|Overall Study|Death|0|||
156697279|NCT00461253|565640847|FG000|Overall Study|Protocol Violation|613|||
156697280|NCT00461253|565640848|FG001|Overall Study|Protocol Violation|236|||
156697281|NCT00461253|565640847|FG000|Overall Study|no response|2609|||
156697282|NCT00461253|565640848|FG001|Overall Study|no response|11789|||
156697283|NCT00461253|565640847|FG000|Overall Study|administrative|773|||
156871291|NCT03848728|566286059|FG001|Overall Study|Transfered to non-study clinic|48|||
156871292|NCT03848728|566286058|FG000|Overall Study|Withdrawal by Subject|1|||
156871293|NCT03848728|566286059|FG001|Overall Study|Withdrawal by Subject|0|||
156871294|NCT00536744|566286062|FG000|Overall Study|Adverse Event|13|||
156871295|NCT00536744|566286063|FG001|Overall Study|Adverse Event|10|||
156871296|NCT00536744|566286062|FG000|Overall Study|Death|2|||
156871297|NCT00536744|566286063|FG001|Overall Study|Death|1|||
156871298|NCT00536744|566286062|FG000|Overall Study|Physician Decision|3|||
156871299|NCT00536744|566286063|FG001|Overall Study|Physician Decision|1|||
156871300|NCT00536744|566286062|FG000|Overall Study|Lost to Follow-up|3|||
156871301|NCT00536744|566286063|FG001|Overall Study|Lost to Follow-up|5|||
156331173|NCT05171777|564311954|FG003|Treatment Continuation Period|Disease Relapse|0|||
156697284|NCT00461253|565640848|FG001|Overall Study|administrative|7773|||
156697285|NCT01933113|565640849|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
156697286|NCT02297438|565640850|FG000|Overall Study|Death|79|||
156697287|NCT02297438|565640851|FG001|Overall Study|Death|86|||
156697288|NCT02297438|565640850|FG000|Overall Study|Lost to Follow-up|9|||
156697289|NCT02297438|565640851|FG001|Overall Study|Lost to Follow-up|7|||
156697290|NCT02297438|565640850|FG000|Overall Study|Withdrawal by Subject|7|||
156697291|NCT02297438|565640851|FG001|Overall Study|Withdrawal by Subject|0|||
156871302|NCT00536744|566286062|FG000|Overall Study|Withdrawal by Subject|7|||
156871303|NCT00536744|566286063|FG001|Overall Study|Withdrawal by Subject|8|||
156871304|NCT00536744|566286062|FG000|Overall Study|PI tried alternative treatment|1|||
156871305|NCT00536744|566286063|FG001|Overall Study|PI tried alternative treatment|3|||
156871306|NCT02581410|566286064|FG000|Vaccination Phase|Adverse Event|2|||
156871307|NCT02581410|566286065|FG001|Vaccination Phase|Adverse Event|1|||
156871308|NCT02581410|566286064|FG000|Vaccination Phase|Withdrawal by Subject|0|||
156871309|NCT02581410|566286065|FG001|Vaccination Phase|Withdrawal by Subject|1|||
156871310|NCT02581410|566286064|FG000|Vaccination Phase|Migrated/moved from study area|0|||
156871311|NCT02581410|566286065|FG001|Vaccination Phase|Migrated/moved from study area|1|||
156871312|NCT02581410|566286064|FG000|End of Study Phase|Adverse Event|4|||
156697292|NCT02297438|565640850|FG000|Overall Study|Other|9|||
156697293|NCT02297438|565640851|FG001|Overall Study|Other|5|||
156697294|NCT02297438|565640850|FG000|Overall Study|Ongoing|65|||
156697295|NCT02297438|565640851|FG001|Overall Study|Ongoing|73|||
156697296|NCT04092894|565640852|FG000|Overall Study|Withdrawal by Subject|2|||
156697297|NCT04092894|565640853|FG001|Overall Study|Withdrawal by Subject|4|||
156697298|NCT04092894|565640852|FG000|Overall Study|Discontinued EEG after randomization|10|||
156697299|NCT04092894|565640853|FG001|Overall Study|Discontinued EEG after randomization|6|||
156697300|NCT01106014|565640854|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
156697301|NCT01106014|565640855|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
156697302|NCT01106014|565640854|FG000|Overall Study|Adverse Event|78|||
156697303|NCT01106014|565640855|FG001|Overall Study|Adverse Event|42|||
156697304|NCT01106014|565640854|FG000|Overall Study|Withdrawal by Subject|43|||
156697305|NCT01106014|565640855|FG001|Overall Study|Withdrawal by Subject|37|||
156697306|NCT01106014|565640854|FG000|Overall Study|Administrative reason|7|||
156697307|NCT01106014|565640855|FG001|Overall Study|Administrative reason|6|||
156697308|NCT01106014|565640854|FG000|Overall Study|Lost to Follow-up|2|||
156697309|NCT01106014|565640855|FG001|Overall Study|Lost to Follow-up|3|||
156697310|NCT05071313|565640856|FG000|Overall Study|Lost to Follow-up|17|||
156697311|NCT05071313|565640857|FG001|Overall Study|Lost to Follow-up|10|||
156697312|NCT05071313|565640856|FG000|Overall Study|Physician Decision|1|||
156697313|NCT05071313|565640857|FG001|Overall Study|Physician Decision|6|||
156697314|NCT05071313|565640856|FG000|Overall Study|Death|1|||
156697315|NCT05071313|565640857|FG001|Overall Study|Death|0|||
156697316|NCT05071313|565640856|FG000|Overall Study|Withdrawal by Subject|10|||
156697317|NCT05071313|565640857|FG001|Overall Study|Withdrawal by Subject|15|||
156697318|NCT05071313|565640856|FG000|Overall Study|Other|1|||
156697319|NCT05071313|565640857|FG001|Overall Study|Other|0|||
156697320|NCT05071313|565640856|FG000|Overall Study|Randomized but not vaccinated|4|||
156697321|NCT05071313|565640857|FG001|Overall Study|Randomized but not vaccinated|2|||
156697322|NCT03107026|565640858|FG000|Overall Study|Adverse Event|2|||
156697323|NCT03107026|565640859|FG001|Overall Study|Adverse Event|14|||
156697324|NCT03107026|565640860|FG002|Overall Study|Adverse Event|23|||
156697325|NCT03107026|565640858|FG000|Overall Study|Lost to Follow-up|12|||
156697326|NCT03107026|565640859|FG001|Overall Study|Lost to Follow-up|12|||
156697327|NCT03107026|565640860|FG002|Overall Study|Lost to Follow-up|13|||
156697328|NCT03107026|565640858|FG000|Overall Study|Protocol Violation|1|||
156697329|NCT03107026|565640859|FG001|Overall Study|Protocol Violation|2|||
156697330|NCT03107026|565640860|FG002|Overall Study|Protocol Violation|0|||
156697331|NCT03107026|565640858|FG000|Overall Study|Pregnancy|1|||
156697332|NCT03107026|565640859|FG001|Overall Study|Pregnancy|0|||
156697333|NCT03107026|565640860|FG002|Overall Study|Pregnancy|0|||
156697334|NCT03107026|565640858|FG000|Overall Study|Withdrawal by Subject|13|||
156697335|NCT03107026|565640859|FG001|Overall Study|Withdrawal by Subject|5|||
156697336|NCT03107026|565640860|FG002|Overall Study|Withdrawal by Subject|17|||
156697337|NCT03107026|565640858|FG000|Overall Study|non compliance with study visits|1|||
156697338|NCT03107026|565640859|FG001|Overall Study|non compliance with study visits|2|||
156697339|NCT03107026|565640860|FG002|Overall Study|non compliance with study visits|0|||
156697340|NCT03107026|565640858|FG000|Overall Study|non-compliance with study drug|2|||
156697341|NCT03107026|565640859|FG001|Overall Study|non-compliance with study drug|2|||
156697342|NCT03107026|565640860|FG002|Overall Study|non-compliance with study drug|3|||
156697343|NCT03107026|565640858|FG000|Overall Study|Physician Decision|0|||
156697344|NCT03107026|565640859|FG001|Overall Study|Physician Decision|1|||
156697345|NCT03107026|565640860|FG002|Overall Study|Physician Decision|0|||
156697346|NCT00062010|565640861|FG000|Overall Study|Ineligible|3|||
156697347|NCT00852969|565640862|FG000|Overall Study|Adverse Event|0|||
156697348|NCT00852969|565640863|FG001|Overall Study|Adverse Event|1|||
156697349|NCT00852969|565640862|FG000|Overall Study|Lost to Follow-up|0|||
156790273|NCT03760081|565983769|FG000|Overall Study|Progressive Disease|5|||
156790274|NCT03760081|565983770|FG001|Overall Study|Progressive Disease|10|||
156790275|NCT03760081|565983769|FG000|Overall Study|Death|1|||
156790276|NCT03760081|565983770|FG001|Overall Study|Death|1|||
156790277|NCT00986102|565983771|FG000|Overall Study|Lost to Follow-up|0|||
156790278|NCT00986102|565983772|FG001|Overall Study|Lost to Follow-up|1|||
156790279|NCT00986102|565983773|FG002|Overall Study|Lost to Follow-up|0|||
156790280|NCT00986102|565983774|FG003|Overall Study|Lost to Follow-up|1|||
156790281|NCT00986102|565983771|FG000|Overall Study|Withdrawal by Subject|1|||
156697350|NCT00852969|565640863|FG001|Overall Study|Lost to Follow-up|1|||
156697351|NCT03596151|565640864|FG000|Overall Study|Withdrawal by Subject|1|||
156697352|NCT00807248|565640866|FG000|Overall Study|Adverse Event|1|||
156697353|NCT00807248|565640867|FG001|Overall Study|Adverse Event|2|||
156697354|NCT00807248|565640868|FG002|Overall Study|Adverse Event|2|||
156697355|NCT00807248|565640869|FG003|Overall Study|Adverse Event|6|||
156697356|NCT00807248|565640866|FG000|Overall Study|Lack of Efficacy|14|||
156697357|NCT00807248|565640867|FG001|Overall Study|Lack of Efficacy|4|||
156697358|NCT00807248|565640868|FG002|Overall Study|Lack of Efficacy|8|||
156697359|NCT00807248|565640869|FG003|Overall Study|Lack of Efficacy|3|||
156697360|NCT00807248|565640866|FG000|Overall Study|Protocol Violation|0|||
156697361|NCT00807248|565640867|FG001|Overall Study|Protocol Violation|1|||
156697362|NCT00807248|565640868|FG002|Overall Study|Protocol Violation|1|||
156697363|NCT00807248|565640869|FG003|Overall Study|Protocol Violation|0|||
156697364|NCT00807248|565640866|FG000|Overall Study|Withdrawal of Consent|5|||
156697365|NCT00807248|565640867|FG001|Overall Study|Withdrawal of Consent|5|||
156871313|NCT02581410|566286065|FG001|End of Study Phase|Adverse Event|3|||
156871314|NCT02581410|566286064|FG000|End of Study Phase|Withdrawal by Subject|1|||
156871315|NCT02581410|566286065|FG001|End of Study Phase|Withdrawal by Subject|2|||
156871316|NCT02581410|566286064|FG000|End of Study Phase|Migrated/moved from study area|0|||
156871317|NCT02581410|566286065|FG001|End of Study Phase|Migrated/moved from study area|3|||
156871318|NCT02581410|566286064|FG000|End of Study Phase|Lost to Follow-up|0|||
156871319|NCT02581410|566286065|FG001|End of Study Phase|Lost to Follow-up|2|||
156871320|NCT02581410|566286064|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
156697366|NCT00807248|565640868|FG002|Overall Study|Withdrawal of Consent|5|||
156697367|NCT00807248|565640869|FG003|Overall Study|Withdrawal of Consent|5|||
156697368|NCT00807248|565640866|FG000|Overall Study|Lost to Follow-up|1|||
156697369|NCT00807248|565640867|FG001|Overall Study|Lost to Follow-up|0|||
156697370|NCT00807248|565640868|FG002|Overall Study|Lost to Follow-up|0|||
156697371|NCT00807248|565640869|FG003|Overall Study|Lost to Follow-up|0|||
156697372|NCT00807248|565640866|FG000|Overall Study|Other Reason|0|||
156697373|NCT00807248|565640867|FG001|Overall Study|Other Reason|0|||
156697374|NCT00807248|565640868|FG002|Overall Study|Other Reason|2|||
156697375|NCT00807248|565640869|FG003|Overall Study|Other Reason|0|||
156697376|NCT02444793|565640870|FG000|Overall Study|Lost to Follow-up|2|||
156697377|NCT02444793|565640871|FG001|Overall Study|Lost to Follow-up|2|||
156697378|NCT02444793|565640872|FG002|Overall Study|Lost to Follow-up|0|||
156697379|NCT02444793|565640873|FG003|Overall Study|Lost to Follow-up|0|||
156697380|NCT02444793|565640870|FG000|Overall Study|Death|0|||
156697381|NCT02444793|565640871|FG001|Overall Study|Death|3|||
156697382|NCT02444793|565640872|FG002|Overall Study|Death|0|||
156697383|NCT02444793|565640873|FG003|Overall Study|Death|0|||
156697384|NCT02444793|565640870|FG000|Overall Study|Other|0|||
156697385|NCT02444793|565640871|FG001|Overall Study|Other|0|||
156697386|NCT02444793|565640872|FG002|Overall Study|Other|2|||
156697387|NCT02444793|565640873|FG003|Overall Study|Other|0|||
156697388|NCT02444793|565640870|FG000|Overall Study|Objective progression or relapse|9|||
156697389|NCT02444793|565640871|FG001|Overall Study|Objective progression or relapse|1|||
156697390|NCT02444793|565640872|FG002|Overall Study|Objective progression or relapse|2|||
156697391|NCT02444793|565640873|FG003|Overall Study|Objective progression or relapse|3|||
156697392|NCT02504671|565640878|FG000|Overall Study|Withdrawal by Subject|1|||
156697393|NCT02504671|565640879|FG001|Overall Study|Withdrawal by Subject|5|||
156697394|NCT02504671|565640880|FG002|Overall Study|Withdrawal by Subject|4|||
156697395|NCT02504671|565640881|FG003|Overall Study|Withdrawal by Subject|4|||
156697396|NCT02504671|565640882|FG004|Overall Study|Withdrawal by Subject|5|||
156697397|NCT02504671|565640883|FG005|Overall Study|Withdrawal by Subject|3|||
156697398|NCT02504671|565640878|FG000|Overall Study|Lack of Efficacy|1|||
156697399|NCT02504671|565640879|FG001|Overall Study|Lack of Efficacy|3|||
156790282|NCT00986102|565983772|FG001|Overall Study|Withdrawal by Subject|1|||
156790283|NCT00986102|565983773|FG002|Overall Study|Withdrawal by Subject|0|||
156790284|NCT00986102|565983774|FG003|Overall Study|Withdrawal by Subject|0|||
156790285|NCT01570192|565983775|FG000|Overall Study|no qualifying organism|6|||
156790286|NCT01570192|565983776|FG001|Overall Study|no qualifying organism|12|||
156790287|NCT01570192|565983775|FG000|Overall Study|changed to palliative care|1|||
156790288|NCT01570192|565983776|FG001|Overall Study|changed to palliative care|0|||
156790289|NCT01570192|565983775|FG000|Overall Study|Physician Decision|0|||
156790290|NCT01570192|565983776|FG001|Overall Study|Physician Decision|1|||
156871321|NCT02581410|566286065|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
156871322|NCT02908672|566286067|FG000|Run-in Period|Death|12|||
156871323|NCT02908672|566286068|FG001|Run-in Period|Death|10|||
156871324|NCT02908672|566286069|FG002|Run-in Period|Death|0|||
156871325|NCT02908672|566286070|FG003|Run-in Period|Death|0|||
156871326|NCT02908672|566286067|FG000|Run-in Period|Lost to Follow-up|1|||
156697400|NCT02504671|565640880|FG002|Overall Study|Lack of Efficacy|1|||
156697401|NCT02504671|565640881|FG003|Overall Study|Lack of Efficacy|0|||
156697402|NCT02504671|565640882|FG004|Overall Study|Lack of Efficacy|4|||
156697403|NCT02504671|565640883|FG005|Overall Study|Lack of Efficacy|4|||
156697404|NCT02504671|565640878|FG000|Overall Study|Adverse Event|1|||
156697405|NCT02504671|565640879|FG001|Overall Study|Adverse Event|1|||
156697406|NCT02504671|565640880|FG002|Overall Study|Adverse Event|0|||
156697407|NCT02504671|565640881|FG003|Overall Study|Adverse Event|1|||
156697408|NCT02504671|565640882|FG004|Overall Study|Adverse Event|0|||
156697409|NCT02504671|565640883|FG005|Overall Study|Adverse Event|2|||
156697410|NCT02504671|565640878|FG000|Overall Study|Protocol Violation|2|||
156697411|NCT02504671|565640879|FG001|Overall Study|Protocol Violation|1|||
156790291|NCT02965976|565983777|FG000|Overall Study|Withdrawal by Subject|2|||
156790292|NCT02965976|565983778|FG001|Overall Study|Withdrawal by Subject|0|||
156871327|NCT02908672|566286068|FG001|Run-in Period|Lost to Follow-up|1|||
156697412|NCT02504671|565640880|FG002|Overall Study|Protocol Violation|0|||
156871328|NCT02908672|566286069|FG002|Run-in Period|Lost to Follow-up|0|||
156871329|NCT02908672|566286070|FG003|Run-in Period|Lost to Follow-up|0|||
156871330|NCT02908672|566286067|FG000|Run-in Period|Reason Not Specified|2|||
156871331|NCT02908672|566286068|FG001|Run-in Period|Reason Not Specified|0|||
156871332|NCT02908672|566286069|FG002|Run-in Period|Reason Not Specified|0|||
156331174|NCT05171777|564311951|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
156331175|NCT05171777|564311952|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
156331176|NCT05171777|564311953|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
156331177|NCT05171777|564311954|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
156331178|NCT05171777|564311951|FG000|Treatment Continuation Period|Physician Decision|0|||
156331179|NCT05171777|564311952|FG001|Treatment Continuation Period|Physician Decision|0|||
156331180|NCT05171777|564311953|FG002|Treatment Continuation Period|Physician Decision|0|||
156331181|NCT05171777|564311954|FG003|Treatment Continuation Period|Physician Decision|4|||
156331182|NCT05171777|564311951|FG000|Treatment Continuation Period|Progressive Disease|0|||
156331183|NCT05171777|564311952|FG001|Treatment Continuation Period|Progressive Disease|0|||
156331184|NCT05171777|564311953|FG002|Treatment Continuation Period|Progressive Disease|6|||
156331185|NCT05171777|564311954|FG003|Treatment Continuation Period|Progressive Disease|20|||
156331186|NCT05171777|564311951|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
156331187|NCT05171777|564311952|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
156331188|NCT05171777|564311953|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
156331189|NCT05171777|564311954|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
156331190|NCT05171777|564311951|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
156331191|NCT05171777|564311952|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
156331192|NCT05171777|564311953|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
156331193|NCT05171777|564311954|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
156331194|NCT05171777|564311951|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
156331195|NCT05171777|564311952|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
156871333|NCT02908672|566286070|FG003|Run-in Period|Reason Not Specified|0|||
156871334|NCT02908672|566286067|FG000|Run-in Period|Protocol Violation|1|||
156871335|NCT02908672|566286068|FG001|Run-in Period|Protocol Violation|1|||
156871336|NCT02908672|566286069|FG002|Run-in Period|Protocol Violation|0|||
156871337|NCT02908672|566286070|FG003|Run-in Period|Protocol Violation|0|||
156871338|NCT02908672|566286067|FG000|Run-in Period|Study Ended by Sponsor|5|||
156871339|NCT02908672|566286068|FG001|Run-in Period|Study Ended by Sponsor|1|||
156871340|NCT02908672|566286069|FG002|Run-in Period|Study Ended by Sponsor|0|||
156871341|NCT02908672|566286070|FG003|Run-in Period|Study Ended by Sponsor|0|||
156871342|NCT02908672|566286067|FG000|Run-in Period|Withdrawal by Subject|3|||
156871343|NCT02908672|566286068|FG001|Run-in Period|Withdrawal by Subject|9|||
156871344|NCT02908672|566286069|FG002|Run-in Period|Withdrawal by Subject|0|||
156871345|NCT02908672|566286070|FG003|Run-in Period|Withdrawal by Subject|0|||
156871346|NCT02908672|566286067|FG000|Triple Combination Period|Death|0|||
156871347|NCT02908672|566286068|FG001|Triple Combination Period|Death|0|||
156871348|NCT02908672|566286069|FG002|Triple Combination Period|Death|150|||
156871349|NCT02908672|566286070|FG003|Triple Combination Period|Death|127|||
156871350|NCT02908672|566286067|FG000|Triple Combination Period|Lost to Follow-up|0|||
156871351|NCT02908672|566286068|FG001|Triple Combination Period|Lost to Follow-up|0|||
156871352|NCT02908672|566286069|FG002|Triple Combination Period|Lost to Follow-up|6|||
156871353|NCT02908672|566286070|FG003|Triple Combination Period|Lost to Follow-up|8|||
156871354|NCT02908672|566286067|FG000|Triple Combination Period|Reason Not Specified|0|||
156871355|NCT02908672|566286068|FG001|Triple Combination Period|Reason Not Specified|0|||
156871356|NCT02908672|566286069|FG002|Triple Combination Period|Reason Not Specified|0|||
156871357|NCT02908672|566286070|FG003|Triple Combination Period|Reason Not Specified|1|||
156871358|NCT02908672|566286067|FG000|Triple Combination Period|Physician Decision|0|||
156871359|NCT02908672|566286068|FG001|Triple Combination Period|Physician Decision|0|||
156871360|NCT02908672|566286069|FG002|Triple Combination Period|Physician Decision|1|||
156871361|NCT02908672|566286070|FG003|Triple Combination Period|Physician Decision|1|||
156871362|NCT02908672|566286067|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
156871363|NCT02908672|566286068|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
156871364|NCT02908672|566286069|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
156871365|NCT02908672|566286070|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
156871366|NCT02908672|566286067|FG000|Triple Combination Period|Withdrawal by Subject|0|||
156331196|NCT05171777|564311953|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
156331197|NCT05171777|564311954|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
156697413|NCT02504671|565640881|FG003|Overall Study|Protocol Violation|0|||
156697414|NCT02504671|565640882|FG004|Overall Study|Protocol Violation|0|||
156871367|NCT02908672|566286068|FG001|Triple Combination Period|Withdrawal by Subject|0|||
156871368|NCT02908672|566286069|FG002|Triple Combination Period|Withdrawal by Subject|13|||
156871369|NCT02908672|566286070|FG003|Triple Combination Period|Withdrawal by Subject|16|||
156871370|NCT00670748|566286071|FG000|Overall Study|Death during treatment|1|||
156871371|NCT00670748|566286072|FG001|Overall Study|Death during treatment|1|||
156871372|NCT00670748|566286073|FG002|Overall Study|Death during treatment|1|||
156871373|NCT00670748|566286074|FG003|Overall Study|Death during treatment|0|||
156871374|NCT00670748|566286071|FG000|Overall Study|Not off study|2|||
156871375|NCT00670748|566286072|FG001|Overall Study|Not off study|1|||
156871376|NCT00670748|566286073|FG002|Overall Study|Not off study|1|||
156697415|NCT02504671|565640883|FG005|Overall Study|Protocol Violation|1|||
156697416|NCT02504671|565640878|FG000|Overall Study|Lost to Follow-up|0|||
156697417|NCT02504671|565640879|FG001|Overall Study|Lost to Follow-up|0|||
156697418|NCT02504671|565640880|FG002|Overall Study|Lost to Follow-up|2|||
156697419|NCT02504671|565640881|FG003|Overall Study|Lost to Follow-up|0|||
156697420|NCT02504671|565640882|FG004|Overall Study|Lost to Follow-up|0|||
156697421|NCT02504671|565640883|FG005|Overall Study|Lost to Follow-up|1|||
156697422|NCT02504671|565640878|FG000|Overall Study|Protocol defined stopping criteria|7|||
156697423|NCT02504671|565640879|FG001|Overall Study|Protocol defined stopping criteria|4|||
156697424|NCT02504671|565640880|FG002|Overall Study|Protocol defined stopping criteria|3|||
156697425|NCT02504671|565640881|FG003|Overall Study|Protocol defined stopping criteria|5|||
156697426|NCT02504671|565640882|FG004|Overall Study|Protocol defined stopping criteria|3|||
156697427|NCT02504671|565640883|FG005|Overall Study|Protocol defined stopping criteria|3|||
156697428|NCT00210249|565640884|FG000|Overall Study|Lost to Follow-up|5|||
156697429|NCT00210249|565640884|FG000|Overall Study|Protocol Violation|11|||
156697430|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
156697431|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
156697432|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
156697433|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
156697434|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
156697435|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
156697436|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
156697437|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
156697438|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
156697439|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
156697440|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
156697441|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
156697442|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
156697443|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
156697444|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
156697445|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
156697446|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
156697447|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
156697448|NCT03182244|565640886|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
156697449|NCT03182244|565640887|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
156697450|NCT03182244|565640886|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
156697451|NCT03182244|565640887|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
156790293|NCT00806026|565983779|FG000|Overall Study|Death|0|||
156790294|NCT00806026|565983780|FG001|Overall Study|Death|0|||
156790295|NCT00806026|565983781|FG002|Overall Study|Death|0|||
156790296|NCT00806026|565983782|FG003|Overall Study|Death|1|||
156790297|NCT00806026|565983783|FG004|Overall Study|Death|0|||
156790298|NCT00806026|565983784|FG005|Overall Study|Death|0|||
156790299|NCT00806026|565983779|FG000|Overall Study|Did not meet entrance criteria|4|||
156790300|NCT00806026|565983780|FG001|Overall Study|Did not meet entrance criteria|1|||
156790301|NCT00806026|565983781|FG002|Overall Study|Did not meet entrance criteria|2|||
156790302|NCT00806026|565983782|FG003|Overall Study|Did not meet entrance criteria|1|||
156790303|NCT00806026|565983783|FG004|Overall Study|Did not meet entrance criteria|0|||
156790304|NCT00806026|565983784|FG005|Overall Study|Did not meet entrance criteria|0|||
156790305|NCT00806026|565983779|FG000|Overall Study|Lack of Efficacy|5|||
156790306|NCT00806026|565983780|FG001|Overall Study|Lack of Efficacy|18|||
156790307|NCT00806026|565983781|FG002|Overall Study|Lack of Efficacy|13|||
156790308|NCT00806026|565983782|FG003|Overall Study|Lack of Efficacy|4|||
156790309|NCT00806026|565983783|FG004|Overall Study|Lack of Efficacy|8|||
156790310|NCT00806026|565983784|FG005|Overall Study|Lack of Efficacy|7|||
156790311|NCT00806026|565983779|FG000|Overall Study|Lost to Follow-up|8|||
156790312|NCT00806026|565983780|FG001|Overall Study|Lost to Follow-up|15|||
156790313|NCT00806026|565983781|FG002|Overall Study|Lost to Follow-up|8|||
156790314|NCT00806026|565983782|FG003|Overall Study|Lost to Follow-up|2|||
156790315|NCT00806026|565983783|FG004|Overall Study|Lost to Follow-up|6|||
156790316|NCT00806026|565983784|FG005|Overall Study|Lost to Follow-up|6|||
156790317|NCT00806026|565983779|FG000|Overall Study|Withdrawal by Subject|14|||
156790318|NCT00806026|565983780|FG001|Overall Study|Withdrawal by Subject|17|||
156790319|NCT00806026|565983781|FG002|Overall Study|Withdrawal by Subject|9|||
156871377|NCT00670748|566286074|FG003|Overall Study|Not off study|1|||
156697452|NCT03182244|565640886|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
156790320|NCT00806026|565983782|FG003|Overall Study|Withdrawal by Subject|2|||
156790321|NCT00806026|565983783|FG004|Overall Study|Withdrawal by Subject|5|||
156790322|NCT00806026|565983784|FG005|Overall Study|Withdrawal by Subject|3|||
156790323|NCT00806026|565983779|FG000|Overall Study|Other|3|||
156790324|NCT00806026|565983780|FG001|Overall Study|Other|6|||
156790325|NCT00806026|565983781|FG002|Overall Study|Other|8|||
156871378|NCT03863080|566286078|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
156697453|NCT03182244|565640887|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
156697454|NCT03182244|565640886|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
156697455|NCT03182244|565640887|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
156697456|NCT02049450|565640888|FG000|Overall Study|Adverse Event|2|||
156697457|NCT02049450|565640888|FG000|Overall Study|Withdrawal by Subject|1|||
156697458|NCT02049450|565640888|FG000|Overall Study|Patients/guardian decision|1|||
156438546|NCT01075217|564697049|FG000|Overall Study|Adverse Event|1|||
156438547|NCT01075217|564697050|FG001|Overall Study|Adverse Event|1|||
156438548|NCT01075217|564697049|FG000|Overall Study|Physician Decision|1|||
156438549|NCT01075217|564697050|FG001|Overall Study|Physician Decision|0|||
156438550|NCT01068743|564697055|FG000|Period 3|Adverse Event|0|||
156438551|NCT01068743|564697056|FG001|Period 3|Adverse Event|1|||
156438552|NCT01068743|564697057|FG002|Period 3|Adverse Event|0|||
156697459|NCT02492880|565640889|FG000|Overall Study|Lost to Follow-up|1|||
156697460|NCT02492880|565640889|FG000|Overall Study|Protocol Violation|1|||
156697461|NCT00292188|565640890|FG000|Single-Blind|Adverse Event|14|||
156697462|NCT00292188|565640891|FG001|Single-Blind|Adverse Event|0|||
156697463|NCT00292188|565640892|FG002|Single-Blind|Adverse Event|0|||
156697464|NCT00292188|565640890|FG000|Single-Blind|Lack of Efficacy|2|||
156697465|NCT00292188|565640891|FG001|Single-Blind|Lack of Efficacy|0|||
156697466|NCT00292188|565640892|FG002|Single-Blind|Lack of Efficacy|0|||
156697467|NCT00292188|565640890|FG000|Single-Blind|Laboratory Abnormality|5|||
156697468|NCT00292188|565640891|FG001|Single-Blind|Laboratory Abnormality|0|||
156697469|NCT00292188|565640892|FG002|Single-Blind|Laboratory Abnormality|0|||
156697470|NCT00292188|565640890|FG000|Single-Blind|Lost to Follow-up|3|||
156697471|NCT00292188|565640891|FG001|Single-Blind|Lost to Follow-up|0|||
156697472|NCT00292188|565640892|FG002|Single-Blind|Lost to Follow-up|0|||
156697473|NCT00292188|565640890|FG000|Single-Blind|Other|77|||
156697474|NCT00292188|565640891|FG001|Single-Blind|Other|0|||
156697475|NCT00292188|565640892|FG002|Single-Blind|Other|0|||
156697476|NCT00292188|565640890|FG000|Single-Blind|Withdrawal by Subject|12|||
156697477|NCT00292188|565640891|FG001|Single-Blind|Withdrawal by Subject|0|||
156697478|NCT00292188|565640892|FG002|Single-Blind|Withdrawal by Subject|0|||
156697479|NCT00292188|565640890|FG000|Single-Blind|Did not receive treatment|1|||
156331198|NCT02364713|564311955|FG000|Overall Study|Ineligible|2|||
156697480|NCT00292188|565640891|FG001|Single-Blind|Did not receive treatment|0|||
156697481|NCT00292188|565640892|FG002|Single-Blind|Did not receive treatment|0|||
156697482|NCT00292188|565640890|FG000|Double-Blind|Adverse Event|0|||
156697483|NCT00292188|565640891|FG001|Double-Blind|Adverse Event|25|||
156697484|NCT00292188|565640892|FG002|Double-Blind|Adverse Event|9|||
156697485|NCT00292188|565640890|FG000|Double-Blind|Lack of Efficacy|0|||
156697486|NCT00292188|565640891|FG001|Double-Blind|Lack of Efficacy|2|||
156331199|NCT02364713|564311956|FG001|Overall Study|Ineligible|2|||
156331200|NCT04686786|564311957|FG000|Overall Study|Adverse Event|9|||
156331201|NCT04686786|564311957|FG000|Overall Study|Death|1|||
156331202|NCT04686786|564311957|FG000|Overall Study|Lack of Efficacy|25|||
156331203|NCT04686786|564311957|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
156331204|NCT04686786|564311957|FG000|Overall Study|Study Terminated by Sponsor|14|||
156331205|NCT04686786|564311957|FG000|Overall Study|Withdrawal by Subject|15|||
156331206|NCT04686786|564311957|FG000|Overall Study|Other than specified|1|||
156331207|NCT03924869|564311958|FG000|Overall Study|Death|73|||
156331208|NCT03924869|564311959|FG001|Overall Study|Death|62|||
156331209|NCT03924869|564311958|FG000|Overall Study|Lost to Follow-up|3|||
156331210|NCT03924869|564311959|FG001|Overall Study|Lost to Follow-up|0|||
156331211|NCT03924869|564311958|FG000|Overall Study|Physician Decision|0|||
156331212|NCT03924869|564311959|FG001|Overall Study|Physician Decision|3|||
156331213|NCT03924869|564311958|FG000|Overall Study|Withdrawal by Subject|7|||
156331214|NCT03924869|564311959|FG001|Overall Study|Withdrawal by Subject|3|||
156331215|NCT03924869|564311958|FG000|Overall Study|Study Terminated By Sponsor|144|||
156331216|NCT03924869|564311959|FG001|Overall Study|Study Terminated By Sponsor|153|||
156331217|NCT03507400|564311960|FG000|Overall Study|discontinued|5|||
156331218|NCT03507400|564311961|FG001|Overall Study|discontinued|1|||
156331219|NCT03507400|564311960|FG000|Overall Study|Lost to Follow-up|8|||
156331220|NCT03507400|564311961|FG001|Overall Study|Lost to Follow-up|6|||
156331221|NCT03507400|564311960|FG000|Overall Study|Protocol Violation|0|||
156331222|NCT03507400|564311961|FG001|Overall Study|Protocol Violation|1|||
156331223|NCT01555983|564311962|FG000|Overall Study|Withdrawal by Subject|1|||
156331224|NCT01555983|564311963|FG001|Overall Study|Withdrawal by Subject|0|||
156331225|NCT01555983|564311964|FG002|Overall Study|Withdrawal by Subject|0|||
156331226|NCT01555983|564311965|FG003|Overall Study|Withdrawal by Subject|0|||
156331227|NCT01555983|564311966|FG004|Overall Study|Withdrawal by Subject|1|||
156331228|NCT01555983|564311967|FG005|Overall Study|Withdrawal by Subject|1|||
156697487|NCT00292188|565640892|FG002|Double-Blind|Lack of Efficacy|12|||
156697488|NCT00292188|565640890|FG000|Double-Blind|Lost to Follow-up|0|||
156697489|NCT00292188|565640891|FG001|Double-Blind|Lost to Follow-up|1|||
156697490|NCT00292188|565640892|FG002|Double-Blind|Lost to Follow-up|0|||
156697491|NCT00292188|565640890|FG000|Double-Blind|Other|0|||
156697492|NCT00292188|565640891|FG001|Double-Blind|Other|3|||
156871379|NCT03863080|566286079|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
156871380|NCT03863080|566286080|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
156871381|NCT03863080|566286081|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
156871382|NCT03863080|566286078|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
156871383|NCT03863080|566286079|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
156871384|NCT03863080|566286080|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
156871385|NCT03863080|566286081|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
156871386|NCT03863080|566286078|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
156871387|NCT03863080|566286079|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
156871388|NCT03863080|566286080|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
156871389|NCT03863080|566286081|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
156871390|NCT02000115|566286082|FG000|Overall Study|Death|56|||
156871391|NCT02000115|566286083|FG001|Overall Study|Death|45|||
156871392|NCT02000115|566286084|FG002|Overall Study|Death|0|||
156871393|NCT02000115|566286085|FG003|Overall Study|Death|0|||
156871394|NCT02000115|566286082|FG000|Overall Study|Missed Visit|6|||
156871395|NCT02000115|566286083|FG001|Overall Study|Missed Visit|8|||
156871396|NCT02000115|566286084|FG002|Overall Study|Missed Visit|1|||
156871397|NCT02000115|566286085|FG003|Overall Study|Missed Visit|0|||
156871398|NCT02000115|566286082|FG000|Overall Study|Protocol Violation|2|||
156871399|NCT02000115|566286083|FG001|Overall Study|Protocol Violation|1|||
156871400|NCT02000115|566286084|FG002|Overall Study|Protocol Violation|0|||
156438553|NCT01068743|564697058|FG003|Period 3|Adverse Event|0|||
156438554|NCT00293293|564697059|FG000|Overall Study|Withdrawal by Subject|1|||
156438555|NCT00293293|564697060|FG001|Overall Study|Withdrawal by Subject|1|||
156438556|NCT00293293|564697059|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
156438557|NCT00293293|564697060|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
156438558|NCT00293293|564697059|FG000|Overall Study|Patient discontinued chemotherapy|0|||
156438559|NCT00293293|564697060|FG001|Overall Study|Patient discontinued chemotherapy|1|||
156438560|NCT02512965|564697064|FG000|Overall Study|Withdrawal by Subject|0|||
156697493|NCT00292188|565640892|FG002|Double-Blind|Other|4|||
156697494|NCT00292188|565640890|FG000|Double-Blind|Withdrawal by Subject|0|||
156697495|NCT00292188|565640891|FG001|Double-Blind|Withdrawal by Subject|0|||
156697496|NCT00292188|565640892|FG002|Double-Blind|Withdrawal by Subject|3|||
156697497|NCT00292188|565640890|FG000|Double-Blind|Laboratory Abnormality|0|||
156697498|NCT00292188|565640891|FG001|Double-Blind|Laboratory Abnormality|0|||
156697499|NCT00292188|565640892|FG002|Double-Blind|Laboratory Abnormality|1|||
156697500|NCT01200992|565640893|FG000|Overall Study|Study terminated early|35|||
156697501|NCT01200992|565640894|FG001|Overall Study|Study terminated early|41|||
156697502|NCT01200992|565640893|FG000|Overall Study|Randomized but not treated|2|||
156697503|NCT01200992|565640894|FG001|Overall Study|Randomized but not treated|0|||
156697504|NCT00792935|565640895|FG000|Overall Study|Adverse Event|2|||
156697505|NCT00792935|565640896|FG001|Overall Study|Adverse Event|1|||
156697506|NCT00792935|565640895|FG000|Overall Study|Lost to Follow-up|0|||
156697507|NCT00792935|565640896|FG001|Overall Study|Lost to Follow-up|1|||
156697508|NCT00792935|565640895|FG000|Overall Study|Protocol Violation|2|||
156438561|NCT02512965|564697065|FG001|Overall Study|Withdrawal by Subject|4|||
156697509|NCT00792935|565640896|FG001|Overall Study|Protocol Violation|0|||
156697510|NCT00792935|565640895|FG000|Overall Study|Withdrawal by Subject|0|||
156697511|NCT00792935|565640896|FG001|Overall Study|Withdrawal by Subject|1|||
156697512|NCT03186781|565640897|FG000|Overall Study|Lost to Follow-up|0|||
156697513|NCT03186781|565640898|FG001|Overall Study|Lost to Follow-up|0|||
156697514|NCT03186781|565640899|FG002|Overall Study|Lost to Follow-up|1|||
156871401|NCT02000115|566286085|FG003|Overall Study|Protocol Violation|0|||
156871402|NCT02000115|566286082|FG000|Overall Study|Physician Decision|2|||
156871403|NCT02000115|566286083|FG001|Overall Study|Physician Decision|0|||
156871404|NCT02000115|566286084|FG002|Overall Study|Physician Decision|0|||
156871405|NCT02000115|566286085|FG003|Overall Study|Physician Decision|0|||
156871406|NCT02000115|566286082|FG000|Overall Study|Withdrawal by Subject|11|||
156871407|NCT02000115|566286083|FG001|Overall Study|Withdrawal by Subject|11|||
156871408|NCT02000115|566286084|FG002|Overall Study|Withdrawal by Subject|0|||
156871409|NCT02000115|566286085|FG003|Overall Study|Withdrawal by Subject|0|||
156871410|NCT02000115|566286082|FG000|Overall Study|Lost to Follow-up|0|||
156871411|NCT02000115|566286083|FG001|Overall Study|Lost to Follow-up|1|||
156871412|NCT02000115|566286084|FG002|Overall Study|Lost to Follow-up|0|||
156871413|NCT02000115|566286085|FG003|Overall Study|Lost to Follow-up|0|||
156871414|NCT02000115|566286082|FG000|Overall Study|Non-compliance|2|||
156871415|NCT02000115|566286083|FG001|Overall Study|Non-compliance|1|||
156438562|NCT00835770|564697066|FG000|Overall Study|MS Relapse|17|||
156697515|NCT03186781|565640900|FG003|Overall Study|Lost to Follow-up|0|||
156697516|NCT03186781|565640901|FG004|Overall Study|Lost to Follow-up|1|||
156697517|NCT03186781|565640902|FG005|Overall Study|Lost to Follow-up|0|||
156697518|NCT03186781|565640897|FG000|Overall Study|Moved from Area|0|||
156697519|NCT03186781|565640898|FG001|Overall Study|Moved from Area|0|||
156697520|NCT03186781|565640899|FG002|Overall Study|Moved from Area|0|||
156438563|NCT00835770|564697067|FG001|Overall Study|MS Relapse|23|||
156697521|NCT03186781|565640900|FG003|Overall Study|Moved from Area|0|||
156697522|NCT03186781|565640901|FG004|Overall Study|Moved from Area|1|||
156697523|NCT03186781|565640902|FG005|Overall Study|Moved from Area|0|||
156697524|NCT03186781|565640897|FG000|Overall Study|Withdrawal by Subject|0|||
156697525|NCT03186781|565640898|FG001|Overall Study|Withdrawal by Subject|0|||
156697526|NCT03186781|565640899|FG002|Overall Study|Withdrawal by Subject|0|||
156790326|NCT00806026|565983782|FG003|Overall Study|Other|2|||
156790327|NCT00806026|565983783|FG004|Overall Study|Other|0|||
156790328|NCT00806026|565983784|FG005|Overall Study|Other|4|||
156790329|NCT00806026|565983779|FG000|Overall Study|Protocol Violation|6|||
156697527|NCT03186781|565640900|FG003|Overall Study|Withdrawal by Subject|0|||
156790330|NCT00806026|565983780|FG001|Overall Study|Protocol Violation|9|||
156790331|NCT00806026|565983781|FG002|Overall Study|Protocol Violation|9|||
156790332|NCT00806026|565983782|FG003|Overall Study|Protocol Violation|0|||
156697528|NCT03186781|565640901|FG004|Overall Study|Withdrawal by Subject|1|||
156697529|NCT03186781|565640902|FG005|Overall Study|Withdrawal by Subject|0|||
156697530|NCT04709835|565640903|FG000|Overall Study|Withdrawal by Subject|0|||
156697531|NCT04709835|565640904|FG001|Overall Study|Withdrawal by Subject|1|||
156697532|NCT04709835|565640905|FG002|Overall Study|Withdrawal by Subject|0|||
156697533|NCT00667810|565640906|FG000|Overall Study|Adverse Event|13|||
156697534|NCT00667810|565640907|FG001|Overall Study|Adverse Event|14|||
156697535|NCT00667810|565640908|FG002|Overall Study|Adverse Event|19|||
156697536|NCT00667810|565640909|FG003|Overall Study|Adverse Event|1|||
156697537|NCT00667810|565640906|FG000|Overall Study|Death|1|||
156697538|NCT00667810|565640907|FG001|Overall Study|Death|1|||
156697539|NCT00667810|565640908|FG002|Overall Study|Death|3|||
156697540|NCT00667810|565640909|FG003|Overall Study|Death|0|||
156697541|NCT00667810|565640906|FG000|Overall Study|Lack of Efficacy|1|||
156697542|NCT00667810|565640907|FG001|Overall Study|Lack of Efficacy|0|||
156697543|NCT00667810|565640908|FG002|Overall Study|Lack of Efficacy|2|||
156697544|NCT00667810|565640909|FG003|Overall Study|Lack of Efficacy|0|||
156871416|NCT02000115|566286084|FG002|Overall Study|Non-compliance|0|||
156871417|NCT02000115|566286085|FG003|Overall Study|Non-compliance|0|||
156871418|NCT02000115|566286082|FG000|Overall Study|Withdrawn on day of randomization|0|||
156871419|NCT02000115|566286083|FG001|Overall Study|Withdrawn on day of randomization|1|||
156871420|NCT02000115|566286084|FG002|Overall Study|Withdrawn on day of randomization|0|||
156871421|NCT02000115|566286085|FG003|Overall Study|Withdrawn on day of randomization|0|||
156871422|NCT02000115|566286082|FG000|Overall Study|Still on Study|0|||
156871423|NCT02000115|566286083|FG001|Overall Study|Still on Study|0|||
156871424|NCT02000115|566286084|FG002|Overall Study|Still on Study|0|||
156871425|NCT02000115|566286085|FG003|Overall Study|Still on Study|53|||
156871426|NCT01967238|566286088|FG000|Overall Study|Adverse Event|1|||
156871427|NCT01967238|566286089|FG001|Overall Study|Adverse Event|1|||
156871428|NCT01967238|566286090|FG002|Overall Study|Adverse Event|0|||
156871429|NCT01967238|566286088|FG000|Overall Study|Lost to Follow-up|1|||
156871430|NCT01967238|566286089|FG001|Overall Study|Lost to Follow-up|0|||
156871431|NCT01967238|566286090|FG002|Overall Study|Lost to Follow-up|1|||
156871432|NCT01967238|566286088|FG000|Overall Study|Withdrawal by Subject|0|||
156871433|NCT01967238|566286089|FG001|Overall Study|Withdrawal by Subject|0|||
156871434|NCT01967238|566286090|FG002|Overall Study|Withdrawal by Subject|1|||
156871435|NCT02484391|566286091|FG000|Overall Study|Lack of Efficacy|15|||
156871436|NCT02484391|566286092|FG001|Overall Study|Lack of Efficacy|14|||
156871437|NCT02484391|566286093|FG002|Overall Study|Lack of Efficacy|3|||
156871438|NCT02484391|566286091|FG000|Overall Study|Lost to Follow-up|0|||
156871439|NCT02484391|566286092|FG001|Overall Study|Lost to Follow-up|0|||
156871440|NCT02484391|566286093|FG002|Overall Study|Lost to Follow-up|2|||
156871441|NCT02484391|566286091|FG000|Overall Study|Physician Decision|1|||
156871442|NCT02484391|566286092|FG001|Overall Study|Physician Decision|3|||
156871443|NCT02484391|566286093|FG002|Overall Study|Physician Decision|0|||
156871444|NCT02484391|566286091|FG000|Overall Study|Went to Transplant|5|||
156871445|NCT02484391|566286092|FG001|Overall Study|Went to Transplant|3|||
156871446|NCT02484391|566286093|FG002|Overall Study|Went to Transplant|2|||
156871447|NCT04949490|566286097|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156871448|NCT04949490|566286098|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156697545|NCT00667810|565640906|FG000|Overall Study|Lost to Follow-up|1|||
156697546|NCT00667810|565640907|FG001|Overall Study|Lost to Follow-up|4|||
156697547|NCT00667810|565640908|FG002|Overall Study|Lost to Follow-up|2|||
156697548|NCT00667810|565640909|FG003|Overall Study|Lost to Follow-up|0|||
156697549|NCT00667810|565640906|FG000|Overall Study|Physician Decision|1|||
156697550|NCT00667810|565640907|FG001|Overall Study|Physician Decision|1|||
156790333|NCT00806026|565983783|FG004|Overall Study|Protocol Violation|2|||
156790334|NCT00806026|565983784|FG005|Overall Study|Protocol Violation|3|||
156790335|NCT00806026|565983779|FG000|Overall Study|Adverse Event|52|||
156871449|NCT04949490|566286099|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156871450|NCT04949490|566286100|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
156871451|NCT04949490|566286101|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156871452|NCT04949490|566286102|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156871453|NCT04949490|566286097|FG000|Group A and Group B|Withdrawal by Subject|0|||
156871454|NCT04949490|566286098|FG001|Group A and Group B|Withdrawal by Subject|0|||
156697551|NCT00667810|565640908|FG002|Overall Study|Physician Decision|2|||
156697552|NCT00667810|565640909|FG003|Overall Study|Physician Decision|0|||
156697553|NCT00667810|565640906|FG000|Overall Study|Protocol Violation|0|||
156697554|NCT00667810|565640907|FG001|Overall Study|Protocol Violation|2|||
156697555|NCT00667810|565640908|FG002|Overall Study|Protocol Violation|0|||
156697556|NCT00667810|565640909|FG003|Overall Study|Protocol Violation|0|||
156697557|NCT00667810|565640906|FG000|Overall Study|Withdrawal by Subject|14|||
156697558|NCT00667810|565640907|FG001|Overall Study|Withdrawal by Subject|20|||
156697559|NCT00667810|565640908|FG002|Overall Study|Withdrawal by Subject|29|||
156697560|NCT00667810|565640909|FG003|Overall Study|Withdrawal by Subject|1|||
156697561|NCT00667810|565640906|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
156697562|NCT00667810|565640907|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
156697563|NCT00667810|565640908|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
156697564|NCT00667810|565640909|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
156697565|NCT00667810|565640906|FG000|Overall Study|Failed to Return|0|||
156697566|NCT00667810|565640907|FG001|Overall Study|Failed to Return|0|||
156697567|NCT00667810|565640908|FG002|Overall Study|Failed to Return|2|||
156697568|NCT00667810|565640909|FG003|Overall Study|Failed to Return|0|||
156697569|NCT00667810|565640906|FG000|Overall Study|Loss of Caregiver|0|||
156697570|NCT00667810|565640907|FG001|Overall Study|Loss of Caregiver|1|||
156697571|NCT00667810|565640908|FG002|Overall Study|Loss of Caregiver|3|||
156697572|NCT00667810|565640909|FG003|Overall Study|Loss of Caregiver|0|||
156697573|NCT00667810|565640906|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
156697574|NCT00667810|565640907|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
156697575|NCT00667810|565640908|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
156697576|NCT00667810|565640909|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
156697577|NCT00667810|565640906|FG000|Overall Study|Other|6|||
156697578|NCT00667810|565640907|FG001|Overall Study|Other|6|||
156697579|NCT00667810|565640908|FG002|Overall Study|Other|5|||
156697580|NCT00667810|565640909|FG003|Overall Study|Other|0|||
156697581|NCT01383135|565640918|FG000|Overall Study|Not Scanned / Imaged|1|||
156697582|NCT01383135|565640919|FG001|Overall Study|Not Scanned / Imaged|0|||
156697583|NCT01383135|565640920|FG002|Overall Study|Not Scanned / Imaged|1|||
156697584|NCT01383135|565640921|FG003|Overall Study|Not Scanned / Imaged|0|||
156697585|NCT03397771|565640922|FG000|Overall Study|2 erroneously randomized, never treated|3|||
156697586|NCT03397771|565640923|FG001|Overall Study|2 erroneously randomized, never treated|1|||
156697587|NCT03397771|565640922|FG000|Overall Study|Withdrawal by Subject|1|||
156697588|NCT03397771|565640923|FG001|Overall Study|Withdrawal by Subject|3|||
156697589|NCT03397771|565640922|FG000|Overall Study|Protocol Violation|2|||
156697590|NCT03397771|565640923|FG001|Overall Study|Protocol Violation|2|||
156697591|NCT03397771|565640922|FG000|Overall Study|Adverse Event|2|||
156697592|NCT03397771|565640923|FG001|Overall Study|Adverse Event|1|||
156697593|NCT02669758|565640926|FG000|Overall Study|Withdrawal by Subject|43|||
156697594|NCT02669758|565640926|FG000|Overall Study|Lost to Follow-up|19|||
156697595|NCT02669758|565640926|FG000|Overall Study|Adverse Event|16|||
156697596|NCT02669758|565640926|FG000|Overall Study|Non-Compliance with Study Drug|8|||
156697597|NCT02669758|565640926|FG000|Overall Study|Lack of Efficacy|5|||
156697598|NCT02669758|565640926|FG000|Overall Study|Pregnancy|1|||
156697599|NCT02669758|565640926|FG000|Overall Study|Study noncompliance|1|||
156697600|NCT02669758|565640926|FG000|Overall Study|Protocol Violation|1|||
156697601|NCT03393806|565640929|FG000|Overall Study|Physician Decision|1|||
156697602|NCT03393806|565640930|FG001|Overall Study|Physician Decision|0|||
156697603|NCT02534844|565640931|FG000|Part B|Withdrawal by Subject|0|||
156697604|NCT02534844|565640932|FG001|Part B|Withdrawal by Subject|0|||
156697605|NCT02534844|565640933|FG002|Part B|Withdrawal by Subject|0|||
156697606|NCT02534844|565640934|FG003|Part B|Withdrawal by Subject|0|||
156697607|NCT02534844|565640935|FG004|Part B|Withdrawal by Subject|2|||
156697608|NCT02534844|565640936|FG005|Part B|Withdrawal by Subject|1|||
156697609|NCT01971970|565640937|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
156697610|NCT01971970|565640938|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
156697611|NCT01971970|565640937|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
156697612|NCT01971970|565640938|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
156697613|NCT01971970|565640937|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
156697614|NCT01971970|565640938|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
156697615|NCT01971970|565640937|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
156697616|NCT01971970|565640938|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
156697617|NCT01971970|565640937|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
156697618|NCT01971970|565640938|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
156697619|NCT01971970|565640937|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
156697620|NCT01971970|565640938|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
156697621|NCT01971970|565640937|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
156697622|NCT01971970|565640938|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
156697623|NCT00848107|565640939|FG000|Overall Study|Lost to Follow-up|2|||
156697624|NCT00848107|565640939|FG000|Overall Study|Withdrawal by Subject|8|||
156697625|NCT00848107|565640939|FG000|Overall Study|Adverse Event|9|||
156697626|NCT00848107|565640939|FG000|Overall Study|Death|1|||
156697627|NCT00848107|565640939|FG000|Overall Study|Pregnancy|1|||
156697628|NCT00859586|565640940|FG000|Overall Study|Donors|4|||
156697629|NCT00507130|565640941|FG000|Overall Study|Lost to Follow-up|0|||
156697630|NCT00507130|565640942|FG001|Overall Study|Lost to Follow-up|0|||
156697631|NCT00507130|565640943|FG002|Overall Study|Lost to Follow-up|1|||
156697632|NCT00507130|565640944|FG003|Overall Study|Lost to Follow-up|1|||
156697633|NCT00507130|565640941|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
156331229|NCT05938920|564311975|FG000|Overall Study|Adverse Event|1|||
156331230|NCT05938920|564311976|FG001|Overall Study|Adverse Event|3|||
156697634|NCT00507130|565640942|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
156697635|NCT00507130|565640943|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
156697636|NCT00507130|565640944|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
156697637|NCT02524730|565640945|FG000|Overall Study|Lost to Follow-up|5|||
156697638|NCT02524730|565640945|FG000|Overall Study|Withdrawal by Subject|18|||
156697639|NCT02524730|565640945|FG000|Overall Study|Death|10|||
156697640|NCT02524730|565640945|FG000|Overall Study|Adverse Event|8|||
156697641|NCT02524730|565640945|FG000|Overall Study|Protocol Violation|1|||
156697642|NCT02524730|565640945|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
156697643|NCT00080938|565640948|FG000|Overall Study|Adverse Event|3|||
156697644|NCT00080938|565640948|FG000|Overall Study|Withdrawal by Subject|6|||
156697645|NCT00080938|565640948|FG000|Overall Study|Death|2|||
156697646|NCT00080938|565640948|FG000|Overall Study|Lack of Efficacy|7|||
156697647|NCT00080938|565640948|FG000|Overall Study|other disease|1|||
156697648|NCT00080938|565640948|FG000|Overall Study|Not started protocol therapy|1|||
156697649|NCT00080938|565640948|FG000|Overall Study|Ineligible|4|||
156697650|NCT02605993|565640949|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
156697651|NCT02605993|565640950|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
156697652|NCT02605993|565640951|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
156697653|NCT02605993|565640952|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
156697654|NCT03493386|565640954|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156697655|NCT03493386|565640955|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
156697656|NCT03493386|565640956|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156697657|NCT03493386|565640957|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156697658|NCT00546572|565640962|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
156697659|NCT00546572|565640963|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
156697660|NCT00546572|565640962|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
156697661|NCT00546572|565640963|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
156697662|NCT00546572|565640962|FG000|Vax 1 / Year 0|Protocol Violation|3|||
156697663|NCT00546572|565640963|FG001|Vax 1 / Year 0|Protocol Violation|4|||
156697664|NCT00546572|565640962|FG000|Vax 1 / Year 0|Death|2|||
156697665|NCT00546572|565640963|FG001|Vax 1 / Year 0|Death|2|||
156697666|NCT00546572|565640962|FG000|Vax 1 / Year 0|Adverse Event|0|||
156697667|NCT00546572|565640963|FG001|Vax 1 / Year 0|Adverse Event|1|||
156697668|NCT00546572|565640962|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
156697669|NCT00546572|565640963|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
156697670|NCT00546572|565640962|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
156697671|NCT00546572|565640963|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
156697672|NCT00546572|565640962|FG000|Vax 2 / Year 1|Other|1|||
156697673|NCT00546572|565640963|FG001|Vax 2 / Year 1|Other|1|||
156697674|NCT00546572|565640962|FG000|Vax 2 / Year 1|Adverse Event|1|||
156697675|NCT00546572|565640963|FG001|Vax 2 / Year 1|Adverse Event|0|||
156697676|NCT00546572|565640962|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
156697677|NCT00546572|565640963|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
156697678|NCT02685202|565640964|FG000|Overall Study|Lost to Follow-up|9|||
156697679|NCT02989168|565640974|FG000|Overall Study|Withdrawal by Subject|2|||
156697680|NCT02989168|565640975|FG001|Overall Study|Withdrawal by Subject|0|||
156697681|NCT02989168|565640974|FG000|Overall Study|Physician Decision|0|||
156697682|NCT02989168|565640975|FG001|Overall Study|Physician Decision|1|||
156697683|NCT02989168|565640974|FG000|Overall Study|Adverse Event|1|||
156697684|NCT02989168|565640975|FG001|Overall Study|Adverse Event|2|||
156697685|NCT02989168|565640974|FG000|Overall Study|Sponsor stopped study.|1|||
156697686|NCT02989168|565640975|FG001|Overall Study|Sponsor stopped study.|0|||
156697687|NCT03456960|565640976|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156697688|NCT03456960|565640977|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156697689|NCT03456960|565640978|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
156697690|NCT03456960|565640979|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
156697691|NCT03456960|565640980|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156697692|NCT03456960|565640981|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156697693|NCT03456960|565640976|FG000|Period 2 (1 Day)|Adverse Event|1|||
156697694|NCT03456960|565640977|FG001|Period 2 (1 Day)|Adverse Event|0|||
156697695|NCT03456960|565640978|FG002|Period 2 (1 Day)|Adverse Event|0|||
156697696|NCT03456960|565640979|FG003|Period 2 (1 Day)|Adverse Event|1|||
156697697|NCT03456960|565640980|FG004|Period 2 (1 Day)|Adverse Event|0|||
156697698|NCT03456960|565640981|FG005|Period 2 (1 Day)|Adverse Event|0|||
156697699|NCT00532935|565640982|FG000|Overall Study|Adverse Event|11|||
156697700|NCT00532935|565640983|FG001|Overall Study|Adverse Event|12|||
156697701|NCT00532935|565640982|FG000|Overall Study|Lack of Efficacy|0|||
156697702|NCT00532935|565640983|FG001|Overall Study|Lack of Efficacy|3|||
156697703|NCT00532935|565640982|FG000|Overall Study|Lost to Follow-up|10|||
156697704|NCT00532935|565640983|FG001|Overall Study|Lost to Follow-up|6|||
156697705|NCT00532935|565640982|FG000|Overall Study|Physician Decision|4|||
156697706|NCT00532935|565640983|FG001|Overall Study|Physician Decision|5|||
156790336|NCT00806026|565983780|FG001|Overall Study|Adverse Event|35|||
156790337|NCT00806026|565983781|FG002|Overall Study|Adverse Event|44|||
156790338|NCT00806026|565983782|FG003|Overall Study|Adverse Event|17|||
156790339|NCT00806026|565983783|FG004|Overall Study|Adverse Event|9|||
156790340|NCT00806026|565983784|FG005|Overall Study|Adverse Event|9|||
156790341|NCT00819832|565983785|FG000|Overall Study|Sponsor Termination of Study|3|||
156790342|NCT00819832|565983786|FG001|Overall Study|Sponsor Termination of Study|0|||
156790343|NCT00819832|565983787|FG002|Overall Study|Sponsor Termination of Study|0|||
156790344|NCT00819832|565983788|FG003|Overall Study|Sponsor Termination of Study|0|||
156790345|NCT00819832|565983789|FG004|Overall Study|Sponsor Termination of Study|0|||
156790346|NCT00819832|565983790|FG005|Overall Study|Sponsor Termination of Study|0|||
156790347|NCT01063881|565983793|FG000|Overall Study|Adverse Event|12|||
156790348|NCT01063881|565983794|FG001|Overall Study|Adverse Event|2|||
156790349|NCT01063881|565983795|FG002|Overall Study|Adverse Event|0|||
156790350|NCT01063881|565983793|FG000|Overall Study|Lost to Follow-up|13|||
156790351|NCT01063881|565983794|FG001|Overall Study|Lost to Follow-up|7|||
156790352|NCT01063881|565983795|FG002|Overall Study|Lost to Follow-up|1|||
156790353|NCT01063881|565983793|FG000|Overall Study|Withdrawal by Subject|25|||
156790354|NCT01063881|565983794|FG001|Overall Study|Withdrawal by Subject|1|||
156790355|NCT01063881|565983795|FG002|Overall Study|Withdrawal by Subject|0|||
156790356|NCT01063881|565983793|FG000|Overall Study|Reason for not completed not specified|5|||
156790357|NCT01063881|565983794|FG001|Overall Study|Reason for not completed not specified|1|||
156790358|NCT01063881|565983795|FG002|Overall Study|Reason for not completed not specified|0|||
156790359|NCT01340170|565983796|FG000|Overall Study|Lost to Follow-up|2|||
156790360|NCT01340170|565983797|FG001|Overall Study|Lost to Follow-up|4|||
156790361|NCT01340170|565983798|FG002|Overall Study|Lost to Follow-up|0|||
156790362|NCT01340170|565983796|FG000|Overall Study|Implant failure|1|||
156790363|NCT01340170|565983797|FG001|Overall Study|Implant failure|3|||
156790364|NCT01340170|565983798|FG002|Overall Study|Implant failure|0|||
156790365|NCT00736476|565983799|FG000|Overall Study|Adverse Event|1|||
156790366|NCT00736476|565983800|FG001|Overall Study|Adverse Event|0|||
156790367|NCT01796470|565983802|FG000|Overall Study|Adverse Event|4|||
156790368|NCT01796470|565983803|FG001|Overall Study|Adverse Event|2|||
156790369|NCT01796470|565983804|FG002|Overall Study|Adverse Event|2|||
156790370|NCT01796470|565983805|FG003|Overall Study|Adverse Event|1|||
156790371|NCT01796470|565983806|FG004|Overall Study|Adverse Event|3|||
156790372|NCT01796470|565983802|FG000|Overall Study|Death|2|||
156790373|NCT01796470|565983803|FG001|Overall Study|Death|0|||
156871455|NCT04949490|566286099|FG002|Group A and Group B|Withdrawal by Subject|1|||
156871456|NCT04949490|566286100|FG003|Group A and Group B|Withdrawal by Subject|0|||
156871457|NCT04949490|566286101|FG004|Group A and Group B|Withdrawal by Subject|0|||
156871458|NCT04949490|566286102|FG005|Group A and Group B|Withdrawal by Subject|0|||
156871459|NCT04949490|566286097|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871460|NCT04949490|566286098|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871461|NCT04949490|566286099|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871462|NCT04949490|566286100|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871463|NCT04949490|566286101|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871464|NCT04949490|566286102|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
156871465|NCT04949490|566286097|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156871466|NCT04949490|566286098|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156697707|NCT00532935|565640982|FG000|Overall Study|Pregnancy|1|||
156790374|NCT01796470|565983804|FG002|Overall Study|Death|0|||
156871467|NCT04949490|566286099|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156871468|NCT04949490|566286100|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156790375|NCT01796470|565983805|FG003|Overall Study|Death|0|||
156790376|NCT01796470|565983806|FG004|Overall Study|Death|1|||
156331231|NCT05938920|564311977|FG002|Overall Study|Adverse Event|2|||
156331232|NCT05938920|564311978|FG003|Overall Study|Adverse Event|1|||
156697708|NCT00532935|565640983|FG001|Overall Study|Pregnancy|0|||
156790377|NCT01796470|565983802|FG000|Overall Study|Initiated New Therapy|9|||
156790378|NCT01796470|565983803|FG001|Overall Study|Initiated New Therapy|0|||
156790379|NCT01796470|565983804|FG002|Overall Study|Initiated New Therapy|0|||
156790380|NCT01796470|565983805|FG003|Overall Study|Initiated New Therapy|0|||
156790381|NCT01796470|565983806|FG004|Overall Study|Initiated New Therapy|2|||
156790382|NCT01796470|565983802|FG000|Overall Study|Lost to Follow-up|0|||
156697709|NCT00532935|565640982|FG000|Overall Study|Protocol Violation|4|||
156697710|NCT00532935|565640983|FG001|Overall Study|Protocol Violation|2|||
156697711|NCT00532935|565640982|FG000|Overall Study|Withdrawal by Subject|10|||
156697712|NCT00532935|565640983|FG001|Overall Study|Withdrawal by Subject|9|||
156697713|NCT00532935|565640982|FG000|Overall Study|Protocol Specific Criteria|11|||
156697714|NCT00532935|565640983|FG001|Overall Study|Protocol Specific Criteria|15|||
156697715|NCT00502801|565640984|FG000|Treatment Period|Withdrawal by Subject|3|||
156697716|NCT00502801|565640984|FG000|Treatment Period|Adverse Event|7|||
156697717|NCT00502801|565640984|FG000|Treatment Period|Death|14|||
156697718|NCT00502801|565640984|FG000|Treatment Period|OTHER|30|||
156697719|NCT00502801|565640984|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
156697720|NCT00502801|565640984|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
156697721|NCT00502801|565640984|FG000|End of Therapy to Test of Cure|Death|3|||
156697722|NCT00502801|565640984|FG000|End of Therapy to Test of Cure|OTHER|2|||
156697723|NCT01769339|565640987|FG000|Overall Study|Lost to Follow-up|42|||
156697724|NCT01769339|565640987|FG000|Overall Study|Adverse Event|1|||
156697725|NCT01195272|565640990|FG000|Overall Study|Adverse Event|1|||
156697726|NCT01195272|565640990|FG000|Overall Study|Lack of Efficacy|3|||
156697727|NCT04969861|565640991|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
156697728|NCT04969861|565640992|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
156697729|NCT00290251|565640993|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697730|NCT00290251|565640994|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697731|NCT00290251|565640995|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697732|NCT00290251|565640996|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697733|NCT00290251|565640997|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697734|NCT00290251|565640998|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
156697735|NCT00290251|565640993|FG000|Treatment 1 (Months 2-4)|headache|0|||
156697736|NCT00290251|565640994|FG001|Treatment 1 (Months 2-4)|headache|0|||
156697737|NCT00290251|565640995|FG002|Treatment 1 (Months 2-4)|headache|0|||
156697738|NCT00290251|565640996|FG003|Treatment 1 (Months 2-4)|headache|0|||
156697739|NCT00290251|565640997|FG004|Treatment 1 (Months 2-4)|headache|1|||
156697740|NCT00290251|565640998|FG005|Treatment 1 (Months 2-4)|headache|0|||
156697741|NCT00290251|565640993|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697742|NCT00290251|565640994|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697743|NCT00290251|565640995|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697744|NCT00290251|565640996|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
156697745|NCT00290251|565640997|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697746|NCT00290251|565640998|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697747|NCT04280705|565642557|FG000|Overall Study|Enrolled but not treated|4|||
156697748|NCT04280705|565642558|FG001|Overall Study|Enrolled but not treated|10|||
156697749|NCT04280705|565642557|FG000|Overall Study|Physician Decision|1|||
156697750|NCT04280705|565642558|FG001|Overall Study|Physician Decision|0|||
156697751|NCT04280705|565642557|FG000|Overall Study|Withdrawal by Subject|7|||
156697752|NCT04280705|565642558|FG001|Overall Study|Withdrawal by Subject|9|||
156697753|NCT04280705|565642557|FG000|Overall Study|Adverse Event|0|||
156697754|NCT04280705|565642558|FG001|Overall Study|Adverse Event|4|||
156871469|NCT04949490|566286101|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
156871470|NCT04949490|566286102|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156871471|NCT04721977|566286103|FG000|Overall Study|Death|15|||
156871472|NCT04721977|566286103|FG000|Overall Study|Ongoing|51|||
156871473|NCT02864394|566286104|FG000|Overall Study|Death|184|||
156871474|NCT02864394|566286105|FG001|Overall Study|Death|189|||
156871475|NCT02864394|566286104|FG000|Overall Study|Lost to Follow-up|0|||
156871476|NCT02864394|566286105|FG001|Overall Study|Lost to Follow-up|2|||
156871477|NCT02864394|566286104|FG000|Overall Study|Sponsor Decision|26|||
156871478|NCT02864394|566286105|FG001|Overall Study|Sponsor Decision|11|||
156871479|NCT02864394|566286104|FG000|Overall Study|Withdrawal by Subject|3|||
156871480|NCT02864394|566286105|FG001|Overall Study|Withdrawal by Subject|10|||
156871481|NCT00905164|566286106|FG000|Period 1|Protocol Violation|0|||
156871482|NCT00905164|566286107|FG001|Period 1|Protocol Violation|1|||
156871483|NCT04730804|566286108|FG000|Overall Study|Physician Decision|0|||
156871484|NCT04730804|566286109|FG001|Overall Study|Physician Decision|0|||
156871485|NCT04730804|566286110|FG002|Overall Study|Physician Decision|0|||
156871486|NCT04730804|566286111|FG003|Overall Study|Physician Decision|0|||
156871487|NCT04730804|566286112|FG004|Overall Study|Physician Decision|0|||
156871488|NCT04730804|566286113|FG005|Overall Study|Physician Decision|1|||
156871489|NCT04730804|566286108|FG000|Overall Study|Withdrawal by Subject|0|||
156871490|NCT04730804|566286109|FG001|Overall Study|Withdrawal by Subject|0|||
156871491|NCT04730804|566286110|FG002|Overall Study|Withdrawal by Subject|0|||
156697755|NCT04280705|565642557|FG000|Overall Study|Transferred to another hospital|1|||
156697756|NCT04280705|565642558|FG001|Overall Study|Transferred to another hospital|1|||
156697757|NCT03986138|565642559|FG000|First MRI Examination|Physician Decision|0|||
156697758|NCT03986138|565642560|FG001|First MRI Examination|Physician Decision|1|||
156697759|NCT03986138|565642559|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
156697760|NCT03986138|565642560|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
156697761|NCT03986138|565642559|FG000|Washout|Withdrawal by Subject|4|||
156697762|NCT03986138|565642560|FG001|Washout|Withdrawal by Subject|5|||
156697763|NCT03986138|565642559|FG000|Washout|Lost to Follow-up|0|||
156697764|NCT03986138|565642560|FG001|Washout|Lost to Follow-up|2|||
156697765|NCT03986138|565642559|FG000|Washout|Adverse Event|1|||
156697766|NCT03986138|565642560|FG001|Washout|Adverse Event|1|||
156697767|NCT03986138|565642559|FG000|Washout|Other reason|5|||
156697768|NCT03986138|565642560|FG001|Washout|Other reason|5|||
156697769|NCT03986138|565642559|FG000|Second MRI Examination|Withdrawal by Subject|0|||
156697770|NCT03986138|565642560|FG001|Second MRI Examination|Withdrawal by Subject|2|||
156697771|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Death|89|||
156697772|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Death|193|||
156697773|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Death|198|||
156697774|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
156697775|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
156697776|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
156697777|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
156697778|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
156697779|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
156697780|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
156697781|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
156697782|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
156697783|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
156697784|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
156697785|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
156697786|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
156697787|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
156697788|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
156697789|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
156697790|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
156697791|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
156697792|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Death|36|||
156697793|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Death|87|||
156697794|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Death|100|||
156697795|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
156697796|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
156697797|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
156697798|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Physician Decision|0|||
156697799|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Physician Decision|1|||
156697800|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Physician Decision|0|||
156697801|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
156697802|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
156697803|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
156697804|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
156871492|NCT04730804|566286111|FG003|Overall Study|Withdrawal by Subject|0|||
156871493|NCT04730804|566286112|FG004|Overall Study|Withdrawal by Subject|1|||
156871494|NCT04730804|566286113|FG005|Overall Study|Withdrawal by Subject|2|||
156871495|NCT01442103|566287687|FG000|Overall Study|Lost to Follow-up|2|||
156871496|NCT02102204|566287692|FG000|Overall Study|Withdrawal by Subject|137|||
156871497|NCT02102204|566287692|FG000|Overall Study|Death|92|||
156871498|NCT02102204|566287692|FG000|Overall Study|Lost to Follow-up|65|||
156871499|NCT02102204|566287692|FG000|Overall Study|Sponsor Decision|5|||
156871500|NCT02102204|566287692|FG000|Overall Study|Ongoing|5|||
156871501|NCT03751657|566287693|FG000|Overall Study|Physician Decision|0|||
156871502|NCT03751657|566287694|FG001|Overall Study|Physician Decision|1|||
156871503|NCT03751657|566287693|FG000|Overall Study|Withdrawal by Subject|1|||
156871504|NCT03751657|566287694|FG001|Overall Study|Withdrawal by Subject|1|||
156871505|NCT03751657|566287693|FG000|Overall Study|Lost to Follow-up|2|||
156871506|NCT03751657|566287694|FG001|Overall Study|Lost to Follow-up|1|||
156871507|NCT03894813|566287701|FG000|Overall Study|Adverse Event|1|||
156871508|NCT03894813|566287702|FG001|Overall Study|Adverse Event|1|||
156871509|NCT03894813|566287701|FG000|Overall Study|Lack of Efficacy|3|||
156871510|NCT03894813|566287702|FG001|Overall Study|Lack of Efficacy|3|||
156871511|NCT03894813|566287701|FG000|Overall Study|Lost to Follow-up|1|||
156871512|NCT03894813|566287702|FG001|Overall Study|Lost to Follow-up|0|||
156871513|NCT03894813|566287701|FG000|Overall Study|Pregnancy|2|||
156871514|NCT03894813|566287702|FG001|Overall Study|Pregnancy|1|||
156697805|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
156697806|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
156697807|NCT02031458|565642561|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
156871515|NCT03894813|566287701|FG000|Overall Study|Protocol Violation|3|||
156871516|NCT03894813|566287702|FG001|Overall Study|Protocol Violation|7|||
156697808|NCT02031458|565642562|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
156871517|NCT03894813|566287701|FG000|Overall Study|Withdrawal by Subject|1|||
156697809|NCT02031458|565642563|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
156697810|NCT02031458|565642561|FG000|Baseline to May 8, 2015|On Treatment|43|||
156697811|NCT02031458|565642562|FG001|Baseline to May 8, 2015|On Treatment|81|||
156697812|NCT02031458|565642563|FG002|Baseline to May 8, 2015|On Treatment|73|||
156697813|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
156697814|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
156697815|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
156697816|NCT04305587|565642564|FG000|Overall Study|Withdrawal by Subject|0|||
156697817|NCT04305587|565642565|FG001|Overall Study|Withdrawal by Subject|0|||
156697818|NCT04305587|565642566|FG002|Overall Study|Withdrawal by Subject|0|||
156697819|NCT04305587|565642567|FG003|Overall Study|Withdrawal by Subject|1|||
156697820|NCT04305587|565642568|FG004|Overall Study|Withdrawal by Subject|0|||
156697821|NCT04305587|565642569|FG005|Overall Study|Withdrawal by Subject|0|||
156697822|NCT04305587|565642570|FG006|Overall Study|Withdrawal by Subject|0|||
156697823|NCT04305587|565642571|FG007|Overall Study|Withdrawal by Subject|0|||
156697824|NCT04305587|565642572|FG008|Overall Study|Withdrawal by Subject|0|||
156697825|NCT02752906|565642573|FG000|Overall Study|Protocol Violation|2|||
156697826|NCT02752906|565642574|FG001|Overall Study|Protocol Violation|1|||
156697827|NCT02752906|565642573|FG000|Overall Study|Withdrawal by Subject|2|||
156697828|NCT02752906|565642574|FG001|Overall Study|Withdrawal by Subject|2|||
156697829|NCT02752906|565642573|FG000|Overall Study|Lost to Follow-up|3|||
156697830|NCT02752906|565642574|FG001|Overall Study|Lost to Follow-up|2|||
156697831|NCT00824616|565642578|FG000|Overall Study|Adverse Event|2|||
156697832|NCT00824616|565642579|FG001|Overall Study|Adverse Event|1|||
156697833|NCT00824616|565642578|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
156697834|NCT00824616|565642579|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
156697835|NCT00824616|565642578|FG000|Overall Study|Hyperglycemia|1|||
156697836|NCT00824616|565642579|FG001|Overall Study|Hyperglycemia|1|||
156697837|NCT00824616|565642578|FG000|Overall Study|Lack of Efficacy|2|||
156697838|NCT00824616|565642579|FG001|Overall Study|Lack of Efficacy|1|||
156697839|NCT00824616|565642578|FG000|Overall Study|Lost to Follow-up|0|||
156790383|NCT01796470|565983803|FG001|Overall Study|Lost to Follow-up|1|||
156790384|NCT01796470|565983804|FG002|Overall Study|Lost to Follow-up|0|||
156790385|NCT01796470|565983805|FG003|Overall Study|Lost to Follow-up|0|||
156790386|NCT01796470|565983806|FG004|Overall Study|Lost to Follow-up|0|||
156790387|NCT01796470|565983802|FG000|Overall Study|Physician Decision|5|||
156790388|NCT01796470|565983803|FG001|Overall Study|Physician Decision|4|||
156790389|NCT01796470|565983804|FG002|Overall Study|Physician Decision|1|||
156790390|NCT01796470|565983805|FG003|Overall Study|Physician Decision|0|||
156790391|NCT01796470|565983806|FG004|Overall Study|Physician Decision|1|||
156790392|NCT01796470|565983802|FG000|Overall Study|Progressive Disease|7|||
156790393|NCT01796470|565983803|FG001|Overall Study|Progressive Disease|7|||
156790394|NCT01796470|565983804|FG002|Overall Study|Progressive Disease|3|||
156790395|NCT01796470|565983805|FG003|Overall Study|Progressive Disease|2|||
156790396|NCT01796470|565983806|FG004|Overall Study|Progressive Disease|0|||
156790397|NCT01796470|565983802|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
156790398|NCT01796470|565983803|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
156790399|NCT01796470|565983804|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
156790400|NCT01796470|565983805|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
156790401|NCT01796470|565983806|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
156790402|NCT01796470|565983802|FG000|Overall Study|Withdrawal by Subject|7|||
156790403|NCT01796470|565983803|FG001|Overall Study|Withdrawal by Subject|0|||
156790404|NCT01796470|565983804|FG002|Overall Study|Withdrawal by Subject|0|||
156790405|NCT01796470|565983805|FG003|Overall Study|Withdrawal by Subject|0|||
156790406|NCT01796470|565983806|FG004|Overall Study|Withdrawal by Subject|1|||
156790407|NCT01927861|565983807|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
156790408|NCT01927861|565983808|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
156790409|NCT01927861|565983807|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
156790410|NCT01927861|565983808|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
156790411|NCT00452530|565983809|FG000|Overall Study|Death|1|||
156790412|NCT00452530|565983810|FG001|Overall Study|Death|0|||
156790413|NCT00452530|565983809|FG000|Overall Study|Adverse Event|40|||
156790414|NCT00452530|565983810|FG001|Overall Study|Adverse Event|44|||
156790415|NCT00452530|565983809|FG000|Overall Study|Withdrawal by Subject|68|||
156790416|NCT00452530|565983810|FG001|Overall Study|Withdrawal by Subject|57|||
156790417|NCT00452530|565983809|FG000|Overall Study|Lost to Follow-up|1|||
156697840|NCT00824616|565642579|FG001|Overall Study|Lost to Follow-up|1|||
156697841|NCT00824616|565642578|FG000|Overall Study|Withdrawal by Subject|1|||
156697842|NCT00824616|565642579|FG001|Overall Study|Withdrawal by Subject|1|||
156697843|NCT00721630|565642580|FG000|Overall Study|Participant found to be ineligible|1|||
156697844|NCT03412396|565642595|FG000|Overall Study|Withdrawal by Subject|2|||
156790418|NCT00452530|565983810|FG001|Overall Study|Lost to Follow-up|0|||
156790419|NCT00452530|565983809|FG000|Overall Study|Poor compliance/noncompliance|1|||
156790420|NCT00452530|565983810|FG001|Overall Study|Poor compliance/noncompliance|2|||
156790421|NCT00452530|565983809|FG000|Overall Study|No longer met study criteria|18|||
156790422|NCT00452530|565983810|FG001|Overall Study|No longer met study criteria|22|||
156790423|NCT00452530|565983809|FG000|Overall Study|Other|7|||
156697845|NCT03412396|565642595|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
156697846|NCT03412396|565642595|FG000|Overall Study|Did not undergo RP|2|||
156697847|NCT03167723|565642598|FG000|Overall Study|Protocol Violation|4|||
156697848|NCT03167723|565642599|FG001|Overall Study|Protocol Violation|6|||
156697849|NCT01259115|565642600|FG000|Period 1|Adverse Event|1|||
156697850|NCT01259115|565642601|FG001|Period 1|Adverse Event|0|||
156697851|NCT01259115|565642600|FG000|Period 1|Protocol Violation|2|||
156697852|NCT01259115|565642601|FG001|Period 1|Protocol Violation|0|||
156697853|NCT01259115|565642600|FG000|Period 1|Lost to Follow-up|0|||
156790424|NCT00452530|565983810|FG001|Overall Study|Other|11|||
156697854|NCT01259115|565642601|FG001|Period 1|Lost to Follow-up|1|||
156790425|NCT02006654|565983813|FG000|Overall Study|Withdrawal before treatment|4|||
156790426|NCT02006654|565983814|FG001|Overall Study|Withdrawal before treatment|2|||
156790427|NCT02006654|565983813|FG000|Overall Study|Adverse Event|16|||
156790428|NCT02006654|565983814|FG001|Overall Study|Adverse Event|17|||
156790429|NCT02006654|565983813|FG000|Overall Study|Death|1|||
156790430|NCT02006654|565983814|FG001|Overall Study|Death|0|||
156790431|NCT02006654|565983813|FG000|Overall Study|Withdrawal by Subject|14|||
156790432|NCT02006654|565983814|FG001|Overall Study|Withdrawal by Subject|12|||
156790433|NCT02006654|565983813|FG000|Overall Study|Protocol Violation|5|||
156790434|NCT02006654|565983814|FG001|Overall Study|Protocol Violation|8|||
156790435|NCT02006654|565983813|FG000|Overall Study|Lost to Follow-up|1|||
156790436|NCT02006654|565983814|FG001|Overall Study|Lost to Follow-up|0|||
156790437|NCT02006654|565983813|FG000|Overall Study|patient's will|2|||
156790438|NCT02006654|565983814|FG001|Overall Study|patient's will|1|||
156790439|NCT02006654|565983813|FG000|Overall Study|insufficient compliance|1|||
156790440|NCT02006654|565983814|FG001|Overall Study|insufficient compliance|0|||
156790441|NCT02006654|565983813|FG000|Overall Study|worsening cognitive condition|0|||
156790442|NCT02006654|565983814|FG001|Overall Study|worsening cognitive condition|1|||
156790443|NCT02006654|565983813|FG000|Overall Study|faecal incontinence|0|||
156790444|NCT02006654|565983814|FG001|Overall Study|faecal incontinence|1|||
156790445|NCT02006654|565983813|FG000|Overall Study|mood disorder|0|||
156790446|NCT02006654|565983814|FG001|Overall Study|mood disorder|1|||
156790447|NCT02006654|565983813|FG000|Overall Study|disallowed medication|1|||
156790448|NCT02006654|565983814|FG001|Overall Study|disallowed medication|0|||
156790449|NCT02006654|565983813|FG000|Overall Study|moving out of state|0|||
156790450|NCT02006654|565983814|FG001|Overall Study|moving out of state|1|||
156790451|NCT01905267|565983817|FG000|Overall Study|Physician Decision|2|||
156790452|NCT01905267|565983818|FG001|Overall Study|Physician Decision|2|||
156790453|NCT02294019|565983819|FG000|Overall Study|Adverse Event|2|||
156790454|NCT02294019|565983819|FG000|Overall Study|Protocol Violation|68|||
156790455|NCT02294019|565983819|FG000|Overall Study|Lost to Follow-up|31|||
156790456|NCT02294019|565983819|FG000|Overall Study|Other|1|||
156790457|NCT02294019|565983819|FG000|Overall Study|Withdrawal by Subject|1|||
156790458|NCT01189227|565983821|FG000|Overall Study|Study terminated due to low accrual|6|||
156790459|NCT01189227|565983822|FG001|Overall Study|Study terminated due to low accrual|3|||
156790460|NCT02991859|565983825|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790461|NCT02991859|565983826|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
156790462|NCT02991859|565983827|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790463|NCT02991859|565983828|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790464|NCT02991859|565983829|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
156790465|NCT02991859|565983830|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790466|NCT02991859|565983831|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790467|NCT02991859|565983832|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790468|NCT02991859|565983833|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790469|NCT02991859|565983834|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790470|NCT02991859|565983835|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790471|NCT02991859|565983836|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790472|NCT02991859|565983837|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790473|NCT02991859|565983838|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790474|NCT02991859|565983839|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156697855|NCT01259115|565642600|FG000|Period 2|Adverse Event|1|||
156790475|NCT02991859|565983840|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790476|NCT02991859|565983841|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790477|NCT02991859|565983825|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790478|NCT02991859|565983826|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790479|NCT02991859|565983827|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790480|NCT02991859|565983828|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790481|NCT02991859|565983829|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156697856|NCT01259115|565642601|FG001|Period 2|Adverse Event|0|||
156697857|NCT01447420|565642615|FG000|Overall Study|Adverse Event|2|||
156697858|NCT01447420|565642616|FG001|Overall Study|Adverse Event|4|||
156697859|NCT01447420|565642617|FG002|Overall Study|Adverse Event|2|||
156697860|NCT01447420|565642615|FG000|Overall Study|Protocol Violation|3|||
156697861|NCT01447420|565642616|FG001|Overall Study|Protocol Violation|3|||
156697862|NCT01447420|565642617|FG002|Overall Study|Protocol Violation|0|||
156697863|NCT01447420|565642615|FG000|Overall Study|Withdrawal by Subject|4|||
156697864|NCT01447420|565642616|FG001|Overall Study|Withdrawal by Subject|1|||
156697865|NCT01447420|565642617|FG002|Overall Study|Withdrawal by Subject|0|||
156697866|NCT01447420|565642615|FG000|Overall Study|Lack of Efficacy|1|||
156697867|NCT01447420|565642616|FG001|Overall Study|Lack of Efficacy|19|||
156697868|NCT01447420|565642617|FG002|Overall Study|Lack of Efficacy|8|||
156697869|NCT02731326|565642618|FG000|Overall Study|Withdrawal by Subject|4|||
156697870|NCT02731326|565642619|FG001|Overall Study|Withdrawal by Subject|1|||
156697871|NCT02731326|565642618|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
156697872|NCT02731326|565642619|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
156697873|NCT02731326|565642618|FG000|Overall Study|Discharged without AliveCor|10|||
156697874|NCT02731326|565642619|FG001|Overall Study|Discharged without AliveCor|0|||
156697875|NCT02731326|565642618|FG000|Overall Study|Duplicate Participant|1|||
156697876|NCT02731326|565642619|FG001|Overall Study|Duplicate Participant|1|||
156697877|NCT04480710|565642624|FG000|Overall Study|Adverse Event|0|||
156697878|NCT04480710|565642625|FG001|Overall Study|Adverse Event|2|||
156697879|NCT04480710|565642626|FG002|Overall Study|Adverse Event|0|||
156697880|NCT04480710|565642627|FG003|Overall Study|Adverse Event|0|||
156697881|NCT04480710|565642624|FG000|Overall Study|Withdrawal by Subject|0|||
156697882|NCT04480710|565642625|FG001|Overall Study|Withdrawal by Subject|1|||
156697883|NCT04480710|565642626|FG002|Overall Study|Withdrawal by Subject|0|||
156790482|NCT02991859|565983830|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790483|NCT02991859|565983831|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156331233|NCT05938920|564311975|FG000|Overall Study|Death|0|||
156331234|NCT05938920|564311976|FG001|Overall Study|Death|1|||
156331235|NCT05938920|564311977|FG002|Overall Study|Death|0|||
156331236|NCT05938920|564311978|FG003|Overall Study|Death|0|||
156331237|NCT05938920|564311975|FG000|Overall Study|Lost to Follow-up|0|||
156331238|NCT05938920|564311976|FG001|Overall Study|Lost to Follow-up|0|||
156331239|NCT05938920|564311977|FG002|Overall Study|Lost to Follow-up|1|||
156331240|NCT05938920|564311978|FG003|Overall Study|Lost to Follow-up|0|||
156331241|NCT05938920|564311975|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
156331242|NCT05938920|564311976|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
156331243|NCT05938920|564311977|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
156331244|NCT05938920|564311978|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
156331245|NCT05938920|564311975|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
156331246|NCT05938920|564311976|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
156331247|NCT05938920|564311977|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
156331248|NCT05938920|564311978|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
156331249|NCT05938920|564311975|FG000|Overall Study|Participant Refused to Come In|0|||
156331250|NCT05938920|564311976|FG001|Overall Study|Participant Refused to Come In|0|||
156331251|NCT05938920|564311977|FG002|Overall Study|Participant Refused to Come In|1|||
156697884|NCT04480710|565642627|FG003|Overall Study|Withdrawal by Subject|0|||
156790484|NCT02991859|565983832|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156697885|NCT04480710|565642624|FG000|Overall Study|Physician Decision|0|||
156697886|NCT04480710|565642625|FG001|Overall Study|Physician Decision|0|||
156697887|NCT04480710|565642626|FG002|Overall Study|Physician Decision|1|||
156790485|NCT02991859|565983833|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790486|NCT02991859|565983834|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790487|NCT02991859|565983835|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156331252|NCT05938920|564311978|FG003|Overall Study|Participant Refused to Come In|0|||
156331253|NCT01251861|564311979|FG000|Overall Study|Disease progression|6|||
156331254|NCT01251861|564311980|FG001|Overall Study|Disease progression|6|||
156331255|NCT01251861|564311979|FG000|Overall Study|Adverse Event|2|||
156331256|NCT01251861|564311980|FG001|Overall Study|Adverse Event|17|||
156331257|NCT01251861|564311979|FG000|Overall Study|Withdrawal by Subject|2|||
156331258|NCT01251861|564311980|FG001|Overall Study|Withdrawal by Subject|2|||
156331259|NCT01251861|564311979|FG000|Overall Study|Alternative therapy|1|||
156331260|NCT01251861|564311980|FG001|Overall Study|Alternative therapy|0|||
156331261|NCT01251861|564311979|FG000|Overall Study|Other complicating disease|0|||
156331262|NCT01251861|564311980|FG001|Overall Study|Other complicating disease|1|||
156331263|NCT01251861|564311979|FG000|Overall Study|Physician Decision|1|||
156331264|NCT01251861|564311980|FG001|Overall Study|Physician Decision|0|||
156331265|NCT01251861|564311979|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
156331266|NCT01251861|564311980|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
156331267|NCT01251861|564311979|FG000|Overall Study|Other|1|||
156331268|NCT01251861|564311980|FG001|Overall Study|Other|0|||
156331269|NCT01251861|564311979|FG000|Overall Study|Never started therapy|4|||
156697888|NCT04480710|565642627|FG003|Overall Study|Physician Decision|0|||
156697889|NCT04480021|565642628|FG000|Overall Study|Lost to Follow-up|3|||
156697890|NCT04480021|565642629|FG001|Overall Study|Lost to Follow-up|4|||
156697891|NCT01103466|565642630|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
156697892|NCT01103466|565642631|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
156697893|NCT01103466|565642632|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
156697894|NCT01103466|565642630|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
156697895|NCT01103466|565642631|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
156697896|NCT01103466|565642632|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
156697897|NCT01103466|565642630|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
156697898|NCT01103466|565642631|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
156697899|NCT01103466|565642632|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
156697900|NCT01103466|565642630|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
156697901|NCT01103466|565642631|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
156697902|NCT01103466|565642632|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
156697903|NCT01103466|565642630|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
156697904|NCT01103466|565642631|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
156697905|NCT01103466|565642632|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
156697906|NCT01103466|565642630|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
156697907|NCT01103466|565642631|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
156697908|NCT01103466|565642632|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
156697909|NCT02994940|565642635|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
156697910|NCT02994940|565642636|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
156697911|NCT02994940|565642635|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
156697912|NCT02994940|565642636|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
156697913|NCT02994940|565642635|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
156697914|NCT02994940|565642636|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
156697915|NCT02987959|565642641|FG000|Overall Study|Grantor stopped supply of drugs|6|||
156697916|NCT02853370|565642642|FG000|Overall Study|Physician Decision|1|||
156697917|NCT02853370|565642642|FG000|Overall Study|Lack of Efficacy|2|||
156697918|NCT02853370|565642642|FG000|Overall Study|Death|1|||
156697919|NCT02853370|565642642|FG000|Overall Study|Adverse Event|4|||
156697920|NCT02853370|565642642|FG000|Overall Study|Withdrawal by Subject|3|||
156697921|NCT00643565|565642644|FG000|Overall Study|Death|12|||
156697922|NCT00643565|565642645|FG001|Overall Study|Death|11|||
156697923|NCT00643565|565642644|FG000|Overall Study|Withdrawal by Subject|4|||
156697924|NCT00643565|565642645|FG001|Overall Study|Withdrawal by Subject|1|||
156697925|NCT00643565|565642644|FG000|Overall Study|Lost to Follow-up|0|||
156697926|NCT00643565|565642645|FG001|Overall Study|Lost to Follow-up|6|||
156697927|NCT00643565|565642644|FG000|Overall Study|Other|7|||
156697928|NCT00643565|565642645|FG001|Overall Study|Other|8|||
156697929|NCT00643565|565642644|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
156871518|NCT03894813|566287702|FG001|Overall Study|Withdrawal by Subject|3|||
156871519|NCT03894813|566287701|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
156871520|NCT03894813|566287702|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
156871521|NCT00807001|566287705|FG000|Overall Study|Non-compliance|0|||
156871522|NCT00807001|566287706|FG001|Overall Study|Non-compliance|1|||
156871523|NCT00807001|566287707|FG002|Overall Study|Non-compliance|0|||
156871524|NCT00807001|566287708|FG003|Overall Study|Non-compliance|0|||
156871525|NCT00807001|566287709|FG004|Overall Study|Non-compliance|0|||
156697930|NCT00643565|565642645|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
156697931|NCT00643565|565642644|FG000|Overall Study|Recurrence of Disease|2|||
156697932|NCT00643565|565642645|FG001|Overall Study|Recurrence of Disease|1|||
156697933|NCT00643565|565642644|FG000|Overall Study|Progression of Disease|18|||
156697934|NCT00643565|565642645|FG001|Overall Study|Progression of Disease|14|||
156697935|NCT00643565|565642644|FG000|Overall Study|Protocol Violation|3|||
156697936|NCT00643565|565642645|FG001|Overall Study|Protocol Violation|0|||
156697937|NCT00643565|565642644|FG000|Overall Study|Did Not Cooperate|0|||
156697938|NCT00643565|565642645|FG001|Overall Study|Did Not Cooperate|1|||
156697939|NCT00643565|565642644|FG000|Overall Study|Administrative|22|||
156697940|NCT00643565|565642645|FG001|Overall Study|Administrative|16|||
156697941|NCT00643565|565642644|FG000|Overall Study|Adverse Event|5|||
156697942|NCT00643565|565642645|FG001|Overall Study|Adverse Event|8|||
156697943|NCT02317614|565642646|FG000|Overall Study|Lost to Follow-up|1|||
156697944|NCT02317614|565642647|FG001|Overall Study|Lost to Follow-up|1|||
156871526|NCT02269267|566287711|FG000|Overall Study|Death|5|||
156697945|NCT02317614|565642646|FG000|Overall Study|Withdrawal by Subject|1|||
156697946|NCT02317614|565642647|FG001|Overall Study|Withdrawal by Subject|0|||
156697947|NCT02317614|565642646|FG000|Overall Study|Death|1|||
156697948|NCT02317614|565642647|FG001|Overall Study|Death|1|||
156697949|NCT03283761|565642650|FG000|Study Treatment|Patient Non-Compliance|1|||
156871527|NCT03773796|566287712|FG000|Overall Study|Adverse Event|1|||
156871528|NCT03773796|566287712|FG000|Overall Study|Withdrawal by Subject|1|||
156871529|NCT03773796|566287712|FG000|Overall Study|Lack of Efficacy|1|||
156530964|NCT00954174|565039819|FG000|Overall Study|Lack of Efficacy|32|||
156331270|NCT01251861|564311980|FG001|Overall Study|Never started therapy|1|||
156331271|NCT01251861|564311979|FG000|Overall Study|Potential interaction of drugs|0|||
156331272|NCT01251861|564311980|FG001|Overall Study|Potential interaction of drugs|1|||
156331273|NCT01314703|564313390|FG000|Overall Study|screen failure and closed enrollment|8|||
156331274|NCT02281773|564313396|FG000|Overall Study|Adverse Event|6|||
156697950|NCT03283761|565642650|FG000|Study Treatment|Alternative Cancer Therapy|7|||
156697951|NCT03283761|565642650|FG000|Study Treatment|Disease progression|21|||
156697952|NCT03283761|565642650|FG000|Study Treatment|Adverse Event|3|||
156697953|NCT03283761|565642650|FG000|Study Treatment|Withdrawal by Subject|4|||
156697954|NCT03283761|565642650|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
156697955|NCT03283761|565642650|FG000|Study Treatment|Symptomatic Deterioration|1|||
156697956|NCT03283761|565642650|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
156697957|NCT03283761|565642650|FG000|Follow up|Lost to Follow-up|1|||
156697958|NCT03283761|565642650|FG000|Follow up|Symptomatic Deterioration|1|||
156697959|NCT03283761|565642650|FG000|Follow up|Death|29|||
156697960|NCT03283761|565642650|FG000|Follow up|study terminated|4|||
156331275|NCT02281773|564313397|FG001|Overall Study|Adverse Event|1|||
156331276|NCT02281773|564313398|FG002|Overall Study|Adverse Event|4|||
156530965|NCT00954174|565039820|FG001|Overall Study|Lack of Efficacy|22|||
156697961|NCT03283761|565642650|FG000|Follow up|Primary Investigator Withdrawal|1|||
156697962|NCT03283761|565642650|FG000|Follow up|Switched to alternative therapy|1|||
156697963|NCT03283761|565642650|FG000|Follow up|Subject is now in Hospice|1|||
156697964|NCT01355159|565642657|FG000|Overall Study|Withdrew consent|39|||
156697965|NCT01355159|565642658|FG001|Overall Study|Withdrew consent|47|||
156697966|NCT01355159|565642657|FG000|Overall Study|No primary outcome data|17|||
156697967|NCT01355159|565642658|FG001|Overall Study|No primary outcome data|11|||
156697968|NCT01355159|565642657|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
156697969|NCT01355159|565642658|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
156697970|NCT01355159|565642657|FG000|Overall Study|Early intrauterine fetal death|6|||
156697971|NCT01355159|565642658|FG001|Overall Study|Early intrauterine fetal death|6|||
156697972|NCT03276221|565642659|FG000|Overall Study|Lost to Follow-up|6|||
156697973|NCT03276221|565642660|FG001|Overall Study|Lost to Follow-up|2|||
156697974|NCT03276221|565642661|FG002|Overall Study|Lost to Follow-up|0|||
156697975|NCT03276221|565642659|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
156697976|NCT03276221|565642660|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
156697977|NCT03276221|565642661|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
156697978|NCT00424775|565642662|FG000|Overall Study|Adverse Event|2|||
156697979|NCT00424775|565642663|FG001|Overall Study|Adverse Event|0|||
156697980|NCT00424775|565642662|FG000|Overall Study|Lack of Efficacy|1|||
156697981|NCT00424775|565642663|FG001|Overall Study|Lack of Efficacy|0|||
156697982|NCT00975286|565642666|FG000|Overall Study|Adverse Event|9|||
156697983|NCT00975286|565642667|FG001|Overall Study|Adverse Event|19|||
156697984|NCT00975286|565642666|FG000|Overall Study|Protocol Violation|1|||
156697985|NCT00975286|565642667|FG001|Overall Study|Protocol Violation|2|||
156697986|NCT00975286|565642666|FG000|Overall Study|Withdrawal by Subject|0|||
156697987|NCT00975286|565642667|FG001|Overall Study|Withdrawal by Subject|2|||
156697988|NCT00975286|565642666|FG000|Overall Study|Familial and Personal Reasons|2|||
156697989|NCT00975286|565642667|FG001|Overall Study|Familial and Personal Reasons|2|||
156697990|NCT00975286|565642666|FG000|Overall Study|Poor Compliance to Protocol|0|||
156790488|NCT02991859|565983836|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790489|NCT02991859|565983837|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
156790490|NCT02991859|565983838|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
156790491|NCT02991859|565983839|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790492|NCT02991859|565983840|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790493|NCT02991859|565983841|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790494|NCT02991859|565983825|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790495|NCT02991859|565983826|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790496|NCT02991859|565983827|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156331277|NCT02281773|564313399|FG003|Overall Study|Adverse Event|8|||
156697991|NCT00975286|565642667|FG001|Overall Study|Poor Compliance to Protocol|2|||
156697992|NCT00975286|565642666|FG000|Overall Study|Sponsor Decision|0|||
156697993|NCT00975286|565642667|FG001|Overall Study|Sponsor Decision|2|||
156790497|NCT02991859|565983828|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790498|NCT02991859|565983829|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790499|NCT02991859|565983830|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
156790500|NCT02991859|565983831|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790501|NCT02991859|565983832|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790502|NCT02991859|565983833|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790503|NCT02991859|565983834|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156697994|NCT00741936|565642669|FG000|Overall Study|Lost to Follow-up|1|||
156697995|NCT00741936|565642670|FG001|Overall Study|Lost to Follow-up|1|||
156331278|NCT02281773|564313400|FG004|Overall Study|Adverse Event|9|||
156697996|NCT00741936|565642669|FG000|Overall Study|Adverse Event|3|||
156697997|NCT00741936|565642670|FG001|Overall Study|Adverse Event|4|||
156697998|NCT00741936|565642669|FG000|Overall Study|Pregnancy|0|||
156697999|NCT00741936|565642670|FG001|Overall Study|Pregnancy|1|||
156698000|NCT00741936|565642669|FG000|Overall Study|Protocol Violation|2|||
156698001|NCT00741936|565642670|FG001|Overall Study|Protocol Violation|0|||
156698002|NCT00741936|565642669|FG000|Overall Study|Lack of Efficacy|0|||
156698003|NCT00741936|565642670|FG001|Overall Study|Lack of Efficacy|2|||
156698004|NCT00741936|565642669|FG000|Overall Study|Low compliance|3|||
156698005|NCT00741936|565642670|FG001|Overall Study|Low compliance|0|||
156698006|NCT01941940|565642671|FG000|Overall Study|Adverse Event|11|||
156698007|NCT01941940|565642671|FG000|Overall Study|Lost to Follow-up|2|||
156698008|NCT01941940|565642671|FG000|Overall Study|Physician Decision|2|||
156698009|NCT01941940|565642671|FG000|Overall Study|Withdrawal by Subject|15|||
156698010|NCT01941940|565642671|FG000|Overall Study|Death|1|||
156698011|NCT01941940|565642671|FG000|Overall Study|Other|1|||
156698012|NCT01941940|565642671|FG000|Overall Study|Other|1|||
156698013|NCT03212521|565642674|FG000|Overall Study|Adverse Event|1|||
156698014|NCT03212521|565642674|FG000|Overall Study|Lost to Follow-up|4|||
156698015|NCT03212521|565642674|FG000|Overall Study|Withdrawal by Subject|1|||
156698016|NCT03212521|565642674|FG000|Overall Study|Other|1|||
156698017|NCT00914459|565642677|FG000|Overall Study|Protocol Violation|0|||
156698018|NCT00914459|565642678|FG001|Overall Study|Protocol Violation|1|||
156698019|NCT00914459|565642677|FG000|Overall Study|Parent/Legal guardian request|1|||
156698020|NCT00914459|565642678|FG001|Overall Study|Parent/Legal guardian request|0|||
156698021|NCT03176459|565642679|FG000|Overall Study|Lost to Follow-up|5|||
156698022|NCT03176459|565642680|FG001|Overall Study|Lost to Follow-up|7|||
156698023|NCT01661179|565642681|FG000|Overall Study|Death|1|||
156698024|NCT01661179|565642681|FG000|Overall Study|Withdrawal by Subject|1|||
156698025|NCT01661179|565642681|FG000|Overall Study|Other Eligibility criteria|4|||
156698026|NCT01083810|565642682|FG000|Overall Study|Lost to Follow-up|23|||
156698027|NCT01083810|565642683|FG001|Overall Study|Lost to Follow-up|11|||
156698028|NCT01083810|565642684|FG002|Overall Study|Lost to Follow-up|4|||
156698029|NCT01083810|565642682|FG000|Overall Study|Adverse Event|15|||
156698030|NCT01083810|565642683|FG001|Overall Study|Adverse Event|11|||
156698031|NCT01083810|565642684|FG002|Overall Study|Adverse Event|4|||
156698032|NCT01083810|565642682|FG000|Overall Study|Withdrawal by Subject|7|||
156698033|NCT01083810|565642683|FG001|Overall Study|Withdrawal by Subject|2|||
156698034|NCT01083810|565642684|FG002|Overall Study|Withdrawal by Subject|4|||
156331279|NCT02281773|564313396|FG000|Overall Study|Protocol Violation|1|||
156331280|NCT02281773|564313397|FG001|Overall Study|Protocol Violation|0|||
156331281|NCT02281773|564313398|FG002|Overall Study|Protocol Violation|0|||
156331282|NCT02281773|564313399|FG003|Overall Study|Protocol Violation|2|||
156331283|NCT02281773|564313400|FG004|Overall Study|Protocol Violation|2|||
156698035|NCT01083810|565642682|FG000|Overall Study|Reason not reported|6|||
156698036|NCT01083810|565642683|FG001|Overall Study|Reason not reported|1|||
156698037|NCT01083810|565642684|FG002|Overall Study|Reason not reported|1|||
156698038|NCT01083810|565642682|FG000|Overall Study|Non-compliance|4|||
156698039|NCT01083810|565642683|FG001|Overall Study|Non-compliance|7|||
156698040|NCT01083810|565642684|FG002|Overall Study|Non-compliance|2|||
156698041|NCT01083810|565642682|FG000|Overall Study|Simplification|4|||
156698042|NCT01083810|565642683|FG001|Overall Study|Simplification|1|||
156698043|NCT01083810|565642684|FG002|Overall Study|Simplification|0|||
156698044|NCT01083810|565642682|FG000|Overall Study|Death|2|||
156698045|NCT01083810|565642683|FG001|Overall Study|Death|2|||
156698046|NCT01083810|565642684|FG002|Overall Study|Death|3|||
156698047|NCT01083810|565642682|FG000|Overall Study|Co-morbidities|1|||
156331284|NCT02281773|564313396|FG000|Overall Study|Lost to Follow-up|2|||
156331285|NCT02281773|564313397|FG001|Overall Study|Lost to Follow-up|2|||
156331286|NCT02281773|564313398|FG002|Overall Study|Lost to Follow-up|6|||
156698048|NCT01083810|565642683|FG001|Overall Study|Co-morbidities|0|||
156698049|NCT01083810|565642684|FG002|Overall Study|Co-morbidities|0|||
156698050|NCT01083810|565642682|FG000|Overall Study|Participation in study|1|||
156331287|NCT02281773|564313399|FG003|Overall Study|Lost to Follow-up|2|||
156331288|NCT02281773|564313400|FG004|Overall Study|Lost to Follow-up|10|||
156530966|NCT00954174|565039821|FG002|Overall Study|Lack of Efficacy|8|||
156698051|NCT01083810|565642683|FG001|Overall Study|Participation in study|0|||
156698052|NCT01083810|565642684|FG002|Overall Study|Participation in study|0|||
156698053|NCT01083810|565642682|FG000|Overall Study|Therapy break|1|||
156530967|NCT00954174|565039822|FG003|Overall Study|Lack of Efficacy|6|||
156698054|NCT01083810|565642683|FG001|Overall Study|Therapy break|2|||
156698055|NCT01083810|565642684|FG002|Overall Study|Therapy break|2|||
156698056|NCT01083810|565642682|FG000|Overall Study|Virologic failure|1|||
156698057|NCT01083810|565642683|FG001|Overall Study|Virologic failure|8|||
156698058|NCT01083810|565642684|FG002|Overall Study|Virologic failure|0|||
156698059|NCT01602965|565642685|FG000|Overall Study|Lost to Follow-up|4|||
156698060|NCT01602965|565642686|FG001|Overall Study|Lost to Follow-up|2|||
156698061|NCT00446199|565642687|FG000|Overall Study|Adverse Event|7|||
156698062|NCT00446199|565642688|FG001|Overall Study|Adverse Event|4|||
156331289|NCT02281773|564313396|FG000|Overall Study|Withdrawal by Subject|2|||
156331290|NCT02281773|564313397|FG001|Overall Study|Withdrawal by Subject|8|||
156698063|NCT00446199|565642689|FG002|Overall Study|Adverse Event|6|||
156698064|NCT00446199|565642690|FG003|Overall Study|Adverse Event|4|||
156698065|NCT00446199|565642687|FG000|Overall Study|Lost to Follow-up|4|||
156698066|NCT00446199|565642688|FG001|Overall Study|Lost to Follow-up|5|||
156698067|NCT00446199|565642689|FG002|Overall Study|Lost to Follow-up|2|||
156698068|NCT00446199|565642690|FG003|Overall Study|Lost to Follow-up|6|||
156698069|NCT00446199|565642687|FG000|Overall Study|Protocol Violation|1|||
156698070|NCT00446199|565642688|FG001|Overall Study|Protocol Violation|2|||
156698071|NCT00446199|565642689|FG002|Overall Study|Protocol Violation|1|||
156698072|NCT00446199|565642690|FG003|Overall Study|Protocol Violation|3|||
156698073|NCT00446199|565642687|FG000|Overall Study|Withdrawal by Subject|2|||
156698074|NCT00446199|565642688|FG001|Overall Study|Withdrawal by Subject|5|||
156698075|NCT00446199|565642689|FG002|Overall Study|Withdrawal by Subject|9|||
156698076|NCT00446199|565642690|FG003|Overall Study|Withdrawal by Subject|10|||
156698077|NCT00446199|565642687|FG000|Overall Study|Site termination|2|||
156698078|NCT00446199|565642688|FG001|Overall Study|Site termination|0|||
156698079|NCT00446199|565642689|FG002|Overall Study|Site termination|0|||
156698080|NCT00446199|565642690|FG003|Overall Study|Site termination|1|||
156698081|NCT00446199|565642687|FG000|Overall Study|Randomization in Error|2|||
156698082|NCT00446199|565642688|FG001|Overall Study|Randomization in Error|0|||
156698083|NCT00446199|565642689|FG002|Overall Study|Randomization in Error|1|||
156698084|NCT00446199|565642690|FG003|Overall Study|Randomization in Error|1|||
156698085|NCT00446199|565642687|FG000|Overall Study|Lack of Efficacy|1|||
156698086|NCT00446199|565642688|FG001|Overall Study|Lack of Efficacy|0|||
156698087|NCT00446199|565642689|FG002|Overall Study|Lack of Efficacy|0|||
156698088|NCT00446199|565642690|FG003|Overall Study|Lack of Efficacy|1|||
156698089|NCT00446199|565642687|FG000|Overall Study|Non-compliant with study drug|1|||
156698090|NCT00446199|565642688|FG001|Overall Study|Non-compliant with study drug|0|||
156698091|NCT00446199|565642689|FG002|Overall Study|Non-compliant with study drug|5|||
156698092|NCT00446199|565642690|FG003|Overall Study|Non-compliant with study drug|0|||
156698093|NCT00446199|565642687|FG000|Overall Study|Non-compliant with visit schedule|1|||
156698094|NCT00446199|565642688|FG001|Overall Study|Non-compliant with visit schedule|1|||
156698095|NCT00446199|565642689|FG002|Overall Study|Non-compliant with visit schedule|1|||
156698096|NCT00446199|565642690|FG003|Overall Study|Non-compliant with visit schedule|2|||
156698097|NCT00446199|565642687|FG000|Overall Study|Hormone fear|0|||
156698098|NCT00446199|565642688|FG001|Overall Study|Hormone fear|0|||
156698099|NCT00446199|565642689|FG002|Overall Study|Hormone fear|0|||
156698100|NCT00446199|565642690|FG003|Overall Study|Hormone fear|1|||
156698101|NCT00446199|565642687|FG000|Overall Study|Lost interest in study participation|0|||
156698102|NCT00446199|565642688|FG001|Overall Study|Lost interest in study participation|1|||
156698103|NCT00446199|565642689|FG002|Overall Study|Lost interest in study participation|0|||
156698104|NCT00446199|565642690|FG003|Overall Study|Lost interest in study participation|0|||
156698105|NCT00446199|565642687|FG000|Overall Study|In-/Exclusion criterion violated|2|||
156871530|NCT03805659|566287714|FG000|Overall Study|Withdrawal by Subject|0|||
156871531|NCT03805659|566287715|FG001|Overall Study|Withdrawal by Subject|1|||
156871532|NCT02273596|566287717|FG000|24-Week Treatment Period|Adverse Event|3|||
156871533|NCT02273596|566287717|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
156871534|NCT02273596|566287717|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
156438564|NCT00835770|564697066|FG000|Overall Study|MS Progression|14|||
156438565|NCT00835770|564697067|FG001|Overall Study|MS Progression|9|||
156438566|NCT00835770|564697066|FG000|Overall Study|Adverse Event|113|||
156438567|NCT00835770|564697067|FG001|Overall Study|Adverse Event|124|||
156698106|NCT00446199|565642688|FG001|Overall Study|In-/Exclusion criterion violated|1|||
156698107|NCT00446199|565642689|FG002|Overall Study|In-/Exclusion criterion violated|2|||
156698108|NCT00446199|565642690|FG003|Overall Study|In-/Exclusion criterion violated|1|||
156698109|NCT00446199|565642687|FG000|Overall Study|Move|0|||
156698110|NCT00446199|565642688|FG001|Overall Study|Move|1|||
156698111|NCT00446199|565642689|FG002|Overall Study|Move|0|||
156698112|NCT00446199|565642690|FG003|Overall Study|Move|0|||
156698113|NCT03071094|565642694|FG000|Overall Study|Death|1|||
156698114|NCT03071094|565642695|FG001|Overall Study|Death|1|||
156698115|NCT03071094|565642694|FG000|Overall Study|Adverse Event|1|||
156698116|NCT03071094|565642695|FG001|Overall Study|Adverse Event|0|||
156698117|NCT02312063|565642696|FG000|Overall Study|Withdrawal by Subject|0|||
156438568|NCT00835770|564697066|FG000|Overall Study|Lost to Follow-up|22|||
156698118|NCT02312063|565642697|FG001|Overall Study|Withdrawal by Subject|1|||
156698119|NCT01079832|565642701|FG000|Overall Study|Withdrawal by Subject|1|||
156698120|NCT03548064|565645578|FG000|Overall Study|Withdrawal by Subject|0|||
156698121|NCT03548064|565645579|FG001|Overall Study|Withdrawal by Subject|0|||
156698122|NCT03548064|565645580|FG002|Overall Study|Withdrawal by Subject|0|||
156698123|NCT03548064|565645581|FG003|Overall Study|Withdrawal by Subject|1|||
156871535|NCT02273596|566287717|FG000|24-Week Treatment Period|Physician Decision|1|||
156438569|NCT00835770|564697067|FG001|Overall Study|Lost to Follow-up|19|||
156438570|NCT00835770|564697066|FG000|Overall Study|Consent Withdrawn|144|||
156698124|NCT03548064|565645582|FG004|Overall Study|Withdrawal by Subject|0|||
156698125|NCT03548064|565645583|FG005|Overall Study|Withdrawal by Subject|0|||
156331291|NCT02281773|564313398|FG002|Overall Study|Withdrawal by Subject|6|||
156331292|NCT02281773|564313399|FG003|Overall Study|Withdrawal by Subject|6|||
156331293|NCT02281773|564313400|FG004|Overall Study|Withdrawal by Subject|8|||
156331294|NCT02281773|564313396|FG000|Overall Study|Other Reason|0|||
156698126|NCT03548064|565645584|FG006|Overall Study|Withdrawal by Subject|0|||
156698127|NCT03548064|565645585|FG007|Overall Study|Withdrawal by Subject|0|||
156698128|NCT03548064|565645578|FG000|Overall Study|Lost to Follow-up|0|||
156331295|NCT02281773|564313397|FG001|Overall Study|Other Reason|4|||
156331296|NCT02281773|564313398|FG002|Overall Study|Other Reason|2|||
156331297|NCT02281773|564313399|FG003|Overall Study|Other Reason|3|||
156331298|NCT02281773|564313400|FG004|Overall Study|Other Reason|1|||
156331299|NCT00385762|564313401|FG000|Overall Study|Adverse Event|1|||
156331300|NCT00385762|564313401|FG000|Overall Study|Lost to Follow-up|1|||
156331301|NCT05439941|564313402|FG000|Overall Study|Lack of Efficacy|8|||
156331302|NCT05439941|564313403|FG001|Overall Study|Lack of Efficacy|5|||
156331303|NCT05439941|564313404|FG002|Overall Study|Lack of Efficacy|3|||
156331304|NCT05439941|564313402|FG000|Overall Study|Treatment Failure|0|||
156331305|NCT05439941|564313403|FG001|Overall Study|Treatment Failure|1|||
156331306|NCT05439941|564313404|FG002|Overall Study|Treatment Failure|0|||
156331307|NCT05439941|564313402|FG000|Overall Study|Adverse Event|1|||
156331308|NCT05439941|564313403|FG001|Overall Study|Adverse Event|3|||
156331309|NCT05439941|564313404|FG002|Overall Study|Adverse Event|0|||
156698129|NCT03548064|565645579|FG001|Overall Study|Lost to Follow-up|0|||
156698130|NCT03548064|565645580|FG002|Overall Study|Lost to Follow-up|0|||
156698131|NCT03548064|565645581|FG003|Overall Study|Lost to Follow-up|0|||
156698132|NCT03548064|565645582|FG004|Overall Study|Lost to Follow-up|2|||
156331310|NCT05439941|564313402|FG000|Overall Study|Adverse Event - Parent Study|1|||
156331311|NCT05439941|564313403|FG001|Overall Study|Adverse Event - Parent Study|0|||
156331312|NCT05439941|564313404|FG002|Overall Study|Adverse Event - Parent Study|0|||
156331313|NCT05439941|564313402|FG000|Overall Study|Pregnancy|1|||
156331314|NCT05439941|564313403|FG001|Overall Study|Pregnancy|0|||
156331315|NCT05439941|564313404|FG002|Overall Study|Pregnancy|0|||
156331316|NCT05439941|564313402|FG000|Overall Study|Withdrawal by Subject|9|||
156331317|NCT05439941|564313403|FG001|Overall Study|Withdrawal by Subject|6|||
156331318|NCT05439941|564313404|FG002|Overall Study|Withdrawal by Subject|10|||
156331319|NCT05439941|564313402|FG000|Overall Study|Non-Compliance|1|||
156331320|NCT05439941|564313403|FG001|Overall Study|Non-Compliance|1|||
156331321|NCT05439941|564313404|FG002|Overall Study|Non-Compliance|1|||
156331322|NCT05439941|564313402|FG000|Overall Study|Lost to Follow-up|2|||
156331323|NCT05439941|564313403|FG001|Overall Study|Lost to Follow-up|2|||
156331324|NCT05439941|564313404|FG002|Overall Study|Lost to Follow-up|0|||
156331325|NCT05439941|564313402|FG000|Overall Study|Physician Decision|1|||
156331326|NCT05439941|564313403|FG001|Overall Study|Physician Decision|0|||
156331327|NCT05439941|564313404|FG002|Overall Study|Physician Decision|0|||
156331328|NCT05439941|564313402|FG000|Overall Study|Trial Termination by Sponsor|78|||
156331329|NCT05439941|564313403|FG001|Overall Study|Trial Termination by Sponsor|83|||
156331330|NCT05439941|564313404|FG002|Overall Study|Trial Termination by Sponsor|65|||
156331331|NCT05439941|564313402|FG000|Overall Study|Other than Reasons Listed|2|||
156331332|NCT05439941|564313403|FG001|Overall Study|Other than Reasons Listed|1|||
156331333|NCT05439941|564313404|FG002|Overall Study|Other than Reasons Listed|0|||
156331334|NCT00573183|564313405|FG000|Overall Study|Lost to Follow-up|52|||
156331335|NCT00573183|564313406|FG001|Overall Study|Lost to Follow-up|50|||
156331336|NCT00573183|564313405|FG000|Overall Study|Withdrawal by Subject|8|||
156331337|NCT00573183|564313406|FG001|Overall Study|Withdrawal by Subject|2|||
156331338|NCT00573183|564313405|FG000|Overall Study|Death|0|||
156331339|NCT00573183|564313406|FG001|Overall Study|Death|1|||
156331340|NCT00573183|564313405|FG000|Overall Study|Adverse Event|2|||
156331341|NCT00573183|564313406|FG001|Overall Study|Adverse Event|0|||
156331342|NCT00573183|564313405|FG000|Overall Study|Incarceration|5|||
156331343|NCT00573183|564313406|FG001|Overall Study|Incarceration|8|||
156331344|NCT00573183|564313405|FG000|Overall Study|Other|5|||
156331345|NCT00573183|564313406|FG001|Overall Study|Other|2|||
156331346|NCT02699697|564313409|FG000|Overall Study|Death|18|||
156331347|NCT02699697|564313410|FG001|Overall Study|Death|15|||
156331348|NCT02699697|564313409|FG000|Overall Study|Physician Decision|0|||
156331349|NCT02699697|564313410|FG001|Overall Study|Physician Decision|1|||
156331350|NCT02699697|564313409|FG000|Overall Study|Lost to Follow-up|2|||
156331351|NCT02699697|564313410|FG001|Overall Study|Lost to Follow-up|3|||
156331352|NCT02699697|564313409|FG000|Overall Study|Refused to follow up|1|||
156331353|NCT02699697|564313410|FG001|Overall Study|Refused to follow up|1|||
156331354|NCT02699697|564313409|FG000|Overall Study|Entered hospice care|5|||
156331355|NCT02699697|564313410|FG001|Overall Study|Entered hospice care|2|||
156331356|NCT02699697|564313409|FG000|Overall Study|Missing reason for discontinuation|6|||
156331357|NCT02699697|564313410|FG001|Overall Study|Missing reason for discontinuation|5|||
156331358|NCT02362035|564313411|FG000|Overall Study|Death|67|||
156331359|NCT02362035|564313411|FG000|Overall Study|Lost to Follow-up|3|||
156331360|NCT02362035|564313411|FG000|Overall Study|Adverse Event|1|||
156331361|NCT02362035|564313411|FG000|Overall Study|Physician Decision|1|||
156698133|NCT03548064|565645583|FG005|Overall Study|Lost to Follow-up|0|||
156698134|NCT03548064|565645584|FG006|Overall Study|Lost to Follow-up|0|||
156698135|NCT03548064|565645585|FG007|Overall Study|Lost to Follow-up|0|||
156698136|NCT03548064|565645578|FG000|Overall Study|Covid-19 Pandemic|0|||
156698137|NCT03548064|565645579|FG001|Overall Study|Covid-19 Pandemic|0|||
156698138|NCT03548064|565645580|FG002|Overall Study|Covid-19 Pandemic|0|||
156871536|NCT02273596|566287717|FG000|24-Week Treatment Period|Protocol Deviation|1|||
156871537|NCT02273596|566287717|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
156438571|NCT00835770|564697067|FG001|Overall Study|Consent Withdrawn|156|||
156438572|NCT00835770|564697066|FG000|Overall Study|Investigator Decision|42|||
156438573|NCT00835770|564697067|FG001|Overall Study|Investigator Decision|42|||
156438574|NCT00835770|564697066|FG000|Overall Study|Participant Non-Compliance|11|||
156438575|NCT00835770|564697067|FG001|Overall Study|Participant Non-Compliance|9|||
156438576|NCT00835770|564697066|FG000|Overall Study|Death|4|||
156438577|NCT00835770|564697067|FG001|Overall Study|Death|6|||
156438578|NCT00835770|564697066|FG000|Overall Study|Other|115|||
156438579|NCT00835770|564697067|FG001|Overall Study|Other|104|||
156438580|NCT00835770|564697066|FG000|Overall Study|Other|2|||
156438581|NCT00835770|564697067|FG001|Overall Study|Other|1|||
156438582|NCT01369498|564697068|FG000|Overall Study|Lack of Efficacy|9|||
156871538|NCT02273596|566287717|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
156871539|NCT02273596|566287717|FG000|Extension Period|Lost to Follow-up|1|||
156871540|NCT02273596|566287717|FG000|Extension Period|Protocol Deviation|1|||
156871541|NCT02604160|566287719|FG000|Overall Study|Protocol Violation|0|||
156871542|NCT02604160|566287720|FG001|Overall Study|Protocol Violation|1|||
156871543|NCT02604160|566287719|FG000|Overall Study|Physician Decision|0|||
156871544|NCT02604160|566287720|FG001|Overall Study|Physician Decision|1|||
156871545|NCT02139592|566287721|FG000|Overall Study|Case Report Forms Uncollected|8|||
156871546|NCT01069900|566287725|FG000|Overall Study|Technical problems|0|||
156871547|NCT01069900|566287726|FG001|Overall Study|Technical problems|1|||
156871548|NCT01069900|566287725|FG000|Overall Study|Lost to Follow-up|7|||
156871549|NCT01069900|566287726|FG001|Overall Study|Lost to Follow-up|1|||
156871550|NCT01069900|566287725|FG000|Overall Study|Withdrawal by Subject|6|||
156871551|NCT01069900|566287726|FG001|Overall Study|Withdrawal by Subject|1|||
156871552|NCT01069900|566287725|FG000|Overall Study|Protocol Violation|4|||
156871553|NCT01069900|566287726|FG001|Overall Study|Protocol Violation|1|||
156871554|NCT01069900|566287725|FG000|Overall Study|Insufficient Therapeutic effect|1|||
156871555|NCT01069900|566287726|FG001|Overall Study|Insufficient Therapeutic effect|0|||
156438583|NCT01369498|564697069|FG001|Overall Study|Lack of Efficacy|9|||
156438584|NCT01369498|564697070|FG002|Overall Study|Lack of Efficacy|1|||
156871556|NCT00145158|566287727|FG000|Overall Study|premature withdrawal|2|||
156871557|NCT00145158|566287728|FG001|Overall Study|premature withdrawal|3|||
156438585|NCT01369498|564697071|FG003|Overall Study|Lack of Efficacy|3|||
156438586|NCT01369498|564697068|FG000|Overall Study|Adverse Event|1|||
156438587|NCT01369498|564697069|FG001|Overall Study|Adverse Event|2|||
156438588|NCT01369498|564697070|FG002|Overall Study|Adverse Event|0|||
156438589|NCT01369498|564697071|FG003|Overall Study|Adverse Event|1|||
156438590|NCT01369498|564697068|FG000|Overall Study|Withdrawal of Consent|0|||
156438591|NCT01369498|564697069|FG001|Overall Study|Withdrawal of Consent|1|||
156438592|NCT01369498|564697070|FG002|Overall Study|Withdrawal of Consent|1|||
156438593|NCT01369498|564697071|FG003|Overall Study|Withdrawal of Consent|1|||
156438594|NCT01369498|564697068|FG000|Overall Study|Death|0|||
156438595|NCT01369498|564697069|FG001|Overall Study|Death|0|||
156438596|NCT01369498|564697070|FG002|Overall Study|Death|1|||
156438597|NCT01369498|564697071|FG003|Overall Study|Death|0|||
156871558|NCT02741518|566287729|FG000|Overall Study|Withdrawal by Subject|1|||
156871559|NCT02741518|566287730|FG001|Overall Study|Withdrawal by Subject|1|||
156871560|NCT00476008|566287733|FG000|Overall Study|Adverse Event|4|||
156871561|NCT00476008|566287734|FG001|Overall Study|Adverse Event|4|||
156871562|NCT00476008|566287733|FG000|Overall Study|Placebo concerns|2|||
156871563|NCT00476008|566287734|FG001|Overall Study|Placebo concerns|2|||
156871564|NCT00476008|566287733|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
156871565|NCT00476008|566287734|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
156871566|NCT00476008|566287733|FG000|Overall Study|Withdrawal by Subject|0|||
156871567|NCT00476008|566287734|FG001|Overall Study|Withdrawal by Subject|1|||
156438598|NCT01369498|564697068|FG000|Overall Study|Investigator's Discretion|1|||
156438599|NCT01369498|564697069|FG001|Overall Study|Investigator's Discretion|0|||
156438600|NCT01369498|564697070|FG002|Overall Study|Investigator's Discretion|1|||
156698139|NCT03548064|565645581|FG003|Overall Study|Covid-19 Pandemic|0|||
156698140|NCT03548064|565645582|FG004|Overall Study|Covid-19 Pandemic|10|||
156438601|NCT01369498|564697071|FG003|Overall Study|Investigator's Discretion|3|||
156438602|NCT01369498|564697068|FG000|Overall Study|Unknown Reason|1|||
156698141|NCT03548064|565645583|FG005|Overall Study|Covid-19 Pandemic|3|||
156698142|NCT03548064|565645584|FG006|Overall Study|Covid-19 Pandemic|0|||
156871568|NCT00476008|566287733|FG000|Overall Study|Death|1|||
156871569|NCT00476008|566287734|FG001|Overall Study|Death|0|||
156871570|NCT01227018|566287735|FG000|Overall Study|Disease progression|9|||
156871571|NCT01227018|566287735|FG000|Overall Study|Toxicity|2|||
156871572|NCT01227018|566287735|FG000|Overall Study|Withdrew after beginning treatment|4|||
156698143|NCT03548064|565645585|FG007|Overall Study|Covid-19 Pandemic|0|||
156698144|NCT03845296|565645588|FG000|Overall Study|On Treatment|2|||
156698145|NCT03845296|565645589|FG001|Overall Study|On Treatment|1|||
156698146|NCT03845296|565645588|FG000|Overall Study|Adverse Event|4|||
156698147|NCT03845296|565645589|FG001|Overall Study|Adverse Event|11|||
156698148|NCT03845296|565645588|FG000|Overall Study|Refusal unrelated to adverse event|0|||
156698149|NCT03845296|565645589|FG001|Overall Study|Refusal unrelated to adverse event|1|||
156698150|NCT03845296|565645588|FG000|Overall Study|Progression/relapse|14|||
156698151|NCT03845296|565645589|FG001|Overall Study|Progression/relapse|18|||
156331362|NCT02362035|564313411|FG000|Overall Study|Subject started another cancer therapy|10|||
156331363|NCT02362035|564313411|FG000|Overall Study|Study terminated by sponsor|45|||
156331364|NCT02362035|564313411|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
156331365|NCT02362035|564313411|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
156698152|NCT03845296|565645588|FG000|Overall Study|Death|4|||
156698153|NCT03845296|565645589|FG001|Overall Study|Death|0|||
156698154|NCT03845296|565645588|FG000|Overall Study|Other - not protocol specified|1|||
156698155|NCT03845296|565645589|FG001|Overall Study|Other - not protocol specified|3|||
156698156|NCT02799095|565645593|FG000|Part A|Adverse Event|1|||
156698157|NCT02799095|565645594|FG001|Part A|Adverse Event|0|||
156698158|NCT02799095|565645595|FG002|Part A|Adverse Event|1|||
156698159|NCT02799095|565645596|FG003|Part A|Adverse Event|4|||
156331366|NCT02362035|564313411|FG000|Overall Study|Disease progression|11|||
156331367|NCT02362035|564313411|FG000|Overall Study|Withdrawal by Subject|20|||
156331368|NCT03270644|564313412|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
156331369|NCT03270644|564313412|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
156698160|NCT02799095|565645597|FG004|Part A|Adverse Event|1|||
156698161|NCT02799095|565645598|FG005|Part A|Adverse Event|0|||
156698162|NCT02799095|565645599|FG006|Part A|Adverse Event|0|||
156790504|NCT02991859|565983835|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790505|NCT02991859|565983836|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790506|NCT02991859|565983837|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790507|NCT02991859|565983838|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790508|NCT02991859|565983839|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790509|NCT02991859|565983840|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790510|NCT02991859|565983841|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790511|NCT02991859|565983825|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790512|NCT02991859|565983826|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790513|NCT02991859|565983827|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790514|NCT02991859|565983828|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790515|NCT02991859|565983829|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156331370|NCT00615108|564313413|FG000|Overall Study|Adverse Event|122|||
156438603|NCT01369498|564697069|FG001|Overall Study|Unknown Reason|0|||
156438604|NCT01369498|564697070|FG002|Overall Study|Unknown Reason|11|||
156438605|NCT01369498|564697071|FG003|Overall Study|Unknown Reason|6|||
156438606|NCT01369498|564697068|FG000|Overall Study|Disease Progression|0|||
156790516|NCT02991859|565983830|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790517|NCT02991859|565983831|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790518|NCT02991859|565983832|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790519|NCT02991859|565983833|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790520|NCT02991859|565983834|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
156790521|NCT02991859|565983835|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790522|NCT02991859|565983836|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790523|NCT02991859|565983837|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790524|NCT02991859|565983838|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790525|NCT02991859|565983839|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156438607|NCT01369498|564697069|FG001|Overall Study|Disease Progression|0|||
156438608|NCT01369498|564697070|FG002|Overall Study|Disease Progression|0|||
156438609|NCT01369498|564697071|FG003|Overall Study|Disease Progression|1|||
156438610|NCT02202499|564697075|FG000|Overall Study|Cancer diagnosis|0|||
156438611|NCT02202499|564697076|FG001|Overall Study|Cancer diagnosis|0|||
156790526|NCT02991859|565983840|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790527|NCT02991859|565983841|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790528|NCT02991859|565983825|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790529|NCT02991859|565983826|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790530|NCT02991859|565983827|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790531|NCT02991859|565983828|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156331371|NCT00615108|564313413|FG000|Overall Study|Other|370|||
156331372|NCT00615108|564313413|FG000|Overall Study|Lost to Follow-up|15|||
156438612|NCT02202499|564697077|FG002|Overall Study|Cancer diagnosis|1|||
156438613|NCT02202499|564697075|FG000|Overall Study|Moved from area|0|||
156698163|NCT02799095|565645600|FG007|Part A|Adverse Event|0|||
156698164|NCT02799095|565645601|FG008|Part A|Adverse Event|0|||
156698165|NCT02799095|565645602|FG009|Part A|Adverse Event|0|||
156698166|NCT02799095|565645603|FG010|Part A|Adverse Event|0|||
156790532|NCT02991859|565983829|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790533|NCT02991859|565983830|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156698167|NCT02799095|565645604|FG011|Part A|Adverse Event|0|||
156698168|NCT02799095|565645605|FG012|Part A|Adverse Event|0|||
156698169|NCT02799095|565645606|FG013|Part A|Adverse Event|0|||
156698170|NCT02799095|565645607|FG014|Part A|Adverse Event|0|||
156438614|NCT02202499|564697076|FG001|Overall Study|Moved from area|0|||
156438615|NCT02202499|564697077|FG002|Overall Study|Moved from area|1|||
156438616|NCT02202499|564697075|FG000|Overall Study|Declined before randomization|1|||
156438617|NCT02202499|564697076|FG001|Overall Study|Declined before randomization|0|||
156438618|NCT02202499|564697077|FG002|Overall Study|Declined before randomization|0|||
156438619|NCT02202499|564697075|FG000|Overall Study|Auto accident|1|||
156438620|NCT02202499|564697076|FG001|Overall Study|Auto accident|0|||
156438621|NCT02202499|564697077|FG002|Overall Study|Auto accident|0|||
156438622|NCT01124734|564697082|FG000|Overall Study|Disease progression|13|||
156438623|NCT01124734|564697082|FG000|Overall Study|Adverse Event|1|||
156438624|NCT01124734|564697082|FG000|Overall Study|Withdrawal by Subject|1|||
156438625|NCT01124734|564697082|FG000|Overall Study|Elected for alternative treatment|2|||
156438626|NCT02204982|564697083|FG000|Overall Study|Patient ineligible-medical monitor|1|||
156438627|NCT02204982|564697084|FG001|Overall Study|Patient ineligible-medical monitor|0|||
156438628|NCT02204982|564697083|FG000|Overall Study|Withdrawal by Subject|1|||
156438629|NCT02204982|564697084|FG001|Overall Study|Withdrawal by Subject|0|||
156438630|NCT02204982|564697083|FG000|Overall Study|Adverse Event|1|||
156438631|NCT02204982|564697084|FG001|Overall Study|Adverse Event|0|||
156438632|NCT02204982|564697083|FG000|Overall Study|Adverse Event and Investigator decision|1|||
156438633|NCT02204982|564697084|FG001|Overall Study|Adverse Event and Investigator decision|0|||
156438634|NCT02204982|564697083|FG000|Overall Study|Physician Decision|0|||
156438635|NCT02204982|564697084|FG001|Overall Study|Physician Decision|2|||
156438636|NCT02204982|564697083|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
156438637|NCT02204982|564697084|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
156438638|NCT02204982|564697083|FG000|Overall Study|Termination of Study bySponsor|0|||
156438639|NCT02204982|564697084|FG001|Overall Study|Termination of Study bySponsor|1|||
156698171|NCT02799095|565645608|FG015|Part A|Adverse Event|0|||
156698172|NCT02799095|565645609|FG016|Part A|Adverse Event|0|||
156698173|NCT02799095|565645593|FG000|Part A|Death|0|||
156871573|NCT01499277|566287738|FG000|Overall Study|Adverse Event|3|||
156871574|NCT01499277|566287739|FG001|Overall Study|Adverse Event|6|||
156871575|NCT01499277|566287738|FG000|Overall Study|Death|3|||
156871576|NCT01499277|566287739|FG001|Overall Study|Death|2|||
156871577|NCT01499277|566287738|FG000|Overall Study|Lost to Follow-up|15|||
156871578|NCT01499277|566287739|FG001|Overall Study|Lost to Follow-up|8|||
156871579|NCT01499277|566287738|FG000|Overall Study|Protocol Violation|2|||
156871580|NCT01499277|566287739|FG001|Overall Study|Protocol Violation|3|||
156871581|NCT01499277|566287738|FG000|Overall Study|Withdrawal by Subject|16|||
156871582|NCT01499277|566287739|FG001|Overall Study|Withdrawal by Subject|6|||
156871583|NCT01499277|566287738|FG000|Overall Study|Lack of therapeutic response and other|8|||
156871584|NCT01499277|566287739|FG001|Overall Study|Lack of therapeutic response and other|7|||
156871585|NCT00790088|566287742|FG000|Overall Study|Protocol Violation|11|||
156871586|NCT00790088|566287742|FG000|Overall Study|Withdrawal by Subject|17|||
156871587|NCT00790088|566287742|FG000|Overall Study|Lost to Follow-up|7|||
156871588|NCT00790088|566287742|FG000|Overall Study|Physician Decision|4|||
156871589|NCT02863419|566287747|FG000|Overall Study|Lost to Follow-up|0|||
156871590|NCT02863419|566287748|FG001|Overall Study|Lost to Follow-up|1|||
156871591|NCT02863419|566287749|FG002|Overall Study|Lost to Follow-up|4|||
156871592|NCT02863419|566287747|FG000|Overall Study|Withdrawal by Subject|5|||
156871593|NCT02863419|566287748|FG001|Overall Study|Withdrawal by Subject|5|||
156871594|NCT02863419|566287749|FG002|Overall Study|Withdrawal by Subject|3|||
156871595|NCT02863419|566287747|FG000|Overall Study|Died|3|||
156871596|NCT02863419|566287748|FG001|Overall Study|Died|4|||
156871597|NCT02863419|566287749|FG002|Overall Study|Died|1|||
156871598|NCT03682770|566287750|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871599|NCT03682770|566287751|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
156698174|NCT02799095|565645594|FG001|Part A|Death|0|||
156871600|NCT03682770|566287752|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871601|NCT03682770|566287753|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156438640|NCT00159783|564697089|FG000|Overall Study|Adverse Event|5|||
156438641|NCT00159783|564697090|FG001|Overall Study|Adverse Event|7|||
156438642|NCT00159783|564697091|FG002|Overall Study|Adverse Event|9|||
156438643|NCT00159783|564697089|FG000|Overall Study|Lack of Efficacy|1|||
156438644|NCT00159783|564697090|FG001|Overall Study|Lack of Efficacy|2|||
156698175|NCT02799095|565645595|FG002|Part A|Death|0|||
156698176|NCT02799095|565645596|FG003|Part A|Death|0|||
156698177|NCT02799095|565645597|FG004|Part A|Death|0|||
156871602|NCT03682770|566287754|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871603|NCT03682770|566287755|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871604|NCT03682770|566287756|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871605|NCT03682770|566287750|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
156871606|NCT03682770|566287751|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
156871607|NCT03682770|566287752|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156698178|NCT02799095|565645598|FG005|Part A|Death|0|||
156698179|NCT02799095|565645599|FG006|Part A|Death|3|||
156698180|NCT02799095|565645600|FG007|Part A|Death|0|||
156698181|NCT02799095|565645601|FG008|Part A|Death|0|||
156698182|NCT02799095|565645602|FG009|Part A|Death|0|||
156698183|NCT02799095|565645603|FG010|Part A|Death|0|||
156698184|NCT02799095|565645604|FG011|Part A|Death|0|||
156698185|NCT02799095|565645605|FG012|Part A|Death|0|||
156698186|NCT02799095|565645606|FG013|Part A|Death|0|||
156698187|NCT02799095|565645607|FG014|Part A|Death|0|||
156698188|NCT02799095|565645608|FG015|Part A|Death|0|||
156698189|NCT02799095|565645609|FG016|Part A|Death|0|||
156790534|NCT02991859|565983831|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790535|NCT02991859|565983832|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790536|NCT02991859|565983833|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
156790537|NCT02991859|565983834|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790538|NCT02991859|565983835|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790539|NCT02991859|565983836|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790540|NCT02991859|565983837|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790541|NCT02991859|565983838|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790542|NCT02991859|565983839|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790543|NCT02991859|565983840|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790544|NCT02991859|565983841|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790545|NCT01016015|565983842|FG000|Overall Study|Not Treated|3|||
156790546|NCT01016015|565983842|FG000|Overall Study|Withdrawal by Subject|1|||
156790547|NCT01016015|565983842|FG000|Overall Study|Adverse Event|15|||
156790548|NCT00930176|565983844|FG000|Overall Study|Death|1|||
156790549|NCT00362609|565983845|FG000|Overall Study|Withdrawal by Subject|0|||
156790550|NCT00362609|565983846|FG001|Overall Study|Withdrawal by Subject|1|||
156790551|NCT00362609|565983845|FG000|Overall Study|Protocol Violation|0|||
156790552|NCT00362609|565983846|FG001|Overall Study|Protocol Violation|1|||
156438645|NCT00159783|564697091|FG002|Overall Study|Lack of Efficacy|3|||
156438646|NCT00159783|564697089|FG000|Overall Study|Withdrawal by Subject|7|||
156790553|NCT01251965|565985411|FG000|Overall Study|Participant/physician decision|1|||
156790554|NCT01251965|565985412|FG001|Overall Study|Participant/physician decision|2|||
156790555|NCT01251965|565985413|FG002|Overall Study|Participant/physician decision|0|||
156790556|NCT01251965|565985411|FG000|Overall Study|Death|0|||
156790557|NCT01251965|565985412|FG001|Overall Study|Death|0|||
156790558|NCT01251965|565985413|FG002|Overall Study|Death|11|||
156438647|NCT00159783|564697090|FG001|Overall Study|Withdrawal by Subject|11|||
156438648|NCT00159783|564697091|FG002|Overall Study|Withdrawal by Subject|12|||
156438649|NCT00159783|564697089|FG000|Overall Study|Lost to Follow-up|6|||
156438650|NCT00159783|564697090|FG001|Overall Study|Lost to Follow-up|5|||
156438651|NCT00159783|564697091|FG002|Overall Study|Lost to Follow-up|11|||
156790559|NCT02529488|565985414|FG000|Overall Study|Adverse Event|1|||
156790560|NCT02529488|565985414|FG000|Overall Study|Death|3|||
156871608|NCT03682770|566287753|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156871609|NCT03682770|566287754|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156871610|NCT03682770|566287755|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156871611|NCT03682770|566287756|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156871612|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871613|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871614|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
156871615|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
156871616|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871617|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871618|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871619|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871620|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871621|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871622|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
156790561|NCT02821000|565985415|FG000|Overall Study|Death|89|||
156790562|NCT02821000|565985415|FG000|Overall Study|Sponsor Decision|12|||
156871623|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156438652|NCT00159783|564697089|FG000|Overall Study|Other|0|||
156438653|NCT00159783|564697090|FG001|Overall Study|Other|2|||
156698190|NCT02799095|565645593|FG000|Part A|Lost to Follow-up|0|||
156698191|NCT02799095|565645594|FG001|Part A|Lost to Follow-up|1|||
156698192|NCT02799095|565645595|FG002|Part A|Lost to Follow-up|0|||
156698193|NCT02799095|565645596|FG003|Part A|Lost to Follow-up|0|||
156698194|NCT02799095|565645597|FG004|Part A|Lost to Follow-up|0|||
156698195|NCT02799095|565645598|FG005|Part A|Lost to Follow-up|0|||
156790563|NCT02821000|565985415|FG000|Overall Study|Withdrawal by Subject|2|||
156790564|NCT04359680|565985416|FG000|Overall Study|Withdrawal by Subject|29|||
156871624|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871625|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871626|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871627|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871628|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
156871629|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
156871630|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871631|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871632|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871633|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871634|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871635|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
156871636|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871637|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871638|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871639|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871640|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871641|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871642|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
156871643|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871644|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871645|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871646|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871647|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156871648|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156698196|NCT02799095|565645599|FG006|Part A|Lost to Follow-up|1|||
156698197|NCT02799095|565645600|FG007|Part A|Lost to Follow-up|0|||
156698198|NCT02799095|565645601|FG008|Part A|Lost to Follow-up|0|||
156698199|NCT02799095|565645602|FG009|Part A|Lost to Follow-up|0|||
156698200|NCT02799095|565645603|FG010|Part A|Lost to Follow-up|0|||
156698201|NCT02799095|565645604|FG011|Part A|Lost to Follow-up|0|||
156698202|NCT02799095|565645605|FG012|Part A|Lost to Follow-up|0|||
156698203|NCT02799095|565645606|FG013|Part A|Lost to Follow-up|0|||
156698204|NCT02799095|565645607|FG014|Part A|Lost to Follow-up|0|||
156698205|NCT02799095|565645608|FG015|Part A|Lost to Follow-up|0|||
156698206|NCT02799095|565645609|FG016|Part A|Lost to Follow-up|0|||
156698207|NCT02799095|565645593|FG000|Part A|Progressive Disease|3|||
156698208|NCT02799095|565645594|FG001|Part A|Progressive Disease|3|||
156698209|NCT02799095|565645595|FG002|Part A|Progressive Disease|3|||
156698210|NCT02799095|565645596|FG003|Part A|Progressive Disease|2|||
156698211|NCT02799095|565645597|FG004|Part A|Progressive Disease|2|||
156698212|NCT02799095|565645598|FG005|Part A|Progressive Disease|0|||
156698213|NCT02799095|565645599|FG006|Part A|Progressive Disease|0|||
156698214|NCT02799095|565645600|FG007|Part A|Progressive Disease|0|||
156698215|NCT02799095|565645601|FG008|Part A|Progressive Disease|0|||
156698216|NCT02799095|565645602|FG009|Part A|Progressive Disease|0|||
156698217|NCT02799095|565645603|FG010|Part A|Progressive Disease|0|||
156790565|NCT04359680|565985417|FG001|Overall Study|Withdrawal by Subject|24|||
156790566|NCT04359680|565985416|FG000|Overall Study|Adverse Event|6|||
156790567|NCT04359680|565985417|FG001|Overall Study|Adverse Event|2|||
156790568|NCT04359680|565985416|FG000|Overall Study|Lost to Follow-up|56|||
156790569|NCT04359680|565985417|FG001|Overall Study|Lost to Follow-up|59|||
156790570|NCT04359680|565985416|FG000|Overall Study|Protocol Violation|3|||
156871649|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156871650|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
156871651|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156438654|NCT00159783|564697091|FG002|Overall Study|Other|4|||
156790571|NCT04359680|565985417|FG001|Overall Study|Protocol Violation|5|||
156790572|NCT04359680|565985416|FG000|Overall Study|Physician Decision|1|||
156790573|NCT04359680|565985417|FG001|Overall Study|Physician Decision|1|||
156790574|NCT04359680|565985416|FG000|Overall Study|Sponsor Decision|0|||
156790575|NCT04359680|565985417|FG001|Overall Study|Sponsor Decision|1|||
156698218|NCT02799095|565645604|FG011|Part A|Progressive Disease|0|||
156698219|NCT02799095|565645605|FG012|Part A|Progressive Disease|0|||
156698220|NCT02799095|565645606|FG013|Part A|Progressive Disease|0|||
156698221|NCT02799095|565645607|FG014|Part A|Progressive Disease|0|||
156698222|NCT02799095|565645608|FG015|Part A|Progressive Disease|0|||
156790576|NCT01832038|565985418|FG000|Overall Study|Death|5|||
156438655|NCT02538107|564697092|FG000|Overall Study|Did not receive any Mircera dose|11|||
156438656|NCT02538107|564697092|FG000|Overall Study|Missing|5|||
156698223|NCT02799095|565645609|FG016|Part A|Progressive Disease|0|||
156698224|NCT02799095|565645593|FG000|Part A|Clinical Progression|1|||
156698225|NCT02799095|565645594|FG001|Part A|Clinical Progression|0|||
156698226|NCT02799095|565645595|FG002|Part A|Clinical Progression|2|||
156790577|NCT01832038|565985418|FG000|Overall Study|Adverse Event|50|||
156871652|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156871653|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156871654|NCT03682770|566287750|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
156871655|NCT03682770|566287751|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
156871656|NCT03682770|566287752|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
156871657|NCT03682770|566287753|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
156871658|NCT03682770|566287754|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
156871659|NCT03682770|566287755|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
156871660|NCT03682770|566287756|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
156871661|NCT03682770|566287750|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871662|NCT03682770|566287751|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871663|NCT03682770|566287752|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871664|NCT03682770|566287753|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871665|NCT03682770|566287754|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
156871666|NCT03682770|566287755|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871667|NCT03682770|566287756|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871668|NCT03682770|566287750|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871669|NCT03682770|566287751|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871670|NCT03682770|566287752|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871671|NCT03682770|566287753|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871672|NCT03682770|566287754|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871673|NCT03682770|566287755|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
156871674|NCT03682770|566287756|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871675|NCT03682770|566287750|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871676|NCT03682770|566287751|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871677|NCT03682770|566287752|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871678|NCT03682770|566287753|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871679|NCT03682770|566287754|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871680|NCT03682770|566287755|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
156871681|NCT03682770|566287756|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
156871682|NCT02362282|566287757|FG000|Overall Study|Withdrawal by Subject|1|||
156871683|NCT02362282|566287758|FG001|Overall Study|Withdrawal by Subject|0|||
156871684|NCT01189032|566287759|FG000|Overall Study|Adverse Event|1|||
156871685|NCT01189032|566287760|FG001|Overall Study|Adverse Event|3|||
156871686|NCT01189032|566287761|FG002|Overall Study|Adverse Event|4|||
156871687|NCT01189032|566287759|FG000|Overall Study|Lack of Efficacy|2|||
156871688|NCT01189032|566287760|FG001|Overall Study|Lack of Efficacy|3|||
156871689|NCT01189032|566287761|FG002|Overall Study|Lack of Efficacy|0|||
156871690|NCT01189032|566287759|FG000|Overall Study|Withdrawal by Subject|1|||
156871691|NCT01189032|566287760|FG001|Overall Study|Withdrawal by Subject|0|||
156871692|NCT01189032|566287761|FG002|Overall Study|Withdrawal by Subject|1|||
156871693|NCT01189032|566287759|FG000|Overall Study|Protocol Violation|1|||
156871694|NCT01189032|566287760|FG001|Overall Study|Protocol Violation|1|||
156871695|NCT01189032|566287761|FG002|Overall Study|Protocol Violation|1|||
156871696|NCT02284243|566287762|FG000|Overall Study|Lack of Efficacy|3|||
156871697|NCT02284243|566287763|FG001|Overall Study|Lack of Efficacy|3|||
156871698|NCT02284243|566287762|FG000|Overall Study|Adverse Event|1|||
156871699|NCT02284243|566287763|FG001|Overall Study|Adverse Event|0|||
156871700|NCT01733680|566287765|FG000|Overall Study|Withdrawal by Subject|0|||
156871701|NCT01733680|566287766|FG001|Overall Study|Withdrawal by Subject|1|||
156871702|NCT01932437|566287767|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156871703|NCT01932437|566287768|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156871704|NCT01932437|566287769|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156871705|NCT01932437|566287770|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156530968|NCT00954174|565039819|FG000|Overall Study|Withdrawal by Subject|14|||
156530969|NCT00954174|565039820|FG001|Overall Study|Withdrawal by Subject|10|||
156530970|NCT00954174|565039821|FG002|Overall Study|Withdrawal by Subject|4|||
156790578|NCT01832038|565985418|FG000|Overall Study|Lack of Efficacy|81|||
156790579|NCT01832038|565985418|FG000|Overall Study|Protocol Violation|7|||
156790580|NCT01832038|565985418|FG000|Overall Study|Lost to Follow-up|10|||
156790581|NCT01832038|565985418|FG000|Overall Study|Withdrawal by Subject|49|||
156790582|NCT01832038|565985418|FG000|Overall Study|Visit non-compliance|2|||
156790583|NCT01832038|565985418|FG000|Overall Study|Subject refused to return visit|2|||
156790584|NCT01832038|565985418|FG000|Overall Study|Not convenient to come back to site|2|||
156790585|NCT01832038|565985418|FG000|Overall Study|Participant was asked to quit|5|||
156790586|NCT01832038|565985418|FG000|Overall Study|Back home|1|||
156790587|NCT01832038|565985418|FG000|Overall Study|Pregnancy|1|||
156790588|NCT01832038|565985418|FG000|Overall Study|Low compliance|3|||
156790589|NCT01832038|565985418|FG000|Overall Study|Prohibit procedure|2|||
156790590|NCT01832038|565985418|FG000|Overall Study|Not possible to visit the hospital|1|||
156871706|NCT01932437|566287771|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156698227|NCT02799095|565645596|FG003|Part A|Clinical Progression|1|||
156698228|NCT02799095|565645597|FG004|Part A|Clinical Progression|5|||
156698229|NCT02799095|565645598|FG005|Part A|Clinical Progression|0|||
156698230|NCT02799095|565645599|FG006|Part A|Clinical Progression|0|||
156698231|NCT02799095|565645600|FG007|Part A|Clinical Progression|0|||
156698232|NCT02799095|565645601|FG008|Part A|Clinical Progression|0|||
156871707|NCT01932437|566287772|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
156871708|NCT02699749|566287773|FG000|Overall Study|Other|0|||
156871709|NCT02699749|566287774|FG001|Overall Study|Other|0|||
156871710|NCT02699749|566287775|FG002|Overall Study|Other|2|||
156871711|NCT02699749|566287776|FG003|Overall Study|Other|0|||
156871712|NCT02699749|566287777|FG004|Overall Study|Other|0|||
156871713|NCT02699749|566287778|FG005|Overall Study|Other|1|||
156871714|NCT02699749|566287779|FG006|Overall Study|Other|1|||
156871715|NCT02699749|566287780|FG007|Overall Study|Other|0|||
156871716|NCT02699749|566287781|FG008|Overall Study|Other|0|||
156871717|NCT02699749|566287782|FG009|Overall Study|Other|0|||
156871718|NCT02699749|566287783|FG010|Overall Study|Other|1|||
156871719|NCT02699749|566287784|FG011|Overall Study|Other|0|||
156871720|NCT02699749|566287785|FG012|Overall Study|Other|0|||
156871721|NCT02699749|566287786|FG013|Overall Study|Other|0|||
156871722|NCT02699749|566287773|FG000|Overall Study|Progressive Disease|3|||
156871723|NCT02699749|566287774|FG001|Overall Study|Progressive Disease|3|||
156871724|NCT02699749|566287775|FG002|Overall Study|Progressive Disease|14|||
156871725|NCT02699749|566287776|FG003|Overall Study|Progressive Disease|3|||
156871726|NCT02699749|566287777|FG004|Overall Study|Progressive Disease|3|||
156871727|NCT02699749|566287778|FG005|Overall Study|Progressive Disease|7|||
156871728|NCT02699749|566287779|FG006|Overall Study|Progressive Disease|5|||
156871729|NCT02699749|566287780|FG007|Overall Study|Progressive Disease|5|||
156871730|NCT02699749|566287781|FG008|Overall Study|Progressive Disease|6|||
156871731|NCT02699749|566287782|FG009|Overall Study|Progressive Disease|6|||
156871732|NCT02699749|566287783|FG010|Overall Study|Progressive Disease|5|||
156871733|NCT02699749|566287784|FG011|Overall Study|Progressive Disease|4|||
156871734|NCT02699749|566287785|FG012|Overall Study|Progressive Disease|3|||
156871735|NCT02699749|566287786|FG013|Overall Study|Progressive Disease|5|||
156871736|NCT02699749|566287773|FG000|Overall Study|Death|0|||
156871737|NCT02699749|566287774|FG001|Overall Study|Death|0|||
156871738|NCT02699749|566287775|FG002|Overall Study|Death|0|||
156871739|NCT02699749|566287776|FG003|Overall Study|Death|0|||
156871740|NCT02699749|566287777|FG004|Overall Study|Death|0|||
156871741|NCT02699749|566287778|FG005|Overall Study|Death|0|||
156871742|NCT02699749|566287779|FG006|Overall Study|Death|0|||
156871743|NCT02699749|566287780|FG007|Overall Study|Death|0|||
156871744|NCT02699749|566287781|FG008|Overall Study|Death|0|||
156871745|NCT02699749|566287782|FG009|Overall Study|Death|0|||
156871746|NCT02699749|566287783|FG010|Overall Study|Death|0|||
156871747|NCT02699749|566287784|FG011|Overall Study|Death|0|||
156871748|NCT02699749|566287785|FG012|Overall Study|Death|0|||
156871749|NCT02699749|566287786|FG013|Overall Study|Death|1|||
156871750|NCT02699749|566287773|FG000|Overall Study|Lost to Follow-up|0|||
156871751|NCT02699749|566287774|FG001|Overall Study|Lost to Follow-up|0|||
156871752|NCT02699749|566287775|FG002|Overall Study|Lost to Follow-up|0|||
156698233|NCT02799095|565645602|FG009|Part A|Clinical Progression|0|||
156698234|NCT02799095|565645603|FG010|Part A|Clinical Progression|0|||
156698235|NCT02799095|565645604|FG011|Part A|Clinical Progression|0|||
156698236|NCT02799095|565645605|FG012|Part A|Clinical Progression|0|||
156871753|NCT02699749|566287776|FG003|Overall Study|Lost to Follow-up|0|||
156871754|NCT02699749|566287777|FG004|Overall Study|Lost to Follow-up|0|||
156871755|NCT02699749|566287778|FG005|Overall Study|Lost to Follow-up|1|||
156871756|NCT02699749|566287779|FG006|Overall Study|Lost to Follow-up|0|||
156871757|NCT02699749|566287780|FG007|Overall Study|Lost to Follow-up|1|||
156871758|NCT02699749|566287781|FG008|Overall Study|Lost to Follow-up|0|||
156698237|NCT02799095|565645606|FG013|Part A|Clinical Progression|0|||
156698238|NCT02799095|565645607|FG014|Part A|Clinical Progression|0|||
156698239|NCT02799095|565645608|FG015|Part A|Clinical Progression|0|||
156698240|NCT02799095|565645609|FG016|Part A|Clinical Progression|0|||
156698241|NCT02799095|565645593|FG000|Part A|Protocol Deviation|0|||
156698242|NCT02799095|565645594|FG001|Part A|Protocol Deviation|0|||
156698243|NCT02799095|565645595|FG002|Part A|Protocol Deviation|1|||
156871759|NCT02699749|566287782|FG009|Overall Study|Lost to Follow-up|0|||
156871760|NCT02699749|566287783|FG010|Overall Study|Lost to Follow-up|0|||
156871761|NCT02699749|566287784|FG011|Overall Study|Lost to Follow-up|0|||
156871762|NCT02699749|566287785|FG012|Overall Study|Lost to Follow-up|0|||
156871763|NCT02699749|566287786|FG013|Overall Study|Lost to Follow-up|0|||
156871764|NCT04139018|566287788|FG000|Overall Study|Screen fail|1|||
156871765|NCT04139018|566287789|FG001|Overall Study|Screen fail|0|||
156871766|NCT04139018|566287788|FG000|Overall Study|Withdrawal by Subject|2|||
156871767|NCT04139018|566287789|FG001|Overall Study|Withdrawal by Subject|0|||
156871768|NCT04139018|566287788|FG000|Overall Study|Lost to Follow-up|0|||
156871769|NCT04139018|566287789|FG001|Overall Study|Lost to Follow-up|1|||
156871770|NCT02565108|566287790|FG000|Overall Study|Adverse Event|1|||
156871771|NCT02565108|566287791|FG001|Overall Study|Adverse Event|0|||
156871772|NCT02565108|566287790|FG000|Overall Study|Withdrew Consent|1|||
156698244|NCT02799095|565645596|FG003|Part A|Protocol Deviation|0|||
156698245|NCT02799095|565645597|FG004|Part A|Protocol Deviation|0|||
156698246|NCT02799095|565645598|FG005|Part A|Protocol Deviation|0|||
156698247|NCT02799095|565645599|FG006|Part A|Protocol Deviation|0|||
156698248|NCT02799095|565645600|FG007|Part A|Protocol Deviation|0|||
156698249|NCT02799095|565645601|FG008|Part A|Protocol Deviation|0|||
156698250|NCT02799095|565645602|FG009|Part A|Protocol Deviation|0|||
156698251|NCT02799095|565645603|FG010|Part A|Protocol Deviation|0|||
156698252|NCT02799095|565645604|FG011|Part A|Protocol Deviation|0|||
156698253|NCT02799095|565645605|FG012|Part A|Protocol Deviation|0|||
156698254|NCT02799095|565645606|FG013|Part A|Protocol Deviation|0|||
156871773|NCT02565108|566287791|FG001|Overall Study|Withdrew Consent|0|||
156871774|NCT01310075|566287792|FG000|Overall Study|Lost to Follow-up|1|||
156871775|NCT01310075|566287793|FG001|Overall Study|Lost to Follow-up|0|||
156871776|NCT01310075|566287792|FG000|Overall Study|Physician Decision|10|||
156871777|NCT01310075|566287793|FG001|Overall Study|Physician Decision|7|||
156871778|NCT01310075|566287792|FG000|Overall Study|Protocol Violation|2|||
156871779|NCT01310075|566287793|FG001|Overall Study|Protocol Violation|2|||
156871780|NCT01310075|566287792|FG000|Overall Study|Withdrawal by Subject|1|||
156871781|NCT01310075|566287793|FG001|Overall Study|Withdrawal by Subject|1|||
156871782|NCT01209325|566287794|FG000|Overall Study|Lost to Follow-up|24|||
156871783|NCT01209325|566287794|FG000|Overall Study|Adverse Event|1|||
156871784|NCT01209325|566287794|FG000|Overall Study|Relocated|3|||
156871785|NCT01209325|566287794|FG000|Overall Study|Refusal after starting therapy|8|||
156871786|NCT01209325|566287794|FG000|Overall Study|Protocol Violation|4|||
156871787|NCT01209325|566287794|FG000|Overall Study|Refusal prior to therapy|1|||
156871788|NCT01209325|566287794|FG000|Overall Study|Incarceration|2|||
156530971|NCT00954174|565039822|FG003|Overall Study|Withdrawal by Subject|3|||
156698255|NCT02799095|565645607|FG014|Part A|Protocol Deviation|0|||
156698256|NCT02799095|565645608|FG015|Part A|Protocol Deviation|0|||
156698257|NCT02799095|565645609|FG016|Part A|Protocol Deviation|0|||
156698258|NCT02799095|565645593|FG000|Part A|Withdrawal by Subject|0|||
156698259|NCT02799095|565645594|FG001|Part A|Withdrawal by Subject|0|||
156698260|NCT02799095|565645595|FG002|Part A|Withdrawal by Subject|0|||
156698261|NCT02799095|565645596|FG003|Part A|Withdrawal by Subject|1|||
156698262|NCT02799095|565645597|FG004|Part A|Withdrawal by Subject|3|||
156698263|NCT02799095|565645598|FG005|Part A|Withdrawal by Subject|1|||
156698264|NCT02799095|565645599|FG006|Part A|Withdrawal by Subject|1|||
156698265|NCT02799095|565645600|FG007|Part A|Withdrawal by Subject|0|||
156698266|NCT02799095|565645601|FG008|Part A|Withdrawal by Subject|0|||
156698267|NCT02799095|565645602|FG009|Part A|Withdrawal by Subject|0|||
156698268|NCT02799095|565645603|FG010|Part A|Withdrawal by Subject|0|||
156698269|NCT02799095|565645604|FG011|Part A|Withdrawal by Subject|0|||
156698270|NCT02799095|565645605|FG012|Part A|Withdrawal by Subject|0|||
156698271|NCT02799095|565645606|FG013|Part A|Withdrawal by Subject|0|||
156698272|NCT02799095|565645607|FG014|Part A|Withdrawal by Subject|0|||
156698273|NCT02799095|565645608|FG015|Part A|Withdrawal by Subject|0|||
156698274|NCT02799095|565645609|FG016|Part A|Withdrawal by Subject|0|||
156698275|NCT02799095|565645593|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
156698276|NCT02799095|565645594|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
156698277|NCT02799095|565645595|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
156698278|NCT02799095|565645596|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
156698279|NCT02799095|565645597|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
156698280|NCT02799095|565645598|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
156698281|NCT02799095|565645599|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
156698282|NCT02799095|565645600|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
156698283|NCT02799095|565645601|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
156698284|NCT02799095|565645602|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
156698285|NCT02799095|565645603|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
156698286|NCT02799095|565645604|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
156530972|NCT00954174|565039819|FG000|Overall Study|Medical Reason|4|||
156698287|NCT02799095|565645605|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
156698288|NCT02799095|565645606|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
156698289|NCT02799095|565645607|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
156698290|NCT02799095|565645608|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
156698291|NCT02799095|565645609|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
156698292|NCT02799095|565645593|FG000|Part B|Death|0|||
156698293|NCT02799095|565645594|FG001|Part B|Death|0|||
156698294|NCT02799095|565645595|FG002|Part B|Death|0|||
156698295|NCT02799095|565645596|FG003|Part B|Death|0|||
156698296|NCT02799095|565645597|FG004|Part B|Death|0|||
156698297|NCT02799095|565645598|FG005|Part B|Death|0|||
156698298|NCT02799095|565645599|FG006|Part B|Death|0|||
156698299|NCT02799095|565645600|FG007|Part B|Death|7|||
156698300|NCT02799095|565645601|FG008|Part B|Death|7|||
156530973|NCT00954174|565039820|FG001|Overall Study|Medical Reason|2|||
156871789|NCT01160822|566287795|FG000|Overall Study|Adverse Event|0|||
156871790|NCT01160822|566287796|FG001|Overall Study|Adverse Event|0|||
156871791|NCT01160822|566287797|FG002|Overall Study|Adverse Event|0|||
156871792|NCT01160822|566287798|FG003|Overall Study|Adverse Event|0|||
156871793|NCT01160822|566287799|FG004|Overall Study|Adverse Event|1|||
156871794|NCT01160822|566287800|FG005|Overall Study|Adverse Event|2|||
156698301|NCT02799095|565645602|FG009|Part B|Death|0|||
156698302|NCT02799095|565645603|FG010|Part B|Death|0|||
156698303|NCT02799095|565645604|FG011|Part B|Death|0|||
156698304|NCT02799095|565645605|FG012|Part B|Death|0|||
156698305|NCT02799095|565645606|FG013|Part B|Death|0|||
156698306|NCT02799095|565645607|FG014|Part B|Death|0|||
156698307|NCT02799095|565645608|FG015|Part B|Death|0|||
156698308|NCT02799095|565645609|FG016|Part B|Death|0|||
156698309|NCT02799095|565645593|FG000|Part B|Progressive Disease|0|||
156698310|NCT02799095|565645594|FG001|Part B|Progressive Disease|0|||
156698311|NCT02799095|565645595|FG002|Part B|Progressive Disease|0|||
156698312|NCT02799095|565645596|FG003|Part B|Progressive Disease|0|||
156698313|NCT02799095|565645597|FG004|Part B|Progressive Disease|0|||
156698314|NCT02799095|565645598|FG005|Part B|Progressive Disease|0|||
156698315|NCT02799095|565645599|FG006|Part B|Progressive Disease|0|||
156698316|NCT02799095|565645600|FG007|Part B|Progressive Disease|1|||
156698317|NCT02799095|565645601|FG008|Part B|Progressive Disease|0|||
156698318|NCT02799095|565645602|FG009|Part B|Progressive Disease|0|||
156698319|NCT02799095|565645603|FG010|Part B|Progressive Disease|0|||
156698320|NCT02799095|565645604|FG011|Part B|Progressive Disease|0|||
156698321|NCT02799095|565645605|FG012|Part B|Progressive Disease|0|||
156698322|NCT02799095|565645606|FG013|Part B|Progressive Disease|0|||
156698323|NCT02799095|565645607|FG014|Part B|Progressive Disease|0|||
156698324|NCT02799095|565645608|FG015|Part B|Progressive Disease|0|||
156698325|NCT02799095|565645609|FG016|Part B|Progressive Disease|0|||
156698326|NCT02799095|565645593|FG000|Part B|Withdrawal by Subject|0|||
156698327|NCT02799095|565645594|FG001|Part B|Withdrawal by Subject|0|||
156698328|NCT02799095|565645595|FG002|Part B|Withdrawal by Subject|0|||
156698329|NCT02799095|565645596|FG003|Part B|Withdrawal by Subject|0|||
156698330|NCT02799095|565645597|FG004|Part B|Withdrawal by Subject|0|||
156698331|NCT02799095|565645598|FG005|Part B|Withdrawal by Subject|0|||
156698332|NCT02799095|565645599|FG006|Part B|Withdrawal by Subject|0|||
156698333|NCT02799095|565645600|FG007|Part B|Withdrawal by Subject|10|||
156698334|NCT02799095|565645601|FG008|Part B|Withdrawal by Subject|7|||
156698335|NCT02799095|565645602|FG009|Part B|Withdrawal by Subject|0|||
156698336|NCT02799095|565645603|FG010|Part B|Withdrawal by Subject|0|||
156698337|NCT02799095|565645604|FG011|Part B|Withdrawal by Subject|0|||
156698338|NCT02799095|565645605|FG012|Part B|Withdrawal by Subject|0|||
156698339|NCT02799095|565645606|FG013|Part B|Withdrawal by Subject|0|||
156698340|NCT02799095|565645607|FG014|Part B|Withdrawal by Subject|0|||
156698341|NCT02799095|565645608|FG015|Part B|Withdrawal by Subject|0|||
156698342|NCT02799095|565645609|FG016|Part B|Withdrawal by Subject|0|||
156698343|NCT02799095|565645593|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
156698344|NCT02799095|565645594|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
156698345|NCT02799095|565645595|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
156698346|NCT02799095|565645596|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
156698347|NCT02799095|565645597|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
156698348|NCT02799095|565645598|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
156698349|NCT02799095|565645599|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
156698350|NCT02799095|565645600|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
156698351|NCT02799095|565645601|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
156698352|NCT02799095|565645602|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
156698353|NCT02799095|565645603|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
156698354|NCT02799095|565645604|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
156698355|NCT02799095|565645605|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
156698356|NCT02799095|565645606|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
156698357|NCT02799095|565645607|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
156698358|NCT02799095|565645608|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
156698359|NCT02799095|565645609|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
156698360|NCT02799095|565645593|FG000|Part C|Adverse Event|0|||
156698361|NCT02799095|565645594|FG001|Part C|Adverse Event|0|||
156698362|NCT02799095|565645595|FG002|Part C|Adverse Event|0|||
156698363|NCT02799095|565645596|FG003|Part C|Adverse Event|0|||
156698364|NCT02799095|565645597|FG004|Part C|Adverse Event|0|||
156790591|NCT01832038|565985418|FG000|Overall Study|Changes of implementation system|3|||
156331373|NCT02476201|564313414|FG000|Overall Study|Unable to program MPP|9|||
156698365|NCT02799095|565645598|FG005|Part C|Adverse Event|0|||
156698366|NCT02799095|565645599|FG006|Part C|Adverse Event|0|||
156698367|NCT02799095|565645600|FG007|Part C|Adverse Event|0|||
156698368|NCT02799095|565645601|FG008|Part C|Adverse Event|0|||
156698369|NCT02799095|565645602|FG009|Part C|Adverse Event|0|||
156698370|NCT02799095|565645603|FG010|Part C|Adverse Event|3|||
156698371|NCT02799095|565645604|FG011|Part C|Adverse Event|1|||
156698372|NCT02799095|565645605|FG012|Part C|Adverse Event|0|||
156698373|NCT02799095|565645606|FG013|Part C|Adverse Event|1|||
156698374|NCT02799095|565645607|FG014|Part C|Adverse Event|0|||
156698375|NCT02799095|565645608|FG015|Part C|Adverse Event|0|||
156698376|NCT02799095|565645609|FG016|Part C|Adverse Event|0|||
156698377|NCT02799095|565645593|FG000|Part C|Death|0|||
156698378|NCT02799095|565645594|FG001|Part C|Death|0|||
156698379|NCT02799095|565645595|FG002|Part C|Death|0|||
156698380|NCT02799095|565645596|FG003|Part C|Death|0|||
156698381|NCT02799095|565645597|FG004|Part C|Death|0|||
156871795|NCT01160822|566287801|FG006|Overall Study|Adverse Event|5|||
156871796|NCT01160822|566287795|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156871797|NCT01160822|566287796|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156871798|NCT01160822|566287797|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156871799|NCT01160822|566287798|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156871800|NCT01160822|566287799|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
156871801|NCT01160822|566287800|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
156871802|NCT01160822|566287801|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
156871803|NCT01160822|566287795|FG000|Overall Study|Withdrawal by Subject|0|||
156871804|NCT01160822|566287796|FG001|Overall Study|Withdrawal by Subject|0|||
156871805|NCT01160822|566287797|FG002|Overall Study|Withdrawal by Subject|0|||
156331374|NCT02476201|564313414|FG000|Overall Study|Study echo not performed|5|||
156530974|NCT00954174|565039821|FG002|Overall Study|Medical Reason|1|||
156530975|NCT00954174|565039822|FG003|Overall Study|Medical Reason|0|||
156530976|NCT00954174|565039819|FG000|Overall Study|Ineligible|40|||
156530977|NCT00954174|565039820|FG001|Overall Study|Ineligible|47|||
156530978|NCT00954174|565039821|FG002|Overall Study|Ineligible|7|||
156698382|NCT02799095|565645598|FG005|Part C|Death|0|||
156698383|NCT02799095|565645599|FG006|Part C|Death|0|||
156698384|NCT02799095|565645600|FG007|Part C|Death|0|||
156698385|NCT02799095|565645601|FG008|Part C|Death|0|||
156698386|NCT02799095|565645602|FG009|Part C|Death|0|||
156698387|NCT02799095|565645603|FG010|Part C|Death|7|||
156698388|NCT02799095|565645604|FG011|Part C|Death|5|||
156698389|NCT02799095|565645605|FG012|Part C|Death|6|||
156698390|NCT02799095|565645606|FG013|Part C|Death|8|||
156698391|NCT02799095|565645607|FG014|Part C|Death|1|||
156698392|NCT02799095|565645608|FG015|Part C|Death|8|||
156698393|NCT02799095|565645609|FG016|Part C|Death|1|||
156698394|NCT02799095|565645593|FG000|Part C|Lost to Follow-up|0|||
156698395|NCT02799095|565645594|FG001|Part C|Lost to Follow-up|0|||
156698396|NCT02799095|565645595|FG002|Part C|Lost to Follow-up|0|||
156698397|NCT02799095|565645596|FG003|Part C|Lost to Follow-up|0|||
156698398|NCT02799095|565645597|FG004|Part C|Lost to Follow-up|0|||
156698399|NCT02799095|565645598|FG005|Part C|Lost to Follow-up|0|||
156698400|NCT02799095|565645599|FG006|Part C|Lost to Follow-up|0|||
156698401|NCT02799095|565645600|FG007|Part C|Lost to Follow-up|0|||
156698402|NCT02799095|565645601|FG008|Part C|Lost to Follow-up|0|||
156698403|NCT02799095|565645602|FG009|Part C|Lost to Follow-up|0|||
156698404|NCT02799095|565645603|FG010|Part C|Lost to Follow-up|1|||
156790592|NCT01832038|565985418|FG000|Overall Study|Plan to pregnancy|7|||
156790593|NCT01832038|565985418|FG000|Overall Study|Bad mood and has suicidal thought|1|||
156790594|NCT01832038|565985418|FG000|Overall Study|Prohibited concomitant medication|1|||
156790595|NCT01832038|565985418|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
156790596|NCT01832038|565985418|FG000|Overall Study|Subject considered the efficacy was poor|1|||
156790597|NCT03810365|565985419|FG000|Overall Study|Lost to Follow-up|2|||
156790598|NCT03810365|565985420|FG001|Overall Study|Lost to Follow-up|2|||
156790599|NCT03810365|565985419|FG000|Overall Study|Withdrawal by Subject|4|||
156790600|NCT03810365|565985420|FG001|Overall Study|Withdrawal by Subject|5|||
156790601|NCT02255279|565985421|FG000|Overall Study|Lost to Follow-up|2|||
156790602|NCT02255279|565985422|FG001|Overall Study|Lost to Follow-up|2|||
156790603|NCT02255279|565985421|FG000|Overall Study|Protocol Violation|0|||
156790604|NCT02255279|565985422|FG001|Overall Study|Protocol Violation|1|||
156790605|NCT02255279|565985421|FG000|Overall Study|Withdrawal by Subject|3|||
156790606|NCT02255279|565985422|FG001|Overall Study|Withdrawal by Subject|6|||
156790607|NCT00107614|565985423|FG000|Overall Study|Physician Decision|10|||
156790608|NCT00107614|565985423|FG000|Overall Study|Death|2|||
156790609|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
156790610|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
156790611|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
156790612|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
156790613|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
156790614|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
156790615|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
156790616|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
156790617|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
156790618|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
156530979|NCT00954174|565039822|FG003|Overall Study|Ineligible|4|||
156698405|NCT02799095|565645604|FG011|Part C|Lost to Follow-up|1|||
156698406|NCT02799095|565645605|FG012|Part C|Lost to Follow-up|1|||
156698407|NCT02799095|565645606|FG013|Part C|Lost to Follow-up|3|||
156698408|NCT02799095|565645607|FG014|Part C|Lost to Follow-up|0|||
156698409|NCT02799095|565645608|FG015|Part C|Lost to Follow-up|0|||
156698410|NCT02799095|565645609|FG016|Part C|Lost to Follow-up|0|||
156698411|NCT02799095|565645593|FG000|Part C|Progressive Disease|0|||
156698412|NCT02799095|565645594|FG001|Part C|Progressive Disease|0|||
156698413|NCT02799095|565645595|FG002|Part C|Progressive Disease|0|||
156698414|NCT02799095|565645596|FG003|Part C|Progressive Disease|0|||
156790619|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
156871806|NCT01160822|566287798|FG003|Overall Study|Withdrawal by Subject|0|||
156871807|NCT01160822|566287799|FG004|Overall Study|Withdrawal by Subject|0|||
156871808|NCT01160822|566287800|FG005|Overall Study|Withdrawal by Subject|0|||
156871809|NCT01160822|566287801|FG006|Overall Study|Withdrawal by Subject|1|||
156871810|NCT01160822|566287795|FG000|Overall Study|Lost to Follow-up|0|||
156698415|NCT02799095|565645597|FG004|Part C|Progressive Disease|0|||
156698416|NCT02799095|565645598|FG005|Part C|Progressive Disease|0|||
156698417|NCT02799095|565645599|FG006|Part C|Progressive Disease|0|||
156698418|NCT02799095|565645600|FG007|Part C|Progressive Disease|0|||
156698419|NCT02799095|565645601|FG008|Part C|Progressive Disease|0|||
156698420|NCT02799095|565645602|FG009|Part C|Progressive Disease|2|||
156698421|NCT02799095|565645603|FG010|Part C|Progressive Disease|13|||
156698422|NCT02799095|565645604|FG011|Part C|Progressive Disease|2|||
156698423|NCT02799095|565645605|FG012|Part C|Progressive Disease|0|||
156698424|NCT02799095|565645606|FG013|Part C|Progressive Disease|1|||
156698425|NCT02799095|565645607|FG014|Part C|Progressive Disease|0|||
156698426|NCT02799095|565645608|FG015|Part C|Progressive Disease|0|||
156698427|NCT02799095|565645609|FG016|Part C|Progressive Disease|0|||
156698428|NCT02799095|565645593|FG000|Part C|Clinical Progression|0|||
156698429|NCT02799095|565645594|FG001|Part C|Clinical Progression|0|||
156871811|NCT01160822|566287796|FG001|Overall Study|Lost to Follow-up|0|||
156698430|NCT02799095|565645595|FG002|Part C|Clinical Progression|0|||
156698431|NCT02799095|565645596|FG003|Part C|Clinical Progression|0|||
156698432|NCT02799095|565645597|FG004|Part C|Clinical Progression|0|||
156698433|NCT02799095|565645598|FG005|Part C|Clinical Progression|0|||
156698434|NCT02799095|565645599|FG006|Part C|Clinical Progression|0|||
156698435|NCT02799095|565645600|FG007|Part C|Clinical Progression|0|||
156698436|NCT02799095|565645601|FG008|Part C|Clinical Progression|0|||
156698437|NCT02799095|565645602|FG009|Part C|Clinical Progression|1|||
156698438|NCT02799095|565645603|FG010|Part C|Clinical Progression|3|||
156698439|NCT02799095|565645604|FG011|Part C|Clinical Progression|0|||
156698440|NCT02799095|565645605|FG012|Part C|Clinical Progression|0|||
156698441|NCT02799095|565645606|FG013|Part C|Clinical Progression|1|||
156698442|NCT02799095|565645607|FG014|Part C|Clinical Progression|0|||
156698443|NCT02799095|565645608|FG015|Part C|Clinical Progression|0|||
156698444|NCT02799095|565645609|FG016|Part C|Clinical Progression|0|||
156698445|NCT02799095|565645593|FG000|Part C|Withdrawal by Subject|0|||
156698446|NCT02799095|565645594|FG001|Part C|Withdrawal by Subject|0|||
156698447|NCT02799095|565645595|FG002|Part C|Withdrawal by Subject|0|||
156698448|NCT02799095|565645596|FG003|Part C|Withdrawal by Subject|0|||
156698449|NCT02799095|565645597|FG004|Part C|Withdrawal by Subject|0|||
156698450|NCT02799095|565645598|FG005|Part C|Withdrawal by Subject|0|||
156698451|NCT02799095|565645599|FG006|Part C|Withdrawal by Subject|0|||
156698452|NCT02799095|565645600|FG007|Part C|Withdrawal by Subject|0|||
156871812|NCT01160822|566287797|FG002|Overall Study|Lost to Follow-up|0|||
156871813|NCT01160822|566287798|FG003|Overall Study|Lost to Follow-up|0|||
156871814|NCT01160822|566287799|FG004|Overall Study|Lost to Follow-up|1|||
156871815|NCT01160822|566287800|FG005|Overall Study|Lost to Follow-up|0|||
156871816|NCT01160822|566287801|FG006|Overall Study|Lost to Follow-up|0|||
156871817|NCT01160822|566287795|FG000|Overall Study|Administrative problems|0|||
156871818|NCT01160822|566287796|FG001|Overall Study|Administrative problems|0|||
156871819|NCT01160822|566287797|FG002|Overall Study|Administrative problems|0|||
156871820|NCT01160822|566287798|FG003|Overall Study|Administrative problems|0|||
156871821|NCT01160822|566287799|FG004|Overall Study|Administrative problems|1|||
156871822|NCT01160822|566287800|FG005|Overall Study|Administrative problems|0|||
156871823|NCT01160822|566287801|FG006|Overall Study|Administrative problems|0|||
156871824|NCT01160822|566287795|FG000|Overall Study|Protocol deviation|0|||
156871825|NCT01160822|566287796|FG001|Overall Study|Protocol deviation|0|||
156871826|NCT01160822|566287797|FG002|Overall Study|Protocol deviation|0|||
156698453|NCT02799095|565645601|FG008|Part C|Withdrawal by Subject|0|||
156871827|NCT01160822|566287798|FG003|Overall Study|Protocol deviation|0|||
156871828|NCT01160822|566287799|FG004|Overall Study|Protocol deviation|2|||
156871829|NCT01160822|566287800|FG005|Overall Study|Protocol deviation|0|||
156871830|NCT01160822|566287801|FG006|Overall Study|Protocol deviation|0|||
156871831|NCT00750438|566287807|FG000|Overall Study|Protocol Violation|4|||
156698454|NCT02799095|565645602|FG009|Part C|Withdrawal by Subject|0|||
156698455|NCT02799095|565645603|FG010|Part C|Withdrawal by Subject|13|||
156698456|NCT02799095|565645604|FG011|Part C|Withdrawal by Subject|15|||
156871832|NCT00750438|566287808|FG001|Overall Study|Protocol Violation|1|||
156871833|NCT00750438|566287807|FG000|Overall Study|Physician Decision|2|||
156698457|NCT02799095|565645605|FG012|Part C|Withdrawal by Subject|13|||
156698458|NCT02799095|565645606|FG013|Part C|Withdrawal by Subject|21|||
156698459|NCT02799095|565645607|FG014|Part C|Withdrawal by Subject|0|||
156698460|NCT02799095|565645608|FG015|Part C|Withdrawal by Subject|12|||
156698461|NCT02799095|565645609|FG016|Part C|Withdrawal by Subject|1|||
156698462|NCT02799095|565645593|FG000|Part C|Physician Decision|0|||
156698463|NCT02799095|565645594|FG001|Part C|Physician Decision|0|||
156698464|NCT02799095|565645595|FG002|Part C|Physician Decision|0|||
156698465|NCT02799095|565645596|FG003|Part C|Physician Decision|0|||
156698466|NCT02799095|565645597|FG004|Part C|Physician Decision|0|||
156871834|NCT00750438|566287808|FG001|Overall Study|Physician Decision|2|||
156871835|NCT00750438|566287807|FG000|Overall Study|Withdrawal by Subject|1|||
156871836|NCT00750438|566287808|FG001|Overall Study|Withdrawal by Subject|1|||
156871837|NCT00787644|566287809|FG000|Overall Study|Lost to Follow-up|1|||
156871838|NCT00787644|566287810|FG001|Overall Study|Lost to Follow-up|1|||
156871839|NCT00787644|566287809|FG000|Overall Study|Withdrawal by Subject|1|||
156871840|NCT00787644|566287810|FG001|Overall Study|Withdrawal by Subject|1|||
156871841|NCT01108185|566287814|FG000|Overall Study|Non-compliance|15|||
156871842|NCT01108185|566287814|FG000|Overall Study|Lost to Follow-up|12|||
156871843|NCT05615922|566287821|FG000|Overall Study|Lost to Follow-up|1|||
156871844|NCT04500158|566287822|FG000|Overall Study|Physician Decision|17|||
156871845|NCT04500158|566287823|FG001|Overall Study|Physician Decision|11|||
156871846|NCT04774094|566287828|FG000|Overall Study|Other|2|||
156698467|NCT02799095|565645598|FG005|Part C|Physician Decision|0|||
156698468|NCT02799095|565645599|FG006|Part C|Physician Decision|0|||
156698469|NCT02799095|565645600|FG007|Part C|Physician Decision|0|||
156698470|NCT02799095|565645601|FG008|Part C|Physician Decision|0|||
156698471|NCT02799095|565645602|FG009|Part C|Physician Decision|0|||
156698472|NCT02799095|565645603|FG010|Part C|Physician Decision|1|||
156698473|NCT02799095|565645604|FG011|Part C|Physician Decision|0|||
156698474|NCT02799095|565645605|FG012|Part C|Physician Decision|0|||
156698475|NCT02799095|565645606|FG013|Part C|Physician Decision|0|||
156698476|NCT02799095|565645607|FG014|Part C|Physician Decision|0|||
156698477|NCT02799095|565645608|FG015|Part C|Physician Decision|0|||
156698478|NCT02799095|565645609|FG016|Part C|Physician Decision|0|||
156698479|NCT02799095|565645593|FG000|Part C|Other|0|||
156698480|NCT02799095|565645594|FG001|Part C|Other|0|||
156698481|NCT02799095|565645595|FG002|Part C|Other|0|||
156698482|NCT02799095|565645596|FG003|Part C|Other|0|||
156698483|NCT02799095|565645597|FG004|Part C|Other|0|||
156698484|NCT02799095|565645598|FG005|Part C|Other|0|||
156698485|NCT02799095|565645599|FG006|Part C|Other|0|||
156698486|NCT02799095|565645600|FG007|Part C|Other|0|||
156698487|NCT02799095|565645601|FG008|Part C|Other|0|||
156698488|NCT02799095|565645602|FG009|Part C|Other|0|||
156698489|NCT02799095|565645603|FG010|Part C|Other|0|||
156698490|NCT02799095|565645604|FG011|Part C|Other|2|||
156698491|NCT02799095|565645605|FG012|Part C|Other|2|||
156698492|NCT02799095|565645606|FG013|Part C|Other|0|||
156698493|NCT02799095|565645607|FG014|Part C|Other|0|||
156698494|NCT02799095|565645608|FG015|Part C|Other|0|||
156698495|NCT02799095|565645609|FG016|Part C|Other|0|||
156698496|NCT02128217|565645614|FG000|Overall Study|Lost to Follow-up|0|||
156698497|NCT02128217|565645615|FG001|Overall Study|Lost to Follow-up|1|||
156698498|NCT00541970|565645616|FG000|Month 7|Protocol Violation|9|||
156698499|NCT00541970|565645617|FG001|Month 7|Protocol Violation|13|||
156698500|NCT00541970|565645618|FG002|Month 7|Protocol Violation|11|||
156698501|NCT00541970|565645619|FG003|Month 7|Protocol Violation|5|||
156871847|NCT04774094|566287828|FG000|Overall Study|Withdrawal by Subject|9|||
156530980|NCT00954174|565039819|FG000|Overall Study|Never Treated|4|||
156530981|NCT00954174|565039820|FG001|Overall Study|Never Treated|17|||
156698502|NCT00541970|565645616|FG000|Month 12|Adverse Event|0|||
156698503|NCT00541970|565645617|FG001|Month 12|Adverse Event|1|||
156698504|NCT00541970|565645618|FG002|Month 12|Adverse Event|1|||
156698505|NCT00541970|565645619|FG003|Month 12|Adverse Event|1|||
156698506|NCT00541970|565645616|FG000|Month 12|Protocol Violation|12|||
156698507|NCT00541970|565645617|FG001|Month 12|Protocol Violation|21|||
156698508|NCT00541970|565645618|FG002|Month 12|Protocol Violation|20|||
156698509|NCT00541970|565645619|FG003|Month 12|Protocol Violation|15|||
156698510|NCT00541970|565645616|FG000|Month 18|Adverse Event|0|||
156698511|NCT00541970|565645617|FG001|Month 18|Adverse Event|1|||
156698512|NCT00541970|565645618|FG002|Month 18|Adverse Event|1|||
156698513|NCT00541970|565645619|FG003|Month 18|Adverse Event|1|||
156698514|NCT00541970|565645616|FG000|Month 18|Protocol Violation|14|||
156698515|NCT00541970|565645617|FG001|Month 18|Protocol Violation|23|||
156698516|NCT00541970|565645618|FG002|Month 18|Protocol Violation|24|||
156698517|NCT00541970|565645619|FG003|Month 18|Protocol Violation|16|||
156698518|NCT00541970|565645616|FG000|Month 24|Adverse Event|0|||
156698519|NCT00541970|565645617|FG001|Month 24|Adverse Event|1|||
156698520|NCT00541970|565645618|FG002|Month 24|Adverse Event|1|||
156698521|NCT00541970|565645619|FG003|Month 24|Adverse Event|1|||
156871848|NCT04774094|566287828|FG000|Overall Study|Lost to Follow-up|7|||
156331375|NCT02476201|564313414|FG000|Overall Study|Adverse Event|4|||
156698522|NCT00541970|565645616|FG000|Month 24|Protocol Violation|29|||
156698523|NCT00541970|565645617|FG001|Month 24|Protocol Violation|31|||
156698524|NCT00541970|565645618|FG002|Month 24|Protocol Violation|31|||
156698525|NCT00541970|565645619|FG003|Month 24|Protocol Violation|21|||
156698526|NCT00541970|565645616|FG000|Month 36|Protocol Violation|61|||
156698527|NCT00541970|565645617|FG001|Month 36|Protocol Violation|66|||
156871849|NCT04774094|566287828|FG000|Overall Study|Lack of Efficacy|5|||
156871850|NCT04774094|566287828|FG000|Overall Study|Death|17|||
156871851|NCT04774094|566287828|FG000|Overall Study|Adverse Event|4|||
156698528|NCT00541970|565645618|FG002|Month 36|Protocol Violation|66|||
156698529|NCT00541970|565645619|FG003|Month 36|Protocol Violation|60|||
156698530|NCT00541970|565645616|FG000|Month 48|Withdrawal by Subject|2|||
156698531|NCT00541970|565645617|FG001|Month 48|Withdrawal by Subject|4|||
156698532|NCT00541970|565645618|FG002|Month 48|Withdrawal by Subject|4|||
156698533|NCT00541970|565645619|FG003|Month 48|Withdrawal by Subject|2|||
156871852|NCT02374450|566287829|FG000|Overall Study|Protocol Violation|0|||
156698534|NCT00541970|565645616|FG000|Month 48|Other|3|||
156698535|NCT00541970|565645617|FG001|Month 48|Other|1|||
156698536|NCT00541970|565645618|FG002|Month 48|Other|1|||
156698537|NCT00541970|565645619|FG003|Month 48|Other|0|||
156698538|NCT00541970|565645616|FG000|Month 48|Lost to Follow-up|66|||
156698539|NCT00541970|565645617|FG001|Month 48|Lost to Follow-up|68|||
156698540|NCT00541970|565645618|FG002|Month 48|Lost to Follow-up|68|||
156698541|NCT00541970|565645619|FG003|Month 48|Lost to Follow-up|73|||
156698542|NCT00541970|565645616|FG000|Month 60|Protocol Violation|78|||
156698543|NCT00541970|565645617|FG001|Month 60|Protocol Violation|77|||
156698544|NCT00541970|565645618|FG002|Month 60|Protocol Violation|82|||
156698545|NCT00541970|565645619|FG003|Month 60|Protocol Violation|72|||
156698546|NCT03222583|565645622|FG000|Overall Study|Withdrawal by Subject|3|||
156698547|NCT03222583|565645623|FG001|Overall Study|Withdrawal by Subject|3|||
156698548|NCT03222583|565645622|FG000|Overall Study|Lost to Follow-up|1|||
156698549|NCT03222583|565645623|FG001|Overall Study|Lost to Follow-up|0|||
156698550|NCT03222583|565645622|FG000|Overall Study|Other|1|||
156698551|NCT03222583|565645623|FG001|Overall Study|Other|3|||
156698552|NCT02622113|565645624|FG000|Overall Study|Adverse Event|4|||
156698553|NCT02622113|565645625|FG001|Overall Study|Adverse Event|4|||
156698554|NCT02622113|565645624|FG000|Overall Study|Physician Decision|0|||
156698555|NCT02622113|565645625|FG001|Overall Study|Physician Decision|1|||
156698556|NCT02622113|565645624|FG000|Overall Study|Withdrawal by Subject|0|||
156698557|NCT02622113|565645625|FG001|Overall Study|Withdrawal by Subject|2|||
156698558|NCT02622113|565645624|FG000|Overall Study|Stopping Criteria|1|||
156698559|NCT02622113|565645625|FG001|Overall Study|Stopping Criteria|3|||
156698560|NCT01570686|565645626|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156698561|NCT01570686|565645627|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156698562|NCT01570686|565645626|FG000|Overall Study|Administrative problems|0|||
156698563|NCT01570686|565645627|FG001|Overall Study|Administrative problems|1|||
156698564|NCT01570686|565645626|FG000|Overall Study|Adverse Event|8|||
156698565|NCT01570686|565645627|FG001|Overall Study|Adverse Event|6|||
156698566|NCT01570686|565645626|FG000|Overall Study|Lost to Follow-up|4|||
156698567|NCT01570686|565645627|FG001|Overall Study|Lost to Follow-up|3|||
156698568|NCT01570686|565645626|FG000|Overall Study|Protocol Deviation|3|||
156698569|NCT01570686|565645627|FG001|Overall Study|Protocol Deviation|0|||
156698570|NCT01570686|565645626|FG000|Overall Study|Withdrawal by Subject|4|||
156698571|NCT01570686|565645627|FG001|Overall Study|Withdrawal by Subject|4|||
156698572|NCT01570686|565645626|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156698573|NCT01570686|565645627|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156698574|NCT00754650|565645628|FG000|Overall Study|Disease Progression|2|||
156698575|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
156698576|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
156698577|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
156698578|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
156698579|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
156698580|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
156698581|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
156698582|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
156698583|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
156698584|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
156698585|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
156698586|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
156698587|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
156698588|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
156698589|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
156698590|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
156698591|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
156698592|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
156698593|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
156698594|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
156698595|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
156698596|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
156698597|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
156698598|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
156698599|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
156698600|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
156698601|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
156698602|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
156698603|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
156698604|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
156698605|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
156698606|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
156698607|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
156871853|NCT02374450|566287830|FG001|Overall Study|Protocol Violation|1|||
156698608|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
156698609|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
156871854|NCT02374450|566287831|FG002|Overall Study|Protocol Violation|0|||
156871855|NCT02374450|566287829|FG000|Overall Study|Withdrawal by Subject|91|||
156871856|NCT02374450|566287830|FG001|Overall Study|Withdrawal by Subject|110|||
156871857|NCT02374450|566287831|FG002|Overall Study|Withdrawal by Subject|4|||
156871858|NCT02374450|566287829|FG000|Overall Study|Lost to Follow-up|168|||
156871859|NCT02374450|566287830|FG001|Overall Study|Lost to Follow-up|194|||
156871860|NCT02374450|566287831|FG002|Overall Study|Lost to Follow-up|138|||
156871861|NCT02374450|566287829|FG000|Overall Study|Death|173|||
156871862|NCT02374450|566287830|FG001|Overall Study|Death|185|||
156871863|NCT02374450|566287831|FG002|Overall Study|Death|81|||
156871864|NCT02374450|566287829|FG000|Overall Study|Migrated from the study area|538|||
156871865|NCT02374450|566287830|FG001|Overall Study|Migrated from the study area|648|||
156871866|NCT02374450|566287831|FG002|Overall Study|Migrated from the study area|181|||
156871867|NCT02374450|566287829|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
156871868|NCT02374450|566287830|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
156871869|NCT02374450|566287831|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
156698610|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
156698611|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
156698612|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
156698613|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
156698614|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
156698615|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
156698616|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
156698617|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
156698618|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
156698619|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
156698620|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
156698621|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
156698622|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
156698623|NCT01345175|565645637|FG000|Overall Study|Physician Decision|0|||
156698624|NCT01345175|565645638|FG001|Overall Study|Physician Decision|1|||
156698625|NCT01345175|565645637|FG000|Overall Study|Withdrawal by Subject|1|||
156698626|NCT01345175|565645638|FG001|Overall Study|Withdrawal by Subject|1|||
156698627|NCT01345175|565645637|FG000|Overall Study|Failed to complete BFI|3|||
156698628|NCT01345175|565645638|FG001|Overall Study|Failed to complete BFI|2|||
156698629|NCT01345175|565645637|FG000|Overall Study|Stopped taking medication|2|||
156698630|NCT01345175|565645638|FG001|Overall Study|Stopped taking medication|2|||
156698631|NCT00505375|565645639|FG000|Overall Study|Death|1|||
156698632|NCT00505375|565645640|FG001|Overall Study|Death|0|||
156698633|NCT00505375|565645639|FG000|Overall Study|Withdrawal by Subject|2|||
156698634|NCT00505375|565645640|FG001|Overall Study|Withdrawal by Subject|2|||
156698635|NCT00505375|565645639|FG000|Overall Study|Lost to Follow-up|0|||
156698636|NCT00505375|565645640|FG001|Overall Study|Lost to Follow-up|2|||
156698637|NCT00505375|565645639|FG000|Overall Study|Pregnancy|1|||
156698638|NCT00505375|565645640|FG001|Overall Study|Pregnancy|0|||
156698639|NCT00505375|565645639|FG000|Overall Study|Travel issues|0|||
156698640|NCT00505375|565645640|FG001|Overall Study|Travel issues|1|||
156698641|NCT04112173|565645644|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
156871870|NCT02374450|566287829|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
156871871|NCT02374450|566287830|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
156871872|NCT02374450|566287831|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
156871873|NCT02374450|566287829|FG000|Overall Study|Other|0|||
156698642|NCT01561430|565645645|FG000|Overall Study|Adverse Event|0|||
156698643|NCT01561430|565645646|FG001|Overall Study|Adverse Event|0|||
156698644|NCT01561430|565645647|FG002|Overall Study|Adverse Event|3|||
156698645|NCT01561430|565645648|FG003|Overall Study|Adverse Event|1|||
156698646|NCT01561430|565645645|FG000|Overall Study|Withdrawal by Subject|0|||
156871874|NCT02374450|566287830|FG001|Overall Study|Other|21|||
156871875|NCT02374450|566287831|FG002|Overall Study|Other|79|||
156871876|NCT05232682|566287834|FG000|Overall Study|Lost to Follow-up|2|||
156698647|NCT01561430|565645646|FG001|Overall Study|Withdrawal by Subject|0|||
156698648|NCT01561430|565645647|FG002|Overall Study|Withdrawal by Subject|1|||
156698649|NCT01561430|565645648|FG003|Overall Study|Withdrawal by Subject|0|||
156698650|NCT01561430|565645645|FG000|Overall Study|Physician Decision|0|||
156698651|NCT01561430|565645646|FG001|Overall Study|Physician Decision|1|||
156871877|NCT01788358|566289443|FG000|Overall Study|Other|11|||
156871878|NCT01788358|566289443|FG000|Overall Study|Logistical difficulties|1|||
156871879|NCT01788358|566289443|FG000|Overall Study|Lost to Follow-up|5|||
156871880|NCT01788358|566289443|FG000|Overall Study|Protocol Violation|3|||
156331376|NCT02476201|564313414|FG000|Overall Study|Death|2|||
156331377|NCT02476201|564313414|FG000|Overall Study|Lost to Follow-up|2|||
156331378|NCT02476201|564313414|FG000|Overall Study|MPP programmed to OFF|2|||
156698652|NCT01561430|565645647|FG002|Overall Study|Physician Decision|0|||
156698653|NCT01561430|565645648|FG003|Overall Study|Physician Decision|0|||
156698654|NCT01561430|565645645|FG000|Overall Study|Sponsor Decision|1|||
156698655|NCT01561430|565645646|FG001|Overall Study|Sponsor Decision|14|||
156698656|NCT01561430|565645647|FG002|Overall Study|Sponsor Decision|13|||
156698657|NCT01561430|565645648|FG003|Overall Study|Sponsor Decision|12|||
156698658|NCT02906930|565645649|FG000|Overall Study|Withdrawal by Subject|0|||
156698659|NCT02906930|565645650|FG001|Overall Study|Withdrawal by Subject|5|||
156698660|NCT02906930|565645651|FG002|Overall Study|Withdrawal by Subject|5|||
156698661|NCT02906930|565645652|FG003|Overall Study|Withdrawal by Subject|4|||
156698662|NCT02906930|565645649|FG000|Overall Study|Lost to Follow-up|5|||
156698663|NCT02906930|565645650|FG001|Overall Study|Lost to Follow-up|7|||
156698664|NCT02906930|565645651|FG002|Overall Study|Lost to Follow-up|5|||
156698665|NCT02906930|565645652|FG003|Overall Study|Lost to Follow-up|2|||
156698666|NCT02906930|565645649|FG000|Overall Study|Death|0|||
156698667|NCT02906930|565645650|FG001|Overall Study|Death|0|||
156698668|NCT02906930|565645651|FG002|Overall Study|Death|1|||
156698669|NCT02906930|565645652|FG003|Overall Study|Death|0|||
156698670|NCT02906930|565645649|FG000|Overall Study|Other|1|||
156698671|NCT02906930|565645650|FG001|Overall Study|Other|2|||
156698672|NCT02906930|565645651|FG002|Overall Study|Other|1|||
156698673|NCT02906930|565645652|FG003|Overall Study|Other|2|||
156698674|NCT04234984|565645662|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
156698675|NCT04234984|565645662|FG000|Follow-up at the Second Time Point|Death|1|||
156698676|NCT04234984|565645662|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
156698677|NCT01055132|565645663|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
156698678|NCT01055132|565645664|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
156698679|NCT01055132|565645663|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
156698680|NCT01055132|565645664|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
156698681|NCT02570113|565645665|FG000|Overall Study|Withdrawal by Subject|3|||
156698682|NCT02746471|565645666|FG000|Overall Study|Death|43|||
156698683|NCT02746471|565645666|FG000|Overall Study|Exited before 36 months|1119|||
156698684|NCT02564211|565645667|FG000|Overall Study|Adverse Event|4|||
156698685|NCT00910091|565645669|FG000|Pre-assignment|Withdrawal by Subject|0|||
156698686|NCT00910091|565645670|FG001|Pre-assignment|Withdrawal by Subject|2|||
156698687|NCT00910091|565645669|FG000|Treatment and Survival|Withdrawal by Subject|3|||
156698688|NCT00910091|565645670|FG001|Treatment and Survival|Withdrawal by Subject|4|||
156698689|NCT00910091|565645669|FG000|Treatment and Survival|Adverse Event|1|||
156698690|NCT00910091|565645670|FG001|Treatment and Survival|Adverse Event|0|||
156331379|NCT02476201|564313414|FG000|Overall Study|Withdrawal by Subject|1|||
156331380|NCT02476201|564313414|FG000|Overall Study|Unsuccessful implant|1|||
156871881|NCT01788358|566289443|FG000|Overall Study|Withdrawal by Subject|26|||
156871882|NCT01788358|566289443|FG000|Overall Study|Lack of Efficacy|1|||
156698691|NCT01908816|565645671|FG000|Overall Study|Subject's no longer requires study drug|0|||
156698692|NCT01908816|565645672|FG001|Overall Study|Subject's no longer requires study drug|0|||
156698693|NCT01908816|565645673|FG002|Overall Study|Subject's no longer requires study drug|0|||
156698694|NCT01908816|565645674|FG003|Overall Study|Subject's no longer requires study drug|1|||
156698695|NCT01908816|565645671|FG000|Overall Study|Protocol deviation|1|||
156698696|NCT01908816|565645672|FG001|Overall Study|Protocol deviation|2|||
156698697|NCT01908816|565645673|FG002|Overall Study|Protocol deviation|1|||
156698698|NCT01908816|565645674|FG003|Overall Study|Protocol deviation|1|||
156698699|NCT01908816|565645671|FG000|Overall Study|Withdrawal by Subject|0|||
156698700|NCT01908816|565645672|FG001|Overall Study|Withdrawal by Subject|4|||
156698701|NCT01908816|565645673|FG002|Overall Study|Withdrawal by Subject|2|||
156698702|NCT01908816|565645674|FG003|Overall Study|Withdrawal by Subject|2|||
156698703|NCT01908816|565645671|FG000|Overall Study|Lost to Follow-up|3|||
156698704|NCT01908816|565645672|FG001|Overall Study|Lost to Follow-up|5|||
156698705|NCT01908816|565645673|FG002|Overall Study|Lost to Follow-up|4|||
156698706|NCT01908816|565645674|FG003|Overall Study|Lost to Follow-up|2|||
156698707|NCT01908816|565645671|FG000|Overall Study|Death|1|||
156698708|NCT01908816|565645672|FG001|Overall Study|Death|0|||
156698709|NCT01908816|565645673|FG002|Overall Study|Death|7|||
156698710|NCT01908816|565645674|FG003|Overall Study|Death|1|||
156698711|NCT01908816|565645671|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156698712|NCT01908816|565645672|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
156698713|NCT01908816|565645673|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
156698714|NCT01908816|565645674|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156698715|NCT01908816|565645671|FG000|Overall Study|Early termination|87|||
156698716|NCT01908816|565645672|FG001|Overall Study|Early termination|60|||
156698717|NCT01908816|565645673|FG002|Overall Study|Early termination|43|||
156871883|NCT01788358|566289443|FG000|Overall Study|Adverse Event|51|||
156698718|NCT01908816|565645674|FG003|Overall Study|Early termination|28|||
156698719|NCT01007942|565645676|FG000|Overall Study|Adverse Event|29|||
156698720|NCT01007942|565645677|FG001|Overall Study|Adverse Event|14|||
156698721|NCT01007942|565645676|FG000|Overall Study|Abnormal test procedure|0|||
156331381|NCT01797731|564313415|FG000|Overall Study|Didn't have proper radiographs required|3|||
156871884|NCT01168219|566289444|FG000|Overall Study|off study before starting treatment|2|||
156698722|NCT01007942|565645677|FG001|Overall Study|Abnormal test procedure|1|||
156698723|NCT01007942|565645676|FG000|Overall Study|Disease progression|217|||
156698724|NCT01007942|565645677|FG001|Overall Study|Disease progression|242|||
156698725|NCT01007942|565645676|FG000|Overall Study|New cancer therapy|5|||
156698726|NCT01007942|565645677|FG001|Overall Study|New cancer therapy|1|||
156698727|NCT01007942|565645676|FG000|Overall Study|Protocol Violation|1|||
156698728|NCT01007942|565645677|FG001|Overall Study|Protocol Violation|1|||
156698729|NCT01007942|565645676|FG000|Overall Study|Withdrawal by Subject|19|||
156698730|NCT01007942|565645677|FG001|Overall Study|Withdrawal by Subject|14|||
156698731|NCT01007942|565645676|FG000|Overall Study|Lost to Follow-up|1|||
156698732|NCT01007942|565645677|FG001|Overall Study|Lost to Follow-up|0|||
156698733|NCT01007942|565645676|FG000|Overall Study|Administrative problems|2|||
156698734|NCT01007942|565645677|FG001|Overall Study|Administrative problems|0|||
156698735|NCT01007942|565645676|FG000|Overall Study|Death|3|||
156698736|NCT01007942|565645677|FG001|Overall Study|Death|2|||
156698737|NCT01007942|565645676|FG000|Overall Study|Patients untreated|4|||
156698738|NCT01007942|565645677|FG001|Overall Study|Patients untreated|3|||
156698739|NCT04492020|565645678|FG000|Overall Study|Adverse Event|1|||
156698740|NCT04492020|565645679|FG001|Overall Study|Adverse Event|3|||
156698741|NCT04492020|565645678|FG000|Overall Study|Withdrawal by Subject|4|||
156698742|NCT04492020|565645679|FG001|Overall Study|Withdrawal by Subject|3|||
156698743|NCT04492020|565645678|FG000|Overall Study|Lost to Follow-up|4|||
156698744|NCT04492020|565645679|FG001|Overall Study|Lost to Follow-up|3|||
156698745|NCT04492020|565645678|FG000|Overall Study|Protocol Violation|5|||
156698746|NCT04492020|565645679|FG001|Overall Study|Protocol Violation|2|||
156698747|NCT04492020|565645678|FG000|Overall Study|Lack of Qualifying Event|25|||
156698748|NCT04492020|565645679|FG001|Overall Study|Lack of Qualifying Event|27|||
156698749|NCT04492020|565645678|FG000|Overall Study|Non-compliance with Study Drug|2|||
156698750|NCT04492020|565645679|FG001|Overall Study|Non-compliance with Study Drug|1|||
156698751|NCT04594707|565645680|FG000|Overall Study|Adverse Event|0|||
156698752|NCT04594707|565645681|FG001|Overall Study|Adverse Event|0|||
156698753|NCT04594707|565645682|FG002|Overall Study|Adverse Event|1|||
156698754|NCT04594707|565645680|FG000|Overall Study|Death|0|||
156698755|NCT04594707|565645681|FG001|Overall Study|Death|2|||
156698756|NCT04594707|565645682|FG002|Overall Study|Death|2|||
156698757|NCT04594707|565645680|FG000|Overall Study|Lung Transplant|0|||
156698758|NCT04594707|565645681|FG001|Overall Study|Lung Transplant|0|||
156698759|NCT04594707|565645682|FG002|Overall Study|Lung Transplant|1|||
156698760|NCT04594707|565645680|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
156698761|NCT04594707|565645681|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
156698762|NCT04594707|565645682|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
156698763|NCT04594707|565645680|FG000|Overall Study|Study Terminated By Sponsor|19|||
156698764|NCT04594707|565645681|FG001|Overall Study|Study Terminated By Sponsor|47|||
156698765|NCT04594707|565645682|FG002|Overall Study|Study Terminated By Sponsor|41|||
156698766|NCT04594707|565645680|FG000|Overall Study|Withdrawal by Subject|1|||
156698767|NCT04594707|565645681|FG001|Overall Study|Withdrawal by Subject|0|||
156698768|NCT04594707|565645682|FG002|Overall Study|Withdrawal by Subject|2|||
156698769|NCT04585789|565645683|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
156698770|NCT04585789|565645684|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
156698771|NCT04585789|565645685|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
156698772|NCT04585789|565645683|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
156698773|NCT04585789|565645684|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
156698774|NCT04585789|565645685|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
156698775|NCT01175811|565645686|FG000|Overall Study|Adverse Event|1|||
156698776|NCT01175811|565645687|FG001|Overall Study|Adverse Event|1|||
156698777|NCT01175811|565645686|FG000|Overall Study|Entry criteria not met|3|||
156698778|NCT01175811|565645687|FG001|Overall Study|Entry criteria not met|1|||
156698779|NCT01175811|565645686|FG000|Overall Study|Lack of Efficacy|1|||
156698780|NCT01175811|565645687|FG001|Overall Study|Lack of Efficacy|0|||
156698781|NCT01175811|565645686|FG000|Overall Study|Lost to Follow-up|3|||
156698782|NCT01175811|565645687|FG001|Overall Study|Lost to Follow-up|2|||
156698783|NCT01175811|565645686|FG000|Overall Study|Physician Decision|1|||
156698784|NCT01175811|565645687|FG001|Overall Study|Physician Decision|1|||
156698785|NCT01175811|565645686|FG000|Overall Study|Protocol Violation|1|||
156698786|NCT01175811|565645687|FG001|Overall Study|Protocol Violation|2|||
156698787|NCT01175811|565645686|FG000|Overall Study|Withdrawal by Subject|6|||
156698788|NCT01175811|565645687|FG001|Overall Study|Withdrawal by Subject|7|||
156698789|NCT02628743|565645690|FG000|Overall Study|Other|3|||
156698790|NCT02628743|565645690|FG000|Overall Study|Withdrawal by Subject|50|||
156698791|NCT02628743|565645690|FG000|Overall Study|Study Terminated by Sponsor|76|||
156698792|NCT02628743|565645690|FG000|Overall Study|Physician Decision|2|||
156698793|NCT00655876|565645691|FG000|Overall Study|Protocol Violation|9|||
156698794|NCT00655876|565645692|FG001|Overall Study|Protocol Violation|7|||
156698795|NCT00326963|565645693|FG000|Overall Study|Adverse Event|2|||
156698796|NCT00326963|565645693|FG000|Overall Study|Injection site reaction|1|||
156698797|NCT00326963|565645693|FG000|Overall Study|Death|1|||
156698798|NCT00326963|565645693|FG000|Overall Study|Failure to return|10|||
156698799|NCT00326963|565645693|FG000|Overall Study|Withdrawal by Subject|10|||
156698800|NCT00326963|565645693|FG000|Overall Study|Refused treatment / did not cooperate|5|||
156698801|NCT00326963|565645693|FG000|Overall Study|Violation of selection criteria at entry|2|||
156698802|NCT00326963|565645693|FG000|Overall Study|Other protocol violation|1|||
156698803|NCT00326963|565645693|FG000|Overall Study|Administrative / other|1|||
156698804|NCT04645966|565645696|FG000|Vaccination Phase|Adverse Event|1|||
156698805|NCT04645966|565645697|FG001|Vaccination Phase|Adverse Event|0|||
156698806|NCT04645966|565645698|FG002|Vaccination Phase|Adverse Event|0|||
156698807|NCT04645966|565645699|FG003|Vaccination Phase|Adverse Event|0|||
156698808|NCT04645966|565645700|FG004|Vaccination Phase|Adverse Event|0|||
156698809|NCT04645966|565645701|FG005|Vaccination Phase|Adverse Event|0|||
156698810|NCT04645966|565645702|FG006|Vaccination Phase|Adverse Event|1|||
156698811|NCT04645966|565645703|FG007|Vaccination Phase|Adverse Event|0|||
156698812|NCT04645966|565645704|FG008|Vaccination Phase|Adverse Event|0|||
156698813|NCT04645966|565645696|FG000|Vaccination Phase|Death|0|||
156698814|NCT04645966|565645697|FG001|Vaccination Phase|Death|0|||
156698815|NCT04645966|565645698|FG002|Vaccination Phase|Death|0|||
156698816|NCT04645966|565645699|FG003|Vaccination Phase|Death|0|||
156698817|NCT04645966|565645700|FG004|Vaccination Phase|Death|0|||
156698818|NCT04645966|565645701|FG005|Vaccination Phase|Death|1|||
156698819|NCT04645966|565645702|FG006|Vaccination Phase|Death|0|||
156698820|NCT04645966|565645703|FG007|Vaccination Phase|Death|0|||
156698821|NCT04645966|565645704|FG008|Vaccination Phase|Death|0|||
156698822|NCT04645966|565645696|FG000|Vaccination Phase|Protocol Violation|0|||
156698823|NCT04645966|565645697|FG001|Vaccination Phase|Protocol Violation|0|||
156698824|NCT04645966|565645698|FG002|Vaccination Phase|Protocol Violation|0|||
156698825|NCT04645966|565645699|FG003|Vaccination Phase|Protocol Violation|0|||
156698826|NCT04645966|565645700|FG004|Vaccination Phase|Protocol Violation|1|||
156698827|NCT04645966|565645701|FG005|Vaccination Phase|Protocol Violation|0|||
156698828|NCT04645966|565645702|FG006|Vaccination Phase|Protocol Violation|0|||
156698829|NCT04645966|565645703|FG007|Vaccination Phase|Protocol Violation|0|||
156698830|NCT04645966|565645704|FG008|Vaccination Phase|Protocol Violation|0|||
156698831|NCT04645966|565645696|FG000|Vaccination Phase|Study terminated by sponsor|0|||
156698832|NCT04645966|565645697|FG001|Vaccination Phase|Study terminated by sponsor|0|||
156698833|NCT04645966|565645698|FG002|Vaccination Phase|Study terminated by sponsor|14|||
156698834|NCT04645966|565645699|FG003|Vaccination Phase|Study terminated by sponsor|15|||
156698835|NCT04645966|565645700|FG004|Vaccination Phase|Study terminated by sponsor|47|||
156698836|NCT04645966|565645701|FG005|Vaccination Phase|Study terminated by sponsor|43|||
156698837|NCT04645966|565645702|FG006|Vaccination Phase|Study terminated by sponsor|29|||
156698838|NCT04645966|565645703|FG007|Vaccination Phase|Study terminated by sponsor|29|||
156698839|NCT04645966|565645704|FG008|Vaccination Phase|Study terminated by sponsor|12|||
156698840|NCT04645966|565645696|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
156698841|NCT04645966|565645697|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
156698842|NCT04645966|565645698|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
156698843|NCT04645966|565645699|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
156698844|NCT04645966|565645700|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
156698845|NCT04645966|565645701|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
156698846|NCT04645966|565645702|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
156698847|NCT04645966|565645703|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
156698848|NCT04645966|565645704|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
156698849|NCT04645966|565645696|FG000|Vaccination Phase|Other|0|||
156698850|NCT04645966|565645697|FG001|Vaccination Phase|Other|0|||
156698851|NCT04645966|565645698|FG002|Vaccination Phase|Other|0|||
156698852|NCT04645966|565645699|FG003|Vaccination Phase|Other|0|||
156698853|NCT04645966|565645700|FG004|Vaccination Phase|Other|0|||
156698854|NCT04645966|565645701|FG005|Vaccination Phase|Other|2|||
156698855|NCT04645966|565645702|FG006|Vaccination Phase|Other|0|||
156698856|NCT04645966|565645703|FG007|Vaccination Phase|Other|0|||
156871885|NCT01168219|566289444|FG000|Overall Study|withdrew before transplant|1|||
156871886|NCT01168219|566289444|FG000|Overall Study|ineligible due to CML|2|||
156871887|NCT01027273|566289445|FG000|Overall Study|Lost to Follow-up|57|||
156871888|NCT01027273|566289446|FG001|Overall Study|Lost to Follow-up|31|||
156871889|NCT01027273|566289445|FG000|Overall Study|Death|2|||
156698857|NCT04645966|565645704|FG008|Vaccination Phase|Other|0|||
156698858|NCT04645966|565645696|FG000|Vaccination Phase|Lost to Follow-up|0|||
156698859|NCT04645966|565645697|FG001|Vaccination Phase|Lost to Follow-up|0|||
156871890|NCT01027273|566289446|FG001|Overall Study|Death|2|||
156698860|NCT04645966|565645698|FG002|Vaccination Phase|Lost to Follow-up|0|||
156698861|NCT04645966|565645699|FG003|Vaccination Phase|Lost to Follow-up|0|||
156698862|NCT04645966|565645700|FG004|Vaccination Phase|Lost to Follow-up|0|||
156698863|NCT04645966|565645701|FG005|Vaccination Phase|Lost to Follow-up|0|||
156698864|NCT04645966|565645702|FG006|Vaccination Phase|Lost to Follow-up|0|||
156871891|NCT02948634|566289450|FG000|Overall Study|Lack of efficacy and study suspended|10|||
156698865|NCT04645966|565645703|FG007|Vaccination Phase|Lost to Follow-up|1|||
156698866|NCT04645966|565645704|FG008|Vaccination Phase|Lost to Follow-up|0|||
156698867|NCT04645966|565645696|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
156698868|NCT04645966|565645697|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
156871892|NCT02948634|566289451|FG001|Overall Study|Lack of efficacy and study suspended|2|||
156438657|NCT02538107|564697092|FG000|Overall Study|Necessity of dialysis|20|||
156438658|NCT02538107|564697092|FG000|Overall Study|Administration of other ESA|11|||
156438659|NCT02538107|564697092|FG000|Overall Study|No further treatment necessary|18|||
156438660|NCT02538107|564697092|FG000|Overall Study|Withdrawal by Subject|17|||
156438661|NCT02538107|564697092|FG000|Overall Study|Death|4|||
156438662|NCT02538107|564697092|FG000|Overall Study|Administrative reason|5|||
156438663|NCT02538107|564697092|FG000|Overall Study|Adverse Event|4|||
156438664|NCT02538107|564697092|FG000|Overall Study|Surgery|1|||
156438665|NCT02538107|564697092|FG000|Overall Study|Other|7|||
156438666|NCT02538107|564697092|FG000|Overall Study|Not recorded|7|||
156438667|NCT02471755|564697093|FG000|Overall Study|Withdrawal by Subject|1|||
156438668|NCT02471755|564697094|FG001|Overall Study|Withdrawal by Subject|0|||
156438669|NCT02471755|564697093|FG000|Overall Study|Lost to Follow-up|0|||
156438670|NCT02471755|564697094|FG001|Overall Study|Lost to Follow-up|1|||
156438671|NCT01576484|564697095|FG000|Overall Study|Adverse Event|1|||
156530982|NCT00954174|565039821|FG002|Overall Study|Never Treated|0|||
156698869|NCT04645966|565645698|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
156698870|NCT04645966|565645699|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
156698871|NCT04645966|565645700|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
156698872|NCT04645966|565645701|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
156698873|NCT04645966|565645702|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
156698874|NCT04645966|565645703|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
156698875|NCT04645966|565645704|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
156698876|NCT04645966|565645696|FG000|Follow-up Phase|Lost to Follow-up|0|||
156698877|NCT04645966|565645697|FG001|Follow-up Phase|Lost to Follow-up|0|||
156698878|NCT04645966|565645698|FG002|Follow-up Phase|Lost to Follow-up|0|||
156698879|NCT04645966|565645699|FG003|Follow-up Phase|Lost to Follow-up|0|||
156698880|NCT04645966|565645700|FG004|Follow-up Phase|Lost to Follow-up|0|||
156698881|NCT04645966|565645701|FG005|Follow-up Phase|Lost to Follow-up|0|||
156698882|NCT04645966|565645702|FG006|Follow-up Phase|Lost to Follow-up|0|||
156698883|NCT04645966|565645703|FG007|Follow-up Phase|Lost to Follow-up|1|||
156698884|NCT04645966|565645704|FG008|Follow-up Phase|Lost to Follow-up|0|||
156698885|NCT00552578|565645708|FG000|Overall Study|Lost to Follow-up|1|||
156698886|NCT00552578|565645709|FG001|Overall Study|Lost to Follow-up|1|||
156698887|NCT00470067|565645710|FG000|Overall Study|Death|1|||
156698888|NCT00470067|565645710|FG000|Overall Study|Disease Progression|6|||
156698889|NCT01460901|565645711|FG000|Overall Study|Withdrawal by Subject|2|||
156698890|NCT04091659|565645716|FG000|Overall Study|Protocol Violation|3|||
156698891|NCT04091659|565645717|FG001|Overall Study|Protocol Violation|0|||
156698892|NCT04091659|565645716|FG000|Overall Study|Lost to Follow-up|0|||
156698893|NCT04091659|565645717|FG001|Overall Study|Lost to Follow-up|1|||
156698894|NCT00895947|565645718|FG000|Overall Study|Adverse Event|3|||
156698895|NCT00895947|565645719|FG001|Overall Study|Adverse Event|4|||
156698896|NCT00895947|565645718|FG000|Overall Study|Lost to Follow-up|3|||
156698897|NCT00895947|565645719|FG001|Overall Study|Lost to Follow-up|4|||
156790620|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
156790621|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
156790622|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
156790623|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
156790624|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
156790625|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
156790626|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
156790627|NCT01755156|565985425|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
156790628|NCT01755156|565985426|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
156790629|NCT01755156|565985425|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
156790630|NCT01755156|565985426|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
156790631|NCT00871000|565985427|FG000|Overall Study|Withdrawal by Subject|1|||
156790632|NCT00871000|565985428|FG001|Overall Study|Withdrawal by Subject|0|||
156790633|NCT00449787|565985431|FG000|Overall Study|Lost to Follow-up|10|||
156790634|NCT00449787|565985432|FG001|Overall Study|Lost to Follow-up|8|||
156790635|NCT00449787|565985431|FG000|Overall Study|Did not require medication|95|||
156790636|NCT00449787|565985432|FG001|Overall Study|Did not require medication|92|||
156790637|NCT03574389|565985435|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
156790638|NCT03574389|565985436|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
156790639|NCT03574389|565985437|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
156790640|NCT03574389|565985438|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
156790641|NCT03574389|565985439|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
156790642|NCT03574389|565985440|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
156871893|NCT01413204|566289452|FG000|Overall Study|Adverse Event|1|||
156438672|NCT01576484|564697096|FG001|Overall Study|Adverse Event|1|||
156698898|NCT00895947|565645718|FG000|Overall Study|Protocol Violation|4|||
156698899|NCT00895947|565645719|FG001|Overall Study|Protocol Violation|2|||
156698900|NCT00895947|565645718|FG000|Overall Study|Withdrawal by Subject|2|||
156438673|NCT01576484|564697095|FG000|Overall Study|Protocol Violation|0|||
156438674|NCT01576484|564697096|FG001|Overall Study|Protocol Violation|2|||
156331382|NCT01797731|564313416|FG001|Overall Study|Didn't have proper radiographs required|3|||
156331383|NCT01189604|564313418|FG000|Overall Study|Impossible to visit|0|||
156331384|NCT01189604|564313419|FG001|Overall Study|Impossible to visit|0|||
156331385|NCT01189604|564313420|FG002|Overall Study|Impossible to visit|0|||
156331386|NCT01189604|564313421|FG003|Overall Study|Impossible to visit|0|||
156331387|NCT01189604|564313422|FG004|Overall Study|Impossible to visit|0|||
156331388|NCT01189604|564313423|FG005|Overall Study|Impossible to visit|1|||
156331389|NCT01189604|564313424|FG006|Overall Study|Impossible to visit|0|||
156331390|NCT01189604|564313418|FG000|Overall Study|Adverse Event|0|||
156331391|NCT01189604|564313419|FG001|Overall Study|Adverse Event|1|||
156331392|NCT01189604|564313420|FG002|Overall Study|Adverse Event|0|||
156331393|NCT01189604|564313421|FG003|Overall Study|Adverse Event|0|||
156331394|NCT01189604|564313422|FG004|Overall Study|Adverse Event|2|||
156331395|NCT01189604|564313423|FG005|Overall Study|Adverse Event|0|||
156331396|NCT01189604|564313424|FG006|Overall Study|Adverse Event|1|||
156331397|NCT01189604|564313418|FG000|Overall Study|Withdrawal by Subject|1|||
156331398|NCT01189604|564313419|FG001|Overall Study|Withdrawal by Subject|0|||
156331399|NCT01189604|564313420|FG002|Overall Study|Withdrawal by Subject|0|||
156331400|NCT01189604|564313421|FG003|Overall Study|Withdrawal by Subject|0|||
156331401|NCT01189604|564313422|FG004|Overall Study|Withdrawal by Subject|0|||
156331402|NCT01189604|564313423|FG005|Overall Study|Withdrawal by Subject|0|||
156331403|NCT01189604|564313424|FG006|Overall Study|Withdrawal by Subject|0|||
156331404|NCT03945214|564313425|FG000|Overall Study|Lost to Follow-up|3|||
156331405|NCT03945214|564313426|FG001|Overall Study|Lost to Follow-up|4|||
156331406|NCT03945214|564313427|FG002|Overall Study|Lost to Follow-up|7|||
156331407|NCT03945214|564313428|FG003|Overall Study|Lost to Follow-up|4|||
156331408|NCT02191137|564313439|FG000|Treatment|Death|4|||
156331409|NCT02191137|564313439|FG000|Treatment|Withdrawal by Subject|3|||
156331410|NCT02191137|564313439|FG000|Treatment|Adverse Event|2|||
156331411|NCT02191137|564313439|FG000|Treatment|Other|1|||
156331412|NCT02191137|564313439|FG000|Follow-up|Lost to Follow-up|2|||
156331413|NCT02191137|564313439|FG000|Follow-up|Ongoing/unknown|2|||
156331414|NCT02191137|564313439|FG000|Follow-up|Adverse Event|1|||
156331415|NCT00538291|564313440|FG000|Overall Study|Adverse Event|2|||
156331416|NCT00538291|564313440|FG000|Overall Study|Withdrawal by Subject|1|||
156331417|NCT00694707|564313441|FG000|Overall Study|Did Not Receive Treatment|0|||
156331418|NCT00694707|564313442|FG001|Overall Study|Did Not Receive Treatment|0|||
156331419|NCT00694707|564313443|FG002|Overall Study|Did Not Receive Treatment|1|||
156331420|NCT00694707|564313444|FG003|Overall Study|Did Not Receive Treatment|1|||
156331421|NCT00694707|564313445|FG004|Overall Study|Did Not Receive Treatment|1|||
156331422|NCT00694707|564313441|FG000|Overall Study|Adverse Event|22|||
156331423|NCT00694707|564313442|FG001|Overall Study|Adverse Event|14|||
156331424|NCT00694707|564313443|FG002|Overall Study|Adverse Event|8|||
156331425|NCT00694707|564313444|FG003|Overall Study|Adverse Event|12|||
156331426|NCT00694707|564313445|FG004|Overall Study|Adverse Event|13|||
156331427|NCT00694707|564313441|FG000|Overall Study|Insufficient Therapeutic Response|33|||
156331428|NCT00694707|564313442|FG001|Overall Study|Insufficient Therapeutic Response|18|||
156331429|NCT00694707|564313443|FG002|Overall Study|Insufficient Therapeutic Response|17|||
156331430|NCT00694707|564313444|FG003|Overall Study|Insufficient Therapeutic Response|15|||
156331431|NCT00694707|564313445|FG004|Overall Study|Insufficient Therapeutic Response|10|||
156331432|NCT00694707|564313441|FG000|Overall Study|Protocol Violation|1|||
156331433|NCT00694707|564313442|FG001|Overall Study|Protocol Violation|2|||
156331434|NCT00694707|564313443|FG002|Overall Study|Protocol Violation|1|||
156331435|NCT00694707|564313444|FG003|Overall Study|Protocol Violation|3|||
156331436|NCT00694707|564313445|FG004|Overall Study|Protocol Violation|1|||
156331437|NCT00694707|564313441|FG000|Overall Study|Withdrawal of Consent|14|||
156790643|NCT03574389|565985441|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
156790644|NCT03574389|565985435|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
156790645|NCT03574389|565985436|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
156790646|NCT03574389|565985437|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
156790647|NCT03574389|565985438|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
156790648|NCT03574389|565985439|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
156790649|NCT03574389|565985440|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
156790650|NCT03574389|565985441|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
156331438|NCT00694707|564313442|FG001|Overall Study|Withdrawal of Consent|18|||
156790651|NCT03574389|565985435|FG000|Vaccination Period|Other|6|||
156790652|NCT03574389|565985436|FG001|Vaccination Period|Other|0|||
156790653|NCT03574389|565985437|FG002|Vaccination Period|Other|0|||
156331439|NCT00694707|564313443|FG002|Overall Study|Withdrawal of Consent|22|||
156331440|NCT00694707|564313444|FG003|Overall Study|Withdrawal of Consent|16|||
156331441|NCT00694707|564313445|FG004|Overall Study|Withdrawal of Consent|15|||
156331442|NCT00694707|564313441|FG000|Overall Study|Lost to Follow-up|0|||
156331443|NCT00694707|564313442|FG001|Overall Study|Lost to Follow-up|1|||
156331444|NCT00694707|564313443|FG002|Overall Study|Lost to Follow-up|2|||
156331445|NCT00694707|564313444|FG003|Overall Study|Lost to Follow-up|0|||
156331446|NCT00694707|564313445|FG004|Overall Study|Lost to Follow-up|0|||
156331447|NCT00694707|564313441|FG000|Overall Study|Jeopardizing Parole Status|1|||
156331448|NCT00694707|564313442|FG001|Overall Study|Jeopardizing Parole Status|0|||
156698901|NCT00895947|565645719|FG001|Overall Study|Withdrawal by Subject|0|||
156698902|NCT03678285|565645728|FG000|Overall Study|Adverse Event|2|||
156698903|NCT03678285|565645728|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
156698904|NCT03678285|565645728|FG000|Overall Study|Dehydrated prior to start of workout|1|||
156698905|NCT00123474|565645729|FG000|Randomized to Treatment|Randomized, never treated|1|||
156698906|NCT00123474|565645730|FG001|Randomized to Treatment|Randomized, never treated|4|||
156698907|NCT00123474|565645731|FG002|Randomized to Treatment|Randomized, never treated|2|||
156698908|NCT00123474|565645732|FG003|Randomized to Treatment|Randomized, never treated|1|||
156698909|NCT00123474|565645729|FG000|As Treated at Study Closure|not reported when site closed|1|||
156698910|NCT00123474|565645730|FG001|As Treated at Study Closure|not reported when site closed|0|||
156698911|NCT00123474|565645731|FG002|As Treated at Study Closure|not reported when site closed|1|||
156790654|NCT03574389|565985438|FG003|Vaccination Period|Other|0|||
156790655|NCT03574389|565985439|FG004|Vaccination Period|Other|0|||
156790656|NCT03574389|565985440|FG005|Vaccination Period|Other|0|||
156790657|NCT03574389|565985441|FG006|Vaccination Period|Other|0|||
156790658|NCT03574389|565985435|FG000|Vaccination Period|Adverse Event|0|||
156790659|NCT03574389|565985436|FG001|Vaccination Period|Adverse Event|1|||
156790660|NCT03574389|565985437|FG002|Vaccination Period|Adverse Event|0|||
156790661|NCT03574389|565985438|FG003|Vaccination Period|Adverse Event|0|||
156790662|NCT03574389|565985439|FG004|Vaccination Period|Adverse Event|0|||
156790663|NCT03574389|565985440|FG005|Vaccination Period|Adverse Event|0|||
156790664|NCT03574389|565985441|FG006|Vaccination Period|Adverse Event|0|||
156790665|NCT03574389|565985435|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
156790666|NCT03574389|565985436|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
156790667|NCT03574389|565985437|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
156790668|NCT03574389|565985438|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
156790669|NCT03574389|565985439|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
156790670|NCT03574389|565985440|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
156790671|NCT03574389|565985441|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
156790672|NCT03436420|565985445|FG000|Overall Study|Lack of Efficacy|3|||
156790673|NCT01061710|565985446|FG000|Overall Study|Protocol Violation|14|||
156790674|NCT00159874|565985447|FG000|Overall Study|Adverse Event|2|||
156790675|NCT00159874|565985448|FG001|Overall Study|Adverse Event|2|||
156790676|NCT00159874|565985449|FG002|Overall Study|Adverse Event|5|||
156790677|NCT00159874|565985450|FG003|Overall Study|Adverse Event|1|||
156790678|NCT00159874|565985451|FG004|Overall Study|Adverse Event|1|||
156790679|NCT00159874|565985452|FG005|Overall Study|Adverse Event|2|||
156790680|NCT00159874|565985453|FG006|Overall Study|Adverse Event|0|||
156790681|NCT00159874|565985447|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
156790682|NCT00159874|565985448|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
156790683|NCT00159874|565985449|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
156790684|NCT00159874|565985450|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
156790685|NCT00159874|565985451|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
156790686|NCT00159874|565985452|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
156790687|NCT00159874|565985453|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
156790688|NCT00159874|565985447|FG000|Overall Study|Lack of Efficacy|2|||
156790689|NCT00159874|565985448|FG001|Overall Study|Lack of Efficacy|0|||
156790690|NCT00159874|565985449|FG002|Overall Study|Lack of Efficacy|1|||
156790691|NCT00159874|565985450|FG003|Overall Study|Lack of Efficacy|1|||
156790692|NCT00159874|565985451|FG004|Overall Study|Lack of Efficacy|0|||
156790693|NCT00159874|565985452|FG005|Overall Study|Lack of Efficacy|3|||
156790694|NCT00159874|565985453|FG006|Overall Study|Lack of Efficacy|0|||
156790695|NCT00159874|565985447|FG000|Overall Study|Lost to Follow-up|1|||
156790696|NCT00159874|565985448|FG001|Overall Study|Lost to Follow-up|0|||
156790697|NCT00159874|565985449|FG002|Overall Study|Lost to Follow-up|3|||
156790698|NCT00159874|565985450|FG003|Overall Study|Lost to Follow-up|0|||
156871894|NCT01413204|566289453|FG001|Overall Study|Adverse Event|2|||
156871895|NCT01413204|566289454|FG002|Overall Study|Adverse Event|2|||
156871896|NCT01413204|566289452|FG000|Overall Study|Physician Decision|3|||
156871897|NCT01413204|566289453|FG001|Overall Study|Physician Decision|0|||
156871898|NCT01413204|566289454|FG002|Overall Study|Physician Decision|2|||
156871899|NCT01413204|566289452|FG000|Overall Study|Withdrawal by Subject|1|||
156871900|NCT01413204|566289453|FG001|Overall Study|Withdrawal by Subject|4|||
156790699|NCT00159874|565985451|FG004|Overall Study|Lost to Follow-up|1|||
156790700|NCT00159874|565985452|FG005|Overall Study|Lost to Follow-up|2|||
156790701|NCT00159874|565985453|FG006|Overall Study|Lost to Follow-up|1|||
156790702|NCT00159874|565985447|FG000|Overall Study|Other|8|||
156438675|NCT01576484|564697095|FG000|Overall Study|Sponsor Decision|2|||
156438676|NCT01576484|564697096|FG001|Overall Study|Sponsor Decision|8|||
156790703|NCT00159874|565985448|FG001|Overall Study|Other|8|||
156790704|NCT00159874|565985449|FG002|Overall Study|Other|8|||
156790705|NCT00159874|565985450|FG003|Overall Study|Other|0|||
156790706|NCT00159874|565985451|FG004|Overall Study|Other|2|||
156871901|NCT01413204|566289454|FG002|Overall Study|Withdrawal by Subject|4|||
156871902|NCT01413204|566289452|FG000|Overall Study|Clearly not eligible for the study|0|||
156438677|NCT01576484|564697095|FG000|Overall Study|Withdrawal by Subject|0|||
156790707|NCT00159874|565985452|FG005|Overall Study|Other|1|||
156871903|NCT01413204|566289453|FG001|Overall Study|Clearly not eligible for the study|0|||
156438678|NCT01576484|564697096|FG001|Overall Study|Withdrawal by Subject|3|||
156438679|NCT01576484|564697095|FG000|Overall Study|Other|2|||
156438680|NCT01576484|564697096|FG001|Overall Study|Other|5|||
156438681|NCT00958633|564697098|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
156438682|NCT00958633|564697099|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
156438683|NCT00958633|564697100|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
156438684|NCT00958633|564697098|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
156698912|NCT00123474|565645732|FG003|As Treated at Study Closure|not reported when site closed|0|||
156871904|NCT01413204|566289454|FG002|Overall Study|Clearly not eligible for the study|1|||
156698913|NCT00123474|565645729|FG000|As Treated at Study Closure|Adverse Event|10|||
156698914|NCT00123474|565645730|FG001|As Treated at Study Closure|Adverse Event|4|||
156871905|NCT01413204|566289452|FG000|Overall Study|Fasting plasma glucose level increased|1|||
156871906|NCT01413204|566289453|FG001|Overall Study|Fasting plasma glucose level increased|0|||
156871907|NCT01413204|566289454|FG002|Overall Study|Fasting plasma glucose level increased|10|||
156698915|NCT00123474|565645731|FG002|As Treated at Study Closure|Adverse Event|10|||
156698916|NCT00123474|565645732|FG003|As Treated at Study Closure|Adverse Event|8|||
156698917|NCT00123474|565645729|FG000|As Treated at Study Closure|Disease Progression|35|||
156698918|NCT00123474|565645730|FG001|As Treated at Study Closure|Disease Progression|42|||
156698919|NCT00123474|565645731|FG002|As Treated at Study Closure|Disease Progression|29|||
156698920|NCT00123474|565645732|FG003|As Treated at Study Closure|Disease Progression|27|||
156698921|NCT00123474|565645729|FG000|As Treated at Study Closure|Investigator Request|12|||
156698922|NCT00123474|565645730|FG001|As Treated at Study Closure|Investigator Request|6|||
156698923|NCT00123474|565645731|FG002|As Treated at Study Closure|Investigator Request|7|||
156331449|NCT00694707|564313443|FG002|Overall Study|Jeopardizing Parole Status|0|||
156331450|NCT00694707|564313444|FG003|Overall Study|Jeopardizing Parole Status|0|||
156331451|NCT00694707|564313445|FG004|Overall Study|Jeopardizing Parole Status|0|||
156331452|NCT00694707|564313441|FG000|Overall Study|Death in the Family|1|||
156331453|NCT00694707|564313442|FG001|Overall Study|Death in the Family|0|||
156331454|NCT00694707|564313443|FG002|Overall Study|Death in the Family|0|||
156331455|NCT00694707|564313444|FG003|Overall Study|Death in the Family|0|||
156331456|NCT00694707|564313445|FG004|Overall Study|Death in the Family|0|||
156331457|NCT00694707|564313441|FG000|Overall Study|Arrest by Police|0|||
156331458|NCT00694707|564313442|FG001|Overall Study|Arrest by Police|1|||
156331459|NCT00694707|564313443|FG002|Overall Study|Arrest by Police|0|||
156331460|NCT00694707|564313444|FG003|Overall Study|Arrest by Police|0|||
156331461|NCT00694707|564313445|FG004|Overall Study|Arrest by Police|0|||
156331462|NCT00694707|564313441|FG000|Overall Study|Administrative Reasons|0|||
156331463|NCT00694707|564313442|FG001|Overall Study|Administrative Reasons|1|||
156331464|NCT00694707|564313443|FG002|Overall Study|Administrative Reasons|0|||
156331465|NCT00694707|564313444|FG003|Overall Study|Administrative Reasons|2|||
156331466|NCT00694707|564313445|FG004|Overall Study|Administrative Reasons|0|||
156331467|NCT00694707|564313441|FG000|Overall Study|Notification of Past Head Injury|0|||
156331468|NCT00694707|564313442|FG001|Overall Study|Notification of Past Head Injury|0|||
156331469|NCT00694707|564313443|FG002|Overall Study|Notification of Past Head Injury|0|||
156331470|NCT00694707|564313444|FG003|Overall Study|Notification of Past Head Injury|1|||
156331471|NCT00694707|564313445|FG004|Overall Study|Notification of Past Head Injury|0|||
156331472|NCT01904058|564313453|FG000|Overall Study|Adverse Event|2|||
156331473|NCT01904058|564313454|FG001|Overall Study|Adverse Event|0|||
156331474|NCT01904058|564313455|FG002|Overall Study|Adverse Event|0|||
156331475|NCT01904058|564313456|FG003|Overall Study|Adverse Event|0|||
156331476|NCT01904058|564313453|FG000|Overall Study|Withdrawal by Subject|1|||
156438685|NCT00958633|564697099|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
156871908|NCT00499616|566289455|FG000|Overall Study|Death|1|||
156871909|NCT00499616|566289456|FG001|Overall Study|Death|5|||
156698924|NCT00123474|565645732|FG003|As Treated at Study Closure|Investigator Request|5|||
156698925|NCT00123474|565645729|FG000|As Treated at Study Closure|non-specified|54|||
156698926|NCT00123474|565645730|FG001|As Treated at Study Closure|non-specified|47|||
156698927|NCT00123474|565645731|FG002|As Treated at Study Closure|non-specified|57|||
156438686|NCT00958633|564697100|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
156438687|NCT00958633|564697098|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
156871910|NCT00499616|566289457|FG002|Overall Study|Death|3|||
156871911|NCT00499616|566289458|FG003|Overall Study|Death|1|||
156530983|NCT00954174|565039822|FG003|Overall Study|Never Treated|3|||
156698928|NCT00123474|565645732|FG003|As Treated at Study Closure|non-specified|60|||
156871912|NCT00499616|566289455|FG000|Overall Study|Lack of Efficacy|5|||
156871913|NCT00499616|566289456|FG001|Overall Study|Lack of Efficacy|0|||
156871914|NCT00499616|566289457|FG002|Overall Study|Lack of Efficacy|19|||
156331477|NCT01904058|564313454|FG001|Overall Study|Withdrawal by Subject|0|||
156331478|NCT01904058|564313455|FG002|Overall Study|Withdrawal by Subject|1|||
156331479|NCT01904058|564313456|FG003|Overall Study|Withdrawal by Subject|0|||
156331480|NCT01904058|564313453|FG000|Overall Study|Pregnancy|0|||
156331481|NCT01904058|564313454|FG001|Overall Study|Pregnancy|0|||
156331482|NCT01904058|564313455|FG002|Overall Study|Pregnancy|0|||
156331483|NCT01904058|564313456|FG003|Overall Study|Pregnancy|1|||
156331484|NCT03096483|564313458|FG000|Overall Study|Withdrawal by site|1|||
156698929|NCT00123474|565645729|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
156698930|NCT00123474|565645730|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
156698931|NCT00123474|565645731|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
156698932|NCT00123474|565645732|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
156698933|NCT00123474|565645729|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
156698934|NCT00123474|565645730|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
156698935|NCT00123474|565645731|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
156698936|NCT00123474|565645732|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
156698937|NCT00616629|565645733|FG000|Overall Study|Protocol Violation|1|||
156698938|NCT00616629|565645734|FG001|Overall Study|Protocol Violation|2|||
156698939|NCT00616629|565645735|FG002|Overall Study|Protocol Violation|1|||
156698940|NCT00616629|565645736|FG003|Overall Study|Protocol Violation|0|||
156698941|NCT00616629|565645737|FG004|Overall Study|Protocol Violation|0|||
156698942|NCT00616629|565645733|FG000|Overall Study|AV-block|1|||
156698943|NCT00616629|565645734|FG001|Overall Study|AV-block|0|||
156698944|NCT00616629|565645735|FG002|Overall Study|AV-block|0|||
156698945|NCT00616629|565645736|FG003|Overall Study|AV-block|0|||
156698946|NCT00616629|565645737|FG004|Overall Study|AV-block|0|||
156698947|NCT01059344|565645738|FG000|Overall Study|Adverse Event|12|||
156698948|NCT01059344|565645739|FG001|Overall Study|Adverse Event|30|||
156871915|NCT00499616|566289458|FG003|Overall Study|Lack of Efficacy|0|||
156871916|NCT00499616|566289455|FG000|Overall Study|Lost to Follow-up|0|||
156871917|NCT00499616|566289456|FG001|Overall Study|Lost to Follow-up|0|||
156871918|NCT00499616|566289457|FG002|Overall Study|Lost to Follow-up|1|||
156871919|NCT00499616|566289458|FG003|Overall Study|Lost to Follow-up|0|||
156871920|NCT00499616|566289455|FG000|Overall Study|Physician Decision|6|||
156871921|NCT00499616|566289456|FG001|Overall Study|Physician Decision|16|||
156871922|NCT00499616|566289457|FG002|Overall Study|Physician Decision|9|||
156871923|NCT00499616|566289458|FG003|Overall Study|Physician Decision|0|||
156871924|NCT00499616|566289455|FG000|Overall Study|Withdrawal by Subject|1|||
156871925|NCT00499616|566289456|FG001|Overall Study|Withdrawal by Subject|0|||
156871926|NCT00499616|566289457|FG002|Overall Study|Withdrawal by Subject|1|||
156871927|NCT00499616|566289458|FG003|Overall Study|Withdrawal by Subject|0|||
156871928|NCT00499616|566289455|FG000|Overall Study|Ineligible|1|||
156871929|NCT00499616|566289456|FG001|Overall Study|Ineligible|2|||
156871930|NCT00499616|566289457|FG002|Overall Study|Ineligible|0|||
156871931|NCT00499616|566289458|FG003|Overall Study|Ineligible|15|||
156871932|NCT00499616|566289455|FG000|Overall Study|Not evaluable|0|||
156871933|NCT00499616|566289456|FG001|Overall Study|Not evaluable|0|||
156871934|NCT00499616|566289457|FG002|Overall Study|Not evaluable|0|||
156871935|NCT00499616|566289458|FG003|Overall Study|Not evaluable|41|||
156871936|NCT00499616|566289455|FG000|Overall Study|Patient/Parent Refusal|1|||
156871937|NCT00499616|566289456|FG001|Overall Study|Patient/Parent Refusal|5|||
156698949|NCT01059344|565645738|FG000|Overall Study|Withdrawal by Subject|6|||
156698950|NCT01059344|565645739|FG001|Overall Study|Withdrawal by Subject|9|||
156698951|NCT01059344|565645738|FG000|Overall Study|Lost to Follow-up|1|||
156698952|NCT01059344|565645739|FG001|Overall Study|Lost to Follow-up|1|||
156698953|NCT01059344|565645738|FG000|Overall Study|Other|3|||
156698954|NCT01059344|565645739|FG001|Overall Study|Other|6|||
156698955|NCT01739348|565645740|FG000|Part I (Base Study)|Adverse Event|41|||
156698956|NCT01739348|565645741|FG001|Part I (Base Study)|Adverse Event|52|||
156698957|NCT01739348|565645742|FG002|Part I (Base Study)|Adverse Event|8|||
156698958|NCT01739348|565645743|FG003|Part I (Base Study)|Adverse Event|33|||
156698959|NCT01739348|565645740|FG000|Part I (Base Study)|Death|10|||
156698960|NCT01739348|565645741|FG001|Part I (Base Study)|Death|7|||
156698961|NCT01739348|565645742|FG002|Part I (Base Study)|Death|2|||
156698962|NCT01739348|565645743|FG003|Part I (Base Study)|Death|8|||
156698963|NCT01739348|565645740|FG000|Part I (Base Study)|Lack of Efficacy|3|||
156698964|NCT01739348|565645741|FG001|Part I (Base Study)|Lack of Efficacy|8|||
156698965|NCT01739348|565645742|FG002|Part I (Base Study)|Lack of Efficacy|0|||
156698966|NCT01739348|565645743|FG003|Part I (Base Study)|Lack of Efficacy|7|||
156698967|NCT01739348|565645740|FG000|Part I (Base Study)|Lost to Follow-up|4|||
156698968|NCT01739348|565645741|FG001|Part I (Base Study)|Lost to Follow-up|2|||
156698969|NCT01739348|565645742|FG002|Part I (Base Study)|Lost to Follow-up|4|||
156871938|NCT00499616|566289457|FG002|Overall Study|Patient/Parent Refusal|3|||
156871939|NCT00499616|566289458|FG003|Overall Study|Patient/Parent Refusal|0|||
156871940|NCT04816669|566289459|FG000|Part 1|Adverse Event|1|||
156871941|NCT04816669|566289460|FG001|Part 1|Adverse Event|1|||
156871942|NCT04816669|566289461|FG002|Part 1|Adverse Event|0|||
156871943|NCT04816669|566289462|FG003|Part 1|Adverse Event|0|||
156871944|NCT04816669|566289459|FG000|Part 1|Lost to Follow-up|2|||
156698970|NCT01739348|565645743|FG003|Part I (Base Study)|Lost to Follow-up|4|||
156698971|NCT01739348|565645740|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
156698972|NCT01739348|565645741|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
156698973|NCT01739348|565645742|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
156698974|NCT01739348|565645743|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
156698975|NCT01739348|565645740|FG000|Part I (Base Study)|Physician Decision|10|||
156698976|NCT01739348|565645741|FG001|Part I (Base Study)|Physician Decision|7|||
156871945|NCT04816669|566289460|FG001|Part 1|Lost to Follow-up|2|||
156698977|NCT01739348|565645742|FG002|Part I (Base Study)|Physician Decision|1|||
156698978|NCT01739348|565645743|FG003|Part I (Base Study)|Physician Decision|4|||
156698979|NCT01739348|565645740|FG000|Part I (Base Study)|Protocol Violation|2|||
156698980|NCT01739348|565645741|FG001|Part I (Base Study)|Protocol Violation|0|||
156698981|NCT01739348|565645742|FG002|Part I (Base Study)|Protocol Violation|1|||
156698982|NCT01739348|565645743|FG003|Part I (Base Study)|Protocol Violation|2|||
156698983|NCT01739348|565645740|FG000|Part I (Base Study)|Screen Failure|2|||
156698984|NCT01739348|565645741|FG001|Part I (Base Study)|Screen Failure|0|||
156698985|NCT01739348|565645742|FG002|Part I (Base Study)|Screen Failure|0|||
156698986|NCT01739348|565645743|FG003|Part I (Base Study)|Screen Failure|0|||
156698987|NCT01739348|565645740|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
156698988|NCT01739348|565645741|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
156698989|NCT01739348|565645742|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
156698990|NCT01739348|565645743|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
156698991|NCT01739348|565645740|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
156698992|NCT01739348|565645741|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
156698993|NCT01739348|565645742|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
156698994|NCT01739348|565645743|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
156698995|NCT01739348|565645740|FG000|Part I (Base Study)|Participant Moved|4|||
156698996|NCT01739348|565645741|FG001|Part I (Base Study)|Participant Moved|3|||
156698997|NCT01739348|565645742|FG002|Part I (Base Study)|Participant Moved|1|||
156698998|NCT01739348|565645743|FG003|Part I (Base Study)|Participant Moved|7|||
156698999|NCT01739348|565645740|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
156699000|NCT01739348|565645741|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
156699001|NCT01739348|565645742|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
156699002|NCT01739348|565645743|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
156699003|NCT01739348|565645740|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
156699004|NCT01739348|565645741|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
156699005|NCT01739348|565645742|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
156699006|NCT01739348|565645743|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
156699007|NCT01739348|565645740|FG000|Part II (Extension Study)|Adverse Event|10|||
156699008|NCT01739348|565645741|FG001|Part II (Extension Study)|Adverse Event|11|||
156699009|NCT01739348|565645742|FG002|Part II (Extension Study)|Adverse Event|7|||
156699010|NCT01739348|565645743|FG003|Part II (Extension Study)|Adverse Event|26|||
156699011|NCT01739348|565645740|FG000|Part II (Extension Study)|Death|3|||
156699012|NCT01739348|565645741|FG001|Part II (Extension Study)|Death|3|||
156699013|NCT01739348|565645742|FG002|Part II (Extension Study)|Death|2|||
156699014|NCT01739348|565645743|FG003|Part II (Extension Study)|Death|6|||
156699015|NCT01739348|565645740|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
156699016|NCT01739348|565645741|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
156699017|NCT01739348|565645742|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
156699018|NCT01739348|565645743|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
156699019|NCT01739348|565645740|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
156699020|NCT01739348|565645741|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
156699021|NCT01739348|565645742|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
156699022|NCT01739348|565645743|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
156699023|NCT01739348|565645740|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
156699024|NCT01739348|565645741|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
156699025|NCT01739348|565645742|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
156699026|NCT01739348|565645743|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
156699027|NCT01739348|565645740|FG000|Part II (Extension Study)|Physician Decision|7|||
156699028|NCT01739348|565645741|FG001|Part II (Extension Study)|Physician Decision|11|||
156699029|NCT01739348|565645742|FG002|Part II (Extension Study)|Physician Decision|6|||
156699030|NCT01739348|565645743|FG003|Part II (Extension Study)|Physician Decision|12|||
156699031|NCT01739348|565645740|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
156699032|NCT01739348|565645741|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
156699033|NCT01739348|565645742|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
156699034|NCT01739348|565645743|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
156699035|NCT01739348|565645740|FG000|Part II (Extension Study)|Participant Moved|3|||
156699036|NCT01739348|565645741|FG001|Part II (Extension Study)|Participant Moved|3|||
156699037|NCT01739348|565645742|FG002|Part II (Extension Study)|Participant Moved|0|||
156699038|NCT01739348|565645743|FG003|Part II (Extension Study)|Participant Moved|3|||
156699039|NCT01739348|565645740|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
156699040|NCT01739348|565645741|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
156699041|NCT01739348|565645742|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
156699042|NCT01739348|565645743|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
156699043|NCT01739348|565645740|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
156790708|NCT00159874|565985453|FG006|Overall Study|Other|3|||
156699044|NCT01739348|565645741|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
156699045|NCT01739348|565645742|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
156699046|NCT01739348|565645743|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
156699047|NCT02695537|565645744|FG000|Overall Study|Adverse Event|3|||
156699048|NCT02695537|565645744|FG000|Overall Study|Lack of Efficacy|28|||
156699049|NCT02695537|565645744|FG000|Overall Study|Withdrawal by Subject|4|||
156699050|NCT02695537|565645744|FG000|Overall Study|Protocol Violation|3|||
156699051|NCT02792699|565645745|FG000|Overall Study|Adverse Event|1|||
156699052|NCT02792699|565645746|FG001|Overall Study|Adverse Event|2|||
156699053|NCT02792699|565645747|FG002|Overall Study|Adverse Event|4|||
156699054|NCT02792699|565645745|FG000|Overall Study|Withdrawal by Subject|4|||
156699055|NCT02792699|565645746|FG001|Overall Study|Withdrawal by Subject|4|||
156699056|NCT02792699|565645747|FG002|Overall Study|Withdrawal by Subject|3|||
156699057|NCT02792699|565645745|FG000|Overall Study|Lost to Follow-up|0|||
156699058|NCT02792699|565645746|FG001|Overall Study|Lost to Follow-up|1|||
156699059|NCT02792699|565645747|FG002|Overall Study|Lost to Follow-up|2|||
156699060|NCT02792699|565645745|FG000|Overall Study|Physician Decision|2|||
156699061|NCT02792699|565645746|FG001|Overall Study|Physician Decision|0|||
156699062|NCT02792699|565645747|FG002|Overall Study|Physician Decision|0|||
156699063|NCT02792699|565645745|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
156699064|NCT02792699|565645746|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
156699065|NCT02792699|565645747|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
156699066|NCT02792699|565645745|FG000|Overall Study|Other|1|||
156699067|NCT02792699|565645746|FG001|Overall Study|Other|0|||
156699068|NCT02792699|565645747|FG002|Overall Study|Other|0|||
156699069|NCT05084963|565645750|FG000|Overall Study|Withdrawal by Subject|0|||
156699070|NCT05084963|565645751|FG001|Overall Study|Withdrawal by Subject|0|||
156699071|NCT05084963|565645752|FG002|Overall Study|Withdrawal by Subject|1|||
156699072|NCT03569228|565645753|FG000|Overall Study|Withdrawal by PI|0|||
156699073|NCT03569228|565645754|FG001|Overall Study|Withdrawal by PI|0|||
156699074|NCT03569228|565645755|FG002|Overall Study|Withdrawal by PI|2|||
156699075|NCT03569228|565645756|FG003|Overall Study|Withdrawal by PI|2|||
156699076|NCT03569228|565645757|FG004|Overall Study|Withdrawal by PI|1|||
156699077|NCT03569228|565645758|FG005|Overall Study|Withdrawal by PI|0|||
156699078|NCT03569228|565645759|FG006|Overall Study|Withdrawal by PI|0|||
156699079|NCT03569228|565645760|FG007|Overall Study|Withdrawal by PI|0|||
156699080|NCT03569228|565645761|FG008|Overall Study|Withdrawal by PI|0|||
156699081|NCT03569228|565645753|FG000|Overall Study|Lost to Follow-up|0|||
156699082|NCT03569228|565645754|FG001|Overall Study|Lost to Follow-up|0|||
156699083|NCT03569228|565645755|FG002|Overall Study|Lost to Follow-up|0|||
156699084|NCT03569228|565645756|FG003|Overall Study|Lost to Follow-up|0|||
156699085|NCT03569228|565645757|FG004|Overall Study|Lost to Follow-up|0|||
156699086|NCT03569228|565645758|FG005|Overall Study|Lost to Follow-up|0|||
156699087|NCT03569228|565645759|FG006|Overall Study|Lost to Follow-up|0|||
156699088|NCT03569228|565645760|FG007|Overall Study|Lost to Follow-up|0|||
156699089|NCT03569228|565645761|FG008|Overall Study|Lost to Follow-up|1|||
156699090|NCT03569228|565645753|FG000|Overall Study|Screen Fail|2|||
156699091|NCT03569228|565645754|FG001|Overall Study|Screen Fail|2|||
156699092|NCT03569228|565645755|FG002|Overall Study|Screen Fail|1|||
156699093|NCT03569228|565645756|FG003|Overall Study|Screen Fail|1|||
156699094|NCT03569228|565645757|FG004|Overall Study|Screen Fail|1|||
156699095|NCT03569228|565645758|FG005|Overall Study|Screen Fail|3|||
156699096|NCT03569228|565645759|FG006|Overall Study|Screen Fail|1|||
156699097|NCT03569228|565645760|FG007|Overall Study|Screen Fail|5|||
156699098|NCT03569228|565645761|FG008|Overall Study|Screen Fail|2|||
156699099|NCT03819049|565645762|FG000|Overall Study|Lost to Follow-up|1|||
156790709|NCT00159874|565985447|FG000|Overall Study|Protocol Violation|0|||
156790710|NCT00159874|565985448|FG001|Overall Study|Protocol Violation|5|||
156790711|NCT00159874|565985449|FG002|Overall Study|Protocol Violation|2|||
156790712|NCT00159874|565985450|FG003|Overall Study|Protocol Violation|0|||
156790713|NCT00159874|565985451|FG004|Overall Study|Protocol Violation|0|||
156790714|NCT00159874|565985452|FG005|Overall Study|Protocol Violation|0|||
156790715|NCT00159874|565985453|FG006|Overall Study|Protocol Violation|0|||
156790716|NCT00159874|565985447|FG000|Overall Study|Death|3|||
156790717|NCT00159874|565985448|FG001|Overall Study|Death|8|||
156790718|NCT00159874|565985449|FG002|Overall Study|Death|15|||
156790719|NCT00159874|565985450|FG003|Overall Study|Death|0|||
156790720|NCT00159874|565985451|FG004|Overall Study|Death|1|||
156790721|NCT00159874|565985452|FG005|Overall Study|Death|2|||
156790722|NCT00159874|565985453|FG006|Overall Study|Death|0|||
156790723|NCT00159874|565985447|FG000|Overall Study|Withdrawal by Subject|2|||
156790724|NCT00159874|565985448|FG001|Overall Study|Withdrawal by Subject|6|||
156790725|NCT00159874|565985449|FG002|Overall Study|Withdrawal by Subject|8|||
156790726|NCT00159874|565985450|FG003|Overall Study|Withdrawal by Subject|4|||
156790727|NCT00159874|565985451|FG004|Overall Study|Withdrawal by Subject|3|||
156699100|NCT03819049|565645763|FG001|Overall Study|Lost to Follow-up|2|||
156699101|NCT03819049|565645764|FG002|Overall Study|Lost to Follow-up|9|||
156699102|NCT03819049|565645765|FG003|Overall Study|Lost to Follow-up|0|||
156699103|NCT03819049|565645766|FG004|Overall Study|Lost to Follow-up|3|||
156699104|NCT03819049|565645767|FG005|Overall Study|Lost to Follow-up|1|||
156699105|NCT03819049|565645768|FG006|Overall Study|Lost to Follow-up|0|||
156699106|NCT03819049|565645762|FG000|Overall Study|Withdrawal by Subject|0|||
156699107|NCT03819049|565645763|FG001|Overall Study|Withdrawal by Subject|0|||
156699108|NCT03819049|565645764|FG002|Overall Study|Withdrawal by Subject|18|||
156699109|NCT03819049|565645765|FG003|Overall Study|Withdrawal by Subject|0|||
156438688|NCT00958633|564697099|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
156438689|NCT00958633|564697100|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
156438690|NCT00958633|564697098|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
156438691|NCT00958633|564697099|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
156438692|NCT00958633|564697100|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
156699110|NCT03819049|565645766|FG004|Overall Study|Withdrawal by Subject|10|||
156699111|NCT03819049|565645767|FG005|Overall Study|Withdrawal by Subject|9|||
156699112|NCT03819049|565645768|FG006|Overall Study|Withdrawal by Subject|1|||
156699113|NCT03819049|565645762|FG000|Overall Study|Ongoing|0|||
156699114|NCT03819049|565645763|FG001|Overall Study|Ongoing|0|||
156699115|NCT03819049|565645764|FG002|Overall Study|Ongoing|75|||
156699116|NCT03819049|565645765|FG003|Overall Study|Ongoing|0|||
156699117|NCT03819049|565645766|FG004|Overall Study|Ongoing|41|||
156699118|NCT03819049|565645767|FG005|Overall Study|Ongoing|0|||
156699119|NCT03819049|565645768|FG006|Overall Study|Ongoing|0|||
156699120|NCT03819049|565645762|FG000|Overall Study|Other|0|||
156699121|NCT03819049|565645763|FG001|Overall Study|Other|0|||
156699122|NCT03819049|565645764|FG002|Overall Study|Other|2|||
156699123|NCT03819049|565645765|FG003|Overall Study|Other|0|||
156699124|NCT03819049|565645766|FG004|Overall Study|Other|0|||
156699125|NCT03819049|565645767|FG005|Overall Study|Other|0|||
156699126|NCT03819049|565645768|FG006|Overall Study|Other|0|||
156699127|NCT03819049|565645762|FG000|Overall Study|Randomized but not vaccinated|0|||
156699128|NCT03819049|565645763|FG001|Overall Study|Randomized but not vaccinated|0|||
156699129|NCT03819049|565645764|FG002|Overall Study|Randomized but not vaccinated|0|||
156699130|NCT03819049|565645765|FG003|Overall Study|Randomized but not vaccinated|1|||
156699131|NCT03819049|565645766|FG004|Overall Study|Randomized but not vaccinated|0|||
156699132|NCT03819049|565645767|FG005|Overall Study|Randomized but not vaccinated|2|||
156699133|NCT03819049|565645768|FG006|Overall Study|Randomized but not vaccinated|1|||
156699134|NCT03819049|565645762|FG000|Overall Study|Physician Decision|0|||
156699135|NCT03819049|565645763|FG001|Overall Study|Physician Decision|0|||
156699136|NCT03819049|565645764|FG002|Overall Study|Physician Decision|0|||
156699137|NCT03819049|565645765|FG003|Overall Study|Physician Decision|0|||
156699138|NCT03819049|565645766|FG004|Overall Study|Physician Decision|0|||
156699139|NCT03819049|565645767|FG005|Overall Study|Physician Decision|0|||
156699140|NCT03819049|565645768|FG006|Overall Study|Physician Decision|1|||
156699141|NCT01986010|565645769|FG000|Overall Study|Adverse Event|0|||
156699142|NCT01986010|565645770|FG001|Overall Study|Adverse Event|1|||
156699143|NCT01986010|565645771|FG002|Overall Study|Adverse Event|0|||
156699144|NCT01986010|565645772|FG003|Overall Study|Adverse Event|0|||
156699145|NCT01986010|565645773|FG004|Overall Study|Adverse Event|0|||
156699146|NCT01986010|565645774|FG005|Overall Study|Adverse Event|0|||
156699147|NCT01986010|565645775|FG006|Overall Study|Adverse Event|0|||
156699148|NCT01986010|565645776|FG007|Overall Study|Adverse Event|0|||
156699149|NCT01986010|565645777|FG008|Overall Study|Adverse Event|0|||
156699150|NCT01986010|565645778|FG009|Overall Study|Adverse Event|0|||
156699151|NCT01986010|565645779|FG010|Overall Study|Adverse Event|0|||
156699152|NCT01986010|565645780|FG011|Overall Study|Adverse Event|0|||
156699153|NCT01986010|565645781|FG012|Overall Study|Adverse Event|0|||
156699154|NCT01986010|565645782|FG013|Overall Study|Adverse Event|0|||
156699155|NCT01986010|565645783|FG014|Overall Study|Adverse Event|0|||
156699156|NCT01986010|565645784|FG015|Overall Study|Adverse Event|1|||
156699157|NCT01986010|565645785|FG016|Overall Study|Adverse Event|0|||
156699158|NCT01986010|565645769|FG000|Overall Study|Lost to Follow-up|2|||
156699159|NCT01986010|565645770|FG001|Overall Study|Lost to Follow-up|1|||
156699160|NCT01986010|565645771|FG002|Overall Study|Lost to Follow-up|2|||
156790728|NCT00159874|565985452|FG005|Overall Study|Withdrawal by Subject|2|||
156790729|NCT00159874|565985453|FG006|Overall Study|Withdrawal by Subject|1|||
156790730|NCT00159874|565985447|FG000|Overall Study|Pregnancy|1|||
156790731|NCT00159874|565985448|FG001|Overall Study|Pregnancy|1|||
156790732|NCT00159874|565985449|FG002|Overall Study|Pregnancy|0|||
156790733|NCT00159874|565985450|FG003|Overall Study|Pregnancy|0|||
156790734|NCT00159874|565985451|FG004|Overall Study|Pregnancy|0|||
156790735|NCT00159874|565985452|FG005|Overall Study|Pregnancy|0|||
156790736|NCT00159874|565985453|FG006|Overall Study|Pregnancy|0|||
156438693|NCT00958633|564697098|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
156699161|NCT01986010|565645772|FG003|Overall Study|Lost to Follow-up|2|||
156699162|NCT01986010|565645773|FG004|Overall Study|Lost to Follow-up|2|||
156699163|NCT01986010|565645774|FG005|Overall Study|Lost to Follow-up|2|||
156790737|NCT02771145|565985456|FG000|Overall Study|Adverse Event|3|||
156438694|NCT00958633|564697099|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
156699164|NCT01986010|565645775|FG006|Overall Study|Lost to Follow-up|0|||
156699165|NCT01986010|565645776|FG007|Overall Study|Lost to Follow-up|0|||
156699166|NCT01986010|565645777|FG008|Overall Study|Lost to Follow-up|4|||
156790738|NCT02771145|565985456|FG000|Overall Study|Lost to Follow-up|1|||
156699167|NCT01986010|565645778|FG009|Overall Study|Lost to Follow-up|2|||
156699168|NCT01986010|565645779|FG010|Overall Study|Lost to Follow-up|0|||
156699169|NCT01986010|565645780|FG011|Overall Study|Lost to Follow-up|1|||
156699170|NCT01986010|565645781|FG012|Overall Study|Lost to Follow-up|1|||
156699171|NCT01986010|565645782|FG013|Overall Study|Lost to Follow-up|1|||
156699172|NCT01986010|565645783|FG014|Overall Study|Lost to Follow-up|2|||
156699173|NCT01986010|565645784|FG015|Overall Study|Lost to Follow-up|0|||
156699174|NCT01986010|565645785|FG016|Overall Study|Lost to Follow-up|0|||
156699175|NCT01986010|565645769|FG000|Overall Study|Physician Decision|0|||
156699176|NCT01986010|565645770|FG001|Overall Study|Physician Decision|0|||
156871946|NCT04816669|566289461|FG002|Part 1|Lost to Follow-up|0|||
156438695|NCT00958633|564697100|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
156438696|NCT00958633|564697098|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
156438697|NCT00958633|564697099|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
156438698|NCT00958633|564697100|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
156438699|NCT00958633|564697098|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
156438700|NCT00958633|564697099|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
156438701|NCT00958633|564697100|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
156438702|NCT00094575|564697107|FG000|Overall Study|Death|146|||
156438703|NCT00094575|564697108|FG001|Overall Study|Death|146|||
156438704|NCT00794118|564697109|FG000|Overall Study|Lost to Follow-up|16|||
156871947|NCT04816669|566289462|FG003|Part 1|Lost to Follow-up|0|||
156871948|NCT04816669|566289459|FG000|Part 1|Protocol Violation|0|||
156871949|NCT04816669|566289460|FG001|Part 1|Protocol Violation|1|||
156871950|NCT04816669|566289461|FG002|Part 1|Protocol Violation|0|||
156871951|NCT04816669|566289462|FG003|Part 1|Protocol Violation|0|||
156871952|NCT04816669|566289459|FG000|Part 1|Withdrawal by Subject|1|||
156871953|NCT04816669|566289460|FG001|Part 1|Withdrawal by Subject|2|||
156871954|NCT04816669|566289461|FG002|Part 1|Withdrawal by Subject|0|||
156871955|NCT04816669|566289462|FG003|Part 1|Withdrawal by Subject|0|||
156871956|NCT04816669|566289459|FG000|Part 2|Other|0|||
156871957|NCT04816669|566289460|FG001|Part 2|Other|0|||
156871958|NCT04816669|566289461|FG002|Part 2|Other|1|||
156871959|NCT04816669|566289462|FG003|Part 2|Other|0|||
156871960|NCT04816669|566289459|FG000|Part 2|Withdrawal by Subject|0|||
156871961|NCT04816669|566289460|FG001|Part 2|Withdrawal by Subject|0|||
156699177|NCT01986010|565645771|FG002|Overall Study|Physician Decision|0|||
156699178|NCT01986010|565645772|FG003|Overall Study|Physician Decision|0|||
156699179|NCT01986010|565645773|FG004|Overall Study|Physician Decision|0|||
156699180|NCT01986010|565645774|FG005|Overall Study|Physician Decision|0|||
156699181|NCT01986010|565645775|FG006|Overall Study|Physician Decision|0|||
156699182|NCT01986010|565645776|FG007|Overall Study|Physician Decision|0|||
156699183|NCT01986010|565645777|FG008|Overall Study|Physician Decision|0|||
156699184|NCT01986010|565645778|FG009|Overall Study|Physician Decision|0|||
156699185|NCT01986010|565645779|FG010|Overall Study|Physician Decision|0|||
156699186|NCT01986010|565645780|FG011|Overall Study|Physician Decision|0|||
156699187|NCT01986010|565645781|FG012|Overall Study|Physician Decision|0|||
156699188|NCT01986010|565645782|FG013|Overall Study|Physician Decision|0|||
156699189|NCT01986010|565645783|FG014|Overall Study|Physician Decision|1|||
156699190|NCT01986010|565645784|FG015|Overall Study|Physician Decision|0|||
156699191|NCT01986010|565645785|FG016|Overall Study|Physician Decision|0|||
156699192|NCT01986010|565645769|FG000|Overall Study|Withdrawal by Subject|2|||
156699193|NCT01986010|565645770|FG001|Overall Study|Withdrawal by Subject|2|||
156699194|NCT01986010|565645771|FG002|Overall Study|Withdrawal by Subject|3|||
156699195|NCT01986010|565645772|FG003|Overall Study|Withdrawal by Subject|0|||
156699196|NCT01986010|565645773|FG004|Overall Study|Withdrawal by Subject|2|||
156699197|NCT01986010|565645774|FG005|Overall Study|Withdrawal by Subject|4|||
156699198|NCT01986010|565645775|FG006|Overall Study|Withdrawal by Subject|0|||
156871962|NCT04816669|566289461|FG002|Part 2|Withdrawal by Subject|0|||
156871963|NCT04816669|566289462|FG003|Part 2|Withdrawal by Subject|1|||
156871964|NCT04816669|566289459|FG000|Part 2|Lost to Follow-up|0|||
156438705|NCT00794118|564697109|FG000|Overall Study|Withdrawal by Subject|9|||
156438706|NCT00794118|564697109|FG000|Overall Study|Changed hospital center|2|||
156699199|NCT01986010|565645776|FG007|Overall Study|Withdrawal by Subject|0|||
156699200|NCT01986010|565645777|FG008|Overall Study|Withdrawal by Subject|0|||
156699201|NCT01986010|565645778|FG009|Overall Study|Withdrawal by Subject|0|||
156699202|NCT01986010|565645779|FG010|Overall Study|Withdrawal by Subject|0|||
156871965|NCT04816669|566289460|FG001|Part 2|Lost to Follow-up|0|||
156438707|NCT04688450|564698651|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
156438708|NCT04688450|564698651|FG000|Overall Study|Withdrawal by Subject|1|||
156699203|NCT01986010|565645780|FG011|Overall Study|Withdrawal by Subject|2|||
156699204|NCT01986010|565645781|FG012|Overall Study|Withdrawal by Subject|0|||
156871966|NCT04816669|566289461|FG002|Part 2|Lost to Follow-up|1|||
156871967|NCT04816669|566289462|FG003|Part 2|Lost to Follow-up|0|||
156699205|NCT01986010|565645782|FG013|Overall Study|Withdrawal by Subject|1|||
156699206|NCT01986010|565645783|FG014|Overall Study|Withdrawal by Subject|2|||
156871968|NCT00867815|566289468|FG000|Overall Study|Lost to Follow-up|1|||
156871969|NCT02015637|566289469|FG000|Overall Study|Lost to Follow-up|3|||
156871970|NCT02015637|566289470|FG001|Overall Study|Lost to Follow-up|5|||
156871971|NCT02015637|566289469|FG000|Overall Study|Adverse Event|3|||
156871972|NCT02015637|566289470|FG001|Overall Study|Adverse Event|0|||
156871973|NCT02015637|566289469|FG000|Overall Study|Did not take study drug|2|||
156699207|NCT01986010|565645784|FG015|Overall Study|Withdrawal by Subject|0|||
156699208|NCT01986010|565645785|FG016|Overall Study|Withdrawal by Subject|0|||
156331485|NCT00369707|564313459|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
156331486|NCT00369707|564313459|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
156331487|NCT00369707|564313459|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
156699209|NCT01986010|565645769|FG000|Overall Study|Status Not Recorded|2|||
156699210|NCT01986010|565645770|FG001|Overall Study|Status Not Recorded|4|||
156699211|NCT01986010|565645771|FG002|Overall Study|Status Not Recorded|2|||
156699212|NCT01986010|565645772|FG003|Overall Study|Status Not Recorded|0|||
156699213|NCT01986010|565645773|FG004|Overall Study|Status Not Recorded|1|||
156699214|NCT01986010|565645774|FG005|Overall Study|Status Not Recorded|2|||
156699215|NCT01986010|565645775|FG006|Overall Study|Status Not Recorded|0|||
156699216|NCT01986010|565645776|FG007|Overall Study|Status Not Recorded|0|||
156699217|NCT01986010|565645777|FG008|Overall Study|Status Not Recorded|2|||
156699218|NCT01986010|565645778|FG009|Overall Study|Status Not Recorded|1|||
156699219|NCT01986010|565645779|FG010|Overall Study|Status Not Recorded|7|||
156699220|NCT01986010|565645780|FG011|Overall Study|Status Not Recorded|7|||
156699221|NCT01986010|565645781|FG012|Overall Study|Status Not Recorded|9|||
156699222|NCT01986010|565645782|FG013|Overall Study|Status Not Recorded|9|||
156699223|NCT01986010|565645783|FG014|Overall Study|Status Not Recorded|5|||
156699224|NCT01986010|565645784|FG015|Overall Study|Status Not Recorded|10|||
156699225|NCT01986010|565645785|FG016|Overall Study|Status Not Recorded|4|||
156331488|NCT00369707|564313459|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
156331489|NCT00369707|564313459|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
156331490|NCT00369707|564313459|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
156699226|NCT01335997|565645788|FG000|Period I and II|Adverse Event|63|||
156699227|NCT01335997|565645789|FG001|Period I and II|Adverse Event|43|||
156699228|NCT01335997|565645788|FG000|Period I and II|Noncompliance with Study Drug|1|||
156699229|NCT01335997|565645789|FG001|Period I and II|Noncompliance with Study Drug|1|||
156699230|NCT01335997|565645788|FG000|Period I and II|Lost to Follow-up|3|||
156699231|NCT01335997|565645789|FG001|Period I and II|Lost to Follow-up|5|||
156699232|NCT01335997|565645788|FG000|Period I and II|Withdrawal by Subject|9|||
156699233|NCT01335997|565645789|FG001|Period I and II|Withdrawal by Subject|4|||
156699234|NCT01335997|565645788|FG000|Period I and II|Study Terminated by Sponsor|406|||
156699235|NCT01335997|565645789|FG001|Period I and II|Study Terminated by Sponsor|415|||
156699236|NCT01335997|565645788|FG000|Period I and II|Protocol Violation|9|||
156699237|NCT01335997|565645789|FG001|Period I and II|Protocol Violation|10|||
156699238|NCT01335997|565645788|FG000|Period I and II|Physician Decision|2|||
156699239|NCT01335997|565645789|FG001|Period I and II|Physician Decision|1|||
156699240|NCT01335997|565645788|FG000|Period III|Adverse Event|0|||
156699241|NCT01335997|565645789|FG001|Period III|Adverse Event|2|||
156699242|NCT01335997|565645788|FG000|Period III|Study Terminated by Sponsor|77|||
156699243|NCT01335997|565645789|FG001|Period III|Study Terminated by Sponsor|76|||
156699244|NCT01335997|565645788|FG000|Period III|Protocol Violation|0|||
156699245|NCT01335997|565645789|FG001|Period III|Protocol Violation|1|||
156699246|NCT01335997|565645788|FG000|Period III|Lost to Follow-up|1|||
156699247|NCT01335997|565645789|FG001|Period III|Lost to Follow-up|0|||
156699248|NCT02440568|565645790|FG000|Overall Study|Death|1|||
156699249|NCT02440568|565645791|FG001|Overall Study|Death|3|||
156699250|NCT02440568|565645792|FG002|Overall Study|Death|4|||
156699251|NCT02440568|565645793|FG003|Overall Study|Death|2|||
156699252|NCT02440568|565645790|FG000|Overall Study|Lack of Efficacy|2|||
156699253|NCT02440568|565645791|FG001|Overall Study|Lack of Efficacy|0|||
156699254|NCT02440568|565645792|FG002|Overall Study|Lack of Efficacy|1|||
156699255|NCT02440568|565645793|FG003|Overall Study|Lack of Efficacy|0|||
156699256|NCT02440568|565645790|FG000|Overall Study|Lost to Follow-up|1|||
156699257|NCT02440568|565645791|FG001|Overall Study|Lost to Follow-up|0|||
156699258|NCT02440568|565645792|FG002|Overall Study|Lost to Follow-up|0|||
156699259|NCT02440568|565645793|FG003|Overall Study|Lost to Follow-up|0|||
156790739|NCT02150863|565985457|FG000|Overall Study|Lost to Follow-up|0|||
156790740|NCT02150863|565985458|FG001|Overall Study|Lost to Follow-up|1|||
156331491|NCT00369707|564313459|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
156699260|NCT03285308|565645795|FG000|Overall Study|Adverse Event|3|||
156699261|NCT03285308|565645796|FG001|Overall Study|Adverse Event|7|||
156790741|NCT02150863|565985459|FG002|Overall Study|Lost to Follow-up|0|||
156790742|NCT01853280|565985463|FG000|Overall Study|Lack of Efficacy|2|||
156790743|NCT01853280|565985464|FG001|Overall Study|Lack of Efficacy|2|||
156790744|NCT01853280|565985463|FG000|Overall Study|Lost to Follow-up|0|||
156790745|NCT01853280|565985464|FG001|Overall Study|Lost to Follow-up|1|||
156790746|NCT01853280|565985463|FG000|Overall Study|Physician Decision|0|||
156699262|NCT03285308|565645795|FG000|Overall Study|Withdrawal by Subject|8|||
156699263|NCT03285308|565645796|FG001|Overall Study|Withdrawal by Subject|9|||
156699264|NCT03285308|565645795|FG000|Overall Study|Lost to Follow-up|3|||
156699265|NCT03285308|565645796|FG001|Overall Study|Lost to Follow-up|1|||
156699266|NCT03285308|565645795|FG000|Overall Study|Protocol Deviation|6|||
156699267|NCT03285308|565645796|FG001|Overall Study|Protocol Deviation|5|||
156790747|NCT01853280|565985464|FG001|Overall Study|Physician Decision|1|||
156331492|NCT00369707|564313459|FG000|Follow up for 2 Years After Treatment|Death|1|||
156331493|NCT00369707|564313459|FG000|Follow up for 2 Years After Treatment|Other|2|||
156699268|NCT03285308|565645795|FG000|Overall Study|Reason not Specified|0|||
156699269|NCT03285308|565645796|FG001|Overall Study|Reason not Specified|1|||
156699270|NCT00681590|565645799|FG000|Overall Study|Withdrawal by Subject|2|||
156699271|NCT00681590|565645800|FG001|Overall Study|Withdrawal by Subject|12|||
156699272|NCT02912650|565645801|FG000|Overall Study|Withdrawal by Subject|1|||
156699273|NCT02912650|565645802|FG001|Overall Study|Withdrawal by Subject|0|||
156699274|NCT02912650|565645803|FG002|Overall Study|Withdrawal by Subject|1|||
156699275|NCT02912650|565645804|FG003|Overall Study|Withdrawal by Subject|5|||
156699276|NCT02912650|565645801|FG000|Overall Study|Adverse Event|0|||
156699277|NCT02912650|565645802|FG001|Overall Study|Adverse Event|0|||
156699278|NCT02912650|565645803|FG002|Overall Study|Adverse Event|1|||
156699279|NCT02912650|565645804|FG003|Overall Study|Adverse Event|0|||
156699280|NCT02562482|565645805|FG000|Overall Study|Enrolled, but did not receive product|4|||
156699281|NCT02562482|565645806|FG001|Overall Study|Enrolled, but did not receive product|0|||
156699282|NCT02562482|565645805|FG000|Overall Study|Lost to Follow-up|9|||
156699283|NCT02562482|565645806|FG001|Overall Study|Lost to Follow-up|6|||
156699284|NCT02562482|565645805|FG000|Overall Study|Moved from area|2|||
156699285|NCT02562482|565645806|FG001|Overall Study|Moved from area|3|||
156699286|NCT02562482|565645805|FG000|Overall Study|Withdrawal by Subject|5|||
156699287|NCT02562482|565645806|FG001|Overall Study|Withdrawal by Subject|3|||
156699288|NCT02562482|565645805|FG000|Overall Study|Physician Decision|1|||
156699289|NCT02562482|565645806|FG001|Overall Study|Physician Decision|3|||
156699290|NCT02562482|565645805|FG000|Overall Study|Illness/Injury unrelated to product|0|||
156699291|NCT02562482|565645806|FG001|Overall Study|Illness/Injury unrelated to product|1|||
156699292|NCT01674647|565645807|FG000|Treatment Period|Death|4|||
156699293|NCT01674647|565645808|FG001|Treatment Period|Death|1|||
156699294|NCT01674647|565645807|FG000|Treatment Period|Efficacy outcome reached|0|||
156699295|NCT01674647|565645808|FG001|Treatment Period|Efficacy outcome reached|1|||
156699296|NCT01674647|565645807|FG000|Treatment Period|Physician Decision|3|||
156699297|NCT01674647|565645808|FG001|Treatment Period|Physician Decision|1|||
156699298|NCT01674647|565645807|FG000|Treatment Period|Adverse Event|60|||
156699299|NCT01674647|565645808|FG001|Treatment Period|Adverse Event|22|||
156699300|NCT01674647|565645807|FG000|Treatment Period|Non-compliance with study drug|3|||
156699301|NCT01674647|565645808|FG001|Treatment Period|Non-compliance with study drug|0|||
156699302|NCT01674647|565645807|FG000|Treatment Period|Lost to Follow-up|1|||
156699303|NCT01674647|565645808|FG001|Treatment Period|Lost to Follow-up|1|||
156699304|NCT01674647|565645807|FG000|Treatment Period|Withdrawal by Subject|19|||
156699305|NCT01674647|565645808|FG001|Treatment Period|Withdrawal by Subject|16|||
156699306|NCT01674647|565645807|FG000|Treatment Period|Switching to other therapy|5|||
156699307|NCT01674647|565645808|FG001|Treatment Period|Switching to other therapy|2|||
156699308|NCT01674647|565645807|FG000|Treatment Period|Logistical difficulties|5|||
156699309|NCT01674647|565645808|FG001|Treatment Period|Logistical difficulties|8|||
156699310|NCT01674647|565645807|FG000|Treatment Period|Treatment failure|0|||
156331494|NCT03449901|564313460|FG000|Overall Study|Progression|57|||
156331495|NCT03449901|564313461|FG001|Overall Study|Progression|12|||
156699311|NCT01674647|565645808|FG001|Treatment Period|Treatment failure|14|||
156699312|NCT01674647|565645807|FG000|Treatment Period|Protocol Violation|56|||
156699313|NCT01674647|565645808|FG001|Treatment Period|Protocol Violation|36|||
156699314|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Death|3|||
156699315|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Death|2|||
156699316|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
156699317|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
156699318|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
156699319|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
156699320|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
156699321|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
156699322|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
156699323|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
156699324|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
156699325|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
156699326|NCT04135196|565645810|FG000|Overall Study|Lost to Follow-up|8|||
156699327|NCT04135196|565645811|FG001|Overall Study|Lost to Follow-up|7|||
156699328|NCT04135196|565645812|FG002|Overall Study|Lost to Follow-up|8|||
156699329|NCT04135196|565645813|FG003|Overall Study|Lost to Follow-up|9|||
156699330|NCT04135196|565645814|FG004|Overall Study|Lost to Follow-up|1|||
156699331|NCT04135196|565645810|FG000|Overall Study|Pregnancy|0|||
156699332|NCT04135196|565645811|FG001|Overall Study|Pregnancy|0|||
156699333|NCT04135196|565645812|FG002|Overall Study|Pregnancy|1|||
156699334|NCT04135196|565645813|FG003|Overall Study|Pregnancy|0|||
156699335|NCT04135196|565645814|FG004|Overall Study|Pregnancy|0|||
156699336|NCT04135196|565645810|FG000|Overall Study|Withdrawal by Subject|0|||
156699337|NCT04135196|565645811|FG001|Overall Study|Withdrawal by Subject|0|||
156699338|NCT04135196|565645812|FG002|Overall Study|Withdrawal by Subject|0|||
156699339|NCT04135196|565645813|FG003|Overall Study|Withdrawal by Subject|0|||
156699340|NCT04135196|565645814|FG004|Overall Study|Withdrawal by Subject|1|||
156699341|NCT00444457|565645816|FG000|Infant Series|Other|0|||
156699342|NCT00444457|565645817|FG001|Infant Series|Other|1|||
156699343|NCT00444457|565645818|FG002|Infant Series|Other|0|||
156699344|NCT00444457|565645819|FG003|Infant Series|Other|0|||
156699345|NCT00444457|565645816|FG000|Infant Series|Parent or legal guardian request|18|||
156699346|NCT00444457|565645817|FG001|Infant Series|Parent or legal guardian request|29|||
156699347|NCT00444457|565645818|FG002|Infant Series|Parent or legal guardian request|34|||
156699348|NCT00444457|565645819|FG003|Infant Series|Parent or legal guardian request|14|||
156699349|NCT00444457|565645816|FG000|Infant Series|Lost to Follow-up|10|||
156699350|NCT00444457|565645817|FG001|Infant Series|Lost to Follow-up|11|||
156699351|NCT00444457|565645818|FG002|Infant Series|Lost to Follow-up|7|||
156699352|NCT00444457|565645819|FG003|Infant Series|Lost to Follow-up|6|||
156699353|NCT00444457|565645816|FG000|Infant Series|Protocol Violation|16|||
156699354|NCT00444457|565645817|FG001|Infant Series|Protocol Violation|8|||
156699355|NCT00444457|565645818|FG002|Infant Series|Protocol Violation|6|||
156699356|NCT00444457|565645819|FG003|Infant Series|Protocol Violation|3|||
156699357|NCT00444457|565645816|FG000|Infant Series|Failed to return|5|||
156699358|NCT00444457|565645817|FG001|Infant Series|Failed to return|4|||
156699359|NCT00444457|565645818|FG002|Infant Series|Failed to return|4|||
156699360|NCT00444457|565645819|FG003|Infant Series|Failed to return|2|||
156699361|NCT00444457|565645816|FG000|Infant Series|Investigator request|4|||
156699362|NCT00444457|565645817|FG001|Infant Series|Investigator request|3|||
156699363|NCT00444457|565645818|FG002|Infant Series|Investigator request|3|||
156699364|NCT00444457|565645819|FG003|Infant Series|Investigator request|2|||
156699365|NCT00444457|565645816|FG000|Infant Series|Other|0|||
156699366|NCT00444457|565645817|FG001|Infant Series|Other|2|||
156699367|NCT00444457|565645818|FG002|Infant Series|Other|4|||
156699368|NCT00444457|565645819|FG003|Infant Series|Other|0|||
156699369|NCT00444457|565645816|FG000|Infant Series|Adverse Event|1|||
156699370|NCT00444457|565645817|FG001|Infant Series|Adverse Event|2|||
156699371|NCT00444457|565645818|FG002|Infant Series|Adverse Event|2|||
156699372|NCT00444457|565645819|FG003|Infant Series|Adverse Event|0|||
156699373|NCT00444457|565645816|FG000|Infant Series|Death|0|||
156699374|NCT00444457|565645817|FG001|Infant Series|Death|1|||
156699375|NCT00444457|565645818|FG002|Infant Series|Death|1|||
156699376|NCT00444457|565645819|FG003|Infant Series|Death|1|||
156699377|NCT00444457|565645816|FG000|After Infant Series|Other|0|||
156699378|NCT00444457|565645817|FG001|After Infant Series|Other|1|||
156699379|NCT00444457|565645818|FG002|After Infant Series|Other|1|||
156699380|NCT00444457|565645819|FG003|After Infant Series|Other|1|||
156699381|NCT00444457|565645816|FG000|After Infant Series|Parent or legal guardian request|4|||
156699382|NCT00444457|565645817|FG001|After Infant Series|Parent or legal guardian request|11|||
156699383|NCT00444457|565645818|FG002|After Infant Series|Parent or legal guardian request|6|||
156699384|NCT00444457|565645819|FG003|After Infant Series|Parent or legal guardian request|3|||
156699385|NCT00444457|565645816|FG000|After Infant Series|Failed to return|7|||
156699386|NCT00444457|565645817|FG001|After Infant Series|Failed to return|6|||
156699387|NCT00444457|565645818|FG002|After Infant Series|Failed to return|5|||
156699388|NCT00444457|565645819|FG003|After Infant Series|Failed to return|1|||
156699389|NCT00444457|565645816|FG000|After Infant Series|Lost to Follow-up|5|||
156699390|NCT00444457|565645817|FG001|After Infant Series|Lost to Follow-up|5|||
156699391|NCT00444457|565645818|FG002|After Infant Series|Lost to Follow-up|5|||
156699392|NCT00444457|565645819|FG003|After Infant Series|Lost to Follow-up|2|||
156699393|NCT00444457|565645816|FG000|After Infant Series|Protocol Violation|2|||
156699394|NCT00444457|565645817|FG001|After Infant Series|Protocol Violation|4|||
156699395|NCT00444457|565645818|FG002|After Infant Series|Protocol Violation|2|||
156699396|NCT00444457|565645819|FG003|After Infant Series|Protocol Violation|2|||
156699397|NCT00444457|565645816|FG000|After Infant Series|Adverse Event|2|||
156699398|NCT00444457|565645817|FG001|After Infant Series|Adverse Event|2|||
156699399|NCT00444457|565645818|FG002|After Infant Series|Adverse Event|0|||
156699400|NCT00444457|565645819|FG003|After Infant Series|Adverse Event|0|||
156699401|NCT00444457|565645816|FG000|After Infant Series|Investigator request|0|||
156699402|NCT00444457|565645817|FG001|After Infant Series|Investigator request|0|||
156699403|NCT00444457|565645818|FG002|After Infant Series|Investigator request|0|||
156699404|NCT00444457|565645819|FG003|After Infant Series|Investigator request|1|||
156699405|NCT00444457|565645816|FG000|After Infant Series|Other|0|||
156871974|NCT02015637|566289470|FG001|Overall Study|Did not take study drug|0|||
156699406|NCT00444457|565645817|FG001|After Infant Series|Other|1|||
156699407|NCT00444457|565645818|FG002|After Infant Series|Other|0|||
156699408|NCT00444457|565645819|FG003|After Infant Series|Other|0|||
156699409|NCT00444457|565645816|FG000|Toddler Dose|Lost to Follow-up|4|||
156699410|NCT00444457|565645817|FG001|Toddler Dose|Lost to Follow-up|1|||
156871975|NCT01491607|566289473|FG000|Overall Study|Lost to Follow-up|7|||
156699411|NCT00444457|565645818|FG002|Toddler Dose|Lost to Follow-up|1|||
156699412|NCT00444457|565645819|FG003|Toddler Dose|Lost to Follow-up|3|||
156699413|NCT00444457|565645816|FG000|Toddler Dose|Failed to return|2|||
156699414|NCT00444457|565645817|FG001|Toddler Dose|Failed to return|2|||
156871976|NCT01491607|566289473|FG000|Overall Study|Withdrawal by Subject|3|||
156699415|NCT00444457|565645818|FG002|Toddler Dose|Failed to return|1|||
156699416|NCT00444457|565645819|FG003|Toddler Dose|Failed to return|3|||
156699417|NCT00444457|565645816|FG000|Toddler Dose|Parent or legal guardian request|0|||
156699418|NCT00444457|565645817|FG001|Toddler Dose|Parent or legal guardian request|3|||
156699419|NCT00444457|565645818|FG002|Toddler Dose|Parent or legal guardian request|2|||
156699420|NCT00444457|565645819|FG003|Toddler Dose|Parent or legal guardian request|1|||
156699421|NCT00444457|565645816|FG000|Toddler Dose|Protocol Violation|1|||
156699422|NCT00444457|565645817|FG001|Toddler Dose|Protocol Violation|0|||
156699423|NCT00444457|565645818|FG002|Toddler Dose|Protocol Violation|0|||
156699424|NCT00444457|565645819|FG003|Toddler Dose|Protocol Violation|1|||
156871977|NCT01317277|566289474|FG000|Overall Study|Lost to Follow-up|3|||
156871978|NCT01317277|566289475|FG001|Overall Study|Lost to Follow-up|1|||
156871979|NCT01317277|566289474|FG000|Overall Study|Lost MEMS|1|||
156871980|NCT01317277|566289475|FG001|Overall Study|Lost MEMS|1|||
156871981|NCT01317277|566289474|FG000|Overall Study|Unable to comply with intervention|1|||
156871982|NCT01317277|566289475|FG001|Overall Study|Unable to comply with intervention|0|||
156871983|NCT01317277|566289474|FG000|Overall Study|Withdrawal by Subject|1|||
156871984|NCT01317277|566289475|FG001|Overall Study|Withdrawal by Subject|0|||
156871985|NCT01317277|566289474|FG000|Overall Study|Adverse Event|1|||
156871986|NCT01317277|566289475|FG001|Overall Study|Adverse Event|0|||
156871987|NCT00774566|566289476|FG000|Overall Study|Protocol Violation|18|||
156871988|NCT00774566|566289477|FG001|Overall Study|Protocol Violation|15|||
156871989|NCT04896073|566289484|FG000|Overall Study|Screen failure|0|||
156871990|NCT04896073|566289485|FG001|Overall Study|Screen failure|2|||
156871991|NCT04896073|566289484|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
156871992|NCT04896073|566289485|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
156871993|NCT00297258|566289486|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
156871994|NCT00297258|566289486|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
156871995|NCT00297258|566289486|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
156871996|NCT00297258|566289486|FG000|Overall Study|Intercurrent Illness|3|||
156871997|NCT00297258|566289486|FG000|Overall Study|Intercurrent Death|2|||
156871998|NCT00297258|566289486|FG000|Overall Study|Deteriorization of General Condition|1|||
156871999|NCT00297258|566289486|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
156872000|NCT00297258|566289486|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
156872001|NCT00297258|566289486|FG000|Overall Study|Switch to Commercial Treatment|1|||
156872002|NCT00297258|566289486|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
156872003|NCT02454517|566289488|FG000|Overall Study|Withdrawal by Subject|3|||
156872004|NCT02454517|566289489|FG001|Overall Study|Withdrawal by Subject|0|||
156872005|NCT02454517|566289488|FG000|Overall Study|Lost to Follow-up|4|||
156872006|NCT02454517|566289489|FG001|Overall Study|Lost to Follow-up|7|||
156438709|NCT03189524|564698656|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
156438710|NCT03189524|564698657|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
156438711|NCT03189524|564698658|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
156438712|NCT03189524|564698656|FG000|Overall Study|Death|2|||
156438713|NCT03189524|564698657|FG001|Overall Study|Death|2|||
156438714|NCT03189524|564698658|FG002|Overall Study|Death|1|||
156438715|NCT03189524|564698656|FG000|Overall Study|Lost to Follow-up|1|||
156438716|NCT03189524|564698657|FG001|Overall Study|Lost to Follow-up|0|||
156438717|NCT03189524|564698658|FG002|Overall Study|Lost to Follow-up|8|||
156438718|NCT03189524|564698656|FG000|Overall Study|Withdrawal by Subject|1|||
156438719|NCT03189524|564698657|FG001|Overall Study|Withdrawal by Subject|1|||
156438720|NCT03189524|564698658|FG002|Overall Study|Withdrawal by Subject|3|||
156438721|NCT03189524|564698656|FG000|Overall Study|Progressive Disease|0|||
156438722|NCT03189524|564698657|FG001|Overall Study|Progressive Disease|2|||
156438723|NCT03189524|564698658|FG002|Overall Study|Progressive Disease|0|||
156438724|NCT01149369|564698661|FG000|Overall Study|Adverse Event|6|||
156438725|NCT01149369|564698662|FG001|Overall Study|Adverse Event|3|||
156438726|NCT02767765|564698663|FG000|Overall Study|Adverse Event|4|||
156438727|NCT02767765|564698663|FG000|Overall Study|Death|1|||
156438728|NCT02767765|564698663|FG000|Overall Study|Insufficient response|1|||
156438729|NCT02767765|564698663|FG000|Overall Study|Lost to Follow-up|2|||
156438730|NCT02767765|564698663|FG000|Overall Study|Investigator decision|1|||
156438731|NCT02767765|564698663|FG000|Overall Study|Non-Compliance|1|||
156438732|NCT02767765|564698663|FG000|Overall Study|Withdrawal by Subject|1|||
156699425|NCT04941729|565649121|FG000|Overall Study|Death|0|||
156699426|NCT04941729|565649122|FG001|Overall Study|Death|1|||
156699427|NCT04941729|565649121|FG000|Overall Study|Study terminated by sponsor|11|||
156699428|NCT04941729|565649122|FG001|Overall Study|Study terminated by sponsor|10|||
156699429|NCT05091307|565649123|FG000|Overall Study|Death|0|||
156438733|NCT04723394|564698664|FG000|Overall Study|Adverse Event|0|||
156438734|NCT04723394|564698665|FG001|Overall Study|Adverse Event|3|||
156438735|NCT04723394|564698664|FG000|Overall Study|Death|8|||
156699430|NCT05091307|565649124|FG001|Overall Study|Death|0|||
156699431|NCT05091307|565649125|FG002|Overall Study|Death|1|||
156872007|NCT02454517|566289488|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
156872008|NCT02454517|566289489|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
156872009|NCT00473382|566289490|FG000|Core Study|Adverse Event|3|||
156438736|NCT04723394|564698665|FG001|Overall Study|Death|8|||
156438737|NCT04723394|564698664|FG000|Overall Study|Lost to Follow-up|20|||
156438738|NCT04723394|564698665|FG001|Overall Study|Lost to Follow-up|17|||
156438739|NCT04723394|564698664|FG000|Overall Study|Physician Decision|1|||
156438740|NCT04723394|564698665|FG001|Overall Study|Physician Decision|0|||
156699432|NCT05091307|565649126|FG003|Overall Study|Death|0|||
156699433|NCT05091307|565649123|FG000|Overall Study|Lost to Follow-up|33|||
156699434|NCT05091307|565649124|FG001|Overall Study|Lost to Follow-up|33|||
156699435|NCT05091307|565649125|FG002|Overall Study|Lost to Follow-up|2|||
156699436|NCT05091307|565649126|FG003|Overall Study|Lost to Follow-up|0|||
156699437|NCT05091307|565649123|FG000|Overall Study|Physician Decision|1|||
156699438|NCT05091307|565649124|FG001|Overall Study|Physician Decision|0|||
156699439|NCT05091307|565649125|FG002|Overall Study|Physician Decision|0|||
156699440|NCT05091307|565649126|FG003|Overall Study|Physician Decision|0|||
156699441|NCT05091307|565649123|FG000|Overall Study|Protocol Violation|1|||
156699442|NCT05091307|565649124|FG001|Overall Study|Protocol Violation|0|||
156699443|NCT05091307|565649125|FG002|Overall Study|Protocol Violation|0|||
156530984|NCT02234323|565039823|FG000|All Enrolled|Not Treated: Completed study in database|2|||
156699444|NCT05091307|565649126|FG003|Overall Study|Protocol Violation|0|||
156699445|NCT05091307|565649123|FG000|Overall Study|Withdrawal by Subject|16|||
156699446|NCT05091307|565649124|FG001|Overall Study|Withdrawal by Subject|16|||
156699447|NCT05091307|565649125|FG002|Overall Study|Withdrawal by Subject|0|||
156699448|NCT05091307|565649126|FG003|Overall Study|Withdrawal by Subject|1|||
156699449|NCT05091307|565649123|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
156699450|NCT05091307|565649124|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
156699451|NCT05091307|565649125|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
156699452|NCT05091307|565649126|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
156699453|NCT05091307|565649123|FG000|Overall Study|Initiated Prohibited Medication|1|||
156699454|NCT05091307|565649124|FG001|Overall Study|Initiated Prohibited Medication|0|||
156699455|NCT05091307|565649125|FG002|Overall Study|Initiated Prohibited Medication|0|||
156699456|NCT05091307|565649126|FG003|Overall Study|Initiated Prohibited Medication|0|||
156699457|NCT05091307|565649123|FG000|Overall Study|Other|4|||
156699458|NCT05091307|565649124|FG001|Overall Study|Other|4|||
156699459|NCT05091307|565649125|FG002|Overall Study|Other|0|||
156699460|NCT05091307|565649126|FG003|Overall Study|Other|0|||
156699461|NCT05091307|565649123|FG000|Overall Study|Randomized but not vaccinated|0|||
156699462|NCT05091307|565649124|FG001|Overall Study|Randomized but not vaccinated|2|||
156699463|NCT05091307|565649125|FG002|Overall Study|Randomized but not vaccinated|0|||
156699464|NCT05091307|565649126|FG003|Overall Study|Randomized but not vaccinated|0|||
156699465|NCT04732221|565649129|FG000|Base Period|Death|2|||
156699466|NCT04732221|565649130|FG001|Base Period|Death|0|||
156699467|NCT04732221|565649131|FG002|Base Period|Death|0|||
156699468|NCT04732221|565649132|FG003|Base Period|Death|0|||
156699469|NCT04732221|565649133|FG004|Base Period|Death|0|||
156699470|NCT04732221|565649134|FG005|Base Period|Death|0|||
156699471|NCT04732221|565649135|FG006|Base Period|Death|0|||
156699472|NCT04732221|565649129|FG000|Base Period|Withdrawal by Subject|0|||
156438741|NCT04723394|564698664|FG000|Overall Study|Withdrawal by Subject|20|||
156438742|NCT04723394|564698665|FG001|Overall Study|Withdrawal by Subject|34|||
156438743|NCT04723394|564698664|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
156438744|NCT04723394|564698665|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
156438745|NCT00774397|564698666|FG000|Overall Study|Adverse Event|1|||
156438746|NCT00774397|564698667|FG001|Overall Study|Adverse Event|3|||
156530985|NCT02234323|565039823|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
156530986|NCT02234323|565039823|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
156699473|NCT04732221|565649130|FG001|Base Period|Withdrawal by Subject|1|||
156699474|NCT04732221|565649131|FG002|Base Period|Withdrawal by Subject|1|||
156699475|NCT04732221|565649132|FG003|Base Period|Withdrawal by Subject|0|||
156699476|NCT04732221|565649133|FG004|Base Period|Withdrawal by Subject|0|||
156699477|NCT04732221|565649134|FG005|Base Period|Withdrawal by Subject|0|||
156699478|NCT04732221|565649135|FG006|Base Period|Withdrawal by Subject|0|||
156699479|NCT04732221|565649129|FG000|Extension Period|Adverse Event|0|||
156699480|NCT04732221|565649130|FG001|Extension Period|Adverse Event|0|||
156699481|NCT04732221|565649131|FG002|Extension Period|Adverse Event|0|||
156699482|NCT04732221|565649132|FG003|Extension Period|Adverse Event|0|||
156790748|NCT01853280|565985463|FG000|Overall Study|Withdrawal by Subject|0|||
156790749|NCT01853280|565985464|FG001|Overall Study|Withdrawal by Subject|1|||
156790750|NCT01853280|565985463|FG000|Overall Study|Ineligible|0|||
156790751|NCT01853280|565985464|FG001|Overall Study|Ineligible|1|||
156790752|NCT00104884|565985465|FG000|Overall Study|Disease progression|4|||
156790753|NCT03654326|565985466|FG000|Overall Study|Withdrawal by Subject|5|||
156790754|NCT03654326|565985467|FG001|Overall Study|Withdrawal by Subject|3|||
156438747|NCT00774397|564698668|FG002|Overall Study|Adverse Event|16|||
156699483|NCT04732221|565649133|FG004|Extension Period|Adverse Event|0|||
156699484|NCT04732221|565649134|FG005|Extension Period|Adverse Event|1|||
156790755|NCT03654326|565985466|FG000|Overall Study|Physician Decision|0|||
156699485|NCT04732221|565649135|FG006|Extension Period|Adverse Event|0|||
156699486|NCT04732221|565649129|FG000|Extension Period|Death|0|||
156438748|NCT00774397|564698669|FG003|Overall Study|Adverse Event|8|||
156438749|NCT00774397|564698670|FG004|Overall Study|Adverse Event|8|||
156438750|NCT00774397|564698671|FG005|Overall Study|Adverse Event|3|||
156438751|NCT00774397|564698672|FG006|Overall Study|Adverse Event|16|||
156438752|NCT00774397|564698666|FG000|Overall Study|Lack of Efficacy|11|||
156438753|NCT00774397|564698667|FG001|Overall Study|Lack of Efficacy|4|||
156438754|NCT00774397|564698668|FG002|Overall Study|Lack of Efficacy|5|||
156438755|NCT00774397|564698669|FG003|Overall Study|Lack of Efficacy|3|||
156438756|NCT00774397|564698670|FG004|Overall Study|Lack of Efficacy|27|||
156438757|NCT00774397|564698671|FG005|Overall Study|Lack of Efficacy|15|||
156438758|NCT00774397|564698672|FG006|Overall Study|Lack of Efficacy|9|||
156438759|NCT00774397|564698666|FG000|Overall Study|Protocol Violation|0|||
156438760|NCT00774397|564698667|FG001|Overall Study|Protocol Violation|1|||
156438761|NCT00774397|564698668|FG002|Overall Study|Protocol Violation|3|||
156699487|NCT04732221|565649130|FG001|Extension Period|Death|0|||
156699488|NCT04732221|565649131|FG002|Extension Period|Death|0|||
156699489|NCT04732221|565649132|FG003|Extension Period|Death|0|||
156699490|NCT04732221|565649133|FG004|Extension Period|Death|1|||
156699491|NCT04732221|565649134|FG005|Extension Period|Death|0|||
156699492|NCT04732221|565649135|FG006|Extension Period|Death|2|||
156699493|NCT04732221|565649129|FG000|Extension Period|Pregnancy|0|||
156699494|NCT04732221|565649130|FG001|Extension Period|Pregnancy|0|||
156699495|NCT04732221|565649131|FG002|Extension Period|Pregnancy|0|||
156699496|NCT04732221|565649132|FG003|Extension Period|Pregnancy|0|||
156699497|NCT04732221|565649133|FG004|Extension Period|Pregnancy|1|||
156699498|NCT04732221|565649134|FG005|Extension Period|Pregnancy|0|||
156699499|NCT04732221|565649135|FG006|Extension Period|Pregnancy|0|||
156699500|NCT04732221|565649129|FG000|Extension Period|Sponsors Decision|0|||
156699501|NCT04732221|565649130|FG001|Extension Period|Sponsors Decision|0|||
156699502|NCT04732221|565649131|FG002|Extension Period|Sponsors Decision|0|||
156438762|NCT00774397|564698669|FG003|Overall Study|Protocol Violation|1|||
156438763|NCT00774397|564698670|FG004|Overall Study|Protocol Violation|2|||
156699503|NCT04732221|565649132|FG003|Extension Period|Sponsors Decision|0|||
156699504|NCT04732221|565649133|FG004|Extension Period|Sponsors Decision|41|||
156699505|NCT04732221|565649134|FG005|Extension Period|Sponsors Decision|40|||
156699506|NCT04732221|565649135|FG006|Extension Period|Sponsors Decision|40|||
156699507|NCT04732221|565649129|FG000|Extension Period|Withdrawal by Subject|0|||
156699508|NCT04732221|565649130|FG001|Extension Period|Withdrawal by Subject|0|||
156699509|NCT04732221|565649131|FG002|Extension Period|Withdrawal by Subject|0|||
156699510|NCT04732221|565649132|FG003|Extension Period|Withdrawal by Subject|0|||
156699511|NCT04732221|565649133|FG004|Extension Period|Withdrawal by Subject|1|||
156699512|NCT04732221|565649134|FG005|Extension Period|Withdrawal by Subject|5|||
156699513|NCT04732221|565649135|FG006|Extension Period|Withdrawal by Subject|2|||
156699514|NCT00379340|565649137|FG000|Overall Study|Death|0|||
156699515|NCT00379340|565649138|FG001|Overall Study|Death|0|||
156699516|NCT00379340|565649139|FG002|Overall Study|Death|0|||
156699517|NCT00379340|565649140|FG003|Overall Study|Death|2|||
156699518|NCT00379340|565649141|FG004|Overall Study|Death|0|||
156699519|NCT00379340|565649137|FG000|Overall Study|Lack of Efficacy|6|||
156699520|NCT00379340|565649138|FG001|Overall Study|Lack of Efficacy|1|||
156699521|NCT00379340|565649139|FG002|Overall Study|Lack of Efficacy|0|||
156699522|NCT00379340|565649140|FG003|Overall Study|Lack of Efficacy|4|||
156699523|NCT00379340|565649141|FG004|Overall Study|Lack of Efficacy|3|||
156699524|NCT00379340|565649137|FG000|Overall Study|Physician Decision|6|||
156699525|NCT00379340|565649138|FG001|Overall Study|Physician Decision|2|||
156438764|NCT00774397|564698671|FG005|Overall Study|Protocol Violation|1|||
156438765|NCT00774397|564698672|FG006|Overall Study|Protocol Violation|0|||
156438766|NCT00774397|564698666|FG000|Overall Study|Lost to Follow-up|0|||
156438767|NCT00774397|564698667|FG001|Overall Study|Lost to Follow-up|1|||
156438768|NCT00774397|564698668|FG002|Overall Study|Lost to Follow-up|1|||
156438769|NCT00774397|564698669|FG003|Overall Study|Lost to Follow-up|1|||
156438770|NCT00774397|564698670|FG004|Overall Study|Lost to Follow-up|0|||
156699526|NCT00379340|565649139|FG002|Overall Study|Physician Decision|1|||
156699527|NCT00379340|565649140|FG003|Overall Study|Physician Decision|2|||
156699528|NCT00379340|565649141|FG004|Overall Study|Physician Decision|3|||
156699529|NCT00379340|565649137|FG000|Overall Study|Withdrawal by Subject|0|||
156699530|NCT00379340|565649138|FG001|Overall Study|Withdrawal by Subject|0|||
156699531|NCT00379340|565649139|FG002|Overall Study|Withdrawal by Subject|0|||
156699532|NCT00379340|565649140|FG003|Overall Study|Withdrawal by Subject|1|||
156699533|NCT00379340|565649141|FG004|Overall Study|Withdrawal by Subject|0|||
156699534|NCT00379340|565649137|FG000|Overall Study|Refusal of further protocol therapy|1|||
156699535|NCT00379340|565649138|FG001|Overall Study|Refusal of further protocol therapy|0|||
156699536|NCT00379340|565649139|FG002|Overall Study|Refusal of further protocol therapy|1|||
156438771|NCT00774397|564698671|FG005|Overall Study|Lost to Follow-up|1|||
156438772|NCT00774397|564698672|FG006|Overall Study|Lost to Follow-up|0|||
156438773|NCT00774397|564698666|FG000|Overall Study|Refused to continue trial medication|1|||
156438774|NCT00774397|564698667|FG001|Overall Study|Refused to continue trial medication|3|||
156438775|NCT00774397|564698668|FG002|Overall Study|Refused to continue trial medication|2|||
156699537|NCT00379340|565649140|FG003|Overall Study|Refusal of further protocol therapy|1|||
156699538|NCT00379340|565649141|FG004|Overall Study|Refusal of further protocol therapy|7|||
156699539|NCT00379340|565649137|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
156699540|NCT00379340|565649138|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
156699541|NCT00379340|565649139|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
156699542|NCT00379340|565649140|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
156699543|NCT00379340|565649141|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
156699544|NCT00379340|565649137|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
156699545|NCT00379340|565649138|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
156699546|NCT00379340|565649139|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
156699547|NCT00379340|565649140|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
156699548|NCT00379340|565649141|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
156699549|NCT05327816|565649146|FG000|Overall Study|Lost to Follow-up|1|||
156699550|NCT05327816|565649147|FG001|Overall Study|Lost to Follow-up|0|||
156699551|NCT05327816|565649148|FG002|Overall Study|Lost to Follow-up|0|||
156699552|NCT05327816|565649149|FG003|Overall Study|Lost to Follow-up|0|||
156699553|NCT05327816|565649150|FG004|Overall Study|Lost to Follow-up|0|||
156699554|NCT05327816|565649151|FG005|Overall Study|Lost to Follow-up|0|||
156699555|NCT05327816|565649152|FG006|Overall Study|Lost to Follow-up|0|||
156699556|NCT05327816|565649153|FG007|Overall Study|Lost to Follow-up|0|||
156699557|NCT05327816|565649154|FG008|Overall Study|Lost to Follow-up|0|||
156699558|NCT05327816|565649155|FG009|Overall Study|Lost to Follow-up|1|||
156699559|NCT05327816|565649156|FG010|Overall Study|Lost to Follow-up|0|||
156699560|NCT05327816|565649146|FG000|Overall Study|Withdrawal by Subject|0|||
156699561|NCT05327816|565649147|FG001|Overall Study|Withdrawal by Subject|0|||
156699562|NCT05327816|565649148|FG002|Overall Study|Withdrawal by Subject|0|||
156699563|NCT05327816|565649149|FG003|Overall Study|Withdrawal by Subject|0|||
156699564|NCT05327816|565649150|FG004|Overall Study|Withdrawal by Subject|1|||
156699565|NCT05327816|565649151|FG005|Overall Study|Withdrawal by Subject|1|||
156699566|NCT05327816|565649152|FG006|Overall Study|Withdrawal by Subject|0|||
156699567|NCT05327816|565649153|FG007|Overall Study|Withdrawal by Subject|0|||
156699568|NCT05327816|565649154|FG008|Overall Study|Withdrawal by Subject|0|||
156699569|NCT05327816|565649155|FG009|Overall Study|Withdrawal by Subject|0|||
156699570|NCT05327816|565649156|FG010|Overall Study|Withdrawal by Subject|0|||
156699571|NCT05327816|565649146|FG000|Overall Study|Study Terminated by Sponsor|11|||
156699572|NCT05327816|565649147|FG001|Overall Study|Study Terminated by Sponsor|12|||
156699573|NCT05327816|565649148|FG002|Overall Study|Study Terminated by Sponsor|12|||
156699574|NCT05327816|565649149|FG003|Overall Study|Study Terminated by Sponsor|12|||
156699575|NCT05327816|565649150|FG004|Overall Study|Study Terminated by Sponsor|11|||
156699576|NCT05327816|565649151|FG005|Overall Study|Study Terminated by Sponsor|11|||
156699577|NCT05327816|565649152|FG006|Overall Study|Study Terminated by Sponsor|11|||
156699578|NCT05327816|565649153|FG007|Overall Study|Study Terminated by Sponsor|11|||
156699579|NCT05327816|565649154|FG008|Overall Study|Study Terminated by Sponsor|11|||
156699580|NCT05327816|565649155|FG009|Overall Study|Study Terminated by Sponsor|11|||
156699581|NCT05327816|565649156|FG010|Overall Study|Study Terminated by Sponsor|12|||
156699582|NCT05327816|565649146|FG000|Overall Study|Randomized but not treated|0|||
156699583|NCT05327816|565649147|FG001|Overall Study|Randomized but not treated|0|||
156699584|NCT05327816|565649148|FG002|Overall Study|Randomized but not treated|0|||
156699585|NCT05327816|565649149|FG003|Overall Study|Randomized but not treated|0|||
156699586|NCT05327816|565649150|FG004|Overall Study|Randomized but not treated|0|||
156699587|NCT05327816|565649151|FG005|Overall Study|Randomized but not treated|0|||
156699588|NCT05327816|565649152|FG006|Overall Study|Randomized but not treated|1|||
156699589|NCT05327816|565649153|FG007|Overall Study|Randomized but not treated|1|||
156331496|NCT03449901|564313460|FG000|Overall Study|Adverse Event|3|||
156331497|NCT03449901|564313461|FG001|Overall Study|Adverse Event|0|||
156331498|NCT03449901|564313460|FG000|Overall Study|Death|6|||
156331499|NCT03449901|564313461|FG001|Overall Study|Death|2|||
156331500|NCT03449901|564313460|FG000|Overall Study|Withdrawal by Subject|12|||
156331501|NCT03449901|564313461|FG001|Overall Study|Withdrawal by Subject|1|||
156331502|NCT03449901|564313460|FG000|Overall Study|Physician Decision|1|||
156331503|NCT03449901|564313461|FG001|Overall Study|Physician Decision|0|||
156331504|NCT03449901|564313460|FG000|Overall Study|Patient elected for surgical intervention|1|||
156331505|NCT03449901|564313461|FG001|Overall Study|Patient elected for surgical intervention|0|||
156331506|NCT03449901|564313460|FG000|Overall Study|Patient off for other complicating disease|1|||
156331507|NCT03449901|564313461|FG001|Overall Study|Patient off for other complicating disease|0|||
156699590|NCT05327816|565649154|FG008|Overall Study|Randomized but not treated|1|||
156699591|NCT05327816|565649155|FG009|Overall Study|Randomized but not treated|0|||
156699592|NCT05327816|565649156|FG010|Overall Study|Randomized but not treated|0|||
156699593|NCT00759902|565649157|FG000|Overall Study|Adverse Event|0|||
156699594|NCT00759902|565649158|FG001|Overall Study|Adverse Event|1|||
156699595|NCT00658658|565649163|FG000|Overall Study|Withdrawal by Subject|0|||
156699596|NCT00658658|565649164|FG001|Overall Study|Withdrawal by Subject|1|||
156699597|NCT00658658|565649165|FG002|Overall Study|Withdrawal by Subject|0|||
156699598|NCT00658658|565649166|FG003|Overall Study|Withdrawal by Subject|0|||
156699599|NCT00658658|565649167|FG004|Overall Study|Withdrawal by Subject|0|||
156699600|NCT00658658|565649163|FG000|Overall Study|Death|4|||
156699601|NCT00658658|565649164|FG001|Overall Study|Death|0|||
156699602|NCT00658658|565649165|FG002|Overall Study|Death|0|||
156699603|NCT00658658|565649166|FG003|Overall Study|Death|1|||
156699604|NCT00658658|565649167|FG004|Overall Study|Death|1|||
156699605|NCT00658658|565649163|FG000|Overall Study|Disease Progression|0|||
156699606|NCT00658658|565649164|FG001|Overall Study|Disease Progression|1|||
156699607|NCT00658658|565649165|FG002|Overall Study|Disease Progression|0|||
156699608|NCT00658658|565649166|FG003|Overall Study|Disease Progression|1|||
156699609|NCT00658658|565649167|FG004|Overall Study|Disease Progression|3|||
156438776|NCT00774397|564698669|FG003|Overall Study|Refused to continue trial medication|2|||
156699610|NCT00658658|565649163|FG000|Overall Study|Protocol-specified Criteria|1|||
156699611|NCT00658658|565649164|FG001|Overall Study|Protocol-specified Criteria|0|||
156699612|NCT00658658|565649165|FG002|Overall Study|Protocol-specified Criteria|0|||
156699613|NCT00658658|565649166|FG003|Overall Study|Protocol-specified Criteria|0|||
156699614|NCT00658658|565649167|FG004|Overall Study|Protocol-specified Criteria|0|||
156699615|NCT00658658|565649163|FG000|Overall Study|Other|0|||
156699616|NCT00658658|565649164|FG001|Overall Study|Other|0|||
156699617|NCT00658658|565649165|FG002|Overall Study|Other|0|||
156699618|NCT00658658|565649166|FG003|Overall Study|Other|0|||
156699619|NCT00658658|565649167|FG004|Overall Study|Other|1|||
156699620|NCT01523457|565649168|FG000|Overall Study|Withdrawal by Subject|7|||
156872010|NCT00473382|566289491|FG001|Core Study|Adverse Event|1|||
156331508|NCT03150173|564313462|FG000|Overall Study|Lost to Follow-up|13|||
156438777|NCT00774397|564698670|FG004|Overall Study|Refused to continue trial medication|6|||
156438778|NCT00774397|564698671|FG005|Overall Study|Refused to continue trial medication|2|||
156530987|NCT02234323|565039823|FG000|All Treated|Death|1|||
156530988|NCT02234323|565039823|FG000|All Treated|Physician Decision|5|||
156530989|NCT02234323|565039823|FG000|All Treated|Lack of Efficacy|3|||
156530990|NCT02234323|565039823|FG000|All Treated|Exceeded lab value limit|2|||
156530991|NCT02234323|565039823|FG000|All Treated|Other|7|||
156530992|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
156530993|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
156530994|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
156530995|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
156530996|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
156530997|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
156530998|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
156530999|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
156531000|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Death|1|||
156438779|NCT00774397|564698672|FG006|Overall Study|Refused to continue trial medication|3|||
156438780|NCT00774397|564698666|FG000|Overall Study|Not treated|0|||
156438781|NCT00774397|564698667|FG001|Overall Study|Not treated|0|||
156438782|NCT00774397|564698668|FG002|Overall Study|Not treated|0|||
156438783|NCT00774397|564698669|FG003|Overall Study|Not treated|0|||
156438784|NCT00774397|564698670|FG004|Overall Study|Not treated|1|||
156438785|NCT00774397|564698671|FG005|Overall Study|Not treated|0|||
156438786|NCT00774397|564698672|FG006|Overall Study|Not treated|1|||
156438787|NCT00774397|564698666|FG000|Overall Study|Other than those stated above|1|||
156438788|NCT00774397|564698667|FG001|Overall Study|Other than those stated above|1|||
156438789|NCT00774397|564698668|FG002|Overall Study|Other than those stated above|3|||
156438790|NCT00774397|564698669|FG003|Overall Study|Other than those stated above|2|||
156438791|NCT00774397|564698670|FG004|Overall Study|Other than those stated above|2|||
156438792|NCT00774397|564698671|FG005|Overall Study|Other than those stated above|0|||
156438793|NCT00774397|564698672|FG006|Overall Study|Other than those stated above|1|||
156438794|NCT01599793|564698673|FG000|Overall Study|Adverse Event|2|||
156438795|NCT02593149|564698678|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
156531001|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Death|1|||
156531002|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
156531003|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
156531004|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
156531005|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
156699621|NCT01523457|565649169|FG001|Overall Study|Withdrawal by Subject|2|||
156331509|NCT03150173|564313463|FG001|Overall Study|Lost to Follow-up|5|||
156331510|NCT02046733|564313467|FG000|Overall Study|never initiated 'treatment visits'|6|||
156331511|NCT02046733|564313468|FG001|Overall Study|never initiated 'treatment visits'|0|||
156331512|NCT03605212|564313469|FG000|Treatment Period|Adverse Event|1|||
156331513|NCT03605212|564313470|FG001|Treatment Period|Adverse Event|0|||
156331514|NCT03605212|564313471|FG002|Treatment Period|Adverse Event|0|||
156331515|NCT03605212|564313472|FG003|Treatment Period|Adverse Event|0|||
156331516|NCT03605212|564313473|FG004|Treatment Period|Adverse Event|0|||
156699622|NCT01367665|565649170|FG000|Overall Study|Death|102|||
156699623|NCT01367665|565649171|FG001|Overall Study|Death|19|||
156331517|NCT03605212|564313469|FG000|Treatment Period|Physician Decision|0|||
156438796|NCT02593149|564698679|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
156438797|NCT02593149|564698678|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
156699624|NCT01367665|565649170|FG000|Overall Study|Lost to Follow-up|222|||
156531006|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
156531007|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
156531008|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
156531009|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
156531010|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
156531011|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
156531012|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
156531013|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
156531014|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
156531015|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
156531016|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
156531017|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
156531018|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
156531019|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
156531020|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
156531021|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
156531022|NCT00559585|565039824|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
156531023|NCT00559585|565039825|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
156531024|NCT00559585|565039824|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
156531025|NCT00559585|565039825|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
156531026|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
156531027|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
156531028|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
156531029|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
156531030|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
156531031|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
156531032|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
156531033|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
156531034|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
156531035|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
156531036|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
156531037|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
156531038|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
156531039|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
156531040|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
156531041|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
156531042|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
156531043|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
156531044|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
156531045|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
156531046|NCT00559585|565039824|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
156531047|NCT00559585|565039825|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
156531048|NCT04209621|565039826|FG000|Overall Study|Death|1|||
156531049|NCT04209621|565039826|FG000|Overall Study|Study Terminated Early|2|||
156531050|NCT02249767|565039827|FG000|Overall Study|Did not use medication|8|||
156531051|NCT02249767|565039828|FG001|Overall Study|Did not use medication|9|||
156531052|NCT02249767|565039829|FG002|Overall Study|Did not use medication|8|||
156531053|NCT01372410|565039830|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
156531054|NCT01372410|565039831|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
156531055|NCT01372410|565039832|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
156531056|NCT01372410|565039833|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
156531057|NCT01372410|565039834|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
156531058|NCT01372410|565039835|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
156531059|NCT01372410|565039836|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
156531060|NCT01372410|565039837|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
156531061|NCT01372410|565039830|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
156531062|NCT01372410|565039831|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
156531063|NCT01372410|565039832|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
156531064|NCT01372410|565039833|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
156531065|NCT01372410|565039834|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
156531066|NCT01372410|565039835|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
156531067|NCT01372410|565039836|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
156531068|NCT01372410|565039837|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
156531069|NCT01372410|565039830|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156531070|NCT01372410|565039831|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156531071|NCT01372410|565039832|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156531072|NCT01372410|565039833|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156699625|NCT01367665|565649171|FG001|Overall Study|Lost to Follow-up|22|||
156790756|NCT03654326|565985467|FG001|Overall Study|Physician Decision|1|||
156438798|NCT02593149|564698679|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
156438799|NCT04532528|564698680|FG000|Overall Study|Adverse Event|12|||
156438800|NCT04532528|564698681|FG001|Overall Study|Adverse Event|17|||
156438801|NCT04532528|564698680|FG000|Overall Study|Withdrawal of consent|16|||
156438802|NCT04532528|564698681|FG001|Overall Study|Withdrawal of consent|17|||
156438803|NCT04532528|564698680|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
156438804|NCT04532528|564698681|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
156438805|NCT04532528|564698680|FG000|Overall Study|Lost to Follow-up|69|||
156438806|NCT04532528|564698681|FG001|Overall Study|Lost to Follow-up|68|||
156438807|NCT04532528|564698680|FG000|Overall Study|Administrative problems|12|||
156438808|NCT04532528|564698681|FG001|Overall Study|Administrative problems|14|||
156438809|NCT04532528|564698680|FG000|Overall Study|Death|3|||
156438810|NCT04532528|564698681|FG001|Overall Study|Death|3|||
156438811|NCT04532528|564698680|FG000|Overall Study|Other|38|||
156438812|NCT04532528|564698681|FG001|Overall Study|Other|46|||
156438813|NCT01636687|564698682|FG000|Induction Period|Withdrawal by Subject|1|||
156438814|NCT01636687|564698683|FG001|Induction Period|Withdrawal by Subject|0|||
156438815|NCT01636687|564698684|FG002|Induction Period|Withdrawal by Subject|0|||
156438816|NCT01636687|564698685|FG003|Induction Period|Withdrawal by Subject|0|||
156438817|NCT01636687|564698686|FG004|Induction Period|Withdrawal by Subject|0|||
156438818|NCT01636687|564698682|FG000|Induction Period|Adverse Event|1|||
156438819|NCT01636687|564698683|FG001|Induction Period|Adverse Event|0|||
156438820|NCT01636687|564698684|FG002|Induction Period|Adverse Event|0|||
156438821|NCT01636687|564698685|FG003|Induction Period|Adverse Event|0|||
156438822|NCT01636687|564698686|FG004|Induction Period|Adverse Event|1|||
156438823|NCT01636687|564698682|FG000|Induction Period|Lack of Efficacy|0|||
156438824|NCT01636687|564698683|FG001|Induction Period|Lack of Efficacy|0|||
156438825|NCT01636687|564698684|FG002|Induction Period|Lack of Efficacy|0|||
156438826|NCT01636687|564698685|FG003|Induction Period|Lack of Efficacy|0|||
156438827|NCT01636687|564698686|FG004|Induction Period|Lack of Efficacy|1|||
156438828|NCT01636687|564698682|FG000|Induction Period|Physician Decision|1|||
156438829|NCT01636687|564698683|FG001|Induction Period|Physician Decision|0|||
156438830|NCT01636687|564698684|FG002|Induction Period|Physician Decision|0|||
156438831|NCT01636687|564698685|FG003|Induction Period|Physician Decision|0|||
156438832|NCT01636687|564698686|FG004|Induction Period|Physician Decision|0|||
156438833|NCT01636687|564698682|FG000|Maintenance Period|Withdrawal by Subject|2|||
156438834|NCT01636687|564698683|FG001|Maintenance Period|Withdrawal by Subject|0|||
156438835|NCT01636687|564698684|FG002|Maintenance Period|Withdrawal by Subject|2|||
156438836|NCT01636687|564698685|FG003|Maintenance Period|Withdrawal by Subject|0|||
156438837|NCT01636687|564698686|FG004|Maintenance Period|Withdrawal by Subject|0|||
156438838|NCT01636687|564698682|FG000|Maintenance Period|Adverse Event|1|||
156438839|NCT01636687|564698683|FG001|Maintenance Period|Adverse Event|0|||
156438840|NCT01636687|564698684|FG002|Maintenance Period|Adverse Event|0|||
156438841|NCT01636687|564698685|FG003|Maintenance Period|Adverse Event|0|||
156438842|NCT01636687|564698686|FG004|Maintenance Period|Adverse Event|0|||
156438843|NCT01636687|564698682|FG000|Maintenance Period|Lack of Efficacy|4|||
156438844|NCT01636687|564698683|FG001|Maintenance Period|Lack of Efficacy|1|||
156438845|NCT01636687|564698684|FG002|Maintenance Period|Lack of Efficacy|0|||
156438846|NCT01636687|564698685|FG003|Maintenance Period|Lack of Efficacy|0|||
156438847|NCT01636687|564698686|FG004|Maintenance Period|Lack of Efficacy|0|||
156438848|NCT01636687|564698682|FG000|Maintenance Period|Lost to Follow-up|1|||
156438849|NCT01636687|564698683|FG001|Maintenance Period|Lost to Follow-up|1|||
156438850|NCT01636687|564698684|FG002|Maintenance Period|Lost to Follow-up|0|||
156438851|NCT01636687|564698685|FG003|Maintenance Period|Lost to Follow-up|0|||
156438852|NCT01636687|564698686|FG004|Maintenance Period|Lost to Follow-up|1|||
156438853|NCT01636687|564698682|FG000|Maintenance Period|Physician Decision|0|||
156438854|NCT01636687|564698683|FG001|Maintenance Period|Physician Decision|0|||
156438855|NCT01636687|564698684|FG002|Maintenance Period|Physician Decision|0|||
156438856|NCT01636687|564698685|FG003|Maintenance Period|Physician Decision|0|||
156438857|NCT01636687|564698686|FG004|Maintenance Period|Physician Decision|1|||
156438858|NCT01636687|564698682|FG000|Extension Period|technical problems|0|||
156438859|NCT01636687|564698683|FG001|Extension Period|technical problems|1|||
156438860|NCT01636687|564698684|FG002|Extension Period|technical problems|2|||
156438861|NCT01636687|564698685|FG003|Extension Period|technical problems|1|||
156438862|NCT01636687|564698686|FG004|Extension Period|technical problems|0|||
156438863|NCT01636687|564698682|FG000|Extension Period|Adverse Event|4|||
156438864|NCT01636687|564698683|FG001|Extension Period|Adverse Event|3|||
156438865|NCT01636687|564698684|FG002|Extension Period|Adverse Event|2|||
156438866|NCT01636687|564698685|FG003|Extension Period|Adverse Event|1|||
156438867|NCT01636687|564698686|FG004|Extension Period|Adverse Event|0|||
156438868|NCT01636687|564698682|FG000|Extension Period|Lack of Efficacy|7|||
156438869|NCT01636687|564698683|FG001|Extension Period|Lack of Efficacy|0|||
156438870|NCT01636687|564698684|FG002|Extension Period|Lack of Efficacy|2|||
156438871|NCT01636687|564698685|FG003|Extension Period|Lack of Efficacy|1|||
156438872|NCT01636687|564698686|FG004|Extension Period|Lack of Efficacy|0|||
156438873|NCT01636687|564698682|FG000|Extension Period|Lost to Follow-up|1|||
156438874|NCT01636687|564698683|FG001|Extension Period|Lost to Follow-up|0|||
156438875|NCT01636687|564698684|FG002|Extension Period|Lost to Follow-up|1|||
156438876|NCT01636687|564698685|FG003|Extension Period|Lost to Follow-up|0|||
156438877|NCT01636687|564698686|FG004|Extension Period|Lost to Follow-up|0|||
156438878|NCT01636687|564698682|FG000|Extension Period|Physician Decision|1|||
156438879|NCT01636687|564698683|FG001|Extension Period|Physician Decision|0|||
156438880|NCT01636687|564698684|FG002|Extension Period|Physician Decision|0|||
156438881|NCT01636687|564698685|FG003|Extension Period|Physician Decision|1|||
156438882|NCT01636687|564698686|FG004|Extension Period|Physician Decision|0|||
156438883|NCT01636687|564698682|FG000|Extension Period|study terminated by sponsor|33|||
156438884|NCT01636687|564698683|FG001|Extension Period|study terminated by sponsor|50|||
156438885|NCT01636687|564698684|FG002|Extension Period|study terminated by sponsor|17|||
156438886|NCT01636687|564698685|FG003|Extension Period|study terminated by sponsor|23|||
156438887|NCT01636687|564698686|FG004|Extension Period|study terminated by sponsor|0|||
156438888|NCT01636687|564698682|FG000|Extension Period|Withdrawal by Subject|1|||
156438889|NCT01636687|564698683|FG001|Extension Period|Withdrawal by Subject|0|||
156438890|NCT01636687|564698684|FG002|Extension Period|Withdrawal by Subject|1|||
156438891|NCT01636687|564698685|FG003|Extension Period|Withdrawal by Subject|1|||
156438892|NCT01636687|564698686|FG004|Extension Period|Withdrawal by Subject|0|||
156438893|NCT01636687|564698682|FG000|Follow-up Period|Withdrawal by Subject|1|||
156438894|NCT01636687|564698683|FG001|Follow-up Period|Withdrawal by Subject|0|||
156438895|NCT01636687|564698684|FG002|Follow-up Period|Withdrawal by Subject|0|||
156438896|NCT01636687|564698685|FG003|Follow-up Period|Withdrawal by Subject|0|||
156438897|NCT01636687|564698686|FG004|Follow-up Period|Withdrawal by Subject|1|||
156438898|NCT01140048|564698687|FG000|Overall Study|Physician Decision|1|||
156438899|NCT01140048|564698687|FG000|Overall Study|Withdrawal by Subject|13|||
156438900|NCT01140048|564698687|FG000|Overall Study|Lost to Follow-up|31|||
156438901|NCT00636207|564698688|FG000|Overall Study|Adverse Event|1|||
156438902|NCT00636207|564698689|FG001|Overall Study|Adverse Event|0|||
156438903|NCT00636207|564698690|FG002|Overall Study|Adverse Event|0|||
156438904|NCT00636207|564698691|FG003|Overall Study|Adverse Event|0|||
156438905|NCT00636207|564698692|FG004|Overall Study|Adverse Event|0|||
156438906|NCT00636207|564698693|FG005|Overall Study|Adverse Event|0|||
156438907|NCT00636207|564698694|FG006|Overall Study|Adverse Event|0|||
156438908|NCT00636207|564698688|FG000|Overall Study|Withdrawal by Subject|0|||
156438909|NCT00636207|564698689|FG001|Overall Study|Withdrawal by Subject|1|||
156438910|NCT00636207|564698690|FG002|Overall Study|Withdrawal by Subject|0|||
156438911|NCT00636207|564698691|FG003|Overall Study|Withdrawal by Subject|0|||
156438912|NCT00636207|564698692|FG004|Overall Study|Withdrawal by Subject|1|||
156438913|NCT00636207|564698693|FG005|Overall Study|Withdrawal by Subject|0|||
156438914|NCT00636207|564698694|FG006|Overall Study|Withdrawal by Subject|0|||
156438915|NCT00666276|564698697|FG000|Overall Study|Protocol Violation|34|||
156438916|NCT02594735|564698698|FG000|Overall Study|Adverse Event|1|||
156438917|NCT00668863|564698699|FG000|Overall Study|Objective Progression or Relapse|42|||
156438918|NCT00668863|564698699|FG000|Overall Study|Adverse Event|13|||
156438919|NCT00668863|564698699|FG000|Overall Study|Study Terminated by Sponsor|8|||
156438920|NCT00668863|564698699|FG000|Overall Study|Global Deterioration of Health Status|4|||
156438921|NCT00668863|564698699|FG000|Overall Study|Withdrawal by Subject|1|||
156438922|NCT00668863|564698699|FG000|Overall Study|Surgery|1|||
156438923|NCT00668863|564698699|FG000|Overall Study|Subject's work scheduling problem|1|||
156438924|NCT00668863|564698699|FG000|Overall Study|Physician Decision|1|||
156438925|NCT00101010|564698700|FG000|Overall Study|Physician Decision|1|||
156438926|NCT01185782|564698701|FG000|Overall Study|Adverse Event|0|||
156438927|NCT01185782|564698702|FG001|Overall Study|Adverse Event|1|||
156438928|NCT01185782|564698701|FG000|Overall Study|Protocol Violation|1|||
156438929|NCT01185782|564698702|FG001|Overall Study|Protocol Violation|0|||
156438930|NCT01185782|564698701|FG000|Overall Study|Poor Response to Treatment|3|||
156438931|NCT01185782|564698702|FG001|Overall Study|Poor Response to Treatment|1|||
156438932|NCT01185782|564698701|FG000|Overall Study|Other|2|||
156438933|NCT01185782|564698702|FG001|Overall Study|Other|5|||
156438934|NCT01185782|564698701|FG000|Overall Study|Randomized but not treated|0|||
156699626|NCT01367665|565649170|FG000|Overall Study|Not Done|118|||
156699627|NCT01367665|565649171|FG001|Overall Study|Not Done|14|||
156438935|NCT01185782|564698702|FG001|Overall Study|Randomized but not treated|4|||
156438936|NCT02507752|564698703|FG000|Overall Study|Adverse Event|1|||
156438937|NCT02507752|564698703|FG000|Overall Study|Protocol Violation|6|||
156438938|NCT02507752|564698703|FG000|Overall Study|Lost to Follow-up|7|||
156438939|NCT02507752|564698703|FG000|Overall Study|Infusion reaction at first infusion|1|||
156438940|NCT02507752|564698703|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
156438941|NCT02507752|564698703|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
156438942|NCT05082935|564698713|FG000|Overall Study|Lost to Follow-up|549|||
156438943|NCT05082935|564698714|FG001|Overall Study|Lost to Follow-up|631|||
156438944|NCT05082935|564698713|FG000|Overall Study|Withdrawal by Subject|27|||
156438945|NCT05082935|564698714|FG001|Overall Study|Withdrawal by Subject|58|||
156438946|NCT01444417|564698716|FG000|Overall Study|Ineligibility Determined|0|||
156438947|NCT01444417|564698717|FG001|Overall Study|Ineligibility Determined|1|||
156699628|NCT03283319|565649172|FG000|Overall Study|Lost to Follow-up|5|||
156438948|NCT01444417|564698716|FG000|Overall Study|Withdrawal by Subject|2|||
156699629|NCT03283319|565649173|FG001|Overall Study|Lost to Follow-up|4|||
156699630|NCT03283319|565649174|FG002|Overall Study|Lost to Follow-up|5|||
156699631|NCT03283319|565649175|FG003|Overall Study|Lost to Follow-up|5|||
156699632|NCT03283319|565649176|FG004|Overall Study|Lost to Follow-up|4|||
156699633|NCT03283319|565649177|FG005|Overall Study|Lost to Follow-up|3|||
156699634|NCT03283319|565649172|FG000|Overall Study|Withdrawal by Subject|2|||
156699635|NCT03283319|565649173|FG001|Overall Study|Withdrawal by Subject|2|||
156699636|NCT03283319|565649174|FG002|Overall Study|Withdrawal by Subject|2|||
156699637|NCT03283319|565649175|FG003|Overall Study|Withdrawal by Subject|1|||
156699638|NCT03283319|565649176|FG004|Overall Study|Withdrawal by Subject|0|||
156699639|NCT03283319|565649177|FG005|Overall Study|Withdrawal by Subject|1|||
156699640|NCT03283319|565649172|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699641|NCT03283319|565649173|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699642|NCT03283319|565649174|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699643|NCT03283319|565649175|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
156699644|NCT03283319|565649176|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699645|NCT03283319|565649177|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699646|NCT03954834|565649179|FG000|Overall Study|Adverse Event|1|||
156699647|NCT03954834|565649180|FG001|Overall Study|Adverse Event|3|||
156699648|NCT03954834|565649181|FG002|Overall Study|Adverse Event|1|||
156699649|NCT03954834|565649182|FG003|Overall Study|Adverse Event|1|||
156699650|NCT03954834|565649179|FG000|Overall Study|Death|0|||
156699651|NCT03954834|565649180|FG001|Overall Study|Death|0|||
156699652|NCT03954834|565649181|FG002|Overall Study|Death|0|||
156699653|NCT03954834|565649182|FG003|Overall Study|Death|1|||
156699654|NCT03954834|565649179|FG000|Overall Study|Physician Decision|0|||
156699655|NCT03954834|565649180|FG001|Overall Study|Physician Decision|1|||
156699656|NCT03954834|565649181|FG002|Overall Study|Physician Decision|0|||
156699657|NCT03954834|565649182|FG003|Overall Study|Physician Decision|2|||
156699658|NCT03954834|565649179|FG000|Overall Study|Protocol Violation|1|||
156699659|NCT03954834|565649180|FG001|Overall Study|Protocol Violation|0|||
156699660|NCT03954834|565649181|FG002|Overall Study|Protocol Violation|0|||
156699661|NCT03954834|565649182|FG003|Overall Study|Protocol Violation|1|||
156699662|NCT03954834|565649179|FG000|Overall Study|Withdrawal by Subject|2|||
156699663|NCT03954834|565649180|FG001|Overall Study|Withdrawal by Subject|3|||
156699664|NCT03954834|565649181|FG002|Overall Study|Withdrawal by Subject|13|||
156699665|NCT03954834|565649182|FG003|Overall Study|Withdrawal by Subject|6|||
156699666|NCT03954834|565649179|FG000|Overall Study|Participant left the country|0|||
156699667|NCT03954834|565649180|FG001|Overall Study|Participant left the country|0|||
156438949|NCT01444417|564698717|FG001|Overall Study|Withdrawal by Subject|0|||
156438950|NCT03531840|564698719|FG000|Overall Study|Death on study|3|||
156438951|NCT03531840|564698720|FG001|Overall Study|Death on study|2|||
156438952|NCT03531840|564698721|FG002|Overall Study|Death on study|1|||
156438953|NCT03531840|564698722|FG003|Overall Study|Death on study|2|||
156438954|NCT03531840|564698719|FG000|Overall Study|Death during follow up|2|||
156438955|NCT03531840|564698720|FG001|Overall Study|Death during follow up|3|||
156438956|NCT03531840|564698721|FG002|Overall Study|Death during follow up|4|||
156438957|NCT03531840|564698722|FG003|Overall Study|Death during follow up|1|||
156438958|NCT01546753|564698723|FG000|Overall Study|anxiety|1|||
156438959|NCT01546753|564698724|FG001|Overall Study|anxiety|1|||
156438960|NCT01546753|564698723|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
156438961|NCT01546753|564698724|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
156438962|NCT00939510|564698725|FG000|Overall Study|Withdrawal by Subject|1|||
156438963|NCT01236560|564698726|FG000|Overall Study|Adverse Event|0|||
156438964|NCT01236560|564698727|FG001|Overall Study|Adverse Event|2|||
156699668|NCT03954834|565649181|FG002|Overall Study|Participant left the country|1|||
156438965|NCT01236560|564698728|FG002|Overall Study|Adverse Event|1|||
156438966|NCT01236560|564698729|FG003|Overall Study|Adverse Event|3|||
156438967|NCT01236560|564698730|FG004|Overall Study|Adverse Event|0|||
156438968|NCT01236560|564698731|FG005|Overall Study|Adverse Event|0|||
156438969|NCT01236560|564698726|FG000|Overall Study|Death|0|||
156438970|NCT01236560|564698727|FG001|Overall Study|Death|1|||
156438971|NCT01236560|564698728|FG002|Overall Study|Death|0|||
156531073|NCT01372410|565039834|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
156699669|NCT03954834|565649182|FG003|Overall Study|Participant left the country|0|||
156699670|NCT03954834|565649179|FG000|Overall Study|Lost to Follow-up|3|||
156438972|NCT01236560|564698729|FG003|Overall Study|Death|1|||
156699671|NCT03954834|565649180|FG001|Overall Study|Lost to Follow-up|2|||
156699672|NCT03954834|565649181|FG002|Overall Study|Lost to Follow-up|3|||
156699673|NCT03954834|565649182|FG003|Overall Study|Lost to Follow-up|5|||
156699674|NCT04711902|565649186|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
156699675|NCT04711902|565649187|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
156699676|NCT04711902|565649188|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
156438973|NCT01236560|564698730|FG004|Overall Study|Death|0|||
156438974|NCT01236560|564698731|FG005|Overall Study|Death|0|||
156699677|NCT04711902|565649189|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
156438975|NCT01236560|564698726|FG000|Overall Study|Lost to Follow-up|0|||
156438976|NCT01236560|564698727|FG001|Overall Study|Lost to Follow-up|1|||
156438977|NCT01236560|564698728|FG002|Overall Study|Lost to Follow-up|1|||
156438978|NCT01236560|564698729|FG003|Overall Study|Lost to Follow-up|0|||
156438979|NCT01236560|564698730|FG004|Overall Study|Lost to Follow-up|0|||
156438980|NCT01236560|564698731|FG005|Overall Study|Lost to Follow-up|0|||
156438981|NCT01236560|564698726|FG000|Overall Study|Physician Decision|0|||
156438982|NCT01236560|564698727|FG001|Overall Study|Physician Decision|1|||
156438983|NCT01236560|564698728|FG002|Overall Study|Physician Decision|8|||
156438984|NCT01236560|564698729|FG003|Overall Study|Physician Decision|0|||
156438985|NCT01236560|564698730|FG004|Overall Study|Physician Decision|0|||
156438986|NCT01236560|564698731|FG005|Overall Study|Physician Decision|0|||
156438987|NCT01236560|564698726|FG000|Overall Study|Withdrawal by Subject|0|||
156438988|NCT01236560|564698727|FG001|Overall Study|Withdrawal by Subject|0|||
156438989|NCT01236560|564698728|FG002|Overall Study|Withdrawal by Subject|1|||
156438990|NCT01236560|564698729|FG003|Overall Study|Withdrawal by Subject|2|||
156438991|NCT01236560|564698730|FG004|Overall Study|Withdrawal by Subject|0|||
156438992|NCT01236560|564698731|FG005|Overall Study|Withdrawal by Subject|0|||
156438993|NCT01236560|564698726|FG000|Overall Study|Progressive disease|5|||
156438994|NCT01236560|564698727|FG001|Overall Study|Progressive disease|19|||
156438995|NCT01236560|564698728|FG002|Overall Study|Progressive disease|9|||
156438996|NCT01236560|564698729|FG003|Overall Study|Progressive disease|16|||
156438997|NCT01236560|564698730|FG004|Overall Study|Progressive disease|0|||
156438998|NCT01236560|564698731|FG005|Overall Study|Progressive disease|0|||
156438999|NCT05061693|564698734|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
156439000|NCT05061693|564698735|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
156439001|NCT05061693|564698736|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
156439002|NCT05061693|564698737|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156439003|NCT05061693|564698738|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156439004|NCT05061693|564698739|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156531074|NCT01372410|565039835|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156531075|NCT01372410|565039836|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156699678|NCT04711902|565649190|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
156699679|NCT04711902|565649191|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
156699680|NCT03786718|565649192|FG000|Overall Study|Lost to Follow-up|3|||
156699681|NCT03786718|565649192|FG000|Overall Study|Withdrawal by Subject|1|||
156699682|NCT03786718|565649192|FG000|Overall Study|Did not use the intervention|2|||
156699683|NCT03786718|565649192|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
156699684|NCT00372411|565649199|FG000|Overall Study|Withdrawal by Subject|3|||
156699685|NCT00372411|565649200|FG001|Overall Study|Withdrawal by Subject|4|||
156699686|NCT00372411|565649201|FG002|Overall Study|Withdrawal by Subject|1|||
156699687|NCT00372411|565649199|FG000|Overall Study|Death|0|||
156699688|NCT00372411|565649200|FG001|Overall Study|Death|2|||
156699689|NCT00372411|565649201|FG002|Overall Study|Death|1|||
156699690|NCT00372411|565649199|FG000|Overall Study|Lost to Follow-up|1|||
156699691|NCT00372411|565649200|FG001|Overall Study|Lost to Follow-up|1|||
156699692|NCT00372411|565649201|FG002|Overall Study|Lost to Follow-up|1|||
156699693|NCT00372411|565649199|FG000|Overall Study|Adverse Event|1|||
156699694|NCT00372411|565649200|FG001|Overall Study|Adverse Event|1|||
156872011|NCT00473382|566289492|FG002|Core Study|Adverse Event|1|||
156439005|NCT05061693|564698740|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156439006|NCT05061693|564698741|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156439007|NCT05061693|564698742|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156439008|NCT05061693|564698743|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156439009|NCT05061693|564698744|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156439010|NCT05061693|564698745|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
156439011|NCT05061693|564698734|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
156439012|NCT05061693|564698735|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
156439013|NCT05061693|564698736|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
156439014|NCT05061693|564698737|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
156439015|NCT05061693|564698738|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
156439016|NCT05061693|564698739|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
156439017|NCT05061693|564698740|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
156439018|NCT05061693|564698741|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
156439019|NCT05061693|564698742|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
156439020|NCT05061693|564698743|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
156439021|NCT05061693|564698744|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
156439022|NCT05061693|564698745|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
156439023|NCT05061693|564698734|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
156699695|NCT00372411|565649201|FG002|Overall Study|Adverse Event|0|||
156699696|NCT01398514|565649202|FG000|Overall Study|Adverse Event|1|||
156439024|NCT05061693|564698735|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156439025|NCT05061693|564698736|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156699697|NCT01398514|565649203|FG001|Overall Study|Adverse Event|0|||
156699698|NCT01398514|565649202|FG000|Overall Study|Non-compliance with study procedures|2|||
156699699|NCT01398514|565649203|FG001|Overall Study|Non-compliance with study procedures|0|||
156699700|NCT01398514|565649202|FG000|Overall Study|Physiologic non-responsiveness|1|||
156699701|NCT01398514|565649203|FG001|Overall Study|Physiologic non-responsiveness|3|||
156699702|NCT01398514|565649202|FG000|Overall Study|Failure to show a conditioned response|4|||
156699703|NCT01398514|565649203|FG001|Overall Study|Failure to show a conditioned response|3|||
156699704|NCT05961215|565649205|FG000|Overall Study|Withdrawal by Subject|1|||
156699705|NCT06187909|565649209|FG000|Overall Study|Withdrawal by Subject|2|||
156699706|NCT06187909|565649210|FG001|Overall Study|Withdrawal by Subject|2|||
156699707|NCT04126213|565649220|FG000|Overall Study|Lost to Follow-up|9|||
156699708|NCT04126213|565649221|FG001|Overall Study|Lost to Follow-up|1|||
156699709|NCT04126213|565649222|FG002|Overall Study|Lost to Follow-up|5|||
156699710|NCT04126213|565649223|FG003|Overall Study|Lost to Follow-up|10|||
156699711|NCT04126213|565649224|FG004|Overall Study|Lost to Follow-up|4|||
156699712|NCT04126213|565649225|FG005|Overall Study|Lost to Follow-up|7|||
156699713|NCT04126213|565649220|FG000|Overall Study|Withdrawal by Subject|3|||
156699714|NCT04126213|565649221|FG001|Overall Study|Withdrawal by Subject|2|||
156699715|NCT04126213|565649222|FG002|Overall Study|Withdrawal by Subject|1|||
156699716|NCT04126213|565649223|FG003|Overall Study|Withdrawal by Subject|1|||
156699717|NCT04126213|565649224|FG004|Overall Study|Withdrawal by Subject|1|||
156699718|NCT04126213|565649225|FG005|Overall Study|Withdrawal by Subject|1|||
156699719|NCT04126213|565649220|FG000|Overall Study|Other|0|||
156699720|NCT04126213|565649221|FG001|Overall Study|Other|0|||
156699721|NCT04126213|565649222|FG002|Overall Study|Other|2|||
156699722|NCT04126213|565649223|FG003|Overall Study|Other|2|||
156699723|NCT04126213|565649224|FG004|Overall Study|Other|0|||
156699724|NCT04126213|565649225|FG005|Overall Study|Other|1|||
156699725|NCT04126213|565649220|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156699726|NCT04126213|565649221|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156699727|NCT04126213|565649222|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156699728|NCT04126213|565649223|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156699729|NCT04126213|565649224|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156699730|NCT04126213|565649225|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156699731|NCT02283983|565649228|FG000|Overall Study|Inclusion criteria not met|0|||
156699732|NCT02283983|565649229|FG001|Overall Study|Inclusion criteria not met|1|||
156699733|NCT02283983|565649228|FG000|Overall Study|Withdrawal by Subject|4|||
156699734|NCT02283983|565649229|FG001|Overall Study|Withdrawal by Subject|2|||
156699735|NCT02283983|565649228|FG000|Overall Study|Protocol Violation|0|||
156331518|NCT03605212|564313470|FG001|Treatment Period|Physician Decision|0|||
156331519|NCT03605212|564313471|FG002|Treatment Period|Physician Decision|0|||
156699736|NCT02283983|565649229|FG001|Overall Study|Protocol Violation|4|||
156699737|NCT02283983|565649228|FG000|Overall Study|Physician Decision|2|||
156699738|NCT02283983|565649229|FG001|Overall Study|Physician Decision|4|||
156699739|NCT02283983|565649228|FG000|Overall Study|Death|1|||
156699740|NCT02283983|565649229|FG001|Overall Study|Death|0|||
156699741|NCT02283983|565649228|FG000|Overall Study|Adverse Event|1|||
156699742|NCT02283983|565649229|FG001|Overall Study|Adverse Event|0|||
156699743|NCT02283983|565649228|FG000|Overall Study|Lost to Follow-up|9|||
156699744|NCT02283983|565649229|FG001|Overall Study|Lost to Follow-up|8|||
156699745|NCT02283983|565649228|FG000|Overall Study|Relapse|1|||
156699746|NCT02283983|565649229|FG001|Overall Study|Relapse|0|||
156699747|NCT00620555|565649231|FG000|Overall Study|Adverse Event|4|||
156699748|NCT00620555|565649231|FG000|Overall Study|Protocol Violation|2|||
156699749|NCT00620555|565649231|FG000|Overall Study|Lack of Efficacy|12|||
156699750|NCT00620555|565649231|FG000|Overall Study|Withdrawal by Subject|1|||
156699751|NCT00620555|565649231|FG000|Overall Study|Choice of other treatment|1|||
156699752|NCT00620555|565649231|FG000|Overall Study|Visit failure against planned|1|||
156699753|NCT00669071|565649233|FG000|Overall Study|Lost to Follow-up|3|||
156699754|NCT00669071|565649233|FG000|Overall Study|Final visit 40 days out of window|1|||
156699755|NCT03734666|565649235|FG000|Overall Study|Other|7|||
156699756|NCT03734666|565649236|FG001|Overall Study|Other|4|||
156699757|NCT03734666|565649235|FG000|Overall Study|Lost to Follow-up|12|||
156699758|NCT03734666|565649236|FG001|Overall Study|Lost to Follow-up|12|||
156331520|NCT03605212|564313472|FG003|Treatment Period|Physician Decision|0|||
156331521|NCT03605212|564313473|FG004|Treatment Period|Physician Decision|1|||
156699759|NCT01910389|565649237|FG000|Overall Study|Withdrawal by Subject|2|||
156699760|NCT01910389|565649238|FG001|Overall Study|Withdrawal by Subject|0|||
156699761|NCT01910389|565649237|FG000|Overall Study|Study Closed|13|||
156699762|NCT01910389|565649238|FG001|Overall Study|Study Closed|8|||
156331522|NCT01254292|564313474|FG000|Comparative Phase|Adverse Event|25|||
156699763|NCT05896202|565649246|FG000|Overall Study|Lost to Follow-up|2|||
156699764|NCT05896202|565649247|FG001|Overall Study|Lost to Follow-up|2|||
156699765|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
156699766|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
156699767|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
156699768|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
156699769|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
156699770|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
156699771|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
156699772|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
156699773|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
156699774|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
156699775|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
156699776|NCT02435836|565649249|FG000|Overall Study|Lost to Follow-up|21|||
156699777|NCT02435836|565649249|FG000|Overall Study|Lack of Efficacy|1|||
156699778|NCT02435836|565649249|FG000|Overall Study|Withdrawal by Subject|236|||
156699779|NCT02435836|565649249|FG000|Overall Study|Insufficient Clinical Response|26|||
156699780|NCT02435836|565649249|FG000|Overall Study|Adverse Event|44|||
156699781|NCT02435836|565649249|FG000|Overall Study|Sponsor discontinued trial|167|||
156699782|NCT02435836|565649249|FG000|Overall Study|Noncompliance|27|||
156699783|NCT02435836|565649249|FG000|Overall Study|Protocol Violation|6|||
156699784|NCT02435836|565649249|FG000|Overall Study|Met Withdrawal Criteria|7|||
156699785|NCT02435836|565649249|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
156699786|NCT03201211|565649252|FG000|Overall Study|Adverse Event|1|||
156699787|NCT03201211|565649253|FG001|Overall Study|Adverse Event|0|||
156699788|NCT03201211|565649254|FG002|Overall Study|Adverse Event|0|||
156699789|NCT03201211|565649252|FG000|Overall Study|Protocol Violation|1|||
156699790|NCT03201211|565649253|FG001|Overall Study|Protocol Violation|0|||
156699791|NCT03201211|565649254|FG002|Overall Study|Protocol Violation|0|||
156699792|NCT03201211|565649252|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156699793|NCT03201211|565649253|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156699794|NCT03201211|565649254|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
156699795|NCT03201211|565649252|FG000|Overall Study|OTHER unknown reasons|0|||
156699796|NCT03201211|565649253|FG001|Overall Study|OTHER unknown reasons|1|||
156699797|NCT03201211|565649254|FG002|Overall Study|OTHER unknown reasons|0|||
156699798|NCT01970865|565649255|FG000|Overall Study|Death|3|||
156699799|NCT01970865|565649256|FG001|Overall Study|Death|2|||
156699800|NCT01970865|565649257|FG002|Overall Study|Death|3|||
156699801|NCT01970865|565649258|FG003|Overall Study|Death|6|||
156699802|NCT01970865|565649259|FG004|Overall Study|Death|9|||
156699803|NCT01970865|565649260|FG005|Overall Study|Death|3|||
156699804|NCT01970865|565649261|FG006|Overall Study|Death|2|||
156699805|NCT01970865|565649262|FG007|Overall Study|Death|3|||
156790757|NCT03654326|565985466|FG000|Overall Study|Unable to adhere to study schedule|0|||
156790758|NCT03654326|565985467|FG001|Overall Study|Unable to adhere to study schedule|1|||
156790759|NCT03654326|565985466|FG000|Overall Study|Lost to Follow-up|1|||
156790760|NCT03654326|565985467|FG001|Overall Study|Lost to Follow-up|1|||
156790761|NCT03473301|565985468|FG000|Overall Study|Protocol Violation|4|||
156790762|NCT03473301|565985469|FG001|Overall Study|Protocol Violation|0|||
156790763|NCT03473301|565985470|FG002|Overall Study|Protocol Violation|0|||
156790764|NCT03473301|565985468|FG000|Overall Study|Withdrawal by Subject|0|||
156790765|NCT03473301|565985469|FG001|Overall Study|Withdrawal by Subject|1|||
156790766|NCT03473301|565985470|FG002|Overall Study|Withdrawal by Subject|0|||
156790767|NCT03473301|565985468|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
156790768|NCT03473301|565985469|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
156790769|NCT03473301|565985470|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
156790770|NCT00835042|565985471|FG000|First Intervention|Withdrawal by Subject|3|||
156790771|NCT00835042|565985472|FG001|First Intervention|Withdrawal by Subject|0|||
156790772|NCT00835042|565985471|FG000|First Intervention|Adverse Event|1|||
156790773|NCT00835042|565985472|FG001|First Intervention|Adverse Event|2|||
156790774|NCT00835042|565985471|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
156790775|NCT00835042|565985472|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
156790776|NCT02662582|565985473|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
156790777|NCT02662582|565985474|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
156790778|NCT02662582|565985473|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
156439026|NCT05061693|564698737|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156439027|NCT05061693|564698738|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156699806|NCT01970865|565649263|FG008|Overall Study|Death|2|||
156699807|NCT01970865|565649264|FG009|Overall Study|Death|2|||
156699808|NCT01970865|565649265|FG010|Overall Study|Death|8|||
156699809|NCT01970865|565649266|FG011|Overall Study|Death|13|||
156790779|NCT02662582|565985474|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
156439028|NCT05061693|564698739|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156439029|NCT05061693|564698740|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156790780|NCT02662582|565985473|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
156790781|NCT02662582|565985474|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
156790782|NCT02662582|565985473|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156699810|NCT01970865|565649267|FG012|Overall Study|Death|25|||
156699811|NCT01970865|565649268|FG013|Overall Study|Death|46|||
156699812|NCT01970865|565649269|FG014|Overall Study|Death|37|||
156699813|NCT01970865|565649270|FG015|Overall Study|Death|22|||
156699814|NCT01970865|565649271|FG016|Overall Study|Death|1|||
156699815|NCT01970865|565649272|FG017|Overall Study|Death|17|||
156872012|NCT00473382|566289490|FG000|Core Study|Death|3|||
156872013|NCT00473382|566289491|FG001|Core Study|Death|5|||
156872014|NCT00473382|566289492|FG002|Core Study|Death|10|||
156331523|NCT01254292|564313475|FG001|Comparative Phase|Adverse Event|25|||
156331524|NCT01254292|564313474|FG000|Comparative Phase|Lost to Follow-up|3|||
156331525|NCT01254292|564313475|FG001|Comparative Phase|Lost to Follow-up|21|||
156331526|NCT01254292|564313474|FG000|Comparative Phase|Pregnancy|2|||
156331527|NCT01254292|564313475|FG001|Comparative Phase|Pregnancy|6|||
156331528|NCT01254292|564313474|FG000|Comparative Phase|Withdrawal by Subject|20|||
156331529|NCT01254292|564313475|FG001|Comparative Phase|Withdrawal by Subject|21|||
156331530|NCT01254292|564313474|FG000|Comparative Phase|Protocol Violation|1|||
156331531|NCT01254292|564313475|FG001|Comparative Phase|Protocol Violation|2|||
156331532|NCT01254292|564313474|FG000|Comparative Phase|Wish for pregnancy|4|||
156331533|NCT01254292|564313475|FG001|Comparative Phase|Wish for pregnancy|6|||
156331534|NCT01254292|564313474|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
156331535|NCT01254292|564313475|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
156331536|NCT01254292|564313474|FG000|LCS12 Extension Phase|Adverse Event|9|||
156331537|NCT01254292|564313475|FG001|LCS12 Extension Phase|Adverse Event|0|||
156331538|NCT01254292|564313474|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
156331539|NCT01254292|564313475|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
156331540|NCT01254292|564313474|FG000|LCS12 Extension Phase|Other unknown|4|||
156331541|NCT01254292|564313475|FG001|LCS12 Extension Phase|Other unknown|0|||
156331542|NCT01254292|564313474|FG000|LCS12 Extension Phase|Pregnancy|2|||
156331543|NCT01254292|564313475|FG001|LCS12 Extension Phase|Pregnancy|0|||
156331544|NCT01254292|564313474|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
156331545|NCT01254292|564313475|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
156331546|NCT01708161|564313484|FG000|Overall Study|Adverse Event|1|||
156331547|NCT01708161|564313485|FG001|Overall Study|Adverse Event|3|||
156331548|NCT01708161|564313486|FG002|Overall Study|Adverse Event|4|||
156331549|NCT01708161|564313487|FG003|Overall Study|Adverse Event|2|||
156331550|NCT01708161|564313488|FG004|Overall Study|Adverse Event|3|||
156331551|NCT01708161|564313489|FG005|Overall Study|Adverse Event|0|||
156331552|NCT01708161|564313484|FG000|Overall Study|Death|0|||
156331553|NCT01708161|564313485|FG001|Overall Study|Death|0|||
156331554|NCT01708161|564313486|FG002|Overall Study|Death|0|||
156331555|NCT01708161|564313487|FG003|Overall Study|Death|1|||
156331556|NCT01708161|564313488|FG004|Overall Study|Death|0|||
156331557|NCT01708161|564313489|FG005|Overall Study|Death|1|||
156331558|NCT01708161|564313484|FG000|Overall Study|Withdrawal by Subject|0|||
156331559|NCT01708161|564313485|FG001|Overall Study|Withdrawal by Subject|1|||
156331560|NCT01708161|564313486|FG002|Overall Study|Withdrawal by Subject|1|||
156331561|NCT01708161|564313487|FG003|Overall Study|Withdrawal by Subject|0|||
156331562|NCT01708161|564313488|FG004|Overall Study|Withdrawal by Subject|0|||
156331563|NCT01708161|564313489|FG005|Overall Study|Withdrawal by Subject|0|||
156331564|NCT01708161|564313484|FG000|Overall Study|Administrative problems|0|||
156331565|NCT01708161|564313485|FG001|Overall Study|Administrative problems|1|||
156331566|NCT01708161|564313486|FG002|Overall Study|Administrative problems|0|||
156331567|NCT01708161|564313487|FG003|Overall Study|Administrative problems|0|||
156331568|NCT01708161|564313488|FG004|Overall Study|Administrative problems|0|||
156331569|NCT01708161|564313489|FG005|Overall Study|Administrative problems|0|||
156331570|NCT01708161|564313484|FG000|Overall Study|Disease progression|3|||
156331571|NCT01708161|564313485|FG001|Overall Study|Disease progression|5|||
156331572|NCT01708161|564313486|FG002|Overall Study|Disease progression|5|||
156331573|NCT01708161|564313487|FG003|Overall Study|Disease progression|13|||
156331574|NCT01708161|564313488|FG004|Overall Study|Disease progression|3|||
156331575|NCT01708161|564313489|FG005|Overall Study|Disease progression|0|||
156331576|NCT01268150|564313490|FG000|Treatment Phase|Progression of disease|18|||
156331577|NCT01268150|564313490|FG000|Treatment Phase|Adverse Event|3|||
156331578|NCT01268150|564313490|FG000|Treatment Phase|Withdrawal by Subject|3|||
156331579|NCT01268150|564313490|FG000|Treatment Phase|Other|4|||
156331580|NCT01268150|564313490|FG000|Extension Phase|Adverse Event|3|||
156331581|NCT01268150|564313490|FG000|Extension Phase|Disease progression|18|||
156331582|NCT01268150|564313490|FG000|Extension Phase|Other|6|||
156331583|NCT01672736|564313491|FG000|Overall Study|Available drug expired on 31 May 16|3|||
156331584|NCT01697358|564313492|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
156331585|NCT01697358|564313493|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
156331586|NCT01697358|564313492|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
156331587|NCT01697358|564313493|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
156331588|NCT01697358|564313492|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
156331589|NCT01697358|564313493|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
156331590|NCT01697358|564313492|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
156331591|NCT01697358|564313493|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
156331592|NCT01697358|564313492|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
156331593|NCT01697358|564313493|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
156331594|NCT01697358|564313492|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
156331595|NCT01697358|564313493|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
156531076|NCT01372410|565039837|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156531077|NCT01372410|565039830|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
156531078|NCT01372410|565039831|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
156699816|NCT01970865|565649255|FG000|Overall Study|Lost to Follow-up|0|||
156699817|NCT01970865|565649256|FG001|Overall Study|Lost to Follow-up|0|||
156699818|NCT01970865|565649257|FG002|Overall Study|Lost to Follow-up|0|||
156699819|NCT01970865|565649258|FG003|Overall Study|Lost to Follow-up|1|||
156699820|NCT01970865|565649259|FG004|Overall Study|Lost to Follow-up|1|||
156699821|NCT01970865|565649260|FG005|Overall Study|Lost to Follow-up|0|||
156699822|NCT01970865|565649261|FG006|Overall Study|Lost to Follow-up|0|||
156699823|NCT01970865|565649262|FG007|Overall Study|Lost to Follow-up|0|||
156699824|NCT01970865|565649263|FG008|Overall Study|Lost to Follow-up|0|||
156699825|NCT01970865|565649264|FG009|Overall Study|Lost to Follow-up|0|||
156699826|NCT01970865|565649265|FG010|Overall Study|Lost to Follow-up|1|||
156699827|NCT01970865|565649266|FG011|Overall Study|Lost to Follow-up|0|||
156699828|NCT01970865|565649267|FG012|Overall Study|Lost to Follow-up|2|||
156699829|NCT01970865|565649268|FG013|Overall Study|Lost to Follow-up|0|||
156699830|NCT01970865|565649269|FG014|Overall Study|Lost to Follow-up|1|||
156699831|NCT01970865|565649270|FG015|Overall Study|Lost to Follow-up|4|||
156699832|NCT01970865|565649271|FG016|Overall Study|Lost to Follow-up|0|||
156699833|NCT01970865|565649272|FG017|Overall Study|Lost to Follow-up|1|||
156699834|NCT01970865|565649255|FG000|Overall Study|Other|0|||
156699835|NCT01970865|565649256|FG001|Overall Study|Other|1|||
156699836|NCT01970865|565649257|FG002|Overall Study|Other|0|||
156699837|NCT01970865|565649258|FG003|Overall Study|Other|1|||
156699838|NCT01970865|565649259|FG004|Overall Study|Other|1|||
156699839|NCT01970865|565649260|FG005|Overall Study|Other|0|||
156699840|NCT01970865|565649261|FG006|Overall Study|Other|1|||
156699841|NCT01970865|565649262|FG007|Overall Study|Other|0|||
156699842|NCT01970865|565649263|FG008|Overall Study|Other|0|||
156699843|NCT01970865|565649264|FG009|Overall Study|Other|0|||
156699844|NCT01970865|565649265|FG010|Overall Study|Other|2|||
156699845|NCT01970865|565649266|FG011|Overall Study|Other|3|||
156699846|NCT01970865|565649267|FG012|Overall Study|Other|8|||
156699847|NCT01970865|565649268|FG013|Overall Study|Other|3|||
156699848|NCT01970865|565649269|FG014|Overall Study|Other|2|||
156699849|NCT01970865|565649270|FG015|Overall Study|Other|3|||
156699850|NCT01970865|565649271|FG016|Overall Study|Other|0|||
156699851|NCT01970865|565649272|FG017|Overall Study|Other|2|||
156699852|NCT01970865|565649255|FG000|Overall Study|Participant refused further follow-up|0|||
156699853|NCT01970865|565649256|FG001|Overall Study|Participant refused further follow-up|0|||
156699854|NCT01970865|565649257|FG002|Overall Study|Participant refused further follow-up|0|||
156331596|NCT01697358|564313492|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
156331597|NCT01697358|564313493|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
156531079|NCT01372410|565039832|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
156531080|NCT01372410|565039833|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
156531081|NCT01372410|565039834|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
156699855|NCT01970865|565649258|FG003|Overall Study|Participant refused further follow-up|2|||
156699856|NCT01970865|565649259|FG004|Overall Study|Participant refused further follow-up|3|||
156699857|NCT01970865|565649260|FG005|Overall Study|Participant refused further follow-up|0|||
156699858|NCT01970865|565649261|FG006|Overall Study|Participant refused further follow-up|0|||
156699859|NCT01970865|565649262|FG007|Overall Study|Participant refused further follow-up|0|||
156699860|NCT01970865|565649263|FG008|Overall Study|Participant refused further follow-up|0|||
156699861|NCT01970865|565649264|FG009|Overall Study|Participant refused further follow-up|0|||
156699862|NCT01970865|565649265|FG010|Overall Study|Participant refused further follow-up|1|||
156699863|NCT01970865|565649266|FG011|Overall Study|Participant refused further follow-up|4|||
156699864|NCT01970865|565649267|FG012|Overall Study|Participant refused further follow-up|7|||
156699865|NCT01970865|565649268|FG013|Overall Study|Participant refused further follow-up|8|||
156699866|NCT01970865|565649269|FG014|Overall Study|Participant refused further follow-up|3|||
156699867|NCT01970865|565649270|FG015|Overall Study|Participant refused further follow-up|11|||
156699868|NCT01970865|565649271|FG016|Overall Study|Participant refused further follow-up|0|||
156331598|NCT01697358|564313492|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
156331599|NCT01697358|564313493|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
156331600|NCT01697358|564313492|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
156331601|NCT01697358|564313493|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
156331602|NCT01697358|564313492|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
156331603|NCT01697358|564313493|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
156331604|NCT04251273|564313494|FG000|Overall Study|Lost to Follow-up|331|||
156331605|NCT04251273|564313495|FG001|Overall Study|Lost to Follow-up|290|||
156331606|NCT00810693|564313496|FG000|Treatment Period|Adverse Event|8|||
156331607|NCT00810693|564313497|FG001|Treatment Period|Adverse Event|1|||
156331608|NCT00810693|564313498|FG002|Treatment Period|Adverse Event|7|||
156699869|NCT01970865|565649272|FG017|Overall Study|Participant refused further follow-up|6|||
156699870|NCT01946191|565649273|FG000|Allocation|Did not complete orientation|1|||
156699871|NCT01946191|565649274|FG001|Allocation|Did not complete orientation|1|||
156699872|NCT01946191|565649273|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
156699873|NCT01946191|565649274|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
156699874|NCT01946191|565649273|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
156699875|NCT01946191|565649274|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
156699876|NCT01946191|565649273|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
156699877|NCT01946191|565649274|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
156699878|NCT02041091|565649275|FG000|Treatment|Adverse Event|3|||
156699879|NCT02041091|565649276|FG001|Treatment|Adverse Event|3|||
156699880|NCT02041091|565649275|FG000|Treatment|Withdrawal by Subject|2|||
156699881|NCT02041091|565649276|FG001|Treatment|Withdrawal by Subject|4|||
156699882|NCT02041091|565649275|FG000|Treatment|Physician Decision|1|||
156699883|NCT02041091|565649276|FG001|Treatment|Physician Decision|0|||
156699884|NCT02041091|565649275|FG000|Treatment|Sponsor Decision|15|||
156699885|NCT02041091|565649276|FG001|Treatment|Sponsor Decision|16|||
156699886|NCT02041091|565649275|FG000|Treatment|Lost to Follow-up|1|||
156699887|NCT02041091|565649276|FG001|Treatment|Lost to Follow-up|0|||
156699888|NCT02041091|565649275|FG000|Optional Safety Extension Period|Adverse Event|4|||
156699889|NCT02041091|565649276|FG001|Optional Safety Extension Period|Adverse Event|2|||
156699890|NCT02041091|565649275|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
156699891|NCT02041091|565649276|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
156699892|NCT02041091|565649275|FG000|Optional Safety Extension Period|Protocol Violation|2|||
156699893|NCT02041091|565649276|FG001|Optional Safety Extension Period|Protocol Violation|0|||
156699894|NCT02041091|565649275|FG000|Optional Safety Extension Period|Physician Decision|2|||
156699895|NCT02041091|565649276|FG001|Optional Safety Extension Period|Physician Decision|1|||
156699896|NCT02041091|565649275|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
156699897|NCT02041091|565649276|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
156699898|NCT02041091|565649275|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
156699899|NCT02041091|565649276|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
156699900|NCT01855074|565649278|FG000|Overall Study|Adverse Event|1|||
156699901|NCT01855074|565649278|FG000|Overall Study|Lost to Follow-up|4|||
156699902|NCT01855074|565649278|FG000|Overall Study|Withdrawal by Subject|8|||
156699903|NCT01855074|565649278|FG000|Overall Study|Started but not treated|1|||
156699904|NCT03118570|565649279|FG000|Overall Study|Adverse Event|2|||
156699905|NCT03118570|565649280|FG001|Overall Study|Adverse Event|0|||
156699906|NCT03118570|565649281|FG002|Overall Study|Adverse Event|0|||
156699907|NCT03118570|565649282|FG003|Overall Study|Adverse Event|0|||
156699908|NCT03118570|565649283|FG004|Overall Study|Adverse Event|3|||
156699909|NCT03118570|565649279|FG000|Overall Study|Withdrawal by Subject|0|||
156699910|NCT03118570|565649280|FG001|Overall Study|Withdrawal by Subject|1|||
156699911|NCT03118570|565649281|FG002|Overall Study|Withdrawal by Subject|4|||
156699912|NCT03118570|565649282|FG003|Overall Study|Withdrawal by Subject|0|||
156699913|NCT03118570|565649283|FG004|Overall Study|Withdrawal by Subject|1|||
156699914|NCT03118570|565649279|FG000|Overall Study|Lost to Follow-up|2|||
156699915|NCT03118570|565649280|FG001|Overall Study|Lost to Follow-up|3|||
156699916|NCT03118570|565649281|FG002|Overall Study|Lost to Follow-up|1|||
156699917|NCT03118570|565649282|FG003|Overall Study|Lost to Follow-up|0|||
156699918|NCT03118570|565649283|FG004|Overall Study|Lost to Follow-up|1|||
156699919|NCT03118570|565649279|FG000|Overall Study|Other, Not Specified|1|||
156699920|NCT03118570|565649280|FG001|Overall Study|Other, Not Specified|3|||
156439030|NCT05061693|564698741|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156699921|NCT03118570|565649281|FG002|Overall Study|Other, Not Specified|0|||
156699922|NCT03118570|565649282|FG003|Overall Study|Other, Not Specified|0|||
156699923|NCT03118570|565649283|FG004|Overall Study|Other, Not Specified|0|||
156699924|NCT03970837|565649284|FG000|Overall Study|Adverse Event|23|||
156699925|NCT03970837|565649285|FG001|Overall Study|Adverse Event|20|||
156699926|NCT03970837|565649286|FG002|Overall Study|Adverse Event|16|||
156699927|NCT03970837|565649287|FG003|Overall Study|Adverse Event|6|||
156699928|NCT03970837|565649288|FG004|Overall Study|Adverse Event|4|||
156699929|NCT03970837|565649289|FG005|Overall Study|Adverse Event|5|||
156699930|NCT03970837|565649290|FG006|Overall Study|Adverse Event|1|||
156699931|NCT03970837|565649291|FG007|Overall Study|Adverse Event|5|||
156699932|NCT03970837|565649292|FG008|Overall Study|Adverse Event|0|||
156699933|NCT03970837|565649293|FG009|Overall Study|Adverse Event|0|||
156699934|NCT03970837|565649294|FG010|Overall Study|Adverse Event|1|||
156699935|NCT03970837|565649295|FG011|Overall Study|Adverse Event|1|||
156699936|NCT03970837|565649284|FG000|Overall Study|Lack of Efficacy|14|||
156699937|NCT03970837|565649285|FG001|Overall Study|Lack of Efficacy|12|||
156699938|NCT03970837|565649286|FG002|Overall Study|Lack of Efficacy|1|||
156699939|NCT03970837|565649287|FG003|Overall Study|Lack of Efficacy|2|||
156699940|NCT03970837|565649288|FG004|Overall Study|Lack of Efficacy|3|||
156699941|NCT03970837|565649289|FG005|Overall Study|Lack of Efficacy|4|||
156699942|NCT03970837|565649290|FG006|Overall Study|Lack of Efficacy|6|||
156699943|NCT03970837|565649291|FG007|Overall Study|Lack of Efficacy|1|||
156439031|NCT05061693|564698742|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156699944|NCT03970837|565649292|FG008|Overall Study|Lack of Efficacy|1|||
156699945|NCT03970837|565649293|FG009|Overall Study|Lack of Efficacy|0|||
156699946|NCT03970837|565649294|FG010|Overall Study|Lack of Efficacy|0|||
156699947|NCT03970837|565649295|FG011|Overall Study|Lack of Efficacy|0|||
156699948|NCT03970837|565649284|FG000|Overall Study|Lost to Follow-up|6|||
156699949|NCT03970837|565649285|FG001|Overall Study|Lost to Follow-up|5|||
156699950|NCT03970837|565649286|FG002|Overall Study|Lost to Follow-up|5|||
156699951|NCT03970837|565649287|FG003|Overall Study|Lost to Follow-up|1|||
156699952|NCT03970837|565649288|FG004|Overall Study|Lost to Follow-up|0|||
156699953|NCT03970837|565649289|FG005|Overall Study|Lost to Follow-up|2|||
156699954|NCT03970837|565649290|FG006|Overall Study|Lost to Follow-up|0|||
156699955|NCT03970837|565649291|FG007|Overall Study|Lost to Follow-up|0|||
156699956|NCT03970837|565649292|FG008|Overall Study|Lost to Follow-up|0|||
156699957|NCT03970837|565649293|FG009|Overall Study|Lost to Follow-up|0|||
156699958|NCT03970837|565649294|FG010|Overall Study|Lost to Follow-up|0|||
156699959|NCT03970837|565649295|FG011|Overall Study|Lost to Follow-up|0|||
156699960|NCT03970837|565649284|FG000|Overall Study|Protocol Violation|1|||
156699961|NCT03970837|565649285|FG001|Overall Study|Protocol Violation|0|||
156439032|NCT05061693|564698743|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156439033|NCT05061693|564698744|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156439034|NCT05061693|564698745|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
156439035|NCT05061693|564698734|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156439036|NCT05061693|564698735|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156699962|NCT03970837|565649286|FG002|Overall Study|Protocol Violation|0|||
156699963|NCT03970837|565649287|FG003|Overall Study|Protocol Violation|0|||
156699964|NCT03970837|565649288|FG004|Overall Study|Protocol Violation|0|||
156699965|NCT03970837|565649289|FG005|Overall Study|Protocol Violation|0|||
156699966|NCT03970837|565649290|FG006|Overall Study|Protocol Violation|0|||
156699967|NCT03970837|565649291|FG007|Overall Study|Protocol Violation|0|||
156699968|NCT03970837|565649292|FG008|Overall Study|Protocol Violation|0|||
156699969|NCT03970837|565649293|FG009|Overall Study|Protocol Violation|0|||
156699970|NCT03970837|565649294|FG010|Overall Study|Protocol Violation|0|||
156699971|NCT03970837|565649295|FG011|Overall Study|Protocol Violation|0|||
156699972|NCT03970837|565649284|FG000|Overall Study|Physician Decision|5|||
156699973|NCT03970837|565649285|FG001|Overall Study|Physician Decision|8|||
156699974|NCT03970837|565649286|FG002|Overall Study|Physician Decision|4|||
156699975|NCT03970837|565649287|FG003|Overall Study|Physician Decision|1|||
156699976|NCT03970837|565649288|FG004|Overall Study|Physician Decision|5|||
156699977|NCT03970837|565649289|FG005|Overall Study|Physician Decision|2|||
156699978|NCT03970837|565649290|FG006|Overall Study|Physician Decision|4|||
156699979|NCT03970837|565649291|FG007|Overall Study|Physician Decision|5|||
156699980|NCT03970837|565649292|FG008|Overall Study|Physician Decision|0|||
156699981|NCT03970837|565649293|FG009|Overall Study|Physician Decision|1|||
156699982|NCT03970837|565649294|FG010|Overall Study|Physician Decision|0|||
156699983|NCT03970837|565649295|FG011|Overall Study|Physician Decision|0|||
156699984|NCT03970837|565649284|FG000|Overall Study|Withdrawal by Subject|32|||
156699985|NCT03970837|565649285|FG001|Overall Study|Withdrawal by Subject|35|||
156699986|NCT03970837|565649286|FG002|Overall Study|Withdrawal by Subject|12|||
156699987|NCT03970837|565649287|FG003|Overall Study|Withdrawal by Subject|8|||
156699988|NCT03970837|565649288|FG004|Overall Study|Withdrawal by Subject|6|||
156699989|NCT03970837|565649289|FG005|Overall Study|Withdrawal by Subject|8|||
156699990|NCT03970837|565649290|FG006|Overall Study|Withdrawal by Subject|2|||
156699991|NCT03970837|565649291|FG007|Overall Study|Withdrawal by Subject|3|||
156699992|NCT03970837|565649292|FG008|Overall Study|Withdrawal by Subject|0|||
156699993|NCT03970837|565649293|FG009|Overall Study|Withdrawal by Subject|0|||
156790783|NCT02662582|565985474|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156790784|NCT04008069|565985475|FG000|Open-Label Period|Adverse Event|1|||
156790785|NCT04008069|565985476|FG001|Open-Label Period|Adverse Event|0|||
156790786|NCT04008069|565985477|FG002|Open-Label Period|Adverse Event|0|||
156790787|NCT04008069|565985475|FG000|Open-Label Period|Lack of Efficacy|4|||
156790788|NCT04008069|565985476|FG001|Open-Label Period|Lack of Efficacy|0|||
156790789|NCT04008069|565985477|FG002|Open-Label Period|Lack of Efficacy|0|||
156790790|NCT04008069|565985475|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
156439037|NCT05061693|564698736|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
156439038|NCT05061693|564698737|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156699994|NCT03970837|565649294|FG010|Overall Study|Withdrawal by Subject|0|||
156699995|NCT03970837|565649295|FG011|Overall Study|Withdrawal by Subject|1|||
156699996|NCT03970837|565649284|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
156699997|NCT03970837|565649285|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
156699998|NCT03970837|565649286|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
156699999|NCT03970837|565649287|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156700000|NCT03970837|565649288|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
156700001|NCT03970837|565649289|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156700002|NCT03970837|565649290|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156700003|NCT03970837|565649291|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156790791|NCT04008069|565985476|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
156790792|NCT04008069|565985477|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
156790793|NCT04008069|565985475|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
156700004|NCT03970837|565649292|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156700005|NCT03970837|565649293|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156700006|NCT03970837|565649294|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156700007|NCT03970837|565649295|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156700008|NCT03970837|565649284|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700009|NCT03970837|565649285|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700010|NCT03970837|565649286|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700011|NCT03970837|565649287|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700012|NCT03970837|565649288|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700013|NCT03970837|565649289|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700014|NCT03970837|565649290|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
156700015|NCT03970837|565649291|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
156700016|NCT03970837|565649292|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
156700017|NCT03970837|565649293|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
156700018|NCT03970837|565649294|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
156700019|NCT03970837|565649295|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
156531082|NCT01372410|565039835|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
156531083|NCT01372410|565039836|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
156531084|NCT01372410|565039837|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
156700020|NCT02582866|565649303|FG000|Overall Study|Death|1|||
156700021|NCT02582866|565649303|FG000|Overall Study|Lack of Efficacy|2|||
156700022|NCT02582866|565649303|FG000|Overall Study|Lost to Follow-up|2|||
156700023|NCT02582866|565649303|FG000|Overall Study|Withdrawal by Subject|7|||
156700024|NCT02582866|565649303|FG000|Overall Study|Investigator decision|5|||
156700025|NCT02582866|565649303|FG000|Overall Study|Participant wants to get pregnant|1|||
156700026|NCT02582866|565649303|FG000|Overall Study|Pregnancy|2|||
156700027|NCT02582866|565649303|FG000|Overall Study|Sponsor decision|1|||
156700028|NCT02582866|565649303|FG000|Overall Study|Withdrawal due to personal reasons|1|||
156700029|NCT01193127|565649312|FG000|Randomized|Surgery Cancelled|0|||
156700030|NCT01193127|565649313|FG001|Randomized|Surgery Cancelled|0|||
156700031|NCT01193127|565649314|FG002|Randomized|Surgery Cancelled|0|||
156700032|NCT01193127|565649315|FG003|Randomized|Surgery Cancelled|1|||
156700033|NCT01193127|565649312|FG000|Treated|Withdrawal by Subject|0|||
156700034|NCT01193127|565649313|FG001|Treated|Withdrawal by Subject|0|||
156700035|NCT01193127|565649314|FG002|Treated|Withdrawal by Subject|0|||
156700036|NCT01193127|565649315|FG003|Treated|Withdrawal by Subject|1|||
156700037|NCT00321737|565649325|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
156700038|NCT00321737|565649326|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
156700039|NCT00321737|565649327|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
156700040|NCT00321737|565649325|FG000|Overall Study|Adverse Event|11|||
156700041|NCT00321737|565649326|FG001|Overall Study|Adverse Event|3|||
156700042|NCT00321737|565649327|FG002|Overall Study|Adverse Event|6|||
156700043|NCT00321737|565649325|FG000|Overall Study|Lost to Follow-up|5|||
156700044|NCT00321737|565649326|FG001|Overall Study|Lost to Follow-up|5|||
156700045|NCT00321737|565649327|FG002|Overall Study|Lost to Follow-up|6|||
156700046|NCT00321737|565649325|FG000|Overall Study|Withdrawal by Subject|19|||
156790794|NCT04008069|565985476|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
156790795|NCT04008069|565985477|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
156790796|NCT00511199|565985478|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
156790797|NCT00511199|565985479|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
156790798|NCT00511199|565985478|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
156790799|NCT00511199|565985479|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
156790800|NCT00511199|565985478|FG000|Overall Study|Withdrawal of Informed Consent|19|||
156790801|NCT00511199|565985479|FG001|Overall Study|Withdrawal of Informed Consent|4|||
156790802|NCT00511199|565985478|FG000|Overall Study|Pregnancy|6|||
156790803|NCT00511199|565985479|FG001|Overall Study|Pregnancy|3|||
156790804|NCT00511199|565985478|FG000|Overall Study|Pregnancy Wish|16|||
156790805|NCT00511199|565985479|FG001|Overall Study|Pregnancy Wish|8|||
156790806|NCT00511199|565985478|FG000|Overall Study|Lost to Follow-up|40|||
156790807|NCT00511199|565985479|FG001|Overall Study|Lost to Follow-up|17|||
156790808|NCT00511199|565985478|FG000|Overall Study|Other Reason|78|||
156790809|NCT00511199|565985479|FG001|Overall Study|Other Reason|37|||
156790810|NCT02314247|565985487|FG000|Overall Study|Adverse Event|2|||
156790811|NCT02314247|565985488|FG001|Overall Study|Adverse Event|1|||
156790812|NCT02314247|565985489|FG002|Overall Study|Adverse Event|0|||
156790813|NCT02314247|565985487|FG000|Overall Study|Withdrawal by Subject|1|||
156790814|NCT02314247|565985488|FG001|Overall Study|Withdrawal by Subject|3|||
156790815|NCT02314247|565985489|FG002|Overall Study|Withdrawal by Subject|1|||
156790816|NCT02314247|565985487|FG000|Overall Study|Progression of Disease|6|||
156700047|NCT00321737|565649326|FG001|Overall Study|Withdrawal by Subject|12|||
156790817|NCT02314247|565985488|FG001|Overall Study|Progression of Disease|2|||
156790818|NCT02314247|565985489|FG002|Overall Study|Progression of Disease|0|||
156790819|NCT01953354|565985490|FG000|Overall Study|Withdrawal by Subject|0|||
156700048|NCT00321737|565649327|FG002|Overall Study|Withdrawal by Subject|17|||
156700049|NCT00321737|565649325|FG000|Overall Study|Protocol Violation|0|||
156700050|NCT00321737|565649326|FG001|Overall Study|Protocol Violation|0|||
156439039|NCT05061693|564698738|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156439040|NCT05061693|564698739|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156439041|NCT05061693|564698740|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156439042|NCT05061693|564698741|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156872015|NCT00473382|566289490|FG000|Core Study|Lost to Follow-up|3|||
156872016|NCT00473382|566289491|FG001|Core Study|Lost to Follow-up|3|||
156872017|NCT00473382|566289492|FG002|Core Study|Lost to Follow-up|3|||
156872018|NCT00473382|566289490|FG000|Core Study|Physician Decision|1|||
156872019|NCT00473382|566289491|FG001|Core Study|Physician Decision|2|||
156872020|NCT00473382|566289492|FG002|Core Study|Physician Decision|2|||
156872021|NCT00473382|566289490|FG000|Core Study|Subject non-compliance|5|||
156872022|NCT00473382|566289491|FG001|Core Study|Subject non-compliance|2|||
156872023|NCT00473382|566289492|FG002|Core Study|Subject non-compliance|1|||
156439043|NCT05061693|564698742|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156439044|NCT05061693|564698743|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156872024|NCT00473382|566289490|FG000|Core Study|Subject needed other treatment|1|||
156872025|NCT00473382|566289491|FG001|Core Study|Subject needed other treatment|3|||
156872026|NCT00473382|566289492|FG002|Core Study|Subject needed other treatment|2|||
156872027|NCT00473382|566289490|FG000|Core Study|Subject's decision|12|||
156872028|NCT00473382|566289491|FG001|Core Study|Subject's decision|11|||
156872029|NCT00473382|566289492|FG002|Core Study|Subject's decision|10|||
156872030|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
156872031|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
156872032|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
156872033|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Death|1|||
156872034|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Death|3|||
156439045|NCT05061693|564698744|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156439046|NCT05061693|564698745|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
156439047|NCT05061693|564698734|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
156439048|NCT05061693|564698735|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
156790820|NCT01953354|565985491|FG001|Overall Study|Withdrawal by Subject|1|||
156790821|NCT01953354|565985490|FG000|Overall Study|Decision of Sponsor|0|||
156790822|NCT01953354|565985491|FG001|Overall Study|Decision of Sponsor|1|||
156790823|NCT01953354|565985490|FG000|Overall Study|Disease Exacerbation|1|||
156790824|NCT01953354|565985491|FG001|Overall Study|Disease Exacerbation|0|||
156790825|NCT00489359|565985492|FG000|Overall Study|Death|0|||
156790826|NCT00489359|565985493|FG001|Overall Study|Death|2|||
156790827|NCT00489359|565985492|FG000|Overall Study|Progressive Disease|5|||
156790828|NCT00489359|565985493|FG001|Overall Study|Progressive Disease|6|||
156790829|NCT00489359|565985492|FG000|Overall Study|Lost to Follow-up|1|||
156790830|NCT00489359|565985493|FG001|Overall Study|Lost to Follow-up|0|||
156790831|NCT00489359|565985492|FG000|Overall Study|Withdrawal by Subject|1|||
156790832|NCT00489359|565985493|FG001|Overall Study|Withdrawal by Subject|5|||
156790833|NCT00489359|565985492|FG000|Overall Study|Adverse Event|0|||
156790834|NCT00489359|565985493|FG001|Overall Study|Adverse Event|16|||
156790835|NCT03180138|565985494|FG000|Overall Study|Mobile-phone could not be verified|2|||
156790836|NCT03180138|565985495|FG001|Overall Study|Mobile-phone could not be verified|13|||
156790837|NCT03180138|565985496|FG002|Overall Study|Mobile-phone could not be verified|15|||
156790838|NCT03180138|565985494|FG000|Overall Study|No prior immunization records|17|||
156790839|NCT03180138|565985495|FG001|Overall Study|No prior immunization records|0|||
156790840|NCT03180138|565985496|FG002|Overall Study|No prior immunization records|6|||
156790841|NCT03180138|565985494|FG000|Overall Study|Found to be >24 mon after randomization|3|||
156790842|NCT03180138|565985495|FG001|Overall Study|Found to be >24 mon after randomization|0|||
156790843|NCT03180138|565985496|FG002|Overall Study|Found to be >24 mon after randomization|3|||
156790844|NCT01260311|565985499|FG000|Overall Study|Adverse Event|11|||
156790845|NCT01260311|565985499|FG000|Overall Study|Lack of Efficacy|4|||
156790846|NCT01260311|565985499|FG000|Overall Study|Lost to Follow-up|25|||
156790847|NCT01260311|565985499|FG000|Overall Study|Withdrawal by Subject|6|||
156790848|NCT01260311|565985499|FG000|Overall Study|Financial Constraints|77|||
156790849|NCT01260311|565985499|FG000|Overall Study|Gone to Province|2|||
156790850|NCT01260311|565985499|FG000|Overall Study|Medication Stopped|1|||
156790851|NCT01260311|565985499|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
156790852|NCT01903733|565985500|FG000|Overall Study|Death|23|||
156790853|NCT01903733|565985501|FG001|Overall Study|Death|54|||
156439049|NCT05061693|564698736|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
156439050|NCT05061693|564698737|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
156790854|NCT01903733|565985502|FG002|Overall Study|Death|30|||
156790855|NCT01903733|565985503|FG003|Overall Study|Death|98|||
156790856|NCT01903733|565985500|FG000|Overall Study|Participant refused further follow-up|35|||
156790857|NCT01903733|565985501|FG001|Overall Study|Participant refused further follow-up|38|||
156790858|NCT01903733|565985502|FG002|Overall Study|Participant refused further follow-up|13|||
156790859|NCT01903733|565985503|FG003|Overall Study|Participant refused further follow-up|9|||
156872035|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Death|3|||
156872036|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
156872037|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
156872038|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
156872039|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
156872040|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
156872041|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
156872042|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
156872043|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
156872044|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
156872045|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
156872046|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
156872047|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
156872048|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
156872049|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
156872050|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
156872051|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Death|1|||
156872052|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Death|7|||
156872053|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Death|4|||
156872054|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
156872055|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
156872056|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
156872057|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
156872058|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
156872059|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
156872060|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
156872061|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
156872062|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
156872063|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
156872064|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
156872065|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
156872066|NCT03565497|566289493|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
156872067|NCT03565497|566289494|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
156872068|NCT03565497|566289495|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
156872069|NCT03565497|566289493|FG000|Overall Study|Lost to Follow-up|1|||
156872070|NCT03565497|566289494|FG001|Overall Study|Lost to Follow-up|1|||
156872071|NCT03565497|566289495|FG002|Overall Study|Lost to Follow-up|2|||
156872072|NCT03565497|566289493|FG000|Overall Study|Withdrawal by Subject|1|||
156872073|NCT03565497|566289494|FG001|Overall Study|Withdrawal by Subject|1|||
156872074|NCT03565497|566289495|FG002|Overall Study|Withdrawal by Subject|1|||
156872075|NCT02999672|566289496|FG000|Overall Study|Death|0|||
156872076|NCT02999672|566289497|FG001|Overall Study|Death|1|||
156872077|NCT02999672|566289496|FG000|Overall Study|Study Terminated by Sponsor|0|||
156872078|NCT02999672|566289497|FG001|Overall Study|Study Terminated by Sponsor|1|||
156872079|NCT02999672|566289496|FG000|Overall Study|Progressive Disease|9|||
156872080|NCT02999672|566289497|FG001|Overall Study|Progressive Disease|5|||
156872081|NCT02999672|566289496|FG000|Overall Study|Adverse Event|4|||
156872082|NCT02999672|566289497|FG001|Overall Study|Adverse Event|0|||
156872083|NCT01470326|566289498|FG000|Overall Study|Protocol Violation|32|||
156872084|NCT01470326|566289498|FG000|Overall Study|No Drug Administration Information|2|||
156872085|NCT01470326|566289498|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
156872086|NCT01166282|566289499|FG000|Open-label Period|Adverse Event|0|||
156872087|NCT01166282|566289500|FG001|Open-label Period|Adverse Event|0|||
156872088|NCT01166282|566289501|FG002|Open-label Period|Adverse Event|6|||
156872089|NCT01166282|566289499|FG000|Open-label Period|Withdrawal by Subject|0|||
156872090|NCT01166282|566289500|FG001|Open-label Period|Withdrawal by Subject|0|||
156872091|NCT01166282|566289501|FG002|Open-label Period|Withdrawal by Subject|4|||
156872092|NCT01166282|566289499|FG000|Open-label Period|Lack of Efficacy|0|||
156872093|NCT01166282|566289500|FG001|Open-label Period|Lack of Efficacy|0|||
156872094|NCT01166282|566289501|FG002|Open-label Period|Lack of Efficacy|2|||
156872095|NCT01166282|566289499|FG000|Open-label Period|Remission|0|||
156872096|NCT01166282|566289500|FG001|Open-label Period|Remission|0|||
156331609|NCT00810693|564313496|FG000|Treatment Period|Death|0|||
156331610|NCT00810693|564313497|FG001|Treatment Period|Death|1|||
156331611|NCT00810693|564313498|FG002|Treatment Period|Death|2|||
156331612|NCT00810693|564313496|FG000|Treatment Period|Lack of Efficacy|0|||
156331613|NCT00810693|564313497|FG001|Treatment Period|Lack of Efficacy|0|||
156331614|NCT00810693|564313498|FG002|Treatment Period|Lack of Efficacy|1|||
156331615|NCT00810693|564313496|FG000|Treatment Period|Lost to Follow-up|1|||
156331616|NCT00810693|564313497|FG001|Treatment Period|Lost to Follow-up|0|||
156331617|NCT00810693|564313498|FG002|Treatment Period|Lost to Follow-up|0|||
156331618|NCT00810693|564313496|FG000|Treatment Period|Non-compliance|1|||
156700051|NCT00321737|565649327|FG002|Overall Study|Protocol Violation|1|||
156700052|NCT00321737|565649325|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
156700053|NCT00321737|565649326|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
156700054|NCT00321737|565649327|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
156700055|NCT00321737|565649325|FG000|Overall Study|Possible Barrett's Esophagus|2|||
156700056|NCT00321737|565649326|FG001|Overall Study|Possible Barrett's Esophagus|1|||
156331619|NCT00810693|564313497|FG001|Treatment Period|Non-compliance|0|||
156331620|NCT00810693|564313498|FG002|Treatment Period|Non-compliance|0|||
156700057|NCT00321737|565649327|FG002|Overall Study|Possible Barrett's Esophagus|1|||
156700058|NCT00321737|565649325|FG000|Overall Study|Therapeutic Failure|6|||
156700059|NCT00321737|565649326|FG001|Overall Study|Therapeutic Failure|0|||
156700060|NCT00321737|565649327|FG002|Overall Study|Therapeutic Failure|2|||
156700061|NCT00321737|565649325|FG000|Overall Study|Pregnancy|0|||
156700062|NCT00321737|565649326|FG001|Overall Study|Pregnancy|2|||
156700063|NCT00321737|565649327|FG002|Overall Study|Pregnancy|0|||
156700064|NCT00321737|565649325|FG000|Overall Study|Noncompliance|2|||
156700065|NCT00321737|565649326|FG001|Overall Study|Noncompliance|0|||
156700066|NCT00321737|565649327|FG002|Overall Study|Noncompliance|0|||
156700067|NCT00321737|565649325|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
156700068|NCT00321737|565649326|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
156700069|NCT00321737|565649327|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
156700070|NCT02283294|565649328|FG000|Overall Study|Lost to Follow-up|1|||
156700071|NCT02283294|565649329|FG001|Overall Study|Lost to Follow-up|1|||
156700072|NCT02283294|565649328|FG000|Overall Study|Withdrawal by Subject|1|||
156700073|NCT02283294|565649329|FG001|Overall Study|Withdrawal by Subject|6|||
156700074|NCT02283294|565649328|FG000|Overall Study|Protocol Violation|1|||
156700075|NCT02283294|565649329|FG001|Overall Study|Protocol Violation|0|||
156700076|NCT02283294|565649328|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
156700077|NCT02283294|565649329|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
156700078|NCT00594646|565649330|FG000|Overall Study|Withdrawal by Subject|1|||
156700079|NCT00594646|565649330|FG000|Overall Study|Lost to Follow-up|15|||
156700080|NCT00006721|565651338|FG000|Overall Study|Adverse Event|0|||
156700081|NCT00006721|565651339|FG001|Overall Study|Adverse Event|4|||
156700082|NCT00006721|565651340|FG002|Overall Study|Adverse Event|4|||
156700083|NCT00006721|565651338|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156700084|NCT00006721|565651339|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
156700085|NCT00006721|565651340|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
156700086|NCT00006721|565651338|FG000|Overall Study|Progression/Relapse|0|||
156700087|NCT00006721|565651339|FG001|Overall Study|Progression/Relapse|1|||
156700088|NCT00006721|565651340|FG002|Overall Study|Progression/Relapse|2|||
156700089|NCT00006721|565651338|FG000|Overall Study|Death|0|||
156700090|NCT00006721|565651339|FG001|Overall Study|Death|1|||
156700091|NCT00006721|565651340|FG002|Overall Study|Death|2|||
156700092|NCT00006721|565651338|FG000|Overall Study|Other - Not Protocol Specified|0|||
156700093|NCT00006721|565651339|FG001|Overall Study|Other - Not Protocol Specified|7|||
156700094|NCT00006721|565651340|FG002|Overall Study|Other - Not Protocol Specified|7|||
156700095|NCT00006721|565651338|FG000|Overall Study|Ineligible|2|||
156700096|NCT00006721|565651339|FG001|Overall Study|Ineligible|12|||
156700097|NCT00006721|565651340|FG002|Overall Study|Ineligible|10|||
156700098|NCT00006721|565651338|FG000|Overall Study|Eligible but no Treatment Received|1|||
156700099|NCT00006721|565651339|FG001|Overall Study|Eligible but no Treatment Received|0|||
156700100|NCT00006721|565651340|FG002|Overall Study|Eligible but no Treatment Received|0|||
156700101|NCT05424042|565651341|FG000|Overall Study|Withdrawal by Subject|2|||
156700102|NCT05424042|565651342|FG001|Overall Study|Withdrawal by Subject|0|||
156700103|NCT05424042|565651343|FG002|Overall Study|Withdrawal by Subject|4|||
156700104|NCT05424042|565651341|FG000|Overall Study|Lost to Follow-up|0|||
156700105|NCT05424042|565651342|FG001|Overall Study|Lost to Follow-up|0|||
156700106|NCT05424042|565651343|FG002|Overall Study|Lost to Follow-up|1|||
156700107|NCT03611543|565651344|FG000|Overall Study|Withdrawal by Subject|4|||
156700108|NCT03611543|565651345|FG001|Overall Study|Withdrawal by Subject|4|||
156700109|NCT03611543|565651344|FG000|Overall Study|Physician Decision|1|||
156700110|NCT03611543|565651345|FG001|Overall Study|Physician Decision|1|||
156700111|NCT03611543|565651344|FG000|Overall Study|Protocol Violation|2|||
156700112|NCT03611543|565651345|FG001|Overall Study|Protocol Violation|2|||
156700113|NCT03611543|565651344|FG000|Overall Study|Device failure|2|||
156700114|NCT03611543|565651345|FG001|Overall Study|Device failure|2|||
156700115|NCT03611543|565651344|FG000|Overall Study|Missing information|5|||
156700116|NCT03611543|565651345|FG001|Overall Study|Missing information|5|||
156700117|NCT03047473|565651346|FG000|Overall Study|Lost to Follow-up|2|||
156700118|NCT01167257|565651347|FG000|Overall Study|Lost to Follow-up|2|||
156700119|NCT01167257|565651348|FG001|Overall Study|Lost to Follow-up|2|||
156700120|NCT01167257|565651347|FG000|Overall Study|Withdrew consent|1|||
156700121|NCT01167257|565651348|FG001|Overall Study|Withdrew consent|1|||
156700122|NCT02213510|565651350|FG000|Overall Study|Death|0|||
156700123|NCT02213510|565651351|FG001|Overall Study|Death|1|||
156700124|NCT02213510|565651350|FG000|Overall Study|Lost to Follow-up|1|||
156700125|NCT02213510|565651351|FG001|Overall Study|Lost to Follow-up|0|||
156700126|NCT00000378|565651354|FG000|Overall Study|Lack of Efficacy|16|||
156700127|NCT00000378|565651355|FG001|Overall Study|Lack of Efficacy|14|||
156700128|NCT01284361|565651358|FG000|Overall Study|Withdrawal by Subject|1|||
156700129|NCT01284361|565651358|FG000|Overall Study|Protocol Violation|5|||
156700130|NCT01284361|565651358|FG000|Overall Study|Adverse Event|1|||
156700131|NCT01284361|565651358|FG000|Overall Study|Lost to Follow-up|2|||
156700132|NCT00805675|565651359|FG000|Overall Study|Adverse Event|0|||
156700133|NCT00805675|565651360|FG001|Overall Study|Adverse Event|0|||
156700134|NCT00805675|565651361|FG002|Overall Study|Adverse Event|1|||
156700135|NCT01957397|565651364|FG000|Test Period 1|sudden leakage/small bag|1|||
156700136|NCT01957397|565651365|FG001|Test Period 1|sudden leakage/small bag|1|||
156700137|NCT01957397|565651364|FG000|Test Period 1|Withdrawal by Subject|1|||
156700138|NCT01957397|565651365|FG001|Test Period 1|Withdrawal by Subject|0|||
156700139|NCT01957397|565651364|FG000|Test Period 2|Adverse Event|0|||
156700140|NCT01957397|565651365|FG001|Test Period 2|Adverse Event|1|||
156700141|NCT01957397|565651364|FG000|Test Period 3|Adverse Event|1|||
156700142|NCT01957397|565651365|FG001|Test Period 3|Adverse Event|2|||
156700143|NCT01957397|565651364|FG000|Test Period 3|the adhesive did not work|1|||
156700144|NCT01957397|565651365|FG001|Test Period 3|the adhesive did not work|0|||
156700145|NCT00540293|565651366|FG000|Overall Study|Adverse event related to study drug|10|||
156700146|NCT00540293|565651366|FG000|Overall Study|Adverse event not related to study drug|7|||
156700147|NCT00540293|565651366|FG000|Overall Study|Withdrawal by Subject|6|||
156700148|NCT00540293|565651366|FG000|Overall Study|Protocol violation, & subject schedule|12|||
156700149|NCT00325195|565651369|FG000|Randomized|Not dosed|5|||
156700150|NCT00325195|565651370|FG001|Randomized|Not dosed|5|||
156700151|NCT00325195|565651371|FG002|Randomized|Not dosed|3|||
156700152|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Adverse Event|15|||
156700153|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Adverse Event|17|||
156700154|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Adverse Event|1|||
156700155|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Death|3|||
156700156|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Death|1|||
156700157|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Death|0|||
156700158|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
156700159|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
156700160|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
156700161|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
156700162|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
156700163|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
156700164|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
156700165|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
156700166|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
156439051|NCT05061693|564698738|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
156700167|NCT04715932|565651372|FG000|Overall Study|Lost to Follow-up|1|||
156700168|NCT04715932|565651373|FG001|Overall Study|Lost to Follow-up|0|||
156700169|NCT03560986|565651374|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
156700170|NCT03560986|565651375|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
156700171|NCT03560986|565651374|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
156700172|NCT03560986|565651375|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
156700173|NCT03560986|565651374|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
156700174|NCT03560986|565651375|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
156700175|NCT03560986|565651374|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
156700176|NCT03560986|565651375|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
156700177|NCT03560986|565651374|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
156700178|NCT03560986|565651375|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
156700179|NCT03560986|565651374|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
156439052|NCT05061693|564698739|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
156439053|NCT05061693|564698740|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
156439054|NCT05061693|564698741|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
156439055|NCT05061693|564698742|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
156439056|NCT05061693|564698743|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
156439057|NCT05061693|564698744|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
156700180|NCT03560986|565651375|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
156700181|NCT03560986|565651374|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
156700182|NCT03560986|565651375|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
156700183|NCT01059539|565651376|FG000|Overall Study|Adverse Event|66|||
156700184|NCT01059539|565651376|FG000|Overall Study|Insufficient Therapeutic Response|26|||
156700185|NCT01059539|565651376|FG000|Overall Study|Protocol Violation|55|||
156700186|NCT01059539|565651376|FG000|Overall Study|Withdrawal of Consent|80|||
156700187|NCT01059539|565651376|FG000|Overall Study|Lost to Follow-up|42|||
156700188|NCT01059539|565651376|FG000|Overall Study|Reason Not Specified|2|||
156700189|NCT01085201|565651380|FG000|Overall Study|Scheduling conflict|1|||
156700190|NCT01085201|565651381|FG001|Overall Study|Scheduling conflict|0|||
156700191|NCT01085201|565651382|FG002|Overall Study|Scheduling conflict|1|||
156700192|NCT01085201|565651383|FG003|Overall Study|Scheduling conflict|0|||
156700193|NCT01085201|565651384|FG004|Overall Study|Scheduling conflict|0|||
156700194|NCT01085201|565651380|FG000|Overall Study|Unknown- no study drug|2|||
156700195|NCT01085201|565651381|FG001|Overall Study|Unknown- no study drug|0|||
156700196|NCT01085201|565651382|FG002|Overall Study|Unknown- no study drug|0|||
156700197|NCT01085201|565651383|FG003|Overall Study|Unknown- no study drug|0|||
156700198|NCT01085201|565651384|FG004|Overall Study|Unknown- no study drug|0|||
156700199|NCT01085201|565651380|FG000|Overall Study|Fond ineligible after consent|0|||
156700200|NCT01085201|565651381|FG001|Overall Study|Fond ineligible after consent|1|||
156700201|NCT01085201|565651382|FG002|Overall Study|Fond ineligible after consent|1|||
156700202|NCT01085201|565651383|FG003|Overall Study|Fond ineligible after consent|0|||
156700203|NCT01085201|565651384|FG004|Overall Study|Fond ineligible after consent|0|||
156700204|NCT00528411|565651385|FG000|Overall Study|Adverse Event|4|||
156700205|NCT00528411|565651386|FG001|Overall Study|Adverse Event|0|||
156700206|NCT00528411|565651387|FG002|Overall Study|Adverse Event|1|||
156700207|NCT00528411|565651385|FG000|Overall Study|Incorrect Enrolment|1|||
156700208|NCT00528411|565651386|FG001|Overall Study|Incorrect Enrolment|1|||
156700209|NCT00528411|565651387|FG002|Overall Study|Incorrect Enrolment|0|||
156700210|NCT00528411|565651385|FG000|Overall Study|Severe non-compliance to protocol|0|||
156700211|NCT00528411|565651386|FG001|Overall Study|Severe non-compliance to protocol|1|||
156700212|NCT00528411|565651387|FG002|Overall Study|Severe non-compliance to protocol|0|||
156700213|NCT00528411|565651385|FG000|Overall Study|Prior commitment medication|0|||
156700214|NCT00528411|565651386|FG001|Overall Study|Prior commitment medication|1|||
156700215|NCT00528411|565651387|FG002|Overall Study|Prior commitment medication|0|||
156700216|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
156700217|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
156700218|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700219|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700220|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
156700221|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700222|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700223|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700224|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700225|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700226|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
156700227|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700228|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700229|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700230|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700231|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700232|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700233|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700234|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700235|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
156700236|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700237|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
156700238|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700239|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700240|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700241|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700242|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700243|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700244|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
156700245|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700246|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
156700247|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700248|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700249|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156439058|NCT05061693|564698745|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
156439059|NCT05061693|564698734|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
156439060|NCT05061693|564698735|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
156439061|NCT05061693|564698736|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
156700250|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156439062|NCT05061693|564698737|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
156790860|NCT01903733|565985500|FG000|Overall Study|Lost to Follow-up|18|||
156700251|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700252|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
156700253|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
156700254|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
156700255|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700256|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
156700257|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700258|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700259|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700260|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700261|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700262|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
156700263|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700264|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700265|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700266|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700267|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700268|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700269|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700270|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700271|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700272|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700273|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
156700274|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700275|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700276|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700277|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700278|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700279|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700280|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
156700281|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
156700282|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
156700283|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700284|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700285|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700286|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700287|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700288|NCT03893565|565651388|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
156700289|NCT03893565|565651389|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
156700290|NCT03893565|565651390|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
156700291|NCT03893565|565651391|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
156700292|NCT03893565|565651392|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
156700293|NCT03893565|565651393|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
156700294|NCT03893565|565651394|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
156700295|NCT03893565|565651395|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
156700296|NCT03893565|565651396|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
156700297|NCT03893565|565651388|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700298|NCT03893565|565651389|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700299|NCT03893565|565651390|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700300|NCT03893565|565651391|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700301|NCT03893565|565651392|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700302|NCT03893565|565651393|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700303|NCT03893565|565651394|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
156700304|NCT03893565|565651395|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700305|NCT03893565|565651396|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700306|NCT03893565|565651388|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700307|NCT03893565|565651389|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700308|NCT03893565|565651390|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700309|NCT03893565|565651391|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700310|NCT03893565|565651392|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156790861|NCT01903733|565985501|FG001|Overall Study|Lost to Follow-up|19|||
156790862|NCT01903733|565985502|FG002|Overall Study|Lost to Follow-up|6|||
156700311|NCT03893565|565651393|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
156700312|NCT03893565|565651394|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
156700313|NCT03893565|565651395|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700314|NCT03893565|565651396|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700315|NCT03893565|565651388|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
156700316|NCT03893565|565651389|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
156700317|NCT03893565|565651390|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
156700318|NCT03893565|565651391|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
156700319|NCT03893565|565651392|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
156700320|NCT03893565|565651393|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
156700321|NCT03893565|565651394|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
156700322|NCT03893565|565651395|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
156700323|NCT03893565|565651396|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
156700324|NCT03893565|565651388|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700325|NCT03893565|565651389|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700326|NCT03893565|565651390|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700327|NCT03893565|565651391|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700328|NCT03893565|565651392|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700329|NCT03893565|565651393|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700330|NCT03893565|565651394|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700331|NCT03893565|565651395|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
156700332|NCT03893565|565651396|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700333|NCT03893565|565651388|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700334|NCT03893565|565651389|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700335|NCT03893565|565651390|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700336|NCT03893565|565651391|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700337|NCT03893565|565651392|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700338|NCT03893565|565651393|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700339|NCT03893565|565651394|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700340|NCT03893565|565651395|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
156700341|NCT03893565|565651396|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700342|NCT03893565|565651388|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700343|NCT03893565|565651389|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700344|NCT03893565|565651390|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700345|NCT03893565|565651391|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700346|NCT03893565|565651392|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700347|NCT03893565|565651393|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700348|NCT03893565|565651394|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700349|NCT03893565|565651395|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
156700350|NCT03893565|565651396|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700351|NCT03893565|565651388|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700352|NCT03893565|565651389|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700353|NCT03893565|565651390|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700354|NCT03893565|565651391|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700355|NCT03893565|565651392|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700356|NCT03893565|565651393|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700357|NCT03893565|565651394|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700358|NCT03893565|565651395|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700359|NCT03893565|565651396|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
156700360|NCT05005312|565651397|FG000|Overall Study|Enrolled, but not treated|0|||
156700361|NCT05005312|565651398|FG001|Overall Study|Enrolled, but not treated|1|||
156700362|NCT01283035|565651399|FG000|Overall Study|Subject later found ineligible|1|||
156700363|NCT00851318|565651400|FG000|Overall Study|Withdrawal by Subject|7|||
156700364|NCT00851318|565651401|FG001|Overall Study|Withdrawal by Subject|1|||
156700365|NCT00851318|565651402|FG002|Overall Study|Withdrawal by Subject|5|||
156700366|NCT00851318|565651403|FG003|Overall Study|Withdrawal by Subject|3|||
156700367|NCT00851318|565651400|FG000|Overall Study|Adverse Event|13|||
156700368|NCT00851318|565651401|FG001|Overall Study|Adverse Event|2|||
156790863|NCT01903733|565985503|FG003|Overall Study|Lost to Follow-up|9|||
156790864|NCT01903733|565985500|FG000|Overall Study|Other|10|||
156790865|NCT01903733|565985501|FG001|Overall Study|Other|15|||
156700369|NCT00851318|565651402|FG002|Overall Study|Adverse Event|9|||
156700370|NCT00851318|565651403|FG003|Overall Study|Adverse Event|12|||
156700371|NCT00851318|565651400|FG000|Overall Study|Pregnancy|0|||
156700372|NCT00851318|565651401|FG001|Overall Study|Pregnancy|0|||
156790866|NCT01903733|565985502|FG002|Overall Study|Other|12|||
156700373|NCT00851318|565651402|FG002|Overall Study|Pregnancy|1|||
156700374|NCT00851318|565651403|FG003|Overall Study|Pregnancy|1|||
156700375|NCT00851318|565651400|FG000|Overall Study|Lack of Efficacy|8|||
156700376|NCT00851318|565651401|FG001|Overall Study|Lack of Efficacy|2|||
156700377|NCT00851318|565651402|FG002|Overall Study|Lack of Efficacy|4|||
156700378|NCT00851318|565651403|FG003|Overall Study|Lack of Efficacy|2|||
156700379|NCT00851318|565651400|FG000|Overall Study|Non-compliance with Study Procedures|2|||
156700380|NCT00851318|565651401|FG001|Overall Study|Non-compliance with Study Procedures|0|||
156700381|NCT00851318|565651402|FG002|Overall Study|Non-compliance with Study Procedures|1|||
156700382|NCT00851318|565651403|FG003|Overall Study|Non-compliance with Study Procedures|0|||
156700383|NCT00851318|565651400|FG000|Overall Study|Physician Decision|0|||
156700384|NCT00851318|565651401|FG001|Overall Study|Physician Decision|0|||
156700385|NCT00851318|565651402|FG002|Overall Study|Physician Decision|1|||
156700386|NCT00851318|565651403|FG003|Overall Study|Physician Decision|1|||
156700387|NCT01715571|565651413|FG000|Overall Study|Lost to Follow-up|8|||
156700388|NCT03870477|565651418|FG000|Overall Study|Early Study Termination|1|||
156700389|NCT02256436|565651427|FG000|Overall Study|Adverse Event|9|||
156700390|NCT02256436|565651428|FG001|Overall Study|Adverse Event|14|||
156700391|NCT02256436|565651427|FG000|Overall Study|Death|216|||
156700392|NCT02256436|565651428|FG001|Overall Study|Death|208|||
156700393|NCT02256436|565651427|FG000|Overall Study|Lost to Follow-up|1|||
156700394|NCT02256436|565651428|FG001|Overall Study|Lost to Follow-up|2|||
156700395|NCT02256436|565651427|FG000|Overall Study|Physician Decision|1|||
156700396|NCT02256436|565651428|FG001|Overall Study|Physician Decision|0|||
156700397|NCT02256436|565651427|FG000|Overall Study|Protocol Violation|0|||
156700398|NCT02256436|565651428|FG001|Overall Study|Protocol Violation|1|||
156700399|NCT02256436|565651427|FG000|Overall Study|Withdrawal by Subject|26|||
156700400|NCT02256436|565651428|FG001|Overall Study|Withdrawal by Subject|10|||
156700401|NCT02256436|565651427|FG000|Overall Study|Transferred to Extension Study|11|||
156700402|NCT02256436|565651428|FG001|Overall Study|Transferred to Extension Study|23|||
156700403|NCT02256436|565651427|FG000|Overall Study|Did Not Continue on Extension Study|8|||
156700404|NCT02256436|565651428|FG001|Overall Study|Did Not Continue on Extension Study|12|||
156700405|NCT00077857|565651431|FG000|Overall Study|Adverse Event|30|||
156700406|NCT00077857|565651432|FG001|Overall Study|Adverse Event|32|||
156700407|NCT00077857|565651431|FG000|Overall Study|Death|7|||
156700408|NCT00077857|565651432|FG001|Overall Study|Death|3|||
156700409|NCT00077857|565651431|FG000|Overall Study|Insufficient therapeutic response|112|||
156700410|NCT00077857|565651432|FG001|Overall Study|Insufficient therapeutic response|128|||
156700411|NCT00077857|565651431|FG000|Overall Study|Violation of selection criteria at entry|3|||
156700412|NCT00077857|565651432|FG001|Overall Study|Violation of selection criteria at entry|1|||
156700413|NCT00077857|565651431|FG000|Overall Study|Other protocol violation|0|||
156700414|NCT00077857|565651432|FG001|Overall Study|Other protocol violation|1|||
156700415|NCT00077857|565651431|FG000|Overall Study|Refused treatment|29|||
156700416|NCT00077857|565651432|FG001|Overall Study|Refused treatment|21|||
156700417|NCT00077857|565651431|FG000|Overall Study|Failure to return|5|||
156700418|NCT00077857|565651432|FG001|Overall Study|Failure to return|5|||
156700419|NCT00077857|565651431|FG000|Overall Study|Other|15|||
156700420|NCT00077857|565651432|FG001|Overall Study|Other|13|||
156700421|NCT06354998|565651433|FG000|Overall Study|Withdrawal by Subject|3|||
156700422|NCT06354998|565651434|FG001|Overall Study|Withdrawal by Subject|0|||
156700423|NCT05442866|565651435|FG000|Overall Study|Death|1|||
156700424|NCT05442866|565651435|FG000|Overall Study|Lost to Follow-up|9|||
156700425|NCT05442866|565651435|FG000|Overall Study|Protocol Violation|1|||
156700426|NCT01394952|565651436|FG000|Overall Study|Lost to Follow-up|0|||
156700427|NCT01394952|565651437|FG001|Overall Study|Lost to Follow-up|5|||
156700428|NCT01394952|565651436|FG000|Overall Study|Withdrawal by Subject|10|||
156700429|NCT01394952|565651437|FG001|Overall Study|Withdrawal by Subject|5|||
156700430|NCT01394952|565651436|FG000|Overall Study|Physician Decision|2|||
156700431|NCT01394952|565651437|FG001|Overall Study|Physician Decision|0|||
156700432|NCT01394952|565651436|FG000|Overall Study|Sponsor Decision|5|||
156700433|NCT01394952|565651437|FG001|Overall Study|Sponsor Decision|7|||
156700434|NCT04740814|565651438|FG000|Overall Study|Adverse Event|3|||
156700435|NCT04740814|565651438|FG000|Overall Study|Protocol Violation|2|||
156700436|NCT04740814|565651438|FG000|Overall Study|Lost to Follow-up|2|||
156700437|NCT04740814|565651438|FG000|Overall Study|Withdrawal by Subject|3|||
156700438|NCT00085423|565651439|FG000|Overall Study|Withdrawal by Subject|1|||
156700439|NCT00085423|565651439|FG000|Overall Study|screen failure|1|||
156700440|NCT01763684|565651441|FG000|Overall Study|Study terminated early due to low enrollment|126|||
156700441|NCT01763684|565651442|FG001|Overall Study|Study terminated early due to low enrollment|127|||
156700442|NCT01763684|565651441|FG000|Overall Study|Study surgery not performed|7|||
156700443|NCT01763684|565651442|FG001|Overall Study|Study surgery not performed|6|||
156700444|NCT02196701|565651443|FG000|Overall Study|Adverse Event|1|||
156700445|NCT02196701|565651443|FG000|Overall Study|Lost to Follow-up|1|||
156700446|NCT02196701|565651443|FG000|Overall Study|Non-adherence to Protocol|1|||
156700447|NCT03275064|565651444|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
156700448|NCT03275064|565651445|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
156790867|NCT01903733|565985503|FG003|Overall Study|Other|3|||
156700449|NCT03275064|565651446|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
156700450|NCT03275064|565651447|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
156700451|NCT03275064|565651448|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
156700452|NCT03275064|565651444|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
156700453|NCT03275064|565651445|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
156700454|NCT03275064|565651446|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
156700455|NCT03275064|565651447|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
156700456|NCT03275064|565651448|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
156700457|NCT03275064|565651444|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
156700458|NCT03275064|565651445|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
156700459|NCT03275064|565651446|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
156700460|NCT03275064|565651447|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
156700461|NCT03275064|565651448|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
156700462|NCT03275064|565651444|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
156700463|NCT03275064|565651445|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
156700464|NCT03275064|565651446|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
156700465|NCT03275064|565651447|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
156700466|NCT03275064|565651448|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
156700467|NCT03275064|565651444|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
156700468|NCT03275064|565651445|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
156700469|NCT03275064|565651446|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
156700470|NCT03275064|565651447|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
156700471|NCT03275064|565651448|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
156700472|NCT03796039|565651450|FG000|Overall Study|Death|2|||
156700473|NCT03796039|565651451|FG001|Overall Study|Death|1|||
156700474|NCT03796039|565651450|FG000|Overall Study|Withdrawal by Subject|7|||
156700475|NCT03796039|565651451|FG001|Overall Study|Withdrawal by Subject|4|||
156700476|NCT01140503|565651452|FG000|Overall Study|Withdrawal by Subject|1|||
156700477|NCT04305496|565651453|FG000|Global Cohort|Withdrawal by Subject|13|||
156700478|NCT04305496|565651454|FG001|Global Cohort|Withdrawal by Subject|6|||
156700479|NCT04305496|565651453|FG000|Global Cohort|Physician Decision|1|||
156700480|NCT04305496|565651454|FG001|Global Cohort|Physician Decision|1|||
156700481|NCT04305496|565651453|FG000|Global Cohort|Subjective disease progression|16|||
156700482|NCT04305496|565651454|FG001|Global Cohort|Subjective disease progression|17|||
156700483|NCT04305496|565651453|FG000|Global Cohort|Condition under investigation worsened|209|||
156700484|NCT04305496|565651454|FG001|Global Cohort|Condition under investigation worsened|273|||
156700485|NCT04305496|565651453|FG000|Global Cohort|Protocol Violation|2|||
156439063|NCT05061693|564698738|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
156700486|NCT04305496|565651454|FG001|Global Cohort|Protocol Violation|0|||
156700487|NCT04305496|565651453|FG000|Global Cohort|Adverse Event|44|||
156700488|NCT04305496|565651454|FG001|Global Cohort|Adverse Event|6|||
156700489|NCT04305496|565651453|FG000|Global Cohort|Death|3|||
156700490|NCT04305496|565651454|FG001|Global Cohort|Death|2|||
156700491|NCT04305496|565651453|FG000|Global Cohort|Any reason not specifically recorded|4|||
156700492|NCT04305496|565651454|FG001|Global Cohort|Any reason not specifically recorded|5|||
156700493|NCT04305496|565651453|FG000|China Cohort|Any reason not specifically recorded|1|||
156700494|NCT04305496|565651454|FG001|China Cohort|Any reason not specifically recorded|1|||
156700495|NCT04305496|565651453|FG000|China Cohort|Adverse Event|8|||
156700496|NCT04305496|565651454|FG001|China Cohort|Adverse Event|2|||
156700497|NCT04305496|565651453|FG000|China Cohort|Condition under investigation worsened|40|||
156700498|NCT04305496|565651454|FG001|China Cohort|Condition under investigation worsened|47|||
156700499|NCT04305496|565651453|FG000|China Cohort|Subjective disease progression|2|||
156700500|NCT04305496|565651454|FG001|China Cohort|Subjective disease progression|2|||
156700501|NCT04305496|565651453|FG000|China Cohort|Withdrawal by Subject|2|||
156700502|NCT04305496|565651454|FG001|China Cohort|Withdrawal by Subject|1|||
156700503|NCT01157897|565651455|FG000|Overall Study|Lost to Follow-up|2|||
156700504|NCT01157897|565651456|FG001|Overall Study|Lost to Follow-up|0|||
156790868|NCT01903733|565985500|FG000|Overall Study|Missing|2|||
156790869|NCT01903733|565985501|FG001|Overall Study|Missing|0|||
156439064|NCT05061693|564698739|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
156439065|NCT05061693|564698740|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
156439066|NCT05061693|564698741|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
156439067|NCT05061693|564698742|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
156700505|NCT01157897|565651457|FG002|Overall Study|Lost to Follow-up|0|||
156700506|NCT01157897|565651458|FG003|Overall Study|Lost to Follow-up|1|||
156700507|NCT01157897|565651455|FG000|Overall Study|Relocated|0|||
156700508|NCT01157897|565651456|FG001|Overall Study|Relocated|2|||
156700509|NCT01157897|565651457|FG002|Overall Study|Relocated|0|||
156700510|NCT01157897|565651458|FG003|Overall Study|Relocated|0|||
156700511|NCT01898650|565651460|FG000|Overall Study|the subject would not lie still for imaging|1|||
156700512|NCT01791153|565651462|FG000|Part 1: Blinded Period|Adverse Event|7|||
156700513|NCT01791153|565651463|FG001|Part 1: Blinded Period|Adverse Event|3|||
156700514|NCT01791153|565651464|FG002|Part 1: Blinded Period|Adverse Event|2|||
156700515|NCT01791153|565651465|FG003|Part 1: Blinded Period|Adverse Event|0|||
156700516|NCT01791153|565651466|FG004|Part 1: Blinded Period|Adverse Event|0|||
156700517|NCT01791153|565651467|FG005|Part 1: Blinded Period|Adverse Event|0|||
156700518|NCT01791153|565651468|FG006|Part 1: Blinded Period|Adverse Event|0|||
156700519|NCT01791153|565651469|FG007|Part 1: Blinded Period|Adverse Event|0|||
156700520|NCT01791153|565651462|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
156700521|NCT01791153|565651463|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
156700522|NCT01791153|565651464|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
156700523|NCT01791153|565651465|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
156700524|NCT01791153|565651466|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
156700525|NCT01791153|565651467|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
156700526|NCT01791153|565651468|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
156700527|NCT01791153|565651469|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
156700528|NCT01791153|565651462|FG000|Part 1: Blinded Period|Non-Compliance|1|||
156700529|NCT01791153|565651463|FG001|Part 1: Blinded Period|Non-Compliance|0|||
156700530|NCT01791153|565651464|FG002|Part 1: Blinded Period|Non-Compliance|0|||
156700531|NCT01791153|565651465|FG003|Part 1: Blinded Period|Non-Compliance|0|||
156700532|NCT01791153|565651466|FG004|Part 1: Blinded Period|Non-Compliance|0|||
156700533|NCT01791153|565651467|FG005|Part 1: Blinded Period|Non-Compliance|0|||
156700534|NCT01791153|565651468|FG006|Part 1: Blinded Period|Non-Compliance|0|||
156700535|NCT01791153|565651469|FG007|Part 1: Blinded Period|Non-Compliance|0|||
156700536|NCT01791153|565651462|FG000|Part 1: Blinded Period|Physician Decision|0|||
156700537|NCT01791153|565651463|FG001|Part 1: Blinded Period|Physician Decision|0|||
156700538|NCT01791153|565651464|FG002|Part 1: Blinded Period|Physician Decision|0|||
156700539|NCT01791153|565651465|FG003|Part 1: Blinded Period|Physician Decision|1|||
156700540|NCT01791153|565651466|FG004|Part 1: Blinded Period|Physician Decision|0|||
156700541|NCT01791153|565651467|FG005|Part 1: Blinded Period|Physician Decision|0|||
156700542|NCT01791153|565651468|FG006|Part 1: Blinded Period|Physician Decision|0|||
156700543|NCT01791153|565651469|FG007|Part 1: Blinded Period|Physician Decision|0|||
156700544|NCT01791153|565651462|FG000|Part 1: Blinded Period|Protocol Violation|0|||
156700545|NCT01791153|565651463|FG001|Part 1: Blinded Period|Protocol Violation|0|||
156700546|NCT01791153|565651464|FG002|Part 1: Blinded Period|Protocol Violation|0|||
156700547|NCT01791153|565651465|FG003|Part 1: Blinded Period|Protocol Violation|1|||
156700548|NCT01791153|565651466|FG004|Part 1: Blinded Period|Protocol Violation|0|||
156700549|NCT01791153|565651467|FG005|Part 1: Blinded Period|Protocol Violation|0|||
156700550|NCT01791153|565651468|FG006|Part 1: Blinded Period|Protocol Violation|0|||
156700551|NCT01791153|565651469|FG007|Part 1: Blinded Period|Protocol Violation|0|||
156700552|NCT01791153|565651462|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
156700553|NCT01791153|565651463|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
156700554|NCT01791153|565651464|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
156700555|NCT01791153|565651465|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
156700556|NCT01791153|565651466|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
156700557|NCT01791153|565651467|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
156700558|NCT01791153|565651468|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
156700559|NCT01791153|565651469|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
156872097|NCT01166282|566289501|FG002|Open-label Period|Remission|4|||
156872098|NCT01166282|566289499|FG000|Open-label Period|Irregular Compliance|0|||
156872099|NCT01166282|566289500|FG001|Open-label Period|Irregular Compliance|0|||
156439068|NCT05061693|564698743|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
156439069|NCT05061693|564698744|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
156439070|NCT05061693|564698745|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
156872100|NCT01166282|566289501|FG002|Open-label Period|Irregular Compliance|1|||
156872101|NCT02577718|566289502|FG000|Overall Study|Death|6|||
156872102|NCT02577718|566289502|FG000|Overall Study|Withdrawal by Subject|2|||
156872103|NCT01075685|566289503|FG000|Overall Study|Protocol Violation|9|||
156439071|NCT05061693|564698734|FG000|24-week Extension Period|Adverse Event|0|||
156439072|NCT05061693|564698735|FG001|24-week Extension Period|Adverse Event|0|||
156439073|NCT05061693|564698736|FG002|24-week Extension Period|Adverse Event|0|||
156439074|NCT05061693|564698737|FG003|24-week Extension Period|Adverse Event|0|||
156439075|NCT05061693|564698738|FG004|24-week Extension Period|Adverse Event|0|||
156700560|NCT01791153|565651462|FG000|Part 2: Open-label Period|Adverse Event|0|||
156700561|NCT01791153|565651463|FG001|Part 2: Open-label Period|Adverse Event|0|||
156872104|NCT01075685|566289504|FG001|Overall Study|Protocol Violation|1|||
156700562|NCT01791153|565651464|FG002|Part 2: Open-label Period|Adverse Event|0|||
156700563|NCT01791153|565651465|FG003|Part 2: Open-label Period|Adverse Event|0|||
156700564|NCT01791153|565651466|FG004|Part 2: Open-label Period|Adverse Event|0|||
156700565|NCT01791153|565651467|FG005|Part 2: Open-label Period|Adverse Event|1|||
156700566|NCT01791153|565651468|FG006|Part 2: Open-label Period|Adverse Event|1|||
156700567|NCT01791153|565651469|FG007|Part 2: Open-label Period|Adverse Event|2|||
156439076|NCT05061693|564698739|FG005|24-week Extension Period|Adverse Event|0|||
156439077|NCT05061693|564698740|FG006|24-week Extension Period|Adverse Event|0|||
156439078|NCT05061693|564698741|FG007|24-week Extension Period|Adverse Event|2|||
156439079|NCT05061693|564698742|FG008|24-week Extension Period|Adverse Event|2|||
156439080|NCT05061693|564698743|FG009|24-week Extension Period|Adverse Event|0|||
156439081|NCT05061693|564698744|FG010|24-week Extension Period|Adverse Event|1|||
156439082|NCT05061693|564698745|FG011|24-week Extension Period|Adverse Event|3|||
156439083|NCT05061693|564698734|FG000|24-week Extension Period|Lack of Efficacy|0|||
156439084|NCT05061693|564698735|FG001|24-week Extension Period|Lack of Efficacy|0|||
156439085|NCT05061693|564698736|FG002|24-week Extension Period|Lack of Efficacy|0|||
156439086|NCT05061693|564698737|FG003|24-week Extension Period|Lack of Efficacy|0|||
156439087|NCT05061693|564698738|FG004|24-week Extension Period|Lack of Efficacy|0|||
156439088|NCT05061693|564698739|FG005|24-week Extension Period|Lack of Efficacy|0|||
156439089|NCT05061693|564698740|FG006|24-week Extension Period|Lack of Efficacy|0|||
156439090|NCT05061693|564698741|FG007|24-week Extension Period|Lack of Efficacy|0|||
156439091|NCT05061693|564698742|FG008|24-week Extension Period|Lack of Efficacy|0|||
156439092|NCT05061693|564698743|FG009|24-week Extension Period|Lack of Efficacy|0|||
156439093|NCT05061693|564698744|FG010|24-week Extension Period|Lack of Efficacy|2|||
156439094|NCT05061693|564698745|FG011|24-week Extension Period|Lack of Efficacy|0|||
156439095|NCT05061693|564698734|FG000|24-week Extension Period|Lost to Follow-up|0|||
156439096|NCT05061693|564698735|FG001|24-week Extension Period|Lost to Follow-up|0|||
156439097|NCT05061693|564698736|FG002|24-week Extension Period|Lost to Follow-up|0|||
156439098|NCT05061693|564698737|FG003|24-week Extension Period|Lost to Follow-up|0|||
156439099|NCT05061693|564698738|FG004|24-week Extension Period|Lost to Follow-up|0|||
156439100|NCT05061693|564698739|FG005|24-week Extension Period|Lost to Follow-up|0|||
156439101|NCT05061693|564698740|FG006|24-week Extension Period|Lost to Follow-up|1|||
156439102|NCT05061693|564698741|FG007|24-week Extension Period|Lost to Follow-up|0|||
156439103|NCT05061693|564698742|FG008|24-week Extension Period|Lost to Follow-up|1|||
156439104|NCT05061693|564698743|FG009|24-week Extension Period|Lost to Follow-up|1|||
156439105|NCT05061693|564698744|FG010|24-week Extension Period|Lost to Follow-up|0|||
156439106|NCT05061693|564698745|FG011|24-week Extension Period|Lost to Follow-up|0|||
156439107|NCT05061693|564698734|FG000|24-week Extension Period|Withdrawal by Subject|0|||
156439108|NCT05061693|564698735|FG001|24-week Extension Period|Withdrawal by Subject|0|||
156439109|NCT05061693|564698736|FG002|24-week Extension Period|Withdrawal by Subject|0|||
156439110|NCT05061693|564698737|FG003|24-week Extension Period|Withdrawal by Subject|0|||
156439111|NCT05061693|564698738|FG004|24-week Extension Period|Withdrawal by Subject|0|||
156439112|NCT05061693|564698739|FG005|24-week Extension Period|Withdrawal by Subject|0|||
156439113|NCT05061693|564698740|FG006|24-week Extension Period|Withdrawal by Subject|0|||
156439114|NCT05061693|564698741|FG007|24-week Extension Period|Withdrawal by Subject|0|||
156439115|NCT05061693|564698742|FG008|24-week Extension Period|Withdrawal by Subject|1|||
156439116|NCT05061693|564698743|FG009|24-week Extension Period|Withdrawal by Subject|2|||
156439117|NCT05061693|564698744|FG010|24-week Extension Period|Withdrawal by Subject|2|||
156439118|NCT05061693|564698745|FG011|24-week Extension Period|Withdrawal by Subject|1|||
156439119|NCT05061693|564698734|FG000|24-week Extension Period|Sponsor Decision|0|||
156439120|NCT05061693|564698735|FG001|24-week Extension Period|Sponsor Decision|0|||
156439121|NCT05061693|564698736|FG002|24-week Extension Period|Sponsor Decision|0|||
156790870|NCT01903733|565985502|FG002|Overall Study|Missing|0|||
156439122|NCT05061693|564698737|FG003|24-week Extension Period|Sponsor Decision|0|||
156439123|NCT05061693|564698738|FG004|24-week Extension Period|Sponsor Decision|0|||
156439124|NCT05061693|564698739|FG005|24-week Extension Period|Sponsor Decision|0|||
156439125|NCT05061693|564698740|FG006|24-week Extension Period|Sponsor Decision|0|||
156439126|NCT05061693|564698741|FG007|24-week Extension Period|Sponsor Decision|1|||
156439127|NCT05061693|564698742|FG008|24-week Extension Period|Sponsor Decision|0|||
156439128|NCT05061693|564698743|FG009|24-week Extension Period|Sponsor Decision|0|||
156439129|NCT05061693|564698744|FG010|24-week Extension Period|Sponsor Decision|0|||
156439130|NCT05061693|564698745|FG011|24-week Extension Period|Sponsor Decision|0|||
156531085|NCT01372410|565039830|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
156531086|NCT01372410|565039831|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
156531087|NCT01372410|565039832|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
156531088|NCT01372410|565039833|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
156531089|NCT01372410|565039834|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
156531090|NCT01372410|565039835|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
156531091|NCT01372410|565039836|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
156531092|NCT01372410|565039837|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
156531093|NCT01372410|565039830|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
156531094|NCT01372410|565039831|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
156531095|NCT01372410|565039832|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
156531096|NCT01372410|565039833|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
156531097|NCT01372410|565039834|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
156531098|NCT01372410|565039835|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
156790871|NCT01903733|565985503|FG003|Overall Study|Missing|0|||
156700568|NCT01791153|565651462|FG000|Part 2: Open-label Period|Death|0|||
156700569|NCT01791153|565651463|FG001|Part 2: Open-label Period|Death|0|||
156439131|NCT05061693|564698734|FG000|24-week Extension Period|Site Closure|0|||
156700570|NCT01791153|565651464|FG002|Part 2: Open-label Period|Death|0|||
156700571|NCT01791153|565651465|FG003|Part 2: Open-label Period|Death|0|||
156700572|NCT01791153|565651466|FG004|Part 2: Open-label Period|Death|0|||
156700573|NCT01791153|565651467|FG005|Part 2: Open-label Period|Death|1|||
156700574|NCT01791153|565651468|FG006|Part 2: Open-label Period|Death|1|||
156700575|NCT01791153|565651469|FG007|Part 2: Open-label Period|Death|1|||
156700576|NCT01791153|565651462|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
156700577|NCT01791153|565651463|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
156700578|NCT01791153|565651464|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
156700579|NCT01791153|565651465|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
156700580|NCT01791153|565651466|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
156700581|NCT01791153|565651467|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
156700582|NCT01791153|565651468|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
156700583|NCT01791153|565651469|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
156700584|NCT01791153|565651462|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
156700585|NCT01791153|565651463|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
156700586|NCT01791153|565651464|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
156700587|NCT01791153|565651465|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
156700588|NCT01791153|565651466|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
156700589|NCT01791153|565651467|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
156700590|NCT01791153|565651468|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
156700591|NCT01791153|565651469|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
156439132|NCT05061693|564698735|FG001|24-week Extension Period|Site Closure|0|||
156439133|NCT05061693|564698736|FG002|24-week Extension Period|Site Closure|0|||
156439134|NCT05061693|564698737|FG003|24-week Extension Period|Site Closure|0|||
156700592|NCT01791153|565651462|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
156700593|NCT01791153|565651463|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
156700594|NCT01791153|565651464|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
156700595|NCT01791153|565651465|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
156700596|NCT01791153|565651466|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
156700597|NCT01791153|565651467|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
156700598|NCT01791153|565651468|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
156700599|NCT01791153|565651469|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
156700600|NCT01791153|565651462|FG000|Part 2: Open-label Period|Physician Decision|0|||
156700601|NCT01791153|565651463|FG001|Part 2: Open-label Period|Physician Decision|0|||
156700602|NCT01791153|565651464|FG002|Part 2: Open-label Period|Physician Decision|0|||
156700603|NCT01791153|565651465|FG003|Part 2: Open-label Period|Physician Decision|0|||
156700604|NCT01791153|565651466|FG004|Part 2: Open-label Period|Physician Decision|1|||
156700605|NCT01791153|565651467|FG005|Part 2: Open-label Period|Physician Decision|1|||
156700606|NCT01791153|565651468|FG006|Part 2: Open-label Period|Physician Decision|0|||
156700607|NCT01791153|565651469|FG007|Part 2: Open-label Period|Physician Decision|0|||
156700608|NCT02357342|565651470|FG000|First 6 Months|Death|2|||
156439135|NCT05061693|564698738|FG004|24-week Extension Period|Site Closure|0|||
156439136|NCT05061693|564698739|FG005|24-week Extension Period|Site Closure|0|||
156439137|NCT05061693|564698740|FG006|24-week Extension Period|Site Closure|0|||
156439138|NCT05061693|564698741|FG007|24-week Extension Period|Site Closure|0|||
156439139|NCT05061693|564698742|FG008|24-week Extension Period|Site Closure|1|||
156439140|NCT05061693|564698743|FG009|24-week Extension Period|Site Closure|0|||
156439141|NCT05061693|564698744|FG010|24-week Extension Period|Site Closure|0|||
156439142|NCT05061693|564698745|FG011|24-week Extension Period|Site Closure|1|||
156439143|NCT03823911|564698746|FG000|Overall Study|Lost to Follow-up|1|||
156439144|NCT03823911|564698747|FG001|Overall Study|Lost to Follow-up|5|||
156439145|NCT03823911|564698748|FG002|Overall Study|Lost to Follow-up|2|||
156439146|NCT03823911|564698746|FG000|Overall Study|Did not meet eligibility criteria|13|||
156439147|NCT03823911|564698747|FG001|Overall Study|Did not meet eligibility criteria|7|||
156439148|NCT03823911|564698748|FG002|Overall Study|Did not meet eligibility criteria|4|||
156439149|NCT03823911|564698746|FG000|Overall Study|Death|0|||
156439150|NCT03823911|564698747|FG001|Overall Study|Death|1|||
156531099|NCT01372410|565039836|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
156439151|NCT03823911|564698748|FG002|Overall Study|Death|0|||
156439152|NCT04009577|564698749|FG000|Core Study|Adverse Event|1|||
156531100|NCT01372410|565039837|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
156531101|NCT01372410|565039830|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
156700609|NCT02357342|565651471|FG001|First 6 Months|Death|0|||
156700610|NCT03923530|565651472|FG000|Overall Study|Withdrawal by Subject|1|||
156700611|NCT03923530|565651472|FG000|Overall Study|screen failure|3|||
156700612|NCT01408628|565651475|FG000|Consented|Withdrawal by Subject|12|||
156700613|NCT01408628|565651475|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
156700614|NCT01408628|565651475|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
156439153|NCT04009577|564698750|FG001|Core Study|Adverse Event|0|||
156531102|NCT01372410|565039831|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
156439154|NCT04009577|564698751|FG002|Core Study|Adverse Event|2|||
156439155|NCT04009577|564698752|FG003|Core Study|Adverse Event|4|||
156439156|NCT04009577|564698749|FG000|Core Study|Withdrawal by Subject|0|||
156439157|NCT04009577|564698750|FG001|Core Study|Withdrawal by Subject|0|||
156439158|NCT04009577|564698751|FG002|Core Study|Withdrawal by Subject|2|||
156439159|NCT04009577|564698752|FG003|Core Study|Withdrawal by Subject|0|||
156439160|NCT04009577|564698749|FG000|Core Study|Other|0|||
156439161|NCT04009577|564698750|FG001|Core Study|Other|0|||
156439162|NCT04009577|564698751|FG002|Core Study|Other|0|||
156439163|NCT04009577|564698752|FG003|Core Study|Other|1|||
156439164|NCT04009577|564698749|FG000|Extension Phase|Adverse Event|0|||
156439165|NCT04009577|564698750|FG001|Extension Phase|Adverse Event|0|||
156439166|NCT04009577|564698751|FG002|Extension Phase|Adverse Event|0|||
156439167|NCT04009577|564698752|FG003|Extension Phase|Adverse Event|1|||
156439168|NCT04009577|564698749|FG000|Extension Phase|Inadequate therapeutic effect|0|||
156439169|NCT04009577|564698750|FG001|Extension Phase|Inadequate therapeutic effect|0|||
156439170|NCT04009577|564698751|FG002|Extension Phase|Inadequate therapeutic effect|1|||
156439171|NCT04009577|564698752|FG003|Extension Phase|Inadequate therapeutic effect|0|||
156439172|NCT04009577|564698749|FG000|Extension Phase|Withdrawal by Subject|0|||
156439173|NCT04009577|564698750|FG001|Extension Phase|Withdrawal by Subject|0|||
156700615|NCT01408628|565651475|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
156700616|NCT01181271|565651476|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
156700617|NCT01181271|565651476|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
156700618|NCT01181271|565651476|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
156700619|NCT01181271|565651476|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
156700620|NCT01753336|565651477|FG000|Overall Study|Patient decision|12|||
156700621|NCT01753336|565651477|FG000|Overall Study|Lost to Follow-up|3|||
156700622|NCT01753336|565651477|FG000|Overall Study|Physician Decision|2|||
156700623|NCT01753336|565651477|FG000|Overall Study|Sponsor's decision|2|||
156700624|NCT01753336|565651477|FG000|Overall Study|Withdrawal by Subject|1|||
156700625|NCT02991430|565651480|FG000|Treatment Period 1|Adverse Event|1|||
156700626|NCT02991430|565651481|FG001|Treatment Period 1|Adverse Event|0|||
156700627|NCT02991430|565651482|FG002|Treatment Period 1|Adverse Event|2|||
156700628|NCT02991430|565651480|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156700629|NCT02991430|565651481|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156700630|NCT02991430|565651482|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156700631|NCT02991430|565651480|FG000|Treatment Period 2|Study Termination|6|||
156700632|NCT02991430|565651481|FG001|Treatment Period 2|Study Termination|3|||
156700633|NCT02991430|565651482|FG002|Treatment Period 2|Study Termination|3|||
156700634|NCT02991430|565651480|FG000|Treatment Period 2|Lost to Follow-up|0|||
156700635|NCT02991430|565651481|FG001|Treatment Period 2|Lost to Follow-up|0|||
156700636|NCT02991430|565651482|FG002|Treatment Period 2|Lost to Follow-up|1|||
156700637|NCT02991430|565651480|FG000|Post-treatment Observation Period|Study Termination|3|||
156700638|NCT02991430|565651481|FG001|Post-treatment Observation Period|Study Termination|6|||
156700639|NCT02991430|565651482|FG002|Post-treatment Observation Period|Study Termination|5|||
156700640|NCT01150890|565651483|FG000|Overall Study|Other|0|||
156700641|NCT01150890|565651484|FG001|Overall Study|Other|1|||
156700642|NCT01150890|565651485|FG002|Overall Study|Other|0|||
156700643|NCT01150890|565651486|FG003|Overall Study|Other|2|||
156700644|NCT01150890|565651483|FG000|Overall Study|Pregnancy|0|||
156700645|NCT01150890|565651484|FG001|Overall Study|Pregnancy|0|||
156439174|NCT04009577|564698751|FG002|Extension Phase|Withdrawal by Subject|1|||
156439175|NCT04009577|564698752|FG003|Extension Phase|Withdrawal by Subject|0|||
156439176|NCT04009577|564698749|FG000|Extension Phase|Not Treated|0|||
156439177|NCT04009577|564698750|FG001|Extension Phase|Not Treated|0|||
156439178|NCT04009577|564698751|FG002|Extension Phase|Not Treated|2|||
156439179|NCT04009577|564698752|FG003|Extension Phase|Not Treated|0|||
156439180|NCT00305695|564698762|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
156439181|NCT00305695|564698763|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
156439182|NCT00305695|564698762|FG000|Overall Study|Did not have baseline scan|1|||
156439183|NCT00305695|564698763|FG001|Overall Study|Did not have baseline scan|1|||
156439184|NCT04305405|564698765|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156439185|NCT04305405|564698766|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156439186|NCT00837616|564698769|FG000|Overall Study|Withdrawal by Subject|0|||
156700646|NCT01150890|565651485|FG002|Overall Study|Pregnancy|0|||
156700647|NCT01150890|565651486|FG003|Overall Study|Pregnancy|1|||
156439187|NCT00837616|564698770|FG001|Overall Study|Withdrawal by Subject|1|||
156700648|NCT01150890|565651483|FG000|Overall Study|Administrative Decision|4|||
156700649|NCT01150890|565651484|FG001|Overall Study|Administrative Decision|4|||
156439188|NCT02674750|564698772|FG000|Overall Study|Death|4|||
156439189|NCT02674750|564698773|FG001|Overall Study|Death|5|||
156700650|NCT01150890|565651485|FG002|Overall Study|Administrative Decision|5|||
156700651|NCT01150890|565651486|FG003|Overall Study|Administrative Decision|6|||
156439190|NCT02674750|564698774|FG002|Overall Study|Death|8|||
156439191|NCT02674750|564698772|FG000|Overall Study|Lost to Follow-up|0|||
156439192|NCT02674750|564698773|FG001|Overall Study|Lost to Follow-up|8|||
156439193|NCT02674750|564698774|FG002|Overall Study|Lost to Follow-up|0|||
156531103|NCT01372410|565039832|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
156700652|NCT01150890|565651483|FG000|Overall Study|Ineligibility determined|0|||
156700653|NCT01150890|565651484|FG001|Overall Study|Ineligibility determined|1|||
156700654|NCT01150890|565651485|FG002|Overall Study|Ineligibility determined|0|||
156700655|NCT01150890|565651486|FG003|Overall Study|Ineligibility determined|0|||
156700656|NCT01150890|565651483|FG000|Overall Study|Adverse Event|0|||
156700657|NCT01150890|565651484|FG001|Overall Study|Adverse Event|0|||
156700658|NCT01150890|565651485|FG002|Overall Study|Adverse Event|2|||
156700659|NCT01150890|565651486|FG003|Overall Study|Adverse Event|0|||
156700660|NCT01150890|565651483|FG000|Overall Study|Withdrawal by Subject|0|||
156700661|NCT01150890|565651484|FG001|Overall Study|Withdrawal by Subject|0|||
156700662|NCT01150890|565651485|FG002|Overall Study|Withdrawal by Subject|2|||
156700663|NCT01150890|565651486|FG003|Overall Study|Withdrawal by Subject|1|||
156700664|NCT01150890|565651483|FG000|Overall Study|Disease progression|0|||
156700665|NCT01150890|565651484|FG001|Overall Study|Disease progression|7|||
156700666|NCT01150890|565651485|FG002|Overall Study|Disease progression|3|||
156790872|NCT01903733|565985500|FG000|Overall Study|Investigator request|18|||
156790873|NCT01903733|565985501|FG001|Overall Study|Investigator request|0|||
156790874|NCT01903733|565985502|FG002|Overall Study|Investigator request|0|||
156790875|NCT01903733|565985503|FG003|Overall Study|Investigator request|0|||
156790876|NCT01714063|565985504|FG000|Overall Study|Equipment malfunction|2|||
156790877|NCT01248468|565985505|FG000|Overall Study|Administrative problem|1|||
156790878|NCT01248468|565985506|FG001|Overall Study|Administrative problem|0|||
156790879|NCT01248468|565985507|FG002|Overall Study|Administrative problem|0|||
156790880|NCT01248468|565985505|FG000|Overall Study|Lost to Follow-up|9|||
156790881|NCT01248468|565985506|FG001|Overall Study|Lost to Follow-up|12|||
156790882|NCT01248468|565985507|FG002|Overall Study|Lost to Follow-up|4|||
156790883|NCT01248468|565985505|FG000|Overall Study|Pregnancy|1|||
156790884|NCT01248468|565985506|FG001|Overall Study|Pregnancy|0|||
156790885|NCT01248468|565985507|FG002|Overall Study|Pregnancy|0|||
156790886|NCT01248468|565985505|FG000|Overall Study|Withdrawal by Subject|4|||
156790887|NCT01248468|565985506|FG001|Overall Study|Withdrawal by Subject|2|||
156790888|NCT01248468|565985507|FG002|Overall Study|Withdrawal by Subject|0|||
156790889|NCT02191397|565985508|FG000|Overall Study|Adverse Event|28|||
156790890|NCT02191397|565985509|FG001|Overall Study|Adverse Event|17|||
156790891|NCT02191397|565985508|FG000|Overall Study|Lack of Efficacy|10|||
156790892|NCT02191397|565985509|FG001|Overall Study|Lack of Efficacy|5|||
156790893|NCT02191397|565985508|FG000|Overall Study|Protocol Violation|0|||
156790894|NCT02191397|565985509|FG001|Overall Study|Protocol Violation|3|||
156331621|NCT00810693|564313496|FG000|Treatment Period|Protocol Violation|1|||
156331622|NCT00810693|564313497|FG001|Treatment Period|Protocol Violation|2|||
156331623|NCT00810693|564313498|FG002|Treatment Period|Protocol Violation|2|||
156331624|NCT00810693|564313496|FG000|Treatment Period|Withdrawal by Subject|6|||
156331625|NCT00810693|564313497|FG001|Treatment Period|Withdrawal by Subject|2|||
156331626|NCT00810693|564313498|FG002|Treatment Period|Withdrawal by Subject|3|||
156331627|NCT00810693|564313496|FG000|Treatment Period|Not treated|0|||
156331628|NCT00810693|564313497|FG001|Treatment Period|Not treated|1|||
156331629|NCT00810693|564313498|FG002|Treatment Period|Not treated|1|||
156331630|NCT00810693|564313496|FG000|Follow-up Period (FUP)|Adverse Event|3|||
156331631|NCT00810693|564313497|FG001|Follow-up Period (FUP)|Adverse Event|1|||
156331632|NCT00810693|564313498|FG002|Follow-up Period (FUP)|Adverse Event|1|||
156331633|NCT00810693|564313496|FG000|Follow-up Period (FUP)|Death|2|||
156331634|NCT00810693|564313497|FG001|Follow-up Period (FUP)|Death|0|||
156331635|NCT00810693|564313498|FG002|Follow-up Period (FUP)|Death|1|||
156331636|NCT00810693|564313496|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
156331637|NCT00810693|564313497|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
156331638|NCT00810693|564313498|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
156331639|NCT00810693|564313496|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
156331640|NCT00810693|564313497|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
156331641|NCT00810693|564313498|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
156331642|NCT00810693|564313496|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
156331643|NCT00810693|564313497|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
156331644|NCT00810693|564313498|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
156331645|NCT00936611|564313503|FG000|Overall Study|Progressive Disease|3|||
156331646|NCT00936611|564313503|FG000|Overall Study|New Systemic Therapy|22|||
156331647|NCT00936611|564313503|FG000|Overall Study|Lost to Follow-up|1|||
156331648|NCT00936611|564313503|FG000|Overall Study|Withdrawal by Subject|2|||
156331649|NCT00936611|564313503|FG000|Overall Study|Still on Follow-up|1|||
156331650|NCT00936611|564313503|FG000|Overall Study|Still on Active Therapy|7|||
156331651|NCT00936611|564313503|FG000|Overall Study|Ineligible for Study Drug|3|||
156331652|NCT02282358|564313504|FG000|Overall Study|Nonevaluable|1|||
156331653|NCT01898208|564313505|FG000|Overall Study|Positive blood culture|17|||
156700667|NCT01150890|565651486|FG003|Overall Study|Disease progression|7|||
156700668|NCT01672970|565651487|FG000|Overall Study|Lack of Efficacy|12|||
156790895|NCT02191397|565985508|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
156790896|NCT02191397|565985509|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
156331654|NCT01898208|564313506|FG001|Overall Study|Positive blood culture|23|||
156700669|NCT01672970|565651487|FG000|Overall Study|Adverse Event|18|||
156700670|NCT01672970|565651487|FG000|Overall Study|Withdrawal by Subject|2|||
156700671|NCT01672970|565651487|FG000|Overall Study|Lost to Follow-up|5|||
156700672|NCT01672970|565651487|FG000|Overall Study|Other|9|||
156700673|NCT01672970|565651487|FG000|Overall Study|Enrolled but not treated|1|||
156700674|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
156700675|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
156700676|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
156700677|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
156700678|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
156700679|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
156531104|NCT01372410|565039833|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
156331655|NCT01898208|564313507|FG002|Overall Study|Positive blood culture|15|||
156331656|NCT01898208|564313505|FG000|Overall Study|Death/comfort care within 24 hours|10|||
156331657|NCT01898208|564313506|FG001|Overall Study|Death/comfort care within 24 hours|9|||
156331658|NCT01898208|564313507|FG002|Overall Study|Death/comfort care within 24 hours|8|||
156331659|NCT01898208|564313505|FG000|Overall Study|Negative Gram Stain|6|||
156331660|NCT01898208|564313506|FG001|Overall Study|Negative Gram Stain|9|||
156331661|NCT01898208|564313507|FG002|Overall Study|Negative Gram Stain|6|||
156331662|NCT01898208|564313505|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
156331663|NCT01898208|564313506|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
156331664|NCT01898208|564313507|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
156331665|NCT01898208|564313505|FG000|Overall Study|System/Technical Error|1|||
156331666|NCT01898208|564313506|FG001|Overall Study|System/Technical Error|2|||
156700680|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
156700681|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
156700682|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Other|0|||
156700683|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Other|1|||
156700684|NCT04430855|565651490|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
156700685|NCT04430855|565651491|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
156700686|NCT04430855|565651490|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
156700687|NCT04430855|565651491|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
156700688|NCT04430855|565651490|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
156700689|NCT04430855|565651491|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
156700690|NCT01770392|565651492|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
156700691|NCT03401450|565651493|FG000|Overall Study|Lost to Follow-up|4|||
156700692|NCT03401450|565651494|FG001|Overall Study|Lost to Follow-up|6|||
156700693|NCT03401450|565651493|FG000|Overall Study|Anesthesia plan changed|2|||
156700694|NCT03401450|565651494|FG001|Overall Study|Anesthesia plan changed|2|||
156700695|NCT03401450|565651493|FG000|Overall Study|Did not complete medication diary|4|||
156700696|NCT03401450|565651494|FG001|Overall Study|Did not complete medication diary|2|||
156700697|NCT03401450|565651493|FG000|Overall Study|post surgery medication change|2|||
156700698|NCT03401450|565651494|FG001|Overall Study|post surgery medication change|1|||
156700699|NCT03401450|565651493|FG000|Overall Study|Cancelled surgery|0|||
156700700|NCT03401450|565651494|FG001|Overall Study|Cancelled surgery|2|||
156700701|NCT03567382|565651495|FG000|Overall Study|Lost to Follow-up|1|||
156700702|NCT03567382|565651496|FG001|Overall Study|Lost to Follow-up|21|||
156700703|NCT03567382|565651497|FG002|Overall Study|Lost to Follow-up|1|||
156700704|NCT03567382|565651498|FG003|Overall Study|Lost to Follow-up|21|||
156700705|NCT03567382|565651495|FG000|Overall Study|Withdrawal by Subject|2|||
156700706|NCT03567382|565651496|FG001|Overall Study|Withdrawal by Subject|14|||
156700707|NCT03567382|565651497|FG002|Overall Study|Withdrawal by Subject|1|||
156700708|NCT03567382|565651498|FG003|Overall Study|Withdrawal by Subject|12|||
156700709|NCT02011386|565651499|FG000|Overall Study|Non-compliance|2|||
156700710|NCT02011386|565651499|FG000|Overall Study|Lack of Efficacy|3|||
156700711|NCT02352779|565651500|FG000|Overall Study|Personal Issues|1|||
156700712|NCT02352779|565651501|FG001|Overall Study|Personal Issues|1|||
156700713|NCT02352779|565651502|FG002|Overall Study|Personal Issues|0|||
156700714|NCT02352779|565651500|FG000|Overall Study|Too Many Forms|2|||
156700715|NCT02352779|565651501|FG001|Overall Study|Too Many Forms|0|||
156700716|NCT02352779|565651502|FG002|Overall Study|Too Many Forms|0|||
156700717|NCT02352779|565651500|FG000|Overall Study|Feeling Overwhelmed|1|||
156700718|NCT02352779|565651501|FG001|Overall Study|Feeling Overwhelmed|0|||
156700719|NCT02352779|565651502|FG002|Overall Study|Feeling Overwhelmed|0|||
156700720|NCT02352779|565651500|FG000|Overall Study|Disliked Intervention|1|||
156700721|NCT02352779|565651501|FG001|Overall Study|Disliked Intervention|0|||
156700722|NCT02352779|565651502|FG002|Overall Study|Disliked Intervention|0|||
156700723|NCT02352779|565651500|FG000|Overall Study|Changed Mind|1|||
156700724|NCT02352779|565651501|FG001|Overall Study|Changed Mind|0|||
156700725|NCT02352779|565651502|FG002|Overall Study|Changed Mind|0|||
156700726|NCT02352779|565651500|FG000|Overall Study|Study Related Symptoms|1|||
156700727|NCT02352779|565651501|FG001|Overall Study|Study Related Symptoms|0|||
156700728|NCT02352779|565651502|FG002|Overall Study|Study Related Symptoms|0|||
156700729|NCT02352779|565651500|FG000|Overall Study|Absence of Symptoms|1|||
156700730|NCT02352779|565651501|FG001|Overall Study|Absence of Symptoms|0|||
156700731|NCT02352779|565651502|FG002|Overall Study|Absence of Symptoms|0|||
156700732|NCT02352779|565651500|FG000|Overall Study|Other Medical Reason|0|||
156700733|NCT02352779|565651501|FG001|Overall Study|Other Medical Reason|0|||
156700734|NCT02352779|565651502|FG002|Overall Study|Other Medical Reason|1|||
156700735|NCT02352779|565651500|FG000|Overall Study|No Reason|0|||
156700736|NCT02352779|565651501|FG001|Overall Study|No Reason|0|||
156700737|NCT02352779|565651502|FG002|Overall Study|No Reason|1|||
156700738|NCT00761865|565651503|FG000|Overall Study|Lost to Follow-up|8|||
156700739|NCT00761865|565651504|FG001|Overall Study|Lost to Follow-up|7|||
156700740|NCT04555720|565651505|FG000|Overall Study|Lost to Follow-up|2|||
156700741|NCT04555720|565651506|FG001|Overall Study|Lost to Follow-up|0|||
156700742|NCT04555720|565651507|FG002|Overall Study|Lost to Follow-up|0|||
156700743|NCT04555720|565651508|FG003|Overall Study|Lost to Follow-up|0|||
156700744|NCT04555720|565651505|FG000|Overall Study|Withdrawal by Subject|4|||
156700745|NCT04555720|565651506|FG001|Overall Study|Withdrawal by Subject|6|||
156700746|NCT04555720|565651507|FG002|Overall Study|Withdrawal by Subject|0|||
156700747|NCT04555720|565651508|FG003|Overall Study|Withdrawal by Subject|0|||
156700748|NCT00719849|565651509|FG000|Overall Study|Death|0|||
156700749|NCT00719849|565651510|FG001|Overall Study|Death|1|||
156700750|NCT02022748|565654772|FG000|Overall Study|Adverse Event|1|||
156700751|NCT02022748|565654773|FG001|Overall Study|Adverse Event|1|||
156700752|NCT02022748|565654774|FG002|Overall Study|Adverse Event|0|||
156700753|NCT02022748|565654772|FG000|Overall Study|Withdrawal by Subject|0|||
156700754|NCT02022748|565654773|FG001|Overall Study|Withdrawal by Subject|1|||
156700755|NCT02022748|565654774|FG002|Overall Study|Withdrawal by Subject|0|||
156700756|NCT04347122|565654775|FG000|Overall Study|Physician Decision|0|||
156700757|NCT04347122|565654776|FG001|Overall Study|Physician Decision|3|||
156700758|NCT04347122|565654777|FG002|Overall Study|Physician Decision|3|||
156700759|NCT04347122|565654778|FG003|Overall Study|Physician Decision|6|||
156700760|NCT03510598|565654779|FG000|Overall Study|Withdrawal by Subject|1|||
156700761|NCT04994483|565654780|FG000|Overall Study|Adverse Event|26|||
156700762|NCT04994483|565654781|FG001|Overall Study|Adverse Event|17|||
156700763|NCT04994483|565654780|FG000|Overall Study|Lost to Follow-up|6|||
156700764|NCT04994483|565654781|FG001|Overall Study|Lost to Follow-up|10|||
156700765|NCT04994483|565654780|FG000|Overall Study|Noncompliance with study drug|8|||
156700766|NCT04994483|565654781|FG001|Overall Study|Noncompliance with study drug|5|||
156700767|NCT04994483|565654780|FG000|Overall Study|Physician Decision|5|||
156700768|NCT04994483|565654781|FG001|Overall Study|Physician Decision|0|||
156700769|NCT04994483|565654780|FG000|Overall Study|Withdrawal by Subject|41|||
156700770|NCT04994483|565654781|FG001|Overall Study|Withdrawal by Subject|38|||
156700771|NCT04994483|565654780|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
156700772|NCT04994483|565654781|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
156700773|NCT04994483|565654780|FG000|Overall Study|Met stopping criteria|1|||
156700774|NCT04994483|565654781|FG001|Overall Study|Met stopping criteria|0|||
156700775|NCT04994483|565654780|FG000|Overall Study|Randomized in error, not treated|4|||
156700776|NCT04994483|565654781|FG001|Overall Study|Randomized in error, not treated|3|||
156700777|NCT04994483|565654780|FG000|Overall Study|Lack of a reliable study partner|0|||
156700778|NCT04994483|565654781|FG001|Overall Study|Lack of a reliable study partner|1|||
156872105|NCT01075685|566289503|FG000|Overall Study|Withdrawal by Subject|20|||
156872106|NCT01075685|566289504|FG001|Overall Study|Withdrawal by Subject|5|||
156872107|NCT01075685|566289503|FG000|Overall Study|Lost to Follow-up|563|||
156872108|NCT01075685|566289504|FG001|Overall Study|Lost to Follow-up|220|||
156872109|NCT02858362|566289507|FG000|Overall Study|Protocol Violation|0|||
156700779|NCT04994483|565654780|FG000|Overall Study|Met MRI exclusion criteria|0|||
156700780|NCT04994483|565654781|FG001|Overall Study|Met MRI exclusion criteria|1|||
156700781|NCT01502410|565654782|FG000|Overall Study|Adverse Event|1|||
156700782|NCT01502410|565654783|FG001|Overall Study|Adverse Event|2|||
156700783|NCT01502410|565654784|FG002|Overall Study|Adverse Event|0|||
156700784|NCT01502410|565654785|FG003|Overall Study|Adverse Event|0|||
156700785|NCT01502410|565654782|FG000|Overall Study|Lack of Efficacy|7|||
156700786|NCT01502410|565654783|FG001|Overall Study|Lack of Efficacy|7|||
156700787|NCT01502410|565654784|FG002|Overall Study|Lack of Efficacy|0|||
156700788|NCT01502410|565654785|FG003|Overall Study|Lack of Efficacy|0|||
156700789|NCT01502410|565654782|FG000|Overall Study|Physician Decision|0|||
156700790|NCT01502410|565654783|FG001|Overall Study|Physician Decision|1|||
156700791|NCT01502410|565654784|FG002|Overall Study|Physician Decision|0|||
156700792|NCT01502410|565654785|FG003|Overall Study|Physician Decision|0|||
156700793|NCT01502410|565654782|FG000|Overall Study|Withdrawal by Subject|2|||
156700794|NCT01502410|565654783|FG001|Overall Study|Withdrawal by Subject|0|||
156700795|NCT01502410|565654784|FG002|Overall Study|Withdrawal by Subject|0|||
156700796|NCT01502410|565654785|FG003|Overall Study|Withdrawal by Subject|0|||
156700797|NCT03700385|565654788|FG000|Overall Study|Lost to Follow-up|1|||
156700798|NCT04590040|565654794|FG000|Treatment Period|Lost to Follow-up|2|||
156700799|NCT04590040|565654795|FG001|Treatment Period|Lost to Follow-up|5|||
156700800|NCT04590040|565654796|FG002|Treatment Period|Lost to Follow-up|0|||
156700801|NCT04590040|565654794|FG000|Treatment Period|Physician Decision|0|||
156700802|NCT04590040|565654795|FG001|Treatment Period|Physician Decision|0|||
156700803|NCT04590040|565654796|FG002|Treatment Period|Physician Decision|2|||
156700804|NCT03537599|565654805|FG000|Overall Study|Disease Progression|2|||
156700805|NCT03537599|565654806|FG001|Overall Study|Disease Progression|1|||
156700806|NCT03537599|565654805|FG000|Overall Study|Death|0|||
156700807|NCT03537599|565654806|FG001|Overall Study|Death|1|||
156700808|NCT05083585|565654807|FG000|Overall Study|Death|1|||
156700809|NCT05083585|565654808|FG001|Overall Study|Death|1|||
156700810|NCT05083585|565654807|FG000|Overall Study|Lost to Follow-up|1|||
156700811|NCT05083585|565654808|FG001|Overall Study|Lost to Follow-up|1|||
156700812|NCT05083585|565654807|FG000|Overall Study|Withdrawal by Subject|2|||
156700813|NCT05083585|565654808|FG001|Overall Study|Withdrawal by Subject|0|||
156700814|NCT05083585|565654807|FG000|Overall Study|Randomized but not vaccinated|2|||
156700815|NCT05083585|565654808|FG001|Overall Study|Randomized but not vaccinated|0|||
156700816|NCT00114166|565654809|FG000|Overall Study|Wrong primary|0|||
156700817|NCT00114166|565654810|FG001|Overall Study|Wrong primary|1|||
156700818|NCT03469336|565654811|FG000|Overall Study|Adverse Event|1|||
156700819|NCT02740699|565654813|FG000|Overall Study|Lost to Follow-up|5|||
156700820|NCT02740699|565654813|FG000|Overall Study|Withdrawal by Subject|14|||
156700821|NCT02740699|565654813|FG000|Overall Study|Physician Decision|5|||
156700822|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700823|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
156700824|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700825|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700826|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700827|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
156700828|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
156700829|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700830|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700831|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700832|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700833|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700834|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700835|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700836|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700837|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700838|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700839|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700840|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700841|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700842|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700843|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700844|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700845|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700846|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700847|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700848|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
156700849|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700850|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700851|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700852|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700853|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700854|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700855|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700856|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700857|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700858|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700859|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700860|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700861|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700862|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700863|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700864|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700865|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700866|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700867|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700868|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700869|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700870|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700871|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700872|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
156439194|NCT02674750|564698772|FG000|Overall Study|Lack of Efficacy|1|||
156700873|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
156700874|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
156700875|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
156700876|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
156700877|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
156700878|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
156700879|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
156700880|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
156700881|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
156700882|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
156700883|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
156700884|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
156700885|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
156700886|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
156700887|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
156700888|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
156700889|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
156700890|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
156700891|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
156700892|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
156700893|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
156700894|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
156700895|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
156700896|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
156700897|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
156700898|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700899|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700900|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700901|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700902|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700903|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700904|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700905|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700906|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700907|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700908|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700909|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700910|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700911|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700912|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700913|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700914|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700915|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700916|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700917|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700918|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700919|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700920|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700921|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700922|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700923|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700924|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700925|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700926|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700927|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
156700928|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
156700929|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700930|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700931|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
156700932|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700933|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700934|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700935|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700936|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156790897|NCT02191397|565985508|FG000|Overall Study|Lost to Follow-up|10|||
156790898|NCT02191397|565985509|FG001|Overall Study|Lost to Follow-up|11|||
156331667|NCT01898208|564313507|FG002|Overall Study|System/Technical Error|3|||
156331668|NCT01898208|564313505|FG000|Overall Study|Lost to Follow-up|3|||
156439195|NCT02674750|564698773|FG001|Overall Study|Lack of Efficacy|17|||
156439196|NCT02674750|564698774|FG002|Overall Study|Lack of Efficacy|3|||
156439197|NCT02674750|564698772|FG000|Overall Study|Withdrawal by Subject|0|||
156439198|NCT02674750|564698773|FG001|Overall Study|Withdrawal by Subject|7|||
156439199|NCT02674750|564698774|FG002|Overall Study|Withdrawal by Subject|1|||
156439200|NCT02674750|564698772|FG000|Overall Study|Other|0|||
156439201|NCT02674750|564698773|FG001|Overall Study|Other|8|||
156439202|NCT02674750|564698774|FG002|Overall Study|Other|0|||
156439203|NCT01685606|564698781|FG000|Overall Study|Withdrawal by Subject|1|||
156439204|NCT01787760|564698782|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
156439205|NCT01787760|564698783|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
156439206|NCT01787760|564698784|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
156439207|NCT01787760|564698782|FG000|Overall Study|Decompensated on left exotropia|0|||
156439208|NCT01787760|564698783|FG001|Overall Study|Decompensated on left exotropia|0|||
156439209|NCT01787760|564698784|FG002|Overall Study|Decompensated on left exotropia|1|||
156439210|NCT01787760|564698782|FG000|Overall Study|Dryness|0|||
156439211|NCT01787760|564698783|FG001|Overall Study|Dryness|1|||
156439212|NCT01787760|564698784|FG002|Overall Study|Dryness|0|||
156439213|NCT01787760|564698782|FG000|Overall Study|Relocation|1|||
156439214|NCT01787760|564698783|FG001|Overall Study|Relocation|1|||
156439215|NCT01787760|564698784|FG002|Overall Study|Relocation|0|||
156439216|NCT01787760|564698782|FG000|Overall Study|Lens discomfort|3|||
156439217|NCT01787760|564698783|FG001|Overall Study|Lens discomfort|0|||
156439218|NCT01787760|564698784|FG002|Overall Study|Lens discomfort|0|||
156439219|NCT01787760|564698782|FG000|Overall Study|Lens handling difficulty|1|||
156439220|NCT01787760|564698783|FG001|Overall Study|Lens handling difficulty|2|||
156439221|NCT01787760|564698784|FG002|Overall Study|Lens handling difficulty|0|||
156439222|NCT01787760|564698782|FG000|Overall Study|Protocol Violation|6|||
156439223|NCT01787760|564698783|FG001|Overall Study|Protocol Violation|0|||
156439224|NCT01787760|564698784|FG002|Overall Study|Protocol Violation|1|||
156439225|NCT01787760|564698782|FG000|Overall Study|Withdrawal by Subject|5|||
156439226|NCT01787760|564698783|FG001|Overall Study|Withdrawal by Subject|1|||
156439227|NCT01787760|564698784|FG002|Overall Study|Withdrawal by Subject|2|||
156439228|NCT01787760|564698782|FG000|Overall Study|Lost to Follow-up|1|||
156439229|NCT01787760|564698783|FG001|Overall Study|Lost to Follow-up|0|||
156439230|NCT01787760|564698784|FG002|Overall Study|Lost to Follow-up|1|||
156439231|NCT01787760|564698782|FG000|Overall Study|Stroke|1|||
156439232|NCT01787760|564698783|FG001|Overall Study|Stroke|0|||
156439233|NCT01787760|564698784|FG002|Overall Study|Stroke|0|||
156439234|NCT01787760|564698782|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
156439235|NCT01787760|564698783|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
156439236|NCT01787760|564698784|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
156439237|NCT01787760|564698782|FG000|Overall Study|Unsatisfactory physiological response|2|||
156439238|NCT01787760|564698783|FG001|Overall Study|Unsatisfactory physiological response|4|||
156439239|NCT01787760|564698784|FG002|Overall Study|Unsatisfactory physiological response|0|||
156439240|NCT01787760|564698782|FG000|Overall Study|Unsatisfactory visual response|1|||
156439241|NCT01787760|564698783|FG001|Overall Study|Unsatisfactory visual response|1|||
156439242|NCT01787760|564698784|FG002|Overall Study|Unsatisfactory visual response|0|||
156439243|NCT01787760|564698782|FG000|Overall Study|Near vision blur|1|||
156439244|NCT01787760|564698783|FG001|Overall Study|Near vision blur|0|||
156439245|NCT01787760|564698784|FG002|Overall Study|Near vision blur|0|||
156439246|NCT03512756|564698785|FG000|Part 1|Death|23|||
156439247|NCT03512756|564698786|FG001|Part 1|Death|18|||
156439248|NCT03512756|564698787|FG002|Part 1|Death|0|||
156439249|NCT03512756|564698788|FG003|Part 1|Death|0|||
156439250|NCT03512756|564698785|FG000|Part 1|Lost to Follow-up|0|||
156439251|NCT03512756|564698786|FG001|Part 1|Lost to Follow-up|3|||
156439252|NCT03512756|564698787|FG002|Part 1|Lost to Follow-up|0|||
156439253|NCT03512756|564698788|FG003|Part 1|Lost to Follow-up|0|||
156439254|NCT03512756|564698785|FG000|Part 1|Physician Decision|0|||
156439255|NCT03512756|564698786|FG001|Part 1|Physician Decision|1|||
156439256|NCT03512756|564698787|FG002|Part 1|Physician Decision|0|||
156439257|NCT03512756|564698788|FG003|Part 1|Physician Decision|0|||
156439258|NCT03512756|564698785|FG000|Part 1|Withdrawal by Subject|2|||
156439259|NCT03512756|564698786|FG001|Part 1|Withdrawal by Subject|2|||
156439260|NCT03512756|564698787|FG002|Part 1|Withdrawal by Subject|0|||
156439261|NCT03512756|564698788|FG003|Part 1|Withdrawal by Subject|0|||
156439262|NCT03512756|564698785|FG000|Part 2|Death|0|||
156439263|NCT03512756|564698786|FG001|Part 2|Death|0|||
156439264|NCT03512756|564698787|FG002|Part 2|Death|32|||
156439265|NCT03512756|564698788|FG003|Part 2|Death|21|||
156439266|NCT03512756|564698785|FG000|Part 2|Lost to Follow-up|0|||
156439267|NCT03512756|564698786|FG001|Part 2|Lost to Follow-up|0|||
156439268|NCT03512756|564698787|FG002|Part 2|Lost to Follow-up|1|||
156439269|NCT03512756|564698788|FG003|Part 2|Lost to Follow-up|0|||
156439270|NCT03512756|564698785|FG000|Part 2|Physician Decision|0|||
156439271|NCT03512756|564698786|FG001|Part 2|Physician Decision|0|||
156439272|NCT03512756|564698787|FG002|Part 2|Physician Decision|2|||
156439273|NCT03512756|564698788|FG003|Part 2|Physician Decision|4|||
156439274|NCT03512756|564698785|FG000|Part 2|Study Terminated by Sponsor|0|||
156439275|NCT03512756|564698786|FG001|Part 2|Study Terminated by Sponsor|0|||
156439276|NCT03512756|564698787|FG002|Part 2|Study Terminated by Sponsor|2|||
156439277|NCT03512756|564698788|FG003|Part 2|Study Terminated by Sponsor|6|||
156439278|NCT03512756|564698785|FG000|Part 2|Protocol Violation|0|||
156439279|NCT03512756|564698786|FG001|Part 2|Protocol Violation|0|||
156439280|NCT03512756|564698787|FG002|Part 2|Protocol Violation|1|||
156439281|NCT03512756|564698788|FG003|Part 2|Protocol Violation|0|||
156439282|NCT03512756|564698785|FG000|Part 2|Withdrawal by Subject|0|||
156439283|NCT03512756|564698786|FG001|Part 2|Withdrawal by Subject|0|||
156439284|NCT03512756|564698787|FG002|Part 2|Withdrawal by Subject|3|||
156439285|NCT03512756|564698788|FG003|Part 2|Withdrawal by Subject|9|||
156439286|NCT01212991|564698789|FG000|Double-blind|Lost to Follow-up|8|||
156439287|NCT01212991|564698790|FG001|Double-blind|Lost to Follow-up|4|||
156439288|NCT01212991|564698791|FG002|Double-blind|Lost to Follow-up|0|||
156439289|NCT01212991|564698789|FG000|Double-blind|Death|699|||
156439290|NCT01212991|564698790|FG001|Double-blind|Death|550|||
156439291|NCT01212991|564698791|FG002|Double-blind|Death|0|||
156439292|NCT01212991|564698789|FG000|Double-blind|Withdrawal by Subject|16|||
156439293|NCT01212991|564698790|FG001|Double-blind|Withdrawal by Subject|19|||
156439294|NCT01212991|564698791|FG002|Double-blind|Withdrawal by Subject|0|||
156439295|NCT01212991|564698789|FG000|Double-blind|Other|7|||
156439296|NCT01212991|564698790|FG001|Double-blind|Other|0|||
156439297|NCT01212991|564698791|FG002|Double-blind|Other|0|||
156439298|NCT01212991|564698789|FG000|Double-blind|Sponsor decision|142|||
156700937|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700938|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700939|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700940|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700941|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700942|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700943|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700944|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700945|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700946|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700947|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156331669|NCT01898208|564313506|FG001|Overall Study|Lost to Follow-up|1|||
156331670|NCT01898208|564313507|FG002|Overall Study|Lost to Follow-up|1|||
156331671|NCT00961649|564313508|FG000|Overall Study|Adverse Event|4|||
156331672|NCT00961649|564313509|FG001|Overall Study|Adverse Event|0|||
156700948|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700949|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700950|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700951|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700952|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700953|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
156700954|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156872110|NCT02858362|566289508|FG001|Overall Study|Protocol Violation|1|||
156331673|NCT00961649|564313510|FG002|Overall Study|Adverse Event|0|||
156331674|NCT00961649|564313511|FG003|Overall Study|Adverse Event|2|||
156331675|NCT00961649|564313508|FG000|Overall Study|Inadequate control of IOP|0|||
156439299|NCT01212991|564698790|FG001|Double-blind|Sponsor decision|38|||
156439300|NCT01212991|564698791|FG002|Double-blind|Sponsor decision|0|||
156439301|NCT01212991|564698789|FG000|Open-label|Death|0|||
156439302|NCT01212991|564698790|FG001|Open-label|Death|0|||
156439303|NCT01212991|564698791|FG002|Open-label|Death|166|||
156439304|NCT01212991|564698789|FG000|Open-label|Lost to Follow-up|0|||
156439305|NCT01212991|564698790|FG001|Open-label|Lost to Follow-up|0|||
156439306|NCT01212991|564698791|FG002|Open-label|Lost to Follow-up|5|||
156439307|NCT01212991|564698789|FG000|Open-label|Withdrawal by Subject|0|||
156439308|NCT01212991|564698790|FG001|Open-label|Withdrawal by Subject|0|||
156439309|NCT01212991|564698791|FG002|Open-label|Withdrawal by Subject|7|||
156439310|NCT01212991|564698789|FG000|Open-label|Sponsor decision|0|||
156331676|NCT00961649|564313509|FG001|Overall Study|Inadequate control of IOP|0|||
156331677|NCT00961649|564313510|FG002|Overall Study|Inadequate control of IOP|0|||
156439311|NCT01212991|564698790|FG001|Open-label|Sponsor decision|0|||
156439312|NCT01212991|564698791|FG002|Open-label|Sponsor decision|53|||
156439313|NCT01212991|564698789|FG000|Open-label|Other|0|||
156439314|NCT01212991|564698790|FG001|Open-label|Other|0|||
156439315|NCT01212991|564698791|FG002|Open-label|Other|3|||
156331678|NCT00961649|564313511|FG003|Overall Study|Inadequate control of IOP|1|||
156439316|NCT03312907|564700043|FG000|Overall Study|Adverse Event|1|||
156439317|NCT03312907|564700044|FG001|Overall Study|Adverse Event|6|||
156439318|NCT03312907|564700045|FG002|Overall Study|Adverse Event|1|||
156439319|NCT03312907|564700043|FG000|Overall Study|Protocol Violation|2|||
156439320|NCT03312907|564700044|FG001|Overall Study|Protocol Violation|3|||
156439321|NCT03312907|564700045|FG002|Overall Study|Protocol Violation|4|||
156700955|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700956|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700957|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700958|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700959|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700960|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700961|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700962|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700963|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700964|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700965|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700966|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700967|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700968|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700969|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700970|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700971|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700972|NCT02393248|565654815|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700973|NCT02393248|565654816|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700974|NCT02393248|565654817|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700975|NCT02393248|565654818|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700976|NCT02393248|565654819|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700977|NCT02393248|565654820|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700978|NCT02393248|565654821|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700979|NCT02393248|565654822|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700980|NCT02393248|565654823|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700981|NCT02393248|565654824|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700982|NCT02393248|565654825|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700983|NCT02393248|565654826|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
156700984|NCT02393248|565654827|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
156700985|NCT02393248|565654828|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
156700986|NCT02393248|565654829|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
156700987|NCT02393248|565654830|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700988|NCT02393248|565654831|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700989|NCT02393248|565654832|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700990|NCT02393248|565654833|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700991|NCT02393248|565654834|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700992|NCT02393248|565654835|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700993|NCT02393248|565654836|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700994|NCT02393248|565654837|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700995|NCT02393248|565654838|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700996|NCT02393248|565654839|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700997|NCT02393248|565654815|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156700998|NCT02393248|565654816|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156700999|NCT02393248|565654817|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701000|NCT02393248|565654818|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701001|NCT02393248|565654819|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701002|NCT02393248|565654820|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701003|NCT02393248|565654821|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701004|NCT02393248|565654822|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701005|NCT02393248|565654823|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701006|NCT02393248|565654824|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701007|NCT02393248|565654825|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
156701008|NCT02393248|565654826|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
156701009|NCT02393248|565654827|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701010|NCT02393248|565654828|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701011|NCT02393248|565654829|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701012|NCT02393248|565654830|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701013|NCT02393248|565654831|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701014|NCT02393248|565654832|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701015|NCT02393248|565654833|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156439322|NCT03312907|564700043|FG000|Overall Study|Lost to Follow-up|2|||
156701016|NCT02393248|565654834|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701017|NCT02393248|565654835|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701018|NCT02393248|565654836|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701019|NCT02393248|565654837|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701020|NCT02393248|565654838|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701021|NCT02393248|565654839|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701022|NCT02393248|565654815|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
156701023|NCT02393248|565654816|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
156701024|NCT02393248|565654817|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
156701025|NCT02393248|565654818|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
156701026|NCT02393248|565654819|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
156701027|NCT02393248|565654820|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
156701028|NCT02393248|565654821|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
156701029|NCT02393248|565654822|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
156701030|NCT02393248|565654823|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
156701031|NCT02393248|565654824|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
156701032|NCT02393248|565654825|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
156701033|NCT02393248|565654826|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
156701034|NCT02393248|565654827|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
156701035|NCT02393248|565654828|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
156701036|NCT02393248|565654829|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
156701037|NCT02393248|565654830|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
156701038|NCT02393248|565654831|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
156701039|NCT02393248|565654832|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
156701040|NCT02393248|565654833|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
156701041|NCT02393248|565654834|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
156701042|NCT02393248|565654835|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
156701043|NCT02393248|565654836|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
156701044|NCT02393248|565654837|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
156701045|NCT02393248|565654838|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
156701046|NCT02393248|565654839|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
156701047|NCT02393248|565654815|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701048|NCT02393248|565654816|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701049|NCT02393248|565654817|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701050|NCT02393248|565654818|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701051|NCT02393248|565654819|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701052|NCT02393248|565654820|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701053|NCT02393248|565654821|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701054|NCT02393248|565654822|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701055|NCT02393248|565654823|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701056|NCT02393248|565654824|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701057|NCT02393248|565654825|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701058|NCT02393248|565654826|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
156701059|NCT02393248|565654827|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701060|NCT02393248|565654828|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
156701061|NCT02393248|565654829|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701062|NCT02393248|565654830|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701063|NCT02393248|565654831|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701064|NCT02393248|565654832|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701065|NCT02393248|565654833|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701066|NCT02393248|565654834|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701067|NCT02393248|565654835|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701068|NCT02393248|565654836|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701069|NCT02393248|565654837|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701070|NCT02393248|565654838|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156790899|NCT02191397|565985508|FG000|Overall Study|Physician Decision|8|||
156439323|NCT03312907|564700044|FG001|Overall Study|Lost to Follow-up|3|||
156331679|NCT00961649|564313508|FG000|Overall Study|Patient has travel plans during holidays|0|||
156331680|NCT00961649|564313509|FG001|Overall Study|Patient has travel plans during holidays|0|||
156331681|NCT00961649|564313510|FG002|Overall Study|Patient has travel plans during holidays|1|||
156331682|NCT00961649|564313511|FG003|Overall Study|Patient has travel plans during holidays|0|||
156331683|NCT00961649|564313508|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
156331684|NCT00961649|564313509|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
156331685|NCT00961649|564313510|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
156331686|NCT00961649|564313511|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
156331687|NCT00961649|564313508|FG000|Overall Study|Study terminated by sponsor|4|||
156439324|NCT03312907|564700045|FG002|Overall Study|Lost to Follow-up|2|||
156439325|NCT03312907|564700043|FG000|Overall Study|Physician Decision|3|||
156701071|NCT02393248|565654839|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701072|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701073|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701074|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701075|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701076|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701077|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701078|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701079|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701080|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701081|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701082|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701083|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701084|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701085|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701086|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701087|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701088|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701089|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701090|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
156701091|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701092|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
156701093|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
156701094|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701095|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
156701096|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701097|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Death|0|||
156701098|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Death|0|||
156701099|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Death|0|||
156701100|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Death|0|||
156701101|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Death|0|||
156701102|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Death|0|||
156701103|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Death|0|||
156701104|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Death|0|||
156701105|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Death|0|||
156701106|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Death|0|||
156701107|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Death|0|||
156701108|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Death|0|||
156701109|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Death|0|||
156701110|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Death|0|||
156701111|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Death|0|||
156701112|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Death|1|||
156701113|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Death|7|||
156701114|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Death|5|||
156701115|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Death|5|||
156701116|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Death|3|||
156701117|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Death|7|||
156701118|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Death|5|||
156701119|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Death|6|||
156701120|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Death|3|||
156701121|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Death|0|||
156701122|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701123|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701124|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701125|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701126|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701127|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701128|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701129|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701130|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701131|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701132|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701133|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156872111|NCT02858362|566289509|FG002|Overall Study|Protocol Violation|0|||
156331688|NCT00961649|564313509|FG001|Overall Study|Study terminated by sponsor|4|||
156701134|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701135|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701136|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701137|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701138|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701139|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701140|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701141|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701142|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701143|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701144|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701145|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
156701146|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701147|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Disease Progression|0|||
156701148|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Disease Progression|0|||
156701149|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Disease Progression|0|||
156701150|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Disease Progression|0|||
156701151|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Disease Progression|0|||
156701152|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Disease Progression|0|||
156701153|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Disease Progression|0|||
156701154|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Disease Progression|0|||
156701155|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Disease Progression|0|||
156701156|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Disease Progression|0|||
156701157|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Disease Progression|0|||
156701158|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Disease Progression|0|||
156701159|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Disease Progression|0|||
156701160|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Disease Progression|0|||
156701161|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Disease Progression|0|||
156701162|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Disease Progression|0|||
156701163|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Disease Progression|0|||
156701164|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Disease Progression|0|||
156701165|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Disease Progression|0|||
156701166|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Disease Progression|0|||
156701167|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Disease Progression|2|||
156701168|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Disease Progression|1|||
156701169|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Disease Progression|0|||
156701170|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Disease Progression|0|||
156701171|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Disease Progression|0|||
156701172|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701173|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701174|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
156439326|NCT03312907|564700044|FG001|Overall Study|Physician Decision|4|||
156439327|NCT03312907|564700045|FG002|Overall Study|Physician Decision|2|||
156439328|NCT03312907|564700043|FG000|Overall Study|Withdrawal by Subject|9|||
156439329|NCT03312907|564700044|FG001|Overall Study|Withdrawal by Subject|14|||
156439330|NCT03312907|564700045|FG002|Overall Study|Withdrawal by Subject|10|||
156439331|NCT03481777|564700046|FG000|Overall Study|Withdrawal by Subject|36|||
156439332|NCT03481777|564700047|FG001|Overall Study|Withdrawal by Subject|31|||
156439333|NCT03481777|564700046|FG000|Overall Study|Non stroke = non target population|277|||
156439334|NCT03481777|564700047|FG001|Overall Study|Non stroke = non target population|254|||
156439335|NCT01780298|564700048|FG000|Overall Study|Physician Decision|1|||
156439336|NCT01780298|564700049|FG001|Overall Study|Physician Decision|5|||
156439337|NCT01780298|564700050|FG002|Overall Study|Physician Decision|1|||
156439338|NCT01780298|564700051|FG003|Overall Study|Physician Decision|1|||
156439339|NCT01780298|564700048|FG000|Overall Study|Subject not matched|1|||
156439340|NCT01780298|564700049|FG001|Overall Study|Subject not matched|0|||
156439341|NCT01780298|564700050|FG002|Overall Study|Subject not matched|1|||
156439342|NCT01780298|564700051|FG003|Overall Study|Subject not matched|0|||
156439343|NCT01780298|564700048|FG000|Overall Study|Adverse Event|0|||
156439344|NCT01780298|564700049|FG001|Overall Study|Adverse Event|0|||
156439345|NCT01780298|564700050|FG002|Overall Study|Adverse Event|2|||
156439346|NCT01780298|564700051|FG003|Overall Study|Adverse Event|0|||
156439347|NCT03613740|564700063|FG000|Overall Study|Lost to Follow-up|1|||
156439348|NCT03613740|564700064|FG001|Overall Study|Lost to Follow-up|1|||
156439349|NCT02407249|564700065|FG000|Overall Study|Did not complete 12-month follow-up|13|||
156439350|NCT02407249|564700065|FG000|Overall Study|Not treated|13|||
156439351|NCT04252586|564700066|FG000|Overall Study|Withdrawal by parent/guardian|3|||
156439352|NCT04252586|564700066|FG000|Overall Study|Adverse Event|1|||
156439353|NCT04252586|564700066|FG000|Overall Study|Death|2|||
156439354|NCT04252586|564700066|FG000|Overall Study|Study terminated by sponsor|4|||
156439355|NCT04252586|564700066|FG000|Overall Study|Sponsor request|10|||
156439356|NCT04252586|564700066|FG000|Overall Study|Did not complete treatment period|1|||
156439357|NCT02748317|564700067|FG000|Overall Study|Withdrawal by Subject|14|||
156439358|NCT02748317|564700067|FG000|Overall Study|Lost to Follow-up|8|||
156439359|NCT02748317|564700067|FG000|Overall Study|Death|1|||
156439360|NCT03452189|564700068|FG000|First Intervention (3 Months)|Adverse Event|1|||
156439361|NCT03452189|564700069|FG001|First Intervention (3 Months)|Adverse Event|0|||
156439362|NCT03452189|564700068|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
156701175|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
156790900|NCT02191397|565985509|FG001|Overall Study|Physician Decision|3|||
156701176|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701177|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701178|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701179|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701180|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701181|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701182|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701183|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701184|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701185|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701186|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701187|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701188|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701189|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701190|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701191|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701192|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
156701193|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
156701194|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701195|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701196|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701197|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701198|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701199|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701200|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701201|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701202|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701203|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701204|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701205|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701206|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701207|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701208|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701209|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701210|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701211|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701212|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701213|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701214|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701215|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701216|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156872112|NCT02858362|566289507|FG000|Overall Study|Withdrawal by Subject|1|||
156439363|NCT03452189|564700069|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
156439364|NCT02724592|564700070|FG000|Overall Study|Lost to Follow-up|4|||
156439365|NCT02724592|564700071|FG001|Overall Study|Lost to Follow-up|1|||
156439366|NCT02374463|564700074|FG000|Overall Study|Withdrawal by Subject|3|||
156439367|NCT02374463|564700075|FG001|Overall Study|Withdrawal by Subject|3|||
156439368|NCT01424397|564700076|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
156331689|NCT00961649|564313510|FG002|Overall Study|Study terminated by sponsor|4|||
156331690|NCT00961649|564313511|FG003|Overall Study|Study terminated by sponsor|1|||
156331691|NCT02155881|564313512|FG000|Overall Study|Withdrawal by Subject|0|||
156331692|NCT02155881|564313513|FG001|Overall Study|Withdrawal by Subject|2|||
156331693|NCT02155881|564313512|FG000|Overall Study|Inappropriately randomized|2|||
156331694|NCT02155881|564313513|FG001|Overall Study|Inappropriately randomized|2|||
156331695|NCT00072176|564313514|FG000|Overall Study|Withdrawal by Subject|1|||
156331696|NCT00072176|564313515|FG001|Overall Study|Withdrawal by Subject|0|||
156331697|NCT00072176|564313514|FG000|Overall Study|Protocol Violation|0|||
156331698|NCT00072176|564313515|FG001|Overall Study|Protocol Violation|1|||
156331699|NCT04128371|564313516|FG000|Overall Study|Lack of Efficacy|1|||
156331700|NCT02840721|564313519|FG000|Treatment Period|Adverse Event|1|||
156331701|NCT02840721|564313519|FG000|Follow-Up|Lack of Efficacy|1|||
156331702|NCT02840721|564313519|FG000|Follow-Up|Withdrawal by Subject|4|||
156331703|NCT02840721|564313519|FG000|Follow-Up|Withdrawal of Consent|2|||
156701217|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
156701218|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701219|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701220|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701221|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701222|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Adverse Event|0|||
156701223|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Adverse Event|0|||
156701224|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Adverse Event|0|||
156701225|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Adverse Event|0|||
156701226|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Adverse Event|0|||
156701227|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Adverse Event|0|||
156701228|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Adverse Event|0|||
156701229|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Adverse Event|0|||
156701230|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Adverse Event|0|||
156701231|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Adverse Event|0|||
156701232|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Adverse Event|0|||
156701233|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Adverse Event|0|||
156701234|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Adverse Event|0|||
156701235|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Adverse Event|0|||
156701236|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Adverse Event|0|||
156701237|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Adverse Event|0|||
156701238|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Adverse Event|0|||
156701239|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Adverse Event|0|||
156701240|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Adverse Event|0|||
156701241|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Adverse Event|0|||
156701242|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Adverse Event|0|||
156701243|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Adverse Event|0|||
156701244|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Adverse Event|0|||
156701245|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Adverse Event|1|||
156701246|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Adverse Event|0|||
156701247|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701248|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701249|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701250|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701251|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701252|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701253|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701254|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701255|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701256|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156331704|NCT03594994|564313522|FG000|Overall Study|Adverse Event|1|||
156331705|NCT03594994|564313523|FG001|Overall Study|Adverse Event|0|||
156331706|NCT03594994|564313522|FG000|Overall Study|Withdrawal by Subject|0|||
156331707|NCT03594994|564313523|FG001|Overall Study|Withdrawal by Subject|1|||
156331708|NCT05274165|564313526|FG000|Overall Study|Withdrawal by Subject|3|||
156331709|NCT05274165|564313527|FG001|Overall Study|Withdrawal by Subject|3|||
156331710|NCT04452344|564313529|FG000|Overall Study|Withdrawal by Subject|3|||
156331711|NCT04452344|564313530|FG001|Overall Study|Withdrawal by Subject|6|||
156331712|NCT04452344|564313529|FG000|Overall Study|Adverse Event|1|||
156331713|NCT04452344|564313530|FG001|Overall Study|Adverse Event|2|||
156331714|NCT04452344|564313529|FG000|Overall Study|Lost to Follow-up|2|||
156331715|NCT04452344|564313530|FG001|Overall Study|Lost to Follow-up|2|||
156331716|NCT04452344|564313529|FG000|Overall Study|No Post-Op Visit|6|||
156331717|NCT04452344|564313530|FG001|Overall Study|No Post-Op Visit|7|||
156331718|NCT03350620|564313532|FG000|Stage 2|Adverse Event|0|||
156331719|NCT03350620|564313533|FG001|Stage 2|Adverse Event|1|||
156331720|NCT03350620|564313534|FG002|Stage 2|Adverse Event|1|||
156331721|NCT03350620|564313532|FG000|Stage 2|Lack of Efficacy|0|||
156331722|NCT03350620|564313533|FG001|Stage 2|Lack of Efficacy|2|||
156331723|NCT03350620|564313534|FG002|Stage 2|Lack of Efficacy|0|||
156331724|NCT03350620|564313532|FG000|Stage 2|Lost to Follow-up|1|||
156331725|NCT03350620|564313533|FG001|Stage 2|Lost to Follow-up|2|||
156331726|NCT03350620|564313534|FG002|Stage 2|Lost to Follow-up|2|||
156331727|NCT03350620|564313532|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
156331728|NCT03350620|564313533|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
156331729|NCT03350620|564313534|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
156331730|NCT03001882|564313537|FG000|Overall Study|Death|1|||
156331731|NCT03001882|564313538|FG001|Overall Study|Death|0|||
156331732|NCT03001882|564313539|FG002|Overall Study|Death|0|||
156331733|NCT03001882|564313540|FG003|Overall Study|Death|3|||
156701257|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701258|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701259|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701260|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701261|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701262|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701263|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701264|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701265|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701266|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701267|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701268|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701269|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701270|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
156701271|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701272|NCT02585934|565654840|FG000|Overall Study|Lost to Follow-up|2|||
156701273|NCT02585934|565654841|FG001|Overall Study|Lost to Follow-up|2|||
156701274|NCT02585934|565654840|FG000|Overall Study|Protocol Violation|14|||
156701275|NCT02585934|565654841|FG001|Overall Study|Protocol Violation|11|||
156701276|NCT02585934|565654840|FG000|Overall Study|Adverse Event|21|||
156701277|NCT02585934|565654841|FG001|Overall Study|Adverse Event|22|||
156701278|NCT02585934|565654840|FG000|Overall Study|Physician Decision|3|||
156701279|NCT02585934|565654841|FG001|Overall Study|Physician Decision|2|||
156701280|NCT02585934|565654840|FG000|Overall Study|Withdrawal by Subject|7|||
156701281|NCT02585934|565654841|FG001|Overall Study|Withdrawal by Subject|21|||
156331734|NCT03001882|564313537|FG000|Overall Study|Participant withdrew consent|0|||
156331735|NCT03001882|564313538|FG001|Overall Study|Participant withdrew consent|1|||
156331736|NCT03001882|564313539|FG002|Overall Study|Participant withdrew consent|0|||
156331737|NCT03001882|564313540|FG003|Overall Study|Participant withdrew consent|5|||
156331738|NCT03001882|564313537|FG000|Overall Study|Other reasons|1|||
156331739|NCT03001882|564313538|FG001|Overall Study|Other reasons|2|||
156331740|NCT03001882|564313539|FG002|Overall Study|Other reasons|0|||
156331741|NCT03001882|564313540|FG003|Overall Study|Other reasons|5|||
156331742|NCT03001882|564313537|FG000|Overall Study|Administrative reason by sponsor|0|||
156331743|NCT03001882|564313538|FG001|Overall Study|Administrative reason by sponsor|0|||
156331744|NCT03001882|564313539|FG002|Overall Study|Administrative reason by sponsor|0|||
156331745|NCT03001882|564313540|FG003|Overall Study|Administrative reason by sponsor|1|||
156331746|NCT03001882|564313537|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
156331747|NCT03001882|564313538|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
156331748|NCT03001882|564313539|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
156331749|NCT03001882|564313540|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
156331750|NCT03001882|564313537|FG000|Overall Study|Not reported|0|||
156331751|NCT03001882|564313538|FG001|Overall Study|Not reported|0|||
156331752|NCT03001882|564313539|FG002|Overall Study|Not reported|0|||
156331753|NCT03001882|564313540|FG003|Overall Study|Not reported|6|||
156331754|NCT03001882|564313537|FG000|Overall Study|Maximum clinical benefit|2|||
156331755|NCT03001882|564313538|FG001|Overall Study|Maximum clinical benefit|3|||
156331756|NCT03001882|564313539|FG002|Overall Study|Maximum clinical benefit|0|||
156331757|NCT03001882|564313540|FG003|Overall Study|Maximum clinical benefit|10|||
156331758|NCT03001882|564313537|FG000|Overall Study|AE unrelated to study drug|3|||
156331759|NCT03001882|564313538|FG001|Overall Study|AE unrelated to study drug|3|||
156331760|NCT03001882|564313539|FG002|Overall Study|AE unrelated to study drug|0|||
156331761|NCT03001882|564313540|FG003|Overall Study|AE unrelated to study drug|11|||
156331762|NCT03001882|564313537|FG000|Overall Study|Study Drug Toxicity|8|||
156331763|NCT03001882|564313538|FG001|Overall Study|Study Drug Toxicity|5|||
156331764|NCT03001882|564313539|FG002|Overall Study|Study Drug Toxicity|0|||
156331765|NCT03001882|564313540|FG003|Overall Study|Study Drug Toxicity|37|||
156331766|NCT03001882|564313537|FG000|Overall Study|Disease progression|16|||
156331767|NCT03001882|564313538|FG001|Overall Study|Disease progression|14|||
156331768|NCT03001882|564313539|FG002|Overall Study|Disease progression|1|||
156331769|NCT03001882|564313540|FG003|Overall Study|Disease progression|90|||
156331770|NCT05985395|564313541|FG000|Overall Study|Physician Decision|2|||
156331771|NCT05985395|564313542|FG001|Overall Study|Physician Decision|1|||
156331772|NCT05985395|564313541|FG000|Overall Study|Withdrawal by Subject|1|||
156331773|NCT05985395|564313542|FG001|Overall Study|Withdrawal by Subject|0|||
156331774|NCT00717093|564314965|FG000|Overall Study|Adverse Event|19|||
156331775|NCT00717093|564314966|FG001|Overall Study|Adverse Event|9|||
156331776|NCT00717093|564314965|FG000|Overall Study|Lack of Efficacy|3|||
156331777|NCT00717093|564314966|FG001|Overall Study|Lack of Efficacy|13|||
156331778|NCT00717093|564314965|FG000|Overall Study|Lost to Follow-up|9|||
156331779|NCT00717093|564314966|FG001|Overall Study|Lost to Follow-up|6|||
156701282|NCT02585934|565654840|FG000|Overall Study|Lack of Efficacy|2|||
156701283|NCT02585934|565654841|FG001|Overall Study|Lack of Efficacy|1|||
156701284|NCT02585934|565654840|FG000|Overall Study|Death|2|||
156701285|NCT02585934|565654841|FG001|Overall Study|Death|0|||
156701286|NCT02585934|565654840|FG000|Overall Study|Caregiver Withdrew Consent|7|||
156701287|NCT02585934|565654841|FG001|Overall Study|Caregiver Withdrew Consent|7|||
156701288|NCT02585934|565654840|FG000|Overall Study|Sponsor Termination|1|||
156701289|NCT02585934|565654841|FG001|Overall Study|Sponsor Termination|2|||
156701290|NCT02585934|565654840|FG000|Overall Study|Another Reason|10|||
156701291|NCT02585934|565654841|FG001|Overall Study|Another Reason|5|||
156701292|NCT04713553|565654842|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
156701293|NCT04713553|565654843|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
156701294|NCT04713553|565654844|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
156701295|NCT04713553|565654845|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
156701296|NCT04713553|565654846|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
156701297|NCT04713553|565654847|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
156701298|NCT04713553|565654848|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
156701299|NCT04713553|565654842|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156701300|NCT04713553|565654843|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156439369|NCT01424397|564700077|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439370|NCT01424397|564700078|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
156439371|NCT01424397|564700079|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439372|NCT01424397|564700080|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439373|NCT01424397|564700081|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439374|NCT01424397|564700082|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439375|NCT01424397|564700083|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439376|NCT01424397|564700084|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439377|NCT01424397|564700085|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439378|NCT01424397|564700086|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439379|NCT01424397|564700087|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
156439380|NCT01951170|564700089|FG000|Overall Study|Investigator decision|1|||
156439381|NCT00077675|564700093|FG000|Overall Study|Adverse Event|1|||
156439382|NCT00077675|564700094|FG001|Overall Study|Adverse Event|2|||
156439383|NCT00077675|564700093|FG000|Overall Study|Lost to Follow-up|6|||
156439384|NCT00077675|564700094|FG001|Overall Study|Lost to Follow-up|3|||
156439385|NCT00077675|564700093|FG000|Overall Study|Withdrawal by Subject|1|||
156439386|NCT00077675|564700094|FG001|Overall Study|Withdrawal by Subject|0|||
156439387|NCT00077675|564700093|FG000|Overall Study|Other|0|||
156439388|NCT00077675|564700094|FG001|Overall Study|Other|1|||
156439389|NCT00077675|564700093|FG000|Overall Study|Never received study treatment|3|||
156439390|NCT00077675|564700094|FG001|Overall Study|Never received study treatment|3|||
156439391|NCT02601820|564700096|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
156439392|NCT02601820|564700096|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
156439393|NCT02601820|564700096|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
156439394|NCT02601820|564700096|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
156439395|NCT01972724|564700097|FG000|Double-Blind|Rescue Criteria Met|1|||
156439396|NCT01972724|564700098|FG001|Double-Blind|Rescue Criteria Met|0|||
156439397|NCT01972724|564700099|FG002|Double-Blind|Rescue Criteria Met|0|||
156439398|NCT01972724|564700097|FG000|Double-Blind|Adverse Event|1|||
156439399|NCT01972724|564700098|FG001|Double-Blind|Adverse Event|0|||
156439400|NCT01972724|564700099|FG002|Double-Blind|Adverse Event|0|||
156439401|NCT01972724|564700097|FG000|Double-Blind|Withdrawal of Consent|2|||
156439402|NCT01972724|564700098|FG001|Double-Blind|Withdrawal of Consent|1|||
156439403|NCT01972724|564700099|FG002|Double-Blind|Withdrawal of Consent|0|||
156439404|NCT01972724|564700097|FG000|Double-Blind|Significant Protocol Deviation|5|||
156439405|NCT01972724|564700098|FG001|Double-Blind|Significant Protocol Deviation|8|||
156439406|NCT01972724|564700099|FG002|Double-Blind|Significant Protocol Deviation|0|||
156439407|NCT01972724|564700097|FG000|Open-Label|Withdrew Consent|0|||
156439408|NCT01972724|564700098|FG001|Open-Label|Withdrew Consent|0|||
156439409|NCT01972724|564700099|FG002|Open-Label|Withdrew Consent|3|||
156439410|NCT01972724|564700097|FG000|Open-Label|Significant Protocol Deviation|0|||
156439411|NCT01972724|564700098|FG001|Open-Label|Significant Protocol Deviation|0|||
156439412|NCT01972724|564700099|FG002|Open-Label|Significant Protocol Deviation|2|||
156439413|NCT02652442|564700104|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
156439414|NCT00244855|564700105|FG000|Overall Study|Withdrawal by Subject|0|||
156439415|NCT00244855|564700106|FG001|Overall Study|Withdrawal by Subject|1|||
156439416|NCT00665444|564700107|FG000|Overall Study|Physician Decision|1|||
156701301|NCT04713553|565654844|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156701302|NCT04713553|565654845|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
156701303|NCT04713553|565654846|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156439417|NCT00665444|564700107|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
156439418|NCT00364013|564700110|FG000|Overall Study|Ineligibility determined|4|||
156439419|NCT00364013|564700111|FG001|Overall Study|Ineligibility determined|2|||
156701304|NCT04713553|565654847|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156701305|NCT04713553|565654848|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156531105|NCT01372410|565039834|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
156531106|NCT01372410|565039835|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
156531107|NCT01372410|565039836|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
156531108|NCT01372410|565039837|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
156531109|NCT01372410|565039830|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
156531110|NCT01372410|565039831|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
156531111|NCT01372410|565039832|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
156531112|NCT01372410|565039833|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
156531113|NCT01372410|565039834|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
156531114|NCT01372410|565039835|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
156531115|NCT01372410|565039836|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
156531116|NCT01372410|565039837|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
156531117|NCT01372410|565039830|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
156531118|NCT01372410|565039831|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
156531119|NCT01372410|565039832|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
156531120|NCT01372410|565039833|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
156531121|NCT01372410|565039834|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
156531122|NCT01372410|565039835|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
156531123|NCT01372410|565039836|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
156531124|NCT01372410|565039837|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
156531125|NCT01372410|565039830|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
156531126|NCT01372410|565039831|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
156531127|NCT01372410|565039832|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
156531128|NCT01372410|565039833|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
156531129|NCT01372410|565039834|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
156531130|NCT01372410|565039835|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
156531131|NCT01372410|565039836|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
156531132|NCT01372410|565039837|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
156531133|NCT02644941|565039838|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
156531134|NCT02644941|565039839|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
156531135|NCT04585646|565039840|FG000|First Intervention|Physician Decision|1|||
156531136|NCT04585646|565039841|FG001|First Intervention|Physician Decision|0|||
156531137|NCT04585646|565039840|FG000|First Intervention|Lost to Follow-up|0|||
156531138|NCT04585646|565039841|FG001|First Intervention|Lost to Follow-up|3|||
156531139|NCT04585646|565039840|FG000|First Intervention|Withdrawal by Subject|0|||
156531140|NCT04585646|565039841|FG001|First Intervention|Withdrawal by Subject|1|||
156531141|NCT01145495|565039842|FG000|Overall Study|Adverse Event|6|||
156531142|NCT01145495|565039842|FG000|Overall Study|Withdrawal by Subject|6|||
156531143|NCT01145495|565039842|FG000|Overall Study|Disease progression after respone|2|||
156531144|NCT01886313|565039845|FG000|Overall Study|Adverse Event|1|||
156531145|NCT01886313|565039846|FG001|Overall Study|Adverse Event|1|||
156531146|NCT03294109|565039853|FG000|Overall Study|Withdrawal by Subject|6|||
156701306|NCT04713553|565654842|FG000|Primary Study (2 Months)|Other|1|||
156701307|NCT04713553|565654843|FG001|Primary Study (2 Months)|Other|2|||
156701308|NCT04713553|565654844|FG002|Primary Study (2 Months)|Other|0|||
156701309|NCT04713553|565654845|FG003|Primary Study (2 Months)|Other|0|||
156701310|NCT04713553|565654846|FG004|Primary Study (2 Months)|Other|1|||
156701311|NCT04713553|565654847|FG005|Primary Study (2 Months)|Other|0|||
156701312|NCT04713553|565654848|FG006|Primary Study (2 Months)|Other|0|||
156701313|NCT04713553|565654842|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
156701314|NCT04713553|565654843|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
156701315|NCT04713553|565654844|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
156701316|NCT04713553|565654845|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
156701317|NCT04713553|565654846|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
156701318|NCT04713553|565654847|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
156701319|NCT04713553|565654848|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
156701320|NCT04713553|565654842|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701321|NCT04713553|565654843|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701322|NCT04713553|565654844|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
156701323|NCT04713553|565654845|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701324|NCT04713553|565654846|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
156790901|NCT02191397|565985508|FG000|Overall Study|Withdrawal by Subject|22|||
156531147|NCT03294109|565039854|FG001|Overall Study|Withdrawal by Subject|5|||
156531148|NCT04195581|565039855|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
156531149|NCT04195581|565039855|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
156531150|NCT04195581|565039855|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
156531151|NCT04195581|565039855|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
156531152|NCT04195581|565039855|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
156701325|NCT04713553|565654847|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701326|NCT04713553|565654848|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701327|NCT02603393|565654862|FG000|Overall Study|Patient/guardian decision|32|||
156439420|NCT00364013|564700110|FG000|Overall Study|Adverse Event|4|||
156439421|NCT00364013|564700111|FG001|Overall Study|Adverse Event|3|||
156439422|NCT00364013|564700110|FG000|Overall Study|Withdrawal by Subject|13|||
156439423|NCT00364013|564700111|FG001|Overall Study|Withdrawal by Subject|18|||
156439424|NCT00364013|564700110|FG000|Overall Study|Physician Decision|3|||
156439425|NCT00364013|564700111|FG001|Overall Study|Physician Decision|3|||
156439426|NCT00364013|564700110|FG000|Overall Study|Lost to Follow-up|10|||
156439427|NCT00364013|564700111|FG001|Overall Study|Lost to Follow-up|3|||
156439428|NCT00364013|564700110|FG000|Overall Study|Protocol-specified criteria|6|||
156439429|NCT00364013|564700111|FG001|Overall Study|Protocol-specified criteria|6|||
156439430|NCT00364013|564700110|FG000|Overall Study|Other|41|||
156439431|NCT00364013|564700111|FG001|Overall Study|Other|47|||
156439432|NCT00364013|564700110|FG000|Overall Study|Ongoing|20|||
156439433|NCT00364013|564700111|FG001|Overall Study|Ongoing|13|||
156439434|NCT03740009|564700115|FG000|Overall Study|Physician Decision|9|||
156439435|NCT03740009|564700115|FG000|Overall Study|Lost to Follow-up|1|||
156439436|NCT01061151|564700116|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
156439437|NCT01061151|564700117|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
156439438|NCT01061151|564700118|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
156439439|NCT01061151|564700119|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
156439440|NCT01061151|564700116|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
156439441|NCT01061151|564700117|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
156439442|NCT01061151|564700118|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
156439443|NCT01061151|564700119|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
156439444|NCT01061151|564700116|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
156439445|NCT01061151|564700117|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
156439446|NCT01061151|564700118|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
156439447|NCT01061151|564700119|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
156439448|NCT01061151|564700116|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
156439449|NCT01061151|564700117|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
156439450|NCT01061151|564700118|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
156439451|NCT01061151|564700119|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
156439452|NCT01061151|564700116|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
156701328|NCT02603393|565654863|FG001|Overall Study|Patient/guardian decision|18|||
156701329|NCT02603393|565654862|FG000|Overall Study|Adverse Event|17|||
156701330|NCT02603393|565654863|FG001|Overall Study|Adverse Event|15|||
156701331|NCT02603393|565654862|FG000|Overall Study|Technical problems|4|||
156701332|NCT02603393|565654863|FG001|Overall Study|Technical problems|7|||
156701333|NCT02603393|565654862|FG000|Overall Study|Lack of Efficacy|7|||
156701334|NCT02603393|565654863|FG001|Overall Study|Lack of Efficacy|2|||
156701335|NCT02603393|565654862|FG000|Overall Study|Death|3|||
156701336|NCT02603393|565654863|FG001|Overall Study|Death|4|||
156701337|NCT02603393|565654862|FG000|Overall Study|Physician Decision|3|||
156701338|NCT02603393|565654863|FG001|Overall Study|Physician Decision|3|||
156701339|NCT02603393|565654862|FG000|Overall Study|Protocol deviation|2|||
156701340|NCT02603393|565654863|FG001|Overall Study|Protocol deviation|3|||
156701341|NCT02603393|565654862|FG000|Overall Study|Lost to Follow-up|1|||
156701342|NCT02603393|565654863|FG001|Overall Study|Lost to Follow-up|2|||
156701343|NCT02603393|565654862|FG000|Overall Study|Non-compliance with study treatment|1|||
156701344|NCT02603393|565654863|FG001|Overall Study|Non-compliance with study treatment|0|||
156701345|NCT02603393|565654862|FG000|Overall Study|Sponsor decision|1|||
156701346|NCT02603393|565654863|FG001|Overall Study|Sponsor decision|0|||
156701347|NCT00699374|565654864|FG000|Overall Study|Death|93|||
156439453|NCT01061151|564700117|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
156439454|NCT01061151|564700118|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
156439455|NCT01061151|564700119|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
156439456|NCT01061151|564700116|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
156439457|NCT01061151|564700117|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
156439458|NCT01061151|564700118|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
156439459|NCT01061151|564700119|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
156439460|NCT01061151|564700116|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
156439461|NCT01061151|564700117|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
156439462|NCT01061151|564700118|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
156439463|NCT01061151|564700119|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
156701348|NCT00699374|565654865|FG001|Overall Study|Death|83|||
156701349|NCT00699374|565654864|FG000|Overall Study|Adverse Event|70|||
156790902|NCT02191397|565985509|FG001|Overall Study|Withdrawal by Subject|27|||
156790903|NCT00472641|565985514|FG000|Overall Study|Lack of Efficacy|3|||
156701350|NCT00699374|565654865|FG001|Overall Study|Adverse Event|67|||
156701351|NCT00699374|565654864|FG000|Overall Study|Global deterioration of health status|7|||
156701352|NCT00699374|565654865|FG001|Overall Study|Global deterioration of health status|8|||
156701353|NCT00699374|565654864|FG000|Overall Study|Lost to Follow-up|3|||
156701354|NCT00699374|565654865|FG001|Overall Study|Lost to Follow-up|5|||
156701355|NCT00699374|565654864|FG000|Overall Study|Withdrawal by Subject|34|||
156701356|NCT00699374|565654865|FG001|Overall Study|Withdrawal by Subject|44|||
156701357|NCT00699374|565654864|FG000|Overall Study|Objective progression or relapse|281|||
156701358|NCT00699374|565654865|FG001|Overall Study|Objective progression or relapse|277|||
156701359|NCT00699374|565654864|FG000|Overall Study|Other|18|||
156701360|NCT00699374|565654865|FG001|Overall Study|Other|15|||
156701361|NCT00699374|565654864|FG000|Overall Study|Protocol Violation|2|||
156701362|NCT00699374|565654865|FG001|Overall Study|Protocol Violation|6|||
156439464|NCT01061151|564700116|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
156439465|NCT01061151|564700117|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
156439466|NCT01061151|564700118|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
156439467|NCT01061151|564700119|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
156439468|NCT01061151|564700116|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
156439469|NCT01061151|564700117|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
156439470|NCT01061151|564700118|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
156439471|NCT01061151|564700119|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
156439472|NCT01061151|564700116|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
156439473|NCT01061151|564700117|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
156439474|NCT01061151|564700118|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
156439475|NCT01061151|564700119|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
156439476|NCT01061151|564700116|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
156439477|NCT01061151|564700117|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
156439478|NCT01061151|564700118|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
156439479|NCT01061151|564700119|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
156439480|NCT01061151|564700116|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
156439481|NCT01061151|564700117|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
156439482|NCT01061151|564700118|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
156439483|NCT01061151|564700119|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
156439484|NCT01061151|564700116|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
156439485|NCT01061151|564700117|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
156439486|NCT01061151|564700118|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
156439487|NCT01061151|564700119|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
156701363|NCT00699374|565654864|FG000|Overall Study|Study terminated by sponsor|13|||
156701364|NCT00699374|565654865|FG001|Overall Study|Study terminated by sponsor|28|||
156701365|NCT00699374|565654864|FG000|Overall Study|Randomized but not treated|4|||
156701366|NCT00699374|565654865|FG001|Overall Study|Randomized but not treated|2|||
156701367|NCT00699374|565654864|FG000|Overall Study|Died 28 days after last dose|5|||
156701368|NCT00699374|565654865|FG001|Overall Study|Died 28 days after last dose|9|||
156701369|NCT01359969|565654869|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
156701370|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
156701371|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
156701372|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
156701373|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
156701374|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
156701375|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
156701376|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
156701377|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
156701378|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
156701379|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
156701380|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
156701381|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
156701382|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
156701383|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
156701384|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
156701385|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
156701386|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
156701387|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
156439488|NCT01061151|564700116|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
156439489|NCT01061151|564700117|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
156439490|NCT01061151|564700118|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
156701388|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
156701389|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
156701390|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Various|0|||
156701391|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Various|0|||
156701392|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Various|0|||
156701393|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Various|25|||
156439491|NCT01061151|564700119|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
156701394|NCT00593736|565654873|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
156701395|NCT00593736|565654874|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
156701396|NCT00593736|565654875|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
156701397|NCT00593736|565654876|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
156701398|NCT00593736|565654873|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
156701399|NCT00593736|565654874|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
156701400|NCT00593736|565654875|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
156701401|NCT00593736|565654876|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
156701402|NCT00593736|565654873|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
156701403|NCT00593736|565654874|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
156701404|NCT00593736|565654875|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
156701405|NCT00593736|565654876|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
156701406|NCT00593736|565654873|FG000|Treatment Period and Placebo Run-out|Various|1|||
156701407|NCT00593736|565654874|FG001|Treatment Period and Placebo Run-out|Various|1|||
156701408|NCT00593736|565654875|FG002|Treatment Period and Placebo Run-out|Various|1|||
156701409|NCT00593736|565654876|FG003|Treatment Period and Placebo Run-out|Various|0|||
156701410|NCT01868893|565654877|FG000|Overall Study|Adverse Event|2|||
156701411|NCT01868893|565654877|FG000|Overall Study|Commercial availability of study drug|17|||
156701412|NCT01868893|565654877|FG000|Overall Study|Neutropenia|1|||
156701413|NCT01857271|565654878|FG000|Overall Study|Lost to Follow-up|1|||
156701414|NCT01783548|565654879|FG000|Overall Study|Adverse Event|8|||
156701415|NCT01783548|565654880|FG001|Overall Study|Adverse Event|4|||
156701416|NCT01783548|565654879|FG000|Overall Study|Withdrawal by Subject|11|||
156701417|NCT01783548|565654880|FG001|Overall Study|Withdrawal by Subject|8|||
156701418|NCT01783548|565654879|FG000|Overall Study|Non-compliance|4|||
156701419|NCT01783548|565654880|FG001|Overall Study|Non-compliance|0|||
156701420|NCT01783548|565654879|FG000|Overall Study|Protocol Violation|2|||
156701421|NCT01783548|565654880|FG001|Overall Study|Protocol Violation|2|||
156701422|NCT01783548|565654879|FG000|Overall Study|Lost to Follow-up|8|||
156701423|NCT01783548|565654880|FG001|Overall Study|Lost to Follow-up|3|||
156701424|NCT01783548|565654879|FG000|Overall Study|Lack of Efficacy|1|||
156701425|NCT01783548|565654880|FG001|Overall Study|Lack of Efficacy|1|||
156701426|NCT03825341|565654883|FG000|Overall Study|Withdrawal by Subject|0|||
156701427|NCT03825341|565654884|FG001|Overall Study|Withdrawal by Subject|1|||
156701428|NCT04283500|565654887|FG000|Overall Study|Lost to Follow-up|8|||
156701429|NCT04283500|565654887|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
156701430|NCT04053465|565654896|FG000|Overall Study|Withdrawal by Subject|4|||
156701431|NCT04053465|565654897|FG001|Overall Study|Withdrawal by Subject|4|||
156701432|NCT04729309|565654898|FG000|Period 1|Subject unable to return for Period 2|3|||
156701433|NCT04729309|565654899|FG001|Period 1|Subject unable to return for Period 2|0|||
156701434|NCT04729309|565654898|FG000|Period 1|Lost to Follow-up|1|||
156701435|NCT04729309|565654899|FG001|Period 1|Lost to Follow-up|0|||
156701436|NCT02085135|565654900|FG000|Overall Study|Adverse Event|4|||
156701437|NCT02085135|565654901|FG001|Overall Study|Adverse Event|7|||
156701438|NCT02085135|565654900|FG000|Overall Study|Lost to Follow-up|2|||
156701439|NCT02085135|565654901|FG001|Overall Study|Lost to Follow-up|2|||
156701440|NCT02085135|565654900|FG000|Overall Study|Withdrawal by Subject|3|||
156701441|NCT02085135|565654901|FG001|Overall Study|Withdrawal by Subject|0|||
156701442|NCT02085135|565654900|FG000|Overall Study|Lack of Efficacy|2|||
156701443|NCT02085135|565654901|FG001|Overall Study|Lack of Efficacy|0|||
156701444|NCT01212588|565654904|FG000|Overall Study|Physician Decision|0|||
156701445|NCT01212588|565654905|FG001|Overall Study|Physician Decision|1|||
156701446|NCT01212588|565654904|FG000|Overall Study|Protocol Violation|1|||
156701447|NCT01212588|565654905|FG001|Overall Study|Protocol Violation|1|||
156331780|NCT00717093|564314965|FG000|Overall Study|Withdrawal by Subject|12|||
156331781|NCT00717093|564314966|FG001|Overall Study|Withdrawal by Subject|19|||
156331782|NCT00717093|564314965|FG000|Overall Study|Other|0|||
156331783|NCT00717093|564314966|FG001|Overall Study|Other|1|||
156331784|NCT00717093|564314965|FG000|Overall Study|Randomized but not treated|1|||
156331785|NCT00717093|564314966|FG001|Overall Study|Randomized but not treated|0|||
156701448|NCT02885181|565654906|FG000|Overall Study|Investigator's Discretion|0|||
156701449|NCT02885181|565654907|FG001|Overall Study|Investigator's Discretion|1|||
156701450|NCT02885181|565654908|FG002|Overall Study|Investigator's Discretion|0|||
156701451|NCT02885181|565654909|FG003|Overall Study|Investigator's Discretion|1|||
156701452|NCT02885181|565654906|FG000|Overall Study|Adverse Event|0|||
156701453|NCT02885181|565654907|FG001|Overall Study|Adverse Event|0|||
156701454|NCT02885181|565654908|FG002|Overall Study|Adverse Event|0|||
156701455|NCT02885181|565654909|FG003|Overall Study|Adverse Event|1|||
156701456|NCT02885181|565654906|FG000|Overall Study|Withdrawal by Subject|0|||
156701457|NCT02885181|565654907|FG001|Overall Study|Withdrawal by Subject|0|||
156790904|NCT00472641|565985514|FG000|Overall Study|Adverse Event|3|||
156790905|NCT00472641|565985514|FG000|Overall Study|Lost to Follow-up|1|||
156331786|NCT01543698|564314971|FG000|Phase 1b|Disease progression|2|||
156331787|NCT01543698|564314972|FG001|Phase 1b|Disease progression|4|||
156331788|NCT01543698|564314973|FG002|Phase 1b|Disease progression|3|||
156531153|NCT04195581|565039855|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
156701458|NCT02885181|565654908|FG002|Overall Study|Withdrawal by Subject|0|||
156701459|NCT02885181|565654909|FG003|Overall Study|Withdrawal by Subject|1|||
156701460|NCT00626392|565654912|FG000|Run-in Period|Adverse Event|0|||
156701461|NCT00626392|565654913|FG001|Run-in Period|Adverse Event|0|||
156701462|NCT00626392|565654914|FG002|Run-in Period|Adverse Event|1|||
156701463|NCT00626392|565654915|FG003|Run-in Period|Adverse Event|0|||
156701464|NCT00626392|565654916|FG004|Run-in Period|Adverse Event|1|||
156701465|NCT00626392|565654917|FG005|Run-in Period|Adverse Event|0|||
156701466|NCT00626392|565654912|FG000|Run-in Period|Withdrawal by Subject|0|||
156701467|NCT00626392|565654913|FG001|Run-in Period|Withdrawal by Subject|1|||
156701468|NCT00626392|565654914|FG002|Run-in Period|Withdrawal by Subject|1|||
156701469|NCT00626392|565654915|FG003|Run-in Period|Withdrawal by Subject|1|||
156701470|NCT00626392|565654916|FG004|Run-in Period|Withdrawal by Subject|3|||
156701471|NCT00626392|565654917|FG005|Run-in Period|Withdrawal by Subject|1|||
156701472|NCT00626392|565654912|FG000|Run-in Period|Noncompliance|1|||
156701473|NCT00626392|565654913|FG001|Run-in Period|Noncompliance|0|||
156701474|NCT00626392|565654914|FG002|Run-in Period|Noncompliance|1|||
156701475|NCT00626392|565654915|FG003|Run-in Period|Noncompliance|0|||
156701476|NCT00626392|565654916|FG004|Run-in Period|Noncompliance|0|||
156701477|NCT00626392|565654917|FG005|Run-in Period|Noncompliance|0|||
156701478|NCT00626392|565654912|FG000|Coadministration Period|Adverse Event|3|||
156701479|NCT00626392|565654913|FG001|Coadministration Period|Adverse Event|1|||
156701480|NCT00626392|565654914|FG002|Coadministration Period|Adverse Event|7|||
156701481|NCT00626392|565654915|FG003|Coadministration Period|Adverse Event|4|||
156701482|NCT00626392|565654916|FG004|Coadministration Period|Adverse Event|3|||
156701483|NCT00626392|565654917|FG005|Coadministration Period|Adverse Event|4|||
156701484|NCT00626392|565654912|FG000|Coadministration Period|Withdrawal by Subject|1|||
156701485|NCT00626392|565654913|FG001|Coadministration Period|Withdrawal by Subject|1|||
156701486|NCT00626392|565654914|FG002|Coadministration Period|Withdrawal by Subject|0|||
156701487|NCT00626392|565654915|FG003|Coadministration Period|Withdrawal by Subject|1|||
156701488|NCT00626392|565654916|FG004|Coadministration Period|Withdrawal by Subject|0|||
156701489|NCT00626392|565654917|FG005|Coadministration Period|Withdrawal by Subject|1|||
156701490|NCT00626392|565654912|FG000|Coadministration Period|Protocol Violation|0|||
156701491|NCT00626392|565654913|FG001|Coadministration Period|Protocol Violation|1|||
156701492|NCT00626392|565654914|FG002|Coadministration Period|Protocol Violation|0|||
156701493|NCT00626392|565654915|FG003|Coadministration Period|Protocol Violation|1|||
156701494|NCT00626392|565654916|FG004|Coadministration Period|Protocol Violation|1|||
156701495|NCT00626392|565654917|FG005|Coadministration Period|Protocol Violation|0|||
156701496|NCT00626392|565654912|FG000|Coadministration Period|Other|0|||
156701497|NCT00626392|565654913|FG001|Coadministration Period|Other|2|||
156701498|NCT00626392|565654914|FG002|Coadministration Period|Other|3|||
156701499|NCT00626392|565654915|FG003|Coadministration Period|Other|1|||
156701500|NCT00626392|565654916|FG004|Coadministration Period|Other|1|||
156701501|NCT00626392|565654917|FG005|Coadministration Period|Other|1|||
156701502|NCT00338455|565654918|FG000|Overall Study|Death|2|||
156701503|NCT00338455|565654919|FG001|Overall Study|Death|1|||
156701504|NCT00338455|565654918|FG000|Overall Study|Physician Decision|1|||
156331789|NCT01543698|564314974|FG003|Phase 1b|Disease progression|2|||
156331790|NCT01543698|564314975|FG004|Phase 1b|Disease progression|10|||
156701505|NCT00338455|565654919|FG001|Overall Study|Physician Decision|0|||
156331791|NCT01543698|564314976|FG005|Phase 1b|Disease progression|6|||
156331792|NCT01543698|564314977|FG006|Phase 1b|Disease progression|5|||
156331793|NCT01543698|564314978|FG007|Phase 1b|Disease progression|3|||
156331794|NCT01543698|564314979|FG008|Phase 1b|Disease progression|4|||
156331795|NCT01543698|564314980|FG009|Phase 1b|Disease progression|5|||
156331796|NCT01543698|564314981|FG010|Phase 1b|Disease progression|1|||
156331797|NCT01543698|564314982|FG011|Phase 1b|Disease progression|0|||
156331798|NCT01543698|564314983|FG012|Phase 1b|Disease progression|0|||
156331799|NCT01543698|564314984|FG013|Phase 1b|Disease progression|0|||
156331800|NCT01543698|564314985|FG014|Phase 1b|Disease progression|0|||
156331801|NCT01543698|564314971|FG000|Phase 1b|Death|0|||
156331802|NCT01543698|564314972|FG001|Phase 1b|Death|0|||
156331803|NCT01543698|564314973|FG002|Phase 1b|Death|1|||
156331804|NCT01543698|564314974|FG003|Phase 1b|Death|1|||
156331805|NCT01543698|564314975|FG004|Phase 1b|Death|0|||
156331806|NCT01543698|564314976|FG005|Phase 1b|Death|0|||
156331807|NCT01543698|564314977|FG006|Phase 1b|Death|0|||
156331808|NCT01543698|564314978|FG007|Phase 1b|Death|0|||
156331809|NCT01543698|564314979|FG008|Phase 1b|Death|0|||
156331810|NCT01543698|564314980|FG009|Phase 1b|Death|0|||
156331811|NCT01543698|564314981|FG010|Phase 1b|Death|1|||
156331812|NCT01543698|564314982|FG011|Phase 1b|Death|0|||
156331813|NCT01543698|564314983|FG012|Phase 1b|Death|0|||
156331814|NCT01543698|564314984|FG013|Phase 1b|Death|0|||
156531154|NCT00821431|565039856|FG000|Overall Study|Adverse Event|6|||
156331815|NCT01543698|564314985|FG014|Phase 1b|Death|0|||
156331816|NCT01543698|564314971|FG000|Phase 1b|Withdrawal by Subject|0|||
156331817|NCT01543698|564314972|FG001|Phase 1b|Withdrawal by Subject|1|||
156331818|NCT01543698|564314973|FG002|Phase 1b|Withdrawal by Subject|0|||
156701506|NCT01517373|565654920|FG000|Run-in Period|Death|1|||
156701507|NCT01517373|565654921|FG001|Run-in Period|Death|0|||
156701508|NCT01517373|565654922|FG002|Run-in Period|Death|0|||
156701509|NCT01517373|565654923|FG003|Run-in Period|Death|0|||
156701510|NCT01517373|565654924|FG004|Run-in Period|Death|0|||
156701511|NCT01517373|565654925|FG005|Run-in Period|Death|0|||
156701512|NCT01517373|565654920|FG000|Run-in Period|Adverse Event|5|||
156531155|NCT00821431|565039857|FG001|Overall Study|Adverse Event|3|||
156531156|NCT00821431|565039856|FG000|Overall Study|Withdrawal by Subject|5|||
156531157|NCT00821431|565039857|FG001|Overall Study|Withdrawal by Subject|0|||
156531158|NCT00821431|565039856|FG000|Overall Study|Lost to Follow-up|1|||
156531159|NCT00821431|565039857|FG001|Overall Study|Lost to Follow-up|0|||
156531160|NCT00821431|565039856|FG000|Overall Study|Protocol Violation|3|||
156531161|NCT00821431|565039857|FG001|Overall Study|Protocol Violation|1|||
156531162|NCT00821431|565039856|FG000|Overall Study|Physician Decision|0|||
156531163|NCT00821431|565039857|FG001|Overall Study|Physician Decision|1|||
156531164|NCT01182766|565039861|FG000|Overall Study|Lost to Follow-up|32|||
156531165|NCT01182766|565039862|FG001|Overall Study|Lost to Follow-up|36|||
156531166|NCT01182766|565039863|FG002|Overall Study|Lost to Follow-up|29|||
156531167|NCT01182766|565039861|FG000|Overall Study|Withdrawal by Subject|14|||
156531168|NCT01182766|565039862|FG001|Overall Study|Withdrawal by Subject|3|||
156531169|NCT01182766|565039863|FG002|Overall Study|Withdrawal by Subject|6|||
156531170|NCT01182766|565039861|FG000|Overall Study|Physician Decision|1|||
156531171|NCT01182766|565039862|FG001|Overall Study|Physician Decision|0|||
156531172|NCT01182766|565039863|FG002|Overall Study|Physician Decision|0|||
156531173|NCT01182766|565039861|FG000|Overall Study|Non-compliance|1|||
156531174|NCT01182766|565039862|FG001|Overall Study|Non-compliance|1|||
156531175|NCT01182766|565039863|FG002|Overall Study|Non-compliance|1|||
156531176|NCT01605253|565039864|FG000|Overall Study|Physician Decision|3|||
156531177|NCT01605253|565039865|FG001|Overall Study|Physician Decision|2|||
156701513|NCT01517373|565654921|FG001|Run-in Period|Adverse Event|0|||
156701514|NCT01517373|565654922|FG002|Run-in Period|Adverse Event|0|||
156701515|NCT01517373|565654923|FG003|Run-in Period|Adverse Event|0|||
156701516|NCT01517373|565654924|FG004|Run-in Period|Adverse Event|0|||
156701517|NCT01517373|565654925|FG005|Run-in Period|Adverse Event|0|||
156701518|NCT01517373|565654920|FG000|Run-in Period|Did not meet eligibility criteria|34|||
156439492|NCT01061151|564700116|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
156439493|NCT01061151|564700117|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
156439494|NCT01061151|564700118|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
156439495|NCT01061151|564700119|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
156439496|NCT01236001|564700121|FG000|Overall Study|Adverse Event|5|||
156439497|NCT01236001|564700122|FG001|Overall Study|Adverse Event|14|||
156439498|NCT01236001|564700121|FG000|Overall Study|Lack of Efficacy|6|||
156439499|NCT01236001|564700122|FG001|Overall Study|Lack of Efficacy|6|||
156439500|NCT01236001|564700121|FG000|Overall Study|Lost to Follow-up|6|||
156439501|NCT01236001|564700122|FG001|Overall Study|Lost to Follow-up|1|||
156439502|NCT01236001|564700121|FG000|Overall Study|Incompliance|1|||
156439503|NCT01236001|564700122|FG001|Overall Study|Incompliance|0|||
156439504|NCT01236001|564700121|FG000|Overall Study|Planned Visit After End of Study|0|||
156439505|NCT01236001|564700122|FG001|Overall Study|Planned Visit After End of Study|1|||
156439506|NCT04530747|564700124|FG000|Overall Study|Withdrawal by Subject|1|||
156439507|NCT04530747|564700125|FG001|Overall Study|Withdrawal by Subject|0|||
156439508|NCT03950622|564700126|FG000|Overall Study|Withdrawal by Subject|1|||
156439509|NCT03950622|564700127|FG001|Overall Study|Withdrawal by Subject|0|||
156439510|NCT03950622|564700126|FG000|Overall Study|Protocol Deviation|0|||
156439511|NCT03950622|564700127|FG001|Overall Study|Protocol Deviation|1|||
156439512|NCT03950622|564700126|FG000|Overall Study|Physician Decision|1|||
156439513|NCT03950622|564700127|FG001|Overall Study|Physician Decision|0|||
156439514|NCT03950622|564700126|FG000|Overall Study|Lost to Follow-up|5|||
156439515|NCT03950622|564700127|FG001|Overall Study|Lost to Follow-up|5|||
156439516|NCT03950622|564700126|FG000|Overall Study|Death|1|||
156439517|NCT03950622|564700127|FG001|Overall Study|Death|1|||
156439518|NCT02092116|564700130|FG000|Overall Study|Withdrawal by Subject|0|||
156439519|NCT02092116|564700131|FG001|Overall Study|Withdrawal by Subject|3|||
156439520|NCT02092116|564700130|FG000|Overall Study|Adverse Event|0|||
156439521|NCT02092116|564700131|FG001|Overall Study|Adverse Event|1|||
156439522|NCT02267824|564700133|FG000|Overall Study|Pregnancy|1|||
156439523|NCT02267824|564700134|FG001|Overall Study|Pregnancy|1|||
156439524|NCT02267824|564700133|FG000|Overall Study|Lost to Follow-up|4|||
156439525|NCT02267824|564700134|FG001|Overall Study|Lost to Follow-up|0|||
156439526|NCT02267824|564700133|FG000|Overall Study|Protocol Violation|3|||
156439527|NCT02267824|564700134|FG001|Overall Study|Protocol Violation|0|||
156531178|NCT01605253|565039864|FG000|Overall Study|Lost to Follow-up|3|||
156531179|NCT01605253|565039865|FG001|Overall Study|Lost to Follow-up|1|||
156531180|NCT02554903|565039866|FG000|Overall Study|Death|1|||
156531181|NCT02554903|565039867|FG001|Overall Study|Death|1|||
156531182|NCT02554903|565039866|FG000|Overall Study|Physician Decision|2|||
156531183|NCT02554903|565039867|FG001|Overall Study|Physician Decision|2|||
156531184|NCT02554903|565039866|FG000|Overall Study|Heart Transplant|1|||
156701519|NCT01517373|565654921|FG001|Run-in Period|Did not meet eligibility criteria|0|||
156701520|NCT01517373|565654922|FG002|Run-in Period|Did not meet eligibility criteria|0|||
156701521|NCT01517373|565654923|FG003|Run-in Period|Did not meet eligibility criteria|0|||
156701522|NCT01517373|565654924|FG004|Run-in Period|Did not meet eligibility criteria|0|||
156701523|NCT01517373|565654925|FG005|Run-in Period|Did not meet eligibility criteria|0|||
156701524|NCT01517373|565654920|FG000|Run-in Period|Lost to Follow-up|1|||
156701525|NCT01517373|565654921|FG001|Run-in Period|Lost to Follow-up|0|||
156701526|NCT01517373|565654922|FG002|Run-in Period|Lost to Follow-up|0|||
156439528|NCT02267824|564700133|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
156439529|NCT02267824|564700134|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
156439530|NCT01832480|564700142|FG000|Overall Study|Lost to Follow-up|33|||
156439531|NCT01832480|564700143|FG001|Overall Study|Lost to Follow-up|30|||
156439532|NCT01832480|564700142|FG000|Overall Study|Withdrawal by Subject|0|||
156439533|NCT01832480|564700143|FG001|Overall Study|Withdrawal by Subject|2|||
156439534|NCT01832480|564700142|FG000|Overall Study|post randomization ineligible|8|||
156439535|NCT01832480|564700143|FG001|Overall Study|post randomization ineligible|10|||
156439536|NCT02261467|564700144|FG000|Overall Study|Enrolled in Error|1|||
156439537|NCT02261467|564700145|FG001|Overall Study|Enrolled in Error|0|||
156439538|NCT02261467|564700144|FG000|Overall Study|Protocol Violation|0|||
156439539|NCT02261467|564700145|FG001|Overall Study|Protocol Violation|1|||
156439540|NCT02261467|564700144|FG000|Overall Study|Personal Reasons|17|||
156439541|NCT02261467|564700145|FG001|Overall Study|Personal Reasons|22|||
156439542|NCT02261467|564700144|FG000|Overall Study|Lost to Follow-up|2|||
156439543|NCT02261467|564700145|FG001|Overall Study|Lost to Follow-up|13|||
156439544|NCT02261467|564700144|FG000|Overall Study|Adverse Event|1|||
156439545|NCT02261467|564700145|FG001|Overall Study|Adverse Event|1|||
156439546|NCT00736853|564700148|FG000|Open-Label Period|Physician Decision|2|||
156439547|NCT00736853|564700149|FG001|Open-Label Period|Physician Decision|0|||
156439548|NCT00736853|564700150|FG002|Open-Label Period|Physician Decision|0|||
156439549|NCT00736853|564700148|FG000|Open-Label Period|Adverse Event|31|||
156701527|NCT01517373|565654923|FG003|Run-in Period|Lost to Follow-up|0|||
156701528|NCT01517373|565654924|FG004|Run-in Period|Lost to Follow-up|0|||
156439550|NCT00736853|564700149|FG001|Open-Label Period|Adverse Event|0|||
156439551|NCT00736853|564700150|FG002|Open-Label Period|Adverse Event|0|||
156439552|NCT00736853|564700148|FG000|Open-Label Period|Withdrawal by Subject|16|||
156439553|NCT00736853|564700149|FG001|Open-Label Period|Withdrawal by Subject|0|||
156439554|NCT00736853|564700150|FG002|Open-Label Period|Withdrawal by Subject|0|||
156439555|NCT00736853|564700148|FG000|Open-Label Period|Started but not treated|42|||
156439556|NCT00736853|564700149|FG001|Open-Label Period|Started but not treated|0|||
156439557|NCT00736853|564700150|FG002|Open-Label Period|Started but not treated|0|||
156439558|NCT00736853|564700148|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
156439559|NCT00736853|564700149|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
156701529|NCT01517373|565654925|FG005|Run-in Period|Lost to Follow-up|0|||
156701530|NCT01517373|565654920|FG000|Run-in Period|Withdrawal by Subject|12|||
156701531|NCT01517373|565654921|FG001|Run-in Period|Withdrawal by Subject|0|||
156701532|NCT01517373|565654922|FG002|Run-in Period|Withdrawal by Subject|0|||
156701533|NCT01517373|565654923|FG003|Run-in Period|Withdrawal by Subject|0|||
156701534|NCT01517373|565654924|FG004|Run-in Period|Withdrawal by Subject|0|||
156701535|NCT01517373|565654925|FG005|Run-in Period|Withdrawal by Subject|0|||
156701536|NCT01517373|565654920|FG000|Run-in Period|Sponsor Decision|3|||
156701537|NCT01517373|565654921|FG001|Run-in Period|Sponsor Decision|0|||
156701538|NCT01517373|565654922|FG002|Run-in Period|Sponsor Decision|0|||
156701539|NCT01517373|565654923|FG003|Run-in Period|Sponsor Decision|0|||
156701540|NCT01517373|565654924|FG004|Run-in Period|Sponsor Decision|0|||
156701541|NCT01517373|565654925|FG005|Run-in Period|Sponsor Decision|0|||
156701542|NCT01517373|565654920|FG000|Run-in Period|Other|1|||
156701543|NCT01517373|565654921|FG001|Run-in Period|Other|0|||
156701544|NCT01517373|565654922|FG002|Run-in Period|Other|0|||
156701545|NCT01517373|565654923|FG003|Run-in Period|Other|0|||
156701546|NCT01517373|565654924|FG004|Run-in Period|Other|0|||
156701547|NCT01517373|565654925|FG005|Run-in Period|Other|0|||
156701548|NCT01517373|565654920|FG000|Treatment Period|Adverse Event|0|||
156701549|NCT01517373|565654921|FG001|Treatment Period|Adverse Event|0|||
156701550|NCT01517373|565654922|FG002|Treatment Period|Adverse Event|0|||
156701551|NCT01517373|565654923|FG003|Treatment Period|Adverse Event|0|||
156701552|NCT01517373|565654924|FG004|Treatment Period|Adverse Event|0|||
156439560|NCT00736853|564700150|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
156701553|NCT01517373|565654925|FG005|Treatment Period|Adverse Event|2|||
156701554|NCT01517373|565654920|FG000|Treatment Period|Lost to Follow-up|0|||
156701555|NCT01517373|565654921|FG001|Treatment Period|Lost to Follow-up|0|||
156701556|NCT01517373|565654922|FG002|Treatment Period|Lost to Follow-up|1|||
156701557|NCT01517373|565654923|FG003|Treatment Period|Lost to Follow-up|1|||
156701558|NCT01517373|565654924|FG004|Treatment Period|Lost to Follow-up|0|||
156439561|NCT00736853|564700148|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
156439562|NCT00736853|564700149|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
156439563|NCT00736853|564700150|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
156701559|NCT01517373|565654925|FG005|Treatment Period|Lost to Follow-up|0|||
156701560|NCT01517373|565654920|FG000|Treatment Period|Withdrawal by Subject|0|||
156439564|NCT00736853|564700148|FG000|Double-Blind Period|Lack of Efficacy|0|||
156439565|NCT00736853|564700149|FG001|Double-Blind Period|Lack of Efficacy|19|||
156439566|NCT00736853|564700150|FG002|Double-Blind Period|Lack of Efficacy|42|||
156439567|NCT00736853|564700148|FG000|Double-Blind Period|Adverse Event|0|||
156439568|NCT00736853|564700149|FG001|Double-Blind Period|Adverse Event|3|||
156439569|NCT00736853|564700150|FG002|Double-Blind Period|Adverse Event|2|||
156439570|NCT00736853|564700148|FG000|Double-Blind Period|Withdrawal by Subject|0|||
156439571|NCT00736853|564700149|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156439572|NCT00736853|564700150|FG002|Double-Blind Period|Withdrawal by Subject|4|||
156439573|NCT00736853|564700148|FG000|Double-Blind Period|Ineligible to participate the study|0|||
156439574|NCT00736853|564700149|FG001|Double-Blind Period|Ineligible to participate the study|1|||
156439575|NCT00736853|564700150|FG002|Double-Blind Period|Ineligible to participate the study|0|||
156701561|NCT01517373|565654921|FG001|Treatment Period|Withdrawal by Subject|3|||
156701562|NCT01517373|565654922|FG002|Treatment Period|Withdrawal by Subject|2|||
156701563|NCT01517373|565654923|FG003|Treatment Period|Withdrawal by Subject|2|||
156701564|NCT01517373|565654924|FG004|Treatment Period|Withdrawal by Subject|2|||
156701565|NCT01517373|565654925|FG005|Treatment Period|Withdrawal by Subject|3|||
156701566|NCT01517373|565654920|FG000|Treatment Period|Other|0|||
156701567|NCT01517373|565654921|FG001|Treatment Period|Other|0|||
156701568|NCT01517373|565654922|FG002|Treatment Period|Other|0|||
156701569|NCT01517373|565654923|FG003|Treatment Period|Other|0|||
156701570|NCT01517373|565654924|FG004|Treatment Period|Other|1|||
156701571|NCT01517373|565654925|FG005|Treatment Period|Other|0|||
156701572|NCT01517373|565654920|FG000|Treatment Period|Protocol Violation|0|||
156701573|NCT01517373|565654921|FG001|Treatment Period|Protocol Violation|0|||
156701574|NCT01517373|565654922|FG002|Treatment Period|Protocol Violation|0|||
156701575|NCT01517373|565654923|FG003|Treatment Period|Protocol Violation|0|||
156701576|NCT01517373|565654924|FG004|Treatment Period|Protocol Violation|1|||
156701577|NCT01517373|565654925|FG005|Treatment Period|Protocol Violation|0|||
156701578|NCT01517373|565654920|FG000|Treatment Period|Lack of Efficacy|0|||
156701579|NCT01517373|565654921|FG001|Treatment Period|Lack of Efficacy|1|||
156701580|NCT01517373|565654922|FG002|Treatment Period|Lack of Efficacy|1|||
156701581|NCT01517373|565654923|FG003|Treatment Period|Lack of Efficacy|3|||
156701582|NCT01517373|565654924|FG004|Treatment Period|Lack of Efficacy|2|||
156701583|NCT01517373|565654925|FG005|Treatment Period|Lack of Efficacy|0|||
156701584|NCT01517373|565654920|FG000|Treatment Period|Medication error without AEs|0|||
156701585|NCT01517373|565654921|FG001|Treatment Period|Medication error without AEs|0|||
156701586|NCT01517373|565654922|FG002|Treatment Period|Medication error without AEs|2|||
156701587|NCT01517373|565654923|FG003|Treatment Period|Medication error without AEs|1|||
156701588|NCT01517373|565654924|FG004|Treatment Period|Medication error without AEs|0|||
156439576|NCT01597258|564700151|FG000|Overall Study|No Drug Administration|1|||
156439577|NCT01764464|564700152|FG000|First Intervention|Withdrawal by Subject|1|||
156439578|NCT01764464|564700153|FG001|First Intervention|Withdrawal by Subject|0|||
156439579|NCT01764464|564700152|FG000|First Intervention|Lost to Follow-up|1|||
156439580|NCT01764464|564700153|FG001|First Intervention|Lost to Follow-up|0|||
156439581|NCT01764464|564700152|FG000|First Intervention|Adverse Event|0|||
156439582|NCT01764464|564700153|FG001|First Intervention|Adverse Event|2|||
156439583|NCT01764464|564700152|FG000|First Intervention|did not receive study drug|0|||
156439584|NCT01764464|564700153|FG001|First Intervention|did not receive study drug|1|||
156439585|NCT01764464|564700152|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
156439586|NCT01764464|564700153|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
156439587|NCT03473340|564700156|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
156439588|NCT03473340|564700157|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
156439589|NCT03473340|564700156|FG000|Overall Study|Withdrawal by Subject|1|||
156531185|NCT02554903|565039867|FG001|Overall Study|Heart Transplant|2|||
156531186|NCT04936841|565039869|FG000|Overall Study|Death|1|||
156531187|NCT00639223|565039870|FG000|Overall Study|Lost to Follow-up|0|||
156531188|NCT00639223|565039871|FG001|Overall Study|Lost to Follow-up|2|||
156531189|NCT04484259|565039875|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
156531190|NCT04484259|565039876|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
156531191|NCT04484259|565039877|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
156531192|NCT04484259|565039878|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
156531193|NCT04484259|565039879|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
156531194|NCT04484259|565039875|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
156531195|NCT04484259|565039876|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
156531196|NCT04484259|565039877|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
156531197|NCT04484259|565039878|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
156531198|NCT04484259|565039879|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
156701589|NCT01517373|565654925|FG005|Treatment Period|Medication error without AEs|2|||
156701590|NCT01085734|565654926|FG000|Overall Study|Adverse Event|0|||
156439590|NCT03473340|564700157|FG001|Overall Study|Withdrawal by Subject|0|||
156439591|NCT03473340|564700156|FG000|Overall Study|Lost to Follow-up|1|||
156439592|NCT03473340|564700157|FG001|Overall Study|Lost to Follow-up|2|||
156439593|NCT02079844|564700158|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
156701591|NCT01085734|565654927|FG001|Overall Study|Adverse Event|2|||
156701592|NCT01085734|565654926|FG000|Overall Study|Death|1|||
156701593|NCT01085734|565654927|FG001|Overall Study|Death|0|||
156701594|NCT01085734|565654926|FG000|Overall Study|Lost to Follow-up|0|||
156701595|NCT01085734|565654927|FG001|Overall Study|Lost to Follow-up|1|||
156701596|NCT01085734|565654926|FG000|Overall Study|Withdrawal by Subject|0|||
156701597|NCT01085734|565654927|FG001|Overall Study|Withdrawal by Subject|1|||
156439594|NCT02079844|564700159|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
156701598|NCT04005352|565654941|FG000|Overall Study|Adverse Event|4|||
156701599|NCT04005352|565654942|FG001|Overall Study|Adverse Event|5|||
156701600|NCT04005352|565654941|FG000|Overall Study|Death|4|||
156701601|NCT04005352|565654942|FG001|Overall Study|Death|2|||
156701602|NCT04005352|565654941|FG000|Overall Study|Lost to Follow-up|6|||
156701603|NCT04005352|565654942|FG001|Overall Study|Lost to Follow-up|2|||
156701604|NCT04005352|565654941|FG000|Overall Study|Physician Decision|7|||
156701605|NCT04005352|565654942|FG001|Overall Study|Physician Decision|13|||
156701606|NCT04005352|565654941|FG000|Overall Study|Protocol Violation|0|||
156701607|NCT04005352|565654942|FG001|Overall Study|Protocol Violation|1|||
156701608|NCT04005352|565654941|FG000|Overall Study|Withdrawal by Subject|28|||
156701609|NCT04005352|565654942|FG001|Overall Study|Withdrawal by Subject|38|||
156790906|NCT03888482|565985515|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
156439595|NCT02079844|564700160|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
156439596|NCT02079844|564700158|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
156439597|NCT02079844|564700159|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
156439598|NCT02079844|564700160|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
156439599|NCT03394885|564700162|FG000|Overall Study|Adverse Event|4|||
156439600|NCT03394885|564700162|FG000|Overall Study|Lack of Efficacy|1|||
156439601|NCT03394885|564700162|FG000|Overall Study|Physician Decision|1|||
156531199|NCT04484259|565039875|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
156701610|NCT00849186|565654943|FG000|Overall Study|Adverse Event|2|||
156701611|NCT00849186|565654943|FG000|Overall Study|Withdrawal by Subject|1|||
156701612|NCT00849186|565654943|FG000|Overall Study|not treated|6|||
156701613|NCT00849186|565654943|FG000|Overall Study|Other|1|||
156790907|NCT03888482|565985516|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
156790908|NCT03888482|565985515|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
156790909|NCT03888482|565985516|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
156790910|NCT05652140|565985519|FG000|Overall Study|Lost to Follow-up|7|||
156790911|NCT05652140|565985520|FG001|Overall Study|Lost to Follow-up|16|||
156790912|NCT05652140|565985521|FG002|Overall Study|Lost to Follow-up|22|||
156790913|NCT05652140|565985522|FG003|Overall Study|Lost to Follow-up|31|||
156790914|NCT00968968|565985525|FG000|Overall Study|Study closed/terminated|10|||
156790915|NCT00968968|565985526|FG001|Overall Study|Study closed/terminated|10|||
156790916|NCT00968968|565985525|FG000|Overall Study|Protocol defined stopping criteria|3|||
156331819|NCT01543698|564314974|FG003|Phase 1b|Withdrawal by Subject|1|||
156331820|NCT01543698|564314975|FG004|Phase 1b|Withdrawal by Subject|0|||
156331821|NCT01543698|564314976|FG005|Phase 1b|Withdrawal by Subject|0|||
156331822|NCT01543698|564314977|FG006|Phase 1b|Withdrawal by Subject|1|||
156331823|NCT01543698|564314978|FG007|Phase 1b|Withdrawal by Subject|0|||
156331824|NCT01543698|564314979|FG008|Phase 1b|Withdrawal by Subject|0|||
156331825|NCT01543698|564314980|FG009|Phase 1b|Withdrawal by Subject|0|||
156331826|NCT01543698|564314981|FG010|Phase 1b|Withdrawal by Subject|0|||
156331827|NCT01543698|564314982|FG011|Phase 1b|Withdrawal by Subject|0|||
156331828|NCT01543698|564314983|FG012|Phase 1b|Withdrawal by Subject|0|||
156331829|NCT01543698|564314984|FG013|Phase 1b|Withdrawal by Subject|0|||
156331830|NCT01543698|564314985|FG014|Phase 1b|Withdrawal by Subject|0|||
156331831|NCT01543698|564314971|FG000|Phase 1b|Adverse Event|1|||
156331832|NCT01543698|564314972|FG001|Phase 1b|Adverse Event|0|||
156331833|NCT01543698|564314973|FG002|Phase 1b|Adverse Event|0|||
156331834|NCT01543698|564314974|FG003|Phase 1b|Adverse Event|1|||
156331835|NCT01543698|564314975|FG004|Phase 1b|Adverse Event|2|||
156331836|NCT01543698|564314976|FG005|Phase 1b|Adverse Event|2|||
156331837|NCT01543698|564314977|FG006|Phase 1b|Adverse Event|0|||
156331838|NCT01543698|564314978|FG007|Phase 1b|Adverse Event|0|||
156331839|NCT01543698|564314979|FG008|Phase 1b|Adverse Event|1|||
156331840|NCT01543698|564314980|FG009|Phase 1b|Adverse Event|1|||
156331841|NCT01543698|564314981|FG010|Phase 1b|Adverse Event|2|||
156331842|NCT01543698|564314982|FG011|Phase 1b|Adverse Event|0|||
156331843|NCT01543698|564314983|FG012|Phase 1b|Adverse Event|0|||
156331844|NCT01543698|564314984|FG013|Phase 1b|Adverse Event|0|||
156331845|NCT01543698|564314985|FG014|Phase 1b|Adverse Event|0|||
156331846|NCT01543698|564314971|FG000|Phase 1b|Administrative problems|1|||
156331847|NCT01543698|564314972|FG001|Phase 1b|Administrative problems|0|||
156331848|NCT01543698|564314973|FG002|Phase 1b|Administrative problems|0|||
156331849|NCT01543698|564314974|FG003|Phase 1b|Administrative problems|0|||
156331850|NCT01543698|564314975|FG004|Phase 1b|Administrative problems|1|||
156331851|NCT01543698|564314976|FG005|Phase 1b|Administrative problems|0|||
156331852|NCT01543698|564314977|FG006|Phase 1b|Administrative problems|0|||
156331853|NCT01543698|564314978|FG007|Phase 1b|Administrative problems|1|||
156331854|NCT01543698|564314979|FG008|Phase 1b|Administrative problems|0|||
156331855|NCT01543698|564314980|FG009|Phase 1b|Administrative problems|0|||
156701614|NCT00417170|565654948|FG000|Overall Study|Adverse Event|1|||
156701615|NCT00417170|565654949|FG001|Overall Study|Adverse Event|1|||
156701616|NCT00417170|565654948|FG000|Overall Study|Withdrawal by Subject|1|||
156701617|NCT00417170|565654949|FG001|Overall Study|Withdrawal by Subject|1|||
156701618|NCT00417170|565654948|FG000|Overall Study|Lost to Follow-up|0|||
156701619|NCT00417170|565654949|FG001|Overall Study|Lost to Follow-up|1|||
156701620|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
156701621|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
156701622|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
156701623|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
156701624|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
156701625|NCT04015908|565654951|FG000|Overall Study|Lost to Follow-up|0|||
156701626|NCT04015908|565654952|FG001|Overall Study|Lost to Follow-up|1|||
156701627|NCT00901576|565654953|FG000|Second Intervention|Withdrawal by Subject|0|||
156701628|NCT00901576|565654954|FG001|Second Intervention|Withdrawal by Subject|0|||
156701629|NCT00901576|565654955|FG002|Second Intervention|Withdrawal by Subject|0|||
156701630|NCT00901576|565654956|FG003|Second Intervention|Withdrawal by Subject|1|||
156701631|NCT00901576|565654957|FG004|Second Intervention|Withdrawal by Subject|0|||
156701632|NCT00901576|565654958|FG005|Second Intervention|Withdrawal by Subject|1|||
156701633|NCT00901576|565654953|FG000|Second Intervention|Physician Decision|1|||
156701634|NCT00901576|565654954|FG001|Second Intervention|Physician Decision|0|||
156701635|NCT00901576|565654955|FG002|Second Intervention|Physician Decision|0|||
156701636|NCT00901576|565654956|FG003|Second Intervention|Physician Decision|0|||
156701637|NCT00901576|565654957|FG004|Second Intervention|Physician Decision|0|||
156701638|NCT00901576|565654958|FG005|Second Intervention|Physician Decision|0|||
156701639|NCT01696279|565654959|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
156701640|NCT01696279|565654960|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
156701641|NCT01696279|565654961|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
156701642|NCT01696279|565654962|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
156701643|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
156439602|NCT03394885|564700162|FG000|Overall Study|Withdrawal by Subject|8|||
156439603|NCT03394885|564700162|FG000|Overall Study|Alternative Therapy|1|||
156439604|NCT00203411|564700163|FG000|Follow-up|Progressive Disease|4|||
156439605|NCT04980755|564700164|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
156439606|NCT04980755|564700164|FG000|Body Reprogramming Courses|Work commitment|2|||
156439607|NCT04980755|564700164|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
156439608|NCT04980755|564700164|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
156439609|NCT02531113|564700171|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
156439610|NCT02531113|564700171|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
156439611|NCT02531113|564700171|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
156439612|NCT02531113|564700171|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
156439613|NCT02531113|564700171|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
156439614|NCT02531113|564700171|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
156439615|NCT02531113|564700171|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
156439616|NCT02531113|564700171|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
156439617|NCT00632424|564700172|FG000|Overall Study|Disease Progression|17|||
156439618|NCT00632424|564700172|FG000|Overall Study|Study Drug Toxicity|1|||
156439619|NCT00801983|564700173|FG000|Period 1|Lost to Follow-up|2|||
156439620|NCT00801983|564700174|FG001|Period 1|Lost to Follow-up|0|||
156439621|NCT00801983|564700173|FG000|Period 1|Withdrawal by Subject|2|||
156439622|NCT00801983|564700174|FG001|Period 1|Withdrawal by Subject|8|||
156439623|NCT00801983|564700173|FG000|Period 2|Withdrawal by Subject|2|||
156701644|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
156701645|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
156701646|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
156701647|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
156701648|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
156439624|NCT00801983|564700174|FG001|Period 2|Withdrawal by Subject|1|||
156439625|NCT04411056|564702374|FG000|Overall Study|surgery cancelled|1|||
156439626|NCT04411056|564702375|FG001|Overall Study|surgery cancelled|0|||
156439627|NCT04411056|564702374|FG000|Overall Study|Equipment problem during intubation|0|||
156439628|NCT04411056|564702375|FG001|Overall Study|Equipment problem during intubation|1|||
156439629|NCT04623008|564702376|FG000|Baseline to T2|Withdrawal by Subject|4|||
156439630|NCT04623008|564702377|FG001|Baseline to T2|Withdrawal by Subject|2|||
156439631|NCT04623008|564702376|FG000|Baseline to T3|Withdrawal by Subject|4|||
156439632|NCT04623008|564702377|FG001|Baseline to T3|Withdrawal by Subject|2|||
156439633|NCT03122886|564702389|FG000|Overall Study|Withdrawal by Subject|1|||
156701649|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
156701650|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
156701651|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
156439634|NCT03122886|564702390|FG001|Overall Study|Withdrawal by Subject|2|||
156701652|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
156701653|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
156701654|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
156701655|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
156701656|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
156701657|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
156701658|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
156701659|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
156701660|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
156701661|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
156701662|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
156701663|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
156701664|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
156701665|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
156701666|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
156701667|NCT01696279|565654959|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
156701668|NCT01696279|565654960|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
156701669|NCT01696279|565654961|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
156701670|NCT01696279|565654962|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
156701671|NCT01696279|565654959|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
156701672|NCT01696279|565654960|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
156701673|NCT01696279|565654961|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
156701674|NCT01696279|565654962|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
156701675|NCT01696279|565654959|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
156701676|NCT01696279|565654960|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
156701677|NCT01696279|565654961|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
156701678|NCT01696279|565654962|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
156701679|NCT01696279|565654959|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
156701680|NCT01696279|565654960|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
156701681|NCT01696279|565654961|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
156701682|NCT01696279|565654962|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
156701683|NCT06077149|565654963|FG000|Overall Study|Death|1|||
156701684|NCT06077149|565654964|FG001|Overall Study|Death|0|||
156701685|NCT06077149|565654963|FG000|Overall Study|Withdrawal by Subject|2|||
156701686|NCT06077149|565654964|FG001|Overall Study|Withdrawal by Subject|0|||
156701687|NCT06077149|565654963|FG000|Overall Study|RSV infection before vaccination|3|||
156701688|NCT06077149|565654964|FG001|Overall Study|RSV infection before vaccination|0|||
156701689|NCT05788289|565654965|FG000|Overall Study|Death|3|||
156701690|NCT02970318|565654968|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
156701691|NCT02970318|565654969|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
156701692|NCT02970318|565654970|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
156701693|NCT02970318|565654971|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
156701694|NCT02970318|565654968|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
156701695|NCT02970318|565654969|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
156701696|NCT02970318|565654970|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
156701697|NCT02970318|565654971|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
156701698|NCT02970318|565654968|FG000|Overall for Arm A & Main for Arm B|Death|41|||
156701699|NCT02970318|565654969|FG001|Overall for Arm A & Main for Arm B|Death|33|||
156701700|NCT02970318|565654970|FG002|Overall for Arm A & Main for Arm B|Death|0|||
156872113|NCT02858362|566289508|FG001|Overall Study|Withdrawal by Subject|0|||
156701701|NCT02970318|565654971|FG003|Overall for Arm A & Main for Arm B|Death|0|||
156701702|NCT02970318|565654968|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
156701703|NCT02970318|565654969|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
156701704|NCT02970318|565654970|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
156701705|NCT02970318|565654971|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
156701706|NCT02970318|565654968|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
156701707|NCT02970318|565654969|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
156701708|NCT02970318|565654970|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
156701709|NCT02970318|565654971|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
156701710|NCT02970318|565654968|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
156701711|NCT02970318|565654969|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
156701712|NCT02970318|565654970|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
156701713|NCT02970318|565654971|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
156701714|NCT02970318|565654968|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
156701715|NCT02970318|565654969|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
156701716|NCT02970318|565654970|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
156701717|NCT02970318|565654971|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
156701718|NCT01096368|565654972|FG000|Overall Study|Death|0|||
156701719|NCT01096368|565654973|FG001|Overall Study|Death|1|||
156701720|NCT01096368|565654974|FG002|Overall Study|Death|0|||
156701721|NCT01096368|565654975|FG003|Overall Study|Death|0|||
156701722|NCT01096368|565654976|FG004|Overall Study|Death|0|||
156701723|NCT01096368|565654972|FG000|Overall Study|Physician Decision|0|||
156701724|NCT01096368|565654973|FG001|Overall Study|Physician Decision|13|||
156701725|NCT01096368|565654974|FG002|Overall Study|Physician Decision|2|||
156701726|NCT01096368|565654975|FG003|Overall Study|Physician Decision|4|||
156701727|NCT01096368|565654976|FG004|Overall Study|Physician Decision|6|||
156701728|NCT01096368|565654972|FG000|Overall Study|Withdrawal by Subject|0|||
156701729|NCT01096368|565654973|FG001|Overall Study|Withdrawal by Subject|52|||
156439635|NCT02279095|564702398|FG000|Overall Study|Non-Compliance|1|||
156439636|NCT02279095|564702398|FG000|Overall Study|Withdrawal by Subject|8|||
156439637|NCT02279095|564702398|FG000|Overall Study|Adverse Event|2|||
156439638|NCT02279095|564702398|FG000|Overall Study|Other|7|||
156439639|NCT02279095|564702398|FG000|Overall Study|Lost to Follow-up|1|||
156439640|NCT05938413|564702399|FG000|Overall Study|Lost to Follow-up|1|||
156439641|NCT05938413|564702400|FG001|Overall Study|Lost to Follow-up|7|||
156439642|NCT05938413|564702399|FG000|Overall Study|Withdrawal by Subject|1|||
156439643|NCT05938413|564702400|FG001|Overall Study|Withdrawal by Subject|1|||
156439644|NCT04714320|564702409|FG000|Overall Study|Voluntary Withdrawal|4|||
156439645|NCT04714320|564702410|FG001|Overall Study|Voluntary Withdrawal|1|||
156439646|NCT04714320|564702411|FG002|Overall Study|Voluntary Withdrawal|2|||
156439647|NCT04714320|564702409|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
156439648|NCT04714320|564702410|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
156439649|NCT04714320|564702411|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
156439650|NCT04714320|564702409|FG000|Overall Study|Reason Not Specified|1|||
156439651|NCT04714320|564702410|FG001|Overall Study|Reason Not Specified|3|||
156439652|NCT04714320|564702411|FG002|Overall Study|Reason Not Specified|3|||
156439653|NCT01875848|564702412|FG000|Overall Study|Withdrawal by Subject|2|||
156439654|NCT01875848|564702413|FG001|Overall Study|Withdrawal by Subject|0|||
156439655|NCT01622868|564702414|FG000|Overall Study|Protocol Violation|7|||
156439656|NCT01622868|564702415|FG001|Overall Study|Protocol Violation|0|||
156439657|NCT04425629|564702417|FG000|Overall Study|Adverse Event|0|||
156439658|NCT04425629|564702418|FG001|Overall Study|Adverse Event|0|||
156701730|NCT01096368|565654974|FG002|Overall Study|Withdrawal by Subject|0|||
156701731|NCT01096368|565654975|FG003|Overall Study|Withdrawal by Subject|10|||
156701732|NCT01096368|565654976|FG004|Overall Study|Withdrawal by Subject|14|||
156701733|NCT01096368|565654972|FG000|Overall Study|Ineligible|0|||
156701734|NCT01096368|565654973|FG001|Overall Study|Ineligible|3|||
156701735|NCT01096368|565654974|FG002|Overall Study|Ineligible|2|||
156701736|NCT01096368|565654975|FG003|Overall Study|Ineligible|0|||
156701737|NCT01096368|565654976|FG004|Overall Study|Ineligible|25|||
156701738|NCT01096368|565654972|FG000|Overall Study|Did not start treatment|0|||
156701739|NCT01096368|565654973|FG001|Overall Study|Did not start treatment|4|||
156701740|NCT01096368|565654974|FG002|Overall Study|Did not start treatment|4|||
156701741|NCT01096368|565654975|FG003|Overall Study|Did not start treatment|0|||
156701742|NCT01096368|565654976|FG004|Overall Study|Did not start treatment|0|||
156701743|NCT01096368|565654972|FG000|Overall Study|Progressive disease|0|||
156701744|NCT01096368|565654973|FG001|Overall Study|Progressive disease|6|||
156701745|NCT01096368|565654974|FG002|Overall Study|Progressive disease|0|||
156701746|NCT01096368|565654975|FG003|Overall Study|Progressive disease|10|||
156701747|NCT01096368|565654976|FG004|Overall Study|Progressive disease|3|||
156701748|NCT01096368|565654972|FG000|Overall Study|Other|0|||
156701749|NCT01096368|565654973|FG001|Overall Study|Other|0|||
156701750|NCT01096368|565654974|FG002|Overall Study|Other|1|||
156701751|NCT01096368|565654975|FG003|Overall Study|Other|0|||
156701752|NCT01096368|565654976|FG004|Overall Study|Other|0|||
156439659|NCT04425629|564702419|FG002|Overall Study|Adverse Event|0|||
156439660|NCT04425629|564702420|FG003|Overall Study|Adverse Event|0|||
156439661|NCT04425629|564702421|FG004|Overall Study|Adverse Event|1|||
156531200|NCT04484259|565039876|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
156701753|NCT01096368|565654972|FG000|Overall Study|Treated with institutional review|0|||
156701754|NCT01096368|565654973|FG001|Overall Study|Treated with institutional review|0|||
156531201|NCT04484259|565039877|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
156701755|NCT01096368|565654974|FG002|Overall Study|Treated with institutional review|0|||
156701756|NCT01096368|565654975|FG003|Overall Study|Treated with institutional review|0|||
156701757|NCT01096368|565654976|FG004|Overall Study|Treated with institutional review|1|||
156701758|NCT03384654|565654978|FG000|Overall Study|Withdrawal by Subject|0|||
156439662|NCT04425629|564702422|FG005|Overall Study|Adverse Event|0|||
156701759|NCT03384654|565654979|FG001|Overall Study|Withdrawal by Subject|0|||
156439663|NCT04425629|564702423|FG006|Overall Study|Adverse Event|0|||
156439664|NCT04425629|564702424|FG007|Overall Study|Adverse Event|0|||
156439665|NCT04425629|564702425|FG008|Overall Study|Adverse Event|0|||
156701760|NCT03384654|565654980|FG002|Overall Study|Withdrawal by Subject|1|||
156701761|NCT03384654|565654981|FG003|Overall Study|Withdrawal by Subject|0|||
156701762|NCT01616953|565654982|FG000|Overall Study|Lost to Follow-up|1|||
156701763|NCT01616953|565654983|FG001|Overall Study|Lost to Follow-up|0|||
156701764|NCT01616953|565654982|FG000|Overall Study|lack of bone and soft tissue|1|||
156331856|NCT01543698|564314981|FG010|Phase 1b|Administrative problems|2|||
156701765|NCT01616953|565654983|FG001|Overall Study|lack of bone and soft tissue|0|||
156701766|NCT01568320|565654984|FG000|Overall Study|Death|20|||
156701767|NCT01568320|565654984|FG000|Overall Study|Lost to Follow-up|9|||
156701768|NCT01568320|565654984|FG000|Overall Study|Withdrawal by Subject|10|||
156701769|NCT01568320|565654984|FG000|Overall Study|Conversion to open repair|1|||
156701770|NCT01568320|565654984|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
156701771|NCT00816361|565654986|FG000|Overall Study|Withdrawal by Subject|0|||
156701772|NCT00816361|565654987|FG001|Overall Study|Withdrawal by Subject|0|||
156701773|NCT00816361|565654988|FG002|Overall Study|Withdrawal by Subject|0|||
156701774|NCT00816361|565654989|FG003|Overall Study|Withdrawal by Subject|0|||
156701775|NCT00816361|565654990|FG004|Overall Study|Withdrawal by Subject|1|||
156790917|NCT00968968|565985526|FG001|Overall Study|Protocol defined stopping criteria|1|||
156790918|NCT00968968|565985525|FG000|Overall Study|Withdrawal by Subject|2|||
156790919|NCT00968968|565985526|FG001|Overall Study|Withdrawal by Subject|0|||
156790920|NCT00968968|565985525|FG000|Overall Study|Physician Decision|1|||
156790921|NCT00968968|565985526|FG001|Overall Study|Physician Decision|2|||
156790922|NCT00968968|565985525|FG000|Overall Study|Lost to Follow-up|0|||
156790923|NCT00968968|565985526|FG001|Overall Study|Lost to Follow-up|1|||
156790924|NCT04401293|565985527|FG000|Overall Study|Withdrawal by Subject|1|||
156790925|NCT04401293|565985528|FG001|Overall Study|Withdrawal by Subject|3|||
156790926|NCT01026038|565985529|FG000|Overall Study|Lost to Follow-up|1|||
156790927|NCT01026038|565985530|FG001|Overall Study|Lost to Follow-up|1|||
156790928|NCT01026038|565985531|FG002|Overall Study|Lost to Follow-up|0|||
156790929|NCT03679884|565985532|FG000|Overall Study|Other|12|||
156790930|NCT03679884|565985533|FG001|Overall Study|Other|12|||
156790931|NCT03679884|565985534|FG002|Overall Study|Other|12|||
156790932|NCT03679884|565985535|FG003|Overall Study|Other|7|||
156790933|NCT03679884|565985536|FG004|Overall Study|Other|8|||
156331857|NCT01543698|564314982|FG011|Phase 1b|Administrative problems|0|||
156331858|NCT01543698|564314983|FG012|Phase 1b|Administrative problems|0|||
156331859|NCT01543698|564314984|FG013|Phase 1b|Administrative problems|0|||
156331860|NCT01543698|564314985|FG014|Phase 1b|Administrative problems|0|||
156331861|NCT01543698|564314971|FG000|Phase 1b|Protocol Violation|2|||
156331862|NCT01543698|564314972|FG001|Phase 1b|Protocol Violation|0|||
156331863|NCT01543698|564314973|FG002|Phase 1b|Protocol Violation|0|||
156331864|NCT01543698|564314974|FG003|Phase 1b|Protocol Violation|0|||
156331865|NCT01543698|564314975|FG004|Phase 1b|Protocol Violation|0|||
156331866|NCT01543698|564314976|FG005|Phase 1b|Protocol Violation|0|||
156331867|NCT01543698|564314977|FG006|Phase 1b|Protocol Violation|0|||
156331868|NCT01543698|564314978|FG007|Phase 1b|Protocol Violation|0|||
156331869|NCT01543698|564314979|FG008|Phase 1b|Protocol Violation|0|||
156331870|NCT01543698|564314980|FG009|Phase 1b|Protocol Violation|0|||
156331871|NCT01543698|564314981|FG010|Phase 1b|Protocol Violation|0|||
156331872|NCT01543698|564314982|FG011|Phase 1b|Protocol Violation|0|||
156331873|NCT01543698|564314983|FG012|Phase 1b|Protocol Violation|0|||
156331874|NCT01543698|564314984|FG013|Phase 1b|Protocol Violation|0|||
156331875|NCT01543698|564314985|FG014|Phase 1b|Protocol Violation|0|||
156331876|NCT01543698|564314971|FG000|Phase 2|Protocol Violation|0|||
156331877|NCT01543698|564314972|FG001|Phase 2|Protocol Violation|0|||
156331878|NCT01543698|564314973|FG002|Phase 2|Protocol Violation|0|||
156331879|NCT01543698|564314974|FG003|Phase 2|Protocol Violation|0|||
156331880|NCT01543698|564314975|FG004|Phase 2|Protocol Violation|0|||
156331881|NCT01543698|564314976|FG005|Phase 2|Protocol Violation|0|||
156331882|NCT01543698|564314977|FG006|Phase 2|Protocol Violation|0|||
156331883|NCT01543698|564314978|FG007|Phase 2|Protocol Violation|0|||
156331884|NCT01543698|564314979|FG008|Phase 2|Protocol Violation|0|||
156331885|NCT01543698|564314980|FG009|Phase 2|Protocol Violation|0|||
156331886|NCT01543698|564314981|FG010|Phase 2|Protocol Violation|0|||
156331887|NCT01543698|564314982|FG011|Phase 2|Protocol Violation|0|||
156331888|NCT01543698|564314983|FG012|Phase 2|Protocol Violation|1|||
156331889|NCT01543698|564314984|FG013|Phase 2|Protocol Violation|0|||
156439666|NCT04425629|564702426|FG009|Overall Study|Adverse Event|3|||
156701776|NCT00816361|565654991|FG005|Overall Study|Withdrawal by Subject|2|||
156701777|NCT00816361|565654992|FG006|Overall Study|Withdrawal by Subject|0|||
156790934|NCT03679884|565985532|FG000|Overall Study|Lack of Efficacy|15|||
156331890|NCT01543698|564314985|FG014|Phase 2|Protocol Violation|0|||
156331891|NCT01543698|564314971|FG000|Phase 2|Disease progression|0|||
156331892|NCT01543698|564314972|FG001|Phase 2|Disease progression|0|||
156331893|NCT01543698|564314973|FG002|Phase 2|Disease progression|0|||
156331894|NCT01543698|564314974|FG003|Phase 2|Disease progression|0|||
156790935|NCT03679884|565985533|FG001|Overall Study|Lack of Efficacy|29|||
156790936|NCT03679884|565985534|FG002|Overall Study|Lack of Efficacy|13|||
156790937|NCT03679884|565985535|FG003|Overall Study|Lack of Efficacy|29|||
156790938|NCT03679884|565985536|FG004|Overall Study|Lack of Efficacy|10|||
156701778|NCT00816361|565654993|FG007|Overall Study|Withdrawal by Subject|2|||
156701779|NCT00816361|565654994|FG008|Overall Study|Withdrawal by Subject|1|||
156701780|NCT00816361|565654986|FG000|Overall Study|Death|4|||
156701781|NCT00816361|565654987|FG001|Overall Study|Death|3|||
156701782|NCT00816361|565654988|FG002|Overall Study|Death|3|||
156701783|NCT00816361|565654989|FG003|Overall Study|Death|3|||
156439667|NCT04425629|564702427|FG010|Overall Study|Adverse Event|2|||
156439668|NCT04425629|564702428|FG011|Overall Study|Adverse Event|1|||
156701784|NCT00816361|565654990|FG004|Overall Study|Death|1|||
156701785|NCT00816361|565654991|FG005|Overall Study|Death|1|||
156701786|NCT00816361|565654992|FG006|Overall Study|Death|3|||
156701787|NCT00816361|565654993|FG007|Overall Study|Death|7|||
156701788|NCT00816361|565654994|FG008|Overall Study|Death|8|||
156701789|NCT00816361|565654986|FG000|Overall Study|Other|0|||
156701790|NCT00816361|565654987|FG001|Overall Study|Other|0|||
156701791|NCT00816361|565654988|FG002|Overall Study|Other|0|||
156701792|NCT00816361|565654989|FG003|Overall Study|Other|0|||
156701793|NCT00816361|565654990|FG004|Overall Study|Other|0|||
156701794|NCT00816361|565654991|FG005|Overall Study|Other|0|||
156701795|NCT00816361|565654992|FG006|Overall Study|Other|0|||
156701796|NCT00816361|565654993|FG007|Overall Study|Other|0|||
156701797|NCT00816361|565654994|FG008|Overall Study|Other|1|||
156701798|NCT02500641|565654997|FG000|Overall Study|Adverse Event|0|||
156331895|NCT01543698|564314975|FG004|Phase 2|Disease progression|0|||
156331896|NCT01543698|564314976|FG005|Phase 2|Disease progression|0|||
156331897|NCT01543698|564314977|FG006|Phase 2|Disease progression|0|||
156331898|NCT01543698|564314978|FG007|Phase 2|Disease progression|0|||
156331899|NCT01543698|564314979|FG008|Phase 2|Disease progression|0|||
156331900|NCT01543698|564314980|FG009|Phase 2|Disease progression|0|||
156331901|NCT01543698|564314981|FG010|Phase 2|Disease progression|0|||
156331902|NCT01543698|564314982|FG011|Phase 2|Disease progression|10|||
156331903|NCT01543698|564314983|FG012|Phase 2|Disease progression|21|||
156331904|NCT01543698|564314984|FG013|Phase 2|Disease progression|30|||
156331905|NCT01543698|564314985|FG014|Phase 2|Disease progression|25|||
156331906|NCT01543698|564314971|FG000|Phase 2|Death|0|||
156331907|NCT01543698|564314972|FG001|Phase 2|Death|0|||
156331908|NCT01543698|564314973|FG002|Phase 2|Death|0|||
156331909|NCT01543698|564314974|FG003|Phase 2|Death|0|||
156331910|NCT01543698|564314975|FG004|Phase 2|Death|0|||
156331911|NCT01543698|564314976|FG005|Phase 2|Death|0|||
156331912|NCT01543698|564314977|FG006|Phase 2|Death|0|||
156331913|NCT01543698|564314978|FG007|Phase 2|Death|0|||
156331914|NCT01543698|564314979|FG008|Phase 2|Death|0|||
156439669|NCT04425629|564702429|FG012|Overall Study|Adverse Event|1|||
156439670|NCT04425629|564702430|FG013|Overall Study|Adverse Event|0|||
156439671|NCT04425629|564702431|FG014|Overall Study|Adverse Event|0|||
156439672|NCT04425629|564702432|FG015|Overall Study|Adverse Event|0|||
156701799|NCT02500641|565654998|FG001|Overall Study|Adverse Event|2|||
156701800|NCT02500641|565654997|FG000|Overall Study|Withdrawal by Subject|4|||
156701801|NCT02500641|565654998|FG001|Overall Study|Withdrawal by Subject|5|||
156701802|NCT02500641|565654997|FG000|Overall Study|Unable to follow study procedures|3|||
156701803|NCT02500641|565654998|FG001|Overall Study|Unable to follow study procedures|2|||
156701804|NCT02500641|565654997|FG000|Overall Study|Protocol Violation|1|||
156701805|NCT02500641|565654998|FG001|Overall Study|Protocol Violation|2|||
156701806|NCT02500641|565654997|FG000|Overall Study|Lost to Follow-up|1|||
156701807|NCT02500641|565654998|FG001|Overall Study|Lost to Follow-up|0|||
156701808|NCT02500641|565654997|FG000|Overall Study|Sponsor decision|1|||
156701809|NCT02500641|565654998|FG001|Overall Study|Sponsor decision|0|||
156701810|NCT02500641|565654997|FG000|Overall Study|Non compliance to study drug|0|||
156701811|NCT02500641|565654998|FG001|Overall Study|Non compliance to study drug|1|||
156701812|NCT03233230|565654999|FG000|Overall Study|Adverse Event|6|||
156439673|NCT04425629|564702433|FG016|Overall Study|Adverse Event|0|||
156701813|NCT03233230|565655000|FG001|Overall Study|Adverse Event|3|||
156701814|NCT03233230|565655001|FG002|Overall Study|Adverse Event|6|||
156701815|NCT03233230|565655002|FG003|Overall Study|Adverse Event|3|||
156701816|NCT03233230|565654999|FG000|Overall Study|Protocol Violation|1|||
156439674|NCT04425629|564702434|FG017|Overall Study|Adverse Event|0|||
156701817|NCT03233230|565655000|FG001|Overall Study|Protocol Violation|2|||
156439675|NCT04425629|564702435|FG018|Overall Study|Adverse Event|0|||
156439676|NCT04425629|564702417|FG000|Overall Study|Lost to Follow-up|1|||
156701818|NCT03233230|565655001|FG002|Overall Study|Protocol Violation|1|||
156872114|NCT02858362|566289509|FG002|Overall Study|Withdrawal by Subject|0|||
156331915|NCT01543698|564314980|FG009|Phase 2|Death|0|||
156331916|NCT01543698|564314981|FG010|Phase 2|Death|0|||
156331917|NCT01543698|564314982|FG011|Phase 2|Death|0|||
156331918|NCT01543698|564314983|FG012|Phase 2|Death|1|||
156331919|NCT01543698|564314984|FG013|Phase 2|Death|1|||
156331920|NCT01543698|564314985|FG014|Phase 2|Death|1|||
156331921|NCT01543698|564314971|FG000|Phase 2|Administrative problems|0|||
156331922|NCT01543698|564314972|FG001|Phase 2|Administrative problems|0|||
156701819|NCT03233230|565655002|FG003|Overall Study|Protocol Violation|1|||
156701820|NCT03233230|565654999|FG000|Overall Study|Lack of Efficacy|1|||
156701821|NCT03233230|565655000|FG001|Overall Study|Lack of Efficacy|0|||
156701822|NCT03233230|565655001|FG002|Overall Study|Lack of Efficacy|0|||
156701823|NCT03233230|565655002|FG003|Overall Study|Lack of Efficacy|0|||
156701824|NCT03233230|565654999|FG000|Overall Study|Other|5|||
156701825|NCT03233230|565655000|FG001|Overall Study|Other|5|||
156701826|NCT03233230|565655001|FG002|Overall Study|Other|5|||
156701827|NCT03233230|565655002|FG003|Overall Study|Other|3|||
156701828|NCT03233230|565654999|FG000|Overall Study|Withdrawal by Subject|2|||
156701829|NCT03233230|565655000|FG001|Overall Study|Withdrawal by Subject|2|||
156701830|NCT03233230|565655001|FG002|Overall Study|Withdrawal by Subject|0|||
156701831|NCT03233230|565655002|FG003|Overall Study|Withdrawal by Subject|1|||
156701832|NCT03233230|565654999|FG000|Overall Study|Lost to Follow-up|0|||
156701833|NCT03233230|565655000|FG001|Overall Study|Lost to Follow-up|3|||
156701834|NCT03233230|565655001|FG002|Overall Study|Lost to Follow-up|0|||
156701835|NCT03233230|565655002|FG003|Overall Study|Lost to Follow-up|0|||
156701836|NCT01584843|565655005|FG000|First Treatment Period|Adverse Event|0|||
156701837|NCT01584843|565655006|FG001|First Treatment Period|Adverse Event|0|||
156701838|NCT01584843|565655007|FG002|First Treatment Period|Adverse Event|1|||
156701839|NCT01584843|565655008|FG003|First Treatment Period|Adverse Event|0|||
156701840|NCT01584843|565655009|FG004|First Treatment Period|Adverse Event|0|||
156701841|NCT01584843|565655010|FG005|First Treatment Period|Adverse Event|0|||
156701842|NCT01584843|565655005|FG000|First Treatment Period|Protocol Violation|0|||
156701843|NCT01584843|565655006|FG001|First Treatment Period|Protocol Violation|0|||
156701844|NCT01584843|565655007|FG002|First Treatment Period|Protocol Violation|0|||
156701845|NCT01584843|565655008|FG003|First Treatment Period|Protocol Violation|0|||
156701846|NCT01584843|565655009|FG004|First Treatment Period|Protocol Violation|0|||
156701847|NCT01584843|565655010|FG005|First Treatment Period|Protocol Violation|1|||
156701848|NCT01584843|565655005|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701849|NCT01584843|565655006|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701850|NCT01584843|565655007|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701851|NCT01584843|565655008|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701852|NCT01584843|565655009|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701853|NCT01584843|565655010|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
156701854|NCT01584843|565655005|FG000|Second Treatment Period|Withdrawal by Subject|0|||
156701855|NCT01584843|565655006|FG001|Second Treatment Period|Withdrawal by Subject|0|||
156701856|NCT01584843|565655007|FG002|Second Treatment Period|Withdrawal by Subject|0|||
156701857|NCT01584843|565655008|FG003|Second Treatment Period|Withdrawal by Subject|0|||
156701858|NCT01584843|565655009|FG004|Second Treatment Period|Withdrawal by Subject|0|||
156701859|NCT01584843|565655010|FG005|Second Treatment Period|Withdrawal by Subject|1|||
156701860|NCT04156620|565655011|FG000|Overall Study|Adverse event - TP 1|5|||
156701861|NCT04156620|565655012|FG001|Overall Study|Adverse event - TP 1|2|||
156701862|NCT04156620|565655011|FG000|Overall Study|Lost to follow-up TP 1|1|||
156701863|NCT04156620|565655012|FG001|Overall Study|Lost to follow-up TP 1|1|||
156701864|NCT04156620|565655011|FG000|Overall Study|Progressive disease - TP 1|0|||
156701865|NCT04156620|565655012|FG001|Overall Study|Progressive disease - TP 1|1|||
156701866|NCT04156620|565655011|FG000|Overall Study|Subject decision - TP 1|3|||
156701867|NCT04156620|565655012|FG001|Overall Study|Subject decision - TP 1|5|||
156701868|NCT04156620|565655011|FG000|Overall Study|Adverse event - TP 2|5|||
156701869|NCT04156620|565655012|FG001|Overall Study|Adverse event - TP 2|6|||
156701870|NCT04156620|565655011|FG000|Overall Study|Death - TP 2|1|||
156701871|NCT04156620|565655012|FG001|Overall Study|Death - TP 2|0|||
156701872|NCT04156620|565655011|FG000|Overall Study|Lost to follow-up - TP 2|5|||
156701873|NCT04156620|565655012|FG001|Overall Study|Lost to follow-up - TP 2|2|||
156701874|NCT04156620|565655011|FG000|Overall Study|Physician decision - TP 2|4|||
156701875|NCT04156620|565655012|FG001|Overall Study|Physician decision - TP 2|2|||
156701876|NCT04156620|565655011|FG000|Overall Study|Pregnancy - TP 2|1|||
156701877|NCT04156620|565655012|FG001|Overall Study|Pregnancy - TP 2|1|||
156701878|NCT04156620|565655011|FG000|Overall Study|Subject decision - TP 2|11|||
156790939|NCT03679884|565985532|FG000|Overall Study|Death|1|||
156790940|NCT03679884|565985533|FG001|Overall Study|Death|0|||
156790941|NCT03679884|565985534|FG002|Overall Study|Death|0|||
156439677|NCT04425629|564702418|FG001|Overall Study|Lost to Follow-up|3|||
156439678|NCT04425629|564702419|FG002|Overall Study|Lost to Follow-up|1|||
156439679|NCT04425629|564702420|FG003|Overall Study|Lost to Follow-up|7|||
156439680|NCT04425629|564702421|FG004|Overall Study|Lost to Follow-up|1|||
156439681|NCT04425629|564702422|FG005|Overall Study|Lost to Follow-up|2|||
156439682|NCT04425629|564702423|FG006|Overall Study|Lost to Follow-up|1|||
156439683|NCT04425629|564702424|FG007|Overall Study|Lost to Follow-up|0|||
156701879|NCT04156620|565655012|FG001|Overall Study|Subject decision - TP 2|9|||
156701880|NCT04156620|565655011|FG000|Overall Study|New therapy for study indication - TP 2|1|||
156701881|NCT04156620|565655012|FG001|Overall Study|New therapy for study indication - TP 2|0|||
156701882|NCT01121666|565655013|FG000|Overall Study|Protocol Violation|29|||
156701883|NCT01121666|565655014|FG001|Overall Study|Protocol Violation|10|||
156701884|NCT01629966|565655015|FG000|Overall Study|Pregnancy|0|||
156701885|NCT01629966|565655016|FG001|Overall Study|Pregnancy|1|||
156701886|NCT01629966|565655017|FG002|Overall Study|Pregnancy|0|||
156439684|NCT04425629|564702425|FG008|Overall Study|Lost to Follow-up|1|||
156790942|NCT03679884|565985535|FG003|Overall Study|Death|0|||
156439685|NCT04425629|564702426|FG009|Overall Study|Lost to Follow-up|64|||
156439686|NCT04425629|564702427|FG010|Overall Study|Lost to Follow-up|70|||
156439687|NCT04425629|564702428|FG011|Overall Study|Lost to Follow-up|98|||
156439688|NCT04425629|564702429|FG012|Overall Study|Lost to Follow-up|30|||
156439689|NCT04425629|564702430|FG013|Overall Study|Lost to Follow-up|0|||
156439690|NCT04425629|564702431|FG014|Overall Study|Lost to Follow-up|5|||
156439691|NCT04425629|564702432|FG015|Overall Study|Lost to Follow-up|4|||
156439692|NCT04425629|564702433|FG016|Overall Study|Lost to Follow-up|0|||
156439693|NCT04425629|564702434|FG017|Overall Study|Lost to Follow-up|3|||
156439694|NCT04425629|564702435|FG018|Overall Study|Lost to Follow-up|1|||
156439695|NCT04425629|564702417|FG000|Overall Study|Subject Decision|0|||
156439696|NCT04425629|564702418|FG001|Overall Study|Subject Decision|2|||
156439697|NCT04425629|564702419|FG002|Overall Study|Subject Decision|1|||
156439698|NCT04425629|564702420|FG003|Overall Study|Subject Decision|3|||
156439699|NCT04425629|564702421|FG004|Overall Study|Subject Decision|6|||
156439700|NCT04425629|564702422|FG005|Overall Study|Subject Decision|6|||
156439701|NCT04425629|564702423|FG006|Overall Study|Subject Decision|3|||
156439702|NCT04425629|564702424|FG007|Overall Study|Subject Decision|3|||
156439703|NCT04425629|564702425|FG008|Overall Study|Subject Decision|1|||
156439704|NCT04425629|564702426|FG009|Overall Study|Subject Decision|70|||
156439705|NCT04425629|564702427|FG010|Overall Study|Subject Decision|95|||
156439706|NCT04425629|564702428|FG011|Overall Study|Subject Decision|124|||
156439707|NCT04425629|564702429|FG012|Overall Study|Subject Decision|25|||
156439708|NCT04425629|564702430|FG013|Overall Study|Subject Decision|0|||
156439709|NCT04425629|564702431|FG014|Overall Study|Subject Decision|1|||
156439710|NCT04425629|564702432|FG015|Overall Study|Subject Decision|4|||
156439711|NCT04425629|564702433|FG016|Overall Study|Subject Decision|1|||
156439712|NCT04425629|564702434|FG017|Overall Study|Subject Decision|0|||
156439713|NCT04425629|564702435|FG018|Overall Study|Subject Decision|2|||
156439714|NCT04425629|564702417|FG000|Overall Study|Death|0|||
156439715|NCT04425629|564702418|FG001|Overall Study|Death|0|||
156439716|NCT04425629|564702419|FG002|Overall Study|Death|0|||
156439717|NCT04425629|564702420|FG003|Overall Study|Death|0|||
156439718|NCT04425629|564702421|FG004|Overall Study|Death|0|||
156439719|NCT04425629|564702422|FG005|Overall Study|Death|0|||
156701887|NCT01629966|565655015|FG000|Overall Study|Lost to Follow-up|10|||
156701888|NCT01629966|565655016|FG001|Overall Study|Lost to Follow-up|13|||
156701889|NCT01629966|565655017|FG002|Overall Study|Lost to Follow-up|9|||
156701890|NCT01629966|565655015|FG000|Overall Study|Withdrawal by Subject|8|||
156701891|NCT01629966|565655016|FG001|Overall Study|Withdrawal by Subject|9|||
156701892|NCT01629966|565655017|FG002|Overall Study|Withdrawal by Subject|16|||
156701893|NCT01629966|565655015|FG000|Overall Study|Protocol Violation|7|||
156701894|NCT01629966|565655016|FG001|Overall Study|Protocol Violation|9|||
156701895|NCT01629966|565655017|FG002|Overall Study|Protocol Violation|7|||
156701896|NCT01629966|565655015|FG000|Overall Study|Lack of Efficacy|5|||
156701897|NCT01629966|565655016|FG001|Overall Study|Lack of Efficacy|2|||
156701898|NCT01629966|565655017|FG002|Overall Study|Lack of Efficacy|4|||
156701899|NCT01629966|565655015|FG000|Overall Study|Adverse Event|11|||
156701900|NCT01629966|565655016|FG001|Overall Study|Adverse Event|18|||
156701901|NCT01629966|565655017|FG002|Overall Study|Adverse Event|30|||
156701902|NCT02132754|565655018|FG000|Overall Study|Adverse Event|0|||
156701903|NCT02132754|565655019|FG001|Overall Study|Adverse Event|0|||
156701904|NCT02132754|565655020|FG002|Overall Study|Adverse Event|0|||
156701905|NCT02132754|565655021|FG003|Overall Study|Adverse Event|0|||
156701906|NCT02132754|565655022|FG004|Overall Study|Adverse Event|0|||
156701907|NCT02132754|565655023|FG005|Overall Study|Adverse Event|0|||
156701908|NCT02132754|565655024|FG006|Overall Study|Adverse Event|0|||
156701909|NCT02132754|565655025|FG007|Overall Study|Adverse Event|0|||
156701910|NCT02132754|565655026|FG008|Overall Study|Adverse Event|0|||
156701911|NCT02132754|565655027|FG009|Overall Study|Adverse Event|0|||
156701912|NCT02132754|565655028|FG010|Overall Study|Adverse Event|0|||
156701913|NCT02132754|565655029|FG011|Overall Study|Adverse Event|0|||
156701914|NCT02132754|565655030|FG012|Overall Study|Adverse Event|0|||
156872115|NCT02858362|566289507|FG000|Overall Study|Early Study Termination|0|||
156872116|NCT02858362|566289508|FG001|Overall Study|Early Study Termination|0|||
156701915|NCT02132754|565655031|FG013|Overall Study|Adverse Event|0|||
156701916|NCT02132754|565655032|FG014|Overall Study|Adverse Event|0|||
156701917|NCT02132754|565655033|FG015|Overall Study|Adverse Event|0|||
156439720|NCT04425629|564702423|FG006|Overall Study|Death|0|||
156439721|NCT04425629|564702424|FG007|Overall Study|Death|0|||
156439722|NCT04425629|564702425|FG008|Overall Study|Death|0|||
156439723|NCT04425629|564702426|FG009|Overall Study|Death|11|||
156439724|NCT04425629|564702427|FG010|Overall Study|Death|2|||
156439725|NCT04425629|564702428|FG011|Overall Study|Death|4|||
156439726|NCT04425629|564702429|FG012|Overall Study|Death|0|||
156439727|NCT04425629|564702430|FG013|Overall Study|Death|0|||
156439728|NCT04425629|564702431|FG014|Overall Study|Death|0|||
156439729|NCT04425629|564702432|FG015|Overall Study|Death|0|||
156439730|NCT04425629|564702433|FG016|Overall Study|Death|0|||
156701918|NCT02132754|565655034|FG016|Overall Study|Adverse Event|0|||
156701919|NCT02132754|565655035|FG017|Overall Study|Adverse Event|1|||
156701920|NCT02132754|565655036|FG018|Overall Study|Adverse Event|0|||
156701921|NCT02132754|565655037|FG019|Overall Study|Adverse Event|0|||
156701922|NCT02132754|565655038|FG020|Overall Study|Adverse Event|0|||
156701923|NCT02132754|565655039|FG021|Overall Study|Adverse Event|0|||
156701924|NCT02132754|565655040|FG022|Overall Study|Adverse Event|0|||
156701925|NCT02132754|565655041|FG023|Overall Study|Adverse Event|0|||
156701926|NCT02132754|565655042|FG024|Overall Study|Adverse Event|0|||
156701927|NCT02132754|565655043|FG025|Overall Study|Adverse Event|1|||
156701928|NCT02132754|565655044|FG026|Overall Study|Adverse Event|1|||
156701929|NCT02132754|565655045|FG027|Overall Study|Adverse Event|0|||
156701930|NCT02132754|565655046|FG028|Overall Study|Adverse Event|0|||
156701931|NCT02132754|565655047|FG029|Overall Study|Adverse Event|0|||
156701932|NCT02132754|565655048|FG030|Overall Study|Adverse Event|1|||
156701933|NCT02132754|565655049|FG031|Overall Study|Adverse Event|0|||
156701934|NCT02132754|565655050|FG032|Overall Study|Adverse Event|1|||
156701935|NCT02132754|565655051|FG033|Overall Study|Adverse Event|1|||
156701936|NCT02132754|565655018|FG000|Overall Study|Clinical Progression|0|||
156701937|NCT02132754|565655019|FG001|Overall Study|Clinical Progression|0|||
156701938|NCT02132754|565655020|FG002|Overall Study|Clinical Progression|0|||
156701939|NCT02132754|565655021|FG003|Overall Study|Clinical Progression|0|||
156701940|NCT02132754|565655022|FG004|Overall Study|Clinical Progression|0|||
156701941|NCT02132754|565655023|FG005|Overall Study|Clinical Progression|0|||
156701942|NCT02132754|565655024|FG006|Overall Study|Clinical Progression|0|||
156701943|NCT02132754|565655025|FG007|Overall Study|Clinical Progression|0|||
156701944|NCT02132754|565655026|FG008|Overall Study|Clinical Progression|0|||
156701945|NCT02132754|565655027|FG009|Overall Study|Clinical Progression|1|||
156701946|NCT02132754|565655028|FG010|Overall Study|Clinical Progression|0|||
156701947|NCT02132754|565655029|FG011|Overall Study|Clinical Progression|0|||
156701948|NCT02132754|565655030|FG012|Overall Study|Clinical Progression|0|||
156701949|NCT02132754|565655031|FG013|Overall Study|Clinical Progression|0|||
156701950|NCT02132754|565655032|FG014|Overall Study|Clinical Progression|0|||
156701951|NCT02132754|565655033|FG015|Overall Study|Clinical Progression|0|||
156701952|NCT02132754|565655034|FG016|Overall Study|Clinical Progression|1|||
156701953|NCT02132754|565655035|FG017|Overall Study|Clinical Progression|1|||
156701954|NCT02132754|565655036|FG018|Overall Study|Clinical Progression|0|||
156701955|NCT02132754|565655037|FG019|Overall Study|Clinical Progression|1|||
156701956|NCT02132754|565655038|FG020|Overall Study|Clinical Progression|0|||
156701957|NCT02132754|565655039|FG021|Overall Study|Clinical Progression|0|||
156701958|NCT02132754|565655040|FG022|Overall Study|Clinical Progression|1|||
156701959|NCT02132754|565655041|FG023|Overall Study|Clinical Progression|0|||
156701960|NCT02132754|565655042|FG024|Overall Study|Clinical Progression|1|||
156701961|NCT02132754|565655043|FG025|Overall Study|Clinical Progression|1|||
156701962|NCT02132754|565655044|FG026|Overall Study|Clinical Progression|0|||
156701963|NCT02132754|565655045|FG027|Overall Study|Clinical Progression|1|||
156701964|NCT02132754|565655046|FG028|Overall Study|Clinical Progression|1|||
156701965|NCT02132754|565655047|FG029|Overall Study|Clinical Progression|0|||
156701966|NCT02132754|565655048|FG030|Overall Study|Clinical Progression|1|||
156701967|NCT02132754|565655049|FG031|Overall Study|Clinical Progression|0|||
156701968|NCT02132754|565655050|FG032|Overall Study|Clinical Progression|0|||
156701969|NCT02132754|565655051|FG033|Overall Study|Clinical Progression|2|||
156701970|NCT02132754|565655018|FG000|Overall Study|Death|0|||
156701971|NCT02132754|565655019|FG001|Overall Study|Death|0|||
156790943|NCT03679884|565985536|FG004|Overall Study|Death|0|||
156790944|NCT03679884|565985532|FG000|Overall Study|Adverse Event|2|||
156790945|NCT03679884|565985533|FG001|Overall Study|Adverse Event|10|||
156790946|NCT03679884|565985534|FG002|Overall Study|Adverse Event|9|||
156790947|NCT03679884|565985535|FG003|Overall Study|Adverse Event|6|||
156790948|NCT03679884|565985536|FG004|Overall Study|Adverse Event|6|||
156790949|NCT03679884|565985532|FG000|Overall Study|Withdrawal by Subject|12|||
156790950|NCT03679884|565985533|FG001|Overall Study|Withdrawal by Subject|23|||
156790951|NCT03679884|565985534|FG002|Overall Study|Withdrawal by Subject|8|||
156790952|NCT03679884|565985535|FG003|Overall Study|Withdrawal by Subject|8|||
156790953|NCT03679884|565985536|FG004|Overall Study|Withdrawal by Subject|9|||
156790954|NCT03679884|565985532|FG000|Overall Study|Lost to Follow-up|1|||
156790955|NCT03679884|565985533|FG001|Overall Study|Lost to Follow-up|4|||
156701972|NCT02132754|565655020|FG002|Overall Study|Death|0|||
156701973|NCT02132754|565655021|FG003|Overall Study|Death|0|||
156701974|NCT02132754|565655022|FG004|Overall Study|Death|0|||
156790956|NCT03679884|565985534|FG002|Overall Study|Lost to Follow-up|2|||
156790957|NCT03679884|565985535|FG003|Overall Study|Lost to Follow-up|0|||
156790958|NCT03679884|565985536|FG004|Overall Study|Lost to Follow-up|3|||
156701975|NCT02132754|565655023|FG005|Overall Study|Death|0|||
156701976|NCT02132754|565655024|FG006|Overall Study|Death|0|||
156701977|NCT02132754|565655025|FG007|Overall Study|Death|0|||
156701978|NCT02132754|565655026|FG008|Overall Study|Death|0|||
156701979|NCT02132754|565655027|FG009|Overall Study|Death|0|||
156701980|NCT02132754|565655028|FG010|Overall Study|Death|0|||
156701981|NCT02132754|565655029|FG011|Overall Study|Death|0|||
156701982|NCT02132754|565655030|FG012|Overall Study|Death|0|||
156701983|NCT02132754|565655031|FG013|Overall Study|Death|0|||
156701984|NCT02132754|565655032|FG014|Overall Study|Death|0|||
156701985|NCT02132754|565655033|FG015|Overall Study|Death|1|||
156701986|NCT02132754|565655034|FG016|Overall Study|Death|0|||
156701987|NCT02132754|565655035|FG017|Overall Study|Death|0|||
156701988|NCT02132754|565655036|FG018|Overall Study|Death|0|||
156701989|NCT02132754|565655037|FG019|Overall Study|Death|1|||
156701990|NCT02132754|565655038|FG020|Overall Study|Death|0|||
156701991|NCT02132754|565655039|FG021|Overall Study|Death|1|||
156701992|NCT02132754|565655040|FG022|Overall Study|Death|0|||
156701993|NCT02132754|565655041|FG023|Overall Study|Death|0|||
156701994|NCT02132754|565655042|FG024|Overall Study|Death|0|||
156701995|NCT02132754|565655043|FG025|Overall Study|Death|0|||
156701996|NCT02132754|565655044|FG026|Overall Study|Death|1|||
156701997|NCT02132754|565655045|FG027|Overall Study|Death|0|||
156701998|NCT02132754|565655046|FG028|Overall Study|Death|0|||
156701999|NCT02132754|565655047|FG029|Overall Study|Death|0|||
156702000|NCT02132754|565655048|FG030|Overall Study|Death|0|||
156702001|NCT02132754|565655049|FG031|Overall Study|Death|0|||
156331923|NCT01543698|564314973|FG002|Phase 2|Administrative problems|0|||
156331924|NCT01543698|564314974|FG003|Phase 2|Administrative problems|0|||
156702002|NCT02132754|565655050|FG032|Overall Study|Death|0|||
156702003|NCT02132754|565655051|FG033|Overall Study|Death|2|||
156702004|NCT02132754|565655018|FG000|Overall Study|Excluded Medication|0|||
156702005|NCT02132754|565655019|FG001|Overall Study|Excluded Medication|0|||
156702006|NCT02132754|565655020|FG002|Overall Study|Excluded Medication|0|||
156702007|NCT02132754|565655021|FG003|Overall Study|Excluded Medication|0|||
156702008|NCT02132754|565655022|FG004|Overall Study|Excluded Medication|0|||
156702009|NCT02132754|565655023|FG005|Overall Study|Excluded Medication|0|||
156702010|NCT02132754|565655024|FG006|Overall Study|Excluded Medication|0|||
156702011|NCT02132754|565655025|FG007|Overall Study|Excluded Medication|0|||
156702012|NCT02132754|565655026|FG008|Overall Study|Excluded Medication|0|||
156702013|NCT02132754|565655027|FG009|Overall Study|Excluded Medication|0|||
156702014|NCT02132754|565655028|FG010|Overall Study|Excluded Medication|0|||
156702015|NCT02132754|565655029|FG011|Overall Study|Excluded Medication|0|||
156702016|NCT02132754|565655030|FG012|Overall Study|Excluded Medication|0|||
156702017|NCT02132754|565655031|FG013|Overall Study|Excluded Medication|0|||
156702018|NCT02132754|565655032|FG014|Overall Study|Excluded Medication|0|||
156702019|NCT02132754|565655033|FG015|Overall Study|Excluded Medication|0|||
156702020|NCT02132754|565655034|FG016|Overall Study|Excluded Medication|0|||
156702021|NCT02132754|565655035|FG017|Overall Study|Excluded Medication|0|||
156702022|NCT02132754|565655036|FG018|Overall Study|Excluded Medication|0|||
156702023|NCT02132754|565655037|FG019|Overall Study|Excluded Medication|0|||
156790959|NCT00480025|565985540|FG000|Overall Study|Protocol Violation|12|||
156790960|NCT00480025|565985541|FG001|Overall Study|Protocol Violation|7|||
156790961|NCT00480025|565985540|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
156790962|NCT00480025|565985541|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
156790963|NCT00480025|565985540|FG000|Overall Study|Disease Progression / Recurrence|449|||
156702024|NCT02132754|565655038|FG020|Overall Study|Excluded Medication|1|||
156702025|NCT02132754|565655039|FG021|Overall Study|Excluded Medication|0|||
156702026|NCT02132754|565655040|FG022|Overall Study|Excluded Medication|0|||
156790964|NCT00480025|565985541|FG001|Overall Study|Disease Progression / Recurrence|224|||
156790965|NCT00480025|565985540|FG000|Overall Study|Adverse Event|44|||
156790966|NCT00480025|565985541|FG001|Overall Study|Adverse Event|12|||
156790967|NCT00480025|565985540|FG000|Overall Study|Other|70|||
156790968|NCT00480025|565985541|FG001|Overall Study|Other|29|||
156790969|NCT00480025|565985540|FG000|Overall Study|SAE including intercurrent illness|76|||
156790970|NCT00480025|565985541|FG001|Overall Study|SAE including intercurrent illness|42|||
156790971|NCT00682435|565985542|FG000|Overall Study|Insufficient data|5|||
156790972|NCT00682435|565985542|FG000|Overall Study|Erroneously enrolled twice|2|||
156790973|NCT01064622|565985544|FG000|Randomized Phase II|Withdrawal by Subject|2|||
156790974|NCT01064622|565985545|FG001|Randomized Phase II|Withdrawal by Subject|2|||
156790975|NCT01064622|565985544|FG000|Randomized Phase II|Protocol Violation|0|||
156790976|NCT01064622|565985545|FG001|Randomized Phase II|Protocol Violation|1|||
156790977|NCT00432991|565987106|FG000|Overall Study|Protocol Violation|7|||
156790978|NCT00432991|565987107|FG001|Overall Study|Protocol Violation|12|||
156790979|NCT00363467|565987108|FG000|Overall Study|Physician Decision|1|||
156790980|NCT05069415|565987111|FG000|Overall Study|Withdrawal by Subject|2|||
156331925|NCT01543698|564314975|FG004|Phase 2|Administrative problems|0|||
156331926|NCT01543698|564314976|FG005|Phase 2|Administrative problems|0|||
156331927|NCT01543698|564314977|FG006|Phase 2|Administrative problems|0|||
156331928|NCT01543698|564314978|FG007|Phase 2|Administrative problems|0|||
156531202|NCT04484259|565039878|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
156702027|NCT02132754|565655041|FG023|Overall Study|Excluded Medication|0|||
156702028|NCT02132754|565655042|FG024|Overall Study|Excluded Medication|0|||
156702029|NCT02132754|565655043|FG025|Overall Study|Excluded Medication|0|||
156702030|NCT02132754|565655044|FG026|Overall Study|Excluded Medication|0|||
156702031|NCT02132754|565655045|FG027|Overall Study|Excluded Medication|0|||
156702032|NCT02132754|565655046|FG028|Overall Study|Excluded Medication|0|||
156702033|NCT02132754|565655047|FG029|Overall Study|Excluded Medication|0|||
156702034|NCT02132754|565655048|FG030|Overall Study|Excluded Medication|0|||
156702035|NCT02132754|565655049|FG031|Overall Study|Excluded Medication|0|||
156702036|NCT02132754|565655050|FG032|Overall Study|Excluded Medication|0|||
156702037|NCT02132754|565655051|FG033|Overall Study|Excluded Medication|1|||
156702038|NCT02132754|565655018|FG000|Overall Study|Physician Decision|0|||
156702039|NCT02132754|565655019|FG001|Overall Study|Physician Decision|0|||
156702040|NCT02132754|565655020|FG002|Overall Study|Physician Decision|0|||
156702041|NCT02132754|565655021|FG003|Overall Study|Physician Decision|0|||
156702042|NCT02132754|565655022|FG004|Overall Study|Physician Decision|0|||
156702043|NCT02132754|565655023|FG005|Overall Study|Physician Decision|0|||
156702044|NCT02132754|565655024|FG006|Overall Study|Physician Decision|0|||
156702045|NCT02132754|565655025|FG007|Overall Study|Physician Decision|0|||
156702046|NCT02132754|565655026|FG008|Overall Study|Physician Decision|0|||
156702047|NCT02132754|565655027|FG009|Overall Study|Physician Decision|1|||
156702048|NCT02132754|565655028|FG010|Overall Study|Physician Decision|0|||
156439731|NCT04425629|564702434|FG017|Overall Study|Death|0|||
156439732|NCT04425629|564702435|FG018|Overall Study|Death|0|||
156439733|NCT04425629|564702417|FG000|Overall Study|Sponsor Request|0|||
156439734|NCT04425629|564702418|FG001|Overall Study|Sponsor Request|0|||
156702049|NCT02132754|565655029|FG011|Overall Study|Physician Decision|1|||
156702050|NCT02132754|565655030|FG012|Overall Study|Physician Decision|1|||
156702051|NCT02132754|565655031|FG013|Overall Study|Physician Decision|0|||
156702052|NCT02132754|565655032|FG014|Overall Study|Physician Decision|0|||
156702053|NCT02132754|565655033|FG015|Overall Study|Physician Decision|1|||
156702054|NCT02132754|565655034|FG016|Overall Study|Physician Decision|0|||
156702055|NCT02132754|565655035|FG017|Overall Study|Physician Decision|0|||
156702056|NCT02132754|565655036|FG018|Overall Study|Physician Decision|0|||
156702057|NCT02132754|565655037|FG019|Overall Study|Physician Decision|0|||
156702058|NCT02132754|565655038|FG020|Overall Study|Physician Decision|0|||
156439735|NCT04425629|564702419|FG002|Overall Study|Sponsor Request|0|||
156439736|NCT04425629|564702420|FG003|Overall Study|Sponsor Request|2|||
156439737|NCT04425629|564702421|FG004|Overall Study|Sponsor Request|2|||
156439738|NCT04425629|564702422|FG005|Overall Study|Sponsor Request|2|||
156439739|NCT04425629|564702423|FG006|Overall Study|Sponsor Request|1|||
156439740|NCT04425629|564702424|FG007|Overall Study|Sponsor Request|0|||
156702059|NCT02132754|565655039|FG021|Overall Study|Physician Decision|0|||
156702060|NCT02132754|565655040|FG022|Overall Study|Physician Decision|0|||
156439741|NCT04425629|564702425|FG008|Overall Study|Sponsor Request|0|||
156439742|NCT04425629|564702426|FG009|Overall Study|Sponsor Request|9|||
156439743|NCT04425629|564702427|FG010|Overall Study|Sponsor Request|9|||
156439744|NCT04425629|564702428|FG011|Overall Study|Sponsor Request|10|||
156439745|NCT04425629|564702429|FG012|Overall Study|Sponsor Request|8|||
156439746|NCT04425629|564702430|FG013|Overall Study|Sponsor Request|0|||
156439747|NCT04425629|564702431|FG014|Overall Study|Sponsor Request|0|||
156439748|NCT04425629|564702432|FG015|Overall Study|Sponsor Request|1|||
156439749|NCT04425629|564702433|FG016|Overall Study|Sponsor Request|0|||
156439750|NCT04425629|564702434|FG017|Overall Study|Sponsor Request|0|||
156439751|NCT04425629|564702435|FG018|Overall Study|Sponsor Request|0|||
156439752|NCT04425629|564702417|FG000|Overall Study|Physician Decision|0|||
156439753|NCT04425629|564702418|FG001|Overall Study|Physician Decision|0|||
156439754|NCT04425629|564702419|FG002|Overall Study|Physician Decision|0|||
156439755|NCT04425629|564702420|FG003|Overall Study|Physician Decision|0|||
156439756|NCT04425629|564702421|FG004|Overall Study|Physician Decision|0|||
156439757|NCT04425629|564702422|FG005|Overall Study|Physician Decision|0|||
156439758|NCT04425629|564702423|FG006|Overall Study|Physician Decision|0|||
156439759|NCT04425629|564702424|FG007|Overall Study|Physician Decision|0|||
156439760|NCT04425629|564702425|FG008|Overall Study|Physician Decision|0|||
156439761|NCT04425629|564702426|FG009|Overall Study|Physician Decision|4|||
156702061|NCT02132754|565655041|FG023|Overall Study|Physician Decision|0|||
156702062|NCT02132754|565655042|FG024|Overall Study|Physician Decision|1|||
156702063|NCT02132754|565655043|FG025|Overall Study|Physician Decision|0|||
156702064|NCT02132754|565655044|FG026|Overall Study|Physician Decision|0|||
156702065|NCT02132754|565655045|FG027|Overall Study|Physician Decision|0|||
156702066|NCT02132754|565655046|FG028|Overall Study|Physician Decision|0|||
156872117|NCT02858362|566289509|FG002|Overall Study|Early Study Termination|3|||
156439762|NCT04425629|564702427|FG010|Overall Study|Physician Decision|3|||
156702067|NCT02132754|565655047|FG029|Overall Study|Physician Decision|0|||
156439763|NCT04425629|564702428|FG011|Overall Study|Physician Decision|5|||
156702068|NCT02132754|565655048|FG030|Overall Study|Physician Decision|0|||
156702069|NCT02132754|565655049|FG031|Overall Study|Physician Decision|1|||
156702070|NCT02132754|565655050|FG032|Overall Study|Physician Decision|0|||
156702071|NCT02132754|565655051|FG033|Overall Study|Physician Decision|3|||
156439764|NCT04425629|564702429|FG012|Overall Study|Physician Decision|1|||
156439765|NCT04425629|564702430|FG013|Overall Study|Physician Decision|0|||
156439766|NCT04425629|564702431|FG014|Overall Study|Physician Decision|0|||
156439767|NCT04425629|564702432|FG015|Overall Study|Physician Decision|1|||
156702072|NCT02132754|565655018|FG000|Overall Study|Progressive Disease|1|||
156702073|NCT02132754|565655019|FG001|Overall Study|Progressive Disease|1|||
156702074|NCT02132754|565655020|FG002|Overall Study|Progressive Disease|1|||
156439768|NCT04425629|564702433|FG016|Overall Study|Physician Decision|0|||
156439769|NCT04425629|564702434|FG017|Overall Study|Physician Decision|0|||
156439770|NCT04425629|564702435|FG018|Overall Study|Physician Decision|0|||
156439771|NCT04425629|564702417|FG000|Overall Study|Lack of Efficacy|0|||
156702075|NCT02132754|565655021|FG003|Overall Study|Progressive Disease|1|||
156702076|NCT02132754|565655022|FG004|Overall Study|Progressive Disease|1|||
156702077|NCT02132754|565655023|FG005|Overall Study|Progressive Disease|1|||
156702078|NCT02132754|565655024|FG006|Overall Study|Progressive Disease|1|||
156702079|NCT02132754|565655025|FG007|Overall Study|Progressive Disease|1|||
156702080|NCT02132754|565655026|FG008|Overall Study|Progressive Disease|1|||
156702081|NCT02132754|565655027|FG009|Overall Study|Progressive Disease|3|||
156702082|NCT02132754|565655028|FG010|Overall Study|Progressive Disease|3|||
156702083|NCT02132754|565655029|FG011|Overall Study|Progressive Disease|2|||
156702084|NCT02132754|565655030|FG012|Overall Study|Progressive Disease|2|||
156702085|NCT02132754|565655031|FG013|Overall Study|Progressive Disease|3|||
156702086|NCT02132754|565655032|FG014|Overall Study|Progressive Disease|2|||
156702087|NCT02132754|565655033|FG015|Overall Study|Progressive Disease|1|||
156702088|NCT02132754|565655034|FG016|Overall Study|Progressive Disease|2|||
156702089|NCT02132754|565655035|FG017|Overall Study|Progressive Disease|1|||
156702090|NCT02132754|565655036|FG018|Overall Study|Progressive Disease|3|||
156702091|NCT02132754|565655037|FG019|Overall Study|Progressive Disease|1|||
156702092|NCT02132754|565655038|FG020|Overall Study|Progressive Disease|1|||
156702093|NCT02132754|565655039|FG021|Overall Study|Progressive Disease|3|||
156702094|NCT02132754|565655040|FG022|Overall Study|Progressive Disease|2|||
156702095|NCT02132754|565655041|FG023|Overall Study|Progressive Disease|3|||
156702096|NCT02132754|565655042|FG024|Overall Study|Progressive Disease|0|||
156702097|NCT02132754|565655043|FG025|Overall Study|Progressive Disease|1|||
156702098|NCT02132754|565655044|FG026|Overall Study|Progressive Disease|2|||
156702099|NCT02132754|565655045|FG027|Overall Study|Progressive Disease|1|||
156702100|NCT02132754|565655046|FG028|Overall Study|Progressive Disease|2|||
156702101|NCT02132754|565655047|FG029|Overall Study|Progressive Disease|3|||
156702102|NCT02132754|565655048|FG030|Overall Study|Progressive Disease|1|||
156702103|NCT02132754|565655049|FG031|Overall Study|Progressive Disease|1|||
156702104|NCT02132754|565655050|FG032|Overall Study|Progressive Disease|3|||
156702105|NCT02132754|565655051|FG033|Overall Study|Progressive Disease|6|||
156702106|NCT02132754|565655018|FG000|Overall Study|Screen Failure|0|||
156702107|NCT02132754|565655019|FG001|Overall Study|Screen Failure|0|||
156702108|NCT02132754|565655020|FG002|Overall Study|Screen Failure|0|||
156702109|NCT02132754|565655021|FG003|Overall Study|Screen Failure|0|||
156702110|NCT02132754|565655022|FG004|Overall Study|Screen Failure|0|||
156702111|NCT02132754|565655023|FG005|Overall Study|Screen Failure|0|||
156702112|NCT02132754|565655024|FG006|Overall Study|Screen Failure|0|||
156702113|NCT02132754|565655025|FG007|Overall Study|Screen Failure|0|||
156702114|NCT02132754|565655026|FG008|Overall Study|Screen Failure|0|||
156702115|NCT02132754|565655027|FG009|Overall Study|Screen Failure|0|||
156702116|NCT02132754|565655028|FG010|Overall Study|Screen Failure|0|||
156702117|NCT02132754|565655029|FG011|Overall Study|Screen Failure|0|||
156702118|NCT02132754|565655030|FG012|Overall Study|Screen Failure|0|||
156702119|NCT02132754|565655031|FG013|Overall Study|Screen Failure|0|||
156702120|NCT02132754|565655032|FG014|Overall Study|Screen Failure|0|||
156702121|NCT02132754|565655033|FG015|Overall Study|Screen Failure|0|||
156702122|NCT02132754|565655034|FG016|Overall Study|Screen Failure|0|||
156702123|NCT02132754|565655035|FG017|Overall Study|Screen Failure|0|||
156702124|NCT02132754|565655036|FG018|Overall Study|Screen Failure|0|||
156702125|NCT02132754|565655037|FG019|Overall Study|Screen Failure|1|||
156702126|NCT02132754|565655038|FG020|Overall Study|Screen Failure|0|||
156702127|NCT02132754|565655039|FG021|Overall Study|Screen Failure|1|||
156702128|NCT02132754|565655040|FG022|Overall Study|Screen Failure|0|||
156702129|NCT02132754|565655041|FG023|Overall Study|Screen Failure|0|||
156702130|NCT02132754|565655042|FG024|Overall Study|Screen Failure|0|||
156702131|NCT02132754|565655043|FG025|Overall Study|Screen Failure|0|||
156702132|NCT02132754|565655044|FG026|Overall Study|Screen Failure|0|||
156702133|NCT02132754|565655045|FG027|Overall Study|Screen Failure|0|||
156702134|NCT02132754|565655046|FG028|Overall Study|Screen Failure|0|||
156702135|NCT02132754|565655047|FG029|Overall Study|Screen Failure|0|||
156702136|NCT02132754|565655048|FG030|Overall Study|Screen Failure|0|||
156702137|NCT02132754|565655049|FG031|Overall Study|Screen Failure|0|||
156702138|NCT02132754|565655050|FG032|Overall Study|Screen Failure|0|||
156702139|NCT02132754|565655051|FG033|Overall Study|Screen Failure|0|||
156702140|NCT02132754|565655018|FG000|Overall Study|Transferred to Extension Study|0|||
156702141|NCT02132754|565655019|FG001|Overall Study|Transferred to Extension Study|0|||
156702142|NCT02132754|565655020|FG002|Overall Study|Transferred to Extension Study|0|||
156790981|NCT05069415|565987112|FG001|Overall Study|Withdrawal by Subject|0|||
156702143|NCT02132754|565655021|FG003|Overall Study|Transferred to Extension Study|0|||
156702144|NCT02132754|565655022|FG004|Overall Study|Transferred to Extension Study|0|||
156702145|NCT02132754|565655023|FG005|Overall Study|Transferred to Extension Study|0|||
156702146|NCT02132754|565655024|FG006|Overall Study|Transferred to Extension Study|0|||
156702147|NCT02132754|565655025|FG007|Overall Study|Transferred to Extension Study|0|||
156702148|NCT02132754|565655026|FG008|Overall Study|Transferred to Extension Study|0|||
156702149|NCT02132754|565655027|FG009|Overall Study|Transferred to Extension Study|0|||
156702150|NCT02132754|565655028|FG010|Overall Study|Transferred to Extension Study|0|||
156702151|NCT02132754|565655029|FG011|Overall Study|Transferred to Extension Study|0|||
156702152|NCT02132754|565655030|FG012|Overall Study|Transferred to Extension Study|0|||
156702153|NCT02132754|565655031|FG013|Overall Study|Transferred to Extension Study|0|||
156702154|NCT02132754|565655032|FG014|Overall Study|Transferred to Extension Study|0|||
156702155|NCT02132754|565655033|FG015|Overall Study|Transferred to Extension Study|0|||
156702156|NCT02132754|565655034|FG016|Overall Study|Transferred to Extension Study|0|||
156702157|NCT02132754|565655035|FG017|Overall Study|Transferred to Extension Study|0|||
156702158|NCT02132754|565655036|FG018|Overall Study|Transferred to Extension Study|0|||
156702159|NCT02132754|565655037|FG019|Overall Study|Transferred to Extension Study|0|||
156702160|NCT02132754|565655038|FG020|Overall Study|Transferred to Extension Study|0|||
156702161|NCT02132754|565655039|FG021|Overall Study|Transferred to Extension Study|0|||
156702162|NCT02132754|565655040|FG022|Overall Study|Transferred to Extension Study|0|||
156702163|NCT02132754|565655041|FG023|Overall Study|Transferred to Extension Study|0|||
156702164|NCT02132754|565655042|FG024|Overall Study|Transferred to Extension Study|0|||
156702165|NCT02132754|565655043|FG025|Overall Study|Transferred to Extension Study|0|||
156702166|NCT02132754|565655044|FG026|Overall Study|Transferred to Extension Study|0|||
156702167|NCT02132754|565655045|FG027|Overall Study|Transferred to Extension Study|0|||
156702168|NCT02132754|565655046|FG028|Overall Study|Transferred to Extension Study|0|||
156702169|NCT02132754|565655047|FG029|Overall Study|Transferred to Extension Study|0|||
156702170|NCT02132754|565655048|FG030|Overall Study|Transferred to Extension Study|0|||
156702171|NCT02132754|565655049|FG031|Overall Study|Transferred to Extension Study|0|||
156702172|NCT02132754|565655050|FG032|Overall Study|Transferred to Extension Study|0|||
156702173|NCT02132754|565655051|FG033|Overall Study|Transferred to Extension Study|6|||
156702174|NCT02132754|565655018|FG000|Overall Study|Withdrawal by Subject|0|||
156702175|NCT02132754|565655019|FG001|Overall Study|Withdrawal by Subject|0|||
156702176|NCT02132754|565655020|FG002|Overall Study|Withdrawal by Subject|0|||
156702177|NCT02132754|565655021|FG003|Overall Study|Withdrawal by Subject|0|||
156702178|NCT02132754|565655022|FG004|Overall Study|Withdrawal by Subject|0|||
156702179|NCT02132754|565655023|FG005|Overall Study|Withdrawal by Subject|0|||
156702180|NCT02132754|565655024|FG006|Overall Study|Withdrawal by Subject|0|||
156702181|NCT02132754|565655025|FG007|Overall Study|Withdrawal by Subject|0|||
156702182|NCT02132754|565655026|FG008|Overall Study|Withdrawal by Subject|0|||
156702183|NCT02132754|565655027|FG009|Overall Study|Withdrawal by Subject|1|||
156702184|NCT02132754|565655028|FG010|Overall Study|Withdrawal by Subject|0|||
156702185|NCT02132754|565655029|FG011|Overall Study|Withdrawal by Subject|0|||
156702186|NCT02132754|565655030|FG012|Overall Study|Withdrawal by Subject|1|||
156702187|NCT02132754|565655031|FG013|Overall Study|Withdrawal by Subject|0|||
156702188|NCT02132754|565655032|FG014|Overall Study|Withdrawal by Subject|1|||
156702189|NCT02132754|565655033|FG015|Overall Study|Withdrawal by Subject|2|||
156702190|NCT02132754|565655034|FG016|Overall Study|Withdrawal by Subject|1|||
156702191|NCT02132754|565655035|FG017|Overall Study|Withdrawal by Subject|0|||
156702192|NCT02132754|565655036|FG018|Overall Study|Withdrawal by Subject|0|||
156702193|NCT02132754|565655037|FG019|Overall Study|Withdrawal by Subject|0|||
156702194|NCT02132754|565655038|FG020|Overall Study|Withdrawal by Subject|1|||
156702195|NCT02132754|565655039|FG021|Overall Study|Withdrawal by Subject|0|||
156702196|NCT02132754|565655040|FG022|Overall Study|Withdrawal by Subject|0|||
156702197|NCT02132754|565655041|FG023|Overall Study|Withdrawal by Subject|0|||
156702198|NCT02132754|565655042|FG024|Overall Study|Withdrawal by Subject|1|||
156702199|NCT02132754|565655043|FG025|Overall Study|Withdrawal by Subject|0|||
156702200|NCT02132754|565655044|FG026|Overall Study|Withdrawal by Subject|0|||
156702201|NCT02132754|565655045|FG027|Overall Study|Withdrawal by Subject|1|||
156702202|NCT02132754|565655046|FG028|Overall Study|Withdrawal by Subject|0|||
156702203|NCT02132754|565655047|FG029|Overall Study|Withdrawal by Subject|0|||
156702204|NCT02132754|565655048|FG030|Overall Study|Withdrawal by Subject|0|||
156702205|NCT02132754|565655049|FG031|Overall Study|Withdrawal by Subject|1|||
156702206|NCT02132754|565655050|FG032|Overall Study|Withdrawal by Subject|0|||
156702207|NCT02132754|565655051|FG033|Overall Study|Withdrawal by Subject|2|||
156702208|NCT00390221|565655052|FG000|Overall Study|Lost to Follow-up|0|||
156702209|NCT00390221|565655053|FG001|Overall Study|Lost to Follow-up|3|||
156702210|NCT00390221|565655054|FG002|Overall Study|Lost to Follow-up|0|||
156702211|NCT00390221|565655052|FG000|Overall Study|Adverse Event|1|||
156702212|NCT00390221|565655053|FG001|Overall Study|Adverse Event|4|||
156702213|NCT00390221|565655054|FG002|Overall Study|Adverse Event|3|||
156702214|NCT00390221|565655052|FG000|Overall Study|Investigator Decision|0|||
156702215|NCT00390221|565655053|FG001|Overall Study|Investigator Decision|0|||
156702216|NCT00390221|565655054|FG002|Overall Study|Investigator Decision|1|||
156702217|NCT00390221|565655052|FG000|Overall Study|Withdrawal by Subject|13|||
156702218|NCT00390221|565655053|FG001|Overall Study|Withdrawal by Subject|9|||
156702219|NCT00390221|565655054|FG002|Overall Study|Withdrawal by Subject|7|||
156702220|NCT00390221|565655052|FG000|Overall Study|Subject Non-compliance|1|||
156702221|NCT00390221|565655053|FG001|Overall Study|Subject Non-compliance|0|||
156702222|NCT00390221|565655054|FG002|Overall Study|Subject Non-compliance|2|||
156702223|NCT00390221|565655052|FG000|Overall Study|Other|3|||
156702224|NCT00390221|565655053|FG001|Overall Study|Other|4|||
156702225|NCT00390221|565655054|FG002|Overall Study|Other|2|||
156702226|NCT00389831|565655061|FG000|Overall Study|Lack of Efficacy|0|||
156702227|NCT00389831|565655062|FG001|Overall Study|Lack of Efficacy|2|||
156702228|NCT00389831|565655061|FG000|Overall Study|Did not receive treatment.|0|||
156702229|NCT00389831|565655062|FG001|Overall Study|Did not receive treatment.|2|||
156702230|NCT00389831|565655061|FG000|Overall Study|Other reasons|0|||
156702231|NCT00389831|565655062|FG001|Overall Study|Other reasons|2|||
156702232|NCT00389831|565655061|FG000|Overall Study|Lost to Follow-up|0|||
156702233|NCT00389831|565655062|FG001|Overall Study|Lost to Follow-up|1|||
156702234|NCT02201290|565655063|FG000|Overall Study|Withdrawal by Subject|2|||
156702235|NCT02201290|565655063|FG000|Overall Study|Lack of Efficacy|2|||
156702236|NCT02201290|565655063|FG000|Overall Study|Adverse Event|1|||
156702237|NCT02370329|565656890|FG000|Overall Study|Alternate treatment|1|||
156702238|NCT02370329|565656890|FG000|Overall Study|Adverse Event|1|||
156702239|NCT02370329|565656890|FG000|Overall Study|Disease progression|3|||
156702240|NCT02370329|565656890|FG000|Overall Study|Physician Decision|2|||
156702241|NCT02370329|565656890|FG000|Overall Study|Study closure|4|||
156702242|NCT00112866|565656892|FG000|Overall Study|Protocol Violation|1|||
156702243|NCT00112866|565656893|FG001|Overall Study|Protocol Violation|0|||
156702244|NCT00112866|565656892|FG000|Overall Study|did not start treatment post-op|1|||
156702245|NCT00112866|565656893|FG001|Overall Study|did not start treatment post-op|2|||
156702246|NCT04663295|565656894|FG000|Run-in Period|Withdrawal by Subject|3|||
156702247|NCT04663295|565656894|FG000|Overall Study Period|Pregnancy|1|||
156702248|NCT04663295|565656894|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
156702249|NCT00699283|565656896|FG000|Overall Study|Lack of Efficacy|15|||
156702250|NCT00699283|565656897|FG001|Overall Study|Lack of Efficacy|5|||
156702251|NCT00699283|565656896|FG000|Overall Study|Lost to Follow-up|2|||
156702252|NCT00699283|565656897|FG001|Overall Study|Lost to Follow-up|0|||
156702253|NCT00699283|565656896|FG000|Overall Study|Withdrawal by Subject|1|||
156702254|NCT00699283|565656897|FG001|Overall Study|Withdrawal by Subject|0|||
156702255|NCT00699283|565656896|FG000|Overall Study|Other Reason|5|||
156702256|NCT00699283|565656897|FG001|Overall Study|Other Reason|1|||
156702257|NCT00699283|565656896|FG000|Overall Study|SAE, non-fatal|1|||
156702258|NCT00699283|565656897|FG001|Overall Study|SAE, non-fatal|1|||
156702259|NCT00699283|565656896|FG000|Overall Study|AE, non-serious non-fatal|8|||
156702260|NCT00699283|565656897|FG001|Overall Study|AE, non-serious non-fatal|1|||
156702261|NCT00699283|565656896|FG000|Overall Study|AE of unknown type|1|||
156702262|NCT00699283|565656897|FG001|Overall Study|AE of unknown type|0|||
156702263|NCT02771795|565656898|FG000|Overall Study|Withdrawal by Subject|47|||
156702264|NCT02771795|565656899|FG001|Overall Study|Withdrawal by Subject|37|||
156702265|NCT02771795|565656898|FG000|Overall Study|Termination by premature discontinuation of study|168|||
156702266|NCT02771795|565656899|FG001|Overall Study|Termination by premature discontinuation of study|185|||
156702267|NCT03317834|565656900|FG000|Overall Study|Death|2|||
156702268|NCT03317834|565656900|FG000|Overall Study|Device Revision|5|||
156702269|NCT03317834|565656900|FG000|Overall Study|Withdrawal by Subject|13|||
156702270|NCT03317834|565656900|FG000|Overall Study|Lost to Follow-up|13|||
156702271|NCT04228783|565656901|FG000|Overall Study|Adverse Event|1|||
156702272|NCT04228783|565656902|FG001|Overall Study|Adverse Event|0|||
156702273|NCT04228783|565656903|FG002|Overall Study|Adverse Event|2|||
156702274|NCT04228783|565656904|FG003|Overall Study|Adverse Event|0|||
156702275|NCT04228783|565656905|FG004|Overall Study|Adverse Event|0|||
156702276|NCT04228783|565656906|FG005|Overall Study|Adverse Event|1|||
156702277|NCT04228783|565656901|FG000|Overall Study|Death|0|||
156702278|NCT04228783|565656902|FG001|Overall Study|Death|0|||
156702279|NCT04228783|565656903|FG002|Overall Study|Death|0|||
156702280|NCT04228783|565656904|FG003|Overall Study|Death|0|||
156702281|NCT04228783|565656905|FG004|Overall Study|Death|1|||
156702282|NCT04228783|565656906|FG005|Overall Study|Death|0|||
156702283|NCT04228783|565656901|FG000|Overall Study|Lost to Follow-up|36|||
156702284|NCT04228783|565656902|FG001|Overall Study|Lost to Follow-up|36|||
156702285|NCT04228783|565656903|FG002|Overall Study|Lost to Follow-up|28|||
156702286|NCT04228783|565656904|FG003|Overall Study|Lost to Follow-up|6|||
156702287|NCT04228783|565656905|FG004|Overall Study|Lost to Follow-up|14|||
156702288|NCT04228783|565656906|FG005|Overall Study|Lost to Follow-up|3|||
156702289|NCT04228783|565656901|FG000|Overall Study|Physician Decision|1|||
156702290|NCT04228783|565656902|FG001|Overall Study|Physician Decision|2|||
156702291|NCT04228783|565656903|FG002|Overall Study|Physician Decision|0|||
156702292|NCT04228783|565656904|FG003|Overall Study|Physician Decision|0|||
156702293|NCT04228783|565656905|FG004|Overall Study|Physician Decision|0|||
156702294|NCT04228783|565656906|FG005|Overall Study|Physician Decision|0|||
156702295|NCT04228783|565656901|FG000|Overall Study|Protocol Violation|0|||
156702296|NCT04228783|565656902|FG001|Overall Study|Protocol Violation|0|||
156702297|NCT04228783|565656903|FG002|Overall Study|Protocol Violation|0|||
156702298|NCT04228783|565656904|FG003|Overall Study|Protocol Violation|1|||
156702299|NCT04228783|565656905|FG004|Overall Study|Protocol Violation|0|||
156702300|NCT04228783|565656906|FG005|Overall Study|Protocol Violation|0|||
156872118|NCT02858362|566289507|FG000|Overall Study|Lost to Follow-up|1|||
156702301|NCT04228783|565656901|FG000|Overall Study|Withdrawal by Subject|6|||
156702302|NCT04228783|565656902|FG001|Overall Study|Withdrawal by Subject|10|||
156702303|NCT04228783|565656903|FG002|Overall Study|Withdrawal by Subject|19|||
156702304|NCT04228783|565656904|FG003|Overall Study|Withdrawal by Subject|1|||
156702305|NCT04228783|565656905|FG004|Overall Study|Withdrawal by Subject|2|||
156702306|NCT04228783|565656906|FG005|Overall Study|Withdrawal by Subject|0|||
156702307|NCT04228783|565656901|FG000|Overall Study|Other|4|||
156702308|NCT04228783|565656902|FG001|Overall Study|Other|3|||
156702309|NCT04228783|565656903|FG002|Overall Study|Other|2|||
156702310|NCT04228783|565656904|FG003|Overall Study|Other|1|||
156702311|NCT04228783|565656905|FG004|Overall Study|Other|0|||
156702312|NCT04228783|565656906|FG005|Overall Study|Other|0|||
156702313|NCT03151811|565656912|FG000|Overall Study|Randomized But Not Treated|18|||
156702314|NCT03151811|565656913|FG001|Overall Study|Randomized But Not Treated|3|||
156702315|NCT03151811|565656912|FG000|Overall Study|Progressive Disease|130|||
156702316|NCT03151811|565656913|FG001|Overall Study|Progressive Disease|170|||
156702317|NCT03151811|565656912|FG000|Overall Study|Adverse Event|49|||
156702318|NCT03151811|565656913|FG001|Overall Study|Adverse Event|40|||
156702319|NCT03151811|565656912|FG000|Overall Study|Lack of Efficacy|6|||
156702320|NCT03151811|565656913|FG001|Overall Study|Lack of Efficacy|8|||
156702321|NCT03151811|565656912|FG000|Overall Study|Physician Decision|21|||
156702322|NCT03151811|565656913|FG001|Overall Study|Physician Decision|9|||
156702323|NCT03151811|565656912|FG000|Overall Study|Withdrawal by Subject|17|||
156702324|NCT03151811|565656913|FG001|Overall Study|Withdrawal by Subject|7|||
156702325|NCT03151811|565656912|FG000|Overall Study|Lost to Follow-up|0|||
156702326|NCT03151811|565656913|FG001|Overall Study|Lost to Follow-up|1|||
156702327|NCT03151811|565656912|FG000|Overall Study|Study Terminated by Sponsor|5|||
156702328|NCT03151811|565656913|FG001|Overall Study|Study Terminated by Sponsor|11|||
156702329|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
156702330|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
156702331|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
156702332|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
156702333|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
156702334|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
156702335|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
156702336|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
156702337|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
156702338|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
156702339|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Death|1|||
156702340|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Death|0|||
156702341|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Death|0|||
156702342|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Death|0|||
156702343|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Death|0|||
156702344|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
156439772|NCT04425629|564702418|FG001|Overall Study|Lack of Efficacy|0|||
156439773|NCT04425629|564702419|FG002|Overall Study|Lack of Efficacy|0|||
156439774|NCT04425629|564702420|FG003|Overall Study|Lack of Efficacy|0|||
156439775|NCT04425629|564702421|FG004|Overall Study|Lack of Efficacy|0|||
156439776|NCT04425629|564702422|FG005|Overall Study|Lack of Efficacy|0|||
156439777|NCT04425629|564702423|FG006|Overall Study|Lack of Efficacy|0|||
156439778|NCT04425629|564702424|FG007|Overall Study|Lack of Efficacy|0|||
156439779|NCT04425629|564702425|FG008|Overall Study|Lack of Efficacy|0|||
156439780|NCT04425629|564702426|FG009|Overall Study|Lack of Efficacy|0|||
156439781|NCT04425629|564702427|FG010|Overall Study|Lack of Efficacy|1|||
156439782|NCT04425629|564702428|FG011|Overall Study|Lack of Efficacy|0|||
156439783|NCT04425629|564702429|FG012|Overall Study|Lack of Efficacy|0|||
156439784|NCT04425629|564702430|FG013|Overall Study|Lack of Efficacy|0|||
156439785|NCT04425629|564702431|FG014|Overall Study|Lack of Efficacy|0|||
156439786|NCT04425629|564702432|FG015|Overall Study|Lack of Efficacy|0|||
156439787|NCT04425629|564702433|FG016|Overall Study|Lack of Efficacy|0|||
156439788|NCT04425629|564702434|FG017|Overall Study|Lack of Efficacy|0|||
156439789|NCT04425629|564702435|FG018|Overall Study|Lack of Efficacy|0|||
156439790|NCT00232180|564702437|FG000|Double-blind (DB) Phase|Death|186|||
156702345|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
156702346|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
156702347|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
156702348|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
156702349|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
156702350|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
156439791|NCT00232180|564702438|FG001|Double-blind (DB) Phase|Death|222|||
156439792|NCT00232180|564702439|FG002|Double-blind (DB) Phase|Death|0|||
156439793|NCT00232180|564702437|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
156702351|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
156702352|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
156702353|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
156702354|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
156439794|NCT00232180|564702438|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
156439795|NCT00232180|564702439|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
156439796|NCT00232180|564702437|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
156702355|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
156702356|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
156531203|NCT04484259|565039879|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
156531204|NCT04484259|565039875|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
156531205|NCT04484259|565039876|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
156531206|NCT04484259|565039877|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
156531207|NCT04484259|565039878|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
156531208|NCT04484259|565039879|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
156531209|NCT04484259|565039875|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
156531210|NCT04484259|565039876|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
156531211|NCT04484259|565039877|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
156531212|NCT04484259|565039878|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
156531213|NCT04484259|565039879|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
156531214|NCT04484259|565039875|FG000|Randomized Treatment|Withdrawal by Subject|1|||
156531215|NCT04484259|565039876|FG001|Randomized Treatment|Withdrawal by Subject|0|||
156531216|NCT04484259|565039877|FG002|Randomized Treatment|Withdrawal by Subject|0|||
156531217|NCT04484259|565039878|FG003|Randomized Treatment|Withdrawal by Subject|0|||
156531218|NCT04484259|565039879|FG004|Randomized Treatment|Withdrawal by Subject|0|||
156531219|NCT03951220|565039880|FG000|Overall Study|Withdrawal by Subject|9|||
156531220|NCT03951220|565039881|FG001|Overall Study|Withdrawal by Subject|2|||
156531221|NCT03951220|565039882|FG002|Overall Study|Withdrawal by Subject|0|||
156531222|NCT04498832|565039883|FG000|Overall Study|Adverse Event|1|||
156531223|NCT04498832|565039884|FG001|Overall Study|Adverse Event|3|||
156531224|NCT04498832|565039883|FG000|Overall Study|Withdrawal by Subject|0|||
156531225|NCT04498832|565039884|FG001|Overall Study|Withdrawal by Subject|1|||
156531226|NCT06268288|565039889|FG000|Overall Study|Withdrawal by Subject|1|||
156531227|NCT06268288|565039890|FG001|Overall Study|Withdrawal by Subject|2|||
156531228|NCT02146326|565039893|FG000|Overall Study|Lost to Follow-up|3|||
156531229|NCT02146326|565039894|FG001|Overall Study|Lost to Follow-up|3|||
156531230|NCT02146326|565039895|FG002|Overall Study|Lost to Follow-up|11|||
156531231|NCT02146326|565039896|FG003|Overall Study|Lost to Follow-up|19|||
156531232|NCT02146326|565039893|FG000|Overall Study|Withdrawal by Subject|2|||
156531233|NCT02146326|565039894|FG001|Overall Study|Withdrawal by Subject|1|||
156531234|NCT02146326|565039895|FG002|Overall Study|Withdrawal by Subject|15|||
156531235|NCT02146326|565039896|FG003|Overall Study|Withdrawal by Subject|11|||
156531236|NCT02146326|565039893|FG000|Overall Study|Separated from mental health center|23|||
156702357|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
156702358|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
156702359|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
156702360|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
156702361|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
156702362|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
156702363|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156790982|NCT05069415|565987111|FG000|Overall Study|Adverse Event|2|||
156331929|NCT01543698|564314979|FG008|Phase 2|Administrative problems|0|||
156331930|NCT01543698|564314980|FG009|Phase 2|Administrative problems|0|||
156531237|NCT02146326|565039894|FG001|Overall Study|Separated from mental health center|33|||
156531238|NCT02146326|565039895|FG002|Overall Study|Separated from mental health center|0|||
156531239|NCT02146326|565039896|FG003|Overall Study|Separated from mental health center|0|||
156531240|NCT02146326|565039893|FG000|Overall Study|Incarcerated|0|||
156531241|NCT02146326|565039894|FG001|Overall Study|Incarcerated|0|||
156531242|NCT02146326|565039895|FG002|Overall Study|Incarcerated|3|||
156531243|NCT02146326|565039896|FG003|Overall Study|Incarcerated|8|||
156531244|NCT02146326|565039893|FG000|Overall Study|Death|0|||
156531245|NCT02146326|565039894|FG001|Overall Study|Death|0|||
156531246|NCT02146326|565039895|FG002|Overall Study|Death|4|||
156531247|NCT02146326|565039896|FG003|Overall Study|Death|4|||
156531248|NCT02146326|565039893|FG000|Overall Study|Unable to complete interview|0|||
156531249|NCT02146326|565039894|FG001|Overall Study|Unable to complete interview|0|||
156331931|NCT01543698|564314981|FG010|Phase 2|Administrative problems|0|||
156331932|NCT01543698|564314982|FG011|Phase 2|Administrative problems|0|||
156331933|NCT01543698|564314983|FG012|Phase 2|Administrative problems|0|||
156331934|NCT01543698|564314984|FG013|Phase 2|Administrative problems|3|||
156331935|NCT01543698|564314985|FG014|Phase 2|Administrative problems|1|||
156331936|NCT01543698|564314971|FG000|Phase 2|Withdrawal by Subject|0|||
156331937|NCT01543698|564314972|FG001|Phase 2|Withdrawal by Subject|0|||
156331938|NCT01543698|564314973|FG002|Phase 2|Withdrawal by Subject|0|||
156331939|NCT01543698|564314974|FG003|Phase 2|Withdrawal by Subject|0|||
156331940|NCT01543698|564314975|FG004|Phase 2|Withdrawal by Subject|0|||
156331941|NCT01543698|564314976|FG005|Phase 2|Withdrawal by Subject|0|||
156331942|NCT01543698|564314977|FG006|Phase 2|Withdrawal by Subject|0|||
156331943|NCT01543698|564314978|FG007|Phase 2|Withdrawal by Subject|0|||
156331944|NCT01543698|564314979|FG008|Phase 2|Withdrawal by Subject|0|||
156331945|NCT01543698|564314980|FG009|Phase 2|Withdrawal by Subject|0|||
156331946|NCT01543698|564314981|FG010|Phase 2|Withdrawal by Subject|0|||
156331947|NCT01543698|564314982|FG011|Phase 2|Withdrawal by Subject|0|||
156439797|NCT00232180|564702438|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
156439798|NCT00232180|564702439|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
156439799|NCT00232180|564702437|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
156439800|NCT00232180|564702438|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
156439801|NCT00232180|564702439|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
156439802|NCT00232180|564702437|FG000|Double-blind (DB) Phase|Adverse Event|83|||
156439803|NCT00232180|564702438|FG001|Double-blind (DB) Phase|Adverse Event|100|||
156439804|NCT00232180|564702439|FG002|Double-blind (DB) Phase|Adverse Event|0|||
156439805|NCT00232180|564702437|FG000|Double-blind (DB) Phase|Other|70|||
156439806|NCT00232180|564702438|FG001|Double-blind (DB) Phase|Other|75|||
156439807|NCT00232180|564702439|FG002|Double-blind (DB) Phase|Other|0|||
156439808|NCT00232180|564702437|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
156439809|NCT00232180|564702438|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
156439810|NCT00232180|564702439|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
156439811|NCT00232180|564702437|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
156439812|NCT00232180|564702438|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
156439813|NCT00232180|564702439|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
156531250|NCT02146326|565039895|FG002|Overall Study|Unable to complete interview|10|||
156702364|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
156702365|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156702366|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156702367|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156872119|NCT02858362|566289508|FG001|Overall Study|Lost to Follow-up|0|||
156331948|NCT01543698|564314983|FG012|Phase 2|Withdrawal by Subject|0|||
156331949|NCT01543698|564314984|FG013|Phase 2|Withdrawal by Subject|3|||
156331950|NCT01543698|564314985|FG014|Phase 2|Withdrawal by Subject|1|||
156331951|NCT01543698|564314971|FG000|Phase 2|Adverse Event|0|||
156331952|NCT01543698|564314972|FG001|Phase 2|Adverse Event|0|||
156331953|NCT01543698|564314973|FG002|Phase 2|Adverse Event|0|||
156331954|NCT01543698|564314974|FG003|Phase 2|Adverse Event|0|||
156331955|NCT01543698|564314975|FG004|Phase 2|Adverse Event|0|||
156331956|NCT01543698|564314976|FG005|Phase 2|Adverse Event|0|||
156331957|NCT01543698|564314977|FG006|Phase 2|Adverse Event|0|||
156331958|NCT01543698|564314978|FG007|Phase 2|Adverse Event|0|||
156331959|NCT01543698|564314979|FG008|Phase 2|Adverse Event|0|||
156331960|NCT01543698|564314980|FG009|Phase 2|Adverse Event|0|||
156331961|NCT01543698|564314981|FG010|Phase 2|Adverse Event|0|||
156331962|NCT01543698|564314982|FG011|Phase 2|Adverse Event|1|||
156331963|NCT01543698|564314983|FG012|Phase 2|Adverse Event|3|||
156331964|NCT01543698|564314984|FG013|Phase 2|Adverse Event|5|||
156331965|NCT01543698|564314985|FG014|Phase 2|Adverse Event|14|||
156331966|NCT00217620|564314986|FG000|Overall Study|Adverse Event|2|||
156331967|NCT00217620|564314986|FG000|Overall Study|Progression|31|||
156331968|NCT00217620|564314986|FG000|Overall Study|Not Protocol Specified|4|||
156331969|NCT00217620|564314986|FG000|Overall Study|Ineligible|13|||
156331970|NCT00217620|564314986|FG000|Overall Study|Never received treatment|1|||
156331971|NCT01863953|564315000|FG000|Overall Study|Adverse Event|0|||
156331972|NCT01863953|564315001|FG001|Overall Study|Adverse Event|0|||
156331973|NCT01863953|564315002|FG002|Overall Study|Adverse Event|1|||
156331974|NCT02008318|564315008|FG000|Overall Study|Adverse Event|4|||
156331975|NCT02008318|564315009|FG001|Overall Study|Adverse Event|0|||
156331976|NCT02008318|564315008|FG000|Overall Study|Physician Decision|2|||
156331977|NCT02008318|564315009|FG001|Overall Study|Physician Decision|0|||
156331978|NCT02008318|564315008|FG000|Overall Study|Progressive Disease|2|||
156331979|NCT02008318|564315009|FG001|Overall Study|Progressive Disease|0|||
156331980|NCT02008318|564315008|FG000|Overall Study|Protocol Violation|1|||
156331981|NCT02008318|564315009|FG001|Overall Study|Protocol Violation|1|||
156331982|NCT02008318|564315008|FG000|Overall Study|Withdrawal by Subject|3|||
156331983|NCT02008318|564315009|FG001|Overall Study|Withdrawal by Subject|0|||
156331984|NCT02336373|564315012|FG000|Overall Study|Protocol closed early|4|||
156331985|NCT02336373|564315012|FG000|Overall Study|Physician Decision|14|||
156331986|NCT02024529|564315015|FG000|Overall Study|Withdrawal by Subject|11|||
156331987|NCT02024529|564315016|FG001|Overall Study|Withdrawal by Subject|21|||
156331988|NCT02024529|564315015|FG000|Overall Study|Lost to Follow-up|2|||
156331989|NCT02024529|564315016|FG001|Overall Study|Lost to Follow-up|4|||
156331990|NCT00691301|564315017|FG000|Overall Study|Adverse Event|10|||
156331991|NCT00691301|564315017|FG000|Overall Study|Death|2|||
156331992|NCT00691301|564315017|FG000|Overall Study|Lack of Efficacy|32|||
156331993|NCT00691301|564315017|FG000|Overall Study|Withdrawal by Subject|4|||
156331994|NCT00691301|564315017|FG000|Overall Study|Concurrent illness|2|||
156439814|NCT00232180|564702437|FG000|Open Label Phase|Death|0|||
156331995|NCT00691301|564315017|FG000|Overall Study|other reason|3|||
156331996|NCT00691301|564315017|FG000|Overall Study|Did not initiate study treatment|1|||
156331997|NCT02642029|564315020|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
156331998|NCT02642029|564315021|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156331999|NCT02642029|564315022|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156332000|NCT02642029|564315023|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156332001|NCT02642029|564315024|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156702368|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156702369|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Other|4|||
156702370|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Other|4|||
156702371|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Other|3|||
156702372|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Other|1|||
156702373|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Other|0|||
156702374|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
156702375|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
156702376|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156702377|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156702378|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156439815|NCT00232180|564702438|FG001|Open Label Phase|Death|0|||
156439816|NCT00232180|564702439|FG002|Open Label Phase|Death|48|||
156439817|NCT00232180|564702437|FG000|Open Label Phase|Lost to Follow-up|0|||
156439818|NCT00232180|564702438|FG001|Open Label Phase|Lost to Follow-up|0|||
156702379|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156702380|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156702381|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156702382|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156702383|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156702384|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Death|1|||
156702385|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Death|0|||
156702386|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Death|0|||
156702387|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Death|0|||
156790983|NCT05069415|565987112|FG001|Overall Study|Adverse Event|0|||
156790984|NCT00101400|565987113|FG000|Survival Follow-Up|Alive|7|||
156790985|NCT03160573|565987114|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
156790986|NCT03160573|565987115|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
156439819|NCT00232180|564702439|FG002|Open Label Phase|Lost to Follow-up|5|||
156439820|NCT00232180|564702437|FG000|Open Label Phase|Protocol Violation|0|||
156439821|NCT00232180|564702438|FG001|Open Label Phase|Protocol Violation|0|||
156531251|NCT02146326|565039896|FG003|Overall Study|Unable to complete interview|6|||
156531252|NCT03153111|565039897|FG000|Overall Study|Death|2|||
156531253|NCT03153111|565039898|FG001|Overall Study|Death|5|||
156531254|NCT03153111|565039897|FG000|Overall Study|Lost to Follow-up|1|||
156531255|NCT03153111|565039898|FG001|Overall Study|Lost to Follow-up|0|||
156531256|NCT03153111|565039897|FG000|Overall Study|Physician Decision|5|||
156531257|NCT03153111|565039898|FG001|Overall Study|Physician Decision|1|||
156531258|NCT03153111|565039897|FG000|Overall Study|Withdrawal by Subject|3|||
156531259|NCT03153111|565039898|FG001|Overall Study|Withdrawal by Subject|3|||
156531260|NCT05066724|565039899|FG000|Overall Study|Adverse Event|1|||
156531261|NCT05066724|565039899|FG000|Overall Study|Non-Compliance With Study Drug|5|||
156531262|NCT05066724|565039899|FG000|Overall Study|Withdrawal by Subject|6|||
156531263|NCT05066724|565039899|FG000|Overall Study|Physician Decision|2|||
156531264|NCT01313117|565039901|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
156531265|NCT01313117|565039901|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
156531266|NCT03602261|565039906|FG000|Overall Study|Adverse Event|5|||
156531267|NCT03602261|565039907|FG001|Overall Study|Adverse Event|1|||
156531268|NCT03602261|565039906|FG000|Overall Study|Physician Decision|1|||
156531269|NCT03602261|565039907|FG001|Overall Study|Physician Decision|0|||
156531270|NCT03602261|565039906|FG000|Overall Study|Withdrawal by Subject|1|||
156531271|NCT03602261|565039907|FG001|Overall Study|Withdrawal by Subject|1|||
156531272|NCT03602261|565039906|FG000|Overall Study|Lack of Efficacy|0|||
156531273|NCT03602261|565039907|FG001|Overall Study|Lack of Efficacy|1|||
156531274|NCT03602261|565039906|FG000|Overall Study|Subject moving out of state|1|||
156531275|NCT03602261|565039907|FG001|Overall Study|Subject moving out of state|0|||
156531276|NCT04567615|565039908|FG000|Randomization|Participant withdrew consent|1|||
156531277|NCT04567615|565039909|FG001|Randomization|Participant withdrew consent|0|||
156531278|NCT04567615|565039910|FG002|Randomization|Participant withdrew consent|0|||
156531279|NCT04567615|565039908|FG000|Randomization|Adverse event unrelated to study drug|0|||
156531280|NCT04567615|565039909|FG001|Randomization|Adverse event unrelated to study drug|1|||
156531281|NCT04567615|565039910|FG002|Randomization|Adverse event unrelated to study drug|0|||
156531282|NCT04567615|565039908|FG000|Treatment Period|Participant Withdrew Consent|2|||
156531283|NCT04567615|565039909|FG001|Treatment Period|Participant Withdrew Consent|5|||
156531284|NCT04567615|565039910|FG002|Treatment Period|Participant Withdrew Consent|1|||
156531285|NCT04567615|565039908|FG000|Treatment Period|Death|1|||
156531286|NCT04567615|565039909|FG001|Treatment Period|Death|2|||
156531287|NCT04567615|565039910|FG002|Treatment Period|Death|0|||
156531288|NCT04567615|565039908|FG000|Treatment Period|Lost to Follow-up|0|||
156531289|NCT04567615|565039909|FG001|Treatment Period|Lost to Follow-up|1|||
156531290|NCT04567615|565039910|FG002|Treatment Period|Lost to Follow-up|0|||
156439822|NCT00232180|564702439|FG002|Open Label Phase|Protocol Violation|3|||
156531291|NCT04567615|565039908|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156702388|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Death|0|||
156702389|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
156702390|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
156702391|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156702392|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156702393|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156702394|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156702395|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156702396|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156702397|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156702398|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156702399|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156531292|NCT04567615|565039909|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
156531293|NCT04567615|565039910|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156531294|NCT04567615|565039908|FG000|Treatment Period|Disease Progression|85|||
156531295|NCT04567615|565039909|FG001|Treatment Period|Disease Progression|63|||
156531296|NCT04567615|565039910|FG002|Treatment Period|Disease Progression|16|||
156531297|NCT04567615|565039908|FG000|Treatment Period|Study Drug Toxicity|3|||
156531298|NCT04567615|565039909|FG001|Treatment Period|Study Drug Toxicity|10|||
156531299|NCT04567615|565039910|FG002|Treatment Period|Study Drug Toxicity|4|||
156531300|NCT04567615|565039908|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
156531301|NCT04567615|565039909|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
156531302|NCT04567615|565039910|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
156531303|NCT04567615|565039908|FG000|Treatment Period|Other Reasons|1|||
156531304|NCT04567615|565039909|FG001|Treatment Period|Other Reasons|2|||
156531305|NCT04567615|565039910|FG002|Treatment Period|Other Reasons|0|||
156531306|NCT04567615|565039908|FG000|Treatment Period|Still On-going Treatment|21|||
156531307|NCT04567615|565039909|FG001|Treatment Period|Still On-going Treatment|22|||
156531308|NCT04567615|565039910|FG002|Treatment Period|Still On-going Treatment|2|||
156531309|NCT00523718|565041582|FG000|Overall Study|Withdrawal by Subject|1|||
156531310|NCT00523718|565041583|FG001|Overall Study|Withdrawal by Subject|0|||
156531311|NCT00523718|565041582|FG000|Overall Study|Protocol Violation|2|||
156702400|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
156702401|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156702402|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156702403|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156702404|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156702405|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156702406|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156702407|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156702408|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156702409|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
156702410|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
156702411|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
156702412|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
156702413|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
156702414|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Other|4|||
156702415|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Other|5|||
156702416|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Other|4|||
156702417|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Other|0|||
156702418|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Other|0|||
156702419|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
156702420|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
156702421|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
156702422|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
156702423|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
156702424|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156702425|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
156702426|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156702427|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156702428|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156702429|NCT00742924|565656927|FG000|Overall Study|Adverse Event|0|||
156531312|NCT00523718|565041583|FG001|Overall Study|Protocol Violation|0|||
156531313|NCT01436071|565041584|FG000|Overall Study|Adverse Event|1|||
156531314|NCT01436071|565041585|FG001|Overall Study|Adverse Event|0|||
156531315|NCT01436071|565041584|FG000|Overall Study|Lack of Efficacy|16|||
156439823|NCT00232180|564702437|FG000|Open Label Phase|Study terminated by sponsor|0|||
156439824|NCT00232180|564702438|FG001|Open Label Phase|Study terminated by sponsor|0|||
156439825|NCT00232180|564702439|FG002|Open Label Phase|Study terminated by sponsor|3|||
156439826|NCT00232180|564702437|FG000|Open Label Phase|Withdrawal by Subject|0|||
156439827|NCT00232180|564702438|FG001|Open Label Phase|Withdrawal by Subject|0|||
156439828|NCT00232180|564702439|FG002|Open Label Phase|Withdrawal by Subject|37|||
156439829|NCT00232180|564702437|FG000|Open Label Phase|Other|0|||
156439830|NCT00232180|564702438|FG001|Open Label Phase|Other|0|||
156439831|NCT00232180|564702439|FG002|Open Label Phase|Other|16|||
156439832|NCT00232180|564702437|FG000|Open Label Phase|Adverse Event|0|||
156439833|NCT00232180|564702438|FG001|Open Label Phase|Adverse Event|0|||
156439834|NCT00232180|564702439|FG002|Open Label Phase|Adverse Event|25|||
156439835|NCT00232180|564702437|FG000|Open Label Phase|Laboratory abnormality|0|||
156439836|NCT00232180|564702438|FG001|Open Label Phase|Laboratory abnormality|0|||
156439837|NCT00232180|564702439|FG002|Open Label Phase|Laboratory abnormality|10|||
156439838|NCT00232180|564702437|FG000|Open Label Phase|Randomized but not treated|0|||
156439839|NCT00232180|564702438|FG001|Open Label Phase|Randomized but not treated|0|||
156439840|NCT00232180|564702439|FG002|Open Label Phase|Randomized but not treated|1|||
156439841|NCT04259450|564702442|FG000|Overall Study|Adverse event/ Toxicity|0|||
156439842|NCT04259450|564702443|FG001|Overall Study|Adverse event/ Toxicity|3|||
156439843|NCT04259450|564702444|FG002|Overall Study|Adverse event/ Toxicity|0|||
156439844|NCT04259450|564702445|FG003|Overall Study|Adverse event/ Toxicity|1|||
156439845|NCT04259450|564702446|FG004|Overall Study|Adverse event/ Toxicity|0|||
156439846|NCT04259450|564702447|FG005|Overall Study|Adverse event/ Toxicity|0|||
156439847|NCT04259450|564702448|FG006|Overall Study|Adverse event/ Toxicity|0|||
156702430|NCT00742924|565656928|FG001|Overall Study|Adverse Event|0|||
156702431|NCT00742924|565656929|FG002|Overall Study|Adverse Event|1|||
156702432|NCT00742924|565656930|FG003|Overall Study|Adverse Event|1|||
156702433|NCT00742924|565656927|FG000|Overall Study|Lack of Efficacy|5|||
156702434|NCT00742924|565656928|FG001|Overall Study|Lack of Efficacy|1|||
156702435|NCT00742924|565656929|FG002|Overall Study|Lack of Efficacy|2|||
156702436|NCT00742924|565656930|FG003|Overall Study|Lack of Efficacy|4|||
156702437|NCT00742924|565656927|FG000|Overall Study|Physician Decision|0|||
156702438|NCT00742924|565656928|FG001|Overall Study|Physician Decision|0|||
156702439|NCT00742924|565656929|FG002|Overall Study|Physician Decision|0|||
156439848|NCT04259450|564702449|FG007|Overall Study|Adverse event/ Toxicity|1|||
156702440|NCT00742924|565656930|FG003|Overall Study|Physician Decision|1|||
156702441|NCT00742924|565656927|FG000|Overall Study|Withdrawal by Subject|0|||
156702442|NCT00742924|565656928|FG001|Overall Study|Withdrawal by Subject|1|||
156702443|NCT00742924|565656929|FG002|Overall Study|Withdrawal by Subject|1|||
156702444|NCT00742924|565656930|FG003|Overall Study|Withdrawal by Subject|0|||
156702445|NCT00660400|565656931|FG000|Overall Study|Lack of insurance approval|1|||
156702446|NCT00660400|565656931|FG000|Overall Study|Suboptimal organ function|1|||
156702447|NCT00660400|565656931|FG000|Overall Study|Intracranial hemorrhage|1|||
156702448|NCT00660400|565656931|FG000|Overall Study|Withdrawal by Subject|1|||
156702449|NCT01161407|565656932|FG000|Overall Study|Protocol Violation|3|||
156702450|NCT01161407|565656933|FG001|Overall Study|Protocol Violation|1|||
156702451|NCT01777620|565656934|FG000|Overall Study|Subject Withdrawal|1|||
156702452|NCT01777620|565656935|FG001|Overall Study|Subject Withdrawal|0|||
156702453|NCT04562155|565656936|FG000|Overall Study|COVID-19 pandemic|0|||
156702454|NCT04562155|565656937|FG001|Overall Study|COVID-19 pandemic|0|||
156439849|NCT04259450|564702450|FG008|Overall Study|Adverse event/ Toxicity|0|||
156439850|NCT04259450|564702451|FG009|Overall Study|Adverse event/ Toxicity|3|||
156439851|NCT04259450|564702442|FG000|Overall Study|Disease progression|2|||
156439852|NCT04259450|564702443|FG001|Overall Study|Disease progression|3|||
156439853|NCT04259450|564702444|FG002|Overall Study|Disease progression|4|||
156439854|NCT04259450|564702445|FG003|Overall Study|Disease progression|4|||
156439855|NCT04259450|564702446|FG004|Overall Study|Disease progression|6|||
156439856|NCT04259450|564702447|FG005|Overall Study|Disease progression|6|||
156439857|NCT04259450|564702448|FG006|Overall Study|Disease progression|6|||
156439858|NCT04259450|564702449|FG007|Overall Study|Disease progression|15|||
156439859|NCT04259450|564702450|FG008|Overall Study|Disease progression|6|||
156439860|NCT04259450|564702451|FG009|Overall Study|Disease progression|18|||
156702455|NCT04562155|565656938|FG002|Overall Study|COVID-19 pandemic|0|||
156702456|NCT04562155|565656939|FG003|Overall Study|COVID-19 pandemic|1|||
156702457|NCT04562155|565656936|FG000|Overall Study|Adverse Event|7|||
156439861|NCT04259450|564702442|FG000|Overall Study|Death|0|||
156439862|NCT04259450|564702443|FG001|Overall Study|Death|0|||
156439863|NCT04259450|564702444|FG002|Overall Study|Death|0|||
156439864|NCT04259450|564702445|FG003|Overall Study|Death|0|||
156702458|NCT04562155|565656937|FG001|Overall Study|Adverse Event|3|||
156439865|NCT04259450|564702446|FG004|Overall Study|Death|0|||
156702459|NCT04562155|565656938|FG002|Overall Study|Adverse Event|8|||
156702460|NCT04562155|565656939|FG003|Overall Study|Adverse Event|1|||
156702461|NCT04562155|565656936|FG000|Overall Study|Withdrawal by Subject|3|||
156439866|NCT04259450|564702447|FG005|Overall Study|Death|0|||
156439867|NCT04259450|564702448|FG006|Overall Study|Death|0|||
156439868|NCT04259450|564702449|FG007|Overall Study|Death|1|||
156439869|NCT04259450|564702450|FG008|Overall Study|Death|1|||
156702462|NCT04562155|565656937|FG001|Overall Study|Withdrawal by Subject|6|||
156702463|NCT04562155|565656938|FG002|Overall Study|Withdrawal by Subject|3|||
156702464|NCT04562155|565656939|FG003|Overall Study|Withdrawal by Subject|3|||
156439870|NCT04259450|564702451|FG009|Overall Study|Death|0|||
156439871|NCT04259450|564702442|FG000|Overall Study|Withdrawal by Subject|0|||
156439872|NCT04259450|564702443|FG001|Overall Study|Withdrawal by Subject|0|||
156702465|NCT04562155|565656936|FG000|Overall Study|Participant personal reason|1|||
156702466|NCT04562155|565656937|FG001|Overall Study|Participant personal reason|0|||
156702467|NCT04562155|565656938|FG002|Overall Study|Participant personal reason|2|||
156702468|NCT04562155|565656939|FG003|Overall Study|Participant personal reason|1|||
156702469|NCT00936897|565656948|FG000|Overall Study|Withdrawal by Subject|9|||
156702470|NCT00936897|565656949|FG001|Overall Study|Withdrawal by Subject|19|||
156702471|NCT00936897|565656948|FG000|Overall Study|Adverse Event|4|||
156439873|NCT04259450|564702444|FG002|Overall Study|Withdrawal by Subject|0|||
156439874|NCT04259450|564702445|FG003|Overall Study|Withdrawal by Subject|0|||
156439875|NCT04259450|564702446|FG004|Overall Study|Withdrawal by Subject|0|||
156439876|NCT04259450|564702447|FG005|Overall Study|Withdrawal by Subject|0|||
156439877|NCT04259450|564702448|FG006|Overall Study|Withdrawal by Subject|0|||
156702472|NCT00936897|565656949|FG001|Overall Study|Adverse Event|13|||
156439878|NCT04259450|564702449|FG007|Overall Study|Withdrawal by Subject|1|||
156439879|NCT04259450|564702450|FG008|Overall Study|Withdrawal by Subject|0|||
156439880|NCT04259450|564702451|FG009|Overall Study|Withdrawal by Subject|0|||
156702473|NCT00936897|565656948|FG000|Overall Study|Other|3|||
156702474|NCT00936897|565656949|FG001|Overall Study|Other|9|||
156702475|NCT00936897|565656948|FG000|Overall Study|Lost to Follow-up|1|||
156702476|NCT00936897|565656949|FG001|Overall Study|Lost to Follow-up|10|||
156702477|NCT00936897|565656948|FG000|Overall Study|Administrative Decision|1|||
156702478|NCT00936897|565656949|FG001|Overall Study|Administrative Decision|2|||
156702479|NCT00936897|565656948|FG000|Overall Study|Protocol Violation|1|||
156702480|NCT00936897|565656949|FG001|Overall Study|Protocol Violation|1|||
156702481|NCT00936897|565656948|FG000|Overall Study|Ineligibility Determined|0|||
156702482|NCT00936897|565656949|FG001|Overall Study|Ineligibility Determined|3|||
156702483|NCT00936897|565656948|FG000|Overall Study|Noncompliance|0|||
156702484|NCT00936897|565656949|FG001|Overall Study|Noncompliance|2|||
156702485|NCT00936897|565656948|FG000|Overall Study|Death|0|||
156702486|NCT00936897|565656949|FG001|Overall Study|Death|1|||
156702487|NCT01844856|565656953|FG000|Overall Study|Lost to Follow-up|15|||
156702488|NCT01844856|565656954|FG001|Overall Study|Lost to Follow-up|3|||
156702489|NCT01844856|565656953|FG000|Overall Study|Adverse Event|3|||
156702490|NCT01844856|565656954|FG001|Overall Study|Adverse Event|6|||
156872120|NCT02858362|566289509|FG002|Overall Study|Lost to Follow-up|0|||
156872121|NCT02194985|566289511|FG000|Overall Study|Adverse Event|1|||
156439881|NCT04259450|564702442|FG000|Overall Study|Other than listed|0|||
156439882|NCT04259450|564702443|FG001|Overall Study|Other than listed|0|||
156439883|NCT04259450|564702444|FG002|Overall Study|Other than listed|0|||
156439884|NCT04259450|564702445|FG003|Overall Study|Other than listed|0|||
156439885|NCT04259450|564702446|FG004|Overall Study|Other than listed|0|||
156439886|NCT04259450|564702447|FG005|Overall Study|Other than listed|0|||
156439887|NCT04259450|564702448|FG006|Overall Study|Other than listed|0|||
156439888|NCT04259450|564702449|FG007|Overall Study|Other than listed|1|||
156439889|NCT04259450|564702450|FG008|Overall Study|Other than listed|1|||
156531316|NCT01436071|565041585|FG001|Overall Study|Lack of Efficacy|7|||
156531317|NCT01436071|565041584|FG000|Overall Study|Protocol Violation|0|||
156702491|NCT01844856|565656953|FG000|Overall Study|Withdrawal by Subject|3|||
156702492|NCT01844856|565656954|FG001|Overall Study|Withdrawal by Subject|2|||
156702493|NCT01844856|565656953|FG000|Overall Study|Noncompliance|2|||
156702494|NCT01844856|565656954|FG001|Overall Study|Noncompliance|3|||
156702495|NCT01844856|565656953|FG000|Overall Study|Enterococcus Resistant|0|||
156702496|NCT01844856|565656954|FG001|Overall Study|Enterococcus Resistant|1|||
156702497|NCT01844856|565656953|FG000|Overall Study|Inadvertently Not Scheduled|1|||
156702498|NCT01844856|565656954|FG001|Overall Study|Inadvertently Not Scheduled|0|||
156702499|NCT01844856|565656953|FG000|Overall Study|Randomized but was a Screen Failure|0|||
156702500|NCT01844856|565656954|FG001|Overall Study|Randomized but was a Screen Failure|1|||
156702501|NCT01001988|565656955|FG000|Overall Study|Protocol Violation|84|||
156702502|NCT01001988|565656955|FG000|Overall Study|Withdrawal by Subject|18|||
156702503|NCT01001988|565656955|FG000|Overall Study|Lost to Follow-up|15|||
156702504|NCT01221363|565656956|FG000|Overall Study|Pregnancy|1|||
156702505|NCT01221363|565656957|FG001|Overall Study|Pregnancy|0|||
156702506|NCT01221363|565656956|FG000|Overall Study|Withdrawal by Subject|11|||
156702507|NCT01221363|565656957|FG001|Overall Study|Withdrawal by Subject|5|||
156702508|NCT04628793|565656958|FG000|Overall Study|Study terminated by sponsor|0|||
156439890|NCT04259450|564702451|FG009|Overall Study|Other than listed|2|||
156439891|NCT00542789|564702458|FG000|Overall Study|Adverse Event|18|||
156531318|NCT01436071|565041585|FG001|Overall Study|Protocol Violation|1|||
156702509|NCT04628793|565656959|FG001|Overall Study|Study terminated by sponsor|0|||
156702510|NCT04628793|565656960|FG002|Overall Study|Study terminated by sponsor|8|||
156702511|NCT04628793|565656958|FG000|Overall Study|Withdrawal by Subject|2|||
156439892|NCT00542789|564702459|FG001|Overall Study|Adverse Event|17|||
156531319|NCT01436071|565041584|FG000|Overall Study|Lost to Follow-up|3|||
156790987|NCT03160573|565987116|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
156439893|NCT00542789|564702458|FG000|Overall Study|Withdrawal by Subject|7|||
156439894|NCT00542789|564702459|FG001|Overall Study|Withdrawal by Subject|3|||
156439895|NCT00542789|564702458|FG000|Overall Study|Protocol Violation|8|||
156439896|NCT00542789|564702459|FG001|Overall Study|Protocol Violation|1|||
156439897|NCT00542789|564702458|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
156439898|NCT00542789|564702459|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
156439899|NCT02584829|564702461|FG000|Overall Study|Physician Decision|1|||
156439900|NCT02584829|564702462|FG001|Overall Study|Physician Decision|0|||
156439901|NCT02584829|564702461|FG000|Overall Study|Withdrawal by Subject|0|||
156439902|NCT02584829|564702462|FG001|Overall Study|Withdrawal by Subject|1|||
156439903|NCT02584829|564702461|FG000|Overall Study|Progressive Disease|0|||
156439904|NCT02584829|564702462|FG001|Overall Study|Progressive Disease|3|||
156439905|NCT00434304|564702464|FG000|Overall Study|Adverse Event|14|||
156439906|NCT00434304|564702464|FG000|Overall Study|Lack of Efficacy|2|||
156439907|NCT00434304|564702464|FG000|Overall Study|Withdrawal by Subject|4|||
156439908|NCT05262738|564702465|FG000|Overall Study|Withdrawal by Subject|1|||
156439909|NCT05262738|564702466|FG001|Overall Study|Withdrawal by Subject|0|||
156439910|NCT00446459|564702477|FG000|8 Months|Protocol Violation|12|||
156439911|NCT00446459|564702477|FG000|12 Months|Protocol Violation|4|||
156439912|NCT00446459|564702477|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
156439913|NCT02597920|564702485|FG000|Overall Study|Worsening of other pre-existing disease|0|||
156439914|NCT02597920|564702486|FG001|Overall Study|Worsening of other pre-existing disease|1|||
156439915|NCT02597920|564702487|FG002|Overall Study|Worsening of other pre-existing disease|0|||
156439916|NCT02597920|564702485|FG000|Overall Study|Other adverse event|20|||
156439917|NCT02597920|564702486|FG001|Overall Study|Other adverse event|30|||
156439918|NCT02597920|564702487|FG002|Overall Study|Other adverse event|0|||
156439919|NCT02597920|564702485|FG000|Overall Study|Lost to Follow-up|7|||
156439920|NCT02597920|564702486|FG001|Overall Study|Lost to Follow-up|9|||
156439921|NCT02597920|564702487|FG002|Overall Study|Lost to Follow-up|0|||
156439922|NCT02597920|564702485|FG000|Overall Study|Refuse to continue in the study|3|||
156439923|NCT02597920|564702486|FG001|Overall Study|Refuse to continue in the study|13|||
156439924|NCT02597920|564702487|FG002|Overall Study|Refuse to continue in the study|1|||
156439925|NCT02597920|564702485|FG000|Overall Study|Other than specified|10|||
156439926|NCT02597920|564702486|FG001|Overall Study|Other than specified|31|||
156439927|NCT02597920|564702487|FG002|Overall Study|Other than specified|5|||
156439928|NCT02597920|564702485|FG000|Overall Study|Other|1|||
156439929|NCT02597920|564702486|FG001|Overall Study|Other|0|||
156439930|NCT02597920|564702487|FG002|Overall Study|Other|0|||
156439931|NCT02675244|564702488|FG000|Overall Study|Death|9|||
156439932|NCT02675244|564702489|FG001|Overall Study|Death|6|||
156439933|NCT02675244|564702488|FG000|Overall Study|Withdrawal by Subject|3|||
156439934|NCT02675244|564702489|FG001|Overall Study|Withdrawal by Subject|6|||
156439935|NCT02675244|564702488|FG000|Overall Study|Lost to Follow-up|1|||
156439936|NCT02675244|564702489|FG001|Overall Study|Lost to Follow-up|1|||
156439937|NCT02675244|564702488|FG000|Overall Study|Ongoing at 2 Years|190|||
156531320|NCT01436071|565041585|FG001|Overall Study|Lost to Follow-up|1|||
156531321|NCT01436071|565041584|FG000|Overall Study|Physician Decision|1|||
156531322|NCT01436071|565041585|FG001|Overall Study|Physician Decision|0|||
156531323|NCT01436071|565041584|FG000|Overall Study|Withdrawal by Subject|2|||
156531324|NCT01436071|565041585|FG001|Overall Study|Withdrawal by Subject|2|||
156702512|NCT04628793|565656959|FG001|Overall Study|Withdrawal by Subject|3|||
156702513|NCT04628793|565656960|FG002|Overall Study|Withdrawal by Subject|0|||
156702514|NCT04628793|565656958|FG000|Overall Study|Lost to Follow-up|0|||
156702515|NCT04628793|565656959|FG001|Overall Study|Lost to Follow-up|1|||
156702516|NCT04628793|565656960|FG002|Overall Study|Lost to Follow-up|0|||
156702517|NCT01329549|565656969|FG000|Overall Study|Withdrawal by Subject|1|||
156702518|NCT01329549|565656969|FG000|Overall Study|Adverse Event|1|||
156702519|NCT03597529|565656972|FG000|Overall Study|Lost to Follow-up|10|||
156702520|NCT03597529|565656973|FG001|Overall Study|Lost to Follow-up|12|||
156702521|NCT03597529|565656972|FG000|Overall Study|Physician Decision|3|||
156702522|NCT03597529|565656973|FG001|Overall Study|Physician Decision|1|||
156790988|NCT03160573|565987117|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
156790989|NCT00382863|565987122|FG000|Overall Study|Death|9|||
156790990|NCT00382863|565987123|FG001|Overall Study|Death|9|||
156439938|NCT02675244|564702489|FG001|Overall Study|Ongoing at 2 Years|185|||
156439939|NCT03292913|564702499|FG000|Overall Study|Death|9|||
156439940|NCT03292913|564702500|FG001|Overall Study|Death|3|||
156439941|NCT03292913|564702499|FG000|Overall Study|Lost to Follow-up|49|||
156439942|NCT03292913|564702500|FG001|Overall Study|Lost to Follow-up|49|||
156439943|NCT03292913|564702499|FG000|Overall Study|Withdrawal by Subject|2|||
156439944|NCT03292913|564702500|FG001|Overall Study|Withdrawal by Subject|0|||
156439945|NCT03292913|564702499|FG000|Overall Study|Clinic closed due to COVID|22|||
156439946|NCT03292913|564702500|FG001|Overall Study|Clinic closed due to COVID|36|||
156531325|NCT01436071|565041584|FG000|Overall Study|Did Not Receive Trial Medication|3|||
156531326|NCT01436071|565041585|FG001|Overall Study|Did Not Receive Trial Medication|3|||
156702523|NCT03597529|565656972|FG000|Overall Study|Withdrawal by Subject|6|||
156439947|NCT04056624|564702501|FG000|Overall Study|Withdrawal by Subject|0|||
156439948|NCT04056624|564702502|FG001|Overall Study|Withdrawal by Subject|0|||
156439949|NCT04056624|564702503|FG002|Overall Study|Withdrawal by Subject|1|||
156439950|NCT04056624|564702501|FG000|Overall Study|Protocol Violation|1|||
156439951|NCT04056624|564702502|FG001|Overall Study|Protocol Violation|2|||
156439952|NCT04056624|564702503|FG002|Overall Study|Protocol Violation|0|||
156439953|NCT01792830|564702512|FG000|Overall Study|Withdrawal by Subject|22|||
156439954|NCT01792830|564702513|FG001|Overall Study|Withdrawal by Subject|0|||
156439955|NCT01792830|564702514|FG002|Overall Study|Withdrawal by Subject|0|||
156439956|NCT01792830|564702515|FG003|Overall Study|Withdrawal by Subject|2|||
156439957|NCT01792830|564702516|FG004|Overall Study|Withdrawal by Subject|1|||
156439958|NCT01792830|564702517|FG005|Overall Study|Withdrawal by Subject|1|||
156439959|NCT01792830|564702518|FG006|Overall Study|Withdrawal by Subject|1|||
156439960|NCT01792830|564702519|FG007|Overall Study|Withdrawal by Subject|1|||
156439961|NCT01792830|564702520|FG008|Overall Study|Withdrawal by Subject|7|||
156439962|NCT01792830|564702521|FG009|Overall Study|Withdrawal by Subject|0|||
156439963|NCT01792830|564702522|FG010|Overall Study|Withdrawal by Subject|2|||
156439964|NCT01792830|564702512|FG000|Overall Study|Death|3|||
156439965|NCT01792830|564702513|FG001|Overall Study|Death|0|||
156439966|NCT01792830|564702514|FG002|Overall Study|Death|0|||
156439967|NCT01792830|564702515|FG003|Overall Study|Death|1|||
156702524|NCT03597529|565656973|FG001|Overall Study|Withdrawal by Subject|3|||
156702525|NCT03597529|565656972|FG000|Overall Study|Non-compliant with study activities|1|||
156702526|NCT03597529|565656973|FG001|Overall Study|Non-compliant with study activities|2|||
156702527|NCT01755767|565656976|FG000|Overall Study|Progressive Disease|8|||
156702528|NCT01755767|565656977|FG001|Overall Study|Progressive Disease|7|||
156702529|NCT01755767|565656978|FG002|Overall Study|Progressive Disease|91|||
156702530|NCT01755767|565656979|FG003|Overall Study|Progressive Disease|43|||
156702531|NCT01755767|565656976|FG000|Overall Study|Clinical Disease Progression|4|||
156702532|NCT01755767|565656977|FG001|Overall Study|Clinical Disease Progression|2|||
156702533|NCT01755767|565656978|FG002|Overall Study|Clinical Disease Progression|29|||
156702534|NCT01755767|565656979|FG003|Overall Study|Clinical Disease Progression|20|||
156702535|NCT01755767|565656976|FG000|Overall Study|Radiographic Disease Progression|9|||
156702536|NCT01755767|565656977|FG001|Overall Study|Radiographic Disease Progression|4|||
156702537|NCT01755767|565656978|FG002|Overall Study|Radiographic Disease Progression|44|||
156702538|NCT01755767|565656979|FG003|Overall Study|Radiographic Disease Progression|27|||
156702539|NCT01755767|565656976|FG000|Overall Study|Adverse Event|6|||
156702540|NCT01755767|565656977|FG001|Overall Study|Adverse Event|0|||
156702541|NCT01755767|565656978|FG002|Overall Study|Adverse Event|28|||
156702542|NCT01755767|565656979|FG003|Overall Study|Adverse Event|11|||
156702543|NCT01755767|565656976|FG000|Overall Study|Death|1|||
156702544|NCT01755767|565656977|FG001|Overall Study|Death|2|||
156702545|NCT01755767|565656978|FG002|Overall Study|Death|15|||
156702546|NCT01755767|565656979|FG003|Overall Study|Death|4|||
156702547|NCT01755767|565656976|FG000|Overall Study|Subject Decision|0|||
156702548|NCT01755767|565656977|FG001|Overall Study|Subject Decision|0|||
156702549|NCT01755767|565656978|FG002|Overall Study|Subject Decision|10|||
156702550|NCT01755767|565656979|FG003|Overall Study|Subject Decision|3|||
156702551|NCT01755767|565656976|FG000|Overall Study|Withdrawal by Subject|0|||
156702552|NCT01755767|565656977|FG001|Overall Study|Withdrawal by Subject|0|||
156702553|NCT01755767|565656978|FG002|Overall Study|Withdrawal by Subject|2|||
156702554|NCT01755767|565656979|FG003|Overall Study|Withdrawal by Subject|1|||
156702555|NCT01755767|565656976|FG000|Overall Study|Other|0|||
156702556|NCT01755767|565656977|FG001|Overall Study|Other|0|||
156702557|NCT01755767|565656978|FG002|Overall Study|Other|2|||
156702558|NCT01755767|565656979|FG003|Overall Study|Other|3|||
156702559|NCT01755767|565656976|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
156702560|NCT01755767|565656977|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
156702561|NCT01755767|565656978|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
156702562|NCT01755767|565656979|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
156439968|NCT01792830|564702516|FG004|Overall Study|Death|0|||
156439969|NCT01792830|564702517|FG005|Overall Study|Death|0|||
156439970|NCT01792830|564702518|FG006|Overall Study|Death|1|||
156702563|NCT04623086|565656980|FG000|Overall Study|Withdrawal by Subject|0|||
156702564|NCT04623086|565656981|FG001|Overall Study|Withdrawal by Subject|0|||
156439971|NCT01792830|564702519|FG007|Overall Study|Death|0|||
156439972|NCT01792830|564702520|FG008|Overall Study|Death|1|||
156439973|NCT01792830|564702521|FG009|Overall Study|Death|0|||
156439974|NCT01792830|564702522|FG010|Overall Study|Death|1|||
156702565|NCT04623086|565656982|FG002|Overall Study|Withdrawal by Subject|10|||
156702566|NCT03464630|565656983|FG000|Overall Study|Lost to Follow-up|62|||
156702567|NCT03464630|565656984|FG001|Overall Study|Lost to Follow-up|52|||
156702568|NCT03464630|565656983|FG000|Overall Study|Withdrawal by Subject|16|||
156702569|NCT03464630|565656984|FG001|Overall Study|Withdrawal by Subject|10|||
156702570|NCT03464630|565656983|FG000|Overall Study|Passive Disengagement|8|||
156702571|NCT03464630|565656984|FG001|Overall Study|Passive Disengagement|4|||
156702572|NCT00191165|565656985|FG000|Overall Study|Adverse Event|2|||
156702573|NCT00191165|565656986|FG001|Overall Study|Adverse Event|0|||
156702574|NCT00191165|565656985|FG000|Overall Study|Protocol Violation|0|||
156702575|NCT00191165|565656986|FG001|Overall Study|Protocol Violation|1|||
156702576|NCT00191165|565656985|FG000|Overall Study|Participant Moved Away|0|||
156702577|NCT00191165|565656986|FG001|Overall Study|Participant Moved Away|1|||
156702578|NCT00715624|565656987|FG000|Overall Study|Adverse Event|12|||
156702579|NCT00715624|565656988|FG001|Overall Study|Adverse Event|37|||
156702580|NCT00715624|565656987|FG000|Overall Study|Lack of Efficacy|11|||
156702581|NCT00715624|565656988|FG001|Overall Study|Lack of Efficacy|11|||
156702582|NCT00715624|565656987|FG000|Overall Study|Lost to Follow-up|1|||
156702583|NCT00715624|565656988|FG001|Overall Study|Lost to Follow-up|2|||
156702584|NCT00715624|565656987|FG000|Overall Study|Protocol Violation|1|||
156702585|NCT00715624|565656988|FG001|Overall Study|Protocol Violation|0|||
156702586|NCT00715624|565656987|FG000|Overall Study|Withdrawal by Subject|11|||
156702587|NCT00715624|565656988|FG001|Overall Study|Withdrawal by Subject|25|||
156702588|NCT00715624|565656987|FG000|Overall Study|Familial and personal reasons|10|||
156702589|NCT00715624|565656988|FG001|Overall Study|Familial and personal reasons|22|||
156702590|NCT00715624|565656987|FG000|Overall Study|Poor compliance|6|||
156702591|NCT00715624|565656988|FG001|Overall Study|Poor compliance|13|||
156702592|NCT00715624|565656987|FG000|Overall Study|Sponsor decision|0|||
156702593|NCT00715624|565656988|FG001|Overall Study|Sponsor decision|4|||
156702594|NCT00715624|565656987|FG000|Overall Study|Incorrect randomization (not treated)|0|||
156702595|NCT00715624|565656988|FG001|Overall Study|Incorrect randomization (not treated)|1|||
156702596|NCT00715624|565656987|FG000|Overall Study|Other|0|||
156702597|NCT00715624|565656988|FG001|Overall Study|Other|1|||
156702598|NCT03200912|565656989|FG000|Overall Study|Adverse Event|3|||
156702599|NCT03200912|565656990|FG001|Overall Study|Adverse Event|0|||
156702600|NCT03200912|565656991|FG002|Overall Study|Adverse Event|0|||
156702601|NCT03200912|565656989|FG000|Overall Study|Withdrawal by Subject|1|||
156702602|NCT03200912|565656990|FG001|Overall Study|Withdrawal by Subject|2|||
156702603|NCT03200912|565656991|FG002|Overall Study|Withdrawal by Subject|4|||
156702604|NCT03200912|565656989|FG000|Overall Study|Non-compliance with study drug|0|||
156702605|NCT03200912|565656990|FG001|Overall Study|Non-compliance with study drug|1|||
156702606|NCT03200912|565656991|FG002|Overall Study|Non-compliance with study drug|0|||
156702607|NCT03196635|565656994|FG000|Overall Study|Withdrawal by Subject|1|||
156702608|NCT00229723|565656995|FG000|Concomitant Phase|Adverse Event|4|||
156702609|NCT00229723|565656996|FG001|Concomitant Phase|Adverse Event|2|||
156702610|NCT00229723|565656997|FG002|Concomitant Phase|Adverse Event|5|||
156702611|NCT00229723|565656998|FG003|Concomitant Phase|Adverse Event|2|||
156702612|NCT00229723|565656999|FG004|Concomitant Phase|Adverse Event|0|||
156702613|NCT00229723|565657000|FG005|Concomitant Phase|Adverse Event|1|||
156702614|NCT00229723|565657001|FG006|Concomitant Phase|Adverse Event|2|||
156702615|NCT00229723|565656995|FG000|Concomitant Phase|Objective disease progression|0|||
156702616|NCT00229723|565656996|FG001|Concomitant Phase|Objective disease progression|0|||
156702617|NCT00229723|565656997|FG002|Concomitant Phase|Objective disease progression|0|||
156702618|NCT00229723|565656998|FG003|Concomitant Phase|Objective disease progression|0|||
156702619|NCT00229723|565656999|FG004|Concomitant Phase|Objective disease progression|0|||
156702620|NCT00229723|565657000|FG005|Concomitant Phase|Objective disease progression|0|||
156702621|NCT00229723|565657001|FG006|Concomitant Phase|Objective disease progression|0|||
156702622|NCT00229723|565656995|FG000|Concomitant Phase|Clinical progression|0|||
156702623|NCT00229723|565656996|FG001|Concomitant Phase|Clinical progression|0|||
156872122|NCT02194985|566289511|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
156702624|NCT00229723|565656997|FG002|Concomitant Phase|Clinical progression|0|||
156702625|NCT00229723|565656998|FG003|Concomitant Phase|Clinical progression|0|||
156702626|NCT00229723|565656999|FG004|Concomitant Phase|Clinical progression|0|||
156702627|NCT00229723|565657000|FG005|Concomitant Phase|Clinical progression|0|||
156702628|NCT00229723|565657001|FG006|Concomitant Phase|Clinical progression|1|||
156702629|NCT00229723|565656995|FG000|Concomitant Phase|Lost to Follow-up|0|||
156702630|NCT00229723|565656996|FG001|Concomitant Phase|Lost to Follow-up|0|||
156702631|NCT00229723|565656997|FG002|Concomitant Phase|Lost to Follow-up|0|||
156702632|NCT00229723|565656998|FG003|Concomitant Phase|Lost to Follow-up|0|||
156702633|NCT00229723|565656999|FG004|Concomitant Phase|Lost to Follow-up|1|||
156702634|NCT00229723|565657000|FG005|Concomitant Phase|Lost to Follow-up|0|||
156702635|NCT00229723|565657001|FG006|Concomitant Phase|Lost to Follow-up|0|||
156872123|NCT02194985|566289511|FG000|Overall Study|Physician Decision|4|||
156872124|NCT02194985|566289511|FG000|Overall Study|Lost to Follow-up|1|||
156439975|NCT01792830|564702512|FG000|Overall Study|Adverse Event|0|||
156439976|NCT01792830|564702513|FG001|Overall Study|Adverse Event|0|||
156439977|NCT01792830|564702514|FG002|Overall Study|Adverse Event|0|||
156439978|NCT01792830|564702515|FG003|Overall Study|Adverse Event|0|||
156439979|NCT01792830|564702516|FG004|Overall Study|Adverse Event|0|||
156439980|NCT01792830|564702517|FG005|Overall Study|Adverse Event|0|||
156439981|NCT01792830|564702518|FG006|Overall Study|Adverse Event|0|||
156439982|NCT01792830|564702519|FG007|Overall Study|Adverse Event|0|||
156439983|NCT01792830|564702520|FG008|Overall Study|Adverse Event|1|||
156439984|NCT01792830|564702521|FG009|Overall Study|Adverse Event|0|||
156439985|NCT01792830|564702522|FG010|Overall Study|Adverse Event|0|||
156439986|NCT01943799|564702538|FG000|Overall Study|Lost to Follow-up|0|||
156702636|NCT00229723|565656995|FG000|Concomitant Phase|Informed consent withdrawn|3|||
156702637|NCT00229723|565656996|FG001|Concomitant Phase|Informed consent withdrawn|2|||
156702638|NCT00229723|565656997|FG002|Concomitant Phase|Informed consent withdrawn|0|||
156702639|NCT00229723|565656998|FG003|Concomitant Phase|Informed consent withdrawn|2|||
156702640|NCT00229723|565656999|FG004|Concomitant Phase|Informed consent withdrawn|0|||
156702641|NCT00229723|565657000|FG005|Concomitant Phase|Informed consent withdrawn|0|||
156702642|NCT00229723|565657001|FG006|Concomitant Phase|Informed consent withdrawn|0|||
156702643|NCT00229723|565656995|FG000|Concomitant Phase|Severe non-compliance|0|||
156702644|NCT00229723|565656996|FG001|Concomitant Phase|Severe non-compliance|1|||
156702645|NCT00229723|565656997|FG002|Concomitant Phase|Severe non-compliance|0|||
156702646|NCT00229723|565656998|FG003|Concomitant Phase|Severe non-compliance|0|||
156702647|NCT00229723|565656999|FG004|Concomitant Phase|Severe non-compliance|1|||
156702648|NCT00229723|565657000|FG005|Concomitant Phase|Severe non-compliance|0|||
156702649|NCT00229723|565657001|FG006|Concomitant Phase|Severe non-compliance|0|||
156702650|NCT00229723|565656995|FG000|Concomitant Phase|Other|3|||
156702651|NCT00229723|565656996|FG001|Concomitant Phase|Other|0|||
156702652|NCT00229723|565656997|FG002|Concomitant Phase|Other|1|||
156702653|NCT00229723|565656998|FG003|Concomitant Phase|Other|1|||
156702654|NCT00229723|565656999|FG004|Concomitant Phase|Other|0|||
156702655|NCT00229723|565657000|FG005|Concomitant Phase|Other|2|||
156702656|NCT00229723|565657001|FG006|Concomitant Phase|Other|0|||
156702657|NCT00229723|565656995|FG000|Maintenance Phase|Adverse Event|7|||
156702658|NCT00229723|565656996|FG001|Maintenance Phase|Adverse Event|2|||
156702659|NCT00229723|565656997|FG002|Maintenance Phase|Adverse Event|1|||
156702660|NCT00229723|565656998|FG003|Maintenance Phase|Adverse Event|4|||
156702661|NCT00229723|565656999|FG004|Maintenance Phase|Adverse Event|7|||
156702662|NCT00229723|565657000|FG005|Maintenance Phase|Adverse Event|5|||
156702663|NCT00229723|565657001|FG006|Maintenance Phase|Adverse Event|2|||
156702664|NCT00229723|565656995|FG000|Maintenance Phase|Objective disease progression|5|||
156702665|NCT00229723|565656996|FG001|Maintenance Phase|Objective disease progression|5|||
156702666|NCT00229723|565656997|FG002|Maintenance Phase|Objective disease progression|3|||
156702667|NCT00229723|565656998|FG003|Maintenance Phase|Objective disease progression|6|||
156702668|NCT00229723|565656999|FG004|Maintenance Phase|Objective disease progression|2|||
156702669|NCT00229723|565657000|FG005|Maintenance Phase|Objective disease progression|9|||
156702670|NCT00229723|565657001|FG006|Maintenance Phase|Objective disease progression|5|||
156702671|NCT00229723|565656995|FG000|Maintenance Phase|Clinical progression|4|||
156702672|NCT00229723|565656996|FG001|Maintenance Phase|Clinical progression|1|||
156702673|NCT00229723|565656997|FG002|Maintenance Phase|Clinical progression|2|||
156702674|NCT00229723|565656998|FG003|Maintenance Phase|Clinical progression|2|||
156702675|NCT00229723|565656999|FG004|Maintenance Phase|Clinical progression|1|||
156702676|NCT00229723|565657000|FG005|Maintenance Phase|Clinical progression|1|||
156702677|NCT00229723|565657001|FG006|Maintenance Phase|Clinical progression|1|||
156702678|NCT00229723|565656995|FG000|Maintenance Phase|Lost to Follow-up|0|||
156702679|NCT00229723|565656996|FG001|Maintenance Phase|Lost to Follow-up|1|||
156702680|NCT00229723|565656997|FG002|Maintenance Phase|Lost to Follow-up|2|||
156702681|NCT00229723|565656998|FG003|Maintenance Phase|Lost to Follow-up|2|||
156702682|NCT00229723|565656999|FG004|Maintenance Phase|Lost to Follow-up|0|||
156702683|NCT00229723|565657000|FG005|Maintenance Phase|Lost to Follow-up|0|||
156702684|NCT00229723|565657001|FG006|Maintenance Phase|Lost to Follow-up|1|||
156702685|NCT00229723|565656995|FG000|Maintenance Phase|Informed consent withdrawn|1|||
156702686|NCT00229723|565656996|FG001|Maintenance Phase|Informed consent withdrawn|0|||
156702687|NCT00229723|565656997|FG002|Maintenance Phase|Informed consent withdrawn|0|||
156702688|NCT00229723|565656998|FG003|Maintenance Phase|Informed consent withdrawn|1|||
156702689|NCT00229723|565656999|FG004|Maintenance Phase|Informed consent withdrawn|1|||
156702690|NCT00229723|565657000|FG005|Maintenance Phase|Informed consent withdrawn|1|||
156702691|NCT00229723|565657001|FG006|Maintenance Phase|Informed consent withdrawn|0|||
156702692|NCT00229723|565656995|FG000|Maintenance Phase|Severe non-compliance|3|||
156702693|NCT00229723|565656996|FG001|Maintenance Phase|Severe non-compliance|1|||
156702694|NCT00229723|565656997|FG002|Maintenance Phase|Severe non-compliance|0|||
156702695|NCT00229723|565656998|FG003|Maintenance Phase|Severe non-compliance|0|||
156702696|NCT00229723|565656999|FG004|Maintenance Phase|Severe non-compliance|1|||
156702697|NCT00229723|565657000|FG005|Maintenance Phase|Severe non-compliance|0|||
156702698|NCT00229723|565657001|FG006|Maintenance Phase|Severe non-compliance|0|||
156332002|NCT02642029|564315025|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156702699|NCT00229723|565656995|FG000|Maintenance Phase|Other|5|||
156702700|NCT00229723|565656996|FG001|Maintenance Phase|Other|4|||
156702701|NCT00229723|565656997|FG002|Maintenance Phase|Other|1|||
156702702|NCT00229723|565656998|FG003|Maintenance Phase|Other|2|||
156702703|NCT00229723|565656999|FG004|Maintenance Phase|Other|3|||
156702704|NCT00229723|565657000|FG005|Maintenance Phase|Other|3|||
156702705|NCT00229723|565657001|FG006|Maintenance Phase|Other|1|||
156332003|NCT02642029|564315020|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156531327|NCT03808688|565041588|FG000|Overall Study|Adverse Event|13|||
156702706|NCT00998309|565657002|FG000|Overall Study|Protocol Violation|4|||
156702707|NCT00735397|565657006|FG000|Overall Study|Adverse Event|194|||
156702708|NCT00735397|565657006|FG000|Overall Study|Lost to Follow-up|33|||
156790991|NCT00382863|565987122|FG000|Overall Study|Lost to Follow-up|1|||
156790992|NCT00382863|565987123|FG001|Overall Study|Lost to Follow-up|2|||
156790993|NCT00382863|565987122|FG000|Overall Study|Withdrawal by Subject|5|||
156790994|NCT00382863|565987123|FG001|Overall Study|Withdrawal by Subject|25|||
156790995|NCT03400787|565987124|FG000|Overall Study|Lost to Follow-up|1|||
156790996|NCT03400787|565987125|FG001|Overall Study|Lost to Follow-up|0|||
156790997|NCT03400787|565987124|FG000|Overall Study|Death|1|||
156790998|NCT03400787|565987125|FG001|Overall Study|Death|0|||
156790999|NCT03400787|565987124|FG000|Overall Study|Protocol Violation|0|||
156791000|NCT03400787|565987125|FG001|Overall Study|Protocol Violation|2|||
156791001|NCT03400787|565987124|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
156791002|NCT03400787|565987125|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
156791003|NCT02595437|565987128|FG000|Triferic Via IV|Withdrawal by Subject|1|||
156791004|NCT02094885|565987129|FG000|Overall Study|Death|1|||
156791005|NCT02094885|565987130|FG001|Overall Study|Death|5|||
156791006|NCT02094885|565987129|FG000|Overall Study|Withdrawn due to age|1|||
156791007|NCT02094885|565987130|FG001|Overall Study|Withdrawn due to age|0|||
156791008|NCT02003898|565987131|FG000|Overall Study|Death|3|||
156791009|NCT02003898|565987131|FG000|Overall Study|Lost to Follow-up|12|||
156791010|NCT02003898|565987131|FG000|Overall Study|Withdrawal by Subject|52|||
156791011|NCT05166902|565987132|FG000|First Intervention|Lost to Follow-up|0|||
156791012|NCT05166902|565987133|FG001|First Intervention|Lost to Follow-up|1|||
156791013|NCT01903720|565987134|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
156791014|NCT01903720|565987134|FG000|Overall Study|Adverse Event|1|||
156791015|NCT01903720|565987134|FG000|Overall Study|Rescinding of informed consent|2|||
156872125|NCT02194985|566289511|FG000|Overall Study|Withdrawal by Subject|2|||
156872126|NCT02561832|566289514|FG000|Overall Study|Withdrawal by Subject|1|||
156872127|NCT02561832|566289515|FG001|Overall Study|Withdrawal by Subject|1|||
156872128|NCT02561832|566289514|FG000|Overall Study|Adverse Event|3|||
156872129|NCT02561832|566289515|FG001|Overall Study|Adverse Event|0|||
156332004|NCT02642029|564315021|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
156332005|NCT02642029|564315022|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156791016|NCT01903720|565987134|FG000|Overall Study|Lost to Follow-up|2|||
156791017|NCT01903720|565987134|FG000|Overall Study|Treatment with alternative drug|1|||
156872130|NCT02561832|566289514|FG000|Overall Study|Disease progression|3|||
156872131|NCT02561832|566289515|FG001|Overall Study|Disease progression|3|||
156332006|NCT02642029|564315023|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156332007|NCT02642029|564315024|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156332008|NCT02642029|564315025|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156332009|NCT02642029|564315020|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156332010|NCT02642029|564315021|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156332011|NCT02642029|564315022|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156332012|NCT02642029|564315023|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156332013|NCT02642029|564315024|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
156332014|NCT02642029|564315025|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156332015|NCT02642029|564315020|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
156332016|NCT02642029|564315021|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
156332017|NCT02642029|564315022|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
156332018|NCT02642029|564315023|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
156332019|NCT02642029|564315024|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
156332020|NCT02642029|564315025|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
156332021|NCT02642029|564315020|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
156332022|NCT02642029|564315021|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156332023|NCT02642029|564315022|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156332024|NCT02642029|564315023|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156332025|NCT02642029|564315024|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156332026|NCT02642029|564315025|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156332027|NCT02642029|564315020|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
156332028|NCT02642029|564315021|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
156332029|NCT02642029|564315022|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
156332030|NCT02642029|564315023|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
156332031|NCT02642029|564315024|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
156332032|NCT02642029|564315025|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
156332033|NCT01823146|564315026|FG000|Overall Study|Withdrawal by Subject|0|||
156332034|NCT01823146|564315027|FG001|Overall Study|Withdrawal by Subject|1|||
156332035|NCT01823146|564315026|FG000|Overall Study|Lost to Follow-up|2|||
156332036|NCT01823146|564315027|FG001|Overall Study|Lost to Follow-up|1|||
156332037|NCT00463580|564315028|FG000|Overall Study|Lost to Follow-up|1|||
156332038|NCT00463580|564315029|FG001|Overall Study|Lost to Follow-up|0|||
156332039|NCT00463580|564315028|FG000|Overall Study|Schedule conflict|2|||
156332040|NCT00463580|564315029|FG001|Overall Study|Schedule conflict|0|||
156439987|NCT01943799|564702539|FG001|Overall Study|Lost to Follow-up|1|||
156439988|NCT01943799|564702540|FG002|Overall Study|Lost to Follow-up|1|||
156439989|NCT01943799|564702541|FG003|Overall Study|Lost to Follow-up|0|||
156439990|NCT01943799|564702538|FG000|Overall Study|Protocol Violation|1|||
156439991|NCT01943799|564702539|FG001|Overall Study|Protocol Violation|0|||
156439992|NCT01943799|564702540|FG002|Overall Study|Protocol Violation|0|||
156531328|NCT03808688|565041589|FG001|Overall Study|Adverse Event|17|||
156531329|NCT03808688|565041588|FG000|Overall Study|Lack of Efficacy|2|||
156531330|NCT03808688|565041589|FG001|Overall Study|Lack of Efficacy|0|||
156531331|NCT03808688|565041588|FG000|Overall Study|Lost to Follow-up|0|||
156531332|NCT03808688|565041589|FG001|Overall Study|Lost to Follow-up|2|||
156531333|NCT03808688|565041588|FG000|Overall Study|Withdrawal by Subject|1|||
156531334|NCT03808688|565041589|FG001|Overall Study|Withdrawal by Subject|0|||
156531335|NCT03808688|565041588|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
156531336|NCT03808688|565041589|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
156531337|NCT03808688|565041588|FG000|Overall Study|IOP Too High|1|||
156531338|NCT03808688|565041589|FG001|Overall Study|IOP Too High|1|||
156531339|NCT03808688|565041588|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
156531340|NCT03808688|565041589|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
156531341|NCT03808688|565041588|FG000|Overall Study|Visit Out of Window|0|||
156531342|NCT03808688|565041589|FG001|Overall Study|Visit Out of Window|1|||
156531343|NCT03808688|565041588|FG000|Overall Study|Medication Non-Compliance|0|||
156531344|NCT03808688|565041589|FG001|Overall Study|Medication Non-Compliance|1|||
156531345|NCT01940354|565041590|FG000|Overall Study|Withdrawal by Subject|4|||
156531346|NCT01940354|565041591|FG001|Overall Study|Withdrawal by Subject|2|||
156531347|NCT03872453|565041592|FG000|Overall Study|Adverse Event|1|||
156531348|NCT03872453|565041593|FG001|Overall Study|Adverse Event|1|||
156439993|NCT01943799|564702541|FG003|Overall Study|Protocol Violation|0|||
156439994|NCT01943799|564702538|FG000|Overall Study|Withdrawal by Subject|4|||
156439995|NCT01943799|564702539|FG001|Overall Study|Withdrawal by Subject|2|||
156439996|NCT01943799|564702540|FG002|Overall Study|Withdrawal by Subject|1|||
156439997|NCT01943799|564702541|FG003|Overall Study|Withdrawal by Subject|0|||
156439998|NCT04594759|564702542|FG000|Overall Study|Lost to Follow-up|3|||
156439999|NCT00396084|564702543|FG000|Overall Study|Adverse Event|0|||
156440000|NCT00396084|564702544|FG001|Overall Study|Adverse Event|0|||
156440001|NCT00396084|564702545|FG002|Overall Study|Adverse Event|0|||
156440002|NCT00396084|564702546|FG003|Overall Study|Adverse Event|0|||
156440003|NCT00396084|564702547|FG004|Overall Study|Adverse Event|1|||
156440004|NCT00396084|564702548|FG005|Overall Study|Adverse Event|2|||
156440005|NCT00396084|564702543|FG000|Overall Study|Withdrawal by Subject|0|||
156440006|NCT00396084|564702544|FG001|Overall Study|Withdrawal by Subject|0|||
156440007|NCT00396084|564702545|FG002|Overall Study|Withdrawal by Subject|0|||
156440008|NCT00396084|564702546|FG003|Overall Study|Withdrawal by Subject|1|||
156440009|NCT00396084|564702547|FG004|Overall Study|Withdrawal by Subject|0|||
156440010|NCT00396084|564702548|FG005|Overall Study|Withdrawal by Subject|0|||
156440011|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
156440012|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
156440013|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
156440014|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
156440015|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
156531349|NCT03872453|565041594|FG002|Overall Study|Adverse Event|0|||
156531350|NCT03872453|565041595|FG003|Overall Study|Adverse Event|0|||
156531351|NCT03872453|565041592|FG000|Overall Study|Lost to Follow-up|8|||
156531352|NCT03872453|565041593|FG001|Overall Study|Lost to Follow-up|7|||
156531353|NCT03872453|565041594|FG002|Overall Study|Lost to Follow-up|4|||
156702709|NCT00735397|565657006|FG000|Overall Study|Participant choice|252|||
156702710|NCT00735397|565657006|FG000|Overall Study|Inadequate therapeutic effect|202|||
156531354|NCT03872453|565041595|FG003|Overall Study|Lost to Follow-up|4|||
156702711|NCT00735397|565657006|FG000|Overall Study|Administrative/Other|502|||
156702712|NCT02677714|565657007|FG000|Overall Study|Withdrawal by Subject|2|||
156440016|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
156440017|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
156440018|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
156440019|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
156440020|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
156440021|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
156440022|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
156440023|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
156440024|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
156440025|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
156440026|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
156531355|NCT03872453|565041592|FG000|Overall Study|Never Treated Migraine|19|||
156531356|NCT03872453|565041593|FG001|Overall Study|Never Treated Migraine|17|||
156702713|NCT02677714|565657008|FG001|Overall Study|Withdrawal by Subject|0|||
156531357|NCT03872453|565041594|FG002|Overall Study|Never Treated Migraine|13|||
156531358|NCT03872453|565041595|FG003|Overall Study|Never Treated Migraine|12|||
156531359|NCT03872453|565041592|FG000|Overall Study|Pregnancy|1|||
156531360|NCT03872453|565041593|FG001|Overall Study|Pregnancy|0|||
156531361|NCT03872453|565041594|FG002|Overall Study|Pregnancy|0|||
156531362|NCT03872453|565041595|FG003|Overall Study|Pregnancy|0|||
156531363|NCT03872453|565041592|FG000|Overall Study|Protocol Deviation|2|||
156531364|NCT03872453|565041593|FG001|Overall Study|Protocol Deviation|0|||
156531365|NCT03872453|565041594|FG002|Overall Study|Protocol Deviation|0|||
156531366|NCT03872453|565041595|FG003|Overall Study|Protocol Deviation|2|||
156531367|NCT03872453|565041592|FG000|Overall Study|Withdrawal by Subject|0|||
156531368|NCT03872453|565041593|FG001|Overall Study|Withdrawal by Subject|1|||
156531369|NCT03872453|565041594|FG002|Overall Study|Withdrawal by Subject|2|||
156531370|NCT03872453|565041595|FG003|Overall Study|Withdrawal by Subject|0|||
156531371|NCT03872453|565041592|FG000|Overall Study|Other Than Specified|1|||
156531372|NCT03872453|565041593|FG001|Overall Study|Other Than Specified|0|||
156531373|NCT03872453|565041594|FG002|Overall Study|Other Than Specified|0|||
156531374|NCT03872453|565041595|FG003|Overall Study|Other Than Specified|0|||
156531375|NCT00352885|565041596|FG000|Overall Study|Withdrawal by Subject|0|||
156531376|NCT00352885|565041597|FG001|Overall Study|Withdrawal by Subject|3|||
156531377|NCT00352885|565041596|FG000|Overall Study|Development of major depression|0|||
156531378|NCT00352885|565041597|FG001|Overall Study|Development of major depression|1|||
156531379|NCT00352885|565041596|FG000|Overall Study|Progression of metastatic melanoma|5|||
156531380|NCT00352885|565041597|FG001|Overall Study|Progression of metastatic melanoma|3|||
156531381|NCT00352885|565041596|FG000|Overall Study|Side effects of IL-2 administration|1|||
156531382|NCT00352885|565041597|FG001|Overall Study|Side effects of IL-2 administration|0|||
156531383|NCT01920594|565041598|FG000|Overall Study|Adverse Event|4|||
156531384|NCT01920594|565041599|FG001|Overall Study|Adverse Event|2|||
156531385|NCT01920594|565041598|FG000|Overall Study|Lost to Follow-up|1|||
156531386|NCT01920594|565041599|FG001|Overall Study|Lost to Follow-up|0|||
156531387|NCT01920594|565041598|FG000|Overall Study|Recovery|2|||
156702714|NCT02865460|565657009|FG000|Overall Study|Adverse Event|1|||
156702715|NCT02865460|565657010|FG001|Overall Study|Adverse Event|0|||
156702716|NCT02865460|565657009|FG000|Overall Study|Withdrawal by Subject|1|||
156702717|NCT02865460|565657010|FG001|Overall Study|Withdrawal by Subject|1|||
156702718|NCT02865460|565657009|FG000|Overall Study|Lost to Follow-up|7|||
156702719|NCT02865460|565657010|FG001|Overall Study|Lost to Follow-up|4|||
156702720|NCT02865460|565657009|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
156702721|NCT02865460|565657010|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
156702722|NCT00171951|565657017|FG000|Overall Study|Adverse Event|1|||
156702723|NCT00171951|565657017|FG000|Overall Study|Abnormal Laboratory Values|2|||
156702724|NCT00171951|565657017|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156702725|NCT00171951|565657017|FG000|Overall Study|Participants Withdrew Consent|3|||
156702726|NCT00171951|565657017|FG000|Overall Study|New Cancer Therapy|5|||
156702727|NCT00171951|565657017|FG000|Overall Study|Reason not Specified|2|||
156702728|NCT04658095|565657018|FG000|Overall Study|Study terminated|5|||
156702729|NCT04658095|565657019|FG001|Overall Study|Study terminated|1|||
156702730|NCT04658095|565657020|FG002|Overall Study|Study terminated|4|||
156702731|NCT04154631|565657022|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
156702732|NCT04154631|565657023|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
156702733|NCT01441947|565657024|FG000|Overall Study|Withdrawal by Subject|3|||
156702734|NCT01441947|565657025|FG001|Overall Study|Withdrawal by Subject|0|||
156702735|NCT04874636|565657026|FG000|Overall Study|Adverse Event|17|||
156702736|NCT04874636|565657027|FG001|Overall Study|Adverse Event|7|||
156702737|NCT04874636|565657026|FG000|Overall Study|Lost to Follow-up|1|||
156702738|NCT04874636|565657027|FG001|Overall Study|Lost to Follow-up|0|||
156702739|NCT04874636|565657026|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156702740|NCT04874636|565657027|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156702741|NCT04874636|565657026|FG000|Overall Study|Physician Decision|1|||
156702742|NCT04874636|565657027|FG001|Overall Study|Physician Decision|0|||
156531388|NCT01920594|565041599|FG001|Overall Study|Recovery|0|||
156531389|NCT01920594|565041598|FG000|Overall Study|Investigator discretion|0|||
156702743|NCT04874636|565657026|FG000|Overall Study|Withdrawal by Subject|6|||
156702744|NCT04874636|565657027|FG001|Overall Study|Withdrawal by Subject|5|||
156531390|NCT01920594|565041599|FG001|Overall Study|Investigator discretion|1|||
156531391|NCT01678209|565041600|FG000|Overall Study|could not scan twice|1|||
156531392|NCT01678209|565041601|FG001|Overall Study|could not scan twice|1|||
156531393|NCT01678209|565041602|FG002|Overall Study|could not scan twice|1|||
156531394|NCT01678209|565041600|FG000|Overall Study|scheduling conflicts|0|||
156531395|NCT01678209|565041601|FG001|Overall Study|scheduling conflicts|0|||
156531396|NCT01678209|565041602|FG002|Overall Study|scheduling conflicts|1|||
156702745|NCT00620659|565657036|FG000|Treatment Period 1|Adverse Event|1|||
156702746|NCT00620659|565657037|FG001|Treatment Period 1|Adverse Event|0|||
156702747|NCT00620659|565657038|FG002|Treatment Period 1|Adverse Event|0|||
156702748|NCT00620659|565657039|FG003|Treatment Period 1|Adverse Event|3|||
156702749|NCT00620659|565657040|FG004|Treatment Period 1|Adverse Event|0|||
156702750|NCT00620659|565657041|FG005|Treatment Period 1|Adverse Event|0|||
156702751|NCT00620659|565657036|FG000|Treatment Period 1|Protocol Violation|1|||
156702752|NCT00620659|565657037|FG001|Treatment Period 1|Protocol Violation|0|||
156702753|NCT00620659|565657038|FG002|Treatment Period 1|Protocol Violation|0|||
156702754|NCT00620659|565657039|FG003|Treatment Period 1|Protocol Violation|0|||
156702755|NCT00620659|565657040|FG004|Treatment Period 1|Protocol Violation|0|||
156702756|NCT00620659|565657041|FG005|Treatment Period 1|Protocol Violation|0|||
156702757|NCT00620659|565657036|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156702758|NCT00620659|565657037|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156702759|NCT00620659|565657038|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156702760|NCT00620659|565657039|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156702761|NCT00620659|565657040|FG004|Treatment Period 1|Withdrawal by Subject|1|||
156702762|NCT00620659|565657041|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156702763|NCT00620659|565657036|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702764|NCT00620659|565657037|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702765|NCT00620659|565657038|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702766|NCT00620659|565657039|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
156702767|NCT00620659|565657040|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702768|NCT00620659|565657041|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702769|NCT00620659|565657036|FG000|Treatment Period 2|Adverse Event|0|||
156702770|NCT00620659|565657037|FG001|Treatment Period 2|Adverse Event|3|||
156702771|NCT00620659|565657038|FG002|Treatment Period 2|Adverse Event|0|||
156702772|NCT00620659|565657039|FG003|Treatment Period 2|Adverse Event|0|||
156702773|NCT00620659|565657040|FG004|Treatment Period 2|Adverse Event|2|||
156702774|NCT00620659|565657041|FG005|Treatment Period 2|Adverse Event|0|||
156702775|NCT00620659|565657036|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156702776|NCT00620659|565657037|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156702777|NCT00620659|565657038|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156702778|NCT00620659|565657039|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156702779|NCT00620659|565657040|FG004|Treatment Period 2|Withdrawal by Subject|3|||
156702780|NCT00620659|565657041|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156702781|NCT00620659|565657036|FG000|Placebo Washout Period 2|Adverse Event|2|||
156702782|NCT00620659|565657037|FG001|Placebo Washout Period 2|Adverse Event|0|||
156702783|NCT00620659|565657038|FG002|Placebo Washout Period 2|Adverse Event|0|||
156702784|NCT00620659|565657039|FG003|Placebo Washout Period 2|Adverse Event|0|||
156702785|NCT00620659|565657040|FG004|Placebo Washout Period 2|Adverse Event|0|||
156702786|NCT00620659|565657041|FG005|Placebo Washout Period 2|Adverse Event|0|||
156702787|NCT00620659|565657036|FG000|Treatment Period 3|Adverse Event|0|||
156702788|NCT00620659|565657037|FG001|Treatment Period 3|Adverse Event|2|||
156702789|NCT00620659|565657038|FG002|Treatment Period 3|Adverse Event|0|||
156702790|NCT00620659|565657039|FG003|Treatment Period 3|Adverse Event|0|||
156702791|NCT00620659|565657040|FG004|Treatment Period 3|Adverse Event|0|||
156702792|NCT00620659|565657041|FG005|Treatment Period 3|Adverse Event|0|||
156702793|NCT00620659|565657036|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156702794|NCT00620659|565657037|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156702795|NCT00620659|565657038|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156702796|NCT00620659|565657039|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156702797|NCT00620659|565657040|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156702798|NCT00620659|565657041|FG005|Treatment Period 3|Withdrawal by Subject|0|||
156702799|NCT03246646|565657044|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
156440027|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
156440028|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
156440029|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
156440030|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
156440031|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
156440032|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
156440033|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
156440034|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
156440035|NCT00311363|564702549|FG000|24-Week Single-Blind Treatment Period|Death|1|||
156440036|NCT00311363|564702550|FG001|24-Week Single-Blind Treatment Period|Death|0|||
156440037|NCT00311363|564702551|FG002|24-Week Single-Blind Treatment Period|Death|0|||
156440038|NCT00311363|564702549|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
156440039|NCT00311363|564702550|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
156440040|NCT00311363|564702551|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
156440041|NCT00311363|564702549|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
156440042|NCT00311363|564702550|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
156440043|NCT00311363|564702551|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
156440044|NCT00311363|564702549|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
156440045|NCT00311363|564702550|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
156440046|NCT00311363|564702551|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
156702800|NCT03246646|565657045|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
156702801|NCT03246646|565657044|FG000|Overall Study|Withdrawal by Subject|3|||
156440047|NCT00311363|564702549|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
156440048|NCT00311363|564702550|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
156440049|NCT00311363|564702551|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
156440050|NCT00311363|564702549|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
156440051|NCT00311363|564702550|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
156440052|NCT00311363|564702551|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
156440053|NCT00311363|564702549|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
156440054|NCT00311363|564702550|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
156440055|NCT00311363|564702551|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
156440056|NCT03811574|564702554|FG000|Overall Study|Withdrawal by Subject|2|||
156440057|NCT03811574|564702555|FG001|Overall Study|Withdrawal by Subject|4|||
156702802|NCT03246646|565657045|FG001|Overall Study|Withdrawal by Subject|0|||
156702803|NCT03246646|565657044|FG000|Overall Study|Lost to Follow-up|7|||
156702804|NCT03246646|565657045|FG001|Overall Study|Lost to Follow-up|0|||
156702805|NCT00968799|565657048|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
156702806|NCT01372774|565657053|FG000|Overall Study|Withdrawal prior to treatment|4|||
156702807|NCT01372774|565657054|FG001|Overall Study|Withdrawal prior to treatment|5|||
156702808|NCT03907462|565657059|FG000|Overall Study|Physician Decision|1|||
156702809|NCT03907462|565657060|FG001|Overall Study|Physician Decision|3|||
156702810|NCT03907462|565657061|FG002|Overall Study|Physician Decision|1|||
156702811|NCT03907462|565657059|FG000|Overall Study|Withdrawal by Subject|6|||
156702812|NCT03907462|565657060|FG001|Overall Study|Withdrawal by Subject|3|||
156702813|NCT03907462|565657061|FG002|Overall Study|Withdrawal by Subject|3|||
156702814|NCT03907462|565657059|FG000|Overall Study|Pregnancy|4|||
156440058|NCT03811574|564702556|FG002|Overall Study|Withdrawal by Subject|0|||
156702815|NCT03907462|565657060|FG001|Overall Study|Pregnancy|2|||
156702816|NCT03907462|565657061|FG002|Overall Study|Pregnancy|6|||
156702817|NCT03907462|565657059|FG000|Overall Study|Lost to Follow-up|16|||
156702818|NCT03907462|565657060|FG001|Overall Study|Lost to Follow-up|18|||
156702819|NCT03907462|565657061|FG002|Overall Study|Lost to Follow-up|22|||
156702820|NCT04639713|565657062|FG000|Overall Study|Protocol Noncompliance|2|||
156702821|NCT04639713|565657062|FG000|Overall Study|Withdrawal by Subject|1|||
156702822|NCT03190330|565659082|FG000|Overall Study|Adverse Event|2|||
156702823|NCT03190330|565659082|FG000|Overall Study|Death|10|||
156702824|NCT03190330|565659082|FG000|Overall Study|Lost to Follow-up|1|||
156702825|NCT03190330|565659082|FG000|Overall Study|Withdrawal by Subject|6|||
156702826|NCT03190330|565659082|FG000|Overall Study|Progressive Disease|1|||
156702827|NCT02081209|565659083|FG000|Overall Study|Withdrawal by Subject|1|||
156702828|NCT00633243|565659084|FG000|Overall Study|Withdrawal by Subject|0|||
156702829|NCT00633243|565659085|FG001|Overall Study|Withdrawal by Subject|1|||
156702830|NCT00633243|565659084|FG000|Overall Study|incarceration|0|||
156702831|NCT00633243|565659085|FG001|Overall Study|incarceration|2|||
156702832|NCT00633243|565659084|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
156702833|NCT00633243|565659085|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
156702834|NCT00633243|565659084|FG000|Overall Study|Not comfortable with self-injecting|0|||
156702835|NCT00633243|565659085|FG001|Overall Study|Not comfortable with self-injecting|1|||
156702836|NCT00633243|565659084|FG000|Overall Study|Mental Health--Depression|0|||
156702837|NCT00633243|565659085|FG001|Overall Study|Mental Health--Depression|1|||
156702838|NCT00633243|565659084|FG000|Overall Study|Couldn't tolerate side-effects|1|||
156702839|NCT00633243|565659085|FG001|Overall Study|Couldn't tolerate side-effects|1|||
156702840|NCT03589768|565659086|FG000|Overall Study|Death|1|||
156702841|NCT03589768|565659087|FG001|Overall Study|Death|0|||
156702842|NCT03589768|565659088|FG002|Overall Study|Death|8|||
156702843|NCT03589768|565659089|FG003|Overall Study|Death|3|||
156702844|NCT03589768|565659086|FG000|Overall Study|Withdrawal by Subject|2|||
156702845|NCT03589768|565659087|FG001|Overall Study|Withdrawal by Subject|0|||
156702846|NCT03589768|565659088|FG002|Overall Study|Withdrawal by Subject|0|||
156702847|NCT03589768|565659089|FG003|Overall Study|Withdrawal by Subject|0|||
156702848|NCT03589768|565659086|FG000|Overall Study|Protocol Violation|1|||
156702849|NCT03589768|565659087|FG001|Overall Study|Protocol Violation|0|||
156702850|NCT03589768|565659088|FG002|Overall Study|Protocol Violation|0|||
156702851|NCT03589768|565659089|FG003|Overall Study|Protocol Violation|0|||
156702852|NCT00554190|565659092|FG000|Overall Study|Termination forms not completed|10|||
156702853|NCT00191113|565659093|FG000|Core Study|Withdrawal by Subject|25|||
156702854|NCT00191113|565659094|FG001|Core Study|Withdrawal by Subject|9|||
156702855|NCT00191113|565659093|FG000|Core Study|Protocol Violation|6|||
156702856|NCT00191113|565659094|FG001|Core Study|Protocol Violation|2|||
156791018|NCT03627468|565987135|FG000|Overall Study|Adverse Event|5|||
156440059|NCT01041417|564702563|FG000|Overall Study|Adverse Event|5|||
156440060|NCT01041417|564702564|FG001|Overall Study|Adverse Event|2|||
156440061|NCT01041417|564702563|FG000|Overall Study|Lost to Follow-up|1|||
156702857|NCT00191113|565659093|FG000|Core Study|Lost to Follow-up|3|||
156702858|NCT00191113|565659094|FG001|Core Study|Lost to Follow-up|0|||
156702859|NCT00191113|565659093|FG000|Core Study|Adverse Event|0|||
156702860|NCT00191113|565659094|FG001|Core Study|Adverse Event|2|||
156702861|NCT00191113|565659093|FG000|Core Study|Lack of Efficacy|0|||
156702862|NCT00191113|565659094|FG001|Core Study|Lack of Efficacy|2|||
156702863|NCT00191113|565659093|FG000|Core Study|Death|1|||
156702864|NCT00191113|565659094|FG001|Core Study|Death|0|||
156702865|NCT02903030|565659095|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156702866|NCT02903030|565659096|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
156702867|NCT01119508|565659097|FG000|Overall Study|Adverse Event|56|||
156702868|NCT01119508|565659097|FG000|Overall Study|Withdrawal by Subject|2|||
156702869|NCT01119508|565659097|FG000|Overall Study|Died before tumor response evaluation|1|||
156702870|NCT00265395|565659098|FG000|Overall Study|Adverse Event|3|||
156702871|NCT00265395|565659099|FG001|Overall Study|Adverse Event|6|||
156702872|NCT00265395|565659098|FG000|Overall Study|Lost to Follow-up|2|||
156702873|NCT00265395|565659099|FG001|Overall Study|Lost to Follow-up|1|||
156702874|NCT00265395|565659098|FG000|Overall Study|Withdrawal by Subject|1|||
156702875|NCT00265395|565659099|FG001|Overall Study|Withdrawal by Subject|6|||
156702876|NCT00265395|565659098|FG000|Overall Study|Protocol Violation|2|||
156702877|NCT00265395|565659099|FG001|Overall Study|Protocol Violation|2|||
156702878|NCT00265395|565659098|FG000|Overall Study|Lack of Efficacy|0|||
156702879|NCT00265395|565659099|FG001|Overall Study|Lack of Efficacy|1|||
156702880|NCT00265395|565659098|FG000|Overall Study|Administrative|0|||
156702881|NCT00265395|565659099|FG001|Overall Study|Administrative|1|||
156702882|NCT00837473|565659102|FG000|Overall Study|Lost to Follow-up|1|||
156702883|NCT00837473|565659102|FG000|Overall Study|Withdrawal by Subject|2|||
156702884|NCT03400943|565659103|FG000|Treatment Period 1|Adverse Event|0|||
156702885|NCT03400943|565659104|FG001|Treatment Period 1|Adverse Event|0|||
156702886|NCT03400943|565659105|FG002|Treatment Period 1|Adverse Event|0|||
156702887|NCT03400943|565659106|FG003|Treatment Period 1|Adverse Event|1|||
156702888|NCT03400943|565659103|FG000|Treatment Period 1|Lost to Follow-up|1|||
156702889|NCT03400943|565659104|FG001|Treatment Period 1|Lost to Follow-up|0|||
156702890|NCT03400943|565659105|FG002|Treatment Period 1|Lost to Follow-up|0|||
156702891|NCT03400943|565659106|FG003|Treatment Period 1|Lost to Follow-up|0|||
156702892|NCT03400943|565659103|FG000|Treatment Period 1|Protocol Violation|0|||
156702893|NCT03400943|565659104|FG001|Treatment Period 1|Protocol Violation|1|||
156702894|NCT03400943|565659105|FG002|Treatment Period 1|Protocol Violation|1|||
156702895|NCT03400943|565659106|FG003|Treatment Period 1|Protocol Violation|0|||
156702896|NCT03400943|565659103|FG000|Treatment Period 1|Study terminated by sponsor|2|||
156702897|NCT03400943|565659104|FG001|Treatment Period 1|Study terminated by sponsor|0|||
156702898|NCT03400943|565659105|FG002|Treatment Period 1|Study terminated by sponsor|0|||
156702899|NCT03400943|565659106|FG003|Treatment Period 1|Study terminated by sponsor|1|||
156702900|NCT03400943|565659103|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156702901|NCT03400943|565659104|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156702902|NCT03400943|565659105|FG002|Treatment Period 1|Withdrawal by Subject|3|||
156702903|NCT03400943|565659106|FG003|Treatment Period 1|Withdrawal by Subject|1|||
156702904|NCT03400943|565659103|FG000|Treatment Period 1|Other|2|||
156702905|NCT03400943|565659104|FG001|Treatment Period 1|Other|1|||
156702906|NCT03400943|565659105|FG002|Treatment Period 1|Other|2|||
156791019|NCT03627468|565987136|FG001|Overall Study|Adverse Event|33|||
156791020|NCT03627468|565987135|FG000|Overall Study|Withdrawal by Subject|13|||
156440062|NCT01041417|564702564|FG001|Overall Study|Lost to Follow-up|1|||
156440063|NCT01041417|564702563|FG000|Overall Study|Death|1|||
156440064|NCT01041417|564702564|FG001|Overall Study|Death|0|||
156440065|NCT02918071|564702567|FG000|Overall Study|Withdrawal by Subject|2|||
156440066|NCT02918071|564702567|FG000|Overall Study|Lost to Follow-up|1|||
156440067|NCT01616459|564702568|FG000|Overall Study|Adverse Event|1|||
156440068|NCT01616459|564702569|FG001|Overall Study|Adverse Event|1|||
156440069|NCT01616459|564702570|FG002|Overall Study|Adverse Event|2|||
156440070|NCT01616459|564702571|FG003|Overall Study|Adverse Event|0|||
156440071|NCT01616459|564702568|FG000|Overall Study|Lost to Follow-up|1|||
156440072|NCT01616459|564702569|FG001|Overall Study|Lost to Follow-up|11|||
156702907|NCT03400943|565659106|FG003|Treatment Period 1|Other|2|||
156702908|NCT03400943|565659103|FG000|Post-treatment Period 1|Adverse Event|2|||
156702909|NCT03400943|565659104|FG001|Post-treatment Period 1|Adverse Event|0|||
156702910|NCT03400943|565659105|FG002|Post-treatment Period 1|Adverse Event|0|||
156702911|NCT03400943|565659106|FG003|Post-treatment Period 1|Adverse Event|0|||
156702912|NCT03400943|565659103|FG000|Post-treatment Period 1|Protocol Violation|1|||
156702913|NCT03400943|565659104|FG001|Post-treatment Period 1|Protocol Violation|0|||
156702914|NCT03400943|565659105|FG002|Post-treatment Period 1|Protocol Violation|0|||
156702915|NCT03400943|565659106|FG003|Post-treatment Period 1|Protocol Violation|0|||
156702916|NCT03400943|565659103|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
156440073|NCT01616459|564702570|FG002|Overall Study|Lost to Follow-up|3|||
156440074|NCT01616459|564702571|FG003|Overall Study|Lost to Follow-up|2|||
156702917|NCT03400943|565659104|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
156702918|NCT03400943|565659105|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
156702919|NCT03400943|565659106|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
156791021|NCT03627468|565987136|FG001|Overall Study|Withdrawal by Subject|23|||
156440075|NCT01616459|564702568|FG000|Overall Study|Protocol Violation|0|||
156702920|NCT03400943|565659103|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
156702921|NCT03400943|565659104|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
156440076|NCT01616459|564702569|FG001|Overall Study|Protocol Violation|0|||
156440077|NCT01616459|564702570|FG002|Overall Study|Protocol Violation|0|||
156440078|NCT01616459|564702571|FG003|Overall Study|Protocol Violation|2|||
156440079|NCT01616459|564702568|FG000|Overall Study|Withdrawal by Subject|2|||
156440080|NCT01616459|564702569|FG001|Overall Study|Withdrawal by Subject|4|||
156440081|NCT01616459|564702570|FG002|Overall Study|Withdrawal by Subject|4|||
156440082|NCT01616459|564702571|FG003|Overall Study|Withdrawal by Subject|4|||
156440083|NCT01616459|564702568|FG000|Overall Study|Other reason|0|||
156791022|NCT03627468|565987135|FG000|Overall Study|Physician Decision|1|||
156791023|NCT03627468|565987136|FG001|Overall Study|Physician Decision|0|||
156791024|NCT03627468|565987135|FG000|Overall Study|Protocol Violation|0|||
156791025|NCT03627468|565987136|FG001|Overall Study|Protocol Violation|2|||
156440084|NCT01616459|564702569|FG001|Overall Study|Other reason|1|||
156440085|NCT01616459|564702570|FG002|Overall Study|Other reason|1|||
156440086|NCT01616459|564702571|FG003|Overall Study|Other reason|0|||
156440087|NCT05985044|564704011|FG000|Overall Study|Death|6|||
156440088|NCT05985044|564704011|FG000|Overall Study|Lost to Follow-up|4|||
156440089|NCT05985044|564704011|FG000|Overall Study|Incapacitation|3|||
156440090|NCT05985044|564704011|FG000|Overall Study|Withdrawal by Subject|2|||
156440091|NCT04300647|564704014|FG000|Pre-Crossover|Death|19|||
156440092|NCT04300647|564704015|FG001|Pre-Crossover|Death|58|||
156440093|NCT04300647|564704016|FG002|Pre-Crossover|Death|0|||
156440094|NCT04300647|564704014|FG000|Pre-Crossover|Lost to Follow-up|0|||
156440095|NCT04300647|564704015|FG001|Pre-Crossover|Lost to Follow-up|3|||
156440096|NCT04300647|564704016|FG002|Pre-Crossover|Lost to Follow-up|0|||
156440097|NCT04300647|564704014|FG000|Pre-Crossover|Withdrawal by Subject|2|||
156440098|NCT04300647|564704015|FG001|Pre-Crossover|Withdrawal by Subject|4|||
156440099|NCT04300647|564704016|FG002|Pre-Crossover|Withdrawal by Subject|0|||
156440100|NCT04300647|564704014|FG000|Pre-Crossover|On-going in Study|24|||
156440101|NCT04300647|564704015|FG001|Pre-Crossover|On-going in Study|61|||
156440102|NCT04300647|564704016|FG002|Pre-Crossover|On-going in Study|0|||
156440103|NCT04300647|564704014|FG000|Post-Crossover|Death|0|||
156440104|NCT04300647|564704015|FG001|Post-Crossover|Death|0|||
156440105|NCT04300647|564704016|FG002|Post-Crossover|Death|3|||
156440106|NCT04300647|564704014|FG000|Post-Crossover|Lost to Follow-up|0|||
156440107|NCT04300647|564704015|FG001|Post-Crossover|Lost to Follow-up|0|||
156440108|NCT04300647|564704016|FG002|Post-Crossover|Lost to Follow-up|1|||
156440109|NCT04300647|564704014|FG000|Post-Crossover|Withdrawal by Subject|0|||
156531397|NCT01678209|565041600|FG000|Overall Study|screen fail|16|||
156440110|NCT04300647|564704015|FG001|Post-Crossover|Withdrawal by Subject|0|||
156440111|NCT04300647|564704016|FG002|Post-Crossover|Withdrawal by Subject|1|||
156440112|NCT04300647|564704014|FG000|Post-Crossover|On-going in Study|0|||
156440113|NCT04300647|564704015|FG001|Post-Crossover|On-going in Study|0|||
156440114|NCT04300647|564704016|FG002|Post-Crossover|On-going in Study|8|||
156440115|NCT05672667|564704017|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
156440116|NCT04524390|564704018|FG000|Double Blind|Consent Withdrawal by subject|2|||
156440117|NCT04524390|564704019|FG001|Double Blind|Consent Withdrawal by subject|1|||
156440118|NCT04524390|564704020|FG002|Double Blind|Consent Withdrawal by subject|0|||
156440119|NCT04524390|564704018|FG000|Double Blind|Adverse Event|5|||
156531398|NCT01678209|565041601|FG001|Overall Study|screen fail|17|||
156531399|NCT01678209|565041602|FG002|Overall Study|screen fail|16|||
156531400|NCT03756350|565041606|FG000|Overall Study|Lost to Follow-up|1|||
156531401|NCT00928564|565041610|FG000|Overall Study|Lost to Follow-up|6|||
156531402|NCT00928564|565041611|FG001|Overall Study|Lost to Follow-up|0|||
156531403|NCT01096342|565041614|FG000|Overall Study|Protocol Violation|1|||
156531404|NCT03434353|565041615|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
156531405|NCT03434353|565041616|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
156531406|NCT03434353|565041617|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
156531407|NCT03434353|565041618|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
156531408|NCT03434353|565041619|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
156531409|NCT03434353|565041615|FG000|Overall Study|Withdrew consent|1|||
156531410|NCT03434353|565041616|FG001|Overall Study|Withdrew consent|0|||
156531411|NCT03434353|565041617|FG002|Overall Study|Withdrew consent|3|||
156531412|NCT03434353|565041618|FG003|Overall Study|Withdrew consent|0|||
156531413|NCT03434353|565041619|FG004|Overall Study|Withdrew consent|0|||
156531414|NCT03434353|565041615|FG000|Overall Study|Adverse Event|1|||
156531415|NCT03434353|565041616|FG001|Overall Study|Adverse Event|0|||
156531416|NCT03434353|565041617|FG002|Overall Study|Adverse Event|0|||
156531417|NCT03434353|565041618|FG003|Overall Study|Adverse Event|0|||
156531418|NCT03434353|565041619|FG004|Overall Study|Adverse Event|1|||
156531419|NCT03434353|565041615|FG000|Overall Study|Lost to Follow-up|2|||
156531420|NCT03434353|565041616|FG001|Overall Study|Lost to Follow-up|0|||
156440120|NCT04524390|564704019|FG001|Double Blind|Adverse Event|3|||
156531421|NCT03434353|565041617|FG002|Overall Study|Lost to Follow-up|0|||
156531422|NCT03434353|565041618|FG003|Overall Study|Lost to Follow-up|0|||
156791026|NCT03627468|565987135|FG000|Overall Study|Lost to Follow-up|10|||
156791027|NCT03627468|565987136|FG001|Overall Study|Lost to Follow-up|16|||
156440121|NCT04524390|564704020|FG002|Double Blind|Adverse Event|0|||
156702922|NCT03400943|565659105|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
156702923|NCT03400943|565659106|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
156702924|NCT03400943|565659103|FG000|Post-treatment Period 1|Other|2|||
156702925|NCT03400943|565659104|FG001|Post-treatment Period 1|Other|0|||
156702926|NCT03400943|565659105|FG002|Post-treatment Period 1|Other|4|||
156702927|NCT03400943|565659106|FG003|Post-treatment Period 1|Other|5|||
156702928|NCT03400943|565659103|FG000|Treatment Period 2|Study terminated by sponsor|0|||
156702929|NCT03400943|565659104|FG001|Treatment Period 2|Study terminated by sponsor|1|||
156702930|NCT03400943|565659105|FG002|Treatment Period 2|Study terminated by sponsor|0|||
156702931|NCT03400943|565659106|FG003|Treatment Period 2|Study terminated by sponsor|0|||
156702932|NCT03400943|565659103|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156702933|NCT03400943|565659104|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156702934|NCT03400943|565659105|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156702935|NCT03400943|565659106|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156702936|NCT03400943|565659103|FG000|Treatment Period 2|Other|1|||
156702937|NCT03400943|565659104|FG001|Treatment Period 2|Other|6|||
156702938|NCT03400943|565659105|FG002|Treatment Period 2|Other|0|||
156702939|NCT03400943|565659106|FG003|Treatment Period 2|Other|0|||
156702940|NCT03400943|565659103|FG000|Follow-up Period|Withdrawal by Subject|1|||
156702941|NCT03400943|565659104|FG001|Follow-up Period|Withdrawal by Subject|0|||
156702942|NCT03400943|565659105|FG002|Follow-up Period|Withdrawal by Subject|0|||
156702943|NCT03400943|565659106|FG003|Follow-up Period|Withdrawal by Subject|0|||
156702944|NCT02563106|565659107|FG000|Overall Study|Withdrawal by Subject|7|||
156702945|NCT02563106|565659108|FG001|Overall Study|Withdrawal by Subject|8|||
156702946|NCT02563106|565659107|FG000|Overall Study|Adverse Event|17|||
156702947|NCT02563106|565659108|FG001|Overall Study|Adverse Event|15|||
156702948|NCT02563106|565659107|FG000|Overall Study|Protocol Violation|1|||
156702949|NCT02563106|565659108|FG001|Overall Study|Protocol Violation|0|||
156702950|NCT02563106|565659107|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
156702951|NCT02563106|565659108|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
156702952|NCT02563106|565659107|FG000|Overall Study|Lost to Follow-up|3|||
156702953|NCT02563106|565659108|FG001|Overall Study|Lost to Follow-up|2|||
156702954|NCT02563106|565659107|FG000|Overall Study|Physician Decision|3|||
156702955|NCT02563106|565659108|FG001|Overall Study|Physician Decision|1|||
156702956|NCT02563106|565659107|FG000|Overall Study|Other reason - not specified|2|||
156702957|NCT02563106|565659108|FG001|Overall Study|Other reason - not specified|1|||
156702958|NCT00537303|565659109|FG000|Overall Study|Adverse Event|1|||
156702959|NCT00537303|565659110|FG001|Overall Study|Adverse Event|4|||
156702960|NCT00537303|565659109|FG000|Overall Study|Lack of Efficacy|6|||
156702961|NCT00537303|565659110|FG001|Overall Study|Lack of Efficacy|7|||
156702962|NCT00537303|565659109|FG000|Overall Study|Protocol Violation|8|||
156702963|NCT00537303|565659110|FG001|Overall Study|Protocol Violation|4|||
156531423|NCT03434353|565041619|FG004|Overall Study|Lost to Follow-up|0|||
156702964|NCT00537303|565659109|FG000|Overall Study|Withdrawal criteria|3|||
156702965|NCT00537303|565659110|FG001|Overall Study|Withdrawal criteria|3|||
156702966|NCT00537303|565659109|FG000|Overall Study|Unclassified|8|||
156702967|NCT00537303|565659110|FG001|Overall Study|Unclassified|7|||
156702968|NCT02338193|565659111|FG000|Overall Study|Withdrawal by Subject|0|||
156702969|NCT02338193|565659112|FG001|Overall Study|Withdrawal by Subject|0|||
156702970|NCT02338193|565659113|FG002|Overall Study|Withdrawal by Subject|2|||
156702971|NCT02338193|565659111|FG000|Overall Study|Pregnancy|0|||
156702972|NCT02338193|565659112|FG001|Overall Study|Pregnancy|1|||
156702973|NCT02338193|565659113|FG002|Overall Study|Pregnancy|1|||
156702974|NCT02338193|565659111|FG000|Overall Study|Noncompliant with visits|2|||
156702975|NCT02338193|565659112|FG001|Overall Study|Noncompliant with visits|2|||
156702976|NCT02338193|565659113|FG002|Overall Study|Noncompliant with visits|7|||
156702977|NCT02338193|565659111|FG000|Overall Study|moved out of state|0|||
156702978|NCT02338193|565659112|FG001|Overall Study|moved out of state|1|||
156702979|NCT02338193|565659113|FG002|Overall Study|moved out of state|0|||
156791028|NCT03627468|565987135|FG000|Overall Study|Death|1|||
156791029|NCT03627468|565987136|FG001|Overall Study|Death|0|||
156791030|NCT03627468|565987135|FG000|Overall Study|Pregnancy|1|||
156791031|NCT03627468|565987136|FG001|Overall Study|Pregnancy|1|||
156791032|NCT03627468|565987135|FG000|Overall Study|Lack of Efficacy|0|||
156791033|NCT03627468|565987136|FG001|Overall Study|Lack of Efficacy|2|||
156791034|NCT03627468|565987135|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
156702980|NCT02338193|565659111|FG000|Overall Study|intolerant of side effects|1|||
156791035|NCT03627468|565987136|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
156791036|NCT01104870|565987137|FG000|Overall Study|Adverse Event|1|||
156791037|NCT01104870|565987138|FG001|Overall Study|Adverse Event|1|||
156791038|NCT01104870|565987139|FG002|Overall Study|Adverse Event|0|||
156791039|NCT01104870|565987137|FG000|Overall Study|Death|0|||
156702981|NCT02338193|565659112|FG001|Overall Study|intolerant of side effects|0|||
156702982|NCT02338193|565659113|FG002|Overall Study|intolerant of side effects|0|||
156702983|NCT01136967|565659114|FG000|Overall Study|Adverse Event|9|||
156702984|NCT01136967|565659115|FG001|Overall Study|Adverse Event|12|||
156702985|NCT01136967|565659114|FG000|Overall Study|Participant Choice|8|||
156702986|NCT01136967|565659115|FG001|Overall Study|Participant Choice|3|||
156791040|NCT01104870|565987138|FG001|Overall Study|Death|0|||
156702987|NCT01136967|565659114|FG000|Overall Study|Lost to Follow-up|0|||
156702988|NCT01136967|565659115|FG001|Overall Study|Lost to Follow-up|1|||
156702989|NCT01136967|565659114|FG000|Overall Study|Withdrawal by Subject|1|||
156702990|NCT01136967|565659115|FG001|Overall Study|Withdrawal by Subject|2|||
156702991|NCT01136967|565659114|FG000|Overall Study|Clinical Progression|3|||
156702992|NCT01136967|565659115|FG001|Overall Study|Clinical Progression|5|||
156702993|NCT01136967|565659114|FG000|Overall Study|Radiation|1|||
156702994|NCT01136967|565659115|FG001|Overall Study|Radiation|0|||
156702995|NCT01136967|565659114|FG000|Overall Study|Non-compliance|1|||
156702996|NCT01136967|565659115|FG001|Overall Study|Non-compliance|0|||
156702997|NCT01136967|565659114|FG000|Overall Study|Investigator's Choice|1|||
156702998|NCT01136967|565659115|FG001|Overall Study|Investigator's Choice|1|||
156702999|NCT01136967|565659114|FG000|Overall Study|Increase in Lesion Size|0|||
156703000|NCT01136967|565659115|FG001|Overall Study|Increase in Lesion Size|2|||
156703001|NCT01136967|565659114|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
156703002|NCT01136967|565659115|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
156703003|NCT01735955|565659120|FG000|Overall Study|Administrative problems|1|||
156703004|NCT01735955|565659120|FG000|Overall Study|Patient/guardian decision|1|||
156703005|NCT01735955|565659120|FG000|Overall Study|Patient withdrew consent|2|||
156703006|NCT01735955|565659120|FG000|Overall Study|Physician Decision|4|||
156703007|NCT01735955|565659120|FG000|Overall Study|Disease progression|24|||
156703008|NCT01735955|565659120|FG000|Overall Study|Adverse Event|5|||
156703009|NCT03839823|565659124|FG000|Overall Study|Adverse Event|8|||
156703010|NCT03839823|565659125|FG001|Overall Study|Adverse Event|4|||
156703011|NCT03839823|565659124|FG000|Overall Study|Death|1|||
156703012|NCT03839823|565659125|FG001|Overall Study|Death|0|||
156703013|NCT03839823|565659124|FG000|Overall Study|Physician Decision|1|||
156703014|NCT03839823|565659125|FG001|Overall Study|Physician Decision|5|||
156703015|NCT03839823|565659124|FG000|Overall Study|Progressive Disease (PD)|65|||
156703016|NCT03839823|565659125|FG001|Overall Study|Progressive Disease (PD)|65|||
156703017|NCT03839823|565659124|FG000|Overall Study|Subject Decision|2|||
156703018|NCT03839823|565659125|FG001|Overall Study|Subject Decision|9|||
156703019|NCT03839823|565659124|FG000|Overall Study|Not Treated|0|||
156703020|NCT03839823|565659125|FG001|Overall Study|Not Treated|10|||
156703021|NCT01716715|565659126|FG000|Overall Study|Never Treated|2|||
156703022|NCT01716715|565659127|FG001|Overall Study|Never Treated|4|||
156703023|NCT03327792|565659128|FG000|Overall Study|Adverse Event|4|||
156703024|NCT03327792|565659129|FG001|Overall Study|Adverse Event|0|||
156703025|NCT03327792|565659128|FG000|Overall Study|Family/Personal issues|3|||
156703026|NCT03327792|565659129|FG001|Overall Study|Family/Personal issues|2|||
156703027|NCT03327792|565659128|FG000|Overall Study|Lost to Follow-up|0|||
156703028|NCT03327792|565659129|FG001|Overall Study|Lost to Follow-up|1|||
156703029|NCT03511326|565659136|FG000|Overall Study|Withdrawal by Subject|1|||
156703030|NCT04058067|565659139|FG000|Overall Study|Adverse Event|2|||
156703031|NCT04058067|565659140|FG001|Overall Study|Adverse Event|0|||
156703032|NCT04058067|565659139|FG000|Overall Study|Death|0|||
156703033|NCT04058067|565659140|FG001|Overall Study|Death|1|||
156703034|NCT04058067|565659139|FG000|Overall Study|Physician Decision|3|||
156703035|NCT04058067|565659140|FG001|Overall Study|Physician Decision|1|||
156703036|NCT04058067|565659139|FG000|Overall Study|Protocol Violation|0|||
156703037|NCT04058067|565659140|FG001|Overall Study|Protocol Violation|1|||
156703038|NCT04058067|565659139|FG000|Overall Study|Withdrawal by Subject|7|||
156703039|NCT04058067|565659140|FG001|Overall Study|Withdrawal by Subject|8|||
156703040|NCT00867503|565659142|FG000|Overall Study|Withdrawal by Subject|1|||
156703041|NCT03421730|565659151|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703042|NCT03421730|565659152|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
156703043|NCT03421730|565659153|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703044|NCT03421730|565659154|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703045|NCT03421730|565659155|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703046|NCT03421730|565659156|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703047|NCT03421730|565659157|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703048|NCT03421730|565659158|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703049|NCT03421730|565659159|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703050|NCT03421730|565659160|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703051|NCT03421730|565659161|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156791041|NCT01104870|565987139|FG002|Overall Study|Death|1|||
156791042|NCT01104870|565987137|FG000|Overall Study|Withdrawal by Subject|0|||
156791043|NCT01104870|565987138|FG001|Overall Study|Withdrawal by Subject|0|||
156531424|NCT04906616|565041620|FG000|Overall Study|Divorce|3|||
156531425|NCT04906616|565041621|FG001|Overall Study|Divorce|2|||
156703052|NCT03421730|565659162|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703053|NCT03421730|565659151|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703054|NCT03421730|565659152|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156791044|NCT01104870|565987139|FG002|Overall Study|Withdrawal by Subject|1|||
156703055|NCT03421730|565659153|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703056|NCT03421730|565659154|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703057|NCT03421730|565659155|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
156703058|NCT03421730|565659156|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703059|NCT03421730|565659157|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703060|NCT03421730|565659158|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703061|NCT03421730|565659159|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703062|NCT03421730|565659160|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703063|NCT03421730|565659161|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703064|NCT03421730|565659162|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703065|NCT02238795|565659163|FG000|Overall Study|Patient without purpura fulminans|1|||
156703066|NCT05187013|565659165|FG000|Overall Study|Withdrawal by Subject|1|||
156703067|NCT05187013|565659166|FG001|Overall Study|Withdrawal by Subject|1|||
156703068|NCT05187013|565659167|FG002|Overall Study|Withdrawal by Subject|0|||
156703069|NCT05187013|565659165|FG000|Overall Study|Death|0|||
156703070|NCT05187013|565659166|FG001|Overall Study|Death|1|||
156703071|NCT05187013|565659167|FG002|Overall Study|Death|0|||
156703072|NCT05187013|565659165|FG000|Overall Study|Lost to Follow-up|20|||
156703073|NCT05187013|565659166|FG001|Overall Study|Lost to Follow-up|17|||
156703074|NCT05187013|565659167|FG002|Overall Study|Lost to Follow-up|0|||
156703075|NCT05187013|565659165|FG000|Overall Study|Ongoing Participants|3|||
156703076|NCT05187013|565659166|FG001|Overall Study|Ongoing Participants|5|||
156703077|NCT05187013|565659167|FG002|Overall Study|Ongoing Participants|0|||
156703078|NCT02387983|565659168|FG000|Overall Study|Adverse Event|4|||
156703079|NCT02387983|565659168|FG000|Overall Study|Protocol Violation|1|||
156703080|NCT02387983|565659168|FG000|Overall Study|Withdrawal by Subject|2|||
156703081|NCT04159935|565659169|FG000|Overall Study|Study terminated due to COVID-19|1|||
156703082|NCT04159935|565659170|FG001|Overall Study|Study terminated due to COVID-19|3|||
156703083|NCT01341782|565659171|FG000|Overall Study|Adverse Event|1|||
156703084|NCT01341782|565659172|FG001|Overall Study|Adverse Event|1|||
156703085|NCT01341782|565659171|FG000|Overall Study|Withdrawal by Subject|6|||
156703086|NCT01341782|565659172|FG001|Overall Study|Withdrawal by Subject|5|||
156703087|NCT01341782|565659171|FG000|Overall Study|Missed 3 consecutive doses|0|||
156703088|NCT01341782|565659172|FG001|Overall Study|Missed 3 consecutive doses|4|||
156703089|NCT01341782|565659171|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
156703090|NCT01341782|565659172|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
156703091|NCT01341782|565659171|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
156703092|NCT01341782|565659172|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
156703093|NCT01341782|565659171|FG000|Overall Study|Other|5|||
156703094|NCT01341782|565659172|FG001|Overall Study|Other|0|||
156703095|NCT02036775|565659173|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703096|NCT02036775|565659174|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703097|NCT02036775|565659175|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703098|NCT02036775|565659176|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703099|NCT02036775|565659177|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703100|NCT02036775|565659178|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
156703101|NCT02927366|565659180|FG000|Overall Study|Adverse Event|1|||
156703102|NCT02927366|565659181|FG001|Overall Study|Adverse Event|0|||
156703103|NCT02927366|565659180|FG000|Overall Study|Patient schedule|1|||
156703104|NCT02927366|565659181|FG001|Overall Study|Patient schedule|0|||
156703105|NCT00724048|565659186|FG000|Overall Study|Adverse Event|1|||
156703106|NCT00724048|565659187|FG001|Overall Study|Adverse Event|1|||
156703107|NCT00724048|565659188|FG002|Overall Study|Adverse Event|1|||
156703108|NCT00724048|565659189|FG003|Overall Study|Adverse Event|0|||
156703109|NCT00724048|565659186|FG000|Overall Study|Lost to Follow-up|0|||
156440122|NCT04524390|564704018|FG000|Double Blind|Liver Transplant|5|||
156440123|NCT04524390|564704019|FG001|Double Blind|Liver Transplant|6|||
156440124|NCT04524390|564704020|FG002|Double Blind|Liver Transplant|0|||
156440125|NCT04524390|564704018|FG000|Double Blind|Disease Progression|0|||
156703110|NCT00724048|565659187|FG001|Overall Study|Lost to Follow-up|1|||
156703111|NCT00724048|565659188|FG002|Overall Study|Lost to Follow-up|0|||
156703112|NCT00724048|565659189|FG003|Overall Study|Lost to Follow-up|0|||
156703113|NCT00724048|565659186|FG000|Overall Study|Withdrawal by Subject|1|||
156703114|NCT00724048|565659187|FG001|Overall Study|Withdrawal by Subject|2|||
156703115|NCT00724048|565659188|FG002|Overall Study|Withdrawal by Subject|1|||
156703116|NCT00724048|565659189|FG003|Overall Study|Withdrawal by Subject|2|||
156703117|NCT00724048|565659186|FG000|Overall Study|Investigator decision|0|||
156703118|NCT00724048|565659187|FG001|Overall Study|Investigator decision|0|||
156440126|NCT04524390|564704019|FG001|Double Blind|Disease Progression|1|||
156440127|NCT04524390|564704020|FG002|Double Blind|Disease Progression|0|||
156440128|NCT04524390|564704018|FG000|Open-Label|Drug interruption criteria|0|||
156703119|NCT00724048|565659188|FG002|Overall Study|Investigator decision|1|||
156703120|NCT00724048|565659189|FG003|Overall Study|Investigator decision|0|||
156703121|NCT00724048|565659186|FG000|Overall Study|Did not tolerate study drug|0|||
156703122|NCT00724048|565659187|FG001|Overall Study|Did not tolerate study drug|0|||
156703123|NCT00724048|565659188|FG002|Overall Study|Did not tolerate study drug|0|||
156703124|NCT00724048|565659189|FG003|Overall Study|Did not tolerate study drug|1|||
156703125|NCT00724048|565659186|FG000|Overall Study|Other than specified|1|||
156703126|NCT00724048|565659187|FG001|Overall Study|Other than specified|1|||
156703127|NCT00724048|565659188|FG002|Overall Study|Other than specified|0|||
156703128|NCT00724048|565659189|FG003|Overall Study|Other than specified|0|||
156703129|NCT00587990|565659192|FG000|Overall Study|Death|0|||
156703130|NCT00587990|565659193|FG001|Overall Study|Death|0|||
156703131|NCT00587990|565659194|FG002|Overall Study|Death|1|||
156703132|NCT00206323|565659197|FG000|Overall Study|Lack of Efficacy|4|||
156703133|NCT00206323|565659198|FG001|Overall Study|Lack of Efficacy|1|||
156703134|NCT00206323|565659197|FG000|Overall Study|Adverse Event|1|||
156703135|NCT00206323|565659198|FG001|Overall Study|Adverse Event|1|||
156703136|NCT00206323|565659197|FG000|Overall Study|Lost to Follow-up|1|||
156703137|NCT00206323|565659198|FG001|Overall Study|Lost to Follow-up|1|||
156703138|NCT02910063|565659199|FG000|Phase 2|Withdrawal by Subject|3|||
156703139|NCT02910063|565659200|FG001|Phase 2|Withdrawal by Subject|0|||
156703140|NCT02910063|565659201|FG002|Phase 2|Withdrawal by Subject|0|||
156703141|NCT02910063|565659199|FG000|Phase 2|Lost to Follow-up|1|||
156703142|NCT02910063|565659200|FG001|Phase 2|Lost to Follow-up|0|||
156703143|NCT02910063|565659201|FG002|Phase 2|Lost to Follow-up|0|||
156703144|NCT02910063|565659199|FG000|Phase 2|Death|24|||
156703145|NCT02910063|565659200|FG001|Phase 2|Death|0|||
156703146|NCT02910063|565659201|FG002|Phase 2|Death|0|||
156703147|NCT03496610|565659202|FG000|Overall Study|Lost to Follow-up|3|||
156703148|NCT03496610|565659203|FG001|Overall Study|Lost to Follow-up|2|||
156703149|NCT03496610|565659202|FG000|Overall Study|Physician Decision|1|||
156703150|NCT03496610|565659203|FG001|Overall Study|Physician Decision|0|||
156703151|NCT03496610|565659202|FG000|Overall Study|Withdrawal by Subject|1|||
156703152|NCT03496610|565659203|FG001|Overall Study|Withdrawal by Subject|0|||
156703153|NCT03334617|565659206|FG000|Overall Study|Adverse Event|0|||
156703154|NCT03334617|565659207|FG001|Overall Study|Adverse Event|0|||
156703155|NCT03334617|565659208|FG002|Overall Study|Adverse Event|0|||
156703156|NCT03334617|565659209|FG003|Overall Study|Adverse Event|0|||
156703157|NCT03334617|565659210|FG004|Overall Study|Adverse Event|0|||
156703158|NCT03334617|565659211|FG005|Overall Study|Adverse Event|0|||
156703159|NCT03334617|565659212|FG006|Overall Study|Adverse Event|0|||
156703160|NCT03334617|565659213|FG007|Overall Study|Adverse Event|0|||
156703161|NCT03334617|565659214|FG008|Overall Study|Adverse Event|1|||
156703162|NCT03334617|565659215|FG009|Overall Study|Adverse Event|0|||
156703163|NCT03334617|565659216|FG010|Overall Study|Adverse Event|0|||
156703164|NCT03334617|565659217|FG011|Overall Study|Adverse Event|0|||
156703165|NCT03334617|565659218|FG012|Overall Study|Adverse Event|1|||
156703166|NCT03334617|565659219|FG013|Overall Study|Adverse Event|0|||
156703167|NCT03334617|565659220|FG014|Overall Study|Adverse Event|0|||
156703168|NCT03334617|565659221|FG015|Overall Study|Adverse Event|0|||
156703169|NCT03334617|565659222|FG016|Overall Study|Adverse Event|0|||
156703170|NCT03334617|565659223|FG017|Overall Study|Adverse Event|0|||
156703171|NCT03334617|565659224|FG018|Overall Study|Adverse Event|0|||
156703172|NCT03334617|565659225|FG019|Overall Study|Adverse Event|0|||
156703173|NCT03334617|565659226|FG020|Overall Study|Adverse Event|0|||
156703174|NCT03334617|565659227|FG021|Overall Study|Adverse Event|0|||
156703175|NCT03334617|565659206|FG000|Overall Study|Death|18|||
156703176|NCT03334617|565659207|FG001|Overall Study|Death|18|||
156791045|NCT02633527|565987140|FG000|Overall Study|Failed to meet eligibility|0|||
156791046|NCT02633527|565987141|FG001|Overall Study|Failed to meet eligibility|1|||
156791047|NCT02633527|565987142|FG002|Overall Study|Failed to meet eligibility|1|||
156791048|NCT02633527|565987143|FG003|Overall Study|Failed to meet eligibility|0|||
156791049|NCT02633527|565987144|FG004|Overall Study|Failed to meet eligibility|1|||
156791050|NCT02633527|565987140|FG000|Overall Study|Adverse Event|0|||
156332041|NCT00463580|564315028|FG000|Overall Study|Medical/psychiatric complications|0|||
156332042|NCT00463580|564315029|FG001|Overall Study|Medical/psychiatric complications|2|||
156332043|NCT00736944|564315030|FG000|Induction|Death|1|||
156531426|NCT03739762|565041622|FG000|Overall Study|Lost to Follow-up|1|||
156531427|NCT03739762|565041623|FG001|Overall Study|Lost to Follow-up|1|||
156703177|NCT03334617|565659208|FG002|Overall Study|Death|20|||
156703178|NCT03334617|565659209|FG003|Overall Study|Death|21|||
156703179|NCT03334617|565659210|FG004|Overall Study|Death|20|||
156703180|NCT03334617|565659211|FG005|Overall Study|Death|16|||
156703181|NCT03334617|565659212|FG006|Overall Study|Death|28|||
156703182|NCT03334617|565659213|FG007|Overall Study|Death|35|||
156791051|NCT02633527|565987141|FG001|Overall Study|Adverse Event|4|||
156332044|NCT00736944|564315030|FG000|Definitive Treatment|Physician Decision|1|||
156703183|NCT03334617|565659214|FG008|Overall Study|Death|47|||
156703184|NCT03334617|565659215|FG009|Overall Study|Death|0|||
156703185|NCT03334617|565659216|FG010|Overall Study|Death|19|||
156703186|NCT03334617|565659217|FG011|Overall Study|Death|6|||
156703187|NCT03334617|565659218|FG012|Overall Study|Death|20|||
156703188|NCT03334617|565659219|FG013|Overall Study|Death|22|||
156703189|NCT03334617|565659220|FG014|Overall Study|Death|17|||
156703190|NCT03334617|565659221|FG015|Overall Study|Death|18|||
156332045|NCT01426438|564315031|FG000|Overall Study|Lost to Follow-up|1|||
156332046|NCT01426438|564315032|FG001|Overall Study|Lost to Follow-up|3|||
156332047|NCT01426438|564315031|FG000|Overall Study|Off study Treatment|9|||
156332048|NCT01426438|564315032|FG001|Overall Study|Off study Treatment|3|||
156531428|NCT03739762|565041622|FG000|Overall Study|Withdrawal by Subject|2|||
156531429|NCT03739762|565041623|FG001|Overall Study|Withdrawal by Subject|6|||
156531430|NCT00929656|565041624|FG000|Overall Study|Lost to Follow-up|0|||
156531431|NCT00929656|565041625|FG001|Overall Study|Lost to Follow-up|1|||
156531432|NCT00607880|565041626|FG000|Overall Study|Unable to place port due to occlusion|1|||
156531433|NCT00607880|565041627|FG001|Overall Study|Unable to place port due to occlusion|0|||
156531434|NCT01990534|565041628|FG000|Overall Study|Death|22|||
156531435|NCT01990534|565041628|FG000|Overall Study|Progressive disease|3|||
156531436|NCT01990534|565041628|FG000|Overall Study|Protocol Violation|1|||
156531437|NCT01990534|565041628|FG000|Overall Study|Withdrawal of Informed Consent|2|||
156531438|NCT01990534|565041628|FG000|Overall Study|Symptomatic Deterioration|1|||
156531439|NCT01990534|565041628|FG000|Overall Study|Withdrawal by Subject|3|||
156531440|NCT01990534|565041628|FG000|Overall Study|Reason not Specified|2|||
156531441|NCT01990534|565041628|FG000|Overall Study|Lost to Follow-up|1|||
156531442|NCT01831544|565041629|FG000|Overall Study|Death|1|||
156531443|NCT01831544|565041629|FG000|Overall Study|Still on original MVAD device|2|||
156531444|NCT03422172|565041630|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
156531445|NCT03422172|565041630|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
156531446|NCT03422172|565041630|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
156531447|NCT04147234|565041631|FG000|Overall Study|Clinical deterioration|0|||
156531448|NCT04147234|565041632|FG001|Overall Study|Clinical deterioration|0|||
156531449|NCT04147234|565041633|FG002|Overall Study|Clinical deterioration|1|||
156531450|NCT04147234|565041634|FG003|Overall Study|Clinical deterioration|0|||
156531451|NCT04147234|565041635|FG004|Overall Study|Clinical deterioration|0|||
156531452|NCT04147234|565041636|FG005|Overall Study|Clinical deterioration|0|||
156531453|NCT04147234|565041637|FG006|Overall Study|Clinical deterioration|0|||
156531454|NCT04147234|565041631|FG000|Overall Study|Withdrawal by Subject|0|||
156531455|NCT04147234|565041632|FG001|Overall Study|Withdrawal by Subject|1|||
156531456|NCT04147234|565041633|FG002|Overall Study|Withdrawal by Subject|1|||
156531457|NCT04147234|565041634|FG003|Overall Study|Withdrawal by Subject|0|||
156531458|NCT04147234|565041635|FG004|Overall Study|Withdrawal by Subject|0|||
156531459|NCT04147234|565041636|FG005|Overall Study|Withdrawal by Subject|0|||
156531460|NCT04147234|565041637|FG006|Overall Study|Withdrawal by Subject|0|||
156531461|NCT04147234|565041631|FG000|Overall Study|Clinical disease progression|1|||
156531462|NCT04147234|565041632|FG001|Overall Study|Clinical disease progression|3|||
156531463|NCT04147234|565041633|FG002|Overall Study|Clinical disease progression|1|||
156531464|NCT04147234|565041634|FG003|Overall Study|Clinical disease progression|1|||
156531465|NCT04147234|565041635|FG004|Overall Study|Clinical disease progression|0|||
156531466|NCT04147234|565041636|FG005|Overall Study|Clinical disease progression|1|||
156531467|NCT04147234|565041637|FG006|Overall Study|Clinical disease progression|0|||
156531468|NCT04147234|565041631|FG000|Overall Study|Objective disease progression|6|||
156531469|NCT04147234|565041632|FG001|Overall Study|Objective disease progression|4|||
156531470|NCT04147234|565041633|FG002|Overall Study|Objective disease progression|3|||
156531471|NCT04147234|565041634|FG003|Overall Study|Objective disease progression|3|||
156531472|NCT04147234|565041635|FG004|Overall Study|Objective disease progression|5|||
156531473|NCT04147234|565041636|FG005|Overall Study|Objective disease progression|2|||
156531474|NCT04147234|565041637|FG006|Overall Study|Objective disease progression|3|||
156531475|NCT04147234|565041631|FG000|Overall Study|Adverse Event|0|||
156531476|NCT04147234|565041632|FG001|Overall Study|Adverse Event|0|||
156703191|NCT03334617|565659222|FG016|Overall Study|Death|12|||
156703192|NCT03334617|565659223|FG017|Overall Study|Death|15|||
156332049|NCT01426438|564315031|FG000|Overall Study|Poor scan quality|3|||
156332050|NCT01426438|564315032|FG001|Overall Study|Poor scan quality|2|||
156332051|NCT01426438|564315031|FG000|Overall Study|Missed Scan|2|||
156332052|NCT01426438|564315032|FG001|Overall Study|Missed Scan|2|||
156332053|NCT01788046|564315033|FG000|Overall Study|Withdrawal by Subject|12|||
156332054|NCT01788046|564315034|FG001|Overall Study|Withdrawal by Subject|12|||
156332055|NCT01788046|564315033|FG000|Overall Study|Lost to Follow-up|12|||
156332056|NCT01788046|564315034|FG001|Overall Study|Lost to Follow-up|19|||
156332057|NCT01788046|564315033|FG000|Overall Study|Death|7|||
156332058|NCT01788046|564315034|FG001|Overall Study|Death|5|||
156332059|NCT01788046|564315033|FG000|Overall Study|Protocol Specified Criteria|25|||
156332060|NCT01788046|564315034|FG001|Overall Study|Protocol Specified Criteria|1|||
156332061|NCT01147640|564315040|FG000|Overall Study|Adverse Event|2|||
156332062|NCT01147640|564315041|FG001|Overall Study|Adverse Event|0|||
156531477|NCT04147234|565041633|FG002|Overall Study|Adverse Event|0|||
156531478|NCT04147234|565041634|FG003|Overall Study|Adverse Event|0|||
156531479|NCT04147234|565041635|FG004|Overall Study|Adverse Event|1|||
156531480|NCT04147234|565041636|FG005|Overall Study|Adverse Event|0|||
156531481|NCT04147234|565041637|FG006|Overall Study|Adverse Event|0|||
156332063|NCT01147640|564315040|FG000|Overall Study|Physician Decision|1|||
156332064|NCT01147640|564315041|FG001|Overall Study|Physician Decision|0|||
156703193|NCT03334617|565659224|FG018|Overall Study|Death|16|||
156703194|NCT03334617|565659225|FG019|Overall Study|Death|27|||
156703195|NCT03334617|565659226|FG020|Overall Study|Death|14|||
156703196|NCT03334617|565659227|FG021|Overall Study|Death|27|||
156703197|NCT03334617|565659206|FG000|Overall Study|Lost to Follow-up|0|||
156703198|NCT03334617|565659207|FG001|Overall Study|Lost to Follow-up|0|||
156703199|NCT03334617|565659208|FG002|Overall Study|Lost to Follow-up|0|||
156703200|NCT03334617|565659209|FG003|Overall Study|Lost to Follow-up|1|||
156703201|NCT03334617|565659210|FG004|Overall Study|Lost to Follow-up|0|||
156703202|NCT03334617|565659211|FG005|Overall Study|Lost to Follow-up|1|||
156703203|NCT03334617|565659212|FG006|Overall Study|Lost to Follow-up|0|||
156703204|NCT03334617|565659213|FG007|Overall Study|Lost to Follow-up|0|||
156703205|NCT03334617|565659214|FG008|Overall Study|Lost to Follow-up|1|||
156703206|NCT03334617|565659215|FG009|Overall Study|Lost to Follow-up|0|||
156703207|NCT03334617|565659216|FG010|Overall Study|Lost to Follow-up|0|||
156703208|NCT03334617|565659217|FG011|Overall Study|Lost to Follow-up|0|||
156703209|NCT03334617|565659218|FG012|Overall Study|Lost to Follow-up|0|||
156703210|NCT03334617|565659219|FG013|Overall Study|Lost to Follow-up|0|||
156703211|NCT03334617|565659220|FG014|Overall Study|Lost to Follow-up|0|||
156703212|NCT03334617|565659221|FG015|Overall Study|Lost to Follow-up|0|||
156703213|NCT03334617|565659222|FG016|Overall Study|Lost to Follow-up|0|||
156703214|NCT03334617|565659223|FG017|Overall Study|Lost to Follow-up|0|||
156703215|NCT03334617|565659224|FG018|Overall Study|Lost to Follow-up|0|||
156703216|NCT03334617|565659225|FG019|Overall Study|Lost to Follow-up|0|||
156703217|NCT03334617|565659226|FG020|Overall Study|Lost to Follow-up|0|||
156703218|NCT03334617|565659227|FG021|Overall Study|Lost to Follow-up|0|||
156703219|NCT03334617|565659206|FG000|Overall Study|Withdrawal by Subject|0|||
156703220|NCT03334617|565659207|FG001|Overall Study|Withdrawal by Subject|1|||
156703221|NCT03334617|565659208|FG002|Overall Study|Withdrawal by Subject|0|||
156703222|NCT03334617|565659209|FG003|Overall Study|Withdrawal by Subject|0|||
156703223|NCT03334617|565659210|FG004|Overall Study|Withdrawal by Subject|1|||
156703224|NCT03334617|565659211|FG005|Overall Study|Withdrawal by Subject|1|||
156703225|NCT03334617|565659212|FG006|Overall Study|Withdrawal by Subject|1|||
156703226|NCT03334617|565659213|FG007|Overall Study|Withdrawal by Subject|2|||
156703227|NCT03334617|565659214|FG008|Overall Study|Withdrawal by Subject|0|||
156703228|NCT03334617|565659215|FG009|Overall Study|Withdrawal by Subject|0|||
156703229|NCT03334617|565659216|FG010|Overall Study|Withdrawal by Subject|0|||
156703230|NCT03334617|565659217|FG011|Overall Study|Withdrawal by Subject|1|||
156703231|NCT03334617|565659218|FG012|Overall Study|Withdrawal by Subject|1|||
156703232|NCT03334617|565659219|FG013|Overall Study|Withdrawal by Subject|0|||
156703233|NCT03334617|565659220|FG014|Overall Study|Withdrawal by Subject|2|||
156703234|NCT03334617|565659221|FG015|Overall Study|Withdrawal by Subject|1|||
156703235|NCT03334617|565659222|FG016|Overall Study|Withdrawal by Subject|0|||
156703236|NCT03334617|565659223|FG017|Overall Study|Withdrawal by Subject|1|||
156703237|NCT03334617|565659224|FG018|Overall Study|Withdrawal by Subject|1|||
156703238|NCT03334617|565659225|FG019|Overall Study|Withdrawal by Subject|1|||
156703239|NCT03334617|565659226|FG020|Overall Study|Withdrawal by Subject|0|||
156703240|NCT03334617|565659227|FG021|Overall Study|Withdrawal by Subject|1|||
156703241|NCT03334617|565659206|FG000|Overall Study|Other|1|||
156703242|NCT03334617|565659207|FG001|Overall Study|Other|2|||
156703243|NCT03334617|565659208|FG002|Overall Study|Other|0|||
156703244|NCT03334617|565659209|FG003|Overall Study|Other|1|||
156703245|NCT03334617|565659210|FG004|Overall Study|Other|1|||
156703246|NCT03334617|565659211|FG005|Overall Study|Other|0|||
156703247|NCT03334617|565659212|FG006|Overall Study|Other|2|||
156440129|NCT04524390|564704019|FG001|Open-Label|Drug interruption criteria|0|||
156440130|NCT04524390|564704020|FG002|Open-Label|Drug interruption criteria|1|||
156440131|NCT04524390|564704018|FG000|Open-Label|Liver Transplant|0|||
156440132|NCT04524390|564704019|FG001|Open-Label|Liver Transplant|0|||
156440133|NCT04524390|564704020|FG002|Open-Label|Liver Transplant|1|||
156703248|NCT03334617|565659213|FG007|Overall Study|Other|1|||
156703249|NCT03334617|565659214|FG008|Overall Study|Other|8|||
156703250|NCT03334617|565659215|FG009|Overall Study|Other|0|||
156791052|NCT02633527|565987142|FG002|Overall Study|Adverse Event|3|||
156791053|NCT02633527|565987143|FG003|Overall Study|Adverse Event|1|||
156703251|NCT03334617|565659216|FG010|Overall Study|Other|3|||
156703252|NCT03334617|565659217|FG011|Overall Study|Other|1|||
156703253|NCT03334617|565659218|FG012|Overall Study|Other|3|||
156703254|NCT03334617|565659219|FG013|Overall Study|Other|1|||
156703255|NCT03334617|565659220|FG014|Overall Study|Other|1|||
156703256|NCT03334617|565659221|FG015|Overall Study|Other|3|||
156791054|NCT02633527|565987144|FG004|Overall Study|Adverse Event|5|||
156440134|NCT04524390|564704018|FG000|Open-Label|Disease Progression|0|||
156440135|NCT04524390|564704019|FG001|Open-Label|Disease Progression|0|||
156703257|NCT03334617|565659222|FG016|Overall Study|Other|3|||
156703258|NCT03334617|565659223|FG017|Overall Study|Other|3|||
156703259|NCT03334617|565659224|FG018|Overall Study|Other|7|||
156703260|NCT03334617|565659225|FG019|Overall Study|Other|4|||
156703261|NCT03334617|565659226|FG020|Overall Study|Other|1|||
156703262|NCT03334617|565659227|FG021|Overall Study|Other|4|||
156703263|NCT03334617|565659206|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
156703264|NCT03334617|565659207|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
156703265|NCT03334617|565659208|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
156703266|NCT03334617|565659209|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
156703267|NCT03334617|565659210|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
156703268|NCT03334617|565659211|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
156703269|NCT03334617|565659212|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
156703270|NCT03334617|565659213|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
156703271|NCT03334617|565659214|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
156703272|NCT03334617|565659215|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
156703273|NCT03334617|565659216|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
156703274|NCT03334617|565659217|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
156703275|NCT03334617|565659218|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
156703276|NCT03334617|565659219|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
156703277|NCT03334617|565659220|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
156703278|NCT03334617|565659221|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
156703279|NCT03334617|565659222|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
156703280|NCT03334617|565659223|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
156703281|NCT03334617|565659224|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
156703282|NCT03334617|565659225|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
156703283|NCT03334617|565659226|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
156703284|NCT03334617|565659227|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
156703285|NCT02329847|565659229|FG000|Overall Study|Death|4|||
156703286|NCT02329847|565659230|FG001|Overall Study|Death|4|||
156703287|NCT02329847|565659231|FG002|Overall Study|Death|22|||
156703288|NCT02329847|565659232|FG003|Overall Study|Death|12|||
156703289|NCT02329847|565659233|FG004|Overall Study|Death|20|||
156703290|NCT02329847|565659234|FG005|Overall Study|Death|13|||
156703291|NCT02329847|565659229|FG000|Overall Study|Lost to Follow-up|0|||
156703292|NCT02329847|565659230|FG001|Overall Study|Lost to Follow-up|0|||
156703293|NCT02329847|565659231|FG002|Overall Study|Lost to Follow-up|2|||
156703294|NCT02329847|565659232|FG003|Overall Study|Lost to Follow-up|3|||
156703295|NCT02329847|565659233|FG004|Overall Study|Lost to Follow-up|0|||
156703296|NCT02329847|565659234|FG005|Overall Study|Lost to Follow-up|1|||
156703297|NCT02329847|565659229|FG000|Overall Study|Physician Decision|0|||
156703298|NCT02329847|565659230|FG001|Overall Study|Physician Decision|0|||
156703299|NCT02329847|565659231|FG002|Overall Study|Physician Decision|0|||
156703300|NCT02329847|565659232|FG003|Overall Study|Physician Decision|0|||
156703301|NCT02329847|565659233|FG004|Overall Study|Physician Decision|1|||
156703302|NCT02329847|565659234|FG005|Overall Study|Physician Decision|0|||
156703303|NCT02329847|565659229|FG000|Overall Study|Withdrawal by Subject|2|||
156703304|NCT02329847|565659230|FG001|Overall Study|Withdrawal by Subject|1|||
156703305|NCT02329847|565659231|FG002|Overall Study|Withdrawal by Subject|5|||
156703306|NCT02329847|565659232|FG003|Overall Study|Withdrawal by Subject|7|||
156703307|NCT02329847|565659233|FG004|Overall Study|Withdrawal by Subject|8|||
156872132|NCT01526733|566289523|FG000|Phase 1|Protocol Violation|1|||
156872133|NCT01526733|566289524|FG001|Phase 1|Protocol Violation|0|||
156872134|NCT01526733|566289523|FG000|Phase 1|Withdrawal by Subject|1|||
156872135|NCT01526733|566289524|FG001|Phase 1|Withdrawal by Subject|1|||
156872136|NCT02839200|566289525|FG000|Overall Study|Withdrawal by Subject|2|||
156440136|NCT04524390|564704020|FG002|Open-Label|Disease Progression|1|||
156703308|NCT02329847|565659234|FG005|Overall Study|Withdrawal by Subject|3|||
156703309|NCT02329847|565659229|FG000|Overall Study|Other|1|||
156703310|NCT02329847|565659230|FG001|Overall Study|Other|2|||
156703311|NCT02329847|565659231|FG002|Overall Study|Other|6|||
156703312|NCT02329847|565659232|FG003|Overall Study|Other|13|||
156703313|NCT02329847|565659233|FG004|Overall Study|Other|10|||
156703314|NCT02329847|565659234|FG005|Overall Study|Other|3|||
156703315|NCT03657342|565659235|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
156703316|NCT03657342|565659236|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
156703317|NCT03657342|565659235|FG000|Overall Study|Withdrawal by Subject|4|||
156703318|NCT03657342|565659236|FG001|Overall Study|Withdrawal by Subject|4|||
156440137|NCT04524390|564704018|FG000|Open-Label|Adverse Event|0|||
156440138|NCT04524390|564704019|FG001|Open-Label|Adverse Event|0|||
156440139|NCT04524390|564704020|FG002|Open-Label|Adverse Event|3|||
156440140|NCT04524390|564704018|FG000|Open-Label|Study Termination by sponsor|0|||
156703319|NCT03657342|565659235|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
156703320|NCT03657342|565659236|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
156703321|NCT03657342|565659235|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
156703322|NCT03657342|565659236|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
156703323|NCT00827632|565659237|FG000|Overall Study|Lost to Follow-up|8|||
156703324|NCT00827632|565659238|FG001|Overall Study|Lost to Follow-up|12|||
156872137|NCT02839200|566289526|FG001|Overall Study|Withdrawal by Subject|0|||
156703325|NCT00827632|565659237|FG000|Overall Study|Early withdrawal|14|||
156703326|NCT00827632|565659238|FG001|Overall Study|Early withdrawal|11|||
156703327|NCT00407758|565659239|FG000|Overall Study|ineligible -improper prior treatment|1|||
156703328|NCT00750308|565659240|FG000|First Treatment|Adverse Event|0|||
156703329|NCT00750308|565659241|FG001|First Treatment|Adverse Event|1|||
156703330|NCT00750308|565659242|FG002|First Treatment|Adverse Event|0|||
156703331|NCT00750308|565659243|FG003|First Treatment|Adverse Event|0|||
156703332|NCT00750308|565659244|FG004|First Treatment|Adverse Event|0|||
156703333|NCT00750308|565659245|FG005|First Treatment|Adverse Event|0|||
156703334|NCT00750308|565659246|FG006|First Treatment|Adverse Event|0|||
156703335|NCT00750308|565659247|FG007|First Treatment|Adverse Event|0|||
156703336|NCT00750308|565659248|FG008|First Treatment|Adverse Event|0|||
156703337|NCT00750308|565659249|FG009|First Treatment|Adverse Event|0|||
156703338|NCT00750308|565659250|FG010|First Treatment|Adverse Event|1|||
156703339|NCT00750308|565659251|FG011|First Treatment|Adverse Event|1|||
156703340|NCT00750308|565659240|FG000|First Treatment|Withdrawal by Subject|0|||
156703341|NCT00750308|565659241|FG001|First Treatment|Withdrawal by Subject|0|||
156703342|NCT00750308|565659242|FG002|First Treatment|Withdrawal by Subject|0|||
156703343|NCT00750308|565659243|FG003|First Treatment|Withdrawal by Subject|1|||
156703344|NCT00750308|565659244|FG004|First Treatment|Withdrawal by Subject|0|||
156703345|NCT00750308|565659245|FG005|First Treatment|Withdrawal by Subject|0|||
156703346|NCT00750308|565659246|FG006|First Treatment|Withdrawal by Subject|0|||
156703347|NCT00750308|565659247|FG007|First Treatment|Withdrawal by Subject|1|||
156703348|NCT00750308|565659248|FG008|First Treatment|Withdrawal by Subject|0|||
156703349|NCT00750308|565659249|FG009|First Treatment|Withdrawal by Subject|0|||
156703350|NCT00750308|565659250|FG010|First Treatment|Withdrawal by Subject|0|||
156703351|NCT00750308|565659251|FG011|First Treatment|Withdrawal by Subject|0|||
156703352|NCT00750308|565659240|FG000|Second Treatment|Adverse Event|0|||
156703353|NCT00750308|565659241|FG001|Second Treatment|Adverse Event|0|||
156703354|NCT00750308|565659242|FG002|Second Treatment|Adverse Event|0|||
156703355|NCT00750308|565659243|FG003|Second Treatment|Adverse Event|0|||
156703356|NCT00750308|565659244|FG004|Second Treatment|Adverse Event|0|||
156703357|NCT00750308|565659245|FG005|Second Treatment|Adverse Event|1|||
156703358|NCT00750308|565659246|FG006|Second Treatment|Adverse Event|0|||
156703359|NCT00750308|565659247|FG007|Second Treatment|Adverse Event|0|||
156703360|NCT00750308|565659248|FG008|Second Treatment|Adverse Event|1|||
156703361|NCT00750308|565659249|FG009|Second Treatment|Adverse Event|0|||
156703362|NCT00750308|565659250|FG010|Second Treatment|Adverse Event|0|||
156703363|NCT00750308|565659251|FG011|Second Treatment|Adverse Event|0|||
156703364|NCT00750308|565659240|FG000|Second Treatment|Withdrawal by Subject|0|||
156703365|NCT00750308|565659241|FG001|Second Treatment|Withdrawal by Subject|0|||
156703366|NCT00750308|565659242|FG002|Second Treatment|Withdrawal by Subject|0|||
156703367|NCT00750308|565659243|FG003|Second Treatment|Withdrawal by Subject|0|||
156703368|NCT00750308|565659244|FG004|Second Treatment|Withdrawal by Subject|1|||
156703369|NCT00750308|565659245|FG005|Second Treatment|Withdrawal by Subject|0|||
156703370|NCT00750308|565659246|FG006|Second Treatment|Withdrawal by Subject|0|||
156703371|NCT00750308|565659247|FG007|Second Treatment|Withdrawal by Subject|0|||
156703372|NCT00750308|565659248|FG008|Second Treatment|Withdrawal by Subject|0|||
156703373|NCT00750308|565659249|FG009|Second Treatment|Withdrawal by Subject|0|||
156703374|NCT00750308|565659250|FG010|Second Treatment|Withdrawal by Subject|0|||
156703375|NCT00750308|565659251|FG011|Second Treatment|Withdrawal by Subject|0|||
156703376|NCT00750308|565659240|FG000|Third Treatment|Withdrawal by Subject|0|||
156703377|NCT00750308|565659241|FG001|Third Treatment|Withdrawal by Subject|1|||
156703378|NCT00750308|565659242|FG002|Third Treatment|Withdrawal by Subject|0|||
156703379|NCT00750308|565659243|FG003|Third Treatment|Withdrawal by Subject|0|||
156703380|NCT00750308|565659244|FG004|Third Treatment|Withdrawal by Subject|0|||
156703381|NCT00750308|565659245|FG005|Third Treatment|Withdrawal by Subject|0|||
156703382|NCT00750308|565659246|FG006|Third Treatment|Withdrawal by Subject|0|||
156703383|NCT00750308|565659247|FG007|Third Treatment|Withdrawal by Subject|0|||
156703384|NCT00750308|565659248|FG008|Third Treatment|Withdrawal by Subject|0|||
156703385|NCT00750308|565659249|FG009|Third Treatment|Withdrawal by Subject|0|||
156791055|NCT02633527|565987140|FG000|Overall Study|Lost to Follow-up|1|||
156332065|NCT01147640|564315040|FG000|Overall Study|Withdrawal by Subject|1|||
156791056|NCT02633527|565987141|FG001|Overall Study|Lost to Follow-up|2|||
156791057|NCT02633527|565987142|FG002|Overall Study|Lost to Follow-up|5|||
156703386|NCT00750308|565659250|FG010|Third Treatment|Withdrawal by Subject|0|||
156703387|NCT00750308|565659251|FG011|Third Treatment|Withdrawal by Subject|0|||
156703388|NCT01822275|565659252|FG000|Overall Study|Withdrawal by Subject|3|||
156703389|NCT01822275|565659252|FG000|Overall Study|Adverse Event|3|||
156703390|NCT01822275|565659252|FG000|Overall Study|Progression|14|||
156703391|NCT01822275|565659252|FG000|Overall Study|Physician Decision|2|||
156703392|NCT00513682|565659253|FG000|Washout Phase|Adverse Event|2|||
156703393|NCT02980874|565659254|FG000|Overall Study|Adverse Event|2|||
156791058|NCT02633527|565987143|FG003|Overall Study|Lost to Follow-up|5|||
156703394|NCT02980874|565659255|FG001|Overall Study|Adverse Event|7|||
156703395|NCT02980874|565659254|FG000|Overall Study|Withdrawal by Subject|7|||
156703396|NCT02980874|565659255|FG001|Overall Study|Withdrawal by Subject|2|||
156332066|NCT01147640|564315041|FG001|Overall Study|Withdrawal by Subject|0|||
156703397|NCT02980874|565659254|FG000|Overall Study|Lost to Follow-up|5|||
156703398|NCT02980874|565659255|FG001|Overall Study|Lost to Follow-up|5|||
156703399|NCT02980874|565659254|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
156703400|NCT02980874|565659255|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
156703401|NCT02980874|565659254|FG000|Overall Study|Unknown study completion status|1|||
156703402|NCT02980874|565659255|FG001|Overall Study|Unknown study completion status|0|||
156703403|NCT02450526|565659256|FG000|DB Period (Cycle 1)|Adverse Event|0|||
156703404|NCT02450526|565659257|FG001|DB Period (Cycle 1)|Adverse Event|0|||
156440141|NCT04524390|564704019|FG001|Open-Label|Study Termination by sponsor|0|||
156703405|NCT02450526|565659258|FG002|DB Period (Cycle 1)|Adverse Event|2|||
156703406|NCT02450526|565659259|FG003|DB Period (Cycle 1)|Adverse Event|0|||
156703407|NCT02450526|565659260|FG004|DB Period (Cycle 1)|Adverse Event|0|||
156703408|NCT02450526|565659256|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
156703409|NCT02450526|565659257|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
156440142|NCT04524390|564704020|FG002|Open-Label|Study Termination by sponsor|45|||
156440143|NCT03873779|564704021|FG000|Overall Study|Withdrawal by Subject|1|||
156440144|NCT02581215|564704022|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
156440145|NCT02581215|564704023|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
156440146|NCT02581215|564704022|FG000|Overall Study|Eligibility Criteria Not Met|0|||
156440147|NCT02581215|564704023|FG001|Overall Study|Eligibility Criteria Not Met|1|||
156440148|NCT02300298|564704030|FG000|Disposition for Nintedanib|Progressive disease|10|||
156440149|NCT02300298|564704031|FG001|Disposition for Nintedanib|Progressive disease|0|||
156440150|NCT02300298|564704030|FG000|Disposition for Docetaxel|Progressive disease|0|||
156440151|NCT02300298|564704031|FG001|Disposition for Docetaxel|Progressive disease|6|||
156440152|NCT02300298|564704030|FG000|Disposition for Docetaxel|other adverse event|0|||
156440153|NCT02300298|564704031|FG001|Disposition for Docetaxel|other adverse event|4|||
156440154|NCT03285763|564704032|FG000|Overall Study|Death|470|||
156440155|NCT03285763|564704032|FG000|Overall Study|Lost to Follow-up|18|||
156440156|NCT03285763|564704032|FG000|Overall Study|Physician Decision|2|||
156440157|NCT03285763|564704032|FG000|Overall Study|Study Terminated By Sponsor|79|||
156440158|NCT03285763|564704032|FG000|Overall Study|Withdrawal by Subject|33|||
156440159|NCT00610649|564704033|FG000|Overall Study|Adverse Event|1|||
156440160|NCT00610649|564704034|FG001|Overall Study|Adverse Event|0|||
156440161|NCT00610649|564704035|FG002|Overall Study|Adverse Event|0|||
156440162|NCT00610649|564704036|FG003|Overall Study|Adverse Event|0|||
156440163|NCT00610649|564704037|FG004|Overall Study|Adverse Event|0|||
156703410|NCT02450526|565659258|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
156703411|NCT02450526|565659259|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
156703412|NCT02450526|565659260|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
156703413|NCT02450526|565659256|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
156703414|NCT02450526|565659257|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
156703415|NCT02450526|565659258|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
156703416|NCT02450526|565659259|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
156703417|NCT02450526|565659260|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
156703418|NCT02450526|565659256|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
156703419|NCT02450526|565659257|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
156703420|NCT02450526|565659258|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
156703421|NCT02450526|565659259|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
156703422|NCT02450526|565659260|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
156703423|NCT02450526|565659256|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
156703424|NCT02450526|565659257|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
156703425|NCT02450526|565659258|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
156703426|NCT02450526|565659259|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
156703427|NCT02450526|565659260|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
156703428|NCT02450526|565659256|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
156703429|NCT02450526|565659257|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
156703430|NCT02450526|565659258|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
156703431|NCT02450526|565659259|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
156440164|NCT00610649|564704038|FG005|Overall Study|Adverse Event|0|||
156440165|NCT00610649|564704039|FG006|Overall Study|Adverse Event|0|||
156440166|NCT00610649|564704040|FG007|Overall Study|Adverse Event|0|||
156440167|NCT00610649|564704041|FG008|Overall Study|Adverse Event|0|||
156531482|NCT00833911|565041648|FG000|Titration|Adverse Event|18|||
156703432|NCT02450526|565659260|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
156703433|NCT02450526|565659256|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
156703434|NCT02450526|565659257|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
156703435|NCT02450526|565659258|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
156703436|NCT02450526|565659259|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
156703437|NCT02450526|565659260|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
156440168|NCT00610649|564704042|FG009|Overall Study|Adverse Event|0|||
156703438|NCT02450526|565659256|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
156440169|NCT00610649|564704043|FG010|Overall Study|Adverse Event|1|||
156440170|NCT00610649|564704033|FG000|Overall Study|Family Emergency|0|||
156440171|NCT00610649|564704034|FG001|Overall Study|Family Emergency|1|||
156531483|NCT00833911|565041648|FG000|Titration|Withdrawal by Subject|3|||
156531484|NCT00833911|565041648|FG000|Maintenance Phase I|Adverse Event|73|||
156531485|NCT00833911|565041648|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
156531486|NCT00833911|565041648|FG000|Maintenance Phase I|Physician Decision|10|||
156531487|NCT00833911|565041648|FG000|Maintenance Phase I|Lack of Efficacy|4|||
156531488|NCT00833911|565041648|FG000|Maintenance Phase II|Adverse Event|6|||
156531489|NCT00833911|565041648|FG000|Maintenance Phase II|Physician Decision|2|||
156531490|NCT00833911|565041648|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
156531491|NCT00833911|565041648|FG000|Maintenance Phase II|Lack of Efficacy|1|||
156531492|NCT01383161|565041649|FG000|Overall Study|Adverse Event|5|||
156531493|NCT01383161|565041650|FG001|Overall Study|Adverse Event|1|||
156531494|NCT01383161|565041649|FG000|Overall Study|Withdrawal by Subject|0|||
156531495|NCT01383161|565041650|FG001|Overall Study|Withdrawal by Subject|2|||
156531496|NCT01383161|565041649|FG000|Overall Study|Lack of Efficacy|0|||
156531497|NCT01383161|565041650|FG001|Overall Study|Lack of Efficacy|1|||
156531498|NCT01423812|565041659|FG000|Overall Study|Lost to Follow-up|2|||
156531499|NCT01423812|565041660|FG001|Overall Study|Lost to Follow-up|2|||
156531500|NCT01423812|565041659|FG000|Overall Study|Withdrawal by Subject|1|||
156531501|NCT01423812|565041660|FG001|Overall Study|Withdrawal by Subject|2|||
156531502|NCT03942406|565041661|FG000|Overall Study|Lost to Follow-up|4|||
156531503|NCT03942406|565041662|FG001|Overall Study|Lost to Follow-up|5|||
156531504|NCT03942406|565041663|FG002|Overall Study|Lost to Follow-up|3|||
156440172|NCT00610649|564704035|FG002|Overall Study|Family Emergency|0|||
156440173|NCT00610649|564704036|FG003|Overall Study|Family Emergency|0|||
156440174|NCT00610649|564704037|FG004|Overall Study|Family Emergency|0|||
156440175|NCT00610649|564704038|FG005|Overall Study|Family Emergency|0|||
156440176|NCT00610649|564704039|FG006|Overall Study|Family Emergency|0|||
156440177|NCT00610649|564704040|FG007|Overall Study|Family Emergency|0|||
156440178|NCT00610649|564704041|FG008|Overall Study|Family Emergency|0|||
156440179|NCT00610649|564704042|FG009|Overall Study|Family Emergency|0|||
156440180|NCT00610649|564704043|FG010|Overall Study|Family Emergency|0|||
156440181|NCT00610649|564704033|FG000|Overall Study|Withdrawal by Subject|0|||
156440182|NCT00610649|564704034|FG001|Overall Study|Withdrawal by Subject|0|||
156440183|NCT00610649|564704035|FG002|Overall Study|Withdrawal by Subject|0|||
156440184|NCT00610649|564704036|FG003|Overall Study|Withdrawal by Subject|0|||
156440185|NCT00610649|564704037|FG004|Overall Study|Withdrawal by Subject|0|||
156440186|NCT00610649|564704038|FG005|Overall Study|Withdrawal by Subject|0|||
156440187|NCT00610649|564704039|FG006|Overall Study|Withdrawal by Subject|0|||
156440188|NCT00610649|564704040|FG007|Overall Study|Withdrawal by Subject|0|||
156440189|NCT00610649|564704041|FG008|Overall Study|Withdrawal by Subject|0|||
156440190|NCT00610649|564704042|FG009|Overall Study|Withdrawal by Subject|1|||
156440191|NCT00610649|564704043|FG010|Overall Study|Withdrawal by Subject|0|||
156440192|NCT00858117|564704047|FG000|Treatment on Study|Adverse Event|2|||
156440193|NCT00858117|564704047|FG000|Follow up for 5 Years|Death|4|||
156440194|NCT00858117|564704047|FG000|Follow up for 5 Years|No further data collected for study|9|||
156440195|NCT00371787|564704048|FG000|Overall Study|Withdrawal by Subject|3|||
156440196|NCT00371787|564704049|FG001|Overall Study|Withdrawal by Subject|1|||
156440197|NCT02765100|564704051|FG000|Overall Study|subject found ineligible after baseline|1|||
156440198|NCT02765100|564704052|FG001|Overall Study|subject found ineligible after baseline|1|||
156440199|NCT02765100|564704051|FG000|Overall Study|Lost to Follow-up|0|||
156440200|NCT02765100|564704052|FG001|Overall Study|Lost to Follow-up|1|||
156440201|NCT00391898|564704055|FG000|Overall Study|Adverse Event|3|||
156440202|NCT00391898|564704056|FG001|Overall Study|Adverse Event|0|||
156440203|NCT00391898|564704055|FG000|Overall Study|Other|8|||
156440204|NCT00391898|564704056|FG001|Overall Study|Other|10|||
156440205|NCT02529995|564704057|FG000|Part A|Ongoing Study at Data Cut-off|14|||
156440206|NCT02529995|564704058|FG001|Part A|Ongoing Study at Data Cut-off|16|||
156440207|NCT02529995|564704057|FG000|Part A|Discontinued Study|1|||
156703439|NCT02450526|565659257|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
156703440|NCT02450526|565659258|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
156440208|NCT02529995|564704058|FG001|Part A|Discontinued Study|0|||
156440209|NCT02529995|564704057|FG000|Part B|Ongoing Study at Data Cut-off|0|||
156440210|NCT02529995|564704058|FG001|Part B|Ongoing Study at Data Cut-off|7|||
156440211|NCT02529995|564704057|FG000|Part B|Discontinued Study|6|||
156703441|NCT02450526|565659259|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
156703442|NCT02450526|565659260|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
156440212|NCT02529995|564704058|FG001|Part B|Discontinued Study|5|||
156703443|NCT02722148|565659261|FG000|Overall Study|Lost to Follow-up|2|||
156440213|NCT02988817|564704059|FG000|Overall Study|Withdrawal by Subject|1|||
156440214|NCT02988817|564704060|FG001|Overall Study|Withdrawal by Subject|0|||
156440215|NCT02988817|564704061|FG002|Overall Study|Withdrawal by Subject|0|||
156440216|NCT02988817|564704062|FG003|Overall Study|Withdrawal by Subject|1|||
156531505|NCT03942406|565041664|FG003|Overall Study|Lost to Follow-up|7|||
156440217|NCT02988817|564704063|FG004|Overall Study|Withdrawal by Subject|3|||
156440218|NCT02988817|564704064|FG005|Overall Study|Withdrawal by Subject|1|||
156531506|NCT03942406|565041665|FG004|Overall Study|Lost to Follow-up|1|||
156531507|NCT03942406|565041666|FG005|Overall Study|Lost to Follow-up|0|||
156531508|NCT03942406|565041667|FG006|Overall Study|Lost to Follow-up|0|||
156531509|NCT03942406|565041661|FG000|Overall Study|Withdrawal by Subject|3|||
156703444|NCT02722148|565659261|FG000|Overall Study|Non compliant with treatment regimen|3|||
156703445|NCT00911807|565659262|FG000|Overall Study|Adverse Event|2|||
156703446|NCT00911807|565659263|FG001|Overall Study|Adverse Event|1|||
156703447|NCT00911807|565659264|FG002|Overall Study|Adverse Event|5|||
156703448|NCT00911807|565659262|FG000|Overall Study|Death|0|||
156703449|NCT00911807|565659263|FG001|Overall Study|Death|0|||
156703450|NCT00911807|565659264|FG002|Overall Study|Death|1|||
156703451|NCT00911807|565659262|FG000|Overall Study|Protocol Violation|6|||
156703452|NCT00911807|565659263|FG001|Overall Study|Protocol Violation|4|||
156703453|NCT00911807|565659264|FG002|Overall Study|Protocol Violation|9|||
156703454|NCT00911807|565659262|FG000|Overall Study|Withdrawal by Subject|8|||
156703455|NCT00911807|565659263|FG001|Overall Study|Withdrawal by Subject|10|||
156703456|NCT00911807|565659264|FG002|Overall Study|Withdrawal by Subject|7|||
156703457|NCT00911807|565659262|FG000|Overall Study|Organizational reasons|1|||
156703458|NCT00911807|565659263|FG001|Overall Study|Organizational reasons|3|||
156703459|NCT00911807|565659264|FG002|Overall Study|Organizational reasons|1|||
156703460|NCT00855803|565659266|FG000|Overall Study|Death|2|||
156703461|NCT00855803|565659266|FG000|Overall Study|Lost to Follow-up|2|||
156703462|NCT00855803|565659266|FG000|Overall Study|Technical inability to undergo procedure|2|||
156703463|NCT00855803|565659266|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
156440219|NCT02988817|564704065|FG006|Overall Study|Withdrawal by Subject|2|||
156440220|NCT02988817|564704066|FG007|Overall Study|Withdrawal by Subject|1|||
156440221|NCT02988817|564704067|FG008|Overall Study|Withdrawal by Subject|1|||
156440222|NCT02988817|564704068|FG009|Overall Study|Withdrawal by Subject|1|||
156440223|NCT02988817|564704069|FG010|Overall Study|Withdrawal by Subject|1|||
156440224|NCT02988817|564704070|FG011|Overall Study|Withdrawal by Subject|12|||
156440225|NCT02988817|564704071|FG012|Overall Study|Withdrawal by Subject|6|||
156440226|NCT02988817|564704072|FG013|Overall Study|Withdrawal by Subject|6|||
156440227|NCT02988817|564704073|FG014|Overall Study|Withdrawal by Subject|4|||
156440228|NCT02988817|564704074|FG015|Overall Study|Withdrawal by Subject|5|||
156440229|NCT02988817|564704075|FG016|Overall Study|Withdrawal by Subject|4|||
156440230|NCT02988817|564704076|FG017|Overall Study|Withdrawal by Subject|11|||
156440231|NCT02988817|564704077|FG018|Overall Study|Withdrawal by Subject|4|||
156440232|NCT02988817|564704078|FG019|Overall Study|Withdrawal by Subject|2|||
156440233|NCT02988817|564704059|FG000|Overall Study|Death|0|||
156440234|NCT02988817|564704060|FG001|Overall Study|Death|1|||
156440235|NCT02988817|564704061|FG002|Overall Study|Death|3|||
156440236|NCT02988817|564704062|FG003|Overall Study|Death|1|||
156440237|NCT02988817|564704063|FG004|Overall Study|Death|6|||
156440238|NCT02988817|564704064|FG005|Overall Study|Death|10|||
156440239|NCT02988817|564704065|FG006|Overall Study|Death|1|||
156440240|NCT02988817|564704066|FG007|Overall Study|Death|2|||
156440241|NCT02988817|564704067|FG008|Overall Study|Death|1|||
156440242|NCT02988817|564704068|FG009|Overall Study|Death|5|||
156440243|NCT02988817|564704069|FG010|Overall Study|Death|1|||
156440244|NCT02988817|564704070|FG011|Overall Study|Death|8|||
156440245|NCT02988817|564704071|FG012|Overall Study|Death|9|||
156440246|NCT02988817|564704072|FG013|Overall Study|Death|17|||
156440247|NCT02988817|564704073|FG014|Overall Study|Death|18|||
156440248|NCT02988817|564704074|FG015|Overall Study|Death|30|||
156440249|NCT02988817|564704075|FG016|Overall Study|Death|17|||
156440250|NCT02988817|564704076|FG017|Overall Study|Death|38|||
156440251|NCT02988817|564704077|FG018|Overall Study|Death|14|||
156440252|NCT02988817|564704078|FG019|Overall Study|Death|16|||
156440253|NCT02988817|564704059|FG000|Overall Study|Other|0|||
156440254|NCT02988817|564704060|FG001|Overall Study|Other|0|||
156440255|NCT02988817|564704061|FG002|Overall Study|Other|0|||
156440256|NCT02988817|564704062|FG003|Overall Study|Other|1|||
156440257|NCT02988817|564704063|FG004|Overall Study|Other|1|||
156440258|NCT02988817|564704064|FG005|Overall Study|Other|0|||
156440259|NCT02988817|564704065|FG006|Overall Study|Other|0|||
156440260|NCT02988817|564704066|FG007|Overall Study|Other|0|||
156703464|NCT00855803|565659266|FG000|Overall Study|Withdrawal by Subject|3|||
156703465|NCT00855803|565659266|FG000|Overall Study|Physician Decision|3|||
156703466|NCT00809159|565659267|FG000|Part 1|Adverse Event|1|||
156703467|NCT00809159|565659268|FG001|Part 1|Adverse Event|1|||
156703468|NCT00809159|565659269|FG002|Part 1|Adverse Event|0|||
156440261|NCT02988817|564704067|FG008|Overall Study|Other|0|||
156440262|NCT02988817|564704068|FG009|Overall Study|Other|0|||
156440263|NCT02988817|564704069|FG010|Overall Study|Other|0|||
156440264|NCT02988817|564704070|FG011|Overall Study|Other|0|||
156440265|NCT02988817|564704071|FG012|Overall Study|Other|0|||
156440266|NCT02988817|564704072|FG013|Overall Study|Other|0|||
156440267|NCT02988817|564704073|FG014|Overall Study|Other|0|||
156703469|NCT00809159|565659270|FG003|Part 1|Adverse Event|0|||
156703470|NCT00809159|565659271|FG004|Part 1|Adverse Event|0|||
156703471|NCT00809159|565659272|FG005|Part 1|Adverse Event|0|||
156703472|NCT00809159|565659267|FG000|Part 1|Lost to Follow-up|1|||
156440268|NCT02988817|564704074|FG015|Overall Study|Other|1|||
156440269|NCT02988817|564704075|FG016|Overall Study|Other|0|||
156440270|NCT02988817|564704076|FG017|Overall Study|Other|0|||
156440271|NCT02988817|564704077|FG018|Overall Study|Other|0|||
156703473|NCT00809159|565659268|FG001|Part 1|Lost to Follow-up|0|||
156440272|NCT02988817|564704078|FG019|Overall Study|Other|0|||
156440273|NCT02988817|564704059|FG000|Overall Study|Lost to Follow-up|0|||
156440274|NCT02988817|564704060|FG001|Overall Study|Lost to Follow-up|0|||
156440275|NCT02988817|564704061|FG002|Overall Study|Lost to Follow-up|0|||
156440276|NCT02988817|564704062|FG003|Overall Study|Lost to Follow-up|0|||
156440277|NCT02988817|564704063|FG004|Overall Study|Lost to Follow-up|0|||
156440278|NCT02988817|564704064|FG005|Overall Study|Lost to Follow-up|0|||
156531510|NCT03942406|565041662|FG001|Overall Study|Withdrawal by Subject|1|||
156531511|NCT03942406|565041663|FG002|Overall Study|Withdrawal by Subject|1|||
156531512|NCT03942406|565041664|FG003|Overall Study|Withdrawal by Subject|3|||
156531513|NCT03942406|565041665|FG004|Overall Study|Withdrawal by Subject|0|||
156531514|NCT03942406|565041666|FG005|Overall Study|Withdrawal by Subject|0|||
156531515|NCT03942406|565041667|FG006|Overall Study|Withdrawal by Subject|0|||
156531516|NCT03942406|565041661|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
156531517|NCT03942406|565041662|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
156531518|NCT03942406|565041663|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
156531519|NCT03942406|565041664|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
156531520|NCT03942406|565041665|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
156531521|NCT03942406|565041666|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
156531522|NCT03942406|565041667|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
156531523|NCT01207596|565041668|FG000|Overall Study|Physician Decision|4|||
156531524|NCT01207596|565041668|FG000|Overall Study|Lack of Efficacy|1|||
156531525|NCT01207596|565041668|FG000|Overall Study|Adverse Event|3|||
156531526|NCT01207596|565041668|FG000|Overall Study|Withdrawal by Subject|1|||
156531527|NCT02596620|565041671|FG000|Overall Study|Lost to Follow-up|1|||
156531528|NCT02596620|565041672|FG001|Overall Study|Lost to Follow-up|1|||
156531529|NCT01054144|565041673|FG000|Overall Study|Death|2|||
156531530|NCT02616614|565041674|FG000|Overall Study|Withdrawal by Subject|10|||
156531531|NCT02616614|565041675|FG001|Overall Study|Withdrawal by Subject|5|||
156531532|NCT02616614|565041676|FG002|Overall Study|Withdrawal by Subject|6|||
156531533|NCT02616614|565041674|FG000|Overall Study|Physician Decision|2|||
156531534|NCT02616614|565041675|FG001|Overall Study|Physician Decision|1|||
156531535|NCT02616614|565041676|FG002|Overall Study|Physician Decision|0|||
156531536|NCT02616614|565041674|FG000|Overall Study|Adverse Event|1|||
156531537|NCT02616614|565041675|FG001|Overall Study|Adverse Event|4|||
156531538|NCT02616614|565041676|FG002|Overall Study|Adverse Event|1|||
156531539|NCT02616614|565041674|FG000|Overall Study|Protocol Violation|0|||
156531540|NCT02616614|565041675|FG001|Overall Study|Protocol Violation|3|||
156531541|NCT02616614|565041676|FG002|Overall Study|Protocol Violation|1|||
156531542|NCT02616614|565041674|FG000|Overall Study|Prohibited Medication|12|||
156531543|NCT02616614|565041675|FG001|Overall Study|Prohibited Medication|9|||
156531544|NCT02616614|565041676|FG002|Overall Study|Prohibited Medication|5|||
156531545|NCT02616614|565041674|FG000|Overall Study|More than 3 applications missed|6|||
156531546|NCT02616614|565041675|FG001|Overall Study|More than 3 applications missed|8|||
156531547|NCT02616614|565041676|FG002|Overall Study|More than 3 applications missed|1|||
156531548|NCT02616614|565041674|FG000|Overall Study|Lost to Follow-up|31|||
156531549|NCT02616614|565041675|FG001|Overall Study|Lost to Follow-up|28|||
156531550|NCT02616614|565041676|FG002|Overall Study|Lost to Follow-up|13|||
156531551|NCT02616614|565041674|FG000|Overall Study|Pregnancy|2|||
156531552|NCT02616614|565041675|FG001|Overall Study|Pregnancy|0|||
156531553|NCT02616614|565041676|FG002|Overall Study|Pregnancy|1|||
156531554|NCT02616614|565041674|FG000|Overall Study|Other|1|||
156531555|NCT02616614|565041675|FG001|Overall Study|Other|2|||
156531556|NCT02616614|565041676|FG002|Overall Study|Other|1|||
156531557|NCT02748018|565041677|FG000|Study Period|Adverse Event|1|||
156531558|NCT02748018|565041678|FG001|Study Period|Adverse Event|3|||
156531559|NCT02748018|565041679|FG002|Study Period|Adverse Event|4|||
156531560|NCT02748018|565041680|FG003|Study Period|Adverse Event|0|||
156531561|NCT02748018|565041681|FG004|Study Period|Adverse Event|3|||
156531562|NCT02748018|565041682|FG005|Study Period|Adverse Event|3|||
156531563|NCT02748018|565041677|FG000|Study Period|Withdrawal by Subject|7|||
156531564|NCT02748018|565041678|FG001|Study Period|Withdrawal by Subject|4|||
156531565|NCT02748018|565041679|FG002|Study Period|Withdrawal by Subject|4|||
156703474|NCT00809159|565659269|FG002|Part 1|Lost to Follow-up|0|||
156440279|NCT02988817|564704065|FG006|Overall Study|Lost to Follow-up|0|||
156531566|NCT02748018|565041680|FG003|Study Period|Withdrawal by Subject|11|||
156531567|NCT02748018|565041681|FG004|Study Period|Withdrawal by Subject|12|||
156531568|NCT02748018|565041682|FG005|Study Period|Withdrawal by Subject|10|||
156531569|NCT02748018|565041677|FG000|Study Period|Pregnancy|0|||
156531570|NCT02748018|565041678|FG001|Study Period|Pregnancy|1|||
156703475|NCT00809159|565659270|FG003|Part 1|Lost to Follow-up|0|||
156440280|NCT02988817|564704066|FG007|Overall Study|Lost to Follow-up|0|||
156531571|NCT02748018|565041679|FG002|Study Period|Pregnancy|0|||
156531572|NCT02748018|565041680|FG003|Study Period|Pregnancy|0|||
156531573|NCT02748018|565041681|FG004|Study Period|Pregnancy|1|||
156531574|NCT02748018|565041682|FG005|Study Period|Pregnancy|0|||
156531575|NCT02748018|565041677|FG000|Study Period|Physician Decision|2|||
156531576|NCT02748018|565041678|FG001|Study Period|Physician Decision|2|||
156703476|NCT00809159|565659271|FG004|Part 1|Lost to Follow-up|0|||
156703477|NCT00809159|565659272|FG005|Part 1|Lost to Follow-up|0|||
156703478|NCT00809159|565659267|FG000|Part 1|Withdrawal by Subject|3|||
156703479|NCT00809159|565659268|FG001|Part 1|Withdrawal by Subject|1|||
156703480|NCT00809159|565659269|FG002|Part 1|Withdrawal by Subject|0|||
156703481|NCT00809159|565659270|FG003|Part 1|Withdrawal by Subject|0|||
156703482|NCT00809159|565659271|FG004|Part 1|Withdrawal by Subject|0|||
156703483|NCT00809159|565659272|FG005|Part 1|Withdrawal by Subject|0|||
156703484|NCT00809159|565659267|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
156703485|NCT00809159|565659268|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
156703486|NCT00809159|565659269|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
156703487|NCT00809159|565659270|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
156703488|NCT00809159|565659271|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
156703489|NCT00809159|565659272|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
156703490|NCT00809159|565659267|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
156703491|NCT00809159|565659268|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
156703492|NCT00809159|565659269|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
156703493|NCT00809159|565659270|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
156703494|NCT00809159|565659271|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
156703495|NCT00809159|565659272|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
156703496|NCT00809159|565659267|FG000|Part 1 and 2|Administrative problems|0|||
156703497|NCT00809159|565659268|FG001|Part 1 and 2|Administrative problems|0|||
156703498|NCT00809159|565659269|FG002|Part 1 and 2|Administrative problems|0|||
156703499|NCT00809159|565659270|FG003|Part 1 and 2|Administrative problems|1|||
156703500|NCT00809159|565659271|FG004|Part 1 and 2|Administrative problems|0|||
156703501|NCT00809159|565659272|FG005|Part 1 and 2|Administrative problems|0|||
156703502|NCT00809159|565659267|FG000|Part 1 and 2|Adverse Event|0|||
156703503|NCT00809159|565659268|FG001|Part 1 and 2|Adverse Event|0|||
156703504|NCT00809159|565659269|FG002|Part 1 and 2|Adverse Event|1|||
156703505|NCT00809159|565659270|FG003|Part 1 and 2|Adverse Event|0|||
156703506|NCT00809159|565659271|FG004|Part 1 and 2|Adverse Event|1|||
156703507|NCT00809159|565659272|FG005|Part 1 and 2|Adverse Event|1|||
156703508|NCT00809159|565659267|FG000|Part 1 and 2|Lost to Follow-up|0|||
156703509|NCT00809159|565659268|FG001|Part 1 and 2|Lost to Follow-up|0|||
156703510|NCT00809159|565659269|FG002|Part 1 and 2|Lost to Follow-up|1|||
156703511|NCT00809159|565659270|FG003|Part 1 and 2|Lost to Follow-up|1|||
156703512|NCT00809159|565659271|FG004|Part 1 and 2|Lost to Follow-up|0|||
156703513|NCT00809159|565659272|FG005|Part 1 and 2|Lost to Follow-up|0|||
156703514|NCT00809159|565659267|FG000|Part 1 and 2|Withdrawal by Subject|0|||
156703515|NCT00809159|565659268|FG001|Part 1 and 2|Withdrawal by Subject|0|||
156703516|NCT00809159|565659269|FG002|Part 1 and 2|Withdrawal by Subject|4|||
156703517|NCT00809159|565659270|FG003|Part 1 and 2|Withdrawal by Subject|0|||
156703518|NCT00809159|565659271|FG004|Part 1 and 2|Withdrawal by Subject|0|||
156703519|NCT00809159|565659272|FG005|Part 1 and 2|Withdrawal by Subject|1|||
156703520|NCT04568031|565659275|FG000|Overall Study|Lost to Follow-up|1|||
156703521|NCT04568031|565659276|FG001|Overall Study|Lost to Follow-up|0|||
156440281|NCT02988817|564704067|FG008|Overall Study|Lost to Follow-up|1|||
156440282|NCT02988817|564704068|FG009|Overall Study|Lost to Follow-up|0|||
156440283|NCT02988817|564704069|FG010|Overall Study|Lost to Follow-up|1|||
156440284|NCT02988817|564704070|FG011|Overall Study|Lost to Follow-up|1|||
156440285|NCT02988817|564704071|FG012|Overall Study|Lost to Follow-up|0|||
156440286|NCT02988817|564704072|FG013|Overall Study|Lost to Follow-up|0|||
156440287|NCT02988817|564704073|FG014|Overall Study|Lost to Follow-up|1|||
156440288|NCT02988817|564704074|FG015|Overall Study|Lost to Follow-up|1|||
156440289|NCT02988817|564704075|FG016|Overall Study|Lost to Follow-up|2|||
156440290|NCT02988817|564704076|FG017|Overall Study|Lost to Follow-up|3|||
156440291|NCT02988817|564704077|FG018|Overall Study|Lost to Follow-up|0|||
156440292|NCT02988817|564704078|FG019|Overall Study|Lost to Follow-up|0|||
156440293|NCT02988817|564704059|FG000|Overall Study|Sponsor decision|0|||
156440294|NCT02988817|564704060|FG001|Overall Study|Sponsor decision|0|||
156440295|NCT02988817|564704061|FG002|Overall Study|Sponsor decision|0|||
156703522|NCT04568031|565659277|FG002|Overall Study|Lost to Follow-up|0|||
156703523|NCT04568031|565659278|FG003|Overall Study|Lost to Follow-up|0|||
156703524|NCT04568031|565659275|FG000|Overall Study|Physician Decision|1|||
156440296|NCT02988817|564704062|FG003|Overall Study|Sponsor decision|0|||
156703525|NCT04568031|565659276|FG001|Overall Study|Physician Decision|0|||
156703526|NCT04568031|565659277|FG002|Overall Study|Physician Decision|1|||
156703527|NCT04568031|565659278|FG003|Overall Study|Physician Decision|0|||
156703528|NCT04568031|565659275|FG000|Overall Study|Withdrawal by Subject|1|||
156703529|NCT04568031|565659276|FG001|Overall Study|Withdrawal by Subject|0|||
156703530|NCT04568031|565659277|FG002|Overall Study|Withdrawal by Subject|4|||
156703531|NCT04568031|565659278|FG003|Overall Study|Withdrawal by Subject|1|||
156440297|NCT02988817|564704063|FG004|Overall Study|Sponsor decision|0|||
156440298|NCT02988817|564704064|FG005|Overall Study|Sponsor decision|0|||
156703532|NCT02304458|565659279|FG000|Overall Study|Adverse Event|0|||
156703533|NCT02304458|565659280|FG001|Overall Study|Adverse Event|0|||
156703534|NCT02304458|565659281|FG002|Overall Study|Adverse Event|7|||
156703535|NCT02304458|565659282|FG003|Overall Study|Adverse Event|0|||
156440299|NCT02988817|564704065|FG006|Overall Study|Sponsor decision|0|||
156703536|NCT02304458|565659283|FG004|Overall Study|Adverse Event|0|||
156703537|NCT02304458|565659284|FG005|Overall Study|Adverse Event|0|||
156703538|NCT02304458|565659285|FG006|Overall Study|Adverse Event|3|||
156703539|NCT02304458|565659286|FG007|Overall Study|Adverse Event|4|||
156703540|NCT02304458|565659279|FG000|Overall Study|Death|0|||
156703541|NCT02304458|565659280|FG001|Overall Study|Death|0|||
156703542|NCT02304458|565659281|FG002|Overall Study|Death|2|||
156703543|NCT02304458|565659282|FG003|Overall Study|Death|0|||
156703544|NCT02304458|565659283|FG004|Overall Study|Death|0|||
156703545|NCT02304458|565659284|FG005|Overall Study|Death|0|||
156703546|NCT02304458|565659285|FG006|Overall Study|Death|1|||
156703547|NCT02304458|565659286|FG007|Overall Study|Death|0|||
156703548|NCT02304458|565659279|FG000|Overall Study|Lack of Efficacy|4|||
156703549|NCT02304458|565659280|FG001|Overall Study|Lack of Efficacy|6|||
156703550|NCT02304458|565659281|FG002|Overall Study|Lack of Efficacy|38|||
156703551|NCT02304458|565659282|FG003|Overall Study|Lack of Efficacy|5|||
156703552|NCT02304458|565659283|FG004|Overall Study|Lack of Efficacy|6|||
156703553|NCT02304458|565659284|FG005|Overall Study|Lack of Efficacy|6|||
156703554|NCT02304458|565659285|FG006|Overall Study|Lack of Efficacy|21|||
156703555|NCT02304458|565659286|FG007|Overall Study|Lack of Efficacy|4|||
156703556|NCT02304458|565659279|FG000|Overall Study|Physician Decision|2|||
156703557|NCT02304458|565659280|FG001|Overall Study|Physician Decision|0|||
156703558|NCT02304458|565659281|FG002|Overall Study|Physician Decision|16|||
156703559|NCT02304458|565659282|FG003|Overall Study|Physician Decision|1|||
156703560|NCT02304458|565659283|FG004|Overall Study|Physician Decision|0|||
156703561|NCT02304458|565659284|FG005|Overall Study|Physician Decision|0|||
156703562|NCT02304458|565659285|FG006|Overall Study|Physician Decision|3|||
156703563|NCT02304458|565659286|FG007|Overall Study|Physician Decision|0|||
156703564|NCT02304458|565659279|FG000|Overall Study|Protocol Violation|0|||
156703565|NCT02304458|565659280|FG001|Overall Study|Protocol Violation|0|||
156703566|NCT02304458|565659281|FG002|Overall Study|Protocol Violation|1|||
156703567|NCT02304458|565659282|FG003|Overall Study|Protocol Violation|0|||
156703568|NCT02304458|565659283|FG004|Overall Study|Protocol Violation|0|||
156703569|NCT02304458|565659284|FG005|Overall Study|Protocol Violation|0|||
156703570|NCT02304458|565659285|FG006|Overall Study|Protocol Violation|0|||
156703571|NCT02304458|565659286|FG007|Overall Study|Protocol Violation|0|||
156703572|NCT02304458|565659279|FG000|Overall Study|Withdrawal by Subject|1|||
156703573|NCT02304458|565659280|FG001|Overall Study|Withdrawal by Subject|0|||
156703574|NCT02304458|565659281|FG002|Overall Study|Withdrawal by Subject|7|||
156703575|NCT02304458|565659282|FG003|Overall Study|Withdrawal by Subject|0|||
156703576|NCT02304458|565659283|FG004|Overall Study|Withdrawal by Subject|0|||
156703577|NCT02304458|565659284|FG005|Overall Study|Withdrawal by Subject|0|||
156703578|NCT02304458|565659285|FG006|Overall Study|Withdrawal by Subject|1|||
156703579|NCT02304458|565659286|FG007|Overall Study|Withdrawal by Subject|0|||
156703580|NCT00186043|565659287|FG000|Overall Study|Lack of Efficacy|1|||
156703581|NCT00186043|565659288|FG001|Overall Study|Lack of Efficacy|3|||
156703582|NCT00186043|565659287|FG000|Overall Study|Lost to Follow-up|4|||
156703583|NCT00186043|565659288|FG001|Overall Study|Lost to Follow-up|6|||
156703584|NCT00186043|565659287|FG000|Overall Study|Withdrawal by Subject|1|||
156703585|NCT00186043|565659288|FG001|Overall Study|Withdrawal by Subject|0|||
156703586|NCT00186043|565659287|FG000|Overall Study|Adverse Event|7|||
156703587|NCT00186043|565659288|FG001|Overall Study|Adverse Event|3|||
156703588|NCT00186043|565659287|FG000|Overall Study|Protocol Violation|2|||
156703589|NCT00186043|565659288|FG001|Overall Study|Protocol Violation|1|||
156703590|NCT04188301|565659291|FG000|Month 3|Lost to Follow-up|0|||
156703591|NCT04188301|565659292|FG001|Month 3|Lost to Follow-up|0|||
156703592|NCT04188301|565659293|FG002|Month 3|Lost to Follow-up|1|||
156703593|NCT04188301|565659291|FG000|Month 12|Lost to Follow-up|0|||
156703594|NCT04188301|565659292|FG001|Month 12|Lost to Follow-up|0|||
156703595|NCT04188301|565659293|FG002|Month 12|Lost to Follow-up|2|||
156703596|NCT04188301|565659291|FG000|Month 12|Death|1|||
156703597|NCT04188301|565659292|FG001|Month 12|Death|1|||
156703598|NCT04188301|565659293|FG002|Month 12|Death|0|||
156703599|NCT04188301|565659291|FG000|Month 18|Lost to Follow-up|6|||
156703600|NCT04188301|565659292|FG001|Month 18|Lost to Follow-up|0|||
156703601|NCT04188301|565659293|FG002|Month 18|Lost to Follow-up|0|||
156703602|NCT00228423|565659294|FG000|Overall Study|Adverse Event|2|||
156703603|NCT00228423|565659295|FG001|Overall Study|Adverse Event|5|||
156703604|NCT00228423|565659294|FG000|Overall Study|Withdrawal by Subject|7|||
156703605|NCT00228423|565659295|FG001|Overall Study|Withdrawal by Subject|3|||
156703606|NCT00228423|565659294|FG000|Overall Study|Protocol Violation|1|||
156703607|NCT00228423|565659295|FG001|Overall Study|Protocol Violation|3|||
156703608|NCT00228423|565659294|FG000|Overall Study|Physician Decision|0|||
156703609|NCT00228423|565659295|FG001|Overall Study|Physician Decision|1|||
156703610|NCT03258853|565659302|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
156703611|NCT03258853|565659303|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
156703612|NCT01709838|565659304|FG000|Overall Study|Withdrawal by Subject|21|||
156703613|NCT01709838|565659304|FG000|Overall Study|Lost to Follow-up|16|||
156703614|NCT01709838|565659304|FG000|Overall Study|Pregnancy|10|||
156703615|NCT01709838|565659304|FG000|Overall Study|Subject/guardian decision|8|||
156703616|NCT01709838|565659304|FG000|Overall Study|Adverse Event|4|||
156703617|NCT01709838|565659304|FG000|Overall Study|Physician Decision|4|||
156703618|NCT01709838|565659304|FG000|Overall Study|Death|3|||
156703619|NCT01709838|565659304|FG000|Overall Study|Protocol Violation|1|||
156703620|NCT04241315|565661191|FG000|Overall Study|Withdrawal by Subject|0|||
156703621|NCT04241315|565661192|FG001|Overall Study|Withdrawal by Subject|1|||
156703622|NCT01555671|565661193|FG000|Overall Study|Physician Decision|20|||
156703623|NCT01555671|565661194|FG001|Overall Study|Physician Decision|25|||
156703624|NCT03047330|565661195|FG000|Sleep Block 1|Withdrawal by Subject|3|||
156703625|NCT00663026|565661202|FG000|Overall Study|Lost to Follow-up|1|||
156703626|NCT00663026|565661203|FG001|Overall Study|Lost to Follow-up|0|||
156703627|NCT00663026|565661204|FG002|Overall Study|Lost to Follow-up|0|||
156703628|NCT00663026|565661202|FG000|Overall Study|Other|1|||
156703629|NCT00663026|565661203|FG001|Overall Study|Other|2|||
156703630|NCT00663026|565661204|FG002|Overall Study|Other|0|||
156703631|NCT00663026|565661202|FG000|Overall Study|Adverse Event|0|||
156703632|NCT00663026|565661203|FG001|Overall Study|Adverse Event|2|||
156703633|NCT00663026|565661204|FG002|Overall Study|Adverse Event|3|||
156703634|NCT00663026|565661202|FG000|Overall Study|Caregiver Request|0|||
156703635|NCT00663026|565661203|FG001|Overall Study|Caregiver Request|2|||
156703636|NCT00663026|565661204|FG002|Overall Study|Caregiver Request|0|||
156703637|NCT00663026|565661202|FG000|Overall Study|Withdrawal by Subject|0|||
156703638|NCT00663026|565661203|FG001|Overall Study|Withdrawal by Subject|0|||
156703639|NCT00663026|565661204|FG002|Overall Study|Withdrawal by Subject|1|||
156703640|NCT04003896|565661205|FG000|Overall Study|Withdrawal by Subject|3|||
156703641|NCT04003896|565661205|FG000|Overall Study|Physician Decision|1|||
156703642|NCT03929757|565661206|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
156703643|NCT03929757|565661207|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
156703644|NCT03929757|565661208|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
156703645|NCT03929757|565661206|FG000|Main Study: Up to Day 365|Other|1|||
156703646|NCT03929757|565661207|FG001|Main Study: Up to Day 365|Other|0|||
156703647|NCT03929757|565661208|FG002|Main Study: Up to Day 365|Other|0|||
156703648|NCT03929757|565661206|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
156703649|NCT03929757|565661207|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
156703650|NCT03929757|565661208|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
156703651|NCT01154816|565661209|FG000|Overall Study|Withdrawal by Subject|1|||
156703652|NCT01154816|565661210|FG001|Overall Study|Withdrawal by Subject|0|||
156703653|NCT01154816|565661211|FG002|Overall Study|Withdrawal by Subject|0|||
156703654|NCT01154816|565661212|FG003|Overall Study|Withdrawal by Subject|1|||
156703655|NCT01154816|565661213|FG004|Overall Study|Withdrawal by Subject|0|||
156703656|NCT01154816|565661214|FG005|Overall Study|Withdrawal by Subject|0|||
156703657|NCT01154816|565661215|FG006|Overall Study|Withdrawal by Subject|0|||
156703658|NCT01154816|565661216|FG007|Overall Study|Withdrawal by Subject|0|||
156703659|NCT01154816|565661217|FG008|Overall Study|Withdrawal by Subject|1|||
156703660|NCT01154816|565661218|FG009|Overall Study|Withdrawal by Subject|3|||
156703661|NCT01154816|565661219|FG010|Overall Study|Withdrawal by Subject|0|||
156703662|NCT01154816|565661220|FG011|Overall Study|Withdrawal by Subject|0|||
156703663|NCT01154816|565661209|FG000|Overall Study|Progressive Disease|13|||
156703664|NCT01154816|565661210|FG001|Overall Study|Progressive Disease|8|||
156703665|NCT01154816|565661211|FG002|Overall Study|Progressive Disease|9|||
156703666|NCT01154816|565661212|FG003|Overall Study|Progressive Disease|9|||
156703667|NCT01154816|565661213|FG004|Overall Study|Progressive Disease|8|||
156703668|NCT01154816|565661214|FG005|Overall Study|Progressive Disease|8|||
156703669|NCT01154816|565661215|FG006|Overall Study|Progressive Disease|5|||
156703670|NCT01154816|565661216|FG007|Overall Study|Progressive Disease|6|||
156703671|NCT01154816|565661217|FG008|Overall Study|Progressive Disease|8|||
156703672|NCT01154816|565661218|FG009|Overall Study|Progressive Disease|6|||
156703673|NCT01154816|565661219|FG010|Overall Study|Progressive Disease|10|||
156703674|NCT01154816|565661220|FG011|Overall Study|Progressive Disease|3|||
156703675|NCT01154816|565661209|FG000|Overall Study|Physician Decision|1|||
156703676|NCT01154816|565661210|FG001|Overall Study|Physician Decision|0|||
156703677|NCT01154816|565661211|FG002|Overall Study|Physician Decision|1|||
156332067|NCT01147640|564315040|FG000|Overall Study|Lost to Follow-up|0|||
156332068|NCT01147640|564315041|FG001|Overall Study|Lost to Follow-up|1|||
156703678|NCT01154816|565661212|FG003|Overall Study|Physician Decision|0|||
156703679|NCT01154816|565661213|FG004|Overall Study|Physician Decision|2|||
156703680|NCT01154816|565661214|FG005|Overall Study|Physician Decision|0|||
156703681|NCT01154816|565661215|FG006|Overall Study|Physician Decision|0|||
156703682|NCT01154816|565661216|FG007|Overall Study|Physician Decision|0|||
156703683|NCT01154816|565661217|FG008|Overall Study|Physician Decision|0|||
156703684|NCT01154816|565661218|FG009|Overall Study|Physician Decision|1|||
156703685|NCT01154816|565661219|FG010|Overall Study|Physician Decision|1|||
156703686|NCT01154816|565661220|FG011|Overall Study|Physician Decision|1|||
156703687|NCT01154816|565661209|FG000|Overall Study|Adverse Event|5|||
156703688|NCT01154816|565661210|FG001|Overall Study|Adverse Event|2|||
156703689|NCT01154816|565661211|FG002|Overall Study|Adverse Event|0|||
156703690|NCT01154816|565661212|FG003|Overall Study|Adverse Event|0|||
156703691|NCT01154816|565661213|FG004|Overall Study|Adverse Event|0|||
156703692|NCT01154816|565661214|FG005|Overall Study|Adverse Event|0|||
156703693|NCT01154816|565661215|FG006|Overall Study|Adverse Event|1|||
156703694|NCT01154816|565661216|FG007|Overall Study|Adverse Event|1|||
156703695|NCT01154816|565661217|FG008|Overall Study|Adverse Event|0|||
156703696|NCT01154816|565661218|FG009|Overall Study|Adverse Event|0|||
156703697|NCT01154816|565661219|FG010|Overall Study|Adverse Event|0|||
156703698|NCT01154816|565661220|FG011|Overall Study|Adverse Event|0|||
156703699|NCT00806286|565661221|FG000|Overall Study|Adverse Event|5|||
156703700|NCT00806286|565661222|FG001|Overall Study|Adverse Event|2|||
156703701|NCT00806286|565661223|FG002|Overall Study|Adverse Event|0|||
156703702|NCT00806286|565661221|FG000|Overall Study|Disease progression|31|||
156703703|NCT00806286|565661222|FG001|Overall Study|Disease progression|38|||
156703704|NCT00806286|565661223|FG002|Overall Study|Disease progression|1|||
156703705|NCT00806286|565661221|FG000|Overall Study|Death|1|||
156703706|NCT00806286|565661222|FG001|Overall Study|Death|6|||
156703707|NCT00806286|565661223|FG002|Overall Study|Death|0|||
156703708|NCT00806286|565661221|FG000|Overall Study|Lost to Follow-up|0|||
156703709|NCT00806286|565661222|FG001|Overall Study|Lost to Follow-up|1|||
156703710|NCT00806286|565661223|FG002|Overall Study|Lost to Follow-up|0|||
156703711|NCT00806286|565661221|FG000|Overall Study|Withdrawal by Subject|8|||
156703712|NCT00806286|565661222|FG001|Overall Study|Withdrawal by Subject|3|||
156703713|NCT00806286|565661223|FG002|Overall Study|Withdrawal by Subject|1|||
156703714|NCT00806286|565661221|FG000|Overall Study|Physician Decision|2|||
156703715|NCT00806286|565661222|FG001|Overall Study|Physician Decision|2|||
156703716|NCT00806286|565661223|FG002|Overall Study|Physician Decision|0|||
156703717|NCT00806286|565661221|FG000|Overall Study|Due to a variety of reasons|7|||
156703718|NCT00806286|565661222|FG001|Overall Study|Due to a variety of reasons|2|||
156703719|NCT00806286|565661223|FG002|Overall Study|Due to a variety of reasons|1|||
156703720|NCT00686075|565661224|FG000|Overall Study|Withdrawal by Subject|4|||
156703721|NCT00686075|565661225|FG001|Overall Study|Withdrawal by Subject|3|||
156703722|NCT00686075|565661226|FG002|Overall Study|Withdrawal by Subject|3|||
156791059|NCT02633527|565987144|FG004|Overall Study|Lost to Follow-up|4|||
156791060|NCT02633527|565987140|FG000|Overall Study|Withdrawal by Subject|0|||
156791061|NCT02633527|565987141|FG001|Overall Study|Withdrawal by Subject|3|||
156440300|NCT02988817|564704066|FG007|Overall Study|Sponsor decision|0|||
156440301|NCT02988817|564704067|FG008|Overall Study|Sponsor decision|0|||
156440302|NCT02988817|564704068|FG009|Overall Study|Sponsor decision|0|||
156440303|NCT02988817|564704069|FG010|Overall Study|Sponsor decision|0|||
156440304|NCT02988817|564704070|FG011|Overall Study|Sponsor decision|1|||
156440305|NCT02988817|564704071|FG012|Overall Study|Sponsor decision|1|||
156440306|NCT02988817|564704072|FG013|Overall Study|Sponsor decision|2|||
156440307|NCT02988817|564704073|FG014|Overall Study|Sponsor decision|2|||
156440308|NCT02988817|564704074|FG015|Overall Study|Sponsor decision|6|||
156440309|NCT02988817|564704075|FG016|Overall Study|Sponsor decision|2|||
156440310|NCT02988817|564704076|FG017|Overall Study|Sponsor decision|3|||
156440311|NCT02988817|564704077|FG018|Overall Study|Sponsor decision|2|||
156440312|NCT02988817|564704078|FG019|Overall Study|Sponsor decision|7|||
156440313|NCT02988817|564704059|FG000|Overall Study|Physician Decision|0|||
156440314|NCT02988817|564704060|FG001|Overall Study|Physician Decision|0|||
156440315|NCT02988817|564704061|FG002|Overall Study|Physician Decision|0|||
156440316|NCT02988817|564704062|FG003|Overall Study|Physician Decision|0|||
156440317|NCT02988817|564704063|FG004|Overall Study|Physician Decision|0|||
156791062|NCT02633527|565987142|FG002|Overall Study|Withdrawal by Subject|5|||
156791063|NCT02633527|565987143|FG003|Overall Study|Withdrawal by Subject|4|||
156791064|NCT02633527|565987144|FG004|Overall Study|Withdrawal by Subject|4|||
156791065|NCT02633527|565987140|FG000|Overall Study|Protocol Violation|0|||
156791066|NCT02633527|565987141|FG001|Overall Study|Protocol Violation|1|||
156791067|NCT02633527|565987142|FG002|Overall Study|Protocol Violation|1|||
156791068|NCT02633527|565987143|FG003|Overall Study|Protocol Violation|1|||
156791069|NCT02633527|565987144|FG004|Overall Study|Protocol Violation|1|||
156791070|NCT02633527|565987140|FG000|Overall Study|Physician Decision|0|||
156791071|NCT02633527|565987141|FG001|Overall Study|Physician Decision|0|||
156791072|NCT02633527|565987142|FG002|Overall Study|Physician Decision|0|||
156791073|NCT02633527|565987143|FG003|Overall Study|Physician Decision|0|||
156791074|NCT02633527|565987144|FG004|Overall Study|Physician Decision|1|||
156440318|NCT02988817|564704064|FG005|Overall Study|Physician Decision|0|||
156703723|NCT00686075|565661227|FG003|Overall Study|Withdrawal by Subject|7|||
156703724|NCT00686075|565661228|FG004|Overall Study|Withdrawal by Subject|1|||
156703725|NCT00686075|565661229|FG005|Overall Study|Withdrawal by Subject|0|||
156703726|NCT00686075|565661230|FG006|Overall Study|Withdrawal by Subject|0|||
156703727|NCT00686075|565661231|FG007|Overall Study|Withdrawal by Subject|2|||
156440319|NCT02988817|564704065|FG006|Overall Study|Physician Decision|0|||
156440320|NCT02988817|564704066|FG007|Overall Study|Physician Decision|0|||
156703728|NCT00686075|565661232|FG008|Overall Study|Withdrawal by Subject|4|||
156703729|NCT00686075|565661233|FG009|Overall Study|Withdrawal by Subject|6|||
156703730|NCT00686075|565661224|FG000|Overall Study|Lost to Follow-up|3|||
156703731|NCT00686075|565661225|FG001|Overall Study|Lost to Follow-up|6|||
156703732|NCT00686075|565661226|FG002|Overall Study|Lost to Follow-up|3|||
156791075|NCT02633527|565987140|FG000|Overall Study|Administrative reason|1|||
156791076|NCT02633527|565987141|FG001|Overall Study|Administrative reason|0|||
156791077|NCT02633527|565987142|FG002|Overall Study|Administrative reason|0|||
156872138|NCT02839200|566289527|FG002|Overall Study|Withdrawal by Subject|1|||
156872139|NCT02839200|566289528|FG003|Overall Study|Withdrawal by Subject|0|||
156872140|NCT02839200|566289529|FG004|Overall Study|Withdrawal by Subject|0|||
156872141|NCT02839200|566289530|FG005|Overall Study|Withdrawal by Subject|1|||
156872142|NCT02839200|566289525|FG000|Overall Study|Lost to Follow-up|2|||
156872143|NCT02839200|566289526|FG001|Overall Study|Lost to Follow-up|0|||
156872144|NCT02839200|566289527|FG002|Overall Study|Lost to Follow-up|0|||
156872145|NCT02839200|566289528|FG003|Overall Study|Lost to Follow-up|0|||
156872146|NCT02839200|566289529|FG004|Overall Study|Lost to Follow-up|1|||
156872147|NCT02839200|566289530|FG005|Overall Study|Lost to Follow-up|0|||
156872148|NCT02839200|566289525|FG000|Overall Study|Adverse Event|0|||
156703733|NCT00686075|565661227|FG003|Overall Study|Lost to Follow-up|2|||
156703734|NCT00686075|565661228|FG004|Overall Study|Lost to Follow-up|3|||
156703735|NCT00686075|565661229|FG005|Overall Study|Lost to Follow-up|3|||
156703736|NCT00686075|565661230|FG006|Overall Study|Lost to Follow-up|0|||
156703737|NCT00686075|565661231|FG007|Overall Study|Lost to Follow-up|0|||
156703738|NCT00686075|565661232|FG008|Overall Study|Lost to Follow-up|2|||
156703739|NCT00686075|565661233|FG009|Overall Study|Lost to Follow-up|3|||
156703740|NCT00686075|565661224|FG000|Overall Study|Other|1|||
156703741|NCT00686075|565661225|FG001|Overall Study|Other|1|||
156703742|NCT00686075|565661226|FG002|Overall Study|Other|0|||
156703743|NCT00686075|565661227|FG003|Overall Study|Other|0|||
156703744|NCT00686075|565661228|FG004|Overall Study|Other|0|||
156703745|NCT00686075|565661229|FG005|Overall Study|Other|0|||
156703746|NCT00686075|565661230|FG006|Overall Study|Other|0|||
156703747|NCT00686075|565661231|FG007|Overall Study|Other|0|||
156703748|NCT00686075|565661232|FG008|Overall Study|Other|0|||
156703749|NCT00686075|565661233|FG009|Overall Study|Other|1|||
156703750|NCT03783039|565661234|FG000|Overall Study|Death|2|||
156703751|NCT03783039|565661235|FG001|Overall Study|Death|1|||
156703752|NCT01682863|565661236|FG000|Overall Study|Subject/guardian decision|19|||
156703753|NCT01682863|565661237|FG001|Overall Study|Subject/guardian decision|12|||
156703754|NCT01682863|565661238|FG002|Overall Study|Subject/guardian decision|10|||
156703755|NCT01682863|565661236|FG000|Overall Study|Lost to Follow-up|5|||
156703756|NCT01682863|565661237|FG001|Overall Study|Lost to Follow-up|1|||
156703757|NCT01682863|565661238|FG002|Overall Study|Lost to Follow-up|6|||
156703758|NCT01682863|565661236|FG000|Overall Study|Death|1|||
156703759|NCT01682863|565661237|FG001|Overall Study|Death|3|||
156703760|NCT01682863|565661238|FG002|Overall Study|Death|4|||
156703761|NCT01682863|565661236|FG000|Overall Study|Protocol deviation|1|||
156703762|NCT01682863|565661237|FG001|Overall Study|Protocol deviation|0|||
156703763|NCT01682863|565661238|FG002|Overall Study|Protocol deviation|1|||
156703764|NCT01682863|565661236|FG000|Overall Study|Technical problems|1|||
156703765|NCT01682863|565661237|FG001|Overall Study|Technical problems|0|||
156703766|NCT01682863|565661238|FG002|Overall Study|Technical problems|0|||
156703767|NCT01682863|565661236|FG000|Overall Study|Adverse Event|0|||
156703768|NCT01682863|565661237|FG001|Overall Study|Adverse Event|1|||
156703769|NCT01682863|565661238|FG002|Overall Study|Adverse Event|2|||
156703770|NCT01682863|565661236|FG000|Overall Study|Physician Decision|0|||
156703771|NCT01682863|565661237|FG001|Overall Study|Physician Decision|0|||
156703772|NCT01682863|565661238|FG002|Overall Study|Physician Decision|1|||
156703773|NCT00977379|565661239|FG000|Overall Study|Withdrawal by Subject|1|||
156703774|NCT00977379|565661240|FG001|Overall Study|Withdrawal by Subject|1|||
156703775|NCT00977379|565661239|FG000|Overall Study|Death|7|||
156703776|NCT00977379|565661240|FG001|Overall Study|Death|9|||
156703777|NCT00977379|565661239|FG000|Overall Study|Premature Study Termination|4|||
156703778|NCT00977379|565661240|FG001|Overall Study|Premature Study Termination|0|||
156703779|NCT00977379|565661239|FG000|Overall Study|Participant Moving House|0|||
156872149|NCT02839200|566289526|FG001|Overall Study|Adverse Event|0|||
156703780|NCT00977379|565661240|FG001|Overall Study|Participant Moving House|1|||
156703781|NCT00977379|565661239|FG000|Overall Study|Randomization Error|0|||
156703782|NCT00977379|565661240|FG001|Overall Study|Randomization Error|1|||
156703783|NCT00918138|565661241|FG000|Overall Study|Subject withdrew consent|1|||
156703784|NCT00918138|565661242|FG001|Overall Study|Subject withdrew consent|1|||
156703785|NCT00918138|565661241|FG000|Overall Study|Death|1|||
156703786|NCT00918138|565661242|FG001|Overall Study|Death|0|||
156703787|NCT03972163|565661243|FG000|Overall Study|Death|0|||
156703788|NCT03972163|565661244|FG001|Overall Study|Death|1|||
156872150|NCT02839200|566289527|FG002|Overall Study|Adverse Event|0|||
156872151|NCT02839200|566289528|FG003|Overall Study|Adverse Event|0|||
156872152|NCT02839200|566289529|FG004|Overall Study|Adverse Event|1|||
156703789|NCT01199471|565661245|FG000|Overall Study|Protocol Violation|4|||
156703790|NCT01199471|565661245|FG000|Overall Study|Withdrawal by Subject|1|||
156703791|NCT01199471|565661245|FG000|Overall Study|Physician Decision|1|||
156703792|NCT02006693|565661246|FG000|Overall Study|No Reason Specified|6|||
156703793|NCT02006693|565661247|FG001|Overall Study|No Reason Specified|8|||
156703794|NCT02006693|565661246|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
156703795|NCT02006693|565661247|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
156703796|NCT02006693|565661246|FG000|Overall Study|XEN Implant Explantation|0|||
156703797|NCT02006693|565661247|FG001|Overall Study|XEN Implant Explantation|1|||
156872153|NCT02839200|566289530|FG005|Overall Study|Adverse Event|0|||
156703798|NCT02006693|565661246|FG000|Overall Study|Death|2|||
156703799|NCT02006693|565661247|FG001|Overall Study|Death|2|||
156703800|NCT02006693|565661246|FG000|Overall Study|Lost to Follow-up|4|||
156703801|NCT02006693|565661247|FG001|Overall Study|Lost to Follow-up|1|||
156703802|NCT02006693|565661246|FG000|Overall Study|Patient Decision|4|||
156703803|NCT02006693|565661247|FG001|Overall Study|Patient Decision|0|||
156703804|NCT03151408|565661248|FG000|Overall Study|Adverse Event|24|||
156703805|NCT03151408|565661249|FG001|Overall Study|Adverse Event|23|||
156703806|NCT03151408|565661248|FG000|Overall Study|Death|46|||
156703807|NCT03151408|565661249|FG001|Overall Study|Death|26|||
156703808|NCT03151408|565661248|FG000|Overall Study|Physician Decision|13|||
156703809|NCT03151408|565661249|FG001|Overall Study|Physician Decision|19|||
156703810|NCT03151408|565661248|FG000|Overall Study|Withdrawal by Subject|16|||
156703811|NCT03151408|565661249|FG001|Overall Study|Withdrawal by Subject|20|||
156703812|NCT03151408|565661248|FG000|Overall Study|Progressive disease|45|||
156703813|NCT03151408|565661249|FG001|Overall Study|Progressive disease|61|||
156703814|NCT03151408|565661248|FG000|Overall Study|non-compliance by patient|1|||
156703815|NCT03151408|565661249|FG001|Overall Study|non-compliance by patient|0|||
156703816|NCT03151408|565661248|FG000|Overall Study|other reasons|56|||
156703817|NCT03151408|565661249|FG001|Overall Study|other reasons|52|||
156703818|NCT03151408|565661248|FG000|Overall Study|randomized and not treated|2|||
156703819|NCT03151408|565661249|FG001|Overall Study|randomized and not treated|2|||
156703820|NCT01475097|565661250|FG000|Overall Study|Protocol Violation|1|||
156703821|NCT01475097|565661251|FG001|Overall Study|Protocol Violation|1|||
156703822|NCT00927394|565661252|FG000|Overall Study|Adverse Event|14|||
156703823|NCT00927394|565661253|FG001|Overall Study|Adverse Event|9|||
156703824|NCT00927394|565661252|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
156703825|NCT00927394|565661253|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
156703826|NCT00927394|565661252|FG000|Overall Study|Withdrawal by Subject|20|||
156703827|NCT00927394|565661253|FG001|Overall Study|Withdrawal by Subject|24|||
156703828|NCT00927394|565661252|FG000|Overall Study|Lost to Follow-up|8|||
156703829|NCT00927394|565661253|FG001|Overall Study|Lost to Follow-up|14|||
156703830|NCT00927394|565661252|FG000|Overall Study|Administrative Problem|1|||
156703831|NCT00927394|565661253|FG001|Overall Study|Administrative Problem|0|||
156703832|NCT00927394|565661252|FG000|Overall Study|Death|1|||
156703833|NCT00927394|565661253|FG001|Overall Study|Death|1|||
156703834|NCT00927394|565661252|FG000|Overall Study|Protocol deviation|16|||
156703835|NCT00927394|565661253|FG001|Overall Study|Protocol deviation|13|||
156703836|NCT00927394|565661252|FG000|Overall Study|Randomized in error|0|||
156703837|NCT00927394|565661253|FG001|Overall Study|Randomized in error|1|||
156703838|NCT04524364|565661255|FG000|Overall Study|Physician Decision|3|||
156703839|NCT04524364|565661256|FG001|Overall Study|Physician Decision|6|||
156703840|NCT04524364|565661255|FG000|Overall Study|Adverse Event|0|||
156703841|NCT04524364|565661256|FG001|Overall Study|Adverse Event|1|||
156703842|NCT04524364|565661255|FG000|Overall Study|Investigational device deficiency|0|||
156703843|NCT04524364|565661256|FG001|Overall Study|Investigational device deficiency|1|||
156703844|NCT04524364|565661255|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
156703845|NCT04524364|565661256|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
156703846|NCT04524364|565661255|FG000|Overall Study|Device unavailability|0|||
156703847|NCT04524364|565661256|FG001|Overall Study|Device unavailability|2|||
156703848|NCT04524364|565661255|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
156872154|NCT02839200|566289525|FG000|Overall Study|Randomized in error|0|||
156872155|NCT02839200|566289526|FG001|Overall Study|Randomized in error|1|||
156332069|NCT01147640|564315040|FG000|Overall Study|Didn't meet eligibility criteria|1|||
156332070|NCT01147640|564315041|FG001|Overall Study|Didn't meet eligibility criteria|0|||
156332071|NCT01604408|564315042|FG000|Treatment Period 1|Protocol Violation|0|||
156332072|NCT01604408|564315043|FG001|Treatment Period 1|Protocol Violation|1|||
156332073|NCT01604408|564315042|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156703849|NCT04524364|565661256|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
156703850|NCT04524364|565661255|FG000|Overall Study|Low International normalized ratio (INR)|1|||
156703851|NCT04524364|565661256|FG001|Overall Study|Low International normalized ratio (INR)|0|||
156703852|NCT02309138|565661257|FG000|Overall Study|Withdrawal by Subject|44|||
156703853|NCT02309138|565661258|FG001|Overall Study|Withdrawal by Subject|15|||
156703854|NCT02309138|565661257|FG000|Overall Study|Protocol Violation|4|||
156703855|NCT02309138|565661258|FG001|Overall Study|Protocol Violation|2|||
156703856|NCT02309138|565661257|FG000|Overall Study|delivered before visit 2|0|||
156703857|NCT02309138|565661258|FG001|Overall Study|delivered before visit 2|1|||
156703858|NCT01338870|565661261|FG000|Overall Study|Lost to Follow-up|0|||
156703859|NCT01338870|565661262|FG001|Overall Study|Lost to Follow-up|0|||
156703860|NCT01338870|565661263|FG002|Overall Study|Lost to Follow-up|1|||
156703861|NCT01338870|565661264|FG003|Overall Study|Lost to Follow-up|0|||
156872156|NCT02839200|566289527|FG002|Overall Study|Randomized in error|0|||
156332074|NCT01604408|564315043|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156703862|NCT01338870|565661265|FG004|Overall Study|Lost to Follow-up|1|||
156703863|NCT01338870|565661266|FG005|Overall Study|Lost to Follow-up|0|||
156703864|NCT01338870|565661261|FG000|Overall Study|Withdrawal by Subject|2|||
156872157|NCT02839200|566289528|FG003|Overall Study|Randomized in error|0|||
156703865|NCT01338870|565661262|FG001|Overall Study|Withdrawal by Subject|3|||
156703866|NCT01338870|565661263|FG002|Overall Study|Withdrawal by Subject|4|||
156703867|NCT01338870|565661264|FG003|Overall Study|Withdrawal by Subject|0|||
156703868|NCT01338870|565661265|FG004|Overall Study|Withdrawal by Subject|0|||
156703869|NCT01338870|565661266|FG005|Overall Study|Withdrawal by Subject|2|||
156703870|NCT01338870|565661261|FG000|Overall Study|Other|3|||
156703871|NCT01338870|565661262|FG001|Overall Study|Other|3|||
156703872|NCT01338870|565661263|FG002|Overall Study|Other|3|||
156703873|NCT01338870|565661264|FG003|Overall Study|Other|2|||
156703874|NCT01338870|565661265|FG004|Overall Study|Other|0|||
156703875|NCT01338870|565661266|FG005|Overall Study|Other|2|||
156703876|NCT01338870|565661261|FG000|Overall Study|Protocol Violation|0|||
156703877|NCT01338870|565661262|FG001|Overall Study|Protocol Violation|2|||
156703878|NCT01338870|565661263|FG002|Overall Study|Protocol Violation|2|||
156703879|NCT01338870|565661264|FG003|Overall Study|Protocol Violation|2|||
156703880|NCT01338870|565661265|FG004|Overall Study|Protocol Violation|1|||
156703881|NCT01338870|565661266|FG005|Overall Study|Protocol Violation|1|||
156703882|NCT01338870|565661261|FG000|Overall Study|Adverse Event|4|||
156703883|NCT01338870|565661262|FG001|Overall Study|Adverse Event|4|||
156703884|NCT01338870|565661263|FG002|Overall Study|Adverse Event|1|||
156703885|NCT01338870|565661264|FG003|Overall Study|Adverse Event|5|||
156703886|NCT01338870|565661265|FG004|Overall Study|Adverse Event|4|||
156440321|NCT02988817|564704067|FG008|Overall Study|Physician Decision|0|||
156440322|NCT02988817|564704068|FG009|Overall Study|Physician Decision|0|||
156440323|NCT02988817|564704069|FG010|Overall Study|Physician Decision|0|||
156440324|NCT02988817|564704070|FG011|Overall Study|Physician Decision|0|||
156440325|NCT02988817|564704071|FG012|Overall Study|Physician Decision|0|||
156440326|NCT02988817|564704072|FG013|Overall Study|Physician Decision|0|||
156440327|NCT02988817|564704073|FG014|Overall Study|Physician Decision|0|||
156440328|NCT02988817|564704074|FG015|Overall Study|Physician Decision|1|||
156440329|NCT02988817|564704075|FG016|Overall Study|Physician Decision|0|||
156440330|NCT02988817|564704076|FG017|Overall Study|Physician Decision|0|||
156440331|NCT02988817|564704077|FG018|Overall Study|Physician Decision|1|||
156440332|NCT02988817|564704078|FG019|Overall Study|Physician Decision|1|||
156440333|NCT02379819|564704087|FG000|Overall Study|Withdrawal by Subject|10|||
156440334|NCT02379819|564704087|FG000|Overall Study|Death|2|||
156440335|NCT02379819|564704087|FG000|Overall Study|Lack of Efficacy|1|||
156440336|NCT02379819|564704087|FG000|Overall Study|Lost to Follow-up|1|||
156440337|NCT01839331|564704088|FG000|Overall Study|Early Termination|3|||
156440338|NCT01839331|564704089|FG001|Overall Study|Early Termination|0|||
156440339|NCT01839331|564704090|FG002|Overall Study|Early Termination|1|||
156440340|NCT01839331|564704091|FG003|Overall Study|Early Termination|2|||
156440341|NCT01839331|564704088|FG000|Overall Study|Protocol Violation|1|||
156440342|NCT01839331|564704089|FG001|Overall Study|Protocol Violation|6|||
156440343|NCT01839331|564704090|FG002|Overall Study|Protocol Violation|4|||
156440344|NCT01839331|564704091|FG003|Overall Study|Protocol Violation|3|||
156440345|NCT03074331|564704096|FG000|Overall Study|Enrolled but Not Treated|1|||
156440346|NCT03074331|564704096|FG000|Overall Study|Lost to Follow-up|5|||
156440347|NCT03074331|564704096|FG000|Overall Study|Withdrew Consent|1|||
156440348|NCT00960141|564704098|FG000|Overall Study|Adverse Event|4|||
156440349|NCT00960141|564704099|FG001|Overall Study|Adverse Event|8|||
156440350|NCT00960141|564704100|FG002|Overall Study|Adverse Event|2|||
156440351|NCT00960141|564704098|FG000|Overall Study|Lack of Efficacy|3|||
156440352|NCT00960141|564704099|FG001|Overall Study|Lack of Efficacy|4|||
156440353|NCT00960141|564704100|FG002|Overall Study|Lack of Efficacy|2|||
156440354|NCT00960141|564704098|FG000|Overall Study|Lost to Follow-up|1|||
156440355|NCT00960141|564704099|FG001|Overall Study|Lost to Follow-up|0|||
156440356|NCT00960141|564704100|FG002|Overall Study|Lost to Follow-up|0|||
156440357|NCT00960141|564704098|FG000|Overall Study|Protocol Violation|1|||
156440358|NCT00960141|564704099|FG001|Overall Study|Protocol Violation|3|||
156440359|NCT00960141|564704100|FG002|Overall Study|Protocol Violation|2|||
156440360|NCT00960141|564704098|FG000|Overall Study|Withdrawal by Subject|1|||
156703887|NCT01338870|565661266|FG005|Overall Study|Adverse Event|1|||
156703888|NCT04546724|565661279|FG000|Overall Study|Withdrawal by Subject|145|||
156703889|NCT04546724|565661280|FG001|Overall Study|Withdrawal by Subject|41|||
156703890|NCT04546724|565661279|FG000|Overall Study|Adverse Event|1|||
156703891|NCT04546724|565661280|FG001|Overall Study|Adverse Event|1|||
156703892|NCT04546724|565661279|FG000|Overall Study|Lost to Follow-up|186|||
156703893|NCT04546724|565661280|FG001|Overall Study|Lost to Follow-up|63|||
156703894|NCT04546724|565661279|FG000|Overall Study|Physician Decision|8|||
156440361|NCT00960141|564704099|FG001|Overall Study|Withdrawal by Subject|2|||
156703895|NCT04546724|565661280|FG001|Overall Study|Physician Decision|2|||
156703896|NCT04546724|565661279|FG000|Overall Study|Death|2|||
156703897|NCT04546724|565661280|FG001|Overall Study|Death|1|||
156703898|NCT04546724|565661279|FG000|Overall Study|subject has been out of town|1|||
156703899|NCT04546724|565661280|FG001|Overall Study|subject has been out of town|0|||
156703900|NCT04546724|565661279|FG000|Overall Study|subject is incarcerated|2|||
156703901|NCT04546724|565661280|FG001|Overall Study|subject is incarcerated|0|||
156440362|NCT00960141|564704100|FG002|Overall Study|Withdrawal by Subject|1|||
156703902|NCT04546724|565661279|FG000|Overall Study|subject is relocating|12|||
156440363|NCT03036813|564704101|FG000|Overall Study|Adverse Event|6|||
156440364|NCT03036813|564704102|FG001|Overall Study|Adverse Event|11|||
156440365|NCT03036813|564704103|FG002|Overall Study|Adverse Event|6|||
156440366|NCT03036813|564704101|FG000|Overall Study|Withdrawal by Subject|12|||
156440367|NCT03036813|564704102|FG001|Overall Study|Withdrawal by Subject|6|||
156440368|NCT03036813|564704103|FG002|Overall Study|Withdrawal by Subject|10|||
156440369|NCT03036813|564704101|FG000|Overall Study|Lost to Follow-up|1|||
156440370|NCT03036813|564704102|FG001|Overall Study|Lost to Follow-up|1|||
156440371|NCT03036813|564704103|FG002|Overall Study|Lost to Follow-up|0|||
156440372|NCT03036813|564704101|FG000|Overall Study|Physician Decision|2|||
156440373|NCT03036813|564704102|FG001|Overall Study|Physician Decision|1|||
156440374|NCT03036813|564704103|FG002|Overall Study|Physician Decision|1|||
156440375|NCT03036813|564704101|FG000|Overall Study|Non-Compliance|1|||
156531577|NCT02748018|565041679|FG002|Study Period|Physician Decision|1|||
156531578|NCT02748018|565041680|FG003|Study Period|Physician Decision|0|||
156531579|NCT02748018|565041681|FG004|Study Period|Physician Decision|2|||
156531580|NCT02748018|565041682|FG005|Study Period|Physician Decision|0|||
156531581|NCT02748018|565041677|FG000|Study Period|Lost to Follow-up|0|||
156531582|NCT02748018|565041678|FG001|Study Period|Lost to Follow-up|0|||
156531583|NCT02748018|565041679|FG002|Study Period|Lost to Follow-up|0|||
156531584|NCT02748018|565041680|FG003|Study Period|Lost to Follow-up|2|||
156531585|NCT02748018|565041681|FG004|Study Period|Lost to Follow-up|0|||
156531586|NCT02748018|565041682|FG005|Study Period|Lost to Follow-up|1|||
156531587|NCT02748018|565041677|FG000|Continuation Period|Adverse Event|2|||
156531588|NCT02748018|565041678|FG001|Continuation Period|Adverse Event|0|||
156531589|NCT02748018|565041679|FG002|Continuation Period|Adverse Event|1|||
156531590|NCT02748018|565041680|FG003|Continuation Period|Adverse Event|1|||
156531591|NCT02748018|565041681|FG004|Continuation Period|Adverse Event|1|||
156531592|NCT02748018|565041682|FG005|Continuation Period|Adverse Event|4|||
156531593|NCT02748018|565041677|FG000|Continuation Period|Withdrawal by Subject|3|||
156531594|NCT02748018|565041678|FG001|Continuation Period|Withdrawal by Subject|5|||
156531595|NCT02748018|565041679|FG002|Continuation Period|Withdrawal by Subject|3|||
156531596|NCT02748018|565041680|FG003|Continuation Period|Withdrawal by Subject|9|||
156531597|NCT02748018|565041681|FG004|Continuation Period|Withdrawal by Subject|11|||
156531598|NCT02748018|565041682|FG005|Continuation Period|Withdrawal by Subject|1|||
156531599|NCT02748018|565041677|FG000|Continuation Period|Lost to Follow-up|0|||
156531600|NCT02748018|565041678|FG001|Continuation Period|Lost to Follow-up|2|||
156531601|NCT02748018|565041679|FG002|Continuation Period|Lost to Follow-up|1|||
156531602|NCT02748018|565041680|FG003|Continuation Period|Lost to Follow-up|0|||
156531603|NCT02748018|565041681|FG004|Continuation Period|Lost to Follow-up|1|||
156531604|NCT02748018|565041682|FG005|Continuation Period|Lost to Follow-up|0|||
156531605|NCT02748018|565041677|FG000|Continuation Period|Pregnancy|1|||
156531606|NCT02748018|565041678|FG001|Continuation Period|Pregnancy|2|||
156531607|NCT02748018|565041679|FG002|Continuation Period|Pregnancy|0|||
156531608|NCT02748018|565041680|FG003|Continuation Period|Pregnancy|0|||
156531609|NCT02748018|565041681|FG004|Continuation Period|Pregnancy|0|||
156531610|NCT02748018|565041682|FG005|Continuation Period|Pregnancy|0|||
156531611|NCT02748018|565041677|FG000|Continuation Period|Physician Decision|0|||
156703903|NCT04546724|565661280|FG001|Overall Study|subject is relocating|4|||
156703904|NCT04546724|565661279|FG000|Overall Study|Subject in another study|1|||
156703905|NCT04546724|565661280|FG001|Overall Study|Subject in another study|1|||
156703906|NCT03583086|565661281|FG000|Overall Study|Death|2|||
156703907|NCT03583086|565661282|FG001|Overall Study|Death|6|||
156703908|NCT03583086|565661283|FG002|Overall Study|Death|12|||
156703909|NCT03583086|565661284|FG003|Overall Study|Death|10|||
156703910|NCT03583086|565661285|FG004|Overall Study|Death|14|||
156703911|NCT03583086|565661286|FG005|Overall Study|Death|14|||
156703912|NCT03583086|565661287|FG006|Overall Study|Death|4|||
156703913|NCT03583086|565661281|FG000|Overall Study|Withdrawal by Subject|0|||
156703914|NCT03583086|565661282|FG001|Overall Study|Withdrawal by Subject|0|||
156703915|NCT03583086|565661283|FG002|Overall Study|Withdrawal by Subject|1|||
156703916|NCT03583086|565661284|FG003|Overall Study|Withdrawal by Subject|0|||
156703917|NCT03583086|565661285|FG004|Overall Study|Withdrawal by Subject|0|||
156703918|NCT03583086|565661286|FG005|Overall Study|Withdrawal by Subject|0|||
156703919|NCT03583086|565661287|FG006|Overall Study|Withdrawal by Subject|1|||
156703920|NCT03583086|565661281|FG000|Overall Study|Refused follow-up|0|||
156703921|NCT03583086|565661282|FG001|Overall Study|Refused follow-up|0|||
156703922|NCT03583086|565661283|FG002|Overall Study|Refused follow-up|1|||
156703923|NCT03583086|565661284|FG003|Overall Study|Refused follow-up|0|||
156703924|NCT03583086|565661285|FG004|Overall Study|Refused follow-up|1|||
156703925|NCT03583086|565661286|FG005|Overall Study|Refused follow-up|0|||
156703926|NCT03583086|565661287|FG006|Overall Study|Refused follow-up|0|||
156703927|NCT03583086|565661281|FG000|Overall Study|Declining Performance Status|0|||
156703928|NCT03583086|565661282|FG001|Overall Study|Declining Performance Status|0|||
156703929|NCT03583086|565661283|FG002|Overall Study|Declining Performance Status|1|||
156440376|NCT03036813|564704102|FG001|Overall Study|Non-Compliance|5|||
156440377|NCT03036813|564704103|FG002|Overall Study|Non-Compliance|3|||
156531612|NCT02748018|565041678|FG001|Continuation Period|Physician Decision|1|||
156531613|NCT02748018|565041679|FG002|Continuation Period|Physician Decision|2|||
156703930|NCT03583086|565661284|FG003|Overall Study|Declining Performance Status|0|||
156703931|NCT03583086|565661285|FG004|Overall Study|Declining Performance Status|0|||
156703932|NCT03583086|565661286|FG005|Overall Study|Declining Performance Status|0|||
156703933|NCT03583086|565661287|FG006|Overall Study|Declining Performance Status|0|||
156703934|NCT03583086|565661281|FG000|Overall Study|Still on study|0|||
156703935|NCT03583086|565661282|FG001|Overall Study|Still on study|0|||
156703936|NCT03583086|565661283|FG002|Overall Study|Still on study|0|||
156703937|NCT03583086|565661284|FG003|Overall Study|Still on study|1|||
156703938|NCT03583086|565661285|FG004|Overall Study|Still on study|0|||
156703939|NCT03583086|565661286|FG005|Overall Study|Still on study|0|||
156703940|NCT03583086|565661287|FG006|Overall Study|Still on study|1|||
156703941|NCT03583086|565661281|FG000|Overall Study|Disease progression|0|||
156703942|NCT03583086|565661282|FG001|Overall Study|Disease progression|0|||
156703943|NCT03583086|565661283|FG002|Overall Study|Disease progression|0|||
156703944|NCT03583086|565661284|FG003|Overall Study|Disease progression|0|||
156703945|NCT03583086|565661285|FG004|Overall Study|Disease progression|0|||
156703946|NCT03583086|565661286|FG005|Overall Study|Disease progression|0|||
156703947|NCT03583086|565661287|FG006|Overall Study|Disease progression|1|||
156703948|NCT03583086|565661281|FG000|Overall Study|Undergoing radiation therapy|0|||
156703949|NCT03583086|565661282|FG001|Overall Study|Undergoing radiation therapy|0|||
156703950|NCT03583086|565661283|FG002|Overall Study|Undergoing radiation therapy|0|||
156703951|NCT03583086|565661284|FG003|Overall Study|Undergoing radiation therapy|0|||
156703952|NCT03583086|565661285|FG004|Overall Study|Undergoing radiation therapy|0|||
156703953|NCT03583086|565661286|FG005|Overall Study|Undergoing radiation therapy|0|||
156703954|NCT03583086|565661287|FG006|Overall Study|Undergoing radiation therapy|1|||
156703955|NCT03583086|565661281|FG000|Overall Study|Lost to Follow-up|0|||
156703956|NCT03583086|565661282|FG001|Overall Study|Lost to Follow-up|0|||
156703957|NCT03583086|565661283|FG002|Overall Study|Lost to Follow-up|0|||
156703958|NCT03583086|565661284|FG003|Overall Study|Lost to Follow-up|0|||
156703959|NCT03583086|565661285|FG004|Overall Study|Lost to Follow-up|0|||
156703960|NCT03583086|565661286|FG005|Overall Study|Lost to Follow-up|1|||
156703961|NCT03583086|565661287|FG006|Overall Study|Lost to Follow-up|0|||
156703962|NCT03583086|565661281|FG000|Overall Study|Adverse Event|0|||
156703963|NCT03583086|565661282|FG001|Overall Study|Adverse Event|0|||
156703964|NCT03583086|565661283|FG002|Overall Study|Adverse Event|0|||
156703965|NCT03583086|565661284|FG003|Overall Study|Adverse Event|0|||
156703966|NCT03583086|565661285|FG004|Overall Study|Adverse Event|0|||
156703967|NCT03583086|565661286|FG005|Overall Study|Adverse Event|1|||
156703968|NCT03583086|565661287|FG006|Overall Study|Adverse Event|0|||
156703969|NCT00396812|565661289|FG000|Overall Study|Physician Decision|1|||
156703970|NCT03201445|565661293|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
156703971|NCT03201445|565661294|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
156703972|NCT03201445|565661293|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
156703973|NCT03201445|565661294|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
156703974|NCT03201445|565661293|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
156703975|NCT03201445|565661294|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
156703976|NCT03201445|565661293|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
156703977|NCT03201445|565661294|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
156703978|NCT03201445|565661293|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
156703979|NCT03201445|565661294|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
156703980|NCT03201445|565661293|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
156703981|NCT03201445|565661294|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
156703982|NCT03201445|565661293|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
156703983|NCT03201445|565661294|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
156703984|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
156703985|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
156703986|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
156703987|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
156703988|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
156703989|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
156703990|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
156703991|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
156703992|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
156703993|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
156703994|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
156703995|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
156703996|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
156703997|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
156440378|NCT03036813|564704101|FG000|Overall Study|Pregnancy|0|||
156703998|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
156703999|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
156440379|NCT03036813|564704102|FG001|Overall Study|Pregnancy|0|||
156440380|NCT03036813|564704103|FG002|Overall Study|Pregnancy|1|||
156440381|NCT03036813|564704101|FG000|Overall Study|Other|0|||
156440382|NCT03036813|564704102|FG001|Overall Study|Other|3|||
156440383|NCT03036813|564704103|FG002|Overall Study|Other|5|||
156440384|NCT01102231|564704104|FG000|Overall Study|Protocol Violation|3|||
156440385|NCT01102231|564704104|FG000|Overall Study|Lack of Efficacy|2|||
156440386|NCT01102231|564704104|FG000|Overall Study|Death|2|||
156440387|NCT01102231|564704104|FG000|Overall Study|Adverse Event|3|||
156440388|NCT01102231|564704104|FG000|Overall Study|Withdrawal by Subject|1|||
156440389|NCT01102231|564704104|FG000|Overall Study|Did not received the treatment|4|||
156440390|NCT00546754|564704105|FG000|Overall Study|Serious Adverse Event|1|||
156440391|NCT00546754|564704106|FG001|Overall Study|Serious Adverse Event|1|||
156440392|NCT00546754|564704105|FG000|Overall Study|Adverse Event|11|||
156440393|NCT00546754|564704106|FG001|Overall Study|Adverse Event|16|||
156440394|NCT00546754|564704105|FG000|Overall Study|Lack of Efficacy|1|||
156440395|NCT00546754|564704106|FG001|Overall Study|Lack of Efficacy|1|||
156440396|NCT00546754|564704105|FG000|Overall Study|Lost to Follow-up|9|||
156440397|NCT00546754|564704106|FG001|Overall Study|Lost to Follow-up|15|||
156440398|NCT00546754|564704105|FG000|Overall Study|Protocol Violation|3|||
156440399|NCT00546754|564704106|FG001|Overall Study|Protocol Violation|0|||
156440400|NCT00546754|564704105|FG000|Overall Study|Withdrawal by Subject|6|||
156440401|NCT00546754|564704106|FG001|Overall Study|Withdrawal by Subject|7|||
156440402|NCT00546754|564704105|FG000|Overall Study|Dyspnea|1|||
156440403|NCT00546754|564704106|FG001|Overall Study|Dyspnea|0|||
156440404|NCT00546754|564704105|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
156440405|NCT00546754|564704106|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
156440406|NCT00546754|564704105|FG000|Overall Study|Hip Replacement|1|||
156440407|NCT00546754|564704106|FG001|Overall Study|Hip Replacement|0|||
156440408|NCT00546754|564704105|FG000|Overall Study|Suicide|1|||
156440409|NCT00546754|564704106|FG001|Overall Study|Suicide|0|||
156440410|NCT00546754|564704105|FG000|Overall Study|Missing Cooperation|1|||
156440411|NCT00546754|564704106|FG001|Overall Study|Missing Cooperation|0|||
156531614|NCT02748018|565041680|FG003|Continuation Period|Physician Decision|0|||
156531615|NCT02748018|565041681|FG004|Continuation Period|Physician Decision|2|||
156531616|NCT02748018|565041682|FG005|Continuation Period|Physician Decision|1|||
156531617|NCT02748018|565041677|FG000|Continuation Period|Protocol Violation|0|||
156531618|NCT02748018|565041678|FG001|Continuation Period|Protocol Violation|1|||
156531619|NCT02748018|565041679|FG002|Continuation Period|Protocol Violation|0|||
156531620|NCT02748018|565041680|FG003|Continuation Period|Protocol Violation|0|||
156531621|NCT02748018|565041681|FG004|Continuation Period|Protocol Violation|0|||
156531622|NCT02748018|565041682|FG005|Continuation Period|Protocol Violation|0|||
156531623|NCT02310672|565041686|FG000|Overall Study|Death|1|||
156531624|NCT02310672|565041686|FG000|Overall Study|Lost to Follow-up|1|||
156531625|NCT02310672|565041686|FG000|Overall Study|Withdrawal by Subject|1|||
156531626|NCT02310672|565041686|FG000|Overall Study|Sponsor's decision|12|||
156531627|NCT04704336|565041690|FG000|Overall Study|Death|2|||
156531628|NCT04704336|565041691|FG001|Overall Study|Death|2|||
156531629|NCT04704336|565041690|FG000|Overall Study|Lost to Follow-up|33|||
156531630|NCT04704336|565041691|FG001|Overall Study|Lost to Follow-up|40|||
156531631|NCT03118674|565041692|FG000|Overall Study|Lost to Follow-up|2|||
156531632|NCT03118674|565041692|FG000|Overall Study|Screen Faliure|8|||
156531633|NCT03118674|565041692|FG000|Overall Study|Withdrawal by Subject|5|||
156531634|NCT00867113|565041693|FG000|Treatment Period|Adverse Event|15|||
156531635|NCT00867113|565041693|FG000|Treatment Period|Death|2|||
156531636|NCT00867113|565041693|FG000|Treatment Period|Withdrawal by Subject|19|||
156531637|NCT00867113|565041693|FG000|Treatment Period|Lost to Follow-up|3|||
156531638|NCT00867113|565041693|FG000|Treatment Period|Administrative problems|1|||
156531639|NCT00867113|565041693|FG000|Treatment Period|Disease progression/relapse|1|||
156531640|NCT00867113|565041693|FG000|Treatment Period|Protocol Violation|4|||
156531641|NCT00867113|565041693|FG000|Post Treatment After Survival Follow-up|Death|1|||
156531642|NCT00867113|565041693|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
156531643|NCT00867113|565041693|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
156531644|NCT00867113|565041693|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
156531645|NCT02178553|565041695|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
156531646|NCT02178553|565041696|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
156531647|NCT02178553|565041695|FG000|Overall Study|Physician Decision|0|||
156531648|NCT02178553|565041696|FG001|Overall Study|Physician Decision|4|||
156531649|NCT02178553|565041695|FG000|Overall Study|Technical problem with injection|1|||
156531650|NCT02178553|565041696|FG001|Overall Study|Technical problem with injection|3|||
156531651|NCT01641809|565041698|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
156704000|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
156440412|NCT00546754|564704105|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
156440413|NCT00546754|564704106|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
156440414|NCT00546754|564704105|FG000|Overall Study|Patient's Decision|0|||
156440415|NCT00546754|564704106|FG001|Overall Study|Patient's Decision|1|||
156440416|NCT00546754|564704105|FG000|Overall Study|Missing|14|||
156440417|NCT00546754|564704106|FG001|Overall Study|Missing|7|||
156440418|NCT05274217|564704109|FG000|Overall Study|Study terminated.|11|||
156704001|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
156704002|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
156704003|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
156704004|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
156704005|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
156704006|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
156704007|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
156704008|NCT03201445|565661293|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
156704009|NCT03201445|565661294|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
156704010|NCT03201445|565661293|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
156704011|NCT03201445|565661294|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
156704012|NCT01228019|565661295|FG000|Overall Study|Dose Violation|70|||
156704013|NCT01228019|565661295|FG000|Overall Study|Duplicate enrollment|1|||
156704014|NCT01228019|565661295|FG000|Overall Study|Missing pre-treatment data|72|||
156704015|NCT01228019|565661295|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
156704016|NCT01228019|565661295|FG000|Overall Study|Violation of Entry Criterion|9|||
156704017|NCT01346293|565661298|FG000|Overall Study|Protocol Violation|30|||
156704018|NCT01346293|565661299|FG001|Overall Study|Protocol Violation|9|||
156704019|NCT01346293|565661298|FG000|Overall Study|Lost to Follow-up|21|||
156704020|NCT01346293|565661299|FG001|Overall Study|Lost to Follow-up|8|||
156704021|NCT01346293|565661298|FG000|Overall Study|Withdrawal by Subject|15|||
156704022|NCT01346293|565661299|FG001|Overall Study|Withdrawal by Subject|4|||
156704023|NCT01346293|565661298|FG000|Overall Study|Other|1|||
156704024|NCT01346293|565661299|FG001|Overall Study|Other|0|||
156704025|NCT01844505|565661302|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
156704026|NCT01844505|565661303|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
156704027|NCT01844505|565661304|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
156704028|NCT01844505|565661302|FG000|Treatment Period|Other Reasons|120|||
156704029|NCT01844505|565661303|FG001|Treatment Period|Other Reasons|136|||
156704030|NCT01844505|565661304|FG002|Treatment Period|Other Reasons|58|||
156704031|NCT01844505|565661302|FG000|Treatment Period|Lost to Follow-up|9|||
156704032|NCT01844505|565661303|FG001|Treatment Period|Lost to Follow-up|11|||
156704033|NCT01844505|565661304|FG002|Treatment Period|Lost to Follow-up|6|||
156704034|NCT01844505|565661302|FG000|Treatment Period|Death|175|||
156704035|NCT01844505|565661303|FG001|Treatment Period|Death|154|||
156704036|NCT01844505|565661304|FG002|Treatment Period|Death|228|||
156704037|NCT02730351|565661305|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
156704038|NCT02730351|565661306|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
156704039|NCT02730351|565661305|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
156704040|NCT02730351|565661306|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
156704041|NCT02730351|565661305|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
156704042|NCT02730351|565661306|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
156704043|NCT02730351|565661305|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
156704044|NCT02730351|565661306|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
156704045|NCT02730351|565661305|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
156704046|NCT02730351|565661306|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
156704047|NCT00128830|565661307|FG000|Overall Study|Adverse Event|10|||
156704048|NCT00128830|565661307|FG000|Overall Study|Withdrawal by Subject|14|||
156704049|NCT00128830|565661307|FG000|Overall Study|Lost to Follow-up|4|||
156704050|NCT00128830|565661307|FG000|Overall Study|Reached a virologic endpoint|29|||
156704051|NCT00128830|565661307|FG000|Overall Study|Non-compliant|4|||
156704052|NCT00128830|565661307|FG000|Overall Study|Discontinued or ineligible for study|2|||
156704053|NCT00128830|565661307|FG000|Overall Study|Other|9|||
156704054|NCT00311402|565661308|FG000|Overall Study|Adverse Event|118|||
156704055|NCT00311402|565661309|FG001|Overall Study|Adverse Event|105|||
156704056|NCT00311402|565661308|FG000|Overall Study|Lost to Follow-up|0|||
156704057|NCT00311402|565661309|FG001|Overall Study|Lost to Follow-up|3|||
156704058|NCT00311402|565661308|FG000|Overall Study|Withdrawal by Subject|17|||
156704059|NCT00311402|565661309|FG001|Overall Study|Withdrawal by Subject|18|||
156704060|NCT00311402|565661308|FG000|Overall Study|Lack of Efficacy|58|||
156704061|NCT00311402|565661309|FG001|Overall Study|Lack of Efficacy|42|||
156704062|NCT00311402|565661308|FG000|Overall Study|Protocol Violation|7|||
156704063|NCT00311402|565661309|FG001|Overall Study|Protocol Violation|6|||
156704064|NCT00311402|565661308|FG000|Overall Study|IRB's rejection etc.|10|||
156704065|NCT00311402|565661309|FG001|Overall Study|IRB's rejection etc.|3|||
156704066|NCT02640053|565661310|FG000|Overall Study|Withdrawal by Subject|2|||
156704067|NCT02640053|565661311|FG001|Overall Study|Withdrawal by Subject|1|||
156704068|NCT02640053|565661310|FG000|Overall Study|Adverse Event|1|||
156704069|NCT02640053|565661311|FG001|Overall Study|Adverse Event|1|||
156704070|NCT02640053|565661310|FG000|Overall Study|Alternative Therapy|1|||
156704071|NCT02640053|565661311|FG001|Overall Study|Alternative Therapy|1|||
156704072|NCT02640053|565661310|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
156704073|NCT02640053|565661311|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
156704074|NCT01268501|565661312|FG000|Overall Study|Lost to Follow-up|1|||
156704075|NCT01268501|565661312|FG000|Overall Study|Withdrawal by Subject|3|||
156704076|NCT01268501|565661312|FG000|Overall Study|Unacceptable Subjective Vision|3|||
156704077|NCT01268501|565661312|FG000|Overall Study|Handling Difficulties|2|||
156704078|NCT02774642|565661313|FG000|Overall Study|Lost to Follow-up|9|||
156704079|NCT02774642|565661314|FG001|Overall Study|Lost to Follow-up|7|||
156704080|NCT00426361|565661316|FG000|Overall Study|Lost to Follow-up|3|||
156704081|NCT00426361|565661317|FG001|Overall Study|Lost to Follow-up|2|||
156704082|NCT00426361|565661318|FG002|Overall Study|Lost to Follow-up|5|||
156704083|NCT00426361|565661316|FG000|Overall Study|Withdrawal by Subject|1|||
156704084|NCT00426361|565661317|FG001|Overall Study|Withdrawal by Subject|3|||
156704085|NCT00426361|565661318|FG002|Overall Study|Withdrawal by Subject|0|||
156704086|NCT02828241|565661321|FG000|Overall Study|Adverse Event|7|||
156704087|NCT02828241|565661322|FG001|Overall Study|Adverse Event|2|||
156704088|NCT02828241|565661321|FG000|Overall Study|Protocol Violation|1|||
156704089|NCT02828241|565661322|FG001|Overall Study|Protocol Violation|0|||
156704090|NCT06281171|565661337|FG000|Timepoint 2|Lost to Follow-up|6|||
156704091|NCT06281171|565661338|FG001|Timepoint 2|Lost to Follow-up|4|||
156704092|NCT06281171|565661337|FG000|Timepoint 3|Lost to Follow-up|0|||
156704093|NCT06281171|565661338|FG001|Timepoint 3|Lost to Follow-up|5|||
156704094|NCT04669691|565661351|FG000|Overall Study|Death|0|||
156704095|NCT04669691|565661352|FG001|Overall Study|Death|1|||
156704096|NCT04669691|565661353|FG002|Overall Study|Death|0|||
156704097|NCT04669691|565661354|FG003|Overall Study|Death|0|||
156704098|NCT04669691|565661355|FG004|Overall Study|Death|0|||
156704099|NCT04669691|565661356|FG005|Overall Study|Death|0|||
156704100|NCT00073021|565661359|FG000|Overall Study|Protocol Violation|2|||
156704101|NCT00073021|565661360|FG001|Overall Study|Protocol Violation|1|||
156704102|NCT00073021|565661359|FG000|Overall Study|Adverse Event|4|||
156704103|NCT00073021|565661360|FG001|Overall Study|Adverse Event|4|||
156704104|NCT00073021|565661359|FG000|Overall Study|Withdrawal by Subject|6|||
156704105|NCT00073021|565661360|FG001|Overall Study|Withdrawal by Subject|5|||
156704106|NCT00073021|565661359|FG000|Overall Study|Physician Decision|3|||
156704107|NCT00073021|565661360|FG001|Overall Study|Physician Decision|1|||
156704108|NCT00073021|565661359|FG000|Overall Study|Lack of Efficacy|11|||
156704109|NCT00073021|565661360|FG001|Overall Study|Lack of Efficacy|5|||
156704110|NCT03918109|565661366|FG000|Overall Study|Withdrawal by Subject|0|||
156704111|NCT03918109|565661367|FG001|Overall Study|Withdrawal by Subject|0|||
156704112|NCT03918109|565661368|FG002|Overall Study|Withdrawal by Subject|2|||
156704113|NCT03918109|565661369|FG003|Overall Study|Withdrawal by Subject|1|||
156704114|NCT03918109|565661366|FG000|Overall Study|Lost to Follow-up|0|||
156704115|NCT03918109|565661367|FG001|Overall Study|Lost to Follow-up|0|||
156704116|NCT03918109|565661368|FG002|Overall Study|Lost to Follow-up|0|||
156704117|NCT03918109|565661369|FG003|Overall Study|Lost to Follow-up|1|||
156704118|NCT00477295|565661374|FG000|Overall Study|Adverse Event|31|||
156704119|NCT00477295|565661375|FG001|Overall Study|Adverse Event|35|||
156704120|NCT00477295|565661374|FG000|Overall Study|Withdrawal by Subject|35|||
156704121|NCT00477295|565661375|FG001|Overall Study|Withdrawal by Subject|24|||
156704122|NCT00477295|565661374|FG000|Overall Study|Lack of Efficacy|23|||
156704123|NCT00477295|565661375|FG001|Overall Study|Lack of Efficacy|23|||
156704124|NCT00477295|565661374|FG000|Overall Study|Protocol Violation|3|||
156704125|NCT00477295|565661375|FG001|Overall Study|Protocol Violation|8|||
156704126|NCT00477295|565661374|FG000|Overall Study|Physician Decision|4|||
156704127|NCT00477295|565661375|FG001|Overall Study|Physician Decision|5|||
156704128|NCT00477295|565661374|FG000|Overall Study|Lost to Follow-up|21|||
156704129|NCT00477295|565661375|FG001|Overall Study|Lost to Follow-up|11|||
156704130|NCT00477295|565661374|FG000|Overall Study|Other|4|||
156704131|NCT00477295|565661375|FG001|Overall Study|Other|3|||
156704132|NCT03050060|565661378|FG000|Overall Study|Adverse Event|7|||
156440419|NCT05274217|564704110|FG001|Overall Study|Study terminated.|0|||
156440420|NCT01697969|564704111|FG000|Overall Study|Did not meet inc/exc criteria|3|||
156440421|NCT04556981|564704115|FG000|Overall Study|Death|0|||
156440422|NCT04556981|564704116|FG001|Overall Study|Death|1|||
156704133|NCT03050060|565661378|FG000|Overall Study|Withdrawal by Subject|1|||
156704134|NCT03050060|565661378|FG000|Overall Study|Progression|7|||
156704135|NCT03276780|565661379|FG000|Overall Study|Withdrawal by Subject|5|||
156704136|NCT03276780|565661380|FG001|Overall Study|Withdrawal by Subject|3|||
156704137|NCT03276780|565661379|FG000|Overall Study|Lost to Follow-up|3|||
156704138|NCT03276780|565661380|FG001|Overall Study|Lost to Follow-up|5|||
156704139|NCT03276780|565661379|FG000|Overall Study|Moved out of state|1|||
156704140|NCT03276780|565661380|FG001|Overall Study|Moved out of state|1|||
156704141|NCT03276780|565661379|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
156704142|NCT03276780|565661380|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
156704143|NCT03276780|565661379|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
156704144|NCT03276780|565661380|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
156704145|NCT00510289|565661381|FG000|Overall Study|Withdrawal by Subject|7|||
156440423|NCT04556981|564704115|FG000|Overall Study|Lost to Follow-up|2|||
156704146|NCT00510289|565661381|FG000|Overall Study|Refused bone marrow biopsy|2|||
156704147|NCT00510289|565661381|FG000|Overall Study|Lost to Follow-up|1|||
156872158|NCT02839200|566289529|FG004|Overall Study|Randomized in error|0|||
156704148|NCT00510289|565661381|FG000|Overall Study|Progressed prior to starting drug|2|||
156704149|NCT00319982|565661385|FG000|Overall Study|Withdrawal by Subject|1|||
156704150|NCT00319982|565661386|FG001|Overall Study|Withdrawal by Subject|0|||
156704151|NCT00758680|565661387|FG000|Overall Study|Adverse Event|0|||
156704152|NCT00758680|565661388|FG001|Overall Study|Adverse Event|0|||
156704153|NCT00758680|565661389|FG002|Overall Study|Adverse Event|0|||
156704154|NCT00758680|565661390|FG003|Overall Study|Adverse Event|0|||
156704155|NCT00758680|565661391|FG004|Overall Study|Adverse Event|0|||
156704156|NCT00758680|565661392|FG005|Overall Study|Adverse Event|0|||
156704157|NCT00758680|565661393|FG006|Overall Study|Adverse Event|0|||
156704158|NCT00758680|565661394|FG007|Overall Study|Adverse Event|1|||
156704159|NCT00758680|565661395|FG008|Overall Study|Adverse Event|0|||
156704160|NCT00758680|565661396|FG009|Overall Study|Adverse Event|1|||
156704161|NCT00758680|565661387|FG000|Overall Study|Laboratory Adverse Event|0|||
156704162|NCT00758680|565661388|FG001|Overall Study|Laboratory Adverse Event|0|||
156704163|NCT00758680|565661389|FG002|Overall Study|Laboratory Adverse Event|0|||
156704164|NCT00758680|565661390|FG003|Overall Study|Laboratory Adverse Event|0|||
156704165|NCT00758680|565661391|FG004|Overall Study|Laboratory Adverse Event|0|||
156704166|NCT00758680|565661392|FG005|Overall Study|Laboratory Adverse Event|0|||
156704167|NCT00758680|565661393|FG006|Overall Study|Laboratory Adverse Event|0|||
156704168|NCT00758680|565661394|FG007|Overall Study|Laboratory Adverse Event|0|||
156704169|NCT00758680|565661395|FG008|Overall Study|Laboratory Adverse Event|1|||
156704170|NCT00758680|565661396|FG009|Overall Study|Laboratory Adverse Event|0|||
156704171|NCT00758680|565661387|FG000|Overall Study|Withdrawal by Subject|0|||
156704172|NCT00758680|565661388|FG001|Overall Study|Withdrawal by Subject|0|||
156704173|NCT00758680|565661389|FG002|Overall Study|Withdrawal by Subject|0|||
156704174|NCT00758680|565661390|FG003|Overall Study|Withdrawal by Subject|0|||
156704175|NCT00758680|565661391|FG004|Overall Study|Withdrawal by Subject|0|||
156704176|NCT00758680|565661392|FG005|Overall Study|Withdrawal by Subject|0|||
156704177|NCT00758680|565661393|FG006|Overall Study|Withdrawal by Subject|1|||
156704178|NCT00758680|565661394|FG007|Overall Study|Withdrawal by Subject|0|||
156704179|NCT00758680|565661395|FG008|Overall Study|Withdrawal by Subject|1|||
156704180|NCT00758680|565661396|FG009|Overall Study|Withdrawal by Subject|0|||
156704181|NCT03480386|565661397|FG000|Overall Study|Did not complete measures at 3-months|17|||
156704182|NCT03480386|565661398|FG001|Overall Study|Did not complete measures at 3-months|14|||
156704183|NCT03480386|565661397|FG000|Overall Study|No baseline measures|11|||
156704184|NCT03480386|565661398|FG001|Overall Study|No baseline measures|14|||
156704185|NCT03480386|565661397|FG000|Overall Study|Death|0|||
156704186|NCT03480386|565661398|FG001|Overall Study|Death|5|||
156704187|NCT03480386|565661397|FG000|Overall Study|Withdrawal by Subject|12|||
156704188|NCT03480386|565661398|FG001|Overall Study|Withdrawal by Subject|8|||
156704189|NCT03480386|565661397|FG000|Overall Study|Lost to Follow-up|2|||
156704190|NCT03480386|565661398|FG001|Overall Study|Lost to Follow-up|1|||
156704191|NCT03480386|565661397|FG000|Overall Study|Complicating disease|0|||
156704192|NCT03480386|565661398|FG001|Overall Study|Complicating disease|1|||
156704193|NCT03480386|565661397|FG000|Overall Study|Disease progression|3|||
156704194|NCT03480386|565661398|FG001|Overall Study|Disease progression|0|||
156704195|NCT03480386|565661397|FG000|Overall Study|Became ineligible|0|||
156704196|NCT03480386|565661398|FG001|Overall Study|Became ineligible|2|||
156704197|NCT00574912|565661399|FG000|Overall Study|Could not place IV lines.|3|||
156704198|NCT00574912|565661399|FG000|Overall Study|scheduling conflicts|3|||
156704199|NCT00574912|565661399|FG000|Overall Study|Physician Decision|2|||
156872159|NCT02839200|566289530|FG005|Overall Study|Randomized in error|0|||
156872160|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
156872161|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
156872162|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
156872163|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
156872164|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
156872165|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
156872166|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
156704200|NCT04240392|565663138|FG000|Overall Study|Withdrawal by Subject|13|||
156704201|NCT04240392|565663139|FG001|Overall Study|Withdrawal by Subject|4|||
156704202|NCT04240392|565663138|FG000|Overall Study|Lost to Follow-up|11|||
156704203|NCT04240392|565663139|FG001|Overall Study|Lost to Follow-up|12|||
156872167|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
156704204|NCT03665441|565663147|FG000|Overall Study|survival follow up ongoing|23|||
156704205|NCT03665441|565663148|FG001|Overall Study|survival follow up ongoing|0|||
156704206|NCT03665441|565663147|FG000|Overall Study|Patients ongoing on treatment|9|||
156704207|NCT03665441|565663148|FG001|Overall Study|Patients ongoing on treatment|6|||
156704208|NCT03665441|565663147|FG000|Overall Study|Randomized but not treated|7|||
156704209|NCT03665441|565663148|FG001|Overall Study|Randomized but not treated|11|||
156704210|NCT05307510|565663149|FG000|Overall Study|Lost to Follow-up|3|||
156704211|NCT05307510|565663150|FG001|Overall Study|Lost to Follow-up|6|||
156704212|NCT05307510|565663149|FG000|Overall Study|Withdrawal by Subject|0|||
156704213|NCT05307510|565663150|FG001|Overall Study|Withdrawal by Subject|1|||
156704214|NCT04345601|565663151|FG000|Overall Study|Death|0|||
156704215|NCT04345601|565663152|FG001|Overall Study|Death|3|||
156704216|NCT04345601|565663153|FG002|Overall Study|Death|2|||
156704217|NCT04345601|565663151|FG000|Overall Study|Lost to Follow-up|0|||
156704218|NCT04345601|565663152|FG001|Overall Study|Lost to Follow-up|0|||
156704219|NCT04345601|565663153|FG002|Overall Study|Lost to Follow-up|2|||
156704220|NCT03610516|565663154|FG000|Treatment Epoch|Adverse Event|3|||
156704221|NCT03610516|565663155|FG001|Treatment Epoch|Adverse Event|1|||
156704222|NCT03610516|565663154|FG000|Treatment Epoch|Death|1|||
156704223|NCT03610516|565663155|FG001|Treatment Epoch|Death|0|||
156704224|NCT03610516|565663154|FG000|Treatment Epoch|Lack of Efficacy|0|||
156704225|NCT03610516|565663155|FG001|Treatment Epoch|Lack of Efficacy|1|||
156704226|NCT03610516|565663154|FG000|Treatment Epoch|No longer requires treatment|1|||
156704227|NCT03610516|565663155|FG001|Treatment Epoch|No longer requires treatment|0|||
156704228|NCT03610516|565663154|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
156704229|NCT03610516|565663155|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
156704230|NCT03610516|565663154|FG000|Treatment Epoch|Physician Decision|8|||
156704231|NCT03610516|565663155|FG001|Treatment Epoch|Physician Decision|5|||
156704232|NCT03610516|565663154|FG000|Treatment Epoch|Protocol Deviation|1|||
156704233|NCT03610516|565663155|FG001|Treatment Epoch|Protocol Deviation|0|||
156704234|NCT03610516|565663154|FG000|Treatment Epoch|Withdrawal by Subject|3|||
156704235|NCT03610516|565663155|FG001|Treatment Epoch|Withdrawal by Subject|1|||
156704236|NCT03610516|565663154|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
156704237|NCT03610516|565663155|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
156704238|NCT03610516|565663154|FG000|Post-Treatment Follow-up|Death|1|||
156704239|NCT03610516|565663155|FG001|Post-Treatment Follow-up|Death|0|||
156704240|NCT00631657|565663156|FG000|6-Month Treatment Period|Adverse Event|47|||
156704241|NCT00631657|565663157|FG001|6-Month Treatment Period|Adverse Event|0|||
156704242|NCT00631657|565663158|FG002|6-Month Treatment Period|Adverse Event|7|||
156704243|NCT00631657|565663156|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
156704244|NCT00631657|565663157|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
156704245|NCT00631657|565663158|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
156704246|NCT00631657|565663156|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
156704247|NCT00631657|565663157|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
156704248|NCT00631657|565663158|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
156704249|NCT00631657|565663156|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
156704250|NCT00631657|565663157|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
156704251|NCT00631657|565663158|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
156704252|NCT00631657|565663156|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
156704253|NCT00631657|565663157|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
156704254|NCT00631657|565663158|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
156704255|NCT00631657|565663156|FG000|6-Month Treatment Period|Other|16|||
156704256|NCT00631657|565663157|FG001|6-Month Treatment Period|Other|0|||
156704257|NCT00631657|565663158|FG002|6-Month Treatment Period|Other|4|||
156704258|NCT00631657|565663156|FG000|6-Month Treatment Period|Not Treated|2|||
156704259|NCT00631657|565663157|FG001|6-Month Treatment Period|Not Treated|0|||
156704260|NCT00631657|565663158|FG002|6-Month Treatment Period|Not Treated|1|||
156704261|NCT00631657|565663156|FG000|7-Day Discontinuation Period|Not Treated|1|||
156704262|NCT00631657|565663157|FG001|7-Day Discontinuation Period|Not Treated|1|||
156704263|NCT00631657|565663158|FG002|7-Day Discontinuation Period|Not Treated|1|||
156704264|NCT00631657|565663156|FG000|7-Day Discontinuation Period|Other|1|||
156704265|NCT00631657|565663157|FG001|7-Day Discontinuation Period|Other|0|||
156704266|NCT00631657|565663158|FG002|7-Day Discontinuation Period|Other|0|||
156704267|NCT05776862|565663181|FG000|Overall Study|Adverse Event|0|||
156704268|NCT05776862|565663182|FG001|Overall Study|Adverse Event|1|||
156704269|NCT05776862|565663181|FG000|Overall Study|non-compliance|1|||
156704270|NCT05776862|565663182|FG001|Overall Study|non-compliance|0|||
156704271|NCT02448706|565663183|FG000|Overall Study|Withdrawal by Subject|4|||
156704272|NCT02448706|565663184|FG001|Overall Study|Withdrawal by Subject|3|||
156704273|NCT02448706|565663183|FG000|Overall Study|Protocol Violation|1|||
156704274|NCT02448706|565663184|FG001|Overall Study|Protocol Violation|1|||
156704275|NCT02315196|565663185|FG000|Overall Study|Withdrew consent|9|||
156704276|NCT04576923|565663186|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
156704277|NCT00049530|565663187|FG000|Overall Study|Lack of Efficacy|25|||
156791078|NCT02633527|565987143|FG003|Overall Study|Administrative reason|1|||
156332075|NCT01604408|564315042|FG000|Treatment Period 2|Protocol Violation|1|||
156704278|NCT00049530|565663187|FG000|Overall Study|Adverse Event|2|||
156704279|NCT00049530|565663187|FG000|Overall Study|Death|1|||
156704280|NCT00049530|565663187|FG000|Overall Study|symptomatic deterioration|1|||
156704281|NCT00049530|565663187|FG000|Overall Study|ineligible|3|||
156332076|NCT01604408|564315043|FG001|Treatment Period 2|Protocol Violation|0|||
156704282|NCT02383810|565663188|FG000|Overall Study|Physician Decision|1|||
156704283|NCT02383810|565663189|FG001|Overall Study|Physician Decision|1|||
156704284|NCT02383810|565663190|FG002|Overall Study|Physician Decision|0|||
156704285|NCT02383810|565663191|FG003|Overall Study|Physician Decision|0|||
156791079|NCT02633527|565987144|FG004|Overall Study|Administrative reason|0|||
156704286|NCT02383810|565663192|FG004|Overall Study|Physician Decision|0|||
156704287|NCT02383810|565663193|FG005|Overall Study|Physician Decision|0|||
156704288|NCT02383810|565663194|FG006|Overall Study|Physician Decision|0|||
156704289|NCT02383810|565663195|FG007|Overall Study|Physician Decision|0|||
156440424|NCT04556981|564704116|FG001|Overall Study|Lost to Follow-up|11|||
156440425|NCT04556981|564704115|FG000|Overall Study|Moved from the study area|1|||
156440426|NCT04556981|564704116|FG001|Overall Study|Moved from the study area|4|||
156704290|NCT02383810|565663188|FG000|Overall Study|Withdrawal by Subject|2|||
156704291|NCT02383810|565663189|FG001|Overall Study|Withdrawal by Subject|3|||
156704292|NCT02383810|565663190|FG002|Overall Study|Withdrawal by Subject|3|||
156704293|NCT02383810|565663191|FG003|Overall Study|Withdrawal by Subject|3|||
156704294|NCT02383810|565663192|FG004|Overall Study|Withdrawal by Subject|0|||
156704295|NCT02383810|565663193|FG005|Overall Study|Withdrawal by Subject|0|||
156704296|NCT02383810|565663194|FG006|Overall Study|Withdrawal by Subject|0|||
156704297|NCT02383810|565663195|FG007|Overall Study|Withdrawal by Subject|0|||
156704298|NCT02383810|565663188|FG000|Overall Study|Adverse Event|0|||
156704299|NCT02383810|565663189|FG001|Overall Study|Adverse Event|2|||
156704300|NCT02383810|565663190|FG002|Overall Study|Adverse Event|4|||
156704301|NCT02383810|565663191|FG003|Overall Study|Adverse Event|5|||
156704302|NCT02383810|565663192|FG004|Overall Study|Adverse Event|0|||
156704303|NCT02383810|565663193|FG005|Overall Study|Adverse Event|1|||
156704304|NCT02383810|565663194|FG006|Overall Study|Adverse Event|1|||
156704305|NCT02383810|565663195|FG007|Overall Study|Adverse Event|0|||
156704306|NCT02383810|565663188|FG000|Overall Study|Lost to Follow-up|0|||
156704307|NCT02383810|565663189|FG001|Overall Study|Lost to Follow-up|1|||
156704308|NCT02383810|565663190|FG002|Overall Study|Lost to Follow-up|0|||
156704309|NCT02383810|565663191|FG003|Overall Study|Lost to Follow-up|1|||
156704310|NCT02383810|565663192|FG004|Overall Study|Lost to Follow-up|0|||
156704311|NCT02383810|565663193|FG005|Overall Study|Lost to Follow-up|0|||
156704312|NCT02383810|565663194|FG006|Overall Study|Lost to Follow-up|0|||
156704313|NCT02383810|565663195|FG007|Overall Study|Lost to Follow-up|0|||
156704314|NCT02383810|565663188|FG000|Overall Study|other|0|||
156704315|NCT02383810|565663189|FG001|Overall Study|other|0|||
156704316|NCT02383810|565663190|FG002|Overall Study|other|0|||
156704317|NCT02383810|565663191|FG003|Overall Study|other|2|||
156704318|NCT02383810|565663192|FG004|Overall Study|other|0|||
156704319|NCT02383810|565663193|FG005|Overall Study|other|0|||
156704320|NCT02383810|565663194|FG006|Overall Study|other|0|||
156704321|NCT02383810|565663195|FG007|Overall Study|other|0|||
156704322|NCT02383810|565663188|FG000|Overall Study|subject did not receive study treatment|0|||
156704323|NCT02383810|565663189|FG001|Overall Study|subject did not receive study treatment|1|||
156704324|NCT02383810|565663190|FG002|Overall Study|subject did not receive study treatment|0|||
156704325|NCT02383810|565663191|FG003|Overall Study|subject did not receive study treatment|0|||
156704326|NCT02383810|565663192|FG004|Overall Study|subject did not receive study treatment|0|||
156704327|NCT02383810|565663193|FG005|Overall Study|subject did not receive study treatment|0|||
156704328|NCT02383810|565663194|FG006|Overall Study|subject did not receive study treatment|0|||
156704329|NCT02383810|565663195|FG007|Overall Study|subject did not receive study treatment|0|||
156704330|NCT01305044|565663198|FG000|Overall Study|Withdrawal by Subject|3|||
156704331|NCT01305044|565663199|FG001|Overall Study|Withdrawal by Subject|6|||
156704332|NCT00492024|565663200|FG000|Treatment|Adverse Event|3|||
156704333|NCT00492024|565663201|FG001|Treatment|Adverse Event|1|||
156704334|NCT00492024|565663200|FG000|Treatment|Lack of Efficacy|21|||
156704335|NCT00492024|565663201|FG001|Treatment|Lack of Efficacy|20|||
156704336|NCT00492024|565663200|FG000|Treatment|Lost to Follow-up|3|||
156791080|NCT02633527|565987140|FG000|Overall Study|Multiple reasons|1|||
156791081|NCT02633527|565987141|FG001|Overall Study|Multiple reasons|0|||
156791082|NCT02633527|565987142|FG002|Overall Study|Multiple reasons|2|||
156791083|NCT02633527|565987143|FG003|Overall Study|Multiple reasons|2|||
156704337|NCT00492024|565663201|FG001|Treatment|Lost to Follow-up|1|||
156704338|NCT00492024|565663200|FG000|Treatment|Withdrawal by Subject|2|||
156704339|NCT00492024|565663201|FG001|Treatment|Withdrawal by Subject|0|||
156704340|NCT00492024|565663200|FG000|Follow up|Lack of Efficacy|0|||
156704341|NCT00492024|565663201|FG001|Follow up|Lack of Efficacy|1|||
156704342|NCT00492024|565663200|FG000|Follow up|Lost to Follow-up|1|||
156791084|NCT02633527|565987144|FG004|Overall Study|Multiple reasons|1|||
156440427|NCT04556981|564704115|FG000|Overall Study|Withdrawal by Subject|2|||
156704343|NCT00492024|565663201|FG001|Follow up|Lost to Follow-up|1|||
156704344|NCT02861014|565663202|FG000|Primary Analysis|Adverse Event|7|||
156704345|NCT02861014|565663202|FG000|Primary Analysis|Death|1|||
156440428|NCT04556981|564704116|FG001|Overall Study|Withdrawal by Subject|2|||
156704346|NCT02861014|565663202|FG000|Primary Analysis|Lack of Efficacy|3|||
156704347|NCT02861014|565663202|FG000|Primary Analysis|Physician Decision|2|||
156704348|NCT02861014|565663202|FG000|Primary Analysis|Pregnancy|4|||
156704349|NCT02861014|565663202|FG000|Primary Analysis|Protocol Violation|2|||
156704350|NCT02861014|565663202|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
156704351|NCT02861014|565663202|FG000|Primary Analysis|Withdrawal by Subject|14|||
156704352|NCT02861014|565663202|FG000|Primary Analysis|Commercial ocrelizumab|3|||
156791085|NCT01898091|565987147|FG000|Overall Study|Lost to Follow-up|1|||
156791086|NCT01898091|565987148|FG001|Overall Study|Lost to Follow-up|1|||
156704353|NCT02861014|565663202|FG000|Safety Follow-up|Adverse Event|1|||
156704354|NCT02861014|565663202|FG000|Safety Follow-up|Pregnancy|1|||
156704355|NCT02861014|565663202|FG000|Safety Follow-up|Withdrawal by Subject|9|||
156704356|NCT02861014|565663202|FG000|Safety Follow-up|Study terminated by sponsor|1|||
156704357|NCT02861014|565663202|FG000|Safety Follow-up|Physician Decision|1|||
156704358|NCT02861014|565663202|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
156704359|NCT02861014|565663202|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
156704360|NCT00926783|565663203|FG000|Overall Study|Incomplete CFAE Procedures|3|||
156704361|NCT00926783|565663204|FG001|Overall Study|Incomplete CFAE Procedures|3|||
156704362|NCT00696787|565663207|FG000|Overall Study|Adverse Event|1|||
156704363|NCT00696787|565663208|FG001|Overall Study|Adverse Event|0|||
156704364|NCT00696787|565663209|FG002|Overall Study|Adverse Event|6|||
156704365|NCT00696787|565663207|FG000|Overall Study|Discontinuation by Sponsor|9|||
156704366|NCT00696787|565663208|FG001|Overall Study|Discontinuation by Sponsor|13|||
156704367|NCT00696787|565663209|FG002|Overall Study|Discontinuation by Sponsor|14|||
156704368|NCT00696787|565663207|FG000|Overall Study|Lack of Efficacy|0|||
156704369|NCT00696787|565663208|FG001|Overall Study|Lack of Efficacy|1|||
156704370|NCT00696787|565663209|FG002|Overall Study|Lack of Efficacy|0|||
156704371|NCT00696787|565663207|FG000|Overall Study|Lost to Follow-up|4|||
156704372|NCT00696787|565663208|FG001|Overall Study|Lost to Follow-up|0|||
156704373|NCT00696787|565663209|FG002|Overall Study|Lost to Follow-up|3|||
156704374|NCT00696787|565663207|FG000|Overall Study|Withdrawal by Subject|0|||
156704375|NCT00696787|565663208|FG001|Overall Study|Withdrawal by Subject|3|||
156704376|NCT00696787|565663209|FG002|Overall Study|Withdrawal by Subject|2|||
156704377|NCT00696787|565663207|FG000|Overall Study|Failed to return|1|||
156704378|NCT00696787|565663208|FG001|Overall Study|Failed to return|3|||
156440429|NCT04556981|564704115|FG000|Overall Study|Other|2|||
156704379|NCT00696787|565663209|FG002|Overall Study|Failed to return|1|||
156704380|NCT02704403|565663210|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
156704381|NCT02704403|565663211|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
156704382|NCT02704403|565663210|FG000|Overall Study|Administrative reasons by sponsor|1251|||
156704383|NCT02704403|565663211|FG001|Overall Study|Administrative reasons by sponsor|616|||
156704384|NCT02704403|565663210|FG000|Overall Study|Death|4|||
156704385|NCT02704403|565663211|FG001|Overall Study|Death|3|||
156704386|NCT02704403|565663210|FG000|Overall Study|Endpoint event|52|||
156704387|NCT02704403|565663211|FG001|Overall Study|Endpoint event|24|||
156440430|NCT04556981|564704116|FG001|Overall Study|Other|1|||
156440431|NCT03764475|564704117|FG000|Overall Study|Adverse Event|11|||
156440432|NCT03764475|564704118|FG001|Overall Study|Adverse Event|2|||
156440433|NCT03764475|564704117|FG000|Overall Study|Lost to Follow-up|24|||
156440434|NCT03764475|564704118|FG001|Overall Study|Lost to Follow-up|10|||
156440435|NCT03764475|564704117|FG000|Overall Study|Withdrawal by Subject|26|||
156440436|NCT03764475|564704118|FG001|Overall Study|Withdrawal by Subject|10|||
156440437|NCT03764475|564704117|FG000|Overall Study|Lack of Efficacy|3|||
156440438|NCT03764475|564704118|FG001|Overall Study|Lack of Efficacy|0|||
156440439|NCT03764475|564704117|FG000|Overall Study|COVID-19 Disruption|2|||
156440440|NCT03764475|564704118|FG001|Overall Study|COVID-19 Disruption|0|||
156440441|NCT00580866|564704119|FG000|Overall Study|Lost to Follow-up|2|||
156440442|NCT00580866|564704120|FG001|Overall Study|Lost to Follow-up|2|||
156440443|NCT02574455|564704124|FG000|Overall Study|Death|197|||
156704388|NCT02704403|565663210|FG000|Overall Study|Lost to Follow-up|22|||
156704389|NCT02704403|565663211|FG001|Overall Study|Lost to Follow-up|11|||
156704390|NCT02704403|565663210|FG000|Overall Study|Protocol Violation|15|||
156704391|NCT02704403|565663211|FG001|Overall Study|Protocol Violation|15|||
156704392|NCT02704403|565663210|FG000|Overall Study|Adverse Event|2|||
156440444|NCT02574455|564704125|FG001|Overall Study|Death|210|||
156440445|NCT02574455|564704124|FG000|Overall Study|Withdrawal of Consent|11|||
156440446|NCT02574455|564704125|FG001|Overall Study|Withdrawal of Consent|28|||
156704393|NCT02704403|565663211|FG001|Overall Study|Adverse Event|0|||
156704394|NCT02704403|565663210|FG000|Overall Study|Withdrawal by Subject|85|||
156704395|NCT02704403|565663211|FG001|Overall Study|Withdrawal by Subject|45|||
156704396|NCT02704403|565663210|FG000|Overall Study|Investigator decision|1|||
156704397|NCT02704403|565663211|FG001|Overall Study|Investigator decision|1|||
156704398|NCT02704403|565663210|FG000|Overall Study|Follow-up not possible|1|||
156704399|NCT02704403|565663211|FG001|Overall Study|Follow-up not possible|2|||
156440447|NCT02574455|564704124|FG000|Overall Study|Lost to Follow-up|4|||
156440448|NCT02574455|564704125|FG001|Overall Study|Lost to Follow-up|4|||
156440449|NCT02574455|564704124|FG000|Overall Study|Sponsor's Decision|55|||
156440450|NCT02574455|564704125|FG001|Overall Study|Sponsor's Decision|20|||
156440451|NCT03144674|564704128|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
156440452|NCT03144674|564704129|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
156704400|NCT00380744|565663214|FG000|Overall Study|Death|0|||
156704401|NCT00380744|565663215|FG001|Overall Study|Death|0|||
156704402|NCT00380744|565663216|FG002|Overall Study|Death|0|||
156704403|NCT00380744|565663217|FG003|Overall Study|Death|0|||
156704404|NCT00380744|565663218|FG004|Overall Study|Death|0|||
156704405|NCT00380744|565663219|FG005|Overall Study|Death|0|||
156704406|NCT00380744|565663220|FG006|Overall Study|Death|1|||
156440453|NCT03144674|564704130|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
156440454|NCT03144674|564704131|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
156440455|NCT03144674|564704128|FG000|Overall Study|Death|3|||
156440456|NCT03144674|564704129|FG001|Overall Study|Death|2|||
156440457|NCT03144674|564704130|FG002|Overall Study|Death|6|||
156704407|NCT00380744|565663214|FG000|Overall Study|Withdrawal by Subject|1|||
156704408|NCT00380744|565663215|FG001|Overall Study|Withdrawal by Subject|0|||
156440458|NCT03144674|564704131|FG003|Overall Study|Death|24|||
156440459|NCT03144674|564704128|FG000|Overall Study|Lost to Follow-up|0|||
156440460|NCT03144674|564704129|FG001|Overall Study|Lost to Follow-up|1|||
156440461|NCT03144674|564704130|FG002|Overall Study|Lost to Follow-up|0|||
156440462|NCT03144674|564704131|FG003|Overall Study|Lost to Follow-up|4|||
156440463|NCT03144674|564704128|FG000|Overall Study|Withdrawal by Participant|0|||
156440464|NCT03144674|564704129|FG001|Overall Study|Withdrawal by Participant|0|||
156440465|NCT03144674|564704130|FG002|Overall Study|Withdrawal by Participant|2|||
156531652|NCT01641809|565041699|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
156531653|NCT01641809|565041700|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
156704409|NCT00380744|565663216|FG002|Overall Study|Withdrawal by Subject|0|||
156704410|NCT00380744|565663217|FG003|Overall Study|Withdrawal by Subject|0|||
156704411|NCT00380744|565663218|FG004|Overall Study|Withdrawal by Subject|0|||
156704412|NCT00380744|565663219|FG005|Overall Study|Withdrawal by Subject|0|||
156704413|NCT00380744|565663220|FG006|Overall Study|Withdrawal by Subject|0|||
156704414|NCT01955083|565663228|FG000|Overall Study|Lost to Follow-up|1|||
156704415|NCT01955083|565663229|FG001|Overall Study|Lost to Follow-up|1|||
156704416|NCT01559389|565663230|FG000|Overall Study|Withdrawal by Subject|20|||
156704417|NCT01559389|565663231|FG001|Overall Study|Withdrawal by Subject|20|||
156704418|NCT02871492|565663232|FG000|Overall Study|Lost to Follow-up|6|||
156704419|NCT02871492|565663233|FG001|Overall Study|Lost to Follow-up|3|||
156704420|NCT02871492|565663234|FG002|Overall Study|Lost to Follow-up|5|||
156704421|NCT02871492|565663232|FG000|Overall Study|Withdrawal by Subject|0|||
156704422|NCT02871492|565663233|FG001|Overall Study|Withdrawal by Subject|0|||
156704423|NCT02871492|565663234|FG002|Overall Study|Withdrawal by Subject|1|||
156704424|NCT01661062|565663235|FG000|Overall Study|Completed Treatment Off Study|3|||
156704425|NCT01661062|565663235|FG000|Overall Study|Withdrawal by Subject|2|||
156704426|NCT02754856|565663238|FG000|Overall Study|Withdrawal by Subject|1|||
156704427|NCT04874155|565663241|FG000|Overall Study|Lost to Follow-up|1|||
156704428|NCT04874155|565663242|FG001|Overall Study|Lost to Follow-up|1|||
156704429|NCT04874155|565663241|FG000|Overall Study|Withdrawal by Subject|2|||
156704430|NCT04874155|565663242|FG001|Overall Study|Withdrawal by Subject|2|||
156704431|NCT00530218|565663243|FG000|Overall Study|CMV Not Detected|13|||
156704432|NCT00530218|565663243|FG000|Overall Study|Death|12|||
156704433|NCT03477903|565663246|FG000|Overall Study|Study Terminated by Sponsor|1|||
156531654|NCT01641809|565041701|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
156531655|NCT01641809|565041698|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
156531656|NCT01641809|565041699|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
156704434|NCT04435184|565663247|FG000|Overall Study|follow-up blood draws missing|3|||
156704435|NCT04435184|565663248|FG001|Overall Study|follow-up blood draws missing|5|||
156704436|NCT00474266|565663249|FG000|Overall Study|Withdrawal by Subject|7|||
156531657|NCT01641809|565041700|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
156531658|NCT01641809|565041701|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
156704437|NCT00474266|565663250|FG001|Overall Study|Withdrawal by Subject|20|||
156704438|NCT00474266|565663251|FG002|Overall Study|Withdrawal by Subject|4|||
156704439|NCT00474266|565663252|FG003|Overall Study|Withdrawal by Subject|7|||
156704440|NCT05330468|565663253|FG000|Overall Study|Death|6|||
156704441|NCT05330468|565663253|FG000|Overall Study|Withdrawal by Subject|4|||
156704442|NCT05330468|565663253|FG000|Overall Study|Lost to Follow-up|4|||
156704443|NCT02365558|565663254|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
156704444|NCT02365558|565663255|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
156704445|NCT02365558|565663254|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
156440466|NCT03144674|564704131|FG003|Overall Study|Withdrawal by Participant|6|||
156704446|NCT02365558|565663255|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
156440467|NCT03144674|564704128|FG000|Overall Study|Discharged from the Trust|0|||
156440468|NCT03144674|564704129|FG001|Overall Study|Discharged from the Trust|0|||
156440469|NCT03144674|564704130|FG002|Overall Study|Discharged from the Trust|1|||
156440470|NCT03144674|564704131|FG003|Overall Study|Discharged from the Trust|0|||
156704447|NCT01425723|565663257|FG000|Overall Study|Lack of Efficacy|0|||
156704448|NCT01425723|565663258|FG001|Overall Study|Lack of Efficacy|1|||
156704449|NCT01425723|565663257|FG000|Overall Study|Withdrawal by Subject|1|||
156704450|NCT01425723|565663258|FG001|Overall Study|Withdrawal by Subject|4|||
156704451|NCT01425723|565663257|FG000|Overall Study|Lost to Follow-up|0|||
156704452|NCT01425723|565663258|FG001|Overall Study|Lost to Follow-up|3|||
156704453|NCT01425723|565663257|FG000|Overall Study|Physician Decision|2|||
156440471|NCT03144674|564704128|FG000|Overall Study|Exclusion Criteria Met|0|||
156440472|NCT03144674|564704129|FG001|Overall Study|Exclusion Criteria Met|0|||
156704454|NCT01425723|565663258|FG001|Overall Study|Physician Decision|0|||
156704455|NCT01425723|565663257|FG000|Overall Study|Other|1|||
156704456|NCT01425723|565663258|FG001|Overall Study|Other|10|||
156440473|NCT03144674|564704130|FG002|Overall Study|Exclusion Criteria Met|1|||
156704457|NCT03835221|565663259|FG000|Methafilcon A|Withdrawal by Subject|1|||
156704458|NCT00861198|565663260|FG000|Overall Study|SpyGlass Failed|5|||
156704459|NCT02288182|565663261|FG000|Overall Study|Adverse Event|0|||
156704460|NCT02288182|565663262|FG001|Overall Study|Adverse Event|1|||
156704461|NCT02288182|565663261|FG000|Overall Study|Lost to Follow-up|0|||
156704462|NCT02288182|565663262|FG001|Overall Study|Lost to Follow-up|1|||
156704463|NCT04619992|565663264|FG000|Overall Study|Withdrawal by Subject|1|||
156704464|NCT04619992|565663265|FG001|Overall Study|Withdrawal by Subject|0|||
156704465|NCT01197755|565663266|FG000|Overall Study|Adverse Event|8|||
156704466|NCT01197755|565663267|FG001|Overall Study|Adverse Event|10|||
156704467|NCT01197755|565663268|FG002|Overall Study|Adverse Event|10|||
156704468|NCT01197755|565663266|FG000|Overall Study|Study-specific discontinuation criteria|2|||
156704469|NCT01197755|565663267|FG001|Overall Study|Study-specific discontinuation criteria|1|||
156704470|NCT01197755|565663268|FG002|Overall Study|Study-specific discontinuation criteria|0|||
156704471|NCT01197755|565663266|FG000|Overall Study|Entered the long-term extension study|18|||
156704472|NCT01197755|565663267|FG001|Overall Study|Entered the long-term extension study|21|||
156704473|NCT01197755|565663268|FG002|Overall Study|Entered the long-term extension study|35|||
156704474|NCT01197755|565663266|FG000|Overall Study|Lack of therapeutic response|0|||
156704475|NCT01197755|565663267|FG001|Overall Study|Lack of therapeutic response|7|||
156704476|NCT01197755|565663268|FG002|Overall Study|Lack of therapeutic response|4|||
156704477|NCT01197755|565663266|FG000|Overall Study|Severe non-compliance to the protocol|2|||
156704478|NCT01197755|565663267|FG001|Overall Study|Severe non-compliance to the protocol|1|||
156704479|NCT01197755|565663268|FG002|Overall Study|Severe non-compliance to the protocol|2|||
156704480|NCT01197755|565663266|FG000|Overall Study|Withdrawal by Subject|1|||
156440474|NCT03144674|564704131|FG003|Overall Study|Exclusion Criteria Met|0|||
156440475|NCT03144674|564704128|FG000|Overall Study|Changed Physicians|0|||
156440476|NCT03144674|564704129|FG001|Overall Study|Changed Physicians|0|||
156704481|NCT01197755|565663267|FG001|Overall Study|Withdrawal by Subject|0|||
156704482|NCT01197755|565663268|FG002|Overall Study|Withdrawal by Subject|0|||
156704483|NCT01197755|565663266|FG000|Overall Study|Lost to Follow-up|0|||
156704484|NCT01197755|565663267|FG001|Overall Study|Lost to Follow-up|0|||
156704485|NCT01197755|565663268|FG002|Overall Study|Lost to Follow-up|1|||
156704486|NCT01197755|565663266|FG000|Overall Study|eg, change in circumstances|7|||
156704487|NCT01197755|565663267|FG001|Overall Study|eg, change in circumstances|3|||
156704488|NCT01197755|565663268|FG002|Overall Study|eg, change in circumstances|2|||
156704489|NCT03365011|565663269|FG000|Overall Study|Withdrawal by Subject|1|||
156704490|NCT03365011|565663270|FG001|Overall Study|Withdrawal by Subject|2|||
156704491|NCT00499174|565663271|FG000|Overall Study|Physician Decision|78|||
156704492|NCT00499174|565663272|FG001|Overall Study|Physician Decision|9|||
156704493|NCT03582826|565663273|FG000|Overall Study|Lost to Follow-up|39|||
156704494|NCT03582826|565663274|FG001|Overall Study|Lost to Follow-up|0|||
156704495|NCT03582826|565663273|FG000|Overall Study|Withdrawal by Subject|2|||
156704496|NCT03582826|565663274|FG001|Overall Study|Withdrawal by Subject|0|||
156704497|NCT01214915|565663275|FG000|Overall Study|Adverse Event|8|||
156704498|NCT01214915|565663275|FG000|Overall Study|Lack of Efficacy|3|||
156704499|NCT01104779|565663277|FG000|Overall Study|Protocol Violation|1|||
156704500|NCT01104779|565663278|FG001|Overall Study|Protocol Violation|2|||
156704501|NCT01104779|565663279|FG002|Overall Study|Protocol Violation|2|||
156704502|NCT01104779|565663277|FG000|Overall Study|Lack of Efficacy|26|||
156704503|NCT01104779|565663278|FG001|Overall Study|Lack of Efficacy|12|||
156704504|NCT01104779|565663279|FG002|Overall Study|Lack of Efficacy|13|||
156704505|NCT01104779|565663277|FG000|Overall Study|Adverse Event|13|||
156704506|NCT01104779|565663278|FG001|Overall Study|Adverse Event|14|||
156704507|NCT01104779|565663279|FG002|Overall Study|Adverse Event|13|||
156440477|NCT03144674|564704130|FG002|Overall Study|Changed Physicians|0|||
156704508|NCT01104779|565663277|FG000|Overall Study|Did not meet inc/exc criteria|1|||
156704509|NCT01104779|565663278|FG001|Overall Study|Did not meet inc/exc criteria|1|||
156704510|NCT01104779|565663279|FG002|Overall Study|Did not meet inc/exc criteria|1|||
156704511|NCT01104779|565663277|FG000|Overall Study|Other reasons|0|||
156704512|NCT01104779|565663278|FG001|Overall Study|Other reasons|1|||
156704513|NCT01104779|565663279|FG002|Overall Study|Other reasons|0|||
156704514|NCT01104779|565663277|FG000|Overall Study|Lost to Follow-up|2|||
156704515|NCT01104779|565663278|FG001|Overall Study|Lost to Follow-up|0|||
156440478|NCT03144674|564704131|FG003|Overall Study|Changed Physicians|1|||
156440479|NCT03144674|564704128|FG000|Overall Study|Removed for Safety|0|||
156440480|NCT03144674|564704129|FG001|Overall Study|Removed for Safety|0|||
156704516|NCT01104779|565663279|FG002|Overall Study|Lost to Follow-up|1|||
156440481|NCT03144674|564704130|FG002|Overall Study|Removed for Safety|0|||
156704517|NCT01104779|565663277|FG000|Overall Study|Withdrawal by Subject|16|||
156704518|NCT01104779|565663278|FG001|Overall Study|Withdrawal by Subject|25|||
156704519|NCT01104779|565663279|FG002|Overall Study|Withdrawal by Subject|32|||
156440482|NCT03144674|564704131|FG003|Overall Study|Removed for Safety|1|||
156704520|NCT03753763|565663280|FG000|Overall Study|Adverse Event|2|||
156704521|NCT03753763|565663281|FG001|Overall Study|Adverse Event|0|||
156704522|NCT03753763|565663280|FG000|Overall Study|Withdrawal by Subject|3|||
156704523|NCT03753763|565663281|FG001|Overall Study|Withdrawal by Subject|1|||
156704524|NCT03753763|565663280|FG000|Overall Study|clinical deterioration|1|||
156704525|NCT03753763|565663281|FG001|Overall Study|clinical deterioration|0|||
156704526|NCT00871741|565663283|FG000|Overall Study|Premature study termination|9|||
156704527|NCT00871741|565663284|FG001|Overall Study|Premature study termination|7|||
156704528|NCT05323123|565663285|FG000|Overall Study|Withdrawal by Subject|2|||
156704529|NCT05323123|565663286|FG001|Overall Study|Withdrawal by Subject|1|||
156704530|NCT05323123|565663285|FG000|Overall Study|Lost to Follow-up|4|||
156704531|NCT05323123|565663286|FG001|Overall Study|Lost to Follow-up|2|||
156704532|NCT05323123|565663285|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
156704533|NCT05323123|565663286|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
156704534|NCT05529472|565663287|FG000|Overall Study|Withdrawal by Subject|1|||
156704535|NCT05529472|565663288|FG001|Overall Study|Withdrawal by Subject|1|||
156704536|NCT04975191|565665095|FG000|Overall Study|Protocol Violation|1|||
156704537|NCT04975191|565665096|FG001|Overall Study|Protocol Violation|2|||
156704538|NCT04975191|565665097|FG002|Overall Study|Protocol Violation|2|||
156704539|NCT04975191|565665098|FG003|Overall Study|Protocol Violation|2|||
156704540|NCT04975191|565665095|FG000|Overall Study|Lost to Follow-up|13|||
156704541|NCT04975191|565665096|FG001|Overall Study|Lost to Follow-up|3|||
156704542|NCT04975191|565665097|FG002|Overall Study|Lost to Follow-up|8|||
156704543|NCT04975191|565665098|FG003|Overall Study|Lost to Follow-up|8|||
156704544|NCT00761657|565665099|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
156704545|NCT00761657|565665100|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
156704546|NCT00761657|565665101|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
156704547|NCT00761657|565665102|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
156704548|NCT00761657|565665103|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
156704549|NCT00761657|565665104|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
156704550|NCT00761657|565665105|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
156704551|NCT00761657|565665106|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
156704552|NCT00761657|565665107|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
156704553|NCT00761657|565665099|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704554|NCT00761657|565665100|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704555|NCT00761657|565665101|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
156704556|NCT00761657|565665102|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
156704557|NCT00761657|565665103|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704558|NCT00761657|565665104|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704559|NCT00761657|565665105|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704560|NCT00761657|565665106|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704561|NCT00761657|565665107|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704562|NCT00761657|565665099|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
156704563|NCT00761657|565665100|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
156704564|NCT00761657|565665101|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
156704565|NCT00761657|565665102|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
156704566|NCT00761657|565665103|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
156704567|NCT00761657|565665104|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
156704568|NCT00761657|565665105|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
156704569|NCT00761657|565665106|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
156704570|NCT00761657|565665107|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
156704571|NCT00761657|565665099|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
156704572|NCT00761657|565665100|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
156704573|NCT00761657|565665101|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
156704574|NCT00761657|565665102|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
156704575|NCT00761657|565665103|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
156704576|NCT00761657|565665104|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
156704577|NCT00761657|565665105|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
156704578|NCT00761657|565665106|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
156704579|NCT00761657|565665107|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
156440483|NCT03144674|564704128|FG000|Overall Study|Site Closed|0|||
156440484|NCT03144674|564704129|FG001|Overall Study|Site Closed|0|||
156440485|NCT03144674|564704130|FG002|Overall Study|Site Closed|0|||
156440486|NCT03144674|564704131|FG003|Overall Study|Site Closed|1|||
156704580|NCT00359801|565665113|FG000|Overall Study|Lost to Follow-up|72|||
156704581|NCT00359801|565665114|FG001|Overall Study|Lost to Follow-up|58|||
156704582|NCT00359801|565665113|FG000|Overall Study|Withdrawal by Subject|143|||
156704583|NCT00359801|565665114|FG001|Overall Study|Withdrawal by Subject|96|||
156704584|NCT00359801|565665113|FG000|Overall Study|Other|66|||
156704585|NCT00359801|565665114|FG001|Overall Study|Other|46|||
156440487|NCT03144674|564704128|FG000|Overall Study|Histological Criteria Not Met|0|||
156440488|NCT03144674|564704129|FG001|Overall Study|Histological Criteria Not Met|0|||
156704586|NCT00359801|565665113|FG000|Overall Study|Final Status Unknown: missing data|7|||
156440489|NCT03144674|564704130|FG002|Overall Study|Histological Criteria Not Met|0|||
156704587|NCT00359801|565665114|FG001|Overall Study|Final Status Unknown: missing data|4|||
156704588|NCT00359801|565665113|FG000|Overall Study|Sponsor Decision|17|||
156704589|NCT00359801|565665114|FG001|Overall Study|Sponsor Decision|16|||
156704590|NCT01392963|565665115|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
156704591|NCT01392963|565665116|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
156704592|NCT01392963|565665115|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
156704593|NCT01392963|565665116|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
156704594|NCT01392963|565665115|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
156704595|NCT01392963|565665116|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
156704596|NCT00450801|565665119|FG000|Overall Study|Death|1|||
156704597|NCT00324649|565665120|FG000|Overall Study|Adverse Event|1|||
156704598|NCT00324649|565665121|FG001|Overall Study|Adverse Event|4|||
156704599|NCT00324649|565665120|FG000|Overall Study|Withdrawal by Subject|0|||
156704600|NCT00324649|565665121|FG001|Overall Study|Withdrawal by Subject|1|||
156704601|NCT00324649|565665120|FG000|Overall Study|Noncompliance|1|||
156704602|NCT00324649|565665121|FG001|Overall Study|Noncompliance|0|||
156704603|NCT01396512|565665124|FG000|Overall Study|Withdrawal by Subject|0|||
156704604|NCT01396512|565665125|FG001|Overall Study|Withdrawal by Subject|1|||
156704605|NCT02618759|565665128|FG000|Overall Study|Lost to Follow-up|0|||
156704606|NCT02618759|565665129|FG001|Overall Study|Lost to Follow-up|1|||
156704607|NCT02618759|565665128|FG000|Overall Study|Withdrawal by Subject|1|||
156704608|NCT02618759|565665129|FG001|Overall Study|Withdrawal by Subject|0|||
156704609|NCT02618759|565665128|FG000|Overall Study|Other Reasons|1|||
156704610|NCT02618759|565665129|FG001|Overall Study|Other Reasons|4|||
156704611|NCT02152605|565665130|FG000|Overall Study|Adverse Event|6|||
156704612|NCT02152605|565665131|FG001|Overall Study|Adverse Event|8|||
156704613|NCT02152605|565665130|FG000|Overall Study|Lack of Efficacy|7|||
156704614|NCT02152605|565665131|FG001|Overall Study|Lack of Efficacy|4|||
156704615|NCT02152605|565665130|FG000|Overall Study|Protocol deviation|1|||
156704616|NCT02152605|565665131|FG001|Overall Study|Protocol deviation|4|||
156704617|NCT02152605|565665130|FG000|Overall Study|Lost to Follow-up|1|||
156704618|NCT02152605|565665131|FG001|Overall Study|Lost to Follow-up|0|||
156704619|NCT02152605|565665130|FG000|Overall Study|Withdrew consent|4|||
156704620|NCT02152605|565665131|FG001|Overall Study|Withdrew consent|2|||
156704621|NCT02500043|565665138|FG000|Overall Study|Randomized, but not Treated|2|||
156704622|NCT02500043|565665139|FG001|Overall Study|Randomized, but not Treated|2|||
156704623|NCT02500043|565665138|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
156704624|NCT02500043|565665139|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
156704625|NCT02500043|565665138|FG000|Overall Study|Adverse Event|33|||
156704626|NCT02500043|565665139|FG001|Overall Study|Adverse Event|11|||
156704627|NCT02500043|565665138|FG000|Overall Study|Clinical Progression|54|||
156332077|NCT01604408|564315042|FG000|Treatment Period 2|Adverse Event|0|||
156332078|NCT01604408|564315043|FG001|Treatment Period 2|Adverse Event|1|||
156704628|NCT02500043|565665139|FG001|Overall Study|Clinical Progression|35|||
156704629|NCT02500043|565665138|FG000|Overall Study|Radiological Progression|192|||
156704630|NCT02500043|565665139|FG001|Overall Study|Radiological Progression|110|||
156704631|NCT02500043|565665138|FG000|Overall Study|Physician's Decision|11|||
156704632|NCT02500043|565665139|FG001|Overall Study|Physician's Decision|3|||
156332079|NCT01604408|564315042|FG000|Treatment Period 3|Protocol Violation|1|||
156332080|NCT01604408|564315043|FG001|Treatment Period 3|Protocol Violation|1|||
156332081|NCT01604408|564315042|FG000|Treatment Period 3|Adverse Event|0|||
156332082|NCT01604408|564315043|FG001|Treatment Period 3|Adverse Event|3|||
156332083|NCT01604408|564315042|FG000|Treatment Period 3|Withdrawal by Subject|3|||
156332084|NCT01604408|564315043|FG001|Treatment Period 3|Withdrawal by Subject|1|||
156332085|NCT01604408|564315042|FG000|Treatment Period 3|Sponsor Decision|1|||
156332086|NCT01604408|564315043|FG001|Treatment Period 3|Sponsor Decision|0|||
156332087|NCT01604408|564315042|FG000|Treatment Period 4|Death|1|||
156332088|NCT01604408|564315043|FG001|Treatment Period 4|Death|0|||
156332089|NCT01604408|564315042|FG000|Treatment Period 4|Withdrawal by Subject|2|||
156332090|NCT01604408|564315043|FG001|Treatment Period 4|Withdrawal by Subject|1|||
156332091|NCT01604408|564315042|FG000|Treatment Period 4|Adverse Event|0|||
156332092|NCT01604408|564315043|FG001|Treatment Period 4|Adverse Event|1|||
156332093|NCT01604408|564315042|FG000|Treatment Period 5|Adverse Event|4|||
156332094|NCT01604408|564315043|FG001|Treatment Period 5|Adverse Event|0|||
156332095|NCT01604408|564315042|FG000|Treatment Period 6|Lost to Follow-up|0|||
156332096|NCT01604408|564315043|FG001|Treatment Period 6|Lost to Follow-up|1|||
156332097|NCT01604408|564315042|FG000|Treatment Period 6|Adverse Event|2|||
156332098|NCT01604408|564315043|FG001|Treatment Period 6|Adverse Event|0|||
156332099|NCT01604408|564315042|FG000|Treatment Period 6|Sponsor decision|0|||
156704633|NCT02500043|565665138|FG000|Overall Study|Withdrawal by Subject|14|||
156704634|NCT02500043|565665139|FG001|Overall Study|Withdrawal by Subject|4|||
156332100|NCT01604408|564315043|FG001|Treatment Period 6|Sponsor decision|1|||
156332101|NCT01604408|564315042|FG000|Observation Period|Adverse Event|1|||
156332102|NCT01604408|564315043|FG001|Observation Period|Adverse Event|1|||
156332103|NCT01604408|564315042|FG000|Observation Period|Withdrawal by Subject|0|||
156332104|NCT01604408|564315043|FG001|Observation Period|Withdrawal by Subject|2|||
156332105|NCT00091442|564315044|FG000|Overall Study|Progressive Disease|220|||
156332106|NCT00091442|564315045|FG001|Overall Study|Progressive Disease|189|||
156332107|NCT00091442|564315044|FG000|Overall Study|Physician Decision|61|||
156704635|NCT02500043|565665138|FG000|Overall Study|Death|11|||
156704636|NCT02500043|565665139|FG001|Overall Study|Death|2|||
156704637|NCT02500043|565665138|FG000|Overall Study|Protocol Deviation|1|||
156704638|NCT02500043|565665139|FG001|Overall Study|Protocol Deviation|0|||
156704639|NCT00580788|565665140|FG000|Overall Study|Adverse Event|0|||
156704640|NCT00580788|565665141|FG001|Overall Study|Adverse Event|0|||
156704641|NCT00580788|565665142|FG002|Overall Study|Adverse Event|0|||
156704642|NCT00580788|565665143|FG003|Overall Study|Adverse Event|1|||
156704643|NCT01564537|565665144|FG000|Overall Study|Site Terminated by Sponsor|1|||
156704644|NCT01564537|565665145|FG001|Overall Study|Site Terminated by Sponsor|0|||
156704645|NCT01564537|565665144|FG000|Overall Study|Withdrawal by Subject|12|||
156704646|NCT01564537|565665145|FG001|Overall Study|Withdrawal by Subject|14|||
156704647|NCT01564537|565665144|FG000|Overall Study|Lost to Follow-up|7|||
156704648|NCT01564537|565665145|FG001|Overall Study|Lost to Follow-up|3|||
156704649|NCT01564537|565665144|FG000|Overall Study|Reason not specified|81|||
156704650|NCT01564537|565665145|FG001|Overall Study|Reason not specified|82|||
156704651|NCT02932306|565665150|FG000|Overall Study|Withdrawal by Subject|16|||
156704652|NCT02932306|565665151|FG001|Overall Study|Withdrawal by Subject|25|||
156704653|NCT02932306|565665150|FG000|Overall Study|Adverse Event|3|||
156704654|NCT02932306|565665151|FG001|Overall Study|Adverse Event|0|||
156704655|NCT02932306|565665150|FG000|Overall Study|Pregnancy|2|||
156704656|NCT02932306|565665151|FG001|Overall Study|Pregnancy|0|||
156704657|NCT02932306|565665150|FG000|Overall Study|Protocol Violation|1|||
156704658|NCT02932306|565665151|FG001|Overall Study|Protocol Violation|1|||
156704659|NCT02932306|565665150|FG000|Overall Study|Noncompliance with Study Drug|1|||
156704660|NCT02932306|565665151|FG001|Overall Study|Noncompliance with Study Drug|1|||
156704661|NCT02932306|565665150|FG000|Overall Study|Lost to Follow-up|36|||
156704662|NCT02932306|565665151|FG001|Overall Study|Lost to Follow-up|40|||
156704663|NCT02932306|565665150|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
156704664|NCT02932306|565665151|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
156704665|NCT02932306|565665150|FG000|Overall Study|Lack of Efficacy|0|||
156704666|NCT02932306|565665151|FG001|Overall Study|Lack of Efficacy|2|||
156704667|NCT02932306|565665150|FG000|Overall Study|Worsening condition|2|||
156704668|NCT02932306|565665151|FG001|Overall Study|Worsening condition|0|||
156704669|NCT02932306|565665150|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
156704670|NCT02932306|565665151|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
156704671|NCT02065700|565665152|FG000|Overall Study|Adverse Event|165|||
156704672|NCT02065700|565665153|FG001|Overall Study|Adverse Event|101|||
156704673|NCT02065700|565665152|FG000|Overall Study|Withdrawal by Subject|90|||
156704674|NCT02065700|565665153|FG001|Overall Study|Withdrawal by Subject|29|||
156704675|NCT02065700|565665152|FG000|Overall Study|Lost to Follow-up|12|||
156704676|NCT02065700|565665153|FG001|Overall Study|Lost to Follow-up|9|||
156704677|NCT02065700|565665152|FG000|Overall Study|Physician Decision|2|||
156704678|NCT02065700|565665153|FG001|Overall Study|Physician Decision|0|||
156704679|NCT02065700|565665152|FG000|Overall Study|Sponsor Request|38|||
156704680|NCT02065700|565665153|FG001|Overall Study|Sponsor Request|15|||
156704681|NCT02065700|565665152|FG000|Overall Study|Treatment Failure|3|||
156704682|NCT02065700|565665153|FG001|Overall Study|Treatment Failure|2|||
156704683|NCT02065700|565665152|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
156704684|NCT02065700|565665153|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
156704685|NCT02065700|565665152|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
156440490|NCT03144674|564704131|FG003|Overall Study|Histological Criteria Not Met|1|||
156704686|NCT02065700|565665153|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
156704687|NCT02065700|565665152|FG000|Overall Study|Non-compliance with Study Procedures|2|||
156704688|NCT02065700|565665153|FG001|Overall Study|Non-compliance with Study Procedures|0|||
156704689|NCT02065700|565665152|FG000|Overall Study|Not Defined|21|||
156704690|NCT02065700|565665153|FG001|Overall Study|Not Defined|3|||
156704691|NCT01635218|565665156|FG000|Overall Study|Lost to Follow-up|3|||
156704692|NCT01635218|565665157|FG001|Overall Study|Lost to Follow-up|7|||
156704693|NCT01635218|565665158|FG002|Overall Study|Lost to Follow-up|6|||
156704694|NCT03559400|565665159|FG000|Overall Study|Lost to Follow-up|9|||
156704695|NCT03559400|565665160|FG001|Overall Study|Lost to Follow-up|7|||
156440491|NCT03144674|564704128|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
156440492|NCT03144674|564704129|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
156440493|NCT03144674|564704130|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
156440494|NCT03144674|564704131|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
156440495|NCT03144674|564704128|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
156440496|NCT03144674|564704129|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
156704696|NCT03559400|565665159|FG000|Overall Study|Death|0|||
156704697|NCT03559400|565665160|FG001|Overall Study|Death|2|||
156704698|NCT03262038|565665165|FG000|Overall Study|Withdrawal by Subject|0|||
156704699|NCT03262038|565665166|FG001|Overall Study|Withdrawal by Subject|1|||
156704700|NCT04933968|565665167|FG000|Overall Study|Adverse Event|0|||
156704701|NCT04933968|565665168|FG001|Overall Study|Adverse Event|0|||
156704702|NCT04933968|565665169|FG002|Overall Study|Adverse Event|1|||
156704703|NCT04933968|565665170|FG003|Overall Study|Adverse Event|1|||
156704704|NCT04933968|565665171|FG004|Overall Study|Adverse Event|0|||
156704705|NCT04933968|565665172|FG005|Overall Study|Adverse Event|0|||
156704706|NCT04933968|565665167|FG000|Overall Study|Lost to Follow-up|1|||
156704707|NCT04933968|565665168|FG001|Overall Study|Lost to Follow-up|0|||
156704708|NCT04933968|565665169|FG002|Overall Study|Lost to Follow-up|1|||
156704709|NCT04933968|565665170|FG003|Overall Study|Lost to Follow-up|0|||
156704710|NCT04933968|565665171|FG004|Overall Study|Lost to Follow-up|0|||
156704711|NCT04933968|565665172|FG005|Overall Study|Lost to Follow-up|0|||
156704712|NCT04933968|565665167|FG000|Overall Study|Randomized not treated|1|||
156704713|NCT04933968|565665168|FG001|Overall Study|Randomized not treated|0|||
156704714|NCT04933968|565665169|FG002|Overall Study|Randomized not treated|0|||
156704715|NCT04933968|565665170|FG003|Overall Study|Randomized not treated|0|||
156704716|NCT04933968|565665171|FG004|Overall Study|Randomized not treated|0|||
156704717|NCT04933968|565665172|FG005|Overall Study|Randomized not treated|0|||
156704718|NCT04933968|565665167|FG000|Overall Study|Sponsor terminated study|0|||
156704719|NCT04933968|565665168|FG001|Overall Study|Sponsor terminated study|0|||
156704720|NCT04933968|565665169|FG002|Overall Study|Sponsor terminated study|0|||
156704721|NCT04933968|565665170|FG003|Overall Study|Sponsor terminated study|1|||
156704722|NCT04933968|565665171|FG004|Overall Study|Sponsor terminated study|2|||
156704723|NCT04933968|565665172|FG005|Overall Study|Sponsor terminated study|0|||
156704724|NCT04933968|565665167|FG000|Overall Study|Other|0|||
156704725|NCT04933968|565665168|FG001|Overall Study|Other|0|||
156704726|NCT04933968|565665169|FG002|Overall Study|Other|0|||
156704727|NCT04933968|565665170|FG003|Overall Study|Other|1|||
156704728|NCT04933968|565665171|FG004|Overall Study|Other|0|||
156704729|NCT04933968|565665172|FG005|Overall Study|Other|0|||
156704730|NCT04933968|565665167|FG000|Overall Study|Missing|1|||
156704731|NCT04933968|565665168|FG001|Overall Study|Missing|3|||
156704732|NCT04933968|565665169|FG002|Overall Study|Missing|2|||
156704733|NCT04933968|565665170|FG003|Overall Study|Missing|1|||
156704734|NCT04933968|565665171|FG004|Overall Study|Missing|1|||
156704735|NCT04933968|565665172|FG005|Overall Study|Missing|0|||
156704736|NCT01724489|565665173|FG000|Overall Study|Adverse Event|8|||
156704737|NCT01724489|565665174|FG001|Overall Study|Adverse Event|3|||
156704738|NCT01724489|565665173|FG000|Overall Study|Surgery, medication|1|||
156704739|NCT01724489|565665174|FG001|Overall Study|Surgery, medication|1|||
156704740|NCT01724489|565665173|FG000|Overall Study|Lost to Follow-up|1|||
156704741|NCT01724489|565665174|FG001|Overall Study|Lost to Follow-up|2|||
156704742|NCT01724489|565665173|FG000|Overall Study|Withdrawal by Subject|6|||
156704743|NCT01724489|565665174|FG001|Overall Study|Withdrawal by Subject|6|||
156704744|NCT01664130|565665177|FG000|Overall Study|competing secondary disease|2|||
156704745|NCT03323437|565665180|FG000|Overall Study|Withdrawal by Subject|0|||
156704746|NCT03323437|565665181|FG001|Overall Study|Withdrawal by Subject|4|||
156704747|NCT01473524|565665184|FG000|DB Phase|Adverse Event|4|||
156704748|NCT01473524|565665185|FG001|DB Phase|Adverse Event|8|||
156704749|NCT01473524|565665186|FG002|DB Phase|Adverse Event|2|||
156704750|NCT01473524|565665187|FG003|DB Phase|Adverse Event|0|||
156704751|NCT01473524|565665188|FG004|DB Phase|Adverse Event|0|||
156704752|NCT01473524|565665189|FG005|DB Phase|Adverse Event|0|||
156704753|NCT01473524|565665184|FG000|DB Phase|Death|1|||
156704754|NCT01473524|565665185|FG001|DB Phase|Death|0|||
156704755|NCT01473524|565665186|FG002|DB Phase|Death|0|||
156704756|NCT01473524|565665187|FG003|DB Phase|Death|0|||
156704757|NCT01473524|565665188|FG004|DB Phase|Death|0|||
156704758|NCT01473524|565665189|FG005|DB Phase|Death|0|||
156332108|NCT00091442|564315045|FG001|Overall Study|Physician Decision|58|||
156332109|NCT00091442|564315044|FG000|Overall Study|Withdrawal by Subject|38|||
156332110|NCT00091442|564315045|FG001|Overall Study|Withdrawal by Subject|46|||
156332111|NCT00091442|564315044|FG000|Overall Study|Adverse Event|29|||
156332112|NCT00091442|564315045|FG001|Overall Study|Adverse Event|48|||
156332113|NCT00091442|564315044|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
156332114|NCT00091442|564315045|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
156332115|NCT00091442|564315044|FG000|Overall Study|Death|9|||
156332116|NCT00091442|564315045|FG001|Overall Study|Death|7|||
156332117|NCT00091442|564315044|FG000|Overall Study|Lost to Follow-up|1|||
156332118|NCT00091442|564315045|FG001|Overall Study|Lost to Follow-up|3|||
156332119|NCT00091442|564315044|FG000|Overall Study|Other|2|||
156332120|NCT00091442|564315045|FG001|Overall Study|Other|6|||
156332121|NCT00917501|564315046|FG000|Overall Study|Lost to Follow-up|4|||
156332122|NCT00917501|564315047|FG001|Overall Study|Lost to Follow-up|1|||
156332123|NCT00917501|564315046|FG000|Overall Study|Withdrawal by Subject|3|||
156332124|NCT00917501|564315047|FG001|Overall Study|Withdrawal by Subject|1|||
156332125|NCT00917501|564315046|FG000|Overall Study|Lack of Efficacy|1|||
156332126|NCT00917501|564315047|FG001|Overall Study|Lack of Efficacy|2|||
156332127|NCT00917501|564315046|FG000|Overall Study|trouble swollowing capsules|0|||
156332128|NCT00917501|564315047|FG001|Overall Study|trouble swollowing capsules|1|||
156332129|NCT00986830|564315052|FG000|Overall Study|Death|1|||
156332130|NCT00986830|564315052|FG000|Overall Study|Lost to Follow-up|1|||
156332131|NCT00986830|564315052|FG000|Overall Study|Lack of Efficacy|1|||
156332132|NCT00986830|564315052|FG000|Overall Study|Unable to access sinus with device|5|||
156332133|NCT01495975|564315053|FG000|Overall Study|Lost to Follow-up|1|||
156332134|NCT01495975|564315054|FG001|Overall Study|Lost to Follow-up|0|||
156332135|NCT00808483|564315055|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
156332136|NCT00808483|564315056|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
156704759|NCT01473524|565665184|FG000|DB Phase|Withdrawal by Subject|2|||
156704760|NCT01473524|565665185|FG001|DB Phase|Withdrawal by Subject|1|||
156704761|NCT01473524|565665186|FG002|DB Phase|Withdrawal by Subject|1|||
156704762|NCT01473524|565665187|FG003|DB Phase|Withdrawal by Subject|0|||
156704763|NCT01473524|565665188|FG004|DB Phase|Withdrawal by Subject|0|||
156704764|NCT01473524|565665189|FG005|DB Phase|Withdrawal by Subject|0|||
156704765|NCT01473524|565665184|FG000|LTSE Phase|Withdrawal by Subject|0|||
156704766|NCT01473524|565665185|FG001|LTSE Phase|Withdrawal by Subject|0|||
156704767|NCT01473524|565665186|FG002|LTSE Phase|Withdrawal by Subject|0|||
156704768|NCT01473524|565665187|FG003|LTSE Phase|Withdrawal by Subject|3|||
156704769|NCT01473524|565665188|FG004|LTSE Phase|Withdrawal by Subject|3|||
156704770|NCT01473524|565665189|FG005|LTSE Phase|Withdrawal by Subject|6|||
156704771|NCT01473524|565665184|FG000|LTSE Phase|Death|0|||
156704772|NCT01473524|565665185|FG001|LTSE Phase|Death|0|||
156704773|NCT01473524|565665186|FG002|LTSE Phase|Death|0|||
156704774|NCT01473524|565665187|FG003|LTSE Phase|Death|0|||
156704775|NCT01473524|565665188|FG004|LTSE Phase|Death|1|||
156704776|NCT01473524|565665189|FG005|LTSE Phase|Death|0|||
156704777|NCT01473524|565665184|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
156704778|NCT01473524|565665185|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
156704779|NCT01473524|565665186|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
156704780|NCT01473524|565665187|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
156704781|NCT01473524|565665188|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
156704782|NCT01473524|565665189|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
156704783|NCT01473524|565665184|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
156704784|NCT01473524|565665185|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
156704785|NCT01473524|565665186|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
156704786|NCT01473524|565665187|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
156704787|NCT01473524|565665188|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
156704788|NCT01473524|565665189|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
156704789|NCT01473524|565665184|FG000|LTSE Phase|Lost to Follow-up|0|||
156704790|NCT01473524|565665185|FG001|LTSE Phase|Lost to Follow-up|0|||
156704791|NCT01473524|565665186|FG002|LTSE Phase|Lost to Follow-up|0|||
156704792|NCT01473524|565665187|FG003|LTSE Phase|Lost to Follow-up|1|||
156704793|NCT01473524|565665188|FG004|LTSE Phase|Lost to Follow-up|3|||
156704794|NCT01473524|565665189|FG005|LTSE Phase|Lost to Follow-up|2|||
156704795|NCT01473524|565665184|FG000|LTSE Phase|Principal Investigator Decision|0|||
156704796|NCT01473524|565665185|FG001|LTSE Phase|Principal Investigator Decision|0|||
156704797|NCT01473524|565665186|FG002|LTSE Phase|Principal Investigator Decision|0|||
156704798|NCT01473524|565665187|FG003|LTSE Phase|Principal Investigator Decision|1|||
156704799|NCT01473524|565665188|FG004|LTSE Phase|Principal Investigator Decision|1|||
156704800|NCT01473524|565665189|FG005|LTSE Phase|Principal Investigator Decision|3|||
156704801|NCT01473524|565665184|FG000|LTSE Phase|Liver Transplantation|0|||
156704802|NCT01473524|565665185|FG001|LTSE Phase|Liver Transplantation|0|||
156704803|NCT01473524|565665186|FG002|LTSE Phase|Liver Transplantation|0|||
156704804|NCT01473524|565665187|FG003|LTSE Phase|Liver Transplantation|0|||
156704805|NCT01473524|565665188|FG004|LTSE Phase|Liver Transplantation|0|||
156704806|NCT01473524|565665189|FG005|LTSE Phase|Liver Transplantation|1|||
156704807|NCT01473524|565665184|FG000|LTSE Phase|Pregnancy|0|||
156704808|NCT01473524|565665185|FG001|LTSE Phase|Pregnancy|0|||
156704809|NCT01473524|565665186|FG002|LTSE Phase|Pregnancy|0|||
156704810|NCT01473524|565665187|FG003|LTSE Phase|Pregnancy|1|||
156704811|NCT01473524|565665188|FG004|LTSE Phase|Pregnancy|0|||
156704812|NCT01473524|565665189|FG005|LTSE Phase|Pregnancy|0|||
156704813|NCT01473524|565665184|FG000|LTSE Phase|Protocol Violation|0|||
156872168|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
156872169|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
156704814|NCT01473524|565665185|FG001|LTSE Phase|Protocol Violation|0|||
156704815|NCT01473524|565665186|FG002|LTSE Phase|Protocol Violation|0|||
156704816|NCT01473524|565665187|FG003|LTSE Phase|Protocol Violation|0|||
156440497|NCT03144674|564704130|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
156704817|NCT01473524|565665188|FG004|LTSE Phase|Protocol Violation|0|||
156872170|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
156440498|NCT03144674|564704131|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
156704818|NCT01473524|565665189|FG005|LTSE Phase|Protocol Violation|1|||
156704819|NCT01544179|565665190|FG000|Overall Study|Death|50|||
156704820|NCT01544179|565665191|FG001|Overall Study|Death|37|||
156704821|NCT01544179|565665190|FG000|Overall Study|Lost to Follow-up|0|||
156704822|NCT01544179|565665191|FG001|Overall Study|Lost to Follow-up|1|||
156704823|NCT01544179|565665190|FG000|Overall Study|Adverse Event|0|||
156704824|NCT01544179|565665191|FG001|Overall Study|Adverse Event|1|||
156704825|NCT01544179|565665190|FG000|Overall Study|Withdrawal by Subject|12|||
156704826|NCT01544179|565665191|FG001|Overall Study|Withdrawal by Subject|7|||
156704827|NCT01544179|565665190|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
156704828|NCT01544179|565665191|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156440499|NCT05510245|564704132|FG000|Overall Study|Withdrawal by Subject|1|||
156704829|NCT02045147|565665192|FG000|Overall Study|Withdrawal by Subject|2|||
156704830|NCT02045147|565665193|FG001|Overall Study|Withdrawal by Subject|0|||
156704831|NCT02045147|565665194|FG002|Overall Study|Withdrawal by Subject|0|||
156704832|NCT02045147|565665195|FG003|Overall Study|Withdrawal by Subject|0|||
156704833|NCT02045147|565665196|FG004|Overall Study|Withdrawal by Subject|0|||
156704834|NCT02045147|565665197|FG005|Overall Study|Withdrawal by Subject|0|||
156704835|NCT02045147|565665198|FG006|Overall Study|Withdrawal by Subject|0|||
156704836|NCT02045147|565665199|FG007|Overall Study|Withdrawal by Subject|1|||
156704837|NCT02045147|565665192|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
156704838|NCT02045147|565665193|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
156704839|NCT02045147|565665194|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
156704840|NCT02045147|565665195|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
156704841|NCT02045147|565665196|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
156704842|NCT02045147|565665197|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
156704843|NCT02045147|565665198|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
156704844|NCT02045147|565665199|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
156704845|NCT04839692|565665200|FG000|Overall Study|Withdrawal by Subject|0|||
156704846|NCT04839692|565665201|FG001|Overall Study|Withdrawal by Subject|3|||
156704847|NCT04839692|565665200|FG000|Overall Study|Physician Decision|1|||
156704848|NCT04839692|565665201|FG001|Overall Study|Physician Decision|0|||
156704849|NCT03146962|565665204|FG000|Overall Study|Lost to Follow-up|1|||
156704850|NCT03146962|565665205|FG001|Overall Study|Lost to Follow-up|1|||
156704851|NCT03146962|565665206|FG002|Overall Study|Lost to Follow-up|0|||
156704852|NCT03146962|565665207|FG003|Overall Study|Lost to Follow-up|0|||
156704853|NCT03146962|565665208|FG004|Overall Study|Lost to Follow-up|0|||
156704854|NCT03146962|565665209|FG005|Overall Study|Lost to Follow-up|0|||
156704855|NCT03146962|565665210|FG006|Overall Study|Lost to Follow-up|0|||
156704856|NCT03146962|565665211|FG007|Overall Study|Lost to Follow-up|0|||
156704857|NCT03146962|565665212|FG008|Overall Study|Lost to Follow-up|0|||
156704858|NCT03146962|565665213|FG009|Overall Study|Lost to Follow-up|0|||
156704859|NCT03146962|565665204|FG000|Overall Study|Adverse Event|0|||
156704860|NCT03146962|565665205|FG001|Overall Study|Adverse Event|3|||
156704861|NCT03146962|565665206|FG002|Overall Study|Adverse Event|0|||
156704862|NCT03146962|565665207|FG003|Overall Study|Adverse Event|0|||
156704863|NCT03146962|565665208|FG004|Overall Study|Adverse Event|0|||
156704864|NCT03146962|565665209|FG005|Overall Study|Adverse Event|0|||
156704865|NCT03146962|565665210|FG006|Overall Study|Adverse Event|0|||
156704866|NCT03146962|565665211|FG007|Overall Study|Adverse Event|1|||
156704867|NCT03146962|565665212|FG008|Overall Study|Adverse Event|0|||
156704868|NCT03146962|565665213|FG009|Overall Study|Adverse Event|0|||
156704869|NCT03146962|565665204|FG000|Overall Study|Withdrawal by Subject|0|||
156704870|NCT03146962|565665205|FG001|Overall Study|Withdrawal by Subject|0|||
156704871|NCT03146962|565665206|FG002|Overall Study|Withdrawal by Subject|0|||
156704872|NCT03146962|565665207|FG003|Overall Study|Withdrawal by Subject|0|||
156704873|NCT03146962|565665208|FG004|Overall Study|Withdrawal by Subject|1|||
156704874|NCT03146962|565665209|FG005|Overall Study|Withdrawal by Subject|0|||
156704875|NCT03146962|565665210|FG006|Overall Study|Withdrawal by Subject|0|||
156704876|NCT03146962|565665211|FG007|Overall Study|Withdrawal by Subject|0|||
156704877|NCT03146962|565665212|FG008|Overall Study|Withdrawal by Subject|0|||
156704878|NCT03146962|565665213|FG009|Overall Study|Withdrawal by Subject|0|||
156704879|NCT03146962|565665204|FG000|Overall Study|Death|0|||
156704880|NCT03146962|565665205|FG001|Overall Study|Death|1|||
156704881|NCT03146962|565665206|FG002|Overall Study|Death|0|||
156440500|NCT05510245|564704133|FG001|Overall Study|Withdrawal by Subject|0|||
156440501|NCT05510245|564704134|FG002|Overall Study|Withdrawal by Subject|0|||
156440502|NCT01395758|564704137|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
156440503|NCT01395758|564704138|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156440504|NCT01395758|564704139|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
156440505|NCT01759771|564704140|FG000|Overall Study|Withdrawal by Subject|1|||
156440506|NCT01759771|564704141|FG001|Overall Study|Withdrawal by Subject|1|||
156440507|NCT01415349|564704142|FG000|Treatment Period 1|Adverse Event|0|||
156440508|NCT01415349|564704143|FG001|Treatment Period 1|Adverse Event|1|||
156440509|NCT01415349|564704142|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156440510|NCT01415349|564704143|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156704882|NCT03146962|565665207|FG003|Overall Study|Death|0|||
156704883|NCT03146962|565665208|FG004|Overall Study|Death|0|||
156704884|NCT03146962|565665209|FG005|Overall Study|Death|0|||
156704885|NCT03146962|565665210|FG006|Overall Study|Death|0|||
156704886|NCT03146962|565665211|FG007|Overall Study|Death|0|||
156704887|NCT03146962|565665212|FG008|Overall Study|Death|0|||
156704888|NCT03146962|565665213|FG009|Overall Study|Death|0|||
156704889|NCT03146962|565665204|FG000|Overall Study|COVID Precautions|1|||
156704890|NCT03146962|565665205|FG001|Overall Study|COVID Precautions|0|||
156704891|NCT03146962|565665206|FG002|Overall Study|COVID Precautions|0|||
156440511|NCT00933400|564704144|FG000|Overall Study|Withdrawal by Subject|21|||
156704892|NCT03146962|565665207|FG003|Overall Study|COVID Precautions|0|||
156704893|NCT03146962|565665208|FG004|Overall Study|COVID Precautions|0|||
156704894|NCT03146962|565665209|FG005|Overall Study|COVID Precautions|0|||
156704895|NCT03146962|565665210|FG006|Overall Study|COVID Precautions|0|||
156704896|NCT03146962|565665211|FG007|Overall Study|COVID Precautions|0|||
156440512|NCT00933400|564704145|FG001|Overall Study|Withdrawal by Subject|1|||
156704897|NCT03146962|565665212|FG008|Overall Study|COVID Precautions|0|||
156704898|NCT03146962|565665213|FG009|Overall Study|COVID Precautions|0|||
156704899|NCT03146962|565665204|FG000|Overall Study|Physician Decision|0|||
156704900|NCT03146962|565665205|FG001|Overall Study|Physician Decision|0|||
156704901|NCT03146962|565665206|FG002|Overall Study|Physician Decision|0|||
156704902|NCT03146962|565665207|FG003|Overall Study|Physician Decision|0|||
156704903|NCT03146962|565665208|FG004|Overall Study|Physician Decision|0|||
156704904|NCT03146962|565665209|FG005|Overall Study|Physician Decision|0|||
156704905|NCT03146962|565665210|FG006|Overall Study|Physician Decision|0|||
156704906|NCT03146962|565665211|FG007|Overall Study|Physician Decision|0|||
156704907|NCT03146962|565665212|FG008|Overall Study|Physician Decision|0|||
156704908|NCT03146962|565665213|FG009|Overall Study|Physician Decision|1|||
156704909|NCT03146962|565665204|FG000|Overall Study|Started New Treatment|0|||
156704910|NCT03146962|565665205|FG001|Overall Study|Started New Treatment|1|||
156704911|NCT03146962|565665206|FG002|Overall Study|Started New Treatment|0|||
156704912|NCT03146962|565665207|FG003|Overall Study|Started New Treatment|0|||
156704913|NCT03146962|565665208|FG004|Overall Study|Started New Treatment|0|||
156704914|NCT03146962|565665209|FG005|Overall Study|Started New Treatment|0|||
156704915|NCT03146962|565665210|FG006|Overall Study|Started New Treatment|0|||
156704916|NCT03146962|565665211|FG007|Overall Study|Started New Treatment|0|||
156704917|NCT03146962|565665212|FG008|Overall Study|Started New Treatment|0|||
156704918|NCT03146962|565665213|FG009|Overall Study|Started New Treatment|0|||
156704919|NCT01635283|565665214|FG000|Overall Study|Tumor Progression|3|||
156704920|NCT01635283|565665214|FG000|Overall Study|Lost to Follow-up|1|||
156704921|NCT04516759|565665215|FG000|Overall Study|Withdrawal by Subject|1|||
156704922|NCT04516759|565665216|FG001|Overall Study|Withdrawal by Subject|1|||
156704923|NCT04516759|565665215|FG000|Overall Study|Other|0|||
156704924|NCT04516759|565665216|FG001|Overall Study|Other|1|||
156704925|NCT03247816|565665225|FG000|Overall Study|Adverse Event|12|||
156704926|NCT03247816|565665225|FG000|Overall Study|Physician Decision|3|||
156704927|NCT03247816|565665225|FG000|Overall Study|Lack of Efficacy|1|||
156704928|NCT03247816|565665225|FG000|Overall Study|Lost to Follow-up|10|||
156704929|NCT03247816|565665225|FG000|Overall Study|Missing Feraccru stop date|3|||
156704930|NCT01439009|565665228|FG000|Overall Study|Physician Decision|5|||
156704931|NCT01439009|565665229|FG001|Overall Study|Physician Decision|3|||
156704932|NCT01439009|565665228|FG000|Overall Study|Protocol Violation|2|||
156704933|NCT01439009|565665229|FG001|Overall Study|Protocol Violation|0|||
156704934|NCT01439009|565665228|FG000|Overall Study|Deviation of exclusion criteria|1|||
156704935|NCT01439009|565665229|FG001|Overall Study|Deviation of exclusion criteria|0|||
156704936|NCT02278055|565665232|FG000|Overall Study|Adverse Event|1|||
156704937|NCT02278055|565665232|FG000|Overall Study|Lost to Follow-up|1|||
156704938|NCT02278055|565665232|FG000|Overall Study|Withdrawal by Subject|2|||
156704939|NCT02278055|565665232|FG000|Overall Study|Progressive Disease|4|||
156704940|NCT01934335|565665233|FG000|Overall Study|Withdrawal by Subject|1|||
156704941|NCT01934335|565665234|FG001|Overall Study|Withdrawal by Subject|1|||
156440513|NCT02139943|564704146|FG000|Overall Study|Adverse Event|0|||
156440514|NCT02139943|564704147|FG001|Overall Study|Adverse Event|1|||
156440515|NCT02139943|564704148|FG002|Overall Study|Adverse Event|2|||
156440516|NCT02139943|564704146|FG000|Overall Study|Lost to Follow-up|3|||
156440517|NCT02139943|564704147|FG001|Overall Study|Lost to Follow-up|2|||
156440518|NCT02139943|564704148|FG002|Overall Study|Lost to Follow-up|2|||
156440519|NCT02139943|564704146|FG000|Overall Study|Withdrawal by Subject|4|||
156440520|NCT02139943|564704147|FG001|Overall Study|Withdrawal by Subject|3|||
156440521|NCT02139943|564704148|FG002|Overall Study|Withdrawal by Subject|0|||
156440522|NCT02139943|564704146|FG000|Overall Study|Other|0|||
156440523|NCT02139943|564704147|FG001|Overall Study|Other|0|||
156440524|NCT02139943|564704148|FG002|Overall Study|Other|1|||
156704942|NCT01111825|565665235|FG000|Overall Study|Withdrawal by Subject|0|||
156440525|NCT02139943|564704146|FG000|Overall Study|Participant wishes to discontinue|2|||
156440526|NCT02139943|564704147|FG001|Overall Study|Participant wishes to discontinue|0|||
156704943|NCT01111825|565665236|FG001|Overall Study|Withdrawal by Subject|0|||
156704944|NCT01111825|565665237|FG002|Overall Study|Withdrawal by Subject|1|||
156704945|NCT01111825|565665238|FG003|Overall Study|Withdrawal by Subject|0|||
156704946|NCT01111825|565665235|FG000|Overall Study|Lost to Follow-up|0|||
156704947|NCT01111825|565665236|FG001|Overall Study|Lost to Follow-up|0|||
156704948|NCT01111825|565665237|FG002|Overall Study|Lost to Follow-up|3|||
156704949|NCT01111825|565665238|FG003|Overall Study|Lost to Follow-up|1|||
156704950|NCT01111825|565665235|FG000|Overall Study|Adverse Event|2|||
156704951|NCT01111825|565665236|FG001|Overall Study|Adverse Event|1|||
156704952|NCT01111825|565665237|FG002|Overall Study|Adverse Event|4|||
156704953|NCT01111825|565665238|FG003|Overall Study|Adverse Event|0|||
156704954|NCT01111825|565665235|FG000|Overall Study|Disease Progression|1|||
156704955|NCT01111825|565665236|FG001|Overall Study|Disease Progression|0|||
156704956|NCT01111825|565665237|FG002|Overall Study|Disease Progression|0|||
156704957|NCT01111825|565665238|FG003|Overall Study|Disease Progression|0|||
156704958|NCT01111825|565665235|FG000|Overall Study|Discontinuation by Sponsor|0|||
156704959|NCT01111825|565665236|FG001|Overall Study|Discontinuation by Sponsor|0|||
156704960|NCT01111825|565665237|FG002|Overall Study|Discontinuation by Sponsor|0|||
156704961|NCT01111825|565665238|FG003|Overall Study|Discontinuation by Sponsor|20|||
156704962|NCT01377987|565665239|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
156704963|NCT01377987|565665240|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
156704964|NCT00469144|565665241|FG000|Overall Study|Death|0|||
156704965|NCT00469144|565665242|FG001|Overall Study|Death|1|||
156332137|NCT00808483|564315055|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
156704966|NCT00469144|565665241|FG000|Overall Study|No Response|5|||
156704967|NCT00469144|565665242|FG001|Overall Study|No Response|5|||
156704968|NCT00469144|565665241|FG000|Overall Study|Progressive Disease|1|||
156704969|NCT00469144|565665242|FG001|Overall Study|Progressive Disease|0|||
156704970|NCT01994291|565665243|FG000|Overall Study|Adverse Event|4|||
156704971|NCT01994291|565665244|FG001|Overall Study|Adverse Event|1|||
156704972|NCT01994291|565665245|FG002|Overall Study|Adverse Event|3|||
156704973|NCT01994291|565665243|FG000|Overall Study|Lost to Follow-up|1|||
156704974|NCT01994291|565665244|FG001|Overall Study|Lost to Follow-up|1|||
156704975|NCT01994291|565665245|FG002|Overall Study|Lost to Follow-up|0|||
156704976|NCT01994291|565665243|FG000|Overall Study|Does not meet entrance criteria|1|||
156704977|NCT01994291|565665244|FG001|Overall Study|Does not meet entrance criteria|0|||
156704978|NCT01994291|565665245|FG002|Overall Study|Does not meet entrance criteria|0|||
156704979|NCT01994291|565665243|FG000|Overall Study|Medication error without associated AE|1|||
156704980|NCT01994291|565665244|FG001|Overall Study|Medication error without associated AE|0|||
156704981|NCT01994291|565665245|FG002|Overall Study|Medication error without associated AE|1|||
156704982|NCT01994291|565665243|FG000|Overall Study|Protocol Violation|1|||
156704983|NCT01994291|565665244|FG001|Overall Study|Protocol Violation|0|||
156704984|NCT01994291|565665245|FG002|Overall Study|Protocol Violation|0|||
156704985|NCT01994291|565665243|FG000|Overall Study|Withdrawal by Subject|6|||
156704986|NCT01994291|565665244|FG001|Overall Study|Withdrawal by Subject|3|||
156704987|NCT01994291|565665245|FG002|Overall Study|Withdrawal by Subject|5|||
156704988|NCT01994291|565665243|FG000|Overall Study|Other|1|||
156704989|NCT01994291|565665244|FG001|Overall Study|Other|2|||
156704990|NCT01994291|565665245|FG002|Overall Study|Other|0|||
156704991|NCT00838435|565665250|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
156704992|NCT00838435|565665250|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
156704993|NCT00838435|565665250|FG000|Part 2 (7 Years)|Adverse Event|2|||
156704994|NCT00838435|565665250|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
156704995|NCT00838435|565665250|FG000|Part 2 (7 Years)|Physician Decision|1|||
156704996|NCT00838435|565665250|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
156704997|NCT00838435|565665250|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
156704998|NCT00678886|565665251|FG000|Overall Study|Withdrawal by Subject|0|||
156704999|NCT00678886|565665252|FG001|Overall Study|Withdrawal by Subject|0|||
156705000|NCT00678886|565665253|FG002|Overall Study|Withdrawal by Subject|4|||
156705001|NCT00678886|565665254|FG003|Overall Study|Withdrawal by Subject|6|||
156705002|NCT00678886|565665251|FG000|Overall Study|Physician Decision|0|||
156705003|NCT00678886|565665252|FG001|Overall Study|Physician Decision|0|||
156705004|NCT00678886|565665253|FG002|Overall Study|Physician Decision|1|||
156705005|NCT00678886|565665254|FG003|Overall Study|Physician Decision|1|||
156705006|NCT00678886|565665251|FG000|Overall Study|Lost to Follow-up|0|||
156705007|NCT00678886|565665252|FG001|Overall Study|Lost to Follow-up|0|||
156705008|NCT00678886|565665253|FG002|Overall Study|Lost to Follow-up|3|||
156705009|NCT00678886|565665254|FG003|Overall Study|Lost to Follow-up|2|||
156705010|NCT00678886|565665251|FG000|Overall Study|Other|0|||
156705011|NCT00678886|565665252|FG001|Overall Study|Other|0|||
156705012|NCT00678886|565665253|FG002|Overall Study|Other|1|||
156705013|NCT00678886|565665254|FG003|Overall Study|Other|0|||
156705014|NCT01147107|565665255|FG000|Overall Study|Lack of Efficacy|5|||
156791087|NCT01898091|565987147|FG000|Overall Study|Withdrawal by Subject|1|||
156791088|NCT01898091|565987148|FG001|Overall Study|Withdrawal by Subject|5|||
156332138|NCT00808483|564315056|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
156332139|NCT00808483|564315055|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
156705015|NCT01147107|565665256|FG001|Overall Study|Lack of Efficacy|0|||
156705016|NCT01147107|565665255|FG000|Overall Study|Withdrawal by Subject|1|||
156705017|NCT01147107|565665256|FG001|Overall Study|Withdrawal by Subject|1|||
156705018|NCT04693416|565665257|FG000|Overall Study|Lost to Follow-up|13|||
156705019|NCT04693416|565665258|FG001|Overall Study|Lost to Follow-up|0|||
156705020|NCT00369317|565665261|FG000|Overall Study|Adverse Event|3|||
156705021|NCT00369317|565665261|FG000|Overall Study|Death|1|||
156332140|NCT00808483|564315056|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
156705022|NCT00369317|565665261|FG000|Overall Study|Lack of Efficacy|5|||
156705023|NCT00369317|565665261|FG000|Overall Study|Physician Decision|2|||
156705024|NCT00369317|565665261|FG000|Overall Study|Withdrawal by Subject|8|||
156705025|NCT00369317|565665261|FG000|Overall Study|Ineligible|1|||
156705026|NCT04572893|565665265|FG000|Part A|Adverse Event|1|||
156705027|NCT04572893|565665266|FG001|Part A|Adverse Event|0|||
156705028|NCT04572893|565665267|FG002|Part A|Adverse Event|0|||
156705029|NCT04572893|565665268|FG003|Part A|Adverse Event|0|||
156791089|NCT03721107|565987149|FG000|Overall Study|Adverse Event|1|||
156705030|NCT04572893|565665269|FG004|Part A|Adverse Event|0|||
156705031|NCT04572893|565665270|FG005|Part A|Adverse Event|0|||
156705032|NCT04572893|565665271|FG006|Part A|Adverse Event|0|||
156705033|NCT04572893|565665265|FG000|Part B|Withdrawal by Subject|0|||
156705034|NCT04572893|565665266|FG001|Part B|Withdrawal by Subject|0|||
156705035|NCT04572893|565665267|FG002|Part B|Withdrawal by Subject|0|||
156705036|NCT04572893|565665268|FG003|Part B|Withdrawal by Subject|0|||
156705037|NCT04572893|565665269|FG004|Part B|Withdrawal by Subject|0|||
156705038|NCT04572893|565665270|FG005|Part B|Withdrawal by Subject|1|||
156705039|NCT04572893|565665271|FG006|Part B|Withdrawal by Subject|0|||
156705040|NCT04572893|565665265|FG000|Part B|Study terminated by sponsor|0|||
156705041|NCT04572893|565665266|FG001|Part B|Study terminated by sponsor|0|||
156705042|NCT04572893|565665267|FG002|Part B|Study terminated by sponsor|0|||
156705043|NCT04572893|565665268|FG003|Part B|Study terminated by sponsor|0|||
156705044|NCT04572893|565665269|FG004|Part B|Study terminated by sponsor|7|||
156705045|NCT04572893|565665270|FG005|Part B|Study terminated by sponsor|5|||
156705046|NCT04572893|565665271|FG006|Part B|Study terminated by sponsor|3|||
156705047|NCT04572893|565665265|FG000|Part B|Lost to Follow-up|0|||
156705048|NCT04572893|565665266|FG001|Part B|Lost to Follow-up|0|||
156705049|NCT04572893|565665267|FG002|Part B|Lost to Follow-up|0|||
156705050|NCT04572893|565665268|FG003|Part B|Lost to Follow-up|0|||
156705051|NCT04572893|565665269|FG004|Part B|Lost to Follow-up|0|||
156705052|NCT04572893|565665270|FG005|Part B|Lost to Follow-up|0|||
156705053|NCT04572893|565665271|FG006|Part B|Lost to Follow-up|1|||
156705054|NCT04572893|565665265|FG000|Part B|Adverse Event|0|||
156705055|NCT04572893|565665266|FG001|Part B|Adverse Event|0|||
156705056|NCT04572893|565665267|FG002|Part B|Adverse Event|0|||
156705057|NCT04572893|565665268|FG003|Part B|Adverse Event|0|||
156705058|NCT04572893|565665269|FG004|Part B|Adverse Event|1|||
156705059|NCT04572893|565665270|FG005|Part B|Adverse Event|1|||
156705060|NCT04572893|565665271|FG006|Part B|Adverse Event|0|||
156705061|NCT02679235|565667016|FG000|Overall Study|Withdrawal by Subject|3|||
156705062|NCT02679235|565667016|FG000|Overall Study|Adverse Event|1|||
156705063|NCT00923273|565667017|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
156705064|NCT00923273|565667018|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
156705065|NCT00923273|565667019|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
156705066|NCT00923273|565667020|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
156705067|NCT00923273|565667021|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
156705068|NCT00923273|565667017|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
156705069|NCT00923273|565667018|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
156705070|NCT00923273|565667019|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
156705071|NCT00923273|565667020|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
156705072|NCT00923273|565667021|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
156705073|NCT01438996|565667024|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
156705074|NCT01438996|565667025|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
156705075|NCT01438996|565667026|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
156705076|NCT02246114|565667027|FG000|Overall Study|miscarriage|1|||
156705077|NCT02246114|565667028|FG001|Overall Study|miscarriage|0|||
156705078|NCT01775189|565667029|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705079|NCT01775189|565667030|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
156705080|NCT01775189|565667031|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705081|NCT01775189|565667032|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705082|NCT01775189|565667033|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705083|NCT01775189|565667034|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705084|NCT01775189|565667035|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705085|NCT01775189|565667029|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705086|NCT01775189|565667030|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
156705087|NCT01775189|565667031|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705088|NCT01775189|565667032|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705089|NCT01775189|565667033|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705090|NCT01775189|565667034|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705091|NCT01775189|565667035|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705092|NCT01775189|565667029|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705093|NCT01775189|565667030|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
156705094|NCT01775189|565667031|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
156705095|NCT01775189|565667032|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705096|NCT01775189|565667033|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705097|NCT01775189|565667034|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705098|NCT01775189|565667035|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705099|NCT01775189|565667029|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705100|NCT01775189|565667030|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705101|NCT01775189|565667031|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705102|NCT01775189|565667032|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705103|NCT01775189|565667033|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705104|NCT01775189|565667034|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
156705105|NCT01775189|565667035|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705106|NCT01775189|565667029|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705107|NCT01775189|565667030|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705108|NCT01775189|565667031|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705109|NCT01775189|565667032|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
156705110|NCT01775189|565667033|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705111|NCT01775189|565667034|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705112|NCT01775189|565667035|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705113|NCT01775189|565667029|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705114|NCT01775189|565667030|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705115|NCT01775189|565667031|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705116|NCT01775189|565667032|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
156705117|NCT01775189|565667033|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705118|NCT01775189|565667034|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705119|NCT01775189|565667035|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
156705120|NCT02227446|565667039|FG000|Overall Study|not eligible post randomization|18|||
156705121|NCT02227446|565667040|FG001|Overall Study|not eligible post randomization|29|||
156705122|NCT02227446|565667039|FG000|Overall Study|Withdrawal by Subject|4|||
156705123|NCT02227446|565667040|FG001|Overall Study|Withdrawal by Subject|5|||
156705124|NCT02121392|565667041|FG000|Prior to Intervention|Protocol Violation|40|||
156705125|NCT02121392|565667042|FG001|Prior to Intervention|Protocol Violation|35|||
156705126|NCT02121392|565667041|FG000|Prior to Intervention|Withdrawal by Subject|8|||
156705127|NCT02121392|565667042|FG001|Prior to Intervention|Withdrawal by Subject|6|||
156705128|NCT02121392|565667041|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
156705129|NCT02121392|565667042|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
156705130|NCT02121392|565667041|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
156705131|NCT02121392|565667042|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
156705132|NCT01352416|565667043|FG000|Overall Study|Physician Decision|1|||
156705133|NCT01352416|565667044|FG001|Overall Study|Physician Decision|2|||
156705134|NCT01352416|565667045|FG002|Overall Study|Physician Decision|2|||
156705135|NCT01352416|565667046|FG003|Overall Study|Physician Decision|1|||
156705136|NCT03016975|565667056|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
156705137|NCT03016975|565667057|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
156705138|NCT03016975|565667058|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
156705139|NCT03016975|565667056|FG000|At 6 Months Follow-up|Death|2|||
156705140|NCT03016975|565667057|FG001|At 6 Months Follow-up|Death|0|||
156705141|NCT03016975|565667058|FG002|At 6 Months Follow-up|Death|0|||
156705142|NCT03016975|565667056|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
156705143|NCT03016975|565667057|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
156705144|NCT03016975|565667058|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
156705145|NCT03016975|565667056|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
156705146|NCT03016975|565667057|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
156705147|NCT03016975|565667058|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
156705148|NCT03016975|565667056|FG000|At 6 Months Follow-up|Aborted implant|1|||
156705149|NCT03016975|565667057|FG001|At 6 Months Follow-up|Aborted implant|0|||
156705150|NCT03016975|565667058|FG002|At 6 Months Follow-up|Aborted implant|0|||
156705151|NCT03016975|565667056|FG000|At 2 Year Follow-up|Death|1|||
156705152|NCT03016975|565667057|FG001|At 2 Year Follow-up|Death|0|||
156705153|NCT03016975|565667058|FG002|At 2 Year Follow-up|Death|0|||
156705154|NCT03016975|565667056|FG000|At 3 Year Follow-up|Death|1|||
156705155|NCT03016975|565667057|FG001|At 3 Year Follow-up|Death|0|||
156705156|NCT03016975|565667058|FG002|At 3 Year Follow-up|Death|0|||
156705157|NCT03016975|565667056|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
156705158|NCT03016975|565667057|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
156705159|NCT03016975|565667058|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
156705160|NCT03016975|565667056|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
156705161|NCT03016975|565667057|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
156705162|NCT03016975|565667058|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
156705163|NCT02901548|565667059|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
156705164|NCT02348723|565667063|FG000|Overall Study|No ablation|21|||
156705165|NCT02348723|565667064|FG001|Overall Study|No ablation|20|||
156705166|NCT02348723|565667063|FG000|Overall Study|Non-compliant with Protocol|1|||
156705167|NCT02348723|565667064|FG001|Overall Study|Non-compliant with Protocol|0|||
156705168|NCT02348723|565667063|FG000|Overall Study|Lost to Follow-up|1|||
156705169|NCT02348723|565667064|FG001|Overall Study|Lost to Follow-up|1|||
156705170|NCT02348723|565667063|FG000|Overall Study|Consent withdrawn|1|||
156705171|NCT02348723|565667064|FG001|Overall Study|Consent withdrawn|3|||
156705172|NCT02348723|565667063|FG000|Overall Study|Reason other than specified|1|||
156705173|NCT02348723|565667064|FG001|Overall Study|Reason other than specified|1|||
156705174|NCT02348723|565667063|FG000|Overall Study|Adverse Event|3|||
156705175|NCT02348723|565667064|FG001|Overall Study|Adverse Event|1|||
156705176|NCT02087189|565667065|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
156705177|NCT01671332|565667069|FG000|Overall Study|Withdrawal by Subject|1|||
156705178|NCT01671332|565667070|FG001|Overall Study|Withdrawal by Subject|1|||
156705179|NCT01458106|565667076|FG000|Overall Study|Withdrawal by Subject|2|||
156705180|NCT01458106|565667077|FG001|Overall Study|Withdrawal by Subject|0|||
156705181|NCT01458106|565667076|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
156705182|NCT01458106|565667077|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
156705183|NCT01458106|565667076|FG000|Overall Study|Withdrawn Per Protocol|0|||
156705184|NCT01458106|565667077|FG001|Overall Study|Withdrawn Per Protocol|1|||
156705185|NCT04428333|565667080|FG000|Overall Study|Physician Decision|5|||
156705186|NCT04428333|565667081|FG001|Overall Study|Physician Decision|6|||
156705187|NCT04428333|565667080|FG000|Overall Study|Withdrawal by Subject|1|||
156705188|NCT04428333|565667081|FG001|Overall Study|Withdrawal by Subject|3|||
156705189|NCT04428333|565667080|FG000|Overall Study|Study Terminated By Sponsor|14|||
156705190|NCT04428333|565667081|FG001|Overall Study|Study Terminated By Sponsor|16|||
156705191|NCT02269163|565667082|FG000|Overall Study|Lost to Follow-up|1|||
156705192|NCT02269163|565667083|FG001|Overall Study|Lost to Follow-up|0|||
156705193|NCT02269163|565667082|FG000|Overall Study|Major protocol violation|0|||
156705194|NCT02269163|565667083|FG001|Overall Study|Major protocol violation|1|||
156705195|NCT02269163|565667082|FG000|Overall Study|Other|2|||
156705196|NCT02269163|565667083|FG001|Overall Study|Other|2|||
156705197|NCT02269163|565667082|FG000|Overall Study|Withdrawal by Subject|0|||
156705198|NCT02269163|565667083|FG001|Overall Study|Withdrawal by Subject|3|||
156705199|NCT02269163|565667082|FG000|Overall Study|Physician Decision|0|||
156705200|NCT02269163|565667083|FG001|Overall Study|Physician Decision|1|||
156705201|NCT02351960|565667084|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
156705202|NCT02351960|565667085|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
156705203|NCT02351960|565667084|FG000|Overall Study|Voluntary Withdrawal|5|||
156705204|NCT02351960|565667085|FG001|Overall Study|Voluntary Withdrawal|4|||
156705205|NCT02351960|565667084|FG000|Overall Study|Significant Protocol Deviation|0|||
156705206|NCT02351960|565667085|FG001|Overall Study|Significant Protocol Deviation|5|||
156705207|NCT03866902|565667088|FG000|Overall Study|Lost to Follow-up|98|||
156705208|NCT03866902|565667089|FG001|Overall Study|Lost to Follow-up|82|||
156705209|NCT03866902|565667088|FG000|Overall Study|Pregnancy|18|||
156705210|NCT03866902|565667089|FG001|Overall Study|Pregnancy|24|||
156705211|NCT04730349|565667094|FG000|Overall Study|Participant withdrew consent|1|||
156705212|NCT04730349|565667095|FG001|Overall Study|Participant withdrew consent|0|||
156705213|NCT04730349|565667094|FG000|Overall Study|Disease progression|6|||
156705214|NCT04730349|565667095|FG001|Overall Study|Disease progression|4|||
156705215|NCT04730349|565667094|FG000|Overall Study|Study drug toxicity|0|||
156705216|NCT04730349|565667095|FG001|Overall Study|Study drug toxicity|1|||
156705217|NCT00638027|565667098|FG000|Overall Study|Adverse Event|0|||
156705218|NCT00638027|565667099|FG001|Overall Study|Adverse Event|2|||
156705219|NCT02092467|565667101|FG000|Overall Study|Death|49|||
156705220|NCT02092467|565667102|FG001|Overall Study|Death|66|||
156705221|NCT02092467|565667103|FG002|Overall Study|Death|38|||
156705222|NCT02092467|565667101|FG000|Overall Study|Lost to Follow-up|38|||
156705223|NCT02092467|565667102|FG001|Overall Study|Lost to Follow-up|35|||
156705224|NCT02092467|565667103|FG002|Overall Study|Lost to Follow-up|40|||
156705225|NCT02092467|565667101|FG000|Overall Study|Global Deterioration of Health Status|1|||
156705226|NCT02092467|565667102|FG001|Overall Study|Global Deterioration of Health Status|0|||
156705227|NCT02092467|565667103|FG002|Overall Study|Global Deterioration of Health Status|0|||
156705228|NCT02092467|565667101|FG000|Overall Study|Other|32|||
156705229|NCT02092467|565667102|FG001|Overall Study|Other|30|||
156705230|NCT02092467|565667103|FG002|Overall Study|Other|24|||
156705231|NCT02092467|565667101|FG000|Overall Study|Withdrawal by Subject|282|||
156705232|NCT02092467|565667102|FG001|Overall Study|Withdrawal by Subject|327|||
156705233|NCT02092467|565667103|FG002|Overall Study|Withdrawal by Subject|289|||
156705234|NCT02092467|565667101|FG000|Overall Study|Randomized but not treated|2|||
156705235|NCT02092467|565667102|FG001|Overall Study|Randomized but not treated|1|||
156705236|NCT02092467|565667103|FG002|Overall Study|Randomized but not treated|7|||
156705237|NCT00371397|565667104|FG000|Session 1|Withdrawal by Subject|1|||
156705238|NCT00371397|565667105|FG001|Session 1|Withdrawal by Subject|0|||
156705239|NCT00371397|565667106|FG002|Session 1|Withdrawal by Subject|0|||
156705240|NCT00371397|565667107|FG003|Session 1|Withdrawal by Subject|0|||
156705241|NCT00371397|565667108|FG004|Session 1|Withdrawal by Subject|0|||
156705242|NCT00371397|565667109|FG005|Session 1|Withdrawal by Subject|0|||
156872171|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
156705243|NCT00371397|565667110|FG006|Session 1|Withdrawal by Subject|0|||
156872172|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
156705244|NCT00371397|565667111|FG007|Session 1|Withdrawal by Subject|1|||
156705245|NCT00371397|565667112|FG008|Session 1|Withdrawal by Subject|0|||
156705246|NCT00371397|565667113|FG009|Session 1|Withdrawal by Subject|0|||
156705247|NCT00371397|565667114|FG010|Session 1|Withdrawal by Subject|0|||
156705248|NCT00371397|565667115|FG011|Session 1|Withdrawal by Subject|0|||
156705249|NCT01284621|565667116|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156332141|NCT02038881|564315057|FG000|Overall Study|Withdrawal by Subject|0|||
156705250|NCT01284621|565667117|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156705251|NCT01284621|565667118|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156705252|NCT01284621|565667119|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156705253|NCT01284621|565667120|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
156332142|NCT02038881|564315058|FG001|Overall Study|Withdrawal by Subject|0|||
156332143|NCT02038881|564315059|FG002|Overall Study|Withdrawal by Subject|1|||
156705254|NCT01284621|565667121|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156705255|NCT02377427|565667124|FG000|Part A (Up to Week 20)|Physician Decision|1|||
156705256|NCT02377427|565667125|FG001|Part A (Up to Week 20)|Physician Decision|0|||
156705257|NCT02377427|565667126|FG002|Part A (Up to Week 20)|Physician Decision|0|||
156705258|NCT02377427|565667127|FG003|Part A (Up to Week 20)|Physician Decision|0|||
156705259|NCT02377427|565667128|FG004|Part A (Up to Week 20)|Physician Decision|0|||
156705260|NCT02377427|565667124|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
156705261|NCT02377427|565667125|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
156705262|NCT02377427|565667126|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
156705263|NCT02377427|565667127|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
156705264|NCT02377427|565667128|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
156705265|NCT02377427|565667124|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
156705266|NCT02377427|565667125|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
156705267|NCT02377427|565667126|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
156705268|NCT02377427|565667127|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
156705269|NCT02377427|565667128|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
156705270|NCT02377427|565667124|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
156705271|NCT02377427|565667125|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
156705272|NCT02377427|565667126|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
156705273|NCT02377427|565667127|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
156705274|NCT02377427|565667128|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
156705275|NCT02342639|565667135|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
156705276|NCT02342639|565667136|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
156705277|NCT02342639|565667135|FG000|Overall Study|Protocol Violation|0|||
156705278|NCT02342639|565667136|FG001|Overall Study|Protocol Violation|2|||
156705279|NCT02293863|565667137|FG000|Overall Study|Death|4|||
156705280|NCT02293863|565667138|FG001|Overall Study|Death|6|||
156705281|NCT02293863|565667139|FG002|Overall Study|Death|4|||
156705282|NCT02293863|565667137|FG000|Overall Study|Lost to Follow-up|2|||
156705283|NCT02293863|565667138|FG001|Overall Study|Lost to Follow-up|2|||
156705284|NCT02293863|565667139|FG002|Overall Study|Lost to Follow-up|2|||
156705285|NCT02293863|565667137|FG000|Overall Study|Withdrawal by Subject|3|||
156705286|NCT02293863|565667138|FG001|Overall Study|Withdrawal by Subject|3|||
156705287|NCT02293863|565667139|FG002|Overall Study|Withdrawal by Subject|1|||
156705288|NCT02293863|565667137|FG000|Overall Study|Reason Not Specified|0|||
156705289|NCT02293863|565667138|FG001|Overall Study|Reason Not Specified|2|||
156332144|NCT02038881|564315057|FG000|Overall Study|Lost to Follow-up|2|||
156705290|NCT02293863|565667139|FG002|Overall Study|Reason Not Specified|2|||
156705291|NCT00416884|565667142|FG000|Overall Study|Study terminated due to low accrual|1|||
156705292|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
156705293|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
156705294|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705295|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705296|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705297|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705298|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705299|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705300|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705301|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705302|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705303|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156332145|NCT02038881|564315058|FG001|Overall Study|Lost to Follow-up|0|||
156705304|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705305|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705306|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
156705307|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
156705308|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705309|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156791090|NCT03721107|565987150|FG001|Overall Study|Adverse Event|1|||
156332146|NCT02038881|564315059|FG002|Overall Study|Lost to Follow-up|0|||
156332147|NCT02038881|564315057|FG000|Overall Study|incarcerated|1|||
156332148|NCT02038881|564315058|FG001|Overall Study|incarcerated|0|||
156705310|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705311|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705312|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705313|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705314|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705315|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705316|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705317|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705318|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705319|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705320|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
156705321|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
156705322|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156531659|NCT01641809|565041698|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
156531660|NCT01641809|565041699|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
156705323|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705324|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705325|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705326|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705327|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705328|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705329|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705330|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705331|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705332|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705333|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705334|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
156705335|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
156705336|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705337|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705338|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705339|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705340|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705341|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705342|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705343|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705344|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705345|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705346|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705347|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705348|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
156705349|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
156705350|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705351|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705352|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705353|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705354|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705355|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705356|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705357|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705358|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705359|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705360|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705361|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705362|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
156705363|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
156705364|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705365|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705366|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705367|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705368|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705369|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705370|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705371|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705372|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705373|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705374|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156531661|NCT01641809|565041700|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
156531662|NCT01641809|565041701|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
156531663|NCT01641809|565041698|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
156531664|NCT01641809|565041699|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
156531665|NCT01641809|565041700|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
156531666|NCT01641809|565041701|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
156531667|NCT01641809|565041698|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
156531668|NCT01641809|565041699|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
156531669|NCT01641809|565041700|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
156531670|NCT01641809|565041701|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
156531671|NCT01641809|565041698|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
156531672|NCT01641809|565041699|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
156531673|NCT01641809|565041700|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
156531674|NCT01641809|565041701|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
156531675|NCT01641809|565041698|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
156531676|NCT01641809|565041699|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
156531677|NCT01641809|565041700|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
156531678|NCT01641809|565041701|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
156531679|NCT01641809|565041698|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
156531680|NCT01641809|565041699|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
156531681|NCT01641809|565041700|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
156531682|NCT01641809|565041701|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
156531683|NCT01641809|565041698|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
156531684|NCT01641809|565041699|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
156531685|NCT01641809|565041700|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
156531686|NCT01641809|565041701|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
156531687|NCT01641809|565041698|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
156531688|NCT01641809|565041699|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
156531689|NCT01641809|565041700|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
156531690|NCT01641809|565041701|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
156531691|NCT01641809|565041698|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
156531692|NCT01641809|565041699|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
156531693|NCT01641809|565041700|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
156531694|NCT01641809|565041701|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
156531695|NCT01641809|565041698|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
156531696|NCT01641809|565041699|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
156531697|NCT01641809|565041700|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
156531698|NCT01641809|565041701|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
156531699|NCT01641809|565041698|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
156531700|NCT01641809|565041699|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
156531701|NCT01641809|565041700|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
156531702|NCT01641809|565041701|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
156705375|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705376|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
156705377|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
156705378|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705379|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705380|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705381|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705382|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705383|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705384|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705385|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705386|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705387|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705388|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156791091|NCT03721107|565987151|FG002|Overall Study|Adverse Event|6|||
156791092|NCT03721107|565987152|FG003|Overall Study|Adverse Event|5|||
156791093|NCT03721107|565987149|FG000|Overall Study|Lost to Follow-up|2|||
156791094|NCT03721107|565987150|FG001|Overall Study|Lost to Follow-up|0|||
156791095|NCT03721107|565987151|FG002|Overall Study|Lost to Follow-up|3|||
156791096|NCT03721107|565987152|FG003|Overall Study|Lost to Follow-up|0|||
156332149|NCT02038881|564315059|FG002|Overall Study|incarcerated|0|||
156332150|NCT00333840|564315060|FG000|First-line Treatment Period|Adverse Event|38|||
156531703|NCT01641809|565041698|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
156531704|NCT01641809|565041699|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
156531705|NCT01641809|565041700|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
156705389|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705390|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
156705391|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
156705392|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705393|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705394|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705395|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705396|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705397|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705398|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156872173|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
156872174|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
156872175|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
156872176|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
156872177|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
156872178|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
156872179|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
156872180|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
156872181|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
156332151|NCT00333840|564315061|FG001|First-line Treatment Period|Adverse Event|37|||
156705399|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705400|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705401|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705402|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705403|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705404|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
156705405|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
156705406|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705407|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705408|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705409|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705410|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705411|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705412|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705413|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705414|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705415|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705416|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705417|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705418|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
156705419|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
156705420|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705421|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705422|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705423|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705424|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705425|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705426|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705427|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705428|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705429|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705430|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705431|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705432|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
156705433|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
156705434|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705435|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705436|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705437|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705438|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705439|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705440|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705441|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156332152|NCT00333840|564315062|FG002|First-line Treatment Period|Adverse Event|0|||
156332153|NCT00333840|564315063|FG003|First-line Treatment Period|Adverse Event|0|||
156705442|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705443|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705444|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705445|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705446|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
156705447|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
156705448|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705449|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705450|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705451|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705452|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705453|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705454|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705455|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705456|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705457|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705458|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705459|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705460|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705461|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705462|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705463|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
156705464|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705465|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705466|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705467|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705468|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705469|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705470|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705471|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705472|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705473|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705474|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705475|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705476|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
156705477|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705478|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705479|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705480|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705481|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705482|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705483|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705484|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705485|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705486|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705487|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705488|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705489|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705490|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
156791097|NCT03721107|565987149|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
156791098|NCT03721107|565987150|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
156791099|NCT03721107|565987151|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
156791100|NCT03721107|565987152|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
156791101|NCT03721107|565987149|FG000|Overall Study|Physician Decision|0|||
156791102|NCT03721107|565987150|FG001|Overall Study|Physician Decision|1|||
156791103|NCT03721107|565987151|FG002|Overall Study|Physician Decision|0|||
156791104|NCT03721107|565987152|FG003|Overall Study|Physician Decision|0|||
156791105|NCT03721107|565987149|FG000|Overall Study|Pregnancy|0|||
156791106|NCT03721107|565987150|FG001|Overall Study|Pregnancy|0|||
156791107|NCT03721107|565987151|FG002|Overall Study|Pregnancy|1|||
156791108|NCT03721107|565987152|FG003|Overall Study|Pregnancy|0|||
156791109|NCT03721107|565987149|FG000|Overall Study|Withdrawal by Subject|1|||
156791110|NCT03721107|565987150|FG001|Overall Study|Withdrawal by Subject|1|||
156332154|NCT00333840|564315060|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
156332155|NCT00333840|564315061|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
156332156|NCT00333840|564315062|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
156332157|NCT00333840|564315063|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
156332158|NCT00333840|564315060|FG000|First-line Treatment Period|Abnormal procedure|2|||
156332159|NCT00333840|564315061|FG001|First-line Treatment Period|Abnormal procedure|0|||
156332160|NCT00333840|564315062|FG002|First-line Treatment Period|Abnormal procedure|0|||
156332161|NCT00333840|564315063|FG003|First-line Treatment Period|Abnormal procedure|0|||
156332162|NCT00333840|564315060|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
156332163|NCT00333840|564315061|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
156332164|NCT00333840|564315062|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
156332165|NCT00333840|564315063|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
156332166|NCT00333840|564315060|FG000|First-line Treatment Period|No longer required study drug|21|||
156332167|NCT00333840|564315061|FG001|First-line Treatment Period|No longer required study drug|8|||
156332168|NCT00333840|564315062|FG002|First-line Treatment Period|No longer required study drug|0|||
156332169|NCT00333840|564315063|FG003|First-line Treatment Period|No longer required study drug|0|||
156332170|NCT00333840|564315060|FG000|First-line Treatment Period|Protocol Violation|17|||
156332171|NCT00333840|564315061|FG001|First-line Treatment Period|Protocol Violation|17|||
156332172|NCT00333840|564315062|FG002|First-line Treatment Period|Protocol Violation|0|||
156332173|NCT00333840|564315063|FG003|First-line Treatment Period|Protocol Violation|0|||
156332174|NCT00333840|564315060|FG000|First-line Treatment Period|Subject withdrew consent|57|||
156332175|NCT00333840|564315061|FG001|First-line Treatment Period|Subject withdrew consent|77|||
156332176|NCT00333840|564315062|FG002|First-line Treatment Period|Subject withdrew consent|0|||
156332177|NCT00333840|564315063|FG003|First-line Treatment Period|Subject withdrew consent|0|||
156332178|NCT00333840|564315060|FG000|First-line Treatment Period|Lost to Follow-up|15|||
156332179|NCT00333840|564315061|FG001|First-line Treatment Period|Lost to Follow-up|6|||
156332180|NCT00333840|564315062|FG002|First-line Treatment Period|Lost to Follow-up|0|||
156332181|NCT00333840|564315063|FG003|First-line Treatment Period|Lost to Follow-up|0|||
156332182|NCT00333840|564315060|FG000|First-line Treatment Period|Administrative problems|12|||
156332183|NCT00333840|564315061|FG001|First-line Treatment Period|Administrative problems|6|||
156332184|NCT00333840|564315062|FG002|First-line Treatment Period|Administrative problems|0|||
156332185|NCT00333840|564315063|FG003|First-line Treatment Period|Administrative problems|0|||
156332186|NCT00333840|564315060|FG000|First-line Treatment Period|Death|19|||
156332187|NCT00333840|564315061|FG001|First-line Treatment Period|Death|2|||
156332188|NCT00333840|564315062|FG002|First-line Treatment Period|Death|0|||
156332189|NCT00333840|564315063|FG003|First-line Treatment Period|Death|0|||
156332190|NCT00333840|564315060|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
156332191|NCT00333840|564315061|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
156332192|NCT00333840|564315062|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
156332193|NCT00333840|564315063|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
156332194|NCT00333840|564315060|FG000|Second-line Treatment Period|Adverse Event|0|||
156332195|NCT00333840|564315061|FG001|Second-line Treatment Period|Adverse Event|0|||
156332196|NCT00333840|564315062|FG002|Second-line Treatment Period|Adverse Event|3|||
156332197|NCT00333840|564315063|FG003|Second-line Treatment Period|Adverse Event|34|||
156332198|NCT00333840|564315060|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
156332199|NCT00333840|564315061|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
156332200|NCT00333840|564315062|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
156332201|NCT00333840|564315063|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
156332202|NCT00333840|564315060|FG000|Second-line Treatment Period|Abnormal procedure|0|||
156332203|NCT00333840|564315061|FG001|Second-line Treatment Period|Abnormal procedure|0|||
156332204|NCT00333840|564315062|FG002|Second-line Treatment Period|Abnormal procedure|0|||
156332205|NCT00333840|564315063|FG003|Second-line Treatment Period|Abnormal procedure|1|||
156332206|NCT00333840|564315060|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
156332207|NCT00333840|564315061|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
156332208|NCT00333840|564315062|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
156332209|NCT00333840|564315063|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
156332210|NCT00333840|564315060|FG000|Second-line Treatment Period|No longer required study drug|0|||
156332211|NCT00333840|564315061|FG001|Second-line Treatment Period|No longer required study drug|0|||
156332212|NCT00333840|564315062|FG002|Second-line Treatment Period|No longer required study drug|1|||
156332213|NCT00333840|564315063|FG003|Second-line Treatment Period|No longer required study drug|14|||
156332214|NCT00333840|564315060|FG000|Second-line Treatment Period|Protocol Violation|0|||
156332215|NCT00333840|564315061|FG001|Second-line Treatment Period|Protocol Violation|0|||
156332216|NCT00333840|564315062|FG002|Second-line Treatment Period|Protocol Violation|1|||
156332217|NCT00333840|564315063|FG003|Second-line Treatment Period|Protocol Violation|10|||
156705491|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705492|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705493|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705494|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705495|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705496|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705497|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705498|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705499|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705500|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705501|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705502|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705503|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705504|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
156705505|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
156705506|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705507|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705508|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705509|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705510|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705511|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705512|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705513|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705514|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705515|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705516|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705517|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705518|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705519|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
156705520|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705521|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705522|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705523|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705524|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705525|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705526|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705527|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705528|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705529|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705530|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705531|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705532|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
156705533|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
156705534|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705535|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705536|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705537|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705538|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705539|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705540|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705541|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705542|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705543|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705544|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705545|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705546|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705547|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705548|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705549|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705550|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705551|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705552|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
156705553|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705554|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705555|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705556|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705557|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705558|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705559|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156791111|NCT03721107|565987151|FG002|Overall Study|Withdrawal by Subject|5|||
156705560|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705561|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705562|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705563|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705564|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705565|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705566|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
156705567|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705568|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705569|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705570|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705571|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705572|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705573|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705574|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705575|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705576|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705577|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705578|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705579|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705580|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
156705581|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705582|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705583|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705584|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705585|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705586|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705587|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705588|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705589|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705590|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705591|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705592|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705593|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705594|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
156705595|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705596|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705597|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705598|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705599|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705600|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705601|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705602|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705603|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705604|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705605|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156440527|NCT02139943|564704148|FG002|Overall Study|Participant wishes to discontinue|0|||
156705606|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705607|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705608|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
156705609|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705610|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705611|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705612|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705613|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705614|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705615|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156440528|NCT02139943|564704146|FG000|Overall Study|Participant in Poor Compliance|1|||
156440529|NCT02139943|564704147|FG001|Overall Study|Participant in Poor Compliance|0|||
156440530|NCT02139943|564704148|FG002|Overall Study|Participant in Poor Compliance|1|||
156440531|NCT02139943|564704146|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
156440532|NCT02139943|564704147|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
156440533|NCT02139943|564704148|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
156705616|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705617|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705618|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705619|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
156705620|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705621|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
156705622|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
156705623|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705624|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705625|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705626|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705627|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705628|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705629|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705630|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705631|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705632|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705633|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705634|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705635|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705636|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
156705637|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705638|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705639|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705640|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705641|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705642|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705643|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705644|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705645|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705646|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705647|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
156705648|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705649|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
156705650|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
156705651|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705652|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705653|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705654|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705655|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705656|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705657|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705658|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705659|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705660|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705661|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705662|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705663|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705664|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705665|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
156705666|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
156705667|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
156705668|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
156705669|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
156705670|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705671|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705672|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705673|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156791112|NCT03721107|565987152|FG003|Overall Study|Withdrawal by Subject|5|||
156791113|NCT03721107|565987149|FG000|Overall Study|Other|1|||
156332218|NCT00333840|564315060|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
156705674|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705675|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705676|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705677|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705678|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705679|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
156705680|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705681|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705682|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705683|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705684|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705685|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705686|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705687|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705688|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705689|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705690|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705691|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705692|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705693|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156332219|NCT00333840|564315061|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
156332220|NCT00333840|564315062|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
156440534|NCT00716859|564704151|FG000|Overall Study|Adverse Event|4|||
156705694|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705695|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705696|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705697|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
156705698|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705699|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705700|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705701|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705702|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705703|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705704|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705705|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705706|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705707|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705708|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
156705709|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
156705710|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
156705711|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705712|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705713|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705714|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705715|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705716|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705717|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705718|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705719|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705720|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705721|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705722|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705723|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705724|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705725|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
156705726|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705727|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705728|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705729|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705730|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705731|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705732|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705733|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705734|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705735|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705736|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705737|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705738|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
156705739|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
156705740|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705741|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705742|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705743|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705744|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705745|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705746|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705747|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705748|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705749|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705750|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705751|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705752|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
156705753|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705754|NCT03433755|565667160|FG000|Overall Study|Lost to Follow-up|1|||
156705755|NCT03433755|565667161|FG001|Overall Study|Lost to Follow-up|0|||
156705756|NCT03433755|565667162|FG002|Overall Study|Lost to Follow-up|0|||
156705757|NCT03433755|565667163|FG003|Overall Study|Lost to Follow-up|0|||
156705758|NCT03433755|565667160|FG000|Overall Study|Decision by Sponsor|1|||
156705759|NCT03433755|565667161|FG001|Overall Study|Decision by Sponsor|0|||
156705760|NCT03433755|565667162|FG002|Overall Study|Decision by Sponsor|0|||
156705761|NCT03433755|565667163|FG003|Overall Study|Decision by Sponsor|0|||
156705762|NCT01565850|565667164|FG000|Overall Study|Adverse Event|0|||
156705763|NCT01565850|565667165|FG001|Overall Study|Adverse Event|1|||
156705764|NCT01565850|565667164|FG000|Overall Study|Lost to Follow-up|12|||
156705765|NCT01565850|565667165|FG001|Overall Study|Lost to Follow-up|4|||
156705766|NCT01565850|565667164|FG000|Overall Study|Investigator's Discretion|2|||
156705767|NCT01565850|565667165|FG001|Overall Study|Investigator's Discretion|1|||
156705768|NCT01565850|565667164|FG000|Overall Study|Participant noncompliance|2|||
156705769|NCT01565850|565667165|FG001|Overall Study|Participant noncompliance|0|||
156705770|NCT01565850|565667164|FG000|Overall Study|Withdrew Consent|4|||
156705771|NCT01565850|565667165|FG001|Overall Study|Withdrew Consent|2|||
156705772|NCT05065567|565667169|FG000|Overall Study|Lost to Follow-up|10|||
156705773|NCT05065567|565667170|FG001|Overall Study|Lost to Follow-up|9|||
156705774|NCT05065567|565667171|FG002|Overall Study|Lost to Follow-up|6|||
156705775|NCT03395405|565668312|FG000|Overall Study|Death|0|||
156705776|NCT03395405|565668313|FG001|Overall Study|Death|2|||
156705777|NCT03395405|565668312|FG000|Overall Study|Lost to Follow-up|0|||
156705778|NCT03395405|565668313|FG001|Overall Study|Lost to Follow-up|1|||
156705779|NCT03395405|565668312|FG000|Overall Study|Protocol Violation|0|||
156705780|NCT03395405|565668313|FG001|Overall Study|Protocol Violation|1|||
156705781|NCT03395405|565668312|FG000|Overall Study|Withdrawal by Subject|3|||
156705782|NCT03395405|565668313|FG001|Overall Study|Withdrawal by Subject|1|||
156705783|NCT03395405|565668312|FG000|Overall Study|COVID-19 Pandemic|1|||
156705784|NCT03395405|565668313|FG001|Overall Study|COVID-19 Pandemic|0|||
156705785|NCT04324073|565668314|FG000|Overall Study|withdrew consent|0|||
156705786|NCT04324073|565668315|FG001|Overall Study|withdrew consent|4|||
156705787|NCT04324073|565668316|FG002|Overall Study|withdrew consent|2|||
156705788|NCT04324073|565668317|FG003|Overall Study|withdrew consent|8|||
156705789|NCT01200069|565668323|FG000|Overall Study|Withdrawal by Subject|0|||
156705790|NCT01200069|565668324|FG001|Overall Study|Withdrawal by Subject|1|||
156705791|NCT04998851|565668325|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
156705792|NCT04998851|565668326|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
156705793|NCT04998851|565668325|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
156705794|NCT04998851|565668326|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
156705795|NCT00070499|565668327|FG000|Overall Study|Adverse Event|6|||
156705796|NCT00070499|565668328|FG001|Overall Study|Adverse Event|6|||
156791114|NCT03721107|565987150|FG001|Overall Study|Other|0|||
156791115|NCT03721107|565987151|FG002|Overall Study|Other|0|||
156791116|NCT03721107|565987152|FG003|Overall Study|Other|1|||
156705797|NCT00070499|565668329|FG002|Overall Study|Adverse Event|19|||
156791117|NCT00563316|565987153|FG000|Overall Study|Adverse Event|2|||
156440535|NCT00716859|564704152|FG001|Overall Study|Adverse Event|1|||
156440536|NCT00716859|564704151|FG000|Overall Study|Lack of Efficacy|3|||
156705798|NCT00070499|565668330|FG003|Overall Study|Adverse Event|15|||
156705799|NCT00070499|565668327|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
156791118|NCT00563316|565987153|FG000|Overall Study|Physician Decision|1|||
156791119|NCT00563316|565987153|FG000|Overall Study|Lost to Follow-up|2|||
156791120|NCT00563316|565987153|FG000|Overall Study|Death|1|||
156705800|NCT00070499|565668328|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
156705801|NCT00070499|565668329|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
156705802|NCT00070499|565668330|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
156705803|NCT00070499|565668327|FG000|Overall Study|Progression/relapse|4|||
156705804|NCT00070499|565668328|FG001|Overall Study|Progression/relapse|2|||
156705805|NCT00070499|565668329|FG002|Overall Study|Progression/relapse|1|||
156705806|NCT00070499|565668330|FG003|Overall Study|Progression/relapse|4|||
156705807|NCT00070499|565668327|FG000|Overall Study|Death|1|||
156705808|NCT00070499|565668328|FG001|Overall Study|Death|1|||
156705809|NCT00070499|565668329|FG002|Overall Study|Death|1|||
156705810|NCT00070499|565668330|FG003|Overall Study|Death|2|||
156705811|NCT00070499|565668327|FG000|Overall Study|Other - not protocol specified|7|||
156705812|NCT00070499|565668328|FG001|Overall Study|Other - not protocol specified|3|||
156705813|NCT00070499|565668329|FG002|Overall Study|Other - not protocol specified|12|||
156705814|NCT00070499|565668330|FG003|Overall Study|Other - not protocol specified|20|||
156705815|NCT00070499|565668327|FG000|Overall Study|Still on protocol treatment|10|||
156705816|NCT00070499|565668328|FG001|Overall Study|Still on protocol treatment|4|||
156705817|NCT00070499|565668329|FG002|Overall Study|Still on protocol treatment|79|||
156705818|NCT00070499|565668330|FG003|Overall Study|Still on protocol treatment|57|||
156705819|NCT00070499|565668327|FG000|Overall Study|Did not start treatment|1|||
156705820|NCT00070499|565668328|FG001|Overall Study|Did not start treatment|0|||
156705821|NCT00070499|565668329|FG002|Overall Study|Did not start treatment|0|||
156705822|NCT00070499|565668330|FG003|Overall Study|Did not start treatment|2|||
156705823|NCT00070499|565668327|FG000|Overall Study|Not eligible|2|||
156705824|NCT00070499|565668328|FG001|Overall Study|Not eligible|5|||
156705825|NCT00070499|565668329|FG002|Overall Study|Not eligible|3|||
156791121|NCT00563316|565987153|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
156791122|NCT00563316|565987153|FG000|Overall Study|Other|1|||
156791123|NCT04818086|565987161|FG000|Overall Study|Physician Decision|1|||
156791124|NCT04818086|565987162|FG001|Overall Study|Physician Decision|0|||
156791125|NCT04818086|565987161|FG000|Overall Study|Withdrawal by Subject|0|||
156791126|NCT04818086|565987162|FG001|Overall Study|Withdrawal by Subject|1|||
156791127|NCT06048705|565987167|FG000|Overall Study|Physician Decision|1|||
156791128|NCT06048705|565987168|FG001|Overall Study|Physician Decision|0|||
156791129|NCT06048705|565987169|FG002|Overall Study|Physician Decision|0|||
156705826|NCT00070499|565668330|FG003|Overall Study|Not eligible|2|||
156705827|NCT00805467|565668331|FG000|Overall Study|Lack of Efficacy|0|||
156791130|NCT06048705|565987167|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
156791131|NCT06048705|565987168|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
156791132|NCT06048705|565987169|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
156791133|NCT06048705|565987167|FG000|Overall Study|Death prior to lymphodepletion|0|||
156791134|NCT06048705|565987168|FG001|Overall Study|Death prior to lymphodepletion|0|||
156791135|NCT06048705|565987169|FG002|Overall Study|Death prior to lymphodepletion|1|||
156791136|NCT02614066|565987170|FG000|Overall Study|Death|6|||
156332221|NCT00333840|564315063|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
156332222|NCT00333840|564315060|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
156332223|NCT00333840|564315061|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
156332224|NCT00333840|564315062|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
156332225|NCT00333840|564315063|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
156332226|NCT00333840|564315060|FG000|Second-line Treatment Period|Administrative problems|0|||
156332227|NCT00333840|564315061|FG001|Second-line Treatment Period|Administrative problems|0|||
156332228|NCT00333840|564315062|FG002|Second-line Treatment Period|Administrative problems|0|||
156332229|NCT00333840|564315063|FG003|Second-line Treatment Period|Administrative problems|7|||
156332230|NCT00333840|564315060|FG000|Second-line Treatment Period|Death|0|||
156332231|NCT00333840|564315061|FG001|Second-line Treatment Period|Death|0|||
156332232|NCT00333840|564315062|FG002|Second-line Treatment Period|Death|0|||
156332233|NCT00333840|564315063|FG003|Second-line Treatment Period|Death|9|||
156332234|NCT02357979|564315064|FG000|Overall Study|Lost to Follow-up|5|||
156332235|NCT02357979|564315065|FG001|Overall Study|Lost to Follow-up|5|||
156332236|NCT00845858|564315066|FG000|Overall Study|Withdrawal by Subject|5|||
156332237|NCT00845858|564315067|FG001|Overall Study|Withdrawal by Subject|1|||
156332238|NCT00845858|564315068|FG002|Overall Study|Withdrawal by Subject|1|||
156332239|NCT00845858|564315066|FG000|Overall Study|Adverse Event|3|||
156332240|NCT00845858|564315067|FG001|Overall Study|Adverse Event|8|||
156332241|NCT00845858|564315068|FG002|Overall Study|Adverse Event|4|||
156332242|NCT00845858|564315066|FG000|Overall Study|Protocol Violation|0|||
156332243|NCT00845858|564315067|FG001|Overall Study|Protocol Violation|0|||
156332244|NCT00845858|564315068|FG002|Overall Study|Protocol Violation|1|||
156705828|NCT00805467|565668332|FG001|Overall Study|Lack of Efficacy|8|||
156705829|NCT00805467|565668333|FG002|Overall Study|Lack of Efficacy|13|||
156705830|NCT00805467|565668334|FG003|Overall Study|Lack of Efficacy|86|||
156791137|NCT02614066|565987171|FG001|Overall Study|Death|14|||
156791138|NCT02614066|565987172|FG002|Overall Study|Death|11|||
156791139|NCT02614066|565987173|FG003|Overall Study|Death|29|||
156791140|NCT02614066|565987170|FG000|Overall Study|Full consent withdrawn|0|||
156791141|NCT02614066|565987171|FG001|Overall Study|Full consent withdrawn|1|||
156705831|NCT00805467|565668331|FG000|Overall Study|Lost to Follow-up|0|||
156705832|NCT00805467|565668332|FG001|Overall Study|Lost to Follow-up|1|||
156705833|NCT00805467|565668333|FG002|Overall Study|Lost to Follow-up|7|||
156705834|NCT00805467|565668334|FG003|Overall Study|Lost to Follow-up|21|||
156705835|NCT00805467|565668331|FG000|Overall Study|Withdrawal by Subject|0|||
156705836|NCT00805467|565668332|FG001|Overall Study|Withdrawal by Subject|6|||
156705837|NCT00805467|565668333|FG002|Overall Study|Withdrawal by Subject|45|||
156705838|NCT00805467|565668334|FG003|Overall Study|Withdrawal by Subject|50|||
156705839|NCT00805467|565668331|FG000|Overall Study|Protocol Violation|0|||
156705840|NCT00805467|565668332|FG001|Overall Study|Protocol Violation|3|||
156705841|NCT00805467|565668333|FG002|Overall Study|Protocol Violation|0|||
156705842|NCT00805467|565668334|FG003|Overall Study|Protocol Violation|5|||
156705843|NCT00805467|565668331|FG000|Overall Study|Adverse Event|0|||
156705844|NCT00805467|565668332|FG001|Overall Study|Adverse Event|13|||
156705845|NCT00805467|565668333|FG002|Overall Study|Adverse Event|26|||
156705846|NCT00805467|565668334|FG003|Overall Study|Adverse Event|57|||
156705847|NCT00805467|565668331|FG000|Overall Study|Death|0|||
156705848|NCT00805467|565668332|FG001|Overall Study|Death|2|||
156705849|NCT00805467|565668333|FG002|Overall Study|Death|7|||
156705850|NCT00805467|565668334|FG003|Overall Study|Death|5|||
156705851|NCT00805467|565668331|FG000|Overall Study|Physician Decision|0|||
156705852|NCT00805467|565668332|FG001|Overall Study|Physician Decision|1|||
156705853|NCT00805467|565668333|FG002|Overall Study|Physician Decision|2|||
156705854|NCT00805467|565668334|FG003|Overall Study|Physician Decision|6|||
156705855|NCT00805467|565668331|FG000|Overall Study|Not reported|0|||
156705856|NCT00805467|565668332|FG001|Overall Study|Not reported|0|||
156705857|NCT00805467|565668333|FG002|Overall Study|Not reported|3|||
156705858|NCT00805467|565668334|FG003|Overall Study|Not reported|7|||
156705859|NCT00213135|565668343|FG000|Overall Study|Adverse Event|9|||
156705860|NCT00213135|565668344|FG001|Overall Study|Adverse Event|5|||
156705861|NCT00213135|565668345|FG002|Overall Study|Adverse Event|5|||
156705862|NCT00213135|565668343|FG000|Overall Study|Lost to Follow-up|11|||
156705863|NCT00213135|565668344|FG001|Overall Study|Lost to Follow-up|8|||
156705864|NCT00213135|565668345|FG002|Overall Study|Lost to Follow-up|4|||
156705865|NCT00213135|565668343|FG000|Overall Study|Protocol Violation|4|||
156705866|NCT00213135|565668344|FG001|Overall Study|Protocol Violation|4|||
156705867|NCT00213135|565668345|FG002|Overall Study|Protocol Violation|10|||
156705868|NCT00213135|565668343|FG000|Overall Study|Death|1|||
156705869|NCT00213135|565668344|FG001|Overall Study|Death|1|||
156705870|NCT00213135|565668345|FG002|Overall Study|Death|2|||
156705871|NCT00213135|565668343|FG000|Overall Study|Disease progression|4|||
156705872|NCT00213135|565668344|FG001|Overall Study|Disease progression|5|||
156705873|NCT00213135|565668345|FG002|Overall Study|Disease progression|21|||
156705874|NCT00213135|565668343|FG000|Overall Study|Other|21|||
156705875|NCT00213135|565668344|FG001|Overall Study|Other|12|||
156705876|NCT00213135|565668345|FG002|Overall Study|Other|15|||
156705877|NCT01908907|565668349|FG000|Overall Study|Physician Decision|1|||
156705878|NCT01908907|565668350|FG001|Overall Study|Physician Decision|0|||
156705879|NCT01908907|565668349|FG000|Overall Study|Protocol Violation|1|||
156705880|NCT01908907|565668350|FG001|Overall Study|Protocol Violation|0|||
156705881|NCT00660907|565668351|FG000|Overall Study|Incorrect Enrollment|1|||
156705882|NCT00660907|565668352|FG001|Overall Study|Incorrect Enrollment|1|||
156705883|NCT00660907|565668351|FG000|Overall Study|Adverse Event|33|||
156705884|NCT00660907|565668352|FG001|Overall Study|Adverse Event|19|||
156705885|NCT00660907|565668351|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
156705886|NCT00660907|565668352|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
156705887|NCT00660907|565668351|FG000|Overall Study|Withdrawal by Subject|23|||
156705888|NCT00660907|565668352|FG001|Overall Study|Withdrawal by Subject|32|||
156705889|NCT00660907|565668351|FG000|Overall Study|Lost to Follow-up|3|||
156705890|NCT00660907|565668352|FG001|Overall Study|Lost to Follow-up|3|||
156705891|NCT00660907|565668351|FG000|Overall Study|Poor/Non-Compliance|5|||
156705892|NCT00660907|565668352|FG001|Overall Study|Poor/Non-Compliance|1|||
156705893|NCT00660907|565668351|FG000|Overall Study|Safety|1|||
156705894|NCT00660907|565668352|FG001|Overall Study|Safety|0|||
156705895|NCT00660907|565668351|FG000|Overall Study|Death|1|||
156705896|NCT00660907|565668352|FG001|Overall Study|Death|3|||
156705897|NCT00660907|565668351|FG000|Overall Study|Various|11|||
156705898|NCT00660907|565668352|FG001|Overall Study|Various|8|||
156705899|NCT00478244|565668357|FG000|Overall Study|Did not receive transplant|1|||
156705900|NCT02886624|565668358|FG000|12-week Post Treatment Follow-up|Death|1|||
156872182|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
156332245|NCT00845858|564315066|FG000|Overall Study|not eligible|0|||
156705901|NCT02886624|565668358|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
156705902|NCT02929056|565668364|FG000|Overall Study|Lost to Follow-up|0|||
156705903|NCT02929056|565668365|FG001|Overall Study|Lost to Follow-up|1|||
156705904|NCT02245412|565668369|FG000|Treatment Period|Death|1|||
156705905|NCT02245412|565668370|FG001|Treatment Period|Death|1|||
156705906|NCT02245412|565668371|FG002|Treatment Period|Death|0|||
156705907|NCT02245412|565668369|FG000|Treatment Period|Physician Decision|1|||
156705908|NCT02245412|565668370|FG001|Treatment Period|Physician Decision|1|||
156705909|NCT02245412|565668371|FG002|Treatment Period|Physician Decision|0|||
156705910|NCT02245412|565668369|FG000|Treatment Period|Withdrawal by Subject|2|||
156705911|NCT02245412|565668370|FG001|Treatment Period|Withdrawal by Subject|1|||
156705912|NCT02245412|565668371|FG002|Treatment Period|Withdrawal by Subject|0|||
156705913|NCT02245412|565668369|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
156705914|NCT02245412|565668370|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
156705915|NCT02245412|565668371|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
156705916|NCT02245412|565668369|FG000|Follow-Up Period|Death|4|||
156705917|NCT02245412|565668370|FG001|Follow-Up Period|Death|2|||
156705918|NCT02245412|565668371|FG002|Follow-Up Period|Death|1|||
156705919|NCT02245412|565668369|FG000|Follow-Up Period|Physician Decision|1|||
156705920|NCT02245412|565668370|FG001|Follow-Up Period|Physician Decision|0|||
156705921|NCT02245412|565668371|FG002|Follow-Up Period|Physician Decision|0|||
156705922|NCT02245412|565668369|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
156705923|NCT02245412|565668370|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
156705924|NCT02245412|565668371|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
156705925|NCT01056289|565668372|FG000|Open-label Phase|Adverse Event|29|||
156705926|NCT01056289|565668373|FG001|Open-label Phase|Adverse Event|0|||
156705927|NCT01056289|565668374|FG002|Open-label Phase|Adverse Event|0|||
156705928|NCT01056289|565668375|FG003|Open-label Phase|Adverse Event|0|||
156705929|NCT01056289|565668372|FG000|Open-label Phase|Lost to Follow-up|30|||
156705930|NCT01056289|565668373|FG001|Open-label Phase|Lost to Follow-up|0|||
156705931|NCT01056289|565668374|FG002|Open-label Phase|Lost to Follow-up|0|||
156705932|NCT01056289|565668375|FG003|Open-label Phase|Lost to Follow-up|0|||
156705933|NCT01056289|565668372|FG000|Open-label Phase|Other|9|||
156705934|NCT01056289|565668373|FG001|Open-label Phase|Other|0|||
156705935|NCT01056289|565668374|FG002|Open-label Phase|Other|0|||
156705936|NCT01056289|565668375|FG003|Open-label Phase|Other|0|||
156705937|NCT01056289|565668372|FG000|Open-label Phase|Protocol Violation|6|||
156705938|NCT01056289|565668373|FG001|Open-label Phase|Protocol Violation|0|||
156705939|NCT01056289|565668374|FG002|Open-label Phase|Protocol Violation|0|||
156705940|NCT01056289|565668375|FG003|Open-label Phase|Protocol Violation|0|||
156705941|NCT01056289|565668372|FG000|Open-label Phase|Withdrawal by Subject|26|||
156705942|NCT01056289|565668373|FG001|Open-label Phase|Withdrawal by Subject|0|||
156705943|NCT01056289|565668374|FG002|Open-label Phase|Withdrawal by Subject|0|||
156705944|NCT01056289|565668375|FG003|Open-label Phase|Withdrawal by Subject|0|||
156705945|NCT01056289|565668372|FG000|Open-label Phase|Lack of Efficacy|18|||
156705946|NCT01056289|565668373|FG001|Open-label Phase|Lack of Efficacy|0|||
156705947|NCT01056289|565668374|FG002|Open-label Phase|Lack of Efficacy|0|||
156705948|NCT01056289|565668375|FG003|Open-label Phase|Lack of Efficacy|0|||
156705949|NCT01056289|565668372|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
156705950|NCT01056289|565668373|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
156705951|NCT01056289|565668374|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
156705952|NCT01056289|565668375|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
156705953|NCT01056289|565668372|FG000|Double-blind Phase|Adverse Event|0|||
156705954|NCT01056289|565668373|FG001|Double-blind Phase|Adverse Event|1|||
156705955|NCT01056289|565668374|FG002|Double-blind Phase|Adverse Event|2|||
156705956|NCT01056289|565668375|FG003|Double-blind Phase|Adverse Event|1|||
156705957|NCT01056289|565668372|FG000|Double-blind Phase|Lost to Follow-up|0|||
156705958|NCT01056289|565668373|FG001|Double-blind Phase|Lost to Follow-up|2|||
156705959|NCT01056289|565668374|FG002|Double-blind Phase|Lost to Follow-up|2|||
156705960|NCT01056289|565668375|FG003|Double-blind Phase|Lost to Follow-up|2|||
156705961|NCT01056289|565668372|FG000|Double-blind Phase|Other|0|||
156705962|NCT01056289|565668373|FG001|Double-blind Phase|Other|0|||
156705963|NCT01056289|565668374|FG002|Double-blind Phase|Other|1|||
156705964|NCT01056289|565668375|FG003|Double-blind Phase|Other|2|||
156705965|NCT01056289|565668372|FG000|Double-blind Phase|Protocol Violation|0|||
156705966|NCT01056289|565668373|FG001|Double-blind Phase|Protocol Violation|0|||
156705967|NCT01056289|565668374|FG002|Double-blind Phase|Protocol Violation|1|||
156705968|NCT01056289|565668375|FG003|Double-blind Phase|Protocol Violation|1|||
156705969|NCT01056289|565668372|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156705970|NCT01056289|565668373|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156705971|NCT01056289|565668374|FG002|Double-blind Phase|Withdrawal by Subject|4|||
156705972|NCT01056289|565668375|FG003|Double-blind Phase|Withdrawal by Subject|2|||
156705973|NCT01056289|565668372|FG000|Double-blind Phase|Discontinuation symptom|0|||
156705974|NCT01056289|565668373|FG001|Double-blind Phase|Discontinuation symptom|1|||
156705975|NCT01056289|565668374|FG002|Double-blind Phase|Discontinuation symptom|2|||
156705976|NCT01056289|565668375|FG003|Double-blind Phase|Discontinuation symptom|2|||
156705977|NCT01056289|565668372|FG000|Double-blind Phase|Physician Decision|0|||
156705978|NCT01056289|565668373|FG001|Double-blind Phase|Physician Decision|0|||
156705979|NCT01056289|565668374|FG002|Double-blind Phase|Physician Decision|1|||
156705980|NCT01056289|565668375|FG003|Double-blind Phase|Physician Decision|0|||
156705981|NCT00459043|565668382|FG000|Overall Study|Withdrawal by Subject|1|||
156705982|NCT00459043|565668383|FG001|Overall Study|Withdrawal by Subject|0|||
156705983|NCT00270855|565668386|FG000|Overall Study|Withdrawal by Subject|8|||
156705984|NCT00270855|565668387|FG001|Overall Study|Withdrawal by Subject|8|||
156705985|NCT05048329|565668390|FG000|Overall Study|Withdrawal by Subject|1|||
156531706|NCT01641809|565041701|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
156531707|NCT01641809|565041698|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
156531708|NCT01641809|565041699|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
156531709|NCT01641809|565041700|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
156531710|NCT01641809|565041701|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
156531711|NCT01641809|565041698|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
156531712|NCT01641809|565041699|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
156791142|NCT02614066|565987172|FG002|Overall Study|Full consent withdrawn|0|||
156791143|NCT02614066|565987173|FG003|Overall Study|Full consent withdrawn|8|||
156791144|NCT02614066|565987170|FG000|Overall Study|Lost to Follow-up|0|||
156531713|NCT01641809|565041700|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
156531714|NCT01641809|565041701|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
156531715|NCT01641809|565041698|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
156531716|NCT01641809|565041699|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
156531717|NCT01641809|565041700|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
156531718|NCT01641809|565041701|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
156531719|NCT01641809|565041698|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
156531720|NCT01641809|565041699|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
156705986|NCT05048329|565668390|FG000|Overall Study|Screenfail|1|||
156705987|NCT03301649|565668391|FG000|Overall Study|Need alternate therapy due to live lice|17|||
156705988|NCT03301649|565668392|FG001|Overall Study|Need alternate therapy due to live lice|25|||
156705989|NCT03301649|565668393|FG002|Overall Study|Need alternate therapy due to live lice|81|||
156705990|NCT03301649|565668391|FG000|Overall Study|Lost to Follow-up|11|||
156705991|NCT03301649|565668392|FG001|Overall Study|Lost to Follow-up|11|||
156705992|NCT03301649|565668393|FG002|Overall Study|Lost to Follow-up|3|||
156705993|NCT03301649|565668391|FG000|Overall Study|Protocol Violation|0|||
156705994|NCT03301649|565668392|FG001|Overall Study|Protocol Violation|1|||
156705995|NCT03301649|565668393|FG002|Overall Study|Protocol Violation|1|||
156705996|NCT03301649|565668391|FG000|Overall Study|Withdrawal by Subject|10|||
156705997|NCT03301649|565668392|FG001|Overall Study|Withdrawal by Subject|4|||
156705998|NCT03301649|565668393|FG002|Overall Study|Withdrawal by Subject|0|||
156705999|NCT03301649|565668391|FG000|Overall Study|Other than specified|5|||
156706000|NCT03301649|565668392|FG001|Overall Study|Other than specified|3|||
156706001|NCT03301649|565668393|FG002|Overall Study|Other than specified|0|||
156706002|NCT01403051|565668394|FG000|Overall Study|Protocol Violation|2|||
156706003|NCT01403051|565668395|FG001|Overall Study|Protocol Violation|0|||
156706004|NCT01403051|565668394|FG000|Overall Study|Death|1|||
156706005|NCT01403051|565668395|FG001|Overall Study|Death|0|||
156706006|NCT01403051|565668394|FG000|Overall Study|Withdrawal by Subject|2|||
156706007|NCT01403051|565668395|FG001|Overall Study|Withdrawal by Subject|1|||
156706008|NCT01403051|565668394|FG000|Overall Study|Lost to Follow-up|5|||
156706009|NCT01403051|565668395|FG001|Overall Study|Lost to Follow-up|5|||
156706010|NCT00887289|565668396|FG000|Overall Study|Lack of Efficacy|14|||
156706011|NCT00887289|565668396|FG000|Overall Study|Adverse Event|27|||
156706012|NCT00887289|565668396|FG000|Overall Study|Withdrawal by Subject|26|||
156531721|NCT01641809|565041700|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
156531722|NCT01641809|565041701|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
156706013|NCT00887289|565668396|FG000|Overall Study|Lost to Follow-up|8|||
156706014|NCT00887289|565668396|FG000|Overall Study|Other|20|||
156706015|NCT00591773|565668397|FG000|Overall Study|Adverse Event|9|||
156706016|NCT00591773|565668398|FG001|Overall Study|Adverse Event|9|||
156706017|NCT00591773|565668399|FG002|Overall Study|Adverse Event|6|||
156706018|NCT00591773|565668397|FG000|Overall Study|Protocol Violation|2|||
156706019|NCT00591773|565668398|FG001|Overall Study|Protocol Violation|3|||
156706020|NCT00591773|565668399|FG002|Overall Study|Protocol Violation|0|||
156706021|NCT00591773|565668397|FG000|Overall Study|Lost to Follow-up|1|||
156706022|NCT00591773|565668398|FG001|Overall Study|Lost to Follow-up|4|||
156706023|NCT00591773|565668399|FG002|Overall Study|Lost to Follow-up|1|||
156791145|NCT02614066|565987171|FG001|Overall Study|Lost to Follow-up|2|||
156791146|NCT02614066|565987172|FG002|Overall Study|Lost to Follow-up|2|||
156332246|NCT00845858|564315067|FG001|Overall Study|not eligible|3|||
156531723|NCT00651157|565041707|FG000|Overall Study|Death|1|||
156531724|NCT00651157|565041707|FG000|Overall Study|Protocol Violation|1|||
156791147|NCT02614066|565987173|FG003|Overall Study|Lost to Follow-up|2|||
156531725|NCT00688181|565041709|FG000|Overall Study|Lost to Follow-up|17|||
156791148|NCT02614066|565987170|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
156531726|NCT00688181|565041709|FG000|Overall Study|Unknown Reason|4|||
156706024|NCT00591773|565668397|FG000|Overall Study|Withdrawal by Subject|2|||
156706025|NCT00591773|565668398|FG001|Overall Study|Withdrawal by Subject|5|||
156706026|NCT00591773|565668399|FG002|Overall Study|Withdrawal by Subject|3|||
156706027|NCT00591773|565668397|FG000|Overall Study|Lack of Efficacy|1|||
156706028|NCT00591773|565668398|FG001|Overall Study|Lack of Efficacy|2|||
156706029|NCT00591773|565668399|FG002|Overall Study|Lack of Efficacy|2|||
156791149|NCT02614066|565987171|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
156531727|NCT00688181|565041709|FG000|Overall Study|Non-clinical Reason|2|||
156531728|NCT01472380|565041713|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
156706030|NCT00591773|565668397|FG000|Overall Study|Other|1|||
156706031|NCT00591773|565668398|FG001|Overall Study|Other|1|||
156706032|NCT00591773|565668399|FG002|Overall Study|Other|4|||
156706033|NCT02135614|565668400|FG000|Overall Study|Randomized but Not Treated|2|||
156706034|NCT02135614|565668401|FG001|Overall Study|Randomized but Not Treated|1|||
156706035|NCT02135614|565668400|FG000|Overall Study|Adverse Event|0|||
156706036|NCT02135614|565668401|FG001|Overall Study|Adverse Event|1|||
156706037|NCT02135614|565668400|FG000|Overall Study|Death|1|||
156706038|NCT02135614|565668401|FG001|Overall Study|Death|0|||
156706039|NCT02135614|565668400|FG000|Overall Study|Investigator's Discretion|0|||
156706040|NCT02135614|565668401|FG001|Overall Study|Investigator's Discretion|1|||
156706041|NCT02135614|565668400|FG000|Overall Study|Withdrew Consent|2|||
156706042|NCT02135614|565668401|FG001|Overall Study|Withdrew Consent|2|||
156706043|NCT02135614|565668400|FG000|Overall Study|Lost to Follow-up|3|||
156706044|NCT02135614|565668401|FG001|Overall Study|Lost to Follow-up|0|||
156706045|NCT03022084|565668402|FG000|Overall Study|Lost to Follow-up|2|||
156706046|NCT03022084|565668403|FG001|Overall Study|Lost to Follow-up|3|||
156706047|NCT00554606|565668404|FG000|Overall Study|Adverse Event|3|||
156706048|NCT00554606|565668404|FG000|Overall Study|Abnormal laboratory values|1|||
156706049|NCT00554606|565668404|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
156706050|NCT00554606|565668404|FG000|Overall Study|Subject withdrew consent|2|||
156706051|NCT00554606|565668404|FG000|Overall Study|Lost to Follow-up|2|||
156706052|NCT00554606|565668404|FG000|Overall Study|Administrative problems|60|||
156706053|NCT00554606|565668404|FG000|Overall Study|Death|1|||
156706054|NCT00554606|565668404|FG000|Overall Study|Protocol deviation|2|||
156440537|NCT00716859|564704152|FG001|Overall Study|Lack of Efficacy|0|||
156440538|NCT00716859|564704151|FG000|Overall Study|Withdrawal by Subject|1|||
156440539|NCT00716859|564704152|FG001|Overall Study|Withdrawal by Subject|3|||
156440540|NCT00716859|564704151|FG000|Overall Study|Not treated|1|||
156440541|NCT00716859|564704152|FG001|Overall Study|Not treated|1|||
156440542|NCT04922021|564705317|FG000|Overall Study|Withdrawal by Subject|4|||
156440543|NCT04922021|564705318|FG001|Overall Study|Withdrawal by Subject|10|||
156440544|NCT04922021|564705317|FG000|Overall Study|Adverse Event|2|||
156440545|NCT04922021|564705318|FG001|Overall Study|Adverse Event|2|||
156440546|NCT04922021|564705317|FG000|Overall Study|Lack of Efficacy|0|||
156440547|NCT04922021|564705318|FG001|Overall Study|Lack of Efficacy|1|||
156440548|NCT04922021|564705317|FG000|Overall Study|Multiple reasons|1|||
156440549|NCT04922021|564705318|FG001|Overall Study|Multiple reasons|0|||
156440550|NCT03237481|564705321|FG000|Overall Study|Lost to Follow-up|1|||
156440551|NCT03237481|564705322|FG001|Overall Study|Lost to Follow-up|0|||
156440552|NCT03237481|564705323|FG002|Overall Study|Lost to Follow-up|0|||
156440553|NCT03237481|564705321|FG000|Overall Study|Protocol Violation|1|||
156440554|NCT03237481|564705322|FG001|Overall Study|Protocol Violation|0|||
156440555|NCT03237481|564705323|FG002|Overall Study|Protocol Violation|0|||
156440556|NCT03237481|564705321|FG000|Overall Study|Withdrawal by Subject|3|||
156440557|NCT03237481|564705322|FG001|Overall Study|Withdrawal by Subject|2|||
156440558|NCT03237481|564705323|FG002|Overall Study|Withdrawal by Subject|1|||
156440559|NCT02544074|564705324|FG000|Overall Study|Withdrawal by Subject|0|||
156440560|NCT02544074|564705325|FG001|Overall Study|Withdrawal by Subject|1|||
156440561|NCT02544074|564705326|FG002|Overall Study|Withdrawal by Subject|0|||
156440562|NCT02544074|564705327|FG003|Overall Study|Withdrawal by Subject|0|||
156440563|NCT02544074|564705328|FG004|Overall Study|Withdrawal by Subject|0|||
156440564|NCT02544074|564705329|FG005|Overall Study|Withdrawal by Subject|0|||
156440565|NCT02544074|564705330|FG006|Overall Study|Withdrawal by Subject|0|||
156440566|NCT02544074|564705331|FG007|Overall Study|Withdrawal by Subject|0|||
156440567|NCT02544074|564705332|FG008|Overall Study|Withdrawal by Subject|0|||
156706055|NCT00605540|565668406|FG000|Overall Study|Death|15|||
156706056|NCT00605540|565668406|FG000|Overall Study|Lost to Follow-up|23|||
156706057|NCT00509366|565668407|FG000|Overall Study|Not Treated (Screen Failure)|1|||
156706058|NCT00509366|565668408|FG001|Overall Study|Not Treated (Screen Failure)|1|||
156706059|NCT00509366|565668409|FG002|Overall Study|Not Treated (Screen Failure)|1|||
156706060|NCT00509366|565668410|FG003|Overall Study|Not Treated (Screen Failure)|0|||
156440568|NCT02544074|564705333|FG009|Overall Study|Withdrawal by Subject|0|||
156440569|NCT02544074|564705334|FG010|Overall Study|Withdrawal by Subject|0|||
156440570|NCT02544074|564705335|FG011|Overall Study|Withdrawal by Subject|0|||
156440571|NCT02544074|564705336|FG012|Overall Study|Withdrawal by Subject|0|||
156440572|NCT02544074|564705337|FG013|Overall Study|Withdrawal by Subject|0|||
156440573|NCT02544074|564705338|FG014|Overall Study|Withdrawal by Subject|0|||
156531729|NCT01472380|565041713|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
156706061|NCT00509366|565668411|FG004|Overall Study|Not Treated (Screen Failure)|0|||
156706062|NCT02119819|565668414|FG000|Overall Study|Adverse Event|3|||
156706063|NCT02119819|565668415|FG001|Overall Study|Adverse Event|1|||
156706064|NCT02119819|565668416|FG002|Overall Study|Adverse Event|2|||
156706065|NCT02119819|565668417|FG003|Overall Study|Adverse Event|3|||
156706066|NCT02119819|565668418|FG004|Overall Study|Adverse Event|0|||
156706067|NCT02119819|565668419|FG005|Overall Study|Adverse Event|1|||
156706068|NCT02119819|565668414|FG000|Overall Study|Lack of Efficacy|0|||
156706069|NCT02119819|565668415|FG001|Overall Study|Lack of Efficacy|0|||
156706070|NCT02119819|565668416|FG002|Overall Study|Lack of Efficacy|0|||
156440574|NCT02544074|564705339|FG015|Overall Study|Withdrawal by Subject|0|||
156440575|NCT02544074|564705340|FG016|Overall Study|Withdrawal by Subject|0|||
156440576|NCT02544074|564705341|FG017|Overall Study|Withdrawal by Subject|0|||
156440577|NCT02544074|564705342|FG018|Overall Study|Withdrawal by Subject|0|||
156440578|NCT02544074|564705343|FG019|Overall Study|Withdrawal by Subject|0|||
156440579|NCT02544074|564705344|FG020|Overall Study|Withdrawal by Subject|0|||
156440580|NCT02544074|564705324|FG000|Overall Study|Tablet error|0|||
156440581|NCT02544074|564705325|FG001|Overall Study|Tablet error|0|||
156440582|NCT02544074|564705326|FG002|Overall Study|Tablet error|0|||
156440583|NCT02544074|564705327|FG003|Overall Study|Tablet error|0|||
156440584|NCT02544074|564705328|FG004|Overall Study|Tablet error|0|||
156440585|NCT02544074|564705329|FG005|Overall Study|Tablet error|1|||
156440586|NCT02544074|564705330|FG006|Overall Study|Tablet error|0|||
156440587|NCT02544074|564705331|FG007|Overall Study|Tablet error|0|||
156440588|NCT02544074|564705332|FG008|Overall Study|Tablet error|0|||
156440589|NCT02544074|564705333|FG009|Overall Study|Tablet error|1|||
156440590|NCT02544074|564705334|FG010|Overall Study|Tablet error|0|||
156440591|NCT02544074|564705335|FG011|Overall Study|Tablet error|0|||
156440592|NCT02544074|564705336|FG012|Overall Study|Tablet error|0|||
156440593|NCT02544074|564705337|FG013|Overall Study|Tablet error|0|||
156440594|NCT02544074|564705338|FG014|Overall Study|Tablet error|0|||
156440595|NCT02544074|564705339|FG015|Overall Study|Tablet error|0|||
156440596|NCT02544074|564705340|FG016|Overall Study|Tablet error|0|||
156440597|NCT02544074|564705341|FG017|Overall Study|Tablet error|0|||
156440598|NCT02544074|564705342|FG018|Overall Study|Tablet error|0|||
156440599|NCT02544074|564705343|FG019|Overall Study|Tablet error|0|||
156440600|NCT02544074|564705344|FG020|Overall Study|Tablet error|0|||
156440601|NCT01998984|564705345|FG000|Overall Study|Adverse Event|0|||
156440602|NCT01998984|564705346|FG001|Overall Study|Adverse Event|0|||
156706071|NCT02119819|565668417|FG003|Overall Study|Lack of Efficacy|0|||
156706072|NCT02119819|565668418|FG004|Overall Study|Lack of Efficacy|0|||
156332247|NCT00845858|564315068|FG002|Overall Study|not eligible|2|||
156332248|NCT01453725|564315069|FG000|Overall Study|Adverse Event|3|||
156332249|NCT01453725|564315070|FG001|Overall Study|Adverse Event|3|||
156332250|NCT01453725|564315069|FG000|Overall Study|Lost to Follow-up|4|||
156332251|NCT01453725|564315070|FG001|Overall Study|Lost to Follow-up|0|||
156332252|NCT01453725|564315069|FG000|Overall Study|Non-compliance With Protocol|1|||
156332253|NCT01453725|564315070|FG001|Overall Study|Non-compliance With Protocol|2|||
156332254|NCT01453725|564315069|FG000|Overall Study|Protocol Violation|1|||
156332255|NCT01453725|564315070|FG001|Overall Study|Protocol Violation|0|||
156332256|NCT01453725|564315069|FG000|Overall Study|Withdrawal by Subject|2|||
156332257|NCT01453725|564315070|FG001|Overall Study|Withdrawal by Subject|3|||
156332258|NCT01453725|564315069|FG000|Overall Study|Pregnancy Wish|0|||
156332259|NCT01453725|564315070|FG001|Overall Study|Pregnancy Wish|2|||
156332260|NCT01453725|564315069|FG000|Overall Study|Pregnancy|1|||
156332261|NCT01453725|564315070|FG001|Overall Study|Pregnancy|0|||
156332262|NCT01453725|564315069|FG000|Overall Study|Physician Decision|1|||
156332263|NCT01453725|564315070|FG001|Overall Study|Physician Decision|1|||
156332264|NCT00875979|564315071|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
156332265|NCT00875979|564315072|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
156332266|NCT00875979|564315071|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
156332267|NCT00875979|564315072|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
156332268|NCT00875979|564315071|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
156332269|NCT00875979|564315072|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
156332270|NCT00875979|564315071|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
156332271|NCT00875979|564315072|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
156332272|NCT00875979|564315071|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
156332273|NCT00875979|564315072|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
156332274|NCT00875979|564315071|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
156332275|NCT00875979|564315072|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
156332276|NCT00875979|564315071|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
156332277|NCT00875979|564315072|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
156332278|NCT00875979|564315071|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
156332279|NCT00875979|564315072|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
156332280|NCT00875979|564315071|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
156332281|NCT00875979|564315072|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
156332282|NCT00216476|564315074|FG000|Overall Study|Withdrawal by Subject|59|||
156332283|NCT00216476|564315075|FG001|Overall Study|Withdrawal by Subject|72|||
156332284|NCT00216476|564315076|FG002|Overall Study|Withdrawal by Subject|9|||
156332285|NCT00216476|564315074|FG000|Overall Study|Lost to Follow-up|10|||
156332286|NCT00216476|564315075|FG001|Overall Study|Lost to Follow-up|9|||
156332287|NCT00216476|564315076|FG002|Overall Study|Lost to Follow-up|1|||
156332288|NCT00216476|564315074|FG000|Overall Study|Adverse Event|6|||
156706073|NCT02119819|565668419|FG005|Overall Study|Lack of Efficacy|1|||
156706074|NCT02119819|565668414|FG000|Overall Study|Lost to Follow-up|0|||
156706075|NCT02119819|565668415|FG001|Overall Study|Lost to Follow-up|0|||
156706076|NCT02119819|565668416|FG002|Overall Study|Lost to Follow-up|1|||
156706077|NCT02119819|565668417|FG003|Overall Study|Lost to Follow-up|2|||
156706078|NCT02119819|565668418|FG004|Overall Study|Lost to Follow-up|1|||
156706079|NCT02119819|565668419|FG005|Overall Study|Lost to Follow-up|2|||
156706080|NCT02119819|565668414|FG000|Overall Study|Physician Decision|1|||
156706081|NCT02119819|565668415|FG001|Overall Study|Physician Decision|1|||
156706082|NCT02119819|565668416|FG002|Overall Study|Physician Decision|0|||
156706083|NCT02119819|565668417|FG003|Overall Study|Physician Decision|0|||
156706084|NCT02119819|565668418|FG004|Overall Study|Physician Decision|0|||
156706085|NCT02119819|565668419|FG005|Overall Study|Physician Decision|1|||
156706086|NCT02119819|565668414|FG000|Overall Study|Withdrawal by Subject|5|||
156706087|NCT02119819|565668415|FG001|Overall Study|Withdrawal by Subject|3|||
156706088|NCT02119819|565668416|FG002|Overall Study|Withdrawal by Subject|0|||
156706089|NCT02119819|565668417|FG003|Overall Study|Withdrawal by Subject|0|||
156706090|NCT02119819|565668418|FG004|Overall Study|Withdrawal by Subject|6|||
156706091|NCT02119819|565668419|FG005|Overall Study|Withdrawal by Subject|10|||
156706092|NCT02119819|565668414|FG000|Overall Study|Jury Duty|0|||
156706093|NCT02119819|565668415|FG001|Overall Study|Jury Duty|0|||
156706094|NCT02119819|565668416|FG002|Overall Study|Jury Duty|1|||
156706095|NCT02119819|565668417|FG003|Overall Study|Jury Duty|0|||
156706096|NCT02119819|565668418|FG004|Overall Study|Jury Duty|0|||
156706097|NCT02119819|565668419|FG005|Overall Study|Jury Duty|0|||
156706098|NCT02119819|565668414|FG000|Overall Study|Protocol Violation|0|||
156706099|NCT02119819|565668415|FG001|Overall Study|Protocol Violation|0|||
156706100|NCT02119819|565668416|FG002|Overall Study|Protocol Violation|0|||
156706101|NCT02119819|565668417|FG003|Overall Study|Protocol Violation|1|||
156706102|NCT02119819|565668418|FG004|Overall Study|Protocol Violation|0|||
156706103|NCT02119819|565668419|FG005|Overall Study|Protocol Violation|0|||
156706104|NCT02119819|565668414|FG000|Overall Study|Left the city to get a job|0|||
156706105|NCT02119819|565668415|FG001|Overall Study|Left the city to get a job|0|||
156706106|NCT02119819|565668416|FG002|Overall Study|Left the city to get a job|0|||
156706107|NCT02119819|565668417|FG003|Overall Study|Left the city to get a job|1|||
156706108|NCT02119819|565668418|FG004|Overall Study|Left the city to get a job|0|||
156706109|NCT02119819|565668419|FG005|Overall Study|Left the city to get a job|0|||
156706110|NCT00282919|565668421|FG000|Overall Study|Lack of Efficacy|4|||
156706111|NCT00282919|565668421|FG000|Overall Study|Withdrawal by Subject|1|||
156706112|NCT00282919|565668421|FG000|Overall Study|Asymptomatic Parasitemia|2|||
156706113|NCT01433549|565668422|FG000|Phase 2: Second Study Product|Adverse Event|0|||
156706114|NCT01433549|565668423|FG001|Phase 2: Second Study Product|Adverse Event|1|||
156706115|NCT04497948|565668428|FG000|Overall Study|Death|2|||
156706116|NCT03257865|565668433|FG000|Overall Study|Adverse Event|4|||
156706117|NCT03257865|565668434|FG001|Overall Study|Adverse Event|8|||
156706118|NCT03257865|565668433|FG000|Overall Study|Lack of Efficacy|1|||
156706119|NCT03257865|565668434|FG001|Overall Study|Lack of Efficacy|2|||
156706120|NCT03257865|565668433|FG000|Overall Study|Non-compliance with Study Drug|0|||
156706121|NCT03257865|565668434|FG001|Overall Study|Non-compliance with Study Drug|2|||
156706122|NCT03257865|565668433|FG000|Overall Study|Withdrawal by Subject|23|||
156706123|NCT03257865|565668434|FG001|Overall Study|Withdrawal by Subject|17|||
156706124|NCT03257865|565668433|FG000|Overall Study|Physician Decision|3|||
156706125|NCT03257865|565668434|FG001|Overall Study|Physician Decision|1|||
156706126|NCT03257865|565668433|FG000|Overall Study|Other|0|||
156706127|NCT03257865|565668434|FG001|Overall Study|Other|1|||
156706128|NCT03257865|565668433|FG000|Overall Study|Lost to Follow-up|4|||
156791150|NCT02614066|565987172|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
156791151|NCT02614066|565987173|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
156791152|NCT02614066|565987170|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
156791153|NCT02614066|565987171|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
156791154|NCT02614066|565987172|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
156791155|NCT02614066|565987173|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
156791156|NCT02614066|565987170|FG000|Overall Study|Reason not specified|0|||
156791157|NCT02614066|565987171|FG001|Overall Study|Reason not specified|2|||
156791158|NCT02614066|565987172|FG002|Overall Study|Reason not specified|1|||
156791159|NCT02614066|565987173|FG003|Overall Study|Reason not specified|1|||
156791160|NCT04565756|565987174|FG000|Overall Study|Withdrawal by Subject|0|||
156791161|NCT04565756|565987175|FG001|Overall Study|Withdrawal by Subject|0|||
156791162|NCT04565756|565987176|FG002|Overall Study|Withdrawal by Subject|0|||
156706129|NCT03257865|565668434|FG001|Overall Study|Lost to Follow-up|4|||
156706130|NCT02549027|565668435|FG000|Washout After Period 4|Withdrawal by Subject|0|||
156706131|NCT02549027|565668436|FG001|Washout After Period 4|Withdrawal by Subject|1|||
156706132|NCT02549027|565668437|FG002|Washout After Period 4|Withdrawal by Subject|1|||
156706133|NCT02549027|565668438|FG003|Washout After Period 4|Withdrawal by Subject|1|||
156706134|NCT02549027|565668439|FG004|Washout After Period 4|Withdrawal by Subject|0|||
156706135|NCT02549027|565668440|FG005|Washout After Period 4|Withdrawal by Subject|0|||
156440603|NCT01998984|564705347|FG002|Overall Study|Adverse Event|0|||
156440604|NCT01998984|564705348|FG003|Overall Study|Adverse Event|1|||
156440605|NCT01998984|564705345|FG000|Overall Study|Lost to Follow-up|0|||
156440606|NCT01998984|564705346|FG001|Overall Study|Lost to Follow-up|1|||
156440607|NCT01998984|564705347|FG002|Overall Study|Lost to Follow-up|0|||
156706136|NCT02549027|565668435|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706137|NCT02549027|565668436|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706138|NCT02549027|565668437|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706139|NCT02549027|565668438|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706140|NCT02549027|565668439|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
156706141|NCT02549027|565668440|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706142|NCT05384171|565668446|FG000|Overall Study|Lost to Follow-up|9|||
156706143|NCT05384171|565668447|FG001|Overall Study|Lost to Follow-up|9|||
156706144|NCT05384171|565668446|FG000|Overall Study|Withdrawal by Subject|3|||
156706145|NCT05384171|565668447|FG001|Overall Study|Withdrawal by Subject|0|||
156706146|NCT01421511|565668448|FG000|Overall Study|Lost to Follow-up|11|||
156706147|NCT01421511|565668449|FG001|Overall Study|Lost to Follow-up|14|||
156706148|NCT01421511|565668448|FG000|Overall Study|Randomized but didn't receive study drug|1|||
156706149|NCT01421511|565668449|FG001|Overall Study|Randomized but didn't receive study drug|7|||
156706150|NCT01421511|565668448|FG000|Overall Study|Physician Decision|0|||
156706151|NCT01421511|565668449|FG001|Overall Study|Physician Decision|1|||
156706152|NCT01421511|565668448|FG000|Overall Study|Withdrawal by Subject|6|||
156706153|NCT01421511|565668449|FG001|Overall Study|Withdrawal by Subject|5|||
156706154|NCT01421511|565668448|FG000|Overall Study|Death|1|||
156706155|NCT01421511|565668449|FG001|Overall Study|Death|1|||
156706156|NCT04853992|565668453|FG000|Treatment Period A|Adverse Event|0|||
156706157|NCT04853992|565668454|FG001|Treatment Period A|Adverse Event|1|||
156706158|NCT04853992|565668453|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
156706159|NCT04853992|565668454|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
156706160|NCT01094886|565668455|FG000|Overall Study|Adverse Event|2|||
156706161|NCT01094886|565668455|FG000|Overall Study|Withdrawal by Subject|5|||
156706162|NCT00402116|565670565|FG000|Overall Study|Jaw infection after surgery-other|1|||
156706163|NCT00402116|565670566|FG001|Overall Study|Jaw infection after surgery-other|0|||
156706164|NCT00402116|565670567|FG002|Overall Study|Jaw infection after surgery-other|0|||
156706165|NCT00402116|565670565|FG000|Overall Study|Withdrawal by Subject|1|||
156706166|NCT00402116|565670566|FG001|Overall Study|Withdrawal by Subject|0|||
156706167|NCT00402116|565670567|FG002|Overall Study|Withdrawal by Subject|5|||
156706168|NCT00402116|565670565|FG000|Overall Study|Treatment completed per protocol|1|||
156706169|NCT00402116|565670566|FG001|Overall Study|Treatment completed per protocol|1|||
156706170|NCT00402116|565670567|FG002|Overall Study|Treatment completed per protocol|2|||
156706171|NCT00402116|565670565|FG000|Overall Study|other complicating disease|0|||
156706172|NCT00402116|565670566|FG001|Overall Study|other complicating disease|0|||
156706173|NCT00402116|565670567|FG002|Overall Study|other complicating disease|2|||
156706174|NCT00402116|565670565|FG000|Overall Study|Disease Progression|0|||
156706175|NCT00402116|565670566|FG001|Overall Study|Disease Progression|4|||
156706176|NCT00402116|565670567|FG002|Overall Study|Disease Progression|38|||
156706177|NCT00402116|565670565|FG000|Overall Study|mistaken thrombocytopenia|0|||
156706178|NCT00402116|565670566|FG001|Overall Study|mistaken thrombocytopenia|0|||
156706179|NCT00402116|565670567|FG002|Overall Study|mistaken thrombocytopenia|1|||
156706180|NCT00402116|565670565|FG000|Overall Study|decline related hyponatremia/tumor|0|||
156706181|NCT00402116|565670566|FG001|Overall Study|decline related hyponatremia/tumor|0|||
156706182|NCT00402116|565670567|FG002|Overall Study|decline related hyponatremia/tumor|1|||
156706183|NCT00402116|565670565|FG000|Overall Study|Adverse Event|0|||
156706184|NCT00402116|565670566|FG001|Overall Study|Adverse Event|1|||
156706185|NCT00402116|565670567|FG002|Overall Study|Adverse Event|6|||
156706186|NCT02899195|565670568|FG000|Concurrent Durvalumab|Adverse Event|4|||
156706187|NCT02899195|565670568|FG000|Concurrent Durvalumab|Physician Decision|1|||
156706188|NCT02899195|565670568|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
156706189|NCT02899195|565670568|FG000|Concurrent Durvalumab|Progressive Disease|5|||
156440608|NCT01998984|564705348|FG003|Overall Study|Lost to Follow-up|1|||
156706190|NCT02899195|565670568|FG000|Maintenance Durvalumab|Adverse Event|1|||
156791163|NCT04565756|565987177|FG003|Overall Study|Withdrawal by Subject|0|||
156440609|NCT01998984|564705345|FG000|Overall Study|Withdrawal by Subject|0|||
156440610|NCT01998984|564705346|FG001|Overall Study|Withdrawal by Subject|0|||
156440611|NCT01998984|564705347|FG002|Overall Study|Withdrawal by Subject|1|||
156440612|NCT01998984|564705348|FG003|Overall Study|Withdrawal by Subject|0|||
156440613|NCT01998984|564705345|FG000|Overall Study|Other|0|||
156706191|NCT02899195|565670568|FG000|Maintenance Durvalumab|Physician Decision|1|||
156706192|NCT02899195|565670568|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
156706193|NCT02899195|565670568|FG000|Maintenance Durvalumab|Progressive Disease|31|||
156706194|NCT04778904|565670570|FG000|Overall Study|Protocol Violation|1|||
156706195|NCT04778904|565670571|FG001|Overall Study|Protocol Violation|0|||
156706196|NCT04778904|565670572|FG002|Overall Study|Protocol Violation|0|||
156440614|NCT01998984|564705346|FG001|Overall Study|Other|0|||
156440615|NCT01998984|564705347|FG002|Overall Study|Other|0|||
156706197|NCT04778904|565670573|FG003|Overall Study|Protocol Violation|0|||
156706198|NCT04778904|565670570|FG000|Overall Study|Withdrawal by Subject|0|||
156706199|NCT04778904|565670571|FG001|Overall Study|Withdrawal by Subject|0|||
156706200|NCT04778904|565670572|FG002|Overall Study|Withdrawal by Subject|1|||
156706201|NCT04778904|565670573|FG003|Overall Study|Withdrawal by Subject|0|||
156706202|NCT03156504|565670574|FG000|Overall Study|Withdrawal by Subject|1|||
156706203|NCT03452137|565670575|FG000|Overall Study|Death|67|||
156706204|NCT03452137|565670576|FG001|Overall Study|Death|70|||
156706205|NCT03452137|565670575|FG000|Overall Study|Lost to Follow-up|4|||
156706206|NCT03452137|565670576|FG001|Overall Study|Lost to Follow-up|2|||
156706207|NCT03452137|565670575|FG000|Overall Study|Physician Decision|0|||
156706208|NCT03452137|565670576|FG001|Overall Study|Physician Decision|1|||
156706209|NCT03452137|565670575|FG000|Overall Study|Study Terminated by Sponsor|120|||
156706210|NCT03452137|565670576|FG001|Overall Study|Study Terminated by Sponsor|121|||
156706211|NCT03452137|565670575|FG000|Overall Study|Withdrawal by Subject|12|||
156706212|NCT03452137|565670576|FG001|Overall Study|Withdrawal by Subject|9|||
156706213|NCT04138043|565670577|FG000|Overall Study|Withdrawal by Subject|0|||
156706214|NCT04138043|565670578|FG001|Overall Study|Withdrawal by Subject|1|||
156706215|NCT03772717|565670579|FG000|Overall Study|Withdrawal by Subject|2|||
156706216|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
156706217|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
156706218|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
156706219|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
156706220|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
156706221|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
156706222|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
156706223|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
156706224|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
156706225|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
156706226|NCT02856802|565670580|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
156706227|NCT02856802|565670581|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
156706228|NCT00587860|565670582|FG000|Overall Study|Lost to Follow-up|2|||
156706229|NCT00587860|565670583|FG001|Overall Study|Lost to Follow-up|2|||
156706230|NCT00587860|565670582|FG000|Overall Study|Withdrawal by Subject|3|||
156706231|NCT00587860|565670583|FG001|Overall Study|Withdrawal by Subject|3|||
156706232|NCT01659125|565670584|FG000|Overall Study|Withdrawal by Subject|2|||
156706233|NCT01659125|565670584|FG000|Overall Study|Lost to Follow-up|7|||
156706234|NCT01659125|565670584|FG000|Overall Study|Technical Problem|1|||
156706235|NCT01659125|565670584|FG000|Overall Study|Time Constraints|2|||
156706236|NCT01659125|565670584|FG000|Overall Study|Failed to Start Treatment|2|||
156706237|NCT02242045|565670585|FG000|Overall Study|Investigator's Discretion|1|||
156706238|NCT02242045|565670585|FG000|Overall Study|Progressive Disease|2|||
156706239|NCT02242045|565670585|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
156706240|NCT02242045|565670585|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
156706241|NCT00749892|565670586|FG000|Overall Study|Withdrawal by Subject|3|||
156706242|NCT04581369|565670587|FG000|Overall Study|Death|7|||
156706243|NCT04581369|565670588|FG001|Overall Study|Death|6|||
156440616|NCT01998984|564705348|FG003|Overall Study|Other|1|||
156440617|NCT05386238|564705349|FG000|Overall Study|Lost to Follow-up|3|||
156706244|NCT04581369|565670589|FG002|Overall Study|Death|0|||
156706245|NCT04581369|565670587|FG000|Overall Study|Lost to Follow-up|7|||
156706246|NCT04581369|565670588|FG001|Overall Study|Lost to Follow-up|3|||
156706247|NCT04581369|565670589|FG002|Overall Study|Lost to Follow-up|0|||
156706248|NCT04581369|565670587|FG000|Overall Study|liver transplant|2|||
156706249|NCT04581369|565670588|FG001|Overall Study|liver transplant|2|||
156706250|NCT04581369|565670589|FG002|Overall Study|liver transplant|0|||
156706251|NCT04581369|565670587|FG000|Overall Study|transitioned to hospice care|0|||
156706252|NCT04581369|565670588|FG001|Overall Study|transitioned to hospice care|5|||
156706253|NCT04581369|565670589|FG002|Overall Study|transitioned to hospice care|0|||
156706254|NCT00780910|565670590|FG000|Overall Study|Adverse Event|2|||
156706255|NCT00106964|565670592|FG000|Overall Study|Lost to Follow-up|8|||
156791164|NCT04565756|565987178|FG004|Overall Study|Withdrawal by Subject|1|||
156791165|NCT04565756|565987179|FG005|Overall Study|Withdrawal by Subject|0|||
156791166|NCT04565756|565987174|FG000|Overall Study|Protocol Violation|0|||
156706256|NCT00106964|565670593|FG001|Overall Study|Lost to Follow-up|6|||
156706257|NCT00106964|565670594|FG002|Overall Study|Lost to Follow-up|2|||
156706258|NCT00106964|565670592|FG000|Overall Study|Pregnancy|2|||
156706259|NCT00106964|565670593|FG001|Overall Study|Pregnancy|3|||
156706260|NCT00106964|565670594|FG002|Overall Study|Pregnancy|2|||
156706261|NCT00106964|565670592|FG000|Overall Study|Death|1|||
156706262|NCT00106964|565670593|FG001|Overall Study|Death|1|||
156706263|NCT00106964|565670594|FG002|Overall Study|Death|0|||
156706264|NCT00106964|565670592|FG000|Overall Study|Incarceration|0|||
156706265|NCT00106964|565670593|FG001|Overall Study|Incarceration|1|||
156706266|NCT00106964|565670594|FG002|Overall Study|Incarceration|0|||
156706267|NCT00106964|565670592|FG000|Overall Study|Site Funding Terminated|0|||
156706268|NCT00106964|565670593|FG001|Overall Study|Site Funding Terminated|1|||
156791167|NCT04565756|565987175|FG001|Overall Study|Protocol Violation|0|||
156706269|NCT00106964|565670594|FG002|Overall Study|Site Funding Terminated|1|||
156706270|NCT00106964|565670592|FG000|Overall Study|Failure to adhere|2|||
156706271|NCT00106964|565670593|FG001|Overall Study|Failure to adhere|0|||
156706272|NCT00106964|565670594|FG002|Overall Study|Failure to adhere|0|||
156706273|NCT00106964|565670592|FG000|Overall Study|Did not meet eligibility criteria|0|||
156706274|NCT00106964|565670593|FG001|Overall Study|Did not meet eligibility criteria|2|||
156706275|NCT00106964|565670594|FG002|Overall Study|Did not meet eligibility criteria|2|||
156706276|NCT00106964|565670592|FG000|Overall Study|Required disallowed medication|0|||
156706277|NCT00106964|565670593|FG001|Overall Study|Required disallowed medication|1|||
156706278|NCT00106964|565670594|FG002|Overall Study|Required disallowed medication|0|||
156706279|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
156706280|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
156706281|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
156706282|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
156706283|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
156706284|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
156706285|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
156706286|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
156706287|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
156706288|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
156706289|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
156706290|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
156706291|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
156706292|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
156706293|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
156706294|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
156706295|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
156706296|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
156706297|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
156706298|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
156706299|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
156706300|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
156706301|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
156706302|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
156706303|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
156706304|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
156706305|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
156706306|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
156706307|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
156706308|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
156706309|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
156706310|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
156706311|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
156706312|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
156706313|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
156706314|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
156706315|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
156706316|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
156706317|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
156706318|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
156706319|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
156791168|NCT04565756|565987176|FG002|Overall Study|Protocol Violation|0|||
156791169|NCT04565756|565987177|FG003|Overall Study|Protocol Violation|0|||
156791170|NCT04565756|565987178|FG004|Overall Study|Protocol Violation|0|||
156791171|NCT04565756|565987179|FG005|Overall Study|Protocol Violation|1|||
156791172|NCT03378635|565987187|FG000|Overall Study|Adverse Event|1|||
156440618|NCT05386238|564705350|FG001|Overall Study|Lost to Follow-up|2|||
156791173|NCT03378635|565987188|FG001|Overall Study|Adverse Event|0|||
156791174|NCT03378635|565987189|FG002|Overall Study|Adverse Event|0|||
156440619|NCT05386238|564705349|FG000|Overall Study|Withdrawal by Subject|0|||
156440620|NCT05386238|564705350|FG001|Overall Study|Withdrawal by Subject|1|||
156440621|NCT04907474|564705351|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
156440622|NCT04907474|564705352|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
156440623|NCT01353313|564705353|FG000|Overall Study|Lost to Follow-up|22|||
156440624|NCT01353313|564705354|FG001|Overall Study|Lost to Follow-up|23|||
156531730|NCT02511678|565041714|FG000|Overall Study|Withdrawal by Subject|2|||
156706320|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
156706321|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
156706322|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
156706323|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
156706324|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
156706325|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
156706326|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
156706327|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
156706328|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
156706329|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
156706330|NCT03207243|565670598|FG000|Overall Study|Adverse Event|2|||
156872183|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
156872184|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
156872185|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
156872186|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
156872187|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
156872188|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
156872189|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
156872190|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
156440625|NCT01353313|564705353|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
156440626|NCT01353313|564705354|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
156706331|NCT03207243|565670599|FG001|Overall Study|Adverse Event|2|||
156706332|NCT03207243|565670598|FG000|Overall Study|Loss of Asthma Control|47|||
156706333|NCT03207243|565670599|FG001|Overall Study|Loss of Asthma Control|31|||
156706334|NCT03207243|565670598|FG000|Overall Study|Withdrawal by Subject|2|||
156706335|NCT03207243|565670599|FG001|Overall Study|Withdrawal by Subject|4|||
156706336|NCT03207243|565670598|FG000|Overall Study|Physician Decision|1|||
156706337|NCT03207243|565670599|FG001|Overall Study|Physician Decision|1|||
156706338|NCT03207243|565670598|FG000|Overall Study|Lost to Follow-up|0|||
156706339|NCT03207243|565670599|FG001|Overall Study|Lost to Follow-up|1|||
156706340|NCT03207243|565670598|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
156706341|NCT03207243|565670599|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
156706342|NCT03207243|565670598|FG000|Overall Study|Protocol Violation|0|||
156706343|NCT03207243|565670599|FG001|Overall Study|Protocol Violation|3|||
156706344|NCT00168818|565670606|FG000|Overall Study|Adverse Event|23|||
156706345|NCT00168818|565670607|FG001|Overall Study|Adverse Event|29|||
156706346|NCT00168818|565670608|FG002|Overall Study|Adverse Event|31|||
156706347|NCT00168818|565670606|FG000|Overall Study|Protocol Violation|16|||
156706348|NCT00168818|565670607|FG001|Overall Study|Protocol Violation|11|||
156706349|NCT00168818|565670608|FG002|Overall Study|Protocol Violation|11|||
156706350|NCT00168818|565670606|FG000|Overall Study|Lost to Follow-up|13|||
156706351|NCT00168818|565670607|FG001|Overall Study|Lost to Follow-up|4|||
156706352|NCT00168818|565670608|FG002|Overall Study|Lost to Follow-up|15|||
156706353|NCT00168818|565670606|FG000|Overall Study|Withdrawal by Subject|43|||
156440627|NCT04755660|564705355|FG000|Overall Study|Lost to Follow-up|1|||
156440628|NCT04755660|564705356|FG001|Overall Study|Lost to Follow-up|1|||
156440629|NCT04755660|564705357|FG002|Overall Study|Lost to Follow-up|0|||
156440630|NCT04755660|564705355|FG000|Overall Study|Withdrawal by Subject|0|||
156440631|NCT04755660|564705356|FG001|Overall Study|Withdrawal by Subject|1|||
156440632|NCT04755660|564705357|FG002|Overall Study|Withdrawal by Subject|1|||
156440633|NCT04755660|564705355|FG000|Overall Study|Physician Decision|0|||
156440634|NCT04755660|564705356|FG001|Overall Study|Physician Decision|0|||
156706354|NCT00168818|565670607|FG001|Overall Study|Withdrawal by Subject|41|||
156706355|NCT00168818|565670608|FG002|Overall Study|Withdrawal by Subject|37|||
156706356|NCT00168818|565670606|FG000|Overall Study|Other|22|||
156706357|NCT00168818|565670607|FG001|Overall Study|Other|24|||
156706358|NCT00168818|565670608|FG002|Overall Study|Other|30|||
156706359|NCT00168818|565670606|FG000|Treatment|Adverse Event|77|||
156706360|NCT00168818|565670607|FG001|Treatment|Adverse Event|89|||
156706361|NCT00168818|565670608|FG002|Treatment|Adverse Event|68|||
156706362|NCT00168818|565670606|FG000|Treatment|Protocol Violation|8|||
156706363|NCT00168818|565670607|FG001|Treatment|Protocol Violation|11|||
156706364|NCT00168818|565670608|FG002|Treatment|Protocol Violation|11|||
156706365|NCT00168818|565670606|FG000|Treatment|Lost to Follow-up|0|||
156706366|NCT00168818|565670607|FG001|Treatment|Lost to Follow-up|2|||
156706367|NCT00168818|565670608|FG002|Treatment|Lost to Follow-up|1|||
156706368|NCT00168818|565670606|FG000|Treatment|Withdrawal by Subject|25|||
156706369|NCT00168818|565670607|FG001|Treatment|Withdrawal by Subject|20|||
156872191|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
156872192|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
156440635|NCT04755660|564705357|FG002|Overall Study|Physician Decision|1|||
156440636|NCT02824029|564705358|FG000|Overall Study|Didn't receive treatment|2|||
156440637|NCT02824029|564705358|FG000|Overall Study|Patient decision to discontinue treatment|3|||
156440638|NCT02824029|564705358|FG000|Overall Study|Non-compliant|5|||
156706370|NCT00168818|565670608|FG002|Treatment|Withdrawal by Subject|22|||
156706371|NCT00168818|565670606|FG000|Treatment|Other|23|||
156440639|NCT02824029|564705358|FG000|Overall Study|Progression of disease|15|||
156440640|NCT02824029|564705358|FG000|Overall Study|Inadequate response to therapy|2|||
156440641|NCT02824029|564705358|FG000|Overall Study|Possible progression per treating physician|1|||
156440642|NCT01693120|564705362|FG000|Enrollment|Lost to Follow-up|1|||
156440643|NCT01693120|564705362|FG000|Enrollment|Withdrawal by Subject|10|||
156440644|NCT01693120|564705362|FG000|Enrollment|Protocol Violation|46|||
156440645|NCT01693120|564705362|FG000|Enrollment|Physician Decision|3|||
156440646|NCT01693120|564705362|FG000|Enrollment|Adverse Event|1|||
156440647|NCT01693120|564705362|FG000|Enrollment|Study closed|8|||
156440648|NCT01693120|564705362|FG000|Enrollment|Other|1|||
156440649|NCT01693120|564705362|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
156440650|NCT01693120|564705362|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
156440651|NCT01693120|564705362|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
156440652|NCT01693120|564705362|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
156440653|NCT01693120|564705362|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
156440654|NCT04153565|564705363|FG000|Overall Study|Death|13|||
156440655|NCT02566902|564705371|FG000|Overall Study|Protocol Violation|2|||
156440656|NCT02566902|564705372|FG001|Overall Study|Protocol Violation|1|||
156440657|NCT02411084|564705373|FG000|Overall Study|Lack of Efficacy|6|||
156440658|NCT02411084|564705374|FG001|Overall Study|Lack of Efficacy|3|||
156440659|NCT02411084|564705373|FG000|Overall Study|Death|5|||
156440660|NCT02411084|564705374|FG001|Overall Study|Death|4|||
156440661|NCT02411084|564705373|FG000|Overall Study|Adverse Event|2|||
156440662|NCT02411084|564705374|FG001|Overall Study|Adverse Event|1|||
156440663|NCT02411084|564705373|FG000|Overall Study|Other reasons|0|||
156706372|NCT00168818|565670607|FG001|Treatment|Other|29|||
156706373|NCT00168818|565670608|FG002|Treatment|Other|31|||
156706374|NCT00603837|565670611|FG000|Overall Study|Physician Decision|3|||
156706375|NCT00603837|565670612|FG001|Overall Study|Physician Decision|0|||
156706376|NCT00856375|565670673|FG000|Overall Study|Other|0|||
156706377|NCT00856375|565670674|FG001|Overall Study|Other|1|||
156706378|NCT00856375|565670673|FG000|Overall Study|Death|32|||
156706379|NCT00856375|565670674|FG001|Overall Study|Death|30|||
156706380|NCT00856375|565670673|FG000|Overall Study|Sponsor Terminated Study|7|||
156706381|NCT00856375|565670674|FG001|Overall Study|Sponsor Terminated Study|7|||
156706382|NCT00856375|565670673|FG000|Overall Study|Withdrawal by Subject|2|||
156706383|NCT00856375|565670674|FG001|Overall Study|Withdrawal by Subject|1|||
156706384|NCT00856375|565670673|FG000|Overall Study|Lost to Follow-up|1|||
156706385|NCT00856375|565670674|FG001|Overall Study|Lost to Follow-up|2|||
156706386|NCT02538965|565670675|FG000|Treatment Period|Other = Death due to disease progression|1|||
156706387|NCT02538965|565670675|FG000|Treatment Period|Adverse Event|2|||
156706388|NCT02538965|565670675|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
156706389|NCT02538965|565670675|FG000|Treatment Period|Treatment Failure|9|||
156706390|NCT02538965|565670675|FG000|Treatment Period|Disease Progression|1|||
156706391|NCT02538965|565670675|FG000|Treatment Period|Physician Decision|2|||
156706392|NCT02538965|565670675|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
156706393|NCT02538965|565670675|FG000|Follow-Up Period|Withdrawal by Parent|4|||
156706394|NCT00875797|565670676|FG000|Overall Study|Protocol Violation|6|||
156706395|NCT00875797|565670677|FG001|Overall Study|Protocol Violation|3|||
156706396|NCT01590797|565670680|FG000|Overall Study|Adverse Event|4|||
156706397|NCT01590797|565670681|FG001|Overall Study|Adverse Event|3|||
156706398|NCT01590797|565670680|FG000|Overall Study|Lack of Efficacy|0|||
156706399|NCT01590797|565670681|FG001|Overall Study|Lack of Efficacy|2|||
156706400|NCT01590797|565670680|FG000|Overall Study|Lost to Follow-up|0|||
156706401|NCT01590797|565670681|FG001|Overall Study|Lost to Follow-up|1|||
156706402|NCT01590797|565670680|FG000|Overall Study|Protocol Violation|4|||
156706403|NCT01590797|565670681|FG001|Overall Study|Protocol Violation|1|||
156440664|NCT02411084|564705374|FG001|Overall Study|Other reasons|5|||
156706404|NCT01590797|565670680|FG000|Overall Study|Withdrawal by Subject|7|||
156791175|NCT03378635|565987187|FG000|Overall Study|Withdrawal by Subject|1|||
156791176|NCT03378635|565987188|FG001|Overall Study|Withdrawal by Subject|0|||
156440665|NCT00642850|564705384|FG000|Overall Study|Death|7|||
156440666|NCT00642850|564705384|FG000|Overall Study|Adverse Event|2|||
156440667|NCT00642850|564705384|FG000|Overall Study|Lack of Efficacy|1|||
156706405|NCT01590797|565670681|FG001|Overall Study|Withdrawal by Subject|5|||
156440668|NCT00642850|564705384|FG000|Overall Study|Protocol Violation|2|||
156531731|NCT02511678|565041714|FG000|Overall Study|Lost to Follow-up|4|||
156791177|NCT03378635|565987189|FG002|Overall Study|Withdrawal by Subject|0|||
156440669|NCT00642850|564705384|FG000|Overall Study|Kidney transplantation|8|||
156531732|NCT02511678|565041714|FG000|Overall Study|Death|19|||
156706406|NCT01590797|565670680|FG000|Overall Study|Other Protocol Specified Criteria|2|||
156706407|NCT01590797|565670681|FG001|Overall Study|Other Protocol Specified Criteria|4|||
156706408|NCT04893018|565670682|FG000|Overall Study|Lost to Follow-up|1|||
156440670|NCT00642850|564705384|FG000|Overall Study|Blood transfusion|6|||
156440671|NCT00642850|564705384|FG000|Overall Study|Other reasons|7|||
156440672|NCT05489484|564705387|FG000|Overall Study|withdrawn|1|||
156440673|NCT00444600|564705393|FG000|Overall Study|Death|7|||
156440674|NCT00444600|564705394|FG001|Overall Study|Death|5|||
156706409|NCT04893018|565670683|FG001|Overall Study|Lost to Follow-up|0|||
156706410|NCT04893018|565670682|FG000|Overall Study|Withdrawal by Subject|2|||
156706411|NCT04893018|565670683|FG001|Overall Study|Withdrawal by Subject|0|||
156706412|NCT04893018|565670682|FG000|Overall Study|Study Terminated|1|||
156706413|NCT04893018|565670683|FG001|Overall Study|Study Terminated|2|||
156706414|NCT03106987|565670684|FG000|Overall Study|Death|37|||
156706415|NCT03106987|565670685|FG001|Overall Study|Death|22|||
156706416|NCT03106987|565670686|FG002|Overall Study|Death|12|||
156706417|NCT03106987|565670687|FG003|Overall Study|Death|8|||
156706418|NCT03106987|565670684|FG000|Overall Study|Lost to Follow-up|2|||
156706419|NCT03106987|565670685|FG001|Overall Study|Lost to Follow-up|0|||
156706420|NCT03106987|565670686|FG002|Overall Study|Lost to Follow-up|2|||
156706421|NCT03106987|565670687|FG003|Overall Study|Lost to Follow-up|2|||
156706422|NCT03106987|565670684|FG000|Overall Study|Withdrawal by Subject|5|||
156706423|NCT03106987|565670685|FG001|Overall Study|Withdrawal by Subject|1|||
156706424|NCT03106987|565670686|FG002|Overall Study|Withdrawal by Subject|4|||
156706425|NCT03106987|565670687|FG003|Overall Study|Withdrawal by Subject|1|||
156706426|NCT03336528|565670689|FG000|Overall Study|Protocol Violation|1|||
156706427|NCT03336528|565670690|FG001|Overall Study|Protocol Violation|1|||
156706428|NCT03336528|565670689|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
156706429|NCT03336528|565670690|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
156706430|NCT03336528|565670689|FG000|Overall Study|Did not receive study medication|1|||
156706431|NCT03336528|565670690|FG001|Overall Study|Did not receive study medication|2|||
156706432|NCT00195338|565670696|FG000|Overall Study|Lost to Follow-up|2|||
156706433|NCT00195338|565670696|FG000|Overall Study|Adverse Event|5|||
156706434|NCT00195338|565670696|FG000|Overall Study|Lack of Efficacy|1|||
156706435|NCT00195338|565670696|FG000|Overall Study|Early closure of the site|4|||
156706436|NCT00811928|565670697|FG000|Overall Study|AEs and SAEs Including Death|7|||
156706437|NCT00811928|565670698|FG001|Overall Study|AEs and SAEs Including Death|11|||
156706438|NCT00811928|565670697|FG000|Overall Study|Withdrawal by Subject|18|||
156706439|NCT00811928|565670698|FG001|Overall Study|Withdrawal by Subject|12|||
156706440|NCT00811928|565670697|FG000|Overall Study|Did Not Take Study Drug|3|||
156706441|NCT00811928|565670698|FG001|Overall Study|Did Not Take Study Drug|0|||
156706442|NCT00811928|565670697|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
156706443|NCT00811928|565670698|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
156706444|NCT00811928|565670697|FG000|Overall Study|Investigator Decision|2|||
156706445|NCT00811928|565670698|FG001|Overall Study|Investigator Decision|1|||
156706446|NCT00811928|565670697|FG000|Overall Study|Poor Compliance|2|||
156706447|NCT00811928|565670698|FG001|Overall Study|Poor Compliance|5|||
156706448|NCT01085357|565670699|FG000|Overall Study|Adverse Event|1|||
156706449|NCT01085357|565670700|FG001|Overall Study|Adverse Event|1|||
156706450|NCT01085357|565670699|FG000|Overall Study|Subject Decision|4|||
156706451|NCT01085357|565670700|FG001|Overall Study|Subject Decision|3|||
156706452|NCT01085357|565670699|FG000|Overall Study|Investigator Decision|1|||
156706453|NCT01085357|565670700|FG001|Overall Study|Investigator Decision|1|||
156706454|NCT01085357|565670699|FG000|Overall Study|Death|11|||
156706455|NCT01085357|565670700|FG001|Overall Study|Death|1|||
156706456|NCT01085357|565670699|FG000|Overall Study|Lost to Follow-up|2|||
156706457|NCT01085357|565670700|FG001|Overall Study|Lost to Follow-up|0|||
156706458|NCT00314951|565670703|FG000|Treatment|Didn't meet criteria for mITT population|16|||
156706459|NCT00314951|565670704|FG001|Treatment|Didn't meet criteria for mITT population|11|||
156706460|NCT00314951|565670703|FG000|Follow-up|mITT failure|44|||
156706461|NCT00314951|565670704|FG001|Follow-up|mITT failure|34|||
156706462|NCT02910011|565670705|FG000|Overall Study|Physician Decision|2|||
156706463|NCT00920790|565670706|FG000|Overall Study|aggravation of general condition|14|||
156706464|NCT04411914|565670707|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
156706465|NCT04411914|565670708|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
156706466|NCT00182325|565670714|FG000|Overall Study|Lost to Follow-up|7|||
156706467|NCT00182325|565670715|FG001|Overall Study|Lost to Follow-up|7|||
156706468|NCT00182325|565670714|FG000|Overall Study|Miscarriage|5|||
156706469|NCT00182325|565670715|FG001|Overall Study|Miscarriage|3|||
156706470|NCT00182325|565670714|FG000|Overall Study|Did not complete survey|22|||
156706471|NCT00182325|565670715|FG001|Overall Study|Did not complete survey|43|||
156332289|NCT00216476|564315075|FG001|Overall Study|Adverse Event|10|||
156332290|NCT00216476|564315076|FG002|Overall Study|Adverse Event|1|||
156706472|NCT01420965|565670719|FG000|Overall Study|Withdrawal by Subject|1|||
156706473|NCT01420965|565670720|FG001|Overall Study|Withdrawal by Subject|0|||
156706474|NCT01420965|565670721|FG002|Overall Study|Withdrawal by Subject|0|||
156706475|NCT01420965|565670719|FG000|Overall Study|Adverse Event|0|||
156332291|NCT00216476|564315074|FG000|Overall Study|Lack of Efficacy|4|||
156332292|NCT00216476|564315075|FG001|Overall Study|Lack of Efficacy|3|||
156332293|NCT00216476|564315076|FG002|Overall Study|Lack of Efficacy|0|||
156332294|NCT00216476|564315074|FG000|Overall Study|Death|2|||
156332295|NCT00216476|564315075|FG001|Overall Study|Death|0|||
156332296|NCT00216476|564315076|FG002|Overall Study|Death|0|||
156332297|NCT00216476|564315074|FG000|Overall Study|Pregnancy|0|||
156332298|NCT00216476|564315075|FG001|Overall Study|Pregnancy|1|||
156332299|NCT00216476|564315076|FG002|Overall Study|Pregnancy|1|||
156332300|NCT00216476|564315074|FG000|Overall Study|Other|0|||
156706476|NCT01420965|565670720|FG001|Overall Study|Adverse Event|1|||
156706477|NCT01420965|565670721|FG002|Overall Study|Adverse Event|0|||
156706478|NCT02015065|565670722|FG000|Overall Study|Death on study|1|||
156706479|NCT02015065|565670723|FG001|Overall Study|Death on study|2|||
156706480|NCT02015065|565670724|FG002|Overall Study|Death on study|1|||
156706481|NCT01292226|565670757|FG000|Overall Study|Adverse Event|5|||
156706482|NCT01292226|565670757|FG000|Overall Study|Death|1|||
156706483|NCT01292226|565670757|FG000|Overall Study|Graft loss|1|||
156706484|NCT01292226|565670757|FG000|Overall Study|Protocol Violation|3|||
156706485|NCT01292226|565670757|FG000|Overall Study|Withdrawal by Subject|1|||
156706486|NCT01292226|565670757|FG000|Overall Study|Other|2|||
156706487|NCT04106661|565670758|FG000|Overall Study|Protocol Violation|3|||
156706488|NCT04106661|565670759|FG001|Overall Study|Protocol Violation|0|||
156706489|NCT04106661|565670758|FG000|Overall Study|Scheduling difficulties|1|||
156706490|NCT04106661|565670759|FG001|Overall Study|Scheduling difficulties|1|||
156706491|NCT00233402|565670760|FG000|Overall Study|No pathology data|12|||
156706492|NCT00233402|565670761|FG001|Overall Study|No pathology data|9|||
156706493|NCT00233402|565670760|FG000|Overall Study|No Ta/T1|89|||
156706494|NCT00233402|565670761|FG001|Overall Study|No Ta/T1|94|||
156706495|NCT00233402|565670760|FG000|Overall Study|Lost to follow up etc|3|||
156706496|NCT00233402|565670761|FG001|Overall Study|Lost to follow up etc|21|||
156706497|NCT03280381|565670762|FG000|Overall Study|Physician Decision|0|||
156706498|NCT03280381|565670763|FG001|Overall Study|Physician Decision|2|||
156706499|NCT03503864|565670766|FG000|Overall Study|Protocol Violation|6|||
156706500|NCT03503864|565670766|FG000|Overall Study|Withdrawal by Subject|7|||
156706501|NCT00468650|565670767|FG000|Overall Study|Lost to Follow-up|4|||
156706502|NCT00468650|565670767|FG000|Overall Study|Withdrawal by Subject|2|||
156706503|NCT00468650|565670767|FG000|Overall Study|Protocol Violation|1|||
156706504|NCT00423319|565670768|FG000|Overall Study|Death|2|||
156706505|NCT00423319|565670769|FG001|Overall Study|Death|0|||
156706506|NCT00423319|565670768|FG000|Overall Study|Adverse Event|93|||
156706507|NCT00423319|565670769|FG001|Overall Study|Adverse Event|112|||
156706508|NCT00423319|565670768|FG000|Overall Study|Withdrawal by Subject|86|||
156706509|NCT00423319|565670769|FG001|Overall Study|Withdrawal by Subject|99|||
156706510|NCT00423319|565670768|FG000|Overall Study|Lost to Follow-up|4|||
156706511|NCT00423319|565670769|FG001|Overall Study|Lost to Follow-up|3|||
156706512|NCT00423319|565670768|FG000|Overall Study|Poor compliance or noncompliance|1|||
156706513|NCT00423319|565670769|FG001|Overall Study|Poor compliance or noncompliance|1|||
156706514|NCT00423319|565670768|FG000|Overall Study|No longer meets study criteria|15|||
156706515|NCT00423319|565670769|FG001|Overall Study|No longer meets study criteria|15|||
156706516|NCT00423319|565670768|FG000|Overall Study|Other|23|||
156706517|NCT00423319|565670769|FG001|Overall Study|Other|22|||
156706518|NCT02639052|565670770|FG000|Overall Study|Lost to Follow-up|1|||
156706519|NCT02655666|565670772|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
156706520|NCT00895414|565670773|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
156706521|NCT00895414|565670774|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
156706522|NCT00895414|565670773|FG000|First Intervention (14 Days)|Physician Decision|0|||
156706523|NCT00895414|565670774|FG001|First Intervention (14 Days)|Physician Decision|1|||
156706524|NCT00478426|565670775|FG000|Overall Study|Withdrawal by Subject|1|||
156706525|NCT00789737|565670780|FG000|Overall Study|Withdrawal by Subject|13|||
156706526|NCT00789737|565670781|FG001|Overall Study|Withdrawal by Subject|22|||
156706527|NCT00789737|565670780|FG000|Overall Study|Lost to Follow-up|10|||
156706528|NCT00789737|565670781|FG001|Overall Study|Lost to Follow-up|14|||
156706529|NCT00789737|565670780|FG000|Overall Study|Adverse Event|8|||
156706530|NCT00789737|565670781|FG001|Overall Study|Adverse Event|8|||
156440675|NCT00444600|564705395|FG002|Overall Study|Death|3|||
156440676|NCT00444600|564705396|FG003|Overall Study|Death|2|||
156706531|NCT00789737|565670780|FG000|Overall Study|Protocol Violation|3|||
156706532|NCT00789737|565670781|FG001|Overall Study|Protocol Violation|0|||
156440677|NCT00444600|564705393|FG000|Overall Study|Dropped|11|||
156706533|NCT00789737|565670780|FG000|Overall Study|Lack of Efficacy|3|||
156706534|NCT00789737|565670781|FG001|Overall Study|Lack of Efficacy|0|||
156706535|NCT00789737|565670780|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
156440678|NCT00444600|564705394|FG001|Overall Study|Dropped|11|||
156706536|NCT00789737|565670781|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
156706537|NCT00789737|565670780|FG000|Overall Study|Other|11|||
156706538|NCT00789737|565670781|FG001|Overall Study|Other|7|||
156706539|NCT01189487|565670782|FG000|Overall Study|Lack of Efficacy|2|||
156706540|NCT01189487|565670782|FG000|Overall Study|Adverse Event|1|||
156706541|NCT04630158|565670783|FG000|Overall Study|Adverse Event|1|||
156706542|NCT04630158|565670784|FG001|Overall Study|Adverse Event|1|||
156706543|NCT04630158|565670785|FG002|Overall Study|Adverse Event|1|||
156706544|NCT04630158|565670783|FG000|Overall Study|Physician Decision|0|||
156706545|NCT04630158|565670784|FG001|Overall Study|Physician Decision|2|||
156706546|NCT04630158|565670785|FG002|Overall Study|Physician Decision|0|||
156706547|NCT04630158|565670783|FG000|Overall Study|Protocol Violation|1|||
156440679|NCT00444600|564705395|FG002|Overall Study|Dropped|7|||
156706548|NCT04630158|565670784|FG001|Overall Study|Protocol Violation|0|||
156706549|NCT04630158|565670785|FG002|Overall Study|Protocol Violation|1|||
156706550|NCT04630158|565670783|FG000|Overall Study|Withdrawal by Subject|2|||
156706551|NCT04630158|565670784|FG001|Overall Study|Withdrawal by Subject|1|||
156706552|NCT04630158|565670785|FG002|Overall Study|Withdrawal by Subject|2|||
156706553|NCT03136965|565670789|FG000|Overall Study|Lost to Follow-up|0|||
156706554|NCT03136965|565670790|FG001|Overall Study|Lost to Follow-up|1|||
156706555|NCT03136965|565670791|FG002|Overall Study|Lost to Follow-up|0|||
156706556|NCT01210612|565670793|FG000|Overall Study|Withdrawal by Subject|0|||
156706557|NCT01210612|565670794|FG001|Overall Study|Withdrawal by Subject|2|||
156706558|NCT02752087|565670795|FG000|Washout|Physician Decision|1|||
156706559|NCT02752087|565670796|FG001|Washout|Physician Decision|0|||
156706560|NCT02458287|565670797|FG000|Overall Study|Adverse Event|0|||
156706561|NCT02458287|565670798|FG001|Overall Study|Adverse Event|0|||
156706562|NCT02458287|565670799|FG002|Overall Study|Adverse Event|0|||
156706563|NCT02458287|565670800|FG003|Overall Study|Adverse Event|1|||
156706564|NCT02458287|565670797|FG000|Overall Study|Lost to Follow-up|0|||
156706565|NCT02458287|565670798|FG001|Overall Study|Lost to Follow-up|1|||
156706566|NCT02458287|565670799|FG002|Overall Study|Lost to Follow-up|1|||
156706567|NCT02458287|565670800|FG003|Overall Study|Lost to Follow-up|0|||
156706568|NCT02458287|565670797|FG000|Overall Study|Protocol Violation|0|||
156706569|NCT02458287|565670798|FG001|Overall Study|Protocol Violation|1|||
156706570|NCT02458287|565670799|FG002|Overall Study|Protocol Violation|0|||
156706571|NCT02458287|565670800|FG003|Overall Study|Protocol Violation|0|||
156706572|NCT02458287|565670797|FG000|Overall Study|Withdrawal by Subject|0|||
156706573|NCT02458287|565670798|FG001|Overall Study|Withdrawal by Subject|2|||
156706574|NCT02458287|565670799|FG002|Overall Study|Withdrawal by Subject|2|||
156706575|NCT02458287|565670800|FG003|Overall Study|Withdrawal by Subject|1|||
156706576|NCT02458287|565670797|FG000|Overall Study|Relocated Out of State|0|||
156706577|NCT02458287|565670798|FG001|Overall Study|Relocated Out of State|0|||
156706578|NCT02458287|565670799|FG002|Overall Study|Relocated Out of State|0|||
156706579|NCT02458287|565670800|FG003|Overall Study|Relocated Out of State|1|||
156706580|NCT00843635|565670801|FG000|Overall Study|Adverse Event|2|||
156706581|NCT00843635|565670802|FG001|Overall Study|Adverse Event|2|||
156706582|NCT00843635|565670803|FG002|Overall Study|Adverse Event|0|||
156706583|NCT02290223|565670804|FG000|6 Months|Lost to Follow-up|9|||
156706584|NCT02290223|565670805|FG001|6 Months|Lost to Follow-up|6|||
156706585|NCT02290223|565670804|FG000|6 Months|Withdrawal by Subject|5|||
156706586|NCT02290223|565670805|FG001|6 Months|Withdrawal by Subject|0|||
156706587|NCT02290223|565670804|FG000|6 Months|deceased (not related to study)|2|||
156706588|NCT02290223|565670805|FG001|6 Months|deceased (not related to study)|0|||
156706589|NCT02290223|565670804|FG000|12 Months|Lost to Follow-up|16|||
156706590|NCT02290223|565670805|FG001|12 Months|Lost to Follow-up|10|||
156706591|NCT02290223|565670804|FG000|12 Months|Refusal|0|||
156706592|NCT02290223|565670805|FG001|12 Months|Refusal|1|||
156706593|NCT05293639|565670806|FG000|Overall Study|Withdrawal by Subject|1|||
156706594|NCT05293639|565670807|FG001|Overall Study|Withdrawal by Subject|1|||
156706595|NCT05293639|565670808|FG002|Overall Study|Withdrawal by Subject|2|||
156706596|NCT05293639|565670806|FG000|Overall Study|Death|0|||
156706597|NCT05293639|565670807|FG001|Overall Study|Death|1|||
156706598|NCT05293639|565670808|FG002|Overall Study|Death|0|||
156706599|NCT05293639|565670806|FG000|Overall Study|Lost to Follow-up|0|||
156706600|NCT05293639|565670807|FG001|Overall Study|Lost to Follow-up|0|||
156706601|NCT05293639|565670808|FG002|Overall Study|Lost to Follow-up|5|||
156706602|NCT05293639|565670806|FG000|Overall Study|Other|0|||
156706603|NCT05293639|565670807|FG001|Overall Study|Other|0|||
156706604|NCT05293639|565670808|FG002|Overall Study|Other|1|||
156706605|NCT00813800|565670812|FG000|Overall Study|Screen Failure after Consent|2|||
156706606|NCT00813800|565670812|FG000|Overall Study|Adverse Event|1|||
156706607|NCT00813800|565670812|FG000|Overall Study|Worsening of depression|2|||
156706608|NCT00813800|565670812|FG000|Overall Study|Physician Decision|1|||
156706609|NCT01860677|565670813|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
156706610|NCT01860677|565670814|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
156440680|NCT00444600|564705396|FG003|Overall Study|Dropped|7|||
156440681|NCT00444600|564705393|FG000|Overall Study|Missed visit|1|||
156706611|NCT00418821|565670816|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
156706612|NCT02823652|565670817|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
156706613|NCT02823652|565670818|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
156706614|NCT02823652|565670819|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
156706615|NCT02823652|565670817|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
156706616|NCT02823652|565670818|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
156706617|NCT02823652|565670819|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
156706618|NCT02823652|565670817|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
156706619|NCT02823652|565670818|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
156706620|NCT02823652|565670819|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
156706621|NCT02823652|565670817|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
156706622|NCT02823652|565670818|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
156440682|NCT00444600|564705394|FG001|Overall Study|Missed visit|0|||
156706623|NCT02823652|565670819|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
156531733|NCT02511678|565041714|FG000|Overall Study|Adverse Event|1|||
156531734|NCT02511678|565041714|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
156531735|NCT02511678|565041714|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
156531736|NCT02511678|565041714|FG000|Overall Study|Required Radiofrequency Ablation|1|||
156531737|NCT02511678|565041714|FG000|Overall Study|Biopsy was Negative|1|||
156531738|NCT02511678|565041714|FG000|Overall Study|Protocol Violation|1|||
156531739|NCT02511678|565041714|FG000|Overall Study|Received Radiation Treatment|1|||
156531740|NCT01295281|565041715|FG000|First Intervention (7 Days)|Death|0|||
156706624|NCT03155945|565670820|FG000|Overall Study|Lost to Follow-up|0|||
156706625|NCT03155945|565670821|FG001|Overall Study|Lost to Follow-up|1|||
156706626|NCT03155945|565670820|FG000|Overall Study|Withdrawal by Subject|0|||
156531741|NCT01295281|565041716|FG001|First Intervention (7 Days)|Death|1|||
156706627|NCT03155945|565670821|FG001|Overall Study|Withdrawal by Subject|1|||
156706628|NCT03155945|565670820|FG000|Overall Study|Other Reason|0|||
156706629|NCT03155945|565670821|FG001|Overall Study|Other Reason|1|||
156706630|NCT02013674|565670822|FG000|Overall Study|Death|0|||
156706631|NCT02013674|565670823|FG001|Overall Study|Death|1|||
156706632|NCT02013674|565670822|FG000|Overall Study|Lost to Follow-up|1|||
156706633|NCT02013674|565670823|FG001|Overall Study|Lost to Follow-up|0|||
156706634|NCT03408639|565673143|FG000|Overall Study|Death|5|||
156706635|NCT03408639|565673144|FG001|Overall Study|Death|5|||
156706636|NCT03408639|565673143|FG000|Overall Study|Lost to Follow-up|1|||
156706637|NCT03408639|565673144|FG001|Overall Study|Lost to Follow-up|4|||
156706638|NCT03408639|565673143|FG000|Overall Study|Withdrawal by Subject|2|||
156706639|NCT03408639|565673144|FG001|Overall Study|Withdrawal by Subject|7|||
156706640|NCT03408639|565673143|FG000|Overall Study|Physician Decision|3|||
156706641|NCT03408639|565673144|FG001|Overall Study|Physician Decision|6|||
156706642|NCT01924754|565673153|FG000|Overall Study|Lost to Follow-up|1|||
156706643|NCT01924754|565673154|FG001|Overall Study|Lost to Follow-up|2|||
156706644|NCT01924754|565673155|FG002|Overall Study|Lost to Follow-up|1|||
156706645|NCT01924754|565673153|FG000|Overall Study|Pregnancy|0|||
156706646|NCT01924754|565673154|FG001|Overall Study|Pregnancy|1|||
156706647|NCT01924754|565673155|FG002|Overall Study|Pregnancy|2|||
156706648|NCT03132155|565673156|FG000|Overall Study|Lack of Efficacy|6|||
156706649|NCT03132155|565673156|FG000|Overall Study|Lost to Follow-up|1|||
156706650|NCT03132155|565673156|FG000|Overall Study|Withdrawal by Subject|1|||
156706651|NCT02925403|565673159|FG000|Overall Study|Lost to Follow-up|0|||
156706652|NCT02925403|565673160|FG001|Overall Study|Lost to Follow-up|1|||
156706653|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
156706654|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
156706655|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
156706656|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
156706657|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
156706658|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
156706659|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
156706660|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
156706661|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
156706662|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
156706663|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
156706664|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
156706665|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
156706666|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
156706667|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
156706668|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
156706669|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
156706670|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
156706671|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
156791178|NCT02413346|565987192|FG000|Overall Study|Adverse Event|6|||
156791179|NCT02413346|565987193|FG001|Overall Study|Adverse Event|6|||
156531742|NCT00292461|565041717|FG000|Overall Study|Adverse Event|4|||
156706672|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
156706673|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
156706674|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
156706675|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
156706676|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
156706677|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
156706678|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
156531743|NCT00292461|565041718|FG001|Overall Study|Adverse Event|2|||
156706679|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
156706680|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
156706681|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
156791180|NCT02413346|565987192|FG000|Overall Study|Withdrawal by Subject|30|||
156531744|NCT00292461|565041717|FG000|Overall Study|Lack of Efficacy|1|||
156791181|NCT02413346|565987193|FG001|Overall Study|Withdrawal by Subject|40|||
156332301|NCT00216476|564315075|FG001|Overall Study|Other|0|||
156706682|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
156706683|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
156706684|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
156706685|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
156706686|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
156706687|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
156706688|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
156706689|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
156706690|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
156706691|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
156706692|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
156706693|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
156706694|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
156706695|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
156706696|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
156706697|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
156706698|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
156706699|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
156706700|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
156706701|NCT00261443|565673161|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
156706702|NCT00261443|565673162|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
156706703|NCT00261443|565673163|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
156706704|NCT00261443|565673161|FG000|3: Assessment of Relapse|Adverse Event|0|||
156706705|NCT00261443|565673162|FG001|3: Assessment of Relapse|Adverse Event|15|||
156706706|NCT00261443|565673163|FG002|3: Assessment of Relapse|Adverse Event|19|||
156706707|NCT00261443|565673161|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
156706708|NCT00261443|565673162|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
156706709|NCT00261443|565673163|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
156706710|NCT00261443|565673161|FG000|3: Assessment of Relapse|Death|0|||
156706711|NCT00261443|565673162|FG001|3: Assessment of Relapse|Death|0|||
156706712|NCT00261443|565673163|FG002|3: Assessment of Relapse|Death|1|||
156706713|NCT00261443|565673161|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
156706714|NCT00261443|565673162|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
156706715|NCT00261443|565673163|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
156706716|NCT00261443|565673161|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
156706717|NCT00261443|565673162|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
156706718|NCT00261443|565673163|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
156706719|NCT00261443|565673161|FG000|3: Assessment of Relapse|Pregnancy|0|||
156706720|NCT00261443|565673162|FG001|3: Assessment of Relapse|Pregnancy|2|||
156706721|NCT00261443|565673163|FG002|3: Assessment of Relapse|Pregnancy|1|||
156706722|NCT00261443|565673161|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
156706723|NCT00261443|565673162|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
156706724|NCT00261443|565673163|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
156706725|NCT00261443|565673161|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
156706726|NCT00261443|565673162|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
156706727|NCT00261443|565673163|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
156706728|NCT00261443|565673161|FG000|3: Assessment of Relapse|Other Reasons|0|||
156706729|NCT00261443|565673162|FG001|3: Assessment of Relapse|Other Reasons|4|||
156706730|NCT00261443|565673163|FG002|3: Assessment of Relapse|Other Reasons|3|||
156706731|NCT00261443|565673161|FG000|4: Extension Phase|Adverse Event|0|||
156706732|NCT00261443|565673162|FG001|4: Extension Phase|Adverse Event|1|||
156706733|NCT00261443|565673163|FG002|4: Extension Phase|Adverse Event|0|||
156706734|NCT00261443|565673161|FG000|4: Extension Phase|Withdrawal by Subject|0|||
156706735|NCT00261443|565673162|FG001|4: Extension Phase|Withdrawal by Subject|1|||
156706736|NCT00261443|565673163|FG002|4: Extension Phase|Withdrawal by Subject|2|||
156706737|NCT00261443|565673161|FG000|4: Extension Phase|Lost to Follow-up|0|||
156706738|NCT00261443|565673162|FG001|4: Extension Phase|Lost to Follow-up|1|||
156706739|NCT00261443|565673163|FG002|4: Extension Phase|Lost to Follow-up|0|||
156706740|NCT02755649|565673164|FG000|Overall Study|Transitioned into OLE study|99|||
156706741|NCT02755649|565673165|FG001|Overall Study|Transitioned into OLE study|98|||
156332302|NCT00216476|564315076|FG002|Overall Study|Other|1|||
156332303|NCT00216476|564315074|FG000|Overall Study|Refuses Injection|11|||
156332304|NCT00216476|564315075|FG001|Overall Study|Refuses Injection|0|||
156332305|NCT00216476|564315076|FG002|Overall Study|Refuses Injection|0|||
156332306|NCT00216476|564315074|FG000|Overall Study|No Further Need for Treatment|3|||
156332307|NCT00216476|564315075|FG001|Overall Study|No Further Need for Treatment|4|||
156791182|NCT02413346|565987192|FG000|Overall Study|Lost to Follow-up|17|||
156791183|NCT02413346|565987193|FG001|Overall Study|Lost to Follow-up|21|||
156706742|NCT02755649|565673166|FG002|Overall Study|Transitioned into OLE study|100|||
156706743|NCT02755649|565673164|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
156706744|NCT02755649|565673165|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
156706745|NCT02755649|565673166|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
156706746|NCT02755649|565673164|FG000|Overall Study|Physician Decision|0|||
156706747|NCT02755649|565673165|FG001|Overall Study|Physician Decision|0|||
156706748|NCT02755649|565673166|FG002|Overall Study|Physician Decision|2|||
156706749|NCT02755649|565673164|FG000|Overall Study|Withdrawal by Subject|0|||
156706750|NCT02755649|565673165|FG001|Overall Study|Withdrawal by Subject|1|||
156706751|NCT02755649|565673166|FG002|Overall Study|Withdrawal by Subject|0|||
156706752|NCT02755649|565673164|FG000|Overall Study|Undecided|1|||
156706753|NCT02755649|565673165|FG001|Overall Study|Undecided|0|||
156706754|NCT02755649|565673166|FG002|Overall Study|Undecided|0|||
156706755|NCT01286753|565673167|FG000|Overall Study|Adverse Event|7|||
156706756|NCT01286753|565673168|FG001|Overall Study|Adverse Event|6|||
156706757|NCT01286753|565673167|FG000|Overall Study|Progression|11|||
156706758|NCT01286753|565673168|FG001|Overall Study|Progression|13|||
156706759|NCT01286753|565673167|FG000|Overall Study|Refused Treatment|1|||
156706760|NCT01286753|565673168|FG001|Overall Study|Refused Treatment|0|||
156706761|NCT01286753|565673167|FG000|Overall Study|Withdrawal of Consent|0|||
156706762|NCT01286753|565673168|FG001|Overall Study|Withdrawal of Consent|2|||
156706763|NCT01286753|565673167|FG000|Overall Study|Discontinued to Join Extension Study|6|||
156706764|NCT01286753|565673168|FG001|Overall Study|Discontinued to Join Extension Study|4|||
156706765|NCT01286753|565673167|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
156706766|NCT01286753|565673168|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
156706767|NCT02126826|565673172|FG000|Overall Study|Withdrawal by Subject|0|||
156706768|NCT02126826|565673173|FG001|Overall Study|Withdrawal by Subject|0|||
156706769|NCT02126826|565673174|FG002|Overall Study|Withdrawal by Subject|0|||
156706770|NCT02126826|565673175|FG003|Overall Study|Withdrawal by Subject|1|||
156706771|NCT02126826|565673176|FG004|Overall Study|Withdrawal by Subject|0|||
156706772|NCT02126826|565673177|FG005|Overall Study|Withdrawal by Subject|0|||
156706773|NCT02126826|565673178|FG006|Overall Study|Withdrawal by Subject|0|||
156706774|NCT01371747|565673179|FG000|Overall Study|Adverse Event|4|||
156706775|NCT01371747|565673180|FG001|Overall Study|Adverse Event|2|||
156706776|NCT01371747|565673181|FG002|Overall Study|Adverse Event|7|||
156706777|NCT01371747|565673182|FG003|Overall Study|Adverse Event|2|||
156706778|NCT01371747|565673183|FG004|Overall Study|Adverse Event|2|||
156706779|NCT01371747|565673184|FG005|Overall Study|Adverse Event|2|||
156706780|NCT01371747|565673179|FG000|Overall Study|Death|1|||
156706781|NCT01371747|565673180|FG001|Overall Study|Death|0|||
156706782|NCT01371747|565673181|FG002|Overall Study|Death|4|||
156706783|NCT01371747|565673182|FG003|Overall Study|Death|1|||
156706784|NCT01371747|565673183|FG004|Overall Study|Death|2|||
156706785|NCT01371747|565673184|FG005|Overall Study|Death|0|||
156706786|NCT01371747|565673179|FG000|Overall Study|Abnormal Renal Function|0|||
156706787|NCT01371747|565673180|FG001|Overall Study|Abnormal Renal Function|2|||
156706788|NCT01371747|565673181|FG002|Overall Study|Abnormal Renal Function|0|||
156706789|NCT01371747|565673182|FG003|Overall Study|Abnormal Renal Function|1|||
156706790|NCT01371747|565673183|FG004|Overall Study|Abnormal Renal Function|0|||
156706791|NCT01371747|565673184|FG005|Overall Study|Abnormal Renal Function|1|||
156706792|NCT01371747|565673179|FG000|Overall Study|High Serum Potassium Results|1|||
156706793|NCT01371747|565673180|FG001|Overall Study|High Serum Potassium Results|1|||
156706794|NCT01371747|565673181|FG002|Overall Study|High Serum Potassium Results|1|||
156706795|NCT01371747|565673182|FG003|Overall Study|High Serum Potassium Results|2|||
156706796|NCT01371747|565673183|FG004|Overall Study|High Serum Potassium Results|0|||
156706797|NCT01371747|565673184|FG005|Overall Study|High Serum Potassium Results|2|||
156706798|NCT01371747|565673179|FG000|Overall Study|Low Serum Potassium Results|1|||
156706799|NCT01371747|565673180|FG001|Overall Study|Low Serum Potassium Results|1|||
156440683|NCT00444600|564705395|FG002|Overall Study|Missed visit|0|||
156440684|NCT00444600|564705396|FG003|Overall Study|Missed visit|1|||
156440685|NCT05132478|564705397|FG000|Overall Study|did not complete survey after consent|1|||
156440686|NCT05132478|564705398|FG001|Overall Study|did not complete survey after consent|1|||
156440687|NCT05132478|564705397|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
156706800|NCT01371747|565673181|FG002|Overall Study|Low Serum Potassium Results|1|||
156440688|NCT05132478|564705398|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
156706801|NCT01371747|565673182|FG003|Overall Study|Low Serum Potassium Results|1|||
156706802|NCT01371747|565673183|FG004|Overall Study|Low Serum Potassium Results|0|||
156706803|NCT01371747|565673184|FG005|Overall Study|Low Serum Potassium Results|3|||
156706804|NCT01371747|565673179|FG000|Overall Study|Protocol Violation|0|||
156706805|NCT01371747|565673180|FG001|Overall Study|Protocol Violation|0|||
156706806|NCT01371747|565673181|FG002|Overall Study|Protocol Violation|1|||
156706807|NCT01371747|565673182|FG003|Overall Study|Protocol Violation|0|||
156706808|NCT01371747|565673183|FG004|Overall Study|Protocol Violation|0|||
156706809|NCT01371747|565673184|FG005|Overall Study|Protocol Violation|0|||
156706810|NCT01371747|565673179|FG000|Overall Study|Non-Compliance|3|||
156872193|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
156706811|NCT01371747|565673180|FG001|Overall Study|Non-Compliance|4|||
156706812|NCT01371747|565673181|FG002|Overall Study|Non-Compliance|3|||
156706813|NCT01371747|565673182|FG003|Overall Study|Non-Compliance|0|||
156706814|NCT01371747|565673183|FG004|Overall Study|Non-Compliance|0|||
156706815|NCT01371747|565673184|FG005|Overall Study|Non-Compliance|1|||
156706816|NCT01371747|565673179|FG000|Overall Study|Physician Decision|0|||
156706817|NCT01371747|565673180|FG001|Overall Study|Physician Decision|0|||
156706818|NCT01371747|565673181|FG002|Overall Study|Physician Decision|0|||
156706819|NCT01371747|565673182|FG003|Overall Study|Physician Decision|0|||
156706820|NCT01371747|565673183|FG004|Overall Study|Physician Decision|1|||
156706821|NCT01371747|565673184|FG005|Overall Study|Physician Decision|0|||
156706822|NCT01371747|565673179|FG000|Overall Study|Withdrawal by Subject|6|||
156706823|NCT01371747|565673180|FG001|Overall Study|Withdrawal by Subject|12|||
156706824|NCT01371747|565673181|FG002|Overall Study|Withdrawal by Subject|5|||
156706825|NCT01371747|565673182|FG003|Overall Study|Withdrawal by Subject|2|||
156706826|NCT01371747|565673183|FG004|Overall Study|Withdrawal by Subject|2|||
156706827|NCT01371747|565673184|FG005|Overall Study|Withdrawal by Subject|4|||
156706828|NCT01371747|565673179|FG000|Overall Study|Other Reasons|2|||
156706829|NCT01371747|565673180|FG001|Overall Study|Other Reasons|1|||
156706830|NCT01371747|565673181|FG002|Overall Study|Other Reasons|2|||
156706831|NCT01371747|565673182|FG003|Overall Study|Other Reasons|0|||
156706832|NCT01371747|565673183|FG004|Overall Study|Other Reasons|0|||
156706833|NCT01371747|565673184|FG005|Overall Study|Other Reasons|1|||
156706834|NCT03092219|565673185|FG000|Overall Study|Protocol Violation|7|||
156706835|NCT03092219|565673186|FG001|Overall Study|Protocol Violation|4|||
156706836|NCT03278626|565673189|FG000|Overall Study|Death|2|||
156706837|NCT03278626|565673189|FG000|Overall Study|Toxicity|1|||
156706838|NCT03278626|565673189|FG000|Overall Study|Disease Progression|2|||
156706839|NCT02856555|565673190|FG000|Overall Study|Adverse Event|1|||
156706840|NCT02856555|565673191|FG001|Overall Study|Adverse Event|0|||
156706841|NCT02856555|565673192|FG002|Overall Study|Adverse Event|0|||
156706842|NCT02856555|565673190|FG000|Overall Study|Lost to Follow-up|1|||
156706843|NCT02856555|565673191|FG001|Overall Study|Lost to Follow-up|3|||
156706844|NCT02856555|565673192|FG002|Overall Study|Lost to Follow-up|0|||
156706845|NCT02856555|565673190|FG000|Overall Study|Withdrawal by Subject|3|||
156706846|NCT02856555|565673191|FG001|Overall Study|Withdrawal by Subject|0|||
156706847|NCT02856555|565673192|FG002|Overall Study|Withdrawal by Subject|0|||
156706848|NCT02856555|565673190|FG000|Overall Study|Randomized but Never Treated|0|||
156706849|NCT02856555|565673191|FG001|Overall Study|Randomized but Never Treated|1|||
156706850|NCT02856555|565673192|FG002|Overall Study|Randomized but Never Treated|0|||
156706851|NCT05013008|565673193|FG000|Overall Study|Exclusion from mBFAS|5|||
156706852|NCT05013008|565673194|FG001|Overall Study|Exclusion from mBFAS|25|||
156706853|NCT02842073|565673195|FG000|Overall Study|Withdrawal by Subject|1|||
156706854|NCT01333397|565673198|FG000|Overall Study|Lost to Follow-up|1|||
156706855|NCT01333397|565673199|FG001|Overall Study|Lost to Follow-up|0|||
156706856|NCT01333397|565673200|FG002|Overall Study|Lost to Follow-up|0|||
156706857|NCT01333397|565673201|FG003|Overall Study|Lost to Follow-up|1|||
156706858|NCT01333397|565673202|FG004|Overall Study|Lost to Follow-up|0|||
156706859|NCT02460679|565673203|FG000|Overall Study|Investigator Decision|1|||
156706860|NCT02460679|565673203|FG000|Overall Study|Withdrawal by Subject|4|||
156706861|NCT01994850|565673213|FG000|Overall Study|Physician Decision|1|||
156706862|NCT01994850|565673213|FG000|Overall Study|Withdrawal by Subject|1|||
156706863|NCT02785952|565673221|FG000|Overall Study|Adverse Event|31|||
156706864|NCT02785952|565673222|FG001|Overall Study|Adverse Event|19|||
156706865|NCT02785952|565673221|FG000|Overall Study|Refusal unrelated to adverse events|10|||
156706866|NCT02785952|565673222|FG001|Overall Study|Refusal unrelated to adverse events|5|||
156706867|NCT02785952|565673221|FG000|Overall Study|Disease progression/relapse|61|||
156706868|NCT02785952|565673222|FG001|Overall Study|Disease progression/relapse|89|||
156706869|NCT02785952|565673221|FG000|Overall Study|Death|11|||
156706870|NCT02785952|565673222|FG001|Overall Study|Death|7|||
156706871|NCT02785952|565673221|FG000|Overall Study|Other- not protocol specified|6|||
156706872|NCT02785952|565673222|FG001|Overall Study|Other- not protocol specified|4|||
156440689|NCT00106080|564705399|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
156706873|NCT02785952|565673221|FG000|Overall Study|On protocol treatment|6|||
156706874|NCT02785952|565673222|FG001|Overall Study|On protocol treatment|3|||
156706875|NCT00642278|565673225|FG000|Overall Study|Adverse Event|2|||
156706876|NCT00642278|565673226|FG001|Overall Study|Adverse Event|1|||
156706877|NCT00642278|565673227|FG002|Overall Study|Adverse Event|3|||
156706878|NCT00642278|565673228|FG003|Overall Study|Adverse Event|1|||
156706879|NCT00642278|565673229|FG004|Overall Study|Adverse Event|2|||
156706880|NCT00642278|565673230|FG005|Overall Study|Adverse Event|2|||
156706881|NCT00642278|565673231|FG006|Overall Study|Adverse Event|0|||
156706882|NCT00642278|565673225|FG000|Overall Study|Lack of Efficacy|0|||
156706883|NCT00642278|565673226|FG001|Overall Study|Lack of Efficacy|1|||
156706884|NCT00642278|565673227|FG002|Overall Study|Lack of Efficacy|0|||
156706885|NCT00642278|565673228|FG003|Overall Study|Lack of Efficacy|0|||
156706886|NCT00642278|565673229|FG004|Overall Study|Lack of Efficacy|0|||
156706887|NCT00642278|565673230|FG005|Overall Study|Lack of Efficacy|0|||
156706888|NCT00642278|565673231|FG006|Overall Study|Lack of Efficacy|0|||
156706889|NCT00642278|565673225|FG000|Overall Study|Lost to Follow-up|5|||
156706890|NCT00642278|565673226|FG001|Overall Study|Lost to Follow-up|1|||
156706891|NCT00642278|565673227|FG002|Overall Study|Lost to Follow-up|0|||
156706892|NCT00642278|565673228|FG003|Overall Study|Lost to Follow-up|1|||
156440690|NCT00106080|564705400|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
156440691|NCT01414738|564705401|FG000|Overall Study|Death|26|||
156440692|NCT01414738|564705401|FG000|Overall Study|Refused testing|5|||
156706893|NCT00642278|565673229|FG004|Overall Study|Lost to Follow-up|0|||
156706894|NCT00642278|565673230|FG005|Overall Study|Lost to Follow-up|1|||
156706895|NCT00642278|565673231|FG006|Overall Study|Lost to Follow-up|1|||
156706896|NCT00642278|565673225|FG000|Overall Study|Physician Decision|0|||
156706897|NCT00642278|565673226|FG001|Overall Study|Physician Decision|0|||
156706898|NCT00642278|565673227|FG002|Overall Study|Physician Decision|0|||
156706899|NCT00642278|565673228|FG003|Overall Study|Physician Decision|1|||
156706900|NCT00642278|565673229|FG004|Overall Study|Physician Decision|0|||
156706901|NCT00642278|565673230|FG005|Overall Study|Physician Decision|0|||
156706902|NCT00642278|565673231|FG006|Overall Study|Physician Decision|0|||
156706903|NCT00642278|565673225|FG000|Overall Study|Protocol Violation|0|||
156706904|NCT00642278|565673226|FG001|Overall Study|Protocol Violation|0|||
156706905|NCT00642278|565673227|FG002|Overall Study|Protocol Violation|1|||
156706906|NCT00642278|565673228|FG003|Overall Study|Protocol Violation|1|||
156706907|NCT00642278|565673229|FG004|Overall Study|Protocol Violation|0|||
156706908|NCT00642278|565673230|FG005|Overall Study|Protocol Violation|1|||
156706909|NCT00642278|565673231|FG006|Overall Study|Protocol Violation|2|||
156706910|NCT00642278|565673225|FG000|Overall Study|Withdrawal by Subject|1|||
156706911|NCT00642278|565673226|FG001|Overall Study|Withdrawal by Subject|1|||
156706912|NCT00642278|565673227|FG002|Overall Study|Withdrawal by Subject|1|||
156706913|NCT00642278|565673228|FG003|Overall Study|Withdrawal by Subject|3|||
156706914|NCT00642278|565673229|FG004|Overall Study|Withdrawal by Subject|6|||
156706915|NCT00642278|565673230|FG005|Overall Study|Withdrawal by Subject|2|||
156706916|NCT00642278|565673231|FG006|Overall Study|Withdrawal by Subject|2|||
156706917|NCT00642278|565673225|FG000|Overall Study|Noncompliance with study drug regimen|0|||
156706918|NCT00642278|565673226|FG001|Overall Study|Noncompliance with study drug regimen|0|||
156706919|NCT00642278|565673227|FG002|Overall Study|Noncompliance with study drug regimen|0|||
156706920|NCT00642278|565673228|FG003|Overall Study|Noncompliance with study drug regimen|1|||
156706921|NCT00642278|565673229|FG004|Overall Study|Noncompliance with study drug regimen|0|||
156706922|NCT00642278|565673230|FG005|Overall Study|Noncompliance with study drug regimen|0|||
156706923|NCT00642278|565673231|FG006|Overall Study|Noncompliance with study drug regimen|0|||
156706924|NCT00642278|565673225|FG000|Overall Study|Other|2|||
156706925|NCT00642278|565673226|FG001|Overall Study|Other|1|||
156706926|NCT00642278|565673227|FG002|Overall Study|Other|0|||
156706927|NCT00642278|565673228|FG003|Overall Study|Other|1|||
156706928|NCT00642278|565673229|FG004|Overall Study|Other|0|||
156706929|NCT00642278|565673230|FG005|Overall Study|Other|1|||
156706930|NCT00642278|565673231|FG006|Overall Study|Other|0|||
156706931|NCT00090363|565673232|FG000|Overall Study|Lost to Follow-up|1|||
156706932|NCT00090363|565673233|FG001|Overall Study|Lost to Follow-up|2|||
156706933|NCT00090363|565673234|FG002|Overall Study|Lost to Follow-up|1|||
156706934|NCT00090363|565673232|FG000|Overall Study|Withdrawal by Subject|7|||
156706935|NCT00090363|565673233|FG001|Overall Study|Withdrawal by Subject|7|||
156440693|NCT01414738|564705401|FG000|Overall Study|Lost to Follow-up|2|||
156440694|NCT01414738|564705401|FG000|Overall Study|Refused, disease progression|8|||
156706936|NCT00090363|565673234|FG002|Overall Study|Withdrawal by Subject|6|||
156706937|NCT00090363|565673232|FG000|Overall Study|Study-specific discontinuation criteria|75|||
156706938|NCT00090363|565673233|FG001|Overall Study|Study-specific discontinuation criteria|74|||
156706939|NCT00090363|565673234|FG002|Overall Study|Study-specific discontinuation criteria|62|||
156706940|NCT00090363|565673232|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156706941|NCT00090363|565673233|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156706942|NCT00090363|565673234|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156706943|NCT00090363|565673232|FG000|Overall Study|Consent expired|7|||
156706944|NCT00090363|565673233|FG001|Overall Study|Consent expired|10|||
156706945|NCT00090363|565673234|FG002|Overall Study|Consent expired|9|||
156706946|NCT00090363|565673232|FG000|Overall Study|Reasons not specified|2|||
156706947|NCT00090363|565673233|FG001|Overall Study|Reasons not specified|1|||
156706948|NCT00090363|565673234|FG002|Overall Study|Reasons not specified|1|||
156706949|NCT00090363|565673232|FG000|Overall Study|Continuing on study off treatment|14|||
156706950|NCT00090363|565673233|FG001|Overall Study|Continuing on study off treatment|13|||
156706951|NCT00090363|565673234|FG002|Overall Study|Continuing on study off treatment|16|||
156440695|NCT01414738|564705401|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
156706952|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
156706953|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156706954|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
156706955|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156706956|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156706957|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
156706958|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156706959|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156706960|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
156706961|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
156706962|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
156706963|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
156706964|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
156706965|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
156706966|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
156706967|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
156706968|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156706969|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156706970|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156706971|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156706972|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
156706973|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
156706974|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
156706975|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
156706976|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
156706977|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
156706978|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
156706979|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
156706980|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
156706981|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
156706982|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
156706983|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
156706984|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
156706985|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
156706986|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
156706987|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
156706988|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
156706989|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
156706990|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
156706991|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
156706992|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
156706993|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156706994|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156706995|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
156706996|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156706997|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
156706998|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
156706999|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
156707000|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
156707001|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
156707002|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
156707003|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
156707004|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
156707005|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
156707006|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
156707007|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
156707008|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
156707009|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
156707010|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
156707011|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
156707012|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
156707013|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
156707014|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
156707015|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
156707016|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
156707017|NCT04642365|565673243|FG000|Overall Study|Death|3|||
156707018|NCT04642365|565673244|FG001|Overall Study|Death|2|||
156707019|NCT04642365|565673245|FG002|Overall Study|Death|4|||
156707020|NCT04642365|565673246|FG003|Overall Study|Death|5|||
156707021|NCT04642365|565673247|FG004|Overall Study|Death|5|||
156707022|NCT04642365|565673248|FG005|Overall Study|Death|3|||
156707023|NCT04642365|565673249|FG006|Overall Study|Death|2|||
156707024|NCT04642365|565673250|FG007|Overall Study|Death|1|||
156707025|NCT04642365|565673243|FG000|Overall Study|Physician Decision|1|||
156707026|NCT04642365|565673244|FG001|Overall Study|Physician Decision|0|||
156707027|NCT04642365|565673245|FG002|Overall Study|Physician Decision|0|||
156707028|NCT04642365|565673246|FG003|Overall Study|Physician Decision|0|||
156440696|NCT01266122|564705402|FG000|Overall Study|Lost to Follow-up|6|||
156707029|NCT04642365|565673247|FG004|Overall Study|Physician Decision|0|||
156707030|NCT04642365|565673248|FG005|Overall Study|Physician Decision|0|||
156707031|NCT04642365|565673249|FG006|Overall Study|Physician Decision|0|||
156707032|NCT04642365|565673250|FG007|Overall Study|Physician Decision|0|||
156707033|NCT04642365|565673243|FG000|Overall Study|Progressive Disease|1|||
156707034|NCT04642365|565673244|FG001|Overall Study|Progressive Disease|1|||
156707035|NCT04642365|565673245|FG002|Overall Study|Progressive Disease|1|||
156707036|NCT04642365|565673246|FG003|Overall Study|Progressive Disease|0|||
156707037|NCT04642365|565673247|FG004|Overall Study|Progressive Disease|0|||
156707038|NCT04642365|565673248|FG005|Overall Study|Progressive Disease|0|||
156707039|NCT04642365|565673249|FG006|Overall Study|Progressive Disease|1|||
156707040|NCT04642365|565673250|FG007|Overall Study|Progressive Disease|0|||
156707041|NCT04642365|565673243|FG000|Overall Study|Study Terminated By Sponsor|0|||
156707042|NCT04642365|565673244|FG001|Overall Study|Study Terminated By Sponsor|2|||
156707043|NCT04642365|565673245|FG002|Overall Study|Study Terminated By Sponsor|1|||
156707044|NCT04642365|565673246|FG003|Overall Study|Study Terminated By Sponsor|1|||
156707045|NCT04642365|565673247|FG004|Overall Study|Study Terminated By Sponsor|1|||
156707046|NCT04642365|565673248|FG005|Overall Study|Study Terminated By Sponsor|2|||
156707047|NCT04642365|565673249|FG006|Overall Study|Study Terminated By Sponsor|2|||
156707048|NCT04642365|565673250|FG007|Overall Study|Study Terminated By Sponsor|1|||
156707049|NCT04642365|565673243|FG000|Overall Study|Symptomatic Deterioration|1|||
156707050|NCT04642365|565673244|FG001|Overall Study|Symptomatic Deterioration|1|||
156707051|NCT04642365|565673245|FG002|Overall Study|Symptomatic Deterioration|0|||
156707052|NCT04642365|565673246|FG003|Overall Study|Symptomatic Deterioration|0|||
156707053|NCT04642365|565673247|FG004|Overall Study|Symptomatic Deterioration|0|||
156707054|NCT04642365|565673248|FG005|Overall Study|Symptomatic Deterioration|1|||
156707055|NCT04642365|565673249|FG006|Overall Study|Symptomatic Deterioration|0|||
156707056|NCT04642365|565673250|FG007|Overall Study|Symptomatic Deterioration|0|||
156707057|NCT04642365|565673243|FG000|Overall Study|Withdrawal by Subject|0|||
156707058|NCT04642365|565673244|FG001|Overall Study|Withdrawal by Subject|0|||
156707059|NCT04642365|565673245|FG002|Overall Study|Withdrawal by Subject|1|||
156707060|NCT04642365|565673246|FG003|Overall Study|Withdrawal by Subject|1|||
156707061|NCT04642365|565673247|FG004|Overall Study|Withdrawal by Subject|0|||
156707062|NCT04642365|565673248|FG005|Overall Study|Withdrawal by Subject|0|||
156707063|NCT04642365|565673249|FG006|Overall Study|Withdrawal by Subject|2|||
156707064|NCT04642365|565673250|FG007|Overall Study|Withdrawal by Subject|0|||
156707065|NCT04642365|565673243|FG000|Overall Study|Adverse Event|0|||
156707066|NCT04642365|565673244|FG001|Overall Study|Adverse Event|0|||
156707067|NCT04642365|565673245|FG002|Overall Study|Adverse Event|0|||
156707068|NCT04642365|565673246|FG003|Overall Study|Adverse Event|0|||
156707069|NCT04642365|565673247|FG004|Overall Study|Adverse Event|0|||
156707070|NCT04642365|565673248|FG005|Overall Study|Adverse Event|0|||
156707071|NCT04642365|565673249|FG006|Overall Study|Adverse Event|0|||
156707072|NCT04642365|565673250|FG007|Overall Study|Adverse Event|1|||
156707073|NCT01144715|565673251|FG000|Overall Study|Lost to Follow-up|2|||
156707074|NCT01144715|565673252|FG001|Overall Study|Lost to Follow-up|1|||
156707075|NCT01144715|565673251|FG000|Overall Study|Withdrawal by Subject|2|||
156707076|NCT01144715|565673252|FG001|Overall Study|Withdrawal by Subject|1|||
156707077|NCT01144715|565673251|FG000|Overall Study|Adverse Event|0|||
156707078|NCT01144715|565673252|FG001|Overall Study|Adverse Event|1|||
156707079|NCT03553576|565673253|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
156707080|NCT03553576|565673254|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
156707081|NCT03553576|565673253|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
156707082|NCT03553576|565673254|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
156707083|NCT03553576|565673253|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
156707084|NCT03553576|565673254|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
156707085|NCT03553576|565673253|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
156707086|NCT03553576|565673254|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
156707087|NCT03553576|565673253|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
156707088|NCT03553576|565673254|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
156707089|NCT03553576|565673253|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
156707090|NCT03553576|565673254|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
156707091|NCT03553576|565673253|FG000|Overall Study|Physician Decision|2|||
156707092|NCT03553576|565673254|FG001|Overall Study|Physician Decision|5|||
156707093|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
156707094|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
156707095|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
156707096|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
156440697|NCT01266122|564705403|FG001|Overall Study|Lost to Follow-up|6|||
156440698|NCT03756571|564705404|FG000|Overall Study|Lost to Follow-up|1|||
156707097|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
156707098|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
156707099|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
156707100|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
156707101|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
156707102|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
156707103|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
156707104|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
156707105|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
156707106|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
156707107|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
156707108|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
156707109|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
156707110|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
156707111|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
156707112|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
156707113|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
156707114|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
156707115|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
156707116|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
156707117|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
156707118|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
156707119|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
156707120|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
156707121|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
156707122|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
156707123|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
156707124|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
156707125|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
156707126|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
156707127|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
156707128|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
156707129|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
156707130|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
156707131|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
156707132|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
156707133|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
156707134|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
156707135|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
156707136|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
156707137|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
156707138|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
156707139|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
156707140|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
156707141|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
156707142|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
156707143|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
156707144|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
156707145|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
156707146|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
156707147|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
156707148|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
156707149|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
156707150|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
156707151|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
156707152|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
156707153|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
156707154|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
156707155|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
156707156|NCT02728843|565673258|FG000|Overall Study|Adverse Event|0|||
156332308|NCT00216476|564315076|FG002|Overall Study|No Further Need for Treatment|1|||
156707157|NCT02728843|565673259|FG001|Overall Study|Adverse Event|2|||
156707158|NCT02728843|565673260|FG002|Overall Study|Adverse Event|3|||
156707159|NCT02728843|565673261|FG003|Overall Study|Adverse Event|1|||
156707160|NCT02728843|565673262|FG004|Overall Study|Adverse Event|2|||
156332309|NCT00216476|564315074|FG000|Overall Study|Non-compliance|0|||
156332310|NCT00216476|564315075|FG001|Overall Study|Non-compliance|4|||
156707161|NCT02728843|565673258|FG000|Overall Study|Lack of Efficacy|0|||
156707162|NCT02728843|565673259|FG001|Overall Study|Lack of Efficacy|1|||
156707163|NCT02728843|565673260|FG002|Overall Study|Lack of Efficacy|1|||
156707164|NCT02728843|565673261|FG003|Overall Study|Lack of Efficacy|0|||
156707165|NCT02728843|565673262|FG004|Overall Study|Lack of Efficacy|0|||
156707166|NCT02728843|565673258|FG000|Overall Study|Protocol Violation|2|||
156707167|NCT02728843|565673259|FG001|Overall Study|Protocol Violation|0|||
156707168|NCT02728843|565673260|FG002|Overall Study|Protocol Violation|4|||
156707169|NCT02728843|565673261|FG003|Overall Study|Protocol Violation|2|||
156707170|NCT02728843|565673262|FG004|Overall Study|Protocol Violation|2|||
156707171|NCT02728843|565673258|FG000|Overall Study|Withdrawal by Subject|1|||
156707172|NCT02728843|565673259|FG001|Overall Study|Withdrawal by Subject|0|||
156707173|NCT02728843|565673260|FG002|Overall Study|Withdrawal by Subject|0|||
156707174|NCT02728843|565673261|FG003|Overall Study|Withdrawal by Subject|1|||
156707175|NCT02728843|565673262|FG004|Overall Study|Withdrawal by Subject|0|||
156707176|NCT02728843|565673258|FG000|Overall Study|Use of rescue medication|0|||
156707177|NCT02728843|565673259|FG001|Overall Study|Use of rescue medication|2|||
156707178|NCT02728843|565673260|FG002|Overall Study|Use of rescue medication|0|||
156707179|NCT02728843|565673261|FG003|Overall Study|Use of rescue medication|2|||
156707180|NCT02728843|565673262|FG004|Overall Study|Use of rescue medication|1|||
156707181|NCT05038800|565673263|FG000|Overall Study|Death|1|||
156707182|NCT05038800|565673264|FG001|Overall Study|Death|1|||
156707183|NCT05038800|565673265|FG002|Overall Study|Death|5|||
156707184|NCT05038800|565673266|FG003|Overall Study|Death|3|||
156707185|NCT05038800|565673267|FG004|Overall Study|Death|1|||
156707186|NCT05038800|565673263|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156707187|NCT05038800|565673264|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156707188|NCT05038800|565673265|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156707189|NCT05038800|565673266|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156707190|NCT05038800|565673267|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156707191|NCT05038800|565673263|FG000|Overall Study|Lack of Efficacy|0|||
156707192|NCT05038800|565673264|FG001|Overall Study|Lack of Efficacy|0|||
156707193|NCT05038800|565673265|FG002|Overall Study|Lack of Efficacy|0|||
156707194|NCT05038800|565673266|FG003|Overall Study|Lack of Efficacy|0|||
156707195|NCT05038800|565673267|FG004|Overall Study|Lack of Efficacy|1|||
156707196|NCT00121134|565673268|FG000|Overall Study|Progression of Disease|5|||
156707197|NCT00121134|565673269|FG001|Overall Study|Progression of Disease|3|||
156707198|NCT00121134|565673270|FG002|Overall Study|Progression of Disease|4|||
156707199|NCT00121134|565673271|FG003|Overall Study|Progression of Disease|2|||
156707200|NCT00121134|565673268|FG000|Overall Study|Toxicity|4|||
156707201|NCT00121134|565673269|FG001|Overall Study|Toxicity|7|||
156707202|NCT00121134|565673270|FG002|Overall Study|Toxicity|13|||
156707203|NCT00121134|565673271|FG003|Overall Study|Toxicity|5|||
156707204|NCT00121134|565673268|FG000|Overall Study|Physician Decision|6|||
156707205|NCT00121134|565673269|FG001|Overall Study|Physician Decision|4|||
156707206|NCT00121134|565673270|FG002|Overall Study|Physician Decision|4|||
156707207|NCT00121134|565673271|FG003|Overall Study|Physician Decision|1|||
156707208|NCT00121134|565673268|FG000|Overall Study|Treatment Delay|1|||
156707209|NCT00121134|565673269|FG001|Overall Study|Treatment Delay|0|||
156707210|NCT00121134|565673270|FG002|Overall Study|Treatment Delay|0|||
156707211|NCT00121134|565673271|FG003|Overall Study|Treatment Delay|0|||
156707212|NCT00121134|565673268|FG000|Overall Study|Intercurrent Illness|0|||
156707213|NCT00121134|565673269|FG001|Overall Study|Intercurrent Illness|0|||
156707214|NCT00121134|565673270|FG002|Overall Study|Intercurrent Illness|0|||
156707215|NCT00121134|565673271|FG003|Overall Study|Intercurrent Illness|1|||
156707216|NCT00121134|565673268|FG000|Overall Study|Patient Personal Reasons|0|||
156707217|NCT00121134|565673269|FG001|Overall Study|Patient Personal Reasons|1|||
156707218|NCT00121134|565673270|FG002|Overall Study|Patient Personal Reasons|0|||
156707219|NCT00121134|565673271|FG003|Overall Study|Patient Personal Reasons|0|||
156707220|NCT02478320|565673277|FG000|Overall Study|Adverse Event|2|||
156707221|NCT02478320|565673278|FG001|Overall Study|Adverse Event|0|||
156707222|NCT02478320|565673277|FG000|Overall Study|Death|1|||
156707223|NCT02478320|565673278|FG001|Overall Study|Death|0|||
156707224|NCT02478320|565673277|FG000|Overall Study|Lack of Efficacy|4|||
156707225|NCT02478320|565673278|FG001|Overall Study|Lack of Efficacy|0|||
156440699|NCT03756571|564705405|FG001|Overall Study|Lost to Follow-up|1|||
156440700|NCT03752151|564705406|FG000|Overall Study|Withdrawal by Subject|1|||
156440701|NCT03752151|564705406|FG000|Overall Study|Protocol Violation|1|||
156707226|NCT02478320|565673277|FG000|Overall Study|Withdrawal by Subject|2|||
156707227|NCT02478320|565673278|FG001|Overall Study|Withdrawal by Subject|0|||
156707228|NCT02478320|565673277|FG000|Overall Study|Screen Failure|3|||
156707229|NCT02478320|565673278|FG001|Overall Study|Screen Failure|0|||
156707230|NCT00197496|565673282|FG000|Baseline to Discharge|not interested|1|||
156707231|NCT00197496|565673283|FG001|Baseline to Discharge|not interested|0|||
156707232|NCT00197496|565673282|FG000|Baseline to Discharge|MRSA|1|||
156707233|NCT00197496|565673283|FG001|Baseline to Discharge|MRSA|0|||
156707234|NCT00197496|565673282|FG000|Baseline to Discharge|Physician Decision|0|||
156707235|NCT00197496|565673283|FG001|Baseline to Discharge|Physician Decision|1|||
156440702|NCT00529516|564705407|FG000|Overall Study|Adverse Event|2|||
156440703|NCT00529516|564705408|FG001|Overall Study|Adverse Event|1|||
156440704|NCT00529516|564705409|FG002|Overall Study|Adverse Event|0|||
156440705|NCT00529516|564705407|FG000|Overall Study|Withdrawal by Subject|1|||
156440706|NCT00529516|564705408|FG001|Overall Study|Withdrawal by Subject|1|||
156440707|NCT00529516|564705409|FG002|Overall Study|Withdrawal by Subject|0|||
156440708|NCT00529516|564705407|FG000|Overall Study|Lost to Follow-up|0|||
156440709|NCT00529516|564705408|FG001|Overall Study|Lost to Follow-up|0|||
156440710|NCT00529516|564705409|FG002|Overall Study|Lost to Follow-up|1|||
156440711|NCT00703820|564705412|FG000|Overall Study|Adverse Event|12|||
156440712|NCT00703820|564705413|FG001|Overall Study|Adverse Event|17|||
156440713|NCT00703820|564705412|FG000|Overall Study|Death|5|||
156440714|NCT00703820|564705413|FG001|Overall Study|Death|0|||
156440715|NCT00703820|564705412|FG000|Overall Study|Lack of Efficacy|11|||
156440716|NCT00703820|564705413|FG001|Overall Study|Lack of Efficacy|11|||
156440717|NCT00703820|564705412|FG000|Overall Study|Received non-protocol therapy|1|||
156440718|NCT00703820|564705413|FG001|Overall Study|Received non-protocol therapy|0|||
156440719|NCT00703820|564705412|FG000|Overall Study|Physician Decision|4|||
156440720|NCT00703820|564705413|FG001|Overall Study|Physician Decision|5|||
156440721|NCT00703820|564705412|FG000|Overall Study|Withdrawal by Subject|2|||
156440722|NCT00703820|564705413|FG001|Overall Study|Withdrawal by Subject|1|||
156440723|NCT00761605|564705415|FG000|Overall Study|Adverse Event|26|||
156440724|NCT00761605|564705415|FG000|Overall Study|Death|2|||
156440725|NCT00761605|564705415|FG000|Overall Study|Lack of Efficacy|26|||
156440726|NCT00761605|564705415|FG000|Overall Study|Lost to Follow-up|29|||
156440727|NCT00761605|564705415|FG000|Overall Study|Withdrawal by Subject|37|||
156440728|NCT00761605|564705415|FG000|Overall Study|Other|21|||
156440729|NCT01007396|564705416|FG000|Overall Study|Lost to Follow-up|47|||
156440730|NCT00350792|564705417|FG000|Overall Study|Adverse Event|11|||
156440731|NCT00350792|564705417|FG000|Overall Study|Death from Study Disease|1|||
156440732|NCT00350792|564705417|FG000|Overall Study|Death from Study Drug Toxicity|1|||
156440733|NCT00350792|564705417|FG000|Overall Study|Death Not Study Drug Related|2|||
156440734|NCT00350792|564705417|FG000|Overall Study|Protocol Violation|1|||
156440735|NCT00350792|564705417|FG000|Overall Study|Withdrawal by Subject|4|||
156440736|NCT00350792|564705417|FG000|Overall Study|Physician Decision|2|||
156440737|NCT00350792|564705417|FG000|Overall Study|Lack of Efficacy|11|||
156440738|NCT03451721|564705418|FG000|Overall Study|Death|1|||
156440739|NCT03283371|564705421|FG000|Placebo-controlled|Adverse Event|1|||
156440740|NCT03283371|564705422|FG001|Placebo-controlled|Adverse Event|1|||
156440741|NCT03283371|564705423|FG002|Placebo-controlled|Adverse Event|0|||
156440742|NCT03283371|564705424|FG003|Placebo-controlled|Adverse Event|0|||
156440743|NCT03283371|564705421|FG000|Placebo-controlled|Lack of Efficacy|1|||
156440744|NCT03283371|564705422|FG001|Placebo-controlled|Lack of Efficacy|0|||
156440745|NCT03283371|564705423|FG002|Placebo-controlled|Lack of Efficacy|0|||
156440746|NCT03283371|564705424|FG003|Placebo-controlled|Lack of Efficacy|0|||
156440747|NCT03283371|564705421|FG000|Placebo-controlled|Withdrawal by Subject|1|||
156440748|NCT03283371|564705422|FG001|Placebo-controlled|Withdrawal by Subject|1|||
156440749|NCT03283371|564705423|FG002|Placebo-controlled|Withdrawal by Subject|0|||
156440750|NCT03283371|564705424|FG003|Placebo-controlled|Withdrawal by Subject|0|||
156440751|NCT03283371|564705421|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
156440752|NCT03283371|564705422|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
156440753|NCT03283371|564705423|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
156440754|NCT03283371|564705424|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
156440755|NCT03283371|564705421|FG000|Open-label Phase|Adverse Event|0|||
156440756|NCT03283371|564705422|FG001|Open-label Phase|Adverse Event|0|||
156440757|NCT03283371|564705423|FG002|Open-label Phase|Adverse Event|2|||
156440758|NCT03283371|564705424|FG003|Open-label Phase|Adverse Event|0|||
156440759|NCT03283371|564705421|FG000|Open-label Phase|Withdrawal by Subject|0|||
156440760|NCT03283371|564705422|FG001|Open-label Phase|Withdrawal by Subject|0|||
156440761|NCT03283371|564705423|FG002|Open-label Phase|Withdrawal by Subject|1|||
156440762|NCT03283371|564705424|FG003|Open-label Phase|Withdrawal by Subject|0|||
156440763|NCT03283371|564705421|FG000|Open-label Phase|Other|0|||
156440764|NCT03283371|564705422|FG001|Open-label Phase|Other|0|||
156440765|NCT03283371|564705423|FG002|Open-label Phase|Other|1|||
156440766|NCT03283371|564705424|FG003|Open-label Phase|Other|1|||
156440767|NCT01373346|564705429|FG000|Overall Study|Death|1|||
156440768|NCT01198028|564705430|FG000|Overall Study|Adverse Event|5|||
156440769|NCT01198028|564705430|FG000|Overall Study|Death|3|||
156440770|NCT01198028|564705430|FG000|Overall Study|Physician Decision|2|||
156440771|NCT00970359|564705432|FG000|Overall Study|Not Treated|4|||
156440772|NCT03887650|564705435|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
156440773|NCT03887650|564705436|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
156440774|NCT03887650|564705435|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
156440775|NCT03887650|564705436|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
156440776|NCT03887650|564705435|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
156440777|NCT03887650|564705436|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
156440778|NCT03942042|564705439|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
156707236|NCT00197496|565673282|FG000|Baseline to Discharge|Protocol Violation|0|||
156707237|NCT00197496|565673283|FG001|Baseline to Discharge|Protocol Violation|1|||
156707238|NCT00197496|565673282|FG000|Follow-up|Lost to Follow-up|2|||
156707239|NCT00197496|565673283|FG001|Follow-up|Lost to Follow-up|1|||
156707240|NCT00857584|565673284|FG000|Overall Study|Lack of Efficacy|1|||
156707241|NCT00857584|565673285|FG001|Overall Study|Lack of Efficacy|2|||
156707242|NCT00857584|565673284|FG000|Overall Study|Adverse Event|2|||
156707243|NCT00857584|565673285|FG001|Overall Study|Adverse Event|2|||
156707244|NCT00857584|565673284|FG000|Overall Study|Physician Decision|1|||
156707245|NCT00857584|565673285|FG001|Overall Study|Physician Decision|1|||
156707246|NCT02533375|565673286|FG000|Overall Study|Lack of Efficacy|3|||
156707247|NCT02533375|565673286|FG000|Overall Study|Adverse Event|2|||
156707248|NCT00673387|565673287|FG000|Overall Study|Withdrawal by Subject|15|||
156707249|NCT00673387|565673288|FG001|Overall Study|Withdrawal by Subject|16|||
156707250|NCT00673387|565673289|FG002|Overall Study|Withdrawal by Subject|20|||
156707251|NCT00673387|565673290|FG003|Overall Study|Withdrawal by Subject|16|||
156707252|NCT00673387|565673291|FG004|Overall Study|Withdrawal by Subject|18|||
156707253|NCT00673387|565673292|FG005|Overall Study|Withdrawal by Subject|21|||
156707254|NCT00673387|565673293|FG006|Overall Study|Withdrawal by Subject|15|||
156707255|NCT00673387|565673294|FG007|Overall Study|Withdrawal by Subject|21|||
156707256|NCT00673387|565673287|FG000|Overall Study|Adverse Event|3|||
156707257|NCT00673387|565673288|FG001|Overall Study|Adverse Event|1|||
156707258|NCT00673387|565673289|FG002|Overall Study|Adverse Event|5|||
156707259|NCT00673387|565673290|FG003|Overall Study|Adverse Event|2|||
156707260|NCT00673387|565673291|FG004|Overall Study|Adverse Event|6|||
156707261|NCT00673387|565673292|FG005|Overall Study|Adverse Event|2|||
156707262|NCT00673387|565673293|FG006|Overall Study|Adverse Event|5|||
156707263|NCT00673387|565673294|FG007|Overall Study|Adverse Event|5|||
156707264|NCT00673387|565673287|FG000|Overall Study|Physician Decision|0|||
156707265|NCT00673387|565673288|FG001|Overall Study|Physician Decision|0|||
156707266|NCT00673387|565673289|FG002|Overall Study|Physician Decision|0|||
156707267|NCT00673387|565673290|FG003|Overall Study|Physician Decision|0|||
156707268|NCT00673387|565673291|FG004|Overall Study|Physician Decision|0|||
156707269|NCT00673387|565673292|FG005|Overall Study|Physician Decision|5|||
156707270|NCT00673387|565673293|FG006|Overall Study|Physician Decision|1|||
156707271|NCT00673387|565673294|FG007|Overall Study|Physician Decision|1|||
156707272|NCT00673387|565673287|FG000|Overall Study|Protocol Violation|3|||
156707273|NCT00673387|565673288|FG001|Overall Study|Protocol Violation|0|||
156707274|NCT00673387|565673289|FG002|Overall Study|Protocol Violation|1|||
156707275|NCT00673387|565673290|FG003|Overall Study|Protocol Violation|2|||
156707276|NCT00673387|565673291|FG004|Overall Study|Protocol Violation|0|||
156707277|NCT00673387|565673292|FG005|Overall Study|Protocol Violation|1|||
156707278|NCT00673387|565673293|FG006|Overall Study|Protocol Violation|1|||
156707279|NCT00673387|565673294|FG007|Overall Study|Protocol Violation|3|||
156707280|NCT00673387|565673287|FG000|Overall Study|Lost to Follow-up|8|||
156707281|NCT00673387|565673288|FG001|Overall Study|Lost to Follow-up|6|||
156707282|NCT00673387|565673289|FG002|Overall Study|Lost to Follow-up|5|||
156707283|NCT00673387|565673290|FG003|Overall Study|Lost to Follow-up|6|||
156707284|NCT00673387|565673291|FG004|Overall Study|Lost to Follow-up|6|||
156707285|NCT00673387|565673292|FG005|Overall Study|Lost to Follow-up|5|||
156707286|NCT00673387|565673293|FG006|Overall Study|Lost to Follow-up|8|||
156707287|NCT00673387|565673294|FG007|Overall Study|Lost to Follow-up|5|||
156707288|NCT00960115|565673295|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
156707289|NCT00960115|565673296|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
156707290|NCT01102374|565673297|FG000|Overall Study|Death|9|||
156707291|NCT01102374|565673298|FG001|Overall Study|Death|13|||
156707292|NCT01102374|565673297|FG000|Overall Study|Lost to Follow-up|7|||
156707293|NCT01102374|565673298|FG001|Overall Study|Lost to Follow-up|6|||
156707294|NCT03014180|565673304|FG000|Overall Study|Protocol Violation|2|||
156707295|NCT02952898|565673307|FG000|Overall Study|Withdrawal by Subject|10|||
156707296|NCT02952898|565673308|FG001|Overall Study|Withdrawal by Subject|8|||
156707297|NCT02952898|565673309|FG002|Overall Study|Withdrawal by Subject|8|||
156791184|NCT02413346|565987192|FG000|Overall Study|Protocol Violation|2|||
156791185|NCT02413346|565987193|FG001|Overall Study|Protocol Violation|0|||
156791186|NCT02413346|565987192|FG000|Overall Study|Other Miscellaneous Reasons|4|||
156791187|NCT02413346|565987193|FG001|Overall Study|Other Miscellaneous Reasons|3|||
156791188|NCT01835431|565987194|FG000|Overall Study|Adverse Event|1|||
156791189|NCT01835431|565987195|FG001|Overall Study|Adverse Event|0|||
156707298|NCT02952898|565673307|FG000|Overall Study|Adverse Event|8|||
156791190|NCT01835431|565987194|FG000|Overall Study|other|0|||
156791191|NCT01835431|565987195|FG001|Overall Study|other|2|||
156707299|NCT02952898|565673308|FG001|Overall Study|Adverse Event|8|||
156707300|NCT02952898|565673309|FG002|Overall Study|Adverse Event|3|||
156707301|NCT02952898|565673307|FG000|Overall Study|Lost to Follow-up|3|||
156707302|NCT02952898|565673308|FG001|Overall Study|Lost to Follow-up|2|||
156707303|NCT02952898|565673309|FG002|Overall Study|Lost to Follow-up|2|||
156707304|NCT02952898|565673307|FG000|Overall Study|Non-compliance with study drug|1|||
156791192|NCT01835431|565987194|FG000|Overall Study|Withdrawal by Subject|6|||
156791193|NCT01835431|565987195|FG001|Overall Study|Withdrawal by Subject|10|||
156791194|NCT01835431|565987194|FG000|Overall Study|Protocol Violation|1|||
156707305|NCT02952898|565673308|FG001|Overall Study|Non-compliance with study drug|1|||
156707306|NCT02952898|565673309|FG002|Overall Study|Non-compliance with study drug|2|||
156707307|NCT02099682|565673310|FG000|Overall Study|Data Not Available|51|||
156707308|NCT02099682|565673310|FG000|Overall Study|Lost to Follow-up|31|||
156707309|NCT02099682|565673310|FG000|Overall Study|Other|29|||
156707310|NCT02802631|565673311|FG000|Overall Study|Withdrawal by Subject|1|||
156707311|NCT02802631|565673312|FG001|Overall Study|Withdrawal by Subject|0|||
156707312|NCT02802631|565673313|FG002|Overall Study|Withdrawal by Subject|0|||
156707313|NCT02802631|565673314|FG003|Overall Study|Withdrawal by Subject|0|||
156707314|NCT02802631|565673315|FG004|Overall Study|Withdrawal by Subject|0|||
156707315|NCT02802631|565673316|FG005|Overall Study|Withdrawal by Subject|0|||
156707316|NCT02802631|565673317|FG006|Overall Study|Withdrawal by Subject|0|||
156707317|NCT02802631|565673318|FG007|Overall Study|Withdrawal by Subject|0|||
156707318|NCT02802631|565673311|FG000|Overall Study|Physician Decision|1|||
156707319|NCT02802631|565673312|FG001|Overall Study|Physician Decision|0|||
156707320|NCT02802631|565673313|FG002|Overall Study|Physician Decision|0|||
156707321|NCT02802631|565673314|FG003|Overall Study|Physician Decision|0|||
156707322|NCT02802631|565673315|FG004|Overall Study|Physician Decision|0|||
156707323|NCT02802631|565673316|FG005|Overall Study|Physician Decision|0|||
156707324|NCT02802631|565673317|FG006|Overall Study|Physician Decision|1|||
156707325|NCT02802631|565673318|FG007|Overall Study|Physician Decision|0|||
156707326|NCT02802631|565673311|FG000|Overall Study|Adverse Event|0|||
156707327|NCT02802631|565673312|FG001|Overall Study|Adverse Event|2|||
156707328|NCT02802631|565673313|FG002|Overall Study|Adverse Event|0|||
156707329|NCT02802631|565673314|FG003|Overall Study|Adverse Event|1|||
156707330|NCT02802631|565673315|FG004|Overall Study|Adverse Event|6|||
156707331|NCT02802631|565673316|FG005|Overall Study|Adverse Event|1|||
156707332|NCT02802631|565673317|FG006|Overall Study|Adverse Event|4|||
156707333|NCT02802631|565673318|FG007|Overall Study|Adverse Event|0|||
156707334|NCT02802631|565673311|FG000|Overall Study|Sponsor Decision|0|||
156707335|NCT02802631|565673312|FG001|Overall Study|Sponsor Decision|0|||
156707336|NCT02802631|565673313|FG002|Overall Study|Sponsor Decision|6|||
156707337|NCT02802631|565673314|FG003|Overall Study|Sponsor Decision|0|||
156707338|NCT02802631|565673315|FG004|Overall Study|Sponsor Decision|2|||
156707339|NCT02802631|565673316|FG005|Overall Study|Sponsor Decision|0|||
156707340|NCT02802631|565673317|FG006|Overall Study|Sponsor Decision|0|||
156707341|NCT02802631|565673318|FG007|Overall Study|Sponsor Decision|4|||
156707342|NCT02212379|565673319|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
156707343|NCT02212379|565673319|FG000|From Baseline to Week 48|Adverse Event|7|||
156707344|NCT02212379|565673319|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
156707345|NCT02212379|565673319|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
156707346|NCT02212379|565673319|FG000|From Week 48 to Week 96|Adverse Event|1|||
156707347|NCT02212379|565673319|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
156707348|NCT02105974|565673320|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
156707349|NCT02105974|565673321|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
156707350|NCT02105974|565673322|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
156707351|NCT02105974|565673320|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
156707352|NCT02105974|565673321|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
156707353|NCT02105974|565673322|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
156707354|NCT02105974|565673320|FG000|2 Week Run-in Period|Adverse Event|6|||
156707355|NCT02105974|565673321|FG001|2 Week Run-in Period|Adverse Event|0|||
156707356|NCT02105974|565673322|FG002|2 Week Run-in Period|Adverse Event|0|||
156707357|NCT02105974|565673320|FG000|2 Week Run-in Period|Study closed/terminated|1|||
156707358|NCT02105974|565673321|FG001|2 Week Run-in Period|Study closed/terminated|0|||
156707359|NCT02105974|565673322|FG002|2 Week Run-in Period|Study closed/terminated|0|||
156707360|NCT02105974|565673320|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
156707361|NCT02105974|565673321|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
156707362|NCT02105974|565673322|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
156707363|NCT02105974|565673320|FG000|2 Week Run-in Period|Withdrew consent|23|||
156707364|NCT02105974|565673321|FG001|2 Week Run-in Period|Withdrew consent|0|||
156707365|NCT02105974|565673322|FG002|2 Week Run-in Period|Withdrew consent|0|||
156707366|NCT02105974|565673320|FG000|2 Week Run-in Period|Investigator discretion|8|||
156707367|NCT02105974|565673321|FG001|2 Week Run-in Period|Investigator discretion|0|||
156791195|NCT01835431|565987195|FG001|Overall Study|Protocol Violation|0|||
156707368|NCT02105974|565673322|FG002|2 Week Run-in Period|Investigator discretion|0|||
156707369|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
156707370|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
156707371|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
156707372|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
156791196|NCT02205359|565987198|FG000|Overall Study|Death|293|||
156707373|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
156707374|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
156707375|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
156707376|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
156791197|NCT02205359|565987199|FG001|Overall Study|Death|327|||
156707377|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
156707378|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
156707379|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
156707380|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
156707381|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
156707382|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
156707383|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
156707384|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
156707385|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
156707386|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
156707387|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
156707388|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
156707389|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
156707390|NCT02968849|565673323|FG000|Overall Study|Death|8|||
156707391|NCT02968849|565673324|FG001|Overall Study|Death|10|||
156707392|NCT02968849|565673323|FG000|Overall Study|Lost to Follow-up|31|||
156707393|NCT02968849|565673324|FG001|Overall Study|Lost to Follow-up|29|||
156707394|NCT02968849|565673323|FG000|Overall Study|Withdrawal by Subject|73|||
156707395|NCT02968849|565673324|FG001|Overall Study|Withdrawal by Subject|64|||
156707396|NCT02968849|565673323|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
156707397|NCT02968849|565673324|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
156707398|NCT02968849|565673323|FG000|Overall Study|Physician Decision|6|||
156707399|NCT02968849|565673324|FG001|Overall Study|Physician Decision|9|||
156707400|NCT02968849|565673323|FG000|Overall Study|Other|16|||
156707401|NCT02968849|565673324|FG001|Overall Study|Other|10|||
156707402|NCT00704730|565673327|FG000|Overall Study|Adverse Event|35|||
156707403|NCT00704730|565673328|FG001|Overall Study|Adverse Event|9|||
156707404|NCT00704730|565673327|FG000|Overall Study|Death|11|||
156707405|NCT00704730|565673328|FG001|Overall Study|Death|5|||
156707406|NCT00704730|565673327|FG000|Overall Study|Physician Decision|2|||
156707407|NCT00704730|565673328|FG001|Overall Study|Physician Decision|0|||
156707408|NCT00704730|565673327|FG000|Overall Study|Did not receive drug|5|||
156707409|NCT00704730|565673328|FG001|Overall Study|Did not receive drug|2|||
156707410|NCT00704730|565673327|FG000|Overall Study|Disease progression per PI|58|||
156707411|NCT00704730|565673328|FG001|Overall Study|Disease progression per PI|67|||
156707412|NCT00704730|565673327|FG000|Overall Study|data unavailable|1|||
156707413|NCT00704730|565673328|FG001|Overall Study|data unavailable|0|||
156707414|NCT00704730|565673327|FG000|Overall Study|Withdrawal by Subject|9|||
156707415|NCT00704730|565673328|FG001|Overall Study|Withdrawal by Subject|13|||
156707416|NCT05833139|565675151|FG000|Study Period 2|Adverse Event|1|||
156707417|NCT03996447|565675152|FG000|First MRI Examination|Adverse Event|2|||
156707418|NCT03996447|565675153|FG001|First MRI Examination|Adverse Event|0|||
156707419|NCT03996447|565675152|FG000|First MRI Examination|Withdrawal by Subject|1|||
156707420|NCT03996447|565675153|FG001|First MRI Examination|Withdrawal by Subject|2|||
156707421|NCT03996447|565675152|FG000|First MRI Examination|Protocol Violation|0|||
156707422|NCT03996447|565675153|FG001|First MRI Examination|Protocol Violation|1|||
156707423|NCT03996447|565675152|FG000|Washout|Adverse Event|2|||
156707424|NCT03996447|565675153|FG001|Washout|Adverse Event|0|||
156707425|NCT03996447|565675152|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
156440779|NCT03942042|564705440|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
156440780|NCT03942042|564705439|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
156791198|NCT02205359|565987198|FG000|Overall Study|Lost to Follow-up|182|||
156791199|NCT02205359|565987199|FG001|Overall Study|Lost to Follow-up|162|||
156791200|NCT02205359|565987198|FG000|Overall Study|Physician Decision|51|||
156791201|NCT02205359|565987199|FG001|Overall Study|Physician Decision|53|||
156791202|NCT02205359|565987198|FG000|Overall Study|Withdrawal by Subject|167|||
156791203|NCT02205359|565987199|FG001|Overall Study|Withdrawal by Subject|169|||
156791204|NCT02792257|565987204|FG000|Overall Study|Lost to Follow-up|3|||
156791205|NCT02792257|565987205|FG001|Overall Study|Lost to Follow-up|4|||
156791206|NCT02792257|565987204|FG000|Overall Study|Allergy|0|||
156791207|NCT02792257|565987205|FG001|Overall Study|Allergy|1|||
156791208|NCT02792257|565987204|FG000|Overall Study|Protocol Violation|2|||
156791209|NCT02792257|565987205|FG001|Overall Study|Protocol Violation|0|||
156791210|NCT02792257|565987204|FG000|Overall Study|Excessive Agitation|0|||
156791211|NCT02792257|565987205|FG001|Overall Study|Excessive Agitation|1|||
156707426|NCT03996447|565675153|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
156707427|NCT03996447|565675152|FG000|Washout|Withdrawal by Subject|0|||
156707428|NCT03996447|565675153|FG001|Washout|Withdrawal by Subject|1|||
156707429|NCT03996447|565675152|FG000|Washout|Other reason|1|||
156707430|NCT03996447|565675153|FG001|Washout|Other reason|1|||
156707431|NCT02094417|565675157|FG000|Overall Study|Adverse Event|0|||
156791212|NCT02792257|565987204|FG000|Overall Study|Not Feeling Well|0|||
156791213|NCT02792257|565987205|FG001|Overall Study|Not Feeling Well|1|||
156791214|NCT02766478|565987207|FG000|Overall Study|Withdrawal by Subject|1|||
156791215|NCT02766478|565987208|FG001|Overall Study|Withdrawal by Subject|1|||
156531745|NCT00292461|565041718|FG001|Overall Study|Lack of Efficacy|0|||
156531746|NCT00292461|565041717|FG000|Overall Study|Withdrawal by Subject|0|||
156531747|NCT00292461|565041718|FG001|Overall Study|Withdrawal by Subject|1|||
156531748|NCT00292461|565041717|FG000|Overall Study|Protocol Violation|4|||
156332311|NCT00216476|564315076|FG002|Overall Study|Non-compliance|1|||
156531749|NCT00292461|565041718|FG001|Overall Study|Protocol Violation|3|||
156531750|NCT00292461|565041717|FG000|Overall Study|Lost to Follow-up|1|||
156531751|NCT00292461|565041718|FG001|Overall Study|Lost to Follow-up|0|||
156531752|NCT03049735|565041720|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
156531753|NCT03049735|565041721|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
156531754|NCT03049735|565041722|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
156531755|NCT03049735|565041720|FG000|Overall Study|Other|5|||
156531756|NCT03049735|565041721|FG001|Overall Study|Other|3|||
156531757|NCT03049735|565041722|FG002|Overall Study|Other|1|||
156531758|NCT03049735|565041720|FG000|Overall Study|Lack of Efficacy|4|||
156531759|NCT03049735|565041721|FG001|Overall Study|Lack of Efficacy|0|||
156531760|NCT03049735|565041722|FG002|Overall Study|Lack of Efficacy|3|||
156531761|NCT03049735|565041720|FG000|Overall Study|Protocol deviation|1|||
156531762|NCT03049735|565041721|FG001|Overall Study|Protocol deviation|0|||
156531763|NCT03049735|565041722|FG002|Overall Study|Protocol deviation|0|||
156531764|NCT03049735|565041720|FG000|Overall Study|Pregnancy|0|||
156531765|NCT03049735|565041721|FG001|Overall Study|Pregnancy|0|||
156531766|NCT03049735|565041722|FG002|Overall Study|Pregnancy|1|||
156531767|NCT03049735|565041720|FG000|Overall Study|Adverse Event|7|||
156531768|NCT03049735|565041721|FG001|Overall Study|Adverse Event|18|||
156531769|NCT03049735|565041722|FG002|Overall Study|Adverse Event|5|||
156531770|NCT03049735|565041720|FG000|Overall Study|Withdrawal by Subject|10|||
156332312|NCT00216476|564315074|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
156332313|NCT00216476|564315075|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
156332314|NCT00216476|564315076|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
156332315|NCT00216476|564315074|FG000|Overall Study|Administrative Reasons|1|||
156332316|NCT00216476|564315075|FG001|Overall Study|Administrative Reasons|1|||
156332317|NCT00216476|564315076|FG002|Overall Study|Administrative Reasons|0|||
156332318|NCT00216476|564315074|FG000|Overall Study|Protocol Deviation|5|||
156332319|NCT00216476|564315075|FG001|Overall Study|Protocol Deviation|1|||
156332320|NCT00216476|564315076|FG002|Overall Study|Protocol Deviation|0|||
156332321|NCT00216476|564315074|FG000|Overall Study|Patient Moved|2|||
156332322|NCT00216476|564315075|FG001|Overall Study|Patient Moved|2|||
156332323|NCT00216476|564315076|FG002|Overall Study|Patient Moved|0|||
156332324|NCT01756053|564315077|FG000|Period 1 (10 Days)|Protocol Violation|1|||
156332325|NCT01756053|564315078|FG001|Period 1 (10 Days)|Protocol Violation|1|||
156332326|NCT01756053|564315077|FG000|Period 2 (10 Days)|Protocol Violation|0|||
156332327|NCT01756053|564315078|FG001|Period 2 (10 Days)|Protocol Violation|2|||
156332328|NCT00285818|564315079|FG000|Overall Study|Withdrawal by Subject|3|||
156332329|NCT00285818|564315080|FG001|Overall Study|Withdrawal by Subject|2|||
156332330|NCT00285818|564315079|FG000|Overall Study|Lost to Follow-up|1|||
156332331|NCT00285818|564315080|FG001|Overall Study|Lost to Follow-up|0|||
156332332|NCT04041375|564315081|FG000|Intervention Phase|Withdrawal by Subject|2|||
156332333|NCT04041375|564315082|FG001|Intervention Phase|Withdrawal by Subject|2|||
156332334|NCT04041375|564315081|FG000|Follow-up Phase|Death|2|||
156332335|NCT04041375|564315082|FG001|Follow-up Phase|Death|0|||
156440781|NCT03942042|564705440|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
156440782|NCT01499199|564705441|FG000|Overall Study|Adverse Event|1|||
156440783|NCT01499199|564705441|FG000|Overall Study|Lack of Efficacy|1|||
156440784|NCT01199705|564705442|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
156440785|NCT01692730|564705443|FG000|Overall Study|Lost to Follow-up|225|||
156440786|NCT01692730|564705444|FG001|Overall Study|Lost to Follow-up|227|||
156440787|NCT01199575|564705445|FG000|Overall Study|Withdrawal by Subject|5|||
156440788|NCT00411216|564705448|FG000|Overall Study|Ten participants were entered into the c|0|||
156440789|NCT00411216|564705449|FG001|Overall Study|Ten participants were entered into the c|2|||
156440790|NCT03960463|564707266|FG000|Overall Study|Withdrawal by Subject|2|||
156440791|NCT03960463|564707267|FG001|Overall Study|Withdrawal by Subject|0|||
156440792|NCT03422276|564707268|FG000|Overall Study|Withdrawal by Subject|21|||
156440793|NCT03422276|564707269|FG001|Overall Study|Withdrawal by Subject|25|||
156440794|NCT03422276|564707270|FG002|Overall Study|Withdrawal by Subject|14|||
156440795|NCT03422276|564707271|FG003|Overall Study|Withdrawal by Subject|16|||
156440796|NCT03422276|564707268|FG000|Overall Study|Death|14|||
156440797|NCT03422276|564707269|FG001|Overall Study|Death|21|||
156440798|NCT03422276|564707270|FG002|Overall Study|Death|3|||
156440799|NCT03422276|564707271|FG003|Overall Study|Death|1|||
156440800|NCT03422276|564707268|FG000|Overall Study|Discontinued, ineligible|4|||
156440801|NCT03422276|564707269|FG001|Overall Study|Discontinued, ineligible|3|||
156440802|NCT03422276|564707270|FG002|Overall Study|Discontinued, ineligible|0|||
156440803|NCT03422276|564707271|FG003|Overall Study|Discontinued, ineligible|0|||
156440804|NCT03422276|564707268|FG000|Overall Study|Lost to Follow-up|15|||
156440805|NCT03422276|564707269|FG001|Overall Study|Lost to Follow-up|8|||
156531771|NCT03049735|565041721|FG001|Overall Study|Withdrawal by Subject|3|||
156531772|NCT03049735|565041722|FG002|Overall Study|Withdrawal by Subject|7|||
156791216|NCT00089583|565987209|FG000|Overall Study|Adverse Event|0|||
156791217|NCT00089583|565987210|FG001|Overall Study|Adverse Event|3|||
156791218|NCT00089583|565987209|FG000|Overall Study|Insufficient Viral Load Response|5|||
156791219|NCT00089583|565987210|FG001|Overall Study|Insufficient Viral Load Response|5|||
156791220|NCT00089583|565987209|FG000|Overall Study|Withdrawal by Subject|0|||
156791221|NCT00089583|565987210|FG001|Overall Study|Withdrawal by Subject|4|||
156791222|NCT00089583|565987209|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
156332336|NCT04041375|564315081|FG000|Follow-up Phase|Lost to Follow-up|2|||
156332337|NCT04041375|564315082|FG001|Follow-up Phase|Lost to Follow-up|1|||
156332338|NCT04041375|564315081|FG000|Follow-up Phase|Too ill|3|||
156440806|NCT03422276|564707270|FG002|Overall Study|Lost to Follow-up|13|||
156440807|NCT03422276|564707271|FG003|Overall Study|Lost to Follow-up|4|||
156440808|NCT03422276|564707268|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
156531773|NCT03049735|565041720|FG000|Overall Study|Lost to Follow-up|1|||
156531774|NCT03049735|565041721|FG001|Overall Study|Lost to Follow-up|5|||
156531775|NCT03049735|565041722|FG002|Overall Study|Lost to Follow-up|5|||
156531776|NCT02684357|565041725|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
156531777|NCT02684357|565041726|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
156531778|NCT02684357|565041727|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
156531779|NCT02684357|565041728|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
156531780|NCT02684357|565041729|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
156531781|NCT02684357|565041730|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
156531782|NCT02684357|565041725|FG000|Part A|Lost to Follow-up|0|||
156332339|NCT04041375|564315082|FG001|Follow-up Phase|Too ill|0|||
156440809|NCT03422276|564707269|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
156440810|NCT03422276|564707270|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
156440811|NCT03422276|564707271|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
156440812|NCT03422276|564707268|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
156440813|NCT03422276|564707269|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
156440814|NCT03422276|564707270|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
156440815|NCT03422276|564707271|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
156440816|NCT03422276|564707268|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
156440817|NCT03422276|564707269|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
156440818|NCT03422276|564707270|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
156440819|NCT03422276|564707271|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
156440820|NCT03422276|564707268|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
156440821|NCT03422276|564707269|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
156440822|NCT03422276|564707270|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
156440823|NCT03422276|564707271|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
156440824|NCT03422276|564707268|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
156440825|NCT03422276|564707269|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
156440826|NCT03422276|564707270|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
156440827|NCT03422276|564707271|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
156440828|NCT05194917|564707272|FG000|Overall Study|Lost to Follow-up|7|||
156531783|NCT02684357|565041726|FG001|Part A|Lost to Follow-up|2|||
156531784|NCT02684357|565041727|FG002|Part A|Lost to Follow-up|2|||
156531785|NCT02684357|565041728|FG003|Part A|Lost to Follow-up|0|||
156332340|NCT04674644|564315083|FG000|Overall Study|with missing data|37|||
156332341|NCT02404220|564315084|FG000|Overall Study|Adverse Event|0|||
156332342|NCT02404220|564315085|FG001|Overall Study|Adverse Event|0|||
156332343|NCT02404220|564315086|FG002|Overall Study|Adverse Event|1|||
156332344|NCT02404220|564315087|FG003|Overall Study|Adverse Event|0|||
156332345|NCT02404220|564315084|FG000|Overall Study|Death|5|||
156332346|NCT02404220|564315085|FG001|Overall Study|Death|5|||
156332347|NCT02404220|564315086|FG002|Overall Study|Death|3|||
156332348|NCT02404220|564315087|FG003|Overall Study|Death|8|||
156332349|NCT02404220|564315084|FG000|Overall Study|Progressive Disease|0|||
156332350|NCT02404220|564315085|FG001|Overall Study|Progressive Disease|0|||
156332351|NCT02404220|564315086|FG002|Overall Study|Progressive Disease|1|||
156332352|NCT02404220|564315087|FG003|Overall Study|Progressive Disease|1|||
156332353|NCT02404220|564315084|FG000|Overall Study|Study Terminated by Sponsor|0|||
156332354|NCT02404220|564315085|FG001|Overall Study|Study Terminated by Sponsor|0|||
156332355|NCT02404220|564315086|FG002|Overall Study|Study Terminated by Sponsor|2|||
156332356|NCT02404220|564315087|FG003|Overall Study|Study Terminated by Sponsor|1|||
156332357|NCT02404220|564315084|FG000|Overall Study|Withdrawal by Subject|0|||
156332358|NCT02404220|564315085|FG001|Overall Study|Withdrawal by Subject|1|||
156332359|NCT02404220|564315086|FG002|Overall Study|Withdrawal by Subject|0|||
156332360|NCT02404220|564315087|FG003|Overall Study|Withdrawal by Subject|0|||
156332361|NCT02404220|564315084|FG000|Overall Study|Enrolled but Never Treated|0|||
156332362|NCT02404220|564315085|FG001|Overall Study|Enrolled but Never Treated|2|||
156332363|NCT02404220|564315086|FG002|Overall Study|Enrolled but Never Treated|0|||
156440829|NCT05194917|564707273|FG001|Overall Study|Lost to Follow-up|5|||
156440830|NCT05194917|564707274|FG002|Overall Study|Lost to Follow-up|6|||
156440831|NCT05194917|564707275|FG003|Overall Study|Lost to Follow-up|5|||
156440832|NCT04941287|564707287|FG000|Overall Study|Rapid decline before starting treatment|3|||
156440833|NCT04941287|564707288|FG001|Overall Study|Rapid decline before starting treatment|1|||
156440834|NCT04279574|564707295|FG000|Overall Study|Death|1|||
156707432|NCT02094417|565675158|FG001|Overall Study|Adverse Event|0|||
156707433|NCT02094417|565675159|FG002|Overall Study|Adverse Event|0|||
156707434|NCT02094417|565675160|FG003|Overall Study|Adverse Event|1|||
156707435|NCT02094417|565675157|FG000|Overall Study|Eligibility criteria|0|||
156707436|NCT02094417|565675158|FG001|Overall Study|Eligibility criteria|1|||
156707437|NCT02094417|565675159|FG002|Overall Study|Eligibility criteria|0|||
156707438|NCT02094417|565675160|FG003|Overall Study|Eligibility criteria|0|||
156707439|NCT02094417|565675157|FG000|Overall Study|No responder|4|||
156707440|NCT02094417|565675158|FG001|Overall Study|No responder|4|||
156707441|NCT02094417|565675159|FG002|Overall Study|No responder|4|||
156707442|NCT02094417|565675160|FG003|Overall Study|No responder|3|||
156707443|NCT02094417|565675157|FG000|Overall Study|Unable to conduct observations or assess|0|||
156707444|NCT02094417|565675158|FG001|Overall Study|Unable to conduct observations or assess|1|||
156707445|NCT02094417|565675159|FG002|Overall Study|Unable to conduct observations or assess|0|||
156707446|NCT02094417|565675160|FG003|Overall Study|Unable to conduct observations or assess|0|||
156707447|NCT02094417|565675157|FG000|Overall Study|Withdrawal by Subject|1|||
156707448|NCT02094417|565675158|FG001|Overall Study|Withdrawal by Subject|2|||
156707449|NCT02094417|565675159|FG002|Overall Study|Withdrawal by Subject|1|||
156707450|NCT02094417|565675160|FG003|Overall Study|Withdrawal by Subject|3|||
156707451|NCT03333941|565675161|FG000|Overall Study|Lost to Follow-up|10|||
156707452|NCT03333941|565675161|FG000|Overall Study|Death|2|||
156707453|NCT03333941|565675161|FG000|Overall Study|Adverse Event|1|||
156707454|NCT01443728|565675164|FG000|Overall Study|Lost to Follow-up|2|||
156707455|NCT01443728|565675165|FG001|Overall Study|Lost to Follow-up|0|||
156707456|NCT01443728|565675164|FG000|Overall Study|Withdrawal by Subject|1|||
156707457|NCT01443728|565675165|FG001|Overall Study|Withdrawal by Subject|1|||
156707458|NCT01443728|565675164|FG000|Overall Study|Adverse Event|0|||
156707459|NCT01443728|565675165|FG001|Overall Study|Adverse Event|2|||
156707460|NCT04971187|565675166|FG000|Overall Study|Screen failures|2|||
156707461|NCT01207583|565675174|FG000|Overall Study|Withdrawal by Subject|0|||
156707462|NCT01207583|565675175|FG001|Overall Study|Withdrawal by Subject|3|||
156707463|NCT01207583|565675176|FG002|Overall Study|Withdrawal by Subject|1|||
156707464|NCT01207583|565675174|FG000|Overall Study|Participant failed to return|1|||
156707465|NCT01207583|565675175|FG001|Overall Study|Participant failed to return|0|||
156707466|NCT01207583|565675176|FG002|Overall Study|Participant failed to return|0|||
156707467|NCT01207583|565675174|FG000|Overall Study|Lost to Follow-up|0|||
156707468|NCT01207583|565675175|FG001|Overall Study|Lost to Follow-up|2|||
156707469|NCT01207583|565675176|FG002|Overall Study|Lost to Follow-up|0|||
156707470|NCT01696058|565675178|FG000|Overall Study|Adverse Event|21|||
156707471|NCT01696058|565675179|FG001|Overall Study|Adverse Event|11|||
156707472|NCT01696058|565675178|FG000|Overall Study|Lack of Efficacy|2|||
156707473|NCT01696058|565675179|FG001|Overall Study|Lack of Efficacy|3|||
156707474|NCT01696058|565675178|FG000|Overall Study|Protocol Violation|9|||
156707475|NCT01696058|565675179|FG001|Overall Study|Protocol Violation|3|||
156707476|NCT01696058|565675178|FG000|Overall Study|Lost to Follow-up|2|||
156707477|NCT01696058|565675179|FG001|Overall Study|Lost to Follow-up|5|||
156707478|NCT01696058|565675178|FG000|Overall Study|Withdrawal by Subject|4|||
156707479|NCT01696058|565675179|FG001|Overall Study|Withdrawal by Subject|6|||
156707480|NCT01696058|565675178|FG000|Overall Study|Other reason prematurely discontinued|5|||
156707481|NCT01696058|565675179|FG001|Overall Study|Other reason prematurely discontinued|3|||
156707482|NCT02186834|565675181|FG000|Dose Escalation|Death|0|||
156707483|NCT02186834|565675182|FG001|Dose Escalation|Death|0|||
156707484|NCT02186834|565675183|FG002|Dose Escalation|Death|0|||
156707485|NCT02186834|565675184|FG003|Dose Escalation|Death|1|||
156440835|NCT04279574|564707296|FG001|Overall Study|Death|0|||
156440836|NCT04279574|564707295|FG000|Overall Study|lost restoration, tooth fracture|1|||
156531786|NCT02684357|565041729|FG004|Part A|Lost to Follow-up|0|||
156531787|NCT02684357|565041730|FG005|Part A|Lost to Follow-up|0|||
156531788|NCT02684357|565041725|FG000|Part A|Withdrawal by Subject|3|||
156707486|NCT02186834|565675185|FG004|Dose Escalation|Death|0|||
156707487|NCT02186834|565675186|FG005|Dose Escalation|Death|0|||
156707488|NCT02186834|565675181|FG000|Treatment at RP2D|Died prior to treatment|0|||
156707489|NCT02186834|565675182|FG001|Treatment at RP2D|Died prior to treatment|0|||
156707490|NCT02186834|565675183|FG002|Treatment at RP2D|Died prior to treatment|0|||
156707491|NCT02186834|565675184|FG003|Treatment at RP2D|Died prior to treatment|0|||
156707492|NCT02186834|565675185|FG004|Treatment at RP2D|Died prior to treatment|0|||
156707493|NCT02186834|565675186|FG005|Treatment at RP2D|Died prior to treatment|1|||
156707494|NCT04746794|565675189|FG000|Overall Study|Did not complete any study assessment|50303|||
156707495|NCT04746794|565675190|FG001|Overall Study|Did not complete any study assessment|44997|||
156531789|NCT02684357|565041726|FG001|Part A|Withdrawal by Subject|0|||
156707496|NCT01422187|565675191|FG000|Overall Study|Personal reason|1|||
156707497|NCT01422187|565675192|FG001|Overall Study|Personal reason|0|||
156707498|NCT01422187|565675193|FG002|Overall Study|Personal reason|0|||
156707499|NCT01422187|565675191|FG000|Overall Study|Lost to Follow-up|0|||
156707500|NCT01422187|565675192|FG001|Overall Study|Lost to Follow-up|1|||
156707501|NCT01422187|565675193|FG002|Overall Study|Lost to Follow-up|0|||
156707502|NCT04611529|565675195|FG000|2-day Follow up|Lost to Follow-up|5|||
156707503|NCT04611529|565675196|FG001|2-day Follow up|Lost to Follow-up|6|||
156707504|NCT04611529|565675197|FG002|2-day Follow up|Lost to Follow-up|3|||
156707505|NCT00741286|565675203|FG000|Overall Study|Lost to Follow-up|15|||
156707506|NCT00741286|565675204|FG001|Overall Study|Lost to Follow-up|10|||
156707507|NCT00741286|565675203|FG000|Overall Study|Adverse Event|1|||
156707508|NCT00741286|565675204|FG001|Overall Study|Adverse Event|6|||
156707509|NCT00741286|565675203|FG000|Overall Study|Protocol Violation|3|||
156707510|NCT00741286|565675204|FG001|Overall Study|Protocol Violation|2|||
156707511|NCT00741286|565675203|FG000|Overall Study|Primary Outcome|1|||
156707512|NCT00741286|565675204|FG001|Overall Study|Primary Outcome|1|||
156707513|NCT00425373|565675215|FG000|Overall Study|Adverse Event|2|||
156707514|NCT00425373|565675216|FG001|Overall Study|Adverse Event|2|||
156707515|NCT00425373|565675217|FG002|Overall Study|Adverse Event|0|||
156707516|NCT00425373|565675218|FG003|Overall Study|Adverse Event|1|||
156707517|NCT00425373|565675219|FG004|Overall Study|Adverse Event|4|||
156707518|NCT00425373|565675220|FG005|Overall Study|Adverse Event|6|||
156707519|NCT00425373|565675221|FG006|Overall Study|Adverse Event|2|||
156707520|NCT00425373|565675222|FG007|Overall Study|Adverse Event|3|||
156707521|NCT00425373|565675223|FG008|Overall Study|Adverse Event|8|||
156707522|NCT00425373|565675215|FG000|Overall Study|Lost to Follow-up|0|||
156707523|NCT00425373|565675216|FG001|Overall Study|Lost to Follow-up|1|||
156707524|NCT00425373|565675217|FG002|Overall Study|Lost to Follow-up|0|||
156707525|NCT00425373|565675218|FG003|Overall Study|Lost to Follow-up|0|||
156707526|NCT00425373|565675219|FG004|Overall Study|Lost to Follow-up|1|||
156707527|NCT00425373|565675220|FG005|Overall Study|Lost to Follow-up|0|||
156707528|NCT00425373|565675221|FG006|Overall Study|Lost to Follow-up|0|||
156707529|NCT00425373|565675222|FG007|Overall Study|Lost to Follow-up|0|||
156707530|NCT00425373|565675223|FG008|Overall Study|Lost to Follow-up|0|||
156707531|NCT00425373|565675215|FG000|Overall Study|Protocol Violation|1|||
156707532|NCT00425373|565675216|FG001|Overall Study|Protocol Violation|0|||
156707533|NCT00425373|565675217|FG002|Overall Study|Protocol Violation|1|||
156707534|NCT00425373|565675218|FG003|Overall Study|Protocol Violation|0|||
156707535|NCT00425373|565675219|FG004|Overall Study|Protocol Violation|0|||
156707536|NCT00425373|565675220|FG005|Overall Study|Protocol Violation|0|||
156707537|NCT00425373|565675221|FG006|Overall Study|Protocol Violation|0|||
156707538|NCT00425373|565675222|FG007|Overall Study|Protocol Violation|5|||
156707539|NCT00425373|565675223|FG008|Overall Study|Protocol Violation|3|||
156707540|NCT00425373|565675215|FG000|Overall Study|Withdrawal by Subject|2|||
156707541|NCT00425373|565675216|FG001|Overall Study|Withdrawal by Subject|0|||
156707542|NCT00425373|565675217|FG002|Overall Study|Withdrawal by Subject|2|||
156707543|NCT00425373|565675218|FG003|Overall Study|Withdrawal by Subject|1|||
156707544|NCT00425373|565675219|FG004|Overall Study|Withdrawal by Subject|4|||
156707545|NCT00425373|565675220|FG005|Overall Study|Withdrawal by Subject|0|||
156707546|NCT00425373|565675221|FG006|Overall Study|Withdrawal by Subject|2|||
156707547|NCT00425373|565675222|FG007|Overall Study|Withdrawal by Subject|2|||
156707548|NCT00425373|565675223|FG008|Overall Study|Withdrawal by Subject|2|||
156707549|NCT00425373|565675215|FG000|Overall Study|Lack of Efficacy|0|||
156707550|NCT00425373|565675216|FG001|Overall Study|Lack of Efficacy|0|||
156707551|NCT00425373|565675217|FG002|Overall Study|Lack of Efficacy|0|||
156707552|NCT00425373|565675218|FG003|Overall Study|Lack of Efficacy|0|||
156707553|NCT00425373|565675219|FG004|Overall Study|Lack of Efficacy|1|||
156707554|NCT00425373|565675220|FG005|Overall Study|Lack of Efficacy|3|||
156707555|NCT00425373|565675221|FG006|Overall Study|Lack of Efficacy|3|||
156707556|NCT00425373|565675222|FG007|Overall Study|Lack of Efficacy|0|||
156707557|NCT00425373|565675223|FG008|Overall Study|Lack of Efficacy|5|||
156707558|NCT00253448|565675224|FG000|Overall Study|Withdrawal by Subject|1|||
156707559|NCT02564887|565675227|FG000|Overall Study|Lost to Follow-up|6|||
156707560|NCT02564887|565675228|FG001|Overall Study|Lost to Follow-up|0|||
156707561|NCT02052011|565675229|FG000|Overall Study|Lost to Follow-up|3|||
156707562|NCT02052011|565675230|FG001|Overall Study|Lost to Follow-up|0|||
156707563|NCT02052011|565675229|FG000|Overall Study|Withdrawal by Subject|1|||
156707564|NCT02052011|565675230|FG001|Overall Study|Withdrawal by Subject|2|||
156707565|NCT00000620|565675231|FG000|Overall Study|Death|86|||
156707566|NCT00000620|565675232|FG001|Overall Study|Death|67|||
156707567|NCT00000620|565675233|FG002|Overall Study|Death|112|||
156707568|NCT00000620|565675234|FG003|Overall Study|Death|126|||
156707569|NCT00000620|565675235|FG004|Overall Study|Death|64|||
156707570|NCT00000620|565675236|FG005|Overall Study|Death|77|||
156707571|NCT00000620|565675237|FG006|Overall Study|Death|91|||
156707572|NCT00000620|565675238|FG007|Overall Study|Death|95|||
156707573|NCT00000620|565675231|FG000|Overall Study|Lost to Follow-up|14|||
156707574|NCT00000620|565675232|FG001|Overall Study|Lost to Follow-up|14|||
156707575|NCT00000620|565675233|FG002|Overall Study|Lost to Follow-up|14|||
156707576|NCT00000620|565675234|FG003|Overall Study|Lost to Follow-up|14|||
156707577|NCT00000620|565675235|FG004|Overall Study|Lost to Follow-up|15|||
156707578|NCT00000620|565675236|FG005|Overall Study|Lost to Follow-up|15|||
156707579|NCT00000620|565675237|FG006|Overall Study|Lost to Follow-up|13|||
156707580|NCT00000620|565675238|FG007|Overall Study|Lost to Follow-up|14|||
156707581|NCT00000620|565675231|FG000|Overall Study|Withdrawal by Subject|40|||
156707582|NCT00000620|565675232|FG001|Overall Study|Withdrawal by Subject|27|||
156707583|NCT00000620|565675233|FG002|Overall Study|Withdrawal by Subject|28|||
156707584|NCT00000620|565675234|FG003|Overall Study|Withdrawal by Subject|27|||
156707585|NCT00000620|565675235|FG004|Overall Study|Withdrawal by Subject|30|||
156707586|NCT00000620|565675236|FG005|Overall Study|Withdrawal by Subject|32|||
156707587|NCT00000620|565675237|FG006|Overall Study|Withdrawal by Subject|32|||
156707588|NCT00000620|565675238|FG007|Overall Study|Withdrawal by Subject|21|||
156707589|NCT00000620|565675231|FG000|Overall Study|missed closeout visit|22|||
156707590|NCT00000620|565675232|FG001|Overall Study|missed closeout visit|28|||
156707591|NCT00000620|565675233|FG002|Overall Study|missed closeout visit|16|||
156707592|NCT00000620|565675234|FG003|Overall Study|missed closeout visit|11|||
156707593|NCT00000620|565675235|FG004|Overall Study|missed closeout visit|26|||
156707594|NCT00000620|565675236|FG005|Overall Study|missed closeout visit|28|||
156707595|NCT00000620|565675237|FG006|Overall Study|missed closeout visit|13|||
156707596|NCT00000620|565675238|FG007|Overall Study|missed closeout visit|16|||
156707597|NCT01851330|565675239|FG000|Overall Study|Lack of Efficacy|10|||
156707598|NCT01851330|565675240|FG001|Overall Study|Lack of Efficacy|9|||
156707599|NCT01851330|565675241|FG002|Overall Study|Lack of Efficacy|2|||
156707600|NCT01851330|565675239|FG000|Overall Study|Lost to Follow-up|1|||
156707601|NCT01851330|565675240|FG001|Overall Study|Lost to Follow-up|6|||
156707602|NCT01851330|565675241|FG002|Overall Study|Lost to Follow-up|9|||
156707603|NCT01851330|565675239|FG000|Overall Study|Withdrew Consent|2|||
156707604|NCT01851330|565675240|FG001|Overall Study|Withdrew Consent|1|||
156707605|NCT01851330|565675241|FG002|Overall Study|Withdrew Consent|0|||
156707606|NCT01851330|565675239|FG000|Overall Study|Investigator's Discretion|0|||
156707607|NCT01851330|565675240|FG001|Overall Study|Investigator's Discretion|0|||
156707608|NCT01851330|565675241|FG002|Overall Study|Investigator's Discretion|1|||
156707609|NCT02648932|565675242|FG000|Overall Study|No transplant|3|||
156707610|NCT02648932|565675243|FG001|Overall Study|No transplant|1|||
156707611|NCT01199016|565675244|FG000|Overall Study|No longer meets eligibility criteria|4|||
156707612|NCT01199016|565675244|FG000|Overall Study|Entrance criteria|5|||
156707613|NCT01199016|565675244|FG000|Overall Study|Protocol Violation|9|||
156707614|NCT01199016|565675244|FG000|Overall Study|Other|13|||
156707615|NCT01199016|565675244|FG000|Overall Study|Withdrawal by Subject|21|||
156707616|NCT01199016|565675244|FG000|Overall Study|Lost to Follow-up|25|||
156707617|NCT02960490|565675253|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
156707618|NCT02960490|565675254|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
156707619|NCT02960490|565675255|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707620|NCT02960490|565675256|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707621|NCT02960490|565675257|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707622|NCT02960490|565675258|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707623|NCT02960490|565675259|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707624|NCT02960490|565675260|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707625|NCT02960490|565675261|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707626|NCT02960490|565675262|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707627|NCT02960490|565675253|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707628|NCT02960490|565675254|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
156707629|NCT02960490|565675255|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707630|NCT02960490|565675256|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707631|NCT02960490|565675257|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707632|NCT02960490|565675258|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707633|NCT02960490|565675259|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707634|NCT02960490|565675260|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707635|NCT02960490|565675261|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156440837|NCT04279574|564707296|FG001|Overall Study|lost restoration, tooth fracture|0|||
156440838|NCT04279574|564707295|FG000|Overall Study|Lost to Follow-up|0|||
156440839|NCT04279574|564707296|FG001|Overall Study|Lost to Follow-up|1|||
156440840|NCT02991807|564707297|FG000|Overall Study|Withdrawal by Subject|2|||
156440841|NCT02991807|564707298|FG001|Overall Study|Withdrawal by Subject|1|||
156440842|NCT02991807|564707297|FG000|Overall Study|Physician Decision|0|||
156440843|NCT02991807|564707298|FG001|Overall Study|Physician Decision|1|||
156707636|NCT02960490|565675262|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707637|NCT02960490|565675253|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
156707638|NCT02960490|565675254|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
156707639|NCT02960490|565675255|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707640|NCT02960490|565675256|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707641|NCT02960490|565675257|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156531790|NCT02684357|565041727|FG002|Part A|Withdrawal by Subject|0|||
156707642|NCT02960490|565675258|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707643|NCT02960490|565675259|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707644|NCT02960490|565675260|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707645|NCT02960490|565675261|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707646|NCT02960490|565675262|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707647|NCT02960490|565675253|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
156707648|NCT02960490|565675254|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
156707649|NCT02960490|565675255|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707650|NCT02960490|565675256|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707651|NCT02960490|565675257|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707652|NCT02960490|565675258|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156791223|NCT00089583|565987210|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
156791224|NCT00089583|565987209|FG000|Overall Study|Participant Refused Study Medication|0|||
156791225|NCT00089583|565987210|FG001|Overall Study|Participant Refused Study Medication|2|||
156440844|NCT02991807|564707297|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
156440845|NCT02991807|564707298|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
156791226|NCT00089583|565987209|FG000|Overall Study|Non-Compliance|0|||
156791227|NCT00089583|565987210|FG001|Overall Study|Non-Compliance|4|||
156791228|NCT00089583|565987209|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
156791229|NCT00089583|565987210|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
156791230|NCT00089583|565987209|FG000|Overall Study|Participant Management Criteria Met|0|||
156791231|NCT00089583|565987210|FG001|Overall Study|Participant Management Criteria Met|1|||
156791232|NCT00089583|565987209|FG000|Overall Study|Reason Not Provided|0|||
156791233|NCT00089583|565987210|FG001|Overall Study|Reason Not Provided|1|||
156791234|NCT00089583|565987209|FG000|Overall Study|Protocol Violation|0|||
156791235|NCT00089583|565987210|FG001|Overall Study|Protocol Violation|3|||
156791236|NCT00089583|565987209|FG000|Overall Study|Principal Investigator Decision|0|||
156791237|NCT00089583|565987210|FG001|Overall Study|Principal Investigator Decision|10|||
156791238|NCT00089583|565987209|FG000|Overall Study|Start of Disallowed Medication|0|||
156791239|NCT00089583|565987210|FG001|Overall Study|Start of Disallowed Medication|1|||
156791240|NCT00089583|565987209|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
156791241|NCT00089583|565987210|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
156791242|NCT00089583|565987209|FG000|Overall Study|Participant Incarcerated|0|||
156791243|NCT00089583|565987210|FG001|Overall Study|Participant Incarcerated|1|||
156791244|NCT01623154|565987211|FG000|Overall Study|Did not drink Pranactin Citric|4|||
156791245|NCT01412983|565987212|FG000|1st Period|Ineligible|0|||
156791246|NCT01412983|565987213|FG001|1st Period|Ineligible|1|||
156791247|NCT01412983|565987212|FG000|1st Period|Positive slit lamp finding|0|||
156791248|NCT01412983|565987213|FG001|1st Period|Positive slit lamp finding|1|||
156791249|NCT01412983|565987212|FG000|1st Period|Unacceptable lens movement|0|||
156791250|NCT01412983|565987213|FG001|1st Period|Unacceptable lens movement|1|||
156791251|NCT01412983|565987212|FG000|1st Period|Inability to maintain wear|0|||
156791252|NCT01412983|565987213|FG001|1st Period|Inability to maintain wear|1|||
156791253|NCT04349098|565987214|FG000|Overall Study|Death|16|||
156791254|NCT04349098|565987215|FG001|Overall Study|Death|8|||
156791255|NCT04349098|565987214|FG000|Overall Study|Lost to Follow-up|11|||
156791256|NCT04349098|565987215|FG001|Overall Study|Lost to Follow-up|8|||
156791257|NCT04349098|565987214|FG000|Overall Study|Withdrawal by Subject|8|||
156791258|NCT04349098|565987215|FG001|Overall Study|Withdrawal by Subject|5|||
156791259|NCT04349098|565987214|FG000|Overall Study|Other|3|||
156791260|NCT04349098|565987215|FG001|Overall Study|Other|5|||
156791261|NCT00800384|565987216|FG000|Overall Study|Withdrawal by Subject|24|||
156791262|NCT00800384|565987217|FG001|Overall Study|Withdrawal by Subject|17|||
156791263|NCT00800384|565987216|FG000|Overall Study|Lost to Follow-up|17|||
156791264|NCT00800384|565987217|FG001|Overall Study|Lost to Follow-up|26|||
156791265|NCT02946996|565987218|FG000|Overall Study|non-evaluable|3|||
156791266|NCT02946996|565987219|FG001|Overall Study|non-evaluable|6|||
156791267|NCT02946996|565987220|FG002|Overall Study|non-evaluable|5|||
156791268|NCT01245049|565987224|FG000|Overall Study|Migrated/moved from study area|0|||
156791269|NCT01245049|565987225|FG001|Overall Study|Migrated/moved from study area|1|||
156791270|NCT01245049|565987224|FG000|Overall Study|Withdrawal by Subject|0|||
156791271|NCT01245049|565987225|FG001|Overall Study|Withdrawal by Subject|1|||
156791272|NCT01245049|565987224|FG000|Overall Study|Lost to Follow-up|1|||
156791273|NCT01245049|565987225|FG001|Overall Study|Lost to Follow-up|2|||
156791274|NCT00450749|565987226|FG000|Overall Study|Withdrawal by Subject|0|||
156791275|NCT00450749|565987227|FG001|Overall Study|Withdrawal by Subject|0|||
156791276|NCT00450749|565987228|FG002|Overall Study|Withdrawal by Subject|2|||
156791277|NCT00450749|565987226|FG000|Overall Study|Noncompliant|0|||
156791278|NCT00450749|565987227|FG001|Overall Study|Noncompliant|1|||
156791279|NCT00450749|565987228|FG002|Overall Study|Noncompliant|0|||
156791280|NCT02151604|565987229|FG000|Overall Study|Lost to Follow-up|3|||
156791281|NCT02151604|565987229|FG000|Overall Study|Withdrawal by Subject|2|||
156791282|NCT02151604|565987229|FG000|Overall Study|Physician Decision|3|||
156707653|NCT02960490|565675259|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707654|NCT02960490|565675260|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707655|NCT02960490|565675261|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707656|NCT02960490|565675262|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707657|NCT02960490|565675253|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707658|NCT02960490|565675254|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707659|NCT02960490|565675255|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
156707660|NCT02960490|565675256|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
156707661|NCT02960490|565675257|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707662|NCT02960490|565675258|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
156707663|NCT02960490|565675259|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707664|NCT02960490|565675260|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707665|NCT02960490|565675261|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707666|NCT02960490|565675262|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707667|NCT02960490|565675253|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707668|NCT02960490|565675254|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707669|NCT02960490|565675255|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
156707670|NCT02960490|565675256|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707671|NCT02960490|565675257|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
156707672|NCT02960490|565675258|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707673|NCT02960490|565675259|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707674|NCT02960490|565675260|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156332364|NCT02404220|564315087|FG003|Overall Study|Enrolled but Never Treated|0|||
156332365|NCT01147172|564315089|FG000|Overall Study|Withdrawal by Subject|2|||
156332366|NCT01147172|564315089|FG000|Overall Study|Lost to Follow-up|2|||
156332367|NCT04357782|564315097|FG000|Overall Study|Discharged from hospital|1|||
156332368|NCT04357782|564315098|FG001|Overall Study|Discharged from hospital|0|||
156332369|NCT04357782|564315097|FG000|Overall Study|Death|0|||
156332370|NCT04357782|564315098|FG001|Overall Study|Death|2|||
156707675|NCT02960490|565675261|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707676|NCT02960490|565675262|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707677|NCT02960490|565675253|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
156707678|NCT02960490|565675254|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
156707679|NCT02960490|565675255|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
156707680|NCT02960490|565675256|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
156707681|NCT02960490|565675257|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
156707682|NCT02960490|565675258|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
156707683|NCT02960490|565675259|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
156707684|NCT02960490|565675260|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
156707685|NCT02960490|565675261|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
156707686|NCT02960490|565675262|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
156707687|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707688|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707689|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707690|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707691|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707692|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707693|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
156707694|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
156707695|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
156707696|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707697|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707698|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707699|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707700|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707701|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707702|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707703|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707704|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
156707705|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707706|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707707|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707708|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707709|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707710|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156791283|NCT02151604|565987229|FG000|Overall Study|Death|1|||
156332371|NCT01786148|564315099|FG000|Overall Study|Lost to Follow-up|21|||
156440846|NCT00332241|564707299|FG000|Overall Study|Lack of Efficacy|6|||
156440847|NCT00332241|564707300|FG001|Overall Study|Lack of Efficacy|1|||
156440848|NCT00332241|564707299|FG000|Overall Study|Adverse Event|3|||
156440849|NCT00332241|564707300|FG001|Overall Study|Adverse Event|5|||
156707711|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707712|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707713|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
156707714|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
156707715|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
156707716|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
156707717|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707718|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707719|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156440850|NCT00332241|564707299|FG000|Overall Study|Withdrawal by Subject|2|||
156440851|NCT00332241|564707300|FG001|Overall Study|Withdrawal by Subject|1|||
156440852|NCT00332241|564707299|FG000|Overall Study|Lost to Follow-up|4|||
156440853|NCT00332241|564707300|FG001|Overall Study|Lost to Follow-up|1|||
156440854|NCT00802464|564707301|FG000|Month 0 - Month 8|Adverse Event|0|||
156707720|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707721|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707722|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707723|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
156707724|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707725|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707726|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707727|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707728|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707729|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707730|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707731|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707732|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707733|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707734|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
156707735|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707736|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707737|NCT02368314|565675267|FG000|Overall Study|Withdrawal by Subject|2|||
156707738|NCT02368314|565675268|FG001|Overall Study|Withdrawal by Subject|1|||
156707739|NCT02368314|565675267|FG000|Overall Study|Adverse Event|1|||
156707740|NCT02368314|565675268|FG001|Overall Study|Adverse Event|2|||
156707741|NCT01266031|565675269|FG000|Overall Study|Not treated|0|||
156707742|NCT01266031|565675270|FG001|Overall Study|Not treated|3|||
156707743|NCT01266031|565675271|FG002|Overall Study|Not treated|2|||
156707744|NCT01307111|565675274|FG000|IUD Insertion|Lost to Follow-up|2|||
156707745|NCT01307111|565675275|FG001|IUD Insertion|Lost to Follow-up|0|||
156707746|NCT01307111|565675274|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
156707747|NCT01307111|565675275|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
156707748|NCT02114385|565675277|FG000|Overall Study|Withdrawal by Subject|3|||
156707749|NCT02114385|565675278|FG001|Overall Study|Withdrawal by Subject|2|||
156707750|NCT02114385|565675277|FG000|Overall Study|Lost to Follow-up|0|||
156707751|NCT02114385|565675278|FG001|Overall Study|Lost to Follow-up|6|||
156707752|NCT02047734|565675282|FG000|Overall Study|Adverse Event|18|||
156707753|NCT02047734|565675283|FG001|Overall Study|Adverse Event|13|||
156707754|NCT02047734|565675284|FG002|Overall Study|Adverse Event|13|||
156707755|NCT02047734|565675282|FG000|Overall Study|Lack of Efficacy|4|||
156707756|NCT02047734|565675283|FG001|Overall Study|Lack of Efficacy|5|||
156707757|NCT02047734|565675284|FG002|Overall Study|Lack of Efficacy|1|||
156707758|NCT02047734|565675282|FG000|Overall Study|Protocol Violation|3|||
156707759|NCT02047734|565675283|FG001|Overall Study|Protocol Violation|1|||
156707760|NCT02047734|565675284|FG002|Overall Study|Protocol Violation|1|||
156707761|NCT02047734|565675282|FG000|Overall Study|Lost to Follow-up|1|||
156707762|NCT02047734|565675283|FG001|Overall Study|Lost to Follow-up|4|||
156707763|NCT02047734|565675284|FG002|Overall Study|Lost to Follow-up|0|||
156707764|NCT02047734|565675282|FG000|Overall Study|Death|0|||
156707765|NCT02047734|565675283|FG001|Overall Study|Death|1|||
156707766|NCT02047734|565675284|FG002|Overall Study|Death|0|||
156707767|NCT02047734|565675282|FG000|Overall Study|Withdrawal by Subject|30|||
156707768|NCT02047734|565675283|FG001|Overall Study|Withdrawal by Subject|31|||
156707769|NCT02047734|565675284|FG002|Overall Study|Withdrawal by Subject|19|||
156707770|NCT02047734|565675282|FG000|Overall Study|Physician Decision|7|||
156707771|NCT02047734|565675283|FG001|Overall Study|Physician Decision|6|||
156707772|NCT02047734|565675284|FG002|Overall Study|Physician Decision|5|||
156707773|NCT02047734|565675282|FG000|Overall Study|Miscellaneous|2|||
156707774|NCT02047734|565675283|FG001|Overall Study|Miscellaneous|4|||
156707775|NCT02047734|565675284|FG002|Overall Study|Miscellaneous|6|||
156707776|NCT02047734|565675282|FG000|Overall Study|Did Not Receive Study Drug|2|||
156791284|NCT00537082|565987230|FG000|Overall Study|Adverse Event|6|||
156791285|NCT00537082|565987231|FG001|Overall Study|Adverse Event|6|||
156791286|NCT00537082|565987232|FG002|Overall Study|Adverse Event|3|||
156791287|NCT00537082|565987230|FG000|Overall Study|Protocol Violation|0|||
156791288|NCT00537082|565987231|FG001|Overall Study|Protocol Violation|2|||
156440855|NCT00802464|564707302|FG001|Month 0 - Month 8|Adverse Event|1|||
156440856|NCT00802464|564707303|FG002|Month 0 - Month 8|Adverse Event|1|||
156440857|NCT00802464|564707304|FG003|Month 0 - Month 8|Adverse Event|2|||
156440858|NCT00802464|564707301|FG000|Month 0 - Month 8|Protocol Violation|0|||
156440859|NCT00802464|564707302|FG001|Month 0 - Month 8|Protocol Violation|0|||
156440860|NCT00802464|564707303|FG002|Month 0 - Month 8|Protocol Violation|1|||
156440861|NCT00802464|564707304|FG003|Month 0 - Month 8|Protocol Violation|0|||
156440862|NCT00802464|564707301|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
156440863|NCT00802464|564707302|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
156440864|NCT00802464|564707303|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
156440865|NCT00802464|564707304|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
156440866|NCT00802464|564707301|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
156707777|NCT02047734|565675283|FG001|Overall Study|Did Not Receive Study Drug|4|||
156707778|NCT02047734|565675284|FG002|Overall Study|Did Not Receive Study Drug|1|||
156707779|NCT00582010|565675285|FG000|Overall Study|Death|0|||
156707780|NCT00582010|565675286|FG001|Overall Study|Death|1|||
156707781|NCT05320887|565675291|FG000|Overall Study|Lost to Follow-up|0|||
156707782|NCT05320887|565675292|FG001|Overall Study|Lost to Follow-up|3|||
156707783|NCT05320887|565675293|FG002|Overall Study|Lost to Follow-up|0|||
156707784|NCT05320887|565675294|FG003|Overall Study|Lost to Follow-up|0|||
156707785|NCT02463357|565675297|FG000|Overall Study|Withdrawal by Subject|1|||
156707786|NCT02463357|565675298|FG001|Overall Study|Withdrawal by Subject|0|||
156440867|NCT00802464|564707302|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
156440868|NCT00802464|564707303|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
156440869|NCT00802464|564707304|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
156440870|NCT00802464|564707301|FG000|Month 0 - Month 8|Other|0|||
156707787|NCT02463357|565675299|FG002|Overall Study|Withdrawal by Subject|0|||
156707788|NCT02463357|565675300|FG003|Overall Study|Withdrawal by Subject|0|||
156707789|NCT02463357|565675301|FG004|Overall Study|Withdrawal by Subject|0|||
156707790|NCT02463357|565675297|FG000|Overall Study|Withdrawal by Subject|0|||
156707791|NCT02463357|565675298|FG001|Overall Study|Withdrawal by Subject|0|||
156707792|NCT02463357|565675299|FG002|Overall Study|Withdrawal by Subject|0|||
156707793|NCT02463357|565675300|FG003|Overall Study|Withdrawal by Subject|0|||
156707794|NCT02463357|565675301|FG004|Overall Study|Withdrawal by Subject|1|||
156707795|NCT01721317|565675302|FG000|Overall Study|Study Closed / Terminated|2|||
156707796|NCT01721317|565675303|FG001|Overall Study|Study Closed / Terminated|2|||
156707797|NCT01721317|565675302|FG000|Overall Study|Physician Decision|0|||
156707798|NCT01721317|565675303|FG001|Overall Study|Physician Decision|1|||
156707799|NCT01721317|565675302|FG000|Overall Study|Withdrawal by Subject|0|||
156707800|NCT01721317|565675303|FG001|Overall Study|Withdrawal by Subject|1|||
156707801|NCT00378573|565675306|FG000|Treatment Period|Adverse Event|9|||
156707802|NCT00378573|565675306|FG000|Treatment Period|Physician Decision|1|||
156707803|NCT00378573|565675306|FG000|Treatment Period|Withdrawal by Subject|2|||
156707804|NCT00378573|565675306|FG000|Treatment Period|Disease Progression|4|||
156707805|NCT00378573|565675306|FG000|Treatment Period|Sponsor decision to close study|1|||
156440871|NCT00802464|564707302|FG001|Month 0 - Month 8|Other|0|||
156440872|NCT00802464|564707303|FG002|Month 0 - Month 8|Other|1|||
156440873|NCT00802464|564707304|FG003|Month 0 - Month 8|Other|0|||
156440874|NCT00802464|564707301|FG000|Month 8 - Month 14|Adverse Event|0|||
156440875|NCT00802464|564707302|FG001|Month 8 - Month 14|Adverse Event|1|||
156440876|NCT00802464|564707303|FG002|Month 8 - Month 14|Adverse Event|0|||
156440877|NCT00802464|564707304|FG003|Month 8 - Month 14|Adverse Event|0|||
156440878|NCT00802464|564707301|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
156440879|NCT00802464|564707302|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
156440880|NCT00802464|564707303|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
156707806|NCT00378573|565675306|FG000|Follow-up|Death|12|||
156791289|NCT00537082|565987232|FG002|Overall Study|Protocol Violation|1|||
156791290|NCT00537082|565987230|FG000|Overall Study|Lack of Efficacy|0|||
156791291|NCT00537082|565987231|FG001|Overall Study|Lack of Efficacy|0|||
156791292|NCT00537082|565987232|FG002|Overall Study|Lack of Efficacy|2|||
156707807|NCT00378573|565675306|FG000|Follow-up|Lost to Follow-up|1|||
156791293|NCT00537082|565987230|FG000|Overall Study|Withdrawal by Subject|0|||
156440881|NCT00802464|564707304|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
156440882|NCT00802464|564707301|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
156707808|NCT00378573|565675306|FG000|Follow-up|Withdrawal by Subject|1|||
156707809|NCT03348163|565675312|FG000|Overall Study|Withdrawal by Subject|2|||
156707810|NCT03348163|565675313|FG001|Overall Study|Withdrawal by Subject|0|||
156707811|NCT00339144|565675314|FG000|Overall Study|Disease progression|5|||
156791294|NCT00537082|565987231|FG001|Overall Study|Withdrawal by Subject|1|||
156707812|NCT00339144|565675315|FG001|Overall Study|Disease progression|2|||
156707813|NCT00339144|565675316|FG002|Overall Study|Disease progression|2|||
156791295|NCT00537082|565987232|FG002|Overall Study|Withdrawal by Subject|0|||
156791296|NCT00537082|565987230|FG000|Overall Study|Discontinued before initiating treatment|3|||
156707814|NCT00339144|565675314|FG000|Overall Study|Study drug toxicity|3|||
156707815|NCT00339144|565675315|FG001|Overall Study|Study drug toxicity|1|||
156707816|NCT00339144|565675316|FG002|Overall Study|Study drug toxicity|1|||
156707817|NCT00339144|565675314|FG000|Overall Study|Participant's request to discontinuation|1|||
156707818|NCT00339144|565675315|FG001|Overall Study|Participant's request to discontinuation|0|||
156707819|NCT00339144|565675316|FG002|Overall Study|Participant's request to discontinuation|1|||
156707820|NCT03485365|565675323|FG000|Overall Study|Protocol Violation|0|||
156707821|NCT03485365|565675324|FG001|Overall Study|Protocol Violation|0|||
156707822|NCT03485365|565675325|FG002|Overall Study|Protocol Violation|0|||
156707823|NCT03485365|565675326|FG003|Overall Study|Protocol Violation|1|||
156707824|NCT03485365|565675327|FG004|Overall Study|Protocol Violation|0|||
156707825|NCT03485365|565675328|FG005|Overall Study|Protocol Violation|0|||
156707826|NCT03485365|565675329|FG006|Overall Study|Protocol Violation|1|||
156707827|NCT03485365|565675330|FG007|Overall Study|Protocol Violation|0|||
156707828|NCT03485365|565675331|FG008|Overall Study|Protocol Violation|0|||
156707829|NCT02181790|565675332|FG000|Overall Study|study terminated|2|||
156707830|NCT02181790|565675333|FG001|Overall Study|study terminated|0|||
156707831|NCT01275430|565675338|FG000|Overall Study|Adverse Event|1|||
156707832|NCT01275430|565675338|FG000|Overall Study|No Contrast Injection|6|||
156707833|NCT01275430|565675338|FG000|Overall Study|Device Malfunction|1|||
156707834|NCT01275430|565675338|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
156707835|NCT04988087|565675339|FG000|Overall Study|Adverse Event|4|||
156707836|NCT04988087|565675340|FG001|Overall Study|Adverse Event|0|||
156707837|NCT04988087|565675341|FG002|Overall Study|Adverse Event|0|||
156707838|NCT04988087|565675342|FG003|Overall Study|Adverse Event|0|||
156707839|NCT04988087|565675339|FG000|Overall Study|Withdrawal by Subject|1|||
156707840|NCT04988087|565675340|FG001|Overall Study|Withdrawal by Subject|1|||
156707841|NCT04988087|565675341|FG002|Overall Study|Withdrawal by Subject|0|||
156707842|NCT04988087|565675342|FG003|Overall Study|Withdrawal by Subject|0|||
156707843|NCT04988087|565675339|FG000|Overall Study|Technical problems|7|||
156707844|NCT04988087|565675340|FG001|Overall Study|Technical problems|9|||
156707845|NCT04988087|565675341|FG002|Overall Study|Technical problems|1|||
156707846|NCT04988087|565675342|FG003|Overall Study|Technical problems|2|||
156707847|NCT02613182|565675343|FG000|Overall Study|Death|6|||
156707848|NCT02613182|565675343|FG000|Overall Study|Physician Decision|1|||
156707849|NCT02613182|565675343|FG000|Overall Study|Study Terminated by Sponsor|21|||
156707850|NCT02613182|565675343|FG000|Overall Study|Withdrawal by Subject|6|||
156707851|NCT01810302|565676922|FG000|Overall Study|Death|1|||
156707852|NCT01810302|565676923|FG001|Overall Study|Death|0|||
156707853|NCT01810302|565676922|FG000|Overall Study|Physician Decision|0|||
156707854|NCT01810302|565676923|FG001|Overall Study|Physician Decision|1|||
156707855|NCT04981717|565676925|FG000|Overall Study|Protocol Violation|0|||
156707856|NCT04981717|565676926|FG001|Overall Study|Protocol Violation|3|||
156332372|NCT01786148|564315100|FG001|Overall Study|Lost to Follow-up|13|||
156332373|NCT01786148|564315099|FG000|Overall Study|Death|0|||
156332374|NCT01786148|564315100|FG001|Overall Study|Death|1|||
156332375|NCT01786148|564315099|FG000|Overall Study|Withdrawal by Subject|0|||
156332376|NCT01786148|564315100|FG001|Overall Study|Withdrawal by Subject|7|||
156332377|NCT01786148|564315099|FG000|Overall Study|Incarceration|1|||
156332378|NCT01786148|564315100|FG001|Overall Study|Incarceration|1|||
156332379|NCT03896165|564315103|FG000|Overall Study|Withdrawal by Subject|2|||
156332380|NCT03672643|564315105|FG000|Overall Study|Adverse Event|3|||
156332381|NCT03672643|564315105|FG000|Overall Study|Death|2|||
156332382|NCT03672643|564315105|FG000|Overall Study|Withdrawal by Subject|1|||
156332383|NCT03672643|564315105|FG000|Overall Study|Progressive disease|11|||
156332384|NCT03672643|564315105|FG000|Overall Study|Global deterioration of health status|1|||
156332385|NCT03672643|564315105|FG000|Overall Study|Refused further treatment|7|||
156332386|NCT03672643|564315105|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
156332387|NCT05268055|564315106|FG000|Overall Study|Lost to Follow-up|68|||
156332388|NCT05268055|564315107|FG001|Overall Study|Lost to Follow-up|68|||
156332389|NCT05268055|564315106|FG000|Overall Study|Withdrawal by Subject|12|||
156332390|NCT05268055|564315107|FG001|Overall Study|Withdrawal by Subject|8|||
156332391|NCT04102189|564315108|FG000|Overall Study|Withdrawal by Subject|1|||
156332392|NCT04102189|564315109|FG001|Overall Study|Withdrawal by Subject|2|||
156332393|NCT04102189|564315108|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156332394|NCT04102189|564315109|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156332395|NCT04102189|564315108|FG000|Overall Study|Lost to Follow-up|1|||
156332396|NCT04102189|564315109|FG001|Overall Study|Lost to Follow-up|0|||
156332397|NCT03774082|564315110|FG000|Overall Study|Death|6|||
156332398|NCT03774082|564315111|FG001|Overall Study|Death|3|||
156332399|NCT03774082|564315112|FG002|Overall Study|Death|2|||
156332400|NCT03774082|564315110|FG000|Overall Study|Subject decision|0|||
156332401|NCT03774082|564315111|FG001|Overall Study|Subject decision|3|||
156332402|NCT03774082|564315112|FG002|Overall Study|Subject decision|0|||
156332403|NCT03774082|564315110|FG000|Overall Study|Lost to Follow-up|2|||
156332404|NCT03774082|564315111|FG001|Overall Study|Lost to Follow-up|0|||
156332405|NCT03774082|564315112|FG002|Overall Study|Lost to Follow-up|0|||
156707857|NCT04981717|565676925|FG000|Overall Study|Adverse Event|1|||
156707858|NCT04981717|565676926|FG001|Overall Study|Adverse Event|3|||
156707859|NCT04981717|565676925|FG000|Overall Study|Pregnancy|1|||
156707860|NCT04981717|565676926|FG001|Overall Study|Pregnancy|0|||
156707861|NCT04981717|565676925|FG000|Overall Study|Physician Decision|1|||
156707862|NCT04981717|565676926|FG001|Overall Study|Physician Decision|0|||
156707863|NCT04981717|565676925|FG000|Overall Study|Sponsor Request|157|||
156707864|NCT04981717|565676926|FG001|Overall Study|Sponsor Request|172|||
156707865|NCT04981717|565676925|FG000|Overall Study|Lost to Follow-up|4|||
156707866|NCT04981717|565676926|FG001|Overall Study|Lost to Follow-up|5|||
156707867|NCT04981717|565676925|FG000|Overall Study|Withdrawal by Subject|50|||
156707868|NCT04981717|565676926|FG001|Overall Study|Withdrawal by Subject|37|||
156707869|NCT02207634|565676927|FG000|Overall Study|Withdrawal by Subject|21|||
156707870|NCT02207634|565676928|FG001|Overall Study|Withdrawal by Subject|31|||
156707871|NCT02207634|565676927|FG000|Overall Study|Lost to Follow-up|1|||
156707872|NCT02207634|565676928|FG001|Overall Study|Lost to Follow-up|0|||
156707873|NCT02585778|565676932|FG000|Overall Study|Adverse Event|17|||
156707874|NCT02585778|565676933|FG001|Overall Study|Adverse Event|4|||
156707875|NCT02585778|565676932|FG000|Overall Study|Participant did not wish to continue|9|||
156707876|NCT02585778|565676933|FG001|Overall Study|Participant did not wish to continue|4|||
156707877|NCT02585778|565676932|FG000|Overall Study|Poor compliance to study protocol|0|||
156707878|NCT02585778|565676933|FG001|Overall Study|Poor compliance to study protocol|2|||
156707879|NCT02585778|565676932|FG000|Overall Study|Death|0|||
156707880|NCT02585778|565676933|FG001|Overall Study|Death|1|||
156707881|NCT02585778|565676932|FG000|Overall Study|Randomized but not treated|1|||
156707882|NCT02585778|565676933|FG001|Overall Study|Randomized but not treated|2|||
156707883|NCT02585778|565676932|FG000|Overall Study|Other than specified above|6|||
156707884|NCT02585778|565676933|FG001|Overall Study|Other than specified above|2|||
156707885|NCT05211726|565676934|FG000|Overall Study|Withdrawal by Subject|2|||
156707886|NCT05211726|565676935|FG001|Overall Study|Withdrawal by Subject|3|||
156707887|NCT05211726|565676934|FG000|Overall Study|Protocol Violation|0|||
156707888|NCT05211726|565676935|FG001|Overall Study|Protocol Violation|1|||
156791297|NCT00537082|565987231|FG001|Overall Study|Discontinued before initiating treatment|0|||
156791298|NCT00537082|565987232|FG002|Overall Study|Discontinued before initiating treatment|0|||
156791299|NCT02568254|565987233|FG000|Period 2|Adverse Event|0|||
156791300|NCT02568254|565987234|FG001|Period 2|Adverse Event|0|||
156791301|NCT02568254|565987235|FG002|Period 2|Adverse Event|1|||
156791302|NCT02568254|565987236|FG003|Period 2|Adverse Event|0|||
156791303|NCT02568254|565987237|FG004|Period 2|Adverse Event|0|||
156791304|NCT02568254|565987238|FG005|Period 2|Adverse Event|0|||
156791305|NCT02568254|565987233|FG000|Period 3|Unstatisfactory Lens fitting|0|||
156791306|NCT02568254|565987234|FG001|Period 3|Unstatisfactory Lens fitting|0|||
156791307|NCT02568254|565987235|FG002|Period 3|Unstatisfactory Lens fitting|0|||
156791308|NCT02568254|565987236|FG003|Period 3|Unstatisfactory Lens fitting|0|||
156791309|NCT02568254|565987237|FG004|Period 3|Unstatisfactory Lens fitting|1|||
156791310|NCT02568254|565987238|FG005|Period 3|Unstatisfactory Lens fitting|0|||
156791311|NCT04495478|565987239|FG000|Overall Study|Withdrawal by Subject|0|||
156791312|NCT04495478|565987240|FG001|Overall Study|Withdrawal by Subject|0|||
156791313|NCT04495478|565987241|FG002|Overall Study|Withdrawal by Subject|0|||
156791314|NCT04495478|565987242|FG003|Overall Study|Withdrawal by Subject|1|||
156791315|NCT04495478|565987243|FG004|Overall Study|Withdrawal by Subject|0|||
156791316|NCT04495478|565987244|FG005|Overall Study|Withdrawal by Subject|0|||
156791317|NCT04495478|565987245|FG006|Overall Study|Withdrawal by Subject|0|||
156791318|NCT04495478|565987239|FG000|Overall Study|Physician Decision|0|||
156791319|NCT04495478|565987240|FG001|Overall Study|Physician Decision|1|||
156791320|NCT04495478|565987241|FG002|Overall Study|Physician Decision|0|||
156791321|NCT04495478|565987242|FG003|Overall Study|Physician Decision|0|||
156791322|NCT04495478|565987243|FG004|Overall Study|Physician Decision|1|||
156791323|NCT04495478|565987244|FG005|Overall Study|Physician Decision|0|||
156791324|NCT04495478|565987245|FG006|Overall Study|Physician Decision|0|||
156791325|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
156791326|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
156440883|NCT00802464|564707302|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
156707889|NCT02714426|565676939|FG000|Overall Study|Withdrawal by Subject|2|||
156707890|NCT02714426|565676940|FG001|Overall Study|Withdrawal by Subject|2|||
156707891|NCT00863772|565676941|FG000|Overall Study|Adverse Event|1|||
156707892|NCT00863772|565676942|FG001|Overall Study|Adverse Event|4|||
156707893|NCT00863772|565676943|FG002|Overall Study|Adverse Event|0|||
156707894|NCT00863772|565676941|FG000|Overall Study|Lack of Efficacy|4|||
156707895|NCT00863772|565676942|FG001|Overall Study|Lack of Efficacy|2|||
156707896|NCT00863772|565676943|FG002|Overall Study|Lack of Efficacy|4|||
156791327|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
156791328|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Adverse Event|5|||
156791329|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Adverse Event|1|||
156791330|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Adverse Event|0|||
156791331|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
156791332|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
156707897|NCT00863772|565676941|FG000|Overall Study|Lost to Follow-up|5|||
156707898|NCT00863772|565676942|FG001|Overall Study|Lost to Follow-up|1|||
156707899|NCT00863772|565676943|FG002|Overall Study|Lost to Follow-up|1|||
156707900|NCT00863772|565676941|FG000|Overall Study|Protocol Violation|2|||
156707901|NCT00863772|565676942|FG001|Overall Study|Protocol Violation|0|||
156707902|NCT00863772|565676943|FG002|Overall Study|Protocol Violation|2|||
156707903|NCT00863772|565676941|FG000|Overall Study|Withdrawal by Subject|4|||
156707904|NCT00863772|565676942|FG001|Overall Study|Withdrawal by Subject|7|||
156707905|NCT00863772|565676943|FG002|Overall Study|Withdrawal by Subject|5|||
156707906|NCT00863772|565676941|FG000|Overall Study|Study terminated by sponsor|44|||
156707907|NCT00863772|565676942|FG001|Overall Study|Study terminated by sponsor|45|||
156707908|NCT00863772|565676943|FG002|Overall Study|Study terminated by sponsor|36|||
156707909|NCT00863772|565676941|FG000|Overall Study|Entered extension study|6|||
156707910|NCT00863772|565676942|FG001|Overall Study|Entered extension study|4|||
156707911|NCT00863772|565676943|FG002|Overall Study|Entered extension study|9|||
156707912|NCT00863772|565676941|FG000|Overall Study|Other|1|||
156707913|NCT00863772|565676942|FG001|Overall Study|Other|2|||
156707914|NCT00863772|565676943|FG002|Overall Study|Other|4|||
156707915|NCT00863772|565676941|FG000|Overall Study|Randomized but not Treated|1|||
156707916|NCT00863772|565676942|FG001|Overall Study|Randomized but not Treated|0|||
156707917|NCT00863772|565676943|FG002|Overall Study|Randomized but not Treated|0|||
156707918|NCT00205803|565676947|FG000|Infant Series|Lost to Follow-up|10|||
156707919|NCT00205803|565676948|FG001|Infant Series|Lost to Follow-up|4|||
156707920|NCT00205803|565676947|FG000|Infant Series|Withdrawal by Subject|2|||
156707921|NCT00205803|565676948|FG001|Infant Series|Withdrawal by Subject|5|||
156707922|NCT00205803|565676947|FG000|Infant Series|Physician Decision|3|||
156707923|NCT00205803|565676948|FG001|Infant Series|Physician Decision|1|||
156707924|NCT00205803|565676947|FG000|Infant Series|Protocol Violation|1|||
156707925|NCT00205803|565676948|FG001|Infant Series|Protocol Violation|0|||
156707926|NCT00205803|565676947|FG000|Infant Series|Lost Kaiser coverage|0|||
156707927|NCT00205803|565676948|FG001|Infant Series|Lost Kaiser coverage|1|||
156707928|NCT00205803|565676947|FG000|Infant Series|Non-compliant|1|||
156707929|NCT00205803|565676948|FG001|Infant Series|Non-compliant|0|||
156707930|NCT00205803|565676947|FG000|Infant Series|Sponsor request|1|||
156707931|NCT00205803|565676948|FG001|Infant Series|Sponsor request|0|||
156707932|NCT00205803|565676947|FG000|After Infant Series|Adverse Event|1|||
156707933|NCT00205803|565676948|FG001|After Infant Series|Adverse Event|1|||
156707934|NCT00205803|565676947|FG000|After Infant Series|Protocol Violation|1|||
156707935|NCT00205803|565676948|FG001|After Infant Series|Protocol Violation|1|||
156707936|NCT00205803|565676947|FG000|After Infant Series|Lost to Follow-up|2|||
156707937|NCT00205803|565676948|FG001|After Infant Series|Lost to Follow-up|1|||
156707938|NCT00205803|565676947|FG000|After Infant Series|Physician Decision|3|||
156707939|NCT00205803|565676948|FG001|After Infant Series|Physician Decision|2|||
156707940|NCT00205803|565676947|FG000|After Infant Series|Withdrawal by Subject|1|||
156707941|NCT00205803|565676948|FG001|After Infant Series|Withdrawal by Subject|4|||
156707942|NCT00205803|565676947|FG000|After Infant Series|Other|10|||
156707943|NCT00205803|565676948|FG001|After Infant Series|Other|4|||
156707944|NCT00205803|565676947|FG000|Toddler Dose|Lost to Follow-up|2|||
156707945|NCT00205803|565676948|FG001|Toddler Dose|Lost to Follow-up|3|||
156707946|NCT03185013|565676951|FG000|Overall Study|Withdrawal by Subject|5|||
156707947|NCT03185013|565676952|FG001|Overall Study|Withdrawal by Subject|3|||
156707948|NCT03185013|565676951|FG000|Overall Study|Adverse Event|1|||
156707949|NCT03185013|565676952|FG001|Overall Study|Adverse Event|0|||
156707950|NCT03185013|565676951|FG000|Overall Study|Progressive Disease|1|||
156707951|NCT03185013|565676952|FG001|Overall Study|Progressive Disease|0|||
156707952|NCT03185013|565676951|FG000|Overall Study|Lost to Follow-up|8|||
156707953|NCT03185013|565676952|FG001|Overall Study|Lost to Follow-up|2|||
156707954|NCT03185013|565676951|FG000|Overall Study|Physician Decision|1|||
156707955|NCT03185013|565676952|FG001|Overall Study|Physician Decision|0|||
156707956|NCT03185013|565676951|FG000|Overall Study|Protocol Deviation|2|||
156707957|NCT03185013|565676952|FG001|Overall Study|Protocol Deviation|0|||
156707958|NCT03185013|565676951|FG000|Overall Study|Reason not Specified|3|||
156707959|NCT03185013|565676952|FG001|Overall Study|Reason not Specified|2|||
156707960|NCT03185013|565676951|FG000|Overall Study|Death|1|||
156707961|NCT03185013|565676952|FG001|Overall Study|Death|0|||
156872194|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
156707962|NCT02071849|565676956|FG000|6-month Primary Endpoint|Did not receive device|4|||
156707963|NCT02071849|565676956|FG000|6-month Primary Endpoint|Adverse Event|1|||
156707964|NCT02071849|565676956|FG000|2-year Extended Follow-up|Adverse Event|1|||
156707965|NCT03255655|565676957|FG000|Overall Study|Lost to Follow-up|7|||
156707966|NCT03255655|565676958|FG001|Overall Study|Lost to Follow-up|4|||
156707967|NCT02056392|565676961|FG000|Overall Study|Lost to Follow-up|0|||
156707968|NCT02056392|565676962|FG001|Overall Study|Lost to Follow-up|1|||
156707969|NCT02056392|565676963|FG002|Overall Study|Lost to Follow-up|2|||
156707970|NCT02056392|565676964|FG003|Overall Study|Lost to Follow-up|0|||
156707971|NCT02056392|565676965|FG004|Overall Study|Lost to Follow-up|0|||
156707972|NCT02056392|565676966|FG005|Overall Study|Lost to Follow-up|0|||
156707973|NCT02056392|565676961|FG000|Overall Study|Protocol Violation|1|||
156707974|NCT02056392|565676962|FG001|Overall Study|Protocol Violation|0|||
156707975|NCT02056392|565676963|FG002|Overall Study|Protocol Violation|1|||
156707976|NCT02056392|565676964|FG003|Overall Study|Protocol Violation|0|||
156707977|NCT02056392|565676965|FG004|Overall Study|Protocol Violation|0|||
156707978|NCT02056392|565676966|FG005|Overall Study|Protocol Violation|0|||
156707979|NCT02056392|565676961|FG000|Overall Study|Withdrawal by Subject|1|||
156707980|NCT02056392|565676962|FG001|Overall Study|Withdrawal by Subject|0|||
156707981|NCT02056392|565676963|FG002|Overall Study|Withdrawal by Subject|0|||
156707982|NCT02056392|565676964|FG003|Overall Study|Withdrawal by Subject|0|||
156707983|NCT02056392|565676965|FG004|Overall Study|Withdrawal by Subject|1|||
156707984|NCT02056392|565676966|FG005|Overall Study|Withdrawal by Subject|0|||
156707985|NCT00658021|565676967|FG000|28-Week Treatment Period|Adverse Event|3|||
156707986|NCT00658021|565676968|FG001|28-Week Treatment Period|Adverse Event|1|||
156707987|NCT00658021|565676969|FG002|28-Week Treatment Period|Adverse Event|0|||
156707988|NCT00658021|565676967|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
156707989|NCT00658021|565676968|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
156440884|NCT00802464|564707303|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
156707990|NCT00658021|565676969|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
156707991|NCT00658021|565676967|FG000|28-Week Treatment Period|Protocol Violation|0|||
156707992|NCT00658021|565676968|FG001|28-Week Treatment Period|Protocol Violation|2|||
156707993|NCT00658021|565676969|FG002|28-Week Treatment Period|Protocol Violation|1|||
156707994|NCT00658021|565676967|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
156440885|NCT00802464|564707304|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
156440886|NCT00402246|564707305|FG000|Overall Study|Death|62|||
156440887|NCT00402246|564707306|FG001|Overall Study|Death|58|||
156440888|NCT00402246|564707305|FG000|Overall Study|Lost to Follow-up|20|||
156707995|NCT00658021|565676968|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
156707996|NCT00658021|565676969|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
156707997|NCT00658021|565676967|FG000|28-Week Treatment Period|Physician Decision|1|||
156707998|NCT00658021|565676968|FG001|28-Week Treatment Period|Physician Decision|2|||
156707999|NCT00658021|565676969|FG002|28-Week Treatment Period|Physician Decision|1|||
156708000|NCT00658021|565676967|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
156708001|NCT00658021|565676968|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
156708002|NCT00658021|565676969|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
156708003|NCT00658021|565676967|FG000|28-Week Treatment Period|Loss of glucose control|1|||
156708004|NCT00658021|565676968|FG001|28-Week Treatment Period|Loss of glucose control|1|||
156708005|NCT00658021|565676969|FG002|28-Week Treatment Period|Loss of glucose control|10|||
156708006|NCT00658021|565676967|FG000|28-Week Treatment Period|Other|2|||
156708007|NCT00658021|565676968|FG001|28-Week Treatment Period|Other|3|||
156708008|NCT00658021|565676969|FG002|28-Week Treatment Period|Other|1|||
156708009|NCT00658021|565676967|FG000|28-Week Treatment Period|Did not receive treatment|2|||
156708010|NCT00658021|565676968|FG001|28-Week Treatment Period|Did not receive treatment|0|||
156708011|NCT00658021|565676969|FG002|28-Week Treatment Period|Did not receive treatment|0|||
156708012|NCT00658021|565676967|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
156708013|NCT00658021|565676968|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
156708014|NCT00658021|565676969|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
156708015|NCT00658021|565676967|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
156708016|NCT00658021|565676968|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
156708017|NCT00658021|565676969|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
156708018|NCT01806506|565676970|FG000|Overall Study|Lost to Follow-up|2|||
156791333|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
156791334|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Death|8|||
156791335|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Death|24|||
156791336|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Death|0|||
156791337|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
156791338|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
156791339|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
156791340|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
156791341|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
156791342|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
156791343|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
156791344|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
156791345|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
156791346|NCT02931539|565987246|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
156791347|NCT02931539|565987247|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
156791348|NCT02931539|565987248|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
156440889|NCT00402246|564707306|FG001|Overall Study|Lost to Follow-up|28|||
156440890|NCT00402246|564707305|FG000|Overall Study|Withdrawal by Subject|72|||
156708019|NCT01806506|565676971|FG001|Overall Study|Lost to Follow-up|1|||
156708020|NCT00725205|565676978|FG000|Overall Study|Adverse Event|22|||
156708021|NCT00725205|565676978|FG000|Overall Study|Investigator Discontinued|1|||
156440891|NCT00402246|564707306|FG001|Overall Study|Withdrawal by Subject|87|||
156708022|NCT00725205|565676978|FG000|Overall Study|Non-compliance With Protocol|14|||
156708023|NCT00725205|565676978|FG000|Overall Study|Other|8|||
156708024|NCT00725205|565676978|FG000|Overall Study|Protocol Defined Clinical Event|1|||
156708025|NCT00725205|565676978|FG000|Overall Study|Treatment Failure|41|||
156708026|NCT05819203|565676982|FG000|Overall Study|Protocol Violation|1|||
156708027|NCT05819203|565676983|FG001|Overall Study|Protocol Violation|2|||
156708028|NCT05819203|565676982|FG000|Overall Study|Withdrawal by Subject|1|||
156708029|NCT05819203|565676983|FG001|Overall Study|Withdrawal by Subject|0|||
156708030|NCT04844762|565676986|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708031|NCT04844762|565676987|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708032|NCT04844762|565676988|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
156708033|NCT04844762|565676989|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708034|NCT04844762|565676990|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708035|NCT04844762|565676991|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708036|NCT04844762|565676986|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
156708037|NCT04844762|565676987|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
156708038|NCT04844762|565676988|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
156708039|NCT04844762|565676989|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
156708040|NCT04844762|565676990|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
156708041|NCT04844762|565676991|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
156708042|NCT04844762|565676986|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708043|NCT04844762|565676987|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708044|NCT04844762|565676988|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708045|NCT04844762|565676989|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
156708046|NCT04844762|565676990|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708047|NCT04844762|565676991|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708048|NCT04844762|565676986|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708049|NCT04844762|565676987|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708050|NCT04844762|565676988|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
156708051|NCT04844762|565676989|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
156708052|NCT04844762|565676990|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
156708053|NCT04844762|565676991|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708054|NCT04844762|565676986|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
156708055|NCT04844762|565676987|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
156708056|NCT04844762|565676988|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708057|NCT04844762|565676989|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708058|NCT04844762|565676990|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708059|NCT04844762|565676991|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708060|NCT04844762|565676986|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708061|NCT04844762|565676987|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708062|NCT04844762|565676988|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708063|NCT04844762|565676989|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708064|NCT04844762|565676990|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708065|NCT04844762|565676991|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708066|NCT04844762|565676986|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708067|NCT04844762|565676987|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708068|NCT04844762|565676988|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708069|NCT04844762|565676989|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708070|NCT04844762|565676990|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
156708071|NCT04844762|565676991|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708072|NCT04844762|565676986|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
156708073|NCT04844762|565676987|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708074|NCT04844762|565676988|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708075|NCT04844762|565676989|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708076|NCT04844762|565676990|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708077|NCT04844762|565676991|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708078|NCT04844762|565676986|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708079|NCT04844762|565676987|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708080|NCT04844762|565676988|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708081|NCT04844762|565676989|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708082|NCT04844762|565676990|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708083|NCT04844762|565676991|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708084|NCT04844762|565676986|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156708085|NCT04844762|565676987|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
156708086|NCT04844762|565676988|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156872195|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
156872196|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
156872197|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
156872198|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
156872199|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Not treated|0|||
156872200|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Not treated|0|||
156872201|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Not treated|1|||
156872202|NCT03614156|566289534|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
156872203|NCT03614156|566289535|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
156872204|NCT03614156|566289536|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
156872205|NCT03614156|566289537|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
156872206|NCT03614156|566289534|FG000|Open-Label Treatment Period|Adverse Event|7|||
156872207|NCT03614156|566289535|FG001|Open-Label Treatment Period|Adverse Event|0|||
156872208|NCT03614156|566289536|FG002|Open-Label Treatment Period|Adverse Event|0|||
156872209|NCT03614156|566289537|FG003|Open-Label Treatment Period|Adverse Event|0|||
156872210|NCT03614156|566289534|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
156872211|NCT03614156|566289535|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
156872212|NCT03614156|566289536|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
156872213|NCT03614156|566289537|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
156872214|NCT03614156|566289534|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
156872215|NCT03614156|566289535|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
156872216|NCT03614156|566289536|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
156872217|NCT03614156|566289537|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
156872218|NCT03614156|566289534|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
156872219|NCT03614156|566289535|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
156872220|NCT03614156|566289536|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
156872221|NCT03614156|566289537|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
156872222|NCT03614156|566289534|FG000|Open-Label Treatment Period|Protocol Violation|2|||
156872223|NCT03614156|566289535|FG001|Open-Label Treatment Period|Protocol Violation|0|||
156708087|NCT04844762|565676989|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156708088|NCT04844762|565676990|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156708089|NCT04844762|565676991|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156708090|NCT04844762|565676986|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708091|NCT04844762|565676987|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708092|NCT04844762|565676988|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708093|NCT04844762|565676989|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
156708094|NCT04844762|565676990|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708095|NCT04844762|565676991|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708096|NCT04400682|565676994|FG000|Period 1|Withdrawal by Subject|1|||
156708097|NCT04400682|565676995|FG001|Period 1|Withdrawal by Subject|4|||
156708098|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
156708099|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
156708100|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708101|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708102|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708103|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708104|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708105|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708106|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708107|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708108|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
156708109|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
156708110|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708111|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708112|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708113|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708114|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708115|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708116|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708117|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708118|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708119|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
156708120|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708121|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708122|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708123|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708124|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708125|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708126|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708127|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708128|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
156708129|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708130|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708131|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708132|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708133|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708134|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708135|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708136|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708137|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708138|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
156708139|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
156708140|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708141|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708142|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708143|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708144|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708145|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708146|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708147|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708148|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
156708149|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
156708150|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708151|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708152|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708153|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708154|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708155|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708156|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708157|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708158|NCT04784533|565676996|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708159|NCT04784533|565676997|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708160|NCT04784533|565676998|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
156708161|NCT04784533|565676999|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708162|NCT04784533|565677000|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708163|NCT04784533|565677001|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156332406|NCT03774082|564315110|FG000|Overall Study|Guardian decision|0|||
156332407|NCT03774082|564315111|FG001|Overall Study|Guardian decision|0|||
156332408|NCT03774082|564315112|FG002|Overall Study|Guardian decision|1|||
156708164|NCT04784533|565677002|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708165|NCT04784533|565677003|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708166|NCT04784533|565677004|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708167|NCT04784533|565677005|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708168|NCT04784533|565676996|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708169|NCT04784533|565676997|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708170|NCT04784533|565676998|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708171|NCT04784533|565676999|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708172|NCT04784533|565677000|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708173|NCT04784533|565677001|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708174|NCT04784533|565677002|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708175|NCT04784533|565677003|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708176|NCT04784533|565677004|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
156708177|NCT04784533|565677005|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708178|NCT04784533|565676996|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708179|NCT04784533|565676997|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708180|NCT04784533|565676998|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708181|NCT04784533|565676999|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708182|NCT04784533|565677000|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708183|NCT04784533|565677001|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156332409|NCT03774082|564315110|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
156332410|NCT03774082|564315111|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
156708184|NCT04784533|565677002|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708185|NCT04784533|565677003|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708186|NCT04784533|565677004|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
156708187|NCT04784533|565677005|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
156708188|NCT00477633|565677006|FG000|Overall Study|Did not receive treatment|23|||
156708189|NCT00477633|565677006|FG000|Overall Study|Adverse Event|143|||
156708190|NCT00477633|565677006|FG000|Overall Study|Pregnancy|23|||
156708191|NCT00477633|565677006|FG000|Overall Study|Lost to Follow-up|271|||
156708192|NCT00477633|565677006|FG000|Overall Study|Withdrawal by Subject|149|||
156708193|NCT00477633|565677006|FG000|Overall Study|Protocol Violation|25|||
156708194|NCT00477633|565677006|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
156708195|NCT02203331|565677013|FG000|Overall Study|Pregnancy|1|||
156708196|NCT02203331|565677014|FG001|Overall Study|Pregnancy|0|||
156708197|NCT02203331|565677015|FG002|Overall Study|Pregnancy|0|||
156708198|NCT02203331|565677016|FG003|Overall Study|Pregnancy|0|||
156708199|NCT02203331|565677017|FG004|Overall Study|Pregnancy|2|||
156708200|NCT02203331|565677018|FG005|Overall Study|Pregnancy|0|||
156708201|NCT02203331|565677013|FG000|Overall Study|Withdrawal by Subject|1|||
156708202|NCT02203331|565677014|FG001|Overall Study|Withdrawal by Subject|0|||
156708203|NCT02203331|565677015|FG002|Overall Study|Withdrawal by Subject|1|||
156708204|NCT02203331|565677016|FG003|Overall Study|Withdrawal by Subject|0|||
156708205|NCT02203331|565677017|FG004|Overall Study|Withdrawal by Subject|0|||
156708206|NCT02203331|565677018|FG005|Overall Study|Withdrawal by Subject|3|||
156708207|NCT02203331|565677013|FG000|Overall Study|Adverse Event|4|||
156708208|NCT02203331|565677014|FG001|Overall Study|Adverse Event|8|||
156708209|NCT02203331|565677015|FG002|Overall Study|Adverse Event|3|||
156708210|NCT02203331|565677016|FG003|Overall Study|Adverse Event|4|||
156708211|NCT02203331|565677017|FG004|Overall Study|Adverse Event|3|||
156708212|NCT02203331|565677018|FG005|Overall Study|Adverse Event|3|||
156708213|NCT02203331|565677013|FG000|Overall Study|Other Reasons|1|||
156708214|NCT02203331|565677014|FG001|Overall Study|Other Reasons|2|||
156708215|NCT02203331|565677015|FG002|Overall Study|Other Reasons|0|||
156708216|NCT02203331|565677016|FG003|Overall Study|Other Reasons|2|||
156708217|NCT02203331|565677017|FG004|Overall Study|Other Reasons|0|||
156708218|NCT02203331|565677018|FG005|Overall Study|Other Reasons|0|||
156708219|NCT02203331|565677013|FG000|Overall Study|Lack of Efficacy|0|||
156708220|NCT02203331|565677014|FG001|Overall Study|Lack of Efficacy|2|||
156708221|NCT02203331|565677015|FG002|Overall Study|Lack of Efficacy|1|||
156708222|NCT02203331|565677016|FG003|Overall Study|Lack of Efficacy|0|||
156708223|NCT02203331|565677017|FG004|Overall Study|Lack of Efficacy|0|||
156708224|NCT02203331|565677018|FG005|Overall Study|Lack of Efficacy|1|||
156708225|NCT02203331|565677013|FG000|Overall Study|Protocol Violation|0|||
156708226|NCT02203331|565677014|FG001|Overall Study|Protocol Violation|2|||
156708227|NCT02203331|565677015|FG002|Overall Study|Protocol Violation|0|||
156708228|NCT02203331|565677016|FG003|Overall Study|Protocol Violation|1|||
156708229|NCT02203331|565677017|FG004|Overall Study|Protocol Violation|1|||
156708230|NCT02203331|565677018|FG005|Overall Study|Protocol Violation|0|||
156708231|NCT02203331|565677013|FG000|Overall Study|Lost to Follow-up|0|||
156708232|NCT02203331|565677014|FG001|Overall Study|Lost to Follow-up|0|||
156708233|NCT02203331|565677015|FG002|Overall Study|Lost to Follow-up|0|||
156708234|NCT02203331|565677016|FG003|Overall Study|Lost to Follow-up|0|||
156708235|NCT02203331|565677017|FG004|Overall Study|Lost to Follow-up|1|||
156708236|NCT02203331|565677018|FG005|Overall Study|Lost to Follow-up|0|||
156708237|NCT03597464|565677019|FG000|Overall Study|Withdrawal by Subject|4|||
156708238|NCT03597464|565677020|FG001|Overall Study|Withdrawal by Subject|5|||
156708239|NCT03597464|565677019|FG000|Overall Study|Lost to Follow-up|3|||
156708240|NCT03597464|565677020|FG001|Overall Study|Lost to Follow-up|1|||
156708241|NCT03597464|565677019|FG000|Overall Study|Pregnancy|3|||
156708242|NCT03597464|565677020|FG001|Overall Study|Pregnancy|1|||
156872224|NCT03614156|566289536|FG002|Open-Label Treatment Period|Protocol Violation|0|||
156332411|NCT03774082|564315112|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
156708243|NCT03597464|565677019|FG000|Overall Study|Lack of Efficacy|2|||
156708244|NCT03597464|565677020|FG001|Overall Study|Lack of Efficacy|0|||
156708245|NCT03597464|565677019|FG000|Overall Study|Physician Decision|2|||
156708246|NCT03597464|565677020|FG001|Overall Study|Physician Decision|2|||
156708247|NCT03597464|565677019|FG000|Overall Study|Protocol Violation|1|||
156708248|NCT03597464|565677020|FG001|Overall Study|Protocol Violation|1|||
156708249|NCT03597464|565677019|FG000|Overall Study|Adverse Event|0|||
156708250|NCT03597464|565677020|FG001|Overall Study|Adverse Event|2|||
156708251|NCT03597464|565677019|FG000|Overall Study|Death|0|||
156708252|NCT03597464|565677020|FG001|Overall Study|Death|3|||
156708253|NCT02542605|565677025|FG000|Part B: Challenge Phase|Sponsor decision|1|||
156708254|NCT02542605|565677026|FG001|Part B: Challenge Phase|Sponsor decision|0|||
156708255|NCT02542605|565677027|FG002|Part B: Challenge Phase|Sponsor decision|0|||
156708256|NCT02542605|565677025|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
156708257|NCT02542605|565677026|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
156708258|NCT02542605|565677027|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
156708259|NCT02682927|565677028|FG000|Overall Study|Adverse Event|0|||
156708260|NCT02682927|565677029|FG001|Overall Study|Adverse Event|0|||
156440892|NCT00402246|564707305|FG000|Overall Study|Physician Decision|24|||
156440893|NCT00402246|564707306|FG001|Overall Study|Physician Decision|26|||
156440894|NCT00402246|564707305|FG000|Overall Study|Protocol Violation|25|||
156440895|NCT00402246|564707306|FG001|Overall Study|Protocol Violation|24|||
156440896|NCT00402246|564707305|FG000|Overall Study|Missed Final Visit|1|||
156440897|NCT00402246|564707306|FG001|Overall Study|Missed Final Visit|2|||
156440898|NCT00402246|564707305|FG000|Overall Study|Insurance Issues|2|||
156440899|NCT00402246|564707306|FG001|Overall Study|Insurance Issues|1|||
156440900|NCT00402246|564707305|FG000|Overall Study|Heart Transplant|0|||
156440901|NCT00402246|564707306|FG001|Overall Study|Heart Transplant|1|||
156440902|NCT00402246|564707305|FG000|Overall Study|Patient's device explanted|6|||
156440903|NCT00402246|564707306|FG001|Overall Study|Patient's device explanted|2|||
156440904|NCT00402246|564707305|FG000|Overall Study|Center Closure|5|||
156440905|NCT00402246|564707306|FG001|Overall Study|Center Closure|3|||
156440906|NCT00402246|564707305|FG000|Overall Study|Deterioriating Condition|3|||
156440907|NCT00402246|564707306|FG001|Overall Study|Deterioriating Condition|2|||
156440908|NCT02622568|564707311|FG000|Overall Study|Lost to Follow-up|5|||
156440909|NCT02622568|564707312|FG001|Overall Study|Lost to Follow-up|5|||
156440910|NCT02647905|564707313|FG000|Overall Study|Lost to Follow-up|1|||
156440911|NCT02647905|564707313|FG000|Overall Study|Withdrawal by Subject|2|||
156440912|NCT00421889|564707315|FG000|Overall Study|Adverse Event|1|||
156440913|NCT00421889|564707316|FG001|Overall Study|Adverse Event|0|||
156440914|NCT00421889|564707317|FG002|Overall Study|Adverse Event|1|||
156440915|NCT00421889|564707318|FG003|Overall Study|Adverse Event|1|||
156440916|NCT00421889|564707319|FG004|Overall Study|Adverse Event|1|||
156440917|NCT00421889|564707320|FG005|Overall Study|Adverse Event|4|||
156440918|NCT00421889|564707321|FG006|Overall Study|Adverse Event|1|||
156440919|NCT00421889|564707322|FG007|Overall Study|Adverse Event|0|||
156440920|NCT00421889|564707323|FG008|Overall Study|Adverse Event|2|||
156440921|NCT00421889|564707315|FG000|Overall Study|Withdrawal by Subject|1|||
156440922|NCT00421889|564707316|FG001|Overall Study|Withdrawal by Subject|3|||
156440923|NCT00421889|564707317|FG002|Overall Study|Withdrawal by Subject|0|||
156440924|NCT00421889|564707318|FG003|Overall Study|Withdrawal by Subject|0|||
156440925|NCT00421889|564707319|FG004|Overall Study|Withdrawal by Subject|2|||
156440926|NCT00421889|564707320|FG005|Overall Study|Withdrawal by Subject|0|||
156440927|NCT00421889|564707321|FG006|Overall Study|Withdrawal by Subject|0|||
156440928|NCT00421889|564707322|FG007|Overall Study|Withdrawal by Subject|0|||
156440929|NCT00421889|564707323|FG008|Overall Study|Withdrawal by Subject|0|||
156440930|NCT00421889|564707315|FG000|Overall Study|Death|0|||
156440931|NCT00421889|564707316|FG001|Overall Study|Death|0|||
156440932|NCT00421889|564707317|FG002|Overall Study|Death|0|||
156440933|NCT00421889|564707318|FG003|Overall Study|Death|0|||
156440934|NCT00421889|564707319|FG004|Overall Study|Death|1|||
156440935|NCT00421889|564707320|FG005|Overall Study|Death|1|||
156440936|NCT00421889|564707321|FG006|Overall Study|Death|0|||
156440937|NCT00421889|564707322|FG007|Overall Study|Death|0|||
156440938|NCT00421889|564707323|FG008|Overall Study|Death|0|||
156708261|NCT02682927|565677030|FG002|Overall Study|Adverse Event|5|||
156708262|NCT02682927|565677031|FG003|Overall Study|Adverse Event|1|||
156708263|NCT02682927|565677032|FG004|Overall Study|Adverse Event|0|||
156708264|NCT02682927|565677033|FG005|Overall Study|Adverse Event|2|||
156708265|NCT02682927|565677028|FG000|Overall Study|Death|0|||
156708266|NCT02682927|565677029|FG001|Overall Study|Death|0|||
156440939|NCT00421889|564707315|FG000|Overall Study|Progressive disease|3|||
156440940|NCT00421889|564707316|FG001|Overall Study|Progressive disease|2|||
156440941|NCT00421889|564707317|FG002|Overall Study|Progressive disease|2|||
156440942|NCT00421889|564707318|FG003|Overall Study|Progressive disease|3|||
156440943|NCT00421889|564707319|FG004|Overall Study|Progressive disease|2|||
156440944|NCT00421889|564707320|FG005|Overall Study|Progressive disease|21|||
156440945|NCT00421889|564707321|FG006|Overall Study|Progressive disease|3|||
156708267|NCT02682927|565677030|FG002|Overall Study|Death|0|||
156440946|NCT00421889|564707322|FG007|Overall Study|Progressive disease|1|||
156708268|NCT02682927|565677031|FG003|Overall Study|Death|1|||
156440947|NCT00421889|564707323|FG008|Overall Study|Progressive disease|5|||
156440948|NCT00421889|564707315|FG000|Overall Study|Patient/Investigator request|0|||
156440949|NCT00421889|564707316|FG001|Overall Study|Patient/Investigator request|0|||
156708269|NCT02682927|565677032|FG004|Overall Study|Death|0|||
156791349|NCT00655746|565987249|FG000|Overall Study|Withdrawal by Subject|1|||
156440950|NCT00421889|564707317|FG002|Overall Study|Patient/Investigator request|0|||
156440951|NCT00421889|564707318|FG003|Overall Study|Patient/Investigator request|0|||
156440952|NCT00421889|564707319|FG004|Overall Study|Patient/Investigator request|0|||
156440953|NCT00421889|564707320|FG005|Overall Study|Patient/Investigator request|9|||
156440954|NCT00421889|564707321|FG006|Overall Study|Patient/Investigator request|0|||
156791350|NCT03178942|565987252|FG000|Overall Study|Withdrawal by Subject|2|||
156791351|NCT03178942|565987253|FG001|Overall Study|Withdrawal by Subject|0|||
156791352|NCT03178942|565987252|FG000|Overall Study|Lost to Follow-up|1|||
156791353|NCT03178942|565987253|FG001|Overall Study|Lost to Follow-up|2|||
156440955|NCT00421889|564707322|FG007|Overall Study|Patient/Investigator request|1|||
156440956|NCT00421889|564707323|FG008|Overall Study|Patient/Investigator request|3|||
156708270|NCT02682927|565677033|FG005|Overall Study|Death|0|||
156440957|NCT00421889|564707315|FG000|Overall Study|Lost to Follow-up|0|||
156440958|NCT00421889|564707316|FG001|Overall Study|Lost to Follow-up|0|||
156440959|NCT00421889|564707317|FG002|Overall Study|Lost to Follow-up|0|||
156440960|NCT00421889|564707318|FG003|Overall Study|Lost to Follow-up|0|||
156440961|NCT00421889|564707319|FG004|Overall Study|Lost to Follow-up|0|||
156440962|NCT00421889|564707320|FG005|Overall Study|Lost to Follow-up|0|||
156440963|NCT00421889|564707321|FG006|Overall Study|Lost to Follow-up|0|||
156440964|NCT00421889|564707322|FG007|Overall Study|Lost to Follow-up|0|||
156708271|NCT02682927|565677028|FG000|Overall Study|Lack of Efficacy|1|||
156708272|NCT02682927|565677029|FG001|Overall Study|Lack of Efficacy|0|||
156708273|NCT02682927|565677030|FG002|Overall Study|Lack of Efficacy|0|||
156708274|NCT02682927|565677031|FG003|Overall Study|Lack of Efficacy|1|||
156708275|NCT02682927|565677032|FG004|Overall Study|Lack of Efficacy|0|||
156708276|NCT02682927|565677033|FG005|Overall Study|Lack of Efficacy|0|||
156708277|NCT02682927|565677028|FG000|Overall Study|Other|0|||
156708278|NCT02682927|565677029|FG001|Overall Study|Other|0|||
156708279|NCT02682927|565677030|FG002|Overall Study|Other|0|||
156708280|NCT02682927|565677031|FG003|Overall Study|Other|2|||
156708281|NCT02682927|565677032|FG004|Overall Study|Other|0|||
156791354|NCT03061214|565987258|FG000|Overall Study|Withdrawal by Subject|21|||
156791355|NCT03061214|565987259|FG001|Overall Study|Withdrawal by Subject|26|||
156791356|NCT03061214|565987260|FG002|Overall Study|Withdrawal by Subject|9|||
156791357|NCT03061214|565987258|FG000|Overall Study|Lost to Follow-up|3|||
156791358|NCT03061214|565987259|FG001|Overall Study|Lost to Follow-up|1|||
156791359|NCT03061214|565987260|FG002|Overall Study|Lost to Follow-up|1|||
156791360|NCT03061214|565987258|FG000|Overall Study|Death|1|||
156791361|NCT03061214|565987259|FG001|Overall Study|Death|1|||
156791362|NCT03061214|565987260|FG002|Overall Study|Death|0|||
156791363|NCT01197300|565988854|FG000|Overall Study|Lost to Follow-up|0|||
156791364|NCT01197300|565988855|FG001|Overall Study|Lost to Follow-up|1|||
156791365|NCT01197300|565988854|FG000|Overall Study|Protocol Violation|0|||
156791366|NCT01197300|565988855|FG001|Overall Study|Protocol Violation|1|||
156791367|NCT02113878|565988856|FG000|Overall Study|Adverse Event|1|||
156791368|NCT02113878|565988857|FG001|Overall Study|Adverse Event|0|||
156791369|NCT02113878|565988856|FG000|Overall Study|Withdrawal by Subject|1|||
156791370|NCT02113878|565988857|FG001|Overall Study|Withdrawal by Subject|0|||
156791371|NCT02113878|565988856|FG000|Overall Study|patient non-compliance|1|||
156791372|NCT02113878|565988857|FG001|Overall Study|patient non-compliance|0|||
156791373|NCT00530257|565988865|FG000|Overall Study|Lost to Follow-up|1|||
156791374|NCT05130281|565988869|FG000|Overall Study|Withdrawal by Subject|0|||
156791375|NCT05130281|565988870|FG001|Overall Study|Withdrawal by Subject|0|||
156791376|NCT05130281|565988871|FG002|Overall Study|Withdrawal by Subject|1|||
156791377|NCT06844812|565988872|FG000|Overall Study|Lost to Follow-up|5|||
156791378|NCT06844812|565988872|FG000|Overall Study|stigmatization concerns|2|||
156791379|NCT06844812|565988872|FG000|Overall Study|medication refusal|2|||
156791380|NCT06844812|565988872|FG000|Overall Study|concerns about possible side effects|2|||
156791381|NCT06844812|565988872|FG000|Overall Study|wanting to seek another specialist opinion|2|||
156791382|NCT06844812|565988872|FG000|Overall Study|side effects (dizziness)|1|||
156791383|NCT03142451|565988901|FG000|Overall Study|Adverse Event|5|||
156791384|NCT03142451|565988902|FG001|Overall Study|Adverse Event|2|||
156791385|NCT03142451|565988901|FG000|Overall Study|Lost to Follow-up|25|||
156791386|NCT03142451|565988902|FG001|Overall Study|Lost to Follow-up|8|||
156791387|NCT03142451|565988901|FG000|Overall Study|Participant request|24|||
156791388|NCT03142451|565988902|FG001|Overall Study|Participant request|12|||
156791389|NCT03142451|565988901|FG000|Overall Study|Protocol Violation|3|||
156791390|NCT03142451|565988902|FG001|Overall Study|Protocol Violation|1|||
156791391|NCT03142451|565988901|FG000|Overall Study|Other|1|||
156791392|NCT03142451|565988902|FG001|Overall Study|Other|1|||
156791393|NCT05333965|565988903|FG000|First Intervention|Adverse Event|0|||
156440965|NCT00421889|564707323|FG008|Overall Study|Lost to Follow-up|1|||
156531791|NCT02684357|565041728|FG003|Part A|Withdrawal by Subject|0|||
156708282|NCT02682927|565677033|FG005|Overall Study|Other|0|||
156708283|NCT02682927|565677028|FG000|Overall Study|Withdrawal by Subject|2|||
156708284|NCT02682927|565677029|FG001|Overall Study|Withdrawal by Subject|0|||
156708285|NCT02682927|565677030|FG002|Overall Study|Withdrawal by Subject|1|||
156791394|NCT05333965|565988904|FG001|First Intervention|Adverse Event|1|||
156791395|NCT05333965|565988903|FG000|First Intervention|Withdrawal by Subject|0|||
156791396|NCT05333965|565988904|FG001|First Intervention|Withdrawal by Subject|1|||
156791397|NCT03048019|565988905|FG000|Overall Study|Adverse Event|1|||
156791398|NCT03048019|565988906|FG001|Overall Study|Adverse Event|0|||
156791399|NCT01730729|565988907|FG000|Overall Study|Adverse Event|1|||
156791400|NCT01730729|565988907|FG000|Overall Study|Death|1|||
156791401|NCT01730729|565988907|FG000|Overall Study|Progressive Disease|12|||
156791402|NCT00203242|565988910|FG000|Overall Study|Lost to Follow-up|1|||
156791403|NCT02837952|565988912|FG000|Overall Study|Adverse Event|0|||
156791404|NCT02837952|565988913|FG001|Overall Study|Adverse Event|1|||
156791405|NCT02837952|565988912|FG000|Overall Study|Withdrawal by Subject|4|||
156791406|NCT02837952|565988913|FG001|Overall Study|Withdrawal by Subject|5|||
156708286|NCT02682927|565677031|FG003|Overall Study|Withdrawal by Subject|0|||
156531792|NCT02684357|565041729|FG004|Part A|Withdrawal by Subject|0|||
156440966|NCT00978042|564707324|FG000|Initial Treatment Period|Treated in Error|0|||
156440967|NCT00978042|564707325|FG001|Initial Treatment Period|Treated in Error|3|||
156708287|NCT02682927|565677032|FG004|Overall Study|Withdrawal by Subject|1|||
156708288|NCT02682927|565677033|FG005|Overall Study|Withdrawal by Subject|1|||
156708289|NCT03316547|565677036|FG000|Overall Study|Death|3|||
156708290|NCT03316547|565677037|FG001|Overall Study|Death|1|||
156708291|NCT03316547|565677036|FG000|Overall Study|Lost to Follow-up|6|||
156708292|NCT03316547|565677037|FG001|Overall Study|Lost to Follow-up|6|||
156708293|NCT03316547|565677036|FG000|Overall Study|Withdrawal by Subject|3|||
156708294|NCT03316547|565677037|FG001|Overall Study|Withdrawal by Subject|2|||
156708295|NCT03316547|565677036|FG000|Overall Study|Transfer to another hospital|6|||
156708296|NCT03316547|565677037|FG001|Overall Study|Transfer to another hospital|4|||
156708297|NCT00278889|565677038|FG000|Overall Study|Withdrawal by Subject|0|||
156708298|NCT00278889|565677039|FG001|Overall Study|Withdrawal by Subject|5|||
156708299|NCT00278889|565677040|FG002|Overall Study|Withdrawal by Subject|3|||
156708300|NCT00278889|565677038|FG000|Overall Study|Lost to Follow-up|1|||
156708301|NCT00278889|565677039|FG001|Overall Study|Lost to Follow-up|1|||
156708302|NCT00278889|565677040|FG002|Overall Study|Lost to Follow-up|0|||
156708303|NCT00278889|565677038|FG000|Overall Study|Death|24|||
156708304|NCT00278889|565677039|FG001|Overall Study|Death|21|||
156708305|NCT00278889|565677040|FG002|Overall Study|Death|17|||
156708306|NCT03462459|565677041|FG000|Overall Study|Death|1|||
156708307|NCT03462459|565677042|FG001|Overall Study|Death|0|||
156708308|NCT03462459|565677041|FG000|Overall Study|Lack of Efficacy|2|||
156708309|NCT03462459|565677042|FG001|Overall Study|Lack of Efficacy|4|||
156708310|NCT03462459|565677041|FG000|Overall Study|Lost to Follow-up|1|||
156440968|NCT00978042|564707324|FG000|Initial Treatment Period|Ineligibility|1|||
156708311|NCT03462459|565677042|FG001|Overall Study|Lost to Follow-up|3|||
156708312|NCT03462459|565677041|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
156708313|NCT03462459|565677042|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
156708314|NCT03462459|565677041|FG000|Overall Study|Withdrawal by Subject|3|||
156708315|NCT03462459|565677042|FG001|Overall Study|Withdrawal by Subject|2|||
156708316|NCT03462459|565677041|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
156708317|NCT03462459|565677042|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
156708318|NCT01243775|565677043|FG000|Overall Study|Withdrawal by Subject|2|||
156708319|NCT01177059|565677044|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
156708320|NCT01177059|565677044|FG000|Overall Study|Withdrew consent|2|||
156708321|NCT01177059|565677044|FG000|Overall Study|Lost to Follow-up|18|||
156708322|NCT04051619|565677045|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
156708323|NCT04051619|565677046|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
156708324|NCT04051619|565677045|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
156708325|NCT04051619|565677046|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
156708326|NCT00974922|565678522|FG000|Overall Study|study terminated|24|||
156708327|NCT00287586|565678523|FG000|Overall Study|Withdrew Consent|19|||
156708328|NCT00287586|565678524|FG001|Overall Study|Withdrew Consent|30|||
156708329|NCT00287586|565678523|FG000|Overall Study|Lost to Follow-up|5|||
156708330|NCT00287586|565678524|FG001|Overall Study|Lost to Follow-up|4|||
156708331|NCT00287586|565678523|FG000|Overall Study|Death|2|||
156708332|NCT00287586|565678524|FG001|Overall Study|Death|3|||
156708333|NCT00287586|565678523|FG000|Overall Study|Elevated Hematocrit|3|||
156708334|NCT00287586|565678524|FG001|Overall Study|Elevated Hematocrit|0|||
156708335|NCT00287586|565678523|FG000|Overall Study|Rash|3|||
156708336|NCT00287586|565678524|FG001|Overall Study|Rash|0|||
156708337|NCT00287586|565678523|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
156708338|NCT00287586|565678524|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
156708339|NCT00287586|565678523|FG000|Overall Study|Stroke|2|||
156708340|NCT00287586|565678524|FG001|Overall Study|Stroke|0|||
156708341|NCT00287586|565678523|FG000|Overall Study|Myocardial Infarction|1|||
156708342|NCT00287586|565678524|FG001|Overall Study|Myocardial Infarction|0|||
156708343|NCT00287586|565678523|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
156708344|NCT00287586|565678524|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
156708345|NCT00287586|565678523|FG000|Overall Study|Cognitive Impairment|1|||
156708346|NCT00287586|565678524|FG001|Overall Study|Cognitive Impairment|0|||
156440969|NCT00978042|564707325|FG001|Initial Treatment Period|Ineligibility|0|||
156440970|NCT00978042|564707324|FG000|Initial Treatment Period|Lost to Follow-up|21|||
156440971|NCT00978042|564707325|FG001|Initial Treatment Period|Lost to Follow-up|3|||
156440972|NCT00978042|564707324|FG000|Initial Treatment Period|Adverse Event|2|||
156708347|NCT00287586|565678523|FG000|Overall Study|Pancreatic Cancer|1|||
156708348|NCT00287586|565678524|FG001|Overall Study|Pancreatic Cancer|3|||
156708349|NCT00287586|565678523|FG000|Overall Study|Sleep Apnea|1|||
156708350|NCT00287586|565678524|FG001|Overall Study|Sleep Apnea|0|||
156708351|NCT00287586|565678523|FG000|Overall Study|Shoulder Pain|1|||
156708352|NCT00287586|565678524|FG001|Overall Study|Shoulder Pain|0|||
156708353|NCT00287586|565678523|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
156708354|NCT00287586|565678524|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
156708355|NCT00287586|565678523|FG000|Overall Study|Nonadherence|1|||
156440973|NCT00978042|564707325|FG001|Initial Treatment Period|Adverse Event|0|||
156440974|NCT00978042|564707324|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
156708356|NCT00287586|565678524|FG001|Overall Study|Nonadherence|1|||
156708357|NCT00287586|565678523|FG000|Overall Study|Enrolled in Another Study|1|||
156708358|NCT00287586|565678524|FG001|Overall Study|Enrolled in Another Study|0|||
156708359|NCT00287586|565678523|FG000|Overall Study|Major Depression|0|||
156708360|NCT00287586|565678524|FG001|Overall Study|Major Depression|2|||
156708361|NCT00287586|565678523|FG000|Overall Study|Lung Cancer|0|||
156708362|NCT00287586|565678524|FG001|Overall Study|Lung Cancer|2|||
156708363|NCT00287586|565678523|FG000|Overall Study|Elevated IPSS Score|0|||
156708364|NCT00287586|565678524|FG001|Overall Study|Elevated IPSS Score|1|||
156872225|NCT03614156|566289537|FG003|Open-Label Treatment Period|Protocol Violation|0|||
156872226|NCT03614156|566289534|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
156872227|NCT03614156|566289535|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
156872228|NCT03614156|566289536|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
156872229|NCT03614156|566289537|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
156872230|NCT03614156|566289534|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
156872231|NCT03614156|566289535|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
156872232|NCT03614156|566289536|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
156872233|NCT03614156|566289537|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
156872234|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
156872235|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
156872236|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
156872237|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
156872238|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156872239|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
156440975|NCT00978042|564707325|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
156440976|NCT00978042|564707324|FG000|Initial Treatment Period|Consent withdrawn|22|||
156440977|NCT00978042|564707325|FG001|Initial Treatment Period|Consent withdrawn|9|||
156440978|NCT00978042|564707324|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
156440979|NCT00978042|564707325|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
156440980|NCT04788641|564707328|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
156440981|NCT04788641|564707329|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
156440982|NCT04788641|564707330|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
156440983|NCT04788641|564707331|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
156440984|NCT04788641|564707328|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
156440985|NCT04788641|564707329|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
156440986|NCT04788641|564707330|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
156440987|NCT04788641|564707331|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
156440988|NCT04788641|564707328|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
156440989|NCT04788641|564707329|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
156440990|NCT04788641|564707330|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
156440991|NCT04788641|564707331|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
156440992|NCT01985334|564707332|FG000|Overall Study|Administrative problems|1|||
156440993|NCT01985334|564707333|FG001|Overall Study|Administrative problems|1|||
156440994|NCT01985334|564707334|FG002|Overall Study|Administrative problems|0|||
156440995|NCT01985334|564707335|FG003|Overall Study|Administrative problems|2|||
156440996|NCT01985334|564707336|FG004|Overall Study|Administrative problems|0|||
156440997|NCT01985334|564707337|FG005|Overall Study|Administrative problems|1|||
156440998|NCT01985334|564707338|FG006|Overall Study|Administrative problems|1|||
156440999|NCT01985334|564707339|FG007|Overall Study|Administrative problems|3|||
156441000|NCT01985334|564707332|FG000|Overall Study|Death|1|||
156441001|NCT01985334|564707333|FG001|Overall Study|Death|0|||
156441002|NCT01985334|564707334|FG002|Overall Study|Death|0|||
156441003|NCT01985334|564707335|FG003|Overall Study|Death|3|||
156441004|NCT01985334|564707336|FG004|Overall Study|Death|0|||
156441005|NCT01985334|564707337|FG005|Overall Study|Death|0|||
156441006|NCT01985334|564707338|FG006|Overall Study|Death|1|||
156441007|NCT01985334|564707339|FG007|Overall Study|Death|2|||
156441008|NCT01985334|564707332|FG000|Overall Study|Worsening of disease|0|||
156441009|NCT01985334|564707333|FG001|Overall Study|Worsening of disease|0|||
156441010|NCT01985334|564707334|FG002|Overall Study|Worsening of disease|0|||
156441011|NCT01985334|564707335|FG003|Overall Study|Worsening of disease|1|||
156441012|NCT01985334|564707336|FG004|Overall Study|Worsening of disease|0|||
156441013|NCT01985334|564707337|FG005|Overall Study|Worsening of disease|3|||
156441014|NCT01985334|564707338|FG006|Overall Study|Worsening of disease|0|||
156441015|NCT01985334|564707339|FG007|Overall Study|Worsening of disease|1|||
156441016|NCT01985334|564707332|FG000|Overall Study|Other|2|||
156441017|NCT01985334|564707333|FG001|Overall Study|Other|9|||
156441018|NCT01985334|564707334|FG002|Overall Study|Other|7|||
156708365|NCT00287586|565678523|FG000|Overall Study|Retroperitoneal Cancer|0|||
156708366|NCT00287586|565678524|FG001|Overall Study|Retroperitoneal Cancer|1|||
156791407|NCT02837952|565988912|FG000|Overall Study|Medication Error|1|||
156791408|NCT02837952|565988913|FG001|Overall Study|Medication Error|0|||
156791409|NCT01517178|565988914|FG000|Period 1|Adverse Event|1|||
156791410|NCT01517178|565988915|FG001|Period 1|Adverse Event|2|||
156791411|NCT01517178|565988914|FG000|Period 1|Lack of Efficacy|0|||
156791412|NCT01517178|565988915|FG001|Period 1|Lack of Efficacy|1|||
156791413|NCT01517178|565988914|FG000|Period 1|E.g. study termination|3|||
156791414|NCT01517178|565988915|FG001|Period 1|E.g. study termination|1|||
156791415|NCT01517178|565988914|FG000|Period 1|Withdrawal by Subject|0|||
156791416|NCT01517178|565988915|FG001|Period 1|Withdrawal by Subject|1|||
156791417|NCT01517178|565988914|FG000|Period 2|Adverse Event|1|||
156791418|NCT01517178|565988915|FG001|Period 2|Adverse Event|0|||
156791419|NCT01517178|565988914|FG000|Period 2|Withdrawal by Subject|3|||
156791420|NCT01517178|565988915|FG001|Period 2|Withdrawal by Subject|0|||
156791421|NCT01517178|565988914|FG000|Period 2|E.g. study termination|2|||
156791422|NCT01517178|565988915|FG001|Period 2|E.g. study termination|2|||
156791423|NCT01959919|565988916|FG000|Overall Study|Did not meet the eligibility criteria|2|||
156791424|NCT03439072|565988919|FG000|Overall Study|Withdrawal by Subject|2|||
156791425|NCT03439072|565988920|FG001|Overall Study|Withdrawal by Subject|3|||
156791426|NCT03439072|565988919|FG000|Overall Study|Physician Decision|0|||
156791427|NCT03439072|565988920|FG001|Overall Study|Physician Decision|1|||
156791428|NCT01537432|565988923|FG000|Overall Study|Lost to Follow-up|3|||
156791429|NCT01537432|565988924|FG001|Overall Study|Lost to Follow-up|1|||
156791430|NCT01537432|565988923|FG000|Overall Study|Withdrawal by Subject|0|||
156791431|NCT01537432|565988924|FG001|Overall Study|Withdrawal by Subject|1|||
156791432|NCT01537432|565988923|FG000|Overall Study|Administrative problems|1|||
156791433|NCT01537432|565988924|FG001|Overall Study|Administrative problems|0|||
156791434|NCT01537432|565988923|FG000|Overall Study|Adverse Event|1|||
156791435|NCT01537432|565988924|FG001|Overall Study|Adverse Event|0|||
156791436|NCT01537432|565988923|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156791437|NCT01537432|565988924|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156791438|NCT00128492|565988927|FG000|Overall Study|AE unrelated to study|2|||
156791439|NCT00128492|565988928|FG001|Overall Study|AE unrelated to study|9|||
156791440|NCT00128492|565988927|FG000|Overall Study|Study drug intolerance (AE)|2|||
156791441|NCT00128492|565988928|FG001|Overall Study|Study drug intolerance (AE)|8|||
156791442|NCT00128492|565988927|FG000|Overall Study|AE related to study|1|||
156791443|NCT00128492|565988928|FG001|Overall Study|AE related to study|4|||
156791444|NCT00128492|565988927|FG000|Overall Study|Death|1|||
156791445|NCT00128492|565988928|FG001|Overall Study|Death|0|||
156791446|NCT00128492|565988927|FG000|Overall Study|Lost to Follow-up|1|||
156791447|NCT00128492|565988928|FG001|Overall Study|Lost to Follow-up|5|||
156791448|NCT00128492|565988927|FG000|Overall Study|Noncompliance|0|||
156791449|NCT00128492|565988928|FG001|Overall Study|Noncompliance|5|||
156872240|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156441019|NCT01985334|564707335|FG003|Overall Study|Other|17|||
156441020|NCT01985334|564707336|FG004|Overall Study|Other|4|||
156441021|NCT01985334|564707337|FG005|Overall Study|Other|8|||
156441022|NCT01985334|564707338|FG006|Overall Study|Other|4|||
156791450|NCT00128492|565988927|FG000|Overall Study|Personal or administrative|10|||
156791451|NCT00128492|565988928|FG001|Overall Study|Personal or administrative|22|||
156791452|NCT00128492|565988927|FG000|Overall Study|Withdrawal by Subject|3|||
156791453|NCT00128492|565988928|FG001|Overall Study|Withdrawal by Subject|5|||
156791454|NCT00128492|565988927|FG000|Overall Study|Pregnancy|0|||
156791455|NCT00128492|565988928|FG001|Overall Study|Pregnancy|1|||
156791456|NCT01550965|565988936|FG000|Overall Study|Adverse Event|26|||
156791457|NCT01550965|565988936|FG000|Overall Study|Withdrawal by Subject|10|||
156791458|NCT01550965|565988936|FG000|Overall Study|Lost to Follow-up|2|||
156791459|NCT01550965|565988936|FG000|Overall Study|Lack of Efficacy|59|||
156791460|NCT01550965|565988936|FG000|Overall Study|Other|13|||
156791461|NCT01347086|565988943|FG000|Overall Study|failed screening visit|0|||
156791462|NCT01347086|565988944|FG001|Overall Study|failed screening visit|0|||
156791463|NCT01347086|565988945|FG002|Overall Study|failed screening visit|1|||
156791464|NCT01347086|565988946|FG003|Overall Study|failed screening visit|0|||
156791465|NCT01347086|565988947|FG004|Overall Study|failed screening visit|0|||
156791466|NCT01347086|565988948|FG005|Overall Study|failed screening visit|0|||
156791467|NCT01347086|565988949|FG006|Overall Study|failed screening visit|1|||
156791468|NCT01347086|565988950|FG007|Overall Study|failed screening visit|1|||
156791469|NCT01347086|565988951|FG008|Overall Study|failed screening visit|0|||
156791470|NCT01347086|565988952|FG009|Overall Study|failed screening visit|1|||
156791471|NCT02624687|565988953|FG000|Overall Study|Withdrawal by Subject|1|||
156791472|NCT02624687|565988954|FG001|Overall Study|Withdrawal by Subject|1|||
156791473|NCT02624687|565988953|FG000|Overall Study|medical leave from work|0|||
156791474|NCT02624687|565988954|FG001|Overall Study|medical leave from work|1|||
156791475|NCT03111108|565988955|FG000|Overall Study|Death|0|||
156791476|NCT03111108|565988956|FG001|Overall Study|Death|1|||
156791477|NCT03111108|565988955|FG000|Overall Study|Withdrawal by Subject|1|||
156441023|NCT01985334|564707339|FG007|Overall Study|Other|7|||
156791478|NCT03111108|565988956|FG001|Overall Study|Withdrawal by Subject|0|||
156791479|NCT01514357|565988957|FG000|Overall Study|Screen failure|2|||
156791480|NCT01514357|565988958|FG001|Overall Study|Screen failure|0|||
156791481|NCT01514357|565988957|FG000|Overall Study|Withdrawal by Subject|2|||
156791482|NCT01514357|565988958|FG001|Overall Study|Withdrawal by Subject|0|||
156791483|NCT00867334|565988959|FG000|Overall Study|Withdrawal by Subject|0|||
156791484|NCT00867334|565988960|FG001|Overall Study|Withdrawal by Subject|1|||
156791485|NCT00867334|565988959|FG000|Overall Study|Withdrawal by Subject|1|||
156791486|NCT00867334|565988960|FG001|Overall Study|Withdrawal by Subject|0|||
156791487|NCT00867334|565988959|FG000|Overall Study|Withdrawal by Subject|1|||
156791488|NCT00867334|565988960|FG001|Overall Study|Withdrawal by Subject|0|||
156791489|NCT00347269|565988965|FG000|Overall Study|Lost to Follow-up|74|||
156791490|NCT00347269|565988966|FG001|Overall Study|Lost to Follow-up|65|||
156791491|NCT00347269|565988965|FG000|Overall Study|Withdrawal by Subject|18|||
156791492|NCT00347269|565988966|FG001|Overall Study|Withdrawal by Subject|38|||
156791493|NCT00347269|565988965|FG000|Overall Study|Death|2|||
156791494|NCT00347269|565988966|FG001|Overall Study|Death|3|||
156791495|NCT04893811|565988967|FG000|Vaccination Phase|Death|1|||
156791496|NCT04893811|565988968|FG001|Vaccination Phase|Death|0|||
156791497|NCT04893811|565988967|FG000|Vaccination Phase|Lost to Follow-up|1|||
156791498|NCT04893811|565988968|FG001|Vaccination Phase|Lost to Follow-up|1|||
156791499|NCT04893811|565988967|FG000|Vaccination Phase|Protocol Violation|2|||
156791500|NCT04893811|565988968|FG001|Vaccination Phase|Protocol Violation|0|||
156791501|NCT04893811|565988967|FG000|Vaccination Phase|Withdrawal by Subject|2|||
156791502|NCT04893811|565988968|FG001|Vaccination Phase|Withdrawal by Subject|1|||
156791503|NCT04893811|565988967|FG000|Vaccination Phase|Other|0|||
156791504|NCT04893811|565988968|FG001|Vaccination Phase|Other|1|||
156791505|NCT04893811|565988967|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
156791506|NCT04893811|565988968|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
156791507|NCT04893811|565988967|FG000|Follow-up Phase|Lost to Follow-up|0|||
156791508|NCT04893811|565988968|FG001|Follow-up Phase|Lost to Follow-up|1|||
156791509|NCT02739828|565988969|FG000|Overall Study|Adverse Event|1|||
156791510|NCT02739828|565988969|FG000|Overall Study|Lost to Follow-up|4|||
156791511|NCT04191733|565988977|FG000|Overall Study|Withdrawn due to study closure|13|||
156791512|NCT04191733|565988978|FG001|Overall Study|Withdrawn due to study closure|14|||
156791513|NCT04191733|565988977|FG000|Overall Study|Withdrawal by Subject|2|||
156791514|NCT04191733|565988978|FG001|Overall Study|Withdrawal by Subject|4|||
156791515|NCT04191733|565988977|FG000|Overall Study|Physician Decision|1|||
156791516|NCT04191733|565988978|FG001|Overall Study|Physician Decision|1|||
156791517|NCT04191733|565988977|FG000|Overall Study|Lost to Follow-up|5|||
156791518|NCT04191733|565988978|FG001|Overall Study|Lost to Follow-up|6|||
156791519|NCT04191733|565988977|FG000|Overall Study|Death|0|||
156791520|NCT04191733|565988978|FG001|Overall Study|Death|1|||
156791521|NCT02202577|565988979|FG000|Overall Study|Lost to Follow-up|6|||
156791522|NCT02202577|565988980|FG001|Overall Study|Lost to Follow-up|16|||
156791523|NCT02202577|565988979|FG000|Overall Study|Protocol Violation|7|||
156791524|NCT02202577|565988980|FG001|Overall Study|Protocol Violation|3|||
156791525|NCT03878602|565988981|FG000|Overall Study|cord blood donation|7|||
156791526|NCT03878602|565988982|FG001|Overall Study|cord blood donation|1|||
156791527|NCT03878602|565988981|FG000|Overall Study|incomplete data collection|2|||
156791528|NCT03878602|565988982|FG001|Overall Study|incomplete data collection|0|||
156791529|NCT06091956|565988983|FG000|Overall Study|Withdrawal by Subject|1|||
156791530|NCT06091956|565988983|FG000|Overall Study|Complicating Disease|1|||
156791531|NCT02176525|565988985|FG000|Overall Study|Adverse Event|0|||
156791532|NCT02176525|565988986|FG001|Overall Study|Adverse Event|0|||
156791533|NCT02176525|565988987|FG002|Overall Study|Adverse Event|0|||
156791534|NCT02176525|565988988|FG003|Overall Study|Adverse Event|1|||
156791535|NCT02176525|565988989|FG004|Overall Study|Adverse Event|1|||
156791536|NCT02176525|565988990|FG005|Overall Study|Adverse Event|0|||
156791537|NCT02176525|565988991|FG006|Overall Study|Adverse Event|1|||
156791538|NCT02176525|565988992|FG007|Overall Study|Adverse Event|0|||
156791539|NCT02176525|565988985|FG000|Overall Study|not treated|1|||
156791540|NCT02176525|565988986|FG001|Overall Study|not treated|0|||
156441024|NCT01985334|564707332|FG000|Overall Study|Protocol deviation|6|||
156441025|NCT01985334|564707333|FG001|Overall Study|Protocol deviation|31|||
156441026|NCT01985334|564707334|FG002|Overall Study|Protocol deviation|25|||
156441027|NCT01985334|564707335|FG003|Overall Study|Protocol deviation|84|||
156441028|NCT01985334|564707336|FG004|Overall Study|Protocol deviation|17|||
156441029|NCT01985334|564707337|FG005|Overall Study|Protocol deviation|47|||
156441030|NCT01985334|564707338|FG006|Overall Study|Protocol deviation|15|||
156441031|NCT01985334|564707339|FG007|Overall Study|Protocol deviation|42|||
156441032|NCT01985334|564707332|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
156441033|NCT01985334|564707333|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
156441034|NCT01985334|564707334|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
156441035|NCT01985334|564707335|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
156441036|NCT01985334|564707336|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
156441037|NCT01985334|564707337|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
156791541|NCT02176525|565988987|FG002|Overall Study|not treated|0|||
156791542|NCT02176525|565988988|FG003|Overall Study|not treated|0|||
156791543|NCT02176525|565988989|FG004|Overall Study|not treated|0|||
156791544|NCT02176525|565988990|FG005|Overall Study|not treated|1|||
156332412|NCT01950390|564315113|FG000|Overall Study|Never started treatment|3|||
156332413|NCT01950390|564315114|FG001|Overall Study|Never started treatment|2|||
156332414|NCT01950390|564315113|FG000|Overall Study|Disease progression|45|||
156332415|NCT01950390|564315114|FG001|Overall Study|Disease progression|52|||
156332416|NCT01950390|564315113|FG000|Overall Study|Adverse Event|22|||
156332417|NCT01950390|564315114|FG001|Overall Study|Adverse Event|16|||
156332418|NCT01950390|564315113|FG000|Overall Study|Death|5|||
156332419|NCT01950390|564315114|FG001|Overall Study|Death|3|||
156332420|NCT01950390|564315113|FG000|Overall Study|Withdrawal by Subject|5|||
156332421|NCT01950390|564315114|FG001|Overall Study|Withdrawal by Subject|1|||
156332422|NCT01950390|564315113|FG000|Overall Study|Alternative therapy|0|||
156332423|NCT01950390|564315114|FG001|Overall Study|Alternative therapy|3|||
156332424|NCT01950390|564315113|FG000|Overall Study|Complicating disease|1|||
156332425|NCT01950390|564315114|FG001|Overall Study|Complicating disease|0|||
156332426|NCT01950390|564315113|FG000|Overall Study|On treatment|1|||
156332427|NCT01950390|564315114|FG001|Overall Study|On treatment|0|||
156332428|NCT01950390|564315113|FG000|Overall Study|Symptomatic deterioration|2|||
156332429|NCT01950390|564315114|FG001|Overall Study|Symptomatic deterioration|1|||
156332430|NCT01950390|564315113|FG000|Overall Study|Physician Decision|0|||
156332431|NCT01950390|564315114|FG001|Overall Study|Physician Decision|4|||
156332432|NCT01950390|564315113|FG000|Overall Study|Lack of clinical benefit|0|||
156332433|NCT01950390|564315114|FG001|Overall Study|Lack of clinical benefit|1|||
156332434|NCT01950390|564315113|FG000|Overall Study|Maintained PR and moved to observation only|0|||
156332435|NCT01950390|564315114|FG001|Overall Study|Maintained PR and moved to observation only|1|||
156332436|NCT00531934|564317330|FG000|Overall Study|Adverse Event|4|||
156332437|NCT00531934|564317331|FG001|Overall Study|Adverse Event|8|||
156332438|NCT00531934|564317330|FG000|Overall Study|Progression|52|||
156332439|NCT00531934|564317331|FG001|Overall Study|Progression|42|||
156332440|NCT00531934|564317330|FG000|Overall Study|Death|7|||
156332441|NCT00531934|564317331|FG001|Overall Study|Death|10|||
156332442|NCT00531934|564317330|FG000|Overall Study|Withdrawal by Subject|1|||
156332443|NCT00531934|564317331|FG001|Overall Study|Withdrawal by Subject|1|||
156332444|NCT00531934|564317330|FG000|Overall Study|Other|2|||
156332445|NCT00531934|564317331|FG001|Overall Study|Other|2|||
156332446|NCT00150709|564317332|FG000|Overall Study|Protocol Violation|7|||
156332447|NCT00150709|564317333|FG001|Overall Study|Protocol Violation|8|||
156332448|NCT00150709|564317334|FG002|Overall Study|Protocol Violation|3|||
156332449|NCT00150709|564317335|FG003|Overall Study|Protocol Violation|1|||
156332450|NCT00150709|564317332|FG000|Overall Study|Adverse Event|8|||
156332451|NCT00150709|564317333|FG001|Overall Study|Adverse Event|2|||
156332452|NCT00150709|564317334|FG002|Overall Study|Adverse Event|2|||
156332453|NCT00150709|564317335|FG003|Overall Study|Adverse Event|3|||
156441038|NCT01985334|564707338|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
156441039|NCT01985334|564707339|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
156708367|NCT00287586|565678523|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
156708368|NCT00287586|565678524|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
156708369|NCT00287586|565678523|FG000|Overall Study|Mood Swings and Irritability|0|||
156708370|NCT00287586|565678524|FG001|Overall Study|Mood Swings and Irritability|1|||
156708371|NCT00287586|565678523|FG000|Overall Study|Bradycardia|0|||
156708372|NCT00287586|565678524|FG001|Overall Study|Bradycardia|1|||
156708373|NCT00287586|565678523|FG000|Overall Study|Itchy Swollen Eyes|0|||
156708374|NCT00287586|565678524|FG001|Overall Study|Itchy Swollen Eyes|1|||
156708375|NCT00287586|565678523|FG000|Overall Study|Recurrent Melanoma|0|||
156708376|NCT00287586|565678524|FG001|Overall Study|Recurrent Melanoma|1|||
156441040|NCT01985334|564707332|FG000|Overall Study|Subject withdrawal of consent|3|||
156441041|NCT01985334|564707333|FG001|Overall Study|Subject withdrawal of consent|6|||
156441042|NCT01985334|564707334|FG002|Overall Study|Subject withdrawal of consent|2|||
156441043|NCT01985334|564707335|FG003|Overall Study|Subject withdrawal of consent|28|||
156441044|NCT01985334|564707336|FG004|Overall Study|Subject withdrawal of consent|4|||
156441045|NCT01985334|564707337|FG005|Overall Study|Subject withdrawal of consent|19|||
156441046|NCT01985334|564707338|FG006|Overall Study|Subject withdrawal of consent|0|||
156441047|NCT01985334|564707339|FG007|Overall Study|Subject withdrawal of consent|20|||
156441048|NCT01985334|564707332|FG000|Overall Study|Adverse Event|0|||
156791545|NCT02176525|565988991|FG006|Overall Study|not treated|0|||
156791546|NCT02176525|565988992|FG007|Overall Study|not treated|0|||
156332454|NCT00150709|564317332|FG000|Overall Study|Lack of Efficacy|6|||
156332455|NCT00150709|564317333|FG001|Overall Study|Lack of Efficacy|11|||
156332456|NCT00150709|564317334|FG002|Overall Study|Lack of Efficacy|9|||
156332457|NCT00150709|564317335|FG003|Overall Study|Lack of Efficacy|0|||
156332458|NCT00150709|564317332|FG000|Overall Study|Withdrawal by Subject|7|||
156332459|NCT00150709|564317333|FG001|Overall Study|Withdrawal by Subject|10|||
156332460|NCT00150709|564317334|FG002|Overall Study|Withdrawal by Subject|5|||
156332461|NCT00150709|564317335|FG003|Overall Study|Withdrawal by Subject|0|||
156332462|NCT00150709|564317332|FG000|Overall Study|Lost to Follow-up|3|||
156332463|NCT00150709|564317333|FG001|Overall Study|Lost to Follow-up|2|||
156708377|NCT01762800|565678526|FG000|Overall Study|Adverse Event|8|||
156332464|NCT00150709|564317334|FG002|Overall Study|Lost to Follow-up|0|||
156332465|NCT00150709|564317335|FG003|Overall Study|Lost to Follow-up|0|||
156441049|NCT01985334|564707333|FG001|Overall Study|Adverse Event|8|||
156441050|NCT01985334|564707334|FG002|Overall Study|Adverse Event|2|||
156441051|NCT01985334|564707335|FG003|Overall Study|Adverse Event|26|||
156441052|NCT01985334|564707336|FG004|Overall Study|Adverse Event|3|||
156708378|NCT01762800|565678527|FG001|Overall Study|Adverse Event|13|||
156708379|NCT01762800|565678526|FG000|Overall Study|Lack of Efficacy|3|||
156708380|NCT01762800|565678527|FG001|Overall Study|Lack of Efficacy|2|||
156708381|NCT01762800|565678526|FG000|Overall Study|Study Closed/Terminated|0|||
156708382|NCT01762800|565678527|FG001|Overall Study|Study Closed/Terminated|1|||
156708383|NCT01762800|565678526|FG000|Overall Study|Physician Decision|1|||
156708384|NCT01762800|565678527|FG001|Overall Study|Physician Decision|1|||
156708385|NCT01762800|565678526|FG000|Overall Study|Withdrawal by Subject|7|||
156708386|NCT01762800|565678527|FG001|Overall Study|Withdrawal by Subject|4|||
156708387|NCT02640482|565678528|FG000|Overall Study|Lost to Follow-up|3|||
156708388|NCT02640482|565678529|FG001|Overall Study|Lost to Follow-up|0|||
156708389|NCT00517881|565678530|FG000|Overall Study|Protocol Violation|2|||
156708390|NCT00517881|565678530|FG000|Overall Study|Adverse Event|1|||
156708391|NCT00517881|565678530|FG000|Overall Study|Renal transplantation|2|||
156708392|NCT00113763|565678531|FG000|Overall Study|Adverse Event|5|||
156708393|NCT00113763|565678532|FG001|Overall Study|Adverse Event|2|||
156708394|NCT00113763|565678531|FG000|Overall Study|Disease Progression|28|||
156708395|NCT00113763|565678532|FG001|Overall Study|Disease Progression|14|||
156708396|NCT00113763|565678531|FG000|Overall Study|Lost to Follow-up|10|||
156708397|NCT00113763|565678532|FG001|Overall Study|Lost to Follow-up|0|||
156708398|NCT00113763|565678531|FG000|Overall Study|Withdrawal by Subject|1|||
156708399|NCT00113763|565678532|FG001|Overall Study|Withdrawal by Subject|4|||
156708400|NCT00113763|565678531|FG000|Overall Study|Other|27|||
156708401|NCT00113763|565678532|FG001|Overall Study|Other|6|||
156708402|NCT00113763|565678531|FG000|Overall Study|Non-compliance|1|||
156708403|NCT00113763|565678532|FG001|Overall Study|Non-compliance|0|||
156708404|NCT00113763|565678531|FG000|Overall Study|Ongoing|1|||
156708405|NCT00113763|565678532|FG001|Overall Study|Ongoing|0|||
156708406|NCT03743415|565678533|FG000|Overall Study|Death|5|||
156708407|NCT03743415|565678534|FG001|Overall Study|Death|3|||
156708408|NCT03743415|565678535|FG002|Overall Study|Death|1|||
156708409|NCT03743415|565678536|FG003|Overall Study|Death|4|||
156708410|NCT03743415|565678537|FG004|Overall Study|Death|0|||
156708411|NCT03743415|565678538|FG005|Overall Study|Death|0|||
156708412|NCT03743415|565678539|FG006|Overall Study|Death|0|||
156708413|NCT03743415|565678540|FG007|Overall Study|Death|0|||
156708414|NCT03743415|565678541|FG008|Overall Study|Death|1|||
156708415|NCT03743415|565678542|FG009|Overall Study|Death|0|||
156708416|NCT03743415|565678533|FG000|Overall Study|Withdrawal by Subject|1|||
156708417|NCT03743415|565678534|FG001|Overall Study|Withdrawal by Subject|0|||
156708418|NCT03743415|565678535|FG002|Overall Study|Withdrawal by Subject|4|||
156708419|NCT03743415|565678536|FG003|Overall Study|Withdrawal by Subject|5|||
156708420|NCT03743415|565678537|FG004|Overall Study|Withdrawal by Subject|5|||
156708421|NCT03743415|565678538|FG005|Overall Study|Withdrawal by Subject|2|||
156708422|NCT03743415|565678539|FG006|Overall Study|Withdrawal by Subject|2|||
156708423|NCT03743415|565678540|FG007|Overall Study|Withdrawal by Subject|5|||
156708424|NCT03743415|565678541|FG008|Overall Study|Withdrawal by Subject|9|||
156708425|NCT03743415|565678542|FG009|Overall Study|Withdrawal by Subject|10|||
156708426|NCT03743415|565678533|FG000|Overall Study|Lost to Follow-up|2|||
156708427|NCT03743415|565678534|FG001|Overall Study|Lost to Follow-up|0|||
156708428|NCT03743415|565678535|FG002|Overall Study|Lost to Follow-up|2|||
156708429|NCT03743415|565678536|FG003|Overall Study|Lost to Follow-up|1|||
156708430|NCT03743415|565678537|FG004|Overall Study|Lost to Follow-up|1|||
156708431|NCT03743415|565678538|FG005|Overall Study|Lost to Follow-up|0|||
156708432|NCT03743415|565678539|FG006|Overall Study|Lost to Follow-up|1|||
156708433|NCT03743415|565678540|FG007|Overall Study|Lost to Follow-up|4|||
156708434|NCT03743415|565678541|FG008|Overall Study|Lost to Follow-up|13|||
156708435|NCT03743415|565678542|FG009|Overall Study|Lost to Follow-up|13|||
156441053|NCT01985334|564707337|FG005|Overall Study|Adverse Event|18|||
156708436|NCT02847260|565678543|FG000|Overall Study|Adverse Event|3|||
156708437|NCT02847260|565678543|FG000|Overall Study|Withdrawal by Subject|2|||
156708438|NCT02847260|565678543|FG000|Overall Study|Clinical Deterioration|1|||
156708439|NCT02847260|565678543|FG000|Overall Study|Physician Decision|1|||
156441054|NCT01985334|564707338|FG006|Overall Study|Adverse Event|3|||
156708440|NCT00264550|565678544|FG000|Overall Study|Death|0|||
156708441|NCT00264550|565678545|FG001|Overall Study|Death|3|||
156708442|NCT00264550|565678546|FG002|Overall Study|Death|0|||
156708443|NCT00264550|565678547|FG003|Overall Study|Death|0|||
156441055|NCT01985334|564707339|FG007|Overall Study|Adverse Event|15|||
156441056|NCT01985334|564707332|FG000|Overall Study|Other|4|||
156708444|NCT00264550|565678544|FG000|Overall Study|Lost to Follow-up|3|||
156708445|NCT00264550|565678545|FG001|Overall Study|Lost to Follow-up|1|||
156708446|NCT00264550|565678546|FG002|Overall Study|Lost to Follow-up|1|||
156708447|NCT00264550|565678547|FG003|Overall Study|Lost to Follow-up|1|||
156708448|NCT00264550|565678544|FG000|Overall Study|Adverse Event|23|||
156708449|NCT00264550|565678545|FG001|Overall Study|Adverse Event|18|||
156708450|NCT00264550|565678546|FG002|Overall Study|Adverse Event|9|||
156708451|NCT00264550|565678547|FG003|Overall Study|Adverse Event|14|||
156708452|NCT00264550|565678544|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156708453|NCT00264550|565678545|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
156708454|NCT00264550|565678546|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
156708455|NCT00264550|565678547|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
156708456|NCT00264550|565678544|FG000|Overall Study|Discontinued oral study agent|0|||
156708457|NCT00264550|565678545|FG001|Overall Study|Discontinued oral study agent|1|||
156708458|NCT00264550|565678546|FG002|Overall Study|Discontinued oral study agent|0|||
156708459|NCT00264550|565678547|FG003|Overall Study|Discontinued oral study agent|0|||
156708460|NCT00264550|565678544|FG000|Overall Study|Other|13|||
156708461|NCT00264550|565678545|FG001|Overall Study|Other|7|||
156708462|NCT00264550|565678546|FG002|Overall Study|Other|3|||
156708463|NCT00264550|565678547|FG003|Overall Study|Other|9|||
156708464|NCT02129608|565678548|FG000|Overall Study|Lost to Follow-up|0|||
156708465|NCT02129608|565678549|FG001|Overall Study|Lost to Follow-up|1|||
156708466|NCT02129608|565678550|FG002|Overall Study|Lost to Follow-up|1|||
156708467|NCT02129608|565678548|FG000|Overall Study|Withdrawal by Subject|0|||
156708468|NCT02129608|565678549|FG001|Overall Study|Withdrawal by Subject|0|||
156708469|NCT02129608|565678550|FG002|Overall Study|Withdrawal by Subject|2|||
156708470|NCT00129389|565678551|FG000|Overall Study|Adverse Event|19|||
156708471|NCT00129389|565678552|FG001|Overall Study|Adverse Event|87|||
156708472|NCT00129389|565678551|FG000|Overall Study|Death|0|||
156708473|NCT00129389|565678552|FG001|Overall Study|Death|1|||
156708474|NCT00129389|565678551|FG000|Overall Study|Lost to Follow-up|2|||
156708475|NCT00129389|565678552|FG001|Overall Study|Lost to Follow-up|1|||
156708476|NCT00129389|565678551|FG000|Overall Study|Physician Decision|0|||
156708477|NCT00129389|565678552|FG001|Overall Study|Physician Decision|4|||
156791547|NCT02100644|565988993|FG000|LTG Escalation Phase|Adverse Event|9|||
156791548|NCT02100644|565988994|FG001|LTG Escalation Phase|Adverse Event|0|||
156791549|NCT02100644|565988995|FG002|LTG Escalation Phase|Adverse Event|0|||
156791550|NCT02100644|565988993|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
156791551|NCT02100644|565988994|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
156791552|NCT02100644|565988995|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
156791553|NCT02100644|565988993|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
156791554|NCT02100644|565988994|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
156791555|NCT02100644|565988995|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
156791556|NCT00478140|565988996|FG000|Overall Study|Clinical Disease Progression|1|||
156791557|NCT00728182|565988997|FG000|Overall Study|Adverse Event|1|||
156791558|NCT00728182|565988998|FG001|Overall Study|Adverse Event|0|||
156791559|NCT00728182|565988997|FG000|Overall Study|Lost to Follow-up|2|||
156791560|NCT00728182|565988998|FG001|Overall Study|Lost to Follow-up|0|||
156791561|NCT00728182|565988997|FG000|Overall Study|Death|0|||
156791562|NCT00728182|565988998|FG001|Overall Study|Death|2|||
156791563|NCT00728182|565988997|FG000|Overall Study|Protocol Noncompliance|0|||
156791564|NCT00728182|565988998|FG001|Overall Study|Protocol Noncompliance|1|||
156791565|NCT02369159|565989002|FG000|Overall Study|Adverse Event|0|||
156791566|NCT02369159|565989003|FG001|Overall Study|Adverse Event|1|||
156791567|NCT02369159|565989002|FG000|Overall Study|Lost to Follow-up|1|||
156791568|NCT02369159|565989003|FG001|Overall Study|Lost to Follow-up|1|||
156791569|NCT02369159|565989002|FG000|Overall Study|Withdrawal by Subject|7|||
156791570|NCT02369159|565989003|FG001|Overall Study|Withdrawal by Subject|0|||
156791571|NCT00425854|565989013|FG000|Overall Study|Progressive Disease|19|||
156791572|NCT00425854|565989014|FG001|Overall Study|Progressive Disease|12|||
156791573|NCT00425854|565989013|FG000|Overall Study|Dose reduction toxicity AE|8|||
156791574|NCT00425854|565989014|FG001|Overall Study|Dose reduction toxicity AE|7|||
156791575|NCT00425854|565989013|FG000|Overall Study|Other Adverse Event|2|||
156791576|NCT00425854|565989014|FG001|Overall Study|Other Adverse Event|2|||
156791577|NCT01514422|565989015|FG000|Overall Study|Lost to Follow-up|1|||
156791578|NCT00176254|565989016|FG000|Overall Study|Lost to Follow-up|1|||
156791579|NCT03289741|565989017|FG000|Overall Study|Adverse Event|1|||
156791580|NCT03289741|565989018|FG001|Overall Study|Adverse Event|1|||
156791581|NCT03289741|565989017|FG000|Overall Study|Physician Decision|2|||
156791582|NCT03289741|565989018|FG001|Overall Study|Physician Decision|2|||
156791583|NCT03289741|565989017|FG000|Overall Study|Withdrawal by Subject|1|||
156791584|NCT03289741|565989018|FG001|Overall Study|Withdrawal by Subject|0|||
156791585|NCT00561821|565989021|FG000|Overall Study|Not treated|0|||
156791586|NCT00561821|565989022|FG001|Overall Study|Not treated|0|||
156791587|NCT00561821|565989023|FG002|Overall Study|Not treated|1|||
156791588|NCT00561821|565989024|FG003|Overall Study|Not treated|0|||
156791589|NCT00561821|565989021|FG000|Overall Study|Withdrawal by Subject|0|||
156332466|NCT00150709|564317332|FG000|Overall Study|Sponsor decision|0|||
156332467|NCT00150709|564317333|FG001|Overall Study|Sponsor decision|0|||
156708478|NCT00129389|565678551|FG000|Overall Study|Protocol Violation|0|||
156708479|NCT00129389|565678552|FG001|Overall Study|Protocol Violation|6|||
156708480|NCT00129389|565678551|FG000|Overall Study|Withdrawal by Subject|9|||
156708481|NCT00129389|565678552|FG001|Overall Study|Withdrawal by Subject|23|||
156708482|NCT00129389|565678551|FG000|Overall Study|Relapse|1|||
156708483|NCT00129389|565678552|FG001|Overall Study|Relapse|0|||
156708484|NCT00129389|565678551|FG000|Overall Study|Not eligible|1|||
156708485|NCT00129389|565678552|FG001|Overall Study|Not eligible|2|||
156708486|NCT00129389|565678551|FG000|Overall Study|Crossed to the other arm|1|||
156708487|NCT00129389|565678552|FG001|Overall Study|Crossed to the other arm|16|||
156708488|NCT01174043|565678554|FG000|Overall Study|Disease progression|5|||
156708489|NCT01174043|565678554|FG000|Overall Study|Adverse Event|3|||
156708490|NCT01174043|565678554|FG000|Overall Study|Death|1|||
156708491|NCT01174043|565678554|FG000|Overall Study|Withdrawal by Subject|2|||
156708492|NCT00789035|565678562|FG000|Overall Study|Adverse Event|0|||
156708493|NCT00789035|565678563|FG001|Overall Study|Adverse Event|2|||
156708494|NCT00789035|565678564|FG002|Overall Study|Adverse Event|0|||
156708495|NCT00789035|565678565|FG003|Overall Study|Adverse Event|1|||
156708496|NCT00789035|565678566|FG004|Overall Study|Adverse Event|3|||
156708497|NCT00789035|565678562|FG000|Overall Study|Lack of Efficacy|3|||
156708498|NCT00789035|565678563|FG001|Overall Study|Lack of Efficacy|0|||
156708499|NCT00789035|565678564|FG002|Overall Study|Lack of Efficacy|0|||
156708500|NCT00789035|565678565|FG003|Overall Study|Lack of Efficacy|0|||
156708501|NCT00789035|565678566|FG004|Overall Study|Lack of Efficacy|2|||
156708502|NCT00789035|565678562|FG000|Overall Study|Protocol Violation|1|||
156708503|NCT00789035|565678563|FG001|Overall Study|Protocol Violation|0|||
156708504|NCT00789035|565678564|FG002|Overall Study|Protocol Violation|0|||
156708505|NCT00789035|565678565|FG003|Overall Study|Protocol Violation|0|||
156708506|NCT00789035|565678566|FG004|Overall Study|Protocol Violation|0|||
156708507|NCT00789035|565678562|FG000|Overall Study|Withdrawal by Subject|0|||
156708508|NCT00789035|565678563|FG001|Overall Study|Withdrawal by Subject|2|||
156708509|NCT00789035|565678564|FG002|Overall Study|Withdrawal by Subject|0|||
156708510|NCT00789035|565678565|FG003|Overall Study|Withdrawal by Subject|0|||
156708511|NCT00789035|565678566|FG004|Overall Study|Withdrawal by Subject|0|||
156708512|NCT00789035|565678562|FG000|Overall Study|Other reason not defined above|2|||
156708513|NCT00789035|565678563|FG001|Overall Study|Other reason not defined above|3|||
156708514|NCT00789035|565678564|FG002|Overall Study|Other reason not defined above|1|||
156708515|NCT00789035|565678565|FG003|Overall Study|Other reason not defined above|0|||
156708516|NCT00789035|565678566|FG004|Overall Study|Other reason not defined above|1|||
156708517|NCT01520870|565678567|FG000|Overall Study|Withdrawal by Subject|2|||
156708518|NCT02289456|565678568|FG000|Induction Period|Death|2|||
156708519|NCT02289456|565678568|FG000|Induction Period|Adverse Event|11|||
156708520|NCT02289456|565678568|FG000|Induction Period|Progressive Disease (PD)|4|||
156708521|NCT02289456|565678568|FG000|Induction Period|Symptomatic Deterioration|4|||
156872241|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156872242|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156872243|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156872244|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
156872245|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
156872246|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
156872247|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
156872248|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
156872249|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
156872250|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
156872251|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
156872252|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
156872253|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
156872254|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
156872255|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
156872256|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
156872257|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
156872258|NCT03614156|566289534|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
156872259|NCT03614156|566289535|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
156872260|NCT03614156|566289536|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
156872261|NCT03614156|566289537|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
156872262|NCT03614156|566289534|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
156872263|NCT03614156|566289535|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
156872264|NCT03614156|566289536|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
156872265|NCT03614156|566289537|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
156872266|NCT03614156|566289534|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
156332468|NCT00150709|564317334|FG002|Overall Study|Sponsor decision|0|||
156332469|NCT00150709|564317335|FG003|Overall Study|Sponsor decision|1|||
156708522|NCT02289456|565678568|FG000|Induction Period|Withdrawal by Subject|2|||
156708523|NCT02289456|565678568|FG000|Induction Period|Miscellaneous|1|||
156708524|NCT02289456|565678568|FG000|Monotherapy Period|Death|1|||
156708525|NCT02289456|565678568|FG000|Monotherapy Period|Adverse Event|1|||
156708526|NCT02289456|565678568|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
156708527|NCT02289456|565678568|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
156708528|NCT02289456|565678568|FG000|Monotherapy Period|Withdrawal by Subject|2|||
156791590|NCT00561821|565989022|FG001|Overall Study|Withdrawal by Subject|1|||
156791591|NCT00561821|565989023|FG002|Overall Study|Withdrawal by Subject|0|||
156791592|NCT00561821|565989024|FG003|Overall Study|Withdrawal by Subject|2|||
156791593|NCT00561821|565989021|FG000|Overall Study|Reasons not related to trial|2|||
156791594|NCT00561821|565989022|FG001|Overall Study|Reasons not related to trial|1|||
156791595|NCT00561821|565989023|FG002|Overall Study|Reasons not related to trial|0|||
156791596|NCT00561821|565989024|FG003|Overall Study|Reasons not related to trial|0|||
156791597|NCT00561821|565989021|FG000|Overall Study|Other (reason not specified)|1|||
156791598|NCT00561821|565989022|FG001|Overall Study|Other (reason not specified)|1|||
156791599|NCT00561821|565989023|FG002|Overall Study|Other (reason not specified)|0|||
156791600|NCT00561821|565989024|FG003|Overall Study|Other (reason not specified)|0|||
156791601|NCT00561821|565989021|FG000|Overall Study|Adverse Event|2|||
156791602|NCT00561821|565989022|FG001|Overall Study|Adverse Event|3|||
156791603|NCT00561821|565989023|FG002|Overall Study|Adverse Event|1|||
156791604|NCT00561821|565989024|FG003|Overall Study|Adverse Event|1|||
156791605|NCT04744831|565990922|FG000|Overall Study|Progressive Disease|31|||
156791606|NCT04744831|565990923|FG001|Overall Study|Progressive Disease|27|||
156791607|NCT04744831|565990924|FG002|Overall Study|Progressive Disease|25|||
156791608|NCT04744831|565990922|FG000|Overall Study|Adverse Event|3|||
156791609|NCT04744831|565990923|FG001|Overall Study|Adverse Event|3|||
156791610|NCT04744831|565990924|FG002|Overall Study|Adverse Event|3|||
156791611|NCT04744831|565990922|FG000|Overall Study|Clinical Progression|3|||
156791612|NCT04744831|565990923|FG001|Overall Study|Clinical Progression|2|||
156791613|NCT04744831|565990924|FG002|Overall Study|Clinical Progression|5|||
156872267|NCT03614156|566289535|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
156872268|NCT03614156|566289536|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
156872269|NCT03614156|566289537|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
156872270|NCT03857867|566289538|FG000|Overall Study|Physician Decision|1|||
156872271|NCT03070964|566289539|FG000|Overall Study|Progressive disease|8|||
156872272|NCT03070964|566289539|FG000|Overall Study|Treatment-unrelated adverse event|2|||
156872273|NCT03070964|566289539|FG000|Overall Study|Never treated|1|||
156872274|NCT03070964|566289539|FG000|Overall Study|Physician Decision|1|||
156872275|NCT03070964|566289539|FG000|Overall Study|Withdrawal by Subject|1|||
156872276|NCT03070964|566289539|FG000|Overall Study|Adverse Event|1|||
156872277|NCT01094119|566289540|FG000|Overall Study|Lack of Efficacy|2|||
156872278|NCT01094119|566289541|FG001|Overall Study|Lack of Efficacy|4|||
156872279|NCT01626872|566289542|FG000|Overall Study|Physician Decision|13|||
156872280|NCT01626872|566289543|FG001|Overall Study|Physician Decision|9|||
156872281|NCT01626872|566289544|FG002|Overall Study|Physician Decision|6|||
156872282|NCT01626872|566289542|FG000|Overall Study|Withdrawal by Subject|19|||
156872283|NCT01626872|566289543|FG001|Overall Study|Withdrawal by Subject|27|||
156872284|NCT01626872|566289544|FG002|Overall Study|Withdrawal by Subject|8|||
156872285|NCT01626872|566289542|FG000|Overall Study|Adverse Event (including Death)|20|||
156872286|NCT01626872|566289543|FG001|Overall Study|Adverse Event (including Death)|28|||
156872287|NCT01626872|566289544|FG002|Overall Study|Adverse Event (including Death)|8|||
156872288|NCT01626872|566289542|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
156872289|NCT01626872|566289543|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
156872290|NCT01626872|566289544|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
156872291|NCT01587924|566289545|FG000|Overall Study|Adverse Event|0|||
156872292|NCT01587924|566289546|FG001|Overall Study|Adverse Event|2|||
156872293|NCT01587924|566289547|FG002|Overall Study|Adverse Event|0|||
156872294|NCT01587924|566289548|FG003|Overall Study|Adverse Event|0|||
156872295|NCT01587924|566289545|FG000|Overall Study|Protocol Violation|2|||
156872296|NCT01587924|566289546|FG001|Overall Study|Protocol Violation|1|||
156872297|NCT01587924|566289547|FG002|Overall Study|Protocol Violation|2|||
156872298|NCT01587924|566289548|FG003|Overall Study|Protocol Violation|1|||
156872299|NCT01587924|566289545|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
156872300|NCT01587924|566289546|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
156872301|NCT01587924|566289547|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
156872302|NCT01587924|566289548|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
156441057|NCT01985334|564707333|FG001|Overall Study|Other|2|||
156441058|NCT01985334|564707334|FG002|Overall Study|Other|3|||
156791614|NCT04744831|565990922|FG000|Overall Study|Other|0|||
156872303|NCT01587924|566289545|FG000|Overall Study|Withdrawal by Subject|0|||
156872304|NCT01587924|566289546|FG001|Overall Study|Withdrawal by Subject|1|||
156872305|NCT01587924|566289547|FG002|Overall Study|Withdrawal by Subject|1|||
156872306|NCT01587924|566289548|FG003|Overall Study|Withdrawal by Subject|0|||
156872307|NCT01578486|566289549|FG000|Overall Study|Physician Decision|3|||
156872308|NCT01578486|566289549|FG000|Overall Study|Withdrawal by Subject|2|||
156441059|NCT01985334|564707335|FG003|Overall Study|Other|10|||
156791615|NCT04744831|565990923|FG001|Overall Study|Other|2|||
156791616|NCT04744831|565990924|FG002|Overall Study|Other|1|||
156791617|NCT04744831|565990922|FG000|Overall Study|Death|0|||
156791618|NCT04744831|565990923|FG001|Overall Study|Death|2|||
156791619|NCT04744831|565990924|FG002|Overall Study|Death|1|||
156791620|NCT05401409|565990927|FG000|Overall Study|Lost to Follow-up|1|||
156872309|NCT02425943|566289550|FG000|Overall Study|Adverse Event|3|||
156872310|NCT02425943|566289551|FG001|Overall Study|Adverse Event|1|||
156872311|NCT02425943|566289550|FG000|Overall Study|Lost to Follow-up|59|||
156872312|NCT02425943|566289551|FG001|Overall Study|Lost to Follow-up|37|||
156872313|NCT02425943|566289550|FG000|Overall Study|Protocol Violation|4|||
156872314|NCT02425943|566289551|FG001|Overall Study|Protocol Violation|1|||
156332470|NCT00150709|564317332|FG000|Overall Study|Site/Investigator discontinued the study|5|||
156332471|NCT00150709|564317333|FG001|Overall Study|Site/Investigator discontinued the study|5|||
156332472|NCT00150709|564317334|FG002|Overall Study|Site/Investigator discontinued the study|2|||
156332473|NCT00150709|564317335|FG003|Overall Study|Site/Investigator discontinued the study|0|||
156332474|NCT00150709|564317332|FG000|Overall Study|Decision of parent(s)|1|||
156332475|NCT00150709|564317333|FG001|Overall Study|Decision of parent(s)|2|||
156332476|NCT00150709|564317334|FG002|Overall Study|Decision of parent(s)|0|||
156332477|NCT00150709|564317335|FG003|Overall Study|Decision of parent(s)|0|||
156332478|NCT00150709|564317332|FG000|Overall Study|Decision of parent(s) and investigator|3|||
156332479|NCT00150709|564317333|FG001|Overall Study|Decision of parent(s) and investigator|0|||
156332480|NCT00150709|564317334|FG002|Overall Study|Decision of parent(s) and investigator|0|||
156332481|NCT00150709|564317335|FG003|Overall Study|Decision of parent(s) and investigator|0|||
156332482|NCT00150709|564317332|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
156332483|NCT00150709|564317333|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
156332484|NCT00150709|564317334|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
156332485|NCT00150709|564317335|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
156332486|NCT00150709|564317332|FG000|Overall Study|Investigator decision|1|||
156332487|NCT00150709|564317333|FG001|Overall Study|Investigator decision|0|||
156332488|NCT00150709|564317334|FG002|Overall Study|Investigator decision|0|||
156332489|NCT00150709|564317335|FG003|Overall Study|Investigator decision|1|||
156332490|NCT00150709|564317332|FG000|Overall Study|Subject relocated|2|||
156332491|NCT00150709|564317333|FG001|Overall Study|Subject relocated|2|||
156332492|NCT00150709|564317334|FG002|Overall Study|Subject relocated|1|||
156332493|NCT00150709|564317335|FG003|Overall Study|Subject relocated|0|||
156332494|NCT00150709|564317332|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
156332495|NCT00150709|564317333|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
156332496|NCT00150709|564317334|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
156332497|NCT00150709|564317335|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
156332498|NCT00150709|564317332|FG000|Overall Study|Convenience|0|||
156332499|NCT00150709|564317333|FG001|Overall Study|Convenience|1|||
156332500|NCT00150709|564317334|FG002|Overall Study|Convenience|0|||
156332501|NCT00150709|564317335|FG003|Overall Study|Convenience|0|||
156332502|NCT00150709|564317332|FG000|Overall Study|Subject entered new drug study|0|||
156332503|NCT00150709|564317333|FG001|Overall Study|Subject entered new drug study|1|||
156708529|NCT02289456|565678568|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
156708530|NCT02289456|565678568|FG000|Monotherapy Period|Miscellaneous|1|||
156708531|NCT01371539|565678571|FG000|Period One: One Week|Lost to Follow-up|0|||
156708532|NCT01371539|565678572|FG001|Period One: One Week|Lost to Follow-up|1|||
156872315|NCT02425943|566289550|FG000|Overall Study|Withdrawal by Subject|64|||
156872316|NCT02425943|566289551|FG001|Overall Study|Withdrawal by Subject|31|||
156872317|NCT02425943|566289550|FG000|Overall Study|Other|6|||
156872318|NCT02425943|566289551|FG001|Overall Study|Other|0|||
156872319|NCT01106248|566289553|FG000|Overall Study|Adverse Event|1|||
156872320|NCT01106248|566289553|FG000|Overall Study|Administrative|2|||
156872321|NCT00357903|566289554|FG000|Overall Study|Adverse Event|87|||
156872322|NCT00357903|566289555|FG001|Overall Study|Adverse Event|4|||
156872323|NCT00357903|566289554|FG000|Overall Study|Death|33|||
156872324|NCT00357903|566289555|FG001|Overall Study|Death|0|||
156872325|NCT00357903|566289554|FG000|Overall Study|Lost to Follow-up|23|||
156872326|NCT00357903|566289555|FG001|Overall Study|Lost to Follow-up|4|||
156872327|NCT00357903|566289554|FG000|Overall Study|Physician Decision|39|||
156872328|NCT00357903|566289555|FG001|Overall Study|Physician Decision|5|||
156332504|NCT00150709|564317334|FG002|Overall Study|Subject entered new drug study|0|||
156708533|NCT01371539|565678571|FG000|Period Two: One Week|Lost to Follow-up|0|||
156872329|NCT00357903|566289554|FG000|Overall Study|Withdrawal by Subject|57|||
156332505|NCT00150709|564317335|FG003|Overall Study|Subject entered new drug study|0|||
156332506|NCT00150709|564317332|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
156332507|NCT00150709|564317333|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
156332508|NCT00150709|564317334|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
156872330|NCT00357903|566289555|FG001|Overall Study|Withdrawal by Subject|7|||
156872331|NCT00357903|566289554|FG000|Overall Study|Completed month 12 only|0|||
156872332|NCT00357903|566289555|FG001|Overall Study|Completed month 12 only|1|||
156872333|NCT00357903|566289554|FG000|Overall Study|Protocol issues|14|||
156332509|NCT00150709|564317335|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
156708534|NCT01371539|565678572|FG001|Period Two: One Week|Lost to Follow-up|1|||
156872334|NCT00357903|566289555|FG001|Overall Study|Protocol issues|3|||
156872335|NCT00357903|566289554|FG000|Overall Study|Response status|61|||
156872336|NCT00357903|566289555|FG001|Overall Study|Response status|9|||
156872337|NCT00357903|566289554|FG000|Overall Study|Other|49|||
156872338|NCT00357903|566289555|FG001|Overall Study|Other|10|||
156708535|NCT01371539|565678571|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
156708536|NCT01371539|565678572|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
156708537|NCT01371539|565678571|FG000|Period Two: One Week|Time/job conflict|0|||
156708538|NCT01371539|565678572|FG001|Period Two: One Week|Time/job conflict|1|||
156872339|NCT03181529|566289556|FG000|Overall Study|Withdrawal by Subject|1|||
156872340|NCT03181529|566289557|FG001|Overall Study|Withdrawal by Subject|1|||
156872341|NCT03181529|566289556|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
156872342|NCT03181529|566289557|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
156872343|NCT00607373|566289560|FG000|Treatment Period|Adverse Event|0|||
156872344|NCT00607373|566289561|FG001|Treatment Period|Adverse Event|4|||
156872345|NCT00607373|566289560|FG000|Treatment Period|Physician Decision|0|||
156872346|NCT00607373|566289561|FG001|Treatment Period|Physician Decision|1|||
156872347|NCT00607373|566289560|FG000|Treatment Period|Withdrawal by Subject|0|||
156872348|NCT00607373|566289561|FG001|Treatment Period|Withdrawal by Subject|1|||
156872349|NCT00607373|566289560|FG000|Follow-up Period|Other|0|||
156872350|NCT00607373|566289561|FG001|Follow-up Period|Other|1|||
156872351|NCT00607373|566289560|FG000|Follow-up Period|Protocol Violation|0|||
156872352|NCT00607373|566289561|FG001|Follow-up Period|Protocol Violation|1|||
156872353|NCT00607373|566289560|FG000|Follow-up Period|Withdrawal by Subject|1|||
156872354|NCT00607373|566289561|FG001|Follow-up Period|Withdrawal by Subject|3|||
156872355|NCT01918306|566289562|FG000|Overall Study|progresive disease|4|||
156872356|NCT01918306|566289563|FG001|Overall Study|progresive disease|0|||
156872357|NCT01918306|566289564|FG002|Overall Study|progresive disease|1|||
156872358|NCT01918306|566289565|FG003|Overall Study|progresive disease|1|||
156872359|NCT01918306|566289562|FG000|Overall Study|Withdrawal by Subject|0|||
156872360|NCT01918306|566289563|FG001|Overall Study|Withdrawal by Subject|0|||
156872361|NCT01918306|566289564|FG002|Overall Study|Withdrawal by Subject|0|||
156872362|NCT01918306|566289565|FG003|Overall Study|Withdrawal by Subject|2|||
156872363|NCT01918306|566289562|FG000|Overall Study|neutropenia|1|||
156872364|NCT01918306|566289563|FG001|Overall Study|neutropenia|0|||
156872365|NCT01918306|566289564|FG002|Overall Study|neutropenia|0|||
156872366|NCT01918306|566289565|FG003|Overall Study|neutropenia|0|||
156872367|NCT01918306|566289562|FG000|Overall Study|Lack of Efficacy|1|||
156872368|NCT01918306|566289563|FG001|Overall Study|Lack of Efficacy|0|||
156872369|NCT01918306|566289564|FG002|Overall Study|Lack of Efficacy|0|||
156872370|NCT01918306|566289565|FG003|Overall Study|Lack of Efficacy|0|||
156872371|NCT01918306|566289562|FG000|Overall Study|progress disease, crossover|0|||
156872372|NCT01918306|566289563|FG001|Overall Study|progress disease, crossover|0|||
156872373|NCT01918306|566289564|FG002|Overall Study|progress disease, crossover|1|||
156872374|NCT01918306|566289565|FG003|Overall Study|progress disease, crossover|0|||
156872375|NCT00314795|566289571|FG000|Overall Study|Adverse Event|8|||
156872376|NCT00314795|566289571|FG000|Overall Study|Death|4|||
156872377|NCT00314795|566289571|FG000|Overall Study|Reason not Specified|3|||
156872378|NCT00314795|566289571|FG000|Overall Study|Renal Transplant|3|||
156872379|NCT00314795|566289571|FG000|Overall Study|Participants Withdrew Consent|2|||
156872380|NCT02170077|566289576|FG000|Overall Study|Withdrawal by Subject|3|||
156332510|NCT00150709|564317332|FG000|Overall Study|Lack of ease of swallowing|0|||
156332511|NCT00150709|564317333|FG001|Overall Study|Lack of ease of swallowing|1|||
156332512|NCT00150709|564317334|FG002|Overall Study|Lack of ease of swallowing|0|||
156332513|NCT00150709|564317335|FG003|Overall Study|Lack of ease of swallowing|0|||
156332514|NCT00316719|564317336|FG000|Overall Study|Adverse Event|0|||
156332515|NCT00316719|564317337|FG001|Overall Study|Adverse Event|6|||
156332516|NCT00316719|564317336|FG000|Overall Study|Consent withdrawn|2|||
156332517|NCT00316719|564317337|FG001|Overall Study|Consent withdrawn|0|||
156332518|NCT02975336|564317338|FG000|DBPC (52 Weeks)|Adverse Event|16|||
156332519|NCT02975336|564317339|FG001|DBPC (52 Weeks)|Adverse Event|17|||
156332520|NCT02975336|564317340|FG002|DBPC (52 Weeks)|Adverse Event|13|||
156332521|NCT02975336|564317341|FG003|DBPC (52 Weeks)|Adverse Event|18|||
156332522|NCT02975336|564317342|FG004|DBPC (52 Weeks)|Adverse Event|0|||
156332523|NCT02975336|564317343|FG005|DBPC (52 Weeks)|Adverse Event|0|||
156332524|NCT02975336|564317344|FG006|DBPC (52 Weeks)|Adverse Event|0|||
156332525|NCT02975336|564317345|FG007|DBPC (52 Weeks)|Adverse Event|0|||
156332526|NCT02975336|564317338|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
156332527|NCT02975336|564317339|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
156332528|NCT02975336|564317340|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
156332529|NCT02975336|564317341|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
156332530|NCT02975336|564317342|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
156332531|NCT02975336|564317343|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
156332532|NCT02975336|564317344|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
156332533|NCT02975336|564317345|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
156332534|NCT02975336|564317338|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
156332535|NCT02975336|564317339|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
156332536|NCT02975336|564317340|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
156332537|NCT02975336|564317341|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
156332538|NCT02975336|564317342|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
156332539|NCT02975336|564317343|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
156332540|NCT02975336|564317344|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
156441060|NCT01985334|564707336|FG004|Overall Study|Other|1|||
156441061|NCT01985334|564707337|FG005|Overall Study|Other|6|||
156441062|NCT01985334|564707338|FG006|Overall Study|Other|2|||
156441063|NCT01985334|564707339|FG007|Overall Study|Other|2|||
156441064|NCT01985334|564707332|FG000|Overall Study|Medication non-compliance|0|||
156441065|NCT01985334|564707333|FG001|Overall Study|Medication non-compliance|4|||
156441066|NCT01985334|564707334|FG002|Overall Study|Medication non-compliance|1|||
156441067|NCT01985334|564707335|FG003|Overall Study|Medication non-compliance|6|||
156441068|NCT01985334|564707336|FG004|Overall Study|Medication non-compliance|2|||
156441069|NCT01985334|564707337|FG005|Overall Study|Medication non-compliance|3|||
156441070|NCT01985334|564707338|FG006|Overall Study|Medication non-compliance|1|||
156441071|NCT01985334|564707339|FG007|Overall Study|Medication non-compliance|3|||
156441072|NCT01985334|564707332|FG000|Overall Study|Use of prohibited treatment|1|||
156441073|NCT01985334|564707333|FG001|Overall Study|Use of prohibited treatment|4|||
156441074|NCT01985334|564707334|FG002|Overall Study|Use of prohibited treatment|1|||
156441075|NCT01985334|564707335|FG003|Overall Study|Use of prohibited treatment|2|||
156441076|NCT01985334|564707336|FG004|Overall Study|Use of prohibited treatment|1|||
156441077|NCT01985334|564707337|FG005|Overall Study|Use of prohibited treatment|6|||
156708539|NCT02620579|565678575|FG000|Overall Study|Physician Decision|0|||
156708540|NCT02620579|565678576|FG001|Overall Study|Physician Decision|0|||
156708541|NCT02620579|565678577|FG002|Overall Study|Physician Decision|0|||
156708542|NCT02620579|565678578|FG003|Overall Study|Physician Decision|1|||
156708543|NCT02620579|565678575|FG000|Overall Study|Withdrawal by Subject|0|||
156708544|NCT02620579|565678576|FG001|Overall Study|Withdrawal by Subject|1|||
156708545|NCT02620579|565678577|FG002|Overall Study|Withdrawal by Subject|1|||
156708546|NCT02620579|565678578|FG003|Overall Study|Withdrawal by Subject|0|||
156708547|NCT00958893|565678581|FG000|Overall Study|Study prematurely terminated|4|||
156708548|NCT02892149|565678584|FG000|Overall Study|Death|262|||
156708549|NCT02892149|565678585|FG001|Overall Study|Death|278|||
156708550|NCT02892149|565678584|FG000|Overall Study|Withdrawal by Subject|53|||
156708551|NCT02892149|565678585|FG001|Overall Study|Withdrawal by Subject|47|||
156708552|NCT02892149|565678584|FG000|Overall Study|Lost to Follow-up|37|||
156708553|NCT02892149|565678585|FG001|Overall Study|Lost to Follow-up|31|||
156708554|NCT02165735|565678590|FG000|Overall Study|Lost to Follow-up|12|||
156708555|NCT02165735|565678591|FG001|Overall Study|Lost to Follow-up|10|||
156708556|NCT02165735|565678590|FG000|Overall Study|Withdrawal by Subject|3|||
156708557|NCT02165735|565678591|FG001|Overall Study|Withdrawal by Subject|0|||
156708558|NCT02165735|565678590|FG000|Overall Study|Participant indicated lack of time|1|||
156708559|NCT02165735|565678591|FG001|Overall Study|Participant indicated lack of time|3|||
156708560|NCT02165735|565678590|FG000|Overall Study|Protocol Violation|0|||
156708561|NCT02165735|565678591|FG001|Overall Study|Protocol Violation|1|||
156708562|NCT03066258|565678592|FG000|Overall Study|Death|1|||
156708563|NCT03066258|565678593|FG001|Overall Study|Death|0|||
156708564|NCT03066258|565678594|FG002|Overall Study|Death|0|||
156708565|NCT03066258|565678595|FG003|Overall Study|Death|0|||
156708566|NCT03066258|565678596|FG004|Overall Study|Death|1|||
156708567|NCT02784795|565678597|FG000|Overall Study|Progressive Disease|2|||
156708568|NCT02784795|565678598|FG001|Overall Study|Progressive Disease|1|||
156708569|NCT02784795|565678599|FG002|Overall Study|Progressive Disease|1|||
156708570|NCT02784795|565678600|FG003|Overall Study|Progressive Disease|0|||
156708571|NCT02784795|565678601|FG004|Overall Study|Progressive Disease|2|||
156708572|NCT02784795|565678602|FG005|Overall Study|Progressive Disease|0|||
156708573|NCT02784795|565678603|FG006|Overall Study|Progressive Disease|2|||
156708574|NCT02784795|565678604|FG007|Overall Study|Progressive Disease|0|||
156708575|NCT02784795|565678605|FG008|Overall Study|Progressive Disease|0|||
156708576|NCT02784795|565678606|FG009|Overall Study|Progressive Disease|0|||
156708577|NCT02784795|565678607|FG010|Overall Study|Progressive Disease|1|||
156708578|NCT02784795|565678608|FG011|Overall Study|Progressive Disease|0|||
156708579|NCT02784795|565678597|FG000|Overall Study|Adverse Event|1|||
156708580|NCT02784795|565678598|FG001|Overall Study|Adverse Event|0|||
156708581|NCT02784795|565678599|FG002|Overall Study|Adverse Event|0|||
156708582|NCT02784795|565678600|FG003|Overall Study|Adverse Event|1|||
156441078|NCT01985334|564707338|FG006|Overall Study|Use of prohibited treatment|2|||
156441079|NCT01985334|564707339|FG007|Overall Study|Use of prohibited treatment|0|||
156441080|NCT01985334|564707332|FG000|Overall Study|Investigator decision|0|||
156441081|NCT01985334|564707333|FG001|Overall Study|Investigator decision|3|||
156708583|NCT02784795|565678601|FG004|Overall Study|Adverse Event|0|||
156708584|NCT02784795|565678602|FG005|Overall Study|Adverse Event|0|||
156708585|NCT02784795|565678603|FG006|Overall Study|Adverse Event|1|||
156708586|NCT02784795|565678604|FG007|Overall Study|Adverse Event|0|||
156708587|NCT02784795|565678605|FG008|Overall Study|Adverse Event|0|||
156708588|NCT02784795|565678606|FG009|Overall Study|Adverse Event|0|||
156708589|NCT02784795|565678607|FG010|Overall Study|Adverse Event|0|||
156708590|NCT02784795|565678608|FG011|Overall Study|Adverse Event|2|||
156708591|NCT02784795|565678597|FG000|Overall Study|Withdrawal by Subject|1|||
156708592|NCT02784795|565678598|FG001|Overall Study|Withdrawal by Subject|0|||
156708593|NCT02784795|565678599|FG002|Overall Study|Withdrawal by Subject|2|||
156708594|NCT02784795|565678600|FG003|Overall Study|Withdrawal by Subject|1|||
156708595|NCT02784795|565678601|FG004|Overall Study|Withdrawal by Subject|3|||
156708596|NCT02784795|565678602|FG005|Overall Study|Withdrawal by Subject|0|||
156708597|NCT02784795|565678603|FG006|Overall Study|Withdrawal by Subject|0|||
156708598|NCT02784795|565678604|FG007|Overall Study|Withdrawal by Subject|1|||
156708599|NCT02784795|565678605|FG008|Overall Study|Withdrawal by Subject|0|||
156708600|NCT02784795|565678606|FG009|Overall Study|Withdrawal by Subject|0|||
156708601|NCT02784795|565678607|FG010|Overall Study|Withdrawal by Subject|0|||
156708602|NCT02784795|565678608|FG011|Overall Study|Withdrawal by Subject|2|||
156708603|NCT02784795|565678597|FG000|Overall Study|Death|0|||
156708604|NCT02784795|565678598|FG001|Overall Study|Death|0|||
156708605|NCT02784795|565678599|FG002|Overall Study|Death|0|||
156708606|NCT02784795|565678600|FG003|Overall Study|Death|0|||
156708607|NCT02784795|565678601|FG004|Overall Study|Death|1|||
156708608|NCT02784795|565678602|FG005|Overall Study|Death|0|||
156708609|NCT02784795|565678603|FG006|Overall Study|Death|0|||
156708610|NCT02784795|565678604|FG007|Overall Study|Death|0|||
156708611|NCT02784795|565678605|FG008|Overall Study|Death|0|||
156708612|NCT02784795|565678606|FG009|Overall Study|Death|0|||
156708613|NCT02784795|565678607|FG010|Overall Study|Death|0|||
156708614|NCT02784795|565678608|FG011|Overall Study|Death|0|||
156708615|NCT02784795|565678597|FG000|Overall Study|Physician Decision|0|||
156708616|NCT02784795|565678598|FG001|Overall Study|Physician Decision|0|||
156708617|NCT02784795|565678599|FG002|Overall Study|Physician Decision|0|||
156708618|NCT02784795|565678600|FG003|Overall Study|Physician Decision|0|||
156708619|NCT02784795|565678601|FG004|Overall Study|Physician Decision|0|||
156708620|NCT02784795|565678602|FG005|Overall Study|Physician Decision|0|||
156708621|NCT02784795|565678603|FG006|Overall Study|Physician Decision|1|||
156708622|NCT02784795|565678604|FG007|Overall Study|Physician Decision|0|||
156708623|NCT02784795|565678605|FG008|Overall Study|Physician Decision|0|||
156708624|NCT02784795|565678606|FG009|Overall Study|Physician Decision|0|||
156708625|NCT02784795|565678607|FG010|Overall Study|Physician Decision|0|||
156708626|NCT02784795|565678608|FG011|Overall Study|Physician Decision|0|||
156708627|NCT00595309|565678609|FG000|Overall Study|Lost to Follow-up|1|||
156708628|NCT00595309|565678609|FG000|Overall Study|planned vaccination against yellow fever|1|||
156708629|NCT00595309|565678609|FG000|Overall Study|acute infection after V0|1|||
156708630|NCT00595309|565678609|FG000|Overall Study|personal reason|1|||
156708631|NCT02797171|565678610|FG000|Overall Study|Lost to Follow-up|2|||
156708632|NCT02797171|565678611|FG001|Overall Study|Lost to Follow-up|0|||
156708633|NCT02797171|565678612|FG002|Overall Study|Lost to Follow-up|2|||
156708634|NCT02797171|565678613|FG003|Overall Study|Lost to Follow-up|1|||
156708635|NCT02797171|565678614|FG004|Overall Study|Lost to Follow-up|2|||
156708636|NCT02797171|565678615|FG005|Overall Study|Lost to Follow-up|0|||
156708637|NCT02797171|565678610|FG000|Overall Study|Withdrawal by Subject|1|||
156708638|NCT02797171|565678611|FG001|Overall Study|Withdrawal by Subject|1|||
156708639|NCT02797171|565678612|FG002|Overall Study|Withdrawal by Subject|0|||
156708640|NCT02797171|565678613|FG003|Overall Study|Withdrawal by Subject|0|||
156708641|NCT02797171|565678614|FG004|Overall Study|Withdrawal by Subject|0|||
156708642|NCT02797171|565678615|FG005|Overall Study|Withdrawal by Subject|0|||
156708643|NCT02797171|565678610|FG000|Overall Study|Protocol Violation|1|||
156708644|NCT02797171|565678611|FG001|Overall Study|Protocol Violation|0|||
156708645|NCT02797171|565678612|FG002|Overall Study|Protocol Violation|0|||
156708646|NCT02797171|565678613|FG003|Overall Study|Protocol Violation|0|||
156708647|NCT02797171|565678614|FG004|Overall Study|Protocol Violation|0|||
156708648|NCT02797171|565678615|FG005|Overall Study|Protocol Violation|0|||
156708649|NCT02797171|565678610|FG000|Overall Study|Participant unable to adhere|0|||
156708650|NCT02797171|565678611|FG001|Overall Study|Participant unable to adhere|1|||
156708651|NCT02797171|565678612|FG002|Overall Study|Participant unable to adhere|0|||
156708652|NCT02797171|565678613|FG003|Overall Study|Participant unable to adhere|0|||
156708653|NCT02797171|565678614|FG004|Overall Study|Participant unable to adhere|0|||
156708654|NCT02797171|565678615|FG005|Overall Study|Participant unable to adhere|0|||
156708655|NCT02797171|565678610|FG000|Overall Study|Not Randomized|0|||
156708656|NCT02797171|565678611|FG001|Overall Study|Not Randomized|0|||
156708657|NCT02797171|565678612|FG002|Overall Study|Not Randomized|0|||
156872381|NCT02170077|566289577|FG001|Overall Study|Withdrawal by Subject|4|||
156708658|NCT02797171|565678613|FG003|Overall Study|Not Randomized|0|||
156708659|NCT02797171|565678614|FG004|Overall Study|Not Randomized|0|||
156708660|NCT02797171|565678615|FG005|Overall Study|Not Randomized|1|||
156708661|NCT00101283|565678616|FG000|Overall Study|Withdrawal by Subject|0|||
156708662|NCT00101283|565678617|FG001|Overall Study|Withdrawal by Subject|1|||
156708663|NCT00101283|565678616|FG000|Overall Study|Insurance Refusal|0|||
156708664|NCT00101283|565678617|FG001|Overall Study|Insurance Refusal|1|||
156708665|NCT00101283|565678616|FG000|Overall Study|Prostate Cancer Recurrence|0|||
156708666|NCT00101283|565678617|FG001|Overall Study|Prostate Cancer Recurrence|1|||
156708667|NCT00711880|565678618|FG000|Overall Study|Adverse Event|11|||
156708668|NCT00711880|565678619|FG001|Overall Study|Adverse Event|2|||
156708669|NCT00711880|565678618|FG000|Overall Study|Patient non-compliance|1|||
156708670|NCT00711880|565678619|FG001|Overall Study|Patient non-compliance|0|||
156708671|NCT00711880|565678618|FG000|Overall Study|Lack of Efficacy|1|||
156708672|NCT00711880|565678619|FG001|Overall Study|Lack of Efficacy|5|||
156708673|NCT00704132|565678620|FG000|Overall Study|Clinical Adverse Experience|1|||
156441082|NCT01985334|564707334|FG002|Overall Study|Investigator decision|0|||
156441083|NCT01985334|564707335|FG003|Overall Study|Investigator decision|7|||
156872382|NCT02170077|566289578|FG002|Overall Study|Withdrawal by Subject|2|||
156872383|NCT02170077|566289576|FG000|Overall Study|Adverse Event|4|||
156872384|NCT02170077|566289577|FG001|Overall Study|Adverse Event|4|||
156872385|NCT02170077|566289578|FG002|Overall Study|Adverse Event|4|||
156872386|NCT02170077|566289576|FG000|Overall Study|Lost to Follow-up|0|||
156872387|NCT02170077|566289577|FG001|Overall Study|Lost to Follow-up|1|||
156872388|NCT02170077|566289578|FG002|Overall Study|Lost to Follow-up|0|||
156872389|NCT02170077|566289576|FG000|Overall Study|Exclusion criteria|2|||
156872390|NCT02170077|566289577|FG001|Overall Study|Exclusion criteria|2|||
156872391|NCT02170077|566289578|FG002|Overall Study|Exclusion criteria|5|||
156872392|NCT02170077|566289576|FG000|Overall Study|Exacerbation of seizures|0|||
156872393|NCT02170077|566289577|FG001|Overall Study|Exacerbation of seizures|2|||
156872394|NCT02170077|566289578|FG002|Overall Study|Exacerbation of seizures|1|||
156872395|NCT01780974|566289583|FG000|Overall Study|Death|1|||
156872396|NCT01780974|566289584|FG001|Overall Study|Death|0|||
156872397|NCT01780974|566289583|FG000|Overall Study|Adverse Event|1|||
156872398|NCT01780974|566289584|FG001|Overall Study|Adverse Event|3|||
156872399|NCT00525161|566289585|FG000|Overall Study|Adverse Event|1|||
156872400|NCT01076361|566289586|FG000|Overall Study|22 leads were excluded from analysis|21|||
156872401|NCT01642589|566289591|FG000|Overall Study|Withdrawal by Subject|1|||
156872402|NCT01642589|566289592|FG001|Overall Study|Withdrawal by Subject|1|||
156872403|NCT00759941|566289597|FG000|Overall Study|Use of medication|1|||
156872404|NCT00759941|566289598|FG001|Overall Study|Use of medication|0|||
156872405|NCT00759941|566289597|FG000|Overall Study|Adverse Event|1|||
156872406|NCT00759941|566289598|FG001|Overall Study|Adverse Event|0|||
156872407|NCT00759941|566289597|FG000|Overall Study|Exited in error by site|1|||
156872408|NCT00759941|566289598|FG001|Overall Study|Exited in error by site|1|||
156872409|NCT02736578|566289599|FG000|Overall Study|Adverse Event|1|||
156872410|NCT02736578|566289600|FG001|Overall Study|Adverse Event|0|||
156872411|NCT00802945|566289601|FG000|Overall Study|Death|27|||
156872412|NCT00802945|566289602|FG001|Overall Study|Death|23|||
156872413|NCT00802945|566289601|FG000|Overall Study|Terminated by sponsor|8|||
156872414|NCT00802945|566289602|FG001|Overall Study|Terminated by sponsor|12|||
156872415|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
156872416|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
156872417|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
156872418|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
156872419|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
156872420|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
156872421|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
156872422|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
156872423|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
156872424|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
156872425|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
156872426|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
156872427|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
156872428|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
156872429|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
156872430|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
156872431|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
156872432|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
156872433|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
156872434|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
156872435|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
156872436|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
156872437|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
156872438|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
156441084|NCT01985334|564707336|FG004|Overall Study|Investigator decision|1|||
156441085|NCT01985334|564707337|FG005|Overall Study|Investigator decision|1|||
156441086|NCT01985334|564707338|FG006|Overall Study|Investigator decision|0|||
156441087|NCT01985334|564707339|FG007|Overall Study|Investigator decision|4|||
156872439|NCT05307692|566289603|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
156441088|NCT01985334|564707332|FG000|Overall Study|Lost to Follow-up|0|||
156708674|NCT00704132|565678621|FG001|Overall Study|Clinical Adverse Experience|0|||
156872440|NCT05307692|566289604|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
156872441|NCT05307692|566289605|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
156872442|NCT05307692|566289606|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
156441089|NCT01985334|564707333|FG001|Overall Study|Lost to Follow-up|2|||
156441090|NCT01985334|564707334|FG002|Overall Study|Lost to Follow-up|0|||
156441091|NCT01985334|564707335|FG003|Overall Study|Lost to Follow-up|3|||
156441092|NCT01985334|564707336|FG004|Overall Study|Lost to Follow-up|1|||
156441093|NCT01985334|564707337|FG005|Overall Study|Lost to Follow-up|4|||
156441094|NCT01985334|564707338|FG006|Overall Study|Lost to Follow-up|0|||
156441095|NCT01985334|564707339|FG007|Overall Study|Lost to Follow-up|3|||
156441096|NCT03988023|564707340|FG000|Overall Study|Non-compliance|3|||
156441097|NCT03988023|564707341|FG001|Overall Study|Non-compliance|0|||
156441098|NCT03988023|564707340|FG000|Overall Study|Withdrawal by Subject|39|||
156441099|NCT03988023|564707341|FG001|Overall Study|Withdrawal by Subject|37|||
156441100|NCT03988023|564707340|FG000|Overall Study|Adverse Event|0|||
156441101|NCT03988023|564707341|FG001|Overall Study|Adverse Event|2|||
156441102|NCT03988023|564707340|FG000|Overall Study|Physician Decision|0|||
156441103|NCT03988023|564707341|FG001|Overall Study|Physician Decision|1|||
156441104|NCT03988023|564707340|FG000|Overall Study|Lost to Follow-up|5|||
156441105|NCT03988023|564707341|FG001|Overall Study|Lost to Follow-up|8|||
156441106|NCT03988023|564707340|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
156441107|NCT03988023|564707341|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
156441108|NCT03988023|564707340|FG000|Overall Study|Lack of Efficacy|3|||
156441109|NCT03988023|564707341|FG001|Overall Study|Lack of Efficacy|1|||
156441110|NCT03988023|564707340|FG000|Overall Study|COVID-19 pandemic|225|||
156441111|NCT03988023|564707341|FG001|Overall Study|COVID-19 pandemic|227|||
156441112|NCT00174382|564707342|FG000|Overall Study|Death|2|||
156441113|NCT00174382|564707342|FG000|Overall Study|Adverse Event|19|||
156441114|NCT00174382|564707342|FG000|Overall Study|Withdrawal by Subject|6|||
156441115|NCT00174382|564707342|FG000|Overall Study|Protocol Violation|3|||
156441116|NCT00174382|564707342|FG000|Overall Study|Arrived early for last visit in error|1|||
156441117|NCT00174382|564707342|FG000|Overall Study|Subject felt pill not effective enough|1|||
156441118|NCT00174382|564707342|FG000|Overall Study|Lost to Follow-up|1|||
156441119|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
156441120|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
156441121|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
156441122|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
156441123|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
156441124|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
156441125|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
156441126|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
156441127|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
156441128|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
156441129|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
156441130|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
156708675|NCT00704132|565678620|FG000|Overall Study|Lack of Efficacy|0|||
156708676|NCT00704132|565678621|FG001|Overall Study|Lack of Efficacy|1|||
156708677|NCT00704132|565678620|FG000|Overall Study|Withdrawal by Subject|0|||
156708678|NCT00704132|565678621|FG001|Overall Study|Withdrawal by Subject|1|||
156708679|NCT00442962|565678622|FG000|Overall Study|Pregnancy|1|||
156708680|NCT00442962|565678622|FG000|Overall Study|Lost to Follow-up|7|||
156708681|NCT04238650|565678623|FG000|Overall Study|Withdrawal by Subject|0|||
156708682|NCT04238650|565678624|FG001|Overall Study|Withdrawal by Subject|1|||
156708683|NCT02756208|565678625|FG000|Overall Study|Withdrawal by Subject|1|||
156708684|NCT02756208|565678626|FG001|Overall Study|Withdrawal by Subject|0|||
156708685|NCT02756208|565678627|FG002|Overall Study|Withdrawal by Subject|1|||
156708686|NCT02756208|565678628|FG003|Overall Study|Withdrawal by Subject|3|||
156708687|NCT02756208|565678625|FG000|Overall Study|Lost to Follow-up|3|||
156332541|NCT02975336|564317345|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
156332542|NCT02975336|564317338|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
156332543|NCT02975336|564317339|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
156332544|NCT02975336|564317340|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
156332545|NCT02975336|564317341|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
156332546|NCT02975336|564317342|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
156332547|NCT02975336|564317343|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
156332548|NCT02975336|564317344|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
156332549|NCT02975336|564317345|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
156332550|NCT02975336|564317338|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
156332551|NCT02975336|564317339|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156332552|NCT02975336|564317340|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
156332553|NCT02975336|564317341|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
156332554|NCT02975336|564317342|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156332555|NCT02975336|564317343|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156332556|NCT02975336|564317344|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156332557|NCT02975336|564317345|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156441131|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
156441132|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
156441133|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
156708688|NCT02756208|565678626|FG001|Overall Study|Lost to Follow-up|1|||
156708689|NCT02756208|565678627|FG002|Overall Study|Lost to Follow-up|1|||
156708690|NCT02756208|565678628|FG003|Overall Study|Lost to Follow-up|1|||
156708691|NCT02756208|565678625|FG000|Overall Study|Physician Decision|1|||
156441134|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
156441135|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
156441136|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
156441137|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
156441138|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
156441139|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
156441140|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
156441141|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
156441142|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
156441143|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
156441144|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
156441145|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
156441146|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
156441147|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
156441148|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
156441149|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
156441150|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
156441151|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
156441152|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
156441153|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
156441154|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
156441155|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
156441156|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
156441157|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
156441158|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
156441159|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
156441160|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
156441161|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
156441162|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
156441163|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
156441164|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
156441165|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
156441166|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
156441167|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
156441168|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
156441169|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
156441170|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
156441171|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
156441172|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
156441173|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
156441174|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
156441175|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
156441176|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
156441177|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
156441178|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
156441179|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
156441180|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
156441181|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
156441182|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
156441183|NCT03903822|564707347|FG000|Treatment Phase (6 Weeks)|Other|2|||
156441184|NCT03903822|564707348|FG001|Treatment Phase (6 Weeks)|Other|1|||
156441185|NCT03903822|564707349|FG002|Treatment Phase (6 Weeks)|Other|0|||
156441186|NCT03903822|564707350|FG003|Treatment Phase (6 Weeks)|Other|0|||
156441187|NCT03903822|564707351|FG004|Treatment Phase (6 Weeks)|Other|1|||
156441188|NCT03903822|564707352|FG005|Treatment Phase (6 Weeks)|Other|1|||
156441189|NCT03903822|564707353|FG006|Treatment Phase (6 Weeks)|Other|0|||
156441190|NCT03903822|564707354|FG007|Treatment Phase (6 Weeks)|Other|0|||
156441191|NCT03903822|564707347|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
156441192|NCT03903822|564707348|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
156441193|NCT03903822|564707349|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
156441194|NCT03903822|564707350|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
156441195|NCT03903822|564707351|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
156531793|NCT02684357|565041730|FG005|Part A|Withdrawal by Subject|0|||
156441196|NCT03903822|564707352|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
156441197|NCT03903822|564707353|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
156441198|NCT03903822|564707354|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
156531794|NCT02684357|565041725|FG000|Part A|Other|0|||
156531795|NCT02684357|565041726|FG001|Part A|Other|1|||
156441199|NCT03903822|564707347|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
156441200|NCT03903822|564707348|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
156531796|NCT02684357|565041727|FG002|Part A|Other|0|||
156531797|NCT02684357|565041728|FG003|Part A|Other|0|||
156872443|NCT05307692|566289603|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
156872444|NCT05307692|566289604|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
156872445|NCT05307692|566289605|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
156872446|NCT05307692|566289606|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
156872447|NCT02656693|566291195|FG000|Overall Study|Pregnancy|1|||
156872448|NCT02656693|566291196|FG001|Overall Study|Pregnancy|1|||
156872449|NCT02656693|566291197|FG002|Overall Study|Pregnancy|1|||
156872450|NCT02656693|566291195|FG000|Overall Study|Bariatric surgery|0|||
156872451|NCT02656693|566291196|FG001|Overall Study|Bariatric surgery|1|||
156872452|NCT02656693|566291197|FG002|Overall Study|Bariatric surgery|2|||
156872453|NCT01596062|566291198|FG000|Overall Study|Adverse Event|1|||
156872454|NCT01596062|566291199|FG001|Overall Study|Adverse Event|0|||
156872455|NCT01596062|566291200|FG002|Overall Study|Adverse Event|2|||
156872456|NCT01596062|566291198|FG000|Overall Study|Lack of Efficacy|0|||
156872457|NCT01596062|566291199|FG001|Overall Study|Lack of Efficacy|0|||
156872458|NCT01596062|566291200|FG002|Overall Study|Lack of Efficacy|1|||
156872459|NCT01255436|566291207|FG000|Overall Study|Lost to Follow-up|178|||
156872460|NCT01255436|566291208|FG001|Overall Study|Lost to Follow-up|191|||
156872461|NCT01255436|566291207|FG000|Overall Study|Death, stroke, or MI|4|||
156872462|NCT01255436|566291208|FG001|Overall Study|Death, stroke, or MI|3|||
156872463|NCT00808080|566291210|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
156872464|NCT01837823|566291211|FG000|Overall Study|Lost to Follow-up|6|||
156872465|NCT03052400|566291212|FG000|Overall Study|Lost to Follow-up|1|||
156872466|NCT03052400|566291213|FG001|Overall Study|Lost to Follow-up|0|||
156872467|NCT03052400|566291212|FG000|Overall Study|Withdrawal by Subject|0|||
156872468|NCT03052400|566291213|FG001|Overall Study|Withdrawal by Subject|1|||
156872469|NCT00372593|566291214|FG000|Overall Study|Adverse Event|43|||
156872470|NCT00372593|566291215|FG001|Overall Study|Adverse Event|45|||
156872471|NCT00372593|566291216|FG002|Overall Study|Adverse Event|0|||
156872472|NCT00372593|566291214|FG000|Overall Study|Death|16|||
156872473|NCT00372593|566291215|FG001|Overall Study|Death|20|||
156872474|NCT00372593|566291216|FG002|Overall Study|Death|1|||
156872475|NCT00372593|566291214|FG000|Overall Study|Lack of Efficacy|82|||
156872476|NCT00372593|566291215|FG001|Overall Study|Lack of Efficacy|71|||
156872477|NCT00372593|566291216|FG002|Overall Study|Lack of Efficacy|2|||
156872478|NCT00372593|566291214|FG000|Overall Study|Lost to Follow-up|1|||
156872479|NCT00372593|566291215|FG001|Overall Study|Lost to Follow-up|0|||
156872480|NCT00372593|566291216|FG002|Overall Study|Lost to Follow-up|0|||
156872481|NCT00372593|566291214|FG000|Overall Study|Physician Decision|42|||
156872482|NCT00372593|566291215|FG001|Overall Study|Physician Decision|41|||
156872483|NCT00372593|566291216|FG002|Overall Study|Physician Decision|0|||
156872484|NCT00372593|566291214|FG000|Overall Study|Ineligible|20|||
156872485|NCT00372593|566291215|FG001|Overall Study|Ineligible|21|||
156872486|NCT00372593|566291216|FG002|Overall Study|Ineligible|1|||
156872487|NCT01237899|566291217|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
156872488|NCT01237899|566291218|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
156872489|NCT01237899|566291219|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
156872490|NCT01237899|566291220|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
156872491|NCT01237899|566291221|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
156872492|NCT01237899|566291222|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
156872493|NCT01237899|566291223|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
156872494|NCT01237899|566291224|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
156872495|NCT01237899|566291225|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
156872496|NCT01237899|566291226|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
156872497|NCT01237899|566291227|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
156872498|NCT00859456|566291228|FG000|Overall Study|Adverse Event|3|||
156872499|NCT00859456|566291228|FG000|Overall Study|Progressive disease|2|||
156872500|NCT00859456|566291228|FG000|Overall Study|Non-compliance|3|||
156872501|NCT02910986|566291232|FG000|Overall Study|non-Latina|14|||
156872502|NCT02910986|566291233|FG001|Overall Study|non-Latina|13|||
156872503|NCT02910986|566291234|FG002|Overall Study|non-Latina|12|||
156872504|NCT02910986|566291232|FG000|Overall Study|Failure to return T! survey|72|||
156872505|NCT02910986|566291233|FG001|Overall Study|Failure to return T! survey|84|||
156872506|NCT02910986|566291234|FG002|Overall Study|Failure to return T! survey|72|||
156332558|NCT02975336|564317338|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
156708692|NCT02756208|565678626|FG001|Overall Study|Physician Decision|0|||
156708693|NCT02756208|565678627|FG002|Overall Study|Physician Decision|0|||
156872507|NCT02910986|566291232|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
156872508|NCT02910986|566291233|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
156872509|NCT02910986|566291234|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
156872510|NCT02910986|566291232|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
156872511|NCT02910986|566291233|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
156872512|NCT02910986|566291234|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
156872513|NCT02304367|566291238|FG000|Overall Study|Lack of Response to Bruosumab|1|||
156872514|NCT02304367|566291238|FG000|Overall Study|Sponsor Decision|3|||
156872515|NCT02304367|566291238|FG000|Overall Study|Death|2|||
156872516|NCT02304367|566291238|FG000|Overall Study|Physician Decision|1|||
156708694|NCT02756208|565678628|FG003|Overall Study|Physician Decision|0|||
156708695|NCT02756208|565678625|FG000|Overall Study|Protocol Violation|0|||
156708696|NCT02756208|565678626|FG001|Overall Study|Protocol Violation|1|||
156708697|NCT02756208|565678627|FG002|Overall Study|Protocol Violation|0|||
156708698|NCT02756208|565678628|FG003|Overall Study|Protocol Violation|0|||
156708699|NCT04841577|565678629|FG000|Overall Study|Adverse Event|5|||
156708700|NCT04841577|565678630|FG001|Overall Study|Adverse Event|10|||
156708701|NCT04841577|565678629|FG000|Overall Study|Lost to Follow-up|8|||
156708702|NCT04841577|565678630|FG001|Overall Study|Lost to Follow-up|7|||
156708703|NCT04841577|565678629|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
156708704|NCT04841577|565678630|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
156708705|NCT04841577|565678629|FG000|Overall Study|Other|0|||
156708706|NCT04841577|565678630|FG001|Overall Study|Other|1|||
156708707|NCT01267994|565678640|FG000|Overall Study|Adverse Event|2|||
156708708|NCT00252239|565678641|FG000|Overall Study|Withdrawal by Subject|1|||
156708709|NCT00252239|565678642|FG001|Overall Study|Withdrawal by Subject|0|||
156708710|NCT00252239|565678643|FG002|Overall Study|Withdrawal by Subject|0|||
156708711|NCT00252239|565678644|FG003|Overall Study|Withdrawal by Subject|1|||
156708712|NCT00252239|565678641|FG000|Overall Study|Lost to Follow-up|0|||
156708713|NCT00252239|565678642|FG001|Overall Study|Lost to Follow-up|0|||
156708714|NCT00252239|565678643|FG002|Overall Study|Lost to Follow-up|2|||
156708715|NCT00252239|565678644|FG003|Overall Study|Lost to Follow-up|0|||
156708716|NCT03276078|565678648|FG000|Overall Study|Adverse Event|1|||
156708717|NCT03968978|565678649|FG000|Overall Study|Adverse Event|1|||
156708718|NCT03968978|565678650|FG001|Overall Study|Adverse Event|0|||
156708719|NCT00086281|565678654|FG000|Phase 1|Adverse Event|0|||
156791621|NCT05401409|565990928|FG001|Overall Study|Lost to Follow-up|0|||
156791622|NCT02410200|565990930|FG000|Overall Study|Adverse Event|2|||
156791623|NCT02144337|565990931|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
156791624|NCT02144337|565990932|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
156791625|NCT02144337|565990931|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
156791626|NCT02144337|565990932|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
156791627|NCT02144337|565990931|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
156791628|NCT02144337|565990932|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
156791629|NCT02144337|565990931|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
156791630|NCT02144337|565990932|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
156791631|NCT02144337|565990931|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
156791632|NCT02144337|565990932|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
156791633|NCT02402907|565990933|FG000|Overall Study|Delivered vaginally|9|||
156791634|NCT02402907|565990934|FG001|Overall Study|Delivered vaginally|3|||
156791635|NCT02402907|565990933|FG000|Overall Study|Delivered outside of Sinai|1|||
156791636|NCT02402907|565990934|FG001|Overall Study|Delivered outside of Sinai|1|||
156791637|NCT02402907|565990933|FG000|Overall Study|Lost to follow up after C-Section|10|||
156791638|NCT02402907|565990934|FG001|Overall Study|Lost to follow up after C-Section|23|||
156791639|NCT03701074|565990935|FG000|Overall Study|Physician Decision|1|||
156791640|NCT03701074|565990936|FG001|Overall Study|Physician Decision|0|||
156791641|NCT01661595|565990941|FG000|Phase 1: Week 0-4|Adverse Event|1|||
156791642|NCT01661595|565990942|FG001|Phase 1: Week 0-4|Adverse Event|0|||
156791643|NCT01661595|565990943|FG002|Phase 1: Week 0-4|Adverse Event|0|||
156791644|NCT01661595|565990944|FG003|Phase 1: Week 0-4|Adverse Event|0|||
156791645|NCT01661595|565990941|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
156791646|NCT01661595|565990942|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
156791647|NCT01661595|565990943|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
156791648|NCT01661595|565990944|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
156791649|NCT01500135|565990945|FG000|Overall Study|Withdrawal of Consent|4|||
156791650|NCT01500135|565990946|FG001|Overall Study|Withdrawal of Consent|0|||
156791651|NCT01500135|565990945|FG000|Overall Study|Lost to Follow-up|6|||
156791652|NCT01500135|565990946|FG001|Overall Study|Lost to Follow-up|4|||
156872517|NCT02304367|566291238|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
156872518|NCT00594815|566291239|FG000|Overall Study|Never Treated|3|||
156872519|NCT00594815|566291239|FG000|Overall Study|Withdrawal by Subject|2|||
156872520|NCT00594815|566291239|FG000|Overall Study|Toxicity|4|||
156872521|NCT03527732|566291240|FG000|Overall Study|Lost to Follow-up|21|||
156791653|NCT01500135|565990945|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
156791654|NCT01500135|565990946|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
156791655|NCT01500135|565990945|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
156708720|NCT00086281|565678655|FG001|Phase 1|Adverse Event|0|||
156708721|NCT00086281|565678656|FG002|Phase 1|Adverse Event|0|||
156708722|NCT00086281|565678657|FG003|Phase 1|Adverse Event|0|||
156708723|NCT00086281|565678658|FG004|Phase 1|Adverse Event|0|||
156708724|NCT00086281|565678659|FG005|Phase 1|Adverse Event|0|||
156708725|NCT00086281|565678660|FG006|Phase 1|Adverse Event|0|||
156708726|NCT00086281|565678661|FG007|Phase 1|Adverse Event|0|||
156708727|NCT00086281|565678662|FG008|Phase 1|Adverse Event|0|||
156708728|NCT00086281|565678663|FG009|Phase 1|Adverse Event|1|||
156791656|NCT01500135|565990946|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
156791657|NCT01500135|565990945|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
156872522|NCT03527732|566291241|FG001|Overall Study|Lost to Follow-up|23|||
156441201|NCT03903822|564707349|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
156441202|NCT03903822|564707350|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
156441203|NCT03903822|564707351|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
156441204|NCT03903822|564707352|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
156441205|NCT03903822|564707353|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
156441206|NCT03903822|564707354|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
156441207|NCT03903822|564707347|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
156441208|NCT03903822|564707348|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
156441209|NCT03903822|564707349|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
156441210|NCT03903822|564707350|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
156441211|NCT03903822|564707351|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
156441212|NCT03903822|564707352|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
156441213|NCT03903822|564707353|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
156441214|NCT03903822|564707354|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
156441215|NCT03903822|564707347|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
156441216|NCT03903822|564707348|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
156441217|NCT03903822|564707349|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
156441218|NCT03903822|564707350|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
156441219|NCT03903822|564707351|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
156441220|NCT03903822|564707352|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
156441221|NCT03903822|564707353|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
156441222|NCT03903822|564707354|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
156441223|NCT03903822|564707347|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
156441224|NCT03903822|564707348|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
156441225|NCT03903822|564707349|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
156441226|NCT03903822|564707350|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
156441227|NCT03903822|564707351|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
156441228|NCT03903822|564707352|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
156441229|NCT03903822|564707353|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
156441230|NCT03903822|564707354|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
156441231|NCT03903822|564707347|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
156441232|NCT03903822|564707348|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
156441233|NCT03903822|564707349|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
156441234|NCT03903822|564707350|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
156441235|NCT03903822|564707351|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
156441236|NCT03903822|564707352|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
156441237|NCT03903822|564707353|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
156441238|NCT03903822|564707354|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
156441239|NCT03903822|564707347|FG000|Follow up Phase (4 Weeks)|Other|1|||
156441240|NCT03903822|564707348|FG001|Follow up Phase (4 Weeks)|Other|1|||
156441241|NCT03903822|564707349|FG002|Follow up Phase (4 Weeks)|Other|0|||
156441242|NCT03903822|564707350|FG003|Follow up Phase (4 Weeks)|Other|0|||
156441243|NCT03903822|564707351|FG004|Follow up Phase (4 Weeks)|Other|0|||
156441244|NCT03903822|564707352|FG005|Follow up Phase (4 Weeks)|Other|0|||
156441245|NCT03903822|564707353|FG006|Follow up Phase (4 Weeks)|Other|0|||
156441246|NCT03903822|564707354|FG007|Follow up Phase (4 Weeks)|Other|0|||
156441247|NCT00785512|564707357|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
156441248|NCT00785512|564707358|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
156441249|NCT00785512|564707357|FG000|Overall Study|Adverse Event|0|||
156441250|NCT00785512|564707358|FG001|Overall Study|Adverse Event|0|||
156441251|NCT00785512|564707357|FG000|Overall Study|Lack of Efficacy|0|||
156441252|NCT00785512|564707358|FG001|Overall Study|Lack of Efficacy|2|||
156441253|NCT00785512|564707357|FG000|Overall Study|Withdrawal by Subject|0|||
156531798|NCT02684357|565041729|FG004|Part A|Other|0|||
156531799|NCT02684357|565041730|FG005|Part A|Other|0|||
156791658|NCT01500135|565990946|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
156791659|NCT01500135|565990945|FG000|Overall Study|Participant was a Safety Concern|1|||
156791660|NCT01500135|565990946|FG001|Overall Study|Participant was a Safety Concern|0|||
156791661|NCT01500135|565990945|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
156791662|NCT01500135|565990946|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
156791663|NCT00661687|565990947|FG000|Overall Study|Study related symptoms and complaints|5|||
156791664|NCT00661687|565990947|FG000|Overall Study|Positive slit lamp findings|4|||
156791665|NCT00661687|565990947|FG000|Overall Study|Inability to maintain wearing schedule|3|||
156791666|NCT00661687|565990947|FG000|Overall Study|Physician Decision|1|||
156791667|NCT00661687|565990947|FG000|Overall Study|Adverse Event|2|||
156872523|NCT03527732|566291242|FG002|Overall Study|Lost to Follow-up|80|||
156872524|NCT03527732|566291243|FG003|Overall Study|Lost to Follow-up|62|||
156872525|NCT03527732|566291244|FG004|Overall Study|Lost to Follow-up|12|||
156441254|NCT00785512|564707358|FG001|Overall Study|Withdrawal by Subject|1|||
156441255|NCT00785512|564707357|FG000|Overall Study|Lost to Follow-up|3|||
156441256|NCT00785512|564707358|FG001|Overall Study|Lost to Follow-up|0|||
156531800|NCT02684357|565041725|FG000|Part B|Adverse Event (Other)|0|||
156872526|NCT03527732|566291245|FG005|Overall Study|Lost to Follow-up|20|||
156441257|NCT00785512|564707357|FG000|Overall Study|Precedure Refused|0|||
156441258|NCT00785512|564707358|FG001|Overall Study|Precedure Refused|0|||
156441259|NCT00785512|564707357|FG000|Overall Study|IVRS Programing Error|0|||
156441260|NCT00785512|564707358|FG001|Overall Study|IVRS Programing Error|0|||
156441261|NCT00785512|564707357|FG000|Overall Study|Physician Decision|0|||
156441262|NCT00785512|564707358|FG001|Overall Study|Physician Decision|0|||
156441263|NCT00785512|564707357|FG000|Overall Study|Lack of compliance|0|||
156441264|NCT00785512|564707358|FG001|Overall Study|Lack of compliance|1|||
156441265|NCT03403413|564707359|FG000|Overall Study|Lack of Efficacy|2|||
156441266|NCT01565148|564707362|FG000|Overall Study|Withdrawal by Subject|1|||
156441267|NCT01565148|564707363|FG001|Overall Study|Withdrawal by Subject|1|||
156531801|NCT02684357|565041726|FG001|Part B|Adverse Event (Other)|0|||
156531802|NCT02684357|565041727|FG002|Part B|Adverse Event (Other)|0|||
156708729|NCT00086281|565678664|FG010|Phase 1|Adverse Event|2|||
156708730|NCT00086281|565678665|FG011|Phase 1|Adverse Event|1|||
156708731|NCT00086281|565678666|FG012|Phase 1|Adverse Event|1|||
156708732|NCT00086281|565678667|FG013|Phase 1|Adverse Event|1|||
156708733|NCT00086281|565678668|FG014|Phase 1|Adverse Event|2|||
156708734|NCT00086281|565678654|FG000|Phase 1|Protocol Violation|0|||
156708735|NCT00086281|565678655|FG001|Phase 1|Protocol Violation|0|||
156708736|NCT00086281|565678656|FG002|Phase 1|Protocol Violation|0|||
156708737|NCT00086281|565678657|FG003|Phase 1|Protocol Violation|0|||
156708738|NCT00086281|565678658|FG004|Phase 1|Protocol Violation|0|||
156708739|NCT00086281|565678659|FG005|Phase 1|Protocol Violation|0|||
156708740|NCT00086281|565678660|FG006|Phase 1|Protocol Violation|0|||
156708741|NCT00086281|565678661|FG007|Phase 1|Protocol Violation|0|||
156708742|NCT00086281|565678662|FG008|Phase 1|Protocol Violation|0|||
156708743|NCT00086281|565678663|FG009|Phase 1|Protocol Violation|0|||
156708744|NCT00086281|565678664|FG010|Phase 1|Protocol Violation|1|||
156708745|NCT00086281|565678665|FG011|Phase 1|Protocol Violation|0|||
156708746|NCT00086281|565678666|FG012|Phase 1|Protocol Violation|0|||
156708747|NCT00086281|565678667|FG013|Phase 1|Protocol Violation|0|||
156708748|NCT00086281|565678668|FG014|Phase 1|Protocol Violation|0|||
156708749|NCT00086281|565678654|FG000|Phase 1|Serious Adverse Event|0|||
156708750|NCT00086281|565678655|FG001|Phase 1|Serious Adverse Event|0|||
156708751|NCT00086281|565678656|FG002|Phase 1|Serious Adverse Event|0|||
156708752|NCT00086281|565678657|FG003|Phase 1|Serious Adverse Event|0|||
156708753|NCT00086281|565678658|FG004|Phase 1|Serious Adverse Event|0|||
156708754|NCT00086281|565678659|FG005|Phase 1|Serious Adverse Event|0|||
156708755|NCT00086281|565678660|FG006|Phase 1|Serious Adverse Event|0|||
156708756|NCT00086281|565678661|FG007|Phase 1|Serious Adverse Event|0|||
156708757|NCT00086281|565678662|FG008|Phase 1|Serious Adverse Event|0|||
156872527|NCT03599089|566291246|FG000|Overall Study|Lost to Follow-up|1|||
156872528|NCT03599089|566291247|FG001|Overall Study|Lost to Follow-up|0|||
156872529|NCT03599089|566291248|FG002|Overall Study|Lost to Follow-up|0|||
156872530|NCT03599089|566291249|FG003|Overall Study|Lost to Follow-up|0|||
156872531|NCT03599089|566291246|FG000|Overall Study|Withdrawal by Subject|2|||
156872532|NCT03599089|566291247|FG001|Overall Study|Withdrawal by Subject|1|||
156872533|NCT03599089|566291248|FG002|Overall Study|Withdrawal by Subject|0|||
156872534|NCT03599089|566291249|FG003|Overall Study|Withdrawal by Subject|0|||
156872535|NCT03599089|566291246|FG000|Overall Study|Lack of Efficacy|0|||
156872536|NCT03599089|566291247|FG001|Overall Study|Lack of Efficacy|0|||
156872537|NCT03599089|566291248|FG002|Overall Study|Lack of Efficacy|1|||
156872538|NCT03599089|566291249|FG003|Overall Study|Lack of Efficacy|2|||
156872539|NCT03214666|566291250|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872540|NCT03214666|566291251|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872541|NCT03214666|566291252|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872542|NCT03214666|566291253|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872543|NCT03214666|566291254|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
156872544|NCT03214666|566291255|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872545|NCT02207088|566291261|FG000|Overall Study|Adverse Event|2|||
156872546|NCT02500797|566291264|FG000|Overall Study|Cancel (rapid disease progression)|0|||
156872547|NCT02500797|566291265|FG001|Overall Study|Cancel (rapid disease progression)|0|||
156872548|NCT02500797|566291266|FG002|Overall Study|Cancel (rapid disease progression)|0|||
156872549|NCT02500797|566291267|FG003|Overall Study|Cancel (rapid disease progression)|0|||
156872550|NCT02500797|566291268|FG004|Overall Study|Cancel (rapid disease progression)|1|||
156441268|NCT01565148|564707364|FG002|Overall Study|Withdrawal by Subject|1|||
156441269|NCT01565148|564707365|FG003|Overall Study|Withdrawal by Subject|2|||
156441270|NCT01565148|564707362|FG000|Overall Study|Lost to Follow-up|4|||
156531803|NCT02684357|565041728|FG003|Part B|Adverse Event (Other)|1|||
156708758|NCT00086281|565678663|FG009|Phase 1|Serious Adverse Event|0|||
156708759|NCT00086281|565678664|FG010|Phase 1|Serious Adverse Event|0|||
156708760|NCT00086281|565678665|FG011|Phase 1|Serious Adverse Event|0|||
156708761|NCT00086281|565678666|FG012|Phase 1|Serious Adverse Event|0|||
156708762|NCT00086281|565678667|FG013|Phase 1|Serious Adverse Event|0|||
156708763|NCT00086281|565678668|FG014|Phase 1|Serious Adverse Event|1|||
156708764|NCT00086281|565678654|FG000|Phase 2|Adverse Event|0|||
156708765|NCT00086281|565678655|FG001|Phase 2|Adverse Event|0|||
156708766|NCT00086281|565678656|FG002|Phase 2|Adverse Event|0|||
156708767|NCT00086281|565678657|FG003|Phase 2|Adverse Event|0|||
156708768|NCT00086281|565678658|FG004|Phase 2|Adverse Event|0|||
156708769|NCT00086281|565678659|FG005|Phase 2|Adverse Event|0|||
156708770|NCT00086281|565678660|FG006|Phase 2|Adverse Event|0|||
156708771|NCT00086281|565678661|FG007|Phase 2|Adverse Event|0|||
156708772|NCT00086281|565678662|FG008|Phase 2|Adverse Event|0|||
156708773|NCT00086281|565678663|FG009|Phase 2|Adverse Event|0|||
156708774|NCT00086281|565678664|FG010|Phase 2|Adverse Event|0|||
156708775|NCT00086281|565678665|FG011|Phase 2|Adverse Event|0|||
156708776|NCT00086281|565678666|FG012|Phase 2|Adverse Event|1|||
156708777|NCT00086281|565678667|FG013|Phase 2|Adverse Event|1|||
156708778|NCT00086281|565678668|FG014|Phase 2|Adverse Event|0|||
156708779|NCT00908310|565678671|FG000|Overall Study|Death|37|||
156708780|NCT00908310|565678671|FG000|Overall Study|Withdrawal by Subject|7|||
156708781|NCT00908310|565678671|FG000|Overall Study|Lost to Follow-up|7|||
156708782|NCT00908310|565678671|FG000|Overall Study|Screening failure|5|||
156708783|NCT00908310|565678671|FG000|Overall Study|Other reasons|4|||
156708784|NCT03456453|565678672|FG000|Overall Study|Withdrawal by Subject|2|||
156708785|NCT03456453|565678673|FG001|Overall Study|Withdrawal by Subject|0|||
156708786|NCT03456453|565678672|FG000|Overall Study|Not released to community|1|||
156708787|NCT03456453|565678673|FG001|Overall Study|Not released to community|5|||
156708788|NCT03456453|565678672|FG000|Overall Study|Lost to Follow-up|0|||
156708789|NCT03456453|565678673|FG001|Overall Study|Lost to Follow-up|2|||
156708790|NCT00896480|565678674|FG000|Overall Study|Disease progression/recurrence|21|||
156708791|NCT00351533|565678675|FG000|Overall Study|Extubated before first BAL|1|||
156708792|NCT00351533|565678676|FG001|Overall Study|Extubated before first BAL|0|||
156708793|NCT00351533|565678675|FG000|Overall Study|Lost to Follow-up|1|||
156708794|NCT00351533|565678676|FG001|Overall Study|Lost to Follow-up|3|||
156708795|NCT00351533|565678675|FG000|Overall Study|Physician Decision|0|||
156708796|NCT00351533|565678676|FG001|Overall Study|Physician Decision|1|||
156708797|NCT00351533|565678675|FG000|Overall Study|Withdrawal by Subject|0|||
156708798|NCT00351533|565678676|FG001|Overall Study|Withdrawal by Subject|1|||
156708799|NCT01104792|565678680|FG000|Overall Study|Adverse Event|77|||
156708800|NCT01104792|565678680|FG000|Overall Study|Insufficient Therapeutic Response|22|||
156708801|NCT01104792|565678680|FG000|Overall Study|Protocol Violation|45|||
156708802|NCT01104792|565678680|FG000|Overall Study|Withdrawal of Consent|179|||
156708803|NCT01104792|565678680|FG000|Overall Study|Lost to Follow-up|43|||
156708804|NCT01104792|565678680|FG000|Overall Study|Reasons Not Specified|27|||
156791668|NCT00912509|565990948|FG000|Overall Study|Lost to Follow-up|1|||
156791669|NCT00912509|565990949|FG001|Overall Study|Lost to Follow-up|0|||
156791670|NCT00912509|565990948|FG000|Overall Study|Lack of Efficacy|4|||
156791671|NCT00912509|565990949|FG001|Overall Study|Lack of Efficacy|3|||
156791672|NCT01362530|565990951|FG000|Base Study (Cycle 1)|Adverse Event|2|||
156791673|NCT01362530|565990952|FG001|Base Study (Cycle 1)|Adverse Event|0|||
156791674|NCT01362530|565990951|FG000|Base Study (Cycle 1)|Physician Decision|0|||
156791675|NCT01362530|565990952|FG001|Base Study (Cycle 1)|Physician Decision|1|||
156791676|NCT01362530|565990951|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
156791677|NCT01362530|565990952|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
156791678|NCT01362530|565990951|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
156791679|NCT01362530|565990952|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
156791680|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
156791681|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
156791682|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
156791683|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
156791684|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
156791685|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
156791686|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
156791687|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
156791688|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
156791689|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
156791690|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
156791691|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
156791692|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
156791693|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
156791694|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
156708805|NCT01104792|565678680|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
156708806|NCT00103610|565678681|FG000|Overall Study|Entered Rescue Procedure|10|||
156708807|NCT00103610|565678682|FG001|Overall Study|Entered Rescue Procedure|52|||
156708808|NCT00103610|565678681|FG000|Overall Study|Death|16|||
156708809|NCT00103610|565678682|FG001|Overall Study|Death|12|||
156708810|NCT00103610|565678681|FG000|Overall Study|Elective Withdrawal|4|||
156708811|NCT00103610|565678682|FG001|Overall Study|Elective Withdrawal|0|||
156708812|NCT00103610|565678681|FG000|Overall Study|Lost to Follow-up|3|||
156708813|NCT00103610|565678682|FG001|Overall Study|Lost to Follow-up|1|||
156708814|NCT00103610|565678681|FG000|Overall Study|Adverse Event|2|||
156708815|NCT00103610|565678682|FG001|Overall Study|Adverse Event|2|||
156332559|NCT02975336|564317339|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
156332560|NCT02975336|564317340|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
156332561|NCT02975336|564317341|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
156332562|NCT02975336|564317342|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
156332563|NCT02975336|564317343|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
156332564|NCT02975336|564317344|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
156332565|NCT02975336|564317345|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
156332566|NCT02975336|564317338|FG000|LTE (104 Weeks)|Adverse Event|0|||
156332567|NCT02975336|564317339|FG001|LTE (104 Weeks)|Adverse Event|0|||
156332568|NCT02975336|564317340|FG002|LTE (104 Weeks)|Adverse Event|0|||
156332569|NCT02975336|564317341|FG003|LTE (104 Weeks)|Adverse Event|0|||
156332570|NCT02975336|564317342|FG004|LTE (104 Weeks)|Adverse Event|7|||
156332571|NCT02975336|564317343|FG005|LTE (104 Weeks)|Adverse Event|4|||
156332572|NCT02975336|564317344|FG006|LTE (104 Weeks)|Adverse Event|2|||
156332573|NCT02975336|564317345|FG007|LTE (104 Weeks)|Adverse Event|0|||
156332574|NCT02975336|564317338|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
156332575|NCT02975336|564317339|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
156332576|NCT02975336|564317340|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
156332577|NCT02975336|564317341|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
156332578|NCT02975336|564317342|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
156332579|NCT02975336|564317343|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
156332580|NCT02975336|564317344|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
156332581|NCT02975336|564317345|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
156332582|NCT02975336|564317338|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
156332583|NCT02975336|564317339|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
156441271|NCT01565148|564707363|FG001|Overall Study|Lost to Follow-up|4|||
156441272|NCT01565148|564707364|FG002|Overall Study|Lost to Follow-up|0|||
156708816|NCT00103610|565678681|FG000|Overall Study|Other|2|||
156708817|NCT00103610|565678682|FG001|Overall Study|Other|7|||
156708818|NCT00103610|565678681|FG000|Overall Study|Failed mobilization|1|||
156708819|NCT00103610|565678682|FG001|Overall Study|Failed mobilization|5|||
156708820|NCT00103610|565678681|FG000|Overall Study|Noncompliance|0|||
156708821|NCT00103610|565678682|FG001|Overall Study|Noncompliance|1|||
156708822|NCT00315731|565678683|FG000|Overall Study|Lost to Follow-up|1|||
156708823|NCT00315731|565678683|FG000|Overall Study|Death|5|||
156441273|NCT01565148|564707365|FG003|Overall Study|Lost to Follow-up|3|||
156708824|NCT01680497|565678685|FG000|Overall Study|Lost to Follow-up|2|||
156708825|NCT04123561|565678688|FG000|Overall Study|Lost to Follow-up|20|||
156708826|NCT04123561|565678689|FG001|Overall Study|Lost to Follow-up|12|||
156708827|NCT04123561|565678690|FG002|Overall Study|Lost to Follow-up|5|||
156708828|NCT04123561|565678688|FG000|Overall Study|Withdrawal by Subject|9|||
156708829|NCT04123561|565678689|FG001|Overall Study|Withdrawal by Subject|7|||
156708830|NCT04123561|565678690|FG002|Overall Study|Withdrawal by Subject|9|||
156708831|NCT04123561|565678688|FG000|Overall Study|Lack of Efficacy|7|||
156708832|NCT04123561|565678689|FG001|Overall Study|Lack of Efficacy|8|||
156708833|NCT04123561|565678690|FG002|Overall Study|Lack of Efficacy|6|||
156708834|NCT04123561|565678688|FG000|Overall Study|Adverse Event|5|||
156708835|NCT04123561|565678689|FG001|Overall Study|Adverse Event|2|||
156708836|NCT04123561|565678690|FG002|Overall Study|Adverse Event|3|||
156708837|NCT04123561|565678688|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
156708838|NCT04123561|565678689|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
156708839|NCT04123561|565678690|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
156708840|NCT04123561|565678688|FG000|Overall Study|Death|0|||
156708841|NCT04123561|565678689|FG001|Overall Study|Death|0|||
156708842|NCT04123561|565678690|FG002|Overall Study|Death|1|||
156708843|NCT04123561|565678688|FG000|Overall Study|Protocol Violation|0|||
156708844|NCT04123561|565678689|FG001|Overall Study|Protocol Violation|1|||
156708845|NCT04123561|565678690|FG002|Overall Study|Protocol Violation|0|||
156708846|NCT02551666|565678706|FG000|Overall Study|Withdrawal by Subject|1|||
156708847|NCT02551666|565678707|FG001|Overall Study|Withdrawal by Subject|3|||
156708848|NCT02017015|565680500|FG000|Overall Study|Adverse Event|9|||
156708849|NCT02017015|565680500|FG000|Overall Study|Withdrawal by Subject|21|||
156332584|NCT02975336|564317340|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
156332585|NCT02975336|564317341|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
156441274|NCT01565148|564707362|FG000|Overall Study|Rescue Therapy|8|||
156708850|NCT02017015|565680500|FG000|Overall Study|Death|4|||
156708851|NCT02017015|565680500|FG000|Overall Study|Progressive Disease|31|||
156708852|NCT02017015|565680500|FG000|Overall Study|Non-compliance with study drug|2|||
156332586|NCT02975336|564317342|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
156441275|NCT01565148|564707363|FG001|Overall Study|Rescue Therapy|5|||
156441276|NCT01565148|564707364|FG002|Overall Study|Rescue Therapy|5|||
156708853|NCT02017015|565680500|FG000|Overall Study|Physician Decision|2|||
156708854|NCT01277601|565680503|FG000|Overall Study|Adverse Event|5|||
156708855|NCT01277601|565680504|FG001|Overall Study|Adverse Event|3|||
156708856|NCT01277601|565680505|FG002|Overall Study|Adverse Event|0|||
156708857|NCT01277601|565680506|FG003|Overall Study|Adverse Event|7|||
156708858|NCT01277601|565680503|FG000|Overall Study|Withdrawal by Subject|18|||
156708859|NCT01277601|565680504|FG001|Overall Study|Withdrawal by Subject|21|||
156791695|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
156791696|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
156791697|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
156791698|NCT01034657|565990953|FG000|Core Phase|Withdrawal by Subject|1|||
156791699|NCT01034657|565990954|FG001|Core Phase|Withdrawal by Subject|0|||
156791700|NCT01034657|565990955|FG002|Core Phase|Withdrawal by Subject|0|||
156791701|NCT01034657|565990953|FG000|Core Phase|Lack of Efficacy|2|||
156791702|NCT01034657|565990954|FG001|Core Phase|Lack of Efficacy|0|||
156791703|NCT01034657|565990955|FG002|Core Phase|Lack of Efficacy|0|||
156791704|NCT01034657|565990953|FG000|Core Phase|Abnormal laboratory value|1|||
156791705|NCT01034657|565990954|FG001|Core Phase|Abnormal laboratory value|0|||
156791706|NCT01034657|565990955|FG002|Core Phase|Abnormal laboratory value|0|||
156791707|NCT01034657|565990953|FG000|Core Phase|Adverse Event|8|||
156791708|NCT01034657|565990954|FG001|Core Phase|Adverse Event|0|||
156791709|NCT01034657|565990955|FG002|Core Phase|Adverse Event|0|||
156791710|NCT01034657|565990953|FG000|Core Phase|Protocol Violation|2|||
156791711|NCT01034657|565990954|FG001|Core Phase|Protocol Violation|0|||
156791712|NCT01034657|565990955|FG002|Core Phase|Protocol Violation|0|||
156791713|NCT01034657|565990953|FG000|Randomized Phase|Withdrawal by Subject|0|||
156791714|NCT01034657|565990954|FG001|Randomized Phase|Withdrawal by Subject|2|||
156791715|NCT01034657|565990955|FG002|Randomized Phase|Withdrawal by Subject|0|||
156791716|NCT01034657|565990953|FG000|Randomized Phase|Lack of Efficacy|5|||
156791717|NCT01034657|565990954|FG001|Randomized Phase|Lack of Efficacy|1|||
156791718|NCT01034657|565990955|FG002|Randomized Phase|Lack of Efficacy|0|||
156791719|NCT01034657|565990953|FG000|Randomized Phase|Abnormal laboratory value|0|||
156791720|NCT01034657|565990954|FG001|Randomized Phase|Abnormal laboratory value|1|||
156791721|NCT01034657|565990955|FG002|Randomized Phase|Abnormal laboratory value|0|||
156791722|NCT01034657|565990953|FG000|Randomized Phase|Adverse Event|0|||
156791723|NCT01034657|565990954|FG001|Randomized Phase|Adverse Event|2|||
156791724|NCT01034657|565990955|FG002|Randomized Phase|Adverse Event|1|||
156791725|NCT02715856|565990956|FG000|Overall Study|Software Issues|12|||
156791726|NCT02715856|565990957|FG001|Overall Study|Software Issues|7|||
156791727|NCT02715856|565990956|FG000|Overall Study|Death|6|||
156791728|NCT02715856|565990957|FG001|Overall Study|Death|5|||
156791729|NCT02715856|565990956|FG000|Overall Study|Non- Compliant|0|||
156791730|NCT02715856|565990957|FG001|Overall Study|Non- Compliant|40|||
156791731|NCT01557569|565990958|FG000|Overall Study|Adverse Event|2|||
156791732|NCT01557569|565990959|FG001|Overall Study|Adverse Event|0|||
156791733|NCT01557569|565990958|FG000|Overall Study|high blood pressure|0|||
156791734|NCT01557569|565990959|FG001|Overall Study|high blood pressure|1|||
156791735|NCT01557569|565990958|FG000|Overall Study|Withdrawal by Subject|3|||
156791736|NCT01557569|565990959|FG001|Overall Study|Withdrawal by Subject|5|||
156791737|NCT01557569|565990958|FG000|Overall Study|noncompliance with rules of residential|0|||
156791738|NCT01557569|565990959|FG001|Overall Study|noncompliance with rules of residential|1|||
156791739|NCT01050218|565990960|FG000|Overall Study|Adverse Event|37|||
156791740|NCT01050218|565990960|FG000|Overall Study|Lack of Efficacy|8|||
156791741|NCT01050218|565990960|FG000|Overall Study|Protocol Violation|3|||
156791742|NCT01050218|565990960|FG000|Overall Study|Withdrawal by Subject|18|||
156791743|NCT01050218|565990960|FG000|Overall Study|Discontinued by sponsor|18|||
156791744|NCT01050218|565990960|FG000|Overall Study|Compliance|2|||
156791745|NCT01050218|565990960|FG000|Overall Study|Failed to return|7|||
156791746|NCT01050218|565990960|FG000|Overall Study|Serious Adverse Event|1|||
156791747|NCT01050218|565990960|FG000|Overall Study|Family emergency|1|||
156791748|NCT03682367|565990963|FG000|Overall Study|Protocol Violation|2|||
156791749|NCT03682367|565990964|FG001|Overall Study|Protocol Violation|1|||
156791750|NCT03682367|565990963|FG000|Overall Study|Closed Study Early|0|||
156791751|NCT03682367|565990964|FG001|Overall Study|Closed Study Early|3|||
156791752|NCT00889005|565990965|FG000|Overall Study|Lost to Follow-up|4|||
156791753|NCT00889005|565990966|FG001|Overall Study|Lost to Follow-up|2|||
156791754|NCT00889005|565990965|FG000|Overall Study|Withdrawal by Subject|4|||
156791755|NCT00889005|565990966|FG001|Overall Study|Withdrawal by Subject|0|||
156791756|NCT01998477|565990967|FG000|Overall Study|Lost to Follow-up|4|||
156791757|NCT01998477|565990968|FG001|Overall Study|Lost to Follow-up|5|||
156791758|NCT01998477|565990967|FG000|Overall Study|Withdrawal by Subject|6|||
156791759|NCT01998477|565990968|FG001|Overall Study|Withdrawal by Subject|0|||
156791760|NCT00129974|565990969|FG000|Overall Study|Other|1|||
156791761|NCT00756314|565990970|FG000|Overall Study|Lost to Follow-up|2|||
156791762|NCT00756314|565990971|FG001|Overall Study|Lost to Follow-up|59|||
156791763|NCT02872142|565990972|FG000|Overall Study|Adverse Event|2|||
156791764|NCT02872142|565990972|FG000|Overall Study|Death|1|||
156791765|NCT02872142|565990972|FG000|Overall Study|Participant Decision|3|||
156791766|NCT00309946|565990973|FG000|Overall Study|Withdrawal by Subject|1|||
156791767|NCT02244957|565990974|FG000|Overall Study|Lack of Efficacy|1|||
156791768|NCT02244957|565990975|FG001|Overall Study|Lack of Efficacy|0|||
156791769|NCT04691115|565990978|FG000|Overall Study|Withdrawal by Subject|0|||
156791770|NCT04691115|565990979|FG001|Overall Study|Withdrawal by Subject|0|||
156791771|NCT04691115|565990980|FG002|Overall Study|Withdrawal by Subject|0|||
156791772|NCT04691115|565990981|FG003|Overall Study|Withdrawal by Subject|0|||
156441277|NCT01565148|564707365|FG003|Overall Study|Rescue Therapy|8|||
156441278|NCT01565148|564707362|FG000|Overall Study|Death|0|||
156441279|NCT01565148|564707363|FG001|Overall Study|Death|0|||
156708860|NCT01277601|565680505|FG002|Overall Study|Withdrawal by Subject|8|||
156708861|NCT01277601|565680506|FG003|Overall Study|Withdrawal by Subject|17|||
156708862|NCT01277601|565680503|FG000|Overall Study|Lost to Follow-up|7|||
156708863|NCT01277601|565680504|FG001|Overall Study|Lost to Follow-up|9|||
156708864|NCT01277601|565680505|FG002|Overall Study|Lost to Follow-up|4|||
156708865|NCT01277601|565680506|FG003|Overall Study|Lost to Follow-up|2|||
156708866|NCT01277601|565680503|FG000|Overall Study|Physician Decision|3|||
156708867|NCT01277601|565680504|FG001|Overall Study|Physician Decision|5|||
156708868|NCT01277601|565680505|FG002|Overall Study|Physician Decision|1|||
156708869|NCT01277601|565680506|FG003|Overall Study|Physician Decision|6|||
156708870|NCT01277601|565680503|FG000|Overall Study|Pregnancy|2|||
156708871|NCT01277601|565680504|FG001|Overall Study|Pregnancy|2|||
156708872|NCT01277601|565680505|FG002|Overall Study|Pregnancy|4|||
156708873|NCT01277601|565680506|FG003|Overall Study|Pregnancy|1|||
156708874|NCT01277601|565680503|FG000|Overall Study|Noncompliance with Study Drug|1|||
156708875|NCT01277601|565680504|FG001|Overall Study|Noncompliance with Study Drug|3|||
156708876|NCT01277601|565680505|FG002|Overall Study|Noncompliance with Study Drug|2|||
156708877|NCT01277601|565680506|FG003|Overall Study|Noncompliance with Study Drug|0|||
156708878|NCT01277601|565680503|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
156708879|NCT01277601|565680504|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
156708880|NCT01277601|565680505|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
156708881|NCT01277601|565680506|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
156708882|NCT01277601|565680503|FG000|Overall Study|Protocol Violation|0|||
156708883|NCT01277601|565680504|FG001|Overall Study|Protocol Violation|2|||
156708884|NCT01277601|565680505|FG002|Overall Study|Protocol Violation|5|||
156708885|NCT01277601|565680506|FG003|Overall Study|Protocol Violation|0|||
156708886|NCT01277601|565680503|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
156708887|NCT01277601|565680504|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
156708888|NCT01277601|565680505|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
156441280|NCT01565148|564707364|FG002|Overall Study|Death|1|||
156441281|NCT01565148|564707365|FG003|Overall Study|Death|0|||
156441282|NCT01565148|564707362|FG000|Overall Study|Physician Decision|2|||
156441283|NCT01565148|564707363|FG001|Overall Study|Physician Decision|5|||
156441284|NCT01565148|564707364|FG002|Overall Study|Physician Decision|0|||
156441285|NCT01565148|564707365|FG003|Overall Study|Physician Decision|0|||
156441286|NCT01388361|564707366|FG000|Overall Study|Adverse Event|0|||
156441287|NCT01388361|564707367|FG001|Overall Study|Adverse Event|5|||
156441288|NCT01388361|564707368|FG002|Overall Study|Adverse Event|1|||
156441289|NCT01388361|564707366|FG000|Overall Study|Protocol Violation|0|||
156441290|NCT01388361|564707367|FG001|Overall Study|Protocol Violation|0|||
156441291|NCT01388361|564707368|FG002|Overall Study|Protocol Violation|2|||
156441292|NCT01388361|564707366|FG000|Overall Study|Withdrawal criteria|12|||
156441293|NCT01388361|564707367|FG001|Overall Study|Withdrawal criteria|7|||
156441294|NCT01388361|564707368|FG002|Overall Study|Withdrawal criteria|10|||
156441295|NCT01388361|564707366|FG000|Overall Study|Unclassified|0|||
156441296|NCT01388361|564707367|FG001|Overall Study|Unclassified|0|||
156441297|NCT01388361|564707368|FG002|Overall Study|Unclassified|1|||
156441298|NCT00529659|564707370|FG000|Overall Study|Adverse Event|8|||
156441299|NCT00529659|564707371|FG001|Overall Study|Adverse Event|7|||
156441300|NCT00529659|564707370|FG000|Overall Study|Lost to Follow-up|0|||
156441301|NCT00529659|564707371|FG001|Overall Study|Lost to Follow-up|2|||
156441302|NCT00529659|564707370|FG000|Overall Study|Physician Decision|0|||
156441303|NCT00529659|564707371|FG001|Overall Study|Physician Decision|2|||
156441304|NCT00529659|564707370|FG000|Overall Study|Protocol Violation|2|||
156441305|NCT00529659|564707371|FG001|Overall Study|Protocol Violation|6|||
156441306|NCT00529659|564707370|FG000|Overall Study|Withdrawal by Subject|1|||
156441307|NCT00529659|564707371|FG001|Overall Study|Withdrawal by Subject|6|||
156441308|NCT03565315|564707372|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
156441309|NCT03565315|564707373|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
156441310|NCT03565315|564707374|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
156441311|NCT03565315|564707375|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
156441312|NCT01170962|564707376|FG000|Treatment Period|Lack of Efficacy|96|||
156441313|NCT01170962|564707377|FG001|Treatment Period|Lack of Efficacy|91|||
156791773|NCT04691115|565990982|FG004|Overall Study|Withdrawal by Subject|0|||
156791774|NCT04691115|565990983|FG005|Overall Study|Withdrawal by Subject|1|||
156791775|NCT04691115|565990984|FG006|Overall Study|Withdrawal by Subject|0|||
156441314|NCT01170962|564707378|FG002|Treatment Period|Lack of Efficacy|7|||
156441315|NCT01170962|564707376|FG000|Treatment Period|Adverse Event|11|||
156791776|NCT04691115|565990985|FG007|Overall Study|Withdrawal by Subject|0|||
156441316|NCT01170962|564707377|FG001|Treatment Period|Adverse Event|12|||
156441317|NCT01170962|564707378|FG002|Treatment Period|Adverse Event|3|||
156708889|NCT01277601|565680506|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
156708890|NCT02260570|565680508|FG000|Overall Study|Withdrawal by Subject|2|||
156708891|NCT02260570|565680509|FG001|Overall Study|Withdrawal by Subject|1|||
156708892|NCT02260570|565680508|FG000|Overall Study|Physician Decision|1|||
156441318|NCT01170962|564707376|FG000|Treatment Period|Withdrawal by Subject|2|||
156441319|NCT01170962|564707377|FG001|Treatment Period|Withdrawal by Subject|1|||
156441320|NCT01170962|564707378|FG002|Treatment Period|Withdrawal by Subject|0|||
156441321|NCT01170962|564707376|FG000|Treatment Period|Lost to Follow-up|1|||
156708893|NCT02260570|565680509|FG001|Overall Study|Physician Decision|1|||
156708894|NCT04034927|565680510|FG000|Overall Study|Adverse Event|4|||
156708895|NCT04034927|565680511|FG001|Overall Study|Adverse Event|9|||
156708896|NCT04034927|565680510|FG000|Overall Study|Death|0|||
156708897|NCT04034927|565680511|FG001|Overall Study|Death|1|||
156708898|NCT04034927|565680510|FG000|Overall Study|Withdrawal by Subject|0|||
156708899|NCT04034927|565680511|FG001|Overall Study|Withdrawal by Subject|3|||
156708900|NCT04034927|565680510|FG000|Overall Study|Still on Treatment|2|||
156708901|NCT04034927|565680511|FG001|Overall Study|Still on Treatment|1|||
156708902|NCT04034927|565680510|FG000|Overall Study|Other|1|||
156708903|NCT04034927|565680511|FG001|Overall Study|Other|1|||
156708904|NCT00369486|565680513|FG000|4-Week Visit|Missed visit|2|||
156708905|NCT00369486|565680514|FG001|4-Week Visit|Missed visit|2|||
156708906|NCT00369486|565680515|FG002|4-Week Visit|Missed visit|0|||
156708907|NCT00369486|565680516|FG003|4-Week Visit|Missed visit|2|||
156708908|NCT00369486|565680517|FG004|4-Week Visit|Missed visit|1|||
156708909|NCT00369486|565680513|FG000|4-Week Visit|Dropped|0|||
156708910|NCT00369486|565680514|FG001|4-Week Visit|Dropped|0|||
156708911|NCT00369486|565680515|FG002|4-Week Visit|Dropped|1|||
156708912|NCT00369486|565680516|FG003|4-Week Visit|Dropped|0|||
156708913|NCT00369486|565680517|FG004|4-Week Visit|Dropped|0|||
156708914|NCT00369486|565680513|FG000|8-Week Visit|Missed visit|0|||
156708915|NCT00369486|565680514|FG001|8-Week Visit|Missed visit|1|||
156708916|NCT00369486|565680515|FG002|8-Week Visit|Missed visit|0|||
156708917|NCT00369486|565680516|FG003|8-Week Visit|Missed visit|0|||
156708918|NCT00369486|565680517|FG004|8-Week Visit|Missed visit|1|||
156708919|NCT00369486|565680513|FG000|8-Week Visit|Dropped|0|||
156708920|NCT00369486|565680514|FG001|8-Week Visit|Dropped|0|||
156708921|NCT00369486|565680515|FG002|8-Week Visit|Dropped|0|||
156708922|NCT00369486|565680516|FG003|8-Week Visit|Dropped|1|||
156708923|NCT00369486|565680517|FG004|8-Week Visit|Dropped|0|||
156708924|NCT00369486|565680513|FG000|17-Week Visit|Missed visit|0|||
156708925|NCT00369486|565680514|FG001|17-Week Visit|Missed visit|0|||
156708926|NCT00369486|565680515|FG002|17-Week Visit|Missed visit|1|||
156708927|NCT00369486|565680516|FG003|17-Week Visit|Missed visit|1|||
156708928|NCT00369486|565680517|FG004|17-Week Visit|Missed visit|1|||
156708929|NCT00369486|565680513|FG000|34-Week Visit|Dropped|0|||
156872551|NCT02500797|566291269|FG005|Overall Study|Cancel (rapid disease progression)|1|||
156872552|NCT02500797|566291270|FG006|Overall Study|Cancel (rapid disease progression)|0|||
156872553|NCT02500797|566291271|FG007|Overall Study|Cancel (rapid disease progression)|0|||
156872554|NCT02500797|566291264|FG000|Overall Study|Withdrawal by Subject|1|||
156872555|NCT02500797|566291265|FG001|Overall Study|Withdrawal by Subject|0|||
156872556|NCT02500797|566291266|FG002|Overall Study|Withdrawal by Subject|0|||
156872557|NCT02500797|566291267|FG003|Overall Study|Withdrawal by Subject|0|||
156872558|NCT02500797|566291268|FG004|Overall Study|Withdrawal by Subject|0|||
156708930|NCT00369486|565680514|FG001|34-Week Visit|Dropped|1|||
156708931|NCT00369486|565680515|FG002|34-Week Visit|Dropped|1|||
156441322|NCT01170962|564707377|FG001|Treatment Period|Lost to Follow-up|1|||
156441323|NCT01170962|564707378|FG002|Treatment Period|Lost to Follow-up|1|||
156708932|NCT00369486|565680516|FG003|34-Week Visit|Dropped|3|||
156708933|NCT00369486|565680517|FG004|34-Week Visit|Dropped|3|||
156708934|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #1|24|||
156708935|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #1|0|||
156708936|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
156708937|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
156872559|NCT02500797|566291269|FG005|Overall Study|Withdrawal by Subject|0|||
156872560|NCT02500797|566291270|FG006|Overall Study|Withdrawal by Subject|0|||
156872561|NCT02500797|566291271|FG007|Overall Study|Withdrawal by Subject|0|||
156872562|NCT00357006|566291278|FG000|Overall Study|Lost to Follow-up|1|||
156708938|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708939|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708940|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
156872563|NCT00357006|566291279|FG001|Overall Study|Lost to Follow-up|2|||
156441324|NCT01170962|564707376|FG000|Treatment Period|Participant no longer meets criteria|0|||
156708941|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
156708942|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
156708943|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
156708944|NCT03888066|565680518|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708945|NCT03888066|565680519|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708946|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708947|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156872564|NCT00357006|566291280|FG002|Overall Study|Lost to Follow-up|1|||
156708948|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
156708949|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
156708950|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708951|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708952|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
156708953|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708954|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #2|5|||
156708955|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #2|0|||
156708956|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
156708957|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
156708958|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
156708959|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
156708960|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
156708961|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
156708962|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #3|11|||
156708963|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #3|0|||
156708964|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
156708965|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
156708966|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
156708967|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156708968|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708969|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708970|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4|3|||
156708971|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4|0|||
156708972|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
156708973|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
156708974|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
156708975|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
156708976|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
156708977|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156708978|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
156708979|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
156708980|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
156708981|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708982|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
156708983|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156708984|NCT03888066|565680518|FG000|Run-in Phase|AE (Adverse Event)|17|||
156708985|NCT03888066|565680519|FG001|Run-in Phase|AE (Adverse Event)|0|||
156708986|NCT03888066|565680518|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
156708987|NCT03888066|565680519|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
156708988|NCT03888066|565680518|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708989|NCT03888066|565680519|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708990|NCT03888066|565680518|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708991|NCT03888066|565680519|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708992|NCT03888066|565680518|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
156708993|NCT03888066|565680519|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156708994|NCT03888066|565680518|FG000|Run-in Phase|Withdrawal by Subject|43|||
156708995|NCT03888066|565680519|FG001|Run-in Phase|Withdrawal by Subject|0|||
156708996|NCT03888066|565680518|FG000|Run-in Phase|AE; Physician Decision|1|||
156708997|NCT03888066|565680519|FG001|Run-in Phase|AE; Physician Decision|0|||
156708998|NCT03888066|565680518|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
156708999|NCT03888066|565680519|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156709000|NCT03888066|565680518|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
156709001|NCT03888066|565680519|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
156709002|NCT03888066|565680518|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
156872565|NCT00357006|566291278|FG000|Overall Study|Withdrawal by Subject|1|||
156872566|NCT00357006|566291279|FG001|Overall Study|Withdrawal by Subject|3|||
156872567|NCT00357006|566291280|FG002|Overall Study|Withdrawal by Subject|2|||
156872568|NCT03710161|566291281|FG000|Overall Study|Study halted due to COVID pandemic|3|||
156531804|NCT02684357|565041729|FG004|Part B|Adverse Event (Other)|1|||
156531805|NCT02684357|565041730|FG005|Part B|Adverse Event (Other)|1|||
156531806|NCT02684357|565041725|FG000|Part B|Lost to Follow-up|0|||
156531807|NCT02684357|565041726|FG001|Part B|Lost to Follow-up|0|||
156709003|NCT03888066|565680519|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156709004|NCT03888066|565680518|FG000|Run-in Phase|Death|1|||
156709005|NCT03888066|565680519|FG001|Run-in Phase|Death|0|||
156709006|NCT03888066|565680518|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
156709007|NCT03888066|565680519|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
156709008|NCT03888066|565680518|FG000|Run-in Phase|Physician Decision|1|||
156709009|NCT03888066|565680519|FG001|Run-in Phase|Physician Decision|0|||
156709010|NCT03888066|565680518|FG000|Run-in Phase|Protocol Violation|13|||
156709011|NCT03888066|565680519|FG001|Run-in Phase|Protocol Violation|0|||
156709012|NCT03888066|565680518|FG000|Run-in Phase|Sponsor Request|34|||
156709013|NCT03888066|565680519|FG001|Run-in Phase|Sponsor Request|0|||
156709014|NCT03888066|565680518|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
156709015|NCT03888066|565680519|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
156709016|NCT03888066|565680518|FG000|Run-in Phase|Withdrawal Of Consent|1|||
156709017|NCT03888066|565680519|FG001|Run-in Phase|Withdrawal Of Consent|0|||
156709018|NCT03888066|565680518|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
156709019|NCT03888066|565680519|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
156709020|NCT03888066|565680518|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
156709021|NCT03888066|565680519|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
156709022|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
156709023|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
156709024|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
156709025|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
156709026|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
156709027|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
156709028|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
156709029|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
156709030|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
156709031|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
156709032|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
156709033|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
156709034|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
156709035|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
156709036|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
156709037|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
156709038|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
156709039|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
156709040|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
156709041|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
156709042|NCT02077140|565680520|FG000|Overall Study|Lost to Follow-up|4|||
156709043|NCT02077140|565680521|FG001|Overall Study|Lost to Follow-up|1|||
156709044|NCT02077140|565680522|FG002|Overall Study|Lost to Follow-up|2|||
156709045|NCT02077140|565680523|FG003|Overall Study|Lost to Follow-up|2|||
156709046|NCT02077140|565680524|FG004|Overall Study|Lost to Follow-up|3|||
156709047|NCT02077140|565680520|FG000|Overall Study|Withdrawal by Subject|0|||
156709048|NCT02077140|565680521|FG001|Overall Study|Withdrawal by Subject|1|||
156709049|NCT02077140|565680522|FG002|Overall Study|Withdrawal by Subject|0|||
156709050|NCT02077140|565680523|FG003|Overall Study|Withdrawal by Subject|2|||
156709051|NCT02077140|565680524|FG004|Overall Study|Withdrawal by Subject|2|||
156709052|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
156709053|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
156709054|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
156709055|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
156709056|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
156709057|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709058|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709059|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709060|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709061|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709062|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
156709063|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
156709064|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
156709065|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
156709066|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
156709067|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156709068|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156531808|NCT02684357|565041727|FG002|Part B|Lost to Follow-up|0|||
156709069|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156709070|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156791777|NCT04691115|565990986|FG008|Overall Study|Withdrawal by Subject|0|||
156791778|NCT04691115|565990987|FG009|Overall Study|Withdrawal by Subject|0|||
156791779|NCT04691115|565990988|FG010|Overall Study|Withdrawal by Subject|0|||
156709071|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156872569|NCT03710161|566291282|FG001|Overall Study|Study halted due to COVID pandemic|2|||
156872570|NCT02637037|566291285|FG000|Overall Study|Positive drug screen at admission|1|||
156872571|NCT02637037|566291286|FG001|Overall Study|Positive drug screen at admission|0|||
156872572|NCT02637037|566291285|FG000|Overall Study|Withdrawal by Subject|2|||
156872573|NCT02637037|566291286|FG001|Overall Study|Withdrawal by Subject|1|||
156872574|NCT02637037|566291285|FG000|Overall Study|Adverse Event|1|||
156872575|NCT02637037|566291286|FG001|Overall Study|Adverse Event|0|||
156872576|NCT03339219|566291287|FG000|Overall Study|Death|12|||
156872577|NCT03339219|566291287|FG000|Overall Study|Site Terminated by Sponsor|22|||
156872578|NCT03339219|566291287|FG000|Overall Study|Withdrawal by Subject|1|||
156872579|NCT02023697|566291291|FG000|Treatment Period|Radiological progression|13|||
156872580|NCT02023697|566291292|FG001|Treatment Period|Radiological progression|17|||
156872581|NCT02023697|566291293|FG002|Treatment Period|Radiological progression|26|||
156872582|NCT02023697|566291291|FG000|Treatment Period|Never Treated|5|||
156872583|NCT02023697|566291292|FG001|Treatment Period|Never Treated|6|||
156872584|NCT02023697|566291293|FG002|Treatment Period|Never Treated|10|||
156872585|NCT02023697|566291291|FG000|Treatment Period|Adverse Event|13|||
156872586|NCT02023697|566291292|FG001|Treatment Period|Adverse Event|25|||
156872587|NCT02023697|566291293|FG002|Treatment Period|Adverse Event|23|||
156872588|NCT02023697|566291291|FG000|Treatment Period|Logistical difficulties|1|||
156872589|NCT02023697|566291292|FG001|Treatment Period|Logistical difficulties|1|||
156872590|NCT02023697|566291293|FG002|Treatment Period|Logistical difficulties|1|||
156872591|NCT02023697|566291291|FG000|Treatment Period|Clinical progression|10|||
156872592|NCT02023697|566291292|FG001|Treatment Period|Clinical progression|8|||
156872593|NCT02023697|566291293|FG002|Treatment Period|Clinical progression|28|||
156872594|NCT02023697|566291291|FG000|Treatment Period|Withdrawal by Subject|4|||
156872595|NCT02023697|566291292|FG001|Treatment Period|Withdrawal by Subject|5|||
156872596|NCT02023697|566291293|FG002|Treatment Period|Withdrawal by Subject|13|||
156872597|NCT02023697|566291291|FG000|Treatment Period|Safety outcome reached|0|||
156872598|NCT02023697|566291292|FG001|Treatment Period|Safety outcome reached|1|||
156441325|NCT01170962|564707377|FG001|Treatment Period|Participant no longer meets criteria|1|||
156709072|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
156441326|NCT01170962|564707378|FG002|Treatment Period|Participant no longer meets criteria|0|||
156441327|NCT01170962|564707376|FG000|Treatment Period|Request to discontinue treatment|7|||
156441328|NCT01170962|564707377|FG001|Treatment Period|Request to discontinue treatment|3|||
156441329|NCT01170962|564707378|FG002|Treatment Period|Request to discontinue treatment|1|||
156441330|NCT01170962|564707376|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
156441331|NCT01170962|564707377|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
156709073|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
156709074|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
156709075|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
156709076|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
156709077|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709078|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709079|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709080|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709081|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709082|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
156709083|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
156709084|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
156709085|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
156709086|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
156709087|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709088|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709089|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709090|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709091|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709092|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709093|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709094|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156872599|NCT02023697|566291293|FG002|Treatment Period|Safety outcome reached|0|||
156441332|NCT01170962|564707378|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
156441333|NCT01170962|564707376|FG000|Follow up Period|Withdrawal by Subject|14|||
156441334|NCT01170962|564707377|FG001|Follow up Period|Withdrawal by Subject|10|||
156709095|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
156709096|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156441335|NCT01170962|564707378|FG002|Follow up Period|Withdrawal by Subject|2|||
156441336|NCT01170962|564707376|FG000|Follow up Period|Lost to Follow-up|13|||
156709097|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709098|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156872600|NCT02023697|566291291|FG000|Treatment Period|Physician Decision|0|||
156872601|NCT02023697|566291292|FG001|Treatment Period|Physician Decision|0|||
156872602|NCT02023697|566291293|FG002|Treatment Period|Physician Decision|1|||
156709099|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709100|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709101|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709102|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
156709103|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
156709104|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
156709105|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
156872603|NCT02023697|566291291|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
156872604|NCT02023697|566291292|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
156872605|NCT02023697|566291293|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
156872606|NCT02023697|566291291|FG000|Active Follow-up Period|Lost to Follow-up|1|||
156872607|NCT02023697|566291292|FG001|Active Follow-up Period|Lost to Follow-up|1|||
156872608|NCT02023697|566291293|FG002|Active Follow-up Period|Lost to Follow-up|1|||
156872609|NCT02023697|566291291|FG000|Active Follow-up Period|Deterioration of general condition|1|||
156872610|NCT02023697|566291292|FG001|Active Follow-up Period|Deterioration of general condition|1|||
156872611|NCT02023697|566291293|FG002|Active Follow-up Period|Deterioration of general condition|1|||
156872612|NCT02023697|566291291|FG000|Active Follow-up Period|Other unspecified|2|||
156872613|NCT02023697|566291292|FG001|Active Follow-up Period|Other unspecified|0|||
156872614|NCT02023697|566291293|FG002|Active Follow-up Period|Other unspecified|1|||
156872615|NCT02023697|566291291|FG000|Active Follow-up Period|Clinical progression|0|||
156872616|NCT02023697|566291292|FG001|Active Follow-up Period|Clinical progression|2|||
156872617|NCT02023697|566291293|FG002|Active Follow-up Period|Clinical progression|1|||
156872618|NCT02023697|566291291|FG000|Active Follow-up Period|Radiological progression|0|||
156872619|NCT02023697|566291292|FG001|Active Follow-up Period|Radiological progression|0|||
156872620|NCT02023697|566291293|FG002|Active Follow-up Period|Radiological progression|1|||
156872621|NCT02023697|566291291|FG000|Active Follow-up Period|Death|83|||
156872622|NCT02023697|566291292|FG001|Active Follow-up Period|Death|82|||
156872623|NCT02023697|566291293|FG002|Active Follow-up Period|Death|87|||
156872624|NCT02023697|566291291|FG000|Long-term Follow-up Period|Death|9|||
156872625|NCT02023697|566291292|FG001|Long-term Follow-up Period|Death|6|||
156872626|NCT02023697|566291293|FG002|Long-term Follow-up Period|Death|4|||
156872627|NCT02023697|566291291|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
156872628|NCT02023697|566291292|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
156872629|NCT02023697|566291293|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
156872630|NCT02023697|566291291|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
156872631|NCT02023697|566291292|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
156872632|NCT02023697|566291293|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
156872633|NCT02023697|566291291|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
156872634|NCT02023697|566291292|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
156872635|NCT02023697|566291293|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
156872636|NCT02023697|566291291|FG000|Long-term Follow-up Period|Technical problems|0|||
156872637|NCT02023697|566291292|FG001|Long-term Follow-up Period|Technical problems|0|||
156872638|NCT02023697|566291293|FG002|Long-term Follow-up Period|Technical problems|1|||
156872639|NCT02023697|566291291|FG000|Long-term Follow-up Period|Other unspecified|6|||
156872640|NCT02023697|566291292|FG001|Long-term Follow-up Period|Other unspecified|3|||
156872641|NCT02023697|566291293|FG002|Long-term Follow-up Period|Other unspecified|5|||
156872642|NCT00541385|566291294|FG000|Overall Study|Adverse Event|6|||
156872643|NCT00541385|566291295|FG001|Overall Study|Adverse Event|3|||
156872644|NCT00541385|566291294|FG000|Overall Study|Withdrawal by Subject|2|||
156872645|NCT00541385|566291295|FG001|Overall Study|Withdrawal by Subject|2|||
156872646|NCT00541385|566291294|FG000|Overall Study|Lost to Follow-up|6|||
156872647|NCT00541385|566291295|FG001|Overall Study|Lost to Follow-up|1|||
156872648|NCT00541385|566291294|FG000|Overall Study|Parasite reappearance/malaria|67|||
156872649|NCT00541385|566291295|FG001|Overall Study|Parasite reappearance/malaria|32|||
156872650|NCT01469377|566291301|FG000|Overall Study|Protocol Deviation|7|||
156872651|NCT01469377|566291302|FG001|Overall Study|Protocol Deviation|10|||
156872652|NCT01469377|566291303|FG002|Overall Study|Protocol Deviation|10|||
156872653|NCT01469377|566291301|FG000|Overall Study|Lost to Follow-up|3|||
156332587|NCT02975336|564317343|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
156872654|NCT01469377|566291302|FG001|Overall Study|Lost to Follow-up|2|||
156332588|NCT02975336|564317344|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
156332589|NCT02975336|564317345|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
156332590|NCT02975336|564317338|FG000|LTE (104 Weeks)|Other|0|||
156332591|NCT02975336|564317339|FG001|LTE (104 Weeks)|Other|0|||
156332592|NCT02975336|564317340|FG002|LTE (104 Weeks)|Other|0|||
156332593|NCT02975336|564317341|FG003|LTE (104 Weeks)|Other|0|||
156332594|NCT02975336|564317342|FG004|LTE (104 Weeks)|Other|55|||
156332595|NCT02975336|564317343|FG005|LTE (104 Weeks)|Other|63|||
156332596|NCT02975336|564317344|FG006|LTE (104 Weeks)|Other|76|||
156332597|NCT02975336|564317345|FG007|LTE (104 Weeks)|Other|72|||
156332598|NCT01816074|564317346|FG000|Phase 1|Time commitment issues|0|||
156332599|NCT01816074|564317347|FG001|Phase 1|Time commitment issues|0|||
156332600|NCT01816074|564317348|FG002|Phase 1|Time commitment issues|1|||
156709106|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
156872655|NCT01469377|566291303|FG002|Overall Study|Lost to Follow-up|5|||
156872656|NCT01469377|566291301|FG000|Overall Study|Withdrawal of Consent|12|||
156872657|NCT01469377|566291302|FG001|Overall Study|Withdrawal of Consent|14|||
156872658|NCT01469377|566291303|FG002|Overall Study|Withdrawal of Consent|15|||
156872659|NCT01469377|566291301|FG000|Overall Study|Adverse Event|8|||
156872660|NCT01469377|566291302|FG001|Overall Study|Adverse Event|18|||
156872661|NCT01469377|566291303|FG002|Overall Study|Adverse Event|36|||
156872662|NCT01469377|566291301|FG000|Overall Study|Insufficient Therapeutic Response|3|||
156872663|NCT01469377|566291302|FG001|Overall Study|Insufficient Therapeutic Response|4|||
156872664|NCT01469377|566291303|FG002|Overall Study|Insufficient Therapeutic Response|0|||
156872665|NCT01469377|566291301|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156872666|NCT01469377|566291302|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156872667|NCT01469377|566291303|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156872668|NCT00074490|566291304|FG000|Overall Study|Progressive malignancy|0|||
156872669|NCT00074490|566291305|FG001|Overall Study|Progressive malignancy|7|||
156872670|NCT00074490|566291306|FG002|Overall Study|Progressive malignancy|0|||
156872671|NCT00074490|566291307|FG003|Overall Study|Progressive malignancy|0|||
156872672|NCT00074490|566291308|FG004|Overall Study|Progressive malignancy|3|||
156872673|NCT00074490|566291309|FG005|Overall Study|Progressive malignancy|0|||
156872674|NCT04139798|566291314|FG000|Overall Study|Withdrawal by Subject|6|||
156872675|NCT04139798|566291315|FG001|Overall Study|Withdrawal by Subject|5|||
156872676|NCT04139798|566291314|FG000|Overall Study|Lost to Follow-up|2|||
156872677|NCT04139798|566291315|FG001|Overall Study|Lost to Follow-up|5|||
156872678|NCT04139798|566291314|FG000|Overall Study|Discontinued|4|||
156872679|NCT04139798|566291315|FG001|Overall Study|Discontinued|2|||
156872680|NCT04139798|566291314|FG000|Overall Study|Adverse Event|1|||
156872681|NCT04139798|566291315|FG001|Overall Study|Adverse Event|3|||
156872682|NCT04139798|566291314|FG000|Overall Study|Protocol Violation|1|||
156872683|NCT04139798|566291315|FG001|Overall Study|Protocol Violation|0|||
156872684|NCT04939415|566291316|FG000|Overall Study|Withdrawal by Subject|1|||
156872685|NCT04939415|566291317|FG001|Overall Study|Withdrawal by Subject|3|||
156872686|NCT04939415|566291316|FG000|Overall Study|Lost to Follow-up|0|||
156872687|NCT04939415|566291317|FG001|Overall Study|Lost to Follow-up|2|||
156872688|NCT03155841|566291320|FG000|Overall Study|Protocol Violation|3|||
156872689|NCT03155841|566291321|FG001|Overall Study|Protocol Violation|4|||
156872690|NCT04308291|566291322|FG000|Run-In Phase|Withdrawal by Subject|4|||
156441337|NCT01170962|564707377|FG001|Follow up Period|Lost to Follow-up|8|||
156441338|NCT01170962|564707378|FG002|Follow up Period|Lost to Follow-up|1|||
156441339|NCT01170962|564707376|FG000|Follow up Period|Death|2|||
156441340|NCT01170962|564707377|FG001|Follow up Period|Death|2|||
156441341|NCT01170962|564707378|FG002|Follow up Period|Death|0|||
156441342|NCT01170962|564707376|FG000|Follow up Period|Others|10|||
156441343|NCT01170962|564707377|FG001|Follow up Period|Others|7|||
156441344|NCT01170962|564707378|FG002|Follow up Period|Others|3|||
156441345|NCT00223795|564707382|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
156441346|NCT00223795|564707383|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
156441347|NCT00223795|564707382|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
156441348|NCT00223795|564707383|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
156441349|NCT01239316|564707385|FG000|Overall Study|Progression/Relapse|11|||
156441350|NCT01239316|564707385|FG000|Overall Study|Adverse Event|1|||
156441351|NCT02299375|564707390|FG000|Overall Study|Adverse Event, serious fatal|1|||
156441352|NCT02299375|564707391|FG001|Overall Study|Adverse Event, serious fatal|3|||
156441353|NCT02299375|564707390|FG000|Overall Study|Adverse Event, non-fatal|8|||
156441354|NCT02299375|564707391|FG001|Overall Study|Adverse Event, non-fatal|9|||
156441355|NCT02299375|564707390|FG000|Overall Study|Lack of Efficacy|1|||
156441356|NCT02299375|564707391|FG001|Overall Study|Lack of Efficacy|3|||
156441357|NCT02299375|564707390|FG000|Overall Study|Protocol Violation|1|||
156441358|NCT02299375|564707391|FG001|Overall Study|Protocol Violation|3|||
156441359|NCT02299375|564707390|FG000|Overall Study|Other: Met stopping criteria|1|||
156441360|NCT02299375|564707391|FG001|Overall Study|Other: Met stopping criteria|0|||
156441361|NCT02299375|564707390|FG000|Overall Study|Other: Study closed/terminated|66|||
156441362|NCT02299375|564707391|FG001|Overall Study|Other: Study closed/terminated|55|||
156441363|NCT02299375|564707390|FG000|Overall Study|Lost to Follow-up|0|||
156441364|NCT02299375|564707391|FG001|Overall Study|Lost to Follow-up|2|||
156872691|NCT04308291|566291322|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
156441365|NCT02299375|564707390|FG000|Overall Study|Physician Decision|1|||
156441366|NCT02299375|564707391|FG001|Overall Study|Physician Decision|1|||
156872692|NCT04308291|566291322|FG000|Study Phase 6-M|Physician Decision|2|||
156872693|NCT04308291|566291322|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
156872694|NCT04308291|566291322|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
156441367|NCT02299375|564707390|FG000|Overall Study|Withdrawal by Subject|1|||
156441368|NCT02299375|564707391|FG001|Overall Study|Withdrawal by Subject|4|||
156441369|NCT00704184|564707392|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
156441370|NCT00704184|564707393|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
156872695|NCT04308291|566291322|FG000|Study Phase 12-M|Physician Decision|2|||
156441371|NCT00704184|564707394|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
156709107|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
156709108|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
156709109|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
156709110|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
156441372|NCT00704184|564707395|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
156441373|NCT00704184|564707396|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
156441374|NCT00704184|564707392|FG000|Open-Label Treatment|Adverse Event|0|||
156441375|NCT00704184|564707393|FG001|Open-Label Treatment|Adverse Event|0|||
156441376|NCT00704184|564707394|FG002|Open-Label Treatment|Adverse Event|2|||
156441377|NCT00704184|564707395|FG003|Open-Label Treatment|Adverse Event|0|||
156441378|NCT00704184|564707396|FG004|Open-Label Treatment|Adverse Event|1|||
156441379|NCT00704184|564707392|FG000|Open-Label Treatment|Lack of Efficacy|0|||
156441380|NCT00704184|564707393|FG001|Open-Label Treatment|Lack of Efficacy|2|||
156441381|NCT00704184|564707394|FG002|Open-Label Treatment|Lack of Efficacy|2|||
156441382|NCT00704184|564707395|FG003|Open-Label Treatment|Lack of Efficacy|2|||
156441383|NCT00704184|564707396|FG004|Open-Label Treatment|Lack of Efficacy|1|||
156441384|NCT00704184|564707392|FG000|Open-Label Treatment|Physician Decision|0|||
156441385|NCT00704184|564707393|FG001|Open-Label Treatment|Physician Decision|0|||
156441386|NCT00704184|564707394|FG002|Open-Label Treatment|Physician Decision|0|||
156441387|NCT00704184|564707395|FG003|Open-Label Treatment|Physician Decision|0|||
156441388|NCT00704184|564707396|FG004|Open-Label Treatment|Physician Decision|1|||
156441389|NCT00704184|564707392|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
156441390|NCT00704184|564707393|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
156441391|NCT00704184|564707394|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
156441392|NCT00704184|564707395|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
156441393|NCT00704184|564707396|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
156441394|NCT01251354|564707406|FG000|Overall Study|Adverse Event|1|||
156441395|NCT01251354|564707406|FG000|Overall Study|Investigator's Decision|1|||
156441396|NCT01251354|564707406|FG000|Overall Study|Disease Progression|4|||
156441397|NCT05135000|564707412|FG000|Overall Study|Adverse Event|2|||
156441398|NCT05135000|564707413|FG001|Overall Study|Adverse Event|0|||
156441399|NCT05135000|564707412|FG000|Overall Study|Lost to Follow-up|1|||
156441400|NCT05135000|564707413|FG001|Overall Study|Lost to Follow-up|0|||
156441401|NCT05135000|564707412|FG000|Overall Study|Study Terminated by Sponsor|6|||
156441402|NCT05135000|564707413|FG001|Overall Study|Study Terminated by Sponsor|3|||
156441403|NCT04201834|564709219|FG000|Overall Study|Screen fail|1|||
156441404|NCT03624972|564709239|FG000|Overall Study|Lost to Follow-up|2|||
156441405|NCT03624972|564709240|FG001|Overall Study|Lost to Follow-up|0|||
156441406|NCT03624972|564709241|FG002|Overall Study|Lost to Follow-up|0|||
156441407|NCT03624972|564709239|FG000|Overall Study|Withdrawal by Subject|0|||
156441408|NCT03624972|564709240|FG001|Overall Study|Withdrawal by Subject|2|||
156441409|NCT03624972|564709241|FG002|Overall Study|Withdrawal by Subject|0|||
156441410|NCT05773313|564709244|FG000|Overall Study|Lost to Follow-up|3|||
156441411|NCT05137236|564709245|FG000|Part A|Other than Specified|1|||
156441412|NCT05137236|564709246|FG001|Part A|Other than Specified|0|||
156441413|NCT05137236|564709247|FG002|Part A|Other than Specified|0|||
156441414|NCT05137236|564709248|FG003|Part A|Other than Specified|0|||
156441415|NCT05137236|564709249|FG004|Part A|Other than Specified|0|||
156441416|NCT05137236|564709250|FG005|Part A|Other than Specified|0|||
156441417|NCT05137236|564709251|FG006|Part A|Other than Specified|0|||
156441418|NCT05137236|564709252|FG007|Part A|Other than Specified|0|||
156441419|NCT05137236|564709245|FG000|Part A|Withdrawal by Subject|0|||
156441420|NCT05137236|564709246|FG001|Part A|Withdrawal by Subject|4|||
156441421|NCT05137236|564709247|FG002|Part A|Withdrawal by Subject|1|||
156441422|NCT05137236|564709248|FG003|Part A|Withdrawal by Subject|1|||
156441423|NCT05137236|564709249|FG004|Part A|Withdrawal by Subject|3|||
156441424|NCT05137236|564709250|FG005|Part A|Withdrawal by Subject|2|||
156441425|NCT05137236|564709251|FG006|Part A|Withdrawal by Subject|0|||
156441426|NCT05137236|564709252|FG007|Part A|Withdrawal by Subject|0|||
156441427|NCT05137236|564709245|FG000|Part A|Lost to Follow-up|5|||
156441428|NCT05137236|564709246|FG001|Part A|Lost to Follow-up|7|||
156441429|NCT05137236|564709247|FG002|Part A|Lost to Follow-up|1|||
156441430|NCT05137236|564709248|FG003|Part A|Lost to Follow-up|3|||
156441431|NCT05137236|564709249|FG004|Part A|Lost to Follow-up|3|||
156441432|NCT05137236|564709250|FG005|Part A|Lost to Follow-up|8|||
156441433|NCT05137236|564709251|FG006|Part A|Lost to Follow-up|0|||
156441434|NCT05137236|564709252|FG007|Part A|Lost to Follow-up|0|||
156441435|NCT05137236|564709245|FG000|Part B|Withdrawal by Subject|0|||
156441436|NCT05137236|564709246|FG001|Part B|Withdrawal by Subject|0|||
156441437|NCT05137236|564709247|FG002|Part B|Withdrawal by Subject|0|||
156441438|NCT05137236|564709248|FG003|Part B|Withdrawal by Subject|0|||
156441439|NCT05137236|564709249|FG004|Part B|Withdrawal by Subject|0|||
156441440|NCT05137236|564709250|FG005|Part B|Withdrawal by Subject|0|||
156441441|NCT05137236|564709251|FG006|Part B|Withdrawal by Subject|0|||
156441442|NCT05137236|564709252|FG007|Part B|Withdrawal by Subject|2|||
156441443|NCT05137236|564709245|FG000|Part B|Lost to Follow-up|0|||
156441444|NCT05137236|564709246|FG001|Part B|Lost to Follow-up|0|||
156709111|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
156872696|NCT04308291|566291322|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
156441445|NCT05137236|564709247|FG002|Part B|Lost to Follow-up|0|||
156441446|NCT05137236|564709248|FG003|Part B|Lost to Follow-up|0|||
156441447|NCT05137236|564709249|FG004|Part B|Lost to Follow-up|0|||
156441448|NCT05137236|564709250|FG005|Part B|Lost to Follow-up|0|||
156441449|NCT05137236|564709251|FG006|Part B|Lost to Follow-up|5|||
156441450|NCT05137236|564709252|FG007|Part B|Lost to Follow-up|5|||
156441451|NCT05137236|564709245|FG000|Part B|Death|0|||
156441452|NCT05137236|564709246|FG001|Part B|Death|0|||
156441453|NCT05137236|564709247|FG002|Part B|Death|0|||
156441454|NCT05137236|564709248|FG003|Part B|Death|0|||
156441455|NCT05137236|564709249|FG004|Part B|Death|0|||
156441456|NCT05137236|564709250|FG005|Part B|Death|0|||
156441457|NCT05137236|564709251|FG006|Part B|Death|0|||
156441458|NCT05137236|564709252|FG007|Part B|Death|2|||
156441459|NCT01534494|564709253|FG000|Overall Study|Withdrawal by Subject|1|||
156441460|NCT04512482|564709255|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
156441461|NCT04512482|564709256|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
156441462|NCT01939899|564709257|FG000|Lead-in Dose Finding Phase|Death|0|||
156441463|NCT01939899|564709258|FG001|Lead-in Dose Finding Phase|Death|3|||
156441464|NCT01939899|564709259|FG002|Lead-in Dose Finding Phase|Death|1|||
156441465|NCT01939899|564709260|FG003|Lead-in Dose Finding Phase|Death|0|||
156441466|NCT01939899|564709261|FG004|Lead-in Dose Finding Phase|Death|0|||
156441467|NCT01939899|564709257|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
156441468|NCT01939899|564709258|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
156441469|NCT01939899|564709259|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
156441470|NCT01939899|564709260|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
156441471|NCT01939899|564709261|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
156441472|NCT01939899|564709257|FG000|Lead-in Dose Finding Phase|Other|0|||
156441473|NCT01939899|564709258|FG001|Lead-in Dose Finding Phase|Other|0|||
156441474|NCT01939899|564709259|FG002|Lead-in Dose Finding Phase|Other|1|||
156441475|NCT01939899|564709260|FG003|Lead-in Dose Finding Phase|Other|0|||
156441476|NCT01939899|564709261|FG004|Lead-in Dose Finding Phase|Other|0|||
156441477|NCT01939899|564709257|FG000|Phase 2|Withdrawal by Subject|0|||
156441478|NCT01939899|564709258|FG001|Phase 2|Withdrawal by Subject|0|||
156441479|NCT01939899|564709259|FG002|Phase 2|Withdrawal by Subject|0|||
156441480|NCT01939899|564709260|FG003|Phase 2|Withdrawal by Subject|2|||
156441481|NCT01939899|564709261|FG004|Phase 2|Withdrawal by Subject|0|||
156441482|NCT01939899|564709257|FG000|Phase 2|Disease Progression|0|||
156441483|NCT01939899|564709258|FG001|Phase 2|Disease Progression|0|||
156709112|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709113|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709114|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709115|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
156709116|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709117|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709118|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709119|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709120|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709121|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709122|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
156441484|NCT01939899|564709259|FG002|Phase 2|Disease Progression|0|||
156441485|NCT01939899|564709260|FG003|Phase 2|Disease Progression|9|||
156441486|NCT01939899|564709261|FG004|Phase 2|Disease Progression|1|||
156441487|NCT05119855|564709265|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
156441488|NCT05119855|564709266|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
156441489|NCT05119855|564709265|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
156441490|NCT05119855|564709266|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
156441491|NCT05119855|564709265|FG000|Overall Study|Lost to Follow-up|6|||
156441492|NCT05119855|564709266|FG001|Overall Study|Lost to Follow-up|8|||
156441493|NCT02932579|564709267|FG000|Overall Study|Withdrawal by Subject|4|||
156441494|NCT02932579|564709268|FG001|Overall Study|Withdrawal by Subject|1|||
156441495|NCT02706717|564709271|FG000|Overall Study|Withdrawal by Subject|1|||
156441496|NCT02706717|564709272|FG001|Overall Study|Withdrawal by Subject|8|||
156441497|NCT02706717|564709271|FG000|Overall Study|Lost to Follow-up|0|||
156441498|NCT02706717|564709272|FG001|Overall Study|Lost to Follow-up|1|||
156441499|NCT02706717|564709271|FG000|Overall Study|Physician Decision|0|||
156441500|NCT02706717|564709272|FG001|Overall Study|Physician Decision|1|||
156441501|NCT02706717|564709271|FG000|Overall Study|Death|0|||
156441502|NCT02706717|564709272|FG001|Overall Study|Death|1|||
156441503|NCT02549170|564709275|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
156441504|NCT02549170|564709276|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
156441505|NCT02549170|564709277|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
156441506|NCT02549170|564709278|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
156441507|NCT02549170|564709279|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
156709123|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
156531809|NCT02684357|565041728|FG003|Part B|Lost to Follow-up|1|||
156531810|NCT02684357|565041729|FG004|Part B|Lost to Follow-up|1|||
156531811|NCT02684357|565041730|FG005|Part B|Lost to Follow-up|7|||
156531812|NCT02684357|565041725|FG000|Part B|Withdrawal by Subject|0|||
156531813|NCT02684357|565041726|FG001|Part B|Withdrawal by Subject|0|||
156531814|NCT02684357|565041727|FG002|Part B|Withdrawal by Subject|0|||
156531815|NCT02684357|565041728|FG003|Part B|Withdrawal by Subject|0|||
156531816|NCT02684357|565041729|FG004|Part B|Withdrawal by Subject|2|||
156531817|NCT02684357|565041730|FG005|Part B|Withdrawal by Subject|4|||
156531818|NCT02684357|565041725|FG000|Part B|Other|0|||
156709124|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
156709125|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
156709126|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
156709127|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
156709128|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
156709129|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
156709130|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
156872697|NCT04411667|566291323|FG000|Overall Study|Physician Decision|1|||
156872698|NCT04411667|566291324|FG001|Overall Study|Physician Decision|0|||
156872699|NCT00949702|566291327|FG000|Overall Study|Death|40|||
156872700|NCT00949702|566291327|FG000|Overall Study|Disease progression|7|||
156872701|NCT00949702|566291327|FG000|Overall Study|Withdrawal of consent|1|||
156872702|NCT03399552|566291329|FG000|Overall Study|No evidence of disease|1|||
156872703|NCT03399552|566291329|FG000|Overall Study|Unevaluable|1|||
156872704|NCT01286480|566291331|FG000|Overall Study|Withdrawal by Subject|5|||
156872705|NCT01286480|566291332|FG001|Overall Study|Withdrawal by Subject|3|||
156872706|NCT00834093|566291333|FG000|Overall Study|Progressive Disease|3|||
156872707|NCT00834093|566291333|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
156872708|NCT00606593|566291334|FG000|Overall Study|Adverse Event|0|||
156531819|NCT02684357|565041726|FG001|Part B|Other|0|||
156531820|NCT02684357|565041727|FG002|Part B|Other|0|||
156531821|NCT02684357|565041728|FG003|Part B|Other|1|||
156531822|NCT02684357|565041729|FG004|Part B|Other|0|||
156531823|NCT02684357|565041730|FG005|Part B|Other|1|||
156531824|NCT01853982|565041731|FG000|Overall Study|Withdrawal by Subject|1|||
156531825|NCT01853982|565041732|FG001|Overall Study|Withdrawal by Subject|0|||
156531826|NCT01853982|565041731|FG000|Overall Study|Death|1|||
156709131|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
156531827|NCT01853982|565041732|FG001|Overall Study|Death|0|||
156531828|NCT01853982|565041731|FG000|Overall Study|Lost to Follow-up|0|||
156531829|NCT01853982|565041732|FG001|Overall Study|Lost to Follow-up|1|||
156531830|NCT00390910|565041733|FG000|Overall Study|Adverse Event|1|||
156531831|NCT00390910|565041734|FG001|Overall Study|Adverse Event|0|||
156531832|NCT00390910|565041735|FG002|Overall Study|Adverse Event|0|||
156531833|NCT00390910|565041733|FG000|Overall Study|Lost to Follow-up|0|||
156531834|NCT00390910|565041734|FG001|Overall Study|Lost to Follow-up|1|||
156709132|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156709133|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156709134|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156531835|NCT00390910|565041735|FG002|Overall Study|Lost to Follow-up|5|||
156531836|NCT00390910|565041733|FG000|Overall Study|Withdrawal by Subject|1|||
156531837|NCT00390910|565041734|FG001|Overall Study|Withdrawal by Subject|3|||
156531838|NCT00390910|565041735|FG002|Overall Study|Withdrawal by Subject|2|||
156531839|NCT00390910|565041733|FG000|Overall Study|Migrated/moved from study area|0|||
156531840|NCT00390910|565041734|FG001|Overall Study|Migrated/moved from study area|0|||
156531841|NCT00390910|565041735|FG002|Overall Study|Migrated/moved from study area|3|||
156531842|NCT01839487|565041736|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
156531843|NCT01839487|565041737|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
156531844|NCT01839487|565041738|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
156531845|NCT01839487|565041739|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
156531846|NCT01839487|565041740|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
156531847|NCT01839487|565041741|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
156531848|NCT01839487|565041736|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
156531849|NCT01839487|565041737|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
156531850|NCT01839487|565041738|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
156531851|NCT01839487|565041739|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
156872709|NCT00606593|566291335|FG001|Overall Study|Adverse Event|0|||
156872710|NCT00606593|566291336|FG002|Overall Study|Adverse Event|0|||
156531852|NCT01839487|565041740|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
156531853|NCT01839487|565041741|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
156531854|NCT01839487|565041736|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
156531855|NCT01839487|565041737|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
156709135|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156709136|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156872711|NCT00606593|566291337|FG003|Overall Study|Adverse Event|1|||
156872712|NCT00606593|566291338|FG004|Overall Study|Adverse Event|1|||
156441508|NCT02549170|564709275|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
156441509|NCT02549170|564709276|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
156709137|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
156709138|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
156709139|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
156709140|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
156709141|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
156709142|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709143|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709144|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709145|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709146|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709147|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
156709148|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
156709149|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
156709150|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
156709151|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
156709152|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709153|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709154|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709155|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709156|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709157|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
156709158|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
156791780|NCT04691115|565990989|FG011|Overall Study|Withdrawal by Subject|0|||
156791781|NCT04691115|565990990|FG012|Overall Study|Withdrawal by Subject|0|||
156441510|NCT02549170|564709277|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
156441511|NCT02549170|564709278|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
156441512|NCT02549170|564709279|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
156441513|NCT02549170|564709275|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
156441514|NCT02549170|564709276|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
156441515|NCT02549170|564709277|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
156441516|NCT02549170|564709278|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
156441517|NCT02549170|564709279|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
156441518|NCT03051165|564709280|FG000|Overall Study|Withdrawal by Subject|1|||
156441519|NCT03051165|564709280|FG000|Overall Study|Early termination of study|12|||
156441520|NCT00818246|564709281|FG000|Overall Study|Impossible to match pictures|5|||
156441521|NCT02121002|564709282|FG000|Overall Study|Physician Decision|2|||
156441522|NCT02121002|564709283|FG001|Overall Study|Physician Decision|0|||
156441523|NCT02121002|564709284|FG002|Overall Study|Physician Decision|0|||
156441524|NCT02121002|564709282|FG000|Overall Study|Withdrawal by Subject|3|||
156441525|NCT02121002|564709283|FG001|Overall Study|Withdrawal by Subject|1|||
156441526|NCT02121002|564709284|FG002|Overall Study|Withdrawal by Subject|4|||
156441527|NCT02121002|564709282|FG000|Overall Study|Protocol Violation|1|||
156441528|NCT02121002|564709283|FG001|Overall Study|Protocol Violation|2|||
156441529|NCT02121002|564709284|FG002|Overall Study|Protocol Violation|4|||
156441530|NCT02121002|564709282|FG000|Overall Study|Concomitant therapy|0|||
156441531|NCT02121002|564709283|FG001|Overall Study|Concomitant therapy|1|||
156441532|NCT02121002|564709284|FG002|Overall Study|Concomitant therapy|1|||
156441533|NCT02121002|564709282|FG000|Overall Study|Others|1|||
156441534|NCT02121002|564709283|FG001|Overall Study|Others|0|||
156441535|NCT02121002|564709284|FG002|Overall Study|Others|1|||
156441536|NCT00409838|564709285|FG000|Short-term Period|Adverse Event|0|||
156441537|NCT00409838|564709286|FG001|Short-term Period|Adverse Event|1|||
156441538|NCT00409838|564709285|FG000|Short-term Period|Lost to Follow-up|0|||
156441539|NCT00409838|564709286|FG001|Short-term Period|Lost to Follow-up|1|||
156441540|NCT00409838|564709285|FG000|Short-term Period|Withdrawal by Subject|2|||
156441541|NCT00409838|564709286|FG001|Short-term Period|Withdrawal by Subject|3|||
156441542|NCT00409838|564709285|FG000|Short-term Period|Never Treated|1|||
156441543|NCT00409838|564709286|FG001|Short-term Period|Never Treated|0|||
156441544|NCT00409838|564709285|FG000|Long-term Extension Period|Adverse Event|10|||
156441545|NCT00409838|564709286|FG001|Long-term Extension Period|Adverse Event|0|||
156441546|NCT00409838|564709285|FG000|Long-term Extension Period|Death|1|||
156441547|NCT00409838|564709286|FG001|Long-term Extension Period|Death|0|||
156441548|NCT00409838|564709285|FG000|Long-term Extension Period|Lack of Efficacy|2|||
156441549|NCT00409838|564709286|FG001|Long-term Extension Period|Lack of Efficacy|0|||
156441550|NCT00409838|564709285|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
156441551|NCT00409838|564709286|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
156441552|NCT00409838|564709285|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
156709159|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
156709160|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
156791782|NCT04691115|565990991|FG013|Overall Study|Withdrawal by Subject|0|||
156441553|NCT00409838|564709286|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
156441554|NCT00409838|564709285|FG000|Long-term Extension Period|Pregnancy|1|||
156441555|NCT00409838|564709286|FG001|Long-term Extension Period|Pregnancy|0|||
156441556|NCT01250769|564709288|FG000|Overall Study|Withdrawal by Subject|0|||
156441557|NCT01250769|564709289|FG001|Overall Study|Withdrawal by Subject|1|||
156441558|NCT01250769|564709290|FG002|Overall Study|Withdrawal by Subject|1|||
156441559|NCT01250769|564709291|FG003|Overall Study|Withdrawal by Subject|0|||
156441560|NCT01250769|564709288|FG000|Overall Study|Adverse Event|0|||
156441561|NCT01250769|564709289|FG001|Overall Study|Adverse Event|0|||
156441562|NCT01250769|564709290|FG002|Overall Study|Adverse Event|1|||
156441563|NCT01250769|564709291|FG003|Overall Study|Adverse Event|0|||
156441564|NCT01290341|564709292|FG000|Overall Study|Protocol Violation|7|||
156441565|NCT01290341|564709293|FG001|Overall Study|Protocol Violation|3|||
156709161|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
156709162|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709163|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709164|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709165|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709166|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709167|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709168|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
156709169|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156441566|NCT01290341|564709292|FG000|Overall Study|Adverse Event|1|||
156441567|NCT01290341|564709293|FG001|Overall Study|Adverse Event|0|||
156441568|NCT01290341|564709292|FG000|Overall Study|Lost to Follow-up|21|||
156441569|NCT01290341|564709293|FG001|Overall Study|Lost to Follow-up|10|||
156441570|NCT01290341|564709292|FG000|Overall Study|Withdrawal by Subject|19|||
156709170|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
156709171|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
156709172|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709173|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709174|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709175|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709176|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709177|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709178|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709179|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
156709180|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
156709181|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709182|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
156709183|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
156709184|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
156332601|NCT01816074|564317349|FG003|Phase 1|Time commitment issues|0|||
156332602|NCT01816074|564317346|FG000|Phase 2|Time commitment Issues|0|||
156332603|NCT01816074|564317347|FG001|Phase 2|Time commitment Issues|2|||
156332604|NCT01816074|564317348|FG002|Phase 2|Time commitment Issues|0|||
156332605|NCT01816074|564317349|FG003|Phase 2|Time commitment Issues|0|||
156332606|NCT01816074|564317346|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
156332607|NCT01816074|564317347|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
156332608|NCT01816074|564317348|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
156332609|NCT01816074|564317349|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
156332610|NCT01816074|564317346|FG000|Phase 2|Physician Decision|0|||
156332611|NCT01816074|564317347|FG001|Phase 2|Physician Decision|0|||
156332612|NCT01816074|564317348|FG002|Phase 2|Physician Decision|0|||
156332613|NCT01816074|564317349|FG003|Phase 2|Physician Decision|1|||
156332614|NCT01816074|564317346|FG000|Phase 2|Withdrawal by Subject|1|||
156332615|NCT01816074|564317347|FG001|Phase 2|Withdrawal by Subject|0|||
156332616|NCT01816074|564317348|FG002|Phase 2|Withdrawal by Subject|0|||
156332617|NCT01816074|564317349|FG003|Phase 2|Withdrawal by Subject|0|||
156332618|NCT00354614|564317356|FG000|Overall Study|Lack of Efficacy|28|||
156332619|NCT03650556|564317357|FG000|Overall Study|Death|2|||
156332620|NCT03650556|564317357|FG000|Overall Study|Withdrawal by Subject|20|||
156332621|NCT03650556|564317357|FG000|Overall Study|Physician Decision|2|||
156332622|NCT03650556|564317357|FG000|Overall Study|Lost to Follow-up|8|||
156332623|NCT03650556|564317357|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
156332624|NCT03650556|564317357|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
156332625|NCT01436396|564317363|FG000|Overall Study|Protocol Violation|7|||
156332626|NCT01436396|564317364|FG001|Overall Study|Protocol Violation|5|||
156332627|NCT01436396|564317363|FG000|Overall Study|Adverse Event|1|||
156332628|NCT01436396|564317364|FG001|Overall Study|Adverse Event|2|||
156332629|NCT01436396|564317363|FG000|Overall Study|Withdrawal by Subject|19|||
156332630|NCT01436396|564317364|FG001|Overall Study|Withdrawal by Subject|29|||
156709185|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
156709186|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
156531856|NCT01839487|565041738|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
156531857|NCT01839487|565041739|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
156709187|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
156709188|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
156709189|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
156709190|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
156709191|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
156709192|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Other|0|||
156709193|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Other|0|||
156531858|NCT01839487|565041740|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
156531859|NCT01839487|565041741|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
156531860|NCT01839487|565041736|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
156531861|NCT01839487|565041737|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
156709194|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Other|0|||
156709195|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Other|0|||
156441571|NCT01290341|564709293|FG001|Overall Study|Withdrawal by Subject|5|||
156441572|NCT01290341|564709292|FG000|Overall Study|Negative baseline culture and others|44|||
156441573|NCT01290341|564709293|FG001|Overall Study|Negative baseline culture and others|11|||
156441574|NCT03951805|564709295|FG000|Overall Study|Adverse Event|1|||
156441575|NCT03951805|564709296|FG001|Overall Study|Adverse Event|0|||
156441576|NCT03951805|564709297|FG002|Overall Study|Adverse Event|0|||
156441577|NCT03951805|564709298|FG003|Overall Study|Adverse Event|0|||
156441578|NCT03684044|564709303|FG000|Overall Study|Adverse Event|3|||
156441579|NCT03684044|564709304|FG001|Overall Study|Adverse Event|0|||
156441580|NCT03684044|564709303|FG000|Overall Study|Death|4|||
156441581|NCT03684044|564709304|FG001|Overall Study|Death|7|||
156441582|NCT03684044|564709303|FG000|Overall Study|Lost to Follow-up|3|||
156441583|NCT03684044|564709304|FG001|Overall Study|Lost to Follow-up|2|||
156441584|NCT03684044|564709303|FG000|Overall Study|Patient Not Available|0|||
156441585|NCT03684044|564709304|FG001|Overall Study|Patient Not Available|2|||
156441586|NCT03684044|564709303|FG000|Overall Study|Physician Decision|1|||
156441587|NCT03684044|564709304|FG001|Overall Study|Physician Decision|0|||
156441588|NCT03684044|564709303|FG000|Overall Study|Withdrawal by Subject|11|||
156441589|NCT03684044|564709304|FG001|Overall Study|Withdrawal by Subject|9|||
156441590|NCT03703336|564709305|FG000|Overall Study|Parent withdrew consent|29|||
156441591|NCT03703336|564709306|FG001|Overall Study|Parent withdrew consent|8|||
156441592|NCT03703336|564709305|FG000|Overall Study|Migration|3|||
156441593|NCT03703336|564709306|FG001|Overall Study|Migration|3|||
156441594|NCT03703336|564709305|FG000|Overall Study|Protocol Violation|3|||
156441595|NCT03703336|564709306|FG001|Overall Study|Protocol Violation|1|||
156441596|NCT03703336|564709305|FG000|Overall Study|Physician Decision|2|||
156441597|NCT03703336|564709306|FG001|Overall Study|Physician Decision|0|||
156441598|NCT03703336|564709305|FG000|Overall Study|Adverse Event|0|||
156441599|NCT03703336|564709306|FG001|Overall Study|Adverse Event|2|||
156441600|NCT03703336|564709305|FG000|Overall Study|Lost to Follow-up|1|||
156441601|NCT03703336|564709306|FG001|Overall Study|Lost to Follow-up|0|||
156441602|NCT00595413|564709307|FG000|Overall Study|Adverse Event|0|||
156441603|NCT00595413|564709308|FG001|Overall Study|Adverse Event|2|||
156441604|NCT00595413|564709309|FG002|Overall Study|Adverse Event|1|||
156441605|NCT00595413|564709310|FG003|Overall Study|Adverse Event|1|||
156441606|NCT00595413|564709307|FG000|Overall Study|Lost to Follow-up|2|||
156441607|NCT00595413|564709308|FG001|Overall Study|Lost to Follow-up|2|||
156441608|NCT00595413|564709309|FG002|Overall Study|Lost to Follow-up|1|||
156441609|NCT00595413|564709310|FG003|Overall Study|Lost to Follow-up|3|||
156531862|NCT01839487|565041738|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
156531863|NCT01839487|565041739|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
156531864|NCT01839487|565041740|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
156709196|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Other|0|||
156709197|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Other|0|||
156709198|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Other|0|||
156709199|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Other|0|||
156709200|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Other|1|||
156441610|NCT00595413|564709307|FG000|Overall Study|Death|0|||
156441611|NCT00595413|564709308|FG001|Overall Study|Death|0|||
156441612|NCT00595413|564709309|FG002|Overall Study|Death|1|||
156441613|NCT00595413|564709310|FG003|Overall Study|Death|0|||
156441614|NCT00595413|564709307|FG000|Overall Study|Other|5|||
156441615|NCT00595413|564709308|FG001|Overall Study|Other|1|||
156441616|NCT00595413|564709309|FG002|Overall Study|Other|5|||
156441617|NCT00595413|564709310|FG003|Overall Study|Other|0|||
156441618|NCT03233633|564709311|FG000|Overall Study|Adverse Event|2|||
156441619|NCT03233633|564709311|FG000|Overall Study|Less Than 3 Days of Data|6|||
156709201|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Other|1|||
156709202|NCT00094861|565680539|FG000|Overall Study|Adverse Event|5|||
156441620|NCT02088853|564709312|FG000|Overall Study|Pregnancy|1|||
156441621|NCT02088853|564709313|FG001|Overall Study|Pregnancy|0|||
156441622|NCT00603954|564709316|FG000|Overall Study|Protocol Violation|1|||
156441623|NCT00603954|564709317|FG001|Overall Study|Protocol Violation|2|||
156441624|NCT02708108|564709318|FG000|Overall Study|Death|1|||
156441625|NCT02708108|564709319|FG001|Overall Study|Death|2|||
156441626|NCT02708108|564709318|FG000|Overall Study|Regimen change|1|||
156441627|NCT02708108|564709319|FG001|Overall Study|Regimen change|0|||
156441628|NCT02708108|564709318|FG000|Overall Study|No MRD and no imaging available|0|||
156441629|NCT02708108|564709319|FG001|Overall Study|No MRD and no imaging available|1|||
156441630|NCT02528188|564709323|FG000|Overall Study|Adverse Event|23|||
156441631|NCT02528188|564709324|FG001|Overall Study|Adverse Event|22|||
156441632|NCT02528188|564709325|FG002|Overall Study|Adverse Event|8|||
156441633|NCT02528188|564709323|FG000|Overall Study|Protocol Violation|4|||
156441634|NCT02528188|564709324|FG001|Overall Study|Protocol Violation|6|||
156441635|NCT02528188|564709325|FG002|Overall Study|Protocol Violation|4|||
156441636|NCT02528188|564709323|FG000|Overall Study|Lack of Efficacy|19|||
156441637|NCT02528188|564709324|FG001|Overall Study|Lack of Efficacy|21|||
156441638|NCT02528188|564709325|FG002|Overall Study|Lack of Efficacy|22|||
156441639|NCT02528188|564709323|FG000|Overall Study|Withdrawal by Subject|97|||
156441640|NCT02528188|564709324|FG001|Overall Study|Withdrawal by Subject|104|||
156441641|NCT02528188|564709325|FG002|Overall Study|Withdrawal by Subject|100|||
156441642|NCT02528188|564709323|FG000|Overall Study|Lost to Follow-up|25|||
156441643|NCT02528188|564709324|FG001|Overall Study|Lost to Follow-up|21|||
156441644|NCT02528188|564709325|FG002|Overall Study|Lost to Follow-up|31|||
156441645|NCT02528188|564709323|FG000|Overall Study|Death|4|||
156441646|NCT02528188|564709324|FG001|Overall Study|Death|4|||
156441647|NCT02528188|564709325|FG002|Overall Study|Death|0|||
156441648|NCT02528188|564709323|FG000|Overall Study|Other|89|||
156441649|NCT02528188|564709324|FG001|Overall Study|Other|91|||
156441650|NCT02528188|564709325|FG002|Overall Study|Other|74|||
156441651|NCT02528188|564709323|FG000|Overall Study|Randomized but not treated|6|||
156441652|NCT02528188|564709324|FG001|Overall Study|Randomized but not treated|7|||
156441653|NCT02528188|564709325|FG002|Overall Study|Randomized but not treated|12|||
156441654|NCT05368831|564709327|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
156441655|NCT00440011|564709330|FG000|Overall Study|Adverse Event|2|||
156441656|NCT00440011|564709331|FG001|Overall Study|Adverse Event|0|||
156441657|NCT00440011|564709330|FG000|Overall Study|Lost to Follow-up|0|||
156441658|NCT00440011|564709331|FG001|Overall Study|Lost to Follow-up|2|||
156441659|NCT00440011|564709330|FG000|Overall Study|Protocol Violation|1|||
156441660|NCT00440011|564709331|FG001|Overall Study|Protocol Violation|1|||
156441661|NCT00440011|564709330|FG000|Overall Study|Withdrawal by Subject|1|||
156441662|NCT00440011|564709331|FG001|Overall Study|Withdrawal by Subject|0|||
156441663|NCT01083316|564709332|FG000|Overall Study|Adverse Event|2|||
156441664|NCT01083316|564709332|FG000|Overall Study|Withdrawal by Subject|1|||
156441665|NCT00419341|564709333|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
156441666|NCT00419341|564709333|FG000|Wash in/Wash Out Period|Adverse Event|2|||
156441667|NCT00419341|564709333|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
156441668|NCT00419341|564709333|FG000|Efficacy Period|Withdrawal by Subject|6|||
156441669|NCT00419341|564709333|FG000|Efficacy Period|Protocol Violation|1|||
156441670|NCT00419341|564709333|FG000|Efficacy Period|Lost to Follow-up|1|||
156441671|NCT00419341|564709333|FG000|Efficacy Period|Non-compliance|1|||
156441672|NCT00419341|564709333|FG000|Efficacy Period|Termination of study site|1|||
156441673|NCT04200365|564709334|FG000|Overall Study|Adverse Event|2|||
156441674|NCT04200365|564709334|FG000|Overall Study|Progressive Disease|4|||
156441675|NCT04200365|564709334|FG000|Overall Study|Lack of Efficacy|1|||
156441676|NCT04200365|564709334|FG000|Overall Study|Study Closure|4|||
156441677|NCT01849055|564709344|FG000|Overall Study|Withdrawal by Subject|0|||
156441678|NCT01849055|564709345|FG001|Overall Study|Withdrawal by Subject|0|||
156441679|NCT01849055|564709346|FG002|Overall Study|Withdrawal by Subject|1|||
156441680|NCT01849055|564709347|FG003|Overall Study|Withdrawal by Subject|0|||
156441681|NCT01849055|564709348|FG004|Overall Study|Withdrawal by Subject|0|||
156441682|NCT01849055|564709349|FG005|Overall Study|Withdrawal by Subject|0|||
156441683|NCT01853748|564710902|FG000|Allocation|Withdrawal by Subject|1|||
156531865|NCT01839487|565041741|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
156531866|NCT01839487|565041736|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
156441684|NCT01853748|564710903|FG001|Allocation|Withdrawal by Subject|13|||
156441685|NCT01853748|564710902|FG000|Allocation|not sufficient to receive intervention|0|||
156441686|NCT01853748|564710903|FG001|Allocation|not sufficient to receive intervention|1|||
156531867|NCT01839487|565041737|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
156441687|NCT01853748|564710902|FG000|Follow-Up|Withdrawal by Subject|7|||
156441688|NCT01853748|564710903|FG001|Follow-Up|Withdrawal by Subject|6|||
156441689|NCT01853748|564710902|FG000|Follow-Up|Adverse Event|67|||
156441690|NCT01853748|564710903|FG001|Follow-Up|Adverse Event|7|||
156531868|NCT01839487|565041738|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
156441691|NCT01853748|564710902|FG000|Follow-Up|not available for data collection|16|||
156441692|NCT01853748|564710903|FG001|Follow-Up|not available for data collection|4|||
156441693|NCT04043455|564710908|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
156441694|NCT04043455|564710909|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
156531869|NCT01839487|565041739|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
156531870|NCT01839487|565041740|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
156531871|NCT01839487|565041741|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
156531872|NCT01839487|565041736|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
156531873|NCT01839487|565041737|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
156531874|NCT01839487|565041738|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
156791783|NCT00830336|565990995|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
156791784|NCT00830336|565990996|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
156791785|NCT01630811|565990997|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
156791786|NCT01630811|565990998|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
156791787|NCT01725308|565991001|FG000|Treatment Period I|Did Not Receive Drug|1|||
156791788|NCT01725308|565991002|FG001|Treatment Period I|Did Not Receive Drug|0|||
156791789|NCT01725308|565991003|FG002|Treatment Period I|Did Not Receive Drug|0|||
156791790|NCT01725308|565991001|FG000|Treatment Period I|Adverse Event|5|||
156791791|NCT01725308|565991002|FG001|Treatment Period I|Adverse Event|4|||
156791792|NCT01725308|565991003|FG002|Treatment Period I|Adverse Event|21|||
156791793|NCT01725308|565991001|FG000|Treatment Period I|Insufficient Response|7|||
156791794|NCT01725308|565991002|FG001|Treatment Period I|Insufficient Response|0|||
156791795|NCT01725308|565991003|FG002|Treatment Period I|Insufficient Response|5|||
156791796|NCT01725308|565991001|FG000|Treatment Period I|Worsening of the Target Disease|8|||
156791797|NCT01725308|565991002|FG001|Treatment Period I|Worsening of the Target Disease|0|||
156791798|NCT01725308|565991003|FG002|Treatment Period I|Worsening of the Target Disease|2|||
156791799|NCT01725308|565991001|FG000|Treatment Period I|Changes in the Episodes|3|||
156791800|NCT01725308|565991002|FG001|Treatment Period I|Changes in the Episodes|0|||
156791801|NCT01725308|565991003|FG002|Treatment Period I|Changes in the Episodes|2|||
156791802|NCT01725308|565991001|FG000|Treatment Period I|Withdrawal of Consent|12|||
156791803|NCT01725308|565991002|FG001|Treatment Period I|Withdrawal of Consent|7|||
156791804|NCT01725308|565991003|FG002|Treatment Period I|Withdrawal of Consent|5|||
156791805|NCT01725308|565991001|FG000|Treatment Period I|Lost to Follow-up|3|||
156791806|NCT01725308|565991002|FG001|Treatment Period I|Lost to Follow-up|2|||
156791807|NCT01725308|565991003|FG002|Treatment Period I|Lost to Follow-up|2|||
156791808|NCT01725308|565991001|FG000|Treatment Period I|Protocol Deviations|3|||
156791809|NCT01725308|565991002|FG001|Treatment Period I|Protocol Deviations|1|||
156791810|NCT01725308|565991003|FG002|Treatment Period I|Protocol Deviations|1|||
156791811|NCT01725308|565991001|FG000|Treatment Period I|Miscellaneous|2|||
156791812|NCT01725308|565991002|FG001|Treatment Period I|Miscellaneous|0|||
156791813|NCT01725308|565991003|FG002|Treatment Period I|Miscellaneous|3|||
156791814|NCT01725308|565991001|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
156791815|NCT01725308|565991002|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
156791816|NCT01725308|565991003|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
156791817|NCT01725308|565991001|FG000|Treatment Period II|Did Not Receive Drug|4|||
156791818|NCT01725308|565991002|FG001|Treatment Period II|Did Not Receive Drug|0|||
156791819|NCT01725308|565991003|FG002|Treatment Period II|Did Not Receive Drug|0|||
156791820|NCT01725308|565991001|FG000|Treatment Period II|Adverse Event|13|||
156791821|NCT01725308|565991002|FG001|Treatment Period II|Adverse Event|8|||
156791822|NCT01725308|565991003|FG002|Treatment Period II|Adverse Event|20|||
156791823|NCT01725308|565991001|FG000|Treatment Period II|Insufficient Response|2|||
156791824|NCT01725308|565991002|FG001|Treatment Period II|Insufficient Response|4|||
156791825|NCT01725308|565991003|FG002|Treatment Period II|Insufficient Response|6|||
156791826|NCT01725308|565991001|FG000|Treatment Period II|Worsening of the Target Disease|1|||
156791827|NCT01725308|565991002|FG001|Treatment Period II|Worsening of the Target Disease|4|||
156791828|NCT01725308|565991003|FG002|Treatment Period II|Worsening of the Target Disease|2|||
156791829|NCT01725308|565991001|FG000|Treatment Period II|Changes in the Episodes|1|||
156791830|NCT01725308|565991002|FG001|Treatment Period II|Changes in the Episodes|0|||
156791831|NCT01725308|565991003|FG002|Treatment Period II|Changes in the Episodes|5|||
156791832|NCT01725308|565991001|FG000|Treatment Period II|Withdrawal of Consent|28|||
156332631|NCT01436396|564317363|FG000|Overall Study|Serious adverse event|2|||
156332632|NCT01436396|564317364|FG001|Overall Study|Serious adverse event|3|||
156332633|NCT01436396|564317363|FG000|Overall Study|Lost to Follow-up|3|||
156332634|NCT01436396|564317364|FG001|Overall Study|Lost to Follow-up|3|||
156332635|NCT01332331|564317367|FG000|Overall Study|Lost to Follow-up|0|||
156332636|NCT01332331|564317368|FG001|Overall Study|Lost to Follow-up|1|||
156332637|NCT01332331|564317367|FG000|Overall Study|Adverse Event|1|||
156332638|NCT01332331|564317368|FG001|Overall Study|Adverse Event|1|||
156332639|NCT01332331|564317367|FG000|Overall Study|Physician Decision|1|||
156791833|NCT01725308|565991002|FG001|Treatment Period II|Withdrawal of Consent|2|||
156791834|NCT01725308|565991003|FG002|Treatment Period II|Withdrawal of Consent|16|||
156791835|NCT01725308|565991001|FG000|Treatment Period II|Lost to Follow-up|1|||
156791836|NCT01725308|565991002|FG001|Treatment Period II|Lost to Follow-up|5|||
156791837|NCT01725308|565991003|FG002|Treatment Period II|Lost to Follow-up|3|||
156791838|NCT01725308|565991001|FG000|Treatment Period II|Protocol Deviations|0|||
156791839|NCT01725308|565991002|FG001|Treatment Period II|Protocol Deviations|0|||
156791840|NCT01725308|565991003|FG002|Treatment Period II|Protocol Deviations|1|||
156332640|NCT01332331|564317368|FG001|Overall Study|Physician Decision|0|||
156531875|NCT01839487|565041739|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
156709203|NCT00094861|565680540|FG001|Overall Study|Adverse Event|2|||
156709204|NCT00094861|565680539|FG000|Overall Study|Withdrawal by Subject|5|||
156709205|NCT00094861|565680540|FG001|Overall Study|Withdrawal by Subject|3|||
156709206|NCT00094861|565680539|FG000|Overall Study|Physician Decision|1|||
156709207|NCT00094861|565680540|FG001|Overall Study|Physician Decision|1|||
156332641|NCT01696695|564317369|FG000|Overall Study|Disease progression|373|||
156332642|NCT01696695|564317369|FG000|Overall Study|Death|29|||
156332643|NCT01696695|564317369|FG000|Overall Study|Adverse Event|74|||
156332644|NCT01696695|564317369|FG000|Overall Study|Withdrawal by Subject|92|||
156332645|NCT01696695|564317369|FG000|Overall Study|Lost to Follow-up|48|||
156332646|NCT01696695|564317369|FG000|Overall Study|Other|74|||
156332647|NCT01696695|564317369|FG000|Overall Study|Major Protocol Violation|192|||
156332648|NCT01024231|564317375|FG000|Overall Study|Other Reasons|1|||
156332649|NCT01024231|564317376|FG001|Overall Study|Other Reasons|2|||
156332650|NCT01024231|564317377|FG002|Overall Study|Other Reasons|0|||
156709208|NCT00094861|565680539|FG000|Overall Study|Lost to Follow-up|0|||
156709209|NCT00094861|565680540|FG001|Overall Study|Lost to Follow-up|1|||
156709210|NCT00094861|565680539|FG000|Overall Study|Death|4|||
156709211|NCT00094861|565680540|FG001|Overall Study|Death|2|||
156709212|NCT00094861|565680539|FG000|Overall Study|Other|3|||
156709213|NCT00094861|565680540|FG001|Overall Study|Other|0|||
156709214|NCT00451204|565680541|FG000|Overall Study|Adverse Event|4|||
156709215|NCT00451204|565680542|FG001|Overall Study|Adverse Event|6|||
156709216|NCT00451204|565680541|FG000|Overall Study|Lack of Efficacy|4|||
156709217|NCT00451204|565680542|FG001|Overall Study|Lack of Efficacy|4|||
156709218|NCT00451204|565680541|FG000|Overall Study|Lost to Follow-up|4|||
156709219|NCT00451204|565680542|FG001|Overall Study|Lost to Follow-up|4|||
156709220|NCT00451204|565680541|FG000|Overall Study|Protocol Violation|1|||
156709221|NCT00451204|565680542|FG001|Overall Study|Protocol Violation|0|||
156709222|NCT00451204|565680541|FG000|Overall Study|Patient refusal|8|||
156709223|NCT00451204|565680542|FG001|Overall Study|Patient refusal|4|||
156709224|NCT00451204|565680541|FG000|Overall Study|Other|1|||
156709225|NCT00451204|565680542|FG001|Overall Study|Other|2|||
156709226|NCT03760185|565680543|FG000|Overall Study|Lost to Follow-up|1|||
156791841|NCT01725308|565991001|FG000|Treatment Period II|Miscellaneous|5|||
156791842|NCT01725308|565991002|FG001|Treatment Period II|Miscellaneous|3|||
156791843|NCT01725308|565991003|FG002|Treatment Period II|Miscellaneous|7|||
156791844|NCT03511209|565991004|FG000|Overall Study|Withdrawal by Subject|2|||
156791845|NCT03511209|565991005|FG001|Overall Study|Withdrawal by Subject|4|||
156791846|NCT03511209|565991004|FG000|Overall Study|Death|1|||
156791847|NCT03511209|565991005|FG001|Overall Study|Death|0|||
156791848|NCT03511209|565991004|FG000|Overall Study|Lost to Follow-up|0|||
156791849|NCT03511209|565991005|FG001|Overall Study|Lost to Follow-up|2|||
156791850|NCT02971137|565991011|FG000|Overall Study|Lost to Follow-up|44|||
156791851|NCT02971137|565991012|FG001|Overall Study|Lost to Follow-up|56|||
156791852|NCT00215657|565991013|FG000|Overall Study|Adverse Event|5|||
156791853|NCT00215657|565991014|FG001|Overall Study|Adverse Event|1|||
156791854|NCT00215657|565991015|FG002|Overall Study|Adverse Event|3|||
156791855|NCT00215657|565991016|FG003|Overall Study|Adverse Event|0|||
156791856|NCT00215657|565991017|FG004|Overall Study|Adverse Event|3|||
156791857|NCT00215657|565991018|FG005|Overall Study|Adverse Event|1|||
156791858|NCT00215657|565991019|FG006|Overall Study|Adverse Event|0|||
156791859|NCT00215657|565991020|FG007|Overall Study|Adverse Event|3|||
156791860|NCT00215657|565991013|FG000|Overall Study|Withdrawal by Subject|6|||
156791861|NCT00215657|565991014|FG001|Overall Study|Withdrawal by Subject|3|||
156791862|NCT00215657|565991015|FG002|Overall Study|Withdrawal by Subject|3|||
156791863|NCT00215657|565991016|FG003|Overall Study|Withdrawal by Subject|1|||
156791864|NCT00215657|565991017|FG004|Overall Study|Withdrawal by Subject|6|||
156791865|NCT00215657|565991018|FG005|Overall Study|Withdrawal by Subject|1|||
156791866|NCT00215657|565991019|FG006|Overall Study|Withdrawal by Subject|10|||
156791867|NCT00215657|565991020|FG007|Overall Study|Withdrawal by Subject|3|||
156791868|NCT00215657|565991013|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
156791869|NCT00215657|565991014|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
156791870|NCT00215657|565991015|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
156791871|NCT00215657|565991016|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
156791872|NCT00215657|565991017|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
156791873|NCT00215657|565991018|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
156791874|NCT00215657|565991019|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
156791875|NCT00215657|565991020|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
156791876|NCT00215657|565991013|FG000|Overall Study|Insufficient testosterone response|5|||
156791877|NCT00215657|565991014|FG001|Overall Study|Insufficient testosterone response|4|||
156791878|NCT00215657|565991015|FG002|Overall Study|Insufficient testosterone response|1|||
156709227|NCT03760185|565680544|FG001|Overall Study|Lost to Follow-up|1|||
156332651|NCT01024231|564317378|FG003|Overall Study|Other Reasons|0|||
156332652|NCT01024231|564317379|FG004|Overall Study|Other Reasons|2|||
156709228|NCT02473523|565680545|FG000|Overall Study|Death|1|||
156709229|NCT02473523|565680545|FG000|Overall Study|Lost to Follow-up|1|||
156872713|NCT00606593|566291339|FG005|Overall Study|Adverse Event|0|||
156872714|NCT00606593|566291340|FG006|Overall Study|Adverse Event|1|||
156872715|NCT00606593|566291341|FG007|Overall Study|Adverse Event|2|||
156872716|NCT00606593|566291342|FG008|Overall Study|Adverse Event|1|||
156872717|NCT00606593|566291343|FG009|Overall Study|Adverse Event|0|||
156872718|NCT00606593|566291334|FG000|Overall Study|Withdrawal of consent|1|||
156872719|NCT00606593|566291335|FG001|Overall Study|Withdrawal of consent|0|||
156332653|NCT01024231|564317380|FG005|Overall Study|Other Reasons|0|||
156332654|NCT01024231|564317381|FG006|Overall Study|Other Reasons|1|||
156332655|NCT01024231|564317375|FG000|Overall Study|Maximum Clinical Benefit|1|||
156332656|NCT01024231|564317376|FG001|Overall Study|Maximum Clinical Benefit|2|||
156332657|NCT01024231|564317377|FG002|Overall Study|Maximum Clinical Benefit|0|||
156332658|NCT01024231|564317378|FG003|Overall Study|Maximum Clinical Benefit|1|||
156332659|NCT01024231|564317379|FG004|Overall Study|Maximum Clinical Benefit|1|||
156332660|NCT01024231|564317380|FG005|Overall Study|Maximum Clinical Benefit|0|||
156332661|NCT01024231|564317381|FG006|Overall Study|Maximum Clinical Benefit|0|||
156332662|NCT01024231|564317375|FG000|Overall Study|Disease Progression|3|||
156332663|NCT01024231|564317376|FG001|Overall Study|Disease Progression|1|||
156332664|NCT01024231|564317377|FG002|Overall Study|Disease Progression|3|||
156332665|NCT01024231|564317378|FG003|Overall Study|Disease Progression|0|||
156332666|NCT01024231|564317379|FG004|Overall Study|Disease Progression|4|||
156332667|NCT01024231|564317380|FG005|Overall Study|Disease Progression|11|||
156332668|NCT01024231|564317381|FG006|Overall Study|Disease Progression|6|||
156441695|NCT04043455|564710910|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
156441696|NCT04043455|564710911|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
156441697|NCT04043455|564710912|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
156441698|NCT04043455|564710913|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
156441699|NCT04043455|564710908|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
156441700|NCT04043455|564710909|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
156441701|NCT04043455|564710910|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
156441702|NCT04043455|564710911|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
156441703|NCT04043455|564710912|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
156441704|NCT04043455|564710913|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
156441705|NCT04043455|564710908|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
156441706|NCT04043455|564710909|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
156441707|NCT04043455|564710910|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
156441708|NCT04043455|564710911|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
156441709|NCT04043455|564710912|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
156441710|NCT04043455|564710913|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
156441711|NCT04043455|564710908|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
156441712|NCT04043455|564710909|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
156441713|NCT04043455|564710910|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
156441714|NCT04043455|564710911|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
156441715|NCT04043455|564710912|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
156441716|NCT04043455|564710913|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
156441717|NCT04043455|564710908|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
156441718|NCT04043455|564710909|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
156441719|NCT04043455|564710910|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
156441720|NCT04043455|564710911|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
156441721|NCT04043455|564710912|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
156441722|NCT04043455|564710913|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
156441723|NCT04043455|564710908|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
156441724|NCT04043455|564710909|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
156441725|NCT04043455|564710910|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
156441726|NCT04043455|564710911|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
156441727|NCT04043455|564710912|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
156441728|NCT04043455|564710913|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
156441729|NCT04043455|564710908|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
156441730|NCT04043455|564710909|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
156441731|NCT04043455|564710910|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
156872720|NCT00606593|566291336|FG002|Overall Study|Withdrawal of consent|1|||
156872721|NCT00606593|566291337|FG003|Overall Study|Withdrawal of consent|0|||
156332669|NCT01024231|564317375|FG000|Overall Study|AE unrelated to Study Drug|0|||
156332670|NCT01024231|564317376|FG001|Overall Study|AE unrelated to Study Drug|1|||
156332671|NCT01024231|564317377|FG002|Overall Study|AE unrelated to Study Drug|0|||
156332672|NCT01024231|564317378|FG003|Overall Study|AE unrelated to Study Drug|0|||
156441732|NCT04043455|564710911|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
156441733|NCT04043455|564710912|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
156441734|NCT04043455|564710913|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
156441735|NCT04043455|564710908|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
156441736|NCT04043455|564710909|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
156441737|NCT04043455|564710910|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
156441738|NCT04043455|564710911|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
156441739|NCT04043455|564710912|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
156441740|NCT04043455|564710913|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
156441741|NCT04043455|564710908|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
156531876|NCT01839487|565041740|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
156531877|NCT01839487|565041741|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
156531878|NCT01839487|565041736|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
156531879|NCT01839487|565041737|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
156531880|NCT01839487|565041738|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
156531881|NCT01839487|565041739|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
156531882|NCT01839487|565041740|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
156531883|NCT01839487|565041741|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
156531884|NCT01839487|565041736|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
156531885|NCT01839487|565041737|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
156531886|NCT01839487|565041738|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
156531887|NCT01839487|565041739|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
156531888|NCT01839487|565041740|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
156531889|NCT01839487|565041741|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
156531890|NCT01839487|565041736|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
156531891|NCT01839487|565041737|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
156531892|NCT01839487|565041738|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
156531893|NCT01839487|565041739|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
156531894|NCT01839487|565041740|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
156531895|NCT01839487|565041741|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
156531896|NCT01016964|565043198|FG000|Overall Study|Lost to Follow-up|3|||
156531897|NCT01016964|565043199|FG001|Overall Study|Lost to Follow-up|3|||
156531898|NCT00440700|565043201|FG000|Overall Study|Withdrawal by Subject|8|||
156531899|NCT00440700|565043202|FG001|Overall Study|Withdrawal by Subject|8|||
156531900|NCT00440700|565043203|FG002|Overall Study|Withdrawal by Subject|4|||
156531901|NCT00909792|565043204|FG000|Period 1|Did not meet inclusion criteria|0|||
156531902|NCT00909792|565043205|FG001|Period 1|Did not meet inclusion criteria|1|||
156531903|NCT00909792|565043204|FG000|Period 2|Biomicroscopy|1|||
156531904|NCT00909792|565043205|FG001|Period 2|Biomicroscopy|0|||
156531905|NCT00909792|565043204|FG000|Period 2|Lost to Follow-up|0|||
156531906|NCT00909792|565043205|FG001|Period 2|Lost to Follow-up|1|||
156531907|NCT01521897|565043208|FG000|Overall Study|Protocol Violation|18|||
156531908|NCT01521897|565043208|FG000|Overall Study|Lost to Follow-up|5|||
156531909|NCT00385203|565043209|FG000|Overall Study|Adverse Event|5|||
156531910|NCT00385203|565043210|FG001|Overall Study|Adverse Event|4|||
156791879|NCT00215657|565991016|FG003|Overall Study|Insufficient testosterone response|12|||
156791880|NCT00215657|565991017|FG004|Overall Study|Insufficient testosterone response|8|||
156791881|NCT00215657|565991018|FG005|Overall Study|Insufficient testosterone response|12|||
156791882|NCT00215657|565991019|FG006|Overall Study|Insufficient testosterone response|4|||
156791883|NCT00215657|565991020|FG007|Overall Study|Insufficient testosterone response|7|||
156791884|NCT00215657|565991013|FG000|Overall Study|Other|3|||
156791885|NCT00215657|565991014|FG001|Overall Study|Other|1|||
156791886|NCT00215657|565991015|FG002|Overall Study|Other|2|||
156791887|NCT00215657|565991016|FG003|Overall Study|Other|3|||
156791888|NCT00215657|565991017|FG004|Overall Study|Other|5|||
156791889|NCT00215657|565991018|FG005|Overall Study|Other|4|||
156791890|NCT00215657|565991019|FG006|Overall Study|Other|6|||
156791891|NCT00215657|565991020|FG007|Overall Study|Other|1|||
156791892|NCT01887600|565991023|FG000|Overall Study|Death|39|||
156791893|NCT01887600|565991024|FG001|Overall Study|Death|16|||
156791894|NCT01887600|565991023|FG000|Overall Study|Lack of Efficacy|3|||
156791895|NCT01887600|565991024|FG001|Overall Study|Lack of Efficacy|26|||
156791896|NCT01887600|565991023|FG000|Overall Study|Lost to Follow-up|5|||
156791897|NCT01887600|565991024|FG001|Overall Study|Lost to Follow-up|1|||
156791898|NCT01887600|565991023|FG000|Overall Study|Physician Decision|7|||
156791899|NCT01887600|565991024|FG001|Overall Study|Physician Decision|8|||
156791900|NCT01887600|565991023|FG000|Overall Study|Protocol Deviation|3|||
156791901|NCT01887600|565991024|FG001|Overall Study|Protocol Deviation|0|||
156791902|NCT01887600|565991023|FG000|Overall Study|Withdrawal by Subject|58|||
156791903|NCT01887600|565991024|FG001|Overall Study|Withdrawal by Subject|52|||
156531911|NCT00385203|565043209|FG000|Overall Study|Death|1|||
156531912|NCT00385203|565043210|FG001|Overall Study|Death|0|||
156531913|NCT00385203|565043209|FG000|Overall Study|Condition under investigation worsened|18|||
156872722|NCT00606593|566291338|FG004|Overall Study|Withdrawal of consent|0|||
156872723|NCT00606593|566291339|FG005|Overall Study|Withdrawal of consent|0|||
156872724|NCT00606593|566291340|FG006|Overall Study|Withdrawal of consent|0|||
156872725|NCT00606593|566291341|FG007|Overall Study|Withdrawal of consent|0|||
156872726|NCT00606593|566291342|FG008|Overall Study|Withdrawal of consent|0|||
156872727|NCT00606593|566291343|FG009|Overall Study|Withdrawal of consent|0|||
156872728|NCT00606593|566291334|FG000|Overall Study|Administrative/Other|0|||
156872729|NCT00606593|566291335|FG001|Overall Study|Administrative/Other|0|||
156872730|NCT00606593|566291336|FG002|Overall Study|Administrative/Other|1|||
156872731|NCT00606593|566291337|FG003|Overall Study|Administrative/Other|0|||
156872732|NCT00606593|566291338|FG004|Overall Study|Administrative/Other|0|||
156872733|NCT00606593|566291339|FG005|Overall Study|Administrative/Other|0|||
156872734|NCT00606593|566291340|FG006|Overall Study|Administrative/Other|0|||
156872735|NCT00606593|566291341|FG007|Overall Study|Administrative/Other|0|||
156872736|NCT00606593|566291342|FG008|Overall Study|Administrative/Other|0|||
156872737|NCT00606593|566291343|FG009|Overall Study|Administrative/Other|0|||
156872738|NCT01724346|566291344|FG000|Overall Study|Death|42|||
156872739|NCT01724346|566291345|FG001|Overall Study|Death|42|||
156872740|NCT01724346|566291344|FG000|Overall Study|Lost to Follow-up|5|||
156872741|NCT01724346|566291345|FG001|Overall Study|Lost to Follow-up|1|||
156872742|NCT01724346|566291344|FG000|Overall Study|Withdrawal by Subject|27|||
156872743|NCT01724346|566291345|FG001|Overall Study|Withdrawal by Subject|19|||
156872744|NCT01724346|566291344|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
156872745|NCT01724346|566291345|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
156872746|NCT01006291|566293215|FG000|Overall Study|Adverse Event|2|||
156872747|NCT01006291|566293216|FG001|Overall Study|Adverse Event|1|||
156872748|NCT01006291|566293217|FG002|Overall Study|Adverse Event|2|||
156872749|NCT01006291|566293215|FG000|Overall Study|Lack of Efficacy|2|||
156872750|NCT01006291|566293216|FG001|Overall Study|Lack of Efficacy|2|||
156872751|NCT01006291|566293217|FG002|Overall Study|Lack of Efficacy|1|||
156872752|NCT01006291|566293215|FG000|Overall Study|Protocol Violation|3|||
156872753|NCT01006291|566293216|FG001|Overall Study|Protocol Violation|3|||
156872754|NCT01006291|566293217|FG002|Overall Study|Protocol Violation|3|||
156872755|NCT01006291|566293215|FG000|Overall Study|Withdrawal criteria|5|||
156872756|NCT01006291|566293216|FG001|Overall Study|Withdrawal criteria|4|||
156872757|NCT01006291|566293217|FG002|Overall Study|Withdrawal criteria|4|||
156872758|NCT01006291|566293215|FG000|Overall Study|Other|14|||
156872759|NCT01006291|566293216|FG001|Overall Study|Other|14|||
156872760|NCT01006291|566293217|FG002|Overall Study|Other|17|||
156872761|NCT00684060|566293218|FG000|Overall Study|Lost to Follow-up|1|||
156872762|NCT00684060|566293219|FG001|Overall Study|Lost to Follow-up|0|||
156872763|NCT00684060|566293218|FG000|Overall Study|New stenosis identified|1|||
156872764|NCT00684060|566293219|FG001|Overall Study|New stenosis identified|0|||
156872765|NCT00684060|566293218|FG000|Overall Study|Unable to collect MRI|1|||
156872766|NCT00684060|566293219|FG001|Overall Study|Unable to collect MRI|2|||
156872767|NCT00684060|566293218|FG000|Overall Study|Death|0|||
156872768|NCT00684060|566293219|FG001|Overall Study|Death|1|||
156872769|NCT00702715|566293220|FG000|Overall Study|Lost to Follow-up|1|||
156872770|NCT00702715|566293221|FG001|Overall Study|Lost to Follow-up|0|||
156872771|NCT01677377|566293226|FG000|Overall Study|Protocol Violation|1|||
156872772|NCT01677377|566293227|FG001|Overall Study|Protocol Violation|0|||
156872773|NCT01677377|566293228|FG002|Overall Study|Protocol Violation|0|||
156872774|NCT01677377|566293226|FG000|Overall Study|Lost to Follow-up|0|||
156872775|NCT01677377|566293227|FG001|Overall Study|Lost to Follow-up|1|||
156872776|NCT01677377|566293228|FG002|Overall Study|Lost to Follow-up|1|||
156872777|NCT01677377|566293226|FG000|Overall Study|Withdrawal by Subject|0|||
156872778|NCT01677377|566293227|FG001|Overall Study|Withdrawal by Subject|0|||
156872779|NCT01677377|566293228|FG002|Overall Study|Withdrawal by Subject|3|||
156872780|NCT01677377|566293226|FG000|Overall Study|Lack of Efficacy|0|||
156441742|NCT04043455|564710909|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
156441743|NCT04043455|564710910|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
156441744|NCT04043455|564710911|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
156441745|NCT04043455|564710912|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
156441746|NCT04043455|564710913|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
156709230|NCT00976911|565680551|FG000|Overall Study|Withdrawal by Subject|4|||
156872781|NCT01677377|566293227|FG001|Overall Study|Lack of Efficacy|0|||
156872782|NCT01677377|566293228|FG002|Overall Study|Lack of Efficacy|1|||
156872783|NCT01677377|566293226|FG000|Overall Study|Pregnancy|0|||
156872784|NCT01677377|566293227|FG001|Overall Study|Pregnancy|0|||
156872785|NCT01677377|566293228|FG002|Overall Study|Pregnancy|1|||
156872786|NCT02260180|566293229|FG000|Overall Study|Adverse Event|2|||
156872787|NCT02260180|566293230|FG001|Overall Study|Adverse Event|0|||
156872788|NCT02260180|566293231|FG002|Overall Study|Adverse Event|1|||
156872789|NCT03180840|566293232|FG000|Overall Study|Withdrawal by Subject|1|||
156872790|NCT00753649|566293243|FG000|Overall Study|Migrated/moved from study area|1|||
156709231|NCT00976911|565680552|FG001|Overall Study|Withdrawal by Subject|6|||
156872791|NCT00753649|566293244|FG001|Overall Study|Migrated/moved from study area|0|||
156872792|NCT00753649|566293243|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
156441747|NCT04043455|564710908|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
156441748|NCT04043455|564710909|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
156531914|NCT00385203|565043210|FG001|Overall Study|Condition under investigation worsened|3|||
156531915|NCT00385203|565043209|FG000|Overall Study|Incorrect enrollment|2|||
156531916|NCT00385203|565043210|FG001|Overall Study|Incorrect enrollment|0|||
156441749|NCT04043455|564710910|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
156441750|NCT04043455|564710911|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
156441751|NCT04043455|564710912|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
156441752|NCT04043455|564710913|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
156441753|NCT04043455|564710908|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
156441754|NCT04043455|564710909|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
156441755|NCT04043455|564710910|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
156441756|NCT04043455|564710911|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
156441757|NCT04043455|564710912|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
156441758|NCT04043455|564710913|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
156441759|NCT05505045|564710914|FG000|Overall Study|Withdrawal by Subject|2|||
156441760|NCT05505045|564710915|FG001|Overall Study|Withdrawal by Subject|1|||
156441761|NCT04104321|564710917|FG000|Overall Study|didn't take the study drug|3|||
156441762|NCT04842500|564710918|FG000|Overall Study|Withdrawal by Subject|4|||
156441763|NCT04842500|564710919|FG001|Overall Study|Withdrawal by Subject|1|||
156441764|NCT04842500|564710920|FG002|Overall Study|Withdrawal by Subject|2|||
156441765|NCT04842500|564710921|FG003|Overall Study|Withdrawal by Subject|3|||
156441766|NCT04842500|564710918|FG000|Overall Study|Protocol Violation|1|||
156441767|NCT04842500|564710919|FG001|Overall Study|Protocol Violation|0|||
156441768|NCT04842500|564710920|FG002|Overall Study|Protocol Violation|0|||
156441769|NCT04842500|564710921|FG003|Overall Study|Protocol Violation|1|||
156441770|NCT02980276|564710922|FG000|Overall Study|Withdrawal by Subject|4|||
156441771|NCT02980276|564710923|FG001|Overall Study|Withdrawal by Subject|4|||
156441772|NCT02980276|564710922|FG000|Overall Study|Physician Decision|0|||
156441773|NCT02980276|564710923|FG001|Overall Study|Physician Decision|1|||
156531917|NCT03308942|565043211|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
156531918|NCT03308942|565043212|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
156531919|NCT03308942|565043213|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
156791904|NCT01887600|565991023|FG000|Overall Study|Adverse Event|21|||
156791905|NCT01887600|565991024|FG001|Overall Study|Adverse Event|9|||
156791906|NCT01887600|565991023|FG000|Overall Study|Non-compliance with study drug|3|||
156791907|NCT01887600|565991024|FG001|Overall Study|Non-compliance with study drug|0|||
156791908|NCT01887600|565991023|FG000|Overall Study|Miscellaneous|6|||
156791909|NCT01887600|565991024|FG001|Overall Study|Miscellaneous|2|||
156791910|NCT01887600|565991023|FG000|Overall Study|Progressive Disease|1|||
156791911|NCT01887600|565991024|FG001|Overall Study|Progressive Disease|0|||
156791912|NCT03688139|565991025|FG000|Overall Study|Lost to Follow-up|2|||
156791913|NCT03688139|565991026|FG001|Overall Study|Lost to Follow-up|0|||
156791914|NCT03688139|565991025|FG000|Overall Study|Physician Decision|0|||
156791915|NCT03688139|565991026|FG001|Overall Study|Physician Decision|1|||
156791916|NCT03688139|565991025|FG000|Overall Study|Withdrawal by Subject|2|||
156791917|NCT03688139|565991026|FG001|Overall Study|Withdrawal by Subject|3|||
156791918|NCT01185366|565991027|FG000|First Line Therapy|Insurance Coverage Denied|1|||
156791919|NCT01185366|565991028|FG001|First Line Therapy|Insurance Coverage Denied|1|||
156791920|NCT01185366|565991027|FG000|First Line Therapy|Withdrawal by Subject|1|||
156791921|NCT01185366|565991028|FG001|First Line Therapy|Withdrawal by Subject|0|||
156791922|NCT01185366|565991027|FG000|First Line Therapy|Lack of Metastatic Site|1|||
156791923|NCT01185366|565991028|FG001|First Line Therapy|Lack of Metastatic Site|0|||
156791924|NCT01185366|565991027|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
156791925|NCT01185366|565991028|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
156791926|NCT01185366|565991027|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
156791927|NCT01185366|565991028|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
156791928|NCT01185366|565991027|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
156441774|NCT02980276|564710922|FG000|Overall Study|Lost to Follow-up|18|||
156441775|NCT02980276|564710923|FG001|Overall Study|Lost to Follow-up|18|||
156441776|NCT02980276|564710922|FG000|Overall Study|Death|1|||
156791929|NCT01185366|565991028|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
156872793|NCT00753649|566293244|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
156872794|NCT00753649|566293243|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
156441777|NCT02980276|564710923|FG001|Overall Study|Death|0|||
156441778|NCT02980276|564710922|FG000|Overall Study|Miscellaneous other|10|||
156441779|NCT02980276|564710923|FG001|Overall Study|Miscellaneous other|4|||
156441780|NCT04139668|564710925|FG000|Overall Study|Withdrawal by Subject|1|||
156531920|NCT03308942|565043214|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
156531921|NCT03308942|565043215|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
156791930|NCT01185366|565991027|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
156791931|NCT01185366|565991028|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
156441781|NCT03346538|564710932|FG000|Overall Study|Physician Decision|0|||
156441782|NCT03346538|564710933|FG001|Overall Study|Physician Decision|1|||
156441783|NCT03346538|564710934|FG002|Overall Study|Physician Decision|0|||
156441784|NCT03346538|564710932|FG000|Overall Study|Withdrawal by Subject|3|||
156441785|NCT03346538|564710933|FG001|Overall Study|Withdrawal by Subject|2|||
156441786|NCT03346538|564710934|FG002|Overall Study|Withdrawal by Subject|0|||
156441787|NCT03346538|564710932|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
156441788|NCT03346538|564710933|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
156441789|NCT03346538|564710934|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
156441790|NCT03088813|564710938|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
156441791|NCT03088813|564710939|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
156441792|NCT03088813|564710940|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
156441793|NCT03088813|564710941|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
156441794|NCT03088813|564710938|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
156441795|NCT03088813|564710939|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
156441796|NCT03088813|564710940|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
156441797|NCT03088813|564710941|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
156441798|NCT03088813|564710938|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
156441799|NCT03088813|564710939|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
156441800|NCT03088813|564710940|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
156441801|NCT03088813|564710941|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
156441802|NCT03088813|564710938|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
156441803|NCT03088813|564710939|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
156441804|NCT03088813|564710940|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
156441805|NCT03088813|564710941|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
156441806|NCT03088813|564710938|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
156441807|NCT03088813|564710939|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
156441808|NCT03088813|564710940|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
156441809|NCT03088813|564710941|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
156441810|NCT03088813|564710938|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
156441811|NCT03088813|564710939|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
156441812|NCT03088813|564710940|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
156441813|NCT03088813|564710941|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
156441814|NCT03088813|564710938|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
156441815|NCT03088813|564710939|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
156441816|NCT03088813|564710940|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
156441817|NCT03088813|564710941|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
156441818|NCT01903811|564710942|FG000|Overall Study|No measurable disease|1|||
156441819|NCT01903811|564710943|FG001|Overall Study|No measurable disease|1|||
156441820|NCT01903811|564710942|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
156441821|NCT01903811|564710943|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
156441822|NCT01903811|564710942|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
156441823|NCT01903811|564710943|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
156441824|NCT01903811|564710942|FG000|Overall Study|Withdrawal by Subject|0|||
156441825|NCT01903811|564710943|FG001|Overall Study|Withdrawal by Subject|1|||
156441826|NCT04440176|564710944|FG000|Overall Study|Withdrawal by Subject|5|||
156441827|NCT04440176|564710945|FG001|Overall Study|Withdrawal by Subject|3|||
156441828|NCT04440176|564710944|FG000|Overall Study|Withdrawal by parent/guardian|4|||
156441829|NCT04440176|564710945|FG001|Overall Study|Withdrawal by parent/guardian|5|||
156441830|NCT04440176|564710944|FG000|Overall Study|Adverse Event|2|||
156441831|NCT04440176|564710945|FG001|Overall Study|Adverse Event|6|||
156441832|NCT04440176|564710944|FG000|Overall Study|Lost to Follow-up|22|||
156441833|NCT04440176|564710945|FG001|Overall Study|Lost to Follow-up|23|||
156441834|NCT04440176|564710944|FG000|Overall Study|Medication error without associated adverse event|0|||
156441835|NCT04440176|564710945|FG001|Overall Study|Medication error without associated adverse event|1|||
156441836|NCT04440176|564710944|FG000|Overall Study|No longer met eligibility criteria|7|||
156709232|NCT00976911|565680551|FG000|Overall Study|Death|138|||
156709233|NCT00976911|565680552|FG001|Overall Study|Death|126|||
156709234|NCT00976911|565680551|FG000|Overall Study|Adverse Event|0|||
156709235|NCT00976911|565680552|FG001|Overall Study|Adverse Event|1|||
156709236|NCT00976911|565680551|FG000|Overall Study|Protocol Violation|2|||
156709237|NCT00976911|565680552|FG001|Overall Study|Protocol Violation|0|||
156709238|NCT00976911|565680551|FG000|Overall Study|Other|8|||
156709239|NCT00976911|565680552|FG001|Overall Study|Other|9|||
156709240|NCT00976911|565680551|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
156709241|NCT00976911|565680552|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
156709242|NCT01191944|565680553|FG000|Overall Study|Adverse Event|11|||
156709243|NCT01191944|565680554|FG001|Overall Study|Adverse Event|12|||
156531922|NCT03308942|565043211|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
156531923|NCT03308942|565043212|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
156709244|NCT01191944|565680553|FG000|Overall Study|Protocol Violation|1|||
156709245|NCT01191944|565680554|FG001|Overall Study|Protocol Violation|2|||
156709246|NCT01191944|565680553|FG000|Overall Study|Withdrawal by Subject|4|||
156709247|NCT01191944|565680554|FG001|Overall Study|Withdrawal by Subject|2|||
156709248|NCT01191944|565680553|FG000|Overall Study|Other|1|||
156709249|NCT01191944|565680554|FG001|Overall Study|Other|3|||
156709250|NCT02954991|565680557|FG000|Overall Study|Death|92|||
156709251|NCT02954991|565680558|FG001|Overall Study|Death|11|||
156709252|NCT02954991|565680559|FG002|Overall Study|Death|2|||
156709253|NCT02954991|565680557|FG000|Overall Study|Lost to Follow-up|3|||
156709254|NCT02954991|565680558|FG001|Overall Study|Lost to Follow-up|2|||
156709255|NCT02954991|565680559|FG002|Overall Study|Lost to Follow-up|0|||
156709256|NCT02954991|565680557|FG000|Overall Study|Withdrawal by Subject|9|||
156709257|NCT02954991|565680558|FG001|Overall Study|Withdrawal by Subject|8|||
156709258|NCT02954991|565680559|FG002|Overall Study|Withdrawal by Subject|1|||
156709259|NCT02954991|565680557|FG000|Overall Study|Study Terminated by Sponsor|18|||
156709260|NCT02954991|565680558|FG001|Overall Study|Study Terminated by Sponsor|10|||
156709261|NCT02954991|565680559|FG002|Overall Study|Study Terminated by Sponsor|1|||
156709262|NCT02954991|565680557|FG000|Overall Study|Miscellaneous|2|||
156709263|NCT02954991|565680558|FG001|Overall Study|Miscellaneous|1|||
156709264|NCT02954991|565680559|FG002|Overall Study|Miscellaneous|1|||
156709265|NCT00576316|565680560|FG000|Overall Study|Adverse Event|9|||
156709266|NCT00576316|565680560|FG000|Overall Study|Withdrawal by Subject|2|||
156709267|NCT00576316|565680560|FG000|Overall Study|Protocol Violation|9|||
156709268|NCT02552303|565680567|FG000|Allocation|Withdrawal by Subject|2|||
156709269|NCT02552303|565680568|FG001|Allocation|Withdrawal by Subject|1|||
156709270|NCT02552303|565680569|FG002|Allocation|Withdrawal by Subject|1|||
156709271|NCT02552303|565680570|FG003|Allocation|Withdrawal by Subject|1|||
156709272|NCT02552303|565680567|FG000|Allocation|ineligible|1|||
156709273|NCT02552303|565680568|FG001|Allocation|ineligible|1|||
156791932|NCT01783938|565991034|FG000|Overall Study|Disease Progression|18|||
156791933|NCT01783938|565991035|FG001|Overall Study|Disease Progression|41|||
156791934|NCT01783938|565991034|FG000|Overall Study|Study Drug Toxicity|27|||
156791935|NCT01783938|565991035|FG001|Overall Study|Study Drug Toxicity|14|||
156791936|NCT01783938|565991034|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
156791937|NCT01783938|565991035|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
156791938|NCT01783938|565991034|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
156791939|NCT01783938|565991035|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
156791940|NCT01783938|565991034|FG000|Overall Study|Participant Withdrew Consent|2|||
156791941|NCT01783938|565991035|FG001|Overall Study|Participant Withdrew Consent|0|||
156791942|NCT01783938|565991034|FG000|Overall Study|Maximum Clinical Benefit|1|||
156791943|NCT01783938|565991035|FG001|Overall Study|Maximum Clinical Benefit|0|||
156791944|NCT01783938|565991034|FG000|Overall Study|Other Reasons|3|||
156791945|NCT01783938|565991035|FG001|Overall Study|Other Reasons|1|||
156791946|NCT00498485|565991036|FG000|Overall Study|Adverse Event|1|||
156791947|NCT00498485|565991037|FG001|Overall Study|Adverse Event|5|||
156791948|NCT00452400|565991040|FG000|Overall Study|Adverse Event|1|||
156791949|NCT00452400|565991041|FG001|Overall Study|Adverse Event|1|||
156791950|NCT00452400|565991042|FG002|Overall Study|Adverse Event|5|||
156791951|NCT00452400|565991043|FG003|Overall Study|Adverse Event|0|||
156791952|NCT00452400|565991044|FG004|Overall Study|Adverse Event|2|||
156791953|NCT00452400|565991040|FG000|Overall Study|Protocol Violation|0|||
156791954|NCT00452400|565991041|FG001|Overall Study|Protocol Violation|0|||
156332673|NCT01024231|564317379|FG004|Overall Study|AE unrelated to Study Drug|0|||
156332674|NCT01024231|564317380|FG005|Overall Study|AE unrelated to Study Drug|0|||
156332675|NCT01024231|564317381|FG006|Overall Study|AE unrelated to Study Drug|0|||
156332676|NCT01024231|564317375|FG000|Overall Study|No longer meets criteria|0|||
156332677|NCT01024231|564317376|FG001|Overall Study|No longer meets criteria|0|||
156332678|NCT01024231|564317377|FG002|Overall Study|No longer meets criteria|0|||
156332679|NCT01024231|564317378|FG003|Overall Study|No longer meets criteria|0|||
156332680|NCT01024231|564317379|FG004|Overall Study|No longer meets criteria|1|||
156332681|NCT01024231|564317380|FG005|Overall Study|No longer meets criteria|0|||
156332682|NCT01024231|564317381|FG006|Overall Study|No longer meets criteria|1|||
156332683|NCT01024231|564317375|FG000|Overall Study|Study Drug Toxicity|1|||
156332684|NCT01024231|564317376|FG001|Overall Study|Study Drug Toxicity|6|||
156332685|NCT01024231|564317377|FG002|Overall Study|Study Drug Toxicity|6|||
156332686|NCT01024231|564317378|FG003|Overall Study|Study Drug Toxicity|4|||
156332687|NCT01024231|564317379|FG004|Overall Study|Study Drug Toxicity|2|||
156332688|NCT01024231|564317380|FG005|Overall Study|Study Drug Toxicity|0|||
156332689|NCT01024231|564317381|FG006|Overall Study|Study Drug Toxicity|7|||
156332690|NCT01024231|564317375|FG000|Overall Study|Death|6|||
156332691|NCT01024231|564317376|FG001|Overall Study|Death|2|||
156709274|NCT02552303|565680569|FG002|Allocation|ineligible|0|||
156709275|NCT02552303|565680570|FG003|Allocation|ineligible|0|||
156791955|NCT00452400|565991042|FG002|Overall Study|Protocol Violation|1|||
156791956|NCT00452400|565991043|FG003|Overall Study|Protocol Violation|0|||
156709276|NCT02552303|565680567|FG000|Follow-Up|Lost to Follow-up|0|||
156709277|NCT02552303|565680568|FG001|Follow-Up|Lost to Follow-up|0|||
156441837|NCT04440176|564710945|FG001|Overall Study|No longer met eligibility criteria|1|||
156441838|NCT04440176|564710944|FG000|Overall Study|Other|1|||
156441839|NCT04440176|564710945|FG001|Overall Study|Other|2|||
156441840|NCT04440176|564710944|FG000|Overall Study|Protocol deviation|6|||
156709278|NCT02552303|565680569|FG002|Follow-Up|Lost to Follow-up|1|||
156709279|NCT02552303|565680570|FG003|Follow-Up|Lost to Follow-up|0|||
156709280|NCT02552303|565680567|FG000|Follow-Up|ineligible|0|||
156709281|NCT02552303|565680568|FG001|Follow-Up|ineligible|2|||
156709282|NCT02552303|565680569|FG002|Follow-Up|ineligible|0|||
156709283|NCT02552303|565680570|FG003|Follow-Up|ineligible|0|||
156709284|NCT02794246|565680571|FG000|Overall Study|Withdrawal by Subject|2|||
156709285|NCT02794246|565680571|FG000|Overall Study|Physician Decision|4|||
156441841|NCT04440176|564710945|FG001|Overall Study|Protocol deviation|8|||
156441842|NCT04440176|564710944|FG000|Overall Study|Randomized but not vaccinated|6|||
156441843|NCT04440176|564710945|FG001|Overall Study|Randomized but not vaccinated|3|||
156441844|NCT01631214|564710946|FG000|Overall Study|Withdrawal by Subject|276|||
156441845|NCT01631214|564710947|FG001|Overall Study|Withdrawal by Subject|290|||
156441846|NCT01631214|564710946|FG000|Overall Study|Death|113|||
156441847|NCT01631214|564710947|FG001|Overall Study|Death|106|||
156441848|NCT01631214|564710946|FG000|Overall Study|Lost to Follow-up|54|||
156441849|NCT01631214|564710947|FG001|Overall Study|Lost to Follow-up|40|||
156441850|NCT01631214|564710946|FG000|Overall Study|Adverse Event|45|||
156441851|NCT01631214|564710947|FG001|Overall Study|Adverse Event|45|||
156441852|NCT01631214|564710946|FG000|Overall Study|Other|22|||
156441853|NCT01631214|564710947|FG001|Overall Study|Other|19|||
156441854|NCT01631214|564710946|FG000|Overall Study|Noncompliance|16|||
156441855|NCT01631214|564710947|FG001|Overall Study|Noncompliance|15|||
156441856|NCT01631214|564710946|FG000|Overall Study|Requirement for Alternative Therapy|8|||
156441857|NCT01631214|564710947|FG001|Overall Study|Requirement for Alternative Therapy|3|||
156441858|NCT01631214|564710946|FG000|Overall Study|Protocol Deviation|4|||
156441859|NCT01631214|564710947|FG001|Overall Study|Protocol Deviation|3|||
156441860|NCT01631214|564710946|FG000|Overall Study|Ineligibility determined|5|||
156441861|NCT01631214|564710947|FG001|Overall Study|Ineligibility determined|2|||
156709286|NCT04602546|565680572|FG000|Overall Study|Training|2|||
156709287|NCT04602546|565680573|FG001|Overall Study|Training|2|||
156441862|NCT01631214|564710946|FG000|Overall Study|Administrative Decision|1|||
156441863|NCT01631214|564710947|FG001|Overall Study|Administrative Decision|0|||
156441864|NCT03575052|564710948|FG000|Overall Study|Adverse Event|6|||
156441865|NCT03575052|564710949|FG001|Overall Study|Adverse Event|10|||
156709288|NCT04602546|565680574|FG002|Overall Study|Training|1|||
156709289|NCT04602546|565680575|FG003|Overall Study|Training|2|||
156709290|NCT04602546|565680576|FG004|Overall Study|Training|0|||
156791957|NCT00452400|565991044|FG004|Overall Study|Protocol Violation|0|||
156791958|NCT00452400|565991040|FG000|Overall Study|Lost to Follow-up|1|||
156791959|NCT00452400|565991041|FG001|Overall Study|Lost to Follow-up|0|||
156791960|NCT00452400|565991042|FG002|Overall Study|Lost to Follow-up|0|||
156791961|NCT00452400|565991043|FG003|Overall Study|Lost to Follow-up|0|||
156791962|NCT00452400|565991044|FG004|Overall Study|Lost to Follow-up|0|||
156791963|NCT00452400|565991040|FG000|Overall Study|Withdrawal by Subject|1|||
156791964|NCT00452400|565991041|FG001|Overall Study|Withdrawal by Subject|0|||
156791965|NCT00452400|565991042|FG002|Overall Study|Withdrawal by Subject|1|||
156791966|NCT00452400|565991043|FG003|Overall Study|Withdrawal by Subject|0|||
156791967|NCT00452400|565991044|FG004|Overall Study|Withdrawal by Subject|0|||
156791968|NCT00452400|565991040|FG000|Overall Study|Lack of Efficacy|2|||
156791969|NCT00452400|565991041|FG001|Overall Study|Lack of Efficacy|0|||
156791970|NCT00452400|565991042|FG002|Overall Study|Lack of Efficacy|0|||
156791971|NCT00452400|565991043|FG003|Overall Study|Lack of Efficacy|0|||
156791972|NCT00452400|565991044|FG004|Overall Study|Lack of Efficacy|0|||
156791973|NCT00452400|565991040|FG000|Overall Study|Other reasons not listed above|0|||
156791974|NCT00452400|565991041|FG001|Overall Study|Other reasons not listed above|0|||
156791975|NCT00452400|565991042|FG002|Overall Study|Other reasons not listed above|0|||
156791976|NCT00452400|565991043|FG003|Overall Study|Other reasons not listed above|1|||
156791977|NCT00452400|565991044|FG004|Overall Study|Other reasons not listed above|1|||
156791978|NCT01712074|565991047|FG000|Placebo Run-in Period|Adverse Event|2|||
156791979|NCT01712074|565991048|FG001|Placebo Run-in Period|Adverse Event|0|||
156791980|NCT01712074|565991049|FG002|Placebo Run-in Period|Adverse Event|0|||
156791981|NCT01712074|565991047|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
156791982|NCT01712074|565991048|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
156791983|NCT01712074|565991049|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
156791984|NCT01712074|565991047|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
156791985|NCT01712074|565991048|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
156791986|NCT01712074|565991049|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
156791987|NCT01712074|565991047|FG000|Placebo Run-in Period|Other|1|||
156791988|NCT01712074|565991048|FG001|Placebo Run-in Period|Other|0|||
156791989|NCT01712074|565991049|FG002|Placebo Run-in Period|Other|0|||
156791990|NCT01712074|565991047|FG000|Placebo Run-in Period|No longer willing to participate|1|||
156791991|NCT01712074|565991048|FG001|Placebo Run-in Period|No longer willing to participate|0|||
156872795|NCT00753649|566293244|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
156872796|NCT00753649|566293243|FG000|Overall Study|Protocol Violation|2|||
156872797|NCT00753649|566293244|FG001|Overall Study|Protocol Violation|0|||
156872798|NCT03544333|566293245|FG000|Overall Study|Withdrawal by Subject|1|||
156872799|NCT03544333|566293246|FG001|Overall Study|Withdrawal by Subject|0|||
156872800|NCT00423917|566293247|FG000|Overall Study|Cancel|2|||
156872801|NCT00423917|566293247|FG000|Overall Study|Ineligible|1|||
156872802|NCT00555061|566293248|FG000|Overall Study|Adverse Event|3|||
156872803|NCT00555061|566293248|FG000|Overall Study|Protocol Violation|1|||
156872804|NCT00555061|566293248|FG000|Overall Study|Lost to Follow-up|2|||
156872805|NCT00555061|566293248|FG000|Overall Study|Withdrawal by Subject|2|||
156872806|NCT00555061|566293248|FG000|Overall Study|Participant enrolled, but never treated|1|||
156872807|NCT00475306|566293249|FG000|Overall Study|Protocol Violation|1|||
156872808|NCT00475306|566293250|FG001|Overall Study|Protocol Violation|1|||
156872809|NCT00475306|566293251|FG002|Overall Study|Protocol Violation|0|||
156872810|NCT00475306|566293252|FG003|Overall Study|Protocol Violation|1|||
156872811|NCT02405442|566293254|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
156872812|NCT02405442|566293255|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
156872813|NCT02405442|566293256|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
156872814|NCT02405442|566293257|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
156872815|NCT02405442|566293254|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
156872816|NCT02405442|566293255|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
156872817|NCT02405442|566293256|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
156872818|NCT02405442|566293257|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
156872819|NCT02405442|566293254|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
156872820|NCT02405442|566293255|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
156872821|NCT02405442|566293256|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
156872822|NCT02405442|566293257|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
156872823|NCT02405442|566293254|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
156872824|NCT02405442|566293255|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
156872825|NCT02405442|566293256|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
156872826|NCT02405442|566293257|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
156872827|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
156872828|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
156872829|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
156872830|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
156872831|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
156872832|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
156872833|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
156872834|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
156872835|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
156872836|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
156872837|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
156872838|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
156872839|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
156872840|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
156872841|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
156872842|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
156872843|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
156872844|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
156872845|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
156872846|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
156872847|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
156872848|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
156872849|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
156872850|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
156872851|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
156872852|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
156872853|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
156872854|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
156872855|NCT02405442|566293254|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
156872856|NCT02405442|566293255|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
156872857|NCT02405442|566293256|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
156332692|NCT01024231|564317377|FG002|Overall Study|Death|1|||
156332693|NCT01024231|564317378|FG003|Overall Study|Death|0|||
156332694|NCT01024231|564317379|FG004|Overall Study|Death|4|||
156872858|NCT02405442|566293257|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
156332695|NCT01024231|564317380|FG005|Overall Study|Death|3|||
156531924|NCT03308942|565043213|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
156531925|NCT03308942|565043214|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
156531926|NCT03308942|565043215|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
156531927|NCT03308942|565043211|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
156531928|NCT03308942|565043212|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
156531929|NCT03308942|565043213|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
156531930|NCT03308942|565043214|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
156531931|NCT03308942|565043215|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
156531932|NCT03308942|565043211|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
156531933|NCT03308942|565043212|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
156531934|NCT03308942|565043213|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
156531935|NCT03308942|565043214|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
156531936|NCT03308942|565043215|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
156531937|NCT03308942|565043211|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
156531938|NCT03308942|565043212|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
156531939|NCT03308942|565043213|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
156531940|NCT03308942|565043214|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
156531941|NCT03308942|565043215|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
156531942|NCT03308942|565043211|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
156531943|NCT03308942|565043212|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
156531944|NCT03308942|565043213|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
156531945|NCT03308942|565043214|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
156531946|NCT03308942|565043215|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
156531947|NCT03308942|565043211|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
156872859|NCT02405442|566293254|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
156872860|NCT02405442|566293255|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
156872861|NCT02405442|566293256|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
156872862|NCT02405442|566293257|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
156872863|NCT02405442|566293254|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
156872864|NCT02405442|566293255|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
156872865|NCT02405442|566293256|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
156872866|NCT02405442|566293257|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
156872867|NCT03830892|566293259|FG000|Overall Study|Physician Decision|2|||
156872868|NCT03830892|566293260|FG001|Overall Study|Physician Decision|3|||
156872869|NCT03830892|566293259|FG000|Overall Study|Study terminated due to COVID|4|||
156872870|NCT03830892|566293260|FG001|Overall Study|Study terminated due to COVID|0|||
156872871|NCT03830892|566293259|FG000|Overall Study|Protocol Violation|0|||
156872872|NCT03830892|566293260|FG001|Overall Study|Protocol Violation|1|||
156872873|NCT03830892|566293259|FG000|Overall Study|Withdrawal by Subject|0|||
156872874|NCT03830892|566293260|FG001|Overall Study|Withdrawal by Subject|2|||
156872875|NCT00975689|566293261|FG000|Overall Study|Adverse Event|0|||
156872876|NCT00975689|566293262|FG001|Overall Study|Adverse Event|3|||
156872877|NCT00975689|566293261|FG000|Overall Study|Withdrawal by Subject|1|||
156872878|NCT00975689|566293262|FG001|Overall Study|Withdrawal by Subject|0|||
156872879|NCT00975689|566293261|FG000|Overall Study|Physician Decision|1|||
156872880|NCT00975689|566293262|FG001|Overall Study|Physician Decision|0|||
156872881|NCT02974543|566293263|FG000|Overall Study|Withdrawal by Subject|1|||
156872882|NCT02974543|566293264|FG001|Overall Study|Withdrawal by Subject|0|||
156872883|NCT03534180|566293265|FG000|Overall Study|Withdrawal by Subject|1|||
156872884|NCT00220636|566293266|FG000|Overall Study|Withdrawal by Subject|4|||
156872885|NCT00330967|566293267|FG000|Overall Study|Withdrawal by Subject|0|||
156872886|NCT00330967|566293268|FG001|Overall Study|Withdrawal by Subject|5|||
156872887|NCT00330967|566293267|FG000|Overall Study|Physician Decision|0|||
156872888|NCT00330967|566293268|FG001|Overall Study|Physician Decision|9|||
156872889|NCT00337675|566293271|FG000|Overall Study|Adverse Event|10|||
156872890|NCT00337675|566293272|FG001|Overall Study|Adverse Event|9|||
156872891|NCT00337675|566293273|FG002|Overall Study|Adverse Event|19|||
156872892|NCT00337675|566293271|FG000|Overall Study|Lack of Efficacy|10|||
156531948|NCT03308942|565043212|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
156531949|NCT03308942|565043213|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
156531950|NCT03308942|565043214|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
156531951|NCT03308942|565043215|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
156531952|NCT01131351|565043216|FG000|Overall Study|Adverse Event|0|||
156872893|NCT00337675|566293272|FG001|Overall Study|Lack of Efficacy|7|||
156872894|NCT00337675|566293273|FG002|Overall Study|Lack of Efficacy|9|||
156872895|NCT00337675|566293271|FG000|Overall Study|Lost to Follow-up|22|||
156872896|NCT00337675|566293272|FG001|Overall Study|Lost to Follow-up|19|||
156531953|NCT01131351|565043217|FG001|Overall Study|Adverse Event|2|||
156531954|NCT01131351|565043216|FG000|Overall Study|Protocol Deviation|0|||
156531955|NCT01131351|565043217|FG001|Overall Study|Protocol Deviation|1|||
156531956|NCT02194062|565043218|FG000|Overall Study|Lost to Follow-up|2|||
156531957|NCT02194062|565043219|FG001|Overall Study|Lost to Follow-up|2|||
156531958|NCT02194062|565043220|FG002|Overall Study|Lost to Follow-up|5|||
156531959|NCT01008696|565043225|FG000|Overall Study|Participant's evasion of hospital visit|5|||
156531960|NCT01008696|565043226|FG001|Overall Study|Participant's evasion of hospital visit|4|||
156531961|NCT01008696|565043225|FG000|Overall Study|Withdrawal by Subject|2|||
156531962|NCT01008696|565043226|FG001|Overall Study|Withdrawal by Subject|4|||
156531963|NCT01008696|565043225|FG000|Overall Study|Physician Decision|5|||
156531964|NCT01008696|565043226|FG001|Overall Study|Physician Decision|1|||
156531965|NCT01008696|565043225|FG000|Overall Study|Adverse Event|1|||
156531966|NCT01008696|565043226|FG001|Overall Study|Adverse Event|0|||
156531967|NCT01008696|565043225|FG000|Overall Study|Participants' non-cooperation|2|||
156531968|NCT01008696|565043226|FG001|Overall Study|Participants' non-cooperation|3|||
156531969|NCT01008696|565043225|FG000|Overall Study|Other|2|||
156531970|NCT01008696|565043226|FG001|Overall Study|Other|3|||
156531971|NCT01008696|565043225|FG000|Overall Study|Other|0|||
156531972|NCT01008696|565043226|FG001|Overall Study|Other|2|||
156531973|NCT01754857|565043227|FG000|Overall Study|Adverse Event|7|||
156531974|NCT01754857|565043227|FG000|Overall Study|Disease progression|3|||
156531975|NCT01754857|565043227|FG000|Overall Study|Physician Decision|2|||
156531976|NCT01754857|565043227|FG000|Overall Study|Withdrawal by Subject|3|||
156531977|NCT01754857|565043227|FG000|Overall Study|other complicating disease|1|||
156531978|NCT01754857|565043227|FG000|Overall Study|ineligible to continue onto maintenance|1|||
156531979|NCT01754857|565043227|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
156531980|NCT01754857|565043227|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
156531981|NCT04964960|565043228|FG000|Overall Study|Withdrawal by Subject|1|||
156531982|NCT04964960|565043228|FG000|Overall Study|Did not complete cycles|1|||
156531983|NCT02960854|565043231|FG000|Overall Study|Not Disclosed|2|||
156531984|NCT02960854|565043232|FG001|Overall Study|Not Disclosed|2|||
156531985|NCT02960854|565043231|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
156531986|NCT02960854|565043232|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
156531987|NCT02960854|565043231|FG000|Overall Study|Subject Withdrew Consent|0|||
156531988|NCT02960854|565043232|FG001|Overall Study|Subject Withdrew Consent|1|||
156531989|NCT02960854|565043231|FG000|Overall Study|Death|4|||
156531990|NCT02960854|565043232|FG001|Overall Study|Death|6|||
156531991|NCT00221195|565043233|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
156531992|NCT00221195|565043234|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
156531993|NCT00221195|565043233|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
156531994|NCT00221195|565043234|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
156531995|NCT00221195|565043233|FG000|Washout Period (Months 7-9)|Death|0|||
156531996|NCT00221195|565043234|FG001|Washout Period (Months 7-9)|Death|1|||
156531997|NCT00221195|565043233|FG000|Therapy 2 (Months 10-15)|Death|1|||
156531998|NCT00221195|565043234|FG001|Therapy 2 (Months 10-15)|Death|0|||
156531999|NCT00221195|565043233|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
156532000|NCT00221195|565043234|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
156532001|NCT00216203|565043236|FG000|Overall Study|Withdrawal by Subject|2|||
156532002|NCT03155373|565043246|FG000|Overall Study|No longer required surgery|1|||
156532003|NCT03155373|565043246|FG000|Overall Study|Protocol Violation|1|||
156532004|NCT03155373|565043246|FG000|Overall Study|Death|2|||
156532005|NCT03155373|565043246|FG000|Overall Study|Withdrawal by Subject|3|||
156532006|NCT02856893|565043247|FG000|Overall Study|Lack of Efficacy|27|||
156532007|NCT02856893|565043248|FG001|Overall Study|Lack of Efficacy|15|||
156532008|NCT02856893|565043249|FG002|Overall Study|Lack of Efficacy|19|||
156532009|NCT02856893|565043247|FG000|Overall Study|Death|1|||
156532010|NCT02856893|565043248|FG001|Overall Study|Death|0|||
156532011|NCT02856893|565043249|FG002|Overall Study|Death|0|||
156532012|NCT02856893|565043247|FG000|Overall Study|Adverse Event|2|||
156532013|NCT02856893|565043248|FG001|Overall Study|Adverse Event|0|||
156709291|NCT04602546|565680572|FG000|Overall Study|Randomized with disqualified data|2|||
156709292|NCT04602546|565680573|FG001|Overall Study|Randomized with disqualified data|0|||
156709293|NCT04602546|565680574|FG002|Overall Study|Randomized with disqualified data|2|||
156532014|NCT02856893|565043249|FG002|Overall Study|Adverse Event|0|||
156532015|NCT02856893|565043247|FG000|Overall Study|Physician Decision|0|||
156532016|NCT02856893|565043248|FG001|Overall Study|Physician Decision|2|||
156532017|NCT02856893|565043249|FG002|Overall Study|Physician Decision|3|||
156532018|NCT02856893|565043247|FG000|Overall Study|Withdrawal by Subject|1|||
156532019|NCT02856893|565043248|FG001|Overall Study|Withdrawal by Subject|1|||
156532020|NCT02856893|565043249|FG002|Overall Study|Withdrawal by Subject|0|||
156532021|NCT02856893|565043247|FG000|Overall Study|Other reasons|2|||
156532022|NCT02856893|565043248|FG001|Overall Study|Other reasons|1|||
156532023|NCT02856893|565043249|FG002|Overall Study|Other reasons|2|||
156532024|NCT01324323|565043257|FG000|Overall Study|Withdrawal by Subject|1|||
156532025|NCT00537485|565043258|FG000|Overall Study|Adverse Event|10|||
156709294|NCT04602546|565680575|FG003|Overall Study|Randomized with disqualified data|5|||
156532026|NCT00537485|565043259|FG001|Overall Study|Adverse Event|5|||
156709295|NCT04602546|565680576|FG004|Overall Study|Randomized with disqualified data|3|||
156532027|NCT00537485|565043258|FG000|Overall Study|Withdrawal by Subject|3|||
156709296|NCT01831258|565680579|FG000|Overall Study|Withdrawal by Subject|2|||
156709297|NCT01831258|565680580|FG001|Overall Study|Withdrawal by Subject|1|||
156709298|NCT01831258|565680579|FG000|Overall Study|Lost to Follow-up|3|||
156709299|NCT01831258|565680580|FG001|Overall Study|Lost to Follow-up|2|||
156709300|NCT01753297|565680590|FG000|Overall Study|Lost to Follow-up|7|||
156709301|NCT01753297|565680591|FG001|Overall Study|Lost to Follow-up|2|||
156709302|NCT01753297|565680590|FG000|Overall Study|Withdrawal by Subject|26|||
156709303|NCT01753297|565680591|FG001|Overall Study|Withdrawal by Subject|23|||
156709304|NCT01753297|565680590|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
156709305|NCT01753297|565680591|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
156709306|NCT01753297|565680590|FG000|Overall Study|Death|0|||
156709307|NCT01753297|565680591|FG001|Overall Study|Death|2|||
156709308|NCT01753297|565680590|FG000|Overall Study|Did not attend end of study visit|7|||
156709309|NCT01753297|565680591|FG001|Overall Study|Did not attend end of study visit|8|||
156709310|NCT01275729|565680592|FG000|Overall Study|Death|3|||
156709311|NCT01275729|565680592|FG000|Overall Study|Withdrawal by Subject|1|||
156709312|NCT00447876|565680593|FG000|Overall Study|Withdrawal by Subject|1|||
156709313|NCT00447876|565680594|FG001|Overall Study|Withdrawal by Subject|4|||
156709314|NCT00447876|565680593|FG000|Overall Study|Lost to Follow-up|1|||
156709315|NCT00447876|565680594|FG001|Overall Study|Lost to Follow-up|0|||
156709316|NCT00447876|565680593|FG000|Overall Study|Deterioration of symptomology|1|||
156709317|NCT00447876|565680594|FG001|Overall Study|Deterioration of symptomology|0|||
156709318|NCT02533180|565680595|FG000|Overall Study|Death|0|||
156791992|NCT01712074|565991049|FG002|Placebo Run-in Period|No longer willing to participate|0|||
156791993|NCT01712074|565991047|FG000|Double Blind Period|Adverse Event|0|||
156791994|NCT01712074|565991048|FG001|Double Blind Period|Adverse Event|2|||
156791995|NCT01712074|565991049|FG002|Double Blind Period|Adverse Event|1|||
156791996|NCT01712074|565991047|FG000|Double Blind Period|No longer willing to participate|0|||
156791997|NCT01712074|565991048|FG001|Double Blind Period|No longer willing to participate|2|||
156791998|NCT01712074|565991049|FG002|Double Blind Period|No longer willing to participate|4|||
156791999|NCT01712074|565991047|FG000|Double Blind Period|Death|0|||
156792000|NCT01712074|565991048|FG001|Double Blind Period|Death|1|||
156792001|NCT01712074|565991049|FG002|Double Blind Period|Death|0|||
156872897|NCT00337675|566293273|FG002|Overall Study|Lost to Follow-up|17|||
156872898|NCT00337675|566293271|FG000|Overall Study|Physician Decision|9|||
156872899|NCT00337675|566293272|FG001|Overall Study|Physician Decision|17|||
156872900|NCT00337675|566293273|FG002|Overall Study|Physician Decision|14|||
156872901|NCT00337675|566293271|FG000|Overall Study|Protocol Violation|21|||
156872902|NCT00337675|566293272|FG001|Overall Study|Protocol Violation|24|||
156872903|NCT00337675|566293273|FG002|Overall Study|Protocol Violation|19|||
156441866|NCT03575052|564710948|FG000|Overall Study|Not further specified|5|||
156441867|NCT03575052|564710949|FG001|Overall Study|Not further specified|7|||
156441868|NCT03575052|564710948|FG000|Overall Study|Withdrawal by Subject|5|||
156441869|NCT03575052|564710949|FG001|Overall Study|Withdrawal by Subject|6|||
156441870|NCT03575052|564710948|FG000|Overall Study|Lost to Follow-up|3|||
156441871|NCT03575052|564710949|FG001|Overall Study|Lost to Follow-up|0|||
156441872|NCT03575052|564710948|FG000|Overall Study|Death|2|||
156441873|NCT03575052|564710949|FG001|Overall Study|Death|1|||
156441874|NCT03575052|564710948|FG000|Overall Study|Lack of Efficacy|2|||
156441875|NCT03575052|564710949|FG001|Overall Study|Lack of Efficacy|1|||
156441876|NCT03575052|564710948|FG000|Overall Study|Study drug noncompliance|1|||
156441877|NCT03575052|564710949|FG001|Overall Study|Study drug noncompliance|2|||
156441878|NCT03575052|564710948|FG000|Overall Study|Protocol Violation|0|||
156441879|NCT03575052|564710949|FG001|Overall Study|Protocol Violation|2|||
156441880|NCT03575052|564710948|FG000|Overall Study|Physician Decision|1|||
156441881|NCT03575052|564710949|FG001|Overall Study|Physician Decision|0|||
156441882|NCT04188379|564710950|FG000|Overall Study|Withdrawal by Subject|10|||
156441883|NCT04188379|564710951|FG001|Overall Study|Withdrawal by Subject|3|||
156441884|NCT04188379|564710950|FG000|Overall Study|Physician Decision|0|||
156441885|NCT04188379|564710951|FG001|Overall Study|Physician Decision|1|||
156441886|NCT04188379|564710950|FG000|Overall Study|Adverse Event|3|||
156441887|NCT04188379|564710951|FG001|Overall Study|Adverse Event|1|||
156441888|NCT04188379|564710950|FG000|Overall Study|Pregnancy|1|||
156441889|NCT04188379|564710951|FG001|Overall Study|Pregnancy|0|||
156441890|NCT04188379|564710950|FG000|Overall Study|Lack of Efficacy|8|||
156441891|NCT04188379|564710951|FG001|Overall Study|Lack of Efficacy|5|||
156441892|NCT04188379|564710950|FG000|Overall Study|Other|0|||
156441893|NCT04188379|564710951|FG001|Overall Study|Other|3|||
156441894|NCT05288283|564710961|FG000|Overall Study|Study Terminated Early|1|||
156441895|NCT05288283|564710962|FG001|Overall Study|Study Terminated Early|1|||
156441896|NCT03112174|564710963|FG000|Overall Study|Withdrawal by Subject|3|||
156441897|NCT03112174|564710964|FG001|Overall Study|Withdrawal by Subject|0|||
156441898|NCT03112174|564710965|FG002|Overall Study|Withdrawal by Subject|11|||
156792002|NCT01712074|565991047|FG000|Double Blind Period|Lost to Follow-up|0|||
156441899|NCT03112174|564710966|FG003|Overall Study|Withdrawal by Subject|9|||
156441900|NCT03112174|564710967|FG004|Overall Study|Withdrawal by Subject|7|||
156441901|NCT03112174|564710963|FG000|Overall Study|Lost to Follow-up|1|||
156792003|NCT01712074|565991048|FG001|Double Blind Period|Lost to Follow-up|2|||
156872904|NCT00337675|566293271|FG000|Overall Study|Withdrawal by Subject|25|||
156872905|NCT00337675|566293272|FG001|Overall Study|Withdrawal by Subject|25|||
156872906|NCT00337675|566293273|FG002|Overall Study|Withdrawal by Subject|19|||
156872907|NCT00337675|566293271|FG000|Overall Study|Progressive Disease|0|||
156872908|NCT00337675|566293272|FG001|Overall Study|Progressive Disease|2|||
156872909|NCT00337675|566293273|FG002|Overall Study|Progressive Disease|0|||
156872910|NCT00337675|566293271|FG000|Overall Study|Trial Terminated|0|||
156872911|NCT00337675|566293272|FG001|Overall Study|Trial Terminated|0|||
156872912|NCT00337675|566293273|FG002|Overall Study|Trial Terminated|2|||
156872913|NCT04269265|566293274|FG000|Overall Study|Physician Decision|1|||
156872914|NCT04269265|566293274|FG000|Overall Study|Withdrawal by Subject|1|||
156872915|NCT04269265|566293274|FG000|Overall Study|Overenrolled (sample size reached)|4|||
156872916|NCT04439136|566293275|FG000|Overall Study|Ineligible|1|||
156872917|NCT04439136|566293275|FG000|Overall Study|Never Started Treatment|2|||
156872918|NCT04439136|566293275|FG000|Overall Study|Adverse Event|4|||
156872919|NCT04439136|566293275|FG000|Overall Study|Death|3|||
156872920|NCT04439136|566293275|FG000|Overall Study|Disease Progression|27|||
156872921|NCT04439136|566293275|FG000|Overall Study|Alternative Therapy|1|||
156872922|NCT04439136|566293275|FG000|Overall Study|Increased Tumor Burden|1|||
156872923|NCT04439136|566293275|FG000|Overall Study|Symptomatic Detrioration|1|||
156872924|NCT04693234|566293276|FG000|Overall Study|Death|79|||
156872925|NCT04693234|566293277|FG001|Overall Study|Death|19|||
156872926|NCT04693234|566293276|FG000|Overall Study|Sponsor Ended Study|47|||
156872927|NCT04693234|566293277|FG001|Overall Study|Sponsor Ended Study|18|||
156872928|NCT04693234|566293276|FG000|Overall Study|Withdrawal by Subject|10|||
156872929|NCT04693234|566293277|FG001|Overall Study|Withdrawal by Subject|2|||
156872930|NCT04693234|566293276|FG000|Overall Study|Lost to Follow-up|2|||
156872931|NCT04693234|566293277|FG001|Overall Study|Lost to Follow-up|1|||
156872932|NCT02578706|566293280|FG000|Overall Study|Withdrawal by Subject|1|||
156872933|NCT02578706|566293281|FG001|Overall Study|Withdrawal by Subject|0|||
156872934|NCT02578706|566293282|FG002|Overall Study|Withdrawal by Subject|0|||
156872935|NCT02578706|566293280|FG000|Overall Study|Lost to Follow-up|0|||
156872936|NCT02578706|566293281|FG001|Overall Study|Lost to Follow-up|4|||
156872937|NCT02578706|566293282|FG002|Overall Study|Lost to Follow-up|0|||
156872938|NCT02578706|566293280|FG000|Overall Study|Physician Decision|0|||
156872939|NCT02578706|566293281|FG001|Overall Study|Physician Decision|1|||
156872940|NCT02578706|566293282|FG002|Overall Study|Physician Decision|0|||
156872941|NCT04849559|566293283|FG000|Overall Study|Withdrawal by Subject|2|||
156872942|NCT04849559|566293284|FG001|Overall Study|Withdrawal by Subject|1|||
156872943|NCT01662102|566293296|FG000|Overall Study|Sponsor's decision|1|||
156872944|NCT01662102|566293297|FG001|Overall Study|Sponsor's decision|0|||
156872945|NCT02357368|566293298|FG000|Overall Study|Lost to Follow-up|0|||
156872946|NCT02357368|566293299|FG001|Overall Study|Lost to Follow-up|0|||
156872947|NCT02357368|566293300|FG002|Overall Study|Lost to Follow-up|0|||
156872948|NCT02357368|566293301|FG003|Overall Study|Lost to Follow-up|1|||
156872949|NCT02357368|566293298|FG000|Overall Study|Pregnancy|3|||
156872950|NCT02357368|566293299|FG001|Overall Study|Pregnancy|2|||
156872951|NCT02357368|566293300|FG002|Overall Study|Pregnancy|0|||
156872952|NCT02357368|566293301|FG003|Overall Study|Pregnancy|0|||
156872953|NCT02357368|566293298|FG000|Overall Study|Withdrawal by Subject|3|||
156872954|NCT02357368|566293299|FG001|Overall Study|Withdrawal by Subject|1|||
156872955|NCT02357368|566293300|FG002|Overall Study|Withdrawal by Subject|1|||
156872956|NCT02357368|566293301|FG003|Overall Study|Withdrawal by Subject|2|||
156872957|NCT01931566|566293302|FG000|Overall Study|Randomized But Not Treated|6|||
156872958|NCT01931566|566293303|FG001|Overall Study|Randomized But Not Treated|9|||
156872959|NCT01931566|566293304|FG002|Overall Study|Randomized But Not Treated|14|||
156872960|NCT01931566|566293302|FG000|Overall Study|Adverse Event|37|||
156532028|NCT00537485|565043259|FG001|Overall Study|Withdrawal by Subject|2|||
156709319|NCT02533180|565680596|FG001|Overall Study|Death|2|||
156709320|NCT02533180|565680595|FG000|Overall Study|Lost to Follow-up|0|||
156709321|NCT02533180|565680596|FG001|Overall Study|Lost to Follow-up|1|||
156709322|NCT02533180|565680595|FG000|Overall Study|Physician Decision|0|||
156709323|NCT02533180|565680596|FG001|Overall Study|Physician Decision|1|||
156709324|NCT02533180|565680595|FG000|Overall Study|Withdrawal by Subject|2|||
156872961|NCT01931566|566293303|FG001|Overall Study|Adverse Event|167|||
156872962|NCT01931566|566293304|FG002|Overall Study|Adverse Event|132|||
156872963|NCT01931566|566293302|FG000|Overall Study|Major Protocol Deviation|5|||
156872964|NCT01931566|566293303|FG001|Overall Study|Major Protocol Deviation|14|||
156709325|NCT02533180|565680596|FG001|Overall Study|Withdrawal by Subject|5|||
156709326|NCT02533180|565680595|FG000|Overall Study|Screen Failure|37|||
156872965|NCT01931566|566293304|FG002|Overall Study|Major Protocol Deviation|21|||
156872966|NCT01931566|566293302|FG000|Overall Study|Lost to Follow-up|3|||
156872967|NCT01931566|566293303|FG001|Overall Study|Lost to Follow-up|26|||
156872968|NCT01931566|566293304|FG002|Overall Study|Lost to Follow-up|23|||
156872969|NCT01931566|566293302|FG000|Overall Study|Voluntary Withdrawal|78|||
156872970|NCT01931566|566293303|FG001|Overall Study|Voluntary Withdrawal|245|||
156872971|NCT01931566|566293304|FG002|Overall Study|Voluntary Withdrawal|225|||
156872972|NCT01931566|566293302|FG000|Overall Study|Study Termination|289|||
156709327|NCT02533180|565680596|FG001|Overall Study|Screen Failure|0|||
156872973|NCT01931566|566293303|FG001|Overall Study|Study Termination|968|||
156872974|NCT01931566|566293304|FG002|Overall Study|Study Termination|1037|||
156872975|NCT01931566|566293302|FG000|Overall Study|Reason Not Specified|11|||
156872976|NCT01931566|566293303|FG001|Overall Study|Reason Not Specified|47|||
156872977|NCT01931566|566293304|FG002|Overall Study|Reason Not Specified|53|||
156872978|NCT01931566|566293302|FG000|Overall Study|Missing|0|||
156872979|NCT01931566|566293303|FG001|Overall Study|Missing|0|||
156872980|NCT01931566|566293304|FG002|Overall Study|Missing|1|||
156872981|NCT00611026|566293306|FG000|Randomized to Double-blind Treatment|Not treated|2|||
156872982|NCT00611026|566293307|FG001|Randomized to Double-blind Treatment|Not treated|1|||
156872983|NCT00611026|566293308|FG002|Randomized to Double-blind Treatment|Not treated|3|||
156872984|NCT00611026|566293306|FG000|Double-blind Treatment Period|Death|1|||
156872985|NCT00611026|566293307|FG001|Double-blind Treatment Period|Death|0|||
156872986|NCT00611026|566293308|FG002|Double-blind Treatment Period|Death|0|||
156872987|NCT00611026|566293306|FG000|Double-blind Treatment Period|Adverse Event|9|||
156872988|NCT00611026|566293307|FG001|Double-blind Treatment Period|Adverse Event|28|||
156872989|NCT00611026|566293308|FG002|Double-blind Treatment Period|Adverse Event|46|||
156872990|NCT00611026|566293306|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
156872991|NCT00611026|566293307|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
156872992|NCT00611026|566293308|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
156872993|NCT00611026|566293306|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
156872994|NCT00611026|566293307|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
156872995|NCT00611026|566293308|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
156872996|NCT00611026|566293306|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
156872997|NCT00611026|566293307|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
156872998|NCT00611026|566293308|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
156872999|NCT00611026|566293306|FG000|Double-blind Treatment Period|Other|13|||
156873000|NCT00611026|566293307|FG001|Double-blind Treatment Period|Other|20|||
156873001|NCT00611026|566293308|FG002|Double-blind Treatment Period|Other|18|||
156873002|NCT00760617|566293309|FG000|Overall Study|Adverse Event|5|||
156873003|NCT00760617|566293310|FG001|Overall Study|Adverse Event|2|||
156873004|NCT00760617|566293311|FG002|Overall Study|Adverse Event|0|||
156873005|NCT00760617|566293309|FG000|Overall Study|Lost to Follow-up|0|||
156873006|NCT00760617|566293310|FG001|Overall Study|Lost to Follow-up|0|||
156441902|NCT03112174|564710964|FG001|Overall Study|Lost to Follow-up|1|||
156441903|NCT03112174|564710965|FG002|Overall Study|Lost to Follow-up|2|||
156441904|NCT03112174|564710966|FG003|Overall Study|Lost to Follow-up|3|||
156441905|NCT03112174|564710967|FG004|Overall Study|Lost to Follow-up|2|||
156441906|NCT03112174|564710963|FG000|Overall Study|Death|8|||
156441907|NCT03112174|564710964|FG001|Overall Study|Death|3|||
156441908|NCT03112174|564710965|FG002|Overall Study|Death|67|||
156441909|NCT03112174|564710966|FG003|Overall Study|Death|73|||
156441910|NCT03112174|564710967|FG004|Overall Study|Death|18|||
156441911|NCT03112174|564710963|FG000|Overall Study|Other, Not Specified|1|||
156441912|NCT03112174|564710964|FG001|Overall Study|Other, Not Specified|0|||
156441913|NCT03112174|564710965|FG002|Overall Study|Other, Not Specified|1|||
156441914|NCT03112174|564710966|FG003|Overall Study|Other, Not Specified|2|||
156441915|NCT03112174|564710967|FG004|Overall Study|Other, Not Specified|0|||
156441916|NCT00093015|564710976|FG000|Overall Study|Withdrawal by Subject|194|||
156441917|NCT00093015|564710977|FG001|Overall Study|Withdrawal by Subject|171|||
156441918|NCT00093015|564710976|FG000|Overall Study|Lost to Follow-up|96|||
156441919|NCT00093015|564710977|FG001|Overall Study|Lost to Follow-up|108|||
156441920|NCT00093015|564710976|FG000|Overall Study|Death|375|||
156441921|NCT00093015|564710977|FG001|Overall Study|Death|385|||
156441922|NCT03076515|564710980|FG000|Overall Study|DMC decision based on interim analysis|25|||
156441923|NCT03076515|564710981|FG001|Overall Study|DMC decision based on interim analysis|29|||
156441924|NCT02101281|564710982|FG000|Overall Study|Adverse Event|0|||
156709328|NCT02533180|565680595|FG000|Overall Study|Protocol Deviation|0|||
156709329|NCT02533180|565680596|FG001|Overall Study|Protocol Deviation|1|||
156709330|NCT02533180|565680595|FG000|Overall Study|Non-compliance|0|||
156709331|NCT02533180|565680596|FG001|Overall Study|Non-compliance|1|||
156709332|NCT00005957|565680597|FG000|Overall Study|No treated|3|||
156709333|NCT00005957|565680598|FG001|Overall Study|No treated|9|||
156709334|NCT00005957|565680597|FG000|Overall Study|Crossover to the other arm|5|||
156709335|NCT00005957|565680598|FG001|Overall Study|Crossover to the other arm|19|||
156709336|NCT01609023|565680599|FG000|Overall Study|Lack of Efficacy|3|||
156873007|NCT00760617|566293311|FG002|Overall Study|Lost to Follow-up|5|||
156873008|NCT01147874|566293315|FG000|Overall Study|Adverse Event|5|||
156873009|NCT01147874|566293315|FG000|Overall Study|Investigator's Request|1|||
156873010|NCT01147874|566293315|FG000|Overall Study|Lost to Follow-up|25|||
156441925|NCT02101281|564710983|FG001|Overall Study|Adverse Event|1|||
156441926|NCT00296036|564710984|FG000|Overall Study|Withdrawal by Subject|1|||
156441927|NCT00296036|564710985|FG001|Overall Study|Withdrawal by Subject|0|||
156532029|NCT00537485|565043258|FG000|Overall Study|Withdrawal by Subject|1|||
156709337|NCT01609023|565680599|FG000|Overall Study|Withdrawal by Subject|4|||
156709338|NCT01609023|565680599|FG000|Overall Study|Lost to Follow-up|8|||
156709339|NCT01609023|565680599|FG000|Overall Study|Toxicity|3|||
156709340|NCT01609023|565680599|FG000|Overall Study|Disease progression|10|||
156709341|NCT01609023|565680599|FG000|Overall Study|Physician Decision|2|||
156709342|NCT01609023|565680599|FG000|Overall Study|Death|2|||
156709343|NCT01609023|565680599|FG000|Overall Study|Personal reasons|1|||
156709344|NCT04172597|565680601|FG000|Overall Study|Disease Progression|0|||
156709345|NCT04172597|565680602|FG001|Overall Study|Disease Progression|0|||
156709346|NCT04172597|565680603|FG002|Overall Study|Disease Progression|0|||
156709347|NCT04172597|565680604|FG003|Overall Study|Disease Progression|0|||
156709348|NCT04172597|565680605|FG004|Overall Study|Disease Progression|1|||
156709349|NCT00794339|565680606|FG000|Overall Study|Withdrawal by Subject|3|||
156709350|NCT00794339|565680606|FG000|Overall Study|Ineligible|4|||
156709351|NCT00794339|565680606|FG000|Overall Study|Tx prior to ATSM|3|||
156709352|NCT00794339|565680606|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
156709353|NCT00794339|565680606|FG000|Overall Study|Tx not per protocol|1|||
156709354|NCT02952586|565680609|FG000|Lead-In Phase (7 Days)|Death|0|||
156709355|NCT02952586|565680610|FG001|Lead-In Phase (7 Days)|Death|1|||
156709356|NCT02952586|565680609|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
156532030|NCT00537485|565043259|FG001|Overall Study|Withdrawal by Subject|3|||
156532031|NCT00537485|565043258|FG000|Overall Study|Physician Decision|1|||
156532032|NCT00537485|565043259|FG001|Overall Study|Physician Decision|0|||
156532033|NCT01601847|565043263|FG000|Overall Study|Death|1|||
156532034|NCT01601847|565043264|FG001|Overall Study|Death|0|||
156532035|NCT01601847|565043263|FG000|Overall Study|Withdrawal by Subject|11|||
156532036|NCT01601847|565043264|FG001|Overall Study|Withdrawal by Subject|7|||
156532037|NCT01601847|565043263|FG000|Overall Study|Lost to Follow-up|1|||
156532038|NCT01601847|565043264|FG001|Overall Study|Lost to Follow-up|3|||
156532039|NCT00631189|565043265|FG000|Initial Phase|Protocol Violation|347|||
156532040|NCT00631189|565043266|FG001|Initial Phase|Protocol Violation|0|||
156532041|NCT00631189|565043267|FG002|Initial Phase|Protocol Violation|0|||
156532042|NCT00631189|565043268|FG003|Initial Phase|Protocol Violation|0|||
156532043|NCT00631189|565043265|FG000|Initial Phase|Withdrawal by Subject|4|||
156532044|NCT00631189|565043266|FG001|Initial Phase|Withdrawal by Subject|0|||
156532045|NCT00631189|565043267|FG002|Initial Phase|Withdrawal by Subject|0|||
156532046|NCT00631189|565043268|FG003|Initial Phase|Withdrawal by Subject|0|||
156532047|NCT00631189|565043265|FG000|Treatment Phase|Withdrawal by Subject|0|||
156532048|NCT00631189|565043266|FG001|Treatment Phase|Withdrawal by Subject|2|||
156532049|NCT00631189|565043267|FG002|Treatment Phase|Withdrawal by Subject|1|||
156532050|NCT00631189|565043268|FG003|Treatment Phase|Withdrawal by Subject|1|||
156532051|NCT00631189|565043265|FG000|Treatment Phase|Protocol Violation|0|||
156532052|NCT00631189|565043266|FG001|Treatment Phase|Protocol Violation|1|||
156532053|NCT00631189|565043267|FG002|Treatment Phase|Protocol Violation|6|||
156532054|NCT00631189|565043268|FG003|Treatment Phase|Protocol Violation|2|||
156532055|NCT00631189|565043265|FG000|Treatment Phase|Adverse Event|0|||
156532056|NCT00631189|565043266|FG001|Treatment Phase|Adverse Event|3|||
156532057|NCT00631189|565043267|FG002|Treatment Phase|Adverse Event|2|||
156532058|NCT00631189|565043268|FG003|Treatment Phase|Adverse Event|4|||
156532059|NCT00631189|565043265|FG000|Treatment Phase|Lost to Follow-up|0|||
156532060|NCT00631189|565043266|FG001|Treatment Phase|Lost to Follow-up|1|||
156532061|NCT00631189|565043267|FG002|Treatment Phase|Lost to Follow-up|0|||
156532062|NCT00631189|565043268|FG003|Treatment Phase|Lost to Follow-up|0|||
156532063|NCT00631189|565043265|FG000|Treatment Phase|Pregnancy|0|||
156532064|NCT00631189|565043266|FG001|Treatment Phase|Pregnancy|0|||
156532065|NCT00631189|565043267|FG002|Treatment Phase|Pregnancy|1|||
156532066|NCT00631189|565043268|FG003|Treatment Phase|Pregnancy|0|||
156532067|NCT00631189|565043265|FG000|Treatment Phase|patient did not take pravastatin|0|||
156532068|NCT00631189|565043266|FG001|Treatment Phase|patient did not take pravastatin|0|||
156709357|NCT02952586|565680610|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
156709358|NCT02952586|565680609|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
156332696|NCT01024231|564317381|FG006|Overall Study|Death|5|||
156332697|NCT01024231|564317375|FG000|Overall Study|Lost to Follow-up|0|||
156709359|NCT02952586|565680610|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
156709360|NCT02952586|565680609|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
156709361|NCT02952586|565680610|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
156709362|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
156709363|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
156709364|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
156709365|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
156532069|NCT00631189|565043267|FG002|Treatment Phase|patient did not take pravastatin|1|||
156532070|NCT00631189|565043268|FG003|Treatment Phase|patient did not take pravastatin|0|||
156532071|NCT04464265|565043269|FG000|Overall Study|Physician Decision|2|||
156532072|NCT00974090|565043270|FG000|Period 1: Double Blind Period|Adverse Event|2|||
156532073|NCT00974090|565043271|FG001|Period 1: Double Blind Period|Adverse Event|1|||
156532074|NCT00974090|565043270|FG000|Period 1: Double Blind Period|Physician Decision|1|||
156532075|NCT00974090|565043271|FG001|Period 1: Double Blind Period|Physician Decision|0|||
156532076|NCT00974090|565043270|FG000|Period 2: Open-label Period|Adverse Event|4|||
156532077|NCT00974090|565043271|FG001|Period 2: Open-label Period|Adverse Event|6|||
156532078|NCT00974090|565043270|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
156709366|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
156709367|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
156709368|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
156709369|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
156709370|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
156709371|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
156709372|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
156709373|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
156709374|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
156709375|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
156709376|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Death|3|||
156709377|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Death|8|||
156709378|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
156709379|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
156709380|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
156709381|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
156792004|NCT01712074|565991049|FG002|Double Blind Period|Lost to Follow-up|1|||
156792005|NCT01712074|565991047|FG000|Double Blind Period|Other|0|||
156792006|NCT01712074|565991048|FG001|Double Blind Period|Other|4|||
156792007|NCT01712074|565991049|FG002|Double Blind Period|Other|1|||
156792008|NCT01712074|565991047|FG000|Double Blind Period|Protocol Violation|0|||
156792009|NCT01712074|565991048|FG001|Double Blind Period|Protocol Violation|0|||
156792010|NCT01712074|565991049|FG002|Double Blind Period|Protocol Violation|1|||
156792011|NCT01712074|565991047|FG000|Double Blind Period|No longer met eligibility criteria|0|||
156792012|NCT01712074|565991048|FG001|Double Blind Period|No longer met eligibility criteria|3|||
156792013|NCT01712074|565991049|FG002|Double Blind Period|No longer met eligibility criteria|0|||
156792014|NCT03478787|565991050|FG000|Overall Study|Adverse Event|5|||
156792015|NCT03478787|565991051|FG001|Overall Study|Adverse Event|1|||
156792016|NCT03478787|565991050|FG000|Overall Study|Protocol Violation|3|||
156792017|NCT03478787|565991051|FG001|Overall Study|Protocol Violation|0|||
156792018|NCT03478787|565991050|FG000|Overall Study|Lack of Efficacy|7|||
156792019|NCT03478787|565991051|FG001|Overall Study|Lack of Efficacy|1|||
156792020|NCT03478787|565991050|FG000|Overall Study|Lost to Follow-up|9|||
156792021|NCT03478787|565991051|FG001|Overall Study|Lost to Follow-up|5|||
156792022|NCT03478787|565991050|FG000|Overall Study|Withdrawal by Subject|2|||
156792023|NCT03478787|565991051|FG001|Overall Study|Withdrawal by Subject|6|||
156792024|NCT03478787|565991050|FG000|Overall Study|Other, Not Specified|3|||
156792025|NCT03478787|565991051|FG001|Overall Study|Other, Not Specified|0|||
156332698|NCT01024231|564317376|FG001|Overall Study|Lost to Follow-up|0|||
156332699|NCT01024231|564317377|FG002|Overall Study|Lost to Follow-up|0|||
156332700|NCT01024231|564317378|FG003|Overall Study|Lost to Follow-up|0|||
156332701|NCT01024231|564317379|FG004|Overall Study|Lost to Follow-up|0|||
156332702|NCT01024231|564317380|FG005|Overall Study|Lost to Follow-up|0|||
156332703|NCT01024231|564317381|FG006|Overall Study|Lost to Follow-up|1|||
156332704|NCT01024231|564317375|FG000|Overall Study|Withdrew Consent|0|||
156332705|NCT01024231|564317376|FG001|Overall Study|Withdrew Consent|1|||
156332706|NCT01024231|564317377|FG002|Overall Study|Withdrew Consent|0|||
156332707|NCT01024231|564317378|FG003|Overall Study|Withdrew Consent|0|||
156332708|NCT01024231|564317379|FG004|Overall Study|Withdrew Consent|0|||
156332709|NCT01024231|564317380|FG005|Overall Study|Withdrew Consent|0|||
156332710|NCT01024231|564317381|FG006|Overall Study|Withdrew Consent|0|||
156332711|NCT01024231|564317375|FG000|Overall Study|Continuing on Treatment|0|||
156332712|NCT01024231|564317376|FG001|Overall Study|Continuing on Treatment|0|||
156332713|NCT01024231|564317377|FG002|Overall Study|Continuing on Treatment|0|||
156332714|NCT01024231|564317378|FG003|Overall Study|Continuing on Treatment|0|||
156332715|NCT01024231|564317379|FG004|Overall Study|Continuing on Treatment|3|||
156332716|NCT01024231|564317380|FG005|Overall Study|Continuing on Treatment|2|||
156332717|NCT01024231|564317381|FG006|Overall Study|Continuing on Treatment|0|||
156332718|NCT00395733|564317382|FG000|Period 2|Withdrawal by Subject|1|||
156332719|NCT00395733|564317383|FG001|Period 2|Withdrawal by Subject|2|||
156332720|NCT00395733|564317382|FG000|Period 2|Protocol Violation|0|||
156332721|NCT00395733|564317383|FG001|Period 2|Protocol Violation|1|||
156332722|NCT00395733|564317382|FG000|Period 2|Adverse Event|0|||
156332723|NCT00395733|564317383|FG001|Period 2|Adverse Event|2|||
156332724|NCT00395733|564317382|FG000|Period 2|Technical problems|1|||
156332725|NCT00395733|564317383|FG001|Period 2|Technical problems|0|||
156332726|NCT03725852|564317384|FG000|Overall Study|Death|1|||
156332727|NCT03725852|564317385|FG001|Overall Study|Death|0|||
156332728|NCT03725852|564317384|FG000|Overall Study|Withdrawal by Subject|1|||
156332729|NCT03725852|564317385|FG001|Overall Study|Withdrawal by Subject|0|||
156332730|NCT03725852|564317384|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
156332731|NCT03725852|564317385|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
156332732|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
156332733|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
156332734|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Death|1|||
156709382|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
156709383|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
156709384|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
156709385|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
156709386|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
156709387|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
156709388|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Other|1|||
156709389|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Other|1|||
156441928|NCT00296036|564710986|FG002|Overall Study|Withdrawal by Subject|2|||
156441929|NCT00296036|564710987|FG003|Overall Study|Withdrawal by Subject|1|||
156441930|NCT00296036|564710988|FG004|Overall Study|Withdrawal by Subject|2|||
156441931|NCT00296036|564710989|FG005|Overall Study|Withdrawal by Subject|1|||
156441932|NCT00296036|564710984|FG000|Overall Study|Protocol Violation|0|||
156441933|NCT00296036|564710985|FG001|Overall Study|Protocol Violation|0|||
156441934|NCT00296036|564710986|FG002|Overall Study|Protocol Violation|0|||
156441935|NCT00296036|564710987|FG003|Overall Study|Protocol Violation|0|||
156441936|NCT00296036|564710988|FG004|Overall Study|Protocol Violation|0|||
156441937|NCT00296036|564710989|FG005|Overall Study|Protocol Violation|3|||
156441938|NCT00529100|564710994|FG000|Overall Study|Adverse Event|0|||
156441939|NCT00529100|564710995|FG001|Overall Study|Adverse Event|5|||
156441940|NCT00529100|564710994|FG000|Overall Study|Protocol Violation|0|||
156441941|NCT00529100|564710995|FG001|Overall Study|Protocol Violation|1|||
156441942|NCT00529100|564710994|FG000|Overall Study|Progressive Disease|0|||
156441943|NCT00529100|564710995|FG001|Overall Study|Progressive Disease|1|||
156441944|NCT00529100|564710994|FG000|Overall Study|Withdrawal by Subject|0|||
156441945|NCT00529100|564710995|FG001|Overall Study|Withdrawal by Subject|1|||
156441946|NCT00529100|564710994|FG000|Overall Study|Participant Ineligibility|0|||
156441947|NCT00529100|564710995|FG001|Overall Study|Participant Ineligibility|1|||
156441948|NCT03733119|564710996|FG000|Overall Study|Physician Decision|2|||
156441949|NCT03733119|564710997|FG001|Overall Study|Physician Decision|1|||
156441950|NCT03733119|564710996|FG000|Overall Study|ineligible to treat per protocol|0|||
156441951|NCT03733119|564710997|FG001|Overall Study|ineligible to treat per protocol|1|||
156441952|NCT00807937|564710998|FG000|Overall Study|Adverse Event|12|||
156441953|NCT00807937|564710999|FG001|Overall Study|Adverse Event|12|||
156441954|NCT00807937|564711000|FG002|Overall Study|Adverse Event|5|||
156441955|NCT00807937|564711001|FG003|Overall Study|Adverse Event|4|||
156441956|NCT00807937|564710998|FG000|Overall Study|Protocol Violation|4|||
156441957|NCT00807937|564710999|FG001|Overall Study|Protocol Violation|5|||
156441958|NCT00807937|564711000|FG002|Overall Study|Protocol Violation|3|||
156441959|NCT00807937|564711001|FG003|Overall Study|Protocol Violation|3|||
156441960|NCT00807937|564710998|FG000|Overall Study|Withdrawal by Subject|5|||
156441961|NCT00807937|564710999|FG001|Overall Study|Withdrawal by Subject|4|||
156441962|NCT00807937|564711000|FG002|Overall Study|Withdrawal by Subject|1|||
156441963|NCT00807937|564711001|FG003|Overall Study|Withdrawal by Subject|4|||
156441964|NCT00807937|564710998|FG000|Overall Study|Lost to Follow-up|4|||
156441965|NCT00807937|564710999|FG001|Overall Study|Lost to Follow-up|0|||
156441966|NCT00807937|564711000|FG002|Overall Study|Lost to Follow-up|2|||
156441967|NCT00807937|564711001|FG003|Overall Study|Lost to Follow-up|1|||
156441968|NCT00807937|564710998|FG000|Overall Study|Lack of Efficacy|0|||
156441969|NCT00807937|564710999|FG001|Overall Study|Lack of Efficacy|0|||
156441970|NCT00807937|564711000|FG002|Overall Study|Lack of Efficacy|1|||
156441971|NCT00807937|564711001|FG003|Overall Study|Lack of Efficacy|2|||
156709390|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Death|5|||
156709391|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Death|8|||
156709392|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
156709393|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
156709394|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
156792026|NCT02539394|565991052|FG000|Overall Study|Protocol Violation|1|||
156792027|NCT02539394|565991053|FG001|Overall Study|Protocol Violation|3|||
156792028|NCT02539394|565991052|FG000|Overall Study|Lost to Follow-up|1|||
156792029|NCT02539394|565991053|FG001|Overall Study|Lost to Follow-up|2|||
156792030|NCT02539394|565991052|FG000|Overall Study|Incomplete dataset|6|||
156792031|NCT02539394|565991053|FG001|Overall Study|Incomplete dataset|6|||
156792032|NCT01316900|565991074|FG000|Overall Study|Adverse Event|10|||
156792033|NCT01316900|565991075|FG001|Overall Study|Adverse Event|10|||
156792034|NCT01316900|565991076|FG002|Overall Study|Adverse Event|15|||
156792035|NCT01316900|565991077|FG003|Overall Study|Adverse Event|9|||
156792036|NCT01316900|565991074|FG000|Overall Study|Lack of Efficacy|17|||
156792037|NCT01316900|565991075|FG001|Overall Study|Lack of Efficacy|9|||
156792038|NCT01316900|565991076|FG002|Overall Study|Lack of Efficacy|5|||
156792039|NCT01316900|565991077|FG003|Overall Study|Lack of Efficacy|7|||
156792040|NCT01316900|565991074|FG000|Overall Study|Protocol Violation|7|||
156792041|NCT01316900|565991075|FG001|Overall Study|Protocol Violation|1|||
156441972|NCT00807937|564710998|FG000|Overall Study|Intake of prohibited medicine|0|||
156441973|NCT00807937|564710999|FG001|Overall Study|Intake of prohibited medicine|0|||
156441974|NCT00807937|564711000|FG002|Overall Study|Intake of prohibited medicine|2|||
156441975|NCT00807937|564711001|FG003|Overall Study|Intake of prohibited medicine|0|||
156873011|NCT01147874|566293315|FG000|Overall Study|Other|5|||
156873012|NCT01147874|566293315|FG000|Overall Study|Protocol Violation|5|||
156873013|NCT01147874|566293315|FG000|Overall Study|Sponsor's Decision|2|||
156873014|NCT01147874|566293315|FG000|Overall Study|Withdrawal by Subject|24|||
156873015|NCT04625101|566293316|FG000|Overall Study|Withdrawal by Subject|0|||
156873016|NCT04625101|566293317|FG001|Overall Study|Withdrawal by Subject|1|||
156873017|NCT04625101|566293316|FG000|Overall Study|Protocol Deviation|1|||
156873018|NCT04625101|566293317|FG001|Overall Study|Protocol Deviation|0|||
156873019|NCT02991040|566293318|FG000|Overall Study|Withdrawal by Subject|2|||
156873020|NCT02991040|566293318|FG000|Overall Study|Lost to Follow-up|2|||
156873021|NCT04287517|566293319|FG000|Overall Study|Withdrawal by Subject|1|||
156873022|NCT04287517|566293320|FG001|Overall Study|Withdrawal by Subject|1|||
156873023|NCT01869764|566293327|FG000|Overall Study|Withdrawal by Subject|0|||
156873024|NCT01869764|566293328|FG001|Overall Study|Withdrawal by Subject|2|||
156873025|NCT02175030|566293329|FG000|Overall Study|Failed screen after consent|7|||
156873026|NCT02175030|566293330|FG001|Overall Study|Failed screen after consent|6|||
156873027|NCT02175030|566293329|FG000|Overall Study|Failed IUD Insertion|20|||
156873028|NCT02175030|566293330|FG001|Overall Study|Failed IUD Insertion|21|||
156873029|NCT02175030|566293329|FG000|Overall Study|Physician Decision|1|||
156873030|NCT02175030|566293330|FG001|Overall Study|Physician Decision|1|||
156873031|NCT02175030|566293329|FG000|Overall Study|Lost to Follow-up|6|||
156873032|NCT02175030|566293330|FG001|Overall Study|Lost to Follow-up|6|||
156873033|NCT02175030|566293329|FG000|Overall Study|Withdrawal by Subject|1|||
156873034|NCT02175030|566293330|FG001|Overall Study|Withdrawal by Subject|4|||
156873035|NCT02533453|566293331|FG000|Overall Study|Adverse Event|6|||
156873036|NCT02533453|566293331|FG000|Overall Study|Protocol Violation|1|||
156873037|NCT02533453|566293331|FG000|Overall Study|Withdrawal by Subject|2|||
156873038|NCT00885534|566293332|FG000|Overall Study|Patient deemed ineligible|1|||
156873039|NCT02453711|566293333|FG000|Overall Study|Withdrawal by Subject|5|||
156873040|NCT02453711|566293334|FG001|Overall Study|Withdrawal by Subject|4|||
156873041|NCT02453711|566293335|FG002|Overall Study|Withdrawal by Subject|6|||
156873042|NCT02453711|566293336|FG003|Overall Study|Withdrawal by Subject|4|||
156873043|NCT02453711|566293337|FG004|Overall Study|Withdrawal by Subject|1|||
156873044|NCT02453711|566293338|FG005|Overall Study|Withdrawal by Subject|1|||
156873045|NCT02453711|566293339|FG006|Overall Study|Withdrawal by Subject|0|||
156873046|NCT02453711|566293340|FG007|Overall Study|Withdrawal by Subject|1|||
156873047|NCT02453711|566293341|FG008|Overall Study|Withdrawal by Subject|7|||
156873048|NCT02453711|566293333|FG000|Overall Study|Lost to Follow-up|5|||
156873049|NCT02453711|566293334|FG001|Overall Study|Lost to Follow-up|3|||
156873050|NCT02453711|566293335|FG002|Overall Study|Lost to Follow-up|2|||
156873051|NCT02453711|566293336|FG003|Overall Study|Lost to Follow-up|3|||
156873052|NCT02453711|566293337|FG004|Overall Study|Lost to Follow-up|1|||
156873053|NCT02453711|566293338|FG005|Overall Study|Lost to Follow-up|5|||
156873054|NCT02453711|566293339|FG006|Overall Study|Lost to Follow-up|2|||
156873055|NCT02453711|566293340|FG007|Overall Study|Lost to Follow-up|6|||
156873056|NCT02453711|566293341|FG008|Overall Study|Lost to Follow-up|6|||
156873057|NCT02453711|566293333|FG000|Overall Study|Death|0|||
156873058|NCT02453711|566293334|FG001|Overall Study|Death|0|||
156873059|NCT02453711|566293335|FG002|Overall Study|Death|0|||
156873060|NCT02453711|566293336|FG003|Overall Study|Death|0|||
156873061|NCT02453711|566293337|FG004|Overall Study|Death|0|||
156873062|NCT02453711|566293338|FG005|Overall Study|Death|0|||
156873063|NCT02453711|566293339|FG006|Overall Study|Death|1|||
156873064|NCT02453711|566293340|FG007|Overall Study|Death|0|||
156873065|NCT02453711|566293341|FG008|Overall Study|Death|0|||
156873066|NCT02453711|566293333|FG000|Overall Study|Unclassified|1|||
156873067|NCT02453711|566293334|FG001|Overall Study|Unclassified|0|||
156873068|NCT02453711|566293335|FG002|Overall Study|Unclassified|1|||
156873069|NCT02453711|566293336|FG003|Overall Study|Unclassified|0|||
156873070|NCT02453711|566293337|FG004|Overall Study|Unclassified|0|||
156873071|NCT02453711|566293338|FG005|Overall Study|Unclassified|0|||
156873072|NCT02453711|566293339|FG006|Overall Study|Unclassified|0|||
156873073|NCT02453711|566293340|FG007|Overall Study|Unclassified|0|||
156873074|NCT02453711|566293341|FG008|Overall Study|Unclassified|0|||
156873075|NCT03695367|566293344|FG000|Overall Study|Missed the Day 28 visit.|1|||
156873076|NCT03695367|566293345|FG001|Overall Study|Missed the Day 28 visit.|0|||
156873077|NCT03695367|566293344|FG000|Overall Study|Lost to Follow-up|0|||
156873078|NCT03695367|566293345|FG001|Overall Study|Lost to Follow-up|1|||
156873079|NCT03695367|566293344|FG000|Overall Study|Withdrawal by Subject|0|||
156873080|NCT03695367|566293345|FG001|Overall Study|Withdrawal by Subject|1|||
156873081|NCT03695367|566293344|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
156873082|NCT03695367|566293345|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
156873083|NCT02506244|566293346|FG000|Overall Study|Did not undergo active monitoring|458|||
156873084|NCT02506244|566293347|FG001|Overall Study|Did not undergo active monitoring|459|||
156873085|NCT02506244|566293348|FG002|Overall Study|Did not undergo active monitoring|0|||
156873086|NCT01958164|566293350|FG000|Overall Study|Adverse Event|0|||
156332735|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Death|0|||
156873087|NCT01958164|566293351|FG001|Overall Study|Adverse Event|2|||
156873088|NCT01958164|566293350|FG000|Overall Study|Lost to Follow-up|2|||
156873089|NCT01958164|566293351|FG001|Overall Study|Lost to Follow-up|3|||
156873090|NCT00740857|566293353|FG000|Overall Study|Withdrawal by Subject|1|||
156873091|NCT00740857|566293354|FG001|Overall Study|Withdrawal by Subject|0|||
156873092|NCT00740857|566293355|FG002|Overall Study|Withdrawal by Subject|0|||
156873093|NCT02963506|566293356|FG000|Double-Blind Period|Adverse Event|0|||
156873094|NCT02963506|566293357|FG001|Double-Blind Period|Adverse Event|0|||
156873095|NCT02963506|566293358|FG002|Double-Blind Period|Adverse Event|1|||
156532079|NCT00974090|565043271|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
156532080|NCT00974090|565043270|FG000|Period 2: Open-label Period|Physician Decision|0|||
156532081|NCT00974090|565043271|FG001|Period 2: Open-label Period|Physician Decision|3|||
156873096|NCT02963506|566293359|FG003|Double-Blind Period|Adverse Event|0|||
156873097|NCT02963506|566293360|FG004|Double-Blind Period|Adverse Event|0|||
156873098|NCT02963506|566293361|FG005|Double-Blind Period|Adverse Event|0|||
156873099|NCT02963506|566293362|FG006|Double-Blind Period|Adverse Event|0|||
156873100|NCT02963506|566293363|FG007|Double-Blind Period|Adverse Event|0|||
156873101|NCT02963506|566293364|FG008|Double-Blind Period|Adverse Event|0|||
156873102|NCT02963506|566293365|FG009|Double-Blind Period|Adverse Event|0|||
156873103|NCT02963506|566293366|FG010|Double-Blind Period|Adverse Event|0|||
156873104|NCT02963506|566293367|FG011|Double-Blind Period|Adverse Event|0|||
156873105|NCT02963506|566293368|FG012|Double-Blind Period|Adverse Event|0|||
156873106|NCT02963506|566293356|FG000|Double-Blind Period|Death|0|||
156873107|NCT02963506|566293357|FG001|Double-Blind Period|Death|0|||
156873108|NCT02963506|566293358|FG002|Double-Blind Period|Death|0|||
156873109|NCT02963506|566293359|FG003|Double-Blind Period|Death|1|||
156873110|NCT02963506|566293360|FG004|Double-Blind Period|Death|0|||
156873111|NCT02963506|566293361|FG005|Double-Blind Period|Death|0|||
156873112|NCT02963506|566293362|FG006|Double-Blind Period|Death|0|||
156873113|NCT02963506|566293363|FG007|Double-Blind Period|Death|0|||
156873114|NCT02963506|566293364|FG008|Double-Blind Period|Death|0|||
156873115|NCT02963506|566293365|FG009|Double-Blind Period|Death|0|||
156873116|NCT02963506|566293366|FG010|Double-Blind Period|Death|0|||
156873117|NCT02963506|566293367|FG011|Double-Blind Period|Death|0|||
156873118|NCT02963506|566293368|FG012|Double-Blind Period|Death|0|||
156873119|NCT02963506|566293356|FG000|Double-Blind Period|Lost to Follow-up|0|||
156873120|NCT02963506|566293357|FG001|Double-Blind Period|Lost to Follow-up|1|||
156873121|NCT02963506|566293358|FG002|Double-Blind Period|Lost to Follow-up|0|||
156873122|NCT02963506|566293359|FG003|Double-Blind Period|Lost to Follow-up|0|||
156873123|NCT02963506|566293360|FG004|Double-Blind Period|Lost to Follow-up|0|||
156873124|NCT02963506|566293361|FG005|Double-Blind Period|Lost to Follow-up|0|||
156873125|NCT02963506|566293362|FG006|Double-Blind Period|Lost to Follow-up|0|||
156873126|NCT02963506|566293363|FG007|Double-Blind Period|Lost to Follow-up|0|||
156873127|NCT02963506|566293364|FG008|Double-Blind Period|Lost to Follow-up|0|||
156873128|NCT02963506|566293365|FG009|Double-Blind Period|Lost to Follow-up|0|||
156873129|NCT02963506|566293366|FG010|Double-Blind Period|Lost to Follow-up|0|||
156873130|NCT02963506|566293367|FG011|Double-Blind Period|Lost to Follow-up|0|||
156873131|NCT02963506|566293368|FG012|Double-Blind Period|Lost to Follow-up|0|||
156873132|NCT02963506|566293356|FG000|Double-Blind Period|Withdrawal by Subject|0|||
156873133|NCT02963506|566293357|FG001|Double-Blind Period|Withdrawal by Subject|0|||
156873134|NCT02963506|566293358|FG002|Double-Blind Period|Withdrawal by Subject|1|||
156873135|NCT02963506|566293359|FG003|Double-Blind Period|Withdrawal by Subject|1|||
156873136|NCT02963506|566293360|FG004|Double-Blind Period|Withdrawal by Subject|0|||
156873137|NCT02963506|566293361|FG005|Double-Blind Period|Withdrawal by Subject|0|||
156873138|NCT02963506|566293362|FG006|Double-Blind Period|Withdrawal by Subject|0|||
156873139|NCT02963506|566293363|FG007|Double-Blind Period|Withdrawal by Subject|0|||
156873140|NCT02963506|566293364|FG008|Double-Blind Period|Withdrawal by Subject|0|||
156873141|NCT02963506|566293365|FG009|Double-Blind Period|Withdrawal by Subject|0|||
156873142|NCT02963506|566293366|FG010|Double-Blind Period|Withdrawal by Subject|0|||
156873143|NCT02963506|566293367|FG011|Double-Blind Period|Withdrawal by Subject|0|||
156873144|NCT02963506|566293368|FG012|Double-Blind Period|Withdrawal by Subject|0|||
156873145|NCT02963506|566293356|FG000|Double-Blind Period|No compliance|0|||
156873146|NCT02963506|566293357|FG001|Double-Blind Period|No compliance|1|||
156873147|NCT02963506|566293358|FG002|Double-Blind Period|No compliance|0|||
156873148|NCT02963506|566293359|FG003|Double-Blind Period|No compliance|0|||
156873149|NCT02963506|566293360|FG004|Double-Blind Period|No compliance|0|||
156332736|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
156332737|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
156332738|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
156332739|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
156332740|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
156332741|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
156332742|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
156873150|NCT02963506|566293361|FG005|Double-Blind Period|No compliance|0|||
156873151|NCT02963506|566293362|FG006|Double-Blind Period|No compliance|0|||
156873152|NCT02963506|566293363|FG007|Double-Blind Period|No compliance|0|||
156873153|NCT02963506|566293364|FG008|Double-Blind Period|No compliance|0|||
156792042|NCT01316900|565991076|FG002|Overall Study|Protocol Violation|4|||
156873154|NCT02963506|566293365|FG009|Double-Blind Period|No compliance|0|||
156873155|NCT02963506|566293366|FG010|Double-Blind Period|No compliance|0|||
156873156|NCT02963506|566293367|FG011|Double-Blind Period|No compliance|0|||
156873157|NCT02963506|566293368|FG012|Double-Blind Period|No compliance|0|||
156873158|NCT02963506|566293356|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873159|NCT02963506|566293357|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
156873160|NCT02963506|566293358|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873161|NCT02963506|566293359|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873162|NCT02963506|566293360|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873163|NCT02963506|566293361|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873164|NCT02963506|566293362|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873165|NCT02963506|566293363|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873166|NCT02963506|566293364|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873167|NCT02963506|566293365|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873168|NCT02963506|566293366|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873169|NCT02963506|566293367|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873170|NCT02963506|566293368|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873171|NCT02963506|566293356|FG000|Dose-Blind Period|Adverse Event|0|||
156873172|NCT02963506|566293357|FG001|Dose-Blind Period|Adverse Event|0|||
156873173|NCT02963506|566293358|FG002|Dose-Blind Period|Adverse Event|0|||
156873174|NCT02963506|566293359|FG003|Dose-Blind Period|Adverse Event|0|||
156873175|NCT02963506|566293360|FG004|Dose-Blind Period|Adverse Event|0|||
156873176|NCT02963506|566293361|FG005|Dose-Blind Period|Adverse Event|1|||
156873177|NCT02963506|566293362|FG006|Dose-Blind Period|Adverse Event|3|||
156792043|NCT01316900|565991077|FG003|Overall Study|Protocol Violation|0|||
156792044|NCT01316900|565991074|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
156792045|NCT01316900|565991075|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
156792046|NCT01316900|565991076|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
156792047|NCT01316900|565991077|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
156873178|NCT02963506|566293363|FG007|Dose-Blind Period|Adverse Event|2|||
156873179|NCT02963506|566293364|FG008|Dose-Blind Period|Adverse Event|2|||
156873180|NCT02963506|566293365|FG009|Dose-Blind Period|Adverse Event|2|||
156873181|NCT02963506|566293366|FG010|Dose-Blind Period|Adverse Event|1|||
156873182|NCT02963506|566293367|FG011|Dose-Blind Period|Adverse Event|1|||
156873183|NCT02963506|566293368|FG012|Dose-Blind Period|Adverse Event|6|||
156873184|NCT02963506|566293356|FG000|Dose-Blind Period|Lack of Efficacy|0|||
156873185|NCT02963506|566293357|FG001|Dose-Blind Period|Lack of Efficacy|0|||
156792048|NCT01316900|565991074|FG000|Overall Study|Lost to Follow-up|1|||
156792049|NCT01316900|565991075|FG001|Overall Study|Lost to Follow-up|0|||
156792050|NCT01316900|565991076|FG002|Overall Study|Lost to Follow-up|1|||
156792051|NCT01316900|565991077|FG003|Overall Study|Lost to Follow-up|1|||
156792052|NCT01316900|565991074|FG000|Overall Study|Withdrawal by Subject|7|||
156792053|NCT01316900|565991075|FG001|Overall Study|Withdrawal by Subject|8|||
156792054|NCT01316900|565991076|FG002|Overall Study|Withdrawal by Subject|6|||
156792055|NCT01316900|565991077|FG003|Overall Study|Withdrawal by Subject|9|||
156792056|NCT00562861|565991078|FG000|Overall Study|Adverse Event|1|||
156792057|NCT00562861|565991079|FG001|Overall Study|Adverse Event|1|||
156792058|NCT00562861|565991078|FG000|Overall Study|Lack of Efficacy|5|||
156792059|NCT00562861|565991079|FG001|Overall Study|Lack of Efficacy|5|||
156792060|NCT00562861|565991078|FG000|Overall Study|noncompliance, moved|7|||
156792061|NCT00562861|565991079|FG001|Overall Study|noncompliance, moved|2|||
156792062|NCT00562861|565991078|FG000|Overall Study|Lost to Follow-up|7|||
156792063|NCT00562861|565991079|FG001|Overall Study|Lost to Follow-up|3|||
156792064|NCT00655356|565991080|FG000|Overall Study|Withdrawal by Subject|3|||
156792065|NCT00655356|565991081|FG001|Overall Study|Withdrawal by Subject|4|||
156792066|NCT00655356|565991080|FG000|Overall Study|Sponsor Request|10|||
156792067|NCT00655356|565991081|FG001|Overall Study|Sponsor Request|4|||
156792068|NCT00655356|565991080|FG000|Overall Study|Adverse Event|1|||
156792069|NCT00655356|565991081|FG001|Overall Study|Adverse Event|1|||
156873186|NCT02963506|566293358|FG002|Dose-Blind Period|Lack of Efficacy|0|||
156873187|NCT02963506|566293359|FG003|Dose-Blind Period|Lack of Efficacy|0|||
156873188|NCT02963506|566293360|FG004|Dose-Blind Period|Lack of Efficacy|0|||
156873189|NCT02963506|566293361|FG005|Dose-Blind Period|Lack of Efficacy|0|||
156873190|NCT02963506|566293362|FG006|Dose-Blind Period|Lack of Efficacy|0|||
156873191|NCT02963506|566293363|FG007|Dose-Blind Period|Lack of Efficacy|1|||
156873192|NCT02963506|566293364|FG008|Dose-Blind Period|Lack of Efficacy|0|||
156332743|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
156332744|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
156332745|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
156332746|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
156332747|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
156792070|NCT00655356|565991080|FG000|Overall Study|Protocol Violation|2|||
156792071|NCT00655356|565991081|FG001|Overall Study|Protocol Violation|1|||
156873193|NCT02963506|566293365|FG009|Dose-Blind Period|Lack of Efficacy|1|||
156873194|NCT02963506|566293366|FG010|Dose-Blind Period|Lack of Efficacy|0|||
156441976|NCT00807937|564710998|FG000|Overall Study|All other reasons (not provided)|2|||
156441977|NCT00807937|564710999|FG001|Overall Study|All other reasons (not provided)|4|||
156441978|NCT00807937|564711000|FG002|Overall Study|All other reasons (not provided)|0|||
156441979|NCT00807937|564711001|FG003|Overall Study|All other reasons (not provided)|1|||
156441980|NCT04629950|564711004|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
156441981|NCT04629950|564711005|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
156441982|NCT04629950|564711006|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
156441983|NCT04629950|564711007|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
156441984|NCT04629950|564711004|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
156441985|NCT04629950|564711005|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
156441986|NCT04629950|564711006|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
156441987|NCT04629950|564711007|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
156441988|NCT04629950|564711004|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
156441989|NCT04629950|564711005|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
156441990|NCT04629950|564711006|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
156441991|NCT04629950|564711007|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
156709395|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
156709396|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
156709397|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
156709398|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
156709399|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
156709400|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Other|1|||
156709401|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Other|0|||
156709402|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Death|17|||
156709403|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Death|11|||
156709404|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
156709405|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
156709406|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
156441992|NCT04629950|564711004|FG000|Extension Study|Withdrawal by Subject|0|||
156441993|NCT04629950|564711005|FG001|Extension Study|Withdrawal by Subject|0|||
156441994|NCT04629950|564711006|FG002|Extension Study|Withdrawal by Subject|1|||
156441995|NCT04629950|564711007|FG003|Extension Study|Withdrawal by Subject|0|||
156441996|NCT04629950|564711004|FG000|Extension Study|Adverse Event|0|||
156441997|NCT04629950|564711005|FG001|Extension Study|Adverse Event|0|||
156441998|NCT04629950|564711006|FG002|Extension Study|Adverse Event|0|||
156441999|NCT04629950|564711007|FG003|Extension Study|Adverse Event|1|||
156442000|NCT01198145|564711008|FG000|Overall Study|Withdrawal by Subject|1|||
156442001|NCT01198145|564711009|FG001|Overall Study|Withdrawal by Subject|1|||
156442002|NCT02568683|564711011|FG000|Overall Study|Death|0|||
156442003|NCT02568683|564711012|FG001|Overall Study|Death|2|||
156442004|NCT02568683|564711011|FG000|Overall Study|Withdrew Consent|1|||
156442005|NCT02568683|564711012|FG001|Overall Study|Withdrew Consent|0|||
156442006|NCT02568683|564711011|FG000|Overall Study|Study Terminated By Sponsor|5|||
156442007|NCT02568683|564711012|FG001|Overall Study|Study Terminated By Sponsor|2|||
156442008|NCT01561989|564711015|FG000|Overall Study|accural target not met.|5|||
156442009|NCT01561989|564711016|FG001|Overall Study|accural target not met.|6|||
156442010|NCT03485950|564711021|FG000|Overall Study|Adverse Event|1|||
156442011|NCT03485950|564711022|FG001|Overall Study|Adverse Event|0|||
156442012|NCT03485950|564711021|FG000|Overall Study|Death|3|||
156442013|NCT03485950|564711022|FG001|Overall Study|Death|2|||
156709407|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
156792072|NCT00655356|565991080|FG000|Overall Study|Other Reason|1|||
156792073|NCT00655356|565991081|FG001|Overall Study|Other Reason|0|||
156792074|NCT01684033|565991082|FG000|Period 1, First 30 Days|Adverse Event|1|||
156792075|NCT01684033|565991083|FG001|Period 1, First 30 Days|Adverse Event|1|||
156792076|NCT01684033|565991082|FG000|Period 1, First 30 Days|Noncompliance|1|||
156792077|NCT01684033|565991083|FG001|Period 1, First 30 Days|Noncompliance|0|||
156792078|NCT01684033|565991082|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
156792079|NCT01684033|565991083|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
156792080|NCT01684033|565991082|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
156792081|NCT01684033|565991083|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
156792082|NCT01684033|565991082|FG000|Period 2, Second 30 Days|Adverse Event|1|||
156792083|NCT01684033|565991083|FG001|Period 2, Second 30 Days|Adverse Event|0|||
156792084|NCT01093573|565991088|FG000|Overall Study|Physician Decision|0|||
156792085|NCT01093573|565991089|FG001|Overall Study|Physician Decision|0|||
156792086|NCT01093573|565991090|FG002|Overall Study|Physician Decision|1|||
156792087|NCT01093573|565991088|FG000|Overall Study|Insurance Denied|0|||
156792088|NCT01093573|565991089|FG001|Overall Study|Insurance Denied|0|||
156792089|NCT01093573|565991090|FG002|Overall Study|Insurance Denied|1|||
156792090|NCT05626686|565991091|FG000|Overall Study|Protocol Violation|3|||
156792091|NCT05626686|565991091|FG000|Overall Study|Withdrawal by Subject|3|||
156792092|NCT02496156|565991092|FG000|Overall Study|Lost to Follow-up|5|||
156442014|NCT03485950|564711021|FG000|Overall Study|Withdrawal by Subject|3|||
156442015|NCT03485950|564711022|FG001|Overall Study|Withdrawal by Subject|0|||
156442016|NCT03930420|564711023|FG000|Overall Study|Withdrawal by Subject|7|||
156442017|NCT03930420|564711024|FG001|Overall Study|Withdrawal by Subject|9|||
156442018|NCT05609032|564711025|FG000|Overall Study|Lost to Follow-up|3|||
156442019|NCT05609032|564711026|FG001|Overall Study|Lost to Follow-up|1|||
156442020|NCT05609032|564711025|FG000|Overall Study|Withdrawal by Subject|1|||
156442021|NCT05609032|564711026|FG001|Overall Study|Withdrawal by Subject|0|||
156442022|NCT00609336|564711027|FG000|Overall Study|Protocol Violation|3|||
156442023|NCT00609336|564711027|FG000|Overall Study|Death|1|||
156442024|NCT00609336|564711027|FG000|Overall Study|LA or Met at Surgery|9|||
156442025|NCT02477605|564711028|FG000|Overall Study|Discontinued prior to treatment|1|||
156442026|NCT02477605|564711029|FG001|Overall Study|Discontinued prior to treatment|0|||
156442027|NCT02477605|564711028|FG000|Overall Study|Lost to Follow-up|0|||
156442028|NCT02477605|564711029|FG001|Overall Study|Lost to Follow-up|2|||
156442029|NCT02477605|564711028|FG000|Overall Study|Withdrawal by Subject|0|||
156442030|NCT02477605|564711029|FG001|Overall Study|Withdrawal by Subject|1|||
156442031|NCT02477605|564711028|FG000|Overall Study|Administered gas during surgery|0|||
156442032|NCT02477605|564711029|FG001|Overall Study|Administered gas during surgery|1|||
156442033|NCT00567489|564711030|FG000|Overall Study|Adverse Event|6|||
156442034|NCT00567489|564711031|FG001|Overall Study|Adverse Event|14|||
156442035|NCT00567489|564711030|FG000|Overall Study|Physician Decision|0|||
156442036|NCT00567489|564711031|FG001|Overall Study|Physician Decision|4|||
156442037|NCT00567489|564711030|FG000|Overall Study|Withdrawal by Subject|0|||
156442038|NCT00567489|564711031|FG001|Overall Study|Withdrawal by Subject|2|||
156442039|NCT00567489|564711030|FG000|Overall Study|Renal Transplantation|0|||
156442040|NCT00567489|564711031|FG001|Overall Study|Renal Transplantation|3|||
156442041|NCT00567489|564711030|FG000|Overall Study|Other|1|||
156442042|NCT00567489|564711031|FG001|Overall Study|Other|0|||
156442043|NCT00068601|564711034|FG000|Overall Study|Ineligible|11|||
156709408|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
156709409|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
156709410|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
156709411|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
156709412|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
156709413|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
156442044|NCT00068601|564711035|FG001|Overall Study|Ineligible|13|||
156442045|NCT00068601|564711034|FG000|Overall Study|Not evaluable: withdrew consent|5|||
156709414|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
156709415|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
156442046|NCT00068601|564711035|FG001|Overall Study|Not evaluable: withdrew consent|4|||
156532082|NCT00974090|565043270|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
156709416|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
156709417|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
156709418|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Other|2|||
156709419|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Other|1|||
156709420|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
156709421|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
156709422|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Death|12|||
156709423|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Death|10|||
156709424|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
156709425|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
156709426|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
156709427|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
156709428|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Other|7|||
156709429|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Other|5|||
156709430|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
156709431|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
156709432|NCT02952586|565680609|FG000|LT Follow-up (up to 45 Months)|Death|51|||
156709433|NCT02952586|565680610|FG001|LT Follow-up (up to 45 Months)|Death|31|||
156709434|NCT02952586|565680609|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
156709435|NCT02952586|565680610|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
156709436|NCT02952586|565680609|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
156709437|NCT02952586|565680610|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
156709438|NCT02952586|565680609|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
156709439|NCT02952586|565680610|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
156709440|NCT00492778|565680611|FG000|Overall Study|Ineligible by Pathology Review|8|||
156709441|NCT00492778|565680612|FG001|Overall Study|Ineligible by Pathology Review|1|||
156709442|NCT03717012|565680625|FG000|Overall Study|Due to trial termination|1|||
156709443|NCT03717012|565680626|FG001|Overall Study|Due to trial termination|2|||
156709444|NCT03717012|565680625|FG000|Overall Study|Protocol Violation|0|||
156709445|NCT03717012|565680626|FG001|Overall Study|Protocol Violation|2|||
156442047|NCT00068601|564711034|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
156332748|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
156332749|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
156792093|NCT02496156|565991093|FG001|Overall Study|Lost to Follow-up|0|||
156792094|NCT02496156|565991092|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
156792095|NCT02496156|565991093|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
156792096|NCT00289900|565991094|FG000|Overall Study|Adverse Event|28|||
156792097|NCT00289900|565991095|FG001|Overall Study|Adverse Event|40|||
156792098|NCT00289900|565991096|FG002|Overall Study|Adverse Event|13|||
156792099|NCT00289900|565991097|FG003|Overall Study|Adverse Event|19|||
156792100|NCT00289900|565991098|FG004|Overall Study|Adverse Event|20|||
156332750|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
156709446|NCT03717012|565680625|FG000|Overall Study|Adverse Event|0|||
156709447|NCT03717012|565680626|FG001|Overall Study|Adverse Event|1|||
156709448|NCT03717012|565680625|FG000|Overall Study|Lung transplant|0|||
156709449|NCT03717012|565680626|FG001|Overall Study|Lung transplant|1|||
156709450|NCT00658879|565680627|FG000|Overall Study|Protocol Violation|1|||
156709451|NCT02640690|565680628|FG000|Overall Study|Lost to Follow-up|7|||
156709452|NCT02640690|565680629|FG001|Overall Study|Lost to Follow-up|7|||
156709453|NCT02640690|565680628|FG000|Overall Study|Withdrawal by Subject|16|||
156709454|NCT02640690|565680629|FG001|Overall Study|Withdrawal by Subject|20|||
156709455|NCT02640690|565680628|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
156709456|NCT02640690|565680629|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
156709457|NCT01118975|565680630|FG000|Overall Study|Adverse Event|0|||
156709458|NCT01118975|565680631|FG001|Overall Study|Adverse Event|1|||
156709459|NCT01645787|565680632|FG000|Washout (2 Weeks)|Adverse Event|1|||
156709460|NCT01645787|565680633|FG001|Washout (2 Weeks)|Adverse Event|0|||
156709461|NCT04315506|565680635|FG000|Overall Study|Lost to Follow-up|74|||
156709462|NCT04315506|565680636|FG001|Overall Study|Lost to Follow-up|82|||
156709463|NCT04315506|565680635|FG000|Overall Study|Withdrawal by Subject|8|||
156709464|NCT04315506|565680636|FG001|Overall Study|Withdrawal by Subject|8|||
156709465|NCT04315506|565680635|FG000|Overall Study|Physician Decision|0|||
156709466|NCT04315506|565680636|FG001|Overall Study|Physician Decision|1|||
156709467|NCT02661217|565680641|FG000|Overall Study|Physician Decision|12|||
156709468|NCT02661217|565680642|FG001|Overall Study|Physician Decision|15|||
156709469|NCT02661217|565680641|FG000|Overall Study|Lost to Follow-up|1|||
156709470|NCT02661217|565680642|FG001|Overall Study|Lost to Follow-up|4|||
156709471|NCT02661217|565680641|FG000|Overall Study|Protocol Deviation|0|||
156709472|NCT02661217|565680642|FG001|Overall Study|Protocol Deviation|4|||
156709473|NCT02661217|565680641|FG000|Overall Study|Non-compliance with study treatment|5|||
156709474|NCT02661217|565680642|FG001|Overall Study|Non-compliance with study treatment|5|||
156709475|NCT02661217|565680641|FG000|Overall Study|Death|21|||
156709476|NCT02661217|565680642|FG001|Overall Study|Death|15|||
156709477|NCT02661217|565680641|FG000|Overall Study|Adverse Event|10|||
156709478|NCT02661217|565680642|FG001|Overall Study|Adverse Event|8|||
156709479|NCT02661217|565680641|FG000|Overall Study|Withdrawal by Subject|15|||
156709480|NCT02661217|565680642|FG001|Overall Study|Withdrawal by Subject|19|||
156709481|NCT02661217|565680641|FG000|Overall Study|Did not enter follow-up epoch|7|||
156709482|NCT02661217|565680642|FG001|Overall Study|Did not enter follow-up epoch|10|||
156709483|NCT02661217|565680641|FG000|Overall Study|Death - no study drug received|1|||
156709484|NCT02661217|565680642|FG001|Overall Study|Death - no study drug received|2|||
156709485|NCT02661217|565680641|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
156709486|NCT02661217|565680642|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
156709487|NCT02075515|565680643|FG000|Overall Study|Serious Adverse Event|1|||
156709488|NCT02075515|565680644|FG001|Overall Study|Serious Adverse Event|1|||
156709489|NCT02075515|565680645|FG002|Overall Study|Serious Adverse Event|1|||
156709490|NCT02075515|565680643|FG000|Overall Study|Non-Serious Adverse Event|0|||
156709491|NCT02075515|565680644|FG001|Overall Study|Non-Serious Adverse Event|1|||
156709492|NCT02075515|565680645|FG002|Overall Study|Non-Serious Adverse Event|0|||
156709493|NCT02075515|565680643|FG000|Overall Study|Withdrawal by Subject|2|||
156709494|NCT02075515|565680644|FG001|Overall Study|Withdrawal by Subject|0|||
156709495|NCT02075515|565680645|FG002|Overall Study|Withdrawal by Subject|1|||
156709496|NCT02075515|565680643|FG000|Overall Study|Lost to Follow-up|1|||
156709497|NCT02075515|565680644|FG001|Overall Study|Lost to Follow-up|3|||
156709498|NCT02075515|565680645|FG002|Overall Study|Lost to Follow-up|6|||
156709499|NCT01098474|565680646|FG000|Active Phase|Other|0|||
156709500|NCT01098474|565680647|FG001|Active Phase|Other|0|||
156709501|NCT01098474|565680648|FG002|Active Phase|Other|3|||
156709502|NCT01098474|565680649|FG003|Active Phase|Other|0|||
156709503|NCT01098474|565680650|FG004|Active Phase|Other|0|||
156709504|NCT01098474|565680651|FG005|Active Phase|Other|0|||
156709505|NCT01098474|565680646|FG000|Active Phase|Withdrawal by Subject|1|||
156709506|NCT01098474|565680647|FG001|Active Phase|Withdrawal by Subject|1|||
156709507|NCT01098474|565680648|FG002|Active Phase|Withdrawal by Subject|2|||
156709508|NCT01098474|565680649|FG003|Active Phase|Withdrawal by Subject|0|||
156709509|NCT01098474|565680650|FG004|Active Phase|Withdrawal by Subject|0|||
156709510|NCT01098474|565680651|FG005|Active Phase|Withdrawal by Subject|0|||
156709511|NCT01098474|565680646|FG000|Active Phase|Lost to Follow-up|1|||
156709512|NCT01098474|565680647|FG001|Active Phase|Lost to Follow-up|0|||
156709513|NCT01098474|565680648|FG002|Active Phase|Lost to Follow-up|0|||
156873195|NCT02963506|566293367|FG011|Dose-Blind Period|Lack of Efficacy|0|||
156873196|NCT02963506|566293368|FG012|Dose-Blind Period|Lack of Efficacy|0|||
156873197|NCT02963506|566293356|FG000|Dose-Blind Period|Lost to Follow-up|0|||
156873198|NCT02963506|566293357|FG001|Dose-Blind Period|Lost to Follow-up|0|||
156532083|NCT00974090|565043271|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
156532084|NCT01284062|565043272|FG000|Overall Study|Adverse Event|4|||
156532085|NCT01284062|565043273|FG001|Overall Study|Adverse Event|5|||
156532086|NCT01284062|565043274|FG002|Overall Study|Adverse Event|0|||
156532087|NCT01284062|565043275|FG003|Overall Study|Adverse Event|5|||
156532088|NCT01284062|565043272|FG000|Overall Study|Lack of Efficacy|3|||
156532089|NCT01284062|565043273|FG001|Overall Study|Lack of Efficacy|2|||
156532090|NCT01284062|565043274|FG002|Overall Study|Lack of Efficacy|2|||
156532091|NCT01284062|565043275|FG003|Overall Study|Lack of Efficacy|1|||
156532092|NCT01284062|565043272|FG000|Overall Study|Medication error without adverse event|0|||
156709514|NCT01098474|565680649|FG003|Active Phase|Lost to Follow-up|0|||
156709515|NCT01098474|565680650|FG004|Active Phase|Lost to Follow-up|0|||
156873199|NCT02963506|566293358|FG002|Dose-Blind Period|Lost to Follow-up|0|||
156873200|NCT02963506|566293359|FG003|Dose-Blind Period|Lost to Follow-up|0|||
156873201|NCT02963506|566293360|FG004|Dose-Blind Period|Lost to Follow-up|0|||
156873202|NCT02963506|566293361|FG005|Dose-Blind Period|Lost to Follow-up|1|||
156332751|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
156332752|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
156332753|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
156332754|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
156332755|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
156532093|NCT01284062|565043273|FG001|Overall Study|Medication error without adverse event|0|||
156709516|NCT01098474|565680651|FG005|Active Phase|Lost to Follow-up|0|||
156709517|NCT01098474|565680646|FG000|Follow Up Phase|Travelled out of study area|0|||
156709518|NCT01098474|565680647|FG001|Follow Up Phase|Travelled out of study area|0|||
156709519|NCT01098474|565680648|FG002|Follow Up Phase|Travelled out of study area|0|||
156709520|NCT01098474|565680649|FG003|Follow Up Phase|Travelled out of study area|0|||
156709521|NCT01098474|565680650|FG004|Follow Up Phase|Travelled out of study area|1|||
156709522|NCT01098474|565680651|FG005|Follow Up Phase|Travelled out of study area|0|||
156709523|NCT01098474|565680646|FG000|Follow Up Phase|Other|0|||
156709524|NCT01098474|565680647|FG001|Follow Up Phase|Other|0|||
156709525|NCT01098474|565680648|FG002|Follow Up Phase|Other|0|||
156709526|NCT01098474|565680649|FG003|Follow Up Phase|Other|0|||
156709527|NCT01098474|565680650|FG004|Follow Up Phase|Other|0|||
156709528|NCT01098474|565680651|FG005|Follow Up Phase|Other|4|||
156709529|NCT01098474|565680646|FG000|Follow Up Phase|Withdrawal by Subject|0|||
156709530|NCT01098474|565680647|FG001|Follow Up Phase|Withdrawal by Subject|0|||
156709531|NCT01098474|565680648|FG002|Follow Up Phase|Withdrawal by Subject|0|||
156709532|NCT01098474|565680649|FG003|Follow Up Phase|Withdrawal by Subject|2|||
156709533|NCT01098474|565680650|FG004|Follow Up Phase|Withdrawal by Subject|0|||
156709534|NCT01098474|565680651|FG005|Follow Up Phase|Withdrawal by Subject|1|||
156709535|NCT01098474|565680646|FG000|Follow Up Phase|Lost to Follow-up|0|||
156709536|NCT01098474|565680647|FG001|Follow Up Phase|Lost to Follow-up|0|||
156709537|NCT01098474|565680648|FG002|Follow Up Phase|Lost to Follow-up|0|||
156709538|NCT01098474|565680649|FG003|Follow Up Phase|Lost to Follow-up|0|||
156709539|NCT01098474|565680650|FG004|Follow Up Phase|Lost to Follow-up|1|||
156709540|NCT01098474|565680651|FG005|Follow Up Phase|Lost to Follow-up|0|||
156709541|NCT05292183|565682306|FG000|Overall Study|Adverse Event|1|||
156709542|NCT03922529|565682311|FG000|Overall Study|Withdrawal by Subject|13|||
156709543|NCT03922529|565682312|FG001|Overall Study|Withdrawal by Subject|12|||
156709544|NCT03922529|565682311|FG000|Overall Study|Death|7|||
156332756|NCT02927262|564317392|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
156332757|NCT02927262|564317393|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
156332758|NCT02927262|564317392|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
156332759|NCT02927262|564317393|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
156332760|NCT02927262|564317392|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
156332761|NCT02927262|564317393|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
156332762|NCT02927262|564317392|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
156332763|NCT02927262|564317393|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
156332764|NCT02913612|564317394|FG000|Overall Study|Lost to Follow-up|6|||
156332765|NCT02913612|564317395|FG001|Overall Study|Lost to Follow-up|5|||
156332766|NCT02913612|564317396|FG002|Overall Study|Lost to Follow-up|2|||
156332767|NCT02913612|564317397|FG003|Overall Study|Lost to Follow-up|0|||
156332768|NCT02913612|564317394|FG000|Overall Study|Physician Decision|1|||
156332769|NCT02913612|564317395|FG001|Overall Study|Physician Decision|4|||
156532094|NCT01284062|565043274|FG002|Overall Study|Medication error without adverse event|1|||
156709545|NCT03922529|565682312|FG001|Overall Study|Death|12|||
156709546|NCT03922529|565682311|FG000|Overall Study|Lost to Follow-up|12|||
156709547|NCT03922529|565682312|FG001|Overall Study|Lost to Follow-up|19|||
156709548|NCT03922529|565682311|FG000|Overall Study|Adverse Event|1|||
156709549|NCT03922529|565682312|FG001|Overall Study|Adverse Event|0|||
156709550|NCT03922529|565682311|FG000|Overall Study|Death after withdrawal|1|||
156709551|NCT03922529|565682312|FG001|Overall Study|Death after withdrawal|0|||
156709552|NCT03922529|565682311|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
156709553|NCT03922529|565682312|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
156873203|NCT02963506|566293362|FG006|Dose-Blind Period|Lost to Follow-up|0|||
156873204|NCT02963506|566293363|FG007|Dose-Blind Period|Lost to Follow-up|0|||
156873205|NCT02963506|566293364|FG008|Dose-Blind Period|Lost to Follow-up|1|||
156873206|NCT02963506|566293365|FG009|Dose-Blind Period|Lost to Follow-up|0|||
156873207|NCT02963506|566293366|FG010|Dose-Blind Period|Lost to Follow-up|0|||
156873208|NCT02963506|566293367|FG011|Dose-Blind Period|Lost to Follow-up|1|||
156873209|NCT02963506|566293368|FG012|Dose-Blind Period|Lost to Follow-up|0|||
156873210|NCT02963506|566293356|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
156873211|NCT02963506|566293357|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
156873212|NCT02963506|566293358|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
156873213|NCT02963506|566293359|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
156873214|NCT02963506|566293360|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
156873215|NCT02963506|566293361|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
156873216|NCT02963506|566293362|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
156873217|NCT02963506|566293363|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
156873218|NCT02963506|566293364|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
156873219|NCT02963506|566293365|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
156873220|NCT02963506|566293366|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
156873221|NCT02963506|566293367|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
156873222|NCT02963506|566293368|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
156873223|NCT02963506|566293356|FG000|Dose-Blind Period|Sponsor decision|0|||
156873224|NCT02963506|566293357|FG001|Dose-Blind Period|Sponsor decision|0|||
156873225|NCT02963506|566293358|FG002|Dose-Blind Period|Sponsor decision|0|||
156873226|NCT02963506|566293359|FG003|Dose-Blind Period|Sponsor decision|0|||
156873227|NCT02963506|566293360|FG004|Dose-Blind Period|Sponsor decision|0|||
156873228|NCT02963506|566293361|FG005|Dose-Blind Period|Sponsor decision|1|||
156873229|NCT02963506|566293362|FG006|Dose-Blind Period|Sponsor decision|0|||
156873230|NCT02963506|566293363|FG007|Dose-Blind Period|Sponsor decision|0|||
156873231|NCT02963506|566293364|FG008|Dose-Blind Period|Sponsor decision|0|||
156873232|NCT02963506|566293365|FG009|Dose-Blind Period|Sponsor decision|0|||
156873233|NCT02963506|566293366|FG010|Dose-Blind Period|Sponsor decision|0|||
156873234|NCT02963506|566293367|FG011|Dose-Blind Period|Sponsor decision|0|||
156873235|NCT02963506|566293368|FG012|Dose-Blind Period|Sponsor decision|0|||
156873236|NCT02963506|566293356|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873237|NCT02963506|566293357|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873238|NCT02963506|566293358|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873239|NCT02963506|566293359|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873240|NCT02963506|566293360|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873241|NCT02963506|566293361|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873242|NCT02963506|566293362|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873243|NCT02963506|566293363|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873244|NCT02963506|566293364|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873245|NCT02963506|566293365|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873246|NCT02963506|566293366|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873247|NCT02963506|566293367|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873248|NCT02963506|566293368|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
156873249|NCT00354432|566293371|FG000|Overall Study|Adverse Event|3|||
156332770|NCT02913612|564317396|FG002|Overall Study|Physician Decision|1|||
156709554|NCT03922529|565682311|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
156709555|NCT03922529|565682312|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
156709556|NCT03355469|565682315|FG000|Overall Study|COVID-19|3|||
156709557|NCT03355469|565682316|FG001|Overall Study|COVID-19|2|||
156709558|NCT03355469|565682317|FG002|Overall Study|COVID-19|3|||
156709559|NCT03355469|565682318|FG003|Overall Study|COVID-19|3|||
156709560|NCT03355469|565682315|FG000|Overall Study|Lost to Follow-up|1|||
156709561|NCT03355469|565682316|FG001|Overall Study|Lost to Follow-up|0|||
156709562|NCT03355469|565682317|FG002|Overall Study|Lost to Follow-up|1|||
156709563|NCT03355469|565682318|FG003|Overall Study|Lost to Follow-up|0|||
156709564|NCT03355469|565682315|FG000|Overall Study|Withdrawal by Subject|2|||
156709565|NCT03355469|565682316|FG001|Overall Study|Withdrawal by Subject|1|||
156709566|NCT03355469|565682317|FG002|Overall Study|Withdrawal by Subject|0|||
156709567|NCT03355469|565682318|FG003|Overall Study|Withdrawal by Subject|3|||
156709568|NCT02731638|565682319|FG000|Overall Study|Lost to Follow-up|6|||
156709569|NCT02731638|565682320|FG001|Overall Study|Lost to Follow-up|9|||
156709570|NCT04158245|565682321|FG000|Overall Study|Lost to Follow-up|1|||
156709571|NCT02291510|565682322|FG000|Overall Study|Adverse Event|0|||
156709572|NCT02291510|565682323|FG001|Overall Study|Adverse Event|0|||
156873250|NCT00354432|566293372|FG001|Overall Study|Adverse Event|1|||
156873251|NCT00354432|566293373|FG002|Overall Study|Adverse Event|5|||
156873252|NCT00354432|566293374|FG003|Overall Study|Adverse Event|5|||
156873253|NCT00354432|566293371|FG000|Overall Study|Off/Toxicity|3|||
156873254|NCT00354432|566293372|FG001|Overall Study|Off/Toxicity|7|||
156873255|NCT00354432|566293373|FG002|Overall Study|Off/Toxicity|5|||
156873256|NCT00354432|566293374|FG003|Overall Study|Off/Toxicity|5|||
156873257|NCT03843541|566293375|FG000|Overall Study|Adverse Event|4|||
156873258|NCT03843541|566293376|FG001|Overall Study|Adverse Event|2|||
156873259|NCT03843541|566293377|FG002|Overall Study|Adverse Event|3|||
156873260|NCT03843541|566293375|FG000|Overall Study|Death|1|||
156873261|NCT03843541|566293376|FG001|Overall Study|Death|0|||
156873262|NCT03843541|566293377|FG002|Overall Study|Death|0|||
156873263|NCT03843541|566293375|FG000|Overall Study|Lack of adherence to study medication|0|||
156873264|NCT03843541|566293376|FG001|Overall Study|Lack of adherence to study medication|0|||
156873265|NCT03843541|566293377|FG002|Overall Study|Lack of adherence to study medication|1|||
156873266|NCT03843541|566293375|FG000|Overall Study|Physician Decision|1|||
156873267|NCT03843541|566293376|FG001|Overall Study|Physician Decision|2|||
156873268|NCT03843541|566293377|FG002|Overall Study|Physician Decision|2|||
156873269|NCT03843541|566293375|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
156873270|NCT03843541|566293376|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
156873271|NCT03843541|566293377|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
156873272|NCT03843541|566293375|FG000|Overall Study|Withdrawal by Subject|6|||
156873273|NCT03843541|566293376|FG001|Overall Study|Withdrawal by Subject|9|||
156873274|NCT03843541|566293377|FG002|Overall Study|Withdrawal by Subject|7|||
156873275|NCT03843541|566293375|FG000|Overall Study|Administration of rescue mucolytic|0|||
156873276|NCT03843541|566293376|FG001|Overall Study|Administration of rescue mucolytic|0|||
156873277|NCT03843541|566293377|FG002|Overall Study|Administration of rescue mucolytic|1|||
156873278|NCT03843541|566293375|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
156873279|NCT03843541|566293376|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
156873280|NCT03843541|566293377|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
156873281|NCT02930018|566293379|FG000|Overall Study|Lost to Follow-up|1|||
156873282|NCT02930018|566293380|FG001|Overall Study|Lost to Follow-up|1|||
156873283|NCT02930018|566293379|FG000|Overall Study|Withdrawal by Subject|5|||
156873284|NCT02930018|566293380|FG001|Overall Study|Withdrawal by Subject|2|||
156873285|NCT03493464|566293381|FG000|Overall Study|Surgery not performed|1|||
156873286|NCT02807402|566293382|FG000|Overall Study|Failure to Return|1|||
156873287|NCT02807402|566293382|FG000|Overall Study|Death|3|||
156873288|NCT02807402|566293382|FG000|Overall Study|Other|2|||
156873289|NCT01077050|566294303|FG000|Overall Study|Subjects signed ICF could not be located|1|||
156873290|NCT01077050|566294303|FG000|Overall Study|Screen failure|8|||
156873291|NCT02565784|566294307|FG000|First Treatment|Adverse Event|1|||
156873292|NCT02565784|566294307|FG000|First Treatment|Withdrawal by Subject|1|||
156873293|NCT02565784|566294307|FG000|Second Treatment|Withdrawal by Subject|2|||
156873294|NCT01193257|566294311|FG000|Overall Study|Death|202|||
156873295|NCT01193257|566294312|FG001|Overall Study|Death|391|||
156873296|NCT01193257|566294311|FG000|Overall Study|Study termination by sponsor|0|||
156873297|NCT01193257|566294312|FG001|Overall Study|Study termination by sponsor|3|||
156873298|NCT01193257|566294311|FG000|Overall Study|Withdrawal by Subject|26|||
156873299|NCT01193257|566294312|FG001|Overall Study|Withdrawal by Subject|86|||
156873300|NCT01193257|566294311|FG000|Overall Study|Lost to Follow-up|2|||
156873301|NCT01193257|566294312|FG001|Overall Study|Lost to Follow-up|3|||
156873302|NCT01193257|566294311|FG000|Overall Study|Unblinded due to futility|135|||
156873303|NCT01193257|566294312|FG001|Overall Study|Unblinded due to futility|251|||
156873304|NCT03126344|566294326|FG000|Overall Study|Lost to Follow-up|0|||
156873305|NCT03126344|566294327|FG001|Overall Study|Lost to Follow-up|0|||
156873306|NCT03126344|566294328|FG002|Overall Study|Lost to Follow-up|5|||
156873307|NCT01715857|566294329|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
156873308|NCT02563067|566294331|FG000|Overall Study|Subject/guardian decision|14|||
156709573|NCT02291510|565682324|FG002|Overall Study|Adverse Event|0|||
156709574|NCT02291510|565682325|FG003|Overall Study|Adverse Event|1|||
156709575|NCT02454608|565682326|FG000|Double-Blind Period|Lack of Efficacy|0|||
156873309|NCT02563067|566294332|FG001|Overall Study|Subject/guardian decision|20|||
156873310|NCT02563067|566294333|FG002|Overall Study|Subject/guardian decision|16|||
156709576|NCT02454608|565682327|FG001|Double-Blind Period|Lack of Efficacy|2|||
156709577|NCT02454608|565682328|FG002|Double-Blind Period|Lack of Efficacy|0|||
156709578|NCT02454608|565682326|FG000|Open Label Period|Lost to Follow-up|0|||
156709579|NCT02454608|565682327|FG001|Open Label Period|Lost to Follow-up|0|||
156709580|NCT02454608|565682328|FG002|Open Label Period|Lost to Follow-up|11|||
156873311|NCT02563067|566294331|FG000|Overall Study|Physician Decision|0|||
156873312|NCT02563067|566294332|FG001|Overall Study|Physician Decision|1|||
156873313|NCT02563067|566294333|FG002|Overall Study|Physician Decision|3|||
156873314|NCT02563067|566294331|FG000|Overall Study|Lost to Follow-up|1|||
156873315|NCT02563067|566294332|FG001|Overall Study|Lost to Follow-up|2|||
156873316|NCT02563067|566294333|FG002|Overall Study|Lost to Follow-up|0|||
156709581|NCT02454608|565682326|FG000|Open Label Period|Withdrawal by Subject|0|||
156709582|NCT02454608|565682327|FG001|Open Label Period|Withdrawal by Subject|0|||
156709583|NCT02454608|565682328|FG002|Open Label Period|Withdrawal by Subject|8|||
156709584|NCT02465398|565682329|FG000|Overall Study|Death|7|||
156709585|NCT02465398|565682329|FG000|Overall Study|Revision|7|||
156709586|NCT02465398|565682329|FG000|Overall Study|did not receive study device|1|||
156709587|NCT02465398|565682329|FG000|Overall Study|Withdrawal by Subject|1|||
156709588|NCT02465398|565682329|FG000|Overall Study|Lost to Follow-up|14|||
156709589|NCT02906358|565682330|FG000|Overall Study|Withdrawal by Subject|10|||
156709590|NCT02906358|565682331|FG001|Overall Study|Withdrawal by Subject|7|||
156709591|NCT02906358|565682330|FG000|Overall Study|Lost to Follow-up|12|||
156709592|NCT02906358|565682331|FG001|Overall Study|Lost to Follow-up|15|||
156709593|NCT02699684|565682332|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
156709594|NCT02699684|565682333|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
156709595|NCT02540850|565682336|FG000|Overall Study|Lost to Follow-up|69|||
156709596|NCT02540850|565682337|FG001|Overall Study|Lost to Follow-up|66|||
156709597|NCT02540850|565682338|FG002|Overall Study|Lost to Follow-up|34|||
156709598|NCT02111603|565682343|FG000|Overall Study|Withdrawal by Subject|1|||
156709599|NCT01582152|565682344|FG000|Overall Study|Disease Progression|4|||
156709600|NCT01582152|565682345|FG001|Overall Study|Disease Progression|5|||
156709601|NCT01582152|565682344|FG000|Overall Study|Adverse Event|2|||
156709602|NCT01582152|565682345|FG001|Overall Study|Adverse Event|1|||
156709603|NCT00230178|565682346|FG000|Overall Study|Adverse Event|1|||
156709604|NCT00230178|565682347|FG001|Overall Study|Adverse Event|5|||
156709605|NCT00230178|565682348|FG002|Overall Study|Adverse Event|2|||
156709606|NCT00230178|565682346|FG000|Overall Study|Withdrawal by Subject|0|||
156709607|NCT00230178|565682347|FG001|Overall Study|Withdrawal by Subject|0|||
156709608|NCT00230178|565682348|FG002|Overall Study|Withdrawal by Subject|1|||
156709609|NCT00230178|565682346|FG000|Overall Study|Various other reasons|3|||
156709610|NCT00230178|565682347|FG001|Overall Study|Various other reasons|2|||
156709611|NCT00230178|565682348|FG002|Overall Study|Various other reasons|4|||
156709612|NCT02252406|565682355|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
156709613|NCT02252406|565682356|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
156709614|NCT02252406|565682355|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
156709615|NCT02252406|565682356|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
156709616|NCT02252406|565682355|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
156709617|NCT02252406|565682356|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
156709618|NCT02252406|565682355|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
156709619|NCT02252406|565682356|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
156709620|NCT02252406|565682355|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
156709621|NCT02252406|565682356|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
156709622|NCT04974749|565682366|FG000|Overall Study|Withdrawal by Subject|2|||
156709623|NCT04974749|565682366|FG000|Overall Study|Gestation|1|||
156709624|NCT00362336|565682367|FG000|Overall Study|Serious Adverse Event|1|||
156709625|NCT00362336|565682368|FG001|Overall Study|Serious Adverse Event|0|||
156709626|NCT00362336|565682369|FG002|Overall Study|Serious Adverse Event|1|||
156709627|NCT00362336|565682367|FG000|Overall Study|Protocol Violation|0|||
156709628|NCT00362336|565682368|FG001|Overall Study|Protocol Violation|0|||
156709629|NCT00362336|565682369|FG002|Overall Study|Protocol Violation|1|||
156709630|NCT00362336|565682367|FG000|Overall Study|Lost to Follow-up|6|||
156709631|NCT00362336|565682368|FG001|Overall Study|Lost to Follow-up|4|||
156709632|NCT00362336|565682369|FG002|Overall Study|Lost to Follow-up|0|||
156709633|NCT00362336|565682367|FG000|Overall Study|Withdrawal by Subject|3|||
156709634|NCT00362336|565682368|FG001|Overall Study|Withdrawal by Subject|3|||
156709635|NCT00362336|565682369|FG002|Overall Study|Withdrawal by Subject|1|||
156709636|NCT04414618|565682370|FG000|Overall Study|Death|3|||
156709637|NCT04414618|565682371|FG001|Overall Study|Death|3|||
156709638|NCT04414618|565682370|FG000|Overall Study|Withdrawal by Subject|2|||
156709639|NCT04414618|565682371|FG001|Overall Study|Withdrawal by Subject|1|||
156709640|NCT04414618|565682370|FG000|Overall Study|Lost to Follow-up|2|||
156709641|NCT04414618|565682371|FG001|Overall Study|Lost to Follow-up|3|||
156709642|NCT04414618|565682370|FG000|Overall Study|Physician Decision|1|||
156709643|NCT04414618|565682371|FG001|Overall Study|Physician Decision|0|||
156709644|NCT01399658|565682372|FG000|Overall Study|Ineligible|1|||
156709645|NCT01399658|565682372|FG000|Overall Study|Machine Technical Issue|3|||
156709646|NCT01399658|565682372|FG000|Overall Study|Alternative therapy|1|||
156709647|NCT01399658|565682372|FG000|Overall Study|No reason given|1|||
156709648|NCT00796107|565682378|FG000|Overall Study|Lack of Efficacy|1|||
156709649|NCT00796107|565682378|FG000|Overall Study|Progressive Disease|5|||
156709650|NCT02681510|565682383|FG000|Overall Study|Withdrawal by Subject|1|||
156709651|NCT02681510|565682383|FG000|Overall Study|Lost to Follow-up|9|||
156709652|NCT03593395|565682397|FG000|Overall Study|Lost to Follow-up|48|||
156709653|NCT03593395|565682398|FG001|Overall Study|Lost to Follow-up|3|||
156709654|NCT03593395|565682397|FG000|Overall Study|Withdrawal by Subject|5|||
156709655|NCT03593395|565682398|FG001|Overall Study|Withdrawal by Subject|24|||
156709656|NCT03593395|565682397|FG000|Overall Study|Death|2|||
156709657|NCT03593395|565682398|FG001|Overall Study|Death|3|||
156873317|NCT02563067|566294331|FG000|Overall Study|Technical problems|0|||
156873318|NCT02563067|566294332|FG001|Overall Study|Technical problems|1|||
156873319|NCT02563067|566294333|FG002|Overall Study|Technical problems|0|||
156873320|NCT02563067|566294331|FG000|Overall Study|Lack of Efficacy|1|||
156873321|NCT02563067|566294332|FG001|Overall Study|Lack of Efficacy|0|||
156873322|NCT02563067|566294333|FG002|Overall Study|Lack of Efficacy|0|||
156873323|NCT02563067|566294331|FG000|Overall Study|Death|0|||
156873324|NCT02563067|566294332|FG001|Overall Study|Death|1|||
156873325|NCT02563067|566294333|FG002|Overall Study|Death|1|||
156873326|NCT02563067|566294331|FG000|Overall Study|Adverse Event|2|||
156873327|NCT02563067|566294332|FG001|Overall Study|Adverse Event|1|||
156873328|NCT02563067|566294333|FG002|Overall Study|Adverse Event|0|||
156873329|NCT02563067|566294331|FG000|Overall Study|Death post Treatment/safety period|1|||
156873330|NCT02563067|566294332|FG001|Overall Study|Death post Treatment/safety period|0|||
156873331|NCT02563067|566294333|FG002|Overall Study|Death post Treatment/safety period|0|||
156873332|NCT01039519|566294346|FG000|Treatment|Progressive disease|20|||
156873333|NCT01039519|566294346|FG000|Treatment|Treatment failure|2|||
156873334|NCT01039519|566294346|FG000|Treatment|Adverse Event|3|||
156873335|NCT01039519|566294346|FG000|Treatment|Physician Decision|2|||
156873336|NCT01039519|566294346|FG000|Survival Follow-up|Death|23|||
156873337|NCT01039519|566294346|FG000|Survival Follow-up|Sponsor decision|4|||
156873338|NCT01330108|566294347|FG000|Overall Study|Withdrawal by Subject|4|||
156873339|NCT00392769|566294350|FG000|Overall Study|Clinical Deterioration|9|||
156873340|NCT00392769|566294350|FG000|Overall Study|Adverse Event|1|||
156873341|NCT00439517|566294352|FG000|Overall Study|Subject on treatment|1|||
156873342|NCT00439517|566294353|FG001|Overall Study|Subject on treatment|0|||
156709658|NCT03593395|565682397|FG000|Overall Study|Physician Decision|0|||
156709659|NCT03593395|565682398|FG001|Overall Study|Physician Decision|6|||
156709660|NCT03593395|565682397|FG000|Overall Study|Participant Relocated|19|||
156709661|NCT03593395|565682398|FG001|Overall Study|Participant Relocated|3|||
156709662|NCT03593395|565682397|FG000|Overall Study|No Information|1|||
156709663|NCT03593395|565682398|FG001|Overall Study|No Information|7|||
156709664|NCT02806024|565682399|FG000|Overall Study|Night Delivery|1|||
156709665|NCT02806024|565682400|FG001|Overall Study|Night Delivery|1|||
156709666|NCT02806024|565682399|FG000|Overall Study|DVT during antepartum admission|0|||
156709667|NCT02806024|565682400|FG001|Overall Study|DVT during antepartum admission|1|||
156709668|NCT00626561|565682403|FG000|Overall Study|Withdrawal by Subject|2|||
156709669|NCT00626561|565682403|FG000|Overall Study|Disease Progression|2|||
156709670|NCT01372748|565682406|FG000|Overall Study|Lost to Follow-up|16|||
156709671|NCT01372748|565682407|FG001|Overall Study|Lost to Follow-up|34|||
156709672|NCT01372748|565682406|FG000|Overall Study|Withdrawal by Subject|7|||
156709673|NCT01372748|565682407|FG001|Overall Study|Withdrawal by Subject|5|||
156709674|NCT00134901|565682408|FG000|Overall Study|Lost to Follow-up|5|||
156709675|NCT00134901|565682409|FG001|Overall Study|Lost to Follow-up|5|||
156709676|NCT00134901|565682408|FG000|Overall Study|discontinued intervention|12|||
156709677|NCT00134901|565682409|FG001|Overall Study|discontinued intervention|10|||
156709678|NCT00606632|565682410|FG000|Overall Study|Withdrawal by Subject|13|||
156709679|NCT00606632|565682410|FG000|Overall Study|Miscellaneous reasons|9|||
156709680|NCT03908437|565682411|FG000|Overall Study|Death|0|||
156709681|NCT03908437|565682412|FG001|Overall Study|Death|1|||
156709682|NCT03908437|565682411|FG000|Overall Study|Lost to Follow-up|31|||
156709683|NCT03908437|565682412|FG001|Overall Study|Lost to Follow-up|24|||
156709684|NCT03633825|565682413|FG000|Enrollment|Did not post on network|5066|||
156709685|NCT03633825|565682414|FG001|Enrollment|Did not post on network|5080|||
156709686|NCT03633825|565682413|FG000|Enrollment|Post not classified as crisis|13967|||
156709687|NCT03633825|565682414|FG001|Enrollment|Post not classified as crisis|13757|||
156709688|NCT03633825|565682413|FG000|Follow up|Lost to Follow-up|478|||
156709689|NCT03633825|565682414|FG001|Follow up|Lost to Follow-up|450|||
156709690|NCT05246670|565682415|FG000|Overall Study|Withdrawal by Subject|2|||
156709691|NCT05246670|565682416|FG001|Overall Study|Withdrawal by Subject|3|||
156709692|NCT05246670|565682417|FG002|Overall Study|Withdrawal by Subject|0|||
156873343|NCT00439517|566294352|FG000|Overall Study|Subject in survival follow-up|1|||
156873344|NCT00439517|566294353|FG001|Overall Study|Subject in survival follow-up|0|||
156709693|NCT05246670|565682418|FG003|Overall Study|Withdrawal by Subject|1|||
156709694|NCT05246670|565682415|FG000|Overall Study|Adverse Event|0|||
156709695|NCT05246670|565682416|FG001|Overall Study|Adverse Event|0|||
156709696|NCT05246670|565682417|FG002|Overall Study|Adverse Event|1|||
156709697|NCT05246670|565682418|FG003|Overall Study|Adverse Event|0|||
156709698|NCT05246670|565682415|FG000|Overall Study|Physician Decision|1|||
156709699|NCT05246670|565682416|FG001|Overall Study|Physician Decision|0|||
156873345|NCT01262989|566294356|FG000|Period 1|Lost to Follow-up|1|||
156873346|NCT01262989|566294357|FG001|Period 1|Lost to Follow-up|1|||
156709700|NCT05246670|565682417|FG002|Overall Study|Physician Decision|0|||
156709701|NCT05246670|565682418|FG003|Overall Study|Physician Decision|0|||
156873347|NCT01262989|566294356|FG000|Period 1|Intercurrent disease|0|||
156873348|NCT01262989|566294357|FG001|Period 1|Intercurrent disease|1|||
156709702|NCT05246670|565682415|FG000|Overall Study|Protocol Violation|1|||
156873349|NCT01262989|566294356|FG000|Period 1|Positive answer for exclusion criteria|0|||
156873350|NCT01262989|566294357|FG001|Period 1|Positive answer for exclusion criteria|1|||
156709703|NCT05246670|565682416|FG001|Overall Study|Protocol Violation|0|||
156709704|NCT05246670|565682417|FG002|Overall Study|Protocol Violation|0|||
156709705|NCT05246670|565682418|FG003|Overall Study|Protocol Violation|0|||
156709706|NCT00356525|565682419|FG000|Overall Study|Progressive Disease|8|||
156709707|NCT00356525|565682420|FG001|Overall Study|Progressive Disease|5|||
156709708|NCT00356525|565682421|FG002|Overall Study|Progressive Disease|4|||
156709709|NCT00356525|565682422|FG003|Overall Study|Progressive Disease|2|||
156709710|NCT00356525|565682419|FG000|Overall Study|Adverse Event|1|||
156709711|NCT00356525|565682420|FG001|Overall Study|Adverse Event|3|||
156709712|NCT00356525|565682421|FG002|Overall Study|Adverse Event|1|||
156709713|NCT00356525|565682422|FG003|Overall Study|Adverse Event|1|||
156709714|NCT00356525|565682419|FG000|Overall Study|Lost to Follow-up|1|||
156709715|NCT00356525|565682420|FG001|Overall Study|Lost to Follow-up|0|||
156709716|NCT00356525|565682421|FG002|Overall Study|Lost to Follow-up|0|||
156709717|NCT00356525|565682422|FG003|Overall Study|Lost to Follow-up|0|||
156709718|NCT00356525|565682419|FG000|Overall Study|Physician Decision|2|||
156709719|NCT00356525|565682420|FG001|Overall Study|Physician Decision|2|||
156709720|NCT00356525|565682421|FG002|Overall Study|Physician Decision|2|||
156709721|NCT00356525|565682422|FG003|Overall Study|Physician Decision|1|||
156709722|NCT00356525|565682419|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
156709723|NCT00356525|565682420|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
156709724|NCT00356525|565682421|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
156709725|NCT00356525|565682422|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
156709726|NCT00356525|565682419|FG000|Overall Study|Withdrawal by Subject|1|||
156709727|NCT00356525|565682420|FG001|Overall Study|Withdrawal by Subject|1|||
156709728|NCT00356525|565682421|FG002|Overall Study|Withdrawal by Subject|0|||
156709729|NCT00356525|565682422|FG003|Overall Study|Withdrawal by Subject|3|||
156709730|NCT00356525|565682419|FG000|Overall Study|Death|0|||
156709731|NCT00356525|565682420|FG001|Overall Study|Death|0|||
156709732|NCT00356525|565682421|FG002|Overall Study|Death|0|||
156709733|NCT00356525|565682422|FG003|Overall Study|Death|1|||
156709734|NCT00356525|565682419|FG000|Overall Study|Sponsor Decision|0|||
156709735|NCT00356525|565682420|FG001|Overall Study|Sponsor Decision|0|||
156709736|NCT00356525|565682421|FG002|Overall Study|Sponsor Decision|0|||
156709737|NCT00356525|565682422|FG003|Overall Study|Sponsor Decision|1|||
156709738|NCT00652340|565682423|FG000|Overall Study|Had not progressed.|4|||
156709739|NCT00652340|565682424|FG001|Overall Study|Had not progressed.|3|||
156709740|NCT03682107|565682425|FG000|Overall Study|Withdrawal by Subject|0|||
156709741|NCT03682107|565682426|FG001|Overall Study|Withdrawal by Subject|1|||
156709742|NCT03682107|565682427|FG002|Overall Study|Withdrawal by Subject|0|||
156709743|NCT03682107|565682428|FG003|Overall Study|Withdrawal by Subject|0|||
156709744|NCT03682107|565682429|FG004|Overall Study|Withdrawal by Subject|0|||
156709745|NCT00214383|565682432|FG000|Overall Study|Lost to Follow-up|16|||
156709746|NCT00214383|565682433|FG001|Overall Study|Lost to Follow-up|26|||
156709747|NCT04152291|565682434|FG000|Overall Study|Covid-19 restrictions|27|||
156709748|NCT04152291|565682434|FG000|Overall Study|Withdrawal by Subject|3|||
156709749|NCT03597295|565682435|FG000|Overall Study|Death|70|||
156709750|NCT03597295|565682435|FG000|Overall Study|Lost to Follow-up|7|||
156709751|NCT00879411|565682436|FG000|Overall Study|lost to follow-up (non-AE)|162|||
156709752|NCT05124691|565682437|FG000|Phase II|Eligibility criteria|0|||
156709753|NCT05124691|565682438|FG001|Phase II|Eligibility criteria|1|||
156709754|NCT05124691|565682439|FG002|Phase II|Eligibility criteria|0|||
156709755|NCT05124691|565682437|FG000|Phase II|Withdrawal by Subject|6|||
156709756|NCT05124691|565682438|FG001|Phase II|Withdrawal by Subject|2|||
156709757|NCT05124691|565682439|FG002|Phase II|Withdrawal by Subject|3|||
156709758|NCT05124691|565682437|FG000|Phase III|Withdrawal by Subject|6|||
156709759|NCT05124691|565682438|FG001|Phase III|Withdrawal by Subject|4|||
156709760|NCT05124691|565682439|FG002|Phase III|Withdrawal by Subject|4|||
156709761|NCT05124691|565682437|FG000|Phase III|Lost to Follow-up|1|||
156709762|NCT05124691|565682438|FG001|Phase III|Lost to Follow-up|0|||
156709763|NCT05124691|565682439|FG002|Phase III|Lost to Follow-up|0|||
156709764|NCT01890434|565682440|FG000|Overall Study|Adverse Event|8|||
156709765|NCT01890434|565682440|FG000|Overall Study|PCI at external hospital|1|||
156709766|NCT01890434|565682440|FG000|Overall Study|Assessment discrepancy|1|||
156792101|NCT00289900|565991099|FG005|Overall Study|Adverse Event|33|||
156709767|NCT01890434|565682440|FG000|Overall Study|CRC didn't contact participant for FU|1|||
156709768|NCT01890434|565682440|FG000|Overall Study|Could not get whole set of images|1|||
156709769|NCT01890434|565682440|FG000|Overall Study|Decline to return for GSPECT|1|||
156792102|NCT00289900|565991094|FG000|Overall Study|Lost to Follow-up|7|||
156792103|NCT00289900|565991095|FG001|Overall Study|Lost to Follow-up|7|||
156709770|NCT01890434|565682440|FG000|Overall Study|GSPECT at rest was not done|1|||
156709771|NCT01890434|565682440|FG000|Overall Study|Participant didn't complete MRI|1|||
156709772|NCT01890434|565682440|FG000|Overall Study|Uncontactable by phone|1|||
156709773|NCT01890434|565682440|FG000|Overall Study|Moved out of position|1|||
156709774|NCT01890434|565682440|FG000|Overall Study|Unable to contact|1|||
156709775|NCT01890434|565682440|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
156709776|NCT00428116|565682441|FG000|Overall Study|Death|1|||
156709777|NCT00428116|565682442|FG001|Overall Study|Death|0|||
156709778|NCT00428116|565682441|FG000|Overall Study|Withdrawal by Subject|1|||
156709779|NCT00428116|565682442|FG001|Overall Study|Withdrawal by Subject|0|||
156709780|NCT00428116|565682441|FG000|Overall Study|Lost to Follow-up|1|||
156709781|NCT00428116|565682442|FG001|Overall Study|Lost to Follow-up|0|||
156709782|NCT01038297|565682443|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
156709783|NCT01038297|565682444|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
156709784|NCT01038297|565682445|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
156709793|NCT03837743|565682458|FG000|Overall Study|Adverse Event|1|||
156709794|NCT03837743|565682458|FG000|Overall Study|Withdrawal by Subject|2|||
156709795|NCT02257385|565682459|FG000|Overall Study|Adverse Event|12|||
156709796|NCT02257385|565682460|FG001|Overall Study|Adverse Event|8|||
156709797|NCT02257385|565682459|FG000|Overall Study|Lack of Efficacy|1|||
156709798|NCT02257385|565682460|FG001|Overall Study|Lack of Efficacy|2|||
156709799|NCT02257385|565682459|FG000|Overall Study|Protocol Violation|5|||
156709800|NCT02257385|565682460|FG001|Overall Study|Protocol Violation|7|||
156709801|NCT02257385|565682459|FG000|Overall Study|Lost to Follow-up|0|||
156709802|NCT02257385|565682460|FG001|Overall Study|Lost to Follow-up|1|||
156709803|NCT02257385|565682459|FG000|Overall Study|Withdrawal by Subject|4|||
156709804|NCT02257385|565682460|FG001|Overall Study|Withdrawal by Subject|4|||
156709805|NCT01449370|565682469|FG000|Overall Study|Disease Progression|5|||
156709806|NCT01449370|565682470|FG001|Overall Study|Disease Progression|4|||
156709807|NCT01449370|565682471|FG002|Overall Study|Disease Progression|8|||
156709808|NCT01449370|565682472|FG003|Overall Study|Disease Progression|3|||
156709809|NCT01449370|565682473|FG004|Overall Study|Disease Progression|3|||
156709810|NCT01449370|565682474|FG005|Overall Study|Disease Progression|3|||
156709811|NCT01449370|565682475|FG006|Overall Study|Disease Progression|3|||
156709812|NCT01449370|565682476|FG007|Overall Study|Disease Progression|2|||
156709813|NCT01449370|565682477|FG008|Overall Study|Disease Progression|9|||
156709814|NCT01449370|565682478|FG009|Overall Study|Disease Progression|1|||
156709815|NCT01449370|565682479|FG010|Overall Study|Disease Progression|3|||
156709816|NCT01449370|565682480|FG011|Overall Study|Disease Progression|3|||
156709817|NCT01449370|565682481|FG012|Overall Study|Disease Progression|2|||
156709818|NCT01449370|565682482|FG013|Overall Study|Disease Progression|8|||
156709819|NCT01449370|565682483|FG014|Overall Study|Disease Progression|3|||
156709820|NCT01449370|565682484|FG015|Overall Study|Disease Progression|1|||
156709821|NCT01449370|565682485|FG016|Overall Study|Disease Progression|4|||
156709822|NCT01449370|565682486|FG017|Overall Study|Disease Progression|3|||
156709823|NCT01449370|565682487|FG018|Overall Study|Disease Progression|1|||
156709824|NCT01449370|565682488|FG019|Overall Study|Disease Progression|2|||
156709825|NCT01449370|565682489|FG020|Overall Study|Disease Progression|5|||
156709826|NCT01449370|565682490|FG021|Overall Study|Disease Progression|2|||
156709827|NCT01449370|565682491|FG022|Overall Study|Disease Progression|3|||
156709828|NCT01449370|565682492|FG023|Overall Study|Disease Progression|7|||
156709829|NCT01449370|565682493|FG024|Overall Study|Disease Progression|3|||
156709830|NCT01449370|565682469|FG000|Overall Study|Adverse Event|1|||
156709831|NCT01449370|565682470|FG001|Overall Study|Adverse Event|2|||
156709832|NCT01449370|565682471|FG002|Overall Study|Adverse Event|0|||
156709833|NCT01449370|565682472|FG003|Overall Study|Adverse Event|1|||
156709834|NCT01449370|565682473|FG004|Overall Study|Adverse Event|0|||
156709835|NCT01449370|565682474|FG005|Overall Study|Adverse Event|0|||
156709836|NCT01449370|565682475|FG006|Overall Study|Adverse Event|0|||
156709837|NCT01449370|565682476|FG007|Overall Study|Adverse Event|0|||
156709838|NCT01449370|565682477|FG008|Overall Study|Adverse Event|1|||
156709839|NCT01449370|565682478|FG009|Overall Study|Adverse Event|1|||
156709840|NCT01449370|565682479|FG010|Overall Study|Adverse Event|0|||
156792104|NCT00289900|565991096|FG002|Overall Study|Lost to Follow-up|8|||
156792105|NCT00289900|565991097|FG003|Overall Study|Lost to Follow-up|8|||
156792106|NCT00289900|565991098|FG004|Overall Study|Lost to Follow-up|4|||
156792107|NCT00289900|565991099|FG005|Overall Study|Lost to Follow-up|8|||
156792108|NCT00289900|565991094|FG000|Overall Study|Participant had flushing|18|||
156709841|NCT01449370|565682480|FG011|Overall Study|Adverse Event|0|||
156709842|NCT01449370|565682481|FG012|Overall Study|Adverse Event|0|||
156709843|NCT01449370|565682482|FG013|Overall Study|Adverse Event|2|||
156709844|NCT01449370|565682483|FG014|Overall Study|Adverse Event|0|||
156709845|NCT01449370|565682484|FG015|Overall Study|Adverse Event|1|||
156709846|NCT01449370|565682485|FG016|Overall Study|Adverse Event|0|||
156792109|NCT00289900|565991095|FG001|Overall Study|Participant had flushing|42|||
156792110|NCT00289900|565991096|FG002|Overall Study|Participant had flushing|1|||
156792111|NCT00289900|565991097|FG003|Overall Study|Participant had flushing|2|||
156709847|NCT01449370|565682486|FG017|Overall Study|Adverse Event|0|||
156709848|NCT01449370|565682487|FG018|Overall Study|Adverse Event|1|||
156709849|NCT01449370|565682488|FG019|Overall Study|Adverse Event|1|||
156709850|NCT01449370|565682489|FG020|Overall Study|Adverse Event|0|||
156532095|NCT01284062|565043275|FG003|Overall Study|Medication error without adverse event|0|||
156709851|NCT01449370|565682490|FG021|Overall Study|Adverse Event|1|||
156709852|NCT01449370|565682491|FG022|Overall Study|Adverse Event|0|||
156709853|NCT01449370|565682492|FG023|Overall Study|Adverse Event|1|||
156709854|NCT01449370|565682493|FG024|Overall Study|Adverse Event|3|||
156709855|NCT01449370|565682469|FG000|Overall Study|Participant Decision|0|||
156709856|NCT01449370|565682470|FG001|Overall Study|Participant Decision|0|||
156709857|NCT01449370|565682471|FG002|Overall Study|Participant Decision|0|||
156709858|NCT01449370|565682472|FG003|Overall Study|Participant Decision|0|||
156709859|NCT01449370|565682473|FG004|Overall Study|Participant Decision|0|||
156709860|NCT01449370|565682474|FG005|Overall Study|Participant Decision|0|||
156709861|NCT01449370|565682475|FG006|Overall Study|Participant Decision|0|||
156709862|NCT01449370|565682476|FG007|Overall Study|Participant Decision|1|||
156709863|NCT01449370|565682477|FG008|Overall Study|Participant Decision|1|||
156709864|NCT01449370|565682478|FG009|Overall Study|Participant Decision|0|||
156709865|NCT01449370|565682479|FG010|Overall Study|Participant Decision|0|||
156709866|NCT01449370|565682480|FG011|Overall Study|Participant Decision|0|||
156709867|NCT01449370|565682481|FG012|Overall Study|Participant Decision|1|||
156709868|NCT01449370|565682482|FG013|Overall Study|Participant Decision|1|||
156709869|NCT01449370|565682483|FG014|Overall Study|Participant Decision|0|||
156709870|NCT01449370|565682484|FG015|Overall Study|Participant Decision|1|||
156709871|NCT01449370|565682485|FG016|Overall Study|Participant Decision|3|||
156709872|NCT01449370|565682486|FG017|Overall Study|Participant Decision|0|||
156792112|NCT00289900|565991098|FG004|Overall Study|Participant had flushing|0|||
156792113|NCT00289900|565991099|FG005|Overall Study|Participant had flushing|4|||
156792114|NCT00289900|565991094|FG000|Overall Study|Other|0|||
156792115|NCT00289900|565991095|FG001|Overall Study|Other|0|||
156792116|NCT00289900|565991096|FG002|Overall Study|Other|0|||
156792117|NCT00289900|565991097|FG003|Overall Study|Other|5|||
156792118|NCT00289900|565991098|FG004|Overall Study|Other|1|||
156792119|NCT00289900|565991099|FG005|Overall Study|Other|0|||
156792120|NCT00289900|565991094|FG000|Overall Study|Participant moved|1|||
156792121|NCT00289900|565991095|FG001|Overall Study|Participant moved|0|||
156792122|NCT00289900|565991096|FG002|Overall Study|Participant moved|0|||
156792123|NCT00289900|565991097|FG003|Overall Study|Participant moved|1|||
156792124|NCT00289900|565991098|FG004|Overall Study|Participant moved|1|||
156792125|NCT00289900|565991099|FG005|Overall Study|Participant moved|1|||
156792126|NCT00289900|565991094|FG000|Overall Study|Withdrawal by Subject|10|||
156792127|NCT00289900|565991095|FG001|Overall Study|Withdrawal by Subject|21|||
156792128|NCT00289900|565991096|FG002|Overall Study|Withdrawal by Subject|8|||
156792129|NCT00289900|565991097|FG003|Overall Study|Withdrawal by Subject|18|||
156792130|NCT00289900|565991098|FG004|Overall Study|Withdrawal by Subject|12|||
156792131|NCT00289900|565991099|FG005|Overall Study|Withdrawal by Subject|11|||
156792132|NCT00289900|565991094|FG000|Overall Study|Protocol Violation|3|||
156792133|NCT00289900|565991095|FG001|Overall Study|Protocol Violation|9|||
156792134|NCT00289900|565991096|FG002|Overall Study|Protocol Violation|2|||
156792135|NCT00289900|565991097|FG003|Overall Study|Protocol Violation|6|||
156792136|NCT00289900|565991098|FG004|Overall Study|Protocol Violation|7|||
156792137|NCT00289900|565991099|FG005|Overall Study|Protocol Violation|4|||
156792138|NCT00289900|565991094|FG000|Overall Study|site terminated|1|||
156792139|NCT00289900|565991095|FG001|Overall Study|site terminated|0|||
156792140|NCT00289900|565991096|FG002|Overall Study|site terminated|1|||
156792141|NCT00289900|565991097|FG003|Overall Study|site terminated|0|||
156792142|NCT00289900|565991098|FG004|Overall Study|site terminated|0|||
156792143|NCT00289900|565991099|FG005|Overall Study|site terminated|0|||
156792144|NCT00289900|565991094|FG000|Overall Study|Not treated|0|||
156792145|NCT00289900|565991095|FG001|Overall Study|Not treated|1|||
156792146|NCT00289900|565991096|FG002|Overall Study|Not treated|0|||
156792147|NCT00289900|565991097|FG003|Overall Study|Not treated|0|||
156792148|NCT00289900|565991098|FG004|Overall Study|Not treated|0|||
156792149|NCT00289900|565991099|FG005|Overall Study|Not treated|0|||
156792150|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
156792151|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
156792152|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
156792153|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
156792154|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
156792155|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
156792156|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
156792157|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156792158|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156709873|NCT01449370|565682487|FG018|Overall Study|Participant Decision|1|||
156709874|NCT01449370|565682488|FG019|Overall Study|Participant Decision|0|||
156709875|NCT01449370|565682489|FG020|Overall Study|Participant Decision|0|||
156709876|NCT01449370|565682490|FG021|Overall Study|Participant Decision|1|||
156709877|NCT01449370|565682491|FG022|Overall Study|Participant Decision|0|||
156709878|NCT01449370|565682492|FG023|Overall Study|Participant Decision|0|||
156792159|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
156792160|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
156709879|NCT01449370|565682493|FG024|Overall Study|Participant Decision|1|||
156709880|NCT01449370|565682469|FG000|Overall Study|Lost to Follow-up|0|||
156709881|NCT01449370|565682470|FG001|Overall Study|Lost to Follow-up|0|||
156709882|NCT01449370|565682471|FG002|Overall Study|Lost to Follow-up|0|||
156709883|NCT01449370|565682472|FG003|Overall Study|Lost to Follow-up|0|||
156709884|NCT01449370|565682473|FG004|Overall Study|Lost to Follow-up|0|||
156709885|NCT01449370|565682474|FG005|Overall Study|Lost to Follow-up|0|||
156709886|NCT01449370|565682475|FG006|Overall Study|Lost to Follow-up|0|||
156709887|NCT01449370|565682476|FG007|Overall Study|Lost to Follow-up|0|||
156709888|NCT01449370|565682477|FG008|Overall Study|Lost to Follow-up|0|||
156709889|NCT01449370|565682478|FG009|Overall Study|Lost to Follow-up|0|||
156709890|NCT01449370|565682479|FG010|Overall Study|Lost to Follow-up|0|||
156709891|NCT01449370|565682480|FG011|Overall Study|Lost to Follow-up|0|||
156709892|NCT01449370|565682481|FG012|Overall Study|Lost to Follow-up|0|||
156709893|NCT01449370|565682482|FG013|Overall Study|Lost to Follow-up|0|||
156792161|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
156792162|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156792163|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156792164|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
156792165|NCT01703221|565991100|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
156792166|NCT01703221|565991101|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
156792167|NCT01703221|565991102|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
156792168|NCT01703221|565991100|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
156792169|NCT01703221|565991101|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
156792170|NCT01703221|565991102|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
156792171|NCT01703221|565991100|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
156792172|NCT01703221|565991101|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
156792173|NCT01703221|565991102|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
156792174|NCT03927846|565991104|FG000|Overall Study|Lost to Follow-up|10|||
156792175|NCT03927846|565991105|FG001|Overall Study|Lost to Follow-up|11|||
156792176|NCT00992394|565991106|FG000|Overall Study|Lack of Efficacy|6|||
156792177|NCT00992394|565991107|FG001|Overall Study|Lack of Efficacy|3|||
156792178|NCT00992394|565991106|FG000|Overall Study|Adverse Event|4|||
156792179|NCT00992394|565991107|FG001|Overall Study|Adverse Event|5|||
156792180|NCT00992394|565991106|FG000|Overall Study|Withdrawal by Subject|8|||
156792181|NCT00992394|565991107|FG001|Overall Study|Withdrawal by Subject|2|||
156792182|NCT00992394|565991106|FG000|Overall Study|Physician Decision|1|||
156792183|NCT00992394|565991107|FG001|Overall Study|Physician Decision|0|||
156792184|NCT00992394|565991106|FG000|Overall Study|Protocol Violation|2|||
156792185|NCT00992394|565991107|FG001|Overall Study|Protocol Violation|4|||
156792186|NCT00992394|565991106|FG000|Overall Study|Lost to Follow-up|2|||
156792187|NCT00992394|565991107|FG001|Overall Study|Lost to Follow-up|0|||
156792188|NCT00992394|565991106|FG000|Overall Study|Other event|1|||
156792189|NCT00992394|565991107|FG001|Overall Study|Other event|0|||
156792190|NCT04280783|565992682|FG000|Overall Study|Family issues unrelated to the study.|1|||
156792191|NCT04280783|565992683|FG001|Overall Study|Family issues unrelated to the study.|0|||
156792192|NCT04280783|565992682|FG000|Overall Study|Withdrawal by Subject|0|||
156792193|NCT04280783|565992683|FG001|Overall Study|Withdrawal by Subject|1|||
156792194|NCT03443401|565992690|FG000|Overall Study|Lost to Follow-up|13|||
156792195|NCT03443401|565992690|FG000|Overall Study|Influential outlier|1|||
156792196|NCT02363283|565992691|FG000|Overall Study|Withdrawal by Subject|1|||
156792197|NCT02363283|565992691|FG000|Overall Study|Not eligible due to transaminitis|1|||
156792198|NCT01394185|565992692|FG000|Overall Study|Withdrawal by Subject|2|||
156792199|NCT01394185|565992693|FG001|Overall Study|Withdrawal by Subject|0|||
156792200|NCT01394185|565992694|FG002|Overall Study|Withdrawal by Subject|0|||
156792201|NCT01394185|565992695|FG003|Overall Study|Withdrawal by Subject|0|||
156792202|NCT01394185|565992696|FG004|Overall Study|Withdrawal by Subject|1|||
156792203|NCT01394185|565992697|FG005|Overall Study|Withdrawal by Subject|0|||
156792204|NCT01394185|565992692|FG000|Overall Study|Change in protocol|3|||
156792205|NCT01394185|565992693|FG001|Overall Study|Change in protocol|0|||
156792206|NCT01394185|565992694|FG002|Overall Study|Change in protocol|0|||
156792207|NCT01394185|565992695|FG003|Overall Study|Change in protocol|0|||
156792208|NCT01394185|565992696|FG004|Overall Study|Change in protocol|3|||
156792209|NCT01394185|565992697|FG005|Overall Study|Change in protocol|0|||
156792210|NCT01394185|565992692|FG000|Overall Study|Protocol Violation|1|||
156792211|NCT01394185|565992693|FG001|Overall Study|Protocol Violation|0|||
156792212|NCT01394185|565992694|FG002|Overall Study|Protocol Violation|0|||
156332771|NCT02913612|564317397|FG003|Overall Study|Physician Decision|0|||
156709894|NCT01449370|565682483|FG014|Overall Study|Lost to Follow-up|0|||
156709895|NCT01449370|565682484|FG015|Overall Study|Lost to Follow-up|0|||
156709896|NCT01449370|565682485|FG016|Overall Study|Lost to Follow-up|0|||
156709897|NCT01449370|565682486|FG017|Overall Study|Lost to Follow-up|0|||
156709898|NCT01449370|565682487|FG018|Overall Study|Lost to Follow-up|0|||
156792213|NCT01394185|565992695|FG003|Overall Study|Protocol Violation|1|||
156792214|NCT01394185|565992696|FG004|Overall Study|Protocol Violation|0|||
156792215|NCT01394185|565992697|FG005|Overall Study|Protocol Violation|1|||
156808760|NCT00620373|566054455|FG000|Overall Study|Unverified cancer status|33|||
156709899|NCT01449370|565682488|FG019|Overall Study|Lost to Follow-up|0|||
156709900|NCT01449370|565682489|FG020|Overall Study|Lost to Follow-up|1|||
156709901|NCT01449370|565682490|FG021|Overall Study|Lost to Follow-up|0|||
156709902|NCT01449370|565682491|FG022|Overall Study|Lost to Follow-up|0|||
156709903|NCT01449370|565682492|FG023|Overall Study|Lost to Follow-up|0|||
156709904|NCT01449370|565682493|FG024|Overall Study|Lost to Follow-up|0|||
156709905|NCT01449370|565682469|FG000|Overall Study|Other|0|||
156709906|NCT01449370|565682470|FG001|Overall Study|Other|0|||
156709907|NCT01449370|565682471|FG002|Overall Study|Other|0|||
156709908|NCT01449370|565682472|FG003|Overall Study|Other|0|||
156709909|NCT01449370|565682473|FG004|Overall Study|Other|0|||
156709910|NCT01449370|565682474|FG005|Overall Study|Other|0|||
156709911|NCT01449370|565682475|FG006|Overall Study|Other|0|||
156709912|NCT01449370|565682476|FG007|Overall Study|Other|0|||
156709913|NCT01449370|565682477|FG008|Overall Study|Other|1|||
156709914|NCT01449370|565682478|FG009|Overall Study|Other|1|||
156709915|NCT01449370|565682479|FG010|Overall Study|Other|0|||
156709916|NCT01449370|565682480|FG011|Overall Study|Other|0|||
156709917|NCT01449370|565682481|FG012|Overall Study|Other|0|||
156709918|NCT01449370|565682482|FG013|Overall Study|Other|0|||
156709919|NCT01449370|565682483|FG014|Overall Study|Other|0|||
156709920|NCT01449370|565682484|FG015|Overall Study|Other|0|||
156709921|NCT01449370|565682485|FG016|Overall Study|Other|0|||
156709922|NCT01449370|565682486|FG017|Overall Study|Other|0|||
156709923|NCT01449370|565682487|FG018|Overall Study|Other|0|||
156709924|NCT01449370|565682488|FG019|Overall Study|Other|0|||
156709925|NCT01449370|565682489|FG020|Overall Study|Other|0|||
156709926|NCT01449370|565682490|FG021|Overall Study|Other|0|||
156709927|NCT01449370|565682491|FG022|Overall Study|Other|1|||
156709928|NCT01449370|565682492|FG023|Overall Study|Other|1|||
156709929|NCT01449370|565682493|FG024|Overall Study|Other|0|||
156709930|NCT01449370|565682469|FG000|Overall Study|Medication Prohibited by Protocol|0|||
156709931|NCT01449370|565682470|FG001|Overall Study|Medication Prohibited by Protocol|0|||
156709932|NCT01449370|565682471|FG002|Overall Study|Medication Prohibited by Protocol|0|||
156709933|NCT01449370|565682472|FG003|Overall Study|Medication Prohibited by Protocol|0|||
156709934|NCT01449370|565682473|FG004|Overall Study|Medication Prohibited by Protocol|0|||
156709935|NCT01449370|565682474|FG005|Overall Study|Medication Prohibited by Protocol|0|||
156709936|NCT01449370|565682475|FG006|Overall Study|Medication Prohibited by Protocol|0|||
156709937|NCT01449370|565682476|FG007|Overall Study|Medication Prohibited by Protocol|0|||
156709938|NCT01449370|565682477|FG008|Overall Study|Medication Prohibited by Protocol|0|||
156709939|NCT01449370|565682478|FG009|Overall Study|Medication Prohibited by Protocol|0|||
156709940|NCT01449370|565682479|FG010|Overall Study|Medication Prohibited by Protocol|0|||
156709941|NCT01449370|565682480|FG011|Overall Study|Medication Prohibited by Protocol|0|||
156709942|NCT01449370|565682481|FG012|Overall Study|Medication Prohibited by Protocol|0|||
156709943|NCT01449370|565682482|FG013|Overall Study|Medication Prohibited by Protocol|0|||
156709944|NCT01449370|565682483|FG014|Overall Study|Medication Prohibited by Protocol|0|||
156709945|NCT01449370|565682484|FG015|Overall Study|Medication Prohibited by Protocol|0|||
156709946|NCT01449370|565682485|FG016|Overall Study|Medication Prohibited by Protocol|0|||
156709947|NCT01449370|565682486|FG017|Overall Study|Medication Prohibited by Protocol|0|||
156709948|NCT01449370|565682487|FG018|Overall Study|Medication Prohibited by Protocol|0|||
156709949|NCT01449370|565682488|FG019|Overall Study|Medication Prohibited by Protocol|0|||
156709950|NCT01449370|565682489|FG020|Overall Study|Medication Prohibited by Protocol|0|||
156709951|NCT01449370|565682490|FG021|Overall Study|Medication Prohibited by Protocol|0|||
156709952|NCT01449370|565682491|FG022|Overall Study|Medication Prohibited by Protocol|0|||
156709953|NCT01449370|565682492|FG023|Overall Study|Medication Prohibited by Protocol|1|||
156709954|NCT01449370|565682493|FG024|Overall Study|Medication Prohibited by Protocol|0|||
156709955|NCT01449370|565682469|FG000|Overall Study|Death|0|||
156709956|NCT01449370|565682470|FG001|Overall Study|Death|0|||
156709957|NCT01449370|565682471|FG002|Overall Study|Death|0|||
156332772|NCT02913612|564317394|FG000|Overall Study|Withdrawal by Subject|2|||
156332773|NCT02913612|564317395|FG001|Overall Study|Withdrawal by Subject|4|||
156332774|NCT02913612|564317396|FG002|Overall Study|Withdrawal by Subject|0|||
156332775|NCT02913612|564317397|FG003|Overall Study|Withdrawal by Subject|0|||
156332776|NCT02913612|564317394|FG000|Overall Study|Hemangioma resolved|1|||
156709958|NCT01449370|565682472|FG003|Overall Study|Death|0|||
156709959|NCT01449370|565682473|FG004|Overall Study|Death|0|||
156709960|NCT01449370|565682474|FG005|Overall Study|Death|0|||
156709961|NCT01449370|565682475|FG006|Overall Study|Death|0|||
156332777|NCT02913612|564317395|FG001|Overall Study|Hemangioma resolved|0|||
156709962|NCT01449370|565682476|FG007|Overall Study|Death|0|||
156709963|NCT01449370|565682477|FG008|Overall Study|Death|0|||
156709964|NCT01449370|565682478|FG009|Overall Study|Death|0|||
156709965|NCT01449370|565682479|FG010|Overall Study|Death|0|||
156709966|NCT01449370|565682480|FG011|Overall Study|Death|0|||
156709967|NCT01449370|565682481|FG012|Overall Study|Death|0|||
156709968|NCT01449370|565682482|FG013|Overall Study|Death|0|||
156709969|NCT01449370|565682483|FG014|Overall Study|Death|0|||
156709970|NCT01449370|565682484|FG015|Overall Study|Death|0|||
156709971|NCT01449370|565682485|FG016|Overall Study|Death|0|||
156709972|NCT01449370|565682486|FG017|Overall Study|Death|0|||
156709973|NCT01449370|565682487|FG018|Overall Study|Death|0|||
156709974|NCT01449370|565682488|FG019|Overall Study|Death|0|||
156709975|NCT01449370|565682489|FG020|Overall Study|Death|0|||
156709976|NCT01449370|565682490|FG021|Overall Study|Death|0|||
156709977|NCT01449370|565682491|FG022|Overall Study|Death|0|||
156709978|NCT01449370|565682492|FG023|Overall Study|Death|0|||
156709979|NCT01449370|565682493|FG024|Overall Study|Death|1|||
156709980|NCT00710866|565682494|FG000|Overall Study|Protocol Violation|5|||
156709981|NCT00710866|565682495|FG001|Overall Study|Protocol Violation|4|||
156709982|NCT00710866|565682494|FG000|Overall Study|Withdrawal by Subject|2|||
156709983|NCT00710866|565682495|FG001|Overall Study|Withdrawal by Subject|1|||
156709984|NCT00710866|565682494|FG000|Overall Study|Lost to Follow-up|1|||
156709985|NCT00710866|565682495|FG001|Overall Study|Lost to Follow-up|0|||
156873351|NCT01262989|566294356|FG000|Period 2|Intercurrent disease|0|||
156873352|NCT01262989|566294357|FG001|Period 2|Intercurrent disease|1|||
156873353|NCT00470275|566294358|FG000|Overall Study|Death|1|||
156442048|NCT00068601|564711035|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
156442049|NCT00068601|564711034|FG000|Overall Study|Death|11|||
156709986|NCT00710866|565682494|FG000|Overall Study|Failed to meet eligibility|1|||
156709987|NCT00710866|565682495|FG001|Overall Study|Failed to meet eligibility|1|||
156709988|NCT00246324|565682499|FG000|Overall Study|Withdrawal by Subject|1|||
156709989|NCT01383707|565684101|FG000|Overall Study|Consent withdrawal|6|||
156709990|NCT01383707|565684101|FG000|Overall Study|Death|19|||
156709991|NCT01383707|565684101|FG000|Overall Study|Other|8|||
156709992|NCT01383707|565684101|FG000|Overall Study|Sponsor's decision|2|||
156709993|NCT01383707|565684101|FG000|Overall Study|Adverse Event|14|||
156709994|NCT01383707|565684101|FG000|Overall Study|Progressive disease|23|||
156709995|NCT00799825|565684104|FG000|Overall Study|Adverse Event|1|||
156709996|NCT00799825|565684104|FG000|Overall Study|Withdrawal by Subject|6|||
156709997|NCT00799825|565684104|FG000|Overall Study|Lost to Follow-up|38|||
156709998|NCT00799825|565684104|FG000|Overall Study|Pregnancy|3|||
156709999|NCT01611857|565684105|FG000|Overall Study|Withdrawal by Subject|0|||
156710000|NCT01611857|565684106|FG001|Overall Study|Withdrawal by Subject|2|||
156710001|NCT02439970|565684107|FG000|Overall Study|Study Terminated|2|||
156710002|NCT02439970|565684108|FG001|Overall Study|Study Terminated|3|||
156710003|NCT00741338|565684111|FG000|Overall Study|Adverse Event|0|||
156710004|NCT00741338|565684112|FG001|Overall Study|Adverse Event|1|||
156710005|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
156710006|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
156710007|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
156710008|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
156710009|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
156710010|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
156710011|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
156710012|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
156710013|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156710014|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156710015|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156710016|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156710017|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156710018|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
156710019|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
156710020|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
156710021|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
156710022|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
156710023|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
156710024|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
156710025|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
156710026|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156710027|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
156710028|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156710029|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156710030|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
156710031|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
156710032|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
156710033|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
156710034|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
156710035|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
156710036|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
156710037|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
156710038|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
156710039|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
156710040|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
156710041|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
156710042|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
156710043|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
156710044|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
156710045|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
156873354|NCT00470275|566294358|FG000|Overall Study|Lack of Efficacy|7|||
156873355|NCT00470275|566294358|FG000|Overall Study|Withdrawal by Subject|2|||
156873356|NCT00459186|566294359|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
156873357|NCT00459186|566294359|FG000|PET Imaging and Assessment|Adverse Event|3|||
156873358|NCT03306173|566294361|FG000|Overall Study|Lost to Follow-up|16|||
156873359|NCT03306173|566294362|FG001|Overall Study|Lost to Follow-up|23|||
156873360|NCT03306173|566294361|FG000|Overall Study|Withdrawal by Subject|4|||
156873361|NCT03306173|566294362|FG001|Overall Study|Withdrawal by Subject|3|||
156873362|NCT03306173|566294361|FG000|Overall Study|Discontinued|4|||
156873363|NCT03306173|566294362|FG001|Overall Study|Discontinued|4|||
156873364|NCT00573144|566294363|FG000|Overall Study|Withdrawal by Subject|2|||
156873365|NCT00573144|566294364|FG001|Overall Study|Withdrawal by Subject|3|||
156710046|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
156710047|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
156710048|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
156710049|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
156710050|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
156710051|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
156710052|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
156710053|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
156710054|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
156710055|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
156710056|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
156710057|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
156710058|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
156710059|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
156710060|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
156710061|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
156710062|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
156710063|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
156710064|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
156710065|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
156710066|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
156710067|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
156710068|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
156710069|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
156710070|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Death|0|||
156710071|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Death|1|||
156710072|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Death|0|||
156710073|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Death|0|||
156710074|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Death|0|||
156710075|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156710076|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
156710077|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156710078|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156710079|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156710080|NCT02370238|565684124|FG000|Overall Study|Death|42|||
156710081|NCT02370238|565684125|FG001|Overall Study|Death|35|||
156710082|NCT02370238|565684124|FG000|Overall Study|Lost to Follow-up|1|||
156710083|NCT02370238|565684125|FG001|Overall Study|Lost to Follow-up|3|||
156710084|NCT02370238|565684124|FG000|Overall Study|Withdrawal by Subject|2|||
156710085|NCT02370238|565684125|FG001|Overall Study|Withdrawal by Subject|6|||
156710086|NCT02370238|565684124|FG000|Overall Study|Other|2|||
156710087|NCT02370238|565684125|FG001|Overall Study|Other|1|||
156710088|NCT01295320|565684126|FG000|Overall Study|Adverse Event|2|||
156710089|NCT01295320|565684126|FG000|Overall Study|Lost to Follow-up|4|||
156710090|NCT01295320|565684126|FG000|Overall Study|Withdrawal by Subject|2|||
156710091|NCT01295320|565684126|FG000|Overall Study|Subject was bedridden|1|||
156710092|NCT01295320|565684126|FG000|Overall Study|Unable to travel|1|||
156710093|NCT00462904|565684127|FG000|Overall Study|Lost to Follow-up|1|||
156710094|NCT02125877|565684128|FG000|Overall Study|Physician Decision|1|||
156710095|NCT02125877|565684129|FG001|Overall Study|Physician Decision|0|||
156710096|NCT02125877|565684128|FG000|Overall Study|Death|0|||
156710097|NCT02125877|565684129|FG001|Overall Study|Death|1|||
156710098|NCT02125877|565684128|FG000|Overall Study|Administrative problems|0|||
156873366|NCT00478023|566294368|FG000|Overall Study|Adverse Event|11|||
156873367|NCT00478023|566294369|FG001|Overall Study|Adverse Event|7|||
156710099|NCT02125877|565684129|FG001|Overall Study|Administrative problems|1|||
156710100|NCT02125877|565684128|FG000|Overall Study|Participant/guardian decision|0|||
156710101|NCT02125877|565684129|FG001|Overall Study|Participant/guardian decision|2|||
156710102|NCT02125877|565684128|FG000|Overall Study|Withdrawal by Subject|2|||
156710103|NCT02125877|565684129|FG001|Overall Study|Withdrawal by Subject|1|||
156710104|NCT02125877|565684128|FG000|Overall Study|Protocol deviation|4|||
156710105|NCT02125877|565684129|FG001|Overall Study|Protocol deviation|1|||
156710106|NCT02125877|565684128|FG000|Overall Study|Adverse Event|6|||
156710107|NCT02125877|565684129|FG001|Overall Study|Adverse Event|4|||
156710108|NCT01973595|565684130|FG000|Washout|Withdrawal by Subject|1|||
156710109|NCT01973595|565684131|FG001|Washout|Withdrawal by Subject|0|||
156710110|NCT01973595|565684132|FG002|Washout|Withdrawal by Subject|1|||
156710111|NCT01973595|565684133|FG003|Washout|Withdrawal by Subject|0|||
156710112|NCT01822366|565684134|FG000|Overall Study|Lost to Follow-up|5|||
156710113|NCT01822366|565684135|FG001|Overall Study|Lost to Follow-up|1|||
156710114|NCT01822366|565684136|FG002|Overall Study|Lost to Follow-up|5|||
156710115|NCT01822366|565684137|FG003|Overall Study|Lost to Follow-up|1|||
156710116|NCT01822366|565684134|FG000|Overall Study|Withdrawal by Subject|0|||
156710117|NCT01822366|565684135|FG001|Overall Study|Withdrawal by Subject|6|||
156710118|NCT01822366|565684136|FG002|Overall Study|Withdrawal by Subject|0|||
156710119|NCT01822366|565684137|FG003|Overall Study|Withdrawal by Subject|6|||
156710120|NCT01822366|565684134|FG000|Overall Study|Partial Intervention Completion|0|||
156710121|NCT01822366|565684135|FG001|Overall Study|Partial Intervention Completion|15|||
156710122|NCT01822366|565684136|FG002|Overall Study|Partial Intervention Completion|0|||
156710123|NCT01822366|565684137|FG003|Overall Study|Partial Intervention Completion|15|||
156710124|NCT05199090|565684138|FG000|Overall Study|Adverse Event|1|||
156710125|NCT05199090|565684139|FG001|Overall Study|Adverse Event|4|||
156710126|NCT05199090|565684140|FG002|Overall Study|Adverse Event|0|||
156710127|NCT05199090|565684141|FG003|Overall Study|Adverse Event|0|||
156710128|NCT05199090|565684142|FG004|Overall Study|Adverse Event|0|||
156710129|NCT05199090|565684143|FG005|Overall Study|Adverse Event|0|||
156710130|NCT05199090|565684138|FG000|Overall Study|Lost to Follow-up|1|||
156710131|NCT05199090|565684139|FG001|Overall Study|Lost to Follow-up|0|||
156710132|NCT05199090|565684140|FG002|Overall Study|Lost to Follow-up|1|||
156710133|NCT05199090|565684141|FG003|Overall Study|Lost to Follow-up|4|||
156710134|NCT05199090|565684142|FG004|Overall Study|Lost to Follow-up|0|||
156710135|NCT05199090|565684143|FG005|Overall Study|Lost to Follow-up|5|||
156710136|NCT05199090|565684138|FG000|Overall Study|Physician Decision|0|||
156710137|NCT05199090|565684139|FG001|Overall Study|Physician Decision|0|||
156710138|NCT05199090|565684140|FG002|Overall Study|Physician Decision|0|||
156710139|NCT05199090|565684141|FG003|Overall Study|Physician Decision|0|||
156710140|NCT05199090|565684142|FG004|Overall Study|Physician Decision|0|||
156710141|NCT05199090|565684143|FG005|Overall Study|Physician Decision|1|||
156710142|NCT05199090|565684138|FG000|Overall Study|Study terminated by sponsor|0|||
156710143|NCT05199090|565684139|FG001|Overall Study|Study terminated by sponsor|6|||
156710144|NCT05199090|565684140|FG002|Overall Study|Study terminated by sponsor|0|||
156710145|NCT05199090|565684141|FG003|Overall Study|Study terminated by sponsor|0|||
156710146|NCT05199090|565684142|FG004|Overall Study|Study terminated by sponsor|0|||
156710147|NCT05199090|565684143|FG005|Overall Study|Study terminated by sponsor|5|||
156710148|NCT05199090|565684138|FG000|Overall Study|Subject decision|0|||
156710149|NCT05199090|565684139|FG001|Overall Study|Subject decision|4|||
156710150|NCT05199090|565684140|FG002|Overall Study|Subject decision|0|||
156710151|NCT05199090|565684141|FG003|Overall Study|Subject decision|2|||
156710152|NCT05199090|565684142|FG004|Overall Study|Subject decision|5|||
156710153|NCT05199090|565684143|FG005|Overall Study|Subject decision|2|||
156710154|NCT03489109|565684144|FG000|Overall Study|Lost to Follow-up|1|||
156710155|NCT03489109|565684145|FG001|Overall Study|Lost to Follow-up|2|||
156710156|NCT04868968|565684146|FG000|Overall Study|Lost to Follow-up|1|||
156710157|NCT00384930|565684149|FG000|Overall Study|Adverse Event|5|||
156710158|NCT00384930|565684150|FG001|Overall Study|Adverse Event|4|||
156710159|NCT00384930|565684151|FG002|Overall Study|Adverse Event|12|||
156710160|NCT00384930|565684152|FG003|Overall Study|Adverse Event|11|||
156710161|NCT00384930|565684153|FG004|Overall Study|Adverse Event|14|||
156710162|NCT00384930|565684149|FG000|Overall Study|Entry Criteria Not Met|2|||
156792216|NCT04110145|565992698|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
156792217|NCT04110145|565992699|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
156792218|NCT04110145|565992700|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
156332778|NCT02913612|564317396|FG002|Overall Study|Hemangioma resolved|0|||
156710163|NCT00384930|565684150|FG001|Overall Study|Entry Criteria Not Met|6|||
156710164|NCT00384930|565684151|FG002|Overall Study|Entry Criteria Not Met|7|||
156710165|NCT00384930|565684152|FG003|Overall Study|Entry Criteria Not Met|8|||
156710166|NCT00384930|565684153|FG004|Overall Study|Entry Criteria Not Met|4|||
156710167|NCT00384930|565684149|FG000|Overall Study|Lack of Efficacy|1|||
156710168|NCT00384930|565684150|FG001|Overall Study|Lack of Efficacy|1|||
156710169|NCT00384930|565684151|FG002|Overall Study|Lack of Efficacy|2|||
156710170|NCT00384930|565684152|FG003|Overall Study|Lack of Efficacy|1|||
156710171|NCT00384930|565684153|FG004|Overall Study|Lack of Efficacy|2|||
156710172|NCT00384930|565684149|FG000|Overall Study|Lost to Follow-up|5|||
156710173|NCT00384930|565684150|FG001|Overall Study|Lost to Follow-up|3|||
156332779|NCT02913612|564317397|FG003|Overall Study|Hemangioma resolved|0|||
156710174|NCT00384930|565684151|FG002|Overall Study|Lost to Follow-up|0|||
156710175|NCT00384930|565684152|FG003|Overall Study|Lost to Follow-up|4|||
156710176|NCT00384930|565684153|FG004|Overall Study|Lost to Follow-up|6|||
156710177|NCT00384930|565684149|FG000|Overall Study|Physician Decision|0|||
156710178|NCT00384930|565684150|FG001|Overall Study|Physician Decision|1|||
156710179|NCT00384930|565684151|FG002|Overall Study|Physician Decision|1|||
156710180|NCT00384930|565684152|FG003|Overall Study|Physician Decision|0|||
156710181|NCT00384930|565684153|FG004|Overall Study|Physician Decision|1|||
156710182|NCT00384930|565684149|FG000|Overall Study|Protocol Violation|1|||
156710183|NCT00384930|565684150|FG001|Overall Study|Protocol Violation|0|||
156710184|NCT00384930|565684151|FG002|Overall Study|Protocol Violation|1|||
156710185|NCT00384930|565684152|FG003|Overall Study|Protocol Violation|6|||
156710186|NCT00384930|565684153|FG004|Overall Study|Protocol Violation|4|||
156710187|NCT00384930|565684149|FG000|Overall Study|Sponsor Decision|3|||
156710188|NCT00384930|565684150|FG001|Overall Study|Sponsor Decision|4|||
156710189|NCT00384930|565684151|FG002|Overall Study|Sponsor Decision|0|||
156710190|NCT00384930|565684152|FG003|Overall Study|Sponsor Decision|5|||
156710191|NCT00384930|565684153|FG004|Overall Study|Sponsor Decision|0|||
156710192|NCT00384930|565684149|FG000|Overall Study|Withdrawal by Subject|9|||
156710193|NCT00384930|565684150|FG001|Overall Study|Withdrawal by Subject|7|||
156710194|NCT00384930|565684151|FG002|Overall Study|Withdrawal by Subject|7|||
156710195|NCT00384930|565684152|FG003|Overall Study|Withdrawal by Subject|6|||
156710196|NCT00384930|565684153|FG004|Overall Study|Withdrawal by Subject|16|||
156710197|NCT00384930|565684149|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
156710198|NCT00384930|565684150|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
156710199|NCT00384930|565684151|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
156710200|NCT00384930|565684152|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
156710201|NCT00384930|565684153|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
156710202|NCT02552732|565684156|FG000|Overall Study|Lost to Follow-up|2|||
156710203|NCT02552732|565684156|FG000|Overall Study|Physician Decision|1|||
156710204|NCT02552732|565684156|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
156710205|NCT02552732|565684156|FG000|Overall Study|Withdrawal by Subject|6|||
156710206|NCT01547130|565684159|FG000|Overall Study|Lost to Follow-up|9|||
156710207|NCT01547130|565684160|FG001|Overall Study|Lost to Follow-up|5|||
156710208|NCT00025259|565684162|FG000|Overall Study|Death|1|||
156710209|NCT00025259|565684163|FG001|Overall Study|Death|3|||
156710210|NCT00025259|565684164|FG002|Overall Study|Death|0|||
156710211|NCT00025259|565684165|FG003|Overall Study|Death|3|||
156710212|NCT00025259|565684166|FG004|Overall Study|Death|0|||
156710213|NCT00025259|565684167|FG005|Overall Study|Death|1|||
156710214|NCT00025259|565684168|FG006|Overall Study|Death|2|||
156710215|NCT00025259|565684162|FG000|Overall Study|Lack of Efficacy|2|||
156710216|NCT00025259|565684163|FG001|Overall Study|Lack of Efficacy|46|||
156710217|NCT00025259|565684164|FG002|Overall Study|Lack of Efficacy|60|||
156710218|NCT00025259|565684165|FG003|Overall Study|Lack of Efficacy|78|||
156710219|NCT00025259|565684166|FG004|Overall Study|Lack of Efficacy|11|||
156710220|NCT00025259|565684167|FG005|Overall Study|Lack of Efficacy|30|||
156710221|NCT00025259|565684168|FG006|Overall Study|Lack of Efficacy|38|||
156710222|NCT00025259|565684162|FG000|Overall Study|Lost to Follow-up|2|||
156710223|NCT00025259|565684163|FG001|Overall Study|Lost to Follow-up|9|||
156332780|NCT02913612|564317394|FG000|Overall Study|Local IRB decision|1|||
156332781|NCT02913612|564317395|FG001|Overall Study|Local IRB decision|0|||
156710224|NCT00025259|565684164|FG002|Overall Study|Lost to Follow-up|13|||
156710225|NCT00025259|565684165|FG003|Overall Study|Lost to Follow-up|13|||
156710226|NCT00025259|565684166|FG004|Overall Study|Lost to Follow-up|1|||
156710227|NCT00025259|565684167|FG005|Overall Study|Lost to Follow-up|3|||
156710228|NCT00025259|565684168|FG006|Overall Study|Lost to Follow-up|1|||
156710229|NCT00025259|565684162|FG000|Overall Study|Physician Decision|12|||
156710230|NCT00025259|565684163|FG001|Overall Study|Physician Decision|1|||
156710231|NCT00025259|565684164|FG002|Overall Study|Physician Decision|0|||
156710232|NCT00025259|565684165|FG003|Overall Study|Physician Decision|5|||
156710233|NCT00025259|565684166|FG004|Overall Study|Physician Decision|4|||
156710234|NCT00025259|565684167|FG005|Overall Study|Physician Decision|2|||
156710235|NCT00025259|565684168|FG006|Overall Study|Physician Decision|1|||
156710236|NCT00025259|565684162|FG000|Overall Study|Protocol Violation|3|||
156710237|NCT00025259|565684163|FG001|Overall Study|Protocol Violation|2|||
156332782|NCT02913612|564317396|FG002|Overall Study|Local IRB decision|0|||
156710238|NCT00025259|565684164|FG002|Overall Study|Protocol Violation|2|||
156710239|NCT00025259|565684165|FG003|Overall Study|Protocol Violation|1|||
156710240|NCT00025259|565684166|FG004|Overall Study|Protocol Violation|2|||
156710241|NCT00025259|565684167|FG005|Overall Study|Protocol Violation|1|||
156710242|NCT00025259|565684168|FG006|Overall Study|Protocol Violation|3|||
156710243|NCT00025259|565684162|FG000|Overall Study|Withdrawal by Subject|9|||
156710244|NCT00025259|565684163|FG001|Overall Study|Withdrawal by Subject|27|||
156710245|NCT00025259|565684164|FG002|Overall Study|Withdrawal by Subject|6|||
156710246|NCT00025259|565684165|FG003|Overall Study|Withdrawal by Subject|14|||
156710247|NCT00025259|565684166|FG004|Overall Study|Withdrawal by Subject|11|||
156710248|NCT00025259|565684167|FG005|Overall Study|Withdrawal by Subject|8|||
156873368|NCT00478023|566294370|FG002|Overall Study|Adverse Event|8|||
156873369|NCT00478023|566294371|FG003|Overall Study|Adverse Event|14|||
156873370|NCT00478023|566294372|FG004|Overall Study|Adverse Event|6|||
156873371|NCT00478023|566294368|FG000|Overall Study|Death|1|||
156873372|NCT00478023|566294369|FG001|Overall Study|Death|0|||
156873373|NCT00478023|566294370|FG002|Overall Study|Death|0|||
156873374|NCT00478023|566294371|FG003|Overall Study|Death|0|||
156873375|NCT00478023|566294372|FG004|Overall Study|Death|0|||
156873376|NCT00478023|566294368|FG000|Overall Study|Lack of Efficacy|11|||
156873377|NCT00478023|566294369|FG001|Overall Study|Lack of Efficacy|10|||
156873378|NCT00478023|566294370|FG002|Overall Study|Lack of Efficacy|4|||
156873379|NCT00478023|566294371|FG003|Overall Study|Lack of Efficacy|5|||
156873380|NCT00478023|566294372|FG004|Overall Study|Lack of Efficacy|41|||
156873381|NCT00478023|566294368|FG000|Overall Study|Lost to Follow-up|3|||
156873382|NCT00478023|566294369|FG001|Overall Study|Lost to Follow-up|1|||
156873383|NCT00478023|566294370|FG002|Overall Study|Lost to Follow-up|1|||
156873384|NCT00478023|566294371|FG003|Overall Study|Lost to Follow-up|1|||
156873385|NCT00478023|566294372|FG004|Overall Study|Lost to Follow-up|0|||
156442050|NCT00068601|564711035|FG001|Overall Study|Death|3|||
156442051|NCT00068601|564711034|FG000|Overall Study|Lost to Follow-up|3|||
156442052|NCT00068601|564711035|FG001|Overall Study|Lost to Follow-up|2|||
156442053|NCT00068601|564711034|FG000|Overall Study|Missing primary outcome data|30|||
156442054|NCT00068601|564711035|FG001|Overall Study|Missing primary outcome data|34|||
156442055|NCT01061671|564711036|FG000|Overall Study|Withdrawal by Subject|16|||
156710249|NCT00025259|565684168|FG006|Overall Study|Withdrawal by Subject|3|||
156873386|NCT00478023|566294368|FG000|Overall Study|Withdrawal by Subject|2|||
156873387|NCT00478023|566294369|FG001|Overall Study|Withdrawal by Subject|3|||
156873388|NCT00478023|566294370|FG002|Overall Study|Withdrawal by Subject|2|||
156873389|NCT00478023|566294371|FG003|Overall Study|Withdrawal by Subject|4|||
156873390|NCT00478023|566294372|FG004|Overall Study|Withdrawal by Subject|5|||
156873391|NCT00478023|566294368|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
156873392|NCT00478023|566294369|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
156873393|NCT00478023|566294370|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
156873394|NCT00478023|566294371|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
156873395|NCT00478023|566294372|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
156873396|NCT03895840|566294373|FG000|Overall Study|Withdrawal by Subject|21|||
156873397|NCT02395081|566294374|FG000|Overall Study|Withdrawal by Subject|1|||
156873398|NCT02395081|566294375|FG001|Overall Study|Withdrawal by Subject|1|||
156873399|NCT02395081|566294376|FG002|Overall Study|Withdrawal by Subject|0|||
156873400|NCT02395081|566294374|FG000|Overall Study|Moved where blood couldn't be collected|4|||
156873401|NCT02395081|566294375|FG001|Overall Study|Moved where blood couldn't be collected|1|||
156873402|NCT02395081|566294376|FG002|Overall Study|Moved where blood couldn't be collected|3|||
156873403|NCT02395081|566294374|FG000|Overall Study|Fetal Loss|2|||
156873404|NCT02395081|566294375|FG001|Overall Study|Fetal Loss|3|||
156873405|NCT02395081|566294376|FG002|Overall Study|Fetal Loss|1|||
156710250|NCT00025259|565684162|FG000|Overall Study|Ineligible|14|||
156710251|NCT00025259|565684163|FG001|Overall Study|Ineligible|1|||
156710252|NCT00025259|565684164|FG002|Overall Study|Ineligible|0|||
156710253|NCT00025259|565684165|FG003|Overall Study|Ineligible|0|||
156710254|NCT00025259|565684166|FG004|Overall Study|Ineligible|6|||
156710255|NCT00025259|565684167|FG005|Overall Study|Ineligible|0|||
156710256|NCT00025259|565684168|FG006|Overall Study|Ineligible|1|||
156710257|NCT00025259|565684162|FG000|Overall Study|Randomization error|1|||
156873406|NCT00068419|566294377|FG000|Overall Study|Adverse Event|3|||
156873407|NCT00068419|566294377|FG000|Overall Study|Lack of Efficacy|24|||
156873408|NCT00068419|566294377|FG000|Overall Study|Lost to Follow-up|1|||
156873409|NCT00068419|566294377|FG000|Overall Study|Physician Decision|7|||
156873410|NCT00068419|566294377|FG000|Overall Study|Withdrawal by Subject|14|||
156873411|NCT00068419|566294377|FG000|Overall Study|Ineligible|11|||
156710258|NCT00025259|565684163|FG001|Overall Study|Randomization error|0|||
156873412|NCT00630838|566294389|FG000|Overall Study|Death|0|||
156873413|NCT00630838|566294390|FG001|Overall Study|Death|1|||
156873414|NCT00630838|566294389|FG000|Overall Study|Lost to Follow-up|0|||
156873415|NCT00630838|566294390|FG001|Overall Study|Lost to Follow-up|1|||
156873416|NCT00928408|566294391|FG000|Overall Study|Other|2|||
156873417|NCT00928408|566294391|FG000|Overall Study|Withdrawal by Subject|4|||
156873418|NCT00928408|566294391|FG000|Overall Study|Death|5|||
156442056|NCT01061671|564711037|FG001|Overall Study|Withdrawal by Subject|20|||
156710259|NCT00025259|565684164|FG002|Overall Study|Randomization error|0|||
156710260|NCT00025259|565684165|FG003|Overall Study|Randomization error|0|||
156710261|NCT00025259|565684166|FG004|Overall Study|Randomization error|1|||
156710262|NCT00025259|565684167|FG005|Overall Study|Randomization error|7|||
156873419|NCT00928408|566294391|FG000|Overall Study|Lost to Follow-up|12|||
156873420|NCT00256997|566294396|FG000|Overall Study|Protocol Violation|1|||
156873421|NCT00256997|566294397|FG001|Overall Study|Protocol Violation|4|||
156442057|NCT01061671|564711036|FG000|Overall Study|Lost to Follow-up|3|||
156710263|NCT00025259|565684168|FG006|Overall Study|Randomization error|2|||
156873422|NCT00256997|566294396|FG000|Overall Study|Lack of Efficacy|1|||
156873423|NCT00256997|566294397|FG001|Overall Study|Lack of Efficacy|4|||
156873424|NCT00256997|566294396|FG000|Overall Study|Death|2|||
156710264|NCT00025259|565684162|FG000|Overall Study|Adverse Event|1|||
156710265|NCT00025259|565684163|FG001|Overall Study|Adverse Event|0|||
156792219|NCT04110145|565992701|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
156792220|NCT04110145|565992702|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
156792221|NCT02371889|565992703|FG000|Overall Study|Adverse medication effect|11|||
156792222|NCT02371889|565992704|FG001|Overall Study|Adverse medication effect|2|||
156792223|NCT02371889|565992703|FG000|Overall Study|Lost to Follow-up|6|||
156792224|NCT02371889|565992704|FG001|Overall Study|Lost to Follow-up|5|||
156792225|NCT02371889|565992703|FG000|Overall Study|Personal time constraints|2|||
156792226|NCT02371889|565992704|FG001|Overall Study|Personal time constraints|4|||
156792227|NCT02371889|565992703|FG000|Overall Study|Lack of Efficacy|0|||
156792228|NCT02371889|565992704|FG001|Overall Study|Lack of Efficacy|2|||
156792229|NCT02371889|565992703|FG000|Overall Study|Relapse|0|||
156792230|NCT02371889|565992704|FG001|Overall Study|Relapse|1|||
156792231|NCT05520333|565992705|FG000|Overall Study|Lost to Follow-up|3|||
156792232|NCT05520333|565992706|FG001|Overall Study|Lost to Follow-up|6|||
156792233|NCT05538728|565992707|FG000|Overall Study|Withdrawal by Subject|1|||
156792234|NCT05538728|565992708|FG001|Overall Study|Withdrawal by Subject|1|||
156442058|NCT01061671|564711037|FG001|Overall Study|Lost to Follow-up|5|||
156442059|NCT01061671|564711036|FG000|Overall Study|Death|28|||
156442060|NCT01061671|564711037|FG001|Overall Study|Death|30|||
156442061|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
156442062|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
156442063|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
156442064|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
156442065|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
156442066|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
156442067|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
156442068|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
156442069|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
156442070|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
156442071|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
156442072|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
156442073|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
156442074|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
156442075|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
156442076|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
156442077|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
156442078|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
156442079|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
156442080|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
156442081|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
156710266|NCT00025259|565684164|FG002|Overall Study|Adverse Event|0|||
156710267|NCT00025259|565684165|FG003|Overall Study|Adverse Event|0|||
156710268|NCT00025259|565684166|FG004|Overall Study|Adverse Event|0|||
156710269|NCT00025259|565684167|FG005|Overall Study|Adverse Event|0|||
156710270|NCT00025259|565684168|FG006|Overall Study|Adverse Event|0|||
156710271|NCT01685840|565684169|FG000|Overall Study|Death|77|||
156710272|NCT01685840|565684170|FG001|Overall Study|Death|66|||
156710273|NCT01685840|565684169|FG000|Overall Study|Lost to Follow-up|27|||
156710274|NCT01685840|565684170|FG001|Overall Study|Lost to Follow-up|25|||
156710275|NCT01685840|565684169|FG000|Overall Study|Physician Decision|3|||
156710276|NCT01685840|565684170|FG001|Overall Study|Physician Decision|7|||
156710277|NCT01685840|565684169|FG000|Overall Study|Withdrawal by Subject|14|||
156710278|NCT01685840|565684170|FG001|Overall Study|Withdrawal by Subject|17|||
156710279|NCT01685840|565684169|FG000|Overall Study|Futility|197|||
156710280|NCT01685840|565684170|FG001|Overall Study|Futility|200|||
156710281|NCT01685840|565684169|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
156710282|NCT01685840|565684170|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
156710283|NCT01004003|565684172|FG000|Overall Study|Progressive disease|2|||
156710284|NCT01004003|565684173|FG001|Overall Study|Progressive disease|1|||
156710285|NCT01004003|565684174|FG002|Overall Study|Progressive disease|1|||
156710286|NCT01004003|565684175|FG003|Overall Study|Progressive disease|0|||
156710287|NCT01004003|565684176|FG004|Overall Study|Progressive disease|2|||
156710288|NCT01004003|565684177|FG005|Overall Study|Progressive disease|1|||
156710289|NCT01004003|565684178|FG006|Overall Study|Progressive disease|1|||
156710290|NCT01004003|565684179|FG007|Overall Study|Progressive disease|39|||
156710291|NCT01004003|565684180|FG008|Overall Study|Progressive disease|22|||
156710292|NCT01004003|565684172|FG000|Overall Study|Adverse Event|4|||
156792235|NCT02254460|565992709|FG000|Overall Study|Adverse Event|1|||
156792236|NCT02254460|565992710|FG001|Overall Study|Adverse Event|0|||
156710293|NCT01004003|565684173|FG001|Overall Study|Adverse Event|2|||
156710294|NCT01004003|565684174|FG002|Overall Study|Adverse Event|3|||
156792237|NCT02336555|565992711|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156873425|NCT00256997|566294397|FG001|Overall Study|Death|0|||
156442082|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
156442083|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
156442084|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
156442085|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
156442086|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
156442087|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
156710295|NCT01004003|565684175|FG003|Overall Study|Adverse Event|3|||
156710296|NCT01004003|565684176|FG004|Overall Study|Adverse Event|2|||
156873426|NCT00256997|566294396|FG000|Overall Study|Adverse Event|4|||
156873427|NCT00256997|566294397|FG001|Overall Study|Adverse Event|0|||
156873428|NCT00256997|566294396|FG000|Overall Study|Lost to Follow-up|3|||
156873429|NCT00256997|566294397|FG001|Overall Study|Lost to Follow-up|5|||
156873430|NCT00256997|566294396|FG000|Overall Study|Withdrawal by Subject|13|||
156873431|NCT00256997|566294397|FG001|Overall Study|Withdrawal by Subject|3|||
156873432|NCT00256997|566294396|FG000|Overall Study|Started but not treated|2|||
156873433|NCT00256997|566294397|FG001|Overall Study|Started but not treated|0|||
156873434|NCT00256997|566294396|FG000|Overall Study|Other|5|||
156873435|NCT00256997|566294397|FG001|Overall Study|Other|8|||
156873436|NCT00256997|566294396|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
156873437|NCT00256997|566294397|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
156873438|NCT00256997|566294396|FG000|Overall Study|Participant Non-compliant|3|||
156873439|NCT00256997|566294397|FG001|Overall Study|Participant Non-compliant|6|||
156873440|NCT00256997|566294396|FG000|Overall Study|Investigator Withdrew Participant|2|||
156873441|NCT00256997|566294397|FG001|Overall Study|Investigator Withdrew Participant|1|||
156873442|NCT01287741|566294400|FG000|Overall Study|Withdrawal by Subject|35|||
156873443|NCT01287741|566294401|FG001|Overall Study|Withdrawal by Subject|38|||
156873444|NCT01287741|566294400|FG000|Overall Study|Protocol Violation|2|||
156873445|NCT01287741|566294401|FG001|Overall Study|Protocol Violation|0|||
156873446|NCT01287741|566294400|FG000|Overall Study|Physician Decision|15|||
156873447|NCT01287741|566294401|FG001|Overall Study|Physician Decision|23|||
156873448|NCT01287741|566294400|FG000|Overall Study|Non-compliance|8|||
156873449|NCT01287741|566294401|FG001|Overall Study|Non-compliance|6|||
156873450|NCT01287741|566294400|FG000|Overall Study|Lost to Follow-up|10|||
156873451|NCT01287741|566294401|FG001|Overall Study|Lost to Follow-up|8|||
156873452|NCT01287741|566294400|FG000|Overall Study|Death|32|||
156873453|NCT01287741|566294401|FG001|Overall Study|Death|44|||
156873454|NCT01287741|566294400|FG000|Overall Study|Adverse Event|4|||
156873455|NCT01287741|566294401|FG001|Overall Study|Adverse Event|6|||
156873456|NCT01287741|566294400|FG000|Overall Study|Study terminated by Sponsor|307|||
156873457|NCT01287741|566294401|FG001|Overall Study|Study terminated by Sponsor|315|||
156873458|NCT01287741|566294400|FG000|Overall Study|Progressive disease|190|||
156873459|NCT01287741|566294401|FG001|Overall Study|Progressive disease|166|||
156873460|NCT01287741|566294400|FG000|Overall Study|Reason not specified|23|||
156873461|NCT01287741|566294401|FG001|Overall Study|Reason not specified|9|||
156873462|NCT04163016|566294403|FG000|Enrollment|Adverse Event|1|||
156873463|NCT04163016|566294404|FG001|Enrollment|Adverse Event|0|||
156873464|NCT04163016|566294405|FG002|Enrollment|Adverse Event|0|||
156873465|NCT04163016|566294406|FG003|Enrollment|Adverse Event|0|||
156873466|NCT04163016|566294403|FG000|Treatment|Adverse Event|0|||
156873467|NCT04163016|566294404|FG001|Treatment|Adverse Event|1|||
156873468|NCT04163016|566294405|FG002|Treatment|Adverse Event|0|||
156873469|NCT04163016|566294406|FG003|Treatment|Adverse Event|0|||
156873470|NCT04163016|566294403|FG000|Treatment|Withdrawal by Subject|0|||
156873471|NCT04163016|566294404|FG001|Treatment|Withdrawal by Subject|2|||
156710297|NCT01004003|565684177|FG005|Overall Study|Adverse Event|2|||
156710298|NCT01004003|565684178|FG006|Overall Study|Adverse Event|7|||
156710299|NCT01004003|565684179|FG007|Overall Study|Adverse Event|21|||
156710300|NCT01004003|565684180|FG008|Overall Study|Adverse Event|6|||
156710301|NCT01004003|565684172|FG000|Overall Study|Refused to continue taking trial med.|0|||
156710302|NCT01004003|565684173|FG001|Overall Study|Refused to continue taking trial med.|0|||
156710303|NCT01004003|565684174|FG002|Overall Study|Refused to continue taking trial med.|0|||
156873472|NCT04163016|566294405|FG002|Treatment|Withdrawal by Subject|0|||
156873473|NCT04163016|566294406|FG003|Treatment|Withdrawal by Subject|0|||
156873474|NCT04163016|566294403|FG000|Treatment|Indeterminate TB-test|0|||
156873475|NCT04163016|566294404|FG001|Treatment|Indeterminate TB-test|0|||
156873476|NCT04163016|566294405|FG002|Treatment|Indeterminate TB-test|0|||
156873477|NCT04163016|566294406|FG003|Treatment|Indeterminate TB-test|1|||
156873478|NCT04163016|566294403|FG000|Treatment|Participant did not want to continue in study|0|||
156873479|NCT04163016|566294404|FG001|Treatment|Participant did not want to continue in study|0|||
156873480|NCT04163016|566294405|FG002|Treatment|Participant did not want to continue in study|0|||
156873481|NCT04163016|566294406|FG003|Treatment|Participant did not want to continue in study|1|||
156873482|NCT01104311|566294411|FG000|Overall Study|Withdrawal by Subject|6|||
156873483|NCT01104311|566294412|FG001|Overall Study|Withdrawal by Subject|6|||
156442088|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
156442089|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
156873484|NCT01104311|566294411|FG000|Overall Study|Protocol Violation|0|||
156873485|NCT01104311|566294412|FG001|Overall Study|Protocol Violation|1|||
156873486|NCT01104311|566294411|FG000|Overall Study|Physician Decision|2|||
156873487|NCT01104311|566294412|FG001|Overall Study|Physician Decision|2|||
156873488|NCT01104311|566294411|FG000|Overall Study|low compliance|1|||
156873489|NCT01104311|566294412|FG001|Overall Study|low compliance|1|||
156873490|NCT01104311|566294411|FG000|Overall Study|Adverse Event|1|||
156873491|NCT01104311|566294412|FG001|Overall Study|Adverse Event|2|||
156873492|NCT04193189|566294413|FG000|Overall Study|Lost to Follow-up|9|||
156873493|NCT04193189|566294414|FG001|Overall Study|Lost to Follow-up|7|||
156873494|NCT04193189|566294415|FG002|Overall Study|Lost to Follow-up|9|||
156710304|NCT01004003|565684175|FG003|Overall Study|Refused to continue taking trial med.|0|||
156710305|NCT01004003|565684176|FG004|Overall Study|Refused to continue taking trial med.|0|||
156710306|NCT01004003|565684177|FG005|Overall Study|Refused to continue taking trial med.|0|||
156710307|NCT01004003|565684178|FG006|Overall Study|Refused to continue taking trial med.|0|||
156710308|NCT01004003|565684179|FG007|Overall Study|Refused to continue taking trial med.|0|||
156710309|NCT01004003|565684180|FG008|Overall Study|Refused to continue taking trial med.|2|||
156710310|NCT01004003|565684172|FG000|Overall Study|Other|0|||
156710311|NCT01004003|565684173|FG001|Overall Study|Other|0|||
156873495|NCT04193189|566294416|FG003|Overall Study|Lost to Follow-up|0|||
156873496|NCT04193189|566294413|FG000|Overall Study|Withdrawal by Subject|1|||
156873497|NCT04193189|566294414|FG001|Overall Study|Withdrawal by Subject|2|||
156873498|NCT04193189|566294415|FG002|Overall Study|Withdrawal by Subject|2|||
156710312|NCT01004003|565684174|FG002|Overall Study|Other|0|||
156710313|NCT01004003|565684175|FG003|Overall Study|Other|0|||
156710314|NCT01004003|565684176|FG004|Overall Study|Other|0|||
156710315|NCT01004003|565684177|FG005|Overall Study|Other|1|||
156710316|NCT01004003|565684178|FG006|Overall Study|Other|0|||
156873499|NCT04193189|566294416|FG003|Overall Study|Withdrawal by Subject|0|||
156873500|NCT04193189|566294413|FG000|Overall Study|Death|1|||
156873501|NCT04193189|566294414|FG001|Overall Study|Death|1|||
156873502|NCT04193189|566294415|FG002|Overall Study|Death|0|||
156873503|NCT04193189|566294416|FG003|Overall Study|Death|0|||
156332783|NCT02913612|564317397|FG003|Overall Study|Local IRB decision|0|||
156332784|NCT02913612|564317394|FG000|Overall Study|Study drug non-compliance|1|||
156332785|NCT02913612|564317395|FG001|Overall Study|Study drug non-compliance|1|||
156710317|NCT01004003|565684179|FG007|Overall Study|Other|0|||
156710318|NCT01004003|565684180|FG008|Overall Study|Other|0|||
156332786|NCT02913612|564317396|FG002|Overall Study|Study drug non-compliance|0|||
156332787|NCT02913612|564317397|FG003|Overall Study|Study drug non-compliance|0|||
156710319|NCT00345631|565684181|FG000|Overall Study|Withdrawal by Subject|1|||
156710320|NCT00345631|565684182|FG001|Overall Study|Withdrawal by Subject|0|||
156710321|NCT00345631|565684183|FG002|Overall Study|Withdrawal by Subject|1|||
156710322|NCT00345631|565684181|FG000|Overall Study|Adverse Event|0|||
156710323|NCT00345631|565684182|FG001|Overall Study|Adverse Event|1|||
156710324|NCT00345631|565684183|FG002|Overall Study|Adverse Event|0|||
156710325|NCT00345631|565684181|FG000|Overall Study|Lost to Follow-up|3|||
156710326|NCT00345631|565684182|FG001|Overall Study|Lost to Follow-up|7|||
156710327|NCT00345631|565684183|FG002|Overall Study|Lost to Follow-up|4|||
156710328|NCT00345631|565684181|FG000|Overall Study|Other reasons|0|||
156710329|NCT00345631|565684182|FG001|Overall Study|Other reasons|0|||
156710330|NCT00345631|565684183|FG002|Overall Study|Other reasons|1|||
156710331|NCT03371459|565684191|FG000|Washout|Lost to Follow-up|0|||
156873504|NCT04193189|566294413|FG000|Overall Study|Protocol Violation|0|||
156873505|NCT04193189|566294414|FG001|Overall Study|Protocol Violation|0|||
156873506|NCT04193189|566294415|FG002|Overall Study|Protocol Violation|0|||
156332788|NCT02913612|564317394|FG000|Overall Study|Insurance issues|0|||
156332789|NCT02913612|564317395|FG001|Overall Study|Insurance issues|1|||
156332790|NCT02913612|564317396|FG002|Overall Study|Insurance issues|0|||
156332791|NCT02913612|564317397|FG003|Overall Study|Insurance issues|0|||
156332792|NCT02913612|564317394|FG000|Overall Study|Needed to treat second hemangioma|0|||
156332793|NCT02913612|564317395|FG001|Overall Study|Needed to treat second hemangioma|1|||
156332794|NCT02913612|564317396|FG002|Overall Study|Needed to treat second hemangioma|0|||
156332795|NCT02913612|564317397|FG003|Overall Study|Needed to treat second hemangioma|0|||
156332796|NCT02913612|564317394|FG000|Overall Study|Study completion criteria not met|0|||
156332797|NCT02913612|564317395|FG001|Overall Study|Study completion criteria not met|1|||
156332798|NCT02913612|564317396|FG002|Overall Study|Study completion criteria not met|0|||
156332799|NCT02913612|564317397|FG003|Overall Study|Study completion criteria not met|0|||
156332800|NCT02913612|564317394|FG000|Overall Study|Ineligible|0|||
156332801|NCT02913612|564317395|FG001|Overall Study|Ineligible|1|||
156332802|NCT02913612|564317396|FG002|Overall Study|Ineligible|0|||
156332803|NCT02913612|564317397|FG003|Overall Study|Ineligible|0|||
156332804|NCT00669396|564317398|FG000|Overall Study|Lost to Follow-up|10|||
156332805|NCT00669396|564317399|FG001|Overall Study|Lost to Follow-up|12|||
156710332|NCT03371459|565684192|FG001|Washout|Lost to Follow-up|1|||
156710333|NCT01589497|565684195|FG000|Overall Study|Withdrawal by Subject|0|||
156873507|NCT04193189|566294416|FG003|Overall Study|Protocol Violation|1|||
156873508|NCT01864603|566296036|FG000|Stage 2|DSMB design modification|86056|||
156873509|NCT01864603|566296037|FG001|Stage 2|DSMB design modification|92558|||
156873510|NCT03901469|566296038|FG000|Overall Study|Radiographic Progression|4|||
156873511|NCT03901469|566296039|FG001|Overall Study|Radiographic Progression|6|||
156873512|NCT03901469|566296040|FG002|Overall Study|Radiographic Progression|3|||
156873513|NCT03901469|566296041|FG003|Overall Study|Radiographic Progression|30|||
156873514|NCT03901469|566296042|FG004|Overall Study|Radiographic Progression|7|||
156873515|NCT03901469|566296043|FG005|Overall Study|Radiographic Progression|2|||
156873516|NCT03901469|566296044|FG006|Overall Study|Radiographic Progression|11|||
156873517|NCT03901469|566296038|FG000|Overall Study|Clinical Progression|0|||
156873518|NCT03901469|566296039|FG001|Overall Study|Clinical Progression|2|||
156873519|NCT03901469|566296040|FG002|Overall Study|Clinical Progression|0|||
156873520|NCT03901469|566296041|FG003|Overall Study|Clinical Progression|7|||
156873521|NCT03901469|566296042|FG004|Overall Study|Clinical Progression|6|||
156873522|NCT03901469|566296043|FG005|Overall Study|Clinical Progression|0|||
156873523|NCT03901469|566296044|FG006|Overall Study|Clinical Progression|2|||
156873524|NCT03901469|566296038|FG000|Overall Study|Adverse Event|1|||
156873525|NCT03901469|566296039|FG001|Overall Study|Adverse Event|0|||
156873526|NCT03901469|566296040|FG002|Overall Study|Adverse Event|0|||
156873527|NCT03901469|566296041|FG003|Overall Study|Adverse Event|0|||
156873528|NCT03901469|566296042|FG004|Overall Study|Adverse Event|0|||
156873529|NCT03901469|566296043|FG005|Overall Study|Adverse Event|0|||
156873530|NCT03901469|566296044|FG006|Overall Study|Adverse Event|9|||
156873531|NCT03901469|566296038|FG000|Overall Study|Physician Decision|0|||
156873532|NCT03901469|566296039|FG001|Overall Study|Physician Decision|0|||
156873533|NCT03901469|566296040|FG002|Overall Study|Physician Decision|0|||
156710334|NCT01589497|565684196|FG001|Overall Study|Withdrawal by Subject|1|||
156710335|NCT01589497|565684197|FG002|Overall Study|Withdrawal by Subject|0|||
156710336|NCT01589497|565684198|FG003|Overall Study|Withdrawal by Subject|1|||
156873534|NCT03901469|566296041|FG003|Overall Study|Physician Decision|1|||
156873535|NCT03901469|566296042|FG004|Overall Study|Physician Decision|0|||
156873536|NCT03901469|566296043|FG005|Overall Study|Physician Decision|0|||
156873537|NCT03901469|566296044|FG006|Overall Study|Physician Decision|0|||
156873538|NCT03901469|566296038|FG000|Overall Study|Withdrawal by Subject|0|||
156873539|NCT03901469|566296039|FG001|Overall Study|Withdrawal by Subject|0|||
156710337|NCT01589497|565684195|FG000|Overall Study|Death|1|||
156710338|NCT01589497|565684196|FG001|Overall Study|Death|0|||
156710339|NCT01589497|565684197|FG002|Overall Study|Death|0|||
156873540|NCT03901469|566296040|FG002|Overall Study|Withdrawal by Subject|0|||
156873541|NCT03901469|566296041|FG003|Overall Study|Withdrawal by Subject|0|||
156873542|NCT03901469|566296042|FG004|Overall Study|Withdrawal by Subject|2|||
156873543|NCT03901469|566296043|FG005|Overall Study|Withdrawal by Subject|0|||
156873544|NCT03901469|566296044|FG006|Overall Study|Withdrawal by Subject|8|||
156873545|NCT03901469|566296038|FG000|Overall Study|Death|0|||
156873546|NCT03901469|566296039|FG001|Overall Study|Death|0|||
156873547|NCT03901469|566296040|FG002|Overall Study|Death|0|||
156873548|NCT03901469|566296041|FG003|Overall Study|Death|3|||
156873549|NCT03901469|566296042|FG004|Overall Study|Death|5|||
156873550|NCT03901469|566296043|FG005|Overall Study|Death|0|||
156873551|NCT03901469|566296044|FG006|Overall Study|Death|1|||
156873552|NCT03901469|566296038|FG000|Overall Study|Termination of study by sponsor|0|||
156873553|NCT03901469|566296039|FG001|Overall Study|Termination of study by sponsor|0|||
156873554|NCT03901469|566296040|FG002|Overall Study|Termination of study by sponsor|0|||
156332806|NCT01262573|564317400|FG000|Overall Study|Withdrawal by Subject|0|||
156332807|NCT01262573|564317401|FG001|Overall Study|Withdrawal by Subject|1|||
156710340|NCT01589497|565684198|FG003|Overall Study|Death|0|||
156710341|NCT01589497|565684195|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
156710342|NCT01589497|565684196|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
156710343|NCT01589497|565684197|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
156710344|NCT01589497|565684198|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
156710345|NCT01885195|565684199|FG000|Overall Study|Adverse Event|29|||
156710346|NCT01885195|565684199|FG000|Overall Study|Death|1|||
156710347|NCT01885195|565684199|FG000|Overall Study|Disease Progression|67|||
156873555|NCT03901469|566296041|FG003|Overall Study|Termination of study by sponsor|0|||
156873556|NCT03901469|566296042|FG004|Overall Study|Termination of study by sponsor|1|||
156873557|NCT03901469|566296043|FG005|Overall Study|Termination of study by sponsor|1|||
156873558|NCT03901469|566296044|FG006|Overall Study|Termination of study by sponsor|0|||
156873559|NCT03901469|566296038|FG000|Overall Study|Not Reported|1|||
156873560|NCT03901469|566296039|FG001|Overall Study|Not Reported|0|||
156873561|NCT03901469|566296040|FG002|Overall Study|Not Reported|0|||
156332808|NCT04402060|564317402|FG000|Overall Study|Death|1|||
156873562|NCT03901469|566296041|FG003|Overall Study|Not Reported|1|||
156873563|NCT03901469|566296042|FG004|Overall Study|Not Reported|0|||
156873564|NCT03901469|566296043|FG005|Overall Study|Not Reported|0|||
156873565|NCT03901469|566296044|FG006|Overall Study|Not Reported|1|||
156873566|NCT02586207|566296045|FG000|Overall Study|Physician Decision|1|||
156332809|NCT04402060|564317403|FG001|Overall Study|Death|12|||
156710348|NCT01885195|565684199|FG000|Overall Study|Protocol Deviation|2|||
156710349|NCT01885195|565684199|FG000|Overall Study|Physician Decision|3|||
156710350|NCT01885195|565684199|FG000|Overall Study|Patient/guardian decision|8|||
156442090|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
156710351|NCT03390426|565684202|FG000|Overall Study|Protocol Violation|0|||
156710352|NCT03390426|565684203|FG001|Overall Study|Protocol Violation|1|||
156710353|NCT00259272|565684210|FG000|Overall Study|Adverse Event|2|||
156710354|NCT00259272|565684211|FG001|Overall Study|Adverse Event|1|||
156710355|NCT00259272|565684212|FG002|Overall Study|Adverse Event|0|||
156710356|NCT00259272|565684213|FG003|Overall Study|Adverse Event|3|||
156710357|NCT00259272|565684210|FG000|Overall Study|Lack of Efficacy|5|||
156710358|NCT00259272|565684211|FG001|Overall Study|Lack of Efficacy|1|||
156710359|NCT00259272|565684212|FG002|Overall Study|Lack of Efficacy|2|||
156710360|NCT00259272|565684213|FG003|Overall Study|Lack of Efficacy|6|||
156710361|NCT00259272|565684210|FG000|Overall Study|Physician Decision|1|||
156710362|NCT00259272|565684211|FG001|Overall Study|Physician Decision|2|||
156710363|NCT00259272|565684212|FG002|Overall Study|Physician Decision|1|||
156710364|NCT00259272|565684213|FG003|Overall Study|Physician Decision|3|||
156710365|NCT00259272|565684210|FG000|Overall Study|Protocol Violation|2|||
156710366|NCT00259272|565684211|FG001|Overall Study|Protocol Violation|0|||
156710367|NCT00259272|565684212|FG002|Overall Study|Protocol Violation|0|||
156710368|NCT00259272|565684213|FG003|Overall Study|Protocol Violation|1|||
156710369|NCT00259272|565684210|FG000|Overall Study|Sponsor Decision|0|||
156710370|NCT00259272|565684211|FG001|Overall Study|Sponsor Decision|1|||
156710371|NCT00259272|565684212|FG002|Overall Study|Sponsor Decision|0|||
156710372|NCT00259272|565684213|FG003|Overall Study|Sponsor Decision|0|||
156710373|NCT00259272|565684210|FG000|Overall Study|Withdrawal by Subject|4|||
156710374|NCT00259272|565684211|FG001|Overall Study|Withdrawal by Subject|2|||
156710375|NCT00259272|565684212|FG002|Overall Study|Withdrawal by Subject|2|||
156710376|NCT00259272|565684213|FG003|Overall Study|Withdrawal by Subject|7|||
156710377|NCT00259272|565684210|FG000|Overall Study|Lost to Follow-up|1|||
156710378|NCT00259272|565684211|FG001|Overall Study|Lost to Follow-up|0|||
156710379|NCT00259272|565684212|FG002|Overall Study|Lost to Follow-up|0|||
156710380|NCT00259272|565684213|FG003|Overall Study|Lost to Follow-up|1|||
156710381|NCT03301623|565684216|FG000|Overall Study|Death|3|||
156710382|NCT03301623|565684217|FG001|Overall Study|Death|1|||
156710383|NCT03301623|565684216|FG000|Overall Study|Withdrawal by Subject|11|||
156710384|NCT03301623|565684217|FG001|Overall Study|Withdrawal by Subject|13|||
156710385|NCT03301623|565684216|FG000|Overall Study|Lost to Follow-up|3|||
156710386|NCT03301623|565684217|FG001|Overall Study|Lost to Follow-up|1|||
156710387|NCT02185053|565684219|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
156710388|NCT02185053|565684220|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
156710389|NCT02185053|565684221|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
156710390|NCT02185053|565684219|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
156710391|NCT02185053|565684220|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
156710392|NCT02185053|565684221|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
156710393|NCT02185053|565684219|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
156710394|NCT02185053|565684220|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
156710395|NCT02185053|565684221|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
156710396|NCT02185053|565684219|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
156710397|NCT02185053|565684220|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
156710398|NCT02185053|565684221|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
156710399|NCT02185053|565684219|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
156710400|NCT02185053|565684220|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
156710401|NCT02185053|565684221|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
156710402|NCT02185053|565684219|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
156710403|NCT02185053|565684220|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
156710404|NCT02185053|565684221|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
156710405|NCT02185053|565684219|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
156710406|NCT02185053|565684220|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
156710407|NCT02185053|565684221|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
156710408|NCT02185053|565684219|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
156710409|NCT02185053|565684220|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
156710410|NCT02185053|565684221|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
156710411|NCT02521376|565684229|FG000|Overall Study|Enrolled, But Not Treated|1|||
156792238|NCT02336555|565992712|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
156532096|NCT01284062|565043272|FG000|Overall Study|Protocol Violation|1|||
156710412|NCT02521376|565684230|FG001|Overall Study|Enrolled, But Not Treated|0|||
156710413|NCT02521376|565684231|FG002|Overall Study|Enrolled, But Not Treated|0|||
156710414|NCT02521376|565684232|FG003|Overall Study|Enrolled, But Not Treated|0|||
156710415|NCT01374269|565684234|FG000|Overall Study|Withdrawal by Subject|4|||
156710416|NCT01374269|565684235|FG001|Overall Study|Withdrawal by Subject|0|||
156710417|NCT01374269|565684234|FG000|Overall Study|Lost to Follow-up|1|||
156710418|NCT01374269|565684235|FG001|Overall Study|Lost to Follow-up|3|||
156710419|NCT01374269|565684234|FG000|Overall Study|closed research|1|||
156808761|NCT04245449|566054456|FG000|Overall Study|COVID shutdown|7|||
156710420|NCT01374269|565684235|FG001|Overall Study|closed research|2|||
156873567|NCT02586207|566296045|FG000|Overall Study|Withdrawal by Subject|1|||
156873568|NCT03048578|566296046|FG000|Overall Study|Withdrawal by Subject|5|||
156873569|NCT03048578|566296047|FG001|Overall Study|Withdrawal by Subject|6|||
156873570|NCT03048578|566296046|FG000|Overall Study|Lost to Follow-up|22|||
156873571|NCT03048578|566296047|FG001|Overall Study|Lost to Follow-up|10|||
156873572|NCT03048578|566296046|FG000|Overall Study|Adverse Event|1|||
156873573|NCT03048578|566296047|FG001|Overall Study|Adverse Event|2|||
156873574|NCT03048578|566296046|FG000|Overall Study|Terminated|3|||
156873575|NCT03048578|566296047|FG001|Overall Study|Terminated|2|||
156873576|NCT00526071|566296048|FG000|Overall Study|Adverse Event|1|||
156873577|NCT00526071|566296048|FG000|Overall Study|Withdrawal by Subject|1|||
156873578|NCT00526071|566296048|FG000|Overall Study|Lack of Response to Study Drug|4|||
156873579|NCT02920242|566296049|FG000|Overall Study|Withdrawal by Subject|1|||
156873580|NCT02920242|566296050|FG001|Overall Study|Withdrawal by Subject|0|||
156873581|NCT02920242|566296051|FG002|Overall Study|Withdrawal by Subject|1|||
156873582|NCT02920242|566296049|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
156873583|NCT02920242|566296050|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
156873584|NCT02920242|566296051|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
156873585|NCT01409811|566296052|FG000|Overall Study|Insurance denial|1|||
156873586|NCT00634101|566296053|FG000|Overall Study|Study Terminated|3|||
156873587|NCT00634101|566296054|FG001|Overall Study|Study Terminated|3|||
156873588|NCT00634101|566296053|FG000|Overall Study|Lost to Follow-up|2|||
156873589|NCT00634101|566296054|FG001|Overall Study|Lost to Follow-up|0|||
156873590|NCT00139477|566296058|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
156873591|NCT00139477|566296059|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
156873592|NCT00139477|566296058|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
156873593|NCT00139477|566296059|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
156873594|NCT00139477|566296058|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
156873595|NCT00139477|566296059|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
156873596|NCT00139477|566296058|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
156873597|NCT00139477|566296059|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
156873598|NCT00139477|566296058|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
156873599|NCT00139477|566296059|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
156873600|NCT00139477|566296058|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
156873601|NCT00139477|566296059|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
156873602|NCT00139477|566296058|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
156873603|NCT00139477|566296059|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
156873604|NCT00441064|566296062|FG000|Overall Study|Adverse Event|1|||
156873605|NCT00441064|566296063|FG001|Overall Study|Adverse Event|0|||
156873606|NCT00441064|566296062|FG000|Overall Study|Abnormal laboratory values|0|||
156873607|NCT00441064|566296063|FG001|Overall Study|Abnormal laboratory values|2|||
156873608|NCT00441064|566296062|FG000|Overall Study|Abnormal test procedure results|0|||
156710421|NCT01653912|565684236|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156710422|NCT01653912|565684237|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
156710423|NCT01653912|565684238|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156710424|NCT01653912|565684239|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156332810|NCT04402060|564317404|FG002|Overall Study|Death|7|||
156332811|NCT04402060|564317402|FG000|Overall Study|Adverse Event|0|||
156332812|NCT04402060|564317403|FG001|Overall Study|Adverse Event|0|||
156332813|NCT04402060|564317404|FG002|Overall Study|Adverse Event|1|||
156332814|NCT04402060|564317402|FG000|Overall Study|Withdrawal by Subject|0|||
156710425|NCT01653912|565684240|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156710426|NCT01653912|565684241|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156710427|NCT01653912|565684236|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156710428|NCT01653912|565684237|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156710429|NCT01653912|565684238|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
156873609|NCT00441064|566296063|FG001|Overall Study|Abnormal test procedure results|1|||
156873610|NCT00441064|566296062|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156873611|NCT00441064|566296063|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156332815|NCT04402060|564317403|FG001|Overall Study|Withdrawal by Subject|1|||
156332816|NCT04402060|564317404|FG002|Overall Study|Withdrawal by Subject|2|||
156710430|NCT01653912|565684239|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156710431|NCT01653912|565684240|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156873612|NCT00441064|566296062|FG000|Overall Study|Protocol Deviation|3|||
156873613|NCT00441064|566296063|FG001|Overall Study|Protocol Deviation|2|||
156873614|NCT00441064|566296062|FG000|Overall Study|Patient withdrew consent|5|||
156873615|NCT00441064|566296063|FG001|Overall Study|Patient withdrew consent|2|||
156873616|NCT03051178|566296064|FG000|Overall Study|Withdrawal by Subject|5|||
156873617|NCT00953056|566296065|FG000|Overall Study|Withdrew Consent|0|||
156873618|NCT00953056|566296066|FG001|Overall Study|Withdrew Consent|0|||
156332817|NCT04402060|564317402|FG000|Overall Study|Sponsor Request|0|||
156332818|NCT04402060|564317403|FG001|Overall Study|Sponsor Request|2|||
156873619|NCT00953056|566296067|FG002|Overall Study|Withdrew Consent|0|||
156873620|NCT00953056|566296068|FG003|Overall Study|Withdrew Consent|0|||
156873621|NCT00953056|566296069|FG004|Overall Study|Withdrew Consent|2|||
156710432|NCT01653912|565684241|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156710433|NCT01653912|565684236|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710434|NCT01653912|565684237|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710435|NCT01653912|565684238|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710436|NCT01653912|565684239|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
156710437|NCT01653912|565684240|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710438|NCT01653912|565684241|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710439|NCT01653912|565684236|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710440|NCT01653912|565684237|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710441|NCT01653912|565684238|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710442|NCT01653912|565684239|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
156710443|NCT01653912|565684240|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710444|NCT01653912|565684241|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710445|NCT01653912|565684236|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710446|NCT01653912|565684237|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710447|NCT01653912|565684238|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710448|NCT01653912|565684239|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710449|NCT01653912|565684240|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710450|NCT01653912|565684241|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
156710451|NCT01653912|565684236|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156873622|NCT00953056|566296070|FG005|Overall Study|Withdrew Consent|3|||
156873623|NCT00953056|566296065|FG000|Overall Study|Serious Adverse Event|0|||
156332819|NCT04402060|564317404|FG002|Overall Study|Sponsor Request|0|||
156332820|NCT04402060|564317402|FG000|Overall Study|Physician Decision|0|||
156710452|NCT01653912|565684237|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156710453|NCT01653912|565684238|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156710454|NCT01653912|565684239|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156710455|NCT01653912|565684240|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156710456|NCT01653912|565684241|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
156710457|NCT01653912|565684236|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710458|NCT01653912|565684237|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710459|NCT01653912|565684238|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710460|NCT01653912|565684239|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710461|NCT01653912|565684240|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710462|NCT01653912|565684241|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
156710463|NCT00708227|565684242|FG000|Overall Study|Physician Decision|0|||
156710464|NCT00708227|565684243|FG001|Overall Study|Physician Decision|3|||
156710465|NCT00708227|565684244|FG002|Overall Study|Physician Decision|1|||
156710466|NCT00708227|565684245|FG003|Overall Study|Physician Decision|2|||
156710467|NCT00708227|565684242|FG000|Overall Study|Withdrawal by Subject|1|||
156710468|NCT00708227|565684243|FG001|Overall Study|Withdrawal by Subject|2|||
156710469|NCT00708227|565684244|FG002|Overall Study|Withdrawal by Subject|0|||
156710470|NCT00708227|565684245|FG003|Overall Study|Withdrawal by Subject|1|||
156710471|NCT01987479|565684246|FG000|Overall Study|Protocol Violation|1|||
156710472|NCT01987479|565684246|FG000|Overall Study|Physician Decision|2|||
156710473|NCT01987479|565684246|FG000|Overall Study|Participant/legal guardian decision|1|||
156710474|NCT01987479|565684246|FG000|Overall Study|Other|5|||
156710475|NCT01987479|565684246|FG000|Overall Study|Lost to Follow-up|1|||
156710476|NCT01987479|565684246|FG000|Overall Study|Adverse Event|7|||
156710477|NCT04007991|565684247|FG000|Overall Study|Withdrawal by Subject|1|||
156710478|NCT04007991|565684248|FG001|Overall Study|Withdrawal by Subject|1|||
156710479|NCT04007991|565684247|FG000|Overall Study|Physician Decision|1|||
156710480|NCT04007991|565684248|FG001|Overall Study|Physician Decision|1|||
156710481|NCT04007991|565684247|FG000|Overall Study|Non-compliance with Study Drug|0|||
156710482|NCT04007991|565684248|FG001|Overall Study|Non-compliance with Study Drug|1|||
156710483|NCT04007991|565684247|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
156710484|NCT04007991|565684248|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
156710485|NCT04007991|565684247|FG000|Overall Study|Adverse event, non-fatal|5|||
156710486|NCT04007991|565684248|FG001|Overall Study|Adverse event, non-fatal|0|||
156710487|NCT04007991|565684247|FG000|Overall Study|Lost to Follow-up|2|||
156710488|NCT04007991|565684248|FG001|Overall Study|Lost to Follow-up|1|||
156710489|NCT01954745|565684249|FG000|Overall Study|Radiological Progression|11|||
156710490|NCT01954745|565684249|FG000|Overall Study|Clinical Progression|5|||
156710491|NCT01954745|565684249|FG000|Overall Study|Adverse Event|2|||
156710492|NCT01954745|565684249|FG000|Overall Study|Death|1|||
156332821|NCT04402060|564317403|FG001|Overall Study|Physician Decision|0|||
156710493|NCT03654599|565684252|FG000|Overall Study|Lost to Follow-up|14|||
156710494|NCT03654599|565684253|FG001|Overall Study|Lost to Follow-up|12|||
156710495|NCT03654599|565684252|FG000|Overall Study|Death|8|||
156710496|NCT03654599|565684253|FG001|Overall Study|Death|6|||
156710497|NCT03654599|565684252|FG000|Overall Study|Withdrawal by Subject|6|||
156442091|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
156442092|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
156442093|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
156442094|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
156442095|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
156442096|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
156442097|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
156710498|NCT03654599|565684253|FG001|Overall Study|Withdrawal by Subject|4|||
156710499|NCT05314816|565684254|FG000|Overall Study|Lost to Follow-up|5|||
156710500|NCT05314816|565684255|FG001|Overall Study|Lost to Follow-up|0|||
156710501|NCT05314816|565684256|FG002|Overall Study|Lost to Follow-up|1|||
156710502|NCT05314816|565684254|FG000|Overall Study|Protocol Violation|13|||
156710503|NCT05314816|565684255|FG001|Overall Study|Protocol Violation|8|||
156710504|NCT05314816|565684256|FG002|Overall Study|Protocol Violation|0|||
156710505|NCT01290302|565686236|FG000|Overall Study|Adverse Event|2|||
156710506|NCT01290302|565686237|FG001|Overall Study|Adverse Event|0|||
156710507|NCT01290302|565686236|FG000|Overall Study|Withdrawal by Subject|1|||
156710508|NCT01290302|565686237|FG001|Overall Study|Withdrawal by Subject|0|||
156710509|NCT01290302|565686236|FG000|Overall Study|Physician Decision|0|||
156710510|NCT01290302|565686237|FG001|Overall Study|Physician Decision|2|||
156710511|NCT01290302|565686236|FG000|Overall Study|Expiration of time for screening window|1|||
156710512|NCT01290302|565686237|FG001|Overall Study|Expiration of time for screening window|0|||
156710513|NCT05938621|565686238|FG000|Overall Study|Lost to Follow-up|1|||
156710514|NCT05938621|565686239|FG001|Overall Study|Lost to Follow-up|5|||
156710515|NCT05938621|565686240|FG002|Overall Study|Lost to Follow-up|2|||
156710516|NCT05938621|565686241|FG003|Overall Study|Lost to Follow-up|2|||
156710517|NCT03816878|565686242|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
156710518|NCT03816878|565686243|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
156710519|NCT03816878|565686242|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
156710520|NCT03816878|565686243|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
156710521|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
156710522|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
156710523|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
156710524|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
156710525|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
156710526|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
156710527|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
156710528|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
156710529|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
156710530|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
156710531|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
156710532|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
156710533|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
156710534|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
156710535|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
156710536|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
156710537|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
156710538|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
156710539|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
156710540|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
156710541|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
156710542|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
156710543|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
156710544|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
156710545|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
156710546|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
156710547|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
156710548|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
156710549|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
156710550|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
156710551|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
156710552|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
156710553|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
156710554|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
156710555|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
156710556|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
156792239|NCT02336555|565992711|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
156808762|NCT01408277|566054457|FG000|Overall Study|Adverse Event|3|||
156710557|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Other than specified|0|||
156710558|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Other than specified|0|||
156710559|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Other than specified|1|||
156710560|NCT04856930|565686248|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
156710561|NCT04856930|565686249|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
156710562|NCT04856930|565686250|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
156710563|NCT04856930|565686248|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
156710564|NCT04856930|565686249|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
156710565|NCT04856930|565686250|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
156710566|NCT04856930|565686248|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
156710567|NCT04856930|565686249|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
156710568|NCT04856930|565686250|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
156710569|NCT04856930|565686248|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
156710570|NCT04856930|565686249|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
156710571|NCT04856930|565686250|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
156710572|NCT00678210|565686252|FG000|Overall Study|Adverse Event|1|||
156710573|NCT00678210|565686253|FG001|Overall Study|Adverse Event|2|||
156710574|NCT00678210|565686254|FG002|Overall Study|Adverse Event|3|||
156710575|NCT00678210|565686255|FG003|Overall Study|Adverse Event|3|||
156710576|NCT00678210|565686252|FG000|Overall Study|Lack of Efficacy|2|||
156710577|NCT00678210|565686253|FG001|Overall Study|Lack of Efficacy|3|||
156710578|NCT00678210|565686254|FG002|Overall Study|Lack of Efficacy|1|||
156710579|NCT00678210|565686255|FG003|Overall Study|Lack of Efficacy|9|||
156710580|NCT00678210|565686252|FG000|Overall Study|Lost to Follow-up|4|||
156710581|NCT00678210|565686253|FG001|Overall Study|Lost to Follow-up|2|||
156710582|NCT00678210|565686254|FG002|Overall Study|Lost to Follow-up|0|||
156710583|NCT00678210|565686255|FG003|Overall Study|Lost to Follow-up|1|||
156710584|NCT00678210|565686252|FG000|Overall Study|Withdrawal by Subject|3|||
156710585|NCT00678210|565686253|FG001|Overall Study|Withdrawal by Subject|4|||
156710586|NCT00678210|565686254|FG002|Overall Study|Withdrawal by Subject|1|||
156710587|NCT00678210|565686255|FG003|Overall Study|Withdrawal by Subject|7|||
156710588|NCT00678210|565686252|FG000|Overall Study|Other|1|||
156710589|NCT00678210|565686253|FG001|Overall Study|Other|0|||
156710590|NCT00678210|565686254|FG002|Overall Study|Other|1|||
156710591|NCT00678210|565686255|FG003|Overall Study|Other|0|||
156710592|NCT04825912|565686256|FG000|Overall Study|Death|3|||
156710593|NCT04825912|565686256|FG000|Overall Study|Withdrawal by Subject|1|||
156710594|NCT00459355|565686257|FG000|Overall Study|Subject no longer met inc criteria|20|||
156710595|NCT00459355|565686258|FG001|Overall Study|Subject no longer met inc criteria|18|||
156710596|NCT00618371|565686261|FG000|Overall Study|Withdrawal by Subject|2|||
156710597|NCT02437903|565686273|FG000|Overall Study|Adverse Event|1|||
156710598|NCT02437903|565686273|FG000|Overall Study|Withdrawal by Subject|1|||
156710599|NCT02437903|565686273|FG000|Overall Study|Lost to Follow-up|3|||
156710600|NCT05445492|565686277|FG000|Overall Study|Physician Decision|1|||
156710601|NCT01141205|565686278|FG000|Overall Study|Physician Decision|1|||
156710602|NCT01141205|565686279|FG001|Overall Study|Physician Decision|1|||
156710603|NCT01141205|565686278|FG000|Overall Study|Lost to Follow-up|1|||
156710604|NCT01141205|565686279|FG001|Overall Study|Lost to Follow-up|0|||
156710605|NCT01141205|565686278|FG000|Overall Study|Withdrawal by Subject|1|||
156710606|NCT01141205|565686279|FG001|Overall Study|Withdrawal by Subject|1|||
156710607|NCT00534404|565686290|FG000|Overall Study|Death|0|||
156710608|NCT00534404|565686291|FG001|Overall Study|Death|0|||
156710609|NCT00534404|565686292|FG002|Overall Study|Death|2|||
156710610|NCT00534404|565686290|FG000|Overall Study|Withdrawal by Subject|8|||
156710611|NCT00534404|565686291|FG001|Overall Study|Withdrawal by Subject|2|||
156710612|NCT00534404|565686292|FG002|Overall Study|Withdrawal by Subject|38|||
156710613|NCT00534404|565686290|FG000|Overall Study|Removed by study staff|2|||
156710614|NCT00534404|565686291|FG001|Overall Study|Removed by study staff|3|||
156710615|NCT00534404|565686292|FG002|Overall Study|Removed by study staff|1|||
156710616|NCT00534404|565686290|FG000|Overall Study|Lost to Follow-up|170|||
156710617|NCT00534404|565686291|FG001|Overall Study|Lost to Follow-up|138|||
156710618|NCT00534404|565686292|FG002|Overall Study|Lost to Follow-up|201|||
156710619|NCT04759768|565686293|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
156710620|NCT04759768|565686294|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
156710621|NCT04759768|565686293|FG000|Washout (7 Days)|Physician Decision|0|||
156710622|NCT04759768|565686294|FG001|Washout (7 Days)|Physician Decision|1|||
156710623|NCT02996487|565686295|FG000|Overall Study|Lost to Follow-up|1|||
156710624|NCT02996487|565686296|FG001|Overall Study|Lost to Follow-up|1|||
156710625|NCT02996487|565686297|FG002|Overall Study|Lost to Follow-up|0|||
156710626|NCT02996487|565686295|FG000|Overall Study|Death|0|||
156710627|NCT02996487|565686296|FG001|Overall Study|Death|1|||
156792240|NCT02336555|565992712|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
156710628|NCT02996487|565686297|FG002|Overall Study|Death|0|||
156710629|NCT02996487|565686295|FG000|Overall Study|Withdrawal by Subject|2|||
156710630|NCT02996487|565686296|FG001|Overall Study|Withdrawal by Subject|3|||
156710631|NCT02996487|565686297|FG002|Overall Study|Withdrawal by Subject|0|||
156710632|NCT02027428|565686298|FG000|Induction|Never treated|7|||
156442098|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
156442099|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
156710633|NCT02027428|565686299|FG001|Induction|Never treated|0|||
156710634|NCT02027428|565686300|FG002|Induction|Never treated|0|||
156442100|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
156442101|NCT02409667|564711040|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
156442102|NCT02409667|564711041|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
156442103|NCT02409667|564711042|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
156442104|NCT02409667|564711043|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
156442105|NCT02409667|564711044|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
156442106|NCT02409667|564711040|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
156442107|NCT02409667|564711041|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
156442108|NCT02409667|564711042|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
156442109|NCT02409667|564711043|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
156442110|NCT02409667|564711044|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
156710635|NCT02027428|565686298|FG000|Induction|Progressive disease|77|||
156710636|NCT02027428|565686299|FG001|Induction|Progressive disease|0|||
156710637|NCT02027428|565686300|FG002|Induction|Progressive disease|0|||
156710638|NCT02027428|565686298|FG000|Induction|Adverse Event|51|||
156710639|NCT02027428|565686299|FG001|Induction|Adverse Event|0|||
156710640|NCT02027428|565686300|FG002|Induction|Adverse Event|0|||
156710641|NCT02027428|565686298|FG000|Induction|Withdrawal by Subject|22|||
156710642|NCT02027428|565686299|FG001|Induction|Withdrawal by Subject|0|||
156710643|NCT02027428|565686300|FG002|Induction|Withdrawal by Subject|0|||
156710644|NCT02027428|565686298|FG000|Induction|Death|21|||
156710645|NCT02027428|565686299|FG001|Induction|Death|0|||
156710646|NCT02027428|565686300|FG002|Induction|Death|0|||
156710647|NCT02027428|565686298|FG000|Induction|Symptomatic deterioration|16|||
156710648|NCT02027428|565686299|FG001|Induction|Symptomatic deterioration|0|||
156710649|NCT02027428|565686300|FG002|Induction|Symptomatic deterioration|0|||
156710650|NCT02027428|565686298|FG000|Induction|Study terminated by sponsor|12|||
156710651|NCT02027428|565686299|FG001|Induction|Study terminated by sponsor|0|||
156710652|NCT02027428|565686300|FG002|Induction|Study terminated by sponsor|0|||
156710653|NCT02027428|565686298|FG000|Induction|Protocol Violation|1|||
156710654|NCT02027428|565686299|FG001|Induction|Protocol Violation|0|||
156710655|NCT02027428|565686300|FG002|Induction|Protocol Violation|0|||
156710656|NCT02027428|565686298|FG000|Induction|Miscellaneous|14|||
156710657|NCT02027428|565686299|FG001|Induction|Miscellaneous|0|||
156710658|NCT02027428|565686300|FG002|Induction|Miscellaneous|0|||
156710659|NCT02027428|565686298|FG000|Induction|Induction Treatment Ongoing|4|||
156710660|NCT02027428|565686299|FG001|Induction|Induction Treatment Ongoing|0|||
156710661|NCT02027428|565686300|FG002|Induction|Induction Treatment Ongoing|0|||
156710662|NCT02027428|565686298|FG000|Maintenance|Death|0|||
156710663|NCT02027428|565686299|FG001|Maintenance|Death|3|||
156710664|NCT02027428|565686300|FG002|Maintenance|Death|2|||
156873624|NCT00953056|566296066|FG001|Overall Study|Serious Adverse Event|0|||
156873625|NCT00953056|566296067|FG002|Overall Study|Serious Adverse Event|0|||
156873626|NCT00953056|566296068|FG003|Overall Study|Serious Adverse Event|0|||
156873627|NCT00953056|566296069|FG004|Overall Study|Serious Adverse Event|0|||
156873628|NCT00953056|566296070|FG005|Overall Study|Serious Adverse Event|1|||
156873629|NCT02813577|566296071|FG000|Overall Study|Study terminated|4|||
156873630|NCT01077076|566296072|FG000|First Intervention|Withdrawal by Subject|1|||
156873631|NCT01077076|566296073|FG001|First Intervention|Withdrawal by Subject|0|||
156873632|NCT01077076|566296074|FG002|First Intervention|Withdrawal by Subject|0|||
156532097|NCT01284062|565043273|FG001|Overall Study|Protocol Violation|0|||
156873633|NCT01077076|566296075|FG003|First Intervention|Withdrawal by Subject|0|||
156873634|NCT01077076|566296076|FG004|First Intervention|Withdrawal by Subject|0|||
156873635|NCT01077076|566296077|FG005|First Intervention|Withdrawal by Subject|0|||
156873636|NCT01077076|566296072|FG000|Third Intervention|Death in the participant's family|0|||
156873637|NCT01077076|566296073|FG001|Third Intervention|Death in the participant's family|0|||
156873638|NCT01077076|566296074|FG002|Third Intervention|Death in the participant's family|0|||
156873639|NCT01077076|566296075|FG003|Third Intervention|Death in the participant's family|0|||
156873640|NCT01077076|566296076|FG004|Third Intervention|Death in the participant's family|0|||
156873641|NCT01077076|566296077|FG005|Third Intervention|Death in the participant's family|1|||
156873642|NCT00060840|566296080|FG000|Overall Study|Change in surgical plan|2|||
156873643|NCT00060840|566296081|FG001|Overall Study|Change in surgical plan|6|||
156873644|NCT00060840|566296080|FG000|Overall Study|Death|0|||
156710665|NCT02027428|565686298|FG000|Maintenance|Adverse Event|0|||
156710666|NCT02027428|565686299|FG001|Maintenance|Adverse Event|21|||
156710667|NCT02027428|565686300|FG002|Maintenance|Adverse Event|1|||
156710668|NCT02027428|565686298|FG000|Maintenance|Progressive disease|0|||
156873645|NCT00060840|566296081|FG001|Overall Study|Death|1|||
156873646|NCT00060840|566296080|FG000|Overall Study|Withdrawal by Subject|0|||
156873647|NCT00060840|566296081|FG001|Overall Study|Withdrawal by Subject|1|||
156710669|NCT02027428|565686299|FG001|Maintenance|Progressive disease|84|||
156710670|NCT02027428|565686300|FG002|Maintenance|Progressive disease|47|||
156710671|NCT02027428|565686298|FG000|Maintenance|Symptomatic deterioration|0|||
156332822|NCT04402060|564317404|FG002|Overall Study|Physician Decision|1|||
156332823|NCT04402060|564317402|FG000|Overall Study|Other|0|||
156332824|NCT04402060|564317403|FG001|Overall Study|Other|1|||
156332825|NCT04402060|564317404|FG002|Overall Study|Other|0|||
156332826|NCT00331422|564317405|FG000|Overall Study|Did not receive entire study regimen|5|||
156332827|NCT02345226|564317406|FG000|Double-Blind Phase|Adverse Event|5|||
156332828|NCT02345226|564317407|FG001|Double-Blind Phase|Adverse Event|6|||
156332829|NCT02345226|564317406|FG000|Double-Blind Phase|Death|3|||
156332830|NCT02345226|564317407|FG001|Double-Blind Phase|Death|0|||
156332831|NCT02345226|564317406|FG000|Double-Blind Phase|Pregnancy|0|||
156332832|NCT02345226|564317407|FG001|Double-Blind Phase|Pregnancy|1|||
156332833|NCT02345226|564317406|FG000|Double-Blind Phase|Lack of Efficacy|1|||
156332834|NCT02345226|564317407|FG001|Double-Blind Phase|Lack of Efficacy|0|||
156332835|NCT02345226|564317406|FG000|Double-Blind Phase|Investigator's Discretion|4|||
156332836|NCT02345226|564317407|FG001|Double-Blind Phase|Investigator's Discretion|3|||
156332837|NCT02345226|564317406|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
156332838|NCT02345226|564317407|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
156332839|NCT02345226|564317406|FG000|Double-Blind Phase|Withdrew Consent|41|||
156332840|NCT02345226|564317407|FG001|Double-Blind Phase|Withdrew Consent|39|||
156332841|NCT02345226|564317406|FG000|Double-Blind Phase|Lost to Follow-up|12|||
156332842|NCT02345226|564317407|FG001|Double-Blind Phase|Lost to Follow-up|16|||
156332843|NCT02345226|564317406|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
156332844|NCT02345226|564317407|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
156442111|NCT02409667|564711040|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
156442112|NCT02409667|564711041|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
156442113|NCT02409667|564711042|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
156442114|NCT02409667|564711043|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
156442115|NCT02409667|564711044|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
156873648|NCT00060840|566296080|FG000|Overall Study|Subinvestigator unavailable|0|||
156873649|NCT00060840|566296081|FG001|Overall Study|Subinvestigator unavailable|1|||
156873650|NCT00060840|566296080|FG000|Overall Study|Physician Decision|1|||
156873651|NCT00060840|566296081|FG001|Overall Study|Physician Decision|0|||
156873652|NCT00060840|566296080|FG000|Overall Study|Other|1|||
156873653|NCT00060840|566296081|FG001|Overall Study|Other|0|||
156873654|NCT01388335|566296082|FG000|Period 1|Progressive Disease|1|||
156873655|NCT01388335|566296082|FG000|Period 2|Progressive Disease|2|||
156873656|NCT01388335|566296082|FG000|Period 2|Sponsor Decision|1|||
156873657|NCT01388335|566296082|FG000|Safety Extension|Progressive Disease|7|||
156873658|NCT01415882|566296083|FG000|Overall Study|Ineligible|1|||
156873659|NCT01415882|566296084|FG001|Overall Study|Ineligible|0|||
156873660|NCT01415882|566296085|FG002|Overall Study|Ineligible|0|||
156873661|NCT01415882|566296086|FG003|Overall Study|Ineligible|3|||
156873662|NCT01415882|566296087|FG004|Overall Study|Ineligible|0|||
156873663|NCT01415882|566296083|FG000|Overall Study|Withdrawal by Subject|0|||
156873664|NCT01415882|566296084|FG001|Overall Study|Withdrawal by Subject|1|||
156873665|NCT01415882|566296085|FG002|Overall Study|Withdrawal by Subject|0|||
156873666|NCT01415882|566296086|FG003|Overall Study|Withdrawal by Subject|1|||
156873667|NCT01415882|566296087|FG004|Overall Study|Withdrawal by Subject|0|||
156873668|NCT00976560|566296088|FG000|Overall Study|Adverse Event|5|||
156873669|NCT00976560|566296089|FG001|Overall Study|Adverse Event|5|||
156873670|NCT00976560|566296088|FG000|Overall Study|Lack of Efficacy|3|||
156873671|NCT00976560|566296089|FG001|Overall Study|Lack of Efficacy|5|||
156332845|NCT02345226|564317406|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
156332846|NCT02345226|564317407|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
156332847|NCT03386474|564317412|FG000|Overall Study|Death|1|||
156332848|NCT03386474|564317413|FG001|Overall Study|Death|0|||
156332849|NCT03386474|564317412|FG000|Overall Study|Adverse Event|0|||
156332850|NCT03386474|564317413|FG001|Overall Study|Adverse Event|1|||
156332851|NCT02711345|564317414|FG000|Overall Study|Adverse Event|0|||
156442116|NCT02409667|564711040|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
156442117|NCT02409667|564711041|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
156873672|NCT00976560|566296088|FG000|Overall Study|Protocol Violation|1|||
156873673|NCT00976560|566296089|FG001|Overall Study|Protocol Violation|0|||
156873674|NCT00976560|566296088|FG000|Overall Study|Lost to Follow-up|1|||
156873675|NCT00976560|566296089|FG001|Overall Study|Lost to Follow-up|0|||
156873676|NCT00976560|566296088|FG000|Overall Study|Physician Decision|2|||
156873677|NCT00976560|566296089|FG001|Overall Study|Physician Decision|0|||
156873678|NCT00976560|566296088|FG000|Overall Study|Withdrawal by Subject|2|||
156332852|NCT02711345|564317415|FG001|Overall Study|Adverse Event|0|||
156332853|NCT02711345|564317416|FG002|Overall Study|Adverse Event|0|||
156332854|NCT02711345|564317417|FG003|Overall Study|Adverse Event|1|||
156332855|NCT02711345|564317418|FG004|Overall Study|Adverse Event|1|||
156332856|NCT02711345|564317419|FG005|Overall Study|Adverse Event|2|||
156332857|NCT02711345|564317420|FG006|Overall Study|Adverse Event|1|||
156332858|NCT02711345|564317421|FG007|Overall Study|Adverse Event|0|||
156332859|NCT02711345|564317422|FG008|Overall Study|Adverse Event|0|||
156873679|NCT00976560|566296089|FG001|Overall Study|Withdrawal by Subject|3|||
156873680|NCT00125164|566296092|FG000|Overall Study|Adverse Event|0|||
156332860|NCT02711345|564317423|FG009|Overall Study|Adverse Event|2|||
156332861|NCT02711345|564317414|FG000|Overall Study|Physician Decision|0|||
156710672|NCT02027428|565686299|FG001|Maintenance|Symptomatic deterioration|4|||
156710673|NCT02027428|565686300|FG002|Maintenance|Symptomatic deterioration|1|||
156710674|NCT02027428|565686298|FG000|Maintenance|Withdrawal by Subject|0|||
156710675|NCT02027428|565686299|FG001|Maintenance|Withdrawal by Subject|6|||
156442118|NCT02409667|564711042|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
156710676|NCT02027428|565686300|FG002|Maintenance|Withdrawal by Subject|5|||
156710677|NCT02027428|565686298|FG000|Maintenance|Protocol Violation|0|||
156710678|NCT02027428|565686299|FG001|Maintenance|Protocol Violation|0|||
156710679|NCT02027428|565686300|FG002|Maintenance|Protocol Violation|1|||
156710680|NCT02027428|565686298|FG000|Maintenance|Other|0|||
156710681|NCT02027428|565686299|FG001|Maintenance|Other|6|||
156710682|NCT02027428|565686300|FG002|Maintenance|Other|3|||
156710683|NCT02027428|565686298|FG000|Survival Follow-up|Death|0|||
156710684|NCT02027428|565686299|FG001|Survival Follow-up|Death|78|||
156710685|NCT02027428|565686300|FG002|Survival Follow-up|Death|45|||
156710686|NCT02027428|565686298|FG000|Survival Follow-up|Lost to Follow-up|0|||
156710687|NCT02027428|565686299|FG001|Survival Follow-up|Lost to Follow-up|1|||
156710688|NCT02027428|565686300|FG002|Survival Follow-up|Lost to Follow-up|1|||
156710689|NCT02859142|565686301|FG000|Overall Study|Adverse Event|1|||
156710690|NCT02859142|565686302|FG001|Overall Study|Adverse Event|2|||
156710691|NCT02859142|565686301|FG000|Overall Study|Lost to Follow-up|1|||
156710692|NCT02859142|565686302|FG001|Overall Study|Lost to Follow-up|4|||
156710693|NCT02859142|565686301|FG000|Overall Study|Withdrawal by Subject|2|||
156710694|NCT02859142|565686302|FG001|Overall Study|Withdrawal by Subject|0|||
156710695|NCT02859142|565686301|FG000|Overall Study|Scheduling difficulties|0|||
156710696|NCT02859142|565686302|FG001|Overall Study|Scheduling difficulties|3|||
156710697|NCT01128543|565686306|FG000|Overall Study|Withdrawal by Subject|3|||
156710698|NCT01128543|565686306|FG000|Overall Study|Protocol Violation|1|||
156710699|NCT02676765|565686307|FG000|Overall Study|Lost to Follow-up|0|||
156710700|NCT02676765|565686308|FG001|Overall Study|Lost to Follow-up|1|||
156710701|NCT02374346|565686312|FG000|Overall Study|operated or discharged during weekend|48|||
156710702|NCT04487067|565686318|FG000|Overall Study|Adverse Event|3|||
156710703|NCT04487067|565686318|FG000|Overall Study|Death Other Than Progressive Disease|60|||
156710704|NCT04487067|565686318|FG000|Overall Study|Death Due To Progressive Disease|40|||
156710705|NCT04487067|565686318|FG000|Overall Study|Lost to Follow-up|3|||
156710706|NCT04487067|565686318|FG000|Overall Study|Progressive Disease|1|||
156710707|NCT04487067|565686318|FG000|Overall Study|Protocol Violation|3|||
156710708|NCT04487067|565686318|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
156710709|NCT04487067|565686318|FG000|Overall Study|Withdrawal by Subject|15|||
156710710|NCT05299528|565686319|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710711|NCT05299528|565686320|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
156710712|NCT05299528|565686321|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710713|NCT05299528|565686322|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710714|NCT05299528|565686323|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710715|NCT05299528|565686324|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710716|NCT05299528|565686325|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710717|NCT05299528|565686319|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710718|NCT05299528|565686320|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710719|NCT05299528|565686321|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710720|NCT05299528|565686322|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156792241|NCT02336555|565992711|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
156792242|NCT02336555|565992712|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
156792243|NCT01772693|565992713|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
156710721|NCT05299528|565686323|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710722|NCT05299528|565686324|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
156710723|NCT05299528|565686325|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710724|NCT05299528|565686319|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
156710725|NCT05299528|565686320|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
156332862|NCT02711345|564317415|FG001|Overall Study|Physician Decision|0|||
156332863|NCT02711345|564317416|FG002|Overall Study|Physician Decision|1|||
156332864|NCT02711345|564317417|FG003|Overall Study|Physician Decision|0|||
156332865|NCT02711345|564317418|FG004|Overall Study|Physician Decision|0|||
156332866|NCT02711345|564317419|FG005|Overall Study|Physician Decision|0|||
156332867|NCT02711345|564317420|FG006|Overall Study|Physician Decision|0|||
156332868|NCT02711345|564317421|FG007|Overall Study|Physician Decision|0|||
156332869|NCT02711345|564317422|FG008|Overall Study|Physician Decision|1|||
156332870|NCT02711345|564317423|FG009|Overall Study|Physician Decision|0|||
156332871|NCT02711345|564317414|FG000|Overall Study|Progressive disease|1|||
156332872|NCT02711345|564317415|FG001|Overall Study|Progressive disease|3|||
156710726|NCT05299528|565686321|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
156710727|NCT05299528|565686322|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
156710728|NCT05299528|565686323|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
156710729|NCT05299528|565686324|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
156710730|NCT05299528|565686325|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
156710731|NCT04324021|565686326|FG000|Overall Study|Adverse Event|1|||
156710732|NCT04324021|565686327|FG001|Overall Study|Adverse Event|0|||
156710733|NCT04324021|565686328|FG002|Overall Study|Adverse Event|0|||
156710734|NCT04324021|565686326|FG000|Overall Study|Lack of Efficacy|0|||
156710735|NCT04324021|565686327|FG001|Overall Study|Lack of Efficacy|0|||
156710736|NCT04324021|565686328|FG002|Overall Study|Lack of Efficacy|1|||
156710737|NCT04324021|565686326|FG000|Overall Study|Death|1|||
156710738|NCT04324021|565686327|FG001|Overall Study|Death|1|||
156710739|NCT04324021|565686328|FG002|Overall Study|Death|0|||
156710740|NCT04877457|565686329|FG000|Overall Study|Early termination of study due to low enrollment|2|||
156710741|NCT04877457|565686330|FG001|Overall Study|Early termination of study due to low enrollment|1|||
156710742|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
156710743|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
156710744|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
156710745|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Death|1|||
156710746|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Death|3|||
156710747|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Death|1|||
156710748|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
156710749|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
156710750|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
156710751|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
156710752|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
156710753|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
156710754|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
156710755|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
156710756|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
156710757|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
156710758|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
156710759|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
156710760|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
156710761|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
156710762|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
156710763|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
156710764|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
156710765|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
156710766|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
156710767|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
156710768|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
156710769|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
156710770|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
156710771|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
156710772|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
156710773|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
156710774|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
156710775|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
156710776|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
156710777|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
156710778|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
156710779|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
156710780|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
156710781|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
156710782|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
156710783|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
156710784|NCT00299130|565686331|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
156710785|NCT00299130|565686332|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
156710786|NCT00299130|565686333|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
156710787|NCT00299130|565686331|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
156710788|NCT00299130|565686332|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
156710789|NCT00299130|565686333|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
156710790|NCT00299130|565686331|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
156710791|NCT00299130|565686332|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
156710792|NCT00299130|565686333|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
156710793|NCT02211417|565686334|FG000|Overall Study|Withdrawal by Subject|11|||
156873681|NCT00125164|566296093|FG001|Overall Study|Adverse Event|0|||
156873682|NCT00125164|566296094|FG002|Overall Study|Adverse Event|2|||
156873683|NCT00125164|566296095|FG003|Overall Study|Adverse Event|4|||
156873684|NCT00125164|566296092|FG000|Overall Study|Lost to Follow-up|0|||
156873685|NCT00125164|566296093|FG001|Overall Study|Lost to Follow-up|0|||
156873686|NCT00125164|566296094|FG002|Overall Study|Lost to Follow-up|1|||
156873687|NCT00125164|566296095|FG003|Overall Study|Lost to Follow-up|1|||
156873688|NCT00125164|566296092|FG000|Overall Study|Withdrawal by Subject|2|||
156873689|NCT00125164|566296093|FG001|Overall Study|Withdrawal by Subject|0|||
156873690|NCT00125164|566296094|FG002|Overall Study|Withdrawal by Subject|1|||
156873691|NCT00125164|566296095|FG003|Overall Study|Withdrawal by Subject|1|||
156873692|NCT00670306|566296096|FG000|Overall Study|Adverse Event|8|||
156873693|NCT00670306|566296096|FG000|Overall Study|Lack of Efficacy|10|||
156873694|NCT00670306|566296096|FG000|Overall Study|Withdrawal by Subject|9|||
156873695|NCT00670306|566296096|FG000|Overall Study|Physician Decision|1|||
156873696|NCT00670306|566296096|FG000|Overall Study|Lost to Follow-up|8|||
156873697|NCT00670306|566296096|FG000|Overall Study|incl/excl criterias did not meet|19|||
156873698|NCT01339052|566296100|FG000|Overall Study|Disease progression|13|||
156873699|NCT01339052|566296101|FG001|Overall Study|Disease progression|46|||
156710794|NCT02211417|565686335|FG001|Overall Study|Withdrawal by Subject|8|||
156710795|NCT02211417|565686334|FG000|Overall Study|Protocol Violation|1|||
156710796|NCT02211417|565686335|FG001|Overall Study|Protocol Violation|0|||
156710797|NCT02211417|565686334|FG000|Overall Study|Pregnancy|0|||
156710798|NCT02211417|565686335|FG001|Overall Study|Pregnancy|1|||
156710799|NCT02211417|565686334|FG000|Overall Study|Lost to Follow-up|2|||
156710800|NCT02211417|565686335|FG001|Overall Study|Lost to Follow-up|3|||
156710801|NCT02211417|565686334|FG000|Overall Study|Adverse Event|1|||
156710802|NCT02211417|565686335|FG001|Overall Study|Adverse Event|4|||
156710803|NCT01198132|565686336|FG000|Overall Study|Withdrawal by Subject|4|||
156710804|NCT01198132|565686337|FG001|Overall Study|Withdrawal by Subject|5|||
156710805|NCT01198132|565686336|FG000|Overall Study|Physician Decision|5|||
156710806|NCT01198132|565686337|FG001|Overall Study|Physician Decision|4|||
156710807|NCT01198132|565686336|FG000|Overall Study|Other Unspecified|3|||
156710808|NCT01198132|565686337|FG001|Overall Study|Other Unspecified|6|||
156710809|NCT01198132|565686336|FG000|Overall Study|Lack of Efficacy|2|||
156710810|NCT01198132|565686337|FG001|Overall Study|Lack of Efficacy|3|||
156710811|NCT01198132|565686336|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
156710812|NCT01198132|565686337|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
156710813|NCT01198132|565686336|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
156710814|NCT01198132|565686337|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
156710815|NCT01198132|565686336|FG000|Overall Study|Adverse Event|0|||
156710816|NCT01198132|565686337|FG001|Overall Study|Adverse Event|1|||
156710817|NCT01198132|565686336|FG000|Overall Study|Protocol Violation|1|||
156710818|NCT01198132|565686337|FG001|Overall Study|Protocol Violation|0|||
156710819|NCT00490841|565686338|FG000|Overall Study|Death|5|||
156710820|NCT00490841|565686338|FG000|Overall Study|Withdrawal by Subject|4|||
156710821|NCT00490841|565686338|FG000|Overall Study|Lost to Follow-up|1|||
156710822|NCT00490841|565686338|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
156710823|NCT01277211|565686339|FG000|Overall Study|Adverse Event|60|||
156710824|NCT01277211|565686340|FG001|Overall Study|Adverse Event|22|||
156710825|NCT01277211|565686339|FG000|Overall Study|Pregnancy|9|||
156710826|NCT01277211|565686340|FG001|Overall Study|Pregnancy|4|||
156710827|NCT01277211|565686339|FG000|Overall Study|Lost to Follow-up|14|||
156710828|NCT01277211|565686340|FG001|Overall Study|Lost to Follow-up|9|||
156710829|NCT01277211|565686339|FG000|Overall Study|Did not wish to continue|17|||
156710830|NCT01277211|565686340|FG001|Overall Study|Did not wish to continue|0|||
156710831|NCT01277211|565686339|FG000|Overall Study|Withdrew Consent|9|||
156873700|NCT01339052|566296100|FG000|Overall Study|Adverse Event|1|||
156873701|NCT01339052|566296101|FG001|Overall Study|Adverse Event|1|||
156873702|NCT01339052|566296100|FG000|Overall Study|Withdrawal by Subject|0|||
156873703|NCT01339052|566296101|FG001|Overall Study|Withdrawal by Subject|3|||
156873704|NCT01339052|566296100|FG000|Overall Study|Physician Decision|1|||
156873705|NCT01339052|566296101|FG001|Overall Study|Physician Decision|0|||
156710832|NCT01277211|565686340|FG001|Overall Study|Withdrew Consent|9|||
156710833|NCT01277211|565686339|FG000|Overall Study|Non-compliance with protocol|13|||
156873706|NCT01301027|566296104|FG000|Overall Study|Physician Decision|2|||
156710834|NCT01277211|565686340|FG001|Overall Study|Non-compliance with protocol|4|||
156710835|NCT01277211|565686339|FG000|Overall Study|Did not meet protocol eligibility|1|||
156710836|NCT01277211|565686340|FG001|Overall Study|Did not meet protocol eligibility|0|||
156873707|NCT01301027|566296105|FG001|Overall Study|Physician Decision|0|||
156873708|NCT01301027|566296104|FG000|Overall Study|Withdrawal by Subject|2|||
156873709|NCT01301027|566296105|FG001|Overall Study|Withdrawal by Subject|3|||
156873710|NCT01301027|566296104|FG000|Overall Study|Adverse Event|0|||
156873711|NCT01301027|566296105|FG001|Overall Study|Adverse Event|2|||
156710837|NCT01277211|565686339|FG000|Overall Study|Administrative|3|||
156710838|NCT01277211|565686340|FG001|Overall Study|Administrative|0|||
156710839|NCT01277211|565686339|FG000|Overall Study|Pregnancy wish|0|||
156710840|NCT01277211|565686340|FG001|Overall Study|Pregnancy wish|2|||
156873712|NCT01301027|566296104|FG000|Overall Study|Fracture|1|||
156873713|NCT01301027|566296105|FG001|Overall Study|Fracture|3|||
156873714|NCT01301027|566296104|FG000|Overall Study|Transplant|0|||
156873715|NCT01301027|566296105|FG001|Overall Study|Transplant|2|||
156873716|NCT01301027|566296104|FG000|Overall Study|Volume Overload|3|||
156873717|NCT01301027|566296105|FG001|Overall Study|Volume Overload|0|||
156873718|NCT00845897|566296106|FG000|Overall Study|Lost to Follow-up|1|||
156873719|NCT00845897|566296107|FG001|Overall Study|Lost to Follow-up|1|||
156873720|NCT00845897|566296108|FG002|Overall Study|Lost to Follow-up|0|||
156873721|NCT00845897|566296106|FG000|Overall Study|Withdrawal by Subject|0|||
156873722|NCT00845897|566296107|FG001|Overall Study|Withdrawal by Subject|3|||
156873723|NCT00845897|566296108|FG002|Overall Study|Withdrawal by Subject|2|||
156873724|NCT00845897|566296106|FG000|Overall Study|Ulcer did not heal|1|||
156873725|NCT00845897|566296107|FG001|Overall Study|Ulcer did not heal|0|||
156873726|NCT00845897|566296108|FG002|Overall Study|Ulcer did not heal|1|||
156873727|NCT00845897|566296106|FG000|Overall Study|Too ill to participate|0|||
156873728|NCT00845897|566296107|FG001|Overall Study|Too ill to participate|1|||
156873729|NCT00845897|566296108|FG002|Overall Study|Too ill to participate|0|||
156873730|NCT02722499|566296110|FG000|Overall Study|Lost to Follow-up|2|||
156873731|NCT02722499|566296111|FG001|Overall Study|Lost to Follow-up|0|||
156710841|NCT01277211|565686339|FG000|Overall Study|Discontinued prior to treatment|24|||
156710842|NCT01277211|565686340|FG001|Overall Study|Discontinued prior to treatment|13|||
156710843|NCT03452943|565686341|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
156710844|NCT03452943|565686342|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
156710845|NCT03452943|565686341|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
156710846|NCT03452943|565686342|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
156710847|NCT03452943|565686341|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
156710848|NCT03452943|565686342|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
156710849|NCT03452943|565686341|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
156873732|NCT02722499|566296112|FG002|Overall Study|Lost to Follow-up|1|||
156873733|NCT03566485|566296123|FG000|Overall Study|Disease progression|5|||
156873734|NCT03566485|566296124|FG001|Overall Study|Disease progression|4|||
156873735|NCT03566485|566296123|FG000|Overall Study|Clinical progression|0|||
156873736|NCT03566485|566296124|FG001|Overall Study|Clinical progression|1|||
156873737|NCT03566485|566296123|FG000|Overall Study|Toxicity|0|||
156873738|NCT03566485|566296124|FG001|Overall Study|Toxicity|2|||
156873739|NCT03610269|566296127|FG000|Overall Study|Physician Decision|10|||
156873740|NCT03610269|566296127|FG000|Overall Study|Protocol Violation|1|||
156873741|NCT03610269|566296127|FG000|Overall Study|Unable to draw blood|1|||
156873742|NCT03610269|566296127|FG000|Overall Study|Screen fail|4|||
156873743|NCT00067002|566296128|FG000|Overall Study|Early Death|1|||
156873744|NCT00067002|566296129|FG001|Overall Study|Early Death|2|||
156873745|NCT00067002|566296128|FG000|Overall Study|Delayed|1|||
156873746|NCT00067002|566296129|FG001|Overall Study|Delayed|1|||
156873747|NCT00067002|566296128|FG000|Overall Study|Graft Failure|5|||
156873748|NCT00067002|566296129|FG001|Overall Study|Graft Failure|6|||
156873749|NCT01354314|566296130|FG000|Overall Study|Lost to Follow-up|1|||
156873750|NCT01354314|566296131|FG001|Overall Study|Lost to Follow-up|0|||
156873751|NCT01354314|566296132|FG002|Overall Study|Lost to Follow-up|1|||
156873752|NCT01354314|566296133|FG003|Overall Study|Lost to Follow-up|1|||
156873753|NCT01354314|566296130|FG000|Overall Study|Withdrawal by Subject|0|||
156710850|NCT03452943|565686342|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
156710851|NCT03452943|565686341|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
156710852|NCT03452943|565686342|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
156873754|NCT01354314|566296131|FG001|Overall Study|Withdrawal by Subject|0|||
156710853|NCT03452943|565686341|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
156710854|NCT03452943|565686342|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
156710855|NCT03516513|565686348|FG000|Overall Study|Withdrawal by Subject|2|||
156710856|NCT03516513|565686349|FG001|Overall Study|Withdrawal by Subject|2|||
156710857|NCT03516513|565686350|FG002|Overall Study|Withdrawal by Subject|0|||
156710858|NCT03516513|565686351|FG003|Overall Study|Withdrawal by Subject|0|||
156710859|NCT04697069|565686352|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
156710860|NCT04697069|565686353|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
156873755|NCT01354314|566296132|FG002|Overall Study|Withdrawal by Subject|1|||
156873756|NCT01354314|566296133|FG003|Overall Study|Withdrawal by Subject|0|||
156873757|NCT01354314|566296130|FG000|Overall Study|Adverse Event|0|||
156873758|NCT01354314|566296131|FG001|Overall Study|Adverse Event|0|||
156873759|NCT01354314|566296132|FG002|Overall Study|Adverse Event|0|||
156873760|NCT01354314|566296133|FG003|Overall Study|Adverse Event|1|||
156873761|NCT01354314|566296130|FG000|Overall Study|Protocol Violation|1|||
156873762|NCT01354314|566296131|FG001|Overall Study|Protocol Violation|1|||
156710861|NCT04697069|565686352|FG000|Overall Study|Study termination|2|||
156873763|NCT01354314|566296132|FG002|Overall Study|Protocol Violation|0|||
156873764|NCT01354314|566296133|FG003|Overall Study|Protocol Violation|0|||
156873765|NCT01354314|566296130|FG000|Overall Study|Less than 90% Adherence|4|||
156873766|NCT01354314|566296131|FG001|Overall Study|Less than 90% Adherence|2|||
156873767|NCT01354314|566296132|FG002|Overall Study|Less than 90% Adherence|6|||
156332873|NCT02711345|564317416|FG002|Overall Study|Progressive disease|5|||
156873768|NCT01354314|566296133|FG003|Overall Study|Less than 90% Adherence|4|||
156873769|NCT00369265|566296135|FG000|Overall Study|Study terminated|4|||
156873770|NCT00369265|566296136|FG001|Overall Study|Study terminated|7|||
156873771|NCT00714870|566296137|FG000|Overall Study|Lost to Follow-up|22|||
156873772|NCT00714870|566296138|FG001|Overall Study|Lost to Follow-up|5|||
156873773|NCT00714870|566296137|FG000|Overall Study|patient unable to come b/c back pain|1|||
156873774|NCT00714870|566296138|FG001|Overall Study|patient unable to come b/c back pain|0|||
156873775|NCT00714870|566296137|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
156873776|NCT00714870|566296138|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
156873777|NCT01599637|566296141|FG000|Overall Study|administrative problems|0|||
156873778|NCT01599637|566296142|FG001|Overall Study|administrative problems|2|||
156873779|NCT01599637|566296143|FG002|Overall Study|administrative problems|0|||
156873780|NCT01599637|566296141|FG000|Overall Study|Adverse Event|1|||
156873781|NCT01599637|566296142|FG001|Overall Study|Adverse Event|0|||
156873782|NCT01599637|566296143|FG002|Overall Study|Adverse Event|0|||
156873783|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
156873784|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
156873785|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
156873786|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
156873787|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873788|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873789|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873790|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873791|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873792|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873793|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
156873794|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873795|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873796|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873797|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
156873798|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
156873799|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
156873800|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
156873801|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873802|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873803|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873804|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
156873805|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873806|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
156873807|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873808|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873809|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873810|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873811|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
156873812|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
156873813|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
156873814|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
156873815|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
156873816|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
156873817|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
156873818|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
156710862|NCT04697069|565686353|FG001|Overall Study|Study termination|1|||
156710863|NCT05180227|565686354|FG000|Overall Study|Hypertension at screening|1|||
156710864|NCT05180227|565686354|FG000|Overall Study|Lost to Follow-up|1|||
156710865|NCT01098487|565686355|FG000|Overall Study|Adverse Event|22|||
156710866|NCT01098487|565686355|FG000|Overall Study|Lack of Efficacy|11|||
156710867|NCT01098487|565686355|FG000|Overall Study|Withdrawal by Subject|7|||
156710868|NCT01098487|565686355|FG000|Overall Study|Lost to Follow-up|3|||
156710869|NCT01098487|565686355|FG000|Overall Study|Physician Decision|1|||
156710870|NCT01130597|565686356|FG000|Overall Study|Protocol-specified (High K+)|1|||
156710871|NCT01130597|565686356|FG000|Overall Study|Adverse Event|4|||
156710872|NCT01130597|565686356|FG000|Overall Study|Death|1|||
156332874|NCT02711345|564317417|FG003|Overall Study|Progressive disease|3|||
156710873|NCT01130597|565686356|FG000|Overall Study|Protocol Violation|1|||
156710874|NCT02516553|565686357|FG000|Overall Study|Progressive disease|2|||
156873819|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873820|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156332875|NCT02711345|564317418|FG004|Overall Study|Progressive disease|7|||
156332876|NCT02711345|564317419|FG005|Overall Study|Progressive disease|2|||
156710875|NCT02516553|565686358|FG001|Overall Study|Progressive disease|2|||
156710876|NCT02516553|565686359|FG002|Overall Study|Progressive disease|3|||
156710877|NCT02516553|565686360|FG003|Overall Study|Progressive disease|5|||
156710878|NCT02516553|565686361|FG004|Overall Study|Progressive disease|3|||
156710879|NCT02516553|565686362|FG005|Overall Study|Progressive disease|0|||
156710880|NCT02516553|565686363|FG006|Overall Study|Progressive disease|5|||
156710881|NCT02516553|565686364|FG007|Overall Study|Progressive disease|5|||
156710882|NCT02516553|565686365|FG008|Overall Study|Progressive disease|11|||
156710883|NCT02516553|565686366|FG009|Overall Study|Progressive disease|3|||
156710884|NCT02516553|565686367|FG010|Overall Study|Progressive disease|10|||
156710885|NCT02516553|565686368|FG011|Overall Study|Progressive disease|8|||
156710886|NCT02516553|565686369|FG012|Overall Study|Progressive disease|8|||
156710887|NCT02516553|565686370|FG013|Overall Study|Progressive disease|2|||
156710888|NCT02516553|565686371|FG014|Overall Study|Progressive disease|2|||
156710889|NCT02516553|565686372|FG015|Overall Study|Progressive disease|2|||
156710890|NCT02516553|565686373|FG016|Overall Study|Progressive disease|1|||
156710891|NCT02516553|565686374|FG017|Overall Study|Progressive disease|9|||
156710892|NCT02516553|565686375|FG018|Overall Study|Progressive disease|12|||
156710893|NCT02516553|565686376|FG019|Overall Study|Progressive disease|7|||
156710894|NCT02516553|565686377|FG020|Overall Study|Progressive disease|16|||
156710895|NCT02516553|565686378|FG021|Overall Study|Progressive disease|18|||
156710896|NCT02516553|565686357|FG000|Overall Study|Dose limiting toxicity|0|||
156710897|NCT02516553|565686358|FG001|Overall Study|Dose limiting toxicity|0|||
156710898|NCT02516553|565686359|FG002|Overall Study|Dose limiting toxicity|0|||
156710899|NCT02516553|565686360|FG003|Overall Study|Dose limiting toxicity|0|||
156710900|NCT02516553|565686361|FG004|Overall Study|Dose limiting toxicity|3|||
156710901|NCT02516553|565686362|FG005|Overall Study|Dose limiting toxicity|1|||
156710902|NCT02516553|565686363|FG006|Overall Study|Dose limiting toxicity|1|||
156710903|NCT02516553|565686364|FG007|Overall Study|Dose limiting toxicity|0|||
156710904|NCT02516553|565686365|FG008|Overall Study|Dose limiting toxicity|1|||
156710905|NCT02516553|565686366|FG009|Overall Study|Dose limiting toxicity|0|||
156710906|NCT02516553|565686367|FG010|Overall Study|Dose limiting toxicity|0|||
156710907|NCT02516553|565686368|FG011|Overall Study|Dose limiting toxicity|1|||
156710908|NCT02516553|565686369|FG012|Overall Study|Dose limiting toxicity|0|||
156710909|NCT02516553|565686370|FG013|Overall Study|Dose limiting toxicity|1|||
156710910|NCT02516553|565686371|FG014|Overall Study|Dose limiting toxicity|0|||
156710911|NCT02516553|565686372|FG015|Overall Study|Dose limiting toxicity|0|||
156710912|NCT02516553|565686373|FG016|Overall Study|Dose limiting toxicity|1|||
156710913|NCT02516553|565686374|FG017|Overall Study|Dose limiting toxicity|1|||
156710914|NCT02516553|565686375|FG018|Overall Study|Dose limiting toxicity|0|||
156710915|NCT02516553|565686376|FG019|Overall Study|Dose limiting toxicity|2|||
156710916|NCT02516553|565686377|FG020|Overall Study|Dose limiting toxicity|0|||
156710917|NCT02516553|565686378|FG021|Overall Study|Dose limiting toxicity|0|||
156710918|NCT02516553|565686357|FG000|Overall Study|Other Adverse Events|0|||
156710919|NCT02516553|565686358|FG001|Overall Study|Other Adverse Events|0|||
156710920|NCT02516553|565686359|FG002|Overall Study|Other Adverse Events|0|||
156710921|NCT02516553|565686360|FG003|Overall Study|Other Adverse Events|1|||
156710922|NCT02516553|565686361|FG004|Overall Study|Other Adverse Events|0|||
156710923|NCT02516553|565686362|FG005|Overall Study|Other Adverse Events|1|||
156710924|NCT02516553|565686363|FG006|Overall Study|Other Adverse Events|0|||
156710925|NCT02516553|565686364|FG007|Overall Study|Other Adverse Events|0|||
156710926|NCT02516553|565686365|FG008|Overall Study|Other Adverse Events|0|||
156710927|NCT02516553|565686366|FG009|Overall Study|Other Adverse Events|1|||
156873821|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873822|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873823|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156710928|NCT02516553|565686367|FG010|Overall Study|Other Adverse Events|3|||
156710929|NCT02516553|565686368|FG011|Overall Study|Other Adverse Events|2|||
156710930|NCT02516553|565686369|FG012|Overall Study|Other Adverse Events|0|||
156873824|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156710931|NCT02516553|565686370|FG013|Overall Study|Other Adverse Events|1|||
156710932|NCT02516553|565686371|FG014|Overall Study|Other Adverse Events|0|||
156710933|NCT02516553|565686372|FG015|Overall Study|Other Adverse Events|0|||
156710934|NCT02516553|565686373|FG016|Overall Study|Other Adverse Events|0|||
156710935|NCT02516553|565686374|FG017|Overall Study|Other Adverse Events|2|||
156710936|NCT02516553|565686375|FG018|Overall Study|Other Adverse Events|1|||
156710937|NCT02516553|565686376|FG019|Overall Study|Other Adverse Events|2|||
156710938|NCT02516553|565686377|FG020|Overall Study|Other Adverse Events|2|||
156710939|NCT02516553|565686378|FG021|Overall Study|Other Adverse Events|1|||
156710940|NCT02516553|565686357|FG000|Overall Study|Refused to continue trial medication|0|||
156710941|NCT02516553|565686358|FG001|Overall Study|Refused to continue trial medication|0|||
156710942|NCT02516553|565686359|FG002|Overall Study|Refused to continue trial medication|0|||
156710943|NCT02516553|565686360|FG003|Overall Study|Refused to continue trial medication|0|||
156710944|NCT02516553|565686361|FG004|Overall Study|Refused to continue trial medication|0|||
156332877|NCT02711345|564317420|FG006|Overall Study|Progressive disease|8|||
156332878|NCT02711345|564317421|FG007|Overall Study|Progressive disease|4|||
156332879|NCT02711345|564317422|FG008|Overall Study|Progressive disease|5|||
156332880|NCT02711345|564317423|FG009|Overall Study|Progressive disease|6|||
156710945|NCT02516553|565686362|FG005|Overall Study|Refused to continue trial medication|0|||
156710946|NCT02516553|565686363|FG006|Overall Study|Refused to continue trial medication|0|||
156710947|NCT02516553|565686364|FG007|Overall Study|Refused to continue trial medication|0|||
156710948|NCT02516553|565686365|FG008|Overall Study|Refused to continue trial medication|0|||
156710949|NCT02516553|565686366|FG009|Overall Study|Refused to continue trial medication|0|||
156710950|NCT02516553|565686367|FG010|Overall Study|Refused to continue trial medication|1|||
156710951|NCT02516553|565686368|FG011|Overall Study|Refused to continue trial medication|0|||
156710952|NCT02516553|565686369|FG012|Overall Study|Refused to continue trial medication|0|||
156710953|NCT02516553|565686370|FG013|Overall Study|Refused to continue trial medication|0|||
156710954|NCT02516553|565686371|FG014|Overall Study|Refused to continue trial medication|0|||
156710955|NCT02516553|565686372|FG015|Overall Study|Refused to continue trial medication|0|||
156710956|NCT02516553|565686373|FG016|Overall Study|Refused to continue trial medication|0|||
156710957|NCT02516553|565686374|FG017|Overall Study|Refused to continue trial medication|0|||
156710958|NCT02516553|565686375|FG018|Overall Study|Refused to continue trial medication|1|||
156710959|NCT02516553|565686376|FG019|Overall Study|Refused to continue trial medication|0|||
156710960|NCT02516553|565686377|FG020|Overall Study|Refused to continue trial medication|0|||
156710961|NCT02516553|565686378|FG021|Overall Study|Refused to continue trial medication|1|||
156710962|NCT02516553|565686357|FG000|Overall Study|other reasons than listed|0|||
156710963|NCT02516553|565686358|FG001|Overall Study|other reasons than listed|0|||
156710964|NCT02516553|565686359|FG002|Overall Study|other reasons than listed|0|||
156710965|NCT02516553|565686360|FG003|Overall Study|other reasons than listed|0|||
156710966|NCT02516553|565686361|FG004|Overall Study|other reasons than listed|0|||
156710967|NCT02516553|565686362|FG005|Overall Study|other reasons than listed|0|||
156710968|NCT02516553|565686363|FG006|Overall Study|other reasons than listed|0|||
156710969|NCT02516553|565686364|FG007|Overall Study|other reasons than listed|1|||
156710970|NCT02516553|565686365|FG008|Overall Study|other reasons than listed|1|||
156710971|NCT02516553|565686366|FG009|Overall Study|other reasons than listed|0|||
156710972|NCT02516553|565686367|FG010|Overall Study|other reasons than listed|1|||
156710973|NCT02516553|565686368|FG011|Overall Study|other reasons than listed|1|||
156710974|NCT02516553|565686369|FG012|Overall Study|other reasons than listed|0|||
156710975|NCT02516553|565686370|FG013|Overall Study|other reasons than listed|0|||
156710976|NCT02516553|565686371|FG014|Overall Study|other reasons than listed|0|||
156710977|NCT02516553|565686372|FG015|Overall Study|other reasons than listed|0|||
156710978|NCT02516553|565686373|FG016|Overall Study|other reasons than listed|0|||
156710979|NCT02516553|565686374|FG017|Overall Study|other reasons than listed|0|||
156710980|NCT02516553|565686375|FG018|Overall Study|other reasons than listed|0|||
156710981|NCT02516553|565686376|FG019|Overall Study|other reasons than listed|0|||
156710982|NCT02516553|565686377|FG020|Overall Study|other reasons than listed|2|||
156710983|NCT02516553|565686378|FG021|Overall Study|other reasons than listed|2|||
156710984|NCT04614246|565686379|FG000|Overall Study|Adverse Event|0|||
156710985|NCT04614246|565686380|FG001|Overall Study|Adverse Event|1|||
156332881|NCT02711345|564317414|FG000|Overall Study|Subject/guardian decision|0|||
156332882|NCT02711345|564317415|FG001|Overall Study|Subject/guardian decision|0|||
156332883|NCT02711345|564317416|FG002|Overall Study|Subject/guardian decision|0|||
156332884|NCT02711345|564317417|FG003|Overall Study|Subject/guardian decision|0|||
156710986|NCT04614246|565686381|FG002|Overall Study|Adverse Event|1|||
156710987|NCT04614246|565686382|FG003|Overall Study|Adverse Event|2|||
156710988|NCT04614246|565686383|FG004|Overall Study|Adverse Event|1|||
156710989|NCT04614246|565686379|FG000|Overall Study|Lost to Follow-up|0|||
156710990|NCT04614246|565686380|FG001|Overall Study|Lost to Follow-up|1|||
156710991|NCT04614246|565686381|FG002|Overall Study|Lost to Follow-up|0|||
156710992|NCT04614246|565686382|FG003|Overall Study|Lost to Follow-up|1|||
156710993|NCT04614246|565686383|FG004|Overall Study|Lost to Follow-up|3|||
156710994|NCT04614246|565686379|FG000|Overall Study|Other reason|0|||
156710995|NCT04614246|565686380|FG001|Overall Study|Other reason|1|||
156710996|NCT04614246|565686381|FG002|Overall Study|Other reason|2|||
156710997|NCT04614246|565686382|FG003|Overall Study|Other reason|0|||
156792244|NCT01772693|565992714|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
156792245|NCT01772693|565992713|FG000|Overall Study|Withdrawal by Subject|2|||
156792246|NCT01772693|565992714|FG001|Overall Study|Withdrawal by Subject|0|||
156792247|NCT01772693|565992713|FG000|Overall Study|Alternative Treatment|2|||
156792248|NCT01772693|565992714|FG001|Overall Study|Alternative Treatment|0|||
156792249|NCT01633112|565992717|FG000|Overall Study|Lack of Efficacy|1|||
156792250|NCT01633112|565992718|FG001|Overall Study|Lack of Efficacy|6|||
156792251|NCT01633112|565992719|FG002|Overall Study|Lack of Efficacy|13|||
156792252|NCT01633112|565992717|FG000|Overall Study|Abnormal laboratory value(s)|3|||
156792253|NCT01633112|565992718|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156792254|NCT01633112|565992719|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156792255|NCT01633112|565992717|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156332885|NCT02711345|564317418|FG004|Overall Study|Subject/guardian decision|0|||
156873825|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
156710998|NCT04614246|565686383|FG004|Overall Study|Other reason|0|||
156710999|NCT04614246|565686379|FG000|Overall Study|Withdrawal by Subject|4|||
156711000|NCT04614246|565686380|FG001|Overall Study|Withdrawal by Subject|2|||
156711001|NCT04614246|565686381|FG002|Overall Study|Withdrawal by Subject|4|||
156711002|NCT04614246|565686382|FG003|Overall Study|Withdrawal by Subject|3|||
156711003|NCT04614246|565686383|FG004|Overall Study|Withdrawal by Subject|4|||
156711004|NCT04614246|565686379|FG000|Overall Study|Physician Decision|0|||
156711005|NCT04614246|565686380|FG001|Overall Study|Physician Decision|2|||
156711006|NCT04614246|565686381|FG002|Overall Study|Physician Decision|1|||
156711007|NCT04614246|565686382|FG003|Overall Study|Physician Decision|0|||
156711008|NCT04614246|565686383|FG004|Overall Study|Physician Decision|0|||
156711009|NCT04614246|565686379|FG000|Overall Study|Study terminated by sponsor|10|||
156711010|NCT04614246|565686380|FG001|Overall Study|Study terminated by sponsor|15|||
156711011|NCT04614246|565686381|FG002|Overall Study|Study terminated by sponsor|12|||
156711012|NCT04614246|565686382|FG003|Overall Study|Study terminated by sponsor|13|||
156711013|NCT04614246|565686383|FG004|Overall Study|Study terminated by sponsor|9|||
156711014|NCT04614246|565686379|FG000|Overall Study|Pregnancy|2|||
156711015|NCT04614246|565686380|FG001|Overall Study|Pregnancy|0|||
156711016|NCT04614246|565686381|FG002|Overall Study|Pregnancy|1|||
156711017|NCT04614246|565686382|FG003|Overall Study|Pregnancy|0|||
156711018|NCT04614246|565686383|FG004|Overall Study|Pregnancy|0|||
156711019|NCT00340678|565686384|FG000|Overall Study|Lost to Follow-up|1|||
156711020|NCT00340678|565686385|FG001|Overall Study|Lost to Follow-up|0|||
156711021|NCT00340678|565686386|FG002|Overall Study|Lost to Follow-up|0|||
156711022|NCT00340678|565686387|FG003|Overall Study|Lost to Follow-up|0|||
156711023|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
156711024|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
156711025|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
156711026|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
156711027|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
156711028|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
156711029|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
156711030|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
156711031|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
156711032|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
156711033|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
156711034|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
156711035|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
156711036|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
156711037|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
156711038|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
156711039|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
156711040|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
156711041|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
156711042|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
156711043|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Death|1|||
156711044|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Death|0|||
156711045|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Death|0|||
156711046|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Death|0|||
156711047|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Death|0|||
156711048|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Death|1|||
156711049|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Death|0|||
156711050|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Death|0|||
156711051|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Death|0|||
156711052|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Death|0|||
156711053|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Death|0|||
156711054|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Death|0|||
156711055|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Death|0|||
156873826|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873827|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
156873828|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
156873829|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873830|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873831|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156711056|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Death|0|||
156711057|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Death|0|||
156711058|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Death|0|||
156711059|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Death|0|||
156532098|NCT01284062|565043274|FG002|Overall Study|Protocol Violation|0|||
156711060|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Death|0|||
156711061|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Death|0|||
156711062|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Death|0|||
156711063|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
156711064|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
156711065|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
156873832|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
156873833|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
156873834|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
156873835|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873836|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873837|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873838|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
156873839|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873840|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
156873841|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873842|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873843|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873844|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873845|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873846|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
156873847|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873848|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873849|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873850|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
156873851|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
156873852|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
156873853|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873854|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
156873855|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
156873856|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873857|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873858|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873859|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873860|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
156873861|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
156873862|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
156873863|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
156711066|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
156711067|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
156711068|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
156711069|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
156711070|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
156711071|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
156711072|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
156711073|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
156711074|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
156711075|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
156711076|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
156711077|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
156711078|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
156711079|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
156711080|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
156711081|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
156711082|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
156711083|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711084|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
156711085|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711086|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
156711087|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
156711088|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
156711089|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
156873864|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
156873865|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
156873866|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
156873867|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873868|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156711090|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711091|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711092|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711093|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156532099|NCT01284062|565043275|FG003|Overall Study|Protocol Violation|2|||
156532100|NCT01284062|565043272|FG000|Overall Study|Withdrawal by Subject|3|||
156711094|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711095|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711096|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156873869|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873870|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873871|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156711097|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711098|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711099|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711100|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711101|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711102|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711103|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
156711104|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
156711105|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
156711106|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
156711107|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
156711108|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
156711109|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
156711110|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
156711111|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
156711112|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
156711113|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
156711114|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
156711115|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
156873872|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
156873873|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873874|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
156873875|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
156873876|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
156873877|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873878|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873879|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
156873880|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873881|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
156873882|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
156873883|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
156873884|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
156711116|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
156711117|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
156711118|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
156711119|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
156711120|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
156711121|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
156711122|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
156711123|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
156711124|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
156711125|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
156711126|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
156711127|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
156711128|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
156711129|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
156711130|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
156711131|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
156711132|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
156711133|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
156711134|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
156873885|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
156711135|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
156711136|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
156711137|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
156711138|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
156711139|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
156711140|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
156711141|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
156711142|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
156711143|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Death|0|||
156873886|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
156873887|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
156711144|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Death|0|||
156711145|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Death|0|||
156711146|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Death|0|||
156711147|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Death|0|||
156711148|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Death|0|||
156711149|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Death|0|||
156711150|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Death|0|||
156711151|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Death|0|||
156711152|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Death|2|||
156711153|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Death|0|||
156873888|NCT04476797|566296153|FG000|Overall Study|Withdrawal by Subject|1|||
156873889|NCT04476797|566296154|FG001|Overall Study|Withdrawal by Subject|0|||
156873890|NCT04476797|566296155|FG002|Overall Study|Withdrawal by Subject|0|||
156873891|NCT04476797|566296153|FG000|Overall Study|Death|0|||
156873892|NCT04476797|566296154|FG001|Overall Study|Death|1|||
156873893|NCT04476797|566296155|FG002|Overall Study|Death|2|||
156873894|NCT04476797|566296153|FG000|Overall Study|Sponsor Terminated Study|0|||
156873895|NCT04476797|566296154|FG001|Overall Study|Sponsor Terminated Study|18|||
156873896|NCT04476797|566296155|FG002|Overall Study|Sponsor Terminated Study|17|||
156873897|NCT02721966|566296157|FG000|Overall Study|Protocol Violation|1|||
156711154|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Death|1|||
156711155|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Death|1|||
156711156|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Death|0|||
156711157|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Death|0|||
156711158|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Death|0|||
156711159|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Death|0|||
156711160|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Death|0|||
156711161|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Death|0|||
156711162|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Death|0|||
156711163|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
156711164|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
156711165|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
156711166|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
156711167|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
156711168|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
156711169|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
156711170|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
156711171|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
156711172|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
156711173|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
156711174|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
156711175|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
156711176|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
156873898|NCT02721966|566296158|FG001|Overall Study|Protocol Violation|0|||
156873899|NCT02721966|566296159|FG002|Overall Study|Protocol Violation|0|||
156873900|NCT02721966|566296160|FG003|Overall Study|Protocol Violation|0|||
156873901|NCT02721966|566296161|FG004|Overall Study|Protocol Violation|0|||
156873902|NCT02721966|566296157|FG000|Overall Study|Withdrawal by Subject|9|||
156873903|NCT02721966|566296158|FG001|Overall Study|Withdrawal by Subject|2|||
156873904|NCT02721966|566296159|FG002|Overall Study|Withdrawal by Subject|3|||
156873905|NCT02721966|566296160|FG003|Overall Study|Withdrawal by Subject|7|||
156873906|NCT02721966|566296161|FG004|Overall Study|Withdrawal by Subject|0|||
156873907|NCT02721966|566296157|FG000|Overall Study|Adverse Event|4|||
156873908|NCT02721966|566296158|FG001|Overall Study|Adverse Event|4|||
156873909|NCT02721966|566296159|FG002|Overall Study|Adverse Event|3|||
156873910|NCT02721966|566296160|FG003|Overall Study|Adverse Event|0|||
156873911|NCT02721966|566296161|FG004|Overall Study|Adverse Event|0|||
156873912|NCT02721966|566296157|FG000|Overall Study|Death|1|||
156873913|NCT02721966|566296158|FG001|Overall Study|Death|0|||
156711177|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
156873914|NCT02721966|566296159|FG002|Overall Study|Death|0|||
156711178|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
156711179|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
156711180|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
156873915|NCT02721966|566296160|FG003|Overall Study|Death|0|||
156332886|NCT02711345|564317419|FG005|Overall Study|Subject/guardian decision|2|||
156873916|NCT02721966|566296161|FG004|Overall Study|Death|0|||
156873917|NCT02721966|566296157|FG000|Overall Study|Lack of Efficacy|7|||
156873918|NCT02721966|566296158|FG001|Overall Study|Lack of Efficacy|4|||
156711181|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
156711182|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
156711183|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711184|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711185|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711186|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711187|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711188|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711189|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711190|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711191|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711192|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
156711193|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
156711194|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
156711195|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
156711196|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711197|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711198|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711199|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711200|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711201|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711202|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711203|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
156711204|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
156711205|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
156711206|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
156711207|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
156711208|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
156711209|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
156711210|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
156711211|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
156711212|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
156711213|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
156711214|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
156711215|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
156711216|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
156711217|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
156711218|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
156711219|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
156711220|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
156711221|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
156711222|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
156711223|NCT00996892|565686391|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
156711224|NCT00996892|565686392|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
156711225|NCT00996892|565686393|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
156711226|NCT00996892|565686394|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
156711227|NCT00996892|565686395|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
156711228|NCT00996892|565686396|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
156711229|NCT00996892|565686397|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
156711230|NCT00996892|565686398|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
156711231|NCT00996892|565686399|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
156711232|NCT00996892|565686400|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
156711233|NCT00996892|565686401|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
156711234|NCT00996892|565686402|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
156711235|NCT00996892|565686403|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
156711236|NCT00996892|565686404|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
156711237|NCT00996892|565686405|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
156711238|NCT00996892|565686406|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
156711239|NCT00996892|565686407|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
156711240|NCT00996892|565686408|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
156711241|NCT00996892|565686409|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
156711242|NCT00996892|565686410|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
156711243|NCT00996892|565686391|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
156711244|NCT00996892|565686392|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
156873919|NCT02721966|566296159|FG002|Overall Study|Lack of Efficacy|0|||
156873920|NCT02721966|566296160|FG003|Overall Study|Lack of Efficacy|0|||
156873921|NCT02721966|566296161|FG004|Overall Study|Lack of Efficacy|0|||
156873922|NCT02721966|566296157|FG000|Overall Study|Lost to Follow-up|0|||
156873923|NCT02721966|566296158|FG001|Overall Study|Lost to Follow-up|0|||
156873924|NCT02721966|566296159|FG002|Overall Study|Lost to Follow-up|3|||
156873925|NCT02721966|566296160|FG003|Overall Study|Lost to Follow-up|0|||
156873926|NCT02721966|566296161|FG004|Overall Study|Lost to Follow-up|0|||
156711245|NCT00996892|565686393|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
156711246|NCT00996892|565686394|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
156711247|NCT00996892|565686395|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
156711248|NCT00996892|565686396|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
156442119|NCT02409667|564711043|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
156442120|NCT02409667|564711044|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
156711249|NCT00996892|565686397|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
156711250|NCT00996892|565686398|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
156711251|NCT00996892|565686399|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
156711252|NCT00996892|565686400|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
156711253|NCT00996892|565686401|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
156711254|NCT00996892|565686402|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
156711255|NCT00996892|565686403|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
156711256|NCT00996892|565686404|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
156442121|NCT02409667|564711040|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
156442122|NCT02409667|564711041|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
156442123|NCT02409667|564711042|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
156442124|NCT02409667|564711043|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
156442125|NCT02409667|564711044|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
156442126|NCT02409667|564711040|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
156442127|NCT02409667|564711041|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
156442128|NCT02409667|564711042|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
156442129|NCT02409667|564711043|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
156442130|NCT02409667|564711044|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
156442131|NCT02409667|564711040|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
156442132|NCT02409667|564711041|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
156442133|NCT02409667|564711042|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
156442134|NCT02409667|564711043|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
156442135|NCT02409667|564711044|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
156442136|NCT02409667|564711040|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
156442137|NCT02409667|564711041|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
156442138|NCT02409667|564711042|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
156442139|NCT02409667|564711043|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
156442140|NCT02409667|564711044|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
156442141|NCT01205048|564711047|FG000|Overall Study|Withdrawal by Subject|14|||
156442142|NCT01205048|564711047|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
156442143|NCT01205048|564711047|FG000|Overall Study|Lost to Follow-up|4|||
156442144|NCT01205048|564711047|FG000|Overall Study|Other|2|||
156442145|NCT01255670|564711048|FG000|Overall Study|Adverse Event|10|||
156442146|NCT01255670|564711049|FG001|Overall Study|Adverse Event|10|||
156442147|NCT01255670|564711048|FG000|Overall Study|Lost to Follow-up|16|||
156442148|NCT01255670|564711049|FG001|Overall Study|Lost to Follow-up|10|||
156442149|NCT00823472|564711050|FG000|Overall Study|Physician Decision|24|||
156442150|NCT00823472|564711051|FG001|Overall Study|Physician Decision|28|||
156442151|NCT04992390|564711059|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
156442152|NCT04992390|564711060|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
156442153|NCT04992390|564711061|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
156442154|NCT04992390|564711059|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
156442155|NCT04992390|564711060|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
156442156|NCT04992390|564711061|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
156442157|NCT04992390|564711059|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
156442158|NCT04992390|564711060|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
156442159|NCT04992390|564711061|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
156442160|NCT04992390|564711059|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
156442161|NCT04992390|564711060|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
156442162|NCT04992390|564711061|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
156711257|NCT00996892|565686405|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
156792256|NCT01633112|565992718|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156792257|NCT01633112|565992719|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156792258|NCT01633112|565992717|FG000|Overall Study|Administrative problems|1|||
156792259|NCT01633112|565992718|FG001|Overall Study|Administrative problems|2|||
156792260|NCT01633112|565992719|FG002|Overall Study|Administrative problems|5|||
156792261|NCT01633112|565992717|FG000|Overall Study|Adverse Event|16|||
156792262|NCT01633112|565992718|FG001|Overall Study|Adverse Event|18|||
156792263|NCT01633112|565992719|FG002|Overall Study|Adverse Event|20|||
156792264|NCT01633112|565992717|FG000|Overall Study|Lost to Follow-up|7|||
156792265|NCT01633112|565992718|FG001|Overall Study|Lost to Follow-up|19|||
156792266|NCT01633112|565992719|FG002|Overall Study|Lost to Follow-up|6|||
156792267|NCT01633112|565992717|FG000|Overall Study|Protocol Violation|4|||
156792268|NCT01633112|565992718|FG001|Overall Study|Protocol Violation|0|||
156792269|NCT01633112|565992719|FG002|Overall Study|Protocol Violation|2|||
156442163|NCT04992390|564711059|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
156442164|NCT04992390|564711060|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
156442165|NCT04992390|564711061|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
156711258|NCT00996892|565686406|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
156711259|NCT00996892|565686407|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
156711260|NCT00996892|565686408|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
156711261|NCT00996892|565686409|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
156711262|NCT00996892|565686410|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
156711263|NCT00996892|565686391|FG000|Expansion Stage 2|Adverse Event|0|||
156711264|NCT00996892|565686392|FG001|Expansion Stage 2|Adverse Event|0|||
156711265|NCT00996892|565686393|FG002|Expansion Stage 2|Adverse Event|0|||
156711266|NCT00996892|565686394|FG003|Expansion Stage 2|Adverse Event|0|||
156711267|NCT00996892|565686395|FG004|Expansion Stage 2|Adverse Event|0|||
156711268|NCT00996892|565686396|FG005|Expansion Stage 2|Adverse Event|0|||
156711269|NCT00996892|565686397|FG006|Expansion Stage 2|Adverse Event|0|||
156711270|NCT00996892|565686398|FG007|Expansion Stage 2|Adverse Event|0|||
156711271|NCT00996892|565686399|FG008|Expansion Stage 2|Adverse Event|0|||
156711272|NCT00996892|565686400|FG009|Expansion Stage 2|Adverse Event|0|||
156711273|NCT00996892|565686401|FG010|Expansion Stage 2|Adverse Event|0|||
156711274|NCT00996892|565686402|FG011|Expansion Stage 2|Adverse Event|0|||
156711275|NCT00996892|565686403|FG012|Expansion Stage 2|Adverse Event|0|||
156711276|NCT00996892|565686404|FG013|Expansion Stage 2|Adverse Event|0|||
156711277|NCT00996892|565686405|FG014|Expansion Stage 2|Adverse Event|0|||
156711278|NCT00996892|565686406|FG015|Expansion Stage 2|Adverse Event|0|||
156711279|NCT00996892|565686407|FG016|Expansion Stage 2|Adverse Event|0|||
156711280|NCT00996892|565686408|FG017|Expansion Stage 2|Adverse Event|0|||
156711281|NCT00996892|565686409|FG018|Expansion Stage 2|Adverse Event|3|||
156711282|NCT00996892|565686410|FG019|Expansion Stage 2|Adverse Event|0|||
156711283|NCT00996892|565686391|FG000|Expansion Stage 2|Death|0|||
156711284|NCT00996892|565686392|FG001|Expansion Stage 2|Death|0|||
156711285|NCT00996892|565686393|FG002|Expansion Stage 2|Death|0|||
156711286|NCT00996892|565686394|FG003|Expansion Stage 2|Death|0|||
156711287|NCT00996892|565686395|FG004|Expansion Stage 2|Death|0|||
156711288|NCT00996892|565686396|FG005|Expansion Stage 2|Death|0|||
156711289|NCT00996892|565686397|FG006|Expansion Stage 2|Death|0|||
156711290|NCT00996892|565686398|FG007|Expansion Stage 2|Death|0|||
156711291|NCT00996892|565686399|FG008|Expansion Stage 2|Death|0|||
156711292|NCT00996892|565686400|FG009|Expansion Stage 2|Death|0|||
156711293|NCT00996892|565686401|FG010|Expansion Stage 2|Death|0|||
156711294|NCT00996892|565686402|FG011|Expansion Stage 2|Death|0|||
156711295|NCT00996892|565686403|FG012|Expansion Stage 2|Death|0|||
156711296|NCT00996892|565686404|FG013|Expansion Stage 2|Death|0|||
156711297|NCT00996892|565686405|FG014|Expansion Stage 2|Death|0|||
156711298|NCT00996892|565686406|FG015|Expansion Stage 2|Death|0|||
156711299|NCT00996892|565686407|FG016|Expansion Stage 2|Death|0|||
156711300|NCT00996892|565686408|FG017|Expansion Stage 2|Death|0|||
156711301|NCT00996892|565686409|FG018|Expansion Stage 2|Death|2|||
156711302|NCT00996892|565686410|FG019|Expansion Stage 2|Death|0|||
156711303|NCT00996892|565686391|FG000|Expansion Stage 2|Physician Decision|0|||
156711304|NCT00996892|565686392|FG001|Expansion Stage 2|Physician Decision|0|||
156711305|NCT00996892|565686393|FG002|Expansion Stage 2|Physician Decision|0|||
156711306|NCT00996892|565686394|FG003|Expansion Stage 2|Physician Decision|0|||
156711307|NCT00996892|565686395|FG004|Expansion Stage 2|Physician Decision|0|||
156711308|NCT00996892|565686396|FG005|Expansion Stage 2|Physician Decision|0|||
156711309|NCT00996892|565686397|FG006|Expansion Stage 2|Physician Decision|0|||
156442166|NCT04992390|564711059|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
156442167|NCT04992390|564711060|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
156442168|NCT04992390|564711061|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
156442169|NCT04992390|564711059|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
156442170|NCT04992390|564711060|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
156442171|NCT04992390|564711061|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
156442172|NCT04992390|564711059|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
156442173|NCT04992390|564711060|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
156442174|NCT04992390|564711061|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
156442175|NCT04992390|564711059|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
156442176|NCT04992390|564711060|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
156442177|NCT04992390|564711061|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
156442178|NCT04992390|564711059|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
156442179|NCT04992390|564711060|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
156442180|NCT04992390|564711061|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
156442181|NCT04992390|564711059|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
156442182|NCT04992390|564711060|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
156442183|NCT04992390|564711061|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
156711310|NCT00996892|565686398|FG007|Expansion Stage 2|Physician Decision|0|||
156711311|NCT00996892|565686399|FG008|Expansion Stage 2|Physician Decision|0|||
156711312|NCT00996892|565686400|FG009|Expansion Stage 2|Physician Decision|0|||
156711313|NCT00996892|565686401|FG010|Expansion Stage 2|Physician Decision|0|||
156711314|NCT00996892|565686402|FG011|Expansion Stage 2|Physician Decision|0|||
156711315|NCT00996892|565686403|FG012|Expansion Stage 2|Physician Decision|0|||
156711316|NCT00996892|565686404|FG013|Expansion Stage 2|Physician Decision|0|||
156711317|NCT00996892|565686405|FG014|Expansion Stage 2|Physician Decision|0|||
156711318|NCT00996892|565686406|FG015|Expansion Stage 2|Physician Decision|0|||
156711319|NCT00996892|565686407|FG016|Expansion Stage 2|Physician Decision|0|||
156711320|NCT00996892|565686408|FG017|Expansion Stage 2|Physician Decision|0|||
156711321|NCT00996892|565686409|FG018|Expansion Stage 2|Physician Decision|1|||
156442184|NCT04992390|564711059|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
156442185|NCT04992390|564711060|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
156442186|NCT04992390|564711061|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
156442187|NCT04992390|564711059|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
156711322|NCT00996892|565686410|FG019|Expansion Stage 2|Physician Decision|0|||
156711323|NCT00996892|565686391|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
156711324|NCT00996892|565686392|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
156711325|NCT00996892|565686393|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
156711326|NCT00996892|565686394|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
156711327|NCT00996892|565686395|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
156442188|NCT04992390|564711060|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
156442189|NCT04992390|564711061|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
156442190|NCT04992390|564711059|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
156442191|NCT04992390|564711060|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
156442192|NCT04992390|564711061|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
156442193|NCT04992390|564711059|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
156442194|NCT04992390|564711060|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
156442195|NCT04992390|564711061|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
156442196|NCT04992390|564711059|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
156442197|NCT04992390|564711060|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
156442198|NCT04992390|564711061|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
156711328|NCT00996892|565686396|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
156711329|NCT00996892|565686397|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
156711330|NCT00996892|565686398|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
156711331|NCT00996892|565686399|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
156711332|NCT00996892|565686400|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
156711333|NCT00996892|565686401|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
156711334|NCT00996892|565686402|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
156711335|NCT00996892|565686403|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
156711336|NCT00996892|565686404|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
156711337|NCT00996892|565686405|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
156711338|NCT00996892|565686406|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
156711339|NCT00996892|565686407|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
156711340|NCT00996892|565686408|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
156711341|NCT00996892|565686409|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
156711342|NCT00996892|565686410|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
156711343|NCT00996892|565686391|FG000|Expansion Stage 2|Disease Progression|0|||
156711344|NCT00996892|565686392|FG001|Expansion Stage 2|Disease Progression|0|||
156711345|NCT00996892|565686393|FG002|Expansion Stage 2|Disease Progression|0|||
156442199|NCT02769858|564711064|FG000|Overall Study|Withdrawal by Subject|2|||
156442200|NCT03783026|564713371|FG000|Treatment Phase|Adverse Event|15|||
156873927|NCT02721966|566296157|FG000|Overall Study|Physician Decision|1|||
156873928|NCT02721966|566296158|FG001|Overall Study|Physician Decision|1|||
156442201|NCT03783026|564713371|FG000|Treatment Phase|Lack of Efficacy|11|||
156442202|NCT03783026|564713371|FG000|Treatment Phase|Withdrawal by Subject|6|||
156442203|NCT03783026|564713371|FG000|Treatment Phase|Lost to Follow-up|2|||
156442204|NCT03783026|564713371|FG000|Treatment Phase|Protocol Deviation|8|||
156442205|NCT03783026|564713371|FG000|Treatment Phase|Did Not Receive Treatment|1|||
156442206|NCT03783026|564713371|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
156442207|NCT04814186|564713372|FG000|Treatment Phase|Adverse Event|1|||
156711346|NCT00996892|565686394|FG003|Expansion Stage 2|Disease Progression|0|||
156711347|NCT00996892|565686395|FG004|Expansion Stage 2|Disease Progression|0|||
156711348|NCT00996892|565686396|FG005|Expansion Stage 2|Disease Progression|0|||
156711349|NCT00996892|565686397|FG006|Expansion Stage 2|Disease Progression|0|||
156873929|NCT02721966|566296159|FG002|Overall Study|Physician Decision|0|||
156442208|NCT04814186|564713372|FG000|Treatment Phase|Death|6|||
156442209|NCT04814186|564713372|FG000|Treatment Phase|Withdrawal by Subject|2|||
156442210|NCT04814186|564713372|FG000|Treatment Phase|Other|1|||
156442211|NCT04814186|564713372|FG000|Follow-Up Phase|Adverse Event|1|||
156442212|NCT04814186|564713372|FG000|Follow-Up Phase|Death|6|||
156442213|NCT04814186|564713372|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
156442214|NCT04814186|564713372|FG000|Follow-Up Phase|Other|1|||
156711350|NCT00996892|565686398|FG007|Expansion Stage 2|Disease Progression|0|||
156711351|NCT00996892|565686399|FG008|Expansion Stage 2|Disease Progression|0|||
156711352|NCT00996892|565686400|FG009|Expansion Stage 2|Disease Progression|0|||
156711353|NCT00996892|565686401|FG010|Expansion Stage 2|Disease Progression|0|||
156442215|NCT01643070|564713373|FG000|Overall Study|Withdrawal by Subject|3|||
156873930|NCT02721966|566296160|FG003|Overall Study|Physician Decision|0|||
156873931|NCT02721966|566296161|FG004|Overall Study|Physician Decision|0|||
156873932|NCT02721966|566296157|FG000|Overall Study|Pregnancy|1|||
156711354|NCT00996892|565686402|FG011|Expansion Stage 2|Disease Progression|0|||
156711355|NCT00996892|565686403|FG012|Expansion Stage 2|Disease Progression|0|||
156711356|NCT00996892|565686404|FG013|Expansion Stage 2|Disease Progression|0|||
156711357|NCT00996892|565686405|FG014|Expansion Stage 2|Disease Progression|0|||
156711358|NCT00996892|565686406|FG015|Expansion Stage 2|Disease Progression|0|||
156711359|NCT00996892|565686407|FG016|Expansion Stage 2|Disease Progression|0|||
156711360|NCT00996892|565686408|FG017|Expansion Stage 2|Disease Progression|0|||
156711361|NCT00996892|565686409|FG018|Expansion Stage 2|Disease Progression|28|||
156711362|NCT00996892|565686410|FG019|Expansion Stage 2|Disease Progression|0|||
156711363|NCT00996892|565686391|FG000|Expansion Stage 2A|Adverse Event|0|||
156711364|NCT00996892|565686392|FG001|Expansion Stage 2A|Adverse Event|0|||
156711365|NCT00996892|565686393|FG002|Expansion Stage 2A|Adverse Event|0|||
156711366|NCT00996892|565686394|FG003|Expansion Stage 2A|Adverse Event|0|||
156711367|NCT00996892|565686395|FG004|Expansion Stage 2A|Adverse Event|0|||
156711368|NCT00996892|565686396|FG005|Expansion Stage 2A|Adverse Event|0|||
156711369|NCT00996892|565686397|FG006|Expansion Stage 2A|Adverse Event|0|||
156711370|NCT00996892|565686398|FG007|Expansion Stage 2A|Adverse Event|0|||
156711371|NCT00996892|565686399|FG008|Expansion Stage 2A|Adverse Event|0|||
156711372|NCT00996892|565686400|FG009|Expansion Stage 2A|Adverse Event|0|||
156711373|NCT00996892|565686401|FG010|Expansion Stage 2A|Adverse Event|0|||
156711374|NCT00996892|565686402|FG011|Expansion Stage 2A|Adverse Event|0|||
156711375|NCT00996892|565686403|FG012|Expansion Stage 2A|Adverse Event|0|||
156711376|NCT00996892|565686404|FG013|Expansion Stage 2A|Adverse Event|0|||
156711377|NCT00996892|565686405|FG014|Expansion Stage 2A|Adverse Event|0|||
156711378|NCT00996892|565686406|FG015|Expansion Stage 2A|Adverse Event|0|||
156711379|NCT00996892|565686407|FG016|Expansion Stage 2A|Adverse Event|0|||
156711380|NCT00996892|565686408|FG017|Expansion Stage 2A|Adverse Event|0|||
156711381|NCT00996892|565686409|FG018|Expansion Stage 2A|Adverse Event|0|||
156711382|NCT00996892|565686410|FG019|Expansion Stage 2A|Adverse Event|8|||
156711383|NCT00996892|565686391|FG000|Expansion Stage 2A|Physician Decision|0|||
156711384|NCT00996892|565686392|FG001|Expansion Stage 2A|Physician Decision|0|||
156711385|NCT00996892|565686393|FG002|Expansion Stage 2A|Physician Decision|0|||
156711386|NCT00996892|565686394|FG003|Expansion Stage 2A|Physician Decision|0|||
156711387|NCT00996892|565686395|FG004|Expansion Stage 2A|Physician Decision|0|||
156711388|NCT00996892|565686396|FG005|Expansion Stage 2A|Physician Decision|0|||
156711389|NCT00996892|565686397|FG006|Expansion Stage 2A|Physician Decision|0|||
156711390|NCT00996892|565686398|FG007|Expansion Stage 2A|Physician Decision|0|||
156711391|NCT00996892|565686399|FG008|Expansion Stage 2A|Physician Decision|0|||
156711392|NCT00996892|565686400|FG009|Expansion Stage 2A|Physician Decision|0|||
156873933|NCT02721966|566296158|FG001|Overall Study|Pregnancy|0|||
156873934|NCT02721966|566296159|FG002|Overall Study|Pregnancy|0|||
156873935|NCT02721966|566296160|FG003|Overall Study|Pregnancy|0|||
156873936|NCT02721966|566296161|FG004|Overall Study|Pregnancy|0|||
156873937|NCT02721966|566296157|FG000|Overall Study|Did not continue to period 2|5|||
156873938|NCT02721966|566296158|FG001|Overall Study|Did not continue to period 2|12|||
156873939|NCT02721966|566296159|FG002|Overall Study|Did not continue to period 2|0|||
156873940|NCT02721966|566296160|FG003|Overall Study|Did not continue to period 2|0|||
156873941|NCT02721966|566296161|FG004|Overall Study|Did not continue to period 2|5|||
156873942|NCT01192191|566296162|FG000|Overall Study|Adverse Event|7|||
156873943|NCT01192191|566296163|FG001|Overall Study|Adverse Event|12|||
156873944|NCT01192191|566296162|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
156873945|NCT01192191|566296163|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
156873946|NCT01192191|566296162|FG000|Overall Study|Lost to Follow-up|0|||
156873947|NCT01192191|566296163|FG001|Overall Study|Lost to Follow-up|1|||
156873948|NCT01192191|566296162|FG000|Overall Study|Withdrawal by Subject|1|||
156873949|NCT01192191|566296163|FG001|Overall Study|Withdrawal by Subject|6|||
156873950|NCT00467753|566296164|FG000|Overall Study|Lost to Follow-up|1|||
156873951|NCT00467753|566296165|FG001|Overall Study|Lost to Follow-up|2|||
156711393|NCT00996892|565686401|FG010|Expansion Stage 2A|Physician Decision|0|||
156711394|NCT00996892|565686402|FG011|Expansion Stage 2A|Physician Decision|0|||
156711395|NCT00996892|565686403|FG012|Expansion Stage 2A|Physician Decision|0|||
156711396|NCT00996892|565686404|FG013|Expansion Stage 2A|Physician Decision|0|||
156711397|NCT00996892|565686405|FG014|Expansion Stage 2A|Physician Decision|0|||
156711398|NCT00996892|565686406|FG015|Expansion Stage 2A|Physician Decision|0|||
156711399|NCT00996892|565686407|FG016|Expansion Stage 2A|Physician Decision|0|||
156711400|NCT00996892|565686408|FG017|Expansion Stage 2A|Physician Decision|0|||
156711401|NCT00996892|565686409|FG018|Expansion Stage 2A|Physician Decision|0|||
156711402|NCT00996892|565686410|FG019|Expansion Stage 2A|Physician Decision|2|||
156711403|NCT00996892|565686391|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
156873952|NCT00467753|566296164|FG000|Overall Study|Adverse Event|2|||
156873953|NCT00467753|566296165|FG001|Overall Study|Adverse Event|0|||
156873954|NCT01047553|566296166|FG000|Overall Study|Adverse Event|10|||
156332887|NCT02711345|564317420|FG006|Overall Study|Subject/guardian decision|3|||
156711404|NCT00996892|565686392|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
156873955|NCT01047553|566296167|FG001|Overall Study|Adverse Event|5|||
156792270|NCT01633112|565992717|FG000|Overall Study|Subject no longer requires study drug|0|||
156792271|NCT01633112|565992718|FG001|Overall Study|Subject no longer requires study drug|0|||
156442216|NCT01643070|564713374|FG001|Overall Study|Withdrawal by Subject|1|||
156442217|NCT01643070|564713373|FG000|Overall Study|Death|1|||
156442218|NCT01643070|564713374|FG001|Overall Study|Death|0|||
156442219|NCT01643070|564713373|FG000|Overall Study|Pregressive disease|0|||
156792272|NCT01633112|565992719|FG002|Overall Study|Subject no longer requires study drug|1|||
156792273|NCT01633112|565992717|FG000|Overall Study|Withdrawal by Subject|20|||
156792274|NCT01633112|565992718|FG001|Overall Study|Withdrawal by Subject|12|||
156792275|NCT01633112|565992719|FG002|Overall Study|Withdrawal by Subject|41|||
156792276|NCT01633112|565992717|FG000|Overall Study|missing Study Completion CRF|1|||
156792277|NCT01633112|565992718|FG001|Overall Study|missing Study Completion CRF|1|||
156792278|NCT01633112|565992719|FG002|Overall Study|missing Study Completion CRF|4|||
156792279|NCT02605967|565992728|FG000|Overall Study|subject / guardian decision|1|||
156792280|NCT02605967|565992729|FG001|Overall Study|subject / guardian decision|2|||
156792281|NCT02605967|565992728|FG000|Overall Study|Physician Decision|10|||
156792282|NCT02605967|565992729|FG001|Overall Study|Physician Decision|1|||
156792283|NCT02605967|565992728|FG000|Overall Study|Death|4|||
156792284|NCT02605967|565992729|FG001|Overall Study|Death|2|||
156792285|NCT02605967|565992728|FG000|Overall Study|Adverse Event|1|||
156792286|NCT02605967|565992729|FG001|Overall Study|Adverse Event|0|||
156792287|NCT02605967|565992728|FG000|Overall Study|progressive disease|66|||
156792288|NCT02605967|565992729|FG001|Overall Study|progressive disease|35|||
156792289|NCT05122143|565992735|FG000|Overall Study|Adverse Event|1|||
156792290|NCT05122143|565992736|FG001|Overall Study|Adverse Event|0|||
156792291|NCT05122143|565992737|FG002|Overall Study|Adverse Event|0|||
156792292|NCT05122143|565992738|FG003|Overall Study|Adverse Event|0|||
156792293|NCT05122143|565992739|FG004|Overall Study|Adverse Event|1|||
156792294|NCT05122143|565992740|FG005|Overall Study|Adverse Event|0|||
156442220|NCT01643070|564713374|FG001|Overall Study|Pregressive disease|2|||
156442221|NCT03554265|564713377|FG000|Overall Study|Withdrawal by Subject|2|||
156442222|NCT03554265|564713378|FG001|Overall Study|Withdrawal by Subject|2|||
156442223|NCT03554265|564713379|FG002|Overall Study|Withdrawal by Subject|3|||
156532101|NCT01284062|565043273|FG001|Overall Study|Withdrawal by Subject|1|||
156532102|NCT01284062|565043274|FG002|Overall Study|Withdrawal by Subject|2|||
156532103|NCT01284062|565043275|FG003|Overall Study|Withdrawal by Subject|5|||
156532104|NCT01284062|565043272|FG000|Overall Study|Other|0|||
156532105|NCT01284062|565043273|FG001|Overall Study|Other|0|||
156532106|NCT01284062|565043274|FG002|Overall Study|Other|0|||
156532107|NCT01284062|565043275|FG003|Overall Study|Other|1|||
156532108|NCT01284062|565043272|FG000|Overall Study|Site Closed|0|||
156532109|NCT01284062|565043273|FG001|Overall Study|Site Closed|0|||
156532110|NCT01284062|565043274|FG002|Overall Study|Site Closed|1|||
156532111|NCT01284062|565043275|FG003|Overall Study|Site Closed|0|||
156532112|NCT01026142|565043280|FG000|Overall Study|Death|136|||
156532113|NCT01026142|565043281|FG001|Overall Study|Death|134|||
156532114|NCT01026142|565043280|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
156532115|NCT01026142|565043281|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
156532116|NCT00634010|565043282|FG000|Overall Study|Adverse Event|2|||
156532117|NCT00634010|565043283|FG001|Overall Study|Adverse Event|5|||
156532118|NCT00634010|565043282|FG000|Overall Study|Withdrawal by Subject|5|||
156532119|NCT00634010|565043283|FG001|Overall Study|Withdrawal by Subject|6|||
156532120|NCT00634010|565043282|FG000|Overall Study|Physician Decision|1|||
156532121|NCT00634010|565043283|FG001|Overall Study|Physician Decision|1|||
156532122|NCT00634010|565043282|FG000|Overall Study|Disease Progression|1|||
156532123|NCT00634010|565043283|FG001|Overall Study|Disease Progression|1|||
156532124|NCT00634010|565043282|FG000|Overall Study|Non-Compliant|1|||
156532125|NCT00634010|565043283|FG001|Overall Study|Non-Compliant|1|||
156532126|NCT01019317|565043284|FG000|Overall Study|Not Eligible|4|||
156532127|NCT04233164|565043285|FG000|Overall Study|Unable to obtain specimen|0|||
156532128|NCT04233164|565043286|FG001|Overall Study|Unable to obtain specimen|1|||
156532129|NCT02014740|565043287|FG000|Overall Study|Lost to Follow-up|4|||
156532130|NCT02014740|565043288|FG001|Overall Study|Lost to Follow-up|4|||
156532131|NCT02014740|565043287|FG000|Overall Study|Withdrawal by Subject|2|||
156532132|NCT02014740|565043288|FG001|Overall Study|Withdrawal by Subject|1|||
156532133|NCT03684642|565043289|FG000|Overall Study|Adverse Event|6|||
156532134|NCT03684642|565043290|FG001|Overall Study|Adverse Event|15|||
156532135|NCT03684642|565043291|FG002|Overall Study|Adverse Event|11|||
156792295|NCT05122143|565992735|FG000|Overall Study|Protocol non-compliance|0|||
156442224|NCT03554265|564713377|FG000|Overall Study|Physician Decision|0|||
156442225|NCT03554265|564713378|FG001|Overall Study|Physician Decision|0|||
156532136|NCT03684642|565043289|FG000|Overall Study|Withdrawal by Subject|35|||
156532137|NCT03684642|565043290|FG001|Overall Study|Withdrawal by Subject|53|||
156532138|NCT03684642|565043291|FG002|Overall Study|Withdrawal by Subject|23|||
156532139|NCT03684642|565043289|FG000|Overall Study|Lack of Efficacy|0|||
156532140|NCT03684642|565043290|FG001|Overall Study|Lack of Efficacy|0|||
156792296|NCT05122143|565992736|FG001|Overall Study|Protocol non-compliance|0|||
156792297|NCT05122143|565992737|FG002|Overall Study|Protocol non-compliance|1|||
156792298|NCT05122143|565992738|FG003|Overall Study|Protocol non-compliance|0|||
156532141|NCT03684642|565043291|FG002|Overall Study|Lack of Efficacy|1|||
156532142|NCT03684642|565043289|FG000|Overall Study|Poor compliance to protocol|0|||
156532143|NCT03684642|565043290|FG001|Overall Study|Poor compliance to protocol|4|||
156532144|NCT03684642|565043291|FG002|Overall Study|Poor compliance to protocol|1|||
156532145|NCT03684642|565043289|FG000|Overall Study|Other than specified|62|||
156532146|NCT03684642|565043290|FG001|Overall Study|Other than specified|60|||
156532147|NCT03684642|565043291|FG002|Overall Study|Other than specified|67|||
156532148|NCT03684642|565043289|FG000|Overall Study|Randomized and not treated|0|||
156532149|NCT03684642|565043290|FG001|Overall Study|Randomized and not treated|0|||
156532150|NCT03684642|565043291|FG002|Overall Study|Randomized and not treated|1|||
156532151|NCT03684642|565043289|FG000|Overall Study|Missing completion status but alive at last contact|0|||
156532152|NCT03684642|565043290|FG001|Overall Study|Missing completion status but alive at last contact|1|||
156711405|NCT00996892|565686393|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
156711406|NCT00996892|565686394|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
156711407|NCT00996892|565686395|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
156711408|NCT00996892|565686396|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
156711409|NCT00996892|565686397|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
156532153|NCT03684642|565043291|FG002|Overall Study|Missing completion status but alive at last contact|2|||
156532154|NCT01843218|565043294|FG000|Overall Study|Withdrawal by Subject|5|||
156711410|NCT00996892|565686398|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
156711411|NCT00996892|565686399|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
156711412|NCT00996892|565686400|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
156711413|NCT00996892|565686401|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
156711414|NCT00996892|565686402|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
156711415|NCT00996892|565686403|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
156711416|NCT00996892|565686404|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
156711417|NCT00996892|565686405|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
156711418|NCT00996892|565686406|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
156711419|NCT00996892|565686407|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
156711420|NCT00996892|565686408|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
156711421|NCT00996892|565686409|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
156711422|NCT00996892|565686410|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
156711423|NCT00996892|565686391|FG000|Expansion Stage 2A|Disease Progression|0|||
156711424|NCT00996892|565686392|FG001|Expansion Stage 2A|Disease Progression|0|||
156711425|NCT00996892|565686393|FG002|Expansion Stage 2A|Disease Progression|0|||
156711426|NCT00996892|565686394|FG003|Expansion Stage 2A|Disease Progression|0|||
156711427|NCT00996892|565686395|FG004|Expansion Stage 2A|Disease Progression|0|||
156711428|NCT00996892|565686396|FG005|Expansion Stage 2A|Disease Progression|0|||
156711429|NCT00996892|565686397|FG006|Expansion Stage 2A|Disease Progression|0|||
156711430|NCT00996892|565686398|FG007|Expansion Stage 2A|Disease Progression|0|||
156711431|NCT00996892|565686399|FG008|Expansion Stage 2A|Disease Progression|0|||
156711432|NCT00996892|565686400|FG009|Expansion Stage 2A|Disease Progression|0|||
156711433|NCT00996892|565686401|FG010|Expansion Stage 2A|Disease Progression|0|||
156711434|NCT00996892|565686402|FG011|Expansion Stage 2A|Disease Progression|0|||
156711435|NCT00996892|565686403|FG012|Expansion Stage 2A|Disease Progression|0|||
156711436|NCT00996892|565686404|FG013|Expansion Stage 2A|Disease Progression|0|||
156711437|NCT00996892|565686405|FG014|Expansion Stage 2A|Disease Progression|0|||
156711438|NCT00996892|565686406|FG015|Expansion Stage 2A|Disease Progression|0|||
156711439|NCT00996892|565686407|FG016|Expansion Stage 2A|Disease Progression|0|||
156711440|NCT00996892|565686408|FG017|Expansion Stage 2A|Disease Progression|0|||
156711441|NCT00996892|565686409|FG018|Expansion Stage 2A|Disease Progression|0|||
156711442|NCT00996892|565686410|FG019|Expansion Stage 2A|Disease Progression|31|||
156711443|NCT02759692|565686411|FG000|Period 1|Test article no longer available|1|||
156711444|NCT02759692|565686412|FG001|Period 1|Test article no longer available|1|||
156711445|NCT02759692|565686411|FG000|Period 1|No longer meets eligibility criteria.|1|||
156792299|NCT05122143|565992739|FG004|Overall Study|Protocol non-compliance|0|||
156792300|NCT05122143|565992740|FG005|Overall Study|Protocol non-compliance|0|||
156792301|NCT05122143|565992735|FG000|Overall Study|Covid contact|0|||
156332888|NCT02711345|564317421|FG007|Overall Study|Subject/guardian decision|1|||
156332889|NCT02711345|564317422|FG008|Overall Study|Subject/guardian decision|0|||
156332890|NCT02711345|564317423|FG009|Overall Study|Subject/guardian decision|4|||
156332891|NCT02711345|564317414|FG000|Overall Study|Death|1|||
156332892|NCT02711345|564317415|FG001|Overall Study|Death|0|||
156332893|NCT02711345|564317416|FG002|Overall Study|Death|0|||
156332894|NCT02711345|564317417|FG003|Overall Study|Death|0|||
156332895|NCT02711345|564317418|FG004|Overall Study|Death|0|||
156332896|NCT02711345|564317419|FG005|Overall Study|Death|0|||
156332897|NCT02711345|564317420|FG006|Overall Study|Death|0|||
156332898|NCT02711345|564317421|FG007|Overall Study|Death|1|||
156332899|NCT02711345|564317422|FG008|Overall Study|Death|0|||
156332900|NCT02711345|564317423|FG009|Overall Study|Death|0|||
156532155|NCT01431534|565043295|FG000|Treatment Phase|Adverse Event|0|||
156532156|NCT01431534|565043296|FG001|Treatment Phase|Adverse Event|0|||
156332901|NCT03780543|564317425|FG000|Overall Study|Adverse Event|1|||
156332902|NCT03780543|564317426|FG001|Overall Study|Adverse Event|0|||
156332903|NCT03780543|564317427|FG002|Overall Study|Adverse Event|2|||
156532157|NCT01431534|565043297|FG002|Treatment Phase|Adverse Event|1|||
156532158|NCT01431534|565043295|FG000|Treatment Phase|Progressive Disease|4|||
156532159|NCT01431534|565043296|FG001|Treatment Phase|Progressive Disease|3|||
156532160|NCT01431534|565043297|FG002|Treatment Phase|Progressive Disease|10|||
156532161|NCT04201821|565043300|FG000|Overall Study|Withdrawal by Subject|2|||
156711446|NCT02759692|565686412|FG001|Period 1|No longer meets eligibility criteria.|0|||
156711447|NCT02759692|565686411|FG000|Period 1|Miss-Randomized|1|||
156711448|NCT02759692|565686412|FG001|Period 1|Miss-Randomized|1|||
156711449|NCT02759692|565686411|FG000|Period 2|Lost to Follow-up|1|||
156711450|NCT02759692|565686412|FG001|Period 2|Lost to Follow-up|0|||
156711451|NCT02759692|565686411|FG000|Period 2|Test article no longer available|0|||
156711452|NCT02759692|565686412|FG001|Period 2|Test article no longer available|1|||
156711453|NCT04042376|565686418|FG000|Overall Study|Withdrawal by Subject|1|||
156711454|NCT04042376|565686418|FG000|Overall Study|Death|3|||
156711455|NCT01059786|565688769|FG000|Overall Study|Did not receive 6 cycles.|0|||
156711456|NCT01059786|565688770|FG001|Overall Study|Did not receive 6 cycles.|0|||
156711457|NCT01059786|565688771|FG002|Overall Study|Did not receive 6 cycles.|4|||
156711458|NCT01059786|565688772|FG003|Overall Study|Did not receive 6 cycles.|1|||
156711459|NCT01059786|565688773|FG004|Overall Study|Did not receive 6 cycles.|0|||
156711460|NCT04205812|565688774|FG000|Randomized Treatment Period|Ongoing|28|||
156711461|NCT04205812|565688775|FG001|Randomized Treatment Period|Ongoing|138|||
156711462|NCT04205812|565688774|FG000|Randomized Treatment Period|Death|94|||
156711463|NCT04205812|565688775|FG001|Randomized Treatment Period|Death|226|||
156711464|NCT04205812|565688774|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
156711465|NCT04205812|565688775|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
156711466|NCT04205812|565688774|FG000|Randomized Treatment Period|Physician Decision|1|||
156711467|NCT04205812|565688775|FG001|Randomized Treatment Period|Physician Decision|4|||
156711468|NCT04205812|565688774|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
156711469|NCT04205812|565688775|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
156711470|NCT04205812|565688774|FG000|Randomized Treatment Period|Progressive Disease|0|||
156711471|NCT04205812|565688775|FG001|Randomized Treatment Period|Progressive Disease|1|||
156711472|NCT04205812|565688774|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
156711473|NCT04205812|565688775|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
156711474|NCT04205812|565688774|FG000|Monotherapy Treatment Period|Ongoing|17|||
156711475|NCT04205812|565688775|FG001|Monotherapy Treatment Period|Ongoing|0|||
156711476|NCT04205812|565688774|FG000|Monotherapy Treatment Period|Death|39|||
156711477|NCT04205812|565688775|FG001|Monotherapy Treatment Period|Death|0|||
156711478|NCT04205812|565688774|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
156711479|NCT04205812|565688775|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
156711480|NCT04205812|565688774|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
156711481|NCT04205812|565688775|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
156711482|NCT04559347|565688776|FG000|Overall Study|Death|1|||
156711483|NCT04559347|565688777|FG001|Overall Study|Death|0|||
156711484|NCT04559347|565688776|FG000|Overall Study|Thoracotomy conversion|1|||
156711485|NCT04559347|565688777|FG001|Overall Study|Thoracotomy conversion|1|||
156711486|NCT04559347|565688776|FG000|Overall Study|Provider unavailable|2|||
156711487|NCT04559347|565688777|FG001|Overall Study|Provider unavailable|1|||
156792302|NCT05122143|565992736|FG001|Overall Study|Covid contact|0|||
156792303|NCT05122143|565992737|FG002|Overall Study|Covid contact|0|||
156792304|NCT05122143|565992738|FG003|Overall Study|Covid contact|0|||
156792305|NCT05122143|565992739|FG004|Overall Study|Covid contact|1|||
156792306|NCT05122143|565992740|FG005|Overall Study|Covid contact|0|||
156792307|NCT01475825|565992741|FG000|Overall Study|Adverse Event|41|||
156792308|NCT01475825|565992742|FG001|Overall Study|Adverse Event|15|||
156792309|NCT01475825|565992743|FG002|Overall Study|Adverse Event|27|||
156792310|NCT01475825|565992744|FG003|Overall Study|Adverse Event|11|||
156792311|NCT01475825|565992741|FG000|Overall Study|Death|1|||
156792312|NCT01475825|565992742|FG001|Overall Study|Death|0|||
156792313|NCT01475825|565992743|FG002|Overall Study|Death|1|||
156792314|NCT01475825|565992744|FG003|Overall Study|Death|0|||
156792315|NCT01475825|565992741|FG000|Overall Study|Lack of Efficacy|0|||
156792316|NCT01475825|565992742|FG001|Overall Study|Lack of Efficacy|0|||
156792317|NCT01475825|565992743|FG002|Overall Study|Lack of Efficacy|1|||
156792318|NCT01475825|565992744|FG003|Overall Study|Lack of Efficacy|0|||
156792319|NCT01475825|565992741|FG000|Overall Study|Lost to Follow-up|0|||
156792320|NCT01475825|565992742|FG001|Overall Study|Lost to Follow-up|0|||
156792321|NCT01475825|565992743|FG002|Overall Study|Lost to Follow-up|3|||
156792322|NCT01475825|565992744|FG003|Overall Study|Lost to Follow-up|1|||
156792323|NCT01475825|565992741|FG000|Overall Study|Non-compliance with Study Drug|1|||
156792324|NCT01475825|565992742|FG001|Overall Study|Non-compliance with Study Drug|2|||
156792325|NCT01475825|565992743|FG002|Overall Study|Non-compliance with Study Drug|4|||
156792326|NCT01475825|565992744|FG003|Overall Study|Non-compliance with Study Drug|0|||
156792327|NCT01475825|565992741|FG000|Overall Study|Other: Not available|0|||
156792328|NCT01475825|565992742|FG001|Overall Study|Other: Not available|0|||
156792329|NCT01475825|565992743|FG002|Overall Study|Other: Not available|2|||
156792330|NCT01475825|565992744|FG003|Overall Study|Other: Not available|0|||
156711488|NCT04559347|565688776|FG000|Overall Study|Other|2|||
156711489|NCT04559347|565688777|FG001|Overall Study|Other|1|||
156711490|NCT00371033|565688778|FG000|Overall Study|Lost to Follow-up|3|||
156711491|NCT00371033|565688779|FG001|Overall Study|Lost to Follow-up|2|||
156711492|NCT00371033|565688778|FG000|Overall Study|No longer interested|2|||
156711493|NCT00371033|565688779|FG001|Overall Study|No longer interested|0|||
156711494|NCT00371033|565688778|FG000|Overall Study|Uknown|3|||
156332904|NCT03780543|564317425|FG000|Overall Study|Lost to Follow-up|2|||
156332905|NCT03780543|564317426|FG001|Overall Study|Lost to Follow-up|0|||
156711495|NCT00371033|565688779|FG001|Overall Study|Uknown|1|||
156711496|NCT05929651|565688786|FG000|Overall Study|Protocol Deviation|1|||
156711497|NCT05929651|565688786|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
156711498|NCT05026177|565688787|FG000|Overall Study|Adverse Event|33|||
156711499|NCT05026177|565688788|FG001|Overall Study|Adverse Event|33|||
156711500|NCT05026177|565688789|FG002|Overall Study|Adverse Event|17|||
156711501|NCT05026177|565688787|FG000|Overall Study|Lost to Follow-up|7|||
156711502|NCT05026177|565688788|FG001|Overall Study|Lost to Follow-up|6|||
156711503|NCT05026177|565688789|FG002|Overall Study|Lost to Follow-up|8|||
156711504|NCT05026177|565688787|FG000|Overall Study|Noncompliance with study drug|6|||
156711505|NCT05026177|565688788|FG001|Overall Study|Noncompliance with study drug|2|||
156711506|NCT05026177|565688789|FG002|Overall Study|Noncompliance with study drug|1|||
156711507|NCT05026177|565688787|FG000|Overall Study|Physician Decision|4|||
156711508|NCT05026177|565688788|FG001|Overall Study|Physician Decision|1|||
156711509|NCT05026177|565688789|FG002|Overall Study|Physician Decision|0|||
156711510|NCT05026177|565688787|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
156711511|NCT05026177|565688788|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
156711512|NCT05026177|565688789|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
156711513|NCT05026177|565688787|FG000|Overall Study|Withdrawal by Subject|53|||
156711514|NCT05026177|565688788|FG001|Overall Study|Withdrawal by Subject|51|||
156711515|NCT05026177|565688789|FG002|Overall Study|Withdrawal by Subject|55|||
156711516|NCT05026177|565688787|FG000|Overall Study|Protocol Violation|0|||
156711517|NCT05026177|565688788|FG001|Overall Study|Protocol Violation|1|||
156711518|NCT05026177|565688789|FG002|Overall Study|Protocol Violation|0|||
156711519|NCT05026177|565688787|FG000|Overall Study|Study terminated by sponsor|70|||
156711520|NCT05026177|565688788|FG001|Overall Study|Study terminated by sponsor|74|||
156711521|NCT05026177|565688789|FG002|Overall Study|Study terminated by sponsor|67|||
156711522|NCT05026177|565688787|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
156711523|NCT05026177|565688788|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
156711524|NCT05026177|565688789|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
156711525|NCT05026177|565688787|FG000|Overall Study|Starting alternative treatment|0|||
156711526|NCT05026177|565688788|FG001|Overall Study|Starting alternative treatment|1|||
156711527|NCT05026177|565688789|FG002|Overall Study|Starting alternative treatment|1|||
156711528|NCT05026177|565688787|FG000|Overall Study|Noncompliance with study procedures|0|||
156711529|NCT05026177|565688788|FG001|Overall Study|Noncompliance with study procedures|1|||
156711530|NCT05026177|565688789|FG002|Overall Study|Noncompliance with study procedures|1|||
156711531|NCT05026177|565688787|FG000|Overall Study|Met stopping criteria|0|||
156711532|NCT05026177|565688788|FG001|Overall Study|Met stopping criteria|0|||
156711533|NCT05026177|565688789|FG002|Overall Study|Met stopping criteria|1|||
156711534|NCT05026177|565688787|FG000|Overall Study|Health issues preventing continuation|0|||
156711535|NCT05026177|565688788|FG001|Overall Study|Health issues preventing continuation|0|||
156711536|NCT05026177|565688789|FG002|Overall Study|Health issues preventing continuation|1|||
156711537|NCT05026177|565688787|FG000|Overall Study|Randomized in error, not treated|0|||
156711538|NCT05026177|565688788|FG001|Overall Study|Randomized in error, not treated|0|||
156711539|NCT05026177|565688789|FG002|Overall Study|Randomized in error, not treated|2|||
156711540|NCT01433055|565688792|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
156711541|NCT01433055|565688793|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
156711542|NCT01433055|565688792|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
156711543|NCT01433055|565688793|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
156711544|NCT00733005|565688799|FG000|Overall Study|Adverse Event|0|||
156711545|NCT00733005|565688800|FG001|Overall Study|Adverse Event|1|||
156711546|NCT00733005|565688799|FG000|Overall Study|Treatment Failure|0|||
156711547|NCT00733005|565688800|FG001|Overall Study|Treatment Failure|1|||
156711548|NCT00733005|565688799|FG000|Overall Study|Withdrawal by Subject|0|||
156711549|NCT00733005|565688800|FG001|Overall Study|Withdrawal by Subject|1|||
156711550|NCT00733005|565688799|FG000|Overall Study|Protocol Violation|2|||
156711551|NCT00733005|565688800|FG001|Overall Study|Protocol Violation|0|||
156711552|NCT05244122|565688805|FG000|Overall Study|Withdrawal by Subject|318|||
156711553|NCT00615199|565688810|FG000|Overall Study|Adverse Event|3|||
156711554|NCT00615199|565688811|FG001|Overall Study|Adverse Event|1|||
156711555|NCT00615199|565688812|FG002|Overall Study|Adverse Event|1|||
156711556|NCT00615199|565688813|FG003|Overall Study|Adverse Event|0|||
156532162|NCT01395316|565043301|FG000|Overall Study|Lost to Follow-up|2|||
156532163|NCT01395316|565043301|FG000|Overall Study|poor MRI quality|1|||
156532164|NCT02540538|565043302|FG000|Overall Study|Pregnancy|0|||
156532165|NCT02540538|565043303|FG001|Overall Study|Pregnancy|1|||
156711557|NCT00615199|565688810|FG000|Overall Study|Lack of Efficacy|2|||
156711558|NCT00615199|565688811|FG001|Overall Study|Lack of Efficacy|0|||
156711559|NCT00615199|565688812|FG002|Overall Study|Lack of Efficacy|0|||
156711560|NCT00615199|565688813|FG003|Overall Study|Lack of Efficacy|1|||
156711561|NCT00615199|565688810|FG000|Overall Study|Lost to Follow-up|1|||
156711562|NCT00615199|565688811|FG001|Overall Study|Lost to Follow-up|0|||
156711563|NCT00615199|565688812|FG002|Overall Study|Lost to Follow-up|0|||
156711564|NCT00615199|565688813|FG003|Overall Study|Lost to Follow-up|0|||
156711565|NCT00615199|565688810|FG000|Overall Study|Other|0|||
156711566|NCT00615199|565688811|FG001|Overall Study|Other|0|||
156711567|NCT00615199|565688812|FG002|Overall Study|Other|0|||
156711568|NCT00615199|565688813|FG003|Overall Study|Other|1|||
156711569|NCT00615199|565688810|FG000|Overall Study|Withdrawal by Subject|2|||
156711570|NCT00615199|565688811|FG001|Overall Study|Withdrawal by Subject|1|||
156711571|NCT00615199|565688812|FG002|Overall Study|Withdrawal by Subject|0|||
156711572|NCT00615199|565688813|FG003|Overall Study|Withdrawal by Subject|0|||
156711573|NCT01009814|565688816|FG000|Overall Study|No longer met study criteria|1|||
156711574|NCT01009814|565688817|FG001|Overall Study|No longer met study criteria|1|||
156711575|NCT01009814|565688818|FG002|Overall Study|No longer met study criteria|0|||
156711576|NCT01009814|565688819|FG003|Overall Study|No longer met study criteria|0|||
156711577|NCT01009814|565688820|FG004|Overall Study|No longer met study criteria|0|||
156711578|NCT02653625|565688821|FG000|Overall Study|Adverse Event|1|||
156711579|NCT02653625|565688821|FG000|Overall Study|Non-compliance with Study Drug|1|||
156711580|NCT02653625|565688821|FG000|Overall Study|Protocol Violation|1|||
156711581|NCT02653625|565688821|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
156711582|NCT03965689|565688822|FG000|Overall Study|Too sick to get study intervention|2|||
156711583|NCT01173120|565688824|FG000|Overall Study|Lack of Efficacy|2|||
156711584|NCT01173120|565688824|FG000|Overall Study|Lost to Follow-up|1|||
156711585|NCT01173120|565688824|FG000|Overall Study|Participant Decision|2|||
156711586|NCT01173120|565688824|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
156711587|NCT01173120|565688824|FG000|Overall Study|Switch-Participant Decision|12|||
156711588|NCT01173120|565688824|FG000|Overall Study|Switch-Difficulty With Device|12|||
156711589|NCT01214655|565688825|FG000|Part A|Progressive Disease|7|||
156711590|NCT01214655|565688826|FG001|Part A|Progressive Disease|0|||
156711591|NCT01214655|565688827|FG002|Part A|Progressive Disease|0|||
156711592|NCT01214655|565688825|FG000|Part A|Physician Decision|1|||
156711593|NCT01214655|565688826|FG001|Part A|Physician Decision|0|||
156711594|NCT01214655|565688827|FG002|Part A|Physician Decision|0|||
156711595|NCT01214655|565688825|FG000|Part B|Progressive disease|0|||
156711596|NCT01214655|565688826|FG001|Part B|Progressive disease|10|||
156711597|NCT01214655|565688827|FG002|Part B|Progressive disease|0|||
156711598|NCT01214655|565688825|FG000|Part B|Death|0|||
156711599|NCT01214655|565688826|FG001|Part B|Death|1|||
156711600|NCT01214655|565688827|FG002|Part B|Death|0|||
156711601|NCT01214655|565688825|FG000|Part B|Withdrawal by Subject|0|||
156711602|NCT01214655|565688826|FG001|Part B|Withdrawal by Subject|2|||
156711603|NCT01214655|565688827|FG002|Part B|Withdrawal by Subject|0|||
156711604|NCT01214655|565688825|FG000|Part C|Progressive Disease|0|||
156711605|NCT01214655|565688826|FG001|Part C|Progressive Disease|0|||
156711606|NCT01214655|565688827|FG002|Part C|Progressive Disease|5|||
156711607|NCT01214655|565688825|FG000|Part C|Death|0|||
156711608|NCT01214655|565688826|FG001|Part C|Death|0|||
156711609|NCT01214655|565688827|FG002|Part C|Death|1|||
156711610|NCT01214655|565688825|FG000|Part C|Physician Decision|0|||
156711611|NCT01214655|565688826|FG001|Part C|Physician Decision|0|||
156711612|NCT01214655|565688827|FG002|Part C|Physician Decision|1|||
156711613|NCT00764881|565688828|FG000|Overall Study|Adverse Event|5|||
156711614|NCT00764881|565688829|FG001|Overall Study|Adverse Event|1|||
156711615|NCT00764881|565688828|FG000|Overall Study|Withdrawal by Subject|1|||
156711616|NCT00764881|565688829|FG001|Overall Study|Withdrawal by Subject|3|||
156711617|NCT00764881|565688828|FG000|Overall Study|Protocol Violation|2|||
156711618|NCT00764881|565688829|FG001|Overall Study|Protocol Violation|2|||
156711619|NCT00764881|565688828|FG000|Overall Study|Lost to Follow-up|2|||
156711620|NCT00764881|565688829|FG001|Overall Study|Lost to Follow-up|0|||
156711621|NCT00764881|565688828|FG000|Overall Study|Noncompliant|1|||
156711622|NCT00764881|565688829|FG001|Overall Study|Noncompliant|0|||
156332906|NCT03780543|564317427|FG002|Overall Study|Lost to Follow-up|1|||
156532166|NCT02540538|565043304|FG002|Overall Study|Pregnancy|0|||
156711623|NCT00764881|565688828|FG000|Overall Study|Accidentally discontinued study drug|1|||
156711624|NCT00764881|565688829|FG001|Overall Study|Accidentally discontinued study drug|0|||
156711625|NCT00764881|565688828|FG000|Overall Study|Wished to become pregnant|1|||
156711626|NCT00764881|565688829|FG001|Overall Study|Wished to become pregnant|0|||
156711627|NCT00764881|565688828|FG000|Overall Study|Carcinoma detected|1|||
156711628|NCT00764881|565688829|FG001|Overall Study|Carcinoma detected|0|||
156711629|NCT00764881|565688828|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
156711630|NCT00764881|565688829|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
156711631|NCT00764881|565688828|FG000|Overall Study|no treatment or no observation|2|||
156711632|NCT00764881|565688829|FG001|Overall Study|no treatment or no observation|2|||
156711633|NCT05256134|565688832|FG000|Overall Study|Study Terminated by Sponsor|11|||
156442226|NCT03554265|564713379|FG002|Overall Study|Physician Decision|1|||
156442227|NCT03025789|564713380|FG000|Overall Study|Lack of Efficacy|6|||
156442228|NCT03025789|564713381|FG001|Overall Study|Lack of Efficacy|1|||
156442229|NCT03025789|564713380|FG000|Overall Study|Death|1|||
156442230|NCT03025789|564713381|FG001|Overall Study|Death|0|||
156442231|NCT03025789|564713380|FG000|Overall Study|Withdrawal by Subject|0|||
156442232|NCT03025789|564713381|FG001|Overall Study|Withdrawal by Subject|2|||
156442233|NCT02652260|564713382|FG000|Base Study|Pregnancy|0|||
156442234|NCT02652260|564713383|FG001|Base Study|Pregnancy|1|||
156442235|NCT02652260|564713382|FG000|Base Study|Withdrawal by Subject|0|||
156442236|NCT02652260|564713383|FG001|Base Study|Withdrawal by Subject|1|||
156442237|NCT02652260|564713382|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
156442238|NCT02652260|564713383|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
156442239|NCT02652260|564713382|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
156442240|NCT02652260|564713383|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
156711634|NCT05256134|565688833|FG001|Overall Study|Study Terminated by Sponsor|10|||
156711635|NCT05256134|565688832|FG000|Overall Study|Withdrawal by Subject|1|||
156711636|NCT05256134|565688833|FG001|Overall Study|Withdrawal by Subject|3|||
156711637|NCT02013817|565688841|FG000|Overall Study|Adverse Event|12|||
156711638|NCT02013817|565688841|FG000|Overall Study|Withdrawal by Subject|4|||
156711639|NCT02013817|565688841|FG000|Overall Study|Death|2|||
156442241|NCT02652260|564713382|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
156442242|NCT02652260|564713383|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
156711640|NCT02013817|565688841|FG000|Overall Study|Other|9|||
156711641|NCT01977417|565688842|FG000|Overall Study|Adverse Event|1|||
156711642|NCT01977417|565688843|FG001|Overall Study|Adverse Event|0|||
156711643|NCT01977417|565688842|FG000|Overall Study|Withdrawal by Subject|2|||
156711644|NCT01977417|565688843|FG001|Overall Study|Withdrawal by Subject|4|||
156711645|NCT01977417|565688842|FG000|Overall Study|Female enrollment goal met|0|||
156711646|NCT01977417|565688843|FG001|Overall Study|Female enrollment goal met|2|||
156711647|NCT01145508|565688844|FG000|Overall Study|Adverse Event|1|||
156711648|NCT01145508|565688845|FG001|Overall Study|Adverse Event|0|||
156711649|NCT01145508|565688844|FG000|Overall Study|Death|1|||
156711650|NCT01145508|565688845|FG001|Overall Study|Death|0|||
156711651|NCT01145508|565688844|FG000|Overall Study|Physician Decision|2|||
156711652|NCT01145508|565688845|FG001|Overall Study|Physician Decision|1|||
156711653|NCT01145508|565688844|FG000|Overall Study|Never started treatment|1|||
156711654|NCT01145508|565688845|FG001|Overall Study|Never started treatment|1|||
156711655|NCT03055624|565688848|FG000|Overall Study|Study closed|9|||
156711656|NCT01434810|565688850|FG000|Overall Study|Did not receive treatment|11|||
156711657|NCT01434810|565688851|FG001|Overall Study|Did not receive treatment|3|||
156711658|NCT01434810|565688850|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
156711659|NCT01434810|565688851|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
156711660|NCT01625988|565688854|FG000|Overall Study|Lost to Follow-up|5|||
156711661|NCT01625988|565688855|FG001|Overall Study|Lost to Follow-up|6|||
156711662|NCT01625988|565688854|FG000|Overall Study|Withdrawal by Subject|8|||
156711663|NCT01625988|565688855|FG001|Overall Study|Withdrawal by Subject|3|||
156711664|NCT01625988|565688854|FG000|Overall Study|Adverse Event|0|||
156711665|NCT01625988|565688855|FG001|Overall Study|Adverse Event|1|||
156711666|NCT01625988|565688854|FG000|Overall Study|Lack of Efficacy|0|||
156711667|NCT01625988|565688855|FG001|Overall Study|Lack of Efficacy|1|||
156711668|NCT01625988|565688854|FG000|Overall Study|Randomized Inappropriately|1|||
156711669|NCT01625988|565688855|FG001|Overall Study|Randomized Inappropriately|0|||
156711670|NCT01625988|565688854|FG000|Overall Study|Protocol Violation|0|||
156711671|NCT01625988|565688855|FG001|Overall Study|Protocol Violation|2|||
156711672|NCT01121562|565688856|FG000|Overall Study|Objective progression or relapse|8|||
156711673|NCT01121562|565688856|FG000|Overall Study|Withdrawal by Subject|1|||
156711674|NCT01121562|565688856|FG000|Overall Study|Adverse Event|1|||
156711675|NCT01121562|565688856|FG000|Overall Study|Sponsor Decision|1|||
156711676|NCT01121562|565688856|FG000|Overall Study|Met study discontinuation criteria|1|||
156711677|NCT00616421|565688857|FG000|Overall Study|Withdrawal by Subject|9|||
156711678|NCT00616421|565688858|FG001|Overall Study|Withdrawal by Subject|11|||
156711679|NCT00616421|565688859|FG002|Overall Study|Withdrawal by Subject|8|||
156711680|NCT00616421|565688857|FG000|Overall Study|Lost to Follow-up|12|||
156442243|NCT02652260|564713382|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
156442244|NCT02652260|564713383|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
156442245|NCT02652260|564713382|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
156442246|NCT02652260|564713383|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
156442247|NCT02652260|564713382|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
156442248|NCT02652260|564713383|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
156711681|NCT00616421|565688858|FG001|Overall Study|Lost to Follow-up|26|||
156711682|NCT00616421|565688859|FG002|Overall Study|Lost to Follow-up|30|||
156711683|NCT00616421|565688857|FG000|Overall Study|Inappropriate enrollment|3|||
156711684|NCT00616421|565688858|FG001|Overall Study|Inappropriate enrollment|0|||
156711685|NCT00616421|565688859|FG002|Overall Study|Inappropriate enrollment|1|||
156711686|NCT00616421|565688857|FG000|Overall Study|Administrative reason|1|||
156711687|NCT00616421|565688858|FG001|Overall Study|Administrative reason|0|||
156711688|NCT00616421|565688859|FG002|Overall Study|Administrative reason|0|||
156711689|NCT00616421|565688857|FG000|Overall Study|Protocol Violation|0|||
156711690|NCT00616421|565688858|FG001|Overall Study|Protocol Violation|1|||
156711691|NCT00616421|565688859|FG002|Overall Study|Protocol Violation|2|||
156711692|NCT00616421|565688857|FG000|Overall Study|Unable to classify|1|||
156711693|NCT00616421|565688858|FG001|Overall Study|Unable to classify|0|||
156711694|NCT00616421|565688859|FG002|Overall Study|Unable to classify|0|||
156711695|NCT01495702|565688860|FG000|Randomized Phase|Randomized But Not Treated|1|||
156711696|NCT01495702|565688861|FG001|Randomized Phase|Randomized But Not Treated|4|||
156711697|NCT01495702|565688860|FG000|Randomized Phase|Adverse Event|2|||
156711698|NCT01495702|565688861|FG001|Randomized Phase|Adverse Event|2|||
156711699|NCT01495702|565688860|FG000|Randomized Phase|Death|1|||
156711700|NCT01495702|565688861|FG001|Randomized Phase|Death|0|||
156711701|NCT01495702|565688860|FG000|Randomized Phase|Lack of Efficacy|2|||
156711702|NCT01495702|565688861|FG001|Randomized Phase|Lack of Efficacy|0|||
156711703|NCT01495702|565688860|FG000|Randomized Phase|Investigators Discretion|2|||
156711704|NCT01495702|565688861|FG001|Randomized Phase|Investigators Discretion|0|||
156711705|NCT01495702|565688860|FG000|Randomized Phase|Withdrew Consent|10|||
156711706|NCT01495702|565688861|FG001|Randomized Phase|Withdrew Consent|18|||
156711707|NCT01495702|565688860|FG000|Randomized Phase|Lost to Follow-up|4|||
156711708|NCT01495702|565688861|FG001|Randomized Phase|Lost to Follow-up|3|||
156711709|NCT01495702|565688860|FG000|Randomized Phase|Participant Noncompliance|1|||
156711710|NCT01495702|565688861|FG001|Randomized Phase|Participant Noncompliance|0|||
156711711|NCT01495702|565688860|FG000|Randomized Phase|Protocol Violation|3|||
156711712|NCT01495702|565688861|FG001|Randomized Phase|Protocol Violation|1|||
156711713|NCT04152863|565688862|FG000|Overall Study|Death|13|||
156711714|NCT04152863|565688863|FG001|Overall Study|Death|12|||
156711715|NCT04152863|565688864|FG002|Overall Study|Death|7|||
156711716|NCT04152863|565688862|FG000|Overall Study|Physician Decision|1|||
156711717|NCT04152863|565688863|FG001|Overall Study|Physician Decision|1|||
156711718|NCT04152863|565688864|FG002|Overall Study|Physician Decision|1|||
156711719|NCT04152863|565688862|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
156711720|NCT04152863|565688863|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
156711721|NCT04152863|565688864|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
156711722|NCT04152863|565688862|FG000|Overall Study|Withdrawal by Subject|2|||
156711723|NCT04152863|565688863|FG001|Overall Study|Withdrawal by Subject|1|||
156711724|NCT04152863|565688864|FG002|Overall Study|Withdrawal by Subject|3|||
156711725|NCT01644617|565688868|FG000|Overall Study|Withdrawal by Subject|3|||
156711726|NCT01644617|565688869|FG001|Overall Study|Withdrawal by Subject|4|||
156711727|NCT01644617|565688870|FG002|Overall Study|Withdrawal by Subject|1|||
156711728|NCT01644617|565688868|FG000|Overall Study|Lost to Follow-up|0|||
156711729|NCT01644617|565688869|FG001|Overall Study|Lost to Follow-up|1|||
156711730|NCT01644617|565688870|FG002|Overall Study|Lost to Follow-up|0|||
156711731|NCT01644617|565688868|FG000|Overall Study|Adverse Event|3|||
156711732|NCT01644617|565688869|FG001|Overall Study|Adverse Event|0|||
156711733|NCT01644617|565688870|FG002|Overall Study|Adverse Event|6|||
156442249|NCT02652260|564713382|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
156442250|NCT02652260|564713383|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
156442251|NCT02652260|564713382|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
156442252|NCT02652260|564713383|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
156442253|NCT02652260|564713382|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
156442254|NCT02652260|564713383|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
156442255|NCT02652260|564713382|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
156442256|NCT02652260|564713383|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
156442257|NCT02652260|564713382|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
156442258|NCT02652260|564713383|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
156442259|NCT02652260|564713382|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
156442260|NCT02652260|564713383|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
156532167|NCT01313650|565043305|FG000|Overall Study|Adverse Event|9|||
156711734|NCT01524978|565688874|FG000|Overall Study|Other|16|||
156711735|NCT01524978|565688875|FG001|Overall Study|Other|2|||
156711736|NCT01524978|565688876|FG002|Overall Study|Other|1|||
156792331|NCT01475825|565992741|FG000|Overall Study|Protocol Violation|1|||
156792332|NCT01475825|565992742|FG001|Overall Study|Protocol Violation|0|||
156792333|NCT01475825|565992743|FG002|Overall Study|Protocol Violation|0|||
156792334|NCT01475825|565992744|FG003|Overall Study|Protocol Violation|0|||
156711737|NCT01524978|565688877|FG003|Overall Study|Other|2|||
156711738|NCT01524978|565688878|FG004|Overall Study|Other|1|||
156711739|NCT01524978|565688879|FG005|Overall Study|Other|3|||
156711740|NCT01524978|565688880|FG006|Overall Study|Other|17|||
156711741|NCT01524978|565688881|FG007|Overall Study|Other|1|||
156711742|NCT01524978|565688882|FG008|Overall Study|Other|2|||
156442261|NCT02723955|564713384|FG000|Escalation Phase|Death|1|||
156711743|NCT01524978|565688883|FG009|Overall Study|Other|2|||
156711744|NCT01524978|565688884|FG010|Overall Study|Other|5|||
156792335|NCT01475825|565992741|FG000|Overall Study|Physician Decision|0|||
156442262|NCT02723955|564713385|FG001|Escalation Phase|Death|1|||
156442263|NCT02723955|564713386|FG002|Escalation Phase|Death|2|||
156442264|NCT02723955|564713387|FG003|Escalation Phase|Death|7|||
156442265|NCT02723955|564713388|FG004|Escalation Phase|Death|18|||
156442266|NCT02723955|564713389|FG005|Escalation Phase|Death|17|||
156442267|NCT02723955|564713390|FG006|Escalation Phase|Death|11|||
156442268|NCT02723955|564713391|FG007|Escalation Phase|Death|21|||
156442269|NCT02723955|564713392|FG008|Escalation Phase|Death|3|||
156442270|NCT02723955|564713393|FG009|Escalation Phase|Death|0|||
156442271|NCT02723955|564713394|FG010|Escalation Phase|Death|0|||
156442272|NCT02723955|564713395|FG011|Escalation Phase|Death|0|||
156442273|NCT02723955|564713396|FG012|Escalation Phase|Death|2|||
156442274|NCT02723955|564713397|FG013|Escalation Phase|Death|4|||
156442275|NCT02723955|564713398|FG014|Escalation Phase|Death|5|||
156442276|NCT02723955|564713399|FG015|Escalation Phase|Death|6|||
156442277|NCT02723955|564713400|FG016|Escalation Phase|Death|6|||
156442278|NCT02723955|564713401|FG017|Escalation Phase|Death|7|||
156442279|NCT02723955|564713402|FG018|Escalation Phase|Death|1|||
156442280|NCT02723955|564713403|FG019|Escalation Phase|Death|3|||
156442281|NCT02723955|564713404|FG020|Escalation Phase|Death|13|||
156442282|NCT02723955|564713405|FG021|Escalation Phase|Death|3|||
156442283|NCT02723955|564713406|FG022|Escalation Phase|Death|2|||
156442284|NCT02723955|564713407|FG023|Escalation Phase|Death|4|||
156442285|NCT02723955|564713408|FG024|Escalation Phase|Death|31|||
156442286|NCT02723955|564713409|FG025|Escalation Phase|Death|7|||
156442287|NCT02723955|564713410|FG026|Escalation Phase|Death|13|||
156442288|NCT02723955|564713411|FG027|Escalation Phase|Death|0|||
156442289|NCT02723955|564713412|FG028|Escalation Phase|Death|1|||
156442290|NCT02723955|564713413|FG029|Escalation Phase|Death|0|||
156442291|NCT02723955|564713414|FG030|Escalation Phase|Death|0|||
156442292|NCT02723955|564713415|FG031|Escalation Phase|Death|0|||
156442293|NCT02723955|564713416|FG032|Escalation Phase|Death|0|||
156442294|NCT02723955|564713417|FG033|Escalation Phase|Death|0|||
156442295|NCT02723955|564713418|FG034|Escalation Phase|Death|0|||
156442296|NCT02723955|564713419|FG035|Escalation Phase|Death|0|||
156442297|NCT02723955|564713420|FG036|Escalation Phase|Death|0|||
156442298|NCT02723955|564713421|FG037|Escalation Phase|Death|0|||
156442299|NCT02723955|564713422|FG038|Escalation Phase|Death|0|||
156442300|NCT02723955|564713423|FG039|Escalation Phase|Death|0|||
156442301|NCT02723955|564713424|FG040|Escalation Phase|Death|0|||
156442302|NCT02723955|564713425|FG041|Escalation Phase|Death|0|||
156442303|NCT02723955|564713426|FG042|Escalation Phase|Death|0|||
156442304|NCT02723955|564713384|FG000|Escalation Phase|Lost to Follow-up|0|||
156442305|NCT02723955|564713385|FG001|Escalation Phase|Lost to Follow-up|0|||
156442306|NCT02723955|564713386|FG002|Escalation Phase|Lost to Follow-up|0|||
156442307|NCT02723955|564713387|FG003|Escalation Phase|Lost to Follow-up|0|||
156442308|NCT02723955|564713388|FG004|Escalation Phase|Lost to Follow-up|0|||
156442309|NCT02723955|564713389|FG005|Escalation Phase|Lost to Follow-up|2|||
156442310|NCT02723955|564713390|FG006|Escalation Phase|Lost to Follow-up|1|||
156442311|NCT02723955|564713391|FG007|Escalation Phase|Lost to Follow-up|1|||
156442312|NCT02723955|564713392|FG008|Escalation Phase|Lost to Follow-up|1|||
156442313|NCT02723955|564713393|FG009|Escalation Phase|Lost to Follow-up|0|||
156442314|NCT02723955|564713394|FG010|Escalation Phase|Lost to Follow-up|0|||
156711745|NCT01524978|565688874|FG000|Overall Study|Withdrawal by Subject|12|||
156711746|NCT01524978|565688875|FG001|Overall Study|Withdrawal by Subject|0|||
156711747|NCT01524978|565688876|FG002|Overall Study|Withdrawal by Subject|1|||
156711748|NCT01524978|565688877|FG003|Overall Study|Withdrawal by Subject|1|||
156442315|NCT02723955|564713395|FG011|Escalation Phase|Lost to Follow-up|0|||
156711749|NCT01524978|565688878|FG004|Overall Study|Withdrawal by Subject|3|||
156711750|NCT01524978|565688879|FG005|Overall Study|Withdrawal by Subject|1|||
156711751|NCT01524978|565688880|FG006|Overall Study|Withdrawal by Subject|6|||
156711752|NCT01524978|565688881|FG007|Overall Study|Withdrawal by Subject|2|||
156711753|NCT01524978|565688882|FG008|Overall Study|Withdrawal by Subject|4|||
156711754|NCT01524978|565688883|FG009|Overall Study|Withdrawal by Subject|0|||
156711755|NCT01524978|565688884|FG010|Overall Study|Withdrawal by Subject|5|||
156711756|NCT01524978|565688874|FG000|Overall Study|Lost to Follow-up|0|||
156711757|NCT01524978|565688875|FG001|Overall Study|Lost to Follow-up|0|||
156442316|NCT02723955|564713396|FG012|Escalation Phase|Lost to Follow-up|1|||
156442317|NCT02723955|564713397|FG013|Escalation Phase|Lost to Follow-up|0|||
156711758|NCT01524978|565688876|FG002|Overall Study|Lost to Follow-up|3|||
156711759|NCT01524978|565688877|FG003|Overall Study|Lost to Follow-up|0|||
156442318|NCT02723955|564713398|FG014|Escalation Phase|Lost to Follow-up|0|||
156442319|NCT02723955|564713399|FG015|Escalation Phase|Lost to Follow-up|0|||
156442320|NCT02723955|564713400|FG016|Escalation Phase|Lost to Follow-up|1|||
156442321|NCT02723955|564713401|FG017|Escalation Phase|Lost to Follow-up|2|||
156442322|NCT02723955|564713402|FG018|Escalation Phase|Lost to Follow-up|0|||
156442323|NCT02723955|564713403|FG019|Escalation Phase|Lost to Follow-up|1|||
156442324|NCT02723955|564713404|FG020|Escalation Phase|Lost to Follow-up|2|||
156442325|NCT02723955|564713405|FG021|Escalation Phase|Lost to Follow-up|1|||
156442326|NCT02723955|564713406|FG022|Escalation Phase|Lost to Follow-up|0|||
156442327|NCT02723955|564713407|FG023|Escalation Phase|Lost to Follow-up|0|||
156442328|NCT02723955|564713408|FG024|Escalation Phase|Lost to Follow-up|1|||
156442329|NCT02723955|564713409|FG025|Escalation Phase|Lost to Follow-up|1|||
156711760|NCT01524978|565688878|FG004|Overall Study|Lost to Follow-up|1|||
156711761|NCT01524978|565688879|FG005|Overall Study|Lost to Follow-up|1|||
156711762|NCT01524978|565688880|FG006|Overall Study|Lost to Follow-up|2|||
156711763|NCT01524978|565688881|FG007|Overall Study|Lost to Follow-up|0|||
156711764|NCT01524978|565688882|FG008|Overall Study|Lost to Follow-up|1|||
156711765|NCT01524978|565688883|FG009|Overall Study|Lost to Follow-up|1|||
156711766|NCT01524978|565688884|FG010|Overall Study|Lost to Follow-up|1|||
156711767|NCT01524978|565688874|FG000|Overall Study|Death|34|||
156711768|NCT01524978|565688875|FG001|Overall Study|Death|2|||
156711769|NCT01524978|565688876|FG002|Overall Study|Death|5|||
156711770|NCT01524978|565688877|FG003|Overall Study|Death|24|||
156711771|NCT01524978|565688878|FG004|Overall Study|Death|4|||
156711772|NCT01524978|565688879|FG005|Overall Study|Death|4|||
156711773|NCT01524978|565688880|FG006|Overall Study|Death|1|||
156711774|NCT01524978|565688881|FG007|Overall Study|Death|9|||
156711775|NCT01524978|565688882|FG008|Overall Study|Death|5|||
156711776|NCT01524978|565688883|FG009|Overall Study|Death|6|||
156711777|NCT01524978|565688884|FG010|Overall Study|Death|17|||
156711778|NCT04289363|565688892|FG000|Overall Study|Lost to Follow-up|14|||
156711779|NCT04289363|565688893|FG001|Overall Study|Lost to Follow-up|0|||
156711780|NCT03126435|565688897|FG000|Overall Study|Death|90|||
156711781|NCT03126435|565688898|FG001|Overall Study|Death|84|||
156711782|NCT03126435|565688897|FG000|Overall Study|Lost to Follow-up|4|||
156711783|NCT03126435|565688898|FG001|Overall Study|Lost to Follow-up|3|||
156711784|NCT03126435|565688897|FG000|Overall Study|Physician Decision|0|||
156711785|NCT03126435|565688898|FG001|Overall Study|Physician Decision|1|||
156711786|NCT03126435|565688897|FG000|Overall Study|Withdrawal by Subject|6|||
156711787|NCT03126435|565688898|FG001|Overall Study|Withdrawal by Subject|12|||
156711788|NCT03126435|565688897|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
156711789|NCT03126435|565688898|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
156711790|NCT03971474|565688899|FG000|Overall Study|Adverse Event|11|||
156711791|NCT03971474|565688900|FG001|Overall Study|Adverse Event|7|||
156711792|NCT03971474|565688899|FG000|Overall Study|Refusal unrelated to adverse event|5|||
156711793|NCT03971474|565688900|FG001|Overall Study|Refusal unrelated to adverse event|1|||
156711794|NCT03971474|565688899|FG000|Overall Study|Progression/relapse|40|||
156711795|NCT03971474|565688900|FG001|Overall Study|Progression/relapse|47|||
156711796|NCT03971474|565688899|FG000|Overall Study|Death|6|||
156711797|NCT03971474|565688900|FG001|Overall Study|Death|3|||
156711798|NCT03971474|565688899|FG000|Overall Study|Other - not protocol specified|5|||
156711799|NCT03971474|565688900|FG001|Overall Study|Other - not protocol specified|4|||
156711800|NCT03971474|565688899|FG000|Overall Study|On treatment|0|||
156711801|NCT03971474|565688900|FG001|Overall Study|On treatment|7|||
156711802|NCT01807065|565688901|FG000|Overall Study|Receive no sip-T due to IV access|1|||
156711803|NCT01807065|565688902|FG001|Overall Study|Receive no sip-T due to IV access|1|||
156711804|NCT01153425|565688904|FG000|Overall Study|Withdrawal by Subject|3|||
156711805|NCT01153425|565688905|FG001|Overall Study|Withdrawal by Subject|3|||
156442330|NCT02723955|564713410|FG026|Escalation Phase|Lost to Follow-up|3|||
156442331|NCT02723955|564713411|FG027|Escalation Phase|Lost to Follow-up|0|||
156442332|NCT02723955|564713412|FG028|Escalation Phase|Lost to Follow-up|1|||
156442333|NCT02723955|564713413|FG029|Escalation Phase|Lost to Follow-up|0|||
156442334|NCT02723955|564713414|FG030|Escalation Phase|Lost to Follow-up|0|||
156711806|NCT01937871|565688906|FG000|Overall Study|Adverse Event|6|||
156711807|NCT01937871|565688907|FG001|Overall Study|Adverse Event|6|||
156711808|NCT01937871|565688908|FG002|Overall Study|Adverse Event|2|||
156711809|NCT01937871|565688906|FG000|Overall Study|Lost to Follow-up|8|||
156711810|NCT01937871|565688907|FG001|Overall Study|Lost to Follow-up|2|||
156711811|NCT01937871|565688908|FG002|Overall Study|Lost to Follow-up|4|||
156711812|NCT01937871|565688906|FG000|Overall Study|Withdrawal by Subject|9|||
156711813|NCT01937871|565688907|FG001|Overall Study|Withdrawal by Subject|6|||
156442335|NCT02723955|564713415|FG031|Escalation Phase|Lost to Follow-up|0|||
156711814|NCT01937871|565688908|FG002|Overall Study|Withdrawal by Subject|4|||
156711815|NCT01937871|565688906|FG000|Overall Study|Physician Decision|0|||
156711816|NCT01937871|565688907|FG001|Overall Study|Physician Decision|1|||
156711817|NCT01937871|565688908|FG002|Overall Study|Physician Decision|0|||
156442336|NCT02723955|564713416|FG032|Escalation Phase|Lost to Follow-up|0|||
156711818|NCT01937871|565688906|FG000|Overall Study|Entry Criteria Not Met|1|||
156711819|NCT01937871|565688907|FG001|Overall Study|Entry Criteria Not Met|2|||
156711820|NCT01937871|565688908|FG002|Overall Study|Entry Criteria Not Met|1|||
156711821|NCT01482312|565688909|FG000|Period 1, 90 Minutes of Wear|Other|1|||
156711822|NCT01482312|565688910|FG001|Period 1, 90 Minutes of Wear|Other|0|||
156711823|NCT01482312|565688911|FG002|Period 1, 90 Minutes of Wear|Other|0|||
156711824|NCT01482312|565688909|FG000|Period 2, 90 Minutes of Wear|Other|1|||
156711825|NCT01482312|565688910|FG001|Period 2, 90 Minutes of Wear|Other|0|||
156711826|NCT01482312|565688911|FG002|Period 2, 90 Minutes of Wear|Other|0|||
156711827|NCT01699815|565688912|FG000|Overall Study|Protocol Violation|4|||
156711828|NCT01699815|565688913|FG001|Overall Study|Protocol Violation|7|||
156442337|NCT02723955|564713417|FG033|Escalation Phase|Lost to Follow-up|0|||
156711829|NCT01699815|565688912|FG000|Overall Study|record could not be located|1|||
156711830|NCT01699815|565688913|FG001|Overall Study|record could not be located|0|||
156711831|NCT01699815|565688912|FG000|Overall Study|Adverse Event|0|||
156711832|NCT01699815|565688913|FG001|Overall Study|Adverse Event|1|||
156711833|NCT03154125|565688914|FG000|Overall Study|Lost to Follow-up|11|||
156711834|NCT03154125|565688915|FG001|Overall Study|Lost to Follow-up|11|||
156711835|NCT03154125|565688916|FG002|Overall Study|Lost to Follow-up|0|||
156711836|NCT03154125|565688914|FG000|Overall Study|Withdrawal by Subject|49|||
156711837|NCT03154125|565688915|FG001|Overall Study|Withdrawal by Subject|55|||
156711838|NCT03154125|565688916|FG002|Overall Study|Withdrawal by Subject|8|||
156711839|NCT03154125|565688914|FG000|Overall Study|Physician Decision|13|||
156711840|NCT03154125|565688915|FG001|Overall Study|Physician Decision|6|||
156711841|NCT03154125|565688916|FG002|Overall Study|Physician Decision|0|||
156711842|NCT03154125|565688914|FG000|Overall Study|Protocol Violation|3|||
156711843|NCT03154125|565688915|FG001|Overall Study|Protocol Violation|5|||
156711844|NCT03154125|565688916|FG002|Overall Study|Protocol Violation|0|||
156711845|NCT00810511|565688917|FG000|Overall Study|Protocol Violation|0|||
156711846|NCT00810511|565688918|FG001|Overall Study|Protocol Violation|1|||
156711847|NCT00810511|565688917|FG000|Overall Study|Lack of Efficacy|9|||
156711848|NCT00810511|565688918|FG001|Overall Study|Lack of Efficacy|1|||
156711849|NCT00810511|565688917|FG000|Overall Study|death in the family|0|||
156711850|NCT00810511|565688918|FG001|Overall Study|death in the family|1|||
156711851|NCT00810511|565688917|FG000|Overall Study|Lost to Follow-up|1|||
156711852|NCT00810511|565688918|FG001|Overall Study|Lost to Follow-up|0|||
156711853|NCT00810511|565688917|FG000|Overall Study|deposits on contact lens|0|||
156711854|NCT00810511|565688918|FG001|Overall Study|deposits on contact lens|1|||
156711855|NCT02652949|565688919|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
156711856|NCT02652949|565688919|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
156711857|NCT02652949|565688919|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
156711858|NCT02652949|565688919|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
156711859|NCT02652949|565688919|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
156711860|NCT02652949|565688919|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
156711861|NCT02652949|565688919|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
156711862|NCT02652949|565688919|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
156711863|NCT02652949|565688919|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
156711864|NCT02652949|565688919|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
156711865|NCT02652949|565688919|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
156711866|NCT02652949|565688919|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
156711867|NCT02652949|565688919|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
156711868|NCT02652949|565688919|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
156711869|NCT02652949|565688919|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
156711870|NCT02652949|565688919|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
156711871|NCT02652949|565688919|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
156711872|NCT00911300|565688920|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
156711873|NCT00911300|565688921|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
156332907|NCT03780543|564317425|FG000|Overall Study|Study terminated by Sponsor|8|||
156711874|NCT00911300|565688920|FG000|Overall Study|Death|1|||
156711875|NCT00911300|565688921|FG001|Overall Study|Death|0|||
156711876|NCT00911300|565688920|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
156711877|NCT00911300|565688921|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
156711878|NCT00911300|565688920|FG000|Overall Study|Adverse Event|14|||
156711879|NCT00911300|565688921|FG001|Overall Study|Adverse Event|6|||
156711880|NCT00911300|565688920|FG000|Overall Study|Protocol Violation|3|||
156711881|NCT00911300|565688921|FG001|Overall Study|Protocol Violation|2|||
156711882|NCT00911300|565688920|FG000|Overall Study|Consent Withdrawn|4|||
156711883|NCT00911300|565688921|FG001|Overall Study|Consent Withdrawn|12|||
156332908|NCT03780543|564317426|FG001|Overall Study|Study terminated by Sponsor|7|||
156332909|NCT03780543|564317427|FG002|Overall Study|Study terminated by Sponsor|13|||
156332910|NCT03780543|564317425|FG000|Overall Study|Withdrawal by Subject|1|||
156711884|NCT00911300|565688920|FG000|Overall Study|Coronary Angiography Performed|1|||
156711885|NCT00911300|565688921|FG001|Overall Study|Coronary Angiography Performed|0|||
156711886|NCT00911300|565688920|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
156711887|NCT00911300|565688921|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
156711888|NCT00911300|565688920|FG000|Overall Study|Received Commercial Treatment|1|||
156711889|NCT00911300|565688921|FG001|Overall Study|Received Commercial Treatment|0|||
156711890|NCT00911300|565688920|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
156711891|NCT00911300|565688921|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
156332911|NCT03780543|564317426|FG001|Overall Study|Withdrawal by Subject|8|||
156332912|NCT03780543|564317427|FG002|Overall Study|Withdrawal by Subject|1|||
156332913|NCT03780543|564317425|FG000|Overall Study|Noncompliance with study drug|1|||
156332914|NCT03780543|564317426|FG001|Overall Study|Noncompliance with study drug|0|||
156711892|NCT00911300|565688920|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
156711893|NCT00911300|565688921|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
156711894|NCT00911300|565688920|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
156711895|NCT00911300|565688921|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
156711896|NCT00911300|565688920|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
156711897|NCT00911300|565688921|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
156711898|NCT00911300|565688920|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
156711899|NCT00911300|565688921|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
156711900|NCT00911300|565688920|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
156711901|NCT00911300|565688921|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
156711902|NCT00911300|565688920|FG000|Overall Study|International Normalized Ratio Too High|0|||
156711903|NCT00911300|565688921|FG001|Overall Study|International Normalized Ratio Too High|1|||
156711904|NCT00911300|565688920|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
156711905|NCT00911300|565688921|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
156711906|NCT00911300|565688920|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
156711907|NCT00911300|565688921|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
156711908|NCT00911300|565688920|FG000|Overall Study|Physician Decision|0|||
156711909|NCT00911300|565688921|FG001|Overall Study|Physician Decision|1|||
156711910|NCT00911300|565688920|FG000|Overall Study|Treatment Stopped by Mistake|0|||
156711911|NCT00911300|565688921|FG001|Overall Study|Treatment Stopped by Mistake|1|||
156711912|NCT00911300|565688920|FG000|Overall Study|Randomized; No Study Medication Received|0|||
156711913|NCT00911300|565688921|FG001|Overall Study|Randomized; No Study Medication Received|2|||
156711914|NCT00699816|565688922|FG000|Overall Study|Protocol Violation|1|||
156711915|NCT00699816|565688923|FG001|Overall Study|Protocol Violation|3|||
156711916|NCT01569295|565688924|FG000|Overall Study|Progressive Disease|75|||
156711917|NCT01569295|565688925|FG001|Overall Study|Progressive Disease|139|||
156711918|NCT01569295|565688924|FG000|Overall Study|Adverse Event|39|||
156711919|NCT01569295|565688925|FG001|Overall Study|Adverse Event|14|||
156711920|NCT01569295|565688924|FG000|Overall Study|Withdrawal by Subject|25|||
156711921|NCT01569295|565688925|FG001|Overall Study|Withdrawal by Subject|12|||
156711922|NCT01569295|565688924|FG000|Overall Study|Death|19|||
156711923|NCT01569295|565688925|FG001|Overall Study|Death|15|||
156711924|NCT01569295|565688924|FG000|Overall Study|Physician Decision|13|||
156711925|NCT01569295|565688925|FG001|Overall Study|Physician Decision|18|||
156711926|NCT01569295|565688924|FG000|Overall Study|Study Terminated by Sponsor|24|||
156711927|NCT01569295|565688925|FG001|Overall Study|Study Terminated by Sponsor|2|||
156711928|NCT01569295|565688924|FG000|Overall Study|Other Reason not Specified|3|||
156711929|NCT01569295|565688925|FG001|Overall Study|Other Reason not Specified|5|||
156711930|NCT01569295|565688924|FG000|Overall Study|Non-Compliance with Study Drug|6|||
156711931|NCT01569295|565688925|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156792336|NCT01475825|565992742|FG001|Overall Study|Physician Decision|1|||
156792337|NCT01475825|565992743|FG002|Overall Study|Physician Decision|0|||
156792338|NCT01475825|565992744|FG003|Overall Study|Physician Decision|0|||
156792339|NCT01475825|565992741|FG000|Overall Study|Withdrawal by Subject|8|||
156792340|NCT01475825|565992742|FG001|Overall Study|Withdrawal by Subject|3|||
156792341|NCT01475825|565992743|FG002|Overall Study|Withdrawal by Subject|11|||
156792342|NCT01475825|565992744|FG003|Overall Study|Withdrawal by Subject|7|||
156792343|NCT01475825|565992741|FG000|Overall Study|Did not enter OLC|15|||
156792344|NCT01475825|565992742|FG001|Overall Study|Did not enter OLC|11|||
156792345|NCT01475825|565992743|FG002|Overall Study|Did not enter OLC|15|||
156792346|NCT01475825|565992744|FG003|Overall Study|Did not enter OLC|11|||
156792347|NCT00160563|565992745|FG000|Overall Study|Adverse Event|1|||
156792348|NCT00160563|565992746|FG001|Overall Study|Adverse Event|1|||
156442338|NCT02723955|564713418|FG034|Escalation Phase|Lost to Follow-up|0|||
156442339|NCT02723955|564713419|FG035|Escalation Phase|Lost to Follow-up|0|||
156442340|NCT02723955|564713420|FG036|Escalation Phase|Lost to Follow-up|0|||
156442341|NCT02723955|564713421|FG037|Escalation Phase|Lost to Follow-up|0|||
156442342|NCT02723955|564713422|FG038|Escalation Phase|Lost to Follow-up|0|||
156442343|NCT02723955|564713423|FG039|Escalation Phase|Lost to Follow-up|0|||
156442344|NCT02723955|564713424|FG040|Escalation Phase|Lost to Follow-up|0|||
156442345|NCT02723955|564713425|FG041|Escalation Phase|Lost to Follow-up|0|||
156442346|NCT02723955|564713426|FG042|Escalation Phase|Lost to Follow-up|0|||
156442347|NCT02723955|564713384|FG000|Escalation Phase|Physician Decision|0|||
156442348|NCT02723955|564713385|FG001|Escalation Phase|Physician Decision|0|||
156442349|NCT02723955|564713386|FG002|Escalation Phase|Physician Decision|0|||
156442350|NCT02723955|564713387|FG003|Escalation Phase|Physician Decision|0|||
156442351|NCT02723955|564713388|FG004|Escalation Phase|Physician Decision|0|||
156442352|NCT02723955|564713389|FG005|Escalation Phase|Physician Decision|2|||
156442353|NCT02723955|564713390|FG006|Escalation Phase|Physician Decision|0|||
156442354|NCT02723955|564713391|FG007|Escalation Phase|Physician Decision|0|||
156442355|NCT02723955|564713392|FG008|Escalation Phase|Physician Decision|0|||
156442356|NCT02723955|564713393|FG009|Escalation Phase|Physician Decision|0|||
156442357|NCT02723955|564713394|FG010|Escalation Phase|Physician Decision|0|||
156442358|NCT02723955|564713395|FG011|Escalation Phase|Physician Decision|0|||
156442359|NCT02723955|564713396|FG012|Escalation Phase|Physician Decision|0|||
156442360|NCT02723955|564713397|FG013|Escalation Phase|Physician Decision|0|||
156442361|NCT02723955|564713398|FG014|Escalation Phase|Physician Decision|0|||
156792349|NCT00160563|565992747|FG002|Overall Study|Adverse Event|1|||
156792350|NCT00160563|565992745|FG000|Overall Study|Lost to Follow-up|1|||
156442362|NCT02723955|564713399|FG015|Escalation Phase|Physician Decision|0|||
156442363|NCT02723955|564713400|FG016|Escalation Phase|Physician Decision|0|||
156442364|NCT02723955|564713401|FG017|Escalation Phase|Physician Decision|0|||
156442365|NCT02723955|564713402|FG018|Escalation Phase|Physician Decision|0|||
156442366|NCT02723955|564713403|FG019|Escalation Phase|Physician Decision|0|||
156442367|NCT02723955|564713404|FG020|Escalation Phase|Physician Decision|0|||
156442368|NCT02723955|564713405|FG021|Escalation Phase|Physician Decision|0|||
156442369|NCT02723955|564713406|FG022|Escalation Phase|Physician Decision|0|||
156442370|NCT02723955|564713407|FG023|Escalation Phase|Physician Decision|0|||
156442371|NCT02723955|564713408|FG024|Escalation Phase|Physician Decision|0|||
156442372|NCT02723955|564713409|FG025|Escalation Phase|Physician Decision|0|||
156442373|NCT02723955|564713410|FG026|Escalation Phase|Physician Decision|2|||
156442374|NCT02723955|564713411|FG027|Escalation Phase|Physician Decision|0|||
156442375|NCT02723955|564713412|FG028|Escalation Phase|Physician Decision|0|||
156442376|NCT02723955|564713413|FG029|Escalation Phase|Physician Decision|0|||
156442377|NCT02723955|564713414|FG030|Escalation Phase|Physician Decision|0|||
156442378|NCT02723955|564713415|FG031|Escalation Phase|Physician Decision|0|||
156442379|NCT02723955|564713416|FG032|Escalation Phase|Physician Decision|0|||
156442380|NCT02723955|564713417|FG033|Escalation Phase|Physician Decision|0|||
156442381|NCT02723955|564713418|FG034|Escalation Phase|Physician Decision|0|||
156442382|NCT02723955|564713419|FG035|Escalation Phase|Physician Decision|0|||
156442383|NCT02723955|564713420|FG036|Escalation Phase|Physician Decision|0|||
156442384|NCT02723955|564713421|FG037|Escalation Phase|Physician Decision|0|||
156442385|NCT02723955|564713422|FG038|Escalation Phase|Physician Decision|0|||
156442386|NCT02723955|564713423|FG039|Escalation Phase|Physician Decision|0|||
156442387|NCT02723955|564713424|FG040|Escalation Phase|Physician Decision|0|||
156442388|NCT02723955|564713425|FG041|Escalation Phase|Physician Decision|0|||
156442389|NCT02723955|564713426|FG042|Escalation Phase|Physician Decision|0|||
156442390|NCT02723955|564713384|FG000|Escalation Phase|Withdrawal by Subject|0|||
156442391|NCT02723955|564713385|FG001|Escalation Phase|Withdrawal by Subject|0|||
156442392|NCT02723955|564713386|FG002|Escalation Phase|Withdrawal by Subject|0|||
156442393|NCT02723955|564713387|FG003|Escalation Phase|Withdrawal by Subject|0|||
156442394|NCT02723955|564713388|FG004|Escalation Phase|Withdrawal by Subject|1|||
156442395|NCT02723955|564713389|FG005|Escalation Phase|Withdrawal by Subject|1|||
156442396|NCT02723955|564713390|FG006|Escalation Phase|Withdrawal by Subject|1|||
156442397|NCT02723955|564713391|FG007|Escalation Phase|Withdrawal by Subject|1|||
156442398|NCT02723955|564713392|FG008|Escalation Phase|Withdrawal by Subject|0|||
156442399|NCT02723955|564713393|FG009|Escalation Phase|Withdrawal by Subject|0|||
156442400|NCT02723955|564713394|FG010|Escalation Phase|Withdrawal by Subject|0|||
156442401|NCT02723955|564713395|FG011|Escalation Phase|Withdrawal by Subject|0|||
156442402|NCT02723955|564713396|FG012|Escalation Phase|Withdrawal by Subject|1|||
156442403|NCT02723955|564713397|FG013|Escalation Phase|Withdrawal by Subject|0|||
156532168|NCT01313650|565043306|FG001|Overall Study|Adverse Event|34|||
156532169|NCT01313650|565043307|FG002|Overall Study|Adverse Event|24|||
156532170|NCT01313650|565043308|FG003|Overall Study|Adverse Event|23|||
156532171|NCT01313650|565043305|FG000|Overall Study|Lack of Efficacy|37|||
156711932|NCT01569295|565688924|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
156442404|NCT02723955|564713398|FG014|Escalation Phase|Withdrawal by Subject|0|||
156442405|NCT02723955|564713399|FG015|Escalation Phase|Withdrawal by Subject|0|||
156442406|NCT02723955|564713400|FG016|Escalation Phase|Withdrawal by Subject|1|||
156442407|NCT02723955|564713401|FG017|Escalation Phase|Withdrawal by Subject|0|||
156442408|NCT02723955|564713402|FG018|Escalation Phase|Withdrawal by Subject|0|||
156442409|NCT02723955|564713403|FG019|Escalation Phase|Withdrawal by Subject|0|||
156442410|NCT02723955|564713404|FG020|Escalation Phase|Withdrawal by Subject|0|||
156442411|NCT02723955|564713405|FG021|Escalation Phase|Withdrawal by Subject|0|||
156442412|NCT02723955|564713406|FG022|Escalation Phase|Withdrawal by Subject|0|||
156442413|NCT02723955|564713407|FG023|Escalation Phase|Withdrawal by Subject|2|||
156442414|NCT02723955|564713408|FG024|Escalation Phase|Withdrawal by Subject|0|||
156442415|NCT02723955|564713409|FG025|Escalation Phase|Withdrawal by Subject|1|||
156442416|NCT02723955|564713410|FG026|Escalation Phase|Withdrawal by Subject|0|||
156711933|NCT01569295|565688925|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
156711934|NCT01569295|565688924|FG000|Overall Study|Lost to Follow-up|1|||
156711935|NCT01569295|565688925|FG001|Overall Study|Lost to Follow-up|1|||
156711936|NCT01895777|565688926|FG000|Overall Study|Adverse Event|1|||
156711937|NCT01895777|565688927|FG001|Overall Study|Adverse Event|2|||
156442417|NCT02723955|564713411|FG027|Escalation Phase|Withdrawal by Subject|0|||
156442418|NCT02723955|564713412|FG028|Escalation Phase|Withdrawal by Subject|1|||
156442419|NCT02723955|564713413|FG029|Escalation Phase|Withdrawal by Subject|0|||
156442420|NCT02723955|564713414|FG030|Escalation Phase|Withdrawal by Subject|0|||
156442421|NCT02723955|564713415|FG031|Escalation Phase|Withdrawal by Subject|0|||
156442422|NCT02723955|564713416|FG032|Escalation Phase|Withdrawal by Subject|0|||
156442423|NCT02723955|564713417|FG033|Escalation Phase|Withdrawal by Subject|0|||
156442424|NCT02723955|564713418|FG034|Escalation Phase|Withdrawal by Subject|0|||
156442425|NCT02723955|564713419|FG035|Escalation Phase|Withdrawal by Subject|0|||
156442426|NCT02723955|564713420|FG036|Escalation Phase|Withdrawal by Subject|0|||
156442427|NCT02723955|564713421|FG037|Escalation Phase|Withdrawal by Subject|0|||
156442428|NCT02723955|564713422|FG038|Escalation Phase|Withdrawal by Subject|0|||
156442429|NCT02723955|564713423|FG039|Escalation Phase|Withdrawal by Subject|0|||
156442430|NCT02723955|564713424|FG040|Escalation Phase|Withdrawal by Subject|0|||
156442431|NCT02723955|564713425|FG041|Escalation Phase|Withdrawal by Subject|0|||
156442432|NCT02723955|564713426|FG042|Escalation Phase|Withdrawal by Subject|0|||
156442433|NCT02723955|564713384|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442434|NCT02723955|564713385|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442435|NCT02723955|564713386|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442436|NCT02723955|564713387|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442437|NCT02723955|564713388|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
156442438|NCT02723955|564713389|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
156442439|NCT02723955|564713390|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
156442440|NCT02723955|564713391|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
156442441|NCT02723955|564713392|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
156442442|NCT02723955|564713393|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442443|NCT02723955|564713394|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442444|NCT02723955|564713395|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442445|NCT02723955|564713396|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442446|NCT02723955|564713397|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442447|NCT02723955|564713398|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442448|NCT02723955|564713399|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442449|NCT02723955|564713400|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442450|NCT02723955|564713401|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442451|NCT02723955|564713402|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442452|NCT02723955|564713403|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442453|NCT02723955|564713404|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442454|NCT02723955|564713405|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442455|NCT02723955|564713406|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442456|NCT02723955|564713407|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442457|NCT02723955|564713408|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442458|NCT02723955|564713409|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442459|NCT02723955|564713410|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442460|NCT02723955|564713411|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442461|NCT02723955|564713412|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442462|NCT02723955|564713413|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442463|NCT02723955|564713414|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442464|NCT02723955|564713415|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442465|NCT02723955|564713416|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442466|NCT02723955|564713417|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442467|NCT02723955|564713418|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442468|NCT02723955|564713419|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442469|NCT02723955|564713420|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442470|NCT02723955|564713421|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442471|NCT02723955|564713422|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442472|NCT02723955|564713423|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442473|NCT02723955|564713424|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156711938|NCT01895777|565688926|FG000|Overall Study|Lost to Follow-up|2|||
156711939|NCT01895777|565688927|FG001|Overall Study|Lost to Follow-up|0|||
156711940|NCT01895777|565688926|FG000|Overall Study|Not treated|1|||
156711941|NCT01895777|565688927|FG001|Overall Study|Not treated|0|||
156442474|NCT02723955|564713425|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156442475|NCT02723955|564713426|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156711942|NCT01895777|565688926|FG000|Overall Study|Other reasons|3|||
156711943|NCT01895777|565688927|FG001|Overall Study|Other reasons|2|||
156711944|NCT01895777|565688926|FG000|Overall Study|Non-compliance with the CTP|2|||
156711945|NCT01895777|565688927|FG001|Overall Study|Non-compliance with the CTP|1|||
156711946|NCT02508935|565688932|FG000|Overall Study|Withdrawal by Subject|1|||
156711947|NCT02508935|565688932|FG000|Overall Study|Withdrawal by Caregiver|8|||
156711948|NCT02508935|565688932|FG000|Overall Study|Pain Score <4|1|||
156711949|NCT02508935|565688932|FG000|Overall Study|Emesis|3|||
156711950|NCT02508935|565688932|FG000|Overall Study|Adverse Event|3|||
156711951|NCT02508935|565688932|FG000|Overall Study|Protocol Violation|1|||
156711952|NCT02508935|565688932|FG000|Overall Study|Physician Decision|1|||
156711953|NCT02508935|565688932|FG000|Overall Study|Trial terminated by sponsor|5|||
156711954|NCT04223752|565688935|FG000|Overall Study|Participant enrolled in error|0|||
156711955|NCT04223752|565688936|FG001|Overall Study|Participant enrolled in error|0|||
156711956|NCT04223752|565688937|FG002|Overall Study|Participant enrolled in error|0|||
156711957|NCT04223752|565688938|FG003|Overall Study|Participant enrolled in error|0|||
156711958|NCT04223752|565688939|FG004|Overall Study|Participant enrolled in error|1|||
156711959|NCT04223752|565688935|FG000|Overall Study|Death|0|||
156711960|NCT04223752|565688936|FG001|Overall Study|Death|0|||
156711961|NCT04223752|565688937|FG002|Overall Study|Death|0|||
156711962|NCT04223752|565688938|FG003|Overall Study|Death|2|||
156711963|NCT04223752|565688939|FG004|Overall Study|Death|1|||
156711964|NCT04759703|565688940|FG000|Overall Study|Withdrawal by Subject|4|||
156711965|NCT04759703|565688941|FG001|Overall Study|Withdrawal by Subject|9|||
156711966|NCT04759703|565688940|FG000|Overall Study|Adverse Event|1|||
156711967|NCT04759703|565688941|FG001|Overall Study|Adverse Event|0|||
156711968|NCT04759703|565688940|FG000|Overall Study|Lost to Follow-up|2|||
156711969|NCT04759703|565688941|FG001|Overall Study|Lost to Follow-up|0|||
156711970|NCT03138655|565688951|FG000|Overall Study|Adverse Event|2|||
156711971|NCT03138655|565688952|FG001|Overall Study|Adverse Event|1|||
156711972|NCT03138655|565688953|FG002|Overall Study|Adverse Event|2|||
156711973|NCT03138655|565688954|FG003|Overall Study|Adverse Event|1|||
156711974|NCT03138655|565688955|FG004|Overall Study|Adverse Event|1|||
156711975|NCT03138655|565688956|FG005|Overall Study|Adverse Event|4|||
156711976|NCT03138655|565688957|FG006|Overall Study|Adverse Event|2|||
156711977|NCT03138655|565688958|FG007|Overall Study|Adverse Event|2|||
156711978|NCT03138655|565688951|FG000|Overall Study|Withdrawal by Subject|0|||
156711979|NCT03138655|565688952|FG001|Overall Study|Withdrawal by Subject|1|||
156711980|NCT03138655|565688953|FG002|Overall Study|Withdrawal by Subject|0|||
156711981|NCT03138655|565688954|FG003|Overall Study|Withdrawal by Subject|0|||
156711982|NCT03138655|565688955|FG004|Overall Study|Withdrawal by Subject|0|||
156711983|NCT03138655|565688956|FG005|Overall Study|Withdrawal by Subject|0|||
156711984|NCT03138655|565688957|FG006|Overall Study|Withdrawal by Subject|1|||
156711985|NCT03138655|565688958|FG007|Overall Study|Withdrawal by Subject|0|||
156711986|NCT03138655|565688951|FG000|Overall Study|Reason not Specified|1|||
156711987|NCT03138655|565688952|FG001|Overall Study|Reason not Specified|0|||
156711988|NCT03138655|565688953|FG002|Overall Study|Reason not Specified|0|||
156711989|NCT03138655|565688954|FG003|Overall Study|Reason not Specified|2|||
156711990|NCT03138655|565688955|FG004|Overall Study|Reason not Specified|1|||
156711991|NCT03138655|565688956|FG005|Overall Study|Reason not Specified|1|||
156711992|NCT03138655|565688957|FG006|Overall Study|Reason not Specified|0|||
156711993|NCT03138655|565688958|FG007|Overall Study|Reason not Specified|0|||
156711994|NCT02800642|565688959|FG000|Overall Study|Death|3|||
156711995|NCT02800642|565688959|FG000|Overall Study|Other|10|||
156711996|NCT02800642|565688959|FG000|Overall Study|Physician Decision|2|||
156711997|NCT02800642|565688959|FG000|Overall Study|Adverse Event|6|||
156711998|NCT02800642|565688959|FG000|Overall Study|Withdrawal by Subject|3|||
156711999|NCT02800642|565688959|FG000|Overall Study|Lost to Follow-up|1|||
156712000|NCT04868500|565688960|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
156712001|NCT04868500|565688961|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
156712002|NCT04868500|565688960|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
156712003|NCT04868500|565688961|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
156712004|NCT03340974|565688962|FG000|Completion of Study -Long Term Follow up|Death|8|||
156712005|NCT03340974|565688963|FG001|Completion of Study -Long Term Follow up|Death|5|||
156712006|NCT03340974|565688964|FG002|Completion of Study -Long Term Follow up|Death|5|||
156712007|NCT03340974|565688965|FG003|Completion of Study -Long Term Follow up|Death|7|||
156712008|NCT03340974|565688962|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
156712009|NCT03340974|565688963|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
156712010|NCT03340974|565688964|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
156712011|NCT03340974|565688965|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
156332915|NCT03780543|564317427|FG002|Overall Study|Noncompliance with study drug|0|||
156712012|NCT03340974|565688962|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
156712013|NCT03340974|565688963|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
156712014|NCT03340974|565688964|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
156712015|NCT03340974|565688965|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
156332916|NCT01033851|564317428|FG000|Overall Study|Withdrawal by Subject|3|||
156332917|NCT01033851|564317429|FG001|Overall Study|Withdrawal by Subject|7|||
156332918|NCT00066729|564317432|FG000|Overall Study|Lost to Follow-up|1|||
156712016|NCT03340974|565688962|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
156712017|NCT03340974|565688963|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
156712018|NCT03340974|565688964|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
156712019|NCT03340974|565688965|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
156712020|NCT00396565|565688972|FG000|Overall Study|Physician Decision|3|||
156712021|NCT00396565|565688973|FG001|Overall Study|Physician Decision|1|||
156712022|NCT00396565|565688974|FG002|Overall Study|Physician Decision|2|||
156712023|NCT00396565|565688972|FG000|Overall Study|Adverse Event|5|||
156712024|NCT00396565|565688973|FG001|Overall Study|Adverse Event|13|||
156712025|NCT00396565|565688974|FG002|Overall Study|Adverse Event|3|||
156712026|NCT00396565|565688972|FG000|Overall Study|Withdrawal by Subject|8|||
156712027|NCT00396565|565688973|FG001|Overall Study|Withdrawal by Subject|13|||
156712028|NCT00396565|565688974|FG002|Overall Study|Withdrawal by Subject|1|||
156712029|NCT00396565|565688972|FG000|Overall Study|Lack of Efficacy|32|||
156712030|NCT00396565|565688973|FG001|Overall Study|Lack of Efficacy|64|||
156712031|NCT00396565|565688974|FG002|Overall Study|Lack of Efficacy|11|||
156712032|NCT05109611|565690803|FG000|Overall Study|Adverse Event|13|||
156712033|NCT05109611|565690804|FG001|Overall Study|Adverse Event|10|||
156712034|NCT05109611|565690803|FG000|Overall Study|Withdrawal by Subject|1|||
156712035|NCT05109611|565690804|FG001|Overall Study|Withdrawal by Subject|0|||
156712036|NCT05109611|565690803|FG000|Overall Study|Lost to Follow-up|1|||
156712037|NCT05109611|565690804|FG001|Overall Study|Lost to Follow-up|2|||
156712038|NCT05109611|565690803|FG000|Overall Study|Protocol Violation|0|||
156712039|NCT05109611|565690804|FG001|Overall Study|Protocol Violation|4|||
156712040|NCT05109611|565690803|FG000|Overall Study|Information unavailable|1|||
156712041|NCT05109611|565690804|FG001|Overall Study|Information unavailable|1|||
156712042|NCT03203850|565690808|FG000|Overall Study|Subject/guardian decision|4|||
156712043|NCT03203850|565690809|FG001|Overall Study|Subject/guardian decision|3|||
156712044|NCT03203850|565690808|FG000|Overall Study|Adverse Event|3|||
156712045|NCT03203850|565690809|FG001|Overall Study|Adverse Event|0|||
156712046|NCT03203850|565690808|FG000|Overall Study|Death|1|||
156712047|NCT03203850|565690809|FG001|Overall Study|Death|0|||
156712048|NCT02717455|565690810|FG000|Overall Study|Adverse Event|1|||
156712049|NCT02717455|565690811|FG001|Overall Study|Adverse Event|0|||
156712050|NCT02717455|565690812|FG002|Overall Study|Adverse Event|0|||
156712051|NCT02717455|565690813|FG003|Overall Study|Adverse Event|2|||
156712052|NCT02717455|565690814|FG004|Overall Study|Adverse Event|2|||
156712053|NCT02717455|565690815|FG005|Overall Study|Adverse Event|2|||
156712054|NCT02717455|565690810|FG000|Overall Study|Withdrawal by Subject|1|||
156712055|NCT02717455|565690811|FG001|Overall Study|Withdrawal by Subject|1|||
156712056|NCT02717455|565690812|FG002|Overall Study|Withdrawal by Subject|0|||
156712057|NCT02717455|565690813|FG003|Overall Study|Withdrawal by Subject|2|||
156712058|NCT02717455|565690814|FG004|Overall Study|Withdrawal by Subject|2|||
156712059|NCT02717455|565690815|FG005|Overall Study|Withdrawal by Subject|1|||
156712060|NCT02717455|565690810|FG000|Overall Study|Death|1|||
156712061|NCT02717455|565690811|FG001|Overall Study|Death|0|||
156712062|NCT02717455|565690812|FG002|Overall Study|Death|0|||
156712063|NCT02717455|565690813|FG003|Overall Study|Death|0|||
156712064|NCT02717455|565690814|FG004|Overall Study|Death|1|||
156712065|NCT02717455|565690815|FG005|Overall Study|Death|0|||
156712066|NCT02717455|565690810|FG000|Overall Study|Did not receive study drug|0|||
156712067|NCT02717455|565690811|FG001|Overall Study|Did not receive study drug|0|||
156712068|NCT02717455|565690812|FG002|Overall Study|Did not receive study drug|0|||
156712069|NCT02717455|565690813|FG003|Overall Study|Did not receive study drug|1|||
156712070|NCT02717455|565690814|FG004|Overall Study|Did not receive study drug|0|||
156712071|NCT02717455|565690815|FG005|Overall Study|Did not receive study drug|1|||
156712072|NCT02717455|565690810|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156712073|NCT02717455|565690811|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156712074|NCT02717455|565690812|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156442476|NCT02723955|564713384|FG000|Escalation Phase|Site Closed|0|||
156712075|NCT02717455|565690813|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156712076|NCT02717455|565690814|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156712077|NCT02717455|565690815|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
156712078|NCT02717455|565690810|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
156792351|NCT00160563|565992746|FG001|Overall Study|Lost to Follow-up|1|||
156442477|NCT02723955|564713385|FG001|Escalation Phase|Site Closed|0|||
156712079|NCT02717455|565690811|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
156712080|NCT02717455|565690812|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
156712081|NCT02717455|565690813|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
156442478|NCT02723955|564713386|FG002|Escalation Phase|Site Closed|0|||
156442479|NCT02723955|564713387|FG003|Escalation Phase|Site Closed|0|||
156442480|NCT02723955|564713388|FG004|Escalation Phase|Site Closed|0|||
156712082|NCT02717455|565690814|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
156792352|NCT00160563|565992747|FG002|Overall Study|Lost to Follow-up|2|||
156712083|NCT02717455|565690815|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
156712084|NCT00886015|565690820|FG000|Overall Study|Death|0|||
156712085|NCT00886015|565690821|FG001|Overall Study|Death|2|||
156712086|NCT01692626|565690822|FG000|Overall Study|Death|0|||
156712087|NCT01692626|565690823|FG001|Overall Study|Death|1|||
156712088|NCT01692626|565690822|FG000|Overall Study|Adverse Event|2|||
156712089|NCT01692626|565690823|FG001|Overall Study|Adverse Event|3|||
156712090|NCT01692626|565690822|FG000|Overall Study|Protocol Violation|1|||
156712091|NCT01692626|565690823|FG001|Overall Study|Protocol Violation|2|||
156712092|NCT01692626|565690822|FG000|Overall Study|Withdrawal by Subject|1|||
156712093|NCT01692626|565690823|FG001|Overall Study|Withdrawal by Subject|0|||
156712094|NCT00855894|565690824|FG000|Overall Study|Death|31|||
156712095|NCT00855894|565690824|FG000|Overall Study|Patient's decision|1|||
156712096|NCT00855894|565690824|FG000|Overall Study|Disease progression|1|||
156712097|NCT02794870|565690836|FG000|Overall Study|Withdrawal by Subject|2|||
156712098|NCT02794870|565690837|FG001|Overall Study|Withdrawal by Subject|0|||
156712099|NCT02540083|565690838|FG000|Overall Study|Withdrawal by Subject|16|||
156712100|NCT02301390|565690839|FG000|Overall Study|Withdrawal by Subject|3|||
156712101|NCT02301390|565690840|FG001|Overall Study|Withdrawal by Subject|5|||
156712102|NCT02301390|565690839|FG000|Overall Study|Protocol Violation|1|||
156712103|NCT02301390|565690840|FG001|Overall Study|Protocol Violation|0|||
156712104|NCT02301390|565690839|FG000|Overall Study|Physician Decision|1|||
156712105|NCT02301390|565690840|FG001|Overall Study|Physician Decision|0|||
156712106|NCT02301390|565690839|FG000|Overall Study|Lost to Follow-up|0|||
156712107|NCT02301390|565690840|FG001|Overall Study|Lost to Follow-up|1|||
156712108|NCT02301390|565690839|FG000|Overall Study|Death|2|||
156712109|NCT02301390|565690840|FG001|Overall Study|Death|2|||
156712110|NCT02301390|565690839|FG000|Overall Study|Procedure not completed|0|||
156712111|NCT02301390|565690840|FG001|Overall Study|Procedure not completed|4|||
156712112|NCT02301390|565690839|FG000|Overall Study|Missed multiple visits|1|||
156712113|NCT02301390|565690840|FG001|Overall Study|Missed multiple visits|1|||
156712114|NCT02301390|565690839|FG000|Overall Study|study terminated|2|||
156712115|NCT02301390|565690840|FG001|Overall Study|study terminated|0|||
156712116|NCT02604407|565690841|FG000|Overall Study|Adverse Event|0|||
156712117|NCT02604407|565690842|FG001|Overall Study|Adverse Event|7|||
156712118|NCT02604407|565690843|FG002|Overall Study|Adverse Event|5|||
156712119|NCT02604407|565690841|FG000|Overall Study|Protocol Violation|2|||
156712120|NCT02604407|565690842|FG001|Overall Study|Protocol Violation|0|||
156712121|NCT02604407|565690843|FG002|Overall Study|Protocol Violation|0|||
156712122|NCT02604407|565690841|FG000|Overall Study|Withdrawal by Subject|3|||
156712123|NCT02604407|565690842|FG001|Overall Study|Withdrawal by Subject|3|||
156712124|NCT02604407|565690843|FG002|Overall Study|Withdrawal by Subject|5|||
156712125|NCT02604407|565690841|FG000|Overall Study|Lost to Follow-up|2|||
156712126|NCT02604407|565690842|FG001|Overall Study|Lost to Follow-up|1|||
156712127|NCT02604407|565690843|FG002|Overall Study|Lost to Follow-up|2|||
156712128|NCT02604407|565690841|FG000|Overall Study|Lack of Efficacy|1|||
156712129|NCT02604407|565690842|FG001|Overall Study|Lack of Efficacy|0|||
156712130|NCT02604407|565690843|FG002|Overall Study|Lack of Efficacy|0|||
156712131|NCT02604407|565690841|FG000|Overall Study|Other|3|||
156712132|NCT02604407|565690842|FG001|Overall Study|Other|1|||
156712133|NCT02604407|565690843|FG002|Overall Study|Other|4|||
156712134|NCT00185588|565690844|FG000|Overall Study|Adverse Event|3|||
156712135|NCT00185588|565690845|FG001|Overall Study|Adverse Event|1|||
156712136|NCT00185588|565690846|FG002|Overall Study|Adverse Event|4|||
156712137|NCT00185588|565690847|FG003|Overall Study|Adverse Event|2|||
156712138|NCT00185588|565690844|FG000|Overall Study|Lost to Follow-up|0|||
156712139|NCT00185588|565690845|FG001|Overall Study|Lost to Follow-up|0|||
156792353|NCT00160563|565992745|FG000|Overall Study|Protocol Violation|0|||
156792354|NCT00160563|565992746|FG001|Overall Study|Protocol Violation|0|||
156442481|NCT02723955|564713389|FG005|Escalation Phase|Site Closed|0|||
156442482|NCT02723955|564713390|FG006|Escalation Phase|Site Closed|0|||
156442483|NCT02723955|564713391|FG007|Escalation Phase|Site Closed|0|||
156442484|NCT02723955|564713392|FG008|Escalation Phase|Site Closed|0|||
156442485|NCT02723955|564713393|FG009|Escalation Phase|Site Closed|0|||
156712140|NCT00185588|565690846|FG002|Overall Study|Lost to Follow-up|1|||
156442486|NCT02723955|564713394|FG010|Escalation Phase|Site Closed|0|||
156712141|NCT00185588|565690847|FG003|Overall Study|Lost to Follow-up|2|||
156712142|NCT00185588|565690844|FG000|Overall Study|Withdrawal by Subject|0|||
156712143|NCT00185588|565690845|FG001|Overall Study|Withdrawal by Subject|1|||
156712144|NCT00185588|565690846|FG002|Overall Study|Withdrawal by Subject|0|||
156712145|NCT00185588|565690847|FG003|Overall Study|Withdrawal by Subject|0|||
156712146|NCT00185588|565690844|FG000|Overall Study|Physician Decision|0|||
156712147|NCT00185588|565690845|FG001|Overall Study|Physician Decision|0|||
156712148|NCT00185588|565690846|FG002|Overall Study|Physician Decision|1|||
156712149|NCT00185588|565690847|FG003|Overall Study|Physician Decision|0|||
156712150|NCT00398866|565690848|FG000|Overall Study|Adverse Event|1|||
156712151|NCT00398866|565690849|FG001|Overall Study|Adverse Event|0|||
156712152|NCT00398866|565690850|FG002|Overall Study|Adverse Event|0|||
156712153|NCT00398866|565690848|FG000|Overall Study|Lack of Efficacy|0|||
156792355|NCT00160563|565992747|FG002|Overall Study|Protocol Violation|3|||
156712154|NCT00398866|565690849|FG001|Overall Study|Lack of Efficacy|0|||
156712155|NCT00398866|565690850|FG002|Overall Study|Lack of Efficacy|1|||
156712156|NCT00398866|565690848|FG000|Overall Study|Lost to Follow-up|7|||
156712157|NCT00398866|565690849|FG001|Overall Study|Lost to Follow-up|6|||
156712158|NCT00398866|565690850|FG002|Overall Study|Lost to Follow-up|4|||
156712159|NCT00398866|565690848|FG000|Overall Study|Withdrawal by Subject|5|||
156712160|NCT00398866|565690849|FG001|Overall Study|Withdrawal by Subject|1|||
156712161|NCT00398866|565690850|FG002|Overall Study|Withdrawal by Subject|2|||
156712162|NCT00398866|565690848|FG000|Overall Study|Unable to complete requirements of study|1|||
156712163|NCT00398866|565690849|FG001|Overall Study|Unable to complete requirements of study|1|||
156712164|NCT00398866|565690850|FG002|Overall Study|Unable to complete requirements of study|1|||
156712165|NCT02481869|565690853|FG000|Overall Study|Lost to Follow-up|3|||
156712166|NCT02481869|565690854|FG001|Overall Study|Lost to Follow-up|4|||
156712167|NCT02481869|565690853|FG000|Overall Study|Withdrawal by Subject|2|||
156712168|NCT02481869|565690854|FG001|Overall Study|Withdrawal by Subject|0|||
156712169|NCT00191191|565690857|FG000|Overall Study|Entry Criteria Exclusion|2|||
156712170|NCT00191191|565690858|FG001|Overall Study|Entry Criteria Exclusion|0|||
156712171|NCT00191191|565690857|FG000|Overall Study|Treated with Another Systemic Agent|1|||
156712172|NCT00191191|565690858|FG001|Overall Study|Treated with Another Systemic Agent|1|||
156712173|NCT00191191|565690857|FG000|Overall Study|Adverse Event|11|||
156712174|NCT00191191|565690858|FG001|Overall Study|Adverse Event|21|||
156712175|NCT00191191|565690857|FG000|Overall Study|Progressive Disease|84|||
156712176|NCT00191191|565690858|FG001|Overall Study|Progressive Disease|72|||
156712177|NCT00191191|565690857|FG000|Overall Study|Toxicity After Dose Reduction|7|||
156712178|NCT00191191|565690858|FG001|Overall Study|Toxicity After Dose Reduction|8|||
156712179|NCT00191191|565690857|FG000|Overall Study|Family/Caregiver Decision|5|||
156712180|NCT00191191|565690858|FG001|Overall Study|Family/Caregiver Decision|7|||
156712181|NCT00191191|565690857|FG000|Overall Study|Lost to Follow-up|1|||
156712182|NCT00191191|565690858|FG001|Overall Study|Lost to Follow-up|0|||
156712183|NCT00191191|565690857|FG000|Overall Study|Physician Decision|3|||
156712184|NCT00191191|565690858|FG001|Overall Study|Physician Decision|2|||
156712185|NCT00191191|565690857|FG000|Overall Study|Good Clinical Practice Violation|0|||
156712186|NCT00191191|565690858|FG001|Overall Study|Good Clinical Practice Violation|1|||
156712187|NCT03790657|565690859|FG000|Overall Study|Adverse Event|1|||
156712188|NCT03790657|565690860|FG001|Overall Study|Adverse Event|1|||
156712189|NCT03790657|565690859|FG000|Overall Study|Withdrawal by Subject|1|||
156712190|NCT03790657|565690860|FG001|Overall Study|Withdrawal by Subject|1|||
156712191|NCT01023035|565690862|FG000|Treatment Period|Adverse Event|27|||
156712192|NCT01023035|565690863|FG001|Treatment Period|Adverse Event|32|||
156712193|NCT01023035|565690864|FG002|Treatment Period|Adverse Event|50|||
156712194|NCT01023035|565690862|FG000|Treatment Period|Non-Medical Reasons|19|||
156712195|NCT01023035|565690863|FG001|Treatment Period|Non-Medical Reasons|22|||
156712196|NCT01023035|565690864|FG002|Treatment Period|Non-Medical Reasons|44|||
156712197|NCT01023035|565690862|FG000|Treatment Period|Treatment Failure|26|||
156712198|NCT01023035|565690863|FG001|Treatment Period|Treatment Failure|31|||
156712199|NCT01023035|565690864|FG002|Treatment Period|Treatment Failure|24|||
156712200|NCT01023035|565690862|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
156712201|NCT01023035|565690863|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
156712202|NCT01023035|565690864|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
156712203|NCT01023035|565690862|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
156712204|NCT01023035|565690863|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
156712205|NCT01023035|565690864|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
156712206|NCT04342819|565690865|FG000|Overall Study|Declined|4|||
156712207|NCT04342819|565690865|FG000|Overall Study|Not meeeting selection criteria|1|||
156712208|NCT00560391|565690869|FG000|Overall Study|Still on treatment|0|||
156712209|NCT00560391|565690870|FG001|Overall Study|Still on treatment|0|||
156712210|NCT00560391|565690871|FG002|Overall Study|Still on treatment|0|||
156712211|NCT00560391|565690872|FG003|Overall Study|Still on treatment|1|||
156792356|NCT00160563|565992745|FG000|Overall Study|Withdrawal by Subject|1|||
156792357|NCT00160563|565992746|FG001|Overall Study|Withdrawal by Subject|2|||
156792358|NCT00160563|565992747|FG002|Overall Study|Withdrawal by Subject|3|||
156792359|NCT00160563|565992745|FG000|Overall Study|Other (listed in the study report)|48|||
156792360|NCT00160563|565992746|FG001|Overall Study|Other (listed in the study report)|40|||
156712212|NCT00560391|565690873|FG004|Overall Study|Still on treatment|2|||
156712213|NCT03607487|565690874|FG000|Overall Study|Withdrawal by Subject|2|||
156712214|NCT03607487|565690875|FG001|Overall Study|Withdrawal by Subject|0|||
156712215|NCT03607487|565690876|FG002|Overall Study|Withdrawal by Subject|0|||
156712216|NCT03607487|565690877|FG003|Overall Study|Withdrawal by Subject|1|||
156712217|NCT05061420|565690878|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
156712218|NCT05061420|565690879|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
156712219|NCT05061420|565690880|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
156712220|NCT05061420|565690878|FG000|Overall Study|Progressive disease|11|||
156712221|NCT05061420|565690879|FG001|Overall Study|Progressive disease|15|||
156712222|NCT05061420|565690880|FG002|Overall Study|Progressive disease|14|||
156808763|NCT01408277|566054458|FG001|Overall Study|Adverse Event|4|||
156712223|NCT05061420|565690878|FG000|Overall Study|Withdrawal by Subject|2|||
156712224|NCT05061420|565690879|FG001|Overall Study|Withdrawal by Subject|0|||
156442487|NCT02723955|564713395|FG011|Escalation Phase|Site Closed|0|||
156442488|NCT02723955|564713396|FG012|Escalation Phase|Site Closed|0|||
156442489|NCT02723955|564713397|FG013|Escalation Phase|Site Closed|0|||
156442490|NCT02723955|564713398|FG014|Escalation Phase|Site Closed|0|||
156442491|NCT02723955|564713399|FG015|Escalation Phase|Site Closed|1|||
156442492|NCT02723955|564713400|FG016|Escalation Phase|Site Closed|0|||
156442493|NCT02723955|564713401|FG017|Escalation Phase|Site Closed|2|||
156442494|NCT02723955|564713402|FG018|Escalation Phase|Site Closed|0|||
156442495|NCT02723955|564713403|FG019|Escalation Phase|Site Closed|0|||
156442496|NCT02723955|564713404|FG020|Escalation Phase|Site Closed|1|||
156442497|NCT02723955|564713405|FG021|Escalation Phase|Site Closed|0|||
156442498|NCT02723955|564713406|FG022|Escalation Phase|Site Closed|0|||
156532172|NCT01313650|565043306|FG001|Overall Study|Lack of Efficacy|20|||
156712225|NCT05061420|565690880|FG002|Overall Study|Withdrawal by Subject|1|||
156712226|NCT05061420|565690878|FG000|Overall Study|Not related to COVID-19|2|||
156712227|NCT05061420|565690879|FG001|Overall Study|Not related to COVID-19|0|||
156332919|NCT00066729|564317432|FG000|Overall Study|Disease progression|1|||
156332920|NCT00338104|564317433|FG000|Overall Study|Protocol Violation|2|||
156332921|NCT00338104|564317434|FG001|Overall Study|Protocol Violation|1|||
156332922|NCT00338104|564317435|FG002|Overall Study|Protocol Violation|3|||
156332923|NCT02362269|564317438|FG000|Overall Study|Moved|1|||
156332924|NCT02362269|564317439|FG001|Overall Study|Moved|0|||
156332925|NCT02362269|564317438|FG000|Overall Study|Lost to Follow-up|0|||
156332926|NCT02362269|564317439|FG001|Overall Study|Lost to Follow-up|6|||
156332927|NCT02215096|564317440|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
156332928|NCT02215096|564317441|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
156332929|NCT02215096|564317442|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
156332930|NCT02215096|564317443|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
156332931|NCT02215096|564317444|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
156332932|NCT02215096|564317440|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
156332933|NCT02215096|564317441|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
156332934|NCT02215096|564317442|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
156332935|NCT02215096|564317443|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
156332936|NCT02215096|564317444|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
156332937|NCT02215096|564317440|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
156332938|NCT02215096|564317441|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
156332939|NCT02215096|564317442|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
156332940|NCT02215096|564317443|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
156332941|NCT02215096|564317444|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
156332942|NCT02215096|564317440|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
156332943|NCT02215096|564317441|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
156332944|NCT02215096|564317442|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
156332945|NCT02215096|564317443|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
156332946|NCT02215096|564317444|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
156332947|NCT02349542|564317445|FG000|Overall Study|Withdrawal by Subject|5|||
156332948|NCT01011738|564317446|FG000|Overall Study|Death|12|||
156332949|NCT01011738|564317447|FG001|Overall Study|Death|3|||
156332950|NCT01011738|564317448|FG002|Overall Study|Death|0|||
156332951|NCT01011738|564317446|FG000|Overall Study|Unknown reasons|312|||
156332952|NCT01011738|564317447|FG001|Overall Study|Unknown reasons|291|||
156332953|NCT01011738|564317448|FG002|Overall Study|Unknown reasons|17|||
156332954|NCT03181893|564317449|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332955|NCT03181893|564317450|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
156332956|NCT03181893|564317451|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332957|NCT03181893|564317452|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332958|NCT03181893|564317453|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332959|NCT03181893|564317454|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332960|NCT03181893|564317455|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332961|NCT03181893|564317456|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332962|NCT03181893|564317457|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332963|NCT03181893|564317458|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332964|NCT03181893|564317459|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156332965|NCT03181893|564317449|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
156332966|NCT03181893|564317450|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
156332967|NCT03181893|564317451|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156332968|NCT03181893|564317452|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156332969|NCT03181893|564317453|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156332970|NCT03181893|564317454|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156532173|NCT01313650|565043307|FG002|Overall Study|Lack of Efficacy|32|||
156532174|NCT01313650|565043308|FG003|Overall Study|Lack of Efficacy|20|||
156532175|NCT01313650|565043305|FG000|Overall Study|Lost to Follow-up|1|||
156532176|NCT01313650|565043306|FG001|Overall Study|Lost to Follow-up|0|||
156532177|NCT01313650|565043307|FG002|Overall Study|Lost to Follow-up|3|||
156532178|NCT01313650|565043308|FG003|Overall Study|Lost to Follow-up|2|||
156532179|NCT01313650|565043305|FG000|Overall Study|Withdrawal by Subject|16|||
156532180|NCT01313650|565043306|FG001|Overall Study|Withdrawal by Subject|20|||
156532181|NCT01313650|565043307|FG002|Overall Study|Withdrawal by Subject|15|||
156532182|NCT01313650|565043308|FG003|Overall Study|Withdrawal by Subject|15|||
156532183|NCT01313650|565043305|FG000|Overall Study|Protocol Violation|4|||
156532184|NCT01313650|565043306|FG001|Overall Study|Protocol Violation|7|||
156712228|NCT05061420|565690880|FG002|Overall Study|Not related to COVID-19|0|||
156712229|NCT01814553|565690881|FG000|Overall Study|PD per clinical progression|6|||
156712230|NCT01814553|565690882|FG001|Overall Study|PD per clinical progression|8|||
156712231|NCT01814553|565690881|FG000|Overall Study|Other Adverse Event|4|||
156712232|NCT01814553|565690882|FG001|Overall Study|Other Adverse Event|5|||
156712233|NCT01814553|565690881|FG000|Overall Study|Withdrawal by Subject|1|||
156712234|NCT01814553|565690882|FG001|Overall Study|Withdrawal by Subject|1|||
156712235|NCT01814553|565690881|FG000|Overall Study|Other than stated|7|||
156712236|NCT01814553|565690882|FG001|Overall Study|Other than stated|8|||
156712237|NCT04036110|565690883|FG000|Overall Study|Lost to Follow-up|3|||
156712238|NCT04036110|565690884|FG001|Overall Study|Lost to Follow-up|2|||
156712239|NCT04036110|565690885|FG002|Overall Study|Lost to Follow-up|1|||
156712240|NCT04036110|565690883|FG000|Overall Study|Study Suspended|4|||
156712241|NCT04036110|565690884|FG001|Overall Study|Study Suspended|5|||
156712242|NCT04036110|565690885|FG002|Overall Study|Study Suspended|1|||
156712243|NCT01941498|565690886|FG000|Overall Study|Relocated out of state|1|||
156712244|NCT03097991|565690887|FG000|Overall Study|Didn't meet study criteria|8|||
156712245|NCT03097991|565690888|FG001|Overall Study|Didn't meet study criteria|0|||
156712246|NCT03097991|565690887|FG000|Overall Study|Withdrawal by Subject|12|||
156442499|NCT02723955|564713407|FG023|Escalation Phase|Site Closed|0|||
156442500|NCT02723955|564713408|FG024|Escalation Phase|Site Closed|3|||
156442501|NCT02723955|564713409|FG025|Escalation Phase|Site Closed|1|||
156442502|NCT02723955|564713410|FG026|Escalation Phase|Site Closed|3|||
156442503|NCT02723955|564713411|FG027|Escalation Phase|Site Closed|1|||
156442504|NCT02723955|564713412|FG028|Escalation Phase|Site Closed|1|||
156442505|NCT02723955|564713413|FG029|Escalation Phase|Site Closed|0|||
156442506|NCT02723955|564713414|FG030|Escalation Phase|Site Closed|0|||
156442507|NCT02723955|564713415|FG031|Escalation Phase|Site Closed|0|||
156442508|NCT02723955|564713416|FG032|Escalation Phase|Site Closed|0|||
156442509|NCT02723955|564713417|FG033|Escalation Phase|Site Closed|0|||
156442510|NCT02723955|564713418|FG034|Escalation Phase|Site Closed|0|||
156442511|NCT02723955|564713419|FG035|Escalation Phase|Site Closed|0|||
156442512|NCT02723955|564713420|FG036|Escalation Phase|Site Closed|0|||
156442513|NCT02723955|564713421|FG037|Escalation Phase|Site Closed|0|||
156532185|NCT01313650|565043307|FG002|Overall Study|Protocol Violation|5|||
156532186|NCT01313650|565043308|FG003|Overall Study|Protocol Violation|6|||
156712247|NCT03097991|565690888|FG001|Overall Study|Withdrawal by Subject|6|||
156712248|NCT03097991|565690887|FG000|Overall Study|Death of Baby|3|||
156712249|NCT03097991|565690888|FG001|Overall Study|Death of Baby|1|||
156712250|NCT03097991|565690887|FG000|Overall Study|Lost to Follow-up|24|||
156712251|NCT03097991|565690888|FG001|Overall Study|Lost to Follow-up|38|||
156712252|NCT03097991|565690887|FG000|Overall Study|Adverse Event|3|||
156712253|NCT03097991|565690888|FG001|Overall Study|Adverse Event|5|||
156712254|NCT02006732|565690889|FG000|Overall Study|Adverse Event|10|||
156712255|NCT02006732|565690890|FG001|Overall Study|Adverse Event|7|||
156712256|NCT02006732|565690891|FG002|Overall Study|Adverse Event|4|||
156712257|NCT02006732|565690892|FG003|Overall Study|Adverse Event|2|||
156712258|NCT02006732|565690889|FG000|Overall Study|Lack of Efficacy|6|||
156712259|NCT02006732|565690890|FG001|Overall Study|Lack of Efficacy|3|||
156532187|NCT01313650|565043305|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
156712260|NCT02006732|565690891|FG002|Overall Study|Lack of Efficacy|1|||
156712261|NCT02006732|565690892|FG003|Overall Study|Lack of Efficacy|1|||
156712262|NCT02006732|565690889|FG000|Overall Study|Protocol Violation|1|||
156712263|NCT02006732|565690890|FG001|Overall Study|Protocol Violation|1|||
156712264|NCT02006732|565690891|FG002|Overall Study|Protocol Violation|0|||
156712265|NCT02006732|565690892|FG003|Overall Study|Protocol Violation|0|||
156712266|NCT02006732|565690889|FG000|Overall Study|Lost to Follow-up|0|||
156712267|NCT02006732|565690890|FG001|Overall Study|Lost to Follow-up|1|||
156712268|NCT02006732|565690891|FG002|Overall Study|Lost to Follow-up|0|||
156712269|NCT02006732|565690892|FG003|Overall Study|Lost to Follow-up|0|||
156712270|NCT02006732|565690889|FG000|Overall Study|Withdrawal by Subject|3|||
156712271|NCT02006732|565690890|FG001|Overall Study|Withdrawal by Subject|0|||
156442514|NCT02723955|564713422|FG038|Escalation Phase|Site Closed|0|||
156442515|NCT02723955|564713423|FG039|Escalation Phase|Site Closed|0|||
156712272|NCT02006732|565690891|FG002|Overall Study|Withdrawal by Subject|4|||
156442516|NCT02723955|564713424|FG040|Escalation Phase|Site Closed|0|||
156442517|NCT02723955|564713425|FG041|Escalation Phase|Site Closed|0|||
156442518|NCT02723955|564713426|FG042|Escalation Phase|Site Closed|0|||
156712273|NCT02006732|565690892|FG003|Overall Study|Withdrawal by Subject|1|||
156712274|NCT01755091|565690893|FG000|Overall Study|Withdrawal by Subject|6|||
156712275|NCT01755091|565690894|FG001|Overall Study|Withdrawal by Subject|1|||
156712276|NCT01755091|565690895|FG002|Overall Study|Withdrawal by Subject|3|||
156712277|NCT01755091|565690893|FG000|Overall Study|Adverse Event|1|||
156712278|NCT01755091|565690894|FG001|Overall Study|Adverse Event|1|||
156712279|NCT01755091|565690895|FG002|Overall Study|Adverse Event|1|||
156712280|NCT01755091|565690893|FG000|Overall Study|Lost to Follow-up|1|||
156712281|NCT01755091|565690894|FG001|Overall Study|Lost to Follow-up|0|||
156712282|NCT01755091|565690895|FG002|Overall Study|Lost to Follow-up|1|||
156712283|NCT01755091|565690893|FG000|Overall Study|Physician Decision|1|||
156712284|NCT01755091|565690894|FG001|Overall Study|Physician Decision|1|||
156712285|NCT01755091|565690895|FG002|Overall Study|Physician Decision|2|||
156712286|NCT01107197|565690897|FG000|Overall Study|Death|12|||
156712287|NCT01107197|565690898|FG001|Overall Study|Death|10|||
156712288|NCT01107197|565690897|FG000|Overall Study|Lost to Follow-up|5|||
156712289|NCT01107197|565690898|FG001|Overall Study|Lost to Follow-up|8|||
156712290|NCT01107197|565690897|FG000|Overall Study|Withdrawal by Subject|3|||
156712291|NCT01107197|565690898|FG001|Overall Study|Withdrawal by Subject|5|||
156712292|NCT01301729|565690899|FG000|Overall Study|Withdrawal by Subject|2|||
156712293|NCT01301729|565690899|FG000|Overall Study|Participant did not Return for Treatment|1|||
156712294|NCT01301729|565690899|FG000|Overall Study|Violated Selection Criteria|1|||
156712295|NCT03071276|565690900|FG000|Overall Study|Adverse Event|1|||
156712296|NCT03071276|565690900|FG000|Overall Study|Lack of Efficacy|14|||
156712297|NCT05794503|565690901|FG000|Overall Study|Operation Cancelled|2|||
156712298|NCT05794503|565690902|FG001|Overall Study|Operation Cancelled|0|||
156712299|NCT05794503|565690901|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
156712300|NCT05794503|565690902|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
156712301|NCT05794503|565690901|FG000|Overall Study|Protocol Violation|1|||
156712302|NCT05794503|565690902|FG001|Overall Study|Protocol Violation|0|||
156712303|NCT00447993|565690903|FG000|Overall Study|Lost to Follow-up|0|||
156712304|NCT00447993|565690904|FG001|Overall Study|Lost to Follow-up|0|||
156712305|NCT00447993|565690905|FG002|Overall Study|Lost to Follow-up|2|||
156712306|NCT00447993|565690906|FG003|Overall Study|Lost to Follow-up|2|||
156792361|NCT00160563|565992747|FG002|Overall Study|Other (listed in the study report)|81|||
156792362|NCT00160563|565992745|FG000|Overall Study|Missing reason|0|||
156792363|NCT00160563|565992746|FG001|Overall Study|Missing reason|1|||
156792364|NCT00160563|565992747|FG002|Overall Study|Missing reason|0|||
156792365|NCT04157738|565992748|FG000|Overall Study|Moved out of state|0|||
156792366|NCT04157738|565992749|FG001|Overall Study|Moved out of state|2|||
156442519|NCT02723955|564713384|FG000|Expansion Phase|Death|0|||
156442520|NCT02723955|564713385|FG001|Expansion Phase|Death|0|||
156442521|NCT02723955|564713386|FG002|Expansion Phase|Death|0|||
156442522|NCT02723955|564713387|FG003|Expansion Phase|Death|0|||
156442523|NCT02723955|564713388|FG004|Expansion Phase|Death|0|||
156442524|NCT02723955|564713389|FG005|Expansion Phase|Death|0|||
156442525|NCT02723955|564713390|FG006|Expansion Phase|Death|0|||
156442526|NCT02723955|564713391|FG007|Expansion Phase|Death|0|||
156712307|NCT00447993|565690903|FG000|Overall Study|Withdrawal by Subject|0|||
156712308|NCT00447993|565690904|FG001|Overall Study|Withdrawal by Subject|0|||
156712309|NCT00447993|565690905|FG002|Overall Study|Withdrawal by Subject|2|||
156712310|NCT00447993|565690906|FG003|Overall Study|Withdrawal by Subject|2|||
156792367|NCT04157738|565992748|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
156792368|NCT04157738|565992749|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
156792369|NCT00395447|565992756|FG000|Overall Study|Death|37|||
156792370|NCT00395447|565992757|FG001|Overall Study|Death|32|||
156792371|NCT00395447|565992756|FG000|Overall Study|Lost to Follow-up|52|||
156332971|NCT03181893|564317455|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156332972|NCT03181893|564317456|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156332973|NCT03181893|564317457|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156332974|NCT03181893|564317458|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156332975|NCT03181893|564317459|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156332976|NCT03181893|564317449|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156332977|NCT03181893|564317450|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156332978|NCT03181893|564317451|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156332979|NCT03181893|564317452|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156332980|NCT03181893|564317453|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156332981|NCT03181893|564317454|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156332982|NCT03181893|564317455|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156332983|NCT03181893|564317456|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
156442527|NCT02723955|564713392|FG008|Expansion Phase|Death|0|||
156442528|NCT02723955|564713393|FG009|Expansion Phase|Death|25|||
156532188|NCT01313650|565043306|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
156442529|NCT02723955|564713394|FG010|Expansion Phase|Death|69|||
156712311|NCT02924727|565690907|FG000|Overall Study|Withdrawal by Subject|2|||
156712312|NCT02924727|565690908|FG001|Overall Study|Withdrawal by Subject|4|||
156712313|NCT02924727|565690907|FG000|Overall Study|Lost to Follow-up|2|||
156712314|NCT02924727|565690908|FG001|Overall Study|Lost to Follow-up|5|||
156712315|NCT02924727|565690907|FG000|Overall Study|Death|221|||
156712316|NCT02924727|565690908|FG001|Overall Study|Death|247|||
156712317|NCT02924727|565690907|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
156712318|NCT02924727|565690908|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
156712319|NCT03052127|565690909|FG000|Overall Study|Withdrawal by Subject|0|||
156712320|NCT03052127|565690910|FG001|Overall Study|Withdrawal by Subject|0|||
156712321|NCT03052127|565690911|FG002|Overall Study|Withdrawal by Subject|0|||
156712322|NCT03052127|565690912|FG003|Overall Study|Withdrawal by Subject|0|||
156712323|NCT03052127|565690913|FG004|Overall Study|Withdrawal by Subject|0|||
156712324|NCT03052127|565690914|FG005|Overall Study|Withdrawal by Subject|0|||
156712325|NCT03052127|565690915|FG006|Overall Study|Withdrawal by Subject|0|||
156712326|NCT03052127|565690916|FG007|Overall Study|Withdrawal by Subject|1|||
156712327|NCT03052127|565690917|FG008|Overall Study|Withdrawal by Subject|1|||
156712328|NCT03052127|565690918|FG009|Overall Study|Withdrawal by Subject|1|||
156712329|NCT03052127|565690919|FG010|Overall Study|Withdrawal by Subject|0|||
156712330|NCT03052127|565690920|FG011|Overall Study|Withdrawal by Subject|0|||
156712331|NCT03052127|565690909|FG000|Overall Study|Discontinuation by Sponsor|0|||
156712332|NCT03052127|565690910|FG001|Overall Study|Discontinuation by Sponsor|0|||
156712333|NCT03052127|565690911|FG002|Overall Study|Discontinuation by Sponsor|0|||
156712334|NCT03052127|565690912|FG003|Overall Study|Discontinuation by Sponsor|0|||
156712335|NCT03052127|565690913|FG004|Overall Study|Discontinuation by Sponsor|0|||
156712336|NCT03052127|565690914|FG005|Overall Study|Discontinuation by Sponsor|0|||
156712337|NCT03052127|565690915|FG006|Overall Study|Discontinuation by Sponsor|0|||
156712338|NCT03052127|565690916|FG007|Overall Study|Discontinuation by Sponsor|0|||
156712339|NCT03052127|565690917|FG008|Overall Study|Discontinuation by Sponsor|4|||
156712340|NCT03052127|565690918|FG009|Overall Study|Discontinuation by Sponsor|2|||
156712341|NCT03052127|565690919|FG010|Overall Study|Discontinuation by Sponsor|5|||
156712342|NCT03052127|565690920|FG011|Overall Study|Discontinuation by Sponsor|13|||
156712343|NCT03052127|565690909|FG000|Overall Study|Inability to comply with trial requirements|0|||
156712344|NCT03052127|565690910|FG001|Overall Study|Inability to comply with trial requirements|0|||
156712345|NCT03052127|565690911|FG002|Overall Study|Inability to comply with trial requirements|1|||
156712346|NCT03052127|565690912|FG003|Overall Study|Inability to comply with trial requirements|0|||
156712347|NCT03052127|565690913|FG004|Overall Study|Inability to comply with trial requirements|0|||
156712348|NCT03052127|565690914|FG005|Overall Study|Inability to comply with trial requirements|0|||
156712349|NCT03052127|565690915|FG006|Overall Study|Inability to comply with trial requirements|0|||
156712350|NCT03052127|565690916|FG007|Overall Study|Inability to comply with trial requirements|0|||
156712351|NCT03052127|565690917|FG008|Overall Study|Inability to comply with trial requirements|0|||
156712352|NCT03052127|565690918|FG009|Overall Study|Inability to comply with trial requirements|0|||
156712353|NCT03052127|565690919|FG010|Overall Study|Inability to comply with trial requirements|0|||
156712354|NCT03052127|565690920|FG011|Overall Study|Inability to comply with trial requirements|0|||
156712355|NCT03052127|565690909|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
156712356|NCT03052127|565690910|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712357|NCT03052127|565690911|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712358|NCT03052127|565690912|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712359|NCT03052127|565690913|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
156712360|NCT03052127|565690914|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
156712361|NCT03052127|565690915|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
156712362|NCT03052127|565690916|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712363|NCT03052127|565690917|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712364|NCT03052127|565690918|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712365|NCT03052127|565690919|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712366|NCT03052127|565690920|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712367|NCT03694327|565690921|FG000|Overall Study|Lost to Follow-up|13|||
156712368|NCT03694327|565690922|FG001|Overall Study|Lost to Follow-up|23|||
156712369|NCT01464931|565690925|FG000|Overall Study|Withdrawal by Subject|1|||
156712370|NCT01464931|565690926|FG001|Overall Study|Withdrawal by Subject|0|||
156712371|NCT01982812|565690927|FG000|Overall Study|Death|1|||
156712372|NCT01982812|565690928|FG001|Overall Study|Death|5|||
156712373|NCT01982812|565690927|FG000|Overall Study|Adverse Event|0|||
156712374|NCT01982812|565690928|FG001|Overall Study|Adverse Event|5|||
156712375|NCT00338728|565690930|FG000|Overall Study|Screen Failure|14|||
156712376|NCT04380961|565690933|FG000|Overall Study|Lost to Follow-up|17|||
156792372|NCT00395447|565992757|FG001|Overall Study|Lost to Follow-up|43|||
156792373|NCT00395447|565992756|FG000|Overall Study|Withdrawal by Subject|24|||
156792374|NCT00395447|565992757|FG001|Overall Study|Withdrawal by Subject|19|||
156442530|NCT02723955|564713395|FG011|Expansion Phase|Death|48|||
156712377|NCT04380961|565690934|FG001|Overall Study|Lost to Follow-up|11|||
156712378|NCT04380961|565690933|FG000|Overall Study|Withdrawal by Subject|3|||
156712379|NCT04380961|565690934|FG001|Overall Study|Withdrawal by Subject|0|||
156712380|NCT04380961|565690933|FG000|Overall Study|Death|22|||
156712381|NCT04380961|565690934|FG001|Overall Study|Death|16|||
156808764|NCT01408277|566054457|FG000|Overall Study|Lost to Follow-up|1|||
156712382|NCT04380961|565690933|FG000|Overall Study|Other|1|||
156712383|NCT04380961|565690934|FG001|Overall Study|Other|0|||
156712384|NCT04380961|565690933|FG000|Overall Study|Randomized but Not Treated|1|||
156712385|NCT04380961|565690934|FG001|Overall Study|Randomized but Not Treated|2|||
156712386|NCT01862484|565690935|FG000|Overall Study|Lack of Efficacy|1|||
156712387|NCT01862484|565690936|FG001|Overall Study|Lack of Efficacy|1|||
156712388|NCT01862484|565690935|FG000|Overall Study|Lost to Follow-up|1|||
156712389|NCT01862484|565690936|FG001|Overall Study|Lost to Follow-up|2|||
156712390|NCT01862484|565690935|FG000|Overall Study|Protocol Violation|0|||
156712391|NCT01862484|565690936|FG001|Overall Study|Protocol Violation|2|||
156712392|NCT01862484|565690935|FG000|Overall Study|Withdrawal by Subject|0|||
156712393|NCT01862484|565690936|FG001|Overall Study|Withdrawal by Subject|3|||
156712394|NCT00993421|565690937|FG000|Overall Study|Adverse Event|2|||
156712395|NCT00993421|565690938|FG001|Overall Study|Adverse Event|7|||
156712396|NCT00993421|565690939|FG002|Overall Study|Adverse Event|6|||
156712397|NCT00993421|565690940|FG003|Overall Study|Adverse Event|9|||
156712398|NCT00993421|565690941|FG004|Overall Study|Adverse Event|5|||
156712399|NCT00993421|565690942|FG005|Overall Study|Adverse Event|7|||
156712400|NCT00993421|565690943|FG006|Overall Study|Adverse Event|1|||
156712401|NCT00993421|565690937|FG000|Overall Study|Sponsor Decision|36|||
156712402|NCT00993421|565690938|FG001|Overall Study|Sponsor Decision|31|||
156712403|NCT00993421|565690939|FG002|Overall Study|Sponsor Decision|28|||
156712404|NCT00993421|565690940|FG003|Overall Study|Sponsor Decision|30|||
156712405|NCT00993421|565690941|FG004|Overall Study|Sponsor Decision|38|||
156712406|NCT00993421|565690942|FG005|Overall Study|Sponsor Decision|30|||
156712407|NCT00993421|565690943|FG006|Overall Study|Sponsor Decision|29|||
156712408|NCT00993421|565690937|FG000|Overall Study|Lost to Follow-up|3|||
156712409|NCT00993421|565690938|FG001|Overall Study|Lost to Follow-up|5|||
156712410|NCT00993421|565690939|FG002|Overall Study|Lost to Follow-up|5|||
156712411|NCT00993421|565690940|FG003|Overall Study|Lost to Follow-up|0|||
156712412|NCT00993421|565690941|FG004|Overall Study|Lost to Follow-up|0|||
156712413|NCT00993421|565690942|FG005|Overall Study|Lost to Follow-up|0|||
156712414|NCT00993421|565690943|FG006|Overall Study|Lost to Follow-up|6|||
156712415|NCT00993421|565690937|FG000|Overall Study|Withdrawal by Subject|3|||
156712416|NCT00993421|565690938|FG001|Overall Study|Withdrawal by Subject|2|||
156712417|NCT00993421|565690939|FG002|Overall Study|Withdrawal by Subject|3|||
156712418|NCT00993421|565690940|FG003|Overall Study|Withdrawal by Subject|3|||
156712419|NCT00993421|565690941|FG004|Overall Study|Withdrawal by Subject|3|||
156712420|NCT00993421|565690942|FG005|Overall Study|Withdrawal by Subject|5|||
156712421|NCT00993421|565690943|FG006|Overall Study|Withdrawal by Subject|3|||
156712422|NCT00993421|565690937|FG000|Overall Study|Death|0|||
156712423|NCT00993421|565690938|FG001|Overall Study|Death|0|||
156712424|NCT00993421|565690939|FG002|Overall Study|Death|0|||
156712425|NCT00993421|565690940|FG003|Overall Study|Death|0|||
156712426|NCT00993421|565690941|FG004|Overall Study|Death|0|||
156712427|NCT00993421|565690942|FG005|Overall Study|Death|0|||
156712428|NCT00993421|565690943|FG006|Overall Study|Death|1|||
156712429|NCT00993421|565690937|FG000|Overall Study|Entry Criteria Exclusion|0|||
156712430|NCT00993421|565690938|FG001|Overall Study|Entry Criteria Exclusion|0|||
156712431|NCT00993421|565690939|FG002|Overall Study|Entry Criteria Exclusion|1|||
156712432|NCT00993421|565690940|FG003|Overall Study|Entry Criteria Exclusion|3|||
156712433|NCT00993421|565690941|FG004|Overall Study|Entry Criteria Exclusion|0|||
156792375|NCT00395447|565992756|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
156792376|NCT00395447|565992757|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
156792377|NCT03766906|565992758|FG000|Overall Study|Withdrawal by Subject|6|||
156792378|NCT01437189|565992760|FG000|Overall Study|Adverse Event|3|||
156792379|NCT01437189|565992760|FG000|Overall Study|Lack of Efficacy|4|||
156792380|NCT01437189|565992760|FG000|Overall Study|Withdrawal by Subject|8|||
156712434|NCT00993421|565690942|FG005|Overall Study|Entry Criteria Exclusion|1|||
156712435|NCT00993421|565690943|FG006|Overall Study|Entry Criteria Exclusion|0|||
156792381|NCT03032484|565992761|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
156712436|NCT00993421|565690937|FG000|Overall Study|Physician Decision|0|||
156712437|NCT00993421|565690938|FG001|Overall Study|Physician Decision|0|||
156712438|NCT00993421|565690939|FG002|Overall Study|Physician Decision|0|||
156792382|NCT03032484|565992762|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
156792383|NCT03032484|565992761|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
156808765|NCT01408277|566054458|FG001|Overall Study|Lost to Follow-up|0|||
156712439|NCT00993421|565690940|FG003|Overall Study|Physician Decision|0|||
156712440|NCT00993421|565690941|FG004|Overall Study|Physician Decision|0|||
156712441|NCT00993421|565690942|FG005|Overall Study|Physician Decision|1|||
156712442|NCT00993421|565690943|FG006|Overall Study|Physician Decision|1|||
156712443|NCT00993421|565690937|FG000|Overall Study|Protocol Violation|0|||
156712444|NCT00993421|565690938|FG001|Overall Study|Protocol Violation|0|||
156712445|NCT00993421|565690939|FG002|Overall Study|Protocol Violation|0|||
156808766|NCT01408277|566054457|FG000|Overall Study|Withdrawal by Subject|2|||
156808767|NCT01408277|566054458|FG001|Overall Study|Withdrawal by Subject|0|||
156808768|NCT01408277|566054457|FG000|Overall Study|Protocol Violation|2|||
156808769|NCT01408277|566054458|FG001|Overall Study|Protocol Violation|0|||
156808770|NCT03801928|566054459|FG000|Overall Study|Adverse Event|1|||
156532189|NCT01313650|565043307|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
156532190|NCT01313650|565043308|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
156532191|NCT01012739|565043309|FG000|Treatment Period 1|Adverse Event|0|||
156532192|NCT01012739|565043310|FG001|Treatment Period 1|Adverse Event|0|||
156532193|NCT01012739|565043311|FG002|Treatment Period 1|Adverse Event|0|||
156532194|NCT01012739|565043312|FG003|Treatment Period 1|Adverse Event|1|||
156532195|NCT01012739|565043309|FG000|Treatment Period 2|Abnormal test procedure results|0|||
156532196|NCT01012739|565043310|FG001|Treatment Period 2|Abnormal test procedure results|0|||
156532197|NCT01012739|565043311|FG002|Treatment Period 2|Abnormal test procedure results|0|||
156532198|NCT01012739|565043312|FG003|Treatment Period 2|Abnormal test procedure results|1|||
156532199|NCT04540133|565043313|FG000|Overall Study|Lost to Follow-up|1|||
156532200|NCT04540133|565043314|FG001|Overall Study|Lost to Follow-up|0|||
156532201|NCT04029480|565043315|FG000|Overall Study|Physician Decision|0|||
156532202|NCT04029480|565043316|FG001|Overall Study|Physician Decision|0|||
156532203|NCT04029480|565043317|FG002|Overall Study|Physician Decision|2|||
156532204|NCT04029480|565043318|FG003|Overall Study|Physician Decision|1|||
156532205|NCT04029480|565043315|FG000|Overall Study|Withdrawal by Subject|2|||
156532206|NCT04029480|565043316|FG001|Overall Study|Withdrawal by Subject|0|||
156532207|NCT04029480|565043317|FG002|Overall Study|Withdrawal by Subject|1|||
156532208|NCT04029480|565043318|FG003|Overall Study|Withdrawal by Subject|1|||
156532209|NCT04786119|565043319|FG000|Overall Study|Withdrawal by Subject|4|||
156532210|NCT04786119|565043320|FG001|Overall Study|Withdrawal by Subject|5|||
156532211|NCT04786119|565043319|FG000|Overall Study|Lost to Follow-up|5|||
156532212|NCT04786119|565043320|FG001|Overall Study|Lost to Follow-up|5|||
156532213|NCT04786119|565043319|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
156532214|NCT04786119|565043320|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
156532215|NCT01658826|565043331|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
156532216|NCT01658826|565043332|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
156532217|NCT01658826|565043331|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
156532218|NCT01658826|565043332|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
156532219|NCT01658826|565043331|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
156532220|NCT01658826|565043332|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
156532221|NCT01658826|565043331|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
156532222|NCT01658826|565043332|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
156532223|NCT01658826|565043331|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
156532224|NCT01658826|565043332|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
156532225|NCT01658826|565043331|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
156532226|NCT01658826|565043332|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
156532227|NCT01658826|565043331|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
156532228|NCT01658826|565043332|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
156712446|NCT00993421|565690940|FG003|Overall Study|Protocol Violation|0|||
156712447|NCT00993421|565690941|FG004|Overall Study|Protocol Violation|0|||
156712448|NCT00993421|565690942|FG005|Overall Study|Protocol Violation|2|||
156712449|NCT00993421|565690943|FG006|Overall Study|Protocol Violation|1|||
156712450|NCT02447744|565690945|FG000|Overall Study|Withdrawal by Subject|3|||
156712451|NCT02447744|565690946|FG001|Overall Study|Withdrawal by Subject|1|||
156712452|NCT02447744|565690945|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
156712453|NCT02447744|565690946|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
156712454|NCT00912912|565690947|FG000|Overall Study|Withdrawal by Subject|1|||
156712455|NCT00912912|565690947|FG000|Overall Study|Disease Progression|3|||
156712456|NCT00306995|565690948|FG000|Study Part I|Withdrawal by Subject|0|||
156712457|NCT00306995|565690949|FG001|Study Part I|Withdrawal by Subject|0|||
156712458|NCT00306995|565690950|FG002|Study Part I|Withdrawal by Subject|0|||
156712459|NCT00306995|565690951|FG003|Study Part I|Withdrawal by Subject|0|||
156712460|NCT00306995|565690952|FG004|Study Part I|Withdrawal by Subject|0|||
156712461|NCT00306995|565690953|FG005|Study Part I|Withdrawal by Subject|0|||
156712462|NCT00306995|565690954|FG006|Study Part I|Withdrawal by Subject|1|||
156712463|NCT00306995|565690948|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
156712464|NCT00306995|565690949|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
156712465|NCT00306995|565690950|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
156712466|NCT00306995|565690951|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
156712467|NCT00306995|565690952|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
156712468|NCT00306995|565690953|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
156712469|NCT00306995|565690954|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
156712470|NCT05422625|565690955|FG000|Overall Study|Withdrawal by Subject|1|||
156712471|NCT05422625|565690956|FG001|Overall Study|Withdrawal by Subject|0|||
156712472|NCT01769456|565692729|FG000|Overall Study|Lost to Follow-up|19|||
156712473|NCT01769456|565692729|FG000|Overall Study|Withdrawal by Subject|3|||
156712474|NCT01769456|565692729|FG000|Overall Study|Did not receive PCC intervention|6|||
156712475|NCT01769456|565692729|FG000|Overall Study|Moved out of the area|3|||
156873956|NCT01047553|566296166|FG000|Overall Study|Withdrawal by Subject|4|||
156712476|NCT01769456|565692729|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
156712477|NCT01769456|565692729|FG000|Overall Study|Parental request to youth to withdraw|1|||
156712478|NCT05377749|565692732|FG000|3 Weeks|Lost to Follow-up|2|||
156712479|NCT05377749|565692733|FG001|3 Weeks|Lost to Follow-up|4|||
156712480|NCT05377749|565692732|FG000|3 Weeks|Withdrawal by Subject|1|||
156712481|NCT05377749|565692733|FG001|3 Weeks|Withdrawal by Subject|1|||
156712482|NCT02969382|565692734|FG000|Overall Study|Adverse Event|8|||
156712483|NCT02969382|565692735|FG001|Overall Study|Adverse Event|10|||
156712484|NCT02969382|565692734|FG000|Overall Study|Lack of Efficacy|4|||
156712485|NCT02969382|565692735|FG001|Overall Study|Lack of Efficacy|5|||
156712486|NCT02969382|565692734|FG000|Overall Study|Death|0|||
156712487|NCT02969382|565692735|FG001|Overall Study|Death|1|||
156712488|NCT02969382|565692734|FG000|Overall Study|PROTOCOL DEVIATION|0|||
156712489|NCT02969382|565692735|FG001|Overall Study|PROTOCOL DEVIATION|1|||
156712490|NCT02969382|565692734|FG000|Overall Study|Withdrawal by Subject|14|||
156712491|NCT02969382|565692735|FG001|Overall Study|Withdrawal by Subject|9|||
156712492|NCT02090725|565692736|FG000|Overall Study|Withdrawal by Subject|1|||
156712493|NCT02090725|565692736|FG000|Overall Study|participants moved from area|3|||
156712494|NCT00403585|565692741|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
156712495|NCT00403585|565692741|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
156712496|NCT00403585|565692741|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
156712497|NCT03685344|565692746|FG000|Overall Study|Withdrawal by Subject|1|||
156712498|NCT03685344|565692747|FG001|Overall Study|Withdrawal by Subject|1|||
156712499|NCT03685344|565692748|FG002|Overall Study|Withdrawal by Subject|2|||
156712500|NCT03685344|565692749|FG003|Overall Study|Withdrawal by Subject|0|||
156712501|NCT03685344|565692746|FG000|Overall Study|Physician Decision|1|||
156712502|NCT03685344|565692747|FG001|Overall Study|Physician Decision|1|||
156712503|NCT03685344|565692748|FG002|Overall Study|Physician Decision|5|||
156712504|NCT03685344|565692749|FG003|Overall Study|Physician Decision|0|||
156712505|NCT03685344|565692746|FG000|Overall Study|Death|1|||
156712506|NCT03685344|565692747|FG001|Overall Study|Death|1|||
156712507|NCT03685344|565692748|FG002|Overall Study|Death|0|||
156712508|NCT03685344|565692749|FG003|Overall Study|Death|0|||
156712509|NCT02121652|565692752|FG000|Overall Study|Lost to Follow-up|2|||
156712510|NCT02121652|565692753|FG001|Overall Study|Lost to Follow-up|1|||
156712511|NCT02121652|565692752|FG000|Overall Study|Death|1|||
156712512|NCT02121652|565692753|FG001|Overall Study|Death|0|||
156712513|NCT02121652|565692752|FG000|Overall Study|Withdrawal by Subject|3|||
156712514|NCT02121652|565692753|FG001|Overall Study|Withdrawal by Subject|3|||
156712515|NCT00799058|565692757|FG000|Overall Study|Withdrawal by Subject|2|||
156712516|NCT00799058|565692758|FG001|Overall Study|Withdrawal by Subject|2|||
156712517|NCT00799058|565692759|FG002|Overall Study|Withdrawal by Subject|2|||
156712518|NCT00799058|565692757|FG000|Overall Study|Lost to Follow-up|1|||
156712519|NCT00799058|565692758|FG001|Overall Study|Lost to Follow-up|2|||
156712520|NCT00799058|565692759|FG002|Overall Study|Lost to Follow-up|1|||
156712521|NCT00799058|565692757|FG000|Overall Study|Adverse Event|0|||
156712522|NCT00799058|565692758|FG001|Overall Study|Adverse Event|2|||
156712523|NCT00799058|565692759|FG002|Overall Study|Adverse Event|0|||
156712524|NCT00799058|565692757|FG000|Overall Study|Pregnancy|1|||
156712525|NCT00799058|565692758|FG001|Overall Study|Pregnancy|0|||
156712526|NCT00799058|565692759|FG002|Overall Study|Pregnancy|0|||
156712527|NCT00799058|565692757|FG000|Overall Study|Not adherent|3|||
156442531|NCT02723955|564713396|FG012|Expansion Phase|Death|0|||
156712528|NCT00799058|565692758|FG001|Overall Study|Not adherent|2|||
156712529|NCT00799058|565692759|FG002|Overall Study|Not adherent|1|||
156442532|NCT02723955|564713397|FG013|Expansion Phase|Death|0|||
156442533|NCT02723955|564713398|FG014|Expansion Phase|Death|0|||
156442534|NCT02723955|564713399|FG015|Expansion Phase|Death|0|||
156712530|NCT00799058|565692757|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
156712531|NCT00799058|565692758|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
156712532|NCT00799058|565692759|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
156442535|NCT02723955|564713400|FG016|Expansion Phase|Death|0|||
156442536|NCT02723955|564713401|FG017|Expansion Phase|Death|0|||
156442537|NCT02723955|564713402|FG018|Expansion Phase|Death|0|||
156712533|NCT00799058|565692757|FG000|Overall Study|IP dispensing error|1|||
156712534|NCT00799058|565692758|FG001|Overall Study|IP dispensing error|0|||
156712535|NCT00799058|565692759|FG002|Overall Study|IP dispensing error|0|||
156712536|NCT00799058|565692757|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
156712537|NCT00799058|565692758|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
156712538|NCT00799058|565692759|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
156712539|NCT00799058|565692757|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
156712540|NCT00799058|565692758|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
156712541|NCT00799058|565692759|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
156712542|NCT00799058|565692757|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
156873957|NCT01047553|566296167|FG001|Overall Study|Withdrawal by Subject|2|||
156442538|NCT02723955|564713403|FG019|Expansion Phase|Death|0|||
156792384|NCT03032484|565992762|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
156442539|NCT02723955|564713404|FG020|Expansion Phase|Death|0|||
156442540|NCT02723955|564713405|FG021|Expansion Phase|Death|0|||
156442541|NCT02723955|564713406|FG022|Expansion Phase|Death|0|||
156442542|NCT02723955|564713407|FG023|Expansion Phase|Death|0|||
156442543|NCT02723955|564713408|FG024|Expansion Phase|Death|0|||
156442544|NCT02723955|564713409|FG025|Expansion Phase|Death|0|||
156442545|NCT02723955|564713410|FG026|Expansion Phase|Death|0|||
156442546|NCT02723955|564713411|FG027|Expansion Phase|Death|0|||
156442547|NCT02723955|564713412|FG028|Expansion Phase|Death|0|||
156442548|NCT02723955|564713413|FG029|Expansion Phase|Death|12|||
156442549|NCT02723955|564713414|FG030|Expansion Phase|Death|202|||
156442550|NCT02723955|564713415|FG031|Expansion Phase|Death|31|||
156442551|NCT02723955|564713416|FG032|Expansion Phase|Death|17|||
156442552|NCT02723955|564713417|FG033|Expansion Phase|Death|2|||
156442553|NCT02723955|564713418|FG034|Expansion Phase|Death|3|||
156442554|NCT02723955|564713419|FG035|Expansion Phase|Death|3|||
156442555|NCT02723955|564713420|FG036|Expansion Phase|Death|1|||
156442556|NCT02723955|564713421|FG037|Expansion Phase|Death|0|||
156442557|NCT02723955|564713422|FG038|Expansion Phase|Death|0|||
156442558|NCT02723955|564713423|FG039|Expansion Phase|Death|0|||
156442559|NCT02723955|564713424|FG040|Expansion Phase|Death|0|||
156442560|NCT02723955|564713425|FG041|Expansion Phase|Death|0|||
156442561|NCT02723955|564713426|FG042|Expansion Phase|Death|0|||
156442562|NCT02723955|564713384|FG000|Expansion Phase|Lost to Follow-up|0|||
156442563|NCT02723955|564713385|FG001|Expansion Phase|Lost to Follow-up|0|||
156442564|NCT02723955|564713386|FG002|Expansion Phase|Lost to Follow-up|0|||
156442565|NCT02723955|564713387|FG003|Expansion Phase|Lost to Follow-up|0|||
156442566|NCT02723955|564713388|FG004|Expansion Phase|Lost to Follow-up|0|||
156442567|NCT02723955|564713389|FG005|Expansion Phase|Lost to Follow-up|0|||
156442568|NCT02723955|564713390|FG006|Expansion Phase|Lost to Follow-up|0|||
156442569|NCT02723955|564713391|FG007|Expansion Phase|Lost to Follow-up|0|||
156442570|NCT02723955|564713392|FG008|Expansion Phase|Lost to Follow-up|0|||
156442571|NCT02723955|564713393|FG009|Expansion Phase|Lost to Follow-up|0|||
156442572|NCT02723955|564713394|FG010|Expansion Phase|Lost to Follow-up|4|||
156442573|NCT02723955|564713395|FG011|Expansion Phase|Lost to Follow-up|1|||
156442574|NCT02723955|564713396|FG012|Expansion Phase|Lost to Follow-up|0|||
156442575|NCT02723955|564713397|FG013|Expansion Phase|Lost to Follow-up|0|||
156442576|NCT02723955|564713398|FG014|Expansion Phase|Lost to Follow-up|0|||
156442577|NCT02723955|564713399|FG015|Expansion Phase|Lost to Follow-up|0|||
156442578|NCT02723955|564713400|FG016|Expansion Phase|Lost to Follow-up|0|||
156442579|NCT02723955|564713401|FG017|Expansion Phase|Lost to Follow-up|0|||
156442580|NCT02723955|564713402|FG018|Expansion Phase|Lost to Follow-up|0|||
156442581|NCT02723955|564713403|FG019|Expansion Phase|Lost to Follow-up|0|||
156442582|NCT02723955|564713404|FG020|Expansion Phase|Lost to Follow-up|0|||
156442583|NCT02723955|564713405|FG021|Expansion Phase|Lost to Follow-up|0|||
156442584|NCT02723955|564713406|FG022|Expansion Phase|Lost to Follow-up|0|||
156442585|NCT02723955|564713407|FG023|Expansion Phase|Lost to Follow-up|0|||
156442586|NCT02723955|564713408|FG024|Expansion Phase|Lost to Follow-up|0|||
156442587|NCT02723955|564713409|FG025|Expansion Phase|Lost to Follow-up|0|||
156442588|NCT02723955|564713410|FG026|Expansion Phase|Lost to Follow-up|0|||
156442589|NCT02723955|564713411|FG027|Expansion Phase|Lost to Follow-up|0|||
156442590|NCT02723955|564713412|FG028|Expansion Phase|Lost to Follow-up|0|||
156442591|NCT02723955|564713413|FG029|Expansion Phase|Lost to Follow-up|1|||
156442592|NCT02723955|564713414|FG030|Expansion Phase|Lost to Follow-up|19|||
156442593|NCT02723955|564713415|FG031|Expansion Phase|Lost to Follow-up|2|||
156442594|NCT02723955|564713416|FG032|Expansion Phase|Lost to Follow-up|1|||
156442595|NCT02723955|564713417|FG033|Expansion Phase|Lost to Follow-up|0|||
156792385|NCT01689649|565992763|FG000|Overall Study|Lack of Efficacy|3|||
156792386|NCT01689649|565992763|FG000|Overall Study|Non-compliance|11|||
156792387|NCT01689649|565992763|FG000|Overall Study|Protocol Violation|3|||
156792388|NCT01689649|565992763|FG000|Overall Study|Lost to Follow-up|5|||
156792389|NCT01725282|565992766|FG000|Overall Study|Adverse Event|1|||
156792390|NCT01725282|565992767|FG001|Overall Study|Adverse Event|3|||
156442596|NCT02723955|564713418|FG034|Expansion Phase|Lost to Follow-up|0|||
156442597|NCT02723955|564713419|FG035|Expansion Phase|Lost to Follow-up|0|||
156442598|NCT02723955|564713420|FG036|Expansion Phase|Lost to Follow-up|0|||
156442599|NCT02723955|564713421|FG037|Expansion Phase|Lost to Follow-up|0|||
156442600|NCT02723955|564713422|FG038|Expansion Phase|Lost to Follow-up|0|||
156442601|NCT02723955|564713423|FG039|Expansion Phase|Lost to Follow-up|0|||
156442602|NCT02723955|564713424|FG040|Expansion Phase|Lost to Follow-up|0|||
156442603|NCT02723955|564713425|FG041|Expansion Phase|Lost to Follow-up|0|||
156442604|NCT02723955|564713426|FG042|Expansion Phase|Lost to Follow-up|0|||
156442605|NCT02723955|564713384|FG000|Expansion Phase|Physician Decision|0|||
156442606|NCT02723955|564713385|FG001|Expansion Phase|Physician Decision|0|||
156442607|NCT02723955|564713386|FG002|Expansion Phase|Physician Decision|0|||
156442608|NCT02723955|564713387|FG003|Expansion Phase|Physician Decision|0|||
156442609|NCT02723955|564713388|FG004|Expansion Phase|Physician Decision|0|||
156442610|NCT02723955|564713389|FG005|Expansion Phase|Physician Decision|0|||
156442611|NCT02723955|564713390|FG006|Expansion Phase|Physician Decision|0|||
156792391|NCT01725282|565992768|FG002|Overall Study|Adverse Event|6|||
156792392|NCT01725282|565992769|FG003|Overall Study|Adverse Event|4|||
156792393|NCT01725282|565992766|FG000|Overall Study|Exacerbation of Target Disease|1|||
156792394|NCT01725282|565992767|FG001|Overall Study|Exacerbation of Target Disease|0|||
156792395|NCT01725282|565992768|FG002|Overall Study|Exacerbation of Target Disease|0|||
156792396|NCT01725282|565992769|FG003|Overall Study|Exacerbation of Target Disease|1|||
156792397|NCT01725282|565992766|FG000|Overall Study|Met Exclusion Criteria|0|||
156792398|NCT01725282|565992767|FG001|Overall Study|Met Exclusion Criteria|0|||
156792399|NCT01725282|565992768|FG002|Overall Study|Met Exclusion Criteria|1|||
156442612|NCT02723955|564713391|FG007|Expansion Phase|Physician Decision|0|||
156442613|NCT02723955|564713392|FG008|Expansion Phase|Physician Decision|0|||
156442614|NCT02723955|564713393|FG009|Expansion Phase|Physician Decision|0|||
156712543|NCT00799058|565692758|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
156712544|NCT00799058|565692759|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
156712545|NCT00799058|565692757|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
156712546|NCT00799058|565692758|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
156712547|NCT00799058|565692759|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
156712548|NCT02088697|565692764|FG000|Period I|Physician Decision|1|||
156712549|NCT02088697|565692765|FG001|Period I|Physician Decision|4|||
156712550|NCT02088697|565692764|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
156712551|NCT02088697|565692765|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
156712552|NCT00247676|565692766|FG000|Overall Study|Death|5|||
156712553|NCT00247676|565692766|FG000|Overall Study|Adverse Event|11|||
156712554|NCT00247676|565692766|FG000|Overall Study|Lack of Efficacy|15|||
156712555|NCT00247676|565692766|FG000|Overall Study|Other|3|||
156712556|NCT00247676|565692766|FG000|Overall Study|Withdrawal by Subject|2|||
156712557|NCT03594071|565692767|FG000|Overall Study|Re-operation|3|||
156712558|NCT03594071|565692767|FG000|Overall Study|Missed visit|2|||
156712559|NCT02287922|565692768|FG000|Overall Study|Adverse Event|1|||
156712560|NCT02287922|565692769|FG001|Overall Study|Adverse Event|1|||
156712561|NCT02287922|565692770|FG002|Overall Study|Adverse Event|3|||
156712562|NCT02287922|565692771|FG003|Overall Study|Adverse Event|4|||
156712563|NCT02287922|565692768|FG000|Overall Study|Withdrawal by Subject|1|||
156712564|NCT02287922|565692769|FG001|Overall Study|Withdrawal by Subject|1|||
156712565|NCT02287922|565692770|FG002|Overall Study|Withdrawal by Subject|1|||
156712566|NCT02287922|565692771|FG003|Overall Study|Withdrawal by Subject|2|||
156712567|NCT02287922|565692768|FG000|Overall Study|Lost to Follow-up|0|||
156712568|NCT02287922|565692769|FG001|Overall Study|Lost to Follow-up|0|||
156712569|NCT02287922|565692770|FG002|Overall Study|Lost to Follow-up|1|||
156712570|NCT02287922|565692771|FG003|Overall Study|Lost to Follow-up|0|||
156712571|NCT02287922|565692768|FG000|Overall Study|Sponsor's decision|0|||
156712572|NCT02287922|565692769|FG001|Overall Study|Sponsor's decision|0|||
156712573|NCT02287922|565692770|FG002|Overall Study|Sponsor's decision|0|||
156712574|NCT02287922|565692771|FG003|Overall Study|Sponsor's decision|1|||
156712575|NCT02287922|565692768|FG000|Overall Study|Other|1|||
156712576|NCT02287922|565692769|FG001|Overall Study|Other|0|||
156712577|NCT02287922|565692770|FG002|Overall Study|Other|2|||
156712578|NCT02287922|565692771|FG003|Overall Study|Other|0|||
156712579|NCT03022370|565692772|FG000|Overall Study|Death|6|||
156712580|NCT03022370|565692773|FG001|Overall Study|Death|12|||
156712581|NCT03022370|565692772|FG000|Overall Study|Lost to Follow-up|174|||
156712582|NCT03022370|565692773|FG001|Overall Study|Lost to Follow-up|109|||
156792400|NCT01725282|565992769|FG003|Overall Study|Met Exclusion Criteria|0|||
156792401|NCT01725282|565992766|FG000|Overall Study|Study Site Withdrawal|0|||
156792402|NCT01725282|565992767|FG001|Overall Study|Study Site Withdrawal|1|||
156442615|NCT02723955|564713394|FG010|Expansion Phase|Physician Decision|0|||
156442616|NCT02723955|564713395|FG011|Expansion Phase|Physician Decision|0|||
156442617|NCT02723955|564713396|FG012|Expansion Phase|Physician Decision|0|||
156442618|NCT02723955|564713397|FG013|Expansion Phase|Physician Decision|0|||
156532229|NCT01658826|565043331|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
156712583|NCT00668317|565692774|FG000|Overall Study|Adverse Event|2|||
156712584|NCT03668808|565692778|FG000|First Intervention|Withdrawal by Subject|2|||
156712585|NCT03668808|565692779|FG001|First Intervention|Withdrawal by Subject|2|||
156712586|NCT01526655|565692782|FG000|Overall Study|Withdrawal by Subject|0|||
156712587|NCT01526655|565692783|FG001|Overall Study|Withdrawal by Subject|1|||
156712588|NCT00280735|565692784|FG000|Overall Study|Adverse Event|5|||
156712589|NCT00280735|565692784|FG000|Overall Study|Lack of Efficacy|3|||
156712590|NCT00280735|565692784|FG000|Overall Study|Withdrawal by Subject|8|||
156792403|NCT01725282|565992768|FG002|Overall Study|Study Site Withdrawal|0|||
156873958|NCT01047553|566296166|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
156442619|NCT02723955|564713398|FG014|Expansion Phase|Physician Decision|0|||
156442620|NCT02723955|564713399|FG015|Expansion Phase|Physician Decision|0|||
156712591|NCT00280735|565692784|FG000|Overall Study|Intercurrent Illness|2|||
156712592|NCT04753216|565692785|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
156712593|NCT04753216|565692785|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
156712594|NCT04753216|565692785|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
156792404|NCT01725282|565992769|FG003|Overall Study|Study Site Withdrawal|0|||
156712595|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
156712596|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Death|1|||
156712597|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
156712598|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
156712599|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
156712600|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
156873959|NCT01047553|566296167|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
156873960|NCT01047553|566296166|FG000|Overall Study|Lost to Follow-up|1|||
156873961|NCT01047553|566296167|FG001|Overall Study|Lost to Follow-up|0|||
156873962|NCT01047553|566296166|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
156873963|NCT01047553|566296167|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
156873964|NCT01047553|566296166|FG000|Overall Study|PI's decision|0|||
156873965|NCT01047553|566296167|FG001|Overall Study|PI's decision|1|||
156442621|NCT02723955|564713400|FG016|Expansion Phase|Physician Decision|0|||
156442622|NCT02723955|564713401|FG017|Expansion Phase|Physician Decision|0|||
156712601|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
156712602|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
156712603|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
156712604|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
156712605|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
156712606|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Other|3|||
156712607|NCT01965860|565692788|FG000|Overall Study|Pregnancy|1|||
156712608|NCT01965860|565692789|FG001|Overall Study|Pregnancy|0|||
156712609|NCT01965860|565692790|FG002|Overall Study|Pregnancy|1|||
156712610|NCT01965860|565692788|FG000|Overall Study|Logistics|1|||
156712611|NCT01965860|565692789|FG001|Overall Study|Logistics|0|||
156712612|NCT01965860|565692790|FG002|Overall Study|Logistics|0|||
156712613|NCT02064296|565692794|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
156712614|NCT02064296|565692795|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
156712615|NCT02064296|565692796|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
156792405|NCT01725282|565992766|FG000|Overall Study|Withdrawal by Subject|0|||
156442623|NCT02723955|564713402|FG018|Expansion Phase|Physician Decision|0|||
156442624|NCT02723955|564713403|FG019|Expansion Phase|Physician Decision|0|||
156792406|NCT01725282|565992767|FG001|Overall Study|Withdrawal by Subject|0|||
156792407|NCT01725282|565992768|FG002|Overall Study|Withdrawal by Subject|1|||
156792408|NCT01725282|565992769|FG003|Overall Study|Withdrawal by Subject|1|||
156792409|NCT01725282|565992766|FG000|Overall Study|Lack of Efficacy|0|||
156792410|NCT01725282|565992767|FG001|Overall Study|Lack of Efficacy|1|||
156792411|NCT01725282|565992768|FG002|Overall Study|Lack of Efficacy|0|||
156792412|NCT01725282|565992769|FG003|Overall Study|Lack of Efficacy|1|||
156792413|NCT01646216|565992777|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
156792414|NCT01646216|565992778|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
156792415|NCT01646216|565992777|FG000|Overall Study|Did not complete training|0|||
156792416|NCT01646216|565992778|FG001|Overall Study|Did not complete training|2|||
156792417|NCT01646216|565992777|FG000|Overall Study|Investigator decision|1|||
156792418|NCT01646216|565992778|FG001|Overall Study|Investigator decision|1|||
156792419|NCT00113373|565992779|FG000|Overall Study|Ineligible: wrong primary|1|||
156792420|NCT00113373|565992779|FG000|Overall Study|Ineligible: second primary|1|||
156792421|NCT00113373|565992779|FG000|Overall Study|Never Treated|1|||
156792422|NCT02395627|565992780|FG000|Overall Study|Withdrawal by Subject|0|||
156792423|NCT02395627|565992781|FG001|Overall Study|Withdrawal by Subject|2|||
156873966|NCT02817464|566296173|FG000|Overall Study|Lost to Follow-up|1|||
156873967|NCT02817464|566296174|FG001|Overall Study|Lost to Follow-up|0|||
156873968|NCT02817464|566296173|FG000|Overall Study|Discontinued early due to personal decision|1|||
156873969|NCT02817464|566296174|FG001|Overall Study|Discontinued early due to personal decision|1|||
156442625|NCT02723955|564713404|FG020|Expansion Phase|Physician Decision|0|||
156442626|NCT02723955|564713405|FG021|Expansion Phase|Physician Decision|0|||
156442627|NCT02723955|564713406|FG022|Expansion Phase|Physician Decision|0|||
156442628|NCT02723955|564713407|FG023|Expansion Phase|Physician Decision|0|||
156442629|NCT02723955|564713408|FG024|Expansion Phase|Physician Decision|0|||
156442630|NCT02723955|564713409|FG025|Expansion Phase|Physician Decision|0|||
156712616|NCT02064296|565692794|FG000|Intervention|Withdrawal by Subject|0|||
156712617|NCT02064296|565692795|FG001|Intervention|Withdrawal by Subject|1|||
156792424|NCT02395627|565992782|FG002|Overall Study|Withdrawal by Subject|0|||
156792425|NCT02395627|565992780|FG000|Overall Study|Did not receive pembrolizumab|3|||
156792426|NCT02395627|565992781|FG001|Overall Study|Did not receive pembrolizumab|1|||
156792427|NCT02395627|565992782|FG002|Overall Study|Did not receive pembrolizumab|0|||
156442631|NCT02723955|564713410|FG026|Expansion Phase|Physician Decision|0|||
156712618|NCT02064296|565692796|FG002|Intervention|Withdrawal by Subject|2|||
156712619|NCT00666328|565692810|FG000|Overall Study|Death|2|||
156712620|NCT00666328|565692810|FG000|Overall Study|Lost to Follow-up|2|||
156792428|NCT02757963|565992785|FG000|Overall Study|Adverse Event|3|||
156792429|NCT02757963|565992785|FG000|Overall Study|Reached Stopping Criteria|1054|||
156792430|NCT02757963|565992785|FG000|Overall Study|Lost to Follow-up|5|||
156873970|NCT01273519|566296176|FG000|Overall Study|Adverse Event|3|||
156442632|NCT02723955|564713411|FG027|Expansion Phase|Physician Decision|0|||
156442633|NCT02723955|564713412|FG028|Expansion Phase|Physician Decision|0|||
156442634|NCT02723955|564713413|FG029|Expansion Phase|Physician Decision|0|||
156442635|NCT02723955|564713414|FG030|Expansion Phase|Physician Decision|1|||
156442636|NCT02723955|564713415|FG031|Expansion Phase|Physician Decision|1|||
156442637|NCT02723955|564713416|FG032|Expansion Phase|Physician Decision|0|||
156442638|NCT02723955|564713417|FG033|Expansion Phase|Physician Decision|0|||
156712621|NCT00666328|565692810|FG000|Overall Study|No longer met eligibility criteria|1|||
156712622|NCT02288325|565692811|FG000|Run-in Period|Adverse Event|48|||
156712623|NCT02288325|565692812|FG001|Run-in Period|Adverse Event|0|||
156712624|NCT02288325|565692813|FG002|Run-in Period|Adverse Event|0|||
156712625|NCT02288325|565692811|FG000|Run-in Period|Lack of Efficacy|16|||
156712626|NCT02288325|565692812|FG001|Run-in Period|Lack of Efficacy|0|||
156712627|NCT02288325|565692813|FG002|Run-in Period|Lack of Efficacy|0|||
156712628|NCT02288325|565692811|FG000|Run-in Period|Withdrawal of Consent|28|||
156712629|NCT02288325|565692812|FG001|Run-in Period|Withdrawal of Consent|0|||
156712630|NCT02288325|565692813|FG002|Run-in Period|Withdrawal of Consent|0|||
156712631|NCT02288325|565692811|FG000|Run-in Period|Lost to Follow-up|25|||
156712632|NCT02288325|565692812|FG001|Run-in Period|Lost to Follow-up|0|||
156712633|NCT02288325|565692813|FG002|Run-in Period|Lost to Follow-up|0|||
156712634|NCT02288325|565692811|FG000|Run-in Period|Protocol Violation|17|||
156712635|NCT02288325|565692812|FG001|Run-in Period|Protocol Violation|0|||
156712636|NCT02288325|565692813|FG002|Run-in Period|Protocol Violation|0|||
156712637|NCT02288325|565692811|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
156712638|NCT02288325|565692812|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
156712639|NCT02288325|565692813|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
156712640|NCT02288325|565692811|FG000|Run-in Period|Reason not Specified|8|||
156712641|NCT02288325|565692812|FG001|Run-in Period|Reason not Specified|0|||
156712642|NCT02288325|565692813|FG002|Run-in Period|Reason not Specified|0|||
156712643|NCT02288325|565692811|FG000|Stabilization Period|Adverse Event|13|||
156712644|NCT02288325|565692812|FG001|Stabilization Period|Adverse Event|0|||
156712645|NCT02288325|565692813|FG002|Stabilization Period|Adverse Event|0|||
156712646|NCT02288325|565692811|FG000|Stabilization Period|Lack of Efficacy|22|||
156712647|NCT02288325|565692812|FG001|Stabilization Period|Lack of Efficacy|0|||
156712648|NCT02288325|565692813|FG002|Stabilization Period|Lack of Efficacy|0|||
156712649|NCT02288325|565692811|FG000|Stabilization Period|Withdrawal of Consent|23|||
156712650|NCT02288325|565692812|FG001|Stabilization Period|Withdrawal of Consent|0|||
156712651|NCT02288325|565692813|FG002|Stabilization Period|Withdrawal of Consent|0|||
156712652|NCT02288325|565692811|FG000|Stabilization Period|Lost to Follow-up|12|||
156712653|NCT02288325|565692812|FG001|Stabilization Period|Lost to Follow-up|0|||
156712654|NCT02288325|565692813|FG002|Stabilization Period|Lost to Follow-up|0|||
156442639|NCT02723955|564713418|FG034|Expansion Phase|Physician Decision|0|||
156442640|NCT02723955|564713419|FG035|Expansion Phase|Physician Decision|0|||
156442641|NCT02723955|564713420|FG036|Expansion Phase|Physician Decision|0|||
156442642|NCT02723955|564713421|FG037|Expansion Phase|Physician Decision|0|||
156442643|NCT02723955|564713422|FG038|Expansion Phase|Physician Decision|0|||
156442644|NCT02723955|564713423|FG039|Expansion Phase|Physician Decision|0|||
156442645|NCT02723955|564713424|FG040|Expansion Phase|Physician Decision|0|||
156442646|NCT02723955|564713425|FG041|Expansion Phase|Physician Decision|0|||
156442647|NCT02723955|564713426|FG042|Expansion Phase|Physician Decision|0|||
156442648|NCT02723955|564713384|FG000|Expansion Phase|Withdrawal by Subject|0|||
156442649|NCT02723955|564713385|FG001|Expansion Phase|Withdrawal by Subject|0|||
156442650|NCT02723955|564713386|FG002|Expansion Phase|Withdrawal by Subject|0|||
156442651|NCT02723955|564713387|FG003|Expansion Phase|Withdrawal by Subject|0|||
156442652|NCT02723955|564713388|FG004|Expansion Phase|Withdrawal by Subject|0|||
156442653|NCT02723955|564713389|FG005|Expansion Phase|Withdrawal by Subject|0|||
156442654|NCT02723955|564713390|FG006|Expansion Phase|Withdrawal by Subject|0|||
156442655|NCT02723955|564713391|FG007|Expansion Phase|Withdrawal by Subject|0|||
156442656|NCT02723955|564713392|FG008|Expansion Phase|Withdrawal by Subject|0|||
156442657|NCT02723955|564713393|FG009|Expansion Phase|Withdrawal by Subject|2|||
156442658|NCT02723955|564713394|FG010|Expansion Phase|Withdrawal by Subject|1|||
156442659|NCT02723955|564713395|FG011|Expansion Phase|Withdrawal by Subject|0|||
156442660|NCT02723955|564713396|FG012|Expansion Phase|Withdrawal by Subject|0|||
156442661|NCT02723955|564713397|FG013|Expansion Phase|Withdrawal by Subject|0|||
156442662|NCT02723955|564713398|FG014|Expansion Phase|Withdrawal by Subject|0|||
156442663|NCT02723955|564713399|FG015|Expansion Phase|Withdrawal by Subject|0|||
156532230|NCT01658826|565043332|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
156712655|NCT02288325|565692811|FG000|Stabilization Period|Protocol Violation|8|||
156712656|NCT02288325|565692812|FG001|Stabilization Period|Protocol Violation|0|||
156712657|NCT02288325|565692813|FG002|Stabilization Period|Protocol Violation|0|||
156712658|NCT02288325|565692811|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
156712659|NCT02288325|565692812|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
156537838|NCT01236573|565062875|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
156712660|NCT02288325|565692813|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
156792431|NCT02757963|565992785|FG000|Overall Study|Physician Decision|1|||
156712661|NCT02288325|565692811|FG000|Stabilization Period|Reason not Specified|15|||
156873971|NCT01273519|566296177|FG001|Overall Study|Adverse Event|0|||
156873972|NCT01273519|566296178|FG002|Overall Study|Adverse Event|0|||
156873973|NCT01273519|566296176|FG000|Overall Study|Lost to Follow-up|2|||
156873974|NCT01273519|566296177|FG001|Overall Study|Lost to Follow-up|1|||
156873975|NCT01273519|566296178|FG002|Overall Study|Lost to Follow-up|3|||
156873976|NCT01273519|566296176|FG000|Overall Study|Lack of Efficacy|8|||
156873977|NCT01273519|566296177|FG001|Overall Study|Lack of Efficacy|3|||
156873978|NCT01273519|566296178|FG002|Overall Study|Lack of Efficacy|4|||
156873979|NCT01273519|566296176|FG000|Overall Study|Other|6|||
156873980|NCT01273519|566296177|FG001|Overall Study|Other|1|||
156873981|NCT01273519|566296178|FG002|Overall Study|Other|1|||
156712662|NCT02288325|565692812|FG001|Stabilization Period|Reason not Specified|0|||
156712663|NCT02288325|565692813|FG002|Stabilization Period|Reason not Specified|0|||
156712664|NCT02288325|565692811|FG000|Double-blind Treatment Period|Adverse Event|0|||
156712665|NCT02288325|565692812|FG001|Double-blind Treatment Period|Adverse Event|2|||
156712666|NCT02288325|565692813|FG002|Double-blind Treatment Period|Adverse Event|5|||
156712667|NCT02288325|565692811|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
156712668|NCT02288325|565692812|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
156712669|NCT02288325|565692813|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
156712670|NCT02288325|565692811|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156712671|NCT02288325|565692812|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
156712672|NCT02288325|565692813|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
156712673|NCT02288325|565692811|FG000|Double-blind Treatment Period|Protocol Violation|0|||
156712674|NCT02288325|565692812|FG001|Double-blind Treatment Period|Protocol Violation|1|||
156712675|NCT02288325|565692813|FG002|Double-blind Treatment Period|Protocol Violation|2|||
156712676|NCT02288325|565692811|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
156712677|NCT02288325|565692812|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
156712678|NCT02288325|565692813|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
156712679|NCT02288325|565692811|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
156712680|NCT02288325|565692812|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
156712681|NCT02288325|565692813|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
156712682|NCT01884337|565692816|FG000|Treatment|Adverse Event|2|||
156712683|NCT01884337|565692817|FG001|Treatment|Adverse Event|2|||
156712684|NCT01884337|565692816|FG000|Treatment|Subj. request to discont. treatment|2|||
156712685|NCT01884337|565692817|FG001|Treatment|Subj. request to discont. treatment|0|||
156712686|NCT01884337|565692816|FG000|Follow-up Period|Lost to Follow-up|1|||
156712687|NCT01884337|565692817|FG001|Follow-up Period|Lost to Follow-up|1|||
156712688|NCT02455518|565692818|FG000|Overall Study|Protocol Violation|0|||
156712689|NCT02455518|565692819|FG001|Overall Study|Protocol Violation|1|||
156712690|NCT02455518|565692820|FG002|Overall Study|Protocol Violation|1|||
156712691|NCT02455518|565692821|FG003|Overall Study|Protocol Violation|3|||
156712692|NCT04186845|565692823|FG000|Overall Study|Death|2|||
156712693|NCT04186845|565692823|FG000|Overall Study|Lost to Follow-up|1|||
156712694|NCT04186845|565692823|FG000|Overall Study|Physician Decision|1|||
156712695|NCT04186845|565692823|FG000|Overall Study|Protocol Violation|1|||
156712696|NCT04186845|565692823|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
156712697|NCT04186845|565692823|FG000|Overall Study|Biopsy ordered but not done|1|||
156712698|NCT04186845|565692823|FG000|Overall Study|It was previously confirmed|1|||
156712699|NCT04186845|565692823|FG000|Overall Study|Patient cancelled scheduled scans|2|||
156712700|NCT04186845|565692823|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
156712701|NCT04186845|565692823|FG000|Overall Study|Subject refused confirmatory imaging|1|||
156712702|NCT04186845|565692823|FG000|Overall Study|Too small to biopsy|1|||
156712703|NCT03151304|565692824|FG000|Overall Study|Termination of study by Sponsor|23|||
156873982|NCT04292899|566296179|FG000|Overall Study|Death|21|||
156873983|NCT04292899|566296180|FG001|Overall Study|Death|28|||
156873984|NCT04292899|566296181|FG002|Overall Study|Death|188|||
156873985|NCT04292899|566296182|FG003|Overall Study|Death|371|||
156873986|NCT04292899|566296179|FG000|Overall Study|Lost to Follow-up|8|||
156873987|NCT04292899|566296180|FG001|Overall Study|Lost to Follow-up|4|||
156873988|NCT04292899|566296181|FG002|Overall Study|Lost to Follow-up|22|||
156873989|NCT04292899|566296182|FG003|Overall Study|Lost to Follow-up|235|||
156873990|NCT04292899|566296179|FG000|Overall Study|Withdrew consent|1|||
156873991|NCT04292899|566296180|FG001|Overall Study|Withdrew consent|0|||
156712704|NCT03151304|565692824|FG000|Overall Study|missing|3|||
156712705|NCT03151304|565692824|FG000|Overall Study|Withdrawal by Subject|8|||
156712706|NCT03151304|565692824|FG000|Overall Study|multiple reasons|30|||
156712707|NCT01332292|565692826|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
156442664|NCT02723955|564713400|FG016|Expansion Phase|Withdrawal by Subject|0|||
156712708|NCT01332292|565692827|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
156712709|NCT01332292|565692826|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
156712710|NCT01332292|565692827|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
156873992|NCT04292899|566296181|FG002|Overall Study|Withdrew consent|11|||
156873993|NCT04292899|566296182|FG003|Overall Study|Withdrew consent|32|||
156873994|NCT04292899|566296179|FG000|Overall Study|Adverse Event|2|||
156873995|NCT04292899|566296180|FG001|Overall Study|Adverse Event|1|||
156442665|NCT02723955|564713401|FG017|Expansion Phase|Withdrawal by Subject|0|||
156442666|NCT02723955|564713402|FG018|Expansion Phase|Withdrawal by Subject|0|||
156442667|NCT02723955|564713403|FG019|Expansion Phase|Withdrawal by Subject|0|||
156442668|NCT02723955|564713404|FG020|Expansion Phase|Withdrawal by Subject|0|||
156442669|NCT02723955|564713405|FG021|Expansion Phase|Withdrawal by Subject|0|||
156442670|NCT02723955|564713406|FG022|Expansion Phase|Withdrawal by Subject|0|||
156442671|NCT02723955|564713407|FG023|Expansion Phase|Withdrawal by Subject|0|||
156442672|NCT02723955|564713408|FG024|Expansion Phase|Withdrawal by Subject|0|||
156442673|NCT02723955|564713409|FG025|Expansion Phase|Withdrawal by Subject|0|||
156442674|NCT02723955|564713410|FG026|Expansion Phase|Withdrawal by Subject|0|||
156442675|NCT02723955|564713411|FG027|Expansion Phase|Withdrawal by Subject|0|||
156442676|NCT02723955|564713412|FG028|Expansion Phase|Withdrawal by Subject|0|||
156442677|NCT02723955|564713413|FG029|Expansion Phase|Withdrawal by Subject|0|||
156442678|NCT02723955|564713414|FG030|Expansion Phase|Withdrawal by Subject|8|||
156442679|NCT02723955|564713415|FG031|Expansion Phase|Withdrawal by Subject|4|||
156442680|NCT02723955|564713416|FG032|Expansion Phase|Withdrawal by Subject|0|||
156442681|NCT02723955|564713417|FG033|Expansion Phase|Withdrawal by Subject|0|||
156442682|NCT02723955|564713418|FG034|Expansion Phase|Withdrawal by Subject|0|||
156442683|NCT02723955|564713419|FG035|Expansion Phase|Withdrawal by Subject|1|||
156442684|NCT02723955|564713420|FG036|Expansion Phase|Withdrawal by Subject|0|||
156442685|NCT02723955|564713421|FG037|Expansion Phase|Withdrawal by Subject|0|||
156442686|NCT02723955|564713422|FG038|Expansion Phase|Withdrawal by Subject|0|||
156442687|NCT02723955|564713423|FG039|Expansion Phase|Withdrawal by Subject|0|||
156442688|NCT02723955|564713424|FG040|Expansion Phase|Withdrawal by Subject|0|||
156442689|NCT02723955|564713425|FG041|Expansion Phase|Withdrawal by Subject|0|||
156442690|NCT02723955|564713426|FG042|Expansion Phase|Withdrawal by Subject|0|||
156442691|NCT02723955|564713384|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442692|NCT02723955|564713385|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442693|NCT02723955|564713386|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442694|NCT02723955|564713387|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442695|NCT02723955|564713388|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442696|NCT02723955|564713389|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442697|NCT02723955|564713390|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442698|NCT02723955|564713391|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442699|NCT02723955|564713392|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442700|NCT02723955|564713393|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
156442701|NCT02723955|564713394|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
156442702|NCT02723955|564713395|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
156442703|NCT02723955|564713396|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442704|NCT02723955|564713397|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442705|NCT02723955|564713398|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442706|NCT02723955|564713399|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442707|NCT02723955|564713400|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442708|NCT02723955|564713401|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442709|NCT02723955|564713402|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442710|NCT02723955|564713403|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442711|NCT02723955|564713404|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442712|NCT02723955|564713405|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442713|NCT02723955|564713406|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442714|NCT02723955|564713407|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442715|NCT02723955|564713408|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442716|NCT02723955|564713409|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442717|NCT02723955|564713410|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442718|NCT02723955|564713411|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442719|NCT02723955|564713412|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442720|NCT02723955|564713413|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156712711|NCT01332292|565692826|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
156712712|NCT01332292|565692827|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
156712713|NCT00098774|565692828|FG000|Overall Study|Adverse Event|2|||
156712714|NCT00098774|565692828|FG000|Overall Study|Disease Progression|9|||
156712715|NCT00098774|565692828|FG000|Overall Study|Withdrawal by Subject|1|||
156712716|NCT00098774|565692828|FG000|Overall Study|Failed (to respond) during induction|4|||
156712717|NCT00098774|565692828|FG000|Overall Study|Physician Decision|2|||
156712718|NCT01330303|565692829|FG000|Period 1|Adverse Event|1|||
156712719|NCT01330303|565692830|FG001|Period 1|Adverse Event|0|||
156712720|NCT01330303|565692829|FG000|Period 1|Protocol Violation|0|||
156712721|NCT01330303|565692830|FG001|Period 1|Protocol Violation|1|||
156712722|NCT01330303|565692829|FG000|Period 1|Withdrawal by Subject|0|||
156712723|NCT01330303|565692830|FG001|Period 1|Withdrawal by Subject|1|||
156712724|NCT00796757|565692831|FG000|Overall Study|Withdrawal by Subject|14|||
156712725|NCT00796757|565692831|FG000|Overall Study|Death|61|||
156712726|NCT00796757|565692831|FG000|Overall Study|Protocol Violation|1|||
156712727|NCT00796757|565692831|FG000|Overall Study|Participant noncompliance|1|||
156712728|NCT00796757|565692831|FG000|Overall Study|Investigator's decision|2|||
156712729|NCT00796757|565692831|FG000|Overall Study|Other|7|||
156712730|NCT02593110|565692833|FG000|Overall Study|Withdrawal by Subject|0|||
156712731|NCT02593110|565692834|FG001|Overall Study|Withdrawal by Subject|3|||
156712732|NCT02593110|565692835|FG002|Overall Study|Withdrawal by Subject|3|||
156712733|NCT02593110|565692836|FG003|Overall Study|Withdrawal by Subject|2|||
156712734|NCT02593110|565692833|FG000|Overall Study|Death|0|||
156712735|NCT02593110|565692834|FG001|Overall Study|Death|0|||
156712736|NCT02593110|565692835|FG002|Overall Study|Death|1|||
156712737|NCT02593110|565692836|FG003|Overall Study|Death|0|||
156712738|NCT03548337|565692837|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
156712739|NCT03548337|565692838|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
156712740|NCT03548337|565692837|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
156712741|NCT03548337|565692838|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
156712742|NCT03548337|565692837|FG000|Infant Series|Lost to Follow-up|2|||
156712743|NCT03548337|565692838|FG001|Infant Series|Lost to Follow-up|1|||
156712744|NCT03548337|565692837|FG000|Infant Series|Adverse Event|0|||
156712745|NCT03548337|565692838|FG001|Infant Series|Adverse Event|2|||
156712746|NCT03548337|565692837|FG000|Infant Series|Randomized but Not Vaccinated|1|||
156712747|NCT03548337|565692838|FG001|Infant Series|Randomized but Not Vaccinated|0|||
156712748|NCT03548337|565692837|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
156712749|NCT03548337|565692838|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
156712750|NCT04502212|565692841|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
156712751|NCT04502212|565692841|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
156712752|NCT01911273|565692843|FG000|Overall Study|Progression of Disease|1|||
156712753|NCT01911273|565692844|FG001|Overall Study|Progression of Disease|0|||
156712754|NCT01911273|565692843|FG000|Overall Study|Withdrawal by Subject|0|||
156712755|NCT01911273|565692844|FG001|Overall Study|Withdrawal by Subject|2|||
156712756|NCT00307437|565692846|FG000|Controlled Period|Adverse Event|7|||
156712757|NCT00307437|565692847|FG001|Controlled Period|Adverse Event|2|||
156712758|NCT00307437|565692848|FG002|Controlled Period|Adverse Event|5|||
156712759|NCT00307437|565692849|FG003|Controlled Period|Adverse Event|0|||
156712760|NCT00307437|565692850|FG004|Controlled Period|Adverse Event|0|||
156792432|NCT02757963|565992785|FG000|Overall Study|Withdrawal by Subject|34|||
156792433|NCT00911157|565992786|FG000|Overall Study|Adverse Event|4|||
156792434|NCT00911157|565992787|FG001|Overall Study|Adverse Event|1|||
156792435|NCT00911157|565992786|FG000|Overall Study|Withdrawal by Subject|1|||
156792436|NCT00911157|565992787|FG001|Overall Study|Withdrawal by Subject|1|||
156792437|NCT00911157|565992786|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
156792438|NCT00911157|565992787|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
156792439|NCT00911157|565992786|FG000|Overall Study|Need to treat for lung cancer|1|||
156792440|NCT00911157|565992787|FG001|Overall Study|Need to treat for lung cancer|0|||
156792441|NCT03769467|565992791|FG000|Overall Study|Adverse Event|1|||
156792442|NCT03769467|565992792|FG001|Overall Study|Adverse Event|1|||
156792443|NCT03769467|565992793|FG002|Overall Study|Adverse Event|0|||
156792444|NCT03769467|565992791|FG000|Overall Study|Death|3|||
156792445|NCT03769467|565992792|FG001|Overall Study|Death|3|||
156792446|NCT03769467|565992793|FG002|Overall Study|Death|0|||
156792447|NCT03769467|565992791|FG000|Overall Study|Study Terminated By Sponsor|2|||
156792448|NCT03769467|565992792|FG001|Overall Study|Study Terminated By Sponsor|1|||
156792449|NCT03769467|565992793|FG002|Overall Study|Study Terminated By Sponsor|0|||
156332984|NCT03181893|564317457|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
156712761|NCT00307437|565692851|FG005|Controlled Period|Adverse Event|0|||
156712762|NCT00307437|565692852|FG006|Controlled Period|Adverse Event|0|||
156332985|NCT03181893|564317458|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156332986|NCT03181893|564317459|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156712763|NCT00307437|565692846|FG000|Controlled Period|Death|0|||
156712764|NCT00307437|565692847|FG001|Controlled Period|Death|0|||
156712765|NCT00307437|565692848|FG002|Controlled Period|Death|1|||
156712766|NCT00307437|565692849|FG003|Controlled Period|Death|0|||
156712767|NCT00307437|565692850|FG004|Controlled Period|Death|0|||
156712768|NCT00307437|565692851|FG005|Controlled Period|Death|0|||
156792450|NCT03769467|565992791|FG000|Overall Study|Withdrawal by Subject|0|||
156792451|NCT03769467|565992792|FG001|Overall Study|Withdrawal by Subject|1|||
156792452|NCT03769467|565992793|FG002|Overall Study|Withdrawal by Subject|0|||
156792453|NCT05259722|565992796|FG000|Overall Study|Adverse Event|2|||
156712769|NCT00307437|565692852|FG006|Controlled Period|Death|0|||
156712770|NCT00307437|565692846|FG000|Controlled Period|Lack of Efficacy|2|||
156712771|NCT00307437|565692847|FG001|Controlled Period|Lack of Efficacy|0|||
156712772|NCT00307437|565692848|FG002|Controlled Period|Lack of Efficacy|0|||
156712773|NCT00307437|565692849|FG003|Controlled Period|Lack of Efficacy|0|||
156712774|NCT00307437|565692850|FG004|Controlled Period|Lack of Efficacy|0|||
156712775|NCT00307437|565692851|FG005|Controlled Period|Lack of Efficacy|0|||
156712776|NCT00307437|565692852|FG006|Controlled Period|Lack of Efficacy|0|||
156712777|NCT00307437|565692846|FG000|Controlled Period|Lost to Follow-up|2|||
156712778|NCT00307437|565692847|FG001|Controlled Period|Lost to Follow-up|3|||
156712779|NCT00307437|565692848|FG002|Controlled Period|Lost to Follow-up|0|||
156712780|NCT00307437|565692849|FG003|Controlled Period|Lost to Follow-up|0|||
156712781|NCT00307437|565692850|FG004|Controlled Period|Lost to Follow-up|0|||
156712782|NCT00307437|565692851|FG005|Controlled Period|Lost to Follow-up|0|||
156712783|NCT00307437|565692852|FG006|Controlled Period|Lost to Follow-up|0|||
156712784|NCT00307437|565692846|FG000|Controlled Period|Other|5|||
156712785|NCT00307437|565692847|FG001|Controlled Period|Other|1|||
156712786|NCT00307437|565692848|FG002|Controlled Period|Other|3|||
156712787|NCT00307437|565692849|FG003|Controlled Period|Other|0|||
156712788|NCT00307437|565692850|FG004|Controlled Period|Other|0|||
156712789|NCT00307437|565692851|FG005|Controlled Period|Other|0|||
156712790|NCT00307437|565692852|FG006|Controlled Period|Other|0|||
156712791|NCT00307437|565692846|FG000|After Controlled Period|Adverse Event|0|||
156712792|NCT00307437|565692847|FG001|After Controlled Period|Adverse Event|0|||
156712793|NCT00307437|565692848|FG002|After Controlled Period|Adverse Event|0|||
156712794|NCT00307437|565692849|FG003|After Controlled Period|Adverse Event|18|||
156712795|NCT00307437|565692850|FG004|After Controlled Period|Adverse Event|16|||
156712796|NCT00307437|565692851|FG005|After Controlled Period|Adverse Event|31|||
156712797|NCT00307437|565692852|FG006|After Controlled Period|Adverse Event|40|||
156712798|NCT00307437|565692846|FG000|After Controlled Period|Death|0|||
156712799|NCT00307437|565692847|FG001|After Controlled Period|Death|0|||
156712800|NCT00307437|565692848|FG002|After Controlled Period|Death|0|||
156712801|NCT00307437|565692849|FG003|After Controlled Period|Death|3|||
156712802|NCT00307437|565692850|FG004|After Controlled Period|Death|1|||
156712803|NCT00307437|565692851|FG005|After Controlled Period|Death|1|||
156712804|NCT00307437|565692852|FG006|After Controlled Period|Death|3|||
156712805|NCT00307437|565692846|FG000|After Controlled Period|Lack of Efficacy|0|||
156712806|NCT00307437|565692847|FG001|After Controlled Period|Lack of Efficacy|0|||
156712807|NCT00307437|565692848|FG002|After Controlled Period|Lack of Efficacy|0|||
156712808|NCT00307437|565692849|FG003|After Controlled Period|Lack of Efficacy|15|||
156712809|NCT00307437|565692850|FG004|After Controlled Period|Lack of Efficacy|17|||
156712810|NCT00307437|565692851|FG005|After Controlled Period|Lack of Efficacy|37|||
156712811|NCT00307437|565692852|FG006|After Controlled Period|Lack of Efficacy|24|||
156712812|NCT00307437|565692846|FG000|After Controlled Period|Lost to Follow-up|0|||
156712813|NCT00307437|565692847|FG001|After Controlled Period|Lost to Follow-up|0|||
156712814|NCT00307437|565692848|FG002|After Controlled Period|Lost to Follow-up|0|||
156712815|NCT00307437|565692849|FG003|After Controlled Period|Lost to Follow-up|7|||
156712816|NCT00307437|565692850|FG004|After Controlled Period|Lost to Follow-up|12|||
156712817|NCT00307437|565692851|FG005|After Controlled Period|Lost to Follow-up|13|||
156712818|NCT00307437|565692852|FG006|After Controlled Period|Lost to Follow-up|18|||
156712819|NCT00307437|565692846|FG000|After Controlled Period|Other|0|||
156712820|NCT00307437|565692847|FG001|After Controlled Period|Other|0|||
156712821|NCT00307437|565692848|FG002|After Controlled Period|Other|0|||
156712822|NCT00307437|565692849|FG003|After Controlled Period|Other|15|||
156712823|NCT00307437|565692850|FG004|After Controlled Period|Other|9|||
156712824|NCT00307437|565692851|FG005|After Controlled Period|Other|40|||
156712825|NCT00307437|565692852|FG006|After Controlled Period|Other|28|||
156712826|NCT04803305|565692853|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
156712827|NCT04803305|565692854|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
156712828|NCT04803305|565692853|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
156792454|NCT05259722|565992797|FG001|Overall Study|Adverse Event|24|||
156712829|NCT04803305|565692854|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
156712830|NCT04803305|565692853|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
156712831|NCT04803305|565692854|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
156712832|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
156712833|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
156712834|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
156712835|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
156712836|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
156712837|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
156712838|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
156712839|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
156712840|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
156712841|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
156792455|NCT05259722|565992796|FG000|Overall Study|Lost to Follow-up|5|||
156792456|NCT05259722|565992797|FG001|Overall Study|Lost to Follow-up|1|||
156712842|NCT00721227|565692855|FG000|Overall Study|Lost to Follow-up|3|||
156712843|NCT00721227|565692856|FG001|Overall Study|Lost to Follow-up|0|||
156712844|NCT00721227|565692855|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
156712845|NCT00721227|565692856|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
156712846|NCT00352417|565692861|FG000|Overall Study|Adverse Event|1|||
156712847|NCT00352417|565692862|FG001|Overall Study|Adverse Event|0|||
156712848|NCT00352417|565692861|FG000|Overall Study|Protocol Violation|0|||
156712849|NCT00352417|565692862|FG001|Overall Study|Protocol Violation|2|||
156712850|NCT00352417|565692861|FG000|Overall Study|Withdrawal by Subject|1|||
156712851|NCT00352417|565692862|FG001|Overall Study|Withdrawal by Subject|2|||
156712852|NCT00352417|565692861|FG000|Overall Study|Lost to Follow-up|1|||
156712853|NCT00352417|565692862|FG001|Overall Study|Lost to Follow-up|0|||
156712854|NCT00352417|565692861|FG000|Overall Study|Schedule Change|2|||
156712855|NCT00352417|565692862|FG001|Overall Study|Schedule Change|1|||
156712856|NCT03207867|565692863|FG000|Overall Study|Adverse Event|1|||
156712857|NCT03207867|565692864|FG001|Overall Study|Adverse Event|0|||
156712858|NCT03207867|565692865|FG002|Overall Study|Adverse Event|1|||
156712859|NCT03207867|565692866|FG003|Overall Study|Adverse Event|0|||
156712860|NCT03207867|565692867|FG004|Overall Study|Adverse Event|0|||
156712861|NCT03207867|565692868|FG005|Overall Study|Adverse Event|2|||
156712862|NCT03207867|565692869|FG006|Overall Study|Adverse Event|1|||
156712863|NCT03207867|565692870|FG007|Overall Study|Adverse Event|1|||
156712864|NCT03207867|565692871|FG008|Overall Study|Adverse Event|2|||
156712865|NCT03207867|565692872|FG009|Overall Study|Adverse Event|2|||
156712866|NCT03207867|565692873|FG010|Overall Study|Adverse Event|0|||
156712867|NCT03207867|565692874|FG011|Overall Study|Adverse Event|0|||
156712868|NCT03207867|565692875|FG012|Overall Study|Adverse Event|0|||
156712869|NCT03207867|565692876|FG013|Overall Study|Adverse Event|0|||
156712870|NCT03207867|565692877|FG014|Overall Study|Adverse Event|0|||
156712871|NCT03207867|565692878|FG015|Overall Study|Adverse Event|0|||
156712872|NCT03207867|565692879|FG016|Overall Study|Adverse Event|3|||
156712873|NCT03207867|565692880|FG017|Overall Study|Adverse Event|1|||
156712874|NCT03207867|565692881|FG018|Overall Study|Adverse Event|2|||
156712875|NCT03207867|565692882|FG019|Overall Study|Adverse Event|1|||
156712876|NCT03207867|565692883|FG020|Overall Study|Adverse Event|0|||
156712877|NCT03207867|565692884|FG021|Overall Study|Adverse Event|0|||
156712878|NCT03207867|565692885|FG022|Overall Study|Adverse Event|0|||
156712879|NCT03207867|565692886|FG023|Overall Study|Adverse Event|0|||
156712880|NCT03207867|565692863|FG000|Overall Study|Death|0|||
156712881|NCT03207867|565692864|FG001|Overall Study|Death|0|||
156712882|NCT03207867|565692865|FG002|Overall Study|Death|0|||
156712883|NCT03207867|565692866|FG003|Overall Study|Death|0|||
156712884|NCT03207867|565692867|FG004|Overall Study|Death|0|||
156712885|NCT03207867|565692868|FG005|Overall Study|Death|1|||
156712886|NCT03207867|565692869|FG006|Overall Study|Death|0|||
156712887|NCT03207867|565692870|FG007|Overall Study|Death|3|||
156712888|NCT03207867|565692871|FG008|Overall Study|Death|1|||
156712889|NCT03207867|565692872|FG009|Overall Study|Death|2|||
156712890|NCT03207867|565692873|FG010|Overall Study|Death|0|||
156712891|NCT03207867|565692874|FG011|Overall Study|Death|1|||
156712892|NCT03207867|565692875|FG012|Overall Study|Death|0|||
156712893|NCT03207867|565692876|FG013|Overall Study|Death|1|||
156712894|NCT03207867|565692877|FG014|Overall Study|Death|0|||
156712895|NCT03207867|565692878|FG015|Overall Study|Death|0|||
156712896|NCT03207867|565692879|FG016|Overall Study|Death|0|||
156712897|NCT03207867|565692880|FG017|Overall Study|Death|2|||
156712898|NCT03207867|565692881|FG018|Overall Study|Death|0|||
156712899|NCT03207867|565692882|FG019|Overall Study|Death|1|||
156712900|NCT03207867|565692883|FG020|Overall Study|Death|0|||
156712901|NCT03207867|565692884|FG021|Overall Study|Death|0|||
156712902|NCT03207867|565692885|FG022|Overall Study|Death|0|||
156712903|NCT03207867|565692886|FG023|Overall Study|Death|0|||
156712904|NCT03207867|565692863|FG000|Overall Study|Physician Decision|3|||
156712905|NCT03207867|565692864|FG001|Overall Study|Physician Decision|5|||
156712906|NCT03207867|565692865|FG002|Overall Study|Physician Decision|0|||
156712907|NCT03207867|565692866|FG003|Overall Study|Physician Decision|3|||
156712908|NCT03207867|565692867|FG004|Overall Study|Physician Decision|2|||
156712909|NCT03207867|565692868|FG005|Overall Study|Physician Decision|0|||
156712910|NCT03207867|565692869|FG006|Overall Study|Physician Decision|0|||
156712911|NCT03207867|565692870|FG007|Overall Study|Physician Decision|0|||
156712912|NCT03207867|565692871|FG008|Overall Study|Physician Decision|4|||
156712913|NCT03207867|565692872|FG009|Overall Study|Physician Decision|2|||
156712914|NCT03207867|565692873|FG010|Overall Study|Physician Decision|0|||
156712915|NCT03207867|565692874|FG011|Overall Study|Physician Decision|4|||
156792457|NCT05259722|565992796|FG000|Overall Study|Lack of Efficacy|8|||
156792458|NCT05259722|565992797|FG001|Overall Study|Lack of Efficacy|26|||
156792459|NCT05259722|565992796|FG000|Overall Study|Withdrawal by Subject|15|||
156792460|NCT05259722|565992797|FG001|Overall Study|Withdrawal by Subject|33|||
156792461|NCT05259722|565992796|FG000|Overall Study|Various reasons|3|||
156792462|NCT05259722|565992797|FG001|Overall Study|Various reasons|9|||
156792463|NCT05259722|565992796|FG000|Overall Study|Not exposed to IMP|1|||
156792464|NCT05259722|565992797|FG001|Overall Study|Not exposed to IMP|12|||
156712916|NCT03207867|565692875|FG012|Overall Study|Physician Decision|0|||
156712917|NCT03207867|565692876|FG013|Overall Study|Physician Decision|0|||
156712918|NCT03207867|565692877|FG014|Overall Study|Physician Decision|2|||
156712919|NCT03207867|565692878|FG015|Overall Study|Physician Decision|1|||
156712920|NCT03207867|565692879|FG016|Overall Study|Physician Decision|1|||
156712921|NCT03207867|565692880|FG017|Overall Study|Physician Decision|2|||
156712922|NCT03207867|565692881|FG018|Overall Study|Physician Decision|1|||
156712923|NCT03207867|565692882|FG019|Overall Study|Physician Decision|3|||
156712924|NCT03207867|565692883|FG020|Overall Study|Physician Decision|0|||
156712925|NCT03207867|565692884|FG021|Overall Study|Physician Decision|0|||
156712926|NCT03207867|565692885|FG022|Overall Study|Physician Decision|0|||
156712927|NCT03207867|565692886|FG023|Overall Study|Physician Decision|0|||
156712928|NCT03207867|565692863|FG000|Overall Study|Progressive Disease|7|||
156712929|NCT03207867|565692864|FG001|Overall Study|Progressive Disease|7|||
156712930|NCT03207867|565692865|FG002|Overall Study|Progressive Disease|9|||
156712931|NCT03207867|565692866|FG003|Overall Study|Progressive Disease|10|||
156712932|NCT03207867|565692867|FG004|Overall Study|Progressive Disease|11|||
156712933|NCT03207867|565692868|FG005|Overall Study|Progressive Disease|10|||
156712934|NCT03207867|565692869|FG006|Overall Study|Progressive Disease|9|||
156712935|NCT03207867|565692870|FG007|Overall Study|Progressive Disease|8|||
156712936|NCT03207867|565692871|FG008|Overall Study|Progressive Disease|19|||
156712937|NCT03207867|565692872|FG009|Overall Study|Progressive Disease|23|||
156712938|NCT03207867|565692873|FG010|Overall Study|Progressive Disease|2|||
156712939|NCT03207867|565692874|FG011|Overall Study|Progressive Disease|24|||
156712940|NCT03207867|565692875|FG012|Overall Study|Progressive Disease|3|||
156712941|NCT03207867|565692876|FG013|Overall Study|Progressive Disease|11|||
156712942|NCT03207867|565692877|FG014|Overall Study|Progressive Disease|9|||
156712943|NCT03207867|565692878|FG015|Overall Study|Progressive Disease|5|||
156712944|NCT03207867|565692879|FG016|Overall Study|Progressive Disease|10|||
156712945|NCT03207867|565692880|FG017|Overall Study|Progressive Disease|14|||
156712946|NCT03207867|565692881|FG018|Overall Study|Progressive Disease|13|||
156712947|NCT03207867|565692882|FG019|Overall Study|Progressive Disease|14|||
156712948|NCT03207867|565692883|FG020|Overall Study|Progressive Disease|6|||
156712949|NCT03207867|565692884|FG021|Overall Study|Progressive Disease|3|||
156712950|NCT03207867|565692885|FG022|Overall Study|Progressive Disease|3|||
156712951|NCT03207867|565692886|FG023|Overall Study|Progressive Disease|3|||
156712952|NCT03207867|565692863|FG000|Overall Study|Patient/guardian Decision|0|||
156712953|NCT03207867|565692864|FG001|Overall Study|Patient/guardian Decision|0|||
156712954|NCT03207867|565692865|FG002|Overall Study|Patient/guardian Decision|1|||
156712955|NCT03207867|565692866|FG003|Overall Study|Patient/guardian Decision|1|||
156712956|NCT03207867|565692867|FG004|Overall Study|Patient/guardian Decision|1|||
156712957|NCT03207867|565692868|FG005|Overall Study|Patient/guardian Decision|2|||
156712958|NCT03207867|565692869|FG006|Overall Study|Patient/guardian Decision|1|||
156712959|NCT03207867|565692870|FG007|Overall Study|Patient/guardian Decision|0|||
156712960|NCT03207867|565692871|FG008|Overall Study|Patient/guardian Decision|1|||
156712961|NCT03207867|565692872|FG009|Overall Study|Patient/guardian Decision|0|||
156712962|NCT03207867|565692873|FG010|Overall Study|Patient/guardian Decision|0|||
156712963|NCT03207867|565692874|FG011|Overall Study|Patient/guardian Decision|1|||
156712964|NCT03207867|565692875|FG012|Overall Study|Patient/guardian Decision|0|||
156712965|NCT03207867|565692876|FG013|Overall Study|Patient/guardian Decision|1|||
156712966|NCT03207867|565692877|FG014|Overall Study|Patient/guardian Decision|2|||
156712967|NCT03207867|565692878|FG015|Overall Study|Patient/guardian Decision|0|||
156712968|NCT03207867|565692879|FG016|Overall Study|Patient/guardian Decision|1|||
156712969|NCT03207867|565692880|FG017|Overall Study|Patient/guardian Decision|3|||
156712970|NCT03207867|565692881|FG018|Overall Study|Patient/guardian Decision|4|||
156712971|NCT03207867|565692882|FG019|Overall Study|Patient/guardian Decision|1|||
156712972|NCT03207867|565692883|FG020|Overall Study|Patient/guardian Decision|0|||
156712973|NCT03207867|565692884|FG021|Overall Study|Patient/guardian Decision|0|||
156712974|NCT03207867|565692885|FG022|Overall Study|Patient/guardian Decision|0|||
156442721|NCT02723955|564713414|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
156712975|NCT03207867|565692886|FG023|Overall Study|Patient/guardian Decision|0|||
156712976|NCT06419907|565694655|FG000|Overall Study|Protocol Violation|0|||
156712977|NCT06419907|565694656|FG001|Overall Study|Protocol Violation|3|||
156712978|NCT06419907|565694657|FG002|Overall Study|Protocol Violation|0|||
156712979|NCT06419907|565694658|FG003|Overall Study|Protocol Violation|1|||
156712980|NCT06419907|565694655|FG000|Overall Study|Lost to Follow-up|0|||
156712981|NCT06419907|565694656|FG001|Overall Study|Lost to Follow-up|0|||
156712982|NCT06419907|565694657|FG002|Overall Study|Lost to Follow-up|2|||
156712983|NCT06419907|565694658|FG003|Overall Study|Lost to Follow-up|1|||
156712984|NCT03130777|565694659|FG000|Overall Study|Death|0|||
156712985|NCT03130777|565694660|FG001|Overall Study|Death|1|||
156712986|NCT03130777|565694659|FG000|Overall Study|Did not meet eligibility criteria|1|||
156712987|NCT03130777|565694660|FG001|Overall Study|Did not meet eligibility criteria|0|||
156712988|NCT02586688|565694661|FG000|Overall Study|Lost to Follow-up|2|||
156712989|NCT02586688|565694662|FG001|Overall Study|Lost to Follow-up|1|||
156712990|NCT02586688|565694661|FG000|Overall Study|Withdrawal by Subject|1|||
156712991|NCT02586688|565694662|FG001|Overall Study|Withdrawal by Subject|1|||
156712992|NCT02586688|565694661|FG000|Overall Study|Adverse Event|3|||
156332987|NCT03181893|564317449|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156332988|NCT03181893|564317450|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156532231|NCT01658826|565043331|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
156532232|NCT01658826|565043332|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
156532233|NCT00866697|565043336|FG000|Overall Study|Study closed/terminated|156|||
156532234|NCT00866697|565043337|FG001|Overall Study|Study closed/terminated|138|||
156532235|NCT00866697|565043336|FG000|Overall Study|Lost to Follow-up|22|||
156532236|NCT00866697|565043337|FG001|Overall Study|Lost to Follow-up|28|||
156532237|NCT00866697|565043336|FG000|Overall Study|Physician Decision|3|||
156532238|NCT00866697|565043337|FG001|Overall Study|Physician Decision|5|||
156532239|NCT00866697|565043336|FG000|Overall Study|Withdrawal by Subject|33|||
156532240|NCT00866697|565043337|FG001|Overall Study|Withdrawal by Subject|57|||
156532241|NCT00447382|565043338|FG000|Overall Study|Adverse Event|1|||
156532242|NCT00447382|565043339|FG001|Overall Study|Adverse Event|1|||
156532243|NCT00447382|565043338|FG000|Overall Study|Lack of Efficacy|1|||
156532244|NCT00447382|565043339|FG001|Overall Study|Lack of Efficacy|0|||
156532245|NCT00447382|565043338|FG000|Overall Study|Protocol Violation|2|||
156532246|NCT00447382|565043339|FG001|Overall Study|Protocol Violation|0|||
156532247|NCT00447382|565043338|FG000|Overall Study|Unclassified|2|||
156532248|NCT00447382|565043339|FG001|Overall Study|Unclassified|5|||
156532249|NCT02408861|565043340|FG000|Overall Study|Death|0|||
156532250|NCT02408861|565043341|FG001|Overall Study|Death|3|||
156532251|NCT02408861|565043342|FG002|Overall Study|Death|1|||
156532252|NCT02408861|565043343|FG003|Overall Study|Death|2|||
156532253|NCT02408861|565043344|FG004|Overall Study|Death|4|||
156532254|NCT02408861|565043345|FG005|Overall Study|Death|1|||
156532255|NCT02408861|565043346|FG006|Overall Study|Death|0|||
156532256|NCT02408861|565043340|FG000|Overall Study|Lost to Follow-up|0|||
156873996|NCT04292899|566296181|FG002|Overall Study|Adverse Event|2|||
156873997|NCT04292899|566296182|FG003|Overall Study|Adverse Event|2|||
156532257|NCT02408861|565043341|FG001|Overall Study|Lost to Follow-up|0|||
156532258|NCT02408861|565043342|FG002|Overall Study|Lost to Follow-up|1|||
156532259|NCT02408861|565043343|FG003|Overall Study|Lost to Follow-up|1|||
156873998|NCT04292899|566296179|FG000|Overall Study|Investigator's Discretion|0|||
156873999|NCT04292899|566296180|FG001|Overall Study|Investigator's Discretion|0|||
156874000|NCT04292899|566296181|FG002|Overall Study|Investigator's Discretion|0|||
156874001|NCT04292899|566296182|FG003|Overall Study|Investigator's Discretion|3|||
156874002|NCT04292899|566296179|FG000|Overall Study|Non-compliance With Study Drug|0|||
156874003|NCT04292899|566296180|FG001|Overall Study|Non-compliance With Study Drug|0|||
156874004|NCT04292899|566296181|FG002|Overall Study|Non-compliance With Study Drug|0|||
156874005|NCT04292899|566296182|FG003|Overall Study|Non-compliance With Study Drug|1|||
156332989|NCT03181893|564317451|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156332990|NCT03181893|564317452|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156332991|NCT03181893|564317453|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156532260|NCT02408861|565043344|FG004|Overall Study|Lost to Follow-up|4|||
156532261|NCT02408861|565043345|FG005|Overall Study|Lost to Follow-up|2|||
156532262|NCT02408861|565043346|FG006|Overall Study|Lost to Follow-up|1|||
156712993|NCT02586688|565694662|FG001|Overall Study|Adverse Event|1|||
156712994|NCT04856917|565694663|FG000|Overall Study|Withdrawal by Subject|4|||
156712995|NCT04856917|565694664|FG001|Overall Study|Withdrawal by Subject|3|||
156712996|NCT04856917|565694665|FG002|Overall Study|Withdrawal by Subject|1|||
156712997|NCT04856917|565694663|FG000|Overall Study|Lost to Follow-up|3|||
156712998|NCT04856917|565694664|FG001|Overall Study|Lost to Follow-up|1|||
156712999|NCT04856917|565694665|FG002|Overall Study|Lost to Follow-up|1|||
156713000|NCT04856917|565694663|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
156713001|NCT04856917|565694664|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
156713002|NCT04856917|565694665|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
156713003|NCT04856917|565694663|FG000|Overall Study|Other|1|||
156713004|NCT04856917|565694664|FG001|Overall Study|Other|1|||
156713005|NCT04856917|565694665|FG002|Overall Study|Other|0|||
156713006|NCT00233948|565694666|FG000|Overall Study|Adverse Event|1|||
156713007|NCT00233948|565694667|FG001|Overall Study|Adverse Event|0|||
156713008|NCT00233948|565694668|FG002|Overall Study|Adverse Event|0|||
156713009|NCT00233948|565694669|FG003|Overall Study|Adverse Event|0|||
156532263|NCT02408861|565043340|FG000|Overall Study|Disease Progression|0|||
156532264|NCT02408861|565043341|FG001|Overall Study|Disease Progression|0|||
156532265|NCT02408861|565043342|FG002|Overall Study|Disease Progression|1|||
156532266|NCT02408861|565043343|FG003|Overall Study|Disease Progression|0|||
156532267|NCT02408861|565043344|FG004|Overall Study|Disease Progression|3|||
156532268|NCT02408861|565043345|FG005|Overall Study|Disease Progression|1|||
156713010|NCT00233948|565694670|FG004|Overall Study|Adverse Event|0|||
156713011|NCT00233948|565694671|FG005|Overall Study|Adverse Event|0|||
156713012|NCT01427608|565694672|FG000|Overall Study|Death|1|||
156874006|NCT04292899|566296179|FG000|Overall Study|Protocol Violation|0|||
156332992|NCT03181893|564317454|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156713013|NCT01427608|565694673|FG001|Overall Study|Death|0|||
156874007|NCT04292899|566296180|FG001|Overall Study|Protocol Violation|0|||
156442722|NCT02723955|564713415|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442723|NCT02723955|564713416|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442724|NCT02723955|564713417|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442725|NCT02723955|564713418|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442726|NCT02723955|564713419|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442727|NCT02723955|564713420|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442728|NCT02723955|564713421|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442729|NCT02723955|564713422|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442730|NCT02723955|564713423|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156460566|NCT04625725|564781646|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
156460567|NCT04625725|564781647|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
156460568|NCT04625725|564781648|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
156460569|NCT04625725|564781649|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
156460570|NCT04625725|564781650|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
156460571|NCT04625725|564781651|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
156460572|NCT04625725|564781646|FG000|Provent Main Study|MISSING REASON|0|||
156460573|NCT04625725|564781647|FG001|Provent Main Study|MISSING REASON|1|||
156460574|NCT04625725|564781648|FG002|Provent Main Study|MISSING REASON|0|||
156460575|NCT04625725|564781649|FG003|Provent Main Study|MISSING REASON|0|||
156460576|NCT04625725|564781650|FG004|Provent Main Study|MISSING REASON|0|||
156460577|NCT04625725|564781651|FG005|Provent Main Study|MISSING REASON|0|||
156460578|NCT04625725|564781646|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
156460579|NCT04625725|564781647|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
156460580|NCT04625725|564781648|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
156460581|NCT04625725|564781649|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
156460582|NCT04625725|564781650|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
156460583|NCT04625725|564781651|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
156460584|NCT04625725|564781646|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
156460585|NCT04625725|564781647|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
156460586|NCT04625725|564781648|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
156460587|NCT04625725|564781649|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
156460588|NCT04625725|564781650|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
156460589|NCT04625725|564781651|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
156460590|NCT04625725|564781646|FG000|Provent Sub Study|Lost to Follow-up|0|||
156460591|NCT04625725|564781647|FG001|Provent Sub Study|Lost to Follow-up|0|||
156460592|NCT04625725|564781648|FG002|Provent Sub Study|Lost to Follow-up|20|||
156460593|NCT04625725|564781649|FG003|Provent Sub Study|Lost to Follow-up|10|||
156460594|NCT04625725|564781650|FG004|Provent Sub Study|Lost to Follow-up|6|||
156460595|NCT04625725|564781651|FG005|Provent Sub Study|Lost to Follow-up|4|||
156460596|NCT04625725|564781646|FG000|Provent Sub Study|Death|0|||
156460597|NCT04625725|564781647|FG001|Provent Sub Study|Death|0|||
156460598|NCT04625725|564781648|FG002|Provent Sub Study|Death|8|||
156460599|NCT04625725|564781649|FG003|Provent Sub Study|Death|5|||
156460600|NCT04625725|564781650|FG004|Provent Sub Study|Death|0|||
156460601|NCT04625725|564781651|FG005|Provent Sub Study|Death|1|||
156460602|NCT04625725|564781646|FG000|Provent Sub Study|Adverse Event|0|||
156460603|NCT04625725|564781647|FG001|Provent Sub Study|Adverse Event|0|||
156460604|NCT04625725|564781648|FG002|Provent Sub Study|Adverse Event|0|||
156460605|NCT04625725|564781649|FG003|Provent Sub Study|Adverse Event|0|||
156460606|NCT04625725|564781650|FG004|Provent Sub Study|Adverse Event|0|||
156460607|NCT04625725|564781651|FG005|Provent Sub Study|Adverse Event|1|||
156460608|NCT04625725|564781646|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
156460609|NCT04625725|564781647|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
156460610|NCT04625725|564781648|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
156460611|NCT04625725|564781649|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
156460612|NCT04625725|564781650|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
156460613|NCT04625725|564781651|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
156460614|NCT04625725|564781646|FG000|Provent Sub Study|Withdrawal by Subject|0|||
156460615|NCT04625725|564781647|FG001|Provent Sub Study|Withdrawal by Subject|0|||
156460616|NCT04625725|564781648|FG002|Provent Sub Study|Withdrawal by Subject|11|||
156460617|NCT04625725|564781649|FG003|Provent Sub Study|Withdrawal by Subject|13|||
156460618|NCT04625725|564781650|FG004|Provent Sub Study|Withdrawal by Subject|5|||
156460619|NCT04625725|564781651|FG005|Provent Sub Study|Withdrawal by Subject|6|||
156442731|NCT02723955|564713424|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442732|NCT02723955|564713425|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442733|NCT02723955|564713426|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156442734|NCT02723955|564713384|FG000|Expansion Phase|Site Closed|0|||
156442735|NCT02723955|564713385|FG001|Expansion Phase|Site Closed|0|||
156442736|NCT02723955|564713386|FG002|Expansion Phase|Site Closed|0|||
156442737|NCT02723955|564713387|FG003|Expansion Phase|Site Closed|0|||
156442738|NCT02723955|564713388|FG004|Expansion Phase|Site Closed|0|||
156442739|NCT02723955|564713389|FG005|Expansion Phase|Site Closed|0|||
156442740|NCT02723955|564713390|FG006|Expansion Phase|Site Closed|0|||
156442741|NCT02723955|564713391|FG007|Expansion Phase|Site Closed|0|||
156442742|NCT02723955|564713392|FG008|Expansion Phase|Site Closed|0|||
156442743|NCT02723955|564713393|FG009|Expansion Phase|Site Closed|1|||
156442744|NCT02723955|564713394|FG010|Expansion Phase|Site Closed|2|||
156442745|NCT02723955|564713395|FG011|Expansion Phase|Site Closed|6|||
156442746|NCT02723955|564713396|FG012|Expansion Phase|Site Closed|0|||
156442747|NCT02723955|564713397|FG013|Expansion Phase|Site Closed|0|||
156442748|NCT02723955|564713398|FG014|Expansion Phase|Site Closed|0|||
156442749|NCT02723955|564713399|FG015|Expansion Phase|Site Closed|0|||
156442750|NCT02723955|564713400|FG016|Expansion Phase|Site Closed|0|||
156442751|NCT02723955|564713401|FG017|Expansion Phase|Site Closed|0|||
156442752|NCT02723955|564713402|FG018|Expansion Phase|Site Closed|0|||
156442753|NCT02723955|564713403|FG019|Expansion Phase|Site Closed|0|||
156442754|NCT02723955|564713404|FG020|Expansion Phase|Site Closed|0|||
156442755|NCT02723955|564713405|FG021|Expansion Phase|Site Closed|0|||
156442756|NCT02723955|564713406|FG022|Expansion Phase|Site Closed|0|||
156442757|NCT02723955|564713407|FG023|Expansion Phase|Site Closed|0|||
156442758|NCT02723955|564713408|FG024|Expansion Phase|Site Closed|0|||
156442759|NCT02723955|564713409|FG025|Expansion Phase|Site Closed|0|||
156442760|NCT02723955|564713410|FG026|Expansion Phase|Site Closed|0|||
156442761|NCT02723955|564713411|FG027|Expansion Phase|Site Closed|0|||
156442762|NCT02723955|564713412|FG028|Expansion Phase|Site Closed|0|||
156442763|NCT02723955|564713413|FG029|Expansion Phase|Site Closed|0|||
156442764|NCT02723955|564713414|FG030|Expansion Phase|Site Closed|8|||
156442765|NCT02723955|564713415|FG031|Expansion Phase|Site Closed|4|||
156442766|NCT02723955|564713416|FG032|Expansion Phase|Site Closed|2|||
156442767|NCT02723955|564713417|FG033|Expansion Phase|Site Closed|2|||
156442768|NCT02723955|564713418|FG034|Expansion Phase|Site Closed|0|||
156442769|NCT02723955|564713419|FG035|Expansion Phase|Site Closed|0|||
156442770|NCT02723955|564713420|FG036|Expansion Phase|Site Closed|0|||
156442771|NCT02723955|564713421|FG037|Expansion Phase|Site Closed|0|||
156442772|NCT02723955|564713422|FG038|Expansion Phase|Site Closed|0|||
156532269|NCT02408861|565043346|FG006|Overall Study|Disease Progression|1|||
156532270|NCT02408861|565043340|FG000|Overall Study|Adverse Event|1|||
156532271|NCT02408861|565043341|FG001|Overall Study|Adverse Event|0|||
156532272|NCT02408861|565043342|FG002|Overall Study|Adverse Event|1|||
156532273|NCT02408861|565043343|FG003|Overall Study|Adverse Event|0|||
156532274|NCT02408861|565043344|FG004|Overall Study|Adverse Event|2|||
156532275|NCT02408861|565043345|FG005|Overall Study|Adverse Event|0|||
156532276|NCT02408861|565043346|FG006|Overall Study|Adverse Event|0|||
156532277|NCT02408861|565043340|FG000|Overall Study|Physician Decision|1|||
156532278|NCT02408861|565043341|FG001|Overall Study|Physician Decision|1|||
156532279|NCT02408861|565043342|FG002|Overall Study|Physician Decision|1|||
156532280|NCT02408861|565043343|FG003|Overall Study|Physician Decision|0|||
156532281|NCT02408861|565043344|FG004|Overall Study|Physician Decision|0|||
156532282|NCT02408861|565043345|FG005|Overall Study|Physician Decision|1|||
156532283|NCT02408861|565043346|FG006|Overall Study|Physician Decision|0|||
156532284|NCT02408861|565043340|FG000|Overall Study|Protocol Violation|1|||
156532285|NCT02408861|565043341|FG001|Overall Study|Protocol Violation|0|||
156532286|NCT02408861|565043342|FG002|Overall Study|Protocol Violation|0|||
156532287|NCT02408861|565043343|FG003|Overall Study|Protocol Violation|0|||
156532288|NCT02408861|565043344|FG004|Overall Study|Protocol Violation|0|||
156532289|NCT02408861|565043345|FG005|Overall Study|Protocol Violation|0|||
156532290|NCT02408861|565043346|FG006|Overall Study|Protocol Violation|0|||
156442773|NCT02723955|564713423|FG039|Expansion Phase|Site Closed|0|||
156442774|NCT02723955|564713424|FG040|Expansion Phase|Site Closed|0|||
156442775|NCT02723955|564713425|FG041|Expansion Phase|Site Closed|0|||
156442776|NCT02723955|564713426|FG042|Expansion Phase|Site Closed|0|||
156442777|NCT02723955|564713384|FG000|Crossover/ Re-treatment Phase|Death|0|||
156442778|NCT02723955|564713385|FG001|Crossover/ Re-treatment Phase|Death|0|||
156442779|NCT02723955|564713386|FG002|Crossover/ Re-treatment Phase|Death|0|||
156442780|NCT02723955|564713387|FG003|Crossover/ Re-treatment Phase|Death|0|||
156532291|NCT02408861|565043340|FG000|Overall Study|Withdrawal by Subject|0|||
156532292|NCT02408861|565043341|FG001|Overall Study|Withdrawal by Subject|0|||
156532293|NCT02408861|565043342|FG002|Overall Study|Withdrawal by Subject|0|||
156532294|NCT02408861|565043343|FG003|Overall Study|Withdrawal by Subject|0|||
156532295|NCT02408861|565043344|FG004|Overall Study|Withdrawal by Subject|1|||
156532296|NCT02408861|565043345|FG005|Overall Study|Withdrawal by Subject|1|||
156532297|NCT02408861|565043346|FG006|Overall Study|Withdrawal by Subject|0|||
156532298|NCT02408861|565043340|FG000|Overall Study|Other Treatment|0|||
156532299|NCT02408861|565043341|FG001|Overall Study|Other Treatment|0|||
156713014|NCT01427608|565694672|FG000|Overall Study|Withdrawal by Subject|7|||
156713015|NCT01427608|565694673|FG001|Overall Study|Withdrawal by Subject|3|||
156713016|NCT01427608|565694672|FG000|Overall Study|Relapsed-all cause|13|||
156713017|NCT01427608|565694673|FG001|Overall Study|Relapsed-all cause|34|||
156713018|NCT01427608|565694672|FG000|Overall Study|Events not attributed to study meds|0|||
156713019|NCT01427608|565694673|FG001|Overall Study|Events not attributed to study meds|1|||
156713020|NCT01473407|565694674|FG000|Overall Study|Physician Decision|1|||
156713021|NCT01473407|565694675|FG001|Overall Study|Physician Decision|4|||
156713022|NCT01473407|565694674|FG000|Overall Study|Lost to Follow-up|10|||
156713023|NCT01473407|565694675|FG001|Overall Study|Lost to Follow-up|4|||
156713024|NCT01473407|565694674|FG000|Overall Study|Adverse Event|8|||
156713025|NCT01473407|565694675|FG001|Overall Study|Adverse Event|8|||
156713026|NCT01473407|565694674|FG000|Overall Study|Randomization Error|3|||
156713027|NCT01473407|565694675|FG001|Overall Study|Randomization Error|1|||
156713028|NCT01473407|565694674|FG000|Overall Study|Withdrawal by Subject|4|||
156713029|NCT01473407|565694675|FG001|Overall Study|Withdrawal by Subject|7|||
156713030|NCT01473407|565694674|FG000|Overall Study|Kidney Transplant|7|||
156713031|NCT01473407|565694675|FG001|Overall Study|Kidney Transplant|6|||
156713032|NCT01473407|565694674|FG000|Overall Study|Vacation/Travel|1|||
156713033|NCT01473407|565694675|FG001|Overall Study|Vacation/Travel|1|||
156713034|NCT01473407|565694674|FG000|Overall Study|Elevated Hemoglobin|1|||
156713035|NCT01473407|565694675|FG001|Overall Study|Elevated Hemoglobin|0|||
156713036|NCT01473407|565694674|FG000|Overall Study|Patient Received Aranesp|1|||
156713037|NCT01473407|565694675|FG001|Overall Study|Patient Received Aranesp|0|||
156713038|NCT01473407|565694674|FG000|Overall Study|Patient Lost Green Card Status|1|||
156713039|NCT01473407|565694675|FG001|Overall Study|Patient Lost Green Card Status|0|||
156713040|NCT01473407|565694674|FG000|Overall Study|Temperature Excursion|2|||
156713041|NCT01473407|565694675|FG001|Overall Study|Temperature Excursion|3|||
156713042|NCT01473407|565694674|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
156713043|NCT01473407|565694675|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
156713044|NCT01473407|565694674|FG000|Overall Study|Sponsor's Decision|10|||
156713045|NCT01473407|565694675|FG001|Overall Study|Sponsor's Decision|10|||
156713046|NCT01473407|565694674|FG000|Overall Study|Site Closure|1|||
156713047|NCT01473407|565694675|FG001|Overall Study|Site Closure|0|||
156713048|NCT04071405|565694676|FG000|Overall Study|Protocol Violation|3|||
156713049|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
156713050|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
156713051|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
156713052|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
156713053|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
156713054|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
156532300|NCT02408861|565043342|FG002|Overall Study|Other Treatment|0|||
156532301|NCT02408861|565043343|FG003|Overall Study|Other Treatment|0|||
156532302|NCT02408861|565043344|FG004|Overall Study|Other Treatment|0|||
156532303|NCT02408861|565043345|FG005|Overall Study|Other Treatment|1|||
156713055|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
156713056|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
156713057|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
156713058|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
156713059|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
156713060|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
156713061|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
156713062|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
156713063|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
156713064|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
156713065|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
156713066|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
156713067|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
156792465|NCT05259722|565992796|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
156713068|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
156792466|NCT05259722|565992797|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
156532304|NCT02408861|565043346|FG006|Overall Study|Other Treatment|1|||
156713069|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
156713070|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
156713071|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
156713072|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
156713073|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
156713074|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
156532305|NCT05028517|565043347|FG000|Overall Study|Lost to Follow-up|13|||
156532306|NCT05028517|565043348|FG001|Overall Study|Lost to Follow-up|20|||
156442781|NCT02723955|564713388|FG004|Crossover/ Re-treatment Phase|Death|0|||
156442782|NCT02723955|564713389|FG005|Crossover/ Re-treatment Phase|Death|0|||
156442783|NCT02723955|564713390|FG006|Crossover/ Re-treatment Phase|Death|0|||
156442784|NCT02723955|564713391|FG007|Crossover/ Re-treatment Phase|Death|0|||
156442785|NCT02723955|564713392|FG008|Crossover/ Re-treatment Phase|Death|0|||
156442786|NCT02723955|564713393|FG009|Crossover/ Re-treatment Phase|Death|0|||
156442787|NCT02723955|564713394|FG010|Crossover/ Re-treatment Phase|Death|0|||
156442788|NCT02723955|564713395|FG011|Crossover/ Re-treatment Phase|Death|0|||
156442789|NCT02723955|564713396|FG012|Crossover/ Re-treatment Phase|Death|0|||
156442790|NCT02723955|564713397|FG013|Crossover/ Re-treatment Phase|Death|0|||
156442791|NCT02723955|564713398|FG014|Crossover/ Re-treatment Phase|Death|0|||
156442792|NCT02723955|564713399|FG015|Crossover/ Re-treatment Phase|Death|0|||
156442793|NCT02723955|564713400|FG016|Crossover/ Re-treatment Phase|Death|0|||
156442794|NCT02723955|564713401|FG017|Crossover/ Re-treatment Phase|Death|0|||
156442795|NCT02723955|564713402|FG018|Crossover/ Re-treatment Phase|Death|0|||
156442796|NCT02723955|564713403|FG019|Crossover/ Re-treatment Phase|Death|0|||
156442797|NCT02723955|564713404|FG020|Crossover/ Re-treatment Phase|Death|0|||
156442798|NCT02723955|564713405|FG021|Crossover/ Re-treatment Phase|Death|0|||
156442799|NCT02723955|564713406|FG022|Crossover/ Re-treatment Phase|Death|0|||
156442800|NCT02723955|564713407|FG023|Crossover/ Re-treatment Phase|Death|0|||
156442801|NCT02723955|564713408|FG024|Crossover/ Re-treatment Phase|Death|0|||
156442802|NCT02723955|564713409|FG025|Crossover/ Re-treatment Phase|Death|0|||
156442803|NCT02723955|564713410|FG026|Crossover/ Re-treatment Phase|Death|0|||
156442804|NCT02723955|564713411|FG027|Crossover/ Re-treatment Phase|Death|0|||
156442805|NCT02723955|564713412|FG028|Crossover/ Re-treatment Phase|Death|0|||
156442806|NCT02723955|564713413|FG029|Crossover/ Re-treatment Phase|Death|0|||
156442807|NCT02723955|564713414|FG030|Crossover/ Re-treatment Phase|Death|0|||
156442808|NCT02723955|564713415|FG031|Crossover/ Re-treatment Phase|Death|0|||
156442809|NCT02723955|564713416|FG032|Crossover/ Re-treatment Phase|Death|0|||
156442810|NCT02723955|564713417|FG033|Crossover/ Re-treatment Phase|Death|0|||
156442811|NCT02723955|564713418|FG034|Crossover/ Re-treatment Phase|Death|0|||
156442812|NCT02723955|564713419|FG035|Crossover/ Re-treatment Phase|Death|0|||
156442813|NCT02723955|564713420|FG036|Crossover/ Re-treatment Phase|Death|0|||
156792467|NCT00962650|565992798|FG000|Overall Study|Transgastric DP was not completed|2|||
156792468|NCT00420056|565992799|FG000|Overall Study|Objective progression or relapse|17|||
156792469|NCT00127933|565992805|FG000|Overall Study|Randomized but not dosed|1|||
156792470|NCT00127933|565992806|FG001|Overall Study|Randomized but not dosed|0|||
156792471|NCT03072875|565992811|FG000|Overall Study|Lost to Follow-up|1|||
156792472|NCT03111732|565992812|FG000|Overall Study|Enrolled in different study|1|||
156792473|NCT03111732|565992812|FG000|Overall Study|Progressive disease|3|||
156792474|NCT03111732|565992812|FG000|Overall Study|Withdrawal by Subject|1|||
156792475|NCT00401830|565992813|FG000|Overall Study|Adverse Event|10|||
156792476|NCT00401830|565992814|FG001|Overall Study|Adverse Event|18|||
156792477|NCT00401830|565992813|FG000|Overall Study|Lack of Efficacy|11|||
156792478|NCT00401830|565992814|FG001|Overall Study|Lack of Efficacy|5|||
156792479|NCT00401830|565992813|FG000|Overall Study|Withdrawal by Subject|4|||
156792480|NCT00401830|565992814|FG001|Overall Study|Withdrawal by Subject|3|||
156792481|NCT00401830|565992813|FG000|Overall Study|Protocol Violation|3|||
156792482|NCT00401830|565992814|FG001|Overall Study|Protocol Violation|3|||
156792483|NCT00401830|565992813|FG000|Overall Study|Non-compliance with drug study|1|||
156792484|NCT00401830|565992814|FG001|Overall Study|Non-compliance with drug study|0|||
156792485|NCT00401830|565992813|FG000|Overall Study|Lost to Follow-up|1|||
156792486|NCT00401830|565992814|FG001|Overall Study|Lost to Follow-up|3|||
156792487|NCT00401830|565992813|FG000|Overall Study|Other: Personal / Family problems|1|||
156792488|NCT00401830|565992814|FG001|Overall Study|Other: Personal / Family problems|0|||
156792489|NCT01943825|565992815|FG000|Overall Study|Lost to Follow-up|9|||
156792490|NCT01943825|565992816|FG001|Overall Study|Lost to Follow-up|3|||
156792491|NCT01943825|565992817|FG002|Overall Study|Lost to Follow-up|12|||
156874008|NCT04292899|566296181|FG002|Overall Study|Protocol Violation|0|||
156442814|NCT02723955|564713421|FG037|Crossover/ Re-treatment Phase|Death|1|||
156792492|NCT01943825|565992818|FG003|Overall Study|Lost to Follow-up|8|||
156442815|NCT02723955|564713422|FG038|Crossover/ Re-treatment Phase|Death|14|||
156442816|NCT02723955|564713423|FG039|Crossover/ Re-treatment Phase|Death|32|||
156442817|NCT02723955|564713424|FG040|Crossover/ Re-treatment Phase|Death|2|||
156442818|NCT02723955|564713425|FG041|Crossover/ Re-treatment Phase|Death|1|||
156442819|NCT02723955|564713426|FG042|Crossover/ Re-treatment Phase|Death|0|||
156442820|NCT02723955|564713384|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442821|NCT02723955|564713385|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442822|NCT02723955|564713386|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156792493|NCT01943825|565992815|FG000|Overall Study|Withdrawal by Subject|1|||
156792494|NCT01943825|565992816|FG001|Overall Study|Withdrawal by Subject|0|||
156792495|NCT01943825|565992817|FG002|Overall Study|Withdrawal by Subject|3|||
156792496|NCT01943825|565992818|FG003|Overall Study|Withdrawal by Subject|2|||
156792497|NCT01943825|565992815|FG000|Overall Study|Other than specified above|0|||
156792498|NCT01943825|565992816|FG001|Overall Study|Other than specified above|1|||
156792499|NCT01943825|565992817|FG002|Overall Study|Other than specified above|0|||
156332993|NCT03181893|564317455|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156332994|NCT03181893|564317456|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156332995|NCT03181893|564317457|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156332996|NCT03181893|564317458|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
156332997|NCT03181893|564317459|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156332998|NCT03181893|564317449|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156332999|NCT03181893|564317450|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333000|NCT03181893|564317451|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333001|NCT03181893|564317452|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333002|NCT03181893|564317453|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333003|NCT03181893|564317454|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333004|NCT03181893|564317455|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333005|NCT03181893|564317456|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333006|NCT03181893|564317457|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333007|NCT03181893|564317458|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156333008|NCT03181893|564317459|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
156333009|NCT04815031|564317460|FG000|Overall Study|No adverse event information (missing information)|33|||
156333010|NCT01361568|564317463|FG000|Overall Study|Adverse Event|0|||
156333011|NCT01361568|564317464|FG001|Overall Study|Adverse Event|0|||
156333012|NCT01361568|564317465|FG002|Overall Study|Adverse Event|0|||
156333013|NCT01361568|564317466|FG003|Overall Study|Adverse Event|0|||
156333014|NCT01361568|564317467|FG004|Overall Study|Adverse Event|1|||
156333015|NCT01361568|564317468|FG005|Overall Study|Adverse Event|0|||
156333016|NCT01361568|564317463|FG000|Overall Study|Physician Decision|0|||
156333017|NCT01361568|564317464|FG001|Overall Study|Physician Decision|0|||
156333018|NCT01361568|564317465|FG002|Overall Study|Physician Decision|0|||
156333019|NCT01361568|564317466|FG003|Overall Study|Physician Decision|0|||
156333020|NCT01361568|564317467|FG004|Overall Study|Physician Decision|0|||
156333021|NCT01361568|564317468|FG005|Overall Study|Physician Decision|1|||
156333022|NCT01361568|564317463|FG000|Overall Study|Withdrawal by Subject|2|||
156333023|NCT01361568|564317464|FG001|Overall Study|Withdrawal by Subject|1|||
156333024|NCT01361568|564317465|FG002|Overall Study|Withdrawal by Subject|0|||
156333025|NCT01361568|564317466|FG003|Overall Study|Withdrawal by Subject|0|||
156333026|NCT01361568|564317467|FG004|Overall Study|Withdrawal by Subject|0|||
156333027|NCT01361568|564317468|FG005|Overall Study|Withdrawal by Subject|1|||
156442823|NCT02723955|564713387|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442824|NCT02723955|564713388|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156333028|NCT02728596|564317469|FG000|Overall Study|Refusal unrelated to adverse event|3|||
156333029|NCT02728596|564317470|FG001|Overall Study|Refusal unrelated to adverse event|6|||
156333030|NCT02728596|564317471|FG002|Overall Study|Refusal unrelated to adverse event|7|||
156713075|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
156713076|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
156713077|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
156713078|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
156713079|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
156713080|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
156713081|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
156713082|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
156713083|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
156713084|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
156713085|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
156713086|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
156713087|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
156713088|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
156333031|NCT02728596|564317472|FG003|Overall Study|Refusal unrelated to adverse event|7|||
156333032|NCT02728596|564317469|FG000|Overall Study|Death|44|||
156442825|NCT02723955|564713389|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442826|NCT02723955|564713390|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442827|NCT02723955|564713391|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442828|NCT02723955|564713392|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442829|NCT02723955|564713393|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442830|NCT02723955|564713394|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156333033|NCT02728596|564317470|FG001|Overall Study|Death|42|||
156333034|NCT02728596|564317471|FG002|Overall Study|Death|123|||
156333035|NCT02728596|564317472|FG003|Overall Study|Death|68|||
156333036|NCT03439657|564317473|FG000|Overall Study|Adverse Event|2|||
156333037|NCT03439657|564317474|FG001|Overall Study|Adverse Event|3|||
156333038|NCT03439657|564317473|FG000|Overall Study|Lost to Follow-up|1|||
156442831|NCT02723955|564713395|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442832|NCT02723955|564713396|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156713089|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
156713090|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
156713091|NCT01027702|565694683|FG000|Overall Study|Received subsequent therapy|1|||
156713092|NCT01027702|565694684|FG001|Overall Study|Received subsequent therapy|2|||
156713093|NCT01027702|565694685|FG002|Overall Study|Received subsequent therapy|0|||
156713094|NCT01027702|565694686|FG003|Overall Study|Received subsequent therapy|4|||
156713095|NCT01027702|565694687|FG004|Overall Study|Received subsequent therapy|1|||
156713096|NCT01027702|565694688|FG005|Overall Study|Received subsequent therapy|0|||
156713097|NCT01027702|565694689|FG006|Overall Study|Received subsequent therapy|1|||
156713098|NCT01027702|565694683|FG000|Overall Study|Death|0|||
156713099|NCT01027702|565694684|FG001|Overall Study|Death|0|||
156713100|NCT01027702|565694685|FG002|Overall Study|Death|1|||
156713101|NCT01027702|565694686|FG003|Overall Study|Death|0|||
156713102|NCT01027702|565694687|FG004|Overall Study|Death|0|||
156713103|NCT01027702|565694688|FG005|Overall Study|Death|0|||
156713104|NCT01027702|565694689|FG006|Overall Study|Death|0|||
156713105|NCT02862730|565694690|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713106|NCT02862730|565694691|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713107|NCT02862730|565694692|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
156713108|NCT02862730|565694693|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713109|NCT02862730|565694694|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713110|NCT02862730|565694695|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713111|NCT02862730|565694696|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713112|NCT02862730|565694690|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
156713113|NCT02862730|565694691|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713114|NCT02862730|565694692|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713115|NCT02862730|565694693|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713116|NCT02862730|565694694|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713117|NCT02862730|565694695|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713118|NCT02862730|565694696|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713119|NCT02862730|565694690|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156713120|NCT02862730|565694691|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156442833|NCT02723955|564713397|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442834|NCT02723955|564713398|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442835|NCT02723955|564713399|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156713121|NCT02862730|565694692|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
156713122|NCT02862730|565694693|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156713123|NCT02862730|565694694|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
156713124|NCT02862730|565694695|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156713125|NCT02862730|565694696|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156713126|NCT02862730|565694690|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713127|NCT02862730|565694691|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713128|NCT02862730|565694692|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713129|NCT02862730|565694693|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
156713130|NCT02862730|565694694|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713131|NCT02862730|565694695|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713132|NCT02862730|565694696|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713133|NCT02276807|565694697|FG000|Overall Study|Withdrawal by Subject|8|||
156713134|NCT02276807|565694698|FG001|Overall Study|Withdrawal by Subject|7|||
156713135|NCT02276807|565694697|FG000|Overall Study|Lost to Follow-up|10|||
156713136|NCT02276807|565694698|FG001|Overall Study|Lost to Follow-up|10|||
156713137|NCT00261950|565694699|FG000|Overall Study|Lost to Follow-up|2|||
156713138|NCT00261950|565694699|FG000|Overall Study|Death|6|||
156713139|NCT00261950|565694699|FG000|Overall Study|Withdrawal by Subject|5|||
156713140|NCT00261950|565694699|FG000|Overall Study|Other|1|||
156713141|NCT00261950|565694699|FG000|Overall Study|Physician Decision|1|||
156713142|NCT00261950|565694699|FG000|Overall Study|Protocol specified Criteria|11|||
156713143|NCT00445432|565694702|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
156713144|NCT00445432|565694703|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
156713145|NCT00445432|565694704|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
156713146|NCT00445432|565694705|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
156713147|NCT00445432|565694702|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
156713148|NCT00445432|565694703|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
156713149|NCT00445432|565694704|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
156713150|NCT00445432|565694705|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
156713151|NCT00445432|565694702|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
156713152|NCT00445432|565694703|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
156713153|NCT00445432|565694704|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
156713154|NCT00445432|565694705|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
156713155|NCT00445432|565694702|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
156713156|NCT00445432|565694703|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
156713157|NCT00445432|565694704|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
156713158|NCT00445432|565694705|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
156713159|NCT00445432|565694702|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
156713160|NCT00445432|565694703|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
156713161|NCT00445432|565694704|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
156442836|NCT02723955|564713400|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442837|NCT02723955|564713401|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442838|NCT02723955|564713402|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442839|NCT02723955|564713403|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442840|NCT02723955|564713404|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442841|NCT02723955|564713405|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442842|NCT02723955|564713406|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442843|NCT02723955|564713407|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442844|NCT02723955|564713408|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442845|NCT02723955|564713409|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442846|NCT02723955|564713410|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442847|NCT02723955|564713411|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442848|NCT02723955|564713412|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442849|NCT02723955|564713413|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442850|NCT02723955|564713414|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442851|NCT02723955|564713415|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442852|NCT02723955|564713416|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442853|NCT02723955|564713417|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442854|NCT02723955|564713418|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442855|NCT02723955|564713419|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442856|NCT02723955|564713420|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442857|NCT02723955|564713421|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442858|NCT02723955|564713422|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442859|NCT02723955|564713423|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
156442860|NCT02723955|564713424|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442861|NCT02723955|564713425|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442862|NCT02723955|564713426|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156442863|NCT02723955|564713384|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442864|NCT02723955|564713385|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442865|NCT02723955|564713386|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442866|NCT02723955|564713387|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442867|NCT02723955|564713388|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442868|NCT02723955|564713389|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442869|NCT02723955|564713390|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442870|NCT02723955|564713391|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442871|NCT02723955|564713392|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442872|NCT02723955|564713393|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442873|NCT02723955|564713394|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442874|NCT02723955|564713395|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442875|NCT02723955|564713396|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442876|NCT02723955|564713397|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
156713162|NCT00445432|565694705|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
156713163|NCT00445432|565694702|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
156713164|NCT00445432|565694703|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
156713165|NCT00445432|565694704|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
156792500|NCT01943825|565992818|FG003|Overall Study|Other than specified above|1|||
156792501|NCT01472835|565992819|FG000|Overall Study|Lost to Follow-up|2|||
156792502|NCT01472835|565992820|FG001|Overall Study|Lost to Follow-up|0|||
156792503|NCT03425188|565992822|FG000|Overall Study|Withdrawal by Subject|1|||
156792504|NCT01044459|565992823|FG000|Overall Study|Withdrawal by Subject|21|||
156792505|NCT01044459|565992824|FG001|Overall Study|Withdrawal by Subject|28|||
156792506|NCT01044459|565992823|FG000|Overall Study|Terminated by Sponsor|22|||
156792507|NCT01044459|565992824|FG001|Overall Study|Terminated by Sponsor|21|||
156442877|NCT02723955|564713398|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442878|NCT02723955|564713399|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442879|NCT02723955|564713400|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442880|NCT02723955|564713401|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442881|NCT02723955|564713402|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442882|NCT02723955|564713403|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
156713166|NCT00445432|565694705|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
156713167|NCT00445432|565694702|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
156792508|NCT01044459|565992823|FG000|Overall Study|Adverse Event|22|||
156442883|NCT02723955|564713404|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
156792509|NCT01044459|565992824|FG001|Overall Study|Adverse Event|20|||
156442884|NCT02723955|564713405|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442885|NCT02723955|564713406|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442886|NCT02723955|564713407|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442887|NCT02723955|564713408|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442888|NCT02723955|564713409|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
156713168|NCT00445432|565694703|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
156713169|NCT00445432|565694704|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
156713170|NCT00445432|565694705|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
156713171|NCT02789137|565694706|FG000|Overall Study|Dropped out/Died|58|||
156713172|NCT01090414|565694707|FG000|Study 101-99|Progressive Disease|28|||
156713173|NCT01090414|565694708|FG001|Study 101-99|Progressive Disease|48|||
156713174|NCT01090414|565694709|FG002|Study 101-99|Progressive Disease|10|||
156713175|NCT01090414|565694710|FG003|Study 101-99|Progressive Disease|4|||
156713176|NCT01090414|565694707|FG000|Study 101-99|Adverse Event|10|||
156713177|NCT01090414|565694708|FG001|Study 101-99|Adverse Event|28|||
156713178|NCT01090414|565694709|FG002|Study 101-99|Adverse Event|18|||
156713179|NCT01090414|565694710|FG003|Study 101-99|Adverse Event|0|||
156713180|NCT01090414|565694707|FG000|Study 101-99|Investigator Request|1|||
156713181|NCT01090414|565694708|FG001|Study 101-99|Investigator Request|11|||
156713182|NCT01090414|565694709|FG002|Study 101-99|Investigator Request|4|||
156713183|NCT01090414|565694710|FG003|Study 101-99|Investigator Request|0|||
156713184|NCT01090414|565694707|FG000|Study 101-99|Death|3|||
156713185|NCT01090414|565694708|FG001|Study 101-99|Death|8|||
156713186|NCT01090414|565694709|FG002|Study 101-99|Death|1|||
156713187|NCT01090414|565694710|FG003|Study 101-99|Death|0|||
156713188|NCT01090414|565694707|FG000|Study 101-99|Sponsor Discontinued Study|0|||
156713189|NCT01090414|565694708|FG001|Study 101-99|Sponsor Discontinued Study|7|||
156713190|NCT01090414|565694709|FG002|Study 101-99|Sponsor Discontinued Study|5|||
156713191|NCT01090414|565694710|FG003|Study 101-99|Sponsor Discontinued Study|0|||
156713192|NCT01090414|565694707|FG000|Study 101-99|Other (Unknown Reasons)|3|||
156713193|NCT01090414|565694708|FG001|Study 101-99|Other (Unknown Reasons)|3|||
156713194|NCT01090414|565694709|FG002|Study 101-99|Other (Unknown Reasons)|0|||
156713195|NCT01090414|565694710|FG003|Study 101-99|Other (Unknown Reasons)|0|||
156713196|NCT01090414|565694707|FG000|Study 101-99|Withdrew Consent|0|||
156713197|NCT01090414|565694708|FG001|Study 101-99|Withdrew Consent|2|||
156713198|NCT01090414|565694709|FG002|Study 101-99|Withdrew Consent|3|||
156713199|NCT01090414|565694710|FG003|Study 101-99|Withdrew Consent|1|||
156713200|NCT01090414|565694707|FG000|Study 101-99|Participant Request|3|||
156713201|NCT01090414|565694708|FG001|Study 101-99|Participant Request|1|||
156713202|NCT01090414|565694709|FG002|Study 101-99|Participant Request|0|||
156713203|NCT01090414|565694710|FG003|Study 101-99|Participant Request|0|||
156713204|NCT04138823|565694729|FG000|Overall Study|Clinical disease progression|0|||
156713205|NCT04138823|565694730|FG001|Overall Study|Clinical disease progression|0|||
156713206|NCT04138823|565694731|FG002|Overall Study|Clinical disease progression|1|||
156713207|NCT04138823|565694729|FG000|Overall Study|Objective disease progression|3|||
156713208|NCT04138823|565694730|FG001|Overall Study|Objective disease progression|2|||
156713209|NCT04138823|565694731|FG002|Overall Study|Objective disease progression|5|||
156713210|NCT02466685|565694733|FG000|Overall Study|Adverse Event|5|||
156713211|NCT02466685|565694734|FG001|Overall Study|Adverse Event|2|||
156713212|NCT02466685|565694733|FG000|Overall Study|Lost to Follow-up|1|||
156713213|NCT02466685|565694734|FG001|Overall Study|Lost to Follow-up|1|||
156713214|NCT02466685|565694733|FG000|Overall Study|Withdrawal by Subject|1|||
156713215|NCT02466685|565694734|FG001|Overall Study|Withdrawal by Subject|0|||
156713216|NCT02466685|565694733|FG000|Overall Study|Physician Decision|1|||
156713217|NCT02466685|565694734|FG001|Overall Study|Physician Decision|1|||
156713218|NCT02565511|565694735|FG000|Overall Study|Study terminated by Sponsor|35|||
156713219|NCT02565511|565694736|FG001|Overall Study|Study terminated by Sponsor|22|||
156442889|NCT02723955|564713410|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442890|NCT02723955|564713411|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
156713220|NCT02565511|565694737|FG002|Overall Study|Study terminated by Sponsor|235|||
156713221|NCT02565511|565694738|FG003|Overall Study|Study terminated by Sponsor|156|||
156713222|NCT02565511|565694735|FG000|Overall Study|Withdrawal by Subject|3|||
156713223|NCT02565511|565694736|FG001|Overall Study|Withdrawal by Subject|0|||
156713224|NCT02565511|565694737|FG002|Overall Study|Withdrawal by Subject|12|||
156713225|NCT02565511|565694738|FG003|Overall Study|Withdrawal by Subject|5|||
156713226|NCT02565511|565694735|FG000|Overall Study|Adverse Event|0|||
156713227|NCT02565511|565694736|FG001|Overall Study|Adverse Event|0|||
156713228|NCT02565511|565694737|FG002|Overall Study|Adverse Event|1|||
156713229|NCT02565511|565694738|FG003|Overall Study|Adverse Event|1|||
156713230|NCT02565511|565694735|FG000|Overall Study|Lost to Follow-up|4|||
156713231|NCT02565511|565694736|FG001|Overall Study|Lost to Follow-up|1|||
156713232|NCT02565511|565694737|FG002|Overall Study|Lost to Follow-up|0|||
156442891|NCT02723955|564713412|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442892|NCT02723955|564713413|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442893|NCT02723955|564713414|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442894|NCT02723955|564713415|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442895|NCT02723955|564713416|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442896|NCT02723955|564713417|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442897|NCT02723955|564713418|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442898|NCT02723955|564713419|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442899|NCT02723955|564713420|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442900|NCT02723955|564713421|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442901|NCT02723955|564713422|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
156442902|NCT02723955|564713423|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
156442903|NCT02723955|564713424|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442904|NCT02723955|564713425|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
156442905|NCT02723955|564713426|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
156442906|NCT02723955|564713384|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
156442907|NCT02723955|564713385|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
156532307|NCT05028517|565043349|FG002|Overall Study|Lost to Follow-up|12|||
156713233|NCT02565511|565694738|FG003|Overall Study|Lost to Follow-up|1|||
156713234|NCT02565511|565694735|FG000|Overall Study|Physician Decision|0|||
156713235|NCT02565511|565694736|FG001|Overall Study|Physician Decision|0|||
156713236|NCT02565511|565694737|FG002|Overall Study|Physician Decision|0|||
156713237|NCT02565511|565694738|FG003|Overall Study|Physician Decision|1|||
156713238|NCT02565511|565694735|FG000|Overall Study|Protocol deviation|0|||
156713239|NCT02565511|565694736|FG001|Overall Study|Protocol deviation|0|||
156713240|NCT02565511|565694737|FG002|Overall Study|Protocol deviation|3|||
156713241|NCT02565511|565694738|FG003|Overall Study|Protocol deviation|0|||
156713242|NCT00104572|565694739|FG000|Overall Study|Withdrawal by Subject|3|||
156713243|NCT00104572|565694740|FG001|Overall Study|Withdrawal by Subject|3|||
156713244|NCT00104572|565694741|FG002|Overall Study|Withdrawal by Subject|0|||
156713245|NCT02969044|565694743|FG000|Overall Study|Withdrawal by Subject|2|||
156713246|NCT02969044|565694744|FG001|Overall Study|Withdrawal by Subject|6|||
156713247|NCT02969044|565694743|FG000|Overall Study|Adverse Event|3|||
156713248|NCT02969044|565694744|FG001|Overall Study|Adverse Event|0|||
156713249|NCT04650204|565694745|FG000|Overall Study|Study was Terminated|2|||
156713250|NCT04650204|565694746|FG001|Overall Study|Study was Terminated|1|||
156713251|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
156713252|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Off-label use|283|||
156713253|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
156713254|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
156713255|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
156713256|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
156713257|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
156713258|NCT01070953|565694755|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
156713259|NCT01070953|565694755|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
156713260|NCT01070953|565694755|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
156713261|NCT04700137|565694756|FG000|Overall Study|Lost to Follow-up|1|||
156713262|NCT04700137|565694757|FG001|Overall Study|Lost to Follow-up|6|||
156713263|NCT04700137|565694758|FG002|Overall Study|Lost to Follow-up|1|||
156792510|NCT01044459|565992823|FG000|Overall Study|Lack of Efficacy|23|||
156792511|NCT01044459|565992824|FG001|Overall Study|Lack of Efficacy|12|||
156792512|NCT01044459|565992823|FG000|Overall Study|Protocol Violation|11|||
156792513|NCT01044459|565992824|FG001|Overall Study|Protocol Violation|16|||
156792514|NCT01044459|565992823|FG000|Overall Study|Other Reason|7|||
156792515|NCT01044459|565992824|FG001|Overall Study|Other Reason|14|||
156792516|NCT01044459|565992823|FG000|Overall Study|COPD exacerbation|9|||
156792517|NCT01044459|565992824|FG001|Overall Study|COPD exacerbation|8|||
156792518|NCT01044459|565992823|FG000|Overall Study|Lost to Follow-up|18|||
156792519|NCT01044459|565992824|FG001|Overall Study|Lost to Follow-up|12|||
156792520|NCT05346640|565992825|FG000|Overall Study|Lack of Efficacy|2|||
156792521|NCT05346640|565992825|FG000|Overall Study|Lost to Follow-up|14|||
156792522|NCT05346640|565992825|FG000|Overall Study|Protocol Violation|4|||
156792523|NCT05346640|565992825|FG000|Overall Study|Withdrawal by Subject|2|||
156792524|NCT05346640|565992825|FG000|Overall Study|Physiological Complications|3|||
156792525|NCT05346640|565992825|FG000|Overall Study|Other Reason|3|||
156792526|NCT04634331|565992826|FG000|Overall Study|Withdrawal by Subject|2|||
156792527|NCT04634331|565992827|FG001|Overall Study|Withdrawal by Subject|2|||
156792528|NCT03726879|565992828|FG000|Overall Study|Death|11|||
156874009|NCT04292899|566296182|FG003|Overall Study|Protocol Violation|1|||
156874010|NCT00948441|566296183|FG000|Overall Study|no longer meet inclusion criteria|1|||
156792529|NCT03726879|565992829|FG001|Overall Study|Death|13|||
156792530|NCT03726879|565992828|FG000|Overall Study|Physician Decision|0|||
156333039|NCT03439657|564317474|FG001|Overall Study|Lost to Follow-up|0|||
156333040|NCT03439657|564317473|FG000|Overall Study|Protocol Violation|1|||
156333041|NCT03439657|564317474|FG001|Overall Study|Protocol Violation|1|||
156333042|NCT03439657|564317473|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
156333043|NCT03439657|564317474|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
156333044|NCT00289016|564317476|FG000|Overall Study|Disease Progression|29|||
156333045|NCT00289016|564317476|FG000|Overall Study|Death|2|||
156713264|NCT04700137|565694759|FG003|Overall Study|Lost to Follow-up|1|||
156874011|NCT00948441|566296184|FG001|Overall Study|no longer meet inclusion criteria|4|||
156874012|NCT00396253|566296185|FG000|Overall Study|Protocol Violation|1|||
156713265|NCT04700137|565694756|FG000|Overall Study|Withdrawal by Subject|0|||
156713266|NCT04700137|565694757|FG001|Overall Study|Withdrawal by Subject|0|||
156713267|NCT04700137|565694758|FG002|Overall Study|Withdrawal by Subject|1|||
156713268|NCT04700137|565694759|FG003|Overall Study|Withdrawal by Subject|0|||
156713269|NCT04700137|565694756|FG000|Overall Study|Death|0|||
156713270|NCT04700137|565694757|FG001|Overall Study|Death|0|||
156713271|NCT04700137|565694758|FG002|Overall Study|Death|1|||
156713272|NCT04700137|565694759|FG003|Overall Study|Death|0|||
156713273|NCT02503787|565694760|FG000|Enrollment|Withdrawal by Subject|6|||
156713274|NCT02503787|565694760|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
156713275|NCT02503787|565694760|FG000|Enrollment|Physician Decision|2|||
156713276|NCT02503787|565694760|FG000|Enrollment|Insurance issue|2|||
156713277|NCT02503787|565694760|FG000|Enrollment|Lost to Follow-up|1|||
156713278|NCT02503787|565694760|FG000|Enrollment|Study closure|1|||
156713279|NCT02503787|565694760|FG000|Enrollment|Adverse Event|1|||
156713280|NCT02503787|565694760|FG000|Enrollment|Protocol Violation|1|||
156713281|NCT02503787|565694760|FG000|Enrollment|Inability to implant system|1|||
156713282|NCT02503787|565694760|FG000|Enrollment|Unable to be programmed|1|||
156713283|NCT02503787|565694760|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
156713284|NCT02503787|565694760|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
156713285|NCT02503787|565694760|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
156713286|NCT02503787|565694760|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
156713287|NCT02503787|565694760|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
156713288|NCT02503787|565694760|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
156713289|NCT04787627|565694761|FG000|Overall Study|Withdrawal by Subject|3|||
156713290|NCT04787627|565694762|FG001|Overall Study|Withdrawal by Subject|0|||
156713291|NCT04787627|565694761|FG000|Overall Study|Physician Decision|2|||
156713292|NCT04787627|565694762|FG001|Overall Study|Physician Decision|0|||
156713293|NCT04787627|565694761|FG000|Overall Study|Excluded|0|||
156713294|NCT04787627|565694762|FG001|Overall Study|Excluded|1|||
156713295|NCT00548093|565694763|FG000|Overall Study|Death|33|||
156713296|NCT00548093|565694764|FG001|Overall Study|Death|13|||
156713297|NCT00548093|565694763|FG000|Overall Study|Lost to Follow-up|3|||
156713298|NCT00548093|565694764|FG001|Overall Study|Lost to Follow-up|1|||
156713299|NCT00548093|565694763|FG000|Overall Study|Objective progression or relapse|1|||
156713300|NCT00548093|565694764|FG001|Overall Study|Objective progression or relapse|1|||
156713301|NCT00548093|565694763|FG000|Overall Study|Other|11|||
156713302|NCT00548093|565694764|FG001|Overall Study|Other|1|||
156713303|NCT00548093|565694763|FG000|Overall Study|Withdrawal by Subject|1|||
156713304|NCT00548093|565694764|FG001|Overall Study|Withdrawal by Subject|0|||
156713305|NCT00548093|565694763|FG000|Overall Study|Completed post-treatment follow-up|1|||
156713306|NCT00548093|565694764|FG001|Overall Study|Completed post-treatment follow-up|0|||
156713307|NCT00174954|565694767|FG000|Overall Study|Adverse Event|2|||
156713308|NCT00174954|565694767|FG000|Overall Study|No tophi found in MRI|1|||
156713309|NCT00174954|565694767|FG000|Overall Study|Physician Decision|1|||
156713310|NCT00839254|565694768|FG000|Overall Study|Protocol Violation|0|||
156713311|NCT00839254|565694769|FG001|Overall Study|Protocol Violation|1|||
156713312|NCT00839254|565694770|FG002|Overall Study|Protocol Violation|1|||
156713313|NCT00839254|565694771|FG003|Overall Study|Protocol Violation|1|||
156713314|NCT00839254|565694772|FG004|Overall Study|Protocol Violation|0|||
156713315|NCT00839254|565694773|FG005|Overall Study|Protocol Violation|0|||
156713316|NCT00839254|565694774|FG006|Overall Study|Protocol Violation|1|||
156713317|NCT00839254|565694775|FG007|Overall Study|Protocol Violation|2|||
156713318|NCT00839254|565694768|FG000|Overall Study|Physician Decision|0|||
156713319|NCT00839254|565694769|FG001|Overall Study|Physician Decision|1|||
156713320|NCT00839254|565694770|FG002|Overall Study|Physician Decision|0|||
156713321|NCT00839254|565694771|FG003|Overall Study|Physician Decision|0|||
156713322|NCT00839254|565694772|FG004|Overall Study|Physician Decision|0|||
156713323|NCT00839254|565694773|FG005|Overall Study|Physician Decision|0|||
156713324|NCT00839254|565694774|FG006|Overall Study|Physician Decision|0|||
156713325|NCT00839254|565694775|FG007|Overall Study|Physician Decision|1|||
156442908|NCT02723955|564713386|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
156713326|NCT00839254|565694768|FG000|Overall Study|Wrong treatment number allocation|0|||
156713327|NCT00839254|565694769|FG001|Overall Study|Wrong treatment number allocation|1|||
156713328|NCT00839254|565694770|FG002|Overall Study|Wrong treatment number allocation|0|||
156713329|NCT00839254|565694771|FG003|Overall Study|Wrong treatment number allocation|0|||
156713330|NCT00839254|565694772|FG004|Overall Study|Wrong treatment number allocation|0|||
156713331|NCT00839254|565694773|FG005|Overall Study|Wrong treatment number allocation|1|||
156713332|NCT00839254|565694774|FG006|Overall Study|Wrong treatment number allocation|0|||
156713333|NCT00839254|565694775|FG007|Overall Study|Wrong treatment number allocation|0|||
156874013|NCT00396253|566296185|FG000|Overall Study|Withdrawal by Subject|7|||
156713334|NCT00839254|565694768|FG000|Overall Study|Adverse Event|12|||
156713335|NCT00839254|565694769|FG001|Overall Study|Adverse Event|6|||
156713336|NCT00839254|565694770|FG002|Overall Study|Adverse Event|3|||
156713337|NCT00839254|565694771|FG003|Overall Study|Adverse Event|5|||
156532308|NCT05028517|565043347|FG000|Overall Study|Withdrawal by Subject|0|||
156532309|NCT05028517|565043348|FG001|Overall Study|Withdrawal by Subject|0|||
156532310|NCT05028517|565043349|FG002|Overall Study|Withdrawal by Subject|1|||
156532311|NCT04890054|565044978|FG000|Overall Study|Lost to Follow-up|202|||
156532312|NCT04890054|565044979|FG001|Overall Study|Lost to Follow-up|219|||
156532313|NCT04313153|565044980|FG000|Overall Study|Adverse Event (includes Death)|14|||
156532314|NCT04313153|565044981|FG001|Overall Study|Adverse Event (includes Death)|19|||
156532315|NCT04313153|565044982|FG002|Overall Study|Adverse Event (includes Death)|10|||
156532316|NCT04313153|565044980|FG000|Overall Study|Physician Decision|4|||
156532317|NCT04313153|565044981|FG001|Overall Study|Physician Decision|2|||
156532318|NCT04313153|565044982|FG002|Overall Study|Physician Decision|1|||
156532319|NCT04313153|565044980|FG000|Overall Study|Withdrawal by Subject|7|||
156532320|NCT04313153|565044981|FG001|Overall Study|Withdrawal by Subject|6|||
156532321|NCT04313153|565044982|FG002|Overall Study|Withdrawal by Subject|2|||
156532322|NCT04313153|565044980|FG000|Overall Study|Lack of Efficacy|3|||
156532323|NCT04313153|565044981|FG001|Overall Study|Lack of Efficacy|3|||
156532324|NCT04313153|565044982|FG002|Overall Study|Lack of Efficacy|0|||
156532325|NCT04313153|565044980|FG000|Overall Study|Lost to Follow-up|1|||
156532326|NCT04313153|565044981|FG001|Overall Study|Lost to Follow-up|0|||
156532327|NCT04313153|565044982|FG002|Overall Study|Lost to Follow-up|2|||
156532328|NCT04313153|565044980|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
156532329|NCT04313153|565044981|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
156532330|NCT04313153|565044982|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
156532331|NCT04313153|565044980|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
156532332|NCT04313153|565044981|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
156532333|NCT04313153|565044982|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
156532334|NCT04313153|565044980|FG000|Overall Study|Change in Dialysis Modality|0|||
156532335|NCT04313153|565044981|FG001|Overall Study|Change in Dialysis Modality|1|||
156532336|NCT04313153|565044982|FG002|Overall Study|Change in Dialysis Modality|2|||
156532337|NCT04313153|565044980|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
156532338|NCT04313153|565044981|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
156792531|NCT03726879|565992829|FG001|Overall Study|Physician Decision|2|||
156792532|NCT03726879|565992828|FG000|Overall Study|Protocol Violation|0|||
156792533|NCT03726879|565992829|FG001|Overall Study|Protocol Violation|1|||
156874014|NCT00396253|566296185|FG000|Overall Study|Death|3|||
156792534|NCT03726879|565992828|FG000|Overall Study|Withdrawal by Subject|5|||
156792535|NCT03726879|565992829|FG001|Overall Study|Withdrawal by Subject|6|||
156792536|NCT03726879|565992828|FG000|Overall Study|TSH result is unstable|0|||
156792537|NCT03726879|565992829|FG001|Overall Study|TSH result is unstable|1|||
156792538|NCT03726879|565992828|FG000|Overall Study|Disease relapse|1|||
156792539|NCT03726879|565992829|FG001|Overall Study|Disease relapse|0|||
156792540|NCT03726879|565992828|FG000|Overall Study|Lost to Follow-up|3|||
156792541|NCT03726879|565992829|FG001|Overall Study|Lost to Follow-up|0|||
156792542|NCT00553475|565992831|FG000|Overall Study|Adverse Event|7|||
156792543|NCT00553475|565992832|FG001|Overall Study|Adverse Event|17|||
156792544|NCT00553475|565992833|FG002|Overall Study|Adverse Event|13|||
156792545|NCT00553475|565992831|FG000|Overall Study|Lack of Efficacy|7|||
156792546|NCT00553475|565992832|FG001|Overall Study|Lack of Efficacy|1|||
156333046|NCT00289016|564317476|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
156333047|NCT00289016|564317476|FG000|Overall Study|Withdrawal by Subject|2|||
156333048|NCT00289016|564317476|FG000|Overall Study|Adverse Event|1|||
156333049|NCT00289016|564317476|FG000|Overall Study|Other|1|||
156333050|NCT00667875|564317478|FG000|Overall Study|Adverse Event|0|||
156333051|NCT00667875|564317479|FG001|Overall Study|Adverse Event|2|||
156333052|NCT00667875|564317480|FG002|Overall Study|Adverse Event|6|||
156333053|NCT00667875|564317478|FG000|Overall Study|Withdrawal by Subject|10|||
156333054|NCT00667875|564317479|FG001|Overall Study|Withdrawal by Subject|9|||
156333055|NCT00667875|564317480|FG002|Overall Study|Withdrawal by Subject|7|||
156333056|NCT03553927|564317481|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
156333057|NCT03553927|564317482|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
156333058|NCT03553927|564317481|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
156333059|NCT03553927|564317482|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
156333060|NCT00976677|564317483|FG000|Overall Study|Adverse Event|1|||
156333061|NCT00976677|564317484|FG001|Overall Study|Adverse Event|0|||
156333062|NCT00976677|564317483|FG000|Overall Study|Withdrawal by Subject|0|||
156333063|NCT00976677|564317484|FG001|Overall Study|Withdrawal by Subject|2|||
156333064|NCT00976677|564317483|FG000|Overall Study|Disease progression|1|||
156333065|NCT00976677|564317484|FG001|Overall Study|Disease progression|1|||
156333066|NCT00976677|564317483|FG000|Overall Study|Trial unblinded|2|||
156333067|NCT00976677|564317484|FG001|Overall Study|Trial unblinded|2|||
156333068|NCT00976677|564317483|FG000|Overall Study|Unknown/Missing|1|||
156333069|NCT00976677|564317484|FG001|Overall Study|Unknown/Missing|0|||
156333070|NCT03355365|564319010|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
156713338|NCT00839254|565694772|FG004|Overall Study|Adverse Event|2|||
156713339|NCT00839254|565694773|FG005|Overall Study|Adverse Event|1|||
156713340|NCT00839254|565694774|FG006|Overall Study|Adverse Event|0|||
156713341|NCT00839254|565694775|FG007|Overall Study|Adverse Event|1|||
156713342|NCT00839254|565694768|FG000|Overall Study|Withdrawal by Subject|87|||
156713343|NCT00839254|565694769|FG001|Overall Study|Withdrawal by Subject|53|||
156713344|NCT00839254|565694770|FG002|Overall Study|Withdrawal by Subject|54|||
156713345|NCT00839254|565694771|FG003|Overall Study|Withdrawal by Subject|32|||
156713346|NCT00839254|565694772|FG004|Overall Study|Withdrawal by Subject|27|||
156713347|NCT00839254|565694773|FG005|Overall Study|Withdrawal by Subject|15|||
156713348|NCT00839254|565694774|FG006|Overall Study|Withdrawal by Subject|22|||
156713349|NCT00839254|565694775|FG007|Overall Study|Withdrawal by Subject|9|||
156713350|NCT00839254|565694768|FG000|Overall Study|Wrong group allocation|0|||
156713351|NCT00839254|565694769|FG001|Overall Study|Wrong group allocation|0|||
156713352|NCT00839254|565694770|FG002|Overall Study|Wrong group allocation|0|||
156713353|NCT00839254|565694771|FG003|Overall Study|Wrong group allocation|0|||
156713354|NCT00839254|565694772|FG004|Overall Study|Wrong group allocation|0|||
156713355|NCT00839254|565694773|FG005|Overall Study|Wrong group allocation|0|||
156713356|NCT00839254|565694774|FG006|Overall Study|Wrong group allocation|1|||
156713357|NCT00839254|565694775|FG007|Overall Study|Wrong group allocation|0|||
156713358|NCT00839254|565694768|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
156713359|NCT00839254|565694769|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713360|NCT00839254|565694770|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713361|NCT00839254|565694771|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713362|NCT00839254|565694772|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713363|NCT00839254|565694773|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
156713364|NCT00839254|565694774|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713365|NCT00839254|565694775|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713366|NCT00839254|565694768|FG000|Overall Study|Withdrawn due to non-compliance|2|||
156713367|NCT00839254|565694769|FG001|Overall Study|Withdrawn due to non-compliance|0|||
156713368|NCT00839254|565694770|FG002|Overall Study|Withdrawn due to non-compliance|0|||
156713369|NCT00839254|565694771|FG003|Overall Study|Withdrawn due to non-compliance|0|||
156713370|NCT00839254|565694772|FG004|Overall Study|Withdrawn due to non-compliance|0|||
156713371|NCT00839254|565694773|FG005|Overall Study|Withdrawn due to non-compliance|0|||
156713372|NCT00839254|565694774|FG006|Overall Study|Withdrawn due to non-compliance|0|||
156713373|NCT00839254|565694775|FG007|Overall Study|Withdrawn due to non-compliance|0|||
156713374|NCT00839254|565694768|FG000|Overall Study|Lost to Follow-up|51|||
156713375|NCT00839254|565694769|FG001|Overall Study|Lost to Follow-up|30|||
156713376|NCT00839254|565694770|FG002|Overall Study|Lost to Follow-up|32|||
156713377|NCT00839254|565694771|FG003|Overall Study|Lost to Follow-up|24|||
156713378|NCT00839254|565694772|FG004|Overall Study|Lost to Follow-up|8|||
156713379|NCT00839254|565694773|FG005|Overall Study|Lost to Follow-up|8|||
156713380|NCT00839254|565694774|FG006|Overall Study|Lost to Follow-up|4|||
156713381|NCT00839254|565694775|FG007|Overall Study|Lost to Follow-up|2|||
156713382|NCT02359994|565694779|FG000|Overall Population Study|Adverse Event|1|||
156713383|NCT02359994|565694780|FG001|Overall Population Study|Adverse Event|1|||
156713384|NCT02359994|565694779|FG000|Overall Population Study|Death|1|||
156713385|NCT02359994|565694780|FG001|Overall Population Study|Death|5|||
156713386|NCT02359994|565694779|FG000|Overall Population Study|Lost to Follow-up|1|||
156713387|NCT02359994|565694780|FG001|Overall Population Study|Lost to Follow-up|1|||
156713388|NCT02359994|565694779|FG000|Overall Population Study|Withdrawal by Subject|1|||
156713389|NCT02359994|565694780|FG001|Overall Population Study|Withdrawal by Subject|0|||
156713390|NCT02359994|565694779|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
156713391|NCT02359994|565694780|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
156713392|NCT02359994|565694779|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
156713393|NCT02359994|565694780|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
156713394|NCT02359994|565694779|FG000|Extended Oncology 24-Month Survival|Death|19|||
156713395|NCT02359994|565694780|FG001|Extended Oncology 24-Month Survival|Death|21|||
156713396|NCT02359994|565694779|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
156713397|NCT02359994|565694780|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
156713398|NCT01823835|565694781|FG000|Overall Study|Adverse Event|0|||
156713399|NCT01823835|565694782|FG001|Overall Study|Adverse Event|0|||
156713400|NCT01823835|565694783|FG002|Overall Study|Adverse Event|0|||
156713401|NCT01823835|565694784|FG003|Overall Study|Adverse Event|0|||
156713402|NCT01823835|565694785|FG004|Overall Study|Adverse Event|1|||
156713403|NCT01823835|565694786|FG005|Overall Study|Adverse Event|0|||
156713404|NCT01823835|565694787|FG006|Overall Study|Adverse Event|1|||
156713405|NCT01823835|565694788|FG007|Overall Study|Adverse Event|0|||
156713406|NCT01823835|565694789|FG008|Overall Study|Adverse Event|0|||
156713407|NCT01823835|565694790|FG009|Overall Study|Adverse Event|0|||
156713408|NCT01823835|565694791|FG010|Overall Study|Adverse Event|1|||
156333071|NCT03355365|564319011|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
156333072|NCT03355365|564319010|FG000|Year 1, First Intervention|Protocol Violation|1|||
156713409|NCT01823835|565694792|FG011|Overall Study|Adverse Event|2|||
156713410|NCT01823835|565694793|FG012|Overall Study|Adverse Event|0|||
156713411|NCT01823835|565694794|FG013|Overall Study|Adverse Event|0|||
156713412|NCT01823835|565694795|FG014|Overall Study|Adverse Event|0|||
156713413|NCT01823835|565694781|FG000|Overall Study|Physician Decision|0|||
156713414|NCT01823835|565694782|FG001|Overall Study|Physician Decision|0|||
156713415|NCT01823835|565694783|FG002|Overall Study|Physician Decision|0|||
156713416|NCT01823835|565694784|FG003|Overall Study|Physician Decision|0|||
156713417|NCT01823835|565694785|FG004|Overall Study|Physician Decision|0|||
156713418|NCT01823835|565694786|FG005|Overall Study|Physician Decision|0|||
156713419|NCT01823835|565694787|FG006|Overall Study|Physician Decision|0|||
156442909|NCT02723955|564713387|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
156442910|NCT02723955|564713388|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
156442911|NCT02723955|564713389|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
156442912|NCT02723955|564713390|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
156442913|NCT02723955|564713391|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
156442914|NCT02723955|564713392|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
156442915|NCT02723955|564713393|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
156442916|NCT02723955|564713394|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
156442917|NCT02723955|564713395|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
156442918|NCT02723955|564713396|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
156442919|NCT02723955|564713397|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
156442920|NCT02723955|564713398|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
156442921|NCT02723955|564713399|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
156442922|NCT02723955|564713400|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
156442923|NCT02723955|564713401|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
156442924|NCT02723955|564713402|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
156442925|NCT02723955|564713403|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
156442926|NCT02723955|564713404|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
156442927|NCT02723955|564713405|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
156713420|NCT01823835|565694788|FG007|Overall Study|Physician Decision|0|||
156713421|NCT01823835|565694789|FG008|Overall Study|Physician Decision|0|||
156713422|NCT01823835|565694790|FG009|Overall Study|Physician Decision|0|||
156713423|NCT01823835|565694791|FG010|Overall Study|Physician Decision|0|||
156713424|NCT01823835|565694792|FG011|Overall Study|Physician Decision|2|||
156713425|NCT01823835|565694793|FG012|Overall Study|Physician Decision|0|||
156713426|NCT01823835|565694794|FG013|Overall Study|Physician Decision|0|||
156713427|NCT01823835|565694795|FG014|Overall Study|Physician Decision|0|||
156713428|NCT01823835|565694781|FG000|Overall Study|Progressive Disease|3|||
156713429|NCT01823835|565694782|FG001|Overall Study|Progressive Disease|4|||
156713430|NCT01823835|565694783|FG002|Overall Study|Progressive Disease|3|||
156713431|NCT01823835|565694784|FG003|Overall Study|Progressive Disease|6|||
156713432|NCT01823835|565694785|FG004|Overall Study|Progressive Disease|4|||
156713433|NCT01823835|565694786|FG005|Overall Study|Progressive Disease|6|||
156713434|NCT01823835|565694787|FG006|Overall Study|Progressive Disease|5|||
156713435|NCT01823835|565694788|FG007|Overall Study|Progressive Disease|3|||
156713436|NCT01823835|565694789|FG008|Overall Study|Progressive Disease|3|||
156713437|NCT01823835|565694790|FG009|Overall Study|Progressive Disease|18|||
156713438|NCT01823835|565694791|FG010|Overall Study|Progressive Disease|8|||
156713439|NCT01823835|565694792|FG011|Overall Study|Progressive Disease|46|||
156713440|NCT01823835|565694793|FG012|Overall Study|Progressive Disease|18|||
156713441|NCT01823835|565694794|FG013|Overall Study|Progressive Disease|4|||
156713442|NCT01823835|565694795|FG014|Overall Study|Progressive Disease|6|||
156713443|NCT01823835|565694781|FG000|Overall Study|Study Termination|0|||
156874015|NCT00396253|566296185|FG000|Overall Study|Physician Decision|1|||
156442928|NCT02723955|564713406|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
156442929|NCT02723955|564713407|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
156442930|NCT02723955|564713408|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
156442931|NCT02723955|564713409|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
156442932|NCT02723955|564713410|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
156442933|NCT02723955|564713411|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
156442934|NCT02723955|564713412|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
156537839|NCT01236573|565062876|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
156713444|NCT01823835|565694782|FG001|Overall Study|Study Termination|0|||
156713445|NCT01823835|565694783|FG002|Overall Study|Study Termination|0|||
156713446|NCT01823835|565694784|FG003|Overall Study|Study Termination|0|||
156713447|NCT01823835|565694785|FG004|Overall Study|Study Termination|1|||
156713448|NCT01823835|565694786|FG005|Overall Study|Study Termination|0|||
156713449|NCT01823835|565694787|FG006|Overall Study|Study Termination|0|||
156713450|NCT01823835|565694788|FG007|Overall Study|Study Termination|0|||
156713451|NCT01823835|565694789|FG008|Overall Study|Study Termination|0|||
156713452|NCT01823835|565694790|FG009|Overall Study|Study Termination|0|||
156442935|NCT02723955|564713413|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
156442936|NCT02723955|564713414|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
156442937|NCT02723955|564713415|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
156442938|NCT02723955|564713416|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
156713453|NCT01823835|565694791|FG010|Overall Study|Study Termination|0|||
156713454|NCT01823835|565694792|FG011|Overall Study|Study Termination|1|||
156713455|NCT01823835|565694793|FG012|Overall Study|Study Termination|0|||
156713456|NCT01823835|565694794|FG013|Overall Study|Study Termination|0|||
156713457|NCT01823835|565694795|FG014|Overall Study|Study Termination|0|||
156713458|NCT01823835|565694781|FG000|Overall Study|Withdrawal by Subject|0|||
156713459|NCT01823835|565694782|FG001|Overall Study|Withdrawal by Subject|0|||
156713460|NCT01823835|565694783|FG002|Overall Study|Withdrawal by Subject|1|||
156713461|NCT01823835|565694784|FG003|Overall Study|Withdrawal by Subject|0|||
156713462|NCT01823835|565694785|FG004|Overall Study|Withdrawal by Subject|0|||
156713463|NCT01823835|565694786|FG005|Overall Study|Withdrawal by Subject|0|||
156713464|NCT01823835|565694787|FG006|Overall Study|Withdrawal by Subject|0|||
156713465|NCT01823835|565694788|FG007|Overall Study|Withdrawal by Subject|0|||
156713466|NCT01823835|565694789|FG008|Overall Study|Withdrawal by Subject|0|||
156713467|NCT01823835|565694790|FG009|Overall Study|Withdrawal by Subject|1|||
156713468|NCT01823835|565694791|FG010|Overall Study|Withdrawal by Subject|1|||
156713469|NCT01823835|565694792|FG011|Overall Study|Withdrawal by Subject|2|||
156713470|NCT01823835|565694793|FG012|Overall Study|Withdrawal by Subject|1|||
156713471|NCT01823835|565694794|FG013|Overall Study|Withdrawal by Subject|0|||
156713472|NCT01823835|565694795|FG014|Overall Study|Withdrawal by Subject|0|||
156792547|NCT00553475|565992833|FG002|Overall Study|Lack of Efficacy|0|||
156442939|NCT02723955|564713417|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
156442940|NCT02723955|564713418|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
156442941|NCT02723955|564713419|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
156442942|NCT02723955|564713420|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
156442943|NCT02723955|564713421|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
156442944|NCT02723955|564713422|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
156442945|NCT02723955|564713423|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
156442946|NCT02723955|564713424|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
156442947|NCT02723955|564713425|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
156442948|NCT02723955|564713426|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
156442949|NCT04999085|564713427|FG000|Overall Study|Death|1|||
156442950|NCT05056246|564713430|FG000|Overall Study|Adverse Event|0|||
156442951|NCT05056246|564713431|FG001|Overall Study|Adverse Event|0|||
156442952|NCT05056246|564713432|FG002|Overall Study|Adverse Event|0|||
156442953|NCT05056246|564713433|FG003|Overall Study|Adverse Event|0|||
156442954|NCT05056246|564713434|FG004|Overall Study|Adverse Event|1|||
156442955|NCT05056246|564713430|FG000|Overall Study|Lost to Follow-up|0|||
156792548|NCT00553475|565992831|FG000|Overall Study|Withdrawal by Subject|1|||
156792549|NCT00553475|565992832|FG001|Overall Study|Withdrawal by Subject|1|||
156792550|NCT00553475|565992833|FG002|Overall Study|Withdrawal by Subject|0|||
156792551|NCT00553475|565992831|FG000|Overall Study|Physician Decision|1|||
156792552|NCT00553475|565992832|FG001|Overall Study|Physician Decision|0|||
156792553|NCT00553475|565992833|FG002|Overall Study|Physician Decision|0|||
156792554|NCT00553475|565992831|FG000|Overall Study|Due to moving|0|||
156792555|NCT00553475|565992832|FG001|Overall Study|Due to moving|1|||
156792556|NCT00553475|565992833|FG002|Overall Study|Due to moving|0|||
156792557|NCT00890097|565992834|FG000|Overall Study|Adverse Event|21|||
156792558|NCT00890097|565992835|FG001|Overall Study|Adverse Event|32|||
156792559|NCT00890097|565992836|FG002|Overall Study|Adverse Event|28|||
156792560|NCT00890097|565992834|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
156792561|NCT00890097|565992835|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
156792562|NCT00890097|565992836|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
156792563|NCT00890097|565992834|FG000|Overall Study|Withdrew Consent|9|||
156792564|NCT00890097|565992835|FG001|Overall Study|Withdrew Consent|6|||
156792565|NCT00890097|565992836|FG002|Overall Study|Withdrew Consent|9|||
156792566|NCT00890097|565992834|FG000|Overall Study|Lost to Follow-up|5|||
156792567|NCT00890097|565992835|FG001|Overall Study|Lost to Follow-up|5|||
156792568|NCT00890097|565992836|FG002|Overall Study|Lost to Follow-up|5|||
156792569|NCT00890097|565992834|FG000|Overall Study|Noncompliance|0|||
156792570|NCT00890097|565992835|FG001|Overall Study|Noncompliance|4|||
156792571|NCT00890097|565992836|FG002|Overall Study|Noncompliance|4|||
156792572|NCT00890097|565992834|FG000|Overall Study|Sponsor Decision|7|||
156442956|NCT05056246|564713431|FG001|Overall Study|Lost to Follow-up|0|||
156713473|NCT00509795|565694798|FG000|Overall Study|Adverse Event|4|||
156713474|NCT00509795|565694799|FG001|Overall Study|Adverse Event|3|||
156713475|NCT00509795|565694800|FG002|Overall Study|Adverse Event|5|||
156713476|NCT00509795|565694801|FG003|Overall Study|Adverse Event|4|||
156713477|NCT00509795|565694798|FG000|Overall Study|Death|3|||
156713478|NCT00509795|565694799|FG001|Overall Study|Death|1|||
156713479|NCT00509795|565694800|FG002|Overall Study|Death|2|||
156792573|NCT00890097|565992835|FG001|Overall Study|Sponsor Decision|11|||
156792574|NCT00890097|565992836|FG002|Overall Study|Sponsor Decision|7|||
156792575|NCT00890097|565992834|FG000|Overall Study|Did not attend final visit|2|||
156792576|NCT00890097|565992835|FG001|Overall Study|Did not attend final visit|3|||
156442957|NCT05056246|564713432|FG002|Overall Study|Lost to Follow-up|0|||
156442958|NCT05056246|564713433|FG003|Overall Study|Lost to Follow-up|2|||
156442959|NCT05056246|564713434|FG004|Overall Study|Lost to Follow-up|0|||
156792577|NCT00890097|565992836|FG002|Overall Study|Did not attend final visit|0|||
156792578|NCT00890097|565992834|FG000|Overall Study|Subject Decision|3|||
156713480|NCT00509795|565694801|FG003|Overall Study|Death|7|||
156713481|NCT00509795|565694798|FG000|Overall Study|Lack of Efficacy|0|||
156713482|NCT00509795|565694799|FG001|Overall Study|Lack of Efficacy|0|||
156713483|NCT00509795|565694800|FG002|Overall Study|Lack of Efficacy|2|||
156713484|NCT00509795|565694801|FG003|Overall Study|Lack of Efficacy|2|||
156713485|NCT00509795|565694798|FG000|Overall Study|Lost to Follow-up|1|||
156713486|NCT00509795|565694799|FG001|Overall Study|Lost to Follow-up|2|||
156713487|NCT00509795|565694800|FG002|Overall Study|Lost to Follow-up|4|||
156713488|NCT00509795|565694801|FG003|Overall Study|Lost to Follow-up|4|||
156713489|NCT00509795|565694798|FG000|Overall Study|OTHER|1|||
156713490|NCT00509795|565694799|FG001|Overall Study|OTHER|0|||
156713491|NCT00509795|565694800|FG002|Overall Study|OTHER|4|||
156713492|NCT00509795|565694801|FG003|Overall Study|OTHER|1|||
156713493|NCT00509795|565694798|FG000|Overall Study|Protocol Violation|3|||
156713494|NCT00509795|565694799|FG001|Overall Study|Protocol Violation|0|||
156713495|NCT00509795|565694800|FG002|Overall Study|Protocol Violation|3|||
156713496|NCT00509795|565694801|FG003|Overall Study|Protocol Violation|1|||
156713497|NCT00509795|565694798|FG000|Overall Study|Withdrawal by Subject|10|||
156713498|NCT00509795|565694799|FG001|Overall Study|Withdrawal by Subject|5|||
156713499|NCT00509795|565694800|FG002|Overall Study|Withdrawal by Subject|7|||
156713500|NCT00509795|565694801|FG003|Overall Study|Withdrawal by Subject|8|||
156713501|NCT03017612|565694802|FG000|Overall Study|Adverse Event|2|||
156713502|NCT01320150|565694803|FG000|Overall Study|Protocol Violation|15|||
156713503|NCT01320150|565694803|FG000|Overall Study|Withdrawal by Subject|5|||
156713504|NCT01320150|565694803|FG000|Overall Study|Death|2|||
156713505|NCT01320150|565694803|FG000|Overall Study|Lost to Follow-up|44|||
156713506|NCT00919854|565694806|FG000|Overall Study|Adverse Event|1|||
156713507|NCT01893346|565694808|FG000|Overall Study|Lost to Follow-up|0|||
156713508|NCT01893346|565694809|FG001|Overall Study|Lost to Follow-up|1|||
156713509|NCT01893346|565694810|FG002|Overall Study|Lost to Follow-up|0|||
156713510|NCT01893346|565694811|FG003|Overall Study|Lost to Follow-up|0|||
156713511|NCT01893346|565694808|FG000|Overall Study|Protocol Violation|1|||
156713512|NCT01893346|565694809|FG001|Overall Study|Protocol Violation|0|||
156713513|NCT01893346|565694810|FG002|Overall Study|Protocol Violation|0|||
156713514|NCT01893346|565694811|FG003|Overall Study|Protocol Violation|0|||
156713515|NCT01893346|565694808|FG000|Overall Study|Withdrawal by Subject|2|||
156713516|NCT01893346|565694809|FG001|Overall Study|Withdrawal by Subject|0|||
156713517|NCT01893346|565694810|FG002|Overall Study|Withdrawal by Subject|0|||
156713518|NCT01893346|565694811|FG003|Overall Study|Withdrawal by Subject|0|||
156713519|NCT00985491|565694812|FG000|Overall Study|Adverse Event|8|||
156713520|NCT00985491|565694812|FG000|Overall Study|device migration|7|||
156713521|NCT00985491|565694812|FG000|Overall Study|Withdrawal by Subject|1|||
156713522|NCT00985491|565694812|FG000|Overall Study|implant failure|3|||
156713523|NCT00143247|565694815|FG000|Overall Study|Death|8|||
156713524|NCT00143247|565694815|FG000|Overall Study|Adverse Event|19|||
156713525|NCT00143247|565694815|FG000|Overall Study|Lack of Efficacy|3|||
156713526|NCT00143247|565694815|FG000|Overall Study|Withdrawal by Subject|55|||
156713527|NCT00143247|565694815|FG000|Overall Study|Study terminated by sponsor|31|||
156713528|NCT00143247|565694815|FG000|Overall Study|Protocol Violation|15|||
156713529|NCT00143247|565694815|FG000|Overall Study|Lost to Follow-up|12|||
156713530|NCT00143247|565694815|FG000|Overall Study|following inaccurate lab adverse event|1|||
156792579|NCT00890097|565992835|FG001|Overall Study|Subject Decision|2|||
156792580|NCT00890097|565992836|FG002|Overall Study|Subject Decision|6|||
156792581|NCT00890097|565992834|FG000|Overall Study|Randomization Error|2|||
156792582|NCT00890097|565992835|FG001|Overall Study|Randomization Error|0|||
156792583|NCT00890097|565992836|FG002|Overall Study|Randomization Error|0|||
156792584|NCT00890097|565992834|FG000|Overall Study|Failed inclusion criteria|3|||
156792585|NCT00890097|565992835|FG001|Overall Study|Failed inclusion criteria|4|||
156792586|NCT00890097|565992836|FG002|Overall Study|Failed inclusion criteria|0|||
156792587|NCT00890097|565992834|FG000|Overall Study|Transportation|0|||
156333073|NCT03355365|564319011|FG001|Year 1, First Intervention|Protocol Violation|0|||
156713531|NCT00143247|565694815|FG000|Overall Study|Other|12|||
156713532|NCT02933255|565694818|FG000|Overall Study|Discontinued due to study closure.|1|||
156713533|NCT02933255|565694819|FG001|Overall Study|Discontinued due to study closure.|0|||
156713534|NCT02766283|565694820|FG000|Overall Study|Lost to Follow-up|27|||
156713535|NCT00805961|565694821|FG000|Modality Therapy|Withdrawal by Subject|1|||
156713536|NCT00805961|565694821|FG000|Modality Therapy|Adverse Event|1|||
156713537|NCT00805961|565694821|FG000|Modality Therapy|Disease Progression|2|||
156713538|NCT00805961|565694821|FG000|Treatment-Free Interval|Adverse Event|3|||
156713539|NCT00805961|565694821|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
156713540|NCT00805961|565694821|FG000|Treatment-Free Interval|Physician Decision|1|||
156713541|NCT00805961|565694821|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
156713542|NCT00805961|565694821|FG000|Maintenance Treatment|Lack of Efficacy|13|||
156333074|NCT03355365|564319010|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
156333075|NCT03355365|564319011|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
156792588|NCT00890097|565992835|FG001|Overall Study|Transportation|2|||
156792589|NCT00890097|565992836|FG002|Overall Study|Transportation|0|||
156792590|NCT00890097|565992834|FG000|Overall Study|Subject Moved|0|||
156792591|NCT00890097|565992835|FG001|Overall Study|Subject Moved|4|||
156442960|NCT05056246|564713430|FG000|Overall Study|Withdrawal by Subject|0|||
156713543|NCT00805961|565694821|FG000|Maintenance Treatment|Intercurrent Illness|7|||
156713544|NCT00805961|565694821|FG000|Maintenance Treatment|Adverse Event|6|||
156713545|NCT00805961|565694821|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
156713546|NCT00805961|565694821|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
156713547|NCT00805961|565694821|FG000|Maintenance Treatment|Withdrawn Consent|1|||
156713548|NCT03086551|565694822|FG000|First Intervention|Failure to meet inclusion criterion|1|||
156442961|NCT05056246|564713431|FG001|Overall Study|Withdrawal by Subject|1|||
156442962|NCT05056246|564713432|FG002|Overall Study|Withdrawal by Subject|0|||
156442963|NCT05056246|564713433|FG003|Overall Study|Withdrawal by Subject|0|||
156442964|NCT05056246|564713434|FG004|Overall Study|Withdrawal by Subject|0|||
156442965|NCT05057897|564713435|FG000|Overall Study|Site closure|2|||
156442966|NCT05057897|564713436|FG001|Overall Study|Site closure|2|||
156442967|NCT05057897|564713435|FG000|Overall Study|Death|1|||
156442968|NCT05057897|564713436|FG001|Overall Study|Death|0|||
156713549|NCT03086551|565694823|FG001|First Intervention|Failure to meet inclusion criterion|0|||
156713550|NCT03086551|565694822|FG000|First Intervention|Lost to Follow-up|0|||
156713551|NCT03086551|565694823|FG001|First Intervention|Lost to Follow-up|1|||
156713552|NCT03086551|565694822|FG000|Washout|Lost to Follow-up|1|||
156713553|NCT03086551|565694823|FG001|Washout|Lost to Follow-up|2|||
156713554|NCT03086551|565694822|FG000|Washout|Withdrawal by Subject|2|||
156713555|NCT03086551|565694823|FG001|Washout|Withdrawal by Subject|1|||
156713556|NCT02215967|565694824|FG000|Overall Study|Patient became ineligible for treatment|0|||
156713557|NCT02215967|565694825|FG001|Overall Study|Patient became ineligible for treatment|0|||
156713558|NCT02215967|565694826|FG002|Overall Study|Patient became ineligible for treatment|0|||
156713559|NCT02215967|565694827|FG003|Overall Study|Patient became ineligible for treatment|3|||
156713560|NCT02215967|565694824|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
156713561|NCT02215967|565694825|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
156713562|NCT02215967|565694826|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
156713563|NCT02215967|565694827|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
156713564|NCT06473519|565696688|FG000|Overall Study|Lost to Follow-up|2|||
156713565|NCT06473519|565696689|FG001|Overall Study|Lost to Follow-up|5|||
156713566|NCT06473519|565696688|FG000|Overall Study|Withdrawal by Subject|1|||
156713567|NCT06473519|565696689|FG001|Overall Study|Withdrawal by Subject|4|||
156713568|NCT06473519|565696688|FG000|Overall Study|Randomized but not vaccinated|1|||
156713569|NCT06473519|565696689|FG001|Overall Study|Randomized but not vaccinated|2|||
156713570|NCT02514447|565696693|FG000|Overall Study|Withdrawal by Subject|3|||
156713571|NCT02514447|565696694|FG001|Overall Study|Withdrawal by Subject|1|||
156713572|NCT02514447|565696695|FG002|Overall Study|Withdrawal by Subject|1|||
156713573|NCT02514447|565696696|FG003|Overall Study|Withdrawal by Subject|0|||
156713574|NCT02514447|565696697|FG004|Overall Study|Withdrawal by Subject|0|||
156713575|NCT02514447|565696698|FG005|Overall Study|Withdrawal by Subject|0|||
156713576|NCT02514447|565696699|FG006|Overall Study|Withdrawal by Subject|0|||
156713577|NCT02514447|565696700|FG007|Overall Study|Withdrawal by Subject|1|||
156713578|NCT02514447|565696701|FG008|Overall Study|Withdrawal by Subject|1|||
156713579|NCT02514447|565696693|FG000|Overall Study|Death|24|||
156713580|NCT02514447|565696694|FG001|Overall Study|Death|28|||
156713581|NCT02514447|565696695|FG002|Overall Study|Death|29|||
156792592|NCT00890097|565992836|FG002|Overall Study|Subject Moved|0|||
156792593|NCT00890097|565992834|FG000|Overall Study|Protocol Deviation|1|||
156792594|NCT00890097|565992835|FG001|Overall Study|Protocol Deviation|1|||
156792595|NCT00890097|565992836|FG002|Overall Study|Protocol Deviation|1|||
156792596|NCT01152385|565992837|FG000|Overall Study|Withdrawal by Subject|3|||
156792597|NCT01152385|565992838|FG001|Overall Study|Withdrawal by Subject|1|||
156792598|NCT01152385|565992839|FG002|Overall Study|Withdrawal by Subject|1|||
156792599|NCT01152385|565992840|FG003|Overall Study|Withdrawal by Subject|1|||
156792600|NCT01152385|565992837|FG000|Overall Study|Protocol Violation|0|||
156792601|NCT01152385|565992838|FG001|Overall Study|Protocol Violation|0|||
156792602|NCT01152385|565992839|FG002|Overall Study|Protocol Violation|0|||
156792603|NCT01152385|565992840|FG003|Overall Study|Protocol Violation|1|||
156792604|NCT01152385|565992837|FG000|Overall Study|Adverse Event|1|||
156442969|NCT05096819|564713437|FG000|Overall Study|Withdrawal by Subject|3|||
156532339|NCT04313153|565044982|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
156532340|NCT04313153|565044980|FG000|Overall Study|Other|5|||
156713582|NCT02514447|565696696|FG003|Overall Study|Death|0|||
156442970|NCT05096819|564713438|FG001|Overall Study|Withdrawal by Subject|0|||
156442971|NCT02152137|564713439|FG000|Overall Study|Withdrawal by Subject|1|||
156713583|NCT02514447|565696697|FG004|Overall Study|Death|3|||
156713584|NCT02514447|565696698|FG005|Overall Study|Death|4|||
156713585|NCT02514447|565696699|FG006|Overall Study|Death|8|||
156713586|NCT02514447|565696700|FG007|Overall Study|Death|6|||
156713587|NCT02514447|565696701|FG008|Overall Study|Death|5|||
156792605|NCT01152385|565992838|FG001|Overall Study|Adverse Event|1|||
156792606|NCT01152385|565992839|FG002|Overall Study|Adverse Event|0|||
156792607|NCT01152385|565992840|FG003|Overall Study|Adverse Event|0|||
156792608|NCT01152385|565992837|FG000|Overall Study|Study-specific withdrawal criteria|1|||
156808771|NCT03801928|566054460|FG001|Overall Study|Adverse Event|0|||
156713588|NCT02514447|565696693|FG000|Overall Study|Lost to Follow-up|1|||
156713589|NCT02514447|565696694|FG001|Overall Study|Lost to Follow-up|0|||
156713590|NCT02514447|565696695|FG002|Overall Study|Lost to Follow-up|0|||
156713591|NCT02514447|565696696|FG003|Overall Study|Lost to Follow-up|0|||
156713592|NCT02514447|565696697|FG004|Overall Study|Lost to Follow-up|0|||
156713593|NCT02514447|565696698|FG005|Overall Study|Lost to Follow-up|0|||
156713594|NCT02514447|565696699|FG006|Overall Study|Lost to Follow-up|0|||
156713595|NCT02514447|565696700|FG007|Overall Study|Lost to Follow-up|0|||
156713596|NCT02514447|565696701|FG008|Overall Study|Lost to Follow-up|1|||
156713597|NCT02514447|565696693|FG000|Overall Study|Sponsor Termination of Study|0|||
156713598|NCT02514447|565696694|FG001|Overall Study|Sponsor Termination of Study|1|||
156713599|NCT02514447|565696695|FG002|Overall Study|Sponsor Termination of Study|1|||
156713600|NCT02514447|565696696|FG003|Overall Study|Sponsor Termination of Study|0|||
156713601|NCT02514447|565696697|FG004|Overall Study|Sponsor Termination of Study|0|||
156713602|NCT02514447|565696698|FG005|Overall Study|Sponsor Termination of Study|0|||
156713603|NCT02514447|565696699|FG006|Overall Study|Sponsor Termination of Study|0|||
156713604|NCT02514447|565696700|FG007|Overall Study|Sponsor Termination of Study|0|||
156713605|NCT02514447|565696701|FG008|Overall Study|Sponsor Termination of Study|0|||
156713606|NCT02514447|565696693|FG000|Overall Study|Study completion per Investigator|1|||
156713607|NCT02514447|565696694|FG001|Overall Study|Study completion per Investigator|0|||
156713608|NCT02514447|565696695|FG002|Overall Study|Study completion per Investigator|1|||
156713609|NCT02514447|565696696|FG003|Overall Study|Study completion per Investigator|2|||
156713610|NCT02514447|565696697|FG004|Overall Study|Study completion per Investigator|0|||
156713611|NCT02514447|565696698|FG005|Overall Study|Study completion per Investigator|0|||
156713612|NCT02514447|565696699|FG006|Overall Study|Study completion per Investigator|0|||
156713613|NCT02514447|565696700|FG007|Overall Study|Study completion per Investigator|0|||
156713614|NCT02514447|565696701|FG008|Overall Study|Study completion per Investigator|1|||
156713615|NCT03560037|565696702|FG000|Overall Study|Protocol Violation|1|||
156713616|NCT03560037|565696703|FG001|Overall Study|Protocol Violation|0|||
156713617|NCT03560037|565696702|FG000|Overall Study|Physician Decision|0|||
156713618|NCT03560037|565696703|FG001|Overall Study|Physician Decision|1|||
156713619|NCT03620708|565696704|FG000|Overall Study|Lost to Follow-up|1|||
156713620|NCT03620708|565696705|FG001|Overall Study|Lost to Follow-up|1|||
156713621|NCT03620708|565696706|FG002|Overall Study|Lost to Follow-up|2|||
156713622|NCT03620708|565696704|FG000|Overall Study|Withdrawal by Subject|0|||
156713623|NCT03620708|565696705|FG001|Overall Study|Withdrawal by Subject|0|||
156713624|NCT03620708|565696706|FG002|Overall Study|Withdrawal by Subject|1|||
156713625|NCT03631199|565696712|FG000|Overall Study|Progressive disease|9|||
156713626|NCT03631199|565696713|FG001|Overall Study|Progressive disease|5|||
156713627|NCT03631199|565696714|FG002|Overall Study|Progressive disease|5|||
156713628|NCT03631199|565696715|FG003|Overall Study|Progressive disease|149|||
156713629|NCT03631199|565696716|FG004|Overall Study|Progressive disease|148|||
156713630|NCT03631199|565696712|FG000|Overall Study|Physician Decision|0|||
156713631|NCT03631199|565696713|FG001|Overall Study|Physician Decision|2|||
156713632|NCT03631199|565696714|FG002|Overall Study|Physician Decision|3|||
156713633|NCT03631199|565696715|FG003|Overall Study|Physician Decision|19|||
156713634|NCT03631199|565696716|FG004|Overall Study|Physician Decision|13|||
156713635|NCT03631199|565696712|FG000|Overall Study|Adverse Event|1|||
156713636|NCT03631199|565696713|FG001|Overall Study|Adverse Event|1|||
156713637|NCT03631199|565696714|FG002|Overall Study|Adverse Event|0|||
156713638|NCT03631199|565696715|FG003|Overall Study|Adverse Event|28|||
156713639|NCT03631199|565696716|FG004|Overall Study|Adverse Event|29|||
156713640|NCT03631199|565696712|FG000|Overall Study|Death|0|||
156713641|NCT03631199|565696713|FG001|Overall Study|Death|1|||
156713642|NCT03631199|565696714|FG002|Overall Study|Death|0|||
156713643|NCT03631199|565696715|FG003|Overall Study|Death|35|||
156713644|NCT03631199|565696716|FG004|Overall Study|Death|48|||
156713645|NCT03631199|565696712|FG000|Overall Study|Subject decision|0|||
156713646|NCT03631199|565696713|FG001|Overall Study|Subject decision|1|||
156713647|NCT03631199|565696714|FG002|Overall Study|Subject decision|0|||
156713648|NCT03631199|565696715|FG003|Overall Study|Subject decision|12|||
156713649|NCT03631199|565696716|FG004|Overall Study|Subject decision|12|||
156713650|NCT03631199|565696712|FG000|Overall Study|No treated|0|||
156713651|NCT03631199|565696713|FG001|Overall Study|No treated|0|||
156713652|NCT03631199|565696714|FG002|Overall Study|No treated|0|||
156713653|NCT03631199|565696715|FG003|Overall Study|No treated|0|||
156713654|NCT03631199|565696716|FG004|Overall Study|No treated|1|||
156713655|NCT03631199|565696712|FG000|Overall Study|Treatment ongoing|0|||
156713656|NCT03631199|565696713|FG001|Overall Study|Treatment ongoing|1|||
156713657|NCT03631199|565696714|FG002|Overall Study|Treatment ongoing|1|||
156713658|NCT03631199|565696715|FG003|Overall Study|Treatment ongoing|76|||
156713659|NCT03631199|565696716|FG004|Overall Study|Treatment ongoing|71|||
156713660|NCT03631199|565696712|FG000|Overall Study|Guardian decision|0|||
156713661|NCT03631199|565696713|FG001|Overall Study|Guardian decision|0|||
156713662|NCT03631199|565696714|FG002|Overall Study|Guardian decision|0|||
156713663|NCT03631199|565696715|FG003|Overall Study|Guardian decision|1|||
156713664|NCT03631199|565696716|FG004|Overall Study|Guardian decision|1|||
156713665|NCT03765788|565696717|FG000|Overall Study|Subject decision|2|||
156713666|NCT03765788|565696718|FG001|Overall Study|Subject decision|3|||
156713667|NCT03765788|565696717|FG000|Overall Study|Physician Decision|2|||
156713668|NCT03765788|565696718|FG001|Overall Study|Physician Decision|4|||
156713669|NCT03765788|565696717|FG000|Overall Study|Death|0|||
156713670|NCT03765788|565696718|FG001|Overall Study|Death|1|||
156713671|NCT03765788|565696717|FG000|Overall Study|Lost to Follow-up|1|||
156713672|NCT03765788|565696718|FG001|Overall Study|Lost to Follow-up|0|||
156713673|NCT00064987|565696723|FG000|Overall Study|Physician Decision|3|||
156713674|NCT00064987|565696724|FG001|Overall Study|Physician Decision|0|||
156713675|NCT01567462|565696725|FG000|Overall Study|Withdrawal by Subject|4|||
156713676|NCT01567462|565696726|FG001|Overall Study|Withdrawal by Subject|7|||
156713677|NCT01720225|565696731|FG000|Overall Study|Withdrawal by Subject|0|||
156713678|NCT01720225|565696732|FG001|Overall Study|Withdrawal by Subject|1|||
156713679|NCT01720225|565696731|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
156713680|NCT01720225|565696732|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
156713681|NCT05223920|565696733|FG000|Overall Study|Adverse Event|6|||
156713682|NCT05223920|565696734|FG001|Overall Study|Adverse Event|3|||
156713683|NCT05223920|565696733|FG000|Overall Study|Death|2|||
156713684|NCT05223920|565696734|FG001|Overall Study|Death|0|||
156713685|NCT05223920|565696733|FG000|Overall Study|Disease Progression|1|||
156713686|NCT05223920|565696734|FG001|Overall Study|Disease Progression|2|||
156713687|NCT05223920|565696733|FG000|Overall Study|Physician Decision|1|||
156713688|NCT05223920|565696734|FG001|Overall Study|Physician Decision|2|||
156713689|NCT05223920|565696733|FG000|Overall Study|Sponsor decision|11|||
156713690|NCT05223920|565696734|FG001|Overall Study|Sponsor decision|9|||
156713691|NCT05223920|565696733|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
156713692|NCT05223920|565696734|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
156713693|NCT05223920|565696733|FG000|Overall Study|Subject decision|1|||
156713694|NCT05223920|565696734|FG001|Overall Study|Subject decision|0|||
156713695|NCT05223920|565696733|FG000|Overall Study|Withdrawal by Subject|1|||
156713696|NCT05223920|565696734|FG001|Overall Study|Withdrawal by Subject|6|||
156713697|NCT00369941|565696735|FG000|Overall Study|Never Treated|1|||
156713698|NCT00369941|565696736|FG001|Overall Study|Never Treated|2|||
156713699|NCT00369941|565696735|FG000|Overall Study|Adverse Event|14|||
156713700|NCT00369941|565696736|FG001|Overall Study|Adverse Event|28|||
156713701|NCT00369941|565696735|FG000|Overall Study|Lack of Efficacy|6|||
156713702|NCT00369941|565696736|FG001|Overall Study|Lack of Efficacy|10|||
156713703|NCT00369941|565696735|FG000|Overall Study|Lost to Follow-up|12|||
156713704|NCT00369941|565696736|FG001|Overall Study|Lost to Follow-up|22|||
156713705|NCT00369941|565696735|FG000|Overall Study|Protocol Violation|5|||
156713706|NCT00369941|565696736|FG001|Overall Study|Protocol Violation|3|||
156713707|NCT00369941|565696735|FG000|Overall Study|Withdrawal by Subject|5|||
156713708|NCT00369941|565696736|FG001|Overall Study|Withdrawal by Subject|18|||
156713709|NCT00369941|565696735|FG000|Overall Study|Pregnancy|4|||
156713710|NCT00369941|565696736|FG001|Overall Study|Pregnancy|2|||
156713711|NCT00369941|565696735|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
156713712|NCT00369941|565696736|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
156713713|NCT00369941|565696735|FG000|Overall Study|Moved|11|||
156713714|NCT00369941|565696736|FG001|Overall Study|Moved|5|||
156713715|NCT00369941|565696735|FG000|Overall Study|Treatment with Prohibited Medication|3|||
156713716|NCT00369941|565696736|FG001|Overall Study|Treatment with Prohibited Medication|1|||
156713717|NCT00369941|565696735|FG000|Overall Study|Employment Interfered with Study Visits|1|||
156713718|NCT00369941|565696736|FG001|Overall Study|Employment Interfered with Study Visits|0|||
156713719|NCT00369941|565696735|FG000|Overall Study|Study Site Terminated|2|||
156713720|NCT00369941|565696736|FG001|Overall Study|Study Site Terminated|0|||
156713721|NCT00369941|565696735|FG000|Overall Study|Miscellaneous|3|||
156713722|NCT00369941|565696736|FG001|Overall Study|Miscellaneous|3|||
156713723|NCT02964312|565696743|FG000|Overall Study|Lost to Follow-up|28|||
156713724|NCT02964312|565696743|FG000|Overall Study|Withdrawal by Subject|11|||
156713725|NCT02964312|565696743|FG000|Overall Study|Lack of Efficacy|10|||
156713726|NCT02964312|565696743|FG000|Overall Study|Did not consent to long-term FU|14|||
156713727|NCT02964312|565696743|FG000|Overall Study|Death|1|||
156713728|NCT02738138|565696744|FG000|Overall Study|Adverse Event|0|||
156874016|NCT00396253|566296185|FG000|Overall Study|Change in eligibility status|1|||
156874017|NCT05340478|566296186|FG000|Overall Study|Scheduling Issues|10|||
156874018|NCT05340478|566296187|FG001|Overall Study|Scheduling Issues|4|||
156874019|NCT05340478|566296186|FG000|Overall Study|Neither member of dyad started treatment|2|||
156874020|NCT05340478|566296187|FG001|Overall Study|Neither member of dyad started treatment|2|||
156874021|NCT05340478|566296186|FG000|Overall Study|Withdrawn from study|2|||
156713729|NCT02738138|565696745|FG001|Overall Study|Adverse Event|1|||
156874022|NCT05340478|566296187|FG001|Overall Study|Withdrawn from study|2|||
156532341|NCT04313153|565044981|FG001|Overall Study|Other|3|||
156713730|NCT02738138|565696744|FG000|Overall Study|Lost to Follow-up|2|||
156713731|NCT02738138|565696745|FG001|Overall Study|Lost to Follow-up|0|||
156713732|NCT02738138|565696744|FG000|Overall Study|Other - not further specified|1|||
156713733|NCT02738138|565696745|FG001|Overall Study|Other - not further specified|0|||
156713734|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Other|34|||
156713735|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Other|0|||
156713736|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Other|0|||
156713737|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Other|0|||
156713738|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Death|14|||
156713739|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Death|0|||
156713740|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Death|0|||
156713741|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Death|0|||
156713742|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
156713743|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
156713744|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
156713745|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
156713746|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
156713747|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
156713748|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
156713749|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
156713750|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
156713751|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
156713752|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
156713753|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
156713754|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
156713755|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
156713756|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
156713757|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
156713758|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
156713759|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
156713760|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
156713761|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
156713762|NCT01995513|565696749|FG000|Period 1: Second Open Label Treatment|Other|0|||
156713763|NCT01995513|565696750|FG001|Period 1: Second Open Label Treatment|Other|2|||
156713764|NCT01995513|565696751|FG002|Period 1: Second Open Label Treatment|Other|0|||
156713765|NCT01995513|565696752|FG003|Period 1: Second Open Label Treatment|Other|0|||
156713766|NCT01995513|565696749|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
156713767|NCT01995513|565696750|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
156713768|NCT01995513|565696751|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
156713769|NCT01995513|565696752|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
156713770|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Death|0|||
156713771|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Death|0|||
156713772|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Death|0|||
156713773|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Death|1|||
156713774|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Other|0|||
156713775|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Other|0|||
156713776|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Other|3|||
156713777|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Other|3|||
156713778|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
156713779|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
156713780|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
156713781|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
156713782|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
156713783|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
156713784|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
156713785|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
156713786|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
156713787|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
156713788|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
156874023|NCT05340478|566296186|FG000|Overall Study|Lost to Follow-up|1|||
156874024|NCT05340478|566296187|FG001|Overall Study|Lost to Follow-up|4|||
156874025|NCT00092443|566296190|FG000|Overall Study|Adverse Event|9|||
156874026|NCT00092443|566296191|FG001|Overall Study|Adverse Event|13|||
156713789|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
156713790|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
156713791|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
156713792|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
156713793|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
156713794|NCT01232452|565696753|FG000|Overall Study|Adverse Event|17|||
156713795|NCT01232452|565696754|FG001|Overall Study|Adverse Event|15|||
156874027|NCT00092443|566296190|FG000|Overall Study|Lost to Follow-up|7|||
156874028|NCT00092443|566296191|FG001|Overall Study|Lost to Follow-up|3|||
156874029|NCT00092443|566296190|FG000|Overall Study|Protocol Violation|11|||
156874030|NCT00092443|566296191|FG001|Overall Study|Protocol Violation|9|||
156713796|NCT01232452|565696753|FG000|Overall Study|Withdrawal by Subject|11|||
156713797|NCT01232452|565696754|FG001|Overall Study|Withdrawal by Subject|8|||
156713798|NCT01232452|565696753|FG000|Overall Study|Physician Decision|8|||
156713799|NCT01232452|565696754|FG001|Overall Study|Physician Decision|12|||
156713800|NCT01232452|565696753|FG000|Overall Study|Protocol entry criterion not met|0|||
156713801|NCT01232452|565696754|FG001|Overall Study|Protocol entry criterion not met|2|||
156713802|NCT01232452|565696753|FG000|Overall Study|Sponsor Decision|3|||
156713803|NCT01232452|565696754|FG001|Overall Study|Sponsor Decision|1|||
156713804|NCT01232452|565696753|FG000|Overall Study|Protocol Violation|0|||
156713805|NCT01232452|565696754|FG001|Overall Study|Protocol Violation|1|||
156713806|NCT05219448|565696759|FG000|Overall Study|Lost to Follow-up|9|||
156713807|NCT05219448|565696760|FG001|Overall Study|Lost to Follow-up|0|||
156713808|NCT01750190|565696761|FG000|Overall Study|Adverse Event|47|||
156713809|NCT01750190|565696762|FG001|Overall Study|Adverse Event|19|||
156713810|NCT01750190|565696761|FG000|Overall Study|Death|38|||
156713811|NCT01750190|565696762|FG001|Overall Study|Death|11|||
156713812|NCT01750190|565696761|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
156713813|NCT01750190|565696762|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
156713814|NCT01750190|565696761|FG000|Overall Study|Lost to Follow-up|28|||
156713815|NCT01750190|565696762|FG001|Overall Study|Lost to Follow-up|7|||
156713816|NCT01750190|565696761|FG000|Overall Study|Physician Decision|16|||
156713817|NCT01750190|565696762|FG001|Overall Study|Physician Decision|17|||
156713818|NCT01750190|565696761|FG000|Overall Study|Protocol Violation|6|||
156713819|NCT01750190|565696762|FG001|Overall Study|Protocol Violation|5|||
156713820|NCT01750190|565696761|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
156713821|NCT01750190|565696762|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
156713822|NCT01750190|565696761|FG000|Overall Study|Withdrawal by Subject|83|||
156713823|NCT01750190|565696762|FG001|Overall Study|Withdrawal by Subject|89|||
156713824|NCT01750190|565696761|FG000|Overall Study|Kidney Transplant|8|||
156713825|NCT01750190|565696762|FG001|Overall Study|Kidney Transplant|4|||
156713826|NCT01750190|565696761|FG000|Overall Study|Dialysis|22|||
156713827|NCT01750190|565696762|FG001|Overall Study|Dialysis|8|||
156713828|NCT01750190|565696761|FG000|Overall Study|Other than Specified|13|||
156713829|NCT01750190|565696762|FG001|Overall Study|Other than Specified|4|||
156713830|NCT03571828|565696767|FG000|Overall Study|Withdrawal by Subject|1|||
156713831|NCT03571828|565696768|FG001|Overall Study|Withdrawal by Subject|0|||
156713832|NCT03571828|565696767|FG000|Overall Study|Decision by sponsor|5|||
156713833|NCT03571828|565696768|FG001|Overall Study|Decision by sponsor|1|||
156713834|NCT03571828|565696767|FG000|Overall Study|Death|2|||
156713835|NCT03571828|565696768|FG001|Overall Study|Death|0|||
156713836|NCT02232984|565696769|FG000|Overall Study|Withdrawal by Subject|5|||
156713837|NCT02232984|565696769|FG000|Overall Study|Death|1|||
156713838|NCT02232984|565696769|FG000|Overall Study|Investigator withdrawal|10|||
156713839|NCT02232984|565696769|FG000|Overall Study|Device implant unsuccessful|53|||
156713840|NCT02232984|565696769|FG000|Overall Study|not disclosed by site|7|||
156713841|NCT02232984|565696769|FG000|Overall Study|Protocol Violation|1|||
156713842|NCT00769379|565696774|FG000|Overall Study|No follow up data mapped to Other.|3|||
156713843|NCT00769379|565696775|FG001|Overall Study|No follow up data mapped to Other.|13|||
156713844|NCT03762239|565696784|FG000|Overall Study|Appointment to the doctor|1|||
156713845|NCT03762239|565696785|FG001|Overall Study|Appointment to the doctor|1|||
156713846|NCT04597632|565696786|FG000|Overall Study|Withdrawal by Subject|10|||
156713847|NCT04597632|565696786|FG000|Overall Study|Lost to Follow-up|1|||
156713848|NCT04597632|565696786|FG000|Overall Study|Death|1|||
156713849|NCT04597632|565696786|FG000|Overall Study|Adverse Event|5|||
156713850|NCT04895982|565696787|FG000|Overall Study|Withdrawal by Subject|0|||
156713851|NCT04895982|565696788|FG001|Overall Study|Withdrawal by Subject|0|||
156792609|NCT01152385|565992838|FG001|Overall Study|Study-specific withdrawal criteria|1|||
156792610|NCT01152385|565992839|FG002|Overall Study|Study-specific withdrawal criteria|2|||
156792611|NCT01152385|565992840|FG003|Overall Study|Study-specific withdrawal criteria|0|||
156333076|NCT03355365|564319010|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
156333077|NCT03355365|564319011|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
156333078|NCT03355365|564319010|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
156333079|NCT03355365|564319011|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
156333080|NCT03355365|564319010|FG000|Year 2, Crossover Intervention|severe COVID|0|||
156713852|NCT04895982|565696789|FG002|Overall Study|Withdrawal by Subject|0|||
156713853|NCT04895982|565696790|FG003|Overall Study|Withdrawal by Subject|0|||
156713854|NCT04895982|565696791|FG004|Overall Study|Withdrawal by Subject|0|||
156713855|NCT04895982|565696792|FG005|Overall Study|Withdrawal by Subject|1|||
156333081|NCT03355365|564319011|FG001|Year 2, Crossover Intervention|severe COVID|1|||
156333082|NCT03355365|564319010|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
156333083|NCT03355365|564319011|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
156713856|NCT04895982|565696793|FG006|Overall Study|Withdrawal by Subject|1|||
156713857|NCT04895982|565696794|FG007|Overall Study|Withdrawal by Subject|0|||
156713858|NCT04895982|565696795|FG008|Overall Study|Withdrawal by Subject|0|||
156792612|NCT01152385|565992837|FG000|Overall Study|Other|4|||
156713859|NCT04895982|565696796|FG009|Overall Study|Withdrawal by Subject|1|||
156713860|NCT04895982|565696797|FG010|Overall Study|Withdrawal by Subject|0|||
156713861|NCT04895982|565696798|FG011|Overall Study|Withdrawal by Subject|1|||
156713862|NCT04895982|565696787|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156713863|NCT04895982|565696788|FG001|Overall Study|Withdrawal by parent/guardian|3|||
156713864|NCT04895982|565696789|FG002|Overall Study|Withdrawal by parent/guardian|3|||
156713865|NCT04895982|565696790|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156713866|NCT04895982|565696791|FG004|Overall Study|Withdrawal by parent/guardian|3|||
156713867|NCT04895982|565696792|FG005|Overall Study|Withdrawal by parent/guardian|2|||
156713868|NCT04895982|565696793|FG006|Overall Study|Withdrawal by parent/guardian|1|||
156713869|NCT04895982|565696794|FG007|Overall Study|Withdrawal by parent/guardian|0|||
156713870|NCT04895982|565696795|FG008|Overall Study|Withdrawal by parent/guardian|3|||
156713871|NCT04895982|565696796|FG009|Overall Study|Withdrawal by parent/guardian|0|||
156713872|NCT04895982|565696797|FG010|Overall Study|Withdrawal by parent/guardian|0|||
156713873|NCT04895982|565696798|FG011|Overall Study|Withdrawal by parent/guardian|0|||
156713874|NCT04895982|565696787|FG000|Overall Study|Other|0|||
156713875|NCT04895982|565696788|FG001|Overall Study|Other|0|||
156713876|NCT04895982|565696789|FG002|Overall Study|Other|1|||
156713877|NCT04895982|565696790|FG003|Overall Study|Other|1|||
156713878|NCT04895982|565696791|FG004|Overall Study|Other|0|||
156713879|NCT04895982|565696792|FG005|Overall Study|Other|0|||
156713880|NCT04895982|565696793|FG006|Overall Study|Other|0|||
156713881|NCT04895982|565696794|FG007|Overall Study|Other|0|||
156713882|NCT04895982|565696795|FG008|Overall Study|Other|0|||
156713883|NCT04895982|565696796|FG009|Overall Study|Other|1|||
156713884|NCT04895982|565696797|FG010|Overall Study|Other|0|||
156713885|NCT04895982|565696798|FG011|Overall Study|Other|0|||
156713886|NCT04895982|565696787|FG000|Overall Study|Protocol Violation|0|||
156713887|NCT04895982|565696788|FG001|Overall Study|Protocol Violation|0|||
156713888|NCT04895982|565696789|FG002|Overall Study|Protocol Violation|1|||
156713889|NCT04895982|565696790|FG003|Overall Study|Protocol Violation|1|||
156713890|NCT04895982|565696791|FG004|Overall Study|Protocol Violation|1|||
156713891|NCT04895982|565696792|FG005|Overall Study|Protocol Violation|0|||
156713892|NCT04895982|565696793|FG006|Overall Study|Protocol Violation|0|||
156713893|NCT04895982|565696794|FG007|Overall Study|Protocol Violation|1|||
156713894|NCT04895982|565696795|FG008|Overall Study|Protocol Violation|0|||
156713895|NCT04895982|565696796|FG009|Overall Study|Protocol Violation|0|||
156713896|NCT04895982|565696797|FG010|Overall Study|Protocol Violation|0|||
156713897|NCT04895982|565696798|FG011|Overall Study|Protocol Violation|0|||
156713898|NCT04895982|565696787|FG000|Overall Study|Lost to Follow-up|0|||
156713899|NCT04895982|565696788|FG001|Overall Study|Lost to Follow-up|0|||
156713900|NCT04895982|565696789|FG002|Overall Study|Lost to Follow-up|1|||
156713901|NCT04895982|565696790|FG003|Overall Study|Lost to Follow-up|0|||
156713902|NCT04895982|565696791|FG004|Overall Study|Lost to Follow-up|0|||
156713903|NCT04895982|565696792|FG005|Overall Study|Lost to Follow-up|1|||
156713904|NCT04895982|565696793|FG006|Overall Study|Lost to Follow-up|0|||
156713905|NCT04895982|565696794|FG007|Overall Study|Lost to Follow-up|0|||
156713906|NCT04895982|565696795|FG008|Overall Study|Lost to Follow-up|1|||
156713907|NCT04895982|565696796|FG009|Overall Study|Lost to Follow-up|0|||
156713908|NCT04895982|565696797|FG010|Overall Study|Lost to Follow-up|0|||
156713909|NCT04895982|565696798|FG011|Overall Study|Lost to Follow-up|0|||
156713910|NCT04895982|565696787|FG000|Overall Study|Refused further study procedures|0|||
156713911|NCT04895982|565696788|FG001|Overall Study|Refused further study procedures|0|||
156713912|NCT04895982|565696789|FG002|Overall Study|Refused further study procedures|1|||
156713913|NCT04895982|565696790|FG003|Overall Study|Refused further study procedures|0|||
156713914|NCT04895982|565696791|FG004|Overall Study|Refused further study procedures|0|||
156713915|NCT04895982|565696792|FG005|Overall Study|Refused further study procedures|0|||
156713916|NCT04895982|565696793|FG006|Overall Study|Refused further study procedures|0|||
156713917|NCT04895982|565696794|FG007|Overall Study|Refused further study procedures|0|||
156713918|NCT04895982|565696795|FG008|Overall Study|Refused further study procedures|0|||
156713919|NCT04895982|565696796|FG009|Overall Study|Refused further study procedures|0|||
156792613|NCT01152385|565992838|FG001|Overall Study|Other|3|||
156792614|NCT01152385|565992839|FG002|Overall Study|Other|2|||
156713920|NCT04895982|565696797|FG010|Overall Study|Refused further study procedures|0|||
156713921|NCT04895982|565696798|FG011|Overall Study|Refused further study procedures|0|||
156713922|NCT02517463|565696804|FG000|Overall Study|Lost to Follow-up|5|||
156713923|NCT02517463|565696805|FG001|Overall Study|Lost to Follow-up|2|||
156713924|NCT00489827|565696813|FG000|Overall Study|Intraoperative exclusion criteria|1|||
156792615|NCT01152385|565992840|FG003|Overall Study|Other|3|||
156713925|NCT00489827|565696814|FG001|Overall Study|Intraoperative exclusion criteria|1|||
156713926|NCT00489827|565696813|FG000|Overall Study|Intraoperative exclusion criteria|1|||
156713927|NCT00489827|565696814|FG001|Overall Study|Intraoperative exclusion criteria|1|||
156713928|NCT02296931|565696815|FG000|Overall Study|Protocol Violation|0|||
156713929|NCT02296931|565696816|FG001|Overall Study|Protocol Violation|2|||
156713930|NCT01590277|565696817|FG000|Overall Study|Withdrawal by Subject|3|||
156713931|NCT01590277|565696817|FG000|Overall Study|Withdrawal by Subject|2|||
156792616|NCT02656173|565992841|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
156713932|NCT01590277|565696817|FG000|Overall Study|Withdrawal by Subject|1|||
156713933|NCT01590277|565696817|FG000|Overall Study|Withdrawal by Subject|1|||
156713934|NCT04386616|565696818|FG000|Overall Study|Death|22|||
156713935|NCT04386616|565696819|FG001|Overall Study|Death|22|||
156713936|NCT04386616|565696820|FG002|Overall Study|Death|21|||
156713937|NCT04386616|565696818|FG000|Overall Study|Lost to Follow-up|5|||
156713938|NCT04386616|565696819|FG001|Overall Study|Lost to Follow-up|8|||
156713939|NCT04386616|565696820|FG002|Overall Study|Lost to Follow-up|6|||
156713940|NCT04386616|565696818|FG000|Overall Study|Withdrawal by Subject|2|||
156713941|NCT04386616|565696819|FG001|Overall Study|Withdrawal by Subject|4|||
156713942|NCT04386616|565696820|FG002|Overall Study|Withdrawal by Subject|1|||
156713943|NCT04386616|565696818|FG000|Overall Study|Adverse Event|1|||
156713944|NCT04386616|565696819|FG001|Overall Study|Adverse Event|1|||
156713945|NCT04386616|565696820|FG002|Overall Study|Adverse Event|0|||
156713946|NCT01377012|565696821|FG000|Core Study|Study terminated by Sponsor|47|||
156713947|NCT01377012|565696822|FG001|Core Study|Study terminated by Sponsor|54|||
156713948|NCT01377012|565696823|FG002|Core Study|Study terminated by Sponsor|46|||
156713949|NCT01377012|565696821|FG000|Core Study|Technical problems|1|||
156713950|NCT01377012|565696822|FG001|Core Study|Technical problems|0|||
156713951|NCT01377012|565696823|FG002|Core Study|Technical problems|0|||
156713952|NCT01377012|565696821|FG000|Core Study|Withdrawal by Subject|15|||
156713953|NCT01377012|565696822|FG001|Core Study|Withdrawal by Subject|23|||
156713954|NCT01377012|565696823|FG002|Core Study|Withdrawal by Subject|18|||
156713955|NCT01377012|565696821|FG000|Core Study|Protocol Violation|7|||
156713956|NCT01377012|565696822|FG001|Core Study|Protocol Violation|3|||
156713957|NCT01377012|565696823|FG002|Core Study|Protocol Violation|2|||
156713958|NCT01377012|565696821|FG000|Core Study|Pregnancy|0|||
156713959|NCT01377012|565696822|FG001|Core Study|Pregnancy|0|||
156713960|NCT01377012|565696823|FG002|Core Study|Pregnancy|1|||
156713961|NCT01377012|565696821|FG000|Core Study|Physician Decision|5|||
156713962|NCT01377012|565696822|FG001|Core Study|Physician Decision|4|||
156713963|NCT01377012|565696823|FG002|Core Study|Physician Decision|10|||
156713964|NCT01377012|565696821|FG000|Core Study|Non-Compliant with study treatment|0|||
156713965|NCT01377012|565696822|FG001|Core Study|Non-Compliant with study treatment|0|||
156713966|NCT01377012|565696823|FG002|Core Study|Non-Compliant with study treatment|1|||
156713967|NCT01377012|565696821|FG000|Core Study|No Longer require treatment|0|||
156713968|NCT01377012|565696822|FG001|Core Study|No Longer require treatment|0|||
156713969|NCT01377012|565696823|FG002|Core Study|No Longer require treatment|1|||
156713970|NCT01377012|565696821|FG000|Core Study|Lost to Follow-up|7|||
156713971|NCT01377012|565696822|FG001|Core Study|Lost to Follow-up|5|||
156713972|NCT01377012|565696823|FG002|Core Study|Lost to Follow-up|4|||
156713973|NCT01377012|565696821|FG000|Core Study|Lack of Efficacy|41|||
156713974|NCT01377012|565696822|FG001|Core Study|Lack of Efficacy|28|||
156713975|NCT01377012|565696823|FG002|Core Study|Lack of Efficacy|37|||
156713976|NCT01377012|565696821|FG000|Core Study|Death|1|||
156713977|NCT01377012|565696822|FG001|Core Study|Death|1|||
156713978|NCT01377012|565696823|FG002|Core Study|Death|1|||
156713979|NCT01377012|565696821|FG000|Core Study|Adverse Event|10|||
156713980|NCT01377012|565696822|FG001|Core Study|Adverse Event|14|||
156713981|NCT01377012|565696823|FG002|Core Study|Adverse Event|13|||
156713982|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
156713983|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
156713984|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
156713985|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
156713986|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
156713987|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
156713988|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
156713989|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
156713990|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
156713991|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
156713992|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
156713993|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
156713994|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
156713995|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
156713996|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
156713997|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
156713998|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
156713999|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
156714000|NCT01632280|565696850|FG000|Overall Study|Withdrawal by Subject|1|||
156714001|NCT01632280|565696851|FG001|Overall Study|Withdrawal by Subject|0|||
156714002|NCT03736031|565696854|FG000|Overall Study|Death|2|||
156714003|NCT03736031|565696855|FG001|Overall Study|Death|4|||
156714004|NCT03736031|565696854|FG000|Overall Study|Lost to Follow-up|21|||
156714005|NCT03736031|565696855|FG001|Overall Study|Lost to Follow-up|2|||
156714006|NCT03736031|565696854|FG000|Overall Study|Withdrawal by Subject|9|||
156714007|NCT03736031|565696855|FG001|Overall Study|Withdrawal by Subject|0|||
156714008|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
156714009|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
156714010|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
156714011|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
156714012|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
156714013|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
156714014|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
156714015|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
156714016|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
156714017|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
156714018|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
156714019|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
156714020|NCT00451178|565696858|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
156714021|NCT00451178|565696859|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
156714022|NCT00451178|565696858|FG000|Prior to Maintenance Therapy|PD|2|||
156714023|NCT00451178|565696859|FG001|Prior to Maintenance Therapy|PD|0|||
156714024|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
156714025|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
156714026|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
156714027|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
156714028|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
156714029|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
156714030|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
156714031|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
156714032|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
156714033|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
156714034|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
156714035|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
156714036|NCT00451178|565696858|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
156714037|NCT00451178|565696859|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
156714038|NCT05221320|565699266|FG000|Overall Study|Lack of Efficacy|3|||
156714039|NCT05221320|565699267|FG001|Overall Study|Lack of Efficacy|7|||
156714040|NCT05221320|565699268|FG002|Overall Study|Lack of Efficacy|10|||
156714041|NCT05221320|565699269|FG003|Overall Study|Lack of Efficacy|1|||
156714042|NCT05221320|565699270|FG004|Overall Study|Lack of Efficacy|0|||
156714043|NCT05221320|565699271|FG005|Overall Study|Lack of Efficacy|0|||
156714044|NCT05221320|565699266|FG000|Overall Study|Physician Decision|1|||
156714045|NCT05221320|565699267|FG001|Overall Study|Physician Decision|0|||
156714046|NCT05221320|565699268|FG002|Overall Study|Physician Decision|3|||
156714047|NCT05221320|565699269|FG003|Overall Study|Physician Decision|1|||
156714048|NCT05221320|565699270|FG004|Overall Study|Physician Decision|0|||
156714049|NCT05221320|565699271|FG005|Overall Study|Physician Decision|0|||
156714050|NCT05221320|565699266|FG000|Overall Study|Withdrawal by Subject|0|||
156714051|NCT05221320|565699267|FG001|Overall Study|Withdrawal by Subject|3|||
156714052|NCT05221320|565699268|FG002|Overall Study|Withdrawal by Subject|1|||
156714053|NCT05221320|565699269|FG003|Overall Study|Withdrawal by Subject|0|||
156714054|NCT05221320|565699270|FG004|Overall Study|Withdrawal by Subject|0|||
156714055|NCT05221320|565699271|FG005|Overall Study|Withdrawal by Subject|0|||
156714056|NCT05221320|565699266|FG000|Overall Study|Death|0|||
156714057|NCT05221320|565699267|FG001|Overall Study|Death|5|||
156714058|NCT05221320|565699268|FG002|Overall Study|Death|6|||
156714059|NCT05221320|565699269|FG003|Overall Study|Death|0|||
156714060|NCT05221320|565699270|FG004|Overall Study|Death|1|||
156714061|NCT05221320|565699271|FG005|Overall Study|Death|0|||
156714062|NCT03300817|565699272|FG000|Overall Study|Withdrawal by Subject|1|||
156714063|NCT03300817|565699272|FG000|Overall Study|Adverse Event|1|||
156714064|NCT03300817|565699272|FG000|Overall Study|Subject Found to be Ineligible|2|||
156714065|NCT03729596|565699274|FG000|Overall Study|Death|3|||
156714066|NCT03729596|565699275|FG001|Overall Study|Death|5|||
156714067|NCT03729596|565699276|FG002|Overall Study|Death|4|||
156714068|NCT03729596|565699277|FG003|Overall Study|Death|1|||
156714069|NCT03729596|565699278|FG004|Overall Study|Death|0|||
156714070|NCT03729596|565699279|FG005|Overall Study|Death|34|||
156714071|NCT03729596|565699280|FG006|Overall Study|Death|18|||
156714072|NCT03729596|565699281|FG007|Overall Study|Death|14|||
156714073|NCT03729596|565699282|FG008|Overall Study|Death|19|||
156714074|NCT03729596|565699283|FG009|Overall Study|Death|9|||
156714075|NCT03729596|565699274|FG000|Overall Study|Lost to Follow-up|0|||
156714076|NCT03729596|565699275|FG001|Overall Study|Lost to Follow-up|0|||
156714077|NCT03729596|565699276|FG002|Overall Study|Lost to Follow-up|0|||
156714078|NCT03729596|565699277|FG003|Overall Study|Lost to Follow-up|0|||
156714079|NCT03729596|565699278|FG004|Overall Study|Lost to Follow-up|0|||
156714080|NCT03729596|565699279|FG005|Overall Study|Lost to Follow-up|0|||
156714081|NCT03729596|565699280|FG006|Overall Study|Lost to Follow-up|1|||
156442972|NCT02152137|564713439|FG000|Overall Study|Originally assigned to Arm B|3|||
156714082|NCT03729596|565699281|FG007|Overall Study|Lost to Follow-up|0|||
156714083|NCT03729596|565699282|FG008|Overall Study|Lost to Follow-up|0|||
156714084|NCT03729596|565699283|FG009|Overall Study|Lost to Follow-up|1|||
156714085|NCT03729596|565699274|FG000|Overall Study|protocol amendment|0|||
156714086|NCT03729596|565699275|FG001|Overall Study|protocol amendment|1|||
156714087|NCT03729596|565699276|FG002|Overall Study|protocol amendment|3|||
156714088|NCT03729596|565699277|FG003|Overall Study|protocol amendment|6|||
156714089|NCT03729596|565699278|FG004|Overall Study|protocol amendment|5|||
156714090|NCT03729596|565699279|FG005|Overall Study|protocol amendment|0|||
156714091|NCT03729596|565699280|FG006|Overall Study|protocol amendment|0|||
156714092|NCT03729596|565699281|FG007|Overall Study|protocol amendment|0|||
156714093|NCT03729596|565699282|FG008|Overall Study|protocol amendment|0|||
156714094|NCT03729596|565699283|FG009|Overall Study|protocol amendment|0|||
156714095|NCT03729596|565699274|FG000|Overall Study|Withdrawal by Subject|0|||
156714096|NCT03729596|565699275|FG001|Overall Study|Withdrawal by Subject|0|||
156714097|NCT03729596|565699276|FG002|Overall Study|Withdrawal by Subject|0|||
156714098|NCT03729596|565699277|FG003|Overall Study|Withdrawal by Subject|0|||
156714099|NCT03729596|565699278|FG004|Overall Study|Withdrawal by Subject|0|||
156714100|NCT03729596|565699279|FG005|Overall Study|Withdrawal by Subject|4|||
156714101|NCT03729596|565699280|FG006|Overall Study|Withdrawal by Subject|2|||
156714102|NCT03729596|565699281|FG007|Overall Study|Withdrawal by Subject|3|||
156714103|NCT03729596|565699282|FG008|Overall Study|Withdrawal by Subject|2|||
156714104|NCT03729596|565699283|FG009|Overall Study|Withdrawal by Subject|3|||
156714105|NCT03729596|565699274|FG000|Overall Study|study terminated by sponsor|0|||
156714106|NCT03729596|565699275|FG001|Overall Study|study terminated by sponsor|0|||
156714107|NCT03729596|565699276|FG002|Overall Study|study terminated by sponsor|0|||
156714108|NCT03729596|565699277|FG003|Overall Study|study terminated by sponsor|0|||
156714109|NCT03729596|565699278|FG004|Overall Study|study terminated by sponsor|1|||
156714110|NCT03729596|565699279|FG005|Overall Study|study terminated by sponsor|3|||
156714111|NCT03729596|565699280|FG006|Overall Study|study terminated by sponsor|0|||
156714112|NCT03729596|565699281|FG007|Overall Study|study terminated by sponsor|1|||
156714113|NCT03729596|565699282|FG008|Overall Study|study terminated by sponsor|0|||
156714114|NCT03729596|565699283|FG009|Overall Study|study terminated by sponsor|0|||
156714115|NCT02498613|565699285|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
156714116|NCT02498613|565699286|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
156714117|NCT02498613|565699287|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
156714118|NCT02498613|565699288|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
156714119|NCT02498613|565699285|FG000|Overall Study|Withdrawal by Subject|3|||
156714120|NCT02498613|565699286|FG001|Overall Study|Withdrawal by Subject|1|||
156442973|NCT04878354|564713440|FG000|Overall Study|Adverse Event|4|||
156442974|NCT04878354|564713441|FG001|Overall Study|Adverse Event|13|||
156442975|NCT04878354|564713440|FG000|Overall Study|Withdrawal by Subject|14|||
156714121|NCT02498613|565699287|FG002|Overall Study|Withdrawal by Subject|0|||
156714122|NCT02498613|565699288|FG003|Overall Study|Withdrawal by Subject|0|||
156714123|NCT05168202|565699289|FG000|Overall Study|Progressive Disease|4|||
156442976|NCT04878354|564713441|FG001|Overall Study|Withdrawal by Subject|12|||
156442977|NCT04878354|564713440|FG000|Overall Study|Lost to Follow-up|4|||
156442978|NCT04878354|564713441|FG001|Overall Study|Lost to Follow-up|1|||
156442979|NCT04878354|564713440|FG000|Overall Study|Lack of Efficacy|1|||
156442980|NCT04878354|564713441|FG001|Overall Study|Lack of Efficacy|0|||
156442981|NCT04878354|564713440|FG000|Overall Study|Protocol Violation|0|||
156442982|NCT04878354|564713441|FG001|Overall Study|Protocol Violation|1|||
156442983|NCT04878354|564713440|FG000|Overall Study|"Reason stated as other in CRF"|2|||
156442984|NCT04878354|564713441|FG001|Overall Study|"Reason stated as other in CRF"|3|||
156442985|NCT03358875|564713442|FG000|Overall Study|Death|409|||
156442986|NCT03358875|564713443|FG001|Overall Study|Death|223|||
156442987|NCT03358875|564713442|FG000|Overall Study|Study Closed by Sponsor|66|||
156442988|NCT03358875|564713443|FG001|Overall Study|Study Closed by Sponsor|29|||
156442989|NCT03358875|564713442|FG000|Overall Study|Withdrawal by Subject|13|||
156442990|NCT03358875|564713443|FG001|Overall Study|Withdrawal by Subject|16|||
156442991|NCT03358875|564713442|FG000|Overall Study|Lost to Follow-up|13|||
156442992|NCT03358875|564713443|FG001|Overall Study|Lost to Follow-up|2|||
156442993|NCT03358875|564713442|FG000|Overall Study|Miscellaneous|33|||
156442994|NCT03358875|564713443|FG001|Overall Study|Miscellaneous|0|||
156442995|NCT03358875|564713442|FG000|Overall Study|Remained on Study|1|||
156442996|NCT03358875|564713443|FG001|Overall Study|Remained on Study|0|||
156442997|NCT05307783|564713456|FG000|Overall Study|Death|7|||
156714124|NCT05168202|565699290|FG001|Overall Study|Progressive Disease|4|||
156714125|NCT05168202|565699291|FG002|Overall Study|Progressive Disease|2|||
156714126|NCT05168202|565699292|FG003|Overall Study|Progressive Disease|3|||
156714127|NCT05168202|565699293|FG004|Overall Study|Progressive Disease|2|||
156442998|NCT05307783|564713456|FG000|Overall Study|Lost to Follow-up|4|||
156442999|NCT04883645|564713457|FG000|Overall Study|Death|1|||
156443000|NCT03460236|564713462|FG000|Overall Study|failed radiographic screening|16|||
156443001|NCT03460236|564713462|FG000|Overall Study|Withdrawal by Subject|11|||
156443002|NCT06194214|564713463|FG000|Overall Study|Adverse Event|1|||
156443003|NCT04540913|564713464|FG000|Overall Study|Withdrawal by Subject|14|||
156443004|NCT04540913|564713465|FG001|Overall Study|Withdrawal by Subject|3|||
156714128|NCT05168202|565699294|FG005|Overall Study|Progressive Disease|3|||
156714129|NCT05168202|565699295|FG006|Overall Study|Progressive Disease|2|||
156874031|NCT00092443|566296190|FG000|Overall Study|Withdrawal by Subject|9|||
156874032|NCT00092443|566296191|FG001|Overall Study|Withdrawal by Subject|11|||
156874033|NCT00092443|566296190|FG000|Overall Study|Moved|5|||
156874034|NCT00092443|566296191|FG001|Overall Study|Moved|5|||
156874035|NCT00092443|566296190|FG000|Overall Study|Other|17|||
156874036|NCT00092443|566296191|FG001|Overall Study|Other|13|||
156874037|NCT04717336|566296192|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
156874038|NCT04717336|566296193|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
156874039|NCT04717336|566296192|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
156874040|NCT04717336|566296193|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
156874041|NCT02039843|566296194|FG000|Randomization and Observation Period|Adverse Event|2|||
156874042|NCT02039843|566296195|FG001|Randomization and Observation Period|Adverse Event|0|||
156874043|NCT02039843|566296194|FG000|Randomization and Observation Period|Death|1|||
156874044|NCT02039843|566296195|FG001|Randomization and Observation Period|Death|0|||
156874045|NCT02039843|566296194|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
156874046|NCT02039843|566296195|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
156874047|NCT02039843|566296194|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
156874048|NCT02039843|566296195|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
156874049|NCT02039843|566296194|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
156874050|NCT02039843|566296195|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
156874051|NCT02039843|566296194|FG000|Pairing With a Study Dog|Death|1|||
156443005|NCT04300231|564713466|FG000|Overall Study|Protocol Violation|4|||
156443006|NCT04300231|564713467|FG001|Overall Study|Protocol Violation|3|||
156443007|NCT04300231|564713468|FG002|Overall Study|Protocol Violation|0|||
156874052|NCT02039843|566296195|FG001|Pairing With a Study Dog|Death|0|||
156874053|NCT02039843|566296194|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
156874054|NCT02039843|566296195|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
156874055|NCT02039843|566296194|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
156874056|NCT02039843|566296195|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
156874057|NCT02039843|566296194|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
156874058|NCT02039843|566296195|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
156874059|NCT01500720|566296199|FG000|Overall Study|Randomized But Not Treated|1|||
156874060|NCT01500720|566296200|FG001|Overall Study|Randomized But Not Treated|1|||
156874061|NCT01500720|566296199|FG000|Overall Study|Other|4|||
156874062|NCT01500720|566296200|FG001|Overall Study|Other|8|||
156874063|NCT04672655|566296201|FG000|Overall Study|Lost to Follow-up|12|||
156874064|NCT04672655|566296202|FG001|Overall Study|Lost to Follow-up|17|||
156874065|NCT04672655|566296201|FG000|Overall Study|Withdrawal by Subject|1|||
156874066|NCT04672655|566296202|FG001|Overall Study|Withdrawal by Subject|0|||
156874067|NCT04672655|566296201|FG000|Overall Study|Withdrawal by Study|1|||
156874068|NCT04672655|566296202|FG001|Overall Study|Withdrawal by Study|0|||
156874069|NCT03079102|566298538|FG000|Overall Study|Physician Decision|0|||
156874070|NCT03079102|566298539|FG001|Overall Study|Physician Decision|1|||
156874071|NCT02923921|566298540|FG000|Overall Study|Sponsor Decision|39|||
156874072|NCT02923921|566298541|FG001|Overall Study|Sponsor Decision|38|||
156874073|NCT02923921|566298540|FG000|Overall Study|Lost to Follow-up|1|||
156874074|NCT02923921|566298541|FG001|Overall Study|Lost to Follow-up|0|||
156874075|NCT02923921|566298540|FG000|Overall Study|Withdrawal by Subject|6|||
156874076|NCT02923921|566298541|FG001|Overall Study|Withdrawal by Subject|13|||
156874077|NCT02923921|566298540|FG000|Overall Study|Unknown, Not Collected|7|||
156443008|NCT04300231|564713469|FG003|Overall Study|Protocol Violation|2|||
156443009|NCT03050814|564713473|FG000|Overall Study|Screen failures|0|||
156443010|NCT03050814|564713474|FG001|Overall Study|Screen failures|0|||
156443011|NCT03050814|564713475|FG002|Overall Study|Screen failures|4|||
156443012|NCT00431834|564713481|FG000|Overall Study|Withdrawal by Subject|7|||
156443013|NCT00431834|564713481|FG000|Overall Study|Death|3|||
156443014|NCT00431834|564713481|FG000|Overall Study|Missed Endpoint Visit|2|||
156443015|NCT00431834|564713481|FG000|Overall Study|Lost to Follow-up|1|||
156443016|NCT01808339|564713482|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
156443017|NCT01808339|564713483|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
156443018|NCT01808339|564713484|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
156443019|NCT01808339|564713485|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
156443020|NCT01808339|564713486|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
156443021|NCT01808339|564713487|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
156443022|NCT01808339|564713482|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156874078|NCT02923921|566298541|FG001|Overall Study|Unknown, Not Collected|6|||
156874079|NCT00854113|566298545|FG000|Overall Study|Adverse Event|0|||
156874080|NCT00854113|566298546|FG001|Overall Study|Adverse Event|0|||
156874081|NCT00854113|566298547|FG002|Overall Study|Adverse Event|0|||
156874082|NCT00854113|566298548|FG003|Overall Study|Adverse Event|0|||
156874083|NCT00854113|566298549|FG004|Overall Study|Adverse Event|0|||
156874084|NCT00854113|566298550|FG005|Overall Study|Adverse Event|0|||
156532342|NCT04313153|565044982|FG002|Overall Study|Other|2|||
156874085|NCT00854113|566298551|FG006|Overall Study|Adverse Event|0|||
156874086|NCT00854113|566298552|FG007|Overall Study|Adverse Event|2|||
156874087|NCT00854113|566298553|FG008|Overall Study|Adverse Event|0|||
156874088|NCT00854113|566298554|FG009|Overall Study|Adverse Event|0|||
156874089|NCT00854113|566298555|FG010|Overall Study|Adverse Event|0|||
156874090|NCT00854113|566298545|FG000|Overall Study|Withdrawal by Subject|0|||
156874091|NCT00854113|566298546|FG001|Overall Study|Withdrawal by Subject|0|||
156532343|NCT05586269|565044983|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
156532344|NCT05586269|565044984|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
156532345|NCT05586269|565044985|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
156532346|NCT05586269|565044986|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
156532347|NCT05586269|565044983|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
156532348|NCT05586269|565044984|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
156532349|NCT05586269|565044985|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
156532350|NCT05586269|565044986|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
156532351|NCT04752475|565044987|FG000|Overall Study|Withdrawal by Subject|1|||
156532352|NCT04752475|565044988|FG001|Overall Study|Withdrawal by Subject|1|||
156532353|NCT03335163|565044992|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
156532354|NCT03335163|565044992|FG000|Overall Study|Withdrawal by Subject|18|||
156532355|NCT02020863|565044993|FG000|Overall Study|Discovery of Metastatic disease|4|||
156532356|NCT02020863|565044993|FG000|Overall Study|Team chose not to place an a line|1|||
156532357|NCT00702845|565044994|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
156532358|NCT00702845|565044995|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
156532359|NCT00702845|565044994|FG000|Overall Study|Too high ovarian response|5|||
156532360|NCT00702845|565044995|FG001|Overall Study|Too high ovarian response|1|||
156532361|NCT00702845|565044994|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
156874092|NCT00854113|566298547|FG002|Overall Study|Withdrawal by Subject|0|||
156874093|NCT00854113|566298548|FG003|Overall Study|Withdrawal by Subject|0|||
156874094|NCT00854113|566298549|FG004|Overall Study|Withdrawal by Subject|0|||
156874095|NCT00854113|566298550|FG005|Overall Study|Withdrawal by Subject|0|||
156874096|NCT00854113|566298551|FG006|Overall Study|Withdrawal by Subject|0|||
156874097|NCT00854113|566298552|FG007|Overall Study|Withdrawal by Subject|1|||
156874098|NCT00854113|566298553|FG008|Overall Study|Withdrawal by Subject|1|||
156874099|NCT00854113|566298554|FG009|Overall Study|Withdrawal by Subject|0|||
156874100|NCT00854113|566298555|FG010|Overall Study|Withdrawal by Subject|0|||
156874101|NCT00796419|566298557|FG000|Overall Study|Death|0|||
156874102|NCT00796419|566298558|FG001|Overall Study|Death|1|||
156874103|NCT00539864|566298559|FG000|Overall Study|Lost to Follow-up|0|||
156874104|NCT00539864|566298560|FG001|Overall Study|Lost to Follow-up|1|||
156874105|NCT00539864|566298559|FG000|Overall Study|Withdrawal by Subject|1|||
156874106|NCT00539864|566298560|FG001|Overall Study|Withdrawal by Subject|1|||
156874107|NCT01250145|566298563|FG000|Overall Study|Adverse Event|2|||
156874108|NCT01250145|566298564|FG001|Overall Study|Adverse Event|1|||
156443023|NCT01808339|564713483|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156443024|NCT01808339|564713484|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156443025|NCT01808339|564713485|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156443026|NCT01808339|564713486|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156443027|NCT01808339|564713487|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156443028|NCT01808339|564713482|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
156443029|NCT01808339|564713483|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
156443030|NCT01808339|564713484|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
156443031|NCT01808339|564713485|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
156443032|NCT01808339|564713486|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
156443033|NCT01808339|564713487|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
156443034|NCT00111813|564713497|FG000|Overall Study|Adverse Event|1|||
156443035|NCT00111813|564713498|FG001|Overall Study|Adverse Event|2|||
156443036|NCT00111813|564713499|FG002|Overall Study|Adverse Event|4|||
156443037|NCT00111813|564713500|FG003|Overall Study|Adverse Event|2|||
156443038|NCT00111813|564713501|FG004|Overall Study|Adverse Event|2|||
156443039|NCT00111813|564713502|FG005|Overall Study|Adverse Event|2|||
156443040|NCT00111813|564713497|FG000|Overall Study|Progressive disease|2|||
156443041|NCT00111813|564713498|FG001|Overall Study|Progressive disease|1|||
156443042|NCT00111813|564713499|FG002|Overall Study|Progressive disease|5|||
156443043|NCT00111813|564713500|FG003|Overall Study|Progressive disease|3|||
156443044|NCT00111813|564713501|FG004|Overall Study|Progressive disease|4|||
156443045|NCT00111813|564713502|FG005|Overall Study|Progressive disease|3|||
156443046|NCT00111813|564713497|FG000|Overall Study|Lack of Efficacy|0|||
156874109|NCT01250145|566298563|FG000|Overall Study|Withdrawal by Subject|0|||
156874110|NCT01250145|566298564|FG001|Overall Study|Withdrawal by Subject|4|||
156874111|NCT02840799|566298565|FG000|Phase 1|Physician Decision|1|||
156443047|NCT00111813|564713498|FG001|Overall Study|Lack of Efficacy|0|||
156443048|NCT00111813|564713499|FG002|Overall Study|Lack of Efficacy|0|||
156443049|NCT00111813|564713500|FG003|Overall Study|Lack of Efficacy|0|||
156532362|NCT00702845|565044995|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
156532363|NCT00702845|565044994|FG000|Overall Study|Insufficient ovarian response|1|||
156532364|NCT00702845|565044995|FG001|Overall Study|Insufficient ovarian response|0|||
156532365|NCT00702845|565044994|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
156532366|NCT00702845|565044995|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
156532367|NCT00702845|565044994|FG000|Overall Study|No or abnormal fertilization|4|||
156532368|NCT00702845|565044995|FG001|Overall Study|No or abnormal fertilization|2|||
156532369|NCT00702845|565044994|FG000|Overall Study|Patient's decision|2|||
156532370|NCT00702845|565044995|FG001|Overall Study|Patient's decision|1|||
156532371|NCT00702845|565044994|FG000|Overall Study|Not randomized|0|||
156532372|NCT00702845|565044995|FG001|Overall Study|Not randomized|1|||
156532373|NCT01448213|565045000|FG000|Overall Study|Lost to Follow-up|12|||
156532374|NCT01448213|565045001|FG001|Overall Study|Lost to Follow-up|10|||
156532375|NCT01448213|565045000|FG000|Overall Study|Adverse Event|4|||
156532376|NCT01448213|565045001|FG001|Overall Study|Adverse Event|10|||
156532377|NCT01448213|565045000|FG000|Overall Study|Protocol Violation|1|||
156532378|NCT01448213|565045001|FG001|Overall Study|Protocol Violation|2|||
156532379|NCT04606771|565045007|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
156532380|NCT04606771|565045008|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
156532381|NCT04606771|565045007|FG000|Overall Study|Death|5|||
156532382|NCT04606771|565045008|FG001|Overall Study|Death|6|||
156532383|NCT04606771|565045007|FG000|Overall Study|Wrong randomisation|0|||
156532384|NCT04606771|565045008|FG001|Overall Study|Wrong randomisation|1|||
156532385|NCT03083847|565045011|FG000|Main|Physician Decision|0|||
156532386|NCT03083847|565045012|FG001|Main|Physician Decision|0|||
156532387|NCT03083847|565045013|FG002|Main|Physician Decision|0|||
156532388|NCT03083847|565045014|FG003|Main|Physician Decision|0|||
156532389|NCT03083847|565045015|FG004|Main|Physician Decision|0|||
156532390|NCT03083847|565045016|FG005|Main|Physician Decision|1|||
156532391|NCT03083847|565045017|FG006|Main|Physician Decision|0|||
156714130|NCT05168202|565699289|FG000|Overall Study|Adverse Event|2|||
156714131|NCT05168202|565699290|FG001|Overall Study|Adverse Event|1|||
156714132|NCT05168202|565699291|FG002|Overall Study|Adverse Event|4|||
156714133|NCT05168202|565699292|FG003|Overall Study|Adverse Event|4|||
156714134|NCT05168202|565699293|FG004|Overall Study|Adverse Event|3|||
156714135|NCT05168202|565699294|FG005|Overall Study|Adverse Event|2|||
156714136|NCT05168202|565699295|FG006|Overall Study|Adverse Event|0|||
156714137|NCT05168202|565699289|FG000|Overall Study|Lack of Efficacy|0|||
156714138|NCT05168202|565699290|FG001|Overall Study|Lack of Efficacy|1|||
156714139|NCT05168202|565699291|FG002|Overall Study|Lack of Efficacy|1|||
156714140|NCT05168202|565699292|FG003|Overall Study|Lack of Efficacy|0|||
156714141|NCT05168202|565699293|FG004|Overall Study|Lack of Efficacy|1|||
156714142|NCT05168202|565699294|FG005|Overall Study|Lack of Efficacy|2|||
156714143|NCT05168202|565699295|FG006|Overall Study|Lack of Efficacy|2|||
156714144|NCT05168202|565699289|FG000|Overall Study|Withdrawal by Subject|0|||
156714145|NCT05168202|565699290|FG001|Overall Study|Withdrawal by Subject|0|||
156714146|NCT05168202|565699291|FG002|Overall Study|Withdrawal by Subject|1|||
156714147|NCT05168202|565699292|FG003|Overall Study|Withdrawal by Subject|1|||
156714148|NCT05168202|565699293|FG004|Overall Study|Withdrawal by Subject|1|||
156714149|NCT05168202|565699294|FG005|Overall Study|Withdrawal by Subject|1|||
156714150|NCT05168202|565699295|FG006|Overall Study|Withdrawal by Subject|0|||
156714151|NCT05168202|565699289|FG000|Overall Study|Disease Relapse|0|||
156714152|NCT05168202|565699290|FG001|Overall Study|Disease Relapse|1|||
156714153|NCT05168202|565699291|FG002|Overall Study|Disease Relapse|0|||
156714154|NCT05168202|565699292|FG003|Overall Study|Disease Relapse|1|||
156714155|NCT05168202|565699293|FG004|Overall Study|Disease Relapse|1|||
156714156|NCT05168202|565699294|FG005|Overall Study|Disease Relapse|0|||
156714157|NCT05168202|565699295|FG006|Overall Study|Disease Relapse|0|||
156714158|NCT05168202|565699289|FG000|Overall Study|Other Reasons|0|||
156714159|NCT05168202|565699290|FG001|Overall Study|Other Reasons|0|||
156714160|NCT05168202|565699291|FG002|Overall Study|Other Reasons|0|||
156714161|NCT05168202|565699292|FG003|Overall Study|Other Reasons|0|||
156714162|NCT05168202|565699293|FG004|Overall Study|Other Reasons|0|||
156714163|NCT05168202|565699294|FG005|Overall Study|Other Reasons|2|||
156532392|NCT03083847|565045018|FG007|Main|Physician Decision|0|||
156714164|NCT05168202|565699295|FG006|Overall Study|Other Reasons|1|||
156714165|NCT05168202|565699289|FG000|Overall Study|Physician Decision|0|||
156714166|NCT05168202|565699290|FG001|Overall Study|Physician Decision|1|||
156714167|NCT05168202|565699291|FG002|Overall Study|Physician Decision|1|||
156532393|NCT03083847|565045019|FG008|Main|Physician Decision|0|||
156532394|NCT03083847|565045020|FG009|Main|Physician Decision|0|||
156532395|NCT03083847|565045011|FG000|Main|Pregnancy|0|||
156532396|NCT03083847|565045012|FG001|Main|Pregnancy|0|||
156532397|NCT03083847|565045013|FG002|Main|Pregnancy|0|||
156532398|NCT03083847|565045014|FG003|Main|Pregnancy|0|||
156532399|NCT03083847|565045015|FG004|Main|Pregnancy|0|||
156532400|NCT03083847|565045016|FG005|Main|Pregnancy|0|||
156532401|NCT03083847|565045017|FG006|Main|Pregnancy|0|||
156714168|NCT05168202|565699292|FG003|Overall Study|Physician Decision|0|||
156714169|NCT05168202|565699293|FG004|Overall Study|Physician Decision|0|||
156714170|NCT05168202|565699294|FG005|Overall Study|Physician Decision|0|||
156714171|NCT05168202|565699295|FG006|Overall Study|Physician Decision|0|||
156714172|NCT05168202|565699289|FG000|Overall Study|Study Terminated by Sponsor|0|||
156714173|NCT05168202|565699290|FG001|Overall Study|Study Terminated by Sponsor|0|||
156714174|NCT05168202|565699291|FG002|Overall Study|Study Terminated by Sponsor|0|||
156714175|NCT05168202|565699292|FG003|Overall Study|Study Terminated by Sponsor|1|||
156714176|NCT05168202|565699293|FG004|Overall Study|Study Terminated by Sponsor|0|||
156714177|NCT05168202|565699294|FG005|Overall Study|Study Terminated by Sponsor|0|||
156714178|NCT05168202|565699295|FG006|Overall Study|Study Terminated by Sponsor|0|||
156714179|NCT04011722|565699297|FG000|30 Days|Death|5|||
156714180|NCT04011722|565699298|FG001|30 Days|Death|1|||
156714181|NCT04011722|565699297|FG000|1 Year|Death|13|||
156714182|NCT04011722|565699298|FG001|1 Year|Death|5|||
156714183|NCT04011722|565699297|FG000|1 Year|Withdrawal by Subject|8|||
156714184|NCT04011722|565699298|FG001|1 Year|Withdrawal by Subject|2|||
156714185|NCT04011722|565699297|FG000|1 Year|Missed Visit|6|||
156714186|NCT04011722|565699298|FG001|1 Year|Missed Visit|1|||
156714187|NCT04011722|565699297|FG000|1 Year|Pending Visit|0|||
156714188|NCT04011722|565699298|FG001|1 Year|Pending Visit|11|||
156714189|NCT04011722|565699297|FG000|1 Year|Not Yet Due|0|||
156714190|NCT04011722|565699298|FG001|1 Year|Not Yet Due|9|||
156714191|NCT04011722|565699297|FG000|2 Year|Death|16|||
156714192|NCT04011722|565699298|FG001|2 Year|Death|1|||
156714193|NCT04011722|565699297|FG000|2 Year|Withdrawal by Subject|10|||
156714194|NCT04011722|565699298|FG001|2 Year|Withdrawal by Subject|1|||
156714195|NCT04011722|565699297|FG000|2 Year|Missed Visit|9|||
156714196|NCT04011722|565699298|FG001|2 Year|Missed Visit|0|||
156714197|NCT04011722|565699297|FG000|2 Year|Visit Pending|1|||
156714198|NCT04011722|565699298|FG001|2 Year|Visit Pending|3|||
156714199|NCT04011722|565699297|FG000|2 Year|Not Yet Due|43|||
156714200|NCT04011722|565699298|FG001|2 Year|Not Yet Due|54|||
156714201|NCT04011722|565699297|FG000|3 Year|Death|10|||
156714202|NCT04011722|565699298|FG001|3 Year|Death|0|||
156714203|NCT04011722|565699297|FG000|3 Year|Withdrawal by Subject|2|||
156714204|NCT04011722|565699298|FG001|3 Year|Withdrawal by Subject|0|||
156714205|NCT04011722|565699297|FG000|3 Year|Missed Visit|2|||
156714206|NCT04011722|565699298|FG001|3 Year|Missed Visit|0|||
156714207|NCT04011722|565699297|FG000|3 Year|Pending Visit|34|||
156714208|NCT04011722|565699298|FG001|3 Year|Pending Visit|0|||
156714209|NCT04011722|565699297|FG000|3 Year|Not Yet Due|99|||
156714210|NCT04011722|565699298|FG001|3 Year|Not Yet Due|0|||
156714211|NCT05626231|565699299|FG000|Provider Enrollment|Worked part-time|4|||
156714212|NCT05626231|565699299|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
156714213|NCT05626231|565699299|FG000|Provider Enrollment|Non-clinical employee|1|||
156714214|NCT05626231|565699299|FG000|Provider Enrollment|Provider does not see clients|3|||
156714215|NCT05626231|565699299|FG000|Provider Enrollment|Other|5|||
156714216|NCT06195930|565699303|FG000|Overall Study|Adverse Event|4|||
156714217|NCT03999996|565699304|FG000|Prior to Booster|Adverse Event|2|||
156714218|NCT03999996|565699305|FG001|Prior to Booster|Adverse Event|0|||
156714219|NCT03999996|565699306|FG002|Prior to Booster|Adverse Event|0|||
156714220|NCT03999996|565699307|FG003|Prior to Booster|Adverse Event|0|||
156714221|NCT03999996|565699304|FG000|Prior to Booster|Lost to Follow-up|17|||
156714222|NCT03999996|565699305|FG001|Prior to Booster|Lost to Follow-up|22|||
156714223|NCT03999996|565699306|FG002|Prior to Booster|Lost to Follow-up|0|||
156714224|NCT03999996|565699307|FG003|Prior to Booster|Lost to Follow-up|0|||
156714225|NCT03999996|565699304|FG000|Prior to Booster|Withdrawal of Consent|51|||
156714226|NCT03999996|565699305|FG001|Prior to Booster|Withdrawal of Consent|8|||
156714227|NCT03999996|565699306|FG002|Prior to Booster|Withdrawal of Consent|0|||
156714228|NCT03999996|565699307|FG003|Prior to Booster|Withdrawal of Consent|0|||
156714229|NCT03999996|565699304|FG000|Prior to Booster|Death|0|||
156792617|NCT02656173|565992842|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
156792618|NCT02656173|565992841|FG000|Overall Study|Adverse Event|7|||
156792619|NCT02656173|565992842|FG001|Overall Study|Adverse Event|5|||
156792620|NCT02656173|565992841|FG000|Overall Study|Withdrawal by Subject|1|||
156792621|NCT02656173|565992842|FG001|Overall Study|Withdrawal by Subject|3|||
156792622|NCT02656173|565992841|FG000|Overall Study|Protocol Violation|0|||
156792623|NCT02656173|565992842|FG001|Overall Study|Protocol Violation|1|||
156714230|NCT03999996|565699305|FG001|Prior to Booster|Death|1|||
156714231|NCT03999996|565699306|FG002|Prior to Booster|Death|0|||
156714232|NCT03999996|565699307|FG003|Prior to Booster|Death|0|||
156714233|NCT03999996|565699304|FG000|Prior to Booster|Reason Not Specified|27|||
156714234|NCT03999996|565699305|FG001|Prior to Booster|Reason Not Specified|4|||
156714235|NCT03999996|565699306|FG002|Prior to Booster|Reason Not Specified|0|||
156714236|NCT03999996|565699307|FG003|Prior to Booster|Reason Not Specified|0|||
156714237|NCT03999996|565699304|FG000|Booster Phase|Lost to Follow-up|0|||
156714238|NCT03999996|565699305|FG001|Booster Phase|Lost to Follow-up|0|||
156714239|NCT03999996|565699306|FG002|Booster Phase|Lost to Follow-up|3|||
156714240|NCT03999996|565699307|FG003|Booster Phase|Lost to Follow-up|3|||
156714241|NCT03999996|565699304|FG000|Booster Phase|Withdrawal of Consent|0|||
156714242|NCT03999996|565699305|FG001|Booster Phase|Withdrawal of Consent|0|||
156714243|NCT03999996|565699306|FG002|Booster Phase|Withdrawal of Consent|0|||
156792624|NCT02656173|565992841|FG000|Overall Study|Miscellaneous|2|||
156792625|NCT02656173|565992842|FG001|Overall Study|Miscellaneous|0|||
156714244|NCT03999996|565699307|FG003|Booster Phase|Withdrawal of Consent|1|||
156714245|NCT03999996|565699304|FG000|Booster Phase|Reason Not Specified|0|||
156714246|NCT03999996|565699305|FG001|Booster Phase|Reason Not Specified|0|||
156714247|NCT03999996|565699306|FG002|Booster Phase|Reason Not Specified|0|||
156714248|NCT03999996|565699307|FG003|Booster Phase|Reason Not Specified|1|||
156714249|NCT03690388|565699308|FG000|Overall Study|Adverse Event|8|||
156714250|NCT03690388|565699309|FG001|Overall Study|Adverse Event|1|||
156714251|NCT03690388|565699308|FG000|Overall Study|Radiographic Progression|14|||
156714252|NCT03690388|565699309|FG001|Overall Study|Radiographic Progression|29|||
156714253|NCT03690388|565699308|FG000|Overall Study|Clinical deterioration|10|||
156714254|NCT03690388|565699309|FG001|Overall Study|Clinical deterioration|6|||
156714255|NCT03690388|565699308|FG000|Overall Study|Withdrawal by Subject|2|||
156714256|NCT03690388|565699309|FG001|Overall Study|Withdrawal by Subject|0|||
156714257|NCT03690388|565699308|FG000|Overall Study|Lack of Efficacy|1|||
156714258|NCT03690388|565699309|FG001|Overall Study|Lack of Efficacy|0|||
156714259|NCT03690388|565699308|FG000|Overall Study|Lost to Follow-up|1|||
156714260|NCT03690388|565699309|FG001|Overall Study|Lost to Follow-up|0|||
156714261|NCT00001521|565699310|FG000|Overall Study|Withdrawal by Subject|3|||
156714262|NCT00001521|565699311|FG001|Overall Study|Withdrawal by Subject|3|||
156714263|NCT00001521|565699310|FG000|Overall Study|Physician Decision|1|||
156714264|NCT00001521|565699311|FG001|Overall Study|Physician Decision|1|||
156714265|NCT00001521|565699310|FG000|Overall Study|Noncompliant|6|||
156714266|NCT00001521|565699311|FG001|Overall Study|Noncompliant|3|||
156714267|NCT03573830|565699316|FG000|Overall Study|Dropped without completing treatment|0|||
156714268|NCT03573830|565699317|FG001|Overall Study|Dropped without completing treatment|7|||
156714269|NCT03573830|565699316|FG000|Overall Study|Lost to Follow-up|4|||
156714270|NCT03573830|565699317|FG001|Overall Study|Lost to Follow-up|0|||
156714271|NCT00266630|565699318|FG000|Overall Study|Adverse Event|8|||
156714272|NCT00266630|565699319|FG001|Overall Study|Adverse Event|6|||
156714273|NCT00266630|565699318|FG000|Overall Study|Lack of Efficacy|1|||
156714274|NCT00266630|565699319|FG001|Overall Study|Lack of Efficacy|4|||
156714275|NCT00266630|565699318|FG000|Overall Study|Entry Criteria not met|1|||
156714276|NCT00266630|565699319|FG001|Overall Study|Entry Criteria not met|0|||
156714277|NCT00266630|565699318|FG000|Overall Study|Protocol Violation|1|||
156714278|NCT00266630|565699319|FG001|Overall Study|Protocol Violation|3|||
156714279|NCT00266630|565699318|FG000|Overall Study|Physician Decision|1|||
156714280|NCT00266630|565699319|FG001|Overall Study|Physician Decision|2|||
156714281|NCT00266630|565699318|FG000|Overall Study|Withdrawal by Subject|10|||
156714282|NCT00266630|565699319|FG001|Overall Study|Withdrawal by Subject|2|||
156714283|NCT00266630|565699318|FG000|Overall Study|Lost to Follow-up|1|||
156714284|NCT00266630|565699319|FG001|Overall Study|Lost to Follow-up|0|||
156714285|NCT00266630|565699318|FG000|Overall Study|Other|19|||
156714286|NCT00266630|565699319|FG001|Overall Study|Other|11|||
156714287|NCT03284723|565699324|FG000|Overall Study|Death|0|||
156714288|NCT03284723|565699325|FG001|Overall Study|Death|0|||
156714289|NCT03284723|565699326|FG002|Overall Study|Death|0|||
156714290|NCT03284723|565699327|FG003|Overall Study|Death|1|||
156714291|NCT03284723|565699328|FG004|Overall Study|Death|0|||
156714292|NCT03284723|565699329|FG005|Overall Study|Death|0|||
156714293|NCT03284723|565699330|FG006|Overall Study|Death|1|||
156714294|NCT03284723|565699331|FG007|Overall Study|Death|0|||
156792626|NCT00834587|565992845|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
156443050|NCT00111813|564713501|FG004|Overall Study|Lack of Efficacy|0|||
156792627|NCT00834587|565992846|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
156792628|NCT03810495|565992847|FG000|Overall Study|Lost to Follow-up|2|||
156792629|NCT03810495|565992847|FG000|Overall Study|Withdrawal by Subject|1|||
156792630|NCT03449147|565992848|FG000|52-week Treatment Period|Death|0|||
156792631|NCT03449147|565992849|FG001|52-week Treatment Period|Death|1|||
156792632|NCT03449147|565992850|FG002|52-week Treatment Period|Death|0|||
156792633|NCT03449147|565992848|FG000|52-week Treatment Period|Lost to Follow-up|6|||
156792634|NCT03449147|565992849|FG001|52-week Treatment Period|Lost to Follow-up|2|||
156443051|NCT00111813|564713502|FG005|Overall Study|Lack of Efficacy|1|||
156443052|NCT00111813|564713497|FG000|Overall Study|Other|0|||
156443053|NCT00111813|564713498|FG001|Overall Study|Other|0|||
156792635|NCT03449147|565992850|FG002|52-week Treatment Period|Lost to Follow-up|5|||
156792636|NCT03449147|565992848|FG000|52-week Treatment Period|Other|0|||
156874112|NCT02840799|566298566|FG001|Phase 1|Physician Decision|3|||
156714295|NCT03284723|565699332|FG008|Overall Study|Death|0|||
156714296|NCT03284723|565699333|FG009|Overall Study|Death|2|||
156443054|NCT00111813|564713499|FG002|Overall Study|Other|1|||
156714297|NCT03284723|565699334|FG010|Overall Study|Death|1|||
156714298|NCT03284723|565699335|FG011|Overall Study|Death|0|||
156714299|NCT03284723|565699324|FG000|Overall Study|Lost to Follow-up|0|||
156714300|NCT03284723|565699325|FG001|Overall Study|Lost to Follow-up|0|||
156714301|NCT03284723|565699326|FG002|Overall Study|Lost to Follow-up|0|||
156714302|NCT03284723|565699327|FG003|Overall Study|Lost to Follow-up|0|||
156714303|NCT03284723|565699328|FG004|Overall Study|Lost to Follow-up|0|||
156714304|NCT03284723|565699329|FG005|Overall Study|Lost to Follow-up|2|||
156714305|NCT03284723|565699330|FG006|Overall Study|Lost to Follow-up|1|||
156792637|NCT03449147|565992849|FG001|52-week Treatment Period|Other|1|||
156714306|NCT03284723|565699331|FG007|Overall Study|Lost to Follow-up|0|||
156714307|NCT03284723|565699332|FG008|Overall Study|Lost to Follow-up|0|||
156714308|NCT03284723|565699333|FG009|Overall Study|Lost to Follow-up|2|||
156714309|NCT03284723|565699334|FG010|Overall Study|Lost to Follow-up|0|||
156714310|NCT03284723|565699335|FG011|Overall Study|Lost to Follow-up|0|||
156714311|NCT03284723|565699324|FG000|Overall Study|Study Terminated By Sponsor|0|||
156714312|NCT03284723|565699325|FG001|Overall Study|Study Terminated By Sponsor|0|||
156714313|NCT03284723|565699326|FG002|Overall Study|Study Terminated By Sponsor|0|||
156714314|NCT03284723|565699327|FG003|Overall Study|Study Terminated By Sponsor|0|||
156714315|NCT03284723|565699328|FG004|Overall Study|Study Terminated By Sponsor|1|||
156714316|NCT03284723|565699329|FG005|Overall Study|Study Terminated By Sponsor|0|||
156714317|NCT03284723|565699330|FG006|Overall Study|Study Terminated By Sponsor|0|||
156714318|NCT03284723|565699331|FG007|Overall Study|Study Terminated By Sponsor|0|||
156714319|NCT03284723|565699332|FG008|Overall Study|Study Terminated By Sponsor|1|||
156714320|NCT03284723|565699333|FG009|Overall Study|Study Terminated By Sponsor|1|||
156714321|NCT03284723|565699334|FG010|Overall Study|Study Terminated By Sponsor|1|||
156714322|NCT03284723|565699335|FG011|Overall Study|Study Terminated By Sponsor|1|||
156714323|NCT03284723|565699324|FG000|Overall Study|Withdrawal by Subject|0|||
156714324|NCT03284723|565699325|FG001|Overall Study|Withdrawal by Subject|0|||
156714325|NCT03284723|565699326|FG002|Overall Study|Withdrawal by Subject|0|||
156714326|NCT03284723|565699327|FG003|Overall Study|Withdrawal by Subject|0|||
156714327|NCT03284723|565699328|FG004|Overall Study|Withdrawal by Subject|5|||
156714328|NCT03284723|565699329|FG005|Overall Study|Withdrawal by Subject|3|||
156714329|NCT03284723|565699330|FG006|Overall Study|Withdrawal by Subject|1|||
156714330|NCT03284723|565699331|FG007|Overall Study|Withdrawal by Subject|0|||
156714331|NCT03284723|565699332|FG008|Overall Study|Withdrawal by Subject|6|||
156714332|NCT03284723|565699333|FG009|Overall Study|Withdrawal by Subject|0|||
156714333|NCT03284723|565699334|FG010|Overall Study|Withdrawal by Subject|3|||
156714334|NCT03284723|565699335|FG011|Overall Study|Withdrawal by Subject|1|||
156714335|NCT03284723|565699324|FG000|Overall Study|Other|1|||
156714336|NCT03284723|565699325|FG001|Overall Study|Other|0|||
156714337|NCT03284723|565699326|FG002|Overall Study|Other|1|||
156714338|NCT03284723|565699327|FG003|Overall Study|Other|0|||
156714339|NCT03284723|565699328|FG004|Overall Study|Other|1|||
156714340|NCT03284723|565699329|FG005|Overall Study|Other|0|||
156714341|NCT03284723|565699330|FG006|Overall Study|Other|0|||
156714342|NCT03284723|565699331|FG007|Overall Study|Other|0|||
156714343|NCT03284723|565699332|FG008|Overall Study|Other|0|||
156714344|NCT03284723|565699333|FG009|Overall Study|Other|0|||
156714345|NCT03284723|565699334|FG010|Overall Study|Other|1|||
156714346|NCT03284723|565699335|FG011|Overall Study|Other|0|||
156714347|NCT03284723|565699324|FG000|Overall Study|Adverse Event|0|||
156714348|NCT03284723|565699325|FG001|Overall Study|Adverse Event|0|||
156714349|NCT03284723|565699326|FG002|Overall Study|Adverse Event|0|||
156714350|NCT03284723|565699327|FG003|Overall Study|Adverse Event|0|||
156714351|NCT03284723|565699328|FG004|Overall Study|Adverse Event|0|||
156714352|NCT03284723|565699329|FG005|Overall Study|Adverse Event|0|||
156714353|NCT03284723|565699330|FG006|Overall Study|Adverse Event|0|||
156714354|NCT03284723|565699331|FG007|Overall Study|Adverse Event|0|||
156714355|NCT03284723|565699332|FG008|Overall Study|Adverse Event|1|||
156714356|NCT03284723|565699333|FG009|Overall Study|Adverse Event|0|||
156714357|NCT03284723|565699334|FG010|Overall Study|Adverse Event|0|||
156714358|NCT03284723|565699335|FG011|Overall Study|Adverse Event|0|||
156714359|NCT01499095|565699340|FG000|Overall Study|Randomized But Not Treated|1|||
156714360|NCT01499095|565699341|FG001|Overall Study|Randomized But Not Treated|1|||
156714361|NCT01499095|565699340|FG000|Overall Study|Adverse Event|12|||
156714362|NCT01499095|565699341|FG001|Overall Study|Adverse Event|7|||
156714363|NCT01499095|565699340|FG000|Overall Study|Lack of Efficacy|2|||
156443055|NCT00111813|564713500|FG003|Overall Study|Other|0|||
156714364|NCT01499095|565699341|FG001|Overall Study|Lack of Efficacy|1|||
156714365|NCT01499095|565699340|FG000|Overall Study|Protocol Violation|6|||
156714366|NCT01499095|565699341|FG001|Overall Study|Protocol Violation|7|||
156443056|NCT00111813|564713501|FG004|Overall Study|Other|0|||
156714367|NCT01499095|565699340|FG000|Overall Study|Received Rescue Therapy|32|||
156714368|NCT01499095|565699341|FG001|Overall Study|Received Rescue Therapy|40|||
156714369|NCT01499095|565699340|FG000|Overall Study|Diverse Reasons|22|||
156714370|NCT01499095|565699341|FG001|Overall Study|Diverse Reasons|25|||
156714371|NCT01499095|565699340|FG000|Overall Study|Lost to Follow-up|6|||
156714372|NCT01499095|565699341|FG001|Overall Study|Lost to Follow-up|4|||
156714373|NCT01499095|565699340|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
156714374|NCT01499095|565699341|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
156714375|NCT01499095|565699340|FG000|Overall Study|Hypoglycemia|3|||
156714376|NCT01499095|565699341|FG001|Overall Study|Hypoglycemia|1|||
156714377|NCT01499095|565699340|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
156714378|NCT01499095|565699341|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
156714379|NCT01499095|565699340|FG000|Overall Study|Change in Injection Schedule|2|||
156714380|NCT01499095|565699341|FG001|Overall Study|Change in Injection Schedule|0|||
156714381|NCT01499095|565699340|FG000|Overall Study|Perceived Lack of Efficacy|1|||
156714382|NCT01499095|565699341|FG001|Overall Study|Perceived Lack of Efficacy|1|||
156714383|NCT01368497|565699345|FG000|Overall Study|Lost to Follow-up|2|||
156714384|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
156714385|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
156714386|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
156714387|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
156714388|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
156714389|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
156714390|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
156714391|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
156714392|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
156714393|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
156714394|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
156714395|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
156714396|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
156714397|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
156714398|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
156714399|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
156714400|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
156714401|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
156714402|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
156714403|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
156714404|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
156714405|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
156714406|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
156714407|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
156714408|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
156714409|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
156714410|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
156714411|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
156714412|NCT01130532|565699346|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
156714413|NCT01130532|565699347|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
156714414|NCT01130532|565699348|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
156714415|NCT01130532|565699349|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
156714416|NCT01130532|565699346|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
156714417|NCT01130532|565699347|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
156714418|NCT01130532|565699348|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
156714419|NCT01130532|565699349|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
156714420|NCT01130532|565699346|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
156714421|NCT01130532|565699347|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
156714422|NCT01130532|565699348|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
156714423|NCT01130532|565699349|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
156714424|NCT01130532|565699346|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
156714425|NCT01130532|565699347|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
156714426|NCT01130532|565699348|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
156714427|NCT01130532|565699349|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
156714428|NCT02762929|565699350|FG000|Overall Study|Adverse Event|0|||
156714429|NCT02762929|565699351|FG001|Overall Study|Adverse Event|0|||
156714430|NCT02762929|565699352|FG002|Overall Study|Adverse Event|0|||
156714431|NCT02762929|565699353|FG003|Overall Study|Adverse Event|1|||
156714432|NCT02762929|565699354|FG004|Overall Study|Adverse Event|0|||
156714433|NCT02762929|565699355|FG005|Overall Study|Adverse Event|0|||
156792638|NCT03449147|565992850|FG002|52-week Treatment Period|Other|2|||
156792639|NCT03449147|565992848|FG000|52-week Treatment Period|Physician Decision|1|||
156792640|NCT03449147|565992849|FG001|52-week Treatment Period|Physician Decision|0|||
156792641|NCT03449147|565992850|FG002|52-week Treatment Period|Physician Decision|3|||
156792642|NCT03449147|565992848|FG000|52-week Treatment Period|Screen Failure|1|||
156792643|NCT03449147|565992849|FG001|52-week Treatment Period|Screen Failure|2|||
156792644|NCT03449147|565992850|FG002|52-week Treatment Period|Screen Failure|0|||
156792645|NCT03449147|565992848|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
156792646|NCT03449147|565992849|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
156792647|NCT03449147|565992850|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
156792648|NCT03449147|565992848|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
156714434|NCT02762929|565699350|FG000|Overall Study|Lost to Follow-up|1|||
156792649|NCT03449147|565992849|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
156792650|NCT03449147|565992850|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
156714435|NCT02762929|565699351|FG001|Overall Study|Lost to Follow-up|2|||
156714436|NCT02762929|565699352|FG002|Overall Study|Lost to Follow-up|0|||
156714437|NCT02762929|565699353|FG003|Overall Study|Lost to Follow-up|1|||
156714438|NCT02762929|565699354|FG004|Overall Study|Lost to Follow-up|0|||
156808772|NCT03801928|566054461|FG002|Overall Study|Adverse Event|1|||
156714439|NCT02762929|565699355|FG005|Overall Study|Lost to Follow-up|0|||
156714440|NCT02762929|565699350|FG000|Overall Study|Withdrawal by Subject|0|||
156714441|NCT02762929|565699351|FG001|Overall Study|Withdrawal by Subject|1|||
156714442|NCT02762929|565699352|FG002|Overall Study|Withdrawal by Subject|0|||
156714443|NCT02762929|565699353|FG003|Overall Study|Withdrawal by Subject|0|||
156714444|NCT02762929|565699354|FG004|Overall Study|Withdrawal by Subject|0|||
156714445|NCT02762929|565699355|FG005|Overall Study|Withdrawal by Subject|0|||
156714446|NCT02762929|565699350|FG000|Overall Study|exclusionary medication disclosed late|0|||
156714447|NCT02762929|565699351|FG001|Overall Study|exclusionary medication disclosed late|0|||
156714448|NCT02762929|565699352|FG002|Overall Study|exclusionary medication disclosed late|0|||
156714449|NCT02762929|565699353|FG003|Overall Study|exclusionary medication disclosed late|1|||
156714450|NCT02762929|565699354|FG004|Overall Study|exclusionary medication disclosed late|0|||
156714451|NCT02762929|565699355|FG005|Overall Study|exclusionary medication disclosed late|0|||
156714452|NCT02656303|565699357|FG000|Overall Study|Adverse Event|3|||
156714453|NCT02656303|565699358|FG001|Overall Study|Adverse Event|2|||
156714454|NCT02656303|565699359|FG002|Overall Study|Adverse Event|0|||
156714455|NCT02656303|565699357|FG000|Overall Study|Death|12|||
156714456|NCT02656303|565699358|FG001|Overall Study|Death|4|||
156714457|NCT02656303|565699359|FG002|Overall Study|Death|1|||
156714458|NCT02656303|565699357|FG000|Overall Study|Lack of Efficacy|1|||
156714459|NCT02656303|565699358|FG001|Overall Study|Lack of Efficacy|0|||
156714460|NCT02656303|565699359|FG002|Overall Study|Lack of Efficacy|0|||
156714461|NCT02656303|565699357|FG000|Overall Study|Non-Compliance with Study|1|||
156714462|NCT02656303|565699358|FG001|Overall Study|Non-Compliance with Study|1|||
156714463|NCT02656303|565699359|FG002|Overall Study|Non-Compliance with Study|0|||
156714464|NCT02656303|565699357|FG000|Overall Study|Investigator Decision|2|||
156714465|NCT02656303|565699358|FG001|Overall Study|Investigator Decision|1|||
156714466|NCT02656303|565699359|FG002|Overall Study|Investigator Decision|0|||
156714467|NCT02656303|565699357|FG000|Overall Study|Progressive Disease|25|||
156714468|NCT02656303|565699358|FG001|Overall Study|Progressive Disease|14|||
156714469|NCT02656303|565699359|FG002|Overall Study|Progressive Disease|10|||
156714470|NCT02656303|565699357|FG000|Overall Study|Study Terminated by Sponsor|20|||
156714471|NCT02656303|565699358|FG001|Overall Study|Study Terminated by Sponsor|7|||
156714472|NCT02656303|565699359|FG002|Overall Study|Study Terminated by Sponsor|5|||
156714473|NCT02656303|565699357|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
156714474|NCT02656303|565699358|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
156714475|NCT02656303|565699359|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
156714476|NCT02656303|565699357|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
156714477|NCT02656303|565699358|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
156714478|NCT02656303|565699359|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
156714479|NCT02656303|565699357|FG000|Overall Study|Reason not Specified|1|||
156714480|NCT02656303|565699358|FG001|Overall Study|Reason not Specified|1|||
156714481|NCT02656303|565699359|FG002|Overall Study|Reason not Specified|2|||
156714482|NCT03041311|565699364|FG000|Overall Study|Death|39|||
156714483|NCT03041311|565699365|FG001|Overall Study|Death|42|||
156714484|NCT03041311|565699364|FG000|Overall Study|Lost to Follow-up|0|||
156714485|NCT03041311|565699365|FG001|Overall Study|Lost to Follow-up|1|||
156714486|NCT03041311|565699364|FG000|Overall Study|Withdrawal by Subject|8|||
156714487|NCT03041311|565699365|FG001|Overall Study|Withdrawal by Subject|5|||
156714488|NCT03041311|565699364|FG000|Overall Study|Sponsor Terminated Study|2|||
156714489|NCT03041311|565699365|FG001|Overall Study|Sponsor Terminated Study|4|||
156714490|NCT03041311|565699364|FG000|Overall Study|Disease Progression|3|||
156714491|NCT03041311|565699365|FG001|Overall Study|Disease Progression|1|||
156714492|NCT03041311|565699364|FG000|Overall Study|Randomized in error, did not receive drug|2|||
156714493|NCT03041311|565699365|FG001|Overall Study|Randomized in error, did not receive drug|0|||
156714494|NCT01842438|565699366|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
156714495|NCT01842438|565699367|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
156714496|NCT01842438|565699366|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
156714497|NCT01842438|565699367|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
156714498|NCT01842438|565699366|FG000|T2: 6month Follow-up|Death|0|||
156714499|NCT01842438|565699367|FG001|T2: 6month Follow-up|Death|1|||
156714500|NCT00782626|565699371|FG000|Overall Study|Adverse Event|1|||
156714501|NCT00782626|565699371|FG000|Overall Study|Progressive Disease|5|||
156714502|NCT00782626|565699371|FG000|Overall Study|Other Complicating Disease|1|||
156714503|NCT04909853|565699372|FG000|Part 1|Assigned but not treated|0|||
156714504|NCT04909853|565699373|FG001|Part 1|Assigned but not treated|0|||
156333084|NCT01303861|564319017|FG000|Overall Study|Lost to Follow-up|34|||
156714505|NCT04909853|565699374|FG002|Part 1|Assigned but not treated|1|||
156714506|NCT04909853|565699375|FG003|Part 1|Assigned but not treated|0|||
156714507|NCT04909853|565699372|FG000|Part 2|Adverse Event|0|||
156333085|NCT01303861|564319018|FG001|Overall Study|Lost to Follow-up|14|||
156333086|NCT01303861|564319019|FG002|Overall Study|Lost to Follow-up|27|||
156333087|NCT01303861|564319020|FG003|Overall Study|Lost to Follow-up|31|||
156714508|NCT04909853|565699373|FG001|Part 2|Adverse Event|0|||
156714509|NCT04909853|565699374|FG002|Part 2|Adverse Event|0|||
156714510|NCT04909853|565699375|FG003|Part 2|Adverse Event|1|||
156714511|NCT00077207|565699378|FG000|Overall Study|Adverse Event|5|||
156714512|NCT00077207|565699378|FG000|Overall Study|Lack of Efficacy|12|||
156714513|NCT00077207|565699378|FG000|Overall Study|Physician Decision|6|||
156714514|NCT00077207|565699378|FG000|Overall Study|Withdrawal by Subject|6|||
156714515|NCT00077207|565699378|FG000|Overall Study|Ineligible|1|||
156714516|NCT03052751|565699381|FG000|Dosing Period 1|Adverse Event|0|||
156714517|NCT03052751|565699382|FG001|Dosing Period 1|Adverse Event|1|||
156714518|NCT03052751|565699383|FG002|Dosing Period 1|Adverse Event|0|||
156714519|NCT03052751|565699384|FG003|Dosing Period 1|Adverse Event|0|||
156714520|NCT03052751|565699385|FG004|Dosing Period 1|Adverse Event|0|||
156714521|NCT03052751|565699386|FG005|Dosing Period 1|Adverse Event|0|||
156714522|NCT03052751|565699381|FG000|Dosing Period 2|Adverse Event|0|||
156714523|NCT03052751|565699382|FG001|Dosing Period 2|Adverse Event|0|||
156714524|NCT03052751|565699383|FG002|Dosing Period 2|Adverse Event|3|||
156714525|NCT03052751|565699384|FG003|Dosing Period 2|Adverse Event|0|||
156714526|NCT03052751|565699385|FG004|Dosing Period 2|Adverse Event|0|||
156714527|NCT03052751|565699386|FG005|Dosing Period 2|Adverse Event|0|||
156714528|NCT03052751|565699381|FG000|Observation Period|Adverse Event|0|||
156714529|NCT03052751|565699382|FG001|Observation Period|Adverse Event|0|||
156714530|NCT03052751|565699383|FG002|Observation Period|Adverse Event|0|||
156714531|NCT03052751|565699384|FG003|Observation Period|Adverse Event|0|||
156714532|NCT03052751|565699385|FG004|Observation Period|Adverse Event|1|||
156714533|NCT03052751|565699386|FG005|Observation Period|Adverse Event|0|||
156714534|NCT00444587|565699397|FG000|Overall Study|Death|2|||
156714535|NCT00444587|565699398|FG001|Overall Study|Death|1|||
156714536|NCT00444587|565699397|FG000|Overall Study|Progression of the disease|73|||
156714537|NCT00444587|565699398|FG001|Overall Study|Progression of the disease|8|||
156714538|NCT00444587|565699397|FG000|Overall Study|Refused treatment/did not cooperate|4|||
156714539|NCT00444587|565699398|FG001|Overall Study|Refused treatment/did not cooperate|1|||
156714540|NCT00444587|565699397|FG000|Overall Study|Investigator decision|3|||
156714541|NCT00444587|565699398|FG001|Overall Study|Investigator decision|0|||
156714542|NCT00444587|565699397|FG000|Overall Study|Protocol Violation|1|||
156714543|NCT00444587|565699398|FG001|Overall Study|Protocol Violation|0|||
156714544|NCT00444587|565699397|FG000|Overall Study|Missing|0|||
156714545|NCT00444587|565699398|FG001|Overall Study|Missing|5|||
156714546|NCT00196326|565699399|FG000|Overall Study|Did not meet protocol requirements|64|||
156714547|NCT00196326|565699399|FG000|Overall Study|Non-compliance with the protocol|81|||
156714548|NCT00196326|565699399|FG000|Overall Study|Physician Decision|3|||
156714549|NCT00196326|565699399|FG000|Overall Study|Withdrawal by Subject|225|||
156714550|NCT00196326|565699399|FG000|Overall Study|Adverse Event|253|||
156714551|NCT00196326|565699399|FG000|Overall Study|Pregnancy|34|||
156714552|NCT00196326|565699399|FG000|Overall Study|Lost to Follow-up|304|||
156714553|NCT00196326|565699399|FG000|Overall Study|Other|22|||
156714554|NCT00524420|565699406|FG000|Overall Study|Lack of Efficacy|1|||
156714555|NCT00524420|565699407|FG001|Overall Study|Lack of Efficacy|0|||
156714556|NCT00577863|565699408|FG000|Overall Study|Adverse Event|4|||
156714557|NCT00577863|565699409|FG001|Overall Study|Adverse Event|2|||
156714558|NCT00577863|565699408|FG000|Overall Study|Death|1|||
156714559|NCT00577863|565699409|FG001|Overall Study|Death|0|||
156714560|NCT00577863|565699408|FG000|Overall Study|Lost to Follow-up|2|||
156714561|NCT00577863|565699409|FG001|Overall Study|Lost to Follow-up|2|||
156714562|NCT00577863|565699408|FG000|Overall Study|Entry Criteria Exclusion|1|||
156714563|NCT00577863|565699409|FG001|Overall Study|Entry Criteria Exclusion|0|||
156714564|NCT00577863|565699408|FG000|Overall Study|Withdrawal by Subject|0|||
156714565|NCT00577863|565699409|FG001|Overall Study|Withdrawal by Subject|2|||
156714566|NCT00577863|565699408|FG000|Overall Study|Sponsor Decision|2|||
156714567|NCT00577863|565699409|FG001|Overall Study|Sponsor Decision|7|||
156714568|NCT00577863|565699408|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
156714569|NCT00577863|565699409|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
156714570|NCT03639779|565699417|FG000|Overall Study|Lost to Follow-up|1|||
156714571|NCT02413229|565699420|FG000|Overall Study|Adverse Event|0|||
156714572|NCT02413229|565699421|FG001|Overall Study|Adverse Event|0|||
156714573|NCT02413229|565699422|FG002|Overall Study|Adverse Event|0|||
156714574|NCT02413229|565699423|FG003|Overall Study|Adverse Event|1|||
156443057|NCT00111813|564713502|FG005|Overall Study|Other|0|||
156443058|NCT01610297|564713503|FG000|Overall Study|Lost to Follow-up|1|||
156443059|NCT00510887|564713507|FG000|Overall Study|Lost to Follow-up|1|||
156443060|NCT02238483|564713511|FG000|Overall Study|Withdrawal by Subject|2|||
156714575|NCT02413229|565699424|FG004|Overall Study|Adverse Event|0|||
156792651|NCT03449147|565992848|FG000|12-Week Off-Treatment Durability Period|Other|0|||
156443061|NCT02238483|564713512|FG001|Overall Study|Withdrawal by Subject|7|||
156714576|NCT02413229|565699425|FG005|Overall Study|Adverse Event|0|||
156714577|NCT02413229|565699426|FG006|Overall Study|Adverse Event|0|||
156714578|NCT02413229|565699427|FG007|Overall Study|Adverse Event|1|||
156714579|NCT02413229|565699420|FG000|Overall Study|Lost to Follow-up|0|||
156714580|NCT02413229|565699421|FG001|Overall Study|Lost to Follow-up|0|||
156714581|NCT02413229|565699422|FG002|Overall Study|Lost to Follow-up|1|||
156714582|NCT02413229|565699423|FG003|Overall Study|Lost to Follow-up|0|||
156714583|NCT02413229|565699424|FG004|Overall Study|Lost to Follow-up|2|||
156714584|NCT02413229|565699425|FG005|Overall Study|Lost to Follow-up|0|||
156443062|NCT02238483|564713511|FG000|Overall Study|Lost to Follow-up|1|||
156714585|NCT02413229|565699426|FG006|Overall Study|Lost to Follow-up|0|||
156714586|NCT02413229|565699427|FG007|Overall Study|Lost to Follow-up|0|||
156714587|NCT02413229|565699420|FG000|Overall Study|Withdrawal by Subject|1|||
156714588|NCT02413229|565699421|FG001|Overall Study|Withdrawal by Subject|1|||
156714589|NCT02413229|565699422|FG002|Overall Study|Withdrawal by Subject|0|||
156714590|NCT02413229|565699423|FG003|Overall Study|Withdrawal by Subject|0|||
156714591|NCT02413229|565699424|FG004|Overall Study|Withdrawal by Subject|1|||
156714592|NCT02413229|565699425|FG005|Overall Study|Withdrawal by Subject|0|||
156714593|NCT02413229|565699426|FG006|Overall Study|Withdrawal by Subject|0|||
156714594|NCT02413229|565699427|FG007|Overall Study|Withdrawal by Subject|2|||
156714595|NCT02413229|565699420|FG000|Overall Study|Progressive Disease|0|||
156714596|NCT02413229|565699421|FG001|Overall Study|Progressive Disease|0|||
156714597|NCT02413229|565699422|FG002|Overall Study|Progressive Disease|0|||
156714598|NCT02413229|565699423|FG003|Overall Study|Progressive Disease|0|||
156714599|NCT02413229|565699424|FG004|Overall Study|Progressive Disease|0|||
156714600|NCT02413229|565699425|FG005|Overall Study|Progressive Disease|0|||
156714601|NCT02413229|565699426|FG006|Overall Study|Progressive Disease|0|||
156714602|NCT02413229|565699427|FG007|Overall Study|Progressive Disease|1|||
156714603|NCT02932462|565699428|FG000|Overall Study|Adverse Event|1|||
156714604|NCT02932462|565699429|FG001|Overall Study|Adverse Event|2|||
156714605|NCT02932462|565699428|FG000|Overall Study|Lost to Follow-up|4|||
156714606|NCT02932462|565699429|FG001|Overall Study|Lost to Follow-up|1|||
156714607|NCT02932462|565699428|FG000|Overall Study|Protocol Violation|0|||
156714608|NCT02932462|565699429|FG001|Overall Study|Protocol Violation|5|||
156714609|NCT02932462|565699428|FG000|Overall Study|Withdrawal by Subject|1|||
156714610|NCT02932462|565699429|FG001|Overall Study|Withdrawal by Subject|4|||
156714611|NCT02932462|565699428|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156714612|NCT02932462|565699429|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156714613|NCT02932462|565699428|FG000|Overall Study|Progressive Disease|1|||
156714614|NCT02932462|565699429|FG001|Overall Study|Progressive Disease|0|||
156714615|NCT02009722|565699436|FG000|Overall Study|Protocol Violation|1|||
156714616|NCT02009722|565699437|FG001|Overall Study|Protocol Violation|2|||
156714617|NCT02009722|565699436|FG000|Overall Study|Did not receive intervention|0|||
156714618|NCT02009722|565699437|FG001|Overall Study|Did not receive intervention|1|||
156714619|NCT02955212|565699438|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
156714620|NCT02955212|565699439|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
156714621|NCT02955212|565699438|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
156714622|NCT02955212|565699439|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
156714623|NCT02955212|565699438|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
156714624|NCT02955212|565699439|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
156714625|NCT02955212|565699438|FG000|Period 1: Double-blind Treatment Period|Other|3|||
156714626|NCT02955212|565699439|FG001|Period 1: Double-blind Treatment Period|Other|2|||
156714627|NCT02955212|565699438|FG000|Period 2: Open-label Extension|Adverse Event|11|||
156714628|NCT02955212|565699439|FG001|Period 2: Open-label Extension|Adverse Event|7|||
156714629|NCT02955212|565699438|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
156714630|NCT02955212|565699439|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
156714631|NCT02955212|565699438|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
156714632|NCT02955212|565699439|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
156714633|NCT02955212|565699438|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
156714634|NCT02955212|565699439|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
156714635|NCT02955212|565699438|FG000|Period 2: Open-label Extension|Other|2|||
156714636|NCT02955212|565699439|FG001|Period 2: Open-label Extension|Other|4|||
156714637|NCT02454933|565699440|FG000|Overall Study|Progressive disease|10|||
156714638|NCT02454933|565699441|FG001|Overall Study|Progressive disease|7|||
156714639|NCT02454933|565699440|FG000|Overall Study|Adverse Event|1|||
156714640|NCT02454933|565699441|FG001|Overall Study|Adverse Event|1|||
156714641|NCT02454933|565699440|FG000|Overall Study|Withdrawal by Subject|0|||
156714642|NCT02454933|565699441|FG001|Overall Study|Withdrawal by Subject|3|||
156714643|NCT02454933|565699440|FG000|Overall Study|Lost to Follow-up|1|||
156714644|NCT02454933|565699441|FG001|Overall Study|Lost to Follow-up|0|||
156714645|NCT02071225|565699447|FG000|Overall Study|Withdrawal of Consent|2|||
156714646|NCT02071225|565699447|FG000|Overall Study|Protocol Deviation|1|||
156714647|NCT02071225|565699447|FG000|Overall Study|Lost to Follow-up|2|||
156714648|NCT02071225|565699447|FG000|Overall Study|Death|25|||
156714649|NCT03164616|565699466|FG000|Overall Study|Death|250|||
156714650|NCT03164616|565699467|FG001|Overall Study|Death|264|||
156714651|NCT03164616|565699468|FG002|Overall Study|Death|279|||
156714652|NCT03164616|565699466|FG000|Overall Study|Lost to Follow-up|2|||
156714653|NCT03164616|565699467|FG001|Overall Study|Lost to Follow-up|2|||
156714654|NCT03164616|565699468|FG002|Overall Study|Lost to Follow-up|2|||
156714655|NCT03164616|565699466|FG000|Overall Study|Withdrawal by Subject|6|||
156714656|NCT03164616|565699467|FG001|Overall Study|Withdrawal by Subject|7|||
156714657|NCT03164616|565699468|FG002|Overall Study|Withdrawal by Subject|16|||
156714658|NCT04388553|565699469|FG000|Overall Study|Protocol Violation|1|||
156714659|NCT04388553|565699470|FG001|Overall Study|Protocol Violation|0|||
156714660|NCT04604795|565699471|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
156714661|NCT04604795|565699472|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
156714662|NCT04604795|565699473|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714663|NCT04604795|565699474|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714664|NCT04604795|565699475|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714665|NCT04604795|565699476|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714666|NCT04604795|565699477|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714667|NCT04604795|565699478|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714668|NCT04604795|565699479|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714669|NCT04604795|565699480|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714670|NCT04604795|565699471|FG000|Part B: Up to Day 14|Adverse Event|0|||
156714671|NCT04604795|565699472|FG001|Part B: Up to Day 14|Adverse Event|0|||
156714672|NCT04604795|565699473|FG002|Part B: Up to Day 14|Adverse Event|0|||
156714673|NCT04604795|565699474|FG003|Part B: Up to Day 14|Adverse Event|0|||
156714674|NCT04604795|565699475|FG004|Part B: Up to Day 14|Adverse Event|2|||
156714675|NCT04604795|565699476|FG005|Part B: Up to Day 14|Adverse Event|1|||
156714676|NCT04604795|565699477|FG006|Part B: Up to Day 14|Adverse Event|0|||
156714677|NCT04604795|565699478|FG007|Part B: Up to Day 14|Adverse Event|0|||
156714678|NCT04604795|565699479|FG008|Part B: Up to Day 14|Adverse Event|0|||
156714679|NCT04604795|565699480|FG009|Part B: Up to Day 14|Adverse Event|0|||
156714680|NCT04604795|565699471|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714681|NCT04604795|565699472|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714682|NCT04604795|565699473|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714683|NCT04604795|565699474|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714684|NCT04604795|565699475|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714685|NCT04604795|565699476|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714686|NCT04604795|565699477|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714687|NCT04604795|565699478|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714688|NCT04604795|565699479|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714689|NCT04604795|565699480|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
156714690|NCT04604795|565699471|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714691|NCT04604795|565699472|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714692|NCT04604795|565699473|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714693|NCT04604795|565699474|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714694|NCT04604795|565699475|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714695|NCT04604795|565699476|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714696|NCT04604795|565699477|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714697|NCT04604795|565699478|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714698|NCT04604795|565699479|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
156714699|NCT04604795|565699480|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714700|NCT04604795|565699471|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714701|NCT04604795|565699472|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714702|NCT04604795|565699473|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714703|NCT04604795|565699474|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714704|NCT04604795|565699475|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714705|NCT04604795|565699476|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714706|NCT04604795|565699477|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714707|NCT04604795|565699478|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714708|NCT04604795|565699479|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
156714709|NCT04604795|565699480|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714710|NCT04604795|565699471|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714711|NCT04604795|565699472|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714712|NCT04604795|565699473|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714713|NCT04604795|565699474|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714714|NCT04604795|565699475|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714715|NCT04604795|565699476|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714716|NCT04604795|565699477|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714717|NCT04604795|565699478|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714718|NCT04604795|565699479|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
156714719|NCT04604795|565699480|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714720|NCT01260701|565699489|FG000|Overall Study|Adverse Event|9|||
156714721|NCT01260701|565699489|FG000|Overall Study|Withdrawal by Subject|2|||
156714722|NCT01260701|565699489|FG000|Overall Study|Progression|53|||
156792652|NCT03449147|565992849|FG001|12-Week Off-Treatment Durability Period|Other|1|||
156792653|NCT03449147|565992850|FG002|12-Week Off-Treatment Durability Period|Other|0|||
156792654|NCT00954538|565992853|FG000|Part III|Withdrawal by Subject|0|||
156792655|NCT00954538|565992854|FG001|Part III|Withdrawal by Subject|0|||
156792656|NCT00954538|565992855|FG002|Part III|Withdrawal by Subject|0|||
156792657|NCT00954538|565992856|FG003|Part III|Withdrawal by Subject|0|||
156792658|NCT00954538|565992857|FG004|Part III|Withdrawal by Subject|1|||
156792659|NCT00954538|565992858|FG005|Part III|Withdrawal by Subject|0|||
156792660|NCT01657942|565992860|FG000|Overall Study|Alternative Treatment|7|||
156532402|NCT03083847|565045018|FG007|Main|Pregnancy|1|||
156714723|NCT01260701|565699489|FG000|Overall Study|Death|2|||
156714724|NCT01260701|565699489|FG000|Overall Study|Not protocol specified|3|||
156714725|NCT01260701|565699489|FG000|Overall Study|Under review|1|||
156714726|NCT01260701|565699489|FG000|Overall Study|Ineligible|4|||
156714727|NCT01260701|565699489|FG000|Overall Study|Did not begin protocol therapy|1|||
156714728|NCT00443729|565700776|FG000|Overall Study|Never Treated|0|||
156714729|NCT00443729|565700777|FG001|Overall Study|Never Treated|1|||
156714730|NCT00443729|565700776|FG000|Overall Study|Lack of Efficacy|4|||
156714731|NCT00443729|565700777|FG001|Overall Study|Lack of Efficacy|2|||
156714732|NCT00443729|565700776|FG000|Overall Study|Lost to Follow-up|0|||
156714733|NCT00443729|565700777|FG001|Overall Study|Lost to Follow-up|1|||
156714734|NCT00443729|565700776|FG000|Overall Study|Physician Decision|2|||
156714735|NCT00443729|565700777|FG001|Overall Study|Physician Decision|1|||
156714736|NCT00443729|565700776|FG000|Overall Study|Protocol Violation|1|||
156714737|NCT00443729|565700777|FG001|Overall Study|Protocol Violation|1|||
156714738|NCT00443729|565700776|FG000|Overall Study|Withdrawal by Subject|3|||
156714739|NCT00443729|565700777|FG001|Overall Study|Withdrawal by Subject|1|||
156714740|NCT03718832|565700778|FG000|Analysis Sample|Withdrawal by Subject|18|||
156714741|NCT03718832|565700779|FG001|Analysis Sample|Withdrawal by Subject|15|||
156714742|NCT03718832|565700778|FG000|Analysis Sample|Legal hold on data|1|||
156714743|NCT03718832|565700779|FG001|Analysis Sample|Legal hold on data|0|||
156714744|NCT03718832|565700778|FG000|Analysis Sample|Participant from treated household|0|||
156714745|NCT03718832|565700779|FG001|Analysis Sample|Participant from treated household|1|||
156714746|NCT03718832|565700778|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
156714747|NCT03718832|565700779|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
156714748|NCT02548156|565700781|FG000|Washout Period 1|Lost to Follow-up|0|||
156714749|NCT02548156|565700782|FG001|Washout Period 1|Lost to Follow-up|0|||
156714750|NCT02548156|565700783|FG002|Washout Period 1|Lost to Follow-up|0|||
156714751|NCT02548156|565700784|FG003|Washout Period 1|Lost to Follow-up|0|||
156714752|NCT02548156|565700785|FG004|Washout Period 1|Lost to Follow-up|1|||
156714753|NCT02548156|565700786|FG005|Washout Period 1|Lost to Follow-up|0|||
156714754|NCT03288714|565700787|FG000|Overall Study|Lost to Follow-up|2|||
156714755|NCT03288714|565700788|FG001|Overall Study|Lost to Follow-up|1|||
156714756|NCT03288714|565700787|FG000|Overall Study|Non-compliance with study schedule|2|||
156714757|NCT03288714|565700788|FG001|Overall Study|Non-compliance with study schedule|0|||
156714758|NCT03288714|565700787|FG000|Overall Study|Withdrawal by Subject|3|||
156714759|NCT03288714|565700788|FG001|Overall Study|Withdrawal by Subject|1|||
156714760|NCT03288714|565700787|FG000|Overall Study|Clinical Worsening|2|||
156714761|NCT03288714|565700788|FG001|Overall Study|Clinical Worsening|1|||
156714762|NCT03288714|565700787|FG000|Overall Study|Adverse Event|1|||
156714763|NCT03288714|565700788|FG001|Overall Study|Adverse Event|0|||
156714764|NCT03280264|565700789|FG000|Overall Study|Adverse Event|1|||
156714765|NCT03280264|565700789|FG000|Overall Study|Physician Decision|1|||
156714766|NCT03280264|565700789|FG000|Overall Study|Withdrawal by Subject|1|||
156714767|NCT01342081|565700800|FG000|Overall Study|Did not receive allocated intervention|0|||
156714768|NCT01342081|565700801|FG001|Overall Study|Did not receive allocated intervention|0|||
156714769|NCT01342081|565700802|FG002|Overall Study|Did not receive allocated intervention|1|||
156714770|NCT01342081|565700800|FG000|Overall Study|Adverse Event|1|||
156714771|NCT01342081|565700801|FG001|Overall Study|Adverse Event|0|||
156714772|NCT01342081|565700802|FG002|Overall Study|Adverse Event|0|||
156714773|NCT01342081|565700800|FG000|Overall Study|Physician Decision|0|||
156714774|NCT01342081|565700801|FG001|Overall Study|Physician Decision|1|||
156714775|NCT01342081|565700802|FG002|Overall Study|Physician Decision|0|||
156714776|NCT01342081|565700800|FG000|Overall Study|Withdrawal by Subject|1|||
156714777|NCT01342081|565700801|FG001|Overall Study|Withdrawal by Subject|1|||
156714778|NCT01342081|565700802|FG002|Overall Study|Withdrawal by Subject|0|||
156714779|NCT04720053|565700807|FG000|Overall Study|Lost to Follow-up|12|||
156714780|NCT01960257|565700808|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
156714781|NCT01960257|565700809|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
156714782|NCT01960257|565700810|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
156714783|NCT01960257|565700808|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
156714784|NCT01960257|565700809|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
156714785|NCT01960257|565700810|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
156714786|NCT01960257|565700808|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
156714787|NCT01960257|565700809|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
156714788|NCT01960257|565700810|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
156714789|NCT01942993|565700811|FG000|Overall Study|Lost to Follow-up|1|||
156714790|NCT01942993|565700811|FG000|Overall Study|Physician Decision|1|||
156792661|NCT01657942|565992860|FG000|Overall Study|Lost to Follow-up|1|||
156714791|NCT01350271|565700812|FG000|Overall Study|Lost to Follow-up|21|||
156714792|NCT01350271|565700813|FG001|Overall Study|Lost to Follow-up|17|||
156714793|NCT01350271|565700814|FG002|Overall Study|Lost to Follow-up|26|||
156714794|NCT02906670|565700818|FG000|Cohort 1, QW|Radiological Progression|1|||
156714795|NCT02906670|565700819|FG001|Cohort 1, QW|Radiological Progression|0|||
156714796|NCT02906670|565700820|FG002|Cohort 1, QW|Radiological Progression|0|||
156714797|NCT02906670|565700821|FG003|Cohort 1, QW|Radiological Progression|0|||
156714798|NCT02906670|565700822|FG004|Cohort 1, QW|Radiological Progression|0|||
156714799|NCT02906670|565700823|FG005|Cohort 1, QW|Radiological Progression|0|||
156714800|NCT02906670|565700824|FG006|Cohort 1, QW|Radiological Progression|0|||
156714801|NCT02906670|565700825|FG007|Cohort 1, QW|Radiological Progression|0|||
156714802|NCT02906670|565700826|FG008|Cohort 1, QW|Radiological Progression|0|||
156714803|NCT02906670|565700827|FG009|Cohort 1, QW|Radiological Progression|0|||
156714804|NCT02906670|565700818|FG000|Cohort 2, QW|Radiological Progression|0|||
156714805|NCT02906670|565700819|FG001|Cohort 2, QW|Radiological Progression|1|||
156714806|NCT02906670|565700820|FG002|Cohort 2, QW|Radiological Progression|0|||
156714807|NCT02906670|565700821|FG003|Cohort 2, QW|Radiological Progression|0|||
156714808|NCT02906670|565700822|FG004|Cohort 2, QW|Radiological Progression|0|||
156714809|NCT02906670|565700823|FG005|Cohort 2, QW|Radiological Progression|0|||
156714810|NCT02906670|565700824|FG006|Cohort 2, QW|Radiological Progression|0|||
156714811|NCT02906670|565700825|FG007|Cohort 2, QW|Radiological Progression|0|||
156714812|NCT02906670|565700826|FG008|Cohort 2, QW|Radiological Progression|0|||
156714813|NCT02906670|565700827|FG009|Cohort 2, QW|Radiological Progression|0|||
156714814|NCT02906670|565700818|FG000|Cohort 3, QW|Radiological Progression|0|||
156714815|NCT02906670|565700819|FG001|Cohort 3, QW|Radiological Progression|0|||
156714816|NCT02906670|565700820|FG002|Cohort 3, QW|Radiological Progression|2|||
156792662|NCT00993473|565994682|FG000|Overall Study|Adverse Event|0|||
156792663|NCT00993473|565994683|FG001|Overall Study|Adverse Event|2|||
156792664|NCT00993473|565994682|FG000|Overall Study|Protocol Violation|1|||
156792665|NCT00993473|565994683|FG001|Overall Study|Protocol Violation|2|||
156792666|NCT00993473|565994682|FG000|Overall Study|Lost to Follow-up|1|||
156792667|NCT00993473|565994683|FG001|Overall Study|Lost to Follow-up|0|||
156792668|NCT00993473|565994682|FG000|Overall Study|Withdrawal by Subject|1|||
156714817|NCT02906670|565700821|FG003|Cohort 3, QW|Radiological Progression|0|||
156714818|NCT02906670|565700822|FG004|Cohort 3, QW|Radiological Progression|0|||
156792669|NCT00993473|565994683|FG001|Overall Study|Withdrawal by Subject|5|||
156792670|NCT00993473|565994682|FG000|Overall Study|Technical problem with CGM device|0|||
156792671|NCT00993473|565994683|FG001|Overall Study|Technical problem with CGM device|1|||
156792672|NCT00993473|565994682|FG000|Overall Study|Family event|1|||
156792673|NCT00993473|565994683|FG001|Overall Study|Family event|0|||
156333088|NCT01303861|564319017|FG000|Overall Study|Lack of Efficacy|3|||
156333089|NCT01303861|564319018|FG001|Overall Study|Lack of Efficacy|2|||
156333090|NCT01303861|564319019|FG002|Overall Study|Lack of Efficacy|1|||
156333091|NCT01303861|564319020|FG003|Overall Study|Lack of Efficacy|0|||
156333092|NCT01303861|564319017|FG000|Overall Study|Withdrawal by Subject|16|||
156333093|NCT01303861|564319018|FG001|Overall Study|Withdrawal by Subject|8|||
156333094|NCT01303861|564319019|FG002|Overall Study|Withdrawal by Subject|8|||
156333095|NCT01303861|564319020|FG003|Overall Study|Withdrawal by Subject|23|||
156333096|NCT01303861|564319017|FG000|Overall Study|Adverse Event|4|||
156333097|NCT01303861|564319018|FG001|Overall Study|Adverse Event|1|||
156333098|NCT01303861|564319019|FG002|Overall Study|Adverse Event|0|||
156333099|NCT01303861|564319020|FG003|Overall Study|Adverse Event|5|||
156333100|NCT01303861|564319017|FG000|Overall Study|Pregnancy|1|||
156333101|NCT01303861|564319018|FG001|Overall Study|Pregnancy|0|||
156333102|NCT01303861|564319019|FG002|Overall Study|Pregnancy|0|||
156333103|NCT01303861|564319020|FG003|Overall Study|Pregnancy|0|||
156333104|NCT00676338|564319032|FG000|Overall Study|Adverse Event|6|||
156333105|NCT00676338|564319033|FG001|Overall Study|Adverse Event|6|||
156333106|NCT00676338|564319034|FG002|Overall Study|Adverse Event|5|||
156333107|NCT00676338|564319035|FG003|Overall Study|Adverse Event|1|||
156333108|NCT00676338|564319032|FG000|Overall Study|Lost to Follow-up|4|||
156333109|NCT00676338|564319033|FG001|Overall Study|Lost to Follow-up|1|||
156333110|NCT00676338|564319034|FG002|Overall Study|Lost to Follow-up|3|||
156333111|NCT00676338|564319035|FG003|Overall Study|Lost to Follow-up|4|||
156333112|NCT00676338|564319032|FG000|Overall Study|Physician Decision|3|||
156333113|NCT00676338|564319033|FG001|Overall Study|Physician Decision|3|||
156333114|NCT00676338|564319034|FG002|Overall Study|Physician Decision|2|||
156333115|NCT00676338|564319035|FG003|Overall Study|Physician Decision|3|||
156333116|NCT00676338|564319032|FG000|Overall Study|Protocol Violation|5|||
156333117|NCT00676338|564319033|FG001|Overall Study|Protocol Violation|9|||
156333118|NCT00676338|564319034|FG002|Overall Study|Protocol Violation|2|||
156333119|NCT00676338|564319035|FG003|Overall Study|Protocol Violation|5|||
156333120|NCT00676338|564319032|FG000|Overall Study|Withdrawal by Subject|17|||
156333121|NCT00676338|564319033|FG001|Overall Study|Withdrawal by Subject|9|||
156333122|NCT00676338|564319034|FG002|Overall Study|Withdrawal by Subject|12|||
156333123|NCT00676338|564319035|FG003|Overall Study|Withdrawal by Subject|6|||
156333124|NCT00676338|564319032|FG000|Overall Study|Entry Criteria Not Met|0|||
156333125|NCT00676338|564319033|FG001|Overall Study|Entry Criteria Not Met|2|||
156333126|NCT00676338|564319034|FG002|Overall Study|Entry Criteria Not Met|1|||
156333127|NCT00676338|564319035|FG003|Overall Study|Entry Criteria Not Met|1|||
156333128|NCT00676338|564319032|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
156443063|NCT02238483|564713512|FG001|Overall Study|Lost to Follow-up|1|||
156443064|NCT02238483|564713511|FG000|Overall Study|Protocol Violation|1|||
156443065|NCT02238483|564713512|FG001|Overall Study|Protocol Violation|2|||
156443066|NCT02238483|564713511|FG000|Overall Study|Death|1|||
156443067|NCT02238483|564713512|FG001|Overall Study|Death|0|||
156443068|NCT02238483|564713511|FG000|Overall Study|Adverse Event|7|||
156443069|NCT02238483|564713512|FG001|Overall Study|Adverse Event|3|||
156443070|NCT02238483|564713511|FG000|Overall Study|Withdrawn due to physician decision|1|||
156443071|NCT02238483|564713512|FG001|Overall Study|Withdrawn due to physician decision|0|||
156443072|NCT02238483|564713511|FG000|Overall Study|Completion status not recorded|1|||
156443073|NCT02238483|564713512|FG001|Overall Study|Completion status not recorded|1|||
156443074|NCT02238483|564713511|FG000|Overall Study|Illness in family member|1|||
156443075|NCT02238483|564713512|FG001|Overall Study|Illness in family member|0|||
156443076|NCT02321514|564713516|FG000|Overall Study|Death|15|||
156443077|NCT02321514|564713516|FG000|Overall Study|Missed Visit|7|||
156443078|NCT02321514|564713516|FG000|Overall Study|Study Exit|3|||
156443079|NCT02178098|564713523|FG000|Overall Study|Withdrawal by Subject|0|||
156443080|NCT02178098|564713524|FG001|Overall Study|Withdrawal by Subject|6|||
156443081|NCT02178098|564713523|FG000|Overall Study|Adverse Event|1|||
156443082|NCT02178098|564713524|FG001|Overall Study|Adverse Event|2|||
156443083|NCT02178098|564713523|FG000|Overall Study|Protocol Violation|1|||
156443084|NCT02178098|564713524|FG001|Overall Study|Protocol Violation|1|||
156443085|NCT02178098|564713523|FG000|Overall Study|Lost to Follow-up|0|||
156443086|NCT02178098|564713524|FG001|Overall Study|Lost to Follow-up|1|||
156443087|NCT02178098|564713523|FG000|Overall Study|Sponsor Request|1|||
156443088|NCT02178098|564713524|FG001|Overall Study|Sponsor Request|0|||
156443089|NCT02178098|564713523|FG000|Overall Study|Other|2|||
156443090|NCT02178098|564713524|FG001|Overall Study|Other|2|||
156443091|NCT01109524|564713529|FG000|Overall Study|Disease Progression|29|||
156443092|NCT01109524|564713529|FG000|Overall Study|Study Drug toxicity|6|||
156443093|NCT01109524|564713529|FG000|Overall Study|Adverse Event|4|||
156443094|NCT01109524|564713529|FG000|Overall Study|Withdrawal by Subject|2|||
156443095|NCT01109524|564713529|FG000|Overall Study|Maximum clinical benefit|3|||
156443096|NCT01109524|564713529|FG000|Overall Study|Death|2|||
156443097|NCT01109524|564713529|FG000|Overall Study|No longer meets criteria|2|||
156443098|NCT01109524|564713529|FG000|Overall Study|Participant requested to end treatment|4|||
156443099|NCT01109524|564713529|FG000|Overall Study|Other|5|||
156443100|NCT01925339|564713536|FG000|Overall Study|Adverse Event|2|||
156443101|NCT01925339|564713537|FG001|Overall Study|Adverse Event|0|||
156443102|NCT03997916|564713544|FG000|Overall Study|Protocol Violation|35|||
156443103|NCT03807778|564713547|FG000|Overall Study|Adverse Event|0|||
156443104|NCT03807778|564713548|FG001|Overall Study|Adverse Event|0|||
156443105|NCT03807778|564713549|FG002|Overall Study|Adverse Event|3|||
156443106|NCT03807778|564713550|FG003|Overall Study|Adverse Event|5|||
156443107|NCT03807778|564713547|FG000|Overall Study|Progressive Disease|4|||
156443108|NCT03807778|564713548|FG001|Overall Study|Progressive Disease|2|||
156443109|NCT03807778|564713549|FG002|Overall Study|Progressive Disease|8|||
156443110|NCT03807778|564713550|FG003|Overall Study|Progressive Disease|15|||
156443111|NCT03807778|564713547|FG000|Overall Study|Symptomatic Deterioration|0|||
156443112|NCT03807778|564713548|FG001|Overall Study|Symptomatic Deterioration|1|||
156443113|NCT03807778|564713549|FG002|Overall Study|Symptomatic Deterioration|0|||
156443114|NCT03807778|564713550|FG003|Overall Study|Symptomatic Deterioration|1|||
156443115|NCT03807778|564713547|FG000|Overall Study|Withdrawal by Subject|0|||
156443116|NCT03807778|564713548|FG001|Overall Study|Withdrawal by Subject|1|||
156443117|NCT03807778|564713549|FG002|Overall Study|Withdrawal by Subject|0|||
156443118|NCT03807778|564713550|FG003|Overall Study|Withdrawal by Subject|1|||
156443119|NCT03807778|564713547|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
156443120|NCT03807778|564713548|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
156443121|NCT03807778|564713549|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
156443122|NCT03807778|564713550|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
156443123|NCT05028582|564713552|FG000|Overall Study|Lost to Follow-up|11|||
156443124|NCT05028582|564713553|FG001|Overall Study|Lost to Follow-up|9|||
156874113|NCT02840799|566298565|FG000|Phase 1|Withdrawal by Subject|4|||
156874114|NCT02840799|566298566|FG001|Phase 1|Withdrawal by Subject|0|||
156874115|NCT02840799|566298565|FG000|Phase 2 (Crossover)|Adverse Event|0|||
156874116|NCT02840799|566298566|FG001|Phase 2 (Crossover)|Adverse Event|1|||
156874117|NCT02840799|566298565|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
156874118|NCT02840799|566298566|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
156443125|NCT05028582|564713552|FG000|Overall Study|Withdrawal by Subject|9|||
156443126|NCT05028582|564713553|FG001|Overall Study|Withdrawal by Subject|10|||
156443127|NCT05028582|564713552|FG000|Overall Study|Adverse Event|5|||
156443128|NCT05028582|564713553|FG001|Overall Study|Adverse Event|2|||
156443129|NCT05028582|564713552|FG000|Overall Study|Miscellaneous|3|||
156443130|NCT05028582|564713553|FG001|Overall Study|Miscellaneous|2|||
156443131|NCT05028582|564713552|FG000|Overall Study|Lack of Efficacy|3|||
156443132|NCT05028582|564713553|FG001|Overall Study|Lack of Efficacy|1|||
156443133|NCT05028582|564713552|FG000|Overall Study|Physician Decision|0|||
156443134|NCT05028582|564713553|FG001|Overall Study|Physician Decision|1|||
156443135|NCT04939246|564713554|FG000|After Treatment|Death|4|||
156443136|NCT04939246|564713554|FG000|After Treatment|Lost to Follow-up|1|||
156443137|NCT04939246|564713554|FG000|After Treatment|Discharged to hospice|2|||
156443138|NCT03324984|564715167|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
156443139|NCT03324984|564715168|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
156443140|NCT04337372|564715171|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
156443141|NCT04337372|564715172|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
156443142|NCT04337372|564715173|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
156443143|NCT04337372|564715174|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
156443144|NCT04337372|564715171|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
156443145|NCT04337372|564715172|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
156443146|NCT04337372|564715173|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
156443147|NCT04337372|564715174|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
156443148|NCT04337372|564715171|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
156443149|NCT04337372|564715172|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
156443150|NCT04337372|564715173|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
156443151|NCT04337372|564715174|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
156443152|NCT04337372|564715171|FG000|Day 2: EEG Measures|Protocol Violation|6|||
156443153|NCT04337372|564715172|FG001|Day 2: EEG Measures|Protocol Violation|6|||
156443154|NCT04337372|564715173|FG002|Day 2: EEG Measures|Protocol Violation|5|||
156443155|NCT04337372|564715174|FG003|Day 2: EEG Measures|Protocol Violation|17|||
156443156|NCT05687903|564715175|FG000|Overall Study|Protocol Deviation|1|||
156443157|NCT05687903|564715176|FG001|Overall Study|Protocol Deviation|1|||
156443158|NCT05687903|564715177|FG002|Overall Study|Protocol Deviation|0|||
156443159|NCT05687903|564715178|FG003|Overall Study|Protocol Deviation|1|||
156443160|NCT05687903|564715179|FG004|Overall Study|Protocol Deviation|0|||
156443161|NCT05613205|564715180|FG000|Overall Study|Lost to Follow-up|0|||
156443162|NCT05613205|564715181|FG001|Overall Study|Lost to Follow-up|0|||
156443163|NCT05613205|564715182|FG002|Overall Study|Lost to Follow-up|1|||
156443164|NCT05613205|564715183|FG003|Overall Study|Lost to Follow-up|1|||
156443165|NCT05613205|564715184|FG004|Overall Study|Lost to Follow-up|0|||
156443166|NCT05613205|564715180|FG000|Overall Study|Withdrawal by Subject|0|||
156443167|NCT05613205|564715181|FG001|Overall Study|Withdrawal by Subject|0|||
156443168|NCT05613205|564715182|FG002|Overall Study|Withdrawal by Subject|1|||
156443169|NCT05613205|564715183|FG003|Overall Study|Withdrawal by Subject|1|||
156443170|NCT05613205|564715184|FG004|Overall Study|Withdrawal by Subject|0|||
156443171|NCT04869982|564715188|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
156443172|NCT04869982|564715189|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
156443173|NCT04869982|564715188|FG000|Overall Study|Migrated / moved from the study area|1|||
156443174|NCT04869982|564715189|FG001|Overall Study|Migrated / moved from the study area|1|||
156443175|NCT04869982|564715188|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
156443176|NCT04869982|564715189|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
156443177|NCT04869982|564715188|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
156443178|NCT04869982|564715189|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
156443179|NCT04869982|564715188|FG000|Overall Study|Solicited adverse event|2|||
156443180|NCT04869982|564715189|FG001|Overall Study|Solicited adverse event|1|||
156443181|NCT04608045|564715190|FG000|Overall Study|Physician Decision|1|||
156443182|NCT02473250|564715192|FG000|Overall Study|Lost to Follow-up|10|||
156443183|NCT02473250|564715192|FG000|Overall Study|Physician Decision|5|||
156443184|NCT02473250|564715192|FG000|Overall Study|Did not tolerate medication washout|3|||
156443185|NCT02473250|564715192|FG000|Overall Study|Antidepressant effect of divalproex|2|||
156443186|NCT03103321|564715193|FG000|Overall Study|Protocol Violation|1|||
156443187|NCT03103321|564715194|FG001|Overall Study|Protocol Violation|1|||
156443188|NCT03103321|564715195|FG002|Overall Study|Protocol Violation|1|||
156443189|NCT03103321|564715196|FG003|Overall Study|Protocol Violation|0|||
156443190|NCT04847999|564715197|FG000|Overall Study|Lost to Follow-up|0|||
156443191|NCT04847999|564715198|FG001|Overall Study|Lost to Follow-up|1|||
156443192|NCT02879448|564715199|FG000|Overall Study|Death|251|||
156714819|NCT02906670|565700823|FG005|Cohort 3, QW|Radiological Progression|0|||
156714820|NCT02906670|565700824|FG006|Cohort 3, QW|Radiological Progression|0|||
156714821|NCT02906670|565700825|FG007|Cohort 3, QW|Radiological Progression|0|||
156714822|NCT02906670|565700826|FG008|Cohort 3, QW|Radiological Progression|0|||
156714823|NCT02906670|565700827|FG009|Cohort 3, QW|Radiological Progression|0|||
156714824|NCT02906670|565700818|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714825|NCT02906670|565700819|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
156443193|NCT02879448|564715200|FG001|Overall Study|Death|263|||
156443194|NCT02879448|564715199|FG000|Overall Study|Lost to Follow-up|23|||
156443195|NCT02879448|564715200|FG001|Overall Study|Lost to Follow-up|28|||
156443196|NCT02879448|564715199|FG000|Overall Study|Withdrawal by Subject|42|||
156714826|NCT02906670|565700820|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
156443197|NCT02879448|564715200|FG001|Overall Study|Withdrawal by Subject|79|||
156443198|NCT02879448|564715199|FG000|Overall Study|Other Reasons|8|||
156443199|NCT02879448|564715200|FG001|Overall Study|Other Reasons|12|||
156443200|NCT03602014|564715202|FG000|Overall Study|Lost to Follow-up|2|||
156443201|NCT03602014|564715203|FG001|Overall Study|Lost to Follow-up|0|||
156443202|NCT03602014|564715204|FG002|Overall Study|Lost to Follow-up|0|||
156443203|NCT06629454|564715205|FG000|Overall Study|Withdraw by Clinician Decision|1|||
156443204|NCT01704079|564715206|FG000|Overall Study|Withdrawal by Subject|5|||
156714827|NCT02906670|565700821|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
156443205|NCT01704079|564715207|FG001|Overall Study|Withdrawal by Subject|7|||
156443206|NCT01704079|564715206|FG000|Overall Study|Lost to Follow-up|2|||
156443207|NCT01704079|564715207|FG001|Overall Study|Lost to Follow-up|5|||
156443208|NCT01704079|564715206|FG000|Overall Study|Adverse Event|4|||
156443209|NCT01704079|564715207|FG001|Overall Study|Adverse Event|7|||
156443210|NCT01704079|564715206|FG000|Overall Study|Protocol Violation|1|||
156443211|NCT01704079|564715207|FG001|Overall Study|Protocol Violation|0|||
156443212|NCT01704079|564715206|FG000|Overall Study|Subject noncompliance|2|||
156443213|NCT01704079|564715207|FG001|Overall Study|Subject noncompliance|3|||
156443214|NCT01704079|564715206|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
156443215|NCT01704079|564715207|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
156443216|NCT06023082|564715208|FG000|Overall Study|Withdrawal by Subject|2|||
156443217|NCT06023082|564715208|FG000|Overall Study|Lost to Follow-up|15|||
156443218|NCT06023082|564715208|FG000|Overall Study|Side effects|5|||
156443219|NCT03584516|564715214|FG000|Part 1|Death|2|||
156443220|NCT03584516|564715215|FG001|Part 1|Death|3|||
156443221|NCT03584516|564715216|FG002|Part 1|Death|0|||
156443222|NCT03584516|564715217|FG003|Part 1|Death|0|||
156443223|NCT03584516|564715218|FG004|Part 1|Death|0|||
156443224|NCT03584516|564715219|FG005|Part 1|Death|0|||
156443225|NCT03584516|564715214|FG000|Part 1|Withdrawal by Subject|2|||
156443226|NCT03584516|564715215|FG001|Part 1|Withdrawal by Subject|0|||
156443227|NCT03584516|564715216|FG002|Part 1|Withdrawal by Subject|0|||
156443228|NCT03584516|564715217|FG003|Part 1|Withdrawal by Subject|0|||
156443229|NCT03584516|564715218|FG004|Part 1|Withdrawal by Subject|0|||
156443230|NCT03584516|564715219|FG005|Part 1|Withdrawal by Subject|0|||
156443231|NCT03584516|564715214|FG000|Part 1|Lost to Follow-up|1|||
156443232|NCT03584516|564715215|FG001|Part 1|Lost to Follow-up|0|||
156443233|NCT03584516|564715216|FG002|Part 1|Lost to Follow-up|0|||
156443234|NCT03584516|564715217|FG003|Part 1|Lost to Follow-up|0|||
156443235|NCT03584516|564715218|FG004|Part 1|Lost to Follow-up|0|||
156443236|NCT03584516|564715219|FG005|Part 1|Lost to Follow-up|0|||
156443237|NCT03584516|564715214|FG000|Part 1|Study Terminated by Sponsor|0|||
156443238|NCT03584516|564715215|FG001|Part 1|Study Terminated by Sponsor|2|||
156443239|NCT03584516|564715216|FG002|Part 1|Study Terminated by Sponsor|0|||
156443240|NCT03584516|564715217|FG003|Part 1|Study Terminated by Sponsor|0|||
156443241|NCT03584516|564715218|FG004|Part 1|Study Terminated by Sponsor|0|||
156443242|NCT03584516|564715219|FG005|Part 1|Study Terminated by Sponsor|0|||
156333129|NCT00676338|564319033|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
156333130|NCT00676338|564319034|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
156333131|NCT00676338|564319035|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
156333132|NCT02122458|564319036|FG000|Overall Study|Withdrawal by Subject|0|||
156333133|NCT02122458|564319037|FG001|Overall Study|Withdrawal by Subject|0|||
156333134|NCT02122458|564319038|FG002|Overall Study|Withdrawal by Subject|0|||
156333135|NCT02122458|564319039|FG003|Overall Study|Withdrawal by Subject|4|||
156333136|NCT02122458|564319040|FG004|Overall Study|Withdrawal by Subject|4|||
156333137|NCT02122458|564319041|FG005|Overall Study|Withdrawal by Subject|4|||
156333138|NCT02122458|564319042|FG006|Overall Study|Withdrawal by Subject|0|||
156333139|NCT02122458|564319036|FG000|Overall Study|Lost to Follow-up|1|||
156333140|NCT02122458|564319037|FG001|Overall Study|Lost to Follow-up|3|||
156333141|NCT02122458|564319038|FG002|Overall Study|Lost to Follow-up|0|||
156443243|NCT03584516|564715214|FG000|Part 1 Expansion|Death|0|||
156443244|NCT03584516|564715215|FG001|Part 1 Expansion|Death|0|||
156443245|NCT03584516|564715216|FG002|Part 1 Expansion|Death|9|||
156714828|NCT02906670|565700822|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714829|NCT02906670|565700823|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714830|NCT02906670|565700824|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714831|NCT02906670|565700825|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714832|NCT02906670|565700826|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714833|NCT02906670|565700827|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
156443246|NCT03584516|564715217|FG003|Part 1 Expansion|Death|8|||
156443247|NCT03584516|564715218|FG004|Part 1 Expansion|Death|4|||
156443248|NCT03584516|564715219|FG005|Part 1 Expansion|Death|5|||
156714834|NCT02906670|565700818|FG000|Cohort 4, Q2W|Radiological Progression|0|||
156714835|NCT02906670|565700819|FG001|Cohort 4, Q2W|Radiological Progression|0|||
156333142|NCT02122458|564319039|FG003|Overall Study|Lost to Follow-up|7|||
156333143|NCT02122458|564319040|FG004|Overall Study|Lost to Follow-up|5|||
156443249|NCT03584516|564715214|FG000|Part 1 Expansion|Lost to Follow-up|0|||
156443250|NCT03584516|564715215|FG001|Part 1 Expansion|Lost to Follow-up|0|||
156443251|NCT03584516|564715216|FG002|Part 1 Expansion|Lost to Follow-up|0|||
156443252|NCT03584516|564715217|FG003|Part 1 Expansion|Lost to Follow-up|1|||
156443253|NCT03584516|564715218|FG004|Part 1 Expansion|Lost to Follow-up|0|||
156443254|NCT03584516|564715219|FG005|Part 1 Expansion|Lost to Follow-up|0|||
156443255|NCT03584516|564715214|FG000|Part 1 Expansion|Physician Decision|0|||
156443256|NCT03584516|564715215|FG001|Part 1 Expansion|Physician Decision|0|||
156443257|NCT03584516|564715216|FG002|Part 1 Expansion|Physician Decision|4|||
156333144|NCT02122458|564319041|FG005|Overall Study|Lost to Follow-up|15|||
156333145|NCT02122458|564319042|FG006|Overall Study|Lost to Follow-up|1|||
156714836|NCT02906670|565700820|FG002|Cohort 4, Q2W|Radiological Progression|0|||
156443258|NCT03584516|564715217|FG003|Part 1 Expansion|Physician Decision|3|||
156443259|NCT03584516|564715218|FG004|Part 1 Expansion|Physician Decision|2|||
156443260|NCT03584516|564715219|FG005|Part 1 Expansion|Physician Decision|3|||
156443261|NCT03584516|564715214|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
156874119|NCT02687191|566298570|FG000|Overall Study|Death|0|||
156443262|NCT03584516|564715215|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
156443263|NCT03584516|564715216|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
156443264|NCT03584516|564715217|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
156443265|NCT03584516|564715218|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
156443266|NCT03584516|564715219|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
156443267|NCT03584516|564715214|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
156443268|NCT03584516|564715215|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
156443269|NCT03584516|564715216|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
156443270|NCT03584516|564715217|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
156443271|NCT03584516|564715218|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
156443272|NCT03584516|564715219|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
156532403|NCT03083847|565045019|FG008|Main|Pregnancy|0|||
156714837|NCT02906670|565700821|FG003|Cohort 4, Q2W|Radiological Progression|0|||
156714838|NCT02906670|565700822|FG004|Cohort 4, Q2W|Radiological Progression|0|||
156714839|NCT02906670|565700823|FG005|Cohort 4, Q2W|Radiological Progression|1|||
156714840|NCT02906670|565700824|FG006|Cohort 4, Q2W|Radiological Progression|0|||
156714841|NCT02906670|565700825|FG007|Cohort 4, Q2W|Radiological Progression|0|||
156714842|NCT02906670|565700826|FG008|Cohort 4, Q2W|Radiological Progression|0|||
156714843|NCT02906670|565700827|FG009|Cohort 4, Q2W|Radiological Progression|0|||
156714844|NCT02906670|565700818|FG000|Cohort 4, Q2W|Clinical Progression|0|||
156714845|NCT02906670|565700819|FG001|Cohort 4, Q2W|Clinical Progression|0|||
156714846|NCT02906670|565700820|FG002|Cohort 4, Q2W|Clinical Progression|0|||
156714847|NCT02906670|565700821|FG003|Cohort 4, Q2W|Clinical Progression|0|||
156714848|NCT02906670|565700822|FG004|Cohort 4, Q2W|Clinical Progression|0|||
156714849|NCT02906670|565700823|FG005|Cohort 4, Q2W|Clinical Progression|2|||
156714850|NCT02906670|565700824|FG006|Cohort 4, Q2W|Clinical Progression|0|||
156714851|NCT02906670|565700825|FG007|Cohort 4, Q2W|Clinical Progression|0|||
156714852|NCT02906670|565700826|FG008|Cohort 4, Q2W|Clinical Progression|0|||
156714853|NCT02906670|565700827|FG009|Cohort 4, Q2W|Clinical Progression|0|||
156714854|NCT02906670|565700818|FG000|Cohort 5, Q2W|Radiological Progression|0|||
156714855|NCT02906670|565700819|FG001|Cohort 5, Q2W|Radiological Progression|0|||
156714856|NCT02906670|565700820|FG002|Cohort 5, Q2W|Radiological Progression|0|||
156714857|NCT02906670|565700821|FG003|Cohort 5, Q2W|Radiological Progression|0|||
156792674|NCT00836901|565994684|FG000|First Intervention|Withdrawal by Subject|1|||
156792675|NCT00836901|565994685|FG001|First Intervention|Withdrawal by Subject|0|||
156792676|NCT01148771|565994688|FG000|Washout Period|Withdrawal by Subject|0|||
156792677|NCT01148771|565994689|FG001|Washout Period|Withdrawal by Subject|1|||
156792678|NCT01047540|565994690|FG000|Overall Study|Protocol Violation|1|||
156792679|NCT01047540|565994691|FG001|Overall Study|Protocol Violation|0|||
156792680|NCT01047540|565994692|FG002|Overall Study|Protocol Violation|0|||
156792681|NCT01047540|565994693|FG003|Overall Study|Protocol Violation|0|||
156792682|NCT01047540|565994694|FG004|Overall Study|Protocol Violation|0|||
156792683|NCT01047540|565994690|FG000|Overall Study|Lost to Follow-up|1|||
156792684|NCT01047540|565994691|FG001|Overall Study|Lost to Follow-up|0|||
156792685|NCT01047540|565994692|FG002|Overall Study|Lost to Follow-up|0|||
156792686|NCT01047540|565994693|FG003|Overall Study|Lost to Follow-up|0|||
156792687|NCT01047540|565994694|FG004|Overall Study|Lost to Follow-up|0|||
156792688|NCT01047540|565994690|FG000|Overall Study|Withdrawal by Subject|1|||
156792689|NCT01047540|565994691|FG001|Overall Study|Withdrawal by Subject|0|||
156792690|NCT01047540|565994692|FG002|Overall Study|Withdrawal by Subject|3|||
156792691|NCT01047540|565994693|FG003|Overall Study|Withdrawal by Subject|0|||
156792692|NCT01047540|565994694|FG004|Overall Study|Withdrawal by Subject|1|||
156792693|NCT01047540|565994690|FG000|Overall Study|Pregnancy|1|||
156792694|NCT01047540|565994691|FG001|Overall Study|Pregnancy|0|||
156792695|NCT01047540|565994692|FG002|Overall Study|Pregnancy|0|||
156792696|NCT01047540|565994693|FG003|Overall Study|Pregnancy|0|||
156792697|NCT01047540|565994694|FG004|Overall Study|Pregnancy|0|||
156792698|NCT01047540|565994690|FG000|Overall Study|Adverse Event|1|||
156792699|NCT01047540|565994691|FG001|Overall Study|Adverse Event|0|||
156792700|NCT01047540|565994692|FG002|Overall Study|Adverse Event|0|||
156792701|NCT01047540|565994693|FG003|Overall Study|Adverse Event|0|||
156792702|NCT01047540|565994694|FG004|Overall Study|Adverse Event|0|||
156792703|NCT03268499|565994700|FG000|Overall Study|Withdrawal by Subject|2|||
156792704|NCT03268499|565994701|FG001|Overall Study|Withdrawal by Subject|1|||
156792705|NCT04064567|565994705|FG000|Overall Study|Lost to Follow-up|23|||
156792706|NCT04064567|565994706|FG001|Overall Study|Lost to Follow-up|22|||
156792707|NCT04064567|565994705|FG000|Overall Study|Withdrawal by Subject|0|||
156792708|NCT04064567|565994706|FG001|Overall Study|Withdrawal by Subject|1|||
156792709|NCT04064567|565994705|FG000|Overall Study|Reincarcerated|7|||
156714858|NCT02906670|565700822|FG004|Cohort 5, Q2W|Radiological Progression|0|||
156792710|NCT04064567|565994706|FG001|Overall Study|Reincarcerated|10|||
156792711|NCT04064567|565994705|FG000|Overall Study|Moved out of U.S.|0|||
156443273|NCT03584516|564715214|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
156443274|NCT03584516|564715215|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
156443275|NCT03584516|564715216|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
156443276|NCT03584516|564715217|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
156443277|NCT03584516|564715218|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
156443278|NCT03584516|564715219|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
156443279|NCT03584516|564715214|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
156443280|NCT03584516|564715215|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
156443281|NCT03584516|564715216|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
156443282|NCT03584516|564715217|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
156443283|NCT03584516|564715218|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
156443284|NCT03584516|564715219|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
156443285|NCT05846646|564715220|FG000|Overall Study|Physician Decision|1|||
156443286|NCT05846646|564715221|FG001|Overall Study|Physician Decision|0|||
156443287|NCT05846646|564715222|FG002|Overall Study|Physician Decision|0|||
156443288|NCT05846646|564715220|FG000|Overall Study|Lack of Efficacy|1|||
156443289|NCT05846646|564715221|FG001|Overall Study|Lack of Efficacy|1|||
156443290|NCT05846646|564715222|FG002|Overall Study|Lack of Efficacy|0|||
156443291|NCT05846646|564715220|FG000|Overall Study|Early Study Termination|1|||
156443292|NCT05846646|564715221|FG001|Overall Study|Early Study Termination|2|||
156443293|NCT05846646|564715222|FG002|Overall Study|Early Study Termination|0|||
156443294|NCT00670046|564715223|FG000|Overall Study|Lost to Follow-up|1|||
156443295|NCT00670046|564715224|FG001|Overall Study|Lost to Follow-up|1|||
156443296|NCT00670046|564715223|FG000|Overall Study|Withdrawal by Subject|0|||
156443297|NCT00670046|564715224|FG001|Overall Study|Withdrawal by Subject|1|||
156443298|NCT03990649|564715225|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
156443299|NCT03990649|564715226|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
156443300|NCT03990649|564715227|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
156443301|NCT03990649|564715225|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
156443302|NCT03990649|564715226|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
156443303|NCT03990649|564715227|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
156443304|NCT03990649|564715225|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
156874120|NCT02687191|566298571|FG001|Overall Study|Death|1|||
156874121|NCT02687191|566298572|FG002|Overall Study|Death|1|||
156874122|NCT02687191|566298573|FG003|Overall Study|Death|0|||
156874123|NCT02687191|566298574|FG004|Overall Study|Death|1|||
156443305|NCT03990649|564715226|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
156443306|NCT03990649|564715227|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
156443307|NCT03990649|564715225|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
156443308|NCT03990649|564715226|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
156443309|NCT03990649|564715227|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
156443310|NCT03990649|564715225|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
156443311|NCT03990649|564715226|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
156443312|NCT03990649|564715227|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
156443313|NCT03990649|564715225|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
156443314|NCT03990649|564715226|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
156443315|NCT03990649|564715227|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
156443316|NCT03990649|564715225|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
156443317|NCT03990649|564715226|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
156443318|NCT03990649|564715227|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
156443319|NCT01443845|564715228|FG000|Overall Study|Protocol Violation|43|||
156443320|NCT01443845|564715229|FG001|Overall Study|Protocol Violation|45|||
156443321|NCT01443845|564715228|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
156443322|NCT01443845|564715229|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
156443323|NCT01443845|564715228|FG000|Overall Study|Deterioration in pulmonary function|1|||
156443324|NCT01443845|564715229|FG001|Overall Study|Deterioration in pulmonary function|4|||
156443325|NCT01443845|564715228|FG000|Overall Study|Lack of Efficacy|10|||
156443326|NCT01443845|564715229|FG001|Overall Study|Lack of Efficacy|5|||
156443327|NCT01443845|564715228|FG000|Overall Study|Adverse Event|64|||
156443328|NCT01443845|564715229|FG001|Overall Study|Adverse Event|138|||
156443329|NCT01443845|564715228|FG000|Overall Study|Withdrawal by Subject|63|||
156443330|NCT01443845|564715229|FG001|Overall Study|Withdrawal by Subject|67|||
156443331|NCT01443845|564715228|FG000|Overall Study|Military Conflict - Site Terminated|20|||
156443332|NCT01443845|564715229|FG001|Overall Study|Military Conflict - Site Terminated|21|||
156532404|NCT03083847|565045020|FG009|Main|Pregnancy|0|||
156532405|NCT03083847|565045011|FG000|Main|Adverse Event|0|||
156443333|NCT01443845|564715228|FG000|Overall Study|Lost to Follow-up|9|||
156443334|NCT01443845|564715229|FG001|Overall Study|Lost to Follow-up|13|||
156443335|NCT01471691|564715230|FG000|Overall Study|Lack of Efficacy|0|||
156443336|NCT01471691|564715231|FG001|Overall Study|Lack of Efficacy|1|||
156874124|NCT02687191|566298575|FG005|Overall Study|Death|1|||
156443337|NCT02461628|564715232|FG000|Overall Study|Refused to complete survey|4|||
156443338|NCT02461628|564715233|FG001|Overall Study|Refused to complete survey|7|||
156443339|NCT02015520|564715234|FG000|Overall Study|Lack of Efficacy|1|||
156443340|NCT02015520|564715235|FG001|Overall Study|Lack of Efficacy|0|||
156443341|NCT02015520|564715236|FG002|Overall Study|Lack of Efficacy|3|||
156443342|NCT02015520|564715237|FG003|Overall Study|Lack of Efficacy|2|||
156443343|NCT02015520|564715234|FG000|Overall Study|Adverse Event|0|||
156443344|NCT02015520|564715235|FG001|Overall Study|Adverse Event|0|||
156443345|NCT02015520|564715236|FG002|Overall Study|Adverse Event|0|||
156443346|NCT02015520|564715237|FG003|Overall Study|Adverse Event|1|||
156443347|NCT02015520|564715234|FG000|Overall Study|Withdrawal by Subject|2|||
156443348|NCT02015520|564715235|FG001|Overall Study|Withdrawal by Subject|2|||
156443349|NCT02015520|564715236|FG002|Overall Study|Withdrawal by Subject|1|||
156443350|NCT02015520|564715237|FG003|Overall Study|Withdrawal by Subject|0|||
156443351|NCT02015520|564715234|FG000|Overall Study|Death|1|||
156443352|NCT02015520|564715235|FG001|Overall Study|Death|0|||
156443353|NCT02015520|564715236|FG002|Overall Study|Death|0|||
156714859|NCT02906670|565700823|FG005|Cohort 5, Q2W|Radiological Progression|0|||
156714860|NCT02906670|565700824|FG006|Cohort 5, Q2W|Radiological Progression|4|||
156714861|NCT02906670|565700825|FG007|Cohort 5, Q2W|Radiological Progression|0|||
156714862|NCT02906670|565700826|FG008|Cohort 5, Q2W|Radiological Progression|0|||
156714863|NCT02906670|565700827|FG009|Cohort 5, Q2W|Radiological Progression|0|||
156714864|NCT02906670|565700818|FG000|Cohort 5, Q2W|Clinical Progression|0|||
156714865|NCT02906670|565700819|FG001|Cohort 5, Q2W|Clinical Progression|0|||
156714866|NCT02906670|565700820|FG002|Cohort 5, Q2W|Clinical Progression|0|||
156714867|NCT02906670|565700821|FG003|Cohort 5, Q2W|Clinical Progression|0|||
156714868|NCT02906670|565700822|FG004|Cohort 5, Q2W|Clinical Progression|0|||
156714869|NCT02906670|565700823|FG005|Cohort 5, Q2W|Clinical Progression|0|||
156714870|NCT02906670|565700824|FG006|Cohort 5, Q2W|Clinical Progression|1|||
156714871|NCT02906670|565700825|FG007|Cohort 5, Q2W|Clinical Progression|0|||
156714872|NCT02906670|565700826|FG008|Cohort 5, Q2W|Clinical Progression|0|||
156714873|NCT02906670|565700827|FG009|Cohort 5, Q2W|Clinical Progression|0|||
156714874|NCT02906670|565700818|FG000|Cohort 5, Q2W|Adverse Event|0|||
156714875|NCT02906670|565700819|FG001|Cohort 5, Q2W|Adverse Event|0|||
156714876|NCT02906670|565700820|FG002|Cohort 5, Q2W|Adverse Event|0|||
156714877|NCT02906670|565700821|FG003|Cohort 5, Q2W|Adverse Event|0|||
156714878|NCT02906670|565700822|FG004|Cohort 5, Q2W|Adverse Event|0|||
156714879|NCT02906670|565700823|FG005|Cohort 5, Q2W|Adverse Event|0|||
156714880|NCT02906670|565700824|FG006|Cohort 5, Q2W|Adverse Event|1|||
156714881|NCT02906670|565700825|FG007|Cohort 5, Q2W|Adverse Event|0|||
156714882|NCT02906670|565700826|FG008|Cohort 5, Q2W|Adverse Event|0|||
156714883|NCT02906670|565700827|FG009|Cohort 5, Q2W|Adverse Event|0|||
156714884|NCT02906670|565700818|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714885|NCT02906670|565700819|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714886|NCT02906670|565700820|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714887|NCT02906670|565700821|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714888|NCT02906670|565700822|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714889|NCT02906670|565700823|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714890|NCT02906670|565700824|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
156714891|NCT02906670|565700825|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714892|NCT02906670|565700826|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714893|NCT02906670|565700827|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714894|NCT02906670|565700818|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
156443354|NCT02015520|564715237|FG003|Overall Study|Death|0|||
156443355|NCT02015520|564715234|FG000|Overall Study|Lost to Follow-up|0|||
156443356|NCT02015520|564715235|FG001|Overall Study|Lost to Follow-up|0|||
156443357|NCT02015520|564715236|FG002|Overall Study|Lost to Follow-up|1|||
156443358|NCT02015520|564715237|FG003|Overall Study|Lost to Follow-up|0|||
156443359|NCT02015520|564715234|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
156443360|NCT02015520|564715235|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
156443361|NCT02015520|564715236|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
156443362|NCT02015520|564715237|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
156443363|NCT02015520|564715234|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
156443364|NCT02015520|564715235|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
156443365|NCT02015520|564715236|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
156443366|NCT02015520|564715237|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
156443367|NCT01854385|564715238|FG000|Pre-Treatment|Withdrawal by Subject|4|||
156443368|NCT01854385|564715238|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
156443369|NCT01854385|564715238|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
156443370|NCT01854385|564715238|FG000|Pre-Treatment|Unable to come for study visits|1|||
156443371|NCT01854385|564715238|FG000|Treatment|Lost to Follow-up|1|||
156714895|NCT02906670|565700819|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
156714896|NCT02906670|565700820|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
156714897|NCT02906670|565700821|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
156714898|NCT02906670|565700822|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
156792712|NCT04064567|565994706|FG001|Overall Study|Moved out of U.S.|1|||
156874125|NCT02687191|566298570|FG000|Overall Study|Withdrawal by Subject|0|||
156874126|NCT02687191|566298571|FG001|Overall Study|Withdrawal by Subject|0|||
156874127|NCT02687191|566298572|FG002|Overall Study|Withdrawal by Subject|0|||
156874128|NCT02687191|566298573|FG003|Overall Study|Withdrawal by Subject|1|||
156874129|NCT02687191|566298574|FG004|Overall Study|Withdrawal by Subject|0|||
156874130|NCT02687191|566298575|FG005|Overall Study|Withdrawal by Subject|0|||
156874131|NCT00943072|566298576|FG000|Overall Study|Adverse Event|0|||
156874132|NCT00943072|566298577|FG001|Overall Study|Adverse Event|3|||
156874133|NCT00943072|566298576|FG000|Overall Study|Death|0|||
156874134|NCT00943072|566298577|FG001|Overall Study|Death|2|||
156874135|NCT00943072|566298576|FG000|Overall Study|Withdrawal by Subject|3|||
156532406|NCT03083847|565045012|FG001|Main|Adverse Event|0|||
156532407|NCT03083847|565045013|FG002|Main|Adverse Event|0|||
156532408|NCT03083847|565045014|FG003|Main|Adverse Event|0|||
156532409|NCT03083847|565045015|FG004|Main|Adverse Event|0|||
156874136|NCT00943072|566298577|FG001|Overall Study|Withdrawal by Subject|1|||
156874137|NCT00943072|566298576|FG000|Overall Study|Protocol Violation|0|||
156874138|NCT00943072|566298577|FG001|Overall Study|Protocol Violation|1|||
156874139|NCT00943072|566298576|FG000|Overall Study|Lost to Follow-up|1|||
156874140|NCT00943072|566298577|FG001|Overall Study|Lost to Follow-up|2|||
156874141|NCT00943072|566298576|FG000|Overall Study|Lack of Efficacy|0|||
156333146|NCT02122458|564319036|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
156333147|NCT02122458|564319037|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
156333148|NCT02122458|564319038|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
156333149|NCT02122458|564319039|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
156333150|NCT02122458|564319040|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
156333151|NCT02122458|564319041|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
156333152|NCT02122458|564319042|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
156333153|NCT02122458|564319036|FG000|Overall Study|Adverse Event|1|||
156333154|NCT02122458|564319037|FG001|Overall Study|Adverse Event|0|||
156333155|NCT02122458|564319038|FG002|Overall Study|Adverse Event|0|||
156333156|NCT02122458|564319039|FG003|Overall Study|Adverse Event|0|||
156333157|NCT02122458|564319040|FG004|Overall Study|Adverse Event|0|||
156333158|NCT02122458|564319041|FG005|Overall Study|Adverse Event|0|||
156333159|NCT02122458|564319042|FG006|Overall Study|Adverse Event|0|||
156333160|NCT02122458|564319036|FG000|Overall Study|Experimental Error|0|||
156333161|NCT02122458|564319037|FG001|Overall Study|Experimental Error|0|||
156333162|NCT02122458|564319038|FG002|Overall Study|Experimental Error|0|||
156333163|NCT02122458|564319039|FG003|Overall Study|Experimental Error|0|||
156333164|NCT02122458|564319040|FG004|Overall Study|Experimental Error|3|||
156333165|NCT02122458|564319041|FG005|Overall Study|Experimental Error|0|||
156333166|NCT02122458|564319042|FG006|Overall Study|Experimental Error|0|||
156333167|NCT02122458|564319036|FG000|Overall Study|Deployed or Moved|0|||
156333168|NCT02122458|564319037|FG001|Overall Study|Deployed or Moved|0|||
156333169|NCT02122458|564319038|FG002|Overall Study|Deployed or Moved|0|||
156333170|NCT02122458|564319039|FG003|Overall Study|Deployed or Moved|0|||
156333171|NCT02122458|564319040|FG004|Overall Study|Deployed or Moved|1|||
156333172|NCT02122458|564319041|FG005|Overall Study|Deployed or Moved|0|||
156333173|NCT02122458|564319042|FG006|Overall Study|Deployed or Moved|0|||
156333174|NCT02122458|564319036|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
156333175|NCT02122458|564319037|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
156333176|NCT02122458|564319038|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
156333177|NCT02122458|564319039|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
156333178|NCT02122458|564319040|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
156333179|NCT02122458|564319041|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
156333180|NCT02122458|564319042|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
156333181|NCT02122458|564319036|FG000|Overall Study|Noncompliance|0|||
156333182|NCT02122458|564319037|FG001|Overall Study|Noncompliance|1|||
156333183|NCT02122458|564319038|FG002|Overall Study|Noncompliance|0|||
156333184|NCT02122458|564319039|FG003|Overall Study|Noncompliance|0|||
156333185|NCT02122458|564319040|FG004|Overall Study|Noncompliance|0|||
156333186|NCT02122458|564319041|FG005|Overall Study|Noncompliance|0|||
156333187|NCT02122458|564319042|FG006|Overall Study|Noncompliance|0|||
156333188|NCT00412542|564319043|FG000|Overall Study|Withdrawal by Subject|0|||
156333189|NCT00412542|564319044|FG001|Overall Study|Withdrawal by Subject|2|||
156333190|NCT00412542|564319043|FG000|Overall Study|Not Eligible|0|||
156333191|NCT00412542|564319044|FG001|Overall Study|Not Eligible|1|||
156333192|NCT02833350|564319045|FG000|Overall Study|Adverse Event|0|||
156333193|NCT02833350|564319046|FG001|Overall Study|Adverse Event|3|||
156333194|NCT02833350|564319047|FG002|Overall Study|Adverse Event|4|||
156333195|NCT02833350|564319048|FG003|Overall Study|Adverse Event|4|||
156333196|NCT02833350|564319049|FG004|Overall Study|Adverse Event|1|||
156333197|NCT02833350|564319050|FG005|Overall Study|Adverse Event|0|||
156333198|NCT02833350|564319051|FG006|Overall Study|Adverse Event|1|||
156333199|NCT02833350|564319045|FG000|Overall Study|Death|0|||
156874142|NCT00943072|566298577|FG001|Overall Study|Lack of Efficacy|4|||
156874143|NCT00943072|566298576|FG000|Overall Study|Other|1|||
156443372|NCT04759833|564715239|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
156443373|NCT04759833|564715240|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
156443374|NCT04759833|564715241|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
156443375|NCT04759833|564715242|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
156443376|NCT04759833|564715243|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
156443377|NCT04759833|564715239|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
156443378|NCT04759833|564715240|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
156443379|NCT04759833|564715241|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
156443380|NCT04759833|564715242|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
156443381|NCT04759833|564715243|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
156443382|NCT04759833|564715239|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
156443383|NCT04759833|564715240|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
156443384|NCT04759833|564715241|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
156443385|NCT04759833|564715242|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
156443386|NCT04759833|564715243|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
156443387|NCT04759833|564715239|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
156443388|NCT04759833|564715240|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
156443389|NCT04759833|564715241|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
156443390|NCT04759833|564715242|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
156443391|NCT04759833|564715243|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
156443392|NCT04759833|564715239|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
156443393|NCT04759833|564715240|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
156443394|NCT04759833|564715241|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
156443395|NCT04759833|564715242|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
156443396|NCT04759833|564715243|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
156443397|NCT04759833|564715239|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
156443398|NCT04759833|564715240|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
156443399|NCT04759833|564715241|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
156443400|NCT04759833|564715242|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
156443401|NCT04759833|564715243|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
156443402|NCT04759833|564715239|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
156443403|NCT04759833|564715240|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
156443404|NCT04759833|564715241|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
156443405|NCT04759833|564715242|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
156443406|NCT04759833|564715243|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
156443407|NCT04759833|564715239|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
156443408|NCT04759833|564715240|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
156443409|NCT04759833|564715241|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
156443410|NCT04759833|564715242|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
156443411|NCT04759833|564715243|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
156443412|NCT04759833|564715239|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
156443413|NCT04759833|564715240|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
156443414|NCT04759833|564715241|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
156443415|NCT04759833|564715242|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
156443416|NCT04759833|564715243|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
156443417|NCT04759833|564715239|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
156443418|NCT04759833|564715240|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
156443419|NCT04759833|564715241|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
156443420|NCT04759833|564715242|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
156443421|NCT04759833|564715243|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
156443422|NCT04759833|564715239|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
156443423|NCT04759833|564715240|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
156443424|NCT04759833|564715241|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
156443425|NCT04759833|564715242|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
156443426|NCT04759833|564715243|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
156443427|NCT04759833|564715239|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
156714899|NCT02906670|565700823|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
156714900|NCT02906670|565700824|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
156714901|NCT02906670|565700825|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
156714902|NCT02906670|565700826|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
156714903|NCT02906670|565700827|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
156714904|NCT02906670|565700818|FG000|Cohort 5P, Q2W|Adverse Event|0|||
156443428|NCT04759833|564715240|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
156443429|NCT04759833|564715241|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
156443430|NCT04759833|564715242|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
156443431|NCT04759833|564715243|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
156443432|NCT04759833|564715239|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
156443433|NCT04759833|564715240|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
156443434|NCT04759833|564715241|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
156443435|NCT04759833|564715242|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
156443436|NCT04759833|564715243|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
156443437|NCT02590432|564715248|FG000|Open-label Treatment Period|Adverse Event|97|||
156443438|NCT02590432|564715249|FG001|Open-label Treatment Period|Adverse Event|79|||
156443439|NCT02590432|564715250|FG002|Open-label Treatment Period|Adverse Event|0|||
156443440|NCT02590432|564715251|FG003|Open-label Treatment Period|Adverse Event|0|||
156443441|NCT02590432|564715252|FG004|Open-label Treatment Period|Adverse Event|0|||
156443442|NCT02590432|564715253|FG005|Open-label Treatment Period|Adverse Event|0|||
156443443|NCT02590432|564715254|FG006|Open-label Treatment Period|Adverse Event|0|||
156443444|NCT02590432|564715255|FG007|Open-label Treatment Period|Adverse Event|0|||
156443445|NCT02590432|564715256|FG008|Open-label Treatment Period|Adverse Event|0|||
156443446|NCT02590432|564715248|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
156443447|NCT02590432|564715249|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
156443448|NCT02590432|564715250|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
156443449|NCT02590432|564715251|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
156443450|NCT02590432|564715252|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
156443451|NCT02590432|564715253|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
156443452|NCT02590432|564715254|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
156443453|NCT02590432|564715255|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
156443454|NCT02590432|564715256|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
156443455|NCT02590432|564715248|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
156443456|NCT02590432|564715249|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
156443457|NCT02590432|564715250|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
156443458|NCT02590432|564715251|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
156443459|NCT02590432|564715252|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
156443460|NCT02590432|564715253|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
156443461|NCT02590432|564715254|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
156443462|NCT02590432|564715255|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
156443463|NCT02590432|564715256|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
156443464|NCT02590432|564715248|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
156443465|NCT02590432|564715249|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
156443466|NCT02590432|564715250|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
156443467|NCT02590432|564715251|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
156443468|NCT02590432|564715252|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
156443469|NCT02590432|564715253|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
156443470|NCT02590432|564715254|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
156443471|NCT02590432|564715255|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
156443472|NCT02590432|564715256|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
156443473|NCT02590432|564715248|FG000|Open-label Treatment Period|Protocol Violation|10|||
156443474|NCT02590432|564715249|FG001|Open-label Treatment Period|Protocol Violation|4|||
156443475|NCT02590432|564715250|FG002|Open-label Treatment Period|Protocol Violation|0|||
156443476|NCT02590432|564715251|FG003|Open-label Treatment Period|Protocol Violation|0|||
156443477|NCT02590432|564715252|FG004|Open-label Treatment Period|Protocol Violation|0|||
156443478|NCT02590432|564715253|FG005|Open-label Treatment Period|Protocol Violation|0|||
156443479|NCT02590432|564715254|FG006|Open-label Treatment Period|Protocol Violation|0|||
156443480|NCT02590432|564715255|FG007|Open-label Treatment Period|Protocol Violation|0|||
156443481|NCT02590432|564715256|FG008|Open-label Treatment Period|Protocol Violation|0|||
156443482|NCT02590432|564715248|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
156532410|NCT03083847|565045016|FG005|Main|Adverse Event|0|||
156792713|NCT05071027|565994707|FG000|Overall Study|Lost to Follow-up|1|||
156792714|NCT05071027|565994708|FG001|Overall Study|Lost to Follow-up|4|||
156792715|NCT04576481|565994710|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
156792716|NCT04576481|565994711|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
156792717|NCT04576481|565994712|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
156792718|NCT04576481|565994713|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
156443483|NCT02590432|564715249|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
156443484|NCT02590432|564715250|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
156443485|NCT02590432|564715251|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
156443486|NCT02590432|564715252|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
156532411|NCT03083847|565045017|FG006|Main|Adverse Event|0|||
156792719|NCT03464461|565994721|FG000|Overall Study|exclusionary medication given ,|1|||
156808773|NCT03801928|566054462|FG003|Overall Study|Adverse Event|2|||
156443487|NCT02590432|564715253|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
156443488|NCT02590432|564715254|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
156443489|NCT02590432|564715255|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
156443490|NCT02590432|564715256|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
156443491|NCT02590432|564715248|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
156443492|NCT02590432|564715249|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
156443493|NCT02590432|564715250|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
156443494|NCT02590432|564715251|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
156443495|NCT02590432|564715252|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
156443496|NCT02590432|564715253|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
156443497|NCT02590432|564715254|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
156443498|NCT02590432|564715255|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
156443499|NCT02590432|564715256|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
156443500|NCT02590432|564715248|FG000|Double-blind Treatment Period|Adverse Event|0|||
156443501|NCT02590432|564715249|FG001|Double-blind Treatment Period|Adverse Event|0|||
156443502|NCT02590432|564715250|FG002|Double-blind Treatment Period|Adverse Event|14|||
156443503|NCT02590432|564715251|FG003|Double-blind Treatment Period|Adverse Event|12|||
156443504|NCT02590432|564715252|FG004|Double-blind Treatment Period|Adverse Event|6|||
156443505|NCT02590432|564715253|FG005|Double-blind Treatment Period|Adverse Event|22|||
156443506|NCT02590432|564715254|FG006|Double-blind Treatment Period|Adverse Event|20|||
156443507|NCT02590432|564715255|FG007|Double-blind Treatment Period|Adverse Event|0|||
156443508|NCT02590432|564715256|FG008|Double-blind Treatment Period|Adverse Event|0|||
156443509|NCT02590432|564715248|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
156443510|NCT02590432|564715249|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
156443511|NCT02590432|564715250|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
156443512|NCT02590432|564715251|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
156443513|NCT02590432|564715252|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
156443514|NCT02590432|564715253|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
156443515|NCT02590432|564715254|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
156443516|NCT02590432|564715255|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
156443517|NCT02590432|564715256|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
156443518|NCT02590432|564715248|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
156443519|NCT02590432|564715249|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
156443520|NCT02590432|564715250|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
156443521|NCT02590432|564715251|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
156443522|NCT02590432|564715252|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
156443523|NCT02590432|564715253|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
156443524|NCT02590432|564715254|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
156443525|NCT02590432|564715255|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
156443526|NCT02590432|564715256|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
156443527|NCT02590432|564715248|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156443528|NCT02590432|564715249|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
156443529|NCT02590432|564715250|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
156443530|NCT02590432|564715251|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
156443531|NCT02590432|564715252|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
156443532|NCT02590432|564715253|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
156443533|NCT02590432|564715254|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
156443534|NCT02590432|564715255|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
156443535|NCT02590432|564715256|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
156443536|NCT02590432|564715248|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
156443537|NCT02590432|564715249|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
156443538|NCT02590432|564715250|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
156443539|NCT02590432|564715251|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
156443540|NCT02590432|564715252|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
156443541|NCT02590432|564715253|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
156443542|NCT02590432|564715254|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
156443543|NCT02590432|564715255|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
156792720|NCT03464461|565994722|FG001|Overall Study|exclusionary medication given ,|2|||
156792721|NCT03464461|565994723|FG002|Overall Study|exclusionary medication given ,|0|||
156792722|NCT03464461|565994721|FG000|Overall Study|Physician Decision|0|||
156792723|NCT03464461|565994722|FG001|Overall Study|Physician Decision|1|||
156792724|NCT03464461|565994723|FG002|Overall Study|Physician Decision|0|||
156443544|NCT02590432|564715256|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
156443545|NCT02590432|564715248|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
156443546|NCT02590432|564715249|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
156532412|NCT03083847|565045018|FG007|Main|Adverse Event|2|||
156792725|NCT05524948|565994724|FG000|Overall Study|Withdrawal by Subject|1|||
156792726|NCT05524948|565994725|FG001|Overall Study|Withdrawal by Subject|0|||
156443547|NCT02590432|564715250|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
156443548|NCT02590432|564715251|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
156443549|NCT02590432|564715252|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
156443550|NCT02590432|564715253|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
156443551|NCT02590432|564715254|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
156443552|NCT02590432|564715255|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
156443553|NCT02590432|564715256|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
156443554|NCT02590432|564715248|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
156443555|NCT02590432|564715249|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
156443556|NCT02590432|564715250|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
156443557|NCT02590432|564715251|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
156792727|NCT05524948|565994724|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
156792728|NCT05524948|565994725|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
156792729|NCT05463952|565994728|FG000|Treatment|Progressive disease|4|||
156792730|NCT05463952|565994728|FG000|Treatment|Ongoing|2|||
156792731|NCT00595075|565994729|FG000|Overall Study|Withdrawal by Subject|1|||
156792732|NCT00595075|565994730|FG001|Overall Study|Withdrawal by Subject|0|||
156792733|NCT05261490|565994733|FG000|Overall Study|Other|1|||
156443558|NCT02590432|564715252|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
156443559|NCT02590432|564715253|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
156443560|NCT02590432|564715254|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
156443561|NCT02590432|564715255|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
156443562|NCT02590432|564715256|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
156443563|NCT02590432|564715248|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
156443564|NCT02590432|564715249|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
156443565|NCT02590432|564715250|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
156443566|NCT02590432|564715251|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
156443567|NCT02590432|564715252|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
156443568|NCT02590432|564715253|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
156443569|NCT02590432|564715254|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
156443570|NCT02590432|564715255|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
156874144|NCT00943072|566298577|FG001|Overall Study|Other|1|||
156874145|NCT01349049|566298578|FG000|Overall Study|Disease progression|3|||
156874146|NCT01349049|566298579|FG001|Overall Study|Disease progression|5|||
156874147|NCT01349049|566298580|FG002|Overall Study|Disease progression|3|||
156443571|NCT02590432|564715256|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
156443572|NCT02590432|564715248|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
156443573|NCT02590432|564715249|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
156443574|NCT02590432|564715250|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
156443575|NCT02590432|564715251|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
156443576|NCT02590432|564715252|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
156792734|NCT05261490|565994734|FG001|Overall Study|Other|0|||
156792735|NCT05261490|565994735|FG002|Overall Study|Other|0|||
156792736|NCT05261490|565994733|FG000|Overall Study|Study Terminated by Sponsor|1|||
156874148|NCT01349049|566298581|FG003|Overall Study|Disease progression|2|||
156333200|NCT02833350|564319046|FG001|Overall Study|Death|0|||
156333201|NCT02833350|564319047|FG002|Overall Study|Death|1|||
156333202|NCT02833350|564319048|FG003|Overall Study|Death|0|||
156333203|NCT02833350|564319049|FG004|Overall Study|Death|0|||
156333204|NCT02833350|564319050|FG005|Overall Study|Death|0|||
156333205|NCT02833350|564319051|FG006|Overall Study|Death|0|||
156333206|NCT02833350|564319045|FG000|Overall Study|Lack of Efficacy|0|||
156333207|NCT02833350|564319046|FG001|Overall Study|Lack of Efficacy|2|||
156333208|NCT02833350|564319047|FG002|Overall Study|Lack of Efficacy|1|||
156333209|NCT02833350|564319048|FG003|Overall Study|Lack of Efficacy|4|||
156333210|NCT02833350|564319049|FG004|Overall Study|Lack of Efficacy|0|||
156333211|NCT02833350|564319050|FG005|Overall Study|Lack of Efficacy|1|||
156333212|NCT02833350|564319051|FG006|Overall Study|Lack of Efficacy|1|||
156333213|NCT02833350|564319045|FG000|Overall Study|Lost to Follow-up|0|||
156333214|NCT02833350|564319046|FG001|Overall Study|Lost to Follow-up|1|||
156333215|NCT02833350|564319047|FG002|Overall Study|Lost to Follow-up|0|||
156333216|NCT02833350|564319048|FG003|Overall Study|Lost to Follow-up|0|||
156333217|NCT02833350|564319049|FG004|Overall Study|Lost to Follow-up|0|||
156333218|NCT02833350|564319050|FG005|Overall Study|Lost to Follow-up|0|||
156333219|NCT02833350|564319051|FG006|Overall Study|Lost to Follow-up|1|||
156333220|NCT02833350|564319045|FG000|Overall Study|Withdrawal by Subject|3|||
156333221|NCT02833350|564319046|FG001|Overall Study|Withdrawal by Subject|3|||
156333222|NCT02833350|564319047|FG002|Overall Study|Withdrawal by Subject|2|||
156333223|NCT02833350|564319048|FG003|Overall Study|Withdrawal by Subject|0|||
156333224|NCT02833350|564319049|FG004|Overall Study|Withdrawal by Subject|2|||
156333225|NCT02833350|564319050|FG005|Overall Study|Withdrawal by Subject|0|||
156333226|NCT02833350|564319051|FG006|Overall Study|Withdrawal by Subject|2|||
156443577|NCT02590432|564715253|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
156443578|NCT02590432|564715254|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
156443579|NCT02590432|564715255|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
156443580|NCT02590432|564715256|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
156443581|NCT02590432|564715248|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
156443582|NCT02590432|564715249|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
156443583|NCT02590432|564715250|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
156443584|NCT02590432|564715251|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
156443585|NCT02590432|564715252|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
156443586|NCT02590432|564715253|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
156443587|NCT02590432|564715254|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
156443588|NCT02590432|564715255|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
156443589|NCT02590432|564715256|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
156792737|NCT05261490|565994734|FG001|Overall Study|Study Terminated by Sponsor|1|||
156792738|NCT05261490|565994735|FG002|Overall Study|Study Terminated by Sponsor|4|||
156792739|NCT05261490|565994733|FG000|Overall Study|Death|1|||
156792740|NCT05261490|565994734|FG001|Overall Study|Death|2|||
156792741|NCT05261490|565994735|FG002|Overall Study|Death|0|||
156792742|NCT01682720|565994740|FG000|Overall Study|Randomized but Not Treated|0|||
156792743|NCT01682720|565994741|FG001|Overall Study|Randomized but Not Treated|1|||
156792744|NCT01682720|565994742|FG002|Overall Study|Randomized but Not Treated|1|||
156792745|NCT01682720|565994743|FG003|Overall Study|Randomized but Not Treated|0|||
156792746|NCT01682720|565994740|FG000|Overall Study|Terminated by Sponsor|83|||
156792747|NCT01682720|565994741|FG001|Overall Study|Terminated by Sponsor|0|||
156792748|NCT01682720|565994742|FG002|Overall Study|Terminated by Sponsor|0|||
156792749|NCT01682720|565994743|FG003|Overall Study|Terminated by Sponsor|0|||
156792750|NCT01682720|565994740|FG000|Overall Study|Efficacy Failure|0|||
156792751|NCT01682720|565994741|FG001|Overall Study|Efficacy Failure|3|||
156792752|NCT01682720|565994742|FG002|Overall Study|Efficacy Failure|3|||
156792753|NCT01682720|565994743|FG003|Overall Study|Efficacy Failure|30|||
156792754|NCT01682720|565994740|FG000|Overall Study|Lost to Follow-up|1|||
156792755|NCT01682720|565994741|FG001|Overall Study|Lost to Follow-up|1|||
156792756|NCT01682720|565994742|FG002|Overall Study|Lost to Follow-up|0|||
156792757|NCT01682720|565994743|FG003|Overall Study|Lost to Follow-up|6|||
156792758|NCT01682720|565994740|FG000|Overall Study|Subject Withdrew Consent|0|||
156792759|NCT01682720|565994741|FG001|Overall Study|Subject Withdrew Consent|0|||
156792760|NCT01682720|565994742|FG002|Overall Study|Subject Withdrew Consent|2|||
156792761|NCT01682720|565994743|FG003|Overall Study|Subject Withdrew Consent|2|||
156792762|NCT01682720|565994740|FG000|Overall Study|Adverse Event|1|||
156792763|NCT01682720|565994741|FG001|Overall Study|Adverse Event|0|||
156792764|NCT01682720|565994742|FG002|Overall Study|Adverse Event|1|||
156792765|NCT01682720|565994743|FG003|Overall Study|Adverse Event|1|||
156792766|NCT01687595|565994744|FG000|Overall Study|Withdrawal by Subject|8|||
156792767|NCT01687595|565994745|FG001|Overall Study|Withdrawal by Subject|0|||
156792768|NCT01687595|565994744|FG000|Overall Study|Lost to Follow-up|3|||
156792769|NCT01687595|565994745|FG001|Overall Study|Lost to Follow-up|1|||
156792770|NCT01687595|565994744|FG000|Overall Study|Investigator's decision|1|||
156792771|NCT01687595|565994745|FG001|Overall Study|Investigator's decision|0|||
156792772|NCT01687595|565994744|FG000|Overall Study|Sponsor's decision|1|||
156792773|NCT01687595|565994745|FG001|Overall Study|Sponsor's decision|0|||
156792774|NCT01687595|565994744|FG000|Overall Study|Noncompliance|1|||
156792775|NCT01687595|565994745|FG001|Overall Study|Noncompliance|2|||
156792776|NCT01687595|565994744|FG000|Overall Study|Other than specified|56|||
156792777|NCT01687595|565994745|FG001|Overall Study|Other than specified|7|||
156792778|NCT04204902|565994746|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
156792779|NCT04204902|565994747|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
156792780|NCT05451329|565994748|FG000|Overall Study|Adverse Event|1|||
156792781|NCT05451329|565994749|FG001|Overall Study|Adverse Event|1|||
156792782|NCT05451329|565994750|FG002|Overall Study|Adverse Event|0|||
156792783|NCT05451329|565994748|FG000|Overall Study|Withdrawal by Subject|1|||
156792784|NCT05451329|565994749|FG001|Overall Study|Withdrawal by Subject|0|||
156792785|NCT05451329|565994750|FG002|Overall Study|Withdrawal by Subject|0|||
156792786|NCT05451329|565994748|FG000|Overall Study|Investigational Product Lot exchange|1|||
156792787|NCT05451329|565994749|FG001|Overall Study|Investigational Product Lot exchange|1|||
156792788|NCT05451329|565994750|FG002|Overall Study|Investigational Product Lot exchange|0|||
156792789|NCT00069953|565994751|FG000|Overall Study|Protocol Violation|2|||
156792790|NCT03253627|565994754|FG000|Overall Study|Lost to Follow-up|1|||
156792791|NCT03253627|565994755|FG001|Overall Study|Lost to Follow-up|2|||
156792792|NCT03253627|565994754|FG000|Overall Study|Withdrawal by Subject|0|||
156792793|NCT03253627|565994755|FG001|Overall Study|Withdrawal by Subject|2|||
156792794|NCT03253627|565994754|FG000|Overall Study|Inability to complete MRI|1|||
156792795|NCT03253627|565994755|FG001|Overall Study|Inability to complete MRI|0|||
156792796|NCT03829683|565994756|FG000|Overall Study|Lost to Follow-up|1|||
156792797|NCT03829683|565994757|FG001|Overall Study|Lost to Follow-up|0|||
156443590|NCT02590432|564715248|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
156443591|NCT02590432|564715249|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
156443592|NCT02590432|564715250|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
156443593|NCT02590432|564715251|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
156443594|NCT02590432|564715252|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
156443595|NCT02590432|564715253|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
156443596|NCT02590432|564715254|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
156443597|NCT02590432|564715255|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
156443598|NCT02590432|564715256|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
156443599|NCT02590432|564715248|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
156443600|NCT02590432|564715249|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
156443601|NCT02590432|564715250|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
156443602|NCT02590432|564715251|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
156443603|NCT02590432|564715252|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
156443604|NCT02590432|564715253|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
156443605|NCT02590432|564715254|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
156443606|NCT02590432|564715255|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
156443607|NCT02590432|564715256|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
156443608|NCT02006758|564715257|FG000|Overall Study|Protocol Violation|1|||
156443609|NCT02006758|564715257|FG000|Overall Study|Death|1|||
156443610|NCT02006758|564715257|FG000|Overall Study|Lost to Follow-up|4|||
156443611|NCT02006758|564715257|FG000|Overall Study|Withdrawal by Subject|4|||
156443612|NCT02006758|564715257|FG000|Overall Study|Procedurally excluded|1|||
156443613|NCT02006758|564715257|FG000|Overall Study|Other|2|||
156443614|NCT00243503|564715259|FG000|Overall Study|Adverse Event|11|||
156443615|NCT00243503|564715259|FG000|Overall Study|Withdrawal by Subject|1|||
156443616|NCT00243503|564715259|FG000|Overall Study|Lack of Efficacy|44|||
156443617|NCT00243503|564715259|FG000|Overall Study|Death|1|||
156443618|NCT00243503|564715259|FG000|Overall Study|Other|1|||
156443619|NCT00914589|564715260|FG000|Overall Study|Adverse Event|1|||
156443620|NCT00914589|564715261|FG001|Overall Study|Adverse Event|0|||
156443621|NCT00914589|564715262|FG002|Overall Study|Adverse Event|1|||
156443622|NCT00914589|564715260|FG000|Overall Study|Protocol Violation|8|||
156443623|NCT00914589|564715261|FG001|Overall Study|Protocol Violation|6|||
156443624|NCT00914589|564715262|FG002|Overall Study|Protocol Violation|3|||
156443625|NCT00914589|564715260|FG000|Overall Study|unclassified|16|||
156443626|NCT00914589|564715261|FG001|Overall Study|unclassified|9|||
156443627|NCT00914589|564715262|FG002|Overall Study|unclassified|7|||
156443628|NCT00914589|564715260|FG000|Overall Study|Death|0|||
156443629|NCT00914589|564715261|FG001|Overall Study|Death|1|||
156443630|NCT00914589|564715262|FG002|Overall Study|Death|1|||
156443631|NCT05052996|564715263|FG000|Overall Study|Still on study|0|||
156443632|NCT05052996|564715264|FG001|Overall Study|Still on study|0|||
156443633|NCT05052996|564715265|FG002|Overall Study|Still on study|47|||
156443634|NCT05052996|564715266|FG003|Overall Study|Still on study|44|||
156443635|NCT05052996|564715263|FG000|Overall Study|Cohort terminated by sponsor|21|||
156443636|NCT05052996|564715264|FG001|Overall Study|Cohort terminated by sponsor|12|||
156443637|NCT05052996|564715265|FG002|Overall Study|Cohort terminated by sponsor|0|||
156443638|NCT05052996|564715266|FG003|Overall Study|Cohort terminated by sponsor|0|||
156443639|NCT05052996|564715263|FG000|Overall Study|Withdrew consent|1|||
156443640|NCT05052996|564715264|FG001|Overall Study|Withdrew consent|0|||
156443641|NCT05052996|564715265|FG002|Overall Study|Withdrew consent|1|||
156443642|NCT05052996|564715266|FG003|Overall Study|Withdrew consent|2|||
156443643|NCT05052996|564715263|FG000|Overall Study|Lost to Follow-up|1|||
156443644|NCT05052996|564715264|FG001|Overall Study|Lost to Follow-up|0|||
156443645|NCT05052996|564715265|FG002|Overall Study|Lost to Follow-up|0|||
156443646|NCT05052996|564715266|FG003|Overall Study|Lost to Follow-up|2|||
156443647|NCT05052996|564715263|FG000|Overall Study|Adverse Event|0|||
156443648|NCT05052996|564715264|FG001|Overall Study|Adverse Event|0|||
156443649|NCT05052996|564715265|FG002|Overall Study|Adverse Event|2|||
156443650|NCT05052996|564715266|FG003|Overall Study|Adverse Event|0|||
156443651|NCT05052996|564715263|FG000|Overall Study|Randomized but never treated|0|||
156443652|NCT05052996|564715264|FG001|Overall Study|Randomized but never treated|0|||
156443653|NCT05052996|564715265|FG002|Overall Study|Randomized but never treated|1|||
156443654|NCT05052996|564715266|FG003|Overall Study|Randomized but never treated|1|||
156443655|NCT05052996|564715263|FG000|Overall Study|Protocol Violation|1|||
156443656|NCT05052996|564715264|FG001|Overall Study|Protocol Violation|0|||
156443657|NCT05052996|564715265|FG002|Overall Study|Protocol Violation|0|||
156443658|NCT05052996|564715266|FG003|Overall Study|Protocol Violation|0|||
156443659|NCT00331136|564715271|FG000|Overall Study|Adverse Event|3|||
156443660|NCT00331136|564715272|FG001|Overall Study|Adverse Event|5|||
156443661|NCT00331136|564715273|FG002|Overall Study|Adverse Event|0|||
156443662|NCT00331136|564715274|FG003|Overall Study|Adverse Event|1|||
156443663|NCT00331136|564715271|FG000|Overall Study|Withdrawal by Subject|0|||
156443664|NCT00331136|564715272|FG001|Overall Study|Withdrawal by Subject|1|||
156443665|NCT00331136|564715273|FG002|Overall Study|Withdrawal by Subject|0|||
156443666|NCT00331136|564715274|FG003|Overall Study|Withdrawal by Subject|0|||
156443667|NCT00331136|564715271|FG000|Overall Study|Lost to Follow-up|0|||
156443668|NCT00331136|564715272|FG001|Overall Study|Lost to Follow-up|1|||
156443669|NCT00331136|564715273|FG002|Overall Study|Lost to Follow-up|0|||
156443670|NCT00331136|564715274|FG003|Overall Study|Lost to Follow-up|0|||
156443671|NCT00331136|564715271|FG000|Overall Study|Protocol Violation|1|||
156443672|NCT00331136|564715272|FG001|Overall Study|Protocol Violation|0|||
156333227|NCT01500031|564319052|FG000|Overall Study|Death|1|||
156443673|NCT00331136|564715273|FG002|Overall Study|Protocol Violation|0|||
156443674|NCT00331136|564715274|FG003|Overall Study|Protocol Violation|0|||
156443675|NCT00331136|564715271|FG000|Overall Study|Not treated|1|||
156443676|NCT00331136|564715272|FG001|Overall Study|Not treated|0|||
156443677|NCT00331136|564715273|FG002|Overall Study|Not treated|0|||
156333228|NCT01500031|564319052|FG000|Overall Study|Withdrawal by Subject|4|||
156333229|NCT01856907|564319055|FG000|Overall Study|Pregnancy|0|||
156333230|NCT01856907|564319056|FG001|Overall Study|Pregnancy|1|||
156333231|NCT01856907|564319057|FG002|Overall Study|Pregnancy|0|||
156333232|NCT01856907|564319055|FG000|Overall Study|Pregnancy|0|||
156333233|NCT01856907|564319056|FG001|Overall Study|Pregnancy|1|||
156333234|NCT01856907|564319057|FG002|Overall Study|Pregnancy|0|||
156333235|NCT01856907|564319055|FG000|Overall Study|Withdrawal by Subject|0|||
156333236|NCT01856907|564319056|FG001|Overall Study|Withdrawal by Subject|1|||
156333237|NCT01856907|564319057|FG002|Overall Study|Withdrawal by Subject|0|||
156333238|NCT00075218|564319058|FG000|Double-Blind Treatment|Adverse Event|23|||
156333239|NCT00075218|564319059|FG001|Double-Blind Treatment|Adverse Event|4|||
156333240|NCT00075218|564319060|FG002|Double-Blind Treatment|Adverse Event|0|||
156333241|NCT00075218|564319058|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
156333242|NCT00075218|564319059|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
156333243|NCT00075218|564319060|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
156333244|NCT00075218|564319058|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
156333245|NCT00075218|564319059|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
156333246|NCT00075218|564319060|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
156333247|NCT00075218|564319058|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
156333248|NCT00075218|564319059|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
156333249|NCT00075218|564319060|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
156333250|NCT00075218|564319058|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
156333251|NCT00075218|564319059|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
156333252|NCT00075218|564319060|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
156333253|NCT00075218|564319058|FG000|Double-Blind Treatment|No study medication taken|2|||
156333254|NCT00075218|564319059|FG001|Double-Blind Treatment|No study medication taken|0|||
156333255|NCT00075218|564319060|FG002|Double-Blind Treatment|No study medication taken|0|||
156333256|NCT00075218|564319058|FG000|Open-Label Treatment|Lack of Efficacy|0|||
156443678|NCT00331136|564715274|FG003|Overall Study|Not treated|0|||
156443679|NCT02372253|564715282|FG000|Overall Study|Non Compliance|2|||
156443680|NCT02372253|564715283|FG001|Overall Study|Non Compliance|0|||
156443681|NCT03201562|564715284|FG000|Overall Study|Physician Decision|0|||
156443682|NCT03201562|564715285|FG001|Overall Study|Physician Decision|0|||
156443683|NCT03201562|564715286|FG002|Overall Study|Physician Decision|1|||
156443684|NCT03201562|564715284|FG000|Overall Study|Adverse Event|0|||
156443685|NCT03201562|564715285|FG001|Overall Study|Adverse Event|0|||
156443686|NCT03201562|564715286|FG002|Overall Study|Adverse Event|1|||
156443687|NCT03201562|564715284|FG000|Overall Study|Lost to Follow-up|0|||
156443688|NCT03201562|564715285|FG001|Overall Study|Lost to Follow-up|1|||
156443689|NCT03201562|564715286|FG002|Overall Study|Lost to Follow-up|2|||
156443690|NCT00393484|564715287|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
156443691|NCT00393484|564715288|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
156443692|NCT00393484|564715287|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
156443693|NCT00393484|564715288|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
156443694|NCT00393484|564715287|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
156443695|NCT00393484|564715288|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
156443696|NCT00393484|564715287|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
156443697|NCT00393484|564715288|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
156333257|NCT00075218|564319059|FG001|Open-Label Treatment|Lack of Efficacy|0|||
156333258|NCT00075218|564319060|FG002|Open-Label Treatment|Lack of Efficacy|174|||
156333259|NCT00075218|564319058|FG000|Open-Label Treatment|Adverse Event|0|||
156333260|NCT00075218|564319059|FG001|Open-Label Treatment|Adverse Event|0|||
156333261|NCT00075218|564319060|FG002|Open-Label Treatment|Adverse Event|51|||
156443698|NCT00393484|564715287|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
156443699|NCT00393484|564715288|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
156443700|NCT00393484|564715287|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
156333262|NCT00075218|564319058|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
156333263|NCT00075218|564319059|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
156443701|NCT00393484|564715288|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
156443702|NCT00393484|564715287|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
156443703|NCT00393484|564715288|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
156443704|NCT00393484|564715287|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
156443705|NCT00393484|564715288|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
156443706|NCT00393484|564715287|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
156443707|NCT00393484|564715288|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
156443708|NCT00393484|564715287|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
156443709|NCT00393484|564715288|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
156443710|NCT01803555|564715289|FG000|Overall Study|Adverse Event|3|||
156443711|NCT01803555|564715290|FG001|Overall Study|Adverse Event|2|||
156443712|NCT01803555|564715289|FG000|Overall Study|Withdrawal by Subject|3|||
156443713|NCT01803555|564715290|FG001|Overall Study|Withdrawal by Subject|3|||
156443714|NCT01803555|564715289|FG000|Overall Study|Non-compliance|1|||
156443715|NCT01803555|564715290|FG001|Overall Study|Non-compliance|1|||
156443716|NCT01803555|564715289|FG000|Overall Study|Protocol Violation|3|||
156443717|NCT01803555|564715290|FG001|Overall Study|Protocol Violation|5|||
156443718|NCT01803555|564715289|FG000|Overall Study|Lost to Follow-up|0|||
156443719|NCT01803555|564715290|FG001|Overall Study|Lost to Follow-up|2|||
156443720|NCT01803555|564715289|FG000|Overall Study|Other than specified|3|||
156443721|NCT01803555|564715290|FG001|Overall Study|Other than specified|5|||
156443722|NCT01551355|564715295|FG000|Overall Study|Lost to Follow-up|51|||
156443723|NCT01551355|564715296|FG001|Overall Study|Lost to Follow-up|49|||
156443724|NCT01551355|564715297|FG002|Overall Study|Lost to Follow-up|34|||
156443725|NCT01551355|564715298|FG003|Overall Study|Lost to Follow-up|24|||
156443726|NCT01551355|564715299|FG004|Overall Study|Lost to Follow-up|9|||
156443727|NCT01551355|564715300|FG005|Overall Study|Lost to Follow-up|6|||
156443728|NCT02318134|564715301|FG000|Overall Study|Withdrawal by Subject|2|||
156443729|NCT02318134|564715302|FG001|Overall Study|Withdrawal by Subject|1|||
156443730|NCT01094184|564715303|FG000|Overall Study|Death|35|||
156443731|NCT01094184|564715304|FG001|Overall Study|Death|11|||
156443732|NCT00031694|564715305|FG000|Overall Study|Adverse Event|12|||
156443733|NCT00031694|564715305|FG000|Overall Study|Death|2|||
156443734|NCT00031694|564715305|FG000|Overall Study|Withdrawal by Subject|5|||
156443735|NCT03892564|564715306|FG000|Overall Study|Withdrawal by Subject|2|||
156443736|NCT03664960|564715307|FG000|Overall Study|Adverse Event|0|||
156443737|NCT03664960|564715308|FG001|Overall Study|Adverse Event|3|||
156443738|NCT03664960|564715307|FG000|Overall Study|Lost to Follow-up|3|||
156443739|NCT03664960|564715308|FG001|Overall Study|Lost to Follow-up|2|||
156443740|NCT03664960|564715307|FG000|Overall Study|Physician Decision|1|||
156443741|NCT03664960|564715308|FG001|Overall Study|Physician Decision|0|||
156443742|NCT03664960|564715307|FG000|Overall Study|Withdrawal by Subject|3|||
156443743|NCT03664960|564715308|FG001|Overall Study|Withdrawal by Subject|14|||
156443744|NCT03664960|564715307|FG000|Overall Study|Sponsor Decision|1|||
156443745|NCT03664960|564715308|FG001|Overall Study|Sponsor Decision|1|||
156443746|NCT03664960|564715307|FG000|Overall Study|Other|1|||
156443747|NCT03664960|564715308|FG001|Overall Study|Other|2|||
156443748|NCT04019444|564715309|FG000|Overall Study|Withdrawal by Subject|0|||
156443749|NCT04019444|564715310|FG001|Overall Study|Withdrawal by Subject|1|||
156443750|NCT04019444|564715311|FG002|Overall Study|Withdrawal by Subject|0|||
156443751|NCT04019444|564715312|FG003|Overall Study|Withdrawal by Subject|1|||
156443752|NCT04019444|564715309|FG000|Overall Study|Solicited Event|0|||
156443753|NCT04019444|564715310|FG001|Overall Study|Solicited Event|0|||
156443754|NCT04019444|564715311|FG002|Overall Study|Solicited Event|2|||
156443755|NCT04019444|564715312|FG003|Overall Study|Solicited Event|0|||
156443756|NCT01207492|564715313|FG000|Overall Study|Still on study|1|||
156443757|NCT01207492|564715313|FG000|Overall Study|Withdrawal by Subject|9|||
156443758|NCT01207492|564715313|FG000|Overall Study|Physician Decision|1|||
156443759|NCT01207492|564715313|FG000|Overall Study|Progressive disease|3|||
156443760|NCT01207492|564715313|FG000|Overall Study|Toxicity|1|||
156443761|NCT00212355|564716793|FG000|Overall Study|Adverse Event|1|||
156443762|NCT00212355|564716793|FG000|Overall Study|Withdrawal by Subject|1|||
156443763|NCT00212355|564716793|FG000|Overall Study|A change of address|1|||
156443764|NCT04310735|564716796|FG000|Overall Study|Withdrawal by Subject|1|||
156443765|NCT04310735|564716797|FG001|Overall Study|Withdrawal by Subject|3|||
156443766|NCT04310735|564716798|FG002|Overall Study|Withdrawal by Subject|8|||
156443767|NCT04310735|564716796|FG000|Overall Study|Equipment malfunction|0|||
156443768|NCT04310735|564716797|FG001|Overall Study|Equipment malfunction|1|||
156443769|NCT04310735|564716798|FG002|Overall Study|Equipment malfunction|0|||
156443770|NCT03012841|564716799|FG000|Overall Study|Protocol Violation|0|||
156443771|NCT03012841|564716800|FG001|Overall Study|Protocol Violation|10|||
156443772|NCT03012841|564716799|FG000|Overall Study|Lost to Follow-up|6|||
156443773|NCT03012841|564716800|FG001|Overall Study|Lost to Follow-up|1|||
156443774|NCT03012841|564716799|FG000|Overall Study|Withdrawal by Subject|6|||
156443775|NCT03012841|564716800|FG001|Overall Study|Withdrawal by Subject|0|||
156443776|NCT03012841|564716799|FG000|Overall Study|Unable to complete 12 month visit|6|||
156532413|NCT03083847|565045019|FG008|Main|Adverse Event|0|||
156443777|NCT03012841|564716800|FG001|Overall Study|Unable to complete 12 month visit|0|||
156443778|NCT03012841|564716799|FG000|Overall Study|Subject relocation|1|||
156443779|NCT03012841|564716800|FG001|Overall Study|Subject relocation|0|||
156443780|NCT03012841|564716799|FG000|Overall Study|Seasonal winter travel|1|||
156443781|NCT03012841|564716800|FG001|Overall Study|Seasonal winter travel|0|||
156443782|NCT03012841|564716799|FG000|Overall Study|Physician Decision|0|||
156443783|NCT03012841|564716800|FG001|Overall Study|Physician Decision|2|||
156443784|NCT03012841|564716799|FG000|Overall Study|No ablation performed|0|||
156443785|NCT03012841|564716800|FG001|Overall Study|No ablation performed|2|||
156443786|NCT03012841|564716799|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
156443787|NCT03012841|564716800|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
156443788|NCT03012841|564716799|FG000|Overall Study|Insurance change|0|||
156443789|NCT03012841|564716800|FG001|Overall Study|Insurance change|1|||
156443790|NCT00186992|564716801|FG000|Overall Study|Withdrawal by Subject|5|||
156443791|NCT00186992|564716801|FG000|Overall Study|Physician's discretion|13|||
156443792|NCT00186992|564716801|FG000|Overall Study|PI Discretion|4|||
156443793|NCT00186992|564716801|FG000|Overall Study|Ineligible|2|||
156443794|NCT00186992|564716801|FG000|Overall Study|Lost to Follow-up|2|||
156443795|NCT00186992|564716801|FG000|Overall Study|Still on Study|9|||
156443796|NCT05696080|564716802|FG000|Overall Study|Lost to Follow-up|2|||
156443797|NCT05696080|564716803|FG001|Overall Study|Lost to Follow-up|1|||
156443798|NCT05696080|564716802|FG000|Overall Study|Physician Decision|1|||
156443799|NCT05696080|564716803|FG001|Overall Study|Physician Decision|0|||
156443800|NCT05696080|564716802|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156443801|NCT05696080|564716803|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156443802|NCT05696080|564716802|FG000|Overall Study|Withdrawal by Subject|12|||
156443803|NCT05696080|564716803|FG001|Overall Study|Withdrawal by Subject|0|||
156443804|NCT03954184|564716804|FG000|Overall Study|Lost to Follow-up|500|||
156443805|NCT03954184|564716805|FG001|Overall Study|Lost to Follow-up|0|||
156443806|NCT03398200|564716806|FG000|Overall Study|Withdrawal by Subject|0|||
156443807|NCT03398200|564716807|FG001|Overall Study|Withdrawal by Subject|1|||
156443808|NCT04065048|564716810|FG000|Overall Study|Withdrawal by Subject|1|||
156443809|NCT04065048|564716811|FG001|Overall Study|Withdrawal by Subject|2|||
156443810|NCT04065048|564716812|FG002|Overall Study|Withdrawal by Subject|1|||
156443811|NCT04065048|564716813|FG003|Overall Study|Withdrawal by Subject|1|||
156443812|NCT04065048|564716810|FG000|Overall Study|Adverse Event|1|||
156443813|NCT04065048|564716811|FG001|Overall Study|Adverse Event|0|||
156443814|NCT04065048|564716812|FG002|Overall Study|Adverse Event|1|||
156443815|NCT04065048|564716813|FG003|Overall Study|Adverse Event|0|||
156443816|NCT03397108|564716814|FG000|Overall Study|Lost to Follow-up|15|||
156443817|NCT03397108|564716815|FG001|Overall Study|Lost to Follow-up|0|||
156443818|NCT03397108|564716814|FG000|Overall Study|Insufficient milk production|3|||
156443819|NCT03397108|564716815|FG001|Overall Study|Insufficient milk production|2|||
156443820|NCT03397108|564716814|FG000|Overall Study|Withdrawal by Subject|2|||
156443821|NCT03397108|564716815|FG001|Overall Study|Withdrawal by Subject|0|||
156443822|NCT02728557|564716821|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
156443823|NCT02728557|564716822|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
156443824|NCT02728557|564716821|FG000|Overall Study|Dissatisfaction with research tasks|0|||
156443825|NCT02728557|564716822|FG001|Overall Study|Dissatisfaction with research tasks|1|||
156443826|NCT02728557|564716821|FG000|Overall Study|Scheduling or change in availability|1|||
156443827|NCT02728557|564716822|FG001|Overall Study|Scheduling or change in availability|1|||
156443828|NCT01718743|564716823|FG000|Overall Study|Physician Decision|7|||
156443829|NCT01718743|564716823|FG000|Overall Study|Withdrawal by Subject|14|||
156443830|NCT01718743|564716823|FG000|Overall Study|Progressive Disease|22|||
156443831|NCT01718743|564716823|FG000|Overall Study|Toxicity|1|||
156443832|NCT01718743|564716823|FG000|Overall Study|Malignancy|1|||
156443833|NCT03416010|564716824|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
156443834|NCT03416010|564716825|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
156443835|NCT03416010|564716824|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
156443836|NCT03416010|564716825|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
156443837|NCT03416010|564716824|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
156443838|NCT03416010|564716825|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
156443839|NCT03416010|564716824|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
156443840|NCT03416010|564716825|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
156443841|NCT03416010|564716824|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
156443842|NCT03416010|564716825|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
156443843|NCT03416010|564716824|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
156443844|NCT03416010|564716825|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
156443845|NCT03416010|564716824|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
156443846|NCT03416010|564716825|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
156443847|NCT03948763|564716826|FG000|Overall Study|Sponsor's decision|0|||
156443848|NCT03948763|564716827|FG001|Overall Study|Sponsor's decision|2|||
156443849|NCT03948763|564716828|FG002|Overall Study|Sponsor's decision|6|||
156443850|NCT03948763|564716829|FG003|Overall Study|Sponsor's decision|4|||
156443851|NCT03948763|564716830|FG004|Overall Study|Sponsor's decision|0|||
156443852|NCT03948763|564716826|FG000|Overall Study|Physician Decision|0|||
156443853|NCT03948763|564716827|FG001|Overall Study|Physician Decision|0|||
156443854|NCT03948763|564716828|FG002|Overall Study|Physician Decision|1|||
156443855|NCT03948763|564716829|FG003|Overall Study|Physician Decision|0|||
156443856|NCT03948763|564716830|FG004|Overall Study|Physician Decision|0|||
156443857|NCT03948763|564716826|FG000|Overall Study|Lost to Follow-up|0|||
156443858|NCT03948763|564716827|FG001|Overall Study|Lost to Follow-up|0|||
156443859|NCT03948763|564716828|FG002|Overall Study|Lost to Follow-up|0|||
156443860|NCT03948763|564716829|FG003|Overall Study|Lost to Follow-up|0|||
156443861|NCT03948763|564716830|FG004|Overall Study|Lost to Follow-up|1|||
156443862|NCT03948763|564716826|FG000|Overall Study|Death|2|||
156443863|NCT03948763|564716827|FG001|Overall Study|Death|12|||
156443864|NCT03948763|564716828|FG002|Overall Study|Death|13|||
156443865|NCT03948763|564716829|FG003|Overall Study|Death|10|||
156443866|NCT03948763|564716830|FG004|Overall Study|Death|11|||
156443867|NCT03948763|564716826|FG000|Overall Study|Withdrawal by Subject|1|||
156443868|NCT03948763|564716827|FG001|Overall Study|Withdrawal by Subject|1|||
156443869|NCT03948763|564716828|FG002|Overall Study|Withdrawal by Subject|0|||
156443870|NCT03948763|564716829|FG003|Overall Study|Withdrawal by Subject|2|||
156443871|NCT03948763|564716830|FG004|Overall Study|Withdrawal by Subject|4|||
156443872|NCT05986565|564716837|FG000|Overall Study|Lost to Follow-up|8|||
156443873|NCT05986565|564716838|FG001|Overall Study|Lost to Follow-up|3|||
156443874|NCT05986565|564716837|FG000|Overall Study|Withdrawal by Subject|0|||
156443875|NCT05986565|564716838|FG001|Overall Study|Withdrawal by Subject|1|||
156443876|NCT03446157|564716841|FG000|Overall Study|Death|11|||
156443877|NCT03446157|564716842|FG001|Overall Study|Death|9|||
156443878|NCT03446157|564716841|FG000|Overall Study|Lost to Follow-up|0|||
156443879|NCT03446157|564716842|FG001|Overall Study|Lost to Follow-up|1|||
156443880|NCT03446157|564716841|FG000|Overall Study|Withdrawal by Subject|2|||
156443881|NCT03446157|564716842|FG001|Overall Study|Withdrawal by Subject|1|||
156443882|NCT02386553|564716843|FG000|Overall Study|Reason Not Specified|1|||
156443883|NCT02386553|564716844|FG001|Overall Study|Reason Not Specified|1|||
156443884|NCT02386553|564716843|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
156443885|NCT02386553|564716844|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
156443896|NCT01121991|564716850|FG000|Overall Study|Lack of Ovarian Response|2|||
156443897|NCT01121991|564716850|FG000|Overall Study|No Oocytes Retrieved|3|||
156443898|NCT01121991|564716850|FG000|Overall Study|No Fertilization|1|||
156443899|NCT01619410|564716851|FG000|Overall Study|Lost to Follow-up|7|||
156443900|NCT01619410|564716852|FG001|Overall Study|Lost to Follow-up|4|||
156443901|NCT02462759|564716853|FG000|Part 1: Double Blind|Death|1|||
156443902|NCT02462759|564716854|FG001|Part 1: Double Blind|Death|0|||
156443903|NCT02462759|564716855|FG002|Part 1: Double Blind|Death|0|||
156443904|NCT02740231|564716856|FG000|Overall Study|Withdrawal by Subject|1|||
156443905|NCT02740231|564716857|FG001|Overall Study|Withdrawal by Subject|1|||
156443906|NCT02740231|564716858|FG002|Overall Study|Withdrawal by Subject|1|||
156443907|NCT02740231|564716859|FG003|Overall Study|Withdrawal by Subject|0|||
156443908|NCT02740231|564716856|FG000|Overall Study|Lack of Efficacy|0|||
156443909|NCT02740231|564716857|FG001|Overall Study|Lack of Efficacy|1|||
156443910|NCT02740231|564716858|FG002|Overall Study|Lack of Efficacy|0|||
156443911|NCT02740231|564716859|FG003|Overall Study|Lack of Efficacy|4|||
156443912|NCT02740231|564716856|FG000|Overall Study|Lost to Follow-up|1|||
156443913|NCT02740231|564716857|FG001|Overall Study|Lost to Follow-up|3|||
156443914|NCT02740231|564716858|FG002|Overall Study|Lost to Follow-up|0|||
156443915|NCT02740231|564716859|FG003|Overall Study|Lost to Follow-up|3|||
156443916|NCT02740231|564716856|FG000|Overall Study|Adverse Event|0|||
156443917|NCT02740231|564716857|FG001|Overall Study|Adverse Event|1|||
156714905|NCT02906670|565700819|FG001|Cohort 5P, Q2W|Adverse Event|0|||
156874149|NCT01349049|566298582|FG004|Overall Study|Disease progression|2|||
156443918|NCT02740231|564716858|FG002|Overall Study|Adverse Event|0|||
156443919|NCT02740231|564716859|FG003|Overall Study|Adverse Event|1|||
156443920|NCT04110054|564716860|FG000|Overall Study|COVID-19 reason other than AE|0|||
156443921|NCT04110054|564716861|FG001|Overall Study|COVID-19 reason other than AE|0|||
156443922|NCT04110054|564716862|FG002|Overall Study|COVID-19 reason other than AE|2|||
156443923|NCT04110054|564716863|FG003|Overall Study|COVID-19 reason other than AE|0|||
156443924|NCT04110054|564716860|FG000|Overall Study|Withdrawal by Subject|0|||
156443925|NCT04110054|564716861|FG001|Overall Study|Withdrawal by Subject|3|||
156443926|NCT04110054|564716862|FG002|Overall Study|Withdrawal by Subject|2|||
156443927|NCT04110054|564716863|FG003|Overall Study|Withdrawal by Subject|0|||
156443928|NCT04110054|564716860|FG000|Overall Study|Adverse Event|1|||
156443929|NCT04110054|564716861|FG001|Overall Study|Adverse Event|1|||
156443930|NCT04110054|564716862|FG002|Overall Study|Adverse Event|4|||
156443931|NCT04110054|564716863|FG003|Overall Study|Adverse Event|3|||
156443932|NCT00520546|564716865|FG000|Overall Study|Withdrawal by Subject|1|||
156443933|NCT00520546|564716865|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
156443934|NCT03655262|564716871|FG000|Overall Study|Withdrawal by Subject|0|||
156443935|NCT03655262|564716872|FG001|Overall Study|Withdrawal by Subject|0|||
156443936|NCT03655262|564716873|FG002|Overall Study|Withdrawal by Subject|1|||
156443937|NCT02554786|564716876|FG000|Overall Study|Subject/guardian decision|29|||
156443938|NCT02554786|564716877|FG001|Overall Study|Subject/guardian decision|17|||
156443939|NCT02554786|564716878|FG002|Overall Study|Subject/guardian decision|18|||
156443940|NCT02554786|564716879|FG003|Overall Study|Subject/guardian decision|30|||
156443941|NCT02554786|564716880|FG004|Overall Study|Subject/guardian decision|20|||
156443942|NCT02554786|564716876|FG000|Overall Study|Lost to Follow-up|4|||
156443943|NCT02554786|564716877|FG001|Overall Study|Lost to Follow-up|3|||
156443944|NCT02554786|564716878|FG002|Overall Study|Lost to Follow-up|4|||
156443945|NCT02554786|564716879|FG003|Overall Study|Lost to Follow-up|2|||
156443946|NCT02554786|564716880|FG004|Overall Study|Lost to Follow-up|2|||
156532414|NCT03083847|565045020|FG009|Main|Adverse Event|0|||
156532415|NCT03083847|565045011|FG000|Main|Withdrawal by Subject|0|||
156532416|NCT03083847|565045012|FG001|Main|Withdrawal by Subject|0|||
156532417|NCT03083847|565045013|FG002|Main|Withdrawal by Subject|0|||
156532418|NCT03083847|565045014|FG003|Main|Withdrawal by Subject|0|||
156532419|NCT03083847|565045015|FG004|Main|Withdrawal by Subject|0|||
156532420|NCT03083847|565045016|FG005|Main|Withdrawal by Subject|0|||
156532421|NCT03083847|565045017|FG006|Main|Withdrawal by Subject|1|||
156532422|NCT03083847|565045018|FG007|Main|Withdrawal by Subject|1|||
156532423|NCT03083847|565045019|FG008|Main|Withdrawal by Subject|0|||
156532424|NCT03083847|565045020|FG009|Main|Withdrawal by Subject|0|||
156532425|NCT01214187|565045021|FG000|Overall Study|Adverse Event|6|||
156532426|NCT01214187|565045022|FG001|Overall Study|Adverse Event|2|||
156532427|NCT01214187|565045021|FG000|Overall Study|Death|1|||
156532428|NCT01214187|565045022|FG001|Overall Study|Death|1|||
156532429|NCT01214187|565045021|FG000|Overall Study|Withdrawal by Subject|0|||
156532430|NCT01214187|565045022|FG001|Overall Study|Withdrawal by Subject|3|||
156532431|NCT02308007|565045024|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
156532432|NCT02308007|565045025|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
156532433|NCT02308007|565045026|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
156532434|NCT02308007|565045024|FG000|Overall Study|Positive for STD at Baseline|7|||
156532435|NCT02308007|565045025|FG001|Overall Study|Positive for STD at Baseline|11|||
156532436|NCT02308007|565045026|FG002|Overall Study|Positive for STD at Baseline|7|||
156532437|NCT02308007|565045024|FG000|Overall Study|Lost to Follow-up|3|||
156532438|NCT02308007|565045025|FG001|Overall Study|Lost to Follow-up|0|||
156532439|NCT02308007|565045026|FG002|Overall Study|Lost to Follow-up|1|||
156532440|NCT01233869|565045027|FG000|Initial Treatment Period (24 Months)|Death|1|||
156532441|NCT01233869|565045028|FG001|Initial Treatment Period (24 Months)|Death|0|||
156532442|NCT01233869|565045029|FG002|Initial Treatment Period (24 Months)|Death|0|||
156532443|NCT01233869|565045030|FG003|Initial Treatment Period (24 Months)|Death|0|||
156532444|NCT01233869|565045027|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
156532445|NCT01233869|565045028|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
156532446|NCT01233869|565045029|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
156532447|NCT01233869|565045030|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
156532448|NCT01233869|565045027|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
156532449|NCT01233869|565045028|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
156532450|NCT01233869|565045029|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
156532451|NCT01233869|565045030|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
156532452|NCT01233869|565045027|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
156532453|NCT01233869|565045028|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
156532454|NCT01233869|565045029|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
156532455|NCT01233869|565045030|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
156532456|NCT01233869|565045027|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
156532457|NCT01233869|565045028|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
156532458|NCT01233869|565045029|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
156532459|NCT01233869|565045030|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
156532460|NCT01233869|565045027|FG000|Extended Treatment Period (46 Months)|Other|3|||
156532461|NCT01233869|565045028|FG001|Extended Treatment Period (46 Months)|Other|0|||
156532462|NCT01233869|565045029|FG002|Extended Treatment Period (46 Months)|Other|0|||
156532463|NCT01233869|565045030|FG003|Extended Treatment Period (46 Months)|Other|3|||
156443947|NCT02554786|564716876|FG000|Overall Study|Protocol deviation|1|||
156443948|NCT02554786|564716877|FG001|Overall Study|Protocol deviation|3|||
156443949|NCT02554786|564716878|FG002|Overall Study|Protocol deviation|3|||
156443950|NCT02554786|564716879|FG003|Overall Study|Protocol deviation|4|||
156443951|NCT02554786|564716880|FG004|Overall Study|Protocol deviation|2|||
156443952|NCT02554786|564716876|FG000|Overall Study|Technical problems|1|||
156443953|NCT02554786|564716877|FG001|Overall Study|Technical problems|1|||
156443954|NCT02554786|564716878|FG002|Overall Study|Technical problems|0|||
156874150|NCT01349049|566298583|FG005|Overall Study|Disease progression|2|||
156874151|NCT01349049|566298584|FG006|Overall Study|Disease progression|3|||
156874152|NCT01349049|566298585|FG007|Overall Study|Disease progression|2|||
156443955|NCT02554786|564716879|FG003|Overall Study|Technical problems|2|||
156443956|NCT02554786|564716880|FG004|Overall Study|Technical problems|1|||
156443957|NCT02554786|564716876|FG000|Overall Study|Adverse Event|0|||
156443958|NCT02554786|564716877|FG001|Overall Study|Adverse Event|0|||
156443959|NCT02554786|564716878|FG002|Overall Study|Adverse Event|0|||
156443960|NCT02554786|564716879|FG003|Overall Study|Adverse Event|0|||
156443961|NCT02554786|564716880|FG004|Overall Study|Adverse Event|2|||
156443962|NCT02554786|564716876|FG000|Overall Study|Death|0|||
156443963|NCT02554786|564716877|FG001|Overall Study|Death|0|||
156443964|NCT02554786|564716878|FG002|Overall Study|Death|0|||
156443965|NCT02554786|564716879|FG003|Overall Study|Death|1|||
156443966|NCT02554786|564716880|FG004|Overall Study|Death|0|||
156443967|NCT02554786|564716876|FG000|Overall Study|Non-compliance with study treatment|0|||
156443968|NCT02554786|564716877|FG001|Overall Study|Non-compliance with study treatment|1|||
156443969|NCT02554786|564716878|FG002|Overall Study|Non-compliance with study treatment|1|||
156443970|NCT02554786|564716879|FG003|Overall Study|Non-compliance with study treatment|0|||
156443971|NCT02554786|564716880|FG004|Overall Study|Non-compliance with study treatment|1|||
156443972|NCT02554786|564716876|FG000|Overall Study|Physician Decision|0|||
156443973|NCT02554786|564716877|FG001|Overall Study|Physician Decision|1|||
156443974|NCT02554786|564716878|FG002|Overall Study|Physician Decision|4|||
156443975|NCT02554786|564716879|FG003|Overall Study|Physician Decision|1|||
156443976|NCT02554786|564716880|FG004|Overall Study|Physician Decision|1|||
156443977|NCT02554786|564716876|FG000|Overall Study|Pregnancy|0|||
156443978|NCT02554786|564716877|FG001|Overall Study|Pregnancy|0|||
156443979|NCT02554786|564716878|FG002|Overall Study|Pregnancy|0|||
156443980|NCT02554786|564716879|FG003|Overall Study|Pregnancy|1|||
156443981|NCT02554786|564716880|FG004|Overall Study|Pregnancy|1|||
156443982|NCT01695954|564716882|FG000|Overall Study|Withdrawal by Subject|4|||
156443983|NCT01695954|564716883|FG001|Overall Study|Withdrawal by Subject|0|||
156443984|NCT01695954|564716882|FG000|Overall Study|Adverse Event|0|||
156443985|NCT01695954|564716883|FG001|Overall Study|Adverse Event|2|||
156443986|NCT04583423|564716895|FG000|Overall Study|Lost to Follow-up|0|||
156443987|NCT04583423|564716896|FG001|Overall Study|Lost to Follow-up|1|||
156443988|NCT04583423|564716897|FG002|Overall Study|Lost to Follow-up|0|||
156443989|NCT04583423|564716898|FG003|Overall Study|Lost to Follow-up|2|||
156443990|NCT04583423|564716895|FG000|Overall Study|Study Terminated by Sponsor|32|||
156443991|NCT04583423|564716896|FG001|Overall Study|Study Terminated by Sponsor|35|||
156443992|NCT04583423|564716897|FG002|Overall Study|Study Terminated by Sponsor|36|||
156443993|NCT04583423|564716898|FG003|Overall Study|Study Terminated by Sponsor|33|||
156443994|NCT04583423|564716895|FG000|Overall Study|Withdrawal by Subject|3|||
156443995|NCT04583423|564716896|FG001|Overall Study|Withdrawal by Subject|1|||
156443996|NCT04583423|564716897|FG002|Overall Study|Withdrawal by Subject|2|||
156443997|NCT04583423|564716898|FG003|Overall Study|Withdrawal by Subject|1|||
156443998|NCT04704284|564716904|FG000|Overall Study|Withdrawal by Subject|1|||
156443999|NCT03830866|564716909|FG000|Overall Study|Death|90|||
156444000|NCT03830866|564716910|FG001|Overall Study|Death|111|||
156444001|NCT03830866|564716909|FG000|Overall Study|Lost to Follow-up|7|||
156444002|NCT03830866|564716910|FG001|Overall Study|Lost to Follow-up|7|||
156444003|NCT03830866|564716909|FG000|Overall Study|Withdrawal by Subject|19|||
156444004|NCT03830866|564716910|FG001|Overall Study|Withdrawal by Subject|16|||
156444005|NCT03830866|564716909|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
156444006|NCT03830866|564716910|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
156444007|NCT03830866|564716909|FG000|Overall Study|Other|1|||
156444008|NCT03830866|564716910|FG001|Overall Study|Other|1|||
156444009|NCT01736215|564716920|FG000|Overall Study|Early termination of erythropoietin use|1|||
156444010|NCT01736215|564716920|FG000|Overall Study|Adverse Event|4|||
156444011|NCT01736215|564716920|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
156714906|NCT02906670|565700820|FG002|Cohort 5P, Q2W|Adverse Event|0|||
156444012|NCT01736215|564716920|FG000|Overall Study|Insufficient data to perform analysis|8|||
156714907|NCT02906670|565700821|FG003|Cohort 5P, Q2W|Adverse Event|0|||
156714908|NCT02906670|565700822|FG004|Cohort 5P, Q2W|Adverse Event|0|||
156444013|NCT01248936|564716921|FG000|Overall Study|Sponsor Decision|259|||
156444014|NCT01248936|564716921|FG000|Overall Study|Progression of Disease|50|||
156444015|NCT01248936|564716921|FG000|Overall Study|Death|26|||
156444016|NCT01248936|564716921|FG000|Overall Study|Withdrawal of Consent|20|||
156444017|NCT01248936|564716921|FG000|Overall Study|Adverse Event|8|||
156444018|NCT01248936|564716921|FG000|Overall Study|Lost to Follow-up|7|||
156444019|NCT01248936|564716921|FG000|Overall Study|Refused Treatment|1|||
156444020|NCT01248936|564716921|FG000|Overall Study|Other reason|3|||
156444021|NCT02692417|564716922|FG000|Overall Study|Withdrawal by Subject|5|||
156444022|NCT02692417|564716923|FG001|Overall Study|Withdrawal by Subject|1|||
156874153|NCT01349049|566298586|FG008|Overall Study|Disease progression|33|||
156444023|NCT02692417|564716922|FG000|Overall Study|Adverse Event|1|||
156444024|NCT02692417|564716923|FG001|Overall Study|Adverse Event|0|||
156444025|NCT03481660|564718480|FG000|Overall Study|Adverse Event|5|||
156444026|NCT03481660|564718481|FG001|Overall Study|Adverse Event|4|||
156444027|NCT03481660|564718480|FG000|Overall Study|Death|13|||
156444028|NCT03481660|564718481|FG001|Overall Study|Death|9|||
156444029|NCT03481660|564718480|FG000|Overall Study|Lost to Follow-up|2|||
156444030|NCT03481660|564718481|FG001|Overall Study|Lost to Follow-up|2|||
156444031|NCT03481660|564718480|FG000|Overall Study|Physician Decision|2|||
156444032|NCT03481660|564718481|FG001|Overall Study|Physician Decision|3|||
156444033|NCT03481660|564718480|FG000|Overall Study|Withdrawal by Subject|14|||
156444034|NCT03481660|564718481|FG001|Overall Study|Withdrawal by Subject|7|||
156444035|NCT03398148|564718482|FG000|Substudy 1 Period 1|Adverse Event|5|||
156444036|NCT03398148|564718483|FG001|Substudy 1 Period 1|Adverse Event|2|||
156444037|NCT03398148|564718484|FG002|Substudy 1 Period 1|Adverse Event|2|||
156444038|NCT03398148|564718485|FG003|Substudy 1 Period 1|Adverse Event|0|||
156444039|NCT03398148|564718486|FG004|Substudy 1 Period 1|Adverse Event|8|||
156444040|NCT03398148|564718487|FG005|Substudy 1 Period 1|Adverse Event|0|||
156444041|NCT03398148|564718488|FG006|Substudy 1 Period 1|Adverse Event|0|||
156444042|NCT03398148|564718489|FG007|Substudy 1 Period 1|Adverse Event|0|||
156874154|NCT01349049|566298578|FG000|Overall Study|Adverse Event|0|||
156874155|NCT01349049|566298579|FG001|Overall Study|Adverse Event|1|||
156874156|NCT01349049|566298580|FG002|Overall Study|Adverse Event|0|||
156874157|NCT01349049|566298581|FG003|Overall Study|Adverse Event|0|||
156874158|NCT01349049|566298582|FG004|Overall Study|Adverse Event|0|||
156874159|NCT01349049|566298583|FG005|Overall Study|Adverse Event|3|||
156874160|NCT01349049|566298584|FG006|Overall Study|Adverse Event|1|||
156874161|NCT01349049|566298585|FG007|Overall Study|Adverse Event|0|||
156874162|NCT01349049|566298586|FG008|Overall Study|Adverse Event|4|||
156874163|NCT01349049|566298578|FG000|Overall Study|Physician Decision|0|||
156874164|NCT01349049|566298579|FG001|Overall Study|Physician Decision|1|||
156874165|NCT01349049|566298580|FG002|Overall Study|Physician Decision|0|||
156874166|NCT01349049|566298581|FG003|Overall Study|Physician Decision|0|||
156874167|NCT01349049|566298582|FG004|Overall Study|Physician Decision|0|||
156874168|NCT01349049|566298583|FG005|Overall Study|Physician Decision|0|||
156874169|NCT01349049|566298584|FG006|Overall Study|Physician Decision|0|||
156874170|NCT01349049|566298585|FG007|Overall Study|Physician Decision|0|||
156874171|NCT01349049|566298586|FG008|Overall Study|Physician Decision|2|||
156874172|NCT01349049|566298578|FG000|Overall Study|Protocol Violation|0|||
156874173|NCT01349049|566298579|FG001|Overall Study|Protocol Violation|0|||
156874174|NCT01349049|566298580|FG002|Overall Study|Protocol Violation|0|||
156874175|NCT01349049|566298581|FG003|Overall Study|Protocol Violation|0|||
156874176|NCT01349049|566298582|FG004|Overall Study|Protocol Violation|0|||
156874177|NCT01349049|566298583|FG005|Overall Study|Protocol Violation|0|||
156444043|NCT03398148|564718490|FG008|Substudy 1 Period 1|Adverse Event|0|||
156444044|NCT03398148|564718491|FG009|Substudy 1 Period 1|Adverse Event|0|||
156444045|NCT03398148|564718492|FG010|Substudy 1 Period 1|Adverse Event|0|||
156444046|NCT03398148|564718493|FG011|Substudy 1 Period 1|Adverse Event|0|||
156444047|NCT03398148|564718494|FG012|Substudy 1 Period 1|Adverse Event|0|||
156444048|NCT03398148|564718495|FG013|Substudy 1 Period 1|Adverse Event|0|||
156444049|NCT03398148|564718496|FG014|Substudy 1 Period 1|Adverse Event|0|||
156444050|NCT03398148|564718482|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
156444051|NCT03398148|564718483|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
156444052|NCT03398148|564718484|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444053|NCT03398148|564718485|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
156444054|NCT03398148|564718486|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
156874178|NCT01349049|566298584|FG006|Overall Study|Protocol Violation|0|||
156444055|NCT03398148|564718487|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444056|NCT03398148|564718488|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444057|NCT03398148|564718489|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444058|NCT03398148|564718490|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444059|NCT03398148|564718491|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444060|NCT03398148|564718492|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444061|NCT03398148|564718493|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444062|NCT03398148|564718494|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444063|NCT03398148|564718495|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444064|NCT03398148|564718496|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
156444065|NCT03398148|564718482|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
156444066|NCT03398148|564718483|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
156444067|NCT03398148|564718484|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
156874179|NCT01349049|566298585|FG007|Overall Study|Protocol Violation|0|||
156874180|NCT01349049|566298586|FG008|Overall Study|Protocol Violation|1|||
156874181|NCT01349049|566298578|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
156874182|NCT01349049|566298579|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
156444068|NCT03398148|564718485|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
156444069|NCT03398148|564718486|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
156874183|NCT01349049|566298580|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
156874184|NCT01349049|566298581|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
156874185|NCT01349049|566298582|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
156444070|NCT03398148|564718487|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
156444071|NCT03398148|564718488|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
156444072|NCT03398148|564718489|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
156444073|NCT03398148|564718490|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
156444074|NCT03398148|564718491|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
156444075|NCT03398148|564718492|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
156444076|NCT03398148|564718493|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
156444077|NCT03398148|564718494|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
156444078|NCT03398148|564718495|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
156444079|NCT03398148|564718496|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
156444080|NCT03398148|564718482|FG000|Substudy 1 Period 1|Other|0|||
156444081|NCT03398148|564718483|FG001|Substudy 1 Period 1|Other|1|||
156444082|NCT03398148|564718484|FG002|Substudy 1 Period 1|Other|0|||
156444083|NCT03398148|564718485|FG003|Substudy 1 Period 1|Other|0|||
156444084|NCT03398148|564718486|FG004|Substudy 1 Period 1|Other|3|||
156444085|NCT03398148|564718487|FG005|Substudy 1 Period 1|Other|0|||
156444086|NCT03398148|564718488|FG006|Substudy 1 Period 1|Other|0|||
156444087|NCT03398148|564718489|FG007|Substudy 1 Period 1|Other|0|||
156444088|NCT03398148|564718490|FG008|Substudy 1 Period 1|Other|0|||
156444089|NCT03398148|564718491|FG009|Substudy 1 Period 1|Other|0|||
156444090|NCT03398148|564718492|FG010|Substudy 1 Period 1|Other|0|||
156444091|NCT03398148|564718493|FG011|Substudy 1 Period 1|Other|0|||
156444092|NCT03398148|564718494|FG012|Substudy 1 Period 1|Other|0|||
156444093|NCT03398148|564718495|FG013|Substudy 1 Period 1|Other|0|||
156444094|NCT03398148|564718496|FG014|Substudy 1 Period 1|Other|0|||
156444095|NCT03398148|564718482|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444096|NCT03398148|564718483|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444097|NCT03398148|564718484|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444098|NCT03398148|564718485|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444099|NCT03398148|564718486|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
156444100|NCT03398148|564718487|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444101|NCT03398148|564718488|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444102|NCT03398148|564718489|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444103|NCT03398148|564718490|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444104|NCT03398148|564718491|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444105|NCT03398148|564718492|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444106|NCT03398148|564718493|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444107|NCT03398148|564718494|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444108|NCT03398148|564718495|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444109|NCT03398148|564718496|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
156444110|NCT03398148|564718482|FG000|Substudy 1 Period 2|Adverse Event|0|||
156444111|NCT03398148|564718483|FG001|Substudy 1 Period 2|Adverse Event|0|||
156444112|NCT03398148|564718484|FG002|Substudy 1 Period 2|Adverse Event|0|||
156874186|NCT01349049|566298583|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
156874187|NCT01349049|566298584|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
156874188|NCT01349049|566298585|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
156874189|NCT01349049|566298586|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
156874190|NCT01349049|566298578|FG000|Overall Study|Other|0|||
156874191|NCT01349049|566298579|FG001|Overall Study|Other|0|||
156874192|NCT01349049|566298580|FG002|Overall Study|Other|0|||
156874193|NCT01349049|566298581|FG003|Overall Study|Other|0|||
156874194|NCT01349049|566298582|FG004|Overall Study|Other|0|||
156874195|NCT01349049|566298583|FG005|Overall Study|Other|1|||
156874196|NCT01349049|566298584|FG006|Overall Study|Other|0|||
156874197|NCT01349049|566298585|FG007|Overall Study|Other|0|||
156874198|NCT01349049|566298586|FG008|Overall Study|Other|4|||
156874199|NCT01349049|566298578|FG000|Overall Study|Death|0|||
156874200|NCT01349049|566298579|FG001|Overall Study|Death|0|||
156874201|NCT01349049|566298580|FG002|Overall Study|Death|0|||
156874202|NCT01349049|566298581|FG003|Overall Study|Death|0|||
156874203|NCT01349049|566298582|FG004|Overall Study|Death|0|||
156874204|NCT01349049|566298583|FG005|Overall Study|Death|0|||
156874205|NCT01349049|566298584|FG006|Overall Study|Death|0|||
156714909|NCT02906670|565700823|FG005|Cohort 5P, Q2W|Adverse Event|0|||
156714910|NCT02906670|565700824|FG006|Cohort 5P, Q2W|Adverse Event|0|||
156874206|NCT01349049|566298585|FG007|Overall Study|Death|1|||
156874207|NCT01349049|566298586|FG008|Overall Study|Death|5|||
156714911|NCT02906670|565700825|FG007|Cohort 5P, Q2W|Adverse Event|1|||
156874208|NCT01349049|566298578|FG000|Overall Study|Non-compliance|0|||
156874209|NCT01349049|566298579|FG001|Overall Study|Non-compliance|0|||
156874210|NCT01349049|566298580|FG002|Overall Study|Non-compliance|0|||
156444113|NCT03398148|564718485|FG003|Substudy 1 Period 2|Adverse Event|0|||
156444114|NCT03398148|564718486|FG004|Substudy 1 Period 2|Adverse Event|0|||
156444115|NCT03398148|564718487|FG005|Substudy 1 Period 2|Adverse Event|2|||
156444116|NCT03398148|564718488|FG006|Substudy 1 Period 2|Adverse Event|4|||
156444117|NCT03398148|564718489|FG007|Substudy 1 Period 2|Adverse Event|0|||
156874211|NCT01349049|566298581|FG003|Overall Study|Non-compliance|1|||
156444118|NCT03398148|564718490|FG008|Substudy 1 Period 2|Adverse Event|0|||
156874212|NCT01349049|566298582|FG004|Overall Study|Non-compliance|0|||
156874213|NCT01349049|566298583|FG005|Overall Study|Non-compliance|0|||
156714912|NCT02906670|565700826|FG008|Cohort 5P, Q2W|Adverse Event|0|||
156714913|NCT02906670|565700827|FG009|Cohort 5P, Q2W|Adverse Event|0|||
156714914|NCT02906670|565700818|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
156333264|NCT00075218|564319060|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
156333265|NCT00075218|564319058|FG000|Open-Label Treatment|Decision of Sponsor|0|||
156333266|NCT00075218|564319059|FG001|Open-Label Treatment|Decision of Sponsor|0|||
156333267|NCT00075218|564319060|FG002|Open-Label Treatment|Decision of Sponsor|8|||
156333268|NCT00075218|564319058|FG000|Open-Label Treatment|Protocol Violation|0|||
156333269|NCT00075218|564319059|FG001|Open-Label Treatment|Protocol Violation|0|||
156333270|NCT00075218|564319060|FG002|Open-Label Treatment|Protocol Violation|1|||
156333271|NCT00075218|564319058|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
156333272|NCT00075218|564319059|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
156333273|NCT00075218|564319060|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
156333274|NCT03643575|564319061|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
156333275|NCT03643575|564319062|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
156333276|NCT03643575|564319063|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
156333277|NCT03643575|564319064|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
156333278|NCT03643575|564319065|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
156333279|NCT03643575|564319066|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
156333280|NCT03643575|564319061|FG000|Washout: 7 Days|Adverse Event|1|||
156333281|NCT03643575|564319062|FG001|Washout: 7 Days|Adverse Event|0|||
156333282|NCT03643575|564319063|FG002|Washout: 7 Days|Adverse Event|0|||
156333283|NCT03643575|564319064|FG003|Washout: 7 Days|Adverse Event|0|||
156333284|NCT03643575|564319065|FG004|Washout: 7 Days|Adverse Event|0|||
156333285|NCT03643575|564319066|FG005|Washout: 7 Days|Adverse Event|0|||
156333286|NCT03643575|564319061|FG000|Washout: 7 Days|Non compliance check in|0|||
156333287|NCT03643575|564319062|FG001|Washout: 7 Days|Non compliance check in|1|||
156333288|NCT03643575|564319063|FG002|Washout: 7 Days|Non compliance check in|0|||
156333289|NCT03643575|564319064|FG003|Washout: 7 Days|Non compliance check in|0|||
156333290|NCT03643575|564319065|FG004|Washout: 7 Days|Non compliance check in|0|||
156333291|NCT03643575|564319066|FG005|Washout: 7 Days|Non compliance check in|0|||
156333292|NCT00850070|564319067|FG000|Overall Study|Lack of Efficacy|1|||
156333293|NCT00850070|564319068|FG001|Overall Study|Lack of Efficacy|1|||
156333294|NCT00850070|564319067|FG000|Overall Study|Adverse Event|2|||
156333295|NCT00850070|564319068|FG001|Overall Study|Adverse Event|0|||
156333296|NCT01522248|564319071|FG000|Overall Study|Lost to Follow-up|1|||
156333297|NCT01522248|564319072|FG001|Overall Study|Lost to Follow-up|0|||
156333298|NCT04515394|564319074|FG000|Overall Study|Participant did not receive treatment|1|||
156333299|NCT00199875|564319075|FG000|Overall Study|Withdrawal by Subject|0|||
156333300|NCT00199875|564319076|FG001|Overall Study|Withdrawal by Subject|0|||
156333301|NCT00199875|564319077|FG002|Overall Study|Withdrawal by Subject|0|||
156333302|NCT00199875|564319078|FG003|Overall Study|Withdrawal by Subject|0|||
156333303|NCT00199875|564319079|FG004|Overall Study|Withdrawal by Subject|1|||
156333304|NCT03469934|564319081|FG000|Overall Study|Withdrawal by Subject|0|||
156333305|NCT03469934|564319082|FG001|Overall Study|Withdrawal by Subject|1|||
156333306|NCT01013350|564319085|FG000|Overall Study|Lost to Follow-up|15|||
156333307|NCT01013350|564319086|FG001|Overall Study|Lost to Follow-up|95|||
156333308|NCT01013350|564319085|FG000|Overall Study|Adverse Event|0|||
156333309|NCT01013350|564319086|FG001|Overall Study|Adverse Event|1|||
156333310|NCT01013350|564319085|FG000|Overall Study|Physician Decision|4|||
156333311|NCT01013350|564319086|FG001|Overall Study|Physician Decision|20|||
156333312|NCT01013350|564319085|FG000|Overall Study|Withdrawal by Subject|15|||
156333313|NCT01013350|564319086|FG001|Overall Study|Withdrawal by Subject|38|||
156333314|NCT01013350|564319085|FG000|Overall Study|Death|3|||
156333315|NCT01013350|564319086|FG001|Overall Study|Death|5|||
156333316|NCT01013350|564319085|FG000|Overall Study|Participant entered interventional study|0|||
156333317|NCT01013350|564319086|FG001|Overall Study|Participant entered interventional study|8|||
156333318|NCT01013350|564319085|FG000|Overall Study|Other|1|||
156333319|NCT01013350|564319086|FG001|Overall Study|Other|25|||
156333320|NCT02808650|564319093|FG000|Overall Study|Death|0|||
156333321|NCT02808650|564319094|FG001|Overall Study|Death|0|||
156333322|NCT02808650|564319095|FG002|Overall Study|Death|0|||
156333323|NCT02808650|564319096|FG003|Overall Study|Death|0|||
156333324|NCT02808650|564319097|FG004|Overall Study|Death|1|||
156333325|NCT02808650|564319093|FG000|Overall Study|Lack of Efficacy|5|||
156333326|NCT02808650|564319094|FG001|Overall Study|Lack of Efficacy|5|||
156333327|NCT02808650|564319095|FG002|Overall Study|Lack of Efficacy|6|||
156333328|NCT02808650|564319096|FG003|Overall Study|Lack of Efficacy|5|||
156333329|NCT02808650|564319097|FG004|Overall Study|Lack of Efficacy|4|||
156333330|NCT02808650|564319093|FG000|Overall Study|Physician Decision|1|||
156333331|NCT02808650|564319094|FG001|Overall Study|Physician Decision|1|||
156333332|NCT02808650|564319095|FG002|Overall Study|Physician Decision|0|||
156333333|NCT02808650|564319096|FG003|Overall Study|Physician Decision|0|||
156333334|NCT02808650|564319097|FG004|Overall Study|Physician Decision|0|||
156333335|NCT02808650|564319093|FG000|Overall Study|Withdrawal by Subject|0|||
156333336|NCT02808650|564319094|FG001|Overall Study|Withdrawal by Subject|0|||
156333337|NCT02808650|564319095|FG002|Overall Study|Withdrawal by Subject|0|||
156874214|NCT01349049|566298584|FG006|Overall Study|Non-compliance|0|||
156874215|NCT01349049|566298585|FG007|Overall Study|Non-compliance|0|||
156874216|NCT01349049|566298586|FG008|Overall Study|Non-compliance|0|||
156874217|NCT01349049|566298578|FG000|Overall Study|Withdrawal by Subject|0|||
156874218|NCT01349049|566298579|FG001|Overall Study|Withdrawal by Subject|0|||
156874219|NCT01349049|566298580|FG002|Overall Study|Withdrawal by Subject|0|||
156874220|NCT01349049|566298581|FG003|Overall Study|Withdrawal by Subject|0|||
156874221|NCT01349049|566298582|FG004|Overall Study|Withdrawal by Subject|0|||
156874222|NCT01349049|566298583|FG005|Overall Study|Withdrawal by Subject|0|||
156874223|NCT01349049|566298584|FG006|Overall Study|Withdrawal by Subject|0|||
156874224|NCT01349049|566298585|FG007|Overall Study|Withdrawal by Subject|0|||
156874225|NCT01349049|566298586|FG008|Overall Study|Withdrawal by Subject|6|||
156874226|NCT00970684|566298592|FG000|Overall Study|Lack of Efficacy|5|||
156874227|NCT00970684|566298592|FG000|Overall Study|Adverse Event|4|||
156874228|NCT00970684|566298592|FG000|Overall Study|Withdrawal by Subject|1|||
156874229|NCT01175083|566298593|FG000|Primary Epoch|Withdrawal by Subject|0|||
156874230|NCT01175083|566298594|FG001|Primary Epoch|Withdrawal by Subject|0|||
156874231|NCT01175083|566298595|FG002|Primary Epoch|Withdrawal by Subject|0|||
156874232|NCT01175083|566298596|FG003|Primary Epoch|Withdrawal by Subject|0|||
156874233|NCT01175083|566298597|FG004|Primary Epoch|Withdrawal by Subject|0|||
156874234|NCT01175083|566298598|FG005|Primary Epoch|Withdrawal by Subject|2|||
156874235|NCT01175083|566298593|FG000|Primary Epoch|Lost to Follow-up|0|||
156874236|NCT01175083|566298594|FG001|Primary Epoch|Lost to Follow-up|0|||
156874237|NCT01175083|566298595|FG002|Primary Epoch|Lost to Follow-up|0|||
156874238|NCT01175083|566298596|FG003|Primary Epoch|Lost to Follow-up|0|||
156874239|NCT01175083|566298597|FG004|Primary Epoch|Lost to Follow-up|0|||
156874240|NCT01175083|566298598|FG005|Primary Epoch|Lost to Follow-up|1|||
156874241|NCT01175083|566298593|FG000|Booster Epoch|Death|0|||
156874242|NCT01175083|566298594|FG001|Booster Epoch|Death|0|||
156874243|NCT01175083|566298595|FG002|Booster Epoch|Death|1|||
156874244|NCT01175083|566298596|FG003|Booster Epoch|Death|0|||
156874245|NCT01175083|566298597|FG004|Booster Epoch|Death|0|||
156874246|NCT01175083|566298598|FG005|Booster Epoch|Death|0|||
156874247|NCT01175083|566298593|FG000|Booster Epoch|Withdrawal by Subject|0|||
156874248|NCT01175083|566298594|FG001|Booster Epoch|Withdrawal by Subject|0|||
156874249|NCT01175083|566298595|FG002|Booster Epoch|Withdrawal by Subject|0|||
156874250|NCT01175083|566298596|FG003|Booster Epoch|Withdrawal by Subject|1|||
156874251|NCT01175083|566298597|FG004|Booster Epoch|Withdrawal by Subject|0|||
156874252|NCT01175083|566298598|FG005|Booster Epoch|Withdrawal by Subject|0|||
156874253|NCT00481091|566298599|FG000|Overall Study|Withdrawal by Subject|0|||
156874254|NCT00481091|566298600|FG001|Overall Study|Withdrawal by Subject|1|||
156874255|NCT00481091|566298601|FG002|Overall Study|Withdrawal by Subject|1|||
156874256|NCT00481091|566298602|FG003|Overall Study|Withdrawal by Subject|0|||
156874257|NCT00481091|566298603|FG004|Overall Study|Withdrawal by Subject|0|||
156874258|NCT00481091|566298604|FG005|Overall Study|Withdrawal by Subject|0|||
156874259|NCT00481091|566298605|FG006|Overall Study|Withdrawal by Subject|0|||
156874260|NCT00481091|566298606|FG007|Overall Study|Withdrawal by Subject|0|||
156874261|NCT00481091|566298607|FG008|Overall Study|Withdrawal by Subject|1|||
156874262|NCT00481091|566298608|FG009|Overall Study|Withdrawal by Subject|6|||
156714915|NCT02906670|565700819|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
156714916|NCT02906670|565700820|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
156714917|NCT02906670|565700821|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
156714918|NCT02906670|565700822|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
156714919|NCT02906670|565700823|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
156714920|NCT02906670|565700824|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
156714921|NCT02906670|565700825|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
156714922|NCT02906670|565700826|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
156714923|NCT02906670|565700827|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
156714924|NCT02906670|565700818|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
156714925|NCT02906670|565700819|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
156714926|NCT02906670|565700820|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
156714927|NCT02906670|565700821|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
156874263|NCT00481091|566298599|FG000|Overall Study|Other, Not Specified|0|||
156874264|NCT00481091|566298600|FG001|Overall Study|Other, Not Specified|1|||
156874265|NCT00481091|566298601|FG002|Overall Study|Other, Not Specified|1|||
156874266|NCT00481091|566298602|FG003|Overall Study|Other, Not Specified|0|||
156874267|NCT00481091|566298603|FG004|Overall Study|Other, Not Specified|0|||
156874268|NCT00481091|566298604|FG005|Overall Study|Other, Not Specified|1|||
156874269|NCT00481091|566298605|FG006|Overall Study|Other, Not Specified|0|||
156874270|NCT00481091|566298606|FG007|Overall Study|Other, Not Specified|0|||
156874271|NCT00481091|566298607|FG008|Overall Study|Other, Not Specified|0|||
156874272|NCT00481091|566298608|FG009|Overall Study|Other, Not Specified|4|||
156874273|NCT00481091|566298599|FG000|Overall Study|Adverse Event|1|||
156874274|NCT00481091|566298600|FG001|Overall Study|Adverse Event|2|||
156874275|NCT00481091|566298601|FG002|Overall Study|Adverse Event|0|||
156874276|NCT00481091|566298602|FG003|Overall Study|Adverse Event|1|||
156874277|NCT00481091|566298603|FG004|Overall Study|Adverse Event|1|||
156874278|NCT00481091|566298604|FG005|Overall Study|Adverse Event|1|||
156874279|NCT00481091|566298605|FG006|Overall Study|Adverse Event|2|||
156874280|NCT00481091|566298606|FG007|Overall Study|Adverse Event|1|||
156874281|NCT00481091|566298607|FG008|Overall Study|Adverse Event|1|||
156874282|NCT00481091|566298608|FG009|Overall Study|Adverse Event|6|||
156874283|NCT00481091|566298599|FG000|Overall Study|Progressive disease clinical|0|||
156874284|NCT00481091|566298600|FG001|Overall Study|Progressive disease clinical|0|||
156874285|NCT00481091|566298601|FG002|Overall Study|Progressive disease clinical|0|||
156874286|NCT00481091|566298602|FG003|Overall Study|Progressive disease clinical|0|||
156874287|NCT00481091|566298603|FG004|Overall Study|Progressive disease clinical|0|||
156874288|NCT00481091|566298604|FG005|Overall Study|Progressive disease clinical|0|||
156874289|NCT00481091|566298605|FG006|Overall Study|Progressive disease clinical|0|||
156874290|NCT00481091|566298606|FG007|Overall Study|Progressive disease clinical|0|||
156874291|NCT00481091|566298607|FG008|Overall Study|Progressive disease clinical|1|||
156874292|NCT00481091|566298608|FG009|Overall Study|Progressive disease clinical|7|||
156874293|NCT00481091|566298599|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
156874294|NCT00481091|566298600|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
156874295|NCT00481091|566298601|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874296|NCT00481091|566298602|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874297|NCT00481091|566298603|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874298|NCT00481091|566298604|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
156874299|NCT00481091|566298605|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874300|NCT00481091|566298606|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156333338|NCT02808650|564319096|FG003|Overall Study|Withdrawal by Subject|1|||
156333339|NCT02808650|564319097|FG004|Overall Study|Withdrawal by Subject|1|||
156333340|NCT02507973|564319104|FG000|Overall Study|Adverse Event|1|||
156333341|NCT04295772|564319107|FG000|Overall Study|Protocol Violation|1|||
156333342|NCT04295772|564319108|FG001|Overall Study|Protocol Violation|0|||
156333343|NCT04295772|564319107|FG000|Overall Study|Ongoing for safety monitoring|14|||
156333344|NCT04295772|564319108|FG001|Overall Study|Ongoing for safety monitoring|1|||
156333345|NCT04295772|564319107|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
156333346|NCT04295772|564319108|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
156333347|NCT01710046|564319112|FG000|Overall Study|Lost to Follow-up|1|||
156333348|NCT01710046|564319113|FG001|Overall Study|Lost to Follow-up|0|||
156333349|NCT01163266|564319120|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
156333350|NCT01163266|564319121|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
156333351|NCT01163266|564319122|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
156333352|NCT01163266|564319120|FG000|Overall Study|Lack of Efficacy|1|||
156333353|NCT01163266|564319121|FG001|Overall Study|Lack of Efficacy|3|||
156333354|NCT01163266|564319122|FG002|Overall Study|Lack of Efficacy|1|||
156333355|NCT01163266|564319120|FG000|Overall Study|Noncompliance with Study Drug|0|||
156333356|NCT01163266|564319121|FG001|Overall Study|Noncompliance with Study Drug|2|||
156333357|NCT01163266|564319122|FG002|Overall Study|Noncompliance with Study Drug|0|||
156333358|NCT01163266|564319120|FG000|Overall Study|Protocol Deviations|2|||
156333359|NCT01163266|564319121|FG001|Overall Study|Protocol Deviations|2|||
156333360|NCT01163266|564319122|FG002|Overall Study|Protocol Deviations|5|||
156333361|NCT01163266|564319120|FG000|Overall Study|Withdrawal of Consent|5|||
156333362|NCT01163266|564319121|FG001|Overall Study|Withdrawal of Consent|7|||
156333363|NCT01163266|564319122|FG002|Overall Study|Withdrawal of Consent|3|||
156333364|NCT01163266|564319120|FG000|Overall Study|Lost to Follow-up|7|||
156333365|NCT01163266|564319121|FG001|Overall Study|Lost to Follow-up|7|||
156333366|NCT01163266|564319122|FG002|Overall Study|Lost to Follow-up|10|||
156333367|NCT01163266|564319120|FG000|Overall Study|Other|1|||
156333368|NCT01163266|564319121|FG001|Overall Study|Other|1|||
156333369|NCT01163266|564319122|FG002|Overall Study|Other|2|||
156333370|NCT02586064|564319123|FG000|Overall Study|Other Obligations|6|||
156333371|NCT02586064|564319124|FG001|Overall Study|Other Obligations|6|||
156333372|NCT02586064|564319123|FG000|Overall Study|Other|3|||
156333373|NCT02586064|564319124|FG001|Overall Study|Other|7|||
156333374|NCT02586064|564319123|FG000|Overall Study|Never Started|3|||
156333375|NCT02586064|564319124|FG001|Overall Study|Never Started|3|||
156333376|NCT02586064|564319123|FG000|Overall Study|Lost Interest|1|||
156333377|NCT02586064|564319124|FG001|Overall Study|Lost Interest|4|||
156333378|NCT02586064|564319123|FG000|Overall Study|Miscellaneous Life Issues|0|||
156333379|NCT02586064|564319124|FG001|Overall Study|Miscellaneous Life Issues|5|||
156333380|NCT02586064|564319123|FG000|Overall Study|Infrequent Attendance|2|||
156333381|NCT02586064|564319124|FG001|Overall Study|Infrequent Attendance|1|||
156333382|NCT02586064|564319123|FG000|Overall Study|Timed Out|2|||
156333383|NCT02586064|564319124|FG001|Overall Study|Timed Out|0|||
156333384|NCT02586064|564319123|FG000|Overall Study|AUD relapse|0|||
156333385|NCT02586064|564319124|FG001|Overall Study|AUD relapse|2|||
156333386|NCT02586064|564319123|FG000|Overall Study|Legal Issue|1|||
156333387|NCT02586064|564319124|FG001|Overall Study|Legal Issue|0|||
156333388|NCT02919696|564319125|FG000|Overall Study|Adverse Event|1|||
156333389|NCT02919696|564319126|FG001|Overall Study|Adverse Event|2|||
156333390|NCT02919696|564319125|FG000|Overall Study|Withdrawal by Subject|2|||
156333391|NCT02919696|564319126|FG001|Overall Study|Withdrawal by Subject|1|||
156333392|NCT02919696|564319125|FG000|Overall Study|Sponsor Decision|1|||
156333393|NCT02919696|564319126|FG001|Overall Study|Sponsor Decision|1|||
156333394|NCT02919696|564319125|FG000|Overall Study|Never Treated|0|||
156333395|NCT02919696|564319126|FG001|Overall Study|Never Treated|1|||
156333396|NCT02158975|564319127|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
156333397|NCT01967173|564319128|FG000|Overall Study|Lost to Follow-up|5|||
156333398|NCT01967173|564319129|FG001|Overall Study|Lost to Follow-up|3|||
156333399|NCT01967173|564319130|FG002|Overall Study|Lost to Follow-up|2|||
156333400|NCT01967173|564319131|FG003|Overall Study|Lost to Follow-up|4|||
156333401|NCT01967173|564319132|FG004|Overall Study|Lost to Follow-up|8|||
156333402|NCT01967173|564319133|FG005|Overall Study|Lost to Follow-up|12|||
156333403|NCT01967173|564319134|FG006|Overall Study|Lost to Follow-up|6|||
156333404|NCT01967173|564319135|FG007|Overall Study|Lost to Follow-up|8|||
156333405|NCT01967173|564319128|FG000|Overall Study|Physician Decision|2|||
156333406|NCT01967173|564319129|FG001|Overall Study|Physician Decision|0|||
156333407|NCT01967173|564319130|FG002|Overall Study|Physician Decision|2|||
156333408|NCT01967173|564319131|FG003|Overall Study|Physician Decision|1|||
156333409|NCT01967173|564319132|FG004|Overall Study|Physician Decision|1|||
156333410|NCT01967173|564319133|FG005|Overall Study|Physician Decision|1|||
156333411|NCT01967173|564319134|FG006|Overall Study|Physician Decision|1|||
156333412|NCT01967173|564319135|FG007|Overall Study|Physician Decision|0|||
156333413|NCT01967173|564319128|FG000|Overall Study|Lack of Efficacy|2|||
156333414|NCT01967173|564319129|FG001|Overall Study|Lack of Efficacy|0|||
156333415|NCT01967173|564319130|FG002|Overall Study|Lack of Efficacy|2|||
156333416|NCT01967173|564319131|FG003|Overall Study|Lack of Efficacy|2|||
156333417|NCT01967173|564319132|FG004|Overall Study|Lack of Efficacy|0|||
156333418|NCT01967173|564319133|FG005|Overall Study|Lack of Efficacy|1|||
156333419|NCT01967173|564319134|FG006|Overall Study|Lack of Efficacy|0|||
156333420|NCT01967173|564319135|FG007|Overall Study|Lack of Efficacy|2|||
156333421|NCT01967173|564319128|FG000|Overall Study|Pregnancy|0|||
156333422|NCT01967173|564319129|FG001|Overall Study|Pregnancy|0|||
156333423|NCT01967173|564319130|FG002|Overall Study|Pregnancy|0|||
156333424|NCT01967173|564319131|FG003|Overall Study|Pregnancy|0|||
156333425|NCT01967173|564319132|FG004|Overall Study|Pregnancy|0|||
156333426|NCT01967173|564319133|FG005|Overall Study|Pregnancy|0|||
156333427|NCT01967173|564319134|FG006|Overall Study|Pregnancy|1|||
156333428|NCT01967173|564319135|FG007|Overall Study|Pregnancy|1|||
156333429|NCT01967173|564319128|FG000|Overall Study|Adverse Event|0|||
156333430|NCT01967173|564319129|FG001|Overall Study|Adverse Event|0|||
156333431|NCT01967173|564319130|FG002|Overall Study|Adverse Event|0|||
156333432|NCT01967173|564319131|FG003|Overall Study|Adverse Event|0|||
156333433|NCT01967173|564319132|FG004|Overall Study|Adverse Event|0|||
156333434|NCT01967173|564319133|FG005|Overall Study|Adverse Event|0|||
156333435|NCT01967173|564319134|FG006|Overall Study|Adverse Event|0|||
156333436|NCT01967173|564319135|FG007|Overall Study|Adverse Event|1|||
156333437|NCT01967173|564319128|FG000|Overall Study|Withdrawal by Subject|15|||
156333438|NCT01967173|564319129|FG001|Overall Study|Withdrawal by Subject|14|||
156333439|NCT01967173|564319130|FG002|Overall Study|Withdrawal by Subject|10|||
156333440|NCT01967173|564319131|FG003|Overall Study|Withdrawal by Subject|7|||
156333441|NCT01967173|564319132|FG004|Overall Study|Withdrawal by Subject|8|||
156333442|NCT01967173|564319133|FG005|Overall Study|Withdrawal by Subject|9|||
156333443|NCT01967173|564319134|FG006|Overall Study|Withdrawal by Subject|10|||
156333444|NCT01967173|564319135|FG007|Overall Study|Withdrawal by Subject|12|||
156333445|NCT03021304|564319140|FG000|Overall Study|Lack of Efficacy|1|||
156333446|NCT00423514|564319146|FG000|Overall Study|Ineligible|1|||
156333447|NCT00423514|564319147|FG001|Overall Study|Ineligible|0|||
156333448|NCT00484094|564319148|FG000|Overall Study|Discontinued|39|||
156333449|NCT00484094|564319148|FG000|Overall Study|Other|3|||
156333450|NCT03308786|564319150|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
156333451|NCT01999868|564319151|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
156333452|NCT01999868|564319152|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
156333453|NCT01999868|564319153|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
156714928|NCT02906670|565700822|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
156333454|NCT01999868|564319151|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
156333455|NCT01999868|564319152|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
156333456|NCT01999868|564319153|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
156333457|NCT01999868|564319151|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
156333458|NCT01999868|564319152|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
156333459|NCT01999868|564319153|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
156333460|NCT01999868|564319151|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
156333461|NCT01999868|564319152|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
156333462|NCT01999868|564319153|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
156333463|NCT01999868|564319151|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
156333464|NCT01999868|564319152|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
156333465|NCT01999868|564319153|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
156444119|NCT03398148|564718491|FG009|Substudy 1 Period 2|Adverse Event|0|||
156444120|NCT03398148|564718492|FG010|Substudy 1 Period 2|Adverse Event|0|||
156444121|NCT03398148|564718493|FG011|Substudy 1 Period 2|Adverse Event|0|||
156444122|NCT03398148|564718494|FG012|Substudy 1 Period 2|Adverse Event|0|||
156444123|NCT03398148|564718495|FG013|Substudy 1 Period 2|Adverse Event|0|||
156444124|NCT03398148|564718496|FG014|Substudy 1 Period 2|Adverse Event|0|||
156444125|NCT03398148|564718482|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444126|NCT03398148|564718483|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444127|NCT03398148|564718484|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156874301|NCT00481091|566298607|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874302|NCT00481091|566298608|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874303|NCT00481091|566298599|FG000|Overall Study|Progressive disease other|1|||
156874304|NCT00481091|566298600|FG001|Overall Study|Progressive disease other|1|||
156874305|NCT00481091|566298601|FG002|Overall Study|Progressive disease other|0|||
156874306|NCT00481091|566298602|FG003|Overall Study|Progressive disease other|1|||
156874307|NCT00481091|566298603|FG004|Overall Study|Progressive disease other|1|||
156874308|NCT00481091|566298604|FG005|Overall Study|Progressive disease other|1|||
156874309|NCT00481091|566298605|FG006|Overall Study|Progressive disease other|0|||
156874310|NCT00481091|566298606|FG007|Overall Study|Progressive disease other|2|||
156874311|NCT00481091|566298607|FG008|Overall Study|Progressive disease other|0|||
156874312|NCT00481091|566298608|FG009|Overall Study|Progressive disease other|0|||
156874313|NCT00481091|566298599|FG000|Overall Study|No reason given|0|||
156874314|NCT00481091|566298600|FG001|Overall Study|No reason given|0|||
156333466|NCT01999868|564319151|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
156333467|NCT01999868|564319152|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
156333468|NCT01999868|564319153|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
156333469|NCT01999868|564319151|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
156333470|NCT01999868|564319152|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
156333471|NCT01999868|564319153|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
156333472|NCT01999868|564319151|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
156333473|NCT01999868|564319152|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
156333474|NCT01999868|564319153|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
156333475|NCT01999868|564319151|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
156333476|NCT01999868|564319152|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
156333477|NCT01999868|564319153|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
156333478|NCT01999868|564319151|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
156333479|NCT01999868|564319152|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
156333480|NCT01999868|564319153|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
156333481|NCT01999868|564319151|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
156333482|NCT01999868|564319152|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
156333483|NCT01999868|564319153|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
156333484|NCT01999868|564319151|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
156333485|NCT01999868|564319152|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
156333486|NCT01999868|564319153|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
156333487|NCT01999868|564319151|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
156333488|NCT01999868|564319152|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
156333489|NCT01999868|564319153|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
156333490|NCT01999868|564319151|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
156333491|NCT01999868|564319152|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
156333492|NCT01999868|564319153|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
156333493|NCT01999868|564319151|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
156333494|NCT01999868|564319152|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
156333495|NCT01999868|564319153|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
156333496|NCT00319501|564319154|FG000|Double-blind Period|Withdrawal by Subject|0|||
156333497|NCT00319501|564319155|FG001|Double-blind Period|Withdrawal by Subject|3|||
156333498|NCT00319501|564319154|FG000|Double-blind Period|Sponsor Request|1|||
156333499|NCT00319501|564319155|FG001|Double-blind Period|Sponsor Request|0|||
156333500|NCT00319501|564319154|FG000|Double-blind Period|Did not receive treatment|42|||
156333501|NCT00319501|564319155|FG001|Double-blind Period|Did not receive treatment|29|||
156333502|NCT00319501|564319154|FG000|Open-label Period|Adverse Event|5|||
156333503|NCT00319501|564319155|FG001|Open-label Period|Adverse Event|0|||
156333504|NCT00319501|564319154|FG000|Open-label Period|Protocol Violation|6|||
156333505|NCT00319501|564319155|FG001|Open-label Period|Protocol Violation|0|||
156333506|NCT00319501|564319154|FG000|Open-label Period|Withdrawal by Subject|38|||
156333507|NCT00319501|564319155|FG001|Open-label Period|Withdrawal by Subject|0|||
156333508|NCT00319501|564319154|FG000|Open-label Period|Principal Investigator decision|6|||
156333509|NCT00319501|564319155|FG001|Open-label Period|Principal Investigator decision|0|||
156333510|NCT00319501|564319154|FG000|Open-label Period|Sponsor request|12|||
156333511|NCT00319501|564319155|FG001|Open-label Period|Sponsor request|0|||
156333512|NCT00319501|564319154|FG000|Open-label Period|Lost to Follow-up|5|||
156333513|NCT00319501|564319155|FG001|Open-label Period|Lost to Follow-up|0|||
156333514|NCT00319501|564319154|FG000|Open-label Period|Did not receive treatment|33|||
156333515|NCT00319501|564319155|FG001|Open-label Period|Did not receive treatment|0|||
156333516|NCT00319501|564319154|FG000|Open-label Period|Other|11|||
156333517|NCT00319501|564319155|FG001|Open-label Period|Other|0|||
156333518|NCT00319501|564319154|FG000|Open-label Extension Period|Adverse Event|2|||
156333519|NCT00319501|564319155|FG001|Open-label Extension Period|Adverse Event|0|||
156333520|NCT00319501|564319154|FG000|Open-label Extension Period|Did not receive treatment|18|||
156333521|NCT00319501|564319155|FG001|Open-label Extension Period|Did not receive treatment|0|||
156333522|NCT00319501|564319154|FG000|Open-label Extension Period|Other|1|||
156333523|NCT00319501|564319155|FG001|Open-label Extension Period|Other|0|||
156333524|NCT00319501|564319154|FG000|Open-label Extension Period|Principal investigator decision|2|||
156333525|NCT00319501|564319155|FG001|Open-label Extension Period|Principal investigator decision|0|||
156333526|NCT00319501|564319154|FG000|Open-label Extension Period|Sponsor request|26|||
156333527|NCT00319501|564319155|FG001|Open-label Extension Period|Sponsor request|0|||
156333528|NCT00319501|564319154|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
156333529|NCT00319501|564319155|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
156333530|NCT01441180|564319156|FG000|Overall Study|Lost to Follow-up|1|||
156333531|NCT01441180|564319157|FG001|Overall Study|Lost to Follow-up|1|||
156333532|NCT01441180|564319158|FG002|Overall Study|Lost to Follow-up|1|||
156333533|NCT01441180|564319156|FG000|Overall Study|Discontinued|0|||
156333534|NCT01441180|564319157|FG001|Overall Study|Discontinued|0|||
156333535|NCT01441180|564319158|FG002|Overall Study|Discontinued|2|||
156333536|NCT01558739|564319159|FG000|Overall Study|Adverse Event|7|||
156333537|NCT01558739|564319159|FG000|Overall Study|Withdrawal by Subject|2|||
156333538|NCT01558739|564319159|FG000|Overall Study|Death|3|||
156333539|NCT01558739|564319159|FG000|Overall Study|Disease Progression|4|||
156333540|NCT01558739|564319159|FG000|Overall Study|Protocol Violation|1|||
156333541|NCT00142298|564319162|FG000|Overall Study|Adverse Event|10|||
156333542|NCT00142298|564319163|FG001|Overall Study|Adverse Event|10|||
156333543|NCT00142298|564319164|FG002|Overall Study|Adverse Event|1|||
156333544|NCT00142298|564319165|FG003|Overall Study|Adverse Event|5|||
156333545|NCT00142298|564319166|FG004|Overall Study|Adverse Event|2|||
156333546|NCT00142298|564319167|FG005|Overall Study|Adverse Event|2|||
156333547|NCT00142298|564319168|FG006|Overall Study|Adverse Event|0|||
156333548|NCT00142298|564319169|FG007|Overall Study|Adverse Event|0|||
156333549|NCT00142298|564319170|FG008|Overall Study|Adverse Event|0|||
156333550|NCT00142298|564319171|FG009|Overall Study|Adverse Event|0|||
156333551|NCT00142298|564319162|FG000|Overall Study|Clinical disease progression|1|||
156333552|NCT00142298|564319163|FG001|Overall Study|Clinical disease progression|0|||
156333553|NCT00142298|564319164|FG002|Overall Study|Clinical disease progression|0|||
156333554|NCT00142298|564319165|FG003|Overall Study|Clinical disease progression|0|||
156333555|NCT00142298|564319166|FG004|Overall Study|Clinical disease progression|0|||
156333556|NCT00142298|564319167|FG005|Overall Study|Clinical disease progression|0|||
156333557|NCT00142298|564319168|FG006|Overall Study|Clinical disease progression|0|||
156333558|NCT00142298|564319169|FG007|Overall Study|Clinical disease progression|0|||
156333559|NCT00142298|564319170|FG008|Overall Study|Clinical disease progression|0|||
156333560|NCT00142298|564319171|FG009|Overall Study|Clinical disease progression|0|||
156333561|NCT00142298|564319162|FG000|Overall Study|Death|1|||
156333562|NCT00142298|564319163|FG001|Overall Study|Death|1|||
156333563|NCT00142298|564319164|FG002|Overall Study|Death|1|||
156333564|NCT00142298|564319165|FG003|Overall Study|Death|0|||
156333565|NCT00142298|564319166|FG004|Overall Study|Death|0|||
156333566|NCT00142298|564319167|FG005|Overall Study|Death|6|||
156333567|NCT00142298|564319168|FG006|Overall Study|Death|0|||
156333568|NCT00142298|564319169|FG007|Overall Study|Death|0|||
156333569|NCT00142298|564319170|FG008|Overall Study|Death|0|||
156333570|NCT00142298|564319171|FG009|Overall Study|Death|0|||
156333571|NCT00142298|564319162|FG000|Overall Study|Lack of Efficacy|44|||
156333572|NCT00142298|564319163|FG001|Overall Study|Lack of Efficacy|62|||
156333573|NCT00142298|564319164|FG002|Overall Study|Lack of Efficacy|9|||
156333574|NCT00142298|564319165|FG003|Overall Study|Lack of Efficacy|12|||
156333575|NCT00142298|564319166|FG004|Overall Study|Lack of Efficacy|1|||
156333576|NCT00142298|564319167|FG005|Overall Study|Lack of Efficacy|0|||
156333577|NCT00142298|564319168|FG006|Overall Study|Lack of Efficacy|0|||
156333578|NCT00142298|564319169|FG007|Overall Study|Lack of Efficacy|1|||
156333579|NCT00142298|564319170|FG008|Overall Study|Lack of Efficacy|0|||
156333580|NCT00142298|564319171|FG009|Overall Study|Lack of Efficacy|0|||
156333581|NCT00142298|564319162|FG000|Overall Study|Non-compliance|15|||
156333582|NCT00142298|564319163|FG001|Overall Study|Non-compliance|13|||
156333583|NCT00142298|564319164|FG002|Overall Study|Non-compliance|0|||
156333584|NCT00142298|564319165|FG003|Overall Study|Non-compliance|6|||
156333585|NCT00142298|564319166|FG004|Overall Study|Non-compliance|1|||
156333586|NCT00142298|564319167|FG005|Overall Study|Non-compliance|0|||
156333587|NCT00142298|564319168|FG006|Overall Study|Non-compliance|0|||
156444128|NCT03398148|564718485|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444129|NCT03398148|564718486|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444130|NCT03398148|564718487|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444131|NCT03398148|564718488|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
156444132|NCT03398148|564718489|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
156444133|NCT03398148|564718490|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444134|NCT03398148|564718491|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444135|NCT03398148|564718492|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156874315|NCT00481091|566298601|FG002|Overall Study|No reason given|1|||
156874316|NCT00481091|566298602|FG003|Overall Study|No reason given|1|||
156874317|NCT00481091|566298603|FG004|Overall Study|No reason given|1|||
156874318|NCT00481091|566298604|FG005|Overall Study|No reason given|0|||
156874319|NCT00481091|566298605|FG006|Overall Study|No reason given|1|||
156874320|NCT00481091|566298606|FG007|Overall Study|No reason given|1|||
156874321|NCT00481091|566298607|FG008|Overall Study|No reason given|1|||
156874322|NCT00481091|566298608|FG009|Overall Study|No reason given|4|||
156444136|NCT03398148|564718493|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444137|NCT03398148|564718494|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444138|NCT03398148|564718495|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444139|NCT03398148|564718496|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156444140|NCT03398148|564718482|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
156444141|NCT03398148|564718483|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
156444142|NCT03398148|564718484|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
156444143|NCT03398148|564718485|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
156444144|NCT03398148|564718486|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
156444145|NCT03398148|564718487|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
156444146|NCT03398148|564718488|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
156444147|NCT03398148|564718489|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
156444148|NCT03398148|564718490|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
156444149|NCT03398148|564718491|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
156444150|NCT03398148|564718492|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
156444151|NCT03398148|564718493|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
156444152|NCT03398148|564718494|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
156444153|NCT03398148|564718495|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
156444154|NCT03398148|564718496|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
156444155|NCT03398148|564718482|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444156|NCT03398148|564718483|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444157|NCT03398148|564718484|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444158|NCT03398148|564718485|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444159|NCT03398148|564718486|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444160|NCT03398148|564718487|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444161|NCT03398148|564718488|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
156444162|NCT03398148|564718489|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444163|NCT03398148|564718490|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444164|NCT03398148|564718491|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444165|NCT03398148|564718492|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156714929|NCT02906670|565700823|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
156874323|NCT02881567|566298609|FG000|Overall Study|Adverse Event|1|||
156874324|NCT02881567|566298609|FG000|Overall Study|Lost to Follow-up|3|||
156714930|NCT02906670|565700824|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
156714931|NCT02906670|565700825|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
156874325|NCT02881567|566298609|FG000|Overall Study|Consent withdrawn|1|||
156874326|NCT02881567|566298609|FG000|Overall Study|Investigator decision|1|||
156874327|NCT02881567|566298609|FG000|Overall Study|Study terminated by sponsor|9|||
156874328|NCT02881567|566298609|FG000|Overall Study|Reason not Specified|3|||
156874329|NCT00373113|566298611|FG000|Overall Study|Death|1|||
156874330|NCT00373113|566298612|FG001|Overall Study|Death|7|||
156874331|NCT00373113|566298611|FG000|Overall Study|Adverse Event|38|||
156874332|NCT00373113|566298612|FG001|Overall Study|Adverse Event|24|||
156874333|NCT00373113|566298611|FG000|Overall Study|Study terminated by sponsor|9|||
156874334|NCT00373113|566298612|FG001|Overall Study|Study terminated by sponsor|1|||
156874335|NCT00373113|566298611|FG000|Overall Study|Global deterioration of health status|10|||
156874336|NCT00373113|566298612|FG001|Overall Study|Global deterioration of health status|7|||
156874337|NCT00373113|566298611|FG000|Overall Study|Lost to Follow-up|1|||
156874338|NCT00373113|566298612|FG001|Overall Study|Lost to Follow-up|3|||
156874339|NCT00373113|566298611|FG000|Overall Study|Objective progression or relapse|150|||
156874340|NCT00373113|566298612|FG001|Overall Study|Objective progression or relapse|169|||
156874341|NCT00373113|566298611|FG000|Overall Study|Other|14|||
156874342|NCT00373113|566298612|FG001|Overall Study|Other|17|||
156874343|NCT00373113|566298611|FG000|Overall Study|Protocol Violation|5|||
156874344|NCT00373113|566298612|FG001|Overall Study|Protocol Violation|1|||
156874345|NCT00373113|566298611|FG000|Overall Study|Withdrawal by Subject|10|||
156874346|NCT00373113|566298612|FG001|Overall Study|Withdrawal by Subject|15|||
156874347|NCT03275350|566298613|FG000|Overall Study|Lost to Follow-up|4|||
156874348|NCT03275350|566298614|FG001|Overall Study|Lost to Follow-up|6|||
156874349|NCT03275350|566298613|FG000|Overall Study|Death|2|||
156874350|NCT03275350|566298614|FG001|Overall Study|Death|1|||
156874351|NCT03275350|566298613|FG000|Overall Study|Physician Decision|1|||
156874352|NCT03275350|566298614|FG001|Overall Study|Physician Decision|0|||
156874353|NCT03275350|566298613|FG000|Overall Study|Incarcerated|1|||
156874354|NCT03275350|566298614|FG001|Overall Study|Incarcerated|1|||
156874355|NCT04661579|566298618|FG000|Overall Study|Lost to Follow-up|19|||
156874356|NCT04661579|566298619|FG001|Overall Study|Lost to Follow-up|10|||
156874357|NCT04661579|566298620|FG002|Overall Study|Lost to Follow-up|2|||
156874358|NCT04661579|566298621|FG003|Overall Study|Lost to Follow-up|7|||
156874359|NCT04661579|566298622|FG004|Overall Study|Lost to Follow-up|11|||
156874360|NCT04661579|566298618|FG000|Overall Study|Physician Decision|2|||
156874361|NCT04661579|566298619|FG001|Overall Study|Physician Decision|0|||
156874362|NCT04661579|566298620|FG002|Overall Study|Physician Decision|0|||
156874363|NCT04661579|566298621|FG003|Overall Study|Physician Decision|1|||
156874364|NCT04661579|566298622|FG004|Overall Study|Physician Decision|0|||
156874365|NCT04661579|566298618|FG000|Overall Study|Withdrawal by Subject|1|||
156874366|NCT04661579|566298619|FG001|Overall Study|Withdrawal by Subject|4|||
156874367|NCT04661579|566298620|FG002|Overall Study|Withdrawal by Subject|0|||
156874368|NCT04661579|566298621|FG003|Overall Study|Withdrawal by Subject|2|||
156874369|NCT04661579|566298622|FG004|Overall Study|Withdrawal by Subject|0|||
156874370|NCT04661579|566298618|FG000|Overall Study|Death|1|||
156874371|NCT04661579|566298619|FG001|Overall Study|Death|0|||
156874372|NCT04661579|566298620|FG002|Overall Study|Death|0|||
156874373|NCT04661579|566298621|FG003|Overall Study|Death|0|||
156874374|NCT04661579|566298622|FG004|Overall Study|Death|0|||
156874375|NCT04661579|566298618|FG000|Overall Study|Other|1|||
156874376|NCT04661579|566298619|FG001|Overall Study|Other|2|||
156874377|NCT04661579|566298620|FG002|Overall Study|Other|1|||
156874378|NCT04661579|566298621|FG003|Overall Study|Other|1|||
156874379|NCT04661579|566298622|FG004|Overall Study|Other|1|||
156874380|NCT04661579|566298618|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
156874381|NCT04661579|566298619|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
156874382|NCT04661579|566298620|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
156874383|NCT04661579|566298621|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
156874384|NCT04661579|566298622|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
156874385|NCT03656562|566298623|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
156874386|NCT03656562|566298624|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
156874387|NCT03656562|566298625|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
156874388|NCT03656562|566298626|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
156874389|NCT03656562|566298623|FG000|Overall Study|Physician Decision|1|||
156874390|NCT03656562|566298624|FG001|Overall Study|Physician Decision|2|||
156874391|NCT03656562|566298625|FG002|Overall Study|Physician Decision|0|||
156874392|NCT03656562|566298626|FG003|Overall Study|Physician Decision|0|||
156874393|NCT03656562|566298623|FG000|Overall Study|Subject Decision|3|||
156874394|NCT03656562|566298624|FG001|Overall Study|Subject Decision|5|||
156874395|NCT03656562|566298625|FG002|Overall Study|Subject Decision|0|||
156874396|NCT03656562|566298626|FG003|Overall Study|Subject Decision|2|||
156874397|NCT04335136|566298627|FG000|Overall Study|Death|8|||
156874398|NCT04335136|566298628|FG001|Overall Study|Death|4|||
156874399|NCT04335136|566298627|FG000|Overall Study|Lost to Follow-up|2|||
156874400|NCT04335136|566298628|FG001|Overall Study|Lost to Follow-up|0|||
156874401|NCT04335136|566298627|FG000|Overall Study|Protocol Violation|1|||
156444166|NCT03398148|564718493|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444167|NCT03398148|564718494|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444168|NCT03398148|564718495|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444169|NCT03398148|564718496|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156874402|NCT04335136|566298628|FG001|Overall Study|Protocol Violation|0|||
156444170|NCT03398148|564718482|FG000|Substudy 1 Period 2|Other|0|||
156444171|NCT03398148|564718483|FG001|Substudy 1 Period 2|Other|0|||
156444172|NCT03398148|564718484|FG002|Substudy 1 Period 2|Other|0|||
156444173|NCT03398148|564718485|FG003|Substudy 1 Period 2|Other|0|||
156444174|NCT03398148|564718486|FG004|Substudy 1 Period 2|Other|0|||
156444175|NCT03398148|564718487|FG005|Substudy 1 Period 2|Other|0|||
156444176|NCT03398148|564718488|FG006|Substudy 1 Period 2|Other|1|||
156444177|NCT03398148|564718489|FG007|Substudy 1 Period 2|Other|0|||
156444178|NCT03398148|564718490|FG008|Substudy 1 Period 2|Other|0|||
156444179|NCT03398148|564718491|FG009|Substudy 1 Period 2|Other|0|||
156444180|NCT03398148|564718492|FG010|Substudy 1 Period 2|Other|0|||
156444181|NCT03398148|564718493|FG011|Substudy 1 Period 2|Other|0|||
156444182|NCT03398148|564718494|FG012|Substudy 1 Period 2|Other|0|||
156444183|NCT03398148|564718495|FG013|Substudy 1 Period 2|Other|0|||
156874403|NCT04335136|566298627|FG000|Overall Study|Withdrawal by Subject|1|||
156874404|NCT04335136|566298628|FG001|Overall Study|Withdrawal by Subject|1|||
156874405|NCT04335136|566298627|FG000|Overall Study|Health-threatening condition|0|||
156444184|NCT03398148|564718496|FG014|Substudy 1 Period 2|Other|0|||
156874406|NCT04335136|566298628|FG001|Overall Study|Health-threatening condition|1|||
156874407|NCT04335136|566298627|FG000|Overall Study|Adverse Event|0|||
156444185|NCT03398148|564718482|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444186|NCT03398148|564718483|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444187|NCT03398148|564718484|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444188|NCT03398148|564718485|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444189|NCT03398148|564718486|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444190|NCT03398148|564718487|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444191|NCT03398148|564718488|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
156444192|NCT03398148|564718489|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444193|NCT03398148|564718490|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444194|NCT03398148|564718491|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444195|NCT03398148|564718492|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444196|NCT03398148|564718493|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444197|NCT03398148|564718494|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444198|NCT03398148|564718495|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444199|NCT03398148|564718496|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
156444200|NCT03398148|564718482|FG000|Substudy 2 Period 1|Adverse Event|0|||
156444201|NCT03398148|564718483|FG001|Substudy 2 Period 1|Adverse Event|0|||
156444202|NCT03398148|564718484|FG002|Substudy 2 Period 1|Adverse Event|0|||
156444203|NCT03398148|564718485|FG003|Substudy 2 Period 1|Adverse Event|0|||
156444204|NCT03398148|564718486|FG004|Substudy 2 Period 1|Adverse Event|0|||
156444205|NCT03398148|564718487|FG005|Substudy 2 Period 1|Adverse Event|0|||
156444206|NCT03398148|564718488|FG006|Substudy 2 Period 1|Adverse Event|0|||
156444207|NCT03398148|564718489|FG007|Substudy 2 Period 1|Adverse Event|0|||
156444208|NCT03398148|564718490|FG008|Substudy 2 Period 1|Adverse Event|0|||
156444209|NCT03398148|564718491|FG009|Substudy 2 Period 1|Adverse Event|12|||
156444210|NCT03398148|564718492|FG010|Substudy 2 Period 1|Adverse Event|2|||
156444211|NCT03398148|564718493|FG011|Substudy 2 Period 1|Adverse Event|0|||
156444212|NCT03398148|564718494|FG012|Substudy 2 Period 1|Adverse Event|0|||
156444213|NCT03398148|564718495|FG013|Substudy 2 Period 1|Adverse Event|0|||
156444214|NCT03398148|564718496|FG014|Substudy 2 Period 1|Adverse Event|0|||
156444215|NCT03398148|564718482|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444216|NCT03398148|564718483|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444217|NCT03398148|564718484|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444218|NCT03398148|564718485|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444219|NCT03398148|564718486|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444220|NCT03398148|564718487|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444221|NCT03398148|564718488|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444222|NCT03398148|564718489|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444223|NCT03398148|564718490|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444224|NCT03398148|564718491|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
156444225|NCT03398148|564718492|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
156444226|NCT03398148|564718493|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444227|NCT03398148|564718494|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444228|NCT03398148|564718495|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156444229|NCT03398148|564718496|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156874408|NCT04335136|566298628|FG001|Overall Study|Adverse Event|1|||
156874409|NCT04335136|566298627|FG000|Overall Study|Erroneously randomized|2|||
156874410|NCT04335136|566298628|FG001|Overall Study|Erroneously randomized|0|||
156874411|NCT01396447|566298629|FG000|Overall Study|Did Not Receive Treatment|3|||
156874412|NCT01396447|566298630|FG001|Overall Study|Did Not Receive Treatment|2|||
156874413|NCT01396447|566298631|FG002|Overall Study|Did Not Receive Treatment|1|||
156874414|NCT01396447|566298632|FG003|Overall Study|Did Not Receive Treatment|0|||
156874415|NCT01396447|566298629|FG000|Overall Study|Adverse Event|15|||
156874416|NCT01396447|566298630|FG001|Overall Study|Adverse Event|12|||
156874417|NCT01396447|566298631|FG002|Overall Study|Adverse Event|12|||
156874418|NCT01396447|566298632|FG003|Overall Study|Adverse Event|17|||
156874419|NCT01396447|566298629|FG000|Overall Study|Insufficient Therapeutic Response|5|||
156874420|NCT01396447|566298630|FG001|Overall Study|Insufficient Therapeutic Response|5|||
156874421|NCT01396447|566298631|FG002|Overall Study|Insufficient Therapeutic Response|2|||
156874422|NCT01396447|566298632|FG003|Overall Study|Insufficient Therapeutic Response|4|||
156874423|NCT01396447|566298629|FG000|Overall Study|Protocol Violation|5|||
156874424|NCT01396447|566298630|FG001|Overall Study|Protocol Violation|2|||
156444230|NCT03398148|564718482|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
156444231|NCT03398148|564718483|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
156444232|NCT03398148|564718484|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
156444233|NCT03398148|564718485|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
156444234|NCT03398148|564718486|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
156444235|NCT03398148|564718487|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
156444236|NCT03398148|564718488|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
156444237|NCT03398148|564718489|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
156444238|NCT03398148|564718490|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
156444239|NCT03398148|564718491|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
156714932|NCT02906670|565700826|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
156874425|NCT01396447|566298631|FG002|Overall Study|Protocol Violation|3|||
156874426|NCT01396447|566298632|FG003|Overall Study|Protocol Violation|7|||
156874427|NCT01396447|566298629|FG000|Overall Study|Withdrawal of Consent|11|||
156333588|NCT00142298|564319169|FG007|Overall Study|Non-compliance|3|||
156333589|NCT00142298|564319170|FG008|Overall Study|Non-compliance|3|||
156333590|NCT00142298|564319171|FG009|Overall Study|Non-compliance|0|||
156333591|NCT00142298|564319162|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
156333592|NCT00142298|564319163|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
156333593|NCT00142298|564319164|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
156444240|NCT03398148|564718492|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
156444241|NCT03398148|564718493|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
156444242|NCT03398148|564718494|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
156444243|NCT03398148|564718495|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
156444244|NCT03398148|564718496|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
156444245|NCT03398148|564718482|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444246|NCT03398148|564718483|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444247|NCT03398148|564718484|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444248|NCT03398148|564718485|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444249|NCT03398148|564718486|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444250|NCT03398148|564718487|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444251|NCT03398148|564718488|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444252|NCT03398148|564718489|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444253|NCT03398148|564718490|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444254|NCT03398148|564718491|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444255|NCT03398148|564718492|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
156444256|NCT03398148|564718493|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444257|NCT03398148|564718494|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444258|NCT03398148|564718495|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444259|NCT03398148|564718496|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
156444260|NCT03398148|564718482|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444261|NCT03398148|564718483|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444262|NCT03398148|564718484|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444263|NCT03398148|564718485|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444264|NCT03398148|564718486|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444265|NCT03398148|564718487|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444266|NCT03398148|564718488|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444267|NCT03398148|564718489|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444268|NCT03398148|564718490|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444269|NCT03398148|564718491|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444270|NCT03398148|564718492|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
156444271|NCT03398148|564718493|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444272|NCT03398148|564718494|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444273|NCT03398148|564718495|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156444274|NCT03398148|564718496|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156532464|NCT01233869|565045027|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
156532465|NCT01233869|565045028|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
156532466|NCT01233869|565045029|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
156792798|NCT03829683|565994756|FG000|Overall Study|Physician Decision|3|||
156333594|NCT00142298|564319165|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
156333595|NCT00142298|564319166|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
156333596|NCT00142298|564319167|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
156444275|NCT03398148|564718482|FG000|Substudy 2 Period 1|Other|0|||
156444276|NCT03398148|564718483|FG001|Substudy 2 Period 1|Other|0|||
156444277|NCT03398148|564718484|FG002|Substudy 2 Period 1|Other|0|||
156444278|NCT03398148|564718485|FG003|Substudy 2 Period 1|Other|0|||
156444279|NCT03398148|564718486|FG004|Substudy 2 Period 1|Other|0|||
156444280|NCT03398148|564718487|FG005|Substudy 2 Period 1|Other|0|||
156444281|NCT03398148|564718488|FG006|Substudy 2 Period 1|Other|0|||
156444282|NCT03398148|564718489|FG007|Substudy 2 Period 1|Other|0|||
156444283|NCT03398148|564718490|FG008|Substudy 2 Period 1|Other|0|||
156444284|NCT03398148|564718491|FG009|Substudy 2 Period 1|Other|4|||
156444285|NCT03398148|564718492|FG010|Substudy 2 Period 1|Other|4|||
156444286|NCT03398148|564718493|FG011|Substudy 2 Period 1|Other|0|||
156444287|NCT03398148|564718494|FG012|Substudy 2 Period 1|Other|0|||
156444288|NCT03398148|564718495|FG013|Substudy 2 Period 1|Other|0|||
156444289|NCT03398148|564718496|FG014|Substudy 2 Period 1|Other|0|||
156444290|NCT03398148|564718482|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444291|NCT03398148|564718483|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
156792799|NCT03829683|565994757|FG001|Overall Study|Physician Decision|1|||
156792800|NCT03829683|565994756|FG000|Overall Study|Withdrawal by Subject|0|||
156792801|NCT03829683|565994757|FG001|Overall Study|Withdrawal by Subject|1|||
156792802|NCT03829683|565994756|FG000|Overall Study|Discharge from hospital|1|||
156792803|NCT03829683|565994757|FG001|Overall Study|Discharge from hospital|0|||
156792804|NCT04629521|565994766|FG000|Overall Study|Death|1|||
156792805|NCT04629521|565994766|FG000|Overall Study|Lost to Follow-up|3|||
156792806|NCT04629521|565994766|FG000|Overall Study|Subject withdrew consent|3|||
156792807|NCT04629521|565994766|FG000|Overall Study|Enrolled in error|1|||
156792808|NCT03163667|565994767|FG000|Overall Study|Death|15|||
156792809|NCT03163667|565994768|FG001|Overall Study|Death|27|||
156792810|NCT03163667|565994767|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
156792811|NCT03163667|565994768|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
156792812|NCT01335685|565994769|FG000|Overall Study|Study Terminated by Sponsor|2|||
156333597|NCT00142298|564319168|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
156333598|NCT00142298|564319169|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
156333599|NCT00142298|564319170|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
156333600|NCT00142298|564319171|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
156333601|NCT00142298|564319162|FG000|Overall Study|Pregnancy|4|||
156333602|NCT00142298|564319163|FG001|Overall Study|Pregnancy|4|||
156333603|NCT00142298|564319164|FG002|Overall Study|Pregnancy|2|||
156333604|NCT00142298|564319165|FG003|Overall Study|Pregnancy|3|||
156333605|NCT00142298|564319166|FG004|Overall Study|Pregnancy|0|||
156333606|NCT00142298|564319167|FG005|Overall Study|Pregnancy|0|||
156333607|NCT00142298|564319168|FG006|Overall Study|Pregnancy|0|||
156333608|NCT00142298|564319169|FG007|Overall Study|Pregnancy|0|||
156333609|NCT00142298|564319170|FG008|Overall Study|Pregnancy|1|||
156333610|NCT00142298|564319171|FG009|Overall Study|Pregnancy|0|||
156333611|NCT00142298|564319162|FG000|Overall Study|Virologic breakthrough|19|||
156333612|NCT00142298|564319163|FG001|Overall Study|Virologic breakthrough|23|||
156333613|NCT00142298|564319164|FG002|Overall Study|Virologic breakthrough|9|||
156333614|NCT00142298|564319165|FG003|Overall Study|Virologic breakthrough|7|||
156333615|NCT00142298|564319166|FG004|Overall Study|Virologic breakthrough|2|||
156333616|NCT00142298|564319167|FG005|Overall Study|Virologic breakthrough|3|||
156333617|NCT00142298|564319168|FG006|Overall Study|Virologic breakthrough|3|||
156333618|NCT00142298|564319169|FG007|Overall Study|Virologic breakthrough|0|||
156333619|NCT00142298|564319170|FG008|Overall Study|Virologic breakthrough|0|||
156333620|NCT00142298|564319171|FG009|Overall Study|Virologic breakthrough|0|||
156333621|NCT00142298|564319162|FG000|Overall Study|Other- not specified|0|||
156333622|NCT00142298|564319163|FG001|Overall Study|Other- not specified|3|||
156333623|NCT00142298|564319164|FG002|Overall Study|Other- not specified|0|||
156333624|NCT00142298|564319165|FG003|Overall Study|Other- not specified|1|||
156333625|NCT00142298|564319166|FG004|Overall Study|Other- not specified|0|||
156333626|NCT00142298|564319167|FG005|Overall Study|Other- not specified|0|||
156333627|NCT00142298|564319168|FG006|Overall Study|Other- not specified|0|||
156333628|NCT00142298|564319169|FG007|Overall Study|Other- not specified|0|||
156333629|NCT00142298|564319170|FG008|Overall Study|Other- not specified|0|||
156333630|NCT00142298|564319171|FG009|Overall Study|Other- not specified|0|||
156333631|NCT00142298|564319162|FG000|Overall Study|Lost to Follow-up|0|||
156333632|NCT00142298|564319163|FG001|Overall Study|Lost to Follow-up|0|||
156333633|NCT00142298|564319164|FG002|Overall Study|Lost to Follow-up|0|||
156333634|NCT00142298|564319165|FG003|Overall Study|Lost to Follow-up|0|||
156333635|NCT00142298|564319166|FG004|Overall Study|Lost to Follow-up|0|||
156333636|NCT00142298|564319167|FG005|Overall Study|Lost to Follow-up|0|||
156333637|NCT00142298|564319168|FG006|Overall Study|Lost to Follow-up|2|||
156333638|NCT00142298|564319169|FG007|Overall Study|Lost to Follow-up|0|||
156333639|NCT00142298|564319170|FG008|Overall Study|Lost to Follow-up|0|||
156333640|NCT00142298|564319171|FG009|Overall Study|Lost to Follow-up|0|||
156333641|NCT00142298|564319162|FG000|Overall Study|Treatment Failure|0|||
156333642|NCT00142298|564319163|FG001|Overall Study|Treatment Failure|0|||
156333643|NCT00142298|564319164|FG002|Overall Study|Treatment Failure|0|||
156333644|NCT00142298|564319165|FG003|Overall Study|Treatment Failure|0|||
156333645|NCT00142298|564319166|FG004|Overall Study|Treatment Failure|0|||
156333646|NCT00142298|564319167|FG005|Overall Study|Treatment Failure|2|||
156333647|NCT00142298|564319168|FG006|Overall Study|Treatment Failure|2|||
156333648|NCT00142298|564319169|FG007|Overall Study|Treatment Failure|0|||
156333649|NCT00142298|564319170|FG008|Overall Study|Treatment Failure|0|||
156333650|NCT00142298|564319171|FG009|Overall Study|Treatment Failure|0|||
156333651|NCT02423772|564319173|FG000|Overall Study|Lost to Follow-up|3|||
156333652|NCT02423772|564319174|FG001|Overall Study|Lost to Follow-up|3|||
156333653|NCT02423772|564319173|FG000|Overall Study|Did not begin intervention|2|||
156333654|NCT02423772|564319174|FG001|Overall Study|Did not begin intervention|5|||
156333655|NCT02612129|564319175|FG000|Single Dose Treatment Period|Screening Failure|1|||
156333656|NCT02612129|564319176|FG001|Single Dose Treatment Period|Screening Failure|0|||
156333657|NCT02612129|564319177|FG002|Single Dose Treatment Period|Screening Failure|0|||
156333658|NCT02612129|564319175|FG000|Continuous Treatment Period|Early Escape|0|||
156333659|NCT02612129|564319176|FG001|Continuous Treatment Period|Early Escape|2|||
156333660|NCT02612129|564319177|FG002|Continuous Treatment Period|Early Escape|0|||
156333661|NCT02612129|564319175|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
156333662|NCT02612129|564319176|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
156333663|NCT02612129|564319177|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
156333664|NCT02612129|564319175|FG000|Continuous Treatment Period|Safety Reasons|0|||
156333665|NCT02612129|564319176|FG001|Continuous Treatment Period|Safety Reasons|3|||
156333666|NCT02612129|564319177|FG002|Continuous Treatment Period|Safety Reasons|0|||
156333667|NCT02612129|564319175|FG000|Continuous Treatment Period|Death|0|||
156333668|NCT02612129|564319176|FG001|Continuous Treatment Period|Death|1|||
156333669|NCT02612129|564319177|FG002|Continuous Treatment Period|Death|0|||
156333670|NCT02612129|564319175|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
156333671|NCT02612129|564319176|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
156333672|NCT02612129|564319177|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
156333673|NCT01066000|564319178|FG000|Overall Study|Protocol Violation|4|||
156333674|NCT01066000|564319178|FG000|Overall Study|Death|3|||
156333675|NCT01066000|564319178|FG000|Overall Study|Withdrawal by Subject|1|||
156333676|NCT01066000|564319178|FG000|Overall Study|Adverse Event|1|||
156333677|NCT01386008|564319179|FG000|Overall Study|exited w/o incident /study discontinued|17|||
156333678|NCT01386008|564319179|FG000|Overall Study|Adverse Event|3|||
156333679|NCT00566111|564319180|FG000|Overall Study|Adverse Event|0|||
156333680|NCT00566111|564319181|FG001|Overall Study|Adverse Event|2|||
156333681|NCT04449861|564319182|FG000|Overall Study|Withdrawal by Subject|4|||
156333682|NCT04449861|564319182|FG000|Overall Study|Lost to Follow-up|5|||
156333683|NCT04449861|564319182|FG000|Overall Study|Death|112|||
156333684|NCT02323113|564320845|FG000|Overall Study|Adverse Event|3|||
156333685|NCT02323113|564320846|FG001|Overall Study|Adverse Event|3|||
156333686|NCT02323113|564320847|FG002|Overall Study|Adverse Event|2|||
156333687|NCT02323113|564320848|FG003|Overall Study|Adverse Event|5|||
156333688|NCT02323113|564320849|FG004|Overall Study|Adverse Event|8|||
156333689|NCT02323113|564320850|FG005|Overall Study|Adverse Event|3|||
156333690|NCT02323113|564320851|FG006|Overall Study|Adverse Event|6|||
156333691|NCT02323113|564320852|FG007|Overall Study|Adverse Event|0|||
156333692|NCT02323113|564320845|FG000|Overall Study|Progressive Disease|0|||
156333693|NCT02323113|564320846|FG001|Overall Study|Progressive Disease|1|||
156333694|NCT02323113|564320847|FG002|Overall Study|Progressive Disease|1|||
156333695|NCT02323113|564320848|FG003|Overall Study|Progressive Disease|0|||
156333696|NCT02323113|564320849|FG004|Overall Study|Progressive Disease|0|||
156333697|NCT02323113|564320850|FG005|Overall Study|Progressive Disease|3|||
156333698|NCT02323113|564320851|FG006|Overall Study|Progressive Disease|0|||
156333699|NCT02323113|564320852|FG007|Overall Study|Progressive Disease|0|||
156333700|NCT02323113|564320845|FG000|Overall Study|Symptomatic Deterioration|0|||
156333701|NCT02323113|564320846|FG001|Overall Study|Symptomatic Deterioration|0|||
156444292|NCT03398148|564718484|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
156874428|NCT01396447|566298630|FG001|Overall Study|Withdrawal of Consent|9|||
156874429|NCT01396447|566298631|FG002|Overall Study|Withdrawal of Consent|4|||
156874430|NCT01396447|566298632|FG003|Overall Study|Withdrawal of Consent|15|||
156874431|NCT01396447|566298629|FG000|Overall Study|Lost to Follow-up|4|||
156874432|NCT01396447|566298630|FG001|Overall Study|Lost to Follow-up|8|||
156874433|NCT01396447|566298631|FG002|Overall Study|Lost to Follow-up|7|||
156874434|NCT01396447|566298632|FG003|Overall Study|Lost to Follow-up|9|||
156874435|NCT01396447|566298629|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156874436|NCT01396447|566298630|FG001|Overall Study|Other Miscellaneous Reasons|2|||
156874437|NCT01396447|566298631|FG002|Overall Study|Other Miscellaneous Reasons|1|||
156874438|NCT01396447|566298632|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156874439|NCT01402102|566298634|FG000|Overall Study|Protocol Violation|1|||
156874440|NCT01402102|566298635|FG001|Overall Study|Protocol Violation|0|||
156874441|NCT01402102|566298634|FG000|Overall Study|Insufficiency of compliance|1|||
156874442|NCT01402102|566298635|FG001|Overall Study|Insufficiency of compliance|1|||
156874443|NCT01402102|566298634|FG000|Overall Study|Withdrawal by Subject|0|||
156874444|NCT01402102|566298635|FG001|Overall Study|Withdrawal by Subject|2|||
156874445|NCT00905645|566298636|FG000|Overall Study|Death (not device related)|10|||
156874446|NCT00905645|566298637|FG001|Overall Study|Death (not device related)|4|||
156444293|NCT03398148|564718485|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444294|NCT03398148|564718486|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444295|NCT03398148|564718487|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444296|NCT03398148|564718488|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444297|NCT03398148|564718489|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444298|NCT03398148|564718490|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
156874447|NCT00905645|566298638|FG002|Overall Study|Death (not device related)|15|||
156874448|NCT00905645|566298639|FG003|Overall Study|Death (not device related)|8|||
156333702|NCT02323113|564320847|FG002|Overall Study|Symptomatic Deterioration|1|||
156333703|NCT02323113|564320848|FG003|Overall Study|Symptomatic Deterioration|0|||
156333704|NCT02323113|564320849|FG004|Overall Study|Symptomatic Deterioration|1|||
156333705|NCT02323113|564320850|FG005|Overall Study|Symptomatic Deterioration|0|||
156444299|NCT03398148|564718491|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
156333706|NCT02323113|564320851|FG006|Overall Study|Symptomatic Deterioration|0|||
156333707|NCT02323113|564320852|FG007|Overall Study|Symptomatic Deterioration|0|||
156874449|NCT00905645|566298636|FG000|Overall Study|Explantation of study device(s)|78|||
156874450|NCT00905645|566298637|FG001|Overall Study|Explantation of study device(s)|47|||
156333708|NCT02323113|564320845|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
156333709|NCT02323113|564320846|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
156444300|NCT03398148|564718492|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
156444301|NCT03398148|564718493|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444302|NCT03398148|564718494|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444303|NCT03398148|564718495|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444304|NCT03398148|564718496|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
156444305|NCT03398148|564718482|FG000|Substudy 2 Period 2|Adverse Event|0|||
156444306|NCT03398148|564718483|FG001|Substudy 2 Period 2|Adverse Event|0|||
156444307|NCT03398148|564718484|FG002|Substudy 2 Period 2|Adverse Event|0|||
156444308|NCT03398148|564718485|FG003|Substudy 2 Period 2|Adverse Event|0|||
156444309|NCT03398148|564718486|FG004|Substudy 2 Period 2|Adverse Event|0|||
156444310|NCT03398148|564718487|FG005|Substudy 2 Period 2|Adverse Event|0|||
156444311|NCT03398148|564718488|FG006|Substudy 2 Period 2|Adverse Event|0|||
156444312|NCT03398148|564718489|FG007|Substudy 2 Period 2|Adverse Event|0|||
156444313|NCT03398148|564718490|FG008|Substudy 2 Period 2|Adverse Event|0|||
156444314|NCT03398148|564718491|FG009|Substudy 2 Period 2|Adverse Event|0|||
156444315|NCT03398148|564718492|FG010|Substudy 2 Period 2|Adverse Event|0|||
156444316|NCT03398148|564718493|FG011|Substudy 2 Period 2|Adverse Event|0|||
156444317|NCT03398148|564718494|FG012|Substudy 2 Period 2|Adverse Event|0|||
156444318|NCT03398148|564718495|FG013|Substudy 2 Period 2|Adverse Event|1|||
156444319|NCT03398148|564718496|FG014|Substudy 2 Period 2|Adverse Event|3|||
156444320|NCT03398148|564718482|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
156444321|NCT03398148|564718483|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
156444322|NCT03398148|564718484|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
156444323|NCT03398148|564718485|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
156444324|NCT03398148|564718486|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
156444325|NCT03398148|564718487|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
156444326|NCT03398148|564718488|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
156444327|NCT03398148|564718489|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
156444328|NCT03398148|564718490|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
156444329|NCT03398148|564718491|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
156444330|NCT03398148|564718492|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
156444331|NCT03398148|564718493|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
156444332|NCT03398148|564718494|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
156444333|NCT03398148|564718495|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
156444334|NCT03398148|564718496|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
156444335|NCT03398148|564718482|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444336|NCT03398148|564718483|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444337|NCT03398148|564718484|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444338|NCT03398148|564718485|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444339|NCT03398148|564718486|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444340|NCT03398148|564718487|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444341|NCT03398148|564718488|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444342|NCT03398148|564718489|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444343|NCT03398148|564718490|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444344|NCT03398148|564718491|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156714933|NCT02906670|565700827|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
156444345|NCT03398148|564718492|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444346|NCT03398148|564718493|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
156444347|NCT03398148|564718494|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156444348|NCT03398148|564718495|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
156444349|NCT03398148|564718496|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
156808774|NCT03801928|566054463|FG004|Overall Study|Adverse Event|0|||
156808775|NCT03801928|566054464|FG005|Overall Study|Adverse Event|2|||
156808776|NCT03801928|566054459|FG000|Overall Study|Lack of Efficacy|0|||
156808777|NCT03801928|566054460|FG001|Overall Study|Lack of Efficacy|0|||
156808778|NCT03801928|566054461|FG002|Overall Study|Lack of Efficacy|1|||
156808779|NCT03801928|566054462|FG003|Overall Study|Lack of Efficacy|0|||
156808780|NCT03801928|566054463|FG004|Overall Study|Lack of Efficacy|0|||
156808781|NCT03801928|566054464|FG005|Overall Study|Lack of Efficacy|0|||
156808782|NCT03801928|566054459|FG000|Overall Study|Lost to Follow-up|5|||
156808783|NCT03801928|566054460|FG001|Overall Study|Lost to Follow-up|1|||
156808784|NCT03801928|566054461|FG002|Overall Study|Lost to Follow-up|1|||
156808785|NCT03801928|566054462|FG003|Overall Study|Lost to Follow-up|4|||
156808786|NCT03801928|566054463|FG004|Overall Study|Lost to Follow-up|4|||
156808787|NCT03801928|566054464|FG005|Overall Study|Lost to Follow-up|2|||
156808788|NCT03801928|566054459|FG000|Overall Study|Withdrawal by Subject|0|||
156808789|NCT03801928|566054460|FG001|Overall Study|Withdrawal by Subject|0|||
156808790|NCT03801928|566054461|FG002|Overall Study|Withdrawal by Subject|2|||
156808791|NCT03801928|566054462|FG003|Overall Study|Withdrawal by Subject|1|||
156808792|NCT03801928|566054463|FG004|Overall Study|Withdrawal by Subject|0|||
156808793|NCT03801928|566054464|FG005|Overall Study|Withdrawal by Subject|0|||
156808794|NCT03801928|566054459|FG000|Overall Study|Other|0|||
156808795|NCT03801928|566054460|FG001|Overall Study|Other|2|||
156808796|NCT03801928|566054461|FG002|Overall Study|Other|0|||
156808797|NCT03801928|566054462|FG003|Overall Study|Other|1|||
156808798|NCT03801928|566054463|FG004|Overall Study|Other|0|||
156808799|NCT03801928|566054464|FG005|Overall Study|Other|1|||
156874451|NCT00905645|566298638|FG002|Overall Study|Explantation of study device(s)|28|||
156874452|NCT00905645|566298639|FG003|Overall Study|Explantation of study device(s)|21|||
156874453|NCT00905645|566298636|FG000|Overall Study|Subject Request|41|||
156874454|NCT00905645|566298637|FG001|Overall Study|Subject Request|17|||
156874455|NCT00905645|566298638|FG002|Overall Study|Subject Request|13|||
156874456|NCT00905645|566298639|FG003|Overall Study|Subject Request|11|||
156874457|NCT00905645|566298636|FG000|Overall Study|Lost to Follow-up|299|||
156874458|NCT00905645|566298637|FG001|Overall Study|Lost to Follow-up|103|||
156874459|NCT00905645|566298638|FG002|Overall Study|Lost to Follow-up|51|||
156874460|NCT00905645|566298639|FG003|Overall Study|Lost to Follow-up|12|||
156874461|NCT01386970|566298640|FG000|Overall Study|Withdrawal by Subject|0|||
156874462|NCT01386970|566298641|FG001|Overall Study|Withdrawal by Subject|1|||
156874463|NCT01386970|566298640|FG000|Overall Study|Adverse Event|4|||
156874464|NCT01386970|566298641|FG001|Overall Study|Adverse Event|1|||
156874465|NCT04881942|566298643|FG000|Overall Study|Adverse Event|0|||
156874466|NCT04881942|566298644|FG001|Overall Study|Adverse Event|0|||
156874467|NCT04881942|566298645|FG002|Overall Study|Adverse Event|0|||
156874468|NCT04881942|566298646|FG003|Overall Study|Adverse Event|0|||
156874469|NCT04881942|566298647|FG004|Overall Study|Adverse Event|1|||
156874470|NCT04881942|566298643|FG000|Overall Study|Alternates|0|||
156874471|NCT04881942|566298644|FG001|Overall Study|Alternates|0|||
156874472|NCT04881942|566298645|FG002|Overall Study|Alternates|0|||
156874473|NCT04881942|566298646|FG003|Overall Study|Alternates|0|||
156874474|NCT04881942|566298647|FG004|Overall Study|Alternates|2|||
156874475|NCT02423902|566298648|FG000|Overall Study|Disease progression|1|||
156874476|NCT02423902|566298649|FG001|Overall Study|Disease progression|4|||
156874477|NCT02136069|566298650|FG000|Overall Study|UC flare-up|1|||
156874478|NCT02136069|566298651|FG001|Overall Study|UC flare-up|0|||
156874479|NCT02136069|566298650|FG000|Overall Study|Adverse Event|6|||
156874480|NCT02136069|566298651|FG001|Overall Study|Adverse Event|8|||
156874481|NCT02136069|566298650|FG000|Overall Study|Death|0|||
156874482|NCT02136069|566298651|FG001|Overall Study|Death|1|||
156874483|NCT02136069|566298650|FG000|Overall Study|Lack of Efficacy|10|||
156874484|NCT02136069|566298651|FG001|Overall Study|Lack of Efficacy|4|||
156874485|NCT02136069|566298650|FG000|Overall Study|Lost to Follow-up|1|||
156874486|NCT02136069|566298651|FG001|Overall Study|Lost to Follow-up|0|||
156874487|NCT02136069|566298650|FG000|Overall Study|Non-Compliance|1|||
156874488|NCT02136069|566298651|FG001|Overall Study|Non-Compliance|0|||
156874489|NCT02136069|566298650|FG000|Overall Study|Physician Decision|5|||
156874490|NCT02136069|566298651|FG001|Overall Study|Physician Decision|4|||
156874491|NCT02136069|566298650|FG000|Overall Study|Withdrawal by Subject|10|||
156874492|NCT02136069|566298651|FG001|Overall Study|Withdrawal by Subject|11|||
156874493|NCT04838626|566298652|FG000|Overall Study|Adverse Event|2|||
156874494|NCT04838626|566298652|FG000|Overall Study|Physician Decision|6|||
156874495|NCT04838626|566298652|FG000|Overall Study|Protocol Violation|3|||
156874496|NCT04838626|566298652|FG000|Overall Study|Withdrawal by Subject|9|||
156874497|NCT04838626|566298652|FG000|Overall Study|Technical Problems|2|||
156874498|NCT00578292|566298655|FG000|Overall Study|Death|1|||
156874499|NCT00578292|566298655|FG000|Overall Study|Graft failure|2|||
156874500|NCT01026324|566298656|FG000|Follow up/Survival|Withdrawal by Subject|1|||
156874501|NCT01026324|566298657|FG001|Follow up/Survival|Withdrawal by Subject|0|||
156874502|NCT01026324|566298658|FG002|Follow up/Survival|Withdrawal by Subject|0|||
156874503|NCT01032889|566298663|FG000|Overall Study|Adverse Event|2|||
156874504|NCT01032889|566298664|FG001|Overall Study|Adverse Event|2|||
156874505|NCT01032889|566298665|FG002|Overall Study|Adverse Event|0|||
156874506|NCT01032889|566298663|FG000|Overall Study|Withdrawal of Consent|1|||
156874507|NCT01032889|566298664|FG001|Overall Study|Withdrawal of Consent|2|||
156874508|NCT01032889|566298665|FG002|Overall Study|Withdrawal of Consent|1|||
156874509|NCT01032889|566298663|FG000|Overall Study|Patient Request|0|||
156874510|NCT01032889|566298664|FG001|Overall Study|Patient Request|1|||
156874511|NCT01032889|566298665|FG002|Overall Study|Patient Request|0|||
156874512|NCT01032889|566298663|FG000|Overall Study|Lost to Follow-up|1|||
156874513|NCT01032889|566298664|FG001|Overall Study|Lost to Follow-up|1|||
156333710|NCT02323113|564320847|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
156333711|NCT02323113|564320848|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
156333712|NCT02323113|564320849|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
156333713|NCT02323113|564320850|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
156874514|NCT01032889|566298665|FG002|Overall Study|Lost to Follow-up|0|||
156874515|NCT01032889|566298663|FG000|Overall Study|Lack of Submental Fat|2|||
156874516|NCT01032889|566298664|FG001|Overall Study|Lack of Submental Fat|8|||
156874517|NCT01032889|566298665|FG002|Overall Study|Lack of Submental Fat|1|||
156874518|NCT01032889|566298663|FG000|Overall Study|Miscellaneous Reasons|2|||
156874519|NCT01032889|566298664|FG001|Overall Study|Miscellaneous Reasons|1|||
156874520|NCT01032889|566298665|FG002|Overall Study|Miscellaneous Reasons|1|||
156874521|NCT02442804|566298666|FG000|Overall Study|Withdrawal by Subject|0|||
156874522|NCT02442804|566298667|FG001|Overall Study|Withdrawal by Subject|1|||
156333714|NCT02323113|564320851|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
156874523|NCT02442804|566298666|FG000|Overall Study|Adverse Event|1|||
156874524|NCT02442804|566298667|FG001|Overall Study|Adverse Event|0|||
156714934|NCT02906670|565700818|FG000|Cohort 4P, QW|Radiological Progression|0|||
156874525|NCT02624986|566298671|FG000|Overall Study|Death|0|||
156874526|NCT02624986|566298672|FG001|Overall Study|Death|1|||
156874527|NCT02624986|566298673|FG002|Overall Study|Death|2|||
156874528|NCT02624986|566298674|FG003|Overall Study|Death|2|||
156874529|NCT02624986|566298675|FG004|Overall Study|Death|2|||
156874530|NCT02624986|566298676|FG005|Overall Study|Death|0|||
156874531|NCT02624986|566298677|FG006|Overall Study|Death|0|||
156874532|NCT02624986|566298678|FG007|Overall Study|Death|1|||
156874533|NCT02624986|566298671|FG000|Overall Study|Study Terminated by Sponsor|1|||
156874534|NCT02624986|566298672|FG001|Overall Study|Study Terminated by Sponsor|1|||
156874535|NCT02624986|566298673|FG002|Overall Study|Study Terminated by Sponsor|0|||
156874536|NCT02624986|566298674|FG003|Overall Study|Study Terminated by Sponsor|1|||
156874537|NCT02624986|566298675|FG004|Overall Study|Study Terminated by Sponsor|2|||
156874538|NCT02624986|566298676|FG005|Overall Study|Study Terminated by Sponsor|2|||
156874539|NCT02624986|566298677|FG006|Overall Study|Study Terminated by Sponsor|4|||
156874540|NCT02624986|566298678|FG007|Overall Study|Study Terminated by Sponsor|3|||
156874541|NCT02624986|566298671|FG000|Overall Study|Progressive Disease|0|||
156874542|NCT02624986|566298672|FG001|Overall Study|Progressive Disease|1|||
156874543|NCT02624986|566298673|FG002|Overall Study|Progressive Disease|0|||
156874544|NCT02624986|566298674|FG003|Overall Study|Progressive Disease|0|||
156874545|NCT02624986|566298675|FG004|Overall Study|Progressive Disease|0|||
156874546|NCT02624986|566298676|FG005|Overall Study|Progressive Disease|0|||
156874547|NCT02624986|566298677|FG006|Overall Study|Progressive Disease|0|||
156874548|NCT02624986|566298678|FG007|Overall Study|Progressive Disease|0|||
156874549|NCT02624986|566298671|FG000|Overall Study|Protocol Violation|1|||
156874550|NCT02624986|566298672|FG001|Overall Study|Protocol Violation|0|||
156874551|NCT02624986|566298673|FG002|Overall Study|Protocol Violation|0|||
156874552|NCT02624986|566298674|FG003|Overall Study|Protocol Violation|0|||
156874553|NCT02624986|566298675|FG004|Overall Study|Protocol Violation|0|||
156874554|NCT02624986|566298676|FG005|Overall Study|Protocol Violation|0|||
156874555|NCT02624986|566298677|FG006|Overall Study|Protocol Violation|0|||
156874556|NCT02624986|566298678|FG007|Overall Study|Protocol Violation|0|||
156874557|NCT02624986|566298671|FG000|Overall Study|Withdrawal by Subject|0|||
156874558|NCT02624986|566298672|FG001|Overall Study|Withdrawal by Subject|0|||
156874559|NCT02624986|566298673|FG002|Overall Study|Withdrawal by Subject|0|||
156874560|NCT02624986|566298674|FG003|Overall Study|Withdrawal by Subject|0|||
156874561|NCT02624986|566298675|FG004|Overall Study|Withdrawal by Subject|0|||
156874562|NCT02624986|566298676|FG005|Overall Study|Withdrawal by Subject|0|||
156874563|NCT02624986|566298677|FG006|Overall Study|Withdrawal by Subject|0|||
156874564|NCT02624986|566298678|FG007|Overall Study|Withdrawal by Subject|1|||
156874565|NCT03532451|566298682|FG000|Overall Study|Withdrawal by Subject|0|||
156874566|NCT03532451|566298683|FG001|Overall Study|Withdrawal by Subject|1|||
156874567|NCT03532451|566298682|FG000|Overall Study|Did not undergo surgery|1|||
156874568|NCT03532451|566298683|FG001|Overall Study|Did not undergo surgery|1|||
156874569|NCT02527421|566298684|FG000|Overall Study|Withdrawal by Subject|1|||
156874570|NCT02527421|566298685|FG001|Overall Study|Withdrawal by Subject|0|||
156874571|NCT02116205|566298686|FG000|Overall Study|Withdrawal by Subject|2|||
156874572|NCT02116205|566298687|FG001|Overall Study|Withdrawal by Subject|4|||
156874573|NCT02116205|566298688|FG002|Overall Study|Withdrawal by Subject|1|||
156874574|NCT02116205|566298689|FG003|Overall Study|Withdrawal by Subject|3|||
156874575|NCT02116205|566298686|FG000|Overall Study|Lost to Follow-up|0|||
156874576|NCT02116205|566298687|FG001|Overall Study|Lost to Follow-up|2|||
156874577|NCT02116205|566298688|FG002|Overall Study|Lost to Follow-up|1|||
156874578|NCT02116205|566298689|FG003|Overall Study|Lost to Follow-up|2|||
156874579|NCT02116205|566298686|FG000|Overall Study|Physician Decision|0|||
156874580|NCT02116205|566298687|FG001|Overall Study|Physician Decision|1|||
156874581|NCT02116205|566298688|FG002|Overall Study|Physician Decision|1|||
156333715|NCT02323113|564320852|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
156874582|NCT02116205|566298689|FG003|Overall Study|Physician Decision|1|||
156874583|NCT02116205|566298686|FG000|Overall Study|Exclusion criteria|0|||
156874584|NCT02116205|566298687|FG001|Overall Study|Exclusion criteria|0|||
156333716|NCT02323113|564320845|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156333717|NCT02323113|564320846|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
156333718|NCT02323113|564320847|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156333719|NCT02323113|564320848|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156338248|NCT05248867|564336596|FG004|Open-label Period|Withdrawal by Subject|7|||
156874585|NCT02116205|566298688|FG002|Overall Study|Exclusion criteria|1|||
156874586|NCT02116205|566298689|FG003|Overall Study|Exclusion criteria|0|||
156874587|NCT04200352|566298695|FG000|Overall Study|Death|1|||
156874588|NCT04200352|566298695|FG000|Overall Study|Adverse Event|6|||
156874589|NCT04200352|566298695|FG000|Overall Study|Withdrawal by parent/guardian|6|||
156874590|NCT04200352|566298695|FG000|Overall Study|Lack of Efficacy|1|||
156874591|NCT04200352|566298695|FG000|Overall Study|Other than specified|6|||
156874592|NCT02541604|566298696|FG000|Overall Study|Death|6|||
156874593|NCT02541604|566298697|FG001|Overall Study|Death|5|||
156444350|NCT03398148|564718482|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
156444351|NCT03398148|564718483|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
156444352|NCT03398148|564718484|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
156444353|NCT03398148|564718485|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
156444354|NCT03398148|564718486|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
156444355|NCT03398148|564718487|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
156444356|NCT03398148|564718488|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
156444357|NCT03398148|564718489|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
156444358|NCT03398148|564718490|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
156444359|NCT03398148|564718491|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
156444360|NCT03398148|564718492|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
156444361|NCT03398148|564718493|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
156444362|NCT03398148|564718494|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
156444363|NCT03398148|564718495|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
156444364|NCT03398148|564718496|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
156444365|NCT03398148|564718482|FG000|Substudy 2 Period 2|Other|0|||
156444366|NCT03398148|564718483|FG001|Substudy 2 Period 2|Other|0|||
156444367|NCT03398148|564718484|FG002|Substudy 2 Period 2|Other|0|||
156444368|NCT03398148|564718485|FG003|Substudy 2 Period 2|Other|0|||
156444369|NCT03398148|564718486|FG004|Substudy 2 Period 2|Other|0|||
156444370|NCT03398148|564718487|FG005|Substudy 2 Period 2|Other|0|||
156444371|NCT03398148|564718488|FG006|Substudy 2 Period 2|Other|0|||
156444372|NCT03398148|564718489|FG007|Substudy 2 Period 2|Other|0|||
156444373|NCT03398148|564718490|FG008|Substudy 2 Period 2|Other|0|||
156444374|NCT03398148|564718491|FG009|Substudy 2 Period 2|Other|0|||
156444375|NCT03398148|564718492|FG010|Substudy 2 Period 2|Other|0|||
156444376|NCT03398148|564718493|FG011|Substudy 2 Period 2|Other|0|||
156444377|NCT03398148|564718494|FG012|Substudy 2 Period 2|Other|0|||
156444378|NCT03398148|564718495|FG013|Substudy 2 Period 2|Other|1|||
156444379|NCT03398148|564718496|FG014|Substudy 2 Period 2|Other|1|||
156444380|NCT03398148|564718482|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444381|NCT03398148|564718483|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444382|NCT03398148|564718484|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444383|NCT03398148|564718485|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444384|NCT03398148|564718486|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444385|NCT03398148|564718487|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444386|NCT03398148|564718488|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444387|NCT03398148|564718489|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444388|NCT03398148|564718490|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444389|NCT03398148|564718491|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444390|NCT03398148|564718492|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444391|NCT03398148|564718493|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444392|NCT03398148|564718494|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
156444393|NCT03398148|564718495|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
156444394|NCT03398148|564718496|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
156444395|NCT04278586|564718497|FG000|Overall Study|Withdrawal by Subject|13|||
156444396|NCT04278586|564718498|FG001|Overall Study|Withdrawal by Subject|6|||
156444397|NCT04278586|564718497|FG000|Overall Study|Lost to Follow-up|37|||
156444398|NCT04278586|564718498|FG001|Overall Study|Lost to Follow-up|24|||
156444399|NCT04607044|564718508|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
156444400|NCT04607044|564718508|FG000|Overall Study|Adverse Event|1|||
156444401|NCT04607044|564718508|FG000|Overall Study|Did not receive study device|3|||
156444402|NCT04607044|564718508|FG000|Overall Study|Death|1|||
156714935|NCT02906670|565700819|FG001|Cohort 4P, QW|Radiological Progression|0|||
156333720|NCT02323113|564320849|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156333721|NCT02323113|564320850|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156333722|NCT02323113|564320851|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156333723|NCT02323113|564320852|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156333724|NCT04092582|564320853|FG000|Overall Study|Death|1|||
156333725|NCT04092582|564320854|FG001|Overall Study|Death|1|||
156333726|NCT04092582|564320853|FG000|Overall Study|Withdrawal by Subject|4|||
156333727|NCT04092582|564320854|FG001|Overall Study|Withdrawal by Subject|1|||
156333728|NCT04092582|564320853|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
156333729|NCT04092582|564320854|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
156333730|NCT02280304|564320857|FG000|Overall Study|Lost to Follow-up|7|||
156333731|NCT02280304|564320858|FG001|Overall Study|Lost to Follow-up|8|||
156333732|NCT01313858|564320861|FG000|Overall Study|Premature Treatment Termination|251|||
156444403|NCT05403801|564718509|FG000|Overall Study|Withdrawal by Subject|2|||
156444404|NCT05075408|564718510|FG000|Overall Study|Withdrawal by Subject|5|||
156444405|NCT05075408|564718511|FG001|Overall Study|Withdrawal by Subject|3|||
156444406|NCT05075408|564718512|FG002|Overall Study|Withdrawal by Subject|4|||
156444407|NCT05075408|564718510|FG000|Overall Study|Adverse Event|5|||
156444408|NCT05075408|564718511|FG001|Overall Study|Adverse Event|7|||
156714936|NCT02906670|565700820|FG002|Cohort 4P, QW|Radiological Progression|0|||
156714937|NCT02906670|565700821|FG003|Cohort 4P, QW|Radiological Progression|3|||
156714938|NCT02906670|565700822|FG004|Cohort 4P, QW|Radiological Progression|0|||
156714939|NCT02906670|565700823|FG005|Cohort 4P, QW|Radiological Progression|0|||
156714940|NCT02906670|565700824|FG006|Cohort 4P, QW|Radiological Progression|0|||
156714941|NCT02906670|565700825|FG007|Cohort 4P, QW|Radiological Progression|0|||
156714942|NCT02906670|565700826|FG008|Cohort 4P, QW|Radiological Progression|0|||
156714943|NCT02906670|565700827|FG009|Cohort 4P, QW|Radiological Progression|0|||
156714944|NCT02906670|565700818|FG000|Cohort 7P, Q2W|Adverse Event|0|||
156714945|NCT02906670|565700819|FG001|Cohort 7P, Q2W|Adverse Event|0|||
156714946|NCT02906670|565700820|FG002|Cohort 7P, Q2W|Adverse Event|0|||
156714947|NCT02906670|565700821|FG003|Cohort 7P, Q2W|Adverse Event|0|||
156333733|NCT01313858|564320862|FG001|Overall Study|Premature Treatment Termination|219|||
156333734|NCT01313858|564320863|FG002|Overall Study|Premature Treatment Termination|191|||
156333735|NCT01313858|564320861|FG000|Overall Study|Lost to Follow-up|35|||
156333736|NCT01313858|564320862|FG001|Overall Study|Lost to Follow-up|51|||
156333737|NCT01313858|564320863|FG002|Overall Study|Lost to Follow-up|47|||
156333738|NCT03689530|564320865|FG000|Overall Study|Withdrawal by Subject|53|||
156333739|NCT03689530|564320866|FG001|Overall Study|Withdrawal by Subject|16|||
156333740|NCT01392443|564320867|FG000|Overall Study|Disease progression|30|||
156333741|NCT01392443|564320867|FG000|Overall Study|Adverse Event|24|||
156333742|NCT01392443|564320867|FG000|Overall Study|Death|7|||
156333743|NCT01392443|564320867|FG000|Overall Study|Withdrawal by Subject|5|||
156333744|NCT01392443|564320867|FG000|Overall Study|Lost to Follow-up|1|||
156333745|NCT01392443|564320867|FG000|Overall Study|Protocol Violation|1|||
156333746|NCT01977794|564320868|FG000|Overall Study|Adverse Event|2|||
156333747|NCT01977794|564320869|FG001|Overall Study|Adverse Event|2|||
156333748|NCT01977794|564320868|FG000|Overall Study|Lost to Follow-up|2|||
156333749|NCT01977794|564320869|FG001|Overall Study|Lost to Follow-up|1|||
156333750|NCT01977794|564320868|FG000|Overall Study|Protocol Violation|1|||
156333751|NCT01977794|564320869|FG001|Overall Study|Protocol Violation|0|||
156333752|NCT01977794|564320868|FG000|Overall Study|Death|1|||
156333753|NCT01977794|564320869|FG001|Overall Study|Death|1|||
156333754|NCT01977794|564320868|FG000|Overall Study|Withdrew consent|2|||
156333755|NCT01977794|564320869|FG001|Overall Study|Withdrew consent|1|||
156333756|NCT01977794|564320868|FG000|Overall Study|Other|0|||
156333757|NCT01977794|564320869|FG001|Overall Study|Other|1|||
156333758|NCT00491075|564320872|FG000|Overall Study|Withdrawal by Subject|1|||
156333759|NCT00491075|564320872|FG000|Overall Study|Physician Decision|1|||
156333760|NCT01603355|564320873|FG000|Overall Study|Lack of Efficacy|2|||
156333761|NCT00246753|564320874|FG000|Overall Study|Withdrawal by Subject|2|||
156333762|NCT00246753|564320874|FG000|Overall Study|Physician Decision|2|||
156333763|NCT00246753|564320874|FG000|Overall Study|Adverse Event|2|||
156333764|NCT00246753|564320874|FG000|Overall Study|Unacceptable toxicity|2|||
156333765|NCT01868503|564320877|FG000|Overall Study|Withdrawal by Subject|1|||
156333766|NCT01868503|564320877|FG000|Overall Study|Protocol Violation|1|||
156333767|NCT03917459|564320880|FG000|Overall Study|Adverse Event|1|||
156333768|NCT03917459|564320881|FG001|Overall Study|Adverse Event|0|||
156333769|NCT03917459|564320880|FG000|Overall Study|Withdrawal by Subject|0|||
156333770|NCT03917459|564320881|FG001|Overall Study|Withdrawal by Subject|1|||
156333771|NCT00131508|564320884|FG000|Overall Study|Disease progression|0|||
156333772|NCT00131508|564320885|FG001|Overall Study|Disease progression|2|||
156333773|NCT00131508|564320884|FG000|Overall Study|Non-Compliance|2|||
156333774|NCT00131508|564320885|FG001|Overall Study|Non-Compliance|4|||
156333775|NCT00131508|564320884|FG000|Overall Study|Withdrawal by Subject|1|||
156333776|NCT00131508|564320885|FG001|Overall Study|Withdrawal by Subject|2|||
156333777|NCT01691898|564320898|FG000|Overall Study|Death|34|||
156333778|NCT01691898|564320899|FG001|Overall Study|Death|32|||
156333779|NCT01691898|564320900|FG002|Overall Study|Death|6|||
156333780|NCT01691898|564320901|FG003|Overall Study|Death|3|||
156333781|NCT01691898|564320902|FG004|Overall Study|Death|8|||
156333782|NCT01691898|564320903|FG005|Overall Study|Death|31|||
156333783|NCT01691898|564320898|FG000|Overall Study|Adverse Event|0|||
156333784|NCT01691898|564320899|FG001|Overall Study|Adverse Event|1|||
156333785|NCT01691898|564320900|FG002|Overall Study|Adverse Event|0|||
156333786|NCT01691898|564320901|FG003|Overall Study|Adverse Event|1|||
156333787|NCT01691898|564320902|FG004|Overall Study|Adverse Event|1|||
156333788|NCT01691898|564320903|FG005|Overall Study|Adverse Event|0|||
156333789|NCT01691898|564320898|FG000|Overall Study|Progression of Disease|1|||
156333790|NCT01691898|564320899|FG001|Overall Study|Progression of Disease|2|||
156333791|NCT01691898|564320900|FG002|Overall Study|Progression of Disease|1|||
156333792|NCT01691898|564320901|FG003|Overall Study|Progression of Disease|0|||
156333793|NCT01691898|564320902|FG004|Overall Study|Progression of Disease|0|||
156333794|NCT01691898|564320903|FG005|Overall Study|Progression of Disease|1|||
156333795|NCT01691898|564320898|FG000|Overall Study|Lost to Follow-up|3|||
156333796|NCT01691898|564320899|FG001|Overall Study|Lost to Follow-up|1|||
156333797|NCT01691898|564320900|FG002|Overall Study|Lost to Follow-up|0|||
156333798|NCT01691898|564320901|FG003|Overall Study|Lost to Follow-up|0|||
156333799|NCT01691898|564320902|FG004|Overall Study|Lost to Follow-up|1|||
156714948|NCT02906670|565700822|FG004|Cohort 7P, Q2W|Adverse Event|0|||
156333800|NCT01691898|564320903|FG005|Overall Study|Lost to Follow-up|0|||
156333801|NCT01691898|564320898|FG000|Overall Study|Withdrawal by Subject|9|||
156333802|NCT01691898|564320899|FG001|Overall Study|Withdrawal by Subject|8|||
156333803|NCT01691898|564320900|FG002|Overall Study|Withdrawal by Subject|2|||
156333804|NCT01691898|564320901|FG003|Overall Study|Withdrawal by Subject|1|||
156333805|NCT01691898|564320902|FG004|Overall Study|Withdrawal by Subject|3|||
156333806|NCT01691898|564320903|FG005|Overall Study|Withdrawal by Subject|3|||
156333807|NCT01691898|564320898|FG000|Overall Study|Non-Compliance|0|||
156444409|NCT05075408|564718512|FG002|Overall Study|Adverse Event|8|||
156444410|NCT05075408|564718510|FG000|Overall Study|Protocol Violation|0|||
156444411|NCT05075408|564718511|FG001|Overall Study|Protocol Violation|1|||
156444412|NCT05075408|564718512|FG002|Overall Study|Protocol Violation|0|||
156444413|NCT05075408|564718510|FG000|Overall Study|Lost to Follow-up|2|||
156444414|NCT05075408|564718511|FG001|Overall Study|Lost to Follow-up|1|||
156444415|NCT05075408|564718512|FG002|Overall Study|Lost to Follow-up|1|||
156444416|NCT05075408|564718510|FG000|Overall Study|Physician Decision|1|||
156444417|NCT05075408|564718511|FG001|Overall Study|Physician Decision|0|||
156444418|NCT05075408|564718512|FG002|Overall Study|Physician Decision|0|||
156444419|NCT05075408|564718510|FG000|Overall Study|Other-unspecified|3|||
156444420|NCT05075408|564718511|FG001|Overall Study|Other-unspecified|2|||
156444421|NCT05075408|564718512|FG002|Overall Study|Other-unspecified|0|||
156444422|NCT03416023|564718513|FG000|Overall Study|Exclusion criteria failure|1|||
156444423|NCT03416023|564718513|FG000|Overall Study|Withdrawal by Subject|6|||
156444424|NCT03416023|564718513|FG000|Overall Study|Explanted|7|||
156444425|NCT03416023|564718513|FG000|Overall Study|Physician Decision|1|||
156444426|NCT03416023|564718513|FG000|Overall Study|Lost to Follow-up|1|||
156444427|NCT03416023|564718513|FG000|Overall Study|Death|1|||
156444428|NCT04468776|564718514|FG000|Overall Study|Lost to Follow-up|4|||
156444429|NCT04468776|564718515|FG001|Overall Study|Lost to Follow-up|3|||
156444430|NCT04468776|564718516|FG002|Overall Study|Lost to Follow-up|4|||
156444431|NCT04468776|564718514|FG000|Overall Study|Withdrawal by Subject|1|||
156444432|NCT04468776|564718515|FG001|Overall Study|Withdrawal by Subject|10|||
156444433|NCT04468776|564718516|FG002|Overall Study|Withdrawal by Subject|4|||
156444434|NCT04468776|564718514|FG000|Overall Study|Physician Decision|0|||
156444435|NCT04468776|564718515|FG001|Overall Study|Physician Decision|1|||
156444436|NCT04468776|564718516|FG002|Overall Study|Physician Decision|1|||
156444437|NCT05384730|564718521|FG000|Overall Study|Adverse Event|1|||
156444438|NCT05384730|564718522|FG001|Overall Study|Adverse Event|0|||
156444439|NCT05384730|564718521|FG000|Overall Study|Lack of social support|2|||
156444440|NCT05384730|564718522|FG001|Overall Study|Lack of social support|0|||
156444441|NCT05384730|564718521|FG000|Overall Study|Hospital readmission|2|||
156444442|NCT05384730|564718522|FG001|Overall Study|Hospital readmission|0|||
156444443|NCT05384730|564718521|FG000|Overall Study|Disease progression|5|||
156444444|NCT05384730|564718522|FG001|Overall Study|Disease progression|0|||
156444445|NCT05384730|564718521|FG000|Overall Study|Overwhelmed with College commitments|0|||
156444446|NCT05384730|564718522|FG001|Overall Study|Overwhelmed with College commitments|2|||
156444447|NCT01000480|564718523|FG000|Induction Phase|Adverse Event|2|||
156444448|NCT01000480|564718523|FG000|Induction Phase|Lost to Follow-up|1|||
156444449|NCT01000480|564718523|FG000|Induction Phase|Physician Decision|1|||
156444450|NCT01000480|564718523|FG000|Induction Phase|Entry Criteria Not Met|3|||
156444451|NCT01000480|564718523|FG000|Concurrent Therapy Phase|Adverse Event|4|||
156714949|NCT02906670|565700823|FG005|Cohort 7P, Q2W|Adverse Event|0|||
156714950|NCT02906670|565700824|FG006|Cohort 7P, Q2W|Adverse Event|0|||
156874594|NCT02541604|566298698|FG002|Overall Study|Death|7|||
156333808|NCT01691898|564320899|FG001|Overall Study|Non-Compliance|0|||
156444452|NCT01000480|564718523|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
156444453|NCT01000480|564718523|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
156444454|NCT01000480|564718523|FG000|Concurrent Therapy Phase|Physician Decision|1|||
156444455|NCT04328727|564718529|FG000|Overall Study|Guardian Decision|1|||
156444456|NCT04328727|564718529|FG000|Overall Study|Participant decision|4|||
156444457|NCT04328727|564718529|FG000|Overall Study|Death|3|||
156444458|NCT04149002|564718533|FG000|Overall Study|Lost to Follow-up|1|||
156444459|NCT04149002|564718534|FG001|Overall Study|Lost to Follow-up|0|||
156444460|NCT04149002|564718533|FG000|Overall Study|Withdrawal by Subject|1|||
156444461|NCT04149002|564718534|FG001|Overall Study|Withdrawal by Subject|0|||
156444462|NCT03330795|564718535|FG000|Overall Study|Death|3|||
156444463|NCT03330795|564718535|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
156444464|NCT05782231|564718536|FG000|Overall Study|Withdrawal by Subject|1|||
156444465|NCT02252172|564718537|FG000|Overall Study|Lost to Follow-up|9|||
156444466|NCT02252172|564718538|FG001|Overall Study|Lost to Follow-up|6|||
156714951|NCT02906670|565700825|FG007|Cohort 7P, Q2W|Adverse Event|0|||
156444467|NCT02252172|564718537|FG000|Overall Study|Death|218|||
156444468|NCT02252172|564718538|FG001|Overall Study|Death|175|||
156444469|NCT02252172|564718537|FG000|Overall Study|Withdrawal by Subject|20|||
156444470|NCT02252172|564718538|FG001|Overall Study|Withdrawal by Subject|15|||
156444471|NCT02252172|564718537|FG000|Overall Study|Physician Decision|0|||
156333809|NCT01691898|564320900|FG002|Overall Study|Non-Compliance|0|||
156444472|NCT02252172|564718538|FG001|Overall Study|Physician Decision|1|||
156333810|NCT01691898|564320901|FG003|Overall Study|Non-Compliance|0|||
156333811|NCT01691898|564320902|FG004|Overall Study|Non-Compliance|1|||
156333812|NCT01691898|564320903|FG005|Overall Study|Non-Compliance|0|||
156333813|NCT02019277|564320904|FG000|Overall Study|Withdrawal by Subject|3|||
156333814|NCT02019277|564320904|FG000|Overall Study|Death|7|||
156333815|NCT02019277|564320904|FG000|Overall Study|Did no Cooperate|1|||
156333816|NCT02019277|564320904|FG000|Overall Study|Adverse Event|1|||
156333817|NCT04738734|564320905|FG000|Overall Study|Withdrawal by Subject|2|||
156333818|NCT04738734|564320906|FG001|Overall Study|Withdrawal by Subject|4|||
156333819|NCT04738734|564320905|FG000|Overall Study|Lost to Follow-up|5|||
156333820|NCT04738734|564320906|FG001|Overall Study|Lost to Follow-up|2|||
156333821|NCT04738734|564320905|FG000|Overall Study|Physician Decision|0|||
156333822|NCT04738734|564320906|FG001|Overall Study|Physician Decision|1|||
156333823|NCT04738734|564320905|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
156333824|NCT04738734|564320906|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
156333825|NCT04093414|564320907|FG000|3 Month Follow up|Physician Decision|0|||
156444473|NCT02252172|564718537|FG000|Overall Study|End of data collection|122|||
156444474|NCT02252172|564718538|FG001|Overall Study|End of data collection|170|||
156444475|NCT02252172|564718537|FG000|Overall Study|Site closure|0|||
156444476|NCT02252172|564718538|FG001|Overall Study|Site closure|1|||
156444477|NCT05575076|564718539|FG000|Overall Study|Adverse Event|24|||
156444478|NCT05575076|564718539|FG000|Overall Study|Death|7|||
156444479|NCT05575076|564718539|FG000|Overall Study|Lost to Follow-up|16|||
156444480|NCT05575076|564718539|FG000|Overall Study|Non-Compliance|3|||
156444481|NCT05575076|564718539|FG000|Overall Study|Physician Decision|6|||
156444482|NCT05575076|564718539|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
156444483|NCT05575076|564718539|FG000|Overall Study|Withdrawal by Subject|71|||
156444484|NCT05575076|564718539|FG000|Overall Study|Study Terminated by Sponsor|630|||
156444485|NCT05575076|564718539|FG000|Overall Study|Other|17|||
156444486|NCT03447249|564718543|FG000|Overall Study|Adverse Event|1|||
156444487|NCT03447249|564718544|FG001|Overall Study|Adverse Event|0|||
156444488|NCT03447249|564718543|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156444489|NCT03447249|564718544|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
156444490|NCT03447249|564718543|FG000|Overall Study|Other|3|||
156444491|NCT03447249|564718544|FG001|Overall Study|Other|0|||
156444492|NCT01426412|564718545|FG000|Overall Study|Withdrawal by Subject|1|||
156444493|NCT01426412|564718546|FG001|Overall Study|Withdrawal by Subject|0|||
156444494|NCT01426412|564718547|FG002|Overall Study|Withdrawal by Subject|0|||
156444495|NCT01426412|564718548|FG003|Overall Study|Withdrawal by Subject|0|||
156444496|NCT01426412|564718549|FG004|Overall Study|Withdrawal by Subject|1|||
156444497|NCT01426412|564718550|FG005|Overall Study|Withdrawal by Subject|0|||
156444498|NCT01426412|564718551|FG006|Overall Study|Withdrawal by Subject|0|||
156444499|NCT01426412|564718552|FG007|Overall Study|Withdrawal by Subject|3|||
156444500|NCT01426412|564718553|FG008|Overall Study|Withdrawal by Subject|1|||
156444501|NCT00988858|564718555|FG000|Overall Study|Adverse Event|7|||
156444502|NCT00988858|564718555|FG000|Overall Study|Death|1|||
156444503|NCT00988858|564718555|FG000|Overall Study|Physician Decision|1|||
156444504|NCT00988858|564718555|FG000|Overall Study|Sponsor Decision|1|||
156444505|NCT02376790|564718556|FG000|Overall Study|Withdrawal by Subject|43|||
156714952|NCT02906670|565700826|FG008|Cohort 7P, Q2W|Adverse Event|0|||
156714953|NCT02906670|565700827|FG009|Cohort 7P, Q2W|Adverse Event|1|||
156333826|NCT04093414|564320908|FG001|3 Month Follow up|Physician Decision|1|||
156333827|NCT04093414|564320907|FG000|6month Follow up|Physician Decision|1|||
156333828|NCT04093414|564320908|FG001|6month Follow up|Physician Decision|3|||
156333829|NCT04889222|564320909|FG000|Overall Study|Did not meet eligibility criteria|8|||
156444506|NCT02376790|564718557|FG001|Overall Study|Withdrawal by Subject|36|||
156444507|NCT02376790|564718558|FG002|Overall Study|Withdrawal by Subject|37|||
156444508|NCT02376790|564718556|FG000|Overall Study|Decision by Sponsor|2|||
156444509|NCT02376790|564718557|FG001|Overall Study|Decision by Sponsor|1|||
156444510|NCT02376790|564718558|FG002|Overall Study|Decision by Sponsor|4|||
156444511|NCT02376790|564718556|FG000|Overall Study|Lost to Follow-up|15|||
156444512|NCT02376790|564718557|FG001|Overall Study|Lost to Follow-up|10|||
156444513|NCT02376790|564718558|FG002|Overall Study|Lost to Follow-up|12|||
156444514|NCT03014453|564718559|FG000|Overall Study|Lost to Follow-up|12|||
156444515|NCT03014453|564718559|FG000|Overall Study|Discontinued GER|3|||
156444516|NCT03014453|564718559|FG000|Overall Study|Excluded|19|||
156444517|NCT03014453|564718559|FG000|Overall Study|Refused to take part in|37|||
156444518|NCT02538341|564718567|FG000|Overall Study|Lost to Follow-up|51|||
156444519|NCT02538341|564718568|FG001|Overall Study|Lost to Follow-up|46|||
156444520|NCT02538341|564718567|FG000|Overall Study|Withdrawal by Subject|3|||
156444521|NCT02538341|564718568|FG001|Overall Study|Withdrawal by Subject|1|||
156444522|NCT02538341|564718567|FG000|Overall Study|Death|2|||
156444523|NCT02538341|564718568|FG001|Overall Study|Death|0|||
156444524|NCT04732338|564718571|FG000|Overall Study|Lost to Follow-up|3|||
156444525|NCT04732338|564718572|FG001|Overall Study|Lost to Follow-up|3|||
156444526|NCT00065260|564718573|FG000|Overall Study|Death|0|||
156444527|NCT00065260|564718574|FG001|Overall Study|Death|1|||
156333830|NCT04889222|564320909|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
156444528|NCT00001277|564718575|FG000|Overall Study|Adverse Event|0|||
156444529|NCT00001277|564718576|FG001|Overall Study|Adverse Event|0|||
156444530|NCT00001277|564718577|FG002|Overall Study|Adverse Event|1|||
156444531|NCT00001277|564718575|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
156444532|NCT00001277|564718576|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
156444533|NCT00001277|564718577|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
156444534|NCT03750968|564718579|FG000|Overall Study|Adverse Event|2|||
156444535|NCT03750968|564718580|FG001|Overall Study|Adverse Event|0|||
156444536|NCT03750968|564718579|FG000|Overall Study|Lost to Follow-up|1|||
156444537|NCT03750968|564718580|FG001|Overall Study|Lost to Follow-up|3|||
156444538|NCT00088413|564718586|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
156444539|NCT00088413|564718587|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
156444540|NCT00088413|564718588|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
156444541|NCT00088413|564718589|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
156444542|NCT00088413|564718586|FG000|Overall Study|Adverse Events/Side Effects|0|||
156444543|NCT00088413|564718587|FG001|Overall Study|Adverse Events/Side Effects|1|||
156444544|NCT00088413|564718588|FG002|Overall Study|Adverse Events/Side Effects|1|||
156444545|NCT00088413|564718589|FG003|Overall Study|Adverse Events/Side Effects|0|||
156444546|NCT00088413|564718586|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
156444547|NCT00088413|564718587|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
156444548|NCT00088413|564718588|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
156444549|NCT00088413|564718589|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
156444550|NCT00088413|564718586|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
156444551|NCT00088413|564718587|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
156444552|NCT00088413|564718588|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
156444553|NCT00088413|564718589|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
156444554|NCT00088413|564718586|FG000|Overall Study|Death|0|||
156444555|NCT00088413|564718587|FG001|Overall Study|Death|1|||
156714954|NCT02906670|565700818|FG000|Cohort 7P, Q2W|Physician Decision|0|||
156714955|NCT02906670|565700819|FG001|Cohort 7P, Q2W|Physician Decision|0|||
156714956|NCT02906670|565700820|FG002|Cohort 7P, Q2W|Physician Decision|0|||
156714957|NCT02906670|565700821|FG003|Cohort 7P, Q2W|Physician Decision|0|||
156714958|NCT02906670|565700822|FG004|Cohort 7P, Q2W|Physician Decision|0|||
156714959|NCT02906670|565700823|FG005|Cohort 7P, Q2W|Physician Decision|0|||
156714960|NCT02906670|565700824|FG006|Cohort 7P, Q2W|Physician Decision|0|||
156714961|NCT02906670|565700825|FG007|Cohort 7P, Q2W|Physician Decision|0|||
156714962|NCT02906670|565700826|FG008|Cohort 7P, Q2W|Physician Decision|0|||
156714963|NCT02906670|565700827|FG009|Cohort 7P, Q2W|Physician Decision|1|||
156714964|NCT02906670|565700818|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714965|NCT02906670|565700819|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714966|NCT02906670|565700820|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714967|NCT02906670|565700821|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714968|NCT02906670|565700822|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714969|NCT02906670|565700823|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714970|NCT02906670|565700824|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714971|NCT02906670|565700825|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714972|NCT02906670|565700826|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156792813|NCT01335685|565994770|FG001|Overall Study|Study Terminated by Sponsor|1|||
156714973|NCT02906670|565700827|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
156714974|NCT02906670|565700818|FG000|Cohort 5P, QW|Radiological Progression|0|||
156714975|NCT02906670|565700819|FG001|Cohort 5P, QW|Radiological Progression|0|||
156792814|NCT01335685|565994771|FG002|Overall Study|Study Terminated by Sponsor|1|||
156792815|NCT01335685|565994772|FG003|Overall Study|Study Terminated by Sponsor|10|||
156792816|NCT01335685|565994773|FG004|Overall Study|Study Terminated by Sponsor|0|||
156792817|NCT01335685|565994774|FG005|Overall Study|Study Terminated by Sponsor|4|||
156444556|NCT00088413|564718588|FG002|Overall Study|Death|0|||
156444557|NCT00088413|564718589|FG003|Overall Study|Death|0|||
156444558|NCT00088413|564718586|FG000|Overall Study|Progressive disease|9|||
156444559|NCT00088413|564718587|FG001|Overall Study|Progressive disease|11|||
156444560|NCT00088413|564718588|FG002|Overall Study|Progressive disease|8|||
156444561|NCT00088413|564718589|FG003|Overall Study|Progressive disease|14|||
156444562|NCT00088413|564718586|FG000|Overall Study|Other|0|||
156444563|NCT00088413|564718587|FG001|Overall Study|Other|1|||
156792818|NCT01335685|565994775|FG006|Overall Study|Study Terminated by Sponsor|2|||
156444564|NCT00088413|564718588|FG002|Overall Study|Other|0|||
156444565|NCT00088413|564718589|FG003|Overall Study|Other|0|||
156444566|NCT00088413|564718586|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
156444567|NCT00088413|564718587|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
156444568|NCT00088413|564718588|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
156714976|NCT02906670|565700820|FG002|Cohort 5P, QW|Radiological Progression|0|||
156714977|NCT02906670|565700821|FG003|Cohort 5P, QW|Radiological Progression|0|||
156714978|NCT02906670|565700822|FG004|Cohort 5P, QW|Radiological Progression|3|||
156792819|NCT01335685|565994776|FG007|Overall Study|Study Terminated by Sponsor|3|||
156714979|NCT02906670|565700823|FG005|Cohort 5P, QW|Radiological Progression|0|||
156874595|NCT02541604|566298699|FG003|Overall Study|Death|2|||
156874596|NCT02541604|566298700|FG004|Overall Study|Death|9|||
156874597|NCT02541604|566298701|FG005|Overall Study|Death|8|||
156874598|NCT02541604|566298702|FG006|Overall Study|Death|9|||
156444569|NCT00088413|564718589|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
156444570|NCT02539225|564718590|FG000|Part A|Adverse Event|13|||
156444571|NCT02539225|564718591|FG001|Part A|Adverse Event|4|||
156444572|NCT02539225|564718590|FG000|Part A|Withdrawal by Subject|2|||
156444573|NCT02539225|564718591|FG001|Part A|Withdrawal by Subject|4|||
156444574|NCT02539225|564718590|FG000|Part A|Physician Decision|4|||
156444575|NCT02539225|564718591|FG001|Part A|Physician Decision|7|||
156444576|NCT02539225|564718590|FG000|Part A|Did Not Receive study Drug|1|||
156444577|NCT02539225|564718591|FG001|Part A|Did Not Receive study Drug|1|||
156444578|NCT02539225|564718590|FG000|Pre Treatment for Part B|Progressive disease|1|||
156444579|NCT02539225|564718591|FG001|Pre Treatment for Part B|Progressive disease|1|||
156444580|NCT02539225|564718590|FG000|Pre Treatment for Part B|Adverse Event|1|||
156444581|NCT02539225|564718591|FG001|Pre Treatment for Part B|Adverse Event|1|||
156444582|NCT02539225|564718590|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
156444583|NCT02539225|564718591|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
156444584|NCT02539225|564718590|FG000|Pre Treatment for Part B|Physician Decision|2|||
156444585|NCT02539225|564718591|FG001|Pre Treatment for Part B|Physician Decision|0|||
156444586|NCT02539225|564718590|FG000|Part B|Adverse Event|4|||
156444587|NCT02539225|564718591|FG001|Part B|Adverse Event|4|||
156444588|NCT02539225|564718590|FG000|Part B|Withdrawal by Subject|0|||
156444589|NCT02539225|564718591|FG001|Part B|Withdrawal by Subject|3|||
156444590|NCT02539225|564718590|FG000|Part B|Physician Decision|0|||
156444591|NCT02539225|564718591|FG001|Part B|Physician Decision|9|||
156444592|NCT03101371|564718594|FG000|Overall Study|Physician Decision|0|||
156444593|NCT03101371|564718595|FG001|Overall Study|Physician Decision|1|||
156444594|NCT03101371|564718594|FG000|Overall Study|Lost to Follow-up|1|||
156444595|NCT03101371|564718595|FG001|Overall Study|Lost to Follow-up|4|||
156444596|NCT03101371|564718594|FG000|Overall Study|Did not meet eligibility criteria|2|||
156444597|NCT03101371|564718595|FG001|Overall Study|Did not meet eligibility criteria|1|||
156444598|NCT03988842|564718599|FG000|Overall Study|Death|1|||
156444599|NCT04766034|564718600|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
156444600|NCT04766034|564718601|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
156444601|NCT04766034|564718602|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
156444602|NCT04766034|564718603|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
156444603|NCT04766034|564718604|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
156444604|NCT04766034|564718600|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
156444605|NCT04766034|564718601|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
156444606|NCT04766034|564718602|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
156444607|NCT04766034|564718603|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
156444608|NCT04766034|564718604|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
156444609|NCT04766034|564718600|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
156444610|NCT04766034|564718601|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
156444611|NCT04766034|564718602|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
156444612|NCT04766034|564718603|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
156444613|NCT04766034|564718604|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
156444614|NCT04766034|564718600|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
156444615|NCT04766034|564718601|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
156444616|NCT04766034|564718602|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
156444617|NCT04766034|564718603|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
156444618|NCT04766034|564718604|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
156444619|NCT01976312|564718605|FG000|Overall Study|Pregnancy|0|||
156444620|NCT01976312|564718606|FG001|Overall Study|Pregnancy|1|||
156444621|NCT01976312|564718605|FG000|Overall Study|Lost to Follow-up|2|||
156444622|NCT01976312|564718606|FG001|Overall Study|Lost to Follow-up|0|||
156444623|NCT01976312|564718605|FG000|Overall Study|Withdrawal by Subject|7|||
156444624|NCT01976312|564718606|FG001|Overall Study|Withdrawal by Subject|2|||
156714980|NCT02906670|565700824|FG006|Cohort 5P, QW|Radiological Progression|0|||
156714981|NCT02906670|565700825|FG007|Cohort 5P, QW|Radiological Progression|0|||
156714982|NCT02906670|565700826|FG008|Cohort 5P, QW|Radiological Progression|0|||
156714983|NCT02906670|565700827|FG009|Cohort 5P, QW|Radiological Progression|0|||
156874599|NCT02541604|566298703|FG007|Overall Study|Death|9|||
156874600|NCT02541604|566298704|FG008|Overall Study|Death|3|||
156874601|NCT02541604|566298705|FG009|Overall Study|Death|4|||
156532467|NCT01233869|565045030|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
156532468|NCT03189862|565045036|FG000|Overall Study|Withdrawal by Subject|1|||
156532469|NCT03189862|565045037|FG001|Overall Study|Withdrawal by Subject|0|||
156532470|NCT03189862|565045036|FG000|Overall Study|Lost to Follow-up|54|||
156532471|NCT03189862|565045037|FG001|Overall Study|Lost to Follow-up|62|||
156532472|NCT00931944|565045039|FG000|Overall Study|Adverse Event|4|||
156532473|NCT00931944|565045039|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
156532474|NCT00931944|565045039|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
156532475|NCT00931944|565045039|FG000|Overall Study|Death|28|||
156532476|NCT00931944|565045039|FG000|Overall Study|Other|2|||
156532477|NCT02545322|565045040|FG000|Overall Study|Withdrawal by Subject|3|||
156532478|NCT03690141|565045041|FG000|Overall Study|Adverse Event|5|||
156532479|NCT03690141|565045041|FG000|Overall Study|Withdrawal by Subject|3|||
156714984|NCT01349192|565700828|FG000|Overall Study|Protocol Violation|0|||
156714985|NCT01349192|565700829|FG001|Overall Study|Protocol Violation|1|||
156714986|NCT01349192|565700828|FG000|Overall Study|Withdrawal by Subject|0|||
156714987|NCT01349192|565700829|FG001|Overall Study|Withdrawal by Subject|2|||
156714988|NCT01349192|565700828|FG000|Overall Study|Lost to Follow-up|1|||
156714989|NCT01349192|565700829|FG001|Overall Study|Lost to Follow-up|3|||
156714990|NCT01349192|565700828|FG000|Overall Study|Failure to adhere to Protocol|2|||
156714991|NCT01349192|565700829|FG001|Overall Study|Failure to adhere to Protocol|0|||
156714992|NCT03749330|565700830|FG000|Overall Study|Clinicians left work in the CICU|0|||
156714993|NCT03749330|565700831|FG001|Overall Study|Clinicians left work in the CICU|2|||
156714994|NCT03749330|565700832|FG002|Overall Study|Clinicians left work in the CICU|0|||
156714995|NCT03749330|565700833|FG003|Overall Study|Clinicians left work in the CICU|0|||
156714996|NCT03749330|565700834|FG004|Overall Study|Clinicians left work in the CICU|0|||
156714997|NCT03749330|565700835|FG005|Overall Study|Clinicians left work in the CICU|0|||
156714998|NCT01973439|565700836|FG000|Overall Study|Lost samples from one PK Day|2|||
156714999|NCT01973439|565700836|FG000|Overall Study|Vomiting after commencing once daily|1|||
156715000|NCT01973439|565700836|FG000|Overall Study|PK curve incomplete|2|||
156715001|NCT02038010|565700837|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
156715002|NCT02038010|565700838|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
156715003|NCT02038010|565700839|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
156715004|NCT02038010|565700840|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
156715005|NCT02038010|565700837|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
156715006|NCT02038010|565700838|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
156715007|NCT02038010|565700839|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
156715008|NCT02038010|565700840|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
156715009|NCT02038010|565700837|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
156715010|NCT02038010|565700838|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
156715011|NCT02038010|565700839|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
156715012|NCT02038010|565700840|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
156715013|NCT02038010|565700837|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
156715014|NCT02038010|565700838|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
156715015|NCT02038010|565700839|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
156715016|NCT02038010|565700840|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
156715017|NCT02038010|565700837|FG000|Follow Up|Death|4|||
156715018|NCT02038010|565700838|FG001|Follow Up|Death|3|||
156715019|NCT02038010|565700839|FG002|Follow Up|Death|0|||
156715020|NCT02038010|565700840|FG003|Follow Up|Death|0|||
156715021|NCT02038010|565700837|FG000|Follow Up|Other|3|||
156715022|NCT02038010|565700838|FG001|Follow Up|Other|0|||
156715023|NCT02038010|565700839|FG002|Follow Up|Other|0|||
156715024|NCT02038010|565700840|FG003|Follow Up|Other|0|||
156715025|NCT00958828|565700844|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
156715026|NCT00958828|565700845|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
156715027|NCT00958828|565700844|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
156715028|NCT00958828|565700845|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
156715029|NCT00344448|565700850|FG000|Screening|Withdrawal by Subject|0|||
156874602|NCT02541604|566298706|FG010|Overall Study|Death|2|||
156874603|NCT02541604|566298707|FG011|Overall Study|Death|3|||
156874604|NCT02541604|566298696|FG000|Overall Study|Lost to Follow-up|2|||
156532480|NCT03690141|565045041|FG000|Overall Study|Physician Decision|4|||
156715030|NCT00344448|565700851|FG001|Screening|Withdrawal by Subject|1|||
156715031|NCT00344448|565700850|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
156715032|NCT00344448|565700851|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
156532481|NCT03690141|565045041|FG000|Overall Study|Disease progression|4|||
156532482|NCT00041067|565045042|FG000|Overall Study|Adverse Event|20|||
156715033|NCT00344448|565700850|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
156715034|NCT00344448|565700851|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
156715035|NCT00344448|565700850|FG000|Open Label|Withdrawal by Subject|1|||
156532483|NCT00041067|565045042|FG000|Overall Study|Progression|19|||
156532484|NCT00041067|565045042|FG000|Overall Study|Patient refusal|12|||
156715036|NCT00344448|565700851|FG001|Open Label|Withdrawal by Subject|1|||
156715037|NCT00344448|565700850|FG000|Open Label|Study terminated|1|||
156715038|NCT00344448|565700851|FG001|Open Label|Study terminated|0|||
156715039|NCT02673775|565700852|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
156715040|NCT02673775|565700853|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
156715041|NCT02673775|565700852|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
156715042|NCT02673775|565700853|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
156715043|NCT02673775|565700852|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
156715044|NCT02673775|565700853|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
156715045|NCT02673775|565700852|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
156715046|NCT02673775|565700853|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
156715047|NCT02441686|565700854|FG000|Induction|Adverse Event|4|||
156715048|NCT02441686|565700854|FG000|Induction|Complicating disease|1|||
156715049|NCT02441686|565700854|FG000|Induction|Physician Decision|1|||
156715050|NCT02441686|565700854|FG000|Induction|Withdrawal by Subject|1|||
156715051|NCT02441686|565700854|FG000|Induction|Did not receive treatment|1|||
156715052|NCT02441686|565700854|FG000|Maintenance|Remaining on Treatment|23|||
156715053|NCT02441686|565700854|FG000|Maintenance|Physician Decision|1|||
156715054|NCT02441686|565700854|FG000|Maintenance|Adverse Event|3|||
156715055|NCT02441686|565700854|FG000|Maintenance|Progressive Disease|10|||
156715056|NCT02441686|565700854|FG000|Maintenance|Withdrawal by Subject|1|||
156715057|NCT00535405|565700855|FG000|Overall Study|Adverse Event|6|||
156715058|NCT00535405|565700856|FG001|Overall Study|Adverse Event|8|||
156715059|NCT00535405|565700857|FG002|Overall Study|Adverse Event|3|||
156715060|NCT00535405|565700858|FG003|Overall Study|Adverse Event|8|||
156715061|NCT00535405|565700859|FG004|Overall Study|Adverse Event|6|||
156715062|NCT00535405|565700855|FG000|Overall Study|Lost to Follow-up|1|||
156715063|NCT00535405|565700856|FG001|Overall Study|Lost to Follow-up|3|||
156715064|NCT00535405|565700857|FG002|Overall Study|Lost to Follow-up|3|||
156715065|NCT00535405|565700858|FG003|Overall Study|Lost to Follow-up|2|||
156715066|NCT00535405|565700859|FG004|Overall Study|Lost to Follow-up|1|||
156715067|NCT00535405|565700855|FG000|Overall Study|Physician Decision|3|||
156715068|NCT00535405|565700856|FG001|Overall Study|Physician Decision|2|||
156715069|NCT00535405|565700857|FG002|Overall Study|Physician Decision|0|||
156715070|NCT00535405|565700858|FG003|Overall Study|Physician Decision|1|||
156715071|NCT00535405|565700859|FG004|Overall Study|Physician Decision|1|||
156715072|NCT00535405|565700855|FG000|Overall Study|Protocol Violation|2|||
156715073|NCT00535405|565700856|FG001|Overall Study|Protocol Violation|2|||
156715074|NCT00535405|565700857|FG002|Overall Study|Protocol Violation|2|||
156715075|NCT00535405|565700858|FG003|Overall Study|Protocol Violation|1|||
156715076|NCT00535405|565700859|FG004|Overall Study|Protocol Violation|0|||
156715077|NCT00535405|565700855|FG000|Overall Study|Withdrawal by Subject|5|||
156715078|NCT00535405|565700856|FG001|Overall Study|Withdrawal by Subject|11|||
156715079|NCT00535405|565700857|FG002|Overall Study|Withdrawal by Subject|10|||
156715080|NCT00535405|565700858|FG003|Overall Study|Withdrawal by Subject|10|||
156715081|NCT00535405|565700859|FG004|Overall Study|Withdrawal by Subject|8|||
156715082|NCT03910673|565700862|FG000|Overall Study|Adverse Event|0|||
156715083|NCT03910673|565700863|FG001|Overall Study|Adverse Event|0|||
156715084|NCT03910673|565700864|FG002|Overall Study|Adverse Event|0|||
156715085|NCT03910673|565700865|FG003|Overall Study|Adverse Event|2|||
156715086|NCT03910673|565700866|FG004|Overall Study|Adverse Event|0|||
156715087|NCT02290405|565700867|FG000|Overall Study|Withdrawal by Subject|1|||
156715088|NCT02290405|565700868|FG001|Overall Study|Withdrawal by Subject|0|||
156715089|NCT02016183|565700869|FG000|Overall Study|Case Report Forms Uncollected|13|||
156715090|NCT02016183|565700869|FG000|Overall Study|Protocol Violation|52|||
156715091|NCT03142191|565700870|FG000|Placebo Controlled Period|Death|0|||
156715092|NCT03142191|565700871|FG001|Placebo Controlled Period|Death|1|||
156792820|NCT01335685|565994769|FG000|Overall Study|Withdrawal by Subject|1|||
156792821|NCT01335685|565994770|FG001|Overall Study|Withdrawal by Subject|0|||
156792822|NCT01335685|565994771|FG002|Overall Study|Withdrawal by Subject|0|||
156792823|NCT01335685|565994772|FG003|Overall Study|Withdrawal by Subject|1|||
156792824|NCT01335685|565994773|FG004|Overall Study|Withdrawal by Subject|0|||
156792825|NCT01335685|565994774|FG005|Overall Study|Withdrawal by Subject|0|||
156792826|NCT01335685|565994775|FG006|Overall Study|Withdrawal by Subject|0|||
156792827|NCT01335685|565994776|FG007|Overall Study|Withdrawal by Subject|0|||
156715093|NCT03142191|565700872|FG002|Placebo Controlled Period|Death|1|||
156715094|NCT03142191|565700873|FG003|Placebo Controlled Period|Death|0|||
156792828|NCT01335685|565994769|FG000|Overall Study|Reason not Specified|0|||
156792829|NCT01335685|565994770|FG001|Overall Study|Reason not Specified|0|||
156715095|NCT03142191|565700874|FG004|Placebo Controlled Period|Death|0|||
156715096|NCT03142191|565700870|FG000|Placebo Controlled Period|Adverse Event|4|||
156715097|NCT03142191|565700871|FG001|Placebo Controlled Period|Adverse Event|5|||
156715098|NCT03142191|565700872|FG002|Placebo Controlled Period|Adverse Event|1|||
156715099|NCT03142191|565700873|FG003|Placebo Controlled Period|Adverse Event|0|||
156715100|NCT03142191|565700874|FG004|Placebo Controlled Period|Adverse Event|0|||
156715101|NCT03142191|565700870|FG000|Placebo Controlled Period|Progressive Disease|1|||
156715102|NCT03142191|565700871|FG001|Placebo Controlled Period|Progressive Disease|0|||
156715103|NCT03142191|565700872|FG002|Placebo Controlled Period|Progressive Disease|1|||
156715104|NCT03142191|565700873|FG003|Placebo Controlled Period|Progressive Disease|0|||
156715105|NCT03142191|565700874|FG004|Placebo Controlled Period|Progressive Disease|0|||
156715106|NCT03142191|565700870|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
156715107|NCT03142191|565700871|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
156715108|NCT03142191|565700872|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
156715109|NCT03142191|565700873|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
156715110|NCT03142191|565700874|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
156715111|NCT03142191|565700870|FG000|Placebo Controlled Period|Other Reasons|1|||
156715112|NCT03142191|565700871|FG001|Placebo Controlled Period|Other Reasons|0|||
156715113|NCT03142191|565700872|FG002|Placebo Controlled Period|Other Reasons|0|||
156715114|NCT03142191|565700873|FG003|Placebo Controlled Period|Other Reasons|0|||
156715115|NCT03142191|565700874|FG004|Placebo Controlled Period|Other Reasons|0|||
156715116|NCT03142191|565700870|FG000|Active Treatment Extension Period|Death|2|||
156715117|NCT03142191|565700871|FG001|Active Treatment Extension Period|Death|1|||
156715118|NCT03142191|565700872|FG002|Active Treatment Extension Period|Death|1|||
156715119|NCT03142191|565700873|FG003|Active Treatment Extension Period|Death|1|||
156715120|NCT03142191|565700874|FG004|Active Treatment Extension Period|Death|0|||
156715121|NCT03142191|565700870|FG000|Active Treatment Extension Period|Adverse Event|6|||
156715122|NCT03142191|565700871|FG001|Active Treatment Extension Period|Adverse Event|5|||
156715123|NCT03142191|565700872|FG002|Active Treatment Extension Period|Adverse Event|4|||
156715124|NCT03142191|565700873|FG003|Active Treatment Extension Period|Adverse Event|1|||
156715125|NCT03142191|565700874|FG004|Active Treatment Extension Period|Adverse Event|0|||
156715126|NCT03142191|565700870|FG000|Active Treatment Extension Period|Progressive Disease|10|||
156715127|NCT03142191|565700871|FG001|Active Treatment Extension Period|Progressive Disease|5|||
156715128|NCT03142191|565700872|FG002|Active Treatment Extension Period|Progressive Disease|4|||
156715129|NCT03142191|565700873|FG003|Active Treatment Extension Period|Progressive Disease|1|||
156715130|NCT03142191|565700874|FG004|Active Treatment Extension Period|Progressive Disease|2|||
156715131|NCT03142191|565700870|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
156715132|NCT03142191|565700871|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
156715133|NCT03142191|565700872|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
156715134|NCT03142191|565700873|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
156715135|NCT03142191|565700874|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
156715136|NCT03142191|565700870|FG000|Active Treatment Extension Period|Physician Decision|2|||
156715137|NCT03142191|565700871|FG001|Active Treatment Extension Period|Physician Decision|0|||
156715138|NCT03142191|565700872|FG002|Active Treatment Extension Period|Physician Decision|0|||
156715139|NCT03142191|565700873|FG003|Active Treatment Extension Period|Physician Decision|0|||
156715140|NCT03142191|565700874|FG004|Active Treatment Extension Period|Physician Decision|0|||
156715141|NCT03142191|565700870|FG000|Active Treatment Extension Period|Other Reasons|3|||
156715142|NCT03142191|565700871|FG001|Active Treatment Extension Period|Other Reasons|3|||
156715143|NCT03142191|565700872|FG002|Active Treatment Extension Period|Other Reasons|3|||
156715144|NCT03142191|565700873|FG003|Active Treatment Extension Period|Other Reasons|8|||
156715145|NCT03142191|565700874|FG004|Active Treatment Extension Period|Other Reasons|3|||
156715146|NCT03142191|565700870|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
156715147|NCT03142191|565700871|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
156715148|NCT03142191|565700872|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
156715149|NCT03142191|565700873|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
156715150|NCT03142191|565700874|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
156715151|NCT00770328|565700879|FG000|Overall Study|Adverse Event|11|||
156715152|NCT00770328|565700880|FG001|Overall Study|Adverse Event|2|||
156715153|NCT00770328|565700879|FG000|Overall Study|Lost to Follow-up|2|||
156715154|NCT00770328|565700880|FG001|Overall Study|Lost to Follow-up|2|||
156715155|NCT01512160|565700883|FG000|Overall Study|Lost to Follow-up|1|||
156715156|NCT01512160|565700884|FG001|Overall Study|Lost to Follow-up|0|||
156715157|NCT01512160|565700885|FG002|Overall Study|Lost to Follow-up|0|||
156715158|NCT01512160|565700886|FG003|Overall Study|Lost to Follow-up|0|||
156715159|NCT01512160|565700883|FG000|Overall Study|Withdrawal by Subject|1|||
156715160|NCT01512160|565700884|FG001|Overall Study|Withdrawal by Subject|0|||
156715161|NCT01512160|565700885|FG002|Overall Study|Withdrawal by Subject|0|||
156715162|NCT01512160|565700886|FG003|Overall Study|Withdrawal by Subject|1|||
156715163|NCT05022212|565700889|FG000|Overall Study|Lost to Follow-up|0|||
156715164|NCT05022212|565700890|FG001|Overall Study|Lost to Follow-up|2|||
156715165|NCT02905032|565700891|FG000|Overall Study|Withdrawal by Subject|2|||
156715166|NCT02905032|565700892|FG001|Overall Study|Withdrawal by Subject|0|||
156715167|NCT02905032|565700893|FG002|Overall Study|Withdrawal by Subject|0|||
156715168|NCT02905032|565700891|FG000|Overall Study|Protocol Violation|6|||
156715169|NCT02905032|565700892|FG001|Overall Study|Protocol Violation|12|||
156715170|NCT02905032|565700893|FG002|Overall Study|Protocol Violation|0|||
156715171|NCT02729909|565700894|FG000|Overall Study|Lost to Follow-up|0|||
156715172|NCT02729909|565700895|FG001|Overall Study|Lost to Follow-up|1|||
156715173|NCT02729909|565700894|FG000|Overall Study|Lack of Efficacy|0|||
156715174|NCT02729909|565700895|FG001|Overall Study|Lack of Efficacy|2|||
156715175|NCT02729909|565700894|FG000|Overall Study|Significant Protocol Deviation|0|||
156715176|NCT02729909|565700895|FG001|Overall Study|Significant Protocol Deviation|2|||
156715177|NCT02729909|565700894|FG000|Overall Study|Voluntary Withdrawal|1|||
156715178|NCT02729909|565700895|FG001|Overall Study|Voluntary Withdrawal|0|||
156715179|NCT00739063|565700897|FG000|Overall Study|Screen failures|8|||
156715180|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
156715181|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
156715182|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
156715183|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
156715184|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
156715185|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
156715186|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
156715187|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
156715188|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
156715189|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
156715190|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
156532485|NCT00041067|565045042|FG000|Overall Study|Other reasons|23|||
156532486|NCT00041067|565045042|FG000|Overall Study|Ineligible|2|||
156532487|NCT00778622|565045043|FG000|Overall Study|Adverse Event|5|||
156532488|NCT00778622|565045044|FG001|Overall Study|Adverse Event|4|||
156532489|NCT00778622|565045045|FG002|Overall Study|Adverse Event|7|||
156532490|NCT00778622|565045043|FG000|Overall Study|Withdrawal by Subject|4|||
156532491|NCT00778622|565045044|FG001|Overall Study|Withdrawal by Subject|5|||
156532492|NCT00778622|565045045|FG002|Overall Study|Withdrawal by Subject|5|||
156532493|NCT00778622|565045043|FG000|Overall Study|Lost to Follow-up|3|||
156532494|NCT00778622|565045044|FG001|Overall Study|Lost to Follow-up|3|||
156532495|NCT00778622|565045045|FG002|Overall Study|Lost to Follow-up|2|||
156532496|NCT00778622|565045043|FG000|Overall Study|Protocol Violation|0|||
156532497|NCT00778622|565045044|FG001|Overall Study|Protocol Violation|3|||
156532498|NCT00778622|565045045|FG002|Overall Study|Protocol Violation|0|||
156532499|NCT00778622|565045043|FG000|Overall Study|Lack of Efficacy|2|||
156532500|NCT00778622|565045044|FG001|Overall Study|Lack of Efficacy|0|||
156532501|NCT00778622|565045045|FG002|Overall Study|Lack of Efficacy|0|||
156532502|NCT00778622|565045043|FG000|Overall Study|immigration|1|||
156532503|NCT00778622|565045044|FG001|Overall Study|immigration|0|||
156532504|NCT00778622|565045045|FG002|Overall Study|immigration|0|||
156532505|NCT00778622|565045043|FG000|Overall Study|Other|1|||
156532506|NCT00778622|565045044|FG001|Overall Study|Other|0|||
156532507|NCT00778622|565045045|FG002|Overall Study|Other|1|||
156532508|NCT04744285|565045046|FG000|Overall Study|Withdrawal by Subject|1|||
156532509|NCT04744285|565045047|FG001|Overall Study|Withdrawal by Subject|1|||
156532510|NCT04744285|565045048|FG002|Overall Study|Withdrawal by Subject|2|||
156532511|NCT04744285|565045049|FG003|Overall Study|Withdrawal by Subject|1|||
156532512|NCT01251120|565045053|FG000|Overall Study|Lack of Efficacy|0|||
156532513|NCT01251120|565045054|FG001|Overall Study|Lack of Efficacy|1|||
156532514|NCT01968070|565045055|FG000|Period 1|Withdrawal by Subject|0|||
156532515|NCT01968070|565045056|FG001|Period 1|Withdrawal by Subject|1|||
156532516|NCT01968070|565045057|FG002|Period 1|Withdrawal by Subject|0|||
156715191|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
156715192|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
156715193|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
156715194|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
156715195|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
156715196|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
156715197|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
156715198|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
156715199|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
156532517|NCT01968070|565045058|FG003|Period 1|Withdrawal by Subject|0|||
156532518|NCT01968070|565045059|FG004|Period 1|Withdrawal by Subject|0|||
156715200|NCT00866359|565700898|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
156715201|NCT00866359|565700899|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
156715202|NCT00866359|565700900|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
156715203|NCT00866359|565700901|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
156715204|NCT01625091|565700902|FG000|Intervention|Death|1|||
156715205|NCT01625091|565700903|FG001|Intervention|Death|1|||
156874605|NCT02541604|566298697|FG001|Overall Study|Lost to Follow-up|0|||
156874606|NCT02541604|566298698|FG002|Overall Study|Lost to Follow-up|1|||
156874607|NCT02541604|566298699|FG003|Overall Study|Lost to Follow-up|0|||
156532519|NCT01968070|565045060|FG005|Period 1|Withdrawal by Subject|0|||
156874608|NCT02541604|566298700|FG004|Overall Study|Lost to Follow-up|0|||
156333831|NCT04889222|564320909|FG000|Overall Study|Did not proceed due to time constraints|5|||
156532520|NCT01968070|565045061|FG006|Period 1|Withdrawal by Subject|1|||
156532521|NCT01968070|565045062|FG007|Period 1|Withdrawal by Subject|0|||
156874609|NCT02541604|566298701|FG005|Overall Study|Lost to Follow-up|1|||
156532522|NCT01968070|565045063|FG008|Period 1|Withdrawal by Subject|0|||
156532523|NCT01968070|565045064|FG009|Period 1|Withdrawal by Subject|0|||
156715206|NCT01625091|565700902|FG000|Intervention|Withdrawal by Subject|4|||
156715207|NCT01625091|565700903|FG001|Intervention|Withdrawal by Subject|1|||
156715208|NCT01625091|565700902|FG000|Intervention|Adverse Event|0|||
156715209|NCT01625091|565700903|FG001|Intervention|Adverse Event|2|||
156715210|NCT01625091|565700902|FG000|Intervention|Lost to Follow-up|4|||
156715211|NCT01625091|565700903|FG001|Intervention|Lost to Follow-up|4|||
156715212|NCT01625091|565700902|FG000|Intervention|Study termination|2|||
156715213|NCT01625091|565700903|FG001|Intervention|Study termination|3|||
156715214|NCT01625091|565700902|FG000|Post-intervention|Death|0|||
156715215|NCT01625091|565700903|FG001|Post-intervention|Death|1|||
156715216|NCT01625091|565700902|FG000|Post-intervention|Lost to Follow-up|2|||
156715217|NCT01625091|565700903|FG001|Post-intervention|Lost to Follow-up|0|||
156715218|NCT01625091|565700902|FG000|Post-intervention|Study termination|2|||
156715219|NCT01625091|565700903|FG001|Post-intervention|Study termination|1|||
156715220|NCT02163057|565700904|FG000|Overall Study|Participant Refusal to Continue|2|||
156715221|NCT02163057|565700905|FG001|Overall Study|Participant Refusal to Continue|2|||
156715222|NCT02163057|565700904|FG000|Overall Study|Participant Significant Noncompliance|0|||
156715223|NCT02163057|565700905|FG001|Overall Study|Participant Significant Noncompliance|1|||
156715224|NCT02163057|565700904|FG000|Overall Study|Progression of Disease|1|||
156715225|NCT02163057|565700905|FG001|Overall Study|Progression of Disease|2|||
156715226|NCT01547390|565700909|FG000|Overall Study|Withdrawal by Subject|10|||
156715227|NCT01547390|565700910|FG001|Overall Study|Withdrawal by Subject|7|||
156715228|NCT01547390|565700909|FG000|Overall Study|termination of pregnancy|0|||
156715229|NCT01547390|565700910|FG001|Overall Study|termination of pregnancy|1|||
156715230|NCT01547390|565700909|FG000|Overall Study|Lost to Follow-up|0|||
156715231|NCT01547390|565700910|FG001|Overall Study|Lost to Follow-up|2|||
156444625|NCT01976312|564718605|FG000|Overall Study|Adverse Event|6|||
156715232|NCT01547390|565700909|FG000|Overall Study|Adverse Event|3|||
156715233|NCT01547390|565700910|FG001|Overall Study|Adverse Event|0|||
156715234|NCT00720382|565700916|FG000|Overall Study|Adverse Event|54|||
156715235|NCT00720382|565700917|FG001|Overall Study|Adverse Event|17|||
156715236|NCT00720382|565700916|FG000|Overall Study|Lack of Efficacy|18|||
156715237|NCT00720382|565700917|FG001|Overall Study|Lack of Efficacy|7|||
156715238|NCT00720382|565700916|FG000|Overall Study|Non-Compliance|15|||
156715239|NCT00720382|565700917|FG001|Overall Study|Non-Compliance|5|||
156715240|NCT00720382|565700916|FG000|Overall Study|Withdrawal by Subject|47|||
156715241|NCT00720382|565700917|FG001|Overall Study|Withdrawal by Subject|11|||
156715242|NCT00720382|565700916|FG000|Overall Study|Lost to Follow-up|28|||
156715243|NCT00720382|565700917|FG001|Overall Study|Lost to Follow-up|14|||
156715244|NCT00720382|565700916|FG000|Overall Study|administrative|14|||
156715245|NCT00720382|565700917|FG001|Overall Study|administrative|5|||
156715246|NCT05192889|565700918|FG000|Block 1: All Eligible Patients|Death|2|||
156715247|NCT05192889|565700919|FG001|Block 1: All Eligible Patients|Death|0|||
156792830|NCT01335685|565994771|FG002|Overall Study|Reason not Specified|1|||
156792831|NCT01335685|565994772|FG003|Overall Study|Reason not Specified|0|||
156792832|NCT01335685|565994773|FG004|Overall Study|Reason not Specified|0|||
156792833|NCT01335685|565994774|FG005|Overall Study|Reason not Specified|1|||
156792834|NCT01335685|565994775|FG006|Overall Study|Reason not Specified|0|||
156792835|NCT01335685|565994776|FG007|Overall Study|Reason not Specified|0|||
156792836|NCT02554474|565994779|FG000|Overall Study|Protocol Violation|1|||
156792837|NCT02554474|565994780|FG001|Overall Study|Protocol Violation|1|||
156792838|NCT02554474|565994779|FG000|Overall Study|Health issue not related to the study|1|||
156792839|NCT02554474|565994780|FG001|Overall Study|Health issue not related to the study|0|||
156792840|NCT02554474|565994779|FG000|Overall Study|Withdrawal by Subject|1|||
156792841|NCT02554474|565994780|FG001|Overall Study|Withdrawal by Subject|1|||
156792842|NCT03211832|565994781|FG000|Overall Study|No longer with agency|32|||
156792843|NCT03211832|565994782|FG001|Overall Study|No longer with agency|49|||
156792844|NCT03211832|565994783|FG002|Overall Study|No longer with agency|30|||
156792845|NCT03211832|565994781|FG000|Overall Study|Declined survey|3|||
156792846|NCT03211832|565994782|FG001|Overall Study|Declined survey|3|||
156792847|NCT03211832|565994783|FG002|Overall Study|Declined survey|2|||
156792848|NCT03211832|565994781|FG000|Overall Study|Not available during data collection|1|||
156792849|NCT03211832|565994782|FG001|Overall Study|Not available during data collection|0|||
156792850|NCT03211832|565994783|FG002|Overall Study|Not available during data collection|2|||
156874610|NCT02541604|566298702|FG006|Overall Study|Lost to Follow-up|1|||
156874611|NCT02541604|566298703|FG007|Overall Study|Lost to Follow-up|0|||
156444626|NCT01976312|564718606|FG001|Overall Study|Adverse Event|6|||
156715248|NCT05192889|565700920|FG002|Block 1: All Eligible Patients|Death|0|||
156715249|NCT05192889|565700918|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
156792851|NCT00855166|565994784|FG000|Overall Study|Adverse Event|0|||
156792852|NCT00855166|565994785|FG001|Overall Study|Adverse Event|2|||
156792853|NCT00855166|565994784|FG000|Overall Study|Death|0|||
156874612|NCT02541604|566298704|FG008|Overall Study|Lost to Follow-up|0|||
156715250|NCT05192889|565700919|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
156715251|NCT05192889|565700920|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
156715252|NCT05192889|565700918|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
156715253|NCT05192889|565700919|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
156792854|NCT00855166|565994785|FG001|Overall Study|Death|1|||
156792855|NCT00855166|565994784|FG000|Overall Study|Withdrawal by Subject|1|||
156792856|NCT00855166|565994785|FG001|Overall Study|Withdrawal by Subject|4|||
156792857|NCT00855166|565994784|FG000|Overall Study|Poor/non-compliance|2|||
156792858|NCT00855166|565994785|FG001|Overall Study|Poor/non-compliance|0|||
156792859|NCT00855166|565994784|FG000|Overall Study|Administrative reasons by sponsor|1|||
156792860|NCT00855166|565994785|FG001|Overall Study|Administrative reasons by sponsor|0|||
156792861|NCT00855166|565994784|FG000|Overall Study|Subject no longer meets study criteria|1|||
156792862|NCT00855166|565994785|FG001|Overall Study|Subject no longer meets study criteria|1|||
156792863|NCT03777020|565994789|FG000|Overall Study|Withdrawal by Subject|4|||
156792864|NCT03777020|565994790|FG001|Overall Study|Withdrawal by Subject|4|||
156792865|NCT03777020|565994789|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
156792866|NCT03777020|565994790|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
156792867|NCT00489476|565994791|FG000|Overall Study|Lost to Follow-up|0|||
156792868|NCT00489476|565994792|FG001|Overall Study|Lost to Follow-up|1|||
156792869|NCT00489476|565994793|FG002|Overall Study|Lost to Follow-up|0|||
156792870|NCT00489476|565994794|FG003|Overall Study|Lost to Follow-up|0|||
156792871|NCT03460704|565994795|FG000|Overall Study|Withdrawal by Subject|11|||
156792872|NCT03460704|565994796|FG001|Overall Study|Withdrawal by Subject|14|||
156792873|NCT03460704|565994795|FG000|Overall Study|Study terminated by the Sponsor|29|||
156792874|NCT03460704|565994796|FG001|Overall Study|Study terminated by the Sponsor|19|||
156792875|NCT03460704|565994795|FG000|Overall Study|Adverse Event|10|||
156792876|NCT03460704|565994796|FG001|Overall Study|Adverse Event|5|||
156792877|NCT03460704|565994795|FG000|Overall Study|Death|3|||
156792878|NCT03460704|565994796|FG001|Overall Study|Death|2|||
156792879|NCT03460704|565994795|FG000|Overall Study|Non-Compliance with Study Drug|3|||
156792880|NCT03460704|565994796|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156792881|NCT03460704|565994795|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156792882|NCT03460704|565994796|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
156792883|NCT03460704|565994795|FG000|Overall Study|Other|2|||
156792884|NCT03460704|565994796|FG001|Overall Study|Other|1|||
156792885|NCT02913326|565994797|FG000|Overall Study|Reason not listed|0|||
156792886|NCT02913326|565994798|FG001|Overall Study|Reason not listed|1|||
156444627|NCT01976312|564718605|FG000|Overall Study|Protocol Violation|2|||
156444628|NCT01976312|564718606|FG001|Overall Study|Protocol Violation|0|||
156444629|NCT01538719|564718607|FG000|Overall Study|Lost to Follow-up|2|||
156444630|NCT01538719|564718608|FG001|Overall Study|Lost to Follow-up|0|||
156444631|NCT02556138|564718613|FG000|Overall Study|Withdrawal by Subject|1|||
156444632|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
156444633|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
156444634|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
156444635|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
156444636|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
156444637|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
156444638|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
156444639|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
156444640|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
156444641|NCT03939312|564718614|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
156444642|NCT03939312|564718614|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
156444643|NCT03939312|564718614|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
156444644|NCT03481816|564718616|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
156444645|NCT03481816|564718617|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
156444646|NCT03481816|564718616|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
156444647|NCT03481816|564718617|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
156444648|NCT03481816|564718616|FG000|Dose Expansion|Withdrawal by Subject|0|||
156444649|NCT03481816|564718617|FG001|Dose Expansion|Withdrawal by Subject|2|||
156444650|NCT03481816|564718616|FG000|Dose Expansion|Physician Decision|0|||
156444651|NCT03481816|564718617|FG001|Dose Expansion|Physician Decision|5|||
156444652|NCT05094141|564718622|FG000|Overall Study|Death|0|||
156444653|NCT05094141|564718623|FG001|Overall Study|Death|0|||
156444654|NCT05094141|564718624|FG002|Overall Study|Death|1|||
156444655|NCT05094141|564718622|FG000|Overall Study|Withdrawal by Subject|0|||
156444656|NCT05094141|564718623|FG001|Overall Study|Withdrawal by Subject|0|||
156444657|NCT05094141|564718624|FG002|Overall Study|Withdrawal by Subject|1|||
156444658|NCT05094141|564718622|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
156444659|NCT05094141|564718623|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
156444660|NCT05094141|564718624|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
156792887|NCT02913326|565994797|FG000|Overall Study|Lost to Follow-up|0|||
156792888|NCT02913326|565994798|FG001|Overall Study|Lost to Follow-up|1|||
156792889|NCT02913326|565994797|FG000|Overall Study|Adverse Event|1|||
156792890|NCT02913326|565994798|FG001|Overall Study|Adverse Event|0|||
156792891|NCT01767857|565994799|FG000|Overall Study|Adverse Event|27|||
156792892|NCT01767857|565994800|FG001|Overall Study|Adverse Event|7|||
156792893|NCT01767857|565994799|FG000|Overall Study|Death|28|||
156715254|NCT05192889|565700920|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
156715255|NCT03713593|565703065|FG000|Overall Study|Sponsor Decision|73|||
156715256|NCT03713593|565703066|FG001|Overall Study|Sponsor Decision|41|||
156715257|NCT03713593|565703065|FG000|Overall Study|Lost to Follow-up|2|||
156715258|NCT03713593|565703066|FG001|Overall Study|Lost to Follow-up|1|||
156715259|NCT03713593|565703065|FG000|Overall Study|Death|314|||
156715260|NCT03713593|565703066|FG001|Overall Study|Death|349|||
156715261|NCT03713593|565703065|FG000|Overall Study|Withdrawal by Subject|6|||
156715262|NCT03713593|565703066|FG001|Overall Study|Withdrawal by Subject|8|||
156715263|NCT05061134|565703067|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
156715264|NCT05061134|565703068|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
156715265|NCT05061134|565703069|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
156715266|NCT05061134|565703067|FG000|Overall Study|Subject not treated|0|||
156715267|NCT05061134|565703068|FG001|Overall Study|Subject not treated|0|||
156715268|NCT05061134|565703069|FG002|Overall Study|Subject not treated|2|||
156715269|NCT05061134|565703067|FG000|Overall Study|Other|0|||
156715270|NCT05061134|565703068|FG001|Overall Study|Other|0|||
156715271|NCT05061134|565703069|FG002|Overall Study|Other|9|||
156715272|NCT05061134|565703067|FG000|Overall Study|Withdrawal by Subject|9|||
156715273|NCT05061134|565703068|FG001|Overall Study|Withdrawal by Subject|8|||
156715274|NCT05061134|565703069|FG002|Overall Study|Withdrawal by Subject|5|||
156715275|NCT05061134|565703067|FG000|Overall Study|Study Terminated by Sponsor|22|||
156715276|NCT05061134|565703068|FG001|Overall Study|Study Terminated by Sponsor|14|||
156715277|NCT05061134|565703069|FG002|Overall Study|Study Terminated by Sponsor|7|||
156715278|NCT05061134|565703067|FG000|Overall Study|Progressive Disease|1|||
156715279|NCT05061134|565703068|FG001|Overall Study|Progressive Disease|2|||
156715280|NCT05061134|565703069|FG002|Overall Study|Progressive Disease|0|||
156715281|NCT05061134|565703067|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
156715282|NCT05061134|565703068|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
156715283|NCT05061134|565703069|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
156715284|NCT05061134|565703067|FG000|Overall Study|Lost to Follow-up|1|||
156715285|NCT05061134|565703068|FG001|Overall Study|Lost to Follow-up|0|||
156715286|NCT05061134|565703069|FG002|Overall Study|Lost to Follow-up|0|||
156715287|NCT05061134|565703067|FG000|Overall Study|Physician Decision|1|||
156715288|NCT05061134|565703068|FG001|Overall Study|Physician Decision|1|||
156715289|NCT05061134|565703069|FG002|Overall Study|Physician Decision|0|||
156715290|NCT05061134|565703067|FG000|Overall Study|Disease progression|1|||
156715291|NCT05061134|565703068|FG001|Overall Study|Disease progression|0|||
156715292|NCT05061134|565703069|FG002|Overall Study|Disease progression|0|||
156715293|NCT05061134|565703067|FG000|Overall Study|Death|43|||
156715294|NCT05061134|565703068|FG001|Overall Study|Death|23|||
156715295|NCT05061134|565703069|FG002|Overall Study|Death|14|||
156715296|NCT05061134|565703067|FG000|Overall Study|Database lock|2|||
156715297|NCT05061134|565703068|FG001|Overall Study|Database lock|0|||
156715298|NCT05061134|565703069|FG002|Overall Study|Database lock|0|||
156715299|NCT03176134|565703070|FG000|Overall Study|Lost to Follow-up|0|||
156715300|NCT03176134|565703071|FG001|Overall Study|Lost to Follow-up|2|||
156715301|NCT03176134|565703072|FG002|Overall Study|Lost to Follow-up|0|||
156715302|NCT03176134|565703073|FG003|Overall Study|Lost to Follow-up|0|||
156715303|NCT03176134|565703074|FG004|Overall Study|Lost to Follow-up|0|||
156715304|NCT03176134|565703075|FG005|Overall Study|Lost to Follow-up|0|||
156715305|NCT03176134|565703076|FG006|Overall Study|Lost to Follow-up|0|||
156715306|NCT03176134|565703077|FG007|Overall Study|Lost to Follow-up|0|||
156715307|NCT03176134|565703070|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156715308|NCT03176134|565703071|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156715309|NCT03176134|565703072|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156715310|NCT03176134|565703073|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156715311|NCT03176134|565703074|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156715312|NCT03176134|565703075|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156715313|NCT03176134|565703076|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
156715314|NCT03176134|565703077|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
156715315|NCT03410056|565703082|FG000|Overall Study|Decision by Sponsor|0|||
156715316|NCT03410056|565703083|FG001|Overall Study|Decision by Sponsor|0|||
156715317|NCT03410056|565703084|FG002|Overall Study|Decision by Sponsor|3|||
156333832|NCT02639546|564320910|FG000|Overall Study|Death|2|||
156333833|NCT02639546|564320911|FG001|Overall Study|Death|2|||
156333834|NCT02639546|564320912|FG002|Overall Study|Death|1|||
156333835|NCT02639546|564320913|FG003|Overall Study|Death|2|||
156333836|NCT02639546|564320914|FG004|Overall Study|Death|2|||
156333837|NCT02639546|564320915|FG005|Overall Study|Death|2|||
156715318|NCT03410056|565703085|FG003|Overall Study|Decision by Sponsor|0|||
156715319|NCT03410056|565703086|FG004|Overall Study|Decision by Sponsor|0|||
156715320|NCT03410056|565703087|FG005|Overall Study|Decision by Sponsor|0|||
156715321|NCT03410056|565703088|FG006|Overall Study|Decision by Sponsor|0|||
156715322|NCT03410056|565703082|FG000|Overall Study|Withdrawal by Subject|0|||
156715323|NCT03410056|565703083|FG001|Overall Study|Withdrawal by Subject|2|||
156715324|NCT03410056|565703084|FG002|Overall Study|Withdrawal by Subject|5|||
156715325|NCT03410056|565703085|FG003|Overall Study|Withdrawal by Subject|5|||
156715326|NCT03410056|565703086|FG004|Overall Study|Withdrawal by Subject|0|||
156715327|NCT03410056|565703087|FG005|Overall Study|Withdrawal by Subject|0|||
156715328|NCT03410056|565703088|FG006|Overall Study|Withdrawal by Subject|0|||
156715329|NCT04182490|565703095|FG000|Overall Study|Withdrawal by Subject|3|||
156715330|NCT04182490|565703096|FG001|Overall Study|Withdrawal by Subject|3|||
156715331|NCT04182490|565703095|FG000|Overall Study|Lost to Follow-up|0|||
156715332|NCT04182490|565703096|FG001|Overall Study|Lost to Follow-up|1|||
156715333|NCT04182490|565703095|FG000|Overall Study|Physician Decision|0|||
156715334|NCT04182490|565703096|FG001|Overall Study|Physician Decision|1|||
156715335|NCT00661193|565703108|FG000|Overall Study|Adverse Event|2|||
156715336|NCT00661193|565703109|FG001|Overall Study|Adverse Event|1|||
156715337|NCT00661193|565703108|FG000|Overall Study|Withdrawal by Subject|3|||
156715338|NCT00661193|565703109|FG001|Overall Study|Withdrawal by Subject|1|||
156715339|NCT00661193|565703108|FG000|Overall Study|Progression|27|||
156715340|NCT00661193|565703109|FG001|Overall Study|Progression|24|||
156715341|NCT00661193|565703108|FG000|Overall Study|Not protocol specified|1|||
156715342|NCT00661193|565703109|FG001|Overall Study|Not protocol specified|0|||
156715343|NCT01811472|565703110|FG000|Overall Study|Adverse Event|1|||
156715344|NCT01811472|565703111|FG001|Overall Study|Adverse Event|0|||
156715345|NCT01811472|565703112|FG002|Overall Study|Adverse Event|4|||
156715346|NCT01811472|565703110|FG000|Overall Study|Lost to Follow-up|0|||
156715347|NCT01811472|565703111|FG001|Overall Study|Lost to Follow-up|0|||
156715348|NCT01811472|565703112|FG002|Overall Study|Lost to Follow-up|1|||
156715349|NCT01811472|565703110|FG000|Overall Study|Subject/guardian decision|1|||
156715350|NCT01811472|565703111|FG001|Overall Study|Subject/guardian decision|0|||
156715351|NCT01811472|565703112|FG002|Overall Study|Subject/guardian decision|0|||
156715352|NCT04882241|565703117|FG000|Overall Study|Ongoing in study|46|||
156715353|NCT04882241|565703118|FG001|Overall Study|Ongoing in study|48|||
156715354|NCT04882241|565703119|FG002|Overall Study|Ongoing in study|0|||
156715355|NCT04882241|565703120|FG003|Overall Study|Ongoing in study|0|||
156715356|NCT04882241|565703117|FG000|Overall Study|Death|13|||
156715357|NCT04882241|565703118|FG001|Overall Study|Death|13|||
156715358|NCT04882241|565703119|FG002|Overall Study|Death|0|||
156715359|NCT04882241|565703120|FG003|Overall Study|Death|0|||
156715360|NCT02719184|565703128|FG000|Overall Study|Other than listed|1|||
156715361|NCT02719184|565703129|FG001|Overall Study|Other than listed|12|||
156715362|NCT02719184|565703130|FG002|Overall Study|Other than listed|13|||
156715363|NCT02719184|565703131|FG003|Overall Study|Other than listed|22|||
156715364|NCT02719184|565703132|FG004|Overall Study|Other than listed|9|||
156715365|NCT02719184|565703128|FG000|Overall Study|Withdrawal by Subject|5|||
156715366|NCT02719184|565703129|FG001|Overall Study|Withdrawal by Subject|3|||
156715367|NCT02719184|565703130|FG002|Overall Study|Withdrawal by Subject|6|||
156874613|NCT02541604|566298705|FG009|Overall Study|Lost to Follow-up|0|||
156874614|NCT02541604|566298706|FG010|Overall Study|Lost to Follow-up|0|||
156874615|NCT02541604|566298707|FG011|Overall Study|Lost to Follow-up|0|||
156874616|NCT02541604|566298696|FG000|Overall Study|Withdrawal by Subject|2|||
156874617|NCT02541604|566298697|FG001|Overall Study|Withdrawal by Subject|0|||
156874618|NCT02541604|566298698|FG002|Overall Study|Withdrawal by Subject|1|||
156874619|NCT02541604|566298699|FG003|Overall Study|Withdrawal by Subject|0|||
156874620|NCT02541604|566298700|FG004|Overall Study|Withdrawal by Subject|1|||
156874621|NCT02541604|566298701|FG005|Overall Study|Withdrawal by Subject|1|||
156874622|NCT02541604|566298702|FG006|Overall Study|Withdrawal by Subject|0|||
156874623|NCT02541604|566298703|FG007|Overall Study|Withdrawal by Subject|0|||
156874624|NCT02541604|566298704|FG008|Overall Study|Withdrawal by Subject|1|||
156874625|NCT02541604|566298705|FG009|Overall Study|Withdrawal by Subject|0|||
156874626|NCT02541604|566298706|FG010|Overall Study|Withdrawal by Subject|0|||
156874627|NCT02541604|566298707|FG011|Overall Study|Withdrawal by Subject|0|||
156715368|NCT02719184|565703131|FG003|Overall Study|Withdrawal by Subject|6|||
156715369|NCT02719184|565703132|FG004|Overall Study|Withdrawal by Subject|0|||
156715370|NCT02719184|565703128|FG000|Overall Study|Lost to Follow-up|0|||
156715371|NCT02719184|565703129|FG001|Overall Study|Lost to Follow-up|4|||
156715372|NCT02719184|565703130|FG002|Overall Study|Lost to Follow-up|1|||
156715373|NCT02719184|565703131|FG003|Overall Study|Lost to Follow-up|3|||
156715374|NCT02719184|565703132|FG004|Overall Study|Lost to Follow-up|0|||
156715375|NCT02719184|565703128|FG000|Overall Study|Protocol Violation|0|||
156715376|NCT02719184|565703129|FG001|Overall Study|Protocol Violation|3|||
156715377|NCT02719184|565703130|FG002|Overall Study|Protocol Violation|0|||
156874628|NCT02541604|566298696|FG000|Overall Study|Study Terminated by Sponsor|1|||
156874629|NCT02541604|566298697|FG001|Overall Study|Study Terminated by Sponsor|4|||
156444661|NCT05094141|564718622|FG000|Overall Study|Did not participate in randomization|0|||
156444662|NCT05094141|564718623|FG001|Overall Study|Did not participate in randomization|0|||
156444663|NCT05094141|564718624|FG002|Overall Study|Did not participate in randomization|33|||
156715378|NCT02719184|565703131|FG003|Overall Study|Protocol Violation|2|||
156715379|NCT02719184|565703132|FG004|Overall Study|Protocol Violation|0|||
156715380|NCT02719184|565703128|FG000|Overall Study|Adverse Event|0|||
156715381|NCT02719184|565703129|FG001|Overall Study|Adverse Event|0|||
156874630|NCT02541604|566298698|FG002|Overall Study|Study Terminated by Sponsor|2|||
156874631|NCT02541604|566298699|FG003|Overall Study|Study Terminated by Sponsor|1|||
156715382|NCT02719184|565703130|FG002|Overall Study|Adverse Event|0|||
156715383|NCT02719184|565703131|FG003|Overall Study|Adverse Event|3|||
156715384|NCT02719184|565703132|FG004|Overall Study|Adverse Event|0|||
156715385|NCT04108299|565703134|FG000|Overall Study|Not interested in participating|2|||
156715386|NCT04108299|565703135|FG001|Overall Study|Not interested in participating|1|||
156715387|NCT04108299|565703136|FG002|Overall Study|Not interested in participating|2|||
156715388|NCT04108299|565703137|FG003|Overall Study|Not interested in participating|1|||
156715389|NCT05024747|565703141|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
156715390|NCT05024747|565703142|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
156715391|NCT05024747|565703141|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
156715392|NCT05024747|565703142|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
156715393|NCT05024747|565703141|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
156715394|NCT05024747|565703142|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
156715395|NCT00662649|565703143|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
156715396|NCT00662649|565703144|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
156715397|NCT00662649|565703145|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
156715398|NCT00662649|565703146|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
156715399|NCT00662649|565703147|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
156715400|NCT00662649|565703143|FG000|Core Study (24 Months)|Adverse Event|22|||
156715401|NCT00662649|565703144|FG001|Core Study (24 Months)|Adverse Event|13|||
156715402|NCT00662649|565703145|FG002|Core Study (24 Months)|Adverse Event|18|||
156715403|NCT00662649|565703146|FG003|Core Study (24 Months)|Adverse Event|0|||
156715404|NCT00662649|565703147|FG004|Core Study (24 Months)|Adverse Event|0|||
156715405|NCT00662649|565703143|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
156715406|NCT00662649|565703144|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
156715407|NCT00662649|565703145|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
156715408|NCT00662649|565703146|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
156715409|NCT00662649|565703147|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
156715410|NCT00662649|565703143|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
156715411|NCT00662649|565703144|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
156715412|NCT00662649|565703145|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
156715413|NCT00662649|565703146|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
156715414|NCT00662649|565703147|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
156715415|NCT00662649|565703143|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
156715416|NCT00662649|565703144|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
156715417|NCT00662649|565703145|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
156715418|NCT00662649|565703146|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
156715419|NCT00662649|565703147|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
156715420|NCT00662649|565703143|FG000|Core Study (24 Months)|Protocol Violation|5|||
156715421|NCT00662649|565703144|FG001|Core Study (24 Months)|Protocol Violation|5|||
156715422|NCT00662649|565703145|FG002|Core Study (24 Months)|Protocol Violation|4|||
156715423|NCT00662649|565703146|FG003|Core Study (24 Months)|Protocol Violation|0|||
156715424|NCT00662649|565703147|FG004|Core Study (24 Months)|Protocol Violation|0|||
156715425|NCT00662649|565703143|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
156715426|NCT00662649|565703144|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
156715427|NCT00662649|565703145|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
156715428|NCT00662649|565703146|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
156715429|NCT00662649|565703147|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
156715430|NCT00662649|565703143|FG000|Core Study (24 Months)|Death|1|||
156715431|NCT00662649|565703144|FG001|Core Study (24 Months)|Death|0|||
156715432|NCT00662649|565703145|FG002|Core Study (24 Months)|Death|2|||
156715433|NCT00662649|565703146|FG003|Core Study (24 Months)|Death|0|||
156715434|NCT00662649|565703147|FG004|Core Study (24 Months)|Death|0|||
156715435|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
156715436|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
156715437|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
156792894|NCT01767857|565994800|FG001|Overall Study|Death|13|||
156792895|NCT01767857|565994799|FG000|Overall Study|Lack of Efficacy|299|||
156792896|NCT01767857|565994800|FG001|Overall Study|Lack of Efficacy|151|||
156792897|NCT01767857|565994799|FG000|Overall Study|Lost to Follow-up|1|||
156792898|NCT01767857|565994800|FG001|Overall Study|Lost to Follow-up|1|||
156792899|NCT01767857|565994799|FG000|Overall Study|Withdrawal by Subject|38|||
156792900|NCT01767857|565994800|FG001|Overall Study|Withdrawal by Subject|18|||
156792901|NCT01767857|565994799|FG000|Overall Study|Physician Decision|17|||
156792902|NCT01767857|565994800|FG001|Overall Study|Physician Decision|10|||
156532524|NCT01968070|565045065|FG010|Period 1|Withdrawal by Subject|0|||
156715438|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
156715439|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
156715440|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
156792903|NCT01767857|565994799|FG000|Overall Study|Protocol Terminated|1|||
156792904|NCT01767857|565994800|FG001|Overall Study|Protocol Terminated|0|||
156715441|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
156715442|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
156715443|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
156715444|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
156715445|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
156715446|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
156715447|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
156715448|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
156715449|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
156715450|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
156715451|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
156715452|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
156715453|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
156715454|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
156715455|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
156715456|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
156715457|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
156715458|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
156715459|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
156715460|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
156715461|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
156715462|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
156715463|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
156715464|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
156715465|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
156715466|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
156715467|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
156715468|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
156715469|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
156715470|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
156715471|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
156715472|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
156715473|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
156715474|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
156715475|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
156715476|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
156715477|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
156715478|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
156715479|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
156715480|NCT01026194|565703149|FG000|Period 1：Double Blind Period|Adverse Event|2|||
156715481|NCT01026194|565703150|FG001|Period 1：Double Blind Period|Adverse Event|1|||
156715482|NCT01026194|565703149|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
156715483|NCT01026194|565703150|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
156715484|NCT01026194|565703149|FG000|Period 1：Double Blind Period|Physician Decision|0|||
156715485|NCT01026194|565703150|FG001|Period 1：Double Blind Period|Physician Decision|4|||
156715486|NCT01026194|565703149|FG000|Period 2：Open-label Period|Adverse Event|4|||
156715487|NCT01026194|565703150|FG001|Period 2：Open-label Period|Adverse Event|5|||
156715488|NCT01026194|565703149|FG000|Period 2：Open-label Period|Physician Decision|3|||
156715489|NCT01026194|565703150|FG001|Period 2：Open-label Period|Physician Decision|1|||
156715490|NCT01026194|565703149|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
156715491|NCT01026194|565703150|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
156715492|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
156715493|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
156715494|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
156715495|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156333838|NCT02639546|564320916|FG006|Overall Study|Death|0|||
156333839|NCT02639546|564320917|FG007|Overall Study|Death|0|||
156333840|NCT02639546|564320910|FG000|Overall Study|Lost to Follow-up|0|||
156333841|NCT02639546|564320911|FG001|Overall Study|Lost to Follow-up|0|||
156333842|NCT02639546|564320912|FG002|Overall Study|Lost to Follow-up|1|||
156333843|NCT02639546|564320913|FG003|Overall Study|Lost to Follow-up|0|||
156333844|NCT02639546|564320914|FG004|Overall Study|Lost to Follow-up|1|||
156333845|NCT02639546|564320915|FG005|Overall Study|Lost to Follow-up|1|||
156333846|NCT02639546|564320916|FG006|Overall Study|Lost to Follow-up|0|||
156333847|NCT02639546|564320917|FG007|Overall Study|Lost to Follow-up|1|||
156333848|NCT02639546|564320910|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
156333849|NCT02639546|564320911|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
156715496|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
156715497|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
156715498|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715499|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715500|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715501|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715502|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715503|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715504|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715505|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715506|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715507|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715508|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715509|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
156715510|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715511|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
156715512|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
156715513|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
156715514|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
156715515|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715516|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715517|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715518|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715519|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715520|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715521|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715522|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715523|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715524|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715525|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715526|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
156715527|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
156715528|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
156715529|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
156715530|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
156715531|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
156715532|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715533|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715534|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715535|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715536|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715537|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715538|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715539|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715540|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715541|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715542|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715543|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715544|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
156715545|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
156715546|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156444664|NCT02576509|564720281|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
156444665|NCT02576509|564720282|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
156444666|NCT02576509|564720281|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
156444667|NCT02576509|564720282|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
156444668|NCT02576509|564720281|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
156444669|NCT02576509|564720282|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
156444670|NCT02576509|564720281|FG000|Treatment Period|Disease progression|263|||
156444671|NCT02576509|564720282|FG001|Treatment Period|Disease progression|244|||
156444672|NCT02576509|564720281|FG000|Treatment Period|Study drug toxicity|37|||
156444673|NCT02576509|564720282|FG001|Treatment Period|Study drug toxicity|41|||
156444674|NCT02576509|564720281|FG000|Treatment Period|Death|1|||
156444675|NCT02576509|564720282|FG001|Treatment Period|Death|1|||
156444676|NCT02576509|564720281|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
156444677|NCT02576509|564720282|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
156715547|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
156715548|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
156715549|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715550|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715551|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715552|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715553|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715554|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715555|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715556|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715557|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715558|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715559|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715560|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715561|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715562|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
156715563|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
156715564|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715565|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715566|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715567|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715568|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715569|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715570|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715571|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715572|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715573|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715574|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715575|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715576|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715577|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715578|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715579|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715580|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715581|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
156715582|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715583|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715584|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715585|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715586|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715587|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715588|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715589|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715590|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715591|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715592|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715593|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715594|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715595|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
156715596|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715597|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715598|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715599|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715600|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715601|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715602|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715603|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715604|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715605|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715606|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156792905|NCT01767857|565994799|FG000|Overall Study|Randomized But Never Treated|19|||
156792906|NCT01767857|565994800|FG001|Overall Study|Randomized But Never Treated|13|||
156792907|NCT01421459|565994801|FG000|Overall Study|Adverse Event|6|||
156792908|NCT01421459|565994802|FG001|Overall Study|Adverse Event|10|||
156792909|NCT01421459|565994801|FG000|Overall Study|Death|1|||
156792910|NCT01421459|565994802|FG001|Overall Study|Death|1|||
156715607|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156792911|NCT01421459|565994801|FG000|Overall Study|Lack of Efficacy|1|||
156792912|NCT01421459|565994802|FG001|Overall Study|Lack of Efficacy|2|||
156792913|NCT01421459|565994801|FG000|Overall Study|Lost to Follow-up|8|||
156792914|NCT01421459|565994802|FG001|Overall Study|Lost to Follow-up|9|||
156532525|NCT01968070|565045066|FG011|Period 1|Withdrawal by Subject|0|||
156532526|NCT01968070|565045067|FG012|Period 1|Withdrawal by Subject|0|||
156532527|NCT01968070|565045068|FG013|Period 1|Withdrawal by Subject|0|||
156532528|NCT01968070|565045069|FG014|Period 1|Withdrawal by Subject|0|||
156532529|NCT01968070|565045070|FG015|Period 1|Withdrawal by Subject|1|||
156532530|NCT01968070|565045071|FG016|Period 1|Withdrawal by Subject|0|||
156532531|NCT01968070|565045072|FG017|Period 1|Withdrawal by Subject|0|||
156532532|NCT01968070|565045055|FG000|Period 1|Protocol Violation|0|||
156532533|NCT01968070|565045056|FG001|Period 1|Protocol Violation|0|||
156532534|NCT01968070|565045057|FG002|Period 1|Protocol Violation|0|||
156532535|NCT01968070|565045058|FG003|Period 1|Protocol Violation|1|||
156532536|NCT01968070|565045059|FG004|Period 1|Protocol Violation|1|||
156532537|NCT01968070|565045060|FG005|Period 1|Protocol Violation|0|||
156532538|NCT01968070|565045061|FG006|Period 1|Protocol Violation|0|||
156532539|NCT01968070|565045062|FG007|Period 1|Protocol Violation|0|||
156532540|NCT01968070|565045063|FG008|Period 1|Protocol Violation|0|||
156532541|NCT01968070|565045064|FG009|Period 1|Protocol Violation|0|||
156532542|NCT01968070|565045065|FG010|Period 1|Protocol Violation|0|||
156532543|NCT01968070|565045066|FG011|Period 1|Protocol Violation|0|||
156532544|NCT01968070|565045067|FG012|Period 1|Protocol Violation|0|||
156532545|NCT01968070|565045068|FG013|Period 1|Protocol Violation|0|||
156532546|NCT01968070|565045069|FG014|Period 1|Protocol Violation|0|||
156532547|NCT01968070|565045070|FG015|Period 1|Protocol Violation|0|||
156532548|NCT01968070|565045071|FG016|Period 1|Protocol Violation|0|||
156532549|NCT01968070|565045072|FG017|Period 1|Protocol Violation|0|||
156532550|NCT01968070|565045055|FG000|Period 1|Lost to Follow-up|0|||
156532551|NCT01968070|565045056|FG001|Period 1|Lost to Follow-up|0|||
156532552|NCT01968070|565045057|FG002|Period 1|Lost to Follow-up|0|||
156532553|NCT01968070|565045058|FG003|Period 1|Lost to Follow-up|1|||
156532554|NCT01968070|565045059|FG004|Period 1|Lost to Follow-up|0|||
156532555|NCT01968070|565045060|FG005|Period 1|Lost to Follow-up|0|||
156532556|NCT01968070|565045061|FG006|Period 1|Lost to Follow-up|0|||
156532557|NCT01968070|565045062|FG007|Period 1|Lost to Follow-up|0|||
156532558|NCT01968070|565045063|FG008|Period 1|Lost to Follow-up|0|||
156532559|NCT01968070|565045064|FG009|Period 1|Lost to Follow-up|0|||
156532560|NCT01968070|565045065|FG010|Period 1|Lost to Follow-up|0|||
156532561|NCT01968070|565045066|FG011|Period 1|Lost to Follow-up|0|||
156532562|NCT01968070|565045067|FG012|Period 1|Lost to Follow-up|0|||
156532563|NCT01968070|565045068|FG013|Period 1|Lost to Follow-up|0|||
156532564|NCT01968070|565045069|FG014|Period 1|Lost to Follow-up|0|||
156532565|NCT01968070|565045070|FG015|Period 1|Lost to Follow-up|0|||
156532566|NCT01968070|565045071|FG016|Period 1|Lost to Follow-up|0|||
156532567|NCT01968070|565045072|FG017|Period 1|Lost to Follow-up|0|||
156532568|NCT01968070|565045055|FG000|Period 1|Adverse Event|0|||
156532569|NCT01968070|565045056|FG001|Period 1|Adverse Event|0|||
156715608|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715609|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715610|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715611|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715612|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
156715613|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715614|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715615|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715616|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715617|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715618|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715619|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715620|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715621|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156792915|NCT01421459|565994801|FG000|Overall Study|Physician Decision|9|||
156792916|NCT01421459|565994802|FG001|Overall Study|Physician Decision|9|||
156792917|NCT01421459|565994801|FG000|Overall Study|Protocol Violation|8|||
156792918|NCT01421459|565994802|FG001|Overall Study|Protocol Violation|5|||
156792919|NCT01421459|565994801|FG000|Overall Study|Withdrawal by Subject|12|||
156532570|NCT01968070|565045057|FG002|Period 1|Adverse Event|0|||
156532571|NCT01968070|565045058|FG003|Period 1|Adverse Event|0|||
156532572|NCT01968070|565045059|FG004|Period 1|Adverse Event|0|||
156792920|NCT01421459|565994802|FG001|Overall Study|Withdrawal by Subject|16|||
156532573|NCT01968070|565045060|FG005|Period 1|Adverse Event|0|||
156792921|NCT01422382|565994805|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
156532574|NCT01968070|565045061|FG006|Period 1|Adverse Event|1|||
156532575|NCT01968070|565045062|FG007|Period 1|Adverse Event|0|||
156532576|NCT01968070|565045063|FG008|Period 1|Adverse Event|0|||
156532577|NCT01968070|565045064|FG009|Period 1|Adverse Event|0|||
156532578|NCT01968070|565045065|FG010|Period 1|Adverse Event|0|||
156532579|NCT01968070|565045066|FG011|Period 1|Adverse Event|0|||
156532580|NCT01968070|565045067|FG012|Period 1|Adverse Event|0|||
156532581|NCT01968070|565045068|FG013|Period 1|Adverse Event|0|||
156532582|NCT01968070|565045069|FG014|Period 1|Adverse Event|0|||
156715622|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715623|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715624|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715625|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715626|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715627|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715628|NCT00758524|565703151|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715629|NCT00758524|565703152|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715630|NCT00758524|565703153|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715631|NCT00758524|565703154|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715632|NCT00758524|565703155|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715633|NCT00758524|565703156|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715634|NCT00758524|565703157|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715635|NCT00758524|565703158|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715636|NCT00758524|565703159|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
156715637|NCT00758524|565703160|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715638|NCT00758524|565703161|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715639|NCT00758524|565703162|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715640|NCT00758524|565703163|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715641|NCT00758524|565703164|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715642|NCT00758524|565703165|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715643|NCT00758524|565703166|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715644|NCT00758524|565703167|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715645|NCT00758524|565703151|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715646|NCT00758524|565703152|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715647|NCT00758524|565703153|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715648|NCT00758524|565703154|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715649|NCT00758524|565703155|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715650|NCT00758524|565703156|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715651|NCT00758524|565703157|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
156715652|NCT00758524|565703158|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715653|NCT00758524|565703159|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715654|NCT00758524|565703160|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715655|NCT00758524|565703161|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715656|NCT00758524|565703162|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715657|NCT00758524|565703163|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156444678|NCT02576509|564720281|FG000|Treatment Period|Participant request to stop treatment|8|||
156444679|NCT02576509|564720282|FG001|Treatment Period|Participant request to stop treatment|18|||
156444680|NCT02576509|564720281|FG000|Treatment Period|Participant withdrew consent|3|||
156444681|NCT02576509|564720282|FG001|Treatment Period|Participant withdrew consent|7|||
156444682|NCT02576509|564720281|FG000|Treatment Period|Lost to Follow-up|0|||
156444683|NCT02576509|564720282|FG001|Treatment Period|Lost to Follow-up|1|||
156444684|NCT02576509|564720281|FG000|Treatment Period|Maximum clinical benefit|1|||
156444685|NCT02576509|564720282|FG001|Treatment Period|Maximum clinical benefit|0|||
156444686|NCT02576509|564720281|FG000|Treatment Period|Poor/non-compliance|1|||
156444687|NCT02576509|564720282|FG001|Treatment Period|Poor/non-compliance|1|||
156444688|NCT02576509|564720281|FG000|Treatment Period|Participant no longer meets criteria|1|||
156444689|NCT02576509|564720282|FG001|Treatment Period|Participant no longer meets criteria|0|||
156444690|NCT02576509|564720281|FG000|Treatment Period|Other reason|12|||
156444691|NCT02576509|564720282|FG001|Treatment Period|Other reason|8|||
156444692|NCT02576509|564720281|FG000|Treatment Period|NOT REPORTED|1|||
156444693|NCT02576509|564720282|FG001|Treatment Period|NOT REPORTED|0|||
156444694|NCT02576509|564720281|FG000|Treatment Period|Administrative reason by sponsor|0|||
156444695|NCT02576509|564720282|FG001|Treatment Period|Administrative reason by sponsor|1|||
156444696|NCT01216176|564720285|FG000|Overall Study|Adverse Event|0|||
156444697|NCT01216176|564720286|FG001|Overall Study|Adverse Event|8|||
156444698|NCT01216176|564720287|FG002|Overall Study|Adverse Event|0|||
156444699|NCT01216176|564720285|FG000|Overall Study|Physician Decision|0|||
156444700|NCT01216176|564720286|FG001|Overall Study|Physician Decision|0|||
156444701|NCT01216176|564720287|FG002|Overall Study|Physician Decision|1|||
156444702|NCT01600014|564720288|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
156444703|NCT01600014|564720289|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
156444704|NCT01600014|564720288|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
156444705|NCT01600014|564720289|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
156532583|NCT01968070|565045070|FG015|Period 1|Adverse Event|0|||
156874632|NCT02541604|566298700|FG004|Overall Study|Study Terminated by Sponsor|0|||
156874633|NCT02541604|566298701|FG005|Overall Study|Study Terminated by Sponsor|0|||
156715658|NCT00758524|565703164|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715659|NCT00758524|565703165|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715660|NCT00758524|565703166|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715661|NCT00758524|565703167|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715662|NCT03519087|565703182|FG000|Clinic Evaluation|Physician Decision|15|||
156715663|NCT03519087|565703183|FG001|Clinic Evaluation|Physician Decision|18|||
156715664|NCT03519087|565703184|FG002|Clinic Evaluation|Physician Decision|0|||
156715665|NCT03519087|565703185|FG003|Clinic Evaluation|Physician Decision|0|||
156715666|NCT03519087|565703186|FG004|Clinic Evaluation|Physician Decision|0|||
156715667|NCT03519087|565703182|FG000|Clinic Evaluation|Protocol Violation|1|||
156715668|NCT03519087|565703183|FG001|Clinic Evaluation|Protocol Violation|0|||
156715669|NCT03519087|565703184|FG002|Clinic Evaluation|Protocol Violation|0|||
156715670|NCT03519087|565703185|FG003|Clinic Evaluation|Protocol Violation|0|||
156715671|NCT03519087|565703186|FG004|Clinic Evaluation|Protocol Violation|0|||
156715672|NCT03519087|565703182|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
156715673|NCT03519087|565703183|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
156715674|NCT03519087|565703184|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
156715675|NCT03519087|565703185|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
156715676|NCT03519087|565703186|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
156715677|NCT03519087|565703182|FG000|Re-randomization for Treatment|Not appropriate|2|||
156715678|NCT03519087|565703183|FG001|Re-randomization for Treatment|Not appropriate|3|||
156715679|NCT03519087|565703184|FG002|Re-randomization for Treatment|Not appropriate|0|||
156715680|NCT03519087|565703185|FG003|Re-randomization for Treatment|Not appropriate|0|||
156715681|NCT03519087|565703186|FG004|Re-randomization for Treatment|Not appropriate|0|||
156715682|NCT03519087|565703182|FG000|Laboratory Testing|Lost to Follow-up|0|||
156715683|NCT03519087|565703183|FG001|Laboratory Testing|Lost to Follow-up|0|||
156715684|NCT03519087|565703184|FG002|Laboratory Testing|Lost to Follow-up|2|||
156715685|NCT03519087|565703185|FG003|Laboratory Testing|Lost to Follow-up|3|||
156874634|NCT02541604|566298702|FG006|Overall Study|Study Terminated by Sponsor|0|||
156874635|NCT02541604|566298703|FG007|Overall Study|Study Terminated by Sponsor|0|||
156715686|NCT03519087|565703186|FG004|Laboratory Testing|Lost to Follow-up|6|||
156715687|NCT03519087|565703182|FG000|Laboratory Testing|Protocol Violation|0|||
156715688|NCT03519087|565703183|FG001|Laboratory Testing|Protocol Violation|0|||
156715689|NCT03519087|565703184|FG002|Laboratory Testing|Protocol Violation|0|||
156715690|NCT03519087|565703185|FG003|Laboratory Testing|Protocol Violation|1|||
156715691|NCT03519087|565703186|FG004|Laboratory Testing|Protocol Violation|0|||
156715692|NCT01137071|565703187|FG000|Overall Study|Disease Progression|11|||
156715693|NCT01137071|565703187|FG000|Overall Study|Withdrawal by Subject|2|||
156715694|NCT01137071|565703187|FG000|Overall Study|Wrongly Included|1|||
156715695|NCT04807400|565703188|FG000|Overall Study|Adverse Event|2|||
156715696|NCT04807400|565703189|FG001|Overall Study|Adverse Event|3|||
156715697|NCT04807400|565703190|FG002|Overall Study|Adverse Event|3|||
156715698|NCT04807400|565703188|FG000|Overall Study|Death|2|||
156715699|NCT04807400|565703189|FG001|Overall Study|Death|0|||
156715700|NCT04807400|565703190|FG002|Overall Study|Death|0|||
156715701|NCT04807400|565703188|FG000|Overall Study|Lost to Follow-up|8|||
156715702|NCT04807400|565703189|FG001|Overall Study|Lost to Follow-up|6|||
156715703|NCT04807400|565703190|FG002|Overall Study|Lost to Follow-up|6|||
156715704|NCT04807400|565703188|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156715705|NCT04807400|565703189|FG001|Overall Study|Non-Compliance With Study Drug|4|||
156874636|NCT02541604|566298704|FG008|Overall Study|Study Terminated by Sponsor|0|||
156715706|NCT04807400|565703190|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156874637|NCT02541604|566298705|FG009|Overall Study|Study Terminated by Sponsor|0|||
156874638|NCT02541604|566298706|FG010|Overall Study|Study Terminated by Sponsor|0|||
156874639|NCT02541604|566298707|FG011|Overall Study|Study Terminated by Sponsor|0|||
156874640|NCT02541604|566298696|FG000|Overall Study|Medical condition may jeopardize safety|0|||
156715707|NCT04807400|565703188|FG000|Overall Study|Participant Decision|20|||
156715708|NCT04807400|565703189|FG001|Overall Study|Participant Decision|19|||
156715709|NCT04807400|565703190|FG002|Overall Study|Participant Decision|26|||
156715710|NCT04807400|565703188|FG000|Overall Study|Physician Decision|0|||
156715711|NCT04807400|565703189|FG001|Overall Study|Physician Decision|1|||
156715712|NCT04807400|565703190|FG002|Overall Study|Physician Decision|0|||
156715713|NCT04807400|565703188|FG000|Overall Study|Protocol Violation|4|||
156715714|NCT04807400|565703189|FG001|Overall Study|Protocol Violation|3|||
156715715|NCT04807400|565703190|FG002|Overall Study|Protocol Violation|7|||
156715716|NCT04807400|565703188|FG000|Overall Study|Withdrawal by Subject|13|||
156715717|NCT04807400|565703189|FG001|Overall Study|Withdrawal by Subject|9|||
156715718|NCT04807400|565703190|FG002|Overall Study|Withdrawal by Subject|20|||
156715719|NCT04807400|565703188|FG000|Overall Study|Mis-randomized|1|||
156715720|NCT04807400|565703189|FG001|Overall Study|Mis-randomized|0|||
156715721|NCT04807400|565703190|FG002|Overall Study|Mis-randomized|0|||
156715722|NCT04194645|565703191|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156874641|NCT02541604|566298697|FG001|Overall Study|Medical condition may jeopardize safety|0|||
156874642|NCT02541604|566298698|FG002|Overall Study|Medical condition may jeopardize safety|0|||
156874643|NCT02541604|566298699|FG003|Overall Study|Medical condition may jeopardize safety|0|||
156874644|NCT02541604|566298700|FG004|Overall Study|Medical condition may jeopardize safety|0|||
156874645|NCT02541604|566298701|FG005|Overall Study|Medical condition may jeopardize safety|0|||
156874646|NCT02541604|566298702|FG006|Overall Study|Medical condition may jeopardize safety|0|||
156874647|NCT02541604|566298703|FG007|Overall Study|Medical condition may jeopardize safety|1|||
156874648|NCT02541604|566298704|FG008|Overall Study|Medical condition may jeopardize safety|0|||
156874649|NCT02541604|566298705|FG009|Overall Study|Medical condition may jeopardize safety|0|||
156874650|NCT02541604|566298706|FG010|Overall Study|Medical condition may jeopardize safety|0|||
156874651|NCT02541604|566298707|FG011|Overall Study|Medical condition may jeopardize safety|0|||
156874652|NCT00828204|566298708|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
156874653|NCT00828204|566298709|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
156874654|NCT00828204|566298708|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
156874655|NCT00828204|566298709|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
156874656|NCT00828204|566298708|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
156874657|NCT00828204|566298709|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
156874658|NCT00828204|566298708|FG000|Main Study: After Study Restart|Adverse Event|0|||
156874659|NCT00828204|566298709|FG001|Main Study: After Study Restart|Adverse Event|2|||
156874660|NCT00828204|566298708|FG000|Main Study: After Study Restart|Noncompliance|0|||
156874661|NCT00828204|566298709|FG001|Main Study: After Study Restart|Noncompliance|1|||
156874662|NCT00828204|566298708|FG000|Extension Study|Lost to Follow-up|0|||
156874663|NCT00828204|566298709|FG001|Extension Study|Lost to Follow-up|1|||
156874664|NCT00828204|566298708|FG000|Extension Study|Physician Decision|0|||
156874665|NCT00828204|566298709|FG001|Extension Study|Physician Decision|2|||
156874666|NCT00806819|566298710|FG000|Overall Study|progressive disease (modified RECIST )|217|||
156874667|NCT00806819|566298711|FG001|Overall Study|progressive disease (modified RECIST )|216|||
156874668|NCT00806819|566298710|FG000|Overall Study|Worsening or AE of underlying disease|18|||
156874669|NCT00806819|566298711|FG001|Overall Study|Worsening or AE of underlying disease|25|||
156874670|NCT00806819|566298710|FG000|Overall Study|Other AE|38|||
156715723|NCT04194645|565703192|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715724|NCT04194645|565703193|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715725|NCT04194645|565703194|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715726|NCT04194645|565703195|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715727|NCT04194645|565703196|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715728|NCT04194645|565703197|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715729|NCT04194645|565703198|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715730|NCT04194645|565703199|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715731|NCT04194645|565703200|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
156715732|NCT04194645|565703201|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715733|NCT04194645|565703202|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715734|NCT04194645|565703203|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715735|NCT04194645|565703204|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715736|NCT04194645|565703205|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715737|NCT03656744|565703206|FG000|Overall Study|Adverse Event|1|||
156715738|NCT03656744|565703207|FG001|Overall Study|Adverse Event|4|||
156715739|NCT03656744|565703208|FG002|Overall Study|Adverse Event|1|||
156715740|NCT03656744|565703206|FG000|Overall Study|Protocol Violation|1|||
156715741|NCT03656744|565703207|FG001|Overall Study|Protocol Violation|0|||
156715742|NCT03656744|565703208|FG002|Overall Study|Protocol Violation|0|||
156715743|NCT03656744|565703206|FG000|Overall Study|Lost to Follow-up|2|||
156715744|NCT03656744|565703207|FG001|Overall Study|Lost to Follow-up|2|||
156715745|NCT03656744|565703208|FG002|Overall Study|Lost to Follow-up|0|||
156715746|NCT03656744|565703206|FG000|Overall Study|Withdrawal by Subject|0|||
156715747|NCT03656744|565703207|FG001|Overall Study|Withdrawal by Subject|1|||
156715748|NCT03656744|565703208|FG002|Overall Study|Withdrawal by Subject|0|||
156874671|NCT00806819|566298711|FG001|Overall Study|Other AE|40|||
156532584|NCT01968070|565045071|FG016|Period 1|Adverse Event|0|||
156532585|NCT01968070|565045072|FG017|Period 1|Adverse Event|0|||
156532586|NCT01968070|565045055|FG000|Period 1|Physician Decision|0|||
156532587|NCT01968070|565045056|FG001|Period 1|Physician Decision|0|||
156532588|NCT01968070|565045057|FG002|Period 1|Physician Decision|0|||
156532589|NCT01968070|565045058|FG003|Period 1|Physician Decision|0|||
156715749|NCT03656744|565703206|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
156715750|NCT03656744|565703207|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
156715751|NCT03656744|565703208|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
156715752|NCT03076775|565703209|FG000|Overall Study|Lost to Follow-up|1|||
156874672|NCT00806819|566298710|FG000|Overall Study|Protocol Violation|9|||
156874673|NCT00806819|566298711|FG001|Overall Study|Protocol Violation|4|||
156874674|NCT00806819|566298710|FG000|Overall Study|Lost to Follow-up|1|||
156874675|NCT00806819|566298711|FG001|Overall Study|Lost to Follow-up|0|||
156532590|NCT01968070|565045059|FG004|Period 1|Physician Decision|0|||
156874676|NCT00806819|566298710|FG000|Overall Study|Withdrawal by Subject|32|||
156715753|NCT03076775|565703210|FG001|Overall Study|Lost to Follow-up|0|||
156715754|NCT00940316|565703211|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
156715755|NCT00940316|565703212|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
156715756|NCT00940316|565703213|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
156715757|NCT00940316|565703211|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
156715758|NCT00940316|565703212|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
156715759|NCT00940316|565703213|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
156715760|NCT00940316|565703211|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
156715761|NCT00940316|565703212|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
156715762|NCT00940316|565703213|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
156715763|NCT00940316|565703211|FG000|Treated After Cycle 5|Adverse Event|0|||
156715764|NCT00940316|565703212|FG001|Treated After Cycle 5|Adverse Event|0|||
156715765|NCT00940316|565703213|FG002|Treated After Cycle 5|Adverse Event|1|||
156715766|NCT00940316|565703211|FG000|Treated After Cycle 5|Progressive disease|0|||
156715767|NCT00940316|565703212|FG001|Treated After Cycle 5|Progressive disease|1|||
156715768|NCT00940316|565703213|FG002|Treated After Cycle 5|Progressive disease|0|||
156715769|NCT00996489|565703216|FG000|Overall Study|Device failure|45|||
156715770|NCT00996489|565703216|FG000|Overall Study|Discontinued|116|||
156715771|NCT00129545|565703219|FG000|Overall Study|Death|5|||
156715772|NCT00129545|565703220|FG001|Overall Study|Death|60|||
156715773|NCT00129545|565703221|FG002|Overall Study|Death|44|||
156715774|NCT00129545|565703219|FG000|Overall Study|Withdrawal by Subject|3|||
156715775|NCT00129545|565703220|FG001|Overall Study|Withdrawal by Subject|18|||
156715776|NCT00129545|565703221|FG002|Overall Study|Withdrawal by Subject|44|||
156715777|NCT00129545|565703219|FG000|Overall Study|Lost to Follow-up|2|||
156715778|NCT00129545|565703220|FG001|Overall Study|Lost to Follow-up|22|||
156715779|NCT00129545|565703221|FG002|Overall Study|Lost to Follow-up|13|||
156715780|NCT00129545|565703219|FG000|Overall Study|Physician Decision|0|||
156715781|NCT00129545|565703220|FG001|Overall Study|Physician Decision|3|||
156874677|NCT00806819|566298711|FG001|Overall Study|Withdrawal by Subject|29|||
156874678|NCT00806819|566298710|FG000|Overall Study|Not treated|6|||
156874679|NCT00806819|566298711|FG001|Overall Study|Not treated|3|||
156874680|NCT00806819|566298710|FG000|Overall Study|Reasons other than stated above|25|||
156874681|NCT00806819|566298711|FG001|Overall Study|Reasons other than stated above|41|||
156874682|NCT02840461|566298715|FG000|Overall Study|Adverse Event|1|||
156874683|NCT02840461|566298716|FG001|Overall Study|Adverse Event|5|||
156444706|NCT01600014|564720288|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
156444707|NCT01600014|564720289|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
156444708|NCT01600014|564720288|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
156444709|NCT01600014|564720289|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
156715782|NCT00129545|565703221|FG002|Overall Study|Physician Decision|10|||
156715783|NCT00129545|565703219|FG000|Overall Study|Device not implanted|16|||
156715784|NCT00129545|565703220|FG001|Overall Study|Device not implanted|61|||
156715785|NCT00129545|565703221|FG002|Overall Study|Device not implanted|0|||
156715786|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
156715787|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
156715788|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
156715789|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
156715790|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
156715791|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
156715792|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
156715793|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
156715794|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
156715795|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
156715796|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
156715797|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
156715798|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
156874684|NCT02840461|566298717|FG002|Overall Study|Adverse Event|3|||
156874685|NCT02840461|566298715|FG000|Overall Study|Lost to Follow-up|10|||
156874686|NCT02840461|566298716|FG001|Overall Study|Lost to Follow-up|7|||
156444710|NCT01600014|564720288|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
156444711|NCT01600014|564720289|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
156444712|NCT01600014|564720288|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
156532591|NCT01968070|565045060|FG005|Period 1|Physician Decision|0|||
156715799|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
156715800|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
156715801|NCT01130493|565703226|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
156715802|NCT01130493|565703227|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
156715803|NCT01130493|565703228|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
156715804|NCT01130493|565703226|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
156532592|NCT01968070|565045061|FG006|Period 1|Physician Decision|0|||
156532593|NCT01968070|565045062|FG007|Period 1|Physician Decision|0|||
156532594|NCT01968070|565045063|FG008|Period 1|Physician Decision|0|||
156715805|NCT01130493|565703227|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
156715806|NCT01130493|565703228|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
156715807|NCT01130493|565703226|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
156792922|NCT02899754|565994806|FG000|Overall Study|Lost to Follow-up|7|||
156792923|NCT02899754|565994807|FG001|Overall Study|Lost to Follow-up|9|||
156792924|NCT04082364|565994808|FG000|Overall Study|Death|23|||
156792925|NCT04082364|565994809|FG001|Overall Study|Death|1|||
156792926|NCT04082364|565994810|FG002|Overall Study|Death|1|||
156792927|NCT04082364|565994811|FG003|Overall Study|Death|2|||
156792928|NCT04082364|565994812|FG004|Overall Study|Death|1|||
156792929|NCT04082364|565994808|FG000|Overall Study|Lost to Follow-up|1|||
156792930|NCT04082364|565994809|FG001|Overall Study|Lost to Follow-up|0|||
156792931|NCT04082364|565994810|FG002|Overall Study|Lost to Follow-up|0|||
156792932|NCT04082364|565994811|FG003|Overall Study|Lost to Follow-up|0|||
156792933|NCT04082364|565994812|FG004|Overall Study|Lost to Follow-up|1|||
156715808|NCT01130493|565703227|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
156715809|NCT01130493|565703228|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
156715810|NCT01130493|565703226|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
156715811|NCT01130493|565703227|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
156715812|NCT01130493|565703228|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
156715813|NCT01130493|565703226|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
156715814|NCT01130493|565703227|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
156792934|NCT04082364|565994808|FG000|Overall Study|Physician Decision|1|||
156792935|NCT04082364|565994809|FG001|Overall Study|Physician Decision|1|||
156792936|NCT04082364|565994810|FG002|Overall Study|Physician Decision|0|||
156792937|NCT04082364|565994811|FG003|Overall Study|Physician Decision|2|||
156874687|NCT02840461|566298717|FG002|Overall Study|Lost to Follow-up|6|||
156333850|NCT02639546|564320912|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
156333851|NCT02639546|564320913|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
156333852|NCT02639546|564320914|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
156333853|NCT02639546|564320915|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
156333854|NCT02639546|564320916|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
156333855|NCT02639546|564320917|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
156333856|NCT02639546|564320910|FG000|Overall Study|Study Terminated By Sponsor|0|||
156333857|NCT02639546|564320911|FG001|Overall Study|Study Terminated By Sponsor|2|||
156333858|NCT02639546|564320912|FG002|Overall Study|Study Terminated By Sponsor|3|||
156333859|NCT02639546|564320913|FG003|Overall Study|Study Terminated By Sponsor|4|||
156333860|NCT02639546|564320914|FG004|Overall Study|Study Terminated By Sponsor|4|||
156333861|NCT02639546|564320915|FG005|Overall Study|Study Terminated By Sponsor|3|||
156333862|NCT02639546|564320916|FG006|Overall Study|Study Terminated By Sponsor|3|||
156333863|NCT02639546|564320917|FG007|Overall Study|Study Terminated By Sponsor|9|||
156333864|NCT02639546|564320910|FG000|Overall Study|Withdrawal by Subject|2|||
156333865|NCT02639546|564320911|FG001|Overall Study|Withdrawal by Subject|2|||
156333866|NCT02639546|564320912|FG002|Overall Study|Withdrawal by Subject|1|||
156333867|NCT02639546|564320913|FG003|Overall Study|Withdrawal by Subject|0|||
156333868|NCT02639546|564320914|FG004|Overall Study|Withdrawal by Subject|0|||
156333869|NCT02639546|564320915|FG005|Overall Study|Withdrawal by Subject|1|||
156333870|NCT02639546|564320916|FG006|Overall Study|Withdrawal by Subject|2|||
156333871|NCT02639546|564320917|FG007|Overall Study|Withdrawal by Subject|1|||
156333872|NCT00113087|564320918|FG000|Overall Study|Death or Transplant|14|||
156333873|NCT00113087|564320919|FG001|Overall Study|Death or Transplant|16|||
156333874|NCT00113087|564320918|FG000|Overall Study|Family or MD withdrew subject|10|||
156333875|NCT00113087|564320919|FG001|Overall Study|Family or MD withdrew subject|5|||
156333876|NCT03452228|564320920|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156333877|NCT03452228|564320921|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
156333878|NCT03452228|564320922|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156333879|NCT03452228|564320920|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156333880|NCT03452228|564320921|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156333881|NCT03452228|564320922|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156333882|NCT03452228|564320920|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
156333883|NCT03452228|564320921|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
156333884|NCT03452228|564320922|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
156333885|NCT03452228|564320920|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156333886|NCT03452228|564320921|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156333887|NCT03452228|564320922|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
156333888|NCT00386607|564320923|FG000|Core|Adverse Event|40|||
156532595|NCT01968070|565045064|FG009|Period 1|Physician Decision|0|||
156715815|NCT01130493|565703228|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
156792938|NCT04082364|565994812|FG004|Overall Study|Physician Decision|1|||
156715816|NCT01130493|565703226|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
156715817|NCT01130493|565703227|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
156715818|NCT01130493|565703228|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
156792939|NCT04082364|565994808|FG000|Overall Study|Withdrawal by Subject|1|||
156715819|NCT01130493|565703226|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
156715820|NCT01130493|565703227|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
156715821|NCT01130493|565703228|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
156715822|NCT01130493|565703226|FG000|Part 2: OLE|Adverse Event|0|||
156715823|NCT01130493|565703227|FG001|Part 2: OLE|Adverse Event|2|||
156715824|NCT01130493|565703228|FG002|Part 2: OLE|Adverse Event|1|||
156715825|NCT01130493|565703226|FG000|Part 2: OLE|Withdrawal by Subject|0|||
156715826|NCT01130493|565703227|FG001|Part 2: OLE|Withdrawal by Subject|1|||
156715827|NCT01130493|565703228|FG002|Part 2: OLE|Withdrawal by Subject|4|||
156715828|NCT03541317|565703232|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
156715829|NCT03541317|565703233|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715830|NCT03541317|565703234|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715831|NCT03541317|565703235|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715832|NCT03541317|565703236|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715833|NCT03541317|565703237|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715834|NCT00879086|565703238|FG000|Overall Study|Adverse Event|3|||
156792940|NCT04082364|565994809|FG001|Overall Study|Withdrawal by Subject|1|||
156792941|NCT04082364|565994810|FG002|Overall Study|Withdrawal by Subject|0|||
156792942|NCT04082364|565994811|FG003|Overall Study|Withdrawal by Subject|0|||
156792943|NCT04082364|565994812|FG004|Overall Study|Withdrawal by Subject|1|||
156792944|NCT04082364|565994808|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
156792945|NCT04082364|565994809|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
156792946|NCT04082364|565994810|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
156792947|NCT04082364|565994811|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
156792948|NCT04082364|565994812|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
156792949|NCT04082364|565994808|FG000|Overall Study|Disease progression|0|||
156792950|NCT04082364|565994809|FG001|Overall Study|Disease progression|0|||
156792951|NCT04082364|565994810|FG002|Overall Study|Disease progression|0|||
156792952|NCT04082364|565994811|FG003|Overall Study|Disease progression|1|||
156792953|NCT04082364|565994812|FG004|Overall Study|Disease progression|0|||
156792954|NCT02514746|565994818|FG000|Overall Study|Chronically Ill|1|||
156792955|NCT02514746|565994819|FG001|Overall Study|Chronically Ill|2|||
156792956|NCT02514746|565994818|FG000|Overall Study|Physician Decision|4|||
156792957|NCT02514746|565994819|FG001|Overall Study|Physician Decision|2|||
156792958|NCT02514746|565994818|FG000|Overall Study|Withdrawal by Subject|12|||
156792959|NCT02514746|565994819|FG001|Overall Study|Withdrawal by Subject|10|||
156792960|NCT02514746|565994818|FG000|Overall Study|Other|5|||
156792961|NCT02514746|565994819|FG001|Overall Study|Other|1|||
156792962|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
156792963|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
156444713|NCT01600014|564720289|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
156444714|NCT01600014|564720288|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
156444715|NCT01600014|564720289|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
156444716|NCT01600014|564720288|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
156444717|NCT01600014|564720289|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
156444718|NCT01600014|564720288|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
156444719|NCT01600014|564720289|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
156444720|NCT01600014|564720288|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
156444721|NCT01600014|564720289|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
156444722|NCT01600014|564720288|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
156532596|NCT01968070|565045065|FG010|Period 1|Physician Decision|0|||
156532597|NCT01968070|565045066|FG011|Period 1|Physician Decision|1|||
156532598|NCT01968070|565045067|FG012|Period 1|Physician Decision|0|||
156532599|NCT01968070|565045068|FG013|Period 1|Physician Decision|0|||
156532600|NCT01968070|565045069|FG014|Period 1|Physician Decision|0|||
156532601|NCT01968070|565045070|FG015|Period 1|Physician Decision|0|||
156532602|NCT01968070|565045071|FG016|Period 1|Physician Decision|0|||
156532603|NCT01968070|565045072|FG017|Period 1|Physician Decision|0|||
156532604|NCT01968070|565045055|FG000|Period 2|Withdrawal by Subject|0|||
156532605|NCT01968070|565045056|FG001|Period 2|Withdrawal by Subject|0|||
156532606|NCT01968070|565045057|FG002|Period 2|Withdrawal by Subject|0|||
156792964|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
156792965|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
156792966|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
156792967|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
156792968|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
156532607|NCT01968070|565045058|FG003|Period 2|Withdrawal by Subject|0|||
156715835|NCT00879086|565703239|FG001|Overall Study|Adverse Event|15|||
156715836|NCT00879086|565703238|FG000|Overall Study|Participant choice|2|||
156715837|NCT00879086|565703239|FG001|Overall Study|Participant choice|2|||
156532608|NCT01968070|565045059|FG004|Period 2|Withdrawal by Subject|1|||
156532609|NCT01968070|565045060|FG005|Period 2|Withdrawal by Subject|0|||
156715838|NCT00879086|565703238|FG000|Overall Study|Progression of disease|40|||
156715839|NCT00879086|565703239|FG001|Overall Study|Progression of disease|26|||
156715840|NCT00879086|565703238|FG000|Overall Study|Withdrawal of consent|2|||
156715841|NCT00879086|565703239|FG001|Overall Study|Withdrawal of consent|1|||
156715842|NCT00879086|565703238|FG000|Overall Study|Other|4|||
156715843|NCT00879086|565703239|FG001|Overall Study|Other|6|||
156715844|NCT00879086|565703238|FG000|Overall Study|Death|1|||
156715845|NCT00879086|565703239|FG001|Overall Study|Death|2|||
156715846|NCT04728802|565703242|FG000|Overall Study|Withdrawal by Subject|4|||
156715847|NCT04728802|565703243|FG001|Overall Study|Withdrawal by Subject|20|||
156715848|NCT04728802|565703242|FG000|Overall Study|Physician Decision|7|||
156715849|NCT04728802|565703243|FG001|Overall Study|Physician Decision|7|||
156715850|NCT04728802|565703242|FG000|Overall Study|Protocol Violation|10|||
156715851|NCT04728802|565703243|FG001|Overall Study|Protocol Violation|4|||
156715852|NCT04728802|565703242|FG000|Overall Study|Transfer|1|||
156715853|NCT04728802|565703243|FG001|Overall Study|Transfer|0|||
156715854|NCT04728802|565703242|FG000|Overall Study|Death|4|||
156715855|NCT04728802|565703243|FG001|Overall Study|Death|5|||
156715856|NCT04728802|565703242|FG000|Overall Study|Other|3|||
156715857|NCT04728802|565703243|FG001|Overall Study|Other|0|||
156715858|NCT02286843|565703246|FG000|Overall Study|Not Treated|4|||
156715859|NCT02286843|565703246|FG000|Overall Study|Protocol Violation|1|||
156715860|NCT02286843|565703246|FG000|Overall Study|Withdrawal by Subject|1|||
156715861|NCT02536846|565703247|FG000|Overall Study|Withdrawal by Subject|1|||
156715862|NCT02123446|565703248|FG000|Washout Period (1 Day)|Physician Decision|1|||
156715863|NCT02123446|565703249|FG001|Washout Period (1 Day)|Physician Decision|0|||
156715864|NCT00111241|565703251|FG000|Overall Study|Lost to Follow-up|1|||
156715865|NCT00111241|565703252|FG001|Overall Study|Lost to Follow-up|0|||
156715866|NCT00111241|565703251|FG000|Overall Study|Withdrawal by Subject|4|||
156792969|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
156792970|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
156333889|NCT00386607|564320924|FG001|Core|Adverse Event|0|||
156333890|NCT00386607|564320923|FG000|Core|Abnormal laboratory value(s)|3|||
156333891|NCT00386607|564320924|FG001|Core|Abnormal laboratory value(s)|0|||
156333892|NCT00386607|564320923|FG000|Core|Unsatisfactory therapeutic effect|23|||
156333893|NCT00386607|564320924|FG001|Core|Unsatisfactory therapeutic effect|0|||
156333894|NCT00386607|564320923|FG000|Core|Condition no longer requires study drug|4|||
156333895|NCT00386607|564320924|FG001|Core|Condition no longer requires study drug|0|||
156333896|NCT00386607|564320923|FG000|Core|Patient withdrew consent|15|||
156333897|NCT00386607|564320924|FG001|Core|Patient withdrew consent|0|||
156333898|NCT00386607|564320923|FG000|Core|Lost to Follow-up|23|||
156333899|NCT00386607|564320924|FG001|Core|Lost to Follow-up|0|||
156333900|NCT00386607|564320923|FG000|Core|Administrative problems|1|||
156333901|NCT00386607|564320924|FG001|Core|Administrative problems|0|||
156333902|NCT00386607|564320923|FG000|Core|Protocol Deviation|6|||
156333903|NCT00386607|564320924|FG001|Core|Protocol Deviation|0|||
156333904|NCT00386607|564320923|FG000|Extension|Adverse Event|0|||
156333905|NCT00386607|564320924|FG001|Extension|Adverse Event|6|||
156333906|NCT00386607|564320923|FG000|Extension|Abnormal laboratory value(s)|0|||
156333907|NCT00386607|564320924|FG001|Extension|Abnormal laboratory value(s)|1|||
156333908|NCT00386607|564320923|FG000|Extension|Administrative problems|0|||
156333909|NCT00386607|564320924|FG001|Extension|Administrative problems|1|||
156333910|NCT00386607|564320923|FG000|Extension|Lost to Follow-up|0|||
156333911|NCT00386607|564320924|FG001|Extension|Lost to Follow-up|3|||
156333912|NCT00386607|564320923|FG000|Extension|Patient withdrew consent|0|||
156333913|NCT00386607|564320924|FG001|Extension|Patient withdrew consent|5|||
156333914|NCT00386607|564320923|FG000|Extension|Unsatisfactory therapeutic effect|0|||
156333915|NCT00386607|564320924|FG001|Extension|Unsatisfactory therapeutic effect|1|||
156333916|NCT02761733|564320925|FG000|Overall Study|Death|3|||
156333917|NCT02761733|564320926|FG001|Overall Study|Death|5|||
156333918|NCT02761733|564320927|FG002|Overall Study|Death|1|||
156333919|NCT02761733|564320928|FG003|Overall Study|Death|1|||
156333920|NCT02761733|564320925|FG000|Overall Study|Lost to Follow-up|6|||
156333921|NCT02761733|564320926|FG001|Overall Study|Lost to Follow-up|7|||
156333922|NCT02761733|564320927|FG002|Overall Study|Lost to Follow-up|0|||
156333923|NCT02761733|564320928|FG003|Overall Study|Lost to Follow-up|3|||
156333924|NCT02761733|564320925|FG000|Overall Study|Physician Decision|4|||
156333925|NCT02761733|564320926|FG001|Overall Study|Physician Decision|0|||
156333926|NCT02761733|564320927|FG002|Overall Study|Physician Decision|0|||
156333927|NCT02761733|564320928|FG003|Overall Study|Physician Decision|0|||
156333928|NCT02761733|564320925|FG000|Overall Study|Withdrawal by Subject|2|||
156333929|NCT02761733|564320926|FG001|Overall Study|Withdrawal by Subject|0|||
156333930|NCT02761733|564320927|FG002|Overall Study|Withdrawal by Subject|0|||
156715867|NCT00111241|565703252|FG001|Overall Study|Withdrawal by Subject|0|||
156715868|NCT00111241|565703251|FG000|Overall Study|Protocol Violation|9|||
156715869|NCT00111241|565703252|FG001|Overall Study|Protocol Violation|8|||
156715870|NCT00111241|565703251|FG000|Overall Study|Adverse Event|1|||
156715871|NCT00111241|565703252|FG001|Overall Study|Adverse Event|0|||
156444723|NCT01600014|564720289|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
156444724|NCT01600014|564720288|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
156444725|NCT01600014|564720289|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
156444726|NCT01600014|564720288|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
156444727|NCT01600014|564720289|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
156444728|NCT01600014|564720288|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
156444729|NCT01600014|564720289|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
156444730|NCT01600014|564720288|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
156444731|NCT01600014|564720289|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
156444732|NCT01600014|564720288|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
156444733|NCT01600014|564720289|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
156444734|NCT01600014|564720288|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
156444735|NCT01600014|564720289|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
156444736|NCT02791230|564720290|FG000|Overall Study|Adverse Event|10|||
156444737|NCT02791230|564720291|FG001|Overall Study|Adverse Event|9|||
156444738|NCT02791230|564720292|FG002|Overall Study|Adverse Event|66|||
156444739|NCT02791230|564720290|FG000|Overall Study|Death|38|||
156444740|NCT02791230|564720291|FG001|Overall Study|Death|25|||
156444741|NCT02791230|564720292|FG002|Overall Study|Death|184|||
156444742|NCT02791230|564720290|FG000|Overall Study|Lack of Efficacy|1|||
156444743|NCT02791230|564720291|FG001|Overall Study|Lack of Efficacy|0|||
156444744|NCT02791230|564720292|FG002|Overall Study|Lack of Efficacy|3|||
156444745|NCT02791230|564720290|FG000|Overall Study|Lost to Follow-up|0|||
156444746|NCT02791230|564720291|FG001|Overall Study|Lost to Follow-up|0|||
156444747|NCT02791230|564720292|FG002|Overall Study|Lost to Follow-up|10|||
156444748|NCT02791230|564720290|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
156444749|NCT02791230|564720291|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
156444750|NCT02791230|564720292|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
156444751|NCT02791230|564720290|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
156444752|NCT02791230|564720291|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
156444753|NCT02791230|564720292|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
156715872|NCT02096744|565703263|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
156808800|NCT03688919|566054465|FG000|Overall Study|Lost to Follow-up|2|||
156808801|NCT03688919|566054466|FG001|Overall Study|Lost to Follow-up|1|||
156333931|NCT02761733|564320928|FG003|Overall Study|Withdrawal by Subject|0|||
156333932|NCT02761733|564320925|FG000|Overall Study|Discharged from Study Site|10|||
156333933|NCT02761733|564320926|FG001|Overall Study|Discharged from Study Site|9|||
156333934|NCT02761733|564320927|FG002|Overall Study|Discharged from Study Site|25|||
156333935|NCT02761733|564320928|FG003|Overall Study|Discharged from Study Site|11|||
156333936|NCT02761733|564320925|FG000|Overall Study|Cognitive Impairment|5|||
156333937|NCT02761733|564320926|FG001|Overall Study|Cognitive Impairment|0|||
156333938|NCT02761733|564320927|FG002|Overall Study|Cognitive Impairment|1|||
156333939|NCT02761733|564320928|FG003|Overall Study|Cognitive Impairment|0|||
156333940|NCT02713204|564320929|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
156333941|NCT02713204|564320930|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156333942|NCT02713204|564320931|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
156333943|NCT02713204|564320932|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156333944|NCT02713204|564320933|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156333945|NCT02713204|564320934|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156333946|NCT02713204|564320935|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156333947|NCT02713204|564320936|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156333948|NCT02713204|564320929|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156333949|NCT02713204|564320930|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156333950|NCT02713204|564320931|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
156333951|NCT02713204|564320932|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156333952|NCT02713204|564320933|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156333953|NCT02713204|564320934|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156333954|NCT02713204|564320935|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156333955|NCT02713204|564320936|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156333956|NCT02713204|564320929|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156333957|NCT02713204|564320930|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
156333958|NCT02713204|564320931|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156333959|NCT02713204|564320932|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156333960|NCT02713204|564320933|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156333961|NCT02713204|564320934|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156333962|NCT02713204|564320935|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156333963|NCT02713204|564320936|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156333964|NCT02713204|564320929|FG000|From Week 12 up to Week 36|Adverse Event|1|||
156333965|NCT02713204|564320930|FG001|From Week 12 up to Week 36|Adverse Event|0|||
156333966|NCT02713204|564320931|FG002|From Week 12 up to Week 36|Adverse Event|0|||
156333967|NCT02713204|564320932|FG003|From Week 12 up to Week 36|Adverse Event|1|||
156333968|NCT02713204|564320933|FG004|From Week 12 up to Week 36|Adverse Event|1|||
156333969|NCT02713204|564320934|FG005|From Week 12 up to Week 36|Adverse Event|0|||
156333970|NCT02713204|564320935|FG006|From Week 12 up to Week 36|Adverse Event|2|||
156333971|NCT02713204|564320936|FG007|From Week 12 up to Week 36|Adverse Event|1|||
156333972|NCT02713204|564320929|FG000|From Week 12 up to Week 36|Death|0|||
156333973|NCT02713204|564320930|FG001|From Week 12 up to Week 36|Death|0|||
156333974|NCT02713204|564320931|FG002|From Week 12 up to Week 36|Death|0|||
156333975|NCT02713204|564320932|FG003|From Week 12 up to Week 36|Death|1|||
156333976|NCT02713204|564320933|FG004|From Week 12 up to Week 36|Death|0|||
156715873|NCT02096744|565703264|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
156715874|NCT02096744|565703263|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
156715875|NCT02096744|565703264|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
156715876|NCT02096744|565703263|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
156715877|NCT02096744|565703264|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
156715878|NCT02445963|565703266|FG000|Overall Study|Lost to Follow-up|1|||
156715879|NCT02445963|565703267|FG001|Overall Study|Lost to Follow-up|0|||
156715880|NCT02445963|565703268|FG002|Overall Study|Lost to Follow-up|0|||
156715881|NCT02445963|565703269|FG003|Overall Study|Lost to Follow-up|0|||
156715882|NCT02445963|565703266|FG000|Overall Study|Change in employment|1|||
156792971|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
156792972|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
156792973|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
156792974|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
156333977|NCT02713204|564320934|FG005|From Week 12 up to Week 36|Death|1|||
156333978|NCT02713204|564320935|FG006|From Week 12 up to Week 36|Death|0|||
156333979|NCT02713204|564320936|FG007|From Week 12 up to Week 36|Death|3|||
156792975|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
156333980|NCT02713204|564320929|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
156333981|NCT02713204|564320930|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
156333982|NCT02713204|564320931|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
156333983|NCT02713204|564320932|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
156333984|NCT02713204|564320933|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
156333985|NCT02713204|564320934|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
156333986|NCT02713204|564320935|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
156444754|NCT02791230|564720290|FG000|Overall Study|Study sites terminated by sponsor|1|||
156444755|NCT02791230|564720291|FG001|Overall Study|Study sites terminated by sponsor|0|||
156444756|NCT02791230|564720292|FG002|Overall Study|Study sites terminated by sponsor|5|||
156444757|NCT02791230|564720290|FG000|Overall Study|Other|9|||
156444758|NCT02791230|564720291|FG001|Overall Study|Other|1|||
156444759|NCT02791230|564720292|FG002|Overall Study|Other|28|||
156444760|NCT02791230|564720290|FG000|Overall Study|Protocol Violation|0|||
156444761|NCT02791230|564720291|FG001|Overall Study|Protocol Violation|0|||
156444762|NCT02791230|564720292|FG002|Overall Study|Protocol Violation|4|||
156444763|NCT02791230|564720290|FG000|Overall Study|Withdrawal by Subject|24|||
156444764|NCT02791230|564720291|FG001|Overall Study|Withdrawal by Subject|13|||
156444765|NCT02791230|564720292|FG002|Overall Study|Withdrawal by Subject|172|||
156444766|NCT02791230|564720290|FG000|Overall Study|Enrolled but not treated|0|||
156444767|NCT02791230|564720291|FG001|Overall Study|Enrolled but not treated|0|||
156444768|NCT02791230|564720292|FG002|Overall Study|Enrolled but not treated|5|||
156444769|NCT05104697|564720295|FG000|Overall Study|Withdrawal by Subject|0|||
156444770|NCT05104697|564720296|FG001|Overall Study|Withdrawal by Subject|1|||
156444771|NCT03899961|564720297|FG000|Overall Study|-delivery prior to|2|||
156444772|NCT03899961|564720298|FG001|Overall Study|-delivery prior to|7|||
156444773|NCT03899961|564720297|FG000|Overall Study|req general anesth|1|||
156444774|NCT03899961|564720298|FG001|Overall Study|req general anesth|2|||
156444775|NCT03899961|564720297|FG000|Overall Study|capacity|5|||
156444776|NCT03899961|564720298|FG001|Overall Study|capacity|6|||
156444777|NCT03899961|564720297|FG000|Overall Study|Withdrawal by Subject|1|||
156333987|NCT02713204|564320936|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
156333988|NCT02713204|564320929|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
156333989|NCT02713204|564320930|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
156444778|NCT03899961|564720298|FG001|Overall Study|Withdrawal by Subject|1|||
156444779|NCT05307978|564720299|FG000|Overall Study|Lost to Follow-up|0|||
156444780|NCT05307978|564720300|FG001|Overall Study|Lost to Follow-up|1|||
156444781|NCT05307978|564720301|FG002|Overall Study|Lost to Follow-up|0|||
156444782|NCT05307978|564720302|FG003|Overall Study|Lost to Follow-up|4|||
156444783|NCT05307978|564720303|FG004|Overall Study|Lost to Follow-up|0|||
156444784|NCT05307978|564720304|FG005|Overall Study|Lost to Follow-up|0|||
156444785|NCT05307978|564720305|FG006|Overall Study|Lost to Follow-up|1|||
156715883|NCT02445963|565703267|FG001|Overall Study|Change in employment|0|||
156792976|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
156333990|NCT02713204|564320931|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
156444786|NCT03651895|564720306|FG000|First Drug Assignment|Adverse Event|4|||
156715884|NCT02445963|565703268|FG002|Overall Study|Change in employment|0|||
156715885|NCT02445963|565703269|FG003|Overall Study|Change in employment|0|||
156715886|NCT02445963|565703266|FG000|Overall Study|Symptoms post-vaccination|0|||
156715887|NCT02445963|565703267|FG001|Overall Study|Symptoms post-vaccination|0|||
156715888|NCT02445963|565703268|FG002|Overall Study|Symptoms post-vaccination|1|||
156715889|NCT02445963|565703269|FG003|Overall Study|Symptoms post-vaccination|0|||
156715890|NCT01957176|565703273|FG000|Overall Study|Adverse Event|2|||
156715891|NCT01957176|565703274|FG001|Overall Study|Adverse Event|0|||
156715892|NCT01957176|565703273|FG000|Overall Study|Physician Decision|2|||
156715893|NCT01957176|565703274|FG001|Overall Study|Physician Decision|1|||
156715894|NCT01957176|565703273|FG000|Overall Study|Withdrawal by Subject|1|||
156715895|NCT01957176|565703274|FG001|Overall Study|Withdrawal by Subject|0|||
156715896|NCT01449812|565703275|FG000|Overall Study|Migrated/moved from study area|1|||
156715897|NCT01449812|565703276|FG001|Overall Study|Migrated/moved from study area|0|||
156715898|NCT01449812|565703277|FG002|Overall Study|Migrated/moved from study area|0|||
156715899|NCT01449812|565703275|FG000|Overall Study|Withdrawal by Subject|0|||
156715900|NCT01449812|565703276|FG001|Overall Study|Withdrawal by Subject|0|||
156715901|NCT01449812|565703277|FG002|Overall Study|Withdrawal by Subject|1|||
156715902|NCT01449812|565703275|FG000|Overall Study|Lost to Follow-up|1|||
156715903|NCT01449812|565703276|FG001|Overall Study|Lost to Follow-up|0|||
156715904|NCT01449812|565703277|FG002|Overall Study|Lost to Follow-up|0|||
156715905|NCT03449446|565703278|FG000|Overall Study|Randomized but Never Treated|0|||
156715906|NCT03449446|565703279|FG001|Overall Study|Randomized but Never Treated|0|||
156715907|NCT03449446|565703280|FG002|Overall Study|Randomized but Never Treated|1|||
156715908|NCT03449446|565703281|FG003|Overall Study|Randomized but Never Treated|1|||
156715909|NCT03449446|565703282|FG004|Overall Study|Randomized but Never Treated|1|||
156715910|NCT03449446|565703283|FG005|Overall Study|Randomized but Never Treated|0|||
156715911|NCT03449446|565703284|FG006|Overall Study|Randomized but Never Treated|0|||
156715912|NCT03449446|565703278|FG000|Overall Study|Unknown Reason|33|||
156715913|NCT03449446|565703279|FG001|Overall Study|Unknown Reason|1|||
156715914|NCT03449446|565703280|FG002|Overall Study|Unknown Reason|1|||
156715915|NCT03449446|565703281|FG003|Overall Study|Unknown Reason|1|||
156874688|NCT02840461|566298715|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
156874689|NCT02840461|566298716|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
156874690|NCT02840461|566298717|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
156874691|NCT02840461|566298715|FG000|Overall Study|Protocol Violation|2|||
156333991|NCT02713204|564320932|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
156333992|NCT02713204|564320933|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
156444787|NCT03651895|564720307|FG001|First Drug Assignment|Adverse Event|5|||
156715916|NCT03449446|565703282|FG004|Overall Study|Unknown Reason|2|||
156715917|NCT03449446|565703283|FG005|Overall Study|Unknown Reason|2|||
156715918|NCT03449446|565703284|FG006|Overall Study|Unknown Reason|0|||
156715919|NCT03449446|565703278|FG000|Overall Study|Withdrew Consent|1|||
156333993|NCT02713204|564320934|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
156333994|NCT02713204|564320935|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
156333995|NCT02713204|564320936|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
156333996|NCT01927627|564320939|FG000|Overall Study|Adverse Event|3|||
156333997|NCT01927627|564320939|FG000|Overall Study|Lack of Efficacy|1|||
156333998|NCT01927627|564320939|FG000|Overall Study|Financial Concerns|1|||
156333999|NCT03608254|564320940|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
156334000|NCT03608254|564320940|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
156334001|NCT00968864|564320942|FG000|Overall Study|Protocol exception/ not evaluable|1|||
156334002|NCT03666624|564320945|FG000|Overall Study|participant grieving over recent death of parent|1|||
156334003|NCT03666624|564320946|FG001|Overall Study|participant grieving over recent death of parent|0|||
156334004|NCT00397215|564320947|FG000|Month 0 (Day 0)|Adverse Event|0|||
156334005|NCT00397215|564320948|FG001|Month 0 (Day 0)|Adverse Event|1|||
156334006|NCT00397215|564320949|FG002|Month 0 (Day 0)|Adverse Event|0|||
156334007|NCT00397215|564320950|FG003|Month 0 (Day 0)|Adverse Event|0|||
156334008|NCT00397215|564320947|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
156334009|NCT00397215|564320948|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
156334010|NCT00397215|564320949|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
156334011|NCT00397215|564320950|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
156334012|NCT00397215|564320947|FG000|Month 0 (Day 0)|Other|4|||
156334013|NCT00397215|564320948|FG001|Month 0 (Day 0)|Other|1|||
156334014|NCT00397215|564320949|FG002|Month 0 (Day 0)|Other|3|||
156334015|NCT00397215|564320950|FG003|Month 0 (Day 0)|Other|3|||
156334016|NCT00397215|564320947|FG000|Month 6 (Day 180)|Adverse Event|0|||
156334017|NCT00397215|564320948|FG001|Month 6 (Day 180)|Adverse Event|3|||
156334018|NCT00397215|564320949|FG002|Month 6 (Day 180)|Adverse Event|2|||
156334019|NCT00397215|564320950|FG003|Month 6 (Day 180)|Adverse Event|0|||
156334020|NCT00397215|564320947|FG000|Month 6 (Day 180)|Other|2|||
156334021|NCT00397215|564320948|FG001|Month 6 (Day 180)|Other|0|||
156334022|NCT00397215|564320949|FG002|Month 6 (Day 180)|Other|3|||
156334023|NCT00397215|564320950|FG003|Month 6 (Day 180)|Other|0|||
156334024|NCT01254630|564320951|FG000|Overall Study|Adverse Event|36|||
156334025|NCT01254630|564320952|FG001|Overall Study|Adverse Event|15|||
156792977|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
156792978|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
156792979|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
156792980|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
156792981|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
156792982|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
156792983|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
156874692|NCT02840461|566298716|FG001|Overall Study|Protocol Violation|3|||
156874693|NCT02840461|566298717|FG002|Overall Study|Protocol Violation|1|||
156874694|NCT02840461|566298715|FG000|Overall Study|Withdrawal by Subject|10|||
156874695|NCT02840461|566298716|FG001|Overall Study|Withdrawal by Subject|6|||
156874696|NCT02840461|566298717|FG002|Overall Study|Withdrawal by Subject|2|||
156532610|NCT01968070|565045061|FG006|Period 2|Withdrawal by Subject|0|||
156532611|NCT01968070|565045062|FG007|Period 2|Withdrawal by Subject|0|||
156532612|NCT01968070|565045063|FG008|Period 2|Withdrawal by Subject|0|||
156532613|NCT01968070|565045064|FG009|Period 2|Withdrawal by Subject|0|||
156532614|NCT01968070|565045065|FG010|Period 2|Withdrawal by Subject|0|||
156532615|NCT01968070|565045066|FG011|Period 2|Withdrawal by Subject|0|||
156532616|NCT01968070|565045067|FG012|Period 2|Withdrawal by Subject|0|||
156532617|NCT01968070|565045068|FG013|Period 2|Withdrawal by Subject|0|||
156532618|NCT01968070|565045069|FG014|Period 2|Withdrawal by Subject|0|||
156532619|NCT01968070|565045070|FG015|Period 2|Withdrawal by Subject|0|||
156532620|NCT01968070|565045071|FG016|Period 2|Withdrawal by Subject|0|||
156532621|NCT01968070|565045072|FG017|Period 2|Withdrawal by Subject|0|||
156532622|NCT01822522|565045075|FG000|Overall Study|Adverse Event|1|||
156532623|NCT01822522|565045076|FG001|Overall Study|Adverse Event|1|||
156532624|NCT01822522|565045077|FG002|Overall Study|Adverse Event|1|||
156532625|NCT01822522|565045078|FG003|Overall Study|Adverse Event|0|||
156532626|NCT01822522|565045079|FG004|Overall Study|Adverse Event|0|||
156532627|NCT01822522|565045080|FG005|Overall Study|Adverse Event|1|||
156532628|NCT01822522|565045075|FG000|Overall Study|Death|3|||
156532629|NCT01822522|565045076|FG001|Overall Study|Death|0|||
156532630|NCT01822522|565045077|FG002|Overall Study|Death|2|||
156532631|NCT01822522|565045078|FG003|Overall Study|Death|0|||
156532632|NCT01822522|565045079|FG004|Overall Study|Death|0|||
156532633|NCT01822522|565045080|FG005|Overall Study|Death|0|||
156532634|NCT01822522|565045075|FG000|Overall Study|Lost to Follow-up|0|||
156532635|NCT01822522|565045076|FG001|Overall Study|Lost to Follow-up|0|||
156532636|NCT01822522|565045077|FG002|Overall Study|Lost to Follow-up|1|||
156532637|NCT01822522|565045078|FG003|Overall Study|Lost to Follow-up|1|||
156532638|NCT01822522|565045079|FG004|Overall Study|Lost to Follow-up|0|||
156532639|NCT01822522|565045080|FG005|Overall Study|Lost to Follow-up|1|||
156532640|NCT01822522|565045075|FG000|Overall Study|Withdrawal by Subject|0|||
156532641|NCT01822522|565045076|FG001|Overall Study|Withdrawal by Subject|0|||
156532642|NCT01822522|565045077|FG002|Overall Study|Withdrawal by Subject|0|||
156532643|NCT01822522|565045078|FG003|Overall Study|Withdrawal by Subject|1|||
156532644|NCT01822522|565045079|FG004|Overall Study|Withdrawal by Subject|0|||
156532645|NCT01822522|565045080|FG005|Overall Study|Withdrawal by Subject|0|||
156532646|NCT01822522|565045075|FG000|Overall Study|Lack of Efficacy|0|||
156532647|NCT01822522|565045076|FG001|Overall Study|Lack of Efficacy|0|||
156532648|NCT01822522|565045077|FG002|Overall Study|Lack of Efficacy|0|||
156532649|NCT01822522|565045078|FG003|Overall Study|Lack of Efficacy|0|||
156532650|NCT01822522|565045079|FG004|Overall Study|Lack of Efficacy|0|||
156532651|NCT01822522|565045080|FG005|Overall Study|Lack of Efficacy|2|||
156532652|NCT01807923|565045081|FG000|Overall Study|Adverse Event|2|||
156874697|NCT02840461|566298715|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
156874698|NCT02840461|566298716|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
156874699|NCT02840461|566298717|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
156874700|NCT01737502|566298720|FG000|Phase I|Disease progression|2|||
156532653|NCT01807923|565045082|FG001|Overall Study|Adverse Event|1|||
156874701|NCT01737502|566298721|FG001|Phase I|Disease progression|3|||
156874702|NCT01737502|566298720|FG000|Phase I|Complicating disease|1|||
156874703|NCT01737502|566298721|FG001|Phase I|Complicating disease|0|||
156874704|NCT01737502|566298720|FG000|Phase II|Adverse Event|0|||
156532654|NCT01807923|565045083|FG002|Overall Study|Adverse Event|2|||
156532655|NCT01807923|565045081|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
156532656|NCT01807923|565045082|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
156532657|NCT01807923|565045083|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
156532658|NCT01807923|565045081|FG000|Overall Study|Physician Decision|0|||
156532659|NCT01807923|565045082|FG001|Overall Study|Physician Decision|0|||
156532660|NCT01807923|565045083|FG002|Overall Study|Physician Decision|1|||
156532661|NCT01807923|565045081|FG000|Overall Study|Not Eligible (Genotype)|0|||
156532662|NCT01807923|565045082|FG001|Overall Study|Not Eligible (Genotype)|0|||
156874705|NCT01737502|566298721|FG001|Phase II|Adverse Event|3|||
156874706|NCT01737502|566298720|FG000|Phase II|Disease progression|0|||
156334026|NCT01254630|564320953|FG002|Overall Study|Adverse Event|40|||
156532663|NCT01807923|565045083|FG002|Overall Study|Not Eligible (Genotype)|1|||
156532664|NCT01807923|565045081|FG000|Overall Study|Randomized But Not Treated|3|||
156715920|NCT03449446|565703279|FG001|Overall Study|Withdrew Consent|3|||
156715921|NCT03449446|565703280|FG002|Overall Study|Withdrew Consent|1|||
156715922|NCT03449446|565703281|FG003|Overall Study|Withdrew Consent|4|||
156715923|NCT03449446|565703282|FG004|Overall Study|Withdrew Consent|4|||
156715924|NCT03449446|565703283|FG005|Overall Study|Withdrew Consent|4|||
156715925|NCT03449446|565703284|FG006|Overall Study|Withdrew Consent|1|||
156715926|NCT03449446|565703278|FG000|Overall Study|Adverse Event|1|||
156715927|NCT03449446|565703279|FG001|Overall Study|Adverse Event|2|||
156715928|NCT03449446|565703280|FG002|Overall Study|Adverse Event|1|||
156715929|NCT03449446|565703281|FG003|Overall Study|Adverse Event|0|||
156715930|NCT03449446|565703282|FG004|Overall Study|Adverse Event|0|||
156715931|NCT03449446|565703283|FG005|Overall Study|Adverse Event|2|||
156715932|NCT03449446|565703284|FG006|Overall Study|Adverse Event|0|||
156715933|NCT03449446|565703278|FG000|Overall Study|Lost to Follow-up|0|||
156715934|NCT03449446|565703279|FG001|Overall Study|Lost to Follow-up|0|||
156715935|NCT03449446|565703280|FG002|Overall Study|Lost to Follow-up|2|||
156715936|NCT03449446|565703281|FG003|Overall Study|Lost to Follow-up|1|||
156715937|NCT03449446|565703282|FG004|Overall Study|Lost to Follow-up|3|||
156715938|NCT03449446|565703283|FG005|Overall Study|Lost to Follow-up|0|||
156715939|NCT03449446|565703284|FG006|Overall Study|Lost to Follow-up|0|||
156715940|NCT03449446|565703278|FG000|Overall Study|Investigator's Discretion|0|||
156715941|NCT03449446|565703279|FG001|Overall Study|Investigator's Discretion|1|||
156715942|NCT03449446|565703280|FG002|Overall Study|Investigator's Discretion|1|||
156715943|NCT03449446|565703281|FG003|Overall Study|Investigator's Discretion|2|||
156715944|NCT03449446|565703282|FG004|Overall Study|Investigator's Discretion|0|||
156715945|NCT03449446|565703283|FG005|Overall Study|Investigator's Discretion|0|||
156715946|NCT03449446|565703284|FG006|Overall Study|Investigator's Discretion|0|||
156715947|NCT03449446|565703278|FG000|Overall Study|Non Compliance with Study Drug|1|||
156715948|NCT03449446|565703279|FG001|Overall Study|Non Compliance with Study Drug|0|||
156715949|NCT03449446|565703280|FG002|Overall Study|Non Compliance with Study Drug|0|||
156715950|NCT03449446|565703281|FG003|Overall Study|Non Compliance with Study Drug|0|||
156715951|NCT03449446|565703282|FG004|Overall Study|Non Compliance with Study Drug|0|||
156715952|NCT03449446|565703283|FG005|Overall Study|Non Compliance with Study Drug|0|||
156715953|NCT03449446|565703284|FG006|Overall Study|Non Compliance with Study Drug|0|||
156715954|NCT03449446|565703278|FG000|Overall Study|Protocol Violation|0|||
156715955|NCT03449446|565703279|FG001|Overall Study|Protocol Violation|0|||
156715956|NCT03449446|565703280|FG002|Overall Study|Protocol Violation|0|||
156715957|NCT03449446|565703281|FG003|Overall Study|Protocol Violation|0|||
156715958|NCT03449446|565703282|FG004|Overall Study|Protocol Violation|1|||
156715959|NCT03449446|565703283|FG005|Overall Study|Protocol Violation|1|||
156792984|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
156792985|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
156792986|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
156792987|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
156792988|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
156792989|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
156792990|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
156792991|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
156792992|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Death|0|||
156792993|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Death|0|||
156792994|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Death|0|||
156792995|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Death|0|||
156792996|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Death|1|||
156792997|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
156792998|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
156792999|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
156793000|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
156793001|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
156793002|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
156793003|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
156793004|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
156793005|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
156793006|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
156793007|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
156874707|NCT01737502|566298721|FG001|Phase II|Disease progression|18|||
156874708|NCT01737502|566298720|FG000|Phase II|Death|0|||
156715960|NCT03449446|565703284|FG006|Overall Study|Protocol Violation|0|||
156715961|NCT03449446|565703278|FG000|Overall Study|Death|0|||
156715962|NCT03449446|565703279|FG001|Overall Study|Death|0|||
156715963|NCT03449446|565703280|FG002|Overall Study|Death|0|||
156715964|NCT03449446|565703281|FG003|Overall Study|Death|0|||
156715965|NCT03449446|565703282|FG004|Overall Study|Death|1|||
156715966|NCT03449446|565703283|FG005|Overall Study|Death|0|||
156715967|NCT03449446|565703284|FG006|Overall Study|Death|0|||
156715968|NCT03180645|565703289|FG000|Overall Study|Adverse Event|0|||
156715969|NCT03180645|565703290|FG001|Overall Study|Adverse Event|1|||
156874709|NCT01737502|566298721|FG001|Phase II|Death|1|||
156715970|NCT03180645|565703291|FG002|Overall Study|Adverse Event|2|||
156715971|NCT00625872|565703292|FG000|Overall Study|Withdrawal by Subject|1|||
156715972|NCT00625872|565703293|FG001|Overall Study|Withdrawal by Subject|0|||
156715973|NCT00625872|565703292|FG000|Overall Study|Does not meet inclusion criteria|1|||
156715974|NCT00625872|565703293|FG001|Overall Study|Does not meet inclusion criteria|0|||
156715975|NCT00625872|565703292|FG000|Overall Study|Terminated by sponsor|2|||
156715976|NCT00625872|565703293|FG001|Overall Study|Terminated by sponsor|5|||
156715977|NCT00625872|565703292|FG000|Overall Study|Randomized but not treated|0|||
156715978|NCT00625872|565703293|FG001|Overall Study|Randomized but not treated|1|||
156715979|NCT04208750|565703294|FG000|Overall Study|Lost to Follow-up|16|||
156715980|NCT04208750|565703295|FG001|Overall Study|Lost to Follow-up|15|||
156715981|NCT02201277|565703299|FG000|Overall Study|Death|3|||
156715982|NCT02201277|565703300|FG001|Overall Study|Death|4|||
156715983|NCT02201277|565703299|FG000|Overall Study|Lost to Follow-up|2|||
156715984|NCT02201277|565703300|FG001|Overall Study|Lost to Follow-up|1|||
156715985|NCT02201277|565703299|FG000|Overall Study|Failed retrieval|1|||
156715986|NCT02201277|565703300|FG001|Overall Study|Failed retrieval|0|||
156715987|NCT02201277|565703299|FG000|Overall Study|Physician Decision|1|||
156715988|NCT02201277|565703300|FG001|Overall Study|Physician Decision|0|||
156715989|NCT04917861|565703301|FG000|Main Study (196 Days)|Adverse Event|0|||
156715990|NCT04917861|565703302|FG001|Main Study (196 Days)|Adverse Event|1|||
156715991|NCT04917861|565703303|FG002|Main Study (196 Days)|Adverse Event|0|||
156444788|NCT03651895|564720306|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
156444789|NCT03651895|564720307|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
156444790|NCT02837510|564720308|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
156444791|NCT02837510|564720309|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
156444792|NCT02837510|564720308|FG000|Washout (2 Weeks)|Adverse Event|0|||
156444793|NCT02837510|564720309|FG001|Washout (2 Weeks)|Adverse Event|1|||
156444794|NCT02837510|564720308|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
156444795|NCT02837510|564720309|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
156444796|NCT02837510|564720308|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
156444797|NCT02837510|564720309|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
156444798|NCT02837510|564720308|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
156444799|NCT02837510|564720309|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
156444800|NCT02837510|564720308|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
156444801|NCT02837510|564720309|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
156444802|NCT05107401|564720312|FG000|Overall Study|Lost to Follow-up|13|||
156444803|NCT05107401|564720313|FG001|Overall Study|Lost to Follow-up|12|||
156444804|NCT05510232|564720314|FG000|Overall Study|Withdrawal by Subject|2|||
156444805|NCT05510232|564720315|FG001|Overall Study|Withdrawal by Subject|7|||
156444806|NCT05510232|564720316|FG002|Overall Study|Withdrawal by Subject|6|||
156444807|NCT05952076|564720331|FG000|Overall Study|Death|1|||
156444808|NCT05952076|564720332|FG001|Overall Study|Death|1|||
156444809|NCT05952076|564720331|FG000|Overall Study|Lost to Follow-up|0|||
156444810|NCT05952076|564720332|FG001|Overall Study|Lost to Follow-up|1|||
156444811|NCT04143061|564720333|FG000|Overall Study|Protocol Deviation|0|||
156444812|NCT04143061|564720334|FG001|Overall Study|Protocol Deviation|0|||
156444813|NCT04143061|564720335|FG002|Overall Study|Protocol Deviation|0|||
156444814|NCT04143061|564720336|FG003|Overall Study|Protocol Deviation|0|||
156444815|NCT04143061|564720337|FG004|Overall Study|Protocol Deviation|0|||
156444816|NCT04143061|564720338|FG005|Overall Study|Protocol Deviation|0|||
156444817|NCT04143061|564720339|FG006|Overall Study|Protocol Deviation|5|||
156444818|NCT04143061|564720340|FG007|Overall Study|Protocol Deviation|5|||
156444819|NCT04143061|564720333|FG000|Overall Study|Withdrawal by Subject|2|||
156444820|NCT04143061|564720334|FG001|Overall Study|Withdrawal by Subject|0|||
156444821|NCT04143061|564720335|FG002|Overall Study|Withdrawal by Subject|0|||
156444822|NCT04143061|564720336|FG003|Overall Study|Withdrawal by Subject|0|||
156444823|NCT04143061|564720337|FG004|Overall Study|Withdrawal by Subject|0|||
156444824|NCT04143061|564720338|FG005|Overall Study|Withdrawal by Subject|1|||
156715992|NCT04917861|565703304|FG003|Main Study (196 Days)|Adverse Event|0|||
156715993|NCT04917861|565703301|FG000|Main Study (196 Days)|Death|0|||
156715994|NCT04917861|565703302|FG001|Main Study (196 Days)|Death|0|||
156715995|NCT04917861|565703303|FG002|Main Study (196 Days)|Death|0|||
156715996|NCT04917861|565703304|FG003|Main Study (196 Days)|Death|1|||
156715997|NCT04917861|565703301|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
156715998|NCT04917861|565703302|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
156715999|NCT04917861|565703303|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
156716000|NCT04917861|565703304|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
156716001|NCT04917861|565703301|FG000|Main Study (196 Days)|Physician Decision|0|||
156716002|NCT04917861|565703302|FG001|Main Study (196 Days)|Physician Decision|0|||
156716003|NCT04917861|565703303|FG002|Main Study (196 Days)|Physician Decision|0|||
156716004|NCT04917861|565703304|FG003|Main Study (196 Days)|Physician Decision|1|||
156444825|NCT04143061|564720339|FG006|Overall Study|Withdrawal by Subject|0|||
156444826|NCT04143061|564720340|FG007|Overall Study|Withdrawal by Subject|0|||
156444827|NCT04143061|564720333|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156444828|NCT04143061|564720334|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156716005|NCT04917861|565703301|FG000|Main Study (196 Days)|Pregnancy|1|||
156444829|NCT04143061|564720335|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156444830|NCT04143061|564720336|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156444831|NCT04143061|564720337|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
156444832|NCT04143061|564720338|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
156444833|NCT04143061|564720339|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
156444834|NCT04143061|564720340|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
156444835|NCT01898494|564720350|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
156444836|NCT01898494|564720351|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
156444837|NCT01898494|564720352|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
156444838|NCT01898494|564720353|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
156444839|NCT01898494|564720354|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
156444840|NCT01898494|564720350|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
156444841|NCT01898494|564720351|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
156444842|NCT01898494|564720352|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
156444843|NCT01898494|564720353|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
156444844|NCT01898494|564720354|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
156444845|NCT01898494|564720350|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
156444846|NCT01898494|564720351|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
156444847|NCT01898494|564720352|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
156444848|NCT01898494|564720353|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
156444849|NCT01898494|564720354|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
156444850|NCT01898494|564720350|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
156444851|NCT01898494|564720351|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
156444852|NCT01898494|564720352|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
156444853|NCT01898494|564720353|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
156444854|NCT01898494|564720354|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
156444855|NCT01898494|564720350|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
156444856|NCT01898494|564720351|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
156444857|NCT01898494|564720352|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
156444858|NCT01898494|564720353|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
156444859|NCT01898494|564720354|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
156444860|NCT01898494|564720350|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
156444861|NCT01898494|564720351|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
156444862|NCT01898494|564720352|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
156444863|NCT01898494|564720353|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
156444864|NCT01898494|564720354|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
156444865|NCT01898494|564720350|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
156444866|NCT01898494|564720351|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
156444867|NCT01898494|564720352|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
156444868|NCT01898494|564720353|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
156444869|NCT01898494|564720354|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
156444870|NCT01898494|564720350|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
156444871|NCT01898494|564720351|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
156444872|NCT01898494|564720352|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
156444873|NCT01898494|564720353|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
156444874|NCT01898494|564720354|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
156444875|NCT01898494|564720350|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
156444876|NCT01898494|564720351|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
156444877|NCT01898494|564720352|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
156444878|NCT01898494|564720353|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
156444879|NCT01898494|564720354|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
156444880|NCT01898494|564720350|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
156444881|NCT01898494|564720351|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
156444882|NCT01898494|564720352|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
156444883|NCT01898494|564720353|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
156532665|NCT01807923|565045082|FG001|Overall Study|Randomized But Not Treated|2|||
156716006|NCT04917861|565703302|FG001|Main Study (196 Days)|Pregnancy|1|||
156716007|NCT04917861|565703303|FG002|Main Study (196 Days)|Pregnancy|0|||
156716008|NCT04917861|565703304|FG003|Main Study (196 Days)|Pregnancy|0|||
156716009|NCT04917861|565703301|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
156716010|NCT04917861|565703302|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
156716011|NCT04917861|565703303|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
156716012|NCT04917861|565703304|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
156716013|NCT04917861|565703301|FG000|Main Study (196 Days)|Other Than Specified|1|||
156716014|NCT04917861|565703302|FG001|Main Study (196 Days)|Other Than Specified|0|||
156716015|NCT04917861|565703303|FG002|Main Study (196 Days)|Other Than Specified|1|||
156716016|NCT04917861|565703304|FG003|Main Study (196 Days)|Other Than Specified|2|||
156716017|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
156716018|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
156444884|NCT01898494|564720354|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
156444885|NCT01898494|564720350|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
156444886|NCT01898494|564720351|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
156444887|NCT01898494|564720352|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
156444888|NCT01898494|564720353|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
156444889|NCT01898494|564720354|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
156444890|NCT01898494|564720350|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
156444891|NCT01898494|564720351|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
156444892|NCT01898494|564720352|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
156444893|NCT01898494|564720353|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
156444894|NCT01898494|564720354|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
156444895|NCT01898494|564720350|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
156444896|NCT01898494|564720351|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
156444897|NCT01898494|564720352|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
156444898|NCT01898494|564720353|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
156444899|NCT01898494|564720354|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
156444900|NCT01898494|564720350|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
156444901|NCT01898494|564720351|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
156444902|NCT01898494|564720352|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
156444903|NCT01898494|564720353|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
156444904|NCT01898494|564720354|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
156444905|NCT03289039|564720355|FG000|Overall Study|Withdrawal by Subject|0|||
156444906|NCT03289039|564720356|FG001|Overall Study|Withdrawal by Subject|1|||
156444907|NCT03289039|564720355|FG000|Overall Study|Became ineligible prior to treatment start|0|||
156444908|NCT03289039|564720356|FG001|Overall Study|Became ineligible prior to treatment start|1|||
156444909|NCT03289039|564720355|FG000|Overall Study|progressed before treatment start|1|||
156444910|NCT03289039|564720356|FG001|Overall Study|progressed before treatment start|0|||
156444911|NCT02819843|564720357|FG000|Overall Study|Disease progression before RT|0|||
156444912|NCT02819843|564720358|FG001|Overall Study|Disease progression before RT|1|||
156444913|NCT04732494|564720359|FG000|Overall Study|Death|39|||
156444914|NCT04732494|564720360|FG001|Overall Study|Death|36|||
156444915|NCT04732494|564720359|FG000|Overall Study|Study Closed by Sponsor|20|||
156444916|NCT04732494|564720360|FG001|Overall Study|Study Closed by Sponsor|15|||
156444917|NCT04732494|564720359|FG000|Overall Study|Withdrawal by Subject|2|||
156444918|NCT04732494|564720360|FG001|Overall Study|Withdrawal by Subject|7|||
156444919|NCT04732494|564720359|FG000|Overall Study|Lost to Follow-up|1|||
156444920|NCT04732494|564720360|FG001|Overall Study|Lost to Follow-up|5|||
156444921|NCT04586920|564720361|FG000|Overall Study|Lost to Follow-up|0|||
156444922|NCT04586920|564720362|FG001|Overall Study|Lost to Follow-up|0|||
156444923|NCT04586920|564720363|FG002|Overall Study|Lost to Follow-up|0|||
156444924|NCT04586920|564720364|FG003|Overall Study|Lost to Follow-up|0|||
156444925|NCT04586920|564720365|FG004|Overall Study|Lost to Follow-up|0|||
156444926|NCT04586920|564720366|FG005|Overall Study|Lost to Follow-up|0|||
156444927|NCT04586920|564720367|FG006|Overall Study|Lost to Follow-up|1|||
156444928|NCT04586920|564720368|FG007|Overall Study|Lost to Follow-up|1|||
156444929|NCT04586920|564720369|FG008|Overall Study|Lost to Follow-up|0|||
156444930|NCT04586920|564720370|FG009|Overall Study|Lost to Follow-up|1|||
156444931|NCT04586920|564720371|FG010|Overall Study|Lost to Follow-up|0|||
156444932|NCT04586920|564720372|FG011|Overall Study|Lost to Follow-up|0|||
156444933|NCT04586920|564720373|FG012|Overall Study|Lost to Follow-up|0|||
156444934|NCT04586920|564720374|FG013|Overall Study|Lost to Follow-up|1|||
156444935|NCT04586920|564720375|FG014|Overall Study|Lost to Follow-up|0|||
156444936|NCT04586920|564720376|FG015|Overall Study|Lost to Follow-up|0|||
156444937|NCT04586920|564720377|FG016|Overall Study|Lost to Follow-up|0|||
156444938|NCT04586920|564720378|FG017|Overall Study|Lost to Follow-up|0|||
156444939|NCT04586920|564720361|FG000|Overall Study|Withdrawal by Subject|0|||
156444940|NCT04586920|564720362|FG001|Overall Study|Withdrawal by Subject|0|||
156444941|NCT04586920|564720363|FG002|Overall Study|Withdrawal by Subject|0|||
156444942|NCT04586920|564720364|FG003|Overall Study|Withdrawal by Subject|0|||
156444943|NCT04586920|564720365|FG004|Overall Study|Withdrawal by Subject|0|||
156444944|NCT04586920|564720366|FG005|Overall Study|Withdrawal by Subject|0|||
156444945|NCT04586920|564720367|FG006|Overall Study|Withdrawal by Subject|0|||
156444946|NCT04586920|564720368|FG007|Overall Study|Withdrawal by Subject|1|||
156444947|NCT04586920|564720369|FG008|Overall Study|Withdrawal by Subject|0|||
156444948|NCT04586920|564720370|FG009|Overall Study|Withdrawal by Subject|1|||
156444949|NCT04586920|564720371|FG010|Overall Study|Withdrawal by Subject|0|||
156444950|NCT04586920|564720372|FG011|Overall Study|Withdrawal by Subject|1|||
156444951|NCT04586920|564720373|FG012|Overall Study|Withdrawal by Subject|0|||
156444952|NCT04586920|564720374|FG013|Overall Study|Withdrawal by Subject|0|||
156716019|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
156444953|NCT04586920|564720375|FG014|Overall Study|Withdrawal by Subject|0|||
156444954|NCT04586920|564720376|FG015|Overall Study|Withdrawal by Subject|0|||
156444955|NCT04586920|564720377|FG016|Overall Study|Withdrawal by Subject|0|||
156716020|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
156532666|NCT01807923|565045083|FG002|Overall Study|Randomized But Not Treated|5|||
156532667|NCT00890929|565045085|FG000|Overall Study|Death before treatment|2|||
156532668|NCT00890929|565045085|FG000|Overall Study|Withdrawal by Subject|3|||
156532669|NCT00890929|565045085|FG000|Overall Study|Physician Decision|1|||
156532670|NCT00108069|565045086|FG000|Overall Study|Never rec'd study drug|0|||
156716021|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
156716022|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
156716023|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
156716024|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
156716025|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
156716026|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
156716027|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
156716028|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
156716029|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
156716030|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
156716031|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
156716032|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
156716033|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
156716034|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
156716035|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
156716036|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
156716037|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
156716038|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
156716039|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
156716040|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
156716041|NCT01128179|565703305|FG000|Overall Study|Death|1|||
156716042|NCT01128179|565703306|FG001|Overall Study|Death|0|||
156716043|NCT01128179|565703305|FG000|Overall Study|Protocol Violation|1|||
156716044|NCT01128179|565703306|FG001|Overall Study|Protocol Violation|0|||
156716045|NCT02694328|565703307|FG000|Overall Study|Adverse Event|27|||
156716046|NCT02694328|565703308|FG001|Overall Study|Adverse Event|33|||
156716047|NCT02694328|565703307|FG000|Overall Study|Withdrawal by Subject|27|||
156716048|NCT02694328|565703308|FG001|Overall Study|Withdrawal by Subject|23|||
156716049|NCT02694328|565703307|FG000|Overall Study|Lost to Follow-up|26|||
156716050|NCT02694328|565703308|FG001|Overall Study|Lost to Follow-up|22|||
156716051|NCT02694328|565703307|FG000|Overall Study|Noncompliant with study drug|11|||
156716052|NCT02694328|565703308|FG001|Overall Study|Noncompliant with study drug|8|||
156716053|NCT02694328|565703307|FG000|Overall Study|Incarceration|1|||
156716054|NCT02694328|565703308|FG001|Overall Study|Incarceration|1|||
156716055|NCT02694328|565703307|FG000|Overall Study|Lack of Efficacy|1|||
156716056|NCT02694328|565703308|FG001|Overall Study|Lack of Efficacy|2|||
156716057|NCT02694328|565703307|FG000|Overall Study|Pregnancy|1|||
156716058|NCT02694328|565703308|FG001|Overall Study|Pregnancy|1|||
156716059|NCT02694328|565703307|FG000|Overall Study|Protocol Violation|6|||
156716060|NCT02694328|565703308|FG001|Overall Study|Protocol Violation|5|||
156716061|NCT02694328|565703307|FG000|Overall Study|Abnormal Laboratory Value|0|||
156716062|NCT02694328|565703308|FG001|Overall Study|Abnormal Laboratory Value|3|||
156716063|NCT02603146|565705239|FG000|Overall Study|Lost to Follow-up|5|||
156716064|NCT02603146|565705240|FG001|Overall Study|Lost to Follow-up|6|||
156716065|NCT02603146|565705239|FG000|Overall Study|Withdrawal by Subject|8|||
156716066|NCT02603146|565705240|FG001|Overall Study|Withdrawal by Subject|10|||
156716067|NCT02603146|565705239|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
156716068|NCT02603146|565705240|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
156716069|NCT02603146|565705239|FG000|Overall Study|Participant moved|2|||
156716070|NCT02603146|565705240|FG001|Overall Study|Participant moved|0|||
156716071|NCT02603146|565705239|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
156874710|NCT01737502|566298720|FG000|Phase II|Transition to hospice care|0|||
156874711|NCT01737502|566298721|FG001|Phase II|Transition to hospice care|1|||
156874712|NCT01326104|566298726|FG000|Overall Study|progressed prior to vaccine|0|||
156874713|NCT01326104|566298727|FG001|Overall Study|progressed prior to vaccine|2|||
156334027|NCT01254630|564320954|FG003|Overall Study|Adverse Event|8|||
156716072|NCT02603146|565705240|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
156716073|NCT00265759|565705244|FG000|Overall Study|Withdrawal by Subject|0|||
156716074|NCT00265759|565705245|FG001|Overall Study|Withdrawal by Subject|1|||
156716075|NCT00265759|565705246|FG002|Overall Study|Withdrawal by Subject|2|||
156716076|NCT00265759|565705247|FG003|Overall Study|Withdrawal by Subject|2|||
156716077|NCT00265759|565705244|FG000|Overall Study|Cancel|0|||
156716078|NCT00265759|565705245|FG001|Overall Study|Cancel|0|||
156716079|NCT00265759|565705246|FG002|Overall Study|Cancel|0|||
156716080|NCT00265759|565705247|FG003|Overall Study|Cancel|3|||
156716081|NCT00265759|565705244|FG000|Overall Study|Ineligible|0|||
156716082|NCT00265759|565705245|FG001|Overall Study|Ineligible|0|||
156532671|NCT00108069|565045087|FG001|Overall Study|Never rec'd study drug|1|||
156532672|NCT00108069|565045086|FG000|Overall Study|Adverse Event|1|||
156874714|NCT01326104|566298726|FG000|Overall Study|unable to make vaccine|0|||
156444956|NCT04586920|564720378|FG017|Overall Study|Withdrawal by Subject|0|||
156444957|NCT05136404|564720383|FG000|Period 1|Adverse Event|0|||
156444958|NCT05136404|564720384|FG001|Period 1|Adverse Event|1|||
156444959|NCT05136404|564720385|FG002|Period 1|Adverse Event|1|||
156444960|NCT05136404|564720383|FG000|Period 2|Inappropriate Behavior|0|||
156444961|NCT05136404|564720384|FG001|Period 2|Inappropriate Behavior|0|||
156444962|NCT05136404|564720385|FG002|Period 2|Inappropriate Behavior|1|||
156444963|NCT05136404|564720383|FG000|Period 3|Adverse Event|0|||
156793008|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
156444964|NCT05136404|564720384|FG001|Period 3|Adverse Event|0|||
156444965|NCT05136404|564720385|FG002|Period 3|Adverse Event|1|||
156444966|NCT02553642|564720386|FG000|Overall Study|Withdrawal by Subject|0|||
156444967|NCT02553642|564720387|FG001|Overall Study|Withdrawal by Subject|3|||
156444968|NCT02553642|564720386|FG000|Overall Study|Physician Decision|0|||
156444969|NCT02553642|564720387|FG001|Overall Study|Physician Decision|1|||
156444970|NCT02553642|564720386|FG000|Overall Study|Additional cancer dx|0|||
156444971|NCT02553642|564720387|FG001|Overall Study|Additional cancer dx|1|||
156444972|NCT02553642|564720386|FG000|Overall Study|Never started treatment|0|||
156444973|NCT02553642|564720387|FG001|Overall Study|Never started treatment|1|||
156444974|NCT01820260|564720389|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444975|NCT01820260|564720390|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444976|NCT01820260|564720391|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444977|NCT01820260|564720392|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444978|NCT01820260|564720393|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444979|NCT01820260|564720394|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444980|NCT01820260|564720395|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
156444981|NCT01820260|564720396|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444982|NCT01820260|564720397|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444983|NCT01820260|564720398|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156793009|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
156793010|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
156793011|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
156793012|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
156793013|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
156793014|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
156793015|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
156793016|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
156793017|NCT03973489|565994829|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
156793018|NCT03973489|565994830|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793019|NCT03973489|565994831|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793020|NCT03973489|565994832|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793021|NCT03973489|565994833|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
156793022|NCT03973489|565994834|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793023|NCT03973489|565994835|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793024|NCT03973489|565994836|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793025|NCT03973489|565994829|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793026|NCT03973489|565994830|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793027|NCT03973489|565994831|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793028|NCT03973489|565994832|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
156793029|NCT03973489|565994833|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
156793030|NCT03973489|565994834|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793031|NCT03973489|565994835|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793032|NCT03973489|565994836|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793033|NCT03973489|565994829|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793034|NCT03973489|565994830|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793035|NCT03973489|565994831|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793036|NCT03973489|565994832|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793037|NCT03973489|565994833|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
156793038|NCT03973489|565994834|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793039|NCT03973489|565994835|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
156444984|NCT01820260|564720399|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156532673|NCT00108069|565045087|FG001|Overall Study|Adverse Event|1|||
156532674|NCT00108069|565045086|FG000|Overall Study|Withdrawal by Subject|1|||
156532675|NCT00108069|565045087|FG001|Overall Study|Withdrawal by Subject|0|||
156532676|NCT00108069|565045086|FG000|Overall Study|Death|1|||
156532677|NCT00108069|565045087|FG001|Overall Study|Death|0|||
156532678|NCT00108069|565045086|FG000|Overall Study|Progessive disease|27|||
156532679|NCT00108069|565045087|FG001|Overall Study|Progessive disease|11|||
156793040|NCT03973489|565994836|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
156532680|NCT01237340|565045093|FG000|Overall Study|Adverse Event|3|||
156532681|NCT01237340|565045093|FG000|Overall Study|Withdrawal by Subject|1|||
156532682|NCT01237340|565045093|FG000|Overall Study|Early termination of the trial|36|||
156532683|NCT03836807|565045094|FG000|Overall Study|Physician Decision|1|||
156532684|NCT03836807|565045095|FG001|Overall Study|Physician Decision|0|||
156532685|NCT00685685|565045096|FG000|Washout Period of 7 Days|Adverse Event|2|||
156532686|NCT00685685|565045097|FG001|Washout Period of 7 Days|Adverse Event|0|||
156532687|NCT00685685|565045096|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156532688|NCT00685685|565045097|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156532689|NCT04029116|565045098|FG000|Overall Study|Adverse Event|0|||
156532690|NCT04029116|565045099|FG001|Overall Study|Adverse Event|2|||
156532691|NCT04029116|565045098|FG000|Overall Study|Lost to Follow-up|3|||
156532692|NCT04029116|565045099|FG001|Overall Study|Lost to Follow-up|5|||
156532693|NCT04029116|565045098|FG000|Overall Study|Physician Decision|2|||
156532694|NCT04029116|565045099|FG001|Overall Study|Physician Decision|0|||
156532695|NCT04029116|565045098|FG000|Overall Study|Pregnancy|1|||
156532696|NCT04029116|565045099|FG001|Overall Study|Pregnancy|2|||
156532697|NCT04029116|565045098|FG000|Overall Study|Withdrawal by Subject|4|||
156532698|NCT04029116|565045099|FG001|Overall Study|Withdrawal by Subject|6|||
156532699|NCT04029116|565045098|FG000|Overall Study|Other|2|||
156532700|NCT04029116|565045099|FG001|Overall Study|Other|1|||
156532701|NCT02469896|565045102|FG000|Overall Study|Withdrawal by Subject|2|||
156532702|NCT02469896|565045103|FG001|Overall Study|Withdrawal by Subject|0|||
156532703|NCT02510560|565045104|FG000|Overall Study|Discontinued from Treatment|27|||
156532704|NCT02510560|565045105|FG001|Overall Study|Discontinued from Treatment|18|||
156532705|NCT02510560|565045106|FG002|Overall Study|Discontinued from Treatment|19|||
156532706|NCT02510560|565045104|FG000|Overall Study|Other|4|||
156532707|NCT02510560|565045105|FG001|Overall Study|Other|4|||
156532708|NCT02510560|565045106|FG002|Overall Study|Other|3|||
156532709|NCT00882310|565045107|FG000|Overall Study|Screen Failure|10|||
156532710|NCT00882310|565045107|FG000|Overall Study|Never received treatment|1|||
156532711|NCT00882310|565045107|FG000|Overall Study|Death|6|||
156532712|NCT00882310|565045107|FG000|Overall Study|Progression of disease|4|||
156532713|NCT00882310|565045107|FG000|Overall Study|Adverse Event|1|||
156532714|NCT02846532|565045112|FG000|Overall Study|Lost to Follow-up|0|||
156532715|NCT02846532|565045113|FG001|Overall Study|Lost to Follow-up|1|||
156532716|NCT02846532|565045114|FG002|Overall Study|Lost to Follow-up|1|||
156532717|NCT02846532|565045112|FG000|Overall Study|Withdrawal by Subject|1|||
156532718|NCT02846532|565045113|FG001|Overall Study|Withdrawal by Subject|2|||
156532719|NCT02846532|565045114|FG002|Overall Study|Withdrawal by Subject|0|||
156532720|NCT04908189|565045116|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
156532721|NCT04908189|565045117|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
156532722|NCT04908189|565045118|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
156532723|NCT04908189|565045116|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
156532724|NCT04908189|565045117|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
156532725|NCT04908189|565045118|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
156532726|NCT04908189|565045116|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
156532727|NCT04908189|565045117|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
156532728|NCT04908189|565045118|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
156532729|NCT04908189|565045116|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
156532730|NCT04908189|565045117|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
156532731|NCT04908189|565045118|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
156532732|NCT04908189|565045116|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
156716083|NCT00265759|565705246|FG002|Overall Study|Ineligible|0|||
156716084|NCT00265759|565705247|FG003|Overall Study|Ineligible|1|||
156716085|NCT00265759|565705244|FG000|Overall Study|Bilateral disease|0|||
156716086|NCT00265759|565705245|FG001|Overall Study|Bilateral disease|0|||
156716087|NCT00265759|565705246|FG002|Overall Study|Bilateral disease|0|||
156716088|NCT00265759|565705247|FG003|Overall Study|Bilateral disease|2|||
156716089|NCT00265759|565705244|FG000|Overall Study|Discontinued due to intolerability|0|||
156874715|NCT01326104|566298727|FG001|Overall Study|unable to make vaccine|2|||
156874716|NCT05064358|566298728|FG000|Overall Study|Death|23|||
156532733|NCT04908189|565045117|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
156532734|NCT04908189|565045118|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
156532735|NCT04908189|565045116|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
156716090|NCT00265759|565705245|FG001|Overall Study|Discontinued due to intolerability|0|||
156716091|NCT00265759|565705246|FG002|Overall Study|Discontinued due to intolerability|0|||
156716092|NCT00265759|565705247|FG003|Overall Study|Discontinued due to intolerability|1|||
156874717|NCT05064358|566298729|FG001|Overall Study|Death|23|||
156874718|NCT05064358|566298730|FG002|Overall Study|Death|25|||
156716093|NCT06082843|565705248|FG000|Overall Study|Withdrawal by Subject|0|||
156716094|NCT06082843|565705249|FG001|Overall Study|Withdrawal by Subject|2|||
156716095|NCT06082843|565705248|FG000|Overall Study|Study terminated by sponsor|12|||
156874719|NCT05064358|566298731|FG003|Overall Study|Death|21|||
156444985|NCT01820260|564720400|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444986|NCT01820260|564720401|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444987|NCT01820260|564720402|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
156444988|NCT01820260|564720389|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444989|NCT01820260|564720390|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444990|NCT01820260|564720391|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444991|NCT01820260|564720392|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444992|NCT01820260|564720393|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444993|NCT01820260|564720394|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444994|NCT01820260|564720395|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444995|NCT01820260|564720396|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444996|NCT01820260|564720397|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444997|NCT01820260|564720398|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
156444998|NCT01820260|564720399|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156444999|NCT01820260|564720400|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156445000|NCT01820260|564720401|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156445001|NCT01820260|564720402|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156445002|NCT05444192|564720403|FG000|Overall Study|Lost to Follow-up|1|||
156445003|NCT05444192|564720404|FG001|Overall Study|Lost to Follow-up|0|||
156445004|NCT04424927|564720409|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
156445005|NCT04424927|564720410|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
156445006|NCT04424927|564720411|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
156445007|NCT04424927|564720412|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
156445008|NCT04424927|564720413|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
156445009|NCT04424927|564720409|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
156445010|NCT04424927|564720410|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
156445011|NCT04424927|564720411|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
156874720|NCT05064358|566298732|FG004|Overall Study|Death|5|||
156874721|NCT05064358|566298728|FG000|Overall Study|Lost to Follow-up|1|||
156874722|NCT05064358|566298729|FG001|Overall Study|Lost to Follow-up|2|||
156334028|NCT01254630|564320951|FG000|Overall Study|Death|461|||
156334029|NCT01254630|564320952|FG001|Overall Study|Death|151|||
156334030|NCT01254630|564320953|FG002|Overall Study|Death|478|||
156334031|NCT01254630|564320954|FG003|Overall Study|Death|139|||
156334032|NCT01254630|564320951|FG000|Overall Study|Lost to Follow-up|80|||
156334033|NCT01254630|564320952|FG001|Overall Study|Lost to Follow-up|26|||
156334034|NCT01254630|564320953|FG002|Overall Study|Lost to Follow-up|89|||
156334035|NCT01254630|564320954|FG003|Overall Study|Lost to Follow-up|32|||
156334036|NCT01254630|564320951|FG000|Overall Study|Physician Decision|24|||
156334037|NCT01254630|564320952|FG001|Overall Study|Physician Decision|8|||
156334038|NCT01254630|564320953|FG002|Overall Study|Physician Decision|16|||
156334039|NCT01254630|564320954|FG003|Overall Study|Physician Decision|7|||
156334040|NCT01254630|564320951|FG000|Overall Study|Withdrawal by Subject|201|||
156334041|NCT01254630|564320952|FG001|Overall Study|Withdrawal by Subject|94|||
156334042|NCT01254630|564320953|FG002|Overall Study|Withdrawal by Subject|188|||
156334043|NCT01254630|564320954|FG003|Overall Study|Withdrawal by Subject|89|||
156334044|NCT01254630|564320951|FG000|Overall Study|Study terminated by sponsor|0|||
156334045|NCT01254630|564320952|FG001|Overall Study|Study terminated by sponsor|994|||
156334046|NCT01254630|564320953|FG002|Overall Study|Study terminated by sponsor|0|||
156334047|NCT01254630|564320954|FG003|Overall Study|Study terminated by sponsor|1010|||
156334048|NCT01254630|564320951|FG000|Overall Study|Status not recorded|0|||
156334049|NCT01254630|564320952|FG001|Overall Study|Status not recorded|0|||
156334050|NCT01254630|564320953|FG002|Overall Study|Status not recorded|1|||
156334051|NCT01254630|564320954|FG003|Overall Study|Status not recorded|0|||
156334052|NCT02959983|564320955|FG000|Overall Study|Protocol Violation|0|||
156334053|NCT02959983|564320956|FG001|Overall Study|Protocol Violation|1|||
156334054|NCT02959983|564320955|FG000|Overall Study|Lack of Efficacy|0|||
156334055|NCT02959983|564320956|FG001|Overall Study|Lack of Efficacy|1|||
156334056|NCT02959983|564320955|FG000|Overall Study|Lost to Follow-up|12|||
156334057|NCT02959983|564320956|FG001|Overall Study|Lost to Follow-up|9|||
156334058|NCT02959983|564320955|FG000|Overall Study|Other|1|||
156334059|NCT02959983|564320956|FG001|Overall Study|Other|1|||
156334060|NCT02959983|564320955|FG000|Overall Study|Physician Decision|1|||
156334061|NCT02959983|564320956|FG001|Overall Study|Physician Decision|0|||
156334062|NCT02959983|564320955|FG000|Overall Study|Adverse Event|5|||
156334063|NCT02959983|564320956|FG001|Overall Study|Adverse Event|1|||
156334064|NCT02959983|564320955|FG000|Overall Study|Withdrawal by Subject|7|||
156334065|NCT02959983|564320956|FG001|Overall Study|Withdrawal by Subject|12|||
156334066|NCT04032652|564320961|FG000|Overall Study|The study was terminated and the PI has|1|||
156334067|NCT04032652|564320962|FG001|Overall Study|The study was terminated and the PI has|1|||
156334068|NCT00370071|564320963|FG000|Overall Study|Withdrawal by Subject|2|||
156334069|NCT02004522|564320964|FG000|Overall Study|Adverse Event|55|||
156334070|NCT02004522|564320965|FG001|Overall Study|Adverse Event|6|||
156334071|NCT02004522|564320964|FG000|Overall Study|Withdrawal by Subject|13|||
156334072|NCT02004522|564320965|FG001|Overall Study|Withdrawal by Subject|7|||
156334073|NCT02004522|564320964|FG000|Overall Study|Death|12|||
156334074|NCT02004522|564320965|FG001|Overall Study|Death|3|||
156793041|NCT03973489|565994829|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
156793042|NCT03973489|565994830|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793043|NCT03973489|565994831|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793044|NCT03973489|565994832|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
156793045|NCT03973489|565994833|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793046|NCT03973489|565994834|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793047|NCT03973489|565994835|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793048|NCT03973489|565994836|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793049|NCT03973489|565994829|FG000|Second Intervention (1 Day)|Adverse Event|0|||
156793050|NCT03973489|565994830|FG001|Second Intervention (1 Day)|Adverse Event|0|||
156793051|NCT03973489|565994831|FG002|Second Intervention (1 Day)|Adverse Event|0|||
156793052|NCT03973489|565994832|FG003|Second Intervention (1 Day)|Adverse Event|1|||
156793053|NCT03973489|565994833|FG004|Second Intervention (1 Day)|Adverse Event|0|||
156793054|NCT03973489|565994834|FG005|Second Intervention (1 Day)|Adverse Event|0|||
156334075|NCT02004522|564320964|FG000|Overall Study|Physician Decision|3|||
156334076|NCT02004522|564320965|FG001|Overall Study|Physician Decision|4|||
156334077|NCT02004522|564320964|FG000|Overall Study|Protocol Violation|1|||
156334078|NCT02004522|564320965|FG001|Overall Study|Protocol Violation|0|||
156334079|NCT02004522|564320964|FG000|Overall Study|Other is reason listed by PI|4|||
156334080|NCT02004522|564320965|FG001|Overall Study|Other is reason listed by PI|1|||
156334081|NCT02004522|564320964|FG000|Overall Study|Never Dosed|2|||
156334082|NCT02004522|564320965|FG001|Overall Study|Never Dosed|4|||
156334083|NCT02004522|564320964|FG000|Overall Study|Disease Progression|35|||
156334084|NCT02004522|564320965|FG001|Overall Study|Disease Progression|31|||
156334085|NCT02004522|564320964|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
156334086|NCT02004522|564320965|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
156334087|NCT01787331|564320966|FG000|Overall Study|Physician Decision|1|||
156334088|NCT01787331|564320966|FG000|Overall Study|Withdrawal by Subject|1|||
156334089|NCT00761631|564320968|FG000|Overall Study|Parent/legal guardian request|8|||
156334090|NCT00761631|564320969|FG001|Overall Study|Parent/legal guardian request|3|||
156334091|NCT00761631|564320970|FG002|Overall Study|Parent/legal guardian request|8|||
156334092|NCT00761631|564320971|FG003|Overall Study|Parent/legal guardian request|0|||
156334093|NCT00761631|564320972|FG004|Overall Study|Parent/legal guardian request|5|||
156334094|NCT00761631|564320973|FG005|Overall Study|Parent/legal guardian request|0|||
156334095|NCT00761631|564320968|FG000|Overall Study|Lost to Follow-up|2|||
156334096|NCT00761631|564320969|FG001|Overall Study|Lost to Follow-up|4|||
156334097|NCT00761631|564320970|FG002|Overall Study|Lost to Follow-up|7|||
156334098|NCT00761631|564320971|FG003|Overall Study|Lost to Follow-up|1|||
156334099|NCT00761631|564320972|FG004|Overall Study|Lost to Follow-up|6|||
156334100|NCT00761631|564320973|FG005|Overall Study|Lost to Follow-up|1|||
156334101|NCT00761631|564320968|FG000|Overall Study|Protocol Violation|2|||
156334102|NCT00761631|564320969|FG001|Overall Study|Protocol Violation|0|||
156334103|NCT00761631|564320970|FG002|Overall Study|Protocol Violation|0|||
156334104|NCT00761631|564320971|FG003|Overall Study|Protocol Violation|1|||
156334105|NCT00761631|564320972|FG004|Overall Study|Protocol Violation|5|||
156334106|NCT00761631|564320973|FG005|Overall Study|Protocol Violation|1|||
156334107|NCT00761631|564320968|FG000|Overall Study|Randomized, not treated|1|||
156334108|NCT00761631|564320969|FG001|Overall Study|Randomized, not treated|0|||
156334109|NCT00761631|564320970|FG002|Overall Study|Randomized, not treated|0|||
156334110|NCT00761631|564320971|FG003|Overall Study|Randomized, not treated|0|||
156334111|NCT00761631|564320972|FG004|Overall Study|Randomized, not treated|0|||
156334112|NCT00761631|564320973|FG005|Overall Study|Randomized, not treated|0|||
156334113|NCT00761631|564320968|FG000|Overall Study|Failed to return|1|||
156334114|NCT00761631|564320969|FG001|Overall Study|Failed to return|0|||
156334115|NCT00761631|564320970|FG002|Overall Study|Failed to return|1|||
156334116|NCT00761631|564320971|FG003|Overall Study|Failed to return|1|||
156334117|NCT00761631|564320972|FG004|Overall Study|Failed to return|5|||
156334118|NCT00761631|564320973|FG005|Overall Study|Failed to return|2|||
156334119|NCT00761631|564320968|FG000|Overall Study|Physician Decision|1|||
156334120|NCT00761631|564320969|FG001|Overall Study|Physician Decision|0|||
156334121|NCT00761631|564320970|FG002|Overall Study|Physician Decision|0|||
156334122|NCT00761631|564320971|FG003|Overall Study|Physician Decision|0|||
156334123|NCT00761631|564320972|FG004|Overall Study|Physician Decision|0|||
156334124|NCT00761631|564320973|FG005|Overall Study|Physician Decision|0|||
156334125|NCT00761631|564320968|FG000|Overall Study|Other|0|||
156334126|NCT00761631|564320969|FG001|Overall Study|Other|0|||
156334127|NCT00761631|564320970|FG002|Overall Study|Other|0|||
156334128|NCT00761631|564320971|FG003|Overall Study|Other|0|||
156334129|NCT00761631|564320972|FG004|Overall Study|Other|1|||
156334130|NCT00761631|564320973|FG005|Overall Study|Other|1|||
156334131|NCT00450255|564320978|FG000|Overall Study|Prior RFA ablation of liver|1|||
156334132|NCT01193842|564320981|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
156334133|NCT01193842|564320982|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
156334134|NCT01193842|564320983|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
156334135|NCT01193842|564320984|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
156334136|NCT01193842|564320985|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
156874723|NCT05064358|566298730|FG002|Overall Study|Lost to Follow-up|0|||
156445012|NCT04424927|564720412|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
156445013|NCT04424927|564720413|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
156445014|NCT04424927|564720409|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
156445015|NCT04424927|564720410|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
156445016|NCT04424927|564720411|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
156445017|NCT04424927|564720412|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
156445018|NCT04424927|564720413|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
156874724|NCT05064358|566298731|FG003|Overall Study|Lost to Follow-up|2|||
156874725|NCT05064358|566298732|FG004|Overall Study|Lost to Follow-up|0|||
156874726|NCT05064358|566298728|FG000|Overall Study|Physician Decision|1|||
156874727|NCT05064358|566298729|FG001|Overall Study|Physician Decision|1|||
156874728|NCT05064358|566298730|FG002|Overall Study|Physician Decision|2|||
156874729|NCT05064358|566298731|FG003|Overall Study|Physician Decision|0|||
156874730|NCT05064358|566298732|FG004|Overall Study|Physician Decision|0|||
156874731|NCT05064358|566298728|FG000|Overall Study|Withdrawal by Subject|4|||
156874732|NCT05064358|566298729|FG001|Overall Study|Withdrawal by Subject|5|||
156874733|NCT05064358|566298730|FG002|Overall Study|Withdrawal by Subject|3|||
156874734|NCT05064358|566298731|FG003|Overall Study|Withdrawal by Subject|6|||
156874735|NCT05064358|566298732|FG004|Overall Study|Withdrawal by Subject|3|||
156874736|NCT05064358|566298728|FG000|Overall Study|Ongoing at the time of analysis|1|||
156874737|NCT05064358|566298729|FG001|Overall Study|Ongoing at the time of analysis|2|||
156874738|NCT05064358|566298730|FG002|Overall Study|Ongoing at the time of analysis|2|||
156874739|NCT05064358|566298731|FG003|Overall Study|Ongoing at the time of analysis|2|||
156445019|NCT04424927|564720409|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
156445020|NCT04424927|564720410|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
156445021|NCT04424927|564720411|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
156445022|NCT04424927|564720412|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
156445023|NCT04424927|564720413|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
156445024|NCT04424927|564720409|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
156445025|NCT04424927|564720410|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
156445026|NCT04424927|564720411|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
156445027|NCT04424927|564720412|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
156445028|NCT04424927|564720413|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
156445029|NCT04424927|564720409|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
156445030|NCT04424927|564720410|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
156445031|NCT04424927|564720411|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
156445032|NCT04424927|564720412|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
156445033|NCT04424927|564720413|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
156445034|NCT04424927|564720409|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
156445035|NCT04424927|564720410|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
156445036|NCT04424927|564720411|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
156445037|NCT04424927|564720412|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
156445038|NCT04424927|564720413|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
156445039|NCT04424927|564720409|FG000|Double-blind Period (24 Weeks)|Other|0|||
156445040|NCT04424927|564720410|FG001|Double-blind Period (24 Weeks)|Other|1|||
156445041|NCT04424927|564720411|FG002|Double-blind Period (24 Weeks)|Other|3|||
156445042|NCT04424927|564720412|FG003|Double-blind Period (24 Weeks)|Other|1|||
156445043|NCT04424927|564720413|FG004|Double-blind Period (24 Weeks)|Other|0|||
156445044|NCT00505934|564720418|FG000|Overall Study|Adverse Event|1|||
156445045|NCT00505934|564720418|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
156445046|NCT00505934|564720418|FG000|Overall Study|Other: IV dose needed to be changed|1|||
156445047|NCT00894543|564720423|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
156445048|NCT00894543|564720424|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
156445049|NCT00894543|564720423|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
156445050|NCT00894543|564720424|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
156445051|NCT04048681|564720425|FG000|Overall Study|family emergency|0|||
156445052|NCT04048681|564720426|FG001|Overall Study|family emergency|0|||
156445053|NCT04048681|564720427|FG002|Overall Study|family emergency|0|||
156445054|NCT04048681|564720428|FG003|Overall Study|family emergency|1|||
156445055|NCT04048681|564720429|FG004|Overall Study|family emergency|0|||
156445056|NCT03380390|564720430|FG000|Overall Study|Adverse Event|3|||
156445057|NCT02886286|564720431|FG000|Overall Study|pump motor stall|0|||
156445058|NCT02886286|564720432|FG001|Overall Study|pump motor stall|1|||
156445059|NCT00390299|564720433|FG000|Overall Study|Cancellation|1|||
156445060|NCT00390299|564720434|FG001|Overall Study|Cancellation|0|||
156445061|NCT00390299|564720435|FG002|Overall Study|Cancellation|0|||
156445062|NCT00390299|564720436|FG003|Overall Study|Cancellation|0|||
156874740|NCT05064358|566298732|FG004|Overall Study|Ongoing at the time of analysis|2|||
156874741|NCT04421027|566298733|FG000|Treatment Period|Adverse Event|5|||
156874742|NCT04421027|566298734|FG001|Treatment Period|Adverse Event|3|||
156874743|NCT04421027|566298735|FG002|Treatment Period|Adverse Event|0|||
156445063|NCT00390299|564720437|FG004|Overall Study|Cancellation|0|||
156445064|NCT01070069|564720439|FG000|Overall Study|Death|1|||
156445065|NCT01070069|564720440|FG001|Overall Study|Death|0|||
156445066|NCT01070069|564720441|FG002|Overall Study|Death|2|||
156445067|NCT01070069|564720442|FG003|Overall Study|Death|0|||
156445068|NCT01070069|564720443|FG004|Overall Study|Death|1|||
156445069|NCT01070069|564720439|FG000|Overall Study|Withdrawal by Subject|1|||
156445070|NCT01070069|564720440|FG001|Overall Study|Withdrawal by Subject|1|||
156445071|NCT01070069|564720441|FG002|Overall Study|Withdrawal by Subject|4|||
156445072|NCT01070069|564720442|FG003|Overall Study|Withdrawal by Subject|0|||
156445073|NCT01070069|564720443|FG004|Overall Study|Withdrawal by Subject|0|||
156445074|NCT01070069|564720439|FG000|Overall Study|Lost to Follow-up|4|||
156445075|NCT01070069|564720440|FG001|Overall Study|Lost to Follow-up|1|||
156445076|NCT01070069|564720441|FG002|Overall Study|Lost to Follow-up|0|||
156445077|NCT01070069|564720442|FG003|Overall Study|Lost to Follow-up|0|||
156445078|NCT01070069|564720443|FG004|Overall Study|Lost to Follow-up|3|||
156445079|NCT03101930|564720446|FG000|Overall Study|Withdrawal by Subject|2|||
156445080|NCT03101930|564720447|FG001|Overall Study|Withdrawal by Subject|1|||
156445081|NCT03101930|564720448|FG002|Overall Study|Withdrawal by Subject|2|||
156445082|NCT00262301|564720449|FG000|Double-blind Phase|Lost to Follow-up|1|||
156445083|NCT00262301|564720450|FG001|Double-blind Phase|Lost to Follow-up|0|||
156445084|NCT00262301|564720451|FG002|Double-blind Phase|Lost to Follow-up|0|||
156445085|NCT00262301|564720449|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
156445086|NCT00262301|564720450|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
156445087|NCT00262301|564720451|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
156445088|NCT01771731|564720452|FG000|Overall Study|Physician Decision|1|||
156445089|NCT01771731|564720453|FG001|Overall Study|Physician Decision|0|||
156445090|NCT01771731|564720452|FG000|Overall Study|Protocol Violation|0|||
156445091|NCT01771731|564720453|FG001|Overall Study|Protocol Violation|1|||
156445092|NCT01771731|564720452|FG000|Overall Study|Adverse event: Pain Crisis|1|||
156445093|NCT01771731|564720453|FG001|Overall Study|Adverse event: Pain Crisis|1|||
156445094|NCT00976495|564720454|FG000|Overall Study|Withdrawal by Subject|0|||
156445095|NCT00976495|564720455|FG001|Overall Study|Withdrawal by Subject|1|||
156445096|NCT00976495|564720456|FG002|Overall Study|Withdrawal by Subject|0|||
156793055|NCT03973489|565994835|FG006|Second Intervention (1 Day)|Adverse Event|0|||
156793056|NCT03973489|565994836|FG007|Second Intervention (1 Day)|Adverse Event|0|||
156793057|NCT03247673|565994837|FG000|Overall Study|Withdrawal by Subject|1|||
156793058|NCT03247673|565994838|FG001|Overall Study|Withdrawal by Subject|0|||
156793059|NCT03247673|565994839|FG002|Overall Study|Withdrawal by Subject|3|||
156793060|NCT03247673|565994837|FG000|Overall Study|Lost to Follow-up|0|||
156793061|NCT03247673|565994838|FG001|Overall Study|Lost to Follow-up|0|||
156793062|NCT03247673|565994839|FG002|Overall Study|Lost to Follow-up|1|||
156793063|NCT04754399|565994845|FG000|Overall Study|Adverse Event|5|||
156793064|NCT04754399|565994845|FG000|Overall Study|Withdrawal by Subject|6|||
156793065|NCT00231465|565994846|FG000|Overall Study|Completed only one cycle|1|||
156793066|NCT00231465|565994846|FG000|Overall Study|Did not have follow up CT scans|1|||
156793067|NCT03624036|565994847|FG000|Overall Study|Death|2|||
156793068|NCT03624036|565994848|FG001|Overall Study|Death|3|||
156793069|NCT03624036|565994849|FG002|Overall Study|Death|0|||
156793070|NCT03624036|565994850|FG003|Overall Study|Death|1|||
156793071|NCT03624036|565994847|FG000|Overall Study|Withdrawal by Subject|1|||
156793072|NCT03624036|565994848|FG001|Overall Study|Withdrawal by Subject|0|||
156793073|NCT03624036|565994849|FG002|Overall Study|Withdrawal by Subject|1|||
156793074|NCT03624036|565994850|FG003|Overall Study|Withdrawal by Subject|0|||
156793075|NCT03624036|565994847|FG000|Overall Study|Enrolled but Never Treated|1|||
156793076|NCT03624036|565994848|FG001|Overall Study|Enrolled but Never Treated|0|||
156793077|NCT03624036|565994849|FG002|Overall Study|Enrolled but Never Treated|0|||
156793078|NCT03624036|565994850|FG003|Overall Study|Enrolled but Never Treated|0|||
156793079|NCT03624036|565994847|FG000|Overall Study|Reason not Specified|3|||
156445097|NCT05321069|564720457|FG000|Overall Study|Adverse Event|52|||
156445098|NCT05321069|564720458|FG001|Overall Study|Adverse Event|52|||
156445099|NCT05321069|564720459|FG002|Overall Study|Adverse Event|64|||
156445100|NCT05321069|564720457|FG000|Overall Study|Protocol Violation|1|||
156445101|NCT05321069|564720458|FG001|Overall Study|Protocol Violation|1|||
156445102|NCT05321069|564720459|FG002|Overall Study|Protocol Violation|0|||
156793080|NCT03624036|565994848|FG001|Overall Study|Reason not Specified|0|||
156793081|NCT03624036|565994849|FG002|Overall Study|Reason not Specified|2|||
156793082|NCT03624036|565994850|FG003|Overall Study|Reason not Specified|2|||
156445103|NCT05321069|564720457|FG000|Overall Study|Withdrawal by Subject|23|||
156793083|NCT01390584|565994858|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
156793084|NCT01390584|565994859|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
156793085|NCT01390584|565994860|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
156793086|NCT01539525|565994861|FG000|Overall Study|Lost to Follow-up|19|||
156445104|NCT05321069|564720458|FG001|Overall Study|Withdrawal by Subject|18|||
156445105|NCT05321069|564720459|FG002|Overall Study|Withdrawal by Subject|12|||
156445106|NCT05321069|564720457|FG000|Overall Study|Lost to Follow-up|1|||
156445107|NCT05321069|564720458|FG001|Overall Study|Lost to Follow-up|0|||
156445108|NCT05321069|564720459|FG002|Overall Study|Lost to Follow-up|1|||
156445109|NCT05321069|564720457|FG000|Overall Study|No reason stated by the participants|23|||
156445110|NCT05321069|564720458|FG001|Overall Study|No reason stated by the participants|22|||
156445111|NCT05321069|564720459|FG002|Overall Study|No reason stated by the participants|16|||
156445112|NCT05321069|564720457|FG000|Overall Study|Lack of Efficacy|1|||
156445113|NCT05321069|564720458|FG001|Overall Study|Lack of Efficacy|1|||
156445114|NCT05321069|564720459|FG002|Overall Study|Lack of Efficacy|0|||
156445115|NCT01044303|564720466|FG000|Overall Study|Lost to Follow-up|2|||
156445116|NCT01609218|564720467|FG000|Period 1|Adverse Event|3|||
156445117|NCT01609218|564720468|FG001|Period 1|Adverse Event|5|||
156445118|NCT01609218|564720467|FG000|Period 1|Sponsor Decision|0|||
156445119|NCT01609218|564720468|FG001|Period 1|Sponsor Decision|1|||
156445120|NCT01609218|564720467|FG000|Period 2|Adverse Event|1|||
156445121|NCT01609218|564720468|FG001|Period 2|Adverse Event|0|||
156445122|NCT00774852|564720471|FG000|Overall Study|Adverse Event|9|||
156445123|NCT00774852|564720472|FG001|Overall Study|Adverse Event|6|||
156445124|NCT00774852|564720471|FG000|Overall Study|Death|2|||
156445125|NCT00774852|564720472|FG001|Overall Study|Death|1|||
156445126|NCT00774852|564720471|FG000|Overall Study|Lack of Efficacy|3|||
156445127|NCT00774852|564720472|FG001|Overall Study|Lack of Efficacy|7|||
156445128|NCT00774852|564720471|FG000|Overall Study|Lost to Follow-up|9|||
156445129|NCT00774852|564720472|FG001|Overall Study|Lost to Follow-up|5|||
156445130|NCT00774852|564720471|FG000|Overall Study|Physician Decision|2|||
156445131|NCT00774852|564720472|FG001|Overall Study|Physician Decision|6|||
156445132|NCT00774852|564720471|FG000|Overall Study|Pregnancy|1|||
156445133|NCT00774852|564720472|FG001|Overall Study|Pregnancy|2|||
156445134|NCT00774852|564720471|FG000|Overall Study|Withdrawal by Subject|2|||
156445135|NCT00774852|564720472|FG001|Overall Study|Withdrawal by Subject|2|||
156445136|NCT00774852|564720471|FG000|Overall Study|Non-responder|15|||
156445137|NCT00774852|564720472|FG001|Overall Study|Non-responder|11|||
156445138|NCT00774852|564720471|FG000|Overall Study|Subject non-compliance|0|||
156445139|NCT00774852|564720472|FG001|Overall Study|Subject non-compliance|1|||
156445140|NCT00774852|564720471|FG000|Overall Study|Protocol Violation|1|||
156445141|NCT00774852|564720472|FG001|Overall Study|Protocol Violation|0|||
156445142|NCT00774852|564720471|FG000|Overall Study|Subject received prohibited medication|1|||
156445143|NCT00774852|564720472|FG001|Overall Study|Subject received prohibited medication|0|||
156716096|NCT06082843|565705249|FG001|Overall Study|Study terminated by sponsor|8|||
156716097|NCT02366689|565705254|FG000|Overall Study|Withdrawal by Subject|1|||
156716098|NCT02366689|565705255|FG001|Overall Study|Withdrawal by Subject|0|||
156716099|NCT02366689|565705256|FG002|Overall Study|Withdrawal by Subject|1|||
156716100|NCT02366689|565705254|FG000|Overall Study|Lost to Follow-up|3|||
156716101|NCT02366689|565705255|FG001|Overall Study|Lost to Follow-up|2|||
156716102|NCT02366689|565705256|FG002|Overall Study|Lost to Follow-up|0|||
156716103|NCT02366689|565705254|FG000|Overall Study|Pregnancy|0|||
156716104|NCT02366689|565705255|FG001|Overall Study|Pregnancy|1|||
156716105|NCT02366689|565705256|FG002|Overall Study|Pregnancy|1|||
156716106|NCT01996241|565705257|FG000|Overall Study|Lost to Follow-up|252|||
156716107|NCT01996241|565705258|FG001|Overall Study|Lost to Follow-up|235|||
156716108|NCT01068262|565705262|FG000|Overall Study|Adverse Event|2|||
156716109|NCT01068262|565705263|FG001|Overall Study|Adverse Event|0|||
156716110|NCT01068262|565705264|FG002|Overall Study|Adverse Event|1|||
156716111|NCT01068262|565705265|FG003|Overall Study|Adverse Event|0|||
156716112|NCT01068262|565705262|FG000|Overall Study|Protocol Violation|1|||
156716113|NCT01068262|565705263|FG001|Overall Study|Protocol Violation|0|||
156716114|NCT01068262|565705264|FG002|Overall Study|Protocol Violation|0|||
156716115|NCT01068262|565705265|FG003|Overall Study|Protocol Violation|0|||
156716116|NCT01068262|565705262|FG000|Overall Study|Withdrawal by Subject|0|||
156716117|NCT01068262|565705263|FG001|Overall Study|Withdrawal by Subject|1|||
156716118|NCT01068262|565705264|FG002|Overall Study|Withdrawal by Subject|0|||
156445144|NCT04428112|564720473|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
156445145|NCT04428112|564720474|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
156445146|NCT04428112|564720473|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
156445147|NCT04428112|564720474|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
156445148|NCT04428112|564720473|FG000|Overall Study|Withdrawal by Subject|9|||
156445149|NCT04428112|564720474|FG001|Overall Study|Withdrawal by Subject|4|||
156716119|NCT01068262|565705265|FG003|Overall Study|Withdrawal by Subject|0|||
156716120|NCT04428034|565705268|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
156716121|NCT02556801|565705271|FG000|Overall Study|Lost to Follow-up|1|||
156716122|NCT02556801|565705272|FG001|Overall Study|Lost to Follow-up|0|||
156716123|NCT02556801|565705273|FG002|Overall Study|Lost to Follow-up|2|||
156716124|NCT02556801|565705274|FG003|Overall Study|Lost to Follow-up|0|||
156716125|NCT02556801|565705271|FG000|Overall Study|Withdrawal by Subject|1|||
156716126|NCT02556801|565705272|FG001|Overall Study|Withdrawal by Subject|1|||
156716127|NCT02556801|565705273|FG002|Overall Study|Withdrawal by Subject|1|||
156716128|NCT02556801|565705274|FG003|Overall Study|Withdrawal by Subject|0|||
156716129|NCT02556801|565705271|FG000|Overall Study|Protocol Violation|0|||
156716130|NCT02556801|565705272|FG001|Overall Study|Protocol Violation|3|||
156874744|NCT04421027|566298736|FG003|Treatment Period|Adverse Event|0|||
156874745|NCT04421027|566298733|FG000|Treatment Period|Death|98|||
156874746|NCT04421027|566298734|FG001|Treatment Period|Death|61|||
156334137|NCT01193842|564320981|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
156716131|NCT02556801|565705273|FG002|Overall Study|Protocol Violation|1|||
156716132|NCT02556801|565705274|FG003|Overall Study|Protocol Violation|1|||
156716133|NCT02556801|565705271|FG000|Overall Study|Adverse Event|0|||
156716134|NCT02556801|565705272|FG001|Overall Study|Adverse Event|2|||
156716135|NCT02556801|565705273|FG002|Overall Study|Adverse Event|0|||
156716136|NCT02556801|565705274|FG003|Overall Study|Adverse Event|3|||
156716137|NCT02556801|565705271|FG000|Overall Study|Pregnancy|0|||
156716138|NCT02556801|565705272|FG001|Overall Study|Pregnancy|1|||
156716139|NCT02556801|565705273|FG002|Overall Study|Pregnancy|0|||
156716140|NCT02556801|565705274|FG003|Overall Study|Pregnancy|0|||
156874747|NCT04421027|566298735|FG002|Treatment Period|Death|0|||
156334138|NCT01193842|564320982|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
156334139|NCT01193842|564320983|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
156334140|NCT01193842|564320984|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
156334141|NCT01193842|564320985|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
156334142|NCT01193842|564320981|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
156334143|NCT01193842|564320982|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
156334144|NCT01193842|564320983|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
156334145|NCT01193842|564320984|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
156334146|NCT01193842|564320985|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
156334147|NCT01193842|564320981|FG000|Phase II: Randomized Groups|Death|0|||
156334148|NCT01193842|564320982|FG001|Phase II: Randomized Groups|Death|0|||
156334149|NCT01193842|564320983|FG002|Phase II: Randomized Groups|Death|0|||
156334150|NCT01193842|564320984|FG003|Phase II: Randomized Groups|Death|1|||
156334151|NCT01193842|564320985|FG004|Phase II: Randomized Groups|Death|1|||
156334152|NCT01193842|564320981|FG000|Phase II: Randomized Groups|Adverse Event|0|||
156334153|NCT01193842|564320982|FG001|Phase II: Randomized Groups|Adverse Event|0|||
156334154|NCT01193842|564320983|FG002|Phase II: Randomized Groups|Adverse Event|0|||
156334155|NCT01193842|564320984|FG003|Phase II: Randomized Groups|Adverse Event|5|||
156334156|NCT01193842|564320985|FG004|Phase II: Randomized Groups|Adverse Event|3|||
156334157|NCT01193842|564320981|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
156334158|NCT01193842|564320982|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
156334159|NCT01193842|564320983|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
156334160|NCT01193842|564320984|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
156334161|NCT01193842|564320985|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
156334162|NCT01193842|564320981|FG000|Phase II: Randomized Groups|Ineligible|0|||
156334163|NCT01193842|564320982|FG001|Phase II: Randomized Groups|Ineligible|0|||
156334164|NCT01193842|564320983|FG002|Phase II: Randomized Groups|Ineligible|0|||
156334165|NCT01193842|564320984|FG003|Phase II: Randomized Groups|Ineligible|0|||
156334166|NCT01193842|564320985|FG004|Phase II: Randomized Groups|Ineligible|1|||
156334167|NCT01193842|564320981|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
156334168|NCT01193842|564320982|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
156334169|NCT01193842|564320983|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
156334170|NCT01193842|564320984|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
156334171|NCT01193842|564320985|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
156334172|NCT02557295|564320987|FG000|Overall Study|Withdrawal by Subject|9|||
156334173|NCT02557295|564320988|FG001|Overall Study|Withdrawal by Subject|2|||
156334174|NCT02557295|564320989|FG002|Overall Study|Withdrawal by Subject|4|||
156334175|NCT02557295|564320990|FG003|Overall Study|Withdrawal by Subject|0|||
156334176|NCT02557295|564320991|FG004|Overall Study|Withdrawal by Subject|0|||
156334177|NCT02557295|564320992|FG005|Overall Study|Withdrawal by Subject|0|||
156334178|NCT02557295|564320993|FG006|Overall Study|Withdrawal by Subject|15|||
156334179|NCT02557295|564320994|FG007|Overall Study|Withdrawal by Subject|1|||
156334180|NCT02557295|564320995|FG008|Overall Study|Withdrawal by Subject|3|||
156334181|NCT02557295|564320987|FG000|Overall Study|Disease Progression|0|||
156334182|NCT02557295|564320988|FG001|Overall Study|Disease Progression|0|||
156334183|NCT02557295|564320989|FG002|Overall Study|Disease Progression|0|||
156334184|NCT02557295|564320990|FG003|Overall Study|Disease Progression|0|||
156334185|NCT02557295|564320991|FG004|Overall Study|Disease Progression|0|||
156334186|NCT02557295|564320992|FG005|Overall Study|Disease Progression|0|||
156334187|NCT02557295|564320993|FG006|Overall Study|Disease Progression|1|||
156334188|NCT02557295|564320994|FG007|Overall Study|Disease Progression|0|||
156334189|NCT02557295|564320995|FG008|Overall Study|Disease Progression|0|||
156334190|NCT02557295|564320987|FG000|Overall Study|Lack of Efficacy|24|||
156716141|NCT02556801|565705271|FG000|Overall Study|Personal reasons patient|0|||
156716142|NCT02556801|565705272|FG001|Overall Study|Personal reasons patient|0|||
156874748|NCT04421027|566298736|FG003|Treatment Period|Death|0|||
156334191|NCT02557295|564320988|FG001|Overall Study|Lack of Efficacy|1|||
156334192|NCT02557295|564320989|FG002|Overall Study|Lack of Efficacy|3|||
156445150|NCT04428112|564720473|FG000|Overall Study|Lost to Follow-up|27|||
156445151|NCT04428112|564720474|FG001|Overall Study|Lost to Follow-up|7|||
156445152|NCT02807779|564720476|FG000|Overall Study|Lost to Follow-up|1|||
156445153|NCT02807779|564720477|FG001|Overall Study|Lost to Follow-up|0|||
156445154|NCT02807779|564720478|FG002|Overall Study|Lost to Follow-up|0|||
156445155|NCT02807779|564720476|FG000|Overall Study|Physician Decision|2|||
156445156|NCT02807779|564720477|FG001|Overall Study|Physician Decision|0|||
156445157|NCT02807779|564720478|FG002|Overall Study|Physician Decision|1|||
156445158|NCT02807779|564720476|FG000|Overall Study|Death|1|||
156445159|NCT02807779|564720477|FG001|Overall Study|Death|1|||
156445160|NCT02807779|564720478|FG002|Overall Study|Death|0|||
156445161|NCT03582722|564720479|FG000|Overall Study|Lost to Follow-up|1|||
156445162|NCT03582722|564720480|FG001|Overall Study|Lost to Follow-up|4|||
156445163|NCT03582722|564720479|FG000|Overall Study|Withdrawal by Subject|3|||
156445164|NCT03582722|564720480|FG001|Overall Study|Withdrawal by Subject|3|||
156445165|NCT01649271|564722482|FG000|Overall Study|Progressive disease|4|||
156445166|NCT01649271|564722483|FG001|Overall Study|Progressive disease|5|||
156445167|NCT01649271|564722482|FG000|Overall Study|Other Adverse Event|0|||
156445168|NCT01649271|564722483|FG001|Overall Study|Other Adverse Event|2|||
156445169|NCT01649271|564722482|FG000|Overall Study|Withdrawal by Subject|1|||
156445170|NCT01649271|564722483|FG001|Overall Study|Withdrawal by Subject|0|||
156445171|NCT01649271|564722482|FG000|Overall Study|Other than stated above|1|||
156445172|NCT01649271|564722483|FG001|Overall Study|Other than stated above|0|||
156716143|NCT02556801|565705273|FG002|Overall Study|Personal reasons patient|0|||
156716144|NCT02556801|565705274|FG003|Overall Study|Personal reasons patient|1|||
156445173|NCT05644002|564722486|FG000|Overall Study|Lost to Follow-up|1|||
156445174|NCT05644002|564722487|FG001|Overall Study|Lost to Follow-up|2|||
156445175|NCT05644002|564722486|FG000|Overall Study|Withdrawal by Subject|0|||
156445176|NCT05644002|564722487|FG001|Overall Study|Withdrawal by Subject|1|||
156445177|NCT05756075|564722490|FG000|Overall Study|Withdrawal by Subject|16|||
156445178|NCT05756075|564722491|FG001|Overall Study|Withdrawal by Subject|9|||
156445179|NCT04038957|564722493|FG000|Overall Study|Withdrawal by Subject|1|||
156445180|NCT04038957|564722493|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
156445181|NCT02605837|564722494|FG000|Overall Study|Adverse Event|3|||
156445182|NCT02605837|564722495|FG001|Overall Study|Adverse Event|1|||
156445183|NCT02605837|564722494|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156445184|NCT02605837|564722495|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156445185|NCT02605837|564722494|FG000|Overall Study|Withdrawal by Subject|8|||
156445186|NCT02605837|564722495|FG001|Overall Study|Withdrawal by Subject|8|||
156445187|NCT02605837|564722494|FG000|Overall Study|Physician Decision|0|||
156445188|NCT02605837|564722495|FG001|Overall Study|Physician Decision|1|||
156445189|NCT03913195|564722496|FG000|Overall Study|Adverse Event|0|||
156445190|NCT03913195|564722497|FG001|Overall Study|Adverse Event|0|||
156445191|NCT03913195|564722498|FG002|Overall Study|Adverse Event|1|||
156445192|NCT03913195|564722499|FG003|Overall Study|Adverse Event|1|||
156445193|NCT03913195|564722500|FG004|Overall Study|Adverse Event|0|||
156445194|NCT03913195|564722496|FG000|Overall Study|Withdrawal by Subject|0|||
156445195|NCT03913195|564722497|FG001|Overall Study|Withdrawal by Subject|0|||
156445196|NCT03913195|564722498|FG002|Overall Study|Withdrawal by Subject|1|||
156445197|NCT03913195|564722499|FG003|Overall Study|Withdrawal by Subject|0|||
156445198|NCT03913195|564722500|FG004|Overall Study|Withdrawal by Subject|1|||
156445199|NCT03913195|564722496|FG000|Overall Study|non adherence to study|0|||
156445200|NCT03913195|564722497|FG001|Overall Study|non adherence to study|0|||
156445201|NCT03913195|564722498|FG002|Overall Study|non adherence to study|1|||
156445202|NCT03913195|564722499|FG003|Overall Study|non adherence to study|0|||
156445203|NCT03913195|564722500|FG004|Overall Study|non adherence to study|0|||
156445204|NCT05419505|564722502|FG000|Overall Study|Adverse Event|0|||
156532736|NCT04908189|565045117|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
156716145|NCT02515331|565705279|FG000|Overall Study|Withdrawal by Subject|0|||
156716146|NCT02515331|565705280|FG001|Overall Study|Withdrawal by Subject|0|||
156716147|NCT02515331|565705281|FG002|Overall Study|Withdrawal by Subject|1|||
156716148|NCT02515331|565705279|FG000|Overall Study|Protocol deviation|0|||
156716149|NCT02515331|565705280|FG001|Overall Study|Protocol deviation|0|||
156716150|NCT02515331|565705281|FG002|Overall Study|Protocol deviation|3|||
156716151|NCT02515331|565705279|FG000|Overall Study|Adverse Event|2|||
156716152|NCT02515331|565705280|FG001|Overall Study|Adverse Event|0|||
156716153|NCT02515331|565705281|FG002|Overall Study|Adverse Event|0|||
156716154|NCT00124748|565705282|FG000|Overall Study|Adverse Event|8|||
156716155|NCT00124748|565705283|FG001|Overall Study|Adverse Event|39|||
156716156|NCT00124748|565705282|FG000|Overall Study|Abnormal laboratory Value|2|||
156445205|NCT05419505|564722503|FG001|Overall Study|Adverse Event|0|||
156445206|NCT05419505|564722504|FG002|Overall Study|Adverse Event|0|||
156445207|NCT05419505|564722505|FG003|Overall Study|Adverse Event|1|||
156445208|NCT05419505|564722506|FG004|Overall Study|Adverse Event|0|||
156532737|NCT04908189|565045118|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
156445209|NCT05419505|564722507|FG005|Overall Study|Adverse Event|0|||
156445210|NCT05419505|564722508|FG006|Overall Study|Adverse Event|0|||
156716157|NCT00124748|565705283|FG001|Overall Study|Abnormal laboratory Value|2|||
156445211|NCT05419505|564722509|FG007|Overall Study|Adverse Event|0|||
156445212|NCT05419505|564722502|FG000|Overall Study|Withdrawal by Subject|1|||
156445213|NCT05419505|564722503|FG001|Overall Study|Withdrawal by Subject|2|||
156445214|NCT05419505|564722504|FG002|Overall Study|Withdrawal by Subject|0|||
156445215|NCT05419505|564722505|FG003|Overall Study|Withdrawal by Subject|0|||
156445216|NCT05419505|564722506|FG004|Overall Study|Withdrawal by Subject|0|||
156445217|NCT05419505|564722507|FG005|Overall Study|Withdrawal by Subject|0|||
156445218|NCT05419505|564722508|FG006|Overall Study|Withdrawal by Subject|1|||
156445219|NCT05419505|564722509|FG007|Overall Study|Withdrawal by Subject|0|||
156445220|NCT05419505|564722502|FG000|Overall Study|Lost to Follow-up|2|||
156445221|NCT05419505|564722503|FG001|Overall Study|Lost to Follow-up|1|||
156445222|NCT05419505|564722504|FG002|Overall Study|Lost to Follow-up|0|||
156445223|NCT05419505|564722505|FG003|Overall Study|Lost to Follow-up|0|||
156445224|NCT05419505|564722506|FG004|Overall Study|Lost to Follow-up|1|||
156445225|NCT05419505|564722507|FG005|Overall Study|Lost to Follow-up|2|||
156445226|NCT05419505|564722508|FG006|Overall Study|Lost to Follow-up|0|||
156445227|NCT05419505|564722509|FG007|Overall Study|Lost to Follow-up|1|||
156445228|NCT02780388|564722510|FG000|Overall Study|Lost to Follow-up|0|||
156445229|NCT02780388|564722511|FG001|Overall Study|Lost to Follow-up|1|||
156445230|NCT02780388|564722512|FG002|Overall Study|Lost to Follow-up|0|||
156445231|NCT02780388|564722513|FG003|Overall Study|Lost to Follow-up|0|||
156445232|NCT02780388|564722514|FG004|Overall Study|Lost to Follow-up|0|||
156445233|NCT02780388|564722510|FG000|Overall Study|Withdrawal by Subject|1|||
156445234|NCT02780388|564722511|FG001|Overall Study|Withdrawal by Subject|1|||
156445235|NCT02780388|564722512|FG002|Overall Study|Withdrawal by Subject|0|||
156445236|NCT02780388|564722513|FG003|Overall Study|Withdrawal by Subject|0|||
156445237|NCT02780388|564722514|FG004|Overall Study|Withdrawal by Subject|0|||
156445238|NCT04527146|564722515|FG000|Overall Study|Withdrawal by Subject|12|||
156445239|NCT04527146|564722516|FG001|Overall Study|Withdrawal by Subject|15|||
156445240|NCT04527146|564722517|FG002|Overall Study|Withdrawal by Subject|7|||
156445241|NCT04527146|564722518|FG003|Overall Study|Withdrawal by Subject|16|||
156445242|NCT04527146|564722515|FG000|Overall Study|Lost to Follow-up|13|||
156445243|NCT04527146|564722516|FG001|Overall Study|Lost to Follow-up|9|||
156445244|NCT04527146|564722517|FG002|Overall Study|Lost to Follow-up|16|||
156445245|NCT04527146|564722518|FG003|Overall Study|Lost to Follow-up|13|||
156445246|NCT04527146|564722515|FG000|Overall Study|Death|0|||
156445247|NCT04527146|564722516|FG001|Overall Study|Death|1|||
156445248|NCT04527146|564722517|FG002|Overall Study|Death|1|||
156445249|NCT04527146|564722518|FG003|Overall Study|Death|0|||
156445250|NCT04527146|564722515|FG000|Overall Study|Adverse Event|0|||
156445251|NCT04527146|564722516|FG001|Overall Study|Adverse Event|0|||
156445252|NCT04527146|564722517|FG002|Overall Study|Adverse Event|1|||
156445253|NCT04527146|564722518|FG003|Overall Study|Adverse Event|0|||
156445254|NCT04527146|564722515|FG000|Overall Study|Ineligible after randomization|2|||
156445255|NCT04527146|564722516|FG001|Overall Study|Ineligible after randomization|0|||
156445256|NCT04527146|564722517|FG002|Overall Study|Ineligible after randomization|2|||
156445257|NCT04527146|564722518|FG003|Overall Study|Ineligible after randomization|2|||
156445258|NCT04527146|564722515|FG000|Overall Study|Moved to a different group|6|||
156445259|NCT04527146|564722516|FG001|Overall Study|Moved to a different group|3|||
156532738|NCT04908189|565045116|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
156532739|NCT04908189|565045117|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
156716158|NCT00124748|565705282|FG000|Overall Study|Abnormal Procedure|0|||
156716159|NCT00124748|565705283|FG001|Overall Study|Abnormal Procedure|1|||
156716160|NCT00124748|565705282|FG000|Overall Study|Lack of Efficacy|20|||
156716161|NCT00124748|565705283|FG001|Overall Study|Lack of Efficacy|41|||
156716162|NCT00124748|565705282|FG000|Overall Study|No longer requires study drug|1|||
156716163|NCT00124748|565705283|FG001|Overall Study|No longer requires study drug|1|||
156716164|NCT00124748|565705282|FG000|Overall Study|Protocol Violation|3|||
156716165|NCT00124748|565705283|FG001|Overall Study|Protocol Violation|1|||
156716166|NCT00124748|565705282|FG000|Overall Study|Withdrawal by Subject|5|||
156716167|NCT00124748|565705283|FG001|Overall Study|Withdrawal by Subject|15|||
156716168|NCT00124748|565705282|FG000|Overall Study|Lost to Follow-up|2|||
156793087|NCT01539525|565994862|FG001|Overall Study|Lost to Follow-up|12|||
156793088|NCT01539525|565994863|FG002|Overall Study|Lost to Follow-up|11|||
156445260|NCT04527146|564722517|FG002|Overall Study|Moved to a different group|0|||
156445261|NCT04527146|564722518|FG003|Overall Study|Moved to a different group|2|||
156445262|NCT04840199|564722519|FG000|Overall Study|Study Terminated by Sponsor|8|||
156445263|NCT04840199|564722520|FG001|Overall Study|Study Terminated by Sponsor|9|||
156445264|NCT04840199|564722519|FG000|Overall Study|Lost to Follow-up|0|||
156445265|NCT04840199|564722520|FG001|Overall Study|Lost to Follow-up|2|||
156445266|NCT04840199|564722519|FG000|Overall Study|Withdrawal by Subject|2|||
156445267|NCT04840199|564722520|FG001|Overall Study|Withdrawal by Subject|0|||
156445268|NCT04840199|564722519|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
156445269|NCT04840199|564722520|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
156445270|NCT03857620|564722521|FG000|Overall Study|Death|4|||
156445271|NCT03857620|564722522|FG001|Overall Study|Death|5|||
156793089|NCT01539525|565994861|FG000|Overall Study|Withdrawal by Subject|0|||
156445272|NCT03857620|564722523|FG002|Overall Study|Death|7|||
156445273|NCT03857620|564722521|FG000|Overall Study|Lost to Follow-up|2|||
156445274|NCT03857620|564722522|FG001|Overall Study|Lost to Follow-up|5|||
156445275|NCT03857620|564722523|FG002|Overall Study|Lost to Follow-up|3|||
156445276|NCT03857620|564722521|FG000|Overall Study|Disease progression or relapse after study registration|1|||
156445277|NCT03857620|564722522|FG001|Overall Study|Disease progression or relapse after study registration|5|||
156445278|NCT03857620|564722523|FG002|Overall Study|Disease progression or relapse after study registration|1|||
156445279|NCT03857620|564722521|FG000|Overall Study|Ineligible|5|||
156445280|NCT03857620|564722522|FG001|Overall Study|Ineligible|0|||
156445281|NCT03857620|564722523|FG002|Overall Study|Ineligible|2|||
156445282|NCT03857620|564722521|FG000|Overall Study|No malignancy|1|||
156716169|NCT00124748|565705283|FG001|Overall Study|Lost to Follow-up|7|||
156716170|NCT00124748|565705282|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
156716171|NCT00124748|565705283|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
156716172|NCT00124748|565705282|FG000|Overall Study|Death|1|||
156716173|NCT00124748|565705283|FG001|Overall Study|Death|3|||
156716174|NCT00322712|565705284|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
156716175|NCT04176250|565705287|FG000|Overall Study|Adverse Event|0|||
156716176|NCT04176250|565705288|FG001|Overall Study|Adverse Event|1|||
156716177|NCT04176250|565705289|FG002|Overall Study|Adverse Event|0|||
156716178|NCT04176250|565705290|FG003|Overall Study|Adverse Event|1|||
156716179|NCT04176250|565705291|FG004|Overall Study|Adverse Event|0|||
156716180|NCT04176250|565705292|FG005|Overall Study|Adverse Event|1|||
156716181|NCT04176250|565705287|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
156716182|NCT04176250|565705288|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
156716183|NCT04176250|565705289|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
156716184|NCT04176250|565705290|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
156716185|NCT04176250|565705291|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
156716186|NCT04176250|565705292|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
156716187|NCT04176250|565705287|FG000|Overall Study|Withdrawal by Subject|0|||
156716188|NCT04176250|565705288|FG001|Overall Study|Withdrawal by Subject|0|||
156716189|NCT04176250|565705289|FG002|Overall Study|Withdrawal by Subject|0|||
156716190|NCT04176250|565705290|FG003|Overall Study|Withdrawal by Subject|0|||
156716191|NCT04176250|565705291|FG004|Overall Study|Withdrawal by Subject|0|||
156716192|NCT04176250|565705292|FG005|Overall Study|Withdrawal by Subject|1|||
156716193|NCT04176250|565705287|FG000|Overall Study|Randomized in error|0|||
156716194|NCT04176250|565705288|FG001|Overall Study|Randomized in error|0|||
156716195|NCT04176250|565705289|FG002|Overall Study|Randomized in error|0|||
156793090|NCT01539525|565994862|FG001|Overall Study|Withdrawal by Subject|3|||
156793091|NCT01539525|565994863|FG002|Overall Study|Withdrawal by Subject|2|||
156793092|NCT01539525|565994861|FG000|Overall Study|Protocol Violation|1|||
156793093|NCT01539525|565994862|FG001|Overall Study|Protocol Violation|1|||
156793094|NCT01539525|565994863|FG002|Overall Study|Protocol Violation|4|||
156793095|NCT02268851|565994864|FG000|Overall Study|Death|0|||
156793096|NCT02268851|565994865|FG001|Overall Study|Death|0|||
156793097|NCT02268851|565994866|FG002|Overall Study|Death|0|||
156793098|NCT02268851|565994867|FG003|Overall Study|Death|1|||
156793099|NCT02268851|565994868|FG004|Overall Study|Death|2|||
156793100|NCT02268851|565994869|FG005|Overall Study|Death|1|||
156793101|NCT02268851|565994864|FG000|Overall Study|Adverse Event|0|||
156793102|NCT02268851|565994865|FG001|Overall Study|Adverse Event|0|||
156793103|NCT02268851|565994866|FG002|Overall Study|Adverse Event|0|||
156793104|NCT02268851|565994867|FG003|Overall Study|Adverse Event|0|||
156793105|NCT02268851|565994868|FG004|Overall Study|Adverse Event|2|||
156793106|NCT02268851|565994869|FG005|Overall Study|Adverse Event|2|||
156793107|NCT02268851|565994864|FG000|Overall Study|Withdrawal by Subject|0|||
156793108|NCT02268851|565994865|FG001|Overall Study|Withdrawal by Subject|0|||
156793109|NCT02268851|565994866|FG002|Overall Study|Withdrawal by Subject|0|||
156793110|NCT02268851|565994867|FG003|Overall Study|Withdrawal by Subject|2|||
156793111|NCT02268851|565994868|FG004|Overall Study|Withdrawal by Subject|0|||
156793112|NCT02268851|565994869|FG005|Overall Study|Withdrawal by Subject|1|||
156793113|NCT02268851|565994864|FG000|Overall Study|Progressive Disease|1|||
156445283|NCT03857620|564722522|FG001|Overall Study|No malignancy|0|||
156445284|NCT03857620|564722523|FG002|Overall Study|No malignancy|1|||
156445285|NCT03857620|564722521|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
156445286|NCT03857620|564722522|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
156445287|NCT03857620|564722523|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
156445288|NCT03857620|564722521|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
156445289|NCT03857620|564722522|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
156445290|NCT03857620|564722523|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
156445291|NCT03857620|564722521|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
156532740|NCT04908189|565045118|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
156532741|NCT04908189|565045116|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
156532742|NCT04908189|565045117|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
156532743|NCT04908189|565045118|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
156532744|NCT04908189|565045116|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
156532745|NCT04908189|565045117|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
156532746|NCT04908189|565045118|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
156532747|NCT04908189|565045116|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
156532748|NCT04908189|565045117|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
156532749|NCT04908189|565045118|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
156532750|NCT04908189|565045116|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
156532751|NCT04908189|565045117|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
156532752|NCT04908189|565045118|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
156532753|NCT04908189|565045116|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
156532754|NCT04908189|565045117|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
156532755|NCT04908189|565045118|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
156532756|NCT04598477|565045120|FG000|Overall Study|Adverse Event|2|||
156532757|NCT04598477|565045121|FG001|Overall Study|Adverse Event|0|||
156532758|NCT04598477|565045120|FG000|Overall Study|Death|0|||
156532759|NCT04598477|565045121|FG001|Overall Study|Death|1|||
156532760|NCT04598477|565045120|FG000|Overall Study|Lost to Follow-up|1|||
156532761|NCT04598477|565045121|FG001|Overall Study|Lost to Follow-up|0|||
156532762|NCT04598477|565045120|FG000|Overall Study|Physician Decision|7|||
156532763|NCT04598477|565045121|FG001|Overall Study|Physician Decision|2|||
156532764|NCT04598477|565045120|FG000|Overall Study|Pregnancy|0|||
156532765|NCT04598477|565045121|FG001|Overall Study|Pregnancy|1|||
156532766|NCT04598477|565045120|FG000|Overall Study|Requires Prohibited Medication|0|||
156532767|NCT04598477|565045121|FG001|Overall Study|Requires Prohibited Medication|1|||
156532768|NCT04598477|565045120|FG000|Overall Study|Study Terminated by Sponsor|18|||
156532769|NCT04598477|565045121|FG001|Overall Study|Study Terminated by Sponsor|12|||
156532770|NCT04598477|565045120|FG000|Overall Study|Withdrawal by Subject|16|||
156532771|NCT04598477|565045121|FG001|Overall Study|Withdrawal by Subject|12|||
156532772|NCT04598477|565045120|FG000|Overall Study|Other|15|||
156532773|NCT04598477|565045121|FG001|Overall Study|Other|8|||
156532774|NCT05359003|565045122|FG000|Overall Study|Withdrawal by Subject|1|||
156532775|NCT05359003|565045123|FG001|Overall Study|Withdrawal by Subject|3|||
156532776|NCT05579990|565045129|FG000|Overall Study|Lost to Follow-up|3|||
156532777|NCT00607022|565045130|FG000|Overall Study|Withdrawal by Subject|1|||
156874749|NCT04421027|566298733|FG000|Treatment Period|Lost to Follow-up|22|||
156532778|NCT00607022|565045131|FG001|Overall Study|Withdrawal by Subject|0|||
156874750|NCT04421027|566298734|FG001|Treatment Period|Lost to Follow-up|20|||
156874751|NCT04421027|566298735|FG002|Treatment Period|Lost to Follow-up|0|||
156874752|NCT04421027|566298736|FG003|Treatment Period|Lost to Follow-up|0|||
156874753|NCT04421027|566298733|FG000|Treatment Period|Other-Unknown|15|||
156874754|NCT04421027|566298734|FG001|Treatment Period|Other-Unknown|9|||
156874755|NCT04421027|566298735|FG002|Treatment Period|Other-Unknown|0|||
156874756|NCT04421027|566298736|FG003|Treatment Period|Other-Unknown|0|||
156874757|NCT04421027|566298733|FG000|Treatment Period|Physician Decision|1|||
156874758|NCT04421027|566298734|FG001|Treatment Period|Physician Decision|1|||
156874759|NCT04421027|566298735|FG002|Treatment Period|Physician Decision|0|||
156874760|NCT04421027|566298736|FG003|Treatment Period|Physician Decision|0|||
156532779|NCT00607022|565045132|FG002|Overall Study|Withdrawal by Subject|0|||
156532780|NCT01310803|565046789|FG000|Overall Study|Subject terminated by Sponsor|1|||
156532781|NCT01310803|565046790|FG001|Overall Study|Subject terminated by Sponsor|0|||
156532782|NCT02113579|565046793|FG000|Overall Study|Adverse Event|1|||
156532783|NCT02113579|565046794|FG001|Overall Study|Adverse Event|0|||
156532784|NCT02113579|565046793|FG000|Overall Study|Withdrawal by Subject|3|||
156874761|NCT04421027|566298733|FG000|Treatment Period|Withdrawal by Subject|7|||
156874762|NCT04421027|566298734|FG001|Treatment Period|Withdrawal by Subject|12|||
156874763|NCT04421027|566298735|FG002|Treatment Period|Withdrawal by Subject|0|||
156874764|NCT04421027|566298736|FG003|Treatment Period|Withdrawal by Subject|0|||
156874765|NCT04421027|566298733|FG000|Treatment Period|Randomized Not Dosed|9|||
156874766|NCT04421027|566298734|FG001|Treatment Period|Randomized Not Dosed|14|||
156874767|NCT04421027|566298735|FG002|Treatment Period|Randomized Not Dosed|0|||
156874768|NCT04421027|566298736|FG003|Treatment Period|Randomized Not Dosed|0|||
156874769|NCT04421027|566298733|FG000|Follow-Up Period|Adverse Event|0|||
156532785|NCT02113579|565046794|FG001|Overall Study|Withdrawal by Subject|2|||
156532786|NCT02113579|565046793|FG000|Overall Study|Lost to Follow-up|6|||
156532787|NCT02113579|565046794|FG001|Overall Study|Lost to Follow-up|2|||
156532788|NCT03047551|565046795|FG000|Overall Study|Did not receive TAS|1|||
156532789|NCT03047551|565046796|FG001|Overall Study|Did not receive TAS|0|||
156532790|NCT03047551|565046795|FG000|Overall Study|Physician Decision|1|||
156532791|NCT03047551|565046796|FG001|Overall Study|Physician Decision|0|||
156874770|NCT04421027|566298734|FG001|Follow-Up Period|Adverse Event|0|||
156445292|NCT03857620|564722522|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
156445293|NCT03857620|564722523|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
156445294|NCT03857620|564722521|FG000|Overall Study|Surgery not performed, patient decision|0|||
156445295|NCT03857620|564722522|FG001|Overall Study|Surgery not performed, patient decision|3|||
156445296|NCT03857620|564722523|FG002|Overall Study|Surgery not performed, patient decision|1|||
156445297|NCT03857620|564722521|FG000|Overall Study|Surgery not performed, other reason|3|||
156445298|NCT03857620|564722522|FG001|Overall Study|Surgery not performed, other reason|1|||
156445299|NCT03857620|564722523|FG002|Overall Study|Surgery not performed, other reason|4|||
156445300|NCT03857620|564722521|FG000|Overall Study|Worsening performance status after surgery performed|0|||
156445301|NCT03857620|564722522|FG001|Overall Study|Worsening performance status after surgery performed|1|||
156445302|NCT03857620|564722523|FG002|Overall Study|Worsening performance status after surgery performed|1|||
156445303|NCT03271151|564722524|FG000|Overall Study|Lost to Follow-up|1|||
156445304|NCT03271151|564722525|FG001|Overall Study|Lost to Follow-up|3|||
156445305|NCT03271151|564722524|FG000|Overall Study|Withdrawal by Subject|1|||
156445306|NCT03271151|564722525|FG001|Overall Study|Withdrawal by Subject|0|||
156445307|NCT02201108|564722528|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
156445308|NCT02201108|564722529|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
156445309|NCT02201108|564722530|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
156445310|NCT02201108|564722528|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
156445311|NCT02201108|564722529|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
156445312|NCT02201108|564722530|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
156445313|NCT02201108|564722528|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
156445314|NCT02201108|564722529|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
156445315|NCT02201108|564722530|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
156445316|NCT02201108|564722528|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
156445317|NCT02201108|564722529|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
156445318|NCT02201108|564722530|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
156445319|NCT02201108|564722528|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
156445320|NCT02201108|564722529|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
156445321|NCT02201108|564722530|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
156445322|NCT02201108|564722528|FG000|Open Label Period (up to Week 192)|Other reason|4|||
156445323|NCT02201108|564722529|FG001|Open Label Period (up to Week 192)|Other reason|7|||
156445324|NCT02201108|564722530|FG002|Open Label Period (up to Week 192)|Other reason|0|||
156445325|NCT02201108|564722528|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
156445326|NCT02201108|564722529|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
156445327|NCT02201108|564722530|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
156445328|NCT02201108|564722528|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
156445329|NCT02201108|564722529|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
156445330|NCT02201108|564722530|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
156445331|NCT02201108|564722528|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
156445332|NCT02201108|564722529|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
156445333|NCT02201108|564722530|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
156445334|NCT04118452|564722531|FG000|Overall Study|Lost to Follow-up|5|||
156445335|NCT04118452|564722532|FG001|Overall Study|Lost to Follow-up|5|||
156716196|NCT04176250|565705290|FG003|Overall Study|Randomized in error|0|||
156874771|NCT04421027|566298735|FG002|Follow-Up Period|Adverse Event|0|||
156445336|NCT04118452|564722531|FG000|Overall Study|Withdrawal by Subject|17|||
156445337|NCT04118452|564722532|FG001|Overall Study|Withdrawal by Subject|17|||
156445338|NCT03438188|564722533|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
156445339|NCT03438188|564722534|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
156445340|NCT03438188|564722535|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
156445341|NCT03438188|564722533|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
156445342|NCT03438188|564722534|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
156445343|NCT03438188|564722535|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
156445344|NCT03438188|564722533|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
156445345|NCT03438188|564722534|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
156445346|NCT03438188|564722535|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
156445347|NCT03438188|564722533|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
156445348|NCT03438188|564722534|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
156445349|NCT03438188|564722535|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
156716197|NCT04176250|565705291|FG004|Overall Study|Randomized in error|1|||
156874772|NCT04421027|566298736|FG003|Follow-Up Period|Adverse Event|3|||
156445350|NCT03438188|564722533|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
156445351|NCT03438188|564722534|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
156445352|NCT03438188|564722535|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
156445353|NCT05215847|564722536|FG000|Overall Study|Lost to Follow-up|1|||
156874773|NCT04421027|566298733|FG000|Follow-Up Period|Death|0|||
156716198|NCT04176250|565705292|FG005|Overall Study|Randomized in error|0|||
156716199|NCT04747470|565705293|FG000|Overall Study|Death|0|||
156334193|NCT02557295|564320990|FG003|Overall Study|Lack of Efficacy|0|||
156334194|NCT02557295|564320991|FG004|Overall Study|Lack of Efficacy|0|||
156334195|NCT02557295|564320992|FG005|Overall Study|Lack of Efficacy|0|||
156334196|NCT02557295|564320993|FG006|Overall Study|Lack of Efficacy|12|||
156716200|NCT04747470|565705294|FG001|Overall Study|Death|3|||
156716201|NCT04747470|565705295|FG002|Overall Study|Death|2|||
156716202|NCT04747470|565705296|FG003|Overall Study|Death|2|||
156716203|NCT04747470|565705297|FG004|Overall Study|Death|2|||
156716204|NCT04747470|565705298|FG005|Overall Study|Death|0|||
156716205|NCT04747470|565705299|FG006|Overall Study|Death|0|||
156716206|NCT04747470|565705300|FG007|Overall Study|Death|0|||
156716207|NCT04747470|565705301|FG008|Overall Study|Death|0|||
156716208|NCT04747470|565705302|FG009|Overall Study|Death|0|||
156716209|NCT04747470|565705303|FG010|Overall Study|Death|0|||
156716210|NCT04747470|565705293|FG000|Overall Study|Withdrew Consent|0|||
156716211|NCT04747470|565705294|FG001|Overall Study|Withdrew Consent|0|||
156716212|NCT04747470|565705295|FG002|Overall Study|Withdrew Consent|0|||
156716213|NCT04747470|565705296|FG003|Overall Study|Withdrew Consent|1|||
156716214|NCT04747470|565705297|FG004|Overall Study|Withdrew Consent|0|||
156716215|NCT04747470|565705298|FG005|Overall Study|Withdrew Consent|0|||
156716216|NCT04747470|565705299|FG006|Overall Study|Withdrew Consent|0|||
156716217|NCT04747470|565705300|FG007|Overall Study|Withdrew Consent|0|||
156716218|NCT04747470|565705301|FG008|Overall Study|Withdrew Consent|0|||
156445354|NCT03433339|564722537|FG000|Overall Study|Lost to Follow-up|2|||
156445355|NCT03433339|564722538|FG001|Overall Study|Lost to Follow-up|0|||
156445356|NCT03433339|564722537|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
156716219|NCT04747470|565705302|FG009|Overall Study|Withdrew Consent|0|||
156716220|NCT04747470|565705303|FG010|Overall Study|Withdrew Consent|0|||
156716221|NCT04747470|565705293|FG000|Overall Study|Study Terminated by Sponsor|0|||
156716222|NCT04747470|565705294|FG001|Overall Study|Study Terminated by Sponsor|0|||
156716223|NCT04747470|565705295|FG002|Overall Study|Study Terminated by Sponsor|1|||
156716224|NCT04747470|565705296|FG003|Overall Study|Study Terminated by Sponsor|0|||
156716225|NCT04747470|565705297|FG004|Overall Study|Study Terminated by Sponsor|2|||
156716226|NCT04747470|565705298|FG005|Overall Study|Study Terminated by Sponsor|0|||
156716227|NCT04747470|565705299|FG006|Overall Study|Study Terminated by Sponsor|0|||
156716228|NCT04747470|565705300|FG007|Overall Study|Study Terminated by Sponsor|0|||
156716229|NCT04747470|565705301|FG008|Overall Study|Study Terminated by Sponsor|0|||
156716230|NCT04747470|565705302|FG009|Overall Study|Study Terminated by Sponsor|0|||
156716231|NCT04747470|565705303|FG010|Overall Study|Study Terminated by Sponsor|0|||
156716232|NCT02105467|565705306|FG000|Period 1|Lost to Follow-up|1|||
156716233|NCT02105467|565705307|FG001|Period 1|Lost to Follow-up|0|||
156716234|NCT02105467|565705306|FG000|Period 1|Death|1|||
156716235|NCT02105467|565705307|FG001|Period 1|Death|0|||
156716236|NCT02105467|565705306|FG000|Period 2|Lost to Follow-up|1|||
156716237|NCT02105467|565705307|FG001|Period 2|Lost to Follow-up|0|||
156334197|NCT02557295|564320994|FG007|Overall Study|Lack of Efficacy|1|||
156334198|NCT02557295|564320995|FG008|Overall Study|Lack of Efficacy|0|||
156334199|NCT02557295|564320987|FG000|Overall Study|Adverse Event|16|||
156334200|NCT02557295|564320988|FG001|Overall Study|Adverse Event|2|||
156334201|NCT02557295|564320989|FG002|Overall Study|Adverse Event|3|||
156334202|NCT02557295|564320990|FG003|Overall Study|Adverse Event|0|||
156334203|NCT02557295|564320991|FG004|Overall Study|Adverse Event|0|||
156334204|NCT02557295|564320992|FG005|Overall Study|Adverse Event|0|||
156334205|NCT02557295|564320993|FG006|Overall Study|Adverse Event|2|||
156334206|NCT02557295|564320994|FG007|Overall Study|Adverse Event|1|||
156334207|NCT02557295|564320995|FG008|Overall Study|Adverse Event|1|||
156334208|NCT02557295|564320987|FG000|Overall Study|Lost to Follow-up|4|||
156334209|NCT02557295|564320988|FG001|Overall Study|Lost to Follow-up|0|||
156334210|NCT02557295|564320989|FG002|Overall Study|Lost to Follow-up|0|||
156334211|NCT02557295|564320990|FG003|Overall Study|Lost to Follow-up|0|||
156334212|NCT02557295|564320991|FG004|Overall Study|Lost to Follow-up|0|||
156334213|NCT02557295|564320992|FG005|Overall Study|Lost to Follow-up|0|||
156334214|NCT02557295|564320993|FG006|Overall Study|Lost to Follow-up|9|||
156334215|NCT02557295|564320994|FG007|Overall Study|Lost to Follow-up|0|||
156334216|NCT02557295|564320995|FG008|Overall Study|Lost to Follow-up|0|||
156334217|NCT02557295|564320987|FG000|Overall Study|Study Close|54|||
156334218|NCT02557295|564320988|FG001|Overall Study|Study Close|3|||
156334219|NCT02557295|564320989|FG002|Overall Study|Study Close|5|||
156334220|NCT02557295|564320990|FG003|Overall Study|Study Close|3|||
156334221|NCT02557295|564320991|FG004|Overall Study|Study Close|0|||
156334222|NCT02557295|564320992|FG005|Overall Study|Study Close|0|||
156716238|NCT02105467|565705306|FG000|Period 2|Death|1|||
156716239|NCT02105467|565705307|FG001|Period 2|Death|0|||
156716240|NCT02105467|565705306|FG000|Period 2|Withdrawal by Subject|0|||
156716241|NCT02105467|565705307|FG001|Period 2|Withdrawal by Subject|2|||
156716242|NCT02105467|565705306|FG000|Period 3|Lost to Follow-up|0|||
156716243|NCT02105467|565705307|FG001|Period 3|Lost to Follow-up|1|||
156716244|NCT03908125|565705308|FG000|Overall Study|Withdrawal by Subject|92|||
156716245|NCT03908125|565705308|FG000|Overall Study|Lost to Follow-up|8|||
156716246|NCT02262325|565705309|FG000|Overall Study|Death|16|||
156445357|NCT03433339|564722538|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
156445358|NCT03433339|564722537|FG000|Overall Study|Withdrawal by Subject|0|||
156445359|NCT03433339|564722538|FG001|Overall Study|Withdrawal by Subject|2|||
156445360|NCT03055858|564722540|FG000|Overall Study|Death|9|||
156445361|NCT03055858|564722540|FG000|Overall Study|Withdrawal by Subject|11|||
156445362|NCT03055858|564722540|FG000|Overall Study|Lost to Follow-up|6|||
156445363|NCT03055858|564722540|FG000|Overall Study|Missed Follow-Up Visits|18|||
156445364|NCT00150813|564722555|FG000|Overall Study|Adverse Event|1|||
156445365|NCT00150813|564722555|FG000|Overall Study|Lack of Efficacy|1|||
156445366|NCT00150813|564722555|FG000|Overall Study|Lost to Follow-up|5|||
156445367|NCT00150813|564722555|FG000|Overall Study|Withdrawal by Subject|5|||
156445368|NCT00150813|564722555|FG000|Overall Study|Remission|3|||
156445369|NCT00150813|564722555|FG000|Overall Study|Planned pregancy|1|||
156445370|NCT00150813|564722555|FG000|Overall Study|Switch to commercially available LEV|2|||
156445371|NCT01046136|564722564|FG000|Overall Study|Withdrawal by Subject|0|||
156445372|NCT01046136|564722565|FG001|Overall Study|Withdrawal by Subject|4|||
156445373|NCT01046136|564722564|FG000|Overall Study|Physician Decision|1|||
156445374|NCT01046136|564722565|FG001|Overall Study|Physician Decision|1|||
156445375|NCT01046136|564722564|FG000|Overall Study|Lost to Follow-up|3|||
156445376|NCT01046136|564722565|FG001|Overall Study|Lost to Follow-up|3|||
156445377|NCT04579250|564722566|FG000|Overall Study|Withdrawal by Subject|1|||
156716247|NCT02262325|565705309|FG000|Overall Study|Lost to Follow-up|1|||
156716248|NCT02815995|565705310|FG000|Overall Study|Disease Progression|3|||
156716249|NCT02815995|565705311|FG001|Overall Study|Disease Progression|7|||
156716250|NCT02815995|565705312|FG002|Overall Study|Disease Progression|2|||
156716251|NCT02815995|565705313|FG003|Overall Study|Disease Progression|4|||
156716252|NCT02815995|565705314|FG004|Overall Study|Disease Progression|3|||
156716253|NCT02815995|565705315|FG005|Overall Study|Disease Progression|9|||
156716254|NCT02815995|565705316|FG006|Overall Study|Disease Progression|3|||
156716255|NCT02815995|565705317|FG007|Overall Study|Disease Progression|1|||
156716256|NCT02815995|565705310|FG000|Overall Study|Adverse Event|1|||
156716257|NCT02815995|565705311|FG001|Overall Study|Adverse Event|2|||
156716258|NCT02815995|565705312|FG002|Overall Study|Adverse Event|2|||
156716259|NCT02815995|565705313|FG003|Overall Study|Adverse Event|0|||
156716260|NCT02815995|565705314|FG004|Overall Study|Adverse Event|0|||
156716261|NCT02815995|565705315|FG005|Overall Study|Adverse Event|1|||
156716262|NCT02815995|565705316|FG006|Overall Study|Adverse Event|0|||
156716263|NCT02815995|565705317|FG007|Overall Study|Adverse Event|0|||
156716264|NCT02815995|565705310|FG000|Overall Study|Pregnancy|0|||
156445378|NCT04579250|564722567|FG001|Overall Study|Withdrawal by Subject|1|||
156445379|NCT04579250|564722568|FG002|Overall Study|Withdrawal by Subject|0|||
156445380|NCT04579250|564722566|FG000|Overall Study|Lost to Follow-up|1|||
156445381|NCT04579250|564722567|FG001|Overall Study|Lost to Follow-up|1|||
156445382|NCT04579250|564722568|FG002|Overall Study|Lost to Follow-up|0|||
156445383|NCT04579250|564722566|FG000|Overall Study|Moved from area|0|||
156445384|NCT04579250|564722567|FG001|Overall Study|Moved from area|1|||
156445385|NCT04579250|564722568|FG002|Overall Study|Moved from area|2|||
156445386|NCT02058108|564722569|FG000|Overall Study|Abnormal Laboratory Values|0|||
156445387|NCT02058108|564722570|FG001|Overall Study|Abnormal Laboratory Values|1|||
156445388|NCT02058108|564722569|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
156445389|NCT02058108|564722570|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156445390|NCT02058108|564722569|FG000|Overall Study|No longer requires study drug|0|||
156445391|NCT02058108|564722570|FG001|Overall Study|No longer requires study drug|1|||
156445392|NCT02058108|564722569|FG000|Overall Study|Withdrawal by Subject|1|||
156445393|NCT02058108|564722570|FG001|Overall Study|Withdrawal by Subject|0|||
156445394|NCT02058108|564722569|FG000|Overall Study|Administrative problems|3|||
156445395|NCT02058108|564722570|FG001|Overall Study|Administrative problems|3|||
156445396|NCT02058108|564722569|FG000|Overall Study|Protocol Violation|0|||
156532792|NCT03047551|565046795|FG000|Overall Study|Withdrawal by Subject|0|||
156445397|NCT02058108|564722570|FG001|Overall Study|Protocol Violation|1|||
156445398|NCT01376700|564722571|FG000|Overall Study|Sponsor terminated study early|8|||
156445399|NCT01376700|564722571|FG000|Overall Study|Low or high titer inhibitor|8|||
156445400|NCT05623345|564722580|FG000|Overall Study|Withdrawal by Subject|14|||
156445401|NCT05623345|564722581|FG001|Overall Study|Withdrawal by Subject|0|||
156445402|NCT05623345|564722582|FG002|Overall Study|Withdrawal by Subject|9|||
156445403|NCT05623345|564722583|FG003|Overall Study|Withdrawal by Subject|20|||
156445404|NCT05623345|564722580|FG000|Overall Study|Lost to Follow-up|3|||
156716265|NCT02815995|565705311|FG001|Overall Study|Pregnancy|0|||
156445405|NCT05623345|564722581|FG001|Overall Study|Lost to Follow-up|0|||
156532793|NCT03047551|565046796|FG001|Overall Study|Withdrawal by Subject|1|||
156716266|NCT02815995|565705312|FG002|Overall Study|Pregnancy|0|||
156445406|NCT05623345|564722582|FG002|Overall Study|Lost to Follow-up|7|||
156445407|NCT05623345|564722583|FG003|Overall Study|Lost to Follow-up|2|||
156532794|NCT03047551|565046795|FG000|Overall Study|Probe malfunction|0|||
156716267|NCT02815995|565705313|FG003|Overall Study|Pregnancy|0|||
156716268|NCT02815995|565705314|FG004|Overall Study|Pregnancy|0|||
156716269|NCT02815995|565705315|FG005|Overall Study|Pregnancy|0|||
156716270|NCT02815995|565705316|FG006|Overall Study|Pregnancy|1|||
156716271|NCT02815995|565705317|FG007|Overall Study|Pregnancy|0|||
156445408|NCT05623345|564722580|FG000|Overall Study|Termination of Study By Sponsor|37|||
156445409|NCT05623345|564722581|FG001|Overall Study|Termination of Study By Sponsor|4|||
156445410|NCT05623345|564722582|FG002|Overall Study|Termination of Study By Sponsor|40|||
156445411|NCT05623345|564722583|FG003|Overall Study|Termination of Study By Sponsor|38|||
156445412|NCT00411151|564722584|FG000|Overall Study|Death|38|||
156445413|NCT00411151|564722584|FG000|Overall Study|Withdrawal by Subject|2|||
156445414|NCT00411151|564722584|FG000|Overall Study|Lost to Follow-up|2|||
156445415|NCT00411151|564722584|FG000|Overall Study|Protocol Violation|1|||
156445416|NCT00411151|564722584|FG000|Overall Study|Trial prematurely closed|4|||
156445417|NCT04452318|564722593|FG000|Overall Study|Physician Decision|1|||
156445418|NCT04452318|564722594|FG001|Overall Study|Physician Decision|2|||
156445419|NCT04452318|564722595|FG002|Overall Study|Physician Decision|0|||
156445420|NCT04452318|564722596|FG003|Overall Study|Physician Decision|2|||
156445421|NCT04452318|564722597|FG004|Overall Study|Physician Decision|0|||
156445422|NCT04452318|564722598|FG005|Overall Study|Physician Decision|2|||
156793114|NCT02268851|565994865|FG001|Overall Study|Progressive Disease|3|||
156793115|NCT02268851|565994866|FG002|Overall Study|Progressive Disease|0|||
156793116|NCT02268851|565994867|FG003|Overall Study|Progressive Disease|0|||
156793117|NCT02268851|565994868|FG004|Overall Study|Progressive Disease|1|||
156793118|NCT02268851|565994869|FG005|Overall Study|Progressive Disease|4|||
156793119|NCT02268851|565994864|FG000|Overall Study|Physician Decision|0|||
156793120|NCT02268851|565994865|FG001|Overall Study|Physician Decision|0|||
156793121|NCT02268851|565994866|FG002|Overall Study|Physician Decision|1|||
156793122|NCT02268851|565994867|FG003|Overall Study|Physician Decision|0|||
156793123|NCT02268851|565994868|FG004|Overall Study|Physician Decision|0|||
156793124|NCT02268851|565994869|FG005|Overall Study|Physician Decision|1|||
156793125|NCT02268851|565994864|FG000|Overall Study|Patient Compliance|0|||
156793126|NCT02268851|565994865|FG001|Overall Study|Patient Compliance|0|||
156793127|NCT02268851|565994866|FG002|Overall Study|Patient Compliance|0|||
156793128|NCT02268851|565994867|FG003|Overall Study|Patient Compliance|0|||
156445423|NCT04452318|564722599|FG006|Overall Study|Physician Decision|5|||
156445424|NCT04452318|564722593|FG000|Overall Study|Death|2|||
156445425|NCT04452318|564722594|FG001|Overall Study|Death|3|||
156445426|NCT04452318|564722595|FG002|Overall Study|Death|0|||
156445427|NCT04452318|564722596|FG003|Overall Study|Death|0|||
156445428|NCT04452318|564722597|FG004|Overall Study|Death|0|||
156445429|NCT04452318|564722598|FG005|Overall Study|Death|0|||
156445430|NCT04452318|564722599|FG006|Overall Study|Death|0|||
156445431|NCT04452318|564722593|FG000|Overall Study|Lost to Follow-up|38|||
156445432|NCT04452318|564722594|FG001|Overall Study|Lost to Follow-up|28|||
156445433|NCT04452318|564722595|FG002|Overall Study|Lost to Follow-up|0|||
156445434|NCT04452318|564722596|FG003|Overall Study|Lost to Follow-up|3|||
156445435|NCT04452318|564722597|FG004|Overall Study|Lost to Follow-up|3|||
156445436|NCT04452318|564722598|FG005|Overall Study|Lost to Follow-up|2|||
156445437|NCT04452318|564722599|FG006|Overall Study|Lost to Follow-up|1|||
156445438|NCT04452318|564722593|FG000|Overall Study|Withdrawal by Subject|46|||
156445439|NCT04452318|564722594|FG001|Overall Study|Withdrawal by Subject|40|||
156445440|NCT04452318|564722595|FG002|Overall Study|Withdrawal by Subject|0|||
156445441|NCT04452318|564722596|FG003|Overall Study|Withdrawal by Subject|18|||
156445442|NCT04452318|564722597|FG004|Overall Study|Withdrawal by Subject|6|||
156793129|NCT02268851|565994868|FG004|Overall Study|Patient Compliance|1|||
156793130|NCT02268851|565994869|FG005|Overall Study|Patient Compliance|1|||
156793131|NCT02268851|565994864|FG000|Overall Study|Co-Morbid Condition|0|||
156793132|NCT02268851|565994865|FG001|Overall Study|Co-Morbid Condition|0|||
156793133|NCT02268851|565994866|FG002|Overall Study|Co-Morbid Condition|0|||
156445443|NCT04452318|564722598|FG005|Overall Study|Withdrawal by Subject|8|||
156445444|NCT04452318|564722599|FG006|Overall Study|Withdrawal by Subject|6|||
156445445|NCT02638337|564722600|FG000|Overall Study|Adverse Event|6|||
156445446|NCT02638337|564722601|FG001|Overall Study|Adverse Event|10|||
156445447|NCT02638337|564722600|FG000|Overall Study|Protocol Violation|3|||
156445448|NCT02638337|564722601|FG001|Overall Study|Protocol Violation|0|||
156445449|NCT02638337|564722600|FG000|Overall Study|Withdrawal by Subject|13|||
156445450|NCT02638337|564722601|FG001|Overall Study|Withdrawal by Subject|16|||
156445451|NCT02638337|564722600|FG000|Overall Study|Lost to Follow-up|7|||
156445452|NCT02638337|564722601|FG001|Overall Study|Lost to Follow-up|7|||
156445453|NCT02638337|564722600|FG000|Overall Study|Other - Miscellaneous|4|||
156445454|NCT02638337|564722601|FG001|Overall Study|Other - Miscellaneous|3|||
156445455|NCT00604669|564722602|FG000|Overall Study|lack of information in chart|7|||
156445456|NCT06061081|564722608|FG000|Overall Study|Withdrawal by Subject|1|||
156445457|NCT06061081|564722609|FG001|Overall Study|Withdrawal by Subject|0|||
156445458|NCT06061081|564722610|FG002|Overall Study|Withdrawal by Subject|0|||
156445459|NCT06061081|564722611|FG003|Overall Study|Withdrawal by Subject|0|||
156445460|NCT06061081|564722612|FG004|Overall Study|Withdrawal by Subject|0|||
156445461|NCT02814838|564722613|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
156445462|NCT02814838|564722614|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
156445463|NCT02814838|564722613|FG000|Overall Study|Consent withdrawal|1|||
156793134|NCT02268851|565994867|FG003|Overall Study|Co-Morbid Condition|0|||
156793135|NCT02268851|565994868|FG004|Overall Study|Co-Morbid Condition|1|||
156793136|NCT02268851|565994869|FG005|Overall Study|Co-Morbid Condition|1|||
156445464|NCT02814838|564722614|FG001|Overall Study|Consent withdrawal|1|||
156445465|NCT00073749|564722615|FG000|Overall Study|Disease Progression|2|||
156445466|NCT00073749|564722616|FG001|Overall Study|Disease Progression|0|||
156445467|NCT00073749|564722617|FG002|Overall Study|Disease Progression|3|||
156445468|NCT00073749|564722618|FG003|Overall Study|Disease Progression|2|||
156445469|NCT00073749|564722619|FG004|Overall Study|Disease Progression|3|||
156445470|NCT00073749|564722620|FG005|Overall Study|Disease Progression|1|||
156445471|NCT00073749|564722621|FG006|Overall Study|Disease Progression|3|||
156445472|NCT00073749|564722615|FG000|Overall Study|Death|0|||
156445473|NCT00073749|564722616|FG001|Overall Study|Death|1|||
156445474|NCT00073749|564722617|FG002|Overall Study|Death|1|||
156445475|NCT00073749|564722618|FG003|Overall Study|Death|0|||
156445476|NCT00073749|564722619|FG004|Overall Study|Death|0|||
156445477|NCT00073749|564722620|FG005|Overall Study|Death|0|||
156445478|NCT00073749|564722621|FG006|Overall Study|Death|29|||
156445479|NCT00073749|564722615|FG000|Overall Study|Adverse Event|0|||
156445480|NCT00073749|564722616|FG001|Overall Study|Adverse Event|3|||
156445481|NCT00073749|564722617|FG002|Overall Study|Adverse Event|6|||
156445482|NCT00073749|564722618|FG003|Overall Study|Adverse Event|4|||
156445483|NCT00073749|564722619|FG004|Overall Study|Adverse Event|2|||
156445484|NCT00073749|564722620|FG005|Overall Study|Adverse Event|1|||
156445485|NCT00073749|564722621|FG006|Overall Study|Adverse Event|0|||
156445486|NCT00073749|564722615|FG000|Overall Study|Physician Decision|0|||
156445487|NCT00073749|564722616|FG001|Overall Study|Physician Decision|0|||
156445488|NCT00073749|564722617|FG002|Overall Study|Physician Decision|1|||
156445489|NCT00073749|564722618|FG003|Overall Study|Physician Decision|0|||
156445490|NCT00073749|564722619|FG004|Overall Study|Physician Decision|0|||
156445491|NCT00073749|564722620|FG005|Overall Study|Physician Decision|2|||
156445492|NCT00073749|564722621|FG006|Overall Study|Physician Decision|0|||
156445493|NCT00073749|564722615|FG000|Overall Study|Withdrawal by Subject|0|||
156445494|NCT00073749|564722616|FG001|Overall Study|Withdrawal by Subject|1|||
156445495|NCT00073749|564722617|FG002|Overall Study|Withdrawal by Subject|0|||
156445496|NCT00073749|564722618|FG003|Overall Study|Withdrawal by Subject|0|||
156445497|NCT00073749|564722619|FG004|Overall Study|Withdrawal by Subject|1|||
156445498|NCT00073749|564722620|FG005|Overall Study|Withdrawal by Subject|0|||
156445499|NCT00073749|564722621|FG006|Overall Study|Withdrawal by Subject|2|||
156445500|NCT00073749|564722615|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
156445501|NCT00073749|564722616|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
156445502|NCT00073749|564722617|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
156445503|NCT00073749|564722618|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
156445504|NCT00073749|564722619|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
156445505|NCT00073749|564722620|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
156445506|NCT00073749|564722621|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
156793137|NCT01694771|565994872|FG000|Overall Study|Adverse Event|18|||
156793138|NCT01694771|565994873|FG001|Overall Study|Adverse Event|16|||
156793139|NCT01694771|565994872|FG000|Overall Study|Lack of Efficacy|1|||
156793140|NCT01694771|565994873|FG001|Overall Study|Lack of Efficacy|0|||
156445507|NCT00073749|564722615|FG000|Overall Study|Lost to Follow-up|0|||
156445508|NCT00073749|564722616|FG001|Overall Study|Lost to Follow-up|0|||
156445509|NCT00073749|564722617|FG002|Overall Study|Lost to Follow-up|0|||
156445510|NCT00073749|564722618|FG003|Overall Study|Lost to Follow-up|0|||
156445511|NCT00073749|564722619|FG004|Overall Study|Lost to Follow-up|0|||
156445512|NCT00073749|564722620|FG005|Overall Study|Lost to Follow-up|0|||
156445513|NCT00073749|564722621|FG006|Overall Study|Lost to Follow-up|2|||
156445514|NCT00073749|564722615|FG000|Overall Study|Other|0|||
156445515|NCT00073749|564722616|FG001|Overall Study|Other|0|||
156445516|NCT00073749|564722617|FG002|Overall Study|Other|0|||
156445517|NCT00073749|564722618|FG003|Overall Study|Other|0|||
156445518|NCT00073749|564722619|FG004|Overall Study|Other|0|||
156445519|NCT00073749|564722620|FG005|Overall Study|Other|2|||
156445520|NCT00073749|564722621|FG006|Overall Study|Other|0|||
156445521|NCT04154384|564722622|FG000|Overall Study|Lost to Follow-up|24|||
156445522|NCT04154384|564722623|FG001|Overall Study|Lost to Follow-up|33|||
156445523|NCT04154384|564722624|FG002|Overall Study|Lost to Follow-up|0|||
156445524|NCT04154384|564722622|FG000|Overall Study|Withdrawal by Subject|7|||
156445525|NCT04154384|564722623|FG001|Overall Study|Withdrawal by Subject|18|||
156445526|NCT04154384|564722624|FG002|Overall Study|Withdrawal by Subject|0|||
156445527|NCT04154384|564722622|FG000|Overall Study|Missing outcome data|1|||
156445528|NCT04154384|564722623|FG001|Overall Study|Missing outcome data|0|||
156445529|NCT04154384|564722624|FG002|Overall Study|Missing outcome data|0|||
156445530|NCT01136876|564722625|FG000|Overall Study|Lost to Follow-up|0|||
156445531|NCT01136876|564722626|FG001|Overall Study|Lost to Follow-up|1|||
156445532|NCT01136876|564722625|FG000|Overall Study|Physician Decision|3|||
156445533|NCT01136876|564722626|FG001|Overall Study|Physician Decision|5|||
156445534|NCT01136876|564722625|FG000|Overall Study|Missing NGAL measurement|2|||
156445535|NCT01136876|564722626|FG001|Overall Study|Missing NGAL measurement|5|||
156445536|NCT04128319|564722627|FG000|Overall Study|Death|3|||
156445537|NCT04484935|564722628|FG000|Overall Study|Other|0|||
156445538|NCT04484935|564722629|FG001|Overall Study|Other|1|||
156445539|NCT04484935|564722628|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156445540|NCT04484935|564722629|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156445541|NCT04484935|564722628|FG000|Overall Study|Lost to Follow-up|1|||
156445542|NCT04484935|564722629|FG001|Overall Study|Lost to Follow-up|0|||
156532795|NCT03047551|565046796|FG001|Overall Study|Probe malfunction|1|||
156532796|NCT03047551|565046795|FG000|Overall Study|Ineligible|0|||
156532797|NCT03047551|565046796|FG001|Overall Study|Ineligible|1|||
156532798|NCT00726622|565046797|FG000|Overall Study|Withdrawal by Subject|16|||
156532799|NCT00726622|565046798|FG001|Overall Study|Withdrawal by Subject|2|||
156532800|NCT00726622|565046797|FG000|Overall Study|Physician Decision|0|||
156532801|NCT00726622|565046798|FG001|Overall Study|Physician Decision|1|||
156532802|NCT00726622|565046797|FG000|Overall Study|Metastasis|2|||
156532803|NCT00726622|565046798|FG001|Overall Study|Metastasis|0|||
156532804|NCT02462928|565046800|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
156532805|NCT02462928|565046801|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
156532806|NCT02462928|565046802|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
156532807|NCT02462928|565046800|FG000|Overall Study|Adverse Event|47|||
156532808|NCT02462928|565046801|FG001|Overall Study|Adverse Event|51|||
156532809|NCT02462928|565046802|FG002|Overall Study|Adverse Event|25|||
156532810|NCT02462928|565046800|FG000|Overall Study|Lack of Efficacy|3|||
156532811|NCT02462928|565046801|FG001|Overall Study|Lack of Efficacy|8|||
156532812|NCT02462928|565046802|FG002|Overall Study|Lack of Efficacy|3|||
156532813|NCT02462928|565046800|FG000|Overall Study|Lost to Follow-up|4|||
156532814|NCT02462928|565046801|FG001|Overall Study|Lost to Follow-up|4|||
156532815|NCT02462928|565046802|FG002|Overall Study|Lost to Follow-up|1|||
156532816|NCT02462928|565046800|FG000|Overall Study|Withdrawal by Patient|31|||
156532817|NCT02462928|565046801|FG001|Overall Study|Withdrawal by Patient|21|||
156532818|NCT02462928|565046802|FG002|Overall Study|Withdrawal by Patient|21|||
156532819|NCT02462928|565046800|FG000|Overall Study|Protocol Violation|0|||
156532820|NCT02462928|565046801|FG001|Overall Study|Protocol Violation|1|||
156532821|NCT02462928|565046802|FG002|Overall Study|Protocol Violation|0|||
156532822|NCT02462928|565046800|FG000|Overall Study|Reason not Specified|4|||
156532823|NCT02462928|565046801|FG001|Overall Study|Reason not Specified|6|||
156532824|NCT02462928|565046802|FG002|Overall Study|Reason not Specified|5|||
156532825|NCT00395863|565046803|FG000|Overall Study|Patients did not complete both exams|2|||
156532826|NCT00395863|565046804|FG001|Overall Study|Patients did not complete both exams|3|||
156532827|NCT03873493|565046806|FG000|Overall Study|Withdrawal by Subject|1|||
156532828|NCT03873493|565046806|FG000|Overall Study|Death|9|||
156532829|NCT03873493|565046806|FG000|Overall Study|Lost to Follow-up|1|||
156532830|NCT03873493|565046806|FG000|Overall Study|Study Terminated by Sponsor|1|||
156532831|NCT03873493|565046806|FG000|Overall Study|Other|2|||
156532832|NCT02973425|565046813|FG000|Overall Study|Lost to Follow-up|49|||
156532833|NCT02973425|565046814|FG001|Overall Study|Lost to Follow-up|53|||
156532834|NCT03503513|565046815|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
156532835|NCT03503513|565046815|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
156532836|NCT03503513|565046815|FG000|Overall Study|Physician Decision|3|||
156532837|NCT03503513|565046815|FG000|Overall Study|Withdrawal by Subject|2|||
156532838|NCT03503513|565046815|FG000|Overall Study|Lost to Follow-up|1|||
156532839|NCT01170039|565046816|FG000|Overall Study|Withdrawal by Subject|5|||
156532840|NCT01170039|565046817|FG001|Overall Study|Withdrawal by Subject|3|||
156532841|NCT01170039|565046816|FG000|Overall Study|Lack of funding, drug not available|3|||
156445543|NCT04484935|564722628|FG000|Overall Study|Death|2|||
156445544|NCT04484935|564722629|FG001|Overall Study|Death|1|||
156445545|NCT04820686|564722630|FG000|Overall Study|Withdrawal by Subject|5|||
156445546|NCT04820686|564722631|FG001|Overall Study|Withdrawal by Subject|2|||
156445547|NCT04820686|564722632|FG002|Overall Study|Withdrawal by Subject|3|||
156445548|NCT04820686|564722630|FG000|Overall Study|Study Termination|25|||
156445549|NCT04820686|564722631|FG001|Overall Study|Study Termination|13|||
156445550|NCT04820686|564722632|FG002|Overall Study|Study Termination|14|||
156445551|NCT04820686|564722630|FG000|Overall Study|Adverse Event|0|||
156445552|NCT04820686|564722631|FG001|Overall Study|Adverse Event|1|||
156445553|NCT04820686|564722632|FG002|Overall Study|Adverse Event|0|||
156445554|NCT01424670|564722633|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
156532842|NCT01170039|565046817|FG001|Overall Study|Lack of funding, drug not available|3|||
156532843|NCT01524133|565046820|FG000|Treatment Phase|Withdrawal by Subject|13|||
156445555|NCT01424670|564722634|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
156532844|NCT01524133|565046821|FG001|Treatment Phase|Withdrawal by Subject|28|||
156532845|NCT01524133|565046822|FG002|Treatment Phase|Withdrawal by Subject|31|||
156532846|NCT01524133|565046820|FG000|Treatment Phase|Physician Decision|6|||
156532847|NCT01524133|565046821|FG001|Treatment Phase|Physician Decision|3|||
156532848|NCT01524133|565046822|FG002|Treatment Phase|Physician Decision|3|||
156532849|NCT01524133|565046820|FG000|Treatment Phase|Lost to Follow-up|0|||
156445556|NCT01424670|564722633|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
156445557|NCT01424670|564722634|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
156532850|NCT01524133|565046821|FG001|Treatment Phase|Lost to Follow-up|1|||
156532851|NCT01524133|565046822|FG002|Treatment Phase|Lost to Follow-up|2|||
156532852|NCT01524133|565046820|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
156445558|NCT01424670|564722633|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
156445559|NCT01424670|564722634|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
156445560|NCT01424670|564722633|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
156445561|NCT01424670|564722634|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
156445562|NCT01424670|564722633|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
156445563|NCT01424670|564722634|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
156445564|NCT01424670|564722633|FG000|Continuation Period|Adverse Event|13|||
156445565|NCT01424670|564722634|FG001|Continuation Period|Adverse Event|5|||
156445566|NCT01424670|564722633|FG000|Continuation Period|Lost to Follow-up|2|||
156445567|NCT01424670|564722634|FG001|Continuation Period|Lost to Follow-up|0|||
156445568|NCT01424670|564722633|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
156445569|NCT01424670|564722634|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
156445570|NCT01424670|564722633|FG000|Continuation Period|Physician Decision|5|||
156445571|NCT01424670|564722634|FG001|Continuation Period|Physician Decision|4|||
156445572|NCT01424670|564722633|FG000|Continuation Period|Withdrawal by Subject|13|||
156445573|NCT01424670|564722634|FG001|Continuation Period|Withdrawal by Subject|4|||
156445574|NCT02759016|564722635|FG000|Overall Study|Not treated with BI 836826|1|||
156445575|NCT02759016|564722636|FG001|Overall Study|Not treated with BI 836826|0|||
156445576|NCT02759016|564722635|FG000|Overall Study|Progressive disease|1|||
156445577|NCT02759016|564722636|FG001|Overall Study|Progressive disease|0|||
156445578|NCT02759016|564722635|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
156445579|NCT02759016|564722636|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
156445580|NCT02759016|564722635|FG000|Overall Study|Other not defined above|2|||
156445581|NCT02759016|564722636|FG001|Overall Study|Other not defined above|1|||
156445582|NCT02891915|564722641|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
156445583|NCT02891915|564722642|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
156445584|NCT02891915|564722641|FG000|Overall Study|Withdrawal by Subject|3|||
156445585|NCT02891915|564722642|FG001|Overall Study|Withdrawal by Subject|3|||
156445586|NCT02891915|564722641|FG000|Overall Study|Became Ineligible After Enrollment|2|||
156445587|NCT02891915|564722642|FG001|Overall Study|Became Ineligible After Enrollment|1|||
156445588|NCT02891915|564722641|FG000|Overall Study|Lost to Follow-up|1|||
156445589|NCT02891915|564722642|FG001|Overall Study|Lost to Follow-up|4|||
156445590|NCT02891915|564722641|FG000|Overall Study|Physician Decision|1|||
156445591|NCT02891915|564722642|FG001|Overall Study|Physician Decision|0|||
156445592|NCT04048382|564722643|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
156445593|NCT04048382|564722644|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
156445594|NCT04048382|564722643|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
156445595|NCT04048382|564722644|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
156445596|NCT04048382|564722643|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
156445597|NCT04048382|564722644|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
156445598|NCT02119650|564722646|FG000|Overall Study|Adverse Event|3|||
156445599|NCT02119650|564722647|FG001|Overall Study|Adverse Event|4|||
156445600|NCT02119650|564722646|FG000|Overall Study|Subject decision|2|||
156445601|NCT02119650|564722647|FG001|Overall Study|Subject decision|3|||
156445602|NCT02119650|564722646|FG000|Overall Study|Disease progression|11|||
156445603|NCT02119650|564722647|FG001|Overall Study|Disease progression|14|||
156445604|NCT02119650|564722646|FG000|Overall Study|Death|5|||
156445605|NCT02119650|564722647|FG001|Overall Study|Death|1|||
156445606|NCT02119650|564722646|FG000|Overall Study|Noncompliance with study treatment|1|||
156793141|NCT01694771|565994872|FG000|Overall Study|Non compliance protocol|7|||
156793142|NCT01694771|565994873|FG001|Overall Study|Non compliance protocol|6|||
156793143|NCT01694771|565994872|FG000|Overall Study|Lost to Follow-up|2|||
156793144|NCT01694771|565994873|FG001|Overall Study|Lost to Follow-up|3|||
156793145|NCT01694771|565994872|FG000|Overall Study|Consent withdrawn|7|||
156793146|NCT01694771|565994873|FG001|Overall Study|Consent withdrawn|9|||
156793147|NCT01694771|565994872|FG000|Overall Study|Other reasons|5|||
156793148|NCT01694771|565994873|FG001|Overall Study|Other reasons|6|||
156793149|NCT02536339|565994875|FG000|Overall Study|Death|20|||
156793150|NCT02536339|565994875|FG000|Overall Study|Withdrawal by Subject|3|||
156793151|NCT02536339|565994875|FG000|Overall Study|Lost to Follow-up|2|||
156793152|NCT02536339|565994875|FG000|Overall Study|Treatment discontinued|2|||
156793153|NCT02536339|565994875|FG000|Overall Study|Physician Decision|1|||
156793154|NCT01905683|565994876|FG000|Overall Study|Protocol Violation|1|||
156793155|NCT01905683|565994876|FG000|Overall Study|Re-injection criteria not met; others|13|||
156793156|NCT01905683|565994876|FG000|Overall Study|Physician Decision|1|||
156793157|NCT01905683|565994876|FG000|Overall Study|Lack of Efficacy|8|||
156445607|NCT02119650|564722647|FG001|Overall Study|Noncompliance with study treatment|1|||
156445608|NCT02119650|564722646|FG000|Overall Study|Study terminated by the sponsor|1|||
156445609|NCT02119650|564722647|FG001|Overall Study|Study terminated by the sponsor|0|||
156445610|NCT02119650|564722646|FG000|Overall Study|Physician Decision|0|||
156445611|NCT02119650|564722647|FG001|Overall Study|Physician Decision|2|||
156445612|NCT02119650|564722646|FG000|Overall Study|Multiple reasons for termination|2|||
156445613|NCT02119650|564722647|FG001|Overall Study|Multiple reasons for termination|1|||
156793158|NCT01905683|565994876|FG000|Overall Study|Withdrawal by Subject|20|||
156793159|NCT01905683|565994876|FG000|Overall Study|Adverse Event|4|||
156445614|NCT04402294|564722648|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
156874774|NCT04421027|566298734|FG001|Follow-Up Period|Death|0|||
156874775|NCT04421027|566298735|FG002|Follow-Up Period|Death|16|||
156874776|NCT04421027|566298736|FG003|Follow-Up Period|Death|17|||
156874777|NCT04421027|566298733|FG000|Follow-Up Period|Lost to Follow-up|0|||
156874778|NCT04421027|566298734|FG001|Follow-Up Period|Lost to Follow-up|0|||
156874779|NCT04421027|566298735|FG002|Follow-Up Period|Lost to Follow-up|7|||
156874780|NCT04421027|566298736|FG003|Follow-Up Period|Lost to Follow-up|7|||
156874781|NCT04421027|566298733|FG000|Follow-Up Period|Protocol Deviation|0|||
156874782|NCT04421027|566298734|FG001|Follow-Up Period|Protocol Deviation|0|||
156874783|NCT04421027|566298735|FG002|Follow-Up Period|Protocol Deviation|1|||
156874784|NCT04421027|566298736|FG003|Follow-Up Period|Protocol Deviation|0|||
156874785|NCT04421027|566298733|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
156874786|NCT04421027|566298734|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
156874787|NCT04421027|566298735|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
156874788|NCT04421027|566298736|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
156874789|NCT04421027|566298733|FG000|Follow-Up Period|Left message, participant did not call back|0|||
156874790|NCT04421027|566298734|FG001|Follow-Up Period|Left message, participant did not call back|0|||
156874791|NCT04421027|566298735|FG002|Follow-Up Period|Left message, participant did not call back|0|||
156874792|NCT04421027|566298736|FG003|Follow-Up Period|Left message, participant did not call back|1|||
156874793|NCT04421027|566298733|FG000|Follow-Up Period|Participant died|0|||
156874794|NCT04421027|566298734|FG001|Follow-Up Period|Participant died|0|||
156874795|NCT04421027|566298735|FG002|Follow-Up Period|Participant died|0|||
156874796|NCT04421027|566298736|FG003|Follow-Up Period|Participant died|1|||
156874797|NCT04421027|566298733|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
156874798|NCT04421027|566298734|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
156445615|NCT04402294|564722649|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
156445616|NCT04402294|564722648|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
156445617|NCT04402294|564722649|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
156445618|NCT04459416|564724952|FG000|Overall Study|Lost to Follow-up|2|||
156445619|NCT04459416|564724953|FG001|Overall Study|Lost to Follow-up|0|||
156445620|NCT04459416|564724952|FG000|Overall Study|Withdrawal by Subject|8|||
156445621|NCT04459416|564724953|FG001|Overall Study|Withdrawal by Subject|10|||
156445622|NCT04459416|564724952|FG000|Overall Study|Disease progression|0|||
156445623|NCT04459416|564724953|FG001|Overall Study|Disease progression|3|||
156445624|NCT03744312|564724954|FG000|Overall Study|Withdrawal by Subject|0|||
156445625|NCT03744312|564724955|FG001|Overall Study|Withdrawal by Subject|1|||
156445626|NCT03744312|564724954|FG000|Overall Study|Screen fail|0|||
156445627|NCT03744312|564724955|FG001|Overall Study|Screen fail|1|||
156445628|NCT05134337|564724956|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
156445629|NCT05134337|564724957|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
156445630|NCT03725722|564724958|FG000|Overall Study|Lack of Efficacy|2|||
156445631|NCT03725722|564724959|FG001|Overall Study|Lack of Efficacy|1|||
156445632|NCT03725722|564724960|FG002|Overall Study|Lack of Efficacy|2|||
156445633|NCT03725722|564724961|FG003|Overall Study|Lack of Efficacy|0|||
156445634|NCT03725722|564724962|FG004|Overall Study|Lack of Efficacy|2|||
156445635|NCT03725722|564724958|FG000|Overall Study|Adverse Event|2|||
156445636|NCT03725722|564724959|FG001|Overall Study|Adverse Event|2|||
156445637|NCT03725722|564724960|FG002|Overall Study|Adverse Event|1|||
156445638|NCT03725722|564724961|FG003|Overall Study|Adverse Event|0|||
156445639|NCT03725722|564724962|FG004|Overall Study|Adverse Event|6|||
156445640|NCT03725722|564724958|FG000|Overall Study|Withdrawal by Subject|4|||
156445641|NCT03725722|564724959|FG001|Overall Study|Withdrawal by Subject|1|||
156445642|NCT03725722|564724960|FG002|Overall Study|Withdrawal by Subject|0|||
156874799|NCT04421027|566298735|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
156874800|NCT04421027|566298736|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
156445643|NCT03725722|564724961|FG003|Overall Study|Withdrawal by Subject|4|||
156445644|NCT03725722|564724962|FG004|Overall Study|Withdrawal by Subject|4|||
156445645|NCT03725722|564724958|FG000|Overall Study|Lost to Follow-up|3|||
156445646|NCT03725722|564724959|FG001|Overall Study|Lost to Follow-up|1|||
156445647|NCT03725722|564724960|FG002|Overall Study|Lost to Follow-up|2|||
156874801|NCT00560352|566298739|FG000|Overall Study|Adverse event unrelated to study drug|2|||
156874802|NCT00560352|566298740|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156445648|NCT03725722|564724961|FG003|Overall Study|Lost to Follow-up|2|||
156445649|NCT03725722|564724962|FG004|Overall Study|Lost to Follow-up|1|||
156445650|NCT03725722|564724958|FG000|Overall Study|Personal reasons|0|||
156445651|NCT03725722|564724959|FG001|Overall Study|Personal reasons|0|||
156445652|NCT03725722|564724960|FG002|Overall Study|Personal reasons|1|||
156445653|NCT03725722|564724961|FG003|Overall Study|Personal reasons|0|||
156445654|NCT03725722|564724962|FG004|Overall Study|Personal reasons|1|||
156445655|NCT03725722|564724958|FG000|Overall Study|COVID-19 situation|0|||
156445656|NCT03725722|564724959|FG001|Overall Study|COVID-19 situation|1|||
156445657|NCT03725722|564724960|FG002|Overall Study|COVID-19 situation|0|||
156874803|NCT00560352|566298741|FG002|Overall Study|Adverse event unrelated to study drug|1|||
156874804|NCT00560352|566298739|FG000|Overall Study|Study drug toxicity|3|||
156874805|NCT00560352|566298740|FG001|Overall Study|Study drug toxicity|0|||
156874806|NCT00560352|566298741|FG002|Overall Study|Study drug toxicity|1|||
156874807|NCT00560352|566298739|FG000|Overall Study|Disease progression|0|||
156874808|NCT00560352|566298740|FG001|Overall Study|Disease progression|1|||
156874809|NCT00560352|566298741|FG002|Overall Study|Disease progression|1|||
156874810|NCT00560352|566298739|FG000|Overall Study|Withdrawal by Subject|1|||
156874811|NCT00560352|566298740|FG001|Overall Study|Withdrawal by Subject|1|||
156874812|NCT00560352|566298741|FG002|Overall Study|Withdrawal by Subject|1|||
156874813|NCT00560352|566298739|FG000|Overall Study|Maximum clinical benefit|1|||
156445658|NCT03725722|564724961|FG003|Overall Study|COVID-19 situation|0|||
156445659|NCT03725722|564724962|FG004|Overall Study|COVID-19 situation|0|||
156445660|NCT01259401|564724966|FG000|4-month Follow-up|Death|0|||
156445661|NCT01259401|564724967|FG001|4-month Follow-up|Death|1|||
156445662|NCT01259401|564724966|FG000|4-month Follow-up|Lost to Follow-up|0|||
156445663|NCT01259401|564724967|FG001|4-month Follow-up|Lost to Follow-up|1|||
156445664|NCT03683069|564724968|FG000|Overall Study|see limitations|12|||
156445665|NCT03683069|564724969|FG001|Overall Study|see limitations|13|||
156445666|NCT05478525|564724970|FG000|Overall Study|Withdrawal by Subject|0|||
156445667|NCT05478525|564724971|FG001|Overall Study|Withdrawal by Subject|1|||
156445668|NCT05478525|564724972|FG002|Overall Study|Withdrawal by Subject|2|||
156445669|NCT05478525|564724973|FG003|Overall Study|Withdrawal by Subject|0|||
156445670|NCT05478525|564724970|FG000|Overall Study|COVID-19 Infection|2|||
156445671|NCT05478525|564724971|FG001|Overall Study|COVID-19 Infection|0|||
156445672|NCT05478525|564724972|FG002|Overall Study|COVID-19 Infection|1|||
156445673|NCT05478525|564724973|FG003|Overall Study|COVID-19 Infection|1|||
156445674|NCT03821844|564724974|FG000|Overall Study|Death|37|||
156445675|NCT03821844|564724975|FG001|Overall Study|Death|31|||
156445676|NCT03821844|564724974|FG000|Overall Study|Discharged|10|||
156445677|NCT03821844|564724975|FG001|Overall Study|Discharged|14|||
156445678|NCT03821844|564724974|FG000|Overall Study|Not present in facility at followup|2|||
156445679|NCT03821844|564724975|FG001|Overall Study|Not present in facility at followup|3|||
156445680|NCT05656911|564724978|FG000|Treatment Phase|Physician Decision|2|||
156445681|NCT05656911|564724979|FG001|Treatment Phase|Physician Decision|0|||
156445682|NCT05656911|564724978|FG000|Treatment Phase|Lack of Efficacy|6|||
156445683|NCT05656911|564724979|FG001|Treatment Phase|Lack of Efficacy|3|||
156445684|NCT05656911|564724978|FG000|Treatment Phase|Subject Decision|4|||
156445685|NCT05656911|564724979|FG001|Treatment Phase|Subject Decision|2|||
156445686|NCT05656911|564724978|FG000|Treatment Phase|Other Reasons|1|||
156445687|NCT05656911|564724979|FG001|Treatment Phase|Other Reasons|0|||
156445688|NCT05656911|564724978|FG000|Treatment Phase|Adverse Event|3|||
156445689|NCT05656911|564724979|FG001|Treatment Phase|Adverse Event|1|||
156445690|NCT05656911|564724978|FG000|Follow-up Phase|Subject Decision|0|||
156445691|NCT05656911|564724979|FG001|Follow-up Phase|Subject Decision|1|||
156445692|NCT05656911|564724978|FG000|Follow-up Phase|Missing|1|||
156445693|NCT05656911|564724979|FG001|Follow-up Phase|Missing|0|||
156445694|NCT00567398|564724985|FG000|Overall Study|Adverse Event|6|||
156445695|NCT00567398|564724986|FG001|Overall Study|Adverse Event|14|||
156445696|NCT00567398|564724985|FG000|Overall Study|Physician Decision|0|||
156445697|NCT00567398|564724986|FG001|Overall Study|Physician Decision|4|||
156445698|NCT00567398|564724985|FG000|Overall Study|Withdrawal by Subject|0|||
156445699|NCT00567398|564724986|FG001|Overall Study|Withdrawal by Subject|2|||
156445700|NCT00567398|564724985|FG000|Overall Study|Renal Transplantation|0|||
156445701|NCT00567398|564724986|FG001|Overall Study|Renal Transplantation|3|||
156445702|NCT00567398|564724985|FG000|Overall Study|Other|1|||
156445703|NCT00567398|564724986|FG001|Overall Study|Other|0|||
156445704|NCT04247542|564724989|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
156445705|NCT04247542|564724990|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
156445706|NCT04247542|564724991|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
156445707|NCT04247542|564724989|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
156445708|NCT04247542|564724990|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
156445709|NCT04247542|564724991|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
156445710|NCT01938547|564724995|FG000|Overall Study|Physician Decision|1|||
156445711|NCT01673984|564724998|FG000|Overall Study|Adverse Event|1|||
156445712|NCT01673984|564724999|FG001|Overall Study|Adverse Event|0|||
156874814|NCT00560352|566298740|FG001|Overall Study|Maximum clinical benefit|0|||
156874815|NCT00560352|566298741|FG002|Overall Study|Maximum clinical benefit|0|||
156445713|NCT01673984|564724998|FG000|Overall Study|Study termination|9|||
156445714|NCT01673984|564724999|FG001|Overall Study|Study termination|6|||
156445715|NCT02919449|564725000|FG000|Overall Study|Withdrawal by Subject|1|||
156445716|NCT02919449|564725000|FG000|Overall Study|Investigator decision|1|||
156445717|NCT00727909|564725004|FG000|Overall Study|Withdrawal by Subject|5|||
156445718|NCT00727909|564725005|FG001|Overall Study|Withdrawal by Subject|11|||
156445719|NCT00727909|564725006|FG002|Overall Study|Withdrawal by Subject|8|||
156445720|NCT00727909|564725007|FG003|Overall Study|Withdrawal by Subject|5|||
156445721|NCT00727909|564725004|FG000|Overall Study|Death|0|||
156445722|NCT00727909|564725005|FG001|Overall Study|Death|0|||
156445723|NCT00727909|564725006|FG002|Overall Study|Death|1|||
156445724|NCT00727909|564725007|FG003|Overall Study|Death|0|||
156445725|NCT01696773|564725008|FG000|Days 15-27, Washout|Adverse Event|1|||
156445726|NCT01696773|564725009|FG001|Days 15-27, Washout|Adverse Event|0|||
156445727|NCT03732820|564725015|FG000|Overall Study|Death|168|||
156445728|NCT03732820|564725016|FG001|Overall Study|Death|203|||
156445729|NCT03732820|564725015|FG000|Overall Study|Other|2|||
156445730|NCT03732820|564725016|FG001|Overall Study|Other|2|||
156445731|NCT03732820|564725015|FG000|Overall Study|Failure to meet randomisation criteria|1|||
156445732|NCT03732820|564725016|FG001|Overall Study|Failure to meet randomisation criteria|1|||
156445733|NCT03732820|564725015|FG000|Overall Study|Patient decision|14|||
156445734|NCT03732820|564725016|FG001|Overall Study|Patient decision|10|||
156445735|NCT03732820|564725015|FG000|Overall Study|Screen failure|0|||
156445736|NCT03732820|564725016|FG001|Overall Study|Screen failure|1|||
156445737|NCT03732820|564725015|FG000|Overall Study|Patients ongoing study at data cut off|210|||
156445738|NCT03732820|564725016|FG001|Overall Study|Patients ongoing study at data cut off|178|||
156445739|NCT03732820|564725015|FG000|Overall Study|Lost to Follow-up|4|||
156445740|NCT03732820|564725016|FG001|Overall Study|Lost to Follow-up|2|||
156445741|NCT02374307|564725017|FG000|3-months Follow-up|Lost to Follow-up|1|||
156445742|NCT02374307|564725018|FG001|3-months Follow-up|Lost to Follow-up|2|||
156445743|NCT02374307|564725017|FG000|3-months Follow-up|Withdrawal by Subject|1|||
156445744|NCT02374307|564725018|FG001|3-months Follow-up|Withdrawal by Subject|4|||
156445745|NCT02374307|564725017|FG000|3-months Follow-up|Death|1|||
156445746|NCT02374307|564725018|FG001|3-months Follow-up|Death|2|||
156445747|NCT02374307|564725017|FG000|3-months Follow-up|Missed first follow-up|5|||
156445748|NCT02374307|564725018|FG001|3-months Follow-up|Missed first follow-up|1|||
156445749|NCT02374307|564725017|FG000|6-months Follow-up|Lost to Follow-up|1|||
156445750|NCT02374307|564725018|FG001|6-months Follow-up|Lost to Follow-up|2|||
156445751|NCT02374307|564725017|FG000|6-months Follow-up|Death|2|||
156445752|NCT02374307|564725018|FG001|6-months Follow-up|Death|1|||
156445753|NCT02374307|564725017|FG000|6-months Follow-up|Withdrawal by Subject|0|||
156445754|NCT02374307|564725018|FG001|6-months Follow-up|Withdrawal by Subject|3|||
156445755|NCT01989455|564725019|FG000|Overall Study|Adverse Event|0|||
156445756|NCT01989455|564725020|FG001|Overall Study|Adverse Event|1|||
156445757|NCT01989455|564725021|FG002|Overall Study|Adverse Event|0|||
156445758|NCT01989455|564725022|FG003|Overall Study|Adverse Event|0|||
156445759|NCT01989455|564725023|FG004|Overall Study|Adverse Event|0|||
156445760|NCT01989455|564725019|FG000|Overall Study|Withdrawal by Subject|0|||
156445761|NCT01989455|564725020|FG001|Overall Study|Withdrawal by Subject|1|||
156445762|NCT01989455|564725021|FG002|Overall Study|Withdrawal by Subject|0|||
156445763|NCT01989455|564725022|FG003|Overall Study|Withdrawal by Subject|0|||
156445764|NCT01989455|564725023|FG004|Overall Study|Withdrawal by Subject|0|||
156445765|NCT01989455|564725019|FG000|Overall Study|Technical problems with infusion|0|||
156445766|NCT01989455|564725020|FG001|Overall Study|Technical problems with infusion|0|||
156445767|NCT01989455|564725021|FG002|Overall Study|Technical problems with infusion|1|||
156445768|NCT01989455|564725022|FG003|Overall Study|Technical problems with infusion|0|||
156445769|NCT01989455|564725023|FG004|Overall Study|Technical problems with infusion|1|||
156445770|NCT00632203|564725024|FG000|Overall Study|Did not start study treatment|1|||
156445771|NCT00632203|564725025|FG001|Overall Study|Did not start study treatment|0|||
156445772|NCT00448669|564725033|FG000|Overall Study|Lost to Follow-up|52|||
156445773|NCT00448669|564725034|FG001|Overall Study|Lost to Follow-up|63|||
156445774|NCT00448669|564725033|FG000|Overall Study|Withdrawal by Subject|90|||
156445775|NCT00448669|564725034|FG001|Overall Study|Withdrawal by Subject|74|||
156445776|NCT00448669|564725033|FG000|Overall Study|Relocated|49|||
156445777|NCT00448669|564725034|FG001|Overall Study|Relocated|36|||
156445778|NCT00448669|564725033|FG000|Overall Study|Were withdrawn by investigator|10|||
156445779|NCT00448669|564725034|FG001|Overall Study|Were withdrawn by investigator|6|||
156445780|NCT00448669|564725033|FG000|Overall Study|Death|2|||
156445781|NCT00448669|564725034|FG001|Overall Study|Death|4|||
156445782|NCT00448669|564725033|FG000|Overall Study|Had other reasons|5|||
156445783|NCT00448669|564725034|FG001|Overall Study|Had other reasons|6|||
156445784|NCT00448669|564725033|FG000|Overall Study|HIV-infected at enrollment|1|||
156445785|NCT00448669|564725034|FG001|Overall Study|HIV-infected at enrollment|2|||
156445786|NCT00448669|564725033|FG000|Overall Study|Never started drug|9|||
156445787|NCT00448669|564725034|FG001|Overall Study|Never started drug|7|||
156532853|NCT01524133|565046821|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
156445788|NCT04287985|564725035|FG000|Overall Study|Adverse Event|1|||
156445789|NCT04287985|564725036|FG001|Overall Study|Adverse Event|0|||
156445790|NCT04287985|564725037|FG002|Overall Study|Adverse Event|0|||
156445791|NCT04287985|564725038|FG003|Overall Study|Adverse Event|0|||
156445792|NCT04287985|564725035|FG000|Overall Study|Protocol Violation|0|||
156445793|NCT04287985|564725036|FG001|Overall Study|Protocol Violation|1|||
156445794|NCT04287985|564725037|FG002|Overall Study|Protocol Violation|0|||
156445795|NCT04287985|564725038|FG003|Overall Study|Protocol Violation|0|||
156445796|NCT04287985|564725035|FG000|Overall Study|Physician Decision|0|||
156445797|NCT04287985|564725036|FG001|Overall Study|Physician Decision|0|||
156445798|NCT04287985|564725037|FG002|Overall Study|Physician Decision|0|||
156445799|NCT04287985|564725038|FG003|Overall Study|Physician Decision|1|||
156445800|NCT04287985|564725035|FG000|Overall Study|Withdrawal by Subject|2|||
156445801|NCT04287985|564725036|FG001|Overall Study|Withdrawal by Subject|1|||
156445802|NCT04287985|564725037|FG002|Overall Study|Withdrawal by Subject|1|||
156445803|NCT04287985|564725038|FG003|Overall Study|Withdrawal by Subject|2|||
156445804|NCT01340066|564725043|FG000|Placebo Run in Period|Screen Failures|27|||
156445805|NCT01340066|564725044|FG001|Placebo Run in Period|Screen Failures|0|||
156445806|NCT01340066|564725045|FG002|Placebo Run in Period|Screen Failures|0|||
156445807|NCT01340066|564725043|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
156445808|NCT01340066|564725044|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
156445809|NCT01340066|564725045|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
156445810|NCT01340066|564725043|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
156445811|NCT01340066|564725044|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
156445812|NCT01340066|564725045|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
156445813|NCT01340066|564725043|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
156445814|NCT01340066|564725044|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
156445815|NCT01340066|564725045|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
156445816|NCT03771352|564725053|FG000|Overall Study|Screen failure|2|||
156445817|NCT03771352|564725053|FG000|Overall Study|Withdrawal by Subject|2|||
156445818|NCT00274469|564725054|FG000|Overall Study|Death|63|||
156445819|NCT00274469|564725055|FG001|Overall Study|Death|74|||
156445820|NCT00274469|564725054|FG000|Overall Study|Did not consent to OS follow-up|16|||
156445821|NCT00274469|564725055|FG001|Overall Study|Did not consent to OS follow-up|19|||
156445822|NCT03338816|564725056|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
156445823|NCT03338816|564725057|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
156445824|NCT03338816|564725058|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
156445825|NCT03338816|564725059|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
156445826|NCT03338816|564725056|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
156445827|NCT03338816|564725057|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
156445828|NCT03338816|564725058|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
156445829|NCT03338816|564725059|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
156445830|NCT03338816|564725056|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
156445831|NCT03338816|564725057|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
156445832|NCT03338816|564725058|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
156445833|NCT03338816|564725059|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
156445834|NCT03338816|564725056|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
156445835|NCT03338816|564725057|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
156445836|NCT03338816|564725058|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
156445837|NCT03338816|564725059|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
156445838|NCT03338816|564725056|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
156445839|NCT03338816|564725057|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
156445840|NCT03338816|564725058|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
156445841|NCT03338816|564725059|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
156445842|NCT03338816|564725056|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
156445843|NCT03338816|564725057|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
156445844|NCT03338816|564725058|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
156445845|NCT03338816|564725059|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
156445846|NCT03338816|564725056|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
156445847|NCT03338816|564725057|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
156445848|NCT03338816|564725058|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
156445849|NCT03338816|564725059|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
156445850|NCT03271489|564725065|FG000|Double-Blind (DB) Period|Adverse Event|4|||
156445851|NCT03271489|564725066|FG001|Double-Blind (DB) Period|Adverse Event|1|||
156445852|NCT03271489|564725065|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
156445853|NCT03271489|564725066|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
156445854|NCT03271489|564725065|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
156445855|NCT03271489|564725066|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
156445856|NCT03271489|564725065|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
156445857|NCT03271489|564725066|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
156445858|NCT03271489|564725065|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
156445859|NCT03271489|564725066|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
156445860|NCT03271489|564725065|FG000|Double-Blind (DB) Period|Other|6|||
156445861|NCT03271489|564725066|FG001|Double-Blind (DB) Period|Other|1|||
156445862|NCT03271489|564725065|FG000|Double-Blind (DB) Period|Missing|1|||
156445863|NCT03271489|564725066|FG001|Double-Blind (DB) Period|Missing|0|||
156793160|NCT01905683|565994876|FG000|Overall Study|Lost to Follow-up|4|||
156793161|NCT02037984|565994879|FG000|Overall Study|Lack of Efficacy|0|||
156445864|NCT03271489|564725065|FG000|Open-Label (OL) Period|Adverse Event|2|||
156445865|NCT03271489|564725066|FG001|Open-Label (OL) Period|Adverse Event|0|||
156445866|NCT03271489|564725065|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
156445867|NCT03271489|564725066|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
156445868|NCT03271489|564725065|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
156445869|NCT03271489|564725066|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
156445870|NCT03271489|564725065|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
156445871|NCT03271489|564725066|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
156445872|NCT03271489|564725065|FG000|Open-Label (OL) Period|No Specified|2|||
156445873|NCT03271489|564725066|FG001|Open-Label (OL) Period|No Specified|2|||
156445874|NCT03271489|564725065|FG000|Open-Label (OL) Period|Missing|2|||
156793162|NCT02037984|565994880|FG001|Overall Study|Lack of Efficacy|0|||
156445875|NCT03271489|564725066|FG001|Open-Label (OL) Period|Missing|0|||
156445876|NCT03271489|564725065|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
156445877|NCT03271489|564725066|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
156445878|NCT03271489|564725065|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
156445879|NCT03271489|564725066|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
156445880|NCT03271489|564725065|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
156445881|NCT03271489|564725066|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
156445882|NCT03271489|564725065|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
156445883|NCT03271489|564725066|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
156445884|NCT03271489|564725065|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
156445885|NCT03271489|564725066|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
156445886|NCT03271489|564725065|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
156445887|NCT03271489|564725066|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
156445888|NCT03271489|564725065|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
156445889|NCT03271489|564725066|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
156445890|NCT03271489|564725065|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
156793163|NCT02037984|565994881|FG002|Overall Study|Lack of Efficacy|3|||
156793164|NCT02037984|565994882|FG003|Overall Study|Lack of Efficacy|10|||
156793165|NCT02037984|565994883|FG004|Overall Study|Lack of Efficacy|2|||
156793166|NCT02037984|565994884|FG005|Overall Study|Lack of Efficacy|2|||
156793167|NCT02037984|565994885|FG006|Overall Study|Lack of Efficacy|4|||
156793168|NCT02037984|565994886|FG007|Overall Study|Lack of Efficacy|3|||
156793169|NCT02037984|565994879|FG000|Overall Study|Lost to Follow-up|1|||
156793170|NCT02037984|565994880|FG001|Overall Study|Lost to Follow-up|0|||
156793171|NCT02037984|565994881|FG002|Overall Study|Lost to Follow-up|3|||
156793172|NCT02037984|565994882|FG003|Overall Study|Lost to Follow-up|5|||
156793173|NCT02037984|565994883|FG004|Overall Study|Lost to Follow-up|2|||
156793174|NCT02037984|565994884|FG005|Overall Study|Lost to Follow-up|2|||
156793175|NCT02037984|565994885|FG006|Overall Study|Lost to Follow-up|2|||
156793176|NCT02037984|565994886|FG007|Overall Study|Lost to Follow-up|4|||
156793177|NCT02037984|565994879|FG000|Overall Study|Physician Decision|0|||
156793178|NCT02037984|565994880|FG001|Overall Study|Physician Decision|0|||
156793179|NCT02037984|565994881|FG002|Overall Study|Physician Decision|0|||
156793180|NCT02037984|565994882|FG003|Overall Study|Physician Decision|0|||
156793181|NCT02037984|565994883|FG004|Overall Study|Physician Decision|0|||
156793182|NCT02037984|565994884|FG005|Overall Study|Physician Decision|0|||
156793183|NCT02037984|565994885|FG006|Overall Study|Physician Decision|1|||
156793184|NCT02037984|565994886|FG007|Overall Study|Physician Decision|0|||
156793185|NCT02037984|565994879|FG000|Overall Study|Protocol Violation|0|||
156793186|NCT02037984|565994880|FG001|Overall Study|Protocol Violation|0|||
156793187|NCT02037984|565994881|FG002|Overall Study|Protocol Violation|0|||
156793188|NCT02037984|565994882|FG003|Overall Study|Protocol Violation|0|||
156793189|NCT02037984|565994883|FG004|Overall Study|Protocol Violation|0|||
156793190|NCT02037984|565994884|FG005|Overall Study|Protocol Violation|1|||
156793191|NCT02037984|565994885|FG006|Overall Study|Protocol Violation|2|||
156793192|NCT02037984|565994886|FG007|Overall Study|Protocol Violation|0|||
156793193|NCT02037984|565994879|FG000|Overall Study|Technical Problems|0|||
156793194|NCT02037984|565994880|FG001|Overall Study|Technical Problems|0|||
156793195|NCT02037984|565994881|FG002|Overall Study|Technical Problems|3|||
156793196|NCT02037984|565994882|FG003|Overall Study|Technical Problems|3|||
156793197|NCT02037984|565994883|FG004|Overall Study|Technical Problems|2|||
156793198|NCT02037984|565994884|FG005|Overall Study|Technical Problems|3|||
156793199|NCT02037984|565994885|FG006|Overall Study|Technical Problems|4|||
156793200|NCT02037984|565994886|FG007|Overall Study|Technical Problems|2|||
156793201|NCT02037984|565994879|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156793202|NCT02037984|565994880|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156793203|NCT02037984|565994881|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
156793204|NCT02037984|565994882|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
156793205|NCT02037984|565994883|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
156793206|NCT02037984|565994884|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
156793207|NCT02037984|565994885|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
156445891|NCT03271489|564725066|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
156445892|NCT01127373|564725067|FG000|Overall Study|Not Treated|3|||
156445893|NCT01127373|564725067|FG000|Overall Study|Lost to Follow-up|7|||
156445894|NCT01127373|564725067|FG000|Overall Study|Withdrawal by Subject|1|||
156445895|NCT01127373|564725067|FG000|Overall Study|Disease progression|1|||
156445896|NCT05450458|564725070|FG000|Overall Study|Lost to Follow-up|4|||
156445897|NCT05494788|564725073|FG000|Initial Treatment Period|Adverse Event|2|||
156445898|NCT05494788|564725073|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
156445899|NCT05494788|564725073|FG000|Extension Period|Adverse Event|1|||
156445900|NCT05494788|564725073|FG000|Extension Period|Withdrawal by Subject|1|||
156445901|NCT00136435|564725074|FG000|Overall Study|Ineligible|8|||
156445902|NCT00136435|564725074|FG000|Overall Study|Induction Death|1|||
156445903|NCT00136435|564725074|FG000|Overall Study|Induction Failure|10|||
156445904|NCT00136435|564725074|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
156445905|NCT00136435|564725074|FG000|Overall Study|Withdrawal by Subject|3|||
156445906|NCT00136435|564725074|FG000|Overall Study|Adverse Event|19|||
156445907|NCT00136435|564725074|FG000|Overall Study|Relapse|4|||
156445908|NCT00136435|564725074|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
156445909|NCT02965846|564725079|FG000|Overall Study|Lost to Follow-up|1|||
156445910|NCT02965846|564725080|FG001|Overall Study|Lost to Follow-up|0|||
156445911|NCT02965846|564725081|FG002|Overall Study|Lost to Follow-up|0|||
156445912|NCT02965846|564725079|FG000|Overall Study|Withdrawal by Subject|0|||
156445913|NCT02965846|564725080|FG001|Overall Study|Withdrawal by Subject|1|||
156445914|NCT02965846|564725081|FG002|Overall Study|Withdrawal by Subject|0|||
156445915|NCT02965846|564725079|FG000|Overall Study|Study Terminated By Sponsor|4|||
156445916|NCT02965846|564725080|FG001|Overall Study|Study Terminated By Sponsor|4|||
156445917|NCT02965846|564725081|FG002|Overall Study|Study Terminated By Sponsor|0|||
156445918|NCT02965846|564725079|FG000|Overall Study|Participants not randomized|0|||
156445919|NCT02965846|564725080|FG001|Overall Study|Participants not randomized|0|||
156445920|NCT02965846|564725081|FG002|Overall Study|Participants not randomized|33|||
156445921|NCT00539734|564725082|FG000|Overall Study|Protocol Violation|1|||
156445922|NCT01017146|564725083|FG000|Overall Study|Adverse Event|11|||
156445923|NCT01017146|564725084|FG001|Overall Study|Adverse Event|1|||
156445924|NCT01017146|564725083|FG000|Overall Study|Lost to Follow-up|14|||
156445925|NCT01017146|564725084|FG001|Overall Study|Lost to Follow-up|14|||
156445926|NCT01017146|564725083|FG000|Overall Study|Noncompliance with Study Product|1|||
156445927|NCT01017146|564725084|FG001|Overall Study|Noncompliance with Study Product|1|||
156445928|NCT01017146|564725083|FG000|Overall Study|Withdrawal by Subject|32|||
156445929|NCT01017146|564725084|FG001|Overall Study|Withdrawal by Subject|16|||
156445930|NCT01017146|564725083|FG000|Overall Study|Relocation|0|||
156445931|NCT01017146|564725084|FG001|Overall Study|Relocation|4|||
156445932|NCT01017146|564725083|FG000|Overall Study|Pregnancy|2|||
156445933|NCT01017146|564725084|FG001|Overall Study|Pregnancy|1|||
156445934|NCT01017146|564725083|FG000|Overall Study|Protocol Violation|2|||
156445935|NCT01017146|564725084|FG001|Overall Study|Protocol Violation|0|||
156445936|NCT01017146|564725083|FG000|Overall Study|Took Excluded Medication|2|||
156445937|NCT01017146|564725084|FG001|Overall Study|Took Excluded Medication|0|||
156445938|NCT01017146|564725083|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
156445939|NCT01017146|564725084|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
156445940|NCT01017146|564725083|FG000|Overall Study|Change in Work Situation|1|||
156445941|NCT01017146|564725084|FG001|Overall Study|Change in Work Situation|0|||
156445942|NCT00087139|564725085|FG000|Overall Study|Adverse Event|18|||
156445943|NCT00087139|564725086|FG001|Overall Study|Adverse Event|17|||
156445944|NCT00087139|564725087|FG002|Overall Study|Adverse Event|13|||
156445945|NCT00087139|564725085|FG000|Overall Study|Death|2|||
156445946|NCT00087139|564725086|FG001|Overall Study|Death|1|||
156445947|NCT00087139|564725087|FG002|Overall Study|Death|0|||
156445948|NCT00087139|564725085|FG000|Overall Study|Withdrawal by Subject|3|||
156445949|NCT00087139|564725086|FG001|Overall Study|Withdrawal by Subject|2|||
156445950|NCT00087139|564725087|FG002|Overall Study|Withdrawal by Subject|2|||
156445951|NCT00087139|564725085|FG000|Overall Study|Physician Decision|1|||
156445952|NCT00087139|564725086|FG001|Overall Study|Physician Decision|1|||
156445953|NCT00087139|564725087|FG002|Overall Study|Physician Decision|1|||
156445954|NCT00087139|564725085|FG000|Overall Study|Disease progression|9|||
156445955|NCT00087139|564725086|FG001|Overall Study|Disease progression|19|||
156445956|NCT00087139|564725087|FG002|Overall Study|Disease progression|12|||
156445957|NCT00087139|564725085|FG000|Overall Study|Ineligible|4|||
156445958|NCT00087139|564725086|FG001|Overall Study|Ineligible|7|||
156445959|NCT00087139|564725087|FG002|Overall Study|Ineligible|4|||
156445960|NCT00087139|564725085|FG000|Overall Study|Symptomatic deterioration|1|||
156445961|NCT00087139|564725086|FG001|Overall Study|Symptomatic deterioration|1|||
156445962|NCT00087139|564725087|FG002|Overall Study|Symptomatic deterioration|3|||
156445963|NCT00087139|564725085|FG000|Overall Study|Use of coumadin|1|||
156716272|NCT02676882|565705318|FG000|Overall Study|Adverse Event|1|||
156445964|NCT00087139|564725086|FG001|Overall Study|Use of coumadin|0|||
156445965|NCT00087139|564725087|FG002|Overall Study|Use of coumadin|0|||
156445966|NCT00087139|564725085|FG000|Overall Study|Response achieved|0|||
156445967|NCT00087139|564725086|FG001|Overall Study|Response achieved|1|||
156445968|NCT00087139|564725087|FG002|Overall Study|Response achieved|0|||
156445969|NCT00087139|564725085|FG000|Overall Study|Extradural disease|0|||
156445970|NCT00087139|564725086|FG001|Overall Study|Extradural disease|0|||
156445971|NCT00087139|564725087|FG002|Overall Study|Extradural disease|1|||
156445972|NCT02671435|564725096|FG000|Overall Study|Death|1|||
156445973|NCT02671435|564725097|FG001|Overall Study|Death|3|||
156334223|NCT02557295|564320993|FG006|Overall Study|Study Close|37|||
156334224|NCT02557295|564320994|FG007|Overall Study|Study Close|3|||
156445974|NCT02671435|564725098|FG002|Overall Study|Death|0|||
156445975|NCT02671435|564725099|FG003|Overall Study|Death|16|||
156445976|NCT02671435|564725100|FG004|Overall Study|Death|14|||
156445977|NCT02671435|564725101|FG005|Overall Study|Death|29|||
156445978|NCT02671435|564725102|FG006|Overall Study|Death|34|||
156445979|NCT02671435|564725103|FG007|Overall Study|Death|28|||
156445980|NCT02671435|564725104|FG008|Overall Study|Death|19|||
156445981|NCT02671435|564725105|FG009|Overall Study|Death|10|||
156445982|NCT02671435|564725106|FG010|Overall Study|Death|8|||
156445983|NCT02671435|564725107|FG011|Overall Study|Death|29|||
156445984|NCT02671435|564725108|FG012|Overall Study|Death|29|||
156445985|NCT02671435|564725109|FG013|Overall Study|Death|29|||
156445986|NCT02671435|564725110|FG014|Overall Study|Death|27|||
156445987|NCT02671435|564725096|FG000|Overall Study|Lost to Follow-up|0|||
156445988|NCT02671435|564725097|FG001|Overall Study|Lost to Follow-up|0|||
156334225|NCT02557295|564320995|FG008|Overall Study|Study Close|19|||
156334226|NCT02557295|564320987|FG000|Overall Study|except for study close|4|||
156334227|NCT02557295|564320988|FG001|Overall Study|except for study close|0|||
156334228|NCT02557295|564320989|FG002|Overall Study|except for study close|0|||
156334229|NCT02557295|564320990|FG003|Overall Study|except for study close|0|||
156334230|NCT02557295|564320991|FG004|Overall Study|except for study close|0|||
156334231|NCT02557295|564320992|FG005|Overall Study|except for study close|0|||
156334232|NCT02557295|564320993|FG006|Overall Study|except for study close|5|||
156334233|NCT02557295|564320994|FG007|Overall Study|except for study close|1|||
156334234|NCT02557295|564320995|FG008|Overall Study|except for study close|0|||
156334235|NCT01067976|564320996|FG000|Overall Study|Study drug never administered|20|||
156334236|NCT01067976|564320996|FG000|Overall Study|Study prematurely discontinued|2|||
156334237|NCT03487549|564321001|FG000|Overall Study|Protocol Violation|0|||
156334238|NCT03487549|564321002|FG001|Overall Study|Protocol Violation|1|||
156334239|NCT03487549|564321001|FG000|Overall Study|Lost to Follow-up|2|||
156334240|NCT03487549|564321002|FG001|Overall Study|Lost to Follow-up|1|||
156334241|NCT03487549|564321001|FG000|Overall Study|Withdrawal by Subject|2|||
156334242|NCT03487549|564321002|FG001|Overall Study|Withdrawal by Subject|0|||
156334243|NCT00533897|564322383|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
156334244|NCT00533897|564322384|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
156334245|NCT00533897|564322385|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
156334246|NCT00533897|564322386|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
156334247|NCT00533897|564322387|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
156334248|NCT00533897|564322388|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
156334249|NCT00533897|564322389|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
156334250|NCT00533897|564322390|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
156334251|NCT00533897|564322383|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
156334252|NCT00533897|564322384|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156334253|NCT00533897|564322385|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156334254|NCT00533897|564322386|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156334255|NCT00533897|564322387|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156334256|NCT00533897|564322388|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156334257|NCT00533897|564322389|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156334258|NCT00533897|564322390|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156334259|NCT00533897|564322383|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
156445989|NCT02671435|564725098|FG002|Overall Study|Lost to Follow-up|1|||
156445990|NCT02671435|564725099|FG003|Overall Study|Lost to Follow-up|0|||
156445991|NCT02671435|564725100|FG004|Overall Study|Lost to Follow-up|1|||
156334260|NCT00533897|564322384|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156334261|NCT00533897|564322385|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156334262|NCT00533897|564322386|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156334263|NCT00533897|564322387|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156445992|NCT02671435|564725101|FG005|Overall Study|Lost to Follow-up|1|||
156445993|NCT02671435|564725102|FG006|Overall Study|Lost to Follow-up|2|||
156445994|NCT02671435|564725103|FG007|Overall Study|Lost to Follow-up|2|||
156445995|NCT02671435|564725104|FG008|Overall Study|Lost to Follow-up|0|||
156445996|NCT02671435|564725105|FG009|Overall Study|Lost to Follow-up|2|||
156445997|NCT02671435|564725106|FG010|Overall Study|Lost to Follow-up|0|||
156334264|NCT00533897|564322388|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156445998|NCT02671435|564725107|FG011|Overall Study|Lost to Follow-up|3|||
156445999|NCT02671435|564725108|FG012|Overall Study|Lost to Follow-up|3|||
156446000|NCT02671435|564725109|FG013|Overall Study|Lost to Follow-up|2|||
156446001|NCT02671435|564725110|FG014|Overall Study|Lost to Follow-up|0|||
156446002|NCT02671435|564725096|FG000|Overall Study|Withdrawal by Subject|2|||
156446003|NCT02671435|564725097|FG001|Overall Study|Withdrawal by Subject|0|||
156446004|NCT02671435|564725098|FG002|Overall Study|Withdrawal by Subject|2|||
156874816|NCT03892967|566298745|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
156874817|NCT03892967|566298746|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
156874818|NCT03892967|566298747|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
156874819|NCT03892967|566298748|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
156874820|NCT03892967|566298749|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
156874821|NCT03892967|566298745|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
156874822|NCT03892967|566298746|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
156874823|NCT03892967|566298747|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
156874824|NCT03892967|566298748|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
156874825|NCT03892967|566298749|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
156874826|NCT03892967|566298745|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
156874827|NCT03892967|566298746|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
156446005|NCT02671435|564725099|FG003|Overall Study|Withdrawal by Subject|2|||
156446006|NCT02671435|564725100|FG004|Overall Study|Withdrawal by Subject|2|||
156446007|NCT02671435|564725101|FG005|Overall Study|Withdrawal by Subject|7|||
156446008|NCT02671435|564725102|FG006|Overall Study|Withdrawal by Subject|2|||
156446009|NCT02671435|564725103|FG007|Overall Study|Withdrawal by Subject|7|||
156446010|NCT02671435|564725104|FG008|Overall Study|Withdrawal by Subject|1|||
156446011|NCT02671435|564725105|FG009|Overall Study|Withdrawal by Subject|1|||
156446012|NCT02671435|564725106|FG010|Overall Study|Withdrawal by Subject|2|||
156446013|NCT02671435|564725107|FG011|Overall Study|Withdrawal by Subject|4|||
156446014|NCT02671435|564725108|FG012|Overall Study|Withdrawal by Subject|4|||
156446015|NCT02671435|564725109|FG013|Overall Study|Withdrawal by Subject|4|||
156446016|NCT02671435|564725110|FG014|Overall Study|Withdrawal by Subject|2|||
156446017|NCT02671435|564725096|FG000|Overall Study|Un-specified|0|||
156446018|NCT02671435|564725097|FG001|Overall Study|Un-specified|0|||
156446019|NCT02671435|564725098|FG002|Overall Study|Un-specified|0|||
156446020|NCT02671435|564725099|FG003|Overall Study|Un-specified|0|||
156446021|NCT02671435|564725100|FG004|Overall Study|Un-specified|1|||
156446022|NCT02671435|564725101|FG005|Overall Study|Un-specified|3|||
156446023|NCT02671435|564725102|FG006|Overall Study|Un-specified|2|||
156446024|NCT02671435|564725103|FG007|Overall Study|Un-specified|3|||
156446025|NCT02671435|564725104|FG008|Overall Study|Un-specified|0|||
156446026|NCT02671435|564725105|FG009|Overall Study|Un-specified|5|||
156446027|NCT02671435|564725106|FG010|Overall Study|Un-specified|8|||
156446028|NCT02671435|564725107|FG011|Overall Study|Un-specified|4|||
156446029|NCT02671435|564725108|FG012|Overall Study|Un-specified|5|||
156446030|NCT02671435|564725109|FG013|Overall Study|Un-specified|9|||
156446031|NCT02671435|564725110|FG014|Overall Study|Un-specified|8|||
156446032|NCT04095104|564725111|FG000|Overall Study|Withdrawal by Subject|0|||
156446033|NCT04095104|564725112|FG001|Overall Study|Withdrawal by Subject|1|||
156446034|NCT05048186|564725115|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
156446035|NCT05048186|564725116|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
156446036|NCT05048186|564725115|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
156446037|NCT05048186|564725116|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
156446038|NCT02412748|564725117|FG000|Overall Study|Lost to Follow-up|38|||
156446039|NCT02412748|564725118|FG001|Overall Study|Lost to Follow-up|39|||
156874828|NCT03892967|566298747|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
156874829|NCT03892967|566298748|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
156874830|NCT03892967|566298749|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
156874831|NCT03892967|566298745|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
156874832|NCT03892967|566298746|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
156874833|NCT03892967|566298747|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
156446040|NCT00976937|564725119|FG000|Overall Study|Adverse Event|4|||
156446041|NCT00976937|564725120|FG001|Overall Study|Adverse Event|5|||
156446042|NCT00976937|564725119|FG000|Overall Study|Lost to Follow-up|2|||
156446043|NCT00976937|564725120|FG001|Overall Study|Lost to Follow-up|1|||
156446044|NCT00976937|564725119|FG000|Overall Study|Withdrawal by Subject|5|||
156446045|NCT00976937|564725120|FG001|Overall Study|Withdrawal by Subject|3|||
156446046|NCT00976937|564725119|FG000|Overall Study|Poor compliance to protocol|3|||
156446047|NCT00976937|564725120|FG001|Overall Study|Poor compliance to protocol|0|||
156334265|NCT00533897|564322389|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156334266|NCT00533897|564322390|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156334267|NCT00533897|564322383|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
156334268|NCT00533897|564322384|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156334269|NCT00533897|564322385|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156334270|NCT00533897|564322386|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156334271|NCT00533897|564322387|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156334272|NCT00533897|564322388|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156334273|NCT00533897|564322389|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156334274|NCT00533897|564322390|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156334275|NCT00533897|564322383|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
156334276|NCT00533897|564322384|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156334277|NCT00533897|564322385|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156334278|NCT00533897|564322386|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156334279|NCT00533897|564322387|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156334280|NCT00533897|564322388|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156334281|NCT00533897|564322389|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156334282|NCT00533897|564322390|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156334283|NCT00533897|564322383|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
156334284|NCT00533897|564322384|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156334285|NCT00533897|564322385|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156334286|NCT00533897|564322386|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156334287|NCT00533897|564322387|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156334288|NCT00533897|564322388|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156334289|NCT00533897|564322389|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156334290|NCT00533897|564322390|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156334291|NCT00533897|564322383|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156334292|NCT00533897|564322384|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
156334293|NCT00533897|564322385|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
156334294|NCT00533897|564322386|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156334295|NCT00533897|564322387|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156334296|NCT00533897|564322388|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156334297|NCT00533897|564322389|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156334298|NCT00533897|564322390|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156334299|NCT00533897|564322383|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156334300|NCT00533897|564322384|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156334301|NCT00533897|564322385|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
156334302|NCT00533897|564322386|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156334303|NCT00533897|564322387|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156334304|NCT00533897|564322388|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156334305|NCT00533897|564322389|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156334306|NCT00533897|564322390|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156334307|NCT00533897|564322383|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156334308|NCT00533897|564322384|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156334309|NCT00533897|564322385|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156334310|NCT00533897|564322386|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156334311|NCT00533897|564322387|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156334312|NCT00533897|564322388|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
156334313|NCT00533897|564322389|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156334314|NCT00533897|564322390|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156334315|NCT00533897|564322383|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156334316|NCT00533897|564322384|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156334317|NCT00533897|564322385|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156334318|NCT00533897|564322386|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156334319|NCT00533897|564322387|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156334320|NCT00533897|564322388|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
156334321|NCT00533897|564322389|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156334322|NCT00533897|564322390|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156334323|NCT00533897|564322383|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156334324|NCT00533897|564322384|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156334325|NCT00533897|564322385|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156334326|NCT00533897|564322386|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156334327|NCT00533897|564322387|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156446048|NCT00976937|564725119|FG000|Overall Study|Personal and Familial Reason|2|||
156446049|NCT00976937|564725120|FG001|Overall Study|Personal and Familial Reason|2|||
156334328|NCT00533897|564322388|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156446050|NCT04218266|564725121|FG000|Overall Study|Death|1|||
156334329|NCT00533897|564322389|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
156446051|NCT04218266|564725122|FG001|Overall Study|Death|2|||
156446052|NCT04218266|564725123|FG002|Overall Study|Death|3|||
156446053|NCT04218266|564725121|FG000|Overall Study|Adverse Event|13|||
156446054|NCT04218266|564725122|FG001|Overall Study|Adverse Event|14|||
156446055|NCT04218266|564725123|FG002|Overall Study|Adverse Event|11|||
156446056|NCT04218266|564725121|FG000|Overall Study|Other|7|||
156446057|NCT04218266|564725122|FG001|Overall Study|Other|5|||
156446058|NCT04218266|564725123|FG002|Overall Study|Other|14|||
156446059|NCT04218266|564725121|FG000|Overall Study|Physician Decision|1|||
156446060|NCT04218266|564725122|FG001|Overall Study|Physician Decision|3|||
156446061|NCT04218266|564725123|FG002|Overall Study|Physician Decision|2|||
156446062|NCT04218266|564725121|FG000|Overall Study|Non-compliance with study drug|0|||
156446063|NCT04218266|564725122|FG001|Overall Study|Non-compliance with study drug|0|||
156446064|NCT04218266|564725123|FG002|Overall Study|Non-compliance with study drug|1|||
156446065|NCT04218266|564725121|FG000|Overall Study|Withdrawal by Subject|1|||
156446066|NCT04218266|564725122|FG001|Overall Study|Withdrawal by Subject|3|||
156446067|NCT04218266|564725123|FG002|Overall Study|Withdrawal by Subject|1|||
156446068|NCT04218266|564725121|FG000|Overall Study|Study drug never administered|2|||
156446069|NCT04218266|564725122|FG001|Overall Study|Study drug never administered|0|||
156446070|NCT04218266|564725123|FG002|Overall Study|Study drug never administered|0|||
156446071|NCT00761189|564725125|FG000|Overall Study|Adverse Event|42|||
156446072|NCT00761189|564725125|FG000|Overall Study|Lack of Efficacy|45|||
156446073|NCT00761189|564725125|FG000|Overall Study|Lost to Follow-up|36|||
156446074|NCT00761189|564725125|FG000|Overall Study|Withdrawal by Subject|49|||
156446075|NCT00761189|564725125|FG000|Overall Study|Other|13|||
156446076|NCT01494922|564725126|FG000|Overall Study|Adverse Event|1|||
156446077|NCT04377308|564725127|FG000|Overall Study|Withdrawal by Subject|0|||
156446078|NCT04377308|564725128|FG001|Overall Study|Withdrawal by Subject|1|||
156446079|NCT00709098|564725137|FG000|Double-blind Period|Withdrawal of consent|3|||
156446080|NCT00709098|564725138|FG001|Double-blind Period|Withdrawal of consent|3|||
156446081|NCT00709098|564725139|FG002|Double-blind Period|Withdrawal of consent|0|||
156446082|NCT00709098|564725137|FG000|Double-blind Period|Administrative reason|1|||
156446083|NCT00709098|564725138|FG001|Double-blind Period|Administrative reason|3|||
156446084|NCT00709098|564725139|FG002|Double-blind Period|Administrative reason|0|||
156446085|NCT00709098|564725137|FG000|Double-blind Period|Death|1|||
156446086|NCT00709098|564725138|FG001|Double-blind Period|Death|1|||
156446087|NCT00709098|564725139|FG002|Double-blind Period|Death|0|||
156446088|NCT00709098|564725137|FG000|Double-blind Period|Lost to Follow-up|1|||
156446089|NCT00709098|564725138|FG001|Double-blind Period|Lost to Follow-up|1|||
156446090|NCT00709098|564725139|FG002|Double-blind Period|Lost to Follow-up|0|||
156446091|NCT00709098|564725137|FG000|Open-label Period|Withdrawal of consent|0|||
156446092|NCT00709098|564725138|FG001|Open-label Period|Withdrawal of consent|0|||
156446093|NCT00709098|564725139|FG002|Open-label Period|Withdrawal of consent|7|||
156446094|NCT00709098|564725137|FG000|Open-label Period|Administrative reason|0|||
156446095|NCT00709098|564725138|FG001|Open-label Period|Administrative reason|0|||
156446096|NCT00709098|564725139|FG002|Open-label Period|Administrative reason|5|||
156446097|NCT00709098|564725137|FG000|Open-label Period|Death|0|||
156446098|NCT00709098|564725138|FG001|Open-label Period|Death|0|||
156446099|NCT00709098|564725139|FG002|Open-label Period|Death|1|||
156446100|NCT00709098|564725137|FG000|Open-label Period|Lost to Follow-up|0|||
156716273|NCT02676882|565705319|FG001|Overall Study|Adverse Event|0|||
156334330|NCT00533897|564322390|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
156334331|NCT00533897|564322383|FG000|Long Term Extension (LTE)|Death|0|||
156334332|NCT00533897|564322384|FG001|Long Term Extension (LTE)|Death|0|||
156334333|NCT00533897|564322385|FG002|Long Term Extension (LTE)|Death|0|||
156334334|NCT00533897|564322386|FG003|Long Term Extension (LTE)|Death|0|||
156334335|NCT00533897|564322387|FG004|Long Term Extension (LTE)|Death|0|||
156446101|NCT00709098|564725138|FG001|Open-label Period|Lost to Follow-up|0|||
156446102|NCT00709098|564725139|FG002|Open-label Period|Lost to Follow-up|1|||
156446103|NCT01227265|564725141|FG000|Overall Study|Did Not Receive Treatment|1|||
156446104|NCT01227265|564725142|FG001|Overall Study|Did Not Receive Treatment|2|||
156446105|NCT01227265|564725143|FG002|Overall Study|Did Not Receive Treatment|0|||
156446106|NCT01227265|564725141|FG000|Overall Study|Administrative|1|||
156446107|NCT01227265|564725142|FG001|Overall Study|Administrative|0|||
156446108|NCT01227265|564725143|FG002|Overall Study|Administrative|2|||
156446109|NCT01227265|564725141|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
156446110|NCT01227265|564725142|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
156446111|NCT01227265|564725143|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
156446112|NCT01227265|564725141|FG000|Overall Study|Protocol Violation|2|||
156446113|NCT01227265|564725142|FG001|Overall Study|Protocol Violation|1|||
156446114|NCT01227265|564725143|FG002|Overall Study|Protocol Violation|0|||
156716274|NCT02676882|565705318|FG000|Overall Study|Lost to Follow-up|1|||
156334336|NCT00533897|564322388|FG005|Long Term Extension (LTE)|Death|0|||
156334337|NCT00533897|564322389|FG006|Long Term Extension (LTE)|Death|1|||
156334338|NCT00533897|564322390|FG007|Long Term Extension (LTE)|Death|3|||
156334339|NCT00533897|564322383|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
156334340|NCT00533897|564322384|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
156334341|NCT00533897|564322385|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
156334342|NCT00533897|564322386|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
156334343|NCT00533897|564322387|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
156334344|NCT00533897|564322388|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
156334345|NCT00533897|564322389|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
156334346|NCT00533897|564322390|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
156446115|NCT01227265|564725141|FG000|Overall Study|Withdrawal by Subject|7|||
156446116|NCT01227265|564725142|FG001|Overall Study|Withdrawal by Subject|7|||
156446117|NCT01227265|564725143|FG002|Overall Study|Withdrawal by Subject|3|||
156446118|NCT01227265|564725141|FG000|Overall Study|Lost to Follow-up|2|||
156446119|NCT01227265|564725142|FG001|Overall Study|Lost to Follow-up|0|||
156446120|NCT01227265|564725143|FG002|Overall Study|Lost to Follow-up|3|||
156446121|NCT01227265|564725141|FG000|Overall Study|Adverse Event|6|||
156446122|NCT01227265|564725142|FG001|Overall Study|Adverse Event|10|||
156446123|NCT01227265|564725143|FG002|Overall Study|Adverse Event|5|||
156446124|NCT01037985|564725145|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
156446125|NCT01037985|564725146|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
156446126|NCT01037985|564725145|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
156446127|NCT01037985|564725146|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
156446128|NCT01037985|564725145|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
156446129|NCT01037985|564725146|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
156446130|NCT01037985|564725145|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
156446131|NCT01037985|564725146|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
156446132|NCT02269475|564725147|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
156446133|NCT02269475|564725148|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
156446134|NCT02269475|564725147|FG000|Overall Study|Withdrawal by Subject|0|||
156446135|NCT02269475|564725148|FG001|Overall Study|Withdrawal by Subject|1|||
156446136|NCT02730871|564725151|FG000|Overall Study|Adverse Event|6|||
156446137|NCT02730871|564725152|FG001|Overall Study|Adverse Event|0|||
156446138|NCT05368558|564725153|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
156446139|NCT05368558|564725154|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
156446140|NCT05368558|564725155|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
156446141|NCT05368558|564725156|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446142|NCT05368558|564725157|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446143|NCT05368558|564725158|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446144|NCT05368558|564725159|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446145|NCT05368558|564725160|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446146|NCT05368558|564725161|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446147|NCT05368558|564725162|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446148|NCT05368558|564725163|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446149|NCT05368558|564725164|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
156446150|NCT05368558|564725153|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446151|NCT05368558|564725154|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446152|NCT05368558|564725155|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446153|NCT05368558|564725156|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
156446154|NCT05368558|564725157|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446155|NCT05368558|564725158|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
156446156|NCT05368558|564725159|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446157|NCT05368558|564725160|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446158|NCT05368558|564725161|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446159|NCT05368558|564725162|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446160|NCT05368558|564725163|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446161|NCT05368558|564725164|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156446162|NCT05368558|564725153|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446163|NCT05368558|564725154|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446164|NCT05368558|564725155|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446165|NCT05368558|564725156|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
156334347|NCT00533897|564322383|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156446166|NCT05368558|564725157|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446167|NCT05368558|564725158|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446168|NCT05368558|564725159|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446169|NCT05368558|564725160|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446170|NCT05368558|564725161|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446171|NCT05368558|564725162|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446172|NCT05368558|564725163|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446173|NCT05368558|564725164|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156446174|NCT05368558|564725153|FG000|Blinded Extension Period (BEP)|other|0|||
156334348|NCT00533897|564322384|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156446175|NCT05368558|564725154|FG001|Blinded Extension Period (BEP)|other|0|||
156446176|NCT05368558|564725155|FG002|Blinded Extension Period (BEP)|other|0|||
156446177|NCT05368558|564725156|FG003|Blinded Extension Period (BEP)|other|0|||
156446178|NCT05368558|564725157|FG004|Blinded Extension Period (BEP)|other|0|||
156446179|NCT05368558|564725158|FG005|Blinded Extension Period (BEP)|other|1|||
156446180|NCT05368558|564725159|FG006|Blinded Extension Period (BEP)|other|0|||
156446181|NCT05368558|564725160|FG007|Blinded Extension Period (BEP)|other|0|||
156446182|NCT05368558|564725161|FG008|Blinded Extension Period (BEP)|other|0|||
156446183|NCT05368558|564725162|FG009|Blinded Extension Period (BEP)|other|0|||
156446184|NCT05368558|564725163|FG010|Blinded Extension Period (BEP)|other|0|||
156446185|NCT05368558|564725164|FG011|Blinded Extension Period (BEP)|other|0|||
156446186|NCT01303445|564725167|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
156446187|NCT01303445|564725168|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
156446188|NCT01303445|564725167|FG000|Second Intervention (7 Days)|Adverse Event|0|||
156446189|NCT01303445|564725168|FG001|Second Intervention (7 Days)|Adverse Event|2|||
156334349|NCT00533897|564322385|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156334350|NCT00533897|564322386|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156334351|NCT00533897|564322387|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156334352|NCT00533897|564322388|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156334353|NCT00533897|564322389|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
156334354|NCT00533897|564322390|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156334355|NCT00533897|564322383|FG000|Long Term Extension (LTE)|Adverse Event|0|||
156334356|NCT00533897|564322384|FG001|Long Term Extension (LTE)|Adverse Event|0|||
156334357|NCT00533897|564322385|FG002|Long Term Extension (LTE)|Adverse Event|0|||
156334358|NCT00533897|564322386|FG003|Long Term Extension (LTE)|Adverse Event|0|||
156334359|NCT00533897|564322387|FG004|Long Term Extension (LTE)|Adverse Event|0|||
156334360|NCT00533897|564322388|FG005|Long Term Extension (LTE)|Adverse Event|0|||
156334361|NCT00533897|564322389|FG006|Long Term Extension (LTE)|Adverse Event|2|||
156334362|NCT00533897|564322390|FG007|Long Term Extension (LTE)|Adverse Event|5|||
156334363|NCT00533897|564322383|FG000|Long Term Extension (LTE)|Pregnancy|0|||
156334364|NCT00533897|564322384|FG001|Long Term Extension (LTE)|Pregnancy|0|||
156334365|NCT00533897|564322385|FG002|Long Term Extension (LTE)|Pregnancy|0|||
156334366|NCT00533897|564322386|FG003|Long Term Extension (LTE)|Pregnancy|0|||
156334367|NCT00533897|564322387|FG004|Long Term Extension (LTE)|Pregnancy|0|||
156334368|NCT00533897|564322388|FG005|Long Term Extension (LTE)|Pregnancy|0|||
156334369|NCT00533897|564322389|FG006|Long Term Extension (LTE)|Pregnancy|0|||
156334370|NCT00533897|564322390|FG007|Long Term Extension (LTE)|Pregnancy|2|||
156334371|NCT00533897|564322383|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
156334372|NCT00533897|564322384|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
156334373|NCT00533897|564322385|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
156334374|NCT00533897|564322386|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
156334375|NCT00533897|564322387|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
156334376|NCT00533897|564322388|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
156334377|NCT00533897|564322389|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
156334378|NCT00533897|564322390|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
156334379|NCT00533897|564322383|FG000|Long Term Extension (LTE)|Other|0|||
156334380|NCT00533897|564322384|FG001|Long Term Extension (LTE)|Other|0|||
156334381|NCT00533897|564322385|FG002|Long Term Extension (LTE)|Other|0|||
156334382|NCT00533897|564322386|FG003|Long Term Extension (LTE)|Other|0|||
156334383|NCT00533897|564322387|FG004|Long Term Extension (LTE)|Other|0|||
156334384|NCT00533897|564322388|FG005|Long Term Extension (LTE)|Other|0|||
156334385|NCT00533897|564322389|FG006|Long Term Extension (LTE)|Other|1|||
156334386|NCT00533897|564322390|FG007|Long Term Extension (LTE)|Other|6|||
156334387|NCT01546207|564322404|FG000|Overall Study|Death|1|||
156334388|NCT01626456|564322405|FG000|Overall Study|Withdrawal by Subject|21|||
156334389|NCT01626456|564322406|FG001|Overall Study|Withdrawal by Subject|46|||
156334390|NCT01626456|564322405|FG000|Overall Study|Adverse Event|2|||
156446190|NCT01303445|564725167|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
156446191|NCT01303445|564725168|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
156446192|NCT01303445|564725167|FG000|Washout (14 Days)|Protocol Violation|1|||
156446193|NCT01303445|564725168|FG001|Washout (14 Days)|Protocol Violation|0|||
156446194|NCT01303445|564725167|FG000|Washout (14 Days)|Lost to Follow-up|0|||
156446195|NCT01303445|564725168|FG001|Washout (14 Days)|Lost to Follow-up|2|||
156446196|NCT01303445|564725167|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
156334391|NCT01626456|564322406|FG001|Overall Study|Adverse Event|27|||
156334392|NCT01626456|564322405|FG000|Overall Study|Lost to Follow-up|2|||
156334393|NCT01626456|564322406|FG001|Overall Study|Lost to Follow-up|27|||
156334394|NCT01626456|564322405|FG000|Overall Study|Lack of Efficacy|6|||
156334395|NCT01626456|564322406|FG001|Overall Study|Lack of Efficacy|7|||
156334396|NCT01626456|564322405|FG000|Overall Study|Physician Decision|1|||
156446197|NCT01303445|564725168|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
156446198|NCT01303445|564725167|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
156446199|NCT01303445|564725168|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
156446200|NCT06024174|564725169|FG000|Overall Study|Other Reasons|1|||
156446201|NCT06024174|564725169|FG000|Overall Study|Study terminated by Sponsor|4|||
156446202|NCT04994509|564725170|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
156446203|NCT04994509|564725171|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
156446204|NCT04994509|564725172|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
156446205|NCT04994509|564725170|FG000|Overall Study|Withdrew Consent|73|||
156446206|NCT04994509|564725171|FG001|Overall Study|Withdrew Consent|72|||
156446207|NCT04994509|564725172|FG002|Overall Study|Withdrew Consent|46|||
156446208|NCT04994509|564725170|FG000|Overall Study|Lost to Follow-up|39|||
156446209|NCT04994509|564725171|FG001|Overall Study|Lost to Follow-up|36|||
156446210|NCT04994509|564725172|FG002|Overall Study|Lost to Follow-up|26|||
156446211|NCT04994509|564725170|FG000|Overall Study|HIV-1 Infection|4|||
156446212|NCT04994509|564725171|FG001|Overall Study|HIV-1 Infection|20|||
156446213|NCT04994509|564725172|FG002|Overall Study|HIV-1 Infection|12|||
156446214|NCT04994509|564725170|FG000|Overall Study|Investigator's Discretion|9|||
156446215|NCT04994509|564725171|FG001|Overall Study|Investigator's Discretion|8|||
156446216|NCT04994509|564725172|FG002|Overall Study|Investigator's Discretion|11|||
156446217|NCT04994509|564725170|FG000|Overall Study|Randomized but Never Treated|10|||
156446218|NCT04994509|564725171|FG001|Overall Study|Randomized but Never Treated|10|||
156446219|NCT04994509|564725172|FG002|Overall Study|Randomized but Never Treated|3|||
156446220|NCT04994509|564725170|FG000|Overall Study|Pregnancy|5|||
156446221|NCT04994509|564725171|FG001|Overall Study|Pregnancy|5|||
156446222|NCT04994509|564725172|FG002|Overall Study|Pregnancy|0|||
156446223|NCT04994509|564725170|FG000|Overall Study|Death|0|||
156446224|NCT04994509|564725171|FG001|Overall Study|Death|5|||
156446225|NCT04994509|564725172|FG002|Overall Study|Death|0|||
156446226|NCT04994509|564725170|FG000|Overall Study|Adverse Event|2|||
156446227|NCT04994509|564725171|FG001|Overall Study|Adverse Event|1|||
156446228|NCT04994509|564725172|FG002|Overall Study|Adverse Event|0|||
156446229|NCT04994509|564725170|FG000|Overall Study|Non-compliance With Study Drug|1|||
156446230|NCT04994509|564725171|FG001|Overall Study|Non-compliance With Study Drug|1|||
156446231|NCT04994509|564725172|FG002|Overall Study|Non-compliance With Study Drug|1|||
156446232|NCT04994509|564725170|FG000|Overall Study|Withdrew Assent|3|||
156446233|NCT04994509|564725171|FG001|Overall Study|Withdrew Assent|0|||
156446234|NCT04994509|564725172|FG002|Overall Study|Withdrew Assent|0|||
156446235|NCT04994509|564725170|FG000|Overall Study|Protocol Violation|1|||
156446236|NCT04994509|564725171|FG001|Overall Study|Protocol Violation|0|||
156446237|NCT04994509|564725172|FG002|Overall Study|Protocol Violation|0|||
156446238|NCT04923347|564726517|FG000|Overall Study|Withdrawal by Subject|14|||
156446239|NCT01991977|564726522|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
156446240|NCT01991977|564726522|FG000|Overall Study|Withdrew after start of treatment|5|||
156446241|NCT03845465|564726524|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
156446242|NCT03845465|564726525|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
156446243|NCT03845465|564726524|FG000|6-month Data Collection|Withdrawal by Subject|0|||
156446244|NCT03845465|564726525|FG001|6-month Data Collection|Withdrawal by Subject|2|||
156446245|NCT03845465|564726524|FG000|12-month Data Collection|Withdrawal by Subject|0|||
156446246|NCT03845465|564726525|FG001|12-month Data Collection|Withdrawal by Subject|2|||
156446247|NCT03547908|564726528|FG000|Blinded Phase|Lost to Follow-up|3|||
156446248|NCT03547908|564726529|FG001|Blinded Phase|Lost to Follow-up|3|||
156446249|NCT03547908|564726530|FG002|Blinded Phase|Lost to Follow-up|0|||
156446250|NCT03547908|564726531|FG003|Blinded Phase|Lost to Follow-up|0|||
156446251|NCT03547908|564726528|FG000|Blinded Phase|Withdrew Consent|2|||
156446252|NCT03547908|564726529|FG001|Blinded Phase|Withdrew Consent|3|||
156446253|NCT03547908|564726530|FG002|Blinded Phase|Withdrew Consent|0|||
156446254|NCT03547908|564726531|FG003|Blinded Phase|Withdrew Consent|0|||
156446255|NCT03547908|564726528|FG000|Blinded Phase|Investigator's Discretion|2|||
156446256|NCT03547908|564726529|FG001|Blinded Phase|Investigator's Discretion|1|||
156446257|NCT03547908|564726530|FG002|Blinded Phase|Investigator's Discretion|0|||
156446258|NCT03547908|564726531|FG003|Blinded Phase|Investigator's Discretion|0|||
156446259|NCT03547908|564726528|FG000|Blinded Phase|Death|2|||
156446260|NCT03547908|564726529|FG001|Blinded Phase|Death|0|||
156446261|NCT03547908|564726530|FG002|Blinded Phase|Death|0|||
156446262|NCT03547908|564726531|FG003|Blinded Phase|Death|0|||
156446263|NCT03547908|564726528|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
156446264|NCT03547908|564726529|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
156446265|NCT03547908|564726530|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
156446266|NCT03547908|564726531|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
156446267|NCT03547908|564726528|FG000|Blinded Phase|Adverse Event|1|||
156446268|NCT03547908|564726529|FG001|Blinded Phase|Adverse Event|0|||
156446269|NCT03547908|564726530|FG002|Blinded Phase|Adverse Event|0|||
156446270|NCT03547908|564726531|FG003|Blinded Phase|Adverse Event|0|||
156446271|NCT03547908|564726528|FG000|Blinded Phase|Randomized But Never Treated|1|||
156446272|NCT03547908|564726529|FG001|Blinded Phase|Randomized But Never Treated|0|||
156446273|NCT03547908|564726530|FG002|Blinded Phase|Randomized But Never Treated|0|||
156446274|NCT03547908|564726531|FG003|Blinded Phase|Randomized But Never Treated|0|||
156446275|NCT03547908|564726528|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
156446276|NCT03547908|564726529|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
156446277|NCT03547908|564726530|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
156446278|NCT03547908|564726531|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
156446279|NCT03547908|564726528|FG000|Open-label Extension Phase|Death|0|||
156446280|NCT03547908|564726529|FG001|Open-label Extension Phase|Death|0|||
156446281|NCT03547908|564726530|FG002|Open-label Extension Phase|Death|1|||
156446282|NCT03547908|564726531|FG003|Open-label Extension Phase|Death|0|||
156446283|NCT04059354|564726534|FG000|Overall Study|COVID-19 pandemic|3|||
156446284|NCT02525692|564726535|FG000|Overall Study|Withdrawal by Subject|1|||
156446285|NCT02525692|564726536|FG001|Overall Study|Withdrawal by Subject|1|||
156446286|NCT02525692|564726537|FG002|Overall Study|Withdrawal by Subject|0|||
156446287|NCT02525692|564726538|FG003|Overall Study|Withdrawal by Subject|5|||
156446288|NCT02525692|564726539|FG004|Overall Study|Withdrawal by Subject|0|||
156446289|NCT02525692|564726540|FG005|Overall Study|Withdrawal by Subject|1|||
156446290|NCT02525692|564726535|FG000|Overall Study|Death|16|||
156446291|NCT02525692|564726536|FG001|Overall Study|Death|18|||
156446292|NCT02525692|564726537|FG002|Overall Study|Death|7|||
156446293|NCT02525692|564726538|FG003|Overall Study|Death|20|||
156446294|NCT02525692|564726539|FG004|Overall Study|Death|3|||
156446295|NCT02525692|564726540|FG005|Overall Study|Death|6|||
156446296|NCT02525692|564726535|FG000|Overall Study|Lost to Follow-up|0|||
156446297|NCT02525692|564726536|FG001|Overall Study|Lost to Follow-up|0|||
156446298|NCT02525692|564726537|FG002|Overall Study|Lost to Follow-up|1|||
156446299|NCT02525692|564726538|FG003|Overall Study|Lost to Follow-up|5|||
156446300|NCT02525692|564726539|FG004|Overall Study|Lost to Follow-up|0|||
156446301|NCT02525692|564726540|FG005|Overall Study|Lost to Follow-up|0|||
156446302|NCT02396199|564726541|FG000|Overall Study|Lost to Follow-up|1|||
156446303|NCT02396199|564726541|FG000|Overall Study|Death|4|||
156446304|NCT02349412|564726542|FG000|Overall Study|Withdrawal by Subject|7|||
156446305|NCT02349412|564726543|FG001|Overall Study|Withdrawal by Subject|7|||
156446306|NCT00979576|564726546|FG000|Combination Treatment Phase|Progressive disease|3|||
156446307|NCT00979576|564726547|FG001|Combination Treatment Phase|Progressive disease|1|||
156446308|NCT00979576|564726548|FG002|Combination Treatment Phase|Progressive disease|5|||
156446309|NCT00979576|564726546|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
156446310|NCT00979576|564726547|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
156446311|NCT00979576|564726548|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
156446312|NCT00979576|564726546|FG000|Combination Treatment Phase|Adverse Event|0|||
156446313|NCT00979576|564726547|FG001|Combination Treatment Phase|Adverse Event|2|||
156446314|NCT00979576|564726548|FG002|Combination Treatment Phase|Adverse Event|2|||
156446315|NCT00979576|564726546|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
156446316|NCT00979576|564726547|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
156446317|NCT00979576|564726548|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
156446318|NCT04855760|564726549|FG000|Overall Study|Adverse Event|21|||
156446319|NCT04855760|564726549|FG000|Overall Study|Withdrawal by Subject|116|||
156446320|NCT04855760|564726549|FG000|Overall Study|Lack of Efficacy|21|||
156446321|NCT04855760|564726549|FG000|Overall Study|Lost to Follow-up|49|||
156446322|NCT04855760|564726549|FG000|Overall Study|Protocol Violation|2|||
156446323|NCT04855760|564726549|FG000|Overall Study|Physician Decision|5|||
156446324|NCT04855760|564726549|FG000|Overall Study|Pregnancy|1|||
156446325|NCT04855760|564726549|FG000|Overall Study|Non-Compliance with Study Drug|11|||
156446326|NCT04855760|564726549|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
156446327|NCT04855760|564726549|FG000|Overall Study|Study Completed by Sponsor|202|||
156446328|NCT04855760|564726549|FG000|Overall Study|Other|13|||
156446329|NCT03424811|564726550|FG000|Overall Study|Lost to Follow-up|9|||
156446330|NCT03424811|564726551|FG001|Overall Study|Lost to Follow-up|0|||
156446331|NCT03517553|564726557|FG000|Overall Study|Withdrawal by Subject|2|||
156446332|NCT04093362|564726558|FG000|Overall Study|Study Termination|1|||
156446333|NCT04093362|564726559|FG001|Overall Study|Study Termination|1|||
156446334|NCT04093362|564726558|FG000|Overall Study|Withdrawal of Consent|1|||
156446335|NCT04093362|564726559|FG001|Overall Study|Withdrawal of Consent|0|||
156716275|NCT02676882|565705319|FG001|Overall Study|Lost to Follow-up|0|||
156446336|NCT04093362|564726558|FG000|Overall Study|Death|1|||
156446337|NCT04093362|564726559|FG001|Overall Study|Death|3|||
156446338|NCT04093362|564726558|FG000|Overall Study|Reason not Specified|1|||
156446339|NCT04093362|564726559|FG001|Overall Study|Reason not Specified|2|||
156446340|NCT03055377|564726560|FG000|Treatment Phase|Lost to Follow-up|28|||
156446341|NCT03055377|564726561|FG001|Treatment Phase|Lost to Follow-up|24|||
156446342|NCT03055377|564726560|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
156446343|NCT03055377|564726561|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
156716276|NCT02676882|565705318|FG000|Overall Study|Withdrawal by Subject|1|||
156716277|NCT02676882|565705319|FG001|Overall Study|Withdrawal by Subject|2|||
156716278|NCT01071915|565705320|FG000|Overall Study|Adverse Event|3|||
156716279|NCT01071915|565705320|FG000|Overall Study|Physician Decision|2|||
156716280|NCT01071915|565705320|FG000|Overall Study|Withdrawal by Subject|2|||
156716281|NCT01071915|565705320|FG000|Overall Study|Miscellaneous Reasons|2|||
156532854|NCT01524133|565046822|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
156532855|NCT01524133|565046820|FG000|Overall Study 52 Weeks|Physician Decision|1|||
156532856|NCT01524133|565046821|FG001|Overall Study 52 Weeks|Physician Decision|0|||
156532857|NCT01524133|565046822|FG002|Overall Study 52 Weeks|Physician Decision|2|||
156532858|NCT01524133|565046820|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
156532859|NCT01524133|565046821|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
156532860|NCT01524133|565046822|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
156532861|NCT00059839|565046824|FG000|Overall Study|Death|1|||
156532862|NCT00059839|565046825|FG001|Overall Study|Death|1|||
156532863|NCT00059839|565046824|FG000|Overall Study|Lack of Efficacy|6|||
156532864|NCT00059839|565046825|FG001|Overall Study|Lack of Efficacy|5|||
156532865|NCT00059839|565046824|FG000|Overall Study|Lost to Follow-up|2|||
156532866|NCT00059839|565046825|FG001|Overall Study|Lost to Follow-up|0|||
156532867|NCT00059839|565046824|FG000|Overall Study|Physician Decision|1|||
156532868|NCT00059839|565046825|FG001|Overall Study|Physician Decision|2|||
156532869|NCT00059839|565046824|FG000|Overall Study|Withdrawal by Subject|1|||
156532870|NCT00059839|565046825|FG001|Overall Study|Withdrawal by Subject|6|||
156532871|NCT00059839|565046824|FG000|Overall Study|Ineligible|1|||
156532872|NCT00059839|565046825|FG001|Overall Study|Ineligible|3|||
156532873|NCT01330914|565046826|FG000|Overall Study|Withdrawal by Subject|4|||
156334397|NCT01626456|564322406|FG001|Overall Study|Physician Decision|4|||
156334398|NCT01626456|564322405|FG000|Overall Study|Protocol Violation|1|||
156334399|NCT01626456|564322406|FG001|Overall Study|Protocol Violation|1|||
156532874|NCT01330914|565046826|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
156532875|NCT05352048|565046831|FG000|Overall Study|Lost to Follow-up|1|||
156532876|NCT05352048|565046831|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
156532877|NCT00528567|565046832|FG000|Overall Study|Death|4|||
156532878|NCT00528567|565046833|FG001|Overall Study|Death|5|||
156532879|NCT00528567|565046832|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
156532880|NCT00528567|565046833|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
156532881|NCT00528567|565046832|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
156532882|NCT00528567|565046833|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
156532883|NCT00528567|565046832|FG000|Overall Study|Violation Criteria at Entry|3|||
156532884|NCT00528567|565046833|FG001|Overall Study|Violation Criteria at Entry|17|||
156532885|NCT00528567|565046832|FG000|Overall Study|Withdrew Consent|59|||
156532886|NCT00528567|565046833|FG001|Overall Study|Withdrew Consent|55|||
156532887|NCT00528567|565046832|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
156532888|NCT00528567|565046833|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
156532889|NCT00528567|565046832|FG000|Overall Study|Failure to Return|1|||
156532890|NCT00528567|565046833|FG001|Overall Study|Failure to Return|4|||
156334400|NCT01626456|564322405|FG000|Overall Study|Site Closure|2|||
156334401|NCT01626456|564322406|FG001|Overall Study|Site Closure|3|||
156334402|NCT01626456|564322405|FG000|Overall Study|Incarceration|0|||
156334403|NCT01626456|564322406|FG001|Overall Study|Incarceration|2|||
156334404|NCT00713323|564322407|FG000|Overall Study|Adverse Event|75|||
156334405|NCT00713323|564322407|FG000|Overall Study|Withdrawal by Subject|15|||
156334406|NCT00713323|564322407|FG000|Overall Study|Lost to Follow-up|11|||
156334407|NCT00713323|564322407|FG000|Overall Study|Lack of Efficacy|36|||
156334408|NCT00713323|564322407|FG000|Overall Study|Low creatine clearance at screening|1|||
156334409|NCT00713323|564322407|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
156334410|NCT00713323|564322407|FG000|Overall Study|Surgery cured allodynic pain|1|||
156334411|NCT00713323|564322407|FG000|Overall Study|Pain free|1|||
156334412|NCT00713323|564322407|FG000|Overall Study|Non-compliance|1|||
156334413|NCT00713323|564322407|FG000|Overall Study|Pain resolved|1|||
156334414|NCT00713323|564322407|FG000|Overall Study|Subject travelling to USA|1|||
156334415|NCT00713323|564322407|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
156334416|NCT00713323|564322407|FG000|Overall Study|Treatment that may interact with Sativex|1|||
156334417|NCT00506662|564322408|FG000|Overall Study|Adverse Event|0|||
156334418|NCT00506662|564322409|FG001|Overall Study|Adverse Event|2|||
156334419|NCT00506662|564322408|FG000|Overall Study|Lack of Efficacy|1|||
156334420|NCT00506662|564322409|FG001|Overall Study|Lack of Efficacy|0|||
156334421|NCT00506662|564322408|FG000|Overall Study|Protocol Violation|2|||
156334422|NCT00506662|564322409|FG001|Overall Study|Protocol Violation|4|||
156334423|NCT00506662|564322408|FG000|Overall Study|Trial terminated|10|||
156334424|NCT00506662|564322409|FG001|Overall Study|Trial terminated|16|||
156334425|NCT00506662|564322408|FG000|Overall Study|Not recorded|4|||
156334426|NCT00506662|564322409|FG001|Overall Study|Not recorded|6|||
156334427|NCT03019185|564322415|FG000|Overall Study|Lost to Follow-up|3|||
156334428|NCT03019185|564322416|FG001|Overall Study|Lost to Follow-up|0|||
156334429|NCT03019185|564322417|FG002|Overall Study|Lost to Follow-up|2|||
156334430|NCT03019185|564322415|FG000|Overall Study|Withdrawal by Subject|1|||
156334431|NCT03019185|564322416|FG001|Overall Study|Withdrawal by Subject|1|||
156334432|NCT03019185|564322417|FG002|Overall Study|Withdrawal by Subject|0|||
156334433|NCT03019185|564322415|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
156334434|NCT03019185|564322416|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
156334435|NCT03019185|564322417|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
156446344|NCT03157167|564726562|FG000|Overall Study|Withdrawal by Subject|1|||
156446345|NCT03157167|564726563|FG001|Overall Study|Withdrawal by Subject|0|||
156446346|NCT03157167|564726564|FG002|Overall Study|Withdrawal by Subject|0|||
156446347|NCT02597946|564726565|FG000|Overall Study|Withdrawal by Subject|1|||
156446348|NCT02597946|564726565|FG000|Overall Study|Progressive disease|16|||
156446349|NCT02597946|564726565|FG000|Overall Study|Other than above|1|||
156446350|NCT04905407|564726566|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
156446351|NCT04905407|564726567|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
156446352|NCT04905407|564726568|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
156446353|NCT04905407|564726569|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
156446354|NCT04905407|564726566|FG000|Part 1 and Part 2|Death|7|||
156446355|NCT04905407|564726567|FG001|Part 1 and Part 2|Death|7|||
156446356|NCT04905407|564726568|FG002|Part 1 and Part 2|Death|7|||
156446357|NCT04905407|564726569|FG003|Part 1 and Part 2|Death|0|||
156446358|NCT04905407|564726566|FG000|Part 1 and Part 2|Other than specified|0|||
156446359|NCT04905407|564726567|FG001|Part 1 and Part 2|Other than specified|0|||
156446360|NCT04905407|564726568|FG002|Part 1 and Part 2|Other than specified|1|||
156446361|NCT04905407|564726569|FG003|Part 1 and Part 2|Other than specified|0|||
156446362|NCT04905407|564726566|FG000|Part 3|Death|0|||
156446363|NCT04905407|564726567|FG001|Part 3|Death|0|||
156446364|NCT04905407|564726568|FG002|Part 3|Death|0|||
156446365|NCT04905407|564726569|FG003|Part 3|Death|2|||
156446366|NCT04868110|564726572|FG000|Overall Study|Withdrawal by Subject|3|||
156446367|NCT04868110|564726573|FG001|Overall Study|Withdrawal by Subject|4|||
156446368|NCT04178733|564726584|FG000|Overall Study|Investigator Decision|0|||
156446369|NCT04178733|564726585|FG001|Overall Study|Investigator Decision|0|||
156446370|NCT04178733|564726586|FG002|Overall Study|Investigator Decision|0|||
156446371|NCT04178733|564726587|FG003|Overall Study|Investigator Decision|1|||
156446372|NCT04178733|564726588|FG004|Overall Study|Investigator Decision|2|||
156446373|NCT03655132|564726591|FG000|Overall Study|Lost to Follow-up|2|||
156446374|NCT03655132|564726592|FG001|Overall Study|Lost to Follow-up|1|||
156446375|NCT03655132|564726591|FG000|Overall Study|Withdrawal by Subject|0|||
156446376|NCT03655132|564726592|FG001|Overall Study|Withdrawal by Subject|1|||
156446377|NCT03655132|564726591|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
156446378|NCT03655132|564726592|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
156446379|NCT02651324|564726594|FG000|Overall Study|drug not administered, due dispensing issue|1|||
156446380|NCT02651324|564726595|FG001|Overall Study|drug not administered, due dispensing issue|0|||
156446381|NCT05919082|564726596|FG000|Overall Study|Adverse Event|3|||
156446382|NCT05919082|564726597|FG001|Overall Study|Adverse Event|0|||
156446383|NCT05919082|564726596|FG000|Overall Study|Lost to Follow-up|0|||
156446384|NCT05919082|564726597|FG001|Overall Study|Lost to Follow-up|1|||
156446385|NCT05919082|564726596|FG000|Overall Study|Withdrawal by Subject|8|||
156446386|NCT05919082|564726597|FG001|Overall Study|Withdrawal by Subject|9|||
156446387|NCT05919082|564726596|FG000|Overall Study|Lack of Efficacy|0|||
156446388|NCT05919082|564726597|FG001|Overall Study|Lack of Efficacy|1|||
156446389|NCT05919082|564726596|FG000|Overall Study|Investigator Decision|1|||
156446390|NCT05919082|564726597|FG001|Overall Study|Investigator Decision|0|||
156446391|NCT02287311|564726598|FG000|Cohort 1: Dose Level 1|Death|2|||
156446392|NCT02287311|564726599|FG001|Cohort 1: Dose Level 1|Death|0|||
156446393|NCT02287311|564726600|FG002|Cohort 1: Dose Level 1|Death|0|||
156446394|NCT02287311|564726601|FG003|Cohort 1: Dose Level 1|Death|3|||
156446395|NCT02287311|564726602|FG004|Cohort 1: Dose Level 1|Death|0|||
156446396|NCT02287311|564726603|FG005|Cohort 1: Dose Level 1|Death|0|||
156446397|NCT02287311|564726604|FG006|Cohort 1: Dose Level 1|Death|1|||
156446398|NCT02287311|564726605|FG007|Cohort 1: Dose Level 1|Death|0|||
156446399|NCT02287311|564726606|FG008|Cohort 1: Dose Level 1|Death|0|||
156446400|NCT02287311|564726598|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
156446401|NCT02287311|564726599|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
156446402|NCT02287311|564726600|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
156716282|NCT01125189|565705321|FG000|Treatment Period|Lack of Efficacy|15|||
156716283|NCT01125189|565705322|FG001|Treatment Period|Lack of Efficacy|18|||
156716284|NCT01125189|565705323|FG002|Treatment Period|Lack of Efficacy|25|||
156446403|NCT02287311|564726601|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
156446404|NCT02287311|564726602|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
156446405|NCT02287311|564726603|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
156446406|NCT02287311|564726604|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
156446407|NCT02287311|564726605|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
156446408|NCT02287311|564726606|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
156446409|NCT02287311|564726598|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
156446410|NCT02287311|564726599|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
156446411|NCT02287311|564726600|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
156446412|NCT02287311|564726601|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
156446413|NCT02287311|564726602|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
156446414|NCT02287311|564726603|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
156446415|NCT02287311|564726604|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
156446416|NCT02287311|564726605|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
156716285|NCT01125189|565705321|FG000|Treatment Period|Adverse Event|7|||
156446417|NCT02287311|564726606|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
156446418|NCT02287311|564726598|FG000|Cohort 2: Dose Level 2|Death|0|||
156446419|NCT02287311|564726599|FG001|Cohort 2: Dose Level 2|Death|2|||
156446420|NCT02287311|564726600|FG002|Cohort 2: Dose Level 2|Death|0|||
156446421|NCT02287311|564726601|FG003|Cohort 2: Dose Level 2|Death|0|||
156446422|NCT02287311|564726602|FG004|Cohort 2: Dose Level 2|Death|2|||
156446423|NCT02287311|564726603|FG005|Cohort 2: Dose Level 2|Death|0|||
156446424|NCT02287311|564726604|FG006|Cohort 2: Dose Level 2|Death|0|||
156446425|NCT02287311|564726605|FG007|Cohort 2: Dose Level 2|Death|2|||
156446426|NCT02287311|564726606|FG008|Cohort 2: Dose Level 2|Death|0|||
156446427|NCT02287311|564726598|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156446428|NCT02287311|564726599|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156446429|NCT02287311|564726600|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156446430|NCT02287311|564726601|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156446431|NCT02287311|564726602|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
156446432|NCT02287311|564726603|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156446433|NCT02287311|564726604|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156446434|NCT02287311|564726605|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156446435|NCT02287311|564726606|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156446436|NCT02287311|564726598|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
156446437|NCT02287311|564726599|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
156446438|NCT02287311|564726600|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
156446439|NCT02287311|564726601|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
156446440|NCT02287311|564726602|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
156446441|NCT02287311|564726603|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
156446442|NCT02287311|564726604|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
156446443|NCT02287311|564726605|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
156446444|NCT02287311|564726606|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
156446445|NCT02287311|564726598|FG000|Cohort 3: Dose Level 3|Death|0|||
156446446|NCT02287311|564726599|FG001|Cohort 3: Dose Level 3|Death|0|||
156446447|NCT02287311|564726600|FG002|Cohort 3: Dose Level 3|Death|4|||
156446448|NCT02287311|564726601|FG003|Cohort 3: Dose Level 3|Death|0|||
156446449|NCT02287311|564726602|FG004|Cohort 3: Dose Level 3|Death|0|||
156532891|NCT00528567|565046832|FG000|Overall Study|Other Protocol Violation|5|||
156532892|NCT00528567|565046833|FG001|Overall Study|Other Protocol Violation|21|||
156532893|NCT00528567|565046832|FG000|Overall Study|Administrative/Other|22|||
156532894|NCT00528567|565046833|FG001|Overall Study|Administrative/Other|75|||
156793208|NCT02037984|565994886|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
156793209|NCT02037984|565994879|FG000|Overall Study|Withdrawal by Subject|0|||
156793210|NCT02037984|565994880|FG001|Overall Study|Withdrawal by Subject|0|||
156793211|NCT02037984|565994881|FG002|Overall Study|Withdrawal by Subject|0|||
156793212|NCT02037984|565994882|FG003|Overall Study|Withdrawal by Subject|1|||
156532895|NCT00056862|565046838|FG000|Overall Study|Protocol Violation|1|||
156532896|NCT00056862|565046839|FG001|Overall Study|Protocol Violation|0|||
156532897|NCT03974334|565046845|FG000|Overall Study|Lost to Follow-up|1|||
156532898|NCT01109173|565046846|FG000|Overall Study|Adverse Event|15|||
156532899|NCT01109173|565046847|FG001|Overall Study|Adverse Event|17|||
156532900|NCT01109173|565046848|FG002|Overall Study|Adverse Event|9|||
156532901|NCT01109173|565046849|FG003|Overall Study|Adverse Event|6|||
156532902|NCT01109173|565046846|FG000|Overall Study|Lost to Follow-up|0|||
156532903|NCT01109173|565046847|FG001|Overall Study|Lost to Follow-up|1|||
156532904|NCT01109173|565046848|FG002|Overall Study|Lost to Follow-up|0|||
156532905|NCT01109173|565046849|FG003|Overall Study|Lost to Follow-up|0|||
156532906|NCT01109173|565046846|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
156532907|NCT01109173|565046847|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
156532908|NCT01109173|565046848|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
156793213|NCT02037984|565994883|FG004|Overall Study|Withdrawal by Subject|1|||
156793214|NCT02037984|565994884|FG005|Overall Study|Withdrawal by Subject|3|||
156793215|NCT02037984|565994885|FG006|Overall Study|Withdrawal by Subject|0|||
156793216|NCT02037984|565994886|FG007|Overall Study|Withdrawal by Subject|1|||
156874834|NCT03892967|566298748|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
156334436|NCT03019185|564322415|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
156532909|NCT01109173|565046849|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
156532910|NCT01109173|565046846|FG000|Overall Study|Noncompliance|0|||
156532911|NCT01109173|565046847|FG001|Overall Study|Noncompliance|1|||
156334437|NCT03019185|564322416|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
156334438|NCT03019185|564322417|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
156334439|NCT02764333|564322423|FG000|Overall Study|Ineligible|1|||
156334440|NCT00491764|564322424|FG000|Overall Study|Adverse Event|1|||
156334441|NCT00491764|564322425|FG001|Overall Study|Adverse Event|2|||
156334442|NCT00491764|564322426|FG002|Overall Study|Adverse Event|4|||
156334443|NCT00491764|564322427|FG003|Overall Study|Adverse Event|4|||
156334444|NCT00491764|564322428|FG004|Overall Study|Adverse Event|0|||
156446450|NCT02287311|564726603|FG005|Cohort 3: Dose Level 3|Death|4|||
156793217|NCT00974233|565994892|FG000|Induction Chemoimmunotherapy|Death|2|||
156446451|NCT02287311|564726604|FG006|Cohort 3: Dose Level 3|Death|0|||
156446452|NCT02287311|564726605|FG007|Cohort 3: Dose Level 3|Death|0|||
156446453|NCT02287311|564726606|FG008|Cohort 3: Dose Level 3|Death|2|||
156446454|NCT02287311|564726598|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
156446455|NCT02287311|564726599|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
156446456|NCT02287311|564726600|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
156446457|NCT02287311|564726601|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
156532912|NCT01109173|565046848|FG002|Overall Study|Noncompliance|0|||
156446458|NCT02287311|564726602|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
156532913|NCT01109173|565046849|FG003|Overall Study|Noncompliance|0|||
156532914|NCT01109173|565046846|FG000|Overall Study|Treatment Failure|25|||
156532915|NCT01109173|565046847|FG001|Overall Study|Treatment Failure|32|||
156532916|NCT01109173|565046848|FG002|Overall Study|Treatment Failure|69|||
156532917|NCT01109173|565046849|FG003|Overall Study|Treatment Failure|64|||
156532918|NCT01109173|565046846|FG000|Overall Study|Protocol Violation|4|||
156532919|NCT01109173|565046847|FG001|Overall Study|Protocol Violation|5|||
156532920|NCT01109173|565046848|FG002|Overall Study|Protocol Violation|1|||
156532921|NCT01109173|565046849|FG003|Overall Study|Protocol Violation|2|||
156532922|NCT01109173|565046846|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
156532923|NCT01109173|565046847|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
156532924|NCT01109173|565046848|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
156532925|NCT01109173|565046849|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
156532926|NCT01109173|565046846|FG000|Overall Study|Not Specifiied|5|||
156532927|NCT01109173|565046847|FG001|Overall Study|Not Specifiied|4|||
156532928|NCT01109173|565046848|FG002|Overall Study|Not Specifiied|9|||
156532929|NCT01109173|565046849|FG003|Overall Study|Not Specifiied|14|||
156446459|NCT02287311|564726603|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
156446460|NCT02287311|564726604|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
156446461|NCT02287311|564726605|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
156446462|NCT02287311|564726606|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
156446463|NCT02287311|564726598|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
156446464|NCT02287311|564726599|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
156446465|NCT02287311|564726600|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
156446466|NCT02287311|564726601|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
156446467|NCT02287311|564726602|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
156446468|NCT02287311|564726603|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
156446469|NCT02287311|564726604|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
156532930|NCT04178967|565046855|FG000|Induction Period|Adverse Event|4|||
156532931|NCT04178967|565046856|FG001|Induction Period|Adverse Event|6|||
156532932|NCT04178967|565046857|FG002|Induction Period|Adverse Event|0|||
156532933|NCT04178967|565046858|FG003|Induction Period|Adverse Event|0|||
156532934|NCT04178967|565046859|FG004|Induction Period|Adverse Event|0|||
156532935|NCT04178967|565046860|FG005|Induction Period|Adverse Event|0|||
156532936|NCT04178967|565046861|FG006|Induction Period|Adverse Event|0|||
156532937|NCT04178967|565046862|FG007|Induction Period|Adverse Event|0|||
156532938|NCT04178967|565046863|FG008|Induction Period|Adverse Event|0|||
156532939|NCT04178967|565046864|FG009|Induction Period|Adverse Event|0|||
156532940|NCT04178967|565046865|FG010|Induction Period|Adverse Event|0|||
156532941|NCT04178967|565046855|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
156532942|NCT04178967|565046856|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
156532943|NCT04178967|565046857|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
156532944|NCT04178967|565046858|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
156532945|NCT04178967|565046859|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
156532946|NCT04178967|565046860|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
156532947|NCT04178967|565046861|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
156532948|NCT04178967|565046862|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
156532949|NCT04178967|565046863|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
156532950|NCT04178967|565046864|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
156532951|NCT04178967|565046865|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
156532952|NCT04178967|565046855|FG000|Induction Period|Lack of Efficacy|4|||
156532953|NCT04178967|565046856|FG001|Induction Period|Lack of Efficacy|1|||
156716286|NCT01125189|565705322|FG001|Treatment Period|Adverse Event|8|||
156716287|NCT01125189|565705323|FG002|Treatment Period|Adverse Event|8|||
156716288|NCT01125189|565705321|FG000|Treatment Period|Withdrawal by Subject|3|||
156716289|NCT01125189|565705322|FG001|Treatment Period|Withdrawal by Subject|1|||
156716290|NCT01125189|565705323|FG002|Treatment Period|Withdrawal by Subject|1|||
156716291|NCT01125189|565705321|FG000|Treatment Period|Death|1|||
156716292|NCT01125189|565705322|FG001|Treatment Period|Death|0|||
156716293|NCT01125189|565705323|FG002|Treatment Period|Death|0|||
156716294|NCT01125189|565705321|FG000|Treatment Period|Lost to Follow-up|1|||
156716295|NCT01125189|565705322|FG001|Treatment Period|Lost to Follow-up|2|||
156446470|NCT02287311|564726605|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
156446471|NCT02287311|564726606|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
156532954|NCT04178967|565046857|FG002|Induction Period|Lack of Efficacy|0|||
156532955|NCT04178967|565046858|FG003|Induction Period|Lack of Efficacy|0|||
156532956|NCT04178967|565046859|FG004|Induction Period|Lack of Efficacy|0|||
156716296|NCT01125189|565705323|FG002|Treatment Period|Lost to Follow-up|1|||
156334445|NCT00491764|564322429|FG005|Overall Study|Adverse Event|1|||
156334446|NCT00491764|564322424|FG000|Overall Study|Lost to Follow-up|0|||
156334447|NCT00491764|564322425|FG001|Overall Study|Lost to Follow-up|1|||
156334448|NCT00491764|564322426|FG002|Overall Study|Lost to Follow-up|0|||
156334449|NCT00491764|564322427|FG003|Overall Study|Lost to Follow-up|1|||
156334450|NCT00491764|564322428|FG004|Overall Study|Lost to Follow-up|0|||
156334451|NCT00491764|564322429|FG005|Overall Study|Lost to Follow-up|3|||
156446472|NCT02365766|564726608|FG000|Overall Study|Withdrawal by Subject|0|||
156446473|NCT02365766|564726609|FG001|Overall Study|Withdrawal by Subject|0|||
156446474|NCT02365766|564726610|FG002|Overall Study|Withdrawal by Subject|1|||
156446475|NCT02365766|564726608|FG000|Overall Study|Eligibility Criteria Not Met|0|||
156446476|NCT02365766|564726609|FG001|Overall Study|Eligibility Criteria Not Met|0|||
156446477|NCT02365766|564726610|FG002|Overall Study|Eligibility Criteria Not Met|1|||
156446478|NCT02724956|564726617|FG000|Overall Study|Physician Decision|1|||
156446479|NCT02724956|564726618|FG001|Overall Study|Physician Decision|0|||
156446480|NCT02724956|564726617|FG000|Overall Study|Lack of Efficacy|0|||
156446481|NCT02724956|564726618|FG001|Overall Study|Lack of Efficacy|1|||
156446482|NCT02724956|564726617|FG000|Overall Study|Withdrawal by Subject|0|||
156446483|NCT02724956|564726618|FG001|Overall Study|Withdrawal by Subject|1|||
156446484|NCT04600752|564726619|FG000|Overall Study|Physician Decision|0|||
156446485|NCT04600752|564726620|FG001|Overall Study|Physician Decision|0|||
156446486|NCT04600752|564726621|FG002|Overall Study|Physician Decision|1|||
156446487|NCT04600752|564726619|FG000|Overall Study|Adverse Event|0|||
156446488|NCT04600752|564726620|FG001|Overall Study|Adverse Event|1|||
156446489|NCT04600752|564726621|FG002|Overall Study|Adverse Event|0|||
156446490|NCT04600752|564726619|FG000|Overall Study|Withdrawal by Subject|2|||
156334452|NCT00491764|564322424|FG000|Overall Study|Withdrawal by Subject|2|||
156334453|NCT00491764|564322425|FG001|Overall Study|Withdrawal by Subject|3|||
156334454|NCT00491764|564322426|FG002|Overall Study|Withdrawal by Subject|1|||
156334455|NCT00491764|564322427|FG003|Overall Study|Withdrawal by Subject|2|||
156334456|NCT00491764|564322428|FG004|Overall Study|Withdrawal by Subject|2|||
156334457|NCT00491764|564322429|FG005|Overall Study|Withdrawal by Subject|4|||
156334458|NCT00491764|564322424|FG000|Overall Study|Non Compliance with the Protocol|1|||
156334459|NCT00491764|564322425|FG001|Overall Study|Non Compliance with the Protocol|0|||
156334460|NCT00491764|564322426|FG002|Overall Study|Non Compliance with the Protocol|0|||
156334461|NCT00491764|564322427|FG003|Overall Study|Non Compliance with the Protocol|0|||
156334462|NCT00491764|564322428|FG004|Overall Study|Non Compliance with the Protocol|0|||
156334463|NCT00491764|564322429|FG005|Overall Study|Non Compliance with the Protocol|0|||
156334464|NCT00491764|564322424|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
156334465|NCT00491764|564322425|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
156334466|NCT00491764|564322426|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
156334467|NCT00491764|564322427|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
156334468|NCT00491764|564322428|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
156334469|NCT00491764|564322429|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
156334470|NCT00491764|564322424|FG000|Overall Study|Administrative|1|||
156446491|NCT04600752|564726620|FG001|Overall Study|Withdrawal by Subject|1|||
156446492|NCT04600752|564726621|FG002|Overall Study|Withdrawal by Subject|0|||
156446493|NCT04600752|564726619|FG000|Overall Study|Lack of Efficacy|1|||
156446494|NCT04600752|564726620|FG001|Overall Study|Lack of Efficacy|0|||
156446495|NCT04600752|564726621|FG002|Overall Study|Lack of Efficacy|0|||
156446496|NCT04436107|564726622|FG000|Overall Study|Sponsor Ended Study|2|||
156446497|NCT04436107|564726623|FG001|Overall Study|Sponsor Ended Study|4|||
156446498|NCT04436107|564726624|FG002|Overall Study|Sponsor Ended Study|8|||
156446499|NCT04436107|564726625|FG003|Overall Study|Sponsor Ended Study|20|||
156446500|NCT04436107|564726622|FG000|Overall Study|Death|3|||
156446501|NCT04436107|564726623|FG001|Overall Study|Death|5|||
156446502|NCT04436107|564726624|FG002|Overall Study|Death|3|||
156446503|NCT04436107|564726625|FG003|Overall Study|Death|18|||
156446504|NCT04436107|564726622|FG000|Overall Study|Withdrawal by Subject|1|||
156446505|NCT04436107|564726623|FG001|Overall Study|Withdrawal by Subject|1|||
156446506|NCT04436107|564726624|FG002|Overall Study|Withdrawal by Subject|0|||
156446507|NCT04436107|564726625|FG003|Overall Study|Withdrawal by Subject|1|||
156446508|NCT01095796|564726626|FG000|Overall Study|Randomized but Not Treated|5|||
156446509|NCT01095796|564726627|FG001|Overall Study|Randomized but Not Treated|2|||
156446510|NCT01095796|564726626|FG000|Overall Study|Adverse Event|9|||
156334471|NCT00491764|564322425|FG001|Overall Study|Administrative|0|||
156334472|NCT00491764|564322426|FG002|Overall Study|Administrative|2|||
156334473|NCT00491764|564322427|FG003|Overall Study|Administrative|1|||
156446511|NCT01095796|564726627|FG001|Overall Study|Adverse Event|19|||
156446512|NCT01095796|564726626|FG000|Overall Study|Death|3|||
156446513|NCT01095796|564726627|FG001|Overall Study|Death|2|||
156446514|NCT01095796|564726626|FG000|Overall Study|Pregnancy|2|||
156446515|NCT01095796|564726627|FG001|Overall Study|Pregnancy|0|||
156446516|NCT01095796|564726626|FG000|Overall Study|Lack of Efficacy|5|||
156446517|NCT01095796|564726627|FG001|Overall Study|Lack of Efficacy|3|||
156446518|NCT01095796|564726626|FG000|Overall Study|Investigator's Discretion|7|||
156446519|NCT01095796|564726627|FG001|Overall Study|Investigator's Discretion|2|||
156446520|NCT01095796|564726626|FG000|Overall Study|Withdrew Consent|16|||
156532957|NCT04178967|565046860|FG005|Induction Period|Lack of Efficacy|0|||
156532958|NCT04178967|565046861|FG006|Induction Period|Lack of Efficacy|0|||
156532959|NCT04178967|565046862|FG007|Induction Period|Lack of Efficacy|0|||
156532960|NCT04178967|565046863|FG008|Induction Period|Lack of Efficacy|0|||
156532961|NCT04178967|565046864|FG009|Induction Period|Lack of Efficacy|0|||
156446521|NCT01095796|564726627|FG001|Overall Study|Withdrew Consent|22|||
156446522|NCT01095796|564726626|FG000|Overall Study|Lost to Follow-up|27|||
156446523|NCT01095796|564726627|FG001|Overall Study|Lost to Follow-up|29|||
156446524|NCT01095796|564726626|FG000|Overall Study|Participant Noncompliance|5|||
156446525|NCT01095796|564726627|FG001|Overall Study|Participant Noncompliance|10|||
156446526|NCT01095796|564726626|FG000|Overall Study|Protocol Violation|1|||
156446527|NCT01095796|564726627|FG001|Overall Study|Protocol Violation|0|||
156446528|NCT01095796|564726626|FG000|Overall Study|Participant Transferred to Another Study|215|||
156446529|NCT01095796|564726627|FG001|Overall Study|Participant Transferred to Another Study|200|||
156446530|NCT05512962|564726628|FG000|Overall Study|Withdrawal by Subject|1|||
156446531|NCT05512962|564726629|FG001|Overall Study|Withdrawal by Subject|0|||
156446532|NCT04950127|564726630|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
156446533|NCT04950127|564726631|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
156446534|NCT04950127|564726632|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
156446535|NCT04950127|564726633|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
156446536|NCT04950127|564726634|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
156446537|NCT04950127|564726635|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
156446538|NCT04950127|564726630|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
156446539|NCT04950127|564726631|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
156446540|NCT04950127|564726632|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
156446541|NCT04950127|564726633|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
156446542|NCT04950127|564726634|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
156446543|NCT04950127|564726635|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
156446544|NCT04950127|564726630|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
156446545|NCT04950127|564726631|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
156446546|NCT04950127|564726632|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
156446547|NCT04950127|564726633|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
156446548|NCT04950127|564726634|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
156446549|NCT04950127|564726635|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
156446550|NCT04950127|564726630|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
156446551|NCT04950127|564726631|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
156446552|NCT04950127|564726632|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
156446553|NCT04950127|564726633|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
156446554|NCT04950127|564726634|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
156446555|NCT04950127|564726635|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
156446556|NCT04950127|564726630|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
156446557|NCT04950127|564726631|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
156446558|NCT04950127|564726632|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
156446559|NCT04950127|564726633|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
156446560|NCT04950127|564726634|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
156446561|NCT04950127|564726635|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
156446562|NCT04315181|564726636|FG000|Overall Study|Non-responsive to drug conditions.|1|||
156446563|NCT01948661|564726637|FG000|Overall Study|Withdrawal by Subject|2|||
156446564|NCT01948661|564726638|FG001|Overall Study|Withdrawal by Subject|4|||
156446565|NCT00522951|564726641|FG000|Period 1|body motion|0|||
156446566|NCT00522951|564726642|FG001|Period 1|body motion|1|||
156446567|NCT00522951|564726641|FG000|Washout Period|Adverse Event|0|||
156446568|NCT00522951|564726642|FG001|Washout Period|Adverse Event|1|||
156446569|NCT00522951|564726641|FG000|Washout Period|Death|0|||
156446570|NCT00522951|564726642|FG001|Washout Period|Death|1|||
156446571|NCT00522951|564726641|FG000|Period 2|Withdrawal by Subject|1|||
156446572|NCT00522951|564726642|FG001|Period 2|Withdrawal by Subject|0|||
156446573|NCT00522951|564726641|FG000|Period 2|residual contrast medium|1|||
156446574|NCT00522951|564726642|FG001|Period 2|residual contrast medium|1|||
156446575|NCT01101451|564726646|FG000|Overall Study|Eligible and never treated|0|||
156532962|NCT04178967|565046865|FG010|Induction Period|Lack of Efficacy|0|||
156532963|NCT04178967|565046855|FG000|Induction Period|Protocol Violation|0|||
156446576|NCT01101451|564726647|FG001|Overall Study|Eligible and never treated|5|||
156532964|NCT04178967|565046856|FG001|Induction Period|Protocol Violation|6|||
156446577|NCT01101451|564726646|FG000|Overall Study|Ineligible and treated|12|||
156446578|NCT01101451|564726647|FG001|Overall Study|Ineligible and treated|8|||
156446579|NCT01101451|564726646|FG000|Overall Study|Ineligible and never treated|2|||
156446580|NCT01101451|564726647|FG001|Overall Study|Ineligible and never treated|2|||
156446581|NCT05480943|564726648|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
156446582|NCT05480943|564726648|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
156446583|NCT05480943|564726648|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
156446584|NCT05480943|564726648|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
156532965|NCT04178967|565046857|FG002|Induction Period|Protocol Violation|0|||
156532966|NCT04178967|565046858|FG003|Induction Period|Protocol Violation|0|||
156446585|NCT02272816|564726649|FG000|Overall Study|Adverse Event|1|||
156446586|NCT04924062|564728268|FG000|Overall Study|Death|49|||
156446587|NCT04924062|564728269|FG001|Overall Study|Death|63|||
156446588|NCT04924062|564728268|FG000|Overall Study|Participant On-going|26|||
156446589|NCT04924062|564728269|FG001|Overall Study|Participant On-going|20|||
156446590|NCT03263026|564728272|FG000|Overall Study|Withdrawal by Subject|1|||
156334474|NCT00491764|564322428|FG004|Overall Study|Administrative|0|||
156334475|NCT00491764|564322429|FG005|Overall Study|Administrative|0|||
156334476|NCT00894166|564322430|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
156334477|NCT00894166|564322431|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
156334478|NCT00894166|564322432|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
156334479|NCT00894166|564322433|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
156334480|NCT00894166|564322434|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
156334481|NCT00894166|564322435|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
156334482|NCT00894166|564322436|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
156334483|NCT00894166|564322437|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
156334484|NCT00894166|564322430|FG000|Overall Study|Death|0|||
156334485|NCT00894166|564322431|FG001|Overall Study|Death|0|||
156334486|NCT00894166|564322432|FG002|Overall Study|Death|0|||
156334487|NCT00894166|564322433|FG003|Overall Study|Death|1|||
156334488|NCT00894166|564322434|FG004|Overall Study|Death|0|||
156334489|NCT00894166|564322435|FG005|Overall Study|Death|0|||
156334490|NCT00894166|564322436|FG006|Overall Study|Death|0|||
156334491|NCT00894166|564322437|FG007|Overall Study|Death|0|||
156334492|NCT05350410|564322438|FG000|Overall Study|Withdrawal by Subject|1|||
156334493|NCT01601132|564322440|FG000|Overall Study|Patient withdrew consent|1|||
156334494|NCT01601132|564322440|FG000|Overall Study|Protocol deviation|1|||
156334495|NCT02110238|564322441|FG000|12 Week Pivotal Phase|Adverse Event|3|||
156334496|NCT02110238|564322442|FG001|12 Week Pivotal Phase|Adverse Event|0|||
156334497|NCT02110238|564322441|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
156334498|NCT02110238|564322442|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
156334499|NCT02110238|564322441|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
156334500|NCT02110238|564322442|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
156334501|NCT02110238|564322441|FG000|12 Week Pivotal Phase|Physician Decision|0|||
156334502|NCT02110238|564322442|FG001|12 Week Pivotal Phase|Physician Decision|2|||
156334503|NCT02110238|564322441|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
156334504|NCT02110238|564322442|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
156334505|NCT02110238|564322441|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
156334506|NCT02110238|564322442|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
156334507|NCT02110238|564322441|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
156334508|NCT02110238|564322442|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
156334509|NCT02110238|564322441|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
156334510|NCT02110238|564322442|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
156334511|NCT02110238|564322441|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
156334512|NCT02110238|564322442|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
156334513|NCT02110238|564322441|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
156334514|NCT02110238|564322442|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
156334515|NCT02110238|564322441|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
156334516|NCT02110238|564322442|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
156334517|NCT01952145|564322443|FG000|Overall Study|Protocol Violation|2|||
156334518|NCT01952145|564322444|FG001|Overall Study|Protocol Violation|1|||
156334519|NCT01952145|564322443|FG000|Overall Study|Death|0|||
156334520|NCT01952145|564322444|FG001|Overall Study|Death|1|||
156334521|NCT01952145|564322443|FG000|Overall Study|Adverse Event|9|||
156334522|NCT01952145|564322444|FG001|Overall Study|Adverse Event|0|||
156334523|NCT01952145|564322443|FG000|Overall Study|Withdrawal Criteria|16|||
156334524|NCT01952145|564322444|FG001|Overall Study|Withdrawal Criteria|11|||
156334525|NCT01952145|564322443|FG000|Overall Study|Unclassified|1|||
156334526|NCT01952145|564322444|FG001|Overall Study|Unclassified|1|||
156334527|NCT00619177|564322449|FG000|Overall Study|Adverse Event|18|||
156334528|NCT00619177|564322449|FG000|Overall Study|Lost to Follow-up|2|||
156334529|NCT00619177|564322449|FG000|Overall Study|Lack of Efficacy|1|||
156334530|NCT00619177|564322449|FG000|Overall Study|Missing termination information|481|||
156334531|NCT00619177|564322449|FG000|Overall Study|Not specified reasons|6|||
156716297|NCT01125189|565705321|FG000|Treatment Period|Poor compliance/noncompliance|0|||
156334532|NCT01297920|564322452|FG000|Overall Study|Adverse Event|42|||
156334533|NCT01297920|564322453|FG001|Overall Study|Adverse Event|10|||
156716298|NCT01125189|565705322|FG001|Treatment Period|Poor compliance/noncompliance|1|||
156334534|NCT01297920|564322454|FG002|Overall Study|Adverse Event|38|||
156334535|NCT01297920|564322452|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
156334536|NCT01297920|564322453|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
156334537|NCT01297920|564322454|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
156334538|NCT01297920|564322452|FG000|Overall Study|Noncompliance|1|||
156334539|NCT01297920|564322453|FG001|Overall Study|Noncompliance|0|||
156334540|NCT01297920|564322454|FG002|Overall Study|Noncompliance|0|||
156446591|NCT03263026|564728273|FG001|Overall Study|Withdrawal by Subject|0|||
156793218|NCT00974233|565994892|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
156532967|NCT04178967|565046859|FG004|Induction Period|Protocol Violation|0|||
156532968|NCT04178967|565046860|FG005|Induction Period|Protocol Violation|0|||
156532969|NCT04178967|565046861|FG006|Induction Period|Protocol Violation|0|||
156532970|NCT04178967|565046862|FG007|Induction Period|Protocol Violation|0|||
156532971|NCT04178967|565046863|FG008|Induction Period|Protocol Violation|0|||
156532972|NCT04178967|565046864|FG009|Induction Period|Protocol Violation|0|||
156532973|NCT04178967|565046865|FG010|Induction Period|Protocol Violation|0|||
156532974|NCT04178967|565046855|FG000|Induction Period|Withdrawal by Subject|6|||
156532975|NCT04178967|565046856|FG001|Induction Period|Withdrawal by Subject|4|||
156532976|NCT04178967|565046857|FG002|Induction Period|Withdrawal by Subject|0|||
156532977|NCT04178967|565046858|FG003|Induction Period|Withdrawal by Subject|0|||
156532978|NCT04178967|565046859|FG004|Induction Period|Withdrawal by Subject|0|||
156532979|NCT04178967|565046860|FG005|Induction Period|Withdrawal by Subject|0|||
156532980|NCT04178967|565046861|FG006|Induction Period|Withdrawal by Subject|0|||
156532981|NCT04178967|565046862|FG007|Induction Period|Withdrawal by Subject|0|||
156532982|NCT04178967|565046863|FG008|Induction Period|Withdrawal by Subject|0|||
156532983|NCT04178967|565046864|FG009|Induction Period|Withdrawal by Subject|0|||
156532984|NCT04178967|565046865|FG010|Induction Period|Withdrawal by Subject|0|||
156532985|NCT04178967|565046855|FG000|Induction Period|Lost to Follow-up|2|||
156532986|NCT04178967|565046856|FG001|Induction Period|Lost to Follow-up|0|||
156532987|NCT04178967|565046857|FG002|Induction Period|Lost to Follow-up|0|||
156532988|NCT04178967|565046858|FG003|Induction Period|Lost to Follow-up|0|||
156532989|NCT04178967|565046859|FG004|Induction Period|Lost to Follow-up|0|||
156532990|NCT04178967|565046860|FG005|Induction Period|Lost to Follow-up|0|||
156532991|NCT04178967|565046861|FG006|Induction Period|Lost to Follow-up|0|||
156532992|NCT04178967|565046862|FG007|Induction Period|Lost to Follow-up|0|||
156532993|NCT04178967|565046863|FG008|Induction Period|Lost to Follow-up|0|||
156532994|NCT04178967|565046864|FG009|Induction Period|Lost to Follow-up|0|||
156532995|NCT04178967|565046865|FG010|Induction Period|Lost to Follow-up|0|||
156532996|NCT04178967|565046855|FG000|Induction Period|Participant Missed Study Visits|0|||
156532997|NCT04178967|565046856|FG001|Induction Period|Participant Missed Study Visits|1|||
156532998|NCT04178967|565046857|FG002|Induction Period|Participant Missed Study Visits|0|||
156532999|NCT04178967|565046858|FG003|Induction Period|Participant Missed Study Visits|0|||
156533000|NCT04178967|565046859|FG004|Induction Period|Participant Missed Study Visits|0|||
156793219|NCT00974233|565994892|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
156793220|NCT00974233|565994892|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
156793221|NCT00974233|565994892|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
156793222|NCT00974233|565994892|FG000|Maintenance Lenalidomide|Adverse Event|8|||
156793223|NCT01691092|565994893|FG000|Overall Study|Lost to Follow-up|10|||
156793224|NCT01691092|565994893|FG000|Overall Study|Physician Decision|4|||
156793225|NCT01691092|565994893|FG000|Overall Study|Withdrawal by Subject|3|||
156793226|NCT01691092|565994893|FG000|Overall Study|non-compliance|3|||
156533001|NCT04178967|565046860|FG005|Induction Period|Participant Missed Study Visits|0|||
156533002|NCT04178967|565046861|FG006|Induction Period|Participant Missed Study Visits|0|||
156533003|NCT04178967|565046862|FG007|Induction Period|Participant Missed Study Visits|0|||
156533004|NCT04178967|565046863|FG008|Induction Period|Participant Missed Study Visits|0|||
156533005|NCT04178967|565046864|FG009|Induction Period|Participant Missed Study Visits|0|||
156533006|NCT04178967|565046865|FG010|Induction Period|Participant Missed Study Visits|0|||
156533007|NCT04178967|565046855|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
156533008|NCT04178967|565046856|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
156533009|NCT04178967|565046857|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
156533010|NCT04178967|565046858|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
156533011|NCT04178967|565046859|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
156533012|NCT04178967|565046860|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
156533013|NCT04178967|565046861|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
156533014|NCT04178967|565046862|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
156533015|NCT04178967|565046863|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
156533016|NCT04178967|565046864|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
156533017|NCT04178967|565046865|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
156533018|NCT04178967|565046855|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156533019|NCT04178967|565046856|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156793227|NCT01691092|565994893|FG000|Overall Study|used for different study|2|||
156533020|NCT04178967|565046857|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156533021|NCT04178967|565046858|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156793228|NCT01691092|565994893|FG000|Overall Study|screen fail|19|||
156533022|NCT04178967|565046859|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156533023|NCT04178967|565046860|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
156533024|NCT04178967|565046861|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156533025|NCT04178967|565046862|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156793229|NCT00581100|565996189|FG000|Overall Study|Death|1|||
156793230|NCT00581100|565996190|FG001|Overall Study|Death|0|||
156446592|NCT03263026|564728272|FG000|Overall Study|Death|1|||
156446593|NCT03263026|564728273|FG001|Overall Study|Death|0|||
156446594|NCT03263026|564728272|FG000|Overall Study|Other/ Various|41|||
156334541|NCT01297920|564322452|FG000|Overall Study|Protocol Violation|1|||
156334542|NCT01297920|564322453|FG001|Overall Study|Protocol Violation|3|||
156334543|NCT01297920|564322454|FG002|Overall Study|Protocol Violation|0|||
156334544|NCT01297920|564322452|FG000|Overall Study|Inadequate Control of IOP|7|||
156446595|NCT03263026|564728273|FG001|Overall Study|Other/ Various|29|||
156446596|NCT04823611|564728276|FG000|Overall Study|Adverse Event|2|||
156446597|NCT04823611|564728277|FG001|Overall Study|Adverse Event|0|||
156446598|NCT04823611|564728278|FG002|Overall Study|Adverse Event|1|||
156446599|NCT04823611|564728279|FG003|Overall Study|Adverse Event|0|||
156446600|NCT04823611|564728280|FG004|Overall Study|Adverse Event|0|||
156446601|NCT04823611|564728281|FG005|Overall Study|Adverse Event|0|||
156446602|NCT04823611|564728282|FG006|Overall Study|Adverse Event|0|||
156446603|NCT05320432|564728283|FG000|Overall Study|Withdrawal by Subject|0|||
156446604|NCT05320432|564728284|FG001|Overall Study|Withdrawal by Subject|2|||
156446605|NCT01707030|564728296|FG000|Overall Study|Death|1|||
156446606|NCT01707030|564728297|FG001|Overall Study|Death|1|||
156446607|NCT01707030|564728296|FG000|Overall Study|Withdrawal by Subject|2|||
156446608|NCT01707030|564728297|FG001|Overall Study|Withdrawal by Subject|3|||
156446609|NCT01707030|564728296|FG000|Overall Study|Lost to Follow-up|8|||
156446610|NCT01707030|564728297|FG001|Overall Study|Lost to Follow-up|13|||
156446611|NCT05415410|564728298|FG000|Overall Study|Death|3|||
156446612|NCT05415410|564728299|FG001|Overall Study|Death|6|||
156446613|NCT05415410|564728300|FG002|Overall Study|Death|1|||
156446614|NCT05415410|564728298|FG000|Overall Study|Trial Terminated by Sponsor|1|||
156446615|NCT05415410|564728299|FG001|Overall Study|Trial Terminated by Sponsor|5|||
156446616|NCT05415410|564728300|FG002|Overall Study|Trial Terminated by Sponsor|0|||
156446617|NCT05415410|564728298|FG000|Overall Study|Adverse Event|2|||
156446618|NCT05415410|564728299|FG001|Overall Study|Adverse Event|1|||
156446619|NCT05415410|564728300|FG002|Overall Study|Adverse Event|0|||
156446620|NCT05415410|564728298|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
156446621|NCT05415410|564728299|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
156446622|NCT05415410|564728300|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
156446623|NCT05415410|564728298|FG000|Overall Study|Withdrawal by Subject|1|||
156446624|NCT05415410|564728299|FG001|Overall Study|Withdrawal by Subject|0|||
156446625|NCT05415410|564728300|FG002|Overall Study|Withdrawal by Subject|0|||
156446626|NCT05415410|564728298|FG000|Overall Study|Pregnancy|5|||
156446627|NCT05415410|564728299|FG001|Overall Study|Pregnancy|2|||
156446628|NCT05415410|564728300|FG002|Overall Study|Pregnancy|0|||
156446629|NCT04437433|564728301|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
156446630|NCT04437433|564728302|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
156446631|NCT04437433|564728301|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
156446632|NCT04437433|564728302|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
156446633|NCT04437433|564728301|FG000|Overall Study|Adverse Event|9|||
156446634|NCT04437433|564728302|FG001|Overall Study|Adverse Event|0|||
156446635|NCT04437433|564728301|FG000|Overall Study|Lack of Efficacy|4|||
156446636|NCT04437433|564728302|FG001|Overall Study|Lack of Efficacy|0|||
156334545|NCT01297920|564322453|FG001|Overall Study|Inadequate Control of IOP|9|||
156334546|NCT01297920|564322454|FG002|Overall Study|Inadequate Control of IOP|17|||
156334547|NCT01297920|564322452|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
156334548|NCT01297920|564322453|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
156334549|NCT01297920|564322454|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
156334550|NCT03212690|564322455|FG000|Overall Study|Protocol Violation|1|||
156334551|NCT00474760|564322456|FG000|Overall Study|Death|0|||
156334552|NCT00474760|564322457|FG001|Overall Study|Death|0|||
156334553|NCT00474760|564322458|FG002|Overall Study|Death|0|||
156334554|NCT00474760|564322459|FG003|Overall Study|Death|0|||
156334555|NCT00474760|564322460|FG004|Overall Study|Death|2|||
156334556|NCT00474760|564322461|FG005|Overall Study|Death|0|||
156334557|NCT00474760|564322462|FG006|Overall Study|Death|0|||
156446637|NCT04437433|564728301|FG000|Overall Study|Withdrawal by Subject|4|||
156446638|NCT04437433|564728302|FG001|Overall Study|Withdrawal by Subject|1|||
156334558|NCT00474760|564322456|FG000|Overall Study|Adverse Event|0|||
156334559|NCT00474760|564322457|FG001|Overall Study|Adverse Event|0|||
156446639|NCT04437433|564728301|FG000|Overall Study|Protocol Deviation|0|||
156446640|NCT04437433|564728302|FG001|Overall Study|Protocol Deviation|1|||
156446641|NCT04437433|564728301|FG000|Overall Study|Other, not specified|0|||
156334560|NCT00474760|564322458|FG002|Overall Study|Adverse Event|0|||
156334561|NCT00474760|564322459|FG003|Overall Study|Adverse Event|0|||
156334562|NCT00474760|564322460|FG004|Overall Study|Adverse Event|1|||
156334563|NCT00474760|564322461|FG005|Overall Study|Adverse Event|7|||
156334564|NCT00474760|564322462|FG006|Overall Study|Adverse Event|0|||
156446642|NCT04437433|564728302|FG001|Overall Study|Other, not specified|1|||
156446643|NCT04791709|564728303|FG000|Overall Study|Withdrawal by Subject|3|||
156446644|NCT00650104|564728304|FG000|Overall Study|Adverse Event|17|||
156446645|NCT00650104|564728304|FG000|Overall Study|Death|2|||
156793231|NCT00581100|565996189|FG000|Overall Study|Adverse Event|2|||
156446646|NCT00650104|564728304|FG000|Overall Study|Withdrawal by Subject|11|||
156446647|NCT00650104|564728304|FG000|Overall Study|Physician Decision|7|||
156446648|NCT00650104|564728304|FG000|Overall Study|Lost to Follow-up|1|||
156446649|NCT00650104|564728304|FG000|Overall Study|Non-compliance|2|||
156446650|NCT00650104|564728304|FG000|Overall Study|Sponsor Terminated Dosing|1|||
156446651|NCT03385629|564728305|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
156446652|NCT03385629|564728306|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
156446653|NCT03385629|564728305|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
156446654|NCT03385629|564728306|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
156446655|NCT03385629|564728305|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
156446656|NCT03385629|564728306|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
156446657|NCT01532388|564728307|FG000|3-month Follow-up|Lost to Follow-up|68|||
156446658|NCT01532388|564728308|FG001|3-month Follow-up|Lost to Follow-up|68|||
156446659|NCT01532388|564728307|FG000|6-month Follow-up|Lost to Follow-up|74|||
156446660|NCT01532388|564728308|FG001|6-month Follow-up|Lost to Follow-up|66|||
156446661|NCT01532388|564728307|FG000|12-month Follow-up|Lost to Follow-up|69|||
156446662|NCT01532388|564728308|FG001|12-month Follow-up|Lost to Follow-up|67|||
156446663|NCT00792636|564728309|FG000|Overall Study|Protocol Violation|17|||
156446664|NCT00792636|564728310|FG001|Overall Study|Protocol Violation|23|||
156446665|NCT00792636|564728311|FG002|Overall Study|Protocol Violation|20|||
156446666|NCT00792636|564728309|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
156446667|NCT00792636|564728310|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
156446668|NCT00792636|564728311|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
156446669|NCT00792636|564728309|FG000|Overall Study|Lost to Follow-up|13|||
156446670|NCT00792636|564728310|FG001|Overall Study|Lost to Follow-up|19|||
156446671|NCT00792636|564728311|FG002|Overall Study|Lost to Follow-up|14|||
156446672|NCT00792636|564728309|FG000|Overall Study|Withdrew Consent|10|||
156446673|NCT00792636|564728310|FG001|Overall Study|Withdrew Consent|13|||
156446674|NCT00792636|564728311|FG002|Overall Study|Withdrew Consent|9|||
156446675|NCT00792636|564728309|FG000|Overall Study|Lack of Efficacy|3|||
156446676|NCT00792636|564728310|FG001|Overall Study|Lack of Efficacy|4|||
156446677|NCT00792636|564728311|FG002|Overall Study|Lack of Efficacy|13|||
156446678|NCT00792636|564728309|FG000|Overall Study|Adverse Event|4|||
156446679|NCT00792636|564728310|FG001|Overall Study|Adverse Event|2|||
156446680|NCT00792636|564728311|FG002|Overall Study|Adverse Event|3|||
156446681|NCT00792636|564728309|FG000|Overall Study|Investigator Discretion|2|||
156446682|NCT00792636|564728310|FG001|Overall Study|Investigator Discretion|0|||
156446683|NCT00792636|564728311|FG002|Overall Study|Investigator Discretion|2|||
156446684|NCT04711135|564728315|FG000|Overall Study|Physician Decision|0|||
156446685|NCT04711135|564728316|FG001|Overall Study|Physician Decision|1|||
156446686|NCT04711135|564728315|FG000|Overall Study|Ongoing treatment|0|||
156446687|NCT04711135|564728316|FG001|Overall Study|Ongoing treatment|1|||
156446688|NCT03578536|564728322|FG000|Overall Study|Lost to Follow-up|1|||
156446689|NCT02538900|564728323|FG000|Overall Study|Death|2|||
156446690|NCT02538900|564728324|FG001|Overall Study|Death|2|||
156446691|NCT02538900|564728325|FG002|Overall Study|Death|2|||
156446692|NCT02538900|564728323|FG000|Overall Study|Withdrawal by Subject|18|||
156446693|NCT02538900|564728324|FG001|Overall Study|Withdrawal by Subject|16|||
156446694|NCT02538900|564728325|FG002|Overall Study|Withdrawal by Subject|15|||
156446695|NCT04431726|564728326|FG000|Overall Study|Ongoing in the Study|55|||
156446696|NCT00999167|564728329|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
156446697|NCT00999167|564728330|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
156446698|NCT00999167|564728331|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
156446699|NCT00999167|564728329|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
156446700|NCT00999167|564728330|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
156446701|NCT00999167|564728331|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
156446702|NCT00999167|564728329|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
156446703|NCT00999167|564728330|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
156446704|NCT00999167|564728331|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
156446705|NCT00999167|564728329|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
156446706|NCT00999167|564728330|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
156446707|NCT00999167|564728331|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
156446708|NCT00999167|564728329|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
156446709|NCT00999167|564728330|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
156446710|NCT00999167|564728331|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
156446711|NCT00999167|564728329|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
156793232|NCT00581100|565996190|FG001|Overall Study|Adverse Event|1|||
156446712|NCT00999167|564728330|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
156446713|NCT00999167|564728331|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
156533026|NCT04178967|565046863|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156446714|NCT00999167|564728329|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
156793233|NCT00581100|565996189|FG000|Overall Study|Withdrawal by Subject|1|||
156446715|NCT00999167|564728330|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
156446716|NCT00999167|564728331|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
156446717|NCT00999167|564728329|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
156446718|NCT00999167|564728330|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
156446719|NCT00999167|564728331|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
156446720|NCT02789020|564728332|FG000|Overall Study|Withdrawal by Subject|6|||
156334565|NCT00474760|564322456|FG000|Overall Study|Laboratory abnormality|0|||
156334566|NCT00474760|564322457|FG001|Overall Study|Laboratory abnormality|0|||
156334567|NCT00474760|564322458|FG002|Overall Study|Laboratory abnormality|0|||
156334568|NCT00474760|564322459|FG003|Overall Study|Laboratory abnormality|0|||
156334569|NCT00474760|564322460|FG004|Overall Study|Laboratory abnormality|0|||
156334570|NCT00474760|564322461|FG005|Overall Study|Laboratory abnormality|1|||
156334571|NCT00474760|564322462|FG006|Overall Study|Laboratory abnormality|0|||
156334572|NCT00474760|564322456|FG000|Overall Study|Withdrawal by Subject|0|||
156334573|NCT00474760|564322457|FG001|Overall Study|Withdrawal by Subject|0|||
156334574|NCT00474760|564322458|FG002|Overall Study|Withdrawal by Subject|0|||
156334575|NCT00474760|564322459|FG003|Overall Study|Withdrawal by Subject|1|||
156334576|NCT00474760|564322460|FG004|Overall Study|Withdrawal by Subject|0|||
156334577|NCT00474760|564322461|FG005|Overall Study|Withdrawal by Subject|1|||
156334578|NCT00474760|564322462|FG006|Overall Study|Withdrawal by Subject|1|||
156334579|NCT00474760|564322456|FG000|Overall Study|Other|0|||
156446721|NCT02789020|564728333|FG001|Overall Study|Withdrawal by Subject|5|||
156446722|NCT04238247|564728336|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
156446723|NCT04238247|564728337|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
156334580|NCT00474760|564322457|FG001|Overall Study|Other|1|||
156334581|NCT00474760|564322458|FG002|Overall Study|Other|0|||
156334582|NCT00474760|564322459|FG003|Overall Study|Other|0|||
156334583|NCT00474760|564322460|FG004|Overall Study|Other|1|||
156334584|NCT00474760|564322461|FG005|Overall Study|Other|0|||
156334585|NCT00474760|564322462|FG006|Overall Study|Other|0|||
156334586|NCT00474760|564322456|FG000|Overall Study|Progressive disease|3|||
156334587|NCT00474760|564322457|FG001|Overall Study|Progressive disease|2|||
156334588|NCT00474760|564322458|FG002|Overall Study|Progressive disease|3|||
156334589|NCT00474760|564322459|FG003|Overall Study|Progressive disease|2|||
156334590|NCT00474760|564322460|FG004|Overall Study|Progressive disease|8|||
156334591|NCT00474760|564322461|FG005|Overall Study|Progressive disease|20|||
156334592|NCT00474760|564322462|FG006|Overall Study|Progressive disease|7|||
156334593|NCT00474760|564322456|FG000|Overall Study|Terminated by sponsor|0|||
156334594|NCT00474760|564322457|FG001|Overall Study|Terminated by sponsor|0|||
156334595|NCT00474760|564322458|FG002|Overall Study|Terminated by sponsor|0|||
156334596|NCT00474760|564322459|FG003|Overall Study|Terminated by sponsor|0|||
156334597|NCT00474760|564322460|FG004|Overall Study|Terminated by sponsor|0|||
156334598|NCT00474760|564322461|FG005|Overall Study|Terminated by sponsor|0|||
156334599|NCT00474760|564322462|FG006|Overall Study|Terminated by sponsor|2|||
156334600|NCT00788073|564322463|FG000|STX209 Then Placebo|Adverse Event|1|||
156334601|NCT00788073|564322464|FG001|STX209 Then Placebo|Adverse Event|0|||
156334602|NCT00788073|564322463|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
156334603|NCT00788073|564322464|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
156334604|NCT00788073|564322463|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
156334605|NCT00788073|564322464|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
156334606|NCT00788073|564322463|FG000|STX209 Then Placebo|unable to return due to travel|0|||
156334607|NCT00788073|564322464|FG001|STX209 Then Placebo|unable to return due to travel|1|||
156334608|NCT00788073|564322463|FG000|Placebo Then STX209|Adverse Event|2|||
156334609|NCT00788073|564322464|FG001|Placebo Then STX209|Adverse Event|0|||
156334610|NCT00788073|564322463|FG000|Placebo Then STX209|Protocol Violation|0|||
156334611|NCT00788073|564322464|FG001|Placebo Then STX209|Protocol Violation|1|||
156334612|NCT01346969|564322465|FG000|Overall Study|Withdrawal by Subject|0|||
156334613|NCT01346969|564322466|FG001|Overall Study|Withdrawal by Subject|0|||
156334614|NCT01346969|564322467|FG002|Overall Study|Withdrawal by Subject|1|||
156334615|NCT01346969|564322468|FG003|Overall Study|Withdrawal by Subject|0|||
156446724|NCT04238247|564728338|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
156446725|NCT04238247|564728339|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
156446726|NCT04238247|564728336|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
156446727|NCT04238247|564728337|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
156334616|NCT01346969|564322465|FG000|Overall Study|Lost to Follow-up|1|||
156334617|NCT01346969|564322466|FG001|Overall Study|Lost to Follow-up|0|||
156334618|NCT01346969|564322467|FG002|Overall Study|Lost to Follow-up|2|||
156334619|NCT01346969|564322468|FG003|Overall Study|Lost to Follow-up|0|||
156334620|NCT01346969|564322465|FG000|Overall Study|Physician Decision|0|||
156334621|NCT01346969|564322466|FG001|Overall Study|Physician Decision|0|||
156334622|NCT01346969|564322467|FG002|Overall Study|Physician Decision|0|||
156334623|NCT01346969|564322468|FG003|Overall Study|Physician Decision|1|||
156334624|NCT01346969|564322465|FG000|Overall Study|Randomized but not treated|1|||
156334625|NCT01346969|564322466|FG001|Overall Study|Randomized but not treated|0|||
156334626|NCT01346969|564322467|FG002|Overall Study|Randomized but not treated|0|||
156716299|NCT01125189|565705323|FG002|Treatment Period|Poor compliance/noncompliance|0|||
156716300|NCT01125189|565705321|FG000|Treatment Period|Participants requested to discontinue|1|||
156716301|NCT01125189|565705322|FG001|Treatment Period|Participants requested to discontinue|3|||
156716302|NCT01125189|565705323|FG002|Treatment Period|Participants requested to discontinue|4|||
156446728|NCT04238247|564728338|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
156446729|NCT04238247|564728339|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
156446730|NCT04238247|564728336|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
156446731|NCT04238247|564728337|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
156446732|NCT04238247|564728338|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
156446733|NCT04238247|564728339|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
156446734|NCT04238247|564728336|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
156446735|NCT04238247|564728337|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
156446736|NCT04238247|564728338|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
156446737|NCT04238247|564728339|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
156446738|NCT01711632|564728340|FG000|Overall Study|Adverse Event|4|||
156446739|NCT01711632|564728340|FG000|Overall Study|Death|3|||
156446740|NCT01711632|564728340|FG000|Overall Study|Lost to Follow-up|3|||
156446741|NCT01711632|564728340|FG000|Overall Study|Withdrawal by Subject|4|||
156446742|NCT01711632|564728340|FG000|Overall Study|Progressive disease|2|||
156446743|NCT01711632|564728340|FG000|Overall Study|No follow up required in re-treatment|3|||
156446744|NCT01711632|564728340|FG000|Overall Study|No follow up required in re-treatment|3|||
156446745|NCT03517969|564728341|FG000|Overall Study|Never started protocol treatment|3|||
156446746|NCT03517969|564728342|FG001|Overall Study|Never started protocol treatment|5|||
156446747|NCT03517969|564728341|FG000|Overall Study|Disease progression|11|||
156446748|NCT03517969|564728342|FG001|Overall Study|Disease progression|16|||
156446749|NCT03517969|564728341|FG000|Overall Study|PSA progression|8|||
156446750|NCT03517969|564728342|FG001|Overall Study|PSA progression|1|||
156446751|NCT03517969|564728341|FG000|Overall Study|Clinical progression|4|||
156446752|NCT03517969|564728342|FG001|Overall Study|Clinical progression|2|||
156446753|NCT03517969|564728341|FG000|Overall Study|Adverse Event|5|||
156446754|NCT03517969|564728342|FG001|Overall Study|Adverse Event|4|||
156446755|NCT03517969|564728341|FG000|Overall Study|Intercurrent illness|1|||
156446756|NCT03517969|564728342|FG001|Overall Study|Intercurrent illness|2|||
156446757|NCT03517969|564728341|FG000|Overall Study|Death|1|||
156446758|NCT03517969|564728342|FG001|Overall Study|Death|1|||
156446759|NCT03517969|564728341|FG000|Overall Study|Withdrawal by Subject|1|||
156446760|NCT03517969|564728342|FG001|Overall Study|Withdrawal by Subject|2|||
156446761|NCT03517969|564728341|FG000|Overall Study|Physician Decision|1|||
156446762|NCT03517969|564728342|FG001|Overall Study|Physician Decision|1|||
156446763|NCT03517969|564728341|FG000|Overall Study|No clinical benefit|1|||
156446764|NCT03517969|564728342|FG001|Overall Study|No clinical benefit|0|||
156446765|NCT03517969|564728341|FG000|Overall Study|Delayed treatment for dental treatment|1|||
156446766|NCT03517969|564728342|FG001|Overall Study|Delayed treatment for dental treatment|0|||
156446767|NCT03517969|564728341|FG000|Overall Study|Difficult to maintain appointment|0|||
156446768|NCT03517969|564728342|FG001|Overall Study|Difficult to maintain appointment|1|||
156446769|NCT03517969|564728341|FG000|Overall Study|Protocol Violation|0|||
156446770|NCT03517969|564728342|FG001|Overall Study|Protocol Violation|1|||
156446771|NCT02860130|564728343|FG000|Overall Study|Adverse Event|2|||
156446772|NCT02860130|564728344|FG001|Overall Study|Adverse Event|3|||
156446773|NCT02860130|564728343|FG000|Overall Study|Protocol Violation|1|||
156446774|NCT02860130|564728344|FG001|Overall Study|Protocol Violation|1|||
156446775|NCT02860130|564728343|FG000|Overall Study|Withdrawal by Subject|0|||
156446776|NCT02860130|564728344|FG001|Overall Study|Withdrawal by Subject|2|||
156446777|NCT02860130|564728343|FG000|Overall Study|Physician Decision|2|||
156446778|NCT02860130|564728344|FG001|Overall Study|Physician Decision|2|||
156446779|NCT02860130|564728343|FG000|Overall Study|Other|2|||
156446780|NCT02860130|564728344|FG001|Overall Study|Other|1|||
156446781|NCT02140645|564728347|FG000|Overall Study|Not linked|5489|||
156446782|NCT02140645|564728348|FG001|Overall Study|Not linked|61654|||
156446783|NCT02140645|564728349|FG002|Overall Study|Not linked|4236|||
156446784|NCT02140645|564728350|FG003|Overall Study|Not linked|13833|||
156446785|NCT02140645|564728351|FG004|Overall Study|Not linked|3286|||
156446786|NCT02140645|564728352|FG005|Overall Study|Not linked|70896|||
156446787|NCT02794480|564728353|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
156446788|NCT02794480|564728354|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
156446789|NCT02794480|564728355|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
156446790|NCT02794480|564728356|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
156446791|NCT02794480|564728353|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
156446792|NCT02794480|564728354|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
156446793|NCT02794480|564728355|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
156446794|NCT02794480|564728356|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
156446795|NCT02794480|564728353|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156446796|NCT02794480|564728354|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156446797|NCT02794480|564728355|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156446798|NCT02794480|564728356|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
156446799|NCT02794480|564728353|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156446800|NCT02794480|564728354|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
156446801|NCT02794480|564728355|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156446802|NCT02794480|564728356|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
156446803|NCT02794480|564728353|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
156446804|NCT02794480|564728354|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156446805|NCT02794480|564728355|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156446806|NCT02794480|564728356|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
156446807|NCT00593489|564728357|FG000|Allocation|did not attend workshop; allocation not|2|||
156446808|NCT00593489|564728358|FG001|Allocation|did not attend workshop; allocation not|1|||
156716303|NCT01125189|565705321|FG000|Treatment Period|Other reasons|1|||
156716304|NCT01125189|565705322|FG001|Treatment Period|Other reasons|1|||
156716305|NCT01125189|565705323|FG002|Treatment Period|Other reasons|0|||
156793234|NCT00581100|565996190|FG001|Overall Study|Withdrawal by Subject|4|||
156793235|NCT00581100|565996189|FG000|Overall Study|Other|3|||
156793236|NCT00581100|565996190|FG001|Overall Study|Other|0|||
156793237|NCT04129398|565996191|FG000|Overall Study|Physician Decision|2|||
156793238|NCT00590317|565996192|FG000|Overall Study|Lack of Efficacy|1|||
156793239|NCT00590317|565996193|FG001|Overall Study|Lack of Efficacy|5|||
156793240|NCT02904265|565996194|FG000|Overall Study|Physician Decision|1|||
156793241|NCT02904265|565996195|FG001|Overall Study|Physician Decision|2|||
156793242|NCT00185614|565996198|FG000|Inter-treatment Period|Physician Decision|1|||
156793243|NCT00185614|565996198|FG000|Inter-treatment Period|Relapse|2|||
156793244|NCT00185614|565996198|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
156793245|NCT00866775|565996208|FG000|Overall Study|Adverse Event|5|||
156793246|NCT00866775|565996209|FG001|Overall Study|Adverse Event|19|||
156793247|NCT00866775|565996208|FG000|Overall Study|Death|1|||
156793248|NCT00866775|565996209|FG001|Overall Study|Death|0|||
156793249|NCT00866775|565996208|FG000|Overall Study|Lost to Follow-up|0|||
156793250|NCT00866775|565996209|FG001|Overall Study|Lost to Follow-up|4|||
156793251|NCT00866775|565996208|FG000|Overall Study|Physician Decision|0|||
156793252|NCT00866775|565996209|FG001|Overall Study|Physician Decision|3|||
156793253|NCT00866775|565996208|FG000|Overall Study|Protocol Violation|3|||
156793254|NCT00866775|565996209|FG001|Overall Study|Protocol Violation|4|||
156793255|NCT00866775|565996208|FG000|Overall Study|Withdrawal by Subject|4|||
156793256|NCT00866775|565996209|FG001|Overall Study|Withdrawal by Subject|4|||
156793257|NCT00866775|565996208|FG000|Overall Study|met exit criteria|23|||
156793258|NCT00866775|565996209|FG001|Overall Study|met exit criteria|17|||
156793259|NCT00866775|565996208|FG000|Overall Study|discontinued due to communication error|0|||
156793260|NCT00866775|565996209|FG001|Overall Study|discontinued due to communication error|1|||
156793261|NCT00003907|565996210|FG000|Overall Study|Adverse Event|2|||
156793262|NCT00003907|565996211|FG001|Overall Study|Adverse Event|11|||
156793263|NCT00003907|565996210|FG000|Overall Study|Death|2|||
156793264|NCT00003907|565996211|FG001|Overall Study|Death|0|||
156793265|NCT00003907|565996210|FG000|Overall Study|Withdrawal by Subject|1|||
156793266|NCT00003907|565996211|FG001|Overall Study|Withdrawal by Subject|3|||
156793267|NCT00003907|565996210|FG000|Overall Study|Progressive disease|4|||
156793268|NCT00003907|565996211|FG001|Overall Study|Progressive disease|4|||
156793269|NCT00003907|565996210|FG000|Overall Study|Complicating disease|1|||
156793270|NCT00003907|565996211|FG001|Overall Study|Complicating disease|0|||
156793271|NCT00003907|565996210|FG000|Overall Study|Other|1|||
156793272|NCT00003907|565996211|FG001|Overall Study|Other|3|||
156793273|NCT00003907|565996210|FG000|Overall Study|ineligible or not treated|2|||
156793274|NCT00003907|565996211|FG001|Overall Study|ineligible or not treated|2|||
156793275|NCT02439957|565996214|FG000|Overall Study|Study Terminated|3|||
156446809|NCT01747486|564728359|FG000|Stage 1|Physician Decision|3|||
156446810|NCT01747486|564728360|FG001|Stage 1|Physician Decision|0|||
156716306|NCT01125189|565705321|FG000|Treatment Period|Completed 24 week treatment period only|2|||
156716307|NCT01125189|565705322|FG001|Treatment Period|Completed 24 week treatment period only|1|||
156716308|NCT01125189|565705323|FG002|Treatment Period|Completed 24 week treatment period only|2|||
156716309|NCT01125189|565705321|FG000|Follow up Period|Withdrawal by Subject|3|||
156716310|NCT01125189|565705322|FG001|Follow up Period|Withdrawal by Subject|2|||
156716311|NCT01125189|565705323|FG002|Follow up Period|Withdrawal by Subject|5|||
156716312|NCT01125189|565705321|FG000|Follow up Period|Death|1|||
156716313|NCT01125189|565705322|FG001|Follow up Period|Death|0|||
156716314|NCT01125189|565705323|FG002|Follow up Period|Death|0|||
156716315|NCT01125189|565705321|FG000|Follow up Period|Lost to Follow-up|12|||
156716316|NCT01125189|565705322|FG001|Follow up Period|Lost to Follow-up|9|||
156716317|NCT01125189|565705323|FG002|Follow up Period|Lost to Follow-up|6|||
156793276|NCT02439957|565996215|FG001|Overall Study|Study Terminated|3|||
156793277|NCT00586157|565996216|FG000|First Intervention|Worsening behavior|1|||
156793278|NCT00586157|565996217|FG001|First Intervention|Worsening behavior|0|||
156793279|NCT00586157|565996216|FG000|Second Intervention|Withdrawal by Subject|1|||
156793280|NCT00586157|565996217|FG001|Second Intervention|Withdrawal by Subject|0|||
156793281|NCT00586157|565996216|FG000|Second Intervention|Worsening behavior|1|||
156446811|NCT01747486|564728359|FG000|Stage 1|Withdrawal by Subject|4|||
156446812|NCT01747486|564728360|FG001|Stage 1|Withdrawal by Subject|3|||
156446813|NCT01747486|564728359|FG000|Stage 1|Disease progression|4|||
156446814|NCT01747486|564728360|FG001|Stage 1|Disease progression|9|||
156446815|NCT01747486|564728359|FG000|Stage 1|Death|1|||
156446816|NCT01747486|564728360|FG001|Stage 1|Death|1|||
156446817|NCT01747486|564728359|FG000|Stage 2|Physician Decision|2|||
156446818|NCT01747486|564728360|FG001|Stage 2|Physician Decision|0|||
156446819|NCT01747486|564728359|FG000|Stage 2|Withdrawal by Subject|1|||
156446820|NCT01747486|564728360|FG001|Stage 2|Withdrawal by Subject|0|||
156446821|NCT01747486|564728359|FG000|Stage 2|New Cancer Therapy|3|||
156446822|NCT01747486|564728360|FG001|Stage 2|New Cancer Therapy|0|||
156446823|NCT01747486|564728359|FG000|Stage 2|Disease Progression|3|||
156446824|NCT01747486|564728360|FG001|Stage 2|Disease Progression|0|||
156446825|NCT00632749|564728364|FG000|Overall Study|Progressive disease|3|||
156446826|NCT00632749|564728365|FG001|Overall Study|Progressive disease|2|||
156446827|NCT00632749|564728366|FG002|Overall Study|Progressive disease|2|||
156446828|NCT00632749|564728367|FG003|Overall Study|Progressive disease|2|||
156446829|NCT00632749|564728368|FG004|Overall Study|Progressive disease|4|||
156446830|NCT00632749|564728369|FG005|Overall Study|Progressive disease|4|||
156446831|NCT00632749|564728370|FG006|Overall Study|Progressive disease|3|||
156446832|NCT00632749|564728371|FG007|Overall Study|Progressive disease|2|||
156446833|NCT00632749|564728372|FG008|Overall Study|Progressive disease|3|||
156446834|NCT00632749|564728373|FG009|Overall Study|Progressive disease|2|||
156446835|NCT00632749|564728374|FG010|Overall Study|Progressive disease|4|||
156446836|NCT00632749|564728375|FG011|Overall Study|Progressive disease|3|||
156446837|NCT00632749|564728376|FG012|Overall Study|Progressive disease|2|||
156446838|NCT00632749|564728377|FG013|Overall Study|Progressive disease|4|||
156446839|NCT00632749|564728364|FG000|Overall Study|Other Adverse event|1|||
156446840|NCT00632749|564728365|FG001|Overall Study|Other Adverse event|1|||
156446841|NCT00632749|564728366|FG002|Overall Study|Other Adverse event|1|||
156446842|NCT00632749|564728367|FG003|Overall Study|Other Adverse event|1|||
156334627|NCT01346969|564322468|FG003|Overall Study|Randomized but not treated|0|||
156334628|NCT05213481|564322469|FG000|Overall Study|Adverse Event|3|||
156334629|NCT05213481|564322469|FG000|Overall Study|Lost to Follow-up|1|||
156334630|NCT04122534|564322470|FG000|Overall Study|Lost to Follow-up|4|||
156334631|NCT02128932|564322478|FG000|Overall Study|Withdrawal by Subject|11|||
156334632|NCT02128932|564322479|FG001|Overall Study|Withdrawal by Subject|7|||
156334633|NCT02128932|564322480|FG002|Overall Study|Withdrawal by Subject|8|||
156334634|NCT02128932|564322478|FG000|Overall Study|Death|2|||
156334635|NCT02128932|564322479|FG001|Overall Study|Death|0|||
156334636|NCT02128932|564322480|FG002|Overall Study|Death|2|||
156334637|NCT02128932|564322478|FG000|Overall Study|Lost to Follow-up|2|||
156446843|NCT00632749|564728368|FG004|Overall Study|Other Adverse event|2|||
156446844|NCT00632749|564728369|FG005|Overall Study|Other Adverse event|4|||
156446845|NCT00632749|564728370|FG006|Overall Study|Other Adverse event|1|||
156446846|NCT00632749|564728371|FG007|Overall Study|Other Adverse event|2|||
156446847|NCT00632749|564728372|FG008|Overall Study|Other Adverse event|2|||
156446848|NCT00632749|564728373|FG009|Overall Study|Other Adverse event|0|||
156446849|NCT00632749|564728374|FG010|Overall Study|Other Adverse event|1|||
156334638|NCT02128932|564322479|FG001|Overall Study|Lost to Follow-up|1|||
156334639|NCT02128932|564322480|FG002|Overall Study|Lost to Follow-up|1|||
156334640|NCT02128932|564322478|FG000|Overall Study|No reason for withdrawal|12|||
156334641|NCT02128932|564322479|FG001|Overall Study|No reason for withdrawal|11|||
156334642|NCT02128932|564322480|FG002|Overall Study|No reason for withdrawal|7|||
156334643|NCT02925117|564322485|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
156334644|NCT02925117|564322486|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
156446850|NCT00632749|564728375|FG011|Overall Study|Other Adverse event|0|||
156793282|NCT00586157|565996217|FG001|Second Intervention|Worsening behavior|0|||
156793283|NCT00586157|565996216|FG000|Second Intervention|Adverse Event|0|||
156793284|NCT00586157|565996217|FG001|Second Intervention|Adverse Event|1|||
156334645|NCT02925117|564322487|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
156446851|NCT00632749|564728376|FG012|Overall Study|Other Adverse event|1|||
156334646|NCT02925117|564322488|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
156334647|NCT02925117|564322489|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156446852|NCT00632749|564728377|FG013|Overall Study|Other Adverse event|0|||
156446853|NCT00632749|564728364|FG000|Overall Study|Refuse to continue medication|0|||
156446854|NCT00632749|564728365|FG001|Overall Study|Refuse to continue medication|0|||
156334648|NCT02925117|564322490|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156446855|NCT00632749|564728366|FG002|Overall Study|Refuse to continue medication|0|||
156334649|NCT02925117|564322491|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156334650|NCT02925117|564322492|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156334651|NCT02925117|564322493|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156446856|NCT00632749|564728367|FG003|Overall Study|Refuse to continue medication|1|||
156446857|NCT00632749|564728368|FG004|Overall Study|Refuse to continue medication|0|||
156446858|NCT00632749|564728369|FG005|Overall Study|Refuse to continue medication|0|||
156446859|NCT00632749|564728370|FG006|Overall Study|Refuse to continue medication|0|||
156446860|NCT00632749|564728371|FG007|Overall Study|Refuse to continue medication|0|||
156446861|NCT00632749|564728372|FG008|Overall Study|Refuse to continue medication|0|||
156446862|NCT00632749|564728373|FG009|Overall Study|Refuse to continue medication|1|||
156446863|NCT00632749|564728374|FG010|Overall Study|Refuse to continue medication|0|||
156446864|NCT00632749|564728375|FG011|Overall Study|Refuse to continue medication|0|||
156446865|NCT00632749|564728376|FG012|Overall Study|Refuse to continue medication|0|||
156446866|NCT00632749|564728377|FG013|Overall Study|Refuse to continue medication|0|||
156446867|NCT00632749|564728364|FG000|Overall Study|Reason other than those specified above|0|||
156446868|NCT00632749|564728365|FG001|Overall Study|Reason other than those specified above|2|||
156446869|NCT00632749|564728366|FG002|Overall Study|Reason other than those specified above|0|||
156446870|NCT00632749|564728367|FG003|Overall Study|Reason other than those specified above|0|||
156446871|NCT00632749|564728368|FG004|Overall Study|Reason other than those specified above|1|||
156446872|NCT00632749|564728369|FG005|Overall Study|Reason other than those specified above|0|||
156446873|NCT00632749|564728370|FG006|Overall Study|Reason other than those specified above|1|||
156446874|NCT00632749|564728371|FG007|Overall Study|Reason other than those specified above|0|||
156446875|NCT00632749|564728372|FG008|Overall Study|Reason other than those specified above|0|||
156446876|NCT00632749|564728373|FG009|Overall Study|Reason other than those specified above|0|||
156446877|NCT00632749|564728374|FG010|Overall Study|Reason other than those specified above|2|||
156446878|NCT00632749|564728375|FG011|Overall Study|Reason other than those specified above|1|||
156446879|NCT00632749|564728376|FG012|Overall Study|Reason other than those specified above|0|||
156446880|NCT00632749|564728377|FG013|Overall Study|Reason other than those specified above|2|||
156446881|NCT00611559|564728378|FG000|Overall Study|Lost to Follow-up|0|||
156446882|NCT00611559|564728379|FG001|Overall Study|Lost to Follow-up|1|||
156446883|NCT00611559|564728380|FG002|Overall Study|Lost to Follow-up|0|||
156446884|NCT00611559|564728378|FG000|Overall Study|Protocol Violation|1|||
156446885|NCT00611559|564728379|FG001|Overall Study|Protocol Violation|0|||
156446886|NCT00611559|564728380|FG002|Overall Study|Protocol Violation|1|||
156446887|NCT00879333|564728381|FG000|Overall Study|Adverse Event|94|||
156446888|NCT00879333|564728382|FG001|Overall Study|Adverse Event|34|||
156446889|NCT00879333|564728381|FG000|Overall Study|Abnormal Laboratory Value|1|||
156446890|NCT00879333|564728382|FG001|Overall Study|Abnormal Laboratory Value|0|||
156446891|NCT00879333|564728381|FG000|Overall Study|Withdrawal by Subject|20|||
156446892|NCT00879333|564728382|FG001|Overall Study|Withdrawal by Subject|7|||
156446893|NCT00879333|564728381|FG000|Overall Study|Lost to Follow-up|2|||
156446894|NCT00879333|564728382|FG001|Overall Study|Lost to Follow-up|1|||
156446895|NCT00879333|564728381|FG000|Overall Study|Administrative Problems|2|||
156446896|NCT00879333|564728382|FG001|Overall Study|Administrative Problems|0|||
156446897|NCT00879333|564728381|FG000|Overall Study|Death|16|||
156446898|NCT00879333|564728382|FG001|Overall Study|Death|5|||
156446899|NCT00879333|564728381|FG000|Overall Study|Disease Progression|292|||
156446900|NCT00879333|564728382|FG001|Overall Study|Disease Progression|169|||
156446901|NCT00879333|564728381|FG000|Overall Study|Protocol Violation|1|||
156446902|NCT00879333|564728382|FG001|Overall Study|Protocol Violation|1|||
156446903|NCT04999592|564728383|FG000|Overall Study|Withdrawal by Subject|1|||
156446904|NCT04999592|564728384|FG001|Overall Study|Withdrawal by Subject|0|||
156446905|NCT03069313|564728385|FG000|Overall Study|Adverse Event|5|||
156446906|NCT01011946|564728387|FG000|Overall Study|Transferred to another hospital|2|||
156446907|NCT01011946|564728387|FG000|Overall Study|No pathological lab value|1|||
156446908|NCT01872078|564728389|FG000|Overall Study|Adverse Event|0|||
156446909|NCT01872078|564728390|FG001|Overall Study|Adverse Event|0|||
156446910|NCT01872078|564728391|FG002|Overall Study|Adverse Event|1|||
156446911|NCT01872078|564728392|FG003|Overall Study|Adverse Event|0|||
156446912|NCT01872078|564728389|FG000|Overall Study|Dose administration non-compliance|0|||
156446913|NCT01872078|564728390|FG001|Overall Study|Dose administration non-compliance|0|||
156446914|NCT01872078|564728391|FG002|Overall Study|Dose administration non-compliance|0|||
156446915|NCT01872078|564728392|FG003|Overall Study|Dose administration non-compliance|1|||
156446916|NCT01872078|564728389|FG000|Overall Study|Protocol Violation|0|||
156446917|NCT01872078|564728390|FG001|Overall Study|Protocol Violation|0|||
156446918|NCT01872078|564728391|FG002|Overall Study|Protocol Violation|1|||
156446919|NCT01872078|564728392|FG003|Overall Study|Protocol Violation|0|||
156446920|NCT01872078|564728389|FG000|Overall Study|Withdrawal by Subject|0|||
156446921|NCT01872078|564728390|FG001|Overall Study|Withdrawal by Subject|0|||
156446922|NCT01872078|564728391|FG002|Overall Study|Withdrawal by Subject|1|||
156446923|NCT01872078|564728392|FG003|Overall Study|Withdrawal by Subject|0|||
156446924|NCT01872078|564728389|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
156446925|NCT01872078|564728390|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
156446926|NCT01872078|564728391|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
156446927|NCT01872078|564728392|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
156446928|NCT02910713|564728393|FG000|Overall Study|Protocol Violation|2|||
156446929|NCT02910713|564728393|FG000|Overall Study|Subject Choice|4|||
156716318|NCT01125189|565705321|FG000|Follow up Period|Other reasons|4|||
156446930|NCT02910713|564728393|FG000|Overall Study|Received One Application|10|||
156446931|NCT02910713|564728393|FG000|Overall Study|Received Neither Application|18|||
156446932|NCT02910713|564728393|FG000|Overall Study|Enrollment cap|7|||
156446933|NCT02910713|564728393|FG000|Overall Study|Investigator Discretion|1|||
156446934|NCT04442126|564728397|FG000|Overall Study|Withdrawal by Subject|0|||
156446935|NCT04442126|564728398|FG001|Overall Study|Withdrawal by Subject|0|||
156446936|NCT04442126|564728399|FG002|Overall Study|Withdrawal by Subject|0|||
156446937|NCT04442126|564728400|FG003|Overall Study|Withdrawal by Subject|2|||
156446938|NCT04442126|564728401|FG004|Overall Study|Withdrawal by Subject|1|||
156446939|NCT04442126|564728402|FG005|Overall Study|Withdrawal by Subject|0|||
156446940|NCT04442126|564728403|FG006|Overall Study|Withdrawal by Subject|1|||
156446941|NCT04442126|564728404|FG007|Overall Study|Withdrawal by Subject|1|||
156446942|NCT04442126|564728405|FG008|Overall Study|Withdrawal by Subject|3|||
156446943|NCT04442126|564728397|FG000|Overall Study|Death|1|||
156446944|NCT04442126|564728398|FG001|Overall Study|Death|0|||
156446945|NCT04442126|564728399|FG002|Overall Study|Death|0|||
156446946|NCT04442126|564728400|FG003|Overall Study|Death|1|||
156446947|NCT04442126|564728401|FG004|Overall Study|Death|2|||
156446948|NCT04442126|564728402|FG005|Overall Study|Death|2|||
156446949|NCT04442126|564728403|FG006|Overall Study|Death|4|||
156446950|NCT04442126|564728404|FG007|Overall Study|Death|1|||
156446951|NCT04442126|564728405|FG008|Overall Study|Death|5|||
156446952|NCT04442126|564728397|FG000|Overall Study|Study Terminated by Sponsor|0|||
156446953|NCT04442126|564728398|FG001|Overall Study|Study Terminated by Sponsor|0|||
156446954|NCT04442126|564728399|FG002|Overall Study|Study Terminated by Sponsor|0|||
156446955|NCT04442126|564728400|FG003|Overall Study|Study Terminated by Sponsor|0|||
156446956|NCT04442126|564728401|FG004|Overall Study|Study Terminated by Sponsor|0|||
156446957|NCT04442126|564728402|FG005|Overall Study|Study Terminated by Sponsor|1|||
156446958|NCT04442126|564728403|FG006|Overall Study|Study Terminated by Sponsor|4|||
156446959|NCT04442126|564728404|FG007|Overall Study|Study Terminated by Sponsor|2|||
156446960|NCT04442126|564728405|FG008|Overall Study|Study Terminated by Sponsor|10|||
156446961|NCT04442126|564728397|FG000|Overall Study|Lost to Follow-up|0|||
156446962|NCT04442126|564728398|FG001|Overall Study|Lost to Follow-up|0|||
156446963|NCT04442126|564728399|FG002|Overall Study|Lost to Follow-up|0|||
156446964|NCT04442126|564728400|FG003|Overall Study|Lost to Follow-up|0|||
156446965|NCT04442126|564728401|FG004|Overall Study|Lost to Follow-up|0|||
156446966|NCT04442126|564728402|FG005|Overall Study|Lost to Follow-up|0|||
156446967|NCT04442126|564728403|FG006|Overall Study|Lost to Follow-up|0|||
156446968|NCT04442126|564728404|FG007|Overall Study|Lost to Follow-up|1|||
156446969|NCT04442126|564728405|FG008|Overall Study|Lost to Follow-up|2|||
156446970|NCT04442126|564728397|FG000|Overall Study|Progressive Disease|0|||
156446971|NCT04442126|564728398|FG001|Overall Study|Progressive Disease|1|||
156446972|NCT04442126|564728399|FG002|Overall Study|Progressive Disease|3|||
156446973|NCT04442126|564728400|FG003|Overall Study|Progressive Disease|0|||
156446974|NCT04442126|564728401|FG004|Overall Study|Progressive Disease|3|||
156446975|NCT04442126|564728402|FG005|Overall Study|Progressive Disease|0|||
156446976|NCT04442126|564728403|FG006|Overall Study|Progressive Disease|0|||
156446977|NCT04442126|564728404|FG007|Overall Study|Progressive Disease|0|||
156446978|NCT04442126|564728405|FG008|Overall Study|Progressive Disease|0|||
156446979|NCT04442126|564728397|FG000|Overall Study|Other|0|||
156446980|NCT04442126|564728398|FG001|Overall Study|Other|0|||
156446981|NCT04442126|564728399|FG002|Overall Study|Other|0|||
156446982|NCT04442126|564728400|FG003|Overall Study|Other|0|||
156446983|NCT04442126|564728401|FG004|Overall Study|Other|0|||
156446984|NCT04442126|564728402|FG005|Overall Study|Other|0|||
156446985|NCT04442126|564728403|FG006|Overall Study|Other|0|||
156446986|NCT04442126|564728404|FG007|Overall Study|Other|0|||
156446987|NCT04442126|564728405|FG008|Overall Study|Other|1|||
156446988|NCT06450405|564728406|FG000|Overall Study|Study funding terminated.|0|||
156446989|NCT06450405|564728407|FG001|Overall Study|Study funding terminated.|2|||
156446990|NCT03767517|564728408|FG000|Overall Study|Lost to Follow-up|16|||
156446991|NCT03767517|564728409|FG001|Overall Study|Lost to Follow-up|10|||
156446992|NCT03767517|564728408|FG000|Overall Study|Death|2|||
156446993|NCT03767517|564728409|FG001|Overall Study|Death|3|||
156446994|NCT05338086|564729830|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
156446995|NCT05338086|564729831|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
156446996|NCT05338086|564729832|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
156716319|NCT01125189|565705322|FG001|Follow up Period|Other reasons|4|||
156716320|NCT01125189|565705323|FG002|Follow up Period|Other reasons|5|||
156716321|NCT00114140|565705324|FG000|Overall Study|Protocol Violation|7|||
156716322|NCT02414958|565705325|FG000|Overall Study|Adverse Event|6|||
156716323|NCT02414958|565705326|FG001|Overall Study|Adverse Event|6|||
156716324|NCT02414958|565705327|FG002|Overall Study|Adverse Event|3|||
156716325|NCT02414958|565705325|FG000|Overall Study|Protocol Violation|10|||
156716326|NCT02414958|565705326|FG001|Overall Study|Protocol Violation|3|||
156716327|NCT02414958|565705327|FG002|Overall Study|Protocol Violation|1|||
156716328|NCT02414958|565705325|FG000|Overall Study|Lost to Follow-up|7|||
156446997|NCT05338086|564729833|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
156446998|NCT05338086|564729834|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
156446999|NCT05338086|564729830|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
156447000|NCT05338086|564729831|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
156447001|NCT05338086|564729832|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
156447002|NCT05338086|564729833|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
156716329|NCT02414958|565705326|FG001|Overall Study|Lost to Follow-up|4|||
156716330|NCT02414958|565705327|FG002|Overall Study|Lost to Follow-up|0|||
156716331|NCT02414958|565705325|FG000|Overall Study|Withdrawal by Subject|5|||
156716332|NCT02414958|565705326|FG001|Overall Study|Withdrawal by Subject|3|||
156716333|NCT02414958|565705327|FG002|Overall Study|Withdrawal by Subject|5|||
156716334|NCT02414958|565705325|FG000|Overall Study|Other than specified|4|||
156716335|NCT02414958|565705326|FG001|Overall Study|Other than specified|4|||
156716336|NCT02414958|565705327|FG002|Overall Study|Other than specified|5|||
156334652|NCT02925117|564322494|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156334653|NCT02925117|564322495|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156334654|NCT02925117|564322496|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156334655|NCT02925117|564322485|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
156334656|NCT02925117|564322486|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
156334657|NCT02925117|564322487|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
156334658|NCT02925117|564322488|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334659|NCT02925117|564322489|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334660|NCT02925117|564322490|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334661|NCT02925117|564322491|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334662|NCT02925117|564322492|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334663|NCT02925117|564322493|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334664|NCT02925117|564322494|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334665|NCT02925117|564322495|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334666|NCT02925117|564322496|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156334667|NCT02925117|564322485|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
156334668|NCT02925117|564322486|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
156334669|NCT02925117|564322487|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334670|NCT02925117|564322488|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334671|NCT02925117|564322489|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334672|NCT02925117|564322490|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156716337|NCT01269918|565705328|FG000|Overall Study|Did not receive study drug|0|||
156716338|NCT01269918|565705329|FG001|Overall Study|Did not receive study drug|3|||
156716339|NCT02500589|565705330|FG000|Overall Study|Withdrawal by Subject|11|||
156716340|NCT02500589|565705331|FG001|Overall Study|Withdrawal by Subject|14|||
156716341|NCT02500589|565705330|FG000|Overall Study|Lost to Follow-up|10|||
156716342|NCT02500589|565705331|FG001|Overall Study|Lost to Follow-up|12|||
156716343|NCT02500589|565705330|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
156716344|NCT02500589|565705331|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
156716345|NCT02500589|565705330|FG000|Overall Study|Death|7|||
156716346|NCT02500589|565705331|FG001|Overall Study|Death|5|||
156716347|NCT03885661|565705332|FG000|Overall Study|Withdrawal by Subject|0|||
156716348|NCT03885661|565705333|FG001|Overall Study|Withdrawal by Subject|1|||
156716349|NCT03885661|565705332|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
156716350|NCT03885661|565705333|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
156716351|NCT05064397|565705334|FG000|Overall Study|Adverse Event|4|||
156716352|NCT05064397|565705334|FG000|Overall Study|Lack of Efficacy|12|||
156716353|NCT05064397|565705334|FG000|Overall Study|Withdrawal by Subject|3|||
156716354|NCT05064397|565705334|FG000|Overall Study|Lost to Follow-up|1|||
156716355|NCT05064397|565705334|FG000|Overall Study|Other reasons|3|||
156716356|NCT03934541|565705337|FG000|Overall Study|Study Terminated by Sponsor|0|||
156716357|NCT03934541|565705338|FG001|Overall Study|Study Terminated by Sponsor|1|||
156716358|NCT03934541|565705339|FG002|Overall Study|Study Terminated by Sponsor|0|||
156716359|NCT03934541|565705340|FG003|Overall Study|Study Terminated by Sponsor|0|||
156716360|NCT01783886|565705345|FG000|Overall Study|Lost to Follow-up|0|||
156716361|NCT01783886|565705346|FG001|Overall Study|Lost to Follow-up|3|||
156716362|NCT01783886|565705347|FG002|Overall Study|Lost to Follow-up|0|||
156716363|NCT01783886|565705345|FG000|Overall Study|Protocol deviation|0|||
156716364|NCT01783886|565705346|FG001|Overall Study|Protocol deviation|0|||
156716365|NCT01783886|565705347|FG002|Overall Study|Protocol deviation|2|||
156716366|NCT01783886|565705345|FG000|Overall Study|Withdrawal of consent by participant|1|||
156716367|NCT01783886|565705346|FG001|Overall Study|Withdrawal of consent by participant|3|||
156716368|NCT01783886|565705347|FG002|Overall Study|Withdrawal of consent by participant|4|||
156716369|NCT01783886|565705345|FG000|Overall Study|Adverse Event|4|||
156716370|NCT01783886|565705346|FG001|Overall Study|Adverse Event|5|||
156716371|NCT01783886|565705347|FG002|Overall Study|Adverse Event|4|||
156716372|NCT02324582|565705348|FG000|Overall Study|Screen Failures|0|||
156716373|NCT02324582|565705349|FG001|Overall Study|Screen Failures|5|||
156716374|NCT04660331|565705350|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
156716375|NCT04660331|565705351|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
156716376|NCT04660331|565705352|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
156716377|NCT03624192|565705353|FG000|Overall Study|Lost to Follow-up|1|||
156716378|NCT03624192|565705354|FG001|Overall Study|Lost to Follow-up|1|||
156716379|NCT00838526|565705357|FG000|Overall Study|Adverse Event|3|||
156716380|NCT00838526|565705358|FG001|Overall Study|Adverse Event|12|||
156716381|NCT00838526|565705357|FG000|Overall Study|Lost to Follow-up|4|||
156716382|NCT00838526|565705358|FG001|Overall Study|Lost to Follow-up|12|||
156716383|NCT00838526|565705357|FG000|Overall Study|Withdrawal by Subject|4|||
156334673|NCT02925117|564322491|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334674|NCT02925117|564322492|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334675|NCT02925117|564322493|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334676|NCT02925117|564322494|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334677|NCT02925117|564322495|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334678|NCT02925117|564322496|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156334679|NCT02925117|564322485|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
156334680|NCT02925117|564322486|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
156334681|NCT02925117|564322487|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
156334682|NCT02925117|564322488|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
156334683|NCT02925117|564322489|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
156334684|NCT02925117|564322490|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
156334685|NCT02925117|564322491|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
156334686|NCT02925117|564322492|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
156334687|NCT02925117|564322493|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
156334688|NCT02925117|564322494|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
156334689|NCT02925117|564322495|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
156334690|NCT02925117|564322496|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
156334691|NCT02925117|564322485|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334692|NCT02925117|564322486|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334693|NCT02925117|564322487|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334694|NCT02925117|564322488|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334695|NCT02925117|564322489|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334696|NCT02925117|564322490|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
156334697|NCT02925117|564322491|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334698|NCT02925117|564322492|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334699|NCT02925117|564322493|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334700|NCT02925117|564322494|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156334701|NCT02925117|564322495|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
156334702|NCT02925117|564322496|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
156334703|NCT02925117|564322485|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156334704|NCT02925117|564322486|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156334705|NCT02925117|564322487|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156334706|NCT02925117|564322488|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156334707|NCT02925117|564322489|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156334708|NCT02925117|564322490|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
156334709|NCT02925117|564322491|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
156334710|NCT02925117|564322492|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
156334711|NCT02925117|564322493|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
156334712|NCT02925117|564322494|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
156334713|NCT02925117|564322495|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
156334714|NCT02925117|564322496|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
156334715|NCT02925117|564322485|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156334716|NCT02925117|564322486|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156334717|NCT02925117|564322487|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156334718|NCT02925117|564322488|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156334719|NCT02925117|564322489|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156334720|NCT02925117|564322490|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
156334721|NCT02925117|564322491|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156334722|NCT02925117|564322492|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156334723|NCT02925117|564322493|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156334724|NCT02925117|564322494|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156334725|NCT02925117|564322495|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156334726|NCT02925117|564322496|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156334727|NCT02925117|564322485|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
156334728|NCT02925117|564322486|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
156334729|NCT02925117|564322487|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
156334730|NCT02925117|564322488|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
156334731|NCT02925117|564322489|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
156334732|NCT02925117|564322490|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
156334733|NCT02925117|564322491|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
156334734|NCT02925117|564322492|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
156334735|NCT02925117|564322493|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
156334736|NCT02925117|564322494|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
156334737|NCT02925117|564322495|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
156334738|NCT02925117|564322496|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
156334739|NCT02663908|564322497|FG000|Overall Study|Withdrawal by Subject|8|||
156447003|NCT05338086|564729834|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
156447004|NCT05338086|564729830|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
156447005|NCT05338086|564729831|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
156447006|NCT05338086|564729832|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
156447007|NCT05338086|564729833|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
156447008|NCT05338086|564729834|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
156447009|NCT05338086|564729830|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
156447010|NCT05338086|564729831|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
156447011|NCT05338086|564729832|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
156447012|NCT05338086|564729833|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
156533027|NCT04178967|565046864|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156533028|NCT04178967|565046865|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156533029|NCT04178967|565046855|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533030|NCT04178967|565046856|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533031|NCT04178967|565046857|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533032|NCT04178967|565046858|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
156533033|NCT04178967|565046859|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533034|NCT04178967|565046860|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533035|NCT04178967|565046861|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533036|NCT04178967|565046862|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533037|NCT04178967|565046863|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533038|NCT04178967|565046864|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156447013|NCT05338086|564729834|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
156447014|NCT05338086|564729830|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
156447015|NCT05338086|564729831|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
156447016|NCT05338086|564729832|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
156447017|NCT05338086|564729833|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
156533039|NCT04178967|565046865|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156533040|NCT04178967|565046855|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533041|NCT04178967|565046856|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533042|NCT04178967|565046857|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533043|NCT04178967|565046858|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533044|NCT04178967|565046859|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533045|NCT04178967|565046860|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533046|NCT04178967|565046861|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
156533047|NCT04178967|565046862|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533048|NCT04178967|565046863|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533049|NCT04178967|565046864|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533050|NCT04178967|565046865|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
156533051|NCT04178967|565046855|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156533052|NCT04178967|565046856|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156533053|NCT04178967|565046857|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156533054|NCT04178967|565046858|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156533055|NCT04178967|565046859|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
156533056|NCT04178967|565046860|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
156533057|NCT04178967|565046861|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156533058|NCT04178967|565046862|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
156533059|NCT04178967|565046863|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156533060|NCT04178967|565046864|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156533061|NCT04178967|565046865|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156533062|NCT04178967|565046855|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
156533063|NCT04178967|565046856|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
156533064|NCT04178967|565046857|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
156533065|NCT04178967|565046858|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
156533066|NCT04178967|565046859|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
156447018|NCT05338086|564729834|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
156447019|NCT05338086|564729830|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
156447020|NCT05338086|564729831|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
156447021|NCT05338086|564729832|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
156447022|NCT05338086|564729833|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
156447023|NCT05338086|564729834|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
156447024|NCT05338086|564729830|FG000|Transition Period (M12 to M18)|Death|0|||
156447025|NCT05338086|564729831|FG001|Transition Period (M12 to M18)|Death|0|||
156447026|NCT05338086|564729832|FG002|Transition Period (M12 to M18)|Death|1|||
156447027|NCT05338086|564729833|FG003|Transition Period (M12 to M18)|Death|0|||
156447028|NCT05338086|564729834|FG004|Transition Period (M12 to M18)|Death|0|||
156447029|NCT05338086|564729830|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
156447030|NCT05338086|564729831|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
156533067|NCT04178967|565046860|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
156874835|NCT03892967|566298749|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
156447031|NCT05338086|564729832|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
156447032|NCT05338086|564729833|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
156447033|NCT05338086|564729834|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
156447034|NCT05338086|564729830|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
156447035|NCT05338086|564729831|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
156447036|NCT05338086|564729832|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
156447037|NCT05338086|564729833|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
156447038|NCT05338086|564729834|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
156447039|NCT05338086|564729830|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
156447040|NCT05338086|564729831|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
156447041|NCT05338086|564729832|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
156447042|NCT05338086|564729833|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
156447043|NCT05338086|564729834|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
156447044|NCT06066541|564729844|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
156447045|NCT06066541|564729845|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
156447046|NCT06066541|564729846|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
156447047|NCT06066541|564729847|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
156447048|NCT06066541|564729848|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
156447049|NCT06066541|564729849|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
156447050|NCT06066541|564729850|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
156447051|NCT06066541|564729844|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
156447052|NCT06066541|564729845|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
156447053|NCT06066541|564729846|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
156447054|NCT06066541|564729847|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
156447055|NCT06066541|564729848|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
156447056|NCT06066541|564729849|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
156447057|NCT06066541|564729850|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
156447058|NCT04533022|564729851|FG000|Overall Study|Withdrawal by Subject|15|||
156447059|NCT04533022|564729851|FG000|Overall Study|Adverse Event|6|||
156447060|NCT04533022|564729851|FG000|Overall Study|Death|1|||
156447061|NCT04533022|564729851|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
156447062|NCT04533022|564729851|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
156447063|NCT02163447|564729852|FG000|Overall Study|Withdrawal by Subject|2|||
156447064|NCT02163447|564729853|FG001|Overall Study|Withdrawal by Subject|0|||
156447065|NCT02163447|564729854|FG002|Overall Study|Withdrawal by Subject|1|||
156447066|NCT02163447|564729852|FG000|Overall Study|Lost to Follow-up|1|||
156447067|NCT02163447|564729853|FG001|Overall Study|Lost to Follow-up|3|||
156447068|NCT02163447|564729854|FG002|Overall Study|Lost to Follow-up|0|||
156447069|NCT02163447|564729852|FG000|Overall Study|Moved out of study area|2|||
156447070|NCT02163447|564729853|FG001|Overall Study|Moved out of study area|3|||
156447071|NCT02163447|564729854|FG002|Overall Study|Moved out of study area|2|||
156447072|NCT02163447|564729852|FG000|Overall Study|Became HIV infected at time of delivery|1|||
156447073|NCT02163447|564729853|FG001|Overall Study|Became HIV infected at time of delivery|0|||
156447074|NCT02163447|564729854|FG002|Overall Study|Became HIV infected at time of delivery|0|||
156447075|NCT05038566|564729860|FG000|Overall Study|Technical Difficulties with the Device|0|||
156447076|NCT05038566|564729861|FG001|Overall Study|Technical Difficulties with the Device|1|||
156447077|NCT04850807|564729868|FG000|Overall Study|Death|50|||
156447078|NCT04850807|564729869|FG001|Overall Study|Death|55|||
156447079|NCT04850807|564729868|FG000|Overall Study|Discharged|17|||
156447080|NCT04850807|564729869|FG001|Overall Study|Discharged|13|||
156447081|NCT04850807|564729868|FG000|Overall Study|Incomplete baseline data|3|||
156447082|NCT04850807|564729869|FG001|Overall Study|Incomplete baseline data|2|||
156447083|NCT03739996|564729870|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
156447084|NCT03739996|564729870|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
156447085|NCT03739996|564729870|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
156447086|NCT03739996|564729870|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
156447087|NCT03739996|564729870|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
156447088|NCT03739996|564729870|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
156447089|NCT03739996|564729870|FG000|Step 3 (SOC ART)|Death|1|||
156447090|NCT03739996|564729870|FG000|Step 3 (SOC ART)|Participant moved|1|||
156447091|NCT05141903|564729871|FG000|Overall Study|Withdrawal by Subject|0|||
156447092|NCT05141903|564729872|FG001|Overall Study|Withdrawal by Subject|1|||
156447093|NCT05141903|564729873|FG002|Overall Study|Withdrawal by Subject|1|||
156447094|NCT05141903|564729874|FG003|Overall Study|Withdrawal by Subject|0|||
156447095|NCT05141903|564729875|FG004|Overall Study|Withdrawal by Subject|0|||
156447096|NCT05141903|564729871|FG000|Overall Study|Other|1|||
156447097|NCT05141903|564729872|FG001|Overall Study|Other|1|||
156447098|NCT05141903|564729873|FG002|Overall Study|Other|0|||
156447099|NCT05141903|564729874|FG003|Overall Study|Other|0|||
156793285|NCT01225952|565996219|FG000|Overall Study|Lost to Follow-up|1|||
156793286|NCT01225952|565996220|FG001|Overall Study|Lost to Follow-up|0|||
156793287|NCT01225952|565996221|FG002|Overall Study|Lost to Follow-up|0|||
156793288|NCT01225952|565996219|FG000|Overall Study|Study Eye Explanted|0|||
156793289|NCT01225952|565996220|FG001|Overall Study|Study Eye Explanted|0|||
156793290|NCT01225952|565996221|FG002|Overall Study|Study Eye Explanted|1|||
156793291|NCT01225952|565996219|FG000|Overall Study|Withdrawal by Subject|4|||
156793292|NCT01225952|565996220|FG001|Overall Study|Withdrawal by Subject|4|||
156793293|NCT01225952|565996221|FG002|Overall Study|Withdrawal by Subject|5|||
156793294|NCT01225952|565996219|FG000|Overall Study|Surgical complications|1|||
156793295|NCT01225952|565996220|FG001|Overall Study|Surgical complications|0|||
156793296|NCT01225952|565996221|FG002|Overall Study|Surgical complications|0|||
156793297|NCT00770679|565996224|FG000|Overall Study|Lost to Follow-up|3|||
156447100|NCT05141903|564729875|FG004|Overall Study|Other|0|||
156447101|NCT05387447|564729879|FG000|Overall Study|Participants changed their minds about study participation.|3|||
156793298|NCT00770679|565996224|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
156793299|NCT00831389|565996225|FG000|Overall Study|Withdrawal by Subject|0|||
156447102|NCT05387447|564729880|FG001|Overall Study|Participants changed their minds about study participation.|5|||
156793300|NCT00831389|565996226|FG001|Overall Study|Withdrawal by Subject|1|||
156793301|NCT00278161|565996228|FG000|Overall Study|Death|11|||
156793302|NCT01817777|565996229|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
156793303|NCT01817777|565996230|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
156793304|NCT01817777|565996231|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
156793305|NCT01817777|565996229|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
156793306|NCT01817777|565996230|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
156793307|NCT01817777|565996231|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
156793308|NCT01817777|565996229|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
156793309|NCT01817777|565996230|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
156793310|NCT01817777|565996231|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
156793311|NCT01817777|565996229|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
156793312|NCT01817777|565996230|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
156793313|NCT01817777|565996231|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
156793314|NCT01817777|565996229|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
156793315|NCT01817777|565996230|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
156793316|NCT01817777|565996231|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
156793317|NCT01935947|565996233|FG000|Overall Study|Adverse Event|0|||
156793318|NCT01935947|565996234|FG001|Overall Study|Adverse Event|2|||
156793319|NCT01935947|565996235|FG002|Overall Study|Adverse Event|0|||
156793320|NCT01935947|565996233|FG000|Overall Study|Diease Progression|2|||
156793321|NCT01935947|565996234|FG001|Overall Study|Diease Progression|2|||
156793322|NCT01935947|565996235|FG002|Overall Study|Diease Progression|2|||
156793323|NCT01935947|565996233|FG000|Overall Study|Death|1|||
156793324|NCT01935947|565996234|FG001|Overall Study|Death|0|||
156447103|NCT05439603|564729889|FG000|Overall Study|met withdrawal criteria|2|||
156447104|NCT05461131|564729890|FG000|Overall Study|Lost to Follow-up|0|||
156447105|NCT05461131|564729891|FG001|Overall Study|Lost to Follow-up|2|||
156447106|NCT03896516|564729892|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
156447107|NCT03896516|564729893|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
156447108|NCT03896516|564729892|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
156447109|NCT03896516|564729893|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
156447110|NCT03896516|564729892|FG000|Washout Period|Physician Decision|3|||
156447111|NCT03896516|564729893|FG001|Washout Period|Physician Decision|1|||
156447112|NCT03896516|564729892|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
156447113|NCT03896516|564729893|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
156447114|NCT04549168|564729901|FG000|Randomization Phase|Adverse Event|0|||
156447115|NCT04549168|564729902|FG001|Randomization Phase|Adverse Event|0|||
156447116|NCT04549168|564729903|FG002|Randomization Phase|Adverse Event|1|||
156447117|NCT04549168|564729901|FG000|Randomization Phase|Other|0|||
156793325|NCT01935947|565996235|FG002|Overall Study|Death|0|||
156793326|NCT00692237|565996236|FG000|Overall Study|Withdrawal by Subject|1|||
156793327|NCT00692237|565996237|FG001|Overall Study|Withdrawal by Subject|3|||
156793328|NCT00692237|565996236|FG000|Overall Study|Adverse Event|0|||
156793329|NCT00692237|565996237|FG001|Overall Study|Adverse Event|1|||
156793330|NCT00752219|565996238|FG000|Overall Study|Clinical failure|0|||
156793331|NCT00752219|565996239|FG001|Overall Study|Clinical failure|1|||
156793332|NCT00752219|565996238|FG000|Overall Study|Adverse Event|5|||
156793333|NCT00752219|565996239|FG001|Overall Study|Adverse Event|3|||
156793334|NCT00752219|565996238|FG000|Overall Study|Protocol deviation|1|||
156793335|NCT00752219|565996239|FG001|Overall Study|Protocol deviation|0|||
156793336|NCT00752219|565996238|FG000|Overall Study|Lost to Follow-up|1|||
156793337|NCT00752219|565996239|FG001|Overall Study|Lost to Follow-up|2|||
156793338|NCT00752219|565996238|FG000|Overall Study|Randomized but not treated|1|||
156793339|NCT00752219|565996239|FG001|Overall Study|Randomized but not treated|0|||
156793340|NCT00752219|565996238|FG000|Overall Study|Other|3|||
156793341|NCT00752219|565996239|FG001|Overall Study|Other|0|||
156793342|NCT02758626|565996247|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
156793343|NCT02758626|565996248|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
156447118|NCT04549168|564729902|FG001|Randomization Phase|Other|2|||
156447119|NCT04549168|564729903|FG002|Randomization Phase|Other|0|||
156447120|NCT04549168|564729901|FG000|Randomization Phase|Withdrawal by Subject|0|||
156447121|NCT04549168|564729902|FG001|Randomization Phase|Withdrawal by Subject|2|||
156447122|NCT04549168|564729903|FG002|Randomization Phase|Withdrawal by Subject|1|||
156447123|NCT05054374|564729924|FG000|Overall Study|Withdrawal by Subject|1|||
156447124|NCT05054374|564729925|FG001|Overall Study|Withdrawal by Subject|0|||
156447125|NCT05054374|564729926|FG002|Overall Study|Withdrawal by Subject|0|||
156447126|NCT05054374|564729927|FG003|Overall Study|Withdrawal by Subject|0|||
156447127|NCT05054374|564729924|FG000|Overall Study|Progressive Disease|5|||
156447128|NCT05054374|564729925|FG001|Overall Study|Progressive Disease|0|||
156447129|NCT05054374|564729926|FG002|Overall Study|Progressive Disease|0|||
156447130|NCT05054374|564729927|FG003|Overall Study|Progressive Disease|0|||
156447131|NCT05691309|564729928|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
156447132|NCT05691309|564729928|FG000|Overall Study|vancomycin levels not evaluable|2|||
156447133|NCT02697136|564729936|FG000|Overall Study|Adverse Event|3|||
156447134|NCT02697136|564729937|FG001|Overall Study|Adverse Event|0|||
156447135|NCT02323321|564729941|FG000|Overall Study|Re-Transplant|1|||
156447136|NCT02323321|564729941|FG000|Overall Study|Death|12|||
156447141|NCT04093752|564729946|FG000|Overall Study|Adverse Event|7|||
156447142|NCT04093752|564729947|FG001|Overall Study|Adverse Event|19|||
156447143|NCT04093752|564729948|FG002|Overall Study|Adverse Event|18|||
156447144|NCT04093752|564729949|FG003|Overall Study|Adverse Event|4|||
156447145|NCT04093752|564729946|FG000|Overall Study|Withdrawal by Subject|6|||
156447146|NCT04093752|564729947|FG001|Overall Study|Withdrawal by Subject|6|||
156447147|NCT04093752|564729948|FG002|Overall Study|Withdrawal by Subject|8|||
156447148|NCT04093752|564729949|FG003|Overall Study|Withdrawal by Subject|20|||
156447149|NCT04093752|564729946|FG000|Overall Study|Lost to Follow-up|2|||
156447150|NCT04093752|564729947|FG001|Overall Study|Lost to Follow-up|1|||
156447151|NCT04093752|564729948|FG002|Overall Study|Lost to Follow-up|1|||
156447152|NCT04093752|564729949|FG003|Overall Study|Lost to Follow-up|1|||
156447153|NCT04093752|564729946|FG000|Overall Study|Death|0|||
156447154|NCT04093752|564729947|FG001|Overall Study|Death|0|||
156447155|NCT04093752|564729948|FG002|Overall Study|Death|1|||
156447156|NCT04093752|564729949|FG003|Overall Study|Death|2|||
156447157|NCT04093752|564729946|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
156447158|NCT04093752|564729947|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
156447159|NCT04093752|564729948|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
156447160|NCT04093752|564729949|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
156447161|NCT04093752|564729946|FG000|Overall Study|Covid 19|0|||
156447162|NCT04093752|564729947|FG001|Overall Study|Covid 19|0|||
156447163|NCT04093752|564729948|FG002|Overall Study|Covid 19|0|||
156447164|NCT04093752|564729949|FG003|Overall Study|Covid 19|1|||
156447165|NCT04093752|564729946|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
156447166|NCT04093752|564729947|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
156447167|NCT04093752|564729948|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
156447168|NCT04093752|564729949|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
156447169|NCT04093752|564729946|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
156447170|NCT04093752|564729947|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
156447171|NCT04093752|564729948|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
156447172|NCT04093752|564729949|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
156447173|NCT04093752|564729946|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
156447174|NCT04093752|564729947|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
156447175|NCT04093752|564729948|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
156447176|NCT04093752|564729949|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
156447177|NCT00901901|564729950|FG000|Treatment Period|Adverse Event|120|||
156447178|NCT00901901|564729951|FG001|Treatment Period|Adverse Event|128|||
156447179|NCT00901901|564729950|FG000|Treatment Period|Withdrawal by Subject|26|||
156447180|NCT00901901|564729951|FG001|Treatment Period|Withdrawal by Subject|24|||
156447181|NCT00901901|564729950|FG000|Treatment Period|Physician Decision|2|||
156447182|NCT00901901|564729951|FG001|Treatment Period|Physician Decision|2|||
156447183|NCT00901901|564729950|FG000|Treatment Period|Lost to Follow-up|3|||
156447184|NCT00901901|564729951|FG001|Treatment Period|Lost to Follow-up|5|||
156447185|NCT00901901|564729950|FG000|Treatment Period|Noncompliance with study medication|4|||
156447186|NCT00901901|564729951|FG001|Treatment Period|Noncompliance with study medication|1|||
156447187|NCT00901901|564729950|FG000|Treatment Period|Missing|1|||
156793344|NCT02758626|565996247|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
156533068|NCT04178967|565046861|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
156533069|NCT04178967|565046862|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
156533070|NCT04178967|565046863|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
156533071|NCT04178967|565046864|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
156533072|NCT04178967|565046865|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
156533073|NCT04178967|565046855|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156533074|NCT04178967|565046856|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156533075|NCT04178967|565046857|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156533076|NCT04178967|565046858|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
156533077|NCT04178967|565046859|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156533078|NCT04178967|565046860|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
156533079|NCT04178967|565046861|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
156533080|NCT04178967|565046862|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
156533081|NCT04178967|565046863|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156533082|NCT04178967|565046864|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156793345|NCT02758626|565996248|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
156793346|NCT02758626|565996247|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
156447188|NCT00901901|564729951|FG001|Treatment Period|Missing|0|||
156447189|NCT00901901|564729950|FG000|Treatment Period|Never treated|0|||
156447190|NCT00901901|564729951|FG001|Treatment Period|Never treated|3|||
156447191|NCT00901901|564729950|FG000|Treatment Period|Protocol driven decision point|0|||
156447192|NCT00901901|564729951|FG001|Treatment Period|Protocol driven decision point|2|||
156447193|NCT00901901|564729950|FG000|Treatment Period|Study terminated by sponsor|2|||
156874836|NCT03892967|566298745|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
156874837|NCT03892967|566298746|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
156874838|NCT03892967|566298747|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
156874839|NCT03892967|566298748|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
156874840|NCT03892967|566298749|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
156874841|NCT03892967|566298745|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
156874842|NCT03892967|566298746|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
156874843|NCT03892967|566298747|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
156874844|NCT03892967|566298748|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
156874845|NCT03892967|566298749|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
156447194|NCT00901901|564729951|FG001|Treatment Period|Study terminated by sponsor|0|||
156447195|NCT00901901|564729950|FG000|Treatment Period|Protocol Violation|5|||
156447196|NCT00901901|564729951|FG001|Treatment Period|Protocol Violation|9|||
156447197|NCT00901901|564729950|FG000|Treatment Period|Switch to commercial drug|1|||
156447198|NCT00901901|564729951|FG001|Treatment Period|Switch to commercial drug|1|||
156447199|NCT00901901|564729950|FG000|Treatment Period|Transfer to treatment continuation study|5|||
156447200|NCT00901901|564729951|FG001|Treatment Period|Transfer to treatment continuation study|2|||
156447201|NCT00901901|564729950|FG000|Follow-up Period|Death|181|||
156793347|NCT02758626|565996248|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
156874846|NCT04434937|566298750|FG000|Overall Study|Death|4|||
156793348|NCT02758626|565996247|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
156793349|NCT02758626|565996248|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
156793350|NCT00456365|565996256|FG000|Overall Study|Lost to Follow-up|1|||
156793351|NCT00456365|565996257|FG001|Overall Study|Lost to Follow-up|3|||
156793352|NCT00456365|565996256|FG000|Overall Study|Withdrawal by Subject|4|||
156874847|NCT04434937|566298750|FG000|Overall Study|Withdrawal by Subject|1|||
156874848|NCT04434937|566298750|FG000|Overall Study|Transitioned to Rollover Study|19|||
156874849|NCT04434937|566298750|FG000|Overall Study|Progressive Disease|18|||
156874850|NCT04549545|566300561|FG000|Initial Period|Withdrawal by Subject|4|||
156874851|NCT04549545|566300562|FG001|Initial Period|Withdrawal by Subject|0|||
156874852|NCT04549545|566300561|FG000|Initial Period|Additional ENT Procedure|3|||
156874853|NCT04549545|566300562|FG001|Initial Period|Additional ENT Procedure|0|||
156874854|NCT04549545|566300561|FG000|Initial Period|Lost to Follow-up|3|||
156874855|NCT04549545|566300562|FG001|Initial Period|Lost to Follow-up|1|||
156874856|NCT04549545|566300561|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
156874857|NCT04549545|566300562|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
156793353|NCT00456365|565996257|FG001|Overall Study|Withdrawal by Subject|7|||
156447202|NCT00901901|564729951|FG001|Follow-up Period|Death|208|||
156447203|NCT00901901|564729950|FG000|Follow-up Period|Protocol driven decision point|47|||
156447204|NCT00901901|564729951|FG001|Follow-up Period|Protocol driven decision point|36|||
156447205|NCT00901901|564729950|FG000|Follow-up Period|Withdrawal by Subject|6|||
156874858|NCT04549545|566300561|FG000|Crossover Period|Additional ENT Procedure|0|||
156447206|NCT00901901|564729951|FG001|Follow-up Period|Withdrawal by Subject|9|||
156447207|NCT00901901|564729950|FG000|Follow-up Period|Lost to Follow-up|12|||
156447208|NCT00901901|564729951|FG001|Follow-up Period|Lost to Follow-up|8|||
156447209|NCT00901901|564729950|FG000|Follow-up Period|Missing|94|||
156447210|NCT00901901|564729951|FG001|Follow-up Period|Missing|80|||
156447211|NCT00951379|564729952|FG000|Overall Study|Adverse Event|4|||
156447212|NCT00951379|564729953|FG001|Overall Study|Adverse Event|1|||
156447213|NCT00951379|564729952|FG000|Overall Study|Withdrawal by Subject|1|||
156447214|NCT00951379|564729953|FG001|Overall Study|Withdrawal by Subject|0|||
156447215|NCT00951379|564729952|FG000|Overall Study|Noncompliance|1|||
156447216|NCT00951379|564729953|FG001|Overall Study|Noncompliance|0|||
156447217|NCT00951379|564729952|FG000|Overall Study|Disease Progression|0|||
156447218|NCT00951379|564729953|FG001|Overall Study|Disease Progression|1|||
156447219|NCT02742519|564729954|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
156447220|NCT02742519|564729955|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
156447221|NCT02742519|564729956|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
156447222|NCT02742519|564729954|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
156447223|NCT02742519|564729955|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
156447224|NCT02742519|564729956|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
156447225|NCT02742519|564729954|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
156447226|NCT02742519|564729955|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
156447227|NCT02742519|564729956|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
156447228|NCT03432858|564729958|FG000|Overall Study|Protocol Violation|2|||
156447229|NCT03432858|564729959|FG001|Overall Study|Protocol Violation|1|||
156447230|NCT03432858|564729960|FG002|Overall Study|Protocol Violation|9|||
156447231|NCT03432858|564729958|FG000|Overall Study|Withdrawal by Subject|0|||
156447232|NCT03432858|564729959|FG001|Overall Study|Withdrawal by Subject|1|||
156447233|NCT03432858|564729960|FG002|Overall Study|Withdrawal by Subject|1|||
156447234|NCT03432858|564729958|FG000|Overall Study|Procedure canceled/rescheduled|0|||
156447235|NCT03432858|564729959|FG001|Overall Study|Procedure canceled/rescheduled|9|||
156447236|NCT03432858|564729960|FG002|Overall Study|Procedure canceled/rescheduled|6|||
156447237|NCT03432858|564729958|FG000|Overall Study|Required postop mobilization with splinting|0|||
156447238|NCT03432858|564729959|FG001|Overall Study|Required postop mobilization with splinting|0|||
156447239|NCT03432858|564729960|FG002|Overall Study|Required postop mobilization with splinting|1|||
156447240|NCT03580369|564729963|FG000|Overall Study|No treatment due to mis-randomization|1|||
156447241|NCT03580369|564729964|FG001|Overall Study|No treatment due to mis-randomization|0|||
156447242|NCT03580369|564729965|FG002|Overall Study|No treatment due to mis-randomization|0|||
156447243|NCT03580369|564729966|FG003|Overall Study|No treatment due to mis-randomization|0|||
156447244|NCT03580369|564729967|FG004|Overall Study|No treatment due to mis-randomization|3|||
156447245|NCT03580369|564729968|FG005|Overall Study|No treatment due to mis-randomization|0|||
156447246|NCT03580369|564729969|FG006|Overall Study|No treatment due to mis-randomization|0|||
156447247|NCT03580369|564729970|FG007|Overall Study|No treatment due to mis-randomization|0|||
156447248|NCT03580369|564729963|FG000|Overall Study|Reason unknown|0|||
156447249|NCT03580369|564729964|FG001|Overall Study|Reason unknown|0|||
156447250|NCT03580369|564729965|FG002|Overall Study|Reason unknown|1|||
156447251|NCT03580369|564729966|FG003|Overall Study|Reason unknown|0|||
156447252|NCT03580369|564729967|FG004|Overall Study|Reason unknown|0|||
156447253|NCT03580369|564729968|FG005|Overall Study|Reason unknown|0|||
156447254|NCT03580369|564729969|FG006|Overall Study|Reason unknown|0|||
156447255|NCT03580369|564729970|FG007|Overall Study|Reason unknown|0|||
156447256|NCT03580369|564729963|FG000|Overall Study|Technical problems|0|||
156447257|NCT03580369|564729964|FG001|Overall Study|Technical problems|0|||
156447258|NCT03580369|564729965|FG002|Overall Study|Technical problems|0|||
156447259|NCT03580369|564729966|FG003|Overall Study|Technical problems|0|||
156447260|NCT03580369|564729967|FG004|Overall Study|Technical problems|1|||
156447261|NCT03580369|564729968|FG005|Overall Study|Technical problems|0|||
156447262|NCT03580369|564729969|FG006|Overall Study|Technical problems|2|||
156447263|NCT03580369|564729970|FG007|Overall Study|Technical problems|0|||
156447264|NCT03580369|564729963|FG000|Overall Study|Pregnancy|2|||
156447265|NCT03580369|564729964|FG001|Overall Study|Pregnancy|0|||
156447266|NCT03580369|564729965|FG002|Overall Study|Pregnancy|3|||
156447267|NCT03580369|564729966|FG003|Overall Study|Pregnancy|0|||
156447268|NCT03580369|564729967|FG004|Overall Study|Pregnancy|2|||
156447269|NCT03580369|564729968|FG005|Overall Study|Pregnancy|0|||
156447270|NCT03580369|564729969|FG006|Overall Study|Pregnancy|0|||
156447271|NCT03580369|564729970|FG007|Overall Study|Pregnancy|0|||
156447272|NCT03580369|564729963|FG000|Overall Study|Lost to Follow-up|2|||
156447273|NCT03580369|564729964|FG001|Overall Study|Lost to Follow-up|0|||
156447274|NCT03580369|564729965|FG002|Overall Study|Lost to Follow-up|2|||
156447275|NCT03580369|564729966|FG003|Overall Study|Lost to Follow-up|0|||
156447276|NCT03580369|564729967|FG004|Overall Study|Lost to Follow-up|3|||
156447277|NCT03580369|564729968|FG005|Overall Study|Lost to Follow-up|0|||
156447278|NCT03580369|564729969|FG006|Overall Study|Lost to Follow-up|1|||
156447279|NCT03580369|564729970|FG007|Overall Study|Lost to Follow-up|0|||
156447280|NCT03580369|564729963|FG000|Overall Study|Physician Decision|4|||
156447281|NCT03580369|564729964|FG001|Overall Study|Physician Decision|0|||
156447282|NCT03580369|564729965|FG002|Overall Study|Physician Decision|4|||
156447283|NCT03580369|564729966|FG003|Overall Study|Physician Decision|1|||
156447284|NCT03580369|564729967|FG004|Overall Study|Physician Decision|1|||
156447285|NCT03580369|564729968|FG005|Overall Study|Physician Decision|0|||
156447286|NCT03580369|564729969|FG006|Overall Study|Physician Decision|0|||
156447287|NCT03580369|564729970|FG007|Overall Study|Physician Decision|0|||
156447288|NCT03580369|564729963|FG000|Overall Study|Lack of Efficacy|3|||
156447289|NCT03580369|564729964|FG001|Overall Study|Lack of Efficacy|0|||
156447290|NCT03580369|564729965|FG002|Overall Study|Lack of Efficacy|7|||
156447291|NCT03580369|564729966|FG003|Overall Study|Lack of Efficacy|0|||
156447292|NCT03580369|564729967|FG004|Overall Study|Lack of Efficacy|2|||
156793354|NCT00456365|565996256|FG000|Overall Study|Pregnancy|1|||
156793355|NCT00456365|565996257|FG001|Overall Study|Pregnancy|1|||
156793356|NCT00456365|565996256|FG000|Overall Study|oncologic diagnosis|1|||
156793357|NCT00456365|565996257|FG001|Overall Study|oncologic diagnosis|1|||
156793358|NCT00803049|565996263|FG000|Overall Study|Adverse Event|21|||
156793359|NCT00803049|565996264|FG001|Overall Study|Adverse Event|33|||
156793360|NCT00803049|565996265|FG002|Overall Study|Adverse Event|13|||
156793361|NCT00803049|565996266|FG003|Overall Study|Adverse Event|27|||
156793362|NCT00803049|565996263|FG000|Overall Study|Lack of Efficacy|10|||
156793363|NCT00803049|565996264|FG001|Overall Study|Lack of Efficacy|19|||
156793364|NCT00803049|565996265|FG002|Overall Study|Lack of Efficacy|6|||
156793365|NCT00803049|565996266|FG003|Overall Study|Lack of Efficacy|13|||
156793366|NCT00803049|565996263|FG000|Overall Study|Lost to Follow-up|0|||
156793367|NCT00803049|565996264|FG001|Overall Study|Lost to Follow-up|2|||
156793368|NCT00803049|565996265|FG002|Overall Study|Lost to Follow-up|0|||
156793369|NCT00803049|565996266|FG003|Overall Study|Lost to Follow-up|3|||
156793370|NCT00803049|565996263|FG000|Overall Study|Death|2|||
156793371|NCT00803049|565996264|FG001|Overall Study|Death|1|||
156793372|NCT00803049|565996265|FG002|Overall Study|Death|0|||
156793373|NCT00803049|565996266|FG003|Overall Study|Death|2|||
156793374|NCT00803049|565996263|FG000|Overall Study|Progressive Disease|6|||
156793375|NCT00803049|565996264|FG001|Overall Study|Progressive Disease|10|||
156793376|NCT00803049|565996265|FG002|Overall Study|Progressive Disease|6|||
156793377|NCT00803049|565996266|FG003|Overall Study|Progressive Disease|6|||
156793378|NCT00803049|565996263|FG000|Overall Study|Withdrawal by Subject|19|||
156793379|NCT00803049|565996264|FG001|Overall Study|Withdrawal by Subject|43|||
156793380|NCT00803049|565996265|FG002|Overall Study|Withdrawal by Subject|16|||
156793381|NCT00803049|565996266|FG003|Overall Study|Withdrawal by Subject|44|||
156793382|NCT00803049|565996263|FG000|Overall Study|Protocol Violation|0|||
156793383|NCT00803049|565996264|FG001|Overall Study|Protocol Violation|1|||
156793384|NCT00803049|565996265|FG002|Overall Study|Protocol Violation|1|||
156793385|NCT00803049|565996266|FG003|Overall Study|Protocol Violation|0|||
156793386|NCT00803049|565996263|FG000|Overall Study|Randomized and Not Treated|0|||
156793387|NCT00803049|565996264|FG001|Overall Study|Randomized and Not Treated|0|||
156793388|NCT00803049|565996265|FG002|Overall Study|Randomized and Not Treated|0|||
156793389|NCT00803049|565996266|FG003|Overall Study|Randomized and Not Treated|2|||
156793390|NCT00803049|565996263|FG000|Overall Study|Other than Specified Above|3|||
156793391|NCT00803049|565996264|FG001|Overall Study|Other than Specified Above|9|||
156793392|NCT00803049|565996265|FG002|Overall Study|Other than Specified Above|2|||
156793393|NCT00803049|565996266|FG003|Overall Study|Other than Specified Above|5|||
156793394|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
156793395|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
156793396|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
156793397|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
156793398|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
156793399|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
156793400|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
156793401|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
156793402|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
156793403|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
156793404|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
156793405|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
156793406|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
156793407|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
156793408|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
156793409|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
156793410|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
156793411|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
156793412|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
156447293|NCT03580369|564729968|FG005|Overall Study|Lack of Efficacy|0|||
156447294|NCT03580369|564729969|FG006|Overall Study|Lack of Efficacy|3|||
156793413|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
156793414|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
156533083|NCT04178967|565046865|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156533084|NCT04178967|565046855|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
156533085|NCT04178967|565046856|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
156334740|NCT02663908|564322498|FG001|Overall Study|Withdrawal by Subject|5|||
156334741|NCT02663908|564322497|FG000|Overall Study|Lost to Follow-up|1|||
156334742|NCT02663908|564322498|FG001|Overall Study|Lost to Follow-up|5|||
156334743|NCT02663908|564322497|FG000|Overall Study|Adverse Event|13|||
156334744|NCT02663908|564322498|FG001|Overall Study|Adverse Event|11|||
156334745|NCT02663908|564322497|FG000|Overall Study|Protocol Violation|1|||
156334746|NCT02663908|564322498|FG001|Overall Study|Protocol Violation|2|||
156334747|NCT02663908|564322497|FG000|Overall Study|Lack of therapeutic response|2|||
156334748|NCT02663908|564322498|FG001|Overall Study|Lack of therapeutic response|0|||
156334749|NCT02663908|564322497|FG000|Overall Study|COVID-19|1|||
156334750|NCT02663908|564322498|FG001|Overall Study|COVID-19|0|||
156334751|NCT02663908|564322497|FG000|Overall Study|Site closed|1|||
156334752|NCT02663908|564322498|FG001|Overall Study|Site closed|0|||
156334753|NCT02663908|564322497|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
156334754|NCT02663908|564322498|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
156334755|NCT02663908|564322497|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
156334756|NCT02663908|564322498|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
156334757|NCT02663908|564322497|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
156334758|NCT02663908|564322498|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
156334759|NCT02663908|564322497|FG000|Overall Study|Death|1|||
156334760|NCT02663908|564322498|FG001|Overall Study|Death|0|||
156334761|NCT02663908|564322497|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
156334762|NCT02663908|564322498|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
156334763|NCT02663908|564322497|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
156334764|NCT02663908|564322498|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
156334765|NCT02764697|564322499|FG000|Overall Study|Lack of Efficacy|3|||
156334766|NCT00437983|564322500|FG000|Overall Study|Adverse Event|6|||
156334767|NCT00437983|564322501|FG001|Overall Study|Adverse Event|6|||
156334768|NCT00437983|564322500|FG000|Overall Study|Protocol Violation|2|||
156334769|NCT00437983|564322501|FG001|Overall Study|Protocol Violation|1|||
156334770|NCT00437983|564322500|FG000|Overall Study|Withdrawal by Subject|5|||
156334771|NCT00437983|564322501|FG001|Overall Study|Withdrawal by Subject|6|||
156334772|NCT01790932|564322502|FG000|Overall Study|Disease Progression|41|||
156334773|NCT01790932|564322502|FG000|Overall Study|Adverse Event|7|||
156334774|NCT01790932|564322502|FG000|Overall Study|Physician Decision|1|||
156334775|NCT01790932|564322502|FG000|Overall Study|Withdrawal by Subject|1|||
156334776|NCT01402011|564322510|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
156334777|NCT01402011|564322511|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
156334778|NCT01402011|564322512|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
156334779|NCT01402011|564322510|FG000|Active Treatment Period|Withdrawal by Subject|1|||
156334780|NCT01402011|564322511|FG001|Active Treatment Period|Withdrawal by Subject|3|||
156334781|NCT01402011|564322512|FG002|Active Treatment Period|Withdrawal by Subject|0|||
156334782|NCT01402011|564322510|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
156334783|NCT01402011|564322511|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
156334784|NCT01402011|564322512|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
156334785|NCT03360747|564322515|FG000|Overall Study|Voluntary Withdrawal|1|||
156334786|NCT02484690|564322516|FG000|Overall Study|Adverse Event|1|||
156334787|NCT02484690|564322517|FG001|Overall Study|Adverse Event|3|||
156334788|NCT02484690|564322518|FG002|Overall Study|Adverse Event|0|||
156334789|NCT02484690|564322519|FG003|Overall Study|Adverse Event|0|||
156334790|NCT02484690|564322520|FG004|Overall Study|Adverse Event|5|||
156334791|NCT02484690|564322516|FG000|Overall Study|Death|0|||
156334792|NCT02484690|564322517|FG001|Overall Study|Death|0|||
156334793|NCT02484690|564322518|FG002|Overall Study|Death|0|||
156334794|NCT02484690|564322519|FG003|Overall Study|Death|0|||
156334795|NCT02484690|564322520|FG004|Overall Study|Death|1|||
156334796|NCT02484690|564322516|FG000|Overall Study|Withdrawal by Subject|1|||
156334797|NCT02484690|564322517|FG001|Overall Study|Withdrawal by Subject|3|||
156334798|NCT02484690|564322518|FG002|Overall Study|Withdrawal by Subject|1|||
156334799|NCT02484690|564322519|FG003|Overall Study|Withdrawal by Subject|2|||
156334800|NCT02484690|564322520|FG004|Overall Study|Withdrawal by Subject|0|||
156334801|NCT02484690|564322516|FG000|Overall Study|Physician Decision|2|||
156334802|NCT02484690|564322517|FG001|Overall Study|Physician Decision|0|||
156334803|NCT02484690|564322518|FG002|Overall Study|Physician Decision|1|||
156334804|NCT02484690|564322519|FG003|Overall Study|Physician Decision|0|||
156334805|NCT02484690|564322520|FG004|Overall Study|Physician Decision|0|||
156334806|NCT02484690|564322516|FG000|Overall Study|Lost to Follow-up|0|||
156334807|NCT02484690|564322517|FG001|Overall Study|Lost to Follow-up|0|||
156334808|NCT02484690|564322518|FG002|Overall Study|Lost to Follow-up|1|||
156334809|NCT02484690|564322519|FG003|Overall Study|Lost to Follow-up|0|||
156334810|NCT02484690|564322520|FG004|Overall Study|Lost to Follow-up|0|||
156447295|NCT03580369|564729970|FG007|Overall Study|Lack of Efficacy|0|||
156447296|NCT03580369|564729963|FG000|Overall Study|Protocol Violation|6|||
156447297|NCT03580369|564729964|FG001|Overall Study|Protocol Violation|0|||
156447298|NCT03580369|564729965|FG002|Overall Study|Protocol Violation|6|||
156447299|NCT03580369|564729966|FG003|Overall Study|Protocol Violation|1|||
156447300|NCT03580369|564729967|FG004|Overall Study|Protocol Violation|8|||
156533086|NCT04178967|565046857|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
156533087|NCT04178967|565046858|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
156533088|NCT04178967|565046859|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
156533089|NCT04178967|565046860|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
156533090|NCT04178967|565046861|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
156533091|NCT04178967|565046862|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
156533092|NCT04178967|565046863|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
156533093|NCT04178967|565046864|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
156533094|NCT04178967|565046865|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
156533095|NCT04178967|565046855|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156533096|NCT04178967|565046856|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156533097|NCT04178967|565046857|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156533098|NCT04178967|565046858|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156533099|NCT04178967|565046859|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156533100|NCT04178967|565046860|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156533101|NCT04178967|565046861|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156533102|NCT04178967|565046862|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156533103|NCT04178967|565046863|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
156533104|NCT04178967|565046864|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
156334811|NCT01759511|564322521|FG000|Overall Study|Adverse Event|4|||
156334812|NCT01759511|564322521|FG000|Overall Study|Death|2|||
156334813|NCT01759511|564322521|FG000|Overall Study|Lack of Efficacy|2|||
156334814|NCT01759511|564322521|FG000|Overall Study|Physician Decision|1|||
156334815|NCT01759511|564322521|FG000|Overall Study|Progressive Disease|5|||
156334816|NCT01759511|564322521|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
156334817|NCT01759511|564322521|FG000|Overall Study|Study Terminated by Sponsor|13|||
156334818|NCT01759511|564322521|FG000|Overall Study|Withdrawal by Subject|3|||
156447301|NCT03580369|564729968|FG005|Overall Study|Protocol Violation|2|||
156447302|NCT03580369|564729969|FG006|Overall Study|Protocol Violation|1|||
156447303|NCT03580369|564729970|FG007|Overall Study|Protocol Violation|0|||
156447304|NCT03580369|564729963|FG000|Overall Study|Adverse Event|7|||
156533105|NCT04178967|565046865|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
156533106|NCT04178967|565046855|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533107|NCT04178967|565046856|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533108|NCT04178967|565046857|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533109|NCT04178967|565046858|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533110|NCT04178967|565046859|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533111|NCT04178967|565046860|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533112|NCT04178967|565046861|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533113|NCT04178967|565046862|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533114|NCT04178967|565046863|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533115|NCT04178967|565046864|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
156447305|NCT03580369|564729964|FG001|Overall Study|Adverse Event|0|||
156533116|NCT04178967|565046865|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156533117|NCT04178967|565046855|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156533118|NCT04178967|565046856|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156533119|NCT04178967|565046857|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156533120|NCT04178967|565046858|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156533121|NCT04178967|565046859|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156533122|NCT04178967|565046860|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156533123|NCT04178967|565046861|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156334819|NCT02569671|564322524|FG000|Overall Study|Lost to Follow-up|2|||
156447306|NCT03580369|564729965|FG002|Overall Study|Adverse Event|14|||
156447307|NCT03580369|564729966|FG003|Overall Study|Adverse Event|1|||
156447308|NCT03580369|564729967|FG004|Overall Study|Adverse Event|6|||
156447309|NCT03580369|564729968|FG005|Overall Study|Adverse Event|0|||
156447310|NCT03580369|564729969|FG006|Overall Study|Adverse Event|1|||
156533124|NCT04178967|565046862|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156533125|NCT04178967|565046863|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
156334820|NCT02569671|564322525|FG001|Overall Study|Lost to Follow-up|1|||
156334821|NCT02569671|564322524|FG000|Overall Study|Withdrawal by Subject|1|||
156447311|NCT03580369|564729970|FG007|Overall Study|Adverse Event|0|||
156447312|NCT03580369|564729963|FG000|Overall Study|Withdrawal by Subject|19|||
156447313|NCT03580369|564729964|FG001|Overall Study|Withdrawal by Subject|0|||
156447314|NCT03580369|564729965|FG002|Overall Study|Withdrawal by Subject|17|||
156447315|NCT03580369|564729966|FG003|Overall Study|Withdrawal by Subject|0|||
156447316|NCT03580369|564729967|FG004|Overall Study|Withdrawal by Subject|16|||
156447317|NCT03580369|564729968|FG005|Overall Study|Withdrawal by Subject|1|||
156447318|NCT03580369|564729969|FG006|Overall Study|Withdrawal by Subject|7|||
156447319|NCT03580369|564729970|FG007|Overall Study|Withdrawal by Subject|0|||
156447320|NCT03912831|564729971|FG000|Overall Study|Death|1|||
156447321|NCT03912831|564729972|FG001|Overall Study|Death|1|||
156447322|NCT03912831|564729973|FG002|Overall Study|Death|1|||
156447323|NCT03912831|564729974|FG003|Overall Study|Death|1|||
156447324|NCT03912831|564729975|FG004|Overall Study|Death|1|||
156447325|NCT03912831|564729976|FG005|Overall Study|Death|1|||
156447326|NCT03912831|564729971|FG000|Overall Study|Reason not Specified|0|||
156447327|NCT03912831|564729972|FG001|Overall Study|Reason not Specified|0|||
156447328|NCT03912831|564729973|FG002|Overall Study|Reason not Specified|0|||
156447329|NCT03912831|564729974|FG003|Overall Study|Reason not Specified|0|||
156447330|NCT03912831|564729975|FG004|Overall Study|Reason not Specified|1|||
156447331|NCT03912831|564729976|FG005|Overall Study|Reason not Specified|0|||
156447332|NCT03912831|564729971|FG000|Overall Study|Withdrawal by Participant|0|||
156447333|NCT03912831|564729972|FG001|Overall Study|Withdrawal by Participant|0|||
156447334|NCT03912831|564729973|FG002|Overall Study|Withdrawal by Participant|0|||
156447335|NCT03912831|564729974|FG003|Overall Study|Withdrawal by Participant|0|||
156447336|NCT03912831|564729975|FG004|Overall Study|Withdrawal by Participant|1|||
156447337|NCT03912831|564729976|FG005|Overall Study|Withdrawal by Participant|0|||
156447338|NCT03527160|564729977|FG000|Overall Study|No urine collected|13|||
156447339|NCT03527160|564729977|FG000|Overall Study|No clinical serum creatinine collected|6|||
156447340|NCT03527160|564729977|FG000|Overall Study|Did not meet inclusion|2|||
156447341|NCT01721291|564729979|FG000|Overall Study|Withdrawal by Subject|1|||
156447342|NCT01721291|564729980|FG001|Overall Study|Withdrawal by Subject|0|||
156447343|NCT01721291|564729979|FG000|Overall Study|did not like the treatment|1|||
156447344|NCT01721291|564729980|FG001|Overall Study|did not like the treatment|0|||
156447345|NCT04623775|564729990|FG000|Randomization|No Longer Meets Study Criteria|2|||
156447346|NCT04623775|564729991|FG001|Randomization|No Longer Meets Study Criteria|1|||
156447347|NCT04623775|564729992|FG002|Randomization|No Longer Meets Study Criteria|0|||
156447348|NCT04623775|564729993|FG003|Randomization|No Longer Meets Study Criteria|0|||
156447349|NCT04623775|564729990|FG000|Randomization|Withdrew Consent|0|||
156447350|NCT04623775|564729991|FG001|Randomization|Withdrew Consent|0|||
156447351|NCT04623775|564729992|FG002|Randomization|Withdrew Consent|0|||
156447352|NCT04623775|564729993|FG003|Randomization|Withdrew Consent|1|||
156447353|NCT04623775|564729990|FG000|Randomization|Other Reasons|0|||
156447354|NCT04623775|564729991|FG001|Randomization|Other Reasons|0|||
156447355|NCT04623775|564729992|FG002|Randomization|Other Reasons|0|||
156447356|NCT04623775|564729993|FG003|Randomization|Other Reasons|1|||
156447357|NCT04623775|564729990|FG000|Treatment Period|participant withdrew consent|4|||
156447358|NCT04623775|564729991|FG001|Treatment Period|participant withdrew consent|0|||
156447359|NCT04623775|564729992|FG002|Treatment Period|participant withdrew consent|1|||
156447360|NCT04623775|564729993|FG003|Treatment Period|participant withdrew consent|2|||
156447361|NCT04623775|564729990|FG000|Treatment Period|Death|3|||
156447362|NCT04623775|564729991|FG001|Treatment Period|Death|1|||
156447363|NCT04623775|564729992|FG002|Treatment Period|Death|4|||
156447364|NCT04623775|564729993|FG003|Treatment Period|Death|2|||
156447365|NCT04623775|564729990|FG000|Treatment Period|Lost to Follow-up|0|||
156447366|NCT04623775|564729991|FG001|Treatment Period|Lost to Follow-up|2|||
156447367|NCT04623775|564729992|FG002|Treatment Period|Lost to Follow-up|0|||
156447368|NCT04623775|564729993|FG003|Treatment Period|Lost to Follow-up|0|||
156447369|NCT04623775|564729990|FG000|Treatment Period|poor/non compliance|0|||
156447370|NCT04623775|564729991|FG001|Treatment Period|poor/non compliance|0|||
156447371|NCT04623775|564729992|FG002|Treatment Period|poor/non compliance|1|||
156447372|NCT04623775|564729993|FG003|Treatment Period|poor/non compliance|0|||
156447373|NCT04623775|564729990|FG000|Treatment Period|participant no longer meets study criteria|0|||
156447374|NCT04623775|564729991|FG001|Treatment Period|participant no longer meets study criteria|1|||
156716384|NCT00838526|565705358|FG001|Overall Study|Withdrawal by Subject|5|||
156716385|NCT00838526|565705357|FG000|Overall Study|Lack of Efficacy|2|||
156447375|NCT04623775|564729992|FG002|Treatment Period|participant no longer meets study criteria|0|||
156447376|NCT04623775|564729993|FG003|Treatment Period|participant no longer meets study criteria|0|||
156447377|NCT04623775|564729990|FG000|Treatment Period|administrative reasons by sponsor|3|||
156447378|NCT04623775|564729991|FG001|Treatment Period|administrative reasons by sponsor|2|||
156447379|NCT04623775|564729992|FG002|Treatment Period|administrative reasons by sponsor|0|||
156447380|NCT04623775|564729993|FG003|Treatment Period|administrative reasons by sponsor|0|||
156447381|NCT04623775|564729990|FG000|Treatment Period|other reasons|2|||
156447382|NCT04623775|564729991|FG001|Treatment Period|other reasons|0|||
156447383|NCT04623775|564729992|FG002|Treatment Period|other reasons|1|||
156447384|NCT04623775|564729993|FG003|Treatment Period|other reasons|1|||
156447385|NCT04623775|564729990|FG000|Treatment Period|disease progression|40|||
156447386|NCT04623775|564729991|FG001|Treatment Period|disease progression|35|||
156716386|NCT00838526|565705358|FG001|Overall Study|Lack of Efficacy|3|||
156716387|NCT00838526|565705357|FG000|Overall Study|Other|11|||
156447387|NCT04623775|564729992|FG002|Treatment Period|disease progression|63|||
156447388|NCT04623775|564729993|FG003|Treatment Period|disease progression|63|||
156447389|NCT04623775|564729990|FG000|Treatment Period|study drug toxicity|12|||
156447390|NCT04623775|564729991|FG001|Treatment Period|study drug toxicity|15|||
156447391|NCT04623775|564729992|FG002|Treatment Period|study drug toxicity|13|||
156447392|NCT04623775|564729993|FG003|Treatment Period|study drug toxicity|12|||
156447393|NCT04623775|564729990|FG000|Treatment Period|AE unrelated to study drug|4|||
156447394|NCT04623775|564729991|FG001|Treatment Period|AE unrelated to study drug|9|||
156447395|NCT04623775|564729992|FG002|Treatment Period|AE unrelated to study drug|12|||
156447396|NCT04623775|564729993|FG003|Treatment Period|AE unrelated to study drug|9|||
156447397|NCT04623775|564729990|FG000|Treatment Period|participant request to discontinue treatment|0|||
156447398|NCT04623775|564729991|FG001|Treatment Period|participant request to discontinue treatment|2|||
156447399|NCT04623775|564729992|FG002|Treatment Period|participant request to discontinue treatment|2|||
156447400|NCT04623775|564729993|FG003|Treatment Period|participant request to discontinue treatment|0|||
156447401|NCT03978637|564729996|FG000|Overall Study|Death|0|||
156447402|NCT03978637|564729997|FG001|Overall Study|Death|2|||
156447403|NCT03978637|564729998|FG002|Overall Study|Death|2|||
156447404|NCT03978637|564729999|FG003|Overall Study|Death|0|||
156447405|NCT03978637|564729996|FG000|Overall Study|Withdrawal by Subject|0|||
156447406|NCT03978637|564729997|FG001|Overall Study|Withdrawal by Subject|0|||
156447407|NCT03978637|564729998|FG002|Overall Study|Withdrawal by Subject|1|||
156447408|NCT03978637|564729999|FG003|Overall Study|Withdrawal by Subject|0|||
156447409|NCT03978637|564729996|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
156447410|NCT03978637|564729997|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
156447411|NCT03978637|564729998|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
156447412|NCT03978637|564729999|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
156447413|NCT03152786|564731380|FG000|Overall Study|Withdrawal by Subject|2|||
156447414|NCT03152786|564731381|FG001|Overall Study|Withdrawal by Subject|1|||
156447415|NCT04112316|564731382|FG000|First Period (8 Weeks)|Protocol Violation|1|||
156447416|NCT04112316|564731383|FG001|First Period (8 Weeks)|Protocol Violation|0|||
156447417|NCT04112316|564731382|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
156447418|NCT04112316|564731383|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
156447419|NCT05415436|564731393|FG000|Overall Study|Surgeon cancelled procedure|1|||
156447420|NCT05415436|564731394|FG001|Overall Study|Surgeon cancelled procedure|0|||
156447421|NCT05415436|564731393|FG000|Overall Study|Death|1|||
156447422|NCT05415436|564731394|FG001|Overall Study|Death|0|||
156447423|NCT05386355|564731405|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
156447424|NCT05386355|564731406|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
156447425|NCT05386355|564731407|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
156447426|NCT05386355|564731408|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
156447427|NCT03775109|564731411|FG000|Overall Study|Adverse Event|1|||
156447428|NCT03775109|564731412|FG001|Overall Study|Adverse Event|0|||
156447429|NCT03775109|564731411|FG000|Overall Study|COVID-19 outbreak|2|||
156447430|NCT03775109|564731412|FG001|Overall Study|COVID-19 outbreak|0|||
156447431|NCT03775109|564731411|FG000|Overall Study|Lost to Follow-up|0|||
156447432|NCT03775109|564731412|FG001|Overall Study|Lost to Follow-up|2|||
156447433|NCT03775109|564731411|FG000|Overall Study|Withdrawal by Subject|1|||
156447434|NCT03775109|564731412|FG001|Overall Study|Withdrawal by Subject|1|||
156447435|NCT03775109|564731411|FG000|Overall Study|Death|0|||
156447436|NCT03775109|564731412|FG001|Overall Study|Death|1|||
156447437|NCT03775109|564731411|FG000|Overall Study|Lack of Efficacy|1|||
156874859|NCT04549545|566300562|FG001|Crossover Period|Additional ENT Procedure|6|||
156874860|NCT04549545|566300561|FG000|Crossover Period|Lost to Follow-up|0|||
156874861|NCT04549545|566300562|FG001|Crossover Period|Lost to Follow-up|1|||
156874862|NCT04549545|566300561|FG000|Crossover Period|Withdrawal by Subject|0|||
156334822|NCT02569671|564322525|FG001|Overall Study|Withdrawal by Subject|3|||
156334823|NCT01757535|564322526|FG000|Overall Study|Disease Relapse|151|||
156334824|NCT01757535|564322527|FG001|Overall Study|Disease Relapse|181|||
156334825|NCT01757535|564322526|FG000|Overall Study|Other Reasons|28|||
156334826|NCT01757535|564322527|FG001|Overall Study|Other Reasons|27|||
156334827|NCT01757535|564322526|FG000|Overall Study|Adverse Event|31|||
156334828|NCT01757535|564322527|FG001|Overall Study|Adverse Event|11|||
156447438|NCT03775109|564731412|FG001|Overall Study|Lack of Efficacy|0|||
156447439|NCT03484702|564731415|FG000|Treatment Period|Death|3|||
156447440|NCT03484702|564731416|FG001|Treatment Period|Death|1|||
156447441|NCT03484702|564731417|FG002|Treatment Period|Death|0|||
156447442|NCT03484702|564731418|FG003|Treatment Period|Death|0|||
156447443|NCT03484702|564731419|FG004|Treatment Period|Death|0|||
156447444|NCT03484702|564731420|FG005|Treatment Period|Death|0|||
156447445|NCT03484702|564731415|FG000|Treatment Period|Adverse Event|1|||
156447446|NCT03484702|564731416|FG001|Treatment Period|Adverse Event|0|||
156874863|NCT04549545|566300562|FG001|Crossover Period|Withdrawal by Subject|4|||
156334829|NCT01757535|564322526|FG000|Overall Study|Withdrew Consent|19|||
156334830|NCT01757535|564322527|FG001|Overall Study|Withdrew Consent|13|||
156447447|NCT03484702|564731417|FG002|Treatment Period|Adverse Event|0|||
156447448|NCT03484702|564731418|FG003|Treatment Period|Adverse Event|0|||
156447449|NCT03484702|564731419|FG004|Treatment Period|Adverse Event|0|||
156447450|NCT03484702|564731420|FG005|Treatment Period|Adverse Event|0|||
156447451|NCT03484702|564731415|FG000|Treatment Period|Participant Withdrew from Study|0|||
156447452|NCT03484702|564731416|FG001|Treatment Period|Participant Withdrew from Study|1|||
156447453|NCT03484702|564731417|FG002|Treatment Period|Participant Withdrew from Study|0|||
156447454|NCT03484702|564731418|FG003|Treatment Period|Participant Withdrew from Study|0|||
156447455|NCT03484702|564731419|FG004|Treatment Period|Participant Withdrew from Study|0|||
156447456|NCT03484702|564731420|FG005|Treatment Period|Participant Withdrew from Study|0|||
156447457|NCT03484702|564731415|FG000|Treatment Period|Physician Decision|0|||
156447458|NCT03484702|564731416|FG001|Treatment Period|Physician Decision|1|||
156447459|NCT03484702|564731417|FG002|Treatment Period|Physician Decision|0|||
156447460|NCT03484702|564731418|FG003|Treatment Period|Physician Decision|0|||
156447461|NCT03484702|564731419|FG004|Treatment Period|Physician Decision|0|||
156447462|NCT03484702|564731420|FG005|Treatment Period|Physician Decision|1|||
156447463|NCT01894061|564731425|FG000|Overall Study|Screen failure|1|||
156447464|NCT01894061|564731425|FG000|Overall Study|Withdrawal by Subject|1|||
156447465|NCT00739648|564731426|FG000|Overall Study|Adverse Event|3|||
156447466|NCT00739648|564731427|FG001|Overall Study|Adverse Event|15|||
156447467|NCT00739648|564731426|FG000|Overall Study|Withdrawal by Subject|13|||
156447468|NCT00739648|564731427|FG001|Overall Study|Withdrawal by Subject|25|||
156447469|NCT00739648|564731426|FG000|Overall Study|Lost to Follow-up|4|||
156447470|NCT00739648|564731427|FG001|Overall Study|Lost to Follow-up|7|||
156447471|NCT00739648|564731426|FG000|Overall Study|Death|2|||
156447472|NCT00739648|564731427|FG001|Overall Study|Death|0|||
156447473|NCT00739648|564731426|FG000|Overall Study|Do not know|4|||
156447474|NCT00739648|564731427|FG001|Overall Study|Do not know|6|||
156447475|NCT05110495|564731428|FG000|Overall Study|Lost to Follow-up|1|||
156447476|NCT05110495|564731428|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
156447477|NCT04173663|564731429|FG000|Overall Study|Withdrawal by Subject|1|||
156447478|NCT04173663|564731430|FG001|Overall Study|Withdrawal by Subject|6|||
156447479|NCT04173663|564731429|FG000|Overall Study|Lost to Follow-up|17|||
156447480|NCT04173663|564731430|FG001|Overall Study|Lost to Follow-up|24|||
156447481|NCT02840474|564731432|FG000|Overall Study|Lost to Follow-up|1|||
156447482|NCT02840474|564731433|FG001|Overall Study|Lost to Follow-up|0|||
156447483|NCT04716634|564731434|FG000|Overall Study|Death|24|||
156447484|NCT04716634|564731435|FG001|Overall Study|Death|24|||
156447485|NCT04716634|564731436|FG002|Overall Study|Death|8|||
156447486|NCT04716634|564731434|FG000|Overall Study|Closed by Sponsor|4|||
156447487|NCT04716634|564731435|FG001|Overall Study|Closed by Sponsor|4|||
156447488|NCT04716634|564731436|FG002|Overall Study|Closed by Sponsor|5|||
156447489|NCT04716634|564731434|FG000|Overall Study|Lost to Follow-up|1|||
156447490|NCT04716634|564731435|FG001|Overall Study|Lost to Follow-up|0|||
156447491|NCT04716634|564731436|FG002|Overall Study|Lost to Follow-up|1|||
156447492|NCT04716634|564731434|FG000|Overall Study|Withdrawal by Subject|0|||
156447493|NCT04716634|564731435|FG001|Overall Study|Withdrawal by Subject|0|||
156447494|NCT04716634|564731436|FG002|Overall Study|Withdrawal by Subject|1|||
156447495|NCT04737772|564731442|FG000|Phase 2 Study|Lost to Follow-up|15|||
156447496|NCT04737772|564731443|FG001|Phase 2 Study|Lost to Follow-up|15|||
156447497|NCT04737772|564731442|FG000|Phase 2 Study|Withdrawal by Subject|0|||
156447498|NCT04737772|564731443|FG001|Phase 2 Study|Withdrawal by Subject|1|||
156447499|NCT04737772|564731442|FG000|Phase 2 Study|Did not take any coaching calls|4|||
156447500|NCT04737772|564731443|FG001|Phase 2 Study|Did not take any coaching calls|0|||
156447501|NCT04737772|564731442|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
156447502|NCT04737772|564731443|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
156447503|NCT04737772|564731442|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
156447504|NCT04737772|564731443|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
156447505|NCT02549339|564731444|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
156447506|NCT02549339|564731445|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
156447507|NCT02549339|564731444|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
156447508|NCT02549339|564731445|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
156716388|NCT00838526|565705358|FG001|Overall Study|Other|7|||
156447509|NCT02549339|564731444|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
156447510|NCT02549339|564731445|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
156447511|NCT02549339|564731444|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
156447512|NCT02549339|564731445|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
156447513|NCT02549339|564731444|FG000|12-month Follow-up|Lack of Efficacy|0|||
156447514|NCT02549339|564731445|FG001|12-month Follow-up|Lack of Efficacy|2|||
156447515|NCT02549339|564731444|FG000|12-month Follow-up|Withdrawal by Subject|8|||
156447516|NCT02549339|564731445|FG001|12-month Follow-up|Withdrawal by Subject|3|||
156447517|NCT02549339|564731444|FG000|12-month Follow-up|Lost to Follow-up|1|||
156447518|NCT02549339|564731445|FG001|12-month Follow-up|Lost to Follow-up|3|||
156447519|NCT02549339|564731444|FG000|12-month Follow-up|Other|0|||
156447520|NCT02549339|564731445|FG001|12-month Follow-up|Other|3|||
156447521|NCT04820855|564731446|FG000|Overall Study|Lost to Follow-up|6|||
156447522|NCT04820855|564731447|FG001|Overall Study|Lost to Follow-up|9|||
156447523|NCT04838262|564731448|FG000|Overall Study|Withdrawal by Subject|9|||
156447524|NCT04838262|564731449|FG001|Overall Study|Withdrawal by Subject|4|||
156447525|NCT02927769|564731450|FG000|Induction Phase|Study drug toxicity|1|||
156447526|NCT02927769|564731451|FG001|Induction Phase|Study drug toxicity|1|||
156447527|NCT02927769|564731450|FG000|Induction Phase|Disease progression|0|||
156447528|NCT02927769|564731451|FG001|Induction Phase|Disease progression|1|||
156447529|NCT02927769|564731450|FG000|Intensification Phase|Study drug toxicity|1|||
156447530|NCT02927769|564731451|FG001|Intensification Phase|Study drug toxicity|0|||
156447531|NCT05956002|564731452|FG000|Treatment Period 3|Adverse Event|0|||
156447532|NCT05956002|564731453|FG001|Treatment Period 3|Adverse Event|0|||
156447533|NCT05956002|564731454|FG002|Treatment Period 3|Adverse Event|1|||
156447534|NCT05956002|564731455|FG003|Treatment Period 3|Adverse Event|0|||
156447535|NCT02307565|564731456|FG000|Overall Study|Adverse Event|3|||
156447536|NCT02307565|564731457|FG001|Overall Study|Adverse Event|2|||
156447537|NCT02307565|564731456|FG000|Overall Study|Withdrawal by Subject|2|||
156447538|NCT02307565|564731457|FG001|Overall Study|Withdrawal by Subject|2|||
156447539|NCT04838613|564731460|FG000|Overall Study|Withdrawal by Subject|3|||
156447540|NCT04838613|564731461|FG001|Overall Study|Withdrawal by Subject|6|||
156447541|NCT04838613|564731460|FG000|Overall Study|Protocol Deviation|3|||
156447542|NCT04838613|564731461|FG001|Overall Study|Protocol Deviation|2|||
156447543|NCT04838613|564731460|FG000|Overall Study|Technical Problems|0|||
156447544|NCT04838613|564731461|FG001|Overall Study|Technical Problems|5|||
156447545|NCT04838613|564731460|FG000|Overall Study|Physician Decision|2|||
156447546|NCT04838613|564731461|FG001|Overall Study|Physician Decision|0|||
156447547|NCT04970654|564731462|FG000|Overall Study|Withdrawal by parents/guardian|1|||
156447548|NCT04970654|564731463|FG001|Overall Study|Withdrawal by parents/guardian|2|||
156447549|NCT04970654|564731462|FG000|Overall Study|Unclassified|2|||
156447550|NCT04970654|564731463|FG001|Overall Study|Unclassified|1|||
156447551|NCT04970654|564731462|FG000|Overall Study|Lost to Follow-up|1|||
156447552|NCT04970654|564731463|FG001|Overall Study|Lost to Follow-up|0|||
156447553|NCT01084707|564731469|FG000|Overall Study|Withdrawal by Subject|6|||
156447554|NCT01091168|564731472|FG000|Overall Study|Progressive disease|250|||
156447555|NCT01091168|564731473|FG001|Overall Study|Progressive disease|234|||
156447556|NCT01091168|564731472|FG000|Overall Study|Adverse Event|21|||
156447557|NCT01091168|564731473|FG001|Overall Study|Adverse Event|24|||
156447558|NCT01091168|564731472|FG000|Overall Study|Lost to Follow-up|0|||
156447559|NCT01091168|564731473|FG001|Overall Study|Lost to Follow-up|1|||
156447560|NCT01091168|564731472|FG000|Overall Study|Physician, patient's decision, other|27|||
156447561|NCT01091168|564731473|FG001|Overall Study|Physician, patient's decision, other|37|||
156447562|NCT05239039|564731475|FG000|Overall Study|Withdrawal by Subject|0|||
156447563|NCT05239039|564731476|FG001|Overall Study|Withdrawal by Subject|1|||
156447564|NCT03690206|564731477|FG000|Overall Study|Withdrawal by Subject|2|||
156447565|NCT03690206|564731478|FG001|Overall Study|Withdrawal by Subject|0|||
156447566|NCT03690206|564731479|FG002|Overall Study|Withdrawal by Subject|0|||
156447567|NCT03690206|564731477|FG000|Overall Study|ICF withdrawal|2|||
156447568|NCT03690206|564731478|FG001|Overall Study|ICF withdrawal|0|||
156447569|NCT03690206|564731479|FG002|Overall Study|ICF withdrawal|0|||
156447570|NCT01959698|564731480|FG000|Overall Study|Adverse Event|0|||
156447571|NCT01959698|564731481|FG001|Overall Study|Adverse Event|0|||
156447572|NCT01959698|564731482|FG002|Overall Study|Adverse Event|0|||
156447573|NCT01959698|564731483|FG003|Overall Study|Adverse Event|0|||
156447574|NCT01959698|564731484|FG004|Overall Study|Adverse Event|0|||
156447575|NCT01959698|564731485|FG005|Overall Study|Adverse Event|0|||
156447576|NCT01959698|564731486|FG006|Overall Study|Adverse Event|1|||
156447577|NCT01959698|564731480|FG000|Overall Study|Physician Decision|1|||
156447578|NCT01959698|564731481|FG001|Overall Study|Physician Decision|0|||
156447579|NCT01959698|564731482|FG002|Overall Study|Physician Decision|1|||
156447580|NCT01959698|564731483|FG003|Overall Study|Physician Decision|2|||
156447581|NCT01959698|564731484|FG004|Overall Study|Physician Decision|0|||
156447582|NCT01959698|564731485|FG005|Overall Study|Physician Decision|3|||
156447583|NCT01959698|564731486|FG006|Overall Study|Physician Decision|3|||
156447584|NCT03897686|564732937|FG000|Overall Study|Protocol Violation|1|||
156447585|NCT03897686|564732938|FG001|Overall Study|Protocol Violation|1|||
156447586|NCT03897686|564732937|FG000|Overall Study|Withdrawal by Subject|1|||
156447587|NCT03897686|564732938|FG001|Overall Study|Withdrawal by Subject|1|||
156447588|NCT04052516|564732939|FG000|Overall Study|Withdrawal by Subject|4|||
156447589|NCT04052516|564732940|FG001|Overall Study|Withdrawal by Subject|5|||
156447590|NCT04052516|564732941|FG002|Overall Study|Withdrawal by Subject|6|||
156447591|NCT04052516|564732939|FG000|Overall Study|Adverse Event|3|||
156447592|NCT04052516|564732940|FG001|Overall Study|Adverse Event|2|||
156447593|NCT04052516|564732941|FG002|Overall Study|Adverse Event|8|||
156447594|NCT04052516|564732939|FG000|Overall Study|Lost to Follow-up|2|||
156447595|NCT04052516|564732940|FG001|Overall Study|Lost to Follow-up|5|||
156447596|NCT04052516|564732941|FG002|Overall Study|Lost to Follow-up|3|||
156447597|NCT04052516|564732939|FG000|Overall Study|Protocol Violation|1|||
156447598|NCT04052516|564732940|FG001|Overall Study|Protocol Violation|1|||
156447599|NCT04052516|564732941|FG002|Overall Study|Protocol Violation|0|||
156447600|NCT04052516|564732939|FG000|Overall Study|Death|1|||
156447601|NCT04052516|564732940|FG001|Overall Study|Death|0|||
156447602|NCT04052516|564732941|FG002|Overall Study|Death|0|||
156447603|NCT04052516|564732939|FG000|Overall Study|Physician Decision|0|||
156447604|NCT04052516|564732940|FG001|Overall Study|Physician Decision|1|||
156447605|NCT04052516|564732941|FG002|Overall Study|Physician Decision|0|||
156334831|NCT01757535|564322526|FG000|Overall Study|Physician Decision|7|||
156334832|NCT01757535|564322527|FG001|Overall Study|Physician Decision|0|||
156334833|NCT01757535|564322526|FG000|Overall Study|Death|2|||
156447606|NCT04052516|564732939|FG000|Overall Study|Pregnancy|1|||
156447607|NCT04052516|564732940|FG001|Overall Study|Pregnancy|0|||
156447608|NCT04052516|564732941|FG002|Overall Study|Pregnancy|0|||
156447609|NCT04052516|564732939|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
156447610|NCT04052516|564732940|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
156447611|NCT04052516|564732941|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
156447612|NCT04052516|564732939|FG000|Overall Study|Reason not recorded|0|||
156447613|NCT04052516|564732940|FG001|Overall Study|Reason not recorded|1|||
156447614|NCT04052516|564732941|FG002|Overall Study|Reason not recorded|0|||
156447615|NCT03625882|564732942|FG000|Overall Study|Protocol Violation|3|||
156447616|NCT05058391|564732943|FG000|Overall Study|Adverse Event|1|||
156447617|NCT03089398|564732944|FG000|Overall Study|Death|4|||
156447618|NCT03089398|564732945|FG001|Overall Study|Death|9|||
156447619|NCT03089398|564732944|FG000|Overall Study|Lost to Follow-up|21|||
156447620|NCT03089398|564732945|FG001|Overall Study|Lost to Follow-up|30|||
156447621|NCT03089398|564732944|FG000|Overall Study|Withdrawal by Subject|2|||
156447622|NCT03089398|564732945|FG001|Overall Study|Withdrawal by Subject|2|||
156447623|NCT05418296|564732950|FG000|Overall Study|Withdrawal by Subject|4|||
156447624|NCT05418296|564732951|FG001|Overall Study|Withdrawal by Subject|1|||
156447625|NCT04419168|564732954|FG000|Overall Study|Protocol Violation|1|||
156447626|NCT04419168|564732955|FG001|Overall Study|Protocol Violation|1|||
156447627|NCT04419168|564732954|FG000|Overall Study|Lost to Follow-up|7|||
156447628|NCT04419168|564732955|FG001|Overall Study|Lost to Follow-up|7|||
156447629|NCT04419168|564732954|FG000|Overall Study|Missed 6-month Visit|48|||
156447630|NCT04419168|564732955|FG001|Overall Study|Missed 6-month Visit|45|||
156447631|NCT03713086|564732958|FG000|Overall Study|Withdrawal by Subject|0|||
156447632|NCT03713086|564732959|FG001|Overall Study|Withdrawal by Subject|2|||
156447633|NCT03713086|564732960|FG002|Overall Study|Withdrawal by Subject|1|||
156447634|NCT03713086|564732961|FG003|Overall Study|Withdrawal by Subject|0|||
156447635|NCT03713086|564732958|FG000|Overall Study|Lost to Follow-up|0|||
156447636|NCT03713086|564732959|FG001|Overall Study|Lost to Follow-up|1|||
156447637|NCT03713086|564732960|FG002|Overall Study|Lost to Follow-up|0|||
156447638|NCT03713086|564732961|FG003|Overall Study|Lost to Follow-up|1|||
156447639|NCT05009251|564732962|FG000|Overall Study|Protocol Violation|100|||
156447640|NCT05009251|564732963|FG001|Overall Study|Protocol Violation|105|||
156447641|NCT05009251|564732964|FG002|Overall Study|Protocol Violation|119|||
156447642|NCT05009251|564732965|FG003|Overall Study|Protocol Violation|120|||
156447643|NCT05009251|564732966|FG004|Overall Study|Protocol Violation|119|||
156447644|NCT05009251|564732962|FG000|Overall Study|Death|25|||
156716389|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
156716390|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
156716391|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
156716392|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
156716393|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
156716394|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
156716395|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
156716396|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
156716397|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
156716398|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
156716399|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
156716400|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
156716401|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
156874864|NCT01865552|566300565|FG000|Period 1|Adverse Event|1|||
156874865|NCT01865552|566300566|FG001|Period 1|Adverse Event|0|||
156334834|NCT01757535|564322527|FG001|Overall Study|Death|2|||
156334835|NCT00589290|564322528|FG000|Overall Study|Withdrawal by Subject|1|||
156334836|NCT01798004|564324400|FG000|Overall Study|Death|2|||
156334837|NCT01798004|564324400|FG000|Overall Study|Lack of Efficacy|8|||
156334838|NCT01798004|564324400|FG000|Overall Study|Physician Decision|25|||
156334839|NCT01798004|564324400|FG000|Overall Study|Withdrawal by Subject|4|||
156334840|NCT01798004|564324400|FG000|Overall Study|Ineligible|4|||
156334841|NCT01798004|564324400|FG000|Overall Study|Patient/parent refusal|7|||
156334842|NCT01798004|564324400|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
156447645|NCT05009251|564732963|FG001|Overall Study|Death|22|||
156447646|NCT05009251|564732964|FG002|Overall Study|Death|24|||
156447647|NCT05009251|564732965|FG003|Overall Study|Death|19|||
156447648|NCT05009251|564732966|FG004|Overall Study|Death|15|||
156447649|NCT02249949|564732971|FG000|Overall Study|Cancelled prior to treatment|2|||
156533126|NCT04178967|565046864|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
156334843|NCT01798004|564324400|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
156334844|NCT03320057|564324401|FG000|Overall Study|Lost to Follow-up|4|||
156334845|NCT03320057|564324402|FG001|Overall Study|Lost to Follow-up|17|||
156334846|NCT03320057|564324401|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
156334847|NCT03320057|564324402|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
156334848|NCT04805541|564324407|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
156334849|NCT05154578|564324408|FG000|Overall Study|Withdrawal by Subject|2|||
156334850|NCT05154578|564324409|FG001|Overall Study|Withdrawal by Subject|3|||
156334851|NCT05154578|564324410|FG002|Overall Study|Withdrawal by Subject|2|||
156334852|NCT05154578|564324411|FG003|Overall Study|Withdrawal by Subject|4|||
156334853|NCT05154578|564324412|FG004|Overall Study|Withdrawal by Subject|0|||
156334854|NCT05154578|564324408|FG000|Overall Study|Lost to Follow-up|0|||
156334855|NCT05154578|564324409|FG001|Overall Study|Lost to Follow-up|1|||
156334856|NCT05154578|564324410|FG002|Overall Study|Lost to Follow-up|0|||
156334857|NCT05154578|564324411|FG003|Overall Study|Lost to Follow-up|3|||
156334858|NCT05154578|564324412|FG004|Overall Study|Lost to Follow-up|0|||
156334859|NCT05154578|564324408|FG000|Overall Study|Adverse Event|0|||
156334860|NCT05154578|564324409|FG001|Overall Study|Adverse Event|0|||
156334861|NCT05154578|564324410|FG002|Overall Study|Adverse Event|0|||
156334862|NCT05154578|564324411|FG003|Overall Study|Adverse Event|1|||
156334863|NCT05154578|564324412|FG004|Overall Study|Adverse Event|0|||
156334864|NCT05154578|564324408|FG000|Overall Study|Relocated to another province|0|||
156334865|NCT05154578|564324409|FG001|Overall Study|Relocated to another province|0|||
156334866|NCT05154578|564324410|FG002|Overall Study|Relocated to another province|1|||
156334867|NCT05154578|564324411|FG003|Overall Study|Relocated to another province|0|||
156334868|NCT05154578|564324412|FG004|Overall Study|Relocated to another province|1|||
156334869|NCT05154578|564324408|FG000|Overall Study|Baby loss|0|||
156334870|NCT05154578|564324409|FG001|Overall Study|Baby loss|1|||
156334871|NCT05154578|564324410|FG002|Overall Study|Baby loss|0|||
156334872|NCT05154578|564324411|FG003|Overall Study|Baby loss|0|||
156334873|NCT05154578|564324412|FG004|Overall Study|Baby loss|0|||
156334874|NCT00142935|564324416|FG000|Overall Study|Other reason|1|||
156334875|NCT00142935|564324417|FG001|Overall Study|Other reason|1|||
156334876|NCT00142935|564324418|FG002|Overall Study|Other reason|1|||
156334877|NCT00142935|564324416|FG000|Overall Study|Lost to Follow-up|2|||
156334878|NCT00142935|564324417|FG001|Overall Study|Lost to Follow-up|5|||
156334879|NCT00142935|564324418|FG002|Overall Study|Lost to Follow-up|5|||
156334880|NCT00142935|564324416|FG000|Overall Study|Death|0|||
156334881|NCT00142935|564324417|FG001|Overall Study|Death|2|||
156334882|NCT00142935|564324418|FG002|Overall Study|Death|1|||
156334883|NCT01330030|564324421|FG000|Overall Study|Lost to Follow-up|16|||
156334884|NCT01330030|564324422|FG001|Overall Study|Lost to Follow-up|17|||
156334885|NCT03626168|564324423|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156334886|NCT03626168|564324424|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156334887|NCT03626168|564324423|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
156334888|NCT03626168|564324424|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
156334889|NCT03626168|564324423|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156334890|NCT03626168|564324424|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
156334891|NCT01419626|564324425|FG000|Overall Study|Protocol Violation|3|||
156334892|NCT01419626|564324426|FG001|Overall Study|Protocol Violation|2|||
156334893|NCT01419626|564324427|FG002|Overall Study|Protocol Violation|2|||
156334894|NCT01419626|564324425|FG000|Overall Study|Withdrawal by Subject|1|||
156334895|NCT01419626|564324426|FG001|Overall Study|Withdrawal by Subject|0|||
156334896|NCT01419626|564324427|FG002|Overall Study|Withdrawal by Subject|0|||
156334897|NCT01419626|564324425|FG000|Overall Study|Lost to Follow-up|0|||
156334898|NCT01419626|564324426|FG001|Overall Study|Lost to Follow-up|1|||
156334899|NCT01419626|564324427|FG002|Overall Study|Lost to Follow-up|1|||
156334900|NCT01365052|564324428|FG000|Overall Study|Adverse Event|4|||
156334901|NCT01365052|564324429|FG001|Overall Study|Adverse Event|4|||
156334902|NCT01146912|564324430|FG000|Overall Study|Already received influenza vaccination|817|||
156334903|NCT01146912|564324431|FG001|Overall Study|Already received influenza vaccination|822|||
156334904|NCT01146912|564324432|FG002|Overall Study|Already received influenza vaccination|13|||
156334905|NCT01146912|564324433|FG003|Overall Study|Already received influenza vaccination|15|||
156334906|NCT01146912|564324434|FG004|Overall Study|Already received influenza vaccination|41|||
156334907|NCT01146912|564324435|FG005|Overall Study|Already received influenza vaccination|61|||
156334908|NCT01146912|564324436|FG006|Overall Study|Already received influenza vaccination|56|||
156334909|NCT01146912|564324437|FG007|Overall Study|Already received influenza vaccination|0|||
156334910|NCT01146912|564324430|FG000|Overall Study|< 14 weeks gestational age|0|||
156334911|NCT01146912|564324431|FG001|Overall Study|< 14 weeks gestational age|0|||
156334912|NCT01146912|564324432|FG002|Overall Study|< 14 weeks gestational age|3|||
156334913|NCT01146912|564324433|FG003|Overall Study|< 14 weeks gestational age|2|||
156874866|NCT01865552|566300567|FG002|Period 1|Adverse Event|0|||
156874867|NCT01865552|566300568|FG003|Period 1|Adverse Event|1|||
156874868|NCT01865552|566300569|FG004|Period 1|Adverse Event|1|||
156874869|NCT01865552|566300570|FG005|Period 1|Adverse Event|1|||
156874870|NCT01865552|566300565|FG000|Period 1|Pathological lab|0|||
156874871|NCT01865552|566300566|FG001|Period 1|Pathological lab|0|||
156447650|NCT02097420|564732974|FG000|Overall Study|Death|6|||
156447651|NCT02097420|564732974|FG000|Overall Study|Valve explanted|13|||
156447652|NCT02097420|564732974|FG000|Overall Study|Other Reason|1|||
156447653|NCT05059262|564732975|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
156447654|NCT05059262|564732976|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
156447655|NCT05059262|564732975|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
156447656|NCT05059262|564732976|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
156447657|NCT05059262|564732975|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
156447658|NCT05059262|564732976|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
156447659|NCT05059262|564732975|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
156447660|NCT05059262|564732976|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
156447661|NCT05059262|564732975|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
156447662|NCT05059262|564732976|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
156447663|NCT05059262|564732975|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
156447664|NCT05059262|564732976|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
156447665|NCT05059262|564732975|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
156447666|NCT05059262|564732976|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
156447667|NCT05059262|564732975|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
156447668|NCT05059262|564732976|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
156447669|NCT05059262|564732975|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
156447670|NCT05059262|564732976|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
156447671|NCT02728076|564732978|FG000|Overall Study|Physician Decision|4|||
156447672|NCT04263311|564732979|FG000|Overall Study|Lost to Follow-up|1|||
156447673|NCT04263311|564732980|FG001|Overall Study|Lost to Follow-up|2|||
156447674|NCT04263311|564732981|FG002|Overall Study|Lost to Follow-up|0|||
156447675|NCT04263311|564732979|FG000|Overall Study|Health Issues|1|||
156447676|NCT04263311|564732980|FG001|Overall Study|Health Issues|0|||
156447677|NCT04263311|564732981|FG002|Overall Study|Health Issues|0|||
156447678|NCT04263311|564732979|FG000|Overall Study|Left the country|1|||
156447679|NCT04263311|564732980|FG001|Overall Study|Left the country|0|||
156447680|NCT04263311|564732981|FG002|Overall Study|Left the country|0|||
156447681|NCT04263311|564732979|FG000|Overall Study|Unable to maintain time commitment|1|||
156447682|NCT04263311|564732980|FG001|Overall Study|Unable to maintain time commitment|0|||
156447683|NCT04263311|564732981|FG002|Overall Study|Unable to maintain time commitment|0|||
156447684|NCT04263311|564732979|FG000|Overall Study|No longer interested|1|||
156447685|NCT04263311|564732980|FG001|Overall Study|No longer interested|0|||
156447686|NCT04263311|564732981|FG002|Overall Study|No longer interested|0|||
156447687|NCT04263311|564732979|FG000|Overall Study|Ineligible post consent|0|||
156447688|NCT04263311|564732980|FG001|Overall Study|Ineligible post consent|0|||
156447689|NCT04263311|564732981|FG002|Overall Study|Ineligible post consent|5|||
156447690|NCT03315754|564732985|FG000|Overall Study|COVID-19 complications leading to death|1|||
156447691|NCT03315754|564732985|FG000|Overall Study|insurance coverage issue|1|||
156447692|NCT02954341|564732986|FG000|Overall Study|Attempted Implant unsuccessful|5|||
156447693|NCT02954341|564732986|FG000|Overall Study|Death|90|||
156447694|NCT02954341|564732986|FG000|Overall Study|Withdrawal by Subject|4|||
156447695|NCT02954341|564732986|FG000|Overall Study|Physician Decision|13|||
156447696|NCT02954341|564732986|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
156447697|NCT02954341|564732986|FG000|Overall Study|Not implanted due to physician's decision|1|||
156447698|NCT02954341|564732986|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
156447699|NCT04245501|564733004|FG000|Overall Study|Adverse Event|2|||
156447700|NCT04245501|564733005|FG001|Overall Study|Adverse Event|0|||
156874872|NCT01865552|566300567|FG002|Period 1|Pathological lab|0|||
156874873|NCT01865552|566300568|FG003|Period 1|Pathological lab|0|||
156874874|NCT01865552|566300569|FG004|Period 1|Pathological lab|1|||
156874875|NCT01865552|566300570|FG005|Period 1|Pathological lab|0|||
156447701|NCT04245501|564733004|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
156447702|NCT04245501|564733005|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
156447703|NCT03526861|564733007|FG000|Initial Treatment Period|Not dosed|1|||
156716402|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
156447704|NCT03526861|564733008|FG001|Initial Treatment Period|Not dosed|1|||
156447705|NCT03526861|564733009|FG002|Initial Treatment Period|Not dosed|1|||
156447706|NCT03526861|564733010|FG003|Initial Treatment Period|Not dosed|0|||
156447707|NCT03526861|564733011|FG004|Initial Treatment Period|Not dosed|0|||
156447708|NCT03526861|564733012|FG005|Initial Treatment Period|Not dosed|0|||
156447709|NCT03526861|564733013|FG006|Initial Treatment Period|Not dosed|0|||
156716403|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
156874876|NCT01865552|566300565|FG000|Period 1|Other|0|||
156874877|NCT01865552|566300566|FG001|Period 1|Other|0|||
156447710|NCT03526861|564733014|FG007|Initial Treatment Period|Not dosed|0|||
156447711|NCT03526861|564733015|FG008|Initial Treatment Period|Not dosed|0|||
156447712|NCT03526861|564733007|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
156447713|NCT03526861|564733008|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
156447714|NCT03526861|564733009|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
156447715|NCT03526861|564733010|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447716|NCT03526861|564733011|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447717|NCT03526861|564733012|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447718|NCT03526861|564733013|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447719|NCT03526861|564733014|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447720|NCT03526861|564733015|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447721|NCT03526861|564733007|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
156447722|NCT03526861|564733008|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
156447723|NCT03526861|564733009|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
156447724|NCT03526861|564733010|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
156447725|NCT03526861|564733011|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
156447726|NCT03526861|564733012|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
156447727|NCT03526861|564733013|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
156447728|NCT03526861|564733014|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
156447729|NCT03526861|564733015|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
156447730|NCT03526861|564733007|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447731|NCT03526861|564733008|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447732|NCT03526861|564733009|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447733|NCT03526861|564733010|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
156447734|NCT03526861|564733011|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
156447735|NCT03526861|564733012|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447736|NCT03526861|564733013|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
156447737|NCT03526861|564733014|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447738|NCT03526861|564733015|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447739|NCT03526861|564733007|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
156447740|NCT03526861|564733008|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
156447741|NCT03526861|564733009|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
156447742|NCT03526861|564733010|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
156447743|NCT03526861|564733011|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
156447744|NCT03526861|564733012|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
156447745|NCT03526861|564733013|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
156447746|NCT03526861|564733014|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
156447747|NCT03526861|564733015|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
156447748|NCT03526861|564733007|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447749|NCT03526861|564733008|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447750|NCT03526861|564733009|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447751|NCT03526861|564733010|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
156447752|NCT03526861|564733011|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156716404|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
156716405|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
156716406|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
156716407|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
156716408|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
156716409|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
156716410|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
156716411|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
156716412|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
156874878|NCT01865552|566300567|FG002|Period 1|Other|0|||
156874879|NCT01865552|566300568|FG003|Period 1|Other|0|||
156874880|NCT01865552|566300569|FG004|Period 1|Other|1|||
156874881|NCT01865552|566300570|FG005|Period 1|Other|0|||
156874882|NCT03083873|566300573|FG000|Overall Study|Death|6|||
156447753|NCT03526861|564733012|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447754|NCT03526861|564733013|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447755|NCT03526861|564733014|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447756|NCT03526861|564733015|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447757|NCT03526861|564733007|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447758|NCT03526861|564733008|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447759|NCT03526861|564733009|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447760|NCT03526861|564733010|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447761|NCT03526861|564733011|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447762|NCT03526861|564733012|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447763|NCT03526861|564733013|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447764|NCT03526861|564733014|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
156447765|NCT03526861|564733015|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
156447766|NCT03526861|564733007|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
156447767|NCT03526861|564733008|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
156447768|NCT03526861|564733009|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
156447769|NCT03526861|564733010|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
156447770|NCT03526861|564733011|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
156447771|NCT03526861|564733012|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
156447772|NCT03526861|564733013|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
156447773|NCT03526861|564733014|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
156447774|NCT03526861|564733015|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
156447775|NCT03526861|564733007|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447776|NCT03526861|564733008|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447777|NCT03526861|564733009|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447778|NCT03526861|564733010|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447779|NCT03526861|564733011|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447780|NCT03526861|564733012|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447781|NCT03526861|564733013|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447782|NCT03526861|564733014|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156447783|NCT03526861|564733015|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
156447784|NCT05524233|564733018|FG000|Overall Study|Lost to Follow-up|2|||
156447785|NCT05524233|564733018|FG000|Overall Study|Adverse Event|2|||
156447786|NCT05524233|564733018|FG000|Overall Study|Withdrawal by Subject|1|||
156447787|NCT04382898|564733019|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
156447788|NCT04382898|564733020|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
156447789|NCT04382898|564733021|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
156447790|NCT04382898|564733022|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
156716413|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
156716414|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
156716415|NCT04338022|565705361|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
156716416|NCT04338022|565705362|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
156716417|NCT05724589|565705367|FG000|Overall Study|Lost to Follow-up|1|||
156716418|NCT02466321|565705368|FG000|Overall Study|Death|26|||
156716419|NCT02466321|565705368|FG000|Overall Study|Revision|6|||
156716420|NCT02466321|565705368|FG000|Overall Study|Lost to Follow-up|60|||
156716421|NCT02466321|565705368|FG000|Overall Study|Did not receive study device|1|||
156716422|NCT00786409|565705369|FG000|Overall Study|Withdrawal by Subject|2|||
156716423|NCT00786409|565705369|FG000|Overall Study|Adverse Event|2|||
156716424|NCT00786409|565705369|FG000|Overall Study|Pregnancy|2|||
156716425|NCT00786409|565705369|FG000|Overall Study|Lost to Follow-up|1|||
156716426|NCT00610129|565705370|FG000|Overall Study|Not treated since patients ineligible|3|||
156716427|NCT01184079|565705377|FG000|Overall Study|Lost to Follow-up|14|||
156716428|NCT01184079|565705378|FG001|Overall Study|Lost to Follow-up|2|||
156716429|NCT04779879|565705381|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156447791|NCT04382898|564733023|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
156447792|NCT04382898|564733019|FG000|Part 1: Dose Titration|Death|6|||
156447793|NCT04382898|564733020|FG001|Part 1: Dose Titration|Death|0|||
156447794|NCT04382898|564733021|FG002|Part 1: Dose Titration|Death|0|||
156447795|NCT04382898|564733022|FG003|Part 1: Dose Titration|Death|0|||
156447796|NCT04382898|564733023|FG004|Part 1: Dose Titration|Death|0|||
156447797|NCT04382898|564733019|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156447798|NCT04382898|564733020|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156447799|NCT04382898|564733021|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
156447800|NCT04382898|564733022|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156447801|NCT04382898|564733023|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156447802|NCT04382898|564733019|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
156447803|NCT04382898|564733020|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
156447804|NCT04382898|564733021|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
156447805|NCT04382898|564733022|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
156447806|NCT04382898|564733023|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
156447807|NCT04382898|564733019|FG000|Part 2: Dose Expansion|Death|0|||
156447808|NCT04382898|564733020|FG001|Part 2: Dose Expansion|Death|17|||
156447809|NCT04382898|564733021|FG002|Part 2: Dose Expansion|Death|13|||
156447810|NCT04382898|564733022|FG003|Part 2: Dose Expansion|Death|1|||
156447811|NCT04382898|564733023|FG004|Part 2: Dose Expansion|Death|0|||
156447812|NCT04382898|564733019|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
156447813|NCT04382898|564733020|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
156447814|NCT04382898|564733021|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
156447815|NCT04382898|564733022|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
156447816|NCT04382898|564733023|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
156447817|NCT04382898|564733019|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
156447818|NCT04382898|564733020|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
156447819|NCT04382898|564733021|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
156447820|NCT04382898|564733022|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
156447821|NCT04382898|564733023|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
156447822|NCT04382898|564733019|FG000|Part 2: Dose Expansion|Other|0|||
156447823|NCT04382898|564733020|FG001|Part 2: Dose Expansion|Other|0|||
156447824|NCT04382898|564733021|FG002|Part 2: Dose Expansion|Other|1|||
156447825|NCT04382898|564733022|FG003|Part 2: Dose Expansion|Other|0|||
156447826|NCT04382898|564733023|FG004|Part 2: Dose Expansion|Other|0|||
156447827|NCT01772472|564733024|FG000|Overall Study|Death|126|||
156447828|NCT01772472|564733025|FG001|Overall Study|Death|94|||
156447829|NCT01772472|564733024|FG000|Overall Study|Lost to Follow-up|51|||
156447830|NCT01772472|564733025|FG001|Overall Study|Lost to Follow-up|50|||
156447831|NCT01772472|564733024|FG000|Overall Study|Other|9|||
156447832|NCT01772472|564733025|FG001|Overall Study|Other|7|||
156447833|NCT01772472|564733024|FG000|Overall Study|Physician Decision|1|||
156447834|NCT01772472|564733025|FG001|Overall Study|Physician Decision|7|||
156447835|NCT01772472|564733024|FG000|Overall Study|Withdrawal by Subject|115|||
156447836|NCT01772472|564733025|FG001|Overall Study|Withdrawal by Subject|90|||
156447837|NCT01772472|564733024|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
156447838|NCT01772472|564733025|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
156447839|NCT04391894|564733026|FG000|Overall Study|Adverse Event|1|||
156447840|NCT04391894|564733027|FG001|Overall Study|Adverse Event|1|||
156447841|NCT04391894|564733028|FG002|Overall Study|Adverse Event|1|||
156447842|NCT04391894|564733029|FG003|Overall Study|Adverse Event|1|||
156447843|NCT04391894|564733030|FG004|Overall Study|Adverse Event|1|||
156447844|NCT04391894|564733026|FG000|Overall Study|Lost to Follow-up|1|||
156447845|NCT04391894|564733027|FG001|Overall Study|Lost to Follow-up|0|||
156447846|NCT04391894|564733028|FG002|Overall Study|Lost to Follow-up|0|||
156447847|NCT04391894|564733029|FG003|Overall Study|Lost to Follow-up|0|||
156447848|NCT04391894|564733030|FG004|Overall Study|Lost to Follow-up|0|||
156447849|NCT04391894|564733026|FG000|Overall Study|Protocol Violation|0|||
156447850|NCT04391894|564733027|FG001|Overall Study|Protocol Violation|0|||
156447851|NCT04391894|564733028|FG002|Overall Study|Protocol Violation|0|||
156533127|NCT04178967|565046865|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
156533128|NCT04178967|565046855|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156447852|NCT04391894|564733029|FG003|Overall Study|Protocol Violation|1|||
156447853|NCT04391894|564733030|FG004|Overall Study|Protocol Violation|0|||
156447854|NCT04391894|564733026|FG000|Overall Study|Withdrawal by Subject|2|||
156447855|NCT04391894|564733027|FG001|Overall Study|Withdrawal by Subject|0|||
156447856|NCT04391894|564733028|FG002|Overall Study|Withdrawal by Subject|3|||
156447857|NCT04391894|564733029|FG003|Overall Study|Withdrawal by Subject|0|||
156447858|NCT04391894|564733030|FG004|Overall Study|Withdrawal by Subject|1|||
156447859|NCT04391894|564733026|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
156447860|NCT04391894|564733027|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
156447861|NCT04391894|564733028|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
156447862|NCT04391894|564733029|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
156447863|NCT04391894|564733030|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
156447864|NCT00446225|564733034|FG000|Overall Study|Protocol Violation|1|||
156447865|NCT00446225|564733035|FG001|Overall Study|Protocol Violation|0|||
156447866|NCT04450342|564733036|FG000|Overall Study|Adverse Event|1|||
156447867|NCT04450342|564733037|FG001|Overall Study|Adverse Event|1|||
156447868|NCT04450342|564733038|FG002|Overall Study|Adverse Event|0|||
156447869|NCT04450342|564733036|FG000|Overall Study|Device not used|1|||
156447870|NCT04450342|564733037|FG001|Overall Study|Device not used|0|||
156447871|NCT04450342|564733038|FG002|Overall Study|Device not used|0|||
156447872|NCT04450342|564733036|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
156447873|NCT04450342|564733037|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
156447874|NCT04450342|564733038|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
156447875|NCT04450342|564733036|FG000|Overall Study|Physician Decision|1|||
156447876|NCT04450342|564733037|FG001|Overall Study|Physician Decision|0|||
156447877|NCT04450342|564733038|FG002|Overall Study|Physician Decision|1|||
156447878|NCT04450342|564733036|FG000|Overall Study|Protocol Deviation|0|||
156447879|NCT04450342|564733037|FG001|Overall Study|Protocol Deviation|1|||
156447880|NCT04450342|564733038|FG002|Overall Study|Protocol Deviation|0|||
156447881|NCT04450342|564733036|FG000|Overall Study|Reoperation|1|||
156447882|NCT04450342|564733037|FG001|Overall Study|Reoperation|1|||
156447883|NCT04450342|564733038|FG002|Overall Study|Reoperation|0|||
156447884|NCT04450342|564733036|FG000|Overall Study|Screen Failures|0|||
156447885|NCT04450342|564733037|FG001|Overall Study|Screen Failures|0|||
156447886|NCT04450342|564733038|FG002|Overall Study|Screen Failures|2|||
156447887|NCT04450342|564733036|FG000|Overall Study|Site Terminated by Sponsor|1|||
156447888|NCT04450342|564733037|FG001|Overall Study|Site Terminated by Sponsor|1|||
156447889|NCT04450342|564733038|FG002|Overall Study|Site Terminated by Sponsor|1|||
156447890|NCT04450342|564733036|FG000|Overall Study|Study Terminated by Sponsor|31|||
156447891|NCT04450342|564733037|FG001|Overall Study|Study Terminated by Sponsor|29|||
156447892|NCT04450342|564733038|FG002|Overall Study|Study Terminated by Sponsor|6|||
156447893|NCT04450342|564733036|FG000|Overall Study|Withdrawal by Subject|0|||
156447894|NCT04450342|564733037|FG001|Overall Study|Withdrawal by Subject|1|||
156447895|NCT04450342|564733038|FG002|Overall Study|Withdrawal by Subject|2|||
156447896|NCT05633407|564733039|FG000|Overall Study|Physician Decision|2|||
156447897|NCT05633407|564733040|FG001|Overall Study|Physician Decision|0|||
156447898|NCT05633407|564733039|FG000|Overall Study|Adverse Event|1|||
156447899|NCT05633407|564733040|FG001|Overall Study|Adverse Event|0|||
156447900|NCT05633407|564733039|FG000|Overall Study|Withdrawal by Subject|1|||
156447901|NCT05633407|564733040|FG001|Overall Study|Withdrawal by Subject|0|||
156447902|NCT05633407|564733039|FG000|Overall Study|Other|1|||
156447903|NCT05633407|564733040|FG001|Overall Study|Other|1|||
156447904|NCT02500758|564733043|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
156447905|NCT02500758|564733044|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
156447906|NCT02500758|564733043|FG000|Washout (1 Week)|Lost to Follow-up|2|||
156447907|NCT02500758|564733044|FG001|Washout (1 Week)|Lost to Follow-up|2|||
156447908|NCT02500758|564733043|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
156447909|NCT02500758|564733044|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
156447910|NCT02500758|564733043|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
156447911|NCT02500758|564733044|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
156447912|NCT02500758|564733043|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
156447913|NCT02500758|564733044|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
156447914|NCT00220740|564733045|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
156447915|NCT00220740|564733046|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
156447916|NCT00220740|564733045|FG000|Efficacy Period|Adverse Event|1|||
156447917|NCT00220740|564733046|FG001|Efficacy Period|Adverse Event|1|||
156447918|NCT00220740|564733045|FG000|Efficacy Period|Withdrawal by Subject|1|||
156447919|NCT00220740|564733046|FG001|Efficacy Period|Withdrawal by Subject|0|||
156447920|NCT00220740|564733045|FG000|Efficacy Period|Protocol Violation|1|||
156447921|NCT00220740|564733046|FG001|Efficacy Period|Protocol Violation|0|||
156447922|NCT00220740|564733045|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
156793415|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
156793416|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
156793417|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
156793418|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
156447923|NCT00220740|564733046|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
156447924|NCT01057433|564733047|FG000|Overall Study|Adverse Event|1|||
156793419|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
156793420|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
156447925|NCT02874534|564733049|FG000|Overall Study|Withdrawal by Subject|5|||
156447926|NCT02874534|564733050|FG001|Overall Study|Withdrawal by Subject|8|||
156447927|NCT02874534|564733049|FG000|Overall Study|Lost to Follow-up|2|||
156447928|NCT02874534|564733050|FG001|Overall Study|Lost to Follow-up|2|||
156447929|NCT02874534|564733049|FG000|Overall Study|Ongoing in study|1|||
156447930|NCT02874534|564733050|FG001|Overall Study|Ongoing in study|1|||
156447931|NCT02923180|564733051|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
156447932|NCT02923180|564733051|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
156447933|NCT05198310|564733052|FG000|Overall Study|Lost to Follow-up|0|||
156447934|NCT05198310|564733053|FG001|Overall Study|Lost to Follow-up|1|||
156447935|NCT05198310|564733054|FG002|Overall Study|Lost to Follow-up|0|||
156447936|NCT05198310|564733055|FG003|Overall Study|Lost to Follow-up|0|||
156447937|NCT05198310|564733056|FG004|Overall Study|Lost to Follow-up|0|||
156447938|NCT05198310|564733057|FG005|Overall Study|Lost to Follow-up|0|||
156447939|NCT05198310|564733058|FG006|Overall Study|Lost to Follow-up|0|||
156447940|NCT05198310|564733059|FG007|Overall Study|Lost to Follow-up|0|||
156447941|NCT05198310|564733052|FG000|Overall Study|Withdrawal by Subject|0|||
156447942|NCT05198310|564733053|FG001|Overall Study|Withdrawal by Subject|0|||
156874883|NCT03083873|566300574|FG001|Overall Study|Death|15|||
156874884|NCT03083873|566300575|FG002|Overall Study|Death|13|||
156874885|NCT03083873|566300576|FG003|Overall Study|Death|9|||
156874886|NCT03083873|566300577|FG004|Overall Study|Death|0|||
156874887|NCT03083873|566300573|FG000|Overall Study|Sponsor Terminated Study|0|||
156874888|NCT03083873|566300574|FG001|Overall Study|Sponsor Terminated Study|1|||
156874889|NCT03083873|566300575|FG002|Overall Study|Sponsor Terminated Study|2|||
156874890|NCT03083873|566300576|FG003|Overall Study|Sponsor Terminated Study|3|||
156874891|NCT03083873|566300577|FG004|Overall Study|Sponsor Terminated Study|0|||
156874892|NCT03083873|566300573|FG000|Overall Study|Lost to Follow-up|0|||
156874893|NCT03083873|566300574|FG001|Overall Study|Lost to Follow-up|1|||
156874894|NCT03083873|566300575|FG002|Overall Study|Lost to Follow-up|1|||
156874895|NCT03083873|566300576|FG003|Overall Study|Lost to Follow-up|0|||
156874896|NCT03083873|566300577|FG004|Overall Study|Lost to Follow-up|0|||
156874897|NCT03083873|566300573|FG000|Overall Study|Withdrawal by Subject|2|||
156874898|NCT03083873|566300574|FG001|Overall Study|Withdrawal by Subject|0|||
156874899|NCT03083873|566300575|FG002|Overall Study|Withdrawal by Subject|0|||
156874900|NCT03083873|566300576|FG003|Overall Study|Withdrawal by Subject|0|||
156874901|NCT03083873|566300577|FG004|Overall Study|Withdrawal by Subject|0|||
156874902|NCT03083873|566300573|FG000|Overall Study|Did Not Receive TIL|2|||
156874903|NCT03083873|566300574|FG001|Overall Study|Did Not Receive TIL|5|||
156874904|NCT03083873|566300575|FG002|Overall Study|Did Not Receive TIL|3|||
156874905|NCT03083873|566300576|FG003|Overall Study|Did Not Receive TIL|1|||
156874906|NCT03083873|566300577|FG004|Overall Study|Did Not Receive TIL|0|||
156874907|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
156874908|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
156874909|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
156874910|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
156874911|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
156874912|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
156874913|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
156874914|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
156874915|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
156874916|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
156874917|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
156874918|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
156874919|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
156874920|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
156874921|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
156874922|NCT00479687|566300578|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
156447943|NCT05198310|564733054|FG002|Overall Study|Withdrawal by Subject|0|||
156447944|NCT05198310|564733055|FG003|Overall Study|Withdrawal by Subject|2|||
156447945|NCT05198310|564733056|FG004|Overall Study|Withdrawal by Subject|0|||
156447946|NCT05198310|564733057|FG005|Overall Study|Withdrawal by Subject|2|||
156447947|NCT05198310|564733058|FG006|Overall Study|Withdrawal by Subject|1|||
156716430|NCT04779879|565705382|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156716431|NCT04779879|565705383|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156716432|NCT04779879|565705384|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
156716433|NCT04779879|565705385|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156716434|NCT04779879|565705386|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156716435|NCT04779879|565705381|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716436|NCT04779879|565705382|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716437|NCT04779879|565705383|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716438|NCT04779879|565705384|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
156716439|NCT04779879|565705385|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716440|NCT04779879|565705386|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716441|NCT04779879|565705381|FG000|Part C: Up to Week 36|Death|0|||
156716442|NCT04779879|565705382|FG001|Part C: Up to Week 36|Death|0|||
156716443|NCT04779879|565705383|FG002|Part C: Up to Week 36|Death|0|||
156716444|NCT04779879|565705384|FG003|Part C: Up to Week 36|Death|0|||
156716445|NCT04779879|565705385|FG004|Part C: Up to Week 36|Death|0|||
156716446|NCT04779879|565705386|FG005|Part C: Up to Week 36|Death|1|||
156716447|NCT04779879|565705381|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
156716448|NCT04779879|565705382|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
156447948|NCT05198310|564733059|FG007|Overall Study|Withdrawal by Subject|3|||
156447949|NCT04116736|564733060|FG000|Overall Study|Withdrew consent during study|3|||
156447950|NCT04116736|564733061|FG001|Overall Study|Withdrew consent during study|1|||
156447951|NCT04116736|564733060|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
156447952|NCT04116736|564733061|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
156447953|NCT04116736|564733060|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
156447954|NCT04116736|564733061|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
156447955|NCT04116736|564733060|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
156447956|NCT04116736|564733061|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
156447957|NCT04116736|564733060|FG000|Overall Study|Subject was enrolled in error|2|||
156447958|NCT04116736|564733061|FG001|Overall Study|Subject was enrolled in error|0|||
156447959|NCT04116736|564733060|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
156447960|NCT04116736|564733061|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
156447961|NCT04116736|564733060|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
156447962|NCT04116736|564733061|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
156447963|NCT04116736|564733060|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
156447964|NCT04116736|564733061|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
156874923|NCT00479687|566300579|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
156874924|NCT00479687|566300580|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
156874925|NCT00479687|566300578|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
156874926|NCT00479687|566300579|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
156874927|NCT00479687|566300580|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
156874928|NCT00479687|566300578|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
156874929|NCT00479687|566300579|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
156874930|NCT00479687|566300580|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
156874931|NCT00479687|566300578|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
156874932|NCT00479687|566300579|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
156874933|NCT00479687|566300580|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
156874934|NCT01474239|566300581|FG000|Overall Study|Disease Progression|37|||
156874935|NCT01474239|566300582|FG001|Overall Study|Disease Progression|25|||
156874936|NCT01474239|566300581|FG000|Overall Study|Adverse Event|12|||
156874937|NCT01474239|566300582|FG001|Overall Study|Adverse Event|3|||
156874938|NCT01474239|566300581|FG000|Overall Study|Withdrawal by Subject|1|||
156874939|NCT01474239|566300582|FG001|Overall Study|Withdrawal by Subject|2|||
156447965|NCT03361748|564733068|FG000|Overall Study|Death|77|||
156447966|NCT03361748|564733068|FG000|Overall Study|Lost to Follow-up|4|||
156447967|NCT03361748|564733068|FG000|Overall Study|Withdrawal by Subject|20|||
156447968|NCT04854096|564733070|FG000|Overall Study|Adverse Event|1|||
156447969|NCT04854096|564733071|FG001|Overall Study|Adverse Event|0|||
156447970|NCT04854096|564733070|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
156874940|NCT01474239|566300581|FG000|Overall Study|Death|1|||
156874941|NCT01474239|566300582|FG001|Overall Study|Death|1|||
156447971|NCT04854096|564733071|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
156447972|NCT04854096|564733070|FG000|Overall Study|Withdrawal by Subject|1|||
156447973|NCT04854096|564733071|FG001|Overall Study|Withdrawal by Subject|0|||
156447974|NCT04854096|564733070|FG000|Overall Study|Other reasons|1|||
156447975|NCT04854096|564733071|FG001|Overall Study|Other reasons|0|||
156447976|NCT04757610|564733072|FG000|Overall Study|Adverse Event|13|||
156447977|NCT04757610|564733073|FG001|Overall Study|Adverse Event|10|||
156447978|NCT04757610|564733074|FG002|Overall Study|Adverse Event|5|||
156447979|NCT04757610|564733072|FG000|Overall Study|Death|5|||
156447980|NCT04757610|564733073|FG001|Overall Study|Death|13|||
156447981|NCT04757610|564733074|FG002|Overall Study|Death|8|||
156447982|NCT04757610|564733072|FG000|Overall Study|Lack of Efficacy|1|||
156533129|NCT04178967|565046856|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156716449|NCT04779879|565705383|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
156716450|NCT04779879|565705384|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
156716451|NCT04779879|565705385|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
156716452|NCT04779879|565705386|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
156716453|NCT05101343|565705387|FG000|Overall Study|Withdrawal by Subject|2|||
156716454|NCT05101343|565705388|FG001|Overall Study|Withdrawal by Subject|1|||
156716455|NCT02854527|565705389|FG000|Overall Study|Adverse Event|0|||
156716456|NCT02854527|565705390|FG001|Overall Study|Adverse Event|0|||
156716457|NCT02854527|565705391|FG002|Overall Study|Adverse Event|0|||
156716458|NCT02854527|565705392|FG003|Overall Study|Adverse Event|0|||
156716459|NCT02854527|565705393|FG004|Overall Study|Adverse Event|1|||
156447983|NCT04757610|564733073|FG001|Overall Study|Lack of Efficacy|2|||
156447984|NCT04757610|564733074|FG002|Overall Study|Lack of Efficacy|3|||
156447985|NCT04757610|564733072|FG000|Overall Study|Lost to Follow-up|7|||
156447986|NCT04757610|564733073|FG001|Overall Study|Lost to Follow-up|2|||
156716460|NCT02854527|565705394|FG005|Overall Study|Adverse Event|0|||
156447987|NCT04757610|564733074|FG002|Overall Study|Lost to Follow-up|7|||
156447988|NCT04757610|564733072|FG000|Overall Study|Physician Decision|4|||
156447989|NCT04757610|564733073|FG001|Overall Study|Physician Decision|1|||
156447990|NCT04757610|564733074|FG002|Overall Study|Physician Decision|2|||
156447991|NCT04757610|564733072|FG000|Overall Study|Withdrawal by Subject|26|||
156447992|NCT04757610|564733073|FG001|Overall Study|Withdrawal by Subject|25|||
156447993|NCT04757610|564733074|FG002|Overall Study|Withdrawal by Subject|25|||
156447994|NCT04757610|564733072|FG000|Overall Study|Study Terminated by Sponsor|105|||
156447995|NCT04757610|564733073|FG001|Overall Study|Study Terminated by Sponsor|105|||
156447996|NCT04757610|564733074|FG002|Overall Study|Study Terminated by Sponsor|110|||
156447997|NCT04757610|564733072|FG000|Overall Study|Randomized in Error|1|||
156447998|NCT04757610|564733073|FG001|Overall Study|Randomized in Error|0|||
156447999|NCT04757610|564733074|FG002|Overall Study|Randomized in Error|0|||
156448000|NCT03819686|564734703|FG000|Overall Study|Lost to Follow-up|2|||
156448001|NCT03819686|564734704|FG001|Overall Study|Lost to Follow-up|3|||
156448002|NCT06143670|564734705|FG000|Overall Study|Lost to Follow-up|0|||
156448003|NCT06143670|564734706|FG001|Overall Study|Lost to Follow-up|1|||
156448004|NCT06143670|564734705|FG000|Overall Study|Withdrawal by Subject|3|||
156448005|NCT06143670|564734706|FG001|Overall Study|Withdrawal by Subject|0|||
156448006|NCT03747484|564734707|FG000|Overall Study|Lack of Efficacy|0|||
156448007|NCT03747484|564734708|FG001|Overall Study|Lack of Efficacy|1|||
156448008|NCT03747484|564734709|FG002|Overall Study|Lack of Efficacy|1|||
156448009|NCT03747484|564734710|FG003|Overall Study|Lack of Efficacy|2|||
156448010|NCT03747484|564734711|FG004|Overall Study|Lack of Efficacy|2|||
156448011|NCT03833245|564734716|FG000|Overall Study|Death|0|||
156448012|NCT03833245|564734717|FG001|Overall Study|Death|1|||
156448013|NCT03347383|564734718|FG000|Overall Study|Death|39|||
156448014|NCT03347383|564734718|FG000|Overall Study|Withdrawal by Subject|3|||
156448015|NCT03347383|564734718|FG000|Overall Study|Lost to Follow-up|9|||
156448016|NCT05691452|564734720|FG000|Overall Study|Withdrawal by Subject|1|||
156448017|NCT05691452|564734721|FG001|Overall Study|Withdrawal by Subject|1|||
156448018|NCT05691452|564734722|FG002|Overall Study|Withdrawal by Subject|0|||
156448019|NCT05691452|564734720|FG000|Overall Study|Physician Decision|1|||
156448020|NCT05691452|564734721|FG001|Overall Study|Physician Decision|0|||
156448021|NCT05691452|564734722|FG002|Overall Study|Physician Decision|0|||
156448022|NCT05691452|564734720|FG000|Overall Study|Lost to Follow-up|0|||
156448023|NCT05691452|564734721|FG001|Overall Study|Lost to Follow-up|0|||
156448024|NCT05691452|564734722|FG002|Overall Study|Lost to Follow-up|1|||
156448025|NCT05691452|564734720|FG000|Overall Study|Adverse Event|0|||
156448026|NCT05691452|564734721|FG001|Overall Study|Adverse Event|0|||
156448027|NCT05691452|564734722|FG002|Overall Study|Adverse Event|1|||
156448028|NCT04842643|564734725|FG000|Overall Study|Physician Decision|1|||
156448029|NCT04842643|564734725|FG000|Overall Study|Other|1|||
156448030|NCT02630823|564734727|FG000|Overall Study|Withdrawal by Subject|1|||
156716461|NCT02854527|565705395|FG006|Overall Study|Adverse Event|0|||
156716462|NCT02854527|565705396|FG007|Overall Study|Adverse Event|0|||
156716463|NCT02854527|565705397|FG008|Overall Study|Adverse Event|0|||
156716464|NCT02854527|565705398|FG009|Overall Study|Adverse Event|0|||
156716465|NCT02854527|565705389|FG000|Overall Study|Lost to Follow-up|0|||
156716466|NCT02854527|565705390|FG001|Overall Study|Lost to Follow-up|0|||
156716467|NCT02854527|565705391|FG002|Overall Study|Lost to Follow-up|0|||
156716468|NCT02854527|565705392|FG003|Overall Study|Lost to Follow-up|1|||
156716469|NCT02854527|565705393|FG004|Overall Study|Lost to Follow-up|0|||
156716470|NCT02854527|565705394|FG005|Overall Study|Lost to Follow-up|0|||
156716471|NCT02854527|565705395|FG006|Overall Study|Lost to Follow-up|0|||
156716472|NCT02854527|565705396|FG007|Overall Study|Lost to Follow-up|0|||
156716473|NCT02854527|565705397|FG008|Overall Study|Lost to Follow-up|0|||
156716474|NCT02854527|565705398|FG009|Overall Study|Lost to Follow-up|0|||
156716475|NCT04075487|565707489|FG000|Overall Study|Withdrawal by Subject|1|||
156716476|NCT05016960|565707492|FG000|Overall Study|Withdrawal by Subject|1|||
156716477|NCT05016960|565707493|FG001|Overall Study|Withdrawal by Subject|9|||
156716478|NCT04467840|565707496|FG000|Overall Study|Death|35|||
156716479|NCT04467840|565707497|FG001|Overall Study|Death|39|||
156716480|NCT04467840|565707496|FG000|Overall Study|Withdrawal by Subject|8|||
156716481|NCT04467840|565707497|FG001|Overall Study|Withdrawal by Subject|4|||
156716482|NCT04467840|565707496|FG000|Overall Study|Adverse Event|2|||
156874942|NCT01474239|566300581|FG000|Overall Study|Clinical Disease Progression|7|||
156448031|NCT02630823|564734727|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
156448032|NCT05062265|564734730|FG000|Overall Study|Withdrawal by Subject|1|||
156448033|NCT05062265|564734731|FG001|Overall Study|Withdrawal by Subject|0|||
156448034|NCT04630262|564734735|FG000|Overall Study|Intraoperative Screen Failure|5|||
156448035|NCT04630262|564734735|FG000|Overall Study|Study terminated prematurely|71|||
156448036|NCT04630262|564734735|FG000|Overall Study|Withdrawal by Subject|2|||
156448037|NCT04630262|564734735|FG000|Overall Study|Physician Decision|2|||
156448038|NCT04703322|564734737|FG000|Overall Study|Ongoing|8|||
156716483|NCT04467840|565707497|FG001|Overall Study|Adverse Event|0|||
156716484|NCT04467840|565707496|FG000|Overall Study|Lost to Follow-up|1|||
156716485|NCT04467840|565707497|FG001|Overall Study|Lost to Follow-up|3|||
156716486|NCT04467840|565707496|FG000|Overall Study|Physician Decision|1|||
156448039|NCT04703322|564734737|FG000|Overall Study|Withdrawal by Subject|1|||
156448040|NCT04638998|564734738|FG000|Overall Study|Withdrawal by Subject|1|||
156448041|NCT04638998|564734739|FG001|Overall Study|Withdrawal by Subject|3|||
156448042|NCT02662062|564734741|FG000|Overall Study|Withdrawal by Subject|1|||
156448043|NCT03988634|564734742|FG000|Double-Blind|Adverse Event|4|||
156448044|NCT03988634|564734743|FG001|Double-Blind|Adverse Event|0|||
156448045|NCT03988634|564734744|FG002|Double-Blind|Adverse Event|0|||
156448046|NCT03988634|564734742|FG000|Double-Blind|Death|18|||
156448047|NCT03988634|564734743|FG001|Double-Blind|Death|26|||
156448048|NCT03988634|564734744|FG002|Double-Blind|Death|0|||
156448049|NCT03988634|564734742|FG000|Double-Blind|Lost to Follow-up|6|||
156448050|NCT03988634|564734743|FG001|Double-Blind|Lost to Follow-up|7|||
156448051|NCT03988634|564734744|FG002|Double-Blind|Lost to Follow-up|0|||
156448052|NCT03988634|564734742|FG000|Double-Blind|Physician Decision|9|||
156448053|NCT03988634|564734743|FG001|Double-Blind|Physician Decision|5|||
156448054|NCT03988634|564734744|FG002|Double-Blind|Physician Decision|0|||
156448055|NCT03988634|564734742|FG000|Double-Blind|Subject decision|24|||
156448056|NCT03988634|564734743|FG001|Double-Blind|Subject decision|13|||
156448057|NCT03988634|564734744|FG002|Double-Blind|Subject decision|0|||
156448058|NCT03988634|564734742|FG000|Open-Label|Adverse Event|0|||
156448059|NCT03988634|564734743|FG001|Open-Label|Adverse Event|0|||
156448060|NCT03988634|564734744|FG002|Open-Label|Adverse Event|7|||
156448061|NCT03988634|564734742|FG000|Open-Label|Physician Decision|0|||
156448062|NCT03988634|564734743|FG001|Open-Label|Physician Decision|0|||
156448063|NCT03988634|564734744|FG002|Open-Label|Physician Decision|1|||
156448064|NCT03988634|564734742|FG000|Open-Label|Technical problems|0|||
156448065|NCT03988634|564734743|FG001|Open-Label|Technical problems|0|||
156448066|NCT03988634|564734744|FG002|Open-Label|Technical problems|1|||
156448067|NCT05374837|564734745|FG000|Overall Study|Lost to Follow-up|17|||
156448068|NCT05374837|564734746|FG001|Overall Study|Lost to Follow-up|18|||
156448069|NCT05406921|564734754|FG000|Overall Study|Withdrawal by Subject|25|||
156448070|NCT05406921|564734755|FG001|Overall Study|Withdrawal by Subject|0|||
156448071|NCT05406921|564734756|FG002|Overall Study|Withdrawal by Subject|25|||
156448072|NCT05406921|564734754|FG000|Overall Study|Protocol Violation|0|||
156448073|NCT05406921|564734755|FG001|Overall Study|Protocol Violation|12|||
156448074|NCT05406921|564734756|FG002|Overall Study|Protocol Violation|0|||
156448075|NCT00676715|564734759|FG000|Treatment Period (TP)|Adverse Event|0|||
156448076|NCT00676715|564734760|FG001|Treatment Period (TP)|Adverse Event|3|||
156448077|NCT00676715|564734761|FG002|Treatment Period (TP)|Adverse Event|2|||
156448078|NCT00676715|564734762|FG003|Treatment Period (TP)|Adverse Event|2|||
156448079|NCT00676715|564734759|FG000|Treatment Period (TP)|Death|0|||
156448080|NCT00676715|564734760|FG001|Treatment Period (TP)|Death|0|||
156448081|NCT00676715|564734761|FG002|Treatment Period (TP)|Death|1|||
156448082|NCT00676715|564734762|FG003|Treatment Period (TP)|Death|0|||
156448083|NCT00676715|564734759|FG000|Treatment Period (TP)|Failure to return|1|||
156448084|NCT00676715|564734760|FG001|Treatment Period (TP)|Failure to return|0|||
156448085|NCT00676715|564734761|FG002|Treatment Period (TP)|Failure to return|0|||
156448086|NCT00676715|564734762|FG003|Treatment Period (TP)|Failure to return|0|||
156448087|NCT00676715|564734759|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
156448088|NCT00676715|564734760|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
156448089|NCT00676715|564734761|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
156448090|NCT00676715|564734762|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
156448091|NCT00676715|564734759|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
156448092|NCT00676715|564734760|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
156448093|NCT00676715|564734761|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
156448094|NCT00676715|564734762|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
156448095|NCT00676715|564734759|FG000|Treatment Period (TP)|Withdrew consent|3|||
156448096|NCT00676715|564734760|FG001|Treatment Period (TP)|Withdrew consent|3|||
156793421|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
156793422|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
156793423|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
156793424|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
156448097|NCT00676715|564734761|FG002|Treatment Period (TP)|Withdrew consent|3|||
156448098|NCT00676715|564734762|FG003|Treatment Period (TP)|Withdrew consent|3|||
156448099|NCT00676715|564734759|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
156448100|NCT00676715|564734760|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
156448101|NCT00676715|564734761|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
156448102|NCT00676715|564734762|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
156448103|NCT00676715|564734759|FG000|Treatment Period (TP)|Administrative|0|||
156448104|NCT00676715|564734760|FG001|Treatment Period (TP)|Administrative|0|||
156448105|NCT00676715|564734761|FG002|Treatment Period (TP)|Administrative|0|||
156448106|NCT00676715|564734762|FG003|Treatment Period (TP)|Administrative|1|||
156448107|NCT00676715|564734759|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
156448108|NCT00676715|564734760|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
156448109|NCT00676715|564734761|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
156334914|NCT01146912|564324434|FG004|Overall Study|< 14 weeks gestational age|0|||
156793425|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
156793426|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
156793427|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
156793428|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
156793429|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
156793430|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156793431|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156334915|NCT01146912|564324435|FG005|Overall Study|< 14 weeks gestational age|0|||
156334916|NCT01146912|564324436|FG006|Overall Study|< 14 weeks gestational age|0|||
156334917|NCT01146912|564324437|FG007|Overall Study|< 14 weeks gestational age|0|||
156334918|NCT01146912|564324430|FG000|Overall Study|Duplicate patient|0|||
156334919|NCT01146912|564324431|FG001|Overall Study|Duplicate patient|0|||
156334920|NCT01146912|564324432|FG002|Overall Study|Duplicate patient|1|||
156334921|NCT01146912|564324433|FG003|Overall Study|Duplicate patient|0|||
156334922|NCT01146912|564324434|FG004|Overall Study|Duplicate patient|0|||
156334923|NCT01146912|564324435|FG005|Overall Study|Duplicate patient|0|||
156334924|NCT01146912|564324436|FG006|Overall Study|Duplicate patient|0|||
156334925|NCT01146912|564324437|FG007|Overall Study|Duplicate patient|0|||
156334926|NCT02980783|564324438|FG000|Overall Study|Lost to Follow-up|1|||
156334927|NCT00880542|564324439|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
156334928|NCT00880542|564324439|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
156334929|NCT00880542|564324439|FG000|REP: Surgical Resection|progressive disease|1|||
156334930|NCT05047770|564324440|FG000|Overall Study|Withdrawal by Subject|15|||
156334931|NCT05047770|564324441|FG001|Overall Study|Withdrawal by Subject|10|||
156334932|NCT05047770|564324442|FG002|Overall Study|Withdrawal by Subject|6|||
156334933|NCT05047770|564324443|FG003|Overall Study|Withdrawal by Subject|12|||
156334934|NCT05047770|564324440|FG000|Overall Study|Lost to Follow-up|7|||
156334935|NCT05047770|564324441|FG001|Overall Study|Lost to Follow-up|5|||
156334936|NCT05047770|564324442|FG002|Overall Study|Lost to Follow-up|12|||
156334937|NCT05047770|564324443|FG003|Overall Study|Lost to Follow-up|13|||
156334938|NCT05047770|564324440|FG000|Overall Study|Other|1|||
156334939|NCT05047770|564324441|FG001|Overall Study|Other|0|||
156334940|NCT05047770|564324442|FG002|Overall Study|Other|1|||
156334941|NCT05047770|564324443|FG003|Overall Study|Other|0|||
156334942|NCT01772160|564324444|FG000|Overall Study|Death|3|||
156334943|NCT01772160|564324444|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
156334944|NCT01772160|564324444|FG000|Overall Study|Consent withdrawal|3|||
156334945|NCT01772160|564324444|FG000|Overall Study|Migrated / moved from the study area|4|||
156334946|NCT01772160|564324444|FG000|Overall Study|Lost to Follow-up|30|||
156334947|NCT01772160|564324444|FG000|Overall Study|Other|5|||
156334948|NCT02202980|564324445|FG000|Overall Study|Lack of Efficacy|1|||
156334949|NCT02202980|564324446|FG001|Overall Study|Lack of Efficacy|0|||
156334950|NCT02202980|564324447|FG002|Overall Study|Lack of Efficacy|7|||
156334951|NCT02202980|564324448|FG003|Overall Study|Lack of Efficacy|0|||
156334952|NCT02202980|564324449|FG004|Overall Study|Lack of Efficacy|3|||
156334953|NCT02202980|564324450|FG005|Overall Study|Lack of Efficacy|1|||
156334954|NCT02202980|564324451|FG006|Overall Study|Lack of Efficacy|11|||
156334955|NCT02202980|564324452|FG007|Overall Study|Lack of Efficacy|2|||
156334956|NCT02202980|564324453|FG008|Overall Study|Lack of Efficacy|2|||
156334957|NCT02202980|564324454|FG009|Overall Study|Lack of Efficacy|0|||
156334958|NCT02202980|564324455|FG010|Overall Study|Lack of Efficacy|0|||
156334959|NCT02202980|564324456|FG011|Overall Study|Lack of Efficacy|3|||
156334960|NCT02202980|564324457|FG012|Overall Study|Lack of Efficacy|10|||
156334961|NCT02202980|564324458|FG013|Overall Study|Lack of Efficacy|0|||
156334962|NCT02202980|564324445|FG000|Overall Study|Protocol Violation|0|||
156334963|NCT02202980|564324446|FG001|Overall Study|Protocol Violation|0|||
156334964|NCT02202980|564324447|FG002|Overall Study|Protocol Violation|0|||
156334965|NCT02202980|564324448|FG003|Overall Study|Protocol Violation|3|||
156334966|NCT02202980|564324449|FG004|Overall Study|Protocol Violation|3|||
156334967|NCT02202980|564324450|FG005|Overall Study|Protocol Violation|0|||
156334968|NCT02202980|564324451|FG006|Overall Study|Protocol Violation|0|||
156334969|NCT02202980|564324452|FG007|Overall Study|Protocol Violation|0|||
156334970|NCT02202980|564324453|FG008|Overall Study|Protocol Violation|0|||
156334971|NCT02202980|564324454|FG009|Overall Study|Protocol Violation|0|||
156334972|NCT02202980|564324455|FG010|Overall Study|Protocol Violation|0|||
156334973|NCT02202980|564324456|FG011|Overall Study|Protocol Violation|0|||
156334974|NCT02202980|564324457|FG012|Overall Study|Protocol Violation|0|||
156334975|NCT02202980|564324458|FG013|Overall Study|Protocol Violation|0|||
156334976|NCT02202980|564324445|FG000|Overall Study|Lost to Follow-up|0|||
156334977|NCT02202980|564324446|FG001|Overall Study|Lost to Follow-up|1|||
156334978|NCT02202980|564324447|FG002|Overall Study|Lost to Follow-up|1|||
156334979|NCT02202980|564324448|FG003|Overall Study|Lost to Follow-up|1|||
156334980|NCT02202980|564324449|FG004|Overall Study|Lost to Follow-up|0|||
156334981|NCT02202980|564324450|FG005|Overall Study|Lost to Follow-up|0|||
156334982|NCT02202980|564324451|FG006|Overall Study|Lost to Follow-up|0|||
156448110|NCT00676715|564734762|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
156448111|NCT00676715|564734759|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
156448112|NCT00676715|564734760|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
156448113|NCT00676715|564734761|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
156448114|NCT00676715|564734762|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
156448115|NCT00676715|564734759|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
156448116|NCT00676715|564734760|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
156448117|NCT00676715|564734761|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
156448118|NCT00676715|564734762|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
156448119|NCT00676715|564734759|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
156448120|NCT00676715|564734760|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
156448121|NCT00676715|564734761|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
156448122|NCT00676715|564734762|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
156448123|NCT00676715|564734759|FG000|Treatment-free Period (TFP)|Death|1|||
156448124|NCT00676715|564734760|FG001|Treatment-free Period (TFP)|Death|1|||
156448125|NCT00676715|564734761|FG002|Treatment-free Period (TFP)|Death|1|||
156448126|NCT00676715|564734762|FG003|Treatment-free Period (TFP)|Death|0|||
156448127|NCT00676715|564734759|FG000|Open Label Extension (OLE)|Reason not provided|3|||
156448128|NCT00676715|564734760|FG001|Open Label Extension (OLE)|Reason not provided|4|||
156448129|NCT00676715|564734761|FG002|Open Label Extension (OLE)|Reason not provided|1|||
156448130|NCT00676715|564734762|FG003|Open Label Extension (OLE)|Reason not provided|4|||
156448131|NCT00676715|564734759|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
156448132|NCT00676715|564734760|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
156448133|NCT00676715|564734761|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
156448134|NCT00676715|564734762|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
156448135|NCT00676715|564734759|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
156448136|NCT00676715|564734760|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
156448137|NCT00676715|564734761|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
156448138|NCT00676715|564734762|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
156448139|NCT00676715|564734759|FG000|Open Label Extension (OLE)|Adverse Event|0|||
156448140|NCT00676715|564734760|FG001|Open Label Extension (OLE)|Adverse Event|3|||
156448141|NCT00676715|564734761|FG002|Open Label Extension (OLE)|Adverse Event|1|||
156448142|NCT00676715|564734762|FG003|Open Label Extension (OLE)|Adverse Event|0|||
156448143|NCT00676715|564734759|FG000|Open Label Extension (OLE)|Death|2|||
156448144|NCT00676715|564734760|FG001|Open Label Extension (OLE)|Death|0|||
156448145|NCT00676715|564734761|FG002|Open Label Extension (OLE)|Death|2|||
156448146|NCT00676715|564734762|FG003|Open Label Extension (OLE)|Death|2|||
156448147|NCT04831281|564734766|FG000|Overall Study|Adverse Event|1|||
156448148|NCT04831281|564734767|FG001|Overall Study|Adverse Event|0|||
156448149|NCT04831281|564734768|FG002|Overall Study|Adverse Event|3|||
156448150|NCT04831281|564734766|FG000|Overall Study|Withdrawal by Subject|0|||
156448151|NCT04831281|564734767|FG001|Overall Study|Withdrawal by Subject|1|||
156448152|NCT04831281|564734768|FG002|Overall Study|Withdrawal by Subject|2|||
156448153|NCT04831281|564734766|FG000|Overall Study|Undetermined|1|||
156448154|NCT04831281|564734767|FG001|Overall Study|Undetermined|1|||
156448155|NCT04831281|564734768|FG002|Overall Study|Undetermined|0|||
156448156|NCT05249439|564734769|FG000|Overall Study|Withdrawal by Subject|2|||
156448157|NCT05249439|564734770|FG001|Overall Study|Withdrawal by Subject|5|||
156448158|NCT05249439|564734769|FG000|Overall Study|Physician Decision|3|||
156448159|NCT05249439|564734770|FG001|Overall Study|Physician Decision|1|||
156448160|NCT00616967|564734771|FG000|Overall Study|Withdrawal by Subject|0|||
156448161|NCT00616967|564734772|FG001|Overall Study|Withdrawal by Subject|0|||
156448162|NCT00616967|564734773|FG002|Overall Study|Withdrawal by Subject|1|||
156448163|NCT02910583|564734774|FG000|Overall Study|Death|7|||
156448164|NCT02910583|564734775|FG001|Overall Study|Death|3|||
156448165|NCT02910583|564734774|FG000|Overall Study|Lost to Follow-up|1|||
156874943|NCT01474239|566300582|FG001|Overall Study|Clinical Disease Progression|1|||
156874944|NCT01474239|566300581|FG000|Overall Study|Withdrawal for Economic Reason|1|||
156448166|NCT02910583|564734775|FG001|Overall Study|Lost to Follow-up|0|||
156448167|NCT02910583|564734774|FG000|Overall Study|Withdrawal by Subject|12|||
156448168|NCT02910583|564734775|FG001|Overall Study|Withdrawal by Subject|8|||
156448169|NCT02910583|564734774|FG000|Overall Study|Other, Not Specified|6|||
156448170|NCT02910583|564734775|FG001|Overall Study|Other, Not Specified|3|||
156448171|NCT03393975|564734776|FG000|Urgent Treatment Period|Physician Decision|0|||
156448172|NCT03393975|564734777|FG001|Urgent Treatment Period|Physician Decision|0|||
156448173|NCT03393975|564734778|FG002|Urgent Treatment Period|Physician Decision|0|||
156448174|NCT03393975|564734779|FG003|Urgent Treatment Period|Physician Decision|1|||
156448175|NCT03393975|564734776|FG000|Prophylaxis Period 1|Reason not Specified|0|||
156448176|NCT03393975|564734777|FG001|Prophylaxis Period 1|Reason not Specified|1|||
156448177|NCT03393975|564734778|FG002|Prophylaxis Period 1|Reason not Specified|0|||
156448178|NCT03393975|564734779|FG003|Prophylaxis Period 1|Reason not Specified|0|||
156448179|NCT03393975|564734776|FG000|Prophylaxis Period 2|Reason not Specified|0|||
156448180|NCT03393975|564734777|FG001|Prophylaxis Period 2|Reason not Specified|1|||
156448181|NCT03393975|564734778|FG002|Prophylaxis Period 2|Reason not Specified|0|||
156874945|NCT01474239|566300582|FG001|Overall Study|Withdrawal for Economic Reason|0|||
156448182|NCT03393975|564734779|FG003|Prophylaxis Period 2|Reason not Specified|0|||
156448183|NCT05021640|564734780|FG000|Overall Study|Lost to Follow-up|0|||
156448184|NCT05021640|564734781|FG001|Overall Study|Lost to Follow-up|0|||
156448185|NCT05021640|564734782|FG002|Overall Study|Lost to Follow-up|0|||
156448186|NCT05021640|564734783|FG003|Overall Study|Lost to Follow-up|0|||
156448187|NCT05021640|564734784|FG004|Overall Study|Lost to Follow-up|1|||
156448188|NCT02312960|564734785|FG000|Overall Study|Death|24|||
156448189|NCT02312960|564734786|FG001|Overall Study|Death|32|||
156448190|NCT02312960|564734787|FG002|Overall Study|Death|25|||
156448191|NCT02312960|564734788|FG003|Overall Study|Death|11|||
156448192|NCT02312960|564734789|FG004|Overall Study|Death|5|||
156533130|NCT04178967|565046857|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156533131|NCT04178967|565046858|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156533132|NCT04178967|565046859|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156448193|NCT02312960|564734790|FG005|Overall Study|Death|5|||
156448194|NCT02312960|564734791|FG006|Overall Study|Death|8|||
156448195|NCT02312960|564734792|FG007|Overall Study|Death|5|||
156448196|NCT02312960|564734793|FG008|Overall Study|Death|7|||
156448197|NCT02312960|564734794|FG009|Overall Study|Death|3|||
156448198|NCT02312960|564734795|FG010|Overall Study|Death|3|||
156448199|NCT02312960|564734796|FG011|Overall Study|Death|1|||
156448200|NCT02312960|564734797|FG012|Overall Study|Death|25|||
156448201|NCT02312960|564734798|FG013|Overall Study|Death|19|||
156448202|NCT02312960|564734785|FG000|Overall Study|Missing|0|||
156448203|NCT02312960|564734786|FG001|Overall Study|Missing|0|||
156448204|NCT02312960|564734787|FG002|Overall Study|Missing|2|||
156448205|NCT02312960|564734788|FG003|Overall Study|Missing|0|||
156448206|NCT02312960|564734789|FG004|Overall Study|Missing|0|||
156448207|NCT02312960|564734790|FG005|Overall Study|Missing|0|||
156448208|NCT02312960|564734791|FG006|Overall Study|Missing|0|||
156874946|NCT01675544|566300583|FG000|Overall Study|Withdrawal by Subject|2|||
156874947|NCT00505778|566300584|FG000|Overall Study|Adverse Event|2|||
156874948|NCT00505778|566300585|FG001|Overall Study|Adverse Event|7|||
156874949|NCT00505778|566300584|FG000|Overall Study|Physician Decision|8|||
156874950|NCT00505778|566300585|FG001|Overall Study|Physician Decision|14|||
156874951|NCT00505778|566300584|FG000|Overall Study|Lost to Follow-up|17|||
156874952|NCT00505778|566300585|FG001|Overall Study|Lost to Follow-up|23|||
156874953|NCT00505778|566300584|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
156874954|NCT00505778|566300585|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
156874955|NCT00505778|566300584|FG000|Overall Study|Protocol Violation|7|||
156874956|NCT00505778|566300585|FG001|Overall Study|Protocol Violation|9|||
156874957|NCT00505778|566300584|FG000|Overall Study|Withdrawal by Subject|29|||
156874958|NCT00505778|566300585|FG001|Overall Study|Withdrawal by Subject|14|||
156874959|NCT00505778|566300584|FG000|Overall Study|Relapse|65|||
156874960|NCT00505778|566300585|FG001|Overall Study|Relapse|65|||
156874961|NCT00505778|566300584|FG000|Overall Study|Took No Study Drug|2|||
156874962|NCT00505778|566300585|FG001|Overall Study|Took No Study Drug|2|||
156874963|NCT03790696|566300587|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
156874964|NCT03790696|566300588|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
156874965|NCT00243269|566300593|FG000|Overall Study|Protocol Violation|2|||
156448209|NCT02312960|564734792|FG007|Overall Study|Missing|0|||
156448210|NCT02312960|564734793|FG008|Overall Study|Missing|0|||
156533133|NCT04178967|565046860|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156533134|NCT04178967|565046861|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156448211|NCT02312960|564734794|FG009|Overall Study|Missing|0|||
156448212|NCT02312960|564734795|FG010|Overall Study|Missing|0|||
156448213|NCT02312960|564734796|FG011|Overall Study|Missing|0|||
156448214|NCT02312960|564734797|FG012|Overall Study|Missing|0|||
156448215|NCT02312960|564734798|FG013|Overall Study|Missing|0|||
156448216|NCT02312960|564734785|FG000|Overall Study|Lost to Follow-up|0|||
156448217|NCT02312960|564734786|FG001|Overall Study|Lost to Follow-up|0|||
156533135|NCT04178967|565046862|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156448218|NCT02312960|564734787|FG002|Overall Study|Lost to Follow-up|1|||
156448219|NCT02312960|564734788|FG003|Overall Study|Lost to Follow-up|0|||
156448220|NCT02312960|564734789|FG004|Overall Study|Lost to Follow-up|0|||
156533136|NCT04178967|565046863|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156874966|NCT00243269|566300594|FG001|Overall Study|Protocol Violation|1|||
156874967|NCT00243269|566300595|FG002|Overall Study|Protocol Violation|0|||
156448221|NCT02312960|564734790|FG005|Overall Study|Lost to Follow-up|0|||
156448222|NCT02312960|564734791|FG006|Overall Study|Lost to Follow-up|1|||
156448223|NCT02312960|564734792|FG007|Overall Study|Lost to Follow-up|1|||
156448224|NCT02312960|564734793|FG008|Overall Study|Lost to Follow-up|0|||
156448225|NCT02312960|564734794|FG009|Overall Study|Lost to Follow-up|1|||
156448226|NCT02312960|564734795|FG010|Overall Study|Lost to Follow-up|0|||
156448227|NCT02312960|564734796|FG011|Overall Study|Lost to Follow-up|0|||
156448228|NCT02312960|564734797|FG012|Overall Study|Lost to Follow-up|1|||
156448229|NCT02312960|564734798|FG013|Overall Study|Lost to Follow-up|0|||
156448230|NCT02312960|564734785|FG000|Overall Study|Withdrawal by Subject|1|||
156448231|NCT02312960|564734786|FG001|Overall Study|Withdrawal by Subject|2|||
156448232|NCT02312960|564734787|FG002|Overall Study|Withdrawal by Subject|0|||
156448233|NCT02312960|564734788|FG003|Overall Study|Withdrawal by Subject|0|||
156448234|NCT02312960|564734789|FG004|Overall Study|Withdrawal by Subject|1|||
156448235|NCT02312960|564734790|FG005|Overall Study|Withdrawal by Subject|0|||
156448236|NCT02312960|564734791|FG006|Overall Study|Withdrawal by Subject|1|||
156448237|NCT02312960|564734792|FG007|Overall Study|Withdrawal by Subject|2|||
156448238|NCT02312960|564734793|FG008|Overall Study|Withdrawal by Subject|2|||
156448239|NCT02312960|564734794|FG009|Overall Study|Withdrawal by Subject|3|||
156448240|NCT02312960|564734795|FG010|Overall Study|Withdrawal by Subject|0|||
156448241|NCT02312960|564734796|FG011|Overall Study|Withdrawal by Subject|0|||
156448242|NCT02312960|564734797|FG012|Overall Study|Withdrawal by Subject|2|||
156448243|NCT02312960|564734798|FG013|Overall Study|Withdrawal by Subject|0|||
156448244|NCT05227209|564734800|FG000|Overall Study|Adverse Event|11|||
156448245|NCT05227209|564734800|FG000|Overall Study|Lost to Follow-up|1|||
156448246|NCT05227209|564734800|FG000|Overall Study|Withdrawal by Subject|7|||
156448247|NCT05227209|564734800|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
156448248|NCT05633953|564734801|FG000|Overall Study|Adverse Event|7|||
156448249|NCT05633953|564734801|FG000|Overall Study|Death|30|||
156448250|NCT05633953|564734801|FG000|Overall Study|Lost to Follow-up|1|||
156448251|NCT05633953|564734801|FG000|Overall Study|Osilodrostat discontinued|4|||
156448252|NCT05633953|564734801|FG000|Overall Study|Physician Decision|1|||
156448253|NCT05633953|564734801|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
156448254|NCT05633953|564734801|FG000|Overall Study|Progressive disease|2|||
156448255|NCT05337748|564734803|FG000|Overall Study|Withdrawal by Subject|1|||
156448256|NCT05337748|564734804|FG001|Overall Study|Withdrawal by Subject|0|||
156448257|NCT05337748|564734803|FG000|Overall Study|Death|1|||
156448258|NCT05337748|564734804|FG001|Overall Study|Death|0|||
156448259|NCT03453619|564734811|FG000|Core Study (Part A)|Physician Decision|0|||
156448260|NCT03453619|564734812|FG001|Core Study (Part A)|Physician Decision|0|||
156448261|NCT03453619|564734813|FG002|Core Study (Part A)|Physician Decision|2|||
156448262|NCT03453619|564734814|FG003|Core Study (Part A)|Physician Decision|0|||
156448263|NCT03453619|564734811|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
156448264|NCT03453619|564734812|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
156448265|NCT03453619|564734813|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
156448266|NCT03453619|564734814|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
156448267|NCT03453619|564734811|FG000|Core Study (Part A)|Other|0|||
156448268|NCT03453619|564734812|FG001|Core Study (Part A)|Other|1|||
156448269|NCT03453619|564734813|FG002|Core Study (Part A)|Other|0|||
156448270|NCT03453619|564734814|FG003|Core Study (Part A)|Other|0|||
156448271|NCT03453619|564734811|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
156448272|NCT03453619|564734812|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
156448273|NCT03453619|564734813|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
156448274|NCT03453619|564734814|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
156448275|NCT03453619|564734811|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
156448276|NCT03453619|564734812|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
156448277|NCT03453619|564734813|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
156448278|NCT03453619|564734814|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
156448279|NCT03453619|564734811|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
156448280|NCT03453619|564734812|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
156448281|NCT03453619|564734813|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
156448282|NCT03453619|564734814|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
156448283|NCT03453619|564734811|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
156448284|NCT03453619|564734812|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
156448285|NCT03453619|564734813|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
156448286|NCT03453619|564734814|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
156448287|NCT04089371|564734815|FG000|Overall Study|Withdrawal by Subject|0|||
156448288|NCT04089371|564734816|FG001|Overall Study|Withdrawal by Subject|1|||
156448289|NCT04089371|564734815|FG000|Overall Study|Study terminated early|0|||
156793432|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156793433|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
156793434|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156793435|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156793436|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
156448290|NCT04089371|564734816|FG001|Overall Study|Study terminated early|9|||
156448291|NCT05229120|564734817|FG000|Overall Study|Withdrawal by Subject|8|||
156448292|NCT03932682|564734820|FG000|Overall Study|Death|1|||
156448293|NCT03932682|564734821|FG001|Overall Study|Death|2|||
156533137|NCT04178967|565046864|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
156793437|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
156874968|NCT00243269|566300596|FG003|Overall Study|Protocol Violation|1|||
156448294|NCT03932682|564734820|FG000|Overall Study|Withdrawal by Subject|37|||
156448295|NCT03932682|564734821|FG001|Overall Study|Withdrawal by Subject|45|||
156448296|NCT03932682|564734820|FG000|Overall Study|Lost to Follow-up|19|||
156448297|NCT03932682|564734821|FG001|Overall Study|Lost to Follow-up|25|||
156448298|NCT03932682|564734820|FG000|Overall Study|Protocol Violation|0|||
156793438|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
156793439|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
156793440|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
156793441|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
156793442|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
156793443|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
156793444|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
156793445|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
156793446|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
156793447|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
156793448|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
156793449|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
156793450|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
156793451|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
156793452|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
156793453|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
156793454|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
156448299|NCT03932682|564734821|FG001|Overall Study|Protocol Violation|2|||
156448300|NCT03932682|564734820|FG000|Overall Study|Other|9|||
156448301|NCT03932682|564734821|FG001|Overall Study|Other|23|||
156448302|NCT03941860|564734833|FG000|Overall Study|Withdrawal by Subject|0|||
156448303|NCT03941860|564734834|FG001|Overall Study|Withdrawal by Subject|1|||
156448304|NCT04833777|564736515|FG000|Overall Study|Lost to Follow-up|1|||
156448305|NCT04833777|564736516|FG001|Overall Study|Lost to Follow-up|0|||
156448306|NCT03101904|564736519|FG000|Wash Out (10 Days)|Adverse Event|1|||
156448307|NCT03101904|564736520|FG001|Wash Out (10 Days)|Adverse Event|0|||
156448308|NCT03101904|564736519|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
156448309|NCT03101904|564736520|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
156448310|NCT02682316|564736521|FG000|Overall Study|Benign Final Pathology|27|||
156448311|NCT02682316|564736522|FG001|Overall Study|Benign Final Pathology|26|||
156448312|NCT02682316|564736521|FG000|Overall Study|Reoperation before 30 days|7|||
156448313|NCT02682316|564736522|FG001|Overall Study|Reoperation before 30 days|6|||
156448314|NCT02682316|564736521|FG000|Overall Study|Ineligible|1|||
156448315|NCT02682316|564736522|FG001|Overall Study|Ineligible|0|||
156448316|NCT02682316|564736521|FG000|Overall Study|Death|1|||
156448317|NCT02682316|564736522|FG001|Overall Study|Death|0|||
156448318|NCT02682316|564736521|FG000|Overall Study|Lost to Follow-up|7|||
156448319|NCT02682316|564736522|FG001|Overall Study|Lost to Follow-up|3|||
156448320|NCT04538417|564736523|FG000|Overall Study|Withdrawal by Subject|2|||
156448321|NCT01331005|564736527|FG000|Overall Study|Lost to Follow-up|2|||
156448322|NCT01331005|564736528|FG001|Overall Study|Lost to Follow-up|1|||
156448323|NCT01331005|564736527|FG000|Overall Study|Withdrawal by Subject|2|||
156448324|NCT01331005|564736528|FG001|Overall Study|Withdrawal by Subject|3|||
156448325|NCT03161379|564736538|FG000|Overall Study|Withdrawal by Subject|4|||
156448326|NCT03161379|564736538|FG000|Overall Study|disease progression during chemotherapy|5|||
156448327|NCT03161379|564736538|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
156448328|NCT03161379|564736538|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
156448329|NCT03131648|564736542|FG000|Initial Treatment Period|Not dosed|2|||
156448330|NCT03131648|564736543|FG001|Initial Treatment Period|Not dosed|2|||
156448331|NCT03131648|564736544|FG002|Initial Treatment Period|Not dosed|0|||
156448332|NCT03131648|564736545|FG003|Initial Treatment Period|Not dosed|0|||
156448333|NCT03131648|564736546|FG004|Initial Treatment Period|Not dosed|0|||
156448334|NCT03131648|564736547|FG005|Initial Treatment Period|Not dosed|0|||
156448335|NCT03131648|564736548|FG006|Initial Treatment Period|Not dosed|0|||
156448336|NCT03131648|564736549|FG007|Initial Treatment Period|Not dosed|0|||
156448337|NCT03131648|564736542|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
156448338|NCT03131648|564736543|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
156448339|NCT03131648|564736544|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156448340|NCT03131648|564736545|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156793455|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
156874969|NCT00243269|566300593|FG000|Overall Study|Lost to Follow-up|1|||
156448341|NCT03131648|564736546|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156448342|NCT03131648|564736547|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156793456|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
156874970|NCT00243269|566300594|FG001|Overall Study|Lost to Follow-up|0|||
156448343|NCT03131648|564736548|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156448344|NCT03131648|564736549|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156448345|NCT03131648|564736542|FG000|Open-label Treatment|Discontinued IMP|0|||
156448346|NCT03131648|564736543|FG001|Open-label Treatment|Discontinued IMP|0|||
156448347|NCT03131648|564736544|FG002|Open-label Treatment|Discontinued IMP|0|||
156448348|NCT03131648|564736545|FG003|Open-label Treatment|Discontinued IMP|0|||
156793457|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
156448349|NCT03131648|564736546|FG004|Open-label Treatment|Discontinued IMP|0|||
156448350|NCT03131648|564736547|FG005|Open-label Treatment|Discontinued IMP|0|||
156448351|NCT03131648|564736548|FG006|Open-label Treatment|Discontinued IMP|112|||
156448352|NCT03131648|564736549|FG007|Open-label Treatment|Discontinued IMP|0|||
156448353|NCT03131648|564736542|FG000|Open-label Treatment|Completed Week 50|0|||
156448354|NCT03131648|564736543|FG001|Open-label Treatment|Completed Week 50|0|||
156448355|NCT03131648|564736544|FG002|Open-label Treatment|Completed Week 50|0|||
156448356|NCT03131648|564736545|FG003|Open-label Treatment|Completed Week 50|0|||
156448357|NCT03131648|564736546|FG004|Open-label Treatment|Completed Week 50|0|||
156448358|NCT03131648|564736547|FG005|Open-label Treatment|Completed Week 50|0|||
156448359|NCT03131648|564736548|FG006|Open-label Treatment|Completed Week 50|6|||
156448360|NCT03131648|564736549|FG007|Open-label Treatment|Completed Week 50|0|||
156448361|NCT03131648|564736542|FG000|Maintenance Treatment Period|Not dosed|0|||
156448362|NCT03131648|564736543|FG001|Maintenance Treatment Period|Not dosed|0|||
156448363|NCT03131648|564736544|FG002|Maintenance Treatment Period|Not dosed|3|||
156448364|NCT03131648|564736545|FG003|Maintenance Treatment Period|Not dosed|2|||
156448365|NCT03131648|564736546|FG004|Maintenance Treatment Period|Not dosed|1|||
156448366|NCT03131648|564736547|FG005|Maintenance Treatment Period|Not dosed|0|||
156448367|NCT03131648|564736548|FG006|Maintenance Treatment Period|Not dosed|0|||
156448368|NCT03131648|564736549|FG007|Maintenance Treatment Period|Not dosed|0|||
156448369|NCT03131648|564736542|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
156448370|NCT03131648|564736543|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
156448371|NCT03131648|564736544|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
156448372|NCT03131648|564736545|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
156448373|NCT03131648|564736546|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
156448374|NCT03131648|564736547|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
156448375|NCT03131648|564736548|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
156448376|NCT03131648|564736549|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
156448377|NCT03131648|564736542|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
156448378|NCT03131648|564736543|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
156448379|NCT03131648|564736544|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
156448380|NCT03131648|564736545|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
156448381|NCT03131648|564736546|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
156448382|NCT03131648|564736547|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
156448383|NCT03131648|564736548|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
156448384|NCT03131648|564736549|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
156448385|NCT03131648|564736542|FG000|Maintenance Treatment Period|Completed Week 50|0|||
156448386|NCT03131648|564736543|FG001|Maintenance Treatment Period|Completed Week 50|0|||
156448387|NCT03131648|564736544|FG002|Maintenance Treatment Period|Completed Week 50|0|||
156448388|NCT03131648|564736545|FG003|Maintenance Treatment Period|Completed Week 50|0|||
156448389|NCT03131648|564736546|FG004|Maintenance Treatment Period|Completed Week 50|1|||
156448390|NCT03131648|564736547|FG005|Maintenance Treatment Period|Completed Week 50|0|||
156448391|NCT03131648|564736548|FG006|Maintenance Treatment Period|Completed Week 50|0|||
156448392|NCT03131648|564736549|FG007|Maintenance Treatment Period|Completed Week 50|0|||
156448393|NCT03131648|564736542|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
156448394|NCT03131648|564736543|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
156448395|NCT03131648|564736544|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
156448396|NCT03131648|564736545|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
156448397|NCT03131648|564736546|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
156448398|NCT03131648|564736547|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
156448399|NCT03131648|564736548|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
156448400|NCT03131648|564736549|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
156448401|NCT02724878|564736550|FG000|Overall Study|Still on Active Therapy|15|||
156448402|NCT02724878|564736550|FG000|Overall Study|Disease Progression|31|||
156448403|NCT02724878|564736550|FG000|Overall Study|Toxicity|5|||
156448404|NCT02724878|564736550|FG000|Overall Study|Death|1|||
156448405|NCT02724878|564736550|FG000|Overall Study|Withdrawal by Subject|4|||
156448406|NCT02724878|564736550|FG000|Overall Study|Lost to Follow-up|2|||
156448407|NCT02724878|564736550|FG000|Overall Study|Protocol Violation|1|||
156448408|NCT02724878|564736550|FG000|Overall Study|Ineligible for Study Drug|5|||
156448409|NCT02724878|564736550|FG000|Overall Study|not started|1|||
156716487|NCT04467840|565707497|FG001|Overall Study|Physician Decision|0|||
156448410|NCT04421378|564736555|FG000|Overall Study|Adverse Event|2|||
156448411|NCT04421378|564736556|FG001|Overall Study|Adverse Event|7|||
156448412|NCT04421378|564736557|FG002|Overall Study|Adverse Event|0|||
156448413|NCT04421378|564736558|FG003|Overall Study|Adverse Event|1|||
156448414|NCT04421378|564736559|FG004|Overall Study|Adverse Event|0|||
156448415|NCT04421378|564736555|FG000|Overall Study|Physician Decision|1|||
156448416|NCT04421378|564736556|FG001|Overall Study|Physician Decision|2|||
156448417|NCT04421378|564736557|FG002|Overall Study|Physician Decision|0|||
156448418|NCT04421378|564736558|FG003|Overall Study|Physician Decision|0|||
156448419|NCT04421378|564736559|FG004|Overall Study|Physician Decision|0|||
156448420|NCT04421378|564736555|FG000|Overall Study|Progressive Disease|16|||
156448421|NCT04421378|564736556|FG001|Overall Study|Progressive Disease|4|||
156448422|NCT04421378|564736557|FG002|Overall Study|Progressive Disease|18|||
156448423|NCT04421378|564736558|FG003|Overall Study|Progressive Disease|11|||
156448424|NCT04421378|564736559|FG004|Overall Study|Progressive Disease|3|||
156448425|NCT04421378|564736555|FG000|Overall Study|Study Terminated by Sponsor|0|||
156448426|NCT04421378|564736556|FG001|Overall Study|Study Terminated by Sponsor|1|||
156448427|NCT04421378|564736557|FG002|Overall Study|Study Terminated by Sponsor|1|||
156448428|NCT04421378|564736558|FG003|Overall Study|Study Terminated by Sponsor|0|||
156448429|NCT04421378|564736559|FG004|Overall Study|Study Terminated by Sponsor|0|||
156448430|NCT04421378|564736555|FG000|Overall Study|Withdrawal by Subject|3|||
156448431|NCT04421378|564736556|FG001|Overall Study|Withdrawal by Subject|1|||
156448432|NCT04421378|564736557|FG002|Overall Study|Withdrawal by Subject|0|||
156448433|NCT04421378|564736558|FG003|Overall Study|Withdrawal by Subject|2|||
156448434|NCT04421378|564736559|FG004|Overall Study|Withdrawal by Subject|0|||
156448435|NCT04421378|564736555|FG000|Overall Study|Other|1|||
156448436|NCT04421378|564736556|FG001|Overall Study|Other|0|||
156448437|NCT04421378|564736557|FG002|Overall Study|Other|0|||
156448438|NCT04421378|564736558|FG003|Overall Study|Other|0|||
156448439|NCT04421378|564736559|FG004|Overall Study|Other|0|||
156448440|NCT04258709|564736560|FG000|Overall Study|Lost to Follow-up|10|||
156448441|NCT04258709|564736561|FG001|Overall Study|Lost to Follow-up|4|||
156448442|NCT04258709|564736560|FG000|Overall Study|Withdrawal by Subject|1|||
156448443|NCT04258709|564736561|FG001|Overall Study|Withdrawal by Subject|0|||
156448444|NCT04258709|564736560|FG000|Overall Study|Fetal demise|0|||
156448445|NCT04258709|564736561|FG001|Overall Study|Fetal demise|1|||
156448446|NCT04258709|564736560|FG000|Overall Study|Protocol Violation|1|||
156448447|NCT04258709|564736561|FG001|Overall Study|Protocol Violation|1|||
156448448|NCT02592330|564736562|FG000|Overall Study|Withdrawal by Subject|1|||
156448449|NCT02592330|564736563|FG001|Overall Study|Withdrawal by Subject|0|||
156448450|NCT02592330|564736562|FG000|Overall Study|Failed Biopsy|1|||
156448451|NCT02592330|564736563|FG001|Overall Study|Failed Biopsy|0|||
156448452|NCT03090152|564736564|FG000|Overall Study|Withdrawal by Subject|0|||
156448453|NCT03090152|564736565|FG001|Overall Study|Withdrawal by Subject|2|||
156448454|NCT03090152|564736566|FG002|Overall Study|Withdrawal by Subject|1|||
156448455|NCT03090152|564736564|FG000|Overall Study|Surgery Canceled|1|||
156448456|NCT03090152|564736565|FG001|Overall Study|Surgery Canceled|0|||
156448457|NCT03090152|564736566|FG002|Overall Study|Surgery Canceled|0|||
156448458|NCT03090152|564736564|FG000|Overall Study|Epidural catheter could not be placed|0|||
156448459|NCT03090152|564736565|FG001|Overall Study|Epidural catheter could not be placed|2|||
156448460|NCT03090152|564736566|FG002|Overall Study|Epidural catheter could not be placed|0|||
156448461|NCT02807636|564736567|FG000|Overall Study|Lost to Follow-up|10|||
156448462|NCT02807636|564736568|FG001|Overall Study|Lost to Follow-up|13|||
156448463|NCT02807636|564736569|FG002|Overall Study|Lost to Follow-up|6|||
156448464|NCT02807636|564736567|FG000|Overall Study|Protocol Deviation|1|||
156448465|NCT02807636|564736568|FG001|Overall Study|Protocol Deviation|0|||
156448466|NCT02807636|564736569|FG002|Overall Study|Protocol Deviation|0|||
156448467|NCT02807636|564736567|FG000|Overall Study|Symptomatic Deterioration|0|||
156448468|NCT02807636|564736568|FG001|Overall Study|Symptomatic Deterioration|1|||
156448469|NCT02807636|564736569|FG002|Overall Study|Symptomatic Deterioration|0|||
156448470|NCT02807636|564736567|FG000|Overall Study|Withdrawal by Subject|39|||
156448471|NCT02807636|564736568|FG001|Overall Study|Withdrawal by Subject|28|||
156448472|NCT02807636|564736569|FG002|Overall Study|Withdrawal by Subject|24|||
156448473|NCT02807636|564736567|FG000|Overall Study|Death|303|||
156448474|NCT02807636|564736568|FG001|Overall Study|Death|332|||
156448475|NCT02807636|564736569|FG002|Overall Study|Death|272|||
156448476|NCT02807636|564736567|FG000|Overall Study|Study Terminated By Sponsor|47|||
156448477|NCT02807636|564736568|FG001|Overall Study|Study Terminated By Sponsor|76|||
156448478|NCT02807636|564736569|FG002|Overall Study|Study Terminated By Sponsor|60|||
156448479|NCT02807636|564736567|FG000|Overall Study|Physician Decision|0|||
156448480|NCT02807636|564736568|FG001|Overall Study|Physician Decision|1|||
156448481|NCT02807636|564736569|FG002|Overall Study|Physician Decision|0|||
156448482|NCT02506959|564736571|FG000|Overall Study|Physician Decision|2|||
156448483|NCT02506959|564736572|FG001|Overall Study|Physician Decision|1|||
156448484|NCT01566695|564736573|FG000|Overall Study|Lack of Efficacy|1|||
156533138|NCT04178967|565046865|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
156533139|NCT04178967|565046855|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156448485|NCT01566695|564736574|FG001|Overall Study|Lack of Efficacy|0|||
156448486|NCT01566695|564736573|FG000|Overall Study|Adverse Event|3|||
156448487|NCT01566695|564736574|FG001|Overall Study|Adverse Event|0|||
156448488|NCT01566695|564736573|FG000|Overall Study|Death|79|||
156448489|NCT01566695|564736574|FG001|Overall Study|Death|86|||
156448490|NCT01566695|564736573|FG000|Overall Study|Withdrawal by Subject|13|||
156448491|NCT01566695|564736574|FG001|Overall Study|Withdrawal by Subject|12|||
156448492|NCT01566695|564736573|FG000|Overall Study|Lost to Follow-up|0|||
156448493|NCT01566695|564736574|FG001|Overall Study|Lost to Follow-up|3|||
156448494|NCT01566695|564736573|FG000|Overall Study|Other reasons|11|||
156448495|NCT01566695|564736574|FG001|Overall Study|Other reasons|8|||
156448496|NCT05470400|564736575|FG000|Overall Study|Lost to Follow-up|0|||
156793458|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
156793459|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
156793460|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
156793461|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
156793462|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
156793463|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
156793464|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
156793465|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
156793466|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
156793467|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
156793468|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
156793469|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
156793470|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
156793471|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
156793472|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
156793473|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
156793474|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
156716488|NCT04467840|565707496|FG000|Overall Study|Other|1|||
156716489|NCT04467840|565707497|FG001|Overall Study|Other|5|||
156716490|NCT04467840|565707496|FG000|Overall Study|Missing study completion status|3|||
156716491|NCT04467840|565707497|FG001|Overall Study|Missing study completion status|1|||
156716492|NCT05126693|565707500|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
156716493|NCT05126693|565707501|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
156716494|NCT05126693|565707500|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
156716495|NCT05126693|565707501|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
156716496|NCT05126693|565707500|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
156716497|NCT05126693|565707501|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
156716498|NCT04688671|565707502|FG000|Overall Study|Adverse Event|3|||
156716499|NCT04688671|565707503|FG001|Overall Study|Adverse Event|1|||
156716500|NCT04688671|565707502|FG000|Overall Study|Withdrawal by Subject|3|||
156716501|NCT04688671|565707503|FG001|Overall Study|Withdrawal by Subject|1|||
156716502|NCT04688671|565707502|FG000|Overall Study|Lack of Efficacy|1|||
156716503|NCT04688671|565707503|FG001|Overall Study|Lack of Efficacy|1|||
156716504|NCT04688671|565707502|FG000|Overall Study|Protocol Violation|1|||
156716505|NCT04688671|565707503|FG001|Overall Study|Protocol Violation|0|||
156716506|NCT04688671|565707502|FG000|Overall Study|Lost to Follow-up|0|||
156716507|NCT04688671|565707503|FG001|Overall Study|Lost to Follow-up|1|||
156716508|NCT00110396|565707508|FG000|Overall Study|Adverse Event|15|||
156716509|NCT00110396|565707508|FG000|Overall Study|Lost to Follow-up|1|||
156716510|NCT00110396|565707508|FG000|Overall Study|Administration of plasmapheresis|1|||
156716511|NCT00110396|565707508|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
156716512|NCT00110396|565707508|FG000|Overall Study|Lack of Efficacy|1|||
156716513|NCT00110396|565707508|FG000|Overall Study|Decided not to continue treatment|1|||
156716514|NCT00110396|565707508|FG000|Overall Study|Patient non-compliance|1|||
156716515|NCT00110396|565707508|FG000|Overall Study|Patient refused to continue|1|||
156716516|NCT00110396|565707508|FG000|Overall Study|Patient refused to participate|1|||
156716517|NCT00110396|565707508|FG000|Overall Study|Patient will|1|||
156716518|NCT00110396|565707508|FG000|Overall Study|Patient's decision|1|||
156716519|NCT00110396|565707508|FG000|Overall Study|Participation in MS vaccine study|1|||
156716520|NCT00110396|565707508|FG000|Overall Study|Pregnancy|1|||
156716521|NCT00110396|565707508|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
156716522|NCT00110396|565707508|FG000|Overall Study|Protocol Violation|2|||
156716523|NCT00110396|565707508|FG000|Overall Study|Patient refused to come back|1|||
156716524|NCT00110396|565707508|FG000|Overall Study|The patient has refused|2|||
156793475|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
156793476|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
156793477|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
156793478|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
156334983|NCT02202980|564324452|FG007|Overall Study|Lost to Follow-up|1|||
156334984|NCT02202980|564324453|FG008|Overall Study|Lost to Follow-up|1|||
156716525|NCT00110396|565707508|FG000|Overall Study|The patient has refused to visit site|1|||
156716526|NCT00110396|565707508|FG000|Overall Study|Patient is to be administered copaxone|1|||
156716527|NCT00811733|565707515|FG000|Overall Study|Investigator Discretion|10|||
156793479|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
156334985|NCT02202980|564324454|FG009|Overall Study|Lost to Follow-up|0|||
156716528|NCT00811733|565707516|FG001|Overall Study|Investigator Discretion|8|||
156716529|NCT00811733|565707515|FG000|Overall Study|Withdrawal by Subject|1|||
156716530|NCT00811733|565707516|FG001|Overall Study|Withdrawal by Subject|2|||
156716531|NCT00793871|565707517|FG000|Overall Study|Death|50|||
156716532|NCT00793871|565707517|FG000|Overall Study|Lost to Follow-up|3|||
156716533|NCT00793871|565707517|FG000|Overall Study|Study terminated by the Sponsor|7|||
156793480|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
156334986|NCT02202980|564324455|FG010|Overall Study|Lost to Follow-up|0|||
156716534|NCT00245466|565707518|FG000|Overall Study|Adverse Event|2|||
156716535|NCT00245466|565707519|FG001|Overall Study|Adverse Event|8|||
156716536|NCT00245466|565707520|FG002|Overall Study|Adverse Event|4|||
156716537|NCT00245466|565707518|FG000|Overall Study|Low prostate specific antigen suppr|16|||
156716538|NCT00245466|565707519|FG001|Overall Study|Low prostate specific antigen suppr|14|||
156716539|NCT00245466|565707520|FG002|Overall Study|Low prostate specific antigen suppr|5|||
156716540|NCT00245466|565707518|FG000|Overall Study|Insufficient testosterone suppr|12|||
156716541|NCT00245466|565707519|FG001|Overall Study|Insufficient testosterone suppr|12|||
156716542|NCT00245466|565707520|FG002|Overall Study|Insufficient testosterone suppr|21|||
156716543|NCT00245466|565707518|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
156716544|NCT00245466|565707519|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
156716545|NCT00245466|565707520|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
156716546|NCT00245466|565707518|FG000|Overall Study|Withdrawal by Subject|2|||
156716547|NCT00245466|565707519|FG001|Overall Study|Withdrawal by Subject|2|||
156716548|NCT00245466|565707520|FG002|Overall Study|Withdrawal by Subject|1|||
156716549|NCT00245466|565707518|FG000|Overall Study|Lost to Follow-up|3|||
156716550|NCT00245466|565707519|FG001|Overall Study|Lost to Follow-up|0|||
156716551|NCT00245466|565707520|FG002|Overall Study|Lost to Follow-up|0|||
156716552|NCT00245466|565707518|FG000|Overall Study|Disease progression|0|||
156716553|NCT00245466|565707519|FG001|Overall Study|Disease progression|3|||
156716554|NCT00245466|565707520|FG002|Overall Study|Disease progression|1|||
156716555|NCT00245466|565707518|FG000|Overall Study|Protocol Violation|1|||
156716556|NCT00245466|565707519|FG001|Overall Study|Protocol Violation|2|||
156716557|NCT00245466|565707520|FG002|Overall Study|Protocol Violation|2|||
156716558|NCT00245466|565707518|FG000|Overall Study|Death|0|||
156716559|NCT00245466|565707519|FG001|Overall Study|Death|2|||
156716560|NCT00245466|565707520|FG002|Overall Study|Death|0|||
156716561|NCT00245466|565707518|FG000|Overall Study|Administrative reasons|0|||
156716562|NCT00245466|565707519|FG001|Overall Study|Administrative reasons|1|||
156716563|NCT00245466|565707520|FG002|Overall Study|Administrative reasons|0|||
156716564|NCT00856193|565707521|FG000|Period 2|Abnormal test procedure results|0|||
156716565|NCT00856193|565707522|FG001|Period 2|Abnormal test procedure results|1|||
156716566|NCT00856193|565707521|FG000|Period 2|Lost to Follow-up|0|||
156716567|NCT00856193|565707522|FG001|Period 2|Lost to Follow-up|1|||
156716568|NCT01928472|565707523|FG000|Overall Study|Death|0|||
156716569|NCT01928472|565707524|FG001|Overall Study|Death|0|||
156716570|NCT01928472|565707525|FG002|Overall Study|Death|1|||
156716571|NCT01928472|565707526|FG003|Overall Study|Death|0|||
156716572|NCT01928472|565707523|FG000|Overall Study|Withdrawal by Subject|4|||
156716573|NCT01928472|565707524|FG001|Overall Study|Withdrawal by Subject|4|||
156716574|NCT01928472|565707525|FG002|Overall Study|Withdrawal by Subject|1|||
156716575|NCT01928472|565707526|FG003|Overall Study|Withdrawal by Subject|2|||
156716576|NCT01928472|565707523|FG000|Overall Study|Lost to Follow-up|2|||
156716577|NCT01928472|565707524|FG001|Overall Study|Lost to Follow-up|3|||
156716578|NCT01928472|565707525|FG002|Overall Study|Lost to Follow-up|4|||
156716579|NCT01928472|565707526|FG003|Overall Study|Lost to Follow-up|0|||
156716580|NCT01928472|565707523|FG000|Overall Study|Administrative Reason|2|||
156716581|NCT01928472|565707524|FG001|Overall Study|Administrative Reason|1|||
156716582|NCT01928472|565707525|FG002|Overall Study|Administrative Reason|0|||
156793481|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
156793482|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
156793483|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
156793484|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
156793485|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
156793486|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
156793487|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
156874971|NCT00243269|566300595|FG002|Overall Study|Lost to Follow-up|1|||
156448497|NCT05470400|564736576|FG001|Overall Study|Lost to Follow-up|0|||
156448498|NCT05470400|564736577|FG002|Overall Study|Lost to Follow-up|0|||
156448499|NCT05470400|564736578|FG003|Overall Study|Lost to Follow-up|0|||
156448500|NCT05470400|564736579|FG004|Overall Study|Lost to Follow-up|0|||
156448501|NCT05470400|564736580|FG005|Overall Study|Lost to Follow-up|0|||
156448502|NCT05470400|564736581|FG006|Overall Study|Lost to Follow-up|0|||
156448503|NCT05470400|564736582|FG007|Overall Study|Lost to Follow-up|1|||
156716583|NCT01928472|565707526|FG003|Overall Study|Administrative Reason|0|||
156716584|NCT01928472|565707523|FG000|Overall Study|Unclassified|0|||
156716585|NCT01928472|565707524|FG001|Overall Study|Unclassified|0|||
156716586|NCT01928472|565707525|FG002|Overall Study|Unclassified|1|||
156716587|NCT01928472|565707526|FG003|Overall Study|Unclassified|0|||
156716588|NCT04542057|565707531|FG000|Overall Study|Death|3|||
156716589|NCT04542057|565707532|FG001|Overall Study|Death|1|||
156716590|NCT04542057|565707531|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
156716591|NCT04542057|565707532|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
156716592|NCT04542057|565707531|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
156448504|NCT05470400|564736575|FG000|Overall Study|Withdrawal by Subject|1|||
156716593|NCT04542057|565707532|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
156716594|NCT04542057|565707531|FG000|Overall Study|Adverse Event|15|||
156793488|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
156793489|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
156793490|NCT05305651|565996273|FG000|Overall Study|Death|1|||
156793491|NCT05305651|565996273|FG000|Overall Study|Withdrawal by Subject|4|||
156793492|NCT05305651|565996273|FG000|Overall Study|Lost to Follow-up|4|||
156716595|NCT04542057|565707532|FG001|Overall Study|Adverse Event|6|||
156716596|NCT04542057|565707531|FG000|Overall Study|COVID-19 adverse event|6|||
156716597|NCT04542057|565707532|FG001|Overall Study|COVID-19 adverse event|4|||
156716598|NCT04542057|565707531|FG000|Overall Study|Lack of Efficacy|2|||
156716599|NCT04542057|565707532|FG001|Overall Study|Lack of Efficacy|5|||
156716600|NCT04542057|565707531|FG000|Overall Study|Study terminated by sponsor|1|||
156716601|NCT04542057|565707532|FG001|Overall Study|Study terminated by sponsor|0|||
156716602|NCT04542057|565707531|FG000|Overall Study|Investigator discretion|2|||
156716603|NCT04542057|565707532|FG001|Overall Study|Investigator discretion|1|||
156716604|NCT04542057|565707531|FG000|Overall Study|Withdrawal by Subject|52|||
156716605|NCT04542057|565707532|FG001|Overall Study|Withdrawal by Subject|30|||
156716606|NCT04542057|565707531|FG000|Overall Study|Lost to Follow-up|8|||
156716607|NCT04542057|565707532|FG001|Overall Study|Lost to Follow-up|11|||
156716608|NCT04542057|565707531|FG000|Overall Study|Other|2|||
156716609|NCT04542057|565707532|FG001|Overall Study|Other|2|||
156716610|NCT00307086|565707535|FG000|Overall Study|ineligible|5|||
156716611|NCT00065156|565707536|FG000|Overall Study|Adverse Event|37|||
156716612|NCT00065156|565707536|FG000|Overall Study|Lack of Efficacy|52|||
156716613|NCT00065156|565707536|FG000|Overall Study|Withdrawal by Subject|8|||
156716614|NCT00065156|565707536|FG000|Overall Study|Lost to Follow-up|1|||
156716615|NCT00065156|565707536|FG000|Overall Study|Death|11|||
156716616|NCT00065156|565707536|FG000|Overall Study|Study Closed by Sponsor|2|||
156716617|NCT00065156|565707536|FG000|Overall Study|Disease Progression|7|||
156716618|NCT00065156|565707536|FG000|Overall Study|Investigator Decision|2|||
156716619|NCT00065156|565707536|FG000|Overall Study|Non-Compliance|2|||
156716620|NCT00065156|565707536|FG000|Overall Study|Loss of Response|1|||
156716621|NCT00065156|565707536|FG000|Overall Study|Secondary Malign Disease|1|||
156716622|NCT04583735|565707537|FG000|Double-masked Treatment Period|Adverse Event|0|||
156716623|NCT04583735|565707538|FG001|Double-masked Treatment Period|Adverse Event|1|||
156716624|NCT04583735|565707537|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
156716625|NCT04583735|565707538|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
156716626|NCT04583735|565707537|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
156716627|NCT04583735|565707538|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
156716628|NCT04583735|565707537|FG000|Open-label Treatment Period|Adverse Event|1|||
156716629|NCT04583735|565707538|FG001|Open-label Treatment Period|Adverse Event|1|||
156716630|NCT04583735|565707537|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
156716631|NCT04583735|565707538|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156716632|NCT04583735|565707537|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
156716633|NCT04583735|565707538|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
156716634|NCT01176513|565707539|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
156716635|NCT01197911|565707540|FG000|Overall Study|Adverse Event|0|||
156716636|NCT01197911|565707541|FG001|Overall Study|Adverse Event|0|||
156716637|NCT01197911|565707542|FG002|Overall Study|Adverse Event|1|||
156716638|NCT02273388|565707546|FG000|Overall Study|Adverse Event|0|||
156716639|NCT02273388|565707547|FG001|Overall Study|Adverse Event|0|||
156716640|NCT02273388|565707548|FG002|Overall Study|Adverse Event|0|||
156716641|NCT02273388|565707549|FG003|Overall Study|Adverse Event|0|||
156793493|NCT01491919|565996276|FG000|Overall Study|Insufficient PK sampling|1|||
156793494|NCT01491919|565996277|FG001|Overall Study|Insufficient PK sampling|2|||
156793495|NCT01491919|565996278|FG002|Overall Study|Insufficient PK sampling|1|||
156793496|NCT00967499|565996279|FG000|Overall Study|Adverse Event|0|||
156793497|NCT00967499|565996280|FG001|Overall Study|Adverse Event|1|||
156793498|NCT00967499|565996279|FG000|Overall Study|Protocol Violation|1|||
156793499|NCT00967499|565996280|FG001|Overall Study|Protocol Violation|0|||
156793500|NCT00967499|565996279|FG000|Overall Study|Sponsor Decision|1|||
156793501|NCT00967499|565996280|FG001|Overall Study|Sponsor Decision|0|||
156793502|NCT00967499|565996279|FG000|Overall Study|Randomized but not treated|63|||
156793503|NCT00967499|565996280|FG001|Overall Study|Randomized but not treated|59|||
156874972|NCT00243269|566300596|FG003|Overall Study|Lost to Follow-up|3|||
156716642|NCT02273388|565707550|FG004|Overall Study|Adverse Event|0|||
156716643|NCT02273388|565707551|FG005|Overall Study|Adverse Event|0|||
156716644|NCT02273388|565707552|FG006|Overall Study|Adverse Event|1|||
156716645|NCT02273388|565707553|FG007|Overall Study|Adverse Event|2|||
156716646|NCT02273388|565707554|FG008|Overall Study|Adverse Event|0|||
156716647|NCT02273388|565707555|FG009|Overall Study|Adverse Event|0|||
156793504|NCT04003389|565996281|FG000|Overall Study|Adverse Event|27|||
156793505|NCT04003389|565996282|FG001|Overall Study|Adverse Event|34|||
156793506|NCT04003389|565996283|FG002|Overall Study|Adverse Event|28|||
156793507|NCT04003389|565996281|FG000|Overall Study|Lost to Follow-up|39|||
156874973|NCT00485134|566300599|FG000|Overall Study|Lost to Follow-up|1|||
156716648|NCT02273388|565707556|FG010|Overall Study|Adverse Event|0|||
156793508|NCT04003389|565996282|FG001|Overall Study|Lost to Follow-up|30|||
156793509|NCT04003389|565996283|FG002|Overall Study|Lost to Follow-up|33|||
156716649|NCT02273388|565707557|FG011|Overall Study|Adverse Event|0|||
156716650|NCT02273388|565707546|FG000|Overall Study|Adverse Event study disease worse|4|||
156716651|NCT02273388|565707547|FG001|Overall Study|Adverse Event study disease worse|3|||
156716652|NCT02273388|565707548|FG002|Overall Study|Adverse Event study disease worse|3|||
156716653|NCT02273388|565707549|FG003|Overall Study|Adverse Event study disease worse|2|||
156716654|NCT02273388|565707550|FG004|Overall Study|Adverse Event study disease worse|4|||
156716655|NCT02273388|565707551|FG005|Overall Study|Adverse Event study disease worse|3|||
156716656|NCT02273388|565707552|FG006|Overall Study|Adverse Event study disease worse|14|||
156716657|NCT02273388|565707553|FG007|Overall Study|Adverse Event study disease worse|6|||
156716658|NCT02273388|565707554|FG008|Overall Study|Adverse Event study disease worse|6|||
156716659|NCT02273388|565707555|FG009|Overall Study|Adverse Event study disease worse|5|||
156716660|NCT02273388|565707556|FG010|Overall Study|Adverse Event study disease worse|10|||
156716661|NCT02273388|565707557|FG011|Overall Study|Adverse Event study disease worse|1|||
156716662|NCT02273388|565707546|FG000|Overall Study|Sponsor decision|0|||
156716663|NCT02273388|565707547|FG001|Overall Study|Sponsor decision|0|||
156716664|NCT02273388|565707548|FG002|Overall Study|Sponsor decision|0|||
156716665|NCT02273388|565707549|FG003|Overall Study|Sponsor decision|0|||
156716666|NCT02273388|565707550|FG004|Overall Study|Sponsor decision|0|||
156716667|NCT02273388|565707551|FG005|Overall Study|Sponsor decision|0|||
156716668|NCT02273388|565707552|FG006|Overall Study|Sponsor decision|0|||
156716669|NCT02273388|565707553|FG007|Overall Study|Sponsor decision|0|||
156716670|NCT02273388|565707554|FG008|Overall Study|Sponsor decision|0|||
156716671|NCT02273388|565707555|FG009|Overall Study|Sponsor decision|0|||
156716672|NCT02273388|565707556|FG010|Overall Study|Sponsor decision|0|||
156716673|NCT02273388|565707557|FG011|Overall Study|Sponsor decision|1|||
156716674|NCT04331808|565707558|FG000|Overall Study|Withdrew consent|1|||
156716675|NCT04331808|565707559|FG001|Overall Study|Withdrew consent|0|||
156716676|NCT04331808|565707560|FG002|Overall Study|Withdrew consent|2|||
156716677|NCT04331808|565707561|FG003|Overall Study|Withdrew consent|3|||
156716678|NCT00952731|565707562|FG000|Overall Study|Drug supply expired|1|||
156716679|NCT00952731|565707563|FG001|Overall Study|Drug supply expired|0|||
156716680|NCT01329900|565707564|FG000|Overall Study|Elevated creatinine/renal function|1|||
156716681|NCT01855828|565707565|FG000|Overall Study|Adverse Event|1|||
156716682|NCT01855828|565707565|FG000|Overall Study|Withdrawal by Subject|1|||
156716683|NCT01866098|565707566|FG000|Overall Study|Lost to Follow-up|11|||
156716684|NCT01866098|565707567|FG001|Overall Study|Lost to Follow-up|18|||
156716685|NCT01866098|565707568|FG002|Overall Study|Lost to Follow-up|13|||
156716686|NCT01866098|565707566|FG000|Overall Study|Physician Decision|0|||
156716687|NCT01866098|565707567|FG001|Overall Study|Physician Decision|1|||
156716688|NCT01866098|565707568|FG002|Overall Study|Physician Decision|2|||
156716689|NCT01866098|565707566|FG000|Overall Study|Adverse Event|1|||
156716690|NCT01866098|565707567|FG001|Overall Study|Adverse Event|5|||
156716691|NCT01866098|565707568|FG002|Overall Study|Adverse Event|4|||
156716692|NCT01866098|565707566|FG000|Overall Study|Protocol Violation|1|||
156716693|NCT01866098|565707567|FG001|Overall Study|Protocol Violation|0|||
156716694|NCT01866098|565707568|FG002|Overall Study|Protocol Violation|0|||
156716695|NCT01866098|565707566|FG000|Overall Study|Withdrawal by Subject|1|||
156716696|NCT01866098|565707567|FG001|Overall Study|Withdrawal by Subject|2|||
156874974|NCT00485134|566300600|FG001|Overall Study|Lost to Follow-up|0|||
156874975|NCT00485134|566300601|FG002|Overall Study|Lost to Follow-up|0|||
156448505|NCT05470400|564736576|FG001|Overall Study|Withdrawal by Subject|0|||
156448506|NCT05470400|564736577|FG002|Overall Study|Withdrawal by Subject|0|||
156448507|NCT05470400|564736578|FG003|Overall Study|Withdrawal by Subject|0|||
156448508|NCT05470400|564736579|FG004|Overall Study|Withdrawal by Subject|0|||
156448509|NCT05470400|564736580|FG005|Overall Study|Withdrawal by Subject|1|||
156448510|NCT05470400|564736581|FG006|Overall Study|Withdrawal by Subject|0|||
156448511|NCT05470400|564736582|FG007|Overall Study|Withdrawal by Subject|2|||
156448512|NCT05323084|564736584|FG000|Period 2 - Washout|Lost to Follow-up|0|||
156448513|NCT05323084|564736585|FG001|Period 2 - Washout|Lost to Follow-up|1|||
156448514|NCT04294225|564736586|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
156448515|NCT04294225|564736586|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
156448516|NCT04294225|564736586|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
156448517|NCT04294225|564736586|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
156448518|NCT04294225|564736586|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
156448519|NCT04812535|564736588|FG000|Overall Study|Withdrawal by Subject|0|||
156448520|NCT04812535|564736589|FG001|Overall Study|Withdrawal by Subject|0|||
156448521|NCT04812535|564736590|FG002|Overall Study|Withdrawal by Subject|0|||
156448522|NCT04812535|564736591|FG003|Overall Study|Withdrawal by Subject|1|||
156448523|NCT04812535|564736588|FG000|Overall Study|Death|7|||
156448524|NCT04812535|564736589|FG001|Overall Study|Death|2|||
156448525|NCT04812535|564736590|FG002|Overall Study|Death|4|||
156448526|NCT04812535|564736591|FG003|Overall Study|Death|1|||
156448527|NCT04812535|564736588|FG000|Overall Study|Due to premature study termination by sponsor|2|||
156448528|NCT04812535|564736589|FG001|Overall Study|Due to premature study termination by sponsor|0|||
156874976|NCT00485134|566300602|FG003|Overall Study|Lost to Follow-up|0|||
156448529|NCT04812535|564736590|FG002|Overall Study|Due to premature study termination by sponsor|1|||
156716697|NCT01866098|565707568|FG002|Overall Study|Withdrawal by Subject|0|||
156716698|NCT01866098|565707566|FG000|Overall Study|Unrelated Hospitalization|2|||
156716699|NCT01866098|565707567|FG001|Overall Study|Unrelated Hospitalization|0|||
156716700|NCT01866098|565707568|FG002|Overall Study|Unrelated Hospitalization|1|||
156716701|NCT01866098|565707566|FG000|Overall Study|Non-compliance|1|||
156716702|NCT01866098|565707567|FG001|Overall Study|Non-compliance|0|||
156716703|NCT01866098|565707568|FG002|Overall Study|Non-compliance|1|||
156716704|NCT01866098|565707566|FG000|Overall Study|Pregnancy|2|||
156716705|NCT01866098|565707567|FG001|Overall Study|Pregnancy|0|||
156716706|NCT01866098|565707568|FG002|Overall Study|Pregnancy|0|||
156716707|NCT01866098|565707566|FG000|Overall Study|Death|0|||
156716708|NCT01866098|565707567|FG001|Overall Study|Death|1|||
156716709|NCT01866098|565707568|FG002|Overall Study|Death|0|||
156716710|NCT04239027|565707569|FG000|Overall Study|Adverse Event|4|||
156716711|NCT04239027|565707569|FG000|Overall Study|Withdrawal by Subject|9|||
156716712|NCT04239027|565707569|FG000|Overall Study|Death|1|||
156716713|NCT04239027|565707569|FG000|Overall Study|Physician Decision|9|||
156716714|NCT04239027|565707569|FG000|Overall Study|Lost to Follow-up|2|||
156716715|NCT04239027|565707569|FG000|Overall Study|Lack of Efficacy|1|||
156716716|NCT04233073|565707579|FG000|Overall Study|Death|5|||
156716717|NCT03172494|565707580|FG000|Overall Study|Adverse Event|5|||
156716718|NCT03172494|565707581|FG001|Overall Study|Adverse Event|1|||
156716719|NCT03172494|565707582|FG002|Overall Study|Adverse Event|15|||
156716720|NCT03172494|565707580|FG000|Overall Study|Protocol Violation|3|||
156716721|NCT03172494|565707581|FG001|Overall Study|Protocol Violation|2|||
156716722|NCT03172494|565707582|FG002|Overall Study|Protocol Violation|1|||
156716723|NCT03172494|565707580|FG000|Overall Study|Lack of Efficacy|0|||
156716724|NCT03172494|565707581|FG001|Overall Study|Lack of Efficacy|0|||
156716725|NCT03172494|565707582|FG002|Overall Study|Lack of Efficacy|4|||
156716726|NCT03172494|565707580|FG000|Overall Study|Pregnancy|0|||
156716727|NCT03172494|565707581|FG001|Overall Study|Pregnancy|1|||
156716728|NCT03172494|565707582|FG002|Overall Study|Pregnancy|0|||
156716729|NCT03172494|565707580|FG000|Overall Study|Withdrawal by Subject|10|||
156716730|NCT03172494|565707581|FG001|Overall Study|Withdrawal by Subject|8|||
156716731|NCT03172494|565707582|FG002|Overall Study|Withdrawal by Subject|8|||
156716732|NCT03172494|565707580|FG000|Overall Study|Severe hypoglycaemic episode|0|||
156716733|NCT03172494|565707581|FG001|Overall Study|Severe hypoglycaemic episode|0|||
156716734|NCT03172494|565707582|FG002|Overall Study|Severe hypoglycaemic episode|1|||
156716735|NCT03172494|565707580|FG000|Overall Study|Non-compliance towards treatment|2|||
156716736|NCT03172494|565707581|FG001|Overall Study|Non-compliance towards treatment|0|||
156716737|NCT03172494|565707582|FG002|Overall Study|Non-compliance towards treatment|0|||
156716738|NCT00143390|565707583|FG000|Overall Study|Death|2|||
156716739|NCT00143390|565707584|FG001|Overall Study|Death|0|||
156716740|NCT00143390|565707583|FG000|Overall Study|Not meeting entry criteria|2|||
156716741|NCT00143390|565707584|FG001|Overall Study|Not meeting entry criteria|5|||
156716742|NCT00143390|565707583|FG000|Overall Study|Withdrawal by Subject|4|||
156716743|NCT00143390|565707584|FG001|Overall Study|Withdrawal by Subject|4|||
156716744|NCT00143390|565707583|FG000|Overall Study|Progressive disease|119|||
156716745|NCT00143390|565707584|FG001|Overall Study|Progressive disease|115|||
156716746|NCT00143390|565707583|FG000|Overall Study|Protocol Violation|2|||
156716747|NCT00143390|565707584|FG001|Overall Study|Protocol Violation|0|||
156716748|NCT00143390|565707583|FG000|Overall Study|Study termination|10|||
156716749|NCT00143390|565707584|FG001|Overall Study|Study termination|15|||
156716750|NCT00143390|565707583|FG000|Overall Study|Adverse Event|9|||
156716751|NCT00143390|565707584|FG001|Overall Study|Adverse Event|8|||
156716752|NCT00143390|565707583|FG000|Overall Study|Other|1|||
156716753|NCT00143390|565707584|FG001|Overall Study|Other|2|||
156716754|NCT00243412|565707585|FG000|Overall Study|Death|0|||
156716755|NCT00243412|565707586|FG001|Overall Study|Death|1|||
156716756|NCT00243412|565707585|FG000|Overall Study|Adverse Event|4|||
156716757|NCT00243412|565707586|FG001|Overall Study|Adverse Event|2|||
156716758|NCT00243412|565707585|FG000|Overall Study|Lost to Follow-up|0|||
156716759|NCT00243412|565707586|FG001|Overall Study|Lost to Follow-up|1|||
156716760|NCT00243412|565707585|FG000|Overall Study|Physician Decision|1|||
156716761|NCT00243412|565707586|FG001|Overall Study|Physician Decision|1|||
156716762|NCT00243412|565707585|FG000|Overall Study|Withdrawal by Subject|4|||
156716763|NCT00243412|565707586|FG001|Overall Study|Withdrawal by Subject|5|||
156716764|NCT00243412|565707585|FG000|Overall Study|Other|1|||
156716765|NCT00243412|565707586|FG001|Overall Study|Other|1|||
156716766|NCT00041132|565707588|FG000|Overall Study|Adverse Event|19|||
156716767|NCT00041132|565707588|FG000|Overall Study|Death|1|||
156716768|NCT00041132|565707588|FG000|Overall Study|Not Eligible|7|||
156716769|NCT00041132|565707588|FG000|Overall Study|Withdrawal by Subject|1|||
156716770|NCT00041132|565707588|FG000|Overall Study|Physician Decision|2|||
156716771|NCT02764151|565707592|FG000|Overall Study|Subject refused further follow-up|0|||
156716772|NCT02764151|565707593|FG001|Overall Study|Subject refused further follow-up|0|||
156716773|NCT02764151|565707594|FG002|Overall Study|Subject refused further follow-up|0|||
156716774|NCT02764151|565707595|FG003|Overall Study|Subject refused further follow-up|1|||
156716775|NCT02764151|565707592|FG000|Overall Study|Other|0|||
156716776|NCT02764151|565707593|FG001|Overall Study|Other|0|||
156716777|NCT02764151|565707594|FG002|Overall Study|Other|0|||
156716778|NCT02764151|565707595|FG003|Overall Study|Other|2|||
156716779|NCT01450683|565707596|FG000|Overall Study|Adverse Event|2|||
156716780|NCT01523002|565707605|FG000|Period 1|Withdrawal by Subject|1|||
156716781|NCT01523002|565707606|FG001|Period 1|Withdrawal by Subject|3|||
156716782|NCT01523002|565707605|FG000|Period 1|Lost to Follow-up|1|||
156716783|NCT01523002|565707606|FG001|Period 1|Lost to Follow-up|0|||
156716784|NCT01523002|565707605|FG000|Period 1|Adverse Event|0|||
156716785|NCT01523002|565707606|FG001|Period 1|Adverse Event|8|||
156716786|NCT01523002|565707605|FG000|Period 2|Withdrawal by Subject|4|||
156716787|NCT01523002|565707606|FG001|Period 2|Withdrawal by Subject|1|||
156716788|NCT01523002|565707605|FG000|Period 2|Adverse Event|2|||
156716789|NCT01523002|565707606|FG001|Period 2|Adverse Event|5|||
156716790|NCT01523002|565707605|FG000|Period 3|Withdrawal by Subject|1|||
156716791|NCT01523002|565707606|FG001|Period 3|Withdrawal by Subject|0|||
156716792|NCT01523002|565707605|FG000|Period 3|Adverse Event|3|||
156716793|NCT01523002|565707606|FG001|Period 3|Adverse Event|0|||
156716794|NCT01256502|565707607|FG000|Overall Study|Had scaffold removed|4|||
156448530|NCT04812535|564736591|FG003|Overall Study|Due to premature study termination by sponsor|3|||
156448531|NCT03436745|564736592|FG000|Overall Study|Ineligible|0|||
156448532|NCT03436745|564736593|FG001|Overall Study|Ineligible|0|||
156716795|NCT01256502|565707607|FG000|Overall Study|Personal reasons|5|||
156716796|NCT01256502|565707607|FG000|Overall Study|Protocol deviation|1|||
156716797|NCT00489255|565707608|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
156716798|NCT00489255|565707609|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
156716799|NCT00489255|565707608|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
156716800|NCT00489255|565707609|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
156716801|NCT00489255|565707608|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
156716802|NCT00489255|565707609|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
156716803|NCT00489255|565707608|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
156716804|NCT00489255|565707609|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
156716805|NCT00489255|565707608|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
156716806|NCT00489255|565707609|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
156716807|NCT00489255|565707608|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
156716808|NCT00489255|565707609|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
156716809|NCT00489255|565707608|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
156716810|NCT00489255|565707609|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
156716811|NCT00489255|565707608|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
156716812|NCT00489255|565707609|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
156716813|NCT00489255|565707608|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
156716814|NCT00489255|565707609|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
156716815|NCT00489255|565707608|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
156716816|NCT00489255|565707609|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
156716817|NCT03485352|565707610|FG000|Overall Study|Lost to Follow-up|9|||
156716818|NCT00852202|565707621|FG000|Overall Study|Adverse Event|2|||
156716819|NCT00852202|565707622|FG001|Overall Study|Adverse Event|3|||
156716820|NCT00852202|565707623|FG002|Overall Study|Adverse Event|7|||
156716821|NCT00852202|565707621|FG000|Overall Study|Lack of Efficacy|4|||
156716822|NCT00852202|565707622|FG001|Overall Study|Lack of Efficacy|1|||
156716823|NCT00852202|565707623|FG002|Overall Study|Lack of Efficacy|2|||
156716824|NCT00852202|565707621|FG000|Overall Study|Protocol Violation|2|||
156716825|NCT00852202|565707622|FG001|Overall Study|Protocol Violation|2|||
156716826|NCT00852202|565707623|FG002|Overall Study|Protocol Violation|7|||
156716827|NCT00852202|565707621|FG000|Overall Study|Withdrawal by Subject|3|||
156716828|NCT00852202|565707622|FG001|Overall Study|Withdrawal by Subject|1|||
156716829|NCT00852202|565707623|FG002|Overall Study|Withdrawal by Subject|2|||
156716830|NCT00852202|565707621|FG000|Overall Study|Lost to Follow-up|5|||
156716831|NCT00852202|565707622|FG001|Overall Study|Lost to Follow-up|5|||
156716832|NCT00852202|565707623|FG002|Overall Study|Lost to Follow-up|6|||
156716833|NCT00852202|565707621|FG000|Overall Study|pregnancy,moving away and surgery|1|||
156716834|NCT00852202|565707622|FG001|Overall Study|pregnancy,moving away and surgery|0|||
156716835|NCT00852202|565707623|FG002|Overall Study|pregnancy,moving away and surgery|2|||
156716836|NCT00141778|565707626|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
156716837|NCT00141778|565707627|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
156716838|NCT00141778|565707628|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
156716839|NCT00141778|565707626|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
156716840|NCT00141778|565707627|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
156716841|NCT00141778|565707628|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
156716842|NCT00141778|565707626|FG000|Started Study Medication|Withdrawal by Subject|0|||
156716843|NCT00141778|565707627|FG001|Started Study Medication|Withdrawal by Subject|2|||
156793510|NCT04003389|565996281|FG000|Overall Study|Protocol Violation|1|||
156793511|NCT04003389|565996282|FG001|Overall Study|Protocol Violation|6|||
156793512|NCT04003389|565996283|FG002|Overall Study|Protocol Violation|5|||
156793513|NCT04003389|565996281|FG000|Overall Study|Withdrawal by Subject|119|||
156793514|NCT04003389|565996282|FG001|Overall Study|Withdrawal by Subject|79|||
156716844|NCT00141778|565707628|FG002|Started Study Medication|Withdrawal by Subject|0|||
156448533|NCT03436745|564736594|FG002|Overall Study|Ineligible|1|||
156448534|NCT00931710|564736599|FG000|Overall Study|Adverse Event|16|||
156448535|NCT00931710|564736600|FG001|Overall Study|Adverse Event|10|||
156716845|NCT00141778|565707626|FG000|Started Study Medication|Difficulty Swallowing|0|||
156716846|NCT00141778|565707627|FG001|Started Study Medication|Difficulty Swallowing|1|||
156716847|NCT00141778|565707628|FG002|Started Study Medication|Difficulty Swallowing|0|||
156716848|NCT00141778|565707626|FG000|Started Study Medication|Chest Discomfort|0|||
156716849|NCT00141778|565707627|FG001|Started Study Medication|Chest Discomfort|0|||
156716850|NCT00141778|565707628|FG002|Started Study Medication|Chest Discomfort|1|||
156716851|NCT00768248|565707629|FG000|Overall Study|Research coordinator didn't collect data|1|||
156716852|NCT00768248|565707630|FG001|Overall Study|Research coordinator didn't collect data|1|||
156716853|NCT01959295|565707633|FG000|Overall Study|Adverse Event|2|||
156716854|NCT01959295|565707634|FG001|Overall Study|Adverse Event|0|||
156716855|NCT01959295|565707633|FG000|Overall Study|Lost to Follow-up|0|||
156716856|NCT01959295|565707634|FG001|Overall Study|Lost to Follow-up|2|||
156716857|NCT01959295|565707633|FG000|Overall Study|Physician Decision|2|||
156716858|NCT01959295|565707634|FG001|Overall Study|Physician Decision|3|||
156716859|NCT01959295|565707633|FG000|Overall Study|Protocol Violation|16|||
156716860|NCT01959295|565707634|FG001|Overall Study|Protocol Violation|5|||
156716861|NCT01959295|565707633|FG000|Overall Study|Withdrawal by Subject|3|||
156716862|NCT01959295|565707634|FG001|Overall Study|Withdrawal by Subject|1|||
156716863|NCT01959295|565707633|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
156716864|NCT01959295|565707634|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
156716865|NCT04100018|565709339|FG000|Pre-Treatment Period|Not Reported|0|||
156716866|NCT04100018|565709340|FG001|Pre-Treatment Period|Not Reported|4|||
156716867|NCT04100018|565709339|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
156716868|NCT04100018|565709340|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
156716869|NCT04100018|565709339|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
156716870|NCT04100018|565709340|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
156716871|NCT04100018|565709339|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
156716872|NCT04100018|565709340|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
156716873|NCT04100018|565709339|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
156716874|NCT04100018|565709340|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
156716875|NCT04100018|565709339|FG000|Treatment Period|Ongoing Treatment|1|||
156716876|NCT04100018|565709340|FG001|Treatment Period|Ongoing Treatment|0|||
156716877|NCT04100018|565709339|FG000|Treatment Period|Other Reason|26|||
156716878|NCT04100018|565709340|FG001|Treatment Period|Other Reason|37|||
156716879|NCT04100018|565709339|FG000|Treatment Period|Completed treatment as per protocol|1|||
156716880|NCT04100018|565709340|FG001|Treatment Period|Completed treatment as per protocol|2|||
156716881|NCT04100018|565709339|FG000|Treatment Period|Maximum clinical benefit|3|||
156716882|NCT04100018|565709340|FG001|Treatment Period|Maximum clinical benefit|0|||
156716883|NCT04100018|565709339|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
156716884|NCT04100018|565709340|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
156716885|NCT04100018|565709339|FG000|Treatment Period|Study drug toxicity|67|||
156716886|NCT04100018|565709340|FG001|Treatment Period|Study drug toxicity|28|||
156716887|NCT04100018|565709339|FG000|Treatment Period|Disease Progression|284|||
156716888|NCT04100018|565709340|FG001|Treatment Period|Disease Progression|327|||
156716889|NCT04100018|565709339|FG000|Treatment Period|Administrative reasons by sponsor|16|||
156716890|NCT04100018|565709340|FG001|Treatment Period|Administrative reasons by sponsor|30|||
156716891|NCT04100018|565709339|FG000|Treatment Period|Poor/Non-Compliance|1|||
156716892|NCT04100018|565709340|FG001|Treatment Period|Poor/Non-Compliance|0|||
156716893|NCT04100018|565709339|FG000|Treatment Period|Lost to Follow-up|2|||
156716894|NCT04100018|565709340|FG001|Treatment Period|Lost to Follow-up|2|||
156716895|NCT04100018|565709339|FG000|Treatment Period|Death|16|||
156716896|NCT04100018|565709340|FG001|Treatment Period|Death|11|||
156716897|NCT04100018|565709339|FG000|Treatment Period|Participant withdrew consent|10|||
156716898|NCT04100018|565709340|FG001|Treatment Period|Participant withdrew consent|10|||
156716899|NCT04100018|565709339|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
156716900|NCT04100018|565709340|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
156716901|NCT04100018|565709339|FG000|Treatment Period|Adverse Event|14|||
156716902|NCT04100018|565709340|FG001|Treatment Period|Adverse Event|6|||
156716903|NCT04100018|565709339|FG000|Treatment Period|Lack of Efficacy|4|||
156716904|NCT04100018|565709340|FG001|Treatment Period|Lack of Efficacy|2|||
156716905|NCT02848001|565709341|FG000|Overall Study|other reasons|0|||
156716906|NCT02848001|565709342|FG001|Overall Study|other reasons|0|||
156716907|NCT02848001|565709343|FG002|Overall Study|other reasons|1|||
156716908|NCT02848001|565709344|FG003|Overall Study|other reasons|0|||
156716909|NCT02848001|565709345|FG004|Overall Study|other reasons|4|||
156716910|NCT02848001|565709346|FG005|Overall Study|other reasons|1|||
156716911|NCT02848001|565709347|FG006|Overall Study|other reasons|0|||
156716912|NCT02848001|565709348|FG007|Overall Study|other reasons|2|||
156716913|NCT02848001|565709349|FG008|Overall Study|other reasons|2|||
156716914|NCT02848001|565709350|FG009|Overall Study|other reasons|3|||
156793515|NCT04003389|565996283|FG002|Overall Study|Withdrawal by Subject|85|||
156716915|NCT02848001|565709351|FG010|Overall Study|other reasons|0|||
156716916|NCT02848001|565709352|FG011|Overall Study|other reasons|1|||
156716917|NCT02848001|565709353|FG012|Overall Study|other reasons|1|||
156716918|NCT02848001|565709354|FG013|Overall Study|other reasons|0|||
156716919|NCT02848001|565709355|FG014|Overall Study|other reasons|0|||
156716920|NCT02848001|565709356|FG015|Overall Study|other reasons|2|||
156716921|NCT02848001|565709357|FG016|Overall Study|other reasons|1|||
156716922|NCT02848001|565709341|FG000|Overall Study|Lack of Efficacy|0|||
156716923|NCT02848001|565709342|FG001|Overall Study|Lack of Efficacy|1|||
156716924|NCT02848001|565709343|FG002|Overall Study|Lack of Efficacy|1|||
156716925|NCT02848001|565709344|FG003|Overall Study|Lack of Efficacy|2|||
156716926|NCT02848001|565709345|FG004|Overall Study|Lack of Efficacy|3|||
156716927|NCT02848001|565709346|FG005|Overall Study|Lack of Efficacy|0|||
156716928|NCT02848001|565709347|FG006|Overall Study|Lack of Efficacy|1|||
156716929|NCT02848001|565709348|FG007|Overall Study|Lack of Efficacy|0|||
156716930|NCT02848001|565709349|FG008|Overall Study|Lack of Efficacy|0|||
156716931|NCT02848001|565709350|FG009|Overall Study|Lack of Efficacy|1|||
156716932|NCT02848001|565709351|FG010|Overall Study|Lack of Efficacy|0|||
156448536|NCT00931710|564736599|FG000|Overall Study|Abnormal test procedure results|2|||
156448537|NCT00931710|564736600|FG001|Overall Study|Abnormal test procedure results|0|||
156716933|NCT02848001|565709352|FG011|Overall Study|Lack of Efficacy|2|||
156716934|NCT02848001|565709353|FG012|Overall Study|Lack of Efficacy|0|||
156716935|NCT02848001|565709354|FG013|Overall Study|Lack of Efficacy|2|||
156716936|NCT02848001|565709355|FG014|Overall Study|Lack of Efficacy|2|||
156716937|NCT02848001|565709356|FG015|Overall Study|Lack of Efficacy|0|||
156716938|NCT02848001|565709357|FG016|Overall Study|Lack of Efficacy|0|||
156716939|NCT02848001|565709341|FG000|Overall Study|Progressive Disease|2|||
156716940|NCT02848001|565709342|FG001|Overall Study|Progressive Disease|1|||
156716941|NCT02848001|565709343|FG002|Overall Study|Progressive Disease|0|||
156716942|NCT02848001|565709344|FG003|Overall Study|Progressive Disease|4|||
156716943|NCT02848001|565709345|FG004|Overall Study|Progressive Disease|3|||
156716944|NCT02848001|565709346|FG005|Overall Study|Progressive Disease|0|||
156716945|NCT02848001|565709347|FG006|Overall Study|Progressive Disease|4|||
156716946|NCT02848001|565709348|FG007|Overall Study|Progressive Disease|1|||
156716947|NCT02848001|565709349|FG008|Overall Study|Progressive Disease|0|||
156716948|NCT02848001|565709350|FG009|Overall Study|Progressive Disease|2|||
156716949|NCT02848001|565709351|FG010|Overall Study|Progressive Disease|3|||
156716950|NCT02848001|565709352|FG011|Overall Study|Progressive Disease|2|||
156716951|NCT02848001|565709353|FG012|Overall Study|Progressive Disease|1|||
156716952|NCT02848001|565709354|FG013|Overall Study|Progressive Disease|0|||
156716953|NCT02848001|565709355|FG014|Overall Study|Progressive Disease|2|||
156716954|NCT02848001|565709356|FG015|Overall Study|Progressive Disease|4|||
156716955|NCT02848001|565709357|FG016|Overall Study|Progressive Disease|0|||
156716956|NCT02848001|565709341|FG000|Overall Study|Adverse Event|0|||
156716957|NCT02848001|565709342|FG001|Overall Study|Adverse Event|0|||
156716958|NCT02848001|565709343|FG002|Overall Study|Adverse Event|0|||
156716959|NCT02848001|565709344|FG003|Overall Study|Adverse Event|0|||
156716960|NCT02848001|565709345|FG004|Overall Study|Adverse Event|2|||
156716961|NCT02848001|565709346|FG005|Overall Study|Adverse Event|0|||
156716962|NCT02848001|565709347|FG006|Overall Study|Adverse Event|0|||
156716963|NCT02848001|565709348|FG007|Overall Study|Adverse Event|0|||
156448538|NCT00931710|564736599|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
156448539|NCT00931710|564736600|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
156448540|NCT00931710|564736599|FG000|Overall Study|Patient withdrew consent|4|||
156448541|NCT00931710|564736600|FG001|Overall Study|Patient withdrew consent|9|||
156448542|NCT00931710|564736599|FG000|Overall Study|Lost to Follow-up|6|||
156448543|NCT00931710|564736600|FG001|Overall Study|Lost to Follow-up|5|||
156448544|NCT00931710|564736599|FG000|Overall Study|Protocol deviation|1|||
156448545|NCT00931710|564736600|FG001|Overall Study|Protocol deviation|2|||
156448546|NCT04401800|564736601|FG000|Overall Study|Death|17|||
156448547|NCT04401800|564736601|FG000|Overall Study|Lost to Follow-up|5|||
156448548|NCT04401800|564736601|FG000|Overall Study|Withdrawal by Subject|4|||
156448549|NCT04927065|564736602|FG000|First Booster|Adverse Event|1|||
156448550|NCT04927065|564736603|FG001|First Booster|Adverse Event|0|||
156533140|NCT04178967|565046856|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156716964|NCT02848001|565709349|FG008|Overall Study|Adverse Event|0|||
156716965|NCT02848001|565709350|FG009|Overall Study|Adverse Event|1|||
156716966|NCT02848001|565709351|FG010|Overall Study|Adverse Event|0|||
156716967|NCT02848001|565709352|FG011|Overall Study|Adverse Event|1|||
156716968|NCT02848001|565709353|FG012|Overall Study|Adverse Event|1|||
156716969|NCT02848001|565709354|FG013|Overall Study|Adverse Event|0|||
156716970|NCT02848001|565709355|FG014|Overall Study|Adverse Event|2|||
156716971|NCT02848001|565709356|FG015|Overall Study|Adverse Event|0|||
156716972|NCT02848001|565709357|FG016|Overall Study|Adverse Event|0|||
156533141|NCT04178967|565046857|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156716973|NCT02848001|565709341|FG000|Overall Study|Death|0|||
156716974|NCT02848001|565709342|FG001|Overall Study|Death|0|||
156716975|NCT02848001|565709343|FG002|Overall Study|Death|0|||
156716976|NCT02848001|565709344|FG003|Overall Study|Death|1|||
156716977|NCT02848001|565709345|FG004|Overall Study|Death|3|||
156874977|NCT00485134|566300603|FG004|Overall Study|Lost to Follow-up|0|||
156874978|NCT00485134|566300604|FG005|Overall Study|Lost to Follow-up|0|||
156874979|NCT00485134|566300605|FG006|Overall Study|Lost to Follow-up|0|||
156874980|NCT00485134|566300606|FG007|Overall Study|Lost to Follow-up|0|||
156874981|NCT00485134|566300599|FG000|Overall Study|Withdrawal by Subject|0|||
156874982|NCT00485134|566300600|FG001|Overall Study|Withdrawal by Subject|1|||
156874983|NCT00485134|566300601|FG002|Overall Study|Withdrawal by Subject|0|||
156874984|NCT00485134|566300602|FG003|Overall Study|Withdrawal by Subject|0|||
156874985|NCT00485134|566300603|FG004|Overall Study|Withdrawal by Subject|0|||
156716978|NCT02848001|565709346|FG005|Overall Study|Death|1|||
156716979|NCT02848001|565709347|FG006|Overall Study|Death|2|||
156716980|NCT02848001|565709348|FG007|Overall Study|Death|3|||
156716981|NCT02848001|565709349|FG008|Overall Study|Death|4|||
156716982|NCT02848001|565709350|FG009|Overall Study|Death|1|||
156716983|NCT02848001|565709351|FG010|Overall Study|Death|0|||
156716984|NCT02848001|565709352|FG011|Overall Study|Death|1|||
156716985|NCT02848001|565709353|FG012|Overall Study|Death|3|||
156716986|NCT02848001|565709354|FG013|Overall Study|Death|0|||
156716987|NCT02848001|565709355|FG014|Overall Study|Death|2|||
156716988|NCT02848001|565709356|FG015|Overall Study|Death|3|||
156716989|NCT02848001|565709357|FG016|Overall Study|Death|0|||
156716990|NCT02848001|565709341|FG000|Overall Study|Physician Decision|0|||
156716991|NCT02848001|565709342|FG001|Overall Study|Physician Decision|0|||
156716992|NCT02848001|565709343|FG002|Overall Study|Physician Decision|0|||
156716993|NCT02848001|565709344|FG003|Overall Study|Physician Decision|0|||
156716994|NCT02848001|565709345|FG004|Overall Study|Physician Decision|0|||
156716995|NCT02848001|565709346|FG005|Overall Study|Physician Decision|0|||
156716996|NCT02848001|565709347|FG006|Overall Study|Physician Decision|0|||
156716997|NCT02848001|565709348|FG007|Overall Study|Physician Decision|0|||
156716998|NCT02848001|565709349|FG008|Overall Study|Physician Decision|1|||
156716999|NCT02848001|565709350|FG009|Overall Study|Physician Decision|1|||
156793516|NCT04003389|565996281|FG000|Overall Study|Miscellaneous|14|||
156793517|NCT04003389|565996282|FG001|Overall Study|Miscellaneous|11|||
156793518|NCT04003389|565996283|FG002|Overall Study|Miscellaneous|14|||
156793519|NCT04003389|565996281|FG000|Overall Study|Participant did not receive study drug|1|||
156793520|NCT04003389|565996282|FG001|Overall Study|Participant did not receive study drug|0|||
156793521|NCT04003389|565996283|FG002|Overall Study|Participant did not receive study drug|0|||
156793522|NCT04818229|565996284|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
156793523|NCT04818229|565996285|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
156793524|NCT04818229|565996286|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
156793525|NCT04818229|565996284|FG000|Overall Study|Adverse Event|3|||
156874986|NCT00485134|566300604|FG005|Overall Study|Withdrawal by Subject|0|||
156874987|NCT00485134|566300605|FG006|Overall Study|Withdrawal by Subject|0|||
156874988|NCT00485134|566300606|FG007|Overall Study|Withdrawal by Subject|0|||
156874989|NCT00485134|566300599|FG000|Overall Study|Change in health status|0|||
156874990|NCT00485134|566300600|FG001|Overall Study|Change in health status|1|||
156874991|NCT00485134|566300601|FG002|Overall Study|Change in health status|2|||
156874992|NCT00485134|566300602|FG003|Overall Study|Change in health status|1|||
156874993|NCT00485134|566300603|FG004|Overall Study|Change in health status|0|||
156874994|NCT00485134|566300604|FG005|Overall Study|Change in health status|1|||
156874995|NCT00485134|566300605|FG006|Overall Study|Change in health status|0|||
156874996|NCT00485134|566300606|FG007|Overall Study|Change in health status|0|||
156874997|NCT00485134|566300599|FG000|Overall Study|Withdrew for adverse event|0|||
156874998|NCT00485134|566300600|FG001|Overall Study|Withdrew for adverse event|0|||
156874999|NCT00485134|566300601|FG002|Overall Study|Withdrew for adverse event|1|||
156448551|NCT04927065|564736604|FG002|First Booster|Adverse Event|0|||
156448552|NCT04927065|564736605|FG003|First Booster|Adverse Event|0|||
156448553|NCT04927065|564736606|FG004|First Booster|Adverse Event|0|||
156448554|NCT04927065|564736607|FG005|First Booster|Adverse Event|0|||
156448555|NCT04927065|564736608|FG006|First Booster|Adverse Event|0|||
156717000|NCT02848001|565709351|FG010|Overall Study|Physician Decision|0|||
156717001|NCT02848001|565709352|FG011|Overall Study|Physician Decision|0|||
156448556|NCT04927065|564736609|FG007|First Booster|Adverse Event|1|||
156448557|NCT04927065|564736610|FG008|First Booster|Adverse Event|0|||
156717002|NCT02848001|565709353|FG012|Overall Study|Physician Decision|2|||
156717003|NCT02848001|565709354|FG013|Overall Study|Physician Decision|0|||
156717004|NCT02848001|565709355|FG014|Overall Study|Physician Decision|0|||
156717005|NCT02848001|565709356|FG015|Overall Study|Physician Decision|0|||
156448558|NCT04927065|564736611|FG009|First Booster|Adverse Event|0|||
156448559|NCT04927065|564736612|FG010|First Booster|Adverse Event|0|||
156717006|NCT02848001|565709357|FG016|Overall Study|Physician Decision|0|||
156717007|NCT02848001|565709341|FG000|Overall Study|Withdrawal by Subject|0|||
156717008|NCT02848001|565709342|FG001|Overall Study|Withdrawal by Subject|0|||
156717009|NCT02848001|565709343|FG002|Overall Study|Withdrawal by Subject|0|||
156793526|NCT04818229|565996285|FG001|Overall Study|Adverse Event|1|||
156793527|NCT04818229|565996286|FG002|Overall Study|Adverse Event|1|||
156793528|NCT04818229|565996284|FG000|Overall Study|Withdrawal by Subject|0|||
156717010|NCT02848001|565709344|FG003|Overall Study|Withdrawal by Subject|0|||
156717011|NCT02848001|565709345|FG004|Overall Study|Withdrawal by Subject|0|||
156875000|NCT00485134|566300602|FG003|Overall Study|Withdrew for adverse event|0|||
156875001|NCT00485134|566300603|FG004|Overall Study|Withdrew for adverse event|0|||
156875002|NCT00485134|566300604|FG005|Overall Study|Withdrew for adverse event|0|||
156875003|NCT00485134|566300605|FG006|Overall Study|Withdrew for adverse event|0|||
156875004|NCT00485134|566300606|FG007|Overall Study|Withdrew for adverse event|0|||
156875005|NCT00485134|566300599|FG000|Overall Study|Positive drug test|0|||
156875006|NCT00485134|566300600|FG001|Overall Study|Positive drug test|0|||
156717012|NCT02848001|565709346|FG005|Overall Study|Withdrawal by Subject|1|||
156717013|NCT02848001|565709347|FG006|Overall Study|Withdrawal by Subject|1|||
156717014|NCT02848001|565709348|FG007|Overall Study|Withdrawal by Subject|1|||
156717015|NCT02848001|565709349|FG008|Overall Study|Withdrawal by Subject|0|||
156717016|NCT02848001|565709350|FG009|Overall Study|Withdrawal by Subject|0|||
156717017|NCT02848001|565709351|FG010|Overall Study|Withdrawal by Subject|0|||
156717018|NCT02848001|565709352|FG011|Overall Study|Withdrawal by Subject|0|||
156717019|NCT02848001|565709353|FG012|Overall Study|Withdrawal by Subject|0|||
156717020|NCT02848001|565709354|FG013|Overall Study|Withdrawal by Subject|0|||
156717021|NCT02848001|565709355|FG014|Overall Study|Withdrawal by Subject|0|||
156717022|NCT02848001|565709356|FG015|Overall Study|Withdrawal by Subject|0|||
156717023|NCT02848001|565709357|FG016|Overall Study|Withdrawal by Subject|0|||
156717024|NCT04358081|565709358|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
156717025|NCT04358081|565709359|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
156717026|NCT04358081|565709360|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
156717027|NCT04358081|565709358|FG000|Treatment Phase of Study|Adverse Event|1|||
156717028|NCT04358081|565709359|FG001|Treatment Phase of Study|Adverse Event|0|||
156717029|NCT04358081|565709360|FG002|Treatment Phase of Study|Adverse Event|1|||
156717030|NCT04358081|565709358|FG000|Treatment Phase of Study|Physician Decision|2|||
156717031|NCT04358081|565709359|FG001|Treatment Phase of Study|Physician Decision|0|||
156717032|NCT04358081|565709360|FG002|Treatment Phase of Study|Physician Decision|1|||
156717033|NCT04358081|565709358|FG000|Treatment Phase of Study|Protocol Violation|1|||
156717034|NCT04358081|565709359|FG001|Treatment Phase of Study|Protocol Violation|0|||
156717035|NCT04358081|565709360|FG002|Treatment Phase of Study|Protocol Violation|0|||
156717036|NCT04358081|565709358|FG000|Study Completion Phase|Death|0|||
156717037|NCT04358081|565709359|FG001|Study Completion Phase|Death|0|||
156717038|NCT04358081|565709360|FG002|Study Completion Phase|Death|1|||
156717039|NCT04358081|565709358|FG000|Study Completion Phase|Lost to Follow-up|1|||
156717040|NCT04358081|565709359|FG001|Study Completion Phase|Lost to Follow-up|0|||
156717041|NCT04358081|565709360|FG002|Study Completion Phase|Lost to Follow-up|1|||
156717042|NCT00696423|565709364|FG000|Overall Study|Lost to Follow-up|0|||
156717043|NCT00696423|565709365|FG001|Overall Study|Lost to Follow-up|5|||
156717044|NCT03989102|565709366|FG000|Year 1|Withdrawal by Subject|6|||
156717045|NCT03989102|565709367|FG001|Year 1|Withdrawal by Subject|2|||
156717046|NCT03989102|565709368|FG002|Year 1|Withdrawal by Subject|7|||
156717047|NCT03989102|565709366|FG000|Year 1|Lost to Follow-up|5|||
156717048|NCT03989102|565709367|FG001|Year 1|Lost to Follow-up|2|||
156717049|NCT03989102|565709368|FG002|Year 1|Lost to Follow-up|5|||
156717050|NCT03989102|565709366|FG000|Year 1|Subject met withdrawal criteria|1|||
156717051|NCT03989102|565709367|FG001|Year 1|Subject met withdrawal criteria|0|||
156717052|NCT03989102|565709368|FG002|Year 1|Subject met withdrawal criteria|1|||
156717053|NCT03989102|565709366|FG000|Year 2|Lost to Follow-up|7|||
156717054|NCT03989102|565709367|FG001|Year 2|Lost to Follow-up|3|||
156717055|NCT03989102|565709368|FG002|Year 2|Lost to Follow-up|4|||
156717056|NCT03989102|565709366|FG000|Year 2|Withdrawal by Subject|3|||
156717057|NCT03989102|565709367|FG001|Year 2|Withdrawal by Subject|1|||
156717058|NCT03989102|565709368|FG002|Year 2|Withdrawal by Subject|2|||
156717059|NCT03989102|565709366|FG000|Year 2|Subject non-compliant|3|||
156717060|NCT03989102|565709367|FG001|Year 2|Subject non-compliant|2|||
156717061|NCT03989102|565709368|FG002|Year 2|Subject non-compliant|0|||
156717062|NCT03989102|565709366|FG000|Year 2|Travel|1|||
156717063|NCT03989102|565709367|FG001|Year 2|Travel|0|||
156717064|NCT03989102|565709368|FG002|Year 2|Travel|1|||
156717065|NCT03989102|565709366|FG000|Year 2|P16 missing|4|||
156717066|NCT03989102|565709367|FG001|Year 2|P16 missing|2|||
156875007|NCT00485134|566300601|FG002|Overall Study|Positive drug test|0|||
156875008|NCT00485134|566300602|FG003|Overall Study|Positive drug test|0|||
156334987|NCT02202980|564324456|FG011|Overall Study|Lost to Follow-up|0|||
156334988|NCT02202980|564324457|FG012|Overall Study|Lost to Follow-up|1|||
156334989|NCT02202980|564324458|FG013|Overall Study|Lost to Follow-up|0|||
156717067|NCT03989102|565709368|FG002|Year 2|P16 missing|1|||
156717068|NCT03989102|565709366|FG000|Year 2|P11 missing|1|||
156717069|NCT03989102|565709367|FG001|Year 2|P11 missing|3|||
156717070|NCT03989102|565709368|FG002|Year 2|P11 missing|7|||
156717071|NCT03989102|565709366|FG000|Year 2|Definitive displacement outside the study site|0|||
156875009|NCT00485134|566300603|FG004|Overall Study|Positive drug test|2|||
156717072|NCT03989102|565709367|FG001|Year 2|Definitive displacement outside the study site|1|||
156717073|NCT03989102|565709368|FG002|Year 2|Definitive displacement outside the study site|0|||
156717074|NCT03989102|565709366|FG000|Year 2|Subject missed last study visit|0|||
156875010|NCT00485134|566300604|FG005|Overall Study|Positive drug test|1|||
156717075|NCT03989102|565709367|FG001|Year 2|Subject missed last study visit|1|||
156448560|NCT04927065|564736613|FG011|First Booster|Adverse Event|0|||
156717076|NCT03989102|565709368|FG002|Year 2|Subject missed last study visit|0|||
156717077|NCT03989102|565709366|FG000|Year 2|Death|0|||
156717078|NCT03989102|565709367|FG001|Year 2|Death|1|||
156717079|NCT03989102|565709368|FG002|Year 2|Death|0|||
156717080|NCT03989102|565709366|FG000|Year 2|Subject not reachable|0|||
156717081|NCT03989102|565709367|FG001|Year 2|Subject not reachable|0|||
156717082|NCT03989102|565709368|FG002|Year 2|Subject not reachable|1|||
156717083|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
156717084|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
156717085|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
156717086|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
156717087|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
156717088|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
156717089|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
156717090|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
156717091|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
156717092|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
156717093|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
156717094|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
156717095|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
156717096|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
156717097|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
156717098|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
156717099|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
156717100|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
156717101|NCT04054765|565709369|FG000|Baseline|Withdrawal by Subject|5|||
156717102|NCT04054765|565709370|FG001|Baseline|Withdrawal by Subject|3|||
156717103|NCT04054765|565709369|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
156717104|NCT04054765|565709370|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
156717105|NCT04054765|565709369|FG000|3-month Follow up|Withdrawal by Subject|0|||
156717106|NCT04054765|565709370|FG001|3-month Follow up|Withdrawal by Subject|3|||
156717107|NCT04054765|565709369|FG000|6-month Follow up|Lost to Follow-up|32|||
156717108|NCT04054765|565709370|FG001|6-month Follow up|Lost to Follow-up|32|||
156717109|NCT01290068|565709371|FG000|Overall Study|Adverse Event|1|||
156717110|NCT01290068|565709372|FG001|Overall Study|Adverse Event|3|||
156717111|NCT01290068|565709371|FG000|Overall Study|Lost to Follow-up|3|||
156717112|NCT01290068|565709372|FG001|Overall Study|Lost to Follow-up|0|||
156717113|NCT01290068|565709371|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
156717114|NCT01290068|565709372|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
156717115|NCT01290068|565709371|FG000|Overall Study|Other|3|||
156717116|NCT01290068|565709372|FG001|Overall Study|Other|1|||
156717117|NCT03283566|565709375|FG000|Overall Study|Lost to Follow-up|1|||
156717118|NCT03283566|565709376|FG001|Overall Study|Lost to Follow-up|2|||
156717119|NCT04515147|565709377|FG000|Overall Study|Withdrawal by Subject|1|||
156717120|NCT04515147|565709378|FG001|Overall Study|Withdrawal by Subject|0|||
156717121|NCT04515147|565709379|FG002|Overall Study|Withdrawal by Subject|10|||
156717122|NCT04515147|565709380|FG003|Overall Study|Withdrawal by Subject|18|||
156717123|NCT04515147|565709381|FG004|Overall Study|Withdrawal by Subject|1|||
156717124|NCT04515147|565709382|FG005|Overall Study|Withdrawal by Subject|8|||
156717125|NCT04515147|565709377|FG000|Overall Study|Lost to Follow-up|0|||
156717126|NCT04515147|565709378|FG001|Overall Study|Lost to Follow-up|1|||
156717127|NCT04515147|565709379|FG002|Overall Study|Lost to Follow-up|5|||
156717128|NCT04515147|565709380|FG003|Overall Study|Lost to Follow-up|6|||
156717129|NCT04515147|565709381|FG004|Overall Study|Lost to Follow-up|2|||
156717130|NCT04515147|565709382|FG005|Overall Study|Lost to Follow-up|1|||
156717131|NCT04515147|565709377|FG000|Overall Study|Adverse Event|0|||
156717132|NCT04515147|565709378|FG001|Overall Study|Adverse Event|0|||
156717133|NCT04515147|565709379|FG002|Overall Study|Adverse Event|0|||
156717134|NCT04515147|565709380|FG003|Overall Study|Adverse Event|2|||
156717135|NCT04515147|565709381|FG004|Overall Study|Adverse Event|0|||
156334990|NCT02202980|564324445|FG000|Overall Study|Withdrew Consent|0|||
156334991|NCT02202980|564324446|FG001|Overall Study|Withdrew Consent|1|||
156334992|NCT02202980|564324447|FG002|Overall Study|Withdrew Consent|2|||
156334993|NCT02202980|564324448|FG003|Overall Study|Withdrew Consent|0|||
156334994|NCT02202980|564324449|FG004|Overall Study|Withdrew Consent|0|||
156717136|NCT04515147|565709382|FG005|Overall Study|Adverse Event|0|||
156717137|NCT04515147|565709377|FG000|Overall Study|Miscellaneous|0|||
156717138|NCT04515147|565709378|FG001|Overall Study|Miscellaneous|0|||
156717139|NCT04515147|565709379|FG002|Overall Study|Miscellaneous|0|||
156717140|NCT04515147|565709380|FG003|Overall Study|Miscellaneous|1|||
156334995|NCT02202980|564324450|FG005|Overall Study|Withdrew Consent|0|||
156334996|NCT02202980|564324451|FG006|Overall Study|Withdrew Consent|0|||
156334997|NCT02202980|564324452|FG007|Overall Study|Withdrew Consent|0|||
156334998|NCT02202980|564324453|FG008|Overall Study|Withdrew Consent|1|||
156334999|NCT02202980|564324454|FG009|Overall Study|Withdrew Consent|0|||
156448561|NCT04927065|564736614|FG012|First Booster|Adverse Event|0|||
156448562|NCT04927065|564736615|FG013|First Booster|Adverse Event|0|||
156717141|NCT04515147|565709381|FG004|Overall Study|Miscellaneous|0|||
156717142|NCT04515147|565709382|FG005|Overall Study|Miscellaneous|1|||
156717143|NCT01431079|565709390|FG000|Overall Study|Lost to Follow-up|35|||
156717144|NCT01431079|565709391|FG001|Overall Study|Lost to Follow-up|39|||
156717145|NCT02790437|565709392|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
156717146|NCT02790437|565709393|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
156717147|NCT02790437|565709392|FG000|Overall Study|Adverse Event|1|||
156717148|NCT02790437|565709393|FG001|Overall Study|Adverse Event|0|||
156717149|NCT02790437|565709392|FG000|Overall Study|Withdrawal by Subject|1|||
156717150|NCT02790437|565709393|FG001|Overall Study|Withdrawal by Subject|0|||
156717151|NCT01202175|565709394|FG000|Overall Study|Lost to Follow-up|2|||
156717152|NCT01202175|565709394|FG000|Overall Study|Withdrawal by Subject|1|||
156717153|NCT01202175|565709394|FG000|Overall Study|Adverse Event|2|||
156717154|NCT01626690|565709397|FG000|Overall Study|Protocol Violation|1|||
156717155|NCT01626690|565709398|FG001|Overall Study|Protocol Violation|0|||
156717156|NCT01626690|565709397|FG000|Overall Study|Adverse Event|1|||
156717157|NCT01626690|565709398|FG001|Overall Study|Adverse Event|0|||
156717158|NCT00942357|565709399|FG000|Overall Study|Ineligible|37|||
156717159|NCT00942357|565709400|FG001|Overall Study|Ineligible|40|||
156717160|NCT01321879|565709404|FG000|Overall Study|Lack of Efficacy|5|||
156717161|NCT01321879|565709404|FG000|Overall Study|Adverse Event|5|||
156717162|NCT01321879|565709404|FG000|Overall Study|Death|3|||
156717163|NCT01321879|565709404|FG000|Overall Study|Withdrawal by Subject|1|||
156717164|NCT01518322|565709411|FG000|Overall Study|FeNO measurement was missing|13|||
156717165|NCT02108912|565709415|FG000|Overall Study|Lost to Follow-up|1|||
156717166|NCT02108912|565709416|FG001|Overall Study|Lost to Follow-up|1|||
156717167|NCT02108912|565709415|FG000|Overall Study|lack of transportation|1|||
156717168|NCT02108912|565709416|FG001|Overall Study|lack of transportation|0|||
156448563|NCT04927065|564736616|FG014|First Booster|Adverse Event|0|||
156448564|NCT04927065|564736617|FG015|First Booster|Adverse Event|0|||
156717169|NCT02108912|565709415|FG000|Overall Study|high blood pressure|1|||
156717170|NCT02108912|565709416|FG001|Overall Study|high blood pressure|0|||
156717171|NCT01876446|565709417|FG000|Overall Study|Death|0|||
156717172|NCT01876446|565709418|FG001|Overall Study|Death|1|||
156717173|NCT01876446|565709417|FG000|Overall Study|Withdrawal by Subject|1|||
156717174|NCT01876446|565709418|FG001|Overall Study|Withdrawal by Subject|2|||
156717175|NCT01876446|565709417|FG000|Overall Study|Physician Decision|1|||
156717176|NCT01876446|565709418|FG001|Overall Study|Physician Decision|3|||
156717177|NCT01808573|565709419|FG000|Overall Study|Death|212|||
156717178|NCT01808573|565709420|FG001|Overall Study|Death|240|||
156717179|NCT01808573|565709419|FG000|Overall Study|Withdrawal by Subject|12|||
156717180|NCT01808573|565709420|FG001|Overall Study|Withdrawal by Subject|10|||
156717181|NCT01808573|565709419|FG000|Overall Study|Lost to Follow-up|3|||
156717182|NCT01808573|565709420|FG001|Overall Study|Lost to Follow-up|0|||
156717183|NCT01808573|565709419|FG000|Overall Study|Discontinuation of study by sponsor|79|||
156717184|NCT01808573|565709420|FG001|Overall Study|Discontinuation of study by sponsor|64|||
156717185|NCT01808573|565709419|FG000|Overall Study|Randomized in Error|1|||
156717186|NCT01808573|565709420|FG001|Overall Study|Randomized in Error|0|||
156448565|NCT04927065|564736602|FG000|First Booster|Death|1|||
156717187|NCT03953612|565709421|FG000|Overall Study|Randomized but did not start|1|||
156717188|NCT03953612|565709422|FG001|Overall Study|Randomized but did not start|1|||
156717189|NCT03953612|565709423|FG002|Overall Study|Randomized but did not start|1|||
156717190|NCT03953612|565709421|FG000|Overall Study|Withdrawal by Subject|2|||
156717191|NCT03953612|565709422|FG001|Overall Study|Withdrawal by Subject|1|||
156717192|NCT03953612|565709423|FG002|Overall Study|Withdrawal by Subject|0|||
156717193|NCT03629184|565709427|FG000|Overall Study|Withdrawal by Subject|2|||
156717194|NCT03629184|565709428|FG001|Overall Study|Withdrawal by Subject|1|||
156717195|NCT03629184|565709427|FG000|Overall Study|Physician Decision|1|||
156448566|NCT04927065|564736603|FG001|First Booster|Death|0|||
156717196|NCT03629184|565709428|FG001|Overall Study|Physician Decision|0|||
156717197|NCT01982955|565709432|FG000|Overall Study|Randomized but not treated|0|||
156717198|NCT01982955|565709433|FG001|Overall Study|Randomized but not treated|0|||
156793529|NCT04818229|565996285|FG001|Overall Study|Withdrawal by Subject|0|||
156793530|NCT04818229|565996286|FG002|Overall Study|Withdrawal by Subject|2|||
156793531|NCT04818229|565996284|FG000|Overall Study|Lost to Follow-up|0|||
156793532|NCT04818229|565996285|FG001|Overall Study|Lost to Follow-up|0|||
156448567|NCT04927065|564736604|FG002|First Booster|Death|0|||
156717199|NCT01982955|565709434|FG002|Overall Study|Randomized but not treated|0|||
156717200|NCT01982955|565709435|FG003|Overall Study|Randomized but not treated|1|||
156717201|NCT01982955|565709436|FG004|Overall Study|Randomized but not treated|0|||
156717202|NCT01682811|565709441|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717203|NCT01682811|565709442|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717204|NCT01682811|565709443|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156793533|NCT04818229|565996286|FG002|Overall Study|Lost to Follow-up|1|||
156448568|NCT04927065|564736605|FG003|First Booster|Death|1|||
156448569|NCT04927065|564736606|FG004|First Booster|Death|0|||
156793534|NCT03186378|565996287|FG000|Overall Study|Lost to Follow-up|1|||
156717205|NCT01682811|565709444|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717206|NCT01682811|565709445|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
156717207|NCT01682811|565709446|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717208|NCT01682811|565709447|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717209|NCT01682811|565709441|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
156717210|NCT01682811|565709442|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
156717211|NCT01682811|565709443|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
156717212|NCT01682811|565709444|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
156717213|NCT01682811|565709445|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
156717214|NCT01682811|565709446|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
156717215|NCT01682811|565709447|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
156717216|NCT01682811|565709441|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717217|NCT01682811|565709442|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717218|NCT01682811|565709443|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717219|NCT01682811|565709444|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717220|NCT01682811|565709445|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
156717221|NCT01682811|565709446|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717222|NCT01682811|565709447|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717223|NCT01682811|565709441|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717224|NCT01682811|565709442|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717225|NCT01682811|565709443|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717226|NCT01682811|565709444|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717227|NCT01682811|565709445|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717228|NCT01682811|565709446|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
156717229|NCT01682811|565709447|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717230|NCT05525520|565711572|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
156717231|NCT05525520|565711573|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
156717232|NCT05525520|565711572|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
156717233|NCT05525520|565711573|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
156717234|NCT05878093|565711576|FG000|Overall Study|Withdrawal by Subject|3|||
156717235|NCT05878093|565711577|FG001|Overall Study|Withdrawal by Subject|1|||
156717236|NCT02721732|565711578|FG000|Overall Study|Adverse Event|2|||
156717237|NCT02721732|565711579|FG001|Overall Study|Adverse Event|0|||
156717238|NCT02721732|565711580|FG002|Overall Study|Adverse Event|2|||
156717239|NCT02721732|565711581|FG003|Overall Study|Adverse Event|0|||
156717240|NCT02721732|565711582|FG004|Overall Study|Adverse Event|1|||
156717241|NCT02721732|565711583|FG005|Overall Study|Adverse Event|0|||
156717242|NCT02721732|565711584|FG006|Overall Study|Adverse Event|1|||
156717243|NCT02721732|565711585|FG007|Overall Study|Adverse Event|0|||
156717244|NCT02721732|565711586|FG008|Overall Study|Adverse Event|1|||
156717245|NCT02721732|565711587|FG009|Overall Study|Adverse Event|1|||
156717246|NCT02721732|565711578|FG000|Overall Study|Death|0|||
156717247|NCT02721732|565711579|FG001|Overall Study|Death|0|||
156717248|NCT02721732|565711580|FG002|Overall Study|Death|0|||
156717249|NCT02721732|565711581|FG003|Overall Study|Death|0|||
156717250|NCT02721732|565711582|FG004|Overall Study|Death|1|||
156717251|NCT02721732|565711583|FG005|Overall Study|Death|0|||
156717252|NCT02721732|565711584|FG006|Overall Study|Death|1|||
156717253|NCT02721732|565711585|FG007|Overall Study|Death|0|||
156717254|NCT02721732|565711586|FG008|Overall Study|Death|0|||
156717255|NCT02721732|565711587|FG009|Overall Study|Death|1|||
156717256|NCT02721732|565711578|FG000|Overall Study|Lack of Efficacy|12|||
156717257|NCT02721732|565711579|FG001|Overall Study|Lack of Efficacy|11|||
156717258|NCT02721732|565711580|FG002|Overall Study|Lack of Efficacy|18|||
156717259|NCT02721732|565711581|FG003|Overall Study|Lack of Efficacy|5|||
156717260|NCT02721732|565711582|FG004|Overall Study|Lack of Efficacy|21|||
156717261|NCT02721732|565711583|FG005|Overall Study|Lack of Efficacy|2|||
156717262|NCT02721732|565711584|FG006|Overall Study|Lack of Efficacy|8|||
156717263|NCT02721732|565711585|FG007|Overall Study|Lack of Efficacy|11|||
156717264|NCT02721732|565711586|FG008|Overall Study|Lack of Efficacy|10|||
156717265|NCT02721732|565711587|FG009|Overall Study|Lack of Efficacy|20|||
156448570|NCT04927065|564736607|FG005|First Booster|Death|1|||
156448571|NCT04927065|564736608|FG006|First Booster|Death|0|||
156448572|NCT04927065|564736609|FG007|First Booster|Death|0|||
156448573|NCT04927065|564736610|FG008|First Booster|Death|0|||
156448574|NCT04927065|564736611|FG009|First Booster|Death|0|||
156448575|NCT04927065|564736612|FG010|First Booster|Death|0|||
156448576|NCT04927065|564736613|FG011|First Booster|Death|0|||
156717266|NCT02721732|565711578|FG000|Overall Study|Physician Decision|0|||
156717267|NCT02721732|565711579|FG001|Overall Study|Physician Decision|0|||
156717268|NCT02721732|565711580|FG002|Overall Study|Physician Decision|1|||
156717269|NCT02721732|565711581|FG003|Overall Study|Physician Decision|0|||
156717270|NCT02721732|565711582|FG004|Overall Study|Physician Decision|0|||
156717271|NCT02721732|565711583|FG005|Overall Study|Physician Decision|0|||
156717272|NCT02721732|565711584|FG006|Overall Study|Physician Decision|0|||
156717273|NCT02721732|565711585|FG007|Overall Study|Physician Decision|0|||
156717274|NCT02721732|565711586|FG008|Overall Study|Physician Decision|0|||
156717275|NCT02721732|565711587|FG009|Overall Study|Physician Decision|0|||
156717276|NCT02721732|565711578|FG000|Overall Study|Withdrawal by Subject|1|||
156717277|NCT02721732|565711579|FG001|Overall Study|Withdrawal by Subject|0|||
156717278|NCT02721732|565711580|FG002|Overall Study|Withdrawal by Subject|0|||
156717279|NCT02721732|565711581|FG003|Overall Study|Withdrawal by Subject|0|||
156717280|NCT02721732|565711582|FG004|Overall Study|Withdrawal by Subject|3|||
156717281|NCT02721732|565711583|FG005|Overall Study|Withdrawal by Subject|0|||
156717282|NCT02721732|565711584|FG006|Overall Study|Withdrawal by Subject|1|||
156717283|NCT02721732|565711585|FG007|Overall Study|Withdrawal by Subject|1|||
156717284|NCT02721732|565711586|FG008|Overall Study|Withdrawal by Subject|0|||
156717285|NCT02721732|565711587|FG009|Overall Study|Withdrawal by Subject|1|||
156717286|NCT02721732|565711578|FG000|Overall Study|Participant Choice|1|||
156717287|NCT02721732|565711579|FG001|Overall Study|Participant Choice|0|||
156717288|NCT02721732|565711580|FG002|Overall Study|Participant Choice|0|||
156717289|NCT02721732|565711581|FG003|Overall Study|Participant Choice|0|||
156717290|NCT02721732|565711582|FG004|Overall Study|Participant Choice|0|||
156717291|NCT02721732|565711583|FG005|Overall Study|Participant Choice|0|||
156717292|NCT02721732|565711584|FG006|Overall Study|Participant Choice|0|||
156717293|NCT02721732|565711585|FG007|Overall Study|Participant Choice|0|||
156717294|NCT02721732|565711586|FG008|Overall Study|Participant Choice|0|||
156717295|NCT02721732|565711587|FG009|Overall Study|Participant Choice|1|||
156717296|NCT02721732|565711578|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717297|NCT02721732|565711579|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717298|NCT02721732|565711580|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
156717299|NCT02721732|565711581|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717300|NCT02721732|565711582|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717301|NCT02721732|565711583|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717302|NCT02721732|565711584|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717303|NCT02721732|565711585|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717304|NCT02721732|565711586|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717305|NCT02721732|565711587|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717306|NCT02721732|565711578|FG000|Overall Study|Progression and withdrew consent|1|||
156717307|NCT02721732|565711579|FG001|Overall Study|Progression and withdrew consent|1|||
156717308|NCT02721732|565711580|FG002|Overall Study|Progression and withdrew consent|0|||
156717309|NCT02721732|565711581|FG003|Overall Study|Progression and withdrew consent|0|||
156717310|NCT02721732|565711582|FG004|Overall Study|Progression and withdrew consent|0|||
156717311|NCT02721732|565711583|FG005|Overall Study|Progression and withdrew consent|0|||
156717312|NCT02721732|565711584|FG006|Overall Study|Progression and withdrew consent|0|||
156717313|NCT02721732|565711585|FG007|Overall Study|Progression and withdrew consent|0|||
156717314|NCT02721732|565711586|FG008|Overall Study|Progression and withdrew consent|0|||
156717315|NCT02721732|565711587|FG009|Overall Study|Progression and withdrew consent|1|||
156717316|NCT02721732|565711578|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
156717317|NCT02721732|565711579|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
156717318|NCT02721732|565711580|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
156717319|NCT02721732|565711581|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
156717320|NCT02721732|565711582|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
156717321|NCT02721732|565711583|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
156717322|NCT02721732|565711584|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
156717323|NCT02721732|565711585|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
156717324|NCT02721732|565711586|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
156717325|NCT02721732|565711587|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
156717326|NCT00725283|565711588|FG000|Overall Study|Missing Code|3|||
156717327|NCT00725283|565711588|FG000|Overall Study|Death|5|||
156717328|NCT00725283|565711588|FG000|Overall Study|Other|6|||
156717329|NCT00725283|565711588|FG000|Overall Study|Withdrawal by Subject|10|||
156717330|NCT00118157|565711589|FG000|Overall Study|Adverse Event|2|||
156793535|NCT03186378|565996288|FG001|Overall Study|Lost to Follow-up|0|||
156793536|NCT03769116|565996289|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
156793537|NCT03769116|565996290|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
156793538|NCT03769116|565996289|FG000|Part 3 - Open Label|Physician Decision|1|||
156793539|NCT03769116|565996290|FG001|Part 3 - Open Label|Physician Decision|0|||
156793540|NCT03769116|565996289|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
156793541|NCT03769116|565996290|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
156793542|NCT03382873|565996291|FG000|Overall Study|Lost to Follow-up|9|||
156793543|NCT03382873|565996292|FG001|Overall Study|Lost to Follow-up|10|||
156717331|NCT00118157|565711589|FG000|Overall Study|Death|8|||
156717332|NCT00118157|565711589|FG000|Overall Study|Withdrawal by Subject|2|||
156875011|NCT00485134|566300605|FG006|Overall Study|Positive drug test|0|||
156717333|NCT01557504|565711592|FG000|Overall Study|Physician Decision|1|||
156717334|NCT01557504|565711593|FG001|Overall Study|Physician Decision|0|||
156793544|NCT03382873|565996291|FG000|Overall Study|Withdrawal by Subject|6|||
156875012|NCT00485134|566300606|FG007|Overall Study|Positive drug test|0|||
156717335|NCT01962103|565711597|FG000|Phase 1|Adverse Event|4|||
156717336|NCT01962103|565711598|FG001|Phase 1|Adverse Event|0|||
156717337|NCT01962103|565711599|FG002|Phase 1|Adverse Event|2|||
156717338|NCT01962103|565711600|FG003|Phase 1|Adverse Event|1|||
156717339|NCT01962103|565711601|FG004|Phase 1|Adverse Event|2|||
156717340|NCT01962103|565711602|FG005|Phase 1|Adverse Event|2|||
156717341|NCT01962103|565711603|FG006|Phase 1|Adverse Event|0|||
156717342|NCT01962103|565711604|FG007|Phase 1|Adverse Event|0|||
156717343|NCT01962103|565711605|FG008|Phase 1|Adverse Event|0|||
156717344|NCT01962103|565711597|FG000|Phase 1|Progressive Disease|8|||
156717345|NCT01962103|565711598|FG001|Phase 1|Progressive Disease|6|||
156717346|NCT01962103|565711599|FG002|Phase 1|Progressive Disease|8|||
156717347|NCT01962103|565711600|FG003|Phase 1|Progressive Disease|4|||
156717348|NCT01962103|565711601|FG004|Phase 1|Progressive Disease|5|||
156717349|NCT01962103|565711602|FG005|Phase 1|Progressive Disease|4|||
156717350|NCT01962103|565711603|FG006|Phase 1|Progressive Disease|0|||
156717351|NCT01962103|565711604|FG007|Phase 1|Progressive Disease|0|||
156717352|NCT01962103|565711605|FG008|Phase 1|Progressive Disease|0|||
156717353|NCT01962103|565711597|FG000|Phase 1|Withdrawal by Subject|0|||
156717354|NCT01962103|565711598|FG001|Phase 1|Withdrawal by Subject|0|||
156717355|NCT01962103|565711599|FG002|Phase 1|Withdrawal by Subject|0|||
156717356|NCT01962103|565711600|FG003|Phase 1|Withdrawal by Subject|2|||
156717357|NCT01962103|565711601|FG004|Phase 1|Withdrawal by Subject|0|||
156717358|NCT01962103|565711602|FG005|Phase 1|Withdrawal by Subject|0|||
156717359|NCT01962103|565711603|FG006|Phase 1|Withdrawal by Subject|0|||
156717360|NCT01962103|565711604|FG007|Phase 1|Withdrawal by Subject|0|||
156717361|NCT01962103|565711605|FG008|Phase 1|Withdrawal by Subject|0|||
156717362|NCT01962103|565711597|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
156717363|NCT01962103|565711598|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
156717364|NCT01962103|565711599|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
156717365|NCT01962103|565711600|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
156717366|NCT01962103|565711601|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
156717367|NCT01962103|565711602|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
156717368|NCT01962103|565711603|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
156717369|NCT01962103|565711604|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
156717370|NCT01962103|565711605|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
156717371|NCT01962103|565711597|FG000|Phase 1|Physician Decision|0|||
156717372|NCT01962103|565711598|FG001|Phase 1|Physician Decision|0|||
156717373|NCT01962103|565711599|FG002|Phase 1|Physician Decision|0|||
156717374|NCT01962103|565711600|FG003|Phase 1|Physician Decision|1|||
156717375|NCT01962103|565711601|FG004|Phase 1|Physician Decision|0|||
156717376|NCT01962103|565711602|FG005|Phase 1|Physician Decision|0|||
156717377|NCT01962103|565711603|FG006|Phase 1|Physician Decision|0|||
156717378|NCT01962103|565711604|FG007|Phase 1|Physician Decision|0|||
156717379|NCT01962103|565711605|FG008|Phase 1|Physician Decision|0|||
156717380|NCT01962103|565711597|FG000|Phase 1|Symptomatic Deterioration|3|||
156717381|NCT01962103|565711598|FG001|Phase 1|Symptomatic Deterioration|2|||
156717382|NCT01962103|565711599|FG002|Phase 1|Symptomatic Deterioration|2|||
156717383|NCT01962103|565711600|FG003|Phase 1|Symptomatic Deterioration|2|||
156717384|NCT01962103|565711601|FG004|Phase 1|Symptomatic Deterioration|1|||
156717385|NCT01962103|565711602|FG005|Phase 1|Symptomatic Deterioration|1|||
156717386|NCT01962103|565711603|FG006|Phase 1|Symptomatic Deterioration|0|||
156717387|NCT01962103|565711604|FG007|Phase 1|Symptomatic Deterioration|0|||
156717388|NCT01962103|565711605|FG008|Phase 1|Symptomatic Deterioration|0|||
156717389|NCT01962103|565711597|FG000|Phase 1|Miscellaneous|1|||
156717390|NCT01962103|565711598|FG001|Phase 1|Miscellaneous|0|||
156717391|NCT01962103|565711599|FG002|Phase 1|Miscellaneous|0|||
156717392|NCT01962103|565711600|FG003|Phase 1|Miscellaneous|0|||
156717393|NCT01962103|565711601|FG004|Phase 1|Miscellaneous|0|||
156717394|NCT01962103|565711602|FG005|Phase 1|Miscellaneous|0|||
156717395|NCT01962103|565711603|FG006|Phase 1|Miscellaneous|0|||
156717396|NCT01962103|565711604|FG007|Phase 1|Miscellaneous|0|||
156717397|NCT01962103|565711605|FG008|Phase 1|Miscellaneous|0|||
156717398|NCT01962103|565711597|FG000|Phase 2|Adverse Event|0|||
156717399|NCT01962103|565711598|FG001|Phase 2|Adverse Event|0|||
156717400|NCT01962103|565711599|FG002|Phase 2|Adverse Event|0|||
156717401|NCT01962103|565711600|FG003|Phase 2|Adverse Event|0|||
156717402|NCT01962103|565711601|FG004|Phase 2|Adverse Event|0|||
156717403|NCT01962103|565711602|FG005|Phase 2|Adverse Event|0|||
156448577|NCT04927065|564736614|FG012|First Booster|Death|0|||
156717404|NCT01962103|565711603|FG006|Phase 2|Adverse Event|1|||
156717405|NCT01962103|565711604|FG007|Phase 2|Adverse Event|0|||
156717406|NCT01962103|565711605|FG008|Phase 2|Adverse Event|3|||
156717407|NCT01962103|565711597|FG000|Phase 2|Progressive Disease|0|||
156717408|NCT01962103|565711598|FG001|Phase 2|Progressive Disease|0|||
156717409|NCT01962103|565711599|FG002|Phase 2|Progressive Disease|0|||
156717410|NCT01962103|565711600|FG003|Phase 2|Progressive Disease|0|||
156717411|NCT01962103|565711601|FG004|Phase 2|Progressive Disease|0|||
156717412|NCT01962103|565711602|FG005|Phase 2|Progressive Disease|0|||
156717413|NCT01962103|565711603|FG006|Phase 2|Progressive Disease|11|||
156717414|NCT01962103|565711604|FG007|Phase 2|Progressive Disease|12|||
156717415|NCT01962103|565711605|FG008|Phase 2|Progressive Disease|11|||
156717416|NCT01962103|565711597|FG000|Phase 2|Symptomatic Deterioration|0|||
156717417|NCT01962103|565711598|FG001|Phase 2|Symptomatic Deterioration|0|||
156717418|NCT01962103|565711599|FG002|Phase 2|Symptomatic Deterioration|0|||
156717419|NCT01962103|565711600|FG003|Phase 2|Symptomatic Deterioration|0|||
156717420|NCT01962103|565711601|FG004|Phase 2|Symptomatic Deterioration|0|||
156717421|NCT01962103|565711602|FG005|Phase 2|Symptomatic Deterioration|0|||
156717422|NCT01962103|565711603|FG006|Phase 2|Symptomatic Deterioration|2|||
156533142|NCT04178967|565046858|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156533143|NCT04178967|565046859|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156533144|NCT04178967|565046860|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156533145|NCT04178967|565046861|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156533146|NCT04178967|565046862|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156533147|NCT04178967|565046863|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156533148|NCT04178967|565046864|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
156533149|NCT04178967|565046865|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
156533150|NCT05211739|565046866|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
156533151|NCT05211739|565046867|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
156533152|NCT05211739|565046866|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
156533153|NCT05211739|565046867|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
156533154|NCT05211739|565046866|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
156533155|NCT05211739|565046867|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
156533156|NCT05211739|565046866|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
156533157|NCT05211739|565046867|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
156533158|NCT00628251|565046868|FG000|Randomised Part|Withdrawal by Subject|0|||
156533159|NCT00628251|565046869|FG001|Randomised Part|Withdrawal by Subject|0|||
156533160|NCT00628251|565046870|FG002|Randomised Part|Withdrawal by Subject|1|||
156533161|NCT00628251|565046868|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
156533162|NCT00628251|565046869|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
156793545|NCT03382873|565996292|FG001|Overall Study|Withdrawal by Subject|11|||
156793546|NCT03382873|565996291|FG000|Overall Study|Visit not completed due to pandemic|16|||
156793547|NCT03382873|565996292|FG001|Overall Study|Visit not completed due to pandemic|41|||
156793548|NCT04105725|565996297|FG000|Primary Intervention|Lost to Follow-up|0|||
156793549|NCT04105725|565996298|FG001|Primary Intervention|Lost to Follow-up|2|||
156793550|NCT04105725|565996297|FG000|Primary Intervention|Withdrawal by Subject|0|||
156793551|NCT04105725|565996298|FG001|Primary Intervention|Withdrawal by Subject|1|||
156717423|NCT01962103|565711604|FG007|Phase 2|Symptomatic Deterioration|2|||
156717424|NCT01962103|565711605|FG008|Phase 2|Symptomatic Deterioration|0|||
156717425|NCT01321749|565711608|FG000|Overall Study|Lost to Follow-up|4|||
156717426|NCT01321749|565711609|FG001|Overall Study|Lost to Follow-up|11|||
156717427|NCT01321749|565711608|FG000|Overall Study|Protocol Violation|4|||
156717428|NCT01321749|565711609|FG001|Overall Study|Protocol Violation|7|||
156717429|NCT01321749|565711608|FG000|Overall Study|Withdrawal by Subject|5|||
156717430|NCT01321749|565711609|FG001|Overall Study|Withdrawal by Subject|4|||
156717431|NCT04179838|565711613|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
156717432|NCT04179838|565711614|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
156717433|NCT04179838|565711613|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
156717434|NCT04179838|565711614|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
156717435|NCT02763046|565711621|FG000|Overall Study|Adverse Event|5|||
156717436|NCT02763046|565711622|FG001|Overall Study|Adverse Event|4|||
156717437|NCT02763046|565711623|FG002|Overall Study|Adverse Event|0|||
156717438|NCT02763046|565711621|FG000|Overall Study|Lack of Efficacy|1|||
156717439|NCT02763046|565711622|FG001|Overall Study|Lack of Efficacy|1|||
156717440|NCT02763046|565711623|FG002|Overall Study|Lack of Efficacy|3|||
156717441|NCT02763046|565711621|FG000|Overall Study|Physician Decision|1|||
156717442|NCT02763046|565711622|FG001|Overall Study|Physician Decision|0|||
156717443|NCT02763046|565711623|FG002|Overall Study|Physician Decision|1|||
156717444|NCT02763046|565711621|FG000|Overall Study|Subject/guardian decision|2|||
156717445|NCT02763046|565711622|FG001|Overall Study|Subject/guardian decision|0|||
156793552|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
156793553|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
156793554|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
156793555|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
156793556|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
156793557|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
156793558|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Other|2|||
156793559|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Other|1|||
156793560|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Other|1|||
156793561|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
156793562|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
156717446|NCT02763046|565711623|FG002|Overall Study|Subject/guardian decision|4|||
156717447|NCT00818766|565711628|FG000|Overall Study|Could not be Contacted on Day 28|11|||
156717448|NCT00818766|565711629|FG001|Overall Study|Could not be Contacted on Day 28|10|||
156448578|NCT04927065|564736615|FG013|First Booster|Death|0|||
156448579|NCT04927065|564736616|FG014|First Booster|Death|0|||
156448580|NCT04927065|564736617|FG015|First Booster|Death|0|||
156448581|NCT04927065|564736602|FG000|First Booster|Lost to Follow-up|8|||
156448582|NCT04927065|564736603|FG001|First Booster|Lost to Follow-up|20|||
156448583|NCT04927065|564736604|FG002|First Booster|Lost to Follow-up|0|||
156448584|NCT04927065|564736605|FG003|First Booster|Lost to Follow-up|11|||
156448585|NCT04927065|564736606|FG004|First Booster|Lost to Follow-up|43|||
156448586|NCT04927065|564736607|FG005|First Booster|Lost to Follow-up|30|||
156717449|NCT00818766|565711628|FG000|Overall Study|Death|1|||
156717450|NCT00818766|565711629|FG001|Overall Study|Death|0|||
156717451|NCT00818766|565711628|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
156717452|NCT00818766|565711629|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
156717453|NCT00086684|565711630|FG000|Overall Study|Adverse Event|12|||
156717454|NCT00086684|565711631|FG001|Overall Study|Adverse Event|17|||
156448587|NCT04927065|564736608|FG006|First Booster|Lost to Follow-up|28|||
156717455|NCT00086684|565711632|FG002|Overall Study|Adverse Event|14|||
156717456|NCT00086684|565711630|FG000|Overall Study|Lack of Efficacy|6|||
156717457|NCT00086684|565711631|FG001|Overall Study|Lack of Efficacy|6|||
156717458|NCT00086684|565711632|FG002|Overall Study|Lack of Efficacy|5|||
156717459|NCT00086684|565711630|FG000|Overall Study|Lost to Follow-up|15|||
156717460|NCT00086684|565711631|FG001|Overall Study|Lost to Follow-up|8|||
156717461|NCT00086684|565711632|FG002|Overall Study|Lost to Follow-up|10|||
156717462|NCT00086684|565711630|FG000|Overall Study|Protocol Violation|8|||
156717463|NCT00086684|565711631|FG001|Overall Study|Protocol Violation|3|||
156717464|NCT00086684|565711632|FG002|Overall Study|Protocol Violation|0|||
156717465|NCT00086684|565711630|FG000|Overall Study|Withdrawal by Subject|0|||
156717466|NCT00086684|565711631|FG001|Overall Study|Withdrawal by Subject|4|||
156717467|NCT00086684|565711632|FG002|Overall Study|Withdrawal by Subject|10|||
156717468|NCT00086684|565711630|FG000|Overall Study|NONCOMPLIANCE|5|||
156793563|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
156448588|NCT04927065|564736609|FG007|First Booster|Lost to Follow-up|23|||
156448589|NCT04927065|564736610|FG008|First Booster|Lost to Follow-up|4|||
156448590|NCT04927065|564736611|FG009|First Booster|Lost to Follow-up|15|||
156448591|NCT04927065|564736612|FG010|First Booster|Lost to Follow-up|0|||
156448592|NCT04927065|564736613|FG011|First Booster|Lost to Follow-up|0|||
156448593|NCT04927065|564736614|FG012|First Booster|Lost to Follow-up|0|||
156448594|NCT04927065|564736615|FG013|First Booster|Lost to Follow-up|0|||
156448595|NCT04927065|564736616|FG014|First Booster|Lost to Follow-up|0|||
156448596|NCT04927065|564736617|FG015|First Booster|Lost to Follow-up|0|||
156448597|NCT04927065|564736602|FG000|First Booster|Physician Decision|1|||
156448598|NCT04927065|564736603|FG001|First Booster|Physician Decision|0|||
156448599|NCT04927065|564736604|FG002|First Booster|Physician Decision|0|||
156448600|NCT04927065|564736605|FG003|First Booster|Physician Decision|3|||
156448601|NCT04927065|564736606|FG004|First Booster|Physician Decision|1|||
156448602|NCT04927065|564736607|FG005|First Booster|Physician Decision|1|||
156448603|NCT04927065|564736608|FG006|First Booster|Physician Decision|0|||
156448604|NCT04927065|564736609|FG007|First Booster|Physician Decision|3|||
156448605|NCT04927065|564736610|FG008|First Booster|Physician Decision|0|||
156448606|NCT04927065|564736611|FG009|First Booster|Physician Decision|0|||
156448607|NCT04927065|564736612|FG010|First Booster|Physician Decision|0|||
156448608|NCT04927065|564736613|FG011|First Booster|Physician Decision|0|||
156448609|NCT04927065|564736614|FG012|First Booster|Physician Decision|0|||
156448610|NCT04927065|564736615|FG013|First Booster|Physician Decision|0|||
156448611|NCT04927065|564736616|FG014|First Booster|Physician Decision|0|||
156448612|NCT04927065|564736617|FG015|First Booster|Physician Decision|0|||
156448613|NCT04927065|564736602|FG000|First Booster|Protocol Violation|4|||
156448614|NCT04927065|564736603|FG001|First Booster|Protocol Violation|4|||
156448615|NCT04927065|564736604|FG002|First Booster|Protocol Violation|0|||
156448616|NCT04927065|564736605|FG003|First Booster|Protocol Violation|3|||
156448617|NCT04927065|564736606|FG004|First Booster|Protocol Violation|0|||
156448618|NCT04927065|564736607|FG005|First Booster|Protocol Violation|0|||
156448619|NCT04927065|564736608|FG006|First Booster|Protocol Violation|0|||
156448620|NCT04927065|564736609|FG007|First Booster|Protocol Violation|2|||
156717469|NCT00086684|565711631|FG001|Overall Study|NONCOMPLIANCE|7|||
156717470|NCT00086684|565711632|FG002|Overall Study|NONCOMPLIANCE|6|||
156793564|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156717471|NCT00086684|565711630|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156793565|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
156793566|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
156875013|NCT00485134|566300599|FG000|Overall Study|Non-compliance|0|||
156448621|NCT04927065|564736610|FG008|First Booster|Protocol Violation|0|||
156533163|NCT00628251|565046870|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
156448622|NCT04927065|564736611|FG009|First Booster|Protocol Violation|0|||
156448623|NCT04927065|564736612|FG010|First Booster|Protocol Violation|0|||
156448624|NCT04927065|564736613|FG011|First Booster|Protocol Violation|0|||
156448625|NCT04927065|564736614|FG012|First Booster|Protocol Violation|0|||
156448626|NCT04927065|564736615|FG013|First Booster|Protocol Violation|0|||
156448627|NCT04927065|564736616|FG014|First Booster|Protocol Violation|0|||
156717472|NCT00086684|565711631|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
156717473|NCT00086684|565711632|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156717474|NCT00086684|565711630|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
156717475|NCT00086684|565711631|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
156717476|NCT00086684|565711632|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
156717477|NCT00086684|565711630|FG000|Overall Study|Other|4|||
156717478|NCT00086684|565711631|FG001|Overall Study|Other|2|||
156717479|NCT00086684|565711632|FG002|Overall Study|Other|3|||
156717480|NCT01103180|565711635|FG000|Overall Study|Withdrawal by Subject|8|||
156717481|NCT01103180|565711636|FG001|Overall Study|Withdrawal by Subject|13|||
156717482|NCT01103180|565711635|FG000|Overall Study|Lost to Follow-up|13|||
156717483|NCT01103180|565711636|FG001|Overall Study|Lost to Follow-up|7|||
156717484|NCT01103180|565711635|FG000|Overall Study|Physician Decision|1|||
156717485|NCT01103180|565711636|FG001|Overall Study|Physician Decision|0|||
156717486|NCT01103180|565711635|FG000|Overall Study|Protocol Violation|0|||
156717487|NCT01103180|565711636|FG001|Overall Study|Protocol Violation|1|||
156717488|NCT01067105|565711637|FG000|Overall Study|Adverse Event|14|||
156717489|NCT01067105|565711637|FG000|Overall Study|Protocol Violation|48|||
156717490|NCT01067105|565711637|FG000|Overall Study|Withdrawal by Subject|36|||
156717491|NCT01067105|565711637|FG000|Overall Study|Lost to Follow-up|6|||
156717492|NCT01067105|565711637|FG000|Overall Study|Physician Decision|6|||
156717493|NCT01067105|565711637|FG000|Overall Study|Other|31|||
156717494|NCT02760004|565711638|FG000|Overall Study|Lost to Follow-up|13|||
156717495|NCT02760004|565711639|FG001|Overall Study|Lost to Follow-up|22|||
156717496|NCT00970593|565711640|FG000|Overall Study|Adverse Event|1|||
156717497|NCT00970593|565711641|FG001|Overall Study|Adverse Event|1|||
156448628|NCT04927065|564736617|FG015|First Booster|Protocol Violation|0|||
156448629|NCT04927065|564736602|FG000|First Booster|Withdrawal by Subject|8|||
156448630|NCT04927065|564736603|FG001|First Booster|Withdrawal by Subject|23|||
156448631|NCT04927065|564736604|FG002|First Booster|Withdrawal by Subject|0|||
156448632|NCT04927065|564736605|FG003|First Booster|Withdrawal by Subject|19|||
156448633|NCT04927065|564736606|FG004|First Booster|Withdrawal by Subject|20|||
156448634|NCT04927065|564736607|FG005|First Booster|Withdrawal by Subject|15|||
156448635|NCT04927065|564736608|FG006|First Booster|Withdrawal by Subject|6|||
156448636|NCT04927065|564736609|FG007|First Booster|Withdrawal by Subject|24|||
156448637|NCT04927065|564736610|FG008|First Booster|Withdrawal by Subject|0|||
156448638|NCT04927065|564736611|FG009|First Booster|Withdrawal by Subject|4|||
156448639|NCT04927065|564736612|FG010|First Booster|Withdrawal by Subject|0|||
156448640|NCT04927065|564736613|FG011|First Booster|Withdrawal by Subject|0|||
156448641|NCT04927065|564736614|FG012|First Booster|Withdrawal by Subject|0|||
156448642|NCT04927065|564736615|FG013|First Booster|Withdrawal by Subject|0|||
156448643|NCT04927065|564736616|FG014|First Booster|Withdrawal by Subject|0|||
156448644|NCT04927065|564736617|FG015|First Booster|Withdrawal by Subject|0|||
156448645|NCT04927065|564736602|FG000|First Booster|Other Than Specified|1|||
156448646|NCT04927065|564736603|FG001|First Booster|Other Than Specified|1|||
156448647|NCT04927065|564736604|FG002|First Booster|Other Than Specified|0|||
156448648|NCT04927065|564736605|FG003|First Booster|Other Than Specified|1|||
156448649|NCT04927065|564736606|FG004|First Booster|Other Than Specified|2|||
156448650|NCT04927065|564736607|FG005|First Booster|Other Than Specified|3|||
156448651|NCT04927065|564736608|FG006|First Booster|Other Than Specified|2|||
156448652|NCT04927065|564736609|FG007|First Booster|Other Than Specified|6|||
156448653|NCT04927065|564736610|FG008|First Booster|Other Than Specified|0|||
156448654|NCT04927065|564736611|FG009|First Booster|Other Than Specified|4|||
156448655|NCT04927065|564736612|FG010|First Booster|Other Than Specified|0|||
156448656|NCT04927065|564736613|FG011|First Booster|Other Than Specified|0|||
156448657|NCT04927065|564736614|FG012|First Booster|Other Than Specified|0|||
156448658|NCT04927065|564736615|FG013|First Booster|Other Than Specified|0|||
156448659|NCT04927065|564736616|FG014|First Booster|Other Than Specified|0|||
156448660|NCT04927065|564736617|FG015|First Booster|Other Than Specified|0|||
156448661|NCT04927065|564736602|FG000|Second Booster|Death|0|||
156533164|NCT00628251|565046868|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
156717498|NCT00970593|565711642|FG002|Overall Study|Adverse Event|0|||
156717499|NCT00970593|565711643|FG003|Overall Study|Adverse Event|0|||
156717500|NCT00970593|565711644|FG004|Overall Study|Adverse Event|0|||
156717501|NCT00970593|565711645|FG005|Overall Study|Adverse Event|0|||
156793567|NCT02916433|565996304|FG000|Overall Study|Withdrawal by Subject|1|||
156448662|NCT04927065|564736603|FG001|Second Booster|Death|0|||
156448663|NCT04927065|564736604|FG002|Second Booster|Death|0|||
156717502|NCT00970593|565711646|FG006|Overall Study|Adverse Event|0|||
156448664|NCT04927065|564736605|FG003|Second Booster|Death|0|||
156448665|NCT04927065|564736606|FG004|Second Booster|Death|0|||
156448666|NCT04927065|564736607|FG005|Second Booster|Death|0|||
156448667|NCT04927065|564736608|FG006|Second Booster|Death|0|||
156448668|NCT04927065|564736609|FG007|Second Booster|Death|0|||
156448669|NCT04927065|564736610|FG008|Second Booster|Death|0|||
156717503|NCT00970593|565711640|FG000|Overall Study|Discontinuation of study by sponsor|0|||
156717504|NCT00970593|565711641|FG001|Overall Study|Discontinuation of study by sponsor|0|||
156717505|NCT00970593|565711642|FG002|Overall Study|Discontinuation of study by sponsor|5|||
156717506|NCT00970593|565711643|FG003|Overall Study|Discontinuation of study by sponsor|0|||
156717507|NCT00970593|565711644|FG004|Overall Study|Discontinuation of study by sponsor|0|||
156717508|NCT00970593|565711645|FG005|Overall Study|Discontinuation of study by sponsor|0|||
156717509|NCT00970593|565711646|FG006|Overall Study|Discontinuation of study by sponsor|2|||
156717510|NCT00970593|565711640|FG000|Overall Study|Withdrawal by Subject|0|||
156717511|NCT00970593|565711641|FG001|Overall Study|Withdrawal by Subject|0|||
156448670|NCT04927065|564736611|FG009|Second Booster|Death|0|||
156448671|NCT04927065|564736612|FG010|Second Booster|Death|2|||
156448672|NCT04927065|564736613|FG011|Second Booster|Death|0|||
156448673|NCT04927065|564736614|FG012|Second Booster|Death|2|||
156448674|NCT04927065|564736615|FG013|Second Booster|Death|2|||
156448675|NCT04927065|564736616|FG014|Second Booster|Death|0|||
156448676|NCT04927065|564736617|FG015|Second Booster|Death|0|||
156448677|NCT04927065|564736602|FG000|Second Booster|Lost to Follow-up|0|||
156448678|NCT04927065|564736603|FG001|Second Booster|Lost to Follow-up|0|||
156448679|NCT04927065|564736604|FG002|Second Booster|Lost to Follow-up|3|||
156448680|NCT04927065|564736605|FG003|Second Booster|Lost to Follow-up|0|||
156448681|NCT04927065|564736606|FG004|Second Booster|Lost to Follow-up|0|||
156448682|NCT04927065|564736607|FG005|Second Booster|Lost to Follow-up|0|||
156448683|NCT04927065|564736608|FG006|Second Booster|Lost to Follow-up|0|||
156448684|NCT04927065|564736609|FG007|Second Booster|Lost to Follow-up|0|||
156448685|NCT04927065|564736610|FG008|Second Booster|Lost to Follow-up|0|||
156448686|NCT04927065|564736611|FG009|Second Booster|Lost to Follow-up|0|||
156448687|NCT04927065|564736612|FG010|Second Booster|Lost to Follow-up|14|||
156448688|NCT04927065|564736613|FG011|Second Booster|Lost to Follow-up|10|||
156448689|NCT04927065|564736614|FG012|Second Booster|Lost to Follow-up|13|||
156448690|NCT04927065|564736615|FG013|Second Booster|Lost to Follow-up|16|||
156448691|NCT04927065|564736616|FG014|Second Booster|Lost to Follow-up|0|||
156448692|NCT04927065|564736617|FG015|Second Booster|Lost to Follow-up|0|||
156448693|NCT04927065|564736602|FG000|Second Booster|Physician Decision|0|||
156448694|NCT04927065|564736603|FG001|Second Booster|Physician Decision|0|||
156448695|NCT04927065|564736604|FG002|Second Booster|Physician Decision|0|||
156448696|NCT04927065|564736605|FG003|Second Booster|Physician Decision|0|||
156448697|NCT04927065|564736606|FG004|Second Booster|Physician Decision|0|||
156448698|NCT04927065|564736607|FG005|Second Booster|Physician Decision|0|||
156448699|NCT04927065|564736608|FG006|Second Booster|Physician Decision|0|||
156448700|NCT04927065|564736609|FG007|Second Booster|Physician Decision|0|||
156448701|NCT04927065|564736610|FG008|Second Booster|Physician Decision|0|||
156448702|NCT04927065|564736611|FG009|Second Booster|Physician Decision|0|||
156448703|NCT04927065|564736612|FG010|Second Booster|Physician Decision|0|||
156448704|NCT04927065|564736613|FG011|Second Booster|Physician Decision|3|||
156448705|NCT04927065|564736614|FG012|Second Booster|Physician Decision|0|||
156448706|NCT04927065|564736615|FG013|Second Booster|Physician Decision|1|||
156448707|NCT04927065|564736616|FG014|Second Booster|Physician Decision|0|||
156448708|NCT04927065|564736617|FG015|Second Booster|Physician Decision|0|||
156448709|NCT04927065|564736602|FG000|Second Booster|Withdrawal by Subject|0|||
156448710|NCT04927065|564736603|FG001|Second Booster|Withdrawal by Subject|0|||
156448711|NCT04927065|564736604|FG002|Second Booster|Withdrawal by Subject|4|||
156448712|NCT04927065|564736605|FG003|Second Booster|Withdrawal by Subject|0|||
156448713|NCT04927065|564736606|FG004|Second Booster|Withdrawal by Subject|0|||
156448714|NCT04927065|564736607|FG005|Second Booster|Withdrawal by Subject|0|||
156448715|NCT04927065|564736608|FG006|Second Booster|Withdrawal by Subject|0|||
156448716|NCT04927065|564736609|FG007|Second Booster|Withdrawal by Subject|0|||
156448717|NCT04927065|564736610|FG008|Second Booster|Withdrawal by Subject|0|||
156448718|NCT04927065|564736611|FG009|Second Booster|Withdrawal by Subject|0|||
156448719|NCT04927065|564736612|FG010|Second Booster|Withdrawal by Subject|3|||
156448720|NCT04927065|564736613|FG011|Second Booster|Withdrawal by Subject|16|||
156448721|NCT04927065|564736614|FG012|Second Booster|Withdrawal by Subject|13|||
156448722|NCT04927065|564736615|FG013|Second Booster|Withdrawal by Subject|9|||
156448723|NCT04927065|564736616|FG014|Second Booster|Withdrawal by Subject|0|||
156448724|NCT04927065|564736617|FG015|Second Booster|Withdrawal by Subject|0|||
156448725|NCT04927065|564736602|FG000|Second Booster|Other Than Specified|0|||
156448726|NCT04927065|564736603|FG001|Second Booster|Other Than Specified|0|||
156448727|NCT04927065|564736604|FG002|Second Booster|Other Than Specified|0|||
156448728|NCT04927065|564736605|FG003|Second Booster|Other Than Specified|0|||
156717512|NCT00970593|565711642|FG002|Overall Study|Withdrawal by Subject|1|||
156448729|NCT04927065|564736606|FG004|Second Booster|Other Than Specified|0|||
156448730|NCT04927065|564736607|FG005|Second Booster|Other Than Specified|0|||
156448731|NCT04927065|564736608|FG006|Second Booster|Other Than Specified|0|||
156448732|NCT04927065|564736609|FG007|Second Booster|Other Than Specified|0|||
156448733|NCT04927065|564736610|FG008|Second Booster|Other Than Specified|0|||
156448734|NCT04927065|564736611|FG009|Second Booster|Other Than Specified|0|||
156448735|NCT04927065|564736612|FG010|Second Booster|Other Than Specified|1|||
156448736|NCT04927065|564736613|FG011|Second Booster|Other Than Specified|1|||
156448737|NCT04927065|564736614|FG012|Second Booster|Other Than Specified|4|||
156448738|NCT04927065|564736615|FG013|Second Booster|Other Than Specified|0|||
156448739|NCT04927065|564736616|FG014|Second Booster|Other Than Specified|0|||
156717513|NCT00970593|565711643|FG003|Overall Study|Withdrawal by Subject|0|||
156717514|NCT00970593|565711644|FG004|Overall Study|Withdrawal by Subject|0|||
156717515|NCT00970593|565711645|FG005|Overall Study|Withdrawal by Subject|0|||
156717516|NCT00970593|565711646|FG006|Overall Study|Withdrawal by Subject|0|||
156717517|NCT02439216|565711653|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
156717518|NCT02439216|565711654|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717519|NCT02439216|565711655|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717520|NCT02439216|565711656|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717521|NCT02439216|565711657|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717522|NCT02439216|565711658|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717523|NCT02439216|565711659|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717524|NCT02439216|565711660|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717525|NCT02439216|565711661|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717526|NCT02439216|565711653|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717527|NCT02439216|565711654|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717528|NCT02439216|565711655|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717529|NCT02439216|565711656|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717530|NCT02439216|565711657|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717531|NCT02439216|565711658|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717532|NCT02439216|565711659|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717533|NCT02439216|565711660|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
156717534|NCT02439216|565711661|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717535|NCT02439216|565711653|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717536|NCT02439216|565711654|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717537|NCT02439216|565711655|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717538|NCT02439216|565711656|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717539|NCT02439216|565711657|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717540|NCT02439216|565711658|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717541|NCT02439216|565711659|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717542|NCT02439216|565711660|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
156717543|NCT02439216|565711661|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
156717544|NCT02439216|565711653|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717545|NCT02439216|565711654|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717546|NCT02439216|565711655|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156793568|NCT02916433|565996305|FG001|Overall Study|Withdrawal by Subject|0|||
156793569|NCT02916433|565996304|FG000|Overall Study|Physician Decision|1|||
156793570|NCT02916433|565996305|FG001|Overall Study|Physician Decision|0|||
156793571|NCT04616196|565997393|FG000|Overall Study|Progressive Disease|3|||
156793572|NCT04616196|565997394|FG001|Overall Study|Progressive Disease|0|||
156448740|NCT04927065|564736617|FG015|Second Booster|Other Than Specified|0|||
156448741|NCT04927065|564736602|FG000|Third Booster|Lost to Follow-up|0|||
156448742|NCT04927065|564736603|FG001|Third Booster|Lost to Follow-up|0|||
156448743|NCT04927065|564736604|FG002|Third Booster|Lost to Follow-up|0|||
156448744|NCT04927065|564736605|FG003|Third Booster|Lost to Follow-up|0|||
156448745|NCT04927065|564736606|FG004|Third Booster|Lost to Follow-up|0|||
156448746|NCT04927065|564736607|FG005|Third Booster|Lost to Follow-up|0|||
156448747|NCT04927065|564736608|FG006|Third Booster|Lost to Follow-up|0|||
156448748|NCT04927065|564736609|FG007|Third Booster|Lost to Follow-up|0|||
156448749|NCT04927065|564736610|FG008|Third Booster|Lost to Follow-up|0|||
156448750|NCT04927065|564736611|FG009|Third Booster|Lost to Follow-up|0|||
156448751|NCT04927065|564736612|FG010|Third Booster|Lost to Follow-up|0|||
156448752|NCT04927065|564736613|FG011|Third Booster|Lost to Follow-up|0|||
156448753|NCT04927065|564736614|FG012|Third Booster|Lost to Follow-up|0|||
156448754|NCT04927065|564736615|FG013|Third Booster|Lost to Follow-up|0|||
156448755|NCT04927065|564736616|FG014|Third Booster|Lost to Follow-up|0|||
156448756|NCT04927065|564736617|FG015|Third Booster|Lost to Follow-up|1|||
156448757|NCT04927065|564736602|FG000|Third Booster|Withdrawal by Subject|0|||
156448758|NCT04927065|564736603|FG001|Third Booster|Withdrawal by Subject|0|||
156448759|NCT04927065|564736604|FG002|Third Booster|Withdrawal by Subject|0|||
156448760|NCT04927065|564736605|FG003|Third Booster|Withdrawal by Subject|0|||
156448761|NCT04927065|564736606|FG004|Third Booster|Withdrawal by Subject|0|||
156448762|NCT04927065|564736607|FG005|Third Booster|Withdrawal by Subject|0|||
156448763|NCT04927065|564736608|FG006|Third Booster|Withdrawal by Subject|0|||
156533165|NCT00628251|565046869|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
156793573|NCT04616196|565997395|FG002|Overall Study|Progressive Disease|4|||
156793574|NCT04616196|565997396|FG003|Overall Study|Progressive Disease|1|||
156793575|NCT04616196|565997393|FG000|Overall Study|Death|2|||
156448764|NCT04927065|564736609|FG007|Third Booster|Withdrawal by Subject|0|||
156448765|NCT04927065|564736610|FG008|Third Booster|Withdrawal by Subject|0|||
156448766|NCT04927065|564736611|FG009|Third Booster|Withdrawal by Subject|0|||
156448767|NCT04927065|564736612|FG010|Third Booster|Withdrawal by Subject|0|||
156448768|NCT04927065|564736613|FG011|Third Booster|Withdrawal by Subject|0|||
156448769|NCT04927065|564736614|FG012|Third Booster|Withdrawal by Subject|0|||
156533166|NCT00628251|565046870|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
156533167|NCT00628251|565046868|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
156533168|NCT00628251|565046869|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
156533169|NCT00628251|565046870|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
156533170|NCT00628251|565046868|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
156533171|NCT00628251|565046869|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
156533172|NCT00628251|565046870|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
156533173|NCT00628251|565046868|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
156533174|NCT00628251|565046869|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
156533175|NCT00628251|565046870|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
156533176|NCT00728481|565046871|FG000|Overall Study|Withdrawal by Subject|0|||
156533177|NCT00728481|565046872|FG001|Overall Study|Withdrawal by Subject|1|||
156533178|NCT00728481|565046871|FG000|Overall Study|Adverse Event|0|||
156533179|NCT00728481|565046872|FG001|Overall Study|Adverse Event|1|||
156717547|NCT02439216|565711656|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717548|NCT02439216|565711657|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717549|NCT02439216|565711658|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717550|NCT02439216|565711659|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717551|NCT02439216|565711660|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717552|NCT02439216|565711661|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
156717553|NCT02439216|565711653|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717554|NCT02439216|565711654|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717555|NCT02439216|565711655|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717556|NCT02439216|565711656|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717557|NCT02439216|565711657|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156793576|NCT04616196|565997394|FG001|Overall Study|Death|4|||
156793577|NCT04616196|565997395|FG002|Overall Study|Death|1|||
156793578|NCT04616196|565997396|FG003|Overall Study|Death|0|||
156793579|NCT04616196|565997393|FG000|Overall Study|Withdrawal by Subject|0|||
156793580|NCT04616196|565997394|FG001|Overall Study|Withdrawal by Subject|2|||
156793581|NCT04616196|565997395|FG002|Overall Study|Withdrawal by Subject|0|||
156793582|NCT04616196|565997396|FG003|Overall Study|Withdrawal by Subject|0|||
156793583|NCT04616196|565997393|FG000|Overall Study|Lost to Follow-up|1|||
156793584|NCT04616196|565997394|FG001|Overall Study|Lost to Follow-up|0|||
156793585|NCT04616196|565997395|FG002|Overall Study|Lost to Follow-up|0|||
156793586|NCT04616196|565997396|FG003|Overall Study|Lost to Follow-up|0|||
156793587|NCT04616196|565997393|FG000|Overall Study|Sponsor request|2|||
156793588|NCT04616196|565997394|FG001|Overall Study|Sponsor request|1|||
156793589|NCT04616196|565997395|FG002|Overall Study|Sponsor request|1|||
156717558|NCT02439216|565711658|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717559|NCT02439216|565711659|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717560|NCT02439216|565711660|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
156717561|NCT02439216|565711661|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
156717562|NCT02094300|565711665|FG000|Overall Study|Death|7|||
156717563|NCT02094300|565711665|FG000|Overall Study|Lost to Follow-up|10|||
156717564|NCT02094300|565711665|FG000|Overall Study|Still be eligible for follow-up|3|||
156717565|NCT00470535|565711670|FG000|Overall Study|Disease Progression|13|||
156717566|NCT00470535|565711670|FG000|Overall Study|Withdrawal by Subject|1|||
156717567|NCT00470535|565711670|FG000|Overall Study|Adverse Event|1|||
156717568|NCT00470535|565711670|FG000|Overall Study|Death|1|||
156717569|NCT00470535|565711670|FG000|Overall Study|Other|2|||
156717570|NCT04123405|565711671|FG000|Overall Study|Adverse Event|1|||
156717571|NCT04123405|565711672|FG001|Overall Study|Adverse Event|2|||
156717572|NCT04123405|565711673|FG002|Overall Study|Adverse Event|3|||
156717573|NCT04123405|565711674|FG003|Overall Study|Adverse Event|3|||
156717574|NCT04123405|565711671|FG000|Overall Study|Exclusion criteria met|1|||
156717575|NCT04123405|565711672|FG001|Overall Study|Exclusion criteria met|2|||
156717576|NCT04123405|565711673|FG002|Overall Study|Exclusion criteria met|0|||
156717577|NCT04123405|565711674|FG003|Overall Study|Exclusion criteria met|2|||
156717578|NCT04123405|565711671|FG000|Overall Study|Withdrawal by Subject|1|||
156717579|NCT04123405|565711672|FG001|Overall Study|Withdrawal by Subject|3|||
156717580|NCT04123405|565711673|FG002|Overall Study|Withdrawal by Subject|0|||
156717581|NCT04123405|565711674|FG003|Overall Study|Withdrawal by Subject|2|||
156793590|NCT04616196|565997396|FG003|Overall Study|Sponsor request|2|||
156793591|NCT06790303|565997397|FG000|Overall Study|Study Terminated by sponsor|4|||
156717582|NCT04123405|565711671|FG000|Overall Study|Contact to subject lost|0|||
156717583|NCT04123405|565711672|FG001|Overall Study|Contact to subject lost|0|||
156793592|NCT06790303|565997397|FG000|Overall Study|Death|4|||
156793593|NCT02579759|565997403|FG000|Overall Study|Protocol Violation|2|||
156793594|NCT02579759|565997404|FG001|Overall Study|Protocol Violation|0|||
156793595|NCT02579759|565997405|FG002|Overall Study|Protocol Violation|0|||
156793596|NCT02579759|565997403|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
156448770|NCT04927065|564736615|FG013|Third Booster|Withdrawal by Subject|0|||
156448771|NCT04927065|564736616|FG014|Third Booster|Withdrawal by Subject|0|||
156448772|NCT04927065|564736617|FG015|Third Booster|Withdrawal by Subject|1|||
156448773|NCT03338790|564736623|FG000|Overall Study|Disease Progression|65|||
156717584|NCT04123405|565711673|FG002|Overall Study|Contact to subject lost|0|||
156717585|NCT04123405|565711674|FG003|Overall Study|Contact to subject lost|1|||
156717586|NCT04123405|565711671|FG000|Overall Study|screening failure|1|||
156717587|NCT04123405|565711672|FG001|Overall Study|screening failure|0|||
156717588|NCT04123405|565711673|FG002|Overall Study|screening failure|0|||
156717589|NCT04123405|565711674|FG003|Overall Study|screening failure|0|||
156717590|NCT01050530|565711675|FG000|Overall Study|Adverse Event|6|||
156717591|NCT01050530|565711676|FG001|Overall Study|Adverse Event|3|||
156717592|NCT01050530|565711675|FG000|Overall Study|Lack of Efficacy|1|||
156717593|NCT01050530|565711676|FG001|Overall Study|Lack of Efficacy|4|||
156717594|NCT01050530|565711675|FG000|Overall Study|Withdrawal by Subject|0|||
156717595|NCT01050530|565711676|FG001|Overall Study|Withdrawal by Subject|3|||
156717596|NCT01050530|565711675|FG000|Overall Study|Protocol Violation|1|||
156717597|NCT01050530|565711676|FG001|Overall Study|Protocol Violation|0|||
156717598|NCT00545714|565711677|FG000|Induction Phase (6 Months)|Physician Decision|3|||
156717599|NCT00545714|565711677|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
156717600|NCT00545714|565711677|FG000|Induction Phase (6 Months)|Disease Progression|1|||
156717601|NCT00545714|565711677|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
156717602|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
156717603|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
156717604|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
156793597|NCT02579759|565997404|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
156793598|NCT02579759|565997405|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
156793599|NCT02579759|565997403|FG000|Overall Study|BfArM hold|13|||
156793600|NCT02579759|565997404|FG001|Overall Study|BfArM hold|12|||
156793601|NCT02579759|565997405|FG002|Overall Study|BfArM hold|12|||
156793602|NCT02579759|565997403|FG000|Overall Study|Sponsor stopped Dose 2|0|||
156793603|NCT02579759|565997404|FG001|Overall Study|Sponsor stopped Dose 2|41|||
156793604|NCT02579759|565997405|FG002|Overall Study|Sponsor stopped Dose 2|0|||
156793605|NCT02579759|565997403|FG000|Overall Study|Non compliance|0|||
156793606|NCT02579759|565997404|FG001|Overall Study|Non compliance|1|||
156793607|NCT02579759|565997405|FG002|Overall Study|Non compliance|0|||
156793608|NCT02579759|565997403|FG000|Overall Study|Pregnancy|0|||
156793609|NCT02579759|565997404|FG001|Overall Study|Pregnancy|1|||
156793610|NCT02579759|565997405|FG002|Overall Study|Pregnancy|0|||
156793611|NCT02579759|565997403|FG000|Overall Study|Inclusion/exclusion criteria|0|||
156793612|NCT02579759|565997404|FG001|Overall Study|Inclusion/exclusion criteria|0|||
156793613|NCT02579759|565997405|FG002|Overall Study|Inclusion/exclusion criteria|1|||
156793614|NCT02579759|565997403|FG000|Overall Study|Adverse Event|4|||
156793615|NCT02579759|565997404|FG001|Overall Study|Adverse Event|3|||
156793616|NCT02579759|565997405|FG002|Overall Study|Adverse Event|1|||
156793617|NCT02579759|565997403|FG000|Overall Study|Withdrawal by Subject|3|||
156793618|NCT02579759|565997404|FG001|Overall Study|Withdrawal by Subject|3|||
156793619|NCT02579759|565997405|FG002|Overall Study|Withdrawal by Subject|5|||
156793620|NCT02579759|565997403|FG000|Overall Study|Lost to Follow-up|2|||
156793621|NCT02579759|565997404|FG001|Overall Study|Lost to Follow-up|2|||
156793622|NCT02579759|565997405|FG002|Overall Study|Lost to Follow-up|2|||
156793623|NCT00833703|565997408|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
156793624|NCT00833703|565997409|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
156793625|NCT01904279|565997412|FG000|Overall Study|Lack of Efficacy|2|||
156793626|NCT01904279|565997413|FG001|Overall Study|Lack of Efficacy|3|||
156793627|NCT01904279|565997412|FG000|Overall Study|Withdrawal by Subject|1|||
156793628|NCT01904279|565997413|FG001|Overall Study|Withdrawal by Subject|0|||
156793629|NCT03283241|565997421|FG000|Overall Study|Adverse Event|4|||
156793630|NCT03283241|565997422|FG001|Overall Study|Adverse Event|1|||
156793631|NCT03283241|565997421|FG000|Overall Study|Withdrawal by Subject|0|||
156793632|NCT03283241|565997422|FG001|Overall Study|Withdrawal by Subject|1|||
156448774|NCT03338790|564736624|FG001|Overall Study|Disease Progression|43|||
156448775|NCT03338790|564736625|FG002|Overall Study|Disease Progression|50|||
156717605|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
156717606|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
156717607|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Death|2|||
156793633|NCT03283241|565997421|FG000|Overall Study|Subject relocated to Finland|0|||
156793634|NCT03283241|565997422|FG001|Overall Study|Subject relocated to Finland|1|||
156793635|NCT05418426|565997423|FG000|Overall Study|Adverse Event|0|||
156793636|NCT05418426|565997424|FG001|Overall Study|Adverse Event|1|||
156793637|NCT05418426|565997425|FG002|Overall Study|Adverse Event|0|||
156793638|NCT05418426|565997423|FG000|Overall Study|Withdrawal by Subject|0|||
156793639|NCT05418426|565997424|FG001|Overall Study|Withdrawal by Subject|1|||
156793640|NCT05418426|565997425|FG002|Overall Study|Withdrawal by Subject|0|||
156793641|NCT05418426|565997423|FG000|Overall Study|Protocol Violation|0|||
156793642|NCT05418426|565997424|FG001|Overall Study|Protocol Violation|0|||
156793643|NCT05418426|565997425|FG002|Overall Study|Protocol Violation|1|||
156448776|NCT03338790|564736626|FG003|Overall Study|Disease Progression|37|||
156448777|NCT03338790|564736623|FG000|Overall Study|Study Drug Toxicity|9|||
156448778|NCT03338790|564736624|FG001|Overall Study|Study Drug Toxicity|8|||
156448779|NCT03338790|564736625|FG002|Overall Study|Study Drug Toxicity|15|||
156717608|NCT03889886|565711679|FG000|Overall Study|Other|0|||
156717609|NCT03889886|565711680|FG001|Overall Study|Other|1|||
156717610|NCT03889886|565711681|FG002|Overall Study|Other|0|||
156717611|NCT03889886|565711682|FG003|Overall Study|Other|1|||
156717612|NCT03889886|565711679|FG000|Overall Study|Withdrawal by Subject|0|||
156717613|NCT03889886|565711680|FG001|Overall Study|Withdrawal by Subject|0|||
156717614|NCT03889886|565711681|FG002|Overall Study|Withdrawal by Subject|1|||
156717615|NCT03889886|565711682|FG003|Overall Study|Withdrawal by Subject|0|||
156717616|NCT03889886|565711679|FG000|Overall Study|Adverse Event|0|||
156717617|NCT03889886|565711680|FG001|Overall Study|Adverse Event|0|||
156717618|NCT03889886|565711681|FG002|Overall Study|Adverse Event|0|||
156717619|NCT03889886|565711682|FG003|Overall Study|Adverse Event|6|||
156717620|NCT00276484|565711683|FG000|Overall Study|Adverse Event|4|||
156717621|NCT00276484|565711684|FG001|Overall Study|Adverse Event|7|||
156717622|NCT00276484|565711683|FG000|Overall Study|Lost to Follow-up|1|||
156717623|NCT00276484|565711684|FG001|Overall Study|Lost to Follow-up|1|||
156717624|NCT00276484|565711683|FG000|Overall Study|Protocol Violation|0|||
156717625|NCT00276484|565711684|FG001|Overall Study|Protocol Violation|1|||
156717626|NCT00276484|565711683|FG000|Overall Study|Withdrawal by Subject|4|||
156717627|NCT00276484|565711684|FG001|Overall Study|Withdrawal by Subject|3|||
156717628|NCT00276484|565711683|FG000|Overall Study|Could not take time off work|0|||
156717629|NCT00276484|565711684|FG001|Overall Study|Could not take time off work|1|||
156717630|NCT03347110|565711698|FG000|Overall Study|Other (Participant is incarcerated)|1|||
156717631|NCT03347110|565711698|FG000|Overall Study|Withdrawal by Subject|9|||
156717632|NCT03347110|565711698|FG000|Overall Study|Lost to Follow-up|1|||
156717633|NCT03347110|565711698|FG000|Overall Study|Lack of Efficacy|2|||
156717634|NCT03347110|565711698|FG000|Overall Study|Adverse Event, non-fatal|9|||
156717635|NCT00116779|565711699|FG000|Overall Study|Adverse Event|4|||
156717636|NCT00116779|565711700|FG001|Overall Study|Adverse Event|2|||
156717637|NCT00116779|565711699|FG000|Overall Study|Protocol Violation|1|||
156717638|NCT00116779|565711700|FG001|Overall Study|Protocol Violation|4|||
156717639|NCT00116779|565711699|FG000|Overall Study|Withdrawal by Subject|4|||
156717640|NCT00116779|565711700|FG001|Overall Study|Withdrawal by Subject|1|||
156717641|NCT00116779|565711699|FG000|Overall Study|Inadequate testosterone suppression|7|||
156717642|NCT00116779|565711700|FG001|Overall Study|Inadequate testosterone suppression|9|||
156717643|NCT00116779|565711699|FG000|Overall Study|Physician Decision|3|||
156717644|NCT00116779|565711700|FG001|Overall Study|Physician Decision|1|||
156717645|NCT00116779|565711699|FG000|Overall Study|Elevated PSA levels|2|||
156717646|NCT00116779|565711700|FG001|Overall Study|Elevated PSA levels|2|||
156717647|NCT00707239|565711701|FG000|Overall Study|Adverse Event|5|||
156717648|NCT00707239|565711702|FG001|Overall Study|Adverse Event|3|||
156717649|NCT00707239|565711703|FG002|Overall Study|Adverse Event|2|||
156717650|NCT00707239|565711701|FG000|Overall Study|Death|3|||
156717651|NCT00707239|565711702|FG001|Overall Study|Death|1|||
156717652|NCT00707239|565711703|FG002|Overall Study|Death|3|||
156717653|NCT00707239|565711701|FG000|Overall Study|Physician Decision|1|||
156717654|NCT00707239|565711702|FG001|Overall Study|Physician Decision|1|||
156717655|NCT00707239|565711703|FG002|Overall Study|Physician Decision|2|||
156717656|NCT00707239|565711701|FG000|Overall Study|Protocol Violation|0|||
156717657|NCT00707239|565711702|FG001|Overall Study|Protocol Violation|0|||
156717658|NCT00707239|565711703|FG002|Overall Study|Protocol Violation|1|||
156717659|NCT00707239|565711701|FG000|Overall Study|Lack of Efficacy|1|||
156717660|NCT00707239|565711702|FG001|Overall Study|Lack of Efficacy|2|||
156717661|NCT00707239|565711703|FG002|Overall Study|Lack of Efficacy|0|||
156717662|NCT00707239|565711701|FG000|Overall Study|Randomized, but not treated|1|||
156717663|NCT00707239|565711702|FG001|Overall Study|Randomized, but not treated|1|||
156717664|NCT00707239|565711703|FG002|Overall Study|Randomized, but not treated|1|||
156717665|NCT00707239|565711701|FG000|Overall Study|Other|8|||
156717666|NCT00707239|565711702|FG001|Overall Study|Other|3|||
156717667|NCT00707239|565711703|FG002|Overall Study|Other|5|||
156717668|NCT03652051|565711704|FG000|Stage 1|Adverse Event|0|||
156717669|NCT03652051|565711705|FG001|Stage 1|Adverse Event|5|||
156875014|NCT00485134|566300600|FG001|Overall Study|Non-compliance|0|||
156448780|NCT03338790|564736626|FG003|Overall Study|Study Drug Toxicity|0|||
156448781|NCT03338790|564736623|FG000|Overall Study|Death|1|||
156448782|NCT03338790|564736624|FG001|Overall Study|Death|1|||
156448783|NCT03338790|564736625|FG002|Overall Study|Death|1|||
156717670|NCT03652051|565711706|FG002|Stage 1|Adverse Event|7|||
156717671|NCT03652051|565711707|FG003|Stage 1|Adverse Event|1|||
156717672|NCT03652051|565711704|FG000|Stage 1|Withdrawal by Subject|0|||
156717673|NCT03652051|565711705|FG001|Stage 1|Withdrawal by Subject|0|||
156717674|NCT03652051|565711706|FG002|Stage 1|Withdrawal by Subject|1|||
156717675|NCT03652051|565711707|FG003|Stage 1|Withdrawal by Subject|0|||
156717676|NCT03652051|565711704|FG000|Stage 2|Adverse Event|0|||
156717677|NCT03652051|565711705|FG001|Stage 2|Adverse Event|2|||
156717678|NCT03652051|565711706|FG002|Stage 2|Adverse Event|1|||
156717679|NCT03652051|565711707|FG003|Stage 2|Adverse Event|0|||
156717680|NCT03652051|565711704|FG000|Stage 2|Protocol Violation|0|||
156717681|NCT03652051|565711705|FG001|Stage 2|Protocol Violation|1|||
156717682|NCT03652051|565711706|FG002|Stage 2|Protocol Violation|6|||
156717683|NCT03652051|565711707|FG003|Stage 2|Protocol Violation|0|||
156717684|NCT03652051|565711704|FG000|Stage 2|Lost to Follow-up|0|||
156717685|NCT03652051|565711705|FG001|Stage 2|Lost to Follow-up|2|||
156717686|NCT03652051|565711706|FG002|Stage 2|Lost to Follow-up|0|||
156717687|NCT03652051|565711707|FG003|Stage 2|Lost to Follow-up|3|||
156717688|NCT03652051|565711704|FG000|Stage 2|Withdrawal by Subject|0|||
156717689|NCT03652051|565711705|FG001|Stage 2|Withdrawal by Subject|11|||
156717690|NCT03652051|565711706|FG002|Stage 2|Withdrawal by Subject|9|||
156717691|NCT03652051|565711707|FG003|Stage 2|Withdrawal by Subject|3|||
156717692|NCT02569801|565711708|FG000|Overall Study|Withdrawal by Subject|9|||
156717693|NCT02569801|565711709|FG001|Overall Study|Withdrawal by Subject|9|||
156717694|NCT02569801|565711708|FG000|Overall Study|Sponsor Decision|13|||
156717695|NCT02569801|565711709|FG001|Overall Study|Sponsor Decision|14|||
156717696|NCT02569801|565711708|FG000|Overall Study|Progressive Disease|2|||
156717697|NCT02569801|565711709|FG001|Overall Study|Progressive Disease|7|||
156717698|NCT02569801|565711708|FG000|Overall Study|Lost to Follow-up|0|||
156717699|NCT02569801|565711709|FG001|Overall Study|Lost to Follow-up|1|||
156717700|NCT02569801|565711708|FG000|Overall Study|Death|12|||
156717701|NCT02569801|565711709|FG001|Overall Study|Death|4|||
156717702|NCT00948155|565711712|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
156717703|NCT00948155|565711713|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
156717704|NCT00948155|565711712|FG000|Washout 14 Days|Lost to Follow-up|1|||
156717705|NCT00948155|565711713|FG001|Washout 14 Days|Lost to Follow-up|2|||
156717706|NCT03404674|565711714|FG000|Overall Study|Inability to Attend Future Visits|0|||
156533180|NCT00728481|565046871|FG000|Overall Study|Study medication non-compliance|0|||
156533181|NCT00728481|565046872|FG001|Overall Study|Study medication non-compliance|2|||
156533182|NCT00728481|565046871|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
156533183|NCT00728481|565046872|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
156533184|NCT01272947|565046873|FG000|Overall Study|Abnormal Laboratory Value|2|||
156533185|NCT01272947|565046874|FG001|Overall Study|Abnormal Laboratory Value|2|||
156533186|NCT02019420|565046875|FG000|Overall Study|Did not receive study drug|2|||
156533187|NCT02019420|565046876|FG001|Overall Study|Did not receive study drug|2|||
156533188|NCT02019420|565046875|FG000|Overall Study|Withdrawal by Subject|1|||
156533189|NCT02019420|565046876|FG001|Overall Study|Withdrawal by Subject|3|||
156533190|NCT02019420|565046875|FG000|Overall Study|At request of sponsor or investigator|0|||
156533191|NCT02019420|565046876|FG001|Overall Study|At request of sponsor or investigator|1|||
156533192|NCT02019420|565046875|FG000|Overall Study|Death|104|||
156717707|NCT03404674|565711715|FG001|Overall Study|Inability to Attend Future Visits|1|||
156717708|NCT03404674|565711716|FG002|Overall Study|Inability to Attend Future Visits|1|||
156717709|NCT03404674|565711717|FG003|Overall Study|Inability to Attend Future Visits|0|||
156717710|NCT03404674|565711718|FG004|Overall Study|Inability to Attend Future Visits|0|||
156717711|NCT03404674|565711719|FG005|Overall Study|Inability to Attend Future Visits|0|||
156717712|NCT03404674|565711714|FG000|Overall Study|Behavioral Problems|0|||
156717713|NCT03404674|565711715|FG001|Overall Study|Behavioral Problems|0|||
156717714|NCT03404674|565711716|FG002|Overall Study|Behavioral Problems|1|||
156717715|NCT03404674|565711717|FG003|Overall Study|Behavioral Problems|0|||
156717716|NCT03404674|565711718|FG004|Overall Study|Behavioral Problems|0|||
156717717|NCT03404674|565711719|FG005|Overall Study|Behavioral Problems|0|||
156717718|NCT03404674|565711714|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
156717719|NCT03404674|565711715|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
156717720|NCT03404674|565711716|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
156717721|NCT03404674|565711717|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
156717722|NCT03404674|565711718|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
156793644|NCT04126174|565997430|FG000|Overall Study|Lost to Follow-up|3|||
156793645|NCT04126174|565997431|FG001|Overall Study|Lost to Follow-up|3|||
156793646|NCT03131479|565997442|FG000|Overall Study|Adverse Event|0|||
156793647|NCT03131479|565997443|FG001|Overall Study|Adverse Event|0|||
156793648|NCT03131479|565997444|FG002|Overall Study|Adverse Event|1|||
156793649|NCT03131479|565997445|FG003|Overall Study|Adverse Event|1|||
156533193|NCT02019420|565046876|FG001|Overall Study|Death|99|||
156717723|NCT03404674|565711719|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
156717724|NCT02635984|565711724|FG000|Overall Study|Lost to Follow-up|2|||
156717725|NCT02635984|565711725|FG001|Overall Study|Lost to Follow-up|4|||
156717726|NCT02635984|565711724|FG000|Overall Study|Study Arm Closed|1|||
156717727|NCT02635984|565711725|FG001|Overall Study|Study Arm Closed|0|||
156793650|NCT03131479|565997446|FG004|Overall Study|Adverse Event|0|||
156793651|NCT03131479|565997442|FG000|Overall Study|Subject/Guardian Decision|0|||
156717728|NCT01487525|565711728|FG000|Overall Study|Withdrawal by Subject|0|||
156717729|NCT01487525|565711729|FG001|Overall Study|Withdrawal by Subject|1|||
156717730|NCT01640249|565711730|FG000|Period 1|Withdrawal by Subject|1|||
156793652|NCT03131479|565997443|FG001|Overall Study|Subject/Guardian Decision|0|||
156793653|NCT03131479|565997444|FG002|Overall Study|Subject/Guardian Decision|0|||
156793654|NCT03131479|565997445|FG003|Overall Study|Subject/Guardian Decision|1|||
156717731|NCT01640249|565711731|FG001|Period 1|Withdrawal by Subject|0|||
156717732|NCT01640249|565711732|FG002|Period 1|Withdrawal by Subject|0|||
156717733|NCT01640249|565711733|FG003|Period 1|Withdrawal by Subject|0|||
156717734|NCT01640249|565711734|FG004|Period 1|Withdrawal by Subject|0|||
156717735|NCT01640249|565711735|FG005|Period 1|Withdrawal by Subject|1|||
156717736|NCT01640249|565711736|FG006|Period 1|Withdrawal by Subject|0|||
156717737|NCT01870778|565711738|FG000|Overall Study|Withdrawal by Subject|8|||
156717738|NCT01870778|565711739|FG001|Overall Study|Withdrawal by Subject|7|||
156717739|NCT01870778|565711738|FG000|Overall Study|Lost to Follow-up|0|||
156717740|NCT01870778|565711739|FG001|Overall Study|Lost to Follow-up|2|||
156717741|NCT00312338|565711740|FG000|Overall Study|Adverse Event|7|||
156717742|NCT00312338|565711741|FG001|Overall Study|Adverse Event|2|||
156717743|NCT00312338|565711740|FG000|Overall Study|Lost to Follow-up|9|||
156717744|NCT00312338|565711741|FG001|Overall Study|Lost to Follow-up|1|||
156717745|NCT00312338|565711740|FG000|Overall Study|Withdrawal by Subject|4|||
156717746|NCT00312338|565711741|FG001|Overall Study|Withdrawal by Subject|0|||
156717747|NCT00312338|565711740|FG000|Overall Study|Subsequent infection|2|||
156717748|NCT00312338|565711741|FG001|Overall Study|Subsequent infection|0|||
156717749|NCT00100828|565711742|FG000|Overall Study|Physician Decision|6|||
156717750|NCT03518008|565711743|FG000|Period 2, Second Week of Wear|Family emergency|0|||
156717751|NCT03518008|565711744|FG001|Period 2, Second Week of Wear|Family emergency|1|||
156717752|NCT01215136|565711745|FG000|Overall Study|Adverse Event|2|||
156717753|NCT01215136|565711746|FG001|Overall Study|Adverse Event|9|||
156448784|NCT03338790|564736626|FG003|Overall Study|Death|0|||
156448785|NCT03338790|564736623|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
156448786|NCT03338790|564736624|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
156448787|NCT03338790|564736625|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
156448788|NCT03338790|564736626|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
156448789|NCT03338790|564736623|FG000|Overall Study|Participant request to discontinue study treatment|3|||
156448790|NCT03338790|564736624|FG001|Overall Study|Participant request to discontinue study treatment|3|||
156448791|NCT03338790|564736625|FG002|Overall Study|Participant request to discontinue study treatment|2|||
156717754|NCT01215136|565711745|FG000|Overall Study|Disease Progression|3|||
156717755|NCT01215136|565711746|FG001|Overall Study|Disease Progression|14|||
156717756|NCT01215136|565711745|FG000|Overall Study|Symptomatic Deterioration|1|||
156717757|NCT01215136|565711746|FG001|Overall Study|Symptomatic Deterioration|1|||
156717758|NCT01215136|565711745|FG000|Overall Study|Death|0|||
156717759|NCT01215136|565711746|FG001|Overall Study|Death|2|||
156717760|NCT01215136|565711745|FG000|Overall Study|Withdrawal by Subject|0|||
156717761|NCT01215136|565711746|FG001|Overall Study|Withdrawal by Subject|1|||
156717762|NCT01125917|565711751|FG000|Overall Study|Adverse Event|43|||
156717763|NCT01125917|565711751|FG000|Overall Study|Lost to Follow-up|23|||
156717764|NCT01125917|565711751|FG000|Overall Study|Withdrawal by Subject|31|||
156717765|NCT01125917|565711751|FG000|Overall Study|Administrative|223|||
156717766|NCT01125917|565711751|FG000|Overall Study|Lack of Efficacy|19|||
156717767|NCT04421131|565711755|FG000|Overall Study|Lost to Follow-up|1|||
156717768|NCT04421131|565711755|FG000|Overall Study|Protocol Violation|2|||
156717769|NCT04421131|565711755|FG000|Overall Study|App crashed|5|||
156717770|NCT02308124|565711756|FG000|Overall Study|Lost to Follow-up|6|||
156717771|NCT02308124|565711757|FG001|Overall Study|Lost to Follow-up|6|||
156717772|NCT02308124|565711758|FG002|Overall Study|Lost to Follow-up|6|||
156717773|NCT02308124|565711756|FG000|Overall Study|Adverse Event|0|||
156717774|NCT02308124|565711757|FG001|Overall Study|Adverse Event|2|||
156717775|NCT02308124|565711758|FG002|Overall Study|Adverse Event|2|||
156717776|NCT02501928|565711763|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156717777|NCT02501928|565711764|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
156717778|NCT02501928|565711765|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
156717779|NCT02501928|565711766|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
156717780|NCT02501928|565711767|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
156717781|NCT02501928|565711768|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
156717782|NCT01526057|565711772|FG000|Overall Study|Withdrawal by Subject|3|||
156717783|NCT01526057|565711773|FG001|Overall Study|Withdrawal by Subject|2|||
156717784|NCT01526057|565711774|FG002|Overall Study|Withdrawal by Subject|2|||
156717785|NCT01526057|565711772|FG000|Overall Study|Adverse Event|3|||
156717786|NCT01526057|565711773|FG001|Overall Study|Adverse Event|1|||
156717787|NCT01526057|565711774|FG002|Overall Study|Adverse Event|1|||
156717788|NCT01526057|565711772|FG000|Overall Study|Death|1|||
156717789|NCT01526057|565711773|FG001|Overall Study|Death|0|||
156448792|NCT03338790|564736626|FG003|Overall Study|Participant request to discontinue study treatment|1|||
156448793|NCT03338790|564736623|FG000|Overall Study|Poor/non-compliance|0|||
156448794|NCT03338790|564736624|FG001|Overall Study|Poor/non-compliance|1|||
156533194|NCT02019420|565046875|FG000|Overall Study|Transferred to other care facility|1|||
156717790|NCT01526057|565711774|FG002|Overall Study|Death|0|||
156717791|NCT01526057|565711772|FG000|Overall Study|Lost to Follow-up|1|||
156717792|NCT01526057|565711773|FG001|Overall Study|Lost to Follow-up|0|||
156717793|NCT01526057|565711774|FG002|Overall Study|Lost to Follow-up|1|||
156717794|NCT01526057|565711772|FG000|Overall Study|Other|1|||
156717795|NCT01526057|565711773|FG001|Overall Study|Other|0|||
156717796|NCT01526057|565711774|FG002|Overall Study|Other|1|||
156717797|NCT01526057|565711772|FG000|Overall Study|Protocol Violation|0|||
156717798|NCT01526057|565711773|FG001|Overall Study|Protocol Violation|0|||
156717799|NCT01526057|565711774|FG002|Overall Study|Protocol Violation|1|||
156717800|NCT02553772|565711776|FG000|Overall Study|Adverse Event|2|||
156717801|NCT02553772|565711777|FG001|Overall Study|Adverse Event|3|||
156717802|NCT02553772|565711776|FG000|Overall Study|Lost to Follow-up|2|||
156717803|NCT02553772|565711777|FG001|Overall Study|Lost to Follow-up|1|||
156717804|NCT02553772|565711776|FG000|Overall Study|Withdrawal of Consent|1|||
156717805|NCT02553772|565711777|FG001|Overall Study|Withdrawal of Consent|1|||
156717806|NCT02553772|565711776|FG000|Overall Study|Lack of Efficacy|1|||
156717807|NCT02553772|565711777|FG001|Overall Study|Lack of Efficacy|0|||
156717808|NCT02553772|565711776|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156717809|NCT02553772|565711777|FG001|Overall Study|Other Miscellaneous Reasons|1|||
156717810|NCT02189837|565711783|FG000|Overall Study|Withdrawal by Subject|2|||
156717811|NCT02189837|565711784|FG001|Overall Study|Withdrawal by Subject|1|||
156717812|NCT02189837|565711785|FG002|Overall Study|Withdrawal by Subject|3|||
156717813|NCT02189837|565711786|FG003|Overall Study|Withdrawal by Subject|1|||
156717814|NCT02189837|565711783|FG000|Overall Study|Sponsor Decision|0|||
156717815|NCT02189837|565711784|FG001|Overall Study|Sponsor Decision|0|||
156717816|NCT02189837|565711785|FG002|Overall Study|Sponsor Decision|0|||
156717817|NCT02189837|565711786|FG003|Overall Study|Sponsor Decision|1|||
156717818|NCT01461538|565711790|FG000|Overall Study|Death|15|||
156717819|NCT01461538|565711791|FG001|Overall Study|Death|6|||
156717820|NCT01461538|565711792|FG002|Overall Study|Death|2|||
156717821|NCT01461538|565711790|FG000|Overall Study|Study Stopped by Sponsor|2|||
156717822|NCT01461538|565711791|FG001|Overall Study|Study Stopped by Sponsor|1|||
156717823|NCT01461538|565711792|FG002|Overall Study|Study Stopped by Sponsor|0|||
156717824|NCT01461538|565711790|FG000|Overall Study|Withdrawal by Subject|1|||
156717825|NCT01461538|565711791|FG001|Overall Study|Withdrawal by Subject|1|||
156717826|NCT01461538|565711792|FG002|Overall Study|Withdrawal by Subject|0|||
156717827|NCT04796961|565713307|FG000|Overall Study|Lost to Follow-up|10|||
156717828|NCT04796961|565713307|FG000|Overall Study|Withdrawal by Subject|3|||
156717829|NCT04796961|565713307|FG000|Overall Study|Left Organization|10|||
156717830|NCT05655546|565713308|FG000|Overall Study|Withdrawal by Subject|2|||
156717831|NCT05655546|565713309|FG001|Overall Study|Withdrawal by Subject|4|||
156717832|NCT03493685|565713310|FG000|Overall Study|Death|4|||
156717833|NCT03493685|565713311|FG001|Overall Study|Death|3|||
156717834|NCT03493685|565713310|FG000|Overall Study|Lost to Follow-up|3|||
156717835|NCT03493685|565713311|FG001|Overall Study|Lost to Follow-up|2|||
156717836|NCT03493685|565713310|FG000|Overall Study|Physician Decision|2|||
156717837|NCT03493685|565713311|FG001|Overall Study|Physician Decision|0|||
156717838|NCT03493685|565713310|FG000|Overall Study|Withdrawal by Subject|7|||
156717839|NCT03493685|565713311|FG001|Overall Study|Withdrawal by Subject|11|||
156717840|NCT04452669|565713312|FG000|Overall Study|Death|1|||
156717841|NCT04452669|565713313|FG001|Overall Study|Death|4|||
156717842|NCT04576507|565713317|FG000|Overall Study|Adverse Event|4|||
156717843|NCT04576507|565713317|FG000|Overall Study|Withdrawal by Subject|1|||
156717844|NCT04653454|565713322|FG000|Overall Study|Withdrawal by Subject|1|||
156717845|NCT04653454|565713322|FG000|Overall Study|Physician Decision|40|||
156717846|NCT03657797|565713323|FG000|Overall Study|Lost to Follow-up|0|||
156717847|NCT03657797|565713324|FG001|Overall Study|Lost to Follow-up|1|||
156717848|NCT03657797|565713325|FG002|Overall Study|Lost to Follow-up|1|||
156717849|NCT03657797|565713326|FG003|Overall Study|Lost to Follow-up|0|||
156717850|NCT03657797|565713323|FG000|Overall Study|Physician Decision|0|||
156717851|NCT03657797|565713324|FG001|Overall Study|Physician Decision|1|||
156717852|NCT03657797|565713325|FG002|Overall Study|Physician Decision|0|||
156717853|NCT03657797|565713326|FG003|Overall Study|Physician Decision|0|||
156717854|NCT03657797|565713323|FG000|Overall Study|Withdrawal by Subject|0|||
156717855|NCT03657797|565713324|FG001|Overall Study|Withdrawal by Subject|1|||
156717856|NCT03657797|565713325|FG002|Overall Study|Withdrawal by Subject|2|||
156717857|NCT03657797|565713326|FG003|Overall Study|Withdrawal by Subject|0|||
156717858|NCT03657797|565713323|FG000|Overall Study|Adverse Event|0|||
156717859|NCT03657797|565713324|FG001|Overall Study|Adverse Event|0|||
156717860|NCT03657797|565713325|FG002|Overall Study|Adverse Event|2|||
156717861|NCT03657797|565713326|FG003|Overall Study|Adverse Event|0|||
156717862|NCT03103087|565713327|FG000|Overall Study|Did not receive any study drug|1|||
156717863|NCT03103087|565713328|FG001|Overall Study|Did not receive any study drug|0|||
156717864|NCT03103087|565713329|FG002|Overall Study|Did not receive any study drug|0|||
156717865|NCT03103087|565713327|FG000|Overall Study|Protocol Violation|1|||
156717866|NCT03103087|565713328|FG001|Overall Study|Protocol Violation|2|||
156717867|NCT03103087|565713329|FG002|Overall Study|Protocol Violation|1|||
156717868|NCT03103087|565713327|FG000|Overall Study|Lack of Efficacy|2|||
156717869|NCT03103087|565713328|FG001|Overall Study|Lack of Efficacy|1|||
156717870|NCT03103087|565713329|FG002|Overall Study|Lack of Efficacy|1|||
156717871|NCT03103087|565713327|FG000|Overall Study|Pregnancy|0|||
156717872|NCT03103087|565713328|FG001|Overall Study|Pregnancy|0|||
156717873|NCT03103087|565713329|FG002|Overall Study|Pregnancy|1|||
156717874|NCT03103087|565713327|FG000|Overall Study|Adverse Event|2|||
156717875|NCT03103087|565713328|FG001|Overall Study|Adverse Event|15|||
156717876|NCT03103087|565713329|FG002|Overall Study|Adverse Event|6|||
156717877|NCT03103087|565713327|FG000|Overall Study|Withdrawal by Subject|13|||
156717878|NCT03103087|565713328|FG001|Overall Study|Withdrawal by Subject|6|||
156717879|NCT03103087|565713329|FG002|Overall Study|Withdrawal by Subject|6|||
156717880|NCT03103087|565713327|FG000|Overall Study|Lost to Follow-up|4|||
156717881|NCT03103087|565713328|FG001|Overall Study|Lost to Follow-up|2|||
156717882|NCT03103087|565713329|FG002|Overall Study|Lost to Follow-up|7|||
156717883|NCT03103087|565713327|FG000|Overall Study|Other reason not reported|1|||
156717884|NCT03103087|565713328|FG001|Overall Study|Other reason not reported|3|||
156717885|NCT03103087|565713329|FG002|Overall Study|Other reason not reported|5|||
156717886|NCT00413699|565713330|FG000|Initial Period|Death|25|||
156717887|NCT00413699|565713331|FG001|Initial Period|Death|30|||
156717888|NCT00413699|565713332|FG002|Initial Period|Death|0|||
156717889|NCT00413699|565713330|FG000|Initial Period|Lack of Efficacy|59|||
156717890|NCT00413699|565713331|FG001|Initial Period|Lack of Efficacy|115|||
156717891|NCT00413699|565713332|FG002|Initial Period|Lack of Efficacy|0|||
156717892|NCT00413699|565713330|FG000|Initial Period|Lost to Follow-up|31|||
156717893|NCT00413699|565713331|FG001|Initial Period|Lost to Follow-up|101|||
156717894|NCT00413699|565713332|FG002|Initial Period|Lost to Follow-up|0|||
156717895|NCT00413699|565713330|FG000|Initial Period|Protocol Violation|38|||
156717896|NCT00413699|565713331|FG001|Initial Period|Protocol Violation|89|||
156717897|NCT00413699|565713332|FG002|Initial Period|Protocol Violation|0|||
156717898|NCT00413699|565713330|FG000|Initial Period|Pregnancy|10|||
156717899|NCT00413699|565713331|FG001|Initial Period|Pregnancy|8|||
156717900|NCT00413699|565713332|FG002|Initial Period|Pregnancy|0|||
156717901|NCT00413699|565713330|FG000|Initial Period|Did not meet entrance criteria|2|||
156717902|NCT00413699|565713331|FG001|Initial Period|Did not meet entrance criteria|2|||
156717903|NCT00413699|565713332|FG002|Initial Period|Did not meet entrance criteria|0|||
156717904|NCT00413699|565713330|FG000|Initial Period|Medication error without adverse event|0|||
156448795|NCT03338790|564736625|FG002|Overall Study|Poor/non-compliance|0|||
156448796|NCT03338790|564736626|FG003|Overall Study|Poor/non-compliance|0|||
156448797|NCT03338790|564736623|FG000|Overall Study|Participant withdrew consent|1|||
156448798|NCT03338790|564736624|FG001|Overall Study|Participant withdrew consent|0|||
156448799|NCT03338790|564736625|FG002|Overall Study|Participant withdrew consent|1|||
156448800|NCT03338790|564736626|FG003|Overall Study|Participant withdrew consent|1|||
156448801|NCT03338790|564736623|FG000|Overall Study|Other reasons|0|||
156448802|NCT03338790|564736624|FG001|Overall Study|Other reasons|5|||
156448803|NCT03338790|564736625|FG002|Overall Study|Other reasons|0|||
156448804|NCT03338790|564736626|FG003|Overall Study|Other reasons|2|||
156448805|NCT03338790|564736623|FG000|Overall Study|Not reported|0|||
156448806|NCT03338790|564736624|FG001|Overall Study|Not reported|0|||
156448807|NCT03338790|564736625|FG002|Overall Study|Not reported|1|||
156448808|NCT03338790|564736626|FG003|Overall Study|Not reported|0|||
156448809|NCT03338790|564736623|FG000|Overall Study|Completed treatment period|1|||
156448810|NCT03338790|564736624|FG001|Overall Study|Completed treatment period|2|||
156448811|NCT03338790|564736625|FG002|Overall Study|Completed treatment period|0|||
156448812|NCT03338790|564736626|FG003|Overall Study|Completed treatment period|0|||
156448813|NCT03846505|564736627|FG000|Treatment Phase|Withdrawal by Subject|9|||
156448814|NCT03846505|564736628|FG001|Treatment Phase|Withdrawal by Subject|11|||
156448815|NCT03846505|564736627|FG000|Treatment Phase|Lost to Follow-up|6|||
156448816|NCT03846505|564736628|FG001|Treatment Phase|Lost to Follow-up|2|||
156448817|NCT03846505|564736627|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
156448818|NCT03846505|564736628|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
156448819|NCT03846505|564736627|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
156448820|NCT03846505|564736628|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
156448821|NCT00601900|564736629|FG000|Overall Study|Withdrawal by Subject|0|||
156448822|NCT00601900|564736630|FG001|Overall Study|Withdrawal by Subject|3|||
156448823|NCT03924986|564736631|FG000|Overall Study|Death|57|||
156448824|NCT03924986|564736632|FG001|Overall Study|Death|66|||
156448825|NCT03924986|564736631|FG000|Overall Study|Study Concluded by Sponsor|51|||
156448826|NCT03924986|564736632|FG001|Overall Study|Study Concluded by Sponsor|41|||
156448827|NCT03924986|564736631|FG000|Overall Study|Withdrawal by Subject|15|||
156448828|NCT03924986|564736632|FG001|Overall Study|Withdrawal by Subject|20|||
156448829|NCT03924986|564736631|FG000|Overall Study|Lost to Follow-up|7|||
156717905|NCT00413699|565713331|FG001|Initial Period|Medication error without adverse event|1|||
156717906|NCT00413699|565713332|FG002|Initial Period|Medication error without adverse event|0|||
156717907|NCT00413699|565713330|FG000|Initial Period|Study terminated by Sponsor|0|||
156717908|NCT00413699|565713331|FG001|Initial Period|Study terminated by Sponsor|1|||
156717909|NCT00413699|565713332|FG002|Initial Period|Study terminated by Sponsor|0|||
156717910|NCT00413699|565713330|FG000|Initial Period|Other|67|||
156448830|NCT03924986|564736632|FG001|Overall Study|Lost to Follow-up|5|||
156448831|NCT03924986|564736631|FG000|Overall Study|Miscellaneous|1|||
156448832|NCT03924986|564736632|FG001|Overall Study|Miscellaneous|0|||
156448833|NCT05592418|564736638|FG000|Overall Study|Adverse Event|1|||
156448834|NCT05592418|564736639|FG001|Overall Study|Adverse Event|0|||
156448835|NCT05592418|564736638|FG000|Overall Study|Lost to Follow-up|1|||
156717911|NCT00413699|565713331|FG001|Initial Period|Other|211|||
156448836|NCT05592418|564736639|FG001|Overall Study|Lost to Follow-up|3|||
156448837|NCT05592418|564736638|FG000|Overall Study|Withdrawal by Subject|2|||
156448838|NCT05592418|564736639|FG001|Overall Study|Withdrawal by Subject|7|||
156448839|NCT01494662|564736642|FG000|Overall Study|Withdrawal by Subject|0|||
156448840|NCT01494662|564736643|FG001|Overall Study|Withdrawal by Subject|0|||
156448841|NCT01494662|564736644|FG002|Overall Study|Withdrawal by Subject|1|||
156448842|NCT01494662|564736645|FG003|Overall Study|Withdrawal by Subject|0|||
156448843|NCT01494662|564736646|FG004|Overall Study|Withdrawal by Subject|0|||
156448844|NCT01494662|564736647|FG005|Overall Study|Withdrawal by Subject|0|||
156448845|NCT01494662|564736648|FG006|Overall Study|Withdrawal by Subject|0|||
156448846|NCT01494662|564736642|FG000|Overall Study|Physician Decision|0|||
156448847|NCT01494662|564736643|FG001|Overall Study|Physician Decision|0|||
156448848|NCT01494662|564736644|FG002|Overall Study|Physician Decision|1|||
156448849|NCT01494662|564736645|FG003|Overall Study|Physician Decision|0|||
156717912|NCT00413699|565713332|FG002|Initial Period|Other|0|||
156717913|NCT00413699|565713330|FG000|Initial Period|Adverse event related to study drug|178|||
156717914|NCT00413699|565713331|FG001|Initial Period|Adverse event related to study drug|527|||
156717915|NCT00413699|565713332|FG002|Initial Period|Adverse event related to study drug|0|||
156717916|NCT00413699|565713330|FG000|Initial Period|Adverse event not related to study drug|113|||
156717917|NCT00413699|565713331|FG001|Initial Period|Adverse event not related to study drug|248|||
156717918|NCT00413699|565713332|FG002|Initial Period|Adverse event not related to study drug|0|||
156717919|NCT00413699|565713330|FG000|Initial Period|Missing end of study page|0|||
156717920|NCT00413699|565713331|FG001|Initial Period|Missing end of study page|4|||
156717921|NCT00413699|565713332|FG002|Initial Period|Missing end of study page|0|||
156717922|NCT00413699|565713330|FG000|Initial Period|No longer willing to participate|116|||
156717923|NCT00413699|565713331|FG001|Initial Period|No longer willing to participate|368|||
156717924|NCT00413699|565713332|FG002|Initial Period|No longer willing to participate|0|||
156717925|NCT00413699|565713330|FG000|Extension Period|No Longer Willing to Participate|0|||
156717926|NCT00413699|565713331|FG001|Extension Period|No Longer Willing to Participate|0|||
156717927|NCT00413699|565713332|FG002|Extension Period|No Longer Willing to Participate|2|||
156717928|NCT00413699|565713330|FG000|Extension Period|Protocol Violation|0|||
156717929|NCT00413699|565713331|FG001|Extension Period|Protocol Violation|0|||
156717930|NCT00413699|565713332|FG002|Extension Period|Protocol Violation|1|||
156717931|NCT00413699|565713330|FG000|Extension Period|Adverse Event|0|||
156717932|NCT00413699|565713331|FG001|Extension Period|Adverse Event|0|||
156717933|NCT00413699|565713332|FG002|Extension Period|Adverse Event|2|||
156717934|NCT02115269|565713333|FG000|Overall Study|Lost to Follow-up|43|||
156717935|NCT02115269|565713333|FG000|Overall Study|Did not complete patient diary|3|||
156717936|NCT02115269|565713333|FG000|Overall Study|Moved to another city|7|||
156717937|NCT02115269|565713333|FG000|Overall Study|Withdrawal by Subject|2|||
156717938|NCT02115269|565713333|FG000|Overall Study|Didn't take study drug|2|||
156717939|NCT00711243|565713335|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
156717940|NCT00711243|565713336|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
156717941|NCT00711243|565713337|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
156717942|NCT00711243|565713338|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
156717943|NCT00711243|565713339|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
156717944|NCT00711243|565713340|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
156717945|NCT00711243|565713335|FG000|Reached First Response/4 Cycles|Death|0|||
156717946|NCT00711243|565713336|FG001|Reached First Response/4 Cycles|Death|0|||
156717947|NCT00711243|565713337|FG002|Reached First Response/4 Cycles|Death|0|||
156717948|NCT00711243|565713338|FG003|Reached First Response/4 Cycles|Death|0|||
156717949|NCT00711243|565713339|FG004|Reached First Response/4 Cycles|Death|0|||
156717950|NCT00711243|565713340|FG005|Reached First Response/4 Cycles|Death|2|||
156717951|NCT00711243|565713335|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
156717952|NCT00711243|565713336|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
156717953|NCT00711243|565713337|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
156717954|NCT00711243|565713338|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
156717955|NCT00711243|565713339|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
156717956|NCT00711243|565713340|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
156717957|NCT00711243|565713335|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
156717958|NCT00711243|565713336|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
156717959|NCT00711243|565713337|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
156717960|NCT00711243|565713338|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
156717961|NCT00711243|565713339|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
156717962|NCT00711243|565713340|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
156717963|NCT00711243|565713335|FG000|Treated Cycle 5 After First Response|Death|0|||
156717964|NCT00711243|565713336|FG001|Treated Cycle 5 After First Response|Death|0|||
156717965|NCT00711243|565713337|FG002|Treated Cycle 5 After First Response|Death|0|||
156875015|NCT00485134|566300601|FG002|Overall Study|Non-compliance|0|||
156448850|NCT01494662|564736646|FG004|Overall Study|Physician Decision|0|||
156717966|NCT00711243|565713338|FG003|Treated Cycle 5 After First Response|Death|0|||
156448851|NCT01494662|564736647|FG005|Overall Study|Physician Decision|0|||
156533195|NCT02019420|565046876|FG001|Overall Study|Transferred to other care facility|1|||
156533196|NCT02401412|565046877|FG000|Overall Study|Lost to Follow-up|1|||
156533197|NCT02401412|565046878|FG001|Overall Study|Lost to Follow-up|0|||
156533198|NCT02401412|565046877|FG000|Overall Study|Discontinued Intervention|15|||
156533199|NCT02401412|565046878|FG001|Overall Study|Discontinued Intervention|21|||
156533200|NCT02401412|565046877|FG000|Overall Study|Withdrawal by Subject|4|||
156533201|NCT02401412|565046878|FG001|Overall Study|Withdrawal by Subject|4|||
156533202|NCT02401412|565046877|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
156533203|NCT02401412|565046878|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
156533204|NCT02401412|565046877|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
156533205|NCT02401412|565046878|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
156533206|NCT02742766|565046887|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533207|NCT02742766|565046888|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533208|NCT02742766|565046889|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533209|NCT02742766|565046890|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533210|NCT02742766|565046891|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533211|NCT02742766|565046892|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533212|NCT02742766|565046893|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533213|NCT02742766|565046894|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533214|NCT02742766|565046895|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533215|NCT02742766|565046896|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533216|NCT02742766|565046897|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533217|NCT02742766|565046898|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533218|NCT02742766|565046899|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533219|NCT02742766|565046900|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
156533220|NCT02742766|565046901|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533221|NCT02742766|565046902|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533222|NCT02742766|565046903|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533223|NCT02742766|565046904|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533224|NCT02742766|565046905|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
156533225|NCT02742766|565046887|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533226|NCT02742766|565046888|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533227|NCT02742766|565046889|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533228|NCT02742766|565046890|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533229|NCT02742766|565046891|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533230|NCT02742766|565046892|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533231|NCT02742766|565046893|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533232|NCT02742766|565046894|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533233|NCT02742766|565046895|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533234|NCT02742766|565046896|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533235|NCT02742766|565046897|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533236|NCT02742766|565046898|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533237|NCT02742766|565046899|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
156533238|NCT02742766|565046900|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
156533239|NCT02742766|565046901|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533240|NCT02742766|565046902|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
156533241|NCT02742766|565046903|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533242|NCT02742766|565046904|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533243|NCT02742766|565046905|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
156533244|NCT03359590|565046907|FG000|First Intervention|Withdrawal by Subject|1|||
156533245|NCT03359590|565046908|FG001|First Intervention|Withdrawal by Subject|1|||
156533246|NCT03359590|565046907|FG000|First Intervention|Protocol Violation|0|||
156533247|NCT03359590|565046908|FG001|First Intervention|Protocol Violation|1|||
156533248|NCT05118204|565046911|FG000|Overall Study|Lost to Follow-up|3|||
156533249|NCT05118204|565046912|FG001|Overall Study|Lost to Follow-up|2|||
156533250|NCT05118204|565046911|FG000|Overall Study|Withdrawal by Subject|0|||
156533251|NCT05118204|565046912|FG001|Overall Study|Withdrawal by Subject|2|||
156533252|NCT05393037|565046916|FG000|Part A|Death|1|||
156533253|NCT05393037|565046917|FG001|Part A|Death|0|||
156533254|NCT05393037|565046916|FG000|Part A|Lost to Follow-up|1|||
156533255|NCT05393037|565046917|FG001|Part A|Lost to Follow-up|1|||
156533256|NCT05393037|565046916|FG000|Part A|Withdrawal by Subject|2|||
156533257|NCT05393037|565046917|FG001|Part A|Withdrawal by Subject|4|||
156717967|NCT00711243|565713339|FG004|Treated Cycle 5 After First Response|Death|0|||
156335000|NCT02202980|564324455|FG010|Overall Study|Withdrew Consent|0|||
156335001|NCT02202980|564324456|FG011|Overall Study|Withdrew Consent|0|||
156335002|NCT02202980|564324457|FG012|Overall Study|Withdrew Consent|0|||
156335003|NCT02202980|564324458|FG013|Overall Study|Withdrew Consent|0|||
156335004|NCT01540838|564324459|FG000|Overall Study|Open nasogastric tube|9|||
156335005|NCT01540838|564324460|FG001|Overall Study|Open nasogastric tube|7|||
156335006|NCT01540838|564324459|FG000|Overall Study|Treatment doses missing|8|||
156335007|NCT01540838|564324460|FG001|Overall Study|Treatment doses missing|12|||
156335008|NCT01540838|564324459|FG000|Overall Study|Additional antibiotic treatment|1|||
156335009|NCT01540838|564324460|FG001|Overall Study|Additional antibiotic treatment|2|||
156533258|NCT05393037|565046916|FG000|Part B|Lost to Follow-up|1|||
156533259|NCT05393037|565046917|FG001|Part B|Lost to Follow-up|0|||
156533260|NCT04014361|565046918|FG000|Period 2|Physician Decision|0|||
156533261|NCT04014361|565046919|FG001|Period 2|Physician Decision|0|||
156533262|NCT04014361|565046920|FG002|Period 2|Physician Decision|0|||
156533263|NCT04014361|565046921|FG003|Period 2|Physician Decision|1|||
156717968|NCT00711243|565713340|FG005|Treated Cycle 5 After First Response|Death|2|||
156717969|NCT00711243|565713335|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717970|NCT00711243|565713336|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717971|NCT00711243|565713337|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717972|NCT00711243|565713338|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717973|NCT00711243|565713339|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717974|NCT00711243|565713340|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
156717975|NCT00711243|565713335|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717976|NCT00711243|565713336|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717977|NCT00711243|565713337|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717978|NCT00711243|565713338|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717979|NCT00711243|565713339|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717980|NCT00711243|565713340|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
156717981|NCT05989672|565713341|FG000|Overall Study|Adverse Event|3|||
156717982|NCT05989672|565713342|FG001|Overall Study|Adverse Event|0|||
156717983|NCT05989672|565713343|FG002|Overall Study|Adverse Event|0|||
156717984|NCT03511105|565713344|FG000|Overall Study|Adverse Event|1|||
156717985|NCT03511105|565713345|FG001|Overall Study|Adverse Event|0|||
156717986|NCT03511105|565713344|FG000|Overall Study|Withdrew consent|1|||
156717987|NCT03511105|565713345|FG001|Overall Study|Withdrew consent|0|||
156717988|NCT02810457|565713346|FG000|Overall Study|Randomised but no treatment received|2|||
156533264|NCT04014361|565046922|FG004|Period 2|Physician Decision|0|||
156533265|NCT04014361|565046923|FG005|Period 2|Physician Decision|0|||
156533266|NCT04014361|565046924|FG006|Period 2|Physician Decision|0|||
156533267|NCT04014361|565046925|FG007|Period 2|Physician Decision|0|||
156533268|NCT06308666|565046926|FG000|Overall Study|Withdrawal by Subject|1|||
156533269|NCT06308666|565046926|FG000|Overall Study|Protocol Violation|2|||
156533270|NCT02593786|565046928|FG000|Overall Study|Disease progression|12|||
156533271|NCT02593786|565046929|FG001|Overall Study|Disease progression|16|||
156533272|NCT02593786|565046930|FG002|Overall Study|Disease progression|10|||
156533273|NCT02593786|565046931|FG003|Overall Study|Disease progression|7|||
156533274|NCT02593786|565046928|FG000|Overall Study|Study drug toxicity|1|||
156533275|NCT02593786|565046929|FG001|Overall Study|Study drug toxicity|0|||
156533276|NCT02593786|565046930|FG002|Overall Study|Study drug toxicity|0|||
156533277|NCT02593786|565046931|FG003|Overall Study|Study drug toxicity|0|||
156533278|NCT02593786|565046928|FG000|Overall Study|Adverse event unrelated to study drug|1|||
156533279|NCT02593786|565046929|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156533280|NCT02593786|565046930|FG002|Overall Study|Adverse event unrelated to study drug|1|||
156533281|NCT02593786|565046931|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156533282|NCT02593786|565046928|FG000|Overall Study|Participant request to discontinue study therapy|0|||
156533283|NCT02593786|565046929|FG001|Overall Study|Participant request to discontinue study therapy|2|||
156533284|NCT02593786|565046930|FG002|Overall Study|Participant request to discontinue study therapy|0|||
156533285|NCT02593786|565046931|FG003|Overall Study|Participant request to discontinue study therapy|0|||
156533286|NCT02593786|565046928|FG000|Overall Study|Other reasons|1|||
156533287|NCT02593786|565046929|FG001|Overall Study|Other reasons|1|||
156533288|NCT02593786|565046930|FG002|Overall Study|Other reasons|0|||
156533289|NCT02593786|565046931|FG003|Overall Study|Other reasons|5|||
156533290|NCT01130051|565046932|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
156717989|NCT02810457|565713347|FG001|Overall Study|Randomised but no treatment received|1|||
156717990|NCT02810457|565713346|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
156717991|NCT02810457|565713347|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
156717992|NCT02810457|565713346|FG000|Overall Study|Adverse Event|37|||
156717993|NCT02810457|565713347|FG001|Overall Study|Adverse Event|43|||
156717994|NCT02810457|565713346|FG000|Overall Study|Patient decision|31|||
156717995|NCT02810457|565713347|FG001|Overall Study|Patient decision|35|||
156717996|NCT02810457|565713346|FG000|Overall Study|Patient lost to follow-up|2|||
156533291|NCT01130051|565046933|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
156533292|NCT01130051|565046932|FG000|Washout Period of 14 Days|Protocol Violation|1|||
156533293|NCT01130051|565046933|FG001|Washout Period of 14 Days|Protocol Violation|1|||
156533294|NCT00835120|565046935|FG000|Overall Study|Lack of Efficacy|1|||
156533295|NCT00835120|565046935|FG000|Overall Study|Lost to Follow-up|3|||
156533296|NCT00835120|565046935|FG000|Overall Study|Adverse Event|2|||
156533297|NCT00835120|565046935|FG000|Overall Study|Withdrawal by Subject|2|||
156533298|NCT01019980|565046936|FG000|Overall Study|Drug not available.|2|||
156533299|NCT01019980|565046937|FG001|Overall Study|Drug not available.|0|||
156533300|NCT03610165|565046938|FG000|Overall Study|Device didn't work|0|||
156533301|NCT03610165|565046939|FG001|Overall Study|Device didn't work|1|||
156793655|NCT03131479|565997446|FG004|Overall Study|Subject/Guardian Decision|0|||
156793656|NCT04439903|565997451|FG000|Overall Study|Withdrawal by Subject|2|||
156793657|NCT04439903|565997451|FG000|Overall Study|Screen Failure|1|||
156793658|NCT04806373|565997454|FG000|Overall Study|Withdrawal by Subject|1|||
156793659|NCT04806373|565997455|FG001|Overall Study|Withdrawal by Subject|1|||
156793660|NCT05810597|565997456|FG000|Period 1|Adverse Event|2|||
156793661|NCT05810597|565997457|FG001|Period 1|Adverse Event|0|||
156793662|NCT05810597|565997456|FG000|Period 1|Physician Decision|1|||
156793663|NCT05810597|565997457|FG001|Period 1|Physician Decision|0|||
156793664|NCT01450631|565997458|FG000|Overall Study|Lost to Follow-up|2|||
156793665|NCT01450631|565997459|FG001|Overall Study|Lost to Follow-up|4|||
156793666|NCT01450631|565997458|FG000|Overall Study|Withdrawal by Subject|1|||
156793667|NCT01450631|565997459|FG001|Overall Study|Withdrawal by Subject|0|||
156793668|NCT05021224|565997465|FG000|Overall Study|Did not complete all survey items|4|||
156793669|NCT05021224|565997466|FG001|Overall Study|Did not complete all survey items|1|||
156793670|NCT05021224|565997467|FG002|Overall Study|Did not complete all survey items|0|||
156793671|NCT05021224|565997468|FG003|Overall Study|Did not complete all survey items|2|||
156793672|NCT03996395|565997469|FG000|Overall Study|Lost to Follow-up|4|||
156793673|NCT03996395|565997469|FG000|Overall Study|Withdrawal by Subject|1|||
156793674|NCT03996395|565997469|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
156793675|NCT05375929|565997476|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
156793676|NCT05375929|565997477|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
156793677|NCT05375929|565997478|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
156793678|NCT05375929|565997479|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
156793679|NCT05375929|565997476|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
156793680|NCT05375929|565997477|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
156793681|NCT05375929|565997478|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156793682|NCT05375929|565997479|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156793683|NCT05375929|565997476|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
156793684|NCT05375929|565997477|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
156793685|NCT05375929|565997478|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
156793686|NCT05375929|565997479|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
156793687|NCT05375929|565997476|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
156793688|NCT05375929|565997477|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
156793689|NCT05375929|565997478|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
156793690|NCT05375929|565997479|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
156793691|NCT05375929|565997476|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
156793692|NCT05375929|565997477|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
156717997|NCT02810457|565713347|FG001|Overall Study|Patient lost to follow-up|2|||
156717998|NCT02810457|565713346|FG000|Overall Study|Death|39|||
156717999|NCT02810457|565713347|FG001|Overall Study|Death|28|||
156718000|NCT02810457|565713346|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
156718001|NCT02810457|565713347|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
156718002|NCT02810457|565713346|FG000|Overall Study|Clinical progression|15|||
156718003|NCT02810457|565713347|FG001|Overall Study|Clinical progression|16|||
156718004|NCT02810457|565713346|FG000|Overall Study|Investigator decision|3|||
156718005|NCT02810457|565713347|FG001|Overall Study|Investigator decision|2|||
156718006|NCT02810457|565713346|FG000|Overall Study|Patient ineligibility|3|||
156718007|NCT02810457|565713347|FG001|Overall Study|Patient ineligibility|0|||
156718008|NCT02810457|565713346|FG000|Overall Study|Miscalculated PD|1|||
156718009|NCT02810457|565713347|FG001|Overall Study|Miscalculated PD|0|||
156718010|NCT02810457|565713346|FG000|Overall Study|Physician Decision|0|||
156718011|NCT02810457|565713347|FG001|Overall Study|Physician Decision|1|||
156718012|NCT02750618|565713348|FG000|Overall Study|Withdrawal by Subject|1|||
156718013|NCT00853099|565713349|FG000|Double-blind Period|Adverse Event|7|||
156718014|NCT00853099|565713350|FG001|Double-blind Period|Adverse Event|9|||
156718015|NCT00853099|565713351|FG002|Double-blind Period|Adverse Event|13|||
156718016|NCT00853099|565713352|FG003|Double-blind Period|Adverse Event|0|||
156718017|NCT00853099|565713349|FG000|Double-blind Period|Withdrawal by Subject|2|||
156718018|NCT00853099|565713350|FG001|Double-blind Period|Withdrawal by Subject|3|||
156718019|NCT00853099|565713351|FG002|Double-blind Period|Withdrawal by Subject|0|||
156718020|NCT00853099|565713352|FG003|Double-blind Period|Withdrawal by Subject|0|||
156718021|NCT00853099|565713349|FG000|Double-blind Period|Lack of Efficacy|14|||
156718022|NCT00853099|565713350|FG001|Double-blind Period|Lack of Efficacy|17|||
156793693|NCT05375929|565997478|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
156793694|NCT05375929|565997479|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
156793695|NCT05375929|565997476|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
156718023|NCT00853099|565713351|FG002|Double-blind Period|Lack of Efficacy|16|||
156875016|NCT00485134|566300602|FG003|Overall Study|Non-compliance|0|||
156718024|NCT00853099|565713352|FG003|Double-blind Period|Lack of Efficacy|0|||
156718025|NCT00853099|565713349|FG000|Double-blind Period|Other|0|||
156718026|NCT00853099|565713350|FG001|Double-blind Period|Other|0|||
156718027|NCT00853099|565713351|FG002|Double-blind Period|Other|1|||
156448852|NCT01494662|564736648|FG006|Overall Study|Physician Decision|0|||
156718028|NCT00853099|565713352|FG003|Double-blind Period|Other|0|||
156718029|NCT00853099|565713349|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
156718030|NCT00853099|565713350|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
156718031|NCT00853099|565713351|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
156448853|NCT04072822|564736649|FG000|Treatment|Adverse Event|9|||
156448854|NCT04072822|564736650|FG001|Treatment|Adverse Event|5|||
156448855|NCT04072822|564736649|FG000|Treatment|Met Stopping Criteria|13|||
156448856|NCT04072822|564736650|FG001|Treatment|Met Stopping Criteria|24|||
156448857|NCT04072822|564736649|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
156448858|NCT04072822|564736650|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
156448859|NCT04072822|564736649|FG000|Treatment|Withdrawal by Subject|0|||
156448860|NCT04072822|564736650|FG001|Treatment|Withdrawal by Subject|2|||
156448861|NCT04072822|564736649|FG000|Treatment|Death|0|||
156448862|NCT04072822|564736650|FG001|Treatment|Death|2|||
156448863|NCT04072822|564736649|FG000|Treatment|Lost to Follow-up|11|||
156448864|NCT04072822|564736650|FG001|Treatment|Lost to Follow-up|3|||
156448865|NCT04072822|564736649|FG000|Treatment|Physician Decision|1|||
156448866|NCT04072822|564736650|FG001|Treatment|Physician Decision|0|||
156448867|NCT04072822|564736649|FG000|Treatment|Other|7|||
156448868|NCT04072822|564736650|FG001|Treatment|Other|9|||
156448869|NCT04072822|564736649|FG000|Follow-up|Withdrawal by Subject|1|||
156448870|NCT04072822|564736650|FG001|Follow-up|Withdrawal by Subject|0|||
156448871|NCT04072822|564736649|FG000|Follow-up|Lost to Follow-up|5|||
156448872|NCT04072822|564736650|FG001|Follow-up|Lost to Follow-up|4|||
156448873|NCT05481320|564736651|FG000|Overall Study|Withdrawal by Subject|1|||
156448874|NCT05481320|564736652|FG001|Overall Study|Withdrawal by Subject|1|||
156718032|NCT00853099|565713352|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
156718033|NCT00853099|565713349|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
156448875|NCT05481320|564736651|FG000|Overall Study|Care recipent passed away|0|||
156448876|NCT05481320|564736652|FG001|Overall Study|Care recipent passed away|1|||
156448877|NCT05481320|564736651|FG000|Overall Study|Out-of-window assessment|0|||
156448878|NCT05481320|564736652|FG001|Overall Study|Out-of-window assessment|1|||
156448879|NCT05481320|564736651|FG000|Overall Study|No longer a primary caregiver|3|||
156448880|NCT05481320|564736652|FG001|Overall Study|No longer a primary caregiver|0|||
156448881|NCT05481320|564736651|FG000|Overall Study|Unable to contact|1|||
156448882|NCT05481320|564736652|FG001|Overall Study|Unable to contact|0|||
156448883|NCT04314895|564736658|FG000|Overall Study|Lost to Follow-up|1|||
156448884|NCT04314895|564736658|FG000|Overall Study|Death|10|||
156448885|NCT04314895|564736658|FG000|Overall Study|Physician Decision|2|||
156448886|NCT03930342|564736662|FG000|Overall Study|Lost to Follow-up|70|||
156448887|NCT03930342|564736663|FG001|Overall Study|Lost to Follow-up|77|||
156448888|NCT02596126|564736664|FG000|Overall Study|Lost to Follow-up|12|||
156448889|NCT02596126|564736665|FG001|Overall Study|Lost to Follow-up|21|||
156448890|NCT02596126|564736664|FG000|Overall Study|Protocol Violation|7|||
156448891|NCT02596126|564736665|FG001|Overall Study|Protocol Violation|9|||
156448892|NCT04774237|564736670|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
156448893|NCT04774237|564736671|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
156448894|NCT04774237|564736672|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
156448895|NCT04774237|564736673|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
156448896|NCT04774237|564736674|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
156448897|NCT04774237|564736675|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
156448898|NCT05792423|564736676|FG000|Overall Study|Withdrawal by Subject|2|||
156448899|NCT06311084|564738351|FG000|Overall Study|Lost to Follow-up|14|||
156448900|NCT01140880|564738359|FG000|Overall Study|Death|0|||
156448901|NCT01140880|564738360|FG001|Overall Study|Death|1|||
156448902|NCT01140880|564738359|FG000|Overall Study|Withdrawal by Subject|6|||
156448903|NCT01140880|564738360|FG001|Overall Study|Withdrawal by Subject|3|||
156448904|NCT01140880|564738359|FG000|Overall Study|Lost to Follow-up|8|||
156448905|NCT01140880|564738360|FG001|Overall Study|Lost to Follow-up|10|||
156448906|NCT01140880|564738359|FG000|Overall Study|Protocol Violation|0|||
156448907|NCT01140880|564738360|FG001|Overall Study|Protocol Violation|30|||
156448908|NCT03958955|564738361|FG000|Overall Study|Adverse Event|1|||
156448909|NCT05082909|564738362|FG000|Overall Study|Protocol Violation|0|||
156448910|NCT05082909|564738363|FG001|Overall Study|Protocol Violation|0|||
156448911|NCT05082909|564738364|FG002|Overall Study|Protocol Violation|1|||
156448912|NCT05082909|564738365|FG003|Overall Study|Protocol Violation|0|||
156448913|NCT05082909|564738366|FG004|Overall Study|Protocol Violation|0|||
156448914|NCT05082909|564738367|FG005|Overall Study|Protocol Violation|0|||
156448915|NCT04088630|564738368|FG000|Overall Study|Lost to Follow-up|3|||
156448916|NCT04088630|564738369|FG001|Overall Study|Lost to Follow-up|2|||
156448917|NCT04088630|564738370|FG002|Overall Study|Lost to Follow-up|6|||
156448918|NCT04088630|564738368|FG000|Overall Study|Death|3|||
156448919|NCT04088630|564738369|FG001|Overall Study|Death|1|||
156448920|NCT04088630|564738370|FG002|Overall Study|Death|1|||
156448921|NCT04088630|564738368|FG000|Overall Study|Physician Decision|0|||
156448922|NCT04088630|564738369|FG001|Overall Study|Physician Decision|1|||
156718034|NCT00853099|565713350|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
156448923|NCT04088630|564738370|FG002|Overall Study|Physician Decision|1|||
156793696|NCT05375929|565997477|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
156793697|NCT05375929|565997478|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
156793698|NCT05375929|565997479|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
156793699|NCT05375929|565997476|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
156793700|NCT05375929|565997477|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
156793701|NCT05375929|565997478|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
156793702|NCT05375929|565997479|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
156793703|NCT05375929|565997476|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
156793704|NCT05375929|565997477|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
156793705|NCT05375929|565997478|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
156793706|NCT05375929|565997479|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
156793707|NCT05375929|565997476|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
156793708|NCT05375929|565997477|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
156793709|NCT05375929|565997478|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
156793710|NCT05375929|565997479|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
156793711|NCT05375929|565997476|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
156793712|NCT05375929|565997477|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
156793713|NCT05375929|565997478|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
156793714|NCT05375929|565997479|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
156793715|NCT03301415|565997480|FG000|Overall Study|Lost to Follow-up|2|||
156793716|NCT03301415|565997480|FG000|Overall Study|Unable to comply with visit schedule|2|||
156793717|NCT00392288|565997481|FG000|Overall Study|Adverse Event|17|||
156793718|NCT00392288|565997482|FG001|Overall Study|Adverse Event|7|||
156793719|NCT00392288|565997483|FG002|Overall Study|Adverse Event|8|||
156793720|NCT00392288|565997481|FG000|Overall Study|Lack of Efficacy|8|||
156793721|NCT00392288|565997482|FG001|Overall Study|Lack of Efficacy|5|||
156793722|NCT00392288|565997483|FG002|Overall Study|Lack of Efficacy|3|||
156793723|NCT00392288|565997481|FG000|Overall Study|Protocol Violation|1|||
156793724|NCT00392288|565997482|FG001|Overall Study|Protocol Violation|3|||
156793725|NCT00392288|565997483|FG002|Overall Study|Protocol Violation|1|||
156793726|NCT00392288|565997481|FG000|Overall Study|Lost to Follow-up|1|||
156793727|NCT00392288|565997482|FG001|Overall Study|Lost to Follow-up|1|||
156448924|NCT00512070|564738378|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
156448925|NCT00512070|564738379|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
156448926|NCT00512070|564738380|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
156448927|NCT00512070|564738378|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
156448928|NCT00512070|564738379|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
156448929|NCT00512070|564738380|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
156793728|NCT00392288|565997483|FG002|Overall Study|Lost to Follow-up|1|||
156793729|NCT00392288|565997481|FG000|Overall Study|Withdrawal by Subject|1|||
156793730|NCT00392288|565997482|FG001|Overall Study|Withdrawal by Subject|0|||
156793731|NCT00392288|565997483|FG002|Overall Study|Withdrawal by Subject|2|||
156793732|NCT00392288|565997481|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
156793733|NCT00392288|565997482|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
156793734|NCT00392288|565997483|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
156793735|NCT00392288|565997481|FG000|Overall Study|Other|3|||
156793736|NCT00392288|565997482|FG001|Overall Study|Other|4|||
156793737|NCT00392288|565997483|FG002|Overall Study|Other|1|||
156793738|NCT04755231|565997486|FG000|Overall Study|Lost to Follow-up|5|||
156793739|NCT04755231|565997486|FG000|Overall Study|Withdrawal by Subject|5|||
156793740|NCT00025233|565997490|FG000|Overall Study|Ineligible: wrong cell type|1|||
156793741|NCT00025233|565997490|FG000|Overall Study|Ineligible: wrong primary|1|||
156793742|NCT00025233|565997490|FG000|Overall Study|Ineligible: improper prior treatment|1|||
156793743|NCT00025233|565997490|FG000|Overall Study|Never treated|1|||
156793744|NCT01720602|565997491|FG000|Overall Study|Adverse Event|3|||
156793745|NCT01720602|565997491|FG000|Overall Study|Progressive disease on therapy|2|||
156793746|NCT02184442|565997492|FG000|Overall Study|Death|61|||
156793747|NCT02184442|565997493|FG001|Overall Study|Death|65|||
156793748|NCT02184442|565997492|FG000|Overall Study|Withdrawal by Subject|3|||
156793749|NCT02184442|565997493|FG001|Overall Study|Withdrawal by Subject|11|||
156448930|NCT05862870|564738386|FG000|Overall Study|Lost to Follow-up|3|||
156448931|NCT04321031|564738387|FG000|Overall Study|Adverse Event|0|||
156448932|NCT04321031|564738388|FG001|Overall Study|Adverse Event|2|||
156448933|NCT04321031|564738389|FG002|Overall Study|Adverse Event|2|||
156793750|NCT00787800|565997495|FG000|Overall Study|Withdrawal by Subject|3|||
156793751|NCT00787800|565997496|FG001|Overall Study|Withdrawal by Subject|5|||
156793752|NCT00787800|565997495|FG000|Overall Study|Death|0|||
156793753|NCT00787800|565997496|FG001|Overall Study|Death|2|||
156793754|NCT00507507|565997502|FG000|Treatment Period|Lost to Follow-up|0|||
156793755|NCT00507507|565997503|FG001|Treatment Period|Lost to Follow-up|2|||
156793756|NCT00507507|565997502|FG000|Treatment Period|Physician Decision|4|||
156793757|NCT00507507|565997503|FG001|Treatment Period|Physician Decision|1|||
156793758|NCT00507507|565997502|FG000|Treatment Period|Protocol Violation|1|||
156533302|NCT00708175|565046951|FG000|Overall Study|Adverse Event|4|||
156533303|NCT00708175|565046952|FG001|Overall Study|Adverse Event|5|||
156533304|NCT00708175|565046951|FG000|Overall Study|Protocol Violation|2|||
156533305|NCT00708175|565046952|FG001|Overall Study|Protocol Violation|3|||
156533306|NCT00708175|565046951|FG000|Overall Study|Lost to Follow-up|5|||
156533307|NCT00708175|565046952|FG001|Overall Study|Lost to Follow-up|3|||
156533308|NCT00708175|565046951|FG000|Overall Study|Withdrawal by Subject|5|||
156533309|NCT00708175|565046952|FG001|Overall Study|Withdrawal by Subject|7|||
156533310|NCT00708175|565046951|FG000|Overall Study|BMD loss >7%|2|||
156533311|NCT00708175|565046952|FG001|Overall Study|BMD loss >7%|3|||
156533312|NCT02038920|565046960|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
156533313|NCT02038920|565046961|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
156533314|NCT02038920|565046962|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
156533315|NCT02038920|565046963|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
156533316|NCT02038920|565046964|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
156533317|NCT02038920|565046965|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
156533318|NCT02038920|565046960|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
156533319|NCT02038920|565046961|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
156533320|NCT02038920|565046962|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
156533321|NCT02038920|565046963|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
156533322|NCT02038920|565046964|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
156533323|NCT02038920|565046965|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
156533324|NCT02038920|565046960|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
156533325|NCT02038920|565046961|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
156533326|NCT02038920|565046962|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
156533327|NCT02038920|565046963|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
156533328|NCT02038920|565046964|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
156533329|NCT02038920|565046965|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
156533330|NCT02038920|565046960|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
156533331|NCT02038920|565046961|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
156533332|NCT02038920|565046962|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
156533333|NCT02038920|565046963|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
156533334|NCT02038920|565046964|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
156533335|NCT02038920|565046965|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
156533336|NCT02038920|565046960|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
156533337|NCT02038920|565046961|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
156533338|NCT02038920|565046962|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
156533339|NCT02038920|565046963|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
156533340|NCT02038920|565046964|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
156533341|NCT02038920|565046965|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
156533342|NCT02038920|565046960|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
156533343|NCT02038920|565046961|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
156533344|NCT02038920|565046962|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
156533345|NCT02038920|565046963|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
156533346|NCT02038920|565046964|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
156533347|NCT02038920|565046965|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
156533348|NCT02038920|565046960|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
156533349|NCT02038920|565046961|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
156533350|NCT02038920|565046962|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
156533351|NCT02038920|565046963|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
156533352|NCT02038920|565046964|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
156533353|NCT02038920|565046965|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
156718035|NCT00853099|565713351|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
156718036|NCT00853099|565713352|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
156718037|NCT00853099|565713349|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
156718038|NCT00853099|565713350|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
156718039|NCT00853099|565713351|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
156718040|NCT00853099|565713352|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
156718041|NCT00853099|565713349|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
156718042|NCT00853099|565713350|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
156533354|NCT02038920|565046960|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
156533355|NCT02038920|565046961|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
156533356|NCT02038920|565046962|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
156533357|NCT02038920|565046963|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
156533358|NCT02038920|565046964|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
156793759|NCT00507507|565997503|FG001|Treatment Period|Protocol Violation|2|||
156718043|NCT00853099|565713351|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
156718044|NCT00853099|565713352|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
156718045|NCT00853099|565713349|FG000|Double-blind + Open-label Periods|Other|0|||
156718046|NCT00853099|565713350|FG001|Double-blind + Open-label Periods|Other|0|||
156718047|NCT00853099|565713351|FG002|Double-blind + Open-label Periods|Other|0|||
156718048|NCT00853099|565713352|FG003|Double-blind + Open-label Periods|Other|6|||
156718049|NCT02203357|565713356|FG000|Overall Study|Lost to Follow-up|58|||
156718050|NCT02203357|565713357|FG001|Overall Study|Lost to Follow-up|66|||
156718051|NCT02203357|565713358|FG002|Overall Study|Lost to Follow-up|70|||
156718052|NCT02687451|565713361|FG000|Overall Study|Withdrawal by Subject|1|||
156718053|NCT02687451|565713362|FG001|Overall Study|Withdrawal by Subject|0|||
156718054|NCT02687451|565713363|FG002|Overall Study|Withdrawal by Subject|0|||
156718055|NCT02687451|565713364|FG003|Overall Study|Withdrawal by Subject|0|||
156718056|NCT02687451|565713365|FG004|Overall Study|Withdrawal by Subject|0|||
156718057|NCT02687451|565713366|FG005|Overall Study|Withdrawal by Subject|1|||
156718058|NCT01778530|565713367|FG000|Overall Study|Progression on study|1|||
156718059|NCT01778530|565713367|FG000|Overall Study|Adverse event/side effect|1|||
156718060|NCT03472014|565713368|FG000|Overall Study|Lost to Follow-up|4|||
156718061|NCT00711087|565713369|FG000|Overall Study|Lost to Follow-up|1|||
156335010|NCT01540838|564324459|FG000|Overall Study|Died before treatment initiation|1|||
156335011|NCT01540838|564324460|FG001|Overall Study|Died before treatment initiation|1|||
156335012|NCT01540838|564324459|FG000|Overall Study|Not BM. Other treatment|3|||
156335013|NCT01540838|564324460|FG001|Overall Study|Not BM. Other treatment|1|||
156335014|NCT02130570|564324461|FG000|Overall Study|Death|3|||
156718062|NCT00711087|565713370|FG001|Overall Study|Lost to Follow-up|0|||
156793760|NCT00507507|565997502|FG000|Treatment Period|Adverse Event|1|||
156793761|NCT00507507|565997503|FG001|Treatment Period|Adverse Event|1|||
156793762|NCT00507507|565997502|FG000|Treatment Period|Withdrawal by Subject|46|||
156335015|NCT02130570|564324462|FG001|Overall Study|Death|5|||
156335016|NCT02130570|564324461|FG000|Overall Study|Withdrawal by Subject|6|||
156335017|NCT02130570|564324462|FG001|Overall Study|Withdrawal by Subject|3|||
156335018|NCT02130570|564324461|FG000|Overall Study|Part of practice that discontinued study|0|||
156335019|NCT02130570|564324462|FG001|Overall Study|Part of practice that discontinued study|5|||
156335020|NCT05224141|564324465|FG000|Overall Study|Ongoing|75|||
156335021|NCT05224141|564324466|FG001|Overall Study|Ongoing|88|||
156335022|NCT05224141|564324465|FG000|Overall Study|Withdrawal by Subject|2|||
156335023|NCT05224141|564324466|FG001|Overall Study|Withdrawal by Subject|4|||
156335024|NCT05224141|564324465|FG000|Overall Study|Death|153|||
156335025|NCT05224141|564324466|FG001|Overall Study|Death|138|||
156335026|NCT04545060|564324472|FG000|Overall Study|Adverse Event|0|||
156335027|NCT04545060|564324473|FG001|Overall Study|Adverse Event|1|||
156335028|NCT04545060|564324472|FG000|Overall Study|Death|0|||
156335029|NCT04545060|564324473|FG001|Overall Study|Death|5|||
156335030|NCT04545060|564324472|FG000|Overall Study|Lost to Follow-up|10|||
156335031|NCT04545060|564324473|FG001|Overall Study|Lost to Follow-up|13|||
156335032|NCT04545060|564324472|FG000|Overall Study|Physician Decision|3|||
156335033|NCT04545060|564324473|FG001|Overall Study|Physician Decision|0|||
156335034|NCT04545060|564324472|FG000|Overall Study|Withdrawal by Subject|17|||
156335035|NCT04545060|564324473|FG001|Overall Study|Withdrawal by Subject|22|||
156335036|NCT02435147|564324475|FG000|Overall Study|non-evaluable DXA scan|11|||
156335037|NCT02939079|564324476|FG000|Overall Study|Adverse Event|2|||
156335038|NCT02939079|564324477|FG001|Overall Study|Adverse Event|1|||
156335039|NCT02939079|564324476|FG000|Overall Study|Lost to Follow-up|0|||
156335040|NCT02939079|564324477|FG001|Overall Study|Lost to Follow-up|2|||
156335041|NCT02939079|564324476|FG000|Overall Study|Protocol Violation|1|||
156335042|NCT02939079|564324477|FG001|Overall Study|Protocol Violation|0|||
156335043|NCT02939079|564324476|FG000|Overall Study|Withdrawal by Subject|0|||
156335044|NCT02939079|564324477|FG001|Overall Study|Withdrawal by Subject|1|||
156335045|NCT02939079|564324476|FG000|Overall Study|relapse during the study|1|||
156335046|NCT02939079|564324477|FG001|Overall Study|relapse during the study|1|||
156335047|NCT00071396|564324488|FG000|Overall Study|Withdrawal by Subject|1|||
156335048|NCT00071396|564324488|FG000|Overall Study|Physician Decision|2|||
156335049|NCT04545554|564324489|FG000|Overall Study|Withdrawal by Subject|0|||
156335050|NCT04545554|564324490|FG001|Overall Study|Withdrawal by Subject|0|||
156335051|NCT04545554|564324491|FG002|Overall Study|Withdrawal by Subject|0|||
156335052|NCT04545554|564324492|FG003|Overall Study|Withdrawal by Subject|1|||
156335053|NCT04545554|564324493|FG004|Overall Study|Withdrawal by Subject|0|||
156335054|NCT04545554|564324494|FG005|Overall Study|Withdrawal by Subject|0|||
156335055|NCT02478372|564324495|FG000|Overall Study|Protocol Violation|12|||
156335056|NCT02478372|564324496|FG001|Overall Study|Protocol Violation|8|||
156335057|NCT02478372|564324495|FG000|Overall Study|Lost to Follow-up|1|||
156335058|NCT02478372|564324496|FG001|Overall Study|Lost to Follow-up|4|||
156335059|NCT02478372|564324495|FG000|Overall Study|Death|0|||
156335060|NCT02478372|564324496|FG001|Overall Study|Death|2|||
156335061|NCT00116428|564324497|FG000|Overall Study|Withdrawal by Subject|2|||
156335062|NCT00116428|564324498|FG001|Overall Study|Withdrawal by Subject|5|||
156718063|NCT01930162|565713371|FG000|Overall Study|Abnormal test procedure result(s)|4|||
156718064|NCT01930162|565713371|FG000|Overall Study|Death|1|||
156718065|NCT01958437|565713372|FG000|Overall Study|Incidental MRI findings|0|||
156718066|NCT01958437|565713373|FG001|Overall Study|Incidental MRI findings|0|||
156718067|NCT01958437|565713374|FG002|Overall Study|Incidental MRI findings|1|||
156718068|NCT01958437|565713375|FG003|Overall Study|Incidental MRI findings|1|||
156718069|NCT02394600|565713378|FG000|Overall Study|Adverse Event|3|||
156718070|NCT02394600|565713379|FG001|Overall Study|Adverse Event|0|||
156718071|NCT02394600|565713378|FG000|Overall Study|Lost to Follow-up|0|||
156718072|NCT02394600|565713379|FG001|Overall Study|Lost to Follow-up|1|||
156718073|NCT02394600|565713378|FG000|Overall Study|Withdrawal by Subject|0|||
156718074|NCT02394600|565713379|FG001|Overall Study|Withdrawal by Subject|1|||
156718075|NCT02394600|565713378|FG000|Overall Study|Protocol Violation|1|||
156718076|NCT02394600|565713379|FG001|Overall Study|Protocol Violation|0|||
156718077|NCT00428246|565713380|FG000|Overall Study|Withdrawal by Subject|0|||
156875017|NCT00485134|566300603|FG004|Overall Study|Non-compliance|1|||
156875018|NCT00485134|566300604|FG005|Overall Study|Non-compliance|2|||
156448934|NCT04321031|564738390|FG003|Overall Study|Adverse Event|2|||
156448935|NCT04321031|564738391|FG004|Overall Study|Adverse Event|2|||
156448936|NCT04321031|564738392|FG005|Overall Study|Adverse Event|2|||
156448937|NCT04321031|564738393|FG006|Overall Study|Adverse Event|0|||
156448938|NCT04321031|564738387|FG000|Overall Study|Lost to Follow-up|0|||
156448939|NCT04321031|564738388|FG001|Overall Study|Lost to Follow-up|0|||
156448940|NCT04321031|564738389|FG002|Overall Study|Lost to Follow-up|0|||
156448941|NCT04321031|564738390|FG003|Overall Study|Lost to Follow-up|1|||
156448942|NCT04321031|564738391|FG004|Overall Study|Lost to Follow-up|0|||
156448943|NCT04321031|564738392|FG005|Overall Study|Lost to Follow-up|2|||
156448944|NCT04321031|564738393|FG006|Overall Study|Lost to Follow-up|1|||
156448945|NCT04321031|564738387|FG000|Overall Study|Withdrawal by Subject|2|||
156448946|NCT04321031|564738388|FG001|Overall Study|Withdrawal by Subject|2|||
156448947|NCT04321031|564738389|FG002|Overall Study|Withdrawal by Subject|1|||
156448948|NCT04321031|564738390|FG003|Overall Study|Withdrawal by Subject|3|||
156448949|NCT04321031|564738391|FG004|Overall Study|Withdrawal by Subject|1|||
156448950|NCT04321031|564738392|FG005|Overall Study|Withdrawal by Subject|0|||
156448951|NCT04321031|564738393|FG006|Overall Study|Withdrawal by Subject|1|||
156448952|NCT04321031|564738387|FG000|Overall Study|Non-compliance with study drug|0|||
156448953|NCT04321031|564738388|FG001|Overall Study|Non-compliance with study drug|0|||
156448954|NCT04321031|564738389|FG002|Overall Study|Non-compliance with study drug|0|||
156448955|NCT04321031|564738390|FG003|Overall Study|Non-compliance with study drug|0|||
156448956|NCT04321031|564738391|FG004|Overall Study|Non-compliance with study drug|0|||
156448957|NCT04321031|564738392|FG005|Overall Study|Non-compliance with study drug|1|||
156448958|NCT04321031|564738393|FG006|Overall Study|Non-compliance with study drug|0|||
156448959|NCT04321031|564738387|FG000|Overall Study|Other|0|||
156448960|NCT04321031|564738388|FG001|Overall Study|Other|0|||
156448961|NCT04321031|564738389|FG002|Overall Study|Other|0|||
156448962|NCT04321031|564738390|FG003|Overall Study|Other|1|||
156448963|NCT04321031|564738391|FG004|Overall Study|Other|0|||
156448964|NCT04321031|564738392|FG005|Overall Study|Other|0|||
156448965|NCT04321031|564738393|FG006|Overall Study|Other|0|||
156448966|NCT02900924|564738394|FG000|Overall Study|Death|52|||
156448967|NCT02900924|564738394|FG000|Overall Study|Lost to Follow-up|4|||
156448968|NCT02900924|564738394|FG000|Overall Study|Withdrawal by Subject|20|||
156448969|NCT02900924|564738394|FG000|Overall Study|Missed Visit|33|||
156448970|NCT03143153|564738397|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
156875019|NCT00485134|566300605|FG006|Overall Study|Non-compliance|2|||
156875020|NCT00485134|566300606|FG007|Overall Study|Non-compliance|0|||
156875021|NCT00485134|566300599|FG000|Overall Study|Unable to comply with study schedule|0|||
156875022|NCT00485134|566300600|FG001|Overall Study|Unable to comply with study schedule|0|||
156875023|NCT00485134|566300601|FG002|Overall Study|Unable to comply with study schedule|0|||
156875024|NCT00485134|566300602|FG003|Overall Study|Unable to comply with study schedule|0|||
156875025|NCT00485134|566300603|FG004|Overall Study|Unable to comply with study schedule|0|||
156875026|NCT00485134|566300604|FG005|Overall Study|Unable to comply with study schedule|0|||
156875027|NCT00485134|566300605|FG006|Overall Study|Unable to comply with study schedule|0|||
156875028|NCT00485134|566300606|FG007|Overall Study|Unable to comply with study schedule|1|||
156875029|NCT00485134|566300599|FG000|Overall Study|Pregnancy|0|||
156448971|NCT03143153|564738398|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
156448972|NCT03143153|564738399|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
156448973|NCT03143153|564738397|FG000|Pre-Treatment|Participant withdrew consent|0|||
156448974|NCT03143153|564738398|FG001|Pre-Treatment|Participant withdrew consent|1|||
156448975|NCT03143153|564738399|FG002|Pre-Treatment|Participant withdrew consent|12|||
156448976|NCT03143153|564738397|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
156448977|NCT03143153|564738398|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
156448978|NCT03143153|564738399|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
156448979|NCT03143153|564738397|FG000|Pre-Treatment|Other Reasons|1|||
156448980|NCT03143153|564738398|FG001|Pre-Treatment|Other Reasons|2|||
156875030|NCT00485134|566300600|FG001|Overall Study|Pregnancy|0|||
156875031|NCT00485134|566300601|FG002|Overall Study|Pregnancy|0|||
156875032|NCT00485134|566300602|FG003|Overall Study|Pregnancy|0|||
156875033|NCT00485134|566300603|FG004|Overall Study|Pregnancy|0|||
156875034|NCT00485134|566300604|FG005|Overall Study|Pregnancy|0|||
156875035|NCT00485134|566300605|FG006|Overall Study|Pregnancy|1|||
156875036|NCT00485134|566300606|FG007|Overall Study|Pregnancy|0|||
156875037|NCT04294680|566300607|FG000|Overall Study|Withdrawal by Subject|2|||
156875038|NCT04294680|566300608|FG001|Overall Study|Withdrawal by Subject|1|||
156875039|NCT04294680|566300607|FG000|Overall Study|Follow-up visits completed outside of window|1|||
156875040|NCT04294680|566300608|FG001|Overall Study|Follow-up visits completed outside of window|0|||
156875041|NCT02675634|566300609|FG000|Test Period 1|Adverse Event|0|||
156875042|NCT02675634|566300610|FG001|Test Period 1|Adverse Event|1|||
156875043|NCT02675634|566300611|FG002|Test Period 1|Adverse Event|0|||
156875044|NCT02675634|566300612|FG003|Test Period 1|Adverse Event|1|||
156875045|NCT02675634|566300613|FG004|Test Period 1|Adverse Event|0|||
156875046|NCT02675634|566300614|FG005|Test Period 1|Adverse Event|0|||
156875047|NCT02675634|566300609|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
156875048|NCT02675634|566300610|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
156875049|NCT02675634|566300611|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
156875050|NCT02675634|566300612|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
156875051|NCT02675634|566300613|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
156875052|NCT02675634|566300614|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
156875053|NCT02675634|566300609|FG000|Test Period 2|Lack of Efficacy|1|||
156875054|NCT02675634|566300610|FG001|Test Period 2|Lack of Efficacy|0|||
156875055|NCT02675634|566300611|FG002|Test Period 2|Lack of Efficacy|0|||
156875056|NCT02675634|566300612|FG003|Test Period 2|Lack of Efficacy|0|||
156875057|NCT02675634|566300613|FG004|Test Period 2|Lack of Efficacy|0|||
156875058|NCT02675634|566300614|FG005|Test Period 2|Lack of Efficacy|0|||
156875059|NCT02675634|566300609|FG000|Test Period 2|Adverse Event|0|||
156875060|NCT02675634|566300610|FG001|Test Period 2|Adverse Event|0|||
156875061|NCT02675634|566300611|FG002|Test Period 2|Adverse Event|0|||
156875062|NCT02675634|566300612|FG003|Test Period 2|Adverse Event|0|||
156875063|NCT02675634|566300613|FG004|Test Period 2|Adverse Event|0|||
156875064|NCT02675634|566300614|FG005|Test Period 2|Adverse Event|1|||
156875065|NCT04380519|566300615|FG000|Overall Study|Withdrawal by Subject|4|||
156875066|NCT04380519|566300616|FG001|Overall Study|Withdrawal by Subject|0|||
156875067|NCT04380519|566300617|FG002|Overall Study|Withdrawal by Subject|1|||
156875068|NCT04380519|566300615|FG000|Overall Study|Death|14|||
156875069|NCT04380519|566300616|FG001|Overall Study|Death|9|||
156875070|NCT04380519|566300617|FG002|Overall Study|Death|6|||
156875071|NCT04380519|566300615|FG000|Overall Study|Adverse Event|0|||
156875072|NCT04380519|566300616|FG001|Overall Study|Adverse Event|1|||
156875073|NCT04380519|566300617|FG002|Overall Study|Adverse Event|0|||
156875074|NCT04380519|566300615|FG000|Overall Study|relatives' decision|0|||
156875075|NCT04380519|566300616|FG001|Overall Study|relatives' decision|1|||
156875076|NCT04380519|566300617|FG002|Overall Study|relatives' decision|0|||
156875077|NCT05300763|566300620|FG000|Overall Study|Adverse Event|0|||
156875078|NCT05300763|566300621|FG001|Overall Study|Adverse Event|1|||
156875079|NCT05300763|566300620|FG000|Overall Study|Major Protocol Deviation|1|||
156875080|NCT05300763|566300621|FG001|Overall Study|Major Protocol Deviation|0|||
156875081|NCT05300763|566300620|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
156875082|NCT05300763|566300621|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
156875083|NCT01485172|566300622|FG000|Overall Study|Adverse Event|2|||
156448981|NCT03143153|564738399|FG002|Pre-Treatment|Other Reasons|1|||
156448982|NCT03143153|564738397|FG000|Pre-Treatment|Disease Progression|1|||
156448983|NCT03143153|564738398|FG001|Pre-Treatment|Disease Progression|1|||
156448984|NCT03143153|564738399|FG002|Pre-Treatment|Disease Progression|2|||
156448985|NCT03143153|564738397|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
156875084|NCT01485172|566300623|FG001|Overall Study|Adverse Event|1|||
156875085|NCT01485172|566300624|FG002|Overall Study|Adverse Event|2|||
156448986|NCT03143153|564738398|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
156448987|NCT03143153|564738399|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
156448988|NCT03143153|564738397|FG000|Treatment|Disease progression|174|||
156718078|NCT00428246|565713381|FG001|Overall Study|Withdrawal by Subject|0|||
156875086|NCT01485172|566300625|FG003|Overall Study|Adverse Event|2|||
156875087|NCT01485172|566300626|FG004|Overall Study|Adverse Event|1|||
156875088|NCT01485172|566300627|FG005|Overall Study|Adverse Event|2|||
156875089|NCT01485172|566300622|FG000|Overall Study|Lack of Efficacy|2|||
156875090|NCT01485172|566300623|FG001|Overall Study|Lack of Efficacy|0|||
156875091|NCT01485172|566300624|FG002|Overall Study|Lack of Efficacy|0|||
156875092|NCT01485172|566300625|FG003|Overall Study|Lack of Efficacy|0|||
156875093|NCT01485172|566300626|FG004|Overall Study|Lack of Efficacy|0|||
156875094|NCT01485172|566300627|FG005|Overall Study|Lack of Efficacy|0|||
156875095|NCT01485172|566300622|FG000|Overall Study|Protocol Violation|0|||
156875096|NCT01485172|566300623|FG001|Overall Study|Protocol Violation|0|||
156875097|NCT01485172|566300624|FG002|Overall Study|Protocol Violation|4|||
156875098|NCT01485172|566300625|FG003|Overall Study|Protocol Violation|5|||
156875099|NCT01485172|566300626|FG004|Overall Study|Protocol Violation|1|||
156875100|NCT01485172|566300627|FG005|Overall Study|Protocol Violation|0|||
156875101|NCT01485172|566300622|FG000|Overall Study|Protocol defined stopping criteria|1|||
156875102|NCT01485172|566300623|FG001|Overall Study|Protocol defined stopping criteria|0|||
156875103|NCT01485172|566300624|FG002|Overall Study|Protocol defined stopping criteria|0|||
156875104|NCT01485172|566300625|FG003|Overall Study|Protocol defined stopping criteria|0|||
156875105|NCT01485172|566300626|FG004|Overall Study|Protocol defined stopping criteria|1|||
156875106|NCT01485172|566300627|FG005|Overall Study|Protocol defined stopping criteria|0|||
156875107|NCT01485172|566300622|FG000|Overall Study|Lost to Follow-up|0|||
156875108|NCT01485172|566300623|FG001|Overall Study|Lost to Follow-up|0|||
156875109|NCT01485172|566300624|FG002|Overall Study|Lost to Follow-up|1|||
156875110|NCT01485172|566300625|FG003|Overall Study|Lost to Follow-up|0|||
156875111|NCT01485172|566300626|FG004|Overall Study|Lost to Follow-up|0|||
156875112|NCT01485172|566300627|FG005|Overall Study|Lost to Follow-up|1|||
156875113|NCT01485172|566300622|FG000|Overall Study|Physician Decision|0|||
156875114|NCT01485172|566300623|FG001|Overall Study|Physician Decision|0|||
156875115|NCT01485172|566300624|FG002|Overall Study|Physician Decision|0|||
156875116|NCT01485172|566300625|FG003|Overall Study|Physician Decision|0|||
156875117|NCT01485172|566300626|FG004|Overall Study|Physician Decision|1|||
156875118|NCT01485172|566300627|FG005|Overall Study|Physician Decision|0|||
156875119|NCT01485172|566300622|FG000|Overall Study|Withdrawal by Subject|2|||
156875120|NCT01485172|566300623|FG001|Overall Study|Withdrawal by Subject|0|||
156875121|NCT01485172|566300624|FG002|Overall Study|Withdrawal by Subject|0|||
156875122|NCT01485172|566300625|FG003|Overall Study|Withdrawal by Subject|1|||
156875123|NCT01485172|566300626|FG004|Overall Study|Withdrawal by Subject|1|||
156875124|NCT01485172|566300627|FG005|Overall Study|Withdrawal by Subject|1|||
156875125|NCT04995419|566300633|FG000|Overall Study|Withdrawal by Subject|3|||
156875126|NCT04995419|566300633|FG000|Overall Study|Progressive Disease|19|||
156875127|NCT04995419|566300633|FG000|Overall Study|Adverse Event|2|||
156875128|NCT04995419|566300633|FG000|Overall Study|Ongoing|16|||
156875129|NCT02948088|566300634|FG000|Overall Study|Lost to Follow-up|8|||
156875130|NCT02948088|566300634|FG000|Overall Study|Death|1|||
156875131|NCT02948088|566300634|FG000|Overall Study|Withdrawal by Subject|4|||
156875132|NCT02948088|566300634|FG000|Overall Study|Other|2|||
156875133|NCT00838513|566300635|FG000|Screening Period|Screen Failure|3|||
156875134|NCT00838513|566300635|FG000|Extension Treatment Period|Death|1|||
156875135|NCT00838513|566300635|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
156875136|NCT00975780|566300636|FG000|Follow Up|Death|88|||
156875137|NCT00975780|566300637|FG001|Follow Up|Death|122|||
156875138|NCT00975780|566300636|FG000|Follow Up|Facility Withdrawal|7|||
156875139|NCT00975780|566300637|FG001|Follow Up|Facility Withdrawal|23|||
156875140|NCT00975780|566300636|FG000|Follow Up|Discharged from Facility|7|||
156875141|NCT00975780|566300637|FG001|Follow Up|Discharged from Facility|12|||
156875142|NCT01976741|566300638|FG000|Overall Study|Withdrawal by Subject|1|||
156875143|NCT01976741|566300639|FG001|Overall Study|Withdrawal by Subject|0|||
156875144|NCT01976741|566300640|FG002|Overall Study|Withdrawal by Subject|1|||
156875145|NCT01976741|566300641|FG003|Overall Study|Withdrawal by Subject|1|||
156875146|NCT01976741|566300642|FG004|Overall Study|Withdrawal by Subject|0|||
156875147|NCT01976741|566300643|FG005|Overall Study|Withdrawal by Subject|0|||
156875148|NCT01976741|566300644|FG006|Overall Study|Withdrawal by Subject|1|||
156875149|NCT01976741|566300645|FG007|Overall Study|Withdrawal by Subject|4|||
156875150|NCT01976741|566300646|FG008|Overall Study|Withdrawal by Subject|0|||
156875151|NCT01976741|566300647|FG009|Overall Study|Withdrawal by Subject|0|||
156875152|NCT01976741|566300638|FG000|Overall Study|Adverse Event|0|||
156875153|NCT01976741|566300639|FG001|Overall Study|Adverse Event|0|||
156875154|NCT01976741|566300640|FG002|Overall Study|Adverse Event|2|||
156875155|NCT01976741|566300641|FG003|Overall Study|Adverse Event|0|||
156875156|NCT01976741|566300642|FG004|Overall Study|Adverse Event|0|||
156875157|NCT01976741|566300643|FG005|Overall Study|Adverse Event|0|||
156875158|NCT01976741|566300644|FG006|Overall Study|Adverse Event|3|||
156875159|NCT01976741|566300645|FG007|Overall Study|Adverse Event|8|||
156875160|NCT01976741|566300646|FG008|Overall Study|Adverse Event|1|||
156875161|NCT01976741|566300647|FG009|Overall Study|Adverse Event|4|||
156875162|NCT04999852|566300648|FG000|Overall Study|Withdrawal by Subject|11|||
156875163|NCT04999852|566300649|FG001|Overall Study|Withdrawal by Subject|1|||
156875164|NCT04999852|566300648|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
156875165|NCT04999852|566300649|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
156448989|NCT03143153|564738398|FG001|Treatment|Disease progression|184|||
156875166|NCT05626322|566300650|FG000|Overall Study|Death|2|||
156875167|NCT05626322|566300651|FG001|Overall Study|Death|0|||
156875168|NCT05626322|566300652|FG002|Overall Study|Death|0|||
156875169|NCT05626322|566300650|FG000|Overall Study|Physician Decision|1|||
156875170|NCT05626322|566300651|FG001|Overall Study|Physician Decision|0|||
156875171|NCT05626322|566300652|FG002|Overall Study|Physician Decision|0|||
156875172|NCT05626322|566300650|FG000|Overall Study|Progressive Disease|0|||
156875173|NCT05626322|566300651|FG001|Overall Study|Progressive Disease|1|||
156875174|NCT05626322|566300652|FG002|Overall Study|Progressive Disease|1|||
156875175|NCT05626322|566300650|FG000|Overall Study|Study terminated by sponsor|0|||
156448990|NCT03143153|564738399|FG002|Treatment|Disease progression|193|||
156448991|NCT03143153|564738397|FG000|Treatment|Study drug toxicity|59|||
156448992|NCT03143153|564738398|FG001|Treatment|Study drug toxicity|33|||
156448993|NCT03143153|564738399|FG002|Treatment|Study drug toxicity|40|||
156448994|NCT03143153|564738397|FG000|Treatment|Death|5|||
156448995|NCT03143153|564738398|FG001|Treatment|Death|3|||
156448996|NCT03143153|564738399|FG002|Treatment|Death|4|||
156875176|NCT05626322|566300651|FG001|Overall Study|Study terminated by sponsor|1|||
156875177|NCT05626322|566300652|FG002|Overall Study|Study terminated by sponsor|0|||
156875178|NCT03776812|566300653|FG000|Overall Study|Death|53|||
156875179|NCT03776812|566300654|FG001|Overall Study|Death|49|||
156875180|NCT03776812|566300655|FG002|Overall Study|Death|56|||
156875181|NCT03776812|566300653|FG000|Overall Study|Withdrawal by Subject|1|||
156875182|NCT03776812|566300654|FG001|Overall Study|Withdrawal by Subject|7|||
156875183|NCT03776812|566300655|FG002|Overall Study|Withdrawal by Subject|2|||
156875184|NCT03776812|566300653|FG000|Overall Study|Lost to Follow-up|1|||
156875185|NCT03776812|566300654|FG001|Overall Study|Lost to Follow-up|1|||
156875186|NCT03776812|566300655|FG002|Overall Study|Lost to Follow-up|0|||
156875187|NCT03776812|566300653|FG000|Overall Study|Did not enter long-term follow-up|3|||
156875188|NCT03776812|566300654|FG001|Overall Study|Did not enter long-term follow-up|3|||
156875189|NCT03776812|566300655|FG002|Overall Study|Did not enter long-term follow-up|2|||
156875190|NCT04758637|566300658|FG000|Overall Study|Lost to Follow-up|0|||
156875191|NCT04758637|566300659|FG001|Overall Study|Lost to Follow-up|1|||
156875192|NCT04758637|566300660|FG002|Overall Study|Lost to Follow-up|0|||
156875193|NCT04758637|566300661|FG003|Overall Study|Lost to Follow-up|0|||
156875194|NCT03350672|566300664|FG000|Overall Study|Withdrawal by Subject|7|||
156875195|NCT03350672|566300665|FG001|Overall Study|Withdrawal by Subject|0|||
156875196|NCT03350672|566300666|FG002|Overall Study|Withdrawal by Subject|0|||
156875197|NCT00048074|566300670|FG000|Overall Study|Adverse Event|46|||
156875198|NCT00048074|566300671|FG001|Overall Study|Adverse Event|41|||
156875199|NCT00048074|566300672|FG002|Overall Study|Adverse Event|53|||
156875200|NCT00048074|566300670|FG000|Overall Study|Death|3|||
156875201|NCT00048074|566300671|FG001|Overall Study|Death|3|||
156875202|NCT00048074|566300672|FG002|Overall Study|Death|2|||
156875203|NCT00048074|566300670|FG000|Overall Study|Lost to Follow-up|2|||
156875204|NCT00048074|566300671|FG001|Overall Study|Lost to Follow-up|6|||
156875205|NCT00048074|566300672|FG002|Overall Study|Lost to Follow-up|6|||
156875206|NCT00048074|566300670|FG000|Overall Study|Withdrawal by Subject|28|||
156875207|NCT00048074|566300671|FG001|Overall Study|Withdrawal by Subject|30|||
156875208|NCT00048074|566300672|FG002|Overall Study|Withdrawal by Subject|35|||
156875209|NCT00048074|566300670|FG000|Overall Study|Protocol Violation|1|||
156875210|NCT00048074|566300671|FG001|Overall Study|Protocol Violation|3|||
156875211|NCT00048074|566300672|FG002|Overall Study|Protocol Violation|0|||
156875212|NCT00048074|566300670|FG000|Overall Study|Study participation was terminated|0|||
156875213|NCT00048074|566300671|FG001|Overall Study|Study participation was terminated|1|||
156718079|NCT00428246|565713382|FG002|Overall Study|Withdrawal by Subject|1|||
156718080|NCT00428246|565713380|FG000|Overall Study|Adverse Event|1|||
156718081|NCT00428246|565713381|FG001|Overall Study|Adverse Event|0|||
156875214|NCT00048074|566300672|FG002|Overall Study|Study participation was terminated|0|||
156875215|NCT00048074|566300670|FG000|Overall Study|Husband ill|0|||
156875216|NCT00048074|566300671|FG001|Overall Study|Husband ill|1|||
156875217|NCT00048074|566300672|FG002|Overall Study|Husband ill|0|||
156875218|NCT00048074|566300670|FG000|Overall Study|Poor compliance|0|||
156875219|NCT00048074|566300671|FG001|Overall Study|Poor compliance|1|||
156875220|NCT00048074|566300672|FG002|Overall Study|Poor compliance|0|||
156875221|NCT00048074|566300670|FG000|Overall Study|Out of station|0|||
156875222|NCT00048074|566300671|FG001|Overall Study|Out of station|1|||
156448997|NCT03143153|564738397|FG000|Treatment|Adverse event unrelated to study drug|19|||
156448998|NCT03143153|564738398|FG001|Treatment|Adverse event unrelated to study drug|28|||
156448999|NCT03143153|564738399|FG002|Treatment|Adverse event unrelated to study drug|12|||
156718082|NCT00428246|565713382|FG002|Overall Study|Adverse Event|0|||
156718083|NCT03442751|565713386|FG000|Overall Study|Withdrawal by Subject|3|||
156718084|NCT03442751|565713387|FG001|Overall Study|Withdrawal by Subject|1|||
156718085|NCT03442751|565713386|FG000|Overall Study|Lost to Follow-up|3|||
156718086|NCT03442751|565713387|FG001|Overall Study|Lost to Follow-up|0|||
156718087|NCT02603887|565713390|FG000|Stage 1|Adverse Event|4|||
156718088|NCT02603887|565713390|FG000|Stage 1|Disease progression|1|||
156718089|NCT02603887|565713390|FG000|Stage 2|FDA guidance|1|||
156718090|NCT01308424|565713391|FG000|Baseline Eligibility|Screen Failures|71|||
156718091|NCT01308424|565713392|FG001|Baseline Eligibility|Screen Failures|0|||
156718092|NCT01308424|565713393|FG002|Baseline Eligibility|Screen Failures|0|||
156718093|NCT01308424|565713391|FG000|Randomization|Adverse Event|0|||
156875223|NCT00048074|566300672|FG002|Overall Study|Out of station|1|||
156875224|NCT00048074|566300670|FG000|Overall Study|Social reasons|1|||
156875225|NCT00048074|566300671|FG001|Overall Study|Social reasons|0|||
156875226|NCT00048074|566300672|FG002|Overall Study|Social reasons|0|||
156875227|NCT02873377|566300673|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
156875228|NCT02873377|566300674|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
156875229|NCT02873377|566300673|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
156875230|NCT02873377|566300674|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
156875231|NCT00993148|566300679|FG000|Overall Study|Lost to Follow-up|2|||
156875232|NCT00993148|566300679|FG000|Overall Study|never initiated treatment|1|||
156875233|NCT03568461|566300699|FG000|Overall Study|Death|7|||
156875234|NCT03568461|566300699|FG000|Overall Study|Physician Decision|5|||
156875235|NCT03568461|566300699|FG000|Overall Study|Subject decision|5|||
156875236|NCT03568461|566300699|FG000|Overall Study|Lost to Follow-up|1|||
156875237|NCT03387085|566300703|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
156875238|NCT00295880|566301976|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
156875239|NCT00295880|566301976|FG000|Overall Study|Unit randomization did not occur|1|||
156875240|NCT01243242|566301977|FG000|Overall Study|Adverse Event|1|||
156875241|NCT01243242|566301978|FG001|Overall Study|Adverse Event|1|||
156875242|NCT01243242|566301977|FG000|Overall Study|Withdrawal by Subject|1|||
156875243|NCT01243242|566301978|FG001|Overall Study|Withdrawal by Subject|1|||
156875244|NCT01243242|566301977|FG000|Overall Study|Physician Decision|0|||
156875245|NCT01243242|566301978|FG001|Overall Study|Physician Decision|1|||
156875246|NCT01243242|566301977|FG000|Overall Study|sponsor decision|0|||
156875247|NCT01243242|566301978|FG001|Overall Study|sponsor decision|1|||
156875248|NCT01243242|566301977|FG000|Overall Study|non compliance|1|||
156875249|NCT01243242|566301978|FG001|Overall Study|non compliance|0|||
156875250|NCT03983317|566301983|FG000|Overall Study|Physician Decision|5|||
156875251|NCT00552188|566301990|FG000|Overall Study|Adverse Event|0|||
156875252|NCT00552188|566301991|FG001|Overall Study|Adverse Event|2|||
156875253|NCT00552188|566301990|FG000|Overall Study|Lost to Follow-up|2|||
156875254|NCT00552188|566301991|FG001|Overall Study|Lost to Follow-up|1|||
156875255|NCT00552188|566301990|FG000|Overall Study|Withdrawal of consent|0|||
156875256|NCT00552188|566301991|FG001|Overall Study|Withdrawal of consent|1|||
156875257|NCT00552188|566301990|FG000|Overall Study|Subject returned to home country|0|||
156875258|NCT00552188|566301991|FG001|Overall Study|Subject returned to home country|1|||
156875259|NCT01256294|566301992|FG000|Overall Study|Adverse Event|1|||
156875260|NCT01256294|566301993|FG001|Overall Study|Adverse Event|0|||
156875261|NCT01256294|566301992|FG000|Overall Study|Withdrawal by Subject|1|||
156875262|NCT01256294|566301993|FG001|Overall Study|Withdrawal by Subject|1|||
156875263|NCT01256294|566301992|FG000|Overall Study|Protocol deviation|2|||
156875264|NCT01256294|566301993|FG001|Overall Study|Protocol deviation|1|||
156875265|NCT04681352|566301994|FG000|Overall Study|Lost to Follow-up|2|||
156875266|NCT04681352|566301994|FG000|Overall Study|Withdrawal by Subject|22|||
156875267|NCT03887702|566301995|FG000|Overall Study|Study terminated|0|||
156875268|NCT03887702|566301996|FG001|Overall Study|Study terminated|0|||
156875269|NCT03887702|566301997|FG002|Overall Study|Study terminated|2|||
156875270|NCT03887702|566301998|FG003|Overall Study|Study terminated|2|||
156875271|NCT01643772|566301999|FG000|Overall Study|Protocol Violation|0|||
156875272|NCT01643772|566302000|FG001|Overall Study|Protocol Violation|0|||
156875273|NCT01643772|566302001|FG002|Overall Study|Protocol Violation|0|||
156875274|NCT01643772|566302002|FG003|Overall Study|Protocol Violation|1|||
156875275|NCT01643772|566301999|FG000|Overall Study|Adverse Event|0|||
156875276|NCT01643772|566302000|FG001|Overall Study|Adverse Event|0|||
156875277|NCT01643772|566302001|FG002|Overall Study|Adverse Event|0|||
156875278|NCT01643772|566302002|FG003|Overall Study|Adverse Event|1|||
156875279|NCT03860818|566302005|FG000|Overall Study|Death|144|||
156875280|NCT03860818|566302006|FG001|Overall Study|Death|195|||
156875281|NCT03860818|566302005|FG000|Overall Study|Graft Loss|32|||
156875282|NCT03860818|566302006|FG001|Overall Study|Graft Loss|45|||
156875283|NCT00792571|566302007|FG000|Overall Study|Death|1|||
156875284|NCT00792571|566302007|FG000|Overall Study|Adverse Event|4|||
156875285|NCT00792571|566302007|FG000|Overall Study|Withdrawal by Subject|1|||
156875286|NCT00792571|566302007|FG000|Overall Study|Other|4|||
156875287|NCT02600819|566302008|FG000|GEN Phase|Adverse Event|2|||
156875288|NCT02600819|566302009|FG001|GEN Phase|Adverse Event|0|||
156875289|NCT02600819|566302008|FG000|GEN Phase|Death|2|||
156875290|NCT02600819|566302009|FG001|GEN Phase|Death|0|||
156875291|NCT02600819|566302008|FG000|GEN Phase|Investigator's Discretion|4|||
156875292|NCT02600819|566302009|FG001|GEN Phase|Investigator's Discretion|0|||
156875293|NCT02600819|566302008|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
156875294|NCT02600819|566302009|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
156875295|NCT02600819|566302008|FG000|GEN Phase|Withdrew Consent|5|||
156875296|NCT02600819|566302009|FG001|GEN Phase|Withdrew Consent|0|||
156875297|NCT02600819|566302008|FG000|GEN Phase|Lost to Follow-up|2|||
156875298|NCT02600819|566302009|FG001|GEN Phase|Lost to Follow-up|0|||
156875299|NCT01621802|566302011|FG000|Overall Study|Protocol Violation|0|||
156449000|NCT03143153|564738397|FG000|Treatment|Participant request to discontinue study treatment|13|||
156875300|NCT01621802|566302012|FG001|Overall Study|Protocol Violation|0|||
156875301|NCT01621802|566302013|FG002|Overall Study|Protocol Violation|0|||
156875302|NCT01621802|566302014|FG003|Overall Study|Protocol Violation|0|||
156875303|NCT01621802|566302015|FG004|Overall Study|Protocol Violation|0|||
156875304|NCT01621802|566302016|FG005|Overall Study|Protocol Violation|1|||
156875305|NCT01621802|566302011|FG000|Overall Study|Withdrawal by Subject|8|||
156875306|NCT01621802|566302012|FG001|Overall Study|Withdrawal by Subject|4|||
156875307|NCT01621802|566302013|FG002|Overall Study|Withdrawal by Subject|4|||
156718094|NCT01308424|565713392|FG001|Randomization|Adverse Event|1|||
156718095|NCT01308424|565713393|FG002|Randomization|Adverse Event|1|||
156718096|NCT01308424|565713391|FG000|Randomization|Lost to Follow-up|0|||
156718097|NCT01308424|565713392|FG001|Randomization|Lost to Follow-up|1|||
156875308|NCT01621802|566302014|FG003|Overall Study|Withdrawal by Subject|2|||
156875309|NCT01621802|566302015|FG004|Overall Study|Withdrawal by Subject|2|||
156875310|NCT01621802|566302016|FG005|Overall Study|Withdrawal by Subject|0|||
156875311|NCT01621802|566302011|FG000|Overall Study|Migrated/moved from study area|0|||
156875312|NCT01621802|566302012|FG001|Overall Study|Migrated/moved from study area|0|||
156875313|NCT01621802|566302013|FG002|Overall Study|Migrated/moved from study area|2|||
156875314|NCT01621802|566302014|FG003|Overall Study|Migrated/moved from study area|0|||
156875315|NCT01621802|566302015|FG004|Overall Study|Migrated/moved from study area|1|||
156718098|NCT01308424|565713393|FG002|Randomization|Lost to Follow-up|0|||
156718099|NCT01308424|565713391|FG000|Randomization|Physician Decision|0|||
156718100|NCT01308424|565713392|FG001|Randomization|Physician Decision|1|||
156718101|NCT01308424|565713393|FG002|Randomization|Physician Decision|1|||
156718102|NCT04620746|565713394|FG000|Overall Study|Adverse Event|2|||
156718103|NCT04620746|565713395|FG001|Overall Study|Adverse Event|0|||
156718104|NCT04620746|565713394|FG000|Overall Study|Uniterpretable skin test|1|||
156718105|NCT04620746|565713395|FG001|Overall Study|Uniterpretable skin test|0|||
156718106|NCT04620746|565713394|FG000|Overall Study|Withdrawal by Subject|0|||
156718107|NCT04620746|565713395|FG001|Overall Study|Withdrawal by Subject|1|||
156718108|NCT05767905|565713398|FG000|Overall Study|Adverse Event|0|||
156718109|NCT05767905|565713399|FG001|Overall Study|Adverse Event|0|||
156718110|NCT05767905|565713400|FG002|Overall Study|Adverse Event|1|||
156718111|NCT01841593|565713403|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
156718112|NCT01841593|565713404|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
156718113|NCT01841593|565713403|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
156718114|NCT01841593|565713404|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
156718115|NCT03125798|565713405|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
156718116|NCT03125798|565713406|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
156718117|NCT03125798|565713405|FG000|Overall Study|Conversion to thoracotomy|7|||
156718118|NCT03125798|565713406|FG001|Overall Study|Conversion to thoracotomy|7|||
156718119|NCT00262028|565713415|FG000|Overall Study|Withdrawal by Subject|6|||
156718120|NCT00262028|565713416|FG001|Overall Study|Withdrawal by Subject|3|||
156718121|NCT00262028|565713417|FG002|Overall Study|Withdrawal by Subject|6|||
156718122|NCT00262028|565713418|FG003|Overall Study|Withdrawal by Subject|5|||
156718123|NCT00262028|565713419|FG004|Overall Study|Withdrawal by Subject|2|||
156718124|NCT00262028|565713420|FG005|Overall Study|Withdrawal by Subject|3|||
156718125|NCT00262028|565713421|FG006|Overall Study|Withdrawal by Subject|5|||
156718126|NCT00262028|565713422|FG007|Overall Study|Withdrawal by Subject|7|||
156718127|NCT00262028|565713423|FG008|Overall Study|Withdrawal by Subject|2|||
156718128|NCT00262028|565713415|FG000|Overall Study|Lost to Follow-up|7|||
156718129|NCT00262028|565713416|FG001|Overall Study|Lost to Follow-up|7|||
156718130|NCT00262028|565713417|FG002|Overall Study|Lost to Follow-up|5|||
156718131|NCT00262028|565713418|FG003|Overall Study|Lost to Follow-up|5|||
156718132|NCT00262028|565713419|FG004|Overall Study|Lost to Follow-up|4|||
156718133|NCT00262028|565713420|FG005|Overall Study|Lost to Follow-up|3|||
156718134|NCT00262028|565713421|FG006|Overall Study|Lost to Follow-up|3|||
156718135|NCT00262028|565713422|FG007|Overall Study|Lost to Follow-up|5|||
156718136|NCT00262028|565713423|FG008|Overall Study|Lost to Follow-up|6|||
156718137|NCT00262028|565713415|FG000|Overall Study|Administrative Reason|11|||
156718138|NCT00262028|565713416|FG001|Overall Study|Administrative Reason|14|||
156718139|NCT00262028|565713417|FG002|Overall Study|Administrative Reason|9|||
156718140|NCT00262028|565713418|FG003|Overall Study|Administrative Reason|12|||
156718141|NCT00262028|565713419|FG004|Overall Study|Administrative Reason|6|||
156718142|NCT00262028|565713420|FG005|Overall Study|Administrative Reason|7|||
156718143|NCT00262028|565713421|FG006|Overall Study|Administrative Reason|4|||
156718144|NCT00262028|565713422|FG007|Overall Study|Administrative Reason|6|||
156718145|NCT00262028|565713423|FG008|Overall Study|Administrative Reason|10|||
156718146|NCT00262028|565713415|FG000|Overall Study|Protocol Violation|0|||
156718147|NCT00262028|565713416|FG001|Overall Study|Protocol Violation|0|||
156718148|NCT00262028|565713417|FG002|Overall Study|Protocol Violation|0|||
156335063|NCT00116428|564324497|FG000|Overall Study|Did not meet inclusion criteria|1|||
156718149|NCT00262028|565713418|FG003|Overall Study|Protocol Violation|1|||
156718150|NCT00262028|565713419|FG004|Overall Study|Protocol Violation|0|||
156718151|NCT00262028|565713420|FG005|Overall Study|Protocol Violation|0|||
156875316|NCT01621802|566302016|FG005|Overall Study|Migrated/moved from study area|0|||
156875317|NCT01621802|566302011|FG000|Overall Study|Others|3|||
156875318|NCT01621802|566302012|FG001|Overall Study|Others|3|||
156335064|NCT00116428|564324498|FG001|Overall Study|Did not meet inclusion criteria|0|||
156335065|NCT01032174|564324499|FG000|Overall Study|Adverse Event|0|||
156335066|NCT01032174|564324500|FG001|Overall Study|Adverse Event|1|||
156335067|NCT00910273|564324502|FG000|Overall Study|Lack of Efficacy|6|||
156335068|NCT00910273|564324503|FG001|Overall Study|Lack of Efficacy|9|||
156335069|NCT00910273|564324502|FG000|Overall Study|Adverse Event|1|||
156718152|NCT00262028|565713421|FG006|Overall Study|Protocol Violation|0|||
156718153|NCT00262028|565713422|FG007|Overall Study|Protocol Violation|0|||
156718154|NCT00262028|565713423|FG008|Overall Study|Protocol Violation|0|||
156718155|NCT00262028|565713415|FG000|Overall Study|Unable to classify|0|||
156718156|NCT00262028|565713416|FG001|Overall Study|Unable to classify|3|||
156718157|NCT00262028|565713417|FG002|Overall Study|Unable to classify|0|||
156718158|NCT00262028|565713418|FG003|Overall Study|Unable to classify|0|||
156718159|NCT00262028|565713419|FG004|Overall Study|Unable to classify|0|||
156718160|NCT00262028|565713420|FG005|Overall Study|Unable to classify|0|||
156718161|NCT00262028|565713421|FG006|Overall Study|Unable to classify|0|||
156718162|NCT00262028|565713422|FG007|Overall Study|Unable to classify|0|||
156718163|NCT00262028|565713423|FG008|Overall Study|Unable to classify|1|||
156718164|NCT01515423|565713424|FG000|Open Label Phase|Adverse Event|57|||
156718165|NCT01515423|565713425|FG001|Open Label Phase|Adverse Event|0|||
156718166|NCT01515423|565713426|FG002|Open Label Phase|Adverse Event|0|||
156718167|NCT01515423|565713424|FG000|Open Label Phase|Death|2|||
156718168|NCT01515423|565713425|FG001|Open Label Phase|Death|0|||
156718169|NCT01515423|565713426|FG002|Open Label Phase|Death|0|||
156718170|NCT01515423|565713424|FG000|Open Label Phase|Lack of Efficacy|117|||
156718171|NCT01515423|565713425|FG001|Open Label Phase|Lack of Efficacy|0|||
156718172|NCT01515423|565713426|FG002|Open Label Phase|Lack of Efficacy|0|||
156718173|NCT01515423|565713424|FG000|Open Label Phase|Lost to Follow-up|21|||
156718174|NCT01515423|565713425|FG001|Open Label Phase|Lost to Follow-up|0|||
156718175|NCT01515423|565713426|FG002|Open Label Phase|Lost to Follow-up|0|||
156718176|NCT01515423|565713424|FG000|Open Label Phase|Withdrawal by Subject|118|||
156718177|NCT01515423|565713425|FG001|Open Label Phase|Withdrawal by Subject|0|||
156718178|NCT01515423|565713426|FG002|Open Label Phase|Withdrawal by Subject|0|||
156718179|NCT01515423|565713424|FG000|Open Label Phase|excluded from DB Phase|70|||
156718180|NCT01515423|565713425|FG001|Open Label Phase|excluded from DB Phase|0|||
156718181|NCT01515423|565713426|FG002|Open Label Phase|excluded from DB Phase|0|||
156718182|NCT01515423|565713424|FG000|Open Label Phase|Other|28|||
156718183|NCT01515423|565713425|FG001|Open Label Phase|Other|0|||
156718184|NCT01515423|565713426|FG002|Open Label Phase|Other|0|||
156718185|NCT01515423|565713424|FG000|DOUBLE BLIND|Adverse Event|0|||
156718186|NCT01515423|565713425|FG001|DOUBLE BLIND|Adverse Event|15|||
156718187|NCT01515423|565713426|FG002|DOUBLE BLIND|Adverse Event|13|||
156718188|NCT01515423|565713424|FG000|DOUBLE BLIND|Death|0|||
156718189|NCT01515423|565713425|FG001|DOUBLE BLIND|Death|1|||
156718190|NCT01515423|565713426|FG002|DOUBLE BLIND|Death|2|||
156718191|NCT01515423|565713424|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
156718192|NCT01515423|565713425|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
156718193|NCT01515423|565713426|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
156718194|NCT01515423|565713424|FG000|DOUBLE BLIND|Pregnancy|0|||
156718195|NCT01515423|565713425|FG001|DOUBLE BLIND|Pregnancy|2|||
156718196|NCT01515423|565713426|FG002|DOUBLE BLIND|Pregnancy|0|||
156718197|NCT01515423|565713424|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
156718198|NCT01515423|565713425|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
156718199|NCT01515423|565713426|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
156718200|NCT01515423|565713424|FG000|DOUBLE BLIND|Other|0|||
156718201|NCT01515423|565713425|FG001|DOUBLE BLIND|Other|6|||
156718202|NCT01515423|565713426|FG002|DOUBLE BLIND|Other|12|||
156718203|NCT01515423|565713424|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
156718204|NCT01515423|565713425|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
156718205|NCT01515423|565713426|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
156718206|NCT00613171|565713431|FG000|Overall Study|Adverse Event|7|||
156718207|NCT00613171|565713431|FG000|Overall Study|Withdrawal by Subject|3|||
156718208|NCT00613171|565713431|FG000|Overall Study|Reason not Specified|4|||
156718209|NCT02860546|565713433|FG000|Overall Study|Clinical Progression|6|||
156793763|NCT00507507|565997503|FG001|Treatment Period|Withdrawal by Subject|47|||
156793764|NCT00507507|565997502|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
156793765|NCT00507507|565997503|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
156793766|NCT00507507|565997502|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
156793767|NCT00507507|565997503|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
156793768|NCT00507507|565997502|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
156718210|NCT02860546|565713433|FG000|Overall Study|Radiological Progression|12|||
156718211|NCT00995774|565713436|FG000|Training Period 2|Withdrawal by Subject|2|||
156718212|NCT00995774|565713437|FG001|Training Period 2|Withdrawal by Subject|0|||
156449001|NCT03143153|564738398|FG001|Treatment|Participant request to discontinue study treatment|15|||
156449002|NCT03143153|564738399|FG002|Treatment|Participant request to discontinue study treatment|20|||
156449003|NCT03143153|564738397|FG000|Treatment|Participant withdrew consent|3|||
156449004|NCT03143153|564738398|FG001|Treatment|Participant withdrew consent|4|||
156449005|NCT03143153|564738399|FG002|Treatment|Participant withdrew consent|12|||
156449006|NCT03143153|564738397|FG000|Treatment|Pregnancy|1|||
156449007|NCT03143153|564738398|FG001|Treatment|Pregnancy|0|||
156449008|NCT03143153|564738399|FG002|Treatment|Pregnancy|0|||
156449009|NCT03143153|564738397|FG000|Treatment|Maximum clinical benefit|1|||
156449010|NCT03143153|564738398|FG001|Treatment|Maximum clinical benefit|3|||
156449011|NCT03143153|564738399|FG002|Treatment|Maximum clinical benefit|4|||
156449012|NCT03143153|564738397|FG000|Treatment|Completed treatment as per Protocol|13|||
156718213|NCT00683657|565713442|FG000|Overall Study|Adverse Event|0|||
156718214|NCT00683657|565713443|FG001|Overall Study|Adverse Event|1|||
156718215|NCT00683657|565713442|FG000|Overall Study|Subject Withdrew Consent|1|||
156718216|NCT00683657|565713443|FG001|Overall Study|Subject Withdrew Consent|0|||
156718217|NCT00972595|565713444|FG000|Period 1|Adverse Event|1|||
156718218|NCT00972595|565713445|FG001|Period 1|Adverse Event|0|||
156718219|NCT01112059|565713446|FG000|Overall Study|Withdrawal by Subject|1|||
156718220|NCT01112059|565713447|FG001|Overall Study|Withdrawal by Subject|0|||
156718221|NCT03567980|565713448|FG000|Overall Study|Adverse Event|1|||
156718222|NCT02575833|565713449|FG000|Overall Study|Withdrawal by Subject|0|||
156718223|NCT02575833|565713450|FG001|Overall Study|Withdrawal by Subject|1|||
156718224|NCT02575833|565713449|FG000|Overall Study|Lost to Follow-up|1|||
156718225|NCT02575833|565713450|FG001|Overall Study|Lost to Follow-up|0|||
156718226|NCT00967330|565713451|FG000|Overall Study|Protocol Violation|3|||
156718227|NCT00967330|565713452|FG001|Overall Study|Protocol Violation|4|||
156718228|NCT00967330|565713451|FG000|Overall Study|Regular|10|||
156718229|NCT00967330|565713452|FG001|Overall Study|Regular|3|||
156718230|NCT00967330|565713451|FG000|Overall Study|Withdrawal by Subject|6|||
156718231|NCT00967330|565713452|FG001|Overall Study|Withdrawal by Subject|0|||
156718232|NCT00967330|565713451|FG000|Overall Study|Lost to Follow-up|1|||
156718233|NCT00967330|565713452|FG001|Overall Study|Lost to Follow-up|1|||
156718234|NCT00967330|565713451|FG000|Overall Study|Death|102|||
156718235|NCT00967330|565713452|FG001|Overall Study|Death|51|||
156718236|NCT00967330|565713451|FG000|Overall Study|Severe protocol deviation|0|||
156718237|NCT00967330|565713452|FG001|Overall Study|Severe protocol deviation|1|||
156718238|NCT02698163|565713453|FG000|Overall Study|Lost to Follow-up|0|||
156718239|NCT02698163|565713454|FG001|Overall Study|Lost to Follow-up|1|||
156718240|NCT01133067|565713455|FG000|Overall Study|Death|136|||
156718241|NCT01133067|565713455|FG000|Overall Study|Lost to Follow-up|3|||
156718242|NCT00349973|565713456|FG000|Overall Study|Adverse Event|3|||
156718243|NCT00349973|565713457|FG001|Overall Study|Adverse Event|3|||
156718244|NCT00349973|565713456|FG000|Overall Study|Withdrawal by Subject|1|||
156718245|NCT00349973|565713457|FG001|Overall Study|Withdrawal by Subject|0|||
156718246|NCT02548143|565713458|FG000|Overall Study|Adverse Event|1|||
156718247|NCT02548143|565713459|FG001|Overall Study|Adverse Event|0|||
156718248|NCT02548143|565713458|FG000|Overall Study|Withdrawal by Subject|0|||
156718249|NCT02548143|565713459|FG001|Overall Study|Withdrawal by Subject|1|||
156718250|NCT05620082|565713463|FG000|Overall Study|Discharged before study end|1|||
156718251|NCT05620082|565713464|FG001|Overall Study|Discharged before study end|4|||
156718252|NCT05620082|565713465|FG002|Overall Study|Discharged before study end|0|||
156718253|NCT05620082|565713463|FG000|Overall Study|Moved to a different ward|1|||
156718254|NCT05620082|565713464|FG001|Overall Study|Moved to a different ward|0|||
156718255|NCT05620082|565713465|FG002|Overall Study|Moved to a different ward|0|||
156718256|NCT05620082|565713463|FG000|Overall Study|Feeling too unwell|1|||
156718257|NCT05620082|565713464|FG001|Overall Study|Feeling too unwell|0|||
156718258|NCT05620082|565713465|FG002|Overall Study|Feeling too unwell|0|||
156718259|NCT02019472|565715153|FG000|Overall Study|Adverse Event|14|||
156718260|NCT02019472|565715154|FG001|Overall Study|Adverse Event|23|||
156718261|NCT02019472|565715155|FG002|Overall Study|Adverse Event|17|||
156718262|NCT02019472|565715153|FG000|Overall Study|Death|0|||
156718263|NCT02019472|565715154|FG001|Overall Study|Death|1|||
156718264|NCT02019472|565715155|FG002|Overall Study|Death|1|||
156718265|NCT02019472|565715153|FG000|Overall Study|Lack of Efficacy|7|||
156718266|NCT02019472|565715154|FG001|Overall Study|Lack of Efficacy|4|||
156718267|NCT02019472|565715155|FG002|Overall Study|Lack of Efficacy|4|||
156718268|NCT02019472|565715153|FG000|Overall Study|Lost to Follow-up|0|||
156718269|NCT02019472|565715154|FG001|Overall Study|Lost to Follow-up|2|||
156718270|NCT02019472|565715155|FG002|Overall Study|Lost to Follow-up|1|||
156718271|NCT02019472|565715153|FG000|Overall Study|Physician Decision|1|||
156718272|NCT02019472|565715154|FG001|Overall Study|Physician Decision|2|||
156718273|NCT02019472|565715155|FG002|Overall Study|Physician Decision|0|||
156718274|NCT02019472|565715153|FG000|Overall Study|Pregnancy|1|||
156718275|NCT02019472|565715154|FG001|Overall Study|Pregnancy|2|||
156718276|NCT02019472|565715155|FG002|Overall Study|Pregnancy|2|||
156718277|NCT02019472|565715153|FG000|Overall Study|Withdrawal by Subject|11|||
156718278|NCT02019472|565715154|FG001|Overall Study|Withdrawal by Subject|10|||
156449013|NCT03143153|564738398|FG001|Treatment|Completed treatment as per Protocol|8|||
156449014|NCT03143153|564738399|FG002|Treatment|Completed treatment as per Protocol|0|||
156875319|NCT01621802|566302013|FG002|Overall Study|Others|3|||
156449015|NCT03143153|564738397|FG000|Treatment|Other reasons|12|||
156449016|NCT03143153|564738398|FG001|Treatment|Other reasons|7|||
156718279|NCT02019472|565715155|FG002|Overall Study|Withdrawal by Subject|11|||
156718280|NCT02019472|565715153|FG000|Overall Study|Other|3|||
156449017|NCT03143153|564738399|FG002|Treatment|Other reasons|15|||
156718281|NCT02019472|565715154|FG001|Overall Study|Other|8|||
156718282|NCT02019472|565715155|FG002|Overall Study|Other|6|||
156718283|NCT00513695|565715156|FG000|Overall Study|Discontinued therapy|2|||
156718284|NCT00513695|565715156|FG000|Overall Study|Progression prior to surgery|3|||
156718285|NCT01866826|565715157|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
156718286|NCT01866826|565715158|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
156718287|NCT01866826|565715157|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
156718288|NCT01866826|565715158|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
156718289|NCT01866826|565715157|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
156718290|NCT01866826|565715158|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
156718291|NCT02288312|565715159|FG000|Overall Study|Pregnancy|1|||
156718292|NCT02288312|565715160|FG001|Overall Study|Pregnancy|0|||
156718293|NCT02288312|565715161|FG002|Overall Study|Pregnancy|0|||
156718294|NCT01276041|565715162|FG000|Overall Study|Adverse Event|2|||
156718295|NCT01276041|565715162|FG000|Overall Study|Protocol Violation|1|||
156718296|NCT00725491|565715163|FG000|Overall Study|Adverse Event|3|||
156718297|NCT00725491|565715164|FG001|Overall Study|Adverse Event|2|||
156718298|NCT00725491|565715163|FG000|Overall Study|Pregnancy|0|||
156718299|NCT00725491|565715164|FG001|Overall Study|Pregnancy|3|||
156718300|NCT00725491|565715163|FG000|Overall Study|Risk for hyperstimulation|2|||
156718301|NCT00725491|565715164|FG001|Overall Study|Risk for hyperstimulation|9|||
156718302|NCT00725491|565715163|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
156718303|NCT00725491|565715164|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
156718304|NCT00725491|565715163|FG000|Overall Study|Fertilization failure|0|||
156718305|NCT00725491|565715164|FG001|Overall Study|Fertilization failure|1|||
156718306|NCT00725491|565715163|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
156718307|NCT00725491|565715164|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
156718308|NCT01495000|565715167|FG000|Overall Study|Lost to Follow-up|2|||
156718309|NCT01495000|565715168|FG001|Overall Study|Lost to Follow-up|2|||
156718310|NCT01495000|565715167|FG000|Overall Study|Protocol Violation|1|||
156718311|NCT01495000|565715168|FG001|Overall Study|Protocol Violation|0|||
156718312|NCT01495000|565715167|FG000|Overall Study|Withdrawal by Subject|10|||
156718313|NCT01495000|565715168|FG001|Overall Study|Withdrawal by Subject|10|||
156718314|NCT02070965|565715169|FG000|Overall Study|Lost to Follow-up|0|||
156718315|NCT02070965|565715170|FG001|Overall Study|Lost to Follow-up|1|||
156718316|NCT02070965|565715171|FG002|Overall Study|Lost to Follow-up|0|||
156718317|NCT02070965|565715169|FG000|Overall Study|Withdrawal by Subject|1|||
156718318|NCT02070965|565715170|FG001|Overall Study|Withdrawal by Subject|1|||
156718319|NCT02070965|565715171|FG002|Overall Study|Withdrawal by Subject|1|||
156718320|NCT02070965|565715169|FG000|Overall Study|Subject moved|1|||
156718321|NCT02070965|565715170|FG001|Overall Study|Subject moved|0|||
156718322|NCT02070965|565715171|FG002|Overall Study|Subject moved|0|||
156718323|NCT02968576|565715172|FG000|Overall Study|Pregnancy|0|||
156718324|NCT02968576|565715173|FG001|Overall Study|Pregnancy|1|||
156718325|NCT02058069|565715176|FG000|Overall Study|Exclusion due to implant size|5|||
156718326|NCT02058069|565715176|FG000|Overall Study|Withdrawal by Subject|6|||
156718327|NCT02222922|565715177|FG000|Overall Study|Death|0|||
156718328|NCT02222922|565715178|FG001|Overall Study|Death|0|||
156718329|NCT02222922|565715179|FG002|Overall Study|Death|0|||
156718330|NCT02222922|565715180|FG003|Overall Study|Death|0|||
156718331|NCT02222922|565715181|FG004|Overall Study|Death|13|||
156718332|NCT02222922|565715182|FG005|Overall Study|Death|0|||
156718333|NCT02222922|565715183|FG006|Overall Study|Death|0|||
156718334|NCT02222922|565715184|FG007|Overall Study|Death|0|||
156718335|NCT02222922|565715185|FG008|Overall Study|Death|2|||
156718336|NCT02222922|565715177|FG000|Overall Study|Lost to Follow-up|0|||
156718337|NCT02222922|565715178|FG001|Overall Study|Lost to Follow-up|0|||
156718338|NCT02222922|565715179|FG002|Overall Study|Lost to Follow-up|1|||
156718339|NCT02222922|565715180|FG003|Overall Study|Lost to Follow-up|0|||
156718340|NCT02222922|565715181|FG004|Overall Study|Lost to Follow-up|9|||
156718341|NCT02222922|565715182|FG005|Overall Study|Lost to Follow-up|1|||
156718342|NCT02222922|565715183|FG006|Overall Study|Lost to Follow-up|0|||
156718343|NCT02222922|565715184|FG007|Overall Study|Lost to Follow-up|0|||
156793769|NCT00507507|565997503|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
156793770|NCT03249558|565997504|FG000|Overall Study|Lost to Follow-up|2|||
156793771|NCT03249558|565997505|FG001|Overall Study|Lost to Follow-up|1|||
156793772|NCT03249558|565997506|FG002|Overall Study|Lost to Follow-up|4|||
156449018|NCT03143153|564738397|FG000|Treatment|Not reported|1|||
156718344|NCT02222922|565715185|FG008|Overall Study|Lost to Follow-up|0|||
156718345|NCT02222922|565715177|FG000|Overall Study|Other|0|||
156718346|NCT02222922|565715178|FG001|Overall Study|Other|0|||
156718347|NCT02222922|565715179|FG002|Overall Study|Other|0|||
156718348|NCT02222922|565715180|FG003|Overall Study|Other|2|||
156718349|NCT02222922|565715181|FG004|Overall Study|Other|10|||
156718350|NCT02222922|565715182|FG005|Overall Study|Other|2|||
156718351|NCT02222922|565715183|FG006|Overall Study|Other|2|||
156718352|NCT02222922|565715184|FG007|Overall Study|Other|4|||
156718353|NCT02222922|565715185|FG008|Overall Study|Other|1|||
156718354|NCT02222922|565715177|FG000|Overall Study|Participant refused further follow-up|1|||
156793773|NCT03249558|565997504|FG000|Overall Study|Physician Decision|1|||
156718355|NCT02222922|565715178|FG001|Overall Study|Participant refused further follow-up|0|||
156718356|NCT02222922|565715179|FG002|Overall Study|Participant refused further follow-up|0|||
156718357|NCT02222922|565715180|FG003|Overall Study|Participant refused further follow-up|1|||
156793774|NCT03249558|565997505|FG001|Overall Study|Physician Decision|0|||
156449019|NCT03143153|564738398|FG001|Treatment|Not reported|0|||
156449020|NCT03143153|564738399|FG002|Treatment|Not reported|0|||
156449021|NCT04237298|564738400|FG000|Overall Study|Lost to Follow-up|4|||
156449022|NCT04237298|564738401|FG001|Overall Study|Lost to Follow-up|5|||
156449023|NCT04556656|564738404|FG000|Overall Study|Withdrawal by Subject|14|||
156449024|NCT04556656|564738405|FG001|Overall Study|Withdrawal by Subject|12|||
156718358|NCT02222922|565715181|FG004|Overall Study|Participant refused further follow-up|6|||
156718359|NCT02222922|565715182|FG005|Overall Study|Participant refused further follow-up|0|||
156718360|NCT02222922|565715183|FG006|Overall Study|Participant refused further follow-up|0|||
156718361|NCT02222922|565715184|FG007|Overall Study|Participant refused further follow-up|0|||
156718362|NCT02222922|565715185|FG008|Overall Study|Participant refused further follow-up|3|||
156718363|NCT02002221|565715186|FG000|Overall Study|Adverse Event|2|||
156718364|NCT02002221|565715187|FG001|Overall Study|Adverse Event|1|||
156718365|NCT02002221|565715186|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156718366|NCT02002221|565715187|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156718367|NCT02002221|565715186|FG000|Overall Study|Patient withdrew consent|0|||
156718368|NCT02002221|565715187|FG001|Overall Study|Patient withdrew consent|1|||
156718369|NCT01998919|565715188|FG000|Overall Study|Death|2|||
156718370|NCT01998919|565715189|FG001|Overall Study|Death|2|||
156718371|NCT01998919|565715188|FG000|Overall Study|Adverse Event|0|||
156718372|NCT01998919|565715189|FG001|Overall Study|Adverse Event|5|||
156718373|NCT01998919|565715188|FG000|Overall Study|Disease progression|31|||
156718374|NCT01998919|565715189|FG001|Overall Study|Disease progression|22|||
156718375|NCT01998919|565715188|FG000|Overall Study|Withdrawal by Subject|2|||
156718376|NCT01998919|565715189|FG001|Overall Study|Withdrawal by Subject|4|||
156718377|NCT01998919|565715188|FG000|Overall Study|Lost to Follow-up|2|||
156718378|NCT01998919|565715189|FG001|Overall Study|Lost to Follow-up|0|||
156718379|NCT01998919|565715188|FG000|Overall Study|Other|5|||
156718380|NCT01998919|565715189|FG001|Overall Study|Other|2|||
156718381|NCT01068860|565715190|FG000|Overall Study|Withdrawal by Subject|0|||
156718382|NCT01068860|565715191|FG001|Overall Study|Withdrawal by Subject|0|||
156718383|NCT01068860|565715192|FG002|Overall Study|Withdrawal by Subject|0|||
156718384|NCT01068860|565715193|FG003|Overall Study|Withdrawal by Subject|0|||
156718385|NCT01068860|565715194|FG004|Overall Study|Withdrawal by Subject|0|||
156718386|NCT01068860|565715195|FG005|Overall Study|Withdrawal by Subject|2|||
156718387|NCT01068860|565715196|FG006|Overall Study|Withdrawal by Subject|0|||
156718388|NCT01068860|565715197|FG007|Overall Study|Withdrawal by Subject|0|||
156718389|NCT01068860|565715198|FG008|Overall Study|Withdrawal by Subject|0|||
156718390|NCT01068860|565715199|FG009|Overall Study|Withdrawal by Subject|3|||
156718391|NCT01068860|565715190|FG000|Overall Study|Administrative problems; misrandomized|0|||
156718392|NCT01068860|565715191|FG001|Overall Study|Administrative problems; misrandomized|0|||
156718393|NCT01068860|565715192|FG002|Overall Study|Administrative problems; misrandomized|0|||
156718394|NCT01068860|565715193|FG003|Overall Study|Administrative problems; misrandomized|1|||
156718395|NCT01068860|565715194|FG004|Overall Study|Administrative problems; misrandomized|0|||
156718396|NCT01068860|565715195|FG005|Overall Study|Administrative problems; misrandomized|0|||
156718397|NCT01068860|565715196|FG006|Overall Study|Administrative problems; misrandomized|0|||
156718398|NCT01068860|565715197|FG007|Overall Study|Administrative problems; misrandomized|0|||
156718399|NCT01068860|565715198|FG008|Overall Study|Administrative problems; misrandomized|0|||
156718400|NCT01068860|565715199|FG009|Overall Study|Administrative problems; misrandomized|1|||
156718401|NCT01068860|565715190|FG000|Overall Study|Lost to Follow-up|0|||
156718402|NCT01068860|565715191|FG001|Overall Study|Lost to Follow-up|1|||
156718403|NCT01068860|565715192|FG002|Overall Study|Lost to Follow-up|0|||
156718404|NCT01068860|565715193|FG003|Overall Study|Lost to Follow-up|0|||
156718405|NCT01068860|565715194|FG004|Overall Study|Lost to Follow-up|0|||
156718406|NCT01068860|565715195|FG005|Overall Study|Lost to Follow-up|0|||
156718407|NCT01068860|565715196|FG006|Overall Study|Lost to Follow-up|0|||
156718408|NCT01068860|565715197|FG007|Overall Study|Lost to Follow-up|0|||
156718409|NCT01068860|565715198|FG008|Overall Study|Lost to Follow-up|0|||
156718410|NCT01068860|565715199|FG009|Overall Study|Lost to Follow-up|0|||
156718411|NCT00897715|565715203|FG000|Overall Study|Lost to Follow-up|0|||
156718412|NCT00897715|565715204|FG001|Overall Study|Lost to Follow-up|1|||
156718413|NCT00897715|565715203|FG000|Overall Study|Physician Decision|1|||
156718414|NCT00897715|565715204|FG001|Overall Study|Physician Decision|0|||
156718415|NCT00897715|565715203|FG000|Overall Study|increased risk of infection|1|||
156718416|NCT00897715|565715204|FG001|Overall Study|increased risk of infection|0|||
156718417|NCT00513240|565715205|FG000|Overall Study|Did not have intended surgery|3|||
156718418|NCT00513240|565715206|FG001|Overall Study|Did not have intended surgery|0|||
156718419|NCT00513240|565715205|FG000|Overall Study|Death|3|||
156718420|NCT00513240|565715206|FG001|Overall Study|Death|3|||
156718421|NCT00513240|565715205|FG000|Overall Study|Withdrawal by Subject|7|||
156718422|NCT00513240|565715206|FG001|Overall Study|Withdrawal by Subject|4|||
156718423|NCT00882518|565715216|FG000|Overall Study|Adverse Event|9|||
156718424|NCT00882518|565715217|FG001|Overall Study|Adverse Event|18|||
156718425|NCT00882518|565715216|FG000|Overall Study|Withdrawal by Subject|9|||
156718426|NCT00882518|565715217|FG001|Overall Study|Withdrawal by Subject|13|||
156718427|NCT00882518|565715216|FG000|Overall Study|Lack of Efficacy|12|||
156718428|NCT00882518|565715217|FG001|Overall Study|Lack of Efficacy|9|||
156718429|NCT00882518|565715216|FG000|Overall Study|Severe non-compliance to protocol|3|||
156718430|NCT00882518|565715217|FG001|Overall Study|Severe non-compliance to protocol|1|||
156718431|NCT00882518|565715216|FG000|Overall Study|Incorrect enrolment|4|||
156718432|NCT00882518|565715217|FG001|Overall Study|Incorrect enrolment|2|||
156718433|NCT00882518|565715216|FG000|Overall Study|Central lab closure for National day|1|||
156718434|NCT00882518|565715217|FG001|Overall Study|Central lab closure for National day|0|||
156718435|NCT00882518|565715216|FG000|Overall Study|Allocating random number by mistake|0|||
156718436|NCT00882518|565715217|FG001|Overall Study|Allocating random number by mistake|1|||
156718437|NCT03238651|565715218|FG000|Overall Study|Other|0|||
156718438|NCT03238651|565715219|FG001|Overall Study|Other|0|||
156718439|NCT03238651|565715220|FG002|Overall Study|Other|0|||
156718440|NCT03238651|565715221|FG003|Overall Study|Other|0|||
156718441|NCT03238651|565715222|FG004|Overall Study|Other|1|||
156718442|NCT03238651|565715218|FG000|Overall Study|Progressive Disease|2|||
156718443|NCT03238651|565715219|FG001|Overall Study|Progressive Disease|2|||
156718444|NCT03238651|565715220|FG002|Overall Study|Progressive Disease|2|||
156718445|NCT03238651|565715221|FG003|Overall Study|Progressive Disease|2|||
156718446|NCT03238651|565715222|FG004|Overall Study|Progressive Disease|0|||
156718447|NCT03238651|565715218|FG000|Overall Study|Withdrawal by Subject|0|||
156718448|NCT03238651|565715219|FG001|Overall Study|Withdrawal by Subject|1|||
156718449|NCT03238651|565715220|FG002|Overall Study|Withdrawal by Subject|0|||
156718450|NCT03238651|565715221|FG003|Overall Study|Withdrawal by Subject|1|||
156718451|NCT03238651|565715222|FG004|Overall Study|Withdrawal by Subject|0|||
156718452|NCT03238651|565715218|FG000|Overall Study|Adverse Event|1|||
156718453|NCT03238651|565715219|FG001|Overall Study|Adverse Event|3|||
156718454|NCT03238651|565715220|FG002|Overall Study|Adverse Event|2|||
156718455|NCT03238651|565715221|FG003|Overall Study|Adverse Event|0|||
156718456|NCT03238651|565715222|FG004|Overall Study|Adverse Event|0|||
156718457|NCT03743051|565715223|FG000|Overall Study|Adverse Event|5|||
156718458|NCT03743051|565715224|FG001|Overall Study|Adverse Event|9|||
156718459|NCT03743051|565715223|FG000|Overall Study|Death|27|||
156718460|NCT03743051|565715224|FG001|Overall Study|Death|26|||
156718461|NCT03743051|565715223|FG000|Overall Study|Lost to Follow-up|4|||
156718462|NCT03743051|565715224|FG001|Overall Study|Lost to Follow-up|8|||
156718463|NCT03743051|565715223|FG000|Overall Study|Withdrawal by Subject|32|||
156718464|NCT03743051|565715224|FG001|Overall Study|Withdrawal by Subject|19|||
156718465|NCT03743051|565715223|FG000|Overall Study|Physician Decision|10|||
156718466|NCT03743051|565715224|FG001|Overall Study|Physician Decision|15|||
156718467|NCT03743051|565715223|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
156718468|NCT03743051|565715224|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
156718469|NCT02137252|565715225|FG000|Overall Study|trial terminated early|2|||
156533359|NCT02038920|565046965|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
156718470|NCT02137252|565715226|FG001|Overall Study|trial terminated early|1|||
156718471|NCT00840749|565715230|FG000|Overall Study|Death|1|||
156718472|NCT00840749|565715231|FG001|Overall Study|Death|2|||
156718473|NCT00840749|565715230|FG000|Overall Study|not treated on study arm|11|||
156718474|NCT00840749|565715231|FG001|Overall Study|not treated on study arm|11|||
156718475|NCT00840749|565715230|FG000|Overall Study|study closed|19|||
156718476|NCT00840749|565715231|FG001|Overall Study|study closed|14|||
156718477|NCT02550561|565715232|FG000|Overall Study|Lost to Follow-up|5|||
156718478|NCT02550561|565715232|FG000|Overall Study|Withdrawal by Subject|1|||
156718479|NCT03473925|565715233|FG000|Overall Study|Death|48|||
156718480|NCT03473925|565715234|FG001|Overall Study|Death|44|||
156718481|NCT03473925|565715233|FG000|Overall Study|Sponsor Decision|2|||
156718482|NCT03473925|565715234|FG001|Overall Study|Sponsor Decision|7|||
156718483|NCT03473925|565715233|FG000|Overall Study|Withdrawal by Subject|1|||
156718484|NCT03473925|565715234|FG001|Overall Study|Withdrawal by Subject|3|||
156718485|NCT03473925|565715233|FG000|Overall Study|Not Treated|1|||
156718486|NCT03473925|565715234|FG001|Overall Study|Not Treated|1|||
156718487|NCT03411863|565715235|FG000|Overall Study|Withdrawal by Subject|3|||
156718488|NCT03411863|565715236|FG001|Overall Study|Withdrawal by Subject|1|||
156718489|NCT03411863|565715235|FG000|Overall Study|Physician Decision|0|||
156718490|NCT03411863|565715236|FG001|Overall Study|Physician Decision|1|||
156718491|NCT03535740|565715237|FG000|Overall Study|Death|44|||
156718492|NCT03535740|565715237|FG000|Overall Study|Lost to Follow-up|1|||
156718493|NCT03535740|565715237|FG000|Overall Study|Withdrawal by Subject|13|||
156718494|NCT03535740|565715237|FG000|Overall Study|Site terminated by Sponsor|45|||
156718495|NCT05198518|565715241|FG000|Screening Visit|Deemed unable to participate|58|||
156718496|NCT05198518|565715242|FG001|Screening Visit|Deemed unable to participate|0|||
156718497|NCT05198518|565715243|FG002|Screening Visit|Deemed unable to participate|0|||
156718498|NCT03645863|565715245|FG000|Overall Study|Withdrawal by Subject|1|||
156718499|NCT03645863|565715246|FG001|Overall Study|Withdrawal by Subject|0|||
156718500|NCT03645863|565715247|FG002|Overall Study|Withdrawal by Subject|0|||
156718501|NCT02756611|565715249|FG000|Overall Study|Death|70|||
156793775|NCT03249558|565997506|FG002|Overall Study|Physician Decision|0|||
156718502|NCT02756611|565715249|FG000|Overall Study|Withdrawal by Subject|2|||
156718503|NCT02756611|565715249|FG000|Overall Study|Lost to Follow-up|3|||
156718504|NCT02756611|565715249|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
156718505|NCT02756611|565715249|FG000|Overall Study|Other|10|||
156718506|NCT05317312|565715250|FG000|Overall Study|Withdrawal by Subject|0|||
156718507|NCT05317312|565715251|FG001|Overall Study|Withdrawal by Subject|1|||
156718508|NCT05317312|565715252|FG002|Overall Study|Withdrawal by Subject|0|||
156718509|NCT05317312|565715253|FG003|Overall Study|Withdrawal by Subject|0|||
156718510|NCT05317312|565715250|FG000|Overall Study|Lost to Follow-up|0|||
156718511|NCT05317312|565715251|FG001|Overall Study|Lost to Follow-up|0|||
156718512|NCT05317312|565715252|FG002|Overall Study|Lost to Follow-up|0|||
156718513|NCT05317312|565715253|FG003|Overall Study|Lost to Follow-up|1|||
156718514|NCT05317312|565715250|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
156718515|NCT05317312|565715251|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
156718516|NCT05317312|565715252|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
156718517|NCT05317312|565715253|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
156718518|NCT00124917|565715254|FG000|Overall Study|Physician Decision|3|||
156718519|NCT03164551|565715255|FG000|Overall Study|Imaging discontinued prior completion|8|||
156718520|NCT03164551|565715256|FG001|Overall Study|Imaging discontinued prior completion|0|||
156718521|NCT03164551|565715255|FG000|Overall Study|Participant was non-compliant|1|||
156718522|NCT03164551|565715256|FG001|Overall Study|Participant was non-compliant|0|||
156718523|NCT03164551|565715255|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
156718524|NCT03164551|565715256|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
156718525|NCT03164551|565715255|FG000|Overall Study|Other|8|||
156718526|NCT03164551|565715256|FG001|Overall Study|Other|2|||
156718527|NCT01422213|565715257|FG000|Overall Study|Adverse Event|8|||
156718528|NCT01422213|565715258|FG001|Overall Study|Adverse Event|7|||
156718529|NCT01422213|565715259|FG002|Overall Study|Adverse Event|11|||
156718530|NCT01422213|565715257|FG000|Overall Study|Lack of Efficacy|10|||
156718531|NCT01422213|565715258|FG001|Overall Study|Lack of Efficacy|2|||
156718532|NCT01422213|565715259|FG002|Overall Study|Lack of Efficacy|2|||
156718533|NCT01422213|565715257|FG000|Overall Study|Non-compliance with study drug|0|||
156718534|NCT01422213|565715258|FG001|Overall Study|Non-compliance with study drug|1|||
156718535|NCT01422213|565715259|FG002|Overall Study|Non-compliance with study drug|0|||
156718536|NCT01422213|565715257|FG000|Overall Study|Protocol Violation|0|||
156718537|NCT01422213|565715258|FG001|Overall Study|Protocol Violation|2|||
156718538|NCT01422213|565715259|FG002|Overall Study|Protocol Violation|4|||
156718539|NCT01422213|565715257|FG000|Overall Study|Withdrawal of Consent|7|||
156718540|NCT01422213|565715258|FG001|Overall Study|Withdrawal of Consent|3|||
156718541|NCT01422213|565715259|FG002|Overall Study|Withdrawal of Consent|5|||
156718542|NCT01422213|565715257|FG000|Overall Study|Lost to Follow-up|3|||
156718543|NCT01422213|565715258|FG001|Overall Study|Lost to Follow-up|3|||
156718544|NCT01422213|565715259|FG002|Overall Study|Lost to Follow-up|5|||
156718545|NCT01422213|565715257|FG000|Overall Study|Administrative or Other Reason(s)|5|||
156718546|NCT01422213|565715258|FG001|Overall Study|Administrative or Other Reason(s)|4|||
156718547|NCT01422213|565715259|FG002|Overall Study|Administrative or Other Reason(s)|2|||
156718548|NCT00951496|565715266|FG000|Overall Study|Did not initiate study treatment|10|||
156718549|NCT00951496|565715267|FG001|Overall Study|Did not initiate study treatment|8|||
156718550|NCT00951496|565715268|FG002|Overall Study|Did not initiate study treatment|13|||
156718551|NCT01169350|565715279|FG000|Overall Study|Physician Decision|3|||
156718552|NCT01169350|565715279|FG000|Overall Study|Lost to Follow-up|2|||
156718553|NCT04870710|565715283|FG000|Overall Study|Lost to Follow-up|3|||
156718554|NCT00476190|565715284|FG000|Overall Study|Ineligible|1|||
156718555|NCT00476190|565715285|FG001|Overall Study|Ineligible|1|||
156718556|NCT00476190|565715284|FG000|Overall Study|Induction Death|2|||
156718557|NCT00476190|565715285|FG001|Overall Study|Induction Death|0|||
156718558|NCT00476190|565715284|FG000|Overall Study|Induction Failure|2|||
156718559|NCT00476190|565715285|FG001|Overall Study|Induction Failure|4|||
156718560|NCT00476190|565715284|FG000|Overall Study|Lost to Follow-up|1|||
156718561|NCT00476190|565715285|FG001|Overall Study|Lost to Follow-up|0|||
156718562|NCT00476190|565715284|FG000|Overall Study|Relapse/Progression|5|||
156718563|NCT00476190|565715285|FG001|Overall Study|Relapse/Progression|2|||
156718564|NCT00476190|565715284|FG000|Overall Study|Remission Death|0|||
156718565|NCT00476190|565715285|FG001|Overall Study|Remission Death|1|||
156718566|NCT00476190|565715284|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
156718567|NCT00476190|565715285|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
156718568|NCT00476190|565715284|FG000|Overall Study|Withdrawal by Subject|6|||
156718569|NCT00476190|565715285|FG001|Overall Study|Withdrawal by Subject|2|||
156718570|NCT00476190|565715284|FG000|Overall Study|Other|9|||
156718571|NCT00476190|565715285|FG001|Overall Study|Other|10|||
156718572|NCT04782076|565715286|FG000|Overall Study|Family Emergency|1|||
156718573|NCT01042093|565715287|FG000|Overall Study|Protocol Violation|2|||
156718574|NCT01042093|565715288|FG001|Overall Study|Protocol Violation|2|||
156718575|NCT01042093|565715289|FG002|Overall Study|Protocol Violation|2|||
156718576|NCT01042093|565715290|FG003|Overall Study|Protocol Violation|3|||
156718577|NCT01042093|565715287|FG000|Overall Study|Withdrawal by Subject|0|||
156718578|NCT01042093|565715288|FG001|Overall Study|Withdrawal by Subject|0|||
156335070|NCT00910273|564324503|FG001|Overall Study|Adverse Event|1|||
156718579|NCT01042093|565715289|FG002|Overall Study|Withdrawal by Subject|0|||
156718580|NCT01042093|565715290|FG003|Overall Study|Withdrawal by Subject|1|||
156718581|NCT02198963|565715296|FG000|Overall Study|Adverse Event|1|||
156718582|NCT02198963|565715296|FG000|Overall Study|Withdrawal by Subject|6|||
156718583|NCT01998841|565715300|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
156718584|NCT01998841|565715301|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
156718585|NCT01998841|565715302|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
156718586|NCT01998841|565715303|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718587|NCT01998841|565715304|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718588|NCT01998841|565715300|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718589|NCT01998841|565715301|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718590|NCT01998841|565715302|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718591|NCT01998841|565715303|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
156718592|NCT01998841|565715304|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
156718593|NCT03447743|565715305|FG000|Overall Study|Withdrawal by Subject|2|||
156718594|NCT03447743|565715305|FG000|Overall Study|Lost to Follow-up|3|||
156718595|NCT03447743|565715305|FG000|Overall Study|Adverse Event|1|||
156718596|NCT03447743|565715305|FG000|Overall Study|Did not meet criteria to continue|1|||
156718597|NCT04211831|565715310|FG000|Overall Study|Withdrawal by Subject|4|||
156718598|NCT04211831|565715311|FG001|Overall Study|Withdrawal by Subject|1|||
156718599|NCT04211831|565715312|FG002|Overall Study|Withdrawal by Subject|1|||
156718600|NCT04211831|565715310|FG000|Overall Study|Protocol Violation|0|||
156718601|NCT04211831|565715311|FG001|Overall Study|Protocol Violation|0|||
156718602|NCT04211831|565715312|FG002|Overall Study|Protocol Violation|1|||
156718603|NCT04211831|565715310|FG000|Overall Study|Adverse Event|0|||
156718604|NCT04211831|565715311|FG001|Overall Study|Adverse Event|1|||
156875320|NCT01621802|566302014|FG003|Overall Study|Others|2|||
156875321|NCT01621802|566302015|FG004|Overall Study|Others|1|||
156875322|NCT01621802|566302016|FG005|Overall Study|Others|0|||
156875323|NCT01621802|566302011|FG000|Overall Study|Lost to Follow-up|36|||
156875324|NCT01621802|566302012|FG001|Overall Study|Lost to Follow-up|16|||
156875325|NCT01621802|566302013|FG002|Overall Study|Lost to Follow-up|24|||
156875326|NCT01621802|566302014|FG003|Overall Study|Lost to Follow-up|7|||
156875327|NCT01621802|566302015|FG004|Overall Study|Lost to Follow-up|31|||
156875328|NCT01621802|566302016|FG005|Overall Study|Lost to Follow-up|11|||
156875329|NCT01149148|566302017|FG000|Overall Study|Lost to Follow-up|1|||
156875330|NCT01149148|566302018|FG001|Overall Study|Lost to Follow-up|2|||
156875331|NCT01149148|566302017|FG000|Overall Study|Death|1|||
156875332|NCT01149148|566302018|FG001|Overall Study|Death|0|||
156875333|NCT03436082|566302019|FG000|Overall Study|Did not undergo procedure|1|||
156875334|NCT03436082|566302020|FG001|Overall Study|Did not undergo procedure|0|||
156875335|NCT04896086|566302021|FG000|Overall Study|Lost to Follow-up|0|||
156875336|NCT04896086|566302022|FG001|Overall Study|Lost to Follow-up|2|||
156875337|NCT04896086|566302023|FG002|Overall Study|Lost to Follow-up|1|||
156875338|NCT04896086|566302024|FG003|Overall Study|Lost to Follow-up|0|||
156875339|NCT04896086|566302025|FG004|Overall Study|Lost to Follow-up|0|||
156875340|NCT04896086|566302021|FG000|Overall Study|Physician Decision|0|||
156875341|NCT04896086|566302022|FG001|Overall Study|Physician Decision|1|||
156875342|NCT04896086|566302023|FG002|Overall Study|Physician Decision|0|||
156875343|NCT04896086|566302024|FG003|Overall Study|Physician Decision|0|||
156875344|NCT04896086|566302025|FG004|Overall Study|Physician Decision|0|||
156875345|NCT04896086|566302021|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
156875346|NCT04896086|566302022|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
156718605|NCT04211831|565715312|FG002|Overall Study|Adverse Event|0|||
156718606|NCT04211831|565715310|FG000|Overall Study|Lack of Efficacy|0|||
156718607|NCT04211831|565715311|FG001|Overall Study|Lack of Efficacy|0|||
156718608|NCT04211831|565715312|FG002|Overall Study|Lack of Efficacy|1|||
156718609|NCT04211831|565715310|FG000|Overall Study|Lost to Follow-up|0|||
156718610|NCT04211831|565715311|FG001|Overall Study|Lost to Follow-up|0|||
156718611|NCT04211831|565715312|FG002|Overall Study|Lost to Follow-up|2|||
156718612|NCT04211831|565715310|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
156718613|NCT04211831|565715311|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
156718614|NCT04211831|565715312|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
156718615|NCT04211831|565715310|FG000|Overall Study|Other|0|||
156718616|NCT04211831|565715311|FG001|Overall Study|Other|1|||
156718617|NCT04211831|565715312|FG002|Overall Study|Other|0|||
156718618|NCT00752128|565715316|FG000|Overall Study|Withdrawal by Subject|4|||
156718619|NCT04135937|565715317|FG000|Overall Study|Lost to Follow-up|2|||
156718620|NCT04135937|565715317|FG000|Overall Study|Withdrawal by Subject|1|||
156718621|NCT00625820|565715318|FG000|Overall Study|Withdrawal by Subject|1|||
156875347|NCT04896086|566302023|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
156875348|NCT04896086|566302024|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
156875349|NCT04896086|566302025|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
156718622|NCT05201794|565717187|FG000|Overall Study|Withdrawal by Subject|13|||
156718623|NCT05201794|565717188|FG001|Overall Study|Withdrawal by Subject|12|||
156718624|NCT05201794|565717189|FG002|Overall Study|Withdrawal by Subject|14|||
156718625|NCT05201794|565717190|FG003|Overall Study|Withdrawal by Subject|0|||
156718626|NCT05201794|565717187|FG000|Overall Study|Adverse Event|5|||
156718627|NCT05201794|565717188|FG001|Overall Study|Adverse Event|5|||
156718628|NCT05201794|565717189|FG002|Overall Study|Adverse Event|4|||
156718629|NCT05201794|565717190|FG003|Overall Study|Adverse Event|0|||
156718630|NCT05201794|565717187|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
156718631|NCT05201794|565717188|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156718632|NCT05201794|565717189|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
156718633|NCT05201794|565717190|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156718634|NCT05201794|565717187|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156718635|NCT05201794|565717188|FG001|Overall Study|Non-Compliance With Study Drug|3|||
156718636|NCT05201794|565717189|FG002|Overall Study|Non-Compliance With Study Drug|3|||
156718637|NCT05201794|565717190|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156718638|NCT05201794|565717187|FG000|Overall Study|Physician Decision|1|||
156718639|NCT05201794|565717188|FG001|Overall Study|Physician Decision|3|||
156718640|NCT05201794|565717189|FG002|Overall Study|Physician Decision|2|||
156718641|NCT05201794|565717190|FG003|Overall Study|Physician Decision|0|||
156718642|NCT05201794|565717187|FG000|Overall Study|Lost to Follow-up|2|||
156718643|NCT05201794|565717188|FG001|Overall Study|Lost to Follow-up|2|||
156718644|NCT05201794|565717189|FG002|Overall Study|Lost to Follow-up|0|||
156718645|NCT05201794|565717190|FG003|Overall Study|Lost to Follow-up|0|||
156718646|NCT05201794|565717187|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
156718647|NCT05201794|565717188|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
156718648|NCT05201794|565717189|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
156718649|NCT05201794|565717190|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
156718650|NCT05201794|565717187|FG000|Overall Study|Protocol Violation|2|||
156718651|NCT05201794|565717188|FG001|Overall Study|Protocol Violation|0|||
156718652|NCT05201794|565717189|FG002|Overall Study|Protocol Violation|1|||
156718653|NCT05201794|565717190|FG003|Overall Study|Protocol Violation|0|||
156718654|NCT05201794|565717187|FG000|Overall Study|Death|1|||
156718655|NCT05201794|565717188|FG001|Overall Study|Death|0|||
156718656|NCT05201794|565717189|FG002|Overall Study|Death|0|||
156718657|NCT05201794|565717190|FG003|Overall Study|Death|0|||
156718658|NCT05201794|565717187|FG000|Overall Study|Site Terminated By Sponsor|0|||
156718659|NCT05201794|565717188|FG001|Overall Study|Site Terminated By Sponsor|1|||
156718660|NCT05201794|565717189|FG002|Overall Study|Site Terminated By Sponsor|0|||
156718661|NCT05201794|565717190|FG003|Overall Study|Site Terminated By Sponsor|0|||
156718662|NCT05201794|565717187|FG000|Overall Study|Other|3|||
156718663|NCT05201794|565717188|FG001|Overall Study|Other|3|||
156718664|NCT05201794|565717189|FG002|Overall Study|Other|3|||
156718665|NCT05201794|565717190|FG003|Overall Study|Other|0|||
156718666|NCT05201794|565717187|FG000|Overall Study|Randomized But Not Treated|1|||
156718667|NCT05201794|565717188|FG001|Overall Study|Randomized But Not Treated|2|||
156718668|NCT05201794|565717189|FG002|Overall Study|Randomized But Not Treated|1|||
156718669|NCT05201794|565717190|FG003|Overall Study|Randomized But Not Treated|0|||
156718670|NCT01490086|565717191|FG000|Overall Study|Consent withdrawn|4|||
156718671|NCT01490086|565717192|FG001|Overall Study|Consent withdrawn|4|||
156718672|NCT01490086|565717193|FG002|Overall Study|Consent withdrawn|3|||
156718673|NCT01490086|565717194|FG003|Overall Study|Consent withdrawn|0|||
156718674|NCT01490086|565717195|FG004|Overall Study|Consent withdrawn|1|||
156718675|NCT01490086|565717191|FG000|Overall Study|Non-compliance|0|||
156718676|NCT01490086|565717192|FG001|Overall Study|Non-compliance|1|||
156718677|NCT01490086|565717193|FG002|Overall Study|Non-compliance|0|||
156718678|NCT01490086|565717194|FG003|Overall Study|Non-compliance|0|||
156718679|NCT01490086|565717195|FG004|Overall Study|Non-compliance|0|||
156718680|NCT01490086|565717191|FG000|Overall Study|Abnormal laboratory findings|1|||
156718681|NCT01490086|565717192|FG001|Overall Study|Abnormal laboratory findings|0|||
156718682|NCT01490086|565717193|FG002|Overall Study|Abnormal laboratory findings|0|||
156718683|NCT01490086|565717194|FG003|Overall Study|Abnormal laboratory findings|0|||
156718684|NCT01490086|565717195|FG004|Overall Study|Abnormal laboratory findings|0|||
156718685|NCT01490086|565717191|FG000|Overall Study|Lost to Follow-up|0|||
156718686|NCT01490086|565717192|FG001|Overall Study|Lost to Follow-up|0|||
156718687|NCT01490086|565717193|FG002|Overall Study|Lost to Follow-up|0|||
156718688|NCT01490086|565717194|FG003|Overall Study|Lost to Follow-up|0|||
156718689|NCT01490086|565717195|FG004|Overall Study|Lost to Follow-up|1|||
156718690|NCT01490086|565717191|FG000|Overall Study|Physician Decision|3|||
156718691|NCT01490086|565717192|FG001|Overall Study|Physician Decision|4|||
156718692|NCT01490086|565717193|FG002|Overall Study|Physician Decision|2|||
156718693|NCT01490086|565717194|FG003|Overall Study|Physician Decision|3|||
156718694|NCT01490086|565717195|FG004|Overall Study|Physician Decision|1|||
156718695|NCT01490086|565717191|FG000|Overall Study|Adverse Event|0|||
156718696|NCT01490086|565717192|FG001|Overall Study|Adverse Event|0|||
156718697|NCT01490086|565717193|FG002|Overall Study|Adverse Event|1|||
156718698|NCT01490086|565717194|FG003|Overall Study|Adverse Event|2|||
156718699|NCT01490086|565717195|FG004|Overall Study|Adverse Event|0|||
156718700|NCT01490086|565717191|FG000|Overall Study|Lack of Efficacy|0|||
156718701|NCT01490086|565717192|FG001|Overall Study|Lack of Efficacy|3|||
156718702|NCT01490086|565717193|FG002|Overall Study|Lack of Efficacy|1|||
156718703|NCT01490086|565717194|FG003|Overall Study|Lack of Efficacy|0|||
156718704|NCT01490086|565717195|FG004|Overall Study|Lack of Efficacy|8|||
156718705|NCT01490086|565717191|FG000|Overall Study|Worsening of symptoms|0|||
156718706|NCT01490086|565717192|FG001|Overall Study|Worsening of symptoms|1|||
156718707|NCT01490086|565717193|FG002|Overall Study|Worsening of symptoms|0|||
156718708|NCT01490086|565717194|FG003|Overall Study|Worsening of symptoms|1|||
156718709|NCT01490086|565717195|FG004|Overall Study|Worsening of symptoms|0|||
156718710|NCT01490086|565717191|FG000|Overall Study|Subject uncontrollable and abusive|0|||
156718711|NCT01490086|565717192|FG001|Overall Study|Subject uncontrollable and abusive|1|||
156718712|NCT01490086|565717193|FG002|Overall Study|Subject uncontrollable and abusive|0|||
156718713|NCT01490086|565717194|FG003|Overall Study|Subject uncontrollable and abusive|0|||
156718714|NCT01490086|565717195|FG004|Overall Study|Subject uncontrollable and abusive|0|||
156718715|NCT01490086|565717191|FG000|Overall Study|Subject left hospital|0|||
156718716|NCT01490086|565717192|FG001|Overall Study|Subject left hospital|1|||
156718717|NCT01490086|565717193|FG002|Overall Study|Subject left hospital|0|||
156718718|NCT01490086|565717194|FG003|Overall Study|Subject left hospital|1|||
156718719|NCT01490086|565717195|FG004|Overall Study|Subject left hospital|0|||
156718720|NCT04510090|565717198|FG000|FE-HS|Withdrawal by Subject|0|||
156718721|NCT04510090|565717199|FG001|FE-HS|Withdrawal by Subject|0|||
156718722|NCT04510090|565717200|FG002|FE-HS|Withdrawal by Subject|0|||
156718723|NCT04510090|565717201|FG003|FE-HS|Withdrawal by Subject|0|||
156718724|NCT04510090|565717202|FG004|FE-HS|Withdrawal by Subject|1|||
156718725|NCT04510090|565717203|FG005|FE-HS|Withdrawal by Subject|0|||
156718726|NCT04510090|565717204|FG006|FE-HS|Withdrawal by Subject|0|||
156718727|NCT04510090|565717205|FG007|FE-HS|Withdrawal by Subject|0|||
156718728|NCT05825404|565717206|FG000|First Intervention (Weeks 2-5)|Death|0|||
156718729|NCT05825404|565717207|FG001|First Intervention (Weeks 2-5)|Death|1|||
156718730|NCT05825404|565717206|FG000|Second Intervention (Weeks 8-11)|Death|0|||
156718731|NCT05825404|565717207|FG001|Second Intervention (Weeks 8-11)|Death|1|||
156718732|NCT01127256|565717208|FG000|Overall Study|Adverse Event|13|||
156718733|NCT01127256|565717209|FG001|Overall Study|Adverse Event|13|||
156718734|NCT01127256|565717208|FG000|Overall Study|Lack of Efficacy|4|||
156718735|NCT01127256|565717209|FG001|Overall Study|Lack of Efficacy|0|||
156718736|NCT01127256|565717208|FG000|Overall Study|Lost to Follow-up|16|||
156718737|NCT01127256|565717209|FG001|Overall Study|Lost to Follow-up|17|||
156718738|NCT01127256|565717208|FG000|Overall Study|Withdrawal by Subject|5|||
156718739|NCT01127256|565717209|FG001|Overall Study|Withdrawal by Subject|9|||
156718740|NCT01127256|565717208|FG000|Overall Study|Protocol Violation|1|||
156793776|NCT03249558|565997504|FG000|Overall Study|Withdrawal by Subject|6|||
156793777|NCT03249558|565997505|FG001|Overall Study|Withdrawal by Subject|5|||
156793778|NCT03249558|565997506|FG002|Overall Study|Withdrawal by Subject|7|||
156793779|NCT03249558|565997504|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
156793780|NCT03249558|565997505|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
156793781|NCT03249558|565997506|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
156793782|NCT03249558|565997504|FG000|Overall Study|Protocol Violation|1|||
156793783|NCT03249558|565997505|FG001|Overall Study|Protocol Violation|1|||
156793784|NCT03249558|565997506|FG002|Overall Study|Protocol Violation|2|||
156793785|NCT03878069|565997507|FG000|Overall Study|Death|0|||
156793786|NCT03878069|565997508|FG001|Overall Study|Death|1|||
156793787|NCT03878069|565997509|FG002|Overall Study|Death|0|||
156793788|NCT04101331|565999432|FG000|Overall Study|Adverse Event|9|||
156793789|NCT04101331|565999432|FG000|Overall Study|Disease progression|82|||
156793790|NCT04101331|565999432|FG000|Overall Study|Withdrawal by Subject|1|||
156793791|NCT04101331|565999432|FG000|Overall Study|Investigator decision|6|||
156793792|NCT04101331|565999432|FG000|Overall Study|Death|6|||
156793793|NCT04101331|565999432|FG000|Overall Study|Allogenic transplant|1|||
156793794|NCT01356940|565999442|FG000|First Intervention (28 Days)|Adverse Event|1|||
156793795|NCT01356940|565999443|FG001|First Intervention (28 Days)|Adverse Event|0|||
156793796|NCT01356940|565999442|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
156793797|NCT01356940|565999443|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
156793798|NCT03412591|565999449|FG000|Overall Study|Withdrawal by Subject|1|||
156718741|NCT01127256|565717209|FG001|Overall Study|Protocol Violation|0|||
156718742|NCT01749826|565717210|FG000|Overall Study|Study Terminated|20|||
156718743|NCT01749826|565717211|FG001|Overall Study|Study Terminated|0|||
156718744|NCT00679211|565717212|FG000|Overall Study|Progressive disease|82|||
156793799|NCT03412591|565999450|FG001|Overall Study|Withdrawal by Subject|8|||
156793800|NCT03412591|565999449|FG000|Overall Study|Adverse Event|0|||
156793801|NCT03412591|565999450|FG001|Overall Study|Adverse Event|1|||
156718745|NCT00679211|565717212|FG000|Overall Study|Adverse Event|7|||
156718746|NCT00679211|565717212|FG000|Overall Study|Withdrawal by Subject|2|||
156718747|NCT00679211|565717212|FG000|Overall Study|Physician Decision|5|||
156718748|NCT00679211|565717212|FG000|Overall Study|Refused to undergo protocol procedures|1|||
156793802|NCT02272985|565999451|FG000|Overall Study|Withdrawal by Subject|1|||
156718749|NCT00679211|565717212|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
156718750|NCT00679211|565717212|FG000|Overall Study|Other|1|||
156718751|NCT00931528|565717213|FG000|Overall Study|Protocol Violation|9|||
156718752|NCT00931528|565717214|FG001|Overall Study|Protocol Violation|12|||
156718753|NCT00931528|565717213|FG000|Overall Study|Withdrawal by Subject|4|||
156718754|NCT00931528|565717214|FG001|Overall Study|Withdrawal by Subject|12|||
156718755|NCT00931528|565717213|FG000|Overall Study|Lost to Follow-up|6|||
156718756|NCT00931528|565717214|FG001|Overall Study|Lost to Follow-up|13|||
156718757|NCT00931528|565717213|FG000|Overall Study|Assessment outside of Time Frame|22|||
156718758|NCT00931528|565717214|FG001|Overall Study|Assessment outside of Time Frame|23|||
156718759|NCT01470248|565717215|FG000|Overall Study|Withdrawal by Subject|1|||
156718760|NCT05085834|565717216|FG000|Overall Study|Lost to Follow-up|9|||
156718761|NCT05085834|565717217|FG001|Overall Study|Lost to Follow-up|2|||
156718762|NCT05085834|565717216|FG000|Overall Study|Adverse Event|6|||
156718763|NCT05085834|565717217|FG001|Overall Study|Adverse Event|0|||
156718764|NCT05085834|565717216|FG000|Overall Study|Death|1|||
156718765|NCT05085834|565717217|FG001|Overall Study|Death|0|||
156718766|NCT05085834|565717216|FG000|Overall Study|Inability to swallow the pill|0|||
156718767|NCT05085834|565717217|FG001|Overall Study|Inability to swallow the pill|1|||
156718768|NCT05842967|565717220|FG000|Period 1: SSA|Adverse Event|1|||
156718769|NCT05842967|565717221|FG001|Period 1: SSA|Adverse Event|1|||
156718770|NCT05842967|565717222|FG002|Period 1: SSA|Adverse Event|0|||
156718771|NCT05842967|565717223|FG003|Period 1: SSA|Adverse Event|0|||
156718772|NCT05842967|565717220|FG000|Period 1: SSA|Death|1|||
156718773|NCT05842967|565717221|FG001|Period 1: SSA|Death|0|||
156718774|NCT05842967|565717222|FG002|Period 1: SSA|Death|0|||
156718775|NCT05842967|565717223|FG003|Period 1: SSA|Death|0|||
156718776|NCT05842967|565717220|FG000|Period 1: SSA|Lost to Follow-up|16|||
156718777|NCT05842967|565717221|FG001|Period 1: SSA|Lost to Follow-up|4|||
156718778|NCT05842967|565717222|FG002|Period 1: SSA|Lost to Follow-up|0|||
156718779|NCT05842967|565717223|FG003|Period 1: SSA|Lost to Follow-up|0|||
156718780|NCT05842967|565717220|FG000|Period 1: SSA|Physician Decision|1|||
156718781|NCT05842967|565717221|FG001|Period 1: SSA|Physician Decision|0|||
156718782|NCT05842967|565717222|FG002|Period 1: SSA|Physician Decision|0|||
156718783|NCT05842967|565717223|FG003|Period 1: SSA|Physician Decision|0|||
156718784|NCT05842967|565717220|FG000|Period 1: SSA|Withdrawal by Subject|2|||
156718785|NCT05842967|565717221|FG001|Period 1: SSA|Withdrawal by Subject|2|||
156718786|NCT05842967|565717222|FG002|Period 1: SSA|Withdrawal by Subject|0|||
156718787|NCT05842967|565717223|FG003|Period 1: SSA|Withdrawal by Subject|0|||
156718788|NCT05842967|565717220|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
156718789|NCT05842967|565717221|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
156718790|NCT05842967|565717222|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
156718791|NCT05842967|565717223|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
156718792|NCT05842967|565717220|FG000|Period 2: SSB|Adverse Event|0|||
156718793|NCT05842967|565717221|FG001|Period 2: SSB|Adverse Event|0|||
156718794|NCT05842967|565717222|FG002|Period 2: SSB|Adverse Event|2|||
156718795|NCT05842967|565717223|FG003|Period 2: SSB|Adverse Event|0|||
156718796|NCT05842967|565717220|FG000|Period 2: SSB|Lost to Follow-up|0|||
156718797|NCT05842967|565717221|FG001|Period 2: SSB|Lost to Follow-up|0|||
156718798|NCT05842967|565717222|FG002|Period 2: SSB|Lost to Follow-up|4|||
156718799|NCT05842967|565717223|FG003|Period 2: SSB|Lost to Follow-up|3|||
156718800|NCT05842967|565717220|FG000|Period 2: SSB|Withdrawal by Subject|0|||
156718801|NCT05842967|565717221|FG001|Period 2: SSB|Withdrawal by Subject|0|||
156718802|NCT05842967|565717222|FG002|Period 2: SSB|Withdrawal by Subject|1|||
156718803|NCT05842967|565717223|FG003|Period 2: SSB|Withdrawal by Subject|0|||
156793803|NCT02272985|565999451|FG000|Overall Study|hip fracture|1|||
156793804|NCT02272985|565999451|FG000|Overall Study|kidney transplantation|1|||
156793805|NCT00505687|565999454|FG000|Overall Study|Important protocol violation|2|||
156793806|NCT00505687|565999454|FG000|Overall Study|Lack of Efficacy|15|||
156449025|NCT04556656|564738404|FG000|Overall Study|Physician Decision|1|||
156718804|NCT05842967|565717220|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
156718805|NCT05842967|565717221|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
156718806|NCT05842967|565717222|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
156718807|NCT05842967|565717223|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
156718808|NCT05842967|565717220|FG000|Period 2: SSB|Protocol Violation|0|||
156718809|NCT05842967|565717221|FG001|Period 2: SSB|Protocol Violation|0|||
156718810|NCT05842967|565717222|FG002|Period 2: SSB|Protocol Violation|0|||
156718811|NCT05842967|565717223|FG003|Period 2: SSB|Protocol Violation|1|||
156718812|NCT01402570|565717231|FG000|Overall Study|Adverse Event|1|||
156718813|NCT03642262|565717234|FG000|Period 1|Withdrawal by Subject|1|||
156718814|NCT03642262|565717235|FG001|Period 1|Withdrawal by Subject|1|||
156718815|NCT03642262|565717234|FG000|Period 1|Adverse Event|0|||
156718816|NCT03642262|565717235|FG001|Period 1|Adverse Event|1|||
156718817|NCT02157935|565717236|FG000|Overall Study|Withdrawal by Subject|25|||
156718818|NCT02157935|565717237|FG001|Overall Study|Withdrawal by Subject|39|||
156793807|NCT00505687|565999454|FG000|Overall Study|Adverse Event|48|||
156718819|NCT02157935|565717236|FG000|Overall Study|Screen failure|1|||
156718820|NCT02157935|565717237|FG001|Overall Study|Screen failure|2|||
156793808|NCT00505687|565999454|FG000|Overall Study|Subject withdrew consent|15|||
156449026|NCT04556656|564738405|FG001|Overall Study|Physician Decision|0|||
156449027|NCT04556656|564738404|FG000|Overall Study|Adverse Event|4|||
156449028|NCT04556656|564738405|FG001|Overall Study|Adverse Event|7|||
156449029|NCT04556656|564738404|FG000|Overall Study|Death|4|||
156449030|NCT04556656|564738405|FG001|Overall Study|Death|0|||
156449031|NCT04556656|564738404|FG000|Overall Study|Lost to Follow-up|3|||
156718821|NCT02157935|565717236|FG000|Overall Study|Protocol Violation|1|||
156718822|NCT02157935|565717237|FG001|Overall Study|Protocol Violation|0|||
156718823|NCT02157935|565717236|FG000|Overall Study|Progressive disease|0|||
156718824|NCT02157935|565717237|FG001|Overall Study|Progressive disease|2|||
156718825|NCT02157935|565717236|FG000|Overall Study|Other|5|||
156718826|NCT02157935|565717237|FG001|Overall Study|Other|12|||
156718827|NCT02157935|565717236|FG000|Overall Study|Lack of Efficacy|0|||
156718828|NCT02157935|565717237|FG001|Overall Study|Lack of Efficacy|1|||
156718829|NCT02157935|565717236|FG000|Overall Study|Death|4|||
156718830|NCT02157935|565717237|FG001|Overall Study|Death|4|||
156718831|NCT02157935|565717236|FG000|Overall Study|Adverse Event|3|||
156718832|NCT02157935|565717237|FG001|Overall Study|Adverse Event|5|||
156718833|NCT01173523|565717238|FG000|Overall Study|Clinical Progression|1|||
156718834|NCT01173523|565717239|FG001|Overall Study|Clinical Progression|1|||
156718835|NCT01173523|565717238|FG000|Overall Study|Progressive Disease|10|||
156718836|NCT01173523|565717239|FG001|Overall Study|Progressive Disease|8|||
156718837|NCT01173523|565717238|FG000|Overall Study|Other|2|||
156718838|NCT01173523|565717239|FG001|Overall Study|Other|3|||
156718839|NCT02302833|565717246|FG000|Overall Study|Lost to Follow-up|3|||
156718840|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
156718841|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
156718842|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
156718843|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
156718844|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
156718845|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
156718846|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
156718847|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
156718848|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
156718849|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
156718850|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
156718851|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
156718852|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
156718853|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
156718854|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
156718855|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
156718856|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
156718857|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
156718858|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
156718859|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
156718860|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
156718861|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
156718862|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
156718863|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
156718864|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
156718865|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
156718866|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
156718867|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
156718868|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
156718869|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
156718870|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Death|9|||
156718871|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Death|18|||
156718872|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Death|5|||
156718873|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Death|0|||
156718874|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Death|0|||
156718875|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Death|0|||
156718876|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718877|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718878|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718879|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
156718880|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718881|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718882|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
156718883|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
156718884|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
156718885|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
156449032|NCT04556656|564738405|FG001|Overall Study|Lost to Follow-up|2|||
156449033|NCT04556656|564738404|FG000|Overall Study|Not further specified|2|||
156533360|NCT02038920|565046960|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
156533361|NCT02038920|565046961|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
156718886|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
156718887|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
156718888|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
156718889|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
156718890|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
156718891|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
156718892|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
156718893|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
156718894|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
156718895|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
156718896|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
156718897|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
156718898|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
156718899|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
156718900|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
156718901|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
156718902|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
156718903|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
156718904|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
156718905|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
156718906|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
156718907|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
156718908|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
156718909|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
156718910|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
156718911|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
156718912|NCT05516108|565717253|FG000|Overall Study|Time Commitment|3|||
156718913|NCT05516108|565717254|FG001|Overall Study|Time Commitment|1|||
156718914|NCT05516108|565717253|FG000|Overall Study|Reason Unknown|2|||
156718915|NCT05516108|565717254|FG001|Overall Study|Reason Unknown|4|||
156718916|NCT02717507|565717255|FG000|Overall Study|Lost to Follow-up|5|||
156718917|NCT02717507|565717256|FG001|Overall Study|Lost to Follow-up|8|||
156718918|NCT02717507|565717255|FG000|Overall Study|Pregnancy|1|||
156718919|NCT02717507|565717256|FG001|Overall Study|Pregnancy|1|||
156718920|NCT02717507|565717255|FG000|Overall Study|Protocol Violation|2|||
156718921|NCT02717507|565717256|FG001|Overall Study|Protocol Violation|2|||
156718922|NCT02717507|565717255|FG000|Overall Study|Withdrawal by Subject|20|||
156718923|NCT02717507|565717256|FG001|Overall Study|Withdrawal by Subject|20|||
156718924|NCT02717507|565717255|FG000|Overall Study|Relapse|1|||
156718925|NCT02717507|565717256|FG001|Overall Study|Relapse|1|||
156718926|NCT02717507|565717255|FG000|Overall Study|Cardiac Event|2|||
156718927|NCT02717507|565717256|FG001|Overall Study|Cardiac Event|6|||
156718928|NCT05017246|565717257|FG000|Overall Study|Withdrawal by Subject|5|||
156718929|NCT05017246|565717258|FG001|Overall Study|Withdrawal by Subject|3|||
156718930|NCT05017246|565717257|FG000|Overall Study|Determined to be ineligible|0|||
156718931|NCT05017246|565717258|FG001|Overall Study|Determined to be ineligible|1|||
156718932|NCT05017246|565717257|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
156718933|NCT05017246|565717258|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
156718934|NCT05017246|565717257|FG000|Overall Study|Technical failure|1|||
156718935|NCT05017246|565717258|FG001|Overall Study|Technical failure|3|||
156718936|NCT02493660|565717261|FG000|Overall Study|Physician Decision|0|||
156718937|NCT02493660|565717262|FG001|Overall Study|Physician Decision|1|||
156718938|NCT02493660|565717261|FG000|Overall Study|Adverse Event|4|||
156718939|NCT02493660|565717262|FG001|Overall Study|Adverse Event|2|||
156533362|NCT02038920|565046962|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
156718940|NCT02493660|565717261|FG000|Overall Study|Withdrawal by Subject|2|||
156718941|NCT02493660|565717262|FG001|Overall Study|Withdrawal by Subject|3|||
156533363|NCT02038920|565046963|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
156533364|NCT02038920|565046964|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
156718942|NCT02493660|565717261|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
156718943|NCT02493660|565717262|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
156718944|NCT02493660|565717261|FG000|Overall Study|Protocol Violation|0|||
156533365|NCT02038920|565046965|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
156718945|NCT02493660|565717262|FG001|Overall Study|Protocol Violation|1|||
156718946|NCT02493660|565717261|FG000|Overall Study|Death|0|||
156718947|NCT02493660|565717262|FG001|Overall Study|Death|1|||
156533366|NCT02038920|565046960|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
156533367|NCT02038920|565046961|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
156533368|NCT02038920|565046962|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
156533369|NCT02038920|565046963|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
156718948|NCT02493660|565717261|FG000|Overall Study|Lost to Follow-up|2|||
156718949|NCT02493660|565717262|FG001|Overall Study|Lost to Follow-up|4|||
156718950|NCT00709995|565717263|FG000|Overall Study|Adverse Event|4|||
156718951|NCT00709995|565717264|FG001|Overall Study|Adverse Event|2|||
156718952|NCT00709995|565717263|FG000|Overall Study|Withdrawal by Subject|1|||
156718953|NCT00709995|565717264|FG001|Overall Study|Withdrawal by Subject|3|||
156718954|NCT01037218|565717272|FG000|Overall Study|Adverse Event|4|||
156718955|NCT01037218|565717273|FG001|Overall Study|Adverse Event|2|||
156718956|NCT01037218|565717274|FG002|Overall Study|Adverse Event|2|||
156718957|NCT01037218|565717275|FG003|Overall Study|Adverse Event|1|||
156718958|NCT01037218|565717272|FG000|Overall Study|Lack of Efficacy|0|||
156718959|NCT01037218|565717273|FG001|Overall Study|Lack of Efficacy|2|||
156718960|NCT01037218|565717274|FG002|Overall Study|Lack of Efficacy|1|||
156718961|NCT01037218|565717275|FG003|Overall Study|Lack of Efficacy|5|||
156718962|NCT01037218|565717272|FG000|Overall Study|Lost to Follow-up|3|||
156718963|NCT01037218|565717273|FG001|Overall Study|Lost to Follow-up|5|||
156718964|NCT01037218|565717274|FG002|Overall Study|Lost to Follow-up|4|||
156718965|NCT01037218|565717275|FG003|Overall Study|Lost to Follow-up|2|||
156718966|NCT01037218|565717272|FG000|Overall Study|Withdrawal by Subject|6|||
156718967|NCT01037218|565717273|FG001|Overall Study|Withdrawal by Subject|7|||
156718968|NCT01037218|565717274|FG002|Overall Study|Withdrawal by Subject|7|||
156718969|NCT01037218|565717275|FG003|Overall Study|Withdrawal by Subject|4|||
156718970|NCT01037218|565717272|FG000|Overall Study|Partner Withdrew Consent|0|||
156718971|NCT01037218|565717273|FG001|Overall Study|Partner Withdrew Consent|3|||
156718972|NCT01037218|565717274|FG002|Overall Study|Partner Withdrew Consent|2|||
156718973|NCT01037218|565717275|FG003|Overall Study|Partner Withdrew Consent|1|||
156718974|NCT01037218|565717272|FG000|Overall Study|Protocol Violation|0|||
156718975|NCT01037218|565717273|FG001|Overall Study|Protocol Violation|0|||
156718976|NCT01037218|565717274|FG002|Overall Study|Protocol Violation|2|||
156718977|NCT01037218|565717275|FG003|Overall Study|Protocol Violation|2|||
156718978|NCT01037218|565717272|FG000|Overall Study|Various|3|||
156718979|NCT01037218|565717273|FG001|Overall Study|Various|2|||
156718980|NCT01037218|565717274|FG002|Overall Study|Various|3|||
156718981|NCT01037218|565717275|FG003|Overall Study|Various|1|||
156718982|NCT02568072|565717276|FG000|Overall Study|Unavailable for appointment|23|||
156718983|NCT02568072|565717276|FG000|Overall Study|Unable to contact|3|||
156718984|NCT02568072|565717276|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
156718985|NCT02568072|565717276|FG000|Overall Study|Withdrawal by Subject|1|||
156718986|NCT02568072|565717276|FG000|Overall Study|Sustained injury, marathon not run|24|||
156718987|NCT00927589|565717278|FG000|Overall Study|Death|1|||
156718988|NCT00927589|565717278|FG000|Overall Study|Physician Decision|1|||
156718989|NCT00927589|565717278|FG000|Overall Study|Withdrawal by Subject|3|||
156718990|NCT00927589|565717278|FG000|Overall Study|Adverse Event|2|||
156718991|NCT00927589|565717278|FG000|Overall Study|Disease Progression|8|||
156718992|NCT00927589|565717278|FG000|Overall Study|Non-compliance|1|||
156718993|NCT05263908|565717280|FG000|Overall Study|No informed consent for publication of study results|397|||
156718994|NCT05263908|565717280|FG000|Overall Study|CRF not collected|1|||
156718995|NCT02714218|565717281|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156718996|NCT02714218|565717282|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156718997|NCT02714218|565717283|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156718998|NCT02714218|565717281|FG000|Pre-Treatment Period|Other reasons|0|||
156718999|NCT02714218|565717282|FG001|Pre-Treatment Period|Other reasons|1|||
156719000|NCT02714218|565717283|FG002|Pre-Treatment Period|Other reasons|0|||
156719001|NCT02714218|565717281|FG000|Treatment Period|Disease Progression|55|||
156719002|NCT02714218|565717282|FG001|Treatment Period|Disease Progression|52|||
156719003|NCT02714218|565717283|FG002|Treatment Period|Disease Progression|14|||
156719004|NCT02714218|565717281|FG000|Treatment Period|Study drug toxicity|46|||
156719005|NCT02714218|565717282|FG001|Treatment Period|Study drug toxicity|70|||
156719006|NCT02714218|565717283|FG002|Treatment Period|Study drug toxicity|6|||
156719007|NCT02714218|565717281|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
156719008|NCT02714218|565717282|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
156719009|NCT02714218|565717283|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
156719010|NCT02714218|565717281|FG000|Treatment Period|Request to discontinue treatment|1|||
156719011|NCT02714218|565717282|FG001|Treatment Period|Request to discontinue treatment|4|||
156719012|NCT02714218|565717283|FG002|Treatment Period|Request to discontinue treatment|1|||
156719013|NCT02714218|565717281|FG000|Treatment Period|Participant withdrew consent|2|||
156719014|NCT02714218|565717282|FG001|Treatment Period|Participant withdrew consent|2|||
156793809|NCT00505687|565999454|FG000|Overall Study|Lost to Follow-up|1|||
156719015|NCT02714218|565717283|FG002|Treatment Period|Participant withdrew consent|0|||
156719016|NCT02714218|565717281|FG000|Treatment Period|Maximum clinical benefit|4|||
156719017|NCT02714218|565717282|FG001|Treatment Period|Maximum clinical benefit|2|||
156719018|NCT02714218|565717283|FG002|Treatment Period|Maximum clinical benefit|0|||
156719019|NCT02714218|565717281|FG000|Treatment Period|Administrative reason by sponsor|2|||
156719020|NCT02714218|565717282|FG001|Treatment Period|Administrative reason by sponsor|1|||
156719021|NCT02714218|565717283|FG002|Treatment Period|Administrative reason by sponsor|0|||
156719022|NCT02714218|565717281|FG000|Treatment Period|Other reasons|6|||
156719023|NCT02714218|565717282|FG001|Treatment Period|Other reasons|6|||
156719024|NCT02714218|565717283|FG002|Treatment Period|Other reasons|0|||
156719025|NCT02714218|565717281|FG000|Treatment Period|Completed treatment as per protocol|36|||
156719026|NCT02714218|565717282|FG001|Treatment Period|Completed treatment as per protocol|27|||
156719027|NCT02714218|565717283|FG002|Treatment Period|Completed treatment as per protocol|3|||
156719028|NCT02714218|565717281|FG000|Treatment Period|Not reported|9|||
156719029|NCT02714218|565717282|FG001|Treatment Period|Not reported|6|||
156719030|NCT02714218|565717283|FG002|Treatment Period|Not reported|0|||
156719031|NCT01641640|565717284|FG000|Overall Study|Enrolled but not treated|1|||
156719032|NCT01641640|565717284|FG000|Overall Study|Efficacy failure|29|||
156719033|NCT01641640|565717284|FG000|Overall Study|Lost to Follow-up|3|||
156719034|NCT01641640|565717284|FG000|Overall Study|Withdrawal by Subject|2|||
156719035|NCT01641640|565717284|FG000|Overall Study|Adverse Event|1|||
156719036|NCT01199939|565717286|FG000|Overall Study|Adverse Event|4|||
156719037|NCT01199939|565717286|FG000|Overall Study|Protocol Violation|3|||
156719038|NCT01199939|565717286|FG000|Overall Study|Lost to Follow-up|2|||
156719039|NCT01199939|565717286|FG000|Overall Study|Reached a virologic endpoint|4|||
156719040|NCT02792517|565717287|FG000|Overall Study|Withdrawal by Subject|10|||
156719041|NCT02792517|565717287|FG000|Overall Study|Decision by Sponsor|7|||
156719042|NCT02792517|565717287|FG000|Overall Study|Lost to Follow-up|3|||
156719043|NCT03875508|565717288|FG000|Overall Study|Adverse Event|1|||
156719044|NCT03875508|565717288|FG000|Overall Study|Lost to Follow-up|8|||
156719045|NCT03875508|565717288|FG000|Overall Study|Lack of Efficacy|1|||
156719046|NCT03875508|565717288|FG000|Overall Study|Other, not specified|2|||
156719047|NCT01113892|565717293|FG000|Overall Study|Lost to Follow-up|2|||
156719048|NCT01113892|565717294|FG001|Overall Study|Lost to Follow-up|2|||
156719049|NCT01113892|565717293|FG000|Overall Study|Withdrawal by Subject|1|||
156719050|NCT01113892|565717294|FG001|Overall Study|Withdrawal by Subject|1|||
156719051|NCT01113892|565717293|FG000|Overall Study|Death|2|||
156719052|NCT01113892|565717294|FG001|Overall Study|Death|4|||
156719053|NCT01113892|565717293|FG000|Overall Study|Graft no longer evaluable|9|||
156719054|NCT01113892|565717294|FG001|Overall Study|Graft no longer evaluable|9|||
156719055|NCT00789854|565717299|FG000|Overall Study|Adverse Event|28|||
156719056|NCT00789854|565717300|FG001|Overall Study|Adverse Event|23|||
156719057|NCT00789854|565717301|FG002|Overall Study|Adverse Event|18|||
156719058|NCT00789854|565717299|FG000|Overall Study|Lost to Follow-up|1|||
156719059|NCT00789854|565717300|FG001|Overall Study|Lost to Follow-up|1|||
156719060|NCT00789854|565717301|FG002|Overall Study|Lost to Follow-up|4|||
156719061|NCT00789854|565717299|FG000|Overall Study|Withdrawal by Subject|9|||
156719062|NCT00789854|565717300|FG001|Overall Study|Withdrawal by Subject|6|||
156719063|NCT00789854|565717301|FG002|Overall Study|Withdrawal by Subject|17|||
156719064|NCT00789854|565717299|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156719065|NCT00789854|565717300|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
156719066|NCT00789854|565717301|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156719067|NCT00789854|565717299|FG000|Overall Study|Severe non-compliance to the protocol|3|||
156719068|NCT00789854|565717300|FG001|Overall Study|Severe non-compliance to the protocol|0|||
156719069|NCT00789854|565717301|FG002|Overall Study|Severe non-compliance to the protocol|0|||
156719070|NCT00789854|565717299|FG000|Overall Study|Safety reasons|0|||
156719071|NCT00789854|565717300|FG001|Overall Study|Safety reasons|0|||
156719072|NCT00789854|565717301|FG002|Overall Study|Safety reasons|2|||
156719073|NCT00789854|565717299|FG000|Overall Study|Other|6|||
156719074|NCT00789854|565717300|FG001|Overall Study|Other|0|||
156719075|NCT00789854|565717301|FG002|Overall Study|Other|5|||
156719076|NCT02766335|565717302|FG000|Initial Registration|Adverse Event|6|||
156719077|NCT02766335|565717303|FG001|Initial Registration|Adverse Event|3|||
156719078|NCT02766335|565717304|FG002|Initial Registration|Adverse Event|0|||
156719079|NCT02766335|565717302|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
156719080|NCT02766335|565717303|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
156719081|NCT02766335|565717304|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
156719082|NCT02766335|565717302|FG000|Initial Registration|Progression/relapse|49|||
156719083|NCT02766335|565717303|FG001|Initial Registration|Progression/relapse|15|||
156719084|NCT02766335|565717304|FG002|Initial Registration|Progression/relapse|0|||
156719085|NCT02766335|565717302|FG000|Initial Registration|Death|1|||
156719086|NCT02766335|565717303|FG001|Initial Registration|Death|3|||
156719087|NCT02766335|565717304|FG002|Initial Registration|Death|0|||
156719088|NCT02766335|565717302|FG000|Initial Registration|not protocol specified|1|||
156533370|NCT02038920|565046964|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
156719089|NCT02766335|565717303|FG001|Initial Registration|not protocol specified|9|||
156719090|NCT02766335|565717304|FG002|Initial Registration|not protocol specified|0|||
156719091|NCT02766335|565717302|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
156719092|NCT02766335|565717303|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
156719093|NCT02766335|565717304|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
156719094|NCT02766335|565717302|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
156719095|NCT02766335|565717303|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
156719096|NCT02766335|565717304|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
156719097|NCT02857816|565717305|FG000|Overall Study|Screen Failure|33|||
156719098|NCT02857816|565717305|FG000|Overall Study|Withdrawal by Subject|4|||
156719099|NCT02857816|565717305|FG000|Overall Study|Lost to Follow-up|1|||
156719100|NCT00729937|565717306|FG000|Overall Study|Lost to Follow-up|49|||
156719101|NCT00729937|565717307|FG001|Overall Study|Lost to Follow-up|58|||
156719102|NCT00729937|565717308|FG002|Overall Study|Lost to Follow-up|18|||
156719103|NCT00729937|565717309|FG003|Overall Study|Lost to Follow-up|33|||
156719104|NCT00729937|565717310|FG004|Overall Study|Lost to Follow-up|18|||
156719105|NCT00729937|565717311|FG005|Overall Study|Lost to Follow-up|23|||
156719106|NCT00729937|565717306|FG000|Overall Study|Physician Decision|7|||
156719107|NCT00729937|565717307|FG001|Overall Study|Physician Decision|16|||
156719108|NCT00729937|565717308|FG002|Overall Study|Physician Decision|2|||
156719109|NCT00729937|565717309|FG003|Overall Study|Physician Decision|0|||
156719110|NCT00729937|565717310|FG004|Overall Study|Physician Decision|5|||
156719111|NCT00729937|565717311|FG005|Overall Study|Physician Decision|8|||
156719112|NCT00729937|565717306|FG000|Overall Study|Death|1|||
156719113|NCT00729937|565717307|FG001|Overall Study|Death|0|||
156719114|NCT00729937|565717308|FG002|Overall Study|Death|1|||
156719115|NCT00729937|565717309|FG003|Overall Study|Death|0|||
156719116|NCT00729937|565717310|FG004|Overall Study|Death|0|||
156719117|NCT00729937|565717311|FG005|Overall Study|Death|1|||
156719118|NCT00729937|565717306|FG000|Overall Study|Withdrawal by Subject|3|||
156719119|NCT00729937|565717307|FG001|Overall Study|Withdrawal by Subject|5|||
156719120|NCT00729937|565717308|FG002|Overall Study|Withdrawal by Subject|6|||
156719121|NCT00729937|565717309|FG003|Overall Study|Withdrawal by Subject|0|||
156719122|NCT00729937|565717310|FG004|Overall Study|Withdrawal by Subject|4|||
156719123|NCT00729937|565717311|FG005|Overall Study|Withdrawal by Subject|2|||
156719124|NCT00729937|565717306|FG000|Overall Study|Randomized but not treated|12|||
156719125|NCT00729937|565717307|FG001|Overall Study|Randomized but not treated|6|||
156719126|NCT00729937|565717308|FG002|Overall Study|Randomized but not treated|1|||
156719127|NCT00729937|565717309|FG003|Overall Study|Randomized but not treated|0|||
156719128|NCT00729937|565717310|FG004|Overall Study|Randomized but not treated|1|||
156719129|NCT00729937|565717311|FG005|Overall Study|Randomized but not treated|3|||
156719130|NCT00729937|565717306|FG000|Overall Study|Did not meet eligibility criteria|2|||
156719131|NCT00729937|565717307|FG001|Overall Study|Did not meet eligibility criteria|1|||
156719132|NCT00729937|565717308|FG002|Overall Study|Did not meet eligibility criteria|0|||
156719133|NCT00729937|565717309|FG003|Overall Study|Did not meet eligibility criteria|0|||
156719134|NCT00729937|565717310|FG004|Overall Study|Did not meet eligibility criteria|0|||
156719135|NCT00729937|565717311|FG005|Overall Study|Did not meet eligibility criteria|0|||
156719136|NCT00729937|565717306|FG000|Overall Study|Incarcerated|0|||
156719137|NCT00729937|565717307|FG001|Overall Study|Incarcerated|2|||
156719138|NCT00729937|565717308|FG002|Overall Study|Incarcerated|1|||
156719139|NCT00729937|565717309|FG003|Overall Study|Incarcerated|1|||
156719140|NCT00729937|565717310|FG004|Overall Study|Incarcerated|0|||
156719141|NCT00729937|565717311|FG005|Overall Study|Incarcerated|0|||
156719142|NCT03200717|565717318|FG000|Overall Study|Progressive disease|24|||
156719143|NCT03200717|565717319|FG001|Overall Study|Progressive disease|5|||
156719144|NCT03200717|565717318|FG000|Overall Study|Adverse Event|11|||
156719145|NCT03200717|565717319|FG001|Overall Study|Adverse Event|8|||
156719146|NCT03200717|565717318|FG000|Overall Study|Physician Decision|3|||
156719147|NCT03200717|565717319|FG001|Overall Study|Physician Decision|2|||
156719148|NCT03200717|565717318|FG000|Overall Study|Death|2|||
156719149|NCT03200717|565717319|FG001|Overall Study|Death|0|||
156719150|NCT03200717|565717318|FG000|Overall Study|Subject/Guardian Decision|1|||
156719151|NCT03200717|565717319|FG001|Overall Study|Subject/Guardian Decision|0|||
156719152|NCT03552380|565717321|FG000|Study Treatment|Disease Progression|3|||
156719153|NCT03552380|565717322|FG001|Study Treatment|Disease Progression|4|||
156719154|NCT03552380|565717321|FG000|Study Treatment|Adverse Event|2|||
156719155|NCT03552380|565717322|FG001|Study Treatment|Adverse Event|2|||
156719156|NCT03552380|565717321|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
156719157|NCT03552380|565717322|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
156719158|NCT03552380|565717321|FG000|Follow up|Death|3|||
156719159|NCT03552380|565717322|FG001|Follow up|Death|4|||
156719160|NCT03552380|565717321|FG000|Follow up|Site IRB terminated|0|||
156719161|NCT03552380|565717322|FG001|Follow up|Site IRB terminated|1|||
156719162|NCT02461160|565717323|FG000|Overall Study|Lost to Follow-up|0|||
156719163|NCT02461160|565717324|FG001|Overall Study|Lost to Follow-up|0|||
156719164|NCT02461160|565717325|FG002|Overall Study|Lost to Follow-up|0|||
156719165|NCT02461160|565717326|FG003|Overall Study|Lost to Follow-up|0|||
156719166|NCT02461160|565717327|FG004|Overall Study|Lost to Follow-up|0|||
156719167|NCT02461160|565717328|FG005|Overall Study|Lost to Follow-up|0|||
156719168|NCT02461160|565717329|FG006|Overall Study|Lost to Follow-up|0|||
156719169|NCT02461160|565717330|FG007|Overall Study|Lost to Follow-up|1|||
156719170|NCT02461160|565717331|FG008|Overall Study|Lost to Follow-up|0|||
156719171|NCT02461160|565717332|FG009|Overall Study|Lost to Follow-up|0|||
156719172|NCT02461160|565717333|FG010|Overall Study|Lost to Follow-up|0|||
156719173|NCT02461160|565717334|FG011|Overall Study|Lost to Follow-up|0|||
156719174|NCT02461160|565717335|FG012|Overall Study|Lost to Follow-up|0|||
156719175|NCT02899962|565717336|FG000|Open-label Phase|Adverse Event|2|||
156719176|NCT02899962|565717337|FG001|Open-label Phase|Adverse Event|0|||
156719177|NCT02899962|565717338|FG002|Open-label Phase|Adverse Event|0|||
156719178|NCT02899962|565717336|FG000|Open-label Phase|Lost to Follow-up|9|||
156719179|NCT02899962|565717337|FG001|Open-label Phase|Lost to Follow-up|0|||
156719180|NCT02899962|565717338|FG002|Open-label Phase|Lost to Follow-up|0|||
156719181|NCT02899962|565717336|FG000|Open-label Phase|Other reasons|9|||
156719182|NCT02899962|565717337|FG001|Open-label Phase|Other reasons|0|||
156719183|NCT02899962|565717338|FG002|Open-label Phase|Other reasons|0|||
156719184|NCT02899962|565717336|FG000|Open-label Phase|Withdrawal by Subject|7|||
156719185|NCT02899962|565717337|FG001|Open-label Phase|Withdrawal by Subject|0|||
156719186|NCT02899962|565717338|FG002|Open-label Phase|Withdrawal by Subject|0|||
156719187|NCT02899962|565717336|FG000|Maintenance Phase|Adverse Event|0|||
156719188|NCT02899962|565717337|FG001|Maintenance Phase|Adverse Event|2|||
156719189|NCT02899962|565717338|FG002|Maintenance Phase|Adverse Event|1|||
156719190|NCT02899962|565717336|FG000|Maintenance Phase|Death|0|||
156719191|NCT02899962|565717337|FG001|Maintenance Phase|Death|0|||
156719192|NCT02899962|565717338|FG002|Maintenance Phase|Death|1|||
156719193|NCT02899962|565717336|FG000|Maintenance Phase|Lack of Efficacy|0|||
156719194|NCT02899962|565717337|FG001|Maintenance Phase|Lack of Efficacy|20|||
156719195|NCT02899962|565717338|FG002|Maintenance Phase|Lack of Efficacy|16|||
156719196|NCT02899962|565717336|FG000|Maintenance Phase|Lost to Follow-up|0|||
156719197|NCT02899962|565717337|FG001|Maintenance Phase|Lost to Follow-up|12|||
156719198|NCT02899962|565717338|FG002|Maintenance Phase|Lost to Follow-up|14|||
156719199|NCT02899962|565717336|FG000|Maintenance Phase|Other reasons|0|||
156719200|NCT02899962|565717337|FG001|Maintenance Phase|Other reasons|9|||
156719201|NCT02899962|565717338|FG002|Maintenance Phase|Other reasons|13|||
156719202|NCT02899962|565717336|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
156719203|NCT02899962|565717337|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
156719204|NCT02899962|565717338|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
156719205|NCT02899962|565717336|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
156719206|NCT02899962|565717337|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
156719207|NCT02899962|565717338|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
156719208|NCT02899962|565717336|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156719209|NCT02899962|565717337|FG001|Maintenance Phase|Withdrawal by Subject|30|||
156719210|NCT02899962|565717338|FG002|Maintenance Phase|Withdrawal by Subject|36|||
156719211|NCT02404805|565717339|FG000|Overall Study|Withdrawal by Subject|1|||
156719212|NCT02404805|565717340|FG001|Overall Study|Withdrawal by Subject|0|||
156719213|NCT02404805|565717341|FG002|Overall Study|Withdrawal by Subject|0|||
156719214|NCT02404805|565717342|FG003|Overall Study|Withdrawal by Subject|0|||
156719215|NCT02404805|565717343|FG004|Overall Study|Withdrawal by Subject|0|||
156719216|NCT02404805|565717344|FG005|Overall Study|Withdrawal by Subject|0|||
156719217|NCT04563754|565719714|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
156719218|NCT04563754|565719715|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
156719219|NCT04563754|565719716|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
156719220|NCT04563754|565719714|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
156719221|NCT04563754|565719715|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
156719222|NCT04563754|565719716|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
156719223|NCT04563754|565719714|FG000|Follow up|Lost to Follow-up|61|||
156719224|NCT04563754|565719715|FG001|Follow up|Lost to Follow-up|23|||
156719225|NCT04563754|565719716|FG002|Follow up|Lost to Follow-up|5|||
156719226|NCT04563754|565719714|FG000|Follow up|Death|0|||
156719227|NCT04563754|565719715|FG001|Follow up|Death|2|||
156719228|NCT04563754|565719716|FG002|Follow up|Death|0|||
156719229|NCT04563754|565719714|FG000|Follow up|Ongoing|0|||
156719230|NCT04563754|565719715|FG001|Follow up|Ongoing|28|||
156719231|NCT04563754|565719716|FG002|Follow up|Ongoing|0|||
156875350|NCT04896086|566302021|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
156449034|NCT04556656|564738405|FG001|Overall Study|Not further specified|1|||
156449035|NCT04541706|564738406|FG000|Overall Study|Withdrawal by Subject|3|||
156449036|NCT04541706|564738406|FG000|Overall Study|Progressive disease|33|||
156449037|NCT04541706|564738406|FG000|Overall Study|Physician Decision|1|||
156449038|NCT04541706|564738406|FG000|Overall Study|Lost to Follow-up|2|||
156449039|NCT04541706|564738406|FG000|Overall Study|Death|5|||
156449040|NCT04541706|564738406|FG000|Overall Study|Adverse Event|1|||
156449041|NCT05536440|564738407|FG000|Overall Study|Adverse Event|0|||
156449042|NCT05536440|564738408|FG001|Overall Study|Adverse Event|0|||
156719232|NCT00070564|565719717|FG000|Overall Study|Progression|2|||
156719233|NCT00070564|565719718|FG001|Overall Study|Progression|4|||
156719234|NCT00070564|565719719|FG002|Overall Study|Progression|7|||
156719235|NCT00070564|565719720|FG003|Overall Study|Progression|7|||
156719236|NCT00070564|565719721|FG004|Overall Study|Progression|1|||
156719237|NCT00070564|565719722|FG005|Overall Study|Progression|0|||
156719238|NCT00070564|565719717|FG000|Overall Study|Delinquent|1|||
156719239|NCT00070564|565719718|FG001|Overall Study|Delinquent|4|||
156719240|NCT00070564|565719719|FG002|Overall Study|Delinquent|2|||
156719241|NCT00070564|565719720|FG003|Overall Study|Delinquent|0|||
156719242|NCT00070564|565719721|FG004|Overall Study|Delinquent|0|||
156719243|NCT00070564|565719722|FG005|Overall Study|Delinquent|0|||
156719244|NCT00070564|565719717|FG000|Overall Study|Adverse Event|150|||
156719245|NCT00070564|565719718|FG001|Overall Study|Adverse Event|142|||
156719246|NCT00070564|565719719|FG002|Overall Study|Adverse Event|120|||
156719247|NCT00070564|565719720|FG003|Overall Study|Adverse Event|108|||
156719248|NCT00070564|565719721|FG004|Overall Study|Adverse Event|63|||
156719249|NCT00070564|565719722|FG005|Overall Study|Adverse Event|36|||
156719250|NCT00070564|565719717|FG000|Overall Study|Death|4|||
156719251|NCT00070564|565719718|FG001|Overall Study|Death|1|||
156719252|NCT00070564|565719719|FG002|Overall Study|Death|5|||
156719253|NCT00070564|565719720|FG003|Overall Study|Death|3|||
156719254|NCT00070564|565719721|FG004|Overall Study|Death|0|||
156719255|NCT00070564|565719722|FG005|Overall Study|Death|1|||
156719256|NCT00070564|565719717|FG000|Overall Study|Other, not protocol specified|17|||
156719257|NCT00070564|565719718|FG001|Overall Study|Other, not protocol specified|15|||
156719258|NCT00070564|565719719|FG002|Overall Study|Other, not protocol specified|14|||
156719259|NCT00070564|565719720|FG003|Overall Study|Other, not protocol specified|19|||
156719260|NCT00070564|565719721|FG004|Overall Study|Other, not protocol specified|6|||
156719261|NCT00070564|565719722|FG005|Overall Study|Other, not protocol specified|7|||
156719262|NCT00070564|565719717|FG000|Overall Study|Withdrawal by Subject|26|||
156719263|NCT00070564|565719718|FG001|Overall Study|Withdrawal by Subject|37|||
156719264|NCT00070564|565719719|FG002|Overall Study|Withdrawal by Subject|23|||
156719265|NCT00070564|565719720|FG003|Overall Study|Withdrawal by Subject|30|||
156719266|NCT00070564|565719721|FG004|Overall Study|Withdrawal by Subject|8|||
156719267|NCT00070564|565719722|FG005|Overall Study|Withdrawal by Subject|8|||
156719268|NCT00070564|565719717|FG000|Overall Study|Not reported|0|||
156719269|NCT00070564|565719718|FG001|Overall Study|Not reported|0|||
156719270|NCT00070564|565719719|FG002|Overall Study|Not reported|0|||
156719271|NCT00070564|565719720|FG003|Overall Study|Not reported|0|||
156719272|NCT00070564|565719721|FG004|Overall Study|Not reported|1|||
156719273|NCT00070564|565719722|FG005|Overall Study|Not reported|0|||
156719274|NCT03565900|565719724|FG000|Overall Study|Disposition Unknown|4|||
156719275|NCT03565900|565719725|FG001|Overall Study|Disposition Unknown|1|||
156719276|NCT03565900|565719724|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156719277|NCT03565900|565719725|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
156719278|NCT03565900|565719724|FG000|Overall Study|Withdrawal by Subject|4|||
156719279|NCT03565900|565719725|FG001|Overall Study|Withdrawal by Subject|5|||
156719280|NCT03565900|565719724|FG000|Overall Study|Randomized By Mistake|0|||
156719281|NCT03565900|565719725|FG001|Overall Study|Randomized By Mistake|2|||
156719282|NCT03565900|565719724|FG000|Overall Study|Physician Decision|7|||
156719283|NCT03565900|565719725|FG001|Overall Study|Physician Decision|11|||
156719284|NCT03565900|565719724|FG000|Overall Study|Death|9|||
156719285|NCT03565900|565719725|FG001|Overall Study|Death|7|||
156719286|NCT03359850|565719728|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
156719287|NCT03359850|565719729|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
156719288|NCT03359850|565719728|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
156719289|NCT03359850|565719729|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
156719290|NCT03359850|565719728|FG000|Extension Phase (Up to 28 Months)|Death|2|||
156719291|NCT03359850|565719729|FG001|Extension Phase (Up to 28 Months)|Death|4|||
156719292|NCT03359850|565719728|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
156719293|NCT03359850|565719729|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
156719294|NCT03359850|565719728|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
156719295|NCT03359850|565719729|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
156719296|NCT03817125|565719747|FG000|Overall Study|Adverse Event|1|||
156719297|NCT03817125|565719748|FG001|Overall Study|Adverse Event|0|||
156719298|NCT03817125|565719747|FG000|Overall Study|Physician Decision|0|||
156719299|NCT03817125|565719748|FG001|Overall Study|Physician Decision|1|||
156719300|NCT03817125|565719747|FG000|Overall Study|Lack of Efficacy|1|||
156719301|NCT03817125|565719748|FG001|Overall Study|Lack of Efficacy|5|||
156719302|NCT00942084|565719749|FG000|Overall Study|Death|2|||
156719303|NCT00281957|565719756|FG000|Overall Study|Adverse Event|7|||
156719304|NCT00281957|565719757|FG001|Overall Study|Adverse Event|2|||
156719305|NCT00281957|565719756|FG000|Overall Study|Death|1|||
156719306|NCT00281957|565719757|FG001|Overall Study|Death|0|||
156719307|NCT00281957|565719756|FG000|Overall Study|Progression/relapse|47|||
156719308|NCT00281957|565719757|FG001|Overall Study|Progression/relapse|35|||
156719309|NCT00281957|565719756|FG000|Overall Study|Not protocol specified|8|||
156719310|NCT00281957|565719757|FG001|Overall Study|Not protocol specified|1|||
156719311|NCT00281957|565719756|FG000|Overall Study|Not eligible|1|||
156719312|NCT00281957|565719757|FG001|Overall Study|Not eligible|2|||
156719313|NCT00281957|565719756|FG000|Overall Study|Did not start treatment|3|||
156719314|NCT00281957|565719757|FG001|Overall Study|Did not start treatment|1|||
156719315|NCT00281957|565719756|FG000|Overall Study|Refusal unrelated to adverse events|0|||
156719316|NCT00281957|565719757|FG001|Overall Study|Refusal unrelated to adverse events|1|||
156719317|NCT00822692|565719765|FG000|Overall Study|Lost to Follow-up|17|||
156719318|NCT00822692|565719766|FG001|Overall Study|Lost to Follow-up|25|||
156719319|NCT03281876|565719767|FG000|Overall Study|Adverse Event|4|||
156449043|NCT05536440|564738409|FG002|Overall Study|Adverse Event|0|||
156449044|NCT05536440|564738410|FG003|Overall Study|Adverse Event|0|||
156449045|NCT05536440|564738411|FG004|Overall Study|Adverse Event|0|||
156449046|NCT05536440|564738412|FG005|Overall Study|Adverse Event|0|||
156449047|NCT05536440|564738413|FG006|Overall Study|Adverse Event|0|||
156449048|NCT05536440|564738414|FG007|Overall Study|Adverse Event|0|||
156719320|NCT03281876|565719768|FG001|Overall Study|Adverse Event|15|||
156719321|NCT03281876|565719767|FG000|Overall Study|Lost to Follow-up|1|||
156719322|NCT03281876|565719768|FG001|Overall Study|Lost to Follow-up|4|||
156719323|NCT03281876|565719767|FG000|Overall Study|Withdrawal by Subject|11|||
156719324|NCT03281876|565719768|FG001|Overall Study|Withdrawal by Subject|15|||
156719325|NCT03281876|565719767|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156719326|NCT03281876|565719768|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156719327|NCT03281876|565719767|FG000|Overall Study|OTHER|5|||
156719328|NCT03281876|565719768|FG001|Overall Study|OTHER|5|||
156719329|NCT02208089|565719769|FG000|Overall Study|Withdrawal by Subject|1|||
156719330|NCT02208089|565719770|FG001|Overall Study|Withdrawal by Subject|0|||
156719331|NCT02208089|565719769|FG000|Overall Study|Lost to Follow-up|6|||
156719332|NCT02208089|565719770|FG001|Overall Study|Lost to Follow-up|0|||
156719333|NCT02443740|565719771|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719334|NCT02443740|565719772|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719335|NCT02443740|565719773|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719336|NCT02443740|565719774|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719337|NCT02443740|565719775|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719338|NCT02443740|565719776|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
156719339|NCT02443740|565719777|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719340|NCT02443740|565719778|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719341|NCT02443740|565719779|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719342|NCT02443740|565719780|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719343|NCT02443740|565719781|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719344|NCT02443740|565719771|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
156719345|NCT02443740|565719772|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719346|NCT02443740|565719773|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719347|NCT02443740|565719774|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719348|NCT02443740|565719775|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719349|NCT02443740|565719776|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719350|NCT02443740|565719777|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
156719351|NCT02443740|565719778|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719352|NCT02443740|565719779|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719353|NCT02443740|565719780|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719354|NCT02443740|565719781|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719355|NCT02443740|565719771|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719356|NCT02443740|565719772|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719357|NCT02443740|565719773|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719358|NCT02443740|565719774|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719359|NCT02443740|565719775|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719360|NCT02443740|565719776|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
156719361|NCT02443740|565719777|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719362|NCT02443740|565719778|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719363|NCT02443740|565719779|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719364|NCT02443740|565719780|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719365|NCT02443740|565719781|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719366|NCT00456300|565719782|FG000|Overall Study|Adverse Event|1|||
156719367|NCT00456300|565719783|FG001|Overall Study|Adverse Event|0|||
156719368|NCT01964976|565719784|FG000|Overall Study|Protocol Violation|31|||
156719369|NCT02452476|565719785|FG000|Overall Study|Death|4|||
156719370|NCT02452476|565719786|FG001|Overall Study|Death|7|||
156719371|NCT02452476|565719785|FG000|Overall Study|Lost to Follow-up|1|||
156719372|NCT02452476|565719786|FG001|Overall Study|Lost to Follow-up|1|||
156719373|NCT02452476|565719785|FG000|Overall Study|Physician Decision|1|||
156719374|NCT02452476|565719786|FG001|Overall Study|Physician Decision|1|||
156719375|NCT02452476|565719785|FG000|Overall Study|Not treated|5|||
156719376|NCT02452476|565719786|FG001|Overall Study|Not treated|1|||
156719377|NCT01074944|565719790|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
156719378|NCT01074944|565719791|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
156719379|NCT01074944|565719792|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
156719380|NCT01074944|565719793|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
156793810|NCT00505687|565999454|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
156793811|NCT00505687|565999454|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
156793812|NCT00505687|565999454|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
156793813|NCT00505687|565999454|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
156793814|NCT00505687|565999454|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
156793815|NCT00505687|565999454|FG000|Overall Study|Other: Disease Progression|1|||
156719381|NCT01074944|565719794|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
156719382|NCT01074944|565719790|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
156719383|NCT01074944|565719791|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
156719384|NCT01074944|565719792|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
156719385|NCT01074944|565719793|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
156719386|NCT01074944|565719794|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
156719387|NCT01074944|565719790|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
156719388|NCT01074944|565719791|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
156719389|NCT01074944|565719792|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
156719390|NCT01074944|565719793|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
156719391|NCT01074944|565719794|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
156719392|NCT01074944|565719790|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
156719393|NCT01074944|565719791|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
156719394|NCT01074944|565719792|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
156719395|NCT01074944|565719793|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
156719396|NCT01074944|565719794|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
156719397|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
156719398|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
156719399|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
156719400|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
156719401|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
156719402|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
156719403|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
156719404|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
156719405|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
156719406|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
156719407|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
156719408|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
156719409|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
156719410|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
156719411|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
156719412|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
156719413|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
156719414|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
156719415|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
156719416|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
156719417|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
156719418|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
156719419|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
156719420|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
156719421|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
156719422|NCT01074944|565719790|FG000|Long Term Treatment|Adverse Event|0|||
156719423|NCT01074944|565719791|FG001|Long Term Treatment|Adverse Event|0|||
156719424|NCT01074944|565719792|FG002|Long Term Treatment|Adverse Event|0|||
156719425|NCT01074944|565719793|FG003|Long Term Treatment|Adverse Event|3|||
156719426|NCT01074944|565719794|FG004|Long Term Treatment|Adverse Event|0|||
156719427|NCT01074944|565719790|FG000|Long Term Treatment|Lost to Follow-up|0|||
156719428|NCT01074944|565719791|FG001|Long Term Treatment|Lost to Follow-up|0|||
156719429|NCT01074944|565719792|FG002|Long Term Treatment|Lost to Follow-up|0|||
156719430|NCT01074944|565719793|FG003|Long Term Treatment|Lost to Follow-up|2|||
156719431|NCT01074944|565719794|FG004|Long Term Treatment|Lost to Follow-up|0|||
156719432|NCT01074944|565719790|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
156719433|NCT01074944|565719791|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
156719434|NCT01074944|565719792|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
156719435|NCT01074944|565719793|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
156719436|NCT01074944|565719794|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
156719437|NCT01074944|565719790|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
156719438|NCT01074944|565719791|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
156719439|NCT01074944|565719792|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
156719440|NCT01074944|565719793|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
156719441|NCT01074944|565719794|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
156719442|NCT01074944|565719790|FG000|Long Term Treatment|Withdrawal by Subject|0|||
156719443|NCT01074944|565719791|FG001|Long Term Treatment|Withdrawal by Subject|0|||
156875351|NCT04896086|566302022|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
156875352|NCT04896086|566302023|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
156449049|NCT05536440|564738415|FG008|Overall Study|Adverse Event|1|||
156719444|NCT01074944|565719792|FG002|Long Term Treatment|Withdrawal by Subject|0|||
156719445|NCT01074944|565719793|FG003|Long Term Treatment|Withdrawal by Subject|2|||
156719446|NCT01074944|565719794|FG004|Long Term Treatment|Withdrawal by Subject|0|||
156719447|NCT01074944|565719790|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
156719448|NCT01074944|565719791|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
156719449|NCT01074944|565719792|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
156719450|NCT01074944|565719793|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
156719451|NCT01074944|565719794|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
156719452|NCT01074944|565719790|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
156719453|NCT01074944|565719791|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
156719454|NCT01074944|565719792|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
156719455|NCT01074944|565719793|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
156719456|NCT01074944|565719794|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
156719457|NCT02348112|565719796|FG000|Overall Study|Withdrawal by Subject|32|||
156719458|NCT02348112|565719797|FG001|Overall Study|Withdrawal by Subject|29|||
156719459|NCT02348112|565719796|FG000|Overall Study|Lost to Follow-up|24|||
156719460|NCT02348112|565719797|FG001|Overall Study|Lost to Follow-up|20|||
156719461|NCT02348112|565719796|FG000|Overall Study|Physician Decision|17|||
156719462|NCT02348112|565719797|FG001|Overall Study|Physician Decision|15|||
156719463|NCT02348112|565719796|FG000|Overall Study|Site closed due to PI leaving|0|||
156719464|NCT02348112|565719797|FG001|Overall Study|Site closed due to PI leaving|30|||
156719465|NCT02348112|565719796|FG000|Overall Study|Sponsor withdrawal|0|||
156719466|NCT02348112|565719797|FG001|Overall Study|Sponsor withdrawal|7|||
156719467|NCT02348112|565719796|FG000|Overall Study|Death|0|||
156719468|NCT02348112|565719797|FG001|Overall Study|Death|1|||
156719469|NCT02552121|565719803|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
156719470|NCT02552121|565719804|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719471|NCT02552121|565719805|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719472|NCT02552121|565719806|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719473|NCT02552121|565719807|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719474|NCT02552121|565719808|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719475|NCT02552121|565719809|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719476|NCT02552121|565719810|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719477|NCT02552121|565719803|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
156719478|NCT02552121|565719804|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719479|NCT02552121|565719805|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719480|NCT02552121|565719806|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719481|NCT02552121|565719807|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719482|NCT02552121|565719808|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719483|NCT02552121|565719809|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719484|NCT02552121|565719810|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719485|NCT02552121|565719803|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719486|NCT02552121|565719804|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
156719487|NCT02552121|565719805|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719488|NCT02552121|565719806|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719489|NCT02552121|565719807|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719490|NCT02552121|565719808|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719491|NCT02552121|565719809|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719492|NCT02552121|565719810|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719493|NCT02552121|565719803|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719494|NCT02552121|565719804|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
156719495|NCT02552121|565719805|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719496|NCT02552121|565719806|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719497|NCT02552121|565719807|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719498|NCT02552121|565719808|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719499|NCT02552121|565719809|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719500|NCT02552121|565719810|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719501|NCT02552121|565719803|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719502|NCT02552121|565719804|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
156719503|NCT02552121|565719805|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719504|NCT02552121|565719806|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719505|NCT02552121|565719807|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719506|NCT02552121|565719808|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719507|NCT02552121|565719809|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719508|NCT02552121|565719810|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719509|NCT02552121|565719803|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156793816|NCT00505687|565999454|FG000|Overall Study|Other: As Per Sponsor|8|||
156793817|NCT00666263|565999457|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
156719510|NCT02552121|565719804|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
156719511|NCT02552121|565719805|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719512|NCT02552121|565719806|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719513|NCT02552121|565719807|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719514|NCT02552121|565719808|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719515|NCT02552121|565719809|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719516|NCT02552121|565719810|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719517|NCT02552121|565719803|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
156719518|NCT02552121|565719804|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
156719519|NCT02552121|565719805|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
156719520|NCT02552121|565719806|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
156719521|NCT02552121|565719807|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
156719522|NCT02552121|565719808|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
156719523|NCT02552121|565719809|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
156719524|NCT02552121|565719810|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
156719525|NCT02552121|565719803|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
156719526|NCT02552121|565719804|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
156719527|NCT02552121|565719805|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
156719528|NCT02552121|565719806|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
156719529|NCT02552121|565719807|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
156719530|NCT02552121|565719808|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
156719531|NCT02552121|565719809|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
156719532|NCT02552121|565719810|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
156719533|NCT02552121|565719803|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
156719534|NCT02552121|565719804|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
156719535|NCT02552121|565719805|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
156719536|NCT02552121|565719806|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
156719537|NCT02552121|565719807|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
156719538|NCT02552121|565719808|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
156719539|NCT02552121|565719809|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
156719540|NCT02552121|565719810|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
156719541|NCT02552121|565719803|FG000|Part 2: Cohort Expansion|Death|0|||
156719542|NCT02552121|565719804|FG001|Part 2: Cohort Expansion|Death|0|||
156719543|NCT02552121|565719805|FG002|Part 2: Cohort Expansion|Death|1|||
156719544|NCT02552121|565719806|FG003|Part 2: Cohort Expansion|Death|0|||
156719545|NCT02552121|565719807|FG004|Part 2: Cohort Expansion|Death|0|||
156719546|NCT02552121|565719808|FG005|Part 2: Cohort Expansion|Death|0|||
156719547|NCT02552121|565719809|FG006|Part 2: Cohort Expansion|Death|0|||
156719548|NCT02552121|565719810|FG007|Part 2: Cohort Expansion|Death|0|||
156719549|NCT02586155|565719811|FG000|Overall Study|Adverse Event|2|||
156719550|NCT02586155|565719812|FG001|Overall Study|Adverse Event|3|||
156719551|NCT02586155|565719811|FG000|Overall Study|Withdrawal by Subject|31|||
156719552|NCT02586155|565719812|FG001|Overall Study|Withdrawal by Subject|24|||
156719553|NCT02586155|565719811|FG000|Overall Study|Lost to Follow-up|7|||
156719554|NCT02586155|565719812|FG001|Overall Study|Lost to Follow-up|13|||
156719555|NCT02586155|565719811|FG000|Overall Study|Death|61|||
156719556|NCT02586155|565719812|FG001|Overall Study|Death|72|||
156719557|NCT02586155|565719811|FG000|Overall Study|Other reasons|26|||
156719558|NCT02586155|565719812|FG001|Overall Study|Other reasons|15|||
156719559|NCT01522456|565719814|FG000|Overall Study|Adverse Event|2|||
156719560|NCT01522456|565719814|FG000|Overall Study|Lost to Follow-up|2|||
156719561|NCT01522456|565719814|FG000|Overall Study|Withdrawal by Subject|2|||
156719562|NCT01522456|565719814|FG000|Overall Study|Pregnancy|1|||
156719563|NCT01522456|565719814|FG000|Overall Study|Tolerability Assessment|1|||
156719564|NCT04052620|565719815|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
156719565|NCT04052620|565719816|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
156719566|NCT04052620|565719815|FG000|Overall Study|Withdrawal by Subject|1|||
156719567|NCT04052620|565719816|FG001|Overall Study|Withdrawal by Subject|0|||
156719568|NCT04052620|565719815|FG000|Overall Study|Lost to Follow-up|1|||
156719569|NCT04052620|565719816|FG001|Overall Study|Lost to Follow-up|1|||
156719570|NCT04052620|565719815|FG000|Overall Study|Adverse Event|1|||
156719571|NCT04052620|565719816|FG001|Overall Study|Adverse Event|0|||
156719572|NCT04052620|565719815|FG000|Overall Study|Subject did not meet study Criteria|0|||
156719573|NCT04052620|565719816|FG001|Overall Study|Subject did not meet study Criteria|1|||
156719574|NCT04052620|565719815|FG000|Overall Study|Screened failure, randomized by mistake|0|||
156719575|NCT04052620|565719816|FG001|Overall Study|Screened failure, randomized by mistake|1|||
156719576|NCT04052620|565719815|FG000|Overall Study|Personal reasons|2|||
156335071|NCT00910273|564324502|FG000|Overall Study|Withdrawal by Subject|1|||
156719577|NCT04052620|565719816|FG001|Overall Study|Personal reasons|4|||
156335072|NCT00910273|564324503|FG001|Overall Study|Withdrawal by Subject|0|||
156335073|NCT00910273|564324502|FG000|Overall Study|Discontinuation of study by sponsor|8|||
156335074|NCT00910273|564324503|FG001|Overall Study|Discontinuation of study by sponsor|2|||
156335075|NCT00910273|564324502|FG000|Overall Study|Protocol Violation|1|||
156335076|NCT00910273|564324503|FG001|Overall Study|Protocol Violation|0|||
156335077|NCT00910273|564324502|FG000|Overall Study|Lost to Follow-up|1|||
156719578|NCT04052620|565719815|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
156719579|NCT04052620|565719816|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
156719580|NCT01406574|565719817|FG000|Overall Study|Adverse Event|0|||
156719581|NCT01406574|565719818|FG001|Overall Study|Adverse Event|0|||
156719582|NCT01406574|565719819|FG002|Overall Study|Adverse Event|1|||
156719583|NCT01406574|565719820|FG003|Overall Study|Adverse Event|3|||
156719584|NCT01406574|565719817|FG000|Overall Study|Physician Decision|0|||
156719585|NCT01406574|565719818|FG001|Overall Study|Physician Decision|0|||
156719586|NCT01406574|565719819|FG002|Overall Study|Physician Decision|0|||
156719587|NCT01406574|565719820|FG003|Overall Study|Physician Decision|1|||
156719588|NCT01406574|565719817|FG000|Overall Study|Withdrawal by Subject|0|||
156719589|NCT01406574|565719818|FG001|Overall Study|Withdrawal by Subject|1|||
156719590|NCT01406574|565719819|FG002|Overall Study|Withdrawal by Subject|0|||
156719591|NCT01406574|565719820|FG003|Overall Study|Withdrawal by Subject|0|||
156719592|NCT01406574|565719817|FG000|Overall Study|Definite progression of primary disease|1|||
156719593|NCT01406574|565719818|FG001|Overall Study|Definite progression of primary disease|0|||
156719594|NCT01406574|565719819|FG002|Overall Study|Definite progression of primary disease|0|||
156719595|NCT01406574|565719820|FG003|Overall Study|Definite progression of primary disease|0|||
156719596|NCT02201784|565719822|FG000|Overall Study|Failure to achieve adequate block|2|||
156719597|NCT02201784|565719823|FG001|Overall Study|Failure to achieve adequate block|0|||
156719598|NCT02046603|565719824|FG000|Overall Study|Other|11|||
156719599|NCT02046603|565719825|FG001|Overall Study|Other|66|||
156719600|NCT02046603|565719824|FG000|Overall Study|Protocol Violation|0|||
156719601|NCT02046603|565719825|FG001|Overall Study|Protocol Violation|1|||
156719602|NCT02046603|565719824|FG000|Overall Study|Participant/legal guardian decision|1|||
156719603|NCT02046603|565719825|FG001|Overall Study|Participant/legal guardian decision|3|||
156719604|NCT02046603|565719824|FG000|Overall Study|Physician Decision|2|||
156719605|NCT02046603|565719825|FG001|Overall Study|Physician Decision|1|||
156719606|NCT02046603|565719824|FG000|Overall Study|Lost to Follow-up|1|||
156719607|NCT02046603|565719825|FG001|Overall Study|Lost to Follow-up|2|||
156719608|NCT02046603|565719824|FG000|Overall Study|Death|0|||
156719609|NCT02046603|565719825|FG001|Overall Study|Death|1|||
156719610|NCT02046603|565719824|FG000|Overall Study|Adverse Event|0|||
156719611|NCT02046603|565719825|FG001|Overall Study|Adverse Event|1|||
156719612|NCT02072980|565719826|FG000|Period 2, Second Wear|Adverse Event|0|||
156719613|NCT02072980|565719827|FG001|Period 2, Second Wear|Adverse Event|1|||
156719614|NCT00946920|565719828|FG000|Overall Study|Withdrawal by Subject|28|||
156719615|NCT00946920|565719829|FG001|Overall Study|Withdrawal by Subject|15|||
156719616|NCT00946920|565719828|FG000|Overall Study|Lost to Follow-up|2|||
156719617|NCT00946920|565719829|FG001|Overall Study|Lost to Follow-up|2|||
156719618|NCT00946920|565719828|FG000|Overall Study|Physician Decision|5|||
156719619|NCT00946920|565719829|FG001|Overall Study|Physician Decision|2|||
156719620|NCT00946920|565719828|FG000|Overall Study|Adverse Event|41|||
156719621|NCT00946920|565719829|FG001|Overall Study|Adverse Event|14|||
156719622|NCT00946920|565719828|FG000|Overall Study|Protocol Violation|16|||
156719623|NCT00946920|565719829|FG001|Overall Study|Protocol Violation|8|||
156719624|NCT00946920|565719828|FG000|Overall Study|Miscellaneous reasons|18|||
156719625|NCT00946920|565719829|FG001|Overall Study|Miscellaneous reasons|3|||
156719626|NCT00193050|565719830|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
156719627|NCT00193050|565719830|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
156719628|NCT00193050|565719830|FG000|Neoadjuvant Treatment|Physician Decision|2|||
156719629|NCT00193050|565719830|FG000|Neoadjuvant Treatment|Adverse Event|2|||
156719630|NCT00193050|565719830|FG000|Adjuvant|Physician Decision|5|||
156719631|NCT00193050|565719830|FG000|Adjuvant|Intercurrent Hospitalization|3|||
156719632|NCT00193050|565719830|FG000|Adjuvant|Lack of Efficacy|2|||
156719633|NCT02431364|565719831|FG000|Overall Study|Adverse Event|0|||
156719634|NCT02431364|565719832|FG001|Overall Study|Adverse Event|1|||
156719635|NCT02431364|565719833|FG002|Overall Study|Adverse Event|0|||
156719636|NCT02431364|565719834|FG003|Overall Study|Adverse Event|0|||
156719637|NCT02431364|565719835|FG004|Overall Study|Adverse Event|0|||
156719638|NCT02431364|565719831|FG000|Overall Study|Randomized but never treated|0|||
156719639|NCT02431364|565719832|FG001|Overall Study|Randomized but never treated|0|||
156719640|NCT02431364|565719833|FG002|Overall Study|Randomized but never treated|0|||
156719641|NCT02431364|565719834|FG003|Overall Study|Randomized but never treated|1|||
156719642|NCT02431364|565719835|FG004|Overall Study|Randomized but never treated|0|||
156719643|NCT00061932|565719836|FG000|Overall Study|Withdrawal by Subject|13|||
156719644|NCT00061932|565719837|FG001|Overall Study|Withdrawal by Subject|4|||
156719645|NCT00916383|565719838|FG000|Overall Study|Adverse Event|1|||
156719646|NCT00916383|565719838|FG000|Overall Study|Death|1|||
156719647|NCT00916383|565719838|FG000|Overall Study|Protocol Violation|1|||
156719648|NCT00258960|565719839|FG000|Overall Study|Death|2|||
156719649|NCT00258960|565719839|FG000|Overall Study|Disease Progression|7|||
156719650|NCT00258960|565719839|FG000|Overall Study|Adverse Event|4|||
156719651|NCT00258960|565719839|FG000|Overall Study|Physician Decision|1|||
156719652|NCT00258960|565719839|FG000|Overall Study|Withdrawal by Subject|1|||
156719653|NCT00258960|565719839|FG000|Overall Study|Mistake|2|||
156719654|NCT00473590|565719840|FG000|Overall Study|Adverse Event|3|||
156719655|NCT00473590|565719841|FG001|Overall Study|Adverse Event|3|||
156719656|NCT00473590|565719840|FG000|Overall Study|Death|4|||
156719657|NCT00473590|565719841|FG001|Overall Study|Death|2|||
156719658|NCT00473590|565719840|FG000|Overall Study|Progression not resulting in death|24|||
156719659|NCT00473590|565719841|FG001|Overall Study|Progression not resulting in death|20|||
156719660|NCT00473590|565719840|FG000|Overall Study|Non-protocol-specified therapy|7|||
156719661|NCT00473590|565719841|FG001|Overall Study|Non-protocol-specified therapy|5|||
156719662|NCT00473590|565719840|FG000|Overall Study|Physician Decision|2|||
156719663|NCT00473590|565719841|FG001|Overall Study|Physician Decision|4|||
156719664|NCT00473590|565719840|FG000|Overall Study|Withdrawal by Subject|5|||
156719665|NCT00473590|565719841|FG001|Overall Study|Withdrawal by Subject|3|||
156719666|NCT00473590|565719840|FG000|Overall Study|Other|0|||
156719667|NCT00473590|565719841|FG001|Overall Study|Other|1|||
156719668|NCT01245283|565719844|FG000|Overall Study|Lost to Follow-up|14|||
156719669|NCT01245283|565719845|FG001|Overall Study|Lost to Follow-up|11|||
156719670|NCT01245283|565719846|FG002|Overall Study|Lost to Follow-up|11|||
156719671|NCT01610492|565719855|FG000|Overall Study|Adverse Event|1|||
156719672|NCT01610492|565719855|FG000|Overall Study|Lack of Efficacy|3|||
156719673|NCT01610492|565719855|FG000|Overall Study|Other: Reached stopping criteria|1|||
156719674|NCT01610492|565719855|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
156719675|NCT03093259|565719857|FG000|Overall Study|Adverse Event|1|||
156719676|NCT03093259|565719858|FG001|Overall Study|Adverse Event|0|||
156719677|NCT03093259|565719857|FG000|Overall Study|Withdrawal by Subject|1|||
156719678|NCT03093259|565719858|FG001|Overall Study|Withdrawal by Subject|0|||
156719679|NCT01757275|565719859|FG000|Overall Study|Lost to Follow-up|1|||
156719680|NCT01757275|565719860|FG001|Overall Study|Lost to Follow-up|2|||
156719681|NCT01757275|565719859|FG000|Overall Study|Adverse Event|3|||
156719682|NCT01757275|565719860|FG001|Overall Study|Adverse Event|3|||
156719683|NCT01757275|565719859|FG000|Overall Study|Withdrawal by Subject|2|||
156719684|NCT01757275|565719860|FG001|Overall Study|Withdrawal by Subject|4|||
156719685|NCT01757275|565719859|FG000|Overall Study|Not treated|3|||
156719686|NCT01757275|565719860|FG001|Overall Study|Not treated|4|||
156719687|NCT01821807|565719863|FG000|Overall Study|Lost to Follow-up|3|||
156719688|NCT01821807|565719864|FG001|Overall Study|Lost to Follow-up|1|||
156719689|NCT03367819|565719866|FG000|Overall Study|Adverse Event|4|||
156719690|NCT03367819|565719867|FG001|Overall Study|Adverse Event|4|||
156719691|NCT03367819|565719866|FG000|Overall Study|Progressive Disease|15|||
156719692|NCT03367819|565719867|FG001|Overall Study|Progressive Disease|13|||
156719693|NCT03367819|565719866|FG000|Overall Study|Withdrawal by Subject|1|||
156719694|NCT03367819|565719867|FG001|Overall Study|Withdrawal by Subject|0|||
156719695|NCT03367819|565719866|FG000|Overall Study|Other|4|||
156719696|NCT03367819|565719867|FG001|Overall Study|Other|2|||
156719697|NCT02633787|565719868|FG000|Overall Study|Withdrawal by Subject|1|||
156719698|NCT01401452|565719869|FG000|Overall Study|Adverse reaction|9|||
156719699|NCT01401452|565719869|FG000|Overall Study|Lost to Follow-up|12|||
156719700|NCT01401452|565719869|FG000|Overall Study|Lack of Efficacy|30|||
156719701|NCT01401452|565719869|FG000|Overall Study|Participant developed breast cancer|1|||
156719702|NCT01401452|565719869|FG000|Overall Study|Tx stopped due to financial reasons|1|||
156719703|NCT01401452|565719869|FG000|Overall Study|Tx stopped by psychiatrist|1|||
156719704|NCT01401452|565719869|FG000|Overall Study|No more visits within the 36 wk followup|4|||
156719705|NCT01401452|565719869|FG000|Overall Study|Subject did not come to follow up visits|2|||
156719706|NCT01401452|565719869|FG000|Overall Study|Subject didn't return for routine visits|1|||
156719707|NCT01401452|565719869|FG000|Overall Study|Subject moved to another city|1|||
156719708|NCT01401452|565719869|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
156719709|NCT01401452|565719869|FG000|Overall Study|Psoriatic arthritis|1|||
156719710|NCT01401452|565719869|FG000|Overall Study|Participant stopped Tx|2|||
156719711|NCT01401452|565719869|FG000|Overall Study|Discontinuation for personal reasons|1|||
156719712|NCT01401452|565719869|FG000|Overall Study|Treatment failure|1|||
156719713|NCT01401452|565719869|FG000|Overall Study|Unsatisfactory output|1|||
156719714|NCT01401452|565719869|FG000|Overall Study|Subject withdrew because of Tx success|1|||
156719715|NCT01401452|565719869|FG000|Overall Study|Subject chose to discontinue treatment|1|||
156719716|NCT01401452|565719869|FG000|Overall Study|Participant withdrew consent|1|||
156719717|NCT00550459|565719870|FG000|Overall Study|Adverse Event|0|||
156719718|NCT00550459|565719871|FG001|Overall Study|Adverse Event|2|||
156719719|NCT00550459|565719870|FG000|Overall Study|Withdrawal by Subject|1|||
156719720|NCT00550459|565719871|FG001|Overall Study|Withdrawal by Subject|1|||
156719721|NCT00584454|565719872|FG000|Overall Study|Adverse Event|1|||
156719722|NCT00584454|565719872|FG000|Overall Study|Relocation|1|||
156793818|NCT00666263|565999458|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
156793819|NCT00666263|565999457|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
156793820|NCT00666263|565999458|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
156793821|NCT00666263|565999457|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
156719723|NCT00584454|565719872|FG000|Overall Study|Clinical Hold|2|||
156719724|NCT01742897|565719873|FG000|Overall Study|Adverse Event|3|||
156719725|NCT01742897|565719873|FG000|Overall Study|Withdrawal by Subject|1|||
156719726|NCT01742897|565719873|FG000|Overall Study|Other|1|||
156719727|NCT01459783|565719875|FG000|Baseline to 6 Months|Death|1|||
156719728|NCT01459783|565719876|FG001|Baseline to 6 Months|Death|0|||
156719729|NCT01459783|565719875|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
156719730|NCT01459783|565719876|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
156719731|NCT01459783|565719875|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
156719732|NCT01459783|565719876|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
156719733|NCT01459783|565719875|FG000|6 Months to 12 Months|Death|0|||
156719734|NCT01459783|565719876|FG001|6 Months to 12 Months|Death|1|||
156719735|NCT01459783|565719875|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
156719736|NCT01459783|565719876|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
156719737|NCT01459783|565719875|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
156719738|NCT01459783|565719876|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
156719739|NCT01459783|565719875|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
156719740|NCT01459783|565719876|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
156719741|NCT02601014|565719877|FG000|Overall Study|Adverse Event|3|||
156719742|NCT02601014|565719878|FG001|Overall Study|Adverse Event|3|||
156719743|NCT02601014|565719877|FG000|Overall Study|Death|3|||
156719744|NCT02601014|565719878|FG001|Overall Study|Death|1|||
156719745|NCT02601014|565719877|FG000|Overall Study|Disease progression|4|||
156719746|NCT02601014|565719878|FG001|Overall Study|Disease progression|8|||
156719747|NCT00445146|565719881|FG000|Overall Study|Withdrew Consent|29|||
156719748|NCT00445146|565719881|FG000|Overall Study|Lack of Efficacy|28|||
156719749|NCT00445146|565719881|FG000|Overall Study|Investigator's Discretion|22|||
156719750|NCT00445146|565719881|FG000|Overall Study|Adverse Event|13|||
156719751|NCT00445146|565719881|FG000|Overall Study|Lost to Follow-up|13|||
156719752|NCT00445146|565719881|FG000|Overall Study|Death|9|||
156719753|NCT00445146|565719881|FG000|Overall Study|Protocol Violation|4|||
156719754|NCT00445146|565719881|FG000|Overall Study|Pregnancy|1|||
156719755|NCT02623725|565719883|FG000|Overall Study|Non compliance with protocol|9|||
156719756|NCT02623725|565719884|FG001|Overall Study|Non compliance with protocol|3|||
156719757|NCT02623725|565719883|FG000|Overall Study|Serious adverse event|0|||
156719758|NCT02623725|565719884|FG001|Overall Study|Serious adverse event|2|||
156719759|NCT02623725|565719883|FG000|Overall Study|Withdrawal by Subject|7|||
156719760|NCT02623725|565719884|FG001|Overall Study|Withdrawal by Subject|1|||
156719761|NCT03918629|565719885|FG000|Overall Study|Adverse Event|19|||
156719762|NCT03918629|565719886|FG001|Overall Study|Adverse Event|20|||
156719763|NCT03918629|565719885|FG000|Overall Study|Death|14|||
156719764|NCT03918629|565719886|FG001|Overall Study|Death|7|||
156719765|NCT03918629|565719885|FG000|Overall Study|Lost to Follow-up|36|||
156719766|NCT03918629|565719886|FG001|Overall Study|Lost to Follow-up|28|||
156719767|NCT03918629|565719885|FG000|Overall Study|Physician Decision|1|||
156719768|NCT03918629|565719886|FG001|Overall Study|Physician Decision|0|||
156719769|NCT03918629|565719885|FG000|Overall Study|Protocol Violation|7|||
156719770|NCT03918629|565719886|FG001|Overall Study|Protocol Violation|4|||
156719771|NCT03918629|565719885|FG000|Overall Study|Withdrawal by Subject|47|||
156719772|NCT03918629|565719886|FG001|Overall Study|Withdrawal by Subject|47|||
156719773|NCT03918629|565719885|FG000|Overall Study|Other|7|||
156719774|NCT03918629|565719886|FG001|Overall Study|Other|11|||
156719775|NCT03918629|565719885|FG000|Overall Study|Randomized but not vaccinated|2|||
156719776|NCT03918629|565719886|FG001|Overall Study|Randomized but not vaccinated|1|||
156719777|NCT02456740|565719887|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
156719778|NCT02456740|565719888|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
156719779|NCT02456740|565719889|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
156719780|NCT02456740|565719890|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719781|NCT02456740|565719891|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719782|NCT02456740|565719892|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719783|NCT02456740|565719893|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719784|NCT02456740|565719894|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719785|NCT02456740|565719895|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719786|NCT02456740|565719887|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
156719787|NCT02456740|565719888|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
156719788|NCT02456740|565719889|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
156793822|NCT00666263|565999458|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
156719789|NCT02456740|565719890|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156793823|NCT03242434|565999459|FG000|Overall Study|Death|0|||
156719790|NCT02456740|565719891|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156719791|NCT02456740|565719892|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156793824|NCT03242434|565999460|FG001|Overall Study|Death|2|||
156719792|NCT02456740|565719893|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156719793|NCT02456740|565719894|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156719794|NCT02456740|565719895|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156719795|NCT02456740|565719887|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
156793825|NCT00414609|565999461|FG000|Core Study|Adverse Event|9|||
156793826|NCT00414609|565999462|FG001|Core Study|Adverse Event|11|||
156719796|NCT02456740|565719888|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
156719797|NCT02456740|565719889|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
156719798|NCT02456740|565719890|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719799|NCT02456740|565719891|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719800|NCT02456740|565719892|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719801|NCT02456740|565719893|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719802|NCT02456740|565719894|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719803|NCT02456740|565719895|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719804|NCT02456740|565719887|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719805|NCT02456740|565719888|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719806|NCT02456740|565719889|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719807|NCT02456740|565719890|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
156719808|NCT02456740|565719891|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
156719809|NCT02456740|565719892|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719810|NCT02456740|565719893|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719811|NCT02456740|565719894|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719812|NCT02456740|565719895|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
156719813|NCT02456740|565719887|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156719814|NCT02456740|565719888|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156719815|NCT02456740|565719889|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156719816|NCT02456740|565719890|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
156719817|NCT02456740|565719891|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
156719818|NCT02456740|565719892|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
156719819|NCT02456740|565719893|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
156719820|NCT02456740|565719894|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
156719821|NCT02456740|565719895|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
156719822|NCT02456740|565719887|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719823|NCT02456740|565719888|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719824|NCT02456740|565719889|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719825|NCT02456740|565719890|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719826|NCT02456740|565719891|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719827|NCT02456740|565719892|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719828|NCT02456740|565719893|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719829|NCT02456740|565719894|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
156719830|NCT02456740|565719895|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719831|NCT02456740|565719887|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156719832|NCT02456740|565719888|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156719833|NCT02456740|565719889|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156719834|NCT02456740|565719890|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
156719835|NCT02456740|565719891|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
156719836|NCT02456740|565719892|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
156719837|NCT02456740|565719893|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
156719838|NCT02456740|565719894|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
156719839|NCT02456740|565719895|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
156719840|NCT01891864|565719898|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
156719841|NCT01891864|565719899|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
156719842|NCT01891864|565719900|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
156719843|NCT01891864|565719901|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
156719844|NCT01891864|565719902|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
156719845|NCT01891864|565719903|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
156719846|NCT01891864|565719898|FG000|Treatment Period 1|Physician Decision|0|||
156719847|NCT01891864|565719899|FG001|Treatment Period 1|Physician Decision|1|||
156719848|NCT01891864|565719900|FG002|Treatment Period 1|Physician Decision|0|||
156719849|NCT01891864|565719901|FG003|Treatment Period 1|Physician Decision|0|||
156719850|NCT01891864|565719902|FG004|Treatment Period 1|Physician Decision|0|||
156719851|NCT01891864|565719903|FG005|Treatment Period 1|Physician Decision|0|||
156719852|NCT01891864|565719898|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156719853|NCT01891864|565719899|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
156719854|NCT01891864|565719900|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156719855|NCT01891864|565719901|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156719856|NCT01891864|565719902|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156793827|NCT00414609|565999463|FG002|Core Study|Adverse Event|0|||
156793828|NCT00414609|565999461|FG000|Core Study|Abnormal laboratory values|0|||
156793829|NCT00414609|565999462|FG001|Core Study|Abnormal laboratory values|1|||
156793830|NCT00414609|565999463|FG002|Core Study|Abnormal laboratory values|0|||
156793831|NCT00414609|565999461|FG000|Core Study|Abnormal test procedure results|1|||
156719857|NCT01891864|565719903|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156719858|NCT01891864|565719898|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
156719859|NCT01891864|565719899|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
156719860|NCT01891864|565719900|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
156719861|NCT01891864|565719901|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
156719862|NCT01891864|565719902|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
156719863|NCT01891864|565719903|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
156719864|NCT01891864|565719898|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156719865|NCT01891864|565719899|FG001|Treatment Period 1|Withdrawal by Subject|5|||
156719866|NCT01891864|565719900|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156719867|NCT01891864|565719901|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156719868|NCT01891864|565719902|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156719869|NCT01891864|565719903|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156719870|NCT01891864|565719898|FG000|Treatment Period 1|Lost to Follow-up|1|||
156719871|NCT01891864|565719899|FG001|Treatment Period 1|Lost to Follow-up|0|||
156719872|NCT01891864|565719900|FG002|Treatment Period 1|Lost to Follow-up|0|||
156719873|NCT01891864|565719901|FG003|Treatment Period 1|Lost to Follow-up|0|||
156719874|NCT01891864|565719902|FG004|Treatment Period 1|Lost to Follow-up|0|||
156719875|NCT01891864|565719903|FG005|Treatment Period 1|Lost to Follow-up|0|||
156719876|NCT01891864|565719898|FG000|Treatment Period 2|Protocol Violation|0|||
156719877|NCT01891864|565719899|FG001|Treatment Period 2|Protocol Violation|0|||
156719878|NCT01891864|565719900|FG002|Treatment Period 2|Protocol Violation|0|||
156719879|NCT01891864|565719901|FG003|Treatment Period 2|Protocol Violation|1|||
156719880|NCT01891864|565719902|FG004|Treatment Period 2|Protocol Violation|0|||
156719881|NCT01891864|565719903|FG005|Treatment Period 2|Protocol Violation|0|||
156719882|NCT01891864|565719898|FG000|Treatment Period 2|Physician Decision|0|||
156719883|NCT01891864|565719899|FG001|Treatment Period 2|Physician Decision|0|||
156719884|NCT01891864|565719900|FG002|Treatment Period 2|Physician Decision|1|||
156719885|NCT01891864|565719901|FG003|Treatment Period 2|Physician Decision|0|||
156719886|NCT01891864|565719902|FG004|Treatment Period 2|Physician Decision|0|||
156719887|NCT01891864|565719903|FG005|Treatment Period 2|Physician Decision|0|||
156719888|NCT01891864|565719898|FG000|Treatment Period 2|Site Termination|0|||
156719889|NCT01891864|565719899|FG001|Treatment Period 2|Site Termination|0|||
156719890|NCT01891864|565719900|FG002|Treatment Period 2|Site Termination|1|||
156719891|NCT01891864|565719901|FG003|Treatment Period 2|Site Termination|2|||
156719892|NCT01891864|565719902|FG004|Treatment Period 2|Site Termination|0|||
156719893|NCT01891864|565719903|FG005|Treatment Period 2|Site Termination|0|||
156719894|NCT01891864|565719898|FG000|Treatment Period 2|Lack of Efficacy|0|||
156719895|NCT01891864|565719899|FG001|Treatment Period 2|Lack of Efficacy|0|||
156719896|NCT01891864|565719900|FG002|Treatment Period 2|Lack of Efficacy|1|||
156719897|NCT01891864|565719901|FG003|Treatment Period 2|Lack of Efficacy|0|||
156719898|NCT01891864|565719902|FG004|Treatment Period 2|Lack of Efficacy|1|||
156719899|NCT01891864|565719903|FG005|Treatment Period 2|Lack of Efficacy|0|||
156719900|NCT01891864|565719898|FG000|Treatment Period 2|Adverse Event|0|||
156719901|NCT01891864|565719899|FG001|Treatment Period 2|Adverse Event|0|||
156719902|NCT01891864|565719900|FG002|Treatment Period 2|Adverse Event|1|||
156719903|NCT01891864|565719901|FG003|Treatment Period 2|Adverse Event|2|||
156719904|NCT01891864|565719902|FG004|Treatment Period 2|Adverse Event|0|||
156719905|NCT01891864|565719903|FG005|Treatment Period 2|Adverse Event|4|||
156719906|NCT01891864|565719898|FG000|Treatment Period 2|Termination of Site|0|||
156719907|NCT01891864|565719899|FG001|Treatment Period 2|Termination of Site|0|||
156719908|NCT01891864|565719900|FG002|Treatment Period 2|Termination of Site|0|||
156719909|NCT01891864|565719901|FG003|Treatment Period 2|Termination of Site|0|||
156719910|NCT01891864|565719902|FG004|Treatment Period 2|Termination of Site|2|||
156719911|NCT01891864|565719903|FG005|Treatment Period 2|Termination of Site|0|||
156719912|NCT01891864|565719898|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156719913|NCT01891864|565719899|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156719914|NCT01891864|565719900|FG002|Treatment Period 2|Withdrawal by Subject|3|||
156719915|NCT01891864|565719901|FG003|Treatment Period 2|Withdrawal by Subject|4|||
156719916|NCT01891864|565719902|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156719917|NCT01891864|565719903|FG005|Treatment Period 2|Withdrawal by Subject|1|||
156719918|NCT01891864|565719898|FG000|Extension Period|Lack of Efficacy|0|||
156719919|NCT01891864|565719899|FG001|Extension Period|Lack of Efficacy|0|||
156719920|NCT01891864|565719900|FG002|Extension Period|Lack of Efficacy|0|||
156719921|NCT01891864|565719901|FG003|Extension Period|Lack of Efficacy|1|||
156793832|NCT00414609|565999462|FG001|Core Study|Abnormal test procedure results|1|||
156793833|NCT00414609|565999463|FG002|Core Study|Abnormal test procedure results|0|||
156793834|NCT00414609|565999461|FG000|Core Study|Protocol deviation|0|||
156793835|NCT00414609|565999462|FG001|Core Study|Protocol deviation|1|||
156793836|NCT00414609|565999463|FG002|Core Study|Protocol deviation|0|||
156793837|NCT00414609|565999461|FG000|Core Study|Patient withdrew consent|10|||
156793838|NCT00414609|565999462|FG001|Core Study|Patient withdrew consent|11|||
156793839|NCT00414609|565999463|FG002|Core Study|Patient withdrew consent|0|||
156793840|NCT00414609|565999461|FG000|Core Study|Lost to Follow-up|7|||
156793841|NCT00414609|565999462|FG001|Core Study|Lost to Follow-up|4|||
156719922|NCT01891864|565719902|FG004|Extension Period|Lack of Efficacy|1|||
156719923|NCT01891864|565719903|FG005|Extension Period|Lack of Efficacy|0|||
156719924|NCT01891864|565719898|FG000|Extension Period|Pregnancy|0|||
156719925|NCT01891864|565719899|FG001|Extension Period|Pregnancy|0|||
156719926|NCT01891864|565719900|FG002|Extension Period|Pregnancy|1|||
156719927|NCT01891864|565719901|FG003|Extension Period|Pregnancy|0|||
156719928|NCT01891864|565719902|FG004|Extension Period|Pregnancy|0|||
156719929|NCT01891864|565719903|FG005|Extension Period|Pregnancy|0|||
156719930|NCT01891864|565719898|FG000|Extension Period|Adverse Event|0|||
156719931|NCT01891864|565719899|FG001|Extension Period|Adverse Event|0|||
156719932|NCT01891864|565719900|FG002|Extension Period|Adverse Event|4|||
156719933|NCT01891864|565719901|FG003|Extension Period|Adverse Event|2|||
156719934|NCT01891864|565719902|FG004|Extension Period|Adverse Event|2|||
156719935|NCT01891864|565719903|FG005|Extension Period|Adverse Event|0|||
156719936|NCT01891864|565719898|FG000|Extension Period|Withdrawal by Subject|0|||
156719937|NCT01891864|565719899|FG001|Extension Period|Withdrawal by Subject|0|||
156719938|NCT01891864|565719900|FG002|Extension Period|Withdrawal by Subject|1|||
156719939|NCT01891864|565719901|FG003|Extension Period|Withdrawal by Subject|2|||
156719940|NCT01891864|565719902|FG004|Extension Period|Withdrawal by Subject|4|||
156719941|NCT01891864|565719903|FG005|Extension Period|Withdrawal by Subject|0|||
156719942|NCT01891864|565719898|FG000|Extension Period|Lost to Follow-up|0|||
156719943|NCT01891864|565719899|FG001|Extension Period|Lost to Follow-up|0|||
156719944|NCT01891864|565719900|FG002|Extension Period|Lost to Follow-up|2|||
156719945|NCT01891864|565719901|FG003|Extension Period|Lost to Follow-up|0|||
156719946|NCT01891864|565719902|FG004|Extension Period|Lost to Follow-up|0|||
156719947|NCT01891864|565719903|FG005|Extension Period|Lost to Follow-up|0|||
156719948|NCT04720105|565719905|FG000|Overall Study|Lack of Efficacy|1|||
156719949|NCT04720105|565719905|FG000|Overall Study|Lost to Follow-up|1|||
156719950|NCT04720105|565719905|FG000|Overall Study|Withdrawal by Subject|3|||
156719951|NCT05373108|565719906|FG000|Overall Study|Withdrawal by Subject|2|||
156719952|NCT02892331|565719907|FG000|Overall Study|Withdrawal by Subject|0|||
156719953|NCT02892331|565719908|FG001|Overall Study|Withdrawal by Subject|1|||
156719954|NCT02892331|565719909|FG002|Overall Study|Withdrawal by Subject|1|||
156719955|NCT02892331|565719907|FG000|Overall Study|Sick family member|0|||
156719956|NCT02892331|565719908|FG001|Overall Study|Sick family member|0|||
156719957|NCT02892331|565719909|FG002|Overall Study|Sick family member|1|||
156719958|NCT02892331|565719907|FG000|Overall Study|Corona virus pandemic|1|||
156719959|NCT02892331|565719908|FG001|Overall Study|Corona virus pandemic|0|||
156719960|NCT02892331|565719909|FG002|Overall Study|Corona virus pandemic|1|||
156719961|NCT02892331|565719907|FG000|Overall Study|Lost to Follow-up|1|||
156719962|NCT02892331|565719908|FG001|Overall Study|Lost to Follow-up|0|||
156719963|NCT02892331|565719909|FG002|Overall Study|Lost to Follow-up|1|||
156719964|NCT02892331|565719907|FG000|Overall Study|Blood pressure was too elevated|0|||
156719965|NCT02892331|565719908|FG001|Overall Study|Blood pressure was too elevated|1|||
156719966|NCT02892331|565719909|FG002|Overall Study|Blood pressure was too elevated|0|||
156719967|NCT02892331|565719907|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
156719968|NCT02892331|565719908|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
156719969|NCT02892331|565719909|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
156719970|NCT04871776|565719911|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
156719971|NCT04871776|565719912|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
156719972|NCT04871776|565719913|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
156719973|NCT04871776|565719911|FG000|Overall Study|Did not meet eligibility criteria|1|||
156719974|NCT04871776|565719912|FG001|Overall Study|Did not meet eligibility criteria|1|||
156719975|NCT04871776|565719913|FG002|Overall Study|Did not meet eligibility criteria|1|||
156719976|NCT04023396|565721787|FG000|Overall Study|Adverse Event|16|||
156719977|NCT04023396|565721787|FG000|Overall Study|Death|1|||
156719978|NCT04023396|565721787|FG000|Overall Study|Lost to Follow-up|1|||
156719979|NCT04023396|565721787|FG000|Overall Study|Withdrawal by Subject|14|||
156719980|NCT04023396|565721787|FG000|Overall Study|Pregnancy|4|||
156793842|NCT00414609|565999463|FG002|Core Study|Lost to Follow-up|0|||
156793843|NCT00414609|565999461|FG000|Core Study|Administrative problems|0|||
156793844|NCT00414609|565999462|FG001|Core Study|Administrative problems|2|||
156793845|NCT00414609|565999463|FG002|Core Study|Administrative problems|0|||
156793846|NCT00414609|565999461|FG000|Core Study|Death|7|||
156719981|NCT04023396|565721787|FG000|Overall Study|Lack of Efficacy|3|||
156719982|NCT04023396|565721787|FG000|Overall Study|Physician Decision|4|||
156719983|NCT04023396|565721787|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
156719984|NCT02325973|565721792|FG000|Overall Study|Death|5|||
156719985|NCT02325973|565721792|FG000|Overall Study|Withdrawal by subject or investigator|16|||
156719986|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
156719987|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
156793847|NCT00414609|565999462|FG001|Core Study|Death|14|||
156793848|NCT00414609|565999463|FG002|Core Study|Death|0|||
156793849|NCT00414609|565999461|FG000|Extension Study|Adverse Event|0|||
156335078|NCT00910273|564324503|FG001|Overall Study|Lost to Follow-up|1|||
156533371|NCT02038920|565046965|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
156533372|NCT02038920|565046960|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
156533373|NCT02038920|565046961|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
156533374|NCT02038920|565046962|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
156533375|NCT02038920|565046963|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
156533376|NCT02038920|565046964|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
156533377|NCT02038920|565046965|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
156533378|NCT02038920|565046960|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
156533379|NCT02038920|565046961|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
156533380|NCT02038920|565046962|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
156533381|NCT02038920|565046963|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
156533382|NCT02038920|565046964|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
156719988|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
156719989|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
156719990|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
156719991|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
156719992|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
156719993|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
156719994|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
156719995|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
156719996|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
156719997|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
156719998|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
156719999|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
156720000|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
156720001|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
156720002|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
156720003|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
156720004|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
156720005|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
156720006|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
156720007|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
156720008|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
156720009|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
156720010|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
156720011|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
156720012|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
156720013|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
156720014|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
156720015|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
156720016|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
156720017|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
156720018|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
156720019|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
156793850|NCT00414609|565999462|FG001|Extension Study|Adverse Event|0|||
156793851|NCT00414609|565999463|FG002|Extension Study|Adverse Event|14|||
156793852|NCT00414609|565999461|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
156793853|NCT00414609|565999462|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
156793854|NCT00414609|565999463|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
156793855|NCT00414609|565999461|FG000|Extension Study|Withdrawal by Subject|0|||
156793856|NCT00414609|565999462|FG001|Extension Study|Withdrawal by Subject|0|||
156793857|NCT00414609|565999463|FG002|Extension Study|Withdrawal by Subject|13|||
156793858|NCT00414609|565999461|FG000|Extension Study|Lost to Follow-up|0|||
156793859|NCT00414609|565999462|FG001|Extension Study|Lost to Follow-up|0|||
156793860|NCT00414609|565999463|FG002|Extension Study|Lost to Follow-up|10|||
156793861|NCT00414609|565999461|FG000|Extension Study|Administrative problems|0|||
156793862|NCT00414609|565999462|FG001|Extension Study|Administrative problems|0|||
156793863|NCT00414609|565999463|FG002|Extension Study|Administrative problems|1|||
156793864|NCT00414609|565999461|FG000|Extension Study|Death|0|||
156793865|NCT00414609|565999462|FG001|Extension Study|Death|0|||
156793866|NCT00414609|565999463|FG002|Extension Study|Death|17|||
156793867|NCT00266032|565999464|FG000|Treatment|Adverse Event|42|||
156793868|NCT00266032|565999465|FG001|Treatment|Adverse Event|26|||
156533383|NCT02038920|565046965|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
156793869|NCT00266032|565999466|FG002|Treatment|Adverse Event|10|||
156793870|NCT00266032|565999464|FG000|Treatment|Lost to Follow-up|19|||
156793871|NCT00266032|565999465|FG001|Treatment|Lost to Follow-up|4|||
156793872|NCT00266032|565999466|FG002|Treatment|Lost to Follow-up|2|||
156720020|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
156720021|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
156720022|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
156720023|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
156720024|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
156720025|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
156720026|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
156720027|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
156720028|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
156720029|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
156720030|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
156720031|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
156720032|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
156720033|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
156720034|NCT01168232|565721797|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
156720035|NCT01168232|565721797|FG000|Overall Study|Ineligible- Wrong cell type|6|||
156720036|NCT01168232|565721797|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
156720037|NCT02861586|565721807|FG000|Overall Study|Withdrawal by Subject|1|||
156720038|NCT02861586|565721808|FG001|Overall Study|Withdrawal by Subject|2|||
156720039|NCT02861586|565721809|FG002|Overall Study|Withdrawal by Subject|0|||
156720040|NCT02861586|565721810|FG003|Overall Study|Withdrawal by Subject|0|||
156720041|NCT02861586|565721811|FG004|Overall Study|Withdrawal by Subject|0|||
156720042|NCT02861586|565721812|FG005|Overall Study|Withdrawal by Subject|1|||
156720043|NCT02861586|565721813|FG006|Overall Study|Withdrawal by Subject|1|||
156720044|NCT02861586|565721814|FG007|Overall Study|Withdrawal by Subject|0|||
156720045|NCT02861586|565721807|FG000|Overall Study|Lost to Follow-up|3|||
156720046|NCT02861586|565721808|FG001|Overall Study|Lost to Follow-up|1|||
156720047|NCT02861586|565721809|FG002|Overall Study|Lost to Follow-up|1|||
156720048|NCT02861586|565721810|FG003|Overall Study|Lost to Follow-up|0|||
156720049|NCT02861586|565721811|FG004|Overall Study|Lost to Follow-up|0|||
156720050|NCT02861586|565721812|FG005|Overall Study|Lost to Follow-up|3|||
156720051|NCT02861586|565721813|FG006|Overall Study|Lost to Follow-up|0|||
156720052|NCT02861586|565721814|FG007|Overall Study|Lost to Follow-up|0|||
156720053|NCT02861586|565721807|FG000|Overall Study|Adverse Event|0|||
156720054|NCT02861586|565721808|FG001|Overall Study|Adverse Event|0|||
156720055|NCT02861586|565721809|FG002|Overall Study|Adverse Event|0|||
156720056|NCT02861586|565721810|FG003|Overall Study|Adverse Event|0|||
156720057|NCT02861586|565721811|FG004|Overall Study|Adverse Event|0|||
156720058|NCT02861586|565721812|FG005|Overall Study|Adverse Event|1|||
156720059|NCT02861586|565721813|FG006|Overall Study|Adverse Event|0|||
156720060|NCT02861586|565721814|FG007|Overall Study|Adverse Event|0|||
156720061|NCT03874117|565721816|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
156720062|NCT03874117|565721817|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
156720063|NCT03874117|565721816|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
156720064|NCT03874117|565721817|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
156720065|NCT03874117|565721816|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156720066|NCT03874117|565721817|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156449050|NCT01416831|564738418|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
156449051|NCT01416831|564738419|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
156449052|NCT04784559|564738420|FG000|Overall Study|Withdrawal by Subject|3|||
156449053|NCT04784559|564738421|FG001|Overall Study|Withdrawal by Subject|2|||
156449054|NCT04784559|564738422|FG002|Overall Study|Withdrawal by Subject|1|||
156449055|NCT04784559|564738420|FG000|Overall Study|Death|2|||
156449056|NCT04784559|564738421|FG001|Overall Study|Death|1|||
156449057|NCT04784559|564738422|FG002|Overall Study|Death|2|||
156449058|NCT04784559|564738420|FG000|Overall Study|Lost to Follow-up|0|||
156449059|NCT04784559|564738421|FG001|Overall Study|Lost to Follow-up|0|||
156449060|NCT04784559|564738422|FG002|Overall Study|Lost to Follow-up|2|||
156449061|NCT04784559|564738420|FG000|Overall Study|Participant worsened, PI decision|1|||
156449062|NCT04784559|564738421|FG001|Overall Study|Participant worsened, PI decision|0|||
156449063|NCT04784559|564738422|FG002|Overall Study|Participant worsened, PI decision|0|||
156449064|NCT04784559|564738420|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
156449065|NCT04784559|564738421|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
156449066|NCT04784559|564738422|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
156720067|NCT03874117|565721816|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
156720068|NCT03874117|565721817|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
156720069|NCT03874117|565721816|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156720070|NCT03874117|565721817|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156720071|NCT05012098|565721818|FG000|Overall Study|Disease progression|5|||
156720072|NCT05012098|565721819|FG001|Overall Study|Disease progression|2|||
156720073|NCT05012098|565721818|FG000|Overall Study|Adverse Event|1|||
156449067|NCT04784559|564738420|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
156449068|NCT04784559|564738421|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
156449069|NCT04784559|564738422|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
156720074|NCT05012098|565721819|FG001|Overall Study|Adverse Event|0|||
156720075|NCT05012098|565721818|FG000|Overall Study|Withdrawal by Subject|1|||
156720076|NCT05012098|565721819|FG001|Overall Study|Withdrawal by Subject|0|||
156720077|NCT05012098|565721818|FG000|Overall Study|Discontinuation per protocol|1|||
156720078|NCT05012098|565721819|FG001|Overall Study|Discontinuation per protocol|0|||
156720079|NCT03018288|565721820|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
156720080|NCT03018288|565721821|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
156720081|NCT03018288|565721822|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
156720082|NCT03018288|565721823|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
156720083|NCT03018288|565721820|FG000|Overall Study|Participant withdrew consent.|0|||
156720084|NCT03018288|565721821|FG001|Overall Study|Participant withdrew consent.|0|||
156720085|NCT03018288|565721822|FG002|Overall Study|Participant withdrew consent.|1|||
156720086|NCT03018288|565721823|FG003|Overall Study|Participant withdrew consent.|0|||
156720087|NCT03018288|565721820|FG000|Overall Study|Switched to alternative treatment.|0|||
156720088|NCT03018288|565721821|FG001|Overall Study|Switched to alternative treatment.|0|||
156720089|NCT03018288|565721822|FG002|Overall Study|Switched to alternative treatment.|1|||
156720090|NCT03018288|565721823|FG003|Overall Study|Switched to alternative treatment.|0|||
156720091|NCT03018288|565721820|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
156720092|NCT03018288|565721821|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
156720093|NCT03018288|565721822|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
156720094|NCT03018288|565721823|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
156720095|NCT03018288|565721820|FG000|Overall Study|Screen failures|0|||
156720096|NCT03018288|565721821|FG001|Overall Study|Screen failures|0|||
156720097|NCT03018288|565721822|FG002|Overall Study|Screen failures|0|||
156720098|NCT03018288|565721823|FG003|Overall Study|Screen failures|51|||
156720099|NCT03018288|565721820|FG000|Overall Study|Chose treatment outside of UNC|0|||
156720100|NCT03018288|565721821|FG001|Overall Study|Chose treatment outside of UNC|0|||
156720101|NCT03018288|565721822|FG002|Overall Study|Chose treatment outside of UNC|0|||
156720102|NCT03018288|565721823|FG003|Overall Study|Chose treatment outside of UNC|1|||
156720103|NCT03018288|565721820|FG000|Overall Study|Unable to comply with protocol requirements|1|||
156720104|NCT03018288|565721821|FG001|Overall Study|Unable to comply with protocol requirements|1|||
156720105|NCT03018288|565721822|FG002|Overall Study|Unable to comply with protocol requirements|0|||
156720106|NCT03018288|565721823|FG003|Overall Study|Unable to comply with protocol requirements|1|||
156720107|NCT03018288|565721820|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
156720108|NCT03018288|565721821|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
156720109|NCT03018288|565721822|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
156720110|NCT03018288|565721823|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
156720111|NCT03018288|565721820|FG000|Overall Study|Physician Decision|0|||
156720112|NCT03018288|565721821|FG001|Overall Study|Physician Decision|0|||
156720113|NCT03018288|565721822|FG002|Overall Study|Physician Decision|0|||
156720114|NCT03018288|565721823|FG003|Overall Study|Physician Decision|1|||
156720115|NCT04815083|565721827|FG000|Overall Study|Physician Decision|1|||
156720116|NCT04815083|565721827|FG000|Overall Study|Study pause|2|||
156720117|NCT04815083|565721827|FG000|Overall Study|Screening failure|4|||
156720118|NCT01922037|565721828|FG000|Overall Study|Withdrawal by Subject|2|||
156720119|NCT01922037|565721829|FG001|Overall Study|Withdrawal by Subject|44|||
156720120|NCT01922037|565721828|FG000|Overall Study|Adverse Event|1|||
156720121|NCT01922037|565721829|FG001|Overall Study|Adverse Event|7|||
156720122|NCT01922037|565721828|FG000|Overall Study|Death|0|||
156720123|NCT01922037|565721829|FG001|Overall Study|Death|5|||
156720124|NCT01922037|565721828|FG000|Overall Study|Pregnancy|0|||
156793873|NCT00266032|565999464|FG000|Treatment|Pregnancy|3|||
156793874|NCT00266032|565999465|FG001|Treatment|Pregnancy|2|||
156449070|NCT04784559|564738420|FG000|Overall Study|Did not meet all inclusion criteria|0|||
156449071|NCT04784559|564738421|FG001|Overall Study|Did not meet all inclusion criteria|1|||
156720125|NCT01922037|565721829|FG001|Overall Study|Pregnancy|2|||
156720126|NCT01922037|565721828|FG000|Overall Study|Participant non-compliance|4|||
156720127|NCT01922037|565721829|FG001|Overall Study|Participant non-compliance|46|||
156720128|NCT01922037|565721828|FG000|Overall Study|Investigator/Sponsor decision|1|||
156720129|NCT01922037|565721829|FG001|Overall Study|Investigator/Sponsor decision|4|||
156720130|NCT01922037|565721828|FG000|Overall Study|Other unspecified|2|||
156720131|NCT01922037|565721829|FG001|Overall Study|Other unspecified|66|||
156720132|NCT01730053|565721830|FG000|Overall Study|Participant moved|0|||
156720133|NCT01730053|565721831|FG001|Overall Study|Participant moved|0|||
156720134|NCT01730053|565721832|FG002|Overall Study|Participant moved|1|||
156720135|NCT01730053|565721833|FG003|Overall Study|Participant moved|0|||
156720136|NCT01730053|565721834|FG004|Overall Study|Participant moved|0|||
156793875|NCT00266032|565999466|FG002|Treatment|Pregnancy|2|||
156720137|NCT01730053|565721835|FG005|Overall Study|Participant moved|0|||
156720138|NCT01730053|565721830|FG000|Overall Study|Physician Decision|0|||
156720139|NCT01730053|565721831|FG001|Overall Study|Physician Decision|0|||
156720140|NCT01730053|565721832|FG002|Overall Study|Physician Decision|0|||
156720141|NCT01730053|565721833|FG003|Overall Study|Physician Decision|1|||
156720142|NCT01730053|565721834|FG004|Overall Study|Physician Decision|0|||
156720143|NCT01730053|565721835|FG005|Overall Study|Physician Decision|0|||
156720144|NCT01730053|565721830|FG000|Overall Study|Adverse Event|2|||
156720145|NCT01730053|565721831|FG001|Overall Study|Adverse Event|6|||
156720146|NCT01730053|565721832|FG002|Overall Study|Adverse Event|3|||
156720147|NCT01730053|565721833|FG003|Overall Study|Adverse Event|3|||
156720148|NCT01730053|565721834|FG004|Overall Study|Adverse Event|2|||
156720149|NCT01730053|565721835|FG005|Overall Study|Adverse Event|2|||
156720150|NCT01730053|565721830|FG000|Overall Study|Poor compliance to protocol|1|||
156720151|NCT01730053|565721831|FG001|Overall Study|Poor compliance to protocol|2|||
156720152|NCT01730053|565721832|FG002|Overall Study|Poor compliance to protocol|2|||
156720153|NCT01730053|565721833|FG003|Overall Study|Poor compliance to protocol|0|||
156720154|NCT01730053|565721834|FG004|Overall Study|Poor compliance to protocol|0|||
156720155|NCT01730053|565721835|FG005|Overall Study|Poor compliance to protocol|2|||
156720156|NCT01730053|565721830|FG000|Overall Study|Other than specified|2|||
156720157|NCT01730053|565721831|FG001|Overall Study|Other than specified|6|||
156720158|NCT01730053|565721832|FG002|Overall Study|Other than specified|5|||
156720159|NCT01730053|565721833|FG003|Overall Study|Other than specified|4|||
156720160|NCT01730053|565721834|FG004|Overall Study|Other than specified|7|||
156720161|NCT01730053|565721835|FG005|Overall Study|Other than specified|9|||
156720162|NCT02243605|565721840|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
156720163|NCT02243605|565721841|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
156720164|NCT02243605|565721840|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
156720165|NCT02243605|565721841|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
156720166|NCT02243605|565721840|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
156720167|NCT02243605|565721841|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
156720168|NCT02243605|565721840|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
156720169|NCT02243605|565721841|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
156720170|NCT02243605|565721840|FG000|Stage 2 - Final Analysis Population|Progression|0|||
156720171|NCT02243605|565721841|FG001|Stage 2 - Final Analysis Population|Progression|1|||
156720172|NCT00075816|565721842|FG000|Overall Study|Did not undergo transplantation|14|||
156720173|NCT00075816|565721843|FG001|Overall Study|Did not undergo transplantation|11|||
156720174|NCT04173507|565721844|FG000|Overall Study|On Treatment|3|||
156720175|NCT04173507|565721844|FG000|Overall Study|Adverse Event|3|||
156720176|NCT04173507|565721844|FG000|Overall Study|Progression/Relapse|34|||
156720177|NCT04173507|565721844|FG000|Overall Study|Death|2|||
156720178|NCT01823328|565721845|FG000|Overall Study|Withdrawal by Subject|8|||
156720179|NCT01823328|565721846|FG001|Overall Study|Withdrawal by Subject|6|||
156720180|NCT02832687|565721847|FG000|Overall Study|Adverse Event|0|||
156720181|NCT02832687|565721848|FG001|Overall Study|Adverse Event|2|||
156720182|NCT02572570|565721849|FG000|Overall Study|Study Terminated|27|||
156720183|NCT01417156|565721852|FG000|Overall Study|Adverse Event|12|||
156720184|NCT01417156|565721852|FG000|Overall Study|Protocol Violation|2|||
156720185|NCT03192488|565721853|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
156720186|NCT03192488|565721854|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
156720187|NCT03192488|565721855|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
156720188|NCT03192488|565721856|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
156720189|NCT03192488|565721857|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
156720190|NCT03192488|565721858|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
156720191|NCT03192488|565721853|FG000|Third Intervention (d1)|Adverse Event|0|||
156720192|NCT03192488|565721854|FG001|Third Intervention (d1)|Adverse Event|0|||
156720193|NCT03192488|565721855|FG002|Third Intervention (d1)|Adverse Event|0|||
156720194|NCT03192488|565721856|FG003|Third Intervention (d1)|Adverse Event|0|||
156720195|NCT03192488|565721857|FG004|Third Intervention (d1)|Adverse Event|1|||
156720196|NCT03192488|565721858|FG005|Third Intervention (d1)|Adverse Event|0|||
156720197|NCT00611923|565721860|FG000|Overall Study|Withdrawal by Subject|2|||
156720198|NCT00611923|565721861|FG001|Overall Study|Withdrawal by Subject|2|||
156720199|NCT00471822|565721865|FG000|Overall Study|Protocol Violation|2|||
156720200|NCT03664232|565721877|FG000|Overall Study|Withdrawal by Subject|0|||
156720201|NCT03664232|565721878|FG001|Overall Study|Withdrawal by Subject|1|||
156720202|NCT03664232|565721879|FG002|Overall Study|Withdrawal by Subject|0|||
156720203|NCT03664232|565721880|FG003|Overall Study|Withdrawal by Subject|1|||
156720204|NCT03664232|565721877|FG000|Overall Study|Adverse Event|0|||
156720205|NCT03664232|565721878|FG001|Overall Study|Adverse Event|0|||
156720206|NCT03664232|565721879|FG002|Overall Study|Adverse Event|1|||
156720207|NCT03664232|565721880|FG003|Overall Study|Adverse Event|0|||
156720208|NCT03664232|565721877|FG000|Overall Study|Other-Non-compliance with study drug|0|||
156720209|NCT03664232|565721878|FG001|Overall Study|Other-Non-compliance with study drug|1|||
156720210|NCT03664232|565721879|FG002|Overall Study|Other-Non-compliance with study drug|0|||
156720211|NCT03664232|565721880|FG003|Overall Study|Other-Non-compliance with study drug|2|||
156720212|NCT03664232|565721877|FG000|Overall Study|Other-Unspecified|0|||
156720213|NCT03664232|565721878|FG001|Overall Study|Other-Unspecified|3|||
156720214|NCT03664232|565721879|FG002|Overall Study|Other-Unspecified|0|||
156720215|NCT03664232|565721880|FG003|Overall Study|Other-Unspecified|1|||
156720216|NCT03664232|565721877|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
156720217|NCT03664232|565721878|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
156720218|NCT03664232|565721879|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
156720219|NCT03664232|565721880|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
156720220|NCT01439802|565721881|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
156720221|NCT01439802|565721881|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
156720222|NCT00742209|565721882|FG000|Overall Study|Adverse Event|11|||
156720223|NCT00742209|565721883|FG001|Overall Study|Adverse Event|4|||
156720224|NCT00742209|565721884|FG002|Overall Study|Adverse Event|17|||
156720225|NCT00742209|565721885|FG003|Overall Study|Adverse Event|16|||
156720226|NCT00742209|565721886|FG004|Overall Study|Adverse Event|13|||
156720227|NCT00742209|565721882|FG000|Overall Study|Participant Withdrew Consent|8|||
156720228|NCT00742209|565721883|FG001|Overall Study|Participant Withdrew Consent|4|||
156720229|NCT00742209|565721884|FG002|Overall Study|Participant Withdrew Consent|14|||
156720230|NCT00742209|565721885|FG003|Overall Study|Participant Withdrew Consent|7|||
156720231|NCT00742209|565721886|FG004|Overall Study|Participant Withdrew Consent|4|||
156720232|NCT00742209|565721882|FG000|Overall Study|Protocol Violation|6|||
156720233|NCT00742209|565721883|FG001|Overall Study|Protocol Violation|5|||
156720234|NCT00742209|565721884|FG002|Overall Study|Protocol Violation|4|||
156720235|NCT00742209|565721885|FG003|Overall Study|Protocol Violation|5|||
156720236|NCT00742209|565721886|FG004|Overall Study|Protocol Violation|3|||
156720237|NCT00742209|565721882|FG000|Overall Study|Lost to Follow-up|3|||
156720238|NCT00742209|565721883|FG001|Overall Study|Lost to Follow-up|4|||
156720239|NCT00742209|565721884|FG002|Overall Study|Lost to Follow-up|5|||
156720240|NCT00742209|565721885|FG003|Overall Study|Lost to Follow-up|5|||
156720241|NCT00742209|565721886|FG004|Overall Study|Lost to Follow-up|3|||
156720242|NCT00742209|565721882|FG000|Overall Study|Lack of Efficacy|6|||
156720243|NCT00742209|565721883|FG001|Overall Study|Lack of Efficacy|1|||
156720244|NCT00742209|565721884|FG002|Overall Study|Lack of Efficacy|1|||
156720245|NCT00742209|565721885|FG003|Overall Study|Lack of Efficacy|3|||
156720246|NCT00742209|565721886|FG004|Overall Study|Lack of Efficacy|1|||
156720247|NCT00742209|565721882|FG000|Overall Study|Investigator Discretion|0|||
156720248|NCT00742209|565721883|FG001|Overall Study|Investigator Discretion|0|||
156720249|NCT00742209|565721884|FG002|Overall Study|Investigator Discretion|5|||
156720250|NCT00742209|565721885|FG003|Overall Study|Investigator Discretion|1|||
156720251|NCT00742209|565721886|FG004|Overall Study|Investigator Discretion|1|||
156720252|NCT02003209|565721890|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
156720253|NCT02003209|565721891|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
156720254|NCT00638508|565721892|FG000|Overall Study|Physician Decision|5|||
156720255|NCT00638508|565721893|FG001|Overall Study|Physician Decision|2|||
156720256|NCT00485264|565721896|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
156720257|NCT00485264|565721897|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
156720258|NCT00485264|565721898|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
156720259|NCT00485264|565721899|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
156720260|NCT00485264|565721900|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
156720261|NCT00485264|565721901|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
156720262|NCT00485264|565721896|FG000|Overall Study|Death|1|||
156720263|NCT00485264|565721897|FG001|Overall Study|Death|0|||
156720264|NCT00485264|565721898|FG002|Overall Study|Death|0|||
156720265|NCT00485264|565721899|FG003|Overall Study|Death|0|||
156720266|NCT00485264|565721900|FG004|Overall Study|Death|1|||
156793876|NCT00266032|565999464|FG000|Treatment|Protocol Violation|6|||
156793877|NCT00266032|565999465|FG001|Treatment|Protocol Violation|14|||
156335079|NCT00660673|564324504|FG000|Overall Study|Adverse Event|84|||
156720267|NCT00485264|565721901|FG005|Overall Study|Death|0|||
156720268|NCT00485264|565721896|FG000|Overall Study|Adverse Event|1|||
156720269|NCT00485264|565721897|FG001|Overall Study|Adverse Event|0|||
156720270|NCT00485264|565721898|FG002|Overall Study|Adverse Event|2|||
156720271|NCT00485264|565721899|FG003|Overall Study|Adverse Event|3|||
156720272|NCT00485264|565721900|FG004|Overall Study|Adverse Event|1|||
156720273|NCT00485264|565721901|FG005|Overall Study|Adverse Event|3|||
156720274|NCT00485264|565721896|FG000|Overall Study|Pregnancy|4|||
156720275|NCT00485264|565721897|FG001|Overall Study|Pregnancy|0|||
156720276|NCT00485264|565721898|FG002|Overall Study|Pregnancy|0|||
156720277|NCT00485264|565721899|FG003|Overall Study|Pregnancy|0|||
156720278|NCT00485264|565721900|FG004|Overall Study|Pregnancy|0|||
156720279|NCT00485264|565721901|FG005|Overall Study|Pregnancy|0|||
156720280|NCT00485264|565721896|FG000|Overall Study|Disallowed Medication|0|||
156720281|NCT00485264|565721897|FG001|Overall Study|Disallowed Medication|0|||
156720282|NCT00485264|565721898|FG002|Overall Study|Disallowed Medication|0|||
156720283|NCT00485264|565721899|FG003|Overall Study|Disallowed Medication|0|||
156720284|NCT00485264|565721900|FG004|Overall Study|Disallowed Medication|0|||
156335080|NCT00660673|564324504|FG000|Overall Study|Lack of Efficacy|7|||
156720285|NCT00485264|565721901|FG005|Overall Study|Disallowed Medication|1|||
156720286|NCT00485264|565721896|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
156720287|NCT00485264|565721897|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
156720288|NCT00485264|565721898|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
156720289|NCT00485264|565721899|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
156720290|NCT00485264|565721900|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
156720291|NCT00485264|565721901|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
156720292|NCT00485264|565721896|FG000|Overall Study|Lack of Efficacy|0|||
156720293|NCT00485264|565721897|FG001|Overall Study|Lack of Efficacy|1|||
156720294|NCT00485264|565721898|FG002|Overall Study|Lack of Efficacy|0|||
156720295|NCT00485264|565721899|FG003|Overall Study|Lack of Efficacy|0|||
156720296|NCT00485264|565721900|FG004|Overall Study|Lack of Efficacy|0|||
156720297|NCT00485264|565721901|FG005|Overall Study|Lack of Efficacy|0|||
156720298|NCT00485264|565721896|FG000|Overall Study|Guardian Consent Withdrawn|1|||
156720299|NCT00485264|565721897|FG001|Overall Study|Guardian Consent Withdrawn|0|||
156720300|NCT00485264|565721898|FG002|Overall Study|Guardian Consent Withdrawn|0|||
156720301|NCT00485264|565721899|FG003|Overall Study|Guardian Consent Withdrawn|0|||
156720302|NCT00485264|565721900|FG004|Overall Study|Guardian Consent Withdrawn|1|||
156720303|NCT00485264|565721901|FG005|Overall Study|Guardian Consent Withdrawn|0|||
156720304|NCT00485264|565721896|FG000|Overall Study|Physician Decision|0|||
156720305|NCT00485264|565721897|FG001|Overall Study|Physician Decision|2|||
156720306|NCT00485264|565721898|FG002|Overall Study|Physician Decision|0|||
156720307|NCT00485264|565721899|FG003|Overall Study|Physician Decision|0|||
156720308|NCT00485264|565721900|FG004|Overall Study|Physician Decision|0|||
156720309|NCT00485264|565721901|FG005|Overall Study|Physician Decision|0|||
156720310|NCT00485264|565721896|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720311|NCT00485264|565721897|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720312|NCT00485264|565721898|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
156720313|NCT00485264|565721899|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720314|NCT00485264|565721900|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720315|NCT00485264|565721901|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720316|NCT00485264|565721896|FG000|Overall Study|Not Able to Attend Clinic|5|||
156720317|NCT00485264|565721897|FG001|Overall Study|Not Able to Attend Clinic|0|||
156720318|NCT00485264|565721898|FG002|Overall Study|Not Able to Attend Clinic|0|||
156720319|NCT00485264|565721899|FG003|Overall Study|Not Able to Attend Clinic|1|||
156720320|NCT00485264|565721900|FG004|Overall Study|Not Able to Attend Clinic|1|||
156720321|NCT00485264|565721901|FG005|Overall Study|Not Able to Attend Clinic|2|||
156720322|NCT00485264|565721896|FG000|Overall Study|Non-Compliant|17|||
156720323|NCT00485264|565721897|FG001|Overall Study|Non-Compliant|2|||
156720324|NCT00485264|565721898|FG002|Overall Study|Non-Compliant|1|||
156720325|NCT00485264|565721899|FG003|Overall Study|Non-Compliant|0|||
156720326|NCT00485264|565721900|FG004|Overall Study|Non-Compliant|1|||
156720327|NCT00485264|565721901|FG005|Overall Study|Non-Compliant|0|||
156720328|NCT00485264|565721896|FG000|Overall Study|Lost to Follow-up|2|||
156720329|NCT00485264|565721897|FG001|Overall Study|Lost to Follow-up|1|||
156720330|NCT00485264|565721898|FG002|Overall Study|Lost to Follow-up|1|||
156720331|NCT00485264|565721899|FG003|Overall Study|Lost to Follow-up|0|||
156720332|NCT00485264|565721900|FG004|Overall Study|Lost to Follow-up|0|||
156720333|NCT00485264|565721901|FG005|Overall Study|Lost to Follow-up|1|||
156720334|NCT00485264|565721896|FG000|Overall Study|Other Reason|3|||
156720335|NCT00485264|565721897|FG001|Overall Study|Other Reason|0|||
156720336|NCT00485264|565721898|FG002|Overall Study|Other Reason|0|||
156720337|NCT00485264|565721899|FG003|Overall Study|Other Reason|0|||
156720338|NCT00485264|565721900|FG004|Overall Study|Other Reason|0|||
156720339|NCT00485264|565721901|FG005|Overall Study|Other Reason|0|||
156720340|NCT03500198|565721902|FG000|Overall Study|Lost to Follow-up|0|||
156720341|NCT03500198|565721903|FG001|Overall Study|Lost to Follow-up|1|||
156720342|NCT01514461|565721904|FG000|Overall Study|Adverse Event|2|||
156720343|NCT01514461|565721905|FG001|Overall Study|Adverse Event|1|||
156449072|NCT04784559|564738422|FG002|Overall Study|Did not meet all inclusion criteria|0|||
156449073|NCT04784559|564738420|FG000|Overall Study|The participant was transferred to IRCU|0|||
156720344|NCT01514461|565721906|FG002|Overall Study|Adverse Event|3|||
156720345|NCT01514461|565721904|FG000|Overall Study|Physician Decision|1|||
156720346|NCT01514461|565721905|FG001|Overall Study|Physician Decision|1|||
156720347|NCT01514461|565721906|FG002|Overall Study|Physician Decision|0|||
156793878|NCT00266032|565999466|FG002|Treatment|Protocol Violation|13|||
156720348|NCT01514461|565721904|FG000|Overall Study|Patient/guardian decision|1|||
156720349|NCT01514461|565721905|FG001|Overall Study|Patient/guardian decision|1|||
156720350|NCT01514461|565721906|FG002|Overall Study|Patient/guardian decision|1|||
156720351|NCT01514461|565721904|FG000|Overall Study|Death|1|||
156793879|NCT00266032|565999464|FG000|Treatment|Withdrawal by Subject|28|||
156793880|NCT00266032|565999465|FG001|Treatment|Withdrawal by Subject|13|||
156720352|NCT01514461|565721905|FG001|Overall Study|Death|0|||
156720353|NCT01514461|565721906|FG002|Overall Study|Death|0|||
156720354|NCT00654095|565721907|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
156720355|NCT00654095|565721907|FG000|Overall Study|Elevated triglyceride level (2)|1|||
156720356|NCT00654095|565721907|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
156720357|NCT00654095|565721907|FG000|Overall Study|Adverse Event|11|||
156720358|NCT00654095|565721907|FG000|Overall Study|Withdrawal by Subject|5|||
156720359|NCT00654095|565721907|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
156720360|NCT00654095|565721907|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
156720361|NCT00654095|565721907|FG000|Overall Study|Did not meet inclusion criteria|1|||
156720362|NCT00595621|565721913|FG000|Open Label Run in|Adverse Event|1|||
156720363|NCT00595621|565721914|FG001|Open Label Run in|Adverse Event|0|||
156720364|NCT00595621|565721913|FG000|Open Label Run in|Physician Decision|1|||
156720365|NCT00595621|565721914|FG001|Open Label Run in|Physician Decision|0|||
156720366|NCT00595621|565721913|FG000|Open Label Run in|Withdrawal by Subject|1|||
156720367|NCT00595621|565721914|FG001|Open Label Run in|Withdrawal by Subject|0|||
156720368|NCT00595621|565721913|FG000|Randomization and Study|Adverse Event|2|||
156720369|NCT00595621|565721914|FG001|Randomization and Study|Adverse Event|0|||
156720370|NCT00595621|565721913|FG000|Randomization and Study|Withdrawal by Subject|0|||
156720371|NCT00595621|565721914|FG001|Randomization and Study|Withdrawal by Subject|1|||
156720372|NCT02440464|565721915|FG000|Overall Study|Withdrawal by Subject|3|||
156720373|NCT02440464|565721916|FG001|Overall Study|Withdrawal by Subject|2|||
156720374|NCT00324987|565721917|FG000|Overall Study|Adverse Event|2|||
156720375|NCT00324987|565721918|FG001|Overall Study|Adverse Event|1|||
156720376|NCT00324987|565721917|FG000|Overall Study|Withdrawal by Subject|1|||
156720377|NCT00324987|565721918|FG001|Overall Study|Withdrawal by Subject|1|||
156720378|NCT00324987|565721917|FG000|Overall Study|Progression|1|||
156720379|NCT00324987|565721918|FG001|Overall Study|Progression|1|||
156720380|NCT00324987|565721917|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
156720381|NCT00324987|565721918|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
156720382|NCT01254643|565721919|FG000|Overall Study|Withdrawal by Subject|1|||
156720383|NCT01062425|565721923|FG000|Overall Study|Protocol Violation|3|||
156720384|NCT01062425|565721924|FG001|Overall Study|Protocol Violation|6|||
156720385|NCT05366010|565721926|FG000|Overall Study|Withdrawal by Subject|1|||
156720386|NCT05366010|565721926|FG000|Overall Study|Protocol Violation|1|||
156720387|NCT05366010|565721926|FG000|Overall Study|Lost to Follow-up|2|||
156720388|NCT05366010|565721926|FG000|Overall Study|Screen Failure|2|||
156720389|NCT02224157|565721927|FG000|Overall Study|Severe non-compliance to protocol|2|||
156720390|NCT02224157|565721928|FG001|Overall Study|Severe non-compliance to protocol|2|||
156720391|NCT02224157|565721927|FG000|Overall Study|Other|13|||
156720392|NCT02224157|565721928|FG001|Overall Study|Other|10|||
156720393|NCT02224157|565721927|FG000|Overall Study|Subject decision|58|||
156720394|NCT02224157|565721928|FG001|Overall Study|Subject decision|50|||
156720395|NCT02224157|565721927|FG000|Overall Study|Prematurely closed site|4|||
156720396|NCT02224157|565721928|FG001|Overall Study|Prematurely closed site|2|||
156720397|NCT02224157|565721927|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
156720398|NCT02224157|565721928|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
156720399|NCT02224157|565721927|FG000|Overall Study|Lost to Follow-up|27|||
156720400|NCT02224157|565721928|FG001|Overall Study|Lost to Follow-up|35|||
156720401|NCT02224157|565721927|FG000|Overall Study|Death|1|||
156720402|NCT02224157|565721928|FG001|Overall Study|Death|1|||
156720403|NCT02224157|565721927|FG000|Overall Study|Adverse Event|1|||
156720404|NCT02224157|565721928|FG001|Overall Study|Adverse Event|3|||
156720405|NCT05906628|565721929|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
156720406|NCT05906628|565721930|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
156720407|NCT05906628|565721929|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
156720408|NCT05906628|565721930|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
156720409|NCT05906628|565721929|FG000|16-Week DBVC Period|Protocol Violation|4|||
156720410|NCT05906628|565721930|FG001|16-Week DBVC Period|Protocol Violation|2|||
156335081|NCT00660673|564324504|FG000|Overall Study|Withdrawal by Subject|22|||
156335082|NCT00660673|564324504|FG000|Overall Study|Administrative|2|||
156720411|NCT05906628|565721929|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
156720412|NCT05906628|565721930|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
156720413|NCT05906628|565721929|FG000|16-Week OLE Period|Death|1|||
156720414|NCT05906628|565721930|FG001|16-Week OLE Period|Death|0|||
156720415|NCT05906628|565721929|FG000|16-Week OLE Period|Lost to Follow-up|1|||
156720416|NCT05906628|565721930|FG001|16-Week OLE Period|Lost to Follow-up|1|||
156720417|NCT05906628|565721929|FG000|16-Week OLE Period|Protocol Violation|0|||
156720418|NCT05906628|565721930|FG001|16-Week OLE Period|Protocol Violation|1|||
156720419|NCT05906628|565721929|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
156720420|NCT05906628|565721930|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
156720421|NCT01108718|565721931|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
156793881|NCT00266032|565999466|FG002|Treatment|Withdrawal by Subject|12|||
156720422|NCT01108718|565721932|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
156720423|NCT01060072|565721935|FG000|Overall Study|Adverse Event|1|||
156720424|NCT01060072|565721936|FG001|Overall Study|Adverse Event|1|||
156720425|NCT01060072|565721935|FG000|Overall Study|Physician Decision|0|||
156720426|NCT01060072|565721936|FG001|Overall Study|Physician Decision|2|||
156720427|NCT01060072|565721935|FG000|Overall Study|Protocol Violation|0|||
156720428|NCT01060072|565721936|FG001|Overall Study|Protocol Violation|1|||
156720429|NCT01060072|565721935|FG000|Overall Study|Acute cholecystitis|1|||
156720430|NCT01060072|565721936|FG001|Overall Study|Acute cholecystitis|0|||
156720431|NCT01060072|565721935|FG000|Overall Study|Excluded Medications|0|||
156449074|NCT04784559|564738421|FG001|Overall Study|The participant was transferred to IRCU|1|||
156449075|NCT04784559|564738422|FG002|Overall Study|The participant was transferred to IRCU|0|||
156449076|NCT04784559|564738420|FG000|Overall Study|SAE|0|||
156449077|NCT04784559|564738421|FG001|Overall Study|SAE|1|||
156449078|NCT04784559|564738422|FG002|Overall Study|SAE|0|||
156449079|NCT04784559|564738420|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
156449080|NCT04784559|564738421|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
156449081|NCT04784559|564738422|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
156449082|NCT04021602|564738431|FG000|Overall Study|Lost to Follow-up|3|||
156449083|NCT04021602|564738432|FG001|Overall Study|Lost to Follow-up|3|||
156449084|NCT04021602|564738433|FG002|Overall Study|Lost to Follow-up|1|||
156449085|NCT04021602|564738431|FG000|Overall Study|Adverse Event|1|||
156449086|NCT04021602|564738432|FG001|Overall Study|Adverse Event|0|||
156449087|NCT04021602|564738433|FG002|Overall Study|Adverse Event|1|||
156449088|NCT03892616|564738434|FG000|Washout Period 2|Met discontinuation criterion|0|||
156449089|NCT03892616|564738435|FG001|Washout Period 2|Met discontinuation criterion|0|||
156449090|NCT03892616|564738436|FG002|Washout Period 2|Met discontinuation criterion|0|||
156449091|NCT03892616|564738437|FG003|Washout Period 2|Met discontinuation criterion|0|||
156449092|NCT03892616|564738438|FG004|Washout Period 2|Met discontinuation criterion|0|||
156449093|NCT03892616|564738439|FG005|Washout Period 2|Met discontinuation criterion|0|||
156449094|NCT03892616|564738440|FG006|Washout Period 2|Met discontinuation criterion|0|||
156449095|NCT03892616|564738441|FG007|Washout Period 2|Met discontinuation criterion|0|||
156449096|NCT03892616|564738442|FG008|Washout Period 2|Met discontinuation criterion|1|||
156449097|NCT03892616|564738443|FG009|Washout Period 2|Met discontinuation criterion|0|||
156720432|NCT01060072|565721936|FG001|Overall Study|Excluded Medications|1|||
156720433|NCT02301169|565721937|FG000|Overall Study|Adverse Event|1|||
156720434|NCT02301169|565721938|FG001|Overall Study|Adverse Event|0|||
156720435|NCT01949662|565721939|FG000|Overall Study|Death|9|||
156720436|NCT01949662|565721940|FG001|Overall Study|Death|7|||
156720437|NCT01949662|565721939|FG000|Overall Study|Discharged before an agitation event|8|||
156720438|NCT01949662|565721940|FG001|Overall Study|Discharged before an agitation event|3|||
156720439|NCT01949662|565721939|FG000|Overall Study|Dropped out|1|||
156720440|NCT01949662|565721940|FG001|Overall Study|Dropped out|3|||
156720441|NCT01949662|565721939|FG000|Overall Study|Ineligible|0|||
156720442|NCT01949662|565721940|FG001|Overall Study|Ineligible|1|||
156720443|NCT02291237|565721941|FG000|Overall Study|Study Terminated by Sponsor|72|||
156720444|NCT02291237|565721942|FG001|Overall Study|Study Terminated by Sponsor|67|||
156720445|NCT02291237|565721941|FG000|Overall Study|Adverse Event|1|||
156720446|NCT02291237|565721942|FG001|Overall Study|Adverse Event|3|||
156720447|NCT02291237|565721941|FG000|Overall Study|Investigator's Discretion|0|||
156720448|NCT02291237|565721942|FG001|Overall Study|Investigator's Discretion|3|||
156720449|NCT02291237|565721941|FG000|Overall Study|Withdrew Consent|11|||
156720450|NCT02291237|565721942|FG001|Overall Study|Withdrew Consent|11|||
156720451|NCT02291237|565721941|FG000|Overall Study|Lost to Follow-up|0|||
156720452|NCT02291237|565721942|FG001|Overall Study|Lost to Follow-up|2|||
156720453|NCT02291237|565721941|FG000|Overall Study|Subject Required Prohibited Medication|2|||
156720454|NCT02291237|565721942|FG001|Overall Study|Subject Required Prohibited Medication|0|||
156720455|NCT01478373|565721946|FG000|Treatment Phase|Protocol Violation|1|||
156720456|NCT01478373|565721946|FG000|Survival Phase|Adverse Event|8|||
156720457|NCT01478373|565721946|FG000|Survival Phase|Protocol Violation|1|||
156720458|NCT01478373|565721946|FG000|Survival Phase|crossover to another study|2|||
156720459|NCT01478373|565721946|FG000|Survival Phase|Progressive Disease|27|||
156720460|NCT04199104|565723696|FG000|Overall Study|Death|148|||
156720461|NCT04199104|565723697|FG001|Overall Study|Death|134|||
156449098|NCT03892616|564738444|FG010|Washout Period 2|Met discontinuation criterion|0|||
156449099|NCT03892616|564738445|FG011|Washout Period 2|Met discontinuation criterion|0|||
156449100|NCT02243709|564738446|FG000|Phase 1|Lost to Follow-up|0|||
156449101|NCT02243709|564738447|FG001|Phase 1|Lost to Follow-up|1|||
156449102|NCT02243709|564738446|FG000|Phase 1|Withdrawal by Subject|1|||
156449103|NCT02243709|564738447|FG001|Phase 1|Withdrawal by Subject|0|||
156449104|NCT02243709|564738446|FG000|Phase 1|Protocol Violation|0|||
156720462|NCT04199104|565723696|FG000|Overall Study|Lost to Follow-up|1|||
156720463|NCT04199104|565723697|FG001|Overall Study|Lost to Follow-up|1|||
156720464|NCT04199104|565723696|FG000|Overall Study|Withdrawal by Subject|4|||
156449105|NCT02243709|564738447|FG001|Phase 1|Protocol Violation|1|||
156720465|NCT04199104|565723697|FG001|Overall Study|Withdrawal by Subject|4|||
156720466|NCT04199104|565723696|FG000|Overall Study|Participants Ongoing|103|||
156449106|NCT02243709|564738446|FG000|Phase 1|Adverse Event|0|||
156449107|NCT02243709|564738447|FG001|Phase 1|Adverse Event|1|||
156449108|NCT03683719|564738448|FG000|Overall Study|Lack of Efficacy|1|||
156449109|NCT03683719|564738449|FG001|Overall Study|Lack of Efficacy|3|||
156720467|NCT04199104|565723697|FG001|Overall Study|Participants Ongoing|116|||
156720468|NCT04075825|565723698|FG000|Overall Study|Withdrawal by Subject|6|||
156720469|NCT04075825|565723699|FG001|Overall Study|Withdrawal by Subject|8|||
156720470|NCT04075825|565723698|FG000|Overall Study|Physician Decision|3|||
156720471|NCT04075825|565723699|FG001|Overall Study|Physician Decision|1|||
156720472|NCT04075825|565723698|FG000|Overall Study|Lost to Follow-up|5|||
156449110|NCT03683719|564738450|FG002|Overall Study|Lack of Efficacy|4|||
156720473|NCT04075825|565723699|FG001|Overall Study|Lost to Follow-up|1|||
156720474|NCT04075825|565723698|FG000|Overall Study|Participation in New Clinical Trial|1|||
156720475|NCT04075825|565723699|FG001|Overall Study|Participation in New Clinical Trial|1|||
156720476|NCT04075825|565723698|FG000|Overall Study|Reason Not Specified|2|||
156720477|NCT04075825|565723699|FG001|Overall Study|Reason Not Specified|2|||
156720478|NCT04581824|565723700|FG000|Overall Study|Lost to Follow-up|1|||
156720479|NCT04581824|565723701|FG001|Overall Study|Lost to Follow-up|0|||
156720480|NCT04581824|565723700|FG000|Overall Study|Withdrawal by Subject|2|||
156720481|NCT04581824|565723701|FG001|Overall Study|Withdrawal by Subject|7|||
156720482|NCT04581824|565723700|FG000|Overall Study|Study terminated by sponsor|37|||
156720483|NCT04581824|565723701|FG001|Overall Study|Study terminated by sponsor|23|||
156720484|NCT04796909|565723702|FG000|Overall Study|Withdrawal by Subject|1|||
156720485|NCT04796909|565723703|FG001|Overall Study|Withdrawal by Subject|1|||
156720486|NCT03879135|565723704|FG000|Overall Study|Physician Decision|0|||
156720487|NCT03879135|565723705|FG001|Overall Study|Physician Decision|0|||
156720488|NCT03879135|565723706|FG002|Overall Study|Physician Decision|0|||
156720489|NCT03879135|565723707|FG003|Overall Study|Physician Decision|1|||
156720490|NCT03879135|565723708|FG004|Overall Study|Physician Decision|0|||
156720491|NCT03879135|565723709|FG005|Overall Study|Physician Decision|0|||
156720492|NCT03879135|565723704|FG000|Overall Study|Withdrawal by Subject|0|||
156720493|NCT03879135|565723705|FG001|Overall Study|Withdrawal by Subject|0|||
156720494|NCT03879135|565723706|FG002|Overall Study|Withdrawal by Subject|0|||
156720495|NCT03879135|565723707|FG003|Overall Study|Withdrawal by Subject|0|||
156720496|NCT03879135|565723708|FG004|Overall Study|Withdrawal by Subject|0|||
156720497|NCT03879135|565723709|FG005|Overall Study|Withdrawal by Subject|1|||
156720498|NCT03879135|565723704|FG000|Overall Study|Site Closed by Sponsor|0|||
156720499|NCT03879135|565723705|FG001|Overall Study|Site Closed by Sponsor|0|||
156720500|NCT03879135|565723706|FG002|Overall Study|Site Closed by Sponsor|0|||
156720501|NCT03879135|565723707|FG003|Overall Study|Site Closed by Sponsor|1|||
156720502|NCT03879135|565723708|FG004|Overall Study|Site Closed by Sponsor|1|||
156720503|NCT03879135|565723709|FG005|Overall Study|Site Closed by Sponsor|0|||
156720504|NCT03428958|565723710|FG000|Overall Study|Adverse Event|0|||
156720505|NCT03428958|565723711|FG001|Overall Study|Adverse Event|0|||
156720506|NCT03428958|565723712|FG002|Overall Study|Adverse Event|0|||
156720507|NCT03428958|565723713|FG003|Overall Study|Adverse Event|1|||
156720508|NCT03428958|565723714|FG004|Overall Study|Adverse Event|0|||
156720509|NCT03428958|565723715|FG005|Overall Study|Adverse Event|2|||
156720510|NCT03428958|565723716|FG006|Overall Study|Adverse Event|1|||
156720511|NCT03428958|565723717|FG007|Overall Study|Adverse Event|0|||
156720512|NCT03428958|565723718|FG008|Overall Study|Adverse Event|0|||
156720513|NCT03428958|565723719|FG009|Overall Study|Adverse Event|0|||
156720514|NCT03428958|565723720|FG010|Overall Study|Adverse Event|0|||
156793882|NCT00266032|565999464|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
156793883|NCT00266032|565999465|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
156793884|NCT00266032|565999466|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
156335083|NCT00660673|564324504|FG000|Overall Study|Protocol Violation|2|||
156720515|NCT03428958|565723721|FG011|Overall Study|Adverse Event|0|||
156720516|NCT03428958|565723722|FG012|Overall Study|Adverse Event|0|||
156720517|NCT03428958|565723723|FG013|Overall Study|Adverse Event|0|||
156335084|NCT03208127|564324505|FG000|Overall Study|Death|1|||
156335085|NCT00579098|564324510|FG000|Overall Study|Lost to Follow-up|2|||
156335086|NCT00579098|564324511|FG001|Overall Study|Lost to Follow-up|0|||
156335087|NCT00579098|564324510|FG000|Overall Study|Adverse Event|2|||
156335088|NCT00579098|564324511|FG001|Overall Study|Adverse Event|3|||
156335089|NCT00579098|564324510|FG000|Overall Study|Withdrawal by Subject|2|||
156335090|NCT00579098|564324511|FG001|Overall Study|Withdrawal by Subject|3|||
156335091|NCT00579098|564324510|FG000|Overall Study|AF returned after ablation|3|||
156335092|NCT00579098|564324511|FG001|Overall Study|AF returned after ablation|2|||
156335093|NCT01254331|564324517|FG000|Initial Phase|Adverse Event|3|||
156335094|NCT01254331|564324517|FG000|Initial Phase|Withdrawal by Subject|1|||
156335095|NCT01254331|564324517|FG000|Initial Phase|Pregnancy|1|||
156335096|NCT01254331|564324517|FG000|Extension Phase|Lack of Efficacy|1|||
156335097|NCT01254331|564324517|FG000|Extension Phase|Lost to Follow-up|3|||
156335098|NCT00633750|564324518|FG000|Overall Study|Adverse Event|2|||
156335099|NCT00633750|564324518|FG000|Overall Study|Withdrawal by Subject|3|||
156335100|NCT03000569|564324519|FG000|Overall Study|Withdrawal by Subject|1|||
156335101|NCT03000569|564324520|FG001|Overall Study|Withdrawal by Subject|0|||
156335102|NCT03540030|564324523|FG000|Overall Study|Withdrawal by Subject|2|||
156335103|NCT03540030|564324524|FG001|Overall Study|Withdrawal by Subject|1|||
156335104|NCT03540030|564324523|FG000|Overall Study|screen fail|7|||
156335105|NCT03540030|564324524|FG001|Overall Study|screen fail|1|||
156335106|NCT03540030|564324523|FG000|Overall Study|never had surgery after signing consent|9|||
156335107|NCT03540030|564324524|FG001|Overall Study|never had surgery after signing consent|1|||
156335108|NCT00447005|564324526|FG000|Overall Study|Adverse Event|1|||
156335109|NCT00447005|564324526|FG000|Overall Study|Lack of Efficacy|11|||
156335110|NCT00492531|564324527|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
156449111|NCT03683719|564738451|FG003|Overall Study|Lack of Efficacy|0|||
156449112|NCT03683719|564738452|FG004|Overall Study|Lack of Efficacy|4|||
156449113|NCT03683719|564738448|FG000|Overall Study|Adverse Event|6|||
156449114|NCT03683719|564738449|FG001|Overall Study|Adverse Event|6|||
156449115|NCT03683719|564738450|FG002|Overall Study|Adverse Event|0|||
156449116|NCT03683719|564738451|FG003|Overall Study|Adverse Event|1|||
156449117|NCT03683719|564738452|FG004|Overall Study|Adverse Event|3|||
156449118|NCT03683719|564738448|FG000|Overall Study|Withdrawal by Subject|4|||
156449119|NCT03683719|564738449|FG001|Overall Study|Withdrawal by Subject|4|||
156449120|NCT03683719|564738450|FG002|Overall Study|Withdrawal by Subject|3|||
156449121|NCT03683719|564738451|FG003|Overall Study|Withdrawal by Subject|5|||
156449122|NCT03683719|564738452|FG004|Overall Study|Withdrawal by Subject|5|||
156449123|NCT03683719|564738448|FG000|Overall Study|Lost to Follow-up|1|||
156449124|NCT03683719|564738449|FG001|Overall Study|Lost to Follow-up|0|||
156449125|NCT03683719|564738450|FG002|Overall Study|Lost to Follow-up|0|||
156449126|NCT03683719|564738451|FG003|Overall Study|Lost to Follow-up|1|||
156449127|NCT03683719|564738452|FG004|Overall Study|Lost to Follow-up|1|||
156720518|NCT03428958|565723724|FG014|Overall Study|Adverse Event|0|||
156720519|NCT03428958|565723725|FG015|Overall Study|Adverse Event|0|||
156720520|NCT03428958|565723726|FG016|Overall Study|Adverse Event|0|||
156720521|NCT03428958|565723710|FG000|Overall Study|Clinical Progression|2|||
156720522|NCT03428958|565723711|FG001|Overall Study|Clinical Progression|3|||
156720523|NCT03428958|565723712|FG002|Overall Study|Clinical Progression|2|||
156720524|NCT03428958|565723713|FG003|Overall Study|Clinical Progression|1|||
156720525|NCT03428958|565723714|FG004|Overall Study|Clinical Progression|0|||
156720526|NCT03428958|565723715|FG005|Overall Study|Clinical Progression|2|||
156720527|NCT03428958|565723716|FG006|Overall Study|Clinical Progression|0|||
156720528|NCT03428958|565723717|FG007|Overall Study|Clinical Progression|0|||
156720529|NCT03428958|565723718|FG008|Overall Study|Clinical Progression|0|||
156720530|NCT03428958|565723719|FG009|Overall Study|Clinical Progression|0|||
156720531|NCT03428958|565723720|FG010|Overall Study|Clinical Progression|0|||
156720532|NCT03428958|565723721|FG011|Overall Study|Clinical Progression|0|||
156720533|NCT03428958|565723722|FG012|Overall Study|Clinical Progression|0|||
156720534|NCT03428958|565723723|FG013|Overall Study|Clinical Progression|0|||
156720535|NCT03428958|565723724|FG014|Overall Study|Clinical Progression|0|||
156720536|NCT03428958|565723725|FG015|Overall Study|Clinical Progression|0|||
156720537|NCT03428958|565723726|FG016|Overall Study|Clinical Progression|0|||
156720538|NCT03428958|565723710|FG000|Overall Study|Progression per RECIST|6|||
156720539|NCT03428958|565723711|FG001|Overall Study|Progression per RECIST|6|||
156720540|NCT03428958|565723712|FG002|Overall Study|Progression per RECIST|7|||
156720541|NCT03428958|565723713|FG003|Overall Study|Progression per RECIST|4|||
156720542|NCT03428958|565723714|FG004|Overall Study|Progression per RECIST|0|||
156720543|NCT03428958|565723715|FG005|Overall Study|Progression per RECIST|7|||
156720544|NCT03428958|565723716|FG006|Overall Study|Progression per RECIST|8|||
156720545|NCT03428958|565723717|FG007|Overall Study|Progression per RECIST|0|||
156720546|NCT03428958|565723718|FG008|Overall Study|Progression per RECIST|0|||
156720547|NCT03428958|565723719|FG009|Overall Study|Progression per RECIST|0|||
156720548|NCT03428958|565723720|FG010|Overall Study|Progression per RECIST|0|||
156720549|NCT03428958|565723721|FG011|Overall Study|Progression per RECIST|0|||
156720550|NCT03428958|565723722|FG012|Overall Study|Progression per RECIST|1|||
156720551|NCT03428958|565723723|FG013|Overall Study|Progression per RECIST|0|||
156720552|NCT03428958|565723724|FG014|Overall Study|Progression per RECIST|0|||
156720553|NCT03428958|565723725|FG015|Overall Study|Progression per RECIST|0|||
156720554|NCT03428958|565723726|FG016|Overall Study|Progression per RECIST|0|||
156720555|NCT03428958|565723710|FG000|Overall Study|Death|2|||
156720556|NCT03428958|565723711|FG001|Overall Study|Death|2|||
156720557|NCT03428958|565723712|FG002|Overall Study|Death|0|||
156449128|NCT03683719|564738448|FG000|Overall Study|Other personal reasons|0|||
156449129|NCT03683719|564738449|FG001|Overall Study|Other personal reasons|0|||
156449130|NCT03683719|564738450|FG002|Overall Study|Other personal reasons|1|||
156533384|NCT02383589|565046966|FG000|Treatment Period|Adverse Event|1|||
156533385|NCT02383589|565046967|FG001|Treatment Period|Adverse Event|3|||
156720558|NCT03428958|565723713|FG003|Overall Study|Death|0|||
156720559|NCT03428958|565723714|FG004|Overall Study|Death|0|||
156720560|NCT03428958|565723715|FG005|Overall Study|Death|7|||
156720561|NCT03428958|565723716|FG006|Overall Study|Death|9|||
156449131|NCT03683719|564738451|FG003|Overall Study|Other personal reasons|0|||
156533386|NCT02383589|565046966|FG000|Treatment Period|Lost to Follow-up|0|||
156720562|NCT03428958|565723717|FG007|Overall Study|Death|6|||
156720563|NCT03428958|565723718|FG008|Overall Study|Death|0|||
156720564|NCT03428958|565723719|FG009|Overall Study|Death|0|||
156720565|NCT03428958|565723720|FG010|Overall Study|Death|3|||
156720566|NCT03428958|565723721|FG011|Overall Study|Death|0|||
156720567|NCT03428958|565723722|FG012|Overall Study|Death|4|||
156720568|NCT03428958|565723723|FG013|Overall Study|Death|0|||
156720569|NCT03428958|565723724|FG014|Overall Study|Death|0|||
156720570|NCT03428958|565723725|FG015|Overall Study|Death|0|||
156720571|NCT03428958|565723726|FG016|Overall Study|Death|0|||
156720572|NCT03428958|565723710|FG000|Overall Study|Lost to Follow-up|0|||
156449132|NCT03683719|564738452|FG004|Overall Study|Other personal reasons|1|||
156449133|NCT02689284|564738453|FG000|Overall Study|Adverse Event|1|||
156449134|NCT02689284|564738454|FG001|Overall Study|Adverse Event|8|||
156449135|NCT02689284|564738453|FG000|Overall Study|Death|0|||
156449136|NCT02689284|564738454|FG001|Overall Study|Death|1|||
156449137|NCT02689284|564738453|FG000|Overall Study|Physician Decision|1|||
156449138|NCT02689284|564738454|FG001|Overall Study|Physician Decision|2|||
156449139|NCT02689284|564738453|FG000|Overall Study|Withdrawal by Subject|0|||
156449140|NCT02689284|564738454|FG001|Overall Study|Withdrawal by Subject|1|||
156449141|NCT02689284|564738453|FG000|Overall Study|progression of cancer|1|||
156449142|NCT02689284|564738454|FG001|Overall Study|progression of cancer|72|||
156449143|NCT02689284|564738453|FG000|Overall Study|decreased heart function|0|||
156449144|NCT02689284|564738454|FG001|Overall Study|decreased heart function|1|||
156449145|NCT02689284|564738453|FG000|Overall Study|concern for anemia|0|||
156449146|NCT02689284|564738454|FG001|Overall Study|concern for anemia|1|||
156449147|NCT02689284|564738453|FG000|Overall Study|no measurable cancer for evaluation|0|||
156449148|NCT02689284|564738454|FG001|Overall Study|no measurable cancer for evaluation|1|||
156449149|NCT05569252|564738455|FG000|Overall Study|Adverse event (central vision loss)|1|||
156449150|NCT05569252|564738456|FG001|Overall Study|Adverse event (central vision loss)|0|||
156449151|NCT05569252|564738457|FG002|Overall Study|Adverse event (central vision loss)|0|||
156449152|NCT05569252|564738458|FG003|Overall Study|Adverse event (central vision loss)|0|||
156449153|NCT03665597|564738459|FG000|Period 1|Adverse Event|1|||
156449154|NCT03665597|564738460|FG001|Period 1|Adverse Event|0|||
156449155|NCT03665597|564738461|FG002|Period 1|Adverse Event|0|||
156449156|NCT03665597|564738462|FG003|Period 1|Adverse Event|1|||
156720573|NCT03428958|565723711|FG001|Overall Study|Lost to Follow-up|0|||
156720574|NCT03428958|565723712|FG002|Overall Study|Lost to Follow-up|0|||
156720575|NCT03428958|565723713|FG003|Overall Study|Lost to Follow-up|0|||
156720576|NCT03428958|565723714|FG004|Overall Study|Lost to Follow-up|0|||
156720577|NCT03428958|565723715|FG005|Overall Study|Lost to Follow-up|1|||
156720578|NCT03428958|565723716|FG006|Overall Study|Lost to Follow-up|1|||
156720579|NCT03428958|565723717|FG007|Overall Study|Lost to Follow-up|0|||
156720580|NCT03428958|565723718|FG008|Overall Study|Lost to Follow-up|0|||
156720581|NCT03428958|565723719|FG009|Overall Study|Lost to Follow-up|0|||
156720582|NCT03428958|565723720|FG010|Overall Study|Lost to Follow-up|0|||
156720583|NCT03428958|565723721|FG011|Overall Study|Lost to Follow-up|0|||
156720584|NCT03428958|565723722|FG012|Overall Study|Lost to Follow-up|0|||
156720585|NCT03428958|565723723|FG013|Overall Study|Lost to Follow-up|0|||
156720586|NCT03428958|565723724|FG014|Overall Study|Lost to Follow-up|0|||
156720587|NCT03428958|565723725|FG015|Overall Study|Lost to Follow-up|0|||
156720588|NCT03428958|565723726|FG016|Overall Study|Lost to Follow-up|0|||
156720589|NCT03428958|565723710|FG000|Overall Study|Physician/Sponsor Decision|1|||
156720590|NCT03428958|565723711|FG001|Overall Study|Physician/Sponsor Decision|0|||
156335111|NCT00492531|564324528|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
156335112|NCT03685123|564324532|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
156335113|NCT03685123|564324533|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
156335114|NCT03685123|564324534|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
156335115|NCT03685123|564324532|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
156335116|NCT03685123|564324533|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
156335117|NCT03685123|564324534|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
156335118|NCT03685123|564324532|FG000|Weight Loss Phase|Lost to Follow-up|1|||
156335119|NCT03685123|564324533|FG001|Weight Loss Phase|Lost to Follow-up|0|||
156335120|NCT03685123|564324534|FG002|Weight Loss Phase|Lost to Follow-up|0|||
156335121|NCT03685123|564324532|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
156335122|NCT03685123|564324533|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
156335123|NCT03685123|564324534|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
156335124|NCT03685123|564324532|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
156335125|NCT03685123|564324533|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
156335126|NCT03685123|564324534|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
156335127|NCT03685123|564324532|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
156335128|NCT03685123|564324533|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
156335129|NCT03685123|564324534|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
156335130|NCT00400764|564324536|FG000|Phase Ib|Adverse Event|1|||
156335131|NCT00400764|564324537|FG001|Phase Ib|Adverse Event|0|||
156335132|NCT00400764|564324538|FG002|Phase Ib|Adverse Event|0|||
156335133|NCT00400764|564324539|FG003|Phase Ib|Adverse Event|0|||
156335134|NCT00400764|564324540|FG004|Phase Ib|Adverse Event|0|||
156335135|NCT00400764|564324536|FG000|Phase Ib|Death|1|||
156335136|NCT00400764|564324537|FG001|Phase Ib|Death|0|||
156335137|NCT00400764|564324538|FG002|Phase Ib|Death|0|||
156335138|NCT00400764|564324539|FG003|Phase Ib|Death|0|||
156335139|NCT00400764|564324540|FG004|Phase Ib|Death|0|||
156335140|NCT00400764|564324536|FG000|Phase Ib|Disease Progression|4|||
156335141|NCT00400764|564324537|FG001|Phase Ib|Disease Progression|4|||
156335142|NCT00400764|564324538|FG002|Phase Ib|Disease Progression|0|||
156335143|NCT00400764|564324539|FG003|Phase Ib|Disease Progression|0|||
156335144|NCT00400764|564324540|FG004|Phase Ib|Disease Progression|0|||
156449157|NCT03665597|564738463|FG004|Period 1|Adverse Event|0|||
156449158|NCT03665597|564738464|FG005|Period 1|Adverse Event|0|||
156449159|NCT03665597|564738465|FG006|Period 1|Adverse Event|0|||
156449160|NCT03665597|564738459|FG000|Period 1|Screen Failure|0|||
156449161|NCT03665597|564738460|FG001|Period 1|Screen Failure|0|||
156449162|NCT03665597|564738461|FG002|Period 1|Screen Failure|0|||
156449163|NCT03665597|564738462|FG003|Period 1|Screen Failure|1|||
156449164|NCT03665597|564738463|FG004|Period 1|Screen Failure|0|||
156449165|NCT03665597|564738464|FG005|Period 1|Screen Failure|0|||
156449166|NCT03665597|564738465|FG006|Period 1|Screen Failure|0|||
156449167|NCT03665597|564738459|FG000|Period 1|Death|0|||
156449168|NCT03665597|564738460|FG001|Period 1|Death|0|||
156449169|NCT03665597|564738461|FG002|Period 1|Death|0|||
156449170|NCT03665597|564738462|FG003|Period 1|Death|0|||
156449171|NCT03665597|564738463|FG004|Period 1|Death|0|||
156449172|NCT03665597|564738464|FG005|Period 1|Death|0|||
156449173|NCT03665597|564738465|FG006|Period 1|Death|45|||
156449174|NCT03665597|564738459|FG000|Period 1|Withdrawal by Subject|0|||
156449175|NCT03665597|564738460|FG001|Period 1|Withdrawal by Subject|0|||
156449176|NCT03665597|564738461|FG002|Period 1|Withdrawal by Subject|0|||
156449177|NCT03665597|564738462|FG003|Period 1|Withdrawal by Subject|0|||
156449178|NCT03665597|564738463|FG004|Period 1|Withdrawal by Subject|0|||
156449179|NCT03665597|564738464|FG005|Period 1|Withdrawal by Subject|0|||
156449180|NCT03665597|564738465|FG006|Period 1|Withdrawal by Subject|5|||
156449181|NCT03665597|564738459|FG000|Period 2|Adverse Event|0|||
156449182|NCT03665597|564738460|FG001|Period 2|Adverse Event|0|||
156449183|NCT03665597|564738461|FG002|Period 2|Adverse Event|0|||
156449184|NCT03665597|564738462|FG003|Period 2|Adverse Event|0|||
156449185|NCT03665597|564738463|FG004|Period 2|Adverse Event|0|||
156449186|NCT03665597|564738464|FG005|Period 2|Adverse Event|1|||
156449187|NCT03665597|564738465|FG006|Period 2|Adverse Event|0|||
156449188|NCT03665597|564738459|FG000|Period 3|Adverse Event|0|||
156449189|NCT03665597|564738460|FG001|Period 3|Adverse Event|1|||
156449190|NCT03665597|564738461|FG002|Period 3|Adverse Event|0|||
156449191|NCT03665597|564738462|FG003|Period 3|Adverse Event|0|||
156449192|NCT03665597|564738463|FG004|Period 3|Adverse Event|0|||
156449193|NCT03665597|564738464|FG005|Period 3|Adverse Event|0|||
156449194|NCT03665597|564738465|FG006|Period 3|Adverse Event|0|||
156449195|NCT03665597|564738459|FG000|Period 3|Death|0|||
156449196|NCT03665597|564738460|FG001|Period 3|Death|0|||
156449197|NCT03665597|564738461|FG002|Period 3|Death|0|||
156449198|NCT03665597|564738462|FG003|Period 3|Death|0|||
156449199|NCT03665597|564738463|FG004|Period 3|Death|1|||
156449200|NCT03665597|564738464|FG005|Period 3|Death|0|||
156449201|NCT03665597|564738465|FG006|Period 3|Death|0|||
156449202|NCT03665597|564738459|FG000|Period 4|Adverse Event|2|||
156720591|NCT03428958|565723712|FG002|Overall Study|Physician/Sponsor Decision|1|||
156720592|NCT03428958|565723713|FG003|Overall Study|Physician/Sponsor Decision|0|||
156720593|NCT03428958|565723714|FG004|Overall Study|Physician/Sponsor Decision|0|||
156720594|NCT03428958|565723715|FG005|Overall Study|Physician/Sponsor Decision|2|||
156720595|NCT03428958|565723716|FG006|Overall Study|Physician/Sponsor Decision|2|||
156720596|NCT03428958|565723717|FG007|Overall Study|Physician/Sponsor Decision|2|||
156720597|NCT03428958|565723718|FG008|Overall Study|Physician/Sponsor Decision|0|||
156720598|NCT03428958|565723719|FG009|Overall Study|Physician/Sponsor Decision|0|||
156720599|NCT03428958|565723720|FG010|Overall Study|Physician/Sponsor Decision|2|||
156720600|NCT03428958|565723721|FG011|Overall Study|Physician/Sponsor Decision|0|||
156720601|NCT03428958|565723722|FG012|Overall Study|Physician/Sponsor Decision|4|||
156720602|NCT03428958|565723723|FG013|Overall Study|Physician/Sponsor Decision|0|||
156720603|NCT03428958|565723724|FG014|Overall Study|Physician/Sponsor Decision|0|||
156720604|NCT03428958|565723725|FG015|Overall Study|Physician/Sponsor Decision|0|||
156720605|NCT03428958|565723726|FG016|Overall Study|Physician/Sponsor Decision|0|||
156449203|NCT03665597|564738460|FG001|Period 4|Adverse Event|2|||
156449204|NCT03665597|564738461|FG002|Period 4|Adverse Event|2|||
156720606|NCT03428958|565723710|FG000|Overall Study|Withdrawal by Subject|0|||
156449205|NCT03665597|564738462|FG003|Period 4|Adverse Event|2|||
156449206|NCT03665597|564738463|FG004|Period 4|Adverse Event|1|||
156449207|NCT03665597|564738464|FG005|Period 4|Adverse Event|0|||
156449208|NCT03665597|564738465|FG006|Period 4|Adverse Event|0|||
156449209|NCT03665597|564738459|FG000|Period 4|Death|0|||
156449210|NCT03665597|564738460|FG001|Period 4|Death|0|||
156449211|NCT03665597|564738461|FG002|Period 4|Death|2|||
156449212|NCT03665597|564738462|FG003|Period 4|Death|0|||
156449213|NCT03665597|564738463|FG004|Period 4|Death|0|||
156449214|NCT03665597|564738464|FG005|Period 4|Death|0|||
156720607|NCT03428958|565723711|FG001|Overall Study|Withdrawal by Subject|0|||
156793885|NCT00266032|565999464|FG000|Open-label Safety Extension|Adverse Event|5|||
156449215|NCT03665597|564738465|FG006|Period 4|Death|0|||
156449216|NCT03665597|564738459|FG000|Period 4|Physician Decision|1|||
156449217|NCT03665597|564738460|FG001|Period 4|Physician Decision|2|||
156449218|NCT03665597|564738461|FG002|Period 4|Physician Decision|0|||
156449219|NCT03665597|564738462|FG003|Period 4|Physician Decision|0|||
156449220|NCT03665597|564738463|FG004|Period 4|Physician Decision|0|||
156449221|NCT03665597|564738464|FG005|Period 4|Physician Decision|0|||
156449222|NCT03665597|564738465|FG006|Period 4|Physician Decision|0|||
156449223|NCT05516147|564738466|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
156793886|NCT00266032|565999465|FG001|Open-label Safety Extension|Adverse Event|0|||
156793887|NCT00266032|565999466|FG002|Open-label Safety Extension|Adverse Event|4|||
156793888|NCT00266032|565999464|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
156793889|NCT00266032|565999465|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
156793890|NCT00266032|565999466|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
156793891|NCT00266032|565999464|FG000|Open-label Safety Extension|Pregnancy|4|||
156793892|NCT00266032|565999465|FG001|Open-label Safety Extension|Pregnancy|1|||
156793893|NCT00266032|565999466|FG002|Open-label Safety Extension|Pregnancy|2|||
156793894|NCT00266032|565999464|FG000|Open-label Safety Extension|Protocol Violation|1|||
156793895|NCT00266032|565999465|FG001|Open-label Safety Extension|Protocol Violation|3|||
156793896|NCT00266032|565999466|FG002|Open-label Safety Extension|Protocol Violation|2|||
156793897|NCT00266032|565999464|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
156449224|NCT05371652|564738470|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
156449225|NCT05371652|564738470|FG000|Overall Study|Withdrawal by Subject|12|||
156449226|NCT05371652|564738470|FG000|Overall Study|Adverse Event|1|||
156449227|NCT05371652|564738470|FG000|Overall Study|Other|11|||
156449228|NCT05256706|564738472|FG000|Overall Study|Lost to Follow-up|9|||
156449229|NCT05256706|564738473|FG001|Overall Study|Lost to Follow-up|3|||
156449230|NCT05256706|564738472|FG000|Overall Study|Withdrawal by Subject|7|||
156720608|NCT03428958|565723712|FG002|Overall Study|Withdrawal by Subject|2|||
156720609|NCT03428958|565723713|FG003|Overall Study|Withdrawal by Subject|0|||
156720610|NCT03428958|565723714|FG004|Overall Study|Withdrawal by Subject|0|||
156720611|NCT03428958|565723715|FG005|Overall Study|Withdrawal by Subject|2|||
156720612|NCT03428958|565723716|FG006|Overall Study|Withdrawal by Subject|4|||
156720613|NCT03428958|565723717|FG007|Overall Study|Withdrawal by Subject|1|||
156720614|NCT03428958|565723718|FG008|Overall Study|Withdrawal by Subject|0|||
156720615|NCT03428958|565723719|FG009|Overall Study|Withdrawal by Subject|0|||
156720616|NCT03428958|565723720|FG010|Overall Study|Withdrawal by Subject|0|||
156720617|NCT03428958|565723721|FG011|Overall Study|Withdrawal by Subject|0|||
156720618|NCT03428958|565723722|FG012|Overall Study|Withdrawal by Subject|0|||
156720619|NCT03428958|565723723|FG013|Overall Study|Withdrawal by Subject|0|||
156720620|NCT03428958|565723724|FG014|Overall Study|Withdrawal by Subject|0|||
156720621|NCT03428958|565723725|FG015|Overall Study|Withdrawal by Subject|0|||
156720622|NCT03428958|565723726|FG016|Overall Study|Withdrawal by Subject|0|||
156720623|NCT03985800|565723727|FG000|Overall Study|Death|1|||
156720624|NCT03985800|565723728|FG001|Overall Study|Death|2|||
156720625|NCT03985800|565723727|FG000|Overall Study|Withdrawal by Subject|3|||
156720626|NCT03985800|565723728|FG001|Overall Study|Withdrawal by Subject|6|||
156720627|NCT03985800|565723727|FG000|Overall Study|Protocol Violation|2|||
156720628|NCT03985800|565723728|FG001|Overall Study|Protocol Violation|0|||
156720629|NCT05258773|565723729|FG000|Overall Study|Screen Failure|1|||
156720630|NCT05258773|565723730|FG001|Overall Study|Screen Failure|1|||
156720631|NCT05258773|565723729|FG000|Overall Study|Adverse Event|1|||
156720632|NCT05258773|565723730|FG001|Overall Study|Adverse Event|0|||
156720633|NCT05258773|565723729|FG000|Overall Study|Withdrawal by Subject|0|||
156720634|NCT05258773|565723730|FG001|Overall Study|Withdrawal by Subject|1|||
156720635|NCT06025721|565723733|FG000|Overall Study|Physician Decision|1|||
156720636|NCT06025721|565723733|FG000|Overall Study|Protocol Violation|1|||
156720637|NCT06025721|565723733|FG000|Overall Study|Incarceration|1|||
156720638|NCT04231825|565723734|FG000|Overall Study|Protocol Violation|3|||
156720639|NCT04231825|565723735|FG001|Overall Study|Protocol Violation|3|||
156720640|NCT04231825|565723734|FG000|Overall Study|Lost to Follow-up|0|||
156720641|NCT04231825|565723735|FG001|Overall Study|Lost to Follow-up|1|||
156720642|NCT01662635|565723736|FG000|Overall Study|scarce samples for evaluation|30|||
156720643|NCT00595920|565723737|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
156720644|NCT00351468|565723738|FG000|Overall Study|Adverse Event|42|||
156720645|NCT00351468|565723738|FG000|Overall Study|Withdrawal by Subject|39|||
156720646|NCT00351468|565723738|FG000|Overall Study|Various -follow up w clinical team|39|||
156720647|NCT00351468|565723738|FG000|Overall Study|Lack of Efficacy|32|||
156793898|NCT00266032|565999465|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
156793899|NCT00266032|565999466|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
156875353|NCT04896086|566302024|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
156793900|NCT00266032|565999464|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
156449231|NCT05256706|564738473|FG001|Overall Study|Withdrawal by Subject|11|||
156449232|NCT05256706|564738472|FG000|Overall Study|Screen Failures|3|||
156720648|NCT00351468|565723738|FG000|Overall Study|Non-compliance|8|||
156720649|NCT00351468|565723738|FG000|Overall Study|Lost to Follow-up|4|||
156720650|NCT00351468|565723738|FG000|Overall Study|Protocol Violation|3|||
156720651|NCT03588910|565723739|FG000|Overall Study|Withdrawal by Subject|1|||
156720652|NCT03588910|565723740|FG001|Overall Study|Withdrawal by Subject|0|||
156720653|NCT03588910|565723739|FG000|Overall Study|Allergy|2|||
156720654|NCT03588910|565723740|FG001|Overall Study|Allergy|0|||
156720655|NCT03588910|565723739|FG000|Overall Study|Protocol Violation|0|||
156720656|NCT03588910|565723740|FG001|Overall Study|Protocol Violation|3|||
156720657|NCT03588910|565723739|FG000|Overall Study|Did not complete Day 1 Survey|5|||
156720658|NCT03588910|565723740|FG001|Overall Study|Did not complete Day 1 Survey|10|||
156449233|NCT05256706|564738473|FG001|Overall Study|Screen Failures|0|||
156449234|NCT04410042|564738474|FG000|Overall Study|Not Eligible|1|||
156449235|NCT04410042|564738475|FG001|Overall Study|Not Eligible|1|||
156449236|NCT03302494|564738476|FG000|Overall Study|Other|7|||
156449237|NCT03302494|564738477|FG001|Overall Study|Other|4|||
156449238|NCT03302494|564738478|FG002|Overall Study|Other|6|||
156449239|NCT03302494|564738476|FG000|Overall Study|Withdrawal by Subject|10|||
156720659|NCT03588910|565723739|FG000|Overall Study|Did not complete Day 7 Survey|5|||
156720660|NCT03588910|565723740|FG001|Overall Study|Did not complete Day 7 Survey|2|||
156720661|NCT04565145|565723741|FG000|Overall Study|Withdrawal by Subject|1|||
156720662|NCT04565145|565723742|FG001|Overall Study|Withdrawal by Subject|1|||
156449240|NCT03302494|564738477|FG001|Overall Study|Withdrawal by Subject|2|||
156449241|NCT03302494|564738478|FG002|Overall Study|Withdrawal by Subject|9|||
156449242|NCT03302494|564738476|FG000|Overall Study|Study Terminated by Sponsor|32|||
156449243|NCT03302494|564738477|FG001|Overall Study|Study Terminated by Sponsor|29|||
156449244|NCT03302494|564738478|FG002|Overall Study|Study Terminated by Sponsor|30|||
156449245|NCT03302494|564738476|FG000|Overall Study|Physician Decision|1|||
156449246|NCT03302494|564738477|FG001|Overall Study|Physician Decision|0|||
156449247|NCT03302494|564738478|FG002|Overall Study|Physician Decision|1|||
156449248|NCT03302494|564738476|FG000|Overall Study|Lost to Follow-up|1|||
156449249|NCT03302494|564738477|FG001|Overall Study|Lost to Follow-up|3|||
156449250|NCT03302494|564738478|FG002|Overall Study|Lost to Follow-up|3|||
156449251|NCT03302494|564738476|FG000|Overall Study|Death|13|||
156449252|NCT03302494|564738477|FG001|Overall Study|Death|11|||
156449253|NCT03302494|564738478|FG002|Overall Study|Death|4|||
156449254|NCT03302494|564738476|FG000|Overall Study|Adverse Event|1|||
156449255|NCT03302494|564738477|FG001|Overall Study|Adverse Event|2|||
156449256|NCT03302494|564738478|FG002|Overall Study|Adverse Event|0|||
156449257|NCT03302494|564738476|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
156449258|NCT03302494|564738477|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
156449259|NCT03302494|564738478|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
156449260|NCT03978871|564738479|FG000|Overall Study|Lost to Follow-up|11|||
156449261|NCT03978871|564738480|FG001|Overall Study|Lost to Follow-up|12|||
156449262|NCT05710107|564738481|FG000|Overall Study|Withdrawal by Subject|1|||
156449263|NCT05710107|564738482|FG001|Overall Study|Withdrawal by Subject|1|||
156449264|NCT05710107|564738481|FG000|Overall Study|Lost to Follow-up|8|||
156449265|NCT05710107|564738482|FG001|Overall Study|Lost to Follow-up|9|||
156449266|NCT05710107|564738481|FG000|Overall Study|Unable to place assigned block|2|||
156449267|NCT05710107|564738482|FG001|Overall Study|Unable to place assigned block|0|||
156449268|NCT05710107|564738481|FG000|Overall Study|Withdrawn by study team|0|||
156449269|NCT05710107|564738482|FG001|Overall Study|Withdrawn by study team|1|||
156449270|NCT04166773|564738483|FG000|Overall Study|Adverse Event|2|||
156449271|NCT04166773|564738484|FG001|Overall Study|Adverse Event|0|||
156449272|NCT04166773|564738485|FG002|Overall Study|Adverse Event|2|||
156449273|NCT04166773|564738486|FG003|Overall Study|Adverse Event|1|||
156449274|NCT04166773|564738483|FG000|Overall Study|Lost to Follow-up|4|||
156449275|NCT04166773|564738484|FG001|Overall Study|Lost to Follow-up|2|||
156449276|NCT04166773|564738485|FG002|Overall Study|Lost to Follow-up|1|||
156449277|NCT04166773|564738486|FG003|Overall Study|Lost to Follow-up|3|||
156449278|NCT04166773|564738483|FG000|Overall Study|Physician Decision|0|||
156449279|NCT04166773|564738484|FG001|Overall Study|Physician Decision|0|||
156449280|NCT04166773|564738485|FG002|Overall Study|Physician Decision|0|||
156449281|NCT04166773|564738486|FG003|Overall Study|Physician Decision|1|||
156449282|NCT04166773|564738483|FG000|Overall Study|Withdrawal by Subject|1|||
156449283|NCT04166773|564738484|FG001|Overall Study|Withdrawal by Subject|1|||
156449284|NCT04166773|564738485|FG002|Overall Study|Withdrawal by Subject|2|||
156449285|NCT04166773|564738486|FG003|Overall Study|Withdrawal by Subject|5|||
156449286|NCT05268302|564738487|FG000|Overall Study|Death|0|||
156449287|NCT05268302|564738488|FG001|Overall Study|Death|1|||
156449288|NCT02811679|564738489|FG000|Overall Study|Adverse Event|1|||
156720663|NCT03096314|565723743|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
156720664|NCT03096314|565723744|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
156720665|NCT02547428|565723745|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
156720666|NCT02547428|565723746|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
156720667|NCT02547428|565723745|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
156449289|NCT02811679|564738489|FG000|Overall Study|Lack of Efficacy|6|||
156449290|NCT02811679|564738489|FG000|Overall Study|Early study closure due to slow accrual|3|||
156720668|NCT02547428|565723746|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
156449291|NCT05319860|564738490|FG000|Overall Study|Death|1|||
156449292|NCT05319860|564738491|FG001|Overall Study|Death|1|||
156449293|NCT05319860|564738490|FG000|Overall Study|Lost to Follow-up|3|||
156449294|NCT05319860|564738491|FG001|Overall Study|Lost to Follow-up|1|||
156449295|NCT05319860|564738490|FG000|Overall Study|Withdrawal by Subject|1|||
156449296|NCT05319860|564738491|FG001|Overall Study|Withdrawal by Subject|7|||
156449297|NCT01361711|564738492|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
156449298|NCT01361711|564738492|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
156449299|NCT01361711|564738492|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
156720669|NCT02547428|565723745|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
156720670|NCT02547428|565723746|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
156720671|NCT02547428|565723745|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
156720672|NCT02547428|565723746|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
156720673|NCT02547428|565723745|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
156449300|NCT01361711|564738492|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
156449301|NCT01361711|564738492|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
156449302|NCT01361711|564738492|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
156449303|NCT01361711|564738492|FG000|Completed Week 18 of Treatment|Other|9|||
156449304|NCT01361711|564738492|FG000|10 Year Follow-up|Still in follow-up|22|||
156449305|NCT01361711|564738492|FG000|10 Year Follow-up|Death|7|||
156449306|NCT01361711|564738492|FG000|10 Year Follow-up|Developed new cancer|1|||
156449307|NCT01361711|564738492|FG000|10 Year Follow-up|Lost to Follow-up|2|||
156449308|NCT01361711|564738492|FG000|10 Year Follow-up|New treatment started|6|||
156449309|NCT01361711|564738492|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
156449310|NCT01361711|564738492|FG000|10 Year Follow-up|Progressive Disease|1|||
156449311|NCT00753090|564739845|FG000|Overall Study|Withdrawal by Subject|10|||
156449312|NCT00753090|564739846|FG001|Overall Study|Withdrawal by Subject|10|||
156449313|NCT00753090|564739845|FG000|Overall Study|Death|17|||
156449314|NCT00753090|564739846|FG001|Overall Study|Death|6|||
156449315|NCT00753090|564739845|FG000|Overall Study|Study Prosthesis Removed|12|||
156449316|NCT00753090|564739846|FG001|Overall Study|Study Prosthesis Removed|3|||
156449317|NCT00753090|564739845|FG000|Overall Study|Lost to Follow-up|2|||
156449318|NCT00753090|564739846|FG001|Overall Study|Lost to Follow-up|2|||
156449319|NCT00753090|564739845|FG000|Overall Study|Other|127|||
156449320|NCT00753090|564739846|FG001|Overall Study|Other|75|||
156449321|NCT05113966|564739847|FG000|Overall Study|Death|21|||
156449322|NCT05113966|564739847|FG000|Overall Study|Study Terminated by Sponsor|9|||
156449323|NCT04521478|564739848|FG000|Overall Study|Protocol Violation|2|||
156449324|NCT04521478|564739849|FG001|Overall Study|Protocol Violation|0|||
156449325|NCT04521478|564739850|FG002|Overall Study|Protocol Violation|1|||
156449326|NCT04521478|564739851|FG003|Overall Study|Protocol Violation|0|||
156449327|NCT04521478|564739852|FG004|Overall Study|Protocol Violation|0|||
156449328|NCT04521478|564739853|FG005|Overall Study|Protocol Violation|0|||
156449329|NCT04521478|564739848|FG000|Overall Study|Technical Problems|0|||
156449330|NCT04521478|564739849|FG001|Overall Study|Technical Problems|0|||
156449331|NCT04521478|564739850|FG002|Overall Study|Technical Problems|0|||
156449332|NCT04521478|564739851|FG003|Overall Study|Technical Problems|1|||
156449333|NCT04521478|564739852|FG004|Overall Study|Technical Problems|0|||
156449334|NCT04521478|564739853|FG005|Overall Study|Technical Problems|0|||
156449335|NCT04521478|564739848|FG000|Overall Study|Burden of Study Procedures|1|||
156449336|NCT04521478|564739849|FG001|Overall Study|Burden of Study Procedures|0|||
156449337|NCT04521478|564739850|FG002|Overall Study|Burden of Study Procedures|0|||
156449338|NCT04521478|564739851|FG003|Overall Study|Burden of Study Procedures|1|||
156449339|NCT04521478|564739852|FG004|Overall Study|Burden of Study Procedures|0|||
156449340|NCT04521478|564739853|FG005|Overall Study|Burden of Study Procedures|1|||
156449341|NCT04521478|564739848|FG000|Overall Study|Lack of Efficacy|0|||
156449342|NCT04521478|564739849|FG001|Overall Study|Lack of Efficacy|0|||
156449343|NCT04521478|564739850|FG002|Overall Study|Lack of Efficacy|0|||
156449344|NCT04521478|564739851|FG003|Overall Study|Lack of Efficacy|0|||
156449345|NCT04521478|564739852|FG004|Overall Study|Lack of Efficacy|1|||
156449346|NCT04521478|564739853|FG005|Overall Study|Lack of Efficacy|1|||
156449347|NCT04521478|564739848|FG000|Overall Study|Adverse Event|7|||
156449348|NCT04521478|564739849|FG001|Overall Study|Adverse Event|0|||
156449349|NCT04521478|564739850|FG002|Overall Study|Adverse Event|2|||
156449350|NCT04521478|564739851|FG003|Overall Study|Adverse Event|1|||
156449351|NCT04521478|564739852|FG004|Overall Study|Adverse Event|2|||
156449352|NCT04521478|564739853|FG005|Overall Study|Adverse Event|7|||
156449353|NCT04521478|564739848|FG000|Overall Study|No Reason Available|0|||
156449354|NCT04521478|564739849|FG001|Overall Study|No Reason Available|2|||
156449355|NCT04521478|564739850|FG002|Overall Study|No Reason Available|0|||
156449356|NCT04521478|564739851|FG003|Overall Study|No Reason Available|0|||
156449357|NCT04521478|564739852|FG004|Overall Study|No Reason Available|1|||
156449358|NCT04521478|564739853|FG005|Overall Study|No Reason Available|0|||
156449359|NCT04521478|564739848|FG000|Overall Study|Other than listed|3|||
156449360|NCT04521478|564739849|FG001|Overall Study|Other than listed|3|||
156449361|NCT04521478|564739850|FG002|Overall Study|Other than listed|3|||
156449362|NCT04521478|564739851|FG003|Overall Study|Other than listed|2|||
156449363|NCT04521478|564739852|FG004|Overall Study|Other than listed|3|||
156449364|NCT04521478|564739853|FG005|Overall Study|Other than listed|3|||
156449365|NCT04521478|564739848|FG000|Overall Study|Not treated|0|||
156449366|NCT04521478|564739849|FG001|Overall Study|Not treated|0|||
156449367|NCT04521478|564739850|FG002|Overall Study|Not treated|0|||
156449368|NCT04521478|564739851|FG003|Overall Study|Not treated|0|||
156449369|NCT04521478|564739852|FG004|Overall Study|Not treated|0|||
156720674|NCT02547428|565723746|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
156449370|NCT04521478|564739853|FG005|Overall Study|Not treated|1|||
156449371|NCT02187003|564739854|FG000|Overall Study|Adverse Event|2|||
156449372|NCT02187003|564739855|FG001|Overall Study|Adverse Event|0|||
156449373|NCT02187003|564739854|FG000|Overall Study|Lost to Follow-up|14|||
156449374|NCT02187003|564739855|FG001|Overall Study|Lost to Follow-up|10|||
156449375|NCT02187003|564739854|FG000|Overall Study|Withdrawal by Subject|3|||
156449376|NCT02187003|564739855|FG001|Overall Study|Withdrawal by Subject|7|||
156449377|NCT02187003|564739854|FG000|Overall Study|Protocol Violation|2|||
156449378|NCT02187003|564739855|FG001|Overall Study|Protocol Violation|4|||
156449379|NCT02187003|564739854|FG000|Overall Study|Other|5|||
156449380|NCT02187003|564739855|FG001|Overall Study|Other|5|||
156449381|NCT02187003|564739854|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156449382|NCT02187003|564739855|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
156449383|NCT05816551|564739856|FG000|Overall Study|Withdrawal by Subject|0|||
156449384|NCT05816551|564739857|FG001|Overall Study|Withdrawal by Subject|1|||
156449385|NCT05816551|564739856|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
156449386|NCT05816551|564739857|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
156449387|NCT03648840|564739861|FG000|First IV Infusion Session|Adverse Event|0|||
156449388|NCT03648840|564739862|FG001|First IV Infusion Session|Adverse Event|2|||
156449389|NCT03648840|564739861|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
156449390|NCT03648840|564739862|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
156449391|NCT03648840|564739861|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
156449392|NCT03648840|564739862|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
156449393|NCT03648840|564739861|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
156449394|NCT03648840|564739862|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
156449395|NCT05382936|564739864|FG000|Overall Study|Progressive Disease|3|||
156449396|NCT05382936|564739865|FG001|Overall Study|Progressive Disease|5|||
156449397|NCT05382936|564739866|FG002|Overall Study|Progressive Disease|2|||
156449398|NCT05382936|564739867|FG003|Overall Study|Progressive Disease|5|||
156449399|NCT05382936|564739864|FG000|Overall Study|Adverse Event|0|||
156449400|NCT05382936|564739865|FG001|Overall Study|Adverse Event|1|||
156449401|NCT05382936|564739866|FG002|Overall Study|Adverse Event|1|||
156449402|NCT05382936|564739867|FG003|Overall Study|Adverse Event|0|||
156449403|NCT05382936|564739864|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
156449404|NCT05382936|564739865|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
156449405|NCT05382936|564739866|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
156449406|NCT05382936|564739867|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
156449407|NCT05382936|564739864|FG000|Overall Study|Withdrawal by Subject|0|||
156449408|NCT05382936|564739865|FG001|Overall Study|Withdrawal by Subject|0|||
156449409|NCT05382936|564739866|FG002|Overall Study|Withdrawal by Subject|1|||
156449410|NCT05382936|564739867|FG003|Overall Study|Withdrawal by Subject|1|||
156449411|NCT05063994|564739868|FG000|Cortef Run-In|Withdrawal of Consent|1|||
156449412|NCT05063994|564739869|FG001|Cortef Run-In|Withdrawal of Consent|0|||
156449413|NCT05063994|564739870|FG002|Cortef Run-In|Withdrawal of Consent|0|||
156449414|NCT05063994|564739868|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
156449415|NCT05063994|564739869|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
156449416|NCT05063994|564739870|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
156449417|NCT05063994|564739868|FG000|Treatment|Physician Decision|0|||
156449418|NCT05063994|564739869|FG001|Treatment|Physician Decision|0|||
156449419|NCT05063994|564739870|FG002|Treatment|Physician Decision|1|||
156449420|NCT05063994|564739868|FG000|Treatment|Withdrawal by Subject|0|||
156449421|NCT05063994|564739869|FG001|Treatment|Withdrawal by Subject|0|||
156449422|NCT05063994|564739870|FG002|Treatment|Withdrawal by Subject|1|||
156449423|NCT05063994|564739868|FG000|Treatment|Withdrawal of Consent|0|||
156449424|NCT05063994|564739869|FG001|Treatment|Withdrawal of Consent|0|||
156449425|NCT05063994|564739870|FG002|Treatment|Withdrawal of Consent|1|||
156449426|NCT01195831|564739875|FG000|Overall Study|Lost to Follow-up|2|||
156449427|NCT01195831|564739876|FG001|Overall Study|Lost to Follow-up|4|||
156449428|NCT01195831|564739875|FG000|Overall Study|Withdrawal by Subject|2|||
156449429|NCT01195831|564739876|FG001|Overall Study|Withdrawal by Subject|2|||
156449430|NCT01195831|564739875|FG000|Overall Study|Adverse Event|4|||
156449431|NCT01195831|564739876|FG001|Overall Study|Adverse Event|2|||
156449432|NCT01195831|564739875|FG000|Overall Study|Protocol Violation|0|||
156449433|NCT01195831|564739876|FG001|Overall Study|Protocol Violation|2|||
156449434|NCT03692676|564739878|FG000|Overall Study|exclude patients with prior use|4424|||
156449435|NCT03692676|564739879|FG001|Overall Study|exclude patients with prior use|24726|||
156449436|NCT03692676|564739880|FG002|Overall Study|exclude patients with prior use|0|||
156449437|NCT03692676|564739881|FG003|Overall Study|exclude patients with prior use|0|||
156449438|NCT03692676|564739878|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
156449439|NCT03692676|564739879|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
156449440|NCT03692676|564739880|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
156449441|NCT03692676|564739881|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
156449442|NCT03692676|564739878|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
156449443|NCT03692676|564739879|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
156449444|NCT03692676|564739880|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
156449445|NCT03692676|564739881|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
156449446|NCT03692676|564739878|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
156449447|NCT03692676|564739879|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
156449448|NCT03692676|564739880|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
156449449|NCT03692676|564739881|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
156449450|NCT03692676|564739878|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
156449451|NCT03692676|564739879|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
156449452|NCT03692676|564739880|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
156449453|NCT03692676|564739881|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
156449454|NCT03692676|564739878|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
156449455|NCT03692676|564739879|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
156449456|NCT03692676|564739880|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
156449457|NCT03692676|564739881|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
156449458|NCT03692676|564739878|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
156449459|NCT03692676|564739879|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
156449460|NCT03692676|564739880|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
156449461|NCT03692676|564739881|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
156449462|NCT03692676|564739878|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
156449463|NCT03692676|564739879|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
156449464|NCT03692676|564739880|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
156449465|NCT03692676|564739881|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
156449466|NCT03692676|564739878|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
156449467|NCT03692676|564739879|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
156449468|NCT03692676|564739880|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
156449469|NCT03692676|564739881|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
156449470|NCT03692676|564739878|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
156449471|NCT03692676|564739879|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
156449472|NCT03692676|564739880|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
156449473|NCT03692676|564739881|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
156449474|NCT03692676|564739878|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
156449475|NCT03692676|564739879|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
156449476|NCT03692676|564739880|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
156449477|NCT03692676|564739881|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
156449478|NCT03692676|564739878|FG000|Overall Study|Other|0|||
156449479|NCT03692676|564739879|FG001|Overall Study|Other|805|||
156449480|NCT03692676|564739880|FG002|Overall Study|Other|758|||
156449481|NCT03692676|564739881|FG003|Overall Study|Other|277|||
156449482|NCT03692676|564739878|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
156449483|NCT03692676|564739879|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
156449484|NCT03692676|564739880|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
156449485|NCT03692676|564739881|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
156449486|NCT01180634|564739882|FG000|Overall Study|Adverse Event|4|||
156449487|NCT01180634|564739883|FG001|Overall Study|Adverse Event|1|||
156449488|NCT01180634|564739882|FG000|Overall Study|Miscellaneous|2|||
156449489|NCT01180634|564739883|FG001|Overall Study|Miscellaneous|0|||
156449490|NCT01180634|564739882|FG000|Overall Study|Withdrawal by Subject|4|||
156449491|NCT01180634|564739883|FG001|Overall Study|Withdrawal by Subject|0|||
156449492|NCT03692611|564739884|FG000|Overall Study|Found to be ineligible postrandomization|3|||
156449493|NCT03692611|564739885|FG001|Overall Study|Found to be ineligible postrandomization|0|||
156449494|NCT04490915|564739887|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
156449495|NCT04490915|564739888|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
156449496|NCT04490915|564739887|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156449497|NCT04490915|564739888|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156449498|NCT04490915|564739887|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156449499|NCT04490915|564739888|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
156449500|NCT04490915|564739887|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
156449501|NCT04490915|564739888|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
156449502|NCT04490915|564739887|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
156449503|NCT04490915|564739888|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
156449504|NCT04490915|564739887|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
156449505|NCT04490915|564739888|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
156449506|NCT04490915|564739887|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
156449507|NCT04490915|564739888|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
156449508|NCT04725240|564739889|FG000|Overall Study|Adverse Event|2|||
156449509|NCT04083235|564739896|FG000|Overall Study|Death|252|||
156449510|NCT04083235|564739897|FG001|Overall Study|Death|277|||
156449511|NCT04083235|564739896|FG000|Overall Study|Withdrawal by Subject|13|||
156449512|NCT04083235|564739897|FG001|Overall Study|Withdrawal by Subject|17|||
156449513|NCT04083235|564739896|FG000|Overall Study|Lost to Follow-up|1|||
156449514|NCT04083235|564739897|FG001|Overall Study|Lost to Follow-up|1|||
156449515|NCT04083235|564739896|FG000|Overall Study|Does not meet entry criteria|1|||
156449516|NCT04083235|564739897|FG001|Overall Study|Does not meet entry criteria|0|||
156449517|NCT04083235|564739896|FG000|Overall Study|Did not receive treatment|13|||
156449518|NCT04083235|564739897|FG001|Overall Study|Did not receive treatment|8|||
156449519|NCT04083235|564739896|FG000|Overall Study|Ongoing at the time of DCO|44|||
156449520|NCT04083235|564739897|FG001|Overall Study|Ongoing at the time of DCO|7|||
156449521|NCT03016169|564739898|FG000|Overall Study|Lost to Follow-up|4|||
156449522|NCT03016169|564739898|FG000|Overall Study|Death|54|||
156449523|NCT03016169|564739898|FG000|Overall Study|Device Explant|11|||
156449524|NCT03016169|564739898|FG000|Overall Study|Withdrawal by Subject|19|||
156449525|NCT03016169|564739898|FG000|Overall Study|Other Reasons|1|||
156449526|NCT04060355|564739899|FG000|Overall Study|Lost to Follow-up|41|||
156449527|NCT03779204|564739903|FG000|Overall Study|Lost to Follow-up|2|||
156449528|NCT03779204|564739904|FG001|Overall Study|Lost to Follow-up|0|||
156449529|NCT04150718|564739905|FG000|Overall Study|Withdrawal by Subject|2|||
156449530|NCT04150718|564739906|FG001|Overall Study|Withdrawal by Subject|7|||
156449531|NCT04150718|564739907|FG002|Overall Study|Withdrawal by Subject|1|||
156449532|NCT04150718|564739905|FG000|Overall Study|Lost to Follow-up|1|||
156449533|NCT04150718|564739906|FG001|Overall Study|Lost to Follow-up|2|||
156449534|NCT04150718|564739907|FG002|Overall Study|Lost to Follow-up|0|||
156449535|NCT04150718|564739905|FG000|Overall Study|Ineligible|1|||
156449536|NCT04150718|564739906|FG001|Overall Study|Ineligible|0|||
156449537|NCT04150718|564739907|FG002|Overall Study|Ineligible|10|||
156449538|NCT04673929|564739908|FG000|Overall Study|Death|73|||
156449539|NCT04673929|564739908|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
156449540|NCT04024813|564739909|FG000|Overall Study|Study terminated by Sponsor|1|||
156449541|NCT02729311|564739910|FG000|Overall Study|Withdrawal by Subject|8|||
156449542|NCT02729311|564739911|FG001|Overall Study|Withdrawal by Subject|2|||
156449543|NCT05324124|564739912|FG000|Period 1|Withdrawal by Subject|1|||
156449544|NCT05324124|564739913|FG001|Period 1|Withdrawal by Subject|0|||
156449545|NCT05324124|564739912|FG000|Period 1|Physician Decision|0|||
156449546|NCT05324124|564739913|FG001|Period 1|Physician Decision|1|||
156449547|NCT05034952|564739914|FG000|Overall Study|Adverse Event|1|||
156449548|NCT05034952|564739915|FG001|Overall Study|Adverse Event|0|||
156449549|NCT05034952|564739916|FG002|Overall Study|Adverse Event|0|||
156449550|NCT05034952|564739917|FG003|Overall Study|Adverse Event|0|||
156449551|NCT05034952|564739914|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156449552|NCT05034952|564739915|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
156449553|NCT05034952|564739916|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
156449554|NCT05034952|564739917|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
156449555|NCT05034952|564739914|FG000|Overall Study|Lost to Follow-up|1|||
156449556|NCT05034952|564739915|FG001|Overall Study|Lost to Follow-up|4|||
156449557|NCT05034952|564739916|FG002|Overall Study|Lost to Follow-up|3|||
156449558|NCT05034952|564739917|FG003|Overall Study|Lost to Follow-up|3|||
156449559|NCT05034952|564739914|FG000|Overall Study|Other|0|||
156449560|NCT05034952|564739915|FG001|Overall Study|Other|0|||
156449561|NCT05034952|564739916|FG002|Overall Study|Other|0|||
156449562|NCT05034952|564739917|FG003|Overall Study|Other|1|||
156449563|NCT02287610|564739918|FG000|Overall Study|Lost to Follow-up|3|||
156449564|NCT02287610|564739918|FG000|Overall Study|Withdrawal by Subject|8|||
156449565|NCT02287610|564739918|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
156793901|NCT00266032|565999465|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
156449566|NCT04783935|564739925|FG000|Overall Study|Withdrawal by Subject|6|||
156449567|NCT04783935|564739925|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
156449568|NCT04783935|564739925|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
156449569|NCT04783935|564739925|FG000|Overall Study|Lost to Follow-up|3|||
156449570|NCT04783935|564739925|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
156449571|NCT00920621|564739929|FG000|Overall Study|Lost to Follow-up|16|||
156449572|NCT00920621|564739930|FG001|Overall Study|Lost to Follow-up|17|||
156449573|NCT00920621|564739931|FG002|Overall Study|Lost to Follow-up|19|||
156449574|NCT00920621|564739932|FG003|Overall Study|Lost to Follow-up|21|||
156449575|NCT00920621|564739929|FG000|Overall Study|Fetal/neonatal deaths|16|||
156449576|NCT00920621|564739930|FG001|Overall Study|Fetal/neonatal deaths|14|||
156449577|NCT00920621|564739931|FG002|Overall Study|Fetal/neonatal deaths|16|||
156449578|NCT00920621|564739932|FG003|Overall Study|Fetal/neonatal deaths|14|||
156449579|NCT00920621|564739929|FG000|Overall Study|Blood sample not collected|22|||
156449580|NCT00920621|564739930|FG001|Overall Study|Blood sample not collected|14|||
156449581|NCT00920621|564739931|FG002|Overall Study|Blood sample not collected|0|||
156449582|NCT00920621|564739932|FG003|Overall Study|Blood sample not collected|0|||
156449583|NCT06074523|564739933|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
156449584|NCT06074523|564739933|FG000|Overall Study|Withdrawal by Subject|1|||
156449585|NCT01426425|564739934|FG000|Overall Study|Exited prior to EP study|22|||
156449586|NCT01426425|564739934|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
156449587|NCT01426425|564739934|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
156449588|NCT00961571|564739935|FG000|Overall Study|Physician Decision|39|||
156449589|NCT04382404|564739937|FG000|Overall Study|Adverse Event|1|||
156449590|NCT04382404|564739937|FG000|Overall Study|Lost to Follow-up|2|||
156449591|NCT05687916|564739938|FG000|Overall Study|Adverse Event|1|||
156449592|NCT05687916|564739939|FG001|Overall Study|Adverse Event|2|||
156449593|NCT05687916|564739940|FG002|Overall Study|Adverse Event|0|||
156449594|NCT05687916|564739938|FG000|Overall Study|Withdrawal by Subject|1|||
156449595|NCT05687916|564739939|FG001|Overall Study|Withdrawal by Subject|0|||
156449596|NCT05687916|564739940|FG002|Overall Study|Withdrawal by Subject|1|||
156449597|NCT05687916|564739938|FG000|Overall Study|Protocol Violation|0|||
156449598|NCT05687916|564739939|FG001|Overall Study|Protocol Violation|2|||
156449599|NCT05687916|564739940|FG002|Overall Study|Protocol Violation|1|||
156449600|NCT05687916|564739938|FG000|Overall Study|Reason not Specified|1|||
156533387|NCT02383589|565046967|FG001|Treatment Period|Lost to Follow-up|1|||
156533388|NCT02383589|565046966|FG000|Treatment Period|Withdrawal by Subject|0|||
156793902|NCT00266032|565999466|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
156793903|NCT00814983|565999469|FG000|Overall Study|Screen failure|1|||
156793904|NCT00814983|565999470|FG001|Overall Study|Screen failure|0|||
156793905|NCT00814983|565999469|FG000|Overall Study|Withdrawal by Subject|1|||
156793906|NCT00814983|565999470|FG001|Overall Study|Withdrawal by Subject|0|||
156793907|NCT00814983|565999469|FG000|Overall Study|Graft failure|1|||
156793908|NCT00814983|565999470|FG001|Overall Study|Graft failure|0|||
156793909|NCT01229111|565999471|FG000|Overall Study|Death|1|||
156793910|NCT04102514|565999472|FG000|Overall Study|Death|3|||
156793911|NCT04102514|565999473|FG001|Overall Study|Death|0|||
156793912|NCT04102514|565999474|FG002|Overall Study|Death|0|||
156793913|NCT04102514|565999475|FG003|Overall Study|Death|0|||
156793914|NCT04102514|565999472|FG000|Overall Study|Lost to Follow-up|0|||
156793915|NCT04102514|565999473|FG001|Overall Study|Lost to Follow-up|0|||
156793916|NCT04102514|565999474|FG002|Overall Study|Lost to Follow-up|3|||
156793917|NCT04102514|565999475|FG003|Overall Study|Lost to Follow-up|0|||
156793918|NCT04102514|565999472|FG000|Overall Study|Physician Decision|0|||
156793919|NCT04102514|565999473|FG001|Overall Study|Physician Decision|0|||
156793920|NCT04102514|565999474|FG002|Overall Study|Physician Decision|1|||
156793921|NCT04102514|565999475|FG003|Overall Study|Physician Decision|0|||
156793922|NCT04102514|565999472|FG000|Overall Study|Withdrawal by Subject|7|||
156793923|NCT04102514|565999473|FG001|Overall Study|Withdrawal by Subject|13|||
156793924|NCT04102514|565999474|FG002|Overall Study|Withdrawal by Subject|7|||
156793925|NCT04102514|565999475|FG003|Overall Study|Withdrawal by Subject|14|||
156793926|NCT04102514|565999472|FG000|Overall Study|Moved to longterm care facility|6|||
156793927|NCT04102514|565999473|FG001|Overall Study|Moved to longterm care facility|0|||
156793928|NCT04102514|565999474|FG002|Overall Study|Moved to longterm care facility|4|||
156793929|NCT04102514|565999475|FG003|Overall Study|Moved to longterm care facility|0|||
156335145|NCT00400764|564324536|FG000|Phase II|Death|0|||
156335146|NCT00400764|564324537|FG001|Phase II|Death|0|||
156335147|NCT00400764|564324538|FG002|Phase II|Death|1|||
156335148|NCT00400764|564324539|FG003|Phase II|Death|2|||
156335149|NCT00400764|564324540|FG004|Phase II|Death|0|||
156335150|NCT00400764|564324536|FG000|Phase II|Lost to Follow-up|0|||
156335151|NCT00400764|564324537|FG001|Phase II|Lost to Follow-up|0|||
156335152|NCT00400764|564324538|FG002|Phase II|Lost to Follow-up|1|||
156335153|NCT00400764|564324539|FG003|Phase II|Lost to Follow-up|0|||
156335154|NCT00400764|564324540|FG004|Phase II|Lost to Follow-up|0|||
156335155|NCT00400764|564324536|FG000|Phase II|Physician Decision|0|||
156335156|NCT00400764|564324537|FG001|Phase II|Physician Decision|0|||
156335157|NCT00400764|564324538|FG002|Phase II|Physician Decision|1|||
156335158|NCT00400764|564324539|FG003|Phase II|Physician Decision|1|||
156335159|NCT00400764|564324540|FG004|Phase II|Physician Decision|0|||
156335160|NCT00400764|564324536|FG000|Phase II|Sponsor's decision to terminate|0|||
156335161|NCT00400764|564324537|FG001|Phase II|Sponsor's decision to terminate|0|||
156335162|NCT00400764|564324538|FG002|Phase II|Sponsor's decision to terminate|18|||
156335163|NCT00400764|564324539|FG003|Phase II|Sponsor's decision to terminate|22|||
156335164|NCT00400764|564324540|FG004|Phase II|Sponsor's decision to terminate|11|||
156335165|NCT00400764|564324536|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
156335166|NCT00400764|564324537|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
156335167|NCT00400764|564324538|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
156793930|NCT02096354|565999488|FG000|Overall Study|Physician Decision|4|||
156793931|NCT02096354|565999489|FG001|Overall Study|Physician Decision|5|||
156793932|NCT02096354|565999490|FG002|Overall Study|Physician Decision|0|||
156793933|NCT02096354|565999488|FG000|Overall Study|Withdrawal by Subject|3|||
156793934|NCT02096354|565999489|FG001|Overall Study|Withdrawal by Subject|1|||
156793935|NCT02096354|565999490|FG002|Overall Study|Withdrawal by Subject|0|||
156875354|NCT04896086|566302025|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
156875355|NCT02249832|566302028|FG000|Overall Study|Withdrawal by Subject|3|||
156875356|NCT02249832|566302028|FG000|Overall Study|Lost to Follow-up|10|||
156875357|NCT02078960|566302031|FG000|Treatment Period|Other|0|||
156875358|NCT02078960|566302032|FG001|Treatment Period|Other|0|||
156875359|NCT02078960|566302033|FG002|Treatment Period|Other|1|||
156875360|NCT02078960|566302031|FG000|Treatment Period|Lack of Efficacy|0|||
156875361|NCT02078960|566302032|FG001|Treatment Period|Lack of Efficacy|1|||
156875362|NCT02078960|566302033|FG002|Treatment Period|Lack of Efficacy|0|||
156875363|NCT02078960|566302031|FG000|Treatment Period|Disease progression - accelerated phase|0|||
156875364|NCT02078960|566302032|FG001|Treatment Period|Disease progression - accelerated phase|1|||
156875365|NCT02078960|566302033|FG002|Treatment Period|Disease progression - accelerated phase|0|||
156875366|NCT02078960|566302031|FG000|Treatment Period|Disease progression - blast phase|1|||
156875367|NCT02078960|566302032|FG001|Treatment Period|Disease progression - blast phase|0|||
156875368|NCT02078960|566302033|FG002|Treatment Period|Disease progression - blast phase|0|||
156875369|NCT02078960|566302031|FG000|Treatment Period|Withdrawal by Subject|0|||
156449601|NCT05687916|564739939|FG001|Overall Study|Reason not Specified|0|||
156449602|NCT05687916|564739940|FG002|Overall Study|Reason not Specified|0|||
156449603|NCT03332017|564739941|FG000|Overall Study|Lost to Follow-up|1|||
156449604|NCT03332017|564739942|FG001|Overall Study|Lost to Follow-up|2|||
156449605|NCT03332017|564739941|FG000|Overall Study|Death|17|||
156449606|NCT03332017|564739942|FG001|Overall Study|Death|16|||
156449607|NCT03332017|564739941|FG000|Overall Study|Withdrawal by Subject|6|||
156449608|NCT03332017|564739942|FG001|Overall Study|Withdrawal by Subject|14|||
156793936|NCT02096354|565999488|FG000|Overall Study|Adverse Event|7|||
156793937|NCT02096354|565999489|FG001|Overall Study|Adverse Event|4|||
156793938|NCT02096354|565999490|FG002|Overall Study|Adverse Event|0|||
156793939|NCT02096354|565999488|FG000|Overall Study|Ineligible|0|||
156793940|NCT02096354|565999489|FG001|Overall Study|Ineligible|0|||
156793941|NCT02096354|565999490|FG002|Overall Study|Ineligible|11|||
156793942|NCT02951819|565999491|FG000|Overall Study|Death|9|||
156793943|NCT02951819|565999492|FG001|Overall Study|Death|7|||
156793944|NCT02951819|565999491|FG000|Overall Study|Withdrawal by Subject|3|||
156793945|NCT02951819|565999492|FG001|Overall Study|Withdrawal by Subject|0|||
156793946|NCT02951819|565999491|FG000|Overall Study|Adverse Event|1|||
156793947|NCT02951819|565999492|FG001|Overall Study|Adverse Event|0|||
156793948|NCT02951819|565999491|FG000|Overall Study|Lack of Efficacy|4|||
156793949|NCT02951819|565999492|FG001|Overall Study|Lack of Efficacy|0|||
156793950|NCT02951819|565999491|FG000|Overall Study|Lost to Follow-up|1|||
156793951|NCT02951819|565999492|FG001|Overall Study|Lost to Follow-up|0|||
156793952|NCT02951819|565999491|FG000|Overall Study|Progressive Disease|1|||
156793953|NCT02951819|565999492|FG001|Overall Study|Progressive Disease|0|||
156793954|NCT02951819|565999491|FG000|Overall Study|Other|9|||
156793955|NCT02951819|565999492|FG001|Overall Study|Other|0|||
156793956|NCT03715829|565999493|FG000|Dose Ranging Period|Adverse Event|2|||
156793957|NCT03715829|565999494|FG001|Dose Ranging Period|Adverse Event|4|||
156793958|NCT03715829|565999495|FG002|Dose Ranging Period|Adverse Event|5|||
156793959|NCT03715829|565999496|FG003|Dose Ranging Period|Adverse Event|2|||
156793960|NCT03715829|565999497|FG004|Dose Ranging Period|Adverse Event|3|||
156793961|NCT03715829|565999498|FG005|Dose Ranging Period|Adverse Event|3|||
156793962|NCT03715829|565999499|FG006|Dose Ranging Period|Adverse Event|0|||
156793963|NCT03715829|565999500|FG007|Dose Ranging Period|Adverse Event|0|||
156793964|NCT03715829|565999501|FG008|Dose Ranging Period|Adverse Event|0|||
156793965|NCT03715829|565999502|FG009|Dose Ranging Period|Adverse Event|0|||
156793966|NCT03715829|565999503|FG010|Dose Ranging Period|Adverse Event|0|||
156793967|NCT03715829|565999493|FG000|Dose Ranging Period|Lack of Efficacy|0|||
156793968|NCT03715829|565999494|FG001|Dose Ranging Period|Lack of Efficacy|1|||
156793969|NCT03715829|565999495|FG002|Dose Ranging Period|Lack of Efficacy|0|||
156793970|NCT03715829|565999496|FG003|Dose Ranging Period|Lack of Efficacy|1|||
156793971|NCT03715829|565999497|FG004|Dose Ranging Period|Lack of Efficacy|0|||
156449609|NCT03332017|564739941|FG000|Overall Study|Other|1|||
156793972|NCT03715829|565999498|FG005|Dose Ranging Period|Lack of Efficacy|0|||
156793973|NCT03715829|565999499|FG006|Dose Ranging Period|Lack of Efficacy|0|||
156793974|NCT03715829|565999500|FG007|Dose Ranging Period|Lack of Efficacy|0|||
156793975|NCT03715829|565999501|FG008|Dose Ranging Period|Lack of Efficacy|0|||
156793976|NCT03715829|565999502|FG009|Dose Ranging Period|Lack of Efficacy|0|||
156793977|NCT03715829|565999503|FG010|Dose Ranging Period|Lack of Efficacy|0|||
156793978|NCT03715829|565999493|FG000|Dose Ranging Period|Lost to Follow-up|2|||
156793979|NCT03715829|565999494|FG001|Dose Ranging Period|Lost to Follow-up|0|||
156875370|NCT02078960|566302032|FG001|Treatment Period|Withdrawal by Subject|1|||
156449610|NCT03332017|564739942|FG001|Overall Study|Other|3|||
156449611|NCT03332017|564739941|FG000|Overall Study|Remained in Study (Ongoing)|47|||
156449612|NCT03332017|564739942|FG001|Overall Study|Remained in Study (Ongoing)|110|||
156449613|NCT01261312|564739943|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
156449614|NCT01261312|564739944|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
156449615|NCT01261312|564739945|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
156449616|NCT01261312|564739946|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449617|NCT01261312|564739947|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449618|NCT01261312|564739948|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449619|NCT01261312|564739949|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449620|NCT01261312|564739950|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449621|NCT01261312|564739951|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449622|NCT01261312|564739952|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449623|NCT01261312|564739953|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449624|NCT01261312|564739954|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449625|NCT01261312|564739955|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156449626|NCT01261312|564739943|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
156449627|NCT01261312|564739944|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
156449628|NCT01261312|564739945|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449629|NCT01261312|564739946|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449630|NCT01261312|564739947|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449631|NCT01261312|564739948|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449632|NCT01261312|564739949|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449633|NCT01261312|564739950|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449634|NCT01261312|564739951|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449635|NCT01261312|564739952|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449636|NCT01261312|564739953|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156335168|NCT00400764|564324539|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
156335169|NCT00400764|564324540|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
156335170|NCT00400764|564324536|FG000|Phase II|Withdrawal by Subject|0|||
156335171|NCT00400764|564324537|FG001|Phase II|Withdrawal by Subject|0|||
156335172|NCT00400764|564324538|FG002|Phase II|Withdrawal by Subject|1|||
156335173|NCT00400764|564324539|FG003|Phase II|Withdrawal by Subject|1|||
156335174|NCT00400764|564324540|FG004|Phase II|Withdrawal by Subject|0|||
156335175|NCT02020577|564324541|FG000|Overall Study|Progressive disease|3|||
156335176|NCT02020577|564324542|FG001|Overall Study|Progressive disease|38|||
156335177|NCT02020577|564324541|FG000|Overall Study|Other AE or clinical progression|0|||
156335178|NCT02020577|564324542|FG001|Overall Study|Other AE or clinical progression|15|||
156335179|NCT02020577|564324541|FG000|Overall Study|Withdrawal by Subject|0|||
156335180|NCT02020577|564324542|FG001|Overall Study|Withdrawal by Subject|1|||
156335181|NCT02020577|564324541|FG000|Overall Study|Other than stated above|0|||
156335182|NCT02020577|564324542|FG001|Overall Study|Other than stated above|1|||
156335183|NCT01893203|564324545|FG000|Overall Study|Withdrawal by Subject|1|||
156335184|NCT01758523|564324546|FG000|Overall Study|Adverse Event|2|||
156335185|NCT01758523|564324547|FG001|Overall Study|Adverse Event|1|||
156335186|NCT01758523|564324546|FG000|Overall Study|Lack of Efficacy|4|||
156335187|NCT01758523|564324547|FG001|Overall Study|Lack of Efficacy|2|||
156335188|NCT01758523|564324546|FG000|Overall Study|Lost to Follow-up|3|||
156335189|NCT01758523|564324547|FG001|Overall Study|Lost to Follow-up|4|||
156335190|NCT01758523|564324546|FG000|Overall Study|Withdrawal by Subject|12|||
156335191|NCT01758523|564324547|FG001|Overall Study|Withdrawal by Subject|7|||
156335192|NCT00722800|564324548|FG000|Overall Study|Withdrawal by Subject|1|||
156335193|NCT00722800|564324549|FG001|Overall Study|Withdrawal by Subject|0|||
156335194|NCT00722800|564324548|FG000|Overall Study|Physician Decision|1|||
156335195|NCT00722800|564324549|FG001|Overall Study|Physician Decision|0|||
156335196|NCT04729621|564324550|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
156335197|NCT04729621|564324551|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
156335198|NCT04729621|564324552|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
156335199|NCT04729621|564324553|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
156335200|NCT04729621|564324554|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
156335201|NCT04729621|564324550|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
156335202|NCT04729621|564324551|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
156335203|NCT04729621|564324552|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
156335204|NCT04729621|564324553|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
156335205|NCT04729621|564324554|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
156335206|NCT04729621|564324550|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
156335207|NCT04729621|564324551|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
156335208|NCT04729621|564324552|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
156335209|NCT04729621|564324553|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
156449637|NCT01261312|564739954|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449638|NCT01261312|564739955|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156449639|NCT01261312|564739943|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
156449640|NCT01261312|564739944|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
156449641|NCT01261312|564739945|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449642|NCT01261312|564739946|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449643|NCT01261312|564739947|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449644|NCT01261312|564739948|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449645|NCT01261312|564739949|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449646|NCT01261312|564739950|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449647|NCT01261312|564739951|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449648|NCT01261312|564739952|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449649|NCT01261312|564739953|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449650|NCT01261312|564739954|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449651|NCT01261312|564739955|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
156449652|NCT01261312|564739943|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
156449653|NCT01261312|564739944|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
156449654|NCT01261312|564739945|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449655|NCT01261312|564739946|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449656|NCT01261312|564739947|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449657|NCT01261312|564739948|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449658|NCT01261312|564739949|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449659|NCT01261312|564739950|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449660|NCT01261312|564739951|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449661|NCT01261312|564739952|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449662|NCT01261312|564739953|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449663|NCT01261312|564739954|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449664|NCT01261312|564739955|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156449665|NCT01261312|564739943|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
156449666|NCT01261312|564739944|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
156449667|NCT01261312|564739945|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
156449668|NCT01261312|564739946|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449669|NCT01261312|564739947|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449670|NCT01261312|564739948|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449671|NCT01261312|564739949|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449672|NCT01261312|564739950|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449673|NCT01261312|564739951|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449674|NCT01261312|564739952|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449675|NCT01261312|564739953|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449676|NCT01261312|564739954|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449677|NCT01261312|564739955|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
156449678|NCT01261312|564739943|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
156449679|NCT01261312|564739944|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
156449680|NCT01261312|564739945|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
156449681|NCT01261312|564739946|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449682|NCT01261312|564739947|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449683|NCT01261312|564739948|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449684|NCT01261312|564739949|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449685|NCT01261312|564739950|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156720675|NCT02547428|565723745|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
156720676|NCT02547428|565723746|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
156720677|NCT02547428|565723745|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
156720678|NCT02547428|565723746|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
156720679|NCT02547428|565723745|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
156720680|NCT02547428|565723746|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
156720681|NCT03318861|565723747|FG000|Overall Study|Death|2|||
156720682|NCT03318861|565723748|FG001|Overall Study|Death|3|||
156720683|NCT03318861|565723749|FG002|Overall Study|Death|3|||
156720684|NCT03318861|565723750|FG003|Overall Study|Death|2|||
156720685|NCT03318861|565723751|FG004|Overall Study|Death|2|||
156720686|NCT03318861|565723747|FG000|Overall Study|Enrolled But Never Treated|0|||
156720687|NCT03318861|565723748|FG001|Overall Study|Enrolled But Never Treated|1|||
156720688|NCT03318861|565723749|FG002|Overall Study|Enrolled But Never Treated|0|||
156720689|NCT03318861|565723750|FG003|Overall Study|Enrolled But Never Treated|1|||
156720690|NCT03318861|565723751|FG004|Overall Study|Enrolled But Never Treated|1|||
156449686|NCT01261312|564739951|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449687|NCT01261312|564739952|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449688|NCT01261312|564739953|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449689|NCT01261312|564739954|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449690|NCT01261312|564739955|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
156449691|NCT01261312|564739943|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
156449692|NCT01261312|564739944|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449693|NCT01261312|564739945|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
156449694|NCT01261312|564739946|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449695|NCT01261312|564739947|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449696|NCT01261312|564739948|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449697|NCT01261312|564739949|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449698|NCT01261312|564739950|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449699|NCT01261312|564739951|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449700|NCT01261312|564739952|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156720691|NCT03318861|565723747|FG000|Overall Study|Informed Consent Withdraw|0|||
156720692|NCT03318861|565723748|FG001|Overall Study|Informed Consent Withdraw|0|||
156720693|NCT03318861|565723749|FG002|Overall Study|Informed Consent Withdraw|0|||
156720694|NCT03318861|565723750|FG003|Overall Study|Informed Consent Withdraw|1|||
156720695|NCT03318861|565723751|FG004|Overall Study|Informed Consent Withdraw|0|||
156720696|NCT03318861|565723747|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
156720697|NCT03318861|565723748|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
156720698|NCT03318861|565723749|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
156720699|NCT03318861|565723750|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
156720700|NCT03318861|565723751|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
156720701|NCT00917852|565723752|FG000|Overall Study|Death|6|||
156720702|NCT03499067|565723753|FG000|First Intervention|Physician Decision|2|||
156720703|NCT03499067|565723754|FG001|First Intervention|Physician Decision|1|||
156720704|NCT03499067|565723753|FG000|First Intervention|Withdrawal by Subject|3|||
156720705|NCT03499067|565723754|FG001|First Intervention|Withdrawal by Subject|6|||
156720706|NCT02392481|565723755|FG000|Overall Study|Adverse Event|0|||
156720707|NCT02392481|565723756|FG001|Overall Study|Adverse Event|0|||
156720708|NCT02392481|565723757|FG002|Overall Study|Adverse Event|1|||
156720709|NCT02392481|565723758|FG003|Overall Study|Adverse Event|2|||
156720710|NCT02392481|565723755|FG000|Overall Study|Withdrawal by Subject|0|||
156720711|NCT02392481|565723756|FG001|Overall Study|Withdrawal by Subject|0|||
156449701|NCT01261312|564739953|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449702|NCT01261312|564739954|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449703|NCT01261312|564739955|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
156449704|NCT01261312|564739943|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449705|NCT01261312|564739944|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449706|NCT01261312|564739945|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449707|NCT01261312|564739946|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
156449708|NCT01261312|564739947|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
156449709|NCT01261312|564739948|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
156449710|NCT01261312|564739949|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449711|NCT01261312|564739950|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449712|NCT01261312|564739951|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449713|NCT01261312|564739952|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449714|NCT01261312|564739953|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449715|NCT01261312|564739954|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449716|NCT01261312|564739955|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
156449717|NCT01261312|564739943|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449718|NCT01261312|564739944|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449719|NCT01261312|564739945|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449720|NCT01261312|564739946|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449721|NCT01261312|564739947|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
156533389|NCT02383589|565046967|FG001|Treatment Period|Withdrawal by Subject|5|||
156533390|NCT02383589|565046966|FG000|Treatment Period|Non-compliance with study drug|0|||
156720712|NCT02392481|565723757|FG002|Overall Study|Withdrawal by Subject|1|||
156720713|NCT02392481|565723758|FG003|Overall Study|Withdrawal by Subject|0|||
156533391|NCT02383589|565046967|FG001|Treatment Period|Non-compliance with study drug|1|||
156720714|NCT02502149|565723759|FG000|Intermediate|Discontinued prematurely|1|||
156720715|NCT02502149|565723760|FG001|Intermediate|Discontinued prematurely|0|||
156720716|NCT02502149|565723761|FG002|Intermediate|Discontinued prematurely|0|||
156720717|NCT02502149|565723762|FG003|Intermediate|Discontinued prematurely|0|||
156533392|NCT02383589|565046966|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
156449722|NCT01261312|564739948|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
156449723|NCT01261312|564739949|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449724|NCT01261312|564739950|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449725|NCT01261312|564739951|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449726|NCT01261312|564739952|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449727|NCT01261312|564739953|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449728|NCT01261312|564739954|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449729|NCT01261312|564739955|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
156449730|NCT01261312|564739943|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449731|NCT01261312|564739944|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449732|NCT01261312|564739945|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449733|NCT01261312|564739946|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449734|NCT01261312|564739947|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
156449735|NCT01261312|564739948|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
156449736|NCT01261312|564739949|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449737|NCT01261312|564739950|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449738|NCT01261312|564739951|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449739|NCT01261312|564739952|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449740|NCT01261312|564739953|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449741|NCT01261312|564739954|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449742|NCT01261312|564739955|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
156449743|NCT01261312|564739943|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449744|NCT01261312|564739944|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449745|NCT01261312|564739945|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449746|NCT01261312|564739946|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
156449747|NCT01261312|564739947|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
156449748|NCT01261312|564739948|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
156449749|NCT01261312|564739949|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449750|NCT01261312|564739950|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449751|NCT01261312|564739951|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449752|NCT01261312|564739952|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449753|NCT01261312|564739953|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449754|NCT01261312|564739954|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449755|NCT01261312|564739955|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
156449756|NCT01261312|564739943|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156720718|NCT02502149|565723763|FG004|Intermediate|Discontinued prematurely|0|||
156720719|NCT02548832|565723764|FG000|Overall Study|Lost to Follow-up|2|||
156720720|NCT02548832|565723765|FG001|Overall Study|Lost to Follow-up|2|||
156720721|NCT02548832|565723766|FG002|Overall Study|Lost to Follow-up|2|||
156720722|NCT02383017|565723770|FG000|Overall Study|Injury Sustained Outside Study|1|||
156720723|NCT02383017|565723771|FG001|Overall Study|Injury Sustained Outside Study|0|||
156720724|NCT02383017|565723770|FG000|Overall Study|Compliance|3|||
156449757|NCT01261312|564739944|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449758|NCT01261312|564739945|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449759|NCT01261312|564739946|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449760|NCT01261312|564739947|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449761|NCT01261312|564739948|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
156449762|NCT01261312|564739949|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449763|NCT01261312|564739950|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449764|NCT01261312|564739951|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449765|NCT01261312|564739952|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449766|NCT01261312|564739953|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156793980|NCT03715829|565999495|FG002|Dose Ranging Period|Lost to Follow-up|1|||
156720725|NCT02383017|565723771|FG001|Overall Study|Compliance|2|||
156449767|NCT01261312|564739954|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449768|NCT01261312|564739955|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156449769|NCT01261312|564739943|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156449770|NCT01261312|564739944|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156449771|NCT01261312|564739945|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156449772|NCT01261312|564739946|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
156449773|NCT01261312|564739947|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
156449774|NCT01261312|564739948|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
156449775|NCT01261312|564739949|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156720726|NCT02383017|565723770|FG000|Overall Study|Found to be Hypogonadal|1|||
156449776|NCT01261312|564739950|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156449777|NCT01261312|564739951|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156449778|NCT01261312|564739952|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156449779|NCT01261312|564739953|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156720727|NCT02383017|565723771|FG001|Overall Study|Found to be Hypogonadal|0|||
156720728|NCT02088177|565723778|FG000|Overall Study|Lost to Follow-up|3|||
156720729|NCT01234350|565723780|FG000|Overall Study|Adverse Event|277|||
156720730|NCT01234350|565723781|FG001|Overall Study|Adverse Event|92|||
156720731|NCT01234350|565723780|FG000|Overall Study|Withdrawal by Subject|61|||
156720732|NCT01234350|565723781|FG001|Overall Study|Withdrawal by Subject|36|||
156720733|NCT01234350|565723780|FG000|Overall Study|Lost to Follow-up|115|||
156720734|NCT01234350|565723781|FG001|Overall Study|Lost to Follow-up|47|||
156720735|NCT01234350|565723780|FG000|Overall Study|Covers a diverse set of reasons|234|||
156720736|NCT01234350|565723781|FG001|Overall Study|Covers a diverse set of reasons|92|||
156720737|NCT00289848|565723782|FG000|Overall Study|Adverse Event|6|||
156720738|NCT00289848|565723783|FG001|Overall Study|Adverse Event|4|||
156875371|NCT02078960|566302033|FG002|Treatment Period|Withdrawal by Subject|1|||
156720739|NCT00289848|565723782|FG000|Overall Study|Death|1|||
156720740|NCT00289848|565723783|FG001|Overall Study|Death|0|||
156720741|NCT00289848|565723782|FG000|Overall Study|Lack of Efficacy|20|||
156720742|NCT00289848|565723783|FG001|Overall Study|Lack of Efficacy|24|||
156720743|NCT00289848|565723782|FG000|Overall Study|Lost to Follow-up|3|||
156720744|NCT00289848|565723783|FG001|Overall Study|Lost to Follow-up|1|||
156720745|NCT00289848|565723782|FG000|Overall Study|Protocol Violation|5|||
156720746|NCT00289848|565723783|FG001|Overall Study|Protocol Violation|2|||
156720747|NCT00289848|565723782|FG000|Overall Study|Withdrawal by Subject|5|||
156720748|NCT00289848|565723783|FG001|Overall Study|Withdrawal by Subject|11|||
156720749|NCT00289848|565723782|FG000|Overall Study|Patient Moved|6|||
156720750|NCT00289848|565723783|FG001|Overall Study|Patient Moved|2|||
156720751|NCT00289848|565723782|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
156720752|NCT00289848|565723783|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
156720753|NCT01433471|565723784|FG000|Overall Study|Withdrawal by Subject|0|||
156720754|NCT01433471|565723785|FG001|Overall Study|Withdrawal by Subject|1|||
156720755|NCT03711188|565723786|FG000|Overall Study|Disease progression|11|||
156720756|NCT03711188|565723786|FG000|Overall Study|Adverse Event|1|||
156720757|NCT00063934|565723791|FG000|Overall Study|Ineligible|1|||
156720758|NCT00395629|565723792|FG000|Core Study|Adverse Event|0|||
156720759|NCT00395629|565723793|FG001|Core Study|Adverse Event|3|||
156720760|NCT00395629|565723794|FG002|Core Study|Adverse Event|4|||
156720761|NCT00395629|565723792|FG000|Core Study|Abnormal laboratory value(s)|0|||
156720762|NCT00395629|565723793|FG001|Core Study|Abnormal laboratory value(s)|0|||
156720763|NCT00395629|565723794|FG002|Core Study|Abnormal laboratory value(s)|1|||
156875372|NCT02078960|566302031|FG000|Treatment Period|Adverse Event|1|||
156875373|NCT02078960|566302032|FG001|Treatment Period|Adverse Event|0|||
156875374|NCT02078960|566302033|FG002|Treatment Period|Adverse Event|0|||
156875375|NCT02078960|566302031|FG000|Treatment Period|Death|0|||
156875376|NCT02078960|566302032|FG001|Treatment Period|Death|0|||
156875377|NCT02078960|566302033|FG002|Treatment Period|Death|1|||
156875378|NCT02078960|566302031|FG000|Follow-up Period|Death|2|||
156875379|NCT02078960|566302032|FG001|Follow-up Period|Death|0|||
156875380|NCT02078960|566302033|FG002|Follow-up Period|Death|0|||
156875381|NCT02078960|566302031|FG000|Follow-up Period|Lost to Follow-up|0|||
156875382|NCT02078960|566302032|FG001|Follow-up Period|Lost to Follow-up|1|||
156875383|NCT02078960|566302033|FG002|Follow-up Period|Lost to Follow-up|0|||
156875384|NCT00859638|566302034|FG000|Overall Study|Lost to Follow-up|6|||
156875385|NCT00859638|566302035|FG001|Overall Study|Lost to Follow-up|1|||
156875386|NCT00859638|566302034|FG000|Overall Study|Withdrawal by Subject|3|||
156875387|NCT00859638|566302035|FG001|Overall Study|Withdrawal by Subject|2|||
156875388|NCT00859638|566302034|FG000|Overall Study|Ill health|1|||
156875389|NCT00859638|566302035|FG001|Overall Study|Ill health|1|||
156875390|NCT04643158|566302039|FG000|Overall Study|Study terminated by sponsor|0|||
156875391|NCT04643158|566302040|FG001|Overall Study|Study terminated by sponsor|0|||
156875392|NCT04643158|566302041|FG002|Overall Study|Study terminated by sponsor|1|||
156335210|NCT04729621|564324554|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
156335211|NCT04729621|564324550|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156335212|NCT04729621|564324551|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156335213|NCT04729621|564324552|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
156335214|NCT04729621|564324553|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
156335215|NCT04729621|564324554|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
156335216|NCT04729621|564324550|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
156335217|NCT04729621|564324551|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
156335218|NCT04729621|564324552|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
156335219|NCT04729621|564324553|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
156335220|NCT04729621|564324554|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
156335221|NCT04729621|564324550|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
156335222|NCT04729621|564324551|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
156335223|NCT04729621|564324552|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
156335224|NCT04729621|564324553|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
156335225|NCT04729621|564324554|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
156335226|NCT01788228|564324555|FG000|Overall Study|Migrated/moved from study area|1|||
156335227|NCT01788228|564324556|FG001|Overall Study|Migrated/moved from study area|0|||
156335228|NCT03113071|564324557|FG000|Overall Study|Withdrawal by Subject|1|||
156449780|NCT01261312|564739954|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156449781|NCT01261312|564739955|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
156720764|NCT00395629|565723792|FG000|Core Study|Protocol Violation|1|||
156720765|NCT00395629|565723793|FG001|Core Study|Protocol Violation|0|||
156720766|NCT00395629|565723794|FG002|Core Study|Protocol Violation|0|||
156720767|NCT00395629|565723792|FG000|Core Study|Withdrawal by Subject|0|||
156720768|NCT00395629|565723793|FG001|Core Study|Withdrawal by Subject|1|||
156720769|NCT00395629|565723794|FG002|Core Study|Withdrawal by Subject|1|||
156720770|NCT00395629|565723792|FG000|Core Study|Lost to Follow-up|0|||
156720771|NCT00395629|565723793|FG001|Core Study|Lost to Follow-up|0|||
156720772|NCT00395629|565723794|FG002|Core Study|Lost to Follow-up|1|||
156720773|NCT00395629|565723792|FG000|Extension Study|Adverse Event|0|||
156720774|NCT00395629|565723793|FG001|Extension Study|Adverse Event|0|||
156720775|NCT00395629|565723794|FG002|Extension Study|Adverse Event|2|||
156720776|NCT00395629|565723792|FG000|Extension Study|Administrative problems|0|||
156720777|NCT00395629|565723793|FG001|Extension Study|Administrative problems|0|||
156720778|NCT00395629|565723794|FG002|Extension Study|Administrative problems|1|||
156720779|NCT03428152|565723795|FG000|Overall Study|Physician Decision|4|||
156720780|NCT03428152|565723796|FG001|Overall Study|Physician Decision|2|||
156720781|NCT03428152|565723795|FG000|Overall Study|Protocol Violation|3|||
156720782|NCT03428152|565723796|FG001|Overall Study|Protocol Violation|5|||
156720783|NCT03428152|565723795|FG000|Overall Study|Lack of Efficacy|0|||
156720784|NCT03428152|565723796|FG001|Overall Study|Lack of Efficacy|4|||
156720785|NCT01686373|565723797|FG000|Overall Study|Lost to Follow-up|3|||
156720786|NCT01686373|565723798|FG001|Overall Study|Lost to Follow-up|0|||
156720787|NCT01686373|565723797|FG000|Overall Study|Withdrawal by Subject|0|||
156720788|NCT01686373|565723798|FG001|Overall Study|Withdrawal by Subject|1|||
156720789|NCT01686373|565723797|FG000|Overall Study|Adverse Event|0|||
156720790|NCT01686373|565723798|FG001|Overall Study|Adverse Event|1|||
156720791|NCT01836471|565723805|FG000|Overall Study|Pregnancy|1|||
156720792|NCT01836471|565723806|FG001|Overall Study|Pregnancy|0|||
156720793|NCT01836471|565723807|FG002|Overall Study|Pregnancy|0|||
156720794|NCT01836471|565723808|FG003|Overall Study|Pregnancy|0|||
156720795|NCT01836471|565723809|FG004|Overall Study|Pregnancy|0|||
156720796|NCT01836471|565723805|FG000|Overall Study|Withdrawal by Subject|3|||
156720797|NCT01836471|565723806|FG001|Overall Study|Withdrawal by Subject|4|||
156720798|NCT01836471|565723807|FG002|Overall Study|Withdrawal by Subject|1|||
156720799|NCT01836471|565723808|FG003|Overall Study|Withdrawal by Subject|0|||
156720800|NCT01836471|565723809|FG004|Overall Study|Withdrawal by Subject|2|||
156720801|NCT01836471|565723805|FG000|Overall Study|Physician Decision|0|||
156720802|NCT01836471|565723806|FG001|Overall Study|Physician Decision|1|||
156720803|NCT01836471|565723807|FG002|Overall Study|Physician Decision|0|||
156720804|NCT01836471|565723808|FG003|Overall Study|Physician Decision|0|||
156720805|NCT01836471|565723809|FG004|Overall Study|Physician Decision|0|||
156720806|NCT01836471|565723805|FG000|Overall Study|Lost to Follow-up|0|||
156720807|NCT01836471|565723806|FG001|Overall Study|Lost to Follow-up|0|||
156720808|NCT01836471|565723807|FG002|Overall Study|Lost to Follow-up|0|||
156720809|NCT01836471|565723808|FG003|Overall Study|Lost to Follow-up|1|||
156720810|NCT01836471|565723809|FG004|Overall Study|Lost to Follow-up|1|||
156449782|NCT01261312|564739943|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449783|NCT01261312|564739944|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449784|NCT01261312|564739945|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449785|NCT01261312|564739946|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
156449786|NCT01261312|564739947|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
156449787|NCT01261312|564739948|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
156449788|NCT01261312|564739949|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449789|NCT01261312|564739950|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449790|NCT01261312|564739951|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449791|NCT01261312|564739952|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449792|NCT01261312|564739953|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449793|NCT01261312|564739954|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156449794|NCT01261312|564739955|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
156533393|NCT02383589|565046967|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
156720811|NCT01836471|565723805|FG000|Overall Study|Adverse Event|6|||
156720812|NCT01836471|565723806|FG001|Overall Study|Adverse Event|3|||
156720813|NCT01836471|565723807|FG002|Overall Study|Adverse Event|1|||
156720814|NCT01836471|565723808|FG003|Overall Study|Adverse Event|1|||
156720815|NCT01836471|565723809|FG004|Overall Study|Adverse Event|2|||
156720816|NCT01836471|565723805|FG000|Overall Study|Non compliance with tx|1|||
156720817|NCT01836471|565723806|FG001|Overall Study|Non compliance with tx|1|||
156720818|NCT01836471|565723807|FG002|Overall Study|Non compliance with tx|0|||
156720819|NCT01836471|565723808|FG003|Overall Study|Non compliance with tx|0|||
156533394|NCT02383589|565046966|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
156720820|NCT01836471|565723809|FG004|Overall Study|Non compliance with tx|0|||
156720821|NCT02570308|565723815|FG000|Overall Study|Death|1|||
156720822|NCT02570308|565723816|FG001|Overall Study|Death|5|||
156720823|NCT02570308|565723817|FG002|Overall Study|Death|4|||
156793981|NCT03715829|565999496|FG003|Dose Ranging Period|Lost to Follow-up|1|||
156793982|NCT03715829|565999497|FG004|Dose Ranging Period|Lost to Follow-up|1|||
156793983|NCT03715829|565999498|FG005|Dose Ranging Period|Lost to Follow-up|2|||
156793984|NCT03715829|565999499|FG006|Dose Ranging Period|Lost to Follow-up|0|||
156793985|NCT03715829|565999500|FG007|Dose Ranging Period|Lost to Follow-up|0|||
156793986|NCT03715829|565999501|FG008|Dose Ranging Period|Lost to Follow-up|0|||
156793987|NCT03715829|565999502|FG009|Dose Ranging Period|Lost to Follow-up|0|||
156793988|NCT03715829|565999503|FG010|Dose Ranging Period|Lost to Follow-up|0|||
156793989|NCT03715829|565999493|FG000|Dose Ranging Period|Protocol Violation|0|||
156793990|NCT03715829|565999494|FG001|Dose Ranging Period|Protocol Violation|0|||
156793991|NCT03715829|565999495|FG002|Dose Ranging Period|Protocol Violation|0|||
156793992|NCT03715829|565999496|FG003|Dose Ranging Period|Protocol Violation|1|||
156793993|NCT03715829|565999497|FG004|Dose Ranging Period|Protocol Violation|0|||
156793994|NCT03715829|565999498|FG005|Dose Ranging Period|Protocol Violation|0|||
156793995|NCT03715829|565999499|FG006|Dose Ranging Period|Protocol Violation|0|||
156793996|NCT03715829|565999500|FG007|Dose Ranging Period|Protocol Violation|0|||
156793997|NCT03715829|565999501|FG008|Dose Ranging Period|Protocol Violation|0|||
156793998|NCT03715829|565999502|FG009|Dose Ranging Period|Protocol Violation|0|||
156793999|NCT03715829|565999503|FG010|Dose Ranging Period|Protocol Violation|0|||
156794000|NCT03715829|565999493|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
156794001|NCT03715829|565999494|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
156794002|NCT03715829|565999495|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
156794003|NCT03715829|565999496|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
156794004|NCT03715829|565999497|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
156794005|NCT03715829|565999498|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
156794006|NCT03715829|565999499|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
156794007|NCT03715829|565999500|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
156794008|NCT03715829|565999501|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
156794009|NCT03715829|565999502|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
156794010|NCT03715829|565999503|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
156794011|NCT03715829|565999493|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794012|NCT03715829|565999494|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794013|NCT03715829|565999495|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
156794014|NCT03715829|565999496|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794015|NCT03715829|565999497|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794016|NCT03715829|565999498|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794017|NCT03715829|565999499|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794018|NCT03715829|565999500|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794019|NCT03715829|565999501|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794020|NCT03715829|565999502|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794021|NCT03715829|565999503|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794022|NCT03715829|565999493|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794023|NCT03715829|565999494|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794024|NCT03715829|565999495|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
156794025|NCT03715829|565999496|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794026|NCT03715829|565999497|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
156794027|NCT03715829|565999498|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794028|NCT03715829|565999499|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794029|NCT03715829|565999500|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794030|NCT03715829|565999501|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794031|NCT03715829|565999502|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794032|NCT03715829|565999503|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794033|NCT03715829|565999493|FG000|Dose Ranging Period|Other|0|||
156335229|NCT03113071|564324558|FG001|Overall Study|Withdrawal by Subject|0|||
156335230|NCT00302107|564324560|FG000|Overall Study|Lost to Follow-up|6|||
156335231|NCT00302107|564324561|FG001|Overall Study|Lost to Follow-up|5|||
156335232|NCT00302107|564324560|FG000|Overall Study|Protocol Violation|1|||
156335233|NCT00302107|564324561|FG001|Overall Study|Protocol Violation|0|||
156794034|NCT03715829|565999494|FG001|Dose Ranging Period|Other|0|||
156794035|NCT03715829|565999495|FG002|Dose Ranging Period|Other|2|||
156794036|NCT03715829|565999496|FG003|Dose Ranging Period|Other|0|||
156794037|NCT03715829|565999497|FG004|Dose Ranging Period|Other|0|||
156794038|NCT03715829|565999498|FG005|Dose Ranging Period|Other|3|||
156794039|NCT03715829|565999499|FG006|Dose Ranging Period|Other|0|||
156794040|NCT03715829|565999500|FG007|Dose Ranging Period|Other|0|||
156794041|NCT03715829|565999501|FG008|Dose Ranging Period|Other|0|||
156794042|NCT03715829|565999502|FG009|Dose Ranging Period|Other|0|||
156794043|NCT03715829|565999503|FG010|Dose Ranging Period|Other|0|||
156794044|NCT03715829|565999493|FG000|Extension Period|Adverse Event|0|||
156794045|NCT03715829|565999494|FG001|Extension Period|Adverse Event|0|||
156794046|NCT03715829|565999495|FG002|Extension Period|Adverse Event|0|||
156335234|NCT00302107|564324560|FG000|Overall Study|Relocation|0|||
156449795|NCT01261312|564739943|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449796|NCT01261312|564739944|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449797|NCT01261312|564739945|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449798|NCT01261312|564739946|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449799|NCT01261312|564739947|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449800|NCT01261312|564739948|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449801|NCT01261312|564739949|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
156449802|NCT01261312|564739950|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
156449803|NCT01261312|564739951|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
156449804|NCT01261312|564739952|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449805|NCT01261312|564739953|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449806|NCT01261312|564739954|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449807|NCT01261312|564739955|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
156449808|NCT01261312|564739943|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449809|NCT01261312|564739944|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449810|NCT01261312|564739945|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449811|NCT01261312|564739946|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449812|NCT01261312|564739947|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449813|NCT01261312|564739948|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449814|NCT01261312|564739949|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449815|NCT01261312|564739950|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
156449816|NCT01261312|564739951|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
156449817|NCT01261312|564739952|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449818|NCT01261312|564739953|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449819|NCT01261312|564739954|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449820|NCT01261312|564739955|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156449821|NCT01261312|564739943|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449822|NCT01261312|564739944|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449823|NCT01261312|564739945|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449824|NCT01261312|564739946|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449825|NCT01261312|564739947|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449826|NCT01261312|564739948|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449827|NCT01261312|564739949|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
156449828|NCT01261312|564739950|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
156449829|NCT01261312|564739951|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
156449830|NCT01261312|564739952|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449831|NCT01261312|564739953|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156720824|NCT02570308|565723818|FG003|Overall Study|Death|4|||
156720825|NCT02570308|565723819|FG004|Overall Study|Death|69|||
156720826|NCT02570308|565723815|FG000|Overall Study|Lost to Follow-up|0|||
156720827|NCT02570308|565723816|FG001|Overall Study|Lost to Follow-up|0|||
156720828|NCT02570308|565723817|FG002|Overall Study|Lost to Follow-up|0|||
156720829|NCT02570308|565723818|FG003|Overall Study|Lost to Follow-up|0|||
156720830|NCT02570308|565723819|FG004|Overall Study|Lost to Follow-up|2|||
156720831|NCT02570308|565723815|FG000|Overall Study|Withdrawal by Subject|0|||
156720832|NCT02570308|565723816|FG001|Overall Study|Withdrawal by Subject|0|||
156720833|NCT02570308|565723817|FG002|Overall Study|Withdrawal by Subject|0|||
156720834|NCT02570308|565723818|FG003|Overall Study|Withdrawal by Subject|0|||
156720835|NCT02570308|565723819|FG004|Overall Study|Withdrawal by Subject|1|||
156720836|NCT02570308|565723815|FG000|Overall Study|Other|0|||
156720837|NCT02570308|565723816|FG001|Overall Study|Other|0|||
156720838|NCT02570308|565723817|FG002|Overall Study|Other|0|||
156720839|NCT02570308|565723818|FG003|Overall Study|Other|0|||
156720840|NCT02570308|565723819|FG004|Overall Study|Other|2|||
156720841|NCT01960413|565723820|FG000|Overall Study|Withdrawal by Subject|1|||
156720842|NCT01960413|565723821|FG001|Overall Study|Withdrawal by Subject|1|||
156720843|NCT01960413|565723820|FG000|Overall Study|Physician Decision|1|||
156720844|NCT01960413|565723821|FG001|Overall Study|Physician Decision|0|||
156720845|NCT01960413|565723820|FG000|Overall Study|Lost to Follow-up|2|||
156720846|NCT01960413|565723821|FG001|Overall Study|Lost to Follow-up|0|||
156449832|NCT01261312|564739954|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449833|NCT01261312|564739955|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156449834|NCT01261312|564739943|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
156720847|NCT00314340|565723823|FG000|Overall Study|lost interest|1|||
156720848|NCT00791778|565723824|FG000|Double-blind Treatment|Adverse Event|49|||
156449835|NCT01261312|564739944|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
156720849|NCT00791778|565723825|FG001|Double-blind Treatment|Adverse Event|9|||
156449836|NCT01261312|564739945|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
156449837|NCT01261312|564739946|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
156720850|NCT00791778|565723824|FG000|Double-blind Treatment|Physician Decision|6|||
156720851|NCT00791778|565723825|FG001|Double-blind Treatment|Physician Decision|26|||
156720852|NCT00791778|565723824|FG000|Double-blind Treatment|Protocol Violation|0|||
156720853|NCT00791778|565723825|FG001|Double-blind Treatment|Protocol Violation|4|||
156720854|NCT00791778|565723824|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
156720855|NCT00791778|565723825|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
156720856|NCT00791778|565723824|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
156720857|NCT00791778|565723825|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
156720858|NCT00791778|565723824|FG000|Follow-up|Withdrawal by Subject|3|||
156720859|NCT00791778|565723825|FG001|Follow-up|Withdrawal by Subject|0|||
156720860|NCT00791778|565723824|FG000|Follow-up|Lost to Follow-up|2|||
156720861|NCT00791778|565723825|FG001|Follow-up|Lost to Follow-up|1|||
156449838|NCT01261312|564739947|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
156449839|NCT01261312|564739948|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
156449840|NCT01261312|564739949|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
156449841|NCT01261312|564739950|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
156720862|NCT02285361|565723826|FG000|Overall Study|Protocol Violation|43|||
156720863|NCT02285361|565723826|FG000|Overall Study|Lost to Follow-up|5|||
156720864|NCT02285361|565723826|FG000|Overall Study|Not taken GIOTRIF|2|||
156720865|NCT02285361|565723826|FG000|Overall Study|Consented prior to the contract date|1|||
156720866|NCT01283464|565723827|FG000|Overall Study|Lost to Follow-up|0|||
156720867|NCT01283464|565723828|FG001|Overall Study|Lost to Follow-up|1|||
156720868|NCT01283464|565723827|FG000|Overall Study|Withdrawal by Subject|1|||
156720869|NCT01283464|565723828|FG001|Overall Study|Withdrawal by Subject|0|||
156720870|NCT01283464|565723827|FG000|Overall Study|Physician Decision|1|||
156720871|NCT01283464|565723828|FG001|Overall Study|Physician Decision|0|||
156720872|NCT03051100|565723829|FG000|Overall Study|Withdrawal by Subject|1|||
156720873|NCT03051100|565723830|FG001|Overall Study|Withdrawal by Subject|0|||
156720874|NCT02059135|565723831|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
156720875|NCT02059135|565723832|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
156720876|NCT02059135|565723831|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
156794047|NCT03715829|565999496|FG003|Extension Period|Adverse Event|0|||
156794048|NCT03715829|565999497|FG004|Extension Period|Adverse Event|0|||
156794049|NCT03715829|565999498|FG005|Extension Period|Adverse Event|0|||
156794050|NCT03715829|565999499|FG006|Extension Period|Adverse Event|3|||
156449842|NCT01261312|564739951|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
156449843|NCT01261312|564739952|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
156449844|NCT01261312|564739953|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
156449845|NCT01261312|564739954|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
156449846|NCT01261312|564739955|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
156449847|NCT01261312|564739943|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449848|NCT01261312|564739944|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449849|NCT01261312|564739945|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449850|NCT01261312|564739946|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449851|NCT01261312|564739947|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449852|NCT01261312|564739948|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449853|NCT01261312|564739949|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
156449854|NCT01261312|564739950|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
156449855|NCT01261312|564739951|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
156449856|NCT01261312|564739952|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449857|NCT01261312|564739953|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449858|NCT01261312|564739954|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449859|NCT01261312|564739955|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156449860|NCT01261312|564739943|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156449861|NCT01261312|564739944|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156449862|NCT01261312|564739945|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156449863|NCT01261312|564739946|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156449864|NCT01261312|564739947|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156449865|NCT01261312|564739948|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156449866|NCT01261312|564739949|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
156449867|NCT01261312|564739950|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
156449868|NCT01261312|564739951|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
156449869|NCT01261312|564739952|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156720877|NCT02059135|565723832|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
156720878|NCT02059135|565723831|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
156720879|NCT02059135|565723832|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
156720880|NCT02059135|565723831|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
156720881|NCT02059135|565723832|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
156720882|NCT02059135|565723831|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
156720883|NCT02059135|565723832|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
156794051|NCT03715829|565999500|FG007|Extension Period|Adverse Event|1|||
156720884|NCT02059135|565723831|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
156794052|NCT03715829|565999501|FG008|Extension Period|Adverse Event|6|||
156449870|NCT01261312|564739953|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156449871|NCT01261312|564739954|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156449872|NCT01261312|564739955|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
156720885|NCT02059135|565723832|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
156720886|NCT02059135|565723831|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
156720887|NCT02059135|565723832|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
156720888|NCT02059135|565723831|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
156720889|NCT02059135|565723832|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
156720890|NCT00191477|565723833|FG000|Overall Study|Tumor Recurrence|49|||
156720891|NCT00191477|565723834|FG001|Overall Study|Tumor Recurrence|48|||
156720892|NCT00191477|565723833|FG000|Overall Study|Death, Study Disease|1|||
156720893|NCT00191477|565723834|FG001|Overall Study|Death, Study Disease|1|||
156720894|NCT00191477|565723833|FG000|Overall Study|Death, Other Cause|3|||
156720895|NCT00191477|565723834|FG001|Overall Study|Death, Other Cause|6|||
156720896|NCT00191477|565723833|FG000|Overall Study|Lost to Follow-up|23|||
156720897|NCT00191477|565723834|FG001|Overall Study|Lost to Follow-up|21|||
156720898|NCT00191477|565723833|FG000|Overall Study|Protocol Violation|1|||
156720899|NCT00191477|565723834|FG001|Overall Study|Protocol Violation|1|||
156720900|NCT00191477|565723833|FG000|Overall Study|Treatment Change|2|||
156720901|NCT00191477|565723834|FG001|Overall Study|Treatment Change|0|||
156720902|NCT00191477|565723833|FG000|Overall Study|Withdrawal by Subject|2|||
156720903|NCT00191477|565723834|FG001|Overall Study|Withdrawal by Subject|0|||
156720904|NCT00191477|565723833|FG000|Overall Study|Other|2|||
156720905|NCT00191477|565723834|FG001|Overall Study|Other|0|||
156720906|NCT00191477|565723833|FG000|Overall Study|Not Eligible|41|||
156720907|NCT00191477|565723834|FG001|Overall Study|Not Eligible|38|||
156720908|NCT00191477|565723833|FG000|Overall Study|Pathological Specimen Lost|1|||
156720909|NCT00191477|565723834|FG001|Overall Study|Pathological Specimen Lost|0|||
156720910|NCT00191477|565723833|FG000|Overall Study|Discontinued Prior to Instillation|13|||
156720911|NCT00191477|565723834|FG001|Overall Study|Discontinued Prior to Instillation|14|||
156720912|NCT03335475|565723841|FG000|Overall Study|Did not wear accelerometer|4|||
156720913|NCT03335475|565723842|FG001|Overall Study|Did not wear accelerometer|0|||
156720914|NCT03335475|565723841|FG000|Overall Study|Withdrawal by Subject|0|||
156720915|NCT03335475|565723842|FG001|Overall Study|Withdrawal by Subject|1|||
156720916|NCT04886596|565723843|FG000|Overall Study|Adverse Event|442|||
156720917|NCT04886596|565723844|FG001|Overall Study|Adverse Event|441|||
156720918|NCT04886596|565723843|FG000|Overall Study|Lost to Follow-up|448|||
156720919|NCT04886596|565723844|FG001|Overall Study|Lost to Follow-up|465|||
156720920|NCT04886596|565723843|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
156720921|NCT04886596|565723844|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
156720922|NCT04886596|565723843|FG000|Overall Study|Migrated/moved from the study area|201|||
156720923|NCT04886596|565723844|FG001|Overall Study|Migrated/moved from the study area|184|||
156720924|NCT04886596|565723843|FG000|Overall Study|Other|298|||
156720925|NCT04886596|565723844|FG001|Overall Study|Other|326|||
156720926|NCT02411656|565723845|FG000|Overall Study|Adverse Event|4|||
156720927|NCT02411656|565723845|FG000|Overall Study|Clinical Progression|33|||
156720928|NCT06481709|565723846|FG000|Overall Study|Withdrawal by Subject|0|||
156720929|NCT06481709|565723847|FG001|Overall Study|Withdrawal by Subject|0|||
156720930|NCT06481709|565723848|FG002|Overall Study|Withdrawal by Subject|2|||
156720931|NCT06481709|565723849|FG003|Overall Study|Withdrawal by Subject|0|||
156720932|NCT05921903|565723850|FG000|Overall Study|Unsolicited non-SAE|0|||
156720933|NCT05921903|565723851|FG001|Overall Study|Unsolicited non-SAE|1|||
156720934|NCT05921903|565723852|FG002|Overall Study|Unsolicited non-SAE|0|||
156720935|NCT05921903|565723850|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
156720936|NCT05921903|565723851|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
156720937|NCT05921903|565723852|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
156720938|NCT05921903|565723850|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
156720939|NCT05921903|565723851|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
156720940|NCT05921903|565723852|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
156720941|NCT03305848|565723853|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
156720942|NCT03305848|565723853|FG000|Overall Study|Physician Decision|2|||
156720943|NCT00923013|565723854|FG000|Overall Study|Refused further treatment|0|||
156720944|NCT00923013|565723855|FG001|Overall Study|Refused further treatment|1|||
156720945|NCT00923013|565723856|FG002|Overall Study|Refused further treatment|2|||
156720946|NCT00923013|565723857|FG003|Overall Study|Refused further treatment|0|||
156720947|NCT00923013|565723858|FG004|Overall Study|Refused further treatment|0|||
156720948|NCT00923013|565723859|FG005|Overall Study|Refused further treatment|0|||
156720949|NCT00923013|565723854|FG000|Overall Study|Switched to alternative treatment|0|||
156720950|NCT00923013|565723855|FG001|Overall Study|Switched to alternative treatment|1|||
156720951|NCT00923013|565723856|FG002|Overall Study|Switched to alternative treatment|0|||
156720952|NCT00923013|565723857|FG003|Overall Study|Switched to alternative treatment|0|||
156720953|NCT00923013|565723858|FG004|Overall Study|Switched to alternative treatment|0|||
156720954|NCT00923013|565723859|FG005|Overall Study|Switched to alternative treatment|0|||
156720955|NCT00923013|565723854|FG000|Overall Study|Death on study|2|||
156720956|NCT00923013|565723855|FG001|Overall Study|Death on study|2|||
156720957|NCT00923013|565723856|FG002|Overall Study|Death on study|0|||
156720958|NCT00923013|565723857|FG003|Overall Study|Death on study|1|||
156720959|NCT00923013|565723858|FG004|Overall Study|Death on study|0|||
156720960|NCT00923013|565723859|FG005|Overall Study|Death on study|0|||
156720961|NCT03326193|565723861|FG000|Overall Study|Sponsor decision|35|||
156720962|NCT01408043|565723862|FG000|Overall Study|unable to collect cells|1|||
156720963|NCT00803790|565725747|FG000|Period 1|Adverse Event|0|||
156720964|NCT00803790|565725748|FG001|Period 1|Adverse Event|1|||
156720965|NCT00803790|565725749|FG002|Period 1|Adverse Event|0|||
156720966|NCT00803790|565725750|FG003|Period 1|Adverse Event|0|||
156875393|NCT04643158|566302042|FG003|Overall Study|Study terminated by sponsor|0|||
156875394|NCT04643158|566302043|FG004|Overall Study|Study terminated by sponsor|0|||
156449873|NCT01261312|564739943|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449874|NCT01261312|564739944|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449875|NCT01261312|564739945|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449876|NCT01261312|564739946|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449877|NCT01261312|564739947|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449878|NCT01261312|564739948|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449879|NCT01261312|564739949|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
156449880|NCT01261312|564739950|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
156449881|NCT01261312|564739951|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
156449882|NCT01261312|564739952|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449883|NCT01261312|564739953|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449884|NCT01261312|564739954|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449885|NCT01261312|564739955|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
156449886|NCT01261312|564739943|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449887|NCT01261312|564739944|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449888|NCT01261312|564739945|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449889|NCT01261312|564739946|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449890|NCT01261312|564739947|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449891|NCT01261312|564739948|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449892|NCT01261312|564739949|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449893|NCT01261312|564739950|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449894|NCT01261312|564739951|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
156449895|NCT01261312|564739952|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
156449896|NCT01261312|564739953|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
156449897|NCT01261312|564739954|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
156449898|NCT01261312|564739955|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
156449899|NCT01261312|564739943|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449900|NCT01261312|564739944|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449901|NCT01261312|564739945|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449902|NCT01261312|564739946|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449903|NCT01261312|564739947|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449904|NCT01261312|564739948|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449905|NCT01261312|564739949|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449906|NCT01261312|564739950|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449907|NCT01261312|564739951|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449908|NCT01261312|564739952|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
156449909|NCT01261312|564739953|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156449910|NCT01261312|564739954|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
156449911|NCT01261312|564739955|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
156449912|NCT01261312|564739943|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449913|NCT01261312|564739944|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449914|NCT01261312|564739945|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449915|NCT01261312|564739946|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449916|NCT01261312|564739947|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449917|NCT01261312|564739948|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449918|NCT01261312|564739949|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449919|NCT01261312|564739950|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449920|NCT01261312|564739951|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156449921|NCT01261312|564739952|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
156720967|NCT00803790|565725747|FG000|Period 1|Lost to Follow-up|1|||
156720968|NCT00803790|565725748|FG001|Period 1|Lost to Follow-up|2|||
156720969|NCT00803790|565725749|FG002|Period 1|Lost to Follow-up|0|||
156720970|NCT00803790|565725750|FG003|Period 1|Lost to Follow-up|0|||
156720971|NCT00803790|565725747|FG000|Period 1|Withdrawal by Subject|8|||
156449922|NCT01261312|564739953|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
156449923|NCT01261312|564739954|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
156449924|NCT01261312|564739955|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
156449925|NCT01261312|564739943|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449926|NCT01261312|564739944|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449927|NCT01261312|564739945|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449928|NCT01261312|564739946|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449929|NCT01261312|564739947|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449930|NCT01261312|564739948|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449931|NCT01261312|564739949|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449932|NCT01261312|564739950|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449933|NCT01261312|564739951|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
156449934|NCT01261312|564739952|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
156720972|NCT00803790|565725748|FG001|Period 1|Withdrawal by Subject|6|||
156720973|NCT00803790|565725749|FG002|Period 1|Withdrawal by Subject|0|||
156449935|NCT01261312|564739953|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
156449936|NCT01261312|564739954|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
156449937|NCT01261312|564739955|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
156449938|NCT01261312|564739943|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449939|NCT01261312|564739944|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449940|NCT01261312|564739945|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449941|NCT01261312|564739946|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449942|NCT01261312|564739947|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449943|NCT01261312|564739948|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449944|NCT01261312|564739949|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449945|NCT01261312|564739950|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449946|NCT01261312|564739951|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
156449947|NCT01261312|564739952|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
156449948|NCT01261312|564739953|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
156449949|NCT01261312|564739954|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
156449950|NCT01261312|564739955|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
156720974|NCT00803790|565725750|FG003|Period 1|Withdrawal by Subject|0|||
156720975|NCT00803790|565725747|FG000|Period 1|positive drug screen or personal reasons|0|||
156720976|NCT00803790|565725748|FG001|Period 1|positive drug screen or personal reasons|3|||
156720977|NCT00803790|565725749|FG002|Period 1|positive drug screen or personal reasons|0|||
156720978|NCT00803790|565725750|FG003|Period 1|positive drug screen or personal reasons|4|||
156720979|NCT00803790|565725747|FG000|Period 1|Protocol Violation|0|||
156720980|NCT00803790|565725748|FG001|Period 1|Protocol Violation|0|||
156720981|NCT00803790|565725749|FG002|Period 1|Protocol Violation|1|||
156720982|NCT00803790|565725750|FG003|Period 1|Protocol Violation|0|||
156720983|NCT00803790|565725747|FG000|Period 2|Adverse Event|0|||
156720984|NCT00803790|565725748|FG001|Period 2|Adverse Event|0|||
156720985|NCT00803790|565725749|FG002|Period 2|Adverse Event|1|||
156720986|NCT00803790|565725750|FG003|Period 2|Adverse Event|1|||
156720987|NCT00803790|565725747|FG000|Period 2|Withdrawal by Subject|1|||
156720988|NCT00803790|565725748|FG001|Period 2|Withdrawal by Subject|0|||
156720989|NCT00803790|565725749|FG002|Period 2|Withdrawal by Subject|0|||
156720990|NCT00803790|565725750|FG003|Period 2|Withdrawal by Subject|0|||
156720991|NCT00803790|565725747|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
156449951|NCT01261312|564739943|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156449952|NCT01261312|564739944|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156720992|NCT00803790|565725748|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
156720993|NCT00803790|565725749|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
156720994|NCT00803790|565725750|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
156720995|NCT04710576|565725751|FG000|Overall Study|Participants still in the study|73|||
156720996|NCT04710576|565725752|FG001|Overall Study|Participants still in the study|70|||
156720997|NCT04710576|565725753|FG002|Overall Study|Participants still in the study|60|||
156720998|NCT04710576|565725751|FG000|Overall Study|Death|2|||
156449953|NCT01261312|564739945|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156720999|NCT04710576|565725752|FG001|Overall Study|Death|7|||
156721000|NCT04710576|565725753|FG002|Overall Study|Death|12|||
156721001|NCT04710576|565725751|FG000|Overall Study|Withdrawal by Subject|4|||
156721002|NCT04710576|565725752|FG001|Overall Study|Withdrawal by Subject|3|||
156721003|NCT04710576|565725753|FG002|Overall Study|Withdrawal by Subject|7|||
156721004|NCT04710576|565725751|FG000|Overall Study|Sponsor decision|1|||
156721005|NCT04710576|565725752|FG001|Overall Study|Sponsor decision|0|||
156721006|NCT04710576|565725753|FG002|Overall Study|Sponsor decision|0|||
156794053|NCT03715829|565999502|FG009|Extension Period|Adverse Event|0|||
156794054|NCT03715829|565999503|FG010|Extension Period|Adverse Event|0|||
156794055|NCT03715829|565999493|FG000|Extension Period|Lack of Efficacy|0|||
156794056|NCT03715829|565999494|FG001|Extension Period|Lack of Efficacy|0|||
156794057|NCT03715829|565999495|FG002|Extension Period|Lack of Efficacy|0|||
156721007|NCT04162847|565725754|FG000|Overall Study|Withdrawal by Subject|7|||
156721008|NCT04162847|565725755|FG001|Overall Study|Withdrawal by Subject|1|||
156721009|NCT02068508|565725758|FG000|Overall Study|Case report forms uncollected|27|||
156721010|NCT02068508|565725758|FG000|Overall Study|Patient did not visit the study site|1|||
156721011|NCT02068508|565725758|FG000|Overall Study|Protocol Violation|4|||
156721012|NCT01217112|565725759|FG000|Overall Study|Adverse Event|0|||
156721013|NCT01217112|565725760|FG001|Overall Study|Adverse Event|2|||
156721014|NCT01217112|565725761|FG002|Overall Study|Adverse Event|0|||
156721015|NCT01217112|565725762|FG003|Overall Study|Adverse Event|2|||
156721016|NCT01217112|565725763|FG004|Overall Study|Adverse Event|0|||
156721017|NCT01217112|565725759|FG000|Overall Study|Withdrawal by Subject|0|||
156721018|NCT01217112|565725760|FG001|Overall Study|Withdrawal by Subject|0|||
156721019|NCT01217112|565725761|FG002|Overall Study|Withdrawal by Subject|1|||
156721020|NCT01217112|565725762|FG003|Overall Study|Withdrawal by Subject|0|||
156721021|NCT01217112|565725763|FG004|Overall Study|Withdrawal by Subject|0|||
156721022|NCT01217112|565725759|FG000|Overall Study|Physician Decision|0|||
156721023|NCT01217112|565725760|FG001|Overall Study|Physician Decision|0|||
156721024|NCT01217112|565725761|FG002|Overall Study|Physician Decision|0|||
156721025|NCT01217112|565725762|FG003|Overall Study|Physician Decision|0|||
156721026|NCT01217112|565725763|FG004|Overall Study|Physician Decision|1|||
156721027|NCT01401361|565725764|FG000|Overall Study|Withdrawal by Subject|16|||
156721028|NCT01401361|565725764|FG000|Overall Study|Lack of Efficacy|6|||
156721029|NCT01401361|565725764|FG000|Overall Study|Physician Decision|1|||
156721030|NCT01401361|565725764|FG000|Overall Study|Lost to Follow-up|3|||
156721031|NCT01401361|565725764|FG000|Overall Study|Subject/family decision post procedure|2|||
156721032|NCT02764762|565725767|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156721033|NCT02764762|565725767|FG000|Overall Study|Lost to Follow-up|4|||
156721034|NCT02764762|565725767|FG000|Overall Study|Voluntary Withdrawal|8|||
156721035|NCT02764762|565725767|FG000|Overall Study|Site Termination|1|||
156721036|NCT02764762|565725767|FG000|Overall Study|Lack of Efficacy|16|||
156794058|NCT03715829|565999496|FG003|Extension Period|Lack of Efficacy|0|||
156794059|NCT03715829|565999497|FG004|Extension Period|Lack of Efficacy|0|||
156794060|NCT03715829|565999498|FG005|Extension Period|Lack of Efficacy|0|||
156794061|NCT03715829|565999499|FG006|Extension Period|Lack of Efficacy|1|||
156794062|NCT03715829|565999500|FG007|Extension Period|Lack of Efficacy|9|||
156794063|NCT03715829|565999501|FG008|Extension Period|Lack of Efficacy|2|||
156335235|NCT00302107|564324561|FG001|Overall Study|Relocation|1|||
156335236|NCT00302107|564324560|FG000|Overall Study|Withdrawal by Subject|0|||
156335237|NCT00302107|564324561|FG001|Overall Study|Withdrawal by Subject|3|||
156335238|NCT00302107|564324560|FG000|Overall Study|Adverse Event|1|||
156335239|NCT00302107|564324561|FG001|Overall Study|Adverse Event|0|||
156335240|NCT00621959|564324562|FG000|Overall Study|Adverse Event|4|||
156335241|NCT00621959|564324563|FG001|Overall Study|Adverse Event|2|||
156335242|NCT00621959|564324562|FG000|Overall Study|Lack of Efficacy|1|||
156335243|NCT00621959|564324563|FG001|Overall Study|Lack of Efficacy|1|||
156335244|NCT00621959|564324562|FG000|Overall Study|Lost to Follow-up|0|||
156335245|NCT00621959|564324563|FG001|Overall Study|Lost to Follow-up|2|||
156335246|NCT00621959|564324562|FG000|Overall Study|Withdrawal by Subject|1|||
156335247|NCT00621959|564324563|FG001|Overall Study|Withdrawal by Subject|1|||
156335248|NCT00621959|564324562|FG000|Overall Study|Other|1|||
156335249|NCT00621959|564324563|FG001|Overall Study|Other|3|||
156335250|NCT06238362|564324566|FG000|Overall Study|Insufficient total sleep time|1|||
156335251|NCT06238362|564324567|FG001|Overall Study|Insufficient total sleep time|0|||
156335252|NCT06238362|564324566|FG000|Overall Study|Inadequate signal quality|1|||
156335253|NCT06238362|564324567|FG001|Overall Study|Inadequate signal quality|0|||
156335254|NCT06956170|564326015|FG000|Overall Study|Death|2|||
156335255|NCT06956170|564326016|FG001|Overall Study|Death|1|||
156335256|NCT06956170|564326015|FG000|Overall Study|Withdrawal by Subject|1|||
156335257|NCT06956170|564326016|FG001|Overall Study|Withdrawal by Subject|0|||
156335258|NCT06956170|564326015|FG000|Overall Study|Ongoing|7|||
156721037|NCT02764762|565725767|FG000|Overall Study|Reason not Specified|1|||
156721038|NCT00471081|565725771|FG000|Active Phase|Protocol Violation|1|||
156721039|NCT00471081|565725772|FG001|Active Phase|Protocol Violation|1|||
156721040|NCT00471081|565725771|FG000|Active Phase|Withdrawal by Subject|0|||
156721041|NCT00471081|565725772|FG001|Active Phase|Withdrawal by Subject|3|||
156721042|NCT00471081|565725771|FG000|Active Phase|Lost to Follow-up|0|||
156721043|NCT00471081|565725772|FG001|Active Phase|Lost to Follow-up|1|||
156721044|NCT00471081|565725771|FG000|Active Phase|Lost health plan/insurance|1|||
156721045|NCT00471081|565725772|FG001|Active Phase|Lost health plan/insurance|8|||
156794064|NCT03715829|565999502|FG009|Extension Period|Lack of Efficacy|0|||
156335259|NCT06956170|564326016|FG001|Overall Study|Ongoing|10|||
156721046|NCT00471081|565725771|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
156721047|NCT00471081|565725772|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
156721048|NCT00471081|565725771|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
156721049|NCT00471081|565725772|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
156335260|NCT04015336|564326017|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
156335261|NCT04622306|564326019|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
156335262|NCT04622306|564326020|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
156335263|NCT04622306|564326021|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
156335264|NCT04622306|564326022|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
156335265|NCT04622306|564326023|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
156335266|NCT04622306|564326024|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
156335267|NCT04622306|564326019|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
156335268|NCT04622306|564326020|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
156335269|NCT04622306|564326021|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
156335270|NCT04622306|564326022|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
156335271|NCT04622306|564326023|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
156335272|NCT04622306|564326024|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
156335273|NCT01200524|564326025|FG000|Overall Study|Withdrawal by Subject|1|||
156335274|NCT01200524|564326026|FG001|Overall Study|Withdrawal by Subject|1|||
156335275|NCT01200524|564326027|FG002|Overall Study|Withdrawal by Subject|3|||
156335276|NCT01200524|564326025|FG000|Overall Study|Adverse Event|1|||
156335277|NCT01200524|564326026|FG001|Overall Study|Adverse Event|0|||
156335278|NCT01200524|564326027|FG002|Overall Study|Adverse Event|0|||
156335279|NCT01200524|564326025|FG000|Overall Study|Non availability of study nurse|0|||
156335280|NCT01200524|564326026|FG001|Overall Study|Non availability of study nurse|0|||
156335281|NCT01200524|564326027|FG002|Overall Study|Non availability of study nurse|1|||
156335282|NCT00697788|564326034|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156335283|NCT00697788|564326035|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
156335284|NCT00697788|564326036|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156335285|NCT00697788|564326037|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156335286|NCT00697788|564326038|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156335287|NCT00697788|564326039|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156335288|NCT00697788|564326040|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156335289|NCT00697788|564326041|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156335290|NCT00697788|564326034|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156335291|NCT00697788|564326035|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156335292|NCT00697788|564326036|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156335293|NCT00697788|564326037|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156335294|NCT00697788|564326038|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
156335295|NCT00697788|564326039|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156335296|NCT00697788|564326040|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156335297|NCT00697788|564326041|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156335298|NCT03228433|564326043|FG000|Overall Study|Lost to Follow-up|1|||
156335299|NCT03228433|564326044|FG001|Overall Study|Lost to Follow-up|0|||
156335300|NCT03228433|564326045|FG002|Overall Study|Lost to Follow-up|0|||
156335301|NCT03228433|564326046|FG003|Overall Study|Lost to Follow-up|0|||
156335302|NCT03228433|564326047|FG004|Overall Study|Lost to Follow-up|0|||
156335303|NCT03228433|564326048|FG005|Overall Study|Lost to Follow-up|0|||
156335304|NCT03228433|564326043|FG000|Overall Study|Positive alcohol test|0|||
156335305|NCT03228433|564326044|FG001|Overall Study|Positive alcohol test|0|||
156335306|NCT03228433|564326045|FG002|Overall Study|Positive alcohol test|0|||
156335307|NCT03228433|564326046|FG003|Overall Study|Positive alcohol test|1|||
156335308|NCT03228433|564326047|FG004|Overall Study|Positive alcohol test|0|||
156335309|NCT03228433|564326048|FG005|Overall Study|Positive alcohol test|0|||
156335310|NCT01180985|564326053|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
156335311|NCT01180985|564326054|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
156335312|NCT00705289|564326055|FG000|Overall Study|Subject or treating physician's choice|131|||
156335313|NCT01030536|564326056|FG000|Overall Study|Withdrawal by Subject|0|||
156335314|NCT01030536|564326057|FG001|Overall Study|Withdrawal by Subject|0|||
156335315|NCT01030536|564326058|FG002|Overall Study|Withdrawal by Subject|1|||
156335316|NCT01030536|564326059|FG003|Overall Study|Withdrawal by Subject|0|||
156335317|NCT01030536|564326060|FG004|Overall Study|Withdrawal by Subject|0|||
156794065|NCT03715829|565999503|FG010|Extension Period|Lack of Efficacy|0|||
156794066|NCT03715829|565999493|FG000|Extension Period|Lost to Follow-up|0|||
156794067|NCT03715829|565999494|FG001|Extension Period|Lost to Follow-up|0|||
156794068|NCT03715829|565999495|FG002|Extension Period|Lost to Follow-up|0|||
156794069|NCT03715829|565999496|FG003|Extension Period|Lost to Follow-up|0|||
156794070|NCT03715829|565999497|FG004|Extension Period|Lost to Follow-up|0|||
156794071|NCT03715829|565999498|FG005|Extension Period|Lost to Follow-up|0|||
156335318|NCT01030536|564326056|FG000|Overall Study|undefined|1|||
156794072|NCT03715829|565999499|FG006|Extension Period|Lost to Follow-up|0|||
156335319|NCT01030536|564326057|FG001|Overall Study|undefined|0|||
156335320|NCT01030536|564326058|FG002|Overall Study|undefined|1|||
156335321|NCT01030536|564326059|FG003|Overall Study|undefined|1|||
156335322|NCT01030536|564326060|FG004|Overall Study|undefined|0|||
156335323|NCT01030536|564326056|FG000|Overall Study|Adverse Event|0|||
156794073|NCT03715829|565999500|FG007|Extension Period|Lost to Follow-up|0|||
156794074|NCT03715829|565999501|FG008|Extension Period|Lost to Follow-up|2|||
156335324|NCT01030536|564326057|FG001|Overall Study|Adverse Event|3|||
156335325|NCT01030536|564326058|FG002|Overall Study|Adverse Event|1|||
156335326|NCT01030536|564326059|FG003|Overall Study|Adverse Event|0|||
156335327|NCT01030536|564326060|FG004|Overall Study|Adverse Event|1|||
156335328|NCT01030536|564326056|FG000|Overall Study|Progressive disease|6|||
156335329|NCT01030536|564326057|FG001|Overall Study|Progressive disease|2|||
156335330|NCT01030536|564326058|FG002|Overall Study|Progressive disease|3|||
156335331|NCT01030536|564326059|FG003|Overall Study|Progressive disease|2|||
156335332|NCT01030536|564326060|FG004|Overall Study|Progressive disease|0|||
156335333|NCT01030536|564326056|FG000|Overall Study|Death|0|||
156335334|NCT01030536|564326057|FG001|Overall Study|Death|1|||
156335335|NCT01030536|564326058|FG002|Overall Study|Death|0|||
156335336|NCT01030536|564326059|FG003|Overall Study|Death|0|||
156335337|NCT01030536|564326060|FG004|Overall Study|Death|0|||
156335338|NCT02763462|564326065|FG000|Overall Study|Protocol Violation|6|||
156335339|NCT00129272|564326066|FG000|Overall Study|Lost to Follow-up|12|||
156335340|NCT00129272|564326067|FG001|Overall Study|Lost to Follow-up|11|||
156335341|NCT00129272|564326066|FG000|Overall Study|Withdrawal by Subject|5|||
156335342|NCT00129272|564326067|FG001|Overall Study|Withdrawal by Subject|11|||
156335343|NCT02601027|564326071|FG000|Registration to Surgery|Withdrawal by Subject|20|||
156335344|NCT02601027|564326072|FG001|Registration to Surgery|Withdrawal by Subject|10|||
156335345|NCT00675948|564326073|FG000|Overall Study|Adverse Event|23|||
156335346|NCT00675948|564326074|FG001|Overall Study|Adverse Event|1|||
156335347|NCT00675948|564326073|FG000|Overall Study|Lack of Efficacy|3|||
156335348|NCT00675948|564326074|FG001|Overall Study|Lack of Efficacy|0|||
156335349|NCT00675948|564326073|FG000|Overall Study|Withdrawal by Subject|7|||
156335350|NCT00675948|564326074|FG001|Overall Study|Withdrawal by Subject|0|||
156335351|NCT00675948|564326073|FG000|Overall Study|Lost to Follow-up|2|||
156335352|NCT00675948|564326074|FG001|Overall Study|Lost to Follow-up|0|||
156335353|NCT00675948|564326073|FG000|Overall Study|Protocol Violation|1|||
156335354|NCT00675948|564326074|FG001|Overall Study|Protocol Violation|0|||
156335355|NCT00675948|564326073|FG000|Overall Study|Pain under control|1|||
156335356|NCT00675948|564326074|FG001|Overall Study|Pain under control|0|||
156335357|NCT00675948|564326073|FG000|Overall Study|Sponsor decision|0|||
156335358|NCT00675948|564326074|FG001|Overall Study|Sponsor decision|1|||
156335359|NCT00675948|564326073|FG000|Overall Study|Patient died|1|||
156335360|NCT00675948|564326074|FG001|Overall Study|Patient died|0|||
156335361|NCT00675948|564326073|FG000|Overall Study|Patient unable to comply with diaries|1|||
156335362|NCT00675948|564326074|FG001|Overall Study|Patient unable to comply with diaries|0|||
156335363|NCT00675948|564326073|FG000|Overall Study|Patient feels unable to take medication|0|||
156335364|NCT00675948|564326074|FG001|Overall Study|Patient feels unable to take medication|1|||
156335365|NCT02100514|564326078|FG000|Treatment Period|Adverse Event|0|||
156335366|NCT02100514|564326079|FG001|Treatment Period|Adverse Event|5|||
156335367|NCT02100514|564326080|FG002|Treatment Period|Adverse Event|0|||
156335368|NCT02100514|564326081|FG003|Treatment Period|Adverse Event|0|||
156335369|NCT02100514|564326082|FG004|Treatment Period|Adverse Event|0|||
156335370|NCT02100514|564326078|FG000|Treatment Period|Death|2|||
156335371|NCT02100514|564326079|FG001|Treatment Period|Death|2|||
156335372|NCT02100514|564326080|FG002|Treatment Period|Death|0|||
156335373|NCT02100514|564326081|FG003|Treatment Period|Death|0|||
156335374|NCT02100514|564326082|FG004|Treatment Period|Death|0|||
156335375|NCT02100514|564326078|FG000|Treatment Period|Lost to Follow-up|5|||
156335376|NCT02100514|564326079|FG001|Treatment Period|Lost to Follow-up|17|||
156335377|NCT02100514|564326080|FG002|Treatment Period|Lost to Follow-up|0|||
156335378|NCT02100514|564326081|FG003|Treatment Period|Lost to Follow-up|0|||
156533395|NCT02383589|565046967|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
156533396|NCT02383589|565046966|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
156794075|NCT03715829|565999502|FG009|Extension Period|Lost to Follow-up|0|||
156794076|NCT03715829|565999503|FG010|Extension Period|Lost to Follow-up|0|||
156794077|NCT03715829|565999493|FG000|Extension Period|Protocol Violation|0|||
156794078|NCT03715829|565999494|FG001|Extension Period|Protocol Violation|0|||
156794079|NCT03715829|565999495|FG002|Extension Period|Protocol Violation|0|||
156533397|NCT02383589|565046967|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
156794080|NCT03715829|565999496|FG003|Extension Period|Protocol Violation|0|||
156794081|NCT03715829|565999497|FG004|Extension Period|Protocol Violation|0|||
156794082|NCT03715829|565999498|FG005|Extension Period|Protocol Violation|0|||
156794083|NCT03715829|565999499|FG006|Extension Period|Protocol Violation|0|||
156794084|NCT03715829|565999500|FG007|Extension Period|Protocol Violation|0|||
156335379|NCT02100514|564326082|FG004|Treatment Period|Lost to Follow-up|0|||
156335380|NCT02100514|564326078|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
156335381|NCT02100514|564326079|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
156335382|NCT02100514|564326080|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
156335383|NCT02100514|564326081|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
156335384|NCT02100514|564326082|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
156335385|NCT02100514|564326078|FG000|Treatment Period|Protocol Violation|1|||
156335386|NCT02100514|564326079|FG001|Treatment Period|Protocol Violation|1|||
156335387|NCT02100514|564326080|FG002|Treatment Period|Protocol Violation|0|||
156721050|NCT00471081|565725771|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
156721051|NCT00471081|565725772|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
156721052|NCT02844933|565725773|FG000|Overall Study|Discontinued due to premature termination of study|3|||
156721053|NCT02844933|565725774|FG001|Overall Study|Discontinued due to premature termination of study|2|||
156721054|NCT01479465|565725775|FG000|Overall Study|Disease Progression|9|||
156721055|NCT01479465|565725776|FG001|Overall Study|Disease Progression|61|||
156721056|NCT01479465|565725777|FG002|Overall Study|Disease Progression|65|||
156721057|NCT01479465|565725778|FG003|Overall Study|Disease Progression|70|||
156721058|NCT01479465|565725775|FG000|Overall Study|Study Discontinued by Sponsor|0|||
156721059|NCT01479465|565725776|FG001|Overall Study|Study Discontinued by Sponsor|7|||
156721060|NCT01479465|565725777|FG002|Overall Study|Study Discontinued by Sponsor|5|||
156721061|NCT01479465|565725778|FG003|Overall Study|Study Discontinued by Sponsor|3|||
156721062|NCT01479465|565725775|FG000|Overall Study|Adverse Event|0|||
156721063|NCT01479465|565725776|FG001|Overall Study|Adverse Event|3|||
156721064|NCT01479465|565725777|FG002|Overall Study|Adverse Event|6|||
156721065|NCT01479465|565725778|FG003|Overall Study|Adverse Event|4|||
156721066|NCT01479465|565725775|FG000|Overall Study|Investigator Discretion|1|||
156721067|NCT01479465|565725776|FG001|Overall Study|Investigator Discretion|4|||
156721068|NCT01479465|565725777|FG002|Overall Study|Investigator Discretion|2|||
156721069|NCT01479465|565725778|FG003|Overall Study|Investigator Discretion|4|||
156721070|NCT01479465|565725775|FG000|Overall Study|Subject Request|1|||
156721071|NCT01479465|565725776|FG001|Overall Study|Subject Request|3|||
156721072|NCT01479465|565725777|FG002|Overall Study|Subject Request|4|||
156721073|NCT01479465|565725778|FG003|Overall Study|Subject Request|2|||
156721074|NCT01479465|565725775|FG000|Overall Study|Subject Withdrew Consent|0|||
156721075|NCT01479465|565725776|FG001|Overall Study|Subject Withdrew Consent|5|||
156721076|NCT01479465|565725777|FG002|Overall Study|Subject Withdrew Consent|2|||
156721077|NCT01479465|565725778|FG003|Overall Study|Subject Withdrew Consent|1|||
156721078|NCT01479465|565725775|FG000|Overall Study|Protocol Violation|0|||
156721079|NCT01479465|565725776|FG001|Overall Study|Protocol Violation|1|||
156721080|NCT01479465|565725777|FG002|Overall Study|Protocol Violation|1|||
156721081|NCT01479465|565725778|FG003|Overall Study|Protocol Violation|0|||
156721082|NCT01479465|565725775|FG000|Overall Study|Death|0|||
156721083|NCT01479465|565725776|FG001|Overall Study|Death|0|||
156721084|NCT01479465|565725777|FG002|Overall Study|Death|0|||
156721085|NCT01479465|565725778|FG003|Overall Study|Death|1|||
156721086|NCT01479465|565725775|FG000|Overall Study|Lost to Follow-up|0|||
156721087|NCT01479465|565725776|FG001|Overall Study|Lost to Follow-up|0|||
156721088|NCT01479465|565725777|FG002|Overall Study|Lost to Follow-up|1|||
156721089|NCT01479465|565725778|FG003|Overall Study|Lost to Follow-up|0|||
156721090|NCT01892501|565725779|FG000|Overall Study|Protocol Violation|2|||
156721091|NCT01892501|565725779|FG000|Overall Study|Puncture not carried out|9|||
156721092|NCT01892501|565725779|FG000|Overall Study|Radiological monitoring not carried out|5|||
156875395|NCT04643158|566302044|FG005|Overall Study|Study terminated by sponsor|1|||
156875396|NCT04643158|566302045|FG006|Overall Study|Study terminated by sponsor|0|||
156875397|NCT04643158|566302039|FG000|Overall Study|Global/country situation|0|||
156875398|NCT04643158|566302040|FG001|Overall Study|Global/country situation|0|||
156875399|NCT04643158|566302041|FG002|Overall Study|Global/country situation|1|||
156875400|NCT04643158|566302042|FG003|Overall Study|Global/country situation|0|||
156875401|NCT04643158|566302043|FG004|Overall Study|Global/country situation|0|||
156875402|NCT04643158|566302044|FG005|Overall Study|Global/country situation|0|||
156875403|NCT04643158|566302045|FG006|Overall Study|Global/country situation|0|||
156875404|NCT04643158|566302039|FG000|Overall Study|Withdrawal by Subject|0|||
156875405|NCT04643158|566302040|FG001|Overall Study|Withdrawal by Subject|0|||
156875406|NCT04643158|566302041|FG002|Overall Study|Withdrawal by Subject|0|||
156875407|NCT04643158|566302042|FG003|Overall Study|Withdrawal by Subject|0|||
156875408|NCT04643158|566302043|FG004|Overall Study|Withdrawal by Subject|0|||
156875409|NCT04643158|566302044|FG005|Overall Study|Withdrawal by Subject|1|||
156875410|NCT04643158|566302045|FG006|Overall Study|Withdrawal by Subject|0|||
156875411|NCT04329806|566302046|FG000|Overall Study|Physician Decision|3|||
156875412|NCT04329806|566302047|FG001|Overall Study|Physician Decision|4|||
156875413|NCT00622440|566302060|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
156721093|NCT01892501|565725779|FG000|Overall Study|Non-contributory histological result|12|||
156721094|NCT02393950|565725787|FG000|Overall Study|Adverse Event|1|||
156721095|NCT02393950|565725788|FG001|Overall Study|Adverse Event|0|||
156721096|NCT02393950|565725787|FG000|Overall Study|Withdrawal by Subject|0|||
156875414|NCT00622440|566302061|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
156875415|NCT00622440|566302060|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
156875416|NCT00622440|566302061|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
156721097|NCT02393950|565725788|FG001|Overall Study|Withdrawal by Subject|1|||
156721098|NCT04335123|565725789|FG000|Overall Study|Withdrawal by Subject|2|||
156721099|NCT04335123|565725790|FG001|Overall Study|Withdrawal by Subject|0|||
156721100|NCT04335123|565725789|FG000|Overall Study|Physician Decision|2|||
156721101|NCT04335123|565725790|FG001|Overall Study|Physician Decision|0|||
156721102|NCT05486091|565725791|FG000|Overall Study|Withdrawal by Subject|1|||
156721103|NCT05486091|565725791|FG000|Overall Study|Lost to Follow-up|2|||
156449954|NCT01261312|564739946|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156449955|NCT01261312|564739947|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156449956|NCT01261312|564739948|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156449957|NCT01261312|564739949|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156449958|NCT01261312|564739950|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156721104|NCT00370552|565725792|FG000|Overall Study|Adverse Event|2|||
156721105|NCT00370552|565725793|FG001|Overall Study|Adverse Event|2|||
156721106|NCT00370552|565725794|FG002|Overall Study|Adverse Event|2|||
156721107|NCT00370552|565725792|FG000|Overall Study|Disease progression|23|||
156721108|NCT00370552|565725793|FG001|Overall Study|Disease progression|23|||
156721109|NCT00370552|565725794|FG002|Overall Study|Disease progression|15|||
156721110|NCT00370552|565725792|FG000|Overall Study|Maximum clinical benefit|3|||
156721111|NCT00370552|565725793|FG001|Overall Study|Maximum clinical benefit|5|||
156721112|NCT00370552|565725794|FG002|Overall Study|Maximum clinical benefit|5|||
156721113|NCT00370552|565725792|FG000|Overall Study|Poor or noncompliance|0|||
156721114|NCT00370552|565725793|FG001|Overall Study|Poor or noncompliance|0|||
156721115|NCT00370552|565725794|FG002|Overall Study|Poor or noncompliance|1|||
156721116|NCT00370552|565725792|FG000|Overall Study|Study drug toxicity|11|||
156721117|NCT00370552|565725793|FG001|Overall Study|Study drug toxicity|8|||
156721118|NCT00370552|565725794|FG002|Overall Study|Study drug toxicity|6|||
156721119|NCT00370552|565725792|FG000|Overall Study|Withdrawal by Subject|2|||
156721120|NCT00370552|565725793|FG001|Overall Study|Withdrawal by Subject|0|||
156721121|NCT00370552|565725794|FG002|Overall Study|Withdrawal by Subject|1|||
156721122|NCT00370552|565725792|FG000|Overall Study|Still on treatment|1|||
156721123|NCT00370552|565725793|FG001|Overall Study|Still on treatment|3|||
156721124|NCT00370552|565725794|FG002|Overall Study|Still on treatment|2|||
156721125|NCT00370552|565725792|FG000|Overall Study|Never treated|1|||
156721126|NCT00370552|565725793|FG001|Overall Study|Never treated|0|||
156721127|NCT00370552|565725794|FG002|Overall Study|Never treated|0|||
156721128|NCT00370552|565725792|FG000|Overall Study|Physician Decision|1|||
156721129|NCT00370552|565725793|FG001|Overall Study|Physician Decision|1|||
156721130|NCT00370552|565725794|FG002|Overall Study|Physician Decision|0|||
156721131|NCT00370552|565725792|FG000|Overall Study|Investigator decision|2|||
156721132|NCT00370552|565725793|FG001|Overall Study|Investigator decision|1|||
156721133|NCT00370552|565725794|FG002|Overall Study|Investigator decision|0|||
156721134|NCT00370552|565725792|FG000|Overall Study|High risk of allergic reaction|0|||
156721135|NCT00370552|565725793|FG001|Overall Study|High risk of allergic reaction|1|||
156721136|NCT00370552|565725794|FG002|Overall Study|High risk of allergic reaction|0|||
156794085|NCT03715829|565999501|FG008|Extension Period|Protocol Violation|1|||
156794086|NCT03715829|565999502|FG009|Extension Period|Protocol Violation|0|||
156449959|NCT01261312|564739951|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
156794087|NCT03715829|565999503|FG010|Extension Period|Protocol Violation|0|||
156449960|NCT01261312|564739952|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
156449961|NCT01261312|564739953|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
156449962|NCT01261312|564739954|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
156449963|NCT01261312|564739955|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
156449964|NCT01261312|564739943|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449965|NCT01261312|564739944|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449966|NCT01261312|564739945|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449967|NCT01261312|564739946|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449968|NCT01261312|564739947|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449969|NCT01261312|564739948|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449970|NCT01261312|564739949|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449971|NCT01261312|564739950|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449972|NCT01261312|564739951|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156449973|NCT01261312|564739952|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
156449974|NCT01261312|564739953|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
156449975|NCT01261312|564739954|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
156449976|NCT01261312|564739955|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
156449977|NCT03336333|564739960|FG000|Overall Study|Remained on study at time of data cut-off|202|||
156449978|NCT03336333|564739961|FG001|Overall Study|Remained on study at time of data cut-off|219|||
156449979|NCT03336333|564739962|FG002|Overall Study|Remained on study at time of data cut-off|102|||
156449980|NCT03336333|564739960|FG000|Overall Study|Death|14|||
156721137|NCT00370552|565725792|FG000|Overall Study|Planned radiation for palliation|0|||
156721138|NCT00370552|565725793|FG001|Overall Study|Planned radiation for palliation|1|||
156721139|NCT00370552|565725794|FG002|Overall Study|Planned radiation for palliation|0|||
156721140|NCT01651117|565725806|FG000|Overall Study|Death|2|||
156721141|NCT01651117|565725807|FG001|Overall Study|Death|3|||
156721142|NCT01651117|565725808|FG002|Overall Study|Death|2|||
156794088|NCT03715829|565999493|FG000|Extension Period|Withdrawal by Subject|0|||
156794089|NCT03715829|565999494|FG001|Extension Period|Withdrawal by Subject|0|||
156449981|NCT03336333|564739961|FG001|Overall Study|Death|16|||
156449982|NCT03336333|564739962|FG002|Overall Study|Death|8|||
156449983|NCT03336333|564739960|FG000|Overall Study|Withdrawal by Subject|16|||
156449984|NCT03336333|564739961|FG001|Overall Study|Withdrawal by Subject|5|||
156449985|NCT03336333|564739962|FG002|Overall Study|Withdrawal by Subject|1|||
156449986|NCT03336333|564739960|FG000|Overall Study|Physician Decision|5|||
156449987|NCT03336333|564739961|FG001|Overall Study|Physician Decision|1|||
156449988|NCT03336333|564739962|FG002|Overall Study|Physician Decision|0|||
156449989|NCT03336333|564739960|FG000|Overall Study|Lost to Follow-up|1|||
156449990|NCT03336333|564739961|FG001|Overall Study|Lost to Follow-up|0|||
156449991|NCT03336333|564739962|FG002|Overall Study|Lost to Follow-up|0|||
156449992|NCT03406871|564739966|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
156449993|NCT03406871|564739967|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
156449994|NCT03406871|564739968|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
156449995|NCT03406871|564739966|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
156449996|NCT03406871|564739967|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
156449997|NCT03406871|564739968|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
156449998|NCT03406871|564739966|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
156449999|NCT03406871|564739967|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
156450000|NCT03406871|564739968|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
156450001|NCT03406871|564739966|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
156450002|NCT03406871|564739967|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
156450003|NCT03406871|564739968|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
156450004|NCT03406871|564739966|FG000|Expansion Cohort(Final Analysis)|Death|0|||
156450005|NCT03406871|564739967|FG001|Expansion Cohort(Final Analysis)|Death|1|||
156450006|NCT03406871|564739968|FG002|Expansion Cohort(Final Analysis)|Death|0|||
156533398|NCT02906787|565046970|FG000|Overall Study|Withdrawal by Subject|12|||
156721143|NCT01651117|565725809|FG003|Overall Study|Death|2|||
156721144|NCT03871543|565725810|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
156721145|NCT03871543|565725810|FG000|Period 1|Investigator Error|1|||
156721146|NCT03871543|565725810|FG000|Period 1|Protocol Violation|2|||
156721147|NCT03871543|565725810|FG000|Period 1|COVID-19 Related|1|||
156721148|NCT03871543|565725810|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
156721149|NCT03871543|565725810|FG000|Period 1|Withdrawal by Subject|10|||
156721150|NCT03871543|565725810|FG000|Period 2|Adverse Event|1|||
156721151|NCT03871543|565725810|FG000|Period 2|Withdrawal by Subject|1|||
156721152|NCT01894919|565725811|FG000|Overall Study|Withdrawal by Subject|1|||
156721153|NCT01894919|565725812|FG001|Overall Study|Withdrawal by Subject|0|||
156721154|NCT01894919|565725813|FG002|Overall Study|Withdrawal by Subject|0|||
156721155|NCT01894919|565725814|FG003|Overall Study|Withdrawal by Subject|0|||
156721156|NCT01894919|565725815|FG004|Overall Study|Withdrawal by Subject|1|||
156721157|NCT01894919|565725816|FG005|Overall Study|Withdrawal by Subject|0|||
156721158|NCT01894919|565725817|FG006|Overall Study|Withdrawal by Subject|0|||
156721159|NCT01894919|565725818|FG007|Overall Study|Withdrawal by Subject|0|||
156721160|NCT01894919|565725819|FG008|Overall Study|Withdrawal by Subject|0|||
156721161|NCT01894919|565725820|FG009|Overall Study|Withdrawal by Subject|1|||
156721162|NCT01894919|565725821|FG010|Overall Study|Withdrawal by Subject|1|||
156721163|NCT01894919|565725822|FG011|Overall Study|Withdrawal by Subject|0|||
156721164|NCT01894919|565725823|FG012|Overall Study|Withdrawal by Subject|0|||
156721165|NCT01894919|565725811|FG000|Overall Study|Adverse Event|0|||
156721166|NCT01894919|565725812|FG001|Overall Study|Adverse Event|0|||
156721167|NCT01894919|565725813|FG002|Overall Study|Adverse Event|0|||
156721168|NCT01894919|565725814|FG003|Overall Study|Adverse Event|0|||
156721169|NCT01894919|565725815|FG004|Overall Study|Adverse Event|0|||
156721170|NCT01894919|565725816|FG005|Overall Study|Adverse Event|0|||
156794090|NCT03715829|565999495|FG002|Extension Period|Withdrawal by Subject|0|||
156794091|NCT03715829|565999496|FG003|Extension Period|Withdrawal by Subject|0|||
156794092|NCT03715829|565999497|FG004|Extension Period|Withdrawal by Subject|0|||
156794093|NCT03715829|565999498|FG005|Extension Period|Withdrawal by Subject|0|||
156794094|NCT03715829|565999499|FG006|Extension Period|Withdrawal by Subject|3|||
156794095|NCT03715829|565999500|FG007|Extension Period|Withdrawal by Subject|3|||
156794096|NCT03715829|565999501|FG008|Extension Period|Withdrawal by Subject|12|||
156794097|NCT03715829|565999502|FG009|Extension Period|Withdrawal by Subject|3|||
156794098|NCT03715829|565999503|FG010|Extension Period|Withdrawal by Subject|0|||
156721171|NCT01894919|565725817|FG006|Overall Study|Adverse Event|0|||
156721172|NCT01894919|565725818|FG007|Overall Study|Adverse Event|0|||
156721173|NCT01894919|565725819|FG008|Overall Study|Adverse Event|0|||
156721174|NCT01894919|565725820|FG009|Overall Study|Adverse Event|0|||
156794099|NCT03715829|565999493|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
156450007|NCT03406871|564739966|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
156721175|NCT01894919|565725821|FG010|Overall Study|Adverse Event|1|||
156450008|NCT03406871|564739967|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
156450009|NCT03406871|564739968|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
156450010|NCT04588298|564739969|FG000|Overall Study|Adverse Event|0|||
156875417|NCT00622440|566302060|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
156335388|NCT02100514|564326081|FG003|Treatment Period|Protocol Violation|0|||
156335389|NCT02100514|564326082|FG004|Treatment Period|Protocol Violation|0|||
156335390|NCT02100514|564326078|FG000|Treatment Period|Withdrawal by Subject|12|||
156335391|NCT02100514|564326079|FG001|Treatment Period|Withdrawal by Subject|37|||
156335392|NCT02100514|564326080|FG002|Treatment Period|Withdrawal by Subject|0|||
156335393|NCT02100514|564326081|FG003|Treatment Period|Withdrawal by Subject|0|||
156335394|NCT02100514|564326082|FG004|Treatment Period|Withdrawal by Subject|0|||
156335395|NCT02100514|564326078|FG000|Treatment Period|Other|9|||
156335396|NCT02100514|564326079|FG001|Treatment Period|Other|11|||
156335397|NCT02100514|564326080|FG002|Treatment Period|Other|0|||
156335398|NCT02100514|564326081|FG003|Treatment Period|Other|0|||
156335399|NCT02100514|564326082|FG004|Treatment Period|Other|0|||
156335400|NCT02100514|564326078|FG000|Extension Period|Withdrew consent|0|||
156335401|NCT02100514|564326079|FG001|Extension Period|Withdrew consent|0|||
156335402|NCT02100514|564326080|FG002|Extension Period|Withdrew consent|2|||
156335403|NCT02100514|564326081|FG003|Extension Period|Withdrew consent|0|||
156335404|NCT02100514|564326082|FG004|Extension Period|Withdrew consent|0|||
156335405|NCT01896102|564326083|FG000|Overall Study|Death|1|||
156335406|NCT01896102|564326083|FG000|Overall Study|Participant to receive allogenic transplant|2|||
156335407|NCT00074984|564326085|FG000|Overall Study|Death|1|||
156335408|NCT00074984|564326086|FG001|Overall Study|Death|2|||
156335409|NCT00074984|564326085|FG000|Overall Study|Withdrawal by Subject|2|||
156335410|NCT00074984|564326086|FG001|Overall Study|Withdrawal by Subject|3|||
156335411|NCT00074984|564326085|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
156335412|NCT00074984|564326086|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
156335413|NCT04289623|564326087|FG000|Wave 1 Emails|Email was not delivered|268|||
156335414|NCT04289623|564326088|FG001|Wave 1 Emails|Email was not delivered|257|||
156335415|NCT04289623|564326089|FG002|Wave 1 Emails|Email was not delivered|0|||
156335416|NCT04289623|564326090|FG003|Wave 1 Emails|Email was not delivered|0|||
156335417|NCT04289623|564326091|FG004|Wave 1 Emails|Email was not delivered|0|||
156335418|NCT04289623|564326092|FG005|Wave 1 Emails|Email was not delivered|0|||
156335419|NCT03758443|564326094|FG000|Induction Period|Adverse Event|2|||
156335420|NCT03758443|564326095|FG001|Induction Period|Adverse Event|4|||
156335421|NCT03758443|564326096|FG002|Induction Period|Adverse Event|2|||
156335422|NCT03758443|564326097|FG003|Induction Period|Adverse Event|3|||
156335423|NCT03758443|564326094|FG000|Induction Period|Physician Decision|1|||
156335424|NCT03758443|564326095|FG001|Induction Period|Physician Decision|1|||
156335425|NCT03758443|564326096|FG002|Induction Period|Physician Decision|3|||
156335426|NCT03758443|564326097|FG003|Induction Period|Physician Decision|0|||
156335427|NCT03758443|564326094|FG000|Induction Period|Protocol Violation|0|||
156335428|NCT03758443|564326095|FG001|Induction Period|Protocol Violation|0|||
156335429|NCT03758443|564326096|FG002|Induction Period|Protocol Violation|0|||
156335430|NCT03758443|564326097|FG003|Induction Period|Protocol Violation|1|||
156335431|NCT03758443|564326094|FG000|Induction Period|Withdrawal by Subject|3|||
156335432|NCT03758443|564326095|FG001|Induction Period|Withdrawal by Subject|2|||
156335433|NCT03758443|564326096|FG002|Induction Period|Withdrawal by Subject|2|||
156335434|NCT03758443|564326097|FG003|Induction Period|Withdrawal by Subject|4|||
156335435|NCT03758443|564326094|FG000|Extended Induction Period|Adverse Event|1|||
156335436|NCT03758443|564326095|FG001|Extended Induction Period|Adverse Event|1|||
156335437|NCT03758443|564326096|FG002|Extended Induction Period|Adverse Event|0|||
156335438|NCT03758443|564326097|FG003|Extended Induction Period|Adverse Event|1|||
156335439|NCT03758443|564326094|FG000|Extended Induction Period|Lost to Follow-up|1|||
156335440|NCT03758443|564326095|FG001|Extended Induction Period|Lost to Follow-up|0|||
156335441|NCT03758443|564326096|FG002|Extended Induction Period|Lost to Follow-up|0|||
156335442|NCT03758443|564326097|FG003|Extended Induction Period|Lost to Follow-up|0|||
156335443|NCT03758443|564326094|FG000|Extended Induction Period|Physician Decision|2|||
156335444|NCT03758443|564326095|FG001|Extended Induction Period|Physician Decision|1|||
156335445|NCT03758443|564326096|FG002|Extended Induction Period|Physician Decision|2|||
156335446|NCT03758443|564326097|FG003|Extended Induction Period|Physician Decision|2|||
156335447|NCT03758443|564326094|FG000|Extended Induction Period|Protocol Violation|0|||
156335448|NCT03758443|564326095|FG001|Extended Induction Period|Protocol Violation|0|||
156335449|NCT03758443|564326096|FG002|Extended Induction Period|Protocol Violation|0|||
156335450|NCT03758443|564326097|FG003|Extended Induction Period|Protocol Violation|1|||
156335451|NCT03758443|564326094|FG000|Extended Induction Period|Withdrawal by Subject|8|||
156335452|NCT03758443|564326095|FG001|Extended Induction Period|Withdrawal by Subject|1|||
156335453|NCT03758443|564326096|FG002|Extended Induction Period|Withdrawal by Subject|7|||
156335454|NCT03758443|564326097|FG003|Extended Induction Period|Withdrawal by Subject|3|||
156335455|NCT03758443|564326094|FG000|Extended Induction Period|Miscellaneous|1|||
156335456|NCT03758443|564326095|FG001|Extended Induction Period|Miscellaneous|0|||
156335457|NCT03758443|564326096|FG002|Extended Induction Period|Miscellaneous|0|||
156335458|NCT03758443|564326097|FG003|Extended Induction Period|Miscellaneous|0|||
156450011|NCT04588298|564739970|FG001|Overall Study|Adverse Event|0|||
156450012|NCT04588298|564739971|FG002|Overall Study|Adverse Event|1|||
156450013|NCT04588298|564739972|FG003|Overall Study|Adverse Event|0|||
156450014|NCT04588298|564739973|FG004|Overall Study|Adverse Event|2|||
156450015|NCT04588298|564739969|FG000|Overall Study|Withdrawal by Subject|1|||
156450016|NCT04588298|564739970|FG001|Overall Study|Withdrawal by Subject|0|||
156450017|NCT04588298|564739971|FG002|Overall Study|Withdrawal by Subject|0|||
156450018|NCT04588298|564739972|FG003|Overall Study|Withdrawal by Subject|1|||
156450019|NCT04588298|564739973|FG004|Overall Study|Withdrawal by Subject|0|||
156450020|NCT02281955|564739974|FG000|Overall Study|Death|1|||
156450021|NCT01748448|564739978|FG000|Treatment Period|Consent withdrawn by subject|1|||
156450022|NCT01748448|564739979|FG001|Treatment Period|Consent withdrawn by subject|0|||
156533399|NCT02906787|565046971|FG001|Overall Study|Withdrawal by Subject|10|||
156335459|NCT03758443|564326094|FG000|Maintenance Period|Adverse Event|1|||
156335460|NCT03758443|564326095|FG001|Maintenance Period|Adverse Event|2|||
156335461|NCT03758443|564326096|FG002|Maintenance Period|Adverse Event|0|||
156335462|NCT03758443|564326097|FG003|Maintenance Period|Adverse Event|0|||
156335463|NCT03758443|564326094|FG000|Maintenance Period|Lost to Follow-up|0|||
156335464|NCT03758443|564326095|FG001|Maintenance Period|Lost to Follow-up|0|||
156335465|NCT03758443|564326096|FG002|Maintenance Period|Lost to Follow-up|0|||
156335466|NCT03758443|564326097|FG003|Maintenance Period|Lost to Follow-up|1|||
156335467|NCT03758443|564326094|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
156335468|NCT03758443|564326095|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
156335469|NCT03758443|564326096|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
156335470|NCT03758443|564326097|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
156335471|NCT03758443|564326094|FG000|Maintenance Period|Protocol Violation|0|||
156335472|NCT03758443|564326095|FG001|Maintenance Period|Protocol Violation|1|||
156335473|NCT03758443|564326096|FG002|Maintenance Period|Protocol Violation|0|||
156335474|NCT03758443|564326097|FG003|Maintenance Period|Protocol Violation|0|||
156335475|NCT03758443|564326094|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
156335476|NCT03758443|564326095|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
156335477|NCT03758443|564326096|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
156335478|NCT03758443|564326097|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
156335479|NCT03758443|564326094|FG000|Maintenance Period|Withdrawal by Subject|1|||
156335480|NCT03758443|564326095|FG001|Maintenance Period|Withdrawal by Subject|0|||
156335481|NCT03758443|564326096|FG002|Maintenance Period|Withdrawal by Subject|1|||
156335482|NCT03758443|564326097|FG003|Maintenance Period|Withdrawal by Subject|1|||
156335483|NCT03758443|564326094|FG000|Maintenance Period|Miscellaneous|0|||
156335484|NCT03758443|564326095|FG001|Maintenance Period|Miscellaneous|0|||
156335485|NCT03758443|564326096|FG002|Maintenance Period|Miscellaneous|1|||
156335486|NCT03758443|564326097|FG003|Maintenance Period|Miscellaneous|0|||
156335487|NCT03080454|564326098|FG000|Baseline|Adverse Event|2|||
156335488|NCT03080454|564326098|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
156335489|NCT03080454|564326098|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
156335490|NCT04138810|564326102|FG000|Overall Study|Withdrawal by Subject|0|||
156335491|NCT04138810|564326103|FG001|Overall Study|Withdrawal by Subject|1|||
156335492|NCT04138810|564326102|FG000|Overall Study|Subject cancelled surgery|1|||
156335493|NCT04138810|564326103|FG001|Overall Study|Subject cancelled surgery|0|||
156335494|NCT00696800|564326104|FG000|Overall Study|Adverse Event|16|||
156335495|NCT00696800|564326105|FG001|Overall Study|Adverse Event|3|||
156335496|NCT00696800|564326104|FG000|Overall Study|Insufficient compliance with medication|2|||
156335497|NCT00696800|564326105|FG001|Overall Study|Insufficient compliance with medication|1|||
156335498|NCT00696800|564326104|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
156335499|NCT00696800|564326105|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
156335500|NCT00696800|564326104|FG000|Overall Study|Insufficient ovarian response|4|||
156335501|NCT00696800|564326105|FG001|Overall Study|Insufficient ovarian response|1|||
156335502|NCT00696800|564326104|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
156335503|NCT00696800|564326105|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
156335504|NCT00696800|564326104|FG000|Overall Study|Too high ovarian response|6|||
156335505|NCT00696800|564326105|FG001|Overall Study|Too high ovarian response|1|||
156335506|NCT00696800|564326104|FG000|Overall Study|No/too few/bad quality oocytes|4|||
156335507|NCT00696800|564326105|FG001|Overall Study|No/too few/bad quality oocytes|3|||
156335508|NCT00696800|564326104|FG000|Overall Study|No/abnormal fertilization|11|||
156335509|NCT00696800|564326105|FG001|Overall Study|No/abnormal fertilization|13|||
156335510|NCT00696800|564326104|FG000|Overall Study|No/too few/bad quality embryos|24|||
156335511|NCT00696800|564326105|FG001|Overall Study|No/too few/bad quality embryos|18|||
156335512|NCT00696800|564326104|FG000|Overall Study|Other Reasons|5|||
156335513|NCT00696800|564326105|FG001|Overall Study|Other Reasons|3|||
156335514|NCT00696800|564326104|FG000|Overall Study|Not treated|1|||
156335515|NCT00696800|564326105|FG001|Overall Study|Not treated|2|||
156335516|NCT00413244|564326111|FG000|Overall Study|Withdrawal by Subject|10|||
156335517|NCT00413244|564326112|FG001|Overall Study|Withdrawal by Subject|1|||
156450023|NCT01748448|564739978|FG000|Treatment Period|Adverse Event|1|||
156450024|NCT01748448|564739979|FG001|Treatment Period|Adverse Event|0|||
156450025|NCT01748448|564739978|FG000|Treatment Period|Personal|0|||
156450026|NCT01748448|564739979|FG001|Treatment Period|Personal|1|||
156450027|NCT02907099|564739980|FG000|Overall Study|Adverse Event|1|||
156450028|NCT02907099|564739980|FG000|Overall Study|Withdrawal by Subject|2|||
156450029|NCT02907099|564739980|FG000|Overall Study|Screen Fail|2|||
156450030|NCT03110315|564739981|FG000|Overall Study|Withdrawal by Subject|1|||
156450031|NCT03110315|564739982|FG001|Overall Study|Withdrawal by Subject|0|||
156450032|NCT04593472|564742020|FG000|Overall Study|Death|31|||
156450033|NCT04593472|564742021|FG001|Overall Study|Death|27|||
156450034|NCT04593472|564742020|FG000|Overall Study|Withdrawal by Subject|12|||
156450035|NCT04593472|564742021|FG001|Overall Study|Withdrawal by Subject|12|||
156450036|NCT04593472|564742020|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
156450037|NCT04593472|564742021|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
156450038|NCT04593472|564742020|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
156450039|NCT04593472|564742021|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
156450040|NCT04593472|564742020|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
156450041|NCT04593472|564742021|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
156450042|NCT04593472|564742020|FG000|Overall Study|Lost to Follow-up|0|||
156450043|NCT04593472|564742021|FG001|Overall Study|Lost to Follow-up|2|||
156450044|NCT04593472|564742020|FG000|Overall Study|Still collecting 24-month assessment|17|||
156450045|NCT04593472|564742021|FG001|Overall Study|Still collecting 24-month assessment|10|||
156450046|NCT02992925|564742022|FG000|Cohort 2|Physician Decision|0|||
156450047|NCT02992925|564742023|FG001|Cohort 2|Physician Decision|0|||
156450048|NCT02992925|564742024|FG002|Cohort 2|Physician Decision|1|||
156450049|NCT02992925|564742025|FG003|Cohort 2|Physician Decision|0|||
156450050|NCT02992925|564742022|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
156450051|NCT02992925|564742023|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
156450052|NCT02992925|564742024|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
156450053|NCT02992925|564742025|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
156450054|NCT03175029|564742028|FG000|Overall Study|Withdrawal by Subject|2|||
156450055|NCT03175029|564742029|FG001|Overall Study|Withdrawal by Subject|1|||
156450056|NCT03175029|564742028|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
156450057|NCT03175029|564742029|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
156450058|NCT03047928|564742033|FG000|Overall Study|Adverse Event|0|||
156450059|NCT03047928|564742034|FG001|Overall Study|Adverse Event|2|||
156450060|NCT03047928|564742035|FG002|Overall Study|Adverse Event|0|||
156450061|NCT03047928|564742033|FG000|Overall Study|Protocol Violation|0|||
156450062|NCT03047928|564742034|FG001|Overall Study|Protocol Violation|1|||
156450063|NCT03047928|564742035|FG002|Overall Study|Protocol Violation|0|||
156450064|NCT03047928|564742033|FG000|Overall Study|included in another protocol|0|||
156450065|NCT03047928|564742034|FG001|Overall Study|included in another protocol|1|||
156450066|NCT03047928|564742035|FG002|Overall Study|included in another protocol|0|||
156450067|NCT04034251|564742036|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
156450068|NCT04034251|564742037|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
156450069|NCT04034251|564742038|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
156450070|NCT04950660|564742039|FG000|Overall Study|Protocol Violation|4|||
156450071|NCT04950660|564742040|FG001|Overall Study|Protocol Violation|2|||
156450072|NCT04950660|564742039|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
156721176|NCT01894919|565725822|FG011|Overall Study|Adverse Event|0|||
156721177|NCT01894919|565725823|FG012|Overall Study|Adverse Event|0|||
156721178|NCT01894919|565725811|FG000|Overall Study|Other-Unspecified|1|||
156450073|NCT04950660|564742040|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
156450074|NCT04950660|564742039|FG000|Overall Study|Withdrawal by Subject|0|||
156450075|NCT04950660|564742040|FG001|Overall Study|Withdrawal by Subject|1|||
156450076|NCT04950660|564742039|FG000|Overall Study|Hypotension|1|||
156450077|NCT04950660|564742040|FG001|Overall Study|Hypotension|0|||
156450078|NCT02437318|564742041|FG000|Overall Study|Progressive disease|207|||
156450079|NCT02437318|564742042|FG001|Overall Study|Progressive disease|240|||
156450080|NCT02437318|564742041|FG000|Overall Study|Subject/guardian decision|24|||
156721179|NCT01894919|565725812|FG001|Overall Study|Other-Unspecified|0|||
156721180|NCT01894919|565725813|FG002|Overall Study|Other-Unspecified|0|||
156721181|NCT01894919|565725814|FG003|Overall Study|Other-Unspecified|0|||
156721182|NCT01894919|565725815|FG004|Overall Study|Other-Unspecified|0|||
156721183|NCT01894919|565725816|FG005|Overall Study|Other-Unspecified|0|||
156721184|NCT01894919|565725817|FG006|Overall Study|Other-Unspecified|0|||
156721185|NCT01894919|565725818|FG007|Overall Study|Other-Unspecified|0|||
156721186|NCT01894919|565725819|FG008|Overall Study|Other-Unspecified|0|||
156721187|NCT01894919|565725820|FG009|Overall Study|Other-Unspecified|0|||
156721188|NCT01894919|565725821|FG010|Overall Study|Other-Unspecified|0|||
156721189|NCT01894919|565725822|FG011|Overall Study|Other-Unspecified|0|||
156450081|NCT02437318|564742042|FG001|Overall Study|Subject/guardian decision|11|||
156450082|NCT02437318|564742041|FG000|Overall Study|Physician Decision|29|||
156450083|NCT02437318|564742042|FG001|Overall Study|Physician Decision|22|||
156450084|NCT02437318|564742041|FG000|Overall Study|Adverse Event|14|||
156450085|NCT02437318|564742042|FG001|Overall Study|Adverse Event|4|||
156450086|NCT02437318|564742041|FG000|Overall Study|Death|4|||
156450087|NCT02437318|564742042|FG001|Overall Study|Death|4|||
156450088|NCT02437318|564742041|FG000|Overall Study|Protocol deviation|5|||
156450089|NCT02437318|564742042|FG001|Overall Study|Protocol deviation|7|||
156450090|NCT02437318|564742041|FG000|Overall Study|Sponsor decision|1|||
156450091|NCT02437318|564742042|FG001|Overall Study|Sponsor decision|0|||
156450092|NCT05273749|564742044|FG000|Overall Study|Adverse Event|14|||
156450093|NCT05273749|564742045|FG001|Overall Study|Adverse Event|8|||
156450094|NCT05273749|564742044|FG000|Overall Study|Lack of Efficacy|2|||
156450095|NCT05273749|564742045|FG001|Overall Study|Lack of Efficacy|8|||
156450096|NCT05273749|564742044|FG000|Overall Study|Physician Decision|0|||
156450097|NCT05273749|564742045|FG001|Overall Study|Physician Decision|2|||
156450098|NCT05273749|564742044|FG000|Overall Study|Withdrawal by Subject|14|||
156450099|NCT05273749|564742045|FG001|Overall Study|Withdrawal by Subject|16|||
156450100|NCT05273749|564742044|FG000|Overall Study|Lost to Follow-up|10|||
156450101|NCT05273749|564742045|FG001|Overall Study|Lost to Follow-up|10|||
156450102|NCT05273749|564742044|FG000|Overall Study|Pregnancy|1|||
156450103|NCT05273749|564742045|FG001|Overall Study|Pregnancy|0|||
156450104|NCT05273749|564742044|FG000|Overall Study|Non-Compliance|3|||
156450105|NCT05273749|564742045|FG001|Overall Study|Non-Compliance|2|||
156450106|NCT05273749|564742044|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
156450107|NCT05273749|564742045|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
156450108|NCT03281291|564742046|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
156450109|NCT03281291|564742047|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
156450110|NCT03281291|564742048|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
156450111|NCT03281291|564742049|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
156450112|NCT03281291|564742050|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
156450113|NCT03281291|564742046|FG000|Overall Study|Protocol Deviation|2|||
156450114|NCT03281291|564742047|FG001|Overall Study|Protocol Deviation|0|||
156450115|NCT03281291|564742048|FG002|Overall Study|Protocol Deviation|1|||
156450116|NCT03281291|564742049|FG003|Overall Study|Protocol Deviation|2|||
156450117|NCT03281291|564742050|FG004|Overall Study|Protocol Deviation|1|||
156450118|NCT03281291|564742046|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
156450119|NCT03281291|564742047|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
156450120|NCT03281291|564742048|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
156450121|NCT03281291|564742049|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
156450122|NCT03281291|564742050|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
156450123|NCT03281291|564742046|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
156450124|NCT03281291|564742047|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
156450125|NCT03281291|564742048|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
156450126|NCT03281291|564742049|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
156450127|NCT03281291|564742050|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
156450128|NCT03281291|564742046|FG000|Overall Study|Lost to Follow-up|10|||
156450129|NCT03281291|564742047|FG001|Overall Study|Lost to Follow-up|10|||
156450130|NCT03281291|564742048|FG002|Overall Study|Lost to Follow-up|4|||
156450131|NCT03281291|564742049|FG003|Overall Study|Lost to Follow-up|6|||
156450132|NCT03281291|564742050|FG004|Overall Study|Lost to Follow-up|10|||
156450133|NCT03281291|564742046|FG000|Overall Study|Other|0|||
156450134|NCT03281291|564742047|FG001|Overall Study|Other|2|||
156450135|NCT03281291|564742048|FG002|Overall Study|Other|0|||
156450136|NCT03281291|564742049|FG003|Overall Study|Other|2|||
156450137|NCT03281291|564742050|FG004|Overall Study|Other|1|||
156450138|NCT04956861|564742051|FG000|Overall Study|Withdrawal by Subject|4|||
156875418|NCT00622440|566302061|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
156875419|NCT00622440|566302060|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
156875420|NCT00622440|566302061|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
156875421|NCT00771953|566302064|FG000|Overall Study|Adverse Event|5|||
156450139|NCT04956861|564742052|FG001|Overall Study|Withdrawal by Subject|4|||
156450140|NCT04956861|564742053|FG002|Overall Study|Withdrawal by Subject|2|||
156450141|NCT04956861|564742051|FG000|Overall Study|Physician Decision|4|||
156875422|NCT00771953|566302065|FG001|Overall Study|Adverse Event|3|||
156450142|NCT04956861|564742052|FG001|Overall Study|Physician Decision|5|||
156450143|NCT04956861|564742053|FG002|Overall Study|Physician Decision|1|||
156450144|NCT02736409|564742054|FG000|Overall Study|Withdrawal by Subject|4|||
156450145|NCT02736409|564742055|FG001|Overall Study|Withdrawal by Subject|2|||
156450146|NCT02736409|564742056|FG002|Overall Study|Withdrawal by Subject|17|||
156450147|NCT02736409|564742057|FG003|Overall Study|Withdrawal by Subject|3|||
156450148|NCT02736409|564742054|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156875423|NCT00771953|566302064|FG000|Overall Study|Death|2|||
156875424|NCT00771953|566302065|FG001|Overall Study|Death|2|||
156335518|NCT01058655|564326114|FG000|Overall Study|Withdrawal by Subject|1|||
156335519|NCT01058655|564326115|FG001|Overall Study|Withdrawal by Subject|0|||
156450149|NCT02736409|564742055|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156450150|NCT02736409|564742056|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156450151|NCT02736409|564742057|FG003|Overall Study|Non-Compliance with Study Drug|1|||
156721190|NCT01894919|565725823|FG012|Overall Study|Other-Unspecified|0|||
156721191|NCT01894919|565725811|FG000|Overall Study|Lost to Follow-up|0|||
156721192|NCT01894919|565725812|FG001|Overall Study|Lost to Follow-up|0|||
156721193|NCT01894919|565725813|FG002|Overall Study|Lost to Follow-up|0|||
156721194|NCT01894919|565725814|FG003|Overall Study|Lost to Follow-up|0|||
156721195|NCT01894919|565725815|FG004|Overall Study|Lost to Follow-up|2|||
156721196|NCT01894919|565725816|FG005|Overall Study|Lost to Follow-up|0|||
156721197|NCT01894919|565725817|FG006|Overall Study|Lost to Follow-up|0|||
156721198|NCT01894919|565725818|FG007|Overall Study|Lost to Follow-up|0|||
156721199|NCT01894919|565725819|FG008|Overall Study|Lost to Follow-up|0|||
156721200|NCT01894919|565725820|FG009|Overall Study|Lost to Follow-up|0|||
156721201|NCT01894919|565725821|FG010|Overall Study|Lost to Follow-up|0|||
156721202|NCT01894919|565725822|FG011|Overall Study|Lost to Follow-up|0|||
156721203|NCT01894919|565725823|FG012|Overall Study|Lost to Follow-up|0|||
156721204|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
156721205|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
156721206|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
156721207|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
156721208|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
156721209|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
156721210|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
156721211|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
156721212|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
156721213|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
156721214|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Other|0|||
156721215|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Other|1|||
156721216|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
156721217|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
156721218|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
156721219|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
156721220|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
156721221|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
156721222|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
156721223|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
156721224|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
156875425|NCT00771953|566302064|FG000|Overall Study|Progression before active Tx|1|||
156335520|NCT01058655|564326116|FG002|Overall Study|Withdrawal by Subject|3|||
156335521|NCT01058655|564326117|FG003|Overall Study|Withdrawal by Subject|4|||
156335522|NCT01058655|564326114|FG000|Overall Study|Prolonged Treatment Delay|0|||
156335523|NCT01058655|564326115|FG001|Overall Study|Prolonged Treatment Delay|0|||
156335524|NCT01058655|564326116|FG002|Overall Study|Prolonged Treatment Delay|0|||
156335525|NCT01058655|564326117|FG003|Overall Study|Prolonged Treatment Delay|2|||
156335526|NCT01058655|564326114|FG000|Overall Study|Symptomatic Deterioration|0|||
156335527|NCT01058655|564326115|FG001|Overall Study|Symptomatic Deterioration|0|||
156335528|NCT01058655|564326116|FG002|Overall Study|Symptomatic Deterioration|0|||
156335529|NCT01058655|564326117|FG003|Overall Study|Symptomatic Deterioration|1|||
156335530|NCT01058655|564326114|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
156335531|NCT01058655|564326115|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
156335532|NCT01058655|564326116|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
156335533|NCT01058655|564326117|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
156335534|NCT01058655|564326114|FG000|Overall Study|Death|0|||
156335535|NCT01058655|564326115|FG001|Overall Study|Death|1|||
156335536|NCT01058655|564326116|FG002|Overall Study|Death|1|||
156335537|NCT01058655|564326117|FG003|Overall Study|Death|0|||
156335538|NCT01058655|564326114|FG000|Overall Study|Disease Progression|1|||
156335539|NCT01058655|564326115|FG001|Overall Study|Disease Progression|2|||
156335540|NCT01058655|564326116|FG002|Overall Study|Disease Progression|4|||
156335541|NCT01058655|564326117|FG003|Overall Study|Disease Progression|24|||
156335542|NCT01058655|564326114|FG000|Overall Study|Other|0|||
156335543|NCT01058655|564326115|FG001|Overall Study|Other|0|||
156335544|NCT01058655|564326116|FG002|Overall Study|Other|0|||
156335545|NCT01058655|564326117|FG003|Overall Study|Other|4|||
156335546|NCT01609231|564326118|FG000|Overall Study|Adverse Event|1|||
156335547|NCT01609231|564326119|FG001|Overall Study|Adverse Event|3|||
156335548|NCT01609231|564326118|FG000|Overall Study|Physician Decision|1|||
156335549|NCT01609231|564326119|FG001|Overall Study|Physician Decision|0|||
156335550|NCT01609231|564326118|FG000|Overall Study|Withdrawal by Subject|1|||
156335551|NCT01609231|564326119|FG001|Overall Study|Withdrawal by Subject|0|||
156335552|NCT01180647|564326120|FG000|Overall Study|Lost to Follow-up|5|||
156450152|NCT02736409|564742054|FG000|Overall Study|Adverse Event|0|||
156450153|NCT02736409|564742055|FG001|Overall Study|Adverse Event|1|||
156450154|NCT02736409|564742056|FG002|Overall Study|Adverse Event|5|||
156450155|NCT02736409|564742057|FG003|Overall Study|Adverse Event|4|||
156450156|NCT02736409|564742054|FG000|Overall Study|Other|0|||
156450157|NCT02736409|564742055|FG001|Overall Study|Other|0|||
156450158|NCT02736409|564742056|FG002|Overall Study|Other|1|||
156450159|NCT02736409|564742057|FG003|Overall Study|Other|1|||
156450160|NCT02736409|564742054|FG000|Overall Study|Pregnancy|0|||
156450161|NCT02736409|564742055|FG001|Overall Study|Pregnancy|0|||
156450162|NCT02736409|564742056|FG002|Overall Study|Pregnancy|1|||
156450163|NCT02736409|564742057|FG003|Overall Study|Pregnancy|0|||
156450164|NCT02736409|564742054|FG000|Overall Study|Lost to Follow-up|0|||
156450165|NCT02736409|564742055|FG001|Overall Study|Lost to Follow-up|0|||
156450166|NCT02736409|564742056|FG002|Overall Study|Lost to Follow-up|2|||
156450167|NCT02736409|564742057|FG003|Overall Study|Lost to Follow-up|1|||
156450168|NCT02736409|564742054|FG000|Overall Study|Physician Decision|0|||
156450169|NCT02736409|564742055|FG001|Overall Study|Physician Decision|0|||
156450170|NCT02736409|564742056|FG002|Overall Study|Physician Decision|0|||
156450171|NCT02736409|564742057|FG003|Overall Study|Physician Decision|2|||
156450172|NCT01415154|564742058|FG000|Overall Study|Lack of Efficacy|4|||
156450173|NCT01415154|564742059|FG001|Overall Study|Lack of Efficacy|5|||
156450174|NCT01415154|564742058|FG000|Overall Study|Withdrawal by Subject|7|||
156450175|NCT01415154|564742059|FG001|Overall Study|Withdrawal by Subject|8|||
156533400|NCT02906787|565046970|FG000|Overall Study|Missed|24|||
156533401|NCT02906787|565046971|FG001|Overall Study|Missed|22|||
156533402|NCT03901053|565046976|FG000|Overall Study|Lost to Follow-up|6|||
156533403|NCT03901053|565046977|FG001|Overall Study|Lost to Follow-up|2|||
156721225|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
156450176|NCT01415154|564742058|FG000|Overall Study|Lost to Follow-up|1|||
156450177|NCT01415154|564742059|FG001|Overall Study|Lost to Follow-up|4|||
156450178|NCT01415154|564742058|FG000|Overall Study|Protocol Violation|0|||
156533404|NCT03901053|565046976|FG000|Overall Study|Withdrawal by Subject|4|||
156533405|NCT03901053|565046977|FG001|Overall Study|Withdrawal by Subject|3|||
156533406|NCT03901053|565046976|FG000|Overall Study|Unsatisfactory Device|1|||
156533407|NCT03901053|565046977|FG001|Overall Study|Unsatisfactory Device|2|||
156721226|NCT03762265|565725828|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
156721227|NCT03762265|565725829|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
156450179|NCT01415154|564742059|FG001|Overall Study|Protocol Violation|1|||
156450180|NCT01415154|564742058|FG000|Overall Study|Satisfactory Response|0|||
156450181|NCT01415154|564742059|FG001|Overall Study|Satisfactory Response|1|||
156450182|NCT01415154|564742058|FG000|Overall Study|Adverse Event|1|||
156450183|NCT01415154|564742059|FG001|Overall Study|Adverse Event|1|||
156450184|NCT03126019|564742061|FG000|Overall Study|Death|5|||
156450185|NCT03126019|564742062|FG001|Overall Study|Death|27|||
156450186|NCT03126019|564742061|FG000|Overall Study|Lost to Follow-up|2|||
156450187|NCT03126019|564742062|FG001|Overall Study|Lost to Follow-up|4|||
156450188|NCT03126019|564742061|FG000|Overall Study|Withdrawal by Subject|1|||
156450189|NCT03126019|564742062|FG001|Overall Study|Withdrawal by Subject|9|||
156450190|NCT03126019|564742061|FG000|Overall Study|Physician Decision|1|||
156450191|NCT03126019|564742062|FG001|Overall Study|Physician Decision|0|||
156450192|NCT03126019|564742061|FG000|Overall Study|Transitioned to Rollover Study|0|||
156450193|NCT03126019|564742062|FG001|Overall Study|Transitioned to Rollover Study|11|||
156450194|NCT03126019|564742061|FG000|Overall Study|Did Not Return to Site for Care|0|||
156450195|NCT03126019|564742062|FG001|Overall Study|Did Not Return to Site for Care|1|||
156721228|NCT03762265|565725828|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
156721229|NCT03762265|565725829|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
156721230|NCT03762265|565725828|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
156721231|NCT03762265|565725829|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
156721232|NCT03762265|565725828|FG000|LTE Period: Weeks 61 to 109|Other|1|||
156721233|NCT03762265|565725829|FG001|LTE Period: Weeks 61 to 109|Other|0|||
156450196|NCT03126019|564742061|FG000|Overall Study|Site Closed|0|||
156450197|NCT03126019|564742062|FG001|Overall Study|Site Closed|1|||
156450198|NCT00170573|564742066|FG000|Overall Study|Violation of inclusion criteria|13|||
156450199|NCT03763708|564742080|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
156450200|NCT03763708|564742081|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
156450201|NCT03763708|564742082|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
156450202|NCT03763708|564742083|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
156721234|NCT02289729|565725830|FG000|Overall Study|Lack of Efficacy|3|||
156450203|NCT03763708|564742084|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
156450204|NCT03763708|564742085|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
156450205|NCT03763708|564742086|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
156450206|NCT03763708|564742087|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
156450207|NCT03763708|564742088|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
156450208|NCT03763708|564742080|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
156533408|NCT03901053|565046976|FG000|Overall Study|No longer meets study criteria|1|||
156533409|NCT03901053|565046977|FG001|Overall Study|No longer meets study criteria|3|||
156450209|NCT03763708|564742081|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
156450210|NCT03763708|564742082|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
156450211|NCT03763708|564742083|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
156450212|NCT03763708|564742084|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
156450213|NCT03763708|564742085|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
156450214|NCT03763708|564742086|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
156450215|NCT03763708|564742087|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
156721235|NCT02289729|565725830|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
156721236|NCT02289729|565725830|FG000|Overall Study|Withdrawal by Subject|1|||
156721237|NCT02289729|565725830|FG000|Overall Study|Death|1|||
156721238|NCT00470470|565725831|FG000|Overall Study|Adverse Event|2|||
156721239|NCT00470470|565725831|FG000|Overall Study|Death|2|||
156721240|NCT00470470|565725831|FG000|Overall Study|Not treated|1|||
156721241|NCT01149863|565725834|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
156721242|NCT01256879|565725835|FG000|Overall Study|Withdrawal by Subject|1|||
156721243|NCT00640315|565725836|FG000|Overall Study|Withdrawal by Subject|0|||
156721244|NCT00640315|565725837|FG001|Overall Study|Withdrawal by Subject|1|||
156721245|NCT00397514|565725838|FG000|Overall Study|Withdrawal by Subject|1|||
156721246|NCT00397514|565725838|FG000|Overall Study|Pacing wire malfunction|1|||
156721247|NCT00397514|565725838|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
156721248|NCT00397514|565725838|FG000|Overall Study|early extubation|2|||
156721249|NCT00397514|565725838|FG000|Overall Study|poor echocardiographic windows|1|||
156721250|NCT00725920|565725839|FG000|Overall Study|Lack of Efficacy|3|||
156721251|NCT00725920|565725840|FG001|Overall Study|Lack of Efficacy|6|||
156721252|NCT02286713|565725841|FG000|One Week Follow-Up|Death|1|||
156721253|NCT02286713|565725842|FG001|One Week Follow-Up|Death|0|||
156721254|NCT02286713|565725841|FG000|One Week Follow-Up|Lost to Follow-up|17|||
156721255|NCT02286713|565725842|FG001|One Week Follow-Up|Lost to Follow-up|21|||
156721256|NCT02286713|565725841|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
156721257|NCT02286713|565725842|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
156721258|NCT02286713|565725841|FG000|Three Month Follow-Up|Death|1|||
156721259|NCT02286713|565725842|FG001|Three Month Follow-Up|Death|1|||
156721260|NCT02286713|565725841|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
156721261|NCT02286713|565725842|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
156721262|NCT02286713|565725841|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
156721263|NCT02286713|565725842|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
156721264|NCT02286713|565725841|FG000|Six Month Follow-Up|Death|2|||
156721265|NCT02286713|565725842|FG001|Six Month Follow-Up|Death|0|||
156721266|NCT02286713|565725841|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
156721267|NCT02286713|565725842|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
156721268|NCT04314037|565725844|FG000|Treatment Period 2|Adverse Event|1|||
156721269|NCT04314037|565725845|FG001|Treatment Period 2|Adverse Event|0|||
156721270|NCT04314037|565725844|FG000|Treatment Period 3|Protocol Violation|1|||
156721271|NCT04314037|565725845|FG001|Treatment Period 3|Protocol Violation|0|||
156721272|NCT04314037|565725844|FG000|Treatment Period 3|Adverse Event|0|||
156721273|NCT04314037|565725845|FG001|Treatment Period 3|Adverse Event|1|||
156721274|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
156721275|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
156721276|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
156721277|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
156721278|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156721279|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
156721280|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
156721281|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
156721282|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
156721283|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Other|1|||
156721284|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Other|0|||
156721285|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Other|4|||
156721286|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156721287|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156721288|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
156721289|NCT00856492|565725852|FG000|Overall Study|Ineligible or withdrew consent|1|||
156721290|NCT00856492|565725853|FG001|Overall Study|Ineligible or withdrew consent|1|||
156721291|NCT00856492|565725854|FG002|Overall Study|Ineligible or withdrew consent|2|||
156721292|NCT06018129|565725855|FG000|Overall Study|Death|1|||
156721293|NCT06018129|565725856|FG001|Overall Study|Death|1|||
156721294|NCT06018129|565725857|FG002|Overall Study|Death|2|||
156721295|NCT06018129|565725855|FG000|Overall Study|Sponsor Decision|2|||
156721296|NCT06018129|565725856|FG001|Overall Study|Sponsor Decision|2|||
156721297|NCT06018129|565725857|FG002|Overall Study|Sponsor Decision|1|||
156721298|NCT03832686|565725858|FG000|Overall Study|Lost to Follow-up|6|||
156721299|NCT03832686|565725859|FG001|Overall Study|Lost to Follow-up|9|||
156335553|NCT01180647|564326121|FG001|Overall Study|Lost to Follow-up|6|||
156721300|NCT03832686|565725858|FG000|Overall Study|Discontinued Intervention|5|||
156335554|NCT00494299|564326130|FG000|Overall Study|Adverse Event|93|||
156450216|NCT03763708|564742088|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
156450217|NCT03763708|564742080|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156450218|NCT03763708|564742081|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156450219|NCT03763708|564742082|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156450220|NCT03763708|564742083|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
156450221|NCT03763708|564742084|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156450222|NCT03763708|564742085|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156450223|NCT03763708|564742086|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156450224|NCT03763708|564742087|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156450225|NCT03763708|564742088|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156450226|NCT03763708|564742080|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156450227|NCT03763708|564742081|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156450228|NCT03763708|564742082|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156450229|NCT03763708|564742083|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156450230|NCT03763708|564742084|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
156721301|NCT03832686|565725859|FG001|Overall Study|Discontinued Intervention|4|||
156721302|NCT03323398|565725860|FG000|Overall Study|Other than Specified|0|||
156721303|NCT03323398|565725861|FG001|Overall Study|Other than Specified|1|||
156721304|NCT03323398|565725862|FG002|Overall Study|Other than Specified|2|||
156721305|NCT03323398|565725863|FG003|Overall Study|Other than Specified|0|||
156721306|NCT03323398|565725864|FG004|Overall Study|Other than Specified|0|||
156721307|NCT03323398|565725865|FG005|Overall Study|Other than Specified|0|||
156721308|NCT03323398|565725866|FG006|Overall Study|Other than Specified|1|||
156721309|NCT03323398|565725867|FG007|Overall Study|Other than Specified|0|||
156721310|NCT03323398|565725868|FG008|Overall Study|Other than Specified|2|||
156721311|NCT03323398|565725860|FG000|Overall Study|Lost to Follow-up|1|||
156721312|NCT03323398|565725861|FG001|Overall Study|Lost to Follow-up|2|||
156721313|NCT03323398|565725862|FG002|Overall Study|Lost to Follow-up|1|||
156721314|NCT03323398|565725863|FG003|Overall Study|Lost to Follow-up|0|||
156721315|NCT03323398|565725864|FG004|Overall Study|Lost to Follow-up|0|||
156721316|NCT03323398|565725865|FG005|Overall Study|Lost to Follow-up|0|||
156721317|NCT03323398|565725866|FG006|Overall Study|Lost to Follow-up|0|||
156721318|NCT03323398|565725867|FG007|Overall Study|Lost to Follow-up|0|||
156721319|NCT03323398|565725868|FG008|Overall Study|Lost to Follow-up|0|||
156721320|NCT03323398|565725860|FG000|Overall Study|Death|4|||
156721321|NCT03323398|565725861|FG001|Overall Study|Death|6|||
156721322|NCT03323398|565725862|FG002|Overall Study|Death|2|||
156721323|NCT03323398|565725863|FG003|Overall Study|Death|2|||
156721324|NCT03323398|565725864|FG004|Overall Study|Death|1|||
156721325|NCT03323398|565725865|FG005|Overall Study|Death|2|||
156721326|NCT03323398|565725866|FG006|Overall Study|Death|0|||
156721327|NCT03323398|565725867|FG007|Overall Study|Death|0|||
156721328|NCT03323398|565725868|FG008|Overall Study|Death|6|||
156721329|NCT03323398|565725860|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
156721330|NCT03323398|565725861|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
156721331|NCT03323398|565725862|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
156721332|NCT03323398|565725863|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
156721333|NCT03323398|565725864|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
156721334|NCT03323398|565725865|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
156721335|NCT03323398|565725866|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
156721336|NCT03323398|565725867|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
156721337|NCT03323398|565725868|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
156721338|NCT03323398|565725860|FG000|Overall Study|Withdrawal by Subject|2|||
156721339|NCT03323398|565725861|FG001|Overall Study|Withdrawal by Subject|1|||
156721340|NCT03323398|565725862|FG002|Overall Study|Withdrawal by Subject|3|||
156721341|NCT03323398|565725863|FG003|Overall Study|Withdrawal by Subject|0|||
156721342|NCT03323398|565725864|FG004|Overall Study|Withdrawal by Subject|0|||
156721343|NCT03323398|565725865|FG005|Overall Study|Withdrawal by Subject|1|||
156721344|NCT03323398|565725866|FG006|Overall Study|Withdrawal by Subject|0|||
156721345|NCT03323398|565725867|FG007|Overall Study|Withdrawal by Subject|0|||
156721346|NCT03323398|565725868|FG008|Overall Study|Withdrawal by Subject|0|||
156721347|NCT03323398|565725860|FG000|Overall Study|Participant was Put on Hospice|0|||
156721348|NCT03323398|565725861|FG001|Overall Study|Participant was Put on Hospice|0|||
156721349|NCT03323398|565725862|FG002|Overall Study|Participant was Put on Hospice|0|||
156721350|NCT03323398|565725863|FG003|Overall Study|Participant was Put on Hospice|0|||
156450231|NCT03763708|564742085|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156450232|NCT03763708|564742086|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156721351|NCT03323398|565725864|FG004|Overall Study|Participant was Put on Hospice|0|||
156721352|NCT03323398|565725865|FG005|Overall Study|Participant was Put on Hospice|0|||
156721353|NCT03323398|565725866|FG006|Overall Study|Participant was Put on Hospice|1|||
156721354|NCT03323398|565725867|FG007|Overall Study|Participant was Put on Hospice|0|||
156721355|NCT03323398|565725868|FG008|Overall Study|Participant was Put on Hospice|0|||
156450233|NCT03763708|564742087|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156450234|NCT03763708|564742088|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156450235|NCT03763708|564742080|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156450236|NCT03763708|564742081|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156450237|NCT03763708|564742082|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156450238|NCT03763708|564742083|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156450239|NCT03763708|564742084|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156450240|NCT03763708|564742085|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
156450241|NCT03763708|564742086|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156450242|NCT03763708|564742087|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156450243|NCT03763708|564742088|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156450244|NCT03763708|564742080|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156450245|NCT03763708|564742081|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156450246|NCT03763708|564742082|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156450247|NCT03763708|564742083|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156450248|NCT03763708|564742084|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156450249|NCT03763708|564742085|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156450250|NCT03763708|564742086|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
156450251|NCT03763708|564742087|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156450252|NCT03763708|564742088|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156450253|NCT03763708|564742080|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
156450254|NCT03763708|564742081|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
156450255|NCT03763708|564742082|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
156450256|NCT03763708|564742083|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
156450257|NCT03763708|564742084|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
156450258|NCT03763708|564742085|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
156450259|NCT03763708|564742086|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
156450260|NCT03763708|564742087|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
156450261|NCT03763708|564742088|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
156450262|NCT03763708|564742080|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
156450263|NCT03763708|564742081|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
156450264|NCT03763708|564742082|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
156450265|NCT03763708|564742083|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
156450266|NCT03763708|564742084|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
156450267|NCT03763708|564742085|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
156450268|NCT03763708|564742086|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
156450269|NCT03763708|564742087|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
156450270|NCT03763708|564742088|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
156450271|NCT03763708|564742080|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
156450272|NCT03763708|564742081|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
156450273|NCT03763708|564742082|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
156450274|NCT03763708|564742083|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
156450275|NCT03763708|564742084|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
156450276|NCT03763708|564742085|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
156450277|NCT03763708|564742086|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
156450278|NCT03763708|564742087|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
156450279|NCT03763708|564742088|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
156450280|NCT03138512|564742091|FG000|Randomization|Participants withdrew consent|0|||
156450281|NCT03138512|564742092|FG001|Randomization|Participants withdrew consent|1|||
156450282|NCT03138512|564742093|FG002|Randomization|Participants withdrew consent|1|||
156450283|NCT03138512|564742094|FG003|Randomization|Participants withdrew consent|0|||
156450284|NCT03138512|564742095|FG004|Randomization|Participants withdrew consent|0|||
156450285|NCT03138512|564742091|FG000|Randomization|Participant no longer meets study criteria|0|||
156450286|NCT03138512|564742092|FG001|Randomization|Participant no longer meets study criteria|3|||
156450287|NCT03138512|564742093|FG002|Randomization|Participant no longer meets study criteria|1|||
156450288|NCT03138512|564742094|FG003|Randomization|Participant no longer meets study criteria|1|||
156794100|NCT03715829|565999494|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794101|NCT03715829|565999495|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794102|NCT03715829|565999496|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794103|NCT03715829|565999497|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794104|NCT03715829|565999498|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794105|NCT03715829|565999499|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
156450289|NCT03138512|564742095|FG004|Randomization|Participant no longer meets study criteria|3|||
156450290|NCT03138512|564742091|FG000|Randomization|Other reasons|1|||
156450291|NCT03138512|564742092|FG001|Randomization|Other reasons|0|||
156450292|NCT03138512|564742093|FG002|Randomization|Other reasons|0|||
156450293|NCT03138512|564742094|FG003|Randomization|Other reasons|0|||
156450294|NCT03138512|564742095|FG004|Randomization|Other reasons|0|||
156450295|NCT03138512|564742091|FG000|Treatment Part A|Disease recurrence|10|||
156450296|NCT03138512|564742092|FG001|Treatment Part A|Disease recurrence|20|||
156450297|NCT03138512|564742093|FG002|Treatment Part A|Disease recurrence|0|||
156450298|NCT03138512|564742094|FG003|Treatment Part A|Disease recurrence|0|||
156450299|NCT03138512|564742095|FG004|Treatment Part A|Disease recurrence|0|||
156450300|NCT03138512|564742091|FG000|Treatment Part A|Study Drug Toxicity|132|||
156450301|NCT03138512|564742092|FG001|Treatment Part A|Study Drug Toxicity|5|||
156450302|NCT03138512|564742093|FG002|Treatment Part A|Study Drug Toxicity|0|||
156450303|NCT03138512|564742094|FG003|Treatment Part A|Study Drug Toxicity|0|||
156450304|NCT03138512|564742095|FG004|Treatment Part A|Study Drug Toxicity|0|||
156450305|NCT03138512|564742091|FG000|Treatment Part A|Death|1|||
156450306|NCT03138512|564742092|FG001|Treatment Part A|Death|0|||
156450307|NCT03138512|564742093|FG002|Treatment Part A|Death|0|||
156450308|NCT03138512|564742094|FG003|Treatment Part A|Death|0|||
156450309|NCT03138512|564742095|FG004|Treatment Part A|Death|0|||
156450310|NCT03138512|564742091|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
156450311|NCT03138512|564742092|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
156450312|NCT03138512|564742093|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
156450313|NCT03138512|564742094|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
156450314|NCT03138512|564742095|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
156450315|NCT03138512|564742091|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
156450316|NCT03138512|564742092|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
156450317|NCT03138512|564742093|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
156450318|NCT03138512|564742094|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
156450319|NCT03138512|564742095|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
156450320|NCT03138512|564742091|FG000|Treatment Part A|Participant withdrew consent|2|||
156450321|NCT03138512|564742092|FG001|Treatment Part A|Participant withdrew consent|4|||
156450322|NCT03138512|564742093|FG002|Treatment Part A|Participant withdrew consent|0|||
156450323|NCT03138512|564742094|FG003|Treatment Part A|Participant withdrew consent|0|||
156450324|NCT03138512|564742095|FG004|Treatment Part A|Participant withdrew consent|0|||
156450325|NCT03138512|564742091|FG000|Treatment Part A|Lost to Follow-up|0|||
156450326|NCT03138512|564742092|FG001|Treatment Part A|Lost to Follow-up|1|||
156721356|NCT03323398|565725860|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
156721357|NCT03323398|565725861|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
156721358|NCT03323398|565725862|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
156721359|NCT03323398|565725863|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
156721360|NCT03323398|565725864|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
156721361|NCT03323398|565725865|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
156721362|NCT03323398|565725866|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
156794106|NCT03715829|565999500|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
156794107|NCT03715829|565999501|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
156450327|NCT03138512|564742093|FG002|Treatment Part A|Lost to Follow-up|0|||
156450328|NCT03138512|564742094|FG003|Treatment Part A|Lost to Follow-up|0|||
156450329|NCT03138512|564742095|FG004|Treatment Part A|Lost to Follow-up|0|||
156450330|NCT03138512|564742091|FG000|Treatment Part A|Poor/non-compliance|1|||
156450331|NCT03138512|564742092|FG001|Treatment Part A|Poor/non-compliance|0|||
156450332|NCT03138512|564742093|FG002|Treatment Part A|Poor/non-compliance|0|||
156450333|NCT03138512|564742094|FG003|Treatment Part A|Poor/non-compliance|0|||
156450334|NCT03138512|564742095|FG004|Treatment Part A|Poor/non-compliance|0|||
156450335|NCT03138512|564742091|FG000|Treatment Part A|Pregnancy|0|||
156450336|NCT03138512|564742092|FG001|Treatment Part A|Pregnancy|1|||
156450337|NCT03138512|564742093|FG002|Treatment Part A|Pregnancy|0|||
156450338|NCT03138512|564742094|FG003|Treatment Part A|Pregnancy|0|||
156450339|NCT03138512|564742095|FG004|Treatment Part A|Pregnancy|0|||
156450340|NCT03138512|564742091|FG000|Treatment Part A|Other reasons|11|||
156450341|NCT03138512|564742092|FG001|Treatment Part A|Other reasons|8|||
156450342|NCT03138512|564742093|FG002|Treatment Part A|Other reasons|0|||
156450343|NCT03138512|564742094|FG003|Treatment Part A|Other reasons|0|||
156450344|NCT03138512|564742095|FG004|Treatment Part A|Other reasons|0|||
156450345|NCT03138512|564742091|FG000|Treatment Part B|Disease recurrence|0|||
156450346|NCT03138512|564742092|FG001|Treatment Part B|Disease recurrence|0|||
156450347|NCT03138512|564742093|FG002|Treatment Part B|Disease recurrence|6|||
156533410|NCT03901053|565046976|FG000|Overall Study|Subject's Medical Status|0|||
156533411|NCT03901053|565046977|FG001|Overall Study|Subject's Medical Status|1|||
156450348|NCT03138512|564742094|FG003|Treatment Part B|Disease recurrence|12|||
156450349|NCT03138512|564742095|FG004|Treatment Part B|Disease recurrence|10|||
156450350|NCT03138512|564742091|FG000|Treatment Part B|Study drug toxicity|0|||
156450351|NCT03138512|564742092|FG001|Treatment Part B|Study drug toxicity|0|||
156450352|NCT03138512|564742093|FG002|Treatment Part B|Study drug toxicity|63|||
156450353|NCT03138512|564742094|FG003|Treatment Part B|Study drug toxicity|3|||
156450354|NCT03138512|564742095|FG004|Treatment Part B|Study drug toxicity|45|||
156450355|NCT03138512|564742091|FG000|Treatment Part B|Death|0|||
156450356|NCT03138512|564742092|FG001|Treatment Part B|Death|0|||
156450357|NCT03138512|564742093|FG002|Treatment Part B|Death|1|||
156533412|NCT03901053|565046976|FG000|Overall Study|Screening Failure|1|||
156533413|NCT03901053|565046977|FG001|Overall Study|Screening Failure|0|||
156721363|NCT03323398|565725867|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
156721364|NCT03323398|565725868|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
156721365|NCT02235454|565725869|FG000|Overall Study|Withdrawal by Subject|2|||
156721366|NCT03641469|565725870|FG000|Overall Study|Ineligible|2|||
156721367|NCT03641469|565725870|FG000|Overall Study|Withdrawal by Subject|5|||
156721368|NCT03641469|565725870|FG000|Overall Study|Physician Decision|1|||
156721369|NCT03641469|565725870|FG000|Overall Study|Protocol Violation|1|||
156721370|NCT03641469|565725870|FG000|Overall Study|Lost to Follow-up|2|||
156721371|NCT06389487|565725871|FG000|Overall Study|Lost to Follow-up|9|||
156721372|NCT06389487|565725872|FG001|Overall Study|Lost to Follow-up|5|||
156721373|NCT06389487|565725873|FG002|Overall Study|Lost to Follow-up|13|||
156721374|NCT06389487|565725871|FG000|Overall Study|Protocol Violation|0|||
156721375|NCT06389487|565725872|FG001|Overall Study|Protocol Violation|0|||
156721376|NCT06389487|565725873|FG002|Overall Study|Protocol Violation|2|||
156721377|NCT06389487|565725871|FG000|Overall Study|Withdrawal by Subject|2|||
156721378|NCT06389487|565725872|FG001|Overall Study|Withdrawal by Subject|2|||
156721379|NCT06389487|565725873|FG002|Overall Study|Withdrawal by Subject|1|||
156721380|NCT06389487|565725871|FG000|Overall Study|Other|1|||
156721381|NCT06389487|565725872|FG001|Overall Study|Other|0|||
156721382|NCT06389487|565725873|FG002|Overall Study|Other|1|||
156721383|NCT05479435|565725874|FG000|Overall Study|Withdrawal by Subject|1|||
156721384|NCT05479435|565725875|FG001|Overall Study|Withdrawal by Subject|0|||
156721385|NCT05479435|565725876|FG002|Overall Study|Withdrawal by Subject|0|||
156721386|NCT05479435|565725874|FG000|Overall Study|Covid 19|0|||
156721387|NCT05479435|565725875|FG001|Overall Study|Covid 19|0|||
156721388|NCT05479435|565725876|FG002|Overall Study|Covid 19|2|||
156721389|NCT00955617|565725880|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
156721390|NCT00955617|565725881|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
156721391|NCT00955617|565725880|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
156721392|NCT00955617|565725881|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
156721393|NCT00955617|565725880|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
156721394|NCT00955617|565725881|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
156721395|NCT00955617|565725880|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
156721396|NCT00955617|565725881|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
156721397|NCT00982657|565725883|FG000|Overall Study|Death|1|||
156721398|NCT00982657|565725884|FG001|Overall Study|Death|0|||
156721399|NCT00982657|565725885|FG002|Overall Study|Death|1|||
156721400|NCT00982657|565725886|FG003|Overall Study|Death|1|||
156721401|NCT00982657|565725883|FG000|Overall Study|Withdrawal by Subject|0|||
156721402|NCT00982657|565725884|FG001|Overall Study|Withdrawal by Subject|0|||
156721403|NCT00982657|565725885|FG002|Overall Study|Withdrawal by Subject|1|||
156721404|NCT00982657|565725886|FG003|Overall Study|Withdrawal by Subject|3|||
156721405|NCT00982657|565725883|FG000|Overall Study|Other|0|||
156794108|NCT03715829|565999502|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794109|NCT03715829|565999503|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794110|NCT03715829|565999493|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
156450358|NCT03138512|564742094|FG003|Treatment Part B|Death|0|||
156450359|NCT03138512|564742095|FG004|Treatment Part B|Death|0|||
156450360|NCT03138512|564742091|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
156450361|NCT03138512|564742092|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
156450362|NCT03138512|564742093|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
156450363|NCT03138512|564742094|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
156721406|NCT00982657|565725884|FG001|Overall Study|Other|0|||
156721407|NCT00982657|565725885|FG002|Overall Study|Other|0|||
156721408|NCT00982657|565725886|FG003|Overall Study|Other|4|||
156721409|NCT00982657|565725883|FG000|Overall Study|On going at date of cut-off|0|||
156721410|NCT00982657|565725884|FG001|Overall Study|On going at date of cut-off|0|||
156721411|NCT00982657|565725885|FG002|Overall Study|On going at date of cut-off|0|||
156721412|NCT00982657|565725886|FG003|Overall Study|On going at date of cut-off|1|||
156721413|NCT02141438|565727387|FG000|Overall Study|Death|1308|||
156721414|NCT02141438|565727387|FG000|Overall Study|Lost to Follow-up|84|||
156721415|NCT02141438|565727387|FG000|Overall Study|Withdrawal by Subject|52|||
156721416|NCT02141438|565727387|FG000|Overall Study|Physician Decision|1|||
156721417|NCT02141438|565727387|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
156450364|NCT03138512|564742095|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
156721418|NCT02546986|565727390|FG000|Treatment Period|Progressive Disease|20|||
156721419|NCT02546986|565727391|FG001|Treatment Period|Progressive Disease|22|||
156721420|NCT02546986|565727390|FG000|Treatment Period|Adverse Event|14|||
156721421|NCT02546986|565727391|FG001|Treatment Period|Adverse Event|6|||
156721422|NCT02546986|565727390|FG000|Treatment Period|Symptomatic Deterioration|4|||
156721423|NCT02546986|565727391|FG001|Treatment Period|Symptomatic Deterioration|3|||
156721424|NCT02546986|565727390|FG000|Treatment Period|Death|3|||
156721425|NCT02546986|565727391|FG001|Treatment Period|Death|4|||
156721426|NCT02546986|565727390|FG000|Treatment Period|Physician Decision|1|||
156721427|NCT02546986|565727391|FG001|Treatment Period|Physician Decision|2|||
156721428|NCT02546986|565727390|FG000|Treatment Period|Protocol Violation|1|||
156721429|NCT02546986|565727391|FG001|Treatment Period|Protocol Violation|0|||
156721430|NCT02546986|565727390|FG000|Treatment Period|Withdrawal by Subject|1|||
156721431|NCT02546986|565727391|FG001|Treatment Period|Withdrawal by Subject|1|||
156721432|NCT02546986|565727390|FG000|Treatment Period|Non-compliance with Study Drug|0|||
156721433|NCT02546986|565727391|FG001|Treatment Period|Non-compliance with Study Drug|1|||
156721434|NCT02546986|565727390|FG000|Treatment Period|Study Terminated by Sponsor|0|||
156721435|NCT02546986|565727391|FG001|Treatment Period|Study Terminated by Sponsor|1|||
156721436|NCT02546986|565727390|FG000|Treatment Period|Miscellaneous|7|||
156721437|NCT02546986|565727391|FG001|Treatment Period|Miscellaneous|9|||
156721438|NCT02546986|565727390|FG000|Survival Follow-Up Phase|Missing Status|3|||
156721439|NCT02546986|565727391|FG001|Survival Follow-Up Phase|Missing Status|5|||
156721440|NCT02546986|565727390|FG000|Survival Follow-Up Phase|Death|18|||
156721441|NCT02546986|565727391|FG001|Survival Follow-Up Phase|Death|12|||
156721442|NCT02546986|565727390|FG000|Survival Follow-Up Phase|Alive|13|||
156721443|NCT02546986|565727391|FG001|Survival Follow-Up Phase|Alive|16|||
156721444|NCT02546986|565727390|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
156721445|NCT02546986|565727391|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
156721446|NCT00739882|565727392|FG000|Double-blind Period|Adverse Event|1|||
156721447|NCT00739882|565727393|FG001|Double-blind Period|Adverse Event|2|||
156721448|NCT00739882|565727392|FG000|Double-blind Period|Protocol Violation|1|||
156721449|NCT00739882|565727393|FG001|Double-blind Period|Protocol Violation|0|||
156721450|NCT00739882|565727392|FG000|Double-blind Period|Lack of Efficacy|1|||
156721451|NCT00739882|565727393|FG001|Double-blind Period|Lack of Efficacy|1|||
156721452|NCT00739882|565727392|FG000|Double-blind Period|Other|16|||
156721453|NCT00739882|565727393|FG001|Double-blind Period|Other|8|||
156721454|NCT00739882|565727392|FG000|Open-label Period|Adverse Event|1|||
156721455|NCT00739882|565727393|FG001|Open-label Period|Adverse Event|0|||
156721456|NCT00739882|565727392|FG000|Open-label Period|Other|9|||
156721457|NCT00739882|565727393|FG001|Open-label Period|Other|5|||
156721458|NCT04021914|565727394|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
156721459|NCT02844543|565727395|FG000|Overall Study|Withdrawal by Subject|4|||
156721460|NCT02844543|565727395|FG000|Overall Study|Did not meet eligibility criteria|1|||
156721461|NCT03349060|565727396|FG000|Overall Study|Adverse Event|9|||
156721462|NCT03349060|565727397|FG001|Overall Study|Adverse Event|9|||
156721463|NCT03349060|565727398|FG002|Overall Study|Adverse Event|7|||
156721464|NCT03349060|565727396|FG000|Overall Study|Lack of Efficacy|1|||
156721465|NCT03349060|565727397|FG001|Overall Study|Lack of Efficacy|0|||
156721466|NCT03349060|565727398|FG002|Overall Study|Lack of Efficacy|2|||
156721467|NCT03349060|565727396|FG000|Overall Study|Lost to Follow-up|2|||
156721468|NCT03349060|565727397|FG001|Overall Study|Lost to Follow-up|1|||
156721469|NCT03349060|565727398|FG002|Overall Study|Lost to Follow-up|1|||
156721470|NCT03349060|565727396|FG000|Overall Study|Protocol Violation|2|||
156721471|NCT03349060|565727397|FG001|Overall Study|Protocol Violation|2|||
156721472|NCT03349060|565727398|FG002|Overall Study|Protocol Violation|1|||
156450365|NCT03138512|564742091|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
156450366|NCT03138512|564742092|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
156450367|NCT03138512|564742093|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
156450368|NCT03138512|564742094|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
156450369|NCT03138512|564742095|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
156721473|NCT03349060|565727396|FG000|Overall Study|Withdrawal by Subject|5|||
156721474|NCT03349060|565727397|FG001|Overall Study|Withdrawal by Subject|3|||
156721475|NCT03349060|565727398|FG002|Overall Study|Withdrawal by Subject|4|||
156794111|NCT03715829|565999494|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
156721476|NCT03349060|565727396|FG000|Overall Study|Medication error,no linked adverse event|0|||
156721477|NCT03349060|565727397|FG001|Overall Study|Medication error,no linked adverse event|0|||
156721478|NCT03349060|565727398|FG002|Overall Study|Medication error,no linked adverse event|1|||
156721479|NCT03349060|565727396|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156721480|NCT03349060|565727397|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
156721481|NCT03349060|565727398|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
156721482|NCT03349060|565727396|FG000|Overall Study|Other|2|||
156721483|NCT03349060|565727397|FG001|Overall Study|Other|1|||
156721484|NCT03349060|565727398|FG002|Overall Study|Other|0|||
156721485|NCT00955409|565727399|FG000|Overall Study|Lack of Efficacy|1|||
156721486|NCT00955409|565727400|FG001|Overall Study|Lack of Efficacy|0|||
156721487|NCT00955409|565727401|FG002|Overall Study|Lack of Efficacy|0|||
156721488|NCT00955409|565727402|FG003|Overall Study|Lack of Efficacy|0|||
156721489|NCT00955409|565727403|FG004|Overall Study|Lack of Efficacy|0|||
156721490|NCT00955409|565727404|FG005|Overall Study|Lack of Efficacy|0|||
156721491|NCT00955409|565727405|FG006|Overall Study|Lack of Efficacy|0|||
156721492|NCT00955409|565727406|FG007|Overall Study|Lack of Efficacy|0|||
156721493|NCT00955409|565727407|FG008|Overall Study|Lack of Efficacy|0|||
156721494|NCT00955409|565727408|FG009|Overall Study|Lack of Efficacy|0|||
156721495|NCT00955409|565727399|FG000|Overall Study|Withdrawal by Subject|1|||
156721496|NCT00955409|565727400|FG001|Overall Study|Withdrawal by Subject|0|||
156450370|NCT03138512|564742091|FG000|Treatment Part B|Participant withdrew consent|0|||
156450371|NCT03138512|564742092|FG001|Treatment Part B|Participant withdrew consent|0|||
156450372|NCT03138512|564742093|FG002|Treatment Part B|Participant withdrew consent|1|||
156450373|NCT03138512|564742094|FG003|Treatment Part B|Participant withdrew consent|1|||
156450374|NCT03138512|564742095|FG004|Treatment Part B|Participant withdrew consent|2|||
156450375|NCT03138512|564742091|FG000|Treatment Part B|Lost to Follow-up|0|||
156450376|NCT03138512|564742092|FG001|Treatment Part B|Lost to Follow-up|0|||
156450377|NCT03138512|564742093|FG002|Treatment Part B|Lost to Follow-up|0|||
156450378|NCT03138512|564742094|FG003|Treatment Part B|Lost to Follow-up|1|||
156450379|NCT03138512|564742095|FG004|Treatment Part B|Lost to Follow-up|0|||
156450380|NCT03138512|564742091|FG000|Treatment Part B|Poor/non-compliance|0|||
156450381|NCT03138512|564742092|FG001|Treatment Part B|Poor/non-compliance|0|||
156450382|NCT03138512|564742093|FG002|Treatment Part B|Poor/non-compliance|1|||
156450383|NCT03138512|564742094|FG003|Treatment Part B|Poor/non-compliance|1|||
156450384|NCT03138512|564742095|FG004|Treatment Part B|Poor/non-compliance|1|||
156450385|NCT03138512|564742091|FG000|Treatment Part B|Other reasons|0|||
156450386|NCT03138512|564742092|FG001|Treatment Part B|Other reasons|0|||
156721497|NCT00955409|565727401|FG002|Overall Study|Withdrawal by Subject|5|||
156721498|NCT00955409|565727402|FG003|Overall Study|Withdrawal by Subject|2|||
156721499|NCT00955409|565727403|FG004|Overall Study|Withdrawal by Subject|0|||
156721500|NCT00955409|565727404|FG005|Overall Study|Withdrawal by Subject|0|||
156721501|NCT00955409|565727405|FG006|Overall Study|Withdrawal by Subject|2|||
156721502|NCT00955409|565727406|FG007|Overall Study|Withdrawal by Subject|0|||
156721503|NCT00955409|565727407|FG008|Overall Study|Withdrawal by Subject|1|||
156721504|NCT00955409|565727408|FG009|Overall Study|Withdrawal by Subject|0|||
156721505|NCT00955409|565727399|FG000|Overall Study|Caregiver Request|2|||
156721506|NCT00955409|565727400|FG001|Overall Study|Caregiver Request|0|||
156721507|NCT00955409|565727401|FG002|Overall Study|Caregiver Request|6|||
156450387|NCT03138512|564742093|FG002|Treatment Part B|Other reasons|3|||
156450388|NCT03138512|564742094|FG003|Treatment Part B|Other reasons|1|||
156450389|NCT03138512|564742095|FG004|Treatment Part B|Other reasons|5|||
156450390|NCT01580488|564742099|FG000|Overall Study|Withdrawal by Subject|1|||
156450391|NCT04177823|564742104|FG000|Overall Study|Physician Decision|1|||
156450392|NCT04177823|564742104|FG000|Overall Study|Withdrawal by Subject|1|||
156450393|NCT04229992|564742105|FG000|Overall Study|Withdrawal by Subject|0|||
156450394|NCT04229992|564742106|FG001|Overall Study|Withdrawal by Subject|2|||
156450395|NCT04229992|564742107|FG002|Overall Study|Withdrawal by Subject|1|||
156450396|NCT04229992|564742108|FG003|Overall Study|Withdrawal by Subject|1|||
156450397|NCT04229992|564742105|FG000|Overall Study|Adverse Event|1|||
156450398|NCT04229992|564742106|FG001|Overall Study|Adverse Event|1|||
156450399|NCT04229992|564742107|FG002|Overall Study|Adverse Event|3|||
156450400|NCT04229992|564742108|FG003|Overall Study|Adverse Event|1|||
156450401|NCT04229992|564742105|FG000|Overall Study|Lost to Follow-up|0|||
156450402|NCT04229992|564742106|FG001|Overall Study|Lost to Follow-up|0|||
156450403|NCT04229992|564742107|FG002|Overall Study|Lost to Follow-up|0|||
156450404|NCT04229992|564742108|FG003|Overall Study|Lost to Follow-up|1|||
156450405|NCT04169373|564742109|FG000|Week 1 to Week 14|Adverse Event|1|||
156450406|NCT04169373|564742110|FG001|Week 1 to Week 14|Adverse Event|0|||
156450407|NCT04169373|564742111|FG002|Week 1 to Week 14|Adverse Event|1|||
156450408|NCT04169373|564742112|FG003|Week 1 to Week 14|Adverse Event|2|||
156450409|NCT04169373|564742109|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
156450410|NCT04169373|564742110|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
156450411|NCT04169373|564742111|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
156450412|NCT04169373|564742112|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
156450413|NCT04169373|564742109|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
156450414|NCT04169373|564742110|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
156450415|NCT04169373|564742111|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
156450416|NCT04169373|564742112|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
156450417|NCT04169373|564742109|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
156450418|NCT04169373|564742110|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
156450419|NCT04169373|564742111|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
156450420|NCT04169373|564742112|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
156450421|NCT04169373|564742109|FG000|Week 1 to Week 14|Other|1|||
156721508|NCT00955409|565727402|FG003|Overall Study|Caregiver Request|5|||
156721509|NCT00955409|565727403|FG004|Overall Study|Caregiver Request|0|||
156721510|NCT00955409|565727404|FG005|Overall Study|Caregiver Request|2|||
156450422|NCT04169373|564742110|FG001|Week 1 to Week 14|Other|3|||
156450423|NCT04169373|564742111|FG002|Week 1 to Week 14|Other|3|||
156450424|NCT04169373|564742112|FG003|Week 1 to Week 14|Other|5|||
156450425|NCT04169373|564742109|FG000|Week 14 to Week 52|Adverse Event|1|||
156450426|NCT04169373|564742110|FG001|Week 14 to Week 52|Adverse Event|0|||
156450427|NCT04169373|564742111|FG002|Week 14 to Week 52|Adverse Event|0|||
156721511|NCT00955409|565727405|FG006|Overall Study|Caregiver Request|3|||
156721512|NCT00955409|565727406|FG007|Overall Study|Caregiver Request|1|||
156721513|NCT00955409|565727407|FG008|Overall Study|Caregiver Request|3|||
156450428|NCT04169373|564742112|FG003|Week 14 to Week 52|Adverse Event|1|||
156450429|NCT04169373|564742109|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
156450430|NCT04169373|564742110|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
156450431|NCT04169373|564742111|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
156450432|NCT04169373|564742112|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
156450433|NCT04169373|564742109|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
156450434|NCT04169373|564742110|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
156450435|NCT04169373|564742111|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
156450436|NCT04169373|564742112|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
156450437|NCT04169373|564742109|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
156450438|NCT04169373|564742110|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
156450439|NCT04169373|564742111|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
156450440|NCT04169373|564742112|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
156450441|NCT04169373|564742109|FG000|Week 14 to Week 52|Other|4|||
156450442|NCT04169373|564742110|FG001|Week 14 to Week 52|Other|5|||
156450443|NCT04169373|564742111|FG002|Week 14 to Week 52|Other|4|||
156450444|NCT04169373|564742112|FG003|Week 14 to Week 52|Other|5|||
156450445|NCT04169373|564742109|FG000|Week 14 to Week 52|Ongoing|0|||
156450446|NCT04169373|564742110|FG001|Week 14 to Week 52|Ongoing|1|||
156450447|NCT04169373|564742111|FG002|Week 14 to Week 52|Ongoing|0|||
156450448|NCT04169373|564742112|FG003|Week 14 to Week 52|Ongoing|0|||
156450449|NCT04610892|564742113|FG000|Overall Study|Adverse Event|1|||
156450450|NCT04610892|564742114|FG001|Overall Study|Adverse Event|0|||
156450451|NCT04610892|564742115|FG002|Overall Study|Adverse Event|0|||
156450452|NCT04610892|564742116|FG003|Overall Study|Adverse Event|1|||
156450453|NCT04610892|564742117|FG004|Overall Study|Adverse Event|3|||
156450454|NCT04610892|564742113|FG000|Overall Study|Death|0|||
156450455|NCT04610892|564742114|FG001|Overall Study|Death|1|||
156450456|NCT04610892|564742115|FG002|Overall Study|Death|0|||
156450457|NCT04610892|564742116|FG003|Overall Study|Death|1|||
156450458|NCT04610892|564742117|FG004|Overall Study|Death|0|||
156450459|NCT04610892|564742113|FG000|Overall Study|Withdrawal by Subject|3|||
156450460|NCT04610892|564742114|FG001|Overall Study|Withdrawal by Subject|2|||
156450461|NCT04610892|564742115|FG002|Overall Study|Withdrawal by Subject|0|||
156450462|NCT04610892|564742116|FG003|Overall Study|Withdrawal by Subject|6|||
156450463|NCT04610892|564742117|FG004|Overall Study|Withdrawal by Subject|6|||
156450464|NCT04610892|564742113|FG000|Overall Study|Subjects who did not receive treatment|1|||
156450465|NCT04610892|564742114|FG001|Overall Study|Subjects who did not receive treatment|0|||
156450466|NCT04610892|564742115|FG002|Overall Study|Subjects who did not receive treatment|0|||
156450467|NCT04610892|564742116|FG003|Overall Study|Subjects who did not receive treatment|0|||
156450468|NCT04610892|564742117|FG004|Overall Study|Subjects who did not receive treatment|2|||
156450469|NCT03699709|564742119|FG000|Overall Study|Death|1|||
156450470|NCT03699709|564742120|FG001|Overall Study|Death|2|||
156450471|NCT03699709|564742119|FG000|Overall Study|Lost to Follow-up|10|||
156450472|NCT03699709|564742120|FG001|Overall Study|Lost to Follow-up|3|||
156450473|NCT03699709|564742119|FG000|Overall Study|Withdrawal by Subject|5|||
156450474|NCT03699709|564742120|FG001|Overall Study|Withdrawal by Subject|0|||
156450475|NCT03699709|564742119|FG000|Overall Study|incarcerated|1|||
156450476|NCT03699709|564742120|FG001|Overall Study|incarcerated|0|||
156450477|NCT03699709|564742119|FG000|Overall Study|scheduled, but no show|0|||
156450478|NCT03699709|564742120|FG001|Overall Study|scheduled, but no show|1|||
156450479|NCT03720795|564742121|FG000|Phase 1|Lost to Follow-up|4|||
156450480|NCT03720795|564742121|FG000|Phase 1|Withdrawal by Subject|6|||
156450481|NCT03720795|564742121|FG000|Phase 1|Protocol Violation|1|||
156450482|NCT03720795|564742121|FG000|Phase 1|Other|1|||
156450483|NCT03720795|564742121|FG000|Phase 2|Lost to Follow-up|5|||
156450484|NCT03720795|564742121|FG000|Phase 2|Withdrawal by Subject|10|||
156450485|NCT03720795|564742121|FG000|Phase 2|Protocol Violation|2|||
156450486|NCT03720795|564742121|FG000|3 Month Follow Up|Lost to Follow-up|2|||
156450487|NCT04322643|564742122|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
156450488|NCT05486078|564742123|FG000|Overall Study|4 drop out and one withdrawn|5|||
156450489|NCT05134233|564742124|FG000|Overall Study|Pregnancy|1|||
156450490|NCT05134233|564742124|FG000|Overall Study|MEP value too low|2|||
156450491|NCT05134233|564742124|FG000|Overall Study|Lost to Follow-up|1|||
156450492|NCT01573442|564742125|FG000|Overall Study|Cancels|9|||
156450493|NCT01573442|564742126|FG001|Overall Study|Cancels|10|||
156450494|NCT04763265|564742132|FG000|Overall Study|Adverse Event|1|||
156450495|NCT04763265|564742133|FG001|Overall Study|Adverse Event|0|||
156450496|NCT04763265|564742132|FG000|Overall Study|Lost to Follow-up|2|||
156450497|NCT04763265|564742133|FG001|Overall Study|Lost to Follow-up|4|||
156450498|NCT04763265|564742132|FG000|Overall Study|Withdrawal by Subject|0|||
156533414|NCT04600336|565046978|FG000|Initial Treatment|Withdrawal by Subject|1|||
156450499|NCT04763265|564742133|FG001|Overall Study|Withdrawal by Subject|1|||
156450500|NCT02908477|564742134|FG000|Overall Study|Withdrawal by Subject|8|||
156450501|NCT02908477|564742135|FG001|Overall Study|Withdrawal by Subject|28|||
156450502|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Other|0|||
156450503|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Other|0|||
156450504|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Other|0|||
156450505|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Other|0|||
156450506|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Other|0|||
156450507|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Other|0|||
156450508|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Other|0|||
156450509|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Other|0|||
156450510|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Other|0|||
156450511|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Other|0|||
156450512|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Other|1|||
156450513|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Other|1|||
156450514|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Other|1|||
156450515|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Other|0|||
156450516|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Other|3|||
156450517|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Other|1|||
156450518|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Other|1|||
156721514|NCT00955409|565727408|FG009|Overall Study|Caregiver Request|0|||
156721515|NCT00955409|565727399|FG000|Overall Study|Investigator Request|0|||
156721516|NCT00955409|565727400|FG001|Overall Study|Investigator Request|0|||
156721517|NCT00955409|565727401|FG002|Overall Study|Investigator Request|1|||
156721518|NCT00955409|565727402|FG003|Overall Study|Investigator Request|0|||
156721519|NCT00955409|565727403|FG004|Overall Study|Investigator Request|0|||
156721520|NCT00955409|565727404|FG005|Overall Study|Investigator Request|0|||
156721521|NCT00955409|565727405|FG006|Overall Study|Investigator Request|0|||
156450519|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Other|0|||
156450520|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450521|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450522|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450523|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450524|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450525|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450526|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
156450527|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450528|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
156450529|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450530|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450531|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450532|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
156450533|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
156721522|NCT00955409|565727406|FG007|Overall Study|Investigator Request|0|||
156721523|NCT00955409|565727407|FG008|Overall Study|Investigator Request|0|||
156450534|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450535|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450536|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450537|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
156450538|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450539|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450540|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450541|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450542|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450543|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450544|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450545|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
156450546|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450547|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156721524|NCT00955409|565727408|FG009|Overall Study|Investigator Request|0|||
156721525|NCT00955409|565727399|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
156721526|NCT00955409|565727400|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
156450548|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450549|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450550|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450551|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156721527|NCT00955409|565727401|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
156721528|NCT00955409|565727402|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
156721529|NCT00955409|565727403|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
156721530|NCT00955409|565727404|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
156721531|NCT00955409|565727405|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
156450552|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450553|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450554|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450555|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156450556|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450557|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450558|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450559|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450560|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450561|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450562|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450563|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450564|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450565|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
156450566|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450567|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450568|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450569|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450570|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450571|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450572|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450573|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
156450574|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Death|0|||
156450575|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Death|0|||
156450576|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Death|0|||
156450577|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Death|0|||
156450578|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Death|0|||
156450579|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Death|0|||
156450580|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Death|0|||
156450581|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Death|0|||
156450582|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Death|0|||
156450583|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Death|1|||
156450584|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Death|0|||
156450585|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Death|1|||
156450586|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Death|0|||
156450587|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Death|1|||
156450588|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Death|0|||
156450589|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Death|0|||
156450590|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Death|2|||
156450591|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Death|0|||
156450592|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
156450593|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
156450594|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
156450595|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
156450596|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
156450597|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
156450598|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
156450599|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
156450600|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
156450601|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
156450602|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
156450603|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
156450604|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
156450605|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
156450606|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
156450607|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
156450608|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
156450609|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
156450610|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Adverse Event|0|||
156721532|NCT00955409|565727406|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
156721533|NCT00955409|565727407|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
156721534|NCT00955409|565727408|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
156721535|NCT00955409|565727399|FG000|Overall Study|Lost to Follow-up|0|||
156721536|NCT00955409|565727400|FG001|Overall Study|Lost to Follow-up|0|||
156721537|NCT00955409|565727401|FG002|Overall Study|Lost to Follow-up|1|||
156721538|NCT00955409|565727402|FG003|Overall Study|Lost to Follow-up|0|||
156721539|NCT00955409|565727403|FG004|Overall Study|Lost to Follow-up|0|||
156721540|NCT00955409|565727404|FG005|Overall Study|Lost to Follow-up|0|||
156450611|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Adverse Event|0|||
156450612|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Adverse Event|0|||
156450613|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Adverse Event|0|||
156450614|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Adverse Event|0|||
156450615|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Adverse Event|0|||
156450616|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Adverse Event|2|||
156450617|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Adverse Event|0|||
156450618|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Adverse Event|0|||
156450619|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Adverse Event|0|||
156450620|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Adverse Event|1|||
156450621|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Adverse Event|2|||
156450622|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Adverse Event|0|||
156450623|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Adverse Event|1|||
156450624|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Adverse Event|0|||
156721541|NCT00955409|565727405|FG006|Overall Study|Lost to Follow-up|1|||
156450625|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Adverse Event|0|||
156450626|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Adverse Event|1|||
156450627|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Adverse Event|0|||
156450628|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
156450629|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
156721542|NCT00955409|565727406|FG007|Overall Study|Lost to Follow-up|0|||
156450630|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
156450631|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
156450632|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
156450633|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
156450634|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
156450635|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
156450636|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
156450637|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
156450638|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
156450639|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
156450640|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
156450641|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
156450642|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
156450643|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
156450644|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
156450645|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
156450646|NCT03269136|564742144|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450647|NCT03269136|564742145|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156721543|NCT00955409|565727407|FG008|Overall Study|Lost to Follow-up|0|||
156721544|NCT00955409|565727408|FG009|Overall Study|Lost to Follow-up|0|||
156721545|NCT00955409|565727399|FG000|Overall Study|Failed to Return|2|||
156721546|NCT00955409|565727400|FG001|Overall Study|Failed to Return|0|||
156721547|NCT00955409|565727401|FG002|Overall Study|Failed to Return|0|||
156721548|NCT00955409|565727402|FG003|Overall Study|Failed to Return|0|||
156721549|NCT00955409|565727403|FG004|Overall Study|Failed to Return|0|||
156721550|NCT00955409|565727404|FG005|Overall Study|Failed to Return|0|||
156721551|NCT00955409|565727405|FG006|Overall Study|Failed to Return|0|||
156721552|NCT00955409|565727406|FG007|Overall Study|Failed to Return|2|||
156721553|NCT00955409|565727407|FG008|Overall Study|Failed to Return|0|||
156721554|NCT00955409|565727408|FG009|Overall Study|Failed to Return|0|||
156721555|NCT00955409|565727399|FG000|Overall Study|Adverse Event (AE)|2|||
156721556|NCT00955409|565727400|FG001|Overall Study|Adverse Event (AE)|0|||
156721557|NCT00955409|565727401|FG002|Overall Study|Adverse Event (AE)|0|||
156721558|NCT00955409|565727402|FG003|Overall Study|Adverse Event (AE)|0|||
156721559|NCT00955409|565727403|FG004|Overall Study|Adverse Event (AE)|0|||
156721560|NCT00955409|565727404|FG005|Overall Study|Adverse Event (AE)|1|||
156450648|NCT03269136|564742146|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156721561|NCT00955409|565727405|FG006|Overall Study|Adverse Event (AE)|2|||
156794112|NCT03715829|565999495|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794113|NCT03715829|565999496|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794114|NCT03715829|565999497|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794115|NCT03715829|565999498|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794116|NCT03715829|565999499|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794117|NCT03715829|565999500|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794118|NCT03715829|565999501|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
156794119|NCT03715829|565999502|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794120|NCT03715829|565999503|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794121|NCT03715829|565999493|FG000|Extension Period|Other|0|||
156794122|NCT03715829|565999494|FG001|Extension Period|Other|0|||
156794123|NCT03715829|565999495|FG002|Extension Period|Other|0|||
156794124|NCT03715829|565999496|FG003|Extension Period|Other|0|||
156794125|NCT03715829|565999497|FG004|Extension Period|Other|0|||
156450649|NCT03269136|564742147|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450650|NCT03269136|564742148|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450651|NCT03269136|564742149|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450652|NCT03269136|564742150|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156533415|NCT04600336|565046979|FG001|Initial Treatment|Withdrawal by Subject|2|||
156721562|NCT00955409|565727406|FG007|Overall Study|Adverse Event (AE)|0|||
156721563|NCT00955409|565727407|FG008|Overall Study|Adverse Event (AE)|2|||
156721564|NCT00955409|565727408|FG009|Overall Study|Adverse Event (AE)|0|||
156335555|NCT00494299|564326131|FG001|Overall Study|Adverse Event|13|||
156450653|NCT03269136|564742151|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450654|NCT03269136|564742152|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450655|NCT03269136|564742153|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156533416|NCT04600336|565046980|FG002|Initial Treatment|Withdrawal by Subject|0|||
156721565|NCT00955409|565727399|FG000|Overall Study|Reason not Specified|2|||
156721566|NCT00955409|565727400|FG001|Overall Study|Reason not Specified|1|||
156721567|NCT00955409|565727401|FG002|Overall Study|Reason not Specified|13|||
156794126|NCT03715829|565999498|FG005|Extension Period|Other|0|||
156794127|NCT03715829|565999499|FG006|Extension Period|Other|1|||
156794128|NCT03715829|565999500|FG007|Extension Period|Other|2|||
156794129|NCT03715829|565999501|FG008|Extension Period|Other|4|||
156794130|NCT03715829|565999502|FG009|Extension Period|Other|0|||
156794131|NCT03715829|565999503|FG010|Extension Period|Other|0|||
156794132|NCT03647137|565999504|FG000|Overall Study|Scan Limitation|2|||
156794133|NCT03647137|565999505|FG001|Overall Study|Scan Limitation|1|||
156794134|NCT03647137|565999506|FG002|Overall Study|Scan Limitation|1|||
156794135|NCT03647137|565999507|FG003|Overall Study|Scan Limitation|2|||
156794136|NCT03579719|565999508|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
156794137|NCT01443026|565999509|FG000|Overall Study|Physician Decision|1|||
156794138|NCT01443026|565999510|FG001|Overall Study|Physician Decision|0|||
156794139|NCT01443026|565999509|FG000|Overall Study|Death|0|||
156794140|NCT01443026|565999510|FG001|Overall Study|Death|1|||
156794141|NCT01443026|565999509|FG000|Overall Study|Withdrawal by Subject|0|||
156794142|NCT01443026|565999510|FG001|Overall Study|Withdrawal by Subject|3|||
156794143|NCT01443026|565999509|FG000|Overall Study|Lost to Follow-up|2|||
156794144|NCT01443026|565999510|FG001|Overall Study|Lost to Follow-up|1|||
156794145|NCT00829868|565999511|FG000|Washout|Physician Decision|1|||
156794146|NCT00829868|565999512|FG001|Washout|Physician Decision|0|||
156794147|NCT01969409|565999513|FG000|Overall Study|Death|2|||
156794148|NCT01969409|565999514|FG001|Overall Study|Death|2|||
156794149|NCT01969409|565999513|FG000|Overall Study|Transplant|1|||
156794150|NCT01969409|565999514|FG001|Overall Study|Transplant|1|||
156794151|NCT01969409|565999513|FG000|Overall Study|Withdrawal by Subject|0|||
156794152|NCT01969409|565999514|FG001|Overall Study|Withdrawal by Subject|1|||
156794153|NCT02799043|565999516|FG000|Overall Study|Adverse Event|0|||
156794154|NCT02799043|565999517|FG001|Overall Study|Adverse Event|1|||
156794155|NCT02799043|565999516|FG000|Overall Study|Death|1|||
156794156|NCT02799043|565999517|FG001|Overall Study|Death|1|||
156794157|NCT02799043|565999516|FG000|Overall Study|Lost to Follow-up|3|||
156794158|NCT02799043|565999517|FG001|Overall Study|Lost to Follow-up|6|||
156794159|NCT02799043|565999516|FG000|Overall Study|Withdrawal by Subject|4|||
156794160|NCT02799043|565999517|FG001|Overall Study|Withdrawal by Subject|4|||
156794161|NCT02799043|565999516|FG000|Overall Study|Moved to different country|0|||
156794162|NCT02799043|565999517|FG001|Overall Study|Moved to different country|1|||
156794163|NCT02799043|565999516|FG000|Overall Study|Trial Screen Failure|1|||
156794164|NCT02799043|565999517|FG001|Overall Study|Trial Screen Failure|0|||
156794165|NCT02799043|565999516|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
156794166|NCT02799043|565999517|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
156794167|NCT01554904|565999520|FG000|Overall Study|Withdrawal by Subject|3|||
156794168|NCT01554904|565999520|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
156794169|NCT01051661|565999521|FG000|Overall Study|Adverse Event|1|||
156794170|NCT01051661|565999522|FG001|Overall Study|Adverse Event|1|||
156794171|NCT01051661|565999523|FG002|Overall Study|Adverse Event|1|||
156794172|NCT01051661|565999524|FG003|Overall Study|Adverse Event|1|||
156794173|NCT01051661|565999525|FG004|Overall Study|Adverse Event|0|||
156794174|NCT01051661|565999526|FG005|Overall Study|Adverse Event|0|||
156794175|NCT01051661|565999521|FG000|Overall Study|Lost to Follow-up|13|||
156794176|NCT01051661|565999522|FG001|Overall Study|Lost to Follow-up|22|||
156794177|NCT01051661|565999523|FG002|Overall Study|Lost to Follow-up|15|||
156794178|NCT01051661|565999524|FG003|Overall Study|Lost to Follow-up|17|||
156450656|NCT03269136|564742154|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450657|NCT03269136|564742155|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450658|NCT03269136|564742156|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
156450659|NCT03269136|564742157|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
156450660|NCT03269136|564742158|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
156450661|NCT03269136|564742159|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156450662|NCT03269136|564742160|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
156794179|NCT01051661|565999525|FG004|Overall Study|Lost to Follow-up|10|||
156794180|NCT01051661|565999526|FG005|Overall Study|Lost to Follow-up|24|||
156794181|NCT01051661|565999521|FG000|Overall Study|Migrated/moved from study area|1|||
156794182|NCT01051661|565999522|FG001|Overall Study|Migrated/moved from study area|6|||
156794183|NCT01051661|565999523|FG002|Overall Study|Migrated/moved from study area|6|||
156794184|NCT01051661|565999524|FG003|Overall Study|Migrated/moved from study area|8|||
156794185|NCT01051661|565999525|FG004|Overall Study|Migrated/moved from study area|7|||
156450663|NCT03269136|564742161|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156794186|NCT01051661|565999526|FG005|Overall Study|Migrated/moved from study area|3|||
156794187|NCT01051661|565999521|FG000|Overall Study|Refused blood sampling|0|||
156794188|NCT01051661|565999522|FG001|Overall Study|Refused blood sampling|0|||
156450664|NCT03269136|564742144|FG000|Part 2A: Dose Expansion|Other|0|||
156450665|NCT03269136|564742145|FG001|Part 2A: Dose Expansion|Other|0|||
156450666|NCT03269136|564742146|FG002|Part 2A: Dose Expansion|Other|0|||
156794189|NCT01051661|565999523|FG002|Overall Study|Refused blood sampling|0|||
156794190|NCT01051661|565999524|FG003|Overall Study|Refused blood sampling|0|||
156794191|NCT01051661|565999525|FG004|Overall Study|Refused blood sampling|0|||
156794192|NCT01051661|565999526|FG005|Overall Study|Refused blood sampling|1|||
156794193|NCT01051661|565999521|FG000|Overall Study|Data not reliable|1|||
156794194|NCT01051661|565999522|FG001|Overall Study|Data not reliable|0|||
156794195|NCT01051661|565999523|FG002|Overall Study|Data not reliable|0|||
156794196|NCT01051661|565999524|FG003|Overall Study|Data not reliable|0|||
156794197|NCT01051661|565999525|FG004|Overall Study|Data not reliable|0|||
156794198|NCT01051661|565999526|FG005|Overall Study|Data not reliable|1|||
156794199|NCT01051661|565999521|FG000|Overall Study|Unable to attend visit(s)|2|||
156794200|NCT01051661|565999522|FG001|Overall Study|Unable to attend visit(s)|4|||
156794201|NCT01051661|565999523|FG002|Overall Study|Unable to attend visit(s)|2|||
156794202|NCT01051661|565999524|FG003|Overall Study|Unable to attend visit(s)|1|||
156794203|NCT01051661|565999525|FG004|Overall Study|Unable to attend visit(s)|3|||
156794204|NCT01051661|565999526|FG005|Overall Study|Unable to attend visit(s)|2|||
156794205|NCT01051661|565999521|FG000|Overall Study|Consent not received from both parents|0|||
156794206|NCT01051661|565999522|FG001|Overall Study|Consent not received from both parents|0|||
156794207|NCT01051661|565999523|FG002|Overall Study|Consent not received from both parents|0|||
156794208|NCT01051661|565999524|FG003|Overall Study|Consent not received from both parents|0|||
156794209|NCT01051661|565999525|FG004|Overall Study|Consent not received from both parents|0|||
156794210|NCT01051661|565999526|FG005|Overall Study|Consent not received from both parents|1|||
156794211|NCT01051661|565999521|FG000|Overall Study|Failure to comply with protocol|0|||
156794212|NCT01051661|565999522|FG001|Overall Study|Failure to comply with protocol|0|||
156794213|NCT01051661|565999523|FG002|Overall Study|Failure to comply with protocol|2|||
156794214|NCT01051661|565999524|FG003|Overall Study|Failure to comply with protocol|0|||
156794215|NCT01051661|565999525|FG004|Overall Study|Failure to comply with protocol|0|||
156794216|NCT01051661|565999526|FG005|Overall Study|Failure to comply with protocol|0|||
156794217|NCT01051661|565999521|FG000|Overall Study|Subject lost legal representation|0|||
156794218|NCT01051661|565999522|FG001|Overall Study|Subject lost legal representation|0|||
156794219|NCT01051661|565999523|FG002|Overall Study|Subject lost legal representation|0|||
156794220|NCT01051661|565999524|FG003|Overall Study|Subject lost legal representation|0|||
156794221|NCT01051661|565999525|FG004|Overall Study|Subject lost legal representation|1|||
156794222|NCT01051661|565999526|FG005|Overall Study|Subject lost legal representation|0|||
156794223|NCT01051661|565999521|FG000|Overall Study|Protocol Violation|0|||
156794224|NCT01051661|565999522|FG001|Overall Study|Protocol Violation|0|||
156794225|NCT01051661|565999523|FG002|Overall Study|Protocol Violation|0|||
156794226|NCT01051661|565999524|FG003|Overall Study|Protocol Violation|1|||
156721568|NCT00955409|565727402|FG003|Overall Study|Reason not Specified|1|||
156721569|NCT00955409|565727403|FG004|Overall Study|Reason not Specified|2|||
156721570|NCT00955409|565727404|FG005|Overall Study|Reason not Specified|0|||
156721571|NCT00955409|565727405|FG006|Overall Study|Reason not Specified|16|||
156721572|NCT00955409|565727406|FG007|Overall Study|Reason not Specified|0|||
156721573|NCT00955409|565727407|FG008|Overall Study|Reason not Specified|8|||
156721574|NCT00955409|565727408|FG009|Overall Study|Reason not Specified|1|||
156721575|NCT00485732|565727409|FG000|Overall Study|Protocol Violation|1|||
156721576|NCT00485732|565727410|FG001|Overall Study|Protocol Violation|3|||
156721577|NCT00485732|565727409|FG000|Overall Study|Withdrawal by Subject|5|||
156721578|NCT00485732|565727410|FG001|Overall Study|Withdrawal by Subject|4|||
156721579|NCT00485732|565727409|FG000|Overall Study|Lost to Follow-up|2|||
156721580|NCT00485732|565727410|FG001|Overall Study|Lost to Follow-up|2|||
156721581|NCT00437021|565727411|FG000|Overall Study|Adverse Event|0|||
156721582|NCT00437021|565727412|FG001|Overall Study|Adverse Event|0|||
156721583|NCT00437021|565727413|FG002|Overall Study|Adverse Event|0|||
156721584|NCT00437021|565727414|FG003|Overall Study|Adverse Event|0|||
156721585|NCT00437021|565727415|FG004|Overall Study|Adverse Event|0|||
156721586|NCT00437021|565727416|FG005|Overall Study|Adverse Event|0|||
156721587|NCT00437021|565727417|FG006|Overall Study|Adverse Event|1|||
156721588|NCT00437021|565727418|FG007|Overall Study|Adverse Event|0|||
156721589|NCT00437021|565727419|FG008|Overall Study|Adverse Event|0|||
156721590|NCT00437021|565727420|FG009|Overall Study|Adverse Event|0|||
156721591|NCT00437021|565727421|FG010|Overall Study|Adverse Event|0|||
156721592|NCT00437021|565727422|FG011|Overall Study|Adverse Event|0|||
156794227|NCT01051661|565999525|FG004|Overall Study|Protocol Violation|2|||
156794228|NCT01051661|565999526|FG005|Overall Study|Protocol Violation|1|||
156794229|NCT01051661|565999521|FG000|Overall Study|Withdrawal by Subject|16|||
156794230|NCT01051661|565999522|FG001|Overall Study|Withdrawal by Subject|30|||
156794231|NCT01051661|565999523|FG002|Overall Study|Withdrawal by Subject|13|||
156794232|NCT01051661|565999524|FG003|Overall Study|Withdrawal by Subject|28|||
156794233|NCT01051661|565999525|FG004|Overall Study|Withdrawal by Subject|12|||
156794234|NCT01051661|565999526|FG005|Overall Study|Withdrawal by Subject|34|||
156721593|NCT00437021|565727411|FG000|Overall Study|Lost to Follow-up|0|||
156721594|NCT00437021|565727412|FG001|Overall Study|Lost to Follow-up|3|||
156721595|NCT00437021|565727413|FG002|Overall Study|Lost to Follow-up|0|||
156721596|NCT00437021|565727414|FG003|Overall Study|Lost to Follow-up|0|||
156721597|NCT00437021|565727415|FG004|Overall Study|Lost to Follow-up|0|||
156721598|NCT00437021|565727416|FG005|Overall Study|Lost to Follow-up|2|||
156794235|NCT01681849|565999527|FG000|Overall Study|Protocol Violation|2|||
156794236|NCT01681849|565999528|FG001|Overall Study|Protocol Violation|0|||
156794237|NCT01681849|565999529|FG002|Overall Study|Protocol Violation|0|||
156721599|NCT00437021|565727417|FG006|Overall Study|Lost to Follow-up|0|||
156721600|NCT00437021|565727418|FG007|Overall Study|Lost to Follow-up|1|||
156721601|NCT00437021|565727419|FG008|Overall Study|Lost to Follow-up|0|||
156721602|NCT00437021|565727420|FG009|Overall Study|Lost to Follow-up|0|||
156721603|NCT00437021|565727421|FG010|Overall Study|Lost to Follow-up|0|||
156721604|NCT00437021|565727422|FG011|Overall Study|Lost to Follow-up|0|||
156721605|NCT00437021|565727411|FG000|Overall Study|Withdrawal by Subject|2|||
156721606|NCT00437021|565727412|FG001|Overall Study|Withdrawal by Subject|1|||
156721607|NCT00437021|565727413|FG002|Overall Study|Withdrawal by Subject|0|||
156721608|NCT00437021|565727414|FG003|Overall Study|Withdrawal by Subject|0|||
156721609|NCT00437021|565727415|FG004|Overall Study|Withdrawal by Subject|0|||
156721610|NCT00437021|565727416|FG005|Overall Study|Withdrawal by Subject|0|||
156721611|NCT00437021|565727417|FG006|Overall Study|Withdrawal by Subject|0|||
156721612|NCT00437021|565727418|FG007|Overall Study|Withdrawal by Subject|0|||
156721613|NCT00437021|565727419|FG008|Overall Study|Withdrawal by Subject|0|||
156721614|NCT00437021|565727420|FG009|Overall Study|Withdrawal by Subject|0|||
156721615|NCT00437021|565727421|FG010|Overall Study|Withdrawal by Subject|0|||
156721616|NCT00437021|565727422|FG011|Overall Study|Withdrawal by Subject|0|||
156721617|NCT05573464|565727423|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
156721618|NCT05573464|565727424|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
156721619|NCT05573464|565727423|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
156721620|NCT05573464|565727424|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
156721621|NCT05573464|565727423|FG000|12-week Treatment Period|Protocol Violation|3|||
156721622|NCT05573464|565727424|FG001|12-week Treatment Period|Protocol Violation|1|||
156721623|NCT05573464|565727423|FG000|12-week Treatment Period|Physician Decision|1|||
156721624|NCT05573464|565727424|FG001|12-week Treatment Period|Physician Decision|2|||
156721625|NCT05573464|565727423|FG000|12-week Treatment Period|Lost to Follow-up|2|||
156721626|NCT05573464|565727424|FG001|12-week Treatment Period|Lost to Follow-up|0|||
156721627|NCT05573464|565727423|FG000|12-week Treatment Period|Adverse Event|20|||
156721628|NCT05573464|565727424|FG001|12-week Treatment Period|Adverse Event|9|||
156721629|NCT05573464|565727423|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
156721630|NCT05573464|565727424|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
156533417|NCT04600336|565046981|FG003|Initial Treatment|Withdrawal by Subject|0|||
156533418|NCT04600336|565046978|FG000|Initial Treatment|Adverse Event|0|||
156721631|NCT05573464|565727423|FG000|12-week Treatment Period|Randomised, not treated|0|||
156721632|NCT05573464|565727424|FG001|12-week Treatment Period|Randomised, not treated|1|||
156721633|NCT05573464|565727423|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
156450667|NCT03269136|564742147|FG003|Part 2A: Dose Expansion|Other|0|||
156450668|NCT03269136|564742148|FG004|Part 2A: Dose Expansion|Other|0|||
156450669|NCT03269136|564742149|FG005|Part 2A: Dose Expansion|Other|0|||
156450670|NCT03269136|564742150|FG006|Part 2A: Dose Expansion|Other|0|||
156450671|NCT03269136|564742151|FG007|Part 2A: Dose Expansion|Other|0|||
156450672|NCT03269136|564742152|FG008|Part 2A: Dose Expansion|Other|0|||
156450673|NCT03269136|564742153|FG009|Part 2A: Dose Expansion|Other|0|||
156450674|NCT03269136|564742154|FG010|Part 2A: Dose Expansion|Other|0|||
156450675|NCT03269136|564742155|FG011|Part 2A: Dose Expansion|Other|0|||
156450676|NCT03269136|564742156|FG012|Part 2A: Dose Expansion|Other|0|||
156450677|NCT03269136|564742157|FG013|Part 2A: Dose Expansion|Other|0|||
156450678|NCT03269136|564742158|FG014|Part 2A: Dose Expansion|Other|0|||
156450679|NCT03269136|564742159|FG015|Part 2A: Dose Expansion|Other|0|||
156450680|NCT03269136|564742160|FG016|Part 2A: Dose Expansion|Other|0|||
156450681|NCT03269136|564742161|FG017|Part 2A: Dose Expansion|Other|1|||
156450682|NCT03269136|564742144|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450683|NCT03269136|564742145|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450684|NCT03269136|564742146|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450685|NCT03269136|564742147|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450686|NCT03269136|564742148|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450687|NCT03269136|564742149|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450688|NCT03269136|564742150|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450689|NCT03269136|564742151|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156533419|NCT04600336|565046979|FG001|Initial Treatment|Adverse Event|2|||
156721634|NCT05573464|565727424|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
156721635|NCT05573464|565727423|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
156721636|NCT05573464|565727424|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
156721637|NCT05573464|565727423|FG000|52-week Treatment Period|Protocol Violation|1|||
156721638|NCT05573464|565727424|FG001|52-week Treatment Period|Protocol Violation|1|||
156721639|NCT05573464|565727423|FG000|52-week Treatment Period|Physician Decision|2|||
156721640|NCT05573464|565727424|FG001|52-week Treatment Period|Physician Decision|2|||
156721641|NCT05573464|565727423|FG000|52-week Treatment Period|Lost to Follow-up|1|||
156721642|NCT05573464|565727424|FG001|52-week Treatment Period|Lost to Follow-up|1|||
156721643|NCT05573464|565727423|FG000|52-week Treatment Period|Adverse Event|11|||
156721644|NCT05573464|565727424|FG001|52-week Treatment Period|Adverse Event|8|||
156721645|NCT05573464|565727423|FG000|52-week Treatment Period|Death|1|||
156721646|NCT05573464|565727424|FG001|52-week Treatment Period|Death|1|||
156721647|NCT05734157|565727425|FG000|Overall Study|Death|3|||
156721648|NCT05734157|565727425|FG000|Overall Study|Withdrawal by Subject|2|||
156721649|NCT05734157|565727425|FG000|Overall Study|Lost to Follow-up|1|||
156721650|NCT05734157|565727425|FG000|Overall Study|Telephone call|3|||
156721651|NCT01415518|565727426|FG000|Overall Study|Withdrawal by Subject|2|||
156721652|NCT01415518|565727427|FG001|Overall Study|Withdrawal by Subject|12|||
156721653|NCT01415518|565727426|FG000|Overall Study|Protocol Violation|6|||
156721654|NCT01415518|565727427|FG001|Overall Study|Protocol Violation|8|||
156721655|NCT01415518|565727426|FG000|Overall Study|Lost to Follow-up|3|||
156721656|NCT01415518|565727427|FG001|Overall Study|Lost to Follow-up|5|||
156721657|NCT01415518|565727426|FG000|Overall Study|Adverse Event|3|||
156721658|NCT01415518|565727427|FG001|Overall Study|Adverse Event|4|||
156335556|NCT00494299|564326130|FG000|Overall Study|Lost to Follow-up|1|||
156450690|NCT03269136|564742152|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450691|NCT03269136|564742153|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450692|NCT03269136|564742154|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450693|NCT03269136|564742155|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450694|NCT03269136|564742156|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450695|NCT03269136|564742157|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450696|NCT03269136|564742158|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450697|NCT03269136|564742159|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450698|NCT03269136|564742160|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
156450699|NCT03269136|564742161|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
156450700|NCT03269136|564742144|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
156450701|NCT03269136|564742145|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
156450702|NCT03269136|564742146|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
156335557|NCT00494299|564326131|FG001|Overall Study|Lost to Follow-up|0|||
156450703|NCT03269136|564742147|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
156450704|NCT03269136|564742148|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
156450705|NCT03269136|564742149|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
156450706|NCT03269136|564742150|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
156450707|NCT03269136|564742151|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
156450708|NCT03269136|564742152|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
156335558|NCT00494299|564326130|FG000|Overall Study|Physician Decision|0|||
156450709|NCT03269136|564742153|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
156450710|NCT03269136|564742154|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
156450711|NCT03269136|564742155|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
156450712|NCT03269136|564742156|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
156533420|NCT04600336|565046980|FG002|Initial Treatment|Adverse Event|0|||
156533421|NCT04600336|565046981|FG003|Initial Treatment|Adverse Event|0|||
156533422|NCT04600336|565046978|FG000|Initial Treatment|Other complicating disease|0|||
156533423|NCT04600336|565046979|FG001|Initial Treatment|Other complicating disease|0|||
156533424|NCT04600336|565046980|FG002|Initial Treatment|Other complicating disease|1|||
156533425|NCT04600336|565046981|FG003|Initial Treatment|Other complicating disease|0|||
156533426|NCT04600336|565046978|FG000|Crossover Treatment|Withdrawal by Subject|0|||
156450713|NCT03269136|564742157|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
156450714|NCT03269136|564742158|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
156533427|NCT04600336|565046979|FG001|Crossover Treatment|Withdrawal by Subject|0|||
156533428|NCT04600336|565046980|FG002|Crossover Treatment|Withdrawal by Subject|2|||
156533429|NCT04600336|565046981|FG003|Crossover Treatment|Withdrawal by Subject|1|||
156721659|NCT01415518|565727426|FG000|Overall Study|Death|1|||
156721660|NCT01415518|565727427|FG001|Overall Study|Death|1|||
156721661|NCT01415518|565727426|FG000|Overall Study|Condition under Investigation Worsened|1|||
156721662|NCT01415518|565727427|FG001|Overall Study|Condition under Investigation Worsened|1|||
156721663|NCT00813150|565727429|FG000|Treatment Period|Adverse Event|16|||
156721664|NCT00813150|565727430|FG001|Treatment Period|Adverse Event|15|||
156721665|NCT00813150|565727429|FG000|Treatment Period|Death|2|||
156721666|NCT00813150|565727430|FG001|Treatment Period|Death|0|||
156721667|NCT00813150|565727429|FG000|Treatment Period|Progressive disease|1|||
156721668|NCT00813150|565727430|FG001|Treatment Period|Progressive disease|0|||
156721669|NCT00813150|565727429|FG000|Treatment Period|Complete response|0|||
156721670|NCT00813150|565727430|FG001|Treatment Period|Complete response|1|||
156533430|NCT04600336|565046978|FG000|Crossover Treatment|Adverse Event|0|||
156533431|NCT04600336|565046979|FG001|Crossover Treatment|Adverse Event|0|||
156721671|NCT00813150|565727429|FG000|Treatment Period|Stable disease|1|||
156721672|NCT00813150|565727430|FG001|Treatment Period|Stable disease|2|||
156721673|NCT00813150|565727429|FG000|Treatment Period|Protocol Violation|3|||
156721674|NCT00813150|565727430|FG001|Treatment Period|Protocol Violation|4|||
156721675|NCT00813150|565727429|FG000|Treatment Period|Withdrawal by Subject|5|||
156721676|NCT00813150|565727430|FG001|Treatment Period|Withdrawal by Subject|3|||
156721677|NCT00813150|565727429|FG000|Treatment Period|Non compliance|0|||
156721678|NCT00813150|565727430|FG001|Treatment Period|Non compliance|1|||
156721679|NCT00813150|565727429|FG000|Treatment Period|Reason not specified|3|||
156721680|NCT00813150|565727430|FG001|Treatment Period|Reason not specified|4|||
156721681|NCT00813150|565727429|FG000|Treatment Period|Data not available|1|||
156721682|NCT00813150|565727430|FG001|Treatment Period|Data not available|2|||
156721683|NCT00813150|565727429|FG000|Long Term Follow-up|Death|0|||
156721684|NCT00813150|565727430|FG001|Long Term Follow-up|Death|4|||
156721685|NCT00813150|565727429|FG000|Long Term Follow-up|Other|0|||
156721686|NCT00813150|565727430|FG001|Long Term Follow-up|Other|3|||
156721687|NCT00813150|565727429|FG000|Long Term Follow-up|Lost to Follow-up|2|||
156721688|NCT00813150|565727430|FG001|Long Term Follow-up|Lost to Follow-up|0|||
156721689|NCT00813150|565727429|FG000|Long Term Follow-up|Progression/Relapse|22|||
156721690|NCT00813150|565727430|FG001|Long Term Follow-up|Progression/Relapse|24|||
156721691|NCT00210210|565727438|FG000|Overall Study|Withdrawal by Subject|3|||
156721692|NCT00210210|565727439|FG001|Overall Study|Withdrawal by Subject|2|||
156721693|NCT00210210|565727438|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
156721694|NCT00210210|565727439|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
156721695|NCT02445248|565727440|FG000|Overall Study|Death|45|||
156721696|NCT02445248|565727441|FG001|Overall Study|Death|12|||
156721697|NCT02445248|565727440|FG000|Overall Study|Progressive disease|13|||
156721698|NCT02445248|565727441|FG001|Overall Study|Progressive disease|1|||
156721699|NCT02445248|565727440|FG000|Overall Study|Subject decision|8|||
156721700|NCT02445248|565727441|FG001|Overall Study|Subject decision|0|||
156721701|NCT02445248|565727440|FG000|Overall Study|Physician Decision|5|||
156721702|NCT02445248|565727441|FG001|Overall Study|Physician Decision|0|||
156721703|NCT02445248|565727440|FG000|Overall Study|Adverse Event|1|||
156721704|NCT02445248|565727441|FG001|Overall Study|Adverse Event|0|||
156721705|NCT02445248|565727440|FG000|Overall Study|Lost to Follow-up|1|||
156721706|NCT02445248|565727441|FG001|Overall Study|Lost to Follow-up|0|||
156721707|NCT02596971|565727444|FG000|Overall Study|Death|5|||
156721708|NCT02596971|565727445|FG001|Overall Study|Death|1|||
156721709|NCT02596971|565727446|FG002|Overall Study|Death|5|||
156721710|NCT02596971|565727444|FG000|Overall Study|Withdrawal by Subject|5|||
156721711|NCT02596971|565727445|FG001|Overall Study|Withdrawal by Subject|1|||
156721712|NCT02596971|565727446|FG002|Overall Study|Withdrawal by Subject|4|||
156721713|NCT04067050|565727447|FG000|One Month|Lost to Follow-up|4|||
156721714|NCT04067050|565727448|FG001|One Month|Lost to Follow-up|0|||
156721715|NCT04067050|565727447|FG000|Two Month|Lost to Follow-up|1|||
156721716|NCT04067050|565727448|FG001|Two Month|Lost to Follow-up|0|||
156721717|NCT04067050|565727447|FG000|Two Month|Adverse Event|1|||
156721718|NCT04067050|565727448|FG001|Two Month|Adverse Event|0|||
156721719|NCT04341363|565727451|FG000|Overall Study|Adverse Event|1|||
156721720|NCT04341363|565727451|FG000|Overall Study|Withdrawal by Subject|1|||
156721721|NCT03534687|565727453|FG000|Overall Study|Lost to Follow-up|7|||
156721722|NCT03534687|565727454|FG001|Overall Study|Lost to Follow-up|2|||
156721723|NCT01293695|565727455|FG000|Overall Study|Withdrawal by Subject|7|||
156721724|NCT01293695|565727456|FG001|Overall Study|Withdrawal by Subject|1|||
156450715|NCT03269136|564742159|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
156450716|NCT03269136|564742160|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
156450717|NCT03269136|564742161|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
156450718|NCT03269136|564742144|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
156450719|NCT03269136|564742145|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
156450720|NCT03269136|564742146|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
156450721|NCT03269136|564742147|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
156450722|NCT03269136|564742148|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
156450723|NCT03269136|564742149|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
156450724|NCT03269136|564742150|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
156450725|NCT03269136|564742151|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
156450726|NCT03269136|564742152|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
156450727|NCT03269136|564742153|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
156450728|NCT03269136|564742154|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
156450729|NCT03269136|564742155|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
156450730|NCT03269136|564742156|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
156450731|NCT03269136|564742157|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
156450732|NCT03269136|564742158|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
156450733|NCT03269136|564742159|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
156450734|NCT03269136|564742160|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
156721725|NCT01293695|565727455|FG000|Overall Study|Lost to Follow-up|8|||
156721726|NCT01293695|565727456|FG001|Overall Study|Lost to Follow-up|6|||
156721727|NCT02069015|565727459|FG000|Overall Study|Lost to Follow-up|39|||
156721728|NCT02069015|565727460|FG001|Overall Study|Lost to Follow-up|32|||
156721729|NCT02069015|565727459|FG000|Overall Study|Withdrawal by Subject|1|||
156721730|NCT02069015|565727460|FG001|Overall Study|Withdrawal by Subject|1|||
156721731|NCT01778855|565727461|FG000|Overall Study|Death|0|||
156721732|NCT01778855|565727462|FG001|Overall Study|Death|1|||
156721733|NCT03776357|565727463|FG000|Overall Study|Lost to Follow-up|3|||
156721734|NCT03751098|565727466|FG000|Overall Study|Withdrawal by Subject|0|||
156721735|NCT03751098|565727467|FG001|Overall Study|Withdrawal by Subject|1|||
156721736|NCT00837148|565727470|FG000|Overall Study|Adverse Event|1|||
156721737|NCT00837148|565727470|FG000|Overall Study|Death|1|||
156721738|NCT00931411|565727478|FG000|First Intervention - 42 Days|Adverse Event|2|||
156450735|NCT03269136|564742161|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
156450736|NCT03269136|564742144|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
156450737|NCT03269136|564742145|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
156450738|NCT03269136|564742146|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
156450739|NCT03269136|564742147|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
156450740|NCT03269136|564742148|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
156450741|NCT03269136|564742149|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
156450742|NCT03269136|564742150|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
156450743|NCT03269136|564742151|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
156450744|NCT03269136|564742152|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
156450745|NCT03269136|564742153|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
156450746|NCT03269136|564742154|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
156450747|NCT03269136|564742155|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
156450748|NCT03269136|564742156|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
156450749|NCT03269136|564742157|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
156450750|NCT03269136|564742158|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
156450751|NCT03269136|564742159|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
156450752|NCT03269136|564742160|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
156450753|NCT03269136|564742161|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
156450754|NCT05071807|564742164|FG000|Overall Study|Withdrawal by Subject|4|||
156450755|NCT05071807|564742165|FG001|Overall Study|Withdrawal by Subject|0|||
156450756|NCT05071807|564742164|FG000|Overall Study|Unrelated medical issues|3|||
156450757|NCT05071807|564742165|FG001|Overall Study|Unrelated medical issues|0|||
156450758|NCT05071807|564742164|FG000|Overall Study|Relocated|0|||
156450759|NCT05071807|564742165|FG001|Overall Study|Relocated|1|||
156450760|NCT04952909|564742166|FG000|Overall Study|Death|3|||
156450761|NCT04856163|564742174|FG000|Overall Study|Lost to Follow-up|97|||
156450762|NCT04856163|564742175|FG001|Overall Study|Lost to Follow-up|100|||
156450763|NCT00881621|564742176|FG000|Overall Study|Physician Decision|34|||
156450764|NCT04359108|564742180|FG000|Overall Study|Withdrawal by Subject|1|||
156450765|NCT04359108|564742181|FG001|Overall Study|Withdrawal by Subject|0|||
156450766|NCT04359108|564742180|FG000|Overall Study|Unable or too feeble to walk independently|0|||
156450767|NCT04359108|564742181|FG001|Overall Study|Unable or too feeble to walk independently|2|||
156450768|NCT04359108|564742180|FG000|Overall Study|Argus II system stopped functioning|0|||
156450769|NCT04359108|564742181|FG001|Overall Study|Argus II system stopped functioning|1|||
156450770|NCT04359108|564742180|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
156450771|NCT04359108|564742181|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
156450772|NCT02515773|564742182|FG000|Overall Study|Withdrawal by Subject|12|||
156450773|NCT02515773|564742183|FG001|Overall Study|Withdrawal by Subject|2|||
156450774|NCT02515773|564742182|FG000|Overall Study|Lost to Follow-up|119|||
156450775|NCT02515773|564742183|FG001|Overall Study|Lost to Follow-up|126|||
156450776|NCT02515773|564742182|FG000|Overall Study|Discharged from Clinic Services|53|||
156450777|NCT02515773|564742183|FG001|Overall Study|Discharged from Clinic Services|84|||
156450778|NCT02515773|564742182|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
156450779|NCT02515773|564742183|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
156450780|NCT02515773|564742182|FG000|Overall Study|Follow-up at non-study site|8|||
156450781|NCT02515773|564742183|FG001|Overall Study|Follow-up at non-study site|16|||
156450782|NCT02515773|564742182|FG000|Overall Study|Moved from area|9|||
156450783|NCT02515773|564742183|FG001|Overall Study|Moved from area|14|||
156450784|NCT04176965|564742184|FG000|Overall Study|Death|1|||
156450785|NCT04176965|564742185|FG001|Overall Study|Death|2|||
156450786|NCT04176965|564742184|FG000|Overall Study|Lost to Follow-up|10|||
156450787|NCT04176965|564742185|FG001|Overall Study|Lost to Follow-up|2|||
156450788|NCT04176965|564742184|FG000|Overall Study|Withdrawal by Subject|6|||
156450789|NCT04176965|564742185|FG001|Overall Study|Withdrawal by Subject|1|||
156450790|NCT03468218|564742186|FG000|Overall Study|Adverse Event|5|||
156450791|NCT03468218|564742186|FG000|Overall Study|Progressive Disease|16|||
156450792|NCT03468218|564742186|FG000|Overall Study|Death|1|||
156450793|NCT03468218|564742186|FG000|Overall Study|Alternate therapy|1|||
156450794|NCT03468218|564742186|FG000|Overall Study|Withdrawal by Subject|2|||
156450795|NCT03033576|564742187|FG000|Overall Study|Ineligible|1|||
156450796|NCT03033576|564742188|FG001|Overall Study|Ineligible|1|||
156450797|NCT03033576|564742187|FG000|Overall Study|Adverse Event|4|||
156450798|NCT03033576|564742188|FG001|Overall Study|Adverse Event|20|||
156450799|NCT03033576|564742187|FG000|Overall Study|Progression/relapse|9|||
156450800|NCT03033576|564742188|FG001|Overall Study|Progression/relapse|36|||
156450801|NCT03033576|564742187|FG000|Overall Study|Death|1|||
156450802|NCT03033576|564742188|FG001|Overall Study|Death|1|||
156450803|NCT03033576|564742187|FG000|Overall Study|Patient refusal|1|||
156450804|NCT03033576|564742188|FG001|Overall Study|Patient refusal|6|||
156450805|NCT03033576|564742187|FG000|Overall Study|Other, unspecified reasons|0|||
156450806|NCT03033576|564742188|FG001|Overall Study|Other, unspecified reasons|4|||
156450807|NCT03033576|564742187|FG000|Overall Study|Currently on protocol therapy|0|||
156450808|NCT03033576|564742188|FG001|Overall Study|Currently on protocol therapy|2|||
156450809|NCT01214616|564742189|FG000|Overall Study|Progressive disease|2|||
156794238|NCT01681849|565999527|FG000|Overall Study|Withdrawal by Subject|3|||
156450810|NCT01214616|564742190|FG001|Overall Study|Progressive disease|2|||
156450811|NCT01214616|564742191|FG002|Overall Study|Progressive disease|2|||
156450812|NCT01214616|564742192|FG003|Overall Study|Progressive disease|4|||
156450813|NCT01214616|564742189|FG000|Overall Study|Dose limiting toxicity|0|||
156450814|NCT01214616|564742190|FG001|Overall Study|Dose limiting toxicity|2|||
156450815|NCT01214616|564742191|FG002|Overall Study|Dose limiting toxicity|0|||
156450816|NCT01214616|564742192|FG003|Overall Study|Dose limiting toxicity|0|||
156450817|NCT01214616|564742189|FG000|Overall Study|Other adverse events|0|||
156450818|NCT01214616|564742190|FG001|Overall Study|Other adverse events|1|||
156450819|NCT01214616|564742191|FG002|Overall Study|Other adverse events|1|||
156450820|NCT01214616|564742192|FG003|Overall Study|Other adverse events|1|||
156450821|NCT01214616|564742189|FG000|Overall Study|Withdrawal by Subject|1|||
156450822|NCT01214616|564742190|FG001|Overall Study|Withdrawal by Subject|0|||
156450823|NCT01214616|564742191|FG002|Overall Study|Withdrawal by Subject|0|||
156450824|NCT01214616|564742192|FG003|Overall Study|Withdrawal by Subject|1|||
156450825|NCT02949362|564742193|FG000|Retrospective Period|Inform consent not signed by participant|4|||
156450826|NCT02949362|564742194|FG001|Retrospective Period|Inform consent not signed by participant|1|||
156450827|NCT02949362|564742195|FG002|Retrospective Period|Inform consent not signed by participant|0|||
156450828|NCT02949362|564742196|FG003|Retrospective Period|Inform consent not signed by participant|0|||
156450829|NCT02949362|564742193|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
156450830|NCT02949362|564742194|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
156450831|NCT02949362|564742195|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
156450832|NCT02949362|564742196|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
156450833|NCT02949362|564742193|FG000|Prospective Period|Other|0|||
156450834|NCT02949362|564742194|FG001|Prospective Period|Other|0|||
156450835|NCT02949362|564742195|FG002|Prospective Period|Other|0|||
156450836|NCT02949362|564742196|FG003|Prospective Period|Other|4|||
156450837|NCT02471638|564742200|FG000|Overall Study|Early Term Withdrawal|10|||
156450838|NCT03376321|564744252|FG000|Overall Study|Other|5|||
156450839|NCT03376321|564744253|FG001|Overall Study|Other|1|||
156450840|NCT03376321|564744252|FG000|Overall Study|Withdrawal by Subject|8|||
156450841|NCT03376321|564744253|FG001|Overall Study|Withdrawal by Subject|14|||
156450842|NCT03376321|564744252|FG000|Overall Study|Lost to Follow-up|1|||
156450843|NCT03376321|564744253|FG001|Overall Study|Lost to Follow-up|7|||
156450844|NCT03376321|564744252|FG000|Overall Study|Death|4|||
156450845|NCT03376321|564744253|FG001|Overall Study|Death|0|||
156450846|NCT03376321|564744252|FG000|Overall Study|Randomized, not treated|5|||
156450847|NCT03376321|564744253|FG001|Overall Study|Randomized, not treated|3|||
156450848|NCT02995434|564744254|FG000|Overall Study|Adverse Event|1|||
156450849|NCT02995434|564744255|FG001|Overall Study|Adverse Event|0|||
156450850|NCT02995434|564744254|FG000|Overall Study|Withdrawal by Subject|6|||
156721739|NCT00931411|565727479|FG001|First Intervention - 42 Days|Adverse Event|3|||
156721740|NCT00931411|565727478|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
156721741|NCT00931411|565727479|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
156721742|NCT00931411|565727478|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
156721743|NCT00931411|565727479|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
156721744|NCT01306305|565727486|FG000|Overall Study|Lost to Follow-up|1|||
156721745|NCT01306305|565727487|FG001|Overall Study|Lost to Follow-up|0|||
156721746|NCT01306305|565727486|FG000|Overall Study|Withdrew consent|1|||
156721747|NCT01306305|565727487|FG001|Overall Study|Withdrew consent|0|||
156721748|NCT04030299|565727488|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
156721749|NCT04030299|565727488|FG000|Overall Study|Withdrawal by Subject|3|||
156721750|NCT00699998|565727489|FG000|Overall Study|Withdrawal by Subject|194|||
156721751|NCT00699998|565727490|FG001|Overall Study|Withdrawal by Subject|83|||
156721752|NCT00699998|565727491|FG002|Overall Study|Withdrawal by Subject|202|||
156721753|NCT00699998|565727492|FG003|Overall Study|Withdrawal by Subject|80|||
156721754|NCT00699998|565727489|FG000|Overall Study|Physician Decision|3|||
156721755|NCT00699998|565727490|FG001|Overall Study|Physician Decision|2|||
156721756|NCT00699998|565727491|FG002|Overall Study|Physician Decision|1|||
156721757|NCT00699998|565727492|FG003|Overall Study|Physician Decision|1|||
156721758|NCT00699998|565727489|FG000|Overall Study|Lost to Follow-up|2|||
156721759|NCT00699998|565727490|FG001|Overall Study|Lost to Follow-up|1|||
156721760|NCT00699998|565727491|FG002|Overall Study|Lost to Follow-up|3|||
156721761|NCT00699998|565727492|FG003|Overall Study|Lost to Follow-up|1|||
156721762|NCT04616612|565727499|FG000|Overall Study|Lost to Follow-up|6|||
156721763|NCT04616612|565727500|FG001|Overall Study|Lost to Follow-up|3|||
156721764|NCT04740918|565727502|FG000|Overall Study|Study Terminated by Sponsor|41|||
156450851|NCT02995434|564744255|FG001|Overall Study|Withdrawal by Subject|3|||
156450852|NCT02543281|564744262|FG000|Overall Study|Lost to Follow-up|0|||
156450853|NCT02543281|564744263|FG001|Overall Study|Lost to Follow-up|0|||
156450854|NCT02543281|564744264|FG002|Overall Study|Lost to Follow-up|1|||
156450855|NCT02530671|564744270|FG000|Overall Study|Lost to Follow-up|2|||
156721765|NCT04740918|565727503|FG001|Overall Study|Study Terminated by Sponsor|32|||
156721766|NCT04740918|565727502|FG000|Overall Study|Death|3|||
156721767|NCT04740918|565727503|FG001|Overall Study|Death|6|||
156721768|NCT04740918|565727502|FG000|Overall Study|Withdrawal by Subject|5|||
156450856|NCT02530671|564744271|FG001|Overall Study|Lost to Follow-up|0|||
156450857|NCT02530671|564744270|FG000|Overall Study|Withdrawal by Subject|1|||
156450858|NCT02530671|564744271|FG001|Overall Study|Withdrawal by Subject|0|||
156450859|NCT05247489|564744272|FG000|Overall Study|Lost to Follow-up|5|||
156450860|NCT05247489|564744273|FG001|Overall Study|Lost to Follow-up|1|||
156450861|NCT05247489|564744272|FG000|Overall Study|Withdrawal by Subject|6|||
156450862|NCT05247489|564744273|FG001|Overall Study|Withdrawal by Subject|7|||
156450863|NCT05247489|564744272|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
156450864|NCT05247489|564744273|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
156450865|NCT05247489|564744272|FG000|Overall Study|Left Country|1|||
156450866|NCT05247489|564744273|FG001|Overall Study|Left Country|0|||
156450867|NCT05247489|564744272|FG000|Overall Study|Noncompliance with Investigational Product|1|||
156450868|NCT05247489|564744273|FG001|Overall Study|Noncompliance with Investigational Product|0|||
156450869|NCT05247489|564744272|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
156450870|NCT05247489|564744273|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
156450871|NCT06283173|564744295|FG000|Overall Study|Did not show for first visit|10|||
156450872|NCT06283173|564744295|FG000|Overall Study|Lost to Follow-up|12|||
156450873|NCT06283173|564744295|FG000|Overall Study|Physician Decision|7|||
156450874|NCT05563246|564744309|FG000|Overall Study|Withdrawal by Subject|1|||
156450875|NCT05563246|564744310|FG001|Overall Study|Withdrawal by Subject|2|||
156450876|NCT05563246|564744311|FG002|Overall Study|Withdrawal by Subject|0|||
156450877|NCT05563246|564744312|FG003|Overall Study|Withdrawal by Subject|0|||
156450878|NCT05563246|564744309|FG000|Overall Study|Protocol Deviation|0|||
156450879|NCT05563246|564744310|FG001|Overall Study|Protocol Deviation|1|||
156450880|NCT05563246|564744311|FG002|Overall Study|Protocol Deviation|0|||
156450881|NCT05563246|564744312|FG003|Overall Study|Protocol Deviation|0|||
156450882|NCT05563246|564744309|FG000|Overall Study|Physician Decision|0|||
156450883|NCT05563246|564744310|FG001|Overall Study|Physician Decision|1|||
156450884|NCT05563246|564744311|FG002|Overall Study|Physician Decision|0|||
156450885|NCT05563246|564744312|FG003|Overall Study|Physician Decision|0|||
156450886|NCT05563246|564744309|FG000|Overall Study|Adverse Event|0|||
156450887|NCT05563246|564744310|FG001|Overall Study|Adverse Event|0|||
156450888|NCT05563246|564744311|FG002|Overall Study|Adverse Event|2|||
156450889|NCT05563246|564744312|FG003|Overall Study|Adverse Event|0|||
156450890|NCT05563246|564744309|FG000|Overall Study|Lost to Follow-up|0|||
156450891|NCT05563246|564744310|FG001|Overall Study|Lost to Follow-up|0|||
156450892|NCT05563246|564744311|FG002|Overall Study|Lost to Follow-up|1|||
156450893|NCT05563246|564744312|FG003|Overall Study|Lost to Follow-up|0|||
156450894|NCT02783300|564744325|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450895|NCT02783300|564744326|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450896|NCT02783300|564744327|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450897|NCT02783300|564744328|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156721769|NCT04740918|565727503|FG001|Overall Study|Withdrawal by Subject|4|||
156721770|NCT04740918|565727502|FG000|Overall Study|Lost to Follow-up|1|||
156721771|NCT04740918|565727503|FG001|Overall Study|Lost to Follow-up|3|||
156721772|NCT04740918|565727502|FG000|Overall Study|Progressive disease|0|||
156721773|NCT04740918|565727503|FG001|Overall Study|Progressive disease|1|||
156721774|NCT01168427|565727504|FG000|Overall Study|Patient exited prior to implant|1|||
156721775|NCT02964247|565727506|FG000|Overall Study|Lost to Follow-up|2|||
156721776|NCT02964247|565727507|FG001|Overall Study|Lost to Follow-up|0|||
156721777|NCT02964247|565727506|FG000|Overall Study|Withdrawal by Subject|1|||
156721778|NCT02964247|565727507|FG001|Overall Study|Withdrawal by Subject|2|||
156721779|NCT03759392|565727508|FG000|Overall Study|Adverse Event|12|||
156721780|NCT03759392|565727509|FG001|Overall Study|Adverse Event|4|||
156721781|NCT03759392|565727508|FG000|Overall Study|Death|2|||
156721782|NCT03759392|565727509|FG001|Overall Study|Death|1|||
156450898|NCT02783300|564744329|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450899|NCT02783300|564744330|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156721783|NCT03759392|565727508|FG000|Overall Study|Withdrawal by Subject|2|||
156875426|NCT00771953|566302065|FG001|Overall Study|Progression before active Tx|2|||
156450900|NCT02783300|564744331|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
156450901|NCT02783300|564744332|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450902|NCT02783300|564744333|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450903|NCT02783300|564744334|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450904|NCT02783300|564744335|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450905|NCT02783300|564744336|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450906|NCT02783300|564744337|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450907|NCT02783300|564744338|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450908|NCT02783300|564744339|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450909|NCT02783300|564744340|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450910|NCT02783300|564744341|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156721784|NCT03759392|565727509|FG001|Overall Study|Withdrawal by Subject|0|||
156721785|NCT03759392|565727508|FG000|Overall Study|Protocol Violation|2|||
156721786|NCT03759392|565727509|FG001|Overall Study|Protocol Violation|0|||
156450911|NCT02783300|564744342|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450912|NCT02783300|564744343|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450913|NCT02783300|564744344|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450914|NCT02783300|564744345|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450915|NCT02783300|564744346|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450916|NCT02783300|564744347|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450917|NCT02783300|564744348|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450918|NCT02783300|564744349|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450919|NCT02783300|564744350|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450920|NCT02783300|564744351|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156450921|NCT02783300|564744325|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450922|NCT02783300|564744326|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450923|NCT02783300|564744327|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450924|NCT02783300|564744328|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
156450925|NCT02783300|564744329|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450926|NCT02783300|564744330|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450927|NCT02783300|564744331|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450928|NCT02783300|564744332|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450929|NCT02783300|564744333|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450930|NCT02783300|564744334|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450931|NCT02783300|564744335|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450932|NCT02783300|564744336|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450933|NCT02783300|564744337|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450934|NCT02783300|564744338|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450935|NCT02783300|564744339|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450936|NCT02783300|564744340|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450937|NCT02783300|564744341|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450938|NCT02783300|564744342|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450939|NCT02783300|564744343|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450940|NCT02783300|564744344|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450941|NCT02783300|564744345|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450942|NCT02783300|564744346|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450943|NCT02783300|564744347|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450944|NCT02783300|564744348|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450945|NCT02783300|564744349|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450946|NCT02783300|564744350|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450947|NCT02783300|564744351|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156450948|NCT02783300|564744325|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
156450949|NCT02783300|564744326|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
156450950|NCT02783300|564744327|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
156450951|NCT02783300|564744328|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
156450952|NCT02783300|564744329|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
156450953|NCT02783300|564744330|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
156450954|NCT02783300|564744331|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
156450955|NCT02783300|564744332|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
156450956|NCT02783300|564744333|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
156450957|NCT02783300|564744334|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
156450958|NCT02783300|564744335|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
156450959|NCT02783300|564744336|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
156450960|NCT02783300|564744337|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
156450961|NCT02783300|564744338|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
156450962|NCT02783300|564744339|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
156450963|NCT02783300|564744340|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
156450964|NCT02783300|564744341|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
156875427|NCT00771953|566302064|FG000|Overall Study|Sponsor decision|1|||
156875428|NCT00771953|566302065|FG001|Overall Study|Sponsor decision|0|||
156875429|NCT00771953|566302064|FG000|Overall Study|Other complicating disease|1|||
156875430|NCT00771953|566302065|FG001|Overall Study|Other complicating disease|0|||
156875431|NCT00771953|566302064|FG000|Overall Study|Withdrawal by Subject|0|||
156875432|NCT00771953|566302065|FG001|Overall Study|Withdrawal by Subject|3|||
156450965|NCT02783300|564744342|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
156450966|NCT02783300|564744343|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
156450967|NCT02783300|564744344|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
156450968|NCT02783300|564744345|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
156450969|NCT02783300|564744346|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
156450970|NCT02783300|564744347|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
156450971|NCT02783300|564744348|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
156533432|NCT04600336|565046980|FG002|Crossover Treatment|Adverse Event|1|||
156875433|NCT00947193|566302068|FG000|Overall Study|Lost to Follow-up|1|||
156875434|NCT00947193|566302069|FG001|Overall Study|Lost to Follow-up|0|||
156450972|NCT02783300|564744349|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
156450973|NCT02783300|564744350|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
156450974|NCT02783300|564744351|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
156450975|NCT02783300|564744325|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450976|NCT02783300|564744326|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450977|NCT02783300|564744327|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450978|NCT02783300|564744328|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450979|NCT02783300|564744329|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450980|NCT02783300|564744330|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450981|NCT02783300|564744331|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
156450982|NCT02783300|564744332|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450983|NCT02783300|564744333|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450984|NCT02783300|564744334|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450985|NCT02783300|564744335|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450986|NCT02783300|564744336|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450987|NCT02783300|564744337|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
156450988|NCT02783300|564744338|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450989|NCT02783300|564744339|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450990|NCT02783300|564744340|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450991|NCT02783300|564744341|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450992|NCT02783300|564744342|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450993|NCT02783300|564744343|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450994|NCT02783300|564744344|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450995|NCT02783300|564744345|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156721787|NCT03759392|565727508|FG000|Overall Study|Physician Decision|0|||
156721788|NCT03759392|565727509|FG001|Overall Study|Physician Decision|1|||
156450996|NCT02783300|564744346|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450997|NCT02783300|564744347|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450998|NCT02783300|564744348|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156450999|NCT02783300|564744349|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156451000|NCT02783300|564744350|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156451001|NCT02783300|564744351|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156451002|NCT02783300|564744325|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451003|NCT02783300|564744326|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451004|NCT02783300|564744327|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451005|NCT02783300|564744328|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156721789|NCT03759392|565727508|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
156721790|NCT03759392|565727509|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
156721791|NCT03759392|565727508|FG000|Overall Study|No longer able to take medicines|1|||
156451006|NCT02783300|564744329|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
156451007|NCT02783300|564744330|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451008|NCT02783300|564744331|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
156451009|NCT02783300|564744332|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451010|NCT02783300|564744333|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451011|NCT02783300|564744334|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
156451012|NCT02783300|564744335|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451013|NCT02783300|564744336|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451014|NCT02783300|564744337|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
156451015|NCT02783300|564744338|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451016|NCT02783300|564744339|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451017|NCT02783300|564744340|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451018|NCT02783300|564744341|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451019|NCT02783300|564744342|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451020|NCT02783300|564744343|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451021|NCT02783300|564744344|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451022|NCT02783300|564744345|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451023|NCT02783300|564744346|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451024|NCT02783300|564744347|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451025|NCT02783300|564744348|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451026|NCT02783300|564744349|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451027|NCT02783300|564744350|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156451028|NCT02783300|564744351|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
156533433|NCT04600336|565046981|FG003|Crossover Treatment|Adverse Event|1|||
156721792|NCT03759392|565727509|FG001|Overall Study|No longer able to take medicines|0|||
156721793|NCT03759392|565727508|FG000|Overall Study|Stopped taking study drug|1|||
156721794|NCT03759392|565727509|FG001|Overall Study|Stopped taking study drug|0|||
156533434|NCT00434421|565048790|FG000|Overall Study|Withdrawal by Subject|1|||
156533435|NCT00434421|565048790|FG000|Overall Study|Non-compliance with study treatment|1|||
156533436|NCT01087957|565048793|FG000|Overall Study|Death|2|||
156451029|NCT02783300|564744325|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451030|NCT02783300|564744326|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451031|NCT02783300|564744327|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451032|NCT02783300|564744328|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451033|NCT02783300|564744329|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451034|NCT02783300|564744330|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451035|NCT02783300|564744331|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451036|NCT02783300|564744332|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451037|NCT02783300|564744333|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451038|NCT02783300|564744334|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451039|NCT02783300|564744335|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451040|NCT02783300|564744336|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451041|NCT02783300|564744337|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451042|NCT02783300|564744338|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451043|NCT02783300|564744339|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451044|NCT02783300|564744340|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
156451045|NCT02783300|564744341|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451046|NCT02783300|564744342|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
156451047|NCT02783300|564744343|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
156451048|NCT02783300|564744344|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
156451049|NCT02783300|564744345|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451050|NCT02783300|564744346|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451051|NCT02783300|564744347|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451052|NCT02783300|564744348|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451053|NCT02783300|564744349|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
156451054|NCT02783300|564744350|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451055|NCT02783300|564744351|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
156451056|NCT02783300|564744325|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451057|NCT02783300|564744326|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451058|NCT02783300|564744327|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451059|NCT02783300|564744328|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451060|NCT02783300|564744329|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451061|NCT02783300|564744330|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451062|NCT02783300|564744331|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451063|NCT02783300|564744332|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451064|NCT02783300|564744333|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451065|NCT02783300|564744334|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451066|NCT02783300|564744335|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451067|NCT02783300|564744336|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451068|NCT02783300|564744337|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451069|NCT02783300|564744338|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451070|NCT02783300|564744339|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451071|NCT02783300|564744340|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451072|NCT02783300|564744341|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
156451073|NCT02783300|564744342|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451074|NCT02783300|564744343|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
156533437|NCT01087957|565048794|FG001|Overall Study|Death|2|||
156533438|NCT01087957|565048793|FG000|Overall Study|Lost to Follow-up|3|||
156533439|NCT01087957|565048794|FG001|Overall Study|Lost to Follow-up|4|||
156533440|NCT01087957|565048793|FG000|Overall Study|Protocol Violation|13|||
156533441|NCT01087957|565048794|FG001|Overall Study|Protocol Violation|25|||
156533442|NCT01087957|565048793|FG000|Overall Study|Withdrawal by Subject|18|||
156533443|NCT01087957|565048794|FG001|Overall Study|Withdrawal by Subject|15|||
156533444|NCT01087957|565048793|FG000|Overall Study|Physician Decision|5|||
156533445|NCT01087957|565048794|FG001|Overall Study|Physician Decision|9|||
156533446|NCT02366728|565048795|FG000|Overall Study|Death|0|||
156533447|NCT02366728|565048796|FG001|Overall Study|Death|0|||
156533448|NCT02366728|565048797|FG002|Overall Study|Death|1|||
156335559|NCT00494299|564326131|FG001|Overall Study|Physician Decision|2|||
156533449|NCT02366728|565048795|FG000|Overall Study|Adverse Event|1|||
156533450|NCT02366728|565048796|FG001|Overall Study|Adverse Event|0|||
156533451|NCT02366728|565048797|FG002|Overall Study|Adverse Event|0|||
156451075|NCT02783300|564744344|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
156451076|NCT02783300|564744345|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451077|NCT02783300|564744346|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451078|NCT02783300|564744347|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451079|NCT02783300|564744348|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451080|NCT02783300|564744349|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451081|NCT02783300|564744350|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451082|NCT02783300|564744351|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
156451083|NCT02783300|564744325|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451084|NCT02783300|564744326|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451085|NCT02783300|564744327|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451086|NCT02783300|564744328|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451087|NCT02783300|564744329|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156721795|NCT01288079|565727510|FG000|Overall Study|Withdrawal by Subject|2|||
156721796|NCT01288079|565727511|FG001|Overall Study|Withdrawal by Subject|4|||
156721797|NCT01288079|565727512|FG002|Overall Study|Withdrawal by Subject|1|||
156721798|NCT01288079|565727513|FG003|Overall Study|Withdrawal by Subject|0|||
156721799|NCT01288079|565727510|FG000|Overall Study|Adverse Event|2|||
156721800|NCT01288079|565727511|FG001|Overall Study|Adverse Event|1|||
156721801|NCT01288079|565727512|FG002|Overall Study|Adverse Event|2|||
156721802|NCT01288079|565727513|FG003|Overall Study|Adverse Event|3|||
156451088|NCT02783300|564744330|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451089|NCT02783300|564744331|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451090|NCT02783300|564744332|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451091|NCT02783300|564744333|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451092|NCT02783300|564744334|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451093|NCT02783300|564744335|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451094|NCT02783300|564744336|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451095|NCT02783300|564744337|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451096|NCT02783300|564744338|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451097|NCT02783300|564744339|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451098|NCT02783300|564744340|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451099|NCT02783300|564744341|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
156451100|NCT02783300|564744342|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451101|NCT02783300|564744343|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
156451102|NCT02783300|564744344|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
156451103|NCT02783300|564744345|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
156451104|NCT02783300|564744346|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451105|NCT02783300|564744347|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451106|NCT02783300|564744348|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451107|NCT02783300|564744349|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451108|NCT02783300|564744350|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451109|NCT02783300|564744351|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156451110|NCT02783300|564744325|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451111|NCT02783300|564744326|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451112|NCT02783300|564744327|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451113|NCT02783300|564744328|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451114|NCT02783300|564744329|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451115|NCT02783300|564744330|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451116|NCT02783300|564744331|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451117|NCT02783300|564744332|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451118|NCT02783300|564744333|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451119|NCT02783300|564744334|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451120|NCT02783300|564744335|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451121|NCT02783300|564744336|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451122|NCT02783300|564744337|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451123|NCT02783300|564744338|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451124|NCT02783300|564744339|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451125|NCT02783300|564744340|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
156451126|NCT02783300|564744341|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451127|NCT02783300|564744342|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451128|NCT02783300|564744343|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156721803|NCT01288079|565727510|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
156721804|NCT01288079|565727511|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
156721805|NCT01288079|565727512|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
156451129|NCT02783300|564744344|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451130|NCT02783300|564744345|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451131|NCT02783300|564744346|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451132|NCT02783300|564744347|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
156451133|NCT02783300|564744348|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451134|NCT02783300|564744349|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451135|NCT02783300|564744350|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451136|NCT02783300|564744351|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
156451137|NCT02783300|564744325|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451138|NCT02783300|564744326|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451139|NCT02783300|564744327|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451140|NCT02783300|564744328|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451141|NCT02783300|564744329|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451142|NCT02783300|564744330|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451143|NCT02783300|564744331|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451144|NCT02783300|564744332|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451145|NCT02783300|564744333|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451146|NCT02783300|564744334|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451147|NCT02783300|564744335|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451148|NCT02783300|564744336|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451149|NCT02783300|564744337|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451150|NCT02783300|564744338|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
156451151|NCT02783300|564744339|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
156451152|NCT02783300|564744340|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
156451153|NCT02783300|564744341|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
156451154|NCT02783300|564744342|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451155|NCT02783300|564744343|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
156451156|NCT02783300|564744344|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
156451157|NCT02783300|564744345|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451158|NCT02783300|564744346|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451159|NCT02783300|564744347|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451160|NCT02783300|564744348|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451161|NCT02783300|564744349|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451162|NCT02783300|564744350|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451163|NCT02783300|564744351|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
156451164|NCT02783300|564744325|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451165|NCT02783300|564744326|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451166|NCT02783300|564744327|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451167|NCT02783300|564744328|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451168|NCT02783300|564744329|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451169|NCT02783300|564744330|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451170|NCT02783300|564744331|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451171|NCT02783300|564744332|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451172|NCT02783300|564744333|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451173|NCT02783300|564744334|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451174|NCT02783300|564744335|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451175|NCT02783300|564744336|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451176|NCT02783300|564744337|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451177|NCT02783300|564744338|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
156451178|NCT02783300|564744339|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
156451179|NCT02783300|564744340|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
156451180|NCT02783300|564744341|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
156451181|NCT02783300|564744342|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
156451182|NCT02783300|564744343|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
156451183|NCT02783300|564744344|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
156451184|NCT02783300|564744345|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
156451185|NCT02783300|564744346|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
156451186|NCT02783300|564744347|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
156451187|NCT02783300|564744348|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
156451188|NCT02783300|564744349|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
156533452|NCT02366728|565048795|FG000|Overall Study|Screen Failure|2|||
156794239|NCT01681849|565999528|FG001|Overall Study|Withdrawal by Subject|5|||
156451189|NCT02783300|564744350|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
156451190|NCT02783300|564744351|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
156451191|NCT02783300|564744325|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451192|NCT02783300|564744326|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451193|NCT02783300|564744327|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451194|NCT02783300|564744328|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451195|NCT02783300|564744329|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451196|NCT02783300|564744330|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451197|NCT02783300|564744331|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451198|NCT02783300|564744332|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451199|NCT02783300|564744333|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451200|NCT02783300|564744334|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451201|NCT02783300|564744335|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451202|NCT02783300|564744336|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451203|NCT02783300|564744337|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451204|NCT02783300|564744338|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451205|NCT02783300|564744339|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451206|NCT02783300|564744340|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451207|NCT02783300|564744341|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451208|NCT02783300|564744342|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451209|NCT02783300|564744343|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451210|NCT02783300|564744344|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451211|NCT02783300|564744345|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451212|NCT02783300|564744346|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451213|NCT02783300|564744347|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451214|NCT02783300|564744348|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451215|NCT02783300|564744349|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451216|NCT02783300|564744350|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
156451217|NCT02783300|564744351|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
156451218|NCT02783300|564744325|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451219|NCT02783300|564744326|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451220|NCT02783300|564744327|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451221|NCT02783300|564744328|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451222|NCT02783300|564744329|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451223|NCT02783300|564744330|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451224|NCT02783300|564744331|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451225|NCT02783300|564744332|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451226|NCT02783300|564744333|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451227|NCT02783300|564744334|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451228|NCT02783300|564744335|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451229|NCT02783300|564744336|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451230|NCT02783300|564744337|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451231|NCT02783300|564744338|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451232|NCT02783300|564744339|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451233|NCT02783300|564744340|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451234|NCT02783300|564744341|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451235|NCT02783300|564744342|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451236|NCT02783300|564744343|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451237|NCT02783300|564744344|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451238|NCT02783300|564744345|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451239|NCT02783300|564744346|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451240|NCT02783300|564744347|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451241|NCT02783300|564744348|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451242|NCT02783300|564744349|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451243|NCT02783300|564744350|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
156451244|NCT02783300|564744351|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
156451245|NCT03535272|564744352|FG000|Overall Study|Lost to Follow-up|71|||
156451246|NCT03535272|564744353|FG001|Overall Study|Lost to Follow-up|73|||
156451247|NCT01744782|564744354|FG000|Overall Study|Death|1|||
156451248|NCT00378105|564744355|FG000|Overall Study|Adverse Event|3|||
156451249|NCT00378105|564744356|FG001|Overall Study|Adverse Event|1|||
156451250|NCT00378105|564744355|FG000|Overall Study|Withdrawal by Subject|3|||
156451251|NCT00378105|564744356|FG001|Overall Study|Withdrawal by Subject|3|||
156451252|NCT00378105|564744355|FG000|Overall Study|Death|1|||
156451253|NCT00378105|564744356|FG001|Overall Study|Death|0|||
156451254|NCT00378105|564744355|FG000|Overall Study|Going to transplant|7|||
156533453|NCT02366728|565048796|FG001|Overall Study|Screen Failure|1|||
156533454|NCT02366728|565048797|FG002|Overall Study|Screen Failure|0|||
156451255|NCT00378105|564744356|FG001|Overall Study|Going to transplant|8|||
156451256|NCT00378105|564744355|FG000|Overall Study|Progressive disease|3|||
156451257|NCT00378105|564744356|FG001|Overall Study|Progressive disease|3|||
156451258|NCT00378105|564744355|FG000|Overall Study|remain on study|3|||
156451259|NCT00378105|564744356|FG001|Overall Study|remain on study|11|||
156451260|NCT00378105|564744355|FG000|Overall Study|Physician Decision|0|||
156451261|NCT00378105|564744356|FG001|Overall Study|Physician Decision|2|||
156451262|NCT00378105|564744355|FG000|Overall Study|Going non-protocol therapy|0|||
156451263|NCT00378105|564744356|FG001|Overall Study|Going non-protocol therapy|1|||
156451264|NCT00378105|564744355|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
156451265|NCT00378105|564744356|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
156451266|NCT03623321|564744357|FG000|Overall Study|Adverse Event|32|||
156451267|NCT03623321|564744357|FG000|Overall Study|Death|9|||
156451268|NCT03623321|564744357|FG000|Overall Study|Lack of Efficacy|9|||
156451269|NCT03623321|564744357|FG000|Overall Study|Lost to Follow-up|6|||
156451270|NCT03623321|564744357|FG000|Overall Study|Noncompliance with study drug|6|||
156451271|NCT03623321|564744357|FG000|Overall Study|Use of prohibited medication|3|||
156451272|NCT03623321|564744357|FG000|Overall Study|Physician Decision|5|||
156451273|NCT03623321|564744357|FG000|Overall Study|Protocol Violation|1|||
156451274|NCT03623321|564744357|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
156451275|NCT03623321|564744357|FG000|Overall Study|Not further specified|43|||
156451276|NCT04241068|564744360|FG000|Core Treatment Period|Adverse Event|91|||
156451277|NCT04241068|564744360|FG000|Core Treatment Period|Change of Treatment|4|||
156451278|NCT04241068|564744360|FG000|Core Treatment Period|Consent Withdrawn|143|||
156451279|NCT04241068|564744360|FG000|Core Treatment Period|Death|26|||
156451280|NCT04241068|564744360|FG000|Core Treatment Period|Disease Progression|67|||
156451281|NCT04241068|564744360|FG000|Core Treatment Period|Investigator Decision|40|||
156451282|NCT04241068|564744360|FG000|Core Treatment Period|Loss of Capacity|9|||
156451283|NCT04241068|564744360|FG000|Core Treatment Period|Lost to Follow-up|11|||
156451284|NCT04241068|564744360|FG000|Core Treatment Period|Relocation|4|||
156451285|NCT04241068|564744360|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
156451286|NCT04241068|564744360|FG000|Core Treatment Period|Study Visit Burden|40|||
156451287|NCT04241068|564744360|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
156451288|NCT04241068|564744360|FG000|Core Treatment Period|Missing|2|||
156451289|NCT04241068|564744360|FG000|Core Treatment Period|Reason Not Specified|41|||
156451290|NCT04241068|564744360|FG000|LTE Period|Adverse Event|19|||
156451291|NCT04241068|564744360|FG000|LTE Period|Change of Treatment|1|||
156451292|NCT04241068|564744360|FG000|LTE Period|Consent Withdrawn|71|||
156451293|NCT04241068|564744360|FG000|LTE Period|Death|8|||
156451294|NCT04241068|564744360|FG000|LTE Period|Disease Progression|11|||
156451295|NCT04241068|564744360|FG000|LTE Period|Investigator Decision|12|||
156451296|NCT04241068|564744360|FG000|LTE Period|Loss of Capacity|2|||
156451297|NCT04241068|564744360|FG000|LTE Period|Lost to Follow-up|7|||
156451298|NCT04241068|564744360|FG000|LTE Period|Relocation|6|||
156451299|NCT04241068|564744360|FG000|LTE Period|Site Terminated by Sponsor|26|||
156451300|NCT04241068|564744360|FG000|LTE Period|Study Terminated by Sponsor|276|||
156451301|NCT04241068|564744360|FG000|LTE Period|Study Visit Burden|10|||
156451302|NCT04241068|564744360|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
156451303|NCT04241068|564744360|FG000|LTE Period|Reason Not Specified|65|||
156451304|NCT04492007|564744362|FG000|Overall Study|Lost to Follow-up|1|||
156451305|NCT04492007|564744363|FG001|Overall Study|Lost to Follow-up|1|||
156451306|NCT04492007|564744364|FG002|Overall Study|Lost to Follow-up|2|||
156451307|NCT04492007|564744365|FG003|Overall Study|Lost to Follow-up|2|||
156451308|NCT04492007|564744362|FG000|Overall Study|Protocol Violation|1|||
156451309|NCT04492007|564744363|FG001|Overall Study|Protocol Violation|1|||
156451310|NCT04492007|564744364|FG002|Overall Study|Protocol Violation|1|||
156451311|NCT04492007|564744365|FG003|Overall Study|Protocol Violation|1|||
156875435|NCT00947193|566302068|FG000|Overall Study|Withdrawal by Subject|1|||
156875436|NCT00947193|566302069|FG001|Overall Study|Withdrawal by Subject|0|||
156335560|NCT00494299|564326130|FG000|Overall Study|Protocol Violation|1|||
156451312|NCT04492007|564744362|FG000|Overall Study|Withdrawal by Subject|0|||
156451313|NCT04492007|564744363|FG001|Overall Study|Withdrawal by Subject|0|||
156451314|NCT04492007|564744364|FG002|Overall Study|Withdrawal by Subject|1|||
156451315|NCT04492007|564744365|FG003|Overall Study|Withdrawal by Subject|1|||
156451316|NCT05178316|564744366|FG000|Overall Study|Adverse Event|5|||
156451317|NCT05178316|564744367|FG001|Overall Study|Adverse Event|4|||
156451318|NCT05178316|564744368|FG002|Overall Study|Adverse Event|9|||
156451319|NCT05178316|564744366|FG000|Overall Study|Enrolled in Error|1|||
156451320|NCT05178316|564744367|FG001|Overall Study|Enrolled in Error|2|||
156451321|NCT05178316|564744368|FG002|Overall Study|Enrolled in Error|1|||
156451322|NCT05178316|564744366|FG000|Overall Study|Lost to Follow-up|3|||
156451323|NCT05178316|564744367|FG001|Overall Study|Lost to Follow-up|15|||
156451324|NCT05178316|564744368|FG002|Overall Study|Lost to Follow-up|11|||
156451325|NCT05178316|564744366|FG000|Overall Study|Noncompliance|1|||
156451326|NCT05178316|564744367|FG001|Overall Study|Noncompliance|3|||
156451327|NCT05178316|564744368|FG002|Overall Study|Noncompliance|1|||
156451328|NCT05178316|564744366|FG000|Overall Study|Other|0|||
156451329|NCT05178316|564744367|FG001|Overall Study|Other|1|||
156451330|NCT05178316|564744368|FG002|Overall Study|Other|0|||
156451331|NCT05178316|564744366|FG000|Overall Study|Physician Decision|0|||
156451332|NCT05178316|564744367|FG001|Overall Study|Physician Decision|3|||
156451333|NCT05178316|564744368|FG002|Overall Study|Physician Decision|2|||
156451334|NCT05178316|564744366|FG000|Overall Study|Protocol deviation|1|||
156451335|NCT05178316|564744367|FG001|Overall Study|Protocol deviation|0|||
156451336|NCT05178316|564744368|FG002|Overall Study|Protocol deviation|1|||
156451337|NCT05178316|564744366|FG000|Overall Study|Sponsor decision|1|||
156451338|NCT05178316|564744367|FG001|Overall Study|Sponsor decision|0|||
156451339|NCT05178316|564744368|FG002|Overall Study|Sponsor decision|1|||
156451340|NCT05178316|564744366|FG000|Overall Study|Withdrawal by Subject|5|||
156451341|NCT05178316|564744367|FG001|Overall Study|Withdrawal by Subject|11|||
156451342|NCT05178316|564744368|FG002|Overall Study|Withdrawal by Subject|5|||
156451343|NCT03907397|564744371|FG000|Overall Study|Lost to Follow-up|0|||
156451344|NCT03907397|564744372|FG001|Overall Study|Lost to Follow-up|1|||
156451345|NCT03907397|564744371|FG000|Overall Study|Physician Decision|2|||
156451346|NCT03907397|564744372|FG001|Overall Study|Physician Decision|1|||
156451347|NCT03907397|564744371|FG000|Overall Study|Withdrawal by Subject|5|||
156451348|NCT03907397|564744372|FG001|Overall Study|Withdrawal by Subject|4|||
156451349|NCT03907397|564744371|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
156451350|NCT03907397|564744372|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
156721806|NCT01288079|565727513|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
156721807|NCT01288079|565727510|FG000|Overall Study|Condition under Investigation Worsened|0|||
156721808|NCT01288079|565727511|FG001|Overall Study|Condition under Investigation Worsened|0|||
156721809|NCT01288079|565727512|FG002|Overall Study|Condition under Investigation Worsened|0|||
156721810|NCT01288079|565727513|FG003|Overall Study|Condition under Investigation Worsened|1|||
156721811|NCT01288079|565727510|FG000|Overall Study|Lack of Efficacy|2|||
156721812|NCT01288079|565727511|FG001|Overall Study|Lack of Efficacy|2|||
156721813|NCT01288079|565727512|FG002|Overall Study|Lack of Efficacy|0|||
156721814|NCT01288079|565727513|FG003|Overall Study|Lack of Efficacy|2|||
156721815|NCT01288079|565727510|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
156721816|NCT01288079|565727511|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
156721817|NCT01288079|565727512|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
156721818|NCT01288079|565727513|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
156721819|NCT01288079|565727510|FG000|Overall Study|Lost to Follow-up|1|||
156721820|NCT01288079|565727511|FG001|Overall Study|Lost to Follow-up|1|||
156721821|NCT01288079|565727512|FG002|Overall Study|Lost to Follow-up|1|||
156721822|NCT01288079|565727513|FG003|Overall Study|Lost to Follow-up|0|||
156721823|NCT01288079|565727510|FG000|Overall Study|Other or Study Termination|11|||
156721824|NCT01288079|565727511|FG001|Overall Study|Other or Study Termination|15|||
156721825|NCT01288079|565727512|FG002|Overall Study|Other or Study Termination|14|||
156721826|NCT01288079|565727513|FG003|Overall Study|Other or Study Termination|8|||
156721827|NCT01530464|565727514|FG000|Washout (24h)|Withdrawal by Subject|1|||
156721828|NCT01530464|565727515|FG001|Washout (24h)|Withdrawal by Subject|0|||
156721829|NCT01530464|565727514|FG000|Washout (24h)|Withdrawal by Subject|0|||
156721830|NCT01530464|565727515|FG001|Washout (24h)|Withdrawal by Subject|1|||
156721831|NCT01709500|565727516|FG000|Overall Study|Randomized but not treated|0|||
156451351|NCT01413100|564744373|FG000|Overall Study|Withdrawal by Subject|1|||
156451352|NCT05369403|564744374|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
156451353|NCT05369403|564744375|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
156451354|NCT05369403|564744376|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
156721832|NCT01709500|565727517|FG001|Overall Study|Randomized but not treated|1|||
156721833|NCT01709500|565727516|FG000|Overall Study|Adverse Event|5|||
156875437|NCT00947193|566302068|FG000|Overall Study|Factor VIII >1%|1|||
156875438|NCT00947193|566302069|FG001|Overall Study|Factor VIII >1%|0|||
156335561|NCT00494299|564326131|FG001|Overall Study|Protocol Violation|2|||
156335562|NCT00494299|564326130|FG000|Overall Study|Withdrawal by Subject|8|||
156451355|NCT05369403|564744374|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
156451356|NCT05369403|564744375|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
156451357|NCT05369403|564744376|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
156451358|NCT05369403|564744374|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
156451359|NCT05369403|564744375|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
156451360|NCT05369403|564744376|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
156451361|NCT05369403|564744374|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
156451362|NCT05369403|564744375|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
156721834|NCT01709500|565727517|FG001|Overall Study|Adverse Event|1|||
156721835|NCT01709500|565727516|FG000|Overall Study|Poor compliance to protocol|2|||
156721836|NCT01709500|565727517|FG001|Overall Study|Poor compliance to protocol|1|||
156721837|NCT01709500|565727516|FG000|Overall Study|Other|3|||
156721838|NCT01709500|565727517|FG001|Overall Study|Other|1|||
156533455|NCT02366728|565048795|FG000|Overall Study|Only yielded 2 vaccines|1|||
156721839|NCT01709500|565727516|FG000|Overall Study|Related to IMP administration|1|||
156875439|NCT04364984|566302070|FG000|Overall Study|Death|2|||
156533456|NCT02366728|565048796|FG001|Overall Study|Only yielded 2 vaccines|0|||
156721840|NCT01709500|565727517|FG001|Overall Study|Related to IMP administration|0|||
156721841|NCT01709500|565727516|FG000|Overall Study|Treatment ongoing|156|||
156721842|NCT01709500|565727517|FG001|Overall Study|Treatment ongoing|78|||
156721843|NCT03539302|565727524|FG000|Overall Study|Spontaneous cardio version|0|||
156721844|NCT03539302|565727525|FG001|Overall Study|Spontaneous cardio version|0|||
156721845|NCT03539302|565727526|FG002|Overall Study|Spontaneous cardio version|0|||
156721846|NCT03539302|565727527|FG003|Overall Study|Spontaneous cardio version|0|||
156721847|NCT03539302|565727528|FG004|Overall Study|Spontaneous cardio version|0|||
156721848|NCT03539302|565727529|FG005|Overall Study|Spontaneous cardio version|1|||
156721849|NCT03539302|565727530|FG006|Overall Study|Spontaneous cardio version|1|||
156721850|NCT02107131|565727532|FG000|Overall Study|Lost to Follow-up|4|||
156721851|NCT02107131|565727533|FG001|Overall Study|Lost to Follow-up|4|||
156721852|NCT02107131|565727532|FG000|Overall Study|Physician Decision|1|||
156721853|NCT02107131|565727533|FG001|Overall Study|Physician Decision|0|||
156721854|NCT02107131|565727532|FG000|Overall Study|Withdrawal by Subject|2|||
156721855|NCT02107131|565727533|FG001|Overall Study|Withdrawal by Subject|0|||
156721856|NCT02107131|565727532|FG000|Overall Study|mental instability|1|||
156721857|NCT02107131|565727533|FG001|Overall Study|mental instability|0|||
156721858|NCT02107131|565727532|FG000|Overall Study|Death|0|||
156721859|NCT02107131|565727533|FG001|Overall Study|Death|1|||
156721860|NCT02107131|565727532|FG000|Overall Study|Protocol Violation|0|||
156451363|NCT05369403|564744376|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
156451364|NCT05369403|564744374|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
156451365|NCT05369403|564744375|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
156451366|NCT05369403|564744376|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
156721861|NCT02107131|565727533|FG001|Overall Study|Protocol Violation|4|||
156721862|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Adverse Event|7|||
156721863|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
156721864|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Non-compliance|3|||
156721865|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Other|17|||
156721866|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Physician Decision|2|||
156721867|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Pregnancy|1|||
156721868|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
156721869|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
156721870|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
156721871|NCT05207865|565728879|FG000|Follow-up Phase|Lost to Follow-up|1|||
156721872|NCT05207865|565728879|FG000|Follow-up Phase|Non-compliance|1|||
156721873|NCT05207865|565728879|FG000|Follow-up Phase|Not reported|2|||
156721874|NCT05207865|565728879|FG000|Follow-up Phase|Not collected|11|||
156721875|NCT05423093|565728880|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
156721876|NCT05423093|565728880|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
156721877|NCT05423093|565728880|FG000|Attended Intervention Session|Lost to Follow-up|3|||
156721878|NCT05423093|565728880|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
156721879|NCT05423093|565728880|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
156721880|NCT05364931|565728881|FG000|Overall Study|Adverse Event|0|||
156721881|NCT05364931|565728882|FG001|Overall Study|Adverse Event|2|||
156721882|NCT05364931|565728883|FG002|Overall Study|Adverse Event|1|||
156451367|NCT05369403|564744374|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
156721883|NCT05364931|565728884|FG003|Overall Study|Adverse Event|0|||
156721884|NCT05364931|565728881|FG000|Overall Study|Lost to Follow-up|1|||
156794240|NCT01681849|565999529|FG002|Overall Study|Withdrawal by Subject|33|||
156451368|NCT05369403|564744375|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
156451369|NCT05369403|564744376|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
156451370|NCT05369403|564744374|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
156451371|NCT05369403|564744375|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
156451372|NCT05369403|564744376|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
156451373|NCT05369403|564744374|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
156451374|NCT05369403|564744375|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
156460620|NCT04625725|564781646|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
156721885|NCT05364931|565728882|FG001|Overall Study|Lost to Follow-up|0|||
156721886|NCT05364931|565728883|FG002|Overall Study|Lost to Follow-up|0|||
156721887|NCT05364931|565728884|FG003|Overall Study|Lost to Follow-up|0|||
156721888|NCT05364931|565728881|FG000|Overall Study|Withdrawal by Subject|1|||
156721889|NCT05364931|565728882|FG001|Overall Study|Withdrawal by Subject|1|||
156721890|NCT05364931|565728883|FG002|Overall Study|Withdrawal by Subject|3|||
156721891|NCT05364931|565728884|FG003|Overall Study|Withdrawal by Subject|2|||
156721892|NCT05364931|565728881|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
156794241|NCT01681849|565999527|FG000|Overall Study|Lost to Follow-up|3|||
156794242|NCT01681849|565999528|FG001|Overall Study|Lost to Follow-up|2|||
156794243|NCT01681849|565999529|FG002|Overall Study|Lost to Follow-up|6|||
156794244|NCT02852005|565999535|FG000|Overall Study|Lost to Follow-up|0|||
156794245|NCT02852005|565999536|FG001|Overall Study|Lost to Follow-up|0|||
156721893|NCT05364931|565728882|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
156721894|NCT05364931|565728883|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
156721895|NCT05364931|565728884|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
156721896|NCT05364931|565728881|FG000|Overall Study|Discontinued|1|||
156721897|NCT05364931|565728882|FG001|Overall Study|Discontinued|0|||
156721898|NCT05364931|565728883|FG002|Overall Study|Discontinued|0|||
156721899|NCT05364931|565728884|FG003|Overall Study|Discontinued|0|||
156875440|NCT04364984|566302071|FG001|Overall Study|Death|2|||
156875441|NCT04364984|566302072|FG002|Overall Study|Death|0|||
156875442|NCT02867384|566302073|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
156875443|NCT02867384|566302074|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
156875444|NCT02867384|566302075|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
156875445|NCT02867384|566302073|FG000|Overall Study|Progression/ Relapse|15|||
156875446|NCT02867384|566302074|FG001|Overall Study|Progression/ Relapse|19|||
156875447|NCT02867384|566302075|FG002|Overall Study|Progression/ Relapse|0|||
156875448|NCT02867384|566302073|FG000|Overall Study|Adverse Event|13|||
156875449|NCT02867384|566302074|FG001|Overall Study|Adverse Event|1|||
156875450|NCT02867384|566302075|FG002|Overall Study|Adverse Event|0|||
156875451|NCT02867384|566302073|FG000|Overall Study|Withdrawal by Subject|6|||
156875452|NCT02867384|566302074|FG001|Overall Study|Withdrawal by Subject|5|||
156335563|NCT00494299|564326131|FG001|Overall Study|Withdrawal by Subject|3|||
156335564|NCT00494299|564326130|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
156335565|NCT00494299|564326131|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
156451375|NCT05369403|564744376|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
156451376|NCT05369403|564744374|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
156451377|NCT05369403|564744375|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
156451378|NCT05369403|564744376|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
156451379|NCT05369403|564744374|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
156451380|NCT05369403|564744375|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
156451381|NCT05369403|564744376|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
156451382|NCT05369403|564744374|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
156451383|NCT05369403|564744375|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
156451384|NCT05369403|564744376|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
156451385|NCT03792256|564744381|FG000|Overall Study|Death|0|||
156451386|NCT03792256|564744382|FG001|Overall Study|Death|1|||
156451387|NCT03792256|564744381|FG000|Overall Study|Lack of Efficacy|0|||
156451388|NCT03792256|564744382|FG001|Overall Study|Lack of Efficacy|1|||
156451389|NCT03792256|564744381|FG000|Overall Study|Withdrawal by Subject|0|||
156451390|NCT03792256|564744382|FG001|Overall Study|Withdrawal by Subject|1|||
156451391|NCT04760678|564744387|FG000|Overall Study|Death|13|||
156451392|NCT04760678|564744387|FG000|Overall Study|Lost to Follow-up|48|||
156451393|NCT04760678|564744387|FG000|Overall Study|Withdrawal by Subject|1|||
156451394|NCT04831216|564744400|FG000|Overall Study|Lost to Follow-up|32|||
156451395|NCT02913872|564744403|FG000|Overall Study|Withdrawal by Subject|1|||
156451396|NCT04739956|564744406|FG000|Overall Study|Withdrawal by Subject|1|||
156451397|NCT04739956|564744407|FG001|Overall Study|Withdrawal by Subject|1|||
156451398|NCT03519581|564744410|FG000|Overall Study|Lost to Follow-up|3|||
156451399|NCT03519581|564744411|FG001|Overall Study|Lost to Follow-up|2|||
156451400|NCT03519581|564744410|FG000|Overall Study|Adverse Event|5|||
156451401|NCT03519581|564744411|FG001|Overall Study|Adverse Event|2|||
156451402|NCT03519581|564744410|FG000|Overall Study|Withdrawal by Subject|2|||
156451403|NCT03519581|564744411|FG001|Overall Study|Withdrawal by Subject|0|||
156451404|NCT03519581|564744410|FG000|Overall Study|Change to insurance|2|||
156451405|NCT03519581|564744411|FG001|Overall Study|Change to insurance|1|||
156451406|NCT03519581|564744410|FG000|Overall Study|Other|2|||
156451407|NCT03519581|564744411|FG001|Overall Study|Other|4|||
156451408|NCT05177848|564744412|FG000|Overall Study|Lost to Follow-up|1|||
156451409|NCT05177848|564744413|FG001|Overall Study|Lost to Follow-up|4|||
156451410|NCT05177848|564744412|FG000|Overall Study|Discontinued|2|||
156451411|NCT05177848|564744413|FG001|Overall Study|Discontinued|1|||
156451412|NCT06414213|564744414|FG000|Overall Study|Lost to Follow-up|1|||
156451413|NCT06414213|564744415|FG001|Overall Study|Lost to Follow-up|1|||
156451414|NCT06414213|564744416|FG002|Overall Study|Lost to Follow-up|3|||
156721900|NCT03593525|565728885|FG000|Overall Study|Withdrawal by Subject|1|||
156721901|NCT03593525|565728886|FG001|Overall Study|Withdrawal by Subject|0|||
156335566|NCT00494299|564326130|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
156335567|NCT00494299|564326131|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
156451415|NCT03850678|564744420|FG000|Overall Study|Withdrawal by Subject|3|||
156721902|NCT03593525|565728885|FG000|Overall Study|Lost to Follow-up|7|||
156875453|NCT02867384|566302075|FG002|Overall Study|Withdrawal by Subject|0|||
156875454|NCT02867384|566302073|FG000|Overall Study|Physician Decision|1|||
156335568|NCT00494299|564326130|FG000|Overall Study|Site Closed by Sponsor|6|||
156451416|NCT03850678|564744421|FG001|Overall Study|Withdrawal by Subject|0|||
156721903|NCT03593525|565728886|FG001|Overall Study|Lost to Follow-up|5|||
156721904|NCT04570670|565728894|FG000|Overall Study|Withdrawal by Subject|1|||
156721905|NCT04570670|565728895|FG001|Overall Study|Withdrawal by Subject|0|||
156721906|NCT00460603|565728896|FG000|Phase 1|Death|1|||
156721907|NCT00460603|565728897|FG001|Phase 1|Death|0|||
156721908|NCT00460603|565728898|FG002|Phase 1|Death|0|||
156721909|NCT00460603|565728899|FG003|Phase 1|Death|2|||
156721910|NCT00460603|565728900|FG004|Phase 1|Death|0|||
156721911|NCT00460603|565728901|FG005|Phase 1|Death|0|||
156721912|NCT00460603|565728902|FG006|Phase 1|Death|0|||
156721913|NCT00460603|565728903|FG007|Phase 1|Death|0|||
156721914|NCT00460603|565728904|FG008|Phase 1|Death|1|||
156721915|NCT00460603|565728905|FG009|Phase 1|Death|0|||
156721916|NCT00460603|565728906|FG010|Phase 1|Death|0|||
156721917|NCT00460603|565728907|FG011|Phase 1|Death|0|||
156451417|NCT03850678|564744420|FG000|Overall Study|Experimenter Error|1|||
156451418|NCT03850678|564744421|FG001|Overall Study|Experimenter Error|1|||
156451419|NCT03850678|564744420|FG000|Overall Study|Did Not Condition To Experiment|7|||
156451420|NCT03850678|564744421|FG001|Overall Study|Did Not Condition To Experiment|2|||
156451421|NCT04552223|564744429|FG000|Overall Study|Withdrawal by Subject|1|||
156451422|NCT04072380|564744433|FG000|Overall Study|Adverse Event|4|||
156451423|NCT04072380|564744434|FG001|Overall Study|Adverse Event|6|||
156451424|NCT04072380|564744435|FG002|Overall Study|Adverse Event|0|||
156451425|NCT04072380|564744433|FG000|Overall Study|Withdrawal by Subject|3|||
156721918|NCT00460603|565728896|FG000|Phase 1|Adverse Event|3|||
156721919|NCT00460603|565728897|FG001|Phase 1|Adverse Event|1|||
156721920|NCT00460603|565728898|FG002|Phase 1|Adverse Event|1|||
156721921|NCT00460603|565728899|FG003|Phase 1|Adverse Event|2|||
156721922|NCT00460603|565728900|FG004|Phase 1|Adverse Event|0|||
156721923|NCT00460603|565728901|FG005|Phase 1|Adverse Event|0|||
156721924|NCT00460603|565728902|FG006|Phase 1|Adverse Event|3|||
156721925|NCT00460603|565728903|FG007|Phase 1|Adverse Event|0|||
156721926|NCT00460603|565728904|FG008|Phase 1|Adverse Event|4|||
156721927|NCT00460603|565728905|FG009|Phase 1|Adverse Event|0|||
156721928|NCT00460603|565728906|FG010|Phase 1|Adverse Event|0|||
156721929|NCT00460603|565728907|FG011|Phase 1|Adverse Event|0|||
156721930|NCT00460603|565728896|FG000|Phase 1|Lack of Efficacy|1|||
156721931|NCT00460603|565728897|FG001|Phase 1|Lack of Efficacy|0|||
156721932|NCT00460603|565728898|FG002|Phase 1|Lack of Efficacy|1|||
156721933|NCT00460603|565728899|FG003|Phase 1|Lack of Efficacy|2|||
156721934|NCT00460603|565728900|FG004|Phase 1|Lack of Efficacy|2|||
156721935|NCT00460603|565728901|FG005|Phase 1|Lack of Efficacy|2|||
156721936|NCT00460603|565728902|FG006|Phase 1|Lack of Efficacy|2|||
156721937|NCT00460603|565728903|FG007|Phase 1|Lack of Efficacy|2|||
156721938|NCT00460603|565728904|FG008|Phase 1|Lack of Efficacy|11|||
156451426|NCT04072380|564744434|FG001|Overall Study|Withdrawal by Subject|1|||
156451427|NCT04072380|564744435|FG002|Overall Study|Withdrawal by Subject|1|||
156451428|NCT04072380|564744433|FG000|Overall Study|Physician Decision|2|||
156451429|NCT04072380|564744434|FG001|Overall Study|Physician Decision|0|||
156451430|NCT04072380|564744435|FG002|Overall Study|Physician Decision|0|||
156451431|NCT04072380|564744433|FG000|Overall Study|Protocol Violation|0|||
156451432|NCT04072380|564744434|FG001|Overall Study|Protocol Violation|2|||
156451433|NCT04072380|564744435|FG002|Overall Study|Protocol Violation|3|||
156451434|NCT04072380|564744433|FG000|Overall Study|Intercurrent Illness and Others|3|||
156451435|NCT04072380|564744434|FG001|Overall Study|Intercurrent Illness and Others|5|||
156451436|NCT04072380|564744435|FG002|Overall Study|Intercurrent Illness and Others|6|||
156451437|NCT03640312|564744438|FG000|Overall Study|Lost to Follow-up|3|||
156451438|NCT03640312|564744439|FG001|Overall Study|Lost to Follow-up|6|||
156451439|NCT05008835|564744441|FG000|Overall Study|Adverse Event|5|||
156451440|NCT05008835|564744442|FG001|Overall Study|Adverse Event|2|||
156451441|NCT05008835|564744443|FG002|Overall Study|Adverse Event|1|||
156451442|NCT05008835|564744441|FG000|Overall Study|Lack of Efficacy|0|||
156451443|NCT05008835|564744442|FG001|Overall Study|Lack of Efficacy|0|||
156451444|NCT05008835|564744443|FG002|Overall Study|Lack of Efficacy|1|||
156451445|NCT05008835|564744441|FG000|Overall Study|Study terminated by sponsor|0|||
156721939|NCT00460603|565728905|FG009|Phase 1|Lack of Efficacy|0|||
156721940|NCT00460603|565728906|FG010|Phase 1|Lack of Efficacy|0|||
156721941|NCT00460603|565728907|FG011|Phase 1|Lack of Efficacy|0|||
156721942|NCT00460603|565728896|FG000|Phase 1|Withdrawal by Subject|1|||
156721943|NCT00460603|565728897|FG001|Phase 1|Withdrawal by Subject|2|||
156721944|NCT00460603|565728898|FG002|Phase 1|Withdrawal by Subject|1|||
156451446|NCT05008835|564744442|FG001|Overall Study|Study terminated by sponsor|0|||
156451447|NCT05008835|564744443|FG002|Overall Study|Study terminated by sponsor|1|||
156451448|NCT05008835|564744441|FG000|Overall Study|Not further specified|3|||
156721945|NCT00460603|565728899|FG003|Phase 1|Withdrawal by Subject|1|||
156721946|NCT00460603|565728900|FG004|Phase 1|Withdrawal by Subject|3|||
156721947|NCT00460603|565728901|FG005|Phase 1|Withdrawal by Subject|0|||
156721948|NCT00460603|565728902|FG006|Phase 1|Withdrawal by Subject|1|||
156721949|NCT00460603|565728903|FG007|Phase 1|Withdrawal by Subject|0|||
156721950|NCT00460603|565728904|FG008|Phase 1|Withdrawal by Subject|2|||
156721951|NCT00460603|565728905|FG009|Phase 1|Withdrawal by Subject|0|||
156721952|NCT00460603|565728906|FG010|Phase 1|Withdrawal by Subject|0|||
156721953|NCT00460603|565728907|FG011|Phase 1|Withdrawal by Subject|0|||
156721954|NCT00460603|565728896|FG000|Phase 1|Other|0|||
156721955|NCT00460603|565728897|FG001|Phase 1|Other|3|||
156721956|NCT00460603|565728898|FG002|Phase 1|Other|1|||
156721957|NCT00460603|565728899|FG003|Phase 1|Other|1|||
156721958|NCT00460603|565728900|FG004|Phase 1|Other|1|||
156721959|NCT00460603|565728901|FG005|Phase 1|Other|2|||
156721960|NCT00460603|565728902|FG006|Phase 1|Other|0|||
156721961|NCT00460603|565728903|FG007|Phase 1|Other|1|||
156721962|NCT00460603|565728904|FG008|Phase 1|Other|0|||
156721963|NCT00460603|565728905|FG009|Phase 1|Other|0|||
156721964|NCT00460603|565728906|FG010|Phase 1|Other|0|||
156721965|NCT00460603|565728907|FG011|Phase 1|Other|0|||
156721966|NCT00460603|565728896|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721967|NCT00460603|565728897|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721968|NCT00460603|565728898|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156451449|NCT05008835|564744442|FG001|Overall Study|Not further specified|2|||
156451450|NCT05008835|564744443|FG002|Overall Study|Not further specified|1|||
156451451|NCT00667251|564746644|FG000|Overall Study|Disease progression|232|||
156451452|NCT00667251|564746645|FG001|Overall Study|Disease progression|203|||
156451453|NCT00667251|564746644|FG000|Overall Study|Toxicity|44|||
156451454|NCT00667251|564746645|FG001|Overall Study|Toxicity|23|||
156721969|NCT00460603|565728899|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721970|NCT00460603|565728900|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721971|NCT00460603|565728901|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721972|NCT00460603|565728902|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721973|NCT00460603|565728903|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156451455|NCT00667251|564746644|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
156451456|NCT00667251|564746645|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
156451457|NCT00667251|564746644|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
156451458|NCT00667251|564746645|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
156451459|NCT00667251|564746644|FG000|Overall Study|Symptomatic progression|8|||
156451460|NCT00667251|564746645|FG001|Overall Study|Symptomatic progression|4|||
156451461|NCT00667251|564746644|FG000|Overall Study|Death|6|||
156451462|NCT00667251|564746645|FG001|Overall Study|Death|11|||
156451463|NCT00667251|564746644|FG000|Overall Study|Intercurrent illness|5|||
156451464|NCT00667251|564746645|FG001|Overall Study|Intercurrent illness|6|||
156451465|NCT00667251|564746644|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
156451466|NCT00667251|564746645|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
156451467|NCT00667251|564746644|FG000|Overall Study|Randomized not Treated|4|||
156451468|NCT00667251|564746645|FG001|Overall Study|Randomized not Treated|1|||
156451469|NCT02671903|564746651|FG000|Period 0 (Run-In)|Death|0|||
156451470|NCT02671903|564746652|FG001|Period 0 (Run-In)|Death|0|||
156451471|NCT02671903|564746653|FG002|Period 0 (Run-In)|Death|3|||
156451472|NCT02671903|564746651|FG000|Period 0 (Run-In)|Physician Decision|0|||
156451473|NCT02671903|564746652|FG001|Period 0 (Run-In)|Physician Decision|0|||
156451474|NCT02671903|564746653|FG002|Period 0 (Run-In)|Physician Decision|4|||
156451475|NCT02671903|564746651|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
156451476|NCT02671903|564746652|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
156451477|NCT02671903|564746653|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
156451478|NCT02671903|564746651|FG000|Period 0 (Run-In)|Protocol Violation|0|||
156451479|NCT02671903|564746652|FG001|Period 0 (Run-In)|Protocol Violation|0|||
156451480|NCT02671903|564746653|FG002|Period 0 (Run-In)|Protocol Violation|1|||
156451481|NCT02671903|564746651|FG000|Period 0 (Run-In)|Adverse Event|0|||
156451482|NCT02671903|564746652|FG001|Period 0 (Run-In)|Adverse Event|0|||
156451483|NCT02671903|564746653|FG002|Period 0 (Run-In)|Adverse Event|1|||
156451484|NCT02671903|564746651|FG000|Period 0 (Run-In)|Implantation Failure|0|||
156451485|NCT02671903|564746652|FG001|Period 0 (Run-In)|Implantation Failure|0|||
156451486|NCT02671903|564746653|FG002|Period 0 (Run-In)|Implantation Failure|2|||
156451487|NCT02671903|564746651|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
156451488|NCT02671903|564746652|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
156451489|NCT02671903|564746653|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
156451490|NCT04390048|564746654|FG000|Overall Study|Withdrawal by Subject|1|||
156451491|NCT04390048|564746655|FG001|Overall Study|Withdrawal by Subject|3|||
156451492|NCT04179500|564746656|FG000|Treatment|Withdrawal by Subject|1|||
156451493|NCT04179500|564746656|FG000|Treatment|Adverse Event|2|||
156451494|NCT04179500|564746656|FG000|Treatment|pyrazinamide resistance|1|||
156451495|NCT03673111|564746667|FG000|Overall Study|Protocol Violation|0|||
156451496|NCT03673111|564746668|FG001|Overall Study|Protocol Violation|0|||
156721974|NCT00460603|565728904|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721975|NCT00460603|565728905|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
156721976|NCT00460603|565728906|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721977|NCT00460603|565728907|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156451497|NCT03673111|564746669|FG002|Overall Study|Protocol Violation|0|||
156451498|NCT03673111|564746670|FG003|Overall Study|Protocol Violation|0|||
156451499|NCT03673111|564746671|FG004|Overall Study|Protocol Violation|0|||
156451500|NCT03673111|564746672|FG005|Overall Study|Protocol Violation|0|||
156451501|NCT03673111|564746673|FG006|Overall Study|Protocol Violation|0|||
156721978|NCT00460603|565728896|FG000|Phase 2|Adverse Event|0|||
156721979|NCT00460603|565728897|FG001|Phase 2|Adverse Event|0|||
156721980|NCT00460603|565728898|FG002|Phase 2|Adverse Event|0|||
156721981|NCT00460603|565728899|FG003|Phase 2|Adverse Event|0|||
156721982|NCT00460603|565728900|FG004|Phase 2|Adverse Event|0|||
156721983|NCT00460603|565728901|FG005|Phase 2|Adverse Event|0|||
156721984|NCT00460603|565728902|FG006|Phase 2|Adverse Event|0|||
156721985|NCT00460603|565728903|FG007|Phase 2|Adverse Event|0|||
156721986|NCT00460603|565728904|FG008|Phase 2|Adverse Event|0|||
156721987|NCT00460603|565728905|FG009|Phase 2|Adverse Event|12|||
156721988|NCT00460603|565728906|FG010|Phase 2|Adverse Event|9|||
156721989|NCT00460603|565728907|FG011|Phase 2|Adverse Event|10|||
156721990|NCT00460603|565728896|FG000|Phase 2|Death|0|||
156721991|NCT00460603|565728897|FG001|Phase 2|Death|0|||
156721992|NCT00460603|565728898|FG002|Phase 2|Death|0|||
156721993|NCT00460603|565728899|FG003|Phase 2|Death|0|||
156721994|NCT00460603|565728900|FG004|Phase 2|Death|0|||
156721995|NCT00460603|565728901|FG005|Phase 2|Death|0|||
156721996|NCT00460603|565728902|FG006|Phase 2|Death|0|||
156721997|NCT00460603|565728903|FG007|Phase 2|Death|0|||
156721998|NCT00460603|565728904|FG008|Phase 2|Death|0|||
156721999|NCT00460603|565728905|FG009|Phase 2|Death|4|||
156722000|NCT00460603|565728906|FG010|Phase 2|Death|2|||
156722001|NCT00460603|565728907|FG011|Phase 2|Death|2|||
156722002|NCT00460603|565728896|FG000|Phase 2|Protocol Violation|0|||
156722003|NCT00460603|565728897|FG001|Phase 2|Protocol Violation|0|||
156722004|NCT00460603|565728898|FG002|Phase 2|Protocol Violation|0|||
156722005|NCT00460603|565728899|FG003|Phase 2|Protocol Violation|0|||
156722006|NCT00460603|565728900|FG004|Phase 2|Protocol Violation|0|||
156722007|NCT00460603|565728901|FG005|Phase 2|Protocol Violation|0|||
156722008|NCT00460603|565728902|FG006|Phase 2|Protocol Violation|0|||
156722009|NCT00460603|565728903|FG007|Phase 2|Protocol Violation|0|||
156722010|NCT00460603|565728904|FG008|Phase 2|Protocol Violation|0|||
156722011|NCT00460603|565728905|FG009|Phase 2|Protocol Violation|1|||
156722012|NCT00460603|565728906|FG010|Phase 2|Protocol Violation|1|||
156722013|NCT00460603|565728907|FG011|Phase 2|Protocol Violation|0|||
156722014|NCT00460603|565728896|FG000|Phase 2|Lost to Follow-up|0|||
156722015|NCT00460603|565728897|FG001|Phase 2|Lost to Follow-up|0|||
156722016|NCT00460603|565728898|FG002|Phase 2|Lost to Follow-up|0|||
156722017|NCT00460603|565728899|FG003|Phase 2|Lost to Follow-up|0|||
156722018|NCT00460603|565728900|FG004|Phase 2|Lost to Follow-up|0|||
156722019|NCT00460603|565728901|FG005|Phase 2|Lost to Follow-up|0|||
156722020|NCT00460603|565728902|FG006|Phase 2|Lost to Follow-up|0|||
156722021|NCT00460603|565728903|FG007|Phase 2|Lost to Follow-up|0|||
156722022|NCT00460603|565728904|FG008|Phase 2|Lost to Follow-up|0|||
156722023|NCT00460603|565728905|FG009|Phase 2|Lost to Follow-up|1|||
156722024|NCT00460603|565728906|FG010|Phase 2|Lost to Follow-up|0|||
156722025|NCT00460603|565728907|FG011|Phase 2|Lost to Follow-up|0|||
156722026|NCT00460603|565728896|FG000|Phase 2|Other|0|||
156722027|NCT00460603|565728897|FG001|Phase 2|Other|0|||
156722028|NCT00460603|565728898|FG002|Phase 2|Other|0|||
156722029|NCT00460603|565728899|FG003|Phase 2|Other|0|||
156722030|NCT00460603|565728900|FG004|Phase 2|Other|0|||
156722031|NCT00460603|565728901|FG005|Phase 2|Other|0|||
156722032|NCT00460603|565728902|FG006|Phase 2|Other|0|||
156722033|NCT00460603|565728903|FG007|Phase 2|Other|0|||
156451502|NCT03673111|564746674|FG007|Overall Study|Protocol Violation|0|||
156451503|NCT03673111|564746675|FG008|Overall Study|Protocol Violation|0|||
156451504|NCT03673111|564746676|FG009|Overall Study|Protocol Violation|0|||
156451505|NCT03673111|564746677|FG010|Overall Study|Protocol Violation|1|||
156451506|NCT03673111|564746678|FG011|Overall Study|Protocol Violation|0|||
156451507|NCT03673111|564746679|FG012|Overall Study|Protocol Violation|0|||
156451508|NCT03673111|564746680|FG013|Overall Study|Protocol Violation|0|||
156722034|NCT00460603|565728904|FG008|Phase 2|Other|0|||
156451509|NCT03673111|564746667|FG000|Overall Study|Adverse Event|1|||
156451510|NCT03673111|564746668|FG001|Overall Study|Adverse Event|0|||
156722035|NCT00460603|565728905|FG009|Phase 2|Other|6|||
156451511|NCT03673111|564746669|FG002|Overall Study|Adverse Event|0|||
156451512|NCT03673111|564746670|FG003|Overall Study|Adverse Event|0|||
156451513|NCT03673111|564746671|FG004|Overall Study|Adverse Event|0|||
156722036|NCT00460603|565728906|FG010|Phase 2|Other|16|||
156533457|NCT02366728|565048797|FG002|Overall Study|Only yielded 2 vaccines|0|||
156722037|NCT00460603|565728907|FG011|Phase 2|Other|7|||
156722038|NCT00460603|565728896|FG000|Phase 2|Objective Progression or Relapse|0|||
156722039|NCT00460603|565728897|FG001|Phase 2|Objective Progression or Relapse|0|||
156722040|NCT00460603|565728898|FG002|Phase 2|Objective Progression or Relapse|0|||
156722041|NCT00460603|565728899|FG003|Phase 2|Objective Progression or Relapse|0|||
156722042|NCT00460603|565728900|FG004|Phase 2|Objective Progression or Relapse|0|||
156722043|NCT00460603|565728901|FG005|Phase 2|Objective Progression or Relapse|0|||
156722044|NCT00460603|565728902|FG006|Phase 2|Objective Progression or Relapse|0|||
156451514|NCT03673111|564746672|FG005|Overall Study|Adverse Event|0|||
156722045|NCT00460603|565728903|FG007|Phase 2|Objective Progression or Relapse|0|||
156722046|NCT00460603|565728904|FG008|Phase 2|Objective Progression or Relapse|0|||
156722047|NCT00460603|565728905|FG009|Phase 2|Objective Progression or Relapse|9|||
156722048|NCT00460603|565728906|FG010|Phase 2|Objective Progression or Relapse|10|||
156722049|NCT00460603|565728907|FG011|Phase 2|Objective Progression or Relapse|17|||
156722050|NCT00460603|565728896|FG000|Phase 2|Global Deterioration of Health Status|0|||
156794246|NCT02852005|565999537|FG002|Overall Study|Lost to Follow-up|0|||
156722051|NCT00460603|565728897|FG001|Phase 2|Global Deterioration of Health Status|0|||
156722052|NCT00460603|565728898|FG002|Phase 2|Global Deterioration of Health Status|0|||
156722053|NCT00460603|565728899|FG003|Phase 2|Global Deterioration of Health Status|0|||
156722054|NCT00460603|565728900|FG004|Phase 2|Global Deterioration of Health Status|0|||
156722055|NCT00460603|565728901|FG005|Phase 2|Global Deterioration of Health Status|0|||
156722056|NCT00460603|565728902|FG006|Phase 2|Global Deterioration of Health Status|0|||
156722057|NCT00460603|565728903|FG007|Phase 2|Global Deterioration of Health Status|0|||
156722058|NCT00460603|565728904|FG008|Phase 2|Global Deterioration of Health Status|0|||
156722059|NCT00460603|565728905|FG009|Phase 2|Global Deterioration of Health Status|0|||
156722060|NCT00460603|565728906|FG010|Phase 2|Global Deterioration of Health Status|1|||
156722061|NCT00460603|565728907|FG011|Phase 2|Global Deterioration of Health Status|0|||
156722062|NCT00460603|565728896|FG000|Phase 2|Withdrawal by Subject|0|||
156722063|NCT00460603|565728897|FG001|Phase 2|Withdrawal by Subject|0|||
156722064|NCT00460603|565728898|FG002|Phase 2|Withdrawal by Subject|0|||
156722065|NCT00460603|565728899|FG003|Phase 2|Withdrawal by Subject|0|||
156722066|NCT00460603|565728900|FG004|Phase 2|Withdrawal by Subject|0|||
156722067|NCT00460603|565728901|FG005|Phase 2|Withdrawal by Subject|0|||
156722068|NCT00460603|565728902|FG006|Phase 2|Withdrawal by Subject|0|||
156722069|NCT00460603|565728903|FG007|Phase 2|Withdrawal by Subject|0|||
156722070|NCT00460603|565728904|FG008|Phase 2|Withdrawal by Subject|0|||
156722071|NCT00460603|565728905|FG009|Phase 2|Withdrawal by Subject|5|||
156722072|NCT00460603|565728906|FG010|Phase 2|Withdrawal by Subject|4|||
156722073|NCT00460603|565728907|FG011|Phase 2|Withdrawal by Subject|5|||
156722074|NCT00460603|565728896|FG000|Phase 2|Randomized, but not treated|0|||
156722075|NCT00460603|565728897|FG001|Phase 2|Randomized, but not treated|0|||
156722076|NCT00460603|565728898|FG002|Phase 2|Randomized, but not treated|0|||
156722077|NCT00460603|565728899|FG003|Phase 2|Randomized, but not treated|0|||
156722078|NCT00460603|565728900|FG004|Phase 2|Randomized, but not treated|0|||
156722079|NCT00460603|565728901|FG005|Phase 2|Randomized, but not treated|0|||
156722080|NCT00460603|565728902|FG006|Phase 2|Randomized, but not treated|0|||
156722081|NCT00460603|565728903|FG007|Phase 2|Randomized, but not treated|0|||
156722082|NCT00460603|565728904|FG008|Phase 2|Randomized, but not treated|0|||
156722083|NCT00460603|565728905|FG009|Phase 2|Randomized, but not treated|3|||
156722084|NCT00460603|565728906|FG010|Phase 2|Randomized, but not treated|0|||
156722085|NCT00460603|565728907|FG011|Phase 2|Randomized, but not treated|0|||
156722086|NCT01082328|565728912|FG000|Overall Study|Adverse Event|1|||
156722087|NCT00031590|565728913|FG000|Overall Study|Adverse Event|1|||
156722088|NCT00031590|565728913|FG000|Overall Study|Withdrawal by parents|2|||
156722089|NCT00957801|565728914|FG000|Overall Study|Withdrawal by Subject|0|||
156722090|NCT00957801|565728915|FG001|Overall Study|Withdrawal by Subject|0|||
156722091|NCT00957801|565728916|FG002|Overall Study|Withdrawal by Subject|0|||
156722092|NCT00957801|565728917|FG003|Overall Study|Withdrawal by Subject|1|||
156722093|NCT05506046|565728920|FG000|Overall Study|Lost to Follow-up|89|||
156722094|NCT05506046|565728921|FG001|Overall Study|Lost to Follow-up|101|||
156722095|NCT05506046|565728922|FG002|Overall Study|Lost to Follow-up|102|||
156722096|NCT05506046|565728923|FG003|Overall Study|Lost to Follow-up|99|||
156722097|NCT01286467|565728929|FG000|Overall Study|Death|1|||
156722098|NCT01286467|565728930|FG001|Overall Study|Death|1|||
156722099|NCT01286467|565728931|FG002|Overall Study|Death|1|||
156722100|NCT01286467|565728932|FG003|Overall Study|Death|0|||
156722101|NCT01286467|565728929|FG000|Overall Study|Lost to Follow-up|0|||
156722102|NCT01286467|565728930|FG001|Overall Study|Lost to Follow-up|0|||
156722103|NCT01286467|565728931|FG002|Overall Study|Lost to Follow-up|0|||
156722104|NCT01286467|565728932|FG003|Overall Study|Lost to Follow-up|1|||
156722105|NCT01286467|565728929|FG000|Overall Study|Withdrawal by Subject|0|||
156722106|NCT01286467|565728930|FG001|Overall Study|Withdrawal by Subject|0|||
156722107|NCT01286467|565728931|FG002|Overall Study|Withdrawal by Subject|1|||
156722108|NCT01286467|565728932|FG003|Overall Study|Withdrawal by Subject|0|||
156722109|NCT01286467|565728929|FG000|Overall Study|Physician Decision|0|||
156722110|NCT01286467|565728930|FG001|Overall Study|Physician Decision|0|||
156722111|NCT01286467|565728931|FG002|Overall Study|Physician Decision|0|||
156722112|NCT01286467|565728932|FG003|Overall Study|Physician Decision|1|||
156722113|NCT01286467|565728929|FG000|Overall Study|Disease progression|3|||
156722114|NCT01286467|565728930|FG001|Overall Study|Disease progression|2|||
156722115|NCT01286467|565728931|FG002|Overall Study|Disease progression|2|||
156722116|NCT01286467|565728932|FG003|Overall Study|Disease progression|3|||
156794247|NCT02852005|565999538|FG003|Overall Study|Lost to Follow-up|0|||
156794248|NCT02852005|565999539|FG004|Overall Study|Lost to Follow-up|1|||
156722117|NCT01286467|565728929|FG000|Overall Study|Adverse Event|0|||
156722118|NCT01286467|565728930|FG001|Overall Study|Adverse Event|1|||
156722119|NCT01286467|565728931|FG002|Overall Study|Adverse Event|2|||
156722120|NCT01286467|565728932|FG003|Overall Study|Adverse Event|3|||
156722121|NCT01286467|565728929|FG000|Overall Study|Study drug stop longer than 14 days|0|||
156722122|NCT01286467|565728930|FG001|Overall Study|Study drug stop longer than 14 days|0|||
156722123|NCT01286467|565728931|FG002|Overall Study|Study drug stop longer than 14 days|1|||
156722124|NCT01286467|565728932|FG003|Overall Study|Study drug stop longer than 14 days|0|||
156722125|NCT00806403|565728933|FG000|Overall Study|Death|4|||
156875455|NCT02867384|566302074|FG001|Overall Study|Physician Decision|2|||
156451515|NCT03673111|564746673|FG006|Overall Study|Adverse Event|0|||
156451516|NCT03673111|564746674|FG007|Overall Study|Adverse Event|0|||
156722126|NCT00806403|565728934|FG001|Overall Study|Death|3|||
156722127|NCT00765102|565728935|FG000|Overall Study|Progressive disease|18|||
156722128|NCT00765102|565728935|FG000|Overall Study|Adverse Event|6|||
156722129|NCT00765102|565728935|FG000|Overall Study|Physician Decision|4|||
156722130|NCT00765102|565728935|FG000|Overall Study|Withdrawal by Subject|2|||
156722131|NCT00765102|565728935|FG000|Overall Study|Protocol Violation|1|||
156722132|NCT01827111|565728936|FG000|Overall Study|Disease Progression|1|||
156722133|NCT03181633|565728937|FG000|Overall Study|Withdrawal by Subject|1|||
156722134|NCT03181633|565728937|FG000|Overall Study|Missing follow-up visit|1|||
156722135|NCT04837196|565728942|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
156722136|NCT04837196|565728943|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
156722137|NCT04837196|565728944|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
156722138|NCT04837196|565728945|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
156722139|NCT04837196|565728946|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
156722140|NCT04837196|565728942|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
156722141|NCT04837196|565728943|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
156722142|NCT04837196|565728944|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
156451517|NCT03673111|564746675|FG008|Overall Study|Adverse Event|0|||
156722143|NCT04837196|565728945|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
156335569|NCT00494299|564326131|FG001|Overall Study|Site Closed by Sponsor|0|||
156335570|NCT00494299|564326130|FG000|Overall Study|Protocol Driven Decision Point|11|||
156451518|NCT03673111|564746676|FG009|Overall Study|Adverse Event|0|||
156451519|NCT03673111|564746677|FG010|Overall Study|Adverse Event|0|||
156451520|NCT03673111|564746678|FG011|Overall Study|Adverse Event|0|||
156451521|NCT03673111|564746679|FG012|Overall Study|Adverse Event|0|||
156451522|NCT03673111|564746680|FG013|Overall Study|Adverse Event|0|||
156451523|NCT03792555|564746683|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
156451524|NCT03792555|564746684|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
156451525|NCT03792555|564746685|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
156451526|NCT03792555|564746683|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
156451527|NCT03792555|564746684|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
156451528|NCT03792555|564746685|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
156451529|NCT03792555|564746683|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
156722144|NCT04837196|565728946|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
156722145|NCT04837196|565728942|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
156722146|NCT04837196|565728943|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
156722147|NCT04837196|565728944|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
156722148|NCT04837196|565728945|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
156722149|NCT04837196|565728946|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
156722150|NCT04837196|565728942|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
156722151|NCT04837196|565728943|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
156722152|NCT04837196|565728944|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
156722153|NCT04837196|565728945|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
156722154|NCT04837196|565728946|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
156722155|NCT04837196|565728942|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
156722156|NCT04837196|565728943|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
156722157|NCT04837196|565728944|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
156722158|NCT04837196|565728945|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
156722159|NCT04837196|565728946|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
156722160|NCT02387840|565728948|FG000|Overall Study|Death|0|||
156722161|NCT02387840|565728949|FG001|Overall Study|Death|0|||
156722162|NCT02387840|565728950|FG002|Overall Study|Death|0|||
156722163|NCT02387840|565728951|FG003|Overall Study|Death|0|||
156722164|NCT02387840|565728952|FG004|Overall Study|Death|0|||
156722165|NCT02387840|565728953|FG005|Overall Study|Death|1|||
156722166|NCT01213966|565728954|FG000|Overall Study|Protocol Violation|1|||
156722167|NCT01213966|565728955|FG001|Overall Study|Protocol Violation|0|||
156722168|NCT01213966|565728956|FG002|Overall Study|Protocol Violation|3|||
156722169|NCT01213966|565728957|FG003|Overall Study|Protocol Violation|1|||
156722170|NCT00273182|565728967|FG000|Overall Study|Death|450|||
156722171|NCT00273182|565728967|FG000|Overall Study|Lost to Follow-up|88|||
156722172|NCT00273182|565728967|FG000|Overall Study|Withdrawal by Subject|257|||
156722173|NCT00273182|565728967|FG000|Overall Study|Device/System Explant|154|||
156722174|NCT00273182|565728967|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
156722175|NCT02208362|565728968|FG000|Overall Study|Participant did not complete treatment|0|||
156722176|NCT02208362|565728969|FG001|Overall Study|Participant did not complete treatment|1|||
156722177|NCT02208362|565728970|FG002|Overall Study|Participant did not complete treatment|0|||
156875456|NCT02867384|566302075|FG002|Overall Study|Physician Decision|0|||
156722178|NCT02208362|565728971|FG003|Overall Study|Participant did not complete treatment|0|||
156722179|NCT02208362|565728972|FG004|Overall Study|Participant did not complete treatment|0|||
156722180|NCT02208362|565728973|FG005|Overall Study|Participant did not complete treatment|0|||
156722181|NCT02208362|565728974|FG006|Overall Study|Participant did not complete treatment|1|||
156722182|NCT02208362|565728975|FG007|Overall Study|Participant did not complete treatment|1|||
156451530|NCT03792555|564746684|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
156451531|NCT03792555|564746685|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
156451532|NCT04485039|564746686|FG000|TPOXX Only|Adverse Event|2|||
156451533|NCT04485039|564746686|FG000|TPOXX Only|Physician Decision|1|||
156722183|NCT02208362|565728976|FG008|Overall Study|Participant did not complete treatment|2|||
156722184|NCT02208362|565728977|FG009|Overall Study|Participant did not complete treatment|0|||
156722185|NCT02208362|565728978|FG010|Overall Study|Participant did not complete treatment|1|||
156722186|NCT02208362|565728979|FG011|Overall Study|Participant did not complete treatment|0|||
156722187|NCT02208362|565728968|FG000|Overall Study|Participant received disallowed treatment|0|||
156722188|NCT02208362|565728969|FG001|Overall Study|Participant received disallowed treatment|0|||
156722189|NCT02208362|565728970|FG002|Overall Study|Participant received disallowed treatment|0|||
156722190|NCT02208362|565728971|FG003|Overall Study|Participant received disallowed treatment|0|||
156722191|NCT02208362|565728972|FG004|Overall Study|Participant received disallowed treatment|0|||
156722192|NCT02208362|565728973|FG005|Overall Study|Participant received disallowed treatment|0|||
156722193|NCT02208362|565728974|FG006|Overall Study|Participant received disallowed treatment|0|||
156722194|NCT02208362|565728975|FG007|Overall Study|Participant received disallowed treatment|0|||
156722195|NCT02208362|565728976|FG008|Overall Study|Participant received disallowed treatment|1|||
156722196|NCT02208362|565728977|FG009|Overall Study|Participant received disallowed treatment|0|||
156722197|NCT02208362|565728978|FG010|Overall Study|Participant received disallowed treatment|0|||
156722198|NCT02208362|565728979|FG011|Overall Study|Participant received disallowed treatment|0|||
156722199|NCT01609790|565728982|FG000|Overall Study|Protocol Violation|1|||
156722200|NCT01609790|565728983|FG001|Overall Study|Protocol Violation|7|||
156722201|NCT01609790|565728984|FG002|Overall Study|Protocol Violation|8|||
156722202|NCT00858273|565728985|FG000|Overall Study|Protocol Violation|3|||
156722203|NCT00858273|565728986|FG001|Overall Study|Protocol Violation|5|||
156794249|NCT02852005|565999535|FG000|Overall Study|Withdrawal by Subject|1|||
156794250|NCT02852005|565999536|FG001|Overall Study|Withdrawal by Subject|0|||
156794251|NCT02852005|565999537|FG002|Overall Study|Withdrawal by Subject|0|||
156794252|NCT02852005|565999538|FG003|Overall Study|Withdrawal by Subject|0|||
156794253|NCT02852005|565999539|FG004|Overall Study|Withdrawal by Subject|0|||
156794254|NCT04525183|565999540|FG000|Overall Study|Withdrawal by Subject|0|||
156794255|NCT04525183|565999541|FG001|Overall Study|Withdrawal by Subject|0|||
156794256|NCT04525183|565999542|FG002|Overall Study|Withdrawal by Subject|3|||
156794257|NCT04525183|565999540|FG000|Overall Study|Study non-compliance|0|||
156794258|NCT04525183|565999541|FG001|Overall Study|Study non-compliance|0|||
156794259|NCT04525183|565999542|FG002|Overall Study|Study non-compliance|1|||
156794260|NCT04525183|565999540|FG000|Overall Study|Recurrent disease before starting on study|0|||
156794261|NCT04525183|565999541|FG001|Overall Study|Recurrent disease before starting on study|0|||
156794262|NCT04525183|565999542|FG002|Overall Study|Recurrent disease before starting on study|1|||
156794263|NCT01922895|565999543|FG000|Overall Study|Death|0|||
156794264|NCT01922895|565999544|FG001|Overall Study|Death|1|||
156794265|NCT01922895|565999543|FG000|Overall Study|Withdrawal by Subject|1|||
156794266|NCT01922895|565999544|FG001|Overall Study|Withdrawal by Subject|2|||
156794267|NCT01922895|565999543|FG000|Overall Study|Lost to Follow-up|5|||
156794268|NCT01922895|565999544|FG001|Overall Study|Lost to Follow-up|11|||
156794269|NCT01916226|565999545|FG000|Overall Study|Adverse Event|1|||
156794270|NCT01916226|565999546|FG001|Overall Study|Adverse Event|0|||
156794271|NCT01916226|565999547|FG002|Overall Study|Adverse Event|1|||
156794272|NCT01916226|565999548|FG003|Overall Study|Adverse Event|1|||
156794273|NCT01916226|565999545|FG000|Overall Study|Lack of Efficacy|0|||
156794274|NCT01916226|565999546|FG001|Overall Study|Lack of Efficacy|0|||
156794275|NCT01916226|565999547|FG002|Overall Study|Lack of Efficacy|2|||
156794276|NCT01916226|565999548|FG003|Overall Study|Lack of Efficacy|1|||
156794277|NCT01916226|565999545|FG000|Overall Study|Protocol Violation|0|||
156794278|NCT01916226|565999546|FG001|Overall Study|Protocol Violation|1|||
156794279|NCT01916226|565999547|FG002|Overall Study|Protocol Violation|0|||
156451534|NCT04485039|564746686|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
156451535|NCT04485039|564746686|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
156451536|NCT04005716|564746690|FG000|Overall Study|Death|175|||
156451537|NCT04005716|564746691|FG001|Overall Study|Death|196|||
156451538|NCT04005716|564746690|FG000|Overall Study|Withdrawal by Subject|1|||
156451539|NCT04005716|564746691|FG001|Overall Study|Withdrawal by Subject|6|||
156451540|NCT04005716|564746690|FG000|Overall Study|Lost to Follow-up|2|||
156451541|NCT04005716|564746691|FG001|Overall Study|Lost to Follow-up|2|||
156451542|NCT00418886|564746698|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
156533458|NCT01187550|565048799|FG000|Overall Study|Protocol Violation|3|||
156794280|NCT01916226|565999548|FG003|Overall Study|Protocol Violation|1|||
156451543|NCT00418886|564746699|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
156722204|NCT01880554|565731326|FG000|Overall Study|Protocol Violation|14|||
156722205|NCT01880554|565731326|FG000|Overall Study|Simon's design requirements|2|||
156722206|NCT03976362|565731330|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
156722207|NCT03976362|565731331|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
156722208|NCT03976362|565731332|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
156722209|NCT03976362|565731330|FG000|Induction Phase|Death|62|||
156722210|NCT03976362|565731331|FG001|Induction Phase|Death|0|||
156722211|NCT03976362|565731332|FG002|Induction Phase|Death|0|||
156722212|NCT03976362|565731330|FG000|Maintenance Phase|Participants Ongoing|0|||
156722213|NCT03976362|565731331|FG001|Maintenance Phase|Participants Ongoing|106|||
156722214|NCT03976362|565731332|FG002|Maintenance Phase|Participants Ongoing|103|||
156722215|NCT03976362|565731330|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156722216|NCT03976362|565731331|FG001|Maintenance Phase|Withdrawal by Subject|4|||
156722217|NCT03976362|565731332|FG002|Maintenance Phase|Withdrawal by Subject|4|||
156722218|NCT03976362|565731330|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
156722219|NCT03976362|565731331|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
156722220|NCT03976362|565731332|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
156722221|NCT03976362|565731330|FG000|Maintenance Phase|Death|0|||
156722222|NCT03976362|565731331|FG001|Maintenance Phase|Death|186|||
156722223|NCT03976362|565731332|FG002|Maintenance Phase|Death|187|||
156722224|NCT04846569|565731333|FG000|Overall Study|Withdrawal by Subject|3|||
156722225|NCT04846569|565731334|FG001|Overall Study|Withdrawal by Subject|1|||
156722226|NCT02512302|565731335|FG000|Period 1|Adverse Event|0|||
156722227|NCT02512302|565731336|FG001|Period 1|Adverse Event|1|||
156722228|NCT02512302|565731337|FG002|Period 1|Adverse Event|0|||
156722229|NCT02512302|565731338|FG003|Period 1|Adverse Event|0|||
156722230|NCT02512302|565731339|FG004|Period 1|Adverse Event|0|||
156722231|NCT02512302|565731340|FG005|Period 1|Adverse Event|0|||
156722232|NCT02512302|565731341|FG006|Period 1|Adverse Event|0|||
156722233|NCT02512302|565731342|FG007|Period 1|Adverse Event|0|||
156722234|NCT02512302|565731343|FG008|Period 1|Adverse Event|0|||
156722235|NCT02512302|565731344|FG009|Period 1|Adverse Event|0|||
156722236|NCT02512302|565731335|FG000|Period 2|Adverse Event|0|||
156722237|NCT02512302|565731336|FG001|Period 2|Adverse Event|0|||
156722238|NCT02512302|565731337|FG002|Period 2|Adverse Event|0|||
156722239|NCT02512302|565731338|FG003|Period 2|Adverse Event|0|||
156722240|NCT02512302|565731339|FG004|Period 2|Adverse Event|0|||
156722241|NCT02512302|565731340|FG005|Period 2|Adverse Event|0|||
156722242|NCT02512302|565731341|FG006|Period 2|Adverse Event|0|||
156722243|NCT02512302|565731342|FG007|Period 2|Adverse Event|0|||
156722244|NCT02512302|565731343|FG008|Period 2|Adverse Event|0|||
156722245|NCT02512302|565731344|FG009|Period 2|Adverse Event|1|||
156722246|NCT02512302|565731335|FG000|Period 3|Lost to Follow-up|0|||
156722247|NCT02512302|565731336|FG001|Period 3|Lost to Follow-up|0|||
156722248|NCT02512302|565731337|FG002|Period 3|Lost to Follow-up|1|||
156722249|NCT02512302|565731338|FG003|Period 3|Lost to Follow-up|0|||
156722250|NCT02512302|565731339|FG004|Period 3|Lost to Follow-up|0|||
156722251|NCT02512302|565731340|FG005|Period 3|Lost to Follow-up|0|||
156722252|NCT02512302|565731341|FG006|Period 3|Lost to Follow-up|0|||
156722253|NCT02512302|565731342|FG007|Period 3|Lost to Follow-up|0|||
156722254|NCT02512302|565731343|FG008|Period 3|Lost to Follow-up|0|||
156722255|NCT02512302|565731344|FG009|Period 3|Lost to Follow-up|0|||
156722256|NCT02512302|565731335|FG000|Period 4|Adverse Event|0|||
156722257|NCT02512302|565731336|FG001|Period 4|Adverse Event|0|||
156722258|NCT02512302|565731337|FG002|Period 4|Adverse Event|0|||
156722259|NCT02512302|565731338|FG003|Period 4|Adverse Event|0|||
156722260|NCT02512302|565731339|FG004|Period 4|Adverse Event|0|||
156722261|NCT02512302|565731340|FG005|Period 4|Adverse Event|0|||
156722262|NCT02512302|565731341|FG006|Period 4|Adverse Event|1|||
156722263|NCT02512302|565731342|FG007|Period 4|Adverse Event|0|||
156451544|NCT00418886|564746698|FG000|Randomized Period|Death|122|||
156451545|NCT00418886|564746699|FG001|Randomized Period|Death|147|||
156722264|NCT02512302|565731343|FG008|Period 4|Adverse Event|0|||
156451546|NCT00418886|564746698|FG000|Randomized Period|Withdrawal by Subject|9|||
156451547|NCT00418886|564746699|FG001|Randomized Period|Withdrawal by Subject|10|||
156451548|NCT00418886|564746698|FG000|Randomized Period|Lost to Follow-up|4|||
156722265|NCT02512302|565731344|FG009|Period 4|Adverse Event|0|||
156722266|NCT00683618|565731347|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
156722267|NCT00683618|565731348|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
156722268|NCT00683618|565731349|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
156722269|NCT00683618|565731347|FG000|Randomised Treatment Period|Protocol Violation|0|||
156722270|NCT00683618|565731348|FG001|Randomised Treatment Period|Protocol Violation|1|||
156722271|NCT00683618|565731349|FG002|Randomised Treatment Period|Protocol Violation|0|||
156451549|NCT00418886|564746699|FG001|Randomized Period|Lost to Follow-up|6|||
156451550|NCT00418886|564746698|FG000|Randomized Period|withdrawn due to other reason|1|||
156722272|NCT00683618|565731347|FG000|Randomised Treatment Period|Adverse Event|2|||
156451551|NCT00418886|564746699|FG001|Randomized Period|withdrawn due to other reason|0|||
156722273|NCT00683618|565731348|FG001|Randomised Treatment Period|Adverse Event|0|||
156722274|NCT00683618|565731349|FG002|Randomised Treatment Period|Adverse Event|2|||
156722275|NCT00683618|565731347|FG000|Randomised Treatment Period|Reason not provided|0|||
156335571|NCT00494299|564326131|FG001|Overall Study|Protocol Driven Decision Point|22|||
156335572|NCT02635776|564326135|FG000|Overall Study|Physician Decision|1|||
156451552|NCT00418886|564746698|FG000|Randomized Period|randomised but no treatment received|0|||
156451553|NCT00418886|564746699|FG001|Randomized Period|randomised but no treatment received|1|||
156451554|NCT03707951|564746700|FG000|Overall Study|Lost to Follow-up|8|||
156451555|NCT03707951|564746701|FG001|Overall Study|Lost to Follow-up|17|||
156451556|NCT03707951|564746700|FG000|Overall Study|Withdrawal by Subject|6|||
156451557|NCT03707951|564746701|FG001|Overall Study|Withdrawal by Subject|6|||
156722276|NCT00683618|565731348|FG001|Randomised Treatment Period|Reason not provided|0|||
156722277|NCT00683618|565731349|FG002|Randomised Treatment Period|Reason not provided|2|||
156722278|NCT00683618|565731347|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
156722279|NCT00683618|565731348|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
156722280|NCT00683618|565731349|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
156722281|NCT00683618|565731347|FG000|Extension Treatment Period|Adverse Event|1|||
156722282|NCT00683618|565731348|FG001|Extension Treatment Period|Adverse Event|0|||
156722283|NCT00683618|565731349|FG002|Extension Treatment Period|Adverse Event|0|||
156722284|NCT00683618|565731347|FG000|Extension Treatment Period|Protocol Violation|1|||
156722285|NCT00683618|565731348|FG001|Extension Treatment Period|Protocol Violation|0|||
156722286|NCT00683618|565731349|FG002|Extension Treatment Period|Protocol Violation|0|||
156722287|NCT02954601|565731350|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
156722288|NCT02954601|565731351|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
156722289|NCT02954601|565731352|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
156722290|NCT02954601|565731353|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
156722291|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
156722292|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
156722293|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
156722294|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
156722295|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
156722296|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722297|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722298|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722299|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722300|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722301|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722302|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722303|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722304|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722305|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722306|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
156722307|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
156722308|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
156722309|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
156722310|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
156722311|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722312|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722313|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722314|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722315|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722316|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722317|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722318|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722319|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722320|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156335573|NCT02635776|564326136|FG001|Overall Study|Physician Decision|0|||
156451558|NCT04347161|564746702|FG000|Overall Study|Death|0|||
156451559|NCT04347161|564746703|FG001|Overall Study|Death|2|||
156451560|NCT04347161|564746702|FG000|Overall Study|Withdrawal by Subject|1|||
156335574|NCT02635776|564326135|FG000|Overall Study|Adverse Event|51|||
156722321|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
156722322|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
156722323|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
156722324|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
156722325|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
156722326|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722327|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722328|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722329|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156451561|NCT04347161|564746703|FG001|Overall Study|Withdrawal by Subject|0|||
156722330|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722331|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722332|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722333|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722334|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722335|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722336|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
156722337|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
156722338|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
156722339|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
156722340|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
156722341|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722342|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722343|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722344|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722345|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722346|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722347|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722348|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722349|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722350|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722351|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
156722352|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722353|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
156722354|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
156722355|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
156722356|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722357|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722358|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722359|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722360|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722361|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156875457|NCT02867384|566302073|FG000|Overall Study|Patient compliance|1|||
156875458|NCT02867384|566302074|FG001|Overall Study|Patient compliance|0|||
156875459|NCT02867384|566302075|FG002|Overall Study|Patient compliance|0|||
156875460|NCT02867384|566302073|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
156875461|NCT02867384|566302074|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
156875462|NCT02867384|566302075|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
156875463|NCT02867384|566302073|FG000|Overall Study|Never start treatment|3|||
156335575|NCT02635776|564326136|FG001|Overall Study|Adverse Event|3|||
156335576|NCT02635776|564326135|FG000|Overall Study|Withdrawal by Subject|41|||
156451562|NCT04347161|564746702|FG000|Overall Study|Lost to Follow-up|0|||
156722362|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722363|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722364|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722365|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722366|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722367|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722368|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722369|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
156722370|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722371|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
156875464|NCT02867384|566302074|FG001|Overall Study|Never start treatment|0|||
156875465|NCT02867384|566302075|FG002|Overall Study|Never start treatment|0|||
156335577|NCT02635776|564326136|FG001|Overall Study|Withdrawal by Subject|7|||
156335578|NCT02635776|564326135|FG000|Overall Study|Lost to Follow-up|4|||
156722372|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722373|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722374|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722375|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722376|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722377|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722378|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722379|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722380|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722381|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722382|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
156722383|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
156722384|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
156722385|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
156722386|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722387|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722388|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722389|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722390|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722391|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722392|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722393|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722394|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722395|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722396|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722397|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722398|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722399|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722400|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722401|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
156722402|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
156722403|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
156722404|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
156722405|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
156722406|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
156722407|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
156722408|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
156722409|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
156722410|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
156722411|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722412|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722413|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722414|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722415|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722416|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
156722417|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
156722418|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
156722419|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
156722420|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
156722421|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
156722422|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
156722423|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
156722424|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
156722425|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
156722426|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722427|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722428|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722429|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722430|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722431|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
156722432|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
156335579|NCT02635776|564326136|FG001|Overall Study|Lost to Follow-up|0|||
156335580|NCT02635776|564326135|FG000|Overall Study|Other reasons|5|||
156335581|NCT02635776|564326136|FG001|Overall Study|Other reasons|1|||
156335582|NCT01903031|564326137|FG000|Overall Study|Not Able to Attend Clinic|1|||
156722433|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
156722434|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
156722435|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
156722436|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
156722437|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
156722438|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722439|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
156722440|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
156722441|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722442|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722443|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722444|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722445|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722446|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
156722447|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
156722448|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
156722449|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
156722450|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
156722451|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
156722452|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
156722453|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
156722454|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
156722455|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
156722456|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722457|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722458|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722459|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722460|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722461|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156794281|NCT01916226|565999545|FG000|Overall Study|Physician Decision|0|||
156794282|NCT01916226|565999546|FG001|Overall Study|Physician Decision|0|||
156794283|NCT01916226|565999547|FG002|Overall Study|Physician Decision|0|||
156794284|NCT01916226|565999548|FG003|Overall Study|Physician Decision|1|||
156794285|NCT00979407|565999549|FG000|Overall Study|Withdrawal by Subject|3|||
156794286|NCT00979407|565999550|FG001|Overall Study|Withdrawal by Subject|4|||
156794287|NCT00979407|565999549|FG000|Overall Study|Lost to Follow-up|3|||
156794288|NCT00979407|565999550|FG001|Overall Study|Lost to Follow-up|3|||
156794289|NCT01166646|565999551|FG000|Overall Study|Protocol Violation|0|||
156794290|NCT01166646|565999552|FG001|Overall Study|Protocol Violation|1|||
156794291|NCT01166646|565999551|FG000|Overall Study|Adverse Event|1|||
156794292|NCT01166646|565999552|FG001|Overall Study|Adverse Event|0|||
156794293|NCT02420314|565999553|FG000|Overall Study|Withdrawal by Subject|1|||
156794294|NCT02420314|565999553|FG000|Overall Study|Protocol Violation|1|||
156794295|NCT05142306|565999554|FG000|Overall Study|Withdrawal by Subject|0|||
156794296|NCT05142306|565999555|FG001|Overall Study|Withdrawal by Subject|0|||
156794297|NCT05142306|565999556|FG002|Overall Study|Withdrawal by Subject|1|||
156794298|NCT05430919|565999557|FG000|Overall Study|Protocol Violation|0|||
156794299|NCT05430919|565999558|FG001|Overall Study|Protocol Violation|0|||
156794300|NCT05430919|565999559|FG002|Overall Study|Protocol Violation|1|||
156794301|NCT05430919|565999560|FG003|Overall Study|Protocol Violation|0|||
156794302|NCT05430919|565999557|FG000|Overall Study|Lost to Follow-up|0|||
156794303|NCT05430919|565999558|FG001|Overall Study|Lost to Follow-up|1|||
156794304|NCT05430919|565999559|FG002|Overall Study|Lost to Follow-up|0|||
156794305|NCT05430919|565999560|FG003|Overall Study|Lost to Follow-up|0|||
156794306|NCT05430919|565999557|FG000|Overall Study|Withdrawal by Subject|3|||
156794307|NCT05430919|565999558|FG001|Overall Study|Withdrawal by Subject|0|||
156794308|NCT05430919|565999559|FG002|Overall Study|Withdrawal by Subject|0|||
156794309|NCT05430919|565999560|FG003|Overall Study|Withdrawal by Subject|1|||
156451563|NCT04347161|564746703|FG001|Overall Study|Lost to Follow-up|1|||
156451564|NCT04347161|564746702|FG000|Overall Study|No longer on study medication|1|||
156451565|NCT04347161|564746703|FG001|Overall Study|No longer on study medication|1|||
156794310|NCT02181413|565999569|FG000|Overall Study|Withdrawal by Subject|45|||
156794311|NCT02181413|565999570|FG001|Overall Study|Withdrawal by Subject|61|||
156794312|NCT02181413|565999569|FG000|Overall Study|Reason Not Specified|2|||
156794313|NCT02181413|565999570|FG001|Overall Study|Reason Not Specified|5|||
156451566|NCT04533347|564746705|FG000|Overall Study|Adverse Event|1|||
156794314|NCT02181413|565999569|FG000|Overall Study|Lost to Follow-up|8|||
156794315|NCT02181413|565999570|FG001|Overall Study|Lost to Follow-up|7|||
156794316|NCT02412436|565999573|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
156794317|NCT02412436|565999573|FG000|Overall Study|Lost to Follow-up|6|||
156794318|NCT02412436|565999573|FG000|Overall Study|Unable to get to clinic|3|||
156794319|NCT02412436|565999573|FG000|Overall Study|Death|1|||
156722462|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
156722463|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
156722464|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
156722465|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
156722466|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
156722467|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
156722468|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722469|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
156722470|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
156722471|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156875466|NCT01349959|566302076|FG000|Overall Study|Adverse Event|7|||
156875467|NCT01652534|566302077|FG000|Overall Study|Lack of Efficacy|1|||
156875468|NCT01652534|566302078|FG001|Overall Study|Lack of Efficacy|0|||
156875469|NCT01941186|566302079|FG000|Follow-up|Lost to Follow-up|1|||
156875470|NCT01941186|566302080|FG001|Follow-up|Lost to Follow-up|0|||
156875471|NCT02105961|566302081|FG000|Overall Study|Adverse Event|18|||
156875472|NCT02105961|566302082|FG001|Overall Study|Adverse Event|7|||
156875473|NCT02105961|566302083|FG002|Overall Study|Adverse Event|13|||
156875474|NCT02105961|566302081|FG000|Overall Study|Lack of Efficacy|3|||
156875475|NCT02105961|566302082|FG001|Overall Study|Lack of Efficacy|0|||
156875476|NCT02105961|566302083|FG002|Overall Study|Lack of Efficacy|3|||
156875477|NCT02105961|566302081|FG000|Overall Study|Lost to Follow-up|2|||
156875478|NCT02105961|566302082|FG001|Overall Study|Lost to Follow-up|0|||
156875479|NCT02105961|566302083|FG002|Overall Study|Lost to Follow-up|1|||
156875480|NCT02105961|566302081|FG000|Overall Study|Physician Decision|3|||
156875481|NCT02105961|566302082|FG001|Overall Study|Physician Decision|3|||
156875482|NCT02105961|566302083|FG002|Overall Study|Physician Decision|2|||
156875483|NCT02105961|566302081|FG000|Overall Study|Withdrawal by Subject|15|||
156875484|NCT02105961|566302082|FG001|Overall Study|Withdrawal by Subject|7|||
156875485|NCT02105961|566302083|FG002|Overall Study|Withdrawal by Subject|11|||
156875486|NCT00811018|566302084|FG000|Overall Study|Additional Chronic Treatment|31|||
156875487|NCT00811018|566302084|FG000|Overall Study|Adverse Event|79|||
156875488|NCT00811018|566302084|FG000|Overall Study|Death|147|||
156875489|NCT00811018|566302084|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
156875490|NCT00811018|566302084|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
156875491|NCT00811018|566302084|FG000|Overall Study|Investigator Decision|57|||
156875492|NCT00811018|566302084|FG000|Overall Study|Lost to Follow-up|19|||
156875493|NCT00811018|566302084|FG000|Overall Study|Pregnancy|6|||
156451567|NCT04533347|564746706|FG001|Overall Study|Adverse Event|2|||
156451568|NCT04533347|564746705|FG000|Overall Study|Lost to Follow-up|2|||
156451569|NCT04533347|564746706|FG001|Overall Study|Lost to Follow-up|0|||
156451570|NCT04533347|564746705|FG000|Overall Study|Withdrawal by Subject|1|||
156451571|NCT04533347|564746706|FG001|Overall Study|Withdrawal by Subject|0|||
156451572|NCT05520190|564746707|FG000|Overall Study|Lost to Follow-up|7|||
156451573|NCT05520190|564746707|FG000|Overall Study|Withdrawal by Subject|2|||
156451574|NCT01999075|564746708|FG000|Overall Study|Lost to Follow-up|0|||
156451575|NCT01999075|564746709|FG001|Overall Study|Lost to Follow-up|2|||
156451576|NCT01999075|564746708|FG000|Overall Study|Withdrawal by Subject|2|||
156451577|NCT01999075|564746709|FG001|Overall Study|Withdrawal by Subject|7|||
156451578|NCT01999075|564746708|FG000|Overall Study|Enrolled in drug trial|3|||
156451579|NCT01999075|564746709|FG001|Overall Study|Enrolled in drug trial|1|||
156451580|NCT01999075|564746708|FG000|Overall Study|Became ineligible|0|||
156451581|NCT01999075|564746709|FG001|Overall Study|Became ineligible|2|||
156533459|NCT01187550|565048800|FG001|Overall Study|Protocol Violation|1|||
156722472|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722473|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722474|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722475|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722476|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156875494|NCT00811018|566302084|FG000|Overall Study|Sponsor Decision|450|||
156875495|NCT00811018|566302084|FG000|Overall Study|Withdrawal by Subject|70|||
156875496|NCT00811018|566302084|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
156875497|NCT00811018|566302084|FG000|Overall Study|Other|26|||
156875498|NCT02722304|566302088|FG000|Overall Study|Study Terminated by Sponsor|1|||
156875499|NCT02722304|566302089|FG001|Overall Study|Study Terminated by Sponsor|0|||
156451582|NCT05948670|564746716|FG000|Overall Study|Protocol Violation|6|||
156451583|NCT05948670|564746717|FG001|Overall Study|Protocol Violation|8|||
156451584|NCT05948670|564746716|FG000|Overall Study|Withdrawal by Subject|0|||
156451585|NCT05948670|564746717|FG001|Overall Study|Withdrawal by Subject|1|||
156533460|NCT01187550|565048799|FG000|Overall Study|Other|3|||
156533461|NCT01187550|565048800|FG001|Overall Study|Other|0|||
156875500|NCT02722304|566302090|FG002|Overall Study|Study Terminated by Sponsor|2|||
156875501|NCT02722304|566302091|FG003|Overall Study|Study Terminated by Sponsor|1|||
156875502|NCT02722304|566302092|FG004|Overall Study|Study Terminated by Sponsor|1|||
156722477|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722478|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722479|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722480|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722481|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722482|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
156722483|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722484|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
156722485|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722486|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722487|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722488|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722489|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722490|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722491|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
156722492|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722493|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722494|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722495|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722496|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722497|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722498|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722499|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722500|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
156722501|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722502|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722503|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722504|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722505|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722506|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722507|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722508|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722509|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722510|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
156722511|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722512|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722513|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722514|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722515|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156794320|NCT02412436|565999573|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
156794321|NCT02544763|565999574|FG000|Overall Study|Adverse Event|8|||
156794322|NCT02544763|565999575|FG001|Overall Study|Adverse Event|8|||
156794323|NCT02544763|565999576|FG002|Overall Study|Adverse Event|0|||
156794324|NCT02544763|565999574|FG000|Overall Study|Withdrawn by parent/guardian|1|||
156722516|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722517|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156794325|NCT02544763|565999575|FG001|Overall Study|Withdrawn by parent/guardian|1|||
156794326|NCT02544763|565999576|FG002|Overall Study|Withdrawn by parent/guardian|1|||
156794327|NCT02544763|565999574|FG000|Overall Study|Met withdrawal criteria|0|||
156794328|NCT02544763|565999575|FG001|Overall Study|Met withdrawal criteria|2|||
156794329|NCT02544763|565999576|FG002|Overall Study|Met withdrawal criteria|0|||
156794330|NCT02544763|565999574|FG000|Overall Study|Physician Decision|0|||
156794331|NCT02544763|565999575|FG001|Overall Study|Physician Decision|1|||
156794332|NCT02544763|565999576|FG002|Overall Study|Physician Decision|0|||
156794333|NCT02544763|565999574|FG000|Overall Study|Difficulties taking IMP|1|||
156794334|NCT02544763|565999575|FG001|Overall Study|Difficulties taking IMP|0|||
156794335|NCT02544763|565999576|FG002|Overall Study|Difficulties taking IMP|0|||
156794336|NCT02528305|565999577|FG000|Overall Study|Withdrawal by Subject|1|||
156794337|NCT02528305|565999577|FG000|Overall Study|Adverse Event|1|||
156794338|NCT02528305|565999577|FG000|Overall Study|Physician Decision|1|||
156794339|NCT01852214|565999578|FG000|Period 1|Adverse Event|1|||
156794340|NCT01852214|565999579|FG001|Period 1|Adverse Event|2|||
156794341|NCT01852214|565999578|FG000|Period 1|Withdrawal by Subject|0|||
156794342|NCT01852214|565999579|FG001|Period 1|Withdrawal by Subject|1|||
156794343|NCT01852214|565999578|FG000|Washout Period|Withdrawal by Subject|0|||
156794344|NCT01852214|565999579|FG001|Washout Period|Withdrawal by Subject|1|||
156875503|NCT02722304|566302088|FG000|Overall Study|Other|0|||
156875504|NCT02722304|566302089|FG001|Overall Study|Other|0|||
156875505|NCT02722304|566302090|FG002|Overall Study|Other|0|||
156875506|NCT02722304|566302091|FG003|Overall Study|Other|1|||
156875507|NCT02722304|566302092|FG004|Overall Study|Other|1|||
156875508|NCT00934362|566302093|FG000|Overall Study|Adverse Event|1|||
156875509|NCT00934362|566302094|FG001|Overall Study|Adverse Event|0|||
156875510|NCT04154189|566302097|FG000|Overall Study|Withdrawal by Subject|4|||
156875511|NCT04154189|566302098|FG001|Overall Study|Withdrawal by Subject|6|||
156451586|NCT04562649|564746718|FG000|Overall Study|Withdrawal by Subject|11|||
156451587|NCT04562649|564746719|FG001|Overall Study|Withdrawal by Subject|8|||
156451588|NCT04562649|564746718|FG000|Overall Study|Lost to Follow-up|26|||
156451589|NCT04562649|564746719|FG001|Overall Study|Lost to Follow-up|20|||
156451590|NCT05368103|564746720|FG000|Overall Study|Withdrawal by Subject|4|||
156451591|NCT05368103|564746720|FG000|Overall Study|Lost to Follow-up|1|||
156451592|NCT05368103|564746720|FG000|Overall Study|Lack of Efficacy|3|||
156451593|NCT03675282|564746723|FG000|Overall Study|Lost to Follow-up|4|||
156451594|NCT03675282|564746724|FG001|Overall Study|Lost to Follow-up|8|||
156451595|NCT03675282|564746725|FG002|Overall Study|Lost to Follow-up|1|||
156451596|NCT03675282|564746726|FG003|Overall Study|Lost to Follow-up|0|||
156451597|NCT03675282|564746727|FG004|Overall Study|Lost to Follow-up|2|||
156451598|NCT03675282|564746728|FG005|Overall Study|Lost to Follow-up|7|||
156451599|NCT03675282|564746723|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
156451600|NCT03675282|564746724|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
156451601|NCT03675282|564746725|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
156451602|NCT03675282|564746726|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
156451603|NCT03675282|564746727|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
156451604|NCT03675282|564746728|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
156451605|NCT03675282|564746723|FG000|Overall Study|Physician Decision|1|||
156451606|NCT03675282|564746724|FG001|Overall Study|Physician Decision|0|||
156451607|NCT03675282|564746725|FG002|Overall Study|Physician Decision|0|||
156451608|NCT03675282|564746726|FG003|Overall Study|Physician Decision|0|||
156451609|NCT03675282|564746727|FG004|Overall Study|Physician Decision|0|||
156451610|NCT03675282|564746728|FG005|Overall Study|Physician Decision|0|||
156451611|NCT05784662|564746729|FG000|Overall Study|Lost to Follow-up|21|||
156451612|NCT05784662|564746730|FG001|Overall Study|Lost to Follow-up|17|||
156451613|NCT03232138|564746731|FG000|Overall Study|Physician Decision|1|||
156451614|NCT03232138|564746732|FG001|Overall Study|Physician Decision|0|||
156451615|NCT03232138|564746731|FG000|Overall Study|Adverse Event|2|||
156451616|NCT03232138|564746732|FG001|Overall Study|Adverse Event|0|||
156451617|NCT03232138|564746731|FG000|Overall Study|Withdrawal by Subject|1|||
156451618|NCT03232138|564746732|FG001|Overall Study|Withdrawal by Subject|2|||
156451619|NCT03920111|564746733|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
156722518|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722519|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722520|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722521|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
156722522|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
156875512|NCT04154189|566302097|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
156875513|NCT04154189|566302098|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
156875514|NCT04154189|566302097|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
156875515|NCT04154189|566302098|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
156875516|NCT04154189|566302097|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
156875517|NCT04154189|566302098|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
156875518|NCT04154189|566302097|FG000|Overall Study|Death|25|||
156875519|NCT04154189|566302098|FG001|Overall Study|Death|25|||
156875520|NCT01092117|566302099|FG000|Index Procedure to 1 Month|Death|1|||
156875521|NCT01092117|566302099|FG000|1 Month|Death|1|||
156875522|NCT01092117|566302099|FG000|1 Month|Withdrawal by Subject|1|||
156875523|NCT01092117|566302099|FG000|1 Month|Lost to Follow-up|1|||
156335583|NCT01903031|564326138|FG001|Overall Study|Not Able to Attend Clinic|1|||
156335584|NCT01903031|564326139|FG002|Overall Study|Not Able to Attend Clinic|0|||
156335585|NCT01903031|564326137|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
156335586|NCT01903031|564326138|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
156451620|NCT03920111|564746734|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
156451621|NCT03920111|564746735|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
156451622|NCT05268393|564746736|FG000|Overall Study|Withdrawal by Subject|2|||
156451623|NCT05268393|564746737|FG001|Overall Study|Withdrawal by Subject|1|||
156451624|NCT00450658|564746738|FG000|Overall Study|Adverse Event|24|||
156451625|NCT00450658|564746739|FG001|Overall Study|Adverse Event|15|||
156451626|NCT00450658|564746738|FG000|Overall Study|Withdrawal by Subject|43|||
156875524|NCT01092117|566302099|FG000|6 Months|Death|2|||
156875525|NCT01092117|566302099|FG000|6 Months|Withdrawal by Subject|3|||
156875526|NCT01092117|566302099|FG000|12 Month|Death|11|||
156875527|NCT01092117|566302099|FG000|12 Month|Withdrawal by Subject|2|||
156875528|NCT01092117|566302099|FG000|12 Month|Lost to Follow-up|1|||
156722523|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722524|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722525|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722526|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722527|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
156722528|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
156722529|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
156722530|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
156722531|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722532|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722533|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722534|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722535|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722536|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
156722537|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722538|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722539|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722540|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722541|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
156722542|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722543|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722544|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722545|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
156722546|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722547|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722548|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722549|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722550|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722551|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722552|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722553|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
156722554|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
156722555|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722556|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
156722557|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
156722558|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
156722559|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722560|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722561|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722562|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722563|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722564|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722565|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722566|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722567|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722568|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722569|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722570|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722571|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722572|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
156722573|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722574|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
156722575|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
156722576|NCT03922321|565731382|FG000|Overall Study|Participant Moved|1|||
156722577|NCT03922321|565731382|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
156722578|NCT02342678|565731386|FG000|Overall Study|Lost to Follow-up|0|||
156722579|NCT02342678|565731387|FG001|Overall Study|Lost to Follow-up|1|||
156722580|NCT02342678|565731386|FG000|Overall Study|Too busy to complete study|0|||
156722581|NCT02342678|565731387|FG001|Overall Study|Too busy to complete study|2|||
156722582|NCT02342678|565731386|FG000|Overall Study|Family illness/emergency|0|||
156722583|NCT02342678|565731387|FG001|Overall Study|Family illness/emergency|1|||
156722584|NCT02342678|565731386|FG000|Overall Study|Illness/medical reason|1|||
156722585|NCT02342678|565731387|FG001|Overall Study|Illness/medical reason|1|||
156722586|NCT00350207|565731392|FG000|Overall Study|Adverse Event|5|||
156722587|NCT00350207|565731393|FG001|Overall Study|Adverse Event|2|||
156722588|NCT00350207|565731394|FG002|Overall Study|Adverse Event|2|||
156722589|NCT00350207|565731392|FG000|Overall Study|Lack of Efficacy|1|||
156451627|NCT00450658|564746739|FG001|Overall Study|Withdrawal by Subject|26|||
156451628|NCT00450658|564746738|FG000|Overall Study|Lost to Follow-up|22|||
156451629|NCT00450658|564746739|FG001|Overall Study|Lost to Follow-up|5|||
156451630|NCT00450658|564746738|FG000|Overall Study|UGI ulcer|33|||
156451631|NCT00450658|564746739|FG001|Overall Study|UGI ulcer|34|||
156451632|NCT00450658|564746738|FG000|Overall Study|misc|21|||
156451633|NCT00450658|564746739|FG001|Overall Study|misc|10|||
156451634|NCT01997840|564746744|FG000|Overall Study|Lost to Follow-up|0|||
156451635|NCT01997840|564746745|FG001|Overall Study|Lost to Follow-up|0|||
156451636|NCT01997840|564746746|FG002|Overall Study|Lost to Follow-up|1|||
156451637|NCT01997840|564746747|FG003|Overall Study|Lost to Follow-up|0|||
156451638|NCT01997840|564746744|FG000|Overall Study|Withdrawal by participant|0|||
156451639|NCT01997840|564746745|FG001|Overall Study|Withdrawal by participant|0|||
156451640|NCT01997840|564746746|FG002|Overall Study|Withdrawal by participant|8|||
156451641|NCT01997840|564746747|FG003|Overall Study|Withdrawal by participant|1|||
156451642|NCT01997840|564746744|FG000|Overall Study|Physician Decision|0|||
156451643|NCT01997840|564746745|FG001|Overall Study|Physician Decision|0|||
156451644|NCT01997840|564746746|FG002|Overall Study|Physician Decision|3|||
156451645|NCT01997840|564746747|FG003|Overall Study|Physician Decision|0|||
156451646|NCT01997840|564746744|FG000|Overall Study|Progressive disease|3|||
156451647|NCT01997840|564746745|FG001|Overall Study|Progressive disease|4|||
156451648|NCT01997840|564746746|FG002|Overall Study|Progressive disease|57|||
156451649|NCT01997840|564746747|FG003|Overall Study|Progressive disease|8|||
156451650|NCT01997840|564746744|FG000|Overall Study|Other reasons|0|||
156451651|NCT01997840|564746745|FG001|Overall Study|Other reasons|0|||
156451652|NCT01997840|564746746|FG002|Overall Study|Other reasons|1|||
156335587|NCT01903031|564326139|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
156335588|NCT01903031|564326137|FG000|Overall Study|Adverse Event|0|||
156335589|NCT01903031|564326138|FG001|Overall Study|Adverse Event|1|||
156335590|NCT01903031|564326139|FG002|Overall Study|Adverse Event|0|||
156722590|NCT00350207|565731393|FG001|Overall Study|Lack of Efficacy|0|||
156722591|NCT00350207|565731394|FG002|Overall Study|Lack of Efficacy|2|||
156722592|NCT00350207|565731392|FG000|Overall Study|Lost to Follow-up|1|||
156722593|NCT00350207|565731393|FG001|Overall Study|Lost to Follow-up|0|||
156722594|NCT00350207|565731394|FG002|Overall Study|Lost to Follow-up|1|||
156335591|NCT01903031|564326137|FG000|Overall Study|Withdrawal by Subject|0|||
156335592|NCT01903031|564326138|FG001|Overall Study|Withdrawal by Subject|1|||
156451653|NCT01997840|564746747|FG003|Overall Study|Other reasons|0|||
156451654|NCT01997840|564746744|FG000|Overall Study|Adverse Event|0|||
156451655|NCT01997840|564746745|FG001|Overall Study|Adverse Event|0|||
156451656|NCT01997840|564746746|FG002|Overall Study|Adverse Event|15|||
156451657|NCT01997840|564746747|FG003|Overall Study|Adverse Event|2|||
156451658|NCT05308004|564746757|FG000|Overall Study|Not seen by Palliative Care NP|0|||
156451659|NCT05308004|564746758|FG001|Overall Study|Not seen by Palliative Care NP|1|||
156451660|NCT03150810|564746760|FG000|Overall Study|Death|4|||
156451661|NCT03150810|564746761|FG001|Overall Study|Death|8|||
156451662|NCT03150810|564746762|FG002|Overall Study|Death|7|||
156451663|NCT03150810|564746763|FG003|Overall Study|Death|2|||
156451664|NCT03150810|564746764|FG004|Overall Study|Death|2|||
156722595|NCT00350207|565731392|FG000|Overall Study|Withdrawal by Subject|0|||
156722596|NCT00350207|565731393|FG001|Overall Study|Withdrawal by Subject|1|||
156722597|NCT00350207|565731394|FG002|Overall Study|Withdrawal by Subject|1|||
156722598|NCT00350207|565731392|FG000|Overall Study|Other|1|||
156722599|NCT00350207|565731393|FG001|Overall Study|Other|3|||
156722600|NCT00350207|565731394|FG002|Overall Study|Other|1|||
156722601|NCT03214224|565731395|FG000|Overall Study|Protocol Violation|1|||
156722602|NCT03214224|565731395|FG000|Overall Study|Withdrawal by Subject|2|||
156722603|NCT03214224|565731395|FG000|Overall Study|Practice controls or therapists|6|||
156722604|NCT03802825|565731404|FG000|Overall Study|Lost to follow-up for intervention|12|||
156794345|NCT00421408|565999580|FG000|Overall Study|Lost to Follow-up|30|||
156451665|NCT03150810|564746765|FG005|Overall Study|Death|10|||
156451666|NCT03150810|564746766|FG006|Overall Study|Death|8|||
156451667|NCT03150810|564746767|FG007|Overall Study|Death|6|||
156451668|NCT03150810|564746768|FG008|Overall Study|Death|18|||
156451669|NCT03150810|564746769|FG009|Overall Study|Death|3|||
156451670|NCT03150810|564746770|FG010|Overall Study|Death|19|||
156451671|NCT03150810|564746771|FG011|Overall Study|Death|1|||
156451672|NCT03150810|564746772|FG012|Overall Study|Death|19|||
156451673|NCT03150810|564746760|FG000|Overall Study|Withdrawal by Subject|0|||
156794346|NCT00421408|565999581|FG001|Overall Study|Lost to Follow-up|20|||
156335593|NCT01903031|564326139|FG002|Overall Study|Withdrawal by Subject|1|||
156451674|NCT03150810|564746761|FG001|Overall Study|Withdrawal by Subject|1|||
156451675|NCT03150810|564746762|FG002|Overall Study|Withdrawal by Subject|1|||
156451676|NCT03150810|564746763|FG003|Overall Study|Withdrawal by Subject|1|||
156335594|NCT01903031|564326137|FG000|Overall Study|Protocol Violation|0|||
156451677|NCT03150810|564746764|FG004|Overall Study|Withdrawal by Subject|0|||
156451678|NCT03150810|564746765|FG005|Overall Study|Withdrawal by Subject|0|||
156722605|NCT03802825|565731405|FG001|Overall Study|Lost to follow-up for intervention|3|||
156722606|NCT03802825|565731404|FG000|Overall Study|Received only 1 component of intervention|0|||
156794347|NCT00421408|565999580|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
156335595|NCT01903031|564326138|FG001|Overall Study|Protocol Violation|0|||
156335596|NCT01903031|564326139|FG002|Overall Study|Protocol Violation|2|||
156335597|NCT01903031|564326137|FG000|Overall Study|Lost to Follow-up|0|||
156451679|NCT03150810|564746766|FG006|Overall Study|Withdrawal by Subject|2|||
156451680|NCT03150810|564746767|FG007|Overall Study|Withdrawal by Subject|0|||
156451681|NCT03150810|564746768|FG008|Overall Study|Withdrawal by Subject|2|||
156451682|NCT03150810|564746769|FG009|Overall Study|Withdrawal by Subject|0|||
156722607|NCT03802825|565731405|FG001|Overall Study|Received only 1 component of intervention|13|||
156722608|NCT05266053|565731406|FG000|Overall Study|Withdrawal by Subject|8|||
156722609|NCT05266053|565731407|FG001|Overall Study|Withdrawal by Subject|4|||
156722610|NCT01051960|565731411|FG000|Overall Study|Adverse Event|1|||
156722611|NCT00360282|565731412|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
156722612|NCT00360282|565731413|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
156722613|NCT00360282|565731414|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
156722614|NCT00360282|565731415|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
156722615|NCT00360282|565731412|FG000|Second Intervention|Adverse Event|0|||
156722616|NCT00360282|565731413|FG001|Second Intervention|Adverse Event|1|||
156722617|NCT00360282|565731414|FG002|Second Intervention|Adverse Event|0|||
156722618|NCT00360282|565731415|FG003|Second Intervention|Adverse Event|0|||
156722619|NCT02996968|565731416|FG000|Overall Study|Withdrawal by Subject|1|||
156722620|NCT02996968|565731417|FG001|Overall Study|Withdrawal by Subject|0|||
156722621|NCT04537078|565731420|FG000|Overall Study|Protocol Violation|3|||
156722622|NCT04537078|565731421|FG001|Overall Study|Protocol Violation|2|||
156722623|NCT04537078|565731420|FG000|Overall Study|Lost to Follow-up|1|||
156722624|NCT04537078|565731421|FG001|Overall Study|Lost to Follow-up|0|||
156722625|NCT04537078|565731420|FG000|Overall Study|Withdrawal by Subject|0|||
156722626|NCT04537078|565731421|FG001|Overall Study|Withdrawal by Subject|1|||
156722627|NCT02626026|565731425|FG000|Overall Study|Randomized but Never Treated|0|||
156722628|NCT02626026|565731426|FG001|Overall Study|Randomized but Never Treated|0|||
156722629|NCT02626026|565731427|FG002|Overall Study|Randomized but Never Treated|0|||
156722630|NCT02626026|565731428|FG003|Overall Study|Randomized but Never Treated|0|||
156722631|NCT02626026|565731429|FG004|Overall Study|Randomized but Never Treated|1|||
156722632|NCT02626026|565731430|FG005|Overall Study|Randomized but Never Treated|0|||
156722633|NCT01592786|565731435|FG000|Overall Study|Adverse Event|60|||
156722634|NCT01592786|565731435|FG000|Overall Study|Lack of Efficacy|19|||
156722635|NCT01592786|565731435|FG000|Overall Study|Protocol Violation|14|||
156722636|NCT01592786|565731435|FG000|Overall Study|Withdrawal by Subject|23|||
156722637|NCT01592786|565731435|FG000|Overall Study|Lost to Follow-up|19|||
156722638|NCT01592786|565731435|FG000|Overall Study|Other|3|||
156722639|NCT01909934|565731436|FG000|Overall Study|Withdrawal by Subject|3|||
156722640|NCT01909934|565731436|FG000|Overall Study|Lost to Follow-up|1|||
156722641|NCT01909934|565731436|FG000|Overall Study|Death|25|||
156722642|NCT01909934|565731436|FG000|Overall Study|Withdrawal of Informed Consent|1|||
156722643|NCT01909934|565731436|FG000|Overall Study|Reason Not Specified|1|||
156722644|NCT03810092|565731437|FG000|Overall Study|no ground support|17|||
156722645|NCT03810092|565731437|FG000|Overall Study|ADL not done at J0|16|||
156722646|NCT03810092|565731437|FG000|Overall Study|No hemoglobin measure at J5|27|||
156722647|NCT04578535|565731439|FG000|Overall Study|Lost to Follow-up|1|||
156722648|NCT04578535|565731440|FG001|Overall Study|Lost to Follow-up|0|||
156722649|NCT04578535|565731441|FG002|Overall Study|Lost to Follow-up|0|||
156722650|NCT04578535|565731442|FG003|Overall Study|Lost to Follow-up|1|||
156722651|NCT04578535|565731443|FG004|Overall Study|Lost to Follow-up|0|||
156722652|NCT04578535|565731444|FG005|Overall Study|Lost to Follow-up|2|||
156722653|NCT04578535|565731439|FG000|Overall Study|Pregnancy|1|||
156722654|NCT04578535|565731440|FG001|Overall Study|Pregnancy|0|||
156722655|NCT04578535|565731441|FG002|Overall Study|Pregnancy|0|||
156722656|NCT04578535|565731442|FG003|Overall Study|Pregnancy|0|||
156722657|NCT04578535|565731443|FG004|Overall Study|Pregnancy|0|||
156722658|NCT04578535|565731444|FG005|Overall Study|Pregnancy|0|||
156722659|NCT04578535|565731439|FG000|Overall Study|Withdrawal by Subject|0|||
156722660|NCT04578535|565731440|FG001|Overall Study|Withdrawal by Subject|0|||
156722661|NCT04578535|565731441|FG002|Overall Study|Withdrawal by Subject|0|||
156722662|NCT04578535|565731442|FG003|Overall Study|Withdrawal by Subject|1|||
156722663|NCT04578535|565731443|FG004|Overall Study|Withdrawal by Subject|1|||
156722664|NCT04578535|565731444|FG005|Overall Study|Withdrawal by Subject|5|||
156722665|NCT04578535|565731439|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
156722666|NCT04578535|565731440|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
156722667|NCT04578535|565731441|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
156722668|NCT04578535|565731442|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
156335598|NCT01903031|564326138|FG001|Overall Study|Lost to Follow-up|0|||
156335599|NCT01903031|564326139|FG002|Overall Study|Lost to Follow-up|1|||
156451683|NCT03150810|564746770|FG010|Overall Study|Withdrawal by Subject|1|||
156722669|NCT04578535|565731443|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
156722670|NCT04578535|565731444|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
156722671|NCT00235755|565731445|FG000|4-Week Titration Phase|Adverse Event|6|||
156722672|NCT00235755|565731446|FG001|4-Week Titration Phase|Adverse Event|14|||
156722673|NCT00235755|565731447|FG002|4-Week Titration Phase|Adverse Event|20|||
156335600|NCT01903031|564326137|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
156335601|NCT01903031|564326138|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
156335602|NCT01903031|564326139|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
156335603|NCT01811225|564326140|FG000|Treatment Period 1|Adverse Event|2|||
156335604|NCT01811225|564326141|FG001|Treatment Period 1|Adverse Event|3|||
156335605|NCT01811225|564326140|FG000|Treatment Period 1|Lost to Follow-up|12|||
156335606|NCT01811225|564326141|FG001|Treatment Period 1|Lost to Follow-up|8|||
156335607|NCT01811225|564326140|FG000|Treatment Period 1|transporation|1|||
156335608|NCT01811225|564326141|FG001|Treatment Period 1|transporation|0|||
156335609|NCT01811225|564326140|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
156335610|NCT01811225|564326141|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
156335611|NCT01811225|564326140|FG000|Treatment Period 2|Lost to Follow-up|1|||
156335612|NCT01811225|564326141|FG001|Treatment Period 2|Lost to Follow-up|2|||
156335613|NCT01811225|564326140|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
156335614|NCT01811225|564326141|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
156335615|NCT00287365|564326142|FG000|Overall Study|sample not acquired|13|||
156335616|NCT02298023|564326143|FG000|Overall Study|Withdrawal by Subject|1|||
156335617|NCT02298023|564326144|FG001|Overall Study|Withdrawal by Subject|0|||
156335618|NCT02298023|564326145|FG002|Overall Study|Withdrawal by Subject|0|||
156335619|NCT00569270|564326146|FG000|Period: First Intervention|Protocol Violation|0|||
156335620|NCT00569270|564326147|FG001|Period: First Intervention|Protocol Violation|1|||
156335621|NCT00913380|564326148|FG000|Clinical Outcomes|Lost to Follow-up|6|||
156335622|NCT00913380|564326149|FG001|Clinical Outcomes|Lost to Follow-up|6|||
156335623|NCT01602120|564326153|FG000|Overall Study|Adverse Event|3|||
156335624|NCT01602120|564326154|FG001|Overall Study|Adverse Event|6|||
156451684|NCT03150810|564746771|FG011|Overall Study|Withdrawal by Subject|0|||
156722674|NCT00235755|565731445|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
156722675|NCT00235755|565731446|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
156722676|NCT00235755|565731447|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
156722677|NCT00235755|565731445|FG000|4-Week Titration Phase|Protocol Violation|2|||
156722678|NCT00235755|565731446|FG001|4-Week Titration Phase|Protocol Violation|2|||
156722679|NCT00235755|565731447|FG002|4-Week Titration Phase|Protocol Violation|1|||
156722680|NCT00235755|565731445|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
156722681|NCT00235755|565731446|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
156722682|NCT00235755|565731447|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
156722683|NCT00235755|565731445|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
156722684|NCT00235755|565731446|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
156722685|NCT00235755|565731447|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
156722686|NCT00235755|565731445|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
156722687|NCT00235755|565731446|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
156722688|NCT00235755|565731447|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
156722689|NCT00235755|565731445|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
156722690|NCT00235755|565731446|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
156722691|NCT00235755|565731447|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
156722692|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Adverse Event|8|||
156722693|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Adverse Event|12|||
156722694|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Adverse Event|26|||
156722695|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
156722696|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
156722697|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
156722698|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
156722699|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
156722700|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
156722701|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
156722702|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
156722703|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
156722704|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
156722705|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
156722706|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
156722707|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
156722708|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
156722709|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
156722710|NCT01707290|565731450|FG000|Overall Study|Adverse event (AE)|1|||
156722711|NCT01707290|565731451|FG001|Overall Study|Adverse event (AE)|0|||
156335625|NCT01602120|564326155|FG002|Overall Study|Adverse Event|0|||
156335626|NCT01602120|564326156|FG003|Overall Study|Adverse Event|2|||
156335627|NCT01602120|564326153|FG000|Overall Study|Death|0|||
156335628|NCT01602120|564326154|FG001|Overall Study|Death|4|||
156451685|NCT03150810|564746772|FG012|Overall Study|Withdrawal by Subject|1|||
156451686|NCT03150810|564746760|FG000|Overall Study|Sponsor Decision|0|||
156451687|NCT03150810|564746761|FG001|Overall Study|Sponsor Decision|2|||
156451688|NCT03150810|564746762|FG002|Overall Study|Sponsor Decision|0|||
156451689|NCT03150810|564746763|FG003|Overall Study|Sponsor Decision|0|||
156451690|NCT03150810|564746764|FG004|Overall Study|Sponsor Decision|1|||
156451691|NCT03150810|564746765|FG005|Overall Study|Sponsor Decision|1|||
156451692|NCT03150810|564746766|FG006|Overall Study|Sponsor Decision|0|||
156451693|NCT03150810|564746767|FG007|Overall Study|Sponsor Decision|0|||
156451694|NCT03150810|564746768|FG008|Overall Study|Sponsor Decision|1|||
156722712|NCT01707290|565731450|FG000|Overall Study|Physician Decision|1|||
156722713|NCT01707290|565731451|FG001|Overall Study|Physician Decision|0|||
156722714|NCT01707290|565731450|FG000|Overall Study|Lost to Follow-up|3|||
156722715|NCT01707290|565731451|FG001|Overall Study|Lost to Follow-up|0|||
156722716|NCT01707290|565731450|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
156722717|NCT01707290|565731451|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
156722718|NCT01707290|565731450|FG000|Overall Study|Commercial drug available|60|||
156722719|NCT01707290|565731451|FG001|Overall Study|Commercial drug available|1|||
156722720|NCT01707290|565731450|FG000|Overall Study|Other unspecified|17|||
156722721|NCT01707290|565731451|FG001|Overall Study|Other unspecified|0|||
156722722|NCT01882985|565731454|FG000|Overall Study|Lost to Follow-up|1|||
156722723|NCT01882985|565731454|FG000|Overall Study|Withdrawal by Subject|1|||
156722724|NCT03193853|565731461|FG000|Overall Study|Death|6|||
156722725|NCT04129125|565731462|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
156722726|NCT04129125|565731462|FG000|Overall Study|Study device was not used|3|||
156722727|NCT01320293|565731470|FG000|Overall Study|Lack of Efficacy|1|||
156722728|NCT01320293|565731470|FG000|Overall Study|Adverse Event|1|||
156722729|NCT01787292|565731473|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
156722730|NCT01787292|565731474|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
156722731|NCT01787292|565731473|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
156722732|NCT01787292|565731474|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
156722733|NCT01532934|565731475|FG000|Overall Study|Lost to Follow-up|11|||
156722734|NCT01532934|565731476|FG001|Overall Study|Lost to Follow-up|11|||
156722735|NCT01532934|565731475|FG000|Overall Study|In controlled environment|3|||
156722736|NCT01532934|565731476|FG001|Overall Study|In controlled environment|2|||
156722737|NCT01147068|565731477|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
156722738|NCT01147068|565731478|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156722739|NCT01147068|565731479|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156722740|NCT01147068|565731480|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156451695|NCT03150810|564746769|FG009|Overall Study|Sponsor Decision|0|||
156451696|NCT03150810|564746770|FG010|Overall Study|Sponsor Decision|0|||
156451697|NCT03150810|564746771|FG011|Overall Study|Sponsor Decision|0|||
156722741|NCT01147068|565731481|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156722742|NCT01147068|565731482|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
156722743|NCT01147068|565731483|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156722744|NCT01147068|565731477|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
156722745|NCT01147068|565731478|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
156722746|NCT01147068|565731479|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
156722747|NCT01147068|565731480|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
156722748|NCT01147068|565731481|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
156722749|NCT01147068|565731482|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
156722750|NCT01147068|565731483|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
156722751|NCT01147068|565731477|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722752|NCT01147068|565731478|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
156722753|NCT01147068|565731479|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722754|NCT01147068|565731480|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722755|NCT01147068|565731481|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722756|NCT01147068|565731482|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
156722757|NCT01147068|565731483|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722758|NCT01147068|565731477|FG000|Subjects That Received 2nd Dose|Other|0|||
156722759|NCT01147068|565731478|FG001|Subjects That Received 2nd Dose|Other|3|||
156722760|NCT01147068|565731479|FG002|Subjects That Received 2nd Dose|Other|3|||
156722761|NCT01147068|565731480|FG003|Subjects That Received 2nd Dose|Other|0|||
156722762|NCT01147068|565731481|FG004|Subjects That Received 2nd Dose|Other|1|||
156722763|NCT01147068|565731482|FG005|Subjects That Received 2nd Dose|Other|0|||
156722764|NCT01147068|565731483|FG006|Subjects That Received 2nd Dose|Other|0|||
156722765|NCT01147068|565731477|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
156722766|NCT01147068|565731478|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
156722767|NCT01147068|565731479|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
156722768|NCT01147068|565731480|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
156722769|NCT01147068|565731481|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
156722770|NCT01147068|565731482|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
156722771|NCT01147068|565731483|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
156722772|NCT01147068|565731477|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722773|NCT01147068|565731478|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722774|NCT01147068|565731479|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722775|NCT01147068|565731480|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
156722776|NCT01147068|565731481|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722777|NCT01147068|565731482|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722778|NCT01147068|565731483|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722779|NCT01147068|565731477|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
156451698|NCT03150810|564746772|FG012|Overall Study|Sponsor Decision|5|||
156451699|NCT03150810|564746760|FG000|Overall Study|Lost to Follow-up|0|||
156451700|NCT03150810|564746761|FG001|Overall Study|Lost to Follow-up|1|||
156451701|NCT03150810|564746762|FG002|Overall Study|Lost to Follow-up|1|||
156451702|NCT03150810|564746763|FG003|Overall Study|Lost to Follow-up|0|||
156451703|NCT03150810|564746764|FG004|Overall Study|Lost to Follow-up|0|||
156451704|NCT03150810|564746765|FG005|Overall Study|Lost to Follow-up|0|||
156451705|NCT03150810|564746766|FG006|Overall Study|Lost to Follow-up|1|||
156451706|NCT03150810|564746767|FG007|Overall Study|Lost to Follow-up|0|||
156451707|NCT03150810|564746768|FG008|Overall Study|Lost to Follow-up|0|||
156451708|NCT03150810|564746769|FG009|Overall Study|Lost to Follow-up|0|||
156451709|NCT03150810|564746770|FG010|Overall Study|Lost to Follow-up|1|||
156451710|NCT03150810|564746771|FG011|Overall Study|Lost to Follow-up|0|||
156451711|NCT03150810|564746772|FG012|Overall Study|Lost to Follow-up|0|||
156451712|NCT03150810|564746760|FG000|Overall Study|Physician Decision|0|||
156451713|NCT03150810|564746761|FG001|Overall Study|Physician Decision|0|||
156451714|NCT03150810|564746762|FG002|Overall Study|Physician Decision|0|||
156451715|NCT03150810|564746763|FG003|Overall Study|Physician Decision|0|||
156451716|NCT03150810|564746764|FG004|Overall Study|Physician Decision|0|||
156451717|NCT03150810|564746765|FG005|Overall Study|Physician Decision|1|||
156451718|NCT03150810|564746766|FG006|Overall Study|Physician Decision|1|||
156451719|NCT03150810|564746767|FG007|Overall Study|Physician Decision|0|||
156722780|NCT01147068|565731478|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
156722781|NCT01147068|565731479|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722782|NCT01147068|565731480|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722783|NCT01147068|565731481|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722784|NCT01147068|565731482|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722785|NCT01147068|565731483|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722786|NCT02962648|565731485|FG000|Overall Study|Withdrawal by Subject|3|||
156722787|NCT02962648|565731485|FG000|Overall Study|Lost to Follow-up|3|||
156722788|NCT02962648|565731485|FG000|Overall Study|Physician Decision|1|||
156722789|NCT02962648|565731485|FG000|Overall Study|Subject had problems with transportation|2|||
156722790|NCT01597778|565731486|FG000|Overall Study|Death|7|||
156722791|NCT01597778|565731487|FG001|Overall Study|Death|10|||
156722792|NCT01597778|565731486|FG000|Overall Study|Withdrawal by Subject|3|||
156722793|NCT01597778|565731487|FG001|Overall Study|Withdrawal by Subject|4|||
156722794|NCT01597778|565731486|FG000|Overall Study|Adverse Event|1|||
156722795|NCT01597778|565731487|FG001|Overall Study|Adverse Event|1|||
156722796|NCT01597778|565731486|FG000|Overall Study|Protocol Violation|1|||
156722797|NCT01597778|565731487|FG001|Overall Study|Protocol Violation|11|||
156722798|NCT01597778|565731486|FG000|Overall Study|Transplanted off protocol|2|||
156722799|NCT01597778|565731487|FG001|Overall Study|Transplanted off protocol|3|||
156722800|NCT03267212|565731489|FG000|First Intervention|Lost to Follow-up|0|||
156722801|NCT03267212|565731490|FG001|First Intervention|Lost to Follow-up|2|||
156722802|NCT03267212|565731489|FG000|First Intervention|Withdrawal by Subject|1|||
156722803|NCT03267212|565731490|FG001|First Intervention|Withdrawal by Subject|1|||
156722804|NCT03267212|565731489|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
156722805|NCT03267212|565731490|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
156722806|NCT04383327|565731492|FG000|Overall Study|Lost to Follow-up|112|||
156722807|NCT04383327|565731493|FG001|Overall Study|Lost to Follow-up|14|||
156722808|NCT04383327|565731494|FG002|Overall Study|Lost to Follow-up|78|||
156722809|NCT04383327|565731495|FG003|Overall Study|Lost to Follow-up|13|||
156722810|NCT04383327|565731496|FG004|Overall Study|Lost to Follow-up|110|||
156722811|NCT04383327|565731497|FG005|Overall Study|Lost to Follow-up|13|||
156722812|NCT04383327|565731498|FG006|Overall Study|Lost to Follow-up|74|||
156722813|NCT04383327|565731499|FG007|Overall Study|Lost to Follow-up|13|||
156722814|NCT04383327|565731500|FG008|Overall Study|Lost to Follow-up|78|||
156722815|NCT04383327|565731501|FG009|Overall Study|Lost to Follow-up|10|||
156722816|NCT04383327|565731502|FG010|Overall Study|Lost to Follow-up|160|||
156451720|NCT03150810|564746768|FG008|Overall Study|Physician Decision|0|||
156451721|NCT03150810|564746769|FG009|Overall Study|Physician Decision|0|||
156451722|NCT03150810|564746770|FG010|Overall Study|Physician Decision|0|||
156451723|NCT03150810|564746771|FG011|Overall Study|Physician Decision|0|||
156533462|NCT01187550|565048799|FG000|Overall Study|Randomized but not treated|8|||
156722817|NCT04383327|565731503|FG011|Overall Study|Lost to Follow-up|13|||
156794348|NCT00421408|565999581|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
156451724|NCT03150810|564746772|FG012|Overall Study|Physician Decision|0|||
156533463|NCT01187550|565048800|FG001|Overall Study|Randomized but not treated|0|||
156451725|NCT03150810|564746760|FG000|Overall Study|Site withdrawal from study|0|||
156451726|NCT03150810|564746761|FG001|Overall Study|Site withdrawal from study|1|||
156335629|NCT01602120|564326155|FG002|Overall Study|Death|0|||
156335630|NCT01602120|564326156|FG003|Overall Study|Death|0|||
156335631|NCT01602120|564326153|FG000|Overall Study|Lost to Follow-up|0|||
156335632|NCT01602120|564326154|FG001|Overall Study|Lost to Follow-up|1|||
156335633|NCT01602120|564326155|FG002|Overall Study|Lost to Follow-up|0|||
156335634|NCT01602120|564326156|FG003|Overall Study|Lost to Follow-up|1|||
156335635|NCT01602120|564326153|FG000|Overall Study|Protocol Violation|1|||
156335636|NCT01602120|564326154|FG001|Overall Study|Protocol Violation|1|||
156335637|NCT01602120|564326155|FG002|Overall Study|Protocol Violation|0|||
156335638|NCT01602120|564326156|FG003|Overall Study|Protocol Violation|0|||
156335639|NCT01602120|564326153|FG000|Overall Study|Non-compliance|0|||
156335640|NCT01602120|564326154|FG001|Overall Study|Non-compliance|3|||
156335641|NCT01602120|564326155|FG002|Overall Study|Non-compliance|0|||
156335642|NCT01602120|564326156|FG003|Overall Study|Non-compliance|1|||
156335643|NCT01602120|564326153|FG000|Overall Study|Withdrawal by Subject|8|||
156335644|NCT01602120|564326154|FG001|Overall Study|Withdrawal by Subject|17|||
156335645|NCT01602120|564326155|FG002|Overall Study|Withdrawal by Subject|0|||
156335646|NCT01602120|564326156|FG003|Overall Study|Withdrawal by Subject|3|||
156335647|NCT01602120|564326153|FG000|Overall Study|Study Terminated by Sponsor|12|||
156335648|NCT01602120|564326154|FG001|Overall Study|Study Terminated by Sponsor|24|||
156335649|NCT01602120|564326155|FG002|Overall Study|Study Terminated by Sponsor|17|||
156335650|NCT01602120|564326156|FG003|Overall Study|Study Terminated by Sponsor|44|||
156335651|NCT01602120|564326153|FG000|Overall Study|Physician Decision|2|||
156335652|NCT01602120|564326154|FG001|Overall Study|Physician Decision|3|||
156335653|NCT01602120|564326155|FG002|Overall Study|Physician Decision|0|||
156335654|NCT01602120|564326156|FG003|Overall Study|Physician Decision|0|||
156335655|NCT01602120|564326153|FG000|Overall Study|Unspecified Reason|3|||
156722818|NCT05691712|565731504|FG000|Overall Study|Adverse Event|0|||
156722819|NCT05691712|565731505|FG001|Overall Study|Adverse Event|1|||
156722820|NCT05691712|565731506|FG002|Overall Study|Adverse Event|2|||
156722821|NCT05691712|565731507|FG003|Overall Study|Adverse Event|1|||
156722822|NCT05691712|565731504|FG000|Overall Study|Withdrawal by Subject|2|||
156722823|NCT05691712|565731505|FG001|Overall Study|Withdrawal by Subject|3|||
156722824|NCT05691712|565731506|FG002|Overall Study|Withdrawal by Subject|3|||
156722825|NCT05691712|565731507|FG003|Overall Study|Withdrawal by Subject|1|||
156722826|NCT05691712|565731504|FG000|Overall Study|Death|1|||
156722827|NCT05691712|565731505|FG001|Overall Study|Death|0|||
156722828|NCT05691712|565731506|FG002|Overall Study|Death|0|||
156722829|NCT05691712|565731507|FG003|Overall Study|Death|0|||
156722830|NCT05691712|565731504|FG000|Overall Study|Pregnancy|0|||
156722831|NCT05691712|565731505|FG001|Overall Study|Pregnancy|1|||
156722832|NCT05691712|565731506|FG002|Overall Study|Pregnancy|0|||
156722833|NCT05691712|565731507|FG003|Overall Study|Pregnancy|0|||
156722834|NCT05691712|565731504|FG000|Overall Study|Assigned Treatment by Mistake|1|||
156722835|NCT05691712|565731505|FG001|Overall Study|Assigned Treatment by Mistake|0|||
156722836|NCT05691712|565731506|FG002|Overall Study|Assigned Treatment by Mistake|0|||
156722837|NCT05691712|565731507|FG003|Overall Study|Assigned Treatment by Mistake|1|||
156722838|NCT05303194|565731508|FG000|Overall Study|Lost to Follow-up|1|||
156722839|NCT05303194|565731509|FG001|Overall Study|Lost to Follow-up|1|||
156722840|NCT05303194|565731508|FG000|Overall Study|Withdrawal by Subject|0|||
156722841|NCT05303194|565731509|FG001|Overall Study|Withdrawal by Subject|1|||
156722842|NCT01289678|565731519|FG000|Overall Study|Physician Decision|6|||
156722843|NCT00991887|565731520|FG000|Overall Study|Lost to Follow-up|2|||
156722844|NCT00991887|565731521|FG001|Overall Study|Lost to Follow-up|1|||
156722845|NCT00226499|565731522|FG000|Overall Study|Adverse Event|10|||
156722846|NCT00226499|565731523|FG001|Overall Study|Adverse Event|6|||
156335656|NCT01602120|564326154|FG001|Overall Study|Unspecified Reason|1|||
156335657|NCT01602120|564326155|FG002|Overall Study|Unspecified Reason|0|||
156335658|NCT01602120|564326156|FG003|Overall Study|Unspecified Reason|2|||
156335659|NCT01187433|564326164|FG000|Overall Study|Protocol Violation|6|||
156335660|NCT01187433|564326165|FG001|Overall Study|Protocol Violation|2|||
156335661|NCT01187433|564326164|FG000|Overall Study|Withdrawal by Subject|5|||
156335662|NCT01187433|564326165|FG001|Overall Study|Withdrawal by Subject|2|||
156451727|NCT03150810|564746762|FG002|Overall Study|Site withdrawal from study|0|||
156335663|NCT04223973|564326166|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
156335664|NCT04223973|564326167|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
156722847|NCT00226499|565731524|FG002|Overall Study|Adverse Event|3|||
156722848|NCT00226499|565731522|FG000|Overall Study|Others|1064|||
156335665|NCT04223973|564326166|FG000|Overall Study|Adverse Event|4|||
156335666|NCT04223973|564326167|FG001|Overall Study|Adverse Event|0|||
156335667|NCT04223973|564326166|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
156335668|NCT04223973|564326167|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
156335669|NCT04223973|564326166|FG000|Overall Study|Physician Decision|1|||
156335670|NCT04223973|564326167|FG001|Overall Study|Physician Decision|1|||
156722849|NCT00226499|565731523|FG001|Overall Study|Others|1066|||
156722850|NCT00226499|565731524|FG002|Overall Study|Others|356|||
156722851|NCT02723344|565731527|FG000|Overall Study|Lost to Follow-up|0|||
156722852|NCT02723344|565731528|FG001|Overall Study|Lost to Follow-up|4|||
156451728|NCT03150810|564746763|FG003|Overall Study|Site withdrawal from study|0|||
156451729|NCT03150810|564746764|FG004|Overall Study|Site withdrawal from study|0|||
156451730|NCT03150810|564746765|FG005|Overall Study|Site withdrawal from study|0|||
156451731|NCT03150810|564746766|FG006|Overall Study|Site withdrawal from study|0|||
156451732|NCT03150810|564746767|FG007|Overall Study|Site withdrawal from study|0|||
156451733|NCT03150810|564746768|FG008|Overall Study|Site withdrawal from study|0|||
156451734|NCT03150810|564746769|FG009|Overall Study|Site withdrawal from study|1|||
156451735|NCT03150810|564746770|FG010|Overall Study|Site withdrawal from study|1|||
156722853|NCT02524847|565731530|FG000|Overall Study|Adverse Event|4|||
156722854|NCT02524847|565731530|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
156722855|NCT02524847|565731530|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
156722856|NCT02524847|565731530|FG000|Overall Study|Death|1|||
156722857|NCT02524847|565731530|FG000|Overall Study|Reason not Specified|1|||
156722858|NCT04352101|565731531|FG000|Overall Study|Physician Decision|2|||
156722859|NCT04352101|565731532|FG001|Overall Study|Physician Decision|1|||
156722860|NCT03170544|565731538|FG000|Part 1|Lost to Follow-up|1|||
156722861|NCT03170544|565731539|FG001|Part 1|Lost to Follow-up|0|||
156722862|NCT03170544|565731540|FG002|Part 1|Lost to Follow-up|0|||
156451736|NCT03150810|564746771|FG011|Overall Study|Site withdrawal from study|0|||
156451737|NCT03150810|564746772|FG012|Overall Study|Site withdrawal from study|0|||
156722863|NCT03170544|565731541|FG003|Part 1|Lost to Follow-up|0|||
156722864|NCT03170544|565731542|FG004|Part 1|Lost to Follow-up|0|||
156722865|NCT03170544|565731543|FG005|Part 1|Lost to Follow-up|0|||
156722866|NCT03170544|565731544|FG006|Part 1|Lost to Follow-up|0|||
156722867|NCT03170544|565731545|FG007|Part 1|Lost to Follow-up|0|||
156722868|NCT03170544|565731546|FG008|Part 1|Lost to Follow-up|0|||
156722869|NCT03170544|565731547|FG009|Part 1|Lost to Follow-up|0|||
156722870|NCT03170544|565731548|FG010|Part 1|Lost to Follow-up|0|||
156722871|NCT03170544|565731549|FG011|Part 1|Lost to Follow-up|0|||
156722872|NCT03170544|565731538|FG000|Part 1|Not treated|0|||
156722873|NCT03170544|565731539|FG001|Part 1|Not treated|0|||
156722874|NCT03170544|565731540|FG002|Part 1|Not treated|0|||
156722875|NCT03170544|565731541|FG003|Part 1|Not treated|1|||
156722876|NCT03170544|565731542|FG004|Part 1|Not treated|0|||
156722877|NCT03170544|565731543|FG005|Part 1|Not treated|0|||
156722878|NCT03170544|565731544|FG006|Part 1|Not treated|0|||
156722879|NCT03170544|565731545|FG007|Part 1|Not treated|0|||
156722880|NCT03170544|565731546|FG008|Part 1|Not treated|0|||
156722881|NCT03170544|565731547|FG009|Part 1|Not treated|0|||
156722882|NCT03170544|565731548|FG010|Part 1|Not treated|0|||
156722883|NCT03170544|565731549|FG011|Part 1|Not treated|0|||
156722884|NCT00359424|565731550|FG000|Overall Study|Death|99|||
156722885|NCT00359424|565731551|FG001|Overall Study|Death|58|||
156722886|NCT00359424|565731550|FG000|Overall Study|Lost to Follow-up|19|||
156722887|NCT00359424|565731551|FG001|Overall Study|Lost to Follow-up|7|||
156722888|NCT00359424|565731550|FG000|Overall Study|Withdrawal by Subject|10|||
156451738|NCT03150810|564746760|FG000|Overall Study|Hospice|0|||
156451739|NCT03150810|564746761|FG001|Overall Study|Hospice|0|||
156451740|NCT03150810|564746762|FG002|Overall Study|Hospice|0|||
156451741|NCT03150810|564746763|FG003|Overall Study|Hospice|0|||
156722889|NCT00359424|565731551|FG001|Overall Study|Withdrawal by Subject|2|||
156722890|NCT00359424|565731550|FG000|Overall Study|follow up not conducted|2|||
156722891|NCT00359424|565731551|FG001|Overall Study|follow up not conducted|0|||
156722892|NCT01120184|565733249|FG000|Overall Study|Adverse Event|0|||
156722893|NCT01120184|565733250|FG001|Overall Study|Adverse Event|1|||
156722894|NCT01120184|565733251|FG002|Overall Study|Adverse Event|0|||
156722895|NCT01120184|565733249|FG000|Overall Study|Lost to Follow-up|13|||
156722896|NCT01120184|565733250|FG001|Overall Study|Lost to Follow-up|13|||
156722897|NCT01120184|565733251|FG002|Overall Study|Lost to Follow-up|11|||
156722898|NCT01120184|565733249|FG000|Overall Study|Physician Decision|9|||
156722899|NCT01120184|565733250|FG001|Overall Study|Physician Decision|1|||
156722900|NCT01120184|565733251|FG002|Overall Study|Physician Decision|3|||
156451742|NCT03150810|564746764|FG004|Overall Study|Hospice|0|||
156722901|NCT01120184|565733249|FG000|Overall Study|Reason not Specified|8|||
156722902|NCT01120184|565733250|FG001|Overall Study|Reason not Specified|3|||
156722903|NCT01120184|565733251|FG002|Overall Study|Reason not Specified|12|||
156722904|NCT01120184|565733249|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
156722905|NCT01120184|565733250|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
156722906|NCT01120184|565733251|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
156722907|NCT01120184|565733249|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
156451743|NCT03150810|564746765|FG005|Overall Study|Hospice|1|||
156451744|NCT03150810|564746766|FG006|Overall Study|Hospice|0|||
156722908|NCT01120184|565733250|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
156722909|NCT01120184|565733251|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
156722910|NCT01120184|565733249|FG000|Overall Study|Death|170|||
156722911|NCT01120184|565733250|FG001|Overall Study|Death|176|||
156722912|NCT01120184|565733251|FG002|Overall Study|Death|169|||
156722913|NCT02525783|565733253|FG000|Overall Study|Lost to Follow-up|10|||
156722914|NCT00824772|565733254|FG000|Overall Study|Withdrawal by Subject|8|||
156722915|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
156722916|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
156722917|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
156722918|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
156722919|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
156722920|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
156722921|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
156722922|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
156722923|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
156722924|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
156722925|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
156722926|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
156722927|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
156722928|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
156722929|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
156722930|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
156722931|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
156722932|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
156722933|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
156722934|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
156722935|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
156722936|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
156722937|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
156722938|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
156722939|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
156722940|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
156722941|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
156722942|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
156722943|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
156722944|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
156722945|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
156722946|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
156722947|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
156533464|NCT00733304|565048801|FG000|Overall Study|Adverse Event|3|||
156722948|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
156722949|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
156722950|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
156722951|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
156722952|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
156722953|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
156722954|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
156722955|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
156722956|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
156722957|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
156722958|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
156722959|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
156722960|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
156722961|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
156722962|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
156722963|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
156722964|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
156722965|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
156722966|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
156722967|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Site closed|0|||
156722968|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Site closed|0|||
156722969|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Site closed|1|||
156722970|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Site closed|0|||
156722971|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
156722972|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
156722973|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
156722974|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
156722975|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
156722976|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
156722977|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
156722978|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
156722979|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
156722980|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
156533465|NCT00733304|565048802|FG001|Overall Study|Adverse Event|0|||
156722981|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
156722982|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
156722983|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
156722984|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
156722985|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
156722986|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
156722987|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
156722988|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
156722989|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
156722990|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
156722991|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
156722992|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
156722993|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
156722994|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
156722995|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
156722996|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
156722997|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
156722998|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
156722999|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
156723000|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
156723001|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
156723002|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
156723003|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
156723004|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
156723005|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
156875529|NCT01092117|566302099|FG000|Year 2|Death|5|||
156875530|NCT01092117|566302099|FG000|Year 2|Withdrawal by Subject|4|||
156875531|NCT01092117|566302099|FG000|Year 2|Lost to Follow-up|1|||
156875532|NCT01092117|566302099|FG000|Year 3|Death|7|||
156875533|NCT01092117|566302099|FG000|Year 3|Withdrawal by Subject|9|||
156875534|NCT01092117|566302099|FG000|Year 3|Lost to Follow-up|3|||
156875535|NCT01092117|566302099|FG000|Year 4|Death|8|||
156875536|NCT01092117|566302099|FG000|Year 4|Withdrawal by Subject|4|||
156875537|NCT01092117|566302099|FG000|Year 4|Lost to Follow-up|4|||
156875538|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
156875539|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
156875540|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
156875541|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
156875542|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
156875543|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
156875544|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
156875545|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
156875546|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
156875547|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
156875548|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
156875549|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
156875550|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
156875551|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
156875552|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
156875553|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
156875554|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
156875555|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
156875556|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
156875557|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
156875558|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
156335671|NCT04223973|564326166|FG000|Overall Study|Withdrawal by Subject|0|||
156723006|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
156723007|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
156723008|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
156723009|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
156723010|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
156723011|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
156723012|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
156723013|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
156875559|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
156875560|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
156875561|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
156875562|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
156875563|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
156335672|NCT04223973|564326167|FG001|Overall Study|Withdrawal by Subject|1|||
156335673|NCT00594659|564326170|FG000|Overall Study|Lost to Follow-up|13|||
156335674|NCT00594659|564326171|FG001|Overall Study|Lost to Follow-up|9|||
156335675|NCT00594659|564326172|FG002|Overall Study|Lost to Follow-up|7|||
156335676|NCT04439201|564326180|FG000|Overall Study|Ineligible|2|||
156451745|NCT03150810|564746767|FG007|Overall Study|Hospice|0|||
156451746|NCT03150810|564746768|FG008|Overall Study|Hospice|0|||
156451747|NCT03150810|564746769|FG009|Overall Study|Hospice|0|||
156451748|NCT03150810|564746770|FG010|Overall Study|Hospice|0|||
156451749|NCT03150810|564746771|FG011|Overall Study|Hospice|0|||
156451750|NCT03150810|564746772|FG012|Overall Study|Hospice|0|||
156451751|NCT03150810|564746760|FG000|Overall Study|Participant relocated abroad.|0|||
156723014|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
156723015|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
156723016|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
156723017|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
156723018|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
156723019|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
156723020|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
156723021|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
156723022|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
156723023|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Missing|1|||
156723024|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Missing|2|||
156723025|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Missing|1|||
156723026|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Missing|1|||
156723027|NCT01002989|565733264|FG000|Overall Study|exclusion criteria, no consent|5|||
156723028|NCT00318474|565733265|FG000|Overall Study|Adverse Event|1|||
156723029|NCT00318474|565733266|FG001|Overall Study|Adverse Event|1|||
156723030|NCT00318474|565733265|FG000|Overall Study|Lost to Follow-up|0|||
156723031|NCT00318474|565733266|FG001|Overall Study|Lost to Follow-up|1|||
156723032|NCT00318474|565733265|FG000|Overall Study|Pregnancy|0|||
156723033|NCT00318474|565733266|FG001|Overall Study|Pregnancy|2|||
156723034|NCT00318474|565733265|FG000|Overall Study|Protocol Violation|1|||
156723035|NCT00318474|565733266|FG001|Overall Study|Protocol Violation|0|||
156723036|NCT00318474|565733265|FG000|Overall Study|Withdrawal by Subject|3|||
156723037|NCT00318474|565733266|FG001|Overall Study|Withdrawal by Subject|2|||
156723038|NCT00318474|565733265|FG000|Overall Study|Fall in GFR|3|||
156723039|NCT00318474|565733266|FG001|Overall Study|Fall in GFR|3|||
156723040|NCT00318474|565733265|FG000|Overall Study|Post-therapy hyperflycemia|0|||
156723041|NCT00318474|565733266|FG001|Overall Study|Post-therapy hyperflycemia|1|||
156723042|NCT00318474|565733265|FG000|Overall Study|Trial terminated|10|||
156723043|NCT00318474|565733266|FG001|Overall Study|Trial terminated|7|||
156723044|NCT05177484|565733267|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
156723045|NCT05177484|565733268|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
156723046|NCT05177484|565733267|FG000|Overall Study|Inadvertently withdrawn|3|||
156723047|NCT05177484|565733268|FG001|Overall Study|Inadvertently withdrawn|1|||
156723048|NCT05177484|565733267|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
156723049|NCT05177484|565733268|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
156723050|NCT02075203|565733269|FG000|Overall Study|Withdrawal by Subject|1|||
156723051|NCT02075203|565733270|FG001|Overall Study|Withdrawal by Subject|0|||
156723052|NCT02075203|565733271|FG002|Overall Study|Withdrawal by Subject|1|||
156723053|NCT02075203|565733269|FG000|Overall Study|Adverse Event|1|||
156723054|NCT02075203|565733270|FG001|Overall Study|Adverse Event|0|||
156723055|NCT02075203|565733271|FG002|Overall Study|Adverse Event|0|||
156723056|NCT02075203|565733269|FG000|Overall Study|participant refused to use contraception|1|||
156723057|NCT02075203|565733270|FG001|Overall Study|participant refused to use contraception|0|||
156723058|NCT02075203|565733271|FG002|Overall Study|participant refused to use contraception|0|||
156723059|NCT00495391|565733272|FG000|Overall Study|Lack of Efficacy|34|||
156794349|NCT00773461|565999585|FG000|Overall Study|Adverse Event|1|||
156723060|NCT00495391|565733273|FG001|Overall Study|Lack of Efficacy|18|||
156723061|NCT00495391|565733272|FG000|Overall Study|Withdrawal by Subject|2|||
156723062|NCT00495391|565733273|FG001|Overall Study|Withdrawal by Subject|3|||
156794350|NCT00773461|565999586|FG001|Overall Study|Adverse Event|3|||
156723063|NCT02712320|565733274|FG000|Overall Study|Lost to Follow-up|1|||
156723064|NCT02712320|565733274|FG000|Overall Study|Withdrawal by Subject|1|||
156723065|NCT02712320|565733274|FG000|Overall Study|Transferred to another facility|1|||
156723066|NCT02712320|565733274|FG000|Overall Study|Treating with the prohibited medications|2|||
156794351|NCT00773461|565999585|FG000|Overall Study|Withdrawal by Subject|4|||
156723067|NCT00568451|565733275|FG000|Overall Study|Disease Progression|0|||
156335677|NCT04439201|564326180|FG000|Overall Study|Never start protocol therapy|1|||
156723068|NCT00568451|565733276|FG001|Overall Study|Disease Progression|0|||
156451752|NCT03150810|564746761|FG001|Overall Study|Participant relocated abroad.|0|||
156723069|NCT00568451|565733277|FG002|Overall Study|Disease Progression|2|||
156723070|NCT00568451|565733278|FG003|Overall Study|Disease Progression|7|||
156794352|NCT00773461|565999586|FG001|Overall Study|Withdrawal by Subject|1|||
156794353|NCT02657356|566001151|FG000|Overall Study|Death|1|||
156794354|NCT02657356|566001152|FG001|Overall Study|Death|0|||
156533466|NCT00733304|565048803|FG002|Overall Study|Adverse Event|0|||
156794355|NCT02657356|566001151|FG000|Overall Study|Withdrawal by Subject|5|||
156794356|NCT02657356|566001152|FG001|Overall Study|Withdrawal by Subject|6|||
156794357|NCT02657356|566001151|FG000|Overall Study|Terminated by Sponsor|8|||
156794358|NCT02657356|566001152|FG001|Overall Study|Terminated by Sponsor|5|||
156794359|NCT02657356|566001151|FG000|Overall Study|Rolled over to EAP study|6|||
156794360|NCT02657356|566001152|FG001|Overall Study|Rolled over to EAP study|4|||
156794361|NCT03379870|566001153|FG000|Overall Study|Lost to Follow-up|1|||
156794362|NCT03379870|566001154|FG001|Overall Study|Lost to Follow-up|0|||
156794363|NCT03379870|566001153|FG000|Overall Study|Protocol Violation|1|||
156794364|NCT03379870|566001154|FG001|Overall Study|Protocol Violation|1|||
156794365|NCT03058952|566001155|FG000|Overall Study|Adverse Event|1|||
156794366|NCT03058952|566001156|FG001|Overall Study|Adverse Event|0|||
156794367|NCT03058952|566001155|FG000|Overall Study|Lost to Follow-up|15|||
156794368|NCT03058952|566001156|FG001|Overall Study|Lost to Follow-up|15|||
156794369|NCT03058952|566001155|FG000|Overall Study|Withdrawal by Subject|7|||
156794370|NCT03058952|566001156|FG001|Overall Study|Withdrawal by Subject|11|||
156794371|NCT03768336|566001159|FG000|Overall Study|Lost to Follow-up|3|||
156794372|NCT03768336|566001160|FG001|Overall Study|Lost to Follow-up|2|||
156794373|NCT03768336|566001159|FG000|Overall Study|Became Ineligible|2|||
156794374|NCT03768336|566001160|FG001|Overall Study|Became Ineligible|0|||
156794375|NCT03768336|566001159|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
156794376|NCT03768336|566001160|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
156794377|NCT03768336|566001159|FG000|Overall Study|Missed final survey (post-treatment|0|||
156794378|NCT03768336|566001160|FG001|Overall Study|Missed final survey (post-treatment|1|||
156794379|NCT05654181|566001161|FG000|Overall Study|Adverse Event|1|||
156794380|NCT05654181|566001162|FG001|Overall Study|Adverse Event|0|||
156794381|NCT05654181|566001163|FG002|Overall Study|Adverse Event|0|||
156794382|NCT05654181|566001164|FG003|Overall Study|Adverse Event|0|||
156794383|NCT05654181|566001165|FG004|Overall Study|Adverse Event|0|||
156794384|NCT05654181|566001166|FG005|Overall Study|Adverse Event|0|||
156794385|NCT05654181|566001167|FG006|Overall Study|Adverse Event|0|||
156794386|NCT05654181|566001168|FG007|Overall Study|Adverse Event|1|||
156794387|NCT05654181|566001169|FG008|Overall Study|Adverse Event|0|||
156794388|NCT05654181|566001170|FG009|Overall Study|Adverse Event|0|||
156794389|NCT05654181|566001161|FG000|Overall Study|Withdrawal by Subject|0|||
156794390|NCT05654181|566001162|FG001|Overall Study|Withdrawal by Subject|0|||
156794391|NCT05654181|566001163|FG002|Overall Study|Withdrawal by Subject|0|||
156794392|NCT05654181|566001164|FG003|Overall Study|Withdrawal by Subject|0|||
156794393|NCT05654181|566001165|FG004|Overall Study|Withdrawal by Subject|0|||
156794394|NCT05654181|566001166|FG005|Overall Study|Withdrawal by Subject|0|||
156794395|NCT05654181|566001167|FG006|Overall Study|Withdrawal by Subject|0|||
156794396|NCT05654181|566001168|FG007|Overall Study|Withdrawal by Subject|1|||
156794397|NCT05654181|566001169|FG008|Overall Study|Withdrawal by Subject|0|||
156794398|NCT05654181|566001170|FG009|Overall Study|Withdrawal by Subject|0|||
156794399|NCT05654181|566001161|FG000|Overall Study|Other|0|||
156794400|NCT05654181|566001162|FG001|Overall Study|Other|0|||
156794401|NCT05654181|566001163|FG002|Overall Study|Other|0|||
156794402|NCT05654181|566001164|FG003|Overall Study|Other|0|||
156794403|NCT05654181|566001165|FG004|Overall Study|Other|1|||
156794404|NCT05654181|566001166|FG005|Overall Study|Other|1|||
156794405|NCT05654181|566001167|FG006|Overall Study|Other|0|||
156794406|NCT05654181|566001168|FG007|Overall Study|Other|0|||
156794407|NCT05654181|566001169|FG008|Overall Study|Other|0|||
156794408|NCT05654181|566001170|FG009|Overall Study|Other|0|||
156794409|NCT01444781|566001171|FG000|Overall Study|Lost to Follow-up|0|||
156875564|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
156875565|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
156875566|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
156335678|NCT04439201|564326180|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
156451753|NCT03150810|564746762|FG002|Overall Study|Participant relocated abroad.|0|||
156451754|NCT03150810|564746763|FG003|Overall Study|Participant relocated abroad.|0|||
156451755|NCT03150810|564746764|FG004|Overall Study|Participant relocated abroad.|0|||
156451756|NCT03150810|564746765|FG005|Overall Study|Participant relocated abroad.|1|||
156451757|NCT03150810|564746766|FG006|Overall Study|Participant relocated abroad.|0|||
156451758|NCT03150810|564746767|FG007|Overall Study|Participant relocated abroad.|0|||
156451759|NCT03150810|564746768|FG008|Overall Study|Participant relocated abroad.|0|||
156451760|NCT03150810|564746769|FG009|Overall Study|Participant relocated abroad.|0|||
156451761|NCT03150810|564746770|FG010|Overall Study|Participant relocated abroad.|0|||
156794410|NCT01444781|566001172|FG001|Overall Study|Lost to Follow-up|3|||
156794411|NCT01444781|566001173|FG002|Overall Study|Lost to Follow-up|1|||
156794412|NCT01444781|566001171|FG000|Overall Study|Withdrawal by Subject|3|||
156794413|NCT01444781|566001172|FG001|Overall Study|Withdrawal by Subject|1|||
156794414|NCT01444781|566001173|FG002|Overall Study|Withdrawal by Subject|2|||
156875567|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
156723071|NCT05344560|565733279|FG000|Period 1|Subject out of visit window|1|||
156723072|NCT05344560|565733280|FG001|Period 1|Subject out of visit window|1|||
156723073|NCT05344560|565733279|FG000|Period 2|Covid-19 Related|1|||
156723074|NCT05344560|565733280|FG001|Period 2|Covid-19 Related|0|||
156723075|NCT05344560|565733279|FG000|Period 2|Adverse Event|1|||
156723076|NCT05344560|565733280|FG001|Period 2|Adverse Event|0|||
156723077|NCT05344560|565733279|FG000|Period 2|Subject out of visit window|1|||
156723078|NCT05344560|565733280|FG001|Period 2|Subject out of visit window|1|||
156723079|NCT05344560|565733279|FG000|Period 3|Subject out of visit window|1|||
156723080|NCT05344560|565733280|FG001|Period 3|Subject out of visit window|0|||
156723081|NCT01620138|565733281|FG000|Overall Study|Withdrawal by Subject|3|||
156723082|NCT01620138|565733282|FG001|Overall Study|Withdrawal by Subject|0|||
156723083|NCT01620138|565733281|FG000|Overall Study|Lack of Efficacy|1|||
156723084|NCT01620138|565733282|FG001|Overall Study|Lack of Efficacy|0|||
156723085|NCT01620138|565733281|FG000|Overall Study|Adverse Event|2|||
156723086|NCT01620138|565733282|FG001|Overall Study|Adverse Event|0|||
156723087|NCT00444535|565733283|FG000|Overall Study|Withdrawal by Subject|5|||
156723088|NCT00444535|565733283|FG000|Overall Study|Physician Decision|5|||
156794415|NCT02254291|566001174|FG000|Overall Study|Withdrawal by Subject|0|||
156794416|NCT02254291|566001175|FG001|Overall Study|Withdrawal by Subject|3|||
156794417|NCT02254291|566001176|FG002|Overall Study|Withdrawal by Subject|1|||
156794418|NCT02254291|566001174|FG000|Overall Study|Missing follow-up information|0|||
156794419|NCT02254291|566001175|FG001|Overall Study|Missing follow-up information|0|||
156794420|NCT02254291|566001176|FG002|Overall Study|Missing follow-up information|1|||
156794421|NCT03033784|566001177|FG000|Overall Study|Anxiety related to MRI scanner|0|||
156794422|NCT03033784|566001178|FG001|Overall Study|Anxiety related to MRI scanner|1|||
156794423|NCT03033784|566001179|FG002|Overall Study|Anxiety related to MRI scanner|0|||
156794424|NCT03033784|566001180|FG003|Overall Study|Anxiety related to MRI scanner|0|||
156794425|NCT03033784|566001181|FG004|Overall Study|Anxiety related to MRI scanner|0|||
156794426|NCT03033784|566001182|FG005|Overall Study|Anxiety related to MRI scanner|0|||
156794427|NCT03033784|566001183|FG006|Overall Study|Anxiety related to MRI scanner|0|||
156794428|NCT03033784|566001184|FG007|Overall Study|Anxiety related to MRI scanner|0|||
156794429|NCT03033784|566001185|FG008|Overall Study|Anxiety related to MRI scanner|0|||
156794430|NCT03033784|566001186|FG009|Overall Study|Anxiety related to MRI scanner|0|||
156794431|NCT03033784|566001187|FG010|Overall Study|Anxiety related to MRI scanner|0|||
156794432|NCT03033784|566001188|FG011|Overall Study|Anxiety related to MRI scanner|0|||
156794433|NCT03033784|566001189|FG012|Overall Study|Anxiety related to MRI scanner|0|||
156794434|NCT03033784|566001177|FG000|Overall Study|Withdrawal by Subject|0|||
156794435|NCT03033784|566001178|FG001|Overall Study|Withdrawal by Subject|0|||
156794436|NCT03033784|566001179|FG002|Overall Study|Withdrawal by Subject|0|||
156794437|NCT03033784|566001180|FG003|Overall Study|Withdrawal by Subject|0|||
156794438|NCT03033784|566001181|FG004|Overall Study|Withdrawal by Subject|0|||
156794439|NCT03033784|566001182|FG005|Overall Study|Withdrawal by Subject|0|||
156794440|NCT03033784|566001183|FG006|Overall Study|Withdrawal by Subject|0|||
156794441|NCT03033784|566001184|FG007|Overall Study|Withdrawal by Subject|0|||
156794442|NCT03033784|566001185|FG008|Overall Study|Withdrawal by Subject|0|||
156794443|NCT03033784|566001186|FG009|Overall Study|Withdrawal by Subject|0|||
156794444|NCT03033784|566001187|FG010|Overall Study|Withdrawal by Subject|0|||
156794445|NCT03033784|566001188|FG011|Overall Study|Withdrawal by Subject|0|||
156794446|NCT03033784|566001189|FG012|Overall Study|Withdrawal by Subject|2|||
156794447|NCT03257657|566001192|FG000|Overall Study|Lost to Follow-up|0|||
156794448|NCT03257657|566001193|FG001|Overall Study|Lost to Follow-up|3|||
156794449|NCT03257657|566001192|FG000|Overall Study|Withdrawn|0|||
156794450|NCT03257657|566001193|FG001|Overall Study|Withdrawn|1|||
156794451|NCT03257657|566001192|FG000|Overall Study|Noted not eligible right after enrolled|0|||
156794452|NCT03257657|566001193|FG001|Overall Study|Noted not eligible right after enrolled|1|||
156794453|NCT02801578|566001194|FG000|Overall Study|Adverse Event|2|||
156794454|NCT00137449|566001195|FG000|Overall Study|Disease Progression|8|||
156794455|NCT00137449|566001196|FG001|Overall Study|Disease Progression|13|||
156794456|NCT00137449|566001195|FG000|Overall Study|Death|4|||
156723089|NCT00444535|565733283|FG000|Overall Study|progressive disease|1|||
156794457|NCT00137449|566001196|FG001|Overall Study|Death|3|||
156794458|NCT00137449|566001195|FG000|Overall Study|Adverse Event|3|||
156723090|NCT00444535|565733283|FG000|Overall Study|Adverse Event|2|||
156723091|NCT01568892|565733284|FG000|Open-label Phase|Adverse Event|2|||
156794459|NCT00137449|566001196|FG001|Overall Study|Adverse Event|1|||
156794460|NCT00137449|566001195|FG000|Overall Study|Withdrawal by Subject|1|||
156794461|NCT00137449|566001196|FG001|Overall Study|Withdrawal by Subject|1|||
156533467|NCT00733304|565048801|FG000|Overall Study|Lack of Efficacy|0|||
156723092|NCT01568892|565733285|FG001|Open-label Phase|Adverse Event|0|||
156723093|NCT01568892|565733284|FG000|Open-label Phase|Lack of Efficacy|4|||
156794462|NCT00668642|566001199|FG000|First Off-cycle|Cancer progression|1|||
156794463|NCT00668642|566001200|FG001|First Off-cycle|Cancer progression|0|||
156794464|NCT00668642|566001199|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
156794465|NCT00668642|566001200|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
156794466|NCT03707821|566001205|FG000|Overall Study|Protocol Violation|0|||
156723094|NCT01568892|565733285|FG001|Open-label Phase|Lack of Efficacy|2|||
156723095|NCT01568892|565733284|FG000|Open-label Phase|Lost to Follow-up|0|||
156723096|NCT01568892|565733285|FG001|Open-label Phase|Lost to Follow-up|1|||
156723097|NCT03922308|565733290|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
156723098|NCT03922308|565733291|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
156723099|NCT03922308|565733292|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
156723100|NCT03922308|565733290|FG000|Overall Study|Lost to Follow-up|1|||
156723101|NCT03922308|565733291|FG001|Overall Study|Lost to Follow-up|0|||
156723102|NCT03922308|565733292|FG002|Overall Study|Lost to Follow-up|0|||
156723103|NCT03922308|565733290|FG000|Overall Study|Reason not Specified|0|||
156723104|NCT03922308|565733291|FG001|Overall Study|Reason not Specified|2|||
156723105|NCT03922308|565733292|FG002|Overall Study|Reason not Specified|1|||
156723106|NCT05005507|565733293|FG000|Overall Study|Premature termination of study|1|||
156723107|NCT03313180|565733297|FG000|Overall Study|Adverse Event|120|||
156723108|NCT03313180|565733297|FG000|Overall Study|Lost to Follow-up|3|||
156723109|NCT03313180|565733297|FG000|Overall Study|Withdrawal by Subject|39|||
156723110|NCT03313180|565733297|FG000|Overall Study|Other than listed above|15|||
156723111|NCT03313180|565733297|FG000|Overall Study|Covid-19 related|2|||
156723112|NCT01697748|565733301|FG000|Overall Study|ineligible skin incision|1|||
156723113|NCT01697748|565733302|FG001|Overall Study|ineligible skin incision|2|||
156723114|NCT01697748|565733301|FG000|Overall Study|ineligible uterine incision|4|||
156723115|NCT01697748|565733302|FG001|Overall Study|ineligible uterine incision|1|||
156723116|NCT01697748|565733301|FG000|Overall Study|Lost to Follow-up|53|||
156723117|NCT01697748|565733302|FG001|Overall Study|Lost to Follow-up|65|||
156723118|NCT01058642|565733304|FG000|Treatment Period 1|Adverse Event|0|||
156723119|NCT01058642|565733305|FG001|Treatment Period 1|Adverse Event|1|||
156723120|NCT01058642|565733306|FG002|Treatment Period 1|Adverse Event|1|||
156723121|NCT01058642|565733307|FG003|Treatment Period 1|Adverse Event|0|||
156723122|NCT01058642|565733304|FG000|Treatment Period 1|Physician Decision|0|||
156723123|NCT01058642|565733305|FG001|Treatment Period 1|Physician Decision|0|||
156723124|NCT01058642|565733306|FG002|Treatment Period 1|Physician Decision|1|||
156723125|NCT01058642|565733307|FG003|Treatment Period 1|Physician Decision|0|||
156723126|NCT01058642|565733304|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156723127|NCT01058642|565733305|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156723128|NCT01058642|565733306|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156723129|NCT01058642|565733307|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156723130|NCT01058642|565733304|FG000|Treatment Period 1|Lack of Efficacy|0|||
156723131|NCT01058642|565733305|FG001|Treatment Period 1|Lack of Efficacy|0|||
156723132|NCT01058642|565733306|FG002|Treatment Period 1|Lack of Efficacy|0|||
156723133|NCT01058642|565733307|FG003|Treatment Period 1|Lack of Efficacy|1|||
156723134|NCT01058642|565733304|FG000|Treatment Period 1|Protocol Violation|0|||
156723135|NCT01058642|565733305|FG001|Treatment Period 1|Protocol Violation|0|||
156723136|NCT01058642|565733306|FG002|Treatment Period 1|Protocol Violation|0|||
156335679|NCT04439201|564326180|FG000|Overall Study|Mutation status not confirmed|4|||
156451762|NCT03150810|564746771|FG011|Overall Study|Participant relocated abroad.|0|||
156451763|NCT03150810|564746772|FG012|Overall Study|Participant relocated abroad.|0|||
156451764|NCT03150810|564746760|FG000|Overall Study|Transferred care to oncologist|0|||
156723137|NCT01058642|565733307|FG003|Treatment Period 1|Protocol Violation|1|||
156723138|NCT01058642|565733304|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
156723139|NCT01058642|565733305|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
156723140|NCT01058642|565733306|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
156723141|NCT01058642|565733307|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
156723142|NCT01704495|565733308|FG000|Subjects Randomized|Other Reason|3|||
156723143|NCT01704495|565733309|FG001|Subjects Randomized|Other Reason|2|||
156723144|NCT01704495|565733310|FG002|Subjects Randomized|Other Reason|3|||
156723145|NCT01704495|565733311|FG003|Subjects Randomized|Other Reason|2|||
156723146|NCT01704495|565733308|FG000|Subjects Randomized|Discontinuation criteria met|4|||
156723147|NCT01704495|565733309|FG001|Subjects Randomized|Discontinuation criteria met|2|||
156723148|NCT01704495|565733310|FG002|Subjects Randomized|Discontinuation criteria met|2|||
156723149|NCT01704495|565733311|FG003|Subjects Randomized|Discontinuation criteria met|0|||
156451765|NCT03150810|564746761|FG001|Overall Study|Transferred care to oncologist|0|||
156451766|NCT03150810|564746762|FG002|Overall Study|Transferred care to oncologist|0|||
156723150|NCT01704495|565733308|FG000|Subjects Randomized|Adverse Event|8|||
156723151|NCT01704495|565733309|FG001|Subjects Randomized|Adverse Event|2|||
156723152|NCT01704495|565733310|FG002|Subjects Randomized|Adverse Event|0|||
156723153|NCT01704495|565733311|FG003|Subjects Randomized|Adverse Event|7|||
156723154|NCT01704495|565733308|FG000|Subjects Randomized|Withdrawal by Subject|5|||
156723155|NCT01704495|565733309|FG001|Subjects Randomized|Withdrawal by Subject|5|||
156723156|NCT01704495|565733310|FG002|Subjects Randomized|Withdrawal by Subject|5|||
156723157|NCT01704495|565733311|FG003|Subjects Randomized|Withdrawal by Subject|5|||
156723158|NCT01704495|565733308|FG000|Subjects Randomized|Protocol Violation|1|||
156723159|NCT01704495|565733309|FG001|Subjects Randomized|Protocol Violation|1|||
156335680|NCT04439201|564326180|FG000|Overall Study|Adverse Event|1|||
156723160|NCT01704495|565733310|FG002|Subjects Randomized|Protocol Violation|2|||
156335681|NCT04439201|564326180|FG000|Overall Study|Death|7|||
156794467|NCT03707821|566001206|FG001|Overall Study|Protocol Violation|1|||
156794468|NCT03707821|566001205|FG000|Overall Study|Unsatisfactory Visual Response|1|||
156794469|NCT03707821|566001206|FG001|Overall Study|Unsatisfactory Visual Response|0|||
156794470|NCT03707821|566001205|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
156794471|NCT03707821|566001206|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
156794472|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
156451767|NCT03150810|564746763|FG003|Overall Study|Transferred care to oncologist|0|||
156451768|NCT03150810|564746764|FG004|Overall Study|Transferred care to oncologist|0|||
156451769|NCT03150810|564746765|FG005|Overall Study|Transferred care to oncologist|0|||
156451770|NCT03150810|564746766|FG006|Overall Study|Transferred care to oncologist|2|||
156451771|NCT03150810|564746767|FG007|Overall Study|Transferred care to oncologist|0|||
156451772|NCT03150810|564746768|FG008|Overall Study|Transferred care to oncologist|0|||
156451773|NCT03150810|564746769|FG009|Overall Study|Transferred care to oncologist|0|||
156451774|NCT03150810|564746770|FG010|Overall Study|Transferred care to oncologist|0|||
156451775|NCT03150810|564746771|FG011|Overall Study|Transferred care to oncologist|0|||
156451776|NCT03150810|564746772|FG012|Overall Study|Transferred care to oncologist|0|||
156451777|NCT04526704|564746773|FG000|Overall Study|Adverse Event|1|||
156451778|NCT04526704|564746774|FG001|Overall Study|Adverse Event|0|||
156794473|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
156794474|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
156794475|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
156794476|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
156794477|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
156794478|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
156794479|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
156794480|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
156794481|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
156794482|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
156451779|NCT04526704|564746773|FG000|Overall Study|Physician Decision|1|||
156723161|NCT01704495|565733311|FG003|Subjects Randomized|Protocol Violation|0|||
156794483|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
156794484|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
156794485|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
156794486|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
156794487|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
156794488|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
156794489|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
156794490|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
156794491|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
156794492|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
156794493|NCT01432444|566001207|FG000|Treatment Phase|Lost to Follow-up|0|||
156794494|NCT01432444|566001208|FG001|Treatment Phase|Lost to Follow-up|33|||
156794495|NCT01432444|566001209|FG002|Treatment Phase|Lost to Follow-up|0|||
156794496|NCT01432444|566001207|FG000|Treatment Phase|Adverse Event|0|||
156794497|NCT01432444|566001208|FG001|Treatment Phase|Adverse Event|37|||
156794498|NCT01432444|566001209|FG002|Treatment Phase|Adverse Event|0|||
156794499|NCT01432444|566001207|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
156794500|NCT01432444|566001208|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
156794501|NCT01432444|566001209|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
156451780|NCT04526704|564746774|FG001|Overall Study|Physician Decision|0|||
156451781|NCT04526704|564746773|FG000|Overall Study|Withdrawal by Subject|2|||
156451782|NCT04526704|564746774|FG001|Overall Study|Withdrawal by Subject|0|||
156451783|NCT06393088|564746775|FG000|Overall Study|Withdrawal by Subject|0|||
156451784|NCT06393088|564746776|FG001|Overall Study|Withdrawal by Subject|2|||
156723162|NCT01704495|565733308|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
156451785|NCT03903146|564746777|FG000|Overall Study|Lost to Follow-up|6|||
156723163|NCT01704495|565733309|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
156723164|NCT01704495|565733310|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
156723165|NCT01704495|565733311|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
156723166|NCT01704495|565733308|FG000|Optional Safety Extension|Adverse Event|0|||
156723167|NCT01704495|565733309|FG001|Optional Safety Extension|Adverse Event|4|||
156723168|NCT01704495|565733310|FG002|Optional Safety Extension|Adverse Event|0|||
156723169|NCT01704495|565733311|FG003|Optional Safety Extension|Adverse Event|1|||
156723170|NCT01704495|565733308|FG000|Optional Safety Extension|Other reason|27|||
156451786|NCT03903146|564746778|FG001|Overall Study|Lost to Follow-up|4|||
156723171|NCT01704495|565733309|FG001|Optional Safety Extension|Other reason|29|||
156794502|NCT01432444|566001207|FG000|Treatment Phase|Physician Decision|0|||
156794503|NCT01432444|566001208|FG001|Treatment Phase|Physician Decision|5|||
156794504|NCT01432444|566001209|FG002|Treatment Phase|Physician Decision|0|||
156451787|NCT03903146|564746777|FG000|Overall Study|Withdrawal by Subject|0|||
156723172|NCT01704495|565733310|FG002|Optional Safety Extension|Other reason|30|||
156451788|NCT03903146|564746778|FG001|Overall Study|Withdrawal by Subject|1|||
156451789|NCT05434078|564746780|FG000|Overall Study|Lost to Follow-up|2|||
156451790|NCT05434078|564746781|FG001|Overall Study|Lost to Follow-up|1|||
156451791|NCT05434078|564746780|FG000|Overall Study|Withdrawal by Subject|1|||
156451792|NCT05434078|564746781|FG001|Overall Study|Withdrawal by Subject|0|||
156451793|NCT03652688|564746782|FG000|Baseline|Withdrawal by Subject|0|||
156451794|NCT03652688|564746783|FG001|Baseline|Withdrawal by Subject|3|||
156451795|NCT03652688|564746782|FG000|Follow-up|Lost to Follow-up|56|||
156451796|NCT03652688|564746783|FG001|Follow-up|Lost to Follow-up|54|||
156451797|NCT03719443|564746787|FG000|Overall Study|Lost to Follow-up|0|||
156451798|NCT03719443|564746788|FG001|Overall Study|Lost to Follow-up|0|||
156451799|NCT03719443|564746789|FG002|Overall Study|Lost to Follow-up|1|||
156451800|NCT03719443|564746790|FG003|Overall Study|Lost to Follow-up|0|||
156451801|NCT03719443|564746791|FG004|Overall Study|Lost to Follow-up|1|||
156451802|NCT03719443|564746792|FG005|Overall Study|Lost to Follow-up|0|||
156451803|NCT03719443|564746793|FG006|Overall Study|Lost to Follow-up|1|||
156451804|NCT03719443|564746787|FG000|Overall Study|Withdrawal by Subject|0|||
156451805|NCT03719443|564746788|FG001|Overall Study|Withdrawal by Subject|0|||
156451806|NCT03719443|564746789|FG002|Overall Study|Withdrawal by Subject|1|||
156451807|NCT03719443|564746790|FG003|Overall Study|Withdrawal by Subject|0|||
156451808|NCT03719443|564746791|FG004|Overall Study|Withdrawal by Subject|0|||
156451809|NCT03719443|564746792|FG005|Overall Study|Withdrawal by Subject|0|||
156451810|NCT03719443|564746793|FG006|Overall Study|Withdrawal by Subject|0|||
156451811|NCT04924660|564746794|FG000|United States|Death|29|||
156451812|NCT04924660|564746795|FG001|United States|Death|32|||
156451813|NCT04924660|564746796|FG002|United States|Death|34|||
156451814|NCT04924660|564746797|FG003|United States|Death|25|||
156451815|NCT04924660|564746798|FG004|United States|Death|26|||
156451816|NCT04924660|564746799|FG005|United States|Death|23|||
156451817|NCT04924660|564746794|FG000|United States|Lost to Follow-up|15|||
156451818|NCT04924660|564746795|FG001|United States|Lost to Follow-up|10|||
156451819|NCT04924660|564746796|FG002|United States|Lost to Follow-up|13|||
156451820|NCT04924660|564746797|FG003|United States|Lost to Follow-up|5|||
156451821|NCT04924660|564746798|FG004|United States|Lost to Follow-up|19|||
156451822|NCT04924660|564746799|FG005|United States|Lost to Follow-up|20|||
156451823|NCT04924660|564746794|FG000|United States|Withdrawal by Subject|8|||
156451824|NCT04924660|564746795|FG001|United States|Withdrawal by Subject|3|||
156451825|NCT04924660|564746796|FG002|United States|Withdrawal by Subject|3|||
156451826|NCT04924660|564746797|FG003|United States|Withdrawal by Subject|3|||
156451827|NCT04924660|564746798|FG004|United States|Withdrawal by Subject|8|||
156451828|NCT04924660|564746799|FG005|United States|Withdrawal by Subject|4|||
156451829|NCT04924660|564746794|FG000|Spain|Death|0|||
156451830|NCT04924660|564746795|FG001|Spain|Death|0|||
156451831|NCT04924660|564746796|FG002|Spain|Death|0|||
156451832|NCT04924660|564746797|FG003|Spain|Death|0|||
156451833|NCT04924660|564746798|FG004|Spain|Death|0|||
156451834|NCT04924660|564746799|FG005|Spain|Death|2|||
156451835|NCT04924660|564746794|FG000|Spain|Lost to Follow-up|0|||
156451836|NCT04924660|564746795|FG001|Spain|Lost to Follow-up|0|||
156451837|NCT04924660|564746796|FG002|Spain|Lost to Follow-up|0|||
156451838|NCT04924660|564746797|FG003|Spain|Lost to Follow-up|0|||
156451839|NCT04924660|564746798|FG004|Spain|Lost to Follow-up|1|||
156451840|NCT04924660|564746799|FG005|Spain|Lost to Follow-up|0|||
156451841|NCT04924660|564746794|FG000|Brazil|Death|0|||
156451842|NCT04924660|564746795|FG001|Brazil|Death|0|||
156451843|NCT04924660|564746796|FG002|Brazil|Death|0|||
156451844|NCT04924660|564746797|FG003|Brazil|Death|0|||
156451845|NCT04924660|564746798|FG004|Brazil|Death|1|||
156451846|NCT04924660|564746799|FG005|Brazil|Death|0|||
156451847|NCT04924660|564746794|FG000|Italy|Lost to Follow-up|0|||
156533468|NCT00733304|565048802|FG001|Overall Study|Lack of Efficacy|0|||
156794505|NCT01432444|566001207|FG000|Treatment Phase|Withdrawal by Subject|0|||
156794506|NCT01432444|566001208|FG001|Treatment Phase|Withdrawal by Subject|41|||
156794507|NCT01432444|566001209|FG002|Treatment Phase|Withdrawal by Subject|0|||
156451848|NCT04924660|564746795|FG001|Italy|Lost to Follow-up|0|||
156451849|NCT04924660|564746796|FG002|Italy|Lost to Follow-up|0|||
156451850|NCT04924660|564746797|FG003|Italy|Lost to Follow-up|0|||
156451851|NCT04924660|564746798|FG004|Italy|Lost to Follow-up|0|||
156451852|NCT04924660|564746799|FG005|Italy|Lost to Follow-up|1|||
156451853|NCT04924660|564746794|FG000|South Africa|Death|0|||
156451854|NCT04924660|564746795|FG001|South Africa|Death|0|||
156794508|NCT01432444|566001207|FG000|Treatment Phase|Protocol Deviation|0|||
156451855|NCT04924660|564746796|FG002|South Africa|Death|0|||
156451856|NCT04924660|564746797|FG003|South Africa|Death|0|||
156451857|NCT04924660|564746798|FG004|South Africa|Death|0|||
156451858|NCT04924660|564746799|FG005|South Africa|Death|1|||
156451859|NCT04924660|564746794|FG000|South Africa|Lost to Follow-up|0|||
156451860|NCT04924660|564746795|FG001|South Africa|Lost to Follow-up|0|||
156451861|NCT04924660|564746796|FG002|South Africa|Lost to Follow-up|0|||
156451862|NCT04924660|564746797|FG003|South Africa|Lost to Follow-up|0|||
156451863|NCT04924660|564746798|FG004|South Africa|Lost to Follow-up|0|||
156451864|NCT04924660|564746799|FG005|South Africa|Lost to Follow-up|1|||
156451865|NCT00554788|564746800|FG000|Overall Study|Adverse Event|0|||
156451866|NCT00554788|564746801|FG001|Overall Study|Adverse Event|1|||
156451867|NCT00554788|564746802|FG002|Overall Study|Adverse Event|2|||
156451868|NCT00554788|564746800|FG000|Overall Study|Lost to Follow-up|4|||
156451869|NCT00554788|564746801|FG001|Overall Study|Lost to Follow-up|3|||
156451870|NCT00554788|564746802|FG002|Overall Study|Lost to Follow-up|3|||
156451871|NCT00554788|564746800|FG000|Overall Study|Physician Decision|1|||
156451872|NCT00554788|564746801|FG001|Overall Study|Physician Decision|1|||
156451873|NCT00554788|564746802|FG002|Overall Study|Physician Decision|3|||
156451874|NCT00554788|564746800|FG000|Overall Study|Withdrawal by Subject|0|||
156451875|NCT00554788|564746801|FG001|Overall Study|Withdrawal by Subject|0|||
156451876|NCT00554788|564746802|FG002|Overall Study|Withdrawal by Subject|1|||
156451877|NCT00554788|564746800|FG000|Overall Study|Refusal of further protocol therapy|0|||
156451878|NCT00554788|564746801|FG001|Overall Study|Refusal of further protocol therapy|1|||
156451879|NCT00554788|564746802|FG002|Overall Study|Refusal of further protocol therapy|1|||
156451880|NCT00554788|564746800|FG000|Overall Study|Progressive disease|0|||
156451881|NCT00554788|564746801|FG001|Overall Study|Progressive disease|0|||
156451882|NCT00554788|564746802|FG002|Overall Study|Progressive disease|3|||
156451883|NCT00554788|564746800|FG000|Overall Study|Ineligible|2|||
156451884|NCT00554788|564746801|FG001|Overall Study|Ineligible|0|||
156451885|NCT00554788|564746802|FG002|Overall Study|Ineligible|1|||
156451886|NCT03557697|564746803|FG000|Overall Study|Withdrawal by Subject|2|||
156451887|NCT03557697|564746804|FG001|Overall Study|Withdrawal by Subject|4|||
156451888|NCT03197662|564746815|FG000|Overall Study|Withdrawn by family|0|||
156451889|NCT03197662|564746816|FG001|Overall Study|Withdrawn by family|2|||
156451890|NCT03721952|564746817|FG000|Overall Study|Lost to Follow-up|0|||
156451891|NCT03721952|564746818|FG001|Overall Study|Lost to Follow-up|0|||
156451892|NCT03721952|564746819|FG002|Overall Study|Lost to Follow-up|2|||
156451893|NCT03721952|564746820|FG003|Overall Study|Lost to Follow-up|0|||
156451894|NCT03721952|564746821|FG004|Overall Study|Lost to Follow-up|0|||
156451895|NCT03721952|564746817|FG000|Overall Study|Protocol Violation|0|||
156451896|NCT03721952|564746818|FG001|Overall Study|Protocol Violation|1|||
156451897|NCT03721952|564746819|FG002|Overall Study|Protocol Violation|0|||
156451898|NCT03721952|564746820|FG003|Overall Study|Protocol Violation|0|||
156451899|NCT03721952|564746821|FG004|Overall Study|Protocol Violation|0|||
156451900|NCT03721952|564746817|FG000|Overall Study|Withdrawal by Subject|1|||
156451901|NCT03721952|564746818|FG001|Overall Study|Withdrawal by Subject|0|||
156451902|NCT03721952|564746819|FG002|Overall Study|Withdrawal by Subject|40|||
156451903|NCT03721952|564746820|FG003|Overall Study|Withdrawal by Subject|28|||
156451904|NCT03721952|564746821|FG004|Overall Study|Withdrawal by Subject|0|||
156723173|NCT01704495|565733311|FG003|Optional Safety Extension|Other reason|28|||
156723174|NCT01704495|565733308|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
156723175|NCT01704495|565733309|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
156723176|NCT01704495|565733310|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
156723177|NCT01704495|565733311|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
156723178|NCT02375971|565733312|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
156723179|NCT02375971|565733313|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
156723180|NCT02375971|565733314|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
156723181|NCT02375971|565733312|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
156723182|NCT02375971|565733313|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
156723183|NCT02375971|565733314|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
156723184|NCT02375971|565733312|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
156723185|NCT02375971|565733313|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
156723186|NCT02375971|565733314|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
156723187|NCT02375971|565733312|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
156723188|NCT02375971|565733313|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
156723189|NCT02375971|565733314|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
156723190|NCT02375971|565733312|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
156723191|NCT02375971|565733313|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
156723192|NCT02375971|565733314|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
156723193|NCT02375971|565733312|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
156723194|NCT02375971|565733313|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
156723195|NCT02375971|565733314|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
156723196|NCT02375971|565733312|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
156723197|NCT02375971|565733313|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
156723198|NCT02375971|565733314|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
156723199|NCT02375971|565733312|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
156723200|NCT02375971|565733313|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
156723201|NCT02375971|565733314|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
156723202|NCT00832455|565733319|FG000|Overall Study|Adverse Event|13|||
156723203|NCT00832455|565733319|FG000|Overall Study|Lost to Follow-up|26|||
156451905|NCT04495894|564746822|FG000|Overall Study|Withdrawal by Subject|2|||
156451906|NCT04495894|564746823|FG001|Overall Study|Withdrawal by Subject|0|||
156451907|NCT04495894|564746824|FG002|Overall Study|Withdrawal by Subject|2|||
156451908|NCT04495894|564746825|FG003|Overall Study|Withdrawal by Subject|3|||
156451909|NCT04495894|564746822|FG000|Overall Study|Early termination|0|||
156451910|NCT04495894|564746823|FG001|Overall Study|Early termination|0|||
156451911|NCT04495894|564746824|FG002|Overall Study|Early termination|3|||
156451912|NCT04495894|564746825|FG003|Overall Study|Early termination|0|||
156451913|NCT03364647|564746826|FG000|Overall Study|Withdrawal by Subject|3|||
156451914|NCT03364647|564746827|FG001|Overall Study|Withdrawal by Subject|1|||
156451915|NCT05746455|564746831|FG000|Overall Study|Discharged from Clinical Service|1|||
156451916|NCT05746455|564746831|FG000|Overall Study|Lost to Follow-up|1|||
156451917|NCT03447470|564746832|FG000|Overall Study|Death|0|||
156451918|NCT03447470|564746833|FG001|Overall Study|Death|1|||
156451919|NCT03447470|564746834|FG002|Overall Study|Death|3|||
156451920|NCT03447470|564746835|FG003|Overall Study|Death|0|||
156451921|NCT03447470|564746836|FG004|Overall Study|Death|1|||
156451922|NCT03447470|564746837|FG005|Overall Study|Death|0|||
156451923|NCT03447470|564746838|FG006|Overall Study|Death|3|||
156451924|NCT03447470|564746839|FG007|Overall Study|Death|3|||
156451925|NCT03447470|564746840|FG008|Overall Study|Death|1|||
156451926|NCT03447470|564746832|FG000|Overall Study|Withdrawal by Subject|1|||
156451927|NCT03447470|564746833|FG001|Overall Study|Withdrawal by Subject|0|||
156451928|NCT03447470|564746834|FG002|Overall Study|Withdrawal by Subject|0|||
156451929|NCT03447470|564746835|FG003|Overall Study|Withdrawal by Subject|0|||
156451930|NCT03447470|564746836|FG004|Overall Study|Withdrawal by Subject|1|||
156451931|NCT03447470|564746837|FG005|Overall Study|Withdrawal by Subject|0|||
156451932|NCT03447470|564746838|FG006|Overall Study|Withdrawal by Subject|1|||
156451933|NCT03447470|564746839|FG007|Overall Study|Withdrawal by Subject|1|||
156451934|NCT03447470|564746840|FG008|Overall Study|Withdrawal by Subject|3|||
156723204|NCT00832455|565733319|FG000|Overall Study|Protocol Violation|4|||
156723205|NCT00832455|565733319|FG000|Overall Study|Withdrawal by Subject|17|||
156723206|NCT00832455|565733319|FG000|Overall Study|Screening Failure|2|||
156723207|NCT00832455|565733319|FG000|Overall Study|Stopped Medication|4|||
156723208|NCT00832455|565733319|FG000|Overall Study|Parent misunderstood study|1|||
156723209|NCT00832455|565733319|FG000|Overall Study|Parent dissatisfied|1|||
156723210|NCT00832455|565733319|FG000|Overall Study|No improvement|3|||
156723211|NCT00832455|565733319|FG000|Overall Study|Patient moved|1|||
156723212|NCT02755103|565733321|FG000|Overall Study|Lost to Follow-up|17|||
156723213|NCT02755103|565733322|FG001|Overall Study|Lost to Follow-up|15|||
156723214|NCT02755103|565733321|FG000|Overall Study|Death|0|||
156723215|NCT02755103|565733322|FG001|Overall Study|Death|1|||
156723216|NCT02755103|565733321|FG000|Overall Study|Physician Decision|0|||
156875568|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
156875569|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
156875570|NCT01623050|566302102|FG000|Overall Study|Lost to Follow-up|9|||
156875571|NCT02147561|566302105|FG000|Overall Study|Lost to Follow-up|3|||
156875572|NCT02147561|566302105|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
156875573|NCT01191762|566302106|FG000|Overall Study|Adverse Event|1|||
156875574|NCT01191762|566302107|FG001|Overall Study|Adverse Event|0|||
156875575|NCT03023813|566302110|FG000|Overall Study|Lost to Follow-up|1|||
156875576|NCT03023813|566302111|FG001|Overall Study|Lost to Follow-up|2|||
156875577|NCT03023813|566302112|FG002|Overall Study|Lost to Follow-up|0|||
156875578|NCT00393861|566302113|FG000|Overall Study|Adverse Event|2|||
156875579|NCT00393861|566302113|FG000|Overall Study|Disease Progression|24|||
156875580|NCT03710083|566302114|FG000|Overall Study|Withdrawal by Subject|2|||
156875581|NCT03710083|566302114|FG000|Overall Study|Unsuccessful Procedure|1|||
156875582|NCT01727024|566302115|FG000|Period 1|Lost to Follow-up|1|||
156875583|NCT01727024|566302116|FG001|Period 1|Lost to Follow-up|1|||
156875584|NCT01727024|566302115|FG000|Period 1|Withdrawal by Subject|2|||
156875585|NCT01727024|566302116|FG001|Period 1|Withdrawal by Subject|3|||
156875586|NCT01587014|566302117|FG000|Overall Study|Death|2|||
156875587|NCT03962504|566302120|FG000|Overall Study|Other|11|||
156875588|NCT03962504|566302121|FG001|Overall Study|Other|32|||
156875589|NCT04695977|566302122|FG000|Overall Study|Sponsor Decision|9|||
156533469|NCT00733304|565048803|FG002|Overall Study|Lack of Efficacy|2|||
156723217|NCT02755103|565733322|FG001|Overall Study|Physician Decision|1|||
156723218|NCT02755103|565733321|FG000|Overall Study|Pregnancy|0|||
156451935|NCT03447470|564746832|FG000|Overall Study|Treatment discontinued|3|||
156451936|NCT03447470|564746833|FG001|Overall Study|Treatment discontinued|2|||
156451937|NCT03447470|564746834|FG002|Overall Study|Treatment discontinued|4|||
156451938|NCT03447470|564746835|FG003|Overall Study|Treatment discontinued|6|||
156451939|NCT03447470|564746836|FG004|Overall Study|Treatment discontinued|2|||
156451940|NCT03447470|564746837|FG005|Overall Study|Treatment discontinued|1|||
156723219|NCT02755103|565733322|FG001|Overall Study|Pregnancy|1|||
156723220|NCT02755103|565733321|FG000|Overall Study|Withdrawal by Subject|3|||
156723221|NCT02755103|565733322|FG001|Overall Study|Withdrawal by Subject|0|||
156723222|NCT04177095|565733331|FG000|Overall Study|Withdrawal by Subject|3|||
156875590|NCT04695977|566302123|FG001|Overall Study|Sponsor Decision|4|||
156875591|NCT04695977|566302122|FG000|Overall Study|Death|2|||
156875592|NCT04695977|566302123|FG001|Overall Study|Death|5|||
156875593|NCT01395524|566303595|FG000|Overall Study|Non-compliance with study schedule|1|||
156875594|NCT01395524|566303596|FG001|Overall Study|Non-compliance with study schedule|0|||
156875595|NCT01395524|566303597|FG002|Overall Study|Non-compliance with study schedule|1|||
156451941|NCT03447470|564746838|FG006|Overall Study|Treatment discontinued|2|||
156451942|NCT03447470|564746839|FG007|Overall Study|Treatment discontinued|4|||
156451943|NCT03447470|564746840|FG008|Overall Study|Treatment discontinued|3|||
156451944|NCT05184192|564746841|FG000|Overall Study|Lost to Follow-up|4|||
156451945|NCT05184192|564746842|FG001|Overall Study|Lost to Follow-up|7|||
156451946|NCT05184192|564746841|FG000|Overall Study|Adverse Event|1|||
156451947|NCT05184192|564746842|FG001|Overall Study|Adverse Event|4|||
156451948|NCT05184192|564746841|FG000|Overall Study|PI withdrawal|1|||
156451949|NCT05184192|564746842|FG001|Overall Study|PI withdrawal|2|||
156451950|NCT05184192|564746841|FG000|Overall Study|Withdrew due to adverse effect|1|||
156451951|NCT05184192|564746842|FG001|Overall Study|Withdrew due to adverse effect|0|||
156451952|NCT05184192|564746841|FG000|Overall Study|Medication schedule|1|||
156451953|NCT05184192|564746842|FG001|Overall Study|Medication schedule|0|||
156451954|NCT05184192|564746841|FG000|Overall Study|Concern for adverse effects|0|||
156451955|NCT05184192|564746842|FG001|Overall Study|Concern for adverse effects|4|||
156451956|NCT04624633|564746843|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
156451957|NCT04624633|564746844|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
156451958|NCT04624633|564746843|FG000|Overall Study|Death|1|||
156451959|NCT04624633|564746844|FG001|Overall Study|Death|0|||
156451960|NCT01902173|564746845|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
156451961|NCT01902173|564746846|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
156451962|NCT01902173|564746847|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
156451963|NCT01902173|564746848|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
156451964|NCT01902173|564746849|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
156451965|NCT01902173|564746850|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
156451966|NCT01902173|564746845|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
156451967|NCT01902173|564746846|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
156451968|NCT01902173|564746847|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
156451969|NCT01902173|564746848|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
156451970|NCT01902173|564746849|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
156723223|NCT04177095|565733331|FG000|Overall Study|Screen Failure|3|||
156723224|NCT04177095|565733331|FG000|Overall Study|Problems with the Trugraf assay|1|||
156723225|NCT02275819|565733332|FG000|Overall Study|Adverse Event|0|||
156723226|NCT02275819|565733333|FG001|Overall Study|Adverse Event|1|||
156723227|NCT01346059|565733334|FG000|Overall Study|Withdrawal by Subject|1|||
156723228|NCT01346059|565733335|FG001|Overall Study|Withdrawal by Subject|0|||
156723229|NCT02556775|565733336|FG000|Overall Study|Withdrawal by Subject|1|||
156723230|NCT02556775|565733337|FG001|Overall Study|Withdrawal by Subject|0|||
156723231|NCT02556775|565733338|FG002|Overall Study|Withdrawal by Subject|1|||
156723232|NCT02556775|565733339|FG003|Overall Study|Withdrawal by Subject|0|||
156723233|NCT02556775|565733336|FG000|Overall Study|Lost to Follow-up|1|||
156723234|NCT02556775|565733337|FG001|Overall Study|Lost to Follow-up|0|||
156723235|NCT02556775|565733338|FG002|Overall Study|Lost to Follow-up|0|||
156723236|NCT02556775|565733339|FG003|Overall Study|Lost to Follow-up|0|||
156723237|NCT00777296|565733340|FG000|Overall Study|Adverse Event|0|||
156723238|NCT00777296|565733341|FG001|Overall Study|Adverse Event|1|||
156723239|NCT00777296|565733342|FG002|Overall Study|Adverse Event|0|||
156723240|NCT00777296|565733343|FG003|Overall Study|Adverse Event|1|||
156723241|NCT00777296|565733340|FG000|Overall Study|Withdrawal by Subject|1|||
156723242|NCT00777296|565733341|FG001|Overall Study|Withdrawal by Subject|0|||
156723243|NCT00777296|565733342|FG002|Overall Study|Withdrawal by Subject|0|||
156723244|NCT00777296|565733343|FG003|Overall Study|Withdrawal by Subject|0|||
156723245|NCT00777296|565733340|FG000|Overall Study|CRF form not completed|0|||
156723246|NCT00777296|565733341|FG001|Overall Study|CRF form not completed|0|||
156723247|NCT00777296|565733342|FG002|Overall Study|CRF form not completed|2|||
156723248|NCT00777296|565733343|FG003|Overall Study|CRF form not completed|0|||
156451971|NCT01902173|564746850|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
156451972|NCT01902173|564746845|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
156451973|NCT01902173|564746846|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
156451974|NCT01902173|564746847|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
156451975|NCT01902173|564746848|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
156451976|NCT01902173|564746849|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
156451977|NCT01902173|564746850|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
156451978|NCT01902173|564746845|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
156451979|NCT01902173|564746846|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
156723249|NCT02211209|565733344|FG000|Overall Study|Investigator judgment|0|||
156723250|NCT02211209|565733345|FG001|Overall Study|Investigator judgment|1|||
156723251|NCT02211209|565733344|FG000|Overall Study|Voluntary withdrawal|1|||
156451980|NCT01902173|564746847|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
156451981|NCT01902173|564746848|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
156451982|NCT01902173|564746849|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
156451983|NCT01902173|564746850|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
156451984|NCT01902173|564746845|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
156875596|NCT01395524|566303595|FG000|Overall Study|Lost to Follow-up|3|||
156794509|NCT01432444|566001208|FG001|Treatment Phase|Protocol Deviation|3|||
156794510|NCT01432444|566001209|FG002|Treatment Phase|Protocol Deviation|0|||
156794511|NCT01432444|566001207|FG000|Treatment Phase|Lack of Efficacy|0|||
156794512|NCT01432444|566001208|FG001|Treatment Phase|Lack of Efficacy|10|||
156794513|NCT01432444|566001209|FG002|Treatment Phase|Lack of Efficacy|0|||
156794514|NCT01432444|566001207|FG000|Extension Phase|Lost to Follow-up|0|||
156794515|NCT01432444|566001208|FG001|Extension Phase|Lost to Follow-up|0|||
156794516|NCT01432444|566001209|FG002|Extension Phase|Lost to Follow-up|17|||
156794517|NCT01432444|566001207|FG000|Extension Phase|Adverse Event|0|||
156794518|NCT01432444|566001208|FG001|Extension Phase|Adverse Event|0|||
156794519|NCT01432444|566001209|FG002|Extension Phase|Adverse Event|10|||
156794520|NCT01432444|566001207|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
156794521|NCT01432444|566001208|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
156794522|NCT01432444|566001209|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
156723252|NCT02211209|565733345|FG001|Overall Study|Voluntary withdrawal|4|||
156723253|NCT02211209|565733344|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
156723254|NCT02211209|565733345|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
156723255|NCT02211209|565733344|FG000|Overall Study|Reason Not Specified|1|||
156723256|NCT02211209|565733345|FG001|Overall Study|Reason Not Specified|0|||
156723257|NCT00658723|565733349|FG000|Overall Study|Lost to Follow-up|0|||
156723258|NCT00658723|565733350|FG001|Overall Study|Lost to Follow-up|2|||
156723259|NCT00658723|565733351|FG002|Overall Study|Lost to Follow-up|2|||
156723260|NCT00658723|565733349|FG000|Overall Study|Death|2|||
156723261|NCT00658723|565733350|FG001|Overall Study|Death|1|||
156723262|NCT00658723|565733351|FG002|Overall Study|Death|4|||
156723263|NCT00658723|565733349|FG000|Overall Study|Scheduling Issue|1|||
156723264|NCT00658723|565733350|FG001|Overall Study|Scheduling Issue|1|||
156723265|NCT00658723|565733351|FG002|Overall Study|Scheduling Issue|0|||
156723266|NCT00658723|565733349|FG000|Overall Study|Withdrawal by Subject|1|||
156723267|NCT00658723|565733350|FG001|Overall Study|Withdrawal by Subject|0|||
156723268|NCT00658723|565733351|FG002|Overall Study|Withdrawal by Subject|1|||
156723269|NCT03876743|565733352|FG000|Overall Study|Lost to Follow-up|6|||
156723270|NCT03876743|565733353|FG001|Overall Study|Lost to Follow-up|4|||
156723271|NCT03876743|565733354|FG002|Overall Study|Lost to Follow-up|4|||
156723272|NCT03876743|565733355|FG003|Overall Study|Lost to Follow-up|7|||
156723273|NCT03889418|565733356|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
156723274|NCT03889418|565733357|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723275|NCT03889418|565733358|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723276|NCT03889418|565733359|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723277|NCT03889418|565733360|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723278|NCT03889418|565733361|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156794523|NCT01432444|566001207|FG000|Extension Phase|Met Withdrawal Criteria|0|||
156794524|NCT01432444|566001208|FG001|Extension Phase|Met Withdrawal Criteria|0|||
156794525|NCT01432444|566001209|FG002|Extension Phase|Met Withdrawal Criteria|144|||
156794526|NCT01432444|566001207|FG000|Extension Phase|Physician Decision|0|||
156794527|NCT01432444|566001208|FG001|Extension Phase|Physician Decision|0|||
156794528|NCT01432444|566001209|FG002|Extension Phase|Physician Decision|1|||
156794529|NCT01432444|566001207|FG000|Extension Phase|Withdrawal by Subject|0|||
156794530|NCT01432444|566001208|FG001|Extension Phase|Withdrawal by Subject|0|||
156794531|NCT01432444|566001209|FG002|Extension Phase|Withdrawal by Subject|13|||
156794532|NCT02014467|566001210|FG000|Overall Study|Adverse Event|4|||
156794533|NCT02014467|566001211|FG001|Overall Study|Adverse Event|0|||
156794534|NCT02014467|566001210|FG000|Overall Study|Protocol Violation|3|||
156794535|NCT02014467|566001211|FG001|Overall Study|Protocol Violation|0|||
156794536|NCT02014467|566001210|FG000|Overall Study|Physician Decision|2|||
156794537|NCT02014467|566001211|FG001|Overall Study|Physician Decision|3|||
156794538|NCT02014467|566001210|FG000|Overall Study|Withdrawal by Subject|16|||
156794539|NCT02014467|566001211|FG001|Overall Study|Withdrawal by Subject|4|||
156875597|NCT01395524|566303596|FG001|Overall Study|Lost to Follow-up|1|||
156723279|NCT03889418|565733362|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723280|NCT03889418|565733363|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156875598|NCT01395524|566303597|FG002|Overall Study|Lost to Follow-up|1|||
156723281|NCT03889418|565733364|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723282|NCT03889418|565733365|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723283|NCT03889418|565733356|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723284|NCT03889418|565733357|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
156723285|NCT03889418|565733358|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
156723286|NCT03889418|565733359|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723287|NCT03889418|565733360|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723288|NCT03889418|565733361|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156794540|NCT00443456|566001213|FG000|Overall Study|Adverse Event|16|||
156794541|NCT00443456|566001213|FG000|Overall Study|Move|1|||
156794542|NCT00443456|566001213|FG000|Overall Study|Withdrawal by Subject|1|||
156794543|NCT00557440|566001214|FG000|Treatment Period 1|Adverse Event|0|||
156794544|NCT00557440|566001215|FG001|Treatment Period 1|Adverse Event|0|||
156875599|NCT01395524|566303595|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
156875600|NCT01395524|566303596|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
156875601|NCT01395524|566303597|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
156875602|NCT01395524|566303595|FG000|Overall Study|Severe noncompliance with protocol|1|||
156875603|NCT01395524|566303596|FG001|Overall Study|Severe noncompliance with protocol|0|||
156875604|NCT01395524|566303597|FG002|Overall Study|Severe noncompliance with protocol|0|||
156875605|NCT01395524|566303595|FG000|Overall Study|Adverse Event|4|||
156875606|NCT01395524|566303596|FG001|Overall Study|Adverse Event|4|||
156875607|NCT01395524|566303597|FG002|Overall Study|Adverse Event|3|||
156875608|NCT01395524|566303595|FG000|Overall Study|Death|1|||
156875609|NCT01395524|566303596|FG001|Overall Study|Death|0|||
156723289|NCT03889418|565733362|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723290|NCT03889418|565733363|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723291|NCT03889418|565733364|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723292|NCT03889418|565733365|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723293|NCT03889418|565733356|FG000|October-December 2019 (Month 7-9)|Death|0|||
156723294|NCT03889418|565733357|FG001|October-December 2019 (Month 7-9)|Death|0|||
156723295|NCT03889418|565733358|FG002|October-December 2019 (Month 7-9)|Death|0|||
156723296|NCT03889418|565733359|FG003|October-December 2019 (Month 7-9)|Death|0|||
156723297|NCT03889418|565733360|FG004|October-December 2019 (Month 7-9)|Death|0|||
156723298|NCT03889418|565733361|FG005|October-December 2019 (Month 7-9)|Death|0|||
156723299|NCT03889418|565733362|FG006|October-December 2019 (Month 7-9)|Death|0|||
156723300|NCT03889418|565733363|FG007|October-December 2019 (Month 7-9)|Death|0|||
156723301|NCT03889418|565733364|FG008|October-December 2019 (Month 7-9)|Death|1|||
156723302|NCT03889418|565733365|FG009|October-December 2019 (Month 7-9)|Death|0|||
156723303|NCT03889418|565733356|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723304|NCT03889418|565733357|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723305|NCT03889418|565733358|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723306|NCT03889418|565733359|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
156723307|NCT03889418|565733360|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723308|NCT03889418|565733361|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723309|NCT03889418|565733362|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723310|NCT03889418|565733363|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
156723311|NCT03889418|565733364|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723312|NCT03889418|565733365|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723313|NCT03889418|565733356|FG000|April - June 2020 (Month 13-15)|Death|0|||
156723314|NCT03889418|565733357|FG001|April - June 2020 (Month 13-15)|Death|1|||
156723315|NCT03889418|565733358|FG002|April - June 2020 (Month 13-15)|Death|0|||
156723316|NCT03889418|565733359|FG003|April - June 2020 (Month 13-15)|Death|0|||
156723317|NCT03889418|565733360|FG004|April - June 2020 (Month 13-15)|Death|0|||
156723318|NCT03889418|565733361|FG005|April - June 2020 (Month 13-15)|Death|0|||
156723319|NCT03889418|565733362|FG006|April - June 2020 (Month 13-15)|Death|0|||
156723320|NCT03889418|565733363|FG007|April - June 2020 (Month 13-15)|Death|0|||
156723321|NCT03889418|565733364|FG008|April - June 2020 (Month 13-15)|Death|0|||
156723322|NCT03889418|565733365|FG009|April - June 2020 (Month 13-15)|Death|0|||
156723323|NCT03889418|565733356|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723324|NCT03889418|565733357|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723325|NCT03889418|565733358|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723326|NCT03889418|565733359|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
156723327|NCT03889418|565733360|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723328|NCT03889418|565733361|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723329|NCT03889418|565733362|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723330|NCT03889418|565733363|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723331|NCT03889418|565733364|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723332|NCT03889418|565733365|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723333|NCT03889418|565733356|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
156723334|NCT03889418|565733357|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723335|NCT03889418|565733358|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
156723336|NCT03889418|565733359|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
156723337|NCT03889418|565733360|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723338|NCT03889418|565733361|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
156875610|NCT01395524|566303597|FG002|Overall Study|Death|0|||
156875611|NCT01395524|566303595|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
156875612|NCT01395524|566303596|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156875613|NCT01395524|566303597|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156875614|NCT01395524|566303595|FG000|Overall Study|Withdrawal by Subject|4|||
156875615|NCT01395524|566303596|FG001|Overall Study|Withdrawal by Subject|8|||
156875616|NCT01395524|566303597|FG002|Overall Study|Withdrawal by Subject|8|||
156875617|NCT01395524|566303595|FG000|Overall Study|Did not receive treatment|1|||
156875618|NCT01395524|566303596|FG001|Overall Study|Did not receive treatment|1|||
156875619|NCT01395524|566303597|FG002|Overall Study|Did not receive treatment|3|||
156875620|NCT01395524|566303595|FG000|Overall Study|Subject had spinal surgery|0|||
156723339|NCT03889418|565733362|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723340|NCT03889418|565733363|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
156723341|NCT03889418|565733364|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723342|NCT03889418|565733365|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723343|NCT03889418|565733356|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723344|NCT03889418|565733357|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
156723345|NCT03889418|565733358|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
156723346|NCT03889418|565733359|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
156723347|NCT03889418|565733360|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723348|NCT03889418|565733361|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723349|NCT03889418|565733362|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723350|NCT03889418|565733363|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
156723351|NCT03889418|565733364|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723352|NCT03889418|565733365|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
156723353|NCT00092118|565733367|FG000|Overall Study|Adverse Event|35|||
156723354|NCT00092118|565733368|FG001|Overall Study|Adverse Event|32|||
156723355|NCT00092118|565733367|FG000|Overall Study|Lack of Efficacy|12|||
156723356|NCT00092118|565733368|FG001|Overall Study|Lack of Efficacy|14|||
156723357|NCT00092118|565733367|FG000|Overall Study|Lost to Follow-up|4|||
156723358|NCT00092118|565733368|FG001|Overall Study|Lost to Follow-up|3|||
156723359|NCT00092118|565733367|FG000|Overall Study|Protocol Violation|23|||
156723360|NCT00092118|565733368|FG001|Overall Study|Protocol Violation|25|||
156723361|NCT00092118|565733367|FG000|Overall Study|Withdrawal by Subject|4|||
156723362|NCT00092118|565733368|FG001|Overall Study|Withdrawal by Subject|10|||
156723363|NCT00092118|565733367|FG000|Overall Study|Other|6|||
156723364|NCT00092118|565733368|FG001|Overall Study|Other|5|||
156723365|NCT01139125|565733371|FG000|Overall Study|Withdrawal by Subject|1|||
156723366|NCT02025725|565733372|FG000|Overall Study|Adverse Event|5|||
156723367|NCT02025725|565733373|FG001|Overall Study|Adverse Event|0|||
156723368|NCT02025725|565733372|FG000|Overall Study|Lost to Follow-up|2|||
156723369|NCT02025725|565733373|FG001|Overall Study|Lost to Follow-up|0|||
156723370|NCT02025725|565733372|FG000|Overall Study|Protocol Violation|1|||
156723371|NCT02025725|565733373|FG001|Overall Study|Protocol Violation|1|||
156723372|NCT02025725|565733372|FG000|Overall Study|Withdrawal by Subject|3|||
156723373|NCT02025725|565733373|FG001|Overall Study|Withdrawal by Subject|2|||
156723374|NCT02025725|565733372|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
156723375|NCT02025725|565733373|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
156723376|NCT02172664|565733381|FG000|Overall Study|Lost to Follow-up|4|||
156451985|NCT01902173|564746846|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
156451986|NCT01902173|564746847|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
156723377|NCT02172664|565733382|FG001|Overall Study|Lost to Follow-up|4|||
156723378|NCT02172664|565733381|FG000|Overall Study|Death|1|||
156723379|NCT02172664|565733382|FG001|Overall Study|Death|1|||
156723380|NCT02172664|565733381|FG000|Overall Study|Moved out of area|1|||
156723381|NCT02172664|565733382|FG001|Overall Study|Moved out of area|1|||
156723382|NCT00739661|565733383|FG000|Overall Study|Adverse Event|2|||
156723383|NCT00739661|565733384|FG001|Overall Study|Adverse Event|0|||
156723384|NCT00739661|565733383|FG000|Overall Study|Physician decision to withdraw patient|1|||
156723385|NCT00739661|565733384|FG001|Overall Study|Physician decision to withdraw patient|0|||
156723386|NCT00739661|565733383|FG000|Overall Study|Patient decision to withdraw|9|||
156723387|NCT00739661|565733384|FG001|Overall Study|Patient decision to withdraw|4|||
156723388|NCT00739661|565733383|FG000|Overall Study|Disease progression, radiographic|33|||
156723389|NCT00739661|565733384|FG001|Overall Study|Disease progression, radiographic|37|||
156723390|NCT00739661|565733383|FG000|Overall Study|Reason for discontinuation not available|1|||
156723391|NCT00739661|565733384|FG001|Overall Study|Reason for discontinuation not available|1|||
156723392|NCT02946463|565733385|FG000|Primary Evaluation Period|Physician Decision|0|||
156723393|NCT02946463|565733386|FG001|Primary Evaluation Period|Physician Decision|1|||
156723394|NCT02946463|565733387|FG002|Primary Evaluation Period|Physician Decision|0|||
156451987|NCT01902173|564746848|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
156451988|NCT01902173|564746849|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
156451989|NCT01902173|564746850|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
156451990|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
156451991|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
156451992|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
156723395|NCT02946463|565733388|FG003|Primary Evaluation Period|Physician Decision|0|||
156723396|NCT02946463|565733385|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
156723397|NCT02946463|565733386|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
156723398|NCT02946463|565733387|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
156723399|NCT02946463|565733388|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
156533470|NCT00733304|565048801|FG000|Overall Study|Lost to Follow-up|0|||
156723400|NCT02946463|565733385|FG000|Extension Period|Death|4|||
156723401|NCT02946463|565733386|FG001|Extension Period|Death|4|||
156723402|NCT02946463|565733387|FG002|Extension Period|Death|0|||
156723403|NCT02946463|565733388|FG003|Extension Period|Death|0|||
156723404|NCT02946463|565733385|FG000|Extension Period|Withdrawal by Subject|4|||
156723405|NCT02946463|565733386|FG001|Extension Period|Withdrawal by Subject|3|||
156723406|NCT02946463|565733387|FG002|Extension Period|Withdrawal by Subject|0|||
156723407|NCT02946463|565733388|FG003|Extension Period|Withdrawal by Subject|0|||
156723408|NCT02946463|565733385|FG000|Extension Period|Other than specified|2|||
156723409|NCT02946463|565733386|FG001|Extension Period|Other than specified|3|||
156723410|NCT02946463|565733387|FG002|Extension Period|Other than specified|2|||
156723411|NCT02946463|565733388|FG003|Extension Period|Other than specified|0|||
156723412|NCT02946463|565733385|FG000|Extension Period|Physician Decision|1|||
156723413|NCT02946463|565733386|FG001|Extension Period|Physician Decision|4|||
156723414|NCT02946463|565733387|FG002|Extension Period|Physician Decision|0|||
156723415|NCT02946463|565733388|FG003|Extension Period|Physician Decision|0|||
156723416|NCT02946463|565733385|FG000|Extension Period|Pregnancy|3|||
156723417|NCT02946463|565733386|FG001|Extension Period|Pregnancy|1|||
156723418|NCT02946463|565733387|FG002|Extension Period|Pregnancy|0|||
156723419|NCT02946463|565733388|FG003|Extension Period|Pregnancy|0|||
156723420|NCT02946463|565733385|FG000|Extension Period|Adverse Event|1|||
156723421|NCT02946463|565733386|FG001|Extension Period|Adverse Event|2|||
156723422|NCT02946463|565733387|FG002|Extension Period|Adverse Event|0|||
156723423|NCT02946463|565733388|FG003|Extension Period|Adverse Event|0|||
156723424|NCT02946463|565733385|FG000|Extension Period|Lost to Follow-up|1|||
156723425|NCT02946463|565733386|FG001|Extension Period|Lost to Follow-up|0|||
156723426|NCT02946463|565733387|FG002|Extension Period|Lost to Follow-up|0|||
156723427|NCT02946463|565733388|FG003|Extension Period|Lost to Follow-up|0|||
156723428|NCT04564092|565733392|FG000|Overall Study|Withdrawal by Subject|1|||
156723429|NCT00420420|565733393|FG000|Overall Study|Adverse Event|5|||
156723430|NCT00420420|565733394|FG001|Overall Study|Adverse Event|3|||
156723431|NCT00420420|565733393|FG000|Overall Study|Protocol Violation|1|||
156723432|NCT00420420|565733394|FG001|Overall Study|Protocol Violation|1|||
156723433|NCT00420420|565733393|FG000|Overall Study|Withdrawal by Subject|1|||
156723434|NCT00420420|565733394|FG001|Overall Study|Withdrawal by Subject|0|||
156723435|NCT00420420|565733393|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
156723436|NCT00420420|565733394|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
156723437|NCT04762160|565733395|FG000|Overall Study|Study terminated early due to business reasons|5|||
156723438|NCT02362360|565733402|FG000|Period 1|Lack of Efficacy|1|||
156723439|NCT02362360|565733403|FG001|Period 1|Lack of Efficacy|0|||
156723440|NCT02362360|565733402|FG000|Period 1|Withdrawal by Subject|2|||
156723441|NCT02362360|565733403|FG001|Period 1|Withdrawal by Subject|1|||
156723442|NCT00868530|565733406|FG000|Overall Study|Adverse Event|3|||
156723443|NCT00868530|565733406|FG000|Overall Study|Lost to Follow-up|1|||
156723444|NCT03760744|565735173|FG000|Overall Study|Lost to Follow-up|3|||
156723445|NCT03760744|565735174|FG001|Overall Study|Lost to Follow-up|0|||
156723446|NCT05142722|565735175|FG000|Overall Study|Lost to Follow-up|16|||
156723447|NCT05142722|565735176|FG001|Overall Study|Lost to Follow-up|38|||
156723448|NCT05142722|565735175|FG000|Overall Study|Withdrawal by Subject|20|||
156723449|NCT05142722|565735176|FG001|Overall Study|Withdrawal by Subject|27|||
156723450|NCT05142722|565735175|FG000|Overall Study|Death|11|||
156723451|NCT05142722|565735176|FG001|Overall Study|Death|17|||
156723452|NCT05142722|565735175|FG000|Overall Study|Physician Decision|0|||
156723453|NCT05142722|565735176|FG001|Overall Study|Physician Decision|1|||
156723454|NCT05142722|565735175|FG000|Overall Study|Participant Moved Away|0|||
156723455|NCT05142722|565735176|FG001|Overall Study|Participant Moved Away|2|||
156723456|NCT05142722|565735175|FG000|Overall Study|Adverse Event|2|||
156723457|NCT05142722|565735176|FG001|Overall Study|Adverse Event|1|||
156451993|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
156451994|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
156451995|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
156451996|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
156451997|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
156451998|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
156451999|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
156452000|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
156452001|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
156452002|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
156723458|NCT05086744|565735177|FG000|Part A|Adverse Event|0|||
156723459|NCT05086744|565735178|FG001|Part A|Adverse Event|1|||
156723460|NCT05086744|565735177|FG000|Part A|Lack of Efficacy|3|||
156723461|NCT05086744|565735178|FG001|Part A|Lack of Efficacy|0|||
156723462|NCT05086744|565735177|FG000|Part A|Protocol deviation|1|||
156723463|NCT05086744|565735178|FG001|Part A|Protocol deviation|0|||
156723464|NCT05086744|565735177|FG000|Part A|Subject decision|1|||
156452003|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
156452004|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
156723465|NCT05086744|565735178|FG001|Part A|Subject decision|0|||
156723466|NCT05086744|565735177|FG000|Part B|Adverse Event|0|||
156723467|NCT05086744|565735178|FG001|Part B|Adverse Event|1|||
156723468|NCT05086744|565735177|FG000|Part B|Lack of Efficacy|0|||
156723469|NCT05086744|565735178|FG001|Part B|Lack of Efficacy|1|||
156723470|NCT05086744|565735177|FG000|Part B|Study terminated by sponsor|1|||
156723471|NCT05086744|565735178|FG001|Part B|Study terminated by sponsor|6|||
156723472|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
156723473|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156723474|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
156723475|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156723476|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
156723477|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156452005|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
156723478|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156723479|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156723480|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723481|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723482|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
156723483|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723484|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723485|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
156723486|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723487|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723488|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156794545|NCT00557440|566001216|FG002|Treatment Period 1|Adverse Event|1|||
156794546|NCT02157610|566001217|FG000|Overall Study|Death|4|||
156794547|NCT02157610|566001218|FG001|Overall Study|Death|4|||
156794548|NCT00124657|566001224|FG000|Overall Study|Toxicity|0|||
156794549|NCT00124657|566001225|FG001|Overall Study|Toxicity|0|||
156794550|NCT00124657|566001226|FG002|Overall Study|Toxicity|1|||
156794551|NCT00124657|566001224|FG000|Overall Study|Non-compliance|1|||
156794552|NCT00124657|566001225|FG001|Overall Study|Non-compliance|0|||
156794553|NCT00124657|566001226|FG002|Overall Study|Non-compliance|4|||
156794554|NCT00124657|566001224|FG000|Overall Study|Progressive disease|14|||
156794555|NCT00124657|566001225|FG001|Overall Study|Progressive disease|5|||
156794556|NCT00124657|566001226|FG002|Overall Study|Progressive disease|27|||
156794557|NCT00124657|566001224|FG000|Overall Study|Intercurrent illness|1|||
156794558|NCT00124657|566001225|FG001|Overall Study|Intercurrent illness|0|||
156794559|NCT00124657|566001226|FG002|Overall Study|Intercurrent illness|0|||
156794560|NCT00619918|566001231|FG000|Overall Study|Withdrawal by Subject|4|||
156794561|NCT00619918|566001232|FG001|Overall Study|Withdrawal by Subject|3|||
156794562|NCT00619918|566001231|FG000|Overall Study|Physician Decision|2|||
156794563|NCT00619918|566001232|FG001|Overall Study|Physician Decision|4|||
156794564|NCT00619918|566001231|FG000|Overall Study|Transfer to outside facility|3|||
156794565|NCT00619918|566001232|FG001|Overall Study|Transfer to outside facility|3|||
156794566|NCT00619918|566001231|FG000|Overall Study|Left before receiving first dose|7|||
156794567|NCT00619918|566001232|FG001|Overall Study|Left before receiving first dose|6|||
156794568|NCT00619918|566001231|FG000|Overall Study|ICU admission|4|||
156794569|NCT00619918|566001232|FG001|Overall Study|ICU admission|6|||
156794570|NCT03533491|566001233|FG000|Overall Study|Lost to Follow-up|2|||
156794571|NCT00721110|566001238|FG000|Overall Study|Ultram use|1|||
156794572|NCT00721110|566001239|FG001|Overall Study|Ultram use|0|||
156794573|NCT00721110|566001240|FG002|Overall Study|Ultram use|0|||
156794574|NCT00721110|566001241|FG003|Overall Study|Ultram use|0|||
156794575|NCT00721110|566001238|FG000|Overall Study|vertical incision|0|||
156794576|NCT00721110|566001239|FG001|Overall Study|vertical incision|0|||
156794577|NCT00721110|566001240|FG002|Overall Study|vertical incision|1|||
156794578|NCT00721110|566001241|FG003|Overall Study|vertical incision|0|||
156794579|NCT04079920|566001247|FG000|Overall Study|Adverse event, not related to study drug|2|||
156794580|NCT04079920|566001247|FG000|Overall Study|Adverse event related to study drug|10|||
156794581|NCT04079920|566001247|FG000|Overall Study|Death|2|||
156794582|NCT04079920|566001247|FG000|Overall Study|Lost to Follow-up|22|||
156794583|NCT04079920|566001247|FG000|Overall Study|Physician Decision|1|||
156794584|NCT04079920|566001247|FG000|Overall Study|Withdrawal by Subject|11|||
156452006|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
156452007|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
156452008|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
156452009|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
156794585|NCT01618708|566001248|FG000|Overall Study|Adverse Event|10|||
156794586|NCT01618708|566001249|FG001|Overall Study|Adverse Event|10|||
156794587|NCT01618708|566001248|FG000|Overall Study|Lost to Follow-up|3|||
156794588|NCT01618708|566001249|FG001|Overall Study|Lost to Follow-up|3|||
156794589|NCT01618708|566001248|FG000|Overall Study|Withdrawal by Subject|17|||
156794590|NCT01618708|566001249|FG001|Overall Study|Withdrawal by Subject|22|||
156794591|NCT01618708|566001248|FG000|Overall Study|Lack of Efficacy|8|||
156794592|NCT01618708|566001249|FG001|Overall Study|Lack of Efficacy|8|||
156452010|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
156452011|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
156452012|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
156452013|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
156723489|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156723490|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
156723491|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156723492|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156723493|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
156723494|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156723495|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
156723496|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
156723497|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
156723498|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
156723499|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
156723500|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
156723501|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
156723502|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
156723503|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
156723504|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723505|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723506|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
156723507|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723508|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723509|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723510|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
156723511|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723512|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723513|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723514|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
156723515|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723516|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723517|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
156723518|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723519|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
156723520|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
156723521|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
156723522|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723523|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723524|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723525|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723526|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156452014|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
156452015|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
156723527|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723528|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723529|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
156723530|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723531|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723532|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723533|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723534|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156794593|NCT01618708|566001248|FG000|Overall Study|Technical problems|2|||
156794594|NCT01618708|566001249|FG001|Overall Study|Technical problems|0|||
156794595|NCT01618708|566001248|FG000|Overall Study|Other than specified above|1|||
156794596|NCT01618708|566001249|FG001|Overall Study|Other than specified above|1|||
156794597|NCT01618708|566001248|FG000|Overall Study|Randomized but not treated|3|||
156794598|NCT01618708|566001249|FG001|Overall Study|Randomized but not treated|2|||
156794599|NCT04042311|566001256|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
156794600|NCT04042311|566001256|FG000|Overall Study|Unable to tolerate|4|||
156794601|NCT04042311|566001256|FG000|Overall Study|Concurrent illness|2|||
156452016|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
156452017|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
156452018|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
156723535|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723536|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723537|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723538|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723539|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723540|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
156723541|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723542|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723543|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723544|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723545|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723546|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723547|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156794602|NCT04042311|566001256|FG000|Overall Study|Adverse Event|2|||
156794603|NCT04042311|566001256|FG000|Overall Study|No longer meeting inclusion criteria|2|||
156794604|NCT04042311|566001256|FG000|Overall Study|No reason given|1|||
156794605|NCT04042311|566001256|FG000|Overall Study|Withdrawal by Subject|4|||
156794606|NCT03518060|566001257|FG000|Overall Study|Death|1|||
156794607|NCT03518060|566001257|FG000|Overall Study|Poor adherence|1|||
156794608|NCT03518060|566001257|FG000|Overall Study|Withdrawal of informed consent|2|||
156794609|NCT03518060|566001257|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
156794610|NCT03518060|566001257|FG000|Overall Study|Physician Decision|7|||
156794611|NCT03518060|566001257|FG000|Overall Study|Adverse drug reactions|23|||
156794612|NCT03518060|566001257|FG000|Overall Study|Withdrawal by Subject|25|||
156794613|NCT03518060|566001257|FG000|Overall Study|Lost to Follow-up|13|||
156794614|NCT04903093|566001259|FG000|Overall Study|Withdrawal by Subject|0|||
156794615|NCT04903093|566001260|FG001|Overall Study|Withdrawal by Subject|0|||
156794616|NCT04903093|566001261|FG002|Overall Study|Withdrawal by Subject|0|||
156794617|NCT04903093|566001262|FG003|Overall Study|Withdrawal by Subject|1|||
156794618|NCT04903093|566001263|FG004|Overall Study|Withdrawal by Subject|0|||
156794619|NCT04903093|566001264|FG005|Overall Study|Withdrawal by Subject|0|||
156794620|NCT03204812|566001270|FG000|Overall Study|Adverse Event|3|||
156794621|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
156794622|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156794623|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156794624|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156794625|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156794626|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
156794627|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156794628|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156794629|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156794630|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156794631|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
156794632|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156794633|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156794634|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156794635|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156794636|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
156794637|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
156794638|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
156794639|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
156794640|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
156794641|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
156794642|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
156794643|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
156794644|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
156794645|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
156794646|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
156452019|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
156794647|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
156794648|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
156794649|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
156794650|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
156794651|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
156452020|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
156452021|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
156452022|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
156452023|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
156452024|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
156452025|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
156452026|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
156452027|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
156452028|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
156452029|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
156452030|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
156452031|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
156452032|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
156452033|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
156452034|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
156452035|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
156452036|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
156452037|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
156452038|NCT01902173|564746845|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
156452039|NCT01902173|564746846|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
156452040|NCT01902173|564746847|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
156452041|NCT01902173|564746848|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
156452042|NCT01902173|564746849|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
156723548|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723549|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
156723550|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723551|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723552|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723553|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723554|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723555|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723556|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723557|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
156723558|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
156794652|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156794653|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156794654|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156875621|NCT01395524|566303596|FG001|Overall Study|Subject had spinal surgery|0|||
156875622|NCT01395524|566303597|FG002|Overall Study|Subject had spinal surgery|1|||
156875623|NCT01296672|566303605|FG000|Overall Study|Lost to Follow-up|73|||
156875624|NCT01296672|566303606|FG001|Overall Study|Lost to Follow-up|18|||
156875625|NCT04248491|566303610|FG000|Overall Study|Lost to Follow-up|1|||
156875626|NCT04248491|566303611|FG001|Overall Study|Lost to Follow-up|0|||
156875627|NCT04605991|566303612|FG000|Overall Study|Adverse Event|5|||
156875628|NCT04605991|566303612|FG000|Overall Study|Lack of Efficacy|1|||
156875629|NCT04605991|566303612|FG000|Overall Study|Lost to Follow-up|8|||
156875630|NCT04605991|566303612|FG000|Overall Study|Physician Decision|4|||
156875631|NCT04605991|566303612|FG000|Overall Study|Withdrawal by Subject|14|||
156875632|NCT04605991|566303612|FG000|Overall Study|Non-compliance with study|1|||
156875633|NCT02123472|566303619|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
156875634|NCT02123472|566303620|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
156875635|NCT03801031|566303621|FG000|Overall Study|Lost to Follow-up|1|||
156875636|NCT03801031|566303622|FG001|Overall Study|Lost to Follow-up|0|||
156452043|NCT01902173|564746850|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
156452044|NCT04015167|564746854|FG000|Overall Study|Lost to Follow-up|40|||
156452045|NCT04015167|564746854|FG000|Overall Study|Adverse Event|5|||
156452046|NCT04015167|564746854|FG000|Overall Study|Withdrawal by Subject|2|||
156452047|NCT04015167|564746854|FG000|Overall Study|Subject went to jail|1|||
156452048|NCT04876118|564746860|FG000|Overall Study|Pregnancy|1|||
156452049|NCT04876118|564746860|FG000|Overall Study|Withdrawal by Subject|14|||
156452050|NCT05089734|564746861|FG000|Overall Study|Still on study|122|||
156794655|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156794656|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
156794657|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
156794658|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
156794659|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
156875637|NCT03801031|566303621|FG000|Overall Study|Unable to comply|1|||
156875638|NCT03801031|566303622|FG001|Overall Study|Unable to comply|0|||
156875639|NCT03801031|566303621|FG000|Overall Study|Withdrawal by Subject|0|||
156875640|NCT03801031|566303622|FG001|Overall Study|Withdrawal by Subject|1|||
156335682|NCT04439201|564326180|FG000|Overall Study|Withdrawal by Subject|2|||
156335683|NCT04439201|564326180|FG000|Overall Study|Disease progression|20|||
156335684|NCT04439201|564326180|FG000|Overall Study|Alternative therapy|1|||
156335685|NCT04439201|564326180|FG000|Overall Study|Physician Decision|1|||
156335686|NCT05136690|564326181|FG000|Period 1|Withdrawal by Subject|0|||
156335687|NCT05136690|564326182|FG001|Period 1|Withdrawal by Subject|1|||
156335688|NCT05136690|564326181|FG000|Period 2|Lost to Follow-up|0|||
156335689|NCT05136690|564326182|FG001|Period 2|Lost to Follow-up|3|||
156335690|NCT05136690|564326181|FG000|Period 2|Withdrawal by Subject|0|||
156335691|NCT05136690|564326182|FG001|Period 2|Withdrawal by Subject|1|||
156335692|NCT03730012|564326184|FG000|Overall Study|Adverse Event|0|||
156335693|NCT03730012|564326185|FG001|Overall Study|Adverse Event|1|||
156335694|NCT03730012|564326184|FG000|Overall Study|Lack of Efficacy|1|||
156335695|NCT03730012|564326185|FG001|Overall Study|Lack of Efficacy|5|||
156335696|NCT03730012|564326184|FG000|Overall Study|Withdrawal by Subject|0|||
156335697|NCT03730012|564326185|FG001|Overall Study|Withdrawal by Subject|1|||
156335698|NCT03730012|564326184|FG000|Overall Study|Miscellaneous|2|||
156335699|NCT03730012|564326185|FG001|Overall Study|Miscellaneous|1|||
156335700|NCT01995825|564328055|FG000|Overall Study|Withdrawal by Subject|1|||
156335701|NCT01995825|564328056|FG001|Overall Study|Withdrawal by Subject|0|||
156335702|NCT01367002|564328057|FG000|Overall Study|Withdrawal by Subject|1|||
156335703|NCT01367002|564328058|FG001|Overall Study|Withdrawal by Subject|0|||
156335704|NCT01367002|564328057|FG000|Overall Study|Physician Decision|0|||
156335705|NCT01367002|564328058|FG001|Overall Study|Physician Decision|2|||
156335706|NCT01516437|564328059|FG000|Overall Study|Reason not specified|0|||
156335707|NCT01516437|564328060|FG001|Overall Study|Reason not specified|0|||
156335708|NCT01516437|564328061|FG002|Overall Study|Reason not specified|1|||
156335709|NCT01516437|564328062|FG003|Overall Study|Reason not specified|1|||
156335710|NCT00403234|564328063|FG000|Overall Study|Withdrawal by Subject|0|||
156335711|NCT00403234|564328064|FG001|Overall Study|Withdrawal by Subject|1|||
156335712|NCT00403234|564328065|FG002|Overall Study|Withdrawal by Subject|0|||
156335713|NCT00403234|564328066|FG003|Overall Study|Withdrawal by Subject|0|||
156335714|NCT00403234|564328063|FG000|Overall Study|Adverse Event|1|||
156335715|NCT00403234|564328064|FG001|Overall Study|Adverse Event|0|||
156335716|NCT00403234|564328065|FG002|Overall Study|Adverse Event|1|||
156335717|NCT00403234|564328066|FG003|Overall Study|Adverse Event|0|||
156335718|NCT00825682|564328067|FG000|Overall Study|personal reasons/ inconvenience|13|||
156335719|NCT00825682|564328068|FG001|Overall Study|personal reasons/ inconvenience|5|||
156335720|NCT00560105|564328069|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
156335721|NCT00560105|564328070|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
156335722|NCT03281577|564328072|FG000|Overall Study|Adverse Event|0|||
156335723|NCT03281577|564328073|FG001|Overall Study|Adverse Event|0|||
156335724|NCT03281577|564328074|FG002|Overall Study|Adverse Event|0|||
156335725|NCT03281577|564328075|FG003|Overall Study|Adverse Event|1|||
156335726|NCT03281577|564328072|FG000|Overall Study|Withdrawal by Subject|1|||
156335727|NCT03281577|564328073|FG001|Overall Study|Withdrawal by Subject|0|||
156335728|NCT03281577|564328074|FG002|Overall Study|Withdrawal by Subject|0|||
156335729|NCT03281577|564328075|FG003|Overall Study|Withdrawal by Subject|0|||
156335730|NCT01550289|564328076|FG000|Overall Study|Protocol Violation|1|||
156335731|NCT01550289|564328077|FG001|Overall Study|Protocol Violation|0|||
156335732|NCT01550289|564328076|FG000|Overall Study|Lost to Follow-up|1|||
156794660|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
156335733|NCT01550289|564328077|FG001|Overall Study|Lost to Follow-up|1|||
156335734|NCT01550289|564328076|FG000|Overall Study|Withdrawal by Subject|11|||
156335735|NCT01550289|564328077|FG001|Overall Study|Withdrawal by Subject|3|||
156452051|NCT05089734|564746862|FG001|Overall Study|Still on study|101|||
156452052|NCT05089734|564746861|FG000|Overall Study|Death|161|||
156794661|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156794662|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156794663|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156794664|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
156794665|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156794666|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
156794667|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
156794668|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
156794669|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
156335736|NCT03539081|564328081|FG000|Overall Study|Withdrawal by Subject|2|||
156335737|NCT03539081|564328082|FG001|Overall Study|Withdrawal by Subject|3|||
156335738|NCT03539081|564328083|FG002|Overall Study|Withdrawal by Subject|0|||
156335739|NCT03539081|564328081|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
156335740|NCT03539081|564328082|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
156335741|NCT03539081|564328083|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
156335742|NCT02025621|564328084|FG000|Overall Study|Withdrawal by Subject|1|||
156723559|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723560|NCT05400655|565735187|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
156723561|NCT05400655|565735188|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
156723562|NCT05400655|565735189|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
156723563|NCT05400655|565735190|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
156723564|NCT05400655|565735191|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
156723565|NCT05400655|565735192|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
156723566|NCT05400655|565735193|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
156723567|NCT05400655|565735194|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
156723568|NCT05400655|565735195|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
156723569|NCT05400655|565735196|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
156723570|NCT05400655|565735197|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
156723571|NCT05400655|565735198|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
156723572|NCT05400655|565735199|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
156723573|NCT05400655|565735200|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
156723574|NCT05400655|565735201|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
156723575|NCT05400655|565735202|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
156723576|NCT05400655|565735203|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
156723577|NCT05400655|565735204|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
156723578|NCT05400655|565735205|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
156723579|NCT05400655|565735206|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
156723580|NCT05400655|565735207|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
156723581|NCT05400655|565735208|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
156723582|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723583|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156794670|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
156794671|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
156794672|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
156794673|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
156794674|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
156794675|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
156794676|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
156794677|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
156794678|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
156794679|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
156875641|NCT01598506|566303624|FG000|Overall Study|Withdrawal by Subject|2|||
156875642|NCT02100696|566303625|FG000|Induction Phase|Adverse Event|0|||
156875643|NCT02100696|566303626|FG001|Induction Phase|Adverse Event|0|||
156875644|NCT02100696|566303627|FG002|Induction Phase|Adverse Event|1|||
156875645|NCT02100696|566303628|FG003|Induction Phase|Adverse Event|0|||
156875646|NCT02100696|566303629|FG004|Induction Phase|Adverse Event|0|||
156875647|NCT02100696|566303630|FG005|Induction Phase|Adverse Event|0|||
156875648|NCT02100696|566303625|FG000|Induction Phase|Lost to Follow-up|1|||
156875649|NCT02100696|566303626|FG001|Induction Phase|Lost to Follow-up|0|||
156875650|NCT02100696|566303627|FG002|Induction Phase|Lost to Follow-up|1|||
156875651|NCT02100696|566303628|FG003|Induction Phase|Lost to Follow-up|0|||
156875652|NCT02100696|566303629|FG004|Induction Phase|Lost to Follow-up|0|||
156875653|NCT02100696|566303630|FG005|Induction Phase|Lost to Follow-up|0|||
156875654|NCT02100696|566303625|FG000|Induction Phase|Protocol Violation|0|||
156875655|NCT02100696|566303626|FG001|Induction Phase|Protocol Violation|1|||
156875656|NCT02100696|566303627|FG002|Induction Phase|Protocol Violation|1|||
156875657|NCT02100696|566303628|FG003|Induction Phase|Protocol Violation|0|||
156875658|NCT02100696|566303629|FG004|Induction Phase|Protocol Violation|0|||
156875659|NCT02100696|566303630|FG005|Induction Phase|Protocol Violation|0|||
156875660|NCT02100696|566303625|FG000|Induction Phase|Withdrawal by Subject|8|||
156875661|NCT02100696|566303626|FG001|Induction Phase|Withdrawal by Subject|2|||
156875662|NCT02100696|566303627|FG002|Induction Phase|Withdrawal by Subject|13|||
156875663|NCT02100696|566303628|FG003|Induction Phase|Withdrawal by Subject|0|||
156875664|NCT02100696|566303629|FG004|Induction Phase|Withdrawal by Subject|0|||
156875665|NCT02100696|566303630|FG005|Induction Phase|Withdrawal by Subject|0|||
156452053|NCT05089734|564746862|FG001|Overall Study|Death|179|||
156723584|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723585|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723586|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723587|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156875666|NCT02100696|566303625|FG000|Induction Phase|Physician Decision|1|||
156875667|NCT02100696|566303626|FG001|Induction Phase|Physician Decision|0|||
156875668|NCT02100696|566303627|FG002|Induction Phase|Physician Decision|2|||
156875669|NCT02100696|566303628|FG003|Induction Phase|Physician Decision|0|||
156875670|NCT02100696|566303629|FG004|Induction Phase|Physician Decision|0|||
156875671|NCT02100696|566303630|FG005|Induction Phase|Physician Decision|0|||
156875672|NCT02100696|566303625|FG000|Induction Phase|Multiple Reasons|5|||
156875673|NCT02100696|566303626|FG001|Induction Phase|Multiple Reasons|2|||
156452054|NCT05089734|564746861|FG000|Overall Study|Withdrew consent|11|||
156452055|NCT05089734|564746862|FG001|Overall Study|Withdrew consent|24|||
156452056|NCT05089734|564746861|FG000|Overall Study|Lost to Follow-up|5|||
156452057|NCT05089734|564746862|FG001|Overall Study|Lost to Follow-up|0|||
156723588|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723589|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723590|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723591|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723592|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156452058|NCT04353661|564748527|FG000|Overall Study|Protocol Violation|0|||
156452059|NCT04353661|564748528|FG001|Overall Study|Protocol Violation|0|||
156452060|NCT04353661|564748529|FG002|Overall Study|Protocol Violation|1|||
156452061|NCT04353661|564748527|FG000|Overall Study|Study termination by the Sponsor|1|||
156452062|NCT04353661|564748528|FG001|Overall Study|Study termination by the Sponsor|1|||
156452063|NCT04353661|564748529|FG002|Overall Study|Study termination by the Sponsor|1|||
156452064|NCT05215314|564748530|FG000|Overall Study|Lost to Follow-up|2|||
156452065|NCT05215314|564748531|FG001|Overall Study|Lost to Follow-up|2|||
156452066|NCT05215314|564748530|FG000|Overall Study|Withdrawal by Subject|2|||
156452067|NCT05215314|564748531|FG001|Overall Study|Withdrawal by Subject|0|||
156452068|NCT05215314|564748530|FG000|Overall Study|Physician Decision|1|||
156452069|NCT05215314|564748531|FG001|Overall Study|Physician Decision|0|||
156452070|NCT03366649|564748532|FG000|Overall Study|Failed preoperative screening|4|||
156452071|NCT03366649|564748533|FG001|Overall Study|Failed preoperative screening|0|||
156723593|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723594|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
156723595|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723596|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723597|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723598|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
156723599|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723600|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
156723601|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
156723602|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723603|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723604|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723605|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723606|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723607|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723608|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723609|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723610|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723611|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723612|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723613|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723614|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723615|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723616|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723617|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
156723618|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723619|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723620|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
156723621|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723622|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
156723623|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723624|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723625|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723626|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723627|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156533471|NCT00733304|565048802|FG001|Overall Study|Lost to Follow-up|1|||
156533472|NCT00733304|565048803|FG002|Overall Study|Lost to Follow-up|0|||
156723628|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723629|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723630|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723631|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156794680|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
156794681|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
156452072|NCT03366649|564748534|FG002|Overall Study|Failed preoperative screening|0|||
156452073|NCT03366649|564748532|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
156533473|NCT00733304|565048801|FG000|Overall Study|Physician Decision|3|||
156723632|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723633|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723634|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156794682|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
156452074|NCT03366649|564748533|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
156452075|NCT03366649|564748534|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
156452076|NCT01785719|564748538|FG000|4-week Baseline Evaluation|Physician Decision|1|||
156452077|NCT01785719|564748539|FG001|4-week Baseline Evaluation|Physician Decision|0|||
156452078|NCT01785719|564748538|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
156452079|NCT01785719|564748539|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
156452080|NCT01785719|564748538|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
156452081|NCT01785719|564748539|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
156452082|NCT01785719|564748538|FG000|4-week Baseline Evaluation|Pregnancy|0|||
156452083|NCT01785719|564748539|FG001|4-week Baseline Evaluation|Pregnancy|2|||
156452084|NCT01785719|564748538|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
156452085|NCT01785719|564748539|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
156452086|NCT01785719|564748538|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
156452087|NCT01785719|564748539|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
156452088|NCT01785719|564748538|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
156452089|NCT01785719|564748539|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
156452090|NCT01785719|564748538|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
156452091|NCT01785719|564748539|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
156452092|NCT01785719|564748538|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
156452093|NCT01785719|564748539|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
156452094|NCT01785719|564748538|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
156452095|NCT01785719|564748539|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
156452096|NCT01785719|564748538|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
156452097|NCT01785719|564748539|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
156723635|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723636|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723637|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156452098|NCT01785719|564748538|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
156452099|NCT01785719|564748539|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
156452100|NCT01785719|564748538|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
156452101|NCT01785719|564748539|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
156452102|NCT01785719|564748538|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
156452103|NCT01785719|564748539|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
156452104|NCT01785719|564748538|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
156452105|NCT01785719|564748539|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
156452106|NCT03443323|564748540|FG000|Overall Study|Lost to Follow-up|2|||
156452107|NCT03443323|564748541|FG001|Overall Study|Lost to Follow-up|2|||
156452108|NCT03443323|564748540|FG000|Overall Study|PI withdrawal|1|||
156452109|NCT03443323|564748541|FG001|Overall Study|PI withdrawal|0|||
156452110|NCT03457142|564748544|FG000|Overall Study|Death|1|||
156452111|NCT03770273|564748545|FG000|Overall Study|Adverse Event|2|||
156452112|NCT03770273|564748546|FG001|Overall Study|Adverse Event|0|||
156723638|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723639|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723640|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723641|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723642|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
156723643|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
156723644|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
156723645|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723646|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
156723647|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
156723648|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156452113|NCT03770273|564748545|FG000|Overall Study|Lost to Follow-up|1|||
156452114|NCT03770273|564748546|FG001|Overall Study|Lost to Follow-up|1|||
156452115|NCT04060654|564748547|FG000|Overall Study|Withdrawal by Subject|1|||
156452116|NCT04060654|564748547|FG000|Overall Study|Lost to Follow-up|5|||
156452117|NCT04887129|564748548|FG000|Overall Study|Lost to Follow-up|0|||
156452118|NCT04887129|564748549|FG001|Overall Study|Lost to Follow-up|24|||
156452119|NCT04887129|564748548|FG000|Overall Study|Withdrawal by Subject|9|||
156723649|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723650|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723651|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723652|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723653|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723654|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723655|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156794683|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
156723656|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156452120|NCT04887129|564748549|FG001|Overall Study|Withdrawal by Subject|57|||
156452121|NCT04887129|564748548|FG000|Overall Study|Other|2|||
156452122|NCT04887129|564748549|FG001|Overall Study|Other|9|||
156452123|NCT04896476|564748550|FG000|Overall Study|Withdrawal by Subject|1|||
156452124|NCT04896476|564748550|FG000|Overall Study|Lost to Follow-up|2|||
156452125|NCT03476187|564748551|FG000|Overall Study|Protocol Violation|7|||
156452126|NCT03476187|564748551|FG000|Overall Study|Physician Decision|5|||
156452127|NCT03056040|564748555|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
156452128|NCT03056040|564748556|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
156452129|NCT03056040|564748555|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
156452130|NCT03056040|564748556|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
156723657|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723658|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723659|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723660|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723661|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723662|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723663|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723664|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723665|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
156723666|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
156723667|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723668|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723669|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723670|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723671|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723672|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723673|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723674|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723675|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723676|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723677|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723678|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723679|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723680|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723681|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156794684|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
156794685|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
156794686|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156794687|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156794688|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
156794689|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156794690|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156794691|NCT02097225|566001276|FG000|Dose Level 4|Adverse Event|0|||
156794692|NCT02097225|566001277|FG001|Dose Level 4|Adverse Event|0|||
156794693|NCT02097225|566001278|FG002|Dose Level 4|Adverse Event|0|||
156794694|NCT02097225|566001279|FG003|Dose Level 4|Adverse Event|0|||
156794695|NCT02097225|566001280|FG004|Dose Level 4|Adverse Event|1|||
156794696|NCT01027351|566001282|FG000|Overall Study|Withdrawal by Subject|1|||
156794697|NCT01027351|566001283|FG001|Overall Study|Withdrawal by Subject|0|||
156794698|NCT01027351|566001284|FG002|Overall Study|Withdrawal by Subject|1|||
156794699|NCT01027351|566001285|FG003|Overall Study|Withdrawal by Subject|0|||
156794700|NCT01027351|566001286|FG004|Overall Study|Withdrawal by Subject|3|||
156794701|NCT01027351|566001287|FG005|Overall Study|Withdrawal by Subject|5|||
156794702|NCT01027351|566001282|FG000|Overall Study|Lost to Follow-up|1|||
156794703|NCT01027351|566001283|FG001|Overall Study|Lost to Follow-up|1|||
156794704|NCT01027351|566001284|FG002|Overall Study|Lost to Follow-up|0|||
156794705|NCT01027351|566001285|FG003|Overall Study|Lost to Follow-up|1|||
156794706|NCT01027351|566001286|FG004|Overall Study|Lost to Follow-up|6|||
156452131|NCT03056040|564748555|FG000|Primary Evaluation Period|Pregnancy|0|||
156452132|NCT03056040|564748556|FG001|Primary Evaluation Period|Pregnancy|1|||
156452133|NCT03056040|564748555|FG000|Primary Evaluation Period|Randomized, not treated|1|||
156794707|NCT01027351|566001287|FG005|Overall Study|Lost to Follow-up|0|||
156794708|NCT01027351|566001282|FG000|Overall Study|Inappropriate enrollment|0|||
156794709|NCT01027351|566001283|FG001|Overall Study|Inappropriate enrollment|0|||
156794710|NCT01027351|566001284|FG002|Overall Study|Inappropriate enrollment|0|||
156335743|NCT02025621|564328085|FG001|Overall Study|Withdrawal by Subject|0|||
156452134|NCT03056040|564748556|FG001|Primary Evaluation Period|Randomized, not treated|1|||
156723682|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723683|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156794711|NCT01027351|566001285|FG003|Overall Study|Inappropriate enrollment|0|||
156723684|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723685|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723686|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
156723687|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723688|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
156723689|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
156723690|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
156723691|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
156723692|NCT03055338|565735219|FG000|Overall Study|Lost to Follow-up|9|||
156723693|NCT03055338|565735220|FG001|Overall Study|Lost to Follow-up|2|||
156723694|NCT03055338|565735221|FG002|Overall Study|Lost to Follow-up|3|||
156723695|NCT03055338|565735219|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
156723696|NCT03055338|565735220|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
156723697|NCT03055338|565735221|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
156723698|NCT03055338|565735219|FG000|Overall Study|Physician Decision|0|||
156723699|NCT03055338|565735220|FG001|Overall Study|Physician Decision|0|||
156723700|NCT03055338|565735221|FG002|Overall Study|Physician Decision|2|||
156723701|NCT03055338|565735219|FG000|Overall Study|Withdrawal by Subject|9|||
156723702|NCT03055338|565735220|FG001|Overall Study|Withdrawal by Subject|8|||
156723703|NCT03055338|565735221|FG002|Overall Study|Withdrawal by Subject|7|||
156723704|NCT03058705|565735222|FG000|Overall Study|Withdrawal by Subject|2|||
156723705|NCT03058705|565735222|FG000|Overall Study|Physician Decision|2|||
156723706|NCT05161481|565735223|FG000|Overall Study|Withdrawal of consent|0|||
156723707|NCT05161481|565735224|FG001|Overall Study|Withdrawal of consent|1|||
156723708|NCT05161481|565735225|FG002|Overall Study|Withdrawal of consent|1|||
156723709|NCT05161481|565735223|FG000|Overall Study|Study terminated by sponsor|3|||
156723710|NCT05161481|565735224|FG001|Overall Study|Study terminated by sponsor|3|||
156723711|NCT05161481|565735225|FG002|Overall Study|Study terminated by sponsor|2|||
156723712|NCT05161481|565735223|FG000|Overall Study|Adverse Event|3|||
156723713|NCT05161481|565735224|FG001|Overall Study|Adverse Event|0|||
156723714|NCT05161481|565735225|FG002|Overall Study|Adverse Event|6|||
156723715|NCT05161481|565735223|FG000|Overall Study|Randomised in error and was not treated|1|||
156723716|NCT05161481|565735224|FG001|Overall Study|Randomised in error and was not treated|0|||
156723717|NCT05161481|565735225|FG002|Overall Study|Randomised in error and was not treated|0|||
156723718|NCT05161481|565735223|FG000|Overall Study|Subject decision|0|||
156335744|NCT02025621|564328084|FG000|Overall Study|Death|0|||
156335745|NCT02025621|564328085|FG001|Overall Study|Death|1|||
156452135|NCT03056040|564748555|FG000|Extension Period|Physician Decision|3|||
156452136|NCT03056040|564748556|FG001|Extension Period|Physician Decision|3|||
156723719|NCT05161481|565735224|FG001|Overall Study|Subject decision|0|||
156723720|NCT05161481|565735225|FG002|Overall Study|Subject decision|1|||
156723721|NCT01102257|565735233|FG000|Overall Study|Adverse Event|1|||
156723722|NCT01102257|565735234|FG001|Overall Study|Adverse Event|0|||
156723723|NCT01102257|565735233|FG000|Overall Study|Adverse Event|1|||
156723724|NCT01102257|565735234|FG001|Overall Study|Adverse Event|0|||
156723725|NCT03752970|565735235|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
156723726|NCT03752970|565735236|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
156723727|NCT03752970|565735237|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
156794712|NCT01027351|566001286|FG004|Overall Study|Inappropriate enrollment|1|||
156794713|NCT01027351|566001287|FG005|Overall Study|Inappropriate enrollment|0|||
156452137|NCT03056040|564748555|FG000|Extension Period|Lost to Follow-up|0|||
156452138|NCT03056040|564748556|FG001|Extension Period|Lost to Follow-up|1|||
156723728|NCT03752970|565735235|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
156723729|NCT03752970|565735236|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
156723730|NCT03752970|565735237|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
156723731|NCT03752970|565735235|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
156723732|NCT03752970|565735236|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
156723733|NCT03752970|565735237|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
156723734|NCT03752970|565735235|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
156723735|NCT03752970|565735236|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
156723736|NCT03752970|565735237|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
156723737|NCT03752970|565735235|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
156723738|NCT03752970|565735236|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
156723739|NCT03752970|565735237|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
156723740|NCT04767282|565735238|FG000|Overall Study|Refused or did not begin surveys|6|||
156452139|NCT03056040|564748555|FG000|Extension Period|Death|0|||
156452140|NCT03056040|564748556|FG001|Extension Period|Death|3|||
156723741|NCT04767282|565735239|FG001|Overall Study|Refused or did not begin surveys|2|||
156723742|NCT04767282|565735240|FG002|Overall Study|Refused or did not begin surveys|2|||
156723743|NCT04767282|565735238|FG000|Overall Study|Duplicate household previously enrolled|2|||
156723744|NCT04767282|565735239|FG001|Overall Study|Duplicate household previously enrolled|0|||
156723745|NCT04767282|565735240|FG002|Overall Study|Duplicate household previously enrolled|8|||
156723746|NCT04767282|565735238|FG000|Overall Study|Unable to confirm legal guardian|0|||
156723747|NCT04767282|565735239|FG001|Overall Study|Unable to confirm legal guardian|2|||
156723748|NCT04767282|565735240|FG002|Overall Study|Unable to confirm legal guardian|8|||
156723749|NCT04767282|565735238|FG000|Overall Study|Withdrawal by Subject|0|||
156723750|NCT04767282|565735239|FG001|Overall Study|Withdrawal by Subject|0|||
156723751|NCT04767282|565735240|FG002|Overall Study|Withdrawal by Subject|6|||
156335746|NCT02025621|564328084|FG000|Overall Study|No longer eligible|10|||
156452141|NCT03056040|564748555|FG000|Extension Period|Withdrawal by Subject|1|||
156452142|NCT03056040|564748556|FG001|Extension Period|Withdrawal by Subject|0|||
156452143|NCT02921230|564748557|FG000|Overall Study|Withdrawal by Subject|20|||
156452144|NCT02921230|564748558|FG001|Overall Study|Withdrawal by Subject|8|||
156452145|NCT02921230|564748557|FG000|Overall Study|Death|12|||
156452146|NCT02921230|564748558|FG001|Overall Study|Death|3|||
156452147|NCT02921230|564748557|FG000|Overall Study|Protocol Violation|17|||
156452148|NCT02921230|564748558|FG001|Overall Study|Protocol Violation|6|||
156452149|NCT02921230|564748557|FG000|Overall Study|Early completion|5|||
156452150|NCT02921230|564748558|FG001|Overall Study|Early completion|1|||
156452151|NCT02921230|564748557|FG000|Overall Study|Pending data entry|1|||
156452152|NCT02921230|564748558|FG001|Overall Study|Pending data entry|0|||
156452153|NCT04142788|564748564|FG000|Overall Study|Trial terminated prematurely|2|||
156452154|NCT04142788|564748565|FG001|Overall Study|Trial terminated prematurely|2|||
156452155|NCT03396926|564748570|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
156452156|NCT03396926|564748571|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
156452157|NCT02035787|564748572|FG000|Overall Study- 12 Months|Adverse Event|3|||
156452158|NCT02035787|564748573|FG001|Overall Study- 12 Months|Adverse Event|0|||
156452159|NCT02035787|564748572|FG000|Overall Study- 12 Months|Complete response|4|||
156452160|NCT02035787|564748573|FG001|Overall Study- 12 Months|Complete response|1|||
156452161|NCT02035787|564748572|FG000|Overall Study- 12 Months|Protocol Violation|1|||
156452162|NCT02035787|564748573|FG001|Overall Study- 12 Months|Protocol Violation|1|||
156723752|NCT04767282|565735238|FG000|Overall Study|Survey comprehension challenges|4|||
156794714|NCT01027351|566001282|FG000|Overall Study|Protocol Violation|1|||
156794715|NCT01027351|566001283|FG001|Overall Study|Protocol Violation|0|||
156794716|NCT01027351|566001284|FG002|Overall Study|Protocol Violation|0|||
156794717|NCT01027351|566001285|FG003|Overall Study|Protocol Violation|1|||
156794718|NCT01027351|566001286|FG004|Overall Study|Protocol Violation|1|||
156794719|NCT01027351|566001287|FG005|Overall Study|Protocol Violation|0|||
156794720|NCT04650893|566001288|FG000|Overall Study|Lost to Follow-up|11|||
156794721|NCT04650893|566001289|FG001|Overall Study|Lost to Follow-up|10|||
156794722|NCT04650893|566001290|FG002|Overall Study|Lost to Follow-up|11|||
156794723|NCT04091438|566001291|FG000|Treatment Period 1 (1 Day)|Other|1|||
156794724|NCT04091438|566001292|FG001|Treatment Period 1 (1 Day)|Other|0|||
156794725|NCT04091438|566001291|FG000|Washout Period (1 Day)|Protocol deviation|0|||
156794726|NCT04091438|566001292|FG001|Washout Period (1 Day)|Protocol deviation|1|||
156794727|NCT04091438|566001291|FG000|Washout Period (1 Day)|Other|0|||
156794728|NCT04091438|566001292|FG001|Washout Period (1 Day)|Other|1|||
156794729|NCT04309500|566001293|FG000|Overall Study|Lost to Follow-up|1|||
156794730|NCT04309500|566001294|FG001|Overall Study|Lost to Follow-up|0|||
156794731|NCT04309500|566001295|FG002|Overall Study|Lost to Follow-up|0|||
156794732|NCT04309500|566001296|FG003|Overall Study|Lost to Follow-up|0|||
156794733|NCT00913835|566001297|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
156794734|NCT00913835|566001298|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
156794735|NCT00913835|566001297|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
156794736|NCT00913835|566001298|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
156794737|NCT00913835|566001297|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
156794738|NCT00913835|566001298|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
156794739|NCT00913835|566001297|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
156794740|NCT00913835|566001298|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
156794741|NCT00913835|566001297|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
156794742|NCT00913835|566001298|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
156794743|NCT00461812|566001299|FG000|Overall Study|study terminated|10|||
156794744|NCT01308788|566001300|FG000|2-year Treatment|medication change by treating physician|4|||
156794745|NCT01308788|566001301|FG001|2-year Treatment|medication change by treating physician|11|||
156794746|NCT00322218|566001302|FG000|Overall Study|Death|3|||
156794747|NCT00322218|566001303|FG001|Overall Study|Death|6|||
156794748|NCT00908141|566001321|FG000|Overall Study|Withdrawal by Subject|0|||
156452163|NCT03853746|564748574|FG000|Overall Study|Withdrawal by Subject|1|||
156794749|NCT00908141|566001322|FG001|Overall Study|Withdrawal by Subject|1|||
156794750|NCT00003645|566002760|FG000|Overall Study|Death|4|||
156794751|NCT00003645|566002761|FG001|Overall Study|Death|1|||
156794752|NCT00003645|566002760|FG000|Overall Study|Lost to Follow-up|7|||
156452164|NCT01396278|564748575|FG000|Overall Study|Adverse Event|0|||
156452165|NCT01396278|564748576|FG001|Overall Study|Adverse Event|0|||
156452166|NCT01396278|564748577|FG002|Overall Study|Adverse Event|0|||
156452167|NCT01396278|564748578|FG003|Overall Study|Adverse Event|2|||
156875674|NCT02100696|566303627|FG002|Induction Phase|Multiple Reasons|8|||
156875675|NCT02100696|566303628|FG003|Induction Phase|Multiple Reasons|0|||
156335747|NCT02025621|564328085|FG001|Overall Study|No longer eligible|15|||
156335748|NCT02025621|564328084|FG000|Overall Study|Surgery initiated before infusion|3|||
156335749|NCT02025621|564328085|FG001|Overall Study|Surgery initiated before infusion|3|||
156452168|NCT01396278|564748579|FG004|Overall Study|Adverse Event|0|||
156452169|NCT01396278|564748575|FG000|Overall Study|Withdraw due to trial termination|2|||
156452170|NCT01396278|564748576|FG001|Overall Study|Withdraw due to trial termination|1|||
156452171|NCT01396278|564748577|FG002|Overall Study|Withdraw due to trial termination|1|||
156452172|NCT01396278|564748578|FG003|Overall Study|Withdraw due to trial termination|0|||
156452173|NCT01396278|564748579|FG004|Overall Study|Withdraw due to trial termination|2|||
156452174|NCT05763823|564748581|FG000|Overall Study|Death|6|||
156452175|NCT05763823|564748581|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156875676|NCT02100696|566303629|FG004|Induction Phase|Multiple Reasons|0|||
156875677|NCT02100696|566303630|FG005|Induction Phase|Multiple Reasons|0|||
156875678|NCT02100696|566303625|FG000|Maintenance Phase|Adverse Event|0|||
156875679|NCT02100696|566303626|FG001|Maintenance Phase|Adverse Event|0|||
156875680|NCT02100696|566303627|FG002|Maintenance Phase|Adverse Event|0|||
156875681|NCT02100696|566303628|FG003|Maintenance Phase|Adverse Event|0|||
156875682|NCT02100696|566303629|FG004|Maintenance Phase|Adverse Event|0|||
156875683|NCT02100696|566303630|FG005|Maintenance Phase|Adverse Event|2|||
156875684|NCT02100696|566303625|FG000|Maintenance Phase|Lost to Follow-up|0|||
156875685|NCT02100696|566303626|FG001|Maintenance Phase|Lost to Follow-up|0|||
156875686|NCT02100696|566303627|FG002|Maintenance Phase|Lost to Follow-up|0|||
156875687|NCT02100696|566303628|FG003|Maintenance Phase|Lost to Follow-up|0|||
156875688|NCT02100696|566303629|FG004|Maintenance Phase|Lost to Follow-up|1|||
156875689|NCT02100696|566303630|FG005|Maintenance Phase|Lost to Follow-up|0|||
156875690|NCT02100696|566303625|FG000|Maintenance Phase|Protocol Violation|0|||
156875691|NCT02100696|566303626|FG001|Maintenance Phase|Protocol Violation|0|||
156875692|NCT02100696|566303627|FG002|Maintenance Phase|Protocol Violation|0|||
156875693|NCT02100696|566303628|FG003|Maintenance Phase|Protocol Violation|0|||
156875694|NCT02100696|566303629|FG004|Maintenance Phase|Protocol Violation|1|||
156875695|NCT02100696|566303630|FG005|Maintenance Phase|Protocol Violation|0|||
156875696|NCT02100696|566303625|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156875697|NCT02100696|566303626|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156875698|NCT02100696|566303627|FG002|Maintenance Phase|Withdrawal by Subject|0|||
156452176|NCT05763823|564748581|FG000|Overall Study|Withdrawal by Subject|6|||
156452177|NCT00999804|564748582|FG000|Overall Study|Lack of Efficacy|9|||
156452178|NCT00999804|564748583|FG001|Overall Study|Lack of Efficacy|2|||
156452179|NCT00999804|564748582|FG000|Overall Study|Adverse Event|4|||
156452180|NCT00999804|564748583|FG001|Overall Study|Adverse Event|3|||
156452181|NCT00999804|564748582|FG000|Overall Study|Withdrawal by Subject|4|||
156452182|NCT00999804|564748583|FG001|Overall Study|Withdrawal by Subject|0|||
156452183|NCT00999804|564748582|FG000|Overall Study|Death|1|||
156452184|NCT00999804|564748583|FG001|Overall Study|Death|0|||
156452185|NCT00999804|564748582|FG000|Overall Study|Ineligible|3|||
156452186|NCT00999804|564748583|FG001|Overall Study|Ineligible|0|||
156452187|NCT05311384|564748584|FG000|Overall Study|Uncontrolled health conditions|2|||
156452188|NCT05311384|564748584|FG000|Overall Study|Withdrawal by Subject|1|||
156452189|NCT02724631|564748591|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
156452190|NCT03766009|564748597|FG000|Usual Care|Death|0|||
156452191|NCT03766009|564748598|FG001|Usual Care|Death|0|||
156452192|NCT03766009|564748599|FG002|Usual Care|Death|0|||
156452193|NCT03766009|564748600|FG003|Usual Care|Death|1|||
156723753|NCT04767282|565735239|FG001|Overall Study|Survey comprehension challenges|0|||
156875699|NCT02100696|566303628|FG003|Maintenance Phase|Withdrawal by Subject|1|||
156875700|NCT02100696|566303629|FG004|Maintenance Phase|Withdrawal by Subject|4|||
156875701|NCT02100696|566303630|FG005|Maintenance Phase|Withdrawal by Subject|2|||
156875702|NCT02100696|566303625|FG000|Maintenance Phase|Physician Decision|0|||
156335750|NCT00739674|564328086|FG000|Overall Study|Screening failures|19|||
156875703|NCT02100696|566303626|FG001|Maintenance Phase|Physician Decision|0|||
156875704|NCT02100696|566303627|FG002|Maintenance Phase|Physician Decision|0|||
156335751|NCT00739674|564328087|FG001|Overall Study|Screening failures|17|||
156452194|NCT03766009|564748601|FG004|Usual Care|Death|0|||
156452195|NCT03766009|564748602|FG005|Usual Care|Death|0|||
156452196|NCT03766009|564748597|FG000|Usual Care|Lost to Follow-up|0|||
156452197|NCT03766009|564748598|FG001|Usual Care|Lost to Follow-up|0|||
156723754|NCT04767282|565735240|FG002|Overall Study|Survey comprehension challenges|0|||
156452198|NCT03766009|564748599|FG002|Usual Care|Lost to Follow-up|0|||
156452199|NCT03766009|564748600|FG003|Usual Care|Lost to Follow-up|1|||
156875705|NCT02100696|566303628|FG003|Maintenance Phase|Physician Decision|0|||
156875706|NCT02100696|566303629|FG004|Maintenance Phase|Physician Decision|1|||
156875707|NCT02100696|566303630|FG005|Maintenance Phase|Physician Decision|0|||
156452200|NCT03766009|564748601|FG004|Usual Care|Lost to Follow-up|0|||
156875708|NCT02100696|566303625|FG000|Maintenance Phase|Multiple Reasons|0|||
156875709|NCT02100696|566303626|FG001|Maintenance Phase|Multiple Reasons|0|||
156875710|NCT02100696|566303627|FG002|Maintenance Phase|Multiple Reasons|0|||
156875711|NCT02100696|566303628|FG003|Maintenance Phase|Multiple Reasons|0|||
156452201|NCT03766009|564748602|FG005|Usual Care|Lost to Follow-up|0|||
156452202|NCT03766009|564748597|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
156723755|NCT01467713|565735242|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
156723756|NCT01467713|565735243|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
156723757|NCT01467713|565735244|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
156723758|NCT01467713|565735245|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
156723759|NCT01467713|565735242|FG000|Overall Study|Major Protocol Deviation|2|||
156723760|NCT01467713|565735243|FG001|Overall Study|Major Protocol Deviation|4|||
156723761|NCT01467713|565735244|FG002|Overall Study|Major Protocol Deviation|4|||
156723762|NCT01467713|565735245|FG003|Overall Study|Major Protocol Deviation|1|||
156723763|NCT01467713|565735242|FG000|Overall Study|Lost to Follow-up|9|||
156723764|NCT01467713|565735243|FG001|Overall Study|Lost to Follow-up|12|||
156723765|NCT01467713|565735244|FG002|Overall Study|Lost to Follow-up|6|||
156723766|NCT01467713|565735245|FG003|Overall Study|Lost to Follow-up|9|||
156723767|NCT01467713|565735242|FG000|Overall Study|Voluntary Withdrawal|18|||
156723768|NCT01467713|565735243|FG001|Overall Study|Voluntary Withdrawal|14|||
156723769|NCT01467713|565735244|FG002|Overall Study|Voluntary Withdrawal|21|||
156723770|NCT01467713|565735245|FG003|Overall Study|Voluntary Withdrawal|20|||
156723771|NCT01467713|565735242|FG000|Overall Study|Study Termination|23|||
156723772|NCT01467713|565735243|FG001|Overall Study|Study Termination|33|||
156723773|NCT01467713|565735244|FG002|Overall Study|Study Termination|28|||
156723774|NCT01467713|565735245|FG003|Overall Study|Study Termination|29|||
156723775|NCT01467713|565735242|FG000|Overall Study|Pregnancy|0|||
156723776|NCT01467713|565735243|FG001|Overall Study|Pregnancy|1|||
156723777|NCT01467713|565735244|FG002|Overall Study|Pregnancy|1|||
156723778|NCT01467713|565735245|FG003|Overall Study|Pregnancy|3|||
156723779|NCT01467713|565735242|FG000|Overall Study|Relapse|35|||
156723780|NCT01467713|565735243|FG001|Overall Study|Relapse|25|||
156723781|NCT01467713|565735244|FG002|Overall Study|Relapse|28|||
156723782|NCT01467713|565735245|FG003|Overall Study|Relapse|35|||
156723783|NCT01467713|565735242|FG000|Overall Study|Reason not Specified|6|||
156723784|NCT01467713|565735243|FG001|Overall Study|Reason not Specified|11|||
156723785|NCT01467713|565735244|FG002|Overall Study|Reason not Specified|8|||
156723786|NCT01467713|565735245|FG003|Overall Study|Reason not Specified|7|||
156723787|NCT01894841|565735248|FG000|Overall Study|Withdrawal by Subject|9|||
156723788|NCT01894841|565735249|FG001|Overall Study|Withdrawal by Subject|4|||
156723789|NCT01894841|565735248|FG000|Overall Study|Withdrawn by investigator|2|||
156723790|NCT01894841|565735249|FG001|Overall Study|Withdrawn by investigator|2|||
156723791|NCT01894841|565735248|FG000|Overall Study|Lost to Follow-up|7|||
156723792|NCT01894841|565735249|FG001|Overall Study|Lost to Follow-up|3|||
156723793|NCT01100086|565735250|FG000|Period 1|Withdrawal by Subject|1|||
156452203|NCT03766009|564748598|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
156452204|NCT03766009|564748599|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
156452205|NCT03766009|564748600|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
156452206|NCT03766009|564748601|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
156533474|NCT00733304|565048802|FG001|Overall Study|Physician Decision|1|||
156723794|NCT01100086|565735251|FG001|Period 1|Withdrawal by Subject|0|||
156723795|NCT01611935|565735252|FG000|Overall Study|Family Declined Participation|1|||
156723796|NCT01611935|565735253|FG001|Overall Study|Family Declined Participation|0|||
156723797|NCT01735916|565735254|FG000|Overall Study|Subject not eligible to be randomized|11|||
156723798|NCT01735916|565735255|FG001|Overall Study|Subject not eligible to be randomized|0|||
156723799|NCT01735916|565735256|FG002|Overall Study|Subject not eligible to be randomized|0|||
156723800|NCT01735916|565735254|FG000|Overall Study|Early termination of study by sponsor|4|||
156723801|NCT01735916|565735255|FG001|Overall Study|Early termination of study by sponsor|19|||
156723802|NCT01735916|565735256|FG002|Overall Study|Early termination of study by sponsor|7|||
156723803|NCT01735916|565735254|FG000|Overall Study|Withdrawal by Subject|3|||
156723804|NCT01735916|565735255|FG001|Overall Study|Withdrawal by Subject|0|||
156723805|NCT01735916|565735256|FG002|Overall Study|Withdrawal by Subject|0|||
156723806|NCT04227197|565735257|FG000|Randomization|Protocol Violation|1|||
156723807|NCT04227197|565735258|FG001|Randomization|Protocol Violation|0|||
156723808|NCT04227197|565735257|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
156723809|NCT04227197|565735258|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
156723810|NCT04227197|565735257|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
156794753|NCT00003645|566002761|FG001|Overall Study|Lost to Follow-up|8|||
156794754|NCT00003645|566002760|FG000|Overall Study|Withdrawal by Subject|1|||
156794755|NCT00003645|566002761|FG001|Overall Study|Withdrawal by Subject|3|||
156794756|NCT03345550|566002764|FG000|Overall Study|Withdrawal by Subject|1|||
156794757|NCT03345550|566002765|FG001|Overall Study|Withdrawal by Subject|0|||
156794758|NCT03345550|566002764|FG000|Overall Study|Lost to Follow-up|4|||
156794759|NCT03345550|566002765|FG001|Overall Study|Lost to Follow-up|5|||
156794760|NCT03014089|566002769|FG000|Overall Study|Withdrawal by Subject|0|||
156794761|NCT03014089|566002770|FG001|Overall Study|Withdrawal by Subject|1|||
156794762|NCT03014089|566002771|FG002|Overall Study|Withdrawal by Subject|1|||
156794763|NCT03014089|566002772|FG003|Overall Study|Withdrawal by Subject|1|||
156452207|NCT03766009|564748602|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
156452208|NCT03766009|564748597|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
156452209|NCT03766009|564748598|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
156452210|NCT03766009|564748599|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
156723811|NCT04227197|565735258|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
156723812|NCT04227197|565735257|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
156723813|NCT04227197|565735258|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
156723814|NCT04227197|565735257|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
156723815|NCT04227197|565735258|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
156723816|NCT04227197|565735257|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
156723817|NCT04227197|565735258|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
156723818|NCT04227197|565735257|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
156723819|NCT04227197|565735258|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
156723820|NCT02549859|565735263|FG000|Long-term 60 Hz DBS|Study Closed|1|||
156723821|NCT01379768|565735264|FG000|Overall Study|Adverse Event|1|||
156723822|NCT01379768|565735265|FG001|Overall Study|Adverse Event|1|||
156723823|NCT01379768|565735266|FG002|Overall Study|Adverse Event|0|||
156723824|NCT01379768|565735264|FG000|Overall Study|Lost to Follow-up|2|||
156723825|NCT01379768|565735265|FG001|Overall Study|Lost to Follow-up|0|||
156723826|NCT01379768|565735266|FG002|Overall Study|Lost to Follow-up|0|||
156723827|NCT01209949|565735274|FG000|Overall Study|Lost to Follow-up|3|||
156723828|NCT00729612|565735279|FG000|Overall Study|Non evaluable for response|10|||
156723829|NCT00708552|565735280|FG000|Overall Study|Adverse Event|10|||
156723830|NCT00708552|565735281|FG001|Overall Study|Adverse Event|3|||
156723831|NCT00708552|565735282|FG002|Overall Study|Adverse Event|4|||
156723832|NCT00708552|565735283|FG003|Overall Study|Adverse Event|6|||
156723833|NCT00708552|565735280|FG000|Overall Study|Lack of Efficacy|0|||
156723834|NCT00708552|565735281|FG001|Overall Study|Lack of Efficacy|4|||
156723835|NCT00708552|565735282|FG002|Overall Study|Lack of Efficacy|1|||
156723836|NCT00708552|565735283|FG003|Overall Study|Lack of Efficacy|0|||
156335752|NCT00739674|564328086|FG000|Overall Study|Site 212 removal|19|||
156335753|NCT00739674|564328087|FG001|Overall Study|Site 212 removal|13|||
156723837|NCT00708552|565735280|FG000|Overall Study|Protocol Violation|0|||
156723838|NCT00708552|565735281|FG001|Overall Study|Protocol Violation|0|||
156723839|NCT00708552|565735282|FG002|Overall Study|Protocol Violation|2|||
156723840|NCT00708552|565735283|FG003|Overall Study|Protocol Violation|4|||
156794764|NCT03014089|566002769|FG000|Overall Study|Lost to Follow-up|1|||
156794765|NCT03014089|566002770|FG001|Overall Study|Lost to Follow-up|0|||
156794766|NCT03014089|566002771|FG002|Overall Study|Lost to Follow-up|0|||
156794767|NCT03014089|566002772|FG003|Overall Study|Lost to Follow-up|0|||
156794768|NCT03014089|566002769|FG000|Overall Study|Adverse Event|1|||
156794769|NCT03014089|566002770|FG001|Overall Study|Adverse Event|0|||
156794770|NCT03014089|566002771|FG002|Overall Study|Adverse Event|1|||
156794771|NCT03014089|566002772|FG003|Overall Study|Adverse Event|0|||
156794772|NCT01149460|566002773|FG000|Overall Study|Withdrawal by Subject|0|||
156794773|NCT01149460|566002774|FG001|Overall Study|Withdrawal by Subject|2|||
156794774|NCT00321932|566002775|FG000|Overall Study|Death|3|||
156794775|NCT00321932|566002776|FG001|Overall Study|Death|6|||
156794776|NCT00321932|566002775|FG000|Overall Study|Withdrawal by Subject|3|||
156794777|NCT00321932|566002776|FG001|Overall Study|Withdrawal by Subject|6|||
156794778|NCT00321932|566002775|FG000|Overall Study|Early relapse|2|||
156794779|NCT00321932|566002776|FG001|Overall Study|Early relapse|8|||
156794780|NCT00321932|566002775|FG000|Overall Study|Missing data|2|||
156794781|NCT00321932|566002776|FG001|Overall Study|Missing data|1|||
156794782|NCT02378480|566002777|FG000|Overall Study|Physician Decision|1|||
156794783|NCT02378480|566002778|FG001|Overall Study|Physician Decision|1|||
156794784|NCT02378480|566002777|FG000|Overall Study|Death|1|||
156794785|NCT02378480|566002778|FG001|Overall Study|Death|2|||
156794786|NCT02378480|566002777|FG000|Overall Study|Randomized, but Not Treated|6|||
156794787|NCT02378480|566002778|FG001|Overall Study|Randomized, but Not Treated|4|||
156794788|NCT02378480|566002777|FG000|Overall Study|Adverse Event|0|||
156794789|NCT02378480|566002778|FG001|Overall Study|Adverse Event|1|||
156794790|NCT02378480|566002777|FG000|Overall Study|Missed EOT/PTE Visit|1|||
156794791|NCT02378480|566002778|FG001|Overall Study|Missed EOT/PTE Visit|2|||
156794792|NCT02378480|566002777|FG000|Overall Study|Withdrawal by Subject|9|||
156794793|NCT02378480|566002778|FG001|Overall Study|Withdrawal by Subject|4|||
156794794|NCT02378480|566002777|FG000|Overall Study|Lost to Follow-up|10|||
156794795|NCT02378480|566002778|FG001|Overall Study|Lost to Follow-up|18|||
156335754|NCT00739674|564328086|FG000|Overall Study|No follow-up data|33|||
156335755|NCT00739674|564328087|FG001|Overall Study|No follow-up data|18|||
156794796|NCT01217892|566002779|FG000|Overall Study|Adverse Event|1|||
156794797|NCT01217892|566002780|FG001|Overall Study|Adverse Event|1|||
156794798|NCT01217892|566002781|FG002|Overall Study|Adverse Event|1|||
156794799|NCT01217892|566002782|FG003|Overall Study|Adverse Event|0|||
156723841|NCT00708552|565735280|FG000|Overall Study|Lost to Follow-up|4|||
156723842|NCT00708552|565735281|FG001|Overall Study|Lost to Follow-up|2|||
156875712|NCT02100696|566303629|FG004|Maintenance Phase|Multiple Reasons|2|||
156875713|NCT02100696|566303630|FG005|Maintenance Phase|Multiple Reasons|1|||
156875714|NCT03865381|566303634|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
156875715|NCT03865381|566303634|FG000|Overall Study|Withdrawal by Subject|2|||
156875716|NCT01583296|566303639|FG000|Overall Study|Withdrawal by Subject|11|||
156875717|NCT01583296|566303640|FG001|Overall Study|Withdrawal by Subject|10|||
156875718|NCT01063283|566303641|FG000|Cycle 1|Adverse Event|2|||
156875719|NCT01063283|566303642|FG001|Cycle 1|Adverse Event|0|||
156875720|NCT01063283|566303643|FG002|Cycle 1|Adverse Event|0|||
156875721|NCT01063283|566303641|FG000|Cycle 1|Technical failure in data collection|1|||
156875722|NCT01063283|566303642|FG001|Cycle 1|Technical failure in data collection|0|||
156875723|NCT01063283|566303643|FG002|Cycle 1|Technical failure in data collection|0|||
156875724|NCT02504216|566303646|FG000|Overall Study|Lost to Follow-up|3|||
156875725|NCT02504216|566303647|FG001|Overall Study|Lost to Follow-up|3|||
156875726|NCT02504216|566303646|FG000|Overall Study|Withdrawal by Subject|8|||
156875727|NCT02504216|566303647|FG001|Overall Study|Withdrawal by Subject|12|||
156875728|NCT00223080|566303648|FG000|Overall Study|Withdrawal by Subject|253|||
156875729|NCT00223080|566303649|FG001|Overall Study|Withdrawal by Subject|232|||
156875730|NCT00223080|566303648|FG000|Overall Study|Required contraindicated med|0|||
156875731|NCT00223080|566303649|FG001|Overall Study|Required contraindicated med|1|||
156875732|NCT00223080|566303648|FG000|Overall Study|Non-compliant|7|||
156723843|NCT00708552|565735282|FG002|Overall Study|Lost to Follow-up|0|||
156723844|NCT00708552|565735283|FG003|Overall Study|Lost to Follow-up|1|||
156723845|NCT00708552|565735280|FG000|Overall Study|Physician Decision|1|||
156723846|NCT00708552|565735281|FG001|Overall Study|Physician Decision|2|||
156723847|NCT00708552|565735282|FG002|Overall Study|Physician Decision|0|||
156723848|NCT00708552|565735283|FG003|Overall Study|Physician Decision|0|||
156723849|NCT00708552|565735280|FG000|Overall Study|Withdrawal by Subject|12|||
156723850|NCT00708552|565735281|FG001|Overall Study|Withdrawal by Subject|7|||
156723851|NCT00708552|565735282|FG002|Overall Study|Withdrawal by Subject|8|||
156723852|NCT00708552|565735283|FG003|Overall Study|Withdrawal by Subject|10|||
156723853|NCT05600283|565735286|FG000|Overall Study|Withdrawal by Subject|3|||
156723854|NCT05600283|565735287|FG001|Overall Study|Withdrawal by Subject|8|||
156723855|NCT05600283|565735286|FG000|Overall Study|invalid individual swab|1|||
156723856|NCT05600283|565735287|FG001|Overall Study|invalid individual swab|0|||
156723857|NCT05600283|565735286|FG000|Overall Study|missing clinician collection|3|||
156723858|NCT05600283|565735287|FG001|Overall Study|missing clinician collection|0|||
156723859|NCT05600283|565735286|FG000|Overall Study|screening failure|0|||
156723860|NCT05600283|565735287|FG001|Overall Study|screening failure|2|||
156723861|NCT02883062|565735288|FG000|Overall Study|Withdrawal by Subject|6|||
156723862|NCT02883062|565735289|FG001|Overall Study|Withdrawal by Subject|0|||
156723863|NCT03839628|565735292|FG000|Overall Study|Withdrawal by Subject|1|||
156723864|NCT00380874|565735293|FG000|Overall Study|Adverse Event|7|||
156723865|NCT00380874|565735294|FG001|Overall Study|Adverse Event|7|||
156723866|NCT00380874|565735293|FG000|Overall Study|Death|1|||
156723867|NCT00380874|565735294|FG001|Overall Study|Death|0|||
156723868|NCT00380874|565735293|FG000|Overall Study|Withdrawal by Subject|2|||
156723869|NCT00380874|565735294|FG001|Overall Study|Withdrawal by Subject|1|||
156723870|NCT00380874|565735293|FG000|Overall Study|Not related to study drug|3|||
156723871|NCT00380874|565735294|FG001|Overall Study|Not related to study drug|2|||
156723872|NCT03380429|565735295|FG000|Overall Study|Physician Decision|0|||
156875733|NCT00223080|566303649|FG001|Overall Study|Non-compliant|7|||
156875734|NCT00223080|566303648|FG000|Overall Study|Moved from study area|37|||
156875735|NCT00223080|566303649|FG001|Overall Study|Moved from study area|47|||
156533475|NCT00733304|565048803|FG002|Overall Study|Physician Decision|3|||
156723873|NCT03380429|565735296|FG001|Overall Study|Physician Decision|1|||
156723874|NCT03380429|565735297|FG002|Overall Study|Physician Decision|0|||
156723875|NCT03380429|565735298|FG003|Overall Study|Physician Decision|1|||
156723876|NCT03380429|565735299|FG004|Overall Study|Physician Decision|1|||
156723877|NCT03380429|565735295|FG000|Overall Study|Withdrawal by Subject|3|||
156723878|NCT03380429|565735296|FG001|Overall Study|Withdrawal by Subject|3|||
156723879|NCT03380429|565735297|FG002|Overall Study|Withdrawal by Subject|5|||
156723880|NCT03380429|565735298|FG003|Overall Study|Withdrawal by Subject|2|||
156723881|NCT03380429|565735299|FG004|Overall Study|Withdrawal by Subject|1|||
156723882|NCT03380429|565735295|FG000|Overall Study|Lost to Follow-up|0|||
156723883|NCT03380429|565735296|FG001|Overall Study|Lost to Follow-up|2|||
156723884|NCT03380429|565735297|FG002|Overall Study|Lost to Follow-up|4|||
156723885|NCT03380429|565735298|FG003|Overall Study|Lost to Follow-up|3|||
156723886|NCT03380429|565735299|FG004|Overall Study|Lost to Follow-up|1|||
156723887|NCT03380429|565735295|FG000|Overall Study|Protocol Violation|1|||
156875736|NCT00223080|566303648|FG000|Overall Study|Lost to Follow-up|259|||
156875737|NCT00223080|566303649|FG001|Overall Study|Lost to Follow-up|284|||
156875738|NCT00223080|566303648|FG000|Overall Study|Death|85|||
156875739|NCT00223080|566303649|FG001|Overall Study|Death|74|||
156875740|NCT00223080|566303648|FG000|Overall Study|Other|14|||
156875741|NCT00223080|566303649|FG001|Overall Study|Other|11|||
156875742|NCT00223080|566303648|FG000|Overall Study|Reason not provided|141|||
156875743|NCT00223080|566303649|FG001|Overall Study|Reason not provided|140|||
156723888|NCT03380429|565735296|FG001|Overall Study|Protocol Violation|0|||
156723889|NCT03380429|565735297|FG002|Overall Study|Protocol Violation|1|||
156452211|NCT03766009|564748600|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
156452212|NCT03766009|564748601|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
156452213|NCT03766009|564748602|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
156452214|NCT03766009|564748597|FG000|Usual Care|No treatment or declined surgery|0|||
156452215|NCT03766009|564748598|FG001|Usual Care|No treatment or declined surgery|0|||
156452216|NCT03766009|564748599|FG002|Usual Care|No treatment or declined surgery|0|||
156452217|NCT03766009|564748600|FG003|Usual Care|No treatment or declined surgery|2|||
156452218|NCT03766009|564748601|FG004|Usual Care|No treatment or declined surgery|0|||
156723890|NCT03380429|565735298|FG003|Overall Study|Protocol Violation|0|||
156723891|NCT03380429|565735299|FG004|Overall Study|Protocol Violation|1|||
156723892|NCT03380429|565735295|FG000|Overall Study|Lack of Efficacy|0|||
156723893|NCT03380429|565735296|FG001|Overall Study|Lack of Efficacy|0|||
156723894|NCT03380429|565735297|FG002|Overall Study|Lack of Efficacy|0|||
156723895|NCT03380429|565735298|FG003|Overall Study|Lack of Efficacy|2|||
156723896|NCT03380429|565735299|FG004|Overall Study|Lack of Efficacy|1|||
156723897|NCT03380429|565735295|FG000|Overall Study|Adverse Event|1|||
156723898|NCT03380429|565735296|FG001|Overall Study|Adverse Event|1|||
156723899|NCT03380429|565735297|FG002|Overall Study|Adverse Event|1|||
156723900|NCT03380429|565735298|FG003|Overall Study|Adverse Event|2|||
156723901|NCT03380429|565735299|FG004|Overall Study|Adverse Event|0|||
156723902|NCT01198470|565735304|FG000|Overall Study|Adverse Event|2|||
156723903|NCT02314026|565735305|FG000|Overall Study|Protocol Violation|28|||
156723904|NCT02949973|565735306|FG000|Overall Study|Physician Decision|1|||
156723905|NCT01139775|565735307|FG000|Overall Study|Adverse Event|0|||
156723906|NCT01139775|565735308|FG001|Overall Study|Adverse Event|6|||
156723907|NCT01139775|565735309|FG002|Overall Study|Adverse Event|2|||
156723908|NCT01139775|565735307|FG000|Overall Study|Protocol Violation|0|||
156723909|NCT01139775|565735308|FG001|Overall Study|Protocol Violation|5|||
156723910|NCT01139775|565735309|FG002|Overall Study|Protocol Violation|0|||
156723911|NCT01139775|565735307|FG000|Overall Study|Withdrawal by Subject|1|||
156723912|NCT01139775|565735308|FG001|Overall Study|Withdrawal by Subject|0|||
156723913|NCT01139775|565735309|FG002|Overall Study|Withdrawal by Subject|2|||
156723914|NCT01139775|565735307|FG000|Overall Study|Physician Decision|0|||
156723915|NCT01139775|565735308|FG001|Overall Study|Physician Decision|2|||
156723916|NCT01139775|565735309|FG002|Overall Study|Physician Decision|2|||
156452219|NCT03766009|564748602|FG005|Usual Care|No treatment or declined surgery|0|||
156452220|NCT03766009|564748597|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
156723917|NCT00586703|565735310|FG000|Overall Study|Death|12|||
156723918|NCT01924689|565735311|FG000|Overall Study|Death|0|||
156723919|NCT01924689|565735312|FG001|Overall Study|Death|1|||
156723920|NCT01924689|565735313|FG002|Overall Study|Death|0|||
156723921|NCT01924689|565735314|FG003|Overall Study|Death|1|||
156723922|NCT01924689|565735315|FG004|Overall Study|Death|0|||
156723923|NCT01924689|565735316|FG005|Overall Study|Death|0|||
156723924|NCT01924689|565735311|FG000|Overall Study|Disease progression|0|||
156723925|NCT01924689|565735312|FG001|Overall Study|Disease progression|0|||
156723926|NCT01924689|565735313|FG002|Overall Study|Disease progression|2|||
156723927|NCT01924689|565735314|FG003|Overall Study|Disease progression|0|||
156723928|NCT01924689|565735315|FG004|Overall Study|Disease progression|3|||
156723929|NCT01924689|565735316|FG005|Overall Study|Disease progression|2|||
156723930|NCT01924689|565735311|FG000|Overall Study|New therapy or study|3|||
156723931|NCT01924689|565735312|FG001|Overall Study|New therapy or study|2|||
156723932|NCT01924689|565735313|FG002|Overall Study|New therapy or study|1|||
156723933|NCT01924689|565735314|FG003|Overall Study|New therapy or study|4|||
156452221|NCT03766009|564748598|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
156723934|NCT01924689|565735315|FG004|Overall Study|New therapy or study|2|||
156723935|NCT01924689|565735316|FG005|Overall Study|New therapy or study|0|||
156723936|NCT01924689|565735311|FG000|Overall Study|Withdrawal of consent|0|||
156723937|NCT01924689|565735312|FG001|Overall Study|Withdrawal of consent|0|||
156723938|NCT01924689|565735313|FG002|Overall Study|Withdrawal of consent|1|||
156723939|NCT01924689|565735314|FG003|Overall Study|Withdrawal of consent|1|||
156723940|NCT01924689|565735315|FG004|Overall Study|Withdrawal of consent|0|||
156723941|NCT01924689|565735316|FG005|Overall Study|Withdrawal of consent|0|||
156723942|NCT01924689|565735311|FG000|Overall Study|Other|0|||
156723943|NCT01924689|565735312|FG001|Overall Study|Other|0|||
156723944|NCT01924689|565735313|FG002|Overall Study|Other|0|||
156723945|NCT01924689|565735314|FG003|Overall Study|Other|0|||
156723946|NCT01924689|565735315|FG004|Overall Study|Other|1|||
156723947|NCT01924689|565735316|FG005|Overall Study|Other|0|||
156723948|NCT05271175|565735318|FG000|One Week Follow up|Lost to Follow-up|10|||
156723949|NCT05271175|565735319|FG001|One Week Follow up|Lost to Follow-up|7|||
156723950|NCT05271175|565735320|FG002|One Week Follow up|Lost to Follow-up|5|||
156723951|NCT05271175|565735318|FG000|One Month Follow up|Lost to Follow-up|12|||
156723952|NCT05271175|565735319|FG001|One Month Follow up|Lost to Follow-up|7|||
156723953|NCT05271175|565735320|FG002|One Month Follow up|Lost to Follow-up|9|||
156452222|NCT03766009|564748599|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
156452223|NCT03766009|564748600|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
156452224|NCT03766009|564748601|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
156452225|NCT03766009|564748602|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
156452226|NCT03766009|564748597|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
156723954|NCT05271175|565735318|FG000|Six Months Follow up|Lost to Follow-up|8|||
156723955|NCT05271175|565735319|FG001|Six Months Follow up|Lost to Follow-up|2|||
156723956|NCT05271175|565735320|FG002|Six Months Follow up|Lost to Follow-up|2|||
156723957|NCT00468819|565735321|FG000|Overall Study|Withdrawal by Subject|4|||
156723958|NCT00468819|565735322|FG001|Overall Study|Withdrawal by Subject|0|||
156723959|NCT00468819|565735323|FG002|Overall Study|Withdrawal by Subject|1|||
156723960|NCT00468819|565735321|FG000|Overall Study|Lost to Follow-up|0|||
156723961|NCT00468819|565735322|FG001|Overall Study|Lost to Follow-up|0|||
156723962|NCT00468819|565735323|FG002|Overall Study|Lost to Follow-up|1|||
156723963|NCT00468819|565735321|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
156723964|NCT00468819|565735322|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
156723965|NCT00468819|565735323|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
156723966|NCT02492867|565735324|FG000|Overall Study|Alternate therapy|1|||
156723967|NCT02492867|565735324|FG000|Overall Study|Withdrawal by Subject|2|||
156723968|NCT02492867|565735324|FG000|Overall Study|Disease progression after treatment started|1|||
156723969|NCT02492867|565735324|FG000|Overall Study|Death|1|||
156723970|NCT03296527|565735325|FG000|Overall Study|Adverse Event|15|||
156723971|NCT03296527|565735326|FG001|Overall Study|Adverse Event|33|||
156723972|NCT03296527|565735325|FG000|Overall Study|Protocol Deviation|4|||
156723973|NCT03296527|565735326|FG001|Overall Study|Protocol Deviation|0|||
156723974|NCT03296527|565735325|FG000|Overall Study|Participant withdrew consent|3|||
156723975|NCT03296527|565735326|FG001|Overall Study|Participant withdrew consent|1|||
156723976|NCT03296527|565735325|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
156723977|NCT03296527|565735326|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
156723978|NCT03296527|565735325|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
156723979|NCT03296527|565735326|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
156723980|NCT03296527|565735325|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
156723981|NCT03296527|565735326|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
156723982|NCT03296527|565735325|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
156723983|NCT03296527|565735326|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
156723984|NCT03296527|565735325|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
156723985|NCT03296527|565735326|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
156723986|NCT01597973|565735327|FG000|Overall Study|Found ineligible before study medication started|4|||
156335756|NCT00739674|564328086|FG000|Overall Study|Dietician consultation >30 days|1|||
156335757|NCT00739674|564328087|FG001|Overall Study|Dietician consultation >30 days|9|||
156335758|NCT00739674|564328086|FG000|Overall Study|Adverse Event|22|||
156335759|NCT00739674|564328087|FG001|Overall Study|Adverse Event|13|||
156335760|NCT00739674|564328086|FG000|Overall Study|Death|1|||
156452227|NCT03766009|564748598|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
156452228|NCT03766009|564748599|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
156723987|NCT01597973|565735328|FG001|Overall Study|Found ineligible before study medication started|2|||
156723988|NCT01597973|565735327|FG000|Overall Study|Eligible pathogen not confirmed|14|||
156723989|NCT01597973|565735328|FG001|Overall Study|Eligible pathogen not confirmed|15|||
156723990|NCT01597973|565735327|FG000|Overall Study|LAR not authorized to consent|0|||
156723991|NCT01597973|565735328|FG001|Overall Study|LAR not authorized to consent|1|||
156723992|NCT01597973|565735327|FG000|Overall Study|Ineligible due to early seizures|1|||
156723993|NCT01597973|565735328|FG001|Overall Study|Ineligible due to early seizures|0|||
156723994|NCT01597973|565735327|FG000|Overall Study|Ineligible due to non-target infection|1|||
156723995|NCT01597973|565735328|FG001|Overall Study|Ineligible due to non-target infection|1|||
156723996|NCT01326845|565735329|FG000|Overall Study|Administrative Problems|5|||
156723997|NCT01326845|565735330|FG001|Overall Study|Administrative Problems|2|||
156723998|NCT01326845|565735329|FG000|Overall Study|Adverse Event|1|||
156723999|NCT01326845|565735330|FG001|Overall Study|Adverse Event|0|||
156724000|NCT01326845|565735329|FG000|Overall Study|Misisng|1|||
156724001|NCT01326845|565735330|FG001|Overall Study|Misisng|3|||
156724002|NCT00682786|565735333|FG000|Overall Study|Withdrawal by Subject|2|||
156724003|NCT00682786|565735334|FG001|Overall Study|Withdrawal by Subject|2|||
156724004|NCT00682786|565735333|FG000|Overall Study|Did not receive irinotecan|0|||
156724005|NCT00682786|565735334|FG001|Overall Study|Did not receive irinotecan|1|||
156724006|NCT01831635|565735335|FG000|Overall Study|Withdrawal by Subject|0|||
156724007|NCT01831635|565735336|FG001|Overall Study|Withdrawal by Subject|2|||
156724008|NCT01831635|565735337|FG002|Overall Study|Withdrawal by Subject|0|||
156724009|NCT02859337|565735338|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
156335761|NCT00739674|564328087|FG001|Overall Study|Death|0|||
156724010|NCT02859337|565735339|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
156724011|NCT02859337|565735340|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
156724012|NCT02859337|565735338|FG000|Overall Study|Withdrawal by Subject|3|||
156724013|NCT02859337|565735339|FG001|Overall Study|Withdrawal by Subject|1|||
156724014|NCT02859337|565735340|FG002|Overall Study|Withdrawal by Subject|0|||
156724015|NCT02859337|565735338|FG000|Overall Study|Lost to Follow-up|1|||
156724016|NCT02859337|565735339|FG001|Overall Study|Lost to Follow-up|0|||
156724017|NCT02859337|565735340|FG002|Overall Study|Lost to Follow-up|0|||
156724018|NCT03817190|565735341|FG000|Overall Study|Early Termination|13|||
156724019|NCT03817190|565735342|FG001|Overall Study|Early Termination|20|||
156724020|NCT03817190|565735341|FG000|Overall Study|Adverse Event|10|||
156724021|NCT03817190|565735342|FG001|Overall Study|Adverse Event|17|||
156724022|NCT03817190|565735341|FG000|Overall Study|Withdrawal by Subject|12|||
156724023|NCT03817190|565735342|FG001|Overall Study|Withdrawal by Subject|8|||
156724024|NCT03817190|565735341|FG000|Overall Study|Lost to Follow-up|11|||
156724025|NCT03817190|565735342|FG001|Overall Study|Lost to Follow-up|7|||
156724026|NCT03817190|565735341|FG000|Overall Study|Lack of Efficacy|7|||
156724027|NCT03817190|565735342|FG001|Overall Study|Lack of Efficacy|5|||
156724028|NCT03817190|565735341|FG000|Overall Study|Investigator Decision|5|||
156724029|NCT03817190|565735342|FG001|Overall Study|Investigator Decision|1|||
156724030|NCT03817190|565735341|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
156724031|NCT03817190|565735342|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
156724032|NCT03817190|565735341|FG000|Overall Study|Lack of Contact|1|||
156724033|NCT03817190|565735342|FG001|Overall Study|Lack of Contact|0|||
156724034|NCT03817190|565735341|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
156875744|NCT00223080|566303648|FG000|Overall Study|Adverse Event|0|||
156875745|NCT00223080|566303649|FG001|Overall Study|Adverse Event|1|||
156875746|NCT02598583|566303650|FG000|Extension Period|Withdrawal by Subject|1|||
156875747|NCT02598583|566303651|FG001|Extension Period|Withdrawal by Subject|0|||
156724035|NCT03817190|565735342|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
156724036|NCT04146012|565735343|FG000|Overall Study|Study Terminated|30|||
156724037|NCT04146012|565735344|FG001|Overall Study|Study Terminated|15|||
156724038|NCT01546025|565735345|FG000|Overall Study|Lost to Follow-up|0|||
156724039|NCT01546025|565735346|FG001|Overall Study|Lost to Follow-up|1|||
156724040|NCT02729025|565735347|FG000|Overall Study|Sponsor Decision|0|||
156724041|NCT02729025|565735348|FG001|Overall Study|Sponsor Decision|1|||
156724042|NCT03668119|565737001|FG000|Pre-treatment|Disease Progression|1|||
156724043|NCT03668119|565737002|FG001|Pre-treatment|Disease Progression|0|||
156724044|NCT03668119|565737001|FG000|Treatment|Disease Progression|76|||
156724045|NCT03668119|565737002|FG001|Treatment|Disease Progression|57|||
156724046|NCT03668119|565737001|FG000|Treatment|Study drug toxicity|19|||
156724047|NCT03668119|565737002|FG001|Treatment|Study drug toxicity|1|||
156724048|NCT03668119|565737001|FG000|Treatment|Death|3|||
156724049|NCT03668119|565737002|FG001|Treatment|Death|0|||
156724050|NCT03668119|565737001|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
156724051|NCT03668119|565737002|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
156724052|NCT03668119|565737001|FG000|Treatment|Withdrawal by Subject|1|||
156724053|NCT03668119|565737002|FG001|Treatment|Withdrawal by Subject|1|||
156724054|NCT03668119|565737001|FG000|Treatment|Participant request to discontinue study treatment|3|||
156724055|NCT03668119|565737002|FG001|Treatment|Participant request to discontinue study treatment|1|||
156724056|NCT03668119|565737001|FG000|Treatment|Maximum Clinical Benefit|0|||
156724057|NCT03668119|565737002|FG001|Treatment|Maximum Clinical Benefit|1|||
156724058|NCT03668119|565737001|FG000|Treatment|Participants completed treatment|27|||
156724059|NCT03668119|565737002|FG001|Treatment|Participants completed treatment|11|||
156724060|NCT03668119|565737001|FG000|Treatment|Other reasons|2|||
156724061|NCT03668119|565737002|FG001|Treatment|Other reasons|1|||
156724062|NCT03769168|565737003|FG000|Overall Study|Adverse Event|0|||
156724063|NCT03769168|565737004|FG001|Overall Study|Adverse Event|1|||
156724064|NCT03769168|565737003|FG000|Overall Study|Lack of Efficacy|2|||
156724065|NCT03769168|565737004|FG001|Overall Study|Lack of Efficacy|4|||
156724066|NCT03769168|565737003|FG000|Overall Study|Post study access to treatment|3|||
156724067|NCT03769168|565737004|FG001|Overall Study|Post study access to treatment|11|||
156724068|NCT03769168|565737003|FG000|Overall Study|Physician Decision|1|||
156724069|NCT03769168|565737004|FG001|Overall Study|Physician Decision|4|||
156724070|NCT03769168|565737003|FG000|Overall Study|Subject Decision|2|||
156724071|NCT03769168|565737004|FG001|Overall Study|Subject Decision|4|||
156724072|NCT03769168|565737003|FG000|Overall Study|Guardian decision|1|||
156724073|NCT03769168|565737004|FG001|Overall Study|Guardian decision|0|||
156724074|NCT04053868|565737005|FG000|Overall Study|Withdrawal by Subject|1|||
156724075|NCT04053868|565737006|FG001|Overall Study|Withdrawal by Subject|0|||
156724076|NCT05731700|565737007|FG000|Overall Study|Death|1|||
156724077|NCT00975611|565737008|FG000|Overall Study|Screen Fail|16|||
156724078|NCT00975611|565737008|FG000|Overall Study|Physician Decision|1|||
156724079|NCT05468164|565737011|FG000|Treatment Period 4|Adverse Event|0|||
156724080|NCT05468164|565737012|FG001|Treatment Period 4|Adverse Event|0|||
156452229|NCT03766009|564748600|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
156452230|NCT03766009|564748601|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
156452231|NCT03766009|564748602|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
156452232|NCT03766009|564748597|FG000|Usual Care|Ineligible|0|||
156452233|NCT03766009|564748598|FG001|Usual Care|Ineligible|1|||
156452234|NCT03766009|564748599|FG002|Usual Care|Ineligible|0|||
156452235|NCT03766009|564748600|FG003|Usual Care|Ineligible|0|||
156452236|NCT03766009|564748601|FG004|Usual Care|Ineligible|0|||
156452237|NCT03766009|564748602|FG005|Usual Care|Ineligible|0|||
156452238|NCT03766009|564748597|FG000|Usual Care|Other: Staff turnover|0|||
156724081|NCT05468164|565737013|FG002|Treatment Period 4|Adverse Event|0|||
156724082|NCT05468164|565737014|FG003|Treatment Period 4|Adverse Event|1|||
156724083|NCT04632927|565737015|FG000|Overall Study|Adverse Event|0|||
156724084|NCT04632927|565737016|FG001|Overall Study|Adverse Event|1|||
156724085|NCT04632927|565737015|FG000|Overall Study|Lack of Efficacy|0|||
156724086|NCT04632927|565737016|FG001|Overall Study|Lack of Efficacy|4|||
156724087|NCT04632927|565737015|FG000|Overall Study|Loss of efficacy|0|||
156724088|NCT04632927|565737016|FG001|Overall Study|Loss of efficacy|1|||
156724089|NCT04632927|565737015|FG000|Overall Study|Non-compliance with study drug|0|||
156724090|NCT04632927|565737016|FG001|Overall Study|Non-compliance with study drug|1|||
156724091|NCT04632927|565737015|FG000|Overall Study|Physician Decision|0|||
156724092|NCT04632927|565737016|FG001|Overall Study|Physician Decision|1|||
156724093|NCT04632927|565737015|FG000|Overall Study|Subject decision|0|||
156724094|NCT04632927|565737016|FG001|Overall Study|Subject decision|1|||
156724095|NCT04632927|565737015|FG000|Overall Study|Withdrawal by Subject|0|||
156724096|NCT04632927|565737016|FG001|Overall Study|Withdrawal by Subject|1|||
156724097|NCT03827291|565737017|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
156724098|NCT03827291|565737018|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
156724099|NCT04795466|565737019|FG000|Overall Study|Adverse Event|3|||
156724100|NCT04795466|565737020|FG001|Overall Study|Adverse Event|1|||
156724101|NCT04795466|565737019|FG000|Overall Study|Physician Decision|1|||
156724102|NCT04795466|565737020|FG001|Overall Study|Physician Decision|0|||
156724103|NCT04795466|565737019|FG000|Overall Study|Withdrawal by Subject|2|||
156724104|NCT04795466|565737020|FG001|Overall Study|Withdrawal by Subject|1|||
156724105|NCT04652726|565737021|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
156724106|NCT04652726|565737022|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
156724107|NCT04652726|565737023|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
156452239|NCT03766009|564748598|FG001|Usual Care|Other: Staff turnover|0|||
156452240|NCT03766009|564748599|FG002|Usual Care|Other: Staff turnover|0|||
156452241|NCT03766009|564748600|FG003|Usual Care|Other: Staff turnover|0|||
156452242|NCT03766009|564748601|FG004|Usual Care|Other: Staff turnover|0|||
156452243|NCT03766009|564748602|FG005|Usual Care|Other: Staff turnover|2|||
156452244|NCT02924272|564748604|FG000|Overall Study|Site Terminated by Sponsor|4|||
156452245|NCT02924272|564748605|FG001|Overall Study|Site Terminated by Sponsor|1|||
156452246|NCT02924272|564748604|FG000|Overall Study|Withdrawal by Subject|2|||
156452247|NCT02924272|564748605|FG001|Overall Study|Withdrawal by Subject|0|||
156452248|NCT02924272|564748604|FG000|Overall Study|Adverse Event|3|||
156452249|NCT02924272|564748605|FG001|Overall Study|Adverse Event|0|||
156452250|NCT02924272|564748604|FG000|Overall Study|Progressive Disease|11|||
156452251|NCT02924272|564748605|FG001|Overall Study|Progressive Disease|8|||
156452252|NCT02924272|564748604|FG000|Overall Study|Clinical Deterioration|1|||
156724108|NCT04652726|565737021|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
156724109|NCT04652726|565737022|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
156724110|NCT04652726|565737023|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
156724111|NCT00536939|565737032|FG000|Overall Study|Withdrawal by Subject|1|||
156724112|NCT00536939|565737033|FG001|Overall Study|Withdrawal by Subject|0|||
156724113|NCT00536939|565737032|FG000|Overall Study|Other Complicating Disease|1|||
156452253|NCT02924272|564748605|FG001|Overall Study|Clinical Deterioration|0|||
156452254|NCT02924272|564748604|FG000|Overall Study|Death|1|||
156724114|NCT00536939|565737033|FG001|Overall Study|Other Complicating Disease|0|||
156724115|NCT04225715|565737034|FG000|Overall Study|Reason not Specified|1|||
156724116|NCT04225715|565737035|FG001|Overall Study|Reason not Specified|0|||
156724117|NCT04225715|565737036|FG002|Overall Study|Reason not Specified|0|||
156724118|NCT04225715|565737037|FG003|Overall Study|Reason not Specified|0|||
156724119|NCT04225715|565737038|FG004|Overall Study|Reason not Specified|0|||
156875748|NCT03237286|566303652|FG000|Overall Study|Withdrawal by Subject|1|||
156452255|NCT02924272|564748605|FG001|Overall Study|Death|0|||
156452256|NCT02924272|564748604|FG000|Overall Study|Reason Not Specified|1|||
156452257|NCT02924272|564748605|FG001|Overall Study|Reason Not Specified|0|||
156452258|NCT03575897|564748609|FG000|Overall Study|Lost to Follow-up|12|||
156452259|NCT03575897|564748610|FG001|Overall Study|Lost to Follow-up|13|||
156724120|NCT04225715|565737039|FG005|Overall Study|Reason not Specified|0|||
156724121|NCT04225715|565737040|FG006|Overall Study|Reason not Specified|0|||
156724122|NCT04225715|565737041|FG007|Overall Study|Reason not Specified|0|||
156724123|NCT04225715|565737042|FG008|Overall Study|Reason not Specified|0|||
156875749|NCT03237286|566303653|FG001|Overall Study|Withdrawal by Subject|0|||
156724124|NCT04225715|565737034|FG000|Overall Study|Protocol Violation|1|||
156724125|NCT04225715|565737035|FG001|Overall Study|Protocol Violation|0|||
156724126|NCT04225715|565737036|FG002|Overall Study|Protocol Violation|0|||
156724127|NCT04225715|565737037|FG003|Overall Study|Protocol Violation|0|||
156724128|NCT04225715|565737038|FG004|Overall Study|Protocol Violation|0|||
156724129|NCT04225715|565737039|FG005|Overall Study|Protocol Violation|9|||
156724130|NCT04225715|565737040|FG006|Overall Study|Protocol Violation|0|||
156724131|NCT04225715|565737041|FG007|Overall Study|Protocol Violation|0|||
156724132|NCT04225715|565737042|FG008|Overall Study|Protocol Violation|0|||
156724133|NCT04225715|565737034|FG000|Overall Study|Withdrawal by Subject|4|||
156724134|NCT04225715|565737035|FG001|Overall Study|Withdrawal by Subject|1|||
156724135|NCT04225715|565737036|FG002|Overall Study|Withdrawal by Subject|1|||
156724136|NCT04225715|565737037|FG003|Overall Study|Withdrawal by Subject|0|||
156724137|NCT04225715|565737038|FG004|Overall Study|Withdrawal by Subject|3|||
156724138|NCT04225715|565737039|FG005|Overall Study|Withdrawal by Subject|1|||
156724139|NCT04225715|565737040|FG006|Overall Study|Withdrawal by Subject|1|||
156724140|NCT04225715|565737041|FG007|Overall Study|Withdrawal by Subject|1|||
156724141|NCT04225715|565737042|FG008|Overall Study|Withdrawal by Subject|0|||
156724142|NCT04225715|565737034|FG000|Overall Study|Adverse Event|0|||
156724143|NCT04225715|565737035|FG001|Overall Study|Adverse Event|0|||
156724144|NCT04225715|565737036|FG002|Overall Study|Adverse Event|0|||
156724145|NCT04225715|565737037|FG003|Overall Study|Adverse Event|0|||
156724146|NCT04225715|565737038|FG004|Overall Study|Adverse Event|0|||
156724147|NCT04225715|565737039|FG005|Overall Study|Adverse Event|0|||
156724148|NCT04225715|565737040|FG006|Overall Study|Adverse Event|0|||
156724149|NCT04225715|565737041|FG007|Overall Study|Adverse Event|0|||
156724150|NCT04225715|565737042|FG008|Overall Study|Adverse Event|1|||
156724151|NCT04225715|565737034|FG000|Overall Study|Arm Terminated By Sponsor|0|||
156724152|NCT04225715|565737035|FG001|Overall Study|Arm Terminated By Sponsor|0|||
156724153|NCT04225715|565737036|FG002|Overall Study|Arm Terminated By Sponsor|0|||
156724154|NCT04225715|565737037|FG003|Overall Study|Arm Terminated By Sponsor|0|||
156724155|NCT04225715|565737038|FG004|Overall Study|Arm Terminated By Sponsor|0|||
156724156|NCT04225715|565737039|FG005|Overall Study|Arm Terminated By Sponsor|0|||
156724157|NCT04225715|565737040|FG006|Overall Study|Arm Terminated By Sponsor|0|||
156724158|NCT04225715|565737041|FG007|Overall Study|Arm Terminated By Sponsor|17|||
156724159|NCT04225715|565737042|FG008|Overall Study|Arm Terminated By Sponsor|18|||
156724160|NCT02275546|565737045|FG000|Treatment Period 2|Withdrawal by Subject|2|||
156724161|NCT02275546|565737046|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156724162|NCT02275546|565737045|FG000|Treatment Period 2|Protocol Violation|0|||
156724163|NCT02275546|565737046|FG001|Treatment Period 2|Protocol Violation|1|||
156724164|NCT00570141|565737056|FG000|Overall Study|Adverse Event|1|||
156724165|NCT00570141|565737056|FG000|Overall Study|Missed visits|1|||
156724166|NCT00570141|565737056|FG000|Overall Study|Lost to Follow-up|1|||
156724167|NCT02309411|565737057|FG000|Overall Study|Physician Decision|1|||
156724168|NCT02309411|565737058|FG001|Overall Study|Physician Decision|0|||
156724169|NCT02309411|565737059|FG002|Overall Study|Physician Decision|0|||
156724170|NCT02309411|565737057|FG000|Overall Study|Withdrawal by Subject|1|||
156724171|NCT02309411|565737058|FG001|Overall Study|Withdrawal by Subject|1|||
156724172|NCT02309411|565737059|FG002|Overall Study|Withdrawal by Subject|0|||
156724173|NCT04878432|565737063|FG000|Overall Study|Adverse Event|1|||
156724174|NCT04878432|565737063|FG000|Overall Study|Death|2|||
156724175|NCT04878432|565737063|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156724176|NCT04878432|565737063|FG000|Overall Study|Withdrawal by Subject|6|||
156724177|NCT04878432|565737063|FG000|Overall Study|Progressive Disease|7|||
156724178|NCT04878432|565737063|FG000|Overall Study|New Therapy for Study Indication|7|||
156724179|NCT04878432|565737063|FG000|Overall Study|Physician Decision|11|||
156724180|NCT03971071|565737064|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
156724181|NCT03971071|565737065|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
156724182|NCT03971071|565737066|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
156724183|NCT03971071|565737067|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
156724184|NCT03971071|565737068|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
156724185|NCT03971071|565737064|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
156724186|NCT03971071|565737065|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
156724187|NCT03971071|565737066|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
156724188|NCT03971071|565737067|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156724189|NCT03971071|565737068|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156724190|NCT03971071|565737064|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
156724191|NCT03971071|565737065|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
156724192|NCT03971071|565737066|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
156724193|NCT03971071|565737067|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
156724194|NCT03971071|565737068|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
156724195|NCT03971071|565737064|FG000|Open-label Treatment Period|Sponsor decision|0|||
156724196|NCT03971071|565737065|FG001|Open-label Treatment Period|Sponsor decision|0|||
156724197|NCT03971071|565737066|FG002|Open-label Treatment Period|Sponsor decision|0|||
156724198|NCT03971071|565737067|FG003|Open-label Treatment Period|Sponsor decision|0|||
156452260|NCT05116787|564748615|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
156724199|NCT03971071|565737068|FG004|Open-label Treatment Period|Sponsor decision|1|||
156724200|NCT03971071|565737064|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
156724201|NCT03971071|565737065|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156724202|NCT03971071|565737066|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
156724203|NCT03971071|565737067|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
156724204|NCT03971071|565737068|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
156724205|NCT03971071|565737064|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
156724206|NCT03971071|565737065|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
156724207|NCT03971071|565737066|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
156724208|NCT03971071|565737067|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
156724209|NCT03971071|565737068|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
156724210|NCT00925704|565737069|FG000|First Intervention|Withdrew consent|0|||
156724211|NCT00925704|565737070|FG001|First Intervention|Withdrew consent|0|||
156724212|NCT00925704|565737071|FG002|First Intervention|Withdrew consent|0|||
156724213|NCT00925704|565737072|FG003|First Intervention|Withdrew consent|1|||
156724214|NCT00925704|565737073|FG004|First Intervention|Withdrew consent|1|||
156724215|NCT00925704|565737074|FG005|First Intervention|Withdrew consent|0|||
156724216|NCT00925704|565737069|FG000|Second Intervention|Withdrawal by Subject|1|||
156724217|NCT00925704|565737070|FG001|Second Intervention|Withdrawal by Subject|0|||
156724218|NCT00925704|565737071|FG002|Second Intervention|Withdrawal by Subject|0|||
156724219|NCT00925704|565737072|FG003|Second Intervention|Withdrawal by Subject|0|||
156724220|NCT00925704|565737073|FG004|Second Intervention|Withdrawal by Subject|1|||
156724221|NCT00925704|565737074|FG005|Second Intervention|Withdrawal by Subject|0|||
156724222|NCT00925704|565737069|FG000|Third Intervention|Withdrew consent|0|||
156724223|NCT00925704|565737070|FG001|Third Intervention|Withdrew consent|0|||
156724224|NCT00925704|565737071|FG002|Third Intervention|Withdrew consent|0|||
156724225|NCT00925704|565737072|FG003|Third Intervention|Withdrew consent|0|||
156724226|NCT00925704|565737073|FG004|Third Intervention|Withdrew consent|0|||
156724227|NCT00925704|565737074|FG005|Third Intervention|Withdrew consent|1|||
156724228|NCT03207815|565737075|FG000|Overall Study|Protocol Violation|3|||
156724229|NCT03207815|565737076|FG001|Overall Study|Protocol Violation|1|||
156724230|NCT03207815|565737075|FG000|Overall Study|Adverse Event|1|||
156724231|NCT03207815|565737076|FG001|Overall Study|Adverse Event|2|||
156724232|NCT03207815|565737075|FG000|Overall Study|Lost to Follow-up|1|||
156724233|NCT03207815|565737076|FG001|Overall Study|Lost to Follow-up|2|||
156724234|NCT03207815|565737075|FG000|Overall Study|Investigator's Discretion|1|||
156724235|NCT03207815|565737076|FG001|Overall Study|Investigator's Discretion|1|||
156724236|NCT03207815|565737075|FG000|Overall Study|Lack of Efficacy|0|||
156724237|NCT03207815|565737076|FG001|Overall Study|Lack of Efficacy|1|||
156875750|NCT03237286|566303654|FG002|Overall Study|Withdrawal by Subject|2|||
156875751|NCT03237286|566303652|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
156875752|NCT03237286|566303653|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
156875753|NCT03237286|566303654|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
156875754|NCT02792829|566303662|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156335762|NCT00739674|564328086|FG000|Overall Study|Lack of Efficacy|1|||
156335763|NCT00739674|564328087|FG001|Overall Study|Lack of Efficacy|0|||
156452261|NCT05116787|564748616|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
156452262|NCT05116787|564748615|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
156452263|NCT05116787|564748616|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
156452264|NCT05116787|564748615|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
156452265|NCT05116787|564748616|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
156452266|NCT05116787|564748615|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
156724238|NCT03207815|565737075|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
156724239|NCT03207815|565737076|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
156724240|NCT03207815|565737075|FG000|Overall Study|Withdrew Consent|1|||
156724241|NCT03207815|565737076|FG001|Overall Study|Withdrew Consent|0|||
156724242|NCT03817853|565737077|FG000|Induction Phase|Adverse Event|5|||
156724243|NCT03817853|565737078|FG001|Induction Phase|Adverse Event|0|||
156724244|NCT03817853|565737079|FG002|Induction Phase|Adverse Event|0|||
156724245|NCT03817853|565737077|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
156452267|NCT05116787|564748616|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
156724246|NCT03817853|565737078|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
156724247|NCT03817853|565737079|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
156724248|NCT03817853|565737077|FG000|Induction Phase|Physician Decision|2|||
156724249|NCT03817853|565737078|FG001|Induction Phase|Physician Decision|0|||
156724250|NCT03817853|565737079|FG002|Induction Phase|Physician Decision|0|||
156724251|NCT03817853|565737077|FG000|Induction Phase|Progressive Disease|6|||
156724252|NCT03817853|565737078|FG001|Induction Phase|Progressive Disease|0|||
156724253|NCT03817853|565737079|FG002|Induction Phase|Progressive Disease|0|||
156724254|NCT03817853|565737077|FG000|Induction Phase|Withdrawal by Subject|4|||
156452268|NCT02737436|564748617|FG000|Washout Period|Lost to Follow-up|5|||
156452269|NCT02737436|564748618|FG001|Washout Period|Lost to Follow-up|11|||
156452270|NCT02737436|564748617|FG000|Data Analysis|Scanning data problems|5|||
156452271|NCT02737436|564748618|FG001|Data Analysis|Scanning data problems|8|||
156452272|NCT02919683|564748619|FG000|Post-Surgery Follow-Up|Death|2|||
156452273|NCT02919683|564748620|FG001|Post-Surgery Follow-Up|Death|2|||
156452274|NCT02919683|564748619|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
156452275|NCT02919683|564748620|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
156724255|NCT03817853|565737078|FG001|Induction Phase|Withdrawal by Subject|0|||
156724256|NCT03817853|565737079|FG002|Induction Phase|Withdrawal by Subject|0|||
156724257|NCT03817853|565737077|FG000|Maintenance Phase|Adverse Event|0|||
156724258|NCT03817853|565737078|FG001|Maintenance Phase|Adverse Event|8|||
156724259|NCT03817853|565737079|FG002|Maintenance Phase|Adverse Event|0|||
156724260|NCT03817853|565737077|FG000|Maintenance Phase|Death|0|||
156724261|NCT03817853|565737078|FG001|Maintenance Phase|Death|5|||
156724262|NCT03817853|565737079|FG002|Maintenance Phase|Death|0|||
156724263|NCT03817853|565737077|FG000|Maintenance Phase|Progressive Disease|0|||
156724264|NCT03817853|565737078|FG001|Maintenance Phase|Progressive Disease|7|||
156724265|NCT03817853|565737079|FG002|Maintenance Phase|Progressive Disease|0|||
156724266|NCT03817853|565737077|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156724267|NCT03817853|565737078|FG001|Maintenance Phase|Withdrawal by Subject|2|||
156724268|NCT03817853|565737079|FG002|Maintenance Phase|Withdrawal by Subject|0|||
156724269|NCT03817853|565737077|FG000|Maintenance Phase|Physician Decision|0|||
156724270|NCT03817853|565737078|FG001|Maintenance Phase|Physician Decision|1|||
156724271|NCT03817853|565737079|FG002|Maintenance Phase|Physician Decision|0|||
156724272|NCT03817853|565737077|FG000|Maintenance Phase|Various reasons|0|||
156724273|NCT03817853|565737078|FG001|Maintenance Phase|Various reasons|4|||
156724274|NCT03817853|565737079|FG002|Maintenance Phase|Various reasons|0|||
156724275|NCT03817853|565737077|FG000|Maintenance Phase|Protocol Deviation|0|||
156724276|NCT03817853|565737078|FG001|Maintenance Phase|Protocol Deviation|1|||
156724277|NCT03817853|565737079|FG002|Maintenance Phase|Protocol Deviation|0|||
156724278|NCT03817853|565737077|FG000|Follow-up Phase|Adverse Event|0|||
156724279|NCT03817853|565737078|FG001|Follow-up Phase|Adverse Event|0|||
156724280|NCT03817853|565737079|FG002|Follow-up Phase|Adverse Event|2|||
156724281|NCT03817853|565737077|FG000|Follow-up Phase|Death|0|||
156724282|NCT03817853|565737078|FG001|Follow-up Phase|Death|0|||
156724283|NCT03817853|565737079|FG002|Follow-up Phase|Death|1|||
156724284|NCT03817853|565737077|FG000|Follow-up Phase|Progressive Disease|0|||
156875755|NCT02792829|566303663|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
156875756|NCT02792829|566303664|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875757|NCT02792829|566303665|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875758|NCT02792829|566303666|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875759|NCT02792829|566303667|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875760|NCT02792829|566303668|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875761|NCT02792829|566303669|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875762|NCT02792829|566303662|FG000|Treatment Period 2|Adverse Event|0|||
156875763|NCT02792829|566303663|FG001|Treatment Period 2|Adverse Event|0|||
156875764|NCT02792829|566303664|FG002|Treatment Period 2|Adverse Event|0|||
156875765|NCT02792829|566303665|FG003|Treatment Period 2|Adverse Event|0|||
156875766|NCT02792829|566303666|FG004|Treatment Period 2|Adverse Event|1|||
156875767|NCT02792829|566303667|FG005|Treatment Period 2|Adverse Event|0|||
156875768|NCT02792829|566303668|FG006|Treatment Period 2|Adverse Event|1|||
156875769|NCT02792829|566303669|FG007|Treatment Period 2|Adverse Event|1|||
156875770|NCT02792829|566303662|FG000|Treatment Period 2|Use of proscribed medications|0|||
156875771|NCT02792829|566303663|FG001|Treatment Period 2|Use of proscribed medications|0|||
156875772|NCT02792829|566303664|FG002|Treatment Period 2|Use of proscribed medications|0|||
156452276|NCT05551637|564748623|FG000|Overall Study|Lack of Efficacy|0|||
156452277|NCT05551637|564748624|FG001|Overall Study|Lack of Efficacy|6|||
156452278|NCT05551637|564748623|FG000|Overall Study|Lost to Follow-up|1|||
156452279|NCT05551637|564748624|FG001|Overall Study|Lost to Follow-up|1|||
156724285|NCT03817853|565737078|FG001|Follow-up Phase|Progressive Disease|0|||
156724286|NCT03817853|565737079|FG002|Follow-up Phase|Progressive Disease|3|||
156724287|NCT03817853|565737077|FG000|Follow-up Phase|Withdrawal by Subject|0|||
156724288|NCT03817853|565737078|FG001|Follow-up Phase|Withdrawal by Subject|0|||
156452280|NCT05179837|564748627|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
156452281|NCT05179837|564748627|FG000|Overall Study|Device malfunctioned|1|||
156452282|NCT05179837|564748627|FG000|Overall Study|Image quality too low|2|||
156724289|NCT03817853|565737079|FG002|Follow-up Phase|Withdrawal by Subject|1|||
156724290|NCT00391768|565737080|FG000|Overall Study|Withdrawal by Subject|0|||
156724291|NCT00391768|565737081|FG001|Overall Study|Withdrawal by Subject|0|||
156724292|NCT00391768|565737082|FG002|Overall Study|Withdrawal by Subject|1|||
156724293|NCT00391768|565737083|FG003|Overall Study|Withdrawal by Subject|0|||
156724294|NCT00391768|565737084|FG004|Overall Study|Withdrawal by Subject|0|||
156875773|NCT02792829|566303665|FG003|Treatment Period 2|Use of proscribed medications|0|||
156875774|NCT02792829|566303666|FG004|Treatment Period 2|Use of proscribed medications|0|||
156452283|NCT05051124|564748628|FG000|Overall Study|Lost to Follow-up|2|||
156452284|NCT05051124|564748628|FG000|Overall Study|Withdrawal by Subject|1|||
156452285|NCT05051124|564748628|FG000|Overall Study|Residential relocation|2|||
156452286|NCT05051124|564748628|FG000|Overall Study|Death|1|||
156452287|NCT04782973|564748629|FG000|Overall Study|Withdrawal by Subject|5|||
156452288|NCT04782973|564748629|FG000|Overall Study|Protocol Violation|6|||
156452289|NCT04782973|564748629|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
156452290|NCT01000961|564748630|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
156452291|NCT01000961|564748631|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156452292|NCT01000961|564748630|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
156452293|NCT01000961|564748631|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
156452294|NCT03476460|564748634|FG000|Overall Study|Withdrawal by Subject|3|||
156452295|NCT03476460|564748635|FG001|Overall Study|Withdrawal by Subject|2|||
156452296|NCT03476460|564748634|FG000|Overall Study|Non-compliance with treatment|3|||
156452297|NCT03476460|564748635|FG001|Overall Study|Non-compliance with treatment|0|||
156452298|NCT03476460|564748634|FG000|Overall Study|Missing laboratory tests|5|||
156452299|NCT03476460|564748635|FG001|Overall Study|Missing laboratory tests|5|||
156452300|NCT03476460|564748634|FG000|Overall Study|Adverse Event|0|||
156452301|NCT03476460|564748635|FG001|Overall Study|Adverse Event|1|||
156452302|NCT03307343|564748636|FG000|Overall Study|Withdrawal by Subject|1|||
156452303|NCT03307343|564748637|FG001|Overall Study|Withdrawal by Subject|2|||
156452304|NCT03307343|564748636|FG000|Overall Study|Pregnancy|0|||
156452305|NCT03307343|564748637|FG001|Overall Study|Pregnancy|2|||
156452306|NCT03307343|564748636|FG000|Overall Study|Physician Decision|1|||
156452307|NCT03307343|564748637|FG001|Overall Study|Physician Decision|0|||
156452308|NCT03307343|564748636|FG000|Overall Study|Lost to Follow-up|0|||
156452309|NCT03307343|564748637|FG001|Overall Study|Lost to Follow-up|2|||
156452310|NCT05364671|564748640|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
156452311|NCT05364671|564748641|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
156452312|NCT05364671|564748640|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
156452313|NCT05364671|564748641|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
156452314|NCT05364671|564748640|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
156452315|NCT05364671|564748641|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
156452316|NCT05364671|564748640|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
156452317|NCT05364671|564748641|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
156452318|NCT05364671|564748640|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
156452319|NCT05364671|564748641|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
156452320|NCT03536754|564748642|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
156452321|NCT03536754|564748643|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
156452322|NCT03536754|564748644|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
156452323|NCT03536754|564748645|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
156452324|NCT03536754|564748646|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
156452325|NCT03536754|564748642|FG000|Open Label Extension|Other|0|||
156452326|NCT03536754|564748643|FG001|Open Label Extension|Other|0|||
156452327|NCT03536754|564748644|FG002|Open Label Extension|Other|0|||
156452328|NCT03536754|564748645|FG003|Open Label Extension|Other|0|||
156452329|NCT03536754|564748646|FG004|Open Label Extension|Other|1|||
156452330|NCT03382652|564748649|FG000|Overall Study|Lost to Follow-up|6|||
156452331|NCT03382652|564748649|FG000|Overall Study|Death|4|||
156724295|NCT00391768|565737085|FG005|Overall Study|Withdrawal by Subject|1|||
156724296|NCT00391768|565737086|FG006|Overall Study|Withdrawal by Subject|1|||
156724297|NCT00391768|565737080|FG000|Overall Study|Lost to Follow-up|0|||
156724298|NCT00391768|565737081|FG001|Overall Study|Lost to Follow-up|0|||
156724299|NCT00391768|565737082|FG002|Overall Study|Lost to Follow-up|0|||
156724300|NCT00391768|565737083|FG003|Overall Study|Lost to Follow-up|1|||
156724301|NCT00391768|565737084|FG004|Overall Study|Lost to Follow-up|2|||
156724302|NCT00391768|565737085|FG005|Overall Study|Lost to Follow-up|2|||
156724303|NCT00391768|565737086|FG006|Overall Study|Lost to Follow-up|3|||
156452332|NCT03382652|564748649|FG000|Overall Study|Revision|5|||
156452333|NCT03382652|564748649|FG000|Overall Study|Patient withdrew|3|||
156724304|NCT01256450|565737089|FG000|Open-label Titration|Adverse Event|39|||
156794800|NCT01217892|566002779|FG000|Overall Study|Withdrawal by Subject|0|||
156452334|NCT03382652|564748649|FG000|Overall Study|Other reasons|21|||
156452335|NCT04810650|564748651|FG000|Overall Study|Disenrolled in error|0|||
156452336|NCT04810650|564748652|FG001|Overall Study|Disenrolled in error|0|||
156452337|NCT04810650|564748653|FG002|Overall Study|Disenrolled in error|0|||
156452338|NCT04810650|564748654|FG003|Overall Study|Disenrolled in error|0|||
156452339|NCT04810650|564748655|FG004|Overall Study|Disenrolled in error|0|||
156452340|NCT04810650|564748656|FG005|Overall Study|Disenrolled in error|0|||
156724305|NCT01256450|565737090|FG001|Open-label Titration|Adverse Event|0|||
156724306|NCT01256450|565737091|FG002|Open-label Titration|Adverse Event|0|||
156724307|NCT01256450|565737089|FG000|Open-label Titration|Lost to Follow-up|7|||
156724308|NCT01256450|565737090|FG001|Open-label Titration|Lost to Follow-up|0|||
156452341|NCT04810650|564748657|FG006|Overall Study|Disenrolled in error|0|||
156452342|NCT04810650|564748658|FG007|Overall Study|Disenrolled in error|0|||
156724309|NCT01256450|565737091|FG002|Open-label Titration|Lost to Follow-up|0|||
156452343|NCT04810650|564748659|FG008|Overall Study|Disenrolled in error|1|||
156452344|NCT04810650|564748660|FG009|Overall Study|Disenrolled in error|0|||
156452345|NCT04810650|564748661|FG010|Overall Study|Disenrolled in error|0|||
156452346|NCT04810650|564748662|FG011|Overall Study|Disenrolled in error|0|||
156452347|NCT04810650|564748663|FG012|Overall Study|Disenrolled in error|0|||
156452348|NCT04810650|564748664|FG013|Overall Study|Disenrolled in error|0|||
156452349|NCT04810650|564748651|FG000|Overall Study|Death|0|||
156452350|NCT04810650|564748652|FG001|Overall Study|Death|0|||
156452351|NCT04810650|564748653|FG002|Overall Study|Death|0|||
156452352|NCT04810650|564748654|FG003|Overall Study|Death|0|||
156452353|NCT04810650|564748655|FG004|Overall Study|Death|0|||
156452354|NCT04810650|564748656|FG005|Overall Study|Death|0|||
156452355|NCT04810650|564748657|FG006|Overall Study|Death|2|||
156452356|NCT04810650|564748658|FG007|Overall Study|Death|2|||
156452357|NCT04810650|564748659|FG008|Overall Study|Death|0|||
156452358|NCT04810650|564748660|FG009|Overall Study|Death|1|||
156452359|NCT04810650|564748661|FG010|Overall Study|Death|0|||
156452360|NCT04810650|564748662|FG011|Overall Study|Death|0|||
156452361|NCT04810650|564748663|FG012|Overall Study|Death|2|||
156452362|NCT04810650|564748664|FG013|Overall Study|Death|1|||
156724310|NCT01256450|565737089|FG000|Open-label Titration|Lack of analgesic effect|30|||
156724311|NCT01256450|565737090|FG001|Open-label Titration|Lack of analgesic effect|0|||
156724312|NCT01256450|565737091|FG002|Open-label Titration|Lack of analgesic effect|0|||
156724313|NCT01256450|565737089|FG000|Open-label Titration|Non-compliance|9|||
156724314|NCT01256450|565737090|FG001|Open-label Titration|Non-compliance|0|||
156724315|NCT01256450|565737091|FG002|Open-label Titration|Non-compliance|0|||
156724316|NCT01256450|565737089|FG000|Open-label Titration|Screen failure|1|||
156724317|NCT01256450|565737090|FG001|Open-label Titration|Screen failure|0|||
156724318|NCT01256450|565737091|FG002|Open-label Titration|Screen failure|0|||
156724319|NCT01256450|565737089|FG000|Open-label Titration|Other|13|||
156724320|NCT01256450|565737090|FG001|Open-label Titration|Other|0|||
156724321|NCT01256450|565737091|FG002|Open-label Titration|Other|0|||
156724322|NCT01256450|565737089|FG000|Double-blind Treatment|Adverse Event|0|||
156724323|NCT01256450|565737090|FG001|Double-blind Treatment|Adverse Event|8|||
156724324|NCT01256450|565737091|FG002|Double-blind Treatment|Adverse Event|6|||
156724325|NCT01256450|565737089|FG000|Double-blind Treatment|Lost to Follow-up|0|||
156724326|NCT01256450|565737090|FG001|Double-blind Treatment|Lost to Follow-up|1|||
156724327|NCT01256450|565737091|FG002|Double-blind Treatment|Lost to Follow-up|7|||
156724328|NCT01256450|565737089|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
156724329|NCT01256450|565737090|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
156724330|NCT01256450|565737091|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
156724331|NCT01256450|565737089|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
156724332|NCT01256450|565737090|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
156724333|NCT01256450|565737091|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
156724334|NCT01256450|565737089|FG000|Double-blind Treatment|Non-compliance|0|||
156724335|NCT01256450|565737090|FG001|Double-blind Treatment|Non-compliance|5|||
156724336|NCT01256450|565737091|FG002|Double-blind Treatment|Non-compliance|4|||
156724337|NCT01256450|565737089|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
156724338|NCT01256450|565737090|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
156724339|NCT01256450|565737091|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
156724340|NCT01256450|565737089|FG000|Double-blind Treatment|Other|0|||
156794801|NCT01217892|566002780|FG001|Overall Study|Withdrawal by Subject|2|||
156794802|NCT01217892|566002781|FG002|Overall Study|Withdrawal by Subject|1|||
156794803|NCT01217892|566002782|FG003|Overall Study|Withdrawal by Subject|0|||
156452363|NCT04810650|564748651|FG000|Overall Study|Moved/transferred care|0|||
156452364|NCT04810650|564748652|FG001|Overall Study|Moved/transferred care|0|||
156724341|NCT01256450|565737090|FG001|Double-blind Treatment|Other|9|||
156724342|NCT01256450|565737091|FG002|Double-blind Treatment|Other|12|||
156794804|NCT01217892|566002779|FG000|Overall Study|Lab value|1|||
156794805|NCT01217892|566002780|FG001|Overall Study|Lab value|0|||
156452365|NCT04810650|564748653|FG002|Overall Study|Moved/transferred care|0|||
156452366|NCT04810650|564748654|FG003|Overall Study|Moved/transferred care|0|||
156452367|NCT04810650|564748655|FG004|Overall Study|Moved/transferred care|0|||
156452368|NCT04810650|564748656|FG005|Overall Study|Moved/transferred care|0|||
156452369|NCT04810650|564748657|FG006|Overall Study|Moved/transferred care|0|||
156452370|NCT04810650|564748658|FG007|Overall Study|Moved/transferred care|1|||
156452371|NCT04810650|564748659|FG008|Overall Study|Moved/transferred care|12|||
156724343|NCT00891020|565737093|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
156724344|NCT00891020|565737094|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
156724345|NCT00891020|565737095|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
156724346|NCT00891020|565737093|FG000|24 Week Treatment Period|Death|0|||
156794806|NCT01217892|566002781|FG002|Overall Study|Lab value|1|||
156452372|NCT04810650|564748660|FG009|Overall Study|Moved/transferred care|10|||
156794807|NCT01217892|566002782|FG003|Overall Study|Lab value|0|||
156724347|NCT00891020|565737094|FG001|24 Week Treatment Period|Death|2|||
156724348|NCT00891020|565737095|FG002|24 Week Treatment Period|Death|0|||
156724349|NCT00891020|565737093|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
156724350|NCT00891020|565737094|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
156724351|NCT00891020|565737095|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
156724352|NCT00891020|565737093|FG000|24 Week Treatment Period|Failure to return|4|||
156724353|NCT00891020|565737094|FG001|24 Week Treatment Period|Failure to return|5|||
156724354|NCT00891020|565737095|FG002|24 Week Treatment Period|Failure to return|5|||
156724355|NCT00891020|565737093|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
156724356|NCT00891020|565737094|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
156724357|NCT00891020|565737095|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
156724358|NCT00891020|565737093|FG000|24 Week Treatment Period|Other protocol violation|1|||
156724359|NCT00891020|565737094|FG001|24 Week Treatment Period|Other protocol violation|1|||
156724360|NCT00891020|565737095|FG002|24 Week Treatment Period|Other protocol violation|2|||
156724361|NCT00891020|565737093|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
156724362|NCT00891020|565737094|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
156724363|NCT00891020|565737095|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
156724364|NCT00891020|565737093|FG000|24 Week Treatment Period|Withdrew consent|6|||
156724365|NCT00891020|565737094|FG001|24 Week Treatment Period|Withdrew consent|3|||
156724366|NCT00891020|565737095|FG002|24 Week Treatment Period|Withdrew consent|15|||
156724367|NCT00891020|565737093|FG000|24 Week Treatment Period|Administrative/Other|5|||
156724368|NCT00891020|565737094|FG001|24 Week Treatment Period|Administrative/Other|6|||
156724369|NCT00891020|565737095|FG002|24 Week Treatment Period|Administrative/Other|1|||
156724370|NCT00891020|565737093|FG000|Long-term Extension Period|Adverse Event|1|||
156724371|NCT00891020|565737094|FG001|Long-term Extension Period|Adverse Event|11|||
156724372|NCT00891020|565737095|FG002|Long-term Extension Period|Adverse Event|10|||
156724373|NCT00891020|565737093|FG000|Long-term Extension Period|Death|0|||
156724374|NCT00891020|565737094|FG001|Long-term Extension Period|Death|0|||
156724375|NCT00891020|565737095|FG002|Long-term Extension Period|Death|1|||
156724376|NCT00891020|565737093|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
156724377|NCT00891020|565737094|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
156724378|NCT00891020|565737095|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
156724379|NCT00891020|565737093|FG000|Long-term Extension Period|Protocol Violation|0|||
156724380|NCT00891020|565737094|FG001|Long-term Extension Period|Protocol Violation|1|||
156724381|NCT00891020|565737095|FG002|Long-term Extension Period|Protocol Violation|1|||
156724382|NCT00891020|565737093|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
156452373|NCT04810650|564748661|FG010|Overall Study|Moved/transferred care|0|||
156452374|NCT04810650|564748662|FG011|Overall Study|Moved/transferred care|0|||
156452375|NCT04810650|564748663|FG012|Overall Study|Moved/transferred care|0|||
156452376|NCT04810650|564748664|FG013|Overall Study|Moved/transferred care|0|||
156452377|NCT04810650|564748651|FG000|Overall Study|Lost to Follow-up|15|||
156452378|NCT04810650|564748652|FG001|Overall Study|Lost to Follow-up|12|||
156452379|NCT04810650|564748653|FG002|Overall Study|Lost to Follow-up|7|||
156452380|NCT04810650|564748654|FG003|Overall Study|Lost to Follow-up|9|||
156452381|NCT04810650|564748655|FG004|Overall Study|Lost to Follow-up|10|||
156452382|NCT04810650|564748656|FG005|Overall Study|Lost to Follow-up|6|||
156452383|NCT04810650|564748657|FG006|Overall Study|Lost to Follow-up|0|||
156452384|NCT04810650|564748658|FG007|Overall Study|Lost to Follow-up|0|||
156452385|NCT04810650|564748659|FG008|Overall Study|Lost to Follow-up|0|||
156452386|NCT04810650|564748660|FG009|Overall Study|Lost to Follow-up|0|||
156724383|NCT00891020|565737094|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
156724384|NCT00891020|565737095|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
156724385|NCT00891020|565737093|FG000|Long-term Extension Period|Failure to return|0|||
156724386|NCT00891020|565737094|FG001|Long-term Extension Period|Failure to return|2|||
156724387|NCT00891020|565737095|FG002|Long-term Extension Period|Failure to return|3|||
156724388|NCT00891020|565737093|FG000|Long-term Extension Period|Administrative|1|||
156724389|NCT00891020|565737094|FG001|Long-term Extension Period|Administrative|2|||
156724390|NCT00891020|565737095|FG002|Long-term Extension Period|Administrative|2|||
156724391|NCT03866512|565737097|FG000|Overall Study|Lost to Follow-up|1|||
156724392|NCT03866512|565737098|FG001|Overall Study|Lost to Follow-up|2|||
156724393|NCT03866512|565737099|FG002|Overall Study|Lost to Follow-up|1|||
156724394|NCT03866512|565737097|FG000|Overall Study|Cannulation issues|0|||
156724395|NCT03866512|565737098|FG001|Overall Study|Cannulation issues|1|||
156724396|NCT03866512|565737099|FG002|Overall Study|Cannulation issues|2|||
156724397|NCT00320710|565737100|FG000|Overall Study|Disease progression|24|||
156724398|NCT00320710|565737101|FG001|Overall Study|Disease progression|19|||
156452387|NCT04810650|564748661|FG010|Overall Study|Lost to Follow-up|1|||
156452388|NCT04810650|564748662|FG011|Overall Study|Lost to Follow-up|0|||
156452389|NCT04810650|564748663|FG012|Overall Study|Lost to Follow-up|3|||
156452390|NCT04810650|564748664|FG013|Overall Study|Lost to Follow-up|9|||
156452391|NCT04810650|564748651|FG000|Overall Study|Participant declined|0|||
156452392|NCT04810650|564748652|FG001|Overall Study|Participant declined|0|||
156452393|NCT04810650|564748653|FG002|Overall Study|Participant declined|0|||
156724399|NCT00320710|565737102|FG002|Overall Study|Disease progression|2|||
156724400|NCT00320710|565737100|FG000|Overall Study|Death|10|||
156724401|NCT00320710|565737101|FG001|Overall Study|Death|7|||
156724402|NCT00320710|565737102|FG002|Overall Study|Death|1|||
156724403|NCT00320710|565737100|FG000|Overall Study|Administrative problems|1|||
156724404|NCT00320710|565737101|FG001|Overall Study|Administrative problems|2|||
156724405|NCT00320710|565737102|FG002|Overall Study|Administrative problems|0|||
156724406|NCT00320710|565737100|FG000|Overall Study|Withdrawal by Subject|20|||
156724407|NCT00320710|565737101|FG001|Overall Study|Withdrawal by Subject|26|||
156724408|NCT00320710|565737102|FG002|Overall Study|Withdrawal by Subject|1|||
156724409|NCT00320710|565737100|FG000|Overall Study|Protocol Violation|6|||
156724410|NCT00320710|565737101|FG001|Overall Study|Protocol Violation|5|||
156724411|NCT00320710|565737102|FG002|Overall Study|Protocol Violation|0|||
156724412|NCT00320710|565737100|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156724413|NCT00320710|565737101|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156724414|NCT00320710|565737102|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156724415|NCT00320710|565737100|FG000|Overall Study|Abnormal laboratory value(s)|12|||
156724416|NCT00320710|565737101|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156724417|NCT00320710|565737102|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156724418|NCT00320710|565737100|FG000|Overall Study|Adverse Event|18|||
156724419|NCT00320710|565737101|FG001|Overall Study|Adverse Event|14|||
156724420|NCT00320710|565737102|FG002|Overall Study|Adverse Event|1|||
156724421|NCT00320710|565737100|FG000|Overall Study|Lost to Follow-up|1|||
156724422|NCT00320710|565737101|FG001|Overall Study|Lost to Follow-up|0|||
156724423|NCT00320710|565737102|FG002|Overall Study|Lost to Follow-up|0|||
156724424|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
156724425|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724426|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724427|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724428|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
156724429|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
156724430|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
156452394|NCT04810650|564748654|FG003|Overall Study|Participant declined|0|||
156452395|NCT04810650|564748655|FG004|Overall Study|Participant declined|0|||
156452396|NCT04810650|564748656|FG005|Overall Study|Participant declined|0|||
156452397|NCT04810650|564748657|FG006|Overall Study|Participant declined|0|||
156724431|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
156724432|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
156452398|NCT04810650|564748658|FG007|Overall Study|Participant declined|0|||
156452399|NCT04810650|564748659|FG008|Overall Study|Participant declined|0|||
156724433|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
156724434|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
156724435|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
156724436|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
156724437|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724438|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724439|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724440|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
156724441|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724442|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724443|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724444|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
156724445|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724446|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724447|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724448|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
156724449|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
156875775|NCT02792829|566303667|FG005|Treatment Period 2|Use of proscribed medications|0|||
156452400|NCT04810650|564748660|FG009|Overall Study|Participant declined|0|||
156724450|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
156724451|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
156724452|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
156724453|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
156724454|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
156724455|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
156724456|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
156724457|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156452401|NCT04810650|564748661|FG010|Overall Study|Participant declined|2|||
156452402|NCT04810650|564748662|FG011|Overall Study|Participant declined|0|||
156452403|NCT04810650|564748663|FG012|Overall Study|Participant declined|0|||
156452404|NCT04810650|564748664|FG013|Overall Study|Participant declined|0|||
156452405|NCT05794243|564748665|FG000|Overall Study|Withdrawal by Subject|1|||
156452406|NCT05794243|564748666|FG001|Overall Study|Withdrawal by Subject|0|||
156452407|NCT05794243|564748667|FG002|Overall Study|Withdrawal by Subject|1|||
156452408|NCT05794243|564748665|FG000|Overall Study|Physician Decision|0|||
156875776|NCT02792829|566303668|FG006|Treatment Period 2|Use of proscribed medications|0|||
156875777|NCT02792829|566303669|FG007|Treatment Period 2|Use of proscribed medications|1|||
156875778|NCT00104520|566303672|FG000|Overall Study|Unrelated adverse event|34|||
156875779|NCT00104520|566303673|FG001|Overall Study|Unrelated adverse event|47|||
156875780|NCT00104520|566303672|FG000|Overall Study|Study drug intolerance|0|||
156875781|NCT00104520|566303673|FG001|Overall Study|Study drug intolerance|1|||
156875782|NCT00104520|566303672|FG000|Overall Study|Related adverse event|13|||
156875783|NCT00104520|566303673|FG001|Overall Study|Related adverse event|15|||
156875784|NCT00104520|566303672|FG000|Overall Study|Lost to Follow-up|1|||
156452409|NCT05794243|564748666|FG001|Overall Study|Physician Decision|3|||
156452410|NCT05794243|564748667|FG002|Overall Study|Physician Decision|1|||
156452411|NCT02761057|564748668|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
156452412|NCT02761057|564748669|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
156452413|NCT02761057|564748670|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
156452414|NCT02761057|564748671|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
156452415|NCT02761057|564748668|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
156452416|NCT02761057|564748669|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
156724458|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724459|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724460|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
156724461|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
156724462|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
156724463|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
156724464|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
156724465|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
156724466|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
156724467|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
156724468|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
156875785|NCT00104520|566303673|FG001|Overall Study|Lost to Follow-up|0|||
156875786|NCT00104520|566303672|FG000|Overall Study|Noncompliance|0|||
156875787|NCT00104520|566303673|FG001|Overall Study|Noncompliance|2|||
156875788|NCT00104520|566303672|FG000|Overall Study|Personal/administrative|1|||
156875789|NCT00104520|566303673|FG001|Overall Study|Personal/administrative|1|||
156452417|NCT02761057|564748670|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
156452418|NCT02761057|564748671|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
156452419|NCT02761057|564748668|FG000|Overall Study|Currently On Study Treatment|0|||
156452420|NCT02761057|564748669|FG001|Overall Study|Currently On Study Treatment|3|||
156452421|NCT02761057|564748670|FG002|Overall Study|Currently On Study Treatment|0|||
156452422|NCT02761057|564748671|FG003|Overall Study|Currently On Study Treatment|0|||
156452423|NCT02761057|564748668|FG000|Overall Study|Adverse Event|11|||
156452424|NCT02761057|564748669|FG001|Overall Study|Adverse Event|9|||
156875790|NCT00104520|566303672|FG000|Overall Study|Other|1|||
156875791|NCT00104520|566303673|FG001|Overall Study|Other|5|||
156452425|NCT02761057|564748670|FG002|Overall Study|Adverse Event|5|||
156452426|NCT02761057|564748671|FG003|Overall Study|Adverse Event|3|||
156452427|NCT02761057|564748668|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
156452428|NCT02761057|564748669|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
156452429|NCT02761057|564748670|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
156452430|NCT02761057|564748671|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
156452431|NCT02761057|564748668|FG000|Overall Study|Progression/Relapse|29|||
156452432|NCT02761057|564748669|FG001|Overall Study|Progression/Relapse|27|||
156452433|NCT02761057|564748670|FG002|Overall Study|Progression/Relapse|20|||
156452434|NCT02761057|564748671|FG003|Overall Study|Progression/Relapse|23|||
156724469|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
156875792|NCT01010867|566303677|FG000|Overall Study|< 50% adherence to probiotic|1|||
156875793|NCT01668589|566303678|FG000|Overall Study|Lost to Follow-up|29|||
156452435|NCT02761057|564748668|FG000|Overall Study|Death|2|||
156452436|NCT02761057|564748669|FG001|Overall Study|Death|2|||
156452437|NCT02761057|564748670|FG002|Overall Study|Death|1|||
156452438|NCT02761057|564748671|FG003|Overall Study|Death|1|||
156452439|NCT02761057|564748668|FG000|Overall Study|Other - Not Protocol Specified|2|||
156452440|NCT02761057|564748669|FG001|Overall Study|Other - Not Protocol Specified|1|||
156452441|NCT02761057|564748670|FG002|Overall Study|Other - Not Protocol Specified|2|||
156724470|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
156724471|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
156875794|NCT01668589|566303679|FG001|Overall Study|Lost to Follow-up|37|||
156875795|NCT01668589|566303680|FG002|Overall Study|Lost to Follow-up|15|||
156452442|NCT02761057|564748671|FG003|Overall Study|Other - Not Protocol Specified|0|||
156452443|NCT05093829|564748673|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
156724472|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
156724473|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
156724474|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
156724475|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
156724476|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
156724477|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
156724478|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
156724479|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
156724480|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
156724481|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
156724482|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
156724483|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
156724484|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
156724485|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
156724486|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
156724487|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
156724488|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
156724489|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
156724490|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
156724491|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
156724492|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
156724493|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
156724494|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
156724495|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
156724496|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724497|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724498|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724499|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
156724500|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724501|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724502|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724503|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
156724504|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724505|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724506|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724507|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
156724508|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724509|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724510|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724511|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
156335764|NCT00739674|564328086|FG000|Overall Study|Lost to Follow-up|52|||
156452444|NCT05093829|564748674|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
156724512|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724513|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724514|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724515|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
156724516|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
156724517|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
156724518|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
156724519|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
156724520|NCT00997373|565737108|FG000|Overall Study|Withdrawal by Subject|5|||
156724521|NCT00997373|565737109|FG001|Overall Study|Withdrawal by Subject|0|||
156724522|NCT00997373|565737108|FG000|Overall Study|wrong tumor type|4|||
156724523|NCT00997373|565737109|FG001|Overall Study|wrong tumor type|0|||
156724524|NCT00997373|565737108|FG000|Overall Study|could not have hysterectomy|6|||
156724525|NCT00997373|565737109|FG001|Overall Study|could not have hysterectomy|0|||
156724526|NCT04578457|565737110|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
156724527|NCT04578457|565737110|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
156724528|NCT04578457|565737110|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
156724529|NCT04578457|565737110|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
156724530|NCT02841995|565737117|FG000|Overall Study|Disease progression|5|||
156724531|NCT02841995|565737118|FG001|Overall Study|Disease progression|11|||
156335765|NCT00739674|564328087|FG001|Overall Study|Lost to Follow-up|30|||
156452445|NCT05093829|564748675|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
156452446|NCT05093829|564748676|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
156452447|NCT05093829|564748677|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
156452448|NCT04806594|564750628|FG000|Overall Study|Withdrawal by Subject|2|||
156452449|NCT04806594|564750628|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
156724532|NCT02841995|565737119|FG002|Overall Study|Disease progression|8|||
156724533|NCT02841995|565737117|FG000|Overall Study|Withdrawal by Subject|2|||
156724534|NCT02841995|565737118|FG001|Overall Study|Withdrawal by Subject|4|||
156724535|NCT02841995|565737119|FG002|Overall Study|Withdrawal by Subject|4|||
156724536|NCT02841995|565737117|FG000|Overall Study|Adverse Event|2|||
156724537|NCT02841995|565737118|FG001|Overall Study|Adverse Event|0|||
156724538|NCT02841995|565737119|FG002|Overall Study|Adverse Event|1|||
156724539|NCT02841995|565737117|FG000|Overall Study|Investigator decision|2|||
156724540|NCT02841995|565737118|FG001|Overall Study|Investigator decision|0|||
156724541|NCT02841995|565737119|FG002|Overall Study|Investigator decision|1|||
156724542|NCT02841995|565737117|FG000|Overall Study|Death|0|||
156724543|NCT02841995|565737118|FG001|Overall Study|Death|0|||
156724544|NCT02841995|565737119|FG002|Overall Study|Death|2|||
156724545|NCT02841995|565737117|FG000|Overall Study|Noncompliance to protocol|1|||
156724546|NCT02841995|565737118|FG001|Overall Study|Noncompliance to protocol|0|||
156724547|NCT02841995|565737119|FG002|Overall Study|Noncompliance to protocol|0|||
156724548|NCT02841995|565737117|FG000|Overall Study|Sponsor decision|1|||
156724549|NCT02841995|565737118|FG001|Overall Study|Sponsor decision|0|||
156724550|NCT02841995|565737119|FG002|Overall Study|Sponsor decision|0|||
156724551|NCT02841995|565737117|FG000|Overall Study|Other|4|||
156724552|NCT02841995|565737118|FG001|Overall Study|Other|1|||
156724553|NCT02841995|565737119|FG002|Overall Study|Other|5|||
156724554|NCT03376789|565737120|FG000|Overall Study|Withdrawal by Subject|3|||
156724555|NCT03376789|565737121|FG001|Overall Study|Withdrawal by Subject|5|||
156724556|NCT03376789|565737120|FG000|Overall Study|Protocol Violation|0|||
156724557|NCT03376789|565737121|FG001|Overall Study|Protocol Violation|1|||
156724558|NCT03376789|565737120|FG000|Overall Study|Adverse Event|0|||
156724559|NCT03376789|565737121|FG001|Overall Study|Adverse Event|1|||
156724560|NCT03376789|565737120|FG000|Overall Study|Lost to Follow-up|1|||
156724561|NCT03376789|565737121|FG001|Overall Study|Lost to Follow-up|1|||
156724562|NCT03376789|565737120|FG000|Overall Study|Per sponsor due to noncompliance|1|||
156724563|NCT03376789|565737121|FG001|Overall Study|Per sponsor due to noncompliance|0|||
156724564|NCT03376789|565737120|FG000|Overall Study|Subject off study medication|0|||
156724565|NCT03376789|565737121|FG001|Overall Study|Subject off study medication|1|||
156724566|NCT01703260|565737122|FG000|Overall Study|Adverse Event|1|||
156724567|NCT01703260|565737123|FG001|Overall Study|Adverse Event|2|||
156724568|NCT01703260|565737124|FG002|Overall Study|Adverse Event|2|||
156724569|NCT01703260|565737122|FG000|Overall Study|Lost to Follow-up|1|||
156724570|NCT01703260|565737123|FG001|Overall Study|Lost to Follow-up|0|||
156724571|NCT01703260|565737124|FG002|Overall Study|Lost to Follow-up|0|||
156724572|NCT01703260|565737122|FG000|Overall Study|Withdrawal by Subject|0|||
156724573|NCT01703260|565737123|FG001|Overall Study|Withdrawal by Subject|0|||
156724574|NCT01703260|565737124|FG002|Overall Study|Withdrawal by Subject|1|||
156724575|NCT01703260|565737122|FG000|Overall Study|Study Termination|1|||
156724576|NCT01703260|565737123|FG001|Overall Study|Study Termination|2|||
156724577|NCT01703260|565737124|FG002|Overall Study|Study Termination|0|||
156794808|NCT01217892|566002779|FG000|Overall Study|Subject no longer meets study criteria|5|||
156452450|NCT04318548|564750629|FG000|Overall Study|Adverse Event|0|||
156452451|NCT04318548|564750630|FG001|Overall Study|Adverse Event|0|||
156335766|NCT00739674|564328086|FG000|Overall Study|Protocol Violation|5|||
156452452|NCT04318548|564750631|FG002|Overall Study|Adverse Event|1|||
156452453|NCT04318548|564750629|FG000|Overall Study|Lost to Follow-up|6|||
156452454|NCT04318548|564750630|FG001|Overall Study|Lost to Follow-up|13|||
156724578|NCT01464424|565737128|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
156724579|NCT01464424|565737129|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
156724580|NCT02632409|565737132|FG000|Randomized|AE unrelated to study Drug|0|||
156724581|NCT02632409|565737133|FG001|Randomized|AE unrelated to study Drug|1|||
156724582|NCT02632409|565737132|FG000|Randomized|Participant withdrew consent|2|||
156724583|NCT02632409|565737133|FG001|Randomized|Participant withdrew consent|1|||
156724584|NCT02632409|565737132|FG000|Randomized|No Longer meets study criteria|5|||
156724585|NCT02632409|565737133|FG001|Randomized|No Longer meets study criteria|0|||
156875796|NCT01668589|566303681|FG003|Overall Study|Lost to Follow-up|5|||
156335767|NCT00739674|564328087|FG001|Overall Study|Protocol Violation|5|||
156452455|NCT04318548|564750631|FG002|Overall Study|Lost to Follow-up|9|||
156724586|NCT02632409|565737132|FG000|Randomized|other reasons|1|||
156724587|NCT02632409|565737133|FG001|Randomized|other reasons|0|||
156724588|NCT02632409|565737132|FG000|Treatment Period|Ongoing Treatment|20|||
156724589|NCT02632409|565737133|FG001|Treatment Period|Ongoing Treatment|21|||
156724590|NCT02632409|565737132|FG000|Treatment Period|Disease Recurrence|147|||
156724591|NCT02632409|565737133|FG001|Treatment Period|Disease Recurrence|90|||
156724592|NCT02632409|565737132|FG000|Treatment Period|Study Drug Toxicity|8|||
156724593|NCT02632409|565737133|FG001|Treatment Period|Study Drug Toxicity|49|||
156452456|NCT04318548|564750629|FG000|Overall Study|Protocol Violation|1|||
156724594|NCT02632409|565737132|FG000|Treatment Period|Death|1|||
156724595|NCT02632409|565737133|FG001|Treatment Period|Death|0|||
156724596|NCT02632409|565737132|FG000|Treatment Period|AE unrelated to study drug|15|||
156724597|NCT02632409|565737133|FG001|Treatment Period|AE unrelated to study drug|16|||
156724598|NCT02632409|565737132|FG000|Treatment Period|Request to discontinue treatment|4|||
156724599|NCT02632409|565737133|FG001|Treatment Period|Request to discontinue treatment|19|||
156724600|NCT02632409|565737132|FG000|Treatment Period|Participant withdrew consent|7|||
156724601|NCT02632409|565737133|FG001|Treatment Period|Participant withdrew consent|5|||
156724602|NCT02632409|565737132|FG000|Treatment Period|Lost to Follow-up|0|||
156724603|NCT02632409|565737133|FG001|Treatment Period|Lost to Follow-up|1|||
156724604|NCT02632409|565737132|FG000|Treatment Period|Maximum clinical benefit|1|||
156724605|NCT02632409|565737133|FG001|Treatment Period|Maximum clinical benefit|0|||
156724606|NCT02632409|565737132|FG000|Treatment Period|No longer meets study criteria|3|||
156724607|NCT02632409|565737133|FG001|Treatment Period|No longer meets study criteria|0|||
156724608|NCT02632409|565737132|FG000|Treatment Period|Administrative Reason by sponsor|0|||
156724609|NCT02632409|565737133|FG001|Treatment Period|Administrative Reason by sponsor|1|||
156724610|NCT02632409|565737132|FG000|Treatment Period|Other Reasons|10|||
156724611|NCT02632409|565737133|FG001|Treatment Period|Other Reasons|6|||
156724612|NCT03331796|565737134|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
156724613|NCT03331796|565737135|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
156724614|NCT03331796|565737136|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
156724615|NCT03331796|565737134|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
156724616|NCT03331796|565737135|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
156724617|NCT03331796|565737136|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
156724618|NCT03331796|565737134|FG000|Extended Follow-up|Adverse Event|1|||
156724619|NCT03331796|565737135|FG001|Extended Follow-up|Adverse Event|0|||
156724620|NCT03331796|565737136|FG002|Extended Follow-up|Adverse Event|1|||
156724621|NCT03331796|565737134|FG000|Extended Follow-up|Lost to Follow-up|0|||
156724622|NCT03331796|565737135|FG001|Extended Follow-up|Lost to Follow-up|0|||
156724623|NCT03331796|565737136|FG002|Extended Follow-up|Lost to Follow-up|1|||
156724624|NCT03331796|565737134|FG000|Extended Follow-up|Withdrawal by Subject|1|||
156724625|NCT03331796|565737135|FG001|Extended Follow-up|Withdrawal by Subject|0|||
156724626|NCT03331796|565737136|FG002|Extended Follow-up|Withdrawal by Subject|0|||
156724627|NCT03331796|565737134|FG000|Extended Follow-up|Termination of Funding|0|||
156724628|NCT03331796|565737135|FG001|Extended Follow-up|Termination of Funding|1|||
156724629|NCT03331796|565737136|FG002|Extended Follow-up|Termination of Funding|0|||
156724630|NCT04426006|565737137|FG000|Inclusion|Protocol Violation|1|||
156724631|NCT04426006|565737137|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
156724632|NCT04426006|565737137|FG000|Inclusion|Blood sample at inclusion not done|1|||
156724633|NCT04426006|565737137|FG000|3 Months|Lost to Follow-up|17|||
156724634|NCT04426006|565737137|FG000|12 Months|Lost to Follow-up|38|||
156724635|NCT01000155|565737138|FG000|Overall Study|Withdrawal by Subject|1|||
156724636|NCT01000155|565737138|FG000|Overall Study|Adverse Event|1|||
156724637|NCT04760626|565737139|FG000|Overall Study|Withdrawal by Subject|24|||
156724638|NCT04760626|565737140|FG001|Overall Study|Withdrawal by Subject|20|||
156724639|NCT04760626|565737139|FG000|Overall Study|Lost to Follow-up|14|||
156794809|NCT01217892|566002780|FG001|Overall Study|Subject no longer meets study criteria|2|||
156794810|NCT01217892|566002781|FG002|Overall Study|Subject no longer meets study criteria|4|||
156794811|NCT01217892|566002782|FG003|Overall Study|Subject no longer meets study criteria|8|||
156794812|NCT01217892|566002779|FG000|Overall Study|Incorrect enrollment|0|||
156794813|NCT01217892|566002780|FG001|Overall Study|Incorrect enrollment|1|||
156794814|NCT01217892|566002781|FG002|Overall Study|Incorrect enrollment|1|||
156794815|NCT01217892|566002782|FG003|Overall Study|Incorrect enrollment|0|||
156794816|NCT01217892|566002779|FG000|Overall Study|Poor/Non-Compliance|0|||
156794817|NCT01217892|566002780|FG001|Overall Study|Poor/Non-Compliance|0|||
156794818|NCT01217892|566002781|FG002|Overall Study|Poor/Non-Compliance|1|||
156794819|NCT01217892|566002782|FG003|Overall Study|Poor/Non-Compliance|0|||
156794820|NCT00480532|566002785|FG000|Overall Study|Withdrawal by Subject|2|||
156794821|NCT00480532|566002786|FG001|Overall Study|Withdrawal by Subject|4|||
156794822|NCT00480532|566002787|FG002|Overall Study|Withdrawal by Subject|3|||
156794823|NCT00480532|566002788|FG003|Overall Study|Withdrawal by Subject|1|||
156335768|NCT00739674|564328086|FG000|Overall Study|Withdrawal by Subject|9|||
156452457|NCT04318548|564750630|FG001|Overall Study|Protocol Violation|0|||
156724640|NCT04760626|565737140|FG001|Overall Study|Lost to Follow-up|19|||
156724641|NCT04760626|565737139|FG000|Overall Study|Physician Decision|3|||
156724642|NCT04760626|565737140|FG001|Overall Study|Physician Decision|5|||
156724643|NCT04760626|565737139|FG000|Overall Study|Death|3|||
156724644|NCT04760626|565737140|FG001|Overall Study|Death|6|||
156724645|NCT04760626|565737139|FG000|Overall Study|Site closure|1|||
156724646|NCT04760626|565737140|FG001|Overall Study|Site closure|0|||
156794824|NCT00480532|566002785|FG000|Overall Study|Protocol Violation|0|||
156794825|NCT00480532|566002786|FG001|Overall Study|Protocol Violation|0|||
156794826|NCT00480532|566002787|FG002|Overall Study|Protocol Violation|1|||
156794827|NCT00480532|566002788|FG003|Overall Study|Protocol Violation|0|||
156724647|NCT00908544|565737143|FG000|Overall Study|Withdrawal by Subject|2|||
156724648|NCT00908544|565737144|FG001|Overall Study|Withdrawal by Subject|4|||
156724649|NCT00908544|565737143|FG000|Overall Study|Lack of Efficacy|0|||
156724650|NCT00908544|565737144|FG001|Overall Study|Lack of Efficacy|1|||
156724651|NCT00908544|565737143|FG000|Overall Study|Pregnancy|1|||
156724652|NCT00908544|565737144|FG001|Overall Study|Pregnancy|0|||
156724653|NCT00908544|565737143|FG000|Overall Study|Relocation abroad|1|||
156724654|NCT00908544|565737144|FG001|Overall Study|Relocation abroad|1|||
156724655|NCT00908544|565737143|FG000|Overall Study|Unable to visit sutdy center|1|||
156724656|NCT00908544|565737144|FG001|Overall Study|Unable to visit sutdy center|0|||
156724657|NCT00740636|565737147|FG000|Overall Study|Adverse Event|0|||
156724658|NCT00740636|565737148|FG001|Overall Study|Adverse Event|2|||
156724659|NCT00740636|565737147|FG000|Overall Study|Patient Ineligible|0|||
156724660|NCT00740636|565737148|FG001|Overall Study|Patient Ineligible|1|||
156724661|NCT00740636|565737147|FG000|Overall Study|Patient Not Treated|0|||
156724662|NCT00740636|565737148|FG001|Overall Study|Patient Not Treated|1|||
156724663|NCT00740636|565737147|FG000|Overall Study|Progressive Disease|1|||
156724664|NCT00740636|565737148|FG001|Overall Study|Progressive Disease|0|||
156724665|NCT00740636|565737147|FG000|Overall Study|Death|1|||
156724666|NCT00740636|565737148|FG001|Overall Study|Death|0|||
156724667|NCT02462603|565737153|FG000|Overall Study|Investigator Decision|1|||
156724668|NCT02462603|565737153|FG000|Overall Study|Non-Compliance|1|||
156724669|NCT02462603|565737153|FG000|Overall Study|Withdrawal by Subject|2|||
156724670|NCT04955691|565738948|FG000|Period 2|Discontinued intervention|1|||
156724671|NCT04955691|565738949|FG001|Period 2|Discontinued intervention|2|||
156724672|NCT05795153|565738950|FG000|Overall Study|Adverse Event|2|||
156724673|NCT05795153|565738950|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156724674|NCT05795153|565738950|FG000|Overall Study|Lost to Follow-up|1|||
156452458|NCT04318548|564750631|FG002|Overall Study|Protocol Violation|2|||
156724675|NCT05795153|565738950|FG000|Overall Study|Subject decision|2|||
156724676|NCT05336227|565738951|FG000|Overall Study|Adverse Event|1|||
156724677|NCT05336227|565738952|FG001|Overall Study|Adverse Event|0|||
156724678|NCT05336227|565738951|FG000|Overall Study|Lost to Follow-up|2|||
156724679|NCT05336227|565738952|FG001|Overall Study|Lost to Follow-up|0|||
156724680|NCT05336227|565738951|FG000|Overall Study|Withdrawal by Subject|1|||
156724681|NCT05336227|565738952|FG001|Overall Study|Withdrawal by Subject|0|||
156724682|NCT04050462|565738953|FG000|Overall Study|Withdrawal by Subject|1|||
156724683|NCT04050462|565738954|FG001|Overall Study|Withdrawal by Subject|0|||
156724684|NCT04050462|565738955|FG002|Overall Study|Withdrawal by Subject|0|||
156724685|NCT05151744|565738958|FG000|Overall Study|Adverse Event|6|||
156724686|NCT05151744|565738959|FG001|Overall Study|Adverse Event|2|||
156724687|NCT05151744|565738958|FG000|Overall Study|Death|1|||
156724688|NCT05151744|565738959|FG001|Overall Study|Death|2|||
156724689|NCT05151744|565738958|FG000|Overall Study|Lack of Efficacy|1|||
156452459|NCT04318548|564750629|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
156452460|NCT04318548|564750630|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
156724690|NCT05151744|565738959|FG001|Overall Study|Lack of Efficacy|1|||
156724691|NCT05151744|565738958|FG000|Overall Study|Lost to Follow-up|2|||
156724692|NCT05151744|565738959|FG001|Overall Study|Lost to Follow-up|2|||
156724693|NCT05151744|565738958|FG000|Overall Study|Need for Rescue Treatment|0|||
156724694|NCT05151744|565738959|FG001|Overall Study|Need for Rescue Treatment|1|||
156724695|NCT05151744|565738958|FG000|Overall Study|Non-compliance with Study Drug|0|||
156724696|NCT05151744|565738959|FG001|Overall Study|Non-compliance with Study Drug|1|||
156724697|NCT05151744|565738958|FG000|Overall Study|Reason not Specified|10|||
156724698|NCT05151744|565738959|FG001|Overall Study|Reason not Specified|0|||
156724699|NCT05151744|565738958|FG000|Overall Study|Physician Decision|2|||
156724700|NCT05151744|565738959|FG001|Overall Study|Physician Decision|1|||
156724701|NCT05151744|565738958|FG000|Overall Study|Protocol Violation|1|||
156724702|NCT05151744|565738959|FG001|Overall Study|Protocol Violation|0|||
156724703|NCT05151744|565738958|FG000|Overall Study|Withdrawal by Subject|6|||
156724704|NCT05151744|565738959|FG001|Overall Study|Withdrawal by Subject|3|||
156724705|NCT05228470|565738960|FG000|Overall Study|Death|6|||
156724706|NCT05228470|565738961|FG001|Overall Study|Death|11|||
156724707|NCT05228470|565738960|FG000|Overall Study|Withdrawal by Subject|1|||
156724708|NCT05228470|565738961|FG001|Overall Study|Withdrawal by Subject|8|||
156724709|NCT05228470|565738960|FG000|Overall Study|Ongoing|1|||
156724710|NCT05228470|565738961|FG001|Overall Study|Ongoing|11|||
156724711|NCT01068678|565738964|FG000|Overall Study|Lack of Efficacy|3|||
156724712|NCT01068678|565738965|FG001|Overall Study|Lack of Efficacy|2|||
156724713|NCT01068678|565738964|FG000|Overall Study|Protocol Violation|5|||
156724714|NCT01068678|565738965|FG001|Overall Study|Protocol Violation|1|||
156724715|NCT01068678|565738964|FG000|Overall Study|Withdrawal criteria|12|||
156724716|NCT01068678|565738965|FG001|Overall Study|Withdrawal criteria|6|||
156724717|NCT01068678|565738964|FG000|Overall Study|Unclassified|18|||
156724718|NCT01068678|565738965|FG001|Overall Study|Unclassified|15|||
156724719|NCT03123120|565738976|FG000|Overall Study|Lost to Follow-up|0|||
156724720|NCT03123120|565738977|FG001|Overall Study|Lost to Follow-up|1|||
156724721|NCT03123120|565738976|FG000|Overall Study|Withdrawal by Subject|0|||
156724722|NCT03123120|565738977|FG001|Overall Study|Withdrawal by Subject|1|||
156724723|NCT02632175|565738978|FG000|Overall Study|Withdrawal by Subject|6|||
156724724|NCT02632175|565738978|FG000|Overall Study|Lost to Follow-up|1|||
156724725|NCT02632175|565738978|FG000|Overall Study|Lack of Efficacy|18|||
156724726|NCT02632175|565738978|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
156724727|NCT02632175|565738978|FG000|Overall Study|Subject noncompliance|3|||
156724728|NCT02632175|565738978|FG000|Overall Study|other|2|||
156724729|NCT02088554|565738979|FG000|Overall Study|Exited before procedure|130|||
156724730|NCT02088554|565738979|FG000|Overall Study|Attempted but not implanted|31|||
156724731|NCT02088554|565738979|FG000|Overall Study|Implant not attempted|19|||
156724732|NCT02088554|565738979|FG000|Overall Study|Pending next visit|532|||
156724733|NCT02088554|565738979|FG000|Overall Study|Death|170|||
156724734|NCT02088554|565738979|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
156724735|NCT02088554|565738979|FG000|Overall Study|Lost to Follow-up|23|||
156724736|NCT02088554|565738979|FG000|Overall Study|Explanted|32|||
156724737|NCT02088554|565738979|FG000|Overall Study|Any other reason not covered by previous categories|11|||
156724738|NCT04066244|565738981|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
156724739|NCT04066244|565738982|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
156724740|NCT04066244|565738983|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
156724741|NCT04066244|565738984|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
156724742|NCT04066244|565738985|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
156724743|NCT04066244|565738986|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
156724744|NCT04066244|565738981|FG000|Part 2 (Cohort 5)|Death|0|||
156724745|NCT04066244|565738982|FG001|Part 2 (Cohort 5)|Death|0|||
156724746|NCT04066244|565738983|FG002|Part 2 (Cohort 5)|Death|0|||
156724747|NCT04066244|565738984|FG003|Part 2 (Cohort 5)|Death|0|||
156724748|NCT04066244|565738985|FG004|Part 2 (Cohort 5)|Death|0|||
156724749|NCT04066244|565738986|FG005|Part 2 (Cohort 5)|Death|2|||
156724750|NCT04066244|565738981|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156724751|NCT04066244|565738982|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156724752|NCT04066244|565738983|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156724753|NCT04066244|565738984|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156335769|NCT00739674|564328087|FG001|Overall Study|Withdrawal by Subject|9|||
156724754|NCT04066244|565738985|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156724755|NCT04066244|565738986|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
156724756|NCT04066244|565738981|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724757|NCT04066244|565738982|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724758|NCT04066244|565738983|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724759|NCT04066244|565738984|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724760|NCT04066244|565738985|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
156724761|NCT04066244|565738986|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724762|NCT00866281|565738987|FG000|Overall Study|Adverse Event|1|||
156724763|NCT00866281|565738988|FG001|Overall Study|Adverse Event|0|||
156724764|NCT00866281|565738987|FG000|Overall Study|Withdrawal by participants|3|||
156724765|NCT00866281|565738988|FG001|Overall Study|Withdrawal by participants|0|||
156724766|NCT00866281|565738987|FG000|Overall Study|Disease progression|3|||
156724767|NCT00866281|565738988|FG001|Overall Study|Disease progression|11|||
156724768|NCT00866281|565738987|FG000|Overall Study|New cancer therapy|0|||
156724769|NCT00866281|565738988|FG001|Overall Study|New cancer therapy|4|||
156724770|NCT02955355|565738994|FG000|Overall Study|Adverse Event|4|||
156724771|NCT02955355|565738994|FG000|Overall Study|Death|1|||
156724772|NCT02955355|565738994|FG000|Overall Study|Physician Decision|21|||
156724773|NCT02955355|565738994|FG000|Overall Study|Site Terminated by Sponsor|35|||
156724774|NCT02955355|565738994|FG000|Overall Study|Withdrawal by Subject|19|||
156724775|NCT02955355|565738994|FG000|Overall Study|Reason Not Specified|5|||
156724776|NCT02612623|565738995|FG000|Overall Study|Withdrawal by Subject|0|||
156724777|NCT02612623|565738996|FG001|Overall Study|Withdrawal by Subject|1|||
156724778|NCT02612623|565738997|FG002|Overall Study|Withdrawal by Subject|0|||
156724779|NCT02612623|565738998|FG003|Overall Study|Withdrawal by Subject|0|||
156724780|NCT02612623|565738995|FG000|Overall Study|Adverse Event|1|||
156724781|NCT02612623|565738996|FG001|Overall Study|Adverse Event|0|||
156724782|NCT02612623|565738997|FG002|Overall Study|Adverse Event|1|||
156724783|NCT02612623|565738998|FG003|Overall Study|Adverse Event|0|||
156724784|NCT01671007|565739005|FG000|Overall Study|Other reasons than listed|166|||
156724785|NCT01671007|565739006|FG001|Overall Study|Other reasons than listed|373|||
156724786|NCT01671007|565739007|FG002|Overall Study|Other reasons than listed|197|||
156724787|NCT01671007|565739008|FG003|Overall Study|Other reasons than listed|228|||
156724788|NCT01671007|565739009|FG004|Overall Study|Other reasons than listed|14|||
156724789|NCT01671007|565739010|FG005|Overall Study|Other reasons than listed|71|||
156724790|NCT01671007|565739011|FG006|Overall Study|Other reasons than listed|17|||
156724791|NCT01671007|565739012|FG007|Overall Study|Other reasons than listed|66|||
156724792|NCT01671007|565739013|FG008|Overall Study|Other reasons than listed|0|||
156724793|NCT01671007|565739005|FG000|Overall Study|Withdrawal by Subject|36|||
156724794|NCT01671007|565739006|FG001|Overall Study|Withdrawal by Subject|59|||
156724795|NCT01671007|565739007|FG002|Overall Study|Withdrawal by Subject|53|||
156724796|NCT01671007|565739008|FG003|Overall Study|Withdrawal by Subject|58|||
156724797|NCT01671007|565739009|FG004|Overall Study|Withdrawal by Subject|4|||
156724798|NCT01671007|565739010|FG005|Overall Study|Withdrawal by Subject|15|||
156794828|NCT01592747|566002789|FG000|Overall Study|Loss of Therapeutic Response|107|||
156794829|NCT01592747|566002790|FG001|Overall Study|Loss of Therapeutic Response|108|||
156794830|NCT01592747|566002791|FG002|Overall Study|Loss of Therapeutic Response|100|||
156794831|NCT01592747|566002789|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
156794832|NCT01592747|566002790|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
156794833|NCT01592747|566002791|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
156794834|NCT01592747|566002789|FG000|Overall Study|Adverse Event|1|||
156794835|NCT01592747|566002790|FG001|Overall Study|Adverse Event|0|||
156794836|NCT01592747|566002791|FG002|Overall Study|Adverse Event|0|||
156794837|NCT01592747|566002789|FG000|Overall Study|Protocol Violation|4|||
156794838|NCT01592747|566002790|FG001|Overall Study|Protocol Violation|0|||
156794839|NCT01592747|566002791|FG002|Overall Study|Protocol Violation|4|||
156794840|NCT01592747|566002789|FG000|Overall Study|Lack of Efficacy|0|||
156875797|NCT01668589|566303678|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
156875798|NCT01668589|566303679|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
156875799|NCT01668589|566303680|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
156875800|NCT01668589|566303681|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
156875801|NCT01668589|566303678|FG000|Overall Study|Death|12|||
156875802|NCT01668589|566303679|FG001|Overall Study|Death|3|||
156875803|NCT01668589|566303680|FG002|Overall Study|Death|2|||
156875804|NCT01668589|566303681|FG003|Overall Study|Death|11|||
156875805|NCT01668589|566303678|FG000|Overall Study|Other|44|||
156875806|NCT01668589|566303679|FG001|Overall Study|Other|10|||
156875807|NCT01668589|566303680|FG002|Overall Study|Other|7|||
156875808|NCT01668589|566303681|FG003|Overall Study|Other|15|||
156875809|NCT00233064|566303682|FG000|Overall Study|Lost to Follow-up|7|||
156875810|NCT00233064|566303683|FG001|Overall Study|Lost to Follow-up|7|||
156875811|NCT00233064|566303682|FG000|Overall Study|Withdrawal by Subject|5|||
156875812|NCT00233064|566303683|FG001|Overall Study|Withdrawal by Subject|3|||
156875813|NCT00233064|566303682|FG000|Overall Study|Death|0|||
156875814|NCT00233064|566303683|FG001|Overall Study|Death|1|||
156875815|NCT00233064|566303682|FG000|Overall Study|Relocation|0|||
156875816|NCT00233064|566303683|FG001|Overall Study|Relocation|1|||
156875817|NCT00233064|566303682|FG000|Overall Study|Protocol Violation|1|||
156875818|NCT00233064|566303683|FG001|Overall Study|Protocol Violation|0|||
156875819|NCT00233064|566303682|FG000|Overall Study|Moved to Dom. Republic|1|||
156875820|NCT00233064|566303683|FG001|Overall Study|Moved to Dom. Republic|0|||
156875821|NCT02302339|566303684|FG000|Overall Study|Lost to Follow-up|1|||
156875822|NCT02302339|566303685|FG001|Overall Study|Lost to Follow-up|0|||
156875823|NCT02302339|566303686|FG002|Overall Study|Lost to Follow-up|0|||
156875824|NCT02302339|566303687|FG003|Overall Study|Lost to Follow-up|0|||
156875825|NCT02302339|566303684|FG000|Overall Study|Withdrawal by Subject|0|||
156875826|NCT02302339|566303685|FG001|Overall Study|Withdrawal by Subject|2|||
156875827|NCT02302339|566303686|FG002|Overall Study|Withdrawal by Subject|1|||
156875828|NCT02302339|566303687|FG003|Overall Study|Withdrawal by Subject|0|||
156875829|NCT04393454|566303690|FG000|Overall Study|Death|1|||
156875830|NCT04393454|566303690|FG000|Overall Study|Lost to Follow-up|1|||
156875831|NCT02752165|566303692|FG000|Overall Study|Withdrawal by Subject|6|||
156875832|NCT02752165|566303693|FG001|Overall Study|Withdrawal by Subject|6|||
156875833|NCT02752165|566303692|FG000|Overall Study|Protocol Violation|6|||
156875834|NCT02752165|566303693|FG001|Overall Study|Protocol Violation|5|||
156875835|NCT02752165|566303692|FG000|Overall Study|Lost to Follow-up|33|||
156875836|NCT02752165|566303693|FG001|Overall Study|Lost to Follow-up|38|||
156875837|NCT01120964|566303694|FG000|Overall Study|Did not receive full treatment|1|||
156875838|NCT01120964|566303695|FG001|Overall Study|Did not receive full treatment|0|||
156875839|NCT01704599|566303699|FG000|Overall Study|Adverse Event|1|||
156875840|NCT00912197|566303700|FG000|Overall Study|Withdrawal by Subject|3|||
156335770|NCT00739674|564328086|FG000|Overall Study|Reason missing|2|||
156335771|NCT00739674|564328087|FG001|Overall Study|Reason missing|0|||
156335772|NCT00739674|564328086|FG000|Overall Study|Clinic closed|6|||
156794841|NCT01592747|566002790|FG001|Overall Study|Lack of Efficacy|1|||
156452461|NCT04318548|564750631|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
156794842|NCT01592747|566002791|FG002|Overall Study|Lack of Efficacy|0|||
156794843|NCT01592747|566002789|FG000|Overall Study|Withdrawal by Subject|2|||
156794844|NCT01592747|566002790|FG001|Overall Study|Withdrawal by Subject|0|||
156794845|NCT01592747|566002791|FG002|Overall Study|Withdrawal by Subject|2|||
156794846|NCT01592747|566002789|FG000|Overall Study|Lost to Follow-up|1|||
156794847|NCT01592747|566002790|FG001|Overall Study|Lost to Follow-up|0|||
156875841|NCT00912197|566303701|FG001|Overall Study|Withdrawal by Subject|3|||
156875842|NCT03304249|566303706|FG000|Overall Study|Lost to Follow-up|8|||
156875843|NCT03304249|566303707|FG001|Overall Study|Lost to Follow-up|10|||
156875844|NCT03304249|566303706|FG000|Overall Study|Withdrawal by Subject|12|||
156875845|NCT03304249|566303707|FG001|Overall Study|Withdrawal by Subject|2|||
156875846|NCT03304249|566303706|FG000|Overall Study|Moved Out of District|4|||
156875847|NCT03304249|566303707|FG001|Overall Study|Moved Out of District|2|||
156875848|NCT00494676|566303713|FG000|Allocation|Withdrawal by Subject|2|||
156875849|NCT00494676|566303714|FG001|Allocation|Withdrawal by Subject|4|||
156875850|NCT00494676|566303713|FG000|First Intervention|Withdrawal by Subject|1|||
156724799|NCT01671007|565739011|FG006|Overall Study|Withdrawal by Subject|1|||
156724800|NCT01671007|565739012|FG007|Overall Study|Withdrawal by Subject|19|||
156724801|NCT01671007|565739013|FG008|Overall Study|Withdrawal by Subject|0|||
156724802|NCT01671007|565739005|FG000|Overall Study|Lost to Follow-up|93|||
156724803|NCT01671007|565739006|FG001|Overall Study|Lost to Follow-up|142|||
156724804|NCT01671007|565739007|FG002|Overall Study|Lost to Follow-up|91|||
156724805|NCT01671007|565739008|FG003|Overall Study|Lost to Follow-up|63|||
156724806|NCT01671007|565739009|FG004|Overall Study|Lost to Follow-up|7|||
156724807|NCT01671007|565739010|FG005|Overall Study|Lost to Follow-up|20|||
156724808|NCT01671007|565739011|FG006|Overall Study|Lost to Follow-up|2|||
156724809|NCT01671007|565739012|FG007|Overall Study|Lost to Follow-up|28|||
156724810|NCT01671007|565739013|FG008|Overall Study|Lost to Follow-up|0|||
156724811|NCT01671007|565739005|FG000|Overall Study|No end of study case report form|3|||
156724812|NCT01671007|565739006|FG001|Overall Study|No end of study case report form|1|||
156724813|NCT01671007|565739007|FG002|Overall Study|No end of study case report form|0|||
156724814|NCT01671007|565739008|FG003|Overall Study|No end of study case report form|2|||
156724815|NCT01671007|565739009|FG004|Overall Study|No end of study case report form|0|||
156724816|NCT01671007|565739010|FG005|Overall Study|No end of study case report form|0|||
156724817|NCT01671007|565739011|FG006|Overall Study|No end of study case report form|0|||
156724818|NCT01671007|565739012|FG007|Overall Study|No end of study case report form|0|||
156724819|NCT01671007|565739013|FG008|Overall Study|No end of study case report form|0|||
156724820|NCT01671007|565739005|FG000|Overall Study|Not eligible|23|||
156724821|NCT01671007|565739006|FG001|Overall Study|Not eligible|76|||
156724822|NCT01671007|565739007|FG002|Overall Study|Not eligible|25|||
156724823|NCT01671007|565739008|FG003|Overall Study|Not eligible|17|||
156724824|NCT01671007|565739009|FG004|Overall Study|Not eligible|0|||
156724825|NCT01671007|565739010|FG005|Overall Study|Not eligible|6|||
156724826|NCT01671007|565739011|FG006|Overall Study|Not eligible|1|||
156724827|NCT01671007|565739012|FG007|Overall Study|Not eligible|19|||
156724828|NCT01671007|565739013|FG008|Overall Study|Not eligible|0|||
156724829|NCT03877068|565739014|FG000|Overall Study|Physician Decision|9|||
156724830|NCT03877068|565739015|FG001|Overall Study|Physician Decision|3|||
156724831|NCT03187301|565739018|FG000|Titration Period|Adverse Event|0|||
156724832|NCT03187301|565739019|FG001|Titration Period|Adverse Event|0|||
156724833|NCT03187301|565739020|FG002|Titration Period|Adverse Event|0|||
156724834|NCT03187301|565739021|FG003|Titration Period|Adverse Event|0|||
156724835|NCT03187301|565739022|FG004|Titration Period|Adverse Event|0|||
156724836|NCT03187301|565739023|FG005|Titration Period|Adverse Event|0|||
156724837|NCT03187301|565739024|FG006|Titration Period|Adverse Event|5|||
156724838|NCT03187301|565739018|FG000|Titration Period|Withdrawal by Subject|0|||
156724839|NCT03187301|565739019|FG001|Titration Period|Withdrawal by Subject|0|||
156724840|NCT03187301|565739020|FG002|Titration Period|Withdrawal by Subject|0|||
156724841|NCT03187301|565739021|FG003|Titration Period|Withdrawal by Subject|0|||
156724842|NCT03187301|565739022|FG004|Titration Period|Withdrawal by Subject|0|||
156724843|NCT03187301|565739023|FG005|Titration Period|Withdrawal by Subject|0|||
156724844|NCT03187301|565739024|FG006|Titration Period|Withdrawal by Subject|1|||
156724845|NCT03187301|565739018|FG000|Titration Period|Exclusion Criteria Met|0|||
156724846|NCT03187301|565739019|FG001|Titration Period|Exclusion Criteria Met|0|||
156724847|NCT03187301|565739020|FG002|Titration Period|Exclusion Criteria Met|0|||
156724848|NCT03187301|565739021|FG003|Titration Period|Exclusion Criteria Met|0|||
156724849|NCT03187301|565739022|FG004|Titration Period|Exclusion Criteria Met|0|||
156724850|NCT03187301|565739023|FG005|Titration Period|Exclusion Criteria Met|0|||
156794848|NCT01592747|566002791|FG002|Overall Study|Lost to Follow-up|1|||
156794849|NCT01592747|566002789|FG000|Overall Study|Other Reasons|1|||
156794850|NCT01592747|566002790|FG001|Overall Study|Other Reasons|1|||
156794851|NCT01592747|566002791|FG002|Overall Study|Other Reasons|0|||
156794852|NCT02367885|566002792|FG000|Overall Study|Lost to Follow-up|1|||
156794853|NCT02367885|566002793|FG001|Overall Study|Lost to Follow-up|0|||
156794854|NCT02367885|566002794|FG002|Overall Study|Lost to Follow-up|0|||
156794855|NCT02367885|566002792|FG000|Overall Study|Withdrawal by Subject|1|||
156794856|NCT02367885|566002793|FG001|Overall Study|Withdrawal by Subject|0|||
156724851|NCT03187301|565739024|FG006|Titration Period|Exclusion Criteria Met|1|||
156724852|NCT03187301|565739018|FG000|Pre-Intervention|Withdrawal by Subject|1|||
156724853|NCT03187301|565739019|FG001|Pre-Intervention|Withdrawal by Subject|0|||
156794857|NCT02367885|566002794|FG002|Overall Study|Withdrawal by Subject|0|||
156794858|NCT01602484|566002795|FG000|Overall Study|Airway issues unrelated to study|0|||
156794859|NCT01602484|566002796|FG001|Overall Study|Airway issues unrelated to study|1|||
156724854|NCT03187301|565739020|FG002|Pre-Intervention|Withdrawal by Subject|0|||
156724855|NCT03187301|565739021|FG003|Pre-Intervention|Withdrawal by Subject|0|||
156724856|NCT03187301|565739022|FG004|Pre-Intervention|Withdrawal by Subject|0|||
156724857|NCT03187301|565739023|FG005|Pre-Intervention|Withdrawal by Subject|0|||
156724858|NCT03187301|565739024|FG006|Pre-Intervention|Withdrawal by Subject|0|||
156724859|NCT03809663|565739027|FG000|Overall Study|Decision by sponsor|24|||
156724860|NCT03809663|565739028|FG001|Overall Study|Decision by sponsor|18|||
156724861|NCT03809663|565739029|FG002|Overall Study|Decision by sponsor|20|||
156724862|NCT03809663|565739030|FG003|Overall Study|Decision by sponsor|20|||
156724863|NCT03809663|565739031|FG004|Overall Study|Decision by sponsor|0|||
156452462|NCT04318548|564750629|FG000|Overall Study|Migrated / moved from the study area|0|||
156452463|NCT04318548|564750630|FG001|Overall Study|Migrated / moved from the study area|0|||
156452464|NCT04318548|564750631|FG002|Overall Study|Migrated / moved from the study area|1|||
156452465|NCT04318548|564750629|FG000|Overall Study|Other|1|||
156452466|NCT04318548|564750630|FG001|Overall Study|Other|2|||
156452467|NCT04318548|564750631|FG002|Overall Study|Other|3|||
156452468|NCT02120456|564750635|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
156452469|NCT02120456|564750636|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
156452470|NCT02120456|564750637|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
156452471|NCT02120456|564750638|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
156452472|NCT02120456|564750639|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
156452473|NCT02120456|564750640|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
156452474|NCT02120456|564750641|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
156452475|NCT02120456|564750642|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
156452476|NCT02120456|564750643|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
156452477|NCT02120456|564750635|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
156452478|NCT02120456|564750636|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
156452479|NCT02120456|564750637|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
156452480|NCT02120456|564750638|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
156452481|NCT02120456|564750639|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
156452482|NCT02120456|564750640|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
156452483|NCT02120456|564750641|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
156452484|NCT02120456|564750642|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
156452485|NCT02120456|564750643|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
156452486|NCT02120456|564750635|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
156452487|NCT02120456|564750636|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
156452488|NCT02120456|564750637|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
156452489|NCT02120456|564750638|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
156452490|NCT02120456|564750639|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
156452491|NCT02120456|564750640|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
156452492|NCT02120456|564750641|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
156452493|NCT02120456|564750642|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
156452494|NCT02120456|564750643|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
156724864|NCT03809663|565739032|FG005|Overall Study|Decision by sponsor|0|||
156724865|NCT03809663|565739027|FG000|Overall Study|Withdrawal by Subject|26|||
156724866|NCT03809663|565739028|FG001|Overall Study|Withdrawal by Subject|22|||
156724867|NCT03809663|565739029|FG002|Overall Study|Withdrawal by Subject|27|||
156724868|NCT03809663|565739030|FG003|Overall Study|Withdrawal by Subject|26|||
156724869|NCT03809663|565739031|FG004|Overall Study|Withdrawal by Subject|0|||
156724870|NCT03809663|565739032|FG005|Overall Study|Withdrawal by Subject|0|||
156724871|NCT03809663|565739027|FG000|Overall Study|Lost to Follow-up|1|||
156724872|NCT03809663|565739028|FG001|Overall Study|Lost to Follow-up|4|||
156724873|NCT03809663|565739029|FG002|Overall Study|Lost to Follow-up|1|||
156724874|NCT03809663|565739030|FG003|Overall Study|Lost to Follow-up|1|||
156724875|NCT03809663|565739031|FG004|Overall Study|Lost to Follow-up|0|||
156724876|NCT03809663|565739032|FG005|Overall Study|Lost to Follow-up|0|||
156724877|NCT02042014|565739036|FG000|Overall Study|Adverse Event|1|||
156724878|NCT02042014|565739036|FG000|Overall Study|Physician Decision|7|||
156724879|NCT02792062|565739037|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
156724880|NCT02792062|565739038|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724881|NCT02792062|565739039|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724882|NCT02792062|565739040|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724883|NCT02792062|565739041|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724884|NCT02792062|565739042|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724885|NCT00558701|565739046|FG000|Overall Study|Protocol Deviations|1|||
156724886|NCT00558701|565739047|FG001|Overall Study|Protocol Deviations|4|||
156724887|NCT02230904|565739048|FG000|Overall Study|Safety follow up could not take place|0|||
156724888|NCT02230904|565739049|FG001|Overall Study|Safety follow up could not take place|1|||
156724889|NCT01262872|565739051|FG000|Step 2|Death|0|||
156724890|NCT01262872|565739052|FG001|Step 2|Death|0|||
156724891|NCT01262872|565739053|FG002|Step 2|Death|0|||
156724892|NCT01262872|565739054|FG003|Step 2|Death|1|||
156724893|NCT01262872|565739055|FG004|Step 2|Death|0|||
156724894|NCT01262872|565739056|FG005|Step 2|Death|2|||
156724895|NCT01262872|565739057|FG006|Step 2|Death|2|||
156724896|NCT01262872|565739058|FG007|Step 2|Death|1|||
156724897|NCT01262872|565739051|FG000|Step 2|Protocol Violation|0|||
156724898|NCT01262872|565739052|FG001|Step 2|Protocol Violation|0|||
156724899|NCT01262872|565739053|FG002|Step 2|Protocol Violation|1|||
156724900|NCT01262872|565739054|FG003|Step 2|Protocol Violation|0|||
156724901|NCT01262872|565739055|FG004|Step 2|Protocol Violation|0|||
156724902|NCT01262872|565739056|FG005|Step 2|Protocol Violation|0|||
156724903|NCT01262872|565739057|FG006|Step 2|Protocol Violation|3|||
156724904|NCT01262872|565739058|FG007|Step 2|Protocol Violation|1|||
156724905|NCT01262872|565739051|FG000|Step 2|Withdrawal by Subject|0|||
156724906|NCT01262872|565739052|FG001|Step 2|Withdrawal by Subject|0|||
156724907|NCT01262872|565739053|FG002|Step 2|Withdrawal by Subject|4|||
156724908|NCT01262872|565739054|FG003|Step 2|Withdrawal by Subject|6|||
156724909|NCT01262872|565739055|FG004|Step 2|Withdrawal by Subject|3|||
156724910|NCT01262872|565739056|FG005|Step 2|Withdrawal by Subject|1|||
156724911|NCT01262872|565739057|FG006|Step 2|Withdrawal by Subject|2|||
156724912|NCT01262872|565739058|FG007|Step 2|Withdrawal by Subject|1|||
156724913|NCT01262872|565739051|FG000|Step 2|Migrated/moved from study area|0|||
156724914|NCT01262872|565739052|FG001|Step 2|Migrated/moved from study area|0|||
156724915|NCT01262872|565739053|FG002|Step 2|Migrated/moved from study area|4|||
156724916|NCT01262872|565739054|FG003|Step 2|Migrated/moved from study area|3|||
156724917|NCT01262872|565739055|FG004|Step 2|Migrated/moved from study area|2|||
156724918|NCT01262872|565739056|FG005|Step 2|Migrated/moved from study area|6|||
156724919|NCT01262872|565739057|FG006|Step 2|Migrated/moved from study area|2|||
156724920|NCT01262872|565739058|FG007|Step 2|Migrated/moved from study area|3|||
156724921|NCT01565889|565739063|FG000|Part A|Withdrawal by Subject|1|||
156724922|NCT01565889|565739064|FG001|Part A|Withdrawal by Subject|0|||
156724923|NCT01565889|565739065|FG002|Part A|Withdrawal by Subject|0|||
156724924|NCT01565889|565739066|FG003|Part A|Withdrawal by Subject|0|||
156724925|NCT01565889|565739067|FG004|Part A|Withdrawal by Subject|0|||
156724926|NCT01565889|565739068|FG005|Part A|Withdrawal by Subject|0|||
156724927|NCT01565889|565739063|FG000|Part B|Withdrawal by Subject|0|||
156724928|NCT01565889|565739064|FG001|Part B|Withdrawal by Subject|0|||
156724929|NCT01565889|565739065|FG002|Part B|Withdrawal by Subject|0|||
156724930|NCT01565889|565739066|FG003|Part B|Withdrawal by Subject|0|||
156724931|NCT01565889|565739067|FG004|Part B|Withdrawal by Subject|0|||
156724932|NCT01565889|565739068|FG005|Part B|Withdrawal by Subject|1|||
156724933|NCT01565889|565739063|FG000|Part B|Lack of Efficacy|0|||
156724934|NCT01565889|565739064|FG001|Part B|Lack of Efficacy|0|||
156724935|NCT01565889|565739065|FG002|Part B|Lack of Efficacy|0|||
156724936|NCT01565889|565739066|FG003|Part B|Lack of Efficacy|0|||
156724937|NCT01565889|565739067|FG004|Part B|Lack of Efficacy|0|||
156724938|NCT01565889|565739068|FG005|Part B|Lack of Efficacy|2|||
156724939|NCT01565889|565739063|FG000|Part B|Lost to Follow-up|0|||
156724940|NCT01565889|565739064|FG001|Part B|Lost to Follow-up|0|||
156724941|NCT01565889|565739065|FG002|Part B|Lost to Follow-up|0|||
156724942|NCT01565889|565739066|FG003|Part B|Lost to Follow-up|0|||
156724943|NCT01565889|565739067|FG004|Part B|Lost to Follow-up|0|||
156724944|NCT01565889|565739068|FG005|Part B|Lost to Follow-up|1|||
156724945|NCT00122382|565739069|FG000|Double-Blind Study|Adverse Event|9|||
156724946|NCT00122382|565739070|FG001|Double-Blind Study|Adverse Event|11|||
156724947|NCT00122382|565739071|FG002|Double-Blind Study|Adverse Event|0|||
156724948|NCT00122382|565739069|FG000|Double-Blind Study|Death|2|||
156724949|NCT00122382|565739070|FG001|Double-Blind Study|Death|2|||
156724950|NCT00122382|565739071|FG002|Double-Blind Study|Death|0|||
156724951|NCT00122382|565739069|FG000|Double-Blind Study|Lack of Efficacy|0|||
156724952|NCT00122382|565739070|FG001|Double-Blind Study|Lack of Efficacy|8|||
156724953|NCT00122382|565739071|FG002|Double-Blind Study|Lack of Efficacy|0|||
156724954|NCT00122382|565739069|FG000|Double-Blind Study|Lost to Follow-up|2|||
156724955|NCT00122382|565739070|FG001|Double-Blind Study|Lost to Follow-up|1|||
156724956|NCT00122382|565739071|FG002|Double-Blind Study|Lost to Follow-up|0|||
156724957|NCT00122382|565739069|FG000|Double-Blind Study|Pregnancy|2|||
156724958|NCT00122382|565739070|FG001|Double-Blind Study|Pregnancy|0|||
156724959|NCT00122382|565739071|FG002|Double-Blind Study|Pregnancy|0|||
156724960|NCT00122382|565739069|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
156724961|NCT00122382|565739070|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
156724962|NCT00122382|565739071|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
156724963|NCT00122382|565739069|FG000|Double-Blind Study|Withdrawal of Consent|7|||
156794860|NCT01378195|566002797|FG000|Overall Study|Lost to Follow-up|29|||
156794861|NCT01378195|566002798|FG001|Overall Study|Lost to Follow-up|18|||
156794862|NCT00425555|566002799|FG000|Overall Study|Withdrawal by Subject|11|||
156724964|NCT00122382|565739070|FG001|Double-Blind Study|Withdrawal of Consent|3|||
156724965|NCT00122382|565739071|FG002|Double-Blind Study|Withdrawal of Consent|0|||
156724966|NCT00122382|565739069|FG000|Double-Blind Study|Protocol Violation|1|||
156724967|NCT00122382|565739070|FG001|Double-Blind Study|Protocol Violation|0|||
156724968|NCT00122382|565739071|FG002|Double-Blind Study|Protocol Violation|0|||
156724969|NCT00122382|565739069|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
156794863|NCT00425555|566002800|FG001|Overall Study|Withdrawal by Subject|8|||
156452495|NCT05192200|564750644|FG000|Treatment Period|Other|1|||
156724970|NCT00122382|565739070|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
156724971|NCT00122382|565739071|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
156724972|NCT00122382|565739069|FG000|Double-Blind Study|Randomized but not treated|0|||
156794864|NCT00425555|566002799|FG000|Overall Study|Lost to Follow-up|0|||
156794865|NCT00425555|566002800|FG001|Overall Study|Lost to Follow-up|1|||
156724973|NCT00122382|565739070|FG001|Double-Blind Study|Randomized but not treated|2|||
156724974|NCT00122382|565739071|FG002|Double-Blind Study|Randomized but not treated|0|||
156724975|NCT00122382|565739069|FG000|Open-Label Study|Adverse Event|0|||
156724976|NCT00122382|565739070|FG001|Open-Label Study|Adverse Event|0|||
156724977|NCT00122382|565739071|FG002|Open-Label Study|Adverse Event|11|||
156724978|NCT00122382|565739069|FG000|Open-Label Study|Death|0|||
156724979|NCT00122382|565739070|FG001|Open-Label Study|Death|0|||
156724980|NCT00122382|565739071|FG002|Open-Label Study|Death|2|||
156724981|NCT00122382|565739069|FG000|Open-Label Study|Lack of Efficacy|0|||
156724982|NCT00122382|565739070|FG001|Open-Label Study|Lack of Efficacy|0|||
156724983|NCT00122382|565739071|FG002|Open-Label Study|Lack of Efficacy|3|||
156724984|NCT00122382|565739069|FG000|Open-Label Study|Lost to Follow-up|0|||
156724985|NCT00122382|565739070|FG001|Open-Label Study|Lost to Follow-up|0|||
156724986|NCT00122382|565739071|FG002|Open-Label Study|Lost to Follow-up|3|||
156724987|NCT00122382|565739069|FG000|Open-Label Study|Pregnancy|0|||
156724988|NCT00122382|565739070|FG001|Open-Label Study|Pregnancy|0|||
156724989|NCT00122382|565739071|FG002|Open-Label Study|Pregnancy|2|||
156724990|NCT00122382|565739069|FG000|Open-Label Study|Poor/Non-Compliance|0|||
156724991|NCT00122382|565739070|FG001|Open-Label Study|Poor/Non-Compliance|0|||
156724992|NCT00122382|565739071|FG002|Open-Label Study|Poor/Non-Compliance|1|||
156724993|NCT00122382|565739069|FG000|Open-Label Study|Withdrawal of Consent|0|||
156724994|NCT00122382|565739070|FG001|Open-Label Study|Withdrawal of Consent|0|||
156724995|NCT00122382|565739071|FG002|Open-Label Study|Withdrawal of Consent|4|||
156724996|NCT02040805|565739073|FG000|Overall Study|Lost to Follow-up|14|||
156724997|NCT02040805|565739074|FG001|Overall Study|Lost to Follow-up|9|||
156724998|NCT02040805|565739073|FG000|Overall Study|Withdrawal by Subject|28|||
156724999|NCT02040805|565739074|FG001|Overall Study|Withdrawal by Subject|41|||
156725000|NCT02174627|565739075|FG000|Overall Study|Missing|0|||
156725001|NCT02174627|565739076|FG001|Overall Study|Missing|1|||
156725002|NCT02174627|565739075|FG000|Overall Study|Incorrect enrolment before randomization|0|||
156725003|NCT02174627|565739076|FG001|Overall Study|Incorrect enrolment before randomization|1|||
156725004|NCT02174627|565739075|FG000|Overall Study|Participant decision|84|||
156725005|NCT02174627|565739076|FG001|Overall Study|Participant decision|128|||
156725006|NCT02166333|565739077|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
156725007|NCT02166333|565739078|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
156725008|NCT02166333|565739079|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
156725009|NCT02166333|565739080|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
156725010|NCT02166333|565739081|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
156725011|NCT02166333|565739082|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
156725012|NCT02166333|565739077|FG000|Stage 1|Death|4|||
156725013|NCT02166333|565739078|FG001|Stage 1|Death|0|||
156725014|NCT02166333|565739079|FG002|Stage 1|Death|2|||
156875851|NCT00494676|566303714|FG001|First Intervention|Withdrawal by Subject|3|||
156875852|NCT00494676|566303713|FG000|Second Intervention|Withdrawal by Subject|1|||
156875853|NCT00494676|566303714|FG001|Second Intervention|Withdrawal by Subject|1|||
156875854|NCT04976192|566303715|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875855|NCT04976192|566303716|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
156875856|NCT04976192|566303717|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875857|NCT04976192|566303718|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875858|NCT04976192|566303719|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875859|NCT04976192|566303720|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156335773|NCT00739674|564328087|FG001|Overall Study|Clinic closed|4|||
156335774|NCT00739674|564328086|FG000|Overall Study|Patient moved|3|||
156335775|NCT00739674|564328087|FG001|Overall Study|Patient moved|2|||
156335776|NCT00739674|564328086|FG000|Overall Study|Non compliant|4|||
156335777|NCT00739674|564328087|FG001|Overall Study|Non compliant|0|||
156335778|NCT00739674|564328086|FG000|Overall Study|Unable to attend visit|3|||
156335779|NCT00739674|564328087|FG001|Overall Study|Unable to attend visit|1|||
156452496|NCT05192200|564750644|FG000|Treatment Period|Lack of Efficacy|1|||
156452497|NCT05192200|564750644|FG000|Treatment Period|Withdrawal by Subject|1|||
156452498|NCT05192200|564750644|FG000|Follow-up|Withdrawal by Subject|1|||
156452499|NCT03445988|564750650|FG000|Overall Study|Lost to Follow-up|14|||
156725015|NCT02166333|565739080|FG003|Stage 1|Death|0|||
156725016|NCT02166333|565739081|FG004|Stage 1|Death|3|||
156725017|NCT02166333|565739082|FG005|Stage 1|Death|2|||
156725018|NCT02166333|565739077|FG000|Stage 1|Lost to Follow-up|12|||
156725019|NCT02166333|565739078|FG001|Stage 1|Lost to Follow-up|0|||
156725020|NCT02166333|565739079|FG002|Stage 1|Lost to Follow-up|6|||
156725021|NCT02166333|565739080|FG003|Stage 1|Lost to Follow-up|0|||
156725022|NCT02166333|565739081|FG004|Stage 1|Lost to Follow-up|3|||
156875860|NCT04976192|566303721|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156725023|NCT02166333|565739082|FG005|Stage 1|Lost to Follow-up|3|||
156335780|NCT00739674|564328086|FG000|Overall Study|Home monitoring off meds|1|||
156725024|NCT02166333|565739077|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
156875861|NCT04976192|566303722|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156335781|NCT00739674|564328087|FG001|Overall Study|Home monitoring off meds|0|||
156335782|NCT00739674|564328086|FG000|Overall Study|Erectile dysfunction|0|||
156452500|NCT03445988|564750651|FG001|Overall Study|Lost to Follow-up|26|||
156452501|NCT03445988|564750652|FG002|Overall Study|Lost to Follow-up|27|||
156725025|NCT02166333|565739078|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
156725026|NCT02166333|565739079|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
156725027|NCT02166333|565739080|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
156725028|NCT02166333|565739081|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
156725029|NCT02166333|565739082|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
156725030|NCT02166333|565739077|FG000|Stage 2|Death|4|||
156725031|NCT02166333|565739078|FG001|Stage 2|Death|2|||
156725032|NCT02166333|565739079|FG002|Stage 2|Death|1|||
156725033|NCT02166333|565739080|FG003|Stage 2|Death|0|||
156725034|NCT02166333|565739081|FG004|Stage 2|Death|0|||
156725035|NCT02166333|565739082|FG005|Stage 2|Death|1|||
156725036|NCT02166333|565739077|FG000|Stage 2|Lost to Follow-up|23|||
156725037|NCT02166333|565739078|FG001|Stage 2|Lost to Follow-up|4|||
156725038|NCT02166333|565739079|FG002|Stage 2|Lost to Follow-up|11|||
156725039|NCT02166333|565739080|FG003|Stage 2|Lost to Follow-up|9|||
156725040|NCT02166333|565739081|FG004|Stage 2|Lost to Follow-up|3|||
156725041|NCT02166333|565739082|FG005|Stage 2|Lost to Follow-up|6|||
156725042|NCT02269098|565739083|FG000|Overall Study|Lost to Follow-up|14|||
156725043|NCT02269098|565739084|FG001|Overall Study|Lost to Follow-up|9|||
156725044|NCT00503698|565739085|FG000|Overall Study|Protocol Violation|5|||
156725045|NCT00503698|565739086|FG001|Overall Study|Protocol Violation|6|||
156725046|NCT00503698|565739085|FG000|Overall Study|Adverse Event|52|||
156725047|NCT00503698|565739086|FG001|Overall Study|Adverse Event|41|||
156725048|NCT00503698|565739085|FG000|Overall Study|Death|1|||
156725049|NCT00503698|565739086|FG001|Overall Study|Death|0|||
156725050|NCT00503698|565739085|FG000|Overall Study|Lack of Efficacy|3|||
156725051|NCT00503698|565739086|FG001|Overall Study|Lack of Efficacy|4|||
156725052|NCT00503698|565739085|FG000|Overall Study|Trial terminated|216|||
156725053|NCT00503698|565739086|FG001|Overall Study|Trial terminated|253|||
156794866|NCT00425555|566002799|FG000|Overall Study|Administrative problems|3|||
156794867|NCT00425555|566002800|FG001|Overall Study|Administrative problems|0|||
156794868|NCT00425555|566002799|FG000|Overall Study|Death|1|||
156794869|NCT00425555|566002800|FG001|Overall Study|Death|2|||
156794870|NCT00425555|566002799|FG000|Overall Study|New cancer therapy|2|||
156794871|NCT00425555|566002800|FG001|Overall Study|New cancer therapy|1|||
156794872|NCT00425555|566002799|FG000|Overall Study|Disease progression|36|||
156794873|NCT00425555|566002800|FG001|Overall Study|Disease progression|33|||
156794874|NCT00425555|566002799|FG000|Overall Study|Adverse Event|25|||
156794875|NCT00425555|566002800|FG001|Overall Study|Adverse Event|15|||
156794876|NCT00425555|566002799|FG000|Overall Study|Protocol Violation|1|||
156794877|NCT00425555|566002800|FG001|Overall Study|Protocol Violation|0|||
156794878|NCT02327169|566002801|FG000|Overall Study|Progressive Disease|1|||
156794879|NCT02327169|566002802|FG001|Overall Study|Progressive Disease|3|||
156794880|NCT02327169|566002803|FG002|Overall Study|Progressive Disease|4|||
156794881|NCT02327169|566002804|FG003|Overall Study|Progressive Disease|3|||
156794882|NCT02327169|566002805|FG004|Overall Study|Progressive Disease|4|||
156794883|NCT02327169|566002806|FG005|Overall Study|Progressive Disease|3|||
156794884|NCT02327169|566002807|FG006|Overall Study|Progressive Disease|3|||
156794885|NCT02327169|566002808|FG007|Overall Study|Progressive Disease|3|||
156794886|NCT02327169|566002809|FG008|Overall Study|Progressive Disease|4|||
156794887|NCT02327169|566002810|FG009|Overall Study|Progressive Disease|4|||
156794888|NCT02327169|566002811|FG010|Overall Study|Progressive Disease|4|||
156794889|NCT02327169|566002812|FG011|Overall Study|Progressive Disease|3|||
156725054|NCT00503698|565739085|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
156725055|NCT00503698|565739086|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
156725056|NCT00503698|565739085|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
156725057|NCT00503698|565739086|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
156725058|NCT00503698|565739085|FG000|Overall Study|Any condition in exclusion criteria|4|||
156725059|NCT00503698|565739086|FG001|Overall Study|Any condition in exclusion criteria|6|||
156725060|NCT00503698|565739085|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
156725061|NCT00503698|565739086|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
156794890|NCT02327169|566002813|FG012|Overall Study|Progressive Disease|1|||
156794891|NCT02327169|566002814|FG013|Overall Study|Progressive Disease|3|||
156725062|NCT00503698|565739085|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
156725063|NCT00503698|565739086|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
156725064|NCT00503698|565739085|FG000|Overall Study|Critically ill|2|||
156725065|NCT00503698|565739086|FG001|Overall Study|Critically ill|0|||
156794892|NCT02327169|566002815|FG014|Overall Study|Progressive Disease|3|||
156794893|NCT02327169|566002801|FG000|Overall Study|Adverse Event|2|||
156794894|NCT02327169|566002802|FG001|Overall Study|Adverse Event|0|||
156794895|NCT02327169|566002803|FG002|Overall Study|Adverse Event|1|||
156794896|NCT02327169|566002804|FG003|Overall Study|Adverse Event|0|||
156794897|NCT02327169|566002805|FG004|Overall Study|Adverse Event|1|||
156794898|NCT02327169|566002806|FG005|Overall Study|Adverse Event|0|||
156725066|NCT00503698|565739085|FG000|Overall Study|Unclassified|48|||
156794899|NCT02327169|566002807|FG006|Overall Study|Adverse Event|0|||
156794900|NCT02327169|566002808|FG007|Overall Study|Adverse Event|0|||
156794901|NCT02327169|566002809|FG008|Overall Study|Adverse Event|0|||
156452502|NCT03445988|564750653|FG003|Overall Study|Lost to Follow-up|66|||
156452503|NCT03445988|564750650|FG000|Overall Study|Withdrawal by Subject|7|||
156452504|NCT03445988|564750651|FG001|Overall Study|Withdrawal by Subject|4|||
156452505|NCT03445988|564750652|FG002|Overall Study|Withdrawal by Subject|3|||
156452506|NCT03445988|564750653|FG003|Overall Study|Withdrawal by Subject|5|||
156452507|NCT03445988|564750650|FG000|Overall Study|Death (unrelated to study)|5|||
156452508|NCT03445988|564750651|FG001|Overall Study|Death (unrelated to study)|1|||
156452509|NCT03445988|564750652|FG002|Overall Study|Death (unrelated to study)|2|||
156452510|NCT03445988|564750653|FG003|Overall Study|Death (unrelated to study)|4|||
156452511|NCT04274764|564750664|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
156452512|NCT04274764|564750665|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
156452513|NCT03611621|564750681|FG000|Overall Study|Graft loss|3|||
156452514|NCT03611621|564750681|FG000|Overall Study|Death|3|||
156452515|NCT03611621|564750681|FG000|Overall Study|Lost to Follow-up|1|||
156452516|NCT04764448|564750687|FG000|Overall Study|Study terminated by sponsor|2|||
156452517|NCT04764448|564750688|FG001|Overall Study|Study terminated by sponsor|2|||
156452518|NCT04764448|564750689|FG002|Overall Study|Study terminated by sponsor|5|||
156452519|NCT04764448|564750687|FG000|Overall Study|Withdrawal by Subject|3|||
156452520|NCT04764448|564750688|FG001|Overall Study|Withdrawal by Subject|3|||
156452521|NCT04764448|564750689|FG002|Overall Study|Withdrawal by Subject|1|||
156452522|NCT01084876|564750690|FG000|Main Study Treatment Period|Adverse Event|12|||
156452523|NCT01084876|564750691|FG001|Main Study Treatment Period|Adverse Event|7|||
156452524|NCT01084876|564750690|FG000|Main Study Treatment Period|Disease Progression|41|||
156452525|NCT01084876|564750691|FG001|Main Study Treatment Period|Disease Progression|24|||
156452526|NCT01084876|564750690|FG000|Main Study Treatment Period|Physician Decision|2|||
156452527|NCT01084876|564750691|FG001|Main Study Treatment Period|Physician Decision|0|||
156452528|NCT01084876|564750690|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
156452529|NCT01084876|564750691|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
156452530|NCT01084876|564750690|FG000|Main Study Treatment Period|Other Reason|0|||
156452531|NCT01084876|564750691|FG001|Main Study Treatment Period|Other Reason|1|||
156452532|NCT01084876|564750690|FG000|Main Study Treatment Period|Other|0|||
156452533|NCT01084876|564750691|FG001|Main Study Treatment Period|Other|1|||
156452534|NCT01084876|564750690|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
156452535|NCT01084876|564750691|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
156452536|NCT01084876|564750690|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
156452537|NCT01084876|564750691|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
156452538|NCT01084876|564750690|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
156452539|NCT01084876|564750691|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
156452540|NCT01084876|564750690|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
156452541|NCT01084876|564750691|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
156452542|NCT01084876|564750690|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
156452543|NCT01084876|564750691|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
156452544|NCT01084876|564750690|FG000|Treatment Period Beyond Cycle 8|Other|6|||
156452545|NCT01084876|564750691|FG001|Treatment Period Beyond Cycle 8|Other|9|||
156452546|NCT04727554|564750692|FG000|Overall Study|Lost to Follow-up|0|||
156452547|NCT04727554|564750693|FG001|Overall Study|Lost to Follow-up|1|||
156452548|NCT04727554|564750692|FG000|Overall Study|Death|2|||
156452549|NCT04727554|564750693|FG001|Overall Study|Death|6|||
156452550|NCT04727554|564750692|FG000|Overall Study|Withdrawal by Subject|1|||
156725067|NCT00503698|565739086|FG001|Overall Study|Unclassified|32|||
156725068|NCT00503698|565739085|FG000|Overall Study|Not exposed to trial drug|11|||
156725069|NCT00503698|565739086|FG001|Overall Study|Not exposed to trial drug|6|||
156725070|NCT03644342|565739092|FG000|Overall Study|Adverse Event|2|||
156725071|NCT03644342|565739093|FG001|Overall Study|Adverse Event|0|||
156725072|NCT03644342|565739092|FG000|Overall Study|Protocol Violation|0|||
156725073|NCT03644342|565739093|FG001|Overall Study|Protocol Violation|1|||
156725074|NCT02259010|565739094|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
156794902|NCT02327169|566002810|FG009|Overall Study|Adverse Event|2|||
156794903|NCT02327169|566002811|FG010|Overall Study|Adverse Event|0|||
156452551|NCT04727554|564750693|FG001|Overall Study|Withdrawal by Subject|0|||
156725075|NCT01662492|565739095|FG000|Overall Study|Other miscellaneous reasons.|1|||
156725076|NCT01662492|565739096|FG001|Overall Study|Other miscellaneous reasons.|0|||
156725077|NCT01662492|565739097|FG002|Overall Study|Other miscellaneous reasons.|1|||
156452552|NCT05653427|564750695|FG000|Overall Study|Study Terminated by Sponsor|13|||
156725078|NCT01662492|565739095|FG000|Overall Study|Withdrawal by Subject|0|||
156725079|NCT01662492|565739096|FG001|Overall Study|Withdrawal by Subject|0|||
156725080|NCT01662492|565739097|FG002|Overall Study|Withdrawal by Subject|1|||
156794904|NCT02327169|566002812|FG011|Overall Study|Adverse Event|3|||
156452553|NCT05028634|564750696|FG000|Overall Study|Withdrawal by Subject|0|||
156452554|NCT05028634|564750697|FG001|Overall Study|Withdrawal by Subject|1|||
156452555|NCT04256941|564750701|FG000|Overall Study|Withdrawal by Subject|0|||
156452556|NCT04256941|564750702|FG001|Overall Study|Withdrawal by Subject|1|||
156452557|NCT04256941|564750701|FG000|Overall Study|Death|1|||
156452558|NCT04256941|564750702|FG001|Overall Study|Death|0|||
156725081|NCT01662492|565739095|FG000|Overall Study|Protocol Violation|1|||
156452559|NCT04256941|564750701|FG000|Overall Study|Disease Progession|0|||
156452560|NCT04256941|564750702|FG001|Overall Study|Disease Progession|2|||
156452561|NCT05076708|564750709|FG000|Overall Study|Withdrawal by Subject|4|||
156452562|NCT05076708|564750709|FG000|Overall Study|Lost to study during switch phase|8|||
156452563|NCT05590403|564750710|FG000|Overall Study|Lost to Follow-up|13|||
156452564|NCT05590403|564750711|FG001|Overall Study|Lost to Follow-up|1|||
156452565|NCT05590403|564750712|FG002|Overall Study|Lost to Follow-up|7|||
156725082|NCT01662492|565739096|FG001|Overall Study|Protocol Violation|0|||
156725083|NCT01662492|565739097|FG002|Overall Study|Protocol Violation|0|||
156725084|NCT01662492|565739095|FG000|Overall Study|Lost to Follow-up|0|||
156725085|NCT01662492|565739096|FG001|Overall Study|Lost to Follow-up|0|||
156725086|NCT01662492|565739097|FG002|Overall Study|Lost to Follow-up|2|||
156725087|NCT01662492|565739095|FG000|Overall Study|Lack of Efficacy|1|||
156725088|NCT01662492|565739096|FG001|Overall Study|Lack of Efficacy|1|||
156725089|NCT01662492|565739097|FG002|Overall Study|Lack of Efficacy|2|||
156725090|NCT01591096|565739098|FG000|Overall Study|Adverse Event|1|||
156725091|NCT03655405|565739101|FG000|Overall Study|Death after initial data collection|4|||
156725092|NCT03655405|565739102|FG001|Overall Study|Death after initial data collection|2|||
156725093|NCT03655405|565739101|FG000|Overall Study|Died before initial data collection|1|||
156725094|NCT03655405|565739102|FG001|Overall Study|Died before initial data collection|2|||
156725095|NCT03655405|565739101|FG000|Overall Study|Protocol Violation|0|||
156794905|NCT02327169|566002813|FG012|Overall Study|Adverse Event|0|||
156875862|NCT04976192|566303723|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156794906|NCT02327169|566002814|FG013|Overall Study|Adverse Event|2|||
156794907|NCT02327169|566002815|FG014|Overall Study|Adverse Event|1|||
156794908|NCT02327169|566002801|FG000|Overall Study|Symptomatic Deterioration|0|||
156794909|NCT02327169|566002802|FG001|Overall Study|Symptomatic Deterioration|0|||
156794910|NCT02327169|566002803|FG002|Overall Study|Symptomatic Deterioration|1|||
156794911|NCT02327169|566002804|FG003|Overall Study|Symptomatic Deterioration|0|||
156794912|NCT02327169|566002805|FG004|Overall Study|Symptomatic Deterioration|1|||
156794913|NCT02327169|566002806|FG005|Overall Study|Symptomatic Deterioration|1|||
156794914|NCT02327169|566002807|FG006|Overall Study|Symptomatic Deterioration|0|||
156794915|NCT02327169|566002808|FG007|Overall Study|Symptomatic Deterioration|0|||
156794916|NCT02327169|566002809|FG008|Overall Study|Symptomatic Deterioration|2|||
156794917|NCT02327169|566002810|FG009|Overall Study|Symptomatic Deterioration|1|||
156794918|NCT02327169|566002811|FG010|Overall Study|Symptomatic Deterioration|0|||
156794919|NCT02327169|566002812|FG011|Overall Study|Symptomatic Deterioration|0|||
156794920|NCT02327169|566002813|FG012|Overall Study|Symptomatic Deterioration|0|||
156794921|NCT02327169|566002814|FG013|Overall Study|Symptomatic Deterioration|2|||
156794922|NCT02327169|566002815|FG014|Overall Study|Symptomatic Deterioration|1|||
156794923|NCT02327169|566002801|FG000|Overall Study|Reason Not Specified|0|||
156794924|NCT02327169|566002802|FG001|Overall Study|Reason Not Specified|0|||
156794925|NCT02327169|566002803|FG002|Overall Study|Reason Not Specified|1|||
156794926|NCT02327169|566002804|FG003|Overall Study|Reason Not Specified|0|||
156794927|NCT02327169|566002805|FG004|Overall Study|Reason Not Specified|0|||
156794928|NCT02327169|566002806|FG005|Overall Study|Reason Not Specified|0|||
156794929|NCT02327169|566002807|FG006|Overall Study|Reason Not Specified|0|||
156794930|NCT02327169|566002808|FG007|Overall Study|Reason Not Specified|0|||
156794931|NCT02327169|566002809|FG008|Overall Study|Reason Not Specified|0|||
156794932|NCT02327169|566002810|FG009|Overall Study|Reason Not Specified|1|||
156794933|NCT02327169|566002811|FG010|Overall Study|Reason Not Specified|2|||
156794934|NCT02327169|566002812|FG011|Overall Study|Reason Not Specified|1|||
156794935|NCT02327169|566002813|FG012|Overall Study|Reason Not Specified|0|||
156794936|NCT02327169|566002814|FG013|Overall Study|Reason Not Specified|0|||
156794937|NCT02327169|566002815|FG014|Overall Study|Reason Not Specified|2|||
156794938|NCT02327169|566002801|FG000|Overall Study|Withdrawal by Subject|1|||
156794939|NCT02327169|566002802|FG001|Overall Study|Withdrawal by Subject|0|||
156794940|NCT02327169|566002803|FG002|Overall Study|Withdrawal by Subject|0|||
156794941|NCT02327169|566002804|FG003|Overall Study|Withdrawal by Subject|0|||
156794942|NCT02327169|566002805|FG004|Overall Study|Withdrawal by Subject|1|||
156452566|NCT05590403|564750713|FG003|Overall Study|Lost to Follow-up|3|||
156452567|NCT05590403|564750714|FG004|Overall Study|Lost to Follow-up|4|||
156725096|NCT03655405|565739102|FG001|Overall Study|Protocol Violation|1|||
156725097|NCT01991743|565739103|FG000|Overall Study|external cephalic version not performed|0|||
156725098|NCT01991743|565739104|FG001|Overall Study|external cephalic version not performed|0|||
156725099|NCT01991743|565739105|FG002|Overall Study|external cephalic version not performed|1|||
156794943|NCT02327169|566002806|FG005|Overall Study|Withdrawal by Subject|0|||
156794944|NCT02327169|566002807|FG006|Overall Study|Withdrawal by Subject|0|||
156794945|NCT02327169|566002808|FG007|Overall Study|Withdrawal by Subject|1|||
156794946|NCT02327169|566002809|FG008|Overall Study|Withdrawal by Subject|0|||
156794947|NCT02327169|566002810|FG009|Overall Study|Withdrawal by Subject|0|||
156794948|NCT02327169|566002811|FG010|Overall Study|Withdrawal by Subject|0|||
156794949|NCT02327169|566002812|FG011|Overall Study|Withdrawal by Subject|0|||
156794950|NCT02327169|566002813|FG012|Overall Study|Withdrawal by Subject|0|||
156452568|NCT05590403|564750710|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
156725100|NCT01991743|565739106|FG003|Overall Study|external cephalic version not performed|0|||
156725101|NCT00848718|565739108|FG000|Overall Study|Adverse Event|2|||
156725102|NCT00848718|565739109|FG001|Overall Study|Adverse Event|2|||
156725103|NCT00848718|565739110|FG002|Overall Study|Adverse Event|1|||
156725104|NCT00848718|565739111|FG003|Overall Study|Adverse Event|1|||
156725105|NCT00848718|565739112|FG004|Overall Study|Adverse Event|1|||
156875863|NCT04976192|566303724|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875864|NCT04976192|566303715|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
156875865|NCT04976192|566303716|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
156875866|NCT04976192|566303717|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
156875867|NCT04976192|566303718|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
156875868|NCT04976192|566303719|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875869|NCT04976192|566303720|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875870|NCT04976192|566303721|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875871|NCT04976192|566303722|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875872|NCT04976192|566303723|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875873|NCT04976192|566303724|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875874|NCT04976192|566303715|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
156875875|NCT04976192|566303716|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875876|NCT04976192|566303717|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
156875877|NCT04976192|566303718|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875878|NCT04976192|566303719|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875879|NCT04976192|566303720|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875880|NCT04976192|566303721|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875881|NCT04976192|566303722|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875882|NCT04976192|566303723|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875883|NCT04976192|566303724|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875884|NCT04976192|566303715|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875885|NCT04976192|566303716|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875886|NCT04976192|566303717|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875887|NCT04976192|566303718|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875888|NCT04976192|566303719|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
156875889|NCT04976192|566303720|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
156875890|NCT04976192|566303721|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
156875891|NCT04976192|566303722|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
156875892|NCT04976192|566303723|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
156875893|NCT04976192|566303724|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
156875894|NCT04976192|566303715|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875895|NCT04976192|566303716|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875896|NCT04976192|566303717|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875897|NCT04976192|566303718|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875898|NCT04976192|566303719|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
156725106|NCT00848718|565739113|FG005|Overall Study|Adverse Event|0|||
156725107|NCT00848718|565739114|FG006|Overall Study|Adverse Event|0|||
156725108|NCT00848718|565739115|FG007|Overall Study|Adverse Event|1|||
156875899|NCT04976192|566303720|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875900|NCT04976192|566303721|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875901|NCT04976192|566303722|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875902|NCT04976192|566303723|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875903|NCT04976192|566303724|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875904|NCT04976192|566303715|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875905|NCT04976192|566303716|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875906|NCT04976192|566303717|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875907|NCT04976192|566303718|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875908|NCT04976192|566303719|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875909|NCT04976192|566303720|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156875910|NCT04976192|566303721|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875911|NCT04976192|566303722|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156335783|NCT00739674|564328087|FG001|Overall Study|Erectile dysfunction|1|||
156452569|NCT05590403|564750711|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
156452570|NCT05590403|564750712|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
156452571|NCT05590403|564750713|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
156452572|NCT05590403|564750714|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
156452573|NCT05590403|564750710|FG000|Overall Study|Other|2|||
156725109|NCT00848718|565739116|FG008|Overall Study|Adverse Event|1|||
156725110|NCT00848718|565739117|FG009|Overall Study|Adverse Event|0|||
156725111|NCT00848718|565739118|FG010|Overall Study|Adverse Event|0|||
156335784|NCT01897454|564328092|FG000|Overall Study|Withdrawal by Subject|1|||
156335785|NCT00983437|564328095|FG000|Overall Study|Adverse Event|9|||
156335786|NCT00983437|564328095|FG000|Overall Study|Lack of Efficacy|1|||
156335787|NCT00983437|564328095|FG000|Overall Study|Withdrawal by Subject|8|||
156335788|NCT00983437|564328095|FG000|Overall Study|Noncompliance to Study Procedures|1|||
156335789|NCT00983437|564328095|FG000|Overall Study|Lost to Follow-up|2|||
156335790|NCT00983437|564328095|FG000|Overall Study|Other Reason|26|||
156335791|NCT00064337|564328097|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
156335792|NCT00064337|564328097|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
156335793|NCT00064337|564328097|FG000|PBSCC or Induction/PBSCC|Progression|3|||
156335794|NCT00064337|564328097|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
156335795|NCT00064337|564328097|FG000|PBSCC or Induction/PBSCC|Death|2|||
156335796|NCT00064337|564328097|FG000|Transplant|Adverse Event|9|||
156335797|NCT00064337|564328097|FG000|Transplant|Not protocol-specified|5|||
156335798|NCT00064337|564328097|FG000|Transplant|Death|3|||
156335799|NCT00064337|564328097|FG000|Transplant|Patient Refusal|2|||
156335800|NCT00064337|564328097|FG000|Transplant|Progression|2|||
156335801|NCT00064337|564328097|FG000|Maintenance|Adverse Event|3|||
156335802|NCT00064337|564328097|FG000|Maintenance|Progression|2|||
156335803|NCT00064337|564328097|FG000|Maintenance|On treatment at time of analysis|2|||
156335804|NCT00064337|564328097|FG000|Maintenance|Not protocol-specified|2|||
156335805|NCT00064337|564328097|FG000|Maintenance|Death|1|||
156335806|NCT00617851|564328100|FG000|Overall Study|Death|0|||
156335807|NCT00617851|564328101|FG001|Overall Study|Death|0|||
156335808|NCT00617851|564328102|FG002|Overall Study|Death|0|||
156335809|NCT00617851|564328103|FG003|Overall Study|Death|1|||
156335810|NCT00617851|564328100|FG000|Overall Study|Withdrawal by Subject|14|||
156335811|NCT00617851|564328101|FG001|Overall Study|Withdrawal by Subject|7|||
156335812|NCT00617851|564328102|FG002|Overall Study|Withdrawal by Subject|12|||
156335813|NCT00617851|564328103|FG003|Overall Study|Withdrawal by Subject|4|||
156335814|NCT00617851|564328100|FG000|Overall Study|Lost to Follow-up|27|||
156335815|NCT00617851|564328101|FG001|Overall Study|Lost to Follow-up|29|||
156335816|NCT00617851|564328102|FG002|Overall Study|Lost to Follow-up|31|||
156335817|NCT00617851|564328103|FG003|Overall Study|Lost to Follow-up|19|||
156335818|NCT00617851|564328100|FG000|Overall Study|Inappropriate Enrollment|5|||
156335819|NCT00617851|564328101|FG001|Overall Study|Inappropriate Enrollment|4|||
156335820|NCT00617851|564328102|FG002|Overall Study|Inappropriate Enrollment|1|||
156335821|NCT00617851|564328103|FG003|Overall Study|Inappropriate Enrollment|1|||
156335822|NCT00617851|564328100|FG000|Overall Study|Unable to classify|1|||
156335823|NCT00617851|564328101|FG001|Overall Study|Unable to classify|0|||
156335824|NCT00617851|564328102|FG002|Overall Study|Unable to classify|1|||
156335825|NCT00617851|564328103|FG003|Overall Study|Unable to classify|0|||
156335826|NCT03750955|564328110|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
156335827|NCT03750955|564328111|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
156335828|NCT03750955|564328110|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
156335829|NCT03750955|564328111|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
156335830|NCT02248701|564328116|FG000|Overall Study|Withdrawal by Subject|2|||
156335831|NCT02248701|564328117|FG001|Overall Study|Withdrawal by Subject|1|||
156335832|NCT02248701|564328116|FG000|Overall Study|Physician Decision|0|||
156335833|NCT02248701|564328117|FG001|Overall Study|Physician Decision|1|||
156335834|NCT02248701|564328116|FG000|Overall Study|Adverse Event|1|||
156335835|NCT02248701|564328117|FG001|Overall Study|Adverse Event|0|||
156335836|NCT02248701|564328116|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
156335837|NCT02248701|564328117|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
156335838|NCT00319553|564328120|FG000|Overall Study|Protocol Violation|1|||
156335839|NCT00319553|564328121|FG001|Overall Study|Protocol Violation|2|||
156335840|NCT00319553|564328120|FG000|Overall Study|Lost to Follow-up|2|||
156725112|NCT00848718|565739119|FG011|Overall Study|Adverse Event|0|||
156725113|NCT00848718|565739120|FG012|Overall Study|Adverse Event|2|||
156725114|NCT00848718|565739108|FG000|Overall Study|Lack of Efficacy|0|||
156725115|NCT00848718|565739109|FG001|Overall Study|Lack of Efficacy|0|||
156335841|NCT00319553|564328121|FG001|Overall Study|Lost to Follow-up|1|||
156335842|NCT00319553|564328120|FG000|Overall Study|Withdrawal by Subject|1|||
156335843|NCT00319553|564328121|FG001|Overall Study|Withdrawal by Subject|1|||
156335844|NCT02747875|564328123|FG000|Overall Study|Physician Decision|1|||
156335845|NCT02747875|564328124|FG001|Overall Study|Physician Decision|0|||
156335846|NCT02747875|564328123|FG000|Overall Study|Adverse Event|0|||
156335847|NCT02747875|564328124|FG001|Overall Study|Adverse Event|1|||
156335848|NCT00762385|564328126|FG000|First Intervention|Lens Issue|1|||
156335849|NCT00762385|564328127|FG001|First Intervention|Lens Issue|1|||
156335850|NCT00762385|564328126|FG000|First Intervention|Lost to Follow-up|0|||
156335851|NCT00762385|564328127|FG001|First Intervention|Lost to Follow-up|2|||
156335852|NCT00762385|564328126|FG000|First Intervention|Ineligible|1|||
156335853|NCT00762385|564328127|FG001|First Intervention|Ineligible|0|||
156335854|NCT00762385|564328126|FG000|First Intervention|Protocol Violation|0|||
156335855|NCT00762385|564328127|FG001|First Intervention|Protocol Violation|1|||
156725116|NCT00848718|565739110|FG002|Overall Study|Lack of Efficacy|1|||
156452574|NCT05590403|564750711|FG001|Overall Study|Other|0|||
156452575|NCT05590403|564750712|FG002|Overall Study|Other|2|||
156452576|NCT05590403|564750713|FG003|Overall Study|Other|2|||
156452577|NCT05590403|564750714|FG004|Overall Study|Other|0|||
156452578|NCT05590403|564750710|FG000|Overall Study|Migrated / moved from the study area|1|||
156452579|NCT05590403|564750711|FG001|Overall Study|Migrated / moved from the study area|1|||
156452580|NCT05590403|564750712|FG002|Overall Study|Migrated / moved from the study area|0|||
156452581|NCT05590403|564750713|FG003|Overall Study|Migrated / moved from the study area|3|||
156452582|NCT05590403|564750714|FG004|Overall Study|Migrated / moved from the study area|1|||
156452583|NCT05590403|564750710|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
156452584|NCT05590403|564750711|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
156452585|NCT05590403|564750712|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
156452586|NCT05590403|564750713|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
156452587|NCT05590403|564750714|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
156452588|NCT04971395|564750715|FG000|Overall Study|Withdrawal by Subject|0|||
156452589|NCT04971395|564750716|FG001|Overall Study|Withdrawal by Subject|1|||
156452590|NCT04971395|564750717|FG002|Overall Study|Withdrawal by Subject|0|||
156452591|NCT04717492|564750718|FG000|Overall Study|Withdrawal by Subject|2|||
156452592|NCT04717492|564750719|FG001|Overall Study|Withdrawal by Subject|13|||
156452593|NCT04717492|564750718|FG000|Overall Study|Lost to Follow-up|2|||
156452594|NCT04717492|564750719|FG001|Overall Study|Lost to Follow-up|9|||
156452595|NCT02975882|564750720|FG000|Overall Study|Adverse Event|1|||
156452596|NCT02975882|564750721|FG001|Overall Study|Adverse Event|2|||
156452597|NCT02975882|564750722|FG002|Overall Study|Adverse Event|1|||
156452598|NCT02975882|564750723|FG003|Overall Study|Adverse Event|1|||
156452599|NCT02975882|564750720|FG000|Overall Study|Death|0|||
156452600|NCT02975882|564750721|FG001|Overall Study|Death|1|||
156452601|NCT02975882|564750722|FG002|Overall Study|Death|0|||
156452602|NCT02975882|564750723|FG003|Overall Study|Death|0|||
156452603|NCT02975882|564750720|FG000|Overall Study|Lack of Efficacy|3|||
156452604|NCT02975882|564750721|FG001|Overall Study|Lack of Efficacy|7|||
156452605|NCT02975882|564750722|FG002|Overall Study|Lack of Efficacy|4|||
156452606|NCT02975882|564750723|FG003|Overall Study|Lack of Efficacy|3|||
156452607|NCT02975882|564750720|FG000|Overall Study|Physician Decision|0|||
156452608|NCT02975882|564750721|FG001|Overall Study|Physician Decision|2|||
156452609|NCT02975882|564750722|FG002|Overall Study|Physician Decision|4|||
156452610|NCT02975882|564750723|FG003|Overall Study|Physician Decision|2|||
156452611|NCT02975882|564750720|FG000|Overall Study|Ineligible|0|||
156452612|NCT02975882|564750721|FG001|Overall Study|Ineligible|1|||
156452613|NCT02975882|564750722|FG002|Overall Study|Ineligible|0|||
156452614|NCT02975882|564750723|FG003|Overall Study|Ineligible|0|||
156452615|NCT03936322|564750724|FG000|Overall Study|Lost to Follow-up|1|||
156452616|NCT03936322|564750724|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
156725117|NCT00848718|565739111|FG003|Overall Study|Lack of Efficacy|0|||
156452617|NCT01160211|564750726|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
156452618|NCT01160211|564750727|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
156452619|NCT01160211|564750728|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
156452620|NCT01160211|564750726|FG000|Overall Study|Lost to Follow-up|4|||
156452621|NCT01160211|564750727|FG001|Overall Study|Lost to Follow-up|8|||
156452622|NCT01160211|564750728|FG002|Overall Study|Lost to Follow-up|4|||
156452623|NCT01160211|564750726|FG000|Overall Study|Physician Decision|1|||
156452624|NCT01160211|564750727|FG001|Overall Study|Physician Decision|0|||
156452625|NCT01160211|564750728|FG002|Overall Study|Physician Decision|0|||
156452626|NCT01160211|564750726|FG000|Overall Study|Withdrawal by Subject|4|||
156725118|NCT00848718|565739112|FG004|Overall Study|Lack of Efficacy|0|||
156725119|NCT00848718|565739113|FG005|Overall Study|Lack of Efficacy|0|||
156725120|NCT00848718|565739114|FG006|Overall Study|Lack of Efficacy|1|||
156725121|NCT00848718|565739115|FG007|Overall Study|Lack of Efficacy|0|||
156725122|NCT00848718|565739116|FG008|Overall Study|Lack of Efficacy|0|||
156725123|NCT00848718|565739117|FG009|Overall Study|Lack of Efficacy|0|||
156725124|NCT00848718|565739118|FG010|Overall Study|Lack of Efficacy|0|||
156725125|NCT00848718|565739119|FG011|Overall Study|Lack of Efficacy|0|||
156725126|NCT00848718|565739120|FG012|Overall Study|Lack of Efficacy|0|||
156725127|NCT00848718|565739108|FG000|Overall Study|Physician Decision|0|||
156725128|NCT00848718|565739109|FG001|Overall Study|Physician Decision|1|||
156725129|NCT00848718|565739110|FG002|Overall Study|Physician Decision|0|||
156725130|NCT00848718|565739111|FG003|Overall Study|Physician Decision|0|||
156725131|NCT00848718|565739112|FG004|Overall Study|Physician Decision|1|||
156725132|NCT00848718|565739113|FG005|Overall Study|Physician Decision|1|||
156725133|NCT00848718|565739114|FG006|Overall Study|Physician Decision|0|||
156725134|NCT00848718|565739115|FG007|Overall Study|Physician Decision|0|||
156725135|NCT00848718|565739116|FG008|Overall Study|Physician Decision|1|||
156725136|NCT00848718|565739117|FG009|Overall Study|Physician Decision|2|||
156725137|NCT00848718|565739118|FG010|Overall Study|Physician Decision|0|||
156725138|NCT00848718|565739119|FG011|Overall Study|Physician Decision|0|||
156725139|NCT00848718|565739120|FG012|Overall Study|Physician Decision|1|||
156725140|NCT00848718|565739108|FG000|Overall Study|Progressive disease before treatment|1|||
156725141|NCT00848718|565739109|FG001|Overall Study|Progressive disease before treatment|5|||
156725142|NCT00848718|565739110|FG002|Overall Study|Progressive disease before treatment|1|||
156725143|NCT00848718|565739111|FG003|Overall Study|Progressive disease before treatment|3|||
156725144|NCT00848718|565739112|FG004|Overall Study|Progressive disease before treatment|4|||
156725145|NCT00848718|565739113|FG005|Overall Study|Progressive disease before treatment|4|||
156725146|NCT00848718|565739114|FG006|Overall Study|Progressive disease before treatment|2|||
156725147|NCT00848718|565739115|FG007|Overall Study|Progressive disease before treatment|1|||
156725148|NCT00848718|565739116|FG008|Overall Study|Progressive disease before treatment|2|||
156725149|NCT00848718|565739117|FG009|Overall Study|Progressive disease before treatment|7|||
156725150|NCT00848718|565739118|FG010|Overall Study|Progressive disease before treatment|3|||
156725151|NCT00848718|565739119|FG011|Overall Study|Progressive disease before treatment|6|||
156725152|NCT00848718|565739120|FG012|Overall Study|Progressive disease before treatment|2|||
156725153|NCT00848718|565739108|FG000|Overall Study|Protocol Violation|0|||
156725154|NCT00848718|565739109|FG001|Overall Study|Protocol Violation|1|||
156725155|NCT00848718|565739110|FG002|Overall Study|Protocol Violation|0|||
156725156|NCT00848718|565739111|FG003|Overall Study|Protocol Violation|0|||
156725157|NCT00848718|565739112|FG004|Overall Study|Protocol Violation|0|||
156725158|NCT00848718|565739113|FG005|Overall Study|Protocol Violation|0|||
156794951|NCT02327169|566002814|FG013|Overall Study|Withdrawal by Subject|0|||
156794952|NCT02327169|566002815|FG014|Overall Study|Withdrawal by Subject|3|||
156794953|NCT02327169|566002801|FG000|Overall Study|Lost to Follow-up|0|||
156794954|NCT02327169|566002802|FG001|Overall Study|Lost to Follow-up|0|||
156794955|NCT02327169|566002803|FG002|Overall Study|Lost to Follow-up|0|||
156794956|NCT02327169|566002804|FG003|Overall Study|Lost to Follow-up|0|||
156794957|NCT02327169|566002805|FG004|Overall Study|Lost to Follow-up|1|||
156794958|NCT02327169|566002806|FG005|Overall Study|Lost to Follow-up|0|||
156794959|NCT02327169|566002807|FG006|Overall Study|Lost to Follow-up|0|||
156794960|NCT02327169|566002808|FG007|Overall Study|Lost to Follow-up|0|||
156794961|NCT02327169|566002809|FG008|Overall Study|Lost to Follow-up|0|||
156794962|NCT02327169|566002810|FG009|Overall Study|Lost to Follow-up|0|||
156794963|NCT02327169|566002811|FG010|Overall Study|Lost to Follow-up|0|||
156794964|NCT02327169|566002812|FG011|Overall Study|Lost to Follow-up|0|||
156794965|NCT02327169|566002813|FG012|Overall Study|Lost to Follow-up|0|||
156794966|NCT02327169|566002814|FG013|Overall Study|Lost to Follow-up|0|||
156794967|NCT02327169|566002815|FG014|Overall Study|Lost to Follow-up|0|||
156794968|NCT03787615|566002816|FG000|Overall Study|Withdrawal by Subject|2|||
156794969|NCT03787615|566002816|FG000|Overall Study|Lost to Follow-up|2|||
156794970|NCT06582732|566002820|FG000|Initial Study Period|Adverse Event|0|||
156794971|NCT06582732|566002821|FG001|Initial Study Period|Adverse Event|0|||
156794972|NCT06582732|566002822|FG002|Initial Study Period|Adverse Event|0|||
156794973|NCT06582732|566002823|FG003|Initial Study Period|Adverse Event|2|||
156794974|NCT06582732|566002824|FG004|Initial Study Period|Adverse Event|0|||
156794975|NCT06582732|566002825|FG005|Initial Study Period|Adverse Event|0|||
156794976|NCT06582732|566002826|FG006|Initial Study Period|Adverse Event|0|||
156794977|NCT06582732|566002820|FG000|Initial Study Period|Death|1|||
156794978|NCT06582732|566002821|FG001|Initial Study Period|Death|0|||
156794979|NCT06582732|566002822|FG002|Initial Study Period|Death|0|||
156794980|NCT06582732|566002823|FG003|Initial Study Period|Death|0|||
156794981|NCT06582732|566002824|FG004|Initial Study Period|Death|1|||
156794982|NCT06582732|566002825|FG005|Initial Study Period|Death|0|||
156794983|NCT06582732|566002826|FG006|Initial Study Period|Death|0|||
156794984|NCT06582732|566002820|FG000|Initial Study Period|Lost to Follow-up|0|||
156794985|NCT06582732|566002821|FG001|Initial Study Period|Lost to Follow-up|0|||
156794986|NCT06582732|566002822|FG002|Initial Study Period|Lost to Follow-up|2|||
156794987|NCT06582732|566002823|FG003|Initial Study Period|Lost to Follow-up|0|||
156533476|NCT00733304|565048801|FG000|Overall Study|Withdrawal by Subject|1|||
156725159|NCT00848718|565739114|FG006|Overall Study|Protocol Violation|0|||
156725160|NCT00848718|565739115|FG007|Overall Study|Protocol Violation|1|||
156725161|NCT00848718|565739116|FG008|Overall Study|Protocol Violation|0|||
156725162|NCT00848718|565739117|FG009|Overall Study|Protocol Violation|0|||
156725163|NCT00848718|565739118|FG010|Overall Study|Protocol Violation|0|||
156725164|NCT00848718|565739119|FG011|Overall Study|Protocol Violation|0|||
156725165|NCT00848718|565739120|FG012|Overall Study|Protocol Violation|1|||
156725166|NCT00848718|565739108|FG000|Overall Study|Withdrawal by Subject|1|||
156725167|NCT00848718|565739109|FG001|Overall Study|Withdrawal by Subject|0|||
156794988|NCT06582732|566002824|FG004|Initial Study Period|Lost to Follow-up|0|||
156794989|NCT06582732|566002825|FG005|Initial Study Period|Lost to Follow-up|0|||
156794990|NCT06582732|566002826|FG006|Initial Study Period|Lost to Follow-up|0|||
156794991|NCT06582732|566002820|FG000|Initial Study Period|Withdrawal by Subject|0|||
156794992|NCT06582732|566002821|FG001|Initial Study Period|Withdrawal by Subject|1|||
156794993|NCT06582732|566002822|FG002|Initial Study Period|Withdrawal by Subject|0|||
156794994|NCT06582732|566002823|FG003|Initial Study Period|Withdrawal by Subject|1|||
156725168|NCT00848718|565739110|FG002|Overall Study|Withdrawal by Subject|0|||
156794995|NCT06582732|566002824|FG004|Initial Study Period|Withdrawal by Subject|3|||
156794996|NCT06582732|566002825|FG005|Initial Study Period|Withdrawal by Subject|1|||
156725169|NCT00848718|565739111|FG003|Overall Study|Withdrawal by Subject|1|||
156725170|NCT00848718|565739112|FG004|Overall Study|Withdrawal by Subject|0|||
156725171|NCT00848718|565739113|FG005|Overall Study|Withdrawal by Subject|0|||
156725172|NCT00848718|565739114|FG006|Overall Study|Withdrawal by Subject|0|||
156725173|NCT00848718|565739115|FG007|Overall Study|Withdrawal by Subject|0|||
156725174|NCT00848718|565739116|FG008|Overall Study|Withdrawal by Subject|0|||
156725175|NCT00848718|565739117|FG009|Overall Study|Withdrawal by Subject|0|||
156725176|NCT00848718|565739118|FG010|Overall Study|Withdrawal by Subject|1|||
156725177|NCT00848718|565739119|FG011|Overall Study|Withdrawal by Subject|0|||
156725178|NCT00848718|565739120|FG012|Overall Study|Withdrawal by Subject|0|||
156725179|NCT00848718|565739108|FG000|Overall Study|Progressive disease during treatment|3|||
156725180|NCT00848718|565739109|FG001|Overall Study|Progressive disease during treatment|0|||
156725181|NCT00848718|565739110|FG002|Overall Study|Progressive disease during treatment|3|||
156725182|NCT00848718|565739111|FG003|Overall Study|Progressive disease during treatment|0|||
156725183|NCT00848718|565739112|FG004|Overall Study|Progressive disease during treatment|0|||
156725184|NCT00848718|565739113|FG005|Overall Study|Progressive disease during treatment|0|||
156725185|NCT00848718|565739114|FG006|Overall Study|Progressive disease during treatment|0|||
156725186|NCT00848718|565739115|FG007|Overall Study|Progressive disease during treatment|2|||
156725187|NCT00848718|565739116|FG008|Overall Study|Progressive disease during treatment|0|||
156725188|NCT00848718|565739117|FG009|Overall Study|Progressive disease during treatment|0|||
156725189|NCT00848718|565739118|FG010|Overall Study|Progressive disease during treatment|0|||
156725190|NCT00848718|565739119|FG011|Overall Study|Progressive disease during treatment|0|||
156725191|NCT00848718|565739120|FG012|Overall Study|Progressive disease during treatment|2|||
156725192|NCT02389829|565739126|FG000|Overall Study|Lost to Follow-up|0|||
156725193|NCT02389829|565739127|FG001|Overall Study|Lost to Follow-up|1|||
156725194|NCT05514873|565739130|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
156725195|NCT05514873|565739130|FG000|Main Treatment Period|Adverse Event|2|||
156725196|NCT05514873|565739130|FG000|Extension Treatment Period|Lost to Follow-up|3|||
156725197|NCT02588612|565740564|FG000|Overall Study|Physician Decision|1|||
156725198|NCT02588612|565740564|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
156725199|NCT02588612|565740564|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
156725200|NCT02588612|565740564|FG000|Overall Study|Death prior to T-cell infusion|1|||
156725201|NCT03123393|565740568|FG000|Overall Study|Study Terminated by Sponsor|6|||
156725202|NCT03123393|565740569|FG001|Overall Study|Study Terminated by Sponsor|9|||
156725203|NCT03123393|565740568|FG000|Overall Study|Withdrawal by Subject|2|||
156725204|NCT03123393|565740569|FG001|Overall Study|Withdrawal by Subject|1|||
156725205|NCT03123393|565740568|FG000|Overall Study|Reason not Specified|13|||
156725206|NCT03123393|565740569|FG001|Overall Study|Reason not Specified|13|||
156725207|NCT00427648|565740570|FG000|Overall Study|Protocol Violation|1|||
156725208|NCT00427648|565740571|FG001|Overall Study|Protocol Violation|2|||
156725209|NCT00427648|565740570|FG000|Overall Study|Adverse Event|0|||
156725210|NCT00427648|565740571|FG001|Overall Study|Adverse Event|1|||
156725211|NCT01681212|565740572|FG000|Overall Study|No longer met study criteria|5|||
156725212|NCT01681212|565740572|FG000|Overall Study|Administrative reason by sponsor|1|||
156725213|NCT01464333|565740573|FG000|Overall Study|Adverse Event|34|||
156725214|NCT01464333|565740573|FG000|Overall Study|Lack of Efficacy|72|||
156725215|NCT01464333|565740573|FG000|Overall Study|Withdrawal by Subject|11|||
156725216|NCT01464333|565740573|FG000|Overall Study|Other|4|||
156725217|NCT01464333|565740573|FG000|Overall Study|No Hospital Visit|42|||
156725218|NCT05047211|565740574|FG000|Overall Study|Lost to Follow-up|8|||
156725219|NCT05047211|565740575|FG001|Overall Study|Lost to Follow-up|5|||
156725220|NCT00561392|565740578|FG000|Overall Study|Adverse Event|38|||
156725221|NCT00561392|565740578|FG000|Overall Study|Lack of Efficacy|2|||
156725222|NCT00561392|565740578|FG000|Overall Study|Protocol Violation|1|||
156725223|NCT00561392|565740578|FG000|Overall Study|Withdrawal by Subject|8|||
156725224|NCT00561392|565740578|FG000|Overall Study|Administrative problems|4|||
156725225|NCT03321968|565740579|FG000|Overall Study|Withdrawal by Subject|1|||
156725226|NCT03321968|565740580|FG001|Overall Study|Withdrawal by Subject|2|||
156725227|NCT03321968|565740581|FG002|Overall Study|Withdrawal by Subject|1|||
156725228|NCT03321968|565740579|FG000|Overall Study|Lost to Follow-up|2|||
156725229|NCT03321968|565740580|FG001|Overall Study|Lost to Follow-up|0|||
156725230|NCT03321968|565740581|FG002|Overall Study|Lost to Follow-up|1|||
156725231|NCT03321968|565740579|FG000|Overall Study|Other than specified|0|||
156725232|NCT03321968|565740580|FG001|Overall Study|Other than specified|0|||
156725233|NCT03321968|565740581|FG002|Overall Study|Other than specified|1|||
156725234|NCT03822468|565740582|FG000|Treatment Period|Progressive disease|98|||
156725235|NCT03822468|565740583|FG001|Treatment Period|Progressive disease|94|||
156725236|NCT03822468|565740582|FG000|Treatment Period|Adverse Event|21|||
156725237|NCT03822468|565740583|FG001|Treatment Period|Adverse Event|24|||
156725238|NCT03822468|565740582|FG000|Treatment Period|Withdrawal by Subject|9|||
156725239|NCT03822468|565740583|FG001|Treatment Period|Withdrawal by Subject|5|||
156725240|NCT03822468|565740582|FG000|Treatment Period|Physician Decision|9|||
156725241|NCT03822468|565740583|FG001|Treatment Period|Physician Decision|7|||
156725242|NCT03822468|565740582|FG000|Treatment Period|Protocol Violation|2|||
156335856|NCT00762385|564328126|FG000|Second Intervention|Protocol Violation|3|||
156335857|NCT00762385|564328127|FG001|Second Intervention|Protocol Violation|3|||
156335858|NCT00591344|564328128|FG000|Overall Study|Transportation issues|1|||
156335859|NCT00591344|564328129|FG001|Overall Study|Transportation issues|0|||
156335860|NCT00591344|564328128|FG000|Overall Study|Moved out of state|1|||
156335861|NCT00591344|564328129|FG001|Overall Study|Moved out of state|0|||
156335862|NCT00591344|564328128|FG000|Overall Study|Medical complications|1|||
156335863|NCT00591344|564328129|FG001|Overall Study|Medical complications|3|||
156335864|NCT00591344|564328128|FG000|Overall Study|Underwent DBS|2|||
156335865|NCT00591344|564328129|FG001|Overall Study|Underwent DBS|2|||
156335866|NCT00591344|564328128|FG000|Overall Study|Death|0|||
156335867|NCT00591344|564328129|FG001|Overall Study|Death|1|||
156335868|NCT00591344|564328128|FG000|Overall Study|Lost to Follow-up|0|||
156335869|NCT00591344|564328129|FG001|Overall Study|Lost to Follow-up|1|||
156335870|NCT00591344|564328128|FG000|Overall Study|Did not want to come off medication|0|||
156335871|NCT00591344|564328129|FG001|Overall Study|Did not want to come off medication|1|||
156335872|NCT03863197|564328130|FG000|Overall Study|Lost to Follow-up|2|||
156335873|NCT03863197|564328131|FG001|Overall Study|Lost to Follow-up|3|||
156335874|NCT03863197|564328130|FG000|Overall Study|Withdrawal by Subject|4|||
156335875|NCT03863197|564328131|FG001|Overall Study|Withdrawal by Subject|0|||
156335876|NCT03863197|564328130|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
156335877|NCT03863197|564328131|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
156335878|NCT01065597|564328132|FG000|Overall Study|Adverse Event|1|||
156335879|NCT01622231|564328133|FG000|Overall Study|Physician Decision|1|||
156335880|NCT01622231|564328133|FG000|Overall Study|Withdrawal by Subject|1|||
156335881|NCT02329080|564328134|FG000|Overall Study|Adverse Event|1|||
156335882|NCT02329080|564328134|FG000|Overall Study|Death|4|||
156335883|NCT02329080|564328134|FG000|Overall Study|Lack of Efficacy|22|||
156335884|NCT02329080|564328134|FG000|Overall Study|Lost to Follow-up|1|||
156335885|NCT02329080|564328134|FG000|Overall Study|Physician Decision|2|||
156335886|NCT02329080|564328134|FG000|Overall Study|Partial response|4|||
156335887|NCT02329080|564328134|FG000|Overall Study|Complete response|4|||
156335888|NCT00973674|564328137|FG000|Overall Study|Protocol Violation|2|||
156335889|NCT00973674|564328138|FG001|Overall Study|Protocol Violation|0|||
156335890|NCT03082261|564328141|FG000|Overall Study|Death|4|||
156335891|NCT03082261|564328141|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
156335892|NCT03082261|564328141|FG000|Overall Study|Insurance denial|1|||
156335893|NCT03082261|564328141|FG000|Overall Study|Peripheral lead added|1|||
156335894|NCT03082261|564328141|FG000|Overall Study|Withdrawal by Subject|40|||
156335895|NCT03082261|564328141|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
156452627|NCT01160211|564750727|FG001|Overall Study|Withdrawal by Subject|2|||
156452628|NCT01160211|564750728|FG002|Overall Study|Withdrawal by Subject|2|||
156452629|NCT01160211|564750726|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
156452630|NCT01160211|564750727|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
156452631|NCT01160211|564750728|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
156452632|NCT02734290|564750729|FG000|Overall Study|Adverse Event|1|||
156452633|NCT02734290|564750730|FG001|Overall Study|Adverse Event|0|||
156452634|NCT02734290|564750729|FG000|Overall Study|Death|1|||
156452635|NCT02734290|564750730|FG001|Overall Study|Death|0|||
156452636|NCT03829410|564750732|FG000|Overall Study|Adverse Event|1|||
156335896|NCT03082261|564328141|FG000|Overall Study|Subject implanted with device other than study device|1|||
156335897|NCT03082261|564328141|FG000|Overall Study|Lost to Follow-up|14|||
156452637|NCT03829410|564750733|FG001|Overall Study|Adverse Event|0|||
156725243|NCT03822468|565740583|FG001|Treatment Period|Protocol Violation|1|||
156725244|NCT03822468|565740582|FG000|Treatment Period|Death|2|||
156725245|NCT03822468|565740583|FG001|Treatment Period|Death|3|||
156725246|NCT03822468|565740582|FG000|Treatment Period|Lost to Follow-up|1|||
156725247|NCT03822468|565740583|FG001|Treatment Period|Lost to Follow-up|1|||
156725248|NCT03822468|565740582|FG000|Treatment Period|Sponsor decision|46|||
156725249|NCT03822468|565740583|FG001|Treatment Period|Sponsor decision|53|||
156725250|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
156725251|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
156725252|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
156725253|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
156725254|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Death|1|||
156725255|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Death|0|||
156725256|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156725257|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156725258|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
156725259|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156335898|NCT03082261|564328141|FG000|Overall Study|Subject moved to a different state|1|||
156335899|NCT03082261|564328141|FG000|Overall Study|Subject non-compliance|2|||
156452638|NCT03829410|564750734|FG002|Overall Study|Adverse Event|1|||
156725260|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
156452639|NCT03829410|564750735|FG003|Overall Study|Adverse Event|4|||
156452640|NCT03829410|564750732|FG000|Overall Study|Physician Decision|0|||
156452641|NCT03829410|564750733|FG001|Overall Study|Physician Decision|0|||
156452642|NCT03829410|564750734|FG002|Overall Study|Physician Decision|0|||
156452643|NCT03829410|564750735|FG003|Overall Study|Physician Decision|2|||
156452644|NCT03829410|564750732|FG000|Overall Study|Disease Progressing|3|||
156452645|NCT03829410|564750733|FG001|Overall Study|Disease Progressing|4|||
156452646|NCT03829410|564750734|FG002|Overall Study|Disease Progressing|2|||
156452647|NCT03829410|564750735|FG003|Overall Study|Disease Progressing|31|||
156452648|NCT03829410|564750732|FG000|Overall Study|Miscellaneous|2|||
156452649|NCT03829410|564750733|FG001|Overall Study|Miscellaneous|4|||
156452650|NCT03829410|564750734|FG002|Overall Study|Miscellaneous|3|||
156452651|NCT03829410|564750735|FG003|Overall Study|Miscellaneous|10|||
156452652|NCT03158129|564750736|FG000|Overall Study|Adverse Event|0|||
156452653|NCT03158129|564750737|FG001|Overall Study|Adverse Event|1|||
156452654|NCT03158129|564750738|FG002|Overall Study|Adverse Event|0|||
156452655|NCT03158129|564750739|FG003|Overall Study|Adverse Event|0|||
156452656|NCT03158129|564750736|FG000|Overall Study|Death|0|||
156452657|NCT03158129|564750737|FG001|Overall Study|Death|0|||
156452658|NCT03158129|564750738|FG002|Overall Study|Death|0|||
156452659|NCT03158129|564750739|FG003|Overall Study|Death|1|||
156452660|NCT03158129|564750736|FG000|Overall Study|High surgical risk|1|||
156452661|NCT03158129|564750737|FG001|Overall Study|High surgical risk|1|||
156452662|NCT03158129|564750738|FG002|Overall Study|High surgical risk|0|||
156452663|NCT03158129|564750739|FG003|Overall Study|High surgical risk|0|||
156452664|NCT03158129|564750736|FG000|Overall Study|Progression|1|||
156452665|NCT03158129|564750737|FG001|Overall Study|Progression|1|||
156452666|NCT03158129|564750738|FG002|Overall Study|Progression|0|||
156452667|NCT03158129|564750739|FG003|Overall Study|Progression|0|||
156452668|NCT03158129|564750736|FG000|Overall Study|Lack of resectability|0|||
156452669|NCT03158129|564750737|FG001|Overall Study|Lack of resectability|1|||
156452670|NCT03158129|564750738|FG002|Overall Study|Lack of resectability|0|||
156452671|NCT03158129|564750739|FG003|Overall Study|Lack of resectability|0|||
156452672|NCT03158129|564750736|FG000|Overall Study|Declined surgery|0|||
156452673|NCT03158129|564750737|FG001|Overall Study|Declined surgery|1|||
156452674|NCT03158129|564750738|FG002|Overall Study|Declined surgery|0|||
156452675|NCT03158129|564750739|FG003|Overall Study|Declined surgery|0|||
156452676|NCT03158129|564750736|FG000|Overall Study|No longer surgical candidate|0|||
156452677|NCT03158129|564750737|FG001|Overall Study|No longer surgical candidate|0|||
156452678|NCT03158129|564750738|FG002|Overall Study|No longer surgical candidate|0|||
156452679|NCT03158129|564750739|FG003|Overall Study|No longer surgical candidate|1|||
156452680|NCT06205407|564750744|FG000|Period 2|Withdrawal by Subject|0|||
156452681|NCT06205407|564750745|FG001|Period 2|Withdrawal by Subject|1|||
156452682|NCT06205407|564750744|FG000|Period 2|Adverse Event|2|||
156452683|NCT06205407|564750745|FG001|Period 2|Adverse Event|1|||
156452684|NCT06491433|564750746|FG000|Overall Study|Protocol Violation|51|||
156452685|NCT06491433|564750746|FG000|Overall Study|consent withdrawal|2|||
156452686|NCT06491433|564750746|FG000|Overall Study|screen failure|1|||
156452687|NCT04676022|564750750|FG000|Overall Study|Screen Failure/|1|||
156452688|NCT04676022|564750751|FG001|Overall Study|Screen Failure/|1|||
156452689|NCT04676022|564750752|FG002|Overall Study|Screen Failure/|85|||
156452690|NCT04676022|564750750|FG000|Overall Study|Lost to Follow-up|1|||
156452691|NCT04676022|564750751|FG001|Overall Study|Lost to Follow-up|1|||
156452692|NCT04676022|564750752|FG002|Overall Study|Lost to Follow-up|0|||
156452693|NCT04676022|564750750|FG000|Overall Study|Adverse Event|2|||
156452694|NCT04676022|564750751|FG001|Overall Study|Adverse Event|0|||
156725261|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156725262|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
156725263|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
156725264|NCT02198664|565740584|FG000|Overall Study|Adverse Event|2|||
156725265|NCT02198664|565740585|FG001|Overall Study|Adverse Event|0|||
156725266|NCT02198664|565740584|FG000|Overall Study|Withdrawal by Subject|11|||
156452695|NCT04676022|564750752|FG002|Overall Study|Adverse Event|1|||
156725267|NCT02198664|565740585|FG001|Overall Study|Withdrawal by Subject|8|||
156725268|NCT02198664|565740584|FG000|Overall Study|Failure to tolerate|2|||
156452696|NCT04676022|564750750|FG000|Overall Study|Physician Decision|2|||
156452697|NCT04676022|564750751|FG001|Overall Study|Physician Decision|0|||
156452698|NCT04676022|564750752|FG002|Overall Study|Physician Decision|1|||
156452699|NCT04676022|564750750|FG000|Overall Study|Withdrawal by Subject|3|||
156452700|NCT04676022|564750751|FG001|Overall Study|Withdrawal by Subject|1|||
156452701|NCT04676022|564750752|FG002|Overall Study|Withdrawal by Subject|6|||
156452702|NCT04676022|564750750|FG000|Overall Study|Will not move forward with permanent implant|6|||
156452703|NCT04676022|564750751|FG001|Overall Study|Will not move forward with permanent implant|0|||
156794997|NCT06582732|566002826|FG006|Initial Study Period|Withdrawal by Subject|2|||
156794998|NCT06582732|566002820|FG000|Initial Study Period|Moved Away|0|||
156794999|NCT06582732|566002821|FG001|Initial Study Period|Moved Away|0|||
156452704|NCT04676022|564750752|FG002|Overall Study|Will not move forward with permanent implant|0|||
156452705|NCT04676022|564750750|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
156725269|NCT02198664|565740585|FG001|Overall Study|Failure to tolerate|0|||
156725270|NCT02198664|565740584|FG000|Overall Study|Not stated|1|||
156725271|NCT02198664|565740585|FG001|Overall Study|Not stated|0|||
156725272|NCT00529308|565740586|FG000|Overall Study|Withdrawal by Subject|1|||
156725273|NCT00529308|565740587|FG001|Overall Study|Withdrawal by Subject|1|||
156725274|NCT00720213|565740588|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
156725275|NCT00720213|565740589|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
156725276|NCT00720213|565740590|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
156725277|NCT01808066|565740596|FG000|Overall Study|Withdrawal by Subject|15|||
156725278|NCT01420068|565740601|FG000|Overall Study|Administrative problems|1|||
156725279|NCT01420068|565740602|FG001|Overall Study|Administrative problems|3|||
156725280|NCT01420068|565740601|FG000|Overall Study|Withdrawal by Subject|1|||
156725281|NCT01420068|565740602|FG001|Overall Study|Withdrawal by Subject|2|||
156725282|NCT01252095|565740603|FG000|Overall Study|Disease progression|1|||
156335900|NCT03082261|564328141|FG000|Overall Study|Subject participation terminated by investigator|9|||
156725283|NCT01252095|565740604|FG001|Overall Study|Disease progression|0|||
156335901|NCT03082261|564328141|FG000|Overall Study|Subject participation terminated by sponsor|4|||
156725284|NCT00365794|565740605|FG000|Overall Study|Withdrawal by Subject|2|||
156725285|NCT00745901|565740606|FG000|Overall Study|Adverse Event|3|||
156725286|NCT00745901|565740607|FG001|Overall Study|Adverse Event|4|||
156725287|NCT00745901|565740606|FG000|Overall Study|Protocol Violation|0|||
156725288|NCT00745901|565740607|FG001|Overall Study|Protocol Violation|1|||
156725289|NCT00745901|565740606|FG000|Overall Study|Withdrawal by Subject|1|||
156725290|NCT00745901|565740607|FG001|Overall Study|Withdrawal by Subject|0|||
156725291|NCT00745901|565740606|FG000|Overall Study|Lost to Follow-up|7|||
156725292|NCT00745901|565740607|FG001|Overall Study|Lost to Follow-up|4|||
156725293|NCT00745901|565740606|FG000|Overall Study|Pregnancy|2|||
156725294|NCT00745901|565740607|FG001|Overall Study|Pregnancy|4|||
156725295|NCT00745901|565740606|FG000|Overall Study|Lack of compliance|2|||
156725296|NCT00745901|565740607|FG001|Overall Study|Lack of compliance|2|||
156725297|NCT00745901|565740606|FG000|Overall Study|Patient's next menses did not start with|1|||
156725298|NCT00745901|565740607|FG001|Overall Study|Patient's next menses did not start with|0|||
156725299|NCT00745901|565740606|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
156725300|NCT00745901|565740607|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
156725301|NCT00745901|565740606|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
156725302|NCT00745901|565740607|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
156725303|NCT00745901|565740606|FG000|Overall Study|Patient didn't take any study medication|7|||
156725304|NCT00745901|565740607|FG001|Overall Study|Patient didn't take any study medication|3|||
156725305|NCT02554682|565740608|FG000|Overall Study|Lost to Follow-up|11|||
156725306|NCT02554682|565740609|FG001|Overall Study|Lost to Follow-up|9|||
156725307|NCT02554682|565740610|FG002|Overall Study|Lost to Follow-up|4|||
156725308|NCT02554682|565740611|FG003|Overall Study|Lost to Follow-up|3|||
156725309|NCT02554682|565740612|FG004|Overall Study|Lost to Follow-up|2|||
156725310|NCT02554682|565740613|FG005|Overall Study|Lost to Follow-up|1|||
156725311|NCT02554682|565740614|FG006|Overall Study|Lost to Follow-up|6|||
156725312|NCT02554682|565740615|FG007|Overall Study|Lost to Follow-up|6|||
156725313|NCT02554682|565740616|FG008|Overall Study|Lost to Follow-up|2|||
156725314|NCT02554682|565740617|FG009|Overall Study|Lost to Follow-up|2|||
156725315|NCT02554682|565740608|FG000|Overall Study|Withdrawal by Subject|2|||
156725316|NCT02554682|565740609|FG001|Overall Study|Withdrawal by Subject|1|||
156725317|NCT02554682|565740610|FG002|Overall Study|Withdrawal by Subject|0|||
156725318|NCT02554682|565740611|FG003|Overall Study|Withdrawal by Subject|0|||
156725319|NCT02554682|565740612|FG004|Overall Study|Withdrawal by Subject|0|||
156725320|NCT02554682|565740613|FG005|Overall Study|Withdrawal by Subject|0|||
156725321|NCT02554682|565740614|FG006|Overall Study|Withdrawal by Subject|0|||
156725322|NCT02554682|565740615|FG007|Overall Study|Withdrawal by Subject|0|||
156725323|NCT02554682|565740616|FG008|Overall Study|Withdrawal by Subject|0|||
156725324|NCT02554682|565740617|FG009|Overall Study|Withdrawal by Subject|0|||
156725325|NCT02554682|565740608|FG000|Overall Study|Physician Decision|2|||
156725326|NCT02554682|565740609|FG001|Overall Study|Physician Decision|2|||
156725327|NCT02554682|565740610|FG002|Overall Study|Physician Decision|0|||
156725328|NCT02554682|565740611|FG003|Overall Study|Physician Decision|0|||
156725329|NCT02554682|565740612|FG004|Overall Study|Physician Decision|0|||
156725330|NCT02554682|565740613|FG005|Overall Study|Physician Decision|0|||
156725331|NCT02554682|565740614|FG006|Overall Study|Physician Decision|0|||
156725332|NCT02554682|565740615|FG007|Overall Study|Physician Decision|0|||
156725333|NCT02554682|565740616|FG008|Overall Study|Physician Decision|0|||
156725334|NCT02554682|565740617|FG009|Overall Study|Physician Decision|0|||
156725335|NCT00884117|565740620|FG000|Overall Study|Adverse Event|2|||
156725336|NCT00884117|565740620|FG000|Overall Study|Withdrawal by Subject|89|||
156725337|NCT00884117|565740620|FG000|Overall Study|Death|3|||
156725338|NCT00884117|565740620|FG000|Overall Study|Lost to Follow-up|143|||
156725339|NCT00884117|565740620|FG000|Overall Study|Other|12|||
156725340|NCT01753310|565740621|FG000|Overall Study|Entered into open label extension study|25|||
156725341|NCT01753310|565740622|FG001|Overall Study|Entered into open label extension study|22|||
156725342|NCT01753310|565740621|FG000|Overall Study|Adverse Event|1|||
156725343|NCT01753310|565740622|FG001|Overall Study|Adverse Event|0|||
156725344|NCT01753310|565740621|FG000|Overall Study|Lost to Follow-up|2|||
156725345|NCT01753310|565740622|FG001|Overall Study|Lost to Follow-up|0|||
156725346|NCT01753310|565740621|FG000|Overall Study|Subject decision|2|||
156725347|NCT01753310|565740622|FG001|Overall Study|Subject decision|2|||
156725348|NCT01753310|565740621|FG000|Overall Study|Sponsor decision|1|||
156725349|NCT01753310|565740622|FG001|Overall Study|Sponsor decision|0|||
156725350|NCT01753310|565740621|FG000|Overall Study|Withdrawal by Subject|1|||
156725351|NCT01753310|565740622|FG001|Overall Study|Withdrawal by Subject|0|||
156725352|NCT01580670|565740623|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
156725353|NCT01580670|565740623|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
156725354|NCT02022202|565740624|FG000|Overall Study|Withdrawal by Subject|2|||
156725355|NCT02022202|565740624|FG000|Overall Study|Disease Progression|3|||
156725356|NCT02022202|565740624|FG000|Overall Study|Desire go to immediately to surgery|3|||
156725357|NCT05581641|565740626|FG000|Overall Study|Withdrawal by Subject|0|||
156725358|NCT05581641|565740627|FG001|Overall Study|Withdrawal by Subject|1|||
156725359|NCT05581641|565740628|FG002|Overall Study|Withdrawal by Subject|3|||
156725360|NCT05581641|565740629|FG003|Overall Study|Withdrawal by Subject|1|||
156725361|NCT05581641|565740626|FG000|Overall Study|Lost to Follow-up|0|||
156725362|NCT05581641|565740627|FG001|Overall Study|Lost to Follow-up|1|||
156725363|NCT05581641|565740628|FG002|Overall Study|Lost to Follow-up|0|||
156725364|NCT05581641|565740629|FG003|Overall Study|Lost to Follow-up|1|||
156725365|NCT05581641|565740626|FG000|Overall Study|Protocol Violation|1|||
156725366|NCT05581641|565740627|FG001|Overall Study|Protocol Violation|0|||
156725367|NCT05581641|565740628|FG002|Overall Study|Protocol Violation|0|||
156725368|NCT05581641|565740629|FG003|Overall Study|Protocol Violation|0|||
156725369|NCT05581641|565740626|FG000|Overall Study|Other|1|||
156725370|NCT05581641|565740627|FG001|Overall Study|Other|0|||
156725371|NCT05581641|565740628|FG002|Overall Study|Other|2|||
156725372|NCT05581641|565740629|FG003|Overall Study|Other|1|||
156725373|NCT04390763|565740630|FG000|Safety run-in Part|Adverse Event|4|||
156725374|NCT04390763|565740631|FG001|Safety run-in Part|Adverse Event|0|||
156725375|NCT04390763|565740632|FG002|Safety run-in Part|Adverse Event|0|||
156725376|NCT04390763|565740633|FG003|Safety run-in Part|Adverse Event|0|||
156725377|NCT04390763|565740630|FG000|Safety run-in Part|Physician Decision|1|||
156725378|NCT04390763|565740631|FG001|Safety run-in Part|Physician Decision|0|||
156725379|NCT04390763|565740632|FG002|Safety run-in Part|Physician Decision|0|||
156725380|NCT04390763|565740633|FG003|Safety run-in Part|Physician Decision|0|||
156725381|NCT04390763|565740630|FG000|Safety run-in Part|Progressive Disease|6|||
156725382|NCT04390763|565740631|FG001|Safety run-in Part|Progressive Disease|0|||
156725383|NCT04390763|565740632|FG002|Safety run-in Part|Progressive Disease|0|||
156725384|NCT04390763|565740633|FG003|Safety run-in Part|Progressive Disease|0|||
156725385|NCT04390763|565740630|FG000|Randomized Part|Adverse Event|0|||
156725386|NCT04390763|565740631|FG001|Randomized Part|Adverse Event|11|||
156725387|NCT04390763|565740632|FG002|Randomized Part|Adverse Event|5|||
156725388|NCT04390763|565740633|FG003|Randomized Part|Adverse Event|5|||
156725389|NCT04390763|565740630|FG000|Randomized Part|Death|0|||
156725390|NCT04390763|565740631|FG001|Randomized Part|Death|3|||
156725391|NCT04390763|565740632|FG002|Randomized Part|Death|4|||
156725392|NCT04390763|565740633|FG003|Randomized Part|Death|2|||
156725393|NCT04390763|565740630|FG000|Randomized Part|Physician Decision|0|||
156725394|NCT04390763|565740631|FG001|Randomized Part|Physician Decision|2|||
156725395|NCT04390763|565740632|FG002|Randomized Part|Physician Decision|2|||
156725396|NCT04390763|565740633|FG003|Randomized Part|Physician Decision|9|||
156725397|NCT04390763|565740630|FG000|Randomized Part|Progressive Disease|0|||
156725398|NCT04390763|565740631|FG001|Randomized Part|Progressive Disease|24|||
156725399|NCT04390763|565740632|FG002|Randomized Part|Progressive Disease|31|||
156725400|NCT04390763|565740633|FG003|Randomized Part|Progressive Disease|23|||
156725401|NCT04390763|565740630|FG000|Randomized Part|Study terminated by sponsor|0|||
156725402|NCT04390763|565740631|FG001|Randomized Part|Study terminated by sponsor|1|||
156725403|NCT04390763|565740632|FG002|Randomized Part|Study terminated by sponsor|0|||
156725404|NCT04390763|565740633|FG003|Randomized Part|Study terminated by sponsor|0|||
156725405|NCT04390763|565740630|FG000|Randomized Part|Participant Decision|0|||
156725406|NCT04390763|565740631|FG001|Randomized Part|Participant Decision|5|||
156725407|NCT04390763|565740632|FG002|Randomized Part|Participant Decision|7|||
156725408|NCT04390763|565740633|FG003|Randomized Part|Participant Decision|6|||
156725409|NCT04390763|565740630|FG000|Randomized Part|Not treated|0|||
156725410|NCT04390763|565740631|FG001|Randomized Part|Not treated|4|||
156725411|NCT04390763|565740632|FG002|Randomized Part|Not treated|2|||
156725412|NCT04390763|565740633|FG003|Randomized Part|Not treated|7|||
156725413|NCT01956773|565740640|FG000|Overall Study|Lost to Follow-up|628|||
156725414|NCT01956773|565740641|FG001|Overall Study|Lost to Follow-up|1|||
156725415|NCT01383174|565740642|FG000|3 Month Assessment|Death|0|||
156725416|NCT01383174|565740643|FG001|3 Month Assessment|Death|1|||
156725417|NCT01383174|565740642|FG000|3 Month Assessment|Lost to Follow-up|2|||
156725418|NCT01383174|565740643|FG001|3 Month Assessment|Lost to Follow-up|0|||
156725419|NCT01383174|565740642|FG000|3 Month Assessment|Refused to complete|4|||
156725420|NCT01383174|565740643|FG001|3 Month Assessment|Refused to complete|0|||
156335902|NCT03082261|564328141|FG000|Overall Study|System explant|19|||
156725421|NCT01383174|565740642|FG000|6 Month Assessment|Lost to Follow-up|1|||
156725422|NCT01383174|565740643|FG001|6 Month Assessment|Lost to Follow-up|1|||
156725423|NCT01383174|565740642|FG000|6 Month Assessment|Refused to complete|4|||
156725424|NCT01383174|565740643|FG001|6 Month Assessment|Refused to complete|0|||
156725425|NCT01153815|565740644|FG000|Overall Study|Adverse Event|3|||
156725426|NCT01153815|565740645|FG001|Overall Study|Adverse Event|1|||
156725427|NCT01153815|565740644|FG000|Overall Study|Withdrawal by Subject|6|||
156725428|NCT01153815|565740645|FG001|Overall Study|Withdrawal by Subject|4|||
156725429|NCT01786993|565740648|FG000|Overall Study|Death|6|||
156725430|NCT01786993|565740649|FG001|Overall Study|Death|7|||
156725431|NCT01786993|565740648|FG000|Overall Study|Withdrawal by Subject|3|||
156725432|NCT01786993|565740649|FG001|Overall Study|Withdrawal by Subject|2|||
156725433|NCT01786993|565740648|FG000|Overall Study|Lost to Follow-up|0|||
156725434|NCT01786993|565740649|FG001|Overall Study|Lost to Follow-up|1|||
156725435|NCT01786993|565740648|FG000|Overall Study|Subject Non-Compliance|1|||
156725436|NCT01786993|565740649|FG001|Overall Study|Subject Non-Compliance|0|||
156725437|NCT01786993|565740648|FG000|Overall Study|System Explant|1|||
156725438|NCT01786993|565740649|FG001|Overall Study|System Explant|0|||
156725439|NCT01786993|565740648|FG000|Overall Study|Hospice Admission|1|||
156725440|NCT01786993|565740649|FG001|Overall Study|Hospice Admission|0|||
156725441|NCT00450437|565740650|FG000|Overall Study|Withdrawal by Subject|10|||
156725442|NCT00450437|565740651|FG001|Overall Study|Withdrawal by Subject|2|||
156725443|NCT00450437|565740652|FG002|Overall Study|Withdrawal by Subject|0|||
156725444|NCT00450437|565740653|FG003|Overall Study|Withdrawal by Subject|1|||
156725445|NCT00450437|565740650|FG000|Overall Study|Lost to Follow-up|31|||
156725446|NCT00450437|565740651|FG001|Overall Study|Lost to Follow-up|12|||
156725447|NCT00450437|565740652|FG002|Overall Study|Lost to Follow-up|19|||
156725448|NCT00450437|565740653|FG003|Overall Study|Lost to Follow-up|9|||
156725449|NCT00450437|565740650|FG000|Overall Study|Protocol Violation|0|||
156725450|NCT00450437|565740651|FG001|Overall Study|Protocol Violation|1|||
156725451|NCT00450437|565740652|FG002|Overall Study|Protocol Violation|0|||
156335903|NCT03082261|564328141|FG000|Overall Study|Unable to place lead(s)|2|||
156335904|NCT03082261|564328141|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
156335905|NCT01281137|564328142|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
156335906|NCT01281137|564328143|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
156335907|NCT01281137|564328142|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
156335908|NCT01281137|564328143|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
156725452|NCT00450437|565740653|FG003|Overall Study|Protocol Violation|1|||
156725453|NCT00450437|565740650|FG000|Overall Study|Inappropriate enrollment|4|||
156725454|NCT00450437|565740651|FG001|Overall Study|Inappropriate enrollment|1|||
156725455|NCT00450437|565740652|FG002|Overall Study|Inappropriate enrollment|3|||
156725456|NCT00450437|565740653|FG003|Overall Study|Inappropriate enrollment|0|||
156335909|NCT01281137|564328142|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
156335910|NCT01281137|564328143|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
156335911|NCT01281137|564328142|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
156335912|NCT01281137|564328143|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
156335913|NCT01281137|564328142|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
156452706|NCT04676022|564750751|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
156452707|NCT04676022|564750752|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
156452708|NCT02274662|564750770|FG000|Overall Study|Death|1|||
156725457|NCT00450437|565740650|FG000|Overall Study|Administrative reason|0|||
156725458|NCT00450437|565740651|FG001|Overall Study|Administrative reason|0|||
156725459|NCT00450437|565740652|FG002|Overall Study|Administrative reason|1|||
156725460|NCT00450437|565740653|FG003|Overall Study|Administrative reason|0|||
156725461|NCT00450437|565740650|FG000|Overall Study|Unable to Classify|1|||
156452709|NCT02274662|564750770|FG000|Overall Study|Lost to Follow-up|3|||
156452710|NCT03134196|564750781|FG000|Overall Study|Death|2|||
156452711|NCT03134196|564750782|FG001|Overall Study|Death|1|||
156725462|NCT00450437|565740651|FG001|Overall Study|Unable to Classify|0|||
156725463|NCT00450437|565740652|FG002|Overall Study|Unable to Classify|1|||
156725464|NCT00450437|565740653|FG003|Overall Study|Unable to Classify|0|||
156725465|NCT01890122|565740654|FG000|Overall Study|Adverse Event|1|||
156725466|NCT01890122|565740655|FG001|Overall Study|Adverse Event|1|||
156725467|NCT01890122|565740656|FG002|Overall Study|Adverse Event|1|||
156725468|NCT01890122|565740657|FG003|Overall Study|Adverse Event|2|||
156725469|NCT01890122|565740654|FG000|Overall Study|Major Protocol Deviation|3|||
156725470|NCT01890122|565740655|FG001|Overall Study|Major Protocol Deviation|1|||
156725471|NCT01890122|565740656|FG002|Overall Study|Major Protocol Deviation|0|||
156725472|NCT01890122|565740657|FG003|Overall Study|Major Protocol Deviation|1|||
156725473|NCT01890122|565740654|FG000|Overall Study|Lost to Follow-up|0|||
156335914|NCT01281137|564328143|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
156335915|NCT00369824|564328148|FG000|Overall Study|Adverse Event|0|||
156335916|NCT00369824|564328149|FG001|Overall Study|Adverse Event|2|||
156335917|NCT00369824|564328150|FG002|Overall Study|Adverse Event|0|||
156335918|NCT00369824|564328151|FG003|Overall Study|Adverse Event|0|||
156335919|NCT00369824|564328152|FG004|Overall Study|Adverse Event|1|||
156335920|NCT00369824|564328153|FG005|Overall Study|Adverse Event|0|||
156335921|NCT00369824|564328148|FG000|Overall Study|Protocol Violation|0|||
156335922|NCT00369824|564328149|FG001|Overall Study|Protocol Violation|1|||
156335923|NCT00369824|564328150|FG002|Overall Study|Protocol Violation|0|||
156335924|NCT00369824|564328151|FG003|Overall Study|Protocol Violation|1|||
156335925|NCT00369824|564328152|FG004|Overall Study|Protocol Violation|1|||
156335926|NCT00369824|564328153|FG005|Overall Study|Protocol Violation|0|||
156335927|NCT00369824|564328148|FG000|Overall Study|Withdrawal by Subject|9|||
156335928|NCT00369824|564328149|FG001|Overall Study|Withdrawal by Subject|5|||
156335929|NCT00369824|564328150|FG002|Overall Study|Withdrawal by Subject|5|||
156335930|NCT00369824|564328151|FG003|Overall Study|Withdrawal by Subject|4|||
156335931|NCT00369824|564328152|FG004|Overall Study|Withdrawal by Subject|6|||
156335932|NCT00369824|564328153|FG005|Overall Study|Withdrawal by Subject|2|||
156335933|NCT00369824|564328148|FG000|Overall Study|Lost to Follow-up|6|||
156335934|NCT00369824|564328149|FG001|Overall Study|Lost to Follow-up|11|||
156335935|NCT00369824|564328150|FG002|Overall Study|Lost to Follow-up|7|||
156335936|NCT00369824|564328151|FG003|Overall Study|Lost to Follow-up|8|||
156335937|NCT00369824|564328152|FG004|Overall Study|Lost to Follow-up|9|||
156335938|NCT00369824|564328153|FG005|Overall Study|Lost to Follow-up|6|||
156335939|NCT00369824|564328148|FG000|Overall Study|Other|0|||
156335940|NCT00369824|564328149|FG001|Overall Study|Other|0|||
156335941|NCT00369824|564328150|FG002|Overall Study|Other|0|||
156335942|NCT00369824|564328151|FG003|Overall Study|Other|2|||
156335943|NCT00369824|564328152|FG004|Overall Study|Other|1|||
156335944|NCT00369824|564328153|FG005|Overall Study|Other|3|||
156335945|NCT03822182|564328156|FG000|Overall Study|Protocol Violation|0|||
156335946|NCT03822182|564328157|FG001|Overall Study|Protocol Violation|1|||
156335947|NCT03822182|564328158|FG002|Overall Study|Protocol Violation|1|||
156335948|NCT00810355|564328159|FG000|Overall Study|Lost to Follow-up|13|||
156335949|NCT00810355|564328160|FG001|Overall Study|Lost to Follow-up|17|||
156335950|NCT00810355|564328161|FG002|Overall Study|Lost to Follow-up|11|||
156335951|NCT00810355|564328159|FG000|Overall Study|Withdrawal by Subject|1|||
156335952|NCT00810355|564328160|FG001|Overall Study|Withdrawal by Subject|0|||
156335953|NCT00810355|564328161|FG002|Overall Study|Withdrawal by Subject|0|||
156335954|NCT01612858|564328163|FG000|Overall Study|Withdrawal by Subject|5|||
156335955|NCT01612858|564328164|FG001|Overall Study|Withdrawal by Subject|1|||
156335956|NCT01484275|564328165|FG000|Overall Study|Study terminated by sponsor|28|||
156335957|NCT01484275|564328166|FG001|Overall Study|Study terminated by sponsor|32|||
156335958|NCT01484275|564328165|FG000|Overall Study|Other|10|||
156335959|NCT01484275|564328166|FG001|Overall Study|Other|0|||
156335960|NCT01484275|564328165|FG000|Overall Study|Death|3|||
156335961|NCT01484275|564328166|FG001|Overall Study|Death|4|||
156335962|NCT01484275|564328165|FG000|Overall Study|Withdrawal by Subject|1|||
156335963|NCT01484275|564328166|FG001|Overall Study|Withdrawal by Subject|5|||
156335964|NCT01484275|564328165|FG000|Overall Study|Lost to Follow-up|1|||
156335965|NCT01484275|564328166|FG001|Overall Study|Lost to Follow-up|1|||
156335966|NCT03113916|564328170|FG000|Overall Study|Withdrawal by Subject|9|||
156335967|NCT03113916|564328171|FG001|Overall Study|Withdrawal by Subject|7|||
156335968|NCT03113916|564328170|FG000|Overall Study|Pregnancy|1|||
156335969|NCT03113916|564328171|FG001|Overall Study|Pregnancy|3|||
156335970|NCT03113916|564328170|FG000|Overall Study|Lost to Follow-up|1|||
156335971|NCT03113916|564328171|FG001|Overall Study|Lost to Follow-up|2|||
156335972|NCT00347360|564328192|FG000|Overall Study|Adverse Event|1|||
156335973|NCT00347360|564328193|FG001|Overall Study|Adverse Event|2|||
156335974|NCT00347360|564328194|FG002|Overall Study|Adverse Event|0|||
156335975|NCT00347360|564328195|FG003|Overall Study|Adverse Event|4|||
156335976|NCT00347360|564328196|FG004|Overall Study|Adverse Event|1|||
156335977|NCT00347360|564328197|FG005|Overall Study|Adverse Event|2|||
156335978|NCT00347360|564328198|FG006|Overall Study|Adverse Event|2|||
156335979|NCT00347360|564328199|FG007|Overall Study|Adverse Event|0|||
156335980|NCT00347360|564328200|FG008|Overall Study|Adverse Event|2|||
156335981|NCT00347360|564328201|FG009|Overall Study|Adverse Event|3|||
156335982|NCT00347360|564328202|FG010|Overall Study|Adverse Event|3|||
156335983|NCT00347360|564328203|FG011|Overall Study|Adverse Event|1|||
156335984|NCT00347360|564328204|FG012|Overall Study|Adverse Event|3|||
156335985|NCT00347360|564328205|FG013|Overall Study|Adverse Event|2|||
156335986|NCT00347360|564328206|FG014|Overall Study|Adverse Event|2|||
156335987|NCT00347360|564328192|FG000|Overall Study|Lost to Follow-up|0|||
156335988|NCT00347360|564328193|FG001|Overall Study|Lost to Follow-up|0|||
156335989|NCT00347360|564328194|FG002|Overall Study|Lost to Follow-up|0|||
156335990|NCT00347360|564328195|FG003|Overall Study|Lost to Follow-up|2|||
156335991|NCT00347360|564328196|FG004|Overall Study|Lost to Follow-up|1|||
156335992|NCT00347360|564328197|FG005|Overall Study|Lost to Follow-up|1|||
156335993|NCT00347360|564328198|FG006|Overall Study|Lost to Follow-up|0|||
156725474|NCT01890122|565740655|FG001|Overall Study|Lost to Follow-up|1|||
156725475|NCT01890122|565740656|FG002|Overall Study|Lost to Follow-up|2|||
156725476|NCT01890122|565740657|FG003|Overall Study|Lost to Follow-up|2|||
156725477|NCT01890122|565740654|FG000|Overall Study|Voluntary Withdrawal|8|||
156725478|NCT01890122|565740655|FG001|Overall Study|Voluntary Withdrawal|8|||
156725479|NCT01890122|565740656|FG002|Overall Study|Voluntary Withdrawal|2|||
156725480|NCT01890122|565740657|FG003|Overall Study|Voluntary Withdrawal|11|||
156725481|NCT01890122|565740654|FG000|Overall Study|Lack of Efficacy|14|||
156725482|NCT01890122|565740655|FG001|Overall Study|Lack of Efficacy|24|||
156725483|NCT01890122|565740656|FG002|Overall Study|Lack of Efficacy|7|||
156795000|NCT06582732|566002822|FG002|Initial Study Period|Moved Away|0|||
156795001|NCT06582732|566002823|FG003|Initial Study Period|Moved Away|0|||
156795002|NCT06582732|566002824|FG004|Initial Study Period|Moved Away|1|||
156795003|NCT06582732|566002825|FG005|Initial Study Period|Moved Away|0|||
156795004|NCT06582732|566002826|FG006|Initial Study Period|Moved Away|0|||
156795005|NCT03931330|566002827|FG000|Overall Study|Physician Decision|1|||
156795006|NCT03412929|566002828|FG000|Overall Study|Protocol Violation|3|||
156795007|NCT04661839|566002831|FG000|Overall Study|Not Treated|0|||
156795008|NCT04661839|566002832|FG001|Overall Study|Not Treated|0|||
156795009|NCT04661839|566002833|FG002|Overall Study|Not Treated|1|||
156795010|NCT04661839|566002834|FG003|Overall Study|Not Treated|0|||
156795011|NCT04661839|566002831|FG000|Overall Study|Lost to Follow-up|1|||
156795012|NCT04661839|566002832|FG001|Overall Study|Lost to Follow-up|0|||
156795013|NCT04661839|566002833|FG002|Overall Study|Lost to Follow-up|0|||
156795014|NCT04661839|566002834|FG003|Overall Study|Lost to Follow-up|1|||
156795015|NCT01946880|566002835|FG000|Overall Study|Lost to Follow-up|1|||
156795016|NCT01946880|566002836|FG001|Overall Study|Lost to Follow-up|0|||
156795017|NCT01946880|566002835|FG000|Overall Study|Physician Decision|1|||
156795018|NCT01946880|566002836|FG001|Overall Study|Physician Decision|1|||
156795019|NCT01946880|566002835|FG000|Overall Study|Withdrawal by Subject|3|||
156795020|NCT01946880|566002836|FG001|Overall Study|Withdrawal by Subject|2|||
156795021|NCT01946880|566002835|FG000|Overall Study|Met Primary Endpoint|1|||
156795022|NCT01946880|566002836|FG001|Overall Study|Met Primary Endpoint|0|||
156795023|NCT01946880|566002835|FG000|Overall Study|Personal and Family Issues|1|||
156795024|NCT01946880|566002836|FG001|Overall Study|Personal and Family Issues|0|||
156795025|NCT02609503|566002837|FG000|Overall Study|Adverse Event|1|||
156795026|NCT02609503|566002837|FG000|Overall Study|Death|1|||
156795027|NCT02609503|566002837|FG000|Overall Study|Withdrawal by Subject|1|||
156795028|NCT02609503|566002837|FG000|Overall Study|Disease progression|1|||
156795029|NCT00581919|566002841|FG000|Overall Study|Adverse Event|8|||
156795030|NCT00581919|566002841|FG000|Overall Study|Death|1|||
156795031|NCT00581919|566002841|FG000|Overall Study|Disease Progression|10|||
156795032|NCT00581919|566002841|FG000|Overall Study|Physician Decision|1|||
156795033|NCT00581919|566002841|FG000|Overall Study|Other Complicating Disease|1|||
156795034|NCT00581919|566002841|FG000|Overall Study|Started Non-Protocol Therapy|2|||
156795035|NCT00581919|566002841|FG000|Overall Study|Withdrawal by Subject|1|||
156795036|NCT02034565|566002842|FG000|Overall Study|Adverse Event|1|||
156795037|NCT02034565|566002843|FG001|Overall Study|Adverse Event|0|||
156795038|NCT03900650|566002844|FG000|Overall Study|Withdrawal by Subject|1|||
156795039|NCT03900650|566002845|FG001|Overall Study|Withdrawal by Subject|1|||
156795040|NCT03900650|566002846|FG002|Overall Study|Withdrawal by Subject|0|||
156795041|NCT03900650|566002847|FG003|Overall Study|Withdrawal by Subject|0|||
156795042|NCT03900650|566002844|FG000|Overall Study|Withdrawn by staff|1|||
156795043|NCT03900650|566002845|FG001|Overall Study|Withdrawn by staff|0|||
156795044|NCT03900650|566002846|FG002|Overall Study|Withdrawn by staff|0|||
156795045|NCT03900650|566002847|FG003|Overall Study|Withdrawn by staff|0|||
156795046|NCT03760068|566002854|FG000|Overall Study|Withdrawal by Subject|7|||
156795047|NCT03760068|566002855|FG001|Overall Study|Withdrawal by Subject|8|||
156795048|NCT03760068|566002854|FG000|Overall Study|Adverse Event|1|||
156795049|NCT03760068|566002855|FG001|Overall Study|Adverse Event|2|||
156335994|NCT00347360|564328199|FG007|Overall Study|Lost to Follow-up|1|||
156335995|NCT00347360|564328200|FG008|Overall Study|Lost to Follow-up|1|||
156725484|NCT01890122|565740657|FG003|Overall Study|Lack of Efficacy|41|||
156725485|NCT01890122|565740654|FG000|Overall Study|Reason not Specified|0|||
156725486|NCT01890122|565740655|FG001|Overall Study|Reason not Specified|1|||
156725487|NCT01890122|565740656|FG002|Overall Study|Reason not Specified|1|||
156725488|NCT01890122|565740657|FG003|Overall Study|Reason not Specified|2|||
156335996|NCT00347360|564328201|FG009|Overall Study|Lost to Follow-up|2|||
156725489|NCT01890122|565740654|FG000|Overall Study|Randomized but not Treated|1|||
156795050|NCT03760068|566002854|FG000|Overall Study|Administrative Decision by Sponsor|0|||
156795051|NCT03760068|566002855|FG001|Overall Study|Administrative Decision by Sponsor|2|||
156795052|NCT03760068|566002854|FG000|Overall Study|Physician Decision|1|||
156795053|NCT03760068|566002855|FG001|Overall Study|Physician Decision|2|||
156795054|NCT03760068|566002854|FG000|Overall Study|Lost to Follow-up|4|||
156795055|NCT03760068|566002855|FG001|Overall Study|Lost to Follow-up|9|||
156335997|NCT00347360|564328202|FG010|Overall Study|Lost to Follow-up|0|||
156795056|NCT03760068|566002854|FG000|Overall Study|Subject Moved Out of State|1|||
156795057|NCT03760068|566002855|FG001|Overall Study|Subject Moved Out of State|0|||
156795058|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
156725490|NCT01890122|565740655|FG001|Overall Study|Randomized but not Treated|1|||
156725491|NCT01890122|565740656|FG002|Overall Study|Randomized but not Treated|0|||
156725492|NCT01890122|565740657|FG003|Overall Study|Randomized but not Treated|0|||
156725493|NCT04025879|565740658|FG000|Randomization|Participant withdrew consent|0|||
156725494|NCT04025879|565740659|FG001|Randomization|Participant withdrew consent|1|||
156725495|NCT04025879|565740658|FG000|Randomization|Participant no longer met study criteria|1|||
156725496|NCT04025879|565740659|FG001|Randomization|Participant no longer met study criteria|1|||
156725497|NCT04025879|565740658|FG000|Treatment|Ongoing treatment|10|||
156725498|NCT04025879|565740659|FG001|Treatment|Ongoing treatment|8|||
156725499|NCT04025879|565740658|FG000|Treatment|Disease progression/recurrence|36|||
156725500|NCT04025879|565740659|FG001|Treatment|Disease progression/recurrence|72|||
156725501|NCT04025879|565740658|FG000|Treatment|Study drug toxicity|36|||
156725502|NCT04025879|565740659|FG001|Treatment|Study drug toxicity|13|||
156725503|NCT04025879|565740658|FG000|Treatment|Death|2|||
156795059|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
156795060|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
156795061|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
156795062|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
156795063|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
156795064|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
156795065|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
156795066|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
156795067|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
156795068|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
156795069|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
156795070|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
156795071|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
156795072|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
156795073|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
156795074|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
156795075|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
156795076|NCT05014919|566002858|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
156795077|NCT05014919|566002859|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
156795078|NCT05014919|566002860|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
156795079|NCT05014919|566002858|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
156795080|NCT05014919|566002859|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
156795081|NCT05014919|566002860|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
156795082|NCT00680914|566002861|FG000|Overall Study|Consent withdrawal|6|||
156795083|NCT00680914|566002862|FG001|Overall Study|Consent withdrawal|3|||
156795084|NCT00680914|566002861|FG000|Overall Study|Lost to Follow-up|4|||
156795085|NCT00680914|566002862|FG001|Overall Study|Lost to Follow-up|0|||
156795086|NCT00680914|566002861|FG000|Overall Study|serious adverse event (SAE)|0|||
156795087|NCT00680914|566002862|FG001|Overall Study|serious adverse event (SAE)|1|||
156795088|NCT01848457|566002863|FG000|Overall Study|Death|1|||
156795089|NCT01848457|566002864|FG001|Overall Study|Death|0|||
156795090|NCT01848457|566002865|FG002|Overall Study|Death|0|||
156795091|NCT01848457|566002866|FG003|Overall Study|Death|0|||
156795092|NCT02940223|566002867|FG000|Overall Study|Failed Requirement|2|||
156795093|NCT02940223|566002868|FG001|Overall Study|Failed Requirement|0|||
156795094|NCT03773562|566002870|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
156875912|NCT04976192|566303723|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156452712|NCT03134196|564750781|FG000|Overall Study|Lost to Follow-up|13|||
156452713|NCT03134196|564750782|FG001|Overall Study|Lost to Follow-up|15|||
156452714|NCT03134196|564750781|FG000|Overall Study|Physician Decision|0|||
156452715|NCT03134196|564750782|FG001|Overall Study|Physician Decision|1|||
156452716|NCT03134196|564750781|FG000|Overall Study|Withdrawal by Subject|19|||
156452717|NCT03134196|564750782|FG001|Overall Study|Withdrawal by Subject|12|||
156452718|NCT03134196|564750781|FG000|Overall Study|Site Unable to Contact Participant|2|||
156452719|NCT03134196|564750782|FG001|Overall Study|Site Unable to Contact Participant|0|||
156725504|NCT04025879|565740659|FG001|Treatment|Death|0|||
156725505|NCT04025879|565740658|FG000|Treatment|Adverse event unrelated to study drug|21|||
156725506|NCT04025879|565740659|FG001|Treatment|Adverse event unrelated to study drug|14|||
156725507|NCT04025879|565740658|FG000|Treatment|Participant request to discontinue study treatment|16|||
156725508|NCT04025879|565740659|FG001|Treatment|Participant request to discontinue study treatment|8|||
156725509|NCT04025879|565740658|FG000|Treatment|Participant withdrew consent|1|||
156725510|NCT04025879|565740659|FG001|Treatment|Participant withdrew consent|3|||
156725511|NCT04025879|565740658|FG000|Treatment|Participant no longer meets study criteria|3|||
156795095|NCT03773562|566002870|FG000|Overall Study|Lost to Follow-up|10|||
156795096|NCT03773562|566002870|FG000|Overall Study|Withdrawal by Subject|1|||
156795097|NCT02298946|566002871|FG000|Overall Study|Did not receive treatment|2|||
156335998|NCT00347360|564328203|FG011|Overall Study|Lost to Follow-up|0|||
156452720|NCT03134196|564750781|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
156725512|NCT04025879|565740659|FG001|Treatment|Participant no longer meets study criteria|2|||
156725513|NCT04025879|565740658|FG000|Treatment|Lost to Follow-up|1|||
156725514|NCT04025879|565740659|FG001|Treatment|Lost to Follow-up|0|||
156725515|NCT04025879|565740658|FG000|Treatment|Other reasons|15|||
156725516|NCT04025879|565740659|FG001|Treatment|Other reasons|17|||
156725517|NCT04025879|565740658|FG000|Treatment|Administrative reason by sponsor|0|||
156725518|NCT04025879|565740659|FG001|Treatment|Administrative reason by sponsor|1|||
156725519|NCT04025879|565740658|FG000|Treatment|Not reported|2|||
156725520|NCT04025879|565740659|FG001|Treatment|Not reported|0|||
156725521|NCT00071110|565740666|FG000|Overall Study|Protocol Violation|0|||
156725522|NCT00071110|565740667|FG001|Overall Study|Protocol Violation|4|||
156725523|NCT01167140|565740674|FG000|Overall Study|Withdrawal by Subject|1|||
156725524|NCT03805412|565740677|FG000|Overall Study|Lost to Follow-up|0|||
156725525|NCT03805412|565740678|FG001|Overall Study|Lost to Follow-up|1|||
156725526|NCT04390113|565740679|FG000|Overall Study|Not Treated|0|||
156725527|NCT04390113|565740680|FG001|Overall Study|Not Treated|1|||
156725528|NCT04390113|565740679|FG000|Overall Study|Adverse Event|1|||
156725529|NCT04390113|565740680|FG001|Overall Study|Adverse Event|0|||
156725530|NCT04390113|565740679|FG000|Overall Study|Death|2|||
156725531|NCT04390113|565740680|FG001|Overall Study|Death|1|||
156725532|NCT04390113|565740679|FG000|Overall Study|Physician Decision|1|||
156725533|NCT04390113|565740680|FG001|Overall Study|Physician Decision|3|||
156725534|NCT04390113|565740679|FG000|Overall Study|Study Terminated by Sponsor|5|||
156725535|NCT04390113|565740680|FG001|Overall Study|Study Terminated by Sponsor|3|||
156725536|NCT04390113|565740679|FG000|Overall Study|Withdrawal by Subject|10|||
156725537|NCT04390113|565740680|FG001|Overall Study|Withdrawal by Subject|5|||
156725538|NCT04390113|565740679|FG000|Overall Study|Other|1|||
156725539|NCT04390113|565740680|FG001|Overall Study|Other|0|||
156725540|NCT04390113|565740679|FG000|Overall Study|Missing|0|||
156725541|NCT04390113|565740680|FG001|Overall Study|Missing|1|||
156725542|NCT04031846|565740681|FG000|Overall Study|Lost to Follow-up|4|||
156725543|NCT04031846|565740682|FG001|Overall Study|Lost to Follow-up|4|||
156725544|NCT04031846|565740681|FG000|Overall Study|Physician Decision|0|||
156725545|NCT04031846|565740682|FG001|Overall Study|Physician Decision|1|||
156725546|NCT04031846|565740681|FG000|Overall Study|Protocol Violation|1|||
156725547|NCT04031846|565740682|FG001|Overall Study|Protocol Violation|1|||
156725548|NCT04031846|565740681|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
156725549|NCT04031846|565740682|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
156725550|NCT02431676|565740683|FG000|Overall Study|no lab obtained|0|||
156725551|NCT02431676|565740684|FG001|Overall Study|no lab obtained|1|||
156725552|NCT02431676|565740685|FG002|Overall Study|no lab obtained|2|||
156725553|NCT00571727|565740686|FG000|Overall Study|Did not enter in this study|1|||
156725554|NCT00571727|565740686|FG000|Overall Study|Non-compliance|4|||
156725555|NCT00571727|565740686|FG000|Overall Study|Lost to Follow-up|30|||
156725556|NCT00571727|565740686|FG000|Overall Study|Poor growth|1|||
156725557|NCT00571727|565740686|FG000|Overall Study|Parent/patient decision|2|||
156725558|NCT00571727|565740686|FG000|Overall Study|Participant transferred to commercial drug|14|||
156725559|NCT00571727|565740686|FG000|Overall Study|Unable to provide study drug|6|||
156725560|NCT00571727|565740686|FG000|Overall Study|On-treatment at end of study|8|||
156725561|NCT01622673|565740687|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156725562|NCT01622673|565740688|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156725563|NCT01622673|565740689|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156725564|NCT01622673|565740690|FG003|Treatment Period 1|Withdrawal by Subject|1|||
156725565|NCT01622673|565740691|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156725566|NCT01622673|565740692|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156725567|NCT01622673|565740687|FG000|Treatment Period 1|Protocol Violation|0|||
156725568|NCT01622673|565740688|FG001|Treatment Period 1|Protocol Violation|1|||
156725569|NCT01622673|565740689|FG002|Treatment Period 1|Protocol Violation|0|||
156725570|NCT01622673|565740690|FG003|Treatment Period 1|Protocol Violation|0|||
156725571|NCT01622673|565740691|FG004|Treatment Period 1|Protocol Violation|0|||
156725572|NCT01622673|565740692|FG005|Treatment Period 1|Protocol Violation|0|||
156725573|NCT01622673|565740687|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156725574|NCT01622673|565740688|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156725575|NCT01622673|565740689|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156725576|NCT01622673|565740690|FG003|Treatment Period 2|Withdrawal by Subject|1|||
156725577|NCT01622673|565740691|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156725578|NCT01622673|565740692|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156725579|NCT01622673|565740687|FG000|Treatment Period 3|Protocol Violation|0|||
156725580|NCT01622673|565740688|FG001|Treatment Period 3|Protocol Violation|1|||
156725581|NCT01622673|565740689|FG002|Treatment Period 3|Protocol Violation|0|||
156725582|NCT01622673|565740690|FG003|Treatment Period 3|Protocol Violation|0|||
156452721|NCT03134196|564750782|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
156725583|NCT01622673|565740691|FG004|Treatment Period 3|Protocol Violation|0|||
156725584|NCT01622673|565740692|FG005|Treatment Period 3|Protocol Violation|0|||
156725585|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
156725586|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
156725587|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
156452722|NCT03134196|564750781|FG000|Overall Study|Scheduling Conflict|1|||
156452723|NCT03134196|564750782|FG001|Overall Study|Scheduling Conflict|0|||
156725588|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
156725589|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
156725590|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
156725591|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
156725592|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
156725593|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
156725594|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
156725595|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
156725596|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
156725597|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
156725598|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
156452724|NCT04683744|564750787|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
156452725|NCT04683744|564750788|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
156725599|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
156725600|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
156725601|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
156725602|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
156452726|NCT04683744|564750789|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
156452727|NCT04592549|564750792|FG000|Overall Study|Withdrawal by Subject|0|||
156452728|NCT04592549|564750793|FG001|Overall Study|Withdrawal by Subject|1|||
156452729|NCT04592549|564750794|FG002|Overall Study|Withdrawal by Subject|0|||
156452730|NCT04592549|564750795|FG003|Overall Study|Withdrawal by Subject|1|||
156452731|NCT04592549|564750796|FG004|Overall Study|Withdrawal by Subject|1|||
156452732|NCT04592549|564750797|FG005|Overall Study|Withdrawal by Subject|0|||
156452733|NCT04592549|564750792|FG000|Overall Study|Lost to Follow-up|2|||
156452734|NCT04592549|564750793|FG001|Overall Study|Lost to Follow-up|0|||
156452735|NCT04592549|564750794|FG002|Overall Study|Lost to Follow-up|0|||
156452736|NCT04592549|564750795|FG003|Overall Study|Lost to Follow-up|1|||
156452737|NCT04592549|564750796|FG004|Overall Study|Lost to Follow-up|1|||
156452738|NCT04592549|564750797|FG005|Overall Study|Lost to Follow-up|1|||
156452739|NCT05603143|564750798|FG000|Overall Study|Withdrew consent|6|||
156452740|NCT05603143|564750799|FG001|Overall Study|Withdrew consent|2|||
156452741|NCT05603143|564750798|FG000|Overall Study|Randomized but never treated|0|||
156452742|NCT05603143|564750799|FG001|Overall Study|Randomized but never treated|3|||
156452743|NCT05603143|564750798|FG000|Overall Study|Adverse Event|2|||
156452744|NCT05603143|564750799|FG001|Overall Study|Adverse Event|0|||
156725603|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
156725604|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
156725605|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
156725606|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
156725607|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
156725608|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
156725609|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
156725610|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
156725611|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
156725612|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
156725613|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
156725614|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
156725615|NCT01682226|565742237|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
156725616|NCT01682226|565742237|FG000|Overall Study|Participants did not receive treatment|2|||
156725617|NCT01682226|565742237|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
156725618|NCT03771898|565742238|FG000|Overall Study|Adverse Event|1|||
156725619|NCT03771898|565742239|FG001|Overall Study|Adverse Event|0|||
156725620|NCT03771898|565742240|FG002|Overall Study|Adverse Event|0|||
156725621|NCT03771898|565742241|FG003|Overall Study|Adverse Event|0|||
156725622|NCT03771898|565742242|FG004|Overall Study|Adverse Event|0|||
156725623|NCT03771898|565742238|FG000|Overall Study|Lost to Follow-up|1|||
156725624|NCT03771898|565742239|FG001|Overall Study|Lost to Follow-up|1|||
156725625|NCT03771898|565742240|FG002|Overall Study|Lost to Follow-up|1|||
156725626|NCT03771898|565742241|FG003|Overall Study|Lost to Follow-up|0|||
156725627|NCT03771898|565742242|FG004|Overall Study|Lost to Follow-up|0|||
156725628|NCT03771898|565742238|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156725629|NCT03771898|565742239|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156725630|NCT03771898|565742240|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156725631|NCT03771898|565742241|FG003|Overall Study|Withdrawal by parent/guardian|0|||
156725632|NCT03771898|565742242|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156452745|NCT05603143|564750798|FG000|Overall Study|Death|0|||
156452746|NCT05603143|564750799|FG001|Overall Study|Death|1|||
156452747|NCT05603143|564750798|FG000|Overall Study|Investigator's discretion|1|||
156452748|NCT05603143|564750799|FG001|Overall Study|Investigator's discretion|0|||
156452749|NCT05603143|564750798|FG000|Overall Study|Lost to Follow-up|0|||
156452750|NCT05603143|564750799|FG001|Overall Study|Lost to Follow-up|1|||
156452751|NCT05603143|564750798|FG000|Overall Study|Protocol Violation|0|||
156452752|NCT05603143|564750799|FG001|Overall Study|Protocol Violation|1|||
156452753|NCT05609760|564750804|FG000|Overall Study|Lost to Follow-up|0|||
156452754|NCT05609760|564750805|FG001|Overall Study|Lost to Follow-up|1|||
156452755|NCT05609760|564750804|FG000|Overall Study|Withdrawal by Subject|1|||
156335999|NCT00347360|564328204|FG012|Overall Study|Lost to Follow-up|1|||
156336000|NCT00347360|564328205|FG013|Overall Study|Lost to Follow-up|0|||
156336001|NCT00347360|564328206|FG014|Overall Study|Lost to Follow-up|0|||
156336002|NCT00347360|564328192|FG000|Overall Study|Protocol Violation|2|||
156452756|NCT05609760|564750805|FG001|Overall Study|Withdrawal by Subject|0|||
156452757|NCT03396588|564750806|FG000|Overall Study|Physician Decision|2|||
156452758|NCT03396588|564750807|FG001|Overall Study|Physician Decision|3|||
156452759|NCT05179395|564750808|FG000|Overall Study|Lack of Efficacy|1|||
156452760|NCT00812461|564750810|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
156452761|NCT00812461|564750811|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
156452762|NCT00812461|564750810|FG000|All Treated Patients|Adverse Event|8|||
156452763|NCT00812461|564750811|FG001|All Treated Patients|Adverse Event|15|||
156452764|NCT00812461|564750810|FG000|All Treated Patients|Lack of Efficacy|13|||
156452765|NCT00812461|564750811|FG001|All Treated Patients|Lack of Efficacy|7|||
156452766|NCT00812461|564750810|FG000|All Treated Patients|Non-compliance|6|||
156452767|NCT00812461|564750811|FG001|All Treated Patients|Non-compliance|9|||
156725633|NCT03771898|565742238|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
156725634|NCT03771898|565742239|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
156725635|NCT03771898|565742240|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
156725636|NCT03771898|565742241|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
156725637|NCT03771898|565742242|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
156725638|NCT03135548|565742243|FG000|Overall Study|Lost to Follow-up|3|||
156725639|NCT03135548|565742244|FG001|Overall Study|Lost to Follow-up|0|||
156725640|NCT03135548|565742245|FG002|Overall Study|Lost to Follow-up|0|||
156725641|NCT03135548|565742243|FG000|Overall Study|Withdrawal by Subject|2|||
156725642|NCT03135548|565742244|FG001|Overall Study|Withdrawal by Subject|2|||
156725643|NCT03135548|565742245|FG002|Overall Study|Withdrawal by Subject|1|||
156725644|NCT03135548|565742243|FG000|Overall Study|Other than listed|0|||
156725645|NCT03135548|565742244|FG001|Overall Study|Other than listed|2|||
156725646|NCT03135548|565742245|FG002|Overall Study|Other than listed|2|||
156725647|NCT04623216|565742246|FG000|Overall Study|Death|5|||
156725648|NCT04623216|565742247|FG001|Overall Study|Death|2|||
156725649|NCT04623216|565742248|FG002|Overall Study|Death|0|||
156725650|NCT04623216|565742249|FG003|Overall Study|Death|0|||
156725651|NCT04623216|565742246|FG000|Overall Study|Terminated by Sponsor|3|||
156725652|NCT04623216|565742247|FG001|Overall Study|Terminated by Sponsor|2|||
156725653|NCT04623216|565742248|FG002|Overall Study|Terminated by Sponsor|2|||
156725654|NCT04623216|565742249|FG003|Overall Study|Terminated by Sponsor|0|||
156725655|NCT04623216|565742246|FG000|Overall Study|Physician Decision|1|||
156725656|NCT04623216|565742247|FG001|Overall Study|Physician Decision|0|||
156725657|NCT04623216|565742248|FG002|Overall Study|Physician Decision|0|||
156725658|NCT04623216|565742249|FG003|Overall Study|Physician Decision|0|||
156725659|NCT03521154|565742250|FG000|Overall Study|Ongoing study at data cut-off|111|||
156725660|NCT03521154|565742251|FG001|Overall Study|Ongoing study at data cut-off|52|||
156725661|NCT05386680|565742252|FG000|Overall Study|Guardian decision|2|||
156725662|NCT00529087|565742257|FG000|Overall Study|Adverse Event|10|||
156725663|NCT00529087|565742258|FG001|Overall Study|Adverse Event|13|||
156725664|NCT00529087|565742259|FG002|Overall Study|Adverse Event|4|||
156725665|NCT00529087|565742257|FG000|Overall Study|Lost to Follow-up|6|||
156725666|NCT00529087|565742258|FG001|Overall Study|Lost to Follow-up|4|||
156725667|NCT00529087|565742259|FG002|Overall Study|Lost to Follow-up|1|||
156725668|NCT00529087|565742257|FG000|Overall Study|Protocol Violation|8|||
156725669|NCT00529087|565742258|FG001|Overall Study|Protocol Violation|7|||
156725670|NCT00529087|565742259|FG002|Overall Study|Protocol Violation|6|||
156725671|NCT00529087|565742257|FG000|Overall Study|Withdrawal by Subject|3|||
156725672|NCT00529087|565742258|FG001|Overall Study|Withdrawal by Subject|3|||
156725673|NCT00529087|565742259|FG002|Overall Study|Withdrawal by Subject|3|||
156725674|NCT00529087|565742257|FG000|Overall Study|Protocol deviation|1|||
156725675|NCT00529087|565742258|FG001|Overall Study|Protocol deviation|1|||
156725676|NCT00529087|565742259|FG002|Overall Study|Protocol deviation|2|||
156725677|NCT04168112|565742260|FG000|Overall Study|Lost to Follow-up|1|||
156795098|NCT02298946|566002872|FG001|Overall Study|Did not receive treatment|0|||
156795099|NCT02298946|566002871|FG000|Overall Study|Unevaluable|2|||
156795100|NCT02298946|566002872|FG001|Overall Study|Unevaluable|1|||
156795101|NCT04197583|566002873|FG000|Overall Study|Study Stent Replacement|34|||
156795102|NCT04197583|566002874|FG001|Overall Study|Study Stent Replacement|8|||
156795103|NCT04197583|566002873|FG000|Overall Study|Lost to Follow-up|14|||
156795104|NCT04197583|566002874|FG001|Overall Study|Lost to Follow-up|3|||
156795105|NCT04197583|566002873|FG000|Overall Study|Death|3|||
156795106|NCT04197583|566002874|FG001|Overall Study|Death|0|||
156452768|NCT00812461|564750810|FG000|All Treated Patients|Protocol Violation|36|||
156452769|NCT00812461|564750811|FG001|All Treated Patients|Protocol Violation|27|||
156452770|NCT00812461|564750810|FG000|All Treated Patients|Withdrawal by Subject|45|||
156452771|NCT00812461|564750811|FG001|All Treated Patients|Withdrawal by Subject|54|||
156452772|NCT00812461|564750810|FG000|All Treated Patients|Lost to Follow-up|11|||
156452773|NCT00812461|564750811|FG001|All Treated Patients|Lost to Follow-up|14|||
156452774|NCT00812461|564750810|FG000|All Treated Patients|Other Reason|13|||
156452775|NCT00812461|564750811|FG001|All Treated Patients|Other Reason|21|||
156452776|NCT02727699|564752466|FG000|Overall Study|Adverse Event|2|||
156452777|NCT02727699|564752467|FG001|Overall Study|Adverse Event|0|||
156452778|NCT02727699|564752466|FG000|Overall Study|Withdrawal by Subject|5|||
156452779|NCT02727699|564752467|FG001|Overall Study|Withdrawal by Subject|3|||
156452780|NCT02727699|564752466|FG000|Overall Study|Protocol Violation|0|||
156452781|NCT02727699|564752467|FG001|Overall Study|Protocol Violation|1|||
156452782|NCT02727699|564752466|FG000|Overall Study|Physician Decision|0|||
156452783|NCT02727699|564752467|FG001|Overall Study|Physician Decision|1|||
156452784|NCT02727699|564752466|FG000|Overall Study|Lost to Follow-up|1|||
156452785|NCT02727699|564752467|FG001|Overall Study|Lost to Follow-up|0|||
156452786|NCT02727699|564752466|FG000|Overall Study|Sponsor Decision|1|||
156452787|NCT02727699|564752467|FG001|Overall Study|Sponsor Decision|0|||
156452788|NCT03891667|564752472|FG000|Overall Study|Physician Decision|1|||
156452789|NCT03891667|564752473|FG001|Overall Study|Physician Decision|1|||
156452790|NCT03891667|564752472|FG000|Overall Study|COVID related pause|1|||
156452791|NCT03891667|564752473|FG001|Overall Study|COVID related pause|0|||
156452792|NCT03891667|564752472|FG000|Overall Study|Withdrawal by Subject|0|||
156452793|NCT03891667|564752473|FG001|Overall Study|Withdrawal by Subject|1|||
156452794|NCT03891667|564752472|FG000|Overall Study|Adverse Event|0|||
156452795|NCT03891667|564752473|FG001|Overall Study|Adverse Event|1|||
156336003|NCT00347360|564328193|FG001|Overall Study|Protocol Violation|3|||
156336004|NCT00347360|564328194|FG002|Overall Study|Protocol Violation|1|||
156336005|NCT00347360|564328195|FG003|Overall Study|Protocol Violation|2|||
156336006|NCT00347360|564328196|FG004|Overall Study|Protocol Violation|1|||
156452796|NCT05659537|564752474|FG000|Overall Study|Adverse Event|5|||
156452797|NCT05659537|564752474|FG000|Overall Study|Lost to Follow-up|4|||
156336007|NCT00347360|564328197|FG005|Overall Study|Protocol Violation|2|||
156336008|NCT00347360|564328198|FG006|Overall Study|Protocol Violation|0|||
156336009|NCT00347360|564328199|FG007|Overall Study|Protocol Violation|0|||
156336010|NCT00347360|564328200|FG008|Overall Study|Protocol Violation|1|||
156336011|NCT00347360|564328201|FG009|Overall Study|Protocol Violation|2|||
156336012|NCT00347360|564328202|FG010|Overall Study|Protocol Violation|0|||
156336013|NCT00347360|564328203|FG011|Overall Study|Protocol Violation|0|||
156336014|NCT00347360|564328204|FG012|Overall Study|Protocol Violation|0|||
156336015|NCT00347360|564328205|FG013|Overall Study|Protocol Violation|1|||
156336016|NCT00347360|564328206|FG014|Overall Study|Protocol Violation|0|||
156336017|NCT00347360|564328192|FG000|Overall Study|Withdrawal by Subject|0|||
156336018|NCT00347360|564328193|FG001|Overall Study|Withdrawal by Subject|1|||
156336019|NCT00347360|564328194|FG002|Overall Study|Withdrawal by Subject|2|||
156336020|NCT00347360|564328195|FG003|Overall Study|Withdrawal by Subject|4|||
156336021|NCT00347360|564328196|FG004|Overall Study|Withdrawal by Subject|1|||
156336022|NCT00347360|564328197|FG005|Overall Study|Withdrawal by Subject|2|||
156336023|NCT00347360|564328198|FG006|Overall Study|Withdrawal by Subject|1|||
156336024|NCT00347360|564328199|FG007|Overall Study|Withdrawal by Subject|1|||
156336025|NCT00347360|564328200|FG008|Overall Study|Withdrawal by Subject|1|||
156336026|NCT00347360|564328201|FG009|Overall Study|Withdrawal by Subject|1|||
156336027|NCT00347360|564328202|FG010|Overall Study|Withdrawal by Subject|0|||
156336028|NCT00347360|564328203|FG011|Overall Study|Withdrawal by Subject|3|||
156336029|NCT00347360|564328204|FG012|Overall Study|Withdrawal by Subject|4|||
156336030|NCT00347360|564328205|FG013|Overall Study|Withdrawal by Subject|2|||
156336031|NCT00347360|564328206|FG014|Overall Study|Withdrawal by Subject|1|||
156336032|NCT00347360|564328192|FG000|Overall Study|Lack of Efficacy|1|||
156336033|NCT00347360|564328193|FG001|Overall Study|Lack of Efficacy|1|||
156452798|NCT05659537|564752474|FG000|Overall Study|Withdrawal by Subject|13|||
156452799|NCT05659537|564752474|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
156452800|NCT05659537|564752474|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
156452801|NCT05659537|564752474|FG000|Overall Study|Participant was suffering from anaemia|1|||
156452802|NCT00506519|564752480|FG000|Overall Study|Death|4|||
156452803|NCT00506519|564752481|FG001|Overall Study|Death|6|||
156336034|NCT00347360|564328194|FG002|Overall Study|Lack of Efficacy|3|||
156336035|NCT00347360|564328195|FG003|Overall Study|Lack of Efficacy|1|||
156336036|NCT00347360|564328196|FG004|Overall Study|Lack of Efficacy|0|||
156452804|NCT00506519|564752482|FG002|Overall Study|Death|0|||
156452805|NCT00506519|564752480|FG000|Overall Study|Adverse Event|1|||
156452806|NCT00506519|564752481|FG001|Overall Study|Adverse Event|0|||
156452807|NCT00506519|564752482|FG002|Overall Study|Adverse Event|0|||
156336037|NCT00347360|564328197|FG005|Overall Study|Lack of Efficacy|1|||
156336038|NCT00347360|564328198|FG006|Overall Study|Lack of Efficacy|0|||
156452808|NCT02105766|564752483|FG000|Overall Study|Physician Decision|1|||
156336039|NCT00347360|564328199|FG007|Overall Study|Lack of Efficacy|1|||
156452809|NCT02105766|564752484|FG001|Overall Study|Physician Decision|1|||
156452810|NCT02105766|564752485|FG002|Overall Study|Physician Decision|0|||
156452811|NCT02105766|564752483|FG000|Overall Study|Lost to Follow-up|2|||
156452812|NCT02105766|564752484|FG001|Overall Study|Lost to Follow-up|0|||
156452813|NCT02105766|564752485|FG002|Overall Study|Lost to Follow-up|0|||
156452814|NCT02105766|564752483|FG000|Overall Study|Death|1|||
156452815|NCT02105766|564752484|FG001|Overall Study|Death|1|||
156452816|NCT02105766|564752485|FG002|Overall Study|Death|0|||
156452817|NCT03867500|564752486|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
156452818|NCT02577835|564752487|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
156452819|NCT04749615|564752488|FG000|Overall Study|Lost to Follow-up|6|||
156452820|NCT04749615|564752489|FG001|Overall Study|Lost to Follow-up|10|||
156452821|NCT03611491|564752490|FG000|Overall Study|Lost to Follow-up|1|||
156452822|NCT05119023|564752492|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
156452823|NCT05119023|564752492|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
156452824|NCT05119023|564752492|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
156452825|NCT05409183|564752494|FG000|Complete Study|Adverse Event|1|||
156452826|NCT05409183|564752495|FG001|Complete Study|Adverse Event|2|||
156452827|NCT05409183|564752494|FG000|Complete Study|Withdrawal by Subject|3|||
156452828|NCT05409183|564752495|FG001|Complete Study|Withdrawal by Subject|0|||
156452829|NCT03194217|564752496|FG000|Overall Study|Adverse Event|0|||
156452830|NCT03194217|564752497|FG001|Overall Study|Adverse Event|2|||
156875913|NCT04976192|566303724|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875914|NCT04073225|566303725|FG000|Overall Study|Lost to Follow-up|4|||
156875915|NCT04073225|566303726|FG001|Overall Study|Lost to Follow-up|3|||
156875916|NCT00124306|566303728|FG000|Overall Study|Adverse Event|7|||
156875917|NCT00124306|566303729|FG001|Overall Study|Adverse Event|2|||
156875918|NCT00124306|566303728|FG000|Overall Study|Lost to Follow-up|10|||
156875919|NCT00124306|566303729|FG001|Overall Study|Lost to Follow-up|6|||
156875920|NCT00124306|566303728|FG000|Overall Study|Lack of Efficacy|3|||
156875921|NCT00124306|566303729|FG001|Overall Study|Lack of Efficacy|6|||
156875922|NCT00124306|566303728|FG000|Overall Study|Personal constraints|0|||
156875923|NCT00124306|566303729|FG001|Overall Study|Personal constraints|2|||
156875924|NCT00124306|566303728|FG000|Overall Study|Use of unacceptable medication|1|||
156875925|NCT00124306|566303729|FG001|Overall Study|Use of unacceptable medication|0|||
156875926|NCT00124306|566303728|FG000|Overall Study|Abnormal lab result|0|||
156875927|NCT00124306|566303729|FG001|Overall Study|Abnormal lab result|1|||
156875928|NCT00124306|566303728|FG000|Overall Study|Other|2|||
156875929|NCT00124306|566303729|FG001|Overall Study|Other|0|||
156875930|NCT04238819|566303730|FG000|Overall Study|Ongoing Treatment|0|||
156875931|NCT04238819|566303731|FG001|Overall Study|Ongoing Treatment|0|||
156875932|NCT04238819|566303732|FG002|Overall Study|Ongoing Treatment|0|||
156875933|NCT04238819|566303733|FG003|Overall Study|Ongoing Treatment|0|||
156875934|NCT04238819|566303734|FG004|Overall Study|Ongoing Treatment|1|||
156875935|NCT04238819|566303735|FG005|Overall Study|Ongoing Treatment|4|||
156875936|NCT04238819|566303736|FG006|Overall Study|Ongoing Treatment|0|||
156875937|NCT04238819|566303730|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
156875938|NCT04238819|566303731|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
156875939|NCT04238819|566303732|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
156875940|NCT04238819|566303733|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
156875941|NCT04238819|566303734|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
156875942|NCT04238819|566303735|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
156875943|NCT04238819|566303736|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
156875944|NCT05767749|566303737|FG000|Overall Study|Withdrawal by Subject|0|||
156875945|NCT05767749|566303738|FG001|Overall Study|Withdrawal by Subject|0|||
156875946|NCT05767749|566303739|FG002|Overall Study|Withdrawal by Subject|2|||
156875947|NCT05767749|566303740|FG003|Overall Study|Withdrawal by Subject|2|||
156336040|NCT00347360|564328200|FG008|Overall Study|Lack of Efficacy|1|||
156452831|NCT03194217|564752498|FG002|Overall Study|Adverse Event|3|||
156452832|NCT03194217|564752499|FG003|Overall Study|Adverse Event|3|||
156452833|NCT03194217|564752496|FG000|Overall Study|Failure to meet randomisation criteria|0|||
156452834|NCT03194217|564752497|FG001|Overall Study|Failure to meet randomisation criteria|0|||
156452835|NCT03194217|564752498|FG002|Overall Study|Failure to meet randomisation criteria|0|||
156452836|NCT03194217|564752499|FG003|Overall Study|Failure to meet randomisation criteria|1|||
156452837|NCT03194217|564752496|FG000|Overall Study|Other|0|||
156452838|NCT03194217|564752497|FG001|Overall Study|Other|1|||
156452839|NCT03194217|564752498|FG002|Overall Study|Other|1|||
156452840|NCT03194217|564752499|FG003|Overall Study|Other|0|||
156452841|NCT02962895|564752500|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
156452842|NCT02962895|564752501|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
156875948|NCT05767749|566303741|FG004|Overall Study|Withdrawal by Subject|2|||
156875949|NCT05767749|566303742|FG005|Overall Study|Withdrawal by Subject|2|||
156875950|NCT00114517|566303743|FG000|Overall Study|Adverse Event|6|||
156875951|NCT00114517|566303744|FG001|Overall Study|Adverse Event|1|||
156875952|NCT00114517|566303745|FG002|Overall Study|Adverse Event|6|||
156875953|NCT00114517|566303746|FG003|Overall Study|Adverse Event|3|||
156452843|NCT02962895|564752502|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
156452844|NCT02962895|564752503|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
156725678|NCT04168112|565742261|FG001|Overall Study|Lost to Follow-up|0|||
156725679|NCT04168112|565742260|FG000|Overall Study|Withdrawal by Subject|1|||
156725680|NCT04168112|565742261|FG001|Overall Study|Withdrawal by Subject|0|||
156725681|NCT01780038|565742264|FG000|Overall Study|Lost to Follow-up|4|||
156725682|NCT01780038|565742265|FG001|Overall Study|Lost to Follow-up|1|||
156725683|NCT03168711|565742266|FG000|Overall Study|Adverse Event|2|||
156725684|NCT03168711|565742267|FG001|Overall Study|Adverse Event|0|||
156725685|NCT03168711|565742266|FG000|Overall Study|Withdrawal by Subject|0|||
156725686|NCT03168711|565742267|FG001|Overall Study|Withdrawal by Subject|1|||
156725687|NCT03168711|565742266|FG000|Overall Study|Death|0|||
156725688|NCT03168711|565742267|FG001|Overall Study|Death|1|||
156875954|NCT00114517|566303743|FG000|Overall Study|Lost to Follow-up|2|||
156336041|NCT00347360|564328201|FG009|Overall Study|Lack of Efficacy|0|||
156336042|NCT00347360|564328202|FG010|Overall Study|Lack of Efficacy|0|||
156336043|NCT00347360|564328203|FG011|Overall Study|Lack of Efficacy|0|||
156336044|NCT00347360|564328204|FG012|Overall Study|Lack of Efficacy|0|||
156452845|NCT02962895|564752504|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
156452846|NCT02962895|564752505|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
156452847|NCT02962895|564752506|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
156452848|NCT02962895|564752500|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
156452849|NCT02962895|564752501|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
156452850|NCT02962895|564752502|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
156452851|NCT02962895|564752503|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
156452852|NCT02962895|564752504|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
156452853|NCT02962895|564752505|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
156452854|NCT02962895|564752506|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
156452855|NCT02962895|564752500|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
156452856|NCT02962895|564752501|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
156452857|NCT02962895|564752502|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
156452858|NCT02962895|564752503|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
156452859|NCT02962895|564752504|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
156452860|NCT02962895|564752505|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
156452861|NCT02962895|564752506|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
156452862|NCT02962895|564752500|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
156725689|NCT03270657|565742270|FG000|Overall Study|Withdrawal by Subject|1|||
156725690|NCT00162981|565742271|FG000|Overall Study|Adverse Event|2|||
156725691|NCT00162981|565742272|FG001|Overall Study|Adverse Event|5|||
156725692|NCT00162981|565742271|FG000|Overall Study|Withdrawal by Subject|1|||
156452863|NCT02962895|564752501|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
156452864|NCT02962895|564752502|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
156725693|NCT00162981|565742272|FG001|Overall Study|Withdrawal by Subject|1|||
156725694|NCT00162981|565742271|FG000|Overall Study|Physician Decision|1|||
156725695|NCT00162981|565742272|FG001|Overall Study|Physician Decision|0|||
156725696|NCT00455403|565742273|FG000|Overall Study|Lost to Follow-up|2|||
156725697|NCT00455403|565742274|FG001|Overall Study|Lost to Follow-up|1|||
156725698|NCT00455403|565742273|FG000|Overall Study|Withdrawal by Subject|1|||
156725699|NCT00455403|565742274|FG001|Overall Study|Withdrawal by Subject|3|||
156725700|NCT00455403|565742273|FG000|Overall Study|Protocol Violation|0|||
156725701|NCT00455403|565742274|FG001|Overall Study|Protocol Violation|2|||
156725702|NCT00449865|565742279|FG000|Overall Study|Withdrawal by Subject|110|||
156725703|NCT00449865|565742280|FG001|Overall Study|Withdrawal by Subject|110|||
156725704|NCT00449865|565742279|FG000|Overall Study|Lost to Follow-up|36|||
156725705|NCT00449865|565742280|FG001|Overall Study|Lost to Follow-up|37|||
156725706|NCT00449865|565742279|FG000|Overall Study|Physician Decision|13|||
156725707|NCT00449865|565742280|FG001|Overall Study|Physician Decision|12|||
156725708|NCT00449865|565742279|FG000|Overall Study|Death|31|||
156725709|NCT00449865|565742280|FG001|Overall Study|Death|40|||
156725710|NCT00449865|565742279|FG000|Overall Study|Protocol Violation|8|||
156725711|NCT00449865|565742280|FG001|Overall Study|Protocol Violation|7|||
156725712|NCT00449865|565742279|FG000|Overall Study|Study was stopped|324|||
156725713|NCT00449865|565742280|FG001|Overall Study|Study was stopped|328|||
156725714|NCT00406367|565742281|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
156725715|NCT00406367|565742282|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
156725716|NCT00406367|565742281|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
156725717|NCT00406367|565742282|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
156725718|NCT00406367|565742281|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
156725719|NCT00406367|565742282|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
156725720|NCT00406367|565742281|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
156875955|NCT00114517|566303744|FG001|Overall Study|Lost to Follow-up|2|||
156336045|NCT00347360|564328205|FG013|Overall Study|Lack of Efficacy|0|||
156452865|NCT02962895|564752503|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
156452866|NCT02962895|564752504|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
156452867|NCT02962895|564752505|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
156452868|NCT02962895|564752506|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
156452869|NCT02962895|564752500|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
156452870|NCT02962895|564752501|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
156452871|NCT02962895|564752502|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
156452872|NCT02962895|564752503|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
156452873|NCT02962895|564752504|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
156452874|NCT02962895|564752505|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
156452875|NCT02962895|564752506|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
156452876|NCT02962895|564752500|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
156452877|NCT02962895|564752501|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
156452878|NCT02962895|564752502|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
156452879|NCT02962895|564752503|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
156452880|NCT02962895|564752504|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
156452881|NCT02962895|564752505|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
156452882|NCT02962895|564752506|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
156452883|NCT02962895|564752500|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
156452884|NCT02962895|564752501|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
156452885|NCT02962895|564752502|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
156452886|NCT02962895|564752503|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
156452887|NCT02962895|564752504|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
156452888|NCT02962895|564752505|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
156452889|NCT02962895|564752506|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
156452890|NCT02962895|564752500|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
156452891|NCT02962895|564752501|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
156452892|NCT02962895|564752502|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
156452893|NCT02962895|564752503|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
156725721|NCT00406367|565742282|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
156725722|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
156725723|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
156725724|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
156725725|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
156725726|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
156725727|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
156725728|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
156725729|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
156725730|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
156725731|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
156725732|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
156725733|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
156725734|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
156725735|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
156725736|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
156725737|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
156725738|NCT00171210|565742283|FG000|Overall Study|Adverse Event|16|||
156725739|NCT00171210|565742284|FG001|Overall Study|Adverse Event|27|||
156725740|NCT00171210|565742283|FG000|Overall Study|Abnormal laboratory value(s)|6|||
156725741|NCT00171210|565742284|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156725742|NCT00171210|565742283|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156725743|NCT00171210|565742284|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156725744|NCT00171210|565742283|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
156725745|NCT00171210|565742284|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
156795107|NCT04197583|566002873|FG000|Overall Study|Physician Decision|1|||
156452894|NCT02962895|564752504|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
156452895|NCT02962895|564752505|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
156725746|NCT00171210|565742283|FG000|Overall Study|Protocol Violation|0|||
156725747|NCT00171210|565742284|FG001|Overall Study|Protocol Violation|2|||
156725748|NCT00171210|565742283|FG000|Overall Study|Withdrawal by Subject|32|||
156725749|NCT00171210|565742284|FG001|Overall Study|Withdrawal by Subject|30|||
156725750|NCT00171210|565742283|FG000|Overall Study|Lost to Follow-up|1|||
156725751|NCT00171210|565742284|FG001|Overall Study|Lost to Follow-up|0|||
156795108|NCT04197583|566002874|FG001|Overall Study|Physician Decision|0|||
156452896|NCT02962895|564752506|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
156725752|NCT00171210|565742283|FG000|Overall Study|Administrative problems|1|||
156725753|NCT00171210|565742284|FG001|Overall Study|Administrative problems|1|||
156725754|NCT00171210|565742283|FG000|Overall Study|Death|2|||
156725755|NCT00171210|565742284|FG001|Overall Study|Death|3|||
156725756|NCT00171210|565742283|FG000|Overall Study|Stopped at end of core|0|||
156725757|NCT00171210|565742284|FG001|Overall Study|Stopped at end of core|32|||
156725758|NCT00171210|565742283|FG000|Overall Study|Stopped at end of extension 1|0|||
156725759|NCT00171210|565742284|FG001|Overall Study|Stopped at end of extension 1|1|||
156725760|NCT03252535|565742286|FG000|Overall Study|Withdrawal by Subject|1|||
156725761|NCT03252535|565742287|FG001|Overall Study|Withdrawal by Subject|0|||
156725762|NCT03252535|565742288|FG002|Overall Study|Withdrawal by Subject|0|||
156725763|NCT03252535|565742286|FG000|Overall Study|Physician Decision|0|||
156725764|NCT03252535|565742287|FG001|Overall Study|Physician Decision|1|||
156725765|NCT03252535|565742288|FG002|Overall Study|Physician Decision|0|||
156725766|NCT03252535|565742286|FG000|Overall Study|Met discontinuation criteria|0|||
156725767|NCT03252535|565742287|FG001|Overall Study|Met discontinuation criteria|1|||
156725768|NCT03252535|565742288|FG002|Overall Study|Met discontinuation criteria|0|||
156725769|NCT01966120|565742293|FG000|Overall Study|Withdrawal by Subject|0|||
156725770|NCT01966120|565742294|FG001|Overall Study|Withdrawal by Subject|5|||
156725771|NCT01966120|565742293|FG000|Overall Study|Lost to Follow-up|1|||
156725772|NCT01966120|565742294|FG001|Overall Study|Lost to Follow-up|1|||
156725773|NCT00461630|565742295|FG000|Overall Study|Death|798|||
156725774|NCT00461630|565742296|FG001|Overall Study|Death|732|||
156725775|NCT00461630|565742295|FG000|Overall Study|Lost to Follow-up|108|||
156725776|NCT00461630|565742296|FG001|Overall Study|Lost to Follow-up|95|||
156725777|NCT00442897|565742301|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
156725778|NCT00442897|565742302|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
156725779|NCT00442897|565742301|FG000|Base Study (12 Week Follow-up)|Death|0|||
156725780|NCT00442897|565742302|FG001|Base Study (12 Week Follow-up)|Death|1|||
156725781|NCT00442897|565742301|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
156725782|NCT00442897|565742302|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
156725783|NCT00442897|565742301|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
156725784|NCT00442897|565742302|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
156725785|NCT00442897|565742301|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
156725786|NCT00442897|565742302|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
156725787|NCT00442897|565742301|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
156725788|NCT00442897|565742302|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
156725789|NCT00442897|565742301|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
156725790|NCT00442897|565742302|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
156725791|NCT00442897|565742301|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
156725792|NCT00442897|565742302|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
156725793|NCT04498182|565742303|FG000|Overall Study|Adverse Event|2|||
156725794|NCT04498182|565742304|FG001|Overall Study|Adverse Event|3|||
156725795|NCT04498182|565742305|FG002|Overall Study|Adverse Event|2|||
156725796|NCT04498182|565742303|FG000|Overall Study|Withdrawal of Consent|3|||
156725797|NCT04498182|565742304|FG001|Overall Study|Withdrawal of Consent|4|||
156725798|NCT04498182|565742305|FG002|Overall Study|Withdrawal of Consent|3|||
156725799|NCT04498182|565742303|FG000|Overall Study|Non-Compliant|1|||
156725800|NCT04498182|565742304|FG001|Overall Study|Non-Compliant|0|||
156725801|NCT04498182|565742305|FG002|Overall Study|Non-Compliant|1|||
156725802|NCT04498182|565742303|FG000|Overall Study|Lost to Follow-up|0|||
156725803|NCT04498182|565742304|FG001|Overall Study|Lost to Follow-up|0|||
156725804|NCT04498182|565742305|FG002|Overall Study|Lost to Follow-up|1|||
156725805|NCT04498182|565742303|FG000|Overall Study|Investigator Decision|0|||
156725806|NCT04498182|565742304|FG001|Overall Study|Investigator Decision|0|||
156725807|NCT04498182|565742305|FG002|Overall Study|Investigator Decision|1|||
156725808|NCT04498182|565742303|FG000|Overall Study|Protocol Violation|1|||
156725809|NCT04498182|565742304|FG001|Overall Study|Protocol Violation|0|||
156725810|NCT04498182|565742305|FG002|Overall Study|Protocol Violation|2|||
156725811|NCT02182843|565742307|FG000|Overall Study|Withdrawal by Subject|7|||
156725812|NCT02182843|565742307|FG000|Overall Study|Lost to Follow-up|2|||
156725813|NCT02182843|565742307|FG000|Overall Study|Adverse Event|1|||
156725814|NCT02187198|565742318|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
156725815|NCT02187198|565742319|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
156725816|NCT02187198|565742318|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
156725817|NCT02187198|565742319|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
156725818|NCT01532518|565742320|FG000|Overall Study|Withdrawal by Subject|0|||
156725819|NCT01532518|565742321|FG001|Overall Study|Withdrawal by Subject|0|||
156725820|NCT01532518|565742322|FG002|Overall Study|Withdrawal by Subject|1|||
156725821|NCT06509438|565742325|FG000|Overall Study|Adverse Event|1|||
156725822|NCT06509438|565742325|FG000|Overall Study|Lost to Follow-up|3|||
156725823|NCT00952068|565742328|FG000|Overall Study|Adverse Event|3|||
156725824|NCT00952068|565742328|FG000|Overall Study|Withdrawal by Subject|4|||
156452897|NCT02962895|564752500|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
156452898|NCT02962895|564752501|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
156452899|NCT02962895|564752502|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
156452900|NCT02962895|564752503|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
156452901|NCT02962895|564752504|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
156452902|NCT02962895|564752505|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
156452903|NCT02962895|564752506|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
156452904|NCT02962895|564752500|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
156452905|NCT02962895|564752501|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
156452906|NCT02962895|564752502|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
156452907|NCT02962895|564752503|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
156452908|NCT02962895|564752504|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
156452909|NCT02962895|564752505|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
156452910|NCT02962895|564752506|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
156452911|NCT02962895|564752500|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
156452912|NCT02962895|564752501|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
156452913|NCT02962895|564752502|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
156452914|NCT02962895|564752503|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
156452915|NCT02962895|564752504|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
156452916|NCT02962895|564752505|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
156452917|NCT02962895|564752506|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
156452918|NCT02962895|564752500|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
156452919|NCT02962895|564752501|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
156452920|NCT02962895|564752502|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
156452921|NCT02962895|564752503|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
156452922|NCT02962895|564752504|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
156452923|NCT02962895|564752505|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
156452924|NCT02962895|564752506|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
156452925|NCT02962895|564752500|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
156452926|NCT02962895|564752501|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
156452927|NCT02962895|564752502|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
156452928|NCT02962895|564752503|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
156452929|NCT02962895|564752504|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
156452930|NCT02962895|564752505|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
156452931|NCT02962895|564752506|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
156452932|NCT02962895|564752500|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
156452933|NCT02962895|564752501|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
156452934|NCT02962895|564752502|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
156452935|NCT02962895|564752503|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
156452936|NCT02962895|564752504|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
156452937|NCT02962895|564752505|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
156725825|NCT00488644|565742329|FG000|Overall Study|Not Eligible|1|||
156725826|NCT00488644|565742329|FG000|Overall Study|Not Evaluable|1|||
156725827|NCT02169271|565742330|FG000|Overall Study|Protocol Violation|1|||
156725828|NCT02169271|565742331|FG001|Overall Study|Protocol Violation|2|||
156725829|NCT03591874|565742332|FG000|Overall Study|Adverse Event|4|||
156725830|NCT03591874|565742333|FG001|Overall Study|Adverse Event|0|||
156725831|NCT03591874|565742332|FG000|Overall Study|Withdrawal by Subject|2|||
156725832|NCT03591874|565742333|FG001|Overall Study|Withdrawal by Subject|1|||
156452938|NCT02962895|564752506|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
156452939|NCT04806451|564752507|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
156725833|NCT03591874|565742332|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
156725834|NCT03591874|565742333|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
156725835|NCT03591874|565742332|FG000|Overall Study|On Study at Time of Study Termination|12|||
156725836|NCT03591874|565742333|FG001|Overall Study|On Study at Time of Study Termination|6|||
156725837|NCT03194542|565742336|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
156725838|NCT03194542|565742337|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
156725839|NCT03194542|565742338|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
156725840|NCT03194542|565742339|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
156725841|NCT03194542|565742336|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
156725842|NCT03194542|565742337|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
156452940|NCT04806451|564752508|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
156725843|NCT03194542|565742338|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
156725844|NCT03194542|565742339|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
156725845|NCT03194542|565742336|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
156725846|NCT03194542|565742337|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
156725847|NCT03194542|565742338|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
156725848|NCT03194542|565742339|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
156452941|NCT04806451|564752507|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
156452942|NCT04806451|564752508|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
156452943|NCT04806451|564752507|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
156452944|NCT04806451|564752508|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
156452945|NCT02936752|564752509|FG000|Overall Study|Death|2|||
156452946|NCT02936752|564752510|FG001|Overall Study|Death|1|||
156452947|NCT02936752|564752509|FG000|Overall Study|Physician Decision|4|||
156452948|NCT02936752|564752510|FG001|Overall Study|Physician Decision|0|||
156452949|NCT02936752|564752509|FG000|Overall Study|Withdrawal by Subject|0|||
156452950|NCT02936752|564752510|FG001|Overall Study|Withdrawal by Subject|2|||
156452951|NCT05894577|564752513|FG000|Overall Study|No receipt of study drug|14|||
156452952|NCT05894577|564752514|FG001|Overall Study|No receipt of study drug|13|||
156452953|NCT05894577|564752513|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
156452954|NCT05894577|564752514|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
156452955|NCT05894577|564752513|FG000|Overall Study|Screen Fail|2|||
156452956|NCT05894577|564752514|FG001|Overall Study|Screen Fail|0|||
156452957|NCT05894577|564752513|FG000|Overall Study|Study drug recall|86|||
156452958|NCT05894577|564752514|FG001|Overall Study|Study drug recall|63|||
156452959|NCT05292365|564752519|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
156452960|NCT05292365|564752520|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
156452961|NCT05292365|564752521|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
156452962|NCT05292365|564752522|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
156452963|NCT05282173|564752523|FG000|Overall Study|Missed|3|||
156452964|NCT05282173|564752524|FG001|Overall Study|Missed|2|||
156452965|NCT05282173|564752525|FG002|Overall Study|Missed|4|||
156452966|NCT02023866|564752536|FG000|Overall Study|Non-compliance|2|||
156452967|NCT02023866|564752536|FG000|Overall Study|Adverse Event|3|||
156452968|NCT02023866|564752536|FG000|Overall Study|Withdrawal by Subject|1|||
156452969|NCT01798498|564752544|FG000|Overall Study|Lost to Follow-up|1|||
156452970|NCT03524118|564752551|FG000|Overall Study|Lost to Follow-up|0|||
156452971|NCT03524118|564752552|FG001|Overall Study|Lost to Follow-up|0|||
156452972|NCT03524118|564752553|FG002|Overall Study|Lost to Follow-up|0|||
156452973|NCT03524118|564752554|FG003|Overall Study|Lost to Follow-up|0|||
156452974|NCT03524118|564752555|FG004|Overall Study|Lost to Follow-up|1|||
156452975|NCT03524118|564752556|FG005|Overall Study|Lost to Follow-up|0|||
156452976|NCT03524118|564752551|FG000|Overall Study|Other|0|||
156452977|NCT03524118|564752552|FG001|Overall Study|Other|1|||
156452978|NCT03524118|564752553|FG002|Overall Study|Other|0|||
156452979|NCT03524118|564752554|FG003|Overall Study|Other|0|||
156452980|NCT03524118|564752555|FG004|Overall Study|Other|1|||
156452981|NCT03524118|564752556|FG005|Overall Study|Other|1|||
156452982|NCT03524118|564752551|FG000|Overall Study|Physician Decision|0|||
156452983|NCT03524118|564752552|FG001|Overall Study|Physician Decision|0|||
156452984|NCT03524118|564752553|FG002|Overall Study|Physician Decision|0|||
156452985|NCT03524118|564752554|FG003|Overall Study|Physician Decision|0|||
156452986|NCT03524118|564752555|FG004|Overall Study|Physician Decision|1|||
156452987|NCT03524118|564752556|FG005|Overall Study|Physician Decision|0|||
156452988|NCT03524118|564752551|FG000|Overall Study|Protocol Violation|0|||
156452989|NCT03524118|564752552|FG001|Overall Study|Protocol Violation|0|||
156452990|NCT03524118|564752553|FG002|Overall Study|Protocol Violation|1|||
156452991|NCT03524118|564752554|FG003|Overall Study|Protocol Violation|0|||
156452992|NCT03524118|564752555|FG004|Overall Study|Protocol Violation|1|||
156452993|NCT03524118|564752556|FG005|Overall Study|Protocol Violation|0|||
156452994|NCT03524118|564752551|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156452995|NCT03524118|564752552|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156452996|NCT03524118|564752553|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156452997|NCT03524118|564752554|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
156452998|NCT03524118|564752555|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
156452999|NCT03524118|564752556|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156453000|NCT01437709|564752559|FG000|Overall Study|Adverse Event|0|||
156453001|NCT01437709|564752560|FG001|Overall Study|Adverse Event|1|||
156453002|NCT01437709|564752561|FG002|Overall Study|Adverse Event|0|||
156725849|NCT03194542|565742336|FG000|Overall Study|Loss of Response|4|||
156725850|NCT03194542|565742337|FG001|Overall Study|Loss of Response|2|||
156725851|NCT03194542|565742338|FG002|Overall Study|Loss of Response|3|||
156725852|NCT03194542|565742339|FG003|Overall Study|Loss of Response|4|||
156725853|NCT03194542|565742336|FG000|Overall Study|Physician Decision|0|||
156725854|NCT03194542|565742337|FG001|Overall Study|Physician Decision|1|||
156725855|NCT03194542|565742338|FG002|Overall Study|Physician Decision|0|||
156453003|NCT01437709|564752559|FG000|Overall Study|Pt trasnferred care|0|||
156453004|NCT01437709|564752560|FG001|Overall Study|Pt trasnferred care|1|||
156453005|NCT01437709|564752561|FG002|Overall Study|Pt trasnferred care|0|||
156453006|NCT04091750|564752562|FG000|Overall Study|Adverse Event|4|||
156453007|NCT04091750|564752562|FG000|Overall Study|Withdrawal by Subject|1|||
156453008|NCT02319759|564752563|FG000|Week 0 - 16|Lack of Efficacy|1|||
156725856|NCT03194542|565742339|FG003|Overall Study|Physician Decision|0|||
156725857|NCT03194542|565742336|FG000|Overall Study|Lack of Efficacy|2|||
156453009|NCT02319759|564752564|FG001|Week 0 - 16|Lack of Efficacy|0|||
156453010|NCT02319759|564752565|FG002|Week 0 - 16|Lack of Efficacy|0|||
156453011|NCT02319759|564752566|FG003|Week 0 - 16|Lack of Efficacy|0|||
156453012|NCT02319759|564752567|FG004|Week 0 - 16|Lack of Efficacy|0|||
156453013|NCT02319759|564752563|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
156453014|NCT02319759|564752564|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
156453015|NCT02319759|564752565|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
156453016|NCT02319759|564752566|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
156453017|NCT02319759|564752567|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
156453018|NCT02319759|564752563|FG000|Week 16 - 24|Lack of Efficacy|1|||
156453019|NCT02319759|564752564|FG001|Week 16 - 24|Lack of Efficacy|0|||
156453020|NCT02319759|564752565|FG002|Week 16 - 24|Lack of Efficacy|1|||
156453021|NCT02319759|564752566|FG003|Week 16 - 24|Lack of Efficacy|0|||
156453022|NCT02319759|564752567|FG004|Week 16 - 24|Lack of Efficacy|0|||
156453023|NCT02319759|564752563|FG000|Week 16 - 24|Lost to Follow-up|1|||
156453024|NCT02319759|564752564|FG001|Week 16 - 24|Lost to Follow-up|0|||
156453025|NCT02319759|564752565|FG002|Week 16 - 24|Lost to Follow-up|0|||
156453026|NCT02319759|564752566|FG003|Week 16 - 24|Lost to Follow-up|0|||
156453027|NCT02319759|564752567|FG004|Week 16 - 24|Lost to Follow-up|0|||
156453028|NCT02319759|564752563|FG000|Week 16 - 24|Withdrawal by Subject|0|||
156453029|NCT02319759|564752564|FG001|Week 16 - 24|Withdrawal by Subject|0|||
156453030|NCT02319759|564752565|FG002|Week 16 - 24|Withdrawal by Subject|2|||
156453031|NCT02319759|564752566|FG003|Week 16 - 24|Withdrawal by Subject|0|||
156453032|NCT02319759|564752567|FG004|Week 16 - 24|Withdrawal by Subject|0|||
156453033|NCT02319759|564752563|FG000|Week 24 - 56|Adverse Event|0|||
156453034|NCT02319759|564752564|FG001|Week 24 - 56|Adverse Event|0|||
156453035|NCT02319759|564752565|FG002|Week 24 - 56|Adverse Event|2|||
156453036|NCT02319759|564752566|FG003|Week 24 - 56|Adverse Event|0|||
156453037|NCT02319759|564752567|FG004|Week 24 - 56|Adverse Event|0|||
156453038|NCT02319759|564752563|FG000|Week 24 - 56|Lack of Efficacy|0|||
156453039|NCT02319759|564752564|FG001|Week 24 - 56|Lack of Efficacy|0|||
156453040|NCT02319759|564752565|FG002|Week 24 - 56|Lack of Efficacy|0|||
156453041|NCT02319759|564752566|FG003|Week 24 - 56|Lack of Efficacy|2|||
156453042|NCT02319759|564752567|FG004|Week 24 - 56|Lack of Efficacy|1|||
156453043|NCT02319759|564752563|FG000|Week 24 - 56|Withdrawal by Subject|0|||
156453044|NCT02319759|564752564|FG001|Week 24 - 56|Withdrawal by Subject|1|||
156453045|NCT02319759|564752565|FG002|Week 24 - 56|Withdrawal by Subject|0|||
156453046|NCT02319759|564752566|FG003|Week 24 - 56|Withdrawal by Subject|0|||
156453047|NCT02319759|564752567|FG004|Week 24 - 56|Withdrawal by Subject|0|||
156453048|NCT02319759|564752563|FG000|Week 24 - 56|Lost to Follow-up|0|||
156453049|NCT02319759|564752564|FG001|Week 24 - 56|Lost to Follow-up|0|||
156453050|NCT02319759|564752565|FG002|Week 24 - 56|Lost to Follow-up|0|||
156453051|NCT02319759|564752566|FG003|Week 24 - 56|Lost to Follow-up|0|||
156453052|NCT02319759|564752567|FG004|Week 24 - 56|Lost to Follow-up|1|||
156453053|NCT01959425|564752568|FG000|Overall Study|Withdrawal by Subject|5|||
156453054|NCT01959425|564752569|FG001|Overall Study|Withdrawal by Subject|4|||
156453055|NCT01959425|564752568|FG000|Overall Study|Lost to Follow-up|1|||
156725858|NCT03194542|565742337|FG001|Overall Study|Lack of Efficacy|2|||
156725859|NCT03194542|565742338|FG002|Overall Study|Lack of Efficacy|2|||
156725860|NCT03194542|565742339|FG003|Overall Study|Lack of Efficacy|6|||
156725861|NCT03194542|565742336|FG000|Overall Study|Withdrawal by Subject|2|||
156725862|NCT03194542|565742337|FG001|Overall Study|Withdrawal by Subject|1|||
156453056|NCT01959425|564752569|FG001|Overall Study|Lost to Follow-up|0|||
156453057|NCT01959425|564752568|FG000|Overall Study|Discontinued Subjects|6|||
156453058|NCT01959425|564752569|FG001|Overall Study|Discontinued Subjects|4|||
156453059|NCT02262728|564752575|FG000|Follow-up Phase (3 Years)|Death|0|||
156453060|NCT02262728|564752576|FG001|Follow-up Phase (3 Years)|Death|1|||
156453061|NCT02262728|564752575|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
156453062|NCT02262728|564752576|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
156453063|NCT02262728|564752575|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
156453064|NCT02262728|564752576|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
156453065|NCT04625283|564752577|FG000|Overall Study|post randomization exclusion|28|||
156453066|NCT04625283|564752578|FG001|Overall Study|post randomization exclusion|20|||
156725863|NCT03194542|565742338|FG002|Overall Study|Withdrawal by Subject|5|||
156725864|NCT03194542|565742339|FG003|Overall Study|Withdrawal by Subject|4|||
156725865|NCT03194542|565742336|FG000|Overall Study|Progressive Disease|1|||
156725866|NCT03194542|565742337|FG001|Overall Study|Progressive Disease|0|||
156725867|NCT03194542|565742338|FG002|Overall Study|Progressive Disease|1|||
156725868|NCT03194542|565742339|FG003|Overall Study|Progressive Disease|1|||
156453067|NCT01824394|564752579|FG000|Overall Study|Early Termination|1|||
156453068|NCT01824394|564752580|FG001|Overall Study|Early Termination|1|||
156453069|NCT01824394|564752581|FG002|Overall Study|Early Termination|3|||
156453070|NCT01824394|564752579|FG000|Overall Study|Withdrawn due to Study Termination|91|||
156725869|NCT03194542|565742336|FG000|Overall Study|Adverse Event|1|||
156453071|NCT01824394|564752580|FG001|Overall Study|Withdrawn due to Study Termination|83|||
156453072|NCT01824394|564752581|FG002|Overall Study|Withdrawn due to Study Termination|41|||
156725870|NCT03194542|565742337|FG001|Overall Study|Adverse Event|2|||
156725871|NCT03194542|565742338|FG002|Overall Study|Adverse Event|0|||
156453073|NCT01824394|564752579|FG000|Overall Study|Lost to Follow-up|0|||
156453074|NCT01824394|564752580|FG001|Overall Study|Lost to Follow-up|9|||
156453075|NCT01824394|564752581|FG002|Overall Study|Lost to Follow-up|3|||
156453076|NCT01824394|564752579|FG000|Overall Study|Death|3|||
156453077|NCT01824394|564752580|FG001|Overall Study|Death|2|||
156453078|NCT01824394|564752581|FG002|Overall Study|Death|4|||
156453079|NCT01824394|564752579|FG000|Overall Study|Discontinued Subjects|1|||
156453080|NCT01824394|564752580|FG001|Overall Study|Discontinued Subjects|1|||
156453081|NCT01824394|564752581|FG002|Overall Study|Discontinued Subjects|2|||
156725872|NCT03194542|565742339|FG003|Overall Study|Adverse Event|5|||
156725873|NCT03194542|565742336|FG000|Overall Study|Death|1|||
156725874|NCT03194542|565742337|FG001|Overall Study|Death|2|||
156725875|NCT03194542|565742338|FG002|Overall Study|Death|0|||
156725876|NCT03194542|565742339|FG003|Overall Study|Death|5|||
156725877|NCT03194542|565742336|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
156725878|NCT03194542|565742337|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
156725879|NCT03194542|565742338|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
156725880|NCT03194542|565742339|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
156725881|NCT02712554|565742342|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
156725882|NCT02712554|565742343|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
156725883|NCT02712554|565742342|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
156725884|NCT02712554|565742343|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
156725885|NCT02712554|565742342|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
156795109|NCT04197583|566002873|FG000|Overall Study|Withdrawal by Subject|1|||
156795110|NCT04197583|566002874|FG001|Overall Study|Withdrawal by Subject|1|||
156795111|NCT04197583|566002873|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
156795112|NCT04197583|566002874|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
156795113|NCT04197583|566002873|FG000|Overall Study|Screen Failure|0|||
156795114|NCT04197583|566002874|FG001|Overall Study|Screen Failure|20|||
156795115|NCT00637156|566002875|FG000|Overall Study|Withdrawal by Subject|0|||
156795116|NCT00637156|566002876|FG001|Overall Study|Withdrawal by Subject|7|||
156795117|NCT00637156|566002875|FG000|Overall Study|Death|0|||
156795118|NCT00637156|566002876|FG001|Overall Study|Death|1|||
156795119|NCT00637156|566002875|FG000|Overall Study|Lost to Follow-up|10|||
156795120|NCT00637156|566002876|FG001|Overall Study|Lost to Follow-up|16|||
156795121|NCT02679274|566002877|FG000|Overall Study|Withdrawal by Subject|1|||
156795122|NCT02679274|566002878|FG001|Overall Study|Withdrawal by Subject|0|||
156795123|NCT03193437|566002885|FG000|Overall Study|Adverse Event|4|||
156795124|NCT03193437|566002885|FG000|Overall Study|Withdrawal by Subject|2|||
156795125|NCT03193437|566002885|FG000|Overall Study|Disease Progression|2|||
156795126|NCT04976855|566002886|FG000|Part I|Withdrawal by Subject|0|||
156795127|NCT04976855|566002887|FG001|Part I|Withdrawal by Subject|1|||
156795128|NCT04976855|566002888|FG002|Part I|Withdrawal by Subject|0|||
156795129|NCT04976855|566002889|FG003|Part I|Withdrawal by Subject|0|||
156795130|NCT04976855|566002890|FG004|Part I|Withdrawal by Subject|0|||
156795131|NCT04976855|566002891|FG005|Part I|Withdrawal by Subject|0|||
156795132|NCT04976855|566002892|FG006|Part I|Withdrawal by Subject|0|||
156795133|NCT04976855|566002886|FG000|Part II|Adverse Event|0|||
156795134|NCT04976855|566002887|FG001|Part II|Adverse Event|0|||
156795135|NCT04976855|566002888|FG002|Part II|Adverse Event|0|||
156795136|NCT04976855|566002889|FG003|Part II|Adverse Event|1|||
156795137|NCT04976855|566002890|FG004|Part II|Adverse Event|0|||
156795138|NCT04976855|566002891|FG005|Part II|Adverse Event|0|||
156795139|NCT04976855|566002892|FG006|Part II|Adverse Event|0|||
156795140|NCT04976855|566002886|FG000|Part II|Withdrawal by Subject|0|||
156795141|NCT04976855|566002887|FG001|Part II|Withdrawal by Subject|0|||
156795142|NCT04976855|566002888|FG002|Part II|Withdrawal by Subject|0|||
156875956|NCT00114517|566303745|FG002|Overall Study|Lost to Follow-up|2|||
156725886|NCT02712554|565742343|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
156875957|NCT00114517|566303746|FG003|Overall Study|Lost to Follow-up|1|||
156875958|NCT00114517|566303743|FG000|Overall Study|Too busy|3|||
156725887|NCT02712554|565742342|FG000|Part B: Qualification Phase|Adverse Event|0|||
156725888|NCT02712554|565742343|FG001|Part B: Qualification Phase|Adverse Event|1|||
156725889|NCT02712554|565742342|FG000|Part B: Treatment Phase|Adverse Event|0|||
156795143|NCT04976855|566002889|FG003|Part II|Withdrawal by Subject|0|||
156795144|NCT04976855|566002890|FG004|Part II|Withdrawal by Subject|1|||
156875959|NCT00114517|566303744|FG001|Overall Study|Too busy|1|||
156453082|NCT01824394|564752579|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
156453083|NCT01824394|564752580|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
156453084|NCT01824394|564752581|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
156795145|NCT04976855|566002891|FG005|Part II|Withdrawal by Subject|0|||
156795146|NCT04976855|566002892|FG006|Part II|Withdrawal by Subject|0|||
156795147|NCT04976855|566002886|FG000|Part II|Lost to Follow-up|0|||
156795148|NCT04976855|566002887|FG001|Part II|Lost to Follow-up|0|||
156795149|NCT04976855|566002888|FG002|Part II|Lost to Follow-up|0|||
156795150|NCT04976855|566002889|FG003|Part II|Lost to Follow-up|0|||
156875960|NCT00114517|566303745|FG002|Overall Study|Too busy|1|||
156453085|NCT02619838|564752582|FG000|Overall Study|Lost to Follow-up|9|||
156453086|NCT02619838|564752582|FG000|Overall Study|Withdrawal by Subject|15|||
156453087|NCT00686335|564752583|FG000|Run-in Period|Adverse Event|1|||
156453088|NCT00686335|564752583|FG000|Run-in Period|asthma exacerbation|1|||
156453089|NCT00686335|564752583|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
156453090|NCT06037369|564752588|FG000|Overall Study|Lost to Follow-up|0|||
156725890|NCT02712554|565742343|FG001|Part B: Treatment Phase|Adverse Event|1|||
156725891|NCT02712554|565742342|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
156725892|NCT02712554|565742343|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
156725893|NCT02712554|565742342|FG000|Part B: Treatment Phase|Other|0|||
156725894|NCT02712554|565742343|FG001|Part B: Treatment Phase|Other|1|||
156725895|NCT03859427|565742345|FG000|Overall Study|Withdrawal by Subject|4|||
156725896|NCT03859427|565742346|FG001|Overall Study|Withdrawal by Subject|7|||
156725897|NCT03859427|565742345|FG000|Overall Study|Decision by sponsor|0|||
156725898|NCT03859427|565742346|FG001|Overall Study|Decision by sponsor|3|||
156725899|NCT03859427|565742345|FG000|Overall Study|Lost to Follow-up|3|||
156725900|NCT03859427|565742346|FG001|Overall Study|Lost to Follow-up|2|||
156725901|NCT03859427|565742345|FG000|Overall Study|Death|22|||
156795151|NCT04976855|566002890|FG004|Part II|Lost to Follow-up|0|||
156795152|NCT04976855|566002891|FG005|Part II|Lost to Follow-up|1|||
156795153|NCT04976855|566002892|FG006|Part II|Lost to Follow-up|0|||
156795154|NCT05487378|566002893|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
156795155|NCT05487378|566002894|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
156795156|NCT05487378|566002893|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
156795157|NCT05487378|566002894|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
156795158|NCT01385995|566002901|FG000|Period 1, 2 Months|Physician Decision|1|||
156795159|NCT01385995|566002902|FG001|Period 1, 2 Months|Physician Decision|0|||
156795160|NCT02414841|566002903|FG000|Overall Study|Withdrawal by Subject|7|||
156795161|NCT02414841|566002904|FG001|Overall Study|Withdrawal by Subject|5|||
156795162|NCT02414841|566002903|FG000|Overall Study|Lost to Follow-up|13|||
156795163|NCT02414841|566002904|FG001|Overall Study|Lost to Follow-up|6|||
156795164|NCT02414841|566002903|FG000|Overall Study|Death|17|||
156795165|NCT02414841|566002904|FG001|Overall Study|Death|14|||
156795166|NCT02414841|566002903|FG000|Overall Study|Received a Kidney Transplant|13|||
156795167|NCT02414841|566002904|FG001|Overall Study|Received a Kidney Transplant|4|||
156795168|NCT02414841|566002903|FG000|Overall Study|Randomized But Not Treated|6|||
156795169|NCT02414841|566002904|FG001|Overall Study|Randomized But Not Treated|4|||
156795170|NCT00112385|566002905|FG000|Overall Study|Lost to Follow-up|1|||
156795171|NCT00112385|566002906|FG001|Overall Study|Lost to Follow-up|0|||
156795172|NCT00112385|566002905|FG000|Overall Study|Withdrawal by Subject|0|||
156795173|NCT00112385|566002906|FG001|Overall Study|Withdrawal by Subject|1|||
156795174|NCT03514134|566004149|FG000|Overall Study|Lost to Follow-up|0|||
156795175|NCT03514134|566004150|FG001|Overall Study|Lost to Follow-up|1|||
156795176|NCT01373281|566004152|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
156795177|NCT01373281|566004153|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
156795178|NCT01373281|566004152|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
156795179|NCT01373281|566004153|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
156795180|NCT01373281|566004152|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
156795181|NCT01373281|566004153|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
156795182|NCT01373281|566004152|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
156795183|NCT01373281|566004153|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
156795184|NCT01373281|566004152|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
156795185|NCT01373281|566004153|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
156795186|NCT01373281|566004152|FG000|Surveillance Expansion Period|Protocol Violation|9|||
156795187|NCT01373281|566004153|FG001|Surveillance Expansion Period|Protocol Violation|1|||
156795188|NCT01373281|566004152|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
156795189|NCT01373281|566004153|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
156795190|NCT01373281|566004152|FG000|Surveillance Expansion Period|Serious adverse event|3|||
156875961|NCT00114517|566303746|FG003|Overall Study|Too busy|2|||
156453091|NCT06037369|564752589|FG001|Overall Study|Lost to Follow-up|1|||
156453092|NCT05783102|564752590|FG000|Overall Study|Lost to Follow-up|1|||
156453093|NCT05783102|564752590|FG000|Overall Study|Withdrawal by Subject|2|||
156725902|NCT03859427|565742346|FG001|Overall Study|Death|25|||
156725903|NCT02503540|565742347|FG000|Overall Study|Death|2|||
156875962|NCT00114517|566303743|FG000|Overall Study|Moved from area|0|||
156725904|NCT02503540|565742347|FG000|Overall Study|Withdrawal by Subject|1|||
156795191|NCT01373281|566004153|FG001|Surveillance Expansion Period|Serious adverse event|4|||
156795192|NCT01397253|566004154|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
156795193|NCT01397253|566004155|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
156795194|NCT02296476|566004156|FG000|Overall Study|Disease Progression|6|||
156795195|NCT02296476|566004157|FG001|Overall Study|Disease Progression|4|||
156795196|NCT02296476|566004158|FG002|Overall Study|Disease Progression|2|||
156453094|NCT04505904|564752591|FG000|Overall Study|Withdrawal by Subject|1|||
156453095|NCT04505904|564752592|FG001|Overall Study|Withdrawal by Subject|2|||
156725905|NCT00564850|565742348|FG000|Overall Study|Protocol Violation|2|||
156336046|NCT00347360|564328206|FG014|Overall Study|Lack of Efficacy|0|||
156336047|NCT00347360|564328192|FG000|Overall Study|Reason not listed/blank|1|||
156453096|NCT04505904|564752593|FG002|Overall Study|Withdrawal by Subject|0|||
156533477|NCT00733304|565048802|FG001|Overall Study|Withdrawal by Subject|1|||
156533478|NCT00733304|565048803|FG002|Overall Study|Withdrawal by Subject|0|||
156725906|NCT02640664|565742349|FG000|Epoch 1|Withdrawal of informed consent|1|||
156725907|NCT02640664|565742350|FG001|Epoch 1|Withdrawal of informed consent|0|||
156725908|NCT02640664|565742351|FG002|Epoch 1|Withdrawal of informed consent|0|||
156725909|NCT02640664|565742349|FG000|Epoch 1|Death|0|||
156725910|NCT02640664|565742350|FG001|Epoch 1|Death|0|||
156725911|NCT02640664|565742351|FG002|Epoch 1|Death|1|||
156453097|NCT04505904|564752594|FG003|Overall Study|Withdrawal by Subject|0|||
156453098|NCT04505904|564752591|FG000|Overall Study|Physician Decision|1|||
156453099|NCT04505904|564752592|FG001|Overall Study|Physician Decision|0|||
156453100|NCT04505904|564752593|FG002|Overall Study|Physician Decision|0|||
156453101|NCT04505904|564752594|FG003|Overall Study|Physician Decision|0|||
156453102|NCT04505904|564752591|FG000|Overall Study|Adverse Event|0|||
156453103|NCT04505904|564752592|FG001|Overall Study|Adverse Event|1|||
156453104|NCT04505904|564752593|FG002|Overall Study|Adverse Event|0|||
156453105|NCT04505904|564752594|FG003|Overall Study|Adverse Event|0|||
156725912|NCT02640664|565742349|FG000|Epoch 2|Withdrawal of informed consent|3|||
156725913|NCT02640664|565742350|FG001|Epoch 2|Withdrawal of informed consent|4|||
156725914|NCT02640664|565742351|FG002|Epoch 2|Withdrawal of informed consent|2|||
156725915|NCT02640664|565742349|FG000|Epoch 2|Subject/guardian decision|0|||
156725916|NCT02640664|565742350|FG001|Epoch 2|Subject/guardian decision|2|||
156725917|NCT02640664|565742351|FG002|Epoch 2|Subject/guardian decision|2|||
156725918|NCT02640664|565742349|FG000|Epoch 2|Lost to Follow-up|3|||
156725919|NCT02640664|565742350|FG001|Epoch 2|Lost to Follow-up|4|||
156725920|NCT02640664|565742351|FG002|Epoch 2|Lost to Follow-up|1|||
156725921|NCT02640664|565742349|FG000|Epoch 2|Death|0|||
156725922|NCT02640664|565742350|FG001|Epoch 2|Death|0|||
156725923|NCT02640664|565742351|FG002|Epoch 2|Death|1|||
156725924|NCT00979654|565742354|FG000|Overall Study|Lost to Follow-up|1|||
156725925|NCT00979654|565742354|FG000|Overall Study|Withdrawal by Subject|22|||
156725926|NCT00979654|565742354|FG000|Overall Study|Death|1|||
156725927|NCT00979654|565742354|FG000|Overall Study|Lack of Efficacy|6|||
156725928|NCT00979654|565742354|FG000|Overall Study|Adverse Event|1|||
156725929|NCT00979654|565742354|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
156725930|NCT00979654|565742354|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
156725931|NCT00979654|565742354|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
156725932|NCT00979654|565742354|FG000|Overall Study|Serious Adverse Event|1|||
156725933|NCT00979654|565742354|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
156725934|NCT01129557|565742355|FG000|Overall Study|Adverse Event|1|||
156725935|NCT01129557|565742356|FG001|Overall Study|Adverse Event|2|||
156725936|NCT01129557|565742357|FG002|Overall Study|Adverse Event|2|||
156725937|NCT01129557|565742355|FG000|Overall Study|Novartis terminated study early|3|||
156725938|NCT01129557|565742356|FG001|Overall Study|Novartis terminated study early|3|||
156725939|NCT01129557|565742357|FG002|Overall Study|Novartis terminated study early|2|||
156725940|NCT01486446|565742358|FG000|Overall Study|Adverse Event|1|||
156725941|NCT01486446|565742359|FG001|Overall Study|Adverse Event|0|||
156725942|NCT01445730|565742360|FG000|Overall Study|Adverse Event|1|||
156725943|NCT01445730|565742360|FG000|Overall Study|For the advice of a dentist|1|||
156725944|NCT01445730|565742360|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
156725945|NCT01611883|565742361|FG000|Overall Study|Adverse Event|1|||
156725946|NCT01611883|565742362|FG001|Overall Study|Adverse Event|1|||
156725947|NCT00734994|565742364|FG000|Overall Study|Withdrawal by Subject|1|||
156725948|NCT05966584|565742368|FG000|Overall Study|Lost to Follow-up|1|||
156725949|NCT05343000|565744339|FG000|Overall Study|Physician Decision|2|||
156725950|NCT04432831|565744340|FG000|Overall Study|Withdrawal by Subject|24|||
156725951|NCT04432831|565744341|FG001|Overall Study|Withdrawal by Subject|28|||
156725952|NCT04432831|565744342|FG002|Overall Study|Withdrawal by Subject|21|||
156725953|NCT04432831|565744340|FG000|Overall Study|Death|23|||
156875963|NCT00114517|566303744|FG001|Overall Study|Moved from area|3|||
156453106|NCT04277442|564752597|FG000|Overall Study|Death|1|||
156875964|NCT00114517|566303745|FG002|Overall Study|Moved from area|2|||
156875965|NCT00114517|566303746|FG003|Overall Study|Moved from area|1|||
156453107|NCT06181760|564752598|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
156533479|NCT01296035|565048815|FG000|Overall Study|Withdrawal by Subject|1|||
156725954|NCT04432831|565744341|FG001|Overall Study|Death|23|||
156725955|NCT04432831|565744342|FG002|Overall Study|Death|17|||
156875966|NCT00114517|566303743|FG000|Overall Study|Did not want estradiol|1|||
156725956|NCT04432831|565744340|FG000|Overall Study|Lost to Follow-up|15|||
156725957|NCT04432831|565744341|FG001|Overall Study|Lost to Follow-up|15|||
156725958|NCT04432831|565744342|FG002|Overall Study|Lost to Follow-up|12|||
156725959|NCT04432831|565744340|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
156875967|NCT00114517|566303744|FG001|Overall Study|Did not want estradiol|1|||
156453108|NCT06181760|564752599|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
156453109|NCT06181760|564752600|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
156453110|NCT06181760|564752601|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
156453111|NCT03524612|564752603|FG000|Overall Study|Lack of Efficacy|10|||
156453112|NCT03524612|564752603|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
156453113|NCT03524612|564752603|FG000|Overall Study|Adverse Event|10|||
156453114|NCT03524612|564752603|FG000|Overall Study|Withdrawal by Subject|7|||
156453115|NCT03524612|564752603|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
156453116|NCT03524612|564752603|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
156453117|NCT03524612|564752603|FG000|Overall Study|New therapy for study indication|6|||
156453118|NCT03524612|564752603|FG000|Overall Study|Death|3|||
156453119|NCT03524612|564752603|FG000|Overall Study|Lost to Follow-up|2|||
156453120|NCT03524612|564752603|FG000|Overall Study|Protocol Violation|1|||
156453121|NCT04938492|564752604|FG000|Overall Study|Lost to Follow-up|17|||
156453122|NCT04938492|564752605|FG001|Overall Study|Lost to Follow-up|18|||
156453123|NCT05084508|564752606|FG000|Overall Study|Lost to Follow-up|6|||
156453124|NCT05084508|564752607|FG001|Overall Study|Lost to Follow-up|3|||
156453125|NCT05084508|564752608|FG002|Overall Study|Lost to Follow-up|7|||
156453126|NCT05084508|564752609|FG003|Overall Study|Lost to Follow-up|3|||
156453127|NCT05084508|564752606|FG000|Overall Study|Withdrawal by Subject|0|||
156453128|NCT05084508|564752607|FG001|Overall Study|Withdrawal by Subject|2|||
156453129|NCT05084508|564752608|FG002|Overall Study|Withdrawal by Subject|3|||
156453130|NCT05084508|564752609|FG003|Overall Study|Withdrawal by Subject|1|||
156453131|NCT05084508|564752606|FG000|Overall Study|Other|0|||
156453132|NCT05084508|564752607|FG001|Overall Study|Other|0|||
156453133|NCT05084508|564752608|FG002|Overall Study|Other|0|||
156453134|NCT05084508|564752609|FG003|Overall Study|Other|1|||
156453135|NCT04137289|564752610|FG000|Overall Study|Death|0|||
156453136|NCT04137289|564752611|FG001|Overall Study|Death|0|||
156453137|NCT04137289|564752612|FG002|Overall Study|Death|0|||
156453138|NCT04137289|564752613|FG003|Overall Study|Death|0|||
156453139|NCT04137289|564752614|FG004|Overall Study|Death|0|||
156453140|NCT04137289|564752615|FG005|Overall Study|Death|0|||
156453141|NCT04137289|564752616|FG006|Overall Study|Death|1|||
156453142|NCT04137289|564752617|FG007|Overall Study|Death|0|||
156453143|NCT04137289|564752618|FG008|Overall Study|Death|0|||
156453144|NCT04137289|564752610|FG000|Overall Study|Clinical disease progression|0|||
156453145|NCT04137289|564752611|FG001|Overall Study|Clinical disease progression|0|||
156336048|NCT00347360|564328193|FG001|Overall Study|Reason not listed/blank|0|||
156453146|NCT04137289|564752612|FG002|Overall Study|Clinical disease progression|0|||
156453147|NCT04137289|564752613|FG003|Overall Study|Clinical disease progression|4|||
156453148|NCT04137289|564752614|FG004|Overall Study|Clinical disease progression|4|||
156453149|NCT04137289|564752615|FG005|Overall Study|Clinical disease progression|2|||
156453150|NCT04137289|564752616|FG006|Overall Study|Clinical disease progression|5|||
156453151|NCT04137289|564752617|FG007|Overall Study|Clinical disease progression|1|||
156453152|NCT04137289|564752618|FG008|Overall Study|Clinical disease progression|0|||
156453153|NCT04137289|564752610|FG000|Overall Study|Lost to Follow-up|0|||
156453154|NCT04137289|564752611|FG001|Overall Study|Lost to Follow-up|0|||
156453155|NCT04137289|564752612|FG002|Overall Study|Lost to Follow-up|0|||
156453156|NCT04137289|564752613|FG003|Overall Study|Lost to Follow-up|1|||
156453157|NCT04137289|564752614|FG004|Overall Study|Lost to Follow-up|0|||
156453158|NCT04137289|564752615|FG005|Overall Study|Lost to Follow-up|0|||
156453159|NCT04137289|564752616|FG006|Overall Study|Lost to Follow-up|0|||
156453160|NCT04137289|564752617|FG007|Overall Study|Lost to Follow-up|0|||
156533480|NCT03085758|565048816|FG000|Overall Study|Death|26|||
156533481|NCT03085758|565048817|FG001|Overall Study|Death|24|||
156795197|NCT00980044|566004163|FG000|Overall Study|Withdrawal by Subject|5|||
156795198|NCT00980044|566004164|FG001|Overall Study|Withdrawal by Subject|7|||
156795199|NCT00980044|566004165|FG002|Overall Study|Withdrawal by Subject|3|||
156795200|NCT00980044|566004163|FG000|Overall Study|Protocol Violation|0|||
156795201|NCT00980044|566004164|FG001|Overall Study|Protocol Violation|0|||
156795202|NCT00980044|566004165|FG002|Overall Study|Protocol Violation|2|||
156795203|NCT03502681|566004168|FG000|Overall Study|Adverse Event|1|||
156795204|NCT03502681|566004169|FG001|Overall Study|Adverse Event|1|||
156795205|NCT03502681|566004168|FG000|Overall Study|Disease Progression|2|||
156795206|NCT03502681|566004169|FG001|Overall Study|Disease Progression|1|||
156795207|NCT00442702|566004170|FG000|Titration Period|Adverse Event|2|||
156336049|NCT00347360|564328194|FG002|Overall Study|Reason not listed/blank|0|||
156336050|NCT00347360|564328195|FG003|Overall Study|Reason not listed/blank|0|||
156453161|NCT04137289|564752618|FG008|Overall Study|Lost to Follow-up|0|||
156453162|NCT04137289|564752610|FG000|Overall Study|Adverse Event|0|||
156453163|NCT04137289|564752611|FG001|Overall Study|Adverse Event|0|||
156453164|NCT04137289|564752612|FG002|Overall Study|Adverse Event|1|||
156453165|NCT04137289|564752613|FG003|Overall Study|Adverse Event|0|||
156453166|NCT04137289|564752614|FG004|Overall Study|Adverse Event|0|||
156453167|NCT04137289|564752615|FG005|Overall Study|Adverse Event|1|||
156453168|NCT04137289|564752616|FG006|Overall Study|Adverse Event|0|||
156453169|NCT04137289|564752617|FG007|Overall Study|Adverse Event|0|||
156453170|NCT04137289|564752618|FG008|Overall Study|Adverse Event|0|||
156453171|NCT04137289|564752610|FG000|Overall Study|Lack of clinical benefit|0|||
156533482|NCT03085758|565048818|FG002|Overall Study|Death|53|||
156336051|NCT00347360|564328196|FG004|Overall Study|Reason not listed/blank|0|||
156336052|NCT00347360|564328197|FG005|Overall Study|Reason not listed/blank|0|||
156336053|NCT00347360|564328198|FG006|Overall Study|Reason not listed/blank|1|||
156336054|NCT00347360|564328199|FG007|Overall Study|Reason not listed/blank|0|||
156336055|NCT00347360|564328200|FG008|Overall Study|Reason not listed/blank|0|||
156336056|NCT00347360|564328201|FG009|Overall Study|Reason not listed/blank|0|||
156336057|NCT00347360|564328202|FG010|Overall Study|Reason not listed/blank|0|||
156336058|NCT00347360|564328203|FG011|Overall Study|Reason not listed/blank|0|||
156336059|NCT00347360|564328204|FG012|Overall Study|Reason not listed/blank|0|||
156336060|NCT00347360|564328205|FG013|Overall Study|Reason not listed/blank|1|||
156336061|NCT00347360|564328206|FG014|Overall Study|Reason not listed/blank|0|||
156336062|NCT00347360|564328192|FG000|Overall Study|Per sponsors instruction|0|||
156336063|NCT00347360|564328193|FG001|Overall Study|Per sponsors instruction|1|||
156336064|NCT00347360|564328194|FG002|Overall Study|Per sponsors instruction|0|||
156336065|NCT00347360|564328195|FG003|Overall Study|Per sponsors instruction|0|||
156336066|NCT00347360|564328196|FG004|Overall Study|Per sponsors instruction|0|||
156336067|NCT00347360|564328197|FG005|Overall Study|Per sponsors instruction|0|||
156336068|NCT00347360|564328198|FG006|Overall Study|Per sponsors instruction|0|||
156336069|NCT00347360|564328199|FG007|Overall Study|Per sponsors instruction|0|||
156336070|NCT00347360|564328200|FG008|Overall Study|Per sponsors instruction|0|||
156336071|NCT00347360|564328201|FG009|Overall Study|Per sponsors instruction|0|||
156336072|NCT00347360|564328202|FG010|Overall Study|Per sponsors instruction|0|||
156336073|NCT00347360|564328203|FG011|Overall Study|Per sponsors instruction|0|||
156336074|NCT00347360|564328204|FG012|Overall Study|Per sponsors instruction|0|||
156336075|NCT00347360|564328205|FG013|Overall Study|Per sponsors instruction|0|||
156336076|NCT00347360|564328206|FG014|Overall Study|Per sponsors instruction|0|||
156336077|NCT00347360|564328192|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
156336078|NCT00347360|564328193|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
156336079|NCT00347360|564328194|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
156336080|NCT00347360|564328195|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
156336081|NCT00347360|564328196|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
156336082|NCT00347360|564328197|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
156336083|NCT00347360|564328198|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
156336084|NCT00347360|564328199|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
156336085|NCT00347360|564328200|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
156336086|NCT00347360|564328201|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
156336087|NCT00347360|564328202|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
156336088|NCT00347360|564328203|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
156336089|NCT00347360|564328204|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
156336090|NCT00347360|564328205|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
156336091|NCT00347360|564328206|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
156795208|NCT00442702|566004171|FG001|Titration Period|Adverse Event|0|||
156336092|NCT00347360|564328192|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
156336093|NCT00347360|564328193|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
156336094|NCT00347360|564328194|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
156336095|NCT00347360|564328195|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
156336096|NCT00347360|564328196|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
156336097|NCT00347360|564328197|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
156336098|NCT00347360|564328198|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
156336099|NCT00347360|564328199|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
156336100|NCT00347360|564328200|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
156336101|NCT00347360|564328201|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
156795209|NCT00442702|566004170|FG000|Titration Period|Death|3|||
156795210|NCT00442702|566004171|FG001|Titration Period|Death|2|||
156795211|NCT00442702|566004170|FG000|Titration Period|Insufficient Therapeutic Response|1|||
156795212|NCT00442702|566004171|FG001|Titration Period|Insufficient Therapeutic Response|0|||
156795213|NCT00442702|566004170|FG000|Titration Period|Refused Treatment|4|||
156795214|NCT00442702|566004171|FG001|Titration Period|Refused Treatment|1|||
156795215|NCT00442702|566004170|FG000|Titration Period|Failure to return|1|||
156795216|NCT00442702|566004171|FG001|Titration Period|Failure to return|0|||
156795217|NCT00442702|566004170|FG000|Titration Period|Hospitalized in another hospital|1|||
156795218|NCT00442702|566004171|FG001|Titration Period|Hospitalized in another hospital|0|||
156795219|NCT00442702|566004170|FG000|Evaluation Period|Adverse Event|1|||
156795220|NCT00442702|566004171|FG001|Evaluation Period|Adverse Event|0|||
156795221|NCT00442702|566004170|FG000|Evaluation Period|Death|1|||
156795222|NCT00442702|566004171|FG001|Evaluation Period|Death|1|||
156336102|NCT00347360|564328202|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
156336103|NCT00347360|564328203|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
156795223|NCT00442702|566004170|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
156795224|NCT00442702|566004171|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
156795225|NCT00442702|566004170|FG000|Evaluation Period|Refused treatment|1|||
156453172|NCT04137289|564752611|FG001|Overall Study|Lack of clinical benefit|0|||
156453173|NCT04137289|564752612|FG002|Overall Study|Lack of clinical benefit|0|||
156453174|NCT04137289|564752613|FG003|Overall Study|Lack of clinical benefit|0|||
156453175|NCT04137289|564752614|FG004|Overall Study|Lack of clinical benefit|0|||
156453176|NCT04137289|564752615|FG005|Overall Study|Lack of clinical benefit|0|||
156453177|NCT04137289|564752616|FG006|Overall Study|Lack of clinical benefit|0|||
156453178|NCT04137289|564752617|FG007|Overall Study|Lack of clinical benefit|0|||
156453179|NCT04137289|564752618|FG008|Overall Study|Lack of clinical benefit|1|||
156453180|NCT04137289|564752610|FG000|Overall Study|Objective disease progression|1|||
156453181|NCT04137289|564752611|FG001|Overall Study|Objective disease progression|1|||
156725960|NCT04432831|565744341|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
156725961|NCT04432831|565744342|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
156725962|NCT04432831|565744340|FG000|Overall Study|Reason Not Specified|7|||
156725963|NCT04432831|565744341|FG001|Overall Study|Reason Not Specified|11|||
156725964|NCT04432831|565744342|FG002|Overall Study|Reason Not Specified|9|||
156725965|NCT04432831|565744340|FG000|Overall Study|Adverse Event|7|||
156725966|NCT04432831|565744341|FG001|Overall Study|Adverse Event|7|||
156453182|NCT04137289|564752612|FG002|Overall Study|Objective disease progression|6|||
156453183|NCT04137289|564752613|FG003|Overall Study|Objective disease progression|18|||
156453184|NCT04137289|564752614|FG004|Overall Study|Objective disease progression|12|||
156453185|NCT04137289|564752615|FG005|Overall Study|Objective disease progression|20|||
156453186|NCT04137289|564752616|FG006|Overall Study|Objective disease progression|18|||
156453187|NCT04137289|564752617|FG007|Overall Study|Objective disease progression|7|||
156453188|NCT04137289|564752618|FG008|Overall Study|Objective disease progression|6|||
156453189|NCT03931174|564752623|FG000|Providers|Staff left organization|26|||
156453190|NCT03931174|564752624|FG001|Providers|Staff left organization|25|||
156453191|NCT03931174|564752623|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
156725967|NCT04432831|565744342|FG002|Overall Study|Adverse Event|7|||
156725968|NCT04432831|565744340|FG000|Overall Study|Physician Decision|1|||
156453192|NCT03931174|564752624|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
156453193|NCT03931174|564752623|FG000|Providers|Lost to Follow-up|4|||
156453194|NCT03931174|564752624|FG001|Providers|Lost to Follow-up|4|||
156453195|NCT03931174|564752623|FG000|Patients|Post-consent screening failure|1|||
156453196|NCT03931174|564752624|FG001|Patients|Post-consent screening failure|1|||
156453197|NCT03931174|564752623|FG000|Patients|Death|1|||
156453198|NCT03931174|564752624|FG001|Patients|Death|1|||
156453199|NCT03931174|564752623|FG000|Patients|Lost to Follow-up|60|||
156453200|NCT03931174|564752624|FG001|Patients|Lost to Follow-up|89|||
156453201|NCT05386030|564752625|FG000|Overall Study|Death|1|||
156453202|NCT05386030|564752626|FG001|Overall Study|Death|0|||
156453203|NCT05386030|564752625|FG000|Overall Study|Physician Decision|2|||
156453204|NCT05386030|564752626|FG001|Overall Study|Physician Decision|1|||
156453205|NCT05386030|564752625|FG000|Overall Study|Lost to Follow-up|19|||
156453206|NCT05386030|564752626|FG001|Overall Study|Lost to Follow-up|7|||
156453207|NCT05386030|564752625|FG000|Overall Study|Withdrawal by Subject|20|||
156725969|NCT04432831|565744341|FG001|Overall Study|Physician Decision|3|||
156725970|NCT04432831|565744342|FG002|Overall Study|Physician Decision|6|||
156725971|NCT04432831|565744340|FG000|Overall Study|Protocol Violation|1|||
156725972|NCT04432831|565744341|FG001|Overall Study|Protocol Violation|0|||
156725973|NCT04432831|565744342|FG002|Overall Study|Protocol Violation|2|||
156725974|NCT04432831|565744340|FG000|Overall Study|Pregnancy|0|||
156725975|NCT04432831|565744341|FG001|Overall Study|Pregnancy|1|||
156725976|NCT04432831|565744342|FG002|Overall Study|Pregnancy|0|||
156725977|NCT04432831|565744340|FG000|Overall Study|Lack of Efficacy|0|||
156725978|NCT04432831|565744341|FG001|Overall Study|Lack of Efficacy|0|||
156725979|NCT04432831|565744342|FG002|Overall Study|Lack of Efficacy|2|||
156725980|NCT03782792|565744343|FG000|Overall Study|Patient left the country|0|||
156336104|NCT00347360|564328204|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
156336105|NCT00347360|564328205|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
156725981|NCT03782792|565744344|FG001|Overall Study|Patient left the country|1|||
156725982|NCT03782792|565744343|FG000|Overall Study|Withdrawal by Subject|1|||
156725983|NCT03782792|565744344|FG001|Overall Study|Withdrawal by Subject|2|||
156875968|NCT00114517|566303745|FG002|Overall Study|Did not want estradiol|0|||
156336106|NCT00347360|564328206|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
156336107|NCT00347360|564328192|FG000|Overall Study|Abnormal lab values|0|||
156336108|NCT00347360|564328193|FG001|Overall Study|Abnormal lab values|0|||
156336109|NCT00347360|564328194|FG002|Overall Study|Abnormal lab values|0|||
156453208|NCT05386030|564752626|FG001|Overall Study|Withdrawal by Subject|10|||
156725984|NCT05271370|565744347|FG000|Overall Study|Study early termination|8|||
156725985|NCT05271370|565744348|FG001|Overall Study|Study early termination|16|||
156453209|NCT05386030|564752625|FG000|Overall Study|Eligibility criteria violation|1|||
156453210|NCT05386030|564752626|FG001|Overall Study|Eligibility criteria violation|1|||
156453211|NCT05386030|564752625|FG000|Overall Study|Personal Reasons|1|||
156453212|NCT05386030|564752626|FG001|Overall Study|Personal Reasons|0|||
156453213|NCT03213691|564752629|FG000|Overall Study|Adverse Event|2|||
156453214|NCT03213691|564752629|FG000|Overall Study|Death|3|||
156453215|NCT03213691|564752629|FG000|Overall Study|Physician Decision|1|||
156453216|NCT03213691|564752629|FG000|Overall Study|Progressive Disease|14|||
156453217|NCT03213691|564752629|FG000|Overall Study|Ineligible|1|||
156453218|NCT05302596|564752632|FG000|Overall Study|Withdrawal by Subject|1|||
156453219|NCT05302596|564752633|FG001|Overall Study|Withdrawal by Subject|1|||
156453220|NCT04977947|564754682|FG000|Overall Study|Lost to Follow-up|1|||
156453221|NCT04977947|564754683|FG001|Overall Study|Lost to Follow-up|1|||
156453222|NCT04029688|564754684|FG000|Overall Study|Death|8|||
156453223|NCT04029688|564754685|FG001|Overall Study|Death|3|||
156453224|NCT04029688|564754686|FG002|Overall Study|Death|6|||
156453225|NCT04029688|564754687|FG003|Overall Study|Death|2|||
156453226|NCT04029688|564754688|FG004|Overall Study|Death|5|||
156453227|NCT04029688|564754689|FG005|Overall Study|Death|0|||
156453228|NCT04029688|564754690|FG006|Overall Study|Death|2|||
156453229|NCT04029688|564754691|FG007|Overall Study|Death|3|||
156453230|NCT04029688|564754684|FG000|Overall Study|Study Terminated by Sponsor|0|||
156453231|NCT04029688|564754685|FG001|Overall Study|Study Terminated by Sponsor|0|||
156453232|NCT04029688|564754686|FG002|Overall Study|Study Terminated by Sponsor|0|||
156453233|NCT04029688|564754687|FG003|Overall Study|Study Terminated by Sponsor|0|||
156453234|NCT04029688|564754688|FG004|Overall Study|Study Terminated by Sponsor|1|||
156453235|NCT04029688|564754689|FG005|Overall Study|Study Terminated by Sponsor|3|||
156453236|NCT04029688|564754690|FG006|Overall Study|Study Terminated by Sponsor|1|||
156725986|NCT05271370|565744349|FG002|Overall Study|Study early termination|29|||
156725987|NCT00617890|565744350|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
156725988|NCT00617890|565744351|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
156453237|NCT04029688|564754691|FG007|Overall Study|Study Terminated by Sponsor|3|||
156453238|NCT04029688|564754684|FG000|Overall Study|Withdrawal by Subject|0|||
156453239|NCT04029688|564754685|FG001|Overall Study|Withdrawal by Subject|0|||
156453240|NCT04029688|564754686|FG002|Overall Study|Withdrawal by Subject|0|||
156453241|NCT04029688|564754687|FG003|Overall Study|Withdrawal by Subject|1|||
156453242|NCT04029688|564754688|FG004|Overall Study|Withdrawal by Subject|0|||
156453243|NCT04029688|564754689|FG005|Overall Study|Withdrawal by Subject|0|||
156725989|NCT00617890|565744352|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
156725990|NCT00617890|565744353|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
156725991|NCT00617890|565744350|FG000|Overall Study|Lack of Efficacy|23|||
156725992|NCT00617890|565744351|FG001|Overall Study|Lack of Efficacy|26|||
156725993|NCT00617890|565744352|FG002|Overall Study|Lack of Efficacy|30|||
156725994|NCT00617890|565744353|FG003|Overall Study|Lack of Efficacy|97|||
156725995|NCT00617890|565744350|FG000|Overall Study|Lost to Follow-up|0|||
156725996|NCT00617890|565744351|FG001|Overall Study|Lost to Follow-up|0|||
156725997|NCT00617890|565744352|FG002|Overall Study|Lost to Follow-up|1|||
156725998|NCT00617890|565744353|FG003|Overall Study|Lost to Follow-up|2|||
156725999|NCT00617890|565744350|FG000|Overall Study|Withdrawal by Subject|4|||
156726000|NCT00617890|565744351|FG001|Overall Study|Withdrawal by Subject|1|||
156726001|NCT00617890|565744352|FG002|Overall Study|Withdrawal by Subject|0|||
156726002|NCT00617890|565744353|FG003|Overall Study|Withdrawal by Subject|2|||
156726003|NCT00617890|565744350|FG000|Overall Study|Protocol Violation|2|||
156726004|NCT00617890|565744351|FG001|Overall Study|Protocol Violation|1|||
156726005|NCT00617890|565744352|FG002|Overall Study|Protocol Violation|0|||
156726006|NCT00617890|565744353|FG003|Overall Study|Protocol Violation|0|||
156726007|NCT00617890|565744350|FG000|Overall Study|Adverse Event|1|||
156726008|NCT00617890|565744351|FG001|Overall Study|Adverse Event|0|||
156726009|NCT00617890|565744352|FG002|Overall Study|Adverse Event|3|||
156726010|NCT00617890|565744353|FG003|Overall Study|Adverse Event|8|||
156726011|NCT00617890|565744350|FG000|Overall Study|Not treated|1|||
156726012|NCT00617890|565744351|FG001|Overall Study|Not treated|0|||
156726013|NCT00617890|565744352|FG002|Overall Study|Not treated|1|||
156726014|NCT00617890|565744353|FG003|Overall Study|Not treated|1|||
156726015|NCT02283268|565744363|FG000|Overall Study|Withdrawal by Subject|1|||
156726016|NCT00333983|565744364|FG000|Overall Study|Lost to Follow-up|2|||
156726017|NCT00333983|565744365|FG001|Overall Study|Lost to Follow-up|1|||
156726018|NCT00333983|565744366|FG002|Overall Study|Lost to Follow-up|0|||
156726019|NCT00333983|565744364|FG000|Overall Study|Adverse Event|1|||
156726020|NCT00333983|565744365|FG001|Overall Study|Adverse Event|1|||
156726021|NCT00333983|565744366|FG002|Overall Study|Adverse Event|1|||
156726022|NCT00333983|565744364|FG000|Overall Study|Withdrawal by Subject|0|||
156726023|NCT00333983|565744365|FG001|Overall Study|Withdrawal by Subject|3|||
156726024|NCT00333983|565744366|FG002|Overall Study|Withdrawal by Subject|1|||
156726025|NCT00833105|565744367|FG000|Overall Study|Withdrawal by Subject|1|||
156726026|NCT00833105|565744367|FG000|Overall Study|Adverse Event|2|||
156453244|NCT04029688|564754690|FG006|Overall Study|Withdrawal by Subject|0|||
156453245|NCT04029688|564754691|FG007|Overall Study|Withdrawal by Subject|0|||
156453246|NCT05875142|564754692|FG000|Overall Study|Lost to Follow-up|0|||
156453247|NCT05875142|564754693|FG001|Overall Study|Lost to Follow-up|1|||
156453248|NCT05875142|564754694|FG002|Overall Study|Lost to Follow-up|1|||
156453249|NCT03436290|564754695|FG000|Overall Study|Post-randomization Exclusion|1|||
156453250|NCT03436290|564754696|FG001|Overall Study|Post-randomization Exclusion|0|||
156453251|NCT03436290|564754695|FG000|Overall Study|Death|6|||
156453252|NCT03436290|564754696|FG001|Overall Study|Death|0|||
156453253|NCT03436290|564754695|FG000|Overall Study|Withdrawal by Subject|4|||
156453254|NCT03436290|564754696|FG001|Overall Study|Withdrawal by Subject|0|||
156453255|NCT03436290|564754695|FG000|Overall Study|Protocol Violation|30|||
156453256|NCT03436290|564754696|FG001|Overall Study|Protocol Violation|0|||
156453257|NCT02677298|564754697|FG000|Double Blind Phase|Adverse Event|2|||
156453258|NCT02677298|564754698|FG001|Double Blind Phase|Adverse Event|1|||
156453259|NCT02677298|564754699|FG002|Double Blind Phase|Adverse Event|0|||
156453260|NCT02677298|564754697|FG000|Double Blind Phase|Physician Decision|5|||
156453261|NCT02677298|564754698|FG001|Double Blind Phase|Physician Decision|0|||
156453262|NCT02677298|564754699|FG002|Double Blind Phase|Physician Decision|0|||
156453263|NCT02677298|564754697|FG000|Double Blind Phase|Lost to Follow-up|11|||
156453264|NCT02677298|564754698|FG001|Double Blind Phase|Lost to Follow-up|7|||
156453265|NCT02677298|564754699|FG002|Double Blind Phase|Lost to Follow-up|0|||
156453266|NCT02677298|564754697|FG000|Double Blind Phase|Withdrawal by Subject|11|||
156453267|NCT02677298|564754698|FG001|Double Blind Phase|Withdrawal by Subject|8|||
156453268|NCT02677298|564754699|FG002|Double Blind Phase|Withdrawal by Subject|0|||
156453269|NCT02677298|564754697|FG000|Double Blind Phase|No study drug available at site|0|||
156453270|NCT02677298|564754698|FG001|Double Blind Phase|No study drug available at site|1|||
156453271|NCT02677298|564754699|FG002|Double Blind Phase|No study drug available at site|0|||
156453272|NCT02677298|564754697|FG000|Open Label Phase|Adverse Event|0|||
156453273|NCT02677298|564754698|FG001|Open Label Phase|Adverse Event|0|||
156795226|NCT00442702|566004171|FG001|Evaluation Period|Refused treatment|1|||
156795227|NCT00442702|566004170|FG000|Evaluation Period|Renal transplant|0|||
156795228|NCT00442702|566004171|FG001|Evaluation Period|Renal transplant|1|||
156795229|NCT00442702|566004170|FG000|Evaluation Period|Failure to return|1|||
156795230|NCT00442702|566004171|FG001|Evaluation Period|Failure to return|0|||
156795231|NCT00442702|566004170|FG000|Evaluation Period|Site closure|0|||
156795232|NCT00442702|566004171|FG001|Evaluation Period|Site closure|1|||
156795233|NCT00500331|566004180|FG000|Overall Study|Adverse Event|0|||
156795234|NCT00500331|566004181|FG001|Overall Study|Adverse Event|2|||
156795235|NCT00500331|566004182|FG002|Overall Study|Adverse Event|0|||
156795236|NCT00500331|566004183|FG003|Overall Study|Adverse Event|1|||
156795237|NCT00500331|566004184|FG004|Overall Study|Adverse Event|2|||
156795238|NCT00500331|566004185|FG005|Overall Study|Adverse Event|2|||
156795239|NCT00500331|566004186|FG006|Overall Study|Adverse Event|0|||
156795240|NCT00500331|566004180|FG000|Overall Study|Lost to Follow-up|1|||
156795241|NCT00500331|566004181|FG001|Overall Study|Lost to Follow-up|1|||
156795242|NCT00500331|566004182|FG002|Overall Study|Lost to Follow-up|1|||
156795243|NCT00500331|566004183|FG003|Overall Study|Lost to Follow-up|2|||
156795244|NCT00500331|566004184|FG004|Overall Study|Lost to Follow-up|1|||
156795245|NCT00500331|566004185|FG005|Overall Study|Lost to Follow-up|0|||
156795246|NCT00500331|566004186|FG006|Overall Study|Lost to Follow-up|0|||
156795247|NCT00500331|566004180|FG000|Overall Study|Protocol Violation|3|||
156795248|NCT00500331|566004181|FG001|Overall Study|Protocol Violation|1|||
156795249|NCT00500331|566004182|FG002|Overall Study|Protocol Violation|1|||
156795250|NCT00500331|566004183|FG003|Overall Study|Protocol Violation|0|||
156795251|NCT00500331|566004184|FG004|Overall Study|Protocol Violation|1|||
156795252|NCT00500331|566004185|FG005|Overall Study|Protocol Violation|1|||
156795253|NCT00500331|566004186|FG006|Overall Study|Protocol Violation|1|||
156795254|NCT00500331|566004180|FG000|Overall Study|Withdrawal by Subject|4|||
156795255|NCT00500331|566004181|FG001|Overall Study|Withdrawal by Subject|0|||
156795256|NCT00500331|566004182|FG002|Overall Study|Withdrawal by Subject|1|||
156795257|NCT00500331|566004183|FG003|Overall Study|Withdrawal by Subject|5|||
156795258|NCT00500331|566004184|FG004|Overall Study|Withdrawal by Subject|0|||
156795259|NCT00500331|566004185|FG005|Overall Study|Withdrawal by Subject|1|||
156795260|NCT00500331|566004186|FG006|Overall Study|Withdrawal by Subject|1|||
156795261|NCT00500331|566004180|FG000|Overall Study|Lack of Efficacy|3|||
156795262|NCT00500331|566004181|FG001|Overall Study|Lack of Efficacy|1|||
156795263|NCT00500331|566004182|FG002|Overall Study|Lack of Efficacy|0|||
156795264|NCT00500331|566004183|FG003|Overall Study|Lack of Efficacy|0|||
156795265|NCT00500331|566004184|FG004|Overall Study|Lack of Efficacy|0|||
156795266|NCT00500331|566004185|FG005|Overall Study|Lack of Efficacy|0|||
156795267|NCT00500331|566004186|FG006|Overall Study|Lack of Efficacy|0|||
156795268|NCT00500331|566004180|FG000|Overall Study|Liver function test abnormality|0|||
156795269|NCT00500331|566004181|FG001|Overall Study|Liver function test abnormality|0|||
156795270|NCT00500331|566004182|FG002|Overall Study|Liver function test abnormality|1|||
156795271|NCT00500331|566004183|FG003|Overall Study|Liver function test abnormality|0|||
156795272|NCT00500331|566004184|FG004|Overall Study|Liver function test abnormality|0|||
156795273|NCT00500331|566004185|FG005|Overall Study|Liver function test abnormality|0|||
156795274|NCT00500331|566004186|FG006|Overall Study|Liver function test abnormality|0|||
156795275|NCT00500331|566004180|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
156795276|NCT00500331|566004181|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
156453274|NCT02677298|564754699|FG002|Open Label Phase|Adverse Event|4|||
156453275|NCT02677298|564754697|FG000|Open Label Phase|Physician Decision|0|||
156453276|NCT02677298|564754698|FG001|Open Label Phase|Physician Decision|0|||
156453277|NCT02677298|564754699|FG002|Open Label Phase|Physician Decision|1|||
156453278|NCT02677298|564754697|FG000|Open Label Phase|Lost to Follow-up|0|||
156453279|NCT02677298|564754698|FG001|Open Label Phase|Lost to Follow-up|0|||
156453280|NCT02677298|564754699|FG002|Open Label Phase|Lost to Follow-up|17|||
156453281|NCT02677298|564754697|FG000|Open Label Phase|Withdrawal by Subject|0|||
156453282|NCT02677298|564754698|FG001|Open Label Phase|Withdrawal by Subject|0|||
156453283|NCT02677298|564754699|FG002|Open Label Phase|Withdrawal by Subject|38|||
156453284|NCT04130438|564754700|FG000|Overall Study|Lost to Follow-up|0|||
156453285|NCT04130438|564754701|FG001|Overall Study|Lost to Follow-up|0|||
156453286|NCT04130438|564754702|FG002|Overall Study|Lost to Follow-up|1|||
156453287|NCT03338933|564754708|FG000|Screening Visit|Lost to Follow-up|1|||
156453288|NCT03338933|564754709|FG001|Screening Visit|Lost to Follow-up|3|||
156453289|NCT03338933|564754710|FG002|Screening Visit|Lost to Follow-up|1|||
156453290|NCT03338933|564754711|FG003|Screening Visit|Lost to Follow-up|4|||
156453291|NCT03338933|564754708|FG000|Screening Visit|Screen fail after consent|2|||
156726027|NCT02898597|565744368|FG000|Overall Study|Protocol Violation|4|||
156726028|NCT02898597|565744369|FG001|Overall Study|Protocol Violation|2|||
156726029|NCT02898597|565744368|FG000|Overall Study|Lost to Follow-up|0|||
156726030|NCT02898597|565744369|FG001|Overall Study|Lost to Follow-up|9|||
156726031|NCT02898597|565744368|FG000|Overall Study|Death|0|||
156726032|NCT02898597|565744369|FG001|Overall Study|Death|1|||
156726033|NCT03656068|565744370|FG000|Overall Study|Withdrawal by Subject|4|||
156726034|NCT03656068|565744370|FG000|Overall Study|Adverse Event|1|||
156726035|NCT01295671|565744379|FG000|Overall Study|Lost to Follow-up|4|||
156726036|NCT01295671|565744380|FG001|Overall Study|Lost to Follow-up|6|||
156726037|NCT01295671|565744381|FG002|Overall Study|Lost to Follow-up|3|||
156726038|NCT01295671|565744379|FG000|Overall Study|Withdrawal by Subject|3|||
156726039|NCT01295671|565744380|FG001|Overall Study|Withdrawal by Subject|1|||
156726040|NCT01295671|565744381|FG002|Overall Study|Withdrawal by Subject|0|||
156726041|NCT01436370|565744382|FG000|Overall Study|Lost to Follow-up|0|||
156726042|NCT01436370|565744383|FG001|Overall Study|Lost to Follow-up|0|||
156726043|NCT01436370|565744384|FG002|Overall Study|Lost to Follow-up|0|||
156726044|NCT01436370|565744385|FG003|Overall Study|Lost to Follow-up|0|||
156726045|NCT01436370|565744386|FG004|Overall Study|Lost to Follow-up|1|||
156726046|NCT01436370|565744387|FG005|Overall Study|Lost to Follow-up|0|||
156726047|NCT01436370|565744388|FG006|Overall Study|Lost to Follow-up|0|||
156726048|NCT01436370|565744389|FG007|Overall Study|Lost to Follow-up|0|||
156726049|NCT02395848|565744390|FG000|Overall Study|Lost to Follow-up|2|||
156726050|NCT02276560|565744391|FG000|Overall Study|Adverse Event|1|||
156726051|NCT02276560|565744392|FG001|Overall Study|Adverse Event|0|||
156726052|NCT02276560|565744393|FG002|Overall Study|Adverse Event|0|||
156726053|NCT01754129|565744394|FG000|Overall Study|Death|13|||
156726054|NCT01754129|565744394|FG000|Overall Study|Duodopa discontinuation|9|||
156726055|NCT01754129|565744394|FG000|Overall Study|Lost to Follow-up|7|||
156726056|NCT01754129|565744394|FG000|Overall Study|Withdrew consent|1|||
156726057|NCT01754129|565744394|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
156726058|NCT02126579|565744396|FG000|Overall Study|disease progression|0|||
156726059|NCT02126579|565744397|FG001|Overall Study|disease progression|0|||
156726060|NCT02126579|565744398|FG002|Overall Study|disease progression|0|||
156726061|NCT02126579|565744399|FG003|Overall Study|disease progression|1|||
156726062|NCT02126579|565744400|FG004|Overall Study|disease progression|0|||
156726063|NCT02126579|565744401|FG005|Overall Study|disease progression|0|||
156726064|NCT02126579|565744402|FG006|Overall Study|disease progression|1|||
156726065|NCT01343043|565744408|FG000|Overall Study|Disease progression before treatment|1|||
156726066|NCT01343043|565744409|FG001|Overall Study|Disease progression before treatment|0|||
156726067|NCT01343043|565744410|FG002|Overall Study|Disease progression before treatment|0|||
156726068|NCT01343043|565744411|FG003|Overall Study|Disease progression before treatment|0|||
156726069|NCT01343043|565744408|FG000|Overall Study|Withdrawal by Subject|1|||
156726070|NCT01343043|565744409|FG001|Overall Study|Withdrawal by Subject|0|||
156726071|NCT01343043|565744410|FG002|Overall Study|Withdrawal by Subject|0|||
156726072|NCT01343043|565744411|FG003|Overall Study|Withdrawal by Subject|0|||
156726073|NCT01343043|565744408|FG000|Overall Study|Death|1|||
156726074|NCT01343043|565744409|FG001|Overall Study|Death|1|||
156726075|NCT01343043|565744410|FG002|Overall Study|Death|0|||
156726076|NCT01343043|565744411|FG003|Overall Study|Death|1|||
156795277|NCT00500331|566004182|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
156795278|NCT00500331|566004183|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
156795279|NCT00500331|566004184|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
156795280|NCT00500331|566004185|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
156453292|NCT03338933|564754709|FG001|Screening Visit|Screen fail after consent|7|||
156453293|NCT03338933|564754710|FG002|Screening Visit|Screen fail after consent|1|||
156795281|NCT00500331|566004186|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
156726077|NCT00502242|565744414|FG000|Overall Study|Lack of Efficacy|1|||
156726078|NCT00502242|565744415|FG001|Overall Study|Lack of Efficacy|11|||
156726079|NCT00502242|565744414|FG000|Overall Study|Adverse Event|31|||
156726080|NCT00502242|565744415|FG001|Overall Study|Adverse Event|20|||
156726081|NCT00502242|565744414|FG000|Overall Study|Physician Decision|2|||
156453294|NCT03338933|564754711|FG003|Screening Visit|Screen fail after consent|4|||
156533483|NCT03085758|565048816|FG000|Overall Study|Lost to Follow-up|1|||
156726082|NCT00502242|565744415|FG001|Overall Study|Physician Decision|3|||
156453295|NCT03338933|564754708|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
156453296|NCT03338933|564754709|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
156453297|NCT03338933|564754710|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
156453298|NCT03338933|564754711|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
156453299|NCT03338933|564754708|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
156453300|NCT03338933|564754709|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
156453301|NCT03338933|564754710|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
156453302|NCT03338933|564754711|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
156453303|NCT03338933|564754708|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
156453304|NCT03338933|564754709|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
156453305|NCT03338933|564754710|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
156453306|NCT03338933|564754711|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
156453307|NCT04515576|564754712|FG000|Overall Study|Withdrawal by Subject|0|||
156453308|NCT04515576|564754713|FG001|Overall Study|Withdrawal by Subject|0|||
156453309|NCT04515576|564754714|FG002|Overall Study|Withdrawal by Subject|0|||
156453310|NCT04515576|564754715|FG003|Overall Study|Withdrawal by Subject|0|||
156453311|NCT04515576|564754716|FG004|Overall Study|Withdrawal by Subject|0|||
156453312|NCT04515576|564754717|FG005|Overall Study|Withdrawal by Subject|1|||
156453313|NCT03812679|564754718|FG000|Overall Study|Adverse Event|2|||
156453314|NCT03812679|564754718|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
156453315|NCT03812679|564754718|FG000|Overall Study|Renal transplant|1|||
156453316|NCT03812679|564754718|FG000|Overall Study|Withdrawal by Subject|1|||
156453317|NCT03812679|564754718|FG000|Overall Study|Termination of study|2|||
156453318|NCT03812679|564754718|FG000|Overall Study|Water device replacement|1|||
156453319|NCT02140554|564754725|FG000|Overall Study|Withdrawal of consent|1|||
156453320|NCT02140554|564754726|FG001|Overall Study|Withdrawal of consent|0|||
156453321|NCT02140554|564754727|FG002|Overall Study|Withdrawal of consent|4|||
156453322|NCT02140554|564754725|FG000|Overall Study|Physician Decision|1|||
156453323|NCT02140554|564754726|FG001|Overall Study|Physician Decision|0|||
156453324|NCT02140554|564754727|FG002|Overall Study|Physician Decision|2|||
156453325|NCT02140554|564754725|FG000|Overall Study|Death|0|||
156453326|NCT02140554|564754726|FG001|Overall Study|Death|0|||
156453327|NCT02140554|564754727|FG002|Overall Study|Death|1|||
156453328|NCT02140554|564754725|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
156453329|NCT02140554|564754726|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
156453330|NCT02140554|564754727|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
156453331|NCT03953508|564754729|FG000|Baseline|Lost to Follow-up|3|||
156453332|NCT03953508|564754730|FG001|Baseline|Lost to Follow-up|2|||
156453333|NCT03953508|564754729|FG000|6-month Follow-up|Lost to Follow-up|62|||
156453334|NCT03953508|564754730|FG001|6-month Follow-up|Lost to Follow-up|70|||
156453335|NCT03771417|564754731|FG000|Overall Study|Withdrawal by Subject|1|||
156453336|NCT03771417|564754732|FG001|Overall Study|Withdrawal by Subject|0|||
156453337|NCT03771417|564754733|FG002|Overall Study|Withdrawal by Subject|0|||
156453338|NCT03771417|564754731|FG000|Overall Study|Covid-19 Shutdown|0|||
156453339|NCT03771417|564754732|FG001|Overall Study|Covid-19 Shutdown|1|||
156453340|NCT03771417|564754733|FG002|Overall Study|Covid-19 Shutdown|0|||
156453341|NCT04456517|564754734|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
156453342|NCT04456517|564754735|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
156453343|NCT02100813|564754736|FG000|Overall Study|Adverse Event|0|||
156453344|NCT02100813|564754737|FG001|Overall Study|Adverse Event|0|||
156453345|NCT02100813|564754738|FG002|Overall Study|Adverse Event|0|||
156453346|NCT02100813|564754739|FG003|Overall Study|Adverse Event|0|||
156453347|NCT02100813|564754740|FG004|Overall Study|Adverse Event|0|||
156453348|NCT02100813|564754741|FG005|Overall Study|Adverse Event|0|||
156453349|NCT02100813|564754742|FG006|Overall Study|Adverse Event|0|||
156453350|NCT02100813|564754743|FG007|Overall Study|Adverse Event|1|||
156726083|NCT00502242|565744414|FG000|Overall Study|Other - Unspecified|8|||
156726084|NCT00502242|565744415|FG001|Overall Study|Other - Unspecified|14|||
156726085|NCT00502242|565744414|FG000|Overall Study|Protocol Violation|3|||
156726086|NCT00502242|565744415|FG001|Overall Study|Protocol Violation|1|||
156726087|NCT00502242|565744414|FG000|Overall Study|Withdrawal by Subject|6|||
156726088|NCT00502242|565744415|FG001|Overall Study|Withdrawal by Subject|7|||
156336110|NCT00347360|564328195|FG003|Overall Study|Abnormal lab values|0|||
156336111|NCT00347360|564328196|FG004|Overall Study|Abnormal lab values|0|||
156453351|NCT01186367|564754744|FG000|Overall Study|Lost to Follow-up|7|||
156453352|NCT01186367|564754745|FG001|Overall Study|Lost to Follow-up|4|||
156453353|NCT01186367|564754746|FG002|Overall Study|Lost to Follow-up|7|||
156453354|NCT01186367|564754744|FG000|Overall Study|Did not receive study treatment|0|||
156533484|NCT03085758|565048817|FG001|Overall Study|Lost to Follow-up|1|||
156533485|NCT03085758|565048818|FG002|Overall Study|Lost to Follow-up|1|||
156726089|NCT02356588|565744416|FG000|Overall Study|Lack of Efficacy|4|||
156726090|NCT02356588|565744417|FG001|Overall Study|Lack of Efficacy|10|||
156726091|NCT02356588|565744416|FG000|Overall Study|Adverse Event|0|||
156336112|NCT00347360|564328197|FG005|Overall Study|Abnormal lab values|0|||
156336113|NCT00347360|564328198|FG006|Overall Study|Abnormal lab values|1|||
156336114|NCT00347360|564328199|FG007|Overall Study|Abnormal lab values|0|||
156336115|NCT00347360|564328200|FG008|Overall Study|Abnormal lab values|0|||
156336116|NCT00347360|564328201|FG009|Overall Study|Abnormal lab values|0|||
156336117|NCT00347360|564328202|FG010|Overall Study|Abnormal lab values|0|||
156453355|NCT01186367|564754745|FG001|Overall Study|Did not receive study treatment|1|||
156453356|NCT01186367|564754746|FG002|Overall Study|Did not receive study treatment|0|||
156453357|NCT04509674|564754748|FG000|Overall Study|Not treated|33|||
156453358|NCT04509674|564754749|FG001|Overall Study|Not treated|26|||
156453359|NCT04509674|564754748|FG000|Overall Study|Protocol Violation|9|||
156453360|NCT04509674|564754749|FG001|Overall Study|Protocol Violation|10|||
156453361|NCT04509674|564754748|FG000|Overall Study|Lost to Follow-up|31|||
156453362|NCT04509674|564754749|FG001|Overall Study|Lost to Follow-up|39|||
156453363|NCT04509674|564754748|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
156453364|NCT04509674|564754749|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
156453365|NCT04509674|564754748|FG000|Overall Study|Adverse event, serious fatal event|11|||
156453366|NCT04509674|564754749|FG001|Overall Study|Adverse event, serious fatal event|4|||
156453367|NCT04509674|564754748|FG000|Overall Study|Adverse event, non-fatal event|107|||
156453368|NCT04509674|564754749|FG001|Overall Study|Adverse event, non-fatal event|118|||
156453369|NCT04509674|564754748|FG000|Overall Study|Other reason than listed|106|||
156453370|NCT04509674|564754749|FG001|Overall Study|Other reason than listed|95|||
156453371|NCT04064164|564754751|FG000|Overall Study|Withdrawal by Subject|8|||
156453372|NCT04064164|564754752|FG001|Overall Study|Withdrawal by Subject|8|||
156453373|NCT04295798|564754760|FG000|Overall Study|Lost to Follow-up|1|||
156453374|NCT04316871|564754765|FG000|Overall Study|Protocol Violation|2|||
156453375|NCT04316871|564754766|FG001|Overall Study|Protocol Violation|2|||
156453376|NCT04316871|564754767|FG002|Overall Study|Protocol Violation|2|||
156453377|NCT04316871|564754768|FG003|Overall Study|Protocol Violation|2|||
156453378|NCT04650269|564754769|FG000|Overall Study|Death|3|||
156453379|NCT04650269|564754769|FG000|Overall Study|Lost to Follow-up|6|||
156453380|NCT01369355|564754771|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
156453381|NCT01369355|564754772|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
156453382|NCT01369355|564754773|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
156453383|NCT01369355|564754774|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
156453384|NCT01369355|564754775|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
156453385|NCT01369355|564754776|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
156453386|NCT01369355|564754777|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
156453387|NCT01369355|564754778|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
156453388|NCT01369355|564754779|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
156453389|NCT01369355|564754771|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
156453390|NCT01369355|564754772|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
156453391|NCT01369355|564754773|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
156453392|NCT01369355|564754774|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
156453393|NCT01369355|564754775|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
156453394|NCT01369355|564754776|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
156453395|NCT01369355|564754777|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
156453396|NCT01369355|564754778|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
156453397|NCT01369355|564754779|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
156453398|NCT01369355|564754771|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
156453399|NCT01369355|564754772|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
156453400|NCT01369355|564754773|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
156453401|NCT01369355|564754774|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
156453402|NCT01369355|564754775|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
156453403|NCT01369355|564754776|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
156453404|NCT01369355|564754777|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
156453405|NCT01369355|564754778|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
156453406|NCT01369355|564754779|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
156453407|NCT01369355|564754771|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
156453408|NCT01369355|564754772|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
156453409|NCT01369355|564754773|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
156453410|NCT01369355|564754774|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
156453411|NCT01369355|564754775|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
156453412|NCT01369355|564754776|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
156453413|NCT01369355|564754777|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
156453414|NCT01369355|564754778|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
156453415|NCT01369355|564754779|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
156795282|NCT00500331|566004180|FG000|Overall Study|Didn't return for continuation of study|1|||
156795283|NCT00500331|566004181|FG001|Overall Study|Didn't return for continuation of study|0|||
156795284|NCT00500331|566004182|FG002|Overall Study|Didn't return for continuation of study|0|||
156795285|NCT00500331|566004183|FG003|Overall Study|Didn't return for continuation of study|0|||
156795286|NCT00500331|566004184|FG004|Overall Study|Didn't return for continuation of study|0|||
156795287|NCT00500331|566004185|FG005|Overall Study|Didn't return for continuation of study|0|||
156795288|NCT00500331|566004186|FG006|Overall Study|Didn't return for continuation of study|0|||
156795289|NCT00500331|566004180|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
156795290|NCT00500331|566004181|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795291|NCT00500331|566004182|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795292|NCT00500331|566004183|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795293|NCT00500331|566004184|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795294|NCT00500331|566004185|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795295|NCT00500331|566004186|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795296|NCT00500331|566004180|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
156795297|NCT00500331|566004181|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
156795298|NCT00500331|566004182|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
156795299|NCT00500331|566004183|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
156795300|NCT00500331|566004184|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
156795301|NCT00500331|566004185|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
156795302|NCT00500331|566004186|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
156795303|NCT00500331|566004180|FG000|Overall Study|Participant was randomized by mistake|1|||
156795304|NCT00500331|566004181|FG001|Overall Study|Participant was randomized by mistake|0|||
156795305|NCT00500331|566004182|FG002|Overall Study|Participant was randomized by mistake|0|||
156795306|NCT00500331|566004183|FG003|Overall Study|Participant was randomized by mistake|0|||
156795307|NCT00500331|566004184|FG004|Overall Study|Participant was randomized by mistake|0|||
156795308|NCT00500331|566004185|FG005|Overall Study|Participant was randomized by mistake|0|||
156795309|NCT00500331|566004186|FG006|Overall Study|Participant was randomized by mistake|0|||
156795310|NCT00500331|566004180|FG000|Overall Study|Diabetologist nurse in the study|0|||
156795311|NCT00500331|566004181|FG001|Overall Study|Diabetologist nurse in the study|0|||
156795312|NCT00500331|566004182|FG002|Overall Study|Diabetologist nurse in the study|1|||
156795313|NCT00500331|566004183|FG003|Overall Study|Diabetologist nurse in the study|0|||
156795314|NCT00500331|566004184|FG004|Overall Study|Diabetologist nurse in the study|0|||
156795315|NCT00500331|566004185|FG005|Overall Study|Diabetologist nurse in the study|0|||
156795316|NCT00500331|566004186|FG006|Overall Study|Diabetologist nurse in the study|0|||
156795317|NCT00500331|566004180|FG000|Overall Study|State ban of biological samples export|0|||
156795318|NCT00500331|566004181|FG001|Overall Study|State ban of biological samples export|0|||
156795319|NCT00500331|566004182|FG002|Overall Study|State ban of biological samples export|0|||
156795320|NCT00500331|566004183|FG003|Overall Study|State ban of biological samples export|1|||
156795321|NCT00500331|566004184|FG004|Overall Study|State ban of biological samples export|0|||
156795322|NCT00500331|566004185|FG005|Overall Study|State ban of biological samples export|0|||
156795323|NCT00500331|566004186|FG006|Overall Study|State ban of biological samples export|0|||
156795324|NCT00500331|566004180|FG000|Overall Study|Protocol violated|0|||
156795325|NCT00500331|566004181|FG001|Overall Study|Protocol violated|0|||
156795326|NCT00500331|566004182|FG002|Overall Study|Protocol violated|0|||
156795327|NCT00500331|566004183|FG003|Overall Study|Protocol violated|1|||
156795328|NCT00500331|566004184|FG004|Overall Study|Protocol violated|0|||
156795329|NCT00500331|566004185|FG005|Overall Study|Protocol violated|0|||
156795330|NCT00500331|566004186|FG006|Overall Study|Protocol violated|0|||
156795331|NCT03436732|566004187|FG000|Overall Study|Not treated-enrolled in different study|1|||
156795332|NCT03436732|566004188|FG001|Overall Study|Not treated-enrolled in different study|0|||
156795333|NCT03436732|566004187|FG000|Overall Study|Off study after cycle 1|1|||
156795334|NCT03436732|566004188|FG001|Overall Study|Off study after cycle 1|0|||
156795335|NCT03436732|566004187|FG000|Overall Study|Adverse Event|2|||
156795336|NCT03436732|566004188|FG001|Overall Study|Adverse Event|0|||
156795337|NCT03436732|566004187|FG000|Overall Study|Death|0|||
156795338|NCT03436732|566004188|FG001|Overall Study|Death|1|||
156795339|NCT00267488|566004189|FG000|Overall Study|Sponsor Terminated Study|9|||
156795340|NCT00267488|566004189|FG000|Overall Study|Protocol Violation|1|||
156795341|NCT00267488|566004189|FG000|Overall Study|Other (Disease Progression)|1|||
156795342|NCT02093520|566004190|FG000|Overall Study|Not treated|6|||
156795343|NCT02093520|566004191|FG001|Overall Study|Not treated|22|||
156795344|NCT00851084|566004192|FG000|Overall Study|Randomized but not treated|1|||
156795345|NCT00851084|566004193|FG001|Overall Study|Randomized but not treated|0|||
156795346|NCT00851084|566004192|FG000|Overall Study|Adverse Event|26|||
156795347|NCT00851084|566004193|FG001|Overall Study|Adverse Event|36|||
156795348|NCT00851084|566004192|FG000|Overall Study|Disease progression|52|||
156795349|NCT00851084|566004193|FG001|Overall Study|Disease progression|47|||
156795350|NCT00851084|566004192|FG000|Overall Study|Poor compliance to protocol|1|||
156795351|NCT00851084|566004193|FG001|Overall Study|Poor compliance to protocol|1|||
156795352|NCT00851084|566004192|FG000|Overall Study|Physician Decision|13|||
156795353|NCT00851084|566004193|FG001|Overall Study|Physician Decision|14|||
156795354|NCT00851084|566004192|FG000|Overall Study|Consent withdrawn|0|||
156336118|NCT00347360|564328203|FG011|Overall Study|Abnormal lab values|0|||
156336119|NCT00347360|564328204|FG012|Overall Study|Abnormal lab values|0|||
156795355|NCT00851084|566004193|FG001|Overall Study|Consent withdrawn|2|||
156795356|NCT00851084|566004192|FG000|Overall Study|Withdrawal by Subject|11|||
156875969|NCT00114517|566303746|FG003|Overall Study|Did not want estradiol|0|||
156875970|NCT00114517|566303743|FG000|Overall Study|Armed-services duty|0|||
156875971|NCT00114517|566303744|FG001|Overall Study|Armed-services duty|1|||
156875972|NCT00114517|566303745|FG002|Overall Study|Armed-services duty|0|||
156875973|NCT00114517|566303746|FG003|Overall Study|Armed-services duty|1|||
156875974|NCT00114517|566303743|FG000|Overall Study|Competing family issue|0|||
156875975|NCT00114517|566303744|FG001|Overall Study|Competing family issue|1|||
156875976|NCT00114517|566303745|FG002|Overall Study|Competing family issue|0|||
156875977|NCT00114517|566303746|FG003|Overall Study|Competing family issue|1|||
156875978|NCT00114517|566303743|FG000|Overall Study|Physician Decision|0|||
156875979|NCT00114517|566303744|FG001|Overall Study|Physician Decision|1|||
156875980|NCT00114517|566303745|FG002|Overall Study|Physician Decision|0|||
156875981|NCT00114517|566303746|FG003|Overall Study|Physician Decision|0|||
156875982|NCT00114517|566303743|FG000|Overall Study|Lost interest|0|||
156875983|NCT00114517|566303744|FG001|Overall Study|Lost interest|0|||
156875984|NCT00114517|566303745|FG002|Overall Study|Lost interest|1|||
156875985|NCT00114517|566303746|FG003|Overall Study|Lost interest|0|||
156875986|NCT00114517|566303743|FG000|Overall Study|Weight increase|0|||
156875987|NCT00114517|566303744|FG001|Overall Study|Weight increase|0|||
156875988|NCT00114517|566303745|FG002|Overall Study|Weight increase|1|||
156875989|NCT00114517|566303746|FG003|Overall Study|Weight increase|0|||
156875990|NCT00114517|566303743|FG000|Overall Study|Concern about blood clots|0|||
156875991|NCT00114517|566303744|FG001|Overall Study|Concern about blood clots|0|||
156875992|NCT00114517|566303745|FG002|Overall Study|Concern about blood clots|1|||
156875993|NCT00114517|566303746|FG003|Overall Study|Concern about blood clots|0|||
156875994|NCT00114517|566303743|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
156875995|NCT00114517|566303744|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
156875996|NCT00114517|566303745|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
156875997|NCT00114517|566303746|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
156875998|NCT04236141|566305703|FG000|Overall Study|Death|18|||
156875999|NCT04236141|566305704|FG001|Overall Study|Death|10|||
156876000|NCT04236141|566305703|FG000|Overall Study|Withdrawal by Participant|1|||
156876001|NCT04236141|566305704|FG001|Overall Study|Withdrawal by Participant|0|||
156876002|NCT04236141|566305703|FG000|Overall Study|Reason not Specified|1|||
156453416|NCT01369355|564754771|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
156453417|NCT01369355|564754772|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
156453418|NCT01369355|564754773|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
156453419|NCT01369355|564754774|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
156726092|NCT02356588|565744417|FG001|Overall Study|Adverse Event|2|||
156726093|NCT02356588|565744416|FG000|Overall Study|Withdrawal by Subject|1|||
156726094|NCT02356588|565744417|FG001|Overall Study|Withdrawal by Subject|0|||
156726095|NCT02356588|565744416|FG000|Overall Study|Protocol Violation|0|||
156726096|NCT02356588|565744417|FG001|Overall Study|Protocol Violation|1|||
156726097|NCT01812109|565744418|FG000|Overall Study|research personnel delay|16|||
156726098|NCT01812109|565744418|FG000|Overall Study|NIRS Unattainable|17|||
156726099|NCT01346696|565744419|FG000|Overall Study|Death|1|||
156726100|NCT04630002|565744420|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
156726101|NCT04630002|565744421|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
156726102|NCT04630002|565744422|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
156726103|NCT04630002|565744420|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
156726104|NCT04630002|565744421|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
156876003|NCT04236141|566305704|FG001|Overall Study|Reason not Specified|0|||
156876004|NCT04236141|566305703|FG000|Overall Study|Study terminated by Sponsor|8|||
156876005|NCT04236141|566305704|FG001|Overall Study|Study terminated by Sponsor|4|||
156876006|NCT01925131|566305705|FG000|Overall Study|Death|0|||
156876007|NCT01925131|566305706|FG001|Overall Study|Death|0|||
156876008|NCT01925131|566305707|FG002|Overall Study|Death|1|||
156876009|NCT01925131|566305708|FG003|Overall Study|Death|0|||
156876010|NCT01925131|566305709|FG004|Overall Study|Death|0|||
156876011|NCT01925131|566305710|FG005|Overall Study|Death|0|||
156876012|NCT01925131|566305705|FG000|Overall Study|Progression/Relapse|1|||
156876013|NCT01925131|566305706|FG001|Overall Study|Progression/Relapse|1|||
156876014|NCT01925131|566305707|FG002|Overall Study|Progression/Relapse|4|||
156876015|NCT01925131|566305708|FG003|Overall Study|Progression/Relapse|0|||
156876016|NCT01925131|566305709|FG004|Overall Study|Progression/Relapse|0|||
156876017|NCT01925131|566305710|FG005|Overall Study|Progression/Relapse|1|||
156453420|NCT01369355|564754775|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
156726105|NCT04630002|565744422|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
156726106|NCT04630002|565744420|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
156726107|NCT04630002|565744421|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
156876018|NCT01925131|566305705|FG000|Overall Study|Patient Refusal|1|||
156876019|NCT01925131|566305706|FG001|Overall Study|Patient Refusal|0|||
156876020|NCT01925131|566305707|FG002|Overall Study|Patient Refusal|0|||
156876021|NCT01925131|566305708|FG003|Overall Study|Patient Refusal|0|||
156876022|NCT01925131|566305709|FG004|Overall Study|Patient Refusal|0|||
156876023|NCT01925131|566305710|FG005|Overall Study|Patient Refusal|0|||
156795357|NCT00851084|566004193|FG001|Overall Study|Withdrawal by Subject|12|||
156795358|NCT00851084|566004192|FG000|Overall Study|Metastatic surgery|6|||
156795359|NCT00851084|566004193|FG001|Overall Study|Metastatic surgery|6|||
156795360|NCT00851084|566004192|FG000|Overall Study|Other|7|||
156795361|NCT00851084|566004193|FG001|Overall Study|Other|1|||
156795362|NCT00734032|566004194|FG000|Overall Study|Adverse Event|0|||
156795363|NCT00734032|566004195|FG001|Overall Study|Adverse Event|1|||
156795364|NCT00734032|566004196|FG002|Overall Study|Adverse Event|0|||
156795365|NCT00734032|566004197|FG003|Overall Study|Adverse Event|0|||
156795366|NCT03468998|566004198|FG000|Overall Study|Withdrawal by Subject|1|||
156795367|NCT03468998|566004199|FG001|Overall Study|Withdrawal by Subject|1|||
156795368|NCT03468998|566004200|FG002|Overall Study|Withdrawal by Subject|0|||
156795369|NCT03468998|566004201|FG003|Overall Study|Withdrawal by Subject|4|||
156795370|NCT03468998|566004202|FG004|Overall Study|Withdrawal by Subject|1|||
156795371|NCT03468998|566004203|FG005|Overall Study|Withdrawal by Subject|0|||
156795372|NCT01892189|566004204|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
156795373|NCT01892189|566004205|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
156795374|NCT01892189|566004206|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
156795375|NCT01892189|566004207|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
156795376|NCT01892189|566004208|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
156795377|NCT01892189|566004209|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
156795378|NCT01892189|566004210|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
156795379|NCT01892189|566004211|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
156795380|NCT01892189|566004212|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
156795381|NCT01892189|566004204|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795382|NCT01892189|566004205|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795383|NCT01892189|566004206|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
156795384|NCT01892189|566004207|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156795385|NCT01892189|566004208|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795386|NCT01892189|566004209|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795387|NCT01892189|566004210|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156795388|NCT01892189|566004211|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795389|NCT01892189|566004212|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156795390|NCT01892189|566004204|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795391|NCT01892189|566004205|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795392|NCT01892189|566004206|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795393|NCT01892189|566004207|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795394|NCT01892189|566004208|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795395|NCT01892189|566004209|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
156795396|NCT01892189|566004210|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795397|NCT01892189|566004211|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795398|NCT01892189|566004212|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795399|NCT02489279|566004217|FG000|Overall Study|Lost to Follow-up|12|||
156795400|NCT02489279|566004218|FG001|Overall Study|Lost to Follow-up|10|||
156795401|NCT02263547|566004219|FG000|Overall Study|Adverse Event|1|||
156795402|NCT02263547|566004219|FG000|Overall Study|Lost to Follow-up|2|||
156795403|NCT03440411|566004220|FG000|Overall Study|Adverse Event|0|||
156795404|NCT03440411|566004221|FG001|Overall Study|Adverse Event|0|||
156795405|NCT03440411|566004222|FG002|Overall Study|Adverse Event|1|||
156795406|NCT03440411|566004223|FG003|Overall Study|Adverse Event|0|||
156795407|NCT03440411|566004220|FG000|Overall Study|PD|2|||
156795408|NCT03440411|566004221|FG001|Overall Study|PD|1|||
156795409|NCT03440411|566004222|FG002|Overall Study|PD|1|||
156795410|NCT03440411|566004223|FG003|Overall Study|PD|1|||
156795411|NCT03440411|566004220|FG000|Overall Study|Withdrawal by Subject|1|||
156795412|NCT03440411|566004221|FG001|Overall Study|Withdrawal by Subject|0|||
156795413|NCT03440411|566004222|FG002|Overall Study|Withdrawal by Subject|0|||
156795414|NCT03440411|566004223|FG003|Overall Study|Withdrawal by Subject|0|||
156795415|NCT03440411|566004220|FG000|Overall Study|Closed study by sponsor|0|||
156795416|NCT03440411|566004221|FG001|Overall Study|Closed study by sponsor|0|||
156795417|NCT03440411|566004222|FG002|Overall Study|Closed study by sponsor|0|||
156795418|NCT03440411|566004223|FG003|Overall Study|Closed study by sponsor|1|||
156795419|NCT00856557|566004224|FG000|Overall Study|No patients with contextual flags|12|||
156795420|NCT00856557|566004225|FG001|Overall Study|No patients with contextual flags|16|||
156795421|NCT03673176|566004226|FG000|Overall Study|Death prior to intervention|1|||
156795422|NCT03673176|566004226|FG000|Overall Study|Death following intervention|3|||
156795423|NCT03673176|566004226|FG000|Overall Study|Withdrawal by Subject|1|||
156795424|NCT02301897|566004227|FG000|Treatment Course 1|Non-Compliance|0|||
156795425|NCT02301897|566004228|FG001|Treatment Course 1|Non-Compliance|0|||
156795426|NCT02301897|566004229|FG002|Treatment Course 1|Non-Compliance|1|||
156795427|NCT02301897|566004227|FG000|Treatment Course 1|Adverse Event|1|||
156795428|NCT02301897|566004228|FG001|Treatment Course 1|Adverse Event|1|||
156795429|NCT02301897|566004229|FG002|Treatment Course 1|Adverse Event|0|||
156795430|NCT02301897|566004227|FG000|Treatment Course 1|Lost to Follow-up|1|||
156795431|NCT02301897|566004228|FG001|Treatment Course 1|Lost to Follow-up|2|||
156795432|NCT02301897|566004229|FG002|Treatment Course 1|Lost to Follow-up|1|||
156453421|NCT01369355|564754776|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
156453422|NCT01369355|564754777|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
156453423|NCT01369355|564754778|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
156726108|NCT04630002|565744422|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
156726109|NCT04630002|565744420|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
156726110|NCT04630002|565744421|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
156726111|NCT04630002|565744422|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
156726112|NCT04630002|565744420|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
156726113|NCT04630002|565744421|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
156726114|NCT04630002|565744422|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
156795433|NCT02301897|566004227|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
156876024|NCT01925131|566305705|FG000|Overall Study|Adverse Event|0|||
156876025|NCT01925131|566305706|FG001|Overall Study|Adverse Event|0|||
156876026|NCT01925131|566305707|FG002|Overall Study|Adverse Event|2|||
156876027|NCT01925131|566305708|FG003|Overall Study|Adverse Event|0|||
156876028|NCT01925131|566305709|FG004|Overall Study|Adverse Event|1|||
156876029|NCT01925131|566305710|FG005|Overall Study|Adverse Event|3|||
156876030|NCT01925131|566305705|FG000|Overall Study|Other - Not Protocol Specified|3|||
156876031|NCT01925131|566305706|FG001|Overall Study|Other - Not Protocol Specified|1|||
156876032|NCT01925131|566305707|FG002|Overall Study|Other - Not Protocol Specified|2|||
156876033|NCT01925131|566305708|FG003|Overall Study|Other - Not Protocol Specified|5|||
156876034|NCT01925131|566305709|FG004|Overall Study|Other - Not Protocol Specified|10|||
156876035|NCT01925131|566305710|FG005|Overall Study|Other - Not Protocol Specified|6|||
156876036|NCT01657461|566305711|FG000|Overall Study|Death|9|||
156876037|NCT01657461|566305712|FG001|Overall Study|Death|12|||
156876038|NCT01657461|566305711|FG000|Overall Study|Lost to Follow-up|0|||
156876039|NCT01657461|566305712|FG001|Overall Study|Lost to Follow-up|3|||
156876040|NCT01657461|566305711|FG000|Overall Study|Physician Decision|0|||
156876041|NCT01657461|566305712|FG001|Overall Study|Physician Decision|2|||
156876042|NCT01657461|566305711|FG000|Overall Study|Withdrawal by Subject|1|||
156876043|NCT01657461|566305712|FG001|Overall Study|Withdrawal by Subject|3|||
156876044|NCT00122980|566305717|FG000|Overall Study|Death|0|||
156876045|NCT00122980|566305718|FG001|Overall Study|Death|1|||
156876046|NCT00122980|566305717|FG000|Overall Study|Physician Decision|2|||
156876047|NCT00122980|566305718|FG001|Overall Study|Physician Decision|0|||
156876048|NCT00122980|566305717|FG000|Overall Study|Protocol Violation|5|||
156876049|NCT00122980|566305718|FG001|Overall Study|Protocol Violation|1|||
156876050|NCT00122980|566305717|FG000|Overall Study|Withdrawal by Subject|2|||
156876051|NCT00122980|566305718|FG001|Overall Study|Withdrawal by Subject|3|||
156876052|NCT00122980|566305717|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
156876053|NCT00122980|566305718|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
156876054|NCT00122980|566305717|FG000|Overall Study|Study termination|27|||
156876055|NCT00122980|566305718|FG001|Overall Study|Study termination|35|||
156876056|NCT02175199|566305719|FG000|Overall Study|Withdrawal by Subject|1|||
156876057|NCT02175199|566305720|FG001|Overall Study|Withdrawal by Subject|5|||
156876058|NCT02175199|566305719|FG000|Overall Study|Randomized in Error|1|||
156876059|NCT02175199|566305720|FG001|Overall Study|Randomized in Error|0|||
156876060|NCT02175199|566305719|FG000|Overall Study|Sponsor Decision|1|||
156876061|NCT02175199|566305720|FG001|Overall Study|Sponsor Decision|0|||
156876062|NCT01124864|566305723|FG000|Overall Study|Follow up phase competed as per protocol|18|||
156876063|NCT01124864|566305724|FG001|Overall Study|Follow up phase competed as per protocol|22|||
156876064|NCT01124864|566305725|FG002|Overall Study|Follow up phase competed as per protocol|24|||
156876065|NCT01124864|566305726|FG003|Overall Study|Follow up phase competed as per protocol|18|||
156876066|NCT01124864|566305727|FG004|Overall Study|Follow up phase competed as per protocol|26|||
156876067|NCT01124864|566305728|FG005|Overall Study|Follow up phase competed as per protocol|2|||
156876068|NCT01124864|566305723|FG000|Overall Study|Death|6|||
156876069|NCT01124864|566305724|FG001|Overall Study|Death|9|||
156876070|NCT01124864|566305725|FG002|Overall Study|Death|6|||
156876071|NCT01124864|566305726|FG003|Overall Study|Death|2|||
156336120|NCT00347360|564328205|FG013|Overall Study|Abnormal lab values|0|||
156336121|NCT00347360|564328206|FG014|Overall Study|Abnormal lab values|0|||
156336122|NCT00347360|564328192|FG000|Overall Study|PI recommended early withdrawal|0|||
156726115|NCT04630002|565744420|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
156795434|NCT02301897|566004228|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
156795435|NCT02301897|566004229|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
156795436|NCT02301897|566004227|FG000|Treatment Course 1|Withdrawal by Subject|0|||
156795437|NCT02301897|566004228|FG001|Treatment Course 1|Withdrawal by Subject|0|||
156795438|NCT02301897|566004229|FG002|Treatment Course 1|Withdrawal by Subject|2|||
156795439|NCT02301897|566004227|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
156795440|NCT02301897|566004228|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
156795441|NCT02301897|566004229|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
156876072|NCT01124864|566305727|FG004|Overall Study|Death|1|||
156876073|NCT01124864|566305728|FG005|Overall Study|Death|0|||
156876074|NCT01124864|566305723|FG000|Overall Study|Withdrawal by Subject|2|||
156453424|NCT01369355|564754779|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
156453425|NCT01369355|564754771|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
156453426|NCT01369355|564754772|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
156453427|NCT01369355|564754773|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
156453428|NCT01369355|564754774|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
156453429|NCT01369355|564754775|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
156453430|NCT01369355|564754776|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
156453431|NCT01369355|564754777|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
156453432|NCT01369355|564754778|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
156453433|NCT01369355|564754779|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
156453434|NCT01369355|564754771|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
156453435|NCT01369355|564754772|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
156453436|NCT01369355|564754773|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
156453437|NCT01369355|564754774|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
156453438|NCT01369355|564754775|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
156453439|NCT01369355|564754776|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
156453440|NCT01369355|564754777|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
156453441|NCT01369355|564754778|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
156453442|NCT01369355|564754779|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
156453443|NCT01369355|564754771|FG000|Long-term Extension (Week 44-272)|Death|0|||
156453444|NCT01369355|564754772|FG001|Long-term Extension (Week 44-272)|Death|0|||
156453445|NCT01369355|564754773|FG002|Long-term Extension (Week 44-272)|Death|0|||
156453446|NCT01369355|564754774|FG003|Long-term Extension (Week 44-272)|Death|0|||
156453447|NCT01369355|564754775|FG004|Long-term Extension (Week 44-272)|Death|0|||
156453448|NCT01369355|564754776|FG005|Long-term Extension (Week 44-272)|Death|0|||
156453449|NCT01369355|564754777|FG006|Long-term Extension (Week 44-272)|Death|0|||
156453450|NCT01369355|564754778|FG007|Long-term Extension (Week 44-272)|Death|1|||
156453451|NCT01369355|564754779|FG008|Long-term Extension (Week 44-272)|Death|3|||
156453452|NCT01369355|564754771|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
156453453|NCT01369355|564754772|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
156453454|NCT01369355|564754773|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
156453455|NCT01369355|564754774|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
156453456|NCT01369355|564754775|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
156453457|NCT01369355|564754776|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
156453458|NCT01369355|564754777|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
156453459|NCT01369355|564754778|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
156453460|NCT01369355|564754779|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
156453461|NCT01369355|564754771|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
156453462|NCT01369355|564754772|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
156453463|NCT01369355|564754773|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
156453464|NCT01369355|564754774|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
156453465|NCT01369355|564754775|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
156726116|NCT04630002|565744421|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
156726117|NCT04630002|565744422|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
156726118|NCT04630002|565744420|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
156726119|NCT04630002|565744421|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
156726120|NCT04630002|565744422|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
156726121|NCT04630002|565744420|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
156726122|NCT04630002|565744421|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
156453466|NCT01369355|564754776|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
156453467|NCT01369355|564754777|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
156533486|NCT03085758|565048816|FG000|Overall Study|Withdrawal by Subject|2|||
156726123|NCT04630002|565744422|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
156726124|NCT01372618|565744427|FG000|Overall Study|PI Died. Study Terminated|9|||
156726125|NCT03448419|565744437|FG000|Overall Study|Adverse Event|10|||
156726126|NCT03448419|565744438|FG001|Overall Study|Adverse Event|9|||
156726127|NCT03448419|565744437|FG000|Overall Study|Lost to Follow-up|0|||
156726128|NCT03448419|565744438|FG001|Overall Study|Lost to Follow-up|2|||
156726129|NCT03448419|565744437|FG000|Overall Study|Withdrawal by Subject|3|||
156726130|NCT03448419|565744438|FG001|Overall Study|Withdrawal by Subject|1|||
156726131|NCT03448419|565744437|FG000|Overall Study|Not treated|0|||
156726132|NCT03448419|565744438|FG001|Overall Study|Not treated|1|||
156726133|NCT03448419|565744437|FG000|Overall Study|Patient did not attend all visits|0|||
156726134|NCT03448419|565744438|FG001|Overall Study|Patient did not attend all visits|2|||
156533487|NCT03085758|565048817|FG001|Overall Study|Withdrawal by Subject|2|||
156533488|NCT03085758|565048818|FG002|Overall Study|Withdrawal by Subject|1|||
156726135|NCT03448419|565744437|FG000|Overall Study|Withdrawn by Sponsor|0|||
156726136|NCT03448419|565744438|FG001|Overall Study|Withdrawn by Sponsor|1|||
156726137|NCT04548193|565744440|FG000|Overall Study|Lost to Follow-up|0|||
156726138|NCT04548193|565744441|FG001|Overall Study|Lost to Follow-up|1|||
156726139|NCT04548193|565744440|FG000|Overall Study|Death|0|||
156453468|NCT01369355|564754778|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
156453469|NCT01369355|564754779|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
156453470|NCT01369355|564754771|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
156453471|NCT01369355|564754772|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
156726140|NCT04548193|565744441|FG001|Overall Study|Death|1|||
156726141|NCT04548193|565744440|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
156726142|NCT04548193|565744441|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
156726143|NCT04548193|565744440|FG000|Overall Study|Withdrawal by Subject|2|||
156726144|NCT04548193|565744441|FG001|Overall Study|Withdrawal by Subject|2|||
156726145|NCT00630825|565744442|FG000|Overall Study|Adverse Event|4|||
156726146|NCT00630825|565744443|FG001|Overall Study|Adverse Event|4|||
156726147|NCT00630825|565744444|FG002|Overall Study|Adverse Event|3|||
156726148|NCT00630825|565744445|FG003|Overall Study|Adverse Event|1|||
156726149|NCT00630825|565744442|FG000|Overall Study|Entry Criteria Not Met|1|||
156726150|NCT00630825|565744443|FG001|Overall Study|Entry Criteria Not Met|0|||
156726151|NCT00630825|565744444|FG002|Overall Study|Entry Criteria Not Met|2|||
156726152|NCT00630825|565744445|FG003|Overall Study|Entry Criteria Not Met|1|||
156453472|NCT01369355|564754773|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
156453473|NCT01369355|564754774|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
156453474|NCT01369355|564754775|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
156453475|NCT01369355|564754776|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
156453476|NCT01369355|564754777|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
156453477|NCT01369355|564754778|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
156453478|NCT01369355|564754779|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
156453479|NCT01369355|564754771|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
156453480|NCT01369355|564754772|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
156533489|NCT03085758|565048816|FG000|Overall Study|Refusal to recall it up to day 90|0|||
156726153|NCT00630825|565744442|FG000|Overall Study|Lost to Follow-up|1|||
156726154|NCT00630825|565744443|FG001|Overall Study|Lost to Follow-up|1|||
156726155|NCT00630825|565744444|FG002|Overall Study|Lost to Follow-up|1|||
156726156|NCT00630825|565744445|FG003|Overall Study|Lost to Follow-up|1|||
156726157|NCT00630825|565744442|FG000|Overall Study|Physician Decision|1|||
156726158|NCT00630825|565744443|FG001|Overall Study|Physician Decision|0|||
156726159|NCT00630825|565744444|FG002|Overall Study|Physician Decision|0|||
156726160|NCT00630825|565744445|FG003|Overall Study|Physician Decision|0|||
156726161|NCT00630825|565744442|FG000|Overall Study|Withdrawal by Subject|2|||
156726162|NCT00630825|565744443|FG001|Overall Study|Withdrawal by Subject|2|||
156726163|NCT00630825|565744444|FG002|Overall Study|Withdrawal by Subject|2|||
156726164|NCT00630825|565744445|FG003|Overall Study|Withdrawal by Subject|3|||
156726165|NCT01081769|565744448|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
156726166|NCT01081769|565744449|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
156726167|NCT01081769|565744448|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
156726168|NCT01081769|565744449|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
156726169|NCT01081769|565744448|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
156726170|NCT01081769|565744449|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
156726171|NCT01081769|565744448|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
156726172|NCT01081769|565744449|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
156726173|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Adverse Event|14|||
156726174|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Adverse Event|11|||
156726175|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Death|1|||
156726176|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Death|1|||
156726177|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
156726178|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
156726179|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
156726180|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
156726181|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Pregnancy|1|||
156726182|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Pregnancy|0|||
156726183|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
156726184|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
156726185|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
156726186|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
156726187|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Other|0|||
156726188|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Other|1|||
156795442|NCT02301897|566004227|FG000|Treatment Course 2|Lost to Follow-up|0|||
156795443|NCT02301897|566004228|FG001|Treatment Course 2|Lost to Follow-up|2|||
156726189|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Ineligibility|3|||
156726190|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Ineligibility|4|||
156726191|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
156726192|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
156726193|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Patient Moved|2|||
156726194|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Patient Moved|2|||
156795444|NCT02301897|566004229|FG002|Treatment Course 2|Lost to Follow-up|0|||
156453481|NCT01369355|564754773|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
156453482|NCT01369355|564754774|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
156453483|NCT01369355|564754775|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
156453484|NCT01369355|564754776|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
156453485|NCT01369355|564754777|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
156726195|NCT03309943|565744450|FG000|Overall Study|Withdrawal by Subject|0|||
156726196|NCT03309943|565744451|FG001|Overall Study|Withdrawal by Subject|1|||
156726197|NCT03309943|565744450|FG000|Overall Study|Inappropriate behavior towards staff|0|||
156726198|NCT03309943|565744451|FG001|Overall Study|Inappropriate behavior towards staff|1|||
156726199|NCT04926831|565744455|FG000|Overall Study|Withdrawal by Subject|2|||
156726200|NCT04926831|565744455|FG000|Overall Study|Adverse Event|2|||
156726201|NCT01804946|565744462|FG000|Overall Study|Protocol Violation|1|||
156726202|NCT01804946|565744463|FG001|Overall Study|Protocol Violation|0|||
156726203|NCT01804946|565744462|FG000|Overall Study|Adverse Event|0|||
156726204|NCT01804946|565744463|FG001|Overall Study|Adverse Event|1|||
156726205|NCT01804946|565744462|FG000|Overall Study|Insufficient data available|0|||
156726206|NCT01804946|565744463|FG001|Overall Study|Insufficient data available|1|||
156726207|NCT01804946|565744462|FG000|Overall Study|Do not meet inclusion criteria|1|||
156726208|NCT01804946|565744463|FG001|Overall Study|Do not meet inclusion criteria|2|||
156726209|NCT00722137|565744466|FG000|Overall Study|Overt Disease Progression|5|||
156726210|NCT00722137|565744467|FG001|Overall Study|Overt Disease Progression|4|||
156726211|NCT00722137|565744466|FG000|Overall Study|Adverse Event|17|||
156726212|NCT00722137|565744467|FG001|Overall Study|Adverse Event|21|||
156726213|NCT00722137|565744466|FG000|Overall Study|Death|12|||
156726214|NCT00722137|565744467|FG001|Overall Study|Death|7|||
156726215|NCT00722137|565744466|FG000|Overall Study|Withdrawal by Subject|6|||
156726216|NCT00722137|565744467|FG001|Overall Study|Withdrawal by Subject|9|||
156726217|NCT00722137|565744466|FG000|Overall Study|Other Reason Unknown|3|||
156726218|NCT00722137|565744467|FG001|Overall Study|Other Reason Unknown|4|||
156795445|NCT02301897|566004227|FG000|Treatment Course 2|Pregnancy|0|||
156795446|NCT02301897|566004228|FG001|Treatment Course 2|Pregnancy|1|||
156795447|NCT02301897|566004229|FG002|Treatment Course 2|Pregnancy|1|||
156795448|NCT02301897|566004227|FG000|Treatment Course 2|Withdrawal by Subject|0|||
156795449|NCT02301897|566004228|FG001|Treatment Course 2|Withdrawal by Subject|2|||
156795450|NCT02301897|566004229|FG002|Treatment Course 2|Withdrawal by Subject|0|||
156795451|NCT02301897|566004227|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
156795452|NCT02301897|566004228|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
156795453|NCT02301897|566004229|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
156795454|NCT00337168|566004230|FG000|Overall Study|Death|5|||
156795455|NCT00337168|566004230|FG000|Overall Study|Not protocol specified|2|||
156795456|NCT00337168|566004230|FG000|Overall Study|Did not start therapy|1|||
156795457|NCT01230060|566004234|FG000|Overall Study|Withdrawal by Subject|1|||
156795458|NCT01052779|566004236|FG000|Overall Study|Adverse Event|1|||
156795459|NCT01052779|566004237|FG001|Overall Study|Adverse Event|4|||
156795460|NCT01052779|566004236|FG000|Overall Study|Withdrawal by Subject|1|||
156795461|NCT01052779|566004237|FG001|Overall Study|Withdrawal by Subject|2|||
156795462|NCT01052779|566004236|FG000|Overall Study|Other-Protocol Violation|1|||
156795463|NCT01052779|566004237|FG001|Overall Study|Other-Protocol Violation|1|||
156795464|NCT01052779|566004236|FG000|Overall Study|Other-Surgery|0|||
156795465|NCT01052779|566004237|FG001|Overall Study|Other-Surgery|2|||
156795466|NCT01052779|566004236|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
156795467|NCT01052779|566004237|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
156795468|NCT03802916|566004238|FG000|Overall Study|Adverse Event|0|||
156795469|NCT03802916|566004239|FG001|Overall Study|Adverse Event|1|||
156795470|NCT03802916|566004238|FG000|Overall Study|Withdrawal by Subject|0|||
156795471|NCT03802916|566004239|FG001|Overall Study|Withdrawal by Subject|1|||
156795472|NCT03663582|566004240|FG000|Overall Study|Physician Decision|1|||
156795473|NCT01285102|566004241|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
156795474|NCT03524157|566004251|FG000|Overall Study|cytology not readable|0|||
156795475|NCT03524157|566004252|FG001|Overall Study|cytology not readable|0|||
156795476|NCT03524157|566004253|FG002|Overall Study|cytology not readable|1|||
156795477|NCT04507763|566004254|FG000|Overall Study|Participants did not meet entrance criteria|201|||
156453486|NCT01369355|564754778|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
156795478|NCT03322566|566004255|FG000|Overall Study|Death|34|||
156795479|NCT03322566|566004256|FG001|Overall Study|Death|35|||
156453487|NCT01369355|564754779|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
156726219|NCT00722137|565744466|FG000|Overall Study|Randomized But Not Treated|2|||
156726220|NCT00722137|565744467|FG001|Overall Study|Randomized But Not Treated|3|||
156726221|NCT03830333|565744468|FG000|Overall Study|Death|0|||
156726222|NCT03830333|565744469|FG001|Overall Study|Death|1|||
156795480|NCT03322566|566004257|FG002|Overall Study|Death|23|||
156795481|NCT03322566|566004255|FG000|Overall Study|Physician Decision|6|||
156795482|NCT03322566|566004256|FG001|Overall Study|Physician Decision|7|||
156795483|NCT03322566|566004257|FG002|Overall Study|Physician Decision|2|||
156795484|NCT03322566|566004255|FG000|Overall Study|Withdrawal by Subject|4|||
156795485|NCT03322566|566004256|FG001|Overall Study|Withdrawal by Subject|3|||
156795486|NCT03322566|566004257|FG002|Overall Study|Withdrawal by Subject|6|||
156795487|NCT03322566|566004255|FG000|Overall Study|Lost to Follow-up|0|||
156795488|NCT03322566|566004256|FG001|Overall Study|Lost to Follow-up|0|||
156795489|NCT03322566|566004257|FG002|Overall Study|Lost to Follow-up|1|||
156795490|NCT03322566|566004255|FG000|Overall Study|Study terminated by sponsor|1|||
156795491|NCT03322566|566004256|FG001|Overall Study|Study terminated by sponsor|0|||
156795492|NCT03322566|566004257|FG002|Overall Study|Study terminated by sponsor|1|||
156795493|NCT03427619|566004258|FG000|Overall Study|Physician Decision|3|||
156795494|NCT03427619|566004258|FG000|Overall Study|Withdrawal by Subject|4|||
156795495|NCT03427619|566004258|FG000|Overall Study|Lost to Follow-up|5|||
156795496|NCT03427619|566004258|FG000|Overall Study|Administrative|4|||
156795497|NCT03427619|566004258|FG000|Overall Study|Other|2|||
156795498|NCT03427619|566004258|FG000|Overall Study|Unknown or Missing Completion Status|48|||
156795499|NCT05763381|566004259|FG000|Overall Study|Lost to Follow-up|2|||
156795500|NCT05763381|566004260|FG001|Overall Study|Lost to Follow-up|3|||
156795501|NCT05763381|566004259|FG000|Overall Study|Withdrawal by Subject|1|||
156795502|NCT05763381|566004260|FG001|Overall Study|Withdrawal by Subject|2|||
156795503|NCT02853136|566004261|FG000|Wash-out|Adverse Event|0|||
156795504|NCT02853136|566004262|FG001|Wash-out|Adverse Event|0|||
156795505|NCT02853136|566004263|FG002|Wash-out|Adverse Event|0|||
156795506|NCT02853136|566004264|FG003|Wash-out|Adverse Event|1|||
156795507|NCT00841815|566004265|FG000|Washout|Withdrawal by Subject|0|||
156795508|NCT00841815|566004266|FG001|Washout|Withdrawal by Subject|1|||
156795509|NCT03729609|566004267|FG000|Overall Study|Protocol Violation|1|||
156795510|NCT00605189|566004273|FG000|Overall Study|Adverse Event|1|||
156795511|NCT00605189|566004274|FG001|Overall Study|Adverse Event|0|||
156795512|NCT00605189|566004275|FG002|Overall Study|Adverse Event|0|||
156795513|NCT00605189|566004273|FG000|Overall Study|Other|2|||
156795514|NCT00605189|566004274|FG001|Overall Study|Other|2|||
156795515|NCT00605189|566004275|FG002|Overall Study|Other|0|||
156795516|NCT02014376|566004278|FG000|Overall Study|Adverse Event|1|||
156795517|NCT02014376|566004279|FG001|Overall Study|Adverse Event|1|||
156795518|NCT02014376|566004280|FG002|Overall Study|Adverse Event|0|||
156795519|NCT02014376|566004278|FG000|Overall Study|Lost to Follow-up|2|||
156795520|NCT02014376|566004279|FG001|Overall Study|Lost to Follow-up|0|||
156795521|NCT02014376|566004280|FG002|Overall Study|Lost to Follow-up|0|||
156726223|NCT03830333|565744468|FG000|Overall Study|Withdrawal by Subject|5|||
156726224|NCT03830333|565744469|FG001|Overall Study|Withdrawal by Subject|1|||
156726225|NCT03830333|565744468|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
156726226|NCT03830333|565744469|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
156726227|NCT01367886|565744470|FG000|Overall Study|Lost to Follow-up|4|||
156726228|NCT01367886|565744470|FG000|Overall Study|Lack of Efficacy|2|||
156453488|NCT01369355|564754771|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156453489|NCT01369355|564754772|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156453490|NCT01369355|564754773|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156453491|NCT01369355|564754774|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156453492|NCT01369355|564754775|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156453493|NCT01369355|564754776|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156726229|NCT01367886|565744470|FG000|Overall Study|Death|1|||
156726230|NCT00985504|565744477|FG000|Acute Treatment Period|Adverse Event|3|||
156726231|NCT00985504|565744478|FG001|Acute Treatment Period|Adverse Event|4|||
156726232|NCT00985504|565744477|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
156726233|NCT00985504|565744478|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
156726234|NCT00985504|565744477|FG000|Acute Treatment Period|Protocol Violation|2|||
156726235|NCT00985504|565744478|FG001|Acute Treatment Period|Protocol Violation|0|||
156726236|NCT00985504|565744477|FG000|Acute Treatment Period|Sponsor Decision|0|||
156726237|NCT00985504|565744478|FG001|Acute Treatment Period|Sponsor Decision|1|||
156726238|NCT00985504|565744477|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
156726239|NCT00985504|565744478|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
156726240|NCT00985504|565744477|FG000|Optimization Period|Adverse Event|7|||
156726241|NCT00985504|565744478|FG001|Optimization Period|Adverse Event|9|||
156795522|NCT03034044|566004281|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
156453494|NCT01369355|564754777|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
156453495|NCT01369355|564754778|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
156453496|NCT01369355|564754779|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
156726242|NCT00985504|565744477|FG000|Optimization Period|Death|0|||
156726243|NCT00985504|565744478|FG001|Optimization Period|Death|1|||
156795523|NCT04134936|566004282|FG000|Overall Study|Adverse Event|3|||
156795524|NCT04134936|566004283|FG001|Overall Study|Adverse Event|2|||
156795525|NCT04134936|566004282|FG000|Overall Study|Withdrawal by Subject|2|||
156795526|NCT04134936|566004283|FG001|Overall Study|Withdrawal by Subject|3|||
156795527|NCT04134936|566004282|FG000|Overall Study|Physician Decision|0|||
156795528|NCT04134936|566004283|FG001|Overall Study|Physician Decision|1|||
156795529|NCT04134936|566004282|FG000|Overall Study|Progressive disease, joined another trial|1|||
156795530|NCT04134936|566004283|FG001|Overall Study|Progressive disease, joined another trial|0|||
156726244|NCT00985504|565744477|FG000|Optimization Period|Lack of Efficacy|5|||
156726245|NCT00985504|565744478|FG001|Optimization Period|Lack of Efficacy|3|||
156726246|NCT00985504|565744477|FG000|Optimization Period|Lost to Follow-up|0|||
156726247|NCT00985504|565744478|FG001|Optimization Period|Lost to Follow-up|1|||
156726248|NCT00985504|565744477|FG000|Optimization Period|Physician Decision|1|||
156726249|NCT00985504|565744478|FG001|Optimization Period|Physician Decision|0|||
156726250|NCT00985504|565744477|FG000|Optimization Period|Protocol Violation|3|||
156726251|NCT00985504|565744478|FG001|Optimization Period|Protocol Violation|1|||
156726252|NCT00985504|565744477|FG000|Optimization Period|Withdrawal by Subject|10|||
156726253|NCT00985504|565744478|FG001|Optimization Period|Withdrawal by Subject|8|||
156726254|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
156726255|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
156726256|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
156726257|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
156726258|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
156726259|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
156726260|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
156726261|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
156726262|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
156726263|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
156726264|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
156726265|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
156726266|NCT03379727|565744481|FG000|Overall Study|Lack of Efficacy|73|||
156726267|NCT03379727|565744481|FG000|Overall Study|Adverse Event|32|||
156726268|NCT03379727|565744481|FG000|Overall Study|Death|18|||
156726269|NCT03379727|565744481|FG000|Overall Study|Patient/guardian decision|17|||
156726270|NCT03379727|565744481|FG000|Overall Study|Physician Decision|104|||
156726271|NCT03379727|565744481|FG000|Overall Study|Protocol Violation|4|||
156726272|NCT03379727|565744481|FG000|Overall Study|Lost to Follow-up|1|||
156726273|NCT00030901|565744485|FG000|Initial Registration|Ineligible|167|||
156726274|NCT00030901|565744486|FG001|Initial Registration|Ineligible|0|||
156726275|NCT00030901|565744487|FG002|Initial Registration|Ineligible|0|||
156726276|NCT00030901|565744485|FG000|Randomization|Adverse Event|0|||
156726277|NCT00030901|565744486|FG001|Randomization|Adverse Event|11|||
156726278|NCT00030901|565744487|FG002|Randomization|Adverse Event|7|||
156726279|NCT00030901|565744485|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
156726280|NCT00030901|565744486|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
156726281|NCT00030901|565744487|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
156795531|NCT04134936|566004282|FG000|Overall Study|Progressive disease|1|||
156795532|NCT04134936|566004283|FG001|Overall Study|Progressive disease|0|||
156795533|NCT04629196|566004284|FG000|Overall Study|Subject discontinued study drug|1|||
156795534|NCT04629196|566004285|FG001|Overall Study|Subject discontinued study drug|0|||
156453497|NCT01369355|564754771|FG000|Long-term Extension (Week 44-272)|Other|0|||
156453498|NCT01369355|564754772|FG001|Long-term Extension (Week 44-272)|Other|0|||
156453499|NCT01369355|564754773|FG002|Long-term Extension (Week 44-272)|Other|0|||
156453500|NCT01369355|564754774|FG003|Long-term Extension (Week 44-272)|Other|0|||
156453501|NCT01369355|564754775|FG004|Long-term Extension (Week 44-272)|Other|0|||
156453502|NCT01369355|564754776|FG005|Long-term Extension (Week 44-272)|Other|0|||
156453503|NCT01369355|564754777|FG006|Long-term Extension (Week 44-272)|Other|110|||
156453504|NCT01369355|564754778|FG007|Long-term Extension (Week 44-272)|Other|9|||
156453505|NCT01369355|564754779|FG008|Long-term Extension (Week 44-272)|Other|17|||
156453506|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
156453507|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
156453508|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
156453509|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
156453510|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
156453511|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
156453512|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
156453513|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
156453514|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
156453515|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
156453516|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
156453517|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
156453518|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
156795535|NCT04629196|566004284|FG000|Overall Study|Subject study drug dosing increased|1|||
156795536|NCT04629196|566004285|FG001|Overall Study|Subject study drug dosing increased|1|||
156453519|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
156726282|NCT00030901|565744485|FG000|Randomization|Progression/Relapse|0|||
156795537|NCT04629196|566004284|FG000|Overall Study|Withdrawal by Subject|1|||
156795538|NCT04629196|566004285|FG001|Overall Study|Withdrawal by Subject|2|||
156453520|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
156453521|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
156453522|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
156453523|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
156453524|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
156453525|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
156453526|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
156453527|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
156726283|NCT00030901|565744486|FG001|Randomization|Progression/Relapse|22|||
156726284|NCT00030901|565744487|FG002|Randomization|Progression/Relapse|21|||
156726285|NCT00030901|565744485|FG000|Randomization|Death|0|||
156726286|NCT00030901|565744486|FG001|Randomization|Death|1|||
156726287|NCT00030901|565744487|FG002|Randomization|Death|3|||
156726288|NCT00030901|565744485|FG000|Randomization|Other|0|||
156726289|NCT00030901|565744486|FG001|Randomization|Other|36|||
156795539|NCT00323622|566004289|FG000|Overall Study|Other|30|||
156795540|NCT00323622|566004290|FG001|Overall Study|Other|91|||
156795541|NCT00323622|566004291|FG002|Overall Study|Other|4|||
156453528|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
156453529|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
156453530|NCT01715285|564754780|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
156453531|NCT01715285|564754781|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
156453532|NCT01715285|564754782|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
156453533|NCT01715285|564754780|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
156453534|NCT01715285|564754781|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
156453535|NCT01715285|564754782|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
156453536|NCT01715285|564754780|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
156453537|NCT01715285|564754781|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
156453538|NCT01715285|564754782|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
156453539|NCT01715285|564754780|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
156453540|NCT01715285|564754781|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
156453541|NCT01715285|564754782|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
156453542|NCT01715285|564754780|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
156453543|NCT01715285|564754781|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
156453544|NCT01715285|564754782|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
156453545|NCT01715285|564754780|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
156453546|NCT01715285|564754781|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
156453547|NCT01715285|564754782|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
156453548|NCT05020249|564754783|FG000|Overall Study|Protocol Violation|1|||
156453549|NCT05020249|564754784|FG001|Overall Study|Protocol Violation|0|||
156453550|NCT04971681|564754790|FG000|Followup|Lost to Follow-up|1|||
156453551|NCT04971681|564754791|FG001|Followup|Lost to Follow-up|0|||
156453552|NCT04149704|564754795|FG000|Three Month Follow-up|Death|2|||
156453553|NCT04149704|564754796|FG001|Three Month Follow-up|Death|0|||
156726290|NCT00030901|565744487|FG002|Randomization|Other|33|||
156795542|NCT00323622|566004292|FG003|Overall Study|Other|12|||
156795543|NCT00323622|566004293|FG004|Overall Study|Other|32|||
156795544|NCT00323622|566004294|FG005|Overall Study|Other|74|||
156795545|NCT00323622|566004295|FG006|Overall Study|Other|5|||
156795546|NCT00323622|566004296|FG007|Overall Study|Other|13|||
156795547|NCT00323622|566004289|FG000|Overall Study|Death|1|||
156795548|NCT00323622|566004290|FG001|Overall Study|Death|1|||
156795549|NCT00323622|566004291|FG002|Overall Study|Death|0|||
156795550|NCT00323622|566004292|FG003|Overall Study|Death|0|||
156795551|NCT00323622|566004293|FG004|Overall Study|Death|7|||
156453554|NCT04149704|564754797|FG002|Three Month Follow-up|Death|0|||
156453555|NCT04149704|564754798|FG003|Three Month Follow-up|Death|0|||
156453556|NCT04149704|564754795|FG000|Three Month Follow-up|Lost to Follow-up|1|||
156453557|NCT04149704|564754796|FG001|Three Month Follow-up|Lost to Follow-up|4|||
156453558|NCT04149704|564754797|FG002|Three Month Follow-up|Lost to Follow-up|5|||
156453559|NCT04149704|564754798|FG003|Three Month Follow-up|Lost to Follow-up|5|||
156453560|NCT04149704|564754795|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
156726291|NCT00030901|565744485|FG000|Randomization|Ineligible|0|||
156795552|NCT00323622|566004294|FG005|Overall Study|Death|0|||
156795553|NCT00323622|566004295|FG006|Overall Study|Death|0|||
156453561|NCT04149704|564754796|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
156453562|NCT04149704|564754797|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
156726292|NCT00030901|565744486|FG001|Randomization|Ineligible|15|||
156795554|NCT00323622|566004296|FG007|Overall Study|Death|2|||
156795555|NCT03709472|566004303|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
156453563|NCT04149704|564754798|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
156460621|NCT04625725|564781647|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
156726293|NCT00030901|565744487|FG002|Randomization|Ineligible|14|||
156726294|NCT01806051|565744492|FG000|Overall Study|Withdrawal by Subject|6|||
156795556|NCT03709472|566004304|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
156795557|NCT03709472|566004303|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
156795558|NCT03709472|566004304|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
156453564|NCT04149704|564754795|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
156453565|NCT04149704|564754796|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
156453566|NCT04149704|564754797|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
156453567|NCT04149704|564754798|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
156453568|NCT04376502|564754803|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
156453569|NCT04632992|564754804|FG000|Overall Study|Adverse Event|0|||
156726295|NCT02576847|565744493|FG000|Overall Study|Adverse Event|27|||
156726296|NCT02576847|565744493|FG000|Overall Study|Lost to Follow-up|22|||
156726297|NCT02576847|565744493|FG000|Overall Study|Physician Decision|1|||
156726298|NCT02576847|565744493|FG000|Overall Study|Pregnancy|1|||
156726299|NCT02576847|565744493|FG000|Overall Study|Protocol Violation|3|||
156726300|NCT02576847|565744493|FG000|Overall Study|Withdrawal by Subject|78|||
156726301|NCT02576847|565744493|FG000|Overall Study|Other|5|||
156726302|NCT02418182|565744494|FG000|Overall Study|Unable to re-consent|18|||
156726303|NCT02418182|565744495|FG001|Overall Study|Unable to re-consent|15|||
156726304|NCT02418182|565744494|FG000|Overall Study|Lost to Follow-up|0|||
156726305|NCT02418182|565744495|FG001|Overall Study|Lost to Follow-up|2|||
156726306|NCT01205776|565744496|FG000|Overall Study|Lost to Follow-up|53|||
156726307|NCT01205776|565744497|FG001|Overall Study|Lost to Follow-up|61|||
156726308|NCT01205776|565744496|FG000|Overall Study|Withdrawal by Subject|11|||
156726309|NCT01205776|565744497|FG001|Overall Study|Withdrawal by Subject|34|||
156876075|NCT01124864|566305724|FG001|Overall Study|Withdrawal by Subject|3|||
156876076|NCT01124864|566305725|FG002|Overall Study|Withdrawal by Subject|4|||
156876077|NCT01124864|566305726|FG003|Overall Study|Withdrawal by Subject|0|||
156876078|NCT01124864|566305727|FG004|Overall Study|Withdrawal by Subject|2|||
156876079|NCT01124864|566305728|FG005|Overall Study|Withdrawal by Subject|1|||
156876080|NCT01124864|566305723|FG000|Overall Study|Lost to Follow-up|1|||
156876081|NCT01124864|566305724|FG001|Overall Study|Lost to Follow-up|1|||
156876082|NCT01124864|566305725|FG002|Overall Study|Lost to Follow-up|0|||
156876083|NCT01124864|566305726|FG003|Overall Study|Lost to Follow-up|1|||
156876084|NCT01124864|566305727|FG004|Overall Study|Lost to Follow-up|0|||
156726310|NCT06360588|565746188|FG000|Overall Study|Adverse Event|3|||
156726311|NCT06360588|565746188|FG000|Overall Study|Death|2|||
156726312|NCT06360588|565746188|FG000|Overall Study|Disease Progression|14|||
156726313|NCT06360588|565746188|FG000|Overall Study|Withdrawal by Subject|1|||
156726314|NCT06360588|565746188|FG000|Overall Study|Lack of Efficacy|1|||
156726315|NCT06360588|565746188|FG000|Overall Study|Ineligible|1|||
156726316|NCT04010240|565746189|FG000|Overall Study|IHC not performed|2299|||
156726317|NCT00570687|565746190|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726318|NCT00570687|565746191|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726319|NCT00570687|565746192|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726320|NCT00570687|565746193|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726321|NCT00570687|565746194|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
156726322|NCT00570687|565746195|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
156726323|NCT00570687|565746196|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
156726324|NCT00570687|565746197|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
156726325|NCT00570687|565746198|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
156726326|NCT00570687|565746199|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
156726327|NCT00570687|565746190|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726328|NCT00570687|565746191|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726329|NCT00570687|565746192|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726330|NCT00570687|565746193|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726331|NCT00570687|565746194|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726332|NCT00570687|565746195|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726333|NCT00570687|565746196|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726334|NCT00570687|565746197|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726335|NCT00570687|565746198|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
156726336|NCT00570687|565746199|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726337|NCT00570687|565746190|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156876085|NCT01124864|566305728|FG005|Overall Study|Lost to Follow-up|0|||
156876086|NCT01124864|566305723|FG000|Overall Study|Protocol Violation|1|||
156453570|NCT04632992|564754805|FG001|Overall Study|Adverse Event|0|||
156533490|NCT03085758|565048817|FG001|Overall Study|Refusal to recall it up to day 90|0|||
156726338|NCT00570687|565746191|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726339|NCT00570687|565746192|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726340|NCT00570687|565746193|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726341|NCT00570687|565746194|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156876087|NCT01124864|566305724|FG001|Overall Study|Protocol Violation|0|||
156876088|NCT01124864|566305725|FG002|Overall Study|Protocol Violation|0|||
156876089|NCT01124864|566305726|FG003|Overall Study|Protocol Violation|0|||
156726342|NCT00570687|565746195|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726343|NCT00570687|565746196|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
156726344|NCT00570687|565746197|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726345|NCT00570687|565746198|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726346|NCT00570687|565746199|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726347|NCT01540487|565746200|FG000|Overall Study|Protocol Violation|1|||
156453571|NCT04632992|564754806|FG002|Overall Study|Adverse Event|0|||
156453572|NCT04632992|564754807|FG003|Overall Study|Adverse Event|0|||
156453573|NCT04632992|564754808|FG004|Overall Study|Adverse Event|0|||
156453574|NCT04632992|564754809|FG005|Overall Study|Adverse Event|0|||
156453575|NCT04632992|564754810|FG006|Overall Study|Adverse Event|0|||
156453576|NCT04632992|564754811|FG007|Overall Study|Adverse Event|0|||
156453577|NCT04632992|564754812|FG008|Overall Study|Adverse Event|0|||
156453578|NCT04632992|564754813|FG009|Overall Study|Adverse Event|0|||
156453579|NCT04632992|564754814|FG010|Overall Study|Adverse Event|0|||
156453580|NCT04632992|564754815|FG011|Overall Study|Adverse Event|0|||
156453581|NCT04632992|564754816|FG012|Overall Study|Adverse Event|1|||
156453582|NCT04632992|564754817|FG013|Overall Study|Adverse Event|0|||
156453583|NCT04632992|564754804|FG000|Overall Study|Death|17|||
156453584|NCT04632992|564754805|FG001|Overall Study|Death|1|||
156453585|NCT04632992|564754806|FG002|Overall Study|Death|14|||
156453586|NCT04632992|564754807|FG003|Overall Study|Death|14|||
156453587|NCT04632992|564754808|FG004|Overall Study|Death|13|||
156453588|NCT04632992|564754809|FG005|Overall Study|Death|6|||
156453589|NCT04632992|564754810|FG006|Overall Study|Death|7|||
156453590|NCT04632992|564754811|FG007|Overall Study|Death|12|||
156453591|NCT04632992|564754812|FG008|Overall Study|Death|15|||
156453592|NCT04632992|564754813|FG009|Overall Study|Death|20|||
156453593|NCT04632992|564754814|FG010|Overall Study|Death|8|||
156453594|NCT04632992|564754815|FG011|Overall Study|Death|2|||
156453595|NCT04632992|564754816|FG012|Overall Study|Death|10|||
156453596|NCT04632992|564754817|FG013|Overall Study|Death|1|||
156453597|NCT04632992|564754804|FG000|Overall Study|Lost to Follow-up|1|||
156453598|NCT04632992|564754805|FG001|Overall Study|Lost to Follow-up|0|||
156453599|NCT04632992|564754806|FG002|Overall Study|Lost to Follow-up|1|||
156453600|NCT04632992|564754807|FG003|Overall Study|Lost to Follow-up|0|||
156453601|NCT04632992|564754808|FG004|Overall Study|Lost to Follow-up|2|||
156453602|NCT04632992|564754809|FG005|Overall Study|Lost to Follow-up|0|||
156453603|NCT04632992|564754810|FG006|Overall Study|Lost to Follow-up|1|||
156453604|NCT04632992|564754811|FG007|Overall Study|Lost to Follow-up|1|||
156453605|NCT04632992|564754812|FG008|Overall Study|Lost to Follow-up|1|||
156453606|NCT04632992|564754813|FG009|Overall Study|Lost to Follow-up|1|||
156453607|NCT04632992|564754814|FG010|Overall Study|Lost to Follow-up|2|||
156453608|NCT04632992|564754815|FG011|Overall Study|Lost to Follow-up|0|||
156453609|NCT04632992|564754816|FG012|Overall Study|Lost to Follow-up|0|||
156453610|NCT04632992|564754817|FG013|Overall Study|Lost to Follow-up|0|||
156453611|NCT04632992|564754804|FG000|Overall Study|Reason not Specified|2|||
156453612|NCT04632992|564754805|FG001|Overall Study|Reason not Specified|0|||
156453613|NCT04632992|564754806|FG002|Overall Study|Reason not Specified|1|||
156453614|NCT04632992|564754807|FG003|Overall Study|Reason not Specified|1|||
156453615|NCT04632992|564754808|FG004|Overall Study|Reason not Specified|0|||
156453616|NCT04632992|564754809|FG005|Overall Study|Reason not Specified|0|||
156453617|NCT04632992|564754810|FG006|Overall Study|Reason not Specified|0|||
156453618|NCT04632992|564754811|FG007|Overall Study|Reason not Specified|0|||
156453619|NCT04632992|564754812|FG008|Overall Study|Reason not Specified|0|||
156453620|NCT04632992|564754813|FG009|Overall Study|Reason not Specified|0|||
156453621|NCT04632992|564754814|FG010|Overall Study|Reason not Specified|1|||
156453622|NCT04632992|564754815|FG011|Overall Study|Reason not Specified|0|||
156453623|NCT04632992|564754816|FG012|Overall Study|Reason not Specified|0|||
156453624|NCT04632992|564754817|FG013|Overall Study|Reason not Specified|0|||
156453625|NCT04632992|564754804|FG000|Overall Study|Physician Decision|0|||
156453626|NCT04632992|564754805|FG001|Overall Study|Physician Decision|0|||
156453627|NCT04632992|564754806|FG002|Overall Study|Physician Decision|0|||
156453628|NCT04632992|564754807|FG003|Overall Study|Physician Decision|2|||
156453629|NCT04632992|564754808|FG004|Overall Study|Physician Decision|1|||
156453630|NCT04632992|564754809|FG005|Overall Study|Physician Decision|0|||
156453631|NCT04632992|564754810|FG006|Overall Study|Physician Decision|0|||
156453632|NCT04632992|564754811|FG007|Overall Study|Physician Decision|0|||
156453633|NCT04632992|564754812|FG008|Overall Study|Physician Decision|0|||
156726348|NCT01540487|565746201|FG001|Overall Study|Protocol Violation|0|||
156453634|NCT04632992|564754813|FG009|Overall Study|Physician Decision|0|||
156453635|NCT04632992|564754814|FG010|Overall Study|Physician Decision|0|||
156726349|NCT04545489|565746203|FG000|Overall Study|Withdrawal by Subject|12|||
156453636|NCT04632992|564754815|FG011|Overall Study|Physician Decision|0|||
156453637|NCT04632992|564754816|FG012|Overall Study|Physician Decision|3|||
156453638|NCT04632992|564754817|FG013|Overall Study|Physician Decision|0|||
156453639|NCT04632992|564754804|FG000|Overall Study|Progressive Disease|0|||
156453640|NCT04632992|564754805|FG001|Overall Study|Progressive Disease|0|||
156453641|NCT04632992|564754806|FG002|Overall Study|Progressive Disease|0|||
156453642|NCT04632992|564754807|FG003|Overall Study|Progressive Disease|0|||
156453643|NCT04632992|564754808|FG004|Overall Study|Progressive Disease|1|||
156453644|NCT04632992|564754809|FG005|Overall Study|Progressive Disease|0|||
156453645|NCT04632992|564754810|FG006|Overall Study|Progressive Disease|0|||
156453646|NCT04632992|564754811|FG007|Overall Study|Progressive Disease|0|||
156453647|NCT04632992|564754812|FG008|Overall Study|Progressive Disease|0|||
156453648|NCT04632992|564754813|FG009|Overall Study|Progressive Disease|1|||
156453649|NCT04632992|564754814|FG010|Overall Study|Progressive Disease|1|||
156453650|NCT04632992|564754815|FG011|Overall Study|Progressive Disease|0|||
156453651|NCT04632992|564754816|FG012|Overall Study|Progressive Disease|2|||
156453652|NCT04632992|564754817|FG013|Overall Study|Progressive Disease|0|||
156453653|NCT04632992|564754804|FG000|Overall Study|Withdrawal by Subject|4|||
156453654|NCT04632992|564754805|FG001|Overall Study|Withdrawal by Subject|1|||
156453655|NCT04632992|564754806|FG002|Overall Study|Withdrawal by Subject|5|||
156453656|NCT04632992|564754807|FG003|Overall Study|Withdrawal by Subject|4|||
156453657|NCT04632992|564754808|FG004|Overall Study|Withdrawal by Subject|3|||
156453658|NCT04632992|564754809|FG005|Overall Study|Withdrawal by Subject|3|||
156453659|NCT04632992|564754810|FG006|Overall Study|Withdrawal by Subject|0|||
156533491|NCT03085758|565048818|FG002|Overall Study|Refusal to recall it up to day 90|1|||
156533492|NCT03085758|565048816|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
156533493|NCT03085758|565048817|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
156533494|NCT03085758|565048818|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
156533495|NCT01122576|565048819|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
156533496|NCT01122576|565048820|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
156533497|NCT01122576|565048821|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
156453660|NCT04632992|564754811|FG007|Overall Study|Withdrawal by Subject|5|||
156453661|NCT04632992|564754812|FG008|Overall Study|Withdrawal by Subject|0|||
156726350|NCT04545489|565746204|FG001|Overall Study|Withdrawal by Subject|4|||
156726351|NCT04545489|565746203|FG000|Overall Study|Lost to Follow-up|17|||
156453662|NCT04632992|564754813|FG009|Overall Study|Withdrawal by Subject|2|||
156533498|NCT01122576|565048819|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
156533499|NCT01122576|565048820|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
156533500|NCT01122576|565048821|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
156533501|NCT01122576|565048819|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
156533502|NCT01122576|565048820|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
156533503|NCT01122576|565048821|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
156533504|NCT05696236|565048822|FG000|Overall Study|Lost to Follow-up|1|||
156533505|NCT05696236|565048823|FG001|Overall Study|Lost to Follow-up|0|||
156533506|NCT05696236|565048822|FG000|Overall Study|Later determined to not be eligible for participation|0|||
156533507|NCT05696236|565048823|FG001|Overall Study|Later determined to not be eligible for participation|1|||
156533508|NCT05696236|565048822|FG000|Overall Study|Withdrawal by Subject|2|||
156533509|NCT05696236|565048823|FG001|Overall Study|Withdrawal by Subject|2|||
156533510|NCT01829360|565048824|FG000|Overall Study|Protocol Violation|0|||
156533511|NCT01829360|565048825|FG001|Overall Study|Protocol Violation|0|||
156533512|NCT01829360|565048826|FG002|Overall Study|Protocol Violation|1|||
156533513|NCT01829360|565048827|FG003|Overall Study|Protocol Violation|0|||
156533514|NCT00024167|565048829|FG000|Overall Study|Death|53|||
156533515|NCT00024167|565048830|FG001|Overall Study|Death|47|||
156533516|NCT01132612|565048831|FG000|Overall Study|Death|0|||
156726352|NCT04545489|565746204|FG001|Overall Study|Lost to Follow-up|18|||
156726353|NCT04545489|565746203|FG000|Overall Study|12month BP not collected|4|||
156726354|NCT04545489|565746204|FG001|Overall Study|12month BP not collected|4|||
156726355|NCT00154284|565746208|FG000|Overall Study|Adverse Event|6|||
156453663|NCT04632992|564754814|FG010|Overall Study|Withdrawal by Subject|8|||
156453664|NCT04632992|564754815|FG011|Overall Study|Withdrawal by Subject|0|||
156453665|NCT04632992|564754816|FG012|Overall Study|Withdrawal by Subject|1|||
156533517|NCT01132612|565048832|FG001|Overall Study|Death|0|||
156533518|NCT01132612|565048833|FG002|Overall Study|Death|1|||
156533519|NCT01132612|565048831|FG000|Overall Study|Protocol deviation|0|||
156533520|NCT01132612|565048832|FG001|Overall Study|Protocol deviation|0|||
156533521|NCT01132612|565048833|FG002|Overall Study|Protocol deviation|3|||
156533522|NCT01132612|565048831|FG000|Overall Study|Lost to Follow-up|2|||
156533523|NCT01132612|565048832|FG001|Overall Study|Lost to Follow-up|2|||
156726356|NCT00154284|565746209|FG001|Overall Study|Adverse Event|9|||
156726357|NCT00154284|565746208|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156726358|NCT00154284|565746209|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156795559|NCT03977155|566006118|FG000|Overall Study|Adverse Event|3|||
156795560|NCT03977155|566006119|FG001|Overall Study|Adverse Event|0|||
156795561|NCT03977155|566006120|FG002|Overall Study|Adverse Event|0|||
156795562|NCT03977155|566006118|FG000|Overall Study|Lost to Follow-up|0|||
156453666|NCT04632992|564754817|FG013|Overall Study|Withdrawal by Subject|1|||
156453667|NCT02677805|564754818|FG000|Double Blind Phase|Lost to Follow-up|8|||
156533524|NCT01132612|565048833|FG002|Overall Study|Lost to Follow-up|7|||
156533525|NCT01132612|565048831|FG000|Overall Study|Adverse Event|5|||
156533526|NCT01132612|565048832|FG001|Overall Study|Adverse Event|2|||
156795563|NCT03977155|566006119|FG001|Overall Study|Lost to Follow-up|1|||
156795564|NCT03977155|566006120|FG002|Overall Study|Lost to Follow-up|0|||
156876090|NCT01124864|566305727|FG004|Overall Study|Protocol Violation|1|||
156726359|NCT00154284|565746208|FG000|Overall Study|Lack of Efficacy|1|||
156726360|NCT00154284|565746209|FG001|Overall Study|Lack of Efficacy|2|||
156726361|NCT00154284|565746208|FG000|Overall Study|Protocol Violation|0|||
156726362|NCT00154284|565746209|FG001|Overall Study|Protocol Violation|1|||
156726363|NCT00326716|565746210|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
156726364|NCT00326716|565746211|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
156726365|NCT00326716|565746212|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
156726366|NCT00326716|565746213|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
156726367|NCT00684411|565746214|FG000|Overall Study|New Primary Cancer|1|||
156726368|NCT00684411|565746214|FG000|Overall Study|Disease Progression|10|||
156726369|NCT00684411|565746214|FG000|Overall Study|Adverse Event|1|||
156726370|NCT05253573|565746215|FG000|Overall Study|Death|1|||
156726371|NCT05253573|565746216|FG001|Overall Study|Death|0|||
156726372|NCT01344824|565746217|FG000|Overall Study|Adverse Event|15|||
156726373|NCT01344824|565746217|FG000|Overall Study|Withdrawal by Subject|6|||
156726374|NCT01344824|565746217|FG000|Overall Study|Other complicating disease|1|||
156726375|NCT01344824|565746217|FG000|Overall Study|Progression|15|||
156726376|NCT01085630|565746220|FG000|Overall Study|Insufficient data|1|||
156726377|NCT01085630|565746221|FG001|Overall Study|Insufficient data|0|||
156726378|NCT01085630|565746220|FG000|Overall Study|Ineligible|3|||
156726379|NCT01085630|565746221|FG001|Overall Study|Ineligible|0|||
156726380|NCT02366637|565746227|FG000|First Intervention Period|Adverse Event|0|||
156726381|NCT02366637|565746228|FG001|First Intervention Period|Adverse Event|1|||
156726382|NCT02366637|565746227|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
156726383|NCT02366637|565746228|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
156726384|NCT02366637|565746227|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
156726385|NCT02366637|565746228|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
156726386|NCT03691207|565746229|FG000|Overall Study|Death|41|||
156726387|NCT03691207|565746230|FG001|Overall Study|Death|26|||
156876091|NCT01124864|566305728|FG005|Overall Study|Protocol Violation|0|||
156876092|NCT01761162|566305735|FG000|Overall Study|Withdrawal by Subject|3|||
156876093|NCT00724711|566305742|FG000|Overall Study|Adverse Event|7|||
156876094|NCT00724711|566305743|FG001|Overall Study|Adverse Event|3|||
156876095|NCT00724711|566305742|FG000|Overall Study|Pregnancy|0|||
156876096|NCT00724711|566305743|FG001|Overall Study|Pregnancy|1|||
156726388|NCT03691207|565746229|FG000|Overall Study|Lost to Follow-up|1|||
156726389|NCT03691207|565746230|FG001|Overall Study|Lost to Follow-up|1|||
156726390|NCT03691207|565746229|FG000|Overall Study|Withdrawal by Subject|2|||
156726391|NCT03691207|565746230|FG001|Overall Study|Withdrawal by Subject|8|||
156795565|NCT03977155|566006118|FG000|Overall Study|Withdrawal by Subject|1|||
156795566|NCT03977155|566006119|FG001|Overall Study|Withdrawal by Subject|1|||
156795567|NCT03977155|566006120|FG002|Overall Study|Withdrawal by Subject|2|||
156795568|NCT03977155|566006118|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
156795569|NCT03977155|566006119|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
156795570|NCT03977155|566006120|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
156795571|NCT00936936|566006121|FG000|Overall Study|Adverse Event|7|||
156795572|NCT00936936|566006122|FG001|Overall Study|Adverse Event|1|||
156795573|NCT00936936|566006121|FG000|Overall Study|Disease Progression|2|||
156795574|NCT00936936|566006122|FG001|Overall Study|Disease Progression|2|||
156795575|NCT00936936|566006121|FG000|Overall Study|Unrelated|3|||
156795576|NCT00936936|566006122|FG001|Overall Study|Unrelated|1|||
156795577|NCT02278003|566006124|FG000|Overall Study|Withdrawal by Subject|11|||
156795578|NCT02278003|566006125|FG001|Overall Study|Withdrawal by Subject|0|||
156795579|NCT02278003|566006124|FG000|Overall Study|Not Treated|1|||
156795580|NCT02278003|566006125|FG001|Overall Study|Not Treated|0|||
156795581|NCT02278003|566006124|FG000|Overall Study|Recognition task improperly completed|7|||
156795582|NCT02278003|566006125|FG001|Overall Study|Recognition task improperly completed|0|||
156795583|NCT03440385|566006126|FG000|Overall Study|Other Reason|4|||
156795584|NCT03440385|566006127|FG001|Overall Study|Other Reason|1|||
156795585|NCT03440385|566006126|FG000|Overall Study|Site Closed|1|||
156795586|NCT03440385|566006127|FG001|Overall Study|Site Closed|0|||
156795587|NCT03440385|566006126|FG000|Overall Study|Lost to Follow-up|2|||
156795588|NCT03440385|566006127|FG001|Overall Study|Lost to Follow-up|0|||
156795589|NCT03440385|566006126|FG000|Overall Study|Withdrawal by Subject|12|||
156795590|NCT03440385|566006127|FG001|Overall Study|Withdrawal by Subject|6|||
156795591|NCT03440385|566006126|FG000|Overall Study|Lack of Efficacy|9|||
156795592|NCT03440385|566006127|FG001|Overall Study|Lack of Efficacy|2|||
156876097|NCT00724711|566305742|FG000|Overall Study|Lack of Efficacy|0|||
156726392|NCT03691207|565746229|FG000|Overall Study|Sponsor decision|1|||
156795593|NCT03440385|566006126|FG000|Overall Study|Adverse Event|15|||
156795594|NCT03440385|566006127|FG001|Overall Study|Adverse Event|11|||
156795595|NCT00488293|566006128|FG000|Overall Study|Lost to Follow-up|28|||
156876098|NCT00724711|566305743|FG001|Overall Study|Lack of Efficacy|1|||
156726393|NCT03691207|565746230|FG001|Overall Study|Sponsor decision|7|||
156795596|NCT00488293|566006129|FG001|Overall Study|Lost to Follow-up|25|||
156876099|NCT00724711|566305742|FG000|Overall Study|Physician Decision|0|||
156795597|NCT00488293|566006128|FG000|Overall Study|Withdrawal by Subject|5|||
156876100|NCT00724711|566305743|FG001|Overall Study|Physician Decision|3|||
156726394|NCT01609010|565746233|FG000|Overall Study|Stable disease (SD)|22|||
156726395|NCT01609010|565746234|FG001|Overall Study|Stable disease (SD)|16|||
156726396|NCT01609010|565746233|FG000|Overall Study|Progressive disease (PD)|8|||
156726397|NCT01609010|565746234|FG001|Overall Study|Progressive disease (PD)|10|||
156726398|NCT01609010|565746233|FG000|Overall Study|Adverse Event|3|||
156726399|NCT01609010|565746234|FG001|Overall Study|Adverse Event|6|||
156726400|NCT01609010|565746233|FG000|Overall Study|Withdrawal by Subject|2|||
156726401|NCT01609010|565746234|FG001|Overall Study|Withdrawal by Subject|2|||
156533527|NCT01132612|565048833|FG002|Overall Study|Adverse Event|15|||
156533528|NCT01132612|565048831|FG000|Overall Study|Withdrawal by Subject|5|||
156533529|NCT01132612|565048832|FG001|Overall Study|Withdrawal by Subject|8|||
156533530|NCT01132612|565048833|FG002|Overall Study|Withdrawal by Subject|19|||
156533531|NCT01132612|565048831|FG000|Overall Study|Administrative problems|5|||
156533532|NCT01132612|565048832|FG001|Overall Study|Administrative problems|1|||
156533533|NCT01132612|565048833|FG002|Overall Study|Administrative problems|52|||
156533534|NCT01132612|565048831|FG000|Overall Study|Lack of Efficacy|23|||
156533535|NCT01132612|565048832|FG001|Overall Study|Lack of Efficacy|22|||
156533536|NCT01132612|565048833|FG002|Overall Study|Lack of Efficacy|73|||
156533537|NCT02252536|565048834|FG000|Overall Study|Lost to Follow-up|5|||
156533538|NCT02252536|565048835|FG001|Overall Study|Lost to Follow-up|3|||
156533539|NCT01438151|565048837|FG000|Overall Study|study terminated|8|||
156533540|NCT00006392|565048844|FG000|Overall Study|Ineligible|11|||
156533541|NCT00006392|565048845|FG001|Overall Study|Ineligible|3|||
156533542|NCT00006392|565048846|FG002|Overall Study|Ineligible|5|||
156533543|NCT00006392|565048847|FG003|Overall Study|Ineligible|5|||
156533544|NCT00006392|565048844|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
156533545|NCT00006392|565048845|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
156533546|NCT00006392|565048846|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
156533547|NCT00006392|565048847|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
156533548|NCT01186796|565048849|FG000|Overall Study|Adverse Event|3|||
156726402|NCT01609010|565746233|FG000|Overall Study|Other|2|||
156453668|NCT02677805|564754819|FG001|Double Blind Phase|Lost to Follow-up|3|||
156726403|NCT01609010|565746234|FG001|Overall Study|Other|0|||
156726404|NCT01609010|565746233|FG000|Overall Study|Other malignancy|1|||
156726405|NCT01609010|565746234|FG001|Overall Study|Other malignancy|0|||
156726406|NCT01609010|565746233|FG000|Overall Study|Pathology review|2|||
156726407|NCT01609010|565746234|FG001|Overall Study|Pathology review|1|||
156726408|NCT01609010|565746233|FG000|Overall Study|Protocol Violation|1|||
156726409|NCT01609010|565746234|FG001|Overall Study|Protocol Violation|1|||
156726410|NCT01609010|565746233|FG000|Overall Study|New cancer|1|||
156726411|NCT01609010|565746234|FG001|Overall Study|New cancer|0|||
156726412|NCT01609010|565746233|FG000|Overall Study|Lost to Follow-up|1|||
156726413|NCT01609010|565746234|FG001|Overall Study|Lost to Follow-up|1|||
156726414|NCT01134107|565746235|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
156726415|NCT01134107|565746236|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
156726416|NCT01134107|565746235|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
156726417|NCT01134107|565746236|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
156726418|NCT01134107|565746235|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
156726419|NCT01134107|565746236|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
156795598|NCT00488293|566006129|FG001|Overall Study|Withdrawal by Subject|3|||
156453669|NCT02677805|564754820|FG002|Double Blind Phase|Lost to Follow-up|0|||
156453670|NCT02677805|564754818|FG000|Double Blind Phase|Withdrawal by Subject|5|||
156453671|NCT02677805|564754819|FG001|Double Blind Phase|Withdrawal by Subject|2|||
156453672|NCT02677805|564754820|FG002|Double Blind Phase|Withdrawal by Subject|0|||
156453673|NCT02677805|564754818|FG000|Open Label Phase|Lost to Follow-up|0|||
156453674|NCT02677805|564754819|FG001|Open Label Phase|Lost to Follow-up|0|||
156453675|NCT02677805|564754820|FG002|Open Label Phase|Lost to Follow-up|10|||
156453676|NCT02677805|564754818|FG000|Open Label Phase|Withdrawal by Subject|0|||
156795599|NCT00488293|566006128|FG000|Overall Study|Death|2|||
156795600|NCT00488293|566006129|FG001|Overall Study|Death|1|||
156795601|NCT00488293|566006128|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
156533549|NCT01186796|565048850|FG001|Overall Study|Adverse Event|0|||
156726420|NCT01134107|565746235|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
156726421|NCT01134107|565746236|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
156533550|NCT01186796|565048849|FG000|Overall Study|Withdrawal by Subject|1|||
156533551|NCT01186796|565048850|FG001|Overall Study|Withdrawal by Subject|1|||
156726422|NCT01134107|565746235|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
156726423|NCT01134107|565746236|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
156726424|NCT01134107|565746235|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
156453677|NCT02677805|564754819|FG001|Open Label Phase|Withdrawal by Subject|0|||
156533552|NCT01186796|565048849|FG000|Overall Study|Protocol Violation|0|||
156533553|NCT01186796|565048850|FG001|Overall Study|Protocol Violation|1|||
156726425|NCT01134107|565746236|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
156726426|NCT01134107|565746235|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
156726427|NCT01134107|565746236|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
156795602|NCT00488293|566006129|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
156795603|NCT02332928|566006132|FG000|Overall Study|Withdrawal by Subject|0|||
156795604|NCT02332928|566006133|FG001|Overall Study|Withdrawal by Subject|2|||
156795605|NCT02332928|566006132|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
156795606|NCT02332928|566006133|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
156726428|NCT02027545|565746238|FG000|Overall Study|Failed to sign HIPAA|0|||
156726429|NCT02027545|565746239|FG001|Overall Study|Failed to sign HIPAA|2|||
156726430|NCT02027545|565746238|FG000|Overall Study|Failed to attend study visit|2|||
156726431|NCT02027545|565746239|FG001|Overall Study|Failed to attend study visit|0|||
156726432|NCT02027545|565746238|FG000|Overall Study|Protocol Violation|1|||
156726433|NCT02027545|565746239|FG001|Overall Study|Protocol Violation|0|||
156726434|NCT04541589|565746243|FG000|Treatment Period|Adverse Event|8|||
156726435|NCT04541589|565746244|FG001|Treatment Period|Adverse Event|2|||
156726436|NCT04541589|565746243|FG000|Treatment Period|Physician Decision|3|||
156726437|NCT04541589|565746244|FG001|Treatment Period|Physician Decision|1|||
156726438|NCT04541589|565746243|FG000|Treatment Period|Subject decision|7|||
156726439|NCT04541589|565746244|FG001|Treatment Period|Subject decision|4|||
156726440|NCT04541589|565746243|FG000|Treatment Period|Withdrawal by Subject|1|||
156726441|NCT04541589|565746244|FG001|Treatment Period|Withdrawal by Subject|0|||
156726442|NCT04541589|565746243|FG000|Safety Follow-up Period|Adverse Event|2|||
156726443|NCT04541589|565746244|FG001|Safety Follow-up Period|Adverse Event|1|||
156726444|NCT04541589|565746243|FG000|Safety Follow-up Period|Physician Decision|1|||
156726445|NCT04541589|565746244|FG001|Safety Follow-up Period|Physician Decision|0|||
156726446|NCT04541589|565746243|FG000|Safety Follow-up Period|Subject decision|5|||
156726447|NCT04541589|565746244|FG001|Safety Follow-up Period|Subject decision|3|||
156726448|NCT04541589|565746243|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
156726449|NCT04541589|565746244|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
156726450|NCT02770170|565746245|FG000|Overall Study|Withdrawal by Subject|0|||
156726451|NCT02770170|565746246|FG001|Overall Study|Withdrawal by Subject|0|||
156726452|NCT02770170|565746247|FG002|Overall Study|Withdrawal by Subject|0|||
156726453|NCT02770170|565746248|FG003|Overall Study|Withdrawal by Subject|2|||
156726454|NCT02770170|565746245|FG000|Overall Study|due to pregnancy|1|||
156795607|NCT01497197|566006134|FG000|Overall Study|Lost to Follow-up|1|||
156795608|NCT01497197|566006135|FG001|Overall Study|Lost to Follow-up|0|||
156726455|NCT02770170|565746246|FG001|Overall Study|due to pregnancy|0|||
156726456|NCT02770170|565746247|FG002|Overall Study|due to pregnancy|0|||
156795609|NCT01497197|566006134|FG000|Overall Study|Protocol Violation|0|||
156795610|NCT01497197|566006135|FG001|Overall Study|Protocol Violation|2|||
156795611|NCT01497197|566006134|FG000|Overall Study|Withdrawal by Subject|2|||
156795612|NCT01497197|566006135|FG001|Overall Study|Withdrawal by Subject|1|||
156795613|NCT01497197|566006134|FG000|Overall Study|Excessive/lack of response to treatment|1|||
156795614|NCT01497197|566006135|FG001|Overall Study|Excessive/lack of response to treatment|0|||
156795615|NCT01497197|566006134|FG000|Overall Study|Risk of OHSS|1|||
156795616|NCT01497197|566006135|FG001|Overall Study|Risk of OHSS|0|||
156795617|NCT01497197|566006134|FG000|Overall Study|No oocytes retrieved|3|||
156795618|NCT01497197|566006135|FG001|Overall Study|No oocytes retrieved|2|||
156876101|NCT00724711|566305742|FG000|Overall Study|Withdrawal by Subject|5|||
156876102|NCT00724711|566305743|FG001|Overall Study|Withdrawal by Subject|4|||
156876103|NCT00724711|566305742|FG000|Overall Study|Lost to Follow-up|4|||
156876104|NCT00724711|566305743|FG001|Overall Study|Lost to Follow-up|5|||
156876105|NCT00724711|566305742|FG000|Overall Study|Protocol Violation|1|||
156876106|NCT00724711|566305743|FG001|Overall Study|Protocol Violation|0|||
156876107|NCT01368562|566305744|FG000|Overall Study|Adverse Event|1|||
156876108|NCT01368562|566305744|FG000|Overall Study|Disease progression|1|||
156876109|NCT01368562|566305744|FG000|Overall Study|Lost to Follow-up|1|||
156876110|NCT01368562|566305744|FG000|Overall Study|Death|6|||
156876111|NCT01368562|566305744|FG000|Overall Study|Unresponsive to treatment|5|||
156876112|NCT01368562|566305744|FG000|Overall Study|Other|3|||
156876113|NCT01368562|566305744|FG000|Overall Study|Other than specified|2|||
156876114|NCT00727441|566305745|FG000|Overall Study|Disease Progression|11|||
156876115|NCT00727441|566305746|FG001|Overall Study|Disease Progression|14|||
156876116|NCT00727441|566305747|FG002|Overall Study|Disease Progression|17|||
156876117|NCT00727441|566305745|FG000|Overall Study|Eligibility|7|||
156795619|NCT01497197|566006134|FG000|Overall Study|No fertilisation|6|||
156795620|NCT01497197|566006135|FG001|Overall Study|No fertilisation|5|||
156795621|NCT01497197|566006134|FG000|Overall Study|Intention to freeze all embryos|0|||
156876118|NCT00727441|566305746|FG001|Overall Study|Eligibility|5|||
156876119|NCT00727441|566305747|FG002|Overall Study|Eligibility|7|||
156876120|NCT00727441|566305745|FG000|Overall Study|Death|0|||
156876121|NCT00727441|566305746|FG001|Overall Study|Death|1|||
156876122|NCT00727441|566305747|FG002|Overall Study|Death|1|||
156876123|NCT00727441|566305745|FG000|Overall Study|Physician Decision|0|||
156726457|NCT02770170|565746248|FG003|Overall Study|due to pregnancy|0|||
156726458|NCT02770170|565746245|FG000|Overall Study|Lack of Efficacy|2|||
156726459|NCT02770170|565746246|FG001|Overall Study|Lack of Efficacy|0|||
156726460|NCT02770170|565746247|FG002|Overall Study|Lack of Efficacy|0|||
156726461|NCT02770170|565746248|FG003|Overall Study|Lack of Efficacy|1|||
156726462|NCT02770170|565746245|FG000|Overall Study|Adverse Event|4|||
156453678|NCT02677805|564754820|FG002|Open Label Phase|Withdrawal by Subject|6|||
156453679|NCT04111536|564754821|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
156453680|NCT04111536|564754822|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
156453681|NCT04111536|564754821|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
156453682|NCT04111536|564754822|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
156453683|NCT04111536|564754821|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
156453684|NCT04111536|564754822|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
156453685|NCT04111536|564754821|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
156453686|NCT04111536|564754822|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
156453687|NCT04187833|564754823|FG000|Overall Study|Withdrawal by Subject|1|||
156453688|NCT04209465|564754827|FG000|Overall Study|Adverse Event|0|||
156453689|NCT04209465|564754828|FG001|Overall Study|Adverse Event|0|||
156453690|NCT04209465|564754829|FG002|Overall Study|Adverse Event|0|||
156453691|NCT04209465|564754830|FG003|Overall Study|Adverse Event|0|||
156453692|NCT04209465|564754831|FG004|Overall Study|Adverse Event|0|||
156453693|NCT04209465|564754832|FG005|Overall Study|Adverse Event|1|||
156453694|NCT04209465|564754833|FG006|Overall Study|Adverse Event|0|||
156453695|NCT04209465|564754834|FG007|Overall Study|Adverse Event|0|||
156453696|NCT04209465|564754835|FG008|Overall Study|Adverse Event|1|||
156453697|NCT04209465|564754836|FG009|Overall Study|Adverse Event|0|||
156453698|NCT04209465|564754837|FG010|Overall Study|Adverse Event|2|||
156453699|NCT04209465|564754838|FG011|Overall Study|Adverse Event|1|||
156453700|NCT04209465|564754839|FG012|Overall Study|Adverse Event|1|||
156453701|NCT04209465|564754827|FG000|Overall Study|Death|1|||
156453702|NCT04209465|564754828|FG001|Overall Study|Death|0|||
156453703|NCT04209465|564754829|FG002|Overall Study|Death|0|||
156726463|NCT02770170|565746246|FG001|Overall Study|Adverse Event|3|||
156726464|NCT02770170|565746247|FG002|Overall Study|Adverse Event|5|||
156726465|NCT02770170|565746248|FG003|Overall Study|Adverse Event|3|||
156726466|NCT02770170|565746245|FG000|Overall Study|due to disease worsening|0|||
156726467|NCT02770170|565746246|FG001|Overall Study|due to disease worsening|0|||
156726468|NCT02770170|565746247|FG002|Overall Study|due to disease worsening|0|||
156726469|NCT02770170|565746248|FG003|Overall Study|due to disease worsening|1|||
156726470|NCT03581123|565746249|FG000|2-month Follow-up|Withdrawal by Subject|5|||
156726471|NCT03581123|565746250|FG001|2-month Follow-up|Withdrawal by Subject|4|||
156726472|NCT03581123|565746251|FG002|2-month Follow-up|Withdrawal by Subject|6|||
156726473|NCT03581123|565746252|FG003|2-month Follow-up|Withdrawal by Subject|4|||
156726474|NCT03581123|565746249|FG000|2-month Follow-up|Lost to Follow-up|8|||
156726475|NCT03581123|565746250|FG001|2-month Follow-up|Lost to Follow-up|1|||
156726476|NCT03581123|565746251|FG002|2-month Follow-up|Lost to Follow-up|2|||
156726477|NCT03581123|565746252|FG003|2-month Follow-up|Lost to Follow-up|2|||
156726478|NCT03581123|565746249|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
156726479|NCT03581123|565746250|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
156726480|NCT03581123|565746251|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
156726481|NCT03581123|565746252|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
156726482|NCT03581123|565746249|FG000|6-Month Follow-up|Lost to Follow-up|3|||
156726483|NCT03581123|565746250|FG001|6-Month Follow-up|Lost to Follow-up|3|||
156726484|NCT03581123|565746251|FG002|6-Month Follow-up|Lost to Follow-up|1|||
156726485|NCT03581123|565746252|FG003|6-Month Follow-up|Lost to Follow-up|1|||
156726486|NCT03581123|565746249|FG000|12-Month Follow-up|Lost to Follow-up|4|||
156726487|NCT03581123|565746250|FG001|12-Month Follow-up|Lost to Follow-up|3|||
156726488|NCT03581123|565746251|FG002|12-Month Follow-up|Lost to Follow-up|4|||
156453704|NCT04209465|564754830|FG003|Overall Study|Death|0|||
156453705|NCT04209465|564754831|FG004|Overall Study|Death|2|||
156453706|NCT04209465|564754832|FG005|Overall Study|Death|7|||
156453707|NCT04209465|564754833|FG006|Overall Study|Death|2|||
156453708|NCT04209465|564754834|FG007|Overall Study|Death|2|||
156453709|NCT04209465|564754835|FG008|Overall Study|Death|1|||
156726489|NCT03581123|565746252|FG003|12-Month Follow-up|Lost to Follow-up|5|||
156876124|NCT00727441|566305746|FG001|Overall Study|Physician Decision|1|||
156876125|NCT00727441|566305747|FG002|Overall Study|Physician Decision|0|||
156876126|NCT00727441|566305745|FG000|Overall Study|Withdrawal by Subject|0|||
156336123|NCT00347360|564328193|FG001|Overall Study|PI recommended early withdrawal|0|||
156336124|NCT00347360|564328194|FG002|Overall Study|PI recommended early withdrawal|0|||
156453710|NCT04209465|564754836|FG009|Overall Study|Death|1|||
156726490|NCT04195685|565746253|FG000|Overall Study|Withdrawal by Subject|6|||
156726491|NCT04195685|565746254|FG001|Overall Study|Withdrawal by Subject|2|||
156453711|NCT04209465|564754837|FG010|Overall Study|Death|1|||
156453712|NCT04209465|564754838|FG011|Overall Study|Death|0|||
156453713|NCT04209465|564754839|FG012|Overall Study|Death|10|||
156453714|NCT04209465|564754827|FG000|Overall Study|Physician Decision|0|||
156453715|NCT04209465|564754828|FG001|Overall Study|Physician Decision|1|||
156453716|NCT04209465|564754829|FG002|Overall Study|Physician Decision|0|||
156453717|NCT04209465|564754830|FG003|Overall Study|Physician Decision|0|||
156453718|NCT04209465|564754831|FG004|Overall Study|Physician Decision|0|||
156453719|NCT04209465|564754832|FG005|Overall Study|Physician Decision|0|||
156726492|NCT04195685|565746253|FG000|Overall Study|Lost to Follow-up|1|||
156726493|NCT04195685|565746254|FG001|Overall Study|Lost to Follow-up|4|||
156876127|NCT00727441|566305746|FG001|Overall Study|Withdrawal by Subject|1|||
156876128|NCT00727441|566305747|FG002|Overall Study|Withdrawal by Subject|0|||
156876129|NCT02810444|566305748|FG000|Overall Study|Screen Failures|14|||
156876130|NCT02810444|566305748|FG000|Overall Study|Withdrawal by Subject|4|||
156876131|NCT02810444|566305748|FG000|Overall Study|Adverse Event|3|||
156876132|NCT00745849|566305749|FG000|First Intervention|Withdrawal by Subject|0|||
156876133|NCT00745849|566305750|FG001|First Intervention|Withdrawal by Subject|1|||
156876134|NCT00745849|566305749|FG000|First Intervention|Lost to Follow-up|1|||
156876135|NCT00745849|566305750|FG001|First Intervention|Lost to Follow-up|1|||
156876136|NCT00745849|566305749|FG000|Second Intervention|Lost to Follow-up|2|||
156876137|NCT00745849|566305750|FG001|Second Intervention|Lost to Follow-up|1|||
156876138|NCT01139008|566305751|FG000|Overall Study|Withdrawal by Subject|5|||
156876139|NCT01139008|566305751|FG000|Overall Study|Non-compliant, lost product|1|||
156876140|NCT02785770|566305754|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
156876141|NCT02785770|566305755|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
156876142|NCT02785770|566305756|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
156876143|NCT02785770|566305757|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
156876144|NCT02785770|566305754|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
156876145|NCT02785770|566305755|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
156876146|NCT02785770|566305756|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
156876147|NCT02785770|566305757|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
156876148|NCT02785770|566305754|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
156876149|NCT02785770|566305755|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
156876150|NCT02785770|566305756|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
156876151|NCT02785770|566305757|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
156876152|NCT01904773|566305758|FG000|Screen|Screen failure|3|||
156876153|NCT01904773|566305759|FG001|Screen|Screen failure|0|||
156876154|NCT01904773|566305760|FG002|Screen|Screen failure|0|||
156876155|NCT01904773|566305761|FG003|Screen|Screen failure|0|||
156876156|NCT01904773|566305762|FG004|Screen|Screen failure|0|||
156876157|NCT01904773|566305763|FG005|Screen|Screen failure|0|||
156876158|NCT01904773|566305764|FG006|Screen|Screen failure|0|||
156876159|NCT01904773|566305765|FG007|Screen|Screen failure|0|||
156876160|NCT01904773|566305766|FG008|Screen|Screen failure|0|||
156876161|NCT01904773|566305758|FG000|Screen|Withdrawal by Subject|1|||
156876162|NCT01904773|566305759|FG001|Screen|Withdrawal by Subject|0|||
156876163|NCT01904773|566305760|FG002|Screen|Withdrawal by Subject|0|||
156876164|NCT01904773|566305761|FG003|Screen|Withdrawal by Subject|0|||
156876165|NCT01904773|566305762|FG004|Screen|Withdrawal by Subject|0|||
156876166|NCT01904773|566305763|FG005|Screen|Withdrawal by Subject|0|||
156876167|NCT01904773|566305764|FG006|Screen|Withdrawal by Subject|0|||
156876168|NCT01904773|566305765|FG007|Screen|Withdrawal by Subject|0|||
156876169|NCT01904773|566305766|FG008|Screen|Withdrawal by Subject|0|||
156876170|NCT01904773|566305758|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
156876171|NCT01904773|566305759|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876172|NCT01904773|566305760|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876173|NCT01904773|566305761|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876174|NCT01904773|566305762|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876175|NCT01904773|566305763|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876176|NCT01904773|566305764|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876177|NCT01904773|566305765|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876178|NCT01904773|566305766|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876179|NCT01904773|566305758|FG000|First Intervention|Adverse Event|0|||
156876180|NCT01904773|566305759|FG001|First Intervention|Adverse Event|0|||
156876181|NCT01904773|566305760|FG002|First Intervention|Adverse Event|0|||
156876182|NCT01904773|566305761|FG003|First Intervention|Adverse Event|0|||
156876183|NCT01904773|566305762|FG004|First Intervention|Adverse Event|0|||
156876184|NCT01904773|566305763|FG005|First Intervention|Adverse Event|0|||
156876185|NCT01904773|566305764|FG006|First Intervention|Adverse Event|1|||
156876186|NCT01904773|566305765|FG007|First Intervention|Adverse Event|0|||
156876187|NCT01904773|566305766|FG008|First Intervention|Adverse Event|0|||
156876188|NCT01904773|566305758|FG000|Placebo Washout First Intervention|Condition worsened|0|||
156876189|NCT01904773|566305759|FG001|Placebo Washout First Intervention|Condition worsened|1|||
156876190|NCT01904773|566305760|FG002|Placebo Washout First Intervention|Condition worsened|0|||
156876191|NCT01904773|566305761|FG003|Placebo Washout First Intervention|Condition worsened|0|||
156876192|NCT01904773|566305762|FG004|Placebo Washout First Intervention|Condition worsened|0|||
156876193|NCT01904773|566305763|FG005|Placebo Washout First Intervention|Condition worsened|0|||
156876194|NCT01904773|566305764|FG006|Placebo Washout First Intervention|Condition worsened|0|||
156876195|NCT01904773|566305765|FG007|Placebo Washout First Intervention|Condition worsened|0|||
156876196|NCT01904773|566305766|FG008|Placebo Washout First Intervention|Condition worsened|0|||
156876197|NCT01904773|566305758|FG000|Fifth Intervention|Adverse Event|0|||
156453720|NCT04209465|564754833|FG006|Overall Study|Physician Decision|0|||
156876198|NCT01904773|566305759|FG001|Fifth Intervention|Adverse Event|0|||
156876199|NCT01904773|566305760|FG002|Fifth Intervention|Adverse Event|0|||
156726494|NCT04509076|565746261|FG000|Overall Study|Withdrawal by Subject|1|||
156726495|NCT04509076|565746262|FG001|Overall Study|Withdrawal by Subject|2|||
156726496|NCT04509076|565746261|FG000|Overall Study|Lost to Follow-up|1|||
156726497|NCT04509076|565746262|FG001|Overall Study|Lost to Follow-up|2|||
156726498|NCT03351608|565746263|FG000|Overall Study|Lost to Follow-up|0|||
156726499|NCT03351608|565746264|FG001|Overall Study|Lost to Follow-up|1|||
156726500|NCT03351608|565746265|FG002|Overall Study|Lost to Follow-up|1|||
156726501|NCT03351608|565746266|FG003|Overall Study|Lost to Follow-up|1|||
156726502|NCT03351608|565746267|FG004|Overall Study|Lost to Follow-up|1|||
156726503|NCT03351608|565746263|FG000|Overall Study|Physician Decision|1|||
156726504|NCT03351608|565746264|FG001|Overall Study|Physician Decision|0|||
156726505|NCT03351608|565746265|FG002|Overall Study|Physician Decision|0|||
156726506|NCT03351608|565746266|FG003|Overall Study|Physician Decision|2|||
156726507|NCT03351608|565746267|FG004|Overall Study|Physician Decision|1|||
156726508|NCT03351608|565746263|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
156726509|NCT03351608|565746264|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
156726510|NCT03351608|565746265|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
156726511|NCT03351608|565746266|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
156726512|NCT03351608|565746267|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
156726513|NCT03351608|565746263|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156726514|NCT03351608|565746264|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156726515|NCT03351608|565746265|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156726516|NCT03351608|565746266|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156726517|NCT03351608|565746267|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156726518|NCT03351608|565746263|FG000|Overall Study|Other|0|||
156726519|NCT03351608|565746264|FG001|Overall Study|Other|1|||
156726520|NCT03351608|565746265|FG002|Overall Study|Other|1|||
156726521|NCT03351608|565746266|FG003|Overall Study|Other|3|||
156726522|NCT03351608|565746267|FG004|Overall Study|Other|0|||
156726523|NCT02877004|565746268|FG000|Overall Study|Pregnancy|0|||
156726524|NCT02877004|565746269|FG001|Overall Study|Pregnancy|0|||
156726525|NCT02877004|565746270|FG002|Overall Study|Pregnancy|1|||
156726526|NCT02727478|565746271|FG000|Overall Study|Withdrawal by Subject|8|||
156726527|NCT02727478|565746272|FG001|Overall Study|Withdrawal by Subject|10|||
156726528|NCT02633293|565746273|FG000|Overall Study|Death|56|||
156726529|NCT02633293|565746273|FG000|Overall Study|Progressive Disease|12|||
156726530|NCT02633293|565746273|FG000|Overall Study|Adverse Event|29|||
156726531|NCT02633293|565746273|FG000|Overall Study|Withdrawal by Subject|41|||
156726532|NCT02633293|565746273|FG000|Overall Study|Protocol Violation|1|||
156726533|NCT02633293|565746273|FG000|Overall Study|Lost to Follow-up|1|||
156726534|NCT02633293|565746273|FG000|Overall Study|Study Terminated by Sponsor|24|||
156726535|NCT02633293|565746273|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
156726536|NCT02633293|565746273|FG000|Overall Study|Lung Transplant|5|||
156726537|NCT02633293|565746273|FG000|Overall Study|Lack of Efficacy|2|||
156726538|NCT02633293|565746273|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
156726539|NCT01418378|565746274|FG000|Overall Study|Death|1|||
156726540|NCT01418378|565746275|FG001|Overall Study|Death|2|||
156726541|NCT01418378|565746274|FG000|Overall Study|Physician Decision|0|||
156726542|NCT01418378|565746275|FG001|Overall Study|Physician Decision|1|||
156726543|NCT01418378|565746274|FG000|Overall Study|ligament imbalance|0|||
156726544|NCT01418378|565746275|FG001|Overall Study|ligament imbalance|1|||
156726545|NCT01418378|565746274|FG000|Overall Study|developed chronic myopathy|0|||
156726546|NCT01418378|565746275|FG001|Overall Study|developed chronic myopathy|1|||
156726547|NCT01790984|565746278|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
156726548|NCT01790984|565746279|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
156876200|NCT01904773|566305761|FG003|Fifth Intervention|Adverse Event|0|||
156336125|NCT00347360|564328195|FG003|Overall Study|PI recommended early withdrawal|0|||
156453721|NCT04209465|564754834|FG007|Overall Study|Physician Decision|0|||
156453722|NCT04209465|564754835|FG008|Overall Study|Physician Decision|0|||
156453723|NCT04209465|564754836|FG009|Overall Study|Physician Decision|0|||
156453724|NCT04209465|564754837|FG010|Overall Study|Physician Decision|0|||
156453725|NCT04209465|564754838|FG011|Overall Study|Physician Decision|0|||
156453726|NCT04209465|564754839|FG012|Overall Study|Physician Decision|0|||
156453727|NCT04209465|564754827|FG000|Overall Study|Progressive Disease|0|||
156453728|NCT04209465|564754828|FG001|Overall Study|Progressive Disease|0|||
156453729|NCT04209465|564754829|FG002|Overall Study|Progressive Disease|1|||
156453730|NCT04209465|564754830|FG003|Overall Study|Progressive Disease|2|||
156453731|NCT04209465|564754831|FG004|Overall Study|Progressive Disease|8|||
156453732|NCT04209465|564754832|FG005|Overall Study|Progressive Disease|5|||
156453733|NCT04209465|564754833|FG006|Overall Study|Progressive Disease|3|||
156453734|NCT04209465|564754834|FG007|Overall Study|Progressive Disease|4|||
156453735|NCT04209465|564754835|FG008|Overall Study|Progressive Disease|1|||
156453736|NCT04209465|564754836|FG009|Overall Study|Progressive Disease|3|||
156453737|NCT04209465|564754837|FG010|Overall Study|Progressive Disease|2|||
156726549|NCT01790984|565746280|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
156726550|NCT01790984|565746281|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
156726551|NCT01051791|565746282|FG000|Overall Study|Failed screening|3|||
156726552|NCT01051791|565746282|FG000|Overall Study|Withdrawal by Subject|1|||
156726553|NCT00288626|565746285|FG000|Overall Study|Death|3|||
156726554|NCT00288626|565746285|FG000|Overall Study|Withdrawal by Subject|4|||
156726555|NCT01609296|565746286|FG000|Overall Study|Death|253|||
156726556|NCT01609296|565746286|FG000|Overall Study|Withdrawal by Subject|151|||
156726557|NCT01609296|565746286|FG000|Overall Study|Lost to Follow-up|21|||
156726558|NCT01609296|565746286|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
156726559|NCT01609296|565746286|FG000|Overall Study|missed visit but known to be alive|28|||
156726560|NCT00546377|565746289|FG000|Overall Study|Deemed ineligible|1|||
156726561|NCT00546377|565746289|FG000|Overall Study|Adverse Event|6|||
156726562|NCT01575834|565746290|FG000|Overall Study|Withdrawal by Subject|352|||
156726563|NCT01575834|565746291|FG001|Overall Study|Withdrawal by Subject|390|||
156726564|NCT01575834|565746290|FG000|Overall Study|Death|81|||
156726565|NCT01575834|565746291|FG001|Overall Study|Death|74|||
156726566|NCT01575834|565746290|FG000|Overall Study|Other|70|||
156726567|NCT01575834|565746291|FG001|Overall Study|Other|70|||
156726568|NCT01575834|565746290|FG000|Overall Study|Adverse Event|63|||
156726569|NCT01575834|565746291|FG001|Overall Study|Adverse Event|61|||
156726570|NCT01575834|565746290|FG000|Overall Study|Lost to Follow-up|55|||
156726571|NCT01575834|565746291|FG001|Overall Study|Lost to Follow-up|68|||
156726572|NCT01575834|565746290|FG000|Overall Study|Noncompliance|52|||
156726573|NCT01575834|565746291|FG001|Overall Study|Noncompliance|27|||
156726574|NCT01575834|565746290|FG000|Overall Study|Administrative decision|15|||
156726575|NCT01575834|565746291|FG001|Overall Study|Administrative decision|33|||
156726576|NCT01575834|565746290|FG000|Overall Study|Ineligibility Determined|5|||
156726577|NCT01575834|565746291|FG001|Overall Study|Ineligibility Determined|8|||
156726578|NCT01575834|565746290|FG000|Overall Study|Protocol Deviation|4|||
156726579|NCT01575834|565746291|FG001|Overall Study|Protocol Deviation|3|||
156726580|NCT01575834|565746290|FG000|Overall Study|Requirement for Alternative Therapy|2|||
156726581|NCT01575834|565746291|FG001|Overall Study|Requirement for Alternative Therapy|4|||
156726582|NCT02155283|565746292|FG000|Overall Study|Lost to Follow-up|3|||
156726583|NCT02155283|565746292|FG000|Overall Study|Withdrawal by Subject|1|||
156726584|NCT02155283|565746292|FG000|Overall Study|Protocol Violation|3|||
156726585|NCT02282813|565746294|FG000|Overall Study|Withdrawal by Subject|4|||
156726586|NCT02282813|565746295|FG001|Overall Study|Withdrawal by Subject|5|||
156726587|NCT02282813|565746296|FG002|Overall Study|Withdrawal by Subject|0|||
156726588|NCT02282813|565746294|FG000|Overall Study|Adverse Event|3|||
156726589|NCT02282813|565746295|FG001|Overall Study|Adverse Event|10|||
156726590|NCT02282813|565746296|FG002|Overall Study|Adverse Event|1|||
156726591|NCT02282813|565746294|FG000|Overall Study|Subject non-compliance|1|||
156726592|NCT02282813|565746295|FG001|Overall Study|Subject non-compliance|4|||
156726593|NCT02282813|565746296|FG002|Overall Study|Subject non-compliance|0|||
156726594|NCT02282813|565746294|FG000|Overall Study|Physician Decision|0|||
156726595|NCT02282813|565746295|FG001|Overall Study|Physician Decision|3|||
156726596|NCT02282813|565746296|FG002|Overall Study|Physician Decision|1|||
156726597|NCT02282813|565746294|FG000|Overall Study|Lost to Follow-up|2|||
156726598|NCT02282813|565746295|FG001|Overall Study|Lost to Follow-up|0|||
156726599|NCT02282813|565746296|FG002|Overall Study|Lost to Follow-up|1|||
156726600|NCT02282813|565746294|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
156726601|NCT02282813|565746295|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
156726602|NCT02282813|565746296|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
156726603|NCT02282813|565746294|FG000|Overall Study|Lack of Efficacy|1|||
156726604|NCT02282813|565746295|FG001|Overall Study|Lack of Efficacy|0|||
156726605|NCT02282813|565746296|FG002|Overall Study|Lack of Efficacy|0|||
156726606|NCT02282813|565746294|FG000|Overall Study|Administrative reasons|0|||
156726607|NCT02282813|565746295|FG001|Overall Study|Administrative reasons|1|||
156726608|NCT02282813|565746296|FG002|Overall Study|Administrative reasons|0|||
156726609|NCT02268916|565746299|FG000|Overall Study|Lost to Follow-up|1|||
156726610|NCT02268916|565746300|FG001|Overall Study|Lost to Follow-up|1|||
156726611|NCT02268916|565746299|FG000|Overall Study|Withdrawal by Subject|6|||
156726612|NCT02268916|565746300|FG001|Overall Study|Withdrawal by Subject|5|||
156726613|NCT02268916|565746299|FG000|Overall Study|Participant did not have diabetes|1|||
156453738|NCT04209465|564754838|FG011|Overall Study|Progressive Disease|1|||
156453739|NCT04209465|564754839|FG012|Overall Study|Progressive Disease|0|||
156453740|NCT04209465|564754827|FG000|Overall Study|Withdrawal by Subject|0|||
156453741|NCT04209465|564754828|FG001|Overall Study|Withdrawal by Subject|0|||
156726614|NCT02268916|565746300|FG001|Overall Study|Participant did not have diabetes|0|||
156726615|NCT02268916|565746299|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
156726616|NCT02268916|565746300|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
156726617|NCT04526288|565746307|FG000|Overall Study|Disease Progression|1|||
156453742|NCT04209465|564754829|FG002|Overall Study|Withdrawal by Subject|0|||
156726618|NCT04526288|565746308|FG001|Overall Study|Disease Progression|0|||
156726619|NCT01796392|565746311|FG000|Overall Study|Withdrawal by Subject|2|||
156726620|NCT01796392|565746312|FG001|Overall Study|Withdrawal by Subject|0|||
156726621|NCT01796392|565746311|FG000|Overall Study|Death|5|||
156453743|NCT04209465|564754830|FG003|Overall Study|Withdrawal by Subject|0|||
156795622|NCT01497197|566006135|FG001|Overall Study|Intention to freeze all embryos|1|||
156453744|NCT04209465|564754831|FG004|Overall Study|Withdrawal by Subject|0|||
156453745|NCT04209465|564754832|FG005|Overall Study|Withdrawal by Subject|1|||
156453746|NCT04209465|564754833|FG006|Overall Study|Withdrawal by Subject|2|||
156453747|NCT04209465|564754834|FG007|Overall Study|Withdrawal by Subject|0|||
156453748|NCT04209465|564754835|FG008|Overall Study|Withdrawal by Subject|1|||
156453749|NCT04209465|564754836|FG009|Overall Study|Withdrawal by Subject|0|||
156453750|NCT04209465|564754837|FG010|Overall Study|Withdrawal by Subject|0|||
156453751|NCT04209465|564754838|FG011|Overall Study|Withdrawal by Subject|2|||
156453752|NCT04209465|564754839|FG012|Overall Study|Withdrawal by Subject|2|||
156453753|NCT04209465|564754827|FG000|Overall Study|Lost to Follow-up|0|||
156453754|NCT04209465|564754828|FG001|Overall Study|Lost to Follow-up|0|||
156453755|NCT04209465|564754829|FG002|Overall Study|Lost to Follow-up|0|||
156453756|NCT04209465|564754830|FG003|Overall Study|Lost to Follow-up|0|||
156453757|NCT04209465|564754831|FG004|Overall Study|Lost to Follow-up|0|||
156726622|NCT01796392|565746312|FG001|Overall Study|Death|1|||
156726623|NCT01796392|565746311|FG000|Overall Study|Excluded for medical reasons|1|||
156726624|NCT01796392|565746312|FG001|Overall Study|Excluded for medical reasons|2|||
156726625|NCT01796392|565746311|FG000|Overall Study|Lost to Follow-up|1|||
156726626|NCT01796392|565746312|FG001|Overall Study|Lost to Follow-up|0|||
156726627|NCT04639219|565746313|FG000|Overall Study|Withdrawal by Subject|8|||
156336126|NCT00347360|564328196|FG004|Overall Study|PI recommended early withdrawal|0|||
156336127|NCT00347360|564328197|FG005|Overall Study|PI recommended early withdrawal|0|||
156336128|NCT00347360|564328198|FG006|Overall Study|PI recommended early withdrawal|0|||
156336129|NCT00347360|564328199|FG007|Overall Study|PI recommended early withdrawal|0|||
156453758|NCT04209465|564754832|FG005|Overall Study|Lost to Follow-up|1|||
156726628|NCT04639219|565746313|FG000|Overall Study|Lost to Follow-up|6|||
156726629|NCT04639219|565746313|FG000|Overall Study|Death|55|||
156726630|NCT02747108|565746317|FG000|Overall Study|Death|2|||
156726631|NCT02747108|565746318|FG001|Overall Study|Death|2|||
156726632|NCT02747108|565746317|FG000|Overall Study|Withdrawal by Subject|1|||
156726633|NCT02747108|565746318|FG001|Overall Study|Withdrawal by Subject|0|||
156726634|NCT02747108|565746317|FG000|Overall Study|Protocol Violation|2|||
156726635|NCT02747108|565746318|FG001|Overall Study|Protocol Violation|0|||
156726636|NCT03474965|565746319|FG000|Overall Study|Pregnancy|1|||
156726637|NCT03474965|565746320|FG001|Overall Study|Pregnancy|0|||
156726638|NCT03474965|565746321|FG002|Overall Study|Pregnancy|0|||
156726639|NCT03474965|565746322|FG003|Overall Study|Pregnancy|0|||
156726640|NCT03474965|565746319|FG000|Overall Study|Lost to Follow-up|0|||
156726641|NCT03474965|565746320|FG001|Overall Study|Lost to Follow-up|0|||
156726642|NCT03474965|565746321|FG002|Overall Study|Lost to Follow-up|1|||
156726643|NCT03474965|565746322|FG003|Overall Study|Lost to Follow-up|0|||
156726644|NCT03474965|565746319|FG000|Overall Study|Death|1|||
156726645|NCT03474965|565746320|FG001|Overall Study|Death|0|||
156726646|NCT03474965|565746321|FG002|Overall Study|Death|0|||
156726647|NCT03474965|565746322|FG003|Overall Study|Death|0|||
156726648|NCT03474965|565746319|FG000|Overall Study|Adverse Event|1|||
156726649|NCT03474965|565746320|FG001|Overall Study|Adverse Event|0|||
156726650|NCT03474965|565746321|FG002|Overall Study|Adverse Event|0|||
156726651|NCT03474965|565746322|FG003|Overall Study|Adverse Event|1|||
156726652|NCT03474965|565746319|FG000|Overall Study|Physician Decision|3|||
156726653|NCT03474965|565746320|FG001|Overall Study|Physician Decision|1|||
156726654|NCT03474965|565746321|FG002|Overall Study|Physician Decision|2|||
156726655|NCT03474965|565746322|FG003|Overall Study|Physician Decision|0|||
156726656|NCT03474965|565746319|FG000|Overall Study|Participant Decision|7|||
156726657|NCT03474965|565746320|FG001|Overall Study|Participant Decision|0|||
156726658|NCT03474965|565746321|FG002|Overall Study|Participant Decision|1|||
156726659|NCT03474965|565746322|FG003|Overall Study|Participant Decision|0|||
156726660|NCT03474965|565746319|FG000|Overall Study|Guardian Decision|4|||
156726661|NCT03474965|565746320|FG001|Overall Study|Guardian Decision|2|||
156726662|NCT03474965|565746321|FG002|Overall Study|Guardian Decision|7|||
156726663|NCT03474965|565746322|FG003|Overall Study|Guardian Decision|2|||
156726664|NCT05678959|565748241|FG000|Overall Study|Study Terminated by Sponsor|76|||
156726665|NCT05678959|565748242|FG001|Overall Study|Study Terminated by Sponsor|76|||
156726666|NCT05678959|565748241|FG000|Overall Study|Physician Decision|2|||
156726667|NCT05678959|565748242|FG001|Overall Study|Physician Decision|3|||
156726668|NCT05678959|565748241|FG000|Overall Study|Adverse Event|1|||
156726669|NCT05678959|565748242|FG001|Overall Study|Adverse Event|1|||
156876201|NCT01904773|566305762|FG004|Fifth Intervention|Adverse Event|0|||
156453759|NCT04209465|564754833|FG006|Overall Study|Lost to Follow-up|0|||
156453760|NCT04209465|564754834|FG007|Overall Study|Lost to Follow-up|0|||
156453761|NCT04209465|564754835|FG008|Overall Study|Lost to Follow-up|1|||
156453762|NCT04209465|564754836|FG009|Overall Study|Lost to Follow-up|0|||
156453763|NCT04209465|564754837|FG010|Overall Study|Lost to Follow-up|0|||
156726670|NCT05678959|565748241|FG000|Overall Study|Guardian Decision|1|||
156726671|NCT05678959|565748242|FG001|Overall Study|Guardian Decision|0|||
156726672|NCT05678959|565748241|FG000|Overall Study|Protocol Deviation|0|||
156453764|NCT04209465|564754838|FG011|Overall Study|Lost to Follow-up|1|||
156726673|NCT05678959|565748242|FG001|Overall Study|Protocol Deviation|1|||
156726674|NCT05678959|565748241|FG000|Overall Study|Subject Decision|1|||
156726675|NCT05678959|565748242|FG001|Overall Study|Subject Decision|0|||
156453765|NCT04209465|564754839|FG012|Overall Study|Lost to Follow-up|0|||
156453766|NCT04209465|564754827|FG000|Overall Study|Started new therapy|0|||
156453767|NCT04209465|564754828|FG001|Overall Study|Started new therapy|0|||
156453768|NCT04209465|564754829|FG002|Overall Study|Started new therapy|0|||
156453769|NCT04209465|564754830|FG003|Overall Study|Started new therapy|0|||
156453770|NCT04209465|564754831|FG004|Overall Study|Started new therapy|0|||
156453771|NCT04209465|564754832|FG005|Overall Study|Started new therapy|1|||
156453772|NCT04209465|564754833|FG006|Overall Study|Started new therapy|0|||
156453773|NCT04209465|564754834|FG007|Overall Study|Started new therapy|0|||
156453774|NCT04209465|564754835|FG008|Overall Study|Started new therapy|0|||
156453775|NCT04209465|564754836|FG009|Overall Study|Started new therapy|0|||
156453776|NCT04209465|564754837|FG010|Overall Study|Started new therapy|0|||
156453777|NCT04209465|564754838|FG011|Overall Study|Started new therapy|0|||
156453778|NCT04209465|564754839|FG012|Overall Study|Started new therapy|0|||
156726676|NCT05678959|565748241|FG000|Overall Study|Technical Problem|0|||
156726677|NCT05678959|565748242|FG001|Overall Study|Technical Problem|1|||
156726678|NCT03503370|565748243|FG000|Overall Study|Death|3|||
156726679|NCT03503370|565748244|FG001|Overall Study|Death|1|||
156726680|NCT03483961|565748245|FG000|Overall Study|Lost to Follow-up|7|||
156726681|NCT03483961|565748246|FG001|Overall Study|Lost to Follow-up|6|||
156726682|NCT03483961|565748247|FG002|Overall Study|Lost to Follow-up|6|||
156726683|NCT03483961|565748248|FG003|Overall Study|Lost to Follow-up|6|||
156726684|NCT03483961|565748249|FG004|Overall Study|Lost to Follow-up|6|||
156726685|NCT03483961|565748250|FG005|Overall Study|Lost to Follow-up|4|||
156726686|NCT03483961|565748251|FG006|Overall Study|Lost to Follow-up|4|||
156726687|NCT03483961|565748252|FG007|Overall Study|Lost to Follow-up|11|||
156726688|NCT03483961|565748253|FG008|Overall Study|Lost to Follow-up|1|||
156726689|NCT03483961|565748254|FG009|Overall Study|Lost to Follow-up|0|||
156726690|NCT03483961|565748245|FG000|Overall Study|Withdrawal by Subject|3|||
156726691|NCT03483961|565748246|FG001|Overall Study|Withdrawal by Subject|4|||
156726692|NCT03483961|565748247|FG002|Overall Study|Withdrawal by Subject|5|||
156726693|NCT03483961|565748248|FG003|Overall Study|Withdrawal by Subject|3|||
156726694|NCT03483961|565748249|FG004|Overall Study|Withdrawal by Subject|4|||
156726695|NCT03483961|565748250|FG005|Overall Study|Withdrawal by Subject|2|||
156726696|NCT03483961|565748251|FG006|Overall Study|Withdrawal by Subject|1|||
156726697|NCT03483961|565748252|FG007|Overall Study|Withdrawal by Subject|2|||
156726698|NCT03483961|565748253|FG008|Overall Study|Withdrawal by Subject|1|||
156726699|NCT03483961|565748254|FG009|Overall Study|Withdrawal by Subject|0|||
156336130|NCT00347360|564328200|FG008|Overall Study|PI recommended early withdrawal|0|||
156336131|NCT00347360|564328201|FG009|Overall Study|PI recommended early withdrawal|1|||
156336132|NCT00347360|564328202|FG010|Overall Study|PI recommended early withdrawal|0|||
156453779|NCT04209465|564754827|FG000|Overall Study|Study terminated early by sponsor|0|||
156453780|NCT04209465|564754828|FG001|Overall Study|Study terminated early by sponsor|0|||
156453781|NCT04209465|564754829|FG002|Overall Study|Study terminated early by sponsor|0|||
156453782|NCT04209465|564754830|FG003|Overall Study|Study terminated early by sponsor|0|||
156453783|NCT04209465|564754831|FG004|Overall Study|Study terminated early by sponsor|0|||
156453784|NCT04209465|564754832|FG005|Overall Study|Study terminated early by sponsor|0|||
156453785|NCT04209465|564754833|FG006|Overall Study|Study terminated early by sponsor|3|||
156453786|NCT04209465|564754834|FG007|Overall Study|Study terminated early by sponsor|0|||
156453787|NCT04209465|564754835|FG008|Overall Study|Study terminated early by sponsor|0|||
156453788|NCT04209465|564754836|FG009|Overall Study|Study terminated early by sponsor|0|||
156453789|NCT04209465|564754837|FG010|Overall Study|Study terminated early by sponsor|0|||
156453790|NCT04209465|564754838|FG011|Overall Study|Study terminated early by sponsor|0|||
156453791|NCT04209465|564754839|FG012|Overall Study|Study terminated early by sponsor|3|||
156453792|NCT04209465|564754827|FG000|Overall Study|Other|0|||
156453793|NCT04209465|564754828|FG001|Overall Study|Other|0|||
156453794|NCT04209465|564754829|FG002|Overall Study|Other|0|||
156453795|NCT04209465|564754830|FG003|Overall Study|Other|0|||
156453796|NCT04209465|564754831|FG004|Overall Study|Other|0|||
156453797|NCT04209465|564754832|FG005|Overall Study|Other|0|||
156453798|NCT04209465|564754833|FG006|Overall Study|Other|0|||
156453799|NCT04209465|564754834|FG007|Overall Study|Other|0|||
156453800|NCT04209465|564754835|FG008|Overall Study|Other|1|||
156453801|NCT04209465|564754836|FG009|Overall Study|Other|0|||
156453802|NCT04209465|564754837|FG010|Overall Study|Other|0|||
156453803|NCT04209465|564754838|FG011|Overall Study|Other|0|||
156533554|NCT02459769|565048851|FG000|Overall Study|Withdrawal by Subject|7|||
156726700|NCT03483961|565748245|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
156795623|NCT01497197|566006134|FG000|Overall Study|All embryos discarded|0|||
156336133|NCT00347360|564328203|FG011|Overall Study|PI recommended early withdrawal|0|||
156453804|NCT04209465|564754839|FG012|Overall Study|Other|0|||
156453805|NCT05647304|564754840|FG000|Overall Study|Withdrawal by Subject|1|||
156453806|NCT05647304|564754841|FG001|Overall Study|Withdrawal by Subject|0|||
156453807|NCT04171999|564754842|FG000|Overall Study|deemed ineligible after randomization|2|||
156533555|NCT02459769|565048852|FG001|Overall Study|Withdrawal by Subject|4|||
156453808|NCT04171999|564754843|FG001|Overall Study|deemed ineligible after randomization|1|||
156453809|NCT03092518|564754844|FG000|Overall Study|Ineligible|2|||
156726701|NCT03483961|565748246|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726702|NCT03483961|565748247|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726703|NCT03483961|565748248|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726704|NCT03483961|565748249|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726705|NCT03483961|565748250|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726706|NCT03483961|565748251|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726707|NCT03483961|565748252|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726708|NCT03483961|565748253|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726709|NCT03483961|565748254|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726710|NCT03483961|565748245|FG000|Overall Study|Adverse Event|0|||
156726711|NCT03483961|565748246|FG001|Overall Study|Adverse Event|0|||
156726712|NCT03483961|565748247|FG002|Overall Study|Adverse Event|1|||
156726713|NCT03483961|565748248|FG003|Overall Study|Adverse Event|0|||
156726714|NCT03483961|565748249|FG004|Overall Study|Adverse Event|0|||
156726715|NCT03483961|565748250|FG005|Overall Study|Adverse Event|0|||
156726716|NCT03483961|565748251|FG006|Overall Study|Adverse Event|0|||
156726717|NCT03483961|565748252|FG007|Overall Study|Adverse Event|0|||
156726718|NCT03483961|565748253|FG008|Overall Study|Adverse Event|0|||
156726719|NCT03483961|565748254|FG009|Overall Study|Adverse Event|0|||
156726720|NCT00734162|565748255|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
156726721|NCT00734162|565748256|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
156726722|NCT00734162|565748257|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
156726723|NCT00734162|565748258|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
156726724|NCT00734162|565748255|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
156726725|NCT00734162|565748256|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
156726726|NCT00734162|565748257|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
156726727|NCT00734162|565748258|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
156726728|NCT00734162|565748255|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
156726729|NCT00734162|565748256|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
156726730|NCT00734162|565748257|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
156726731|NCT00734162|565748258|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
156726732|NCT00734162|565748255|FG000|Open-Label Phase|Withdrew Consent|1|||
156726733|NCT00734162|565748256|FG001|Open-Label Phase|Withdrew Consent|0|||
156726734|NCT00734162|565748257|FG002|Open-Label Phase|Withdrew Consent|1|||
156726735|NCT00734162|565748258|FG003|Open-Label Phase|Withdrew Consent|1|||
156726736|NCT00734162|565748255|FG000|Open-Label Phase|Lost to Follow-up|1|||
156726737|NCT00734162|565748256|FG001|Open-Label Phase|Lost to Follow-up|2|||
156726738|NCT00734162|565748257|FG002|Open-Label Phase|Lost to Follow-up|0|||
156726739|NCT00734162|565748258|FG003|Open-Label Phase|Lost to Follow-up|1|||
156726740|NCT00734162|565748255|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
156726741|NCT00734162|565748256|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
156726742|NCT00734162|565748257|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
156726743|NCT00734162|565748258|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
156726744|NCT00566020|565748259|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
156726745|NCT00566020|565748260|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
156726746|NCT00566020|565748259|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
156726747|NCT00566020|565748260|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
156726748|NCT00566020|565748259|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
156726749|NCT00566020|565748260|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
156726750|NCT00566020|565748259|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
156726751|NCT00566020|565748260|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
156726752|NCT00566020|565748259|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
156726753|NCT00566020|565748260|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
156726754|NCT00566020|565748259|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
156726755|NCT00566020|565748260|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
156726756|NCT02058537|565748261|FG000|Overall Study|Withdrawal by Subject|1|||
156795624|NCT01497197|566006135|FG001|Overall Study|All embryos discarded|3|||
156795625|NCT01497197|566006134|FG000|Overall Study|Other|3|||
156795626|NCT01497197|566006135|FG001|Overall Study|Other|1|||
156795627|NCT04484857|566006136|FG000|Overall Study|Adverse Event|2|||
156795628|NCT04484857|566006136|FG000|Overall Study|Death|10|||
156795629|NCT04484857|566006136|FG000|Overall Study|Withdrawal by Subject|3|||
156795630|NCT04484857|566006136|FG000|Overall Study|Transferred/Relocation|5|||
156726757|NCT02609607|565748267|FG000|Overall Study|Lost to Follow-up|0|||
156726758|NCT02609607|565748268|FG001|Overall Study|Lost to Follow-up|1|||
156795631|NCT04484857|566006136|FG000|Overall Study|Kidney Transplant|7|||
156876202|NCT01904773|566305763|FG005|Fifth Intervention|Adverse Event|0|||
156726759|NCT00651261|565748269|FG000|Overall Study|Adverse Event|32|||
156336134|NCT00347360|564328204|FG012|Overall Study|PI recommended early withdrawal|0|||
156336135|NCT00347360|564328205|FG013|Overall Study|PI recommended early withdrawal|0|||
156336136|NCT00347360|564328206|FG014|Overall Study|PI recommended early withdrawal|0|||
156336137|NCT00347360|564328192|FG000|Overall Study|Did not meet criteria before ABPM|0|||
156336138|NCT00347360|564328193|FG001|Overall Study|Did not meet criteria before ABPM|0|||
156336139|NCT00347360|564328194|FG002|Overall Study|Did not meet criteria before ABPM|0|||
156336140|NCT00347360|564328195|FG003|Overall Study|Did not meet criteria before ABPM|0|||
156336141|NCT00347360|564328196|FG004|Overall Study|Did not meet criteria before ABPM|0|||
156336142|NCT00347360|564328197|FG005|Overall Study|Did not meet criteria before ABPM|0|||
156336143|NCT00347360|564328198|FG006|Overall Study|Did not meet criteria before ABPM|0|||
156336144|NCT00347360|564328199|FG007|Overall Study|Did not meet criteria before ABPM|0|||
156336145|NCT00347360|564328200|FG008|Overall Study|Did not meet criteria before ABPM|0|||
156336146|NCT00347360|564328201|FG009|Overall Study|Did not meet criteria before ABPM|0|||
156336147|NCT00347360|564328202|FG010|Overall Study|Did not meet criteria before ABPM|1|||
156336148|NCT00347360|564328203|FG011|Overall Study|Did not meet criteria before ABPM|0|||
156453810|NCT02547987|564754845|FG000|Overall Study|Withdrawal by Subject|1|||
156726760|NCT00651261|565748270|FG001|Overall Study|Adverse Event|22|||
156726761|NCT00651261|565748269|FG000|Overall Study|Death|18|||
156726762|NCT00651261|565748270|FG001|Overall Study|Death|18|||
156726763|NCT00651261|565748269|FG000|Overall Study|Withdrawal by Subject|22|||
156726764|NCT00651261|565748270|FG001|Overall Study|Withdrawal by Subject|40|||
156726765|NCT00651261|565748269|FG000|Overall Study|Induction failure|24|||
156726766|NCT00651261|565748270|FG001|Overall Study|Induction failure|35|||
156726767|NCT00651261|565748269|FG000|Overall Study|Disease progression|58|||
156726768|NCT00651261|565748270|FG001|Overall Study|Disease progression|58|||
156726769|NCT00651261|565748269|FG000|Overall Study|Alternative therapy|109|||
156726770|NCT00651261|565748270|FG001|Overall Study|Alternative therapy|107|||
156726771|NCT00651261|565748269|FG000|Overall Study|Other disease or participant decisions|23|||
156726772|NCT00651261|565748270|FG001|Overall Study|Other disease or participant decisions|23|||
156453811|NCT02547987|564754845|FG000|Overall Study|Adverse Event|2|||
156453812|NCT05089019|564754857|FG000|Period 1|Withdrawal by Subject|0|||
156453813|NCT05089019|564754858|FG001|Period 1|Withdrawal by Subject|1|||
156453814|NCT05089019|564754857|FG000|Washout Period|Adverse Event|3|||
156453815|NCT05089019|564754858|FG001|Washout Period|Adverse Event|4|||
156453816|NCT05089019|564754857|FG000|Washout Period|Lost to Follow-up|1|||
156453817|NCT05089019|564754858|FG001|Washout Period|Lost to Follow-up|0|||
156453818|NCT05089019|564754857|FG000|Washout Period|Physician Decision|2|||
156453819|NCT05089019|564754858|FG001|Washout Period|Physician Decision|0|||
156453820|NCT05089019|564754857|FG000|Washout Period|Withdrawal by Subject|6|||
156453821|NCT05089019|564754858|FG001|Washout Period|Withdrawal by Subject|3|||
156453822|NCT05089019|564754857|FG000|Period 2|Adverse Event|4|||
156453823|NCT05089019|564754858|FG001|Period 2|Adverse Event|2|||
156453824|NCT05089019|564754857|FG000|Period 2|Lost to Follow-up|1|||
156453825|NCT05089019|564754858|FG001|Period 2|Lost to Follow-up|0|||
156453826|NCT05089019|564754857|FG000|Period 2|Withdrawal by Subject|0|||
156453827|NCT05089019|564754858|FG001|Period 2|Withdrawal by Subject|1|||
156453828|NCT05170009|564754859|FG000|Overall Study|Physician Decision|0|||
156453829|NCT05170009|564754860|FG001|Overall Study|Physician Decision|1|||
156453830|NCT04925986|564754861|FG000|Overall Study|Death|0|||
156453831|NCT04925986|564754862|FG001|Overall Study|Death|0|||
156453832|NCT04925986|564754863|FG002|Overall Study|Death|2|||
156453833|NCT04925986|564754864|FG003|Overall Study|Death|0|||
156453834|NCT04925986|564754861|FG000|Overall Study|Lack of Efficacy|1|||
156453835|NCT04925986|564754862|FG001|Overall Study|Lack of Efficacy|2|||
156453836|NCT04925986|564754863|FG002|Overall Study|Lack of Efficacy|0|||
156453837|NCT04925986|564754864|FG003|Overall Study|Lack of Efficacy|1|||
156453838|NCT04925986|564754861|FG000|Overall Study|Withdrawal by Subject|0|||
156453839|NCT04925986|564754862|FG001|Overall Study|Withdrawal by Subject|0|||
156453840|NCT04925986|564754863|FG002|Overall Study|Withdrawal by Subject|1|||
156453841|NCT04925986|564754864|FG003|Overall Study|Withdrawal by Subject|2|||
156453842|NCT05457647|564754866|FG000|Overall Study|Lost to Follow-up|3|||
156726773|NCT00651261|565748269|FG000|Overall Study|Never treated|5|||
156726774|NCT00651261|565748270|FG001|Overall Study|Never treated|3|||
156453843|NCT03115476|564754867|FG000|LP0084-1369|Death|1|||
156726775|NCT04610346|565748273|FG000|Overall Study|Withdrawal by Subject|1|||
156726776|NCT04610346|565748274|FG001|Overall Study|Withdrawal by Subject|1|||
156726777|NCT04610346|565748273|FG000|Overall Study|did not complete shelter onboarding|2|||
156726778|NCT04610346|565748274|FG001|Overall Study|did not complete shelter onboarding|1|||
156533556|NCT02459769|565048853|FG002|Overall Study|Withdrawal by Subject|8|||
156726779|NCT00558467|565748275|FG000|Overall Study|Adverse Event|1|||
156453844|NCT03115476|564754868|FG001|LP0084-1369|Death|0|||
156453845|NCT03115476|564754869|FG002|LP0084-1369|Death|2|||
156453846|NCT03115476|564754867|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
156453847|NCT03115476|564754868|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
156453848|NCT03115476|564754869|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
156453849|NCT03865498|564754870|FG000|Overall Study|Lack of Efficacy|12|||
156453850|NCT03865498|564754871|FG001|Overall Study|Lack of Efficacy|11|||
156453851|NCT03865498|564754870|FG000|Overall Study|Lost to Follow-up|125|||
156453852|NCT03865498|564754871|FG001|Overall Study|Lost to Follow-up|133|||
156453853|NCT03865498|564754870|FG000|Overall Study|Withdrawal by Subject|2|||
156453854|NCT03865498|564754871|FG001|Overall Study|Withdrawal by Subject|4|||
156453855|NCT01648023|564754872|FG000|Overall Study|Screen Fail Post Randomization|1|||
156453856|NCT01648023|564754873|FG001|Overall Study|Screen Fail Post Randomization|2|||
156453857|NCT05296525|564754877|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
156453858|NCT05296525|564754878|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
156453859|NCT05296525|564754879|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
156453860|NCT05296525|564754880|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
156453861|NCT02547363|564754883|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
156453862|NCT02547363|564754884|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
156453863|NCT02547363|564754883|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
156453864|NCT02547363|564754884|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
156453865|NCT02547363|564754883|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
156453866|NCT02547363|564754884|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
156453867|NCT02547363|564754883|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
156453868|NCT02547363|564754884|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
156453869|NCT02547363|564754883|FG000|12-month Follow-up|Withdrawal by Subject|4|||
156453870|NCT02547363|564754884|FG001|12-month Follow-up|Withdrawal by Subject|3|||
156453871|NCT02547363|564754883|FG000|12-month Follow-up|Lost to Follow-up|4|||
156453872|NCT02547363|564754884|FG001|12-month Follow-up|Lost to Follow-up|1|||
156453873|NCT02547363|564754883|FG000|12-month Follow-up|Lack of Efficacy|1|||
156453874|NCT02547363|564754884|FG001|12-month Follow-up|Lack of Efficacy|1|||
156453875|NCT02547363|564754883|FG000|12-month Follow-up|Other|1|||
156453876|NCT02547363|564754884|FG001|12-month Follow-up|Other|0|||
156453877|NCT05228457|564754885|FG000|Overall Study|Withdrawal by Subject|1|||
156453878|NCT05228457|564754886|FG001|Overall Study|Withdrawal by Subject|1|||
156453879|NCT03161028|564754889|FG000|Overall Study|Withdrawal by Subject|6|||
156453880|NCT03161028|564754890|FG001|Overall Study|Withdrawal by Subject|4|||
156453881|NCT03161028|564754889|FG000|Overall Study|Adverse Event|5|||
156453882|NCT03161028|564754890|FG001|Overall Study|Adverse Event|1|||
156453883|NCT03161028|564754889|FG000|Overall Study|Study drug side effects|2|||
156453884|NCT03161028|564754890|FG001|Overall Study|Study drug side effects|2|||
156453885|NCT03161028|564754889|FG000|Overall Study|Administrative PD/UP|4|||
156453886|NCT03161028|564754890|FG001|Overall Study|Administrative PD/UP|2|||
156453887|NCT03161028|564754889|FG000|Overall Study|Lost to Follow-up|2|||
156453888|NCT03161028|564754890|FG001|Overall Study|Lost to Follow-up|0|||
156453889|NCT03161028|564754889|FG000|Overall Study|Unable to comply with procedures|1|||
156453890|NCT03161028|564754890|FG001|Overall Study|Unable to comply with procedures|1|||
156453891|NCT03492216|564754893|FG000|Overall Study|Death|1|||
156453892|NCT03492216|564754894|FG001|Overall Study|Death|0|||
156453893|NCT03492216|564754895|FG002|Overall Study|Death|4|||
156453894|NCT03492216|564754896|FG003|Overall Study|Death|0|||
156453895|NCT03492216|564754893|FG000|Overall Study|Withdrawal by Subject|5|||
156453896|NCT03492216|564754894|FG001|Overall Study|Withdrawal by Subject|3|||
156453897|NCT03492216|564754895|FG002|Overall Study|Withdrawal by Subject|1|||
156453898|NCT03492216|564754896|FG003|Overall Study|Withdrawal by Subject|1|||
156453899|NCT03492216|564754893|FG000|Overall Study|Lost to Follow-up|9|||
156453900|NCT03492216|564754894|FG001|Overall Study|Lost to Follow-up|2|||
156453901|NCT03492216|564754895|FG002|Overall Study|Lost to Follow-up|7|||
156453902|NCT03492216|564754896|FG003|Overall Study|Lost to Follow-up|8|||
156533557|NCT02459769|565048854|FG003|Overall Study|Withdrawal by Subject|5|||
156533558|NCT02459769|565048851|FG000|Overall Study|Lost to Follow-up|1|||
156533559|NCT02459769|565048852|FG001|Overall Study|Lost to Follow-up|0|||
156533560|NCT02459769|565048853|FG002|Overall Study|Lost to Follow-up|1|||
156533561|NCT02459769|565048854|FG003|Overall Study|Lost to Follow-up|0|||
156533562|NCT03838198|565048855|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
156533563|NCT03838198|565048856|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
156453903|NCT03492216|564754893|FG000|Overall Study|Moved|5|||
156453904|NCT03492216|564754894|FG001|Overall Study|Moved|3|||
156453905|NCT03492216|564754895|FG002|Overall Study|Moved|3|||
156453906|NCT03492216|564754896|FG003|Overall Study|Moved|5|||
156453907|NCT03492216|564754893|FG000|Overall Study|Too ill|0|||
156453908|NCT03492216|564754894|FG001|Overall Study|Too ill|1|||
156533564|NCT03838198|565048857|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
156533565|NCT03838198|565048858|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
156726780|NCT00558467|565748276|FG001|Overall Study|Adverse Event|2|||
156726781|NCT00558467|565748275|FG000|Overall Study|Lack of Efficacy|0|||
156453909|NCT03492216|564754895|FG002|Overall Study|Too ill|0|||
156453910|NCT03492216|564754896|FG003|Overall Study|Too ill|0|||
156453911|NCT03492216|564754893|FG000|Overall Study|Incarcerated|0|||
156453912|NCT03492216|564754894|FG001|Overall Study|Incarcerated|0|||
156453913|NCT03492216|564754895|FG002|Overall Study|Incarcerated|2|||
156453914|NCT03492216|564754896|FG003|Overall Study|Incarcerated|0|||
156453915|NCT00736723|564754897|FG000|Overall Study|Withdrawal by Subject|4|||
156726782|NCT00558467|565748276|FG001|Overall Study|Lack of Efficacy|1|||
156726783|NCT00558467|565748275|FG000|Overall Study|Patient moving out of state|0|||
156726784|NCT00558467|565748276|FG001|Overall Study|Patient moving out of state|1|||
156726785|NCT00931255|565748277|FG000|Overall Study|Follow up biopsy not done|2|||
156726786|NCT00931255|565748278|FG001|Overall Study|Follow up biopsy not done|3|||
156726787|NCT02019264|565748281|FG000|Overall Study|Not treated|6|||
156726788|NCT02019264|565748282|FG001|Overall Study|Not treated|4|||
156726789|NCT02019264|565748281|FG000|Overall Study|Lost to Follow-up|50|||
156726790|NCT02019264|565748282|FG001|Overall Study|Lost to Follow-up|47|||
156726791|NCT02019264|565748281|FG000|Overall Study|Withdrawal by Subject|142|||
156726792|NCT02019264|565748282|FG001|Overall Study|Withdrawal by Subject|117|||
156726793|NCT02019264|565748281|FG000|Overall Study|Administrative reason|36|||
156726794|NCT02019264|565748282|FG001|Overall Study|Administrative reason|28|||
156726795|NCT02019264|565748281|FG000|Overall Study|Missing|14|||
156726796|NCT02019264|565748282|FG001|Overall Study|Missing|11|||
156726797|NCT01684423|565748287|FG000|Overall Study|Withdrawal by Subject|0|||
156726798|NCT01684423|565748288|FG001|Overall Study|Withdrawal by Subject|0|||
156726799|NCT01684423|565748289|FG002|Overall Study|Withdrawal by Subject|1|||
156726800|NCT01684423|565748290|FG003|Overall Study|Withdrawal by Subject|0|||
156726801|NCT01684423|565748291|FG004|Overall Study|Withdrawal by Subject|0|||
156726802|NCT01741688|565748294|FG000|Overall Study|Lack of insurance coverage|2|||
156726803|NCT01741688|565748294|FG000|Overall Study|Withdrawal by Subject|1|||
156726804|NCT03850496|565748299|FG000|Overall Study|Withdrawal by Subject|1|||
156726805|NCT03850496|565748300|FG001|Overall Study|Withdrawal by Subject|0|||
156726806|NCT03850496|565748301|FG002|Overall Study|Withdrawal by Subject|0|||
156726807|NCT03850496|565748299|FG000|Overall Study|Lost to Follow-up|0|||
156726808|NCT03850496|565748300|FG001|Overall Study|Lost to Follow-up|1|||
156795632|NCT04484857|566006136|FG000|Overall Study|Other than specified|4|||
156795633|NCT04484857|566006136|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
156795634|NCT01425814|566006137|FG000|Period 1|Stability criteria not fulfilled|0|||
156795635|NCT01425814|566006138|FG001|Period 1|Stability criteria not fulfilled|1|||
156795636|NCT01425814|566006139|FG002|Period 1|Stability criteria not fulfilled|0|||
156795637|NCT01425814|566006140|FG003|Period 1|Stability criteria not fulfilled|0|||
156795638|NCT01425814|566006141|FG004|Period 1|Stability criteria not fulfilled|0|||
156726809|NCT03850496|565748301|FG002|Overall Study|Lost to Follow-up|4|||
156726810|NCT00869999|565748309|FG000|Overall Study|Withdrawal by Subject|1|||
156726811|NCT00869999|565748309|FG000|Overall Study|removed prior to starting therapy|1|||
156726812|NCT00463047|565748312|FG000|Titration Period 1|Adverse Event|10|||
156726813|NCT00463047|565748313|FG001|Titration Period 1|Adverse Event|8|||
156795639|NCT01425814|566006142|FG005|Period 1|Stability criteria not fulfilled|0|||
156795640|NCT01425814|566006137|FG000|Period 2|Stability criteria not fulfilled|0|||
156795641|NCT01425814|566006138|FG001|Period 2|Stability criteria not fulfilled|1|||
156795642|NCT01425814|566006139|FG002|Period 2|Stability criteria not fulfilled|0|||
156795643|NCT01425814|566006140|FG003|Period 2|Stability criteria not fulfilled|0|||
156795644|NCT01425814|566006141|FG004|Period 2|Stability criteria not fulfilled|0|||
156795645|NCT01425814|566006142|FG005|Period 2|Stability criteria not fulfilled|0|||
156795646|NCT01425814|566006137|FG000|Period 3|Adverse Event|0|||
156795647|NCT01425814|566006138|FG001|Period 3|Adverse Event|0|||
156795648|NCT01425814|566006139|FG002|Period 3|Adverse Event|0|||
156795649|NCT01425814|566006140|FG003|Period 3|Adverse Event|0|||
156795650|NCT01425814|566006141|FG004|Period 3|Adverse Event|0|||
156795651|NCT01425814|566006142|FG005|Period 3|Adverse Event|1|||
156795652|NCT01425814|566006137|FG000|Period 4|Adverse Event|1|||
156795653|NCT01425814|566006138|FG001|Period 4|Adverse Event|0|||
156795654|NCT01425814|566006139|FG002|Period 4|Adverse Event|1|||
156795655|NCT01425814|566006140|FG003|Period 4|Adverse Event|0|||
156795656|NCT01425814|566006141|FG004|Period 4|Adverse Event|0|||
156795657|NCT01425814|566006142|FG005|Period 4|Adverse Event|0|||
156795658|NCT01425814|566006137|FG000|Period 5|Stability criteria not fulfilled|0|||
156795659|NCT01425814|566006138|FG001|Period 5|Stability criteria not fulfilled|0|||
156795660|NCT01425814|566006139|FG002|Period 5|Stability criteria not fulfilled|1|||
156795661|NCT01425814|566006140|FG003|Period 5|Stability criteria not fulfilled|0|||
156795662|NCT01425814|566006141|FG004|Period 5|Stability criteria not fulfilled|0|||
156726814|NCT00463047|565748312|FG000|Titration Period 1|Lack of Efficacy|10|||
156726815|NCT00463047|565748313|FG001|Titration Period 1|Lack of Efficacy|4|||
156795663|NCT01425814|566006142|FG005|Period 5|Stability criteria not fulfilled|1|||
156795664|NCT00565747|566006143|FG000|Overall Study|No embryo transfer|67|||
156795665|NCT00565747|566006144|FG001|Overall Study|No embryo transfer|73|||
156795666|NCT02684461|566006145|FG000|Overall Study|Adverse Event|1|||
156795667|NCT02684461|566006146|FG001|Overall Study|Adverse Event|0|||
156795668|NCT02684461|566006147|FG002|Overall Study|Adverse Event|0|||
156795669|NCT02684461|566006145|FG000|Overall Study|Lack of Efficacy|1|||
156795670|NCT02684461|566006146|FG001|Overall Study|Lack of Efficacy|2|||
156795671|NCT02684461|566006147|FG002|Overall Study|Lack of Efficacy|0|||
156795672|NCT04507204|566006148|FG000|Overall Study|Adverse Event|8|||
156795673|NCT04507204|566006149|FG001|Overall Study|Adverse Event|13|||
156795674|NCT04507204|566006148|FG000|Overall Study|Death|0|||
156795675|NCT04507204|566006149|FG001|Overall Study|Death|1|||
156795676|NCT04507204|566006148|FG000|Overall Study|Lost to Follow-up|15|||
156453916|NCT00736723|564754898|FG001|Overall Study|Withdrawal by Subject|3|||
156453917|NCT01799265|564754901|FG000|Overall Study|Lost to Follow-up|1|||
156453918|NCT01799265|564754902|FG001|Overall Study|Lost to Follow-up|0|||
156726816|NCT00463047|565748312|FG000|Titration Period 1|Lost to Follow-up|2|||
156726817|NCT00463047|565748313|FG001|Titration Period 1|Lost to Follow-up|0|||
156726818|NCT00463047|565748312|FG000|Titration Period 1|Non-compliance with study medication|3|||
156726819|NCT00463047|565748313|FG001|Titration Period 1|Non-compliance with study medication|5|||
156726820|NCT00463047|565748312|FG000|Titration Period 1|Protocol Violation|5|||
156726821|NCT00463047|565748313|FG001|Titration Period 1|Protocol Violation|5|||
156726822|NCT00463047|565748312|FG000|Titration Period 1|Withdrawal by Subject|3|||
156726823|NCT00463047|565748313|FG001|Titration Period 1|Withdrawal by Subject|5|||
156726824|NCT00463047|565748312|FG000|Titration Period 1|Non-compliance procedures|4|||
156726825|NCT00463047|565748313|FG001|Titration Period 1|Non-compliance procedures|10|||
156726826|NCT00463047|565748312|FG000|Titration Period 1|Other|0|||
156726827|NCT00463047|565748313|FG001|Titration Period 1|Other|2|||
156726828|NCT00463047|565748312|FG000|Titration Period 2|Adverse Event|9|||
156726829|NCT00463047|565748313|FG001|Titration Period 2|Adverse Event|9|||
156726830|NCT00463047|565748312|FG000|Titration Period 2|Lack of Efficacy|6|||
156726831|NCT00463047|565748313|FG001|Titration Period 2|Lack of Efficacy|4|||
156726832|NCT00463047|565748312|FG000|Titration Period 2|Withdrawal by Subject|1|||
156726833|NCT00463047|565748313|FG001|Titration Period 2|Withdrawal by Subject|0|||
156726834|NCT00463047|565748312|FG000|Titration Period 2|Protocol Violation|2|||
156726835|NCT00463047|565748313|FG001|Titration Period 2|Protocol Violation|3|||
156726836|NCT00463047|565748312|FG000|Titration Period 2|Lost to Follow-up|1|||
156726837|NCT00463047|565748313|FG001|Titration Period 2|Lost to Follow-up|2|||
156726838|NCT00463047|565748312|FG000|Titration Period 2|Non-compliance study medication|4|||
156726839|NCT00463047|565748313|FG001|Titration Period 2|Non-compliance study medication|2|||
156726840|NCT00463047|565748312|FG000|Titration Period 2|Non-compliance procedures|4|||
156726841|NCT00463047|565748313|FG001|Titration Period 2|Non-compliance procedures|1|||
156726842|NCT00463047|565748312|FG000|Titration Period 2|Other|3|||
156726843|NCT00463047|565748313|FG001|Titration Period 2|Other|2|||
156726844|NCT00463047|565748312|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
156726845|NCT00463047|565748313|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
156726846|NCT00463047|565748312|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
156726847|NCT00463047|565748313|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
156726848|NCT00463047|565748312|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
156726849|NCT00463047|565748313|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
156726850|NCT00463047|565748312|FG000|Double-Blind Treatment Period 1|Other|1|||
156726851|NCT00463047|565748313|FG001|Double-Blind Treatment Period 1|Other|0|||
156726852|NCT00463047|565748312|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
156726853|NCT00463047|565748313|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
156795677|NCT04507204|566006149|FG001|Overall Study|Lost to Follow-up|14|||
156795678|NCT04507204|566006148|FG000|Overall Study|Poor Compliance with Protocol|2|||
156795679|NCT04507204|566006149|FG001|Overall Study|Poor Compliance with Protocol|4|||
156795680|NCT04507204|566006148|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
156795681|NCT04507204|566006149|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
156795682|NCT04507204|566006148|FG000|Overall Study|Withdrawal of Patient Consent|21|||
156795683|NCT04507204|566006149|FG001|Overall Study|Withdrawal of Patient Consent|13|||
156795684|NCT03580044|566006150|FG000|Overall Study|Death|2|||
156795685|NCT03580044|566006151|FG001|Overall Study|Death|1|||
156795686|NCT03580044|566006150|FG000|Overall Study|Withdrawal by Subject|1|||
156795687|NCT03580044|566006151|FG001|Overall Study|Withdrawal by Subject|1|||
156795688|NCT02697448|566006156|FG000|Overall Study|Protocol Violation|2|||
156795689|NCT02697448|566006157|FG001|Overall Study|Protocol Violation|4|||
156795690|NCT02697448|566006156|FG000|Overall Study|Clinical concerns during ablation|1|||
156795691|NCT02697448|566006157|FG001|Overall Study|Clinical concerns during ablation|1|||
156795692|NCT02697448|566006156|FG000|Overall Study|No data collected|2|||
156795693|NCT02697448|566006157|FG001|Overall Study|No data collected|0|||
156795694|NCT02919618|566006162|FG000|Overall Study|Death|1|||
156795695|NCT02592863|566006163|FG000|Overall Study|Withdrawal by Subject|2|||
156795696|NCT02592863|566006164|FG001|Overall Study|Withdrawal by Subject|2|||
156795697|NCT02592863|566006163|FG000|Overall Study|Lost to Follow-up|1|||
156795698|NCT02592863|566006164|FG001|Overall Study|Lost to Follow-up|1|||
156795699|NCT02743221|566006165|FG000|Overall Study|Progressive disease|29|||
156795700|NCT02743221|566006166|FG001|Overall Study|Progressive disease|38|||
156795701|NCT02743221|566006165|FG000|Overall Study|Adverse Event|17|||
156795702|NCT02743221|566006166|FG001|Overall Study|Adverse Event|14|||
156795703|NCT02743221|566006165|FG000|Overall Study|non medical reason|8|||
156795704|NCT02743221|566006166|FG001|Overall Study|non medical reason|2|||
156795705|NCT02743221|566006165|FG000|Overall Study|Physician Decision|2|||
156795706|NCT02743221|566006166|FG001|Overall Study|Physician Decision|5|||
156795707|NCT02743221|566006165|FG000|Overall Study|Patient not eligible, not treated|0|||
156795708|NCT02743221|566006166|FG001|Overall Study|Patient not eligible, not treated|1|||
156795709|NCT03411044|566006169|FG000|Overall Study|Death|30|||
156453919|NCT01799265|564754901|FG000|Overall Study|Protocol Violation|2|||
156726854|NCT00463047|565748312|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
156726855|NCT00463047|565748313|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
156726856|NCT00463047|565748312|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
156726857|NCT00463047|565748313|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
156726858|NCT03674112|565748314|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
156726859|NCT03674112|565748315|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
156726860|NCT03674112|565748314|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
156726861|NCT03674112|565748315|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
156726862|NCT03674112|565748314|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
156726863|NCT03674112|565748315|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
156726864|NCT03674112|565748314|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
156726865|NCT03674112|565748315|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
156726866|NCT03674112|565748314|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
156726867|NCT03674112|565748315|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
156336149|NCT00347360|564328204|FG012|Overall Study|Did not meet criteria before ABPM|0|||
156336150|NCT00347360|564328205|FG013|Overall Study|Did not meet criteria before ABPM|0|||
156336151|NCT00347360|564328206|FG014|Overall Study|Did not meet criteria before ABPM|0|||
156336152|NCT00347360|564328192|FG000|Overall Study|Randomized in error|0|||
156336153|NCT00347360|564328193|FG001|Overall Study|Randomized in error|0|||
156336154|NCT00347360|564328194|FG002|Overall Study|Randomized in error|0|||
156336155|NCT00347360|564328195|FG003|Overall Study|Randomized in error|0|||
156336156|NCT00347360|564328196|FG004|Overall Study|Randomized in error|0|||
156336157|NCT00347360|564328197|FG005|Overall Study|Randomized in error|0|||
156336158|NCT00347360|564328198|FG006|Overall Study|Randomized in error|0|||
156336159|NCT00347360|564328199|FG007|Overall Study|Randomized in error|0|||
156336160|NCT00347360|564328200|FG008|Overall Study|Randomized in error|0|||
156336161|NCT00347360|564328201|FG009|Overall Study|Randomized in error|0|||
156336162|NCT00347360|564328202|FG010|Overall Study|Randomized in error|0|||
156336163|NCT00347360|564328203|FG011|Overall Study|Randomized in error|1|||
156336164|NCT00347360|564328204|FG012|Overall Study|Randomized in error|0|||
156336165|NCT00347360|564328205|FG013|Overall Study|Randomized in error|0|||
156336166|NCT00347360|564328206|FG014|Overall Study|Randomized in error|0|||
156336167|NCT00347360|564328192|FG000|Overall Study|Failed inclusion criteria #4|0|||
156336168|NCT00347360|564328193|FG001|Overall Study|Failed inclusion criteria #4|0|||
156336169|NCT00347360|564328194|FG002|Overall Study|Failed inclusion criteria #4|0|||
156336170|NCT00347360|564328195|FG003|Overall Study|Failed inclusion criteria #4|0|||
156336171|NCT00347360|564328196|FG004|Overall Study|Failed inclusion criteria #4|0|||
156336172|NCT00347360|564328197|FG005|Overall Study|Failed inclusion criteria #4|0|||
156336173|NCT00347360|564328198|FG006|Overall Study|Failed inclusion criteria #4|0|||
156336174|NCT00347360|564328199|FG007|Overall Study|Failed inclusion criteria #4|0|||
156336175|NCT00347360|564328200|FG008|Overall Study|Failed inclusion criteria #4|0|||
156336176|NCT00347360|564328201|FG009|Overall Study|Failed inclusion criteria #4|0|||
156336177|NCT00347360|564328202|FG010|Overall Study|Failed inclusion criteria #4|0|||
156336178|NCT00347360|564328203|FG011|Overall Study|Failed inclusion criteria #4|1|||
156336179|NCT00347360|564328204|FG012|Overall Study|Failed inclusion criteria #4|0|||
156336180|NCT00347360|564328205|FG013|Overall Study|Failed inclusion criteria #4|0|||
156336181|NCT00347360|564328206|FG014|Overall Study|Failed inclusion criteria #4|0|||
156336182|NCT00347360|564328192|FG000|Overall Study|Prolonged duration between visits|0|||
156336183|NCT00347360|564328193|FG001|Overall Study|Prolonged duration between visits|0|||
156336184|NCT00347360|564328194|FG002|Overall Study|Prolonged duration between visits|0|||
156336185|NCT00347360|564328195|FG003|Overall Study|Prolonged duration between visits|0|||
156336186|NCT00347360|564328196|FG004|Overall Study|Prolonged duration between visits|0|||
156336187|NCT00347360|564328197|FG005|Overall Study|Prolonged duration between visits|0|||
156336188|NCT00347360|564328198|FG006|Overall Study|Prolonged duration between visits|0|||
156336189|NCT00347360|564328199|FG007|Overall Study|Prolonged duration between visits|0|||
156336190|NCT00347360|564328200|FG008|Overall Study|Prolonged duration between visits|0|||
156336191|NCT00347360|564328201|FG009|Overall Study|Prolonged duration between visits|0|||
156336192|NCT00347360|564328202|FG010|Overall Study|Prolonged duration between visits|0|||
156336193|NCT00347360|564328203|FG011|Overall Study|Prolonged duration between visits|0|||
156336194|NCT00347360|564328204|FG012|Overall Study|Prolonged duration between visits|1|||
156726868|NCT03674112|565748314|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
156726869|NCT03674112|565748315|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
156726870|NCT03674112|565748314|FG000|Follow-Up Period (≥3 Years)|Death|2|||
156336195|NCT00347360|564328205|FG013|Overall Study|Prolonged duration between visits|0|||
156336196|NCT00347360|564328206|FG014|Overall Study|Prolonged duration between visits|0|||
156336197|NCT00347360|564328192|FG000|Overall Study|Subject left town, ran out of study drug|0|||
156336198|NCT00347360|564328193|FG001|Overall Study|Subject left town, ran out of study drug|0|||
156336199|NCT00347360|564328194|FG002|Overall Study|Subject left town, ran out of study drug|0|||
156336200|NCT00347360|564328195|FG003|Overall Study|Subject left town, ran out of study drug|0|||
156336201|NCT00347360|564328196|FG004|Overall Study|Subject left town, ran out of study drug|0|||
156453920|NCT01799265|564754902|FG001|Overall Study|Protocol Violation|1|||
156453921|NCT01799265|564754901|FG000|Overall Study|inadequate sleep study|0|||
156726871|NCT03674112|565748315|FG001|Follow-Up Period (≥3 Years)|Death|0|||
156726872|NCT03674112|565748314|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
156726873|NCT03674112|565748315|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
156726874|NCT02220764|565748321|FG000|Overall Study|Lost to Follow-up|3|||
156726875|NCT02220764|565748322|FG001|Overall Study|Lost to Follow-up|1|||
156726876|NCT02220764|565748321|FG000|Overall Study|Death|1|||
156726877|NCT02220764|565748322|FG001|Overall Study|Death|0|||
156726878|NCT05000164|565748323|FG000|Overall Study|Adverse Event|1|||
156726879|NCT05000164|565748323|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
156726880|NCT05000164|565748323|FG000|Overall Study|Lens Discomfort|3|||
156726881|NCT05000164|565748323|FG000|Overall Study|Withdrew Consent during Study|2|||
156726882|NCT05000164|565748323|FG000|Overall Study|Subject Withdrawn by PI|2|||
156726883|NCT05000164|565748323|FG000|Overall Study|Other Fractured Test Article|1|||
156726884|NCT03020992|565748324|FG000|Overall Study|Adverse Event|5|||
156726885|NCT03020992|565748324|FG000|Overall Study|Withdrawal by Subject|1|||
156726886|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
156726887|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
156726888|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
156726889|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
156726890|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Pregnancy|0|||
156726891|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Pregnancy|1|||
156726892|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
156726893|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
156726894|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
156726895|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
156726896|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
156726897|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
156726898|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Other|3|||
156726899|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Other|0|||
156726900|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Adverse Event|0|||
156726901|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Adverse Event|4|||
156726902|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
156726903|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
156726904|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
156726905|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
156726906|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
156726907|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
156726908|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
156726909|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
156726910|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Death|0|||
156726911|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Death|1|||
156726912|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
156726913|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
156726914|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
156795710|NCT03411044|566006169|FG000|Overall Study|Withdrawal by Subject|48|||
156795711|NCT03411044|566006169|FG000|Overall Study|Lost to Follow-up|78|||
156453922|NCT01799265|564754902|FG001|Overall Study|inadequate sleep study|2|||
156453923|NCT05351554|564754913|FG000|Overall Study|Study terminated by sponsor|1|||
156453924|NCT05030233|564754914|FG000|Overall Study|withdrawn for transfer|1|||
156453925|NCT05030233|564754915|FG001|Overall Study|withdrawn for transfer|0|||
156453926|NCT04342494|564756853|FG000|Overall Study|Questionnaire partially completed|1|||
156453927|NCT04342494|564756854|FG001|Overall Study|Questionnaire partially completed|0|||
156453928|NCT04342494|564756855|FG002|Overall Study|Questionnaire partially completed|2|||
156453929|NCT04342494|564756856|FG003|Overall Study|Questionnaire partially completed|0|||
156453930|NCT04342494|564756857|FG004|Overall Study|Questionnaire partially completed|1|||
156453931|NCT04342494|564756853|FG000|Overall Study|Lost to Follow-up|49|||
156795712|NCT03411044|566006169|FG000|Overall Study|Adverse Event|30|||
156795713|NCT03411044|566006169|FG000|Overall Study|Missing status|4|||
156453932|NCT04342494|564756854|FG001|Overall Study|Lost to Follow-up|38|||
156453933|NCT04342494|564756855|FG002|Overall Study|Lost to Follow-up|34|||
156453934|NCT04342494|564756856|FG003|Overall Study|Lost to Follow-up|34|||
156453935|NCT04342494|564756857|FG004|Overall Study|Lost to Follow-up|35|||
156453936|NCT06190691|564756868|FG000|Overall Study|Adverse Event|2|||
156453937|NCT06190691|564756869|FG001|Overall Study|Adverse Event|0|||
156453938|NCT06190691|564756870|FG002|Overall Study|Adverse Event|0|||
156533566|NCT03838198|565048855|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
156795714|NCT01674062|566006177|FG000|Overall Study|Insufficient Therapeutic Response|56|||
156795715|NCT01674062|566006178|FG001|Overall Study|Insufficient Therapeutic Response|26|||
156726915|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
156726916|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
156726917|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
156726918|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
156726919|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
156726920|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
156726921|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
156726922|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
156726923|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
156726924|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
156726925|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
156726926|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
156726927|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
156726928|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
156726929|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
156726930|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
156726931|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
156726932|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
156726933|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
156726934|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
156726935|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
156726936|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
156726937|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
156726938|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
156726939|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
156726940|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
156726941|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
156726942|NCT03493854|565748327|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
156726943|NCT03493854|565748328|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
156726944|NCT03493854|565748327|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
156726945|NCT03493854|565748328|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
156726946|NCT03493854|565748327|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
156726947|NCT03493854|565748328|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
156726948|NCT00410813|565748331|FG000|Overall Study|Adverse Event|6|||
156726949|NCT00410813|565748332|FG001|Overall Study|Adverse Event|11|||
156726950|NCT00410813|565748331|FG000|Overall Study|Progression|32|||
156726951|NCT00410813|565748332|FG001|Overall Study|Progression|21|||
156726952|NCT00410813|565748331|FG000|Overall Study|Not protocol specified|3|||
156726953|NCT00410813|565748332|FG001|Overall Study|Not protocol specified|4|||
156726954|NCT00410813|565748331|FG000|Overall Study|Ineligible|2|||
156726955|NCT00410813|565748332|FG001|Overall Study|Ineligible|4|||
156726956|NCT00410813|565748331|FG000|Overall Study|Death|0|||
156726957|NCT00410813|565748332|FG001|Overall Study|Death|2|||
156726958|NCT04278417|565748341|FG000|Overall Study|Withdrawal by Subject|20|||
156726959|NCT04278417|565748342|FG001|Overall Study|Withdrawal by Subject|20|||
156726960|NCT04278417|565748341|FG000|Overall Study|Progressive disease|0|||
156726961|NCT04278417|565748342|FG001|Overall Study|Progressive disease|2|||
156726962|NCT04278417|565748341|FG000|Overall Study|Physician Decision|4|||
156726963|NCT04278417|565748342|FG001|Overall Study|Physician Decision|6|||
156726964|NCT04278417|565748341|FG000|Overall Study|Lost to Follow-up|11|||
156726965|NCT04278417|565748342|FG001|Overall Study|Lost to Follow-up|13|||
156726966|NCT04278417|565748341|FG000|Overall Study|Death|8|||
156726967|NCT04278417|565748342|FG001|Overall Study|Death|9|||
156726968|NCT04278417|565748341|FG000|Overall Study|Adverse Event|3|||
156726969|NCT04278417|565748342|FG001|Overall Study|Adverse Event|5|||
156726970|NCT00594165|565748343|FG000|Overall Study|Major protocol violation|1|||
156726971|NCT00594165|565748343|FG000|Overall Study|Lack of Efficacy|12|||
156726972|NCT00594165|565748343|FG000|Overall Study|Adverse Event|52|||
156726973|NCT00594165|565748343|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
156726974|NCT00594165|565748343|FG000|Overall Study|Subject withdrew consent|27|||
156726975|NCT00594165|565748343|FG000|Overall Study|Study ended per sponsor|102|||
156726976|NCT00594165|565748343|FG000|Overall Study|Lost to Follow-up|4|||
156453939|NCT06190691|564756871|FG003|Overall Study|Adverse Event|0|||
156453940|NCT03016754|564756873|FG000|Overall Study|Death|5|||
156453941|NCT03016754|564756874|FG001|Overall Study|Death|4|||
156453942|NCT03016754|564756875|FG002|Overall Study|Death|5|||
156726977|NCT00594165|565748343|FG000|Overall Study|Other: PI discretion|5|||
156726978|NCT00594165|565748343|FG000|Overall Study|Other: Subject moving|3|||
156726979|NCT00594165|565748343|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
156795716|NCT01674062|566006177|FG000|Overall Study|Other|8|||
156795717|NCT01674062|566006178|FG001|Overall Study|Other|1|||
156795718|NCT01674062|566006177|FG000|Overall Study|Adverse Event|1|||
156795719|NCT01674062|566006178|FG001|Overall Study|Adverse Event|1|||
156336202|NCT00347360|564328197|FG005|Overall Study|Subject left town, ran out of study drug|0|||
156336203|NCT00347360|564328198|FG006|Overall Study|Subject left town, ran out of study drug|0|||
156336204|NCT00347360|564328199|FG007|Overall Study|Subject left town, ran out of study drug|0|||
156336205|NCT00347360|564328200|FG008|Overall Study|Subject left town, ran out of study drug|0|||
156336206|NCT00347360|564328201|FG009|Overall Study|Subject left town, ran out of study drug|0|||
156336207|NCT00347360|564328202|FG010|Overall Study|Subject left town, ran out of study drug|0|||
156336208|NCT00347360|564328203|FG011|Overall Study|Subject left town, ran out of study drug|0|||
156336209|NCT00347360|564328204|FG012|Overall Study|Subject left town, ran out of study drug|0|||
156336210|NCT00347360|564328205|FG013|Overall Study|Subject left town, ran out of study drug|1|||
156336211|NCT00347360|564328206|FG014|Overall Study|Subject left town, ran out of study drug|0|||
156336212|NCT00347360|564328192|FG000|Overall Study|Subject refuse to sign updated consent|0|||
156336213|NCT00347360|564328193|FG001|Overall Study|Subject refuse to sign updated consent|0|||
156336214|NCT00347360|564328194|FG002|Overall Study|Subject refuse to sign updated consent|0|||
156336215|NCT00347360|564328195|FG003|Overall Study|Subject refuse to sign updated consent|0|||
156336216|NCT00347360|564328196|FG004|Overall Study|Subject refuse to sign updated consent|0|||
156336217|NCT00347360|564328197|FG005|Overall Study|Subject refuse to sign updated consent|0|||
156336218|NCT00347360|564328198|FG006|Overall Study|Subject refuse to sign updated consent|0|||
156533567|NCT03838198|565048856|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
156533568|NCT03838198|565048857|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
156726980|NCT00594165|565748343|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
156726981|NCT00594165|565748343|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
156726982|NCT00594165|565748343|FG000|Overall Study|Other: Site terminated participation|2|||
156726983|NCT04830969|565748344|FG000|Overall Study|Withdrawal by Subject|6|||
156726984|NCT04830969|565748345|FG001|Overall Study|Withdrawal by Subject|2|||
156726985|NCT04830969|565748344|FG000|Overall Study|Protocol Violation|3|||
156726986|NCT04830969|565748345|FG001|Overall Study|Protocol Violation|9|||
156726987|NCT04830969|565748344|FG000|Overall Study|Lost to Follow-up|4|||
156726988|NCT04830969|565748345|FG001|Overall Study|Lost to Follow-up|4|||
156726989|NCT00996125|565748346|FG000|Overall Study|Adverse Event|0|||
156726990|NCT00996125|565748347|FG001|Overall Study|Adverse Event|2|||
156726991|NCT00996125|565748346|FG000|Overall Study|Lost to Follow-up|1|||
156726992|NCT00996125|565748347|FG001|Overall Study|Lost to Follow-up|6|||
156726993|NCT00996125|565748346|FG000|Overall Study|Withdrawal by Subject|4|||
156726994|NCT00996125|565748347|FG001|Overall Study|Withdrawal by Subject|3|||
156726995|NCT05236764|565748348|FG000|Overall Study|In follow up (ongoing)|1|||
156726996|NCT05236764|565748348|FG000|Overall Study|Taken off study - secondary graft failure|1|||
156726997|NCT05236764|565748348|FG000|Overall Study|Death|1|||
156726998|NCT02203721|565748352|FG000|Overall Study|Lost to Follow-up|1|||
156726999|NCT02203721|565748353|FG001|Overall Study|Lost to Follow-up|0|||
156727000|NCT02203721|565748352|FG000|Overall Study|Death|0|||
156727001|NCT02203721|565748353|FG001|Overall Study|Death|2|||
156727002|NCT02203721|565748352|FG000|Overall Study|Illness|0|||
156727003|NCT02203721|565748353|FG001|Overall Study|Illness|1|||
156727004|NCT00703157|565748354|FG000|Overall Study|Lost to Follow-up|0|||
156727005|NCT00703157|565748355|FG001|Overall Study|Lost to Follow-up|1|||
156727006|NCT00703157|565748354|FG000|Overall Study|source data permanently lost/ other|4|||
156727007|NCT00703157|565748355|FG001|Overall Study|source data permanently lost/ other|1|||
156727008|NCT00347009|565748356|FG000|Overall Study|Death|1|||
156727009|NCT00347009|565748356|FG000|Overall Study|Adverse Event|6|||
156727010|NCT00347009|565748356|FG000|Overall Study|Withdrawal by Subject|3|||
156727011|NCT00347009|565748356|FG000|Overall Study|Physician Decision|5|||
156727012|NCT00347009|565748356|FG000|Overall Study|Lost to Follow-up|4|||
156727013|NCT00347009|565748356|FG000|Overall Study|Protocol Violation|2|||
156727014|NCT00347009|565748356|FG000|Overall Study|Adverse Laboratory Experience|1|||
156727015|NCT00347009|565748356|FG000|Overall Study|Insufficient Viral Suppression|3|||
156727016|NCT00347009|565748356|FG000|Overall Study|Increased ALT/HBV DNA|1|||
156727017|NCT00347009|565748356|FG000|Overall Study|Serious Adverse Event|1|||
156727018|NCT02907177|565748359|FG000|Overall Study|Death|0|||
156727019|NCT02907177|565748360|FG001|Overall Study|Death|1|||
156727020|NCT02907177|565748359|FG000|Overall Study|Physician Decision|3|||
156727021|NCT02907177|565748360|FG001|Overall Study|Physician Decision|3|||
156727022|NCT02907177|565748359|FG000|Overall Study|Withdrawal by Subject|15|||
156336219|NCT00347360|564328199|FG007|Overall Study|Subject refuse to sign updated consent|0|||
156336220|NCT00347360|564328200|FG008|Overall Study|Subject refuse to sign updated consent|0|||
156453943|NCT03016754|564756876|FG003|Overall Study|Death|1|||
156727023|NCT02907177|565748360|FG001|Overall Study|Withdrawal by Subject|7|||
156453944|NCT03016754|564756873|FG000|Overall Study|Lost to Follow-up|23|||
156453945|NCT03016754|564756874|FG001|Overall Study|Lost to Follow-up|17|||
156453946|NCT03016754|564756875|FG002|Overall Study|Lost to Follow-up|4|||
156453947|NCT03016754|564756876|FG003|Overall Study|Lost to Follow-up|2|||
156453948|NCT03016754|564756873|FG000|Overall Study|Withdrawal by Subject|6|||
156453949|NCT03016754|564756874|FG001|Overall Study|Withdrawal by Subject|6|||
156453950|NCT03016754|564756875|FG002|Overall Study|Withdrawal by Subject|2|||
156453951|NCT03016754|564756876|FG003|Overall Study|Withdrawal by Subject|2|||
156453952|NCT03016754|564756873|FG000|Overall Study|Other/Unknown|2|||
156453953|NCT03016754|564756874|FG001|Overall Study|Other/Unknown|4|||
156453954|NCT03016754|564756875|FG002|Overall Study|Other/Unknown|2|||
156453955|NCT03016754|564756876|FG003|Overall Study|Other/Unknown|1|||
156453956|NCT03016754|564756873|FG000|Overall Study|Protocol Violation|0|||
156453957|NCT03016754|564756874|FG001|Overall Study|Protocol Violation|0|||
156453958|NCT03016754|564756875|FG002|Overall Study|Protocol Violation|0|||
156453959|NCT03016754|564756876|FG003|Overall Study|Protocol Violation|4|||
156453960|NCT04019873|564756877|FG000|Overall Study|Discontinued from the treatment|1|||
156453961|NCT04019873|564756878|FG001|Overall Study|Discontinued from the treatment|39|||
156453962|NCT04019873|564756879|FG002|Overall Study|Discontinued from the treatment|2|||
156453963|NCT04185298|564756887|FG000|Overall Study|Lost to Follow-up|1|||
156453964|NCT04185298|564756888|FG001|Overall Study|Lost to Follow-up|3|||
156453965|NCT04185298|564756887|FG000|Overall Study|Withdrawal by Subject|0|||
156453966|NCT04185298|564756888|FG001|Overall Study|Withdrawal by Subject|3|||
156453967|NCT03896789|564756889|FG000|Baseline|Lost to Follow-up|1|||
156453968|NCT03896789|564756890|FG001|Baseline|Lost to Follow-up|2|||
156453969|NCT03896789|564756889|FG000|Baseline|Death|3|||
156453970|NCT03896789|564756890|FG001|Baseline|Death|6|||
156453971|NCT03896789|564756889|FG000|Post-Randomization|Lost to Follow-up|12|||
156453972|NCT03896789|564756890|FG001|Post-Randomization|Lost to Follow-up|11|||
156453973|NCT03896789|564756889|FG000|Post-Randomization|Death|12|||
156453974|NCT03896789|564756890|FG001|Post-Randomization|Death|13|||
156453975|NCT01606215|564756891|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
156453976|NCT01606215|564756892|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
156453977|NCT05087992|564756893|FG000|Overall Study|Adverse Event|0|||
156453978|NCT05087992|564756894|FG001|Overall Study|Adverse Event|1|||
156453979|NCT05087992|564756895|FG002|Overall Study|Adverse Event|0|||
156453980|NCT05087992|564756893|FG000|Overall Study|Withdrawal by Subject|2|||
156453981|NCT05087992|564756894|FG001|Overall Study|Withdrawal by Subject|0|||
156453982|NCT05087992|564756895|FG002|Overall Study|Withdrawal by Subject|0|||
156453983|NCT05087992|564756893|FG000|Overall Study|clinical disease progression|3|||
156453984|NCT05087992|564756894|FG001|Overall Study|clinical disease progression|1|||
156876203|NCT01904773|566305764|FG006|Fifth Intervention|Adverse Event|0|||
156876204|NCT01904773|566305765|FG007|Fifth Intervention|Adverse Event|1|||
156876205|NCT01904773|566305766|FG008|Fifth Intervention|Adverse Event|0|||
156876206|NCT01904773|566305758|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876207|NCT01904773|566305759|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
156876208|NCT01904773|566305760|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876209|NCT01904773|566305761|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876210|NCT01904773|566305762|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876211|NCT01904773|566305763|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876212|NCT01904773|566305764|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876213|NCT01904773|566305765|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876214|NCT01904773|566305766|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876215|NCT03390101|566305767|FG000|Weeks 0-12|Withdrawal by Subject|0|||
156876216|NCT03390101|566305768|FG001|Weeks 0-12|Withdrawal by Subject|1|||
156876217|NCT03390101|566305769|FG002|Weeks 0-12|Withdrawal by Subject|1|||
156876218|NCT03390101|566305767|FG000|Weeks 0-12|Lost to Follow-up|0|||
156453985|NCT05087992|564756895|FG002|Overall Study|clinical disease progression|0|||
156453986|NCT05087992|564756893|FG000|Overall Study|objective disease progression|4|||
156453987|NCT05087992|564756894|FG001|Overall Study|objective disease progression|1|||
156453988|NCT05087992|564756895|FG002|Overall Study|objective disease progression|0|||
156453989|NCT01842542|564756896|FG000|Overall Study|Withdrawal by Subject|2|||
156453990|NCT01842542|564756896|FG000|Overall Study|Lack of Efficacy|1|||
156453991|NCT01842542|564756896|FG000|Overall Study|Protocol Non-compliance|2|||
156453992|NCT01842542|564756896|FG000|Overall Study|Lost to Follow-up|1|||
156453993|NCT02919306|564756897|FG000|Overall Study|Withdrawal by Subject|1|||
156453994|NCT02919306|564756898|FG001|Overall Study|Withdrawal by Subject|0|||
156876219|NCT03390101|566305768|FG001|Weeks 0-12|Lost to Follow-up|1|||
156453995|NCT02919306|564756897|FG000|Overall Study|Protocol Violation|1|||
156453996|NCT02919306|564756898|FG001|Overall Study|Protocol Violation|0|||
156453997|NCT04473222|564756899|FG000|Overall Study|Lost to Follow-up|13|||
156876220|NCT03390101|566305769|FG002|Weeks 0-12|Lost to Follow-up|0|||
156876221|NCT03390101|566305767|FG000|Weeks 12-54|Withdrawal by Subject|0|||
156453998|NCT04473222|564756900|FG001|Overall Study|Lost to Follow-up|13|||
156453999|NCT04473222|564756899|FG000|Overall Study|Withdrawal by Subject|0|||
156454000|NCT04473222|564756900|FG001|Overall Study|Withdrawal by Subject|1|||
156454001|NCT04473222|564756899|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
156454002|NCT04473222|564756900|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
156454003|NCT04293055|564756901|FG000|Overall Study|Lost to Follow-up|1|||
156454004|NCT04293055|564756902|FG001|Overall Study|Lost to Follow-up|1|||
156454005|NCT04293055|564756901|FG000|Overall Study|Did not trigger randomization|6|||
156454006|NCT04293055|564756902|FG001|Overall Study|Did not trigger randomization|5|||
156454007|NCT06424236|564756905|FG000|Overall Study|Adverse Event|0|||
156454008|NCT06424236|564756906|FG001|Overall Study|Adverse Event|1|||
156454009|NCT06424236|564756907|FG002|Overall Study|Adverse Event|0|||
156454010|NCT06424236|564756905|FG000|Overall Study|Withdrawal by Subject|3|||
156454011|NCT06424236|564756906|FG001|Overall Study|Withdrawal by Subject|1|||
156454012|NCT06424236|564756907|FG002|Overall Study|Withdrawal by Subject|2|||
156454013|NCT06424236|564756905|FG000|Overall Study|Physician Decision|0|||
156454014|NCT06424236|564756906|FG001|Overall Study|Physician Decision|1|||
156454015|NCT06424236|564756907|FG002|Overall Study|Physician Decision|0|||
156454016|NCT06424236|564756905|FG000|Overall Study|Study Terminated by Sponsor|11|||
156454017|NCT06424236|564756906|FG001|Overall Study|Study Terminated by Sponsor|20|||
156727024|NCT02907177|565748359|FG000|Overall Study|Sponsor's Decision|50|||
156727025|NCT02907177|565748360|FG001|Overall Study|Sponsor's Decision|57|||
156727026|NCT03482635|565748361|FG000|Overall Study|Lack of Efficacy|0|||
156454018|NCT06424236|564756907|FG002|Overall Study|Study Terminated by Sponsor|16|||
156454019|NCT06424236|564756905|FG000|Overall Study|Lost to Follow-up|0|||
156454020|NCT06424236|564756906|FG001|Overall Study|Lost to Follow-up|1|||
156454021|NCT06424236|564756907|FG002|Overall Study|Lost to Follow-up|0|||
156727027|NCT03482635|565748362|FG001|Overall Study|Lack of Efficacy|0|||
156727028|NCT03482635|565748363|FG002|Overall Study|Lack of Efficacy|1|||
156727029|NCT03482635|565748364|FG003|Overall Study|Lack of Efficacy|3|||
156454022|NCT06424236|564756905|FG000|Overall Study|Disease Progression|0|||
156454023|NCT06424236|564756906|FG001|Overall Study|Disease Progression|1|||
156454024|NCT06424236|564756907|FG002|Overall Study|Disease Progression|2|||
156454025|NCT06424236|564756905|FG000|Overall Study|Other|0|||
156454026|NCT06424236|564756906|FG001|Overall Study|Other|0|||
156454027|NCT06424236|564756907|FG002|Overall Study|Other|1|||
156454028|NCT00227344|564756909|FG000|Overall Study|study terminated early|12|||
156454029|NCT00227344|564756910|FG001|Overall Study|study terminated early|5|||
156454030|NCT01987895|564756911|FG000|Overall Study|Withdrawal by Subject|12|||
156454031|NCT01987895|564756912|FG001|Overall Study|Withdrawal by Subject|7|||
156454032|NCT01987895|564756911|FG000|Overall Study|Physician Decision|8|||
156454033|NCT01987895|564756912|FG001|Overall Study|Physician Decision|10|||
156454034|NCT01987895|564756911|FG000|Overall Study|Death|7|||
156454035|NCT01987895|564756912|FG001|Overall Study|Death|7|||
156454036|NCT01987895|564756911|FG000|Overall Study|Lost to Follow-up|3|||
156454037|NCT01987895|564756912|FG001|Overall Study|Lost to Follow-up|5|||
156454038|NCT01987895|564756911|FG000|Overall Study|randomized before giving IC|0|||
156454039|NCT01987895|564756912|FG001|Overall Study|randomized before giving IC|1|||
156727030|NCT03482635|565748361|FG000|Overall Study|Adverse Event|2|||
156727031|NCT03482635|565748362|FG001|Overall Study|Adverse Event|2|||
156727032|NCT03482635|565748363|FG002|Overall Study|Adverse Event|0|||
156727033|NCT03482635|565748364|FG003|Overall Study|Adverse Event|3|||
156727034|NCT03482635|565748361|FG000|Overall Study|Withdrawal by Subject|2|||
156727035|NCT03482635|565748362|FG001|Overall Study|Withdrawal by Subject|1|||
156727036|NCT03482635|565748363|FG002|Overall Study|Withdrawal by Subject|0|||
156727037|NCT03482635|565748364|FG003|Overall Study|Withdrawal by Subject|1|||
156727038|NCT03482635|565748361|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
156727039|NCT03482635|565748362|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
156727040|NCT03482635|565748363|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
156727041|NCT03482635|565748364|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
156727042|NCT03482635|565748361|FG000|Overall Study|Not treated|0|||
156727043|NCT03482635|565748362|FG001|Overall Study|Not treated|0|||
156727044|NCT03482635|565748363|FG002|Overall Study|Not treated|0|||
156727045|NCT03482635|565748364|FG003|Overall Study|Not treated|1|||
156727046|NCT04681066|565748365|FG000|Overall Study|Lost to Follow-up|3|||
156727047|NCT04681066|565748366|FG001|Overall Study|Lost to Follow-up|1|||
156727048|NCT04681066|565748367|FG002|Overall Study|Lost to Follow-up|2|||
156727049|NCT04681066|565748368|FG003|Overall Study|Lost to Follow-up|1|||
156727050|NCT04681066|565748365|FG000|Overall Study|Withdrawal by Subject|2|||
156727051|NCT04681066|565748366|FG001|Overall Study|Withdrawal by Subject|1|||
156727052|NCT04681066|565748367|FG002|Overall Study|Withdrawal by Subject|0|||
156727053|NCT04681066|565748368|FG003|Overall Study|Withdrawal by Subject|3|||
156727054|NCT04681066|565748365|FG000|Overall Study|Death|0|||
156727055|NCT04681066|565748366|FG001|Overall Study|Death|1|||
156727056|NCT04681066|565748367|FG002|Overall Study|Death|0|||
156727057|NCT04681066|565748368|FG003|Overall Study|Death|0|||
156454040|NCT01539083|564756919|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
156454041|NCT01539083|564756920|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
156454042|NCT01539083|564756921|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
156454043|NCT01539083|564756919|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
156454044|NCT01539083|564756920|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
156454045|NCT01539083|564756921|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
156454046|NCT01539083|564756919|FG000|Before Randomization (VCD Induction)|Death|6|||
156727058|NCT04495829|565748369|FG000|Overall Study|Lost to Follow-up|2|||
156727059|NCT04495829|565748369|FG000|Overall Study|Inclusion criterion not met|3|||
156727060|NCT01205269|565748372|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156727061|NCT01205269|565748373|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156454047|NCT01539083|564756920|FG001|Before Randomization (VCD Induction)|Death|0|||
156454048|NCT01539083|564756921|FG002|Before Randomization (VCD Induction)|Death|0|||
156454049|NCT01539083|564756919|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
156727062|NCT01205269|565748374|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156727063|NCT01205269|565748375|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
156727064|NCT01205269|565748376|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156727065|NCT01205269|565748377|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156727066|NCT00987337|565748378|FG000|Overall Study|Adverse Event|10|||
156727067|NCT00987337|565748379|FG001|Overall Study|Adverse Event|9|||
156727068|NCT00987337|565748380|FG002|Overall Study|Adverse Event|8|||
156727069|NCT00987337|565748378|FG000|Overall Study|Insufficient Virologic Response|10|||
156727070|NCT00987337|565748379|FG001|Overall Study|Insufficient Virologic Response|7|||
156727071|NCT00987337|565748380|FG002|Overall Study|Insufficient Virologic Response|12|||
156336221|NCT00347360|564328201|FG009|Overall Study|Subject refuse to sign updated consent|0|||
156454050|NCT01539083|564756920|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
156454051|NCT01539083|564756921|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
156727072|NCT00987337|565748378|FG000|Overall Study|Virologic Breakthrough|2|||
156727073|NCT00987337|565748379|FG001|Overall Study|Virologic Breakthrough|2|||
156795720|NCT01674062|566006177|FG000|Overall Study|Death|0|||
156795721|NCT01674062|566006178|FG001|Overall Study|Death|1|||
156795722|NCT01674062|566006177|FG000|Overall Study|Programming Error|1|||
156795723|NCT01674062|566006178|FG001|Overall Study|Programming Error|0|||
156795724|NCT03895372|566006179|FG000|Investigational Treatment Period|Adverse Event|1|||
156795725|NCT03895372|566006180|FG001|Investigational Treatment Period|Adverse Event|0|||
156795726|NCT03895372|566006181|FG002|Investigational Treatment Period|Adverse Event|0|||
156795727|NCT03895372|566006182|FG003|Investigational Treatment Period|Adverse Event|0|||
156795728|NCT03895372|566006183|FG004|Investigational Treatment Period|Adverse Event|0|||
156795729|NCT03895372|566006184|FG005|Investigational Treatment Period|Adverse Event|0|||
156795730|NCT03895372|566006185|FG006|Investigational Treatment Period|Adverse Event|4|||
156795731|NCT03895372|566006186|FG007|Investigational Treatment Period|Adverse Event|3|||
156795732|NCT03895372|566006179|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
156795733|NCT03895372|566006180|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
156795734|NCT03895372|566006181|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
156795735|NCT03895372|566006182|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
156795736|NCT03895372|566006183|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
156795737|NCT03895372|566006184|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
156795738|NCT03895372|566006185|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
156795739|NCT03895372|566006186|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
156795740|NCT03895372|566006179|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
156795741|NCT03895372|566006180|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
156795742|NCT03895372|566006181|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
156795743|NCT03895372|566006182|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
156795744|NCT03895372|566006183|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
156795745|NCT03895372|566006184|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
156795746|NCT03895372|566006185|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
156795747|NCT03895372|566006186|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
156795748|NCT03895372|566006179|FG000|Investigational Treatment Period|Other|0|||
156795749|NCT03895372|566006180|FG001|Investigational Treatment Period|Other|0|||
156795750|NCT03895372|566006181|FG002|Investigational Treatment Period|Other|0|||
156795751|NCT03895372|566006182|FG003|Investigational Treatment Period|Other|0|||
156795752|NCT03895372|566006183|FG004|Investigational Treatment Period|Other|0|||
156795753|NCT03895372|566006184|FG005|Investigational Treatment Period|Other|1|||
156795754|NCT03895372|566006185|FG006|Investigational Treatment Period|Other|0|||
156795755|NCT03895372|566006186|FG007|Investigational Treatment Period|Other|2|||
156795756|NCT03895372|566006179|FG000|Investigational Treatment Period|Protocol Violation|0|||
156795757|NCT03895372|566006180|FG001|Investigational Treatment Period|Protocol Violation|0|||
156795758|NCT03895372|566006181|FG002|Investigational Treatment Period|Protocol Violation|0|||
156795759|NCT03895372|566006182|FG003|Investigational Treatment Period|Protocol Violation|1|||
156795760|NCT03895372|566006183|FG004|Investigational Treatment Period|Protocol Violation|0|||
156795761|NCT03895372|566006184|FG005|Investigational Treatment Period|Protocol Violation|0|||
156795762|NCT03895372|566006185|FG006|Investigational Treatment Period|Protocol Violation|0|||
156795763|NCT03895372|566006186|FG007|Investigational Treatment Period|Protocol Violation|0|||
156795764|NCT03895372|566006179|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
156795765|NCT03895372|566006180|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
156795766|NCT03895372|566006181|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
156795767|NCT03895372|566006182|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
156727074|NCT00987337|565748380|FG002|Overall Study|Virologic Breakthrough|8|||
156454052|NCT01539083|564756919|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
156727075|NCT00987337|565748378|FG000|Overall Study|Lost to Follow-up|10|||
156727076|NCT00987337|565748379|FG001|Overall Study|Lost to Follow-up|6|||
156727077|NCT00987337|565748380|FG002|Overall Study|Lost to Follow-up|2|||
156727078|NCT00987337|565748378|FG000|Overall Study|Withdrawal by Subject|6|||
156727079|NCT00987337|565748379|FG001|Overall Study|Withdrawal by Subject|9|||
156727080|NCT00987337|565748380|FG002|Overall Study|Withdrawal by Subject|9|||
156727081|NCT00987337|565748378|FG000|Overall Study|Other|0|||
156727082|NCT00987337|565748379|FG001|Overall Study|Other|2|||
156727083|NCT00987337|565748380|FG002|Overall Study|Other|5|||
156727084|NCT00987337|565748378|FG000|Overall Study|Protocol Violation|1|||
156454053|NCT01539083|564756920|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
156454054|NCT01539083|564756921|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
156454055|NCT01539083|564756919|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
156454056|NCT01539083|564756920|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
156454057|NCT01539083|564756921|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
156727085|NCT00987337|565748379|FG001|Overall Study|Protocol Violation|0|||
156727086|NCT00987337|565748380|FG002|Overall Study|Protocol Violation|2|||
156727087|NCT00987337|565748378|FG000|Overall Study|Participant Relapsed|18|||
156727088|NCT00987337|565748379|FG001|Overall Study|Participant Relapsed|20|||
156727089|NCT00987337|565748380|FG002|Overall Study|Participant Relapsed|5|||
156727090|NCT00669669|565748386|FG000|Overall Study|To late to start treatment|1|||
156727091|NCT03103152|565748387|FG000|Overall Study|Physician Decision|5|||
156727092|NCT03103152|565748388|FG001|Overall Study|Physician Decision|2|||
156727093|NCT03103152|565748389|FG002|Overall Study|Physician Decision|6|||
156727094|NCT03103152|565748390|FG003|Overall Study|Physician Decision|3|||
156727095|NCT03103152|565748391|FG004|Overall Study|Physician Decision|3|||
156727096|NCT03103152|565748392|FG005|Overall Study|Physician Decision|1|||
156727097|NCT03103152|565748387|FG000|Overall Study|Protocol Violation|2|||
156727098|NCT03103152|565748388|FG001|Overall Study|Protocol Violation|2|||
156727099|NCT03103152|565748389|FG002|Overall Study|Protocol Violation|1|||
156727100|NCT03103152|565748390|FG003|Overall Study|Protocol Violation|2|||
156727101|NCT03103152|565748391|FG004|Overall Study|Protocol Violation|1|||
156727102|NCT03103152|565748392|FG005|Overall Study|Protocol Violation|1|||
156727103|NCT03103152|565748387|FG000|Overall Study|Inter-current illness|0|||
156727104|NCT03103152|565748388|FG001|Overall Study|Inter-current illness|0|||
156727105|NCT03103152|565748389|FG002|Overall Study|Inter-current illness|1|||
156727106|NCT03103152|565748390|FG003|Overall Study|Inter-current illness|0|||
156727107|NCT03103152|565748391|FG004|Overall Study|Inter-current illness|0|||
156727108|NCT03103152|565748392|FG005|Overall Study|Inter-current illness|0|||
156727109|NCT03103152|565748387|FG000|Overall Study|Death|0|||
156727110|NCT03103152|565748388|FG001|Overall Study|Death|1|||
156727111|NCT03103152|565748389|FG002|Overall Study|Death|0|||
156727112|NCT03103152|565748390|FG003|Overall Study|Death|0|||
156727113|NCT03103152|565748391|FG004|Overall Study|Death|0|||
156727114|NCT03103152|565748392|FG005|Overall Study|Death|0|||
156727115|NCT03103152|565748387|FG000|Overall Study|Adverse Event|0|||
156727116|NCT03103152|565748388|FG001|Overall Study|Adverse Event|0|||
156727117|NCT03103152|565748389|FG002|Overall Study|Adverse Event|1|||
156727118|NCT03103152|565748390|FG003|Overall Study|Adverse Event|0|||
156727119|NCT03103152|565748391|FG004|Overall Study|Adverse Event|0|||
156727120|NCT03103152|565748392|FG005|Overall Study|Adverse Event|1|||
156727121|NCT03103152|565748387|FG000|Overall Study|Withdrawal by Subject|1|||
156727122|NCT03103152|565748388|FG001|Overall Study|Withdrawal by Subject|0|||
156727123|NCT03103152|565748389|FG002|Overall Study|Withdrawal by Subject|1|||
156727124|NCT03103152|565748390|FG003|Overall Study|Withdrawal by Subject|1|||
156727125|NCT03103152|565748391|FG004|Overall Study|Withdrawal by Subject|1|||
156727126|NCT03103152|565748392|FG005|Overall Study|Withdrawal by Subject|1|||
156727127|NCT03103152|565748387|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
156727128|NCT03103152|565748388|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
156727129|NCT03103152|565748389|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
156727130|NCT03103152|565748390|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
156727131|NCT03103152|565748391|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
156727132|NCT03103152|565748392|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
156727133|NCT03103152|565748387|FG000|Overall Study|Unacceptable side effects|0|||
156454058|NCT01539083|564756919|FG000|Before Randomization (VCD Induction)|Other|5|||
156454059|NCT01539083|564756920|FG001|Before Randomization (VCD Induction)|Other|0|||
156727134|NCT03103152|565748388|FG001|Overall Study|Unacceptable side effects|0|||
156727135|NCT03103152|565748389|FG002|Overall Study|Unacceptable side effects|0|||
156727136|NCT03103152|565748390|FG003|Overall Study|Unacceptable side effects|0|||
156727137|NCT03103152|565748391|FG004|Overall Study|Unacceptable side effects|0|||
156876222|NCT03390101|566305768|FG001|Weeks 12-54|Withdrawal by Subject|3|||
156727138|NCT03103152|565748392|FG005|Overall Study|Unacceptable side effects|1|||
156727139|NCT03103152|565748387|FG000|Overall Study|Lost to Follow-up|0|||
156727140|NCT03103152|565748388|FG001|Overall Study|Lost to Follow-up|1|||
156727141|NCT03103152|565748389|FG002|Overall Study|Lost to Follow-up|0|||
156454060|NCT01539083|564756921|FG002|Before Randomization (VCD Induction)|Other|0|||
156454061|NCT01539083|564756919|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
156454062|NCT01539083|564756920|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
156454063|NCT01539083|564756921|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
156454064|NCT01539083|564756919|FG000|After Randomization (TP and VTP)|Other|0|||
156454065|NCT01539083|564756920|FG001|After Randomization (TP and VTP)|Other|1|||
156454066|NCT01539083|564756921|FG002|After Randomization (TP and VTP)|Other|1|||
156454067|NCT01539083|564756919|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
156454068|NCT01539083|564756920|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
156454069|NCT01539083|564756921|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
156454070|NCT01539083|564756919|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
156454071|NCT01539083|564756920|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
156454072|NCT01539083|564756921|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
156454073|NCT01539083|564756919|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
156454074|NCT01539083|564756920|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
156454075|NCT01539083|564756921|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
156454076|NCT01539083|564756919|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
156454077|NCT01539083|564756920|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
156454078|NCT01539083|564756921|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
156454079|NCT01539083|564756919|FG000|After Randomization (TP and VTP)|Death|0|||
156454080|NCT01539083|564756920|FG001|After Randomization (TP and VTP)|Death|6|||
156454081|NCT01539083|564756921|FG002|After Randomization (TP and VTP)|Death|11|||
156454082|NCT05006872|564756930|FG000|Overall Study|Lost to Follow-up|37|||
156454083|NCT05006872|564756931|FG001|Overall Study|Lost to Follow-up|31|||
156454084|NCT05499377|564756937|FG000|Overall Study|Withdrawal by Subject|2|||
156454085|NCT05499377|564756938|FG001|Overall Study|Withdrawal by Subject|0|||
156454086|NCT05499377|564756937|FG000|Overall Study|Physician Decision|1|||
156454087|NCT05499377|564756938|FG001|Overall Study|Physician Decision|0|||
156454088|NCT04332926|564756939|FG000|Overall Study|Withdrawal by Subject|6|||
156454089|NCT04332926|564756939|FG000|Overall Study|Physician Decision|6|||
156454090|NCT04350463|564756947|FG000|Overall Study|Other reason|0|||
156454091|NCT04350463|564756948|FG001|Overall Study|Other reason|0|||
156454092|NCT04350463|564756949|FG002|Overall Study|Other reason|0|||
156454093|NCT04350463|564756950|FG003|Overall Study|Other reason|1|||
156454094|NCT04350463|564756947|FG000|Overall Study|Lost to Follow-up|0|||
156454095|NCT04350463|564756948|FG001|Overall Study|Lost to Follow-up|0|||
156454096|NCT04350463|564756949|FG002|Overall Study|Lost to Follow-up|0|||
156454097|NCT04350463|564756950|FG003|Overall Study|Lost to Follow-up|2|||
156454098|NCT04350463|564756947|FG000|Overall Study|Withdrawal by Subject|4|||
156454099|NCT04350463|564756948|FG001|Overall Study|Withdrawal by Subject|0|||
156454100|NCT04350463|564756949|FG002|Overall Study|Withdrawal by Subject|1|||
156454101|NCT04350463|564756950|FG003|Overall Study|Withdrawal by Subject|4|||
156454102|NCT04350463|564756947|FG000|Overall Study|Adverse Event|0|||
156454103|NCT04350463|564756948|FG001|Overall Study|Adverse Event|0|||
156454104|NCT04350463|564756949|FG002|Overall Study|Adverse Event|0|||
156454105|NCT04350463|564756950|FG003|Overall Study|Adverse Event|2|||
156454106|NCT04350463|564756947|FG000|Overall Study|Death|27|||
156454107|NCT04350463|564756948|FG001|Overall Study|Death|2|||
156454108|NCT04350463|564756949|FG002|Overall Study|Death|13|||
156454109|NCT04350463|564756950|FG003|Overall Study|Death|26|||
156454110|NCT04652700|564756951|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
156454111|NCT04652700|564756952|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
156454112|NCT04652700|564756951|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
156454113|NCT04652700|564756952|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
156454114|NCT04652700|564756951|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
156454115|NCT04652700|564756952|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
156454116|NCT04652700|564756951|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
156454117|NCT04652700|564756952|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
156454118|NCT04652700|564756951|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
156454119|NCT04652700|564756952|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
156454120|NCT04652700|564756951|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
156533569|NCT03838198|565048858|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
156533570|NCT02378220|565048863|FG000|Overall Study|Death|6|||
156454121|NCT04652700|564756952|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
156454122|NCT04652700|564756951|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
156454123|NCT04652700|564756952|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
156454124|NCT04652700|564756951|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
156454125|NCT04652700|564756952|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
156454126|NCT04652700|564756951|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
156454127|NCT04652700|564756952|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
156727142|NCT03103152|565748390|FG003|Overall Study|Lost to Follow-up|1|||
156727143|NCT03103152|565748391|FG004|Overall Study|Lost to Follow-up|0|||
156727144|NCT03103152|565748392|FG005|Overall Study|Lost to Follow-up|1|||
156727145|NCT03103152|565748387|FG000|Overall Study|Testicular pain|0|||
156727146|NCT03103152|565748388|FG001|Overall Study|Testicular pain|0|||
156727147|NCT03103152|565748389|FG002|Overall Study|Testicular pain|0|||
156727148|NCT03103152|565748390|FG003|Overall Study|Testicular pain|1|||
156727149|NCT03103152|565748391|FG004|Overall Study|Testicular pain|0|||
156727150|NCT03103152|565748392|FG005|Overall Study|Testicular pain|0|||
156727151|NCT03100903|565750342|FG000|Overall Study|Withdrawal by Subject|0|||
156727152|NCT03100903|565750343|FG001|Overall Study|Withdrawal by Subject|0|||
156727153|NCT03100903|565750344|FG002|Overall Study|Withdrawal by Subject|1|||
156727154|NCT04659993|565750345|FG000|Overall Study|Withdrawal by Subject|2|||
156727155|NCT04659993|565750345|FG000|Overall Study|Lost to Follow-up|2|||
156727156|NCT00754234|565750349|FG000|Overall Study|Withdrawal by Subject|3|||
156727157|NCT03263936|565750350|FG000|Overall Study|Adverse Event|0|||
156727158|NCT03263936|565750351|FG001|Overall Study|Adverse Event|1|||
156727159|NCT03263936|565750352|FG002|Overall Study|Adverse Event|0|||
156727160|NCT03263936|565750350|FG000|Overall Study|Death|0|||
156727161|NCT03263936|565750351|FG001|Overall Study|Death|1|||
156727162|NCT03263936|565750352|FG002|Overall Study|Death|0|||
156727163|NCT03868930|565750353|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
156727164|NCT03868930|565750354|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
156727165|NCT03868930|565750353|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
156727166|NCT03868930|565750354|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
156727167|NCT03868930|565750353|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
156727168|NCT03868930|565750354|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
156727169|NCT03868930|565750353|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
156727170|NCT03868930|565750354|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
156727171|NCT03868930|565750353|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
156727172|NCT03868930|565750354|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
156727173|NCT02151851|565750357|FG000|Overall Study|Lack of Efficacy|67|||
156727174|NCT02151851|565750358|FG001|Overall Study|Lack of Efficacy|94|||
156795768|NCT03895372|566006183|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
156795769|NCT03895372|566006184|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
156454128|NCT03097549|564756953|FG000|Overall Study|Withdrawal by Subject|1|||
156727175|NCT02151851|565750357|FG000|Overall Study|Protocol Violation|0|||
156795770|NCT03895372|566006185|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
156795771|NCT03895372|566006186|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
156795772|NCT03895372|566006179|FG000|Extension Treatment Period|Adverse Event|0|||
156795773|NCT03895372|566006180|FG001|Extension Treatment Period|Adverse Event|1|||
156795774|NCT03895372|566006181|FG002|Extension Treatment Period|Adverse Event|0|||
156795775|NCT03895372|566006182|FG003|Extension Treatment Period|Adverse Event|1|||
156795776|NCT03895372|566006183|FG004|Extension Treatment Period|Adverse Event|0|||
156795777|NCT03895372|566006184|FG005|Extension Treatment Period|Adverse Event|0|||
156795778|NCT03895372|566006185|FG006|Extension Treatment Period|Adverse Event|3|||
156795779|NCT03895372|566006186|FG007|Extension Treatment Period|Adverse Event|3|||
156795780|NCT03895372|566006179|FG000|Extension Treatment Period|Other|1|||
156795781|NCT03895372|566006180|FG001|Extension Treatment Period|Other|3|||
156795782|NCT03895372|566006181|FG002|Extension Treatment Period|Other|0|||
156795783|NCT03895372|566006182|FG003|Extension Treatment Period|Other|0|||
156795784|NCT03895372|566006183|FG004|Extension Treatment Period|Other|1|||
156795785|NCT03895372|566006184|FG005|Extension Treatment Period|Other|0|||
156795786|NCT03895372|566006185|FG006|Extension Treatment Period|Other|0|||
156795787|NCT03895372|566006186|FG007|Extension Treatment Period|Other|2|||
156795788|NCT03895372|566006179|FG000|Extension Treatment Period|Pregnancy|0|||
156795789|NCT03895372|566006180|FG001|Extension Treatment Period|Pregnancy|0|||
156795790|NCT03895372|566006181|FG002|Extension Treatment Period|Pregnancy|0|||
156795791|NCT03895372|566006182|FG003|Extension Treatment Period|Pregnancy|0|||
156795792|NCT03895372|566006183|FG004|Extension Treatment Period|Pregnancy|1|||
156795793|NCT03895372|566006184|FG005|Extension Treatment Period|Pregnancy|0|||
156795794|NCT03895372|566006185|FG006|Extension Treatment Period|Pregnancy|0|||
156795795|NCT03895372|566006186|FG007|Extension Treatment Period|Pregnancy|0|||
156795796|NCT03895372|566006179|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
156454129|NCT03097549|564756954|FG001|Overall Study|Withdrawal by Subject|0|||
156727176|NCT02151851|565750358|FG001|Overall Study|Protocol Violation|1|||
156795797|NCT03895372|566006180|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
156795798|NCT03895372|566006181|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
156727177|NCT02151851|565750357|FG000|Overall Study|Withdrawal by Subject|2|||
156727178|NCT02151851|565750358|FG001|Overall Study|Withdrawal by Subject|5|||
156795799|NCT03895372|566006182|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
156795800|NCT03895372|566006183|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
156795801|NCT03895372|566006184|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
156876223|NCT03390101|566305769|FG002|Weeks 12-54|Withdrawal by Subject|1|||
156727179|NCT02151851|565750357|FG000|Overall Study|Medical impairment|1|||
156454130|NCT03097549|564756953|FG000|Overall Study|Lost to Follow-up|1|||
156727180|NCT02151851|565750358|FG001|Overall Study|Medical impairment|0|||
156727181|NCT02151851|565750357|FG000|Overall Study|Low compliance to study visits|0|||
156727182|NCT02151851|565750358|FG001|Overall Study|Low compliance to study visits|1|||
156727183|NCT02151851|565750357|FG000|Overall Study|Subject entered into study in error|0|||
156727184|NCT02151851|565750358|FG001|Overall Study|Subject entered into study in error|1|||
156727185|NCT02151851|565750357|FG000|Overall Study|Adverse Event|6|||
156727186|NCT02151851|565750358|FG001|Overall Study|Adverse Event|28|||
156727187|NCT02640950|565750359|FG000|Overall Study|Adverse Event|1|||
156727188|NCT02640950|565750359|FG000|Overall Study|Withdrawal by Subject|1|||
156727189|NCT00652626|565750360|FG000|Initial Treatment Phase|Adverse Event|0|||
156727190|NCT00652626|565750361|FG001|Initial Treatment Phase|Adverse Event|0|||
156727191|NCT00652626|565750362|FG002|Initial Treatment Phase|Adverse Event|0|||
156727192|NCT00652626|565750363|FG003|Initial Treatment Phase|Adverse Event|0|||
156727193|NCT00652626|565750364|FG004|Initial Treatment Phase|Adverse Event|1|||
156727194|NCT00652626|565750365|FG005|Initial Treatment Phase|Adverse Event|0|||
156727195|NCT00652626|565750366|FG006|Initial Treatment Phase|Adverse Event|0|||
156727196|NCT00652626|565750360|FG000|Initial Treatment Phase|Protocol Violation|0|||
156727197|NCT00652626|565750361|FG001|Initial Treatment Phase|Protocol Violation|0|||
156727198|NCT00652626|565750362|FG002|Initial Treatment Phase|Protocol Violation|0|||
156727199|NCT00652626|565750363|FG003|Initial Treatment Phase|Protocol Violation|1|||
156727200|NCT00652626|565750364|FG004|Initial Treatment Phase|Protocol Violation|0|||
156727201|NCT00652626|565750365|FG005|Initial Treatment Phase|Protocol Violation|0|||
156727202|NCT00652626|565750366|FG006|Initial Treatment Phase|Protocol Violation|0|||
156727203|NCT00652626|565750360|FG000|Initial Treatment Phase|Physician Decision|0|||
156727204|NCT00652626|565750361|FG001|Initial Treatment Phase|Physician Decision|0|||
156727205|NCT00652626|565750362|FG002|Initial Treatment Phase|Physician Decision|0|||
156727206|NCT00652626|565750363|FG003|Initial Treatment Phase|Physician Decision|0|||
156727207|NCT00652626|565750364|FG004|Initial Treatment Phase|Physician Decision|1|||
156727208|NCT00652626|565750365|FG005|Initial Treatment Phase|Physician Decision|0|||
156727209|NCT00652626|565750366|FG006|Initial Treatment Phase|Physician Decision|0|||
156727210|NCT00652626|565750360|FG000|Initial Treatment Phase|Sponsor Request|0|||
156727211|NCT00652626|565750361|FG001|Initial Treatment Phase|Sponsor Request|0|||
156727212|NCT00652626|565750362|FG002|Initial Treatment Phase|Sponsor Request|1|||
156727213|NCT00652626|565750363|FG003|Initial Treatment Phase|Sponsor Request|0|||
156727214|NCT00652626|565750364|FG004|Initial Treatment Phase|Sponsor Request|0|||
156727215|NCT00652626|565750365|FG005|Initial Treatment Phase|Sponsor Request|0|||
156727216|NCT00652626|565750366|FG006|Initial Treatment Phase|Sponsor Request|0|||
156727217|NCT00652626|565750360|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
156727218|NCT00652626|565750361|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
156727219|NCT00652626|565750362|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
156727220|NCT00652626|565750363|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
156727221|NCT00652626|565750364|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
156727222|NCT00652626|565750365|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
156727223|NCT00652626|565750366|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
156727224|NCT00652626|565750360|FG000|Extension Phase|Withdrawal by Subject|0|||
156727225|NCT00652626|565750361|FG001|Extension Phase|Withdrawal by Subject|0|||
156727226|NCT00652626|565750362|FG002|Extension Phase|Withdrawal by Subject|0|||
156727227|NCT00652626|565750363|FG003|Extension Phase|Withdrawal by Subject|0|||
156727228|NCT00652626|565750364|FG004|Extension Phase|Withdrawal by Subject|0|||
156727229|NCT00652626|565750365|FG005|Extension Phase|Withdrawal by Subject|2|||
156727230|NCT00652626|565750366|FG006|Extension Phase|Withdrawal by Subject|0|||
156727231|NCT00652626|565750360|FG000|Extension Phase|Adverse Event|0|||
156727232|NCT00652626|565750361|FG001|Extension Phase|Adverse Event|0|||
156727233|NCT00652626|565750362|FG002|Extension Phase|Adverse Event|0|||
156727234|NCT00652626|565750363|FG003|Extension Phase|Adverse Event|0|||
156727235|NCT00652626|565750364|FG004|Extension Phase|Adverse Event|0|||
156727236|NCT00652626|565750365|FG005|Extension Phase|Adverse Event|2|||
156727237|NCT00652626|565750366|FG006|Extension Phase|Adverse Event|1|||
156727238|NCT00652626|565750360|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156727239|NCT00652626|565750361|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156727240|NCT00652626|565750362|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156727241|NCT00652626|565750363|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156727242|NCT00652626|565750364|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156795802|NCT03895372|566006185|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
156795803|NCT03895372|566006186|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
156795804|NCT03685149|566006187|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
156795805|NCT03685149|566006188|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
156454131|NCT03097549|564756954|FG001|Overall Study|Lost to Follow-up|0|||
156795806|NCT03685149|566006187|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156727243|NCT00652626|565750365|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
156454132|NCT01824537|564756957|FG000|Overall Study|Lost to Follow-up|78|||
156727244|NCT00652626|565750366|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156454133|NCT01824537|564756958|FG001|Overall Study|Lost to Follow-up|87|||
156454134|NCT04282148|564756959|FG000|Overall Study|Death|7|||
156454135|NCT04282148|564756959|FG000|Overall Study|Withdrawal by Subject|1|||
156454136|NCT04282148|564756959|FG000|Overall Study|Physician Decision|1|||
156454137|NCT06215521|564756960|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
156454138|NCT06215521|564756961|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
156454139|NCT06215521|564756962|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
156454140|NCT06215521|564756963|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
156454141|NCT06215521|564756964|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
156454142|NCT06215521|564756965|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
156454143|NCT04096040|564756966|FG000|Overall Study|Protocol Violation|12|||
156454144|NCT04096040|564756966|FG000|Overall Study|Non-compliant site|4|||
156454145|NCT04973254|564756967|FG000|Overall Study|Not adherent|0|||
156454146|NCT04973254|564756968|FG001|Overall Study|Not adherent|1|||
156454147|NCT04973254|564756969|FG002|Overall Study|Not adherent|0|||
156454148|NCT04044768|564756970|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
156454149|NCT04044768|564756971|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
156454150|NCT03808818|564756972|FG000|Overall Study|Death|6|||
156454151|NCT03808818|564756973|FG001|Overall Study|Death|6|||
156454152|NCT03808818|564756972|FG000|Overall Study|Withdrawal by Subject|7|||
156454153|NCT03808818|564756973|FG001|Overall Study|Withdrawal by Subject|18|||
156454154|NCT03808818|564756972|FG000|Overall Study|Lost to Follow-up|31|||
156454155|NCT03808818|564756973|FG001|Overall Study|Lost to Follow-up|33|||
156454156|NCT03858634|564756974|FG000|Overall Study|Withdrawal by Subject|1|||
156454157|NCT03858634|564756975|FG001|Overall Study|Withdrawal by Subject|0|||
156454158|NCT03858634|564756974|FG000|Overall Study|Adverse Event|1|||
156454159|NCT03858634|564756975|FG001|Overall Study|Adverse Event|0|||
156454160|NCT03858634|564756974|FG000|Overall Study|Lost to Follow-up|0|||
156454161|NCT03858634|564756975|FG001|Overall Study|Lost to Follow-up|1|||
156454162|NCT03858634|564756974|FG000|Overall Study|Other, Not Specified|1|||
156454163|NCT03858634|564756975|FG001|Overall Study|Other, Not Specified|1|||
156454164|NCT05415722|564756976|FG000|Overall Study|Lost to Follow-up|0|||
156454165|NCT05415722|564756977|FG001|Overall Study|Lost to Follow-up|2|||
156454166|NCT05415722|564756978|FG002|Overall Study|Lost to Follow-up|0|||
156454167|NCT05415722|564756979|FG003|Overall Study|Lost to Follow-up|1|||
156454168|NCT05415722|564756980|FG004|Overall Study|Lost to Follow-up|0|||
156727245|NCT00652626|565750360|FG000|Extension Phase|Physician Decision|0|||
156727246|NCT00652626|565750361|FG001|Extension Phase|Physician Decision|0|||
156727247|NCT00652626|565750362|FG002|Extension Phase|Physician Decision|0|||
156727248|NCT00652626|565750363|FG003|Extension Phase|Physician Decision|0|||
156727249|NCT00652626|565750364|FG004|Extension Phase|Physician Decision|0|||
156727250|NCT00652626|565750365|FG005|Extension Phase|Physician Decision|1|||
156727251|NCT00652626|565750366|FG006|Extension Phase|Physician Decision|1|||
156727252|NCT00652626|565750360|FG000|Extension Phase|Death|0|||
156727253|NCT00652626|565750361|FG001|Extension Phase|Death|0|||
156727254|NCT00652626|565750362|FG002|Extension Phase|Death|0|||
156727255|NCT00652626|565750363|FG003|Extension Phase|Death|0|||
156727256|NCT00652626|565750364|FG004|Extension Phase|Death|0|||
156727257|NCT00652626|565750365|FG005|Extension Phase|Death|1|||
156727258|NCT00652626|565750366|FG006|Extension Phase|Death|1|||
156727259|NCT04003636|565750367|FG000|Overall Study|Death|409|||
156727260|NCT04003636|565750368|FG001|Overall Study|Death|443|||
156727261|NCT04003636|565750367|FG000|Overall Study|Lost to Follow-up|0|||
156727262|NCT04003636|565750368|FG001|Overall Study|Lost to Follow-up|1|||
156727263|NCT04003636|565750367|FG000|Overall Study|Withdrawal by Subject|5|||
156727264|NCT04003636|565750368|FG001|Overall Study|Withdrawal by Subject|2|||
156727265|NCT04003636|565750367|FG000|Overall Study|Participant On-going|119|||
156795807|NCT03685149|566006188|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156795808|NCT03685149|566006187|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
156795809|NCT03685149|566006188|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
156795810|NCT02655601|566006192|FG000|Overall Study|Adverse Event|0|||
156795811|NCT02655601|566006193|FG001|Overall Study|Adverse Event|0|||
156795812|NCT02655601|566006194|FG002|Overall Study|Adverse Event|0|||
156727266|NCT04003636|565750368|FG001|Overall Study|Participant On-going|90|||
156727267|NCT03048747|565750369|FG000|Overall Study|Adverse Event|2|||
156727268|NCT03048747|565750369|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
156727269|NCT03048747|565750369|FG000|Overall Study|Physician Decision|1|||
156727270|NCT00298272|565750370|FG000|Double-blind Phase|Adverse Event|2|||
156727271|NCT00298272|565750371|FG001|Double-blind Phase|Adverse Event|0|||
156727272|NCT00298272|565750370|FG000|Double-blind Phase|Failure to Return|2|||
156795813|NCT02655601|566006195|FG003|Overall Study|Adverse Event|1|||
156454169|NCT05415722|564756981|FG005|Overall Study|Lost to Follow-up|0|||
156454170|NCT05415722|564756982|FG006|Overall Study|Lost to Follow-up|1|||
156454171|NCT05415722|564756976|FG000|Overall Study|Physician Decision|0|||
156454172|NCT05415722|564756977|FG001|Overall Study|Physician Decision|0|||
156454173|NCT05415722|564756978|FG002|Overall Study|Physician Decision|0|||
156454174|NCT05415722|564756979|FG003|Overall Study|Physician Decision|1|||
156454175|NCT05415722|564756980|FG004|Overall Study|Physician Decision|0|||
156454176|NCT05415722|564756981|FG005|Overall Study|Physician Decision|0|||
156727273|NCT00298272|565750371|FG001|Double-blind Phase|Failure to Return|0|||
156727274|NCT00298272|565750370|FG000|Double-blind Phase|Protocol Violation|2|||
156727275|NCT00298272|565750371|FG001|Double-blind Phase|Protocol Violation|0|||
156727276|NCT00298272|565750370|FG000|Double-blind Phase|Withdrawal by Subject|2|||
156727277|NCT00298272|565750371|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156727278|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Adverse Event|1|||
156727279|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Adverse Event|2|||
156727280|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
156727281|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
156727282|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Failure to Return|1|||
156727283|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Failure to Return|0|||
156727284|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
156727285|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
156727286|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
156727287|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
156727288|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
156727289|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
156727290|NCT00298272|565750370|FG000|Safety Follow-up Phase|Failure to Return|1|||
156727291|NCT00298272|565750371|FG001|Safety Follow-up Phase|Failure to Return|1|||
156727292|NCT00298272|565750370|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
156727293|NCT00298272|565750371|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
156727294|NCT00298272|565750370|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
156727295|NCT00298272|565750371|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
156727296|NCT00915018|565750372|FG000|Overall Study|Death|75|||
156727297|NCT00915018|565750373|FG001|Overall Study|Death|70|||
156727298|NCT00915018|565750372|FG000|Overall Study|Lost to Follow-up|10|||
156727299|NCT00915018|565750373|FG001|Overall Study|Lost to Follow-up|5|||
156727300|NCT00915018|565750372|FG000|Overall Study|Withdrawal by Subject|38|||
156727301|NCT00915018|565750373|FG001|Overall Study|Withdrawal by Subject|27|||
156727302|NCT00915018|565750372|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
156727303|NCT00915018|565750373|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
156727304|NCT00457002|565750374|FG000|Overall Study|Death|40|||
156727305|NCT00457002|565750375|FG001|Overall Study|Death|47|||
156727306|NCT00457002|565750374|FG000|Overall Study|Adverse Event|284|||
156727307|NCT00457002|565750375|FG001|Overall Study|Adverse Event|260|||
156727308|NCT00457002|565750374|FG000|Overall Study|Withdrawal by Subject|299|||
156727309|NCT00457002|565750375|FG001|Overall Study|Withdrawal by Subject|271|||
156727310|NCT00457002|565750374|FG000|Overall Study|Lost to Follow-up|72|||
156727311|NCT00457002|565750375|FG001|Overall Study|Lost to Follow-up|71|||
156727312|NCT00457002|565750374|FG000|Overall Study|Poor/Non-compliance|46|||
156727313|NCT00457002|565750375|FG001|Overall Study|Poor/Non-compliance|33|||
156727314|NCT00457002|565750374|FG000|Overall Study|No longer met criteria|41|||
156727315|NCT00457002|565750375|FG001|Overall Study|No longer met criteria|37|||
156727316|NCT00457002|565750374|FG000|Overall Study|Administrative reason by Sponsor|1|||
156727317|NCT00457002|565750375|FG001|Overall Study|Administrative reason by Sponsor|0|||
156727318|NCT00457002|565750374|FG000|Overall Study|non-specified|29|||
156727319|NCT00457002|565750375|FG001|Overall Study|non-specified|38|||
156727320|NCT00457002|565750374|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
156727321|NCT00457002|565750375|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
156727322|NCT01623310|565750376|FG000|Overall Study|Adverse Event|21|||
156727323|NCT01623310|565750376|FG000|Overall Study|Lost to Follow-up|18|||
156727324|NCT01623310|565750376|FG000|Overall Study|Lack of Efficacy|6|||
156727325|NCT01623310|565750376|FG000|Overall Study|Protocol Violation|6|||
156727326|NCT01623310|565750376|FG000|Overall Study|Withdrawal by Subject|25|||
156727327|NCT01623310|565750376|FG000|Overall Study|Became potentially child-bearing|1|||
156727328|NCT01623310|565750376|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
156727329|NCT01623310|565750376|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
156727330|NCT00454246|565750377|FG000|Overall Study|Adverse Event|2|||
156727331|NCT00454246|565750378|FG001|Overall Study|Adverse Event|2|||
156727332|NCT00454246|565750379|FG002|Overall Study|Adverse Event|0|||
156727333|NCT00454246|565750377|FG000|Overall Study|Violation of selection criteria at entry|6|||
156727334|NCT00454246|565750378|FG001|Overall Study|Violation of selection criteria at entry|0|||
156727335|NCT00454246|565750379|FG002|Overall Study|Violation of selection criteria at entry|0|||
156727336|NCT00454246|565750377|FG000|Overall Study|Protocol Violation|1|||
156727337|NCT00454246|565750378|FG001|Overall Study|Protocol Violation|0|||
156727338|NCT00454246|565750379|FG002|Overall Study|Protocol Violation|0|||
156727339|NCT00454246|565750377|FG000|Overall Study|Refused Treatment|1|||
156727340|NCT00454246|565750378|FG001|Overall Study|Refused Treatment|1|||
156727341|NCT00454246|565750379|FG002|Overall Study|Refused Treatment|0|||
156727342|NCT00454246|565750377|FG000|Overall Study|Failure to return|1|||
156727343|NCT00454246|565750378|FG001|Overall Study|Failure to return|0|||
156727344|NCT00454246|565750379|FG002|Overall Study|Failure to return|0|||
156727345|NCT00454246|565750377|FG000|Overall Study|Early termination of study|62|||
156727346|NCT00454246|565750378|FG001|Overall Study|Early termination of study|26|||
156727347|NCT00454246|565750379|FG002|Overall Study|Early termination of study|9|||
156727348|NCT05326529|565750380|FG000|Overall Study|Lack of Efficacy|0|||
156727349|NCT05326529|565750381|FG001|Overall Study|Lack of Efficacy|1|||
156727350|NCT05326529|565750382|FG002|Overall Study|Lack of Efficacy|0|||
156727351|NCT05326529|565750380|FG000|Overall Study|Physician Decision|0|||
156727352|NCT05326529|565750381|FG001|Overall Study|Physician Decision|0|||
156727353|NCT05326529|565750382|FG002|Overall Study|Physician Decision|2|||
156727354|NCT00932373|565750384|FG000|Overall Study|Progressive disease|3|||
156727355|NCT00932373|565750385|FG001|Overall Study|Progressive disease|1|||
156727356|NCT00932373|565750386|FG002|Overall Study|Progressive disease|0|||
156727357|NCT00932373|565750387|FG003|Overall Study|Progressive disease|0|||
156727358|NCT00932373|565750388|FG004|Overall Study|Progressive disease|10|||
156727359|NCT00932373|565750389|FG005|Overall Study|Progressive disease|1|||
156727360|NCT00932373|565750390|FG006|Overall Study|Progressive disease|0|||
156727361|NCT00932373|565750391|FG007|Overall Study|Progressive disease|2|||
156727362|NCT00932373|565750392|FG008|Overall Study|Progressive disease|1|||
156727363|NCT00932373|565750393|FG009|Overall Study|Progressive disease|9|||
156727364|NCT00932373|565750394|FG010|Overall Study|Progressive disease|2|||
156727365|NCT00932373|565750384|FG000|Overall Study|Adverse Event|0|||
156727366|NCT00932373|565750385|FG001|Overall Study|Adverse Event|0|||
156727367|NCT00932373|565750386|FG002|Overall Study|Adverse Event|0|||
156727368|NCT00932373|565750387|FG003|Overall Study|Adverse Event|0|||
156727369|NCT00932373|565750388|FG004|Overall Study|Adverse Event|2|||
156727370|NCT00932373|565750389|FG005|Overall Study|Adverse Event|1|||
156727371|NCT00932373|565750390|FG006|Overall Study|Adverse Event|0|||
156727372|NCT00932373|565750391|FG007|Overall Study|Adverse Event|1|||
156727373|NCT00932373|565750392|FG008|Overall Study|Adverse Event|0|||
156727374|NCT00932373|565750393|FG009|Overall Study|Adverse Event|2|||
156727375|NCT00932373|565750394|FG010|Overall Study|Adverse Event|1|||
156727376|NCT00932373|565750384|FG000|Overall Study|Physician Decision|0|||
156727377|NCT00932373|565750385|FG001|Overall Study|Physician Decision|0|||
156727378|NCT00932373|565750386|FG002|Overall Study|Physician Decision|1|||
156727379|NCT00932373|565750387|FG003|Overall Study|Physician Decision|0|||
156727380|NCT00932373|565750388|FG004|Overall Study|Physician Decision|2|||
156727381|NCT00932373|565750389|FG005|Overall Study|Physician Decision|0|||
156727382|NCT00932373|565750390|FG006|Overall Study|Physician Decision|0|||
156727383|NCT00932373|565750391|FG007|Overall Study|Physician Decision|0|||
156727384|NCT00932373|565750392|FG008|Overall Study|Physician Decision|0|||
156727385|NCT00932373|565750393|FG009|Overall Study|Physician Decision|1|||
156727386|NCT00932373|565750394|FG010|Overall Study|Physician Decision|0|||
156727387|NCT00932373|565750384|FG000|Overall Study|Dose limiting toxicity|0|||
156727388|NCT00932373|565750385|FG001|Overall Study|Dose limiting toxicity|0|||
156727389|NCT00932373|565750386|FG002|Overall Study|Dose limiting toxicity|0|||
156727390|NCT00932373|565750387|FG003|Overall Study|Dose limiting toxicity|0|||
156727391|NCT00932373|565750388|FG004|Overall Study|Dose limiting toxicity|0|||
156727392|NCT00932373|565750389|FG005|Overall Study|Dose limiting toxicity|1|||
156727393|NCT00932373|565750390|FG006|Overall Study|Dose limiting toxicity|0|||
156727394|NCT00932373|565750391|FG007|Overall Study|Dose limiting toxicity|0|||
156727395|NCT00932373|565750392|FG008|Overall Study|Dose limiting toxicity|0|||
156727396|NCT00932373|565750393|FG009|Overall Study|Dose limiting toxicity|0|||
156727397|NCT00932373|565750394|FG010|Overall Study|Dose limiting toxicity|0|||
156727398|NCT00932373|565750384|FG000|Overall Study|Withdrawal by Subject|0|||
156727399|NCT00932373|565750385|FG001|Overall Study|Withdrawal by Subject|0|||
156727400|NCT00932373|565750386|FG002|Overall Study|Withdrawal by Subject|0|||
156727401|NCT00932373|565750387|FG003|Overall Study|Withdrawal by Subject|0|||
156727402|NCT00932373|565750388|FG004|Overall Study|Withdrawal by Subject|0|||
156727403|NCT00932373|565750389|FG005|Overall Study|Withdrawal by Subject|0|||
156727404|NCT00932373|565750390|FG006|Overall Study|Withdrawal by Subject|0|||
156727405|NCT00932373|565750391|FG007|Overall Study|Withdrawal by Subject|0|||
156727406|NCT00932373|565750392|FG008|Overall Study|Withdrawal by Subject|1|||
156727407|NCT00932373|565750393|FG009|Overall Study|Withdrawal by Subject|0|||
156727408|NCT00932373|565750394|FG010|Overall Study|Withdrawal by Subject|0|||
156727409|NCT00932373|565750384|FG000|Overall Study|Clinical progression|0|||
156454177|NCT05415722|564756982|FG006|Overall Study|Physician Decision|1|||
156454178|NCT05415722|564756976|FG000|Overall Study|Protocol Violation|0|||
156727410|NCT00932373|565750385|FG001|Overall Study|Clinical progression|0|||
156727411|NCT00932373|565750386|FG002|Overall Study|Clinical progression|0|||
156727412|NCT00932373|565750387|FG003|Overall Study|Clinical progression|0|||
156727413|NCT00932373|565750388|FG004|Overall Study|Clinical progression|0|||
156727414|NCT00932373|565750389|FG005|Overall Study|Clinical progression|0|||
156727415|NCT00932373|565750390|FG006|Overall Study|Clinical progression|1|||
156727416|NCT00932373|565750391|FG007|Overall Study|Clinical progression|0|||
156727417|NCT00932373|565750392|FG008|Overall Study|Clinical progression|0|||
156727418|NCT00932373|565750393|FG009|Overall Study|Clinical progression|0|||
156727419|NCT00932373|565750394|FG010|Overall Study|Clinical progression|0|||
156727420|NCT00932373|565750384|FG000|Overall Study|Lack of Efficacy|0|||
156454179|NCT05415722|564756977|FG001|Overall Study|Protocol Violation|0|||
156727421|NCT00932373|565750385|FG001|Overall Study|Lack of Efficacy|0|||
156454180|NCT05415722|564756978|FG002|Overall Study|Protocol Violation|0|||
156454181|NCT05415722|564756979|FG003|Overall Study|Protocol Violation|1|||
156454182|NCT05415722|564756980|FG004|Overall Study|Protocol Violation|0|||
156454183|NCT05415722|564756981|FG005|Overall Study|Protocol Violation|0|||
156727422|NCT00932373|565750386|FG002|Overall Study|Lack of Efficacy|0|||
156727423|NCT00932373|565750387|FG003|Overall Study|Lack of Efficacy|0|||
156727424|NCT00932373|565750388|FG004|Overall Study|Lack of Efficacy|0|||
156727425|NCT00932373|565750389|FG005|Overall Study|Lack of Efficacy|0|||
156727426|NCT00932373|565750390|FG006|Overall Study|Lack of Efficacy|0|||
156727427|NCT00932373|565750391|FG007|Overall Study|Lack of Efficacy|0|||
156727428|NCT00932373|565750392|FG008|Overall Study|Lack of Efficacy|0|||
156727429|NCT00932373|565750393|FG009|Overall Study|Lack of Efficacy|1|||
156727430|NCT00932373|565750394|FG010|Overall Study|Lack of Efficacy|0|||
156727431|NCT04134767|565750396|FG000|Overall Study|Death|0|||
156727432|NCT04134767|565750397|FG001|Overall Study|Death|1|||
156727433|NCT04134767|565750396|FG000|Overall Study|Removed for harassing staff|0|||
156727434|NCT04134767|565750397|FG001|Overall Study|Removed for harassing staff|1|||
156727435|NCT04134767|565750396|FG000|Overall Study|Lost to Follow-up|44|||
156727436|NCT04134767|565750397|FG001|Overall Study|Lost to Follow-up|40|||
156727437|NCT02582242|565750398|FG000|Overall Study|Adverse Event|4|||
156727438|NCT02582242|565750399|FG001|Overall Study|Adverse Event|3|||
156727439|NCT02582242|565750398|FG000|Overall Study|Protocol Violation|3|||
156727440|NCT02582242|565750399|FG001|Overall Study|Protocol Violation|1|||
156727441|NCT02582242|565750398|FG000|Overall Study|Lost to Follow-up|0|||
156727442|NCT02582242|565750399|FG001|Overall Study|Lost to Follow-up|1|||
156727443|NCT02582242|565750398|FG000|Overall Study|Withdrawal by Subject|11|||
156727444|NCT02582242|565750399|FG001|Overall Study|Withdrawal by Subject|11|||
156727445|NCT02582242|565750398|FG000|Overall Study|Unclassified|2|||
156727446|NCT02582242|565750399|FG001|Overall Study|Unclassified|1|||
156727447|NCT00638404|565750400|FG000|Overall Study|Physician Decision|8|||
156727448|NCT00638404|565750401|FG001|Overall Study|Physician Decision|0|||
156727449|NCT02101736|565750405|FG000|Overall Study|Protocol Violation|3|||
156727450|NCT02101736|565750406|FG001|Overall Study|Protocol Violation|0|||
156727451|NCT02101736|565750405|FG000|Overall Study|Withdrawal by Subject|1|||
156727452|NCT02101736|565750406|FG001|Overall Study|Withdrawal by Subject|1|||
156727453|NCT02282631|565750407|FG000|Overall Study|Lost to Follow-up|2|||
156727454|NCT02282631|565750408|FG001|Overall Study|Lost to Follow-up|0|||
156727455|NCT00687271|565750409|FG000|Overall Study|Adverse Event|1|||
156727456|NCT00687271|565750410|FG001|Overall Study|Adverse Event|3|||
156727457|NCT00687271|565750411|FG002|Overall Study|Adverse Event|1|||
156727458|NCT00687271|565750412|FG003|Overall Study|Adverse Event|0|||
156727459|NCT00687271|565750409|FG000|Overall Study|Lost to Follow-up|0|||
156727460|NCT00687271|565750410|FG001|Overall Study|Lost to Follow-up|1|||
156727461|NCT00687271|565750411|FG002|Overall Study|Lost to Follow-up|0|||
156727462|NCT00687271|565750412|FG003|Overall Study|Lost to Follow-up|0|||
156727463|NCT00687271|565750409|FG000|Overall Study|Protocol Violation|2|||
156727464|NCT00687271|565750410|FG001|Overall Study|Protocol Violation|1|||
156727465|NCT00687271|565750411|FG002|Overall Study|Protocol Violation|1|||
156727466|NCT00687271|565750412|FG003|Overall Study|Protocol Violation|0|||
156727467|NCT00687271|565750409|FG000|Overall Study|Withdrawal by Subject|0|||
156727468|NCT00687271|565750410|FG001|Overall Study|Withdrawal by Subject|1|||
156727469|NCT00687271|565750411|FG002|Overall Study|Withdrawal by Subject|3|||
156727470|NCT00687271|565750412|FG003|Overall Study|Withdrawal by Subject|0|||
156727471|NCT01017874|565750416|FG000|Overall Study|Withdrawal by Subject|23|||
156727472|NCT01017874|565750417|FG001|Overall Study|Withdrawal by Subject|20|||
156727473|NCT01017874|565750416|FG000|Overall Study|Sponsor decision|3|||
156727474|NCT01017874|565750417|FG001|Overall Study|Sponsor decision|1|||
156727475|NCT01017874|565750416|FG000|Overall Study|Lost to Follow-up|3|||
156727476|NCT01017874|565750417|FG001|Overall Study|Lost to Follow-up|2|||
156727477|NCT01017874|565750416|FG000|Overall Study|Physician Decision|1|||
156727478|NCT01017874|565750417|FG001|Overall Study|Physician Decision|3|||
156727479|NCT00808210|565750421|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
156727480|NCT00808210|565750422|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
156795814|NCT02655601|566006196|FG004|Overall Study|Adverse Event|1|||
156795815|NCT02655601|566006197|FG005|Overall Study|Adverse Event|0|||
156795816|NCT02655601|566006192|FG000|Overall Study|Physician Decision|0|||
156727481|NCT00808210|565750421|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
156727482|NCT00808210|565750422|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
156727483|NCT00808210|565750421|FG000|Double-Blind TX Period|Adverse Event|0|||
156795817|NCT02655601|566006193|FG001|Overall Study|Physician Decision|0|||
156454184|NCT05415722|564756982|FG006|Overall Study|Protocol Violation|0|||
156727484|NCT00808210|565750422|FG001|Double-Blind TX Period|Adverse Event|1|||
156727485|NCT00808210|565750421|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
156727486|NCT00808210|565750422|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
156727487|NCT00808210|565750421|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
156727488|NCT00808210|565750422|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
156727489|NCT00808210|565750421|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
156454185|NCT05415722|564756976|FG000|Overall Study|Sponsor Discretion|0|||
156454186|NCT05415722|564756977|FG001|Overall Study|Sponsor Discretion|0|||
156454187|NCT05415722|564756978|FG002|Overall Study|Sponsor Discretion|0|||
156727490|NCT00808210|565750422|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
156727491|NCT02044302|565750423|FG000|Overall Study|study terminated|2|||
156727492|NCT02044302|565750424|FG001|Overall Study|study terminated|0|||
156727493|NCT00778817|565750426|FG000|Overall Study|Adverse Event|2|||
156727494|NCT00778817|565750426|FG000|Overall Study|Withdrawal by Subject|2|||
156727495|NCT02509507|565750427|FG000|Overall Study|Death|21|||
156454188|NCT05415722|564756979|FG003|Overall Study|Sponsor Discretion|0|||
156454189|NCT05415722|564756980|FG004|Overall Study|Sponsor Discretion|1|||
156454190|NCT05415722|564756981|FG005|Overall Study|Sponsor Discretion|1|||
156454191|NCT05415722|564756982|FG006|Overall Study|Sponsor Discretion|0|||
156454192|NCT05415722|564756976|FG000|Overall Study|Withdrawal by Subject|0|||
156454193|NCT05415722|564756977|FG001|Overall Study|Withdrawal by Subject|1|||
156454194|NCT05415722|564756978|FG002|Overall Study|Withdrawal by Subject|0|||
156454195|NCT05415722|564756979|FG003|Overall Study|Withdrawal by Subject|1|||
156454196|NCT05415722|564756980|FG004|Overall Study|Withdrawal by Subject|1|||
156454197|NCT05415722|564756981|FG005|Overall Study|Withdrawal by Subject|0|||
156454198|NCT05415722|564756982|FG006|Overall Study|Withdrawal by Subject|1|||
156454199|NCT04537715|564756984|FG000|Overall Study|Death|3|||
156454200|NCT04537715|564756985|FG001|Overall Study|Death|1|||
156454201|NCT04537715|564756984|FG000|Overall Study|Withdrawal by Subject|3|||
156454202|NCT04537715|564756985|FG001|Overall Study|Withdrawal by Subject|1|||
156454203|NCT04537715|564756984|FG000|Overall Study|Other|4|||
156454204|NCT04537715|564756985|FG001|Overall Study|Other|3|||
156454205|NCT04537715|564756984|FG000|Overall Study|Progressive disease|1|||
156454206|NCT04537715|564756985|FG001|Overall Study|Progressive disease|0|||
156454207|NCT03448107|564756986|FG000|Overall Study|Lost to Follow-up|229|||
156454208|NCT03448107|564756987|FG001|Overall Study|Lost to Follow-up|258|||
156454209|NCT04700163|564756988|FG000|Overall Study|Lost to Follow-up|0|||
156454210|NCT04700163|564756989|FG001|Overall Study|Lost to Follow-up|0|||
156454211|NCT04700163|564756990|FG002|Overall Study|Lost to Follow-up|0|||
156454212|NCT04700163|564756991|FG003|Overall Study|Lost to Follow-up|0|||
156454213|NCT04700163|564756992|FG004|Overall Study|Lost to Follow-up|0|||
156454214|NCT04700163|564756993|FG005|Overall Study|Lost to Follow-up|1|||
156454215|NCT05543629|564757000|FG000|Overall Study|Death|1|||
156454216|NCT05543629|564757001|FG001|Overall Study|Death|0|||
156454217|NCT05543629|564757002|FG002|Overall Study|Death|1|||
156454218|NCT05543629|564757003|FG003|Overall Study|Death|0|||
156454219|NCT05543629|564757004|FG004|Overall Study|Death|0|||
156454220|NCT05543629|564757005|FG005|Overall Study|Death|1|||
156454221|NCT05543629|564757006|FG006|Overall Study|Death|2|||
156454222|NCT05543629|564757007|FG007|Overall Study|Death|2|||
156454223|NCT05543629|564757000|FG000|Overall Study|Other Reasons|0|||
156454224|NCT05543629|564757001|FG001|Overall Study|Other Reasons|0|||
156454225|NCT05543629|564757002|FG002|Overall Study|Other Reasons|0|||
156454226|NCT05543629|564757003|FG003|Overall Study|Other Reasons|0|||
156454227|NCT05543629|564757004|FG004|Overall Study|Other Reasons|1|||
156454228|NCT05543629|564757005|FG005|Overall Study|Other Reasons|0|||
156454229|NCT05543629|564757006|FG006|Overall Study|Other Reasons|0|||
156454230|NCT05543629|564757007|FG007|Overall Study|Other Reasons|0|||
156454231|NCT05543629|564757000|FG000|Overall Study|Physician Decision|0|||
156454232|NCT05543629|564757001|FG001|Overall Study|Physician Decision|0|||
156454233|NCT05543629|564757002|FG002|Overall Study|Physician Decision|3|||
156454234|NCT05543629|564757003|FG003|Overall Study|Physician Decision|0|||
156454235|NCT05543629|564757004|FG004|Overall Study|Physician Decision|0|||
156454236|NCT05543629|564757005|FG005|Overall Study|Physician Decision|0|||
156727496|NCT02509507|565750428|FG001|Overall Study|Death|3|||
156727497|NCT02509507|565750429|FG002|Overall Study|Death|22|||
156727498|NCT02509507|565750430|FG003|Overall Study|Death|14|||
156454237|NCT05543629|564757006|FG006|Overall Study|Physician Decision|1|||
156454238|NCT05543629|564757007|FG007|Overall Study|Physician Decision|0|||
156454239|NCT05543629|564757000|FG000|Overall Study|Study terminated by Sponsor|1|||
156454240|NCT05543629|564757001|FG001|Overall Study|Study terminated by Sponsor|0|||
156454241|NCT05543629|564757002|FG002|Overall Study|Study terminated by Sponsor|0|||
156454242|NCT05543629|564757003|FG003|Overall Study|Study terminated by Sponsor|1|||
156727499|NCT02509507|565750431|FG004|Overall Study|Death|8|||
156727500|NCT02509507|565750432|FG005|Overall Study|Death|12|||
156454243|NCT05543629|564757004|FG004|Overall Study|Study terminated by Sponsor|0|||
156454244|NCT05543629|564757005|FG005|Overall Study|Study terminated by Sponsor|4|||
156454245|NCT05543629|564757006|FG006|Overall Study|Study terminated by Sponsor|1|||
156454246|NCT05543629|564757007|FG007|Overall Study|Study terminated by Sponsor|0|||
156454247|NCT05543629|564757000|FG000|Overall Study|Withdrawal by Subject|1|||
156454248|NCT05543629|564757001|FG001|Overall Study|Withdrawal by Subject|1|||
156454249|NCT05543629|564757002|FG002|Overall Study|Withdrawal by Subject|0|||
156454250|NCT05543629|564757003|FG003|Overall Study|Withdrawal by Subject|2|||
156454251|NCT05543629|564757004|FG004|Overall Study|Withdrawal by Subject|1|||
156454252|NCT05543629|564757005|FG005|Overall Study|Withdrawal by Subject|1|||
156727501|NCT02509507|565750433|FG006|Overall Study|Death|5|||
156727502|NCT02509507|565750434|FG007|Overall Study|Death|4|||
156727503|NCT02509507|565750435|FG008|Overall Study|Death|8|||
156727504|NCT02509507|565750427|FG000|Overall Study|Lost to Follow-up|0|||
156727505|NCT02509507|565750428|FG001|Overall Study|Lost to Follow-up|1|||
156454253|NCT05543629|564757006|FG006|Overall Study|Withdrawal by Subject|1|||
156454254|NCT05543629|564757007|FG007|Overall Study|Withdrawal by Subject|1|||
156454255|NCT05543629|564757000|FG000|Overall Study|Not Reported|2|||
156454256|NCT05543629|564757001|FG001|Overall Study|Not Reported|2|||
156454257|NCT05543629|564757002|FG002|Overall Study|Not Reported|0|||
156454258|NCT05543629|564757003|FG003|Overall Study|Not Reported|0|||
156454259|NCT05543629|564757004|FG004|Overall Study|Not Reported|1|||
156454260|NCT05543629|564757005|FG005|Overall Study|Not Reported|1|||
156454261|NCT05543629|564757006|FG006|Overall Study|Not Reported|3|||
156454262|NCT05543629|564757007|FG007|Overall Study|Not Reported|0|||
156454263|NCT04568603|564757008|FG000|Overall Study|Physician Decision|1|||
156454264|NCT04564742|564757009|FG000|Overall Study|Lost to Follow-up|1|||
156454265|NCT04564742|564757010|FG001|Overall Study|Lost to Follow-up|0|||
156454266|NCT04564742|564757009|FG000|Overall Study|Consent Withdrawal|4|||
156454267|NCT04564742|564757010|FG001|Overall Study|Consent Withdrawal|4|||
156454268|NCT05869383|564757015|FG000|Overall Study|Withdrawal by Subject|2|||
156454269|NCT05869383|564757016|FG001|Overall Study|Withdrawal by Subject|0|||
156454270|NCT03084536|564757021|FG000|Overall Study|Determined to be ineligible|0|||
156454271|NCT03084536|564757022|FG001|Overall Study|Determined to be ineligible|0|||
156454272|NCT03084536|564757023|FG002|Overall Study|Determined to be ineligible|16|||
156454273|NCT03084536|564757021|FG000|Overall Study|Withdrawal by Subject|0|||
156454274|NCT03084536|564757022|FG001|Overall Study|Withdrawal by Subject|0|||
156454275|NCT03084536|564757023|FG002|Overall Study|Withdrawal by Subject|4|||
156454276|NCT03084536|564757021|FG000|Overall Study|Physician Decision|0|||
156454277|NCT03084536|564757022|FG001|Overall Study|Physician Decision|0|||
156454278|NCT03084536|564757023|FG002|Overall Study|Physician Decision|3|||
156454279|NCT03084536|564757021|FG000|Overall Study|Death|0|||
156454280|NCT03084536|564757022|FG001|Overall Study|Death|0|||
156454281|NCT03084536|564757023|FG002|Overall Study|Death|1|||
156454282|NCT03084536|564757021|FG000|Overall Study|Lost to Follow-up|0|||
156454283|NCT03084536|564757022|FG001|Overall Study|Lost to Follow-up|0|||
156454284|NCT03084536|564757023|FG002|Overall Study|Lost to Follow-up|1|||
156454285|NCT03084536|564757021|FG000|Overall Study|Protocol Violation|0|||
156454286|NCT03084536|564757022|FG001|Overall Study|Protocol Violation|0|||
156454287|NCT03084536|564757023|FG002|Overall Study|Protocol Violation|1|||
156454288|NCT03084536|564757021|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
156454289|NCT03084536|564757022|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
156454290|NCT03084536|564757023|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
156454291|NCT04728347|564759157|FG000|Overall Study|Sponsor decision|0|||
156454292|NCT04728347|564759158|FG001|Overall Study|Sponsor decision|0|||
156454293|NCT04728347|564759159|FG002|Overall Study|Sponsor decision|1|||
156454294|NCT04728347|564759160|FG003|Overall Study|Sponsor decision|0|||
156454295|NCT05835336|564759161|FG000|Overall Study|Withdrawal by Subject|5|||
156454296|NCT05835336|564759161|FG000|Overall Study|Did not complete the personalization process|3|||
156454297|NCT04489771|564759162|FG000|Overall Study|Death|27|||
156454298|NCT04489771|564759163|FG001|Overall Study|Death|25|||
156454299|NCT04489771|564759162|FG000|Overall Study|Withdrawal by Subject|1|||
156454300|NCT04489771|564759163|FG001|Overall Study|Withdrawal by Subject|0|||
156454301|NCT04489771|564759162|FG000|Overall Study|Participants Ongoing in Study|50|||
156454302|NCT04489771|564759163|FG001|Overall Study|Participants Ongoing in Study|51|||
156454303|NCT04059484|564759165|FG000|Overall Study|Adverse Event|2|||
156727506|NCT02509507|565750429|FG002|Overall Study|Lost to Follow-up|0|||
156727507|NCT02509507|565750430|FG003|Overall Study|Lost to Follow-up|0|||
156727508|NCT02509507|565750431|FG004|Overall Study|Lost to Follow-up|0|||
156727509|NCT02509507|565750432|FG005|Overall Study|Lost to Follow-up|2|||
156727510|NCT02509507|565750433|FG006|Overall Study|Lost to Follow-up|0|||
156727511|NCT02509507|565750434|FG007|Overall Study|Lost to Follow-up|0|||
156454304|NCT04059484|564759166|FG001|Overall Study|Adverse Event|5|||
156454305|NCT04059484|564759165|FG000|Overall Study|Withdrawal by Subject|5|||
156454306|NCT04059484|564759166|FG001|Overall Study|Withdrawal by Subject|3|||
156454307|NCT04059484|564759165|FG000|Overall Study|Progressive disease|112|||
156454308|NCT04059484|564759166|FG001|Overall Study|Progressive disease|112|||
156533571|NCT02378220|565048864|FG001|Overall Study|Death|1|||
156727512|NCT02509507|565750435|FG008|Overall Study|Lost to Follow-up|0|||
156727513|NCT02509507|565750427|FG000|Overall Study|Withdrawal by Subject|2|||
156727514|NCT02509507|565750428|FG001|Overall Study|Withdrawal by Subject|0|||
156454309|NCT04059484|564759165|FG000|Overall Study|Other|8|||
156454310|NCT04059484|564759166|FG001|Overall Study|Other|3|||
156454311|NCT04059484|564759165|FG000|Overall Study|Ongoing|20|||
156454312|NCT04059484|564759166|FG001|Overall Study|Ongoing|20|||
156454313|NCT04292223|564759167|FG000|Overall Study|Adverse Event|1|||
156454314|NCT04292223|564759167|FG000|Overall Study|Lost to Follow-up|1|||
156454315|NCT04292223|564759167|FG000|Overall Study|Noncompliance with study drug|2|||
156454316|NCT04292223|564759167|FG000|Overall Study|Patient moved out of the state|1|||
156727515|NCT02509507|565750429|FG002|Overall Study|Withdrawal by Subject|1|||
156727516|NCT02509507|565750430|FG003|Overall Study|Withdrawal by Subject|4|||
156727517|NCT02509507|565750431|FG004|Overall Study|Withdrawal by Subject|1|||
156727518|NCT02509507|565750432|FG005|Overall Study|Withdrawal by Subject|3|||
156727519|NCT02509507|565750433|FG006|Overall Study|Withdrawal by Subject|4|||
156727520|NCT02509507|565750434|FG007|Overall Study|Withdrawal by Subject|0|||
156727521|NCT02509507|565750435|FG008|Overall Study|Withdrawal by Subject|1|||
156727522|NCT03150719|565750436|FG000|Overall Study|Adverse Event|0|||
156727523|NCT03150719|565750437|FG001|Overall Study|Adverse Event|1|||
156727524|NCT03150719|565750436|FG000|Overall Study|Death|0|||
156727525|NCT03150719|565750437|FG001|Overall Study|Death|1|||
156727526|NCT03150719|565750436|FG000|Overall Study|Other|1|||
156727527|NCT03150719|565750437|FG001|Overall Study|Other|0|||
156727528|NCT03337113|565750443|FG000|Overall Study|Adverse Event|1|||
156727529|NCT03337113|565750444|FG001|Overall Study|Adverse Event|1|||
156727530|NCT03337113|565750445|FG002|Overall Study|Adverse Event|0|||
156727531|NCT03337113|565750446|FG003|Overall Study|Adverse Event|1|||
156727532|NCT03337113|565750443|FG000|Overall Study|Physician Decision|0|||
156727533|NCT03337113|565750444|FG001|Overall Study|Physician Decision|2|||
156727534|NCT03337113|565750445|FG002|Overall Study|Physician Decision|0|||
156727535|NCT03337113|565750446|FG003|Overall Study|Physician Decision|1|||
156727536|NCT03337113|565750443|FG000|Overall Study|Withdrawal by Subject|0|||
156454317|NCT04719390|564759168|FG000|Overall Study|Withdrawal by Subject|1|||
156454318|NCT00753545|564759169|FG000|Overall Study|Death|98|||
156454319|NCT00753545|564759170|FG001|Overall Study|Death|112|||
156454320|NCT00753545|564759169|FG000|Overall Study|Lost to Follow-up|2|||
156454321|NCT00753545|564759170|FG001|Overall Study|Lost to Follow-up|3|||
156454322|NCT00753545|564759169|FG000|Overall Study|Protocol Violation|1|||
156454323|NCT00753545|564759170|FG001|Overall Study|Protocol Violation|0|||
156454324|NCT00753545|564759169|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
156454325|NCT00753545|564759170|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
156454326|NCT05453773|564759171|FG000|Overall Study|Withdrawal by Subject|3|||
156454327|NCT05453773|564759171|FG000|Overall Study|Lost to Follow-up|3|||
156454328|NCT05453773|564759171|FG000|Overall Study|Difficult Blood Draw|3|||
156454329|NCT04633122|564759174|FG000|Overall Study|Remained on treatment|19|||
156454330|NCT04633122|564759175|FG001|Overall Study|Remained on treatment|14|||
156454331|NCT04633122|564759174|FG000|Overall Study|Survival follow-up stopped|22|||
156454332|NCT04633122|564759175|FG001|Overall Study|Survival follow-up stopped|25|||
156454333|NCT03839940|564759176|FG000|Overall Study|Withdrawal by Subject|3|||
156454334|NCT03839940|564759177|FG001|Overall Study|Withdrawal by Subject|0|||
156454335|NCT03839940|564759176|FG000|Overall Study|Protocol Violation|0|||
156454336|NCT03839940|564759177|FG001|Overall Study|Protocol Violation|1|||
156454337|NCT03839940|564759176|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
156454338|NCT03839940|564759177|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
156454339|NCT04799899|564759178|FG000|Overall Study|Lost to Follow-up|2|||
156454340|NCT04799899|564759179|FG001|Overall Study|Lost to Follow-up|4|||
156454341|NCT02561247|564759180|FG000|Overall Study|Protocol Violation|1|||
156454342|NCT02561247|564759180|FG000|Overall Study|Withdrawal by Subject|1|||
156454343|NCT02561247|564759180|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
156454344|NCT04963270|564759181|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
156454345|NCT04963270|564759182|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
156454346|NCT04963270|564759183|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
156727537|NCT03337113|565750444|FG001|Overall Study|Withdrawal by Subject|0|||
156727538|NCT03337113|565750445|FG002|Overall Study|Withdrawal by Subject|1|||
156727539|NCT03337113|565750446|FG003|Overall Study|Withdrawal by Subject|0|||
156727540|NCT00507455|565750453|FG000|Overall Study|Adverse Event|3|||
156727541|NCT00507455|565750454|FG001|Overall Study|Adverse Event|3|||
156727542|NCT00507455|565750455|FG002|Overall Study|Adverse Event|6|||
156727543|NCT00507455|565750453|FG000|Overall Study|Withdrawal by Subject|2|||
156795818|NCT02655601|566006194|FG002|Overall Study|Physician Decision|0|||
156795819|NCT02655601|566006195|FG003|Overall Study|Physician Decision|0|||
156795820|NCT02655601|566006196|FG004|Overall Study|Physician Decision|1|||
156795821|NCT02655601|566006197|FG005|Overall Study|Physician Decision|1|||
156454347|NCT04963270|564759184|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
156727544|NCT00507455|565750454|FG001|Overall Study|Withdrawal by Subject|1|||
156795822|NCT02655601|566006192|FG000|Overall Study|Withdrawal by Subject|0|||
156454348|NCT04963270|564759181|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156454349|NCT04963270|564759182|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
156795823|NCT02655601|566006193|FG001|Overall Study|Withdrawal by Subject|0|||
156795824|NCT02655601|566006194|FG002|Overall Study|Withdrawal by Subject|0|||
156454350|NCT04963270|564759183|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156454351|NCT04963270|564759184|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156454352|NCT04963270|564759181|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
156727545|NCT00507455|565750455|FG002|Overall Study|Withdrawal by Subject|2|||
156727546|NCT00507455|565750453|FG000|Overall Study|Protocol Violation|4|||
156727547|NCT00507455|565750454|FG001|Overall Study|Protocol Violation|1|||
156727548|NCT00507455|565750455|FG002|Overall Study|Protocol Violation|1|||
156727549|NCT00507455|565750453|FG000|Overall Study|Lost to Follow-up|2|||
156727550|NCT00507455|565750454|FG001|Overall Study|Lost to Follow-up|0|||
156727551|NCT00507455|565750455|FG002|Overall Study|Lost to Follow-up|2|||
156727552|NCT00507455|565750453|FG000|Overall Study|Lack of Efficacy|0|||
156727553|NCT00507455|565750454|FG001|Overall Study|Lack of Efficacy|1|||
156454353|NCT04963270|564759182|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156454354|NCT04963270|564759183|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156454355|NCT04963270|564759184|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156454356|NCT04963270|564759181|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
156454357|NCT04963270|564759182|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
156454358|NCT04963270|564759183|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
156454359|NCT04963270|564759184|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
156454360|NCT04963270|564759181|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
156454361|NCT04963270|564759182|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
156454362|NCT04963270|564759183|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
156454363|NCT04963270|564759184|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
156454364|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
156454365|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
156454366|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
156454367|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
156454368|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
156454369|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
156454370|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
156454371|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
156454372|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
156454373|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
156454374|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
156454375|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
156454376|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
156454377|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
156454378|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
156454379|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
156454380|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
156454381|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
156454382|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
156454383|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
156454384|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
156454385|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
156454386|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
156454387|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
156454388|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
156454389|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
156454390|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
156454391|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
156454392|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
156454393|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
156454394|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
156454395|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
156454396|NCT04963270|564759181|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
156454397|NCT04963270|564759182|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
156454398|NCT04963270|564759183|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
156454399|NCT04963270|564759184|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
156454400|NCT03560609|564759189|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
156454401|NCT03560609|564759190|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
156454402|NCT01098812|564759199|FG000|Overall Study|Death|2|||
156454403|NCT01098812|564759200|FG001|Overall Study|Death|0|||
156454404|NCT01098812|564759201|FG002|Overall Study|Death|1|||
156454405|NCT01098812|564759199|FG000|Overall Study|Lost to Follow-up|0|||
156454406|NCT01098812|564759200|FG001|Overall Study|Lost to Follow-up|1|||
156454407|NCT01098812|564759201|FG002|Overall Study|Lost to Follow-up|0|||
156454408|NCT04908722|564759202|FG000|Overall Study|Protocol deviation|1|||
156454409|NCT04908722|564759203|FG001|Overall Study|Protocol deviation|0|||
156454410|NCT04908722|564759204|FG002|Overall Study|Protocol deviation|0|||
156454411|NCT04908722|564759205|FG003|Overall Study|Protocol deviation|0|||
156454412|NCT04908722|564759206|FG004|Overall Study|Protocol deviation|0|||
156454413|NCT04908722|564759207|FG005|Overall Study|Protocol deviation|1|||
156727554|NCT00507455|565750455|FG002|Overall Study|Lack of Efficacy|0|||
156727555|NCT00507455|565750453|FG000|Overall Study|Other - miscellaneous reason|1|||
156876224|NCT03390101|566305767|FG000|Weeks 12-54|Pregnancy|1|||
156454414|NCT04908722|564759202|FG000|Overall Study|Lost to Follow-up|33|||
156454415|NCT04908722|564759203|FG001|Overall Study|Lost to Follow-up|33|||
156454416|NCT04908722|564759204|FG002|Overall Study|Lost to Follow-up|36|||
156454417|NCT04908722|564759205|FG003|Overall Study|Lost to Follow-up|30|||
156454418|NCT04908722|564759206|FG004|Overall Study|Lost to Follow-up|32|||
156454419|NCT04908722|564759207|FG005|Overall Study|Lost to Follow-up|34|||
156454420|NCT04908722|564759202|FG000|Overall Study|Physician Decision|1|||
156454421|NCT04908722|564759203|FG001|Overall Study|Physician Decision|1|||
156454422|NCT04908722|564759204|FG002|Overall Study|Physician Decision|1|||
156454423|NCT04908722|564759205|FG003|Overall Study|Physician Decision|2|||
156454424|NCT04908722|564759206|FG004|Overall Study|Physician Decision|0|||
156454425|NCT04908722|564759207|FG005|Overall Study|Physician Decision|0|||
156454426|NCT04908722|564759202|FG000|Overall Study|Death|1|||
156454427|NCT04908722|564759203|FG001|Overall Study|Death|0|||
156454428|NCT04908722|564759204|FG002|Overall Study|Death|0|||
156454429|NCT04908722|564759205|FG003|Overall Study|Death|0|||
156454430|NCT04908722|564759206|FG004|Overall Study|Death|0|||
156454431|NCT04908722|564759207|FG005|Overall Study|Death|1|||
156454432|NCT04908722|564759202|FG000|Overall Study|Withdrawal by Subject|12|||
156454433|NCT04908722|564759203|FG001|Overall Study|Withdrawal by Subject|8|||
156454434|NCT04908722|564759204|FG002|Overall Study|Withdrawal by Subject|7|||
156454435|NCT04908722|564759205|FG003|Overall Study|Withdrawal by Subject|6|||
156454436|NCT04908722|564759206|FG004|Overall Study|Withdrawal by Subject|12|||
156454437|NCT04908722|564759207|FG005|Overall Study|Withdrawal by Subject|14|||
156454438|NCT04908722|564759202|FG000|Overall Study|Other|3|||
156454439|NCT04908722|564759203|FG001|Overall Study|Other|1|||
156454440|NCT04908722|564759204|FG002|Overall Study|Other|3|||
156454441|NCT04908722|564759205|FG003|Overall Study|Other|2|||
156454442|NCT04908722|564759206|FG004|Overall Study|Other|4|||
156454443|NCT04908722|564759207|FG005|Overall Study|Other|1|||
156454444|NCT04908722|564759202|FG000|Overall Study|Initiated prohibited medication|0|||
156727556|NCT00507455|565750454|FG001|Overall Study|Other - miscellaneous reason|0|||
156727557|NCT00507455|565750455|FG002|Overall Study|Other - miscellaneous reason|1|||
156727558|NCT01372995|565750456|FG000|Overall Study|Spouse withdrew participant from study|0|||
156727559|NCT01372995|565750457|FG001|Overall Study|Spouse withdrew participant from study|1|||
156727560|NCT01372995|565750458|FG002|Overall Study|Spouse withdrew participant from study|0|||
156727561|NCT01372995|565750456|FG000|Overall Study|Physician Decision|0|||
156727562|NCT01372995|565750457|FG001|Overall Study|Physician Decision|0|||
156727563|NCT01372995|565750458|FG002|Overall Study|Physician Decision|1|||
156727564|NCT01297517|565750466|FG000|Overall Study|Adverse Event|21|||
156727565|NCT01297517|565750467|FG001|Overall Study|Adverse Event|7|||
156727566|NCT01297517|565750468|FG002|Overall Study|Adverse Event|16|||
156727567|NCT01297517|565750466|FG000|Overall Study|Lost to Follow-up|1|||
156727568|NCT01297517|565750467|FG001|Overall Study|Lost to Follow-up|0|||
156727569|NCT01297517|565750468|FG002|Overall Study|Lost to Follow-up|1|||
156727570|NCT01297517|565750466|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
156727571|NCT01297517|565750467|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
156727572|NCT01297517|565750468|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
156727573|NCT01297517|565750466|FG000|Overall Study|Noncompliance|1|||
156727574|NCT01297517|565750467|FG001|Overall Study|Noncompliance|0|||
156727575|NCT01297517|565750468|FG002|Overall Study|Noncompliance|0|||
156727576|NCT01297517|565750466|FG000|Overall Study|Protocol Violation|1|||
156727577|NCT01297517|565750467|FG001|Overall Study|Protocol Violation|1|||
156727578|NCT01297517|565750468|FG002|Overall Study|Protocol Violation|1|||
156727579|NCT01297517|565750466|FG000|Overall Study|Inadequate Control of IOP|1|||
156876225|NCT03390101|566305768|FG001|Weeks 12-54|Pregnancy|0|||
156454445|NCT04908722|564759203|FG001|Overall Study|Initiated prohibited medication|0|||
156454446|NCT04908722|564759204|FG002|Overall Study|Initiated prohibited medication|0|||
156454447|NCT04908722|564759205|FG003|Overall Study|Initiated prohibited medication|1|||
156454448|NCT04908722|564759206|FG004|Overall Study|Initiated prohibited medication|0|||
156454449|NCT04908722|564759207|FG005|Overall Study|Initiated prohibited medication|1|||
156454450|NCT04908722|564759202|FG000|Overall Study|Randomized but not vaccinated|3|||
156727580|NCT01297517|565750467|FG001|Overall Study|Inadequate Control of IOP|1|||
156727581|NCT01297517|565750468|FG002|Overall Study|Inadequate Control of IOP|2|||
156454451|NCT04908722|564759203|FG001|Overall Study|Randomized but not vaccinated|1|||
156454452|NCT04908722|564759204|FG002|Overall Study|Randomized but not vaccinated|2|||
156454453|NCT04908722|564759205|FG003|Overall Study|Randomized but not vaccinated|2|||
156454454|NCT04908722|564759206|FG004|Overall Study|Randomized but not vaccinated|3|||
156454455|NCT04908722|564759207|FG005|Overall Study|Randomized but not vaccinated|4|||
156454456|NCT02979327|564759214|FG000|First Intervention|Protocol Violation|1|||
156454457|NCT02979327|564759215|FG001|First Intervention|Protocol Violation|0|||
156454458|NCT01073566|564759221|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
156454459|NCT01073566|564759222|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
156533572|NCT00578786|565048865|FG000|Overall Study|Adverse Event|27|||
156727582|NCT02914613|565750469|FG000|Overall Study|Withdrawal by Subject|1|||
156727583|NCT02914613|565750470|FG001|Overall Study|Withdrawal by Subject|2|||
156727584|NCT02914613|565750469|FG000|Overall Study|Adverse Event|1|||
156727585|NCT02914613|565750470|FG001|Overall Study|Adverse Event|0|||
156727586|NCT01163851|565750473|FG000|Overall Study|Site Closure|0|||
156727587|NCT01163851|565750474|FG001|Overall Study|Site Closure|1|||
156727588|NCT01163851|565750473|FG000|Overall Study|Enrolled but not treated|1|||
156727589|NCT01163851|565750474|FG001|Overall Study|Enrolled but not treated|0|||
156727590|NCT00789373|565750475|FG000|Induction|Adverse Event|64|||
156727591|NCT00789373|565750476|FG001|Induction|Adverse Event|0|||
156727592|NCT00789373|565750477|FG002|Induction|Adverse Event|0|||
156727593|NCT00789373|565750475|FG000|Induction|Death Due to study disease|24|||
156727594|NCT00789373|565750476|FG001|Induction|Death Due to study disease|0|||
156727595|NCT00789373|565750477|FG002|Induction|Death Due to study disease|0|||
156727596|NCT00789373|565750475|FG000|Induction|Death due to adverse event|19|||
156727597|NCT00789373|565750476|FG001|Induction|Death due to adverse event|0|||
156727598|NCT00789373|565750477|FG002|Induction|Death due to adverse event|0|||
156727599|NCT00789373|565750475|FG000|Induction|Death due to toxicity|11|||
156727600|NCT00789373|565750476|FG001|Induction|Death due to toxicity|0|||
156727601|NCT00789373|565750477|FG002|Induction|Death due to toxicity|0|||
156727602|NCT00789373|565750475|FG000|Induction|Death due to procedure|1|||
156727603|NCT00789373|565750476|FG001|Induction|Death due to procedure|0|||
156727604|NCT00789373|565750477|FG002|Induction|Death due to procedure|0|||
156727605|NCT00789373|565750475|FG000|Induction|Investigator decision|7|||
156727606|NCT00789373|565750476|FG001|Induction|Investigator decision|0|||
156727607|NCT00789373|565750477|FG002|Induction|Investigator decision|0|||
156727608|NCT00789373|565750475|FG000|Induction|Protocol entry criteria not met|9|||
156727609|NCT00789373|565750476|FG001|Induction|Protocol entry criteria not met|0|||
156727610|NCT00789373|565750477|FG002|Induction|Protocol entry criteria not met|0|||
156727611|NCT00789373|565750475|FG000|Induction|Lost to Follow-up|6|||
156727612|NCT00789373|565750476|FG001|Induction|Lost to Follow-up|0|||
156727613|NCT00789373|565750477|FG002|Induction|Lost to Follow-up|0|||
156727614|NCT00789373|565750475|FG000|Induction|Protocol Violation|1|||
156727615|NCT00789373|565750476|FG001|Induction|Protocol Violation|0|||
156727616|NCT00789373|565750477|FG002|Induction|Protocol Violation|0|||
156727617|NCT00789373|565750475|FG000|Induction|Progressive Disease|220|||
156727618|NCT00789373|565750476|FG001|Induction|Progressive Disease|0|||
156727619|NCT00789373|565750477|FG002|Induction|Progressive Disease|0|||
156727620|NCT00789373|565750475|FG000|Induction|Withdrawal by Subject|37|||
156727621|NCT00789373|565750476|FG001|Induction|Withdrawal by Subject|0|||
156727622|NCT00789373|565750477|FG002|Induction|Withdrawal by Subject|0|||
156727623|NCT00789373|565750475|FG000|Maintenance|Adverse Event|0|||
156727624|NCT00789373|565750476|FG001|Maintenance|Adverse Event|65|||
156727625|NCT00789373|565750477|FG002|Maintenance|Adverse Event|12|||
156727626|NCT00789373|565750475|FG000|Maintenance|Death due to study disease|0|||
156727627|NCT00789373|565750476|FG001|Maintenance|Death due to study disease|3|||
156727628|NCT00789373|565750477|FG002|Maintenance|Death due to study disease|1|||
156727629|NCT00789373|565750475|FG000|Maintenance|Death due to adverse event|0|||
156876226|NCT03390101|566305769|FG002|Weeks 12-54|Pregnancy|0|||
156876227|NCT03390101|566305767|FG000|Weeks 12-54|Adverse Event|2|||
156727630|NCT00789373|565750476|FG001|Maintenance|Death due to adverse event|4|||
156727631|NCT00789373|565750477|FG002|Maintenance|Death due to adverse event|1|||
156727632|NCT00789373|565750475|FG000|Maintenance|Death due to toxicity|0|||
156727633|NCT00789373|565750476|FG001|Maintenance|Death due to toxicity|1|||
156727634|NCT00789373|565750477|FG002|Maintenance|Death due to toxicity|2|||
156727635|NCT00789373|565750475|FG000|Maintenance|Investigator Decision|0|||
156727636|NCT00789373|565750476|FG001|Maintenance|Investigator Decision|4|||
156727637|NCT00789373|565750477|FG002|Maintenance|Investigator Decision|2|||
156727638|NCT00789373|565750475|FG000|Maintenance|Protocol entry criteria not met|0|||
156727639|NCT00789373|565750476|FG001|Maintenance|Protocol entry criteria not met|2|||
156727640|NCT00789373|565750477|FG002|Maintenance|Protocol entry criteria not met|0|||
156727641|NCT00789373|565750475|FG000|Maintenance|Lost to Follow-up|0|||
156727642|NCT00789373|565750476|FG001|Maintenance|Lost to Follow-up|2|||
156727643|NCT00789373|565750477|FG002|Maintenance|Lost to Follow-up|0|||
156727644|NCT00789373|565750475|FG000|Maintenance|Progressive Disease|0|||
156727645|NCT00789373|565750476|FG001|Maintenance|Progressive Disease|253|||
156727646|NCT00789373|565750477|FG002|Maintenance|Progressive Disease|152|||
156727647|NCT00789373|565750475|FG000|Maintenance|Withdrawal by Subject|0|||
156727648|NCT00789373|565750476|FG001|Maintenance|Withdrawal by Subject|21|||
156727649|NCT00789373|565750477|FG002|Maintenance|Withdrawal by Subject|8|||
156727650|NCT00789373|565750475|FG000|Maintenance|Sponsor Decision|0|||
156727651|NCT00789373|565750476|FG001|Maintenance|Sponsor Decision|0|||
156727652|NCT00789373|565750477|FG002|Maintenance|Sponsor Decision|2|||
156727653|NCT00789373|565750475|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
156727654|NCT00789373|565750476|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
156727655|NCT00789373|565750477|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
156727656|NCT04938180|565750483|FG000|Overall Study|Adverse Event|1|||
156727657|NCT01964222|565750484|FG000|Overall Study|Lost to Follow-up|7|||
156727658|NCT01964222|565750485|FG001|Overall Study|Lost to Follow-up|5|||
156727659|NCT01964222|565750484|FG000|Overall Study|Withdrawal by Subject|6|||
156876228|NCT03390101|566305768|FG001|Weeks 12-54|Adverse Event|1|||
156727660|NCT01964222|565750485|FG001|Overall Study|Withdrawal by Subject|6|||
156727661|NCT01964222|565750484|FG000|Overall Study|Screening Failure|2|||
156876229|NCT03390101|566305769|FG002|Weeks 12-54|Adverse Event|1|||
156454460|NCT05780437|564759223|FG000|Overall Study|Withdrawal by Subject|22|||
156454461|NCT05780437|564759224|FG001|Overall Study|Withdrawal by Subject|16|||
156727662|NCT01964222|565750485|FG001|Overall Study|Screening Failure|0|||
156727663|NCT03363776|565750493|FG000|Overall Study|Progressive disease|2|||
156727664|NCT03363776|565750494|FG001|Overall Study|Progressive disease|3|||
156727665|NCT03363776|565750495|FG002|Overall Study|Progressive disease|1|||
156727666|NCT03363776|565750493|FG000|Overall Study|Study drug toxicity|0|||
156727667|NCT03363776|565750494|FG001|Overall Study|Study drug toxicity|0|||
156727668|NCT03363776|565750495|FG002|Overall Study|Study drug toxicity|1|||
156727669|NCT03363776|565750493|FG000|Overall Study|Death|1|||
156727670|NCT03363776|565750494|FG001|Overall Study|Death|0|||
156727671|NCT03363776|565750495|FG002|Overall Study|Death|0|||
156727672|NCT04157348|565750496|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
156727673|NCT04157348|565750497|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
156727674|NCT04157348|565750496|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
156727675|NCT04157348|565750497|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
156727676|NCT04157348|565750496|FG000|Double-blind Treatment Period|Adverse Event|0|||
156727677|NCT04157348|565750497|FG001|Double-blind Treatment Period|Adverse Event|1|||
156727678|NCT04157348|565750496|FG000|Open-label Extension Period|Adverse Event|1|||
156727679|NCT04157348|565750497|FG001|Open-label Extension Period|Adverse Event|1|||
156727680|NCT04157348|565750496|FG000|Open-label Extension Period|Death|0|||
156727681|NCT04157348|565750497|FG001|Open-label Extension Period|Death|1|||
156727682|NCT04157348|565750496|FG000|Open-label Extension Period|Lack of Efficacy|2|||
156727683|NCT04157348|565750497|FG001|Open-label Extension Period|Lack of Efficacy|2|||
156454462|NCT03474679|564759234|FG000|Overall Study|Death|7|||
156454463|NCT03474679|564759234|FG000|Overall Study|Withdrawal by Subject|1|||
156727684|NCT04157348|565750496|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
156727685|NCT04157348|565750497|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
156727686|NCT04157348|565750496|FG000|Open-label Extension Period|Ongoing|60|||
156727687|NCT04157348|565750497|FG001|Open-label Extension Period|Ongoing|57|||
156727688|NCT04157348|565750496|FG000|Open-label Extension Period|other reasons|1|||
156727689|NCT04157348|565750497|FG001|Open-label Extension Period|other reasons|1|||
156727690|NCT02062450|565750512|FG000|Overall Study|No follow-up visit|124|||
156727691|NCT02589639|565750514|FG000|Overall Study|Lost to Follow-up|1|||
156727692|NCT02589639|565750515|FG001|Overall Study|Lost to Follow-up|0|||
156727693|NCT02589639|565750516|FG002|Overall Study|Lost to Follow-up|0|||
156727694|NCT02589639|565750514|FG000|Overall Study|Protocol Violation|1|||
156727695|NCT02589639|565750515|FG001|Overall Study|Protocol Violation|0|||
156727696|NCT02589639|565750516|FG002|Overall Study|Protocol Violation|0|||
156727697|NCT02589639|565750514|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
156727698|NCT02589639|565750515|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
156727699|NCT02589639|565750516|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
156727700|NCT02589639|565750514|FG000|Overall Study|Adverse Event|4|||
156727701|NCT02589639|565750515|FG001|Overall Study|Adverse Event|5|||
156727702|NCT02589639|565750516|FG002|Overall Study|Adverse Event|3|||
156727703|NCT02589639|565750514|FG000|Overall Study|Other reason than specified above|1|||
156727704|NCT02589639|565750515|FG001|Overall Study|Other reason than specified above|2|||
156727705|NCT02589639|565750516|FG002|Overall Study|Other reason than specified above|1|||
156727706|NCT02589639|565750514|FG000|Overall Study|Not Treated|0|||
156727707|NCT02589639|565750515|FG001|Overall Study|Not Treated|3|||
156727708|NCT02589639|565750516|FG002|Overall Study|Not Treated|0|||
156727709|NCT01481766|565752137|FG000|4 months|Lost to Follow-up|3|||
156727710|NCT01481766|565752138|FG001|4 months|Lost to Follow-up|2|||
156727711|NCT01481766|565752139|FG002|4 months|Lost to Follow-up|1|||
156727712|NCT01481766|565752140|FG003|4 months|Lost to Follow-up|5|||
156727713|NCT01481766|565752137|FG000|12 months|Lost to Follow-up|7|||
156727714|NCT01481766|565752138|FG001|12 months|Lost to Follow-up|8|||
156727715|NCT01481766|565752139|FG002|12 months|Lost to Follow-up|5|||
156727716|NCT01481766|565752140|FG003|12 months|Lost to Follow-up|3|||
156727717|NCT00347958|565752141|FG000|Overall Study|Adverse Event|1|||
156727718|NCT00347958|565752141|FG000|Overall Study|Protocol Violation|2|||
156727719|NCT00347958|565752141|FG000|Overall Study|Withdrawal by Subject|1|||
156727720|NCT02159053|565752142|FG000|Overall Study|Death|2|||
156727721|NCT02159053|565752143|FG001|Overall Study|Death|0|||
156727722|NCT02159053|565752144|FG002|Overall Study|Death|1|||
156727723|NCT02159053|565752142|FG000|Overall Study|Physician Decision|0|||
156336222|NCT00347360|564328202|FG010|Overall Study|Subject refuse to sign updated consent|0|||
156454464|NCT03452579|564759235|FG000|Overall Study|Death|0|||
156454465|NCT03452579|564759236|FG001|Overall Study|Death|1|||
156454466|NCT03452579|564759235|FG000|Overall Study|Withdrawal by Subject|2|||
156336223|NCT00347360|564328203|FG011|Overall Study|Subject refuse to sign updated consent|0|||
156454467|NCT03452579|564759236|FG001|Overall Study|Withdrawal by Subject|0|||
156533573|NCT00578786|565048866|FG001|Overall Study|Adverse Event|37|||
156727724|NCT02159053|565752143|FG001|Overall Study|Physician Decision|1|||
156727725|NCT02159053|565752144|FG002|Overall Study|Physician Decision|1|||
156727726|NCT02159053|565752142|FG000|Overall Study|Lack of Efficacy|3|||
156727727|NCT02159053|565752143|FG001|Overall Study|Lack of Efficacy|4|||
156727728|NCT02159053|565752144|FG002|Overall Study|Lack of Efficacy|7|||
156795825|NCT02655601|566006195|FG003|Overall Study|Withdrawal by Subject|0|||
156795826|NCT02655601|566006196|FG004|Overall Study|Withdrawal by Subject|4|||
156795827|NCT02655601|566006197|FG005|Overall Study|Withdrawal by Subject|8|||
156795828|NCT02655601|566006192|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
156795829|NCT02655601|566006193|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795830|NCT02655601|566006194|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795831|NCT02655601|566006195|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795832|NCT02655601|566006196|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795833|NCT02655601|566006197|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795834|NCT04642079|566006200|FG000|Overall Study|Lost to Follow-up|2|||
156795835|NCT04642079|566006201|FG001|Overall Study|Lost to Follow-up|5|||
156795836|NCT04642079|566006202|FG002|Overall Study|Lost to Follow-up|2|||
156795837|NCT04642079|566006203|FG003|Overall Study|Lost to Follow-up|0|||
156795838|NCT04642079|566006200|FG000|Overall Study|Withdrawal by Subject|0|||
156795839|NCT04642079|566006201|FG001|Overall Study|Withdrawal by Subject|4|||
156795840|NCT04642079|566006202|FG002|Overall Study|Withdrawal by Subject|1|||
156795841|NCT04642079|566006203|FG003|Overall Study|Withdrawal by Subject|2|||
156795842|NCT04642079|566006200|FG000|Overall Study|Other|0|||
156795843|NCT04642079|566006201|FG001|Overall Study|Other|0|||
156795844|NCT04642079|566006202|FG002|Overall Study|Other|0|||
156795845|NCT04642079|566006203|FG003|Overall Study|Other|1|||
156795846|NCT04642079|566006200|FG000|Overall Study|No longer met eligibility criteria|1|||
156795847|NCT04642079|566006201|FG001|Overall Study|No longer met eligibility criteria|0|||
156795848|NCT04642079|566006202|FG002|Overall Study|No longer met eligibility criteria|1|||
156795849|NCT04642079|566006203|FG003|Overall Study|No longer met eligibility criteria|1|||
156795850|NCT02226653|566006204|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
156795851|NCT02226653|566006205|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
156795852|NCT02226653|566006204|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
156795853|NCT02226653|566006205|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
156795854|NCT00759395|566006207|FG000|Overall Study|Adverse Event|1|||
156795855|NCT00759395|566006208|FG001|Overall Study|Adverse Event|0|||
156795856|NCT00759395|566006207|FG000|Overall Study|Withdrawal by Subject|1|||
156795857|NCT00759395|566006208|FG001|Overall Study|Withdrawal by Subject|0|||
156795858|NCT00759395|566006207|FG000|Overall Study|Lack of Efficacy|0|||
156795859|NCT00759395|566006208|FG001|Overall Study|Lack of Efficacy|2|||
156795860|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
156795861|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
156795862|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
156795863|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
156795864|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
156795865|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
156795866|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
156795867|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
156795868|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
156795869|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
156795870|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
156795871|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
156795872|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
156795873|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
156795874|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
156795875|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
156795876|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
156795877|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
156795878|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
156795879|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
156795880|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
156795881|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
156795882|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
156795883|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
156795884|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
156795885|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
156795886|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
156795887|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
156795888|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
156795889|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
156808802|NCT03688919|566054465|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
156808803|NCT03688919|566054466|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
156808804|NCT01484496|566054473|FG000|Period 1|Protocol Violation|3|||
156808805|NCT01484496|566054474|FG001|Period 1|Protocol Violation|4|||
156808806|NCT01484496|566054475|FG002|Period 1|Protocol Violation|0|||
156727729|NCT02159053|565752142|FG000|Overall Study|Adverse Event|7|||
156454468|NCT03452579|564759235|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
156454469|NCT03452579|564759236|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
156454470|NCT03452579|564759235|FG000|Overall Study|Physician Decision|1|||
156454471|NCT03452579|564759236|FG001|Overall Study|Physician Decision|1|||
156727730|NCT02159053|565752143|FG001|Overall Study|Adverse Event|6|||
156727731|NCT02159053|565752144|FG002|Overall Study|Adverse Event|5|||
156727732|NCT02159053|565752142|FG000|Overall Study|Participants/guardian decision|8|||
156727733|NCT02159053|565752143|FG001|Overall Study|Participants/guardian decision|10|||
156454472|NCT03452579|564759235|FG000|Overall Study|Adverse Event|1|||
156454473|NCT03452579|564759236|FG001|Overall Study|Adverse Event|4|||
156454474|NCT04858321|564759241|FG000|Overall Study|Withdrawal by Subject|3|||
156454475|NCT02573493|564759244|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
156454476|NCT02573493|564759245|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
156454477|NCT02573493|564759246|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
156454478|NCT02573493|564759247|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
156454479|NCT02146378|564759250|FG000|Overall Study|No information of administration|2|||
156454480|NCT04629716|564759251|FG000|Overall Study|Lost to Follow-up|7|||
156454481|NCT04629716|564759252|FG001|Overall Study|Lost to Follow-up|3|||
156454482|NCT04623671|564759253|FG000|Overall Study|Adverse Event|0|||
156454483|NCT04623671|564759254|FG001|Overall Study|Adverse Event|1|||
156454484|NCT04623671|564759253|FG000|Overall Study|Lost to Follow-up|2|||
156454485|NCT04623671|564759254|FG001|Overall Study|Lost to Follow-up|1|||
156454486|NCT04623671|564759253|FG000|Overall Study|Death|5|||
156454487|NCT04623671|564759254|FG001|Overall Study|Death|5|||
156454488|NCT04025554|564759255|FG000|Overall Study|Adverse Event|3|||
156454489|NCT01802788|564759259|FG000|Overall Study|Withdrawal by Subject|102|||
156454490|NCT01802788|564759260|FG001|Overall Study|Withdrawal by Subject|5|||
156454491|NCT01802788|564759259|FG000|Overall Study|Death|382|||
156454492|NCT01802788|564759260|FG001|Overall Study|Death|18|||
156454493|NCT01802788|564759259|FG000|Overall Study|Lost to Follow-up|31|||
156454494|NCT01802788|564759260|FG001|Overall Study|Lost to Follow-up|2|||
156454495|NCT01802788|564759259|FG000|Overall Study|Physician Decision|3|||
156454496|NCT01802788|564759260|FG001|Overall Study|Physician Decision|0|||
156454497|NCT01802788|564759259|FG000|Overall Study|Patient Non-Compliance|1|||
156454498|NCT01802788|564759260|FG001|Overall Study|Patient Non-Compliance|0|||
156454499|NCT01802788|564759259|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
156454500|NCT01802788|564759260|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
156454501|NCT01802788|564759259|FG000|Overall Study|Other Reasons|19|||
156454502|NCT01802788|564759260|FG001|Overall Study|Other Reasons|0|||
156454503|NCT05257486|564759261|FG000|Overall Study|Protocol Violation|3|||
156454504|NCT03021096|564759262|FG000|Overall Study|Lost to Follow-up|4|||
156727734|NCT02159053|565752144|FG002|Overall Study|Participants/guardian decision|6|||
156727735|NCT00356603|565752147|FG000|Overall Study|Other|6|||
156727736|NCT00356603|565752148|FG001|Overall Study|Other|3|||
156727737|NCT01262287|565752149|FG000|Overall Study|Lost to Follow-up|2|||
156727738|NCT01262287|565752150|FG001|Overall Study|Lost to Follow-up|1|||
156727739|NCT02492984|565752152|FG000|Overall Study|Adverse Event|1|||
156727740|NCT02492984|565752153|FG001|Overall Study|Adverse Event|0|||
156795890|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
156727741|NCT02492984|565752152|FG000|Overall Study|Protocol Violation|1|||
156727742|NCT02492984|565752153|FG001|Overall Study|Protocol Violation|0|||
156727743|NCT02492984|565752152|FG000|Overall Study|Withdrawal by Subject|1|||
156727744|NCT02492984|565752153|FG001|Overall Study|Withdrawal by Subject|0|||
156727745|NCT00459290|565752154|FG000|Overall Study|Adverse Event|3|||
156727746|NCT00459290|565752154|FG000|Overall Study|Ineligible|2|||
156727747|NCT05483686|565752155|FG000|Overall Study|Lost to Follow-up|5|||
156727748|NCT05483686|565752156|FG001|Overall Study|Lost to Follow-up|7|||
156727749|NCT06152224|565752158|FG000|Overall Study|Withdrawal by Subject|1|||
156795891|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
156795892|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
156727750|NCT06152224|565752159|FG001|Overall Study|Withdrawal by Subject|0|||
156727751|NCT06152224|565752158|FG000|Overall Study|Lost to Follow-up|0|||
156795893|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
156795894|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
156795895|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
156795896|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
156454505|NCT03021096|564759262|FG000|Overall Study|Protocol Violation|2|||
156454506|NCT03848065|564759263|FG000|Overall Study|Death|0|||
156454507|NCT03848065|564759264|FG001|Overall Study|Death|1|||
156454508|NCT03848065|564759265|FG002|Overall Study|Death|0|||
156454509|NCT03848065|564759263|FG000|Overall Study|Lost to Follow-up|0|||
156454510|NCT03848065|564759264|FG001|Overall Study|Lost to Follow-up|0|||
156454511|NCT03848065|564759265|FG002|Overall Study|Lost to Follow-up|1|||
156454512|NCT03848065|564759263|FG000|Overall Study|Physician Decision|0|||
156727752|NCT06152224|565752159|FG001|Overall Study|Lost to Follow-up|1|||
156454513|NCT03848065|564759264|FG001|Overall Study|Physician Decision|0|||
156454514|NCT03848065|564759265|FG002|Overall Study|Physician Decision|1|||
156454515|NCT03313076|564759267|FG000|Overall Study|Withdrawal by Subject|2|||
156454516|NCT03313076|564759268|FG001|Overall Study|Withdrawal by Subject|0|||
156454517|NCT03313076|564759269|FG002|Overall Study|Withdrawal by Subject|0|||
156454518|NCT03313076|564759270|FG003|Overall Study|Withdrawal by Subject|0|||
156454519|NCT03313076|564759267|FG000|Overall Study|Lost to Follow-up|0|||
156454520|NCT03313076|564759268|FG001|Overall Study|Lost to Follow-up|2|||
156454521|NCT03313076|564759269|FG002|Overall Study|Lost to Follow-up|2|||
156454522|NCT03313076|564759270|FG003|Overall Study|Lost to Follow-up|2|||
156454523|NCT03270501|564759273|FG000|Overall Study|Screen failure|6|||
156454524|NCT03270501|564759273|FG000|Overall Study|Lost to Follow-up|2|||
156454525|NCT03270501|564759273|FG000|Overall Study|Adverse Event|1|||
156454526|NCT00764751|564759276|FG000|Overall Study|Adverse Event|1|||
156454527|NCT00764751|564759277|FG001|Overall Study|Adverse Event|1|||
156454528|NCT00764751|564759276|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
156454529|NCT00764751|564759277|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
156454530|NCT04065841|564759284|FG000|Overall Study|Adverse Event|4|||
156454531|NCT04065841|564759285|FG001|Overall Study|Adverse Event|2|||
156454532|NCT04065841|564759286|FG002|Overall Study|Adverse Event|10|||
156454533|NCT04065841|564759287|FG003|Overall Study|Adverse Event|1|||
156454534|NCT04065841|564759284|FG000|Overall Study|Lost to Follow-up|1|||
156454535|NCT04065841|564759285|FG001|Overall Study|Lost to Follow-up|2|||
156454536|NCT04065841|564759286|FG002|Overall Study|Lost to Follow-up|2|||
156454537|NCT04065841|564759287|FG003|Overall Study|Lost to Follow-up|2|||
156454538|NCT04065841|564759284|FG000|Overall Study|Physician Decision|1|||
156454539|NCT04065841|564759285|FG001|Overall Study|Physician Decision|0|||
156454540|NCT04065841|564759286|FG002|Overall Study|Physician Decision|0|||
156454541|NCT04065841|564759287|FG003|Overall Study|Physician Decision|0|||
156454542|NCT04065841|564759284|FG000|Overall Study|Protocol Violation|0|||
156454543|NCT04065841|564759285|FG001|Overall Study|Protocol Violation|1|||
156454544|NCT04065841|564759286|FG002|Overall Study|Protocol Violation|0|||
156454545|NCT04065841|564759287|FG003|Overall Study|Protocol Violation|0|||
156454546|NCT04065841|564759284|FG000|Overall Study|Study terminated by Sponsor|22|||
156454547|NCT04065841|564759285|FG001|Overall Study|Study terminated by Sponsor|16|||
156454548|NCT04065841|564759286|FG002|Overall Study|Study terminated by Sponsor|28|||
156454549|NCT04065841|564759287|FG003|Overall Study|Study terminated by Sponsor|17|||
156454550|NCT04065841|564759284|FG000|Overall Study|Withdrawal by Subject|1|||
156454551|NCT04065841|564759285|FG001|Overall Study|Withdrawal by Subject|1|||
156454552|NCT04065841|564759286|FG002|Overall Study|Withdrawal by Subject|2|||
156454553|NCT04065841|564759287|FG003|Overall Study|Withdrawal by Subject|0|||
156454554|NCT01420237|564759288|FG000|Overall Study|Death|13|||
156454555|NCT01420237|564759288|FG000|Overall Study|Withdrawal by Subject|41|||
156727753|NCT06152224|565752158|FG000|Overall Study|On Follow Up|18|||
156727754|NCT06152224|565752159|FG001|Overall Study|On Follow Up|18|||
156727755|NCT05780983|565752160|FG000|Overall Study|Withdrawal by Subject|1|||
156727756|NCT06028438|565752161|FG000|Overall Study|Adverse Event|3|||
156727757|NCT06028438|565752162|FG001|Overall Study|Adverse Event|9|||
156727758|NCT06028438|565752161|FG000|Overall Study|Lack of Efficacy|1|||
156727759|NCT06028438|565752162|FG001|Overall Study|Lack of Efficacy|1|||
156727760|NCT06028438|565752161|FG000|Overall Study|Lost to Follow-up|1|||
156727761|NCT06028438|565752162|FG001|Overall Study|Lost to Follow-up|0|||
156727762|NCT06028438|565752161|FG000|Overall Study|Withdrawal by Subject|1|||
156727763|NCT06028438|565752162|FG001|Overall Study|Withdrawal by Subject|0|||
156727764|NCT06028438|565752161|FG000|Overall Study|Other|3|||
156727765|NCT06028438|565752162|FG001|Overall Study|Other|3|||
156727766|NCT05625802|565752163|FG000|Overall Study|Lost to Follow-up|1|||
156727767|NCT05625802|565752164|FG001|Overall Study|Lost to Follow-up|0|||
156727768|NCT01019694|565752171|FG000|Overall Study|Adverse Event|12|||
156727769|NCT01019694|565752172|FG001|Overall Study|Adverse Event|16|||
156876230|NCT04838977|566305770|FG000|Overall Study|Lost to Follow-up|2|||
156876231|NCT04838977|566305771|FG001|Overall Study|Lost to Follow-up|3|||
156454556|NCT01420237|564759288|FG000|Overall Study|Lost to Follow-up|32|||
156454557|NCT01420237|564759288|FG000|Overall Study|Adverse Event|10|||
156454558|NCT01420237|564759288|FG000|Overall Study|Investigative Site Termination|43|||
156454559|NCT01420237|564759288|FG000|Overall Study|Censored because study device not implanted|21|||
156454560|NCT01420237|564759288|FG000|Overall Study|Censored because surgery not performed|2|||
156454561|NCT01420237|564759288|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
156454562|NCT01420237|564759288|FG000|Overall Study|Sponsor terminated study early|127|||
156454563|NCT05270408|564759290|FG000|Started Treatment|Withdrawal by Subject|0|||
156454564|NCT05270408|564759291|FG001|Started Treatment|Withdrawal by Subject|0|||
156454565|NCT05270408|564759292|FG002|Started Treatment|Withdrawal by Subject|3|||
156727770|NCT01019694|565752173|FG002|Overall Study|Adverse Event|19|||
156727771|NCT01019694|565752171|FG000|Overall Study|Protocol Violation|2|||
156727772|NCT01019694|565752172|FG001|Overall Study|Protocol Violation|6|||
156727773|NCT01019694|565752173|FG002|Overall Study|Protocol Violation|4|||
156454566|NCT05270408|564759290|FG000|Started Treatment|Adverse Event|0|||
156454567|NCT05270408|564759291|FG001|Started Treatment|Adverse Event|0|||
156727774|NCT01019694|565752171|FG000|Overall Study|Lost to Follow-up|5|||
156727775|NCT01019694|565752172|FG001|Overall Study|Lost to Follow-up|3|||
156727776|NCT01019694|565752173|FG002|Overall Study|Lost to Follow-up|3|||
156727777|NCT01019694|565752171|FG000|Overall Study|Withdrawal by Subject|4|||
156727778|NCT01019694|565752172|FG001|Overall Study|Withdrawal by Subject|6|||
156727779|NCT01019694|565752173|FG002|Overall Study|Withdrawal by Subject|12|||
156727780|NCT01019694|565752171|FG000|Overall Study|Not treated|0|||
156727781|NCT01019694|565752172|FG001|Overall Study|Not treated|2|||
156727782|NCT01019694|565752173|FG002|Overall Study|Not treated|3|||
156727783|NCT01019694|565752171|FG000|Overall Study|Other reason (not specified)|1|||
156727784|NCT01019694|565752172|FG001|Overall Study|Other reason (not specified)|5|||
156727785|NCT01019694|565752173|FG002|Overall Study|Other reason (not specified)|6|||
156727786|NCT00026494|565752176|FG000|Overall Study|Withdrawal by Subject|1|||
156727787|NCT00026494|565752177|FG001|Overall Study|Withdrawal by Subject|0|||
156727788|NCT00026494|565752178|FG002|Overall Study|Withdrawal by Subject|1|||
156727789|NCT00026494|565752179|FG003|Overall Study|Withdrawal by Subject|0|||
156727790|NCT00026494|565752176|FG000|Overall Study|Patient non-compliance|1|||
156727791|NCT00026494|565752177|FG001|Overall Study|Patient non-compliance|0|||
156727792|NCT00026494|565752178|FG002|Overall Study|Patient non-compliance|0|||
156727793|NCT00026494|565752179|FG003|Overall Study|Patient non-compliance|0|||
156727794|NCT00026494|565752176|FG000|Overall Study|Patient not treated|0|||
156727795|NCT00026494|565752177|FG001|Overall Study|Patient not treated|0|||
156727796|NCT00026494|565752178|FG002|Overall Study|Patient not treated|2|||
156727797|NCT00026494|565752179|FG003|Overall Study|Patient not treated|0|||
156727798|NCT00026494|565752176|FG000|Overall Study|Clinical progression|0|||
156727799|NCT00026494|565752177|FG001|Overall Study|Clinical progression|0|||
156727800|NCT00026494|565752178|FG002|Overall Study|Clinical progression|3|||
156727801|NCT00026494|565752179|FG003|Overall Study|Clinical progression|0|||
156727802|NCT00441129|565752180|FG000|Overall Study|Withdrawal by Subject|6|||
156727803|NCT00441129|565752181|FG001|Overall Study|Withdrawal by Subject|14|||
156727804|NCT03777436|565752182|FG000|Placebo-controlled Phase|Adverse Event|8|||
156727805|NCT03777436|565752183|FG001|Placebo-controlled Phase|Adverse Event|10|||
156727806|NCT03777436|565752184|FG002|Placebo-controlled Phase|Adverse Event|0|||
156727807|NCT03777436|565752182|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
156727808|NCT03777436|565752183|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
156727809|NCT03777436|565752184|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
156727810|NCT03777436|565752182|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
156727811|NCT03777436|565752183|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
156727812|NCT03777436|565752184|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
156727813|NCT03777436|565752182|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
156727814|NCT03777436|565752183|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
156727815|NCT03777436|565752184|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
156727816|NCT03777436|565752182|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
156727817|NCT03777436|565752183|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
156727818|NCT03777436|565752184|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
156727819|NCT03777436|565752182|FG000|Placebo-controlled Phase|Physician Decision|0|||
156727820|NCT03777436|565752183|FG001|Placebo-controlled Phase|Physician Decision|1|||
156727821|NCT03777436|565752184|FG002|Placebo-controlled Phase|Physician Decision|0|||
156727822|NCT03777436|565752182|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
156727823|NCT03777436|565752183|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
156727824|NCT03777436|565752184|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
156727825|NCT03777436|565752182|FG000|Apremilast Extension Phase|Adverse Event|0|||
156727826|NCT03777436|565752183|FG001|Apremilast Extension Phase|Adverse Event|0|||
156727827|NCT03777436|565752184|FG002|Apremilast Extension Phase|Adverse Event|6|||
156727828|NCT03777436|565752182|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
156727829|NCT03777436|565752183|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
156727830|NCT03777436|565752184|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
156727831|NCT03777436|565752182|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
156727832|NCT03777436|565752183|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
156454568|NCT05270408|564759292|FG002|Started Treatment|Adverse Event|1|||
156727833|NCT03777436|565752184|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
156727834|NCT03777436|565752182|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
156727835|NCT03777436|565752183|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
156727836|NCT03777436|565752184|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
156727837|NCT03777436|565752182|FG000|Apremilast Extension Phase|Miscellaneous|0|||
156727838|NCT03777436|565752183|FG001|Apremilast Extension Phase|Miscellaneous|0|||
156727839|NCT03777436|565752184|FG002|Apremilast Extension Phase|Miscellaneous|1|||
156727840|NCT02035202|565752185|FG000|Overall Study|Lost to Follow-up|8|||
156727841|NCT02035202|565752186|FG001|Overall Study|Lost to Follow-up|16|||
156727842|NCT02035202|565752187|FG002|Overall Study|Lost to Follow-up|2|||
156454569|NCT05270408|564759290|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
156727843|NCT00758485|565752190|FG000|Overall Study|Lost to Follow-up|0|||
156727844|NCT00758485|565752191|FG001|Overall Study|Lost to Follow-up|1|||
156727845|NCT00758485|565752190|FG000|Overall Study|Not Treated|1|||
156727846|NCT00758485|565752191|FG001|Overall Study|Not Treated|2|||
156727847|NCT00656292|565752192|FG000|Overall Study|Withdrawal by Subject|2|||
156727848|NCT00656292|565752193|FG001|Overall Study|Withdrawal by Subject|3|||
156727849|NCT00656292|565752192|FG000|Overall Study|Screen failure|1|||
156727850|NCT00656292|565752193|FG001|Overall Study|Screen failure|2|||
156727851|NCT00921557|565752194|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
156727852|NCT00921557|565752195|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
156727853|NCT00921557|565752196|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
156727854|NCT00921557|565752194|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
156727855|NCT00921557|565752195|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
156727856|NCT00921557|565752196|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
156727857|NCT00921557|565752194|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
156727858|NCT00921557|565752195|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
156727859|NCT00921557|565752196|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
156727860|NCT00921557|565752194|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
156727861|NCT00921557|565752195|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
156727862|NCT00921557|565752196|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
156727863|NCT00921557|565752194|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
156727864|NCT00921557|565752195|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
156727865|NCT00921557|565752196|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
156727866|NCT03259425|565752197|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
156727867|NCT02527434|565752203|FG000|Overall Study|Lost to Follow-up|2|||
156727868|NCT02527434|565752204|FG001|Overall Study|Lost to Follow-up|2|||
156727869|NCT02527434|565752205|FG002|Overall Study|Lost to Follow-up|0|||
156727870|NCT02527434|565752203|FG000|Overall Study|Death|19|||
156727871|NCT02527434|565752204|FG001|Overall Study|Death|6|||
156727872|NCT02527434|565752205|FG002|Overall Study|Death|17|||
156727873|NCT02527434|565752203|FG000|Overall Study|Withdrawal by Subject|5|||
156727874|NCT02527434|565752204|FG001|Overall Study|Withdrawal by Subject|3|||
156727875|NCT02527434|565752205|FG002|Overall Study|Withdrawal by Subject|3|||
156727876|NCT02527434|565752203|FG000|Overall Study|Reason Not Specified|1|||
156727877|NCT02527434|565752204|FG001|Overall Study|Reason Not Specified|0|||
156727878|NCT02527434|565752205|FG002|Overall Study|Reason Not Specified|0|||
156727879|NCT02527434|565752203|FG000|Overall Study|Site closure|1|||
156727880|NCT02527434|565752204|FG001|Overall Study|Site closure|0|||
156727881|NCT02527434|565752205|FG002|Overall Study|Site closure|0|||
156727882|NCT02861807|565752206|FG000|Overall Study|Lost to Follow-up|7|||
156727883|NCT02861807|565752207|FG001|Overall Study|Lost to Follow-up|6|||
156795897|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
156795898|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
156454570|NCT05270408|564759291|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
156454571|NCT05270408|564759292|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
156454572|NCT04338061|564759294|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
156454573|NCT04338061|564759295|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
156454574|NCT04338061|564759294|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
156454575|NCT04338061|564759295|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
156454576|NCT04338061|564759294|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
156795899|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
156795900|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
156795901|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
156795902|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
156454577|NCT04338061|564759295|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
156454578|NCT04338061|564759294|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
156454579|NCT04338061|564759295|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
156454580|NCT04338061|564759294|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
156454581|NCT04338061|564759295|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
156454582|NCT04338061|564759294|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
156795903|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
156795904|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
156795905|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
156795906|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
156727884|NCT02861807|565752206|FG000|Overall Study|Withdrawal by Subject|5|||
156727885|NCT02861807|565752207|FG001|Overall Study|Withdrawal by Subject|8|||
156727886|NCT00568061|565752210|FG000|Overall Study|Inclusion / exclusion criteria|5|||
156795907|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
156795908|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
156795909|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
156808807|NCT01484496|566054476|FG003|Period 1|Protocol Violation|0|||
156727887|NCT00568061|565752211|FG001|Overall Study|Inclusion / exclusion criteria|1|||
156727888|NCT00568061|565752210|FG000|Overall Study|Adverse Event|0|||
156727889|NCT00568061|565752211|FG001|Overall Study|Adverse Event|1|||
156727890|NCT05027451|565752212|FG000|Overall Study|Lost to Follow-up|1|||
156454583|NCT04338061|564759295|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
156454584|NCT04338061|564759294|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
156454585|NCT04338061|564759295|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
156454586|NCT04338061|564759294|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
156454587|NCT04338061|564759295|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
156454588|NCT04338061|564759294|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
156454589|NCT04338061|564759295|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
156454590|NCT04338061|564759294|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
156454591|NCT04338061|564759295|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
156454592|NCT04338061|564759294|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
156454593|NCT04338061|564759295|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
156454594|NCT04338061|564759294|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
156454595|NCT04338061|564759295|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
156727891|NCT05027451|565752213|FG001|Overall Study|Lost to Follow-up|1|||
156727892|NCT02693002|565752215|FG000|Overall Study|Withdrawal by Subject|1|||
156454596|NCT04492722|564759297|FG000|Overall Study|Adverse Event|7|||
156454597|NCT04492722|564759298|FG001|Overall Study|Adverse Event|2|||
156454598|NCT04492722|564759299|FG002|Overall Study|Adverse Event|3|||
156454599|NCT04492722|564759300|FG003|Overall Study|Adverse Event|0|||
156454600|NCT04492722|564759297|FG000|Overall Study|Death|0|||
156454601|NCT04492722|564759298|FG001|Overall Study|Death|0|||
156454602|NCT04492722|564759299|FG002|Overall Study|Death|0|||
156454603|NCT04492722|564759300|FG003|Overall Study|Death|1|||
156454604|NCT04492722|564759297|FG000|Overall Study|Lost to Follow-up|0|||
156454605|NCT04492722|564759298|FG001|Overall Study|Lost to Follow-up|1|||
156454606|NCT04492722|564759299|FG002|Overall Study|Lost to Follow-up|0|||
156454607|NCT04492722|564759300|FG003|Overall Study|Lost to Follow-up|1|||
156454608|NCT04492722|564759297|FG000|Overall Study|Physician Decision|0|||
156454609|NCT04492722|564759298|FG001|Overall Study|Physician Decision|3|||
156454610|NCT04492722|564759299|FG002|Overall Study|Physician Decision|1|||
156454611|NCT04492722|564759300|FG003|Overall Study|Physician Decision|1|||
156454612|NCT04492722|564759297|FG000|Overall Study|Withdrawal by Subject|6|||
156454613|NCT04492722|564759298|FG001|Overall Study|Withdrawal by Subject|6|||
156533574|NCT00578786|565048867|FG002|Overall Study|Adverse Event|17|||
156727893|NCT02693002|565752216|FG001|Overall Study|Withdrawal by Subject|0|||
156727894|NCT00812981|565752219|FG000|Overall Study|Other|0|||
156727895|NCT00812981|565752220|FG001|Overall Study|Other|1|||
156727896|NCT04666259|565752224|FG000|Treatment Phase|Physician Decision|9|||
156727897|NCT04666259|565752225|FG001|Treatment Phase|Physician Decision|3|||
156727898|NCT04666259|565752226|FG002|Treatment Phase|Physician Decision|3|||
156727899|NCT04666259|565752224|FG000|Treatment Phase|Adverse Event|3|||
156727900|NCT04666259|565752225|FG001|Treatment Phase|Adverse Event|1|||
156876232|NCT04838977|566305770|FG000|Overall Study|Withdrawal by Subject|1|||
156876233|NCT04838977|566305771|FG001|Overall Study|Withdrawal by Subject|1|||
156876234|NCT01088048|566305775|FG000|Overall Study|Adverse Event|7|||
156876235|NCT01088048|566305776|FG001|Overall Study|Adverse Event|9|||
156876236|NCT01088048|566305777|FG002|Overall Study|Adverse Event|7|||
156876237|NCT01088048|566305778|FG003|Overall Study|Adverse Event|5|||
156876238|NCT01088048|566305779|FG004|Overall Study|Adverse Event|6|||
156727901|NCT04666259|565752226|FG002|Treatment Phase|Adverse Event|0|||
156727902|NCT04666259|565752224|FG000|Treatment Phase|Subject decision|1|||
156727903|NCT04666259|565752225|FG001|Treatment Phase|Subject decision|2|||
156727904|NCT04666259|565752226|FG002|Treatment Phase|Subject decision|0|||
156727905|NCT04666259|565752224|FG000|Treatment Phase|Progressive disease|0|||
156727906|NCT04666259|565752225|FG001|Treatment Phase|Progressive disease|1|||
156727907|NCT04666259|565752226|FG002|Treatment Phase|Progressive disease|0|||
156727908|NCT04666259|565752224|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
156727909|NCT04666259|565752225|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
156727910|NCT04666259|565752226|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
156876239|NCT01088048|566305780|FG005|Overall Study|Adverse Event|3|||
156876240|NCT01088048|566305781|FG006|Overall Study|Adverse Event|3|||
156876241|NCT01088048|566305782|FG007|Overall Study|Adverse Event|0|||
156876242|NCT01088048|566305783|FG008|Overall Study|Adverse Event|2|||
156533575|NCT00578786|565048865|FG000|Overall Study|Lack of Efficacy|2|||
156454614|NCT04492722|564759299|FG002|Overall Study|Withdrawal by Subject|0|||
156727911|NCT04666259|565752224|FG000|Safety Follow-up Phase|Physician Decision|2|||
156727912|NCT04666259|565752225|FG001|Safety Follow-up Phase|Physician Decision|0|||
156727913|NCT04666259|565752226|FG002|Safety Follow-up Phase|Physician Decision|0|||
156727914|NCT04666259|565752224|FG000|Safety Follow-up Phase|Subject decision|1|||
156533576|NCT00578786|565048866|FG001|Overall Study|Lack of Efficacy|5|||
156727915|NCT04666259|565752225|FG001|Safety Follow-up Phase|Subject decision|0|||
156876243|NCT01088048|566305784|FG009|Overall Study|Adverse Event|2|||
156876244|NCT01088048|566305775|FG000|Overall Study|Withdrew Consent|1|||
156876245|NCT01088048|566305776|FG001|Overall Study|Withdrew Consent|1|||
156876246|NCT01088048|566305777|FG002|Overall Study|Withdrew Consent|1|||
156876247|NCT01088048|566305778|FG003|Overall Study|Withdrew Consent|1|||
156727916|NCT04666259|565752226|FG002|Safety Follow-up Phase|Subject decision|0|||
156727917|NCT04666259|565752224|FG000|Safety Follow-up Phase|Death|0|||
156727918|NCT04666259|565752225|FG001|Safety Follow-up Phase|Death|1|||
156727919|NCT04666259|565752226|FG002|Safety Follow-up Phase|Death|0|||
156727920|NCT04178122|565752227|FG000|Overall Study|Withdrawal by Subject|1|||
156727921|NCT04178122|565752228|FG001|Overall Study|Withdrawal by Subject|1|||
156727922|NCT04178122|565752227|FG000|Overall Study|Death|2|||
156727923|NCT04178122|565752228|FG001|Overall Study|Death|0|||
156795910|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
156795911|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
156795912|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
156795913|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
156795914|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
156454615|NCT04492722|564759300|FG003|Overall Study|Withdrawal by Subject|3|||
156727924|NCT04178122|565752227|FG000|Overall Study|Did not complete testing|3|||
156727925|NCT04178122|565752228|FG001|Overall Study|Did not complete testing|13|||
156727926|NCT05343364|565752229|FG000|Overall Study|Miscellaneous|0|||
156727927|NCT05343364|565752230|FG001|Overall Study|Miscellaneous|1|||
156727928|NCT01753570|565752231|FG000|Overall Study|Adverse Event|1|||
156727929|NCT01753570|565752232|FG001|Overall Study|Adverse Event|0|||
156727930|NCT01753570|565752233|FG002|Overall Study|Adverse Event|1|||
156727931|NCT01753570|565752231|FG000|Overall Study|Physician Decision|0|||
156727932|NCT01753570|565752232|FG001|Overall Study|Physician Decision|1|||
156727933|NCT01753570|565752233|FG002|Overall Study|Physician Decision|0|||
156727934|NCT01753570|565752231|FG000|Overall Study|Withdrawal by Subject|1|||
156727935|NCT01753570|565752232|FG001|Overall Study|Withdrawal by Subject|4|||
156727936|NCT01753570|565752233|FG002|Overall Study|Withdrawal by Subject|0|||
156727937|NCT01791894|565752234|FG000|Overall Study|Adverse Event|1|||
156727938|NCT01422889|565752235|FG000|Overall Study|No Data Entered for Study Stent|9|||
156727939|NCT02684097|565752240|FG000|Overall Study|Lack of Efficacy|13|||
156727940|NCT02684097|565752241|FG001|Overall Study|Lack of Efficacy|6|||
156727941|NCT00462709|565752242|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
156727942|NCT00462709|565752242|FG000|Overall Study|Lost to Follow-up|10|||
156727943|NCT00462709|565752242|FG000|Overall Study|Withdrawal by Subject|8|||
156727944|NCT00462709|565752242|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
156727945|NCT00462709|565752242|FG000|Overall Study|Death|2|||
156727946|NCT00462709|565752242|FG000|Overall Study|Logistical reasons|2|||
156727947|NCT00462709|565752242|FG000|Overall Study|Physician Decision|1|||
156727948|NCT00462709|565752242|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
156727949|NCT02748356|565752243|FG000|Overall Study|Withdrawal by Subject|1|||
156727950|NCT00425750|565752244|FG000|Overall Study|Death|1|||
156727951|NCT00425750|565752244|FG000|Overall Study|Withdrawal by Subject|3|||
156727952|NCT00425750|565752244|FG000|Overall Study|Adverse Event|3|||
156727953|NCT00425750|565752244|FG000|Overall Study|Progression of disease|18|||
156727954|NCT01732458|565752245|FG000|Overall Study|Lost to Follow-up|0|||
156727955|NCT01732458|565752246|FG001|Overall Study|Lost to Follow-up|2|||
156727956|NCT01732458|565752247|FG002|Overall Study|Lost to Follow-up|0|||
156727957|NCT01732458|565752248|FG003|Overall Study|Lost to Follow-up|0|||
156727958|NCT01732458|565752245|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156727959|NCT01732458|565752246|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156727960|NCT01732458|565752247|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156727961|NCT01732458|565752248|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156727962|NCT01732458|565752245|FG000|Overall Study|Physician Decision|1|||
156727963|NCT01732458|565752246|FG001|Overall Study|Physician Decision|2|||
156727964|NCT01732458|565752247|FG002|Overall Study|Physician Decision|2|||
156727965|NCT01732458|565752248|FG003|Overall Study|Physician Decision|0|||
156727966|NCT01732458|565752245|FG000|Overall Study|Protocol Violation|2|||
156727967|NCT01732458|565752246|FG001|Overall Study|Protocol Violation|0|||
156727968|NCT01732458|565752247|FG002|Overall Study|Protocol Violation|0|||
156727969|NCT01732458|565752248|FG003|Overall Study|Protocol Violation|2|||
156727970|NCT01732458|565752245|FG000|Overall Study|Screen Failure|0|||
156727971|NCT01732458|565752246|FG001|Overall Study|Screen Failure|1|||
156727972|NCT01732458|565752247|FG002|Overall Study|Screen Failure|0|||
156795915|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
156795916|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
156795917|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
156795918|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
156795919|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
156795920|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
156795921|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
156795922|NCT01435356|566006211|FG000|Overall Study|Adverse Event|2|||
156795923|NCT01435356|566006212|FG001|Overall Study|Adverse Event|0|||
156795924|NCT01435356|566006211|FG000|Overall Study|Disease progression/recurrence|17|||
156795925|NCT01435356|566006212|FG001|Overall Study|Disease progression/recurrence|10|||
156727973|NCT01732458|565752248|FG003|Overall Study|Screen Failure|0|||
156727974|NCT05107492|565752250|FG000|Overall Study|Lost to Follow-up|1|||
156727975|NCT05107492|565752251|FG001|Overall Study|Lost to Follow-up|0|||
156727976|NCT04331067|565752252|FG000|Overall Study|Adverse Event|1|||
156727977|NCT04331067|565752253|FG001|Overall Study|Adverse Event|3|||
156727978|NCT04331067|565752254|FG002|Overall Study|Adverse Event|1|||
156727979|NCT04331067|565752252|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
156727980|NCT04331067|565752253|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
156727981|NCT04331067|565752254|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
156727982|NCT05870371|565752255|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
156727983|NCT05870371|565752256|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
156727984|NCT02522884|565752259|FG000|Overall Study|Withdrawal by Subject|6|||
156876248|NCT01088048|566305779|FG004|Overall Study|Withdrew Consent|2|||
156727985|NCT02522884|565752259|FG000|Overall Study|Death|3|||
156727986|NCT02522884|565752259|FG000|Overall Study|Missed 12-month Follow-up|9|||
156727987|NCT04495751|565752260|FG000|Overall Study|Withdrawal by Subject|1|||
156727988|NCT04495751|565752261|FG001|Overall Study|Withdrawal by Subject|0|||
156727989|NCT04495751|565752260|FG000|Overall Study|Lost to Follow-up|1|||
156727990|NCT04495751|565752261|FG001|Overall Study|Lost to Follow-up|0|||
156727991|NCT03289754|565752262|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
156727992|NCT04873934|565752263|FG000|Overall Study|Adverse Event|0|||
156727993|NCT04873934|565752264|FG001|Overall Study|Adverse Event|1|||
156727994|NCT04873934|565752263|FG000|Overall Study|Death|0|||
156727995|NCT04873934|565752264|FG001|Overall Study|Death|2|||
156727996|NCT04873934|565752263|FG000|Overall Study|Lost to Follow-up|13|||
156727997|NCT04873934|565752264|FG001|Overall Study|Lost to Follow-up|9|||
156727998|NCT04873934|565752263|FG000|Overall Study|Physician Decision|1|||
156727999|NCT04873934|565752264|FG001|Overall Study|Physician Decision|1|||
156728000|NCT04873934|565752263|FG000|Overall Study|Protocol deviation|2|||
156728001|NCT04873934|565752264|FG001|Overall Study|Protocol deviation|1|||
156728002|NCT04873934|565752263|FG000|Overall Study|Subject decision|1|||
156728003|NCT04873934|565752264|FG001|Overall Study|Subject decision|8|||
156728004|NCT04873934|565752263|FG000|Overall Study|Withdrew consent|0|||
156728005|NCT04873934|565752264|FG001|Overall Study|Withdrew consent|4|||
156728006|NCT04873934|565752263|FG000|Overall Study|Missing|1|||
156728007|NCT04873934|565752264|FG001|Overall Study|Missing|0|||
156728008|NCT00708461|565752265|FG000|Overall Study|Lost to Follow-up|18|||
156728009|NCT00708461|565752266|FG001|Overall Study|Lost to Follow-up|11|||
156728010|NCT00708461|565752265|FG000|Overall Study|Withdrawal by Subject|8|||
156728011|NCT00708461|565752266|FG001|Overall Study|Withdrawal by Subject|9|||
156728012|NCT00708461|565752265|FG000|Overall Study|left workforce|115|||
156728013|NCT00708461|565752266|FG001|Overall Study|left workforce|180|||
156728014|NCT03584854|565752268|FG000|Overall Study|Primary outcome not measured|1|||
156728015|NCT03584854|565752269|FG001|Overall Study|Primary outcome not measured|2|||
156728016|NCT02968173|565752270|FG000|Overall Study|Withdrawal by Subject|1|||
156728017|NCT00153179|565752277|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
156728018|NCT00153179|565752278|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
156728019|NCT00153179|565752279|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
156728020|NCT00153179|565752280|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
156728021|NCT00314327|565752285|FG000|Overall Study|Withdrawal by Subject|1|||
156728022|NCT02134015|565752286|FG000|Overall Study|Protocol Violation|0|||
156728023|NCT02134015|565752287|FG001|Overall Study|Protocol Violation|1|||
156728024|NCT02134015|565752286|FG000|Overall Study|Death|2|||
156728025|NCT02134015|565752287|FG001|Overall Study|Death|1|||
156728026|NCT02134015|565752286|FG000|Overall Study|Reason not provided|1|||
156728027|NCT02134015|565752287|FG001|Overall Study|Reason not provided|2|||
156728028|NCT02134015|565752286|FG000|Overall Study|Clinical progression|14|||
156728029|NCT02134015|565752287|FG001|Overall Study|Clinical progression|7|||
156728030|NCT02134015|565752286|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
156728031|NCT02134015|565752287|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
156454616|NCT04492722|564759297|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
156454617|NCT04492722|564759298|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
156728032|NCT02134015|565752286|FG000|Overall Study|Study terminated by sponsor|2|||
156876249|NCT01088048|566305780|FG005|Overall Study|Withdrew Consent|1|||
156876250|NCT01088048|566305781|FG006|Overall Study|Withdrew Consent|0|||
156454618|NCT04492722|564759299|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
156454619|NCT04492722|564759300|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
156728033|NCT02134015|565752287|FG001|Overall Study|Study terminated by sponsor|3|||
156728034|NCT02134015|565752286|FG000|Overall Study|Adverse Event|9|||
156728035|NCT02134015|565752287|FG001|Overall Study|Adverse Event|10|||
156728036|NCT02134015|565752286|FG000|Overall Study|Withdrawal by Subject|3|||
156728037|NCT02134015|565752287|FG001|Overall Study|Withdrawal by Subject|7|||
156728038|NCT02453334|565753951|FG000|Overall Study|Death|15|||
156728039|NCT02453334|565753952|FG001|Overall Study|Death|13|||
156728040|NCT02453334|565753951|FG000|Overall Study|Adverse Event|2|||
156728041|NCT02453334|565753952|FG001|Overall Study|Adverse Event|1|||
156728042|NCT02453334|565753951|FG000|Overall Study|Lost to Follow-up|5|||
156728043|NCT02453334|565753952|FG001|Overall Study|Lost to Follow-up|9|||
156728044|NCT02453334|565753951|FG000|Overall Study|Physician Decision|1|||
156728045|NCT02453334|565753952|FG001|Overall Study|Physician Decision|0|||
156728046|NCT02453334|565753951|FG000|Overall Study|Withdrawal by Subject|17|||
156728047|NCT02453334|565753952|FG001|Overall Study|Withdrawal by Subject|13|||
156728048|NCT02453334|565753951|FG000|Overall Study|Other reason|1|||
156728049|NCT02453334|565753952|FG001|Overall Study|Other reason|4|||
156728050|NCT01841762|565753953|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
156728051|NCT01841762|565753953|FG000|Treatment Period|Adverse Event|16|||
156728052|NCT01841762|565753953|FG000|Treatment Period|Death|1|||
156728053|NCT01841762|565753953|FG000|Treatment Period|Withdrawal by Subject|7|||
156728054|NCT01841762|565753953|FG000|Treatment Period|Lost to Follow-up|1|||
156728055|NCT01841762|565753953|FG000|Treatment Period|Physician Decision|2|||
156728056|NCT01841762|565753953|FG000|Treatment Period|Other, including non-compliance|5|||
156728057|NCT01841762|565753953|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
156728058|NCT01841762|565753953|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
156728059|NCT01841762|565753953|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
156728060|NCT01841762|565753953|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
156728061|NCT01954056|565753961|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
156728062|NCT01954056|565753962|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
156728063|NCT06110494|565753976|FG000|Overall Study|Protocol Violation|2|||
156728064|NCT06110494|565753977|FG001|Overall Study|Protocol Violation|0|||
156728065|NCT06110494|565753978|FG002|Overall Study|Protocol Violation|1|||
156728066|NCT06110494|565753976|FG000|Overall Study|Dixon's test for outlier analysis|1|||
156728067|NCT06110494|565753977|FG001|Overall Study|Dixon's test for outlier analysis|1|||
156728068|NCT06110494|565753978|FG002|Overall Study|Dixon's test for outlier analysis|0|||
156728069|NCT00105079|565753979|FG000|Overall Study|Adverse Event|5|||
156728070|NCT00105079|565753980|FG001|Overall Study|Adverse Event|12|||
156728071|NCT00105079|565753979|FG000|Overall Study|Death|3|||
156876251|NCT01088048|566305782|FG007|Overall Study|Withdrew Consent|2|||
156454620|NCT04492722|564759297|FG000|Overall Study|Due to Covid-19 pandemic|7|||
156728072|NCT00105079|565753980|FG001|Overall Study|Death|1|||
156728073|NCT00105079|565753979|FG000|Overall Study|Lost to Follow-up|12|||
156728074|NCT00105079|565753980|FG001|Overall Study|Lost to Follow-up|12|||
156728075|NCT00105079|565753979|FG000|Overall Study|Lack of Efficacy|9|||
156728076|NCT00105079|565753980|FG001|Overall Study|Lack of Efficacy|3|||
156876252|NCT01088048|566305783|FG008|Overall Study|Withdrew Consent|2|||
156876253|NCT01088048|566305784|FG009|Overall Study|Withdrew Consent|1|||
156876254|NCT01088048|566305775|FG000|Overall Study|Concomitant Medication Prohibited|1|||
156876255|NCT01088048|566305776|FG001|Overall Study|Concomitant Medication Prohibited|0|||
156876256|NCT01088048|566305777|FG002|Overall Study|Concomitant Medication Prohibited|0|||
156876257|NCT01088048|566305778|FG003|Overall Study|Concomitant Medication Prohibited|0|||
156876258|NCT01088048|566305779|FG004|Overall Study|Concomitant Medication Prohibited|0|||
156876259|NCT01088048|566305780|FG005|Overall Study|Concomitant Medication Prohibited|0|||
156876260|NCT01088048|566305781|FG006|Overall Study|Concomitant Medication Prohibited|0|||
156876261|NCT01088048|566305782|FG007|Overall Study|Concomitant Medication Prohibited|0|||
156876262|NCT01088048|566305783|FG008|Overall Study|Concomitant Medication Prohibited|0|||
156876263|NCT01088048|566305784|FG009|Overall Study|Concomitant Medication Prohibited|0|||
156876264|NCT01088048|566305775|FG000|Overall Study|Investigator Request|2|||
156876265|NCT01088048|566305776|FG001|Overall Study|Investigator Request|2|||
156876266|NCT01088048|566305777|FG002|Overall Study|Investigator Request|0|||
156876267|NCT01088048|566305778|FG003|Overall Study|Investigator Request|0|||
156876268|NCT01088048|566305779|FG004|Overall Study|Investigator Request|3|||
156876269|NCT01088048|566305780|FG005|Overall Study|Investigator Request|1|||
156876270|NCT01088048|566305781|FG006|Overall Study|Investigator Request|1|||
156876271|NCT01088048|566305782|FG007|Overall Study|Investigator Request|0|||
156876272|NCT01088048|566305783|FG008|Overall Study|Investigator Request|0|||
156876273|NCT01088048|566305784|FG009|Overall Study|Investigator Request|0|||
156876274|NCT01088048|566305775|FG000|Overall Study|Patient Non-compliance|0|||
156876275|NCT01088048|566305776|FG001|Overall Study|Patient Non-compliance|1|||
156876276|NCT01088048|566305777|FG002|Overall Study|Patient Non-compliance|0|||
156876277|NCT01088048|566305778|FG003|Overall Study|Patient Non-compliance|0|||
156876278|NCT01088048|566305779|FG004|Overall Study|Patient Non-compliance|0|||
156876279|NCT01088048|566305780|FG005|Overall Study|Patient Non-compliance|0|||
156876280|NCT01088048|566305781|FG006|Overall Study|Patient Non-compliance|0|||
156876281|NCT01088048|566305782|FG007|Overall Study|Patient Non-compliance|0|||
156876282|NCT01088048|566305783|FG008|Overall Study|Patient Non-compliance|0|||
156454621|NCT04492722|564759298|FG001|Overall Study|Due to Covid-19 pandemic|3|||
156728077|NCT00105079|565753979|FG000|Overall Study|Refused treatment|6|||
156728078|NCT00105079|565753980|FG001|Overall Study|Refused treatment|4|||
156728079|NCT00105079|565753979|FG000|Overall Study|Violation of selection criteria at entry|0|||
156728080|NCT00105079|565753980|FG001|Overall Study|Violation of selection criteria at entry|2|||
156728081|NCT00105079|565753979|FG000|Overall Study|Protocol Violation|1|||
156876283|NCT01088048|566305784|FG009|Overall Study|Patient Non-compliance|0|||
156876284|NCT01088048|566305775|FG000|Overall Study|Disease Progression|7|||
156876285|NCT01088048|566305776|FG001|Overall Study|Disease Progression|4|||
156454622|NCT04492722|564759299|FG002|Overall Study|Due to Covid-19 pandemic|7|||
156454623|NCT04492722|564759300|FG003|Overall Study|Due to Covid-19 pandemic|6|||
156876286|NCT01088048|566305777|FG002|Overall Study|Disease Progression|3|||
156876287|NCT01088048|566305778|FG003|Overall Study|Disease Progression|5|||
156876288|NCT01088048|566305779|FG004|Overall Study|Disease Progression|3|||
156876289|NCT01088048|566305780|FG005|Overall Study|Disease Progression|3|||
156876290|NCT01088048|566305781|FG006|Overall Study|Disease Progression|2|||
156876291|NCT01088048|566305782|FG007|Overall Study|Disease Progression|1|||
156876292|NCT01088048|566305783|FG008|Overall Study|Disease Progression|0|||
156876293|NCT01088048|566305784|FG009|Overall Study|Disease Progression|0|||
156876294|NCT01088048|566305775|FG000|Overall Study|Death|1|||
156876295|NCT01088048|566305776|FG001|Overall Study|Death|5|||
156876296|NCT01088048|566305777|FG002|Overall Study|Death|3|||
156876297|NCT01088048|566305778|FG003|Overall Study|Death|3|||
156876298|NCT01088048|566305779|FG004|Overall Study|Death|1|||
156876299|NCT01088048|566305780|FG005|Overall Study|Death|3|||
156876300|NCT01088048|566305781|FG006|Overall Study|Death|0|||
156876301|NCT01088048|566305782|FG007|Overall Study|Death|0|||
156876302|NCT01088048|566305783|FG008|Overall Study|Death|3|||
156876303|NCT01088048|566305784|FG009|Overall Study|Death|1|||
156876304|NCT01088048|566305775|FG000|Overall Study|Other|3|||
156876305|NCT01088048|566305776|FG001|Overall Study|Other|5|||
156876306|NCT01088048|566305777|FG002|Overall Study|Other|0|||
156876307|NCT01088048|566305778|FG003|Overall Study|Other|0|||
156876308|NCT01088048|566305779|FG004|Overall Study|Other|2|||
156876309|NCT01088048|566305780|FG005|Overall Study|Other|0|||
156876310|NCT01088048|566305781|FG006|Overall Study|Other|0|||
156876311|NCT01088048|566305782|FG007|Overall Study|Other|2|||
156876312|NCT01088048|566305783|FG008|Overall Study|Other|0|||
156876313|NCT01088048|566305784|FG009|Overall Study|Other|0|||
156876314|NCT00950859|566305785|FG000|Overall Study|Adverse Event|3|||
156876315|NCT00950859|566305786|FG001|Overall Study|Adverse Event|3|||
156876316|NCT00950859|566305785|FG000|Overall Study|Insufficient Viral Load Response|12|||
156876317|NCT00950859|566305786|FG001|Overall Study|Insufficient Viral Load Response|3|||
156876318|NCT00950859|566305785|FG000|Overall Study|Protocol Violation|1|||
156876319|NCT00950859|566305786|FG001|Overall Study|Protocol Violation|1|||
156876320|NCT00950859|566305785|FG000|Overall Study|Lost to Follow-up|0|||
156876321|NCT00950859|566305786|FG001|Overall Study|Lost to Follow-up|3|||
156876322|NCT01343693|566305788|FG000|Overall Study|Lost to Follow-up|9|||
156876323|NCT00265148|566305789|FG000|Overall Study|Adverse Event|2|||
156876324|NCT00265148|566305790|FG001|Overall Study|Adverse Event|2|||
156876325|NCT00265148|566305789|FG000|Overall Study|Lack of Efficacy|0|||
156876326|NCT00265148|566305790|FG001|Overall Study|Lack of Efficacy|2|||
156876327|NCT00265148|566305789|FG000|Overall Study|Protocol Violation|3|||
156876328|NCT00265148|566305790|FG001|Overall Study|Protocol Violation|2|||
156876329|NCT00265148|566305789|FG000|Overall Study|Lost to Follow-up|0|||
156876330|NCT00265148|566305790|FG001|Overall Study|Lost to Follow-up|1|||
156876331|NCT00265148|566305789|FG000|Overall Study|Withdrawal by Subject|2|||
156876332|NCT00265148|566305790|FG001|Overall Study|Withdrawal by Subject|1|||
156876333|NCT00265148|566305789|FG000|Overall Study|Physician Decision|1|||
156876334|NCT00265148|566305790|FG001|Overall Study|Physician Decision|0|||
156876335|NCT00265148|566305789|FG000|Overall Study|Increasing frailty|0|||
156876336|NCT00265148|566305790|FG001|Overall Study|Increasing frailty|1|||
156876337|NCT00265148|566305789|FG000|Overall Study|Subject chose to change of the dose|1|||
156876338|NCT00265148|566305790|FG001|Overall Study|Subject chose to change of the dose|0|||
156876339|NCT01463007|566305791|FG000|Overall Study|Physician Decision|1|||
156876340|NCT03583385|566305792|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156876341|NCT03583385|566305793|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156876342|NCT03583385|566305792|FG000|Treatment Period 2|Adverse Event|1|||
156876343|NCT03583385|566305793|FG001|Treatment Period 2|Adverse Event|0|||
156876344|NCT00545272|566305799|FG000|Overall Study|Protocol deviation|0|||
156876345|NCT00545272|566305800|FG001|Overall Study|Protocol deviation|1|||
156876346|NCT00545272|566305801|FG002|Overall Study|Protocol deviation|0|||
156876347|NCT00545272|566305802|FG003|Overall Study|Protocol deviation|1|||
156876348|NCT00545272|566305803|FG004|Overall Study|Protocol deviation|0|||
156876349|NCT00545272|566305804|FG005|Overall Study|Protocol deviation|1|||
156454624|NCT04492722|564759297|FG000|Overall Study|Failure to meet randomisation criteria|2|||
156454625|NCT04492722|564759298|FG001|Overall Study|Failure to meet randomisation criteria|3|||
156876350|NCT00545272|566305799|FG000|Overall Study|Adverse Event|0|||
156876351|NCT00545272|566305800|FG001|Overall Study|Adverse Event|0|||
156876352|NCT00545272|566305801|FG002|Overall Study|Adverse Event|1|||
156876353|NCT00545272|566305802|FG003|Overall Study|Adverse Event|0|||
156876354|NCT00545272|566305803|FG004|Overall Study|Adverse Event|0|||
156876355|NCT00545272|566305804|FG005|Overall Study|Adverse Event|1|||
156876356|NCT00545272|566305799|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156876357|NCT00545272|566305800|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156876358|NCT00545272|566305801|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156876359|NCT00545272|566305802|FG003|Overall Study|Abnormal laboratory value(s)|0|||
156876360|NCT00545272|566305803|FG004|Overall Study|Abnormal laboratory value(s)|0|||
156876361|NCT00545272|566305804|FG005|Overall Study|Abnormal laboratory value(s)|1|||
156876362|NCT00545272|566305799|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156728082|NCT00105079|565753980|FG001|Overall Study|Protocol Violation|0|||
156728083|NCT00105079|565753979|FG000|Overall Study|Other|3|||
156728084|NCT00105079|565753980|FG001|Overall Study|Other|1|||
156728085|NCT01464593|565753983|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
156728086|NCT00386360|565753984|FG000|Overall Study|Adverse Event|4|||
156728087|NCT00386360|565753985|FG001|Overall Study|Adverse Event|2|||
156728088|NCT00386360|565753984|FG000|Overall Study|Physician Decision|2|||
156728089|NCT00386360|565753985|FG001|Overall Study|Physician Decision|2|||
156454626|NCT04492722|564759299|FG002|Overall Study|Failure to meet randomisation criteria|4|||
156728090|NCT00386360|565753984|FG000|Overall Study|Lost to Follow-up|0|||
156728091|NCT00386360|565753985|FG001|Overall Study|Lost to Follow-up|2|||
156728092|NCT00386360|565753984|FG000|Overall Study|Protocol Violation|0|||
156728093|NCT00386360|565753985|FG001|Overall Study|Protocol Violation|3|||
156728094|NCT00386360|565753984|FG000|Overall Study|Withdrawal by Subject|3|||
156728095|NCT00386360|565753985|FG001|Overall Study|Withdrawal by Subject|6|||
156728096|NCT00386360|565753984|FG000|Overall Study|Did not take any study medication|0|||
156728097|NCT00386360|565753985|FG001|Overall Study|Did not take any study medication|2|||
156728106|NCT02490371|565753992|FG000|Overall Study|Lost to Follow-up|1|||
156728107|NCT02490371|565753993|FG001|Overall Study|Lost to Follow-up|1|||
156728108|NCT01073605|565753996|FG000|Overall Study|Ongoing at Cutoff Date|1|||
156728109|NCT01073605|565753997|FG001|Overall Study|Ongoing at Cutoff Date|1|||
156728110|NCT01073605|565753998|FG002|Overall Study|Ongoing at Cutoff Date|0|||
156728111|NCT01073605|565753996|FG000|Overall Study|Adverse Event|2|||
156728112|NCT01073605|565753997|FG001|Overall Study|Adverse Event|1|||
156728113|NCT01073605|565753998|FG002|Overall Study|Adverse Event|0|||
156728114|NCT01073605|565753996|FG000|Overall Study|Lost to Follow-up|3|||
156728115|NCT01073605|565753997|FG001|Overall Study|Lost to Follow-up|4|||
156728116|NCT01073605|565753998|FG002|Overall Study|Lost to Follow-up|9|||
156728117|NCT01073605|565753996|FG000|Overall Study|Other|25|||
156728118|NCT01073605|565753997|FG001|Overall Study|Other|21|||
156728119|NCT01073605|565753998|FG002|Overall Study|Other|29|||
156728120|NCT01073605|565753996|FG000|Overall Study|Withdrawal by Subject|31|||
156728121|NCT01073605|565753997|FG001|Overall Study|Withdrawal by Subject|39|||
156728122|NCT01073605|565753998|FG002|Overall Study|Withdrawal by Subject|22|||
156728123|NCT01073605|565753996|FG000|Overall Study|Randomized But Not Treated|0|||
156728124|NCT01073605|565753997|FG001|Overall Study|Randomized But Not Treated|1|||
156728125|NCT01073605|565753998|FG002|Overall Study|Randomized But Not Treated|1|||
156728126|NCT03018080|565753999|FG000|Overall Study|Death|12|||
156728127|NCT03018080|565754000|FG001|Overall Study|Death|19|||
156728128|NCT03491462|565754001|FG000|Overall Study|Lost to Follow-up|2|||
156728129|NCT03491462|565754002|FG001|Overall Study|Lost to Follow-up|0|||
156728130|NCT03491462|565754001|FG000|Overall Study|Adverse Event|11|||
156728131|NCT03491462|565754002|FG001|Overall Study|Adverse Event|1|||
156728132|NCT03491462|565754001|FG000|Overall Study|Physician Decision|3|||
156728133|NCT03491462|565754002|FG001|Overall Study|Physician Decision|0|||
156728134|NCT03491462|565754001|FG000|Overall Study|Withdrawal by Subject|22|||
156728135|NCT03491462|565754002|FG001|Overall Study|Withdrawal by Subject|15|||
156728136|NCT00740792|565754003|FG000|Overall Study|Adverse Event|3|||
156728137|NCT00740792|565754004|FG001|Overall Study|Adverse Event|1|||
156728138|NCT00740792|565754005|FG002|Overall Study|Adverse Event|1|||
156728139|NCT00740792|565754006|FG003|Overall Study|Adverse Event|3|||
156728140|NCT00740792|565754003|FG000|Overall Study|Lack of Efficacy|1|||
156454627|NCT04492722|564759300|FG003|Overall Study|Failure to meet randomisation criteria|2|||
156533577|NCT00578786|565048867|FG002|Overall Study|Lack of Efficacy|2|||
156728141|NCT00740792|565754004|FG001|Overall Study|Lack of Efficacy|1|||
156728142|NCT00740792|565754005|FG002|Overall Study|Lack of Efficacy|0|||
156728143|NCT00740792|565754006|FG003|Overall Study|Lack of Efficacy|3|||
156728144|NCT00740792|565754003|FG000|Overall Study|Lost to Follow-up|2|||
156728145|NCT00740792|565754004|FG001|Overall Study|Lost to Follow-up|1|||
156728146|NCT00740792|565754005|FG002|Overall Study|Lost to Follow-up|0|||
156728147|NCT00740792|565754006|FG003|Overall Study|Lost to Follow-up|0|||
156728148|NCT00740792|565754003|FG000|Overall Study|Protocol Violation|0|||
156728149|NCT00740792|565754004|FG001|Overall Study|Protocol Violation|1|||
156728150|NCT00740792|565754005|FG002|Overall Study|Protocol Violation|0|||
156728151|NCT00740792|565754006|FG003|Overall Study|Protocol Violation|2|||
156728152|NCT00740792|565754003|FG000|Overall Study|Withdrawal by Subject|1|||
156728153|NCT00740792|565754004|FG001|Overall Study|Withdrawal by Subject|1|||
156728154|NCT00740792|565754005|FG002|Overall Study|Withdrawal by Subject|0|||
156728155|NCT00740792|565754006|FG003|Overall Study|Withdrawal by Subject|0|||
156728156|NCT00740792|565754003|FG000|Overall Study|administrative|3|||
156728157|NCT00740792|565754004|FG001|Overall Study|administrative|3|||
156454628|NCT04492722|564759297|FG000|Overall Study|Early termination from the study|54|||
156454629|NCT04492722|564759298|FG001|Overall Study|Early termination from the study|51|||
156454630|NCT04492722|564759299|FG002|Overall Study|Early termination from the study|50|||
156454631|NCT04492722|564759300|FG003|Overall Study|Early termination from the study|50|||
156454632|NCT04492722|564759297|FG000|Overall Study|Missing|3|||
156454633|NCT04492722|564759298|FG001|Overall Study|Missing|0|||
156454634|NCT04492722|564759299|FG002|Overall Study|Missing|0|||
156454635|NCT04492722|564759300|FG003|Overall Study|Missing|5|||
156454636|NCT04492722|564759297|FG000|Overall Study|Participants who did not receive treatment|0|||
156728158|NCT00740792|565754005|FG002|Overall Study|administrative|8|||
156728159|NCT00740792|565754006|FG003|Overall Study|administrative|2|||
156728160|NCT01455597|565754007|FG000|Overall Study|Adverse Event|7|||
156728161|NCT01455597|565754008|FG001|Overall Study|Adverse Event|0|||
156454637|NCT04492722|564759298|FG001|Overall Study|Participants who did not receive treatment|1|||
156454638|NCT04492722|564759299|FG002|Overall Study|Participants who did not receive treatment|4|||
156454639|NCT04492722|564759300|FG003|Overall Study|Participants who did not receive treatment|0|||
156454640|NCT04074759|564759301|FG000|Overall Study|Withdrawal by Subject|0|||
156454641|NCT04074759|564759302|FG001|Overall Study|Withdrawal by Subject|0|||
156454642|NCT04074759|564759303|FG002|Overall Study|Withdrawal by Subject|0|||
156454643|NCT04074759|564759304|FG003|Overall Study|Withdrawal by Subject|0|||
156454644|NCT04074759|564759305|FG004|Overall Study|Withdrawal by Subject|0|||
156454645|NCT04074759|564759306|FG005|Overall Study|Withdrawal by Subject|2|||
156454646|NCT04074759|564759307|FG006|Overall Study|Withdrawal by Subject|0|||
156454647|NCT04074759|564759308|FG007|Overall Study|Withdrawal by Subject|2|||
156454648|NCT04074759|564759309|FG008|Overall Study|Withdrawal by Subject|1|||
156454649|NCT04074759|564759310|FG009|Overall Study|Withdrawal by Subject|2|||
156454650|NCT04074759|564759311|FG010|Overall Study|Withdrawal by Subject|9|||
156454651|NCT04074759|564759312|FG011|Overall Study|Withdrawal by Subject|2|||
156454652|NCT04074759|564759313|FG012|Overall Study|Withdrawal by Subject|1|||
156454653|NCT04074759|564759314|FG013|Overall Study|Withdrawal by Subject|3|||
156454654|NCT04074759|564759315|FG014|Overall Study|Withdrawal by Subject|2|||
156454655|NCT04074759|564759316|FG015|Overall Study|Withdrawal by Subject|0|||
156728162|NCT01455597|565754009|FG002|Overall Study|Adverse Event|5|||
156728163|NCT01455597|565754010|FG003|Overall Study|Adverse Event|1|||
156728164|NCT01455597|565754007|FG000|Overall Study|Lack of Efficacy|0|||
156728165|NCT01455597|565754008|FG001|Overall Study|Lack of Efficacy|1|||
156728166|NCT01455597|565754009|FG002|Overall Study|Lack of Efficacy|2|||
156728167|NCT01455597|565754010|FG003|Overall Study|Lack of Efficacy|0|||
156728168|NCT01455597|565754007|FG000|Overall Study|Lost to Follow-up|3|||
156728169|NCT01455597|565754008|FG001|Overall Study|Lost to Follow-up|0|||
156728170|NCT01455597|565754009|FG002|Overall Study|Lost to Follow-up|2|||
156728171|NCT01455597|565754010|FG003|Overall Study|Lost to Follow-up|1|||
156728172|NCT01455597|565754007|FG000|Overall Study|Withdrew Consent|6|||
156728173|NCT01455597|565754008|FG001|Overall Study|Withdrew Consent|5|||
156728174|NCT01455597|565754009|FG002|Overall Study|Withdrew Consent|8|||
156728175|NCT01455597|565754010|FG003|Overall Study|Withdrew Consent|5|||
156728176|NCT01455597|565754007|FG000|Overall Study|Reason not Specified|1|||
156728177|NCT01455597|565754008|FG001|Overall Study|Reason not Specified|2|||
156728178|NCT01455597|565754009|FG002|Overall Study|Reason not Specified|3|||
156728179|NCT01455597|565754010|FG003|Overall Study|Reason not Specified|3|||
156728180|NCT01737710|565754012|FG000|Overall Study|Lost to Follow-up|0|||
156728181|NCT01737710|565754013|FG001|Overall Study|Lost to Follow-up|2|||
156728182|NCT01737710|565754014|FG002|Overall Study|Lost to Follow-up|2|||
156728183|NCT01737710|565754015|FG003|Overall Study|Lost to Follow-up|0|||
156728184|NCT01737710|565754016|FG004|Overall Study|Lost to Follow-up|0|||
156728185|NCT01737710|565754012|FG000|Overall Study|Withdrawal by Subject|1|||
156728186|NCT01737710|565754013|FG001|Overall Study|Withdrawal by Subject|1|||
156728187|NCT01737710|565754014|FG002|Overall Study|Withdrawal by Subject|1|||
156728188|NCT01737710|565754015|FG003|Overall Study|Withdrawal by Subject|0|||
156728189|NCT01737710|565754016|FG004|Overall Study|Withdrawal by Subject|0|||
156728190|NCT01737710|565754012|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
156728191|NCT01737710|565754013|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
156795926|NCT01435356|566006211|FG000|Overall Study|Protocol Violation|0|||
156454656|NCT04074759|564759317|FG016|Overall Study|Withdrawal by Subject|0|||
156454657|NCT04074759|564759318|FG017|Overall Study|Withdrawal by Subject|3|||
156454658|NCT04074759|564759319|FG018|Overall Study|Withdrawal by Subject|1|||
156454659|NCT04074759|564759301|FG000|Overall Study|Death|1|||
156454660|NCT04074759|564759302|FG001|Overall Study|Death|0|||
156454661|NCT04074759|564759303|FG002|Overall Study|Death|1|||
156728192|NCT01737710|565754014|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
156728193|NCT01737710|565754015|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
156728194|NCT01737710|565754016|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
156728195|NCT03412734|565754020|FG000|Overall Study|Incorrect labeling of samples|2|||
156728196|NCT03412734|565754021|FG001|Overall Study|Incorrect labeling of samples|0|||
156728197|NCT03412734|565754020|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
156728198|NCT03412734|565754021|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
156728199|NCT00423332|565754022|FG000|Overall Study|Adverse Event|6|||
156728200|NCT00423332|565754023|FG001|Overall Study|Adverse Event|2|||
156728201|NCT00423332|565754022|FG000|Overall Study|Withdrawal by Subject|1|||
156728202|NCT00423332|565754023|FG001|Overall Study|Withdrawal by Subject|0|||
156728203|NCT00423332|565754022|FG000|Overall Study|Condition under investigation worsened|1|||
156728204|NCT00423332|565754023|FG001|Overall Study|Condition under investigation worsened|1|||
156728205|NCT00423332|565754022|FG000|Overall Study|Progressive at Week 6|0|||
156728206|NCT00423332|565754023|FG001|Overall Study|Progressive at Week 6|1|||
156728207|NCT00423332|565754022|FG000|Overall Study|Unblinded before 12 weeks|1|||
156728208|NCT00423332|565754023|FG001|Overall Study|Unblinded before 12 weeks|3|||
156728209|NCT00685399|565754026|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156728210|NCT00685399|565754027|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156728211|NCT00685399|565754028|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156728212|NCT00685399|565754029|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156728213|NCT00685399|565754030|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156728214|NCT00685399|565754031|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156728215|NCT00685399|565754032|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156728216|NCT00685399|565754033|FG007|Treatment Period 1|Withdrawal by Subject|0|||
156728217|NCT00685399|565754026|FG000|Treatment Period 1|Protocol Violation|1|||
156728218|NCT00685399|565754027|FG001|Treatment Period 1|Protocol Violation|0|||
156728219|NCT00685399|565754028|FG002|Treatment Period 1|Protocol Violation|0|||
156728220|NCT00685399|565754029|FG003|Treatment Period 1|Protocol Violation|0|||
156728221|NCT00685399|565754030|FG004|Treatment Period 1|Protocol Violation|0|||
156728222|NCT00685399|565754031|FG005|Treatment Period 1|Protocol Violation|0|||
156728223|NCT00685399|565754032|FG006|Treatment Period 1|Protocol Violation|0|||
156728224|NCT00685399|565754033|FG007|Treatment Period 1|Protocol Violation|0|||
156728225|NCT00685399|565754026|FG000|Treatment Period 1|Administrative|2|||
156728226|NCT00685399|565754027|FG001|Treatment Period 1|Administrative|0|||
156728227|NCT00685399|565754028|FG002|Treatment Period 1|Administrative|0|||
156728228|NCT00685399|565754029|FG003|Treatment Period 1|Administrative|0|||
156728229|NCT00685399|565754030|FG004|Treatment Period 1|Administrative|0|||
156728230|NCT00685399|565754031|FG005|Treatment Period 1|Administrative|0|||
156728231|NCT00685399|565754032|FG006|Treatment Period 1|Administrative|0|||
156728232|NCT00685399|565754033|FG007|Treatment Period 1|Administrative|0|||
156728233|NCT00685399|565754026|FG000|Treatment Period 1|Lack of Efficacy|1|||
156728234|NCT00685399|565754027|FG001|Treatment Period 1|Lack of Efficacy|0|||
156728235|NCT00685399|565754028|FG002|Treatment Period 1|Lack of Efficacy|0|||
156728236|NCT00685399|565754029|FG003|Treatment Period 1|Lack of Efficacy|0|||
156728237|NCT00685399|565754030|FG004|Treatment Period 1|Lack of Efficacy|0|||
156728238|NCT00685399|565754031|FG005|Treatment Period 1|Lack of Efficacy|0|||
156728239|NCT00685399|565754032|FG006|Treatment Period 1|Lack of Efficacy|0|||
156728240|NCT00685399|565754033|FG007|Treatment Period 1|Lack of Efficacy|0|||
156728241|NCT00685399|565754026|FG000|Treatment Period 2|Administrative Problems|0|||
156728242|NCT00685399|565754027|FG001|Treatment Period 2|Administrative Problems|2|||
156728243|NCT00685399|565754028|FG002|Treatment Period 2|Administrative Problems|1|||
156728244|NCT00685399|565754029|FG003|Treatment Period 2|Administrative Problems|0|||
156728245|NCT00685399|565754030|FG004|Treatment Period 2|Administrative Problems|0|||
156728246|NCT00685399|565754031|FG005|Treatment Period 2|Administrative Problems|0|||
156728247|NCT00685399|565754032|FG006|Treatment Period 2|Administrative Problems|0|||
156728248|NCT00685399|565754033|FG007|Treatment Period 2|Administrative Problems|0|||
156728249|NCT00685399|565754026|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156728250|NCT00685399|565754027|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156728251|NCT00685399|565754028|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156728252|NCT00685399|565754029|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156728253|NCT00685399|565754030|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156728254|NCT00685399|565754031|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156728255|NCT00685399|565754032|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156728256|NCT00685399|565754033|FG007|Treatment Period 2|Withdrawal by Subject|2|||
156728257|NCT00685399|565754026|FG000|Treatment Period 2|Adverse Event|0|||
156728258|NCT00685399|565754027|FG001|Treatment Period 2|Adverse Event|0|||
156728259|NCT00685399|565754028|FG002|Treatment Period 2|Adverse Event|0|||
156728260|NCT00685399|565754029|FG003|Treatment Period 2|Adverse Event|0|||
156728261|NCT00685399|565754030|FG004|Treatment Period 2|Adverse Event|0|||
156728262|NCT00685399|565754031|FG005|Treatment Period 2|Adverse Event|1|||
156728263|NCT00685399|565754032|FG006|Treatment Period 2|Adverse Event|0|||
156728264|NCT00685399|565754033|FG007|Treatment Period 2|Adverse Event|0|||
156728265|NCT00685399|565754026|FG000|Treatment Period 2|Lack of Efficacy|0|||
156795927|NCT01435356|566006212|FG001|Overall Study|Protocol Violation|1|||
156795928|NCT01435356|566006211|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
156808808|NCT01484496|566054473|FG000|Period 1|Physician Decision|5|||
156728266|NCT00685399|565754027|FG001|Treatment Period 2|Lack of Efficacy|10|||
156728267|NCT00685399|565754028|FG002|Treatment Period 2|Lack of Efficacy|2|||
156728268|NCT00685399|565754029|FG003|Treatment Period 2|Lack of Efficacy|0|||
156728269|NCT00685399|565754030|FG004|Treatment Period 2|Lack of Efficacy|0|||
156728270|NCT00685399|565754031|FG005|Treatment Period 2|Lack of Efficacy|1|||
156728271|NCT00685399|565754032|FG006|Treatment Period 2|Lack of Efficacy|0|||
156454662|NCT04074759|564759304|FG003|Overall Study|Death|1|||
156454663|NCT04074759|564759305|FG004|Overall Study|Death|2|||
156454664|NCT04074759|564759306|FG005|Overall Study|Death|0|||
156454665|NCT04074759|564759307|FG006|Overall Study|Death|1|||
156454666|NCT04074759|564759308|FG007|Overall Study|Death|0|||
156454667|NCT04074759|564759309|FG008|Overall Study|Death|3|||
156454668|NCT04074759|564759310|FG009|Overall Study|Death|2|||
156454669|NCT04074759|564759311|FG010|Overall Study|Death|4|||
156454670|NCT04074759|564759312|FG011|Overall Study|Death|1|||
156454671|NCT04074759|564759313|FG012|Overall Study|Death|0|||
156454672|NCT04074759|564759314|FG013|Overall Study|Death|2|||
156454673|NCT04074759|564759315|FG014|Overall Study|Death|1|||
156454674|NCT04074759|564759316|FG015|Overall Study|Death|0|||
156454675|NCT04074759|564759317|FG016|Overall Study|Death|1|||
156454676|NCT04074759|564759318|FG017|Overall Study|Death|0|||
156454677|NCT04074759|564759319|FG018|Overall Study|Death|1|||
156454678|NCT04074759|564759301|FG000|Overall Study|Lost to Follow-up|0|||
156454679|NCT04074759|564759302|FG001|Overall Study|Lost to Follow-up|0|||
156454680|NCT04074759|564759303|FG002|Overall Study|Lost to Follow-up|0|||
156454681|NCT04074759|564759304|FG003|Overall Study|Lost to Follow-up|0|||
156454682|NCT04074759|564759305|FG004|Overall Study|Lost to Follow-up|0|||
156454683|NCT04074759|564759306|FG005|Overall Study|Lost to Follow-up|0|||
156454684|NCT04074759|564759307|FG006|Overall Study|Lost to Follow-up|0|||
156454685|NCT04074759|564759308|FG007|Overall Study|Lost to Follow-up|0|||
156454686|NCT04074759|564759309|FG008|Overall Study|Lost to Follow-up|0|||
156454687|NCT04074759|564759310|FG009|Overall Study|Lost to Follow-up|0|||
156454688|NCT04074759|564759311|FG010|Overall Study|Lost to Follow-up|1|||
156454689|NCT04074759|564759312|FG011|Overall Study|Lost to Follow-up|0|||
156454690|NCT04074759|564759313|FG012|Overall Study|Lost to Follow-up|0|||
156454691|NCT04074759|564759314|FG013|Overall Study|Lost to Follow-up|0|||
156454692|NCT04074759|564759315|FG014|Overall Study|Lost to Follow-up|0|||
156454693|NCT04074759|564759316|FG015|Overall Study|Lost to Follow-up|0|||
156454694|NCT04074759|564759317|FG016|Overall Study|Lost to Follow-up|1|||
156454695|NCT04074759|564759318|FG017|Overall Study|Lost to Follow-up|0|||
156454696|NCT04074759|564759319|FG018|Overall Study|Lost to Follow-up|1|||
156454697|NCT04074759|564759301|FG000|Overall Study|Other|0|||
156454698|NCT04074759|564759302|FG001|Overall Study|Other|1|||
156454699|NCT04074759|564759303|FG002|Overall Study|Other|1|||
156454700|NCT04074759|564759304|FG003|Overall Study|Other|0|||
156454701|NCT04074759|564759305|FG004|Overall Study|Other|2|||
156454702|NCT04074759|564759306|FG005|Overall Study|Other|1|||
156454703|NCT04074759|564759307|FG006|Overall Study|Other|2|||
156454704|NCT04074759|564759308|FG007|Overall Study|Other|1|||
156454705|NCT04074759|564759309|FG008|Overall Study|Other|1|||
156454706|NCT04074759|564759310|FG009|Overall Study|Other|4|||
156454707|NCT04074759|564759311|FG010|Overall Study|Other|4|||
156454708|NCT04074759|564759312|FG011|Overall Study|Other|2|||
156728272|NCT00685399|565754033|FG007|Treatment Period 2|Lack of Efficacy|0|||
156728273|NCT00685399|565754026|FG000|Extension|Administrative Issues|0|||
156728274|NCT00685399|565754027|FG001|Extension|Administrative Issues|0|||
156728275|NCT00685399|565754028|FG002|Extension|Administrative Issues|0|||
156728276|NCT00685399|565754029|FG003|Extension|Administrative Issues|1|||
156728277|NCT00685399|565754030|FG004|Extension|Administrative Issues|0|||
156728278|NCT00685399|565754031|FG005|Extension|Administrative Issues|0|||
156454709|NCT04074759|564759313|FG012|Overall Study|Other|0|||
156454710|NCT04074759|564759314|FG013|Overall Study|Other|0|||
156533578|NCT00578786|565048865|FG000|Overall Study|Early Escape from Prior Study|2|||
156728279|NCT00685399|565754032|FG006|Extension|Administrative Issues|0|||
156728280|NCT00685399|565754033|FG007|Extension|Administrative Issues|0|||
156728281|NCT00685399|565754026|FG000|Extension|Withdrawal by Subject|0|||
156728282|NCT00685399|565754027|FG001|Extension|Withdrawal by Subject|0|||
156728283|NCT00685399|565754028|FG002|Extension|Withdrawal by Subject|0|||
156728284|NCT00685399|565754029|FG003|Extension|Withdrawal by Subject|1|||
156728285|NCT00685399|565754030|FG004|Extension|Withdrawal by Subject|0|||
156728286|NCT00685399|565754031|FG005|Extension|Withdrawal by Subject|0|||
156728287|NCT00685399|565754032|FG006|Extension|Withdrawal by Subject|0|||
156728288|NCT00685399|565754033|FG007|Extension|Withdrawal by Subject|0|||
156728289|NCT00685399|565754026|FG000|Extension|Protocol Violation|0|||
156728290|NCT00685399|565754027|FG001|Extension|Protocol Violation|0|||
156728291|NCT00685399|565754028|FG002|Extension|Protocol Violation|0|||
156454711|NCT04074759|564759315|FG014|Overall Study|Other|0|||
156454712|NCT04074759|564759316|FG015|Overall Study|Other|1|||
156454713|NCT04074759|564759317|FG016|Overall Study|Other|0|||
156454714|NCT04074759|564759318|FG017|Overall Study|Other|0|||
156454715|NCT04074759|564759319|FG018|Overall Study|Other|0|||
156454716|NCT04074759|564759301|FG000|Overall Study|Missing end of study status|0|||
156454717|NCT04074759|564759302|FG001|Overall Study|Missing end of study status|0|||
156454718|NCT04074759|564759303|FG002|Overall Study|Missing end of study status|0|||
156454719|NCT04074759|564759304|FG003|Overall Study|Missing end of study status|0|||
156728292|NCT00685399|565754029|FG003|Extension|Protocol Violation|1|||
156728293|NCT00685399|565754030|FG004|Extension|Protocol Violation|0|||
156728294|NCT00685399|565754031|FG005|Extension|Protocol Violation|0|||
156728295|NCT00685399|565754032|FG006|Extension|Protocol Violation|0|||
156454720|NCT04074759|564759305|FG004|Overall Study|Missing end of study status|0|||
156454721|NCT04074759|564759306|FG005|Overall Study|Missing end of study status|0|||
156454722|NCT04074759|564759307|FG006|Overall Study|Missing end of study status|0|||
156454723|NCT04074759|564759308|FG007|Overall Study|Missing end of study status|0|||
156454724|NCT04074759|564759309|FG008|Overall Study|Missing end of study status|0|||
156454725|NCT04074759|564759310|FG009|Overall Study|Missing end of study status|0|||
156454726|NCT04074759|564759311|FG010|Overall Study|Missing end of study status|2|||
156533579|NCT00578786|565048866|FG001|Overall Study|Early Escape from Prior Study|1|||
156728296|NCT00685399|565754033|FG007|Extension|Protocol Violation|0|||
156728297|NCT00685399|565754026|FG000|Extension|Lack of Efficacy|0|||
156728298|NCT00685399|565754027|FG001|Extension|Lack of Efficacy|0|||
156728299|NCT00685399|565754028|FG002|Extension|Lack of Efficacy|0|||
156728300|NCT00685399|565754029|FG003|Extension|Lack of Efficacy|2|||
156728301|NCT00685399|565754030|FG004|Extension|Lack of Efficacy|0|||
156728302|NCT00685399|565754031|FG005|Extension|Lack of Efficacy|0|||
156728303|NCT00685399|565754032|FG006|Extension|Lack of Efficacy|0|||
156728304|NCT00685399|565754033|FG007|Extension|Lack of Efficacy|0|||
156728305|NCT00685399|565754026|FG000|Extension|Adverse Event|0|||
156728306|NCT00685399|565754027|FG001|Extension|Adverse Event|0|||
156728307|NCT00685399|565754028|FG002|Extension|Adverse Event|0|||
156728308|NCT00685399|565754029|FG003|Extension|Adverse Event|2|||
156728309|NCT00685399|565754030|FG004|Extension|Adverse Event|0|||
156728310|NCT00685399|565754031|FG005|Extension|Adverse Event|0|||
156728311|NCT00685399|565754032|FG006|Extension|Adverse Event|0|||
156728312|NCT00685399|565754033|FG007|Extension|Adverse Event|0|||
156728313|NCT02993250|565754034|FG000|Overall Study|Lost to Follow-up|0|||
156728314|NCT02993250|565754035|FG001|Overall Study|Lost to Follow-up|1|||
156795929|NCT01435356|566006212|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
156795930|NCT01435356|566006211|FG000|Overall Study|Withdrawal by Subject|1|||
156795931|NCT01435356|566006212|FG001|Overall Study|Withdrawal by Subject|1|||
156795932|NCT01435356|566006211|FG000|Overall Study|Facial palsy|1|||
156795933|NCT01435356|566006212|FG001|Overall Study|Facial palsy|0|||
156876363|NCT00545272|566305800|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156876364|NCT00545272|566305801|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156876365|NCT00545272|566305802|FG003|Overall Study|Abnormal test procedure result(s)|0|||
156876366|NCT00545272|566305803|FG004|Overall Study|Abnormal test procedure result(s)|1|||
156876367|NCT00545272|566305804|FG005|Overall Study|Abnormal test procedure result(s)|0|||
156876368|NCT00545272|566305799|FG000|Overall Study|Lost to Follow-up|0|||
156876369|NCT00545272|566305800|FG001|Overall Study|Lost to Follow-up|0|||
156876370|NCT00545272|566305801|FG002|Overall Study|Lost to Follow-up|0|||
156876371|NCT00545272|566305802|FG003|Overall Study|Lost to Follow-up|0|||
156876372|NCT00545272|566305803|FG004|Overall Study|Lost to Follow-up|1|||
156876373|NCT00545272|566305804|FG005|Overall Study|Lost to Follow-up|0|||
156876374|NCT02314637|566305805|FG000|Overall Study|Adverse Event|4|||
156876375|NCT02314637|566305806|FG001|Overall Study|Adverse Event|8|||
156876376|NCT02314637|566305805|FG000|Overall Study|Lack of Efficacy|1|||
156876377|NCT02314637|566305806|FG001|Overall Study|Lack of Efficacy|0|||
156876378|NCT02314637|566305805|FG000|Overall Study|Physician Decision|5|||
156876379|NCT02314637|566305806|FG001|Overall Study|Physician Decision|2|||
156876380|NCT02314637|566305805|FG000|Overall Study|Withdrawal by Subject|5|||
156876381|NCT02314637|566305806|FG001|Overall Study|Withdrawal by Subject|4|||
156876382|NCT02314637|566305805|FG000|Overall Study|Other Reason|1|||
156454727|NCT04074759|564759312|FG011|Overall Study|Missing end of study status|0|||
156795934|NCT01435356|566006211|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
156795935|NCT01435356|566006212|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
156795936|NCT01435356|566006211|FG000|Overall Study|Physician Decision|1|||
156795937|NCT01435356|566006212|FG001|Overall Study|Physician Decision|0|||
156795938|NCT01435356|566006211|FG000|Overall Study|Patient decision|3|||
156795939|NCT01435356|566006212|FG001|Overall Study|Patient decision|0|||
156795940|NCT01435356|566006211|FG000|Overall Study|Patient moved to another city|1|||
156795941|NCT01435356|566006212|FG001|Overall Study|Patient moved to another city|1|||
156795942|NCT02796651|566006213|FG000|Overall Study|Adverse Event|6|||
156795943|NCT02796651|566006213|FG000|Overall Study|Lost to Follow-up|1|||
156795944|NCT02796651|566006213|FG000|Overall Study|Withdrawal by Subject|4|||
156795945|NCT02796651|566006213|FG000|Overall Study|Protocol Violation|4|||
156876383|NCT02314637|566305806|FG001|Overall Study|Other Reason|0|||
156876384|NCT02934503|566305807|FG000|Overall Study|progression of disease|3|||
156876385|NCT02934503|566305807|FG000|Overall Study|Withdrawal by Subject|1|||
156876386|NCT00724867|566305808|FG000|Overall Study|Adverse Event|25|||
156533580|NCT00578786|565048867|FG002|Overall Study|Early Escape from Prior Study|2|||
156454728|NCT04074759|564759313|FG012|Overall Study|Missing end of study status|0|||
156728315|NCT00356148|565754036|FG000|Overall Study|Reoperation within 30 days|2|||
156728316|NCT00356148|565754037|FG001|Overall Study|Reoperation within 30 days|1|||
156795946|NCT02796651|566006213|FG000|Overall Study|Lack of Efficacy|1|||
156795947|NCT02796651|566006213|FG000|Overall Study|Other|10|||
156795948|NCT02251041|566006217|FG000|Overall Study|Did not receive intervention|15|||
156728317|NCT02737930|565754039|FG000|Overall Study|Withdrawal by Subject|0|||
156728318|NCT02737930|565754040|FG001|Overall Study|Withdrawal by Subject|1|||
156728319|NCT04481789|565754041|FG000|Period 1|Withdrawal by Subject|1|||
156728320|NCT04481789|565754042|FG001|Period 1|Withdrawal by Subject|0|||
156728321|NCT04481789|565754043|FG002|Period 1|Withdrawal by Subject|0|||
156728322|NCT04481789|565754044|FG003|Period 1|Withdrawal by Subject|0|||
156728323|NCT04481789|565754045|FG004|Period 1|Withdrawal by Subject|0|||
156728324|NCT04481789|565754046|FG005|Period 1|Withdrawal by Subject|0|||
156728325|NCT03124407|565754051|FG000|Overall Study|Lost to Follow-up|1|||
156728326|NCT03124407|565754052|FG001|Overall Study|Lost to Follow-up|0|||
156728327|NCT03124407|565754053|FG002|Overall Study|Lost to Follow-up|0|||
156795949|NCT02251041|566006218|FG001|Overall Study|Did not receive intervention|4|||
156795950|NCT02971163|566006221|FG000|Overall Study|Lost to Follow-up|4|||
156795951|NCT02971163|566006222|FG001|Overall Study|Lost to Follow-up|2|||
156795952|NCT00526799|566006223|FG000|Overall Study|Withdrawal by Subject|1|||
156795953|NCT00526799|566006224|FG001|Overall Study|Withdrawal by Subject|0|||
156795954|NCT00526799|566006223|FG000|Overall Study|Intercurrent Complicating Disease|0|||
156795955|NCT00526799|566006224|FG001|Overall Study|Intercurrent Complicating Disease|1|||
156795956|NCT02871219|566006226|FG000|Overall Study|Adverse Event|15|||
156795957|NCT02871219|566006226|FG000|Overall Study|Death|3|||
156795958|NCT02871219|566006226|FG000|Overall Study|Progression|3|||
156795959|NCT02871219|566006226|FG000|Overall Study|Infections|7|||
156795960|NCT02871219|566006226|FG000|Overall Study|Infusion Related|4|||
156795961|NCT00050011|566006228|FG000|Overall Study|Adverse Event|41|||
156795962|NCT00050011|566006229|FG001|Overall Study|Adverse Event|46|||
156795963|NCT00050011|566006228|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156795964|NCT00050011|566006229|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156795965|NCT00050011|566006228|FG000|Overall Study|Abnormal test procedure results|0|||
156795966|NCT00050011|566006229|FG001|Overall Study|Abnormal test procedure results|1|||
156795967|NCT00050011|566006228|FG000|Overall Study|Lack of Efficacy|16|||
156795968|NCT00050011|566006229|FG001|Overall Study|Lack of Efficacy|21|||
156795969|NCT00050011|566006228|FG000|Overall Study|Participant condition no longer required|1|||
156795970|NCT00050011|566006229|FG001|Overall Study|Participant condition no longer required|0|||
156795971|NCT00050011|566006228|FG000|Overall Study|Protocol Violation|4|||
156795972|NCT00050011|566006229|FG001|Overall Study|Protocol Violation|10|||
156795973|NCT00050011|566006228|FG000|Overall Study|Withdrawal by Subject|34|||
156795974|NCT00050011|566006229|FG001|Overall Study|Withdrawal by Subject|26|||
156795975|NCT00050011|566006228|FG000|Overall Study|Lost to Follow-up|7|||
156795976|NCT00050011|566006229|FG001|Overall Study|Lost to Follow-up|9|||
156795977|NCT00050011|566006228|FG000|Overall Study|Administrative problems|10|||
156795978|NCT00050011|566006229|FG001|Overall Study|Administrative problems|6|||
156795979|NCT00050011|566006228|FG000|Overall Study|Death|7|||
156795980|NCT00050011|566006229|FG001|Overall Study|Death|4|||
156795981|NCT00050011|566006228|FG000|Overall Study|Unknown - Reason is missing|0|||
156795982|NCT00050011|566006229|FG001|Overall Study|Unknown - Reason is missing|2|||
156795983|NCT00835354|566006230|FG000|First Intervention|Adverse Event|0|||
156795984|NCT00835354|566006231|FG001|First Intervention|Adverse Event|1|||
156795985|NCT02061085|566006232|FG000|Overall Study|Adverse Event|8|||
156795986|NCT02038036|566006234|FG000|Core Study|Adverse Event|7|||
156795987|NCT02038036|566006235|FG001|Core Study|Adverse Event|7|||
156795988|NCT02038036|566006234|FG000|Core Study|Death|1|||
156795989|NCT02038036|566006235|FG001|Core Study|Death|1|||
156795990|NCT02038036|566006234|FG000|Core Study|Disease progression|2|||
156795991|NCT02038036|566006235|FG001|Core Study|Disease progression|2|||
156795992|NCT02038036|566006234|FG000|Core Study|Lost to Follow-up|0|||
156795993|NCT02038036|566006235|FG001|Core Study|Lost to Follow-up|1|||
156795994|NCT02038036|566006234|FG000|Core Study|Physician Decision|2|||
156795995|NCT02038036|566006235|FG001|Core Study|Physician Decision|1|||
156795996|NCT02038036|566006234|FG000|Core Study|Subject/guardian decision|0|||
156795997|NCT02038036|566006235|FG001|Core Study|Subject/guardian decision|1|||
156795998|NCT02038036|566006234|FG000|Core Study|Withdrawal by Subject|3|||
156876387|NCT00724867|566305808|FG000|Overall Study|Lack of Efficacy|14|||
156876388|NCT00724867|566305808|FG000|Overall Study|Lost to Follow-up|12|||
156795999|NCT02038036|566006235|FG001|Core Study|Withdrawal by Subject|1|||
156796000|NCT02038036|566006234|FG000|Crossover Period|Withdrawal by Subject|0|||
156796001|NCT02038036|566006235|FG001|Crossover Period|Withdrawal by Subject|3|||
156796002|NCT02038036|566006234|FG000|Crossover Period|Adverse Event|0|||
156796003|NCT02038036|566006235|FG001|Crossover Period|Adverse Event|9|||
156876389|NCT00724867|566305808|FG000|Overall Study|Non-compliance with study drug|6|||
156728328|NCT03124407|565754054|FG003|Overall Study|Lost to Follow-up|0|||
156796004|NCT02038036|566006234|FG000|Crossover Period|Death|0|||
156796005|NCT02038036|566006235|FG001|Crossover Period|Death|2|||
156796006|NCT02038036|566006234|FG000|Crossover Period|Disease progression|0|||
156796007|NCT02038036|566006235|FG001|Crossover Period|Disease progression|3|||
156796008|NCT02038036|566006234|FG000|Crossover Period|Lost to Follow-up|0|||
156796009|NCT02038036|566006235|FG001|Crossover Period|Lost to Follow-up|1|||
156796010|NCT02038036|566006234|FG000|Crossover Period|Physician Decision|0|||
156796011|NCT02038036|566006235|FG001|Crossover Period|Physician Decision|2|||
156796012|NCT02613507|566006240|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
156796013|NCT02613507|566006241|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
156454729|NCT04074759|564759314|FG013|Overall Study|Missing end of study status|0|||
156454730|NCT04074759|564759315|FG014|Overall Study|Missing end of study status|0|||
156454731|NCT04074759|564759316|FG015|Overall Study|Missing end of study status|0|||
156454732|NCT04074759|564759317|FG016|Overall Study|Missing end of study status|1|||
156728329|NCT03124407|565754051|FG000|Overall Study|Adverse Event|0|||
156728330|NCT03124407|565754052|FG001|Overall Study|Adverse Event|0|||
156728331|NCT03124407|565754053|FG002|Overall Study|Adverse Event|1|||
156728332|NCT03124407|565754054|FG003|Overall Study|Adverse Event|0|||
156454733|NCT04074759|564759318|FG017|Overall Study|Missing end of study status|0|||
156454734|NCT04074759|564759319|FG018|Overall Study|Missing end of study status|0|||
156454735|NCT03631784|564759321|FG000|Overall Study|Participants Ongoing|1|||
156454736|NCT03631784|564759322|FG001|Overall Study|Participants Ongoing|0|||
156454737|NCT03631784|564759321|FG000|Overall Study|Withdrawal by Subject|3|||
156454738|NCT03631784|564759322|FG001|Overall Study|Withdrawal by Subject|3|||
156454739|NCT03631784|564759321|FG000|Overall Study|Sponsor's Decision|36|||
156454740|NCT03631784|564759322|FG001|Overall Study|Sponsor's Decision|52|||
156454741|NCT03631784|564759321|FG000|Overall Study|Lost to Follow-up|1|||
156454742|NCT03631784|564759322|FG001|Overall Study|Lost to Follow-up|0|||
156454743|NCT03631784|564759321|FG000|Overall Study|Death|71|||
156454744|NCT03631784|564759322|FG001|Overall Study|Death|49|||
156454745|NCT05329220|564759323|FG000|Active Trial Period|Adverse Event|0|||
156454746|NCT05329220|564759324|FG001|Active Trial Period|Adverse Event|0|||
156454747|NCT05329220|564759325|FG002|Active Trial Period|Adverse Event|0|||
156454748|NCT05329220|564759326|FG003|Active Trial Period|Adverse Event|0|||
156454749|NCT05329220|564759327|FG004|Active Trial Period|Adverse Event|1|||
156454750|NCT05329220|564759328|FG005|Active Trial Period|Adverse Event|0|||
156454751|NCT05329220|564759323|FG000|Active Trial Period|Lost to Follow-up|0|||
156454752|NCT05329220|564759324|FG001|Active Trial Period|Lost to Follow-up|0|||
156454753|NCT05329220|564759325|FG002|Active Trial Period|Lost to Follow-up|0|||
156454754|NCT05329220|564759326|FG003|Active Trial Period|Lost to Follow-up|0|||
156454755|NCT05329220|564759327|FG004|Active Trial Period|Lost to Follow-up|32|||
156454756|NCT05329220|564759328|FG005|Active Trial Period|Lost to Follow-up|28|||
156454757|NCT05329220|564759323|FG000|Active Trial Period|Physician Decision|0|||
156454758|NCT05329220|564759324|FG001|Active Trial Period|Physician Decision|0|||
156454759|NCT05329220|564759325|FG002|Active Trial Period|Physician Decision|0|||
156454760|NCT05329220|564759326|FG003|Active Trial Period|Physician Decision|0|||
156454761|NCT05329220|564759327|FG004|Active Trial Period|Physician Decision|2|||
156454762|NCT05329220|564759328|FG005|Active Trial Period|Physician Decision|0|||
156454763|NCT05329220|564759323|FG000|Active Trial Period|Protocol Violation|0|||
156454764|NCT05329220|564759324|FG001|Active Trial Period|Protocol Violation|0|||
156454765|NCT05329220|564759325|FG002|Active Trial Period|Protocol Violation|0|||
156454766|NCT05329220|564759326|FG003|Active Trial Period|Protocol Violation|0|||
156454767|NCT05329220|564759327|FG004|Active Trial Period|Protocol Violation|1|||
156454768|NCT05329220|564759328|FG005|Active Trial Period|Protocol Violation|3|||
156454769|NCT05329220|564759323|FG000|Active Trial Period|Withdrawal by Subject|0|||
156454770|NCT05329220|564759324|FG001|Active Trial Period|Withdrawal by Subject|0|||
156454771|NCT05329220|564759325|FG002|Active Trial Period|Withdrawal by Subject|0|||
156454772|NCT05329220|564759326|FG003|Active Trial Period|Withdrawal by Subject|1|||
156454773|NCT05329220|564759327|FG004|Active Trial Period|Withdrawal by Subject|12|||
156454774|NCT05329220|564759328|FG005|Active Trial Period|Withdrawal by Subject|13|||
156454775|NCT05329220|564759323|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
156454776|NCT05329220|564759324|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
156454777|NCT05329220|564759325|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
156454778|NCT05329220|564759326|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
156454779|NCT05329220|564759327|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
156454780|NCT05329220|564759328|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
156728333|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
156728334|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
156454781|NCT05329220|564759323|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
156454782|NCT05329220|564759324|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
156454783|NCT05329220|564759325|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
156454784|NCT05329220|564759326|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
156454785|NCT05329220|564759327|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
156454786|NCT05329220|564759328|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
156454787|NCT05329220|564759323|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
156454788|NCT05329220|564759324|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
156454789|NCT05329220|564759325|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
156728335|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
156728336|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
156876390|NCT00724867|566305808|FG000|Overall Study|Physician Decision|17|||
156876391|NCT00724867|566305808|FG000|Overall Study|Protocol Violation|1|||
156876392|NCT00724867|566305808|FG000|Overall Study|Withdrawal by Subject|31|||
156876393|NCT00724867|566305808|FG000|Overall Study|Sponsor decision to end study|14|||
156876394|NCT00724867|566305808|FG000|Overall Study|Subject incarcerated|1|||
156454790|NCT05329220|564759326|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
156454791|NCT05329220|564759327|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
156454792|NCT05329220|564759328|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
156454793|NCT05329220|564759323|FG000|Follow-up Period|Adverse Event|0|||
156454794|NCT05329220|564759324|FG001|Follow-up Period|Adverse Event|0|||
156454795|NCT05329220|564759325|FG002|Follow-up Period|Adverse Event|0|||
156454796|NCT05329220|564759326|FG003|Follow-up Period|Adverse Event|0|||
156454797|NCT05329220|564759327|FG004|Follow-up Period|Adverse Event|2|||
156454798|NCT05329220|564759328|FG005|Follow-up Period|Adverse Event|1|||
156454799|NCT05329220|564759323|FG000|Follow-up Period|Death|0|||
156454800|NCT05329220|564759324|FG001|Follow-up Period|Death|0|||
156454801|NCT05329220|564759325|FG002|Follow-up Period|Death|1|||
156454802|NCT05329220|564759326|FG003|Follow-up Period|Death|1|||
156454803|NCT05329220|564759327|FG004|Follow-up Period|Death|0|||
156454804|NCT05329220|564759328|FG005|Follow-up Period|Death|1|||
156454805|NCT05329220|564759323|FG000|Follow-up Period|Lost to Follow-up|0|||
156454806|NCT05329220|564759324|FG001|Follow-up Period|Lost to Follow-up|1|||
156454807|NCT05329220|564759325|FG002|Follow-up Period|Lost to Follow-up|2|||
156454808|NCT05329220|564759326|FG003|Follow-up Period|Lost to Follow-up|2|||
156454809|NCT05329220|564759327|FG004|Follow-up Period|Lost to Follow-up|113|||
156454810|NCT05329220|564759328|FG005|Follow-up Period|Lost to Follow-up|89|||
156454811|NCT05329220|564759323|FG000|Follow-up Period|Physician Decision|0|||
156728337|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
156728338|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
156728339|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
156728340|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
156728341|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
156728342|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
156728343|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
156728344|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
156728345|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
156728346|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
156728347|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728348|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728349|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728350|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728351|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
156728352|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
156728353|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728354|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728355|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728356|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728357|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
156728358|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
156728359|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
156728360|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
156728361|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
156728362|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
156728363|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728364|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
156728365|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728366|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728367|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728368|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728369|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
156728370|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
156728371|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
156876395|NCT00724867|566305808|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
156876396|NCT00724867|566305808|FG000|Overall Study|Subject moved out of state|1|||
156876397|NCT00724867|566305808|FG000|Overall Study|Elected to exit due to site closure|2|||
156876398|NCT00436345|566305809|FG000|Overall Study|ICU resident beyond follow-up period|3|||
156876399|NCT00436345|566305810|FG001|Overall Study|ICU resident beyond follow-up period|0|||
156454812|NCT05329220|564759324|FG001|Follow-up Period|Physician Decision|0|||
156454813|NCT05329220|564759325|FG002|Follow-up Period|Physician Decision|0|||
156454814|NCT05329220|564759326|FG003|Follow-up Period|Physician Decision|0|||
156454815|NCT05329220|564759327|FG004|Follow-up Period|Physician Decision|2|||
156454816|NCT05329220|564759328|FG005|Follow-up Period|Physician Decision|2|||
156728372|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
156728373|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
156728374|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
156728375|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
156728376|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
156728377|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
156728378|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
156728379|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
156728380|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
156728381|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728382|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728383|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
156728384|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
156728385|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728386|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728387|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728388|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728389|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
156728390|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
156728391|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728392|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728393|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728394|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728395|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
156728396|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728397|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728398|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728399|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728400|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728401|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728402|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
156728403|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728404|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728405|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728406|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728407|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
156728408|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728409|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728410|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728411|NCT02105987|565754058|FG000|Continuation Phase|Protocol Violation|0|||
156728412|NCT02105987|565754059|FG001|Continuation Phase|Protocol Violation|0|||
156796014|NCT02613507|566006240|FG000|Pre-Treamtent|Participant withdrew consent|0|||
156796015|NCT02613507|566006241|FG001|Pre-Treamtent|Participant withdrew consent|4|||
156796016|NCT02613507|566006240|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
156796017|NCT02613507|566006241|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
156796018|NCT02613507|566006240|FG000|Treatment|Not reported|3|||
156796019|NCT02613507|566006241|FG001|Treatment|Not reported|0|||
156796020|NCT02613507|566006240|FG000|Treatment|Other reasons|8|||
156796021|NCT02613507|566006241|FG001|Treatment|Other reasons|0|||
156796022|NCT02613507|566006240|FG000|Treatment|Participant no longer meets criteria|3|||
156796023|NCT02613507|566006241|FG001|Treatment|Participant no longer meets criteria|0|||
156796024|NCT02613507|566006240|FG000|Treatment|Maximum clinical benefit|5|||
156796025|NCT02613507|566006241|FG001|Treatment|Maximum clinical benefit|10|||
156796026|NCT02613507|566006240|FG000|Treatment|Lost to Follow-up|1|||
156796027|NCT02613507|566006241|FG001|Treatment|Lost to Follow-up|0|||
156796028|NCT02613507|566006240|FG000|Treatment|Participant withdrew consent|0|||
156796029|NCT02613507|566006241|FG001|Treatment|Participant withdrew consent|2|||
156796030|NCT02613507|566006240|FG000|Treatment|Participant request to discontinue study treatment|13|||
156796031|NCT02613507|566006241|FG001|Treatment|Participant request to discontinue study treatment|17|||
156796032|NCT02613507|566006240|FG000|Treatment|Adverse event unrelated to study drug|20|||
156796033|NCT02613507|566006241|FG001|Treatment|Adverse event unrelated to study drug|3|||
156796034|NCT02613507|566006240|FG000|Treatment|Death|2|||
156728413|NCT02105987|565754060|FG002|Continuation Phase|Protocol Violation|0|||
156796035|NCT02613507|566006241|FG001|Treatment|Death|0|||
156796036|NCT02613507|566006240|FG000|Treatment|Study drug toxicity|19|||
156796037|NCT02613507|566006241|FG001|Treatment|Study drug toxicity|14|||
156796038|NCT02613507|566006240|FG000|Treatment|Disease progression|263|||
156796039|NCT02613507|566006241|FG001|Treatment|Disease progression|110|||
156796040|NCT03648372|566006257|FG000|Overall Study|Withdrawal by Subject|2|||
156796041|NCT03648372|566006258|FG001|Overall Study|Withdrawal by Subject|0|||
156796042|NCT03648372|566006259|FG002|Overall Study|Withdrawal by Subject|0|||
156728414|NCT02105987|565754061|FG003|Continuation Phase|Protocol Violation|0|||
156728415|NCT02105987|565754062|FG004|Continuation Phase|Protocol Violation|1|||
156728416|NCT02105987|565754063|FG005|Continuation Phase|Protocol Violation|0|||
156728417|NCT00984542|565754076|FG000|Overall Study|disease progression|19|||
156728418|NCT00984542|565754076|FG000|Overall Study|toxicity|7|||
156728419|NCT00984542|565754076|FG000|Overall Study|Death|7|||
156728420|NCT00984542|565754076|FG000|Overall Study|complicating disease|3|||
156728421|NCT00984542|565754076|FG000|Overall Study|Withdrawal by Subject|3|||
156728422|NCT00984542|565754076|FG000|Overall Study|clinical deterioration|2|||
156728423|NCT02097745|565754081|FG000|Overall Study|Adverse Event|25|||
156728424|NCT02097745|565754081|FG000|Overall Study|Death|16|||
156728425|NCT02097745|565754081|FG000|Overall Study|Failure to Return|14|||
156728426|NCT02097745|565754081|FG000|Overall Study|Administrative/Other|27|||
156728427|NCT02097745|565754081|FG000|Overall Study|Reason Not Specified|96|||
156728428|NCT04468347|565754084|FG000|Overall Study|Withdrawal by Subject|0|||
156728429|NCT04468347|565754085|FG001|Overall Study|Withdrawal by Subject|1|||
156728430|NCT04468347|565754086|FG002|Overall Study|Withdrawal by Subject|3|||
156728431|NCT04468347|565754087|FG003|Overall Study|Withdrawal by Subject|3|||
156728432|NCT04468347|565754084|FG000|Overall Study|Lost to Follow-up|0|||
156728433|NCT04468347|565754085|FG001|Overall Study|Lost to Follow-up|0|||
156728434|NCT04468347|565754086|FG002|Overall Study|Lost to Follow-up|1|||
156728435|NCT04468347|565754087|FG003|Overall Study|Lost to Follow-up|1|||
156728436|NCT04468347|565754084|FG000|Overall Study|Physician Decision|1|||
156728437|NCT04468347|565754085|FG001|Overall Study|Physician Decision|0|||
156728438|NCT04468347|565754086|FG002|Overall Study|Physician Decision|2|||
156728439|NCT04468347|565754087|FG003|Overall Study|Physician Decision|0|||
156728440|NCT04468347|565754084|FG000|Overall Study|Protocol Violation|1|||
156728441|NCT04468347|565754085|FG001|Overall Study|Protocol Violation|0|||
156728442|NCT04468347|565754086|FG002|Overall Study|Protocol Violation|0|||
156454817|NCT05329220|564759323|FG000|Follow-up Period|Protocol Violation|0|||
156454818|NCT05329220|564759324|FG001|Follow-up Period|Protocol Violation|0|||
156454819|NCT05329220|564759325|FG002|Follow-up Period|Protocol Violation|0|||
156454820|NCT05329220|564759326|FG003|Follow-up Period|Protocol Violation|0|||
156454821|NCT05329220|564759327|FG004|Follow-up Period|Protocol Violation|0|||
156454822|NCT05329220|564759328|FG005|Follow-up Period|Protocol Violation|1|||
156454823|NCT05329220|564759323|FG000|Follow-up Period|Withdrawal by Subject|0|||
156454824|NCT05329220|564759324|FG001|Follow-up Period|Withdrawal by Subject|0|||
156454825|NCT05329220|564759325|FG002|Follow-up Period|Withdrawal by Subject|1|||
156728443|NCT04468347|565754087|FG003|Overall Study|Protocol Violation|0|||
156728444|NCT02505217|565754088|FG000|Overall Study|Withdrawal by Subject|1|||
156728445|NCT02505217|565754089|FG001|Overall Study|Withdrawal by Subject|2|||
156728446|NCT01408303|565754090|FG000|Overall Study|Adverse Event|3|||
156728447|NCT01408303|565754091|FG001|Overall Study|Adverse Event|7|||
156728448|NCT01408303|565754092|FG002|Overall Study|Adverse Event|2|||
156728449|NCT01408303|565754090|FG000|Overall Study|Lost to Follow-up|0|||
156728450|NCT01408303|565754091|FG001|Overall Study|Lost to Follow-up|1|||
156728451|NCT01408303|565754092|FG002|Overall Study|Lost to Follow-up|2|||
156728452|NCT01408303|565754090|FG000|Overall Study|Withdrawal by Subject|2|||
156728453|NCT01408303|565754091|FG001|Overall Study|Withdrawal by Subject|3|||
156728454|NCT01408303|565754092|FG002|Overall Study|Withdrawal by Subject|1|||
156728455|NCT01408303|565754090|FG000|Overall Study|Protocol Violation|0|||
156728456|NCT01408303|565754091|FG001|Overall Study|Protocol Violation|1|||
156728457|NCT01408303|565754092|FG002|Overall Study|Protocol Violation|0|||
156728458|NCT01408303|565754090|FG000|Overall Study|Noncompliance|1|||
156728459|NCT01408303|565754091|FG001|Overall Study|Noncompliance|0|||
156728460|NCT01408303|565754092|FG002|Overall Study|Noncompliance|1|||
156728461|NCT01207687|565754093|FG000|Overall Study|Adverse Event|1|||
156728462|NCT01207687|565754093|FG000|Overall Study|Withdrawal by Subject|1|||
156728463|NCT01801865|565754094|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
156728464|NCT01801865|565754094|FG000|Overall Study|Physician Decision|7|||
156728465|NCT01500382|565754097|FG000|Washout Period|Study site went out of business|0|||
156728466|NCT01500382|565754098|FG001|Washout Period|Study site went out of business|0|||
156796043|NCT03648372|566006260|FG003|Overall Study|Withdrawal by Subject|0|||
156454826|NCT05329220|564759326|FG003|Follow-up Period|Withdrawal by Subject|1|||
156454827|NCT05329220|564759327|FG004|Follow-up Period|Withdrawal by Subject|34|||
156454828|NCT05329220|564759328|FG005|Follow-up Period|Withdrawal by Subject|35|||
156454829|NCT05329220|564759323|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
156728467|NCT01500382|565754099|FG002|Washout Period|Study site went out of business|1|||
156728468|NCT01500382|565754100|FG003|Washout Period|Study site went out of business|0|||
156728469|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
156728470|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
156728471|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
156728472|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
156728473|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
156728474|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
156728475|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
156728476|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
156728477|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
156728478|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
156728479|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Adverse Event|5|||
156728480|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Adverse Event|11|||
156728481|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
156728482|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
156728483|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Physician Decision|6|||
156728484|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Physician Decision|3|||
156728485|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Pregnancy|2|||
156728486|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Pregnancy|2|||
156728487|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
156728488|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
156728489|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
156728490|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
156728491|NCT03867201|565754103|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
156728492|NCT03867201|565754104|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
156728493|NCT03867201|565754103|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
156728494|NCT03867201|565754104|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
156728495|NCT05763875|565754109|FG000|Overall Study|Subject decision|5|||
156728496|NCT05763875|565754110|FG001|Overall Study|Subject decision|2|||
156728497|NCT05763875|565754111|FG002|Overall Study|Subject decision|1|||
156728498|NCT05763875|565754109|FG000|Overall Study|Lost to Follow-up|4|||
156728499|NCT05763875|565754110|FG001|Overall Study|Lost to Follow-up|1|||
156728500|NCT05763875|565754111|FG002|Overall Study|Lost to Follow-up|2|||
156728501|NCT05763875|565754109|FG000|Overall Study|Adverse Event|1|||
156728502|NCT05763875|565754110|FG001|Overall Study|Adverse Event|0|||
156728503|NCT05763875|565754111|FG002|Overall Study|Adverse Event|0|||
156728504|NCT01777282|565754112|FG000|Overall Study|Persistent Hyperglycemia|0|||
156728505|NCT01777282|565754113|FG001|Overall Study|Persistent Hyperglycemia|0|||
156728506|NCT01777282|565754114|FG002|Overall Study|Persistent Hyperglycemia|1|||
156728507|NCT01777282|565754115|FG003|Overall Study|Persistent Hyperglycemia|0|||
156728508|NCT01777282|565754116|FG004|Overall Study|Persistent Hyperglycemia|0|||
156728509|NCT01777282|565754112|FG000|Overall Study|New Antidiabetic Medication|0|||
156728510|NCT01777282|565754113|FG001|Overall Study|New Antidiabetic Medication|0|||
156728511|NCT01777282|565754114|FG002|Overall Study|New Antidiabetic Medication|1|||
156728512|NCT01777282|565754115|FG003|Overall Study|New Antidiabetic Medication|0|||
156728513|NCT01777282|565754116|FG004|Overall Study|New Antidiabetic Medication|0|||
156728514|NCT01777282|565754112|FG000|Overall Study|Adverse Event|4|||
156728515|NCT01777282|565754113|FG001|Overall Study|Adverse Event|4|||
156728516|NCT01777282|565754114|FG002|Overall Study|Adverse Event|2|||
156728517|NCT01777282|565754115|FG003|Overall Study|Adverse Event|1|||
156728518|NCT01777282|565754116|FG004|Overall Study|Adverse Event|3|||
156728519|NCT01777282|565754112|FG000|Overall Study|Withdrawal by Subject|4|||
156728520|NCT01777282|565754113|FG001|Overall Study|Withdrawal by Subject|0|||
156728521|NCT01777282|565754114|FG002|Overall Study|Withdrawal by Subject|0|||
156728522|NCT01777282|565754115|FG003|Overall Study|Withdrawal by Subject|1|||
156728523|NCT01777282|565754116|FG004|Overall Study|Withdrawal by Subject|2|||
156728524|NCT01777282|565754112|FG000|Overall Study|Protocol Violation|2|||
156728525|NCT01777282|565754113|FG001|Overall Study|Protocol Violation|0|||
156728526|NCT01777282|565754114|FG002|Overall Study|Protocol Violation|1|||
156728527|NCT01777282|565754115|FG003|Overall Study|Protocol Violation|0|||
156728528|NCT01777282|565754116|FG004|Overall Study|Protocol Violation|2|||
156728529|NCT01777282|565754112|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
156728530|NCT01777282|565754113|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
156728531|NCT01777282|565754114|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
156728532|NCT01777282|565754115|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
156728533|NCT01777282|565754116|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
156876400|NCT01311024|566305811|FG000|Overall Study|Protocol Violation|35|||
156876401|NCT01311024|566305812|FG001|Overall Study|Protocol Violation|22|||
156876402|NCT01092546|566305813|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
156876403|NCT02280408|566305814|FG000|Overall Study|Lost to Follow-up|0|||
156876404|NCT02280408|566305815|FG001|Overall Study|Lost to Follow-up|2|||
156876405|NCT02280408|566305816|FG002|Overall Study|Lost to Follow-up|0|||
156876406|NCT02280408|566305817|FG003|Overall Study|Lost to Follow-up|0|||
156876407|NCT01519869|566305818|FG000|Overall Study|Lost to Follow-up|1|||
156876408|NCT00126490|566305826|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
156728534|NCT00550745|565754117|FG000|Overall Study|Death|20|||
156728535|NCT00550745|565754118|FG001|Overall Study|Death|16|||
156728536|NCT00550745|565754117|FG000|Overall Study|Lost to Follow-up|45|||
156728537|NCT00550745|565754118|FG001|Overall Study|Lost to Follow-up|30|||
156728538|NCT00550745|565754117|FG000|Overall Study|Physician Decision|0|||
156728539|NCT00550745|565754118|FG001|Overall Study|Physician Decision|2|||
156728540|NCT00550745|565754117|FG000|Overall Study|Protocol Violation|4|||
156876409|NCT00200356|566305827|FG000|Overall Study|Lack of Efficacy|3|||
156728541|NCT00550745|565754118|FG001|Overall Study|Protocol Violation|2|||
156728542|NCT00550745|565754117|FG000|Overall Study|Withdrawal by Subject|17|||
156728543|NCT00550745|565754118|FG001|Overall Study|Withdrawal by Subject|10|||
156728544|NCT00550745|565754117|FG000|Overall Study|Screen failure|1|||
156728545|NCT00550745|565754118|FG001|Overall Study|Screen failure|0|||
156728546|NCT01131455|565754119|FG000|Overall Study|Death of PI|6|||
156728547|NCT01131455|565754120|FG001|Overall Study|Death of PI|4|||
156728548|NCT01131455|565754121|FG002|Overall Study|Death of PI|0|||
156728549|NCT00764660|565754122|FG000|Overall Study|Adverse Event|6|||
156728550|NCT00764660|565754123|FG001|Overall Study|Adverse Event|3|||
156728551|NCT00764660|565754122|FG000|Overall Study|Lost to Follow-up|3|||
156728552|NCT00764660|565754123|FG001|Overall Study|Lost to Follow-up|4|||
156728553|NCT00764660|565754122|FG000|Overall Study|Withdrawal by Subject|7|||
156728554|NCT00764660|565754123|FG001|Overall Study|Withdrawal by Subject|3|||
156728555|NCT00764660|565754122|FG000|Overall Study|Noncompliance With Protocol|5|||
156728556|NCT00764660|565754123|FG001|Overall Study|Noncompliance With Protocol|1|||
156728557|NCT00764660|565754122|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
156728558|NCT00764660|565754123|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
156728559|NCT00300885|565755830|FG000|Treatment|Adverse Event|134|||
156728560|NCT00300885|565755831|FG001|Treatment|Adverse Event|82|||
156728561|NCT00300885|565755830|FG000|Treatment|Death|20|||
156728562|NCT00300885|565755831|FG001|Treatment|Death|7|||
156728563|NCT00300885|565755830|FG000|Treatment|Lack of Efficacy|1|||
156728564|NCT00300885|565755831|FG001|Treatment|Lack of Efficacy|1|||
156728565|NCT00300885|565755830|FG000|Treatment|Lost to Follow-up|3|||
156728566|NCT00300885|565755831|FG001|Treatment|Lost to Follow-up|2|||
156728567|NCT00300885|565755830|FG000|Treatment|Physician Decision|4|||
156728568|NCT00300885|565755831|FG001|Treatment|Physician Decision|5|||
156728569|NCT00300885|565755830|FG000|Treatment|Protocol Violation|11|||
156728570|NCT00300885|565755831|FG001|Treatment|Protocol Violation|11|||
156728571|NCT00300885|565755830|FG000|Treatment|Withdrawal by Subject|26|||
156728572|NCT00300885|565755831|FG001|Treatment|Withdrawal by Subject|23|||
156728573|NCT00300885|565755830|FG000|Treatment|Disease progression|171|||
156728574|NCT00300885|565755831|FG001|Treatment|Disease progression|238|||
156728575|NCT00300885|565755830|FG000|Treatment|Random code broken (subject died)|0|||
156728576|NCT00300885|565755831|FG001|Treatment|Random code broken (subject died)|1|||
156728577|NCT00300885|565755830|FG000|Treatment|Non-compliant with study medication|3|||
156728578|NCT00300885|565755831|FG001|Treatment|Non-compliant with study medication|4|||
156728579|NCT00300885|565755830|FG000|Follow-up|Death|141|||
156728580|NCT00300885|565755831|FG001|Follow-up|Death|163|||
156728581|NCT00300885|565755830|FG000|Follow-up|Lost to Follow-up|11|||
156728582|NCT00300885|565755831|FG001|Follow-up|Lost to Follow-up|7|||
156728583|NCT00300885|565755830|FG000|Follow-up|Withdrawal by Subject|26|||
156728584|NCT00300885|565755831|FG001|Follow-up|Withdrawal by Subject|25|||
156728585|NCT01637922|565755832|FG000|Overall Study|Adverse Event|0|||
156728586|NCT01637922|565755833|FG001|Overall Study|Adverse Event|1|||
156728587|NCT01637922|565755832|FG000|Overall Study|Protocol Violation|0|||
156728588|NCT01637922|565755833|FG001|Overall Study|Protocol Violation|1|||
156728589|NCT01637922|565755832|FG000|Overall Study|Withdrawal by Subject|0|||
156728590|NCT01637922|565755833|FG001|Overall Study|Withdrawal by Subject|3|||
156728591|NCT01637922|565755832|FG000|Overall Study|Lost to Follow-up|2|||
156796044|NCT03648372|566006261|FG004|Overall Study|Withdrawal by Subject|0|||
156796045|NCT03648372|566006262|FG005|Overall Study|Withdrawal by Subject|1|||
156796046|NCT03648372|566006263|FG006|Overall Study|Withdrawal by Subject|2|||
156796047|NCT03648372|566006264|FG007|Overall Study|Withdrawal by Subject|0|||
156796048|NCT03648372|566006265|FG008|Overall Study|Withdrawal by Subject|0|||
156796049|NCT03648372|566006266|FG009|Overall Study|Withdrawal by Subject|0|||
156796050|NCT03648372|566006267|FG010|Overall Study|Withdrawal by Subject|2|||
156796051|NCT03648372|566006268|FG011|Overall Study|Withdrawal by Subject|0|||
156796052|NCT03648372|566006269|FG012|Overall Study|Withdrawal by Subject|2|||
156796053|NCT03648372|566006270|FG013|Overall Study|Withdrawal by Subject|0|||
156796054|NCT03648372|566006271|FG014|Overall Study|Withdrawal by Subject|0|||
156796055|NCT03648372|566006272|FG015|Overall Study|Withdrawal by Subject|0|||
156796056|NCT03648372|566006273|FG016|Overall Study|Withdrawal by Subject|1|||
156796057|NCT03648372|566006274|FG017|Overall Study|Withdrawal by Subject|0|||
156796058|NCT03648372|566006275|FG018|Overall Study|Withdrawal by Subject|0|||
156728592|NCT01637922|565755833|FG001|Overall Study|Lost to Follow-up|0|||
156728593|NCT01515865|565755834|FG000|Part A (Open-label)|Other|3|||
156728594|NCT01515865|565755835|FG001|Part A (Open-label)|Other|0|||
156728595|NCT01515865|565755836|FG002|Part A (Open-label)|Other|0|||
156728596|NCT01515865|565755834|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
156728597|NCT01515865|565755835|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
156728598|NCT01515865|565755836|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
156728599|NCT01515865|565755834|FG000|Part B (Open-label)|Other|1|||
156728600|NCT01515865|565755835|FG001|Part B (Open-label)|Other|0|||
156728601|NCT01515865|565755836|FG002|Part B (Open-label)|Other|0|||
156728602|NCT02693106|565755837|FG000|Overall Study|No time|3|||
156728603|NCT03981900|565755838|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
156728604|NCT03981900|565755838|FG000|Overall Study|Adverse Event|5|||
156728605|NCT03981900|565755838|FG000|Overall Study|Protocol Violation|1|||
156728606|NCT03981900|565755838|FG000|Overall Study|Withdrawal by Subject|7|||
156728607|NCT03981900|565755838|FG000|Overall Study|Lost to Follow-up|46|||
156728608|NCT03981900|565755838|FG000|Overall Study|Decision of the researcher|3|||
156728609|NCT03981900|565755838|FG000|Overall Study|Death|3|||
156728610|NCT03981900|565755838|FG000|Overall Study|Other|5|||
156728611|NCT04090060|565755848|FG000|Overall Study|Lost to Follow-up|76|||
156728612|NCT04090060|565755849|FG001|Overall Study|Lost to Follow-up|77|||
156728613|NCT01164579|565755850|FG000|Overall Study|Lack of Efficacy|0|||
156728614|NCT01164579|565755851|FG001|Overall Study|Lack of Efficacy|0|||
156728615|NCT01164579|565755852|FG002|Overall Study|Lack of Efficacy|6|||
156728616|NCT01164579|565755850|FG000|Overall Study|Lost to Follow-up|1|||
156728617|NCT01164579|565755851|FG001|Overall Study|Lost to Follow-up|1|||
156728618|NCT01164579|565755852|FG002|Overall Study|Lost to Follow-up|0|||
156728619|NCT01164579|565755850|FG000|Overall Study|Withdrawal by Subject|2|||
156728620|NCT01164579|565755851|FG001|Overall Study|Withdrawal by Subject|5|||
156728621|NCT01164579|565755852|FG002|Overall Study|Withdrawal by Subject|3|||
156728622|NCT01164579|565755850|FG000|Overall Study|Protocol Violation|0|||
156728623|NCT01164579|565755851|FG001|Overall Study|Protocol Violation|1|||
156728624|NCT01164579|565755852|FG002|Overall Study|Protocol Violation|2|||
156728625|NCT01164579|565755850|FG000|Overall Study|Adverse Event|4|||
156728626|NCT01164579|565755851|FG001|Overall Study|Adverse Event|2|||
156728627|NCT01164579|565755852|FG002|Overall Study|Adverse Event|5|||
156728628|NCT01164579|565755850|FG000|Overall Study|Reason not specified|1|||
156728629|NCT01164579|565755851|FG001|Overall Study|Reason not specified|0|||
156728630|NCT01164579|565755852|FG002|Overall Study|Reason not specified|0|||
156728631|NCT02176655|565755853|FG000|Overall Study|Subjects did not treat|6|||
156728632|NCT00179660|565755862|FG000|Overall Study|Adverse Event|7|||
156728633|NCT00179660|565755862|FG000|Overall Study|Lack of therapeutic effect|28|||
156728634|NCT00179660|565755862|FG000|Overall Study|Withdrawal by Subject|2|||
156728635|NCT00179660|565755862|FG000|Overall Study|Lost to Follow-up|1|||
156728636|NCT00179660|565755862|FG000|Overall Study|Death|3|||
156728637|NCT00179660|565755862|FG000|Overall Study|Other - Unspecified|9|||
156728638|NCT04478695|565755863|FG000|Overall Study|Death|1|||
156728639|NCT04478695|565755864|FG001|Overall Study|Death|0|||
156728640|NCT00644917|565755865|FG000|Overall Study|Withdrawal by Subject|2|||
156728641|NCT00402688|565755866|FG000|Overall Study|Adverse Event|12|||
156728642|NCT00402688|565755867|FG001|Overall Study|Adverse Event|9|||
156728643|NCT00402688|565755868|FG002|Overall Study|Adverse Event|3|||
156728644|NCT00402688|565755866|FG000|Overall Study|Withdrawal by Subject|3|||
156728645|NCT00402688|565755867|FG001|Overall Study|Withdrawal by Subject|1|||
156728646|NCT00402688|565755868|FG002|Overall Study|Withdrawal by Subject|1|||
156728647|NCT00402688|565755866|FG000|Overall Study|Physician Decision|0|||
156728648|NCT00402688|565755867|FG001|Overall Study|Physician Decision|0|||
156728649|NCT00402688|565755868|FG002|Overall Study|Physician Decision|1|||
156728650|NCT00402688|565755866|FG000|Overall Study|Lack of Efficacy|4|||
156728651|NCT00402688|565755867|FG001|Overall Study|Lack of Efficacy|4|||
156728652|NCT00402688|565755868|FG002|Overall Study|Lack of Efficacy|5|||
156728653|NCT00402688|565755866|FG000|Overall Study|Protocol Violation|1|||
156728654|NCT00402688|565755867|FG001|Overall Study|Protocol Violation|1|||
156728655|NCT00402688|565755868|FG002|Overall Study|Protocol Violation|1|||
156728656|NCT00402688|565755866|FG000|Overall Study|Lost to Follow-up|1|||
156728657|NCT00402688|565755867|FG001|Overall Study|Lost to Follow-up|0|||
156728658|NCT00402688|565755868|FG002|Overall Study|Lost to Follow-up|2|||
156728659|NCT00402688|565755866|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
156728660|NCT00402688|565755867|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
156728661|NCT00402688|565755868|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
156728662|NCT00402688|565755866|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
156728663|NCT00402688|565755867|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
156728664|NCT00402688|565755868|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
156728665|NCT00402688|565755866|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
156728666|NCT00402688|565755867|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
156728667|NCT00402688|565755868|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
156728668|NCT00927862|565755869|FG000|Overall Study|Missing data needed for endpt analyses|27|||
156728669|NCT00927862|565755870|FG001|Overall Study|Missing data needed for endpt analyses|45|||
156728670|NCT04157296|565755880|FG000|Overall Study|Withdrawal by Subject|0|||
156728671|NCT04157296|565755881|FG001|Overall Study|Withdrawal by Subject|1|||
156728672|NCT04157296|565755880|FG000|Overall Study|Did not obtain second fMRI.|0|||
156728673|NCT04157296|565755881|FG001|Overall Study|Did not obtain second fMRI.|1|||
156728674|NCT04157296|565755880|FG000|Overall Study|MRI failed/no second fMRI|0|||
156728675|NCT04157296|565755881|FG001|Overall Study|MRI failed/no second fMRI|1|||
156728676|NCT02088905|565755888|FG000|Overall Study|Withdrawal by Subject|5|||
156728677|NCT02088905|565755889|FG001|Overall Study|Withdrawal by Subject|1|||
156728678|NCT01562782|565755895|FG000|Overall Study|Withdrawal by Subject|3|||
156728679|NCT01562782|565755896|FG001|Overall Study|Withdrawal by Subject|3|||
156728680|NCT01562782|565755895|FG000|Overall Study|screen failure|1|||
156728681|NCT01562782|565755896|FG001|Overall Study|screen failure|2|||
156454830|NCT05329220|564759324|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
156454831|NCT05329220|564759325|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
156454832|NCT05329220|564759326|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
156454833|NCT05329220|564759327|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
156728682|NCT02308540|565755897|FG000|Overall Study|Lost to Follow-up|0|||
156728683|NCT02308540|565755898|FG001|Overall Study|Lost to Follow-up|0|||
156728684|NCT02308540|565755899|FG002|Overall Study|Lost to Follow-up|0|||
156728685|NCT02308540|565755900|FG003|Overall Study|Lost to Follow-up|0|||
156728686|NCT02308540|565755901|FG004|Overall Study|Lost to Follow-up|0|||
156728687|NCT02308540|565755902|FG005|Overall Study|Lost to Follow-up|1|||
156728688|NCT04109391|565755903|FG000|Overall Study|Adverse Event|2|||
156728689|NCT04109391|565755904|FG001|Overall Study|Adverse Event|2|||
156728690|NCT04109391|565755905|FG002|Overall Study|Adverse Event|0|||
156728691|NCT04109391|565755903|FG000|Overall Study|Withdrawal by Subject|2|||
156796059|NCT03648372|566006276|FG019|Overall Study|Withdrawal by Subject|0|||
156454834|NCT05329220|564759328|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
156454835|NCT05329220|564759323|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
156454836|NCT05329220|564759324|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
156454837|NCT05329220|564759325|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
156454838|NCT05329220|564759326|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
156454839|NCT05329220|564759327|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
156454840|NCT05329220|564759328|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
156454841|NCT05329220|564759323|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
156454842|NCT05329220|564759324|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
156454843|NCT05329220|564759325|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
156454844|NCT05329220|564759326|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
156454845|NCT05329220|564759327|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
156454846|NCT05329220|564759328|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
156454847|NCT05329220|564759323|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
156454848|NCT05329220|564759324|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
156454849|NCT05329220|564759325|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
156454850|NCT05329220|564759326|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
156454851|NCT05329220|564759327|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
156454852|NCT05329220|564759328|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
156454853|NCT05329220|564759323|FG000|Follow-up Period|EARLY TERMINATION|0|||
156454854|NCT05329220|564759324|FG001|Follow-up Period|EARLY TERMINATION|0|||
156454855|NCT05329220|564759325|FG002|Follow-up Period|EARLY TERMINATION|0|||
156454856|NCT05329220|564759326|FG003|Follow-up Period|EARLY TERMINATION|0|||
156454857|NCT05329220|564759327|FG004|Follow-up Period|EARLY TERMINATION|0|||
156454858|NCT05329220|564759328|FG005|Follow-up Period|EARLY TERMINATION|1|||
156454859|NCT05329220|564759323|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
156454860|NCT05329220|564759324|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
156454861|NCT05329220|564759325|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
156454862|NCT05329220|564759326|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
156454863|NCT05329220|564759327|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
156454864|NCT05329220|564759328|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
156454865|NCT05329220|564759323|FG000|Follow-up Period|DROPPED|0|||
156454866|NCT05329220|564759324|FG001|Follow-up Period|DROPPED|0|||
156454867|NCT05329220|564759325|FG002|Follow-up Period|DROPPED|0|||
156454868|NCT05329220|564759326|FG003|Follow-up Period|DROPPED|0|||
156454869|NCT05329220|564759327|FG004|Follow-up Period|DROPPED|0|||
156454870|NCT05329220|564759328|FG005|Follow-up Period|DROPPED|1|||
156454871|NCT05329220|564759323|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
156454872|NCT05329220|564759324|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
156454873|NCT05329220|564759325|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
156454874|NCT05329220|564759326|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
156454875|NCT05329220|564759327|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
156454876|NCT05329220|564759328|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
156454877|NCT02465268|564759330|FG000|Overall Study|Withdrawal by Subject|4|||
156454878|NCT02465268|564759331|FG001|Overall Study|Withdrawal by Subject|3|||
156454879|NCT02465268|564759332|FG002|Overall Study|Withdrawal by Subject|1|||
156454880|NCT02465268|564759330|FG000|Overall Study|Not evaluable per protocol criteria|3|||
156454881|NCT02465268|564759331|FG001|Overall Study|Not evaluable per protocol criteria|2|||
156454882|NCT02465268|564759332|FG002|Overall Study|Not evaluable per protocol criteria|1|||
156728692|NCT04109391|565755904|FG001|Overall Study|Withdrawal by Subject|0|||
156728693|NCT04109391|565755905|FG002|Overall Study|Withdrawal by Subject|0|||
156796060|NCT03648372|566006277|FG020|Overall Study|Withdrawal by Subject|0|||
156454883|NCT02465268|564759330|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
156454884|NCT02465268|564759331|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
156454885|NCT02465268|564759332|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
156454886|NCT02465268|564759330|FG000|Overall Study|Study drug did not pass QA/QC|1|||
156728694|NCT04109391|565755903|FG000|Overall Study|Pregnancy|1|||
156728695|NCT04109391|565755904|FG001|Overall Study|Pregnancy|0|||
156728696|NCT04109391|565755905|FG002|Overall Study|Pregnancy|0|||
156728697|NCT04109391|565755903|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
156728698|NCT04109391|565755904|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
156728699|NCT04109391|565755905|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
156728700|NCT04109391|565755903|FG000|Overall Study|Lost to Follow-up|0|||
156728701|NCT04109391|565755904|FG001|Overall Study|Lost to Follow-up|0|||
156728702|NCT04109391|565755905|FG002|Overall Study|Lost to Follow-up|1|||
156728703|NCT04109391|565755903|FG000|Overall Study|Lack of Efficacy|2|||
156728704|NCT04109391|565755904|FG001|Overall Study|Lack of Efficacy|2|||
156728705|NCT04109391|565755905|FG002|Overall Study|Lack of Efficacy|3|||
156728706|NCT02097238|565755911|FG000|Overall Study|Death|1|||
156728707|NCT02097238|565755911|FG000|Overall Study|Physician Decision|1|||
156728708|NCT02097238|565755911|FG000|Overall Study|Progressive Disease|17|||
156728709|NCT01106911|565755912|FG000|Overall Study|Physician Decision|2|||
156728710|NCT01106911|565755912|FG000|Overall Study|deemed ineligible after screening|3|||
156728711|NCT01282372|565755921|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
156728712|NCT01282372|565755921|FG000|Overall Study|Lost to Follow-up|23|||
156728713|NCT01282372|565755921|FG000|Overall Study|Withdrawal by Subject|11|||
156728714|NCT01282372|565755921|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
156728715|NCT01282372|565755921|FG000|Overall Study|Death|1|||
156728716|NCT01282372|565755921|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
156728717|NCT01282372|565755921|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
156728718|NCT01282372|565755921|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
156728719|NCT01282372|565755921|FG000|Overall Study|Adverse Event|12|||
156728720|NCT01814696|565755922|FG000|Overall Study|Withdrawal by Subject|1|||
156728721|NCT01814696|565755923|FG001|Overall Study|Withdrawal by Subject|0|||
156728722|NCT01814696|565755922|FG000|Overall Study|Randomized to wrong group|1|||
156728723|NCT01814696|565755923|FG001|Overall Study|Randomized to wrong group|0|||
156728724|NCT02064816|565755930|FG000|Overall Study|Adverse Event|3|||
156728725|NCT02064816|565755931|FG001|Overall Study|Adverse Event|2|||
156728726|NCT02064816|565755930|FG000|Overall Study|Withdrawal by Subject|2|||
156796061|NCT03648372|566006257|FG000|Overall Study|Progressive Disease|2|||
156796062|NCT03648372|566006258|FG001|Overall Study|Progressive Disease|3|||
156796063|NCT03648372|566006259|FG002|Overall Study|Progressive Disease|4|||
156796064|NCT03648372|566006260|FG003|Overall Study|Progressive Disease|3|||
156796065|NCT03648372|566006261|FG004|Overall Study|Progressive Disease|2|||
156796066|NCT03648372|566006262|FG005|Overall Study|Progressive Disease|2|||
156796067|NCT03648372|566006263|FG006|Overall Study|Progressive Disease|3|||
156796068|NCT03648372|566006264|FG007|Overall Study|Progressive Disease|3|||
156796069|NCT03648372|566006265|FG008|Overall Study|Progressive Disease|5|||
156796070|NCT03648372|566006266|FG009|Overall Study|Progressive Disease|5|||
156796071|NCT03648372|566006267|FG010|Overall Study|Progressive Disease|2|||
156796072|NCT03648372|566006268|FG011|Overall Study|Progressive Disease|3|||
156796073|NCT03648372|566006269|FG012|Overall Study|Progressive Disease|3|||
156796074|NCT03648372|566006270|FG013|Overall Study|Progressive Disease|3|||
156796075|NCT03648372|566006271|FG014|Overall Study|Progressive Disease|6|||
156796076|NCT03648372|566006272|FG015|Overall Study|Progressive Disease|0|||
156796077|NCT03648372|566006273|FG016|Overall Study|Progressive Disease|0|||
156796078|NCT03648372|566006274|FG017|Overall Study|Progressive Disease|0|||
156796079|NCT03648372|566006275|FG018|Overall Study|Progressive Disease|0|||
156796080|NCT03648372|566006276|FG019|Overall Study|Progressive Disease|0|||
156796081|NCT03648372|566006277|FG020|Overall Study|Progressive Disease|0|||
156796082|NCT03648372|566006257|FG000|Overall Study|Other|0|||
156796083|NCT03648372|566006258|FG001|Overall Study|Other|0|||
156796084|NCT03648372|566006259|FG002|Overall Study|Other|0|||
156454887|NCT02465268|564759331|FG001|Overall Study|Study drug did not pass QA/QC|0|||
156796085|NCT03648372|566006260|FG003|Overall Study|Other|0|||
156728727|NCT02064816|565755931|FG001|Overall Study|Withdrawal by Subject|1|||
156728728|NCT02064816|565755930|FG000|Overall Study|Lost to Follow-up|2|||
156728729|NCT02064816|565755931|FG001|Overall Study|Lost to Follow-up|1|||
156728730|NCT02064816|565755930|FG000|Overall Study|Therapeutic failure|0|||
156728731|NCT02064816|565755931|FG001|Overall Study|Therapeutic failure|1|||
156796086|NCT03648372|566006261|FG004|Overall Study|Other|1|||
156796087|NCT03648372|566006262|FG005|Overall Study|Other|0|||
156796088|NCT03648372|566006263|FG006|Overall Study|Other|0|||
156796089|NCT03648372|566006264|FG007|Overall Study|Other|0|||
156796090|NCT03648372|566006265|FG008|Overall Study|Other|0|||
156728732|NCT02064816|565755930|FG000|Overall Study|Other|1|||
156796091|NCT03648372|566006266|FG009|Overall Study|Other|0|||
156796092|NCT03648372|566006267|FG010|Overall Study|Other|1|||
156796093|NCT03648372|566006268|FG011|Overall Study|Other|2|||
156796094|NCT03648372|566006269|FG012|Overall Study|Other|1|||
156454888|NCT02465268|564759332|FG002|Overall Study|Study drug did not pass QA/QC|0|||
156454889|NCT02465268|564759330|FG000|Overall Study|Adverse Event|0|||
156454890|NCT02465268|564759331|FG001|Overall Study|Adverse Event|1|||
156454891|NCT02465268|564759332|FG002|Overall Study|Adverse Event|0|||
156454892|NCT02465268|564759330|FG000|Overall Study|Physician Decision|0|||
156454893|NCT02465268|564759331|FG001|Overall Study|Physician Decision|1|||
156454894|NCT02465268|564759332|FG002|Overall Study|Physician Decision|0|||
156454895|NCT03322267|564759334|FG000|Overall Study|Lack of Efficacy|11|||
156454896|NCT03322267|564759334|FG000|Overall Study|Adverse Event|1|||
156454897|NCT03322267|564759334|FG000|Overall Study|Withdrawal by Subject|2|||
156454898|NCT04719832|564759338|FG000|Overall Study|Adverse Event|2|||
156454899|NCT04719832|564759339|FG001|Overall Study|Adverse Event|0|||
156454900|NCT04719832|564759338|FG000|Overall Study|Lack of Efficacy|2|||
156454901|NCT04719832|564759339|FG001|Overall Study|Lack of Efficacy|4|||
156728733|NCT02064816|565755931|FG001|Overall Study|Other|3|||
156728734|NCT01757184|565755934|FG000|Double-blind Period|Adverse Event|1|||
156728735|NCT01757184|565755935|FG001|Double-blind Period|Adverse Event|0|||
156728736|NCT01757184|565755936|FG002|Double-blind Period|Adverse Event|0|||
156728737|NCT01757184|565755937|FG003|Double-blind Period|Adverse Event|0|||
156728738|NCT01757184|565755934|FG000|Open-label Period|Lost to Follow-up|0|||
156728739|NCT01757184|565755935|FG001|Open-label Period|Lost to Follow-up|0|||
156728740|NCT01757184|565755936|FG002|Open-label Period|Lost to Follow-up|2|||
156728741|NCT01757184|565755937|FG003|Open-label Period|Lost to Follow-up|0|||
156728742|NCT01757184|565755934|FG000|Open-label Period|Withdrawal by Subject|0|||
156728743|NCT01757184|565755935|FG001|Open-label Period|Withdrawal by Subject|0|||
156728744|NCT01757184|565755936|FG002|Open-label Period|Withdrawal by Subject|1|||
156728745|NCT01757184|565755937|FG003|Open-label Period|Withdrawal by Subject|1|||
156728746|NCT01757184|565755934|FG000|Open-label Period|Discontinued by Sponsor|0|||
156728747|NCT01757184|565755935|FG001|Open-label Period|Discontinued by Sponsor|0|||
156728748|NCT01757184|565755936|FG002|Open-label Period|Discontinued by Sponsor|1|||
156728749|NCT01757184|565755937|FG003|Open-label Period|Discontinued by Sponsor|2|||
156728750|NCT03515811|565755938|FG000|Overall Study|Lost to Follow-up|2|||
156728751|NCT03515811|565755939|FG001|Overall Study|Lost to Follow-up|1|||
156728752|NCT03515811|565755938|FG000|Overall Study|Protocol Violation|1|||
156728753|NCT03515811|565755939|FG001|Overall Study|Protocol Violation|1|||
156728754|NCT03515811|565755938|FG000|Overall Study|Death|1|||
156728755|NCT03515811|565755939|FG001|Overall Study|Death|1|||
156728756|NCT03515811|565755938|FG000|Overall Study|Withdrawal by Subject|0|||
156728757|NCT03515811|565755939|FG001|Overall Study|Withdrawal by Subject|2|||
156728758|NCT03515811|565755938|FG000|Overall Study|Technical Problems|1|||
156728759|NCT03515811|565755939|FG001|Overall Study|Technical Problems|0|||
156728760|NCT03515811|565755938|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
156728761|NCT03515811|565755939|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
156728762|NCT03515811|565755938|FG000|Overall Study|COVID-19|0|||
156728763|NCT03515811|565755939|FG001|Overall Study|COVID-19|1|||
156728764|NCT00237458|565755940|FG000|Overall Study|Lack of Efficacy|1|||
156728765|NCT00237458|565755940|FG000|Overall Study|Adverse Event|1|||
156728766|NCT00237458|565755940|FG000|Overall Study|Withdrawal by Subject|1|||
156728767|NCT04339062|565755941|FG000|Overall Study|Death|0|||
156796095|NCT03648372|566006270|FG013|Overall Study|Other|3|||
156796096|NCT03648372|566006271|FG014|Overall Study|Other|0|||
156796097|NCT03648372|566006272|FG015|Overall Study|Other|5|||
156796098|NCT03648372|566006273|FG016|Overall Study|Other|1|||
156796099|NCT03648372|566006274|FG017|Overall Study|Other|5|||
156796100|NCT03648372|566006275|FG018|Overall Study|Other|0|||
156336224|NCT00347360|564328204|FG012|Overall Study|Subject refuse to sign updated consent|0|||
156336225|NCT00347360|564328205|FG013|Overall Study|Subject refuse to sign updated consent|0|||
156336226|NCT00347360|564328206|FG014|Overall Study|Subject refuse to sign updated consent|1|||
156336227|NCT00347360|564328192|FG000|Overall Study|Visits conflicted with new job|0|||
156336228|NCT00347360|564328193|FG001|Overall Study|Visits conflicted with new job|0|||
156454902|NCT04719832|564759338|FG000|Overall Study|Lost to Follow-up|0|||
156454903|NCT04719832|564759339|FG001|Overall Study|Lost to Follow-up|2|||
156454904|NCT04719832|564759338|FG000|Overall Study|Physician Decision|0|||
156454905|NCT04719832|564759339|FG001|Overall Study|Physician Decision|1|||
156728768|NCT04339062|565755942|FG001|Overall Study|Death|1|||
156728769|NCT03218826|565755943|FG000|Overall Study|Non-compliance with protocol|1|||
156728770|NCT03218826|565755944|FG001|Overall Study|Non-compliance with protocol|0|||
156728771|NCT03218826|565755945|FG002|Overall Study|Non-compliance with protocol|2|||
156728772|NCT03218826|565755946|FG003|Overall Study|Non-compliance with protocol|1|||
156728773|NCT03218826|565755947|FG004|Overall Study|Non-compliance with protocol|1|||
156796101|NCT03648372|566006276|FG019|Overall Study|Other|1|||
156454906|NCT04719832|564759338|FG000|Overall Study|Pregnancy|1|||
156796102|NCT03648372|566006277|FG020|Overall Study|Other|0|||
156454907|NCT04719832|564759339|FG001|Overall Study|Pregnancy|1|||
156728774|NCT01197534|565755948|FG000|Overall Study|Not reported|16|||
156728775|NCT01197534|565755949|FG001|Overall Study|Not reported|10|||
156728776|NCT01197534|565755950|FG002|Overall Study|Not reported|16|||
156796103|NCT03648372|566006257|FG000|Overall Study|Lost to Follow-up|0|||
156796104|NCT03648372|566006258|FG001|Overall Study|Lost to Follow-up|0|||
156728777|NCT01197534|565755948|FG000|Overall Study|Enrolment in long term extension|57|||
156728778|NCT01197534|565755949|FG001|Overall Study|Enrolment in long term extension|66|||
156728779|NCT01197534|565755950|FG002|Overall Study|Enrolment in long term extension|119|||
156728780|NCT01197534|565755948|FG000|Overall Study|Severe non-compliance to protocol|3|||
156728781|NCT01197534|565755949|FG001|Overall Study|Severe non-compliance to protocol|4|||
156728782|NCT01197534|565755950|FG002|Overall Study|Severe non-compliance to protocol|1|||
156728783|NCT01197534|565755948|FG000|Overall Study|Lack of therapeutic response|9|||
156728784|NCT01197534|565755949|FG001|Overall Study|Lack of therapeutic response|4|||
156728785|NCT01197534|565755950|FG002|Overall Study|Lack of therapeutic response|9|||
156728786|NCT01197534|565755948|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
156728787|NCT01197534|565755949|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
156728788|NCT01197534|565755950|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
156728789|NCT01197534|565755948|FG000|Overall Study|Lost to Follow-up|1|||
156728790|NCT01197534|565755949|FG001|Overall Study|Lost to Follow-up|4|||
156336229|NCT00347360|564328194|FG002|Overall Study|Visits conflicted with new job|0|||
156336230|NCT00347360|564328195|FG003|Overall Study|Visits conflicted with new job|0|||
156336231|NCT00347360|564328196|FG004|Overall Study|Visits conflicted with new job|0|||
156336232|NCT00347360|564328197|FG005|Overall Study|Visits conflicted with new job|0|||
156336233|NCT00347360|564328198|FG006|Overall Study|Visits conflicted with new job|1|||
156336234|NCT00347360|564328199|FG007|Overall Study|Visits conflicted with new job|0|||
156336235|NCT00347360|564328200|FG008|Overall Study|Visits conflicted with new job|0|||
156336236|NCT00347360|564328201|FG009|Overall Study|Visits conflicted with new job|0|||
156336237|NCT00347360|564328202|FG010|Overall Study|Visits conflicted with new job|0|||
156336238|NCT00347360|564328203|FG011|Overall Study|Visits conflicted with new job|0|||
156336239|NCT00347360|564328204|FG012|Overall Study|Visits conflicted with new job|0|||
156336240|NCT00347360|564328205|FG013|Overall Study|Visits conflicted with new job|0|||
156728791|NCT01197534|565755950|FG002|Overall Study|Lost to Follow-up|2|||
156728792|NCT01197534|565755948|FG000|Overall Study|Adverse Event|35|||
156728793|NCT01197534|565755949|FG001|Overall Study|Adverse Event|36|||
156728794|NCT01197534|565755950|FG002|Overall Study|Adverse Event|24|||
156728795|NCT01276756|565755953|FG000|Overall Study|Lost to Follow-up|2|||
156728796|NCT01276756|565755954|FG001|Overall Study|Lost to Follow-up|0|||
156728797|NCT01276756|565755953|FG000|Overall Study|Adverse Event|3|||
156728798|NCT01276756|565755954|FG001|Overall Study|Adverse Event|2|||
156728799|NCT05868577|565755955|FG000|Overall Study|Lost to Follow-up|5|||
156728800|NCT05868577|565755956|FG001|Overall Study|Lost to Follow-up|5|||
156728801|NCT02630251|565755961|FG000|Overall Study|Physician Decision|0|||
156728802|NCT02630251|565755962|FG001|Overall Study|Physician Decision|0|||
156728803|NCT02630251|565755963|FG002|Overall Study|Physician Decision|1|||
156728804|NCT02630251|565755964|FG003|Overall Study|Physician Decision|0|||
156728805|NCT04586244|565755967|FG000|Overall Study|Lost to Follow-up|1|||
156728806|NCT04586244|565755968|FG001|Overall Study|Lost to Follow-up|0|||
156728807|NCT04586244|565755969|FG002|Overall Study|Lost to Follow-up|0|||
156728808|NCT04586244|565755970|FG003|Overall Study|Lost to Follow-up|1|||
156728809|NCT04586244|565755971|FG004|Overall Study|Lost to Follow-up|0|||
156728810|NCT04586244|565755967|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
156728811|NCT04586244|565755968|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
156728812|NCT04586244|565755969|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
156728813|NCT04586244|565755970|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
156728814|NCT04586244|565755971|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
156728815|NCT02670525|565755972|FG000|Overall Study|Death|94|||
156728816|NCT02670525|565755973|FG001|Overall Study|Death|14|||
156728817|NCT02670525|565755972|FG000|Overall Study|Lost to Follow-up|4|||
156728818|NCT02670525|565755973|FG001|Overall Study|Lost to Follow-up|1|||
156728819|NCT02670525|565755972|FG000|Overall Study|Subject withdrew consent|1|||
156728820|NCT02670525|565755973|FG001|Overall Study|Subject withdrew consent|0|||
156336241|NCT00347360|564328206|FG014|Overall Study|Visits conflicted with new job|0|||
156728821|NCT02670525|565755972|FG000|Overall Study|Unknown, data entry delayed|123|||
156728822|NCT02670525|565755973|FG001|Overall Study|Unknown, data entry delayed|78|||
156728823|NCT03564119|565755976|FG000|Overall Study|Adverse Event|4|||
156728824|NCT03564119|565755977|FG001|Overall Study|Adverse Event|0|||
156728825|NCT03564119|565755976|FG000|Overall Study|Lost to Follow-up|1|||
156728826|NCT03564119|565755977|FG001|Overall Study|Lost to Follow-up|4|||
156728827|NCT03564119|565755976|FG000|Overall Study|Protocol Violation|1|||
156728828|NCT03564119|565755977|FG001|Overall Study|Protocol Violation|0|||
156728829|NCT03564119|565755976|FG000|Overall Study|Withdrawal by Subject|9|||
156728830|NCT03564119|565755977|FG001|Overall Study|Withdrawal by Subject|4|||
156728831|NCT03564119|565755976|FG000|Overall Study|Other Than Specified|0|||
156728832|NCT03564119|565755977|FG001|Overall Study|Other Than Specified|1|||
156728833|NCT00634036|565755978|FG000|Overall Study|Lost to Follow-up|1|||
156728834|NCT00634036|565755979|FG001|Overall Study|Lost to Follow-up|1|||
156728835|NCT00634036|565755978|FG000|Overall Study|Withdrawal by Subject|1|||
156728836|NCT00634036|565755979|FG001|Overall Study|Withdrawal by Subject|1|||
156336242|NCT01449539|564328207|FG000|Overall Study|Withdrawal by Subject|3|||
156728837|NCT03517540|565755980|FG000|Overall Study|Protocol Violation|2|||
156728838|NCT03517540|565755981|FG001|Overall Study|Protocol Violation|0|||
156728839|NCT03517540|565755982|FG002|Overall Study|Protocol Violation|0|||
156728840|NCT03517540|565755983|FG003|Overall Study|Protocol Violation|1|||
156728841|NCT03517540|565755980|FG000|Overall Study|Adverse Event|9|||
156728842|NCT03517540|565755981|FG001|Overall Study|Adverse Event|3|||
156728843|NCT03517540|565755982|FG002|Overall Study|Adverse Event|8|||
156728844|NCT03517540|565755983|FG003|Overall Study|Adverse Event|1|||
156728845|NCT03517540|565755980|FG000|Overall Study|Withdrawal by Subject|3|||
156728846|NCT03517540|565755981|FG001|Overall Study|Withdrawal by Subject|4|||
156728847|NCT03517540|565755982|FG002|Overall Study|Withdrawal by Subject|1|||
156728848|NCT03517540|565755983|FG003|Overall Study|Withdrawal by Subject|3|||
156728849|NCT03896022|565755988|FG000|Overall Study|Withdrawal by Subject|1|||
156728850|NCT03896022|565755989|FG001|Overall Study|Withdrawal by Subject|0|||
156728851|NCT03896022|565755990|FG002|Overall Study|Withdrawal by Subject|0|||
156728852|NCT03896022|565755988|FG000|Overall Study|Did not have procedure|3|||
156728853|NCT03896022|565755989|FG001|Overall Study|Did not have procedure|0|||
156728854|NCT03896022|565755990|FG002|Overall Study|Did not have procedure|0|||
156728855|NCT00615550|565755991|FG000|Overall Study|Lost to Follow-up|6|||
156728856|NCT00615550|565755992|FG001|Overall Study|Lost to Follow-up|1|||
156728857|NCT02741076|565755993|FG000|Overall Study|Adverse Event|0|||
156728858|NCT02741076|565755994|FG001|Overall Study|Adverse Event|1|||
156728859|NCT02741076|565755995|FG002|Overall Study|Adverse Event|1|||
156728860|NCT02741076|565755996|FG003|Overall Study|Adverse Event|0|||
156728861|NCT02741076|565755993|FG000|Overall Study|Lack of Efficacy|1|||
156728862|NCT02741076|565755994|FG001|Overall Study|Lack of Efficacy|0|||
156728863|NCT02741076|565755995|FG002|Overall Study|Lack of Efficacy|0|||
156728864|NCT02741076|565755996|FG003|Overall Study|Lack of Efficacy|0|||
156728865|NCT02741076|565755993|FG000|Overall Study|Withdrawal by Subject|0|||
156728866|NCT02741076|565755994|FG001|Overall Study|Withdrawal by Subject|1|||
156728867|NCT02741076|565755995|FG002|Overall Study|Withdrawal by Subject|0|||
156728868|NCT02741076|565755996|FG003|Overall Study|Withdrawal by Subject|0|||
156796105|NCT03648372|566006259|FG002|Overall Study|Lost to Follow-up|0|||
156796106|NCT03648372|566006260|FG003|Overall Study|Lost to Follow-up|0|||
156796107|NCT03648372|566006261|FG004|Overall Study|Lost to Follow-up|0|||
156796108|NCT03648372|566006262|FG005|Overall Study|Lost to Follow-up|0|||
156796109|NCT03648372|566006263|FG006|Overall Study|Lost to Follow-up|0|||
156796110|NCT03648372|566006264|FG007|Overall Study|Lost to Follow-up|0|||
156796111|NCT03648372|566006265|FG008|Overall Study|Lost to Follow-up|0|||
156796112|NCT03648372|566006266|FG009|Overall Study|Lost to Follow-up|0|||
156796113|NCT03648372|566006267|FG010|Overall Study|Lost to Follow-up|0|||
156796114|NCT03648372|566006268|FG011|Overall Study|Lost to Follow-up|0|||
156796115|NCT03648372|566006269|FG012|Overall Study|Lost to Follow-up|0|||
156796116|NCT03648372|566006270|FG013|Overall Study|Lost to Follow-up|1|||
156796117|NCT03648372|566006271|FG014|Overall Study|Lost to Follow-up|0|||
156796118|NCT03648372|566006272|FG015|Overall Study|Lost to Follow-up|1|||
156796119|NCT03648372|566006273|FG016|Overall Study|Lost to Follow-up|0|||
156796120|NCT03648372|566006274|FG017|Overall Study|Lost to Follow-up|1|||
156796121|NCT03648372|566006275|FG018|Overall Study|Lost to Follow-up|0|||
156796122|NCT03648372|566006276|FG019|Overall Study|Lost to Follow-up|0|||
156796123|NCT03648372|566006277|FG020|Overall Study|Lost to Follow-up|0|||
156796124|NCT03648372|566006257|FG000|Overall Study|Start of a New Systemic Treatment|0|||
156796125|NCT03648372|566006258|FG001|Overall Study|Start of a New Systemic Treatment|0|||
156796126|NCT03648372|566006259|FG002|Overall Study|Start of a New Systemic Treatment|0|||
156796127|NCT03648372|566006260|FG003|Overall Study|Start of a New Systemic Treatment|0|||
156336243|NCT01449539|564328207|FG000|Overall Study|Toxicity not study related|1|||
156336244|NCT01387789|564328210|FG000|Overall Study|Adverse Event|5|||
156454908|NCT04719832|564759338|FG000|Overall Study|Withdrawal by Subject|5|||
156728869|NCT02741076|565755993|FG000|Overall Study|Sponsor Request|2|||
156728870|NCT02741076|565755994|FG001|Overall Study|Sponsor Request|3|||
156728871|NCT02741076|565755995|FG002|Overall Study|Sponsor Request|0|||
156796128|NCT03648372|566006261|FG004|Overall Study|Start of a New Systemic Treatment|0|||
156796129|NCT03648372|566006262|FG005|Overall Study|Start of a New Systemic Treatment|0|||
156796130|NCT03648372|566006263|FG006|Overall Study|Start of a New Systemic Treatment|0|||
156796131|NCT03648372|566006264|FG007|Overall Study|Start of a New Systemic Treatment|2|||
156454909|NCT04719832|564759339|FG001|Overall Study|Withdrawal by Subject|5|||
156796132|NCT03648372|566006265|FG008|Overall Study|Start of a New Systemic Treatment|0|||
156728872|NCT02741076|565755996|FG003|Overall Study|Sponsor Request|1|||
156728873|NCT02741076|565755993|FG000|Overall Study|No additional information available|0|||
156728874|NCT02741076|565755994|FG001|Overall Study|No additional information available|0|||
156728875|NCT02741076|565755995|FG002|Overall Study|No additional information available|1|||
156728876|NCT02741076|565755996|FG003|Overall Study|No additional information available|1|||
156728877|NCT01779440|565755997|FG000|Overall Study|Withdrawal by Subject|3|||
156728878|NCT01779440|565755998|FG001|Overall Study|Withdrawal by Subject|5|||
156796133|NCT03648372|566006266|FG009|Overall Study|Start of a New Systemic Treatment|0|||
156728879|NCT00086619|565756001|FG000|Overall Study|Withdrawal by Subject|6|||
156796134|NCT03648372|566006267|FG010|Overall Study|Start of a New Systemic Treatment|1|||
156796135|NCT03648372|566006268|FG011|Overall Study|Start of a New Systemic Treatment|0|||
156796136|NCT03648372|566006269|FG012|Overall Study|Start of a New Systemic Treatment|0|||
156796137|NCT03648372|566006270|FG013|Overall Study|Start of a New Systemic Treatment|0|||
156796138|NCT03648372|566006271|FG014|Overall Study|Start of a New Systemic Treatment|0|||
156796139|NCT03648372|566006272|FG015|Overall Study|Start of a New Systemic Treatment|0|||
156796140|NCT03648372|566006273|FG016|Overall Study|Start of a New Systemic Treatment|0|||
156796141|NCT03648372|566006274|FG017|Overall Study|Start of a New Systemic Treatment|0|||
156796142|NCT03648372|566006275|FG018|Overall Study|Start of a New Systemic Treatment|0|||
156796143|NCT03648372|566006276|FG019|Overall Study|Start of a New Systemic Treatment|0|||
156796144|NCT03648372|566006277|FG020|Overall Study|Start of a New Systemic Treatment|0|||
156796145|NCT02471144|566007979|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
156796146|NCT02471144|566007980|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
156796147|NCT02471144|566007981|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
156796148|NCT02471144|566007982|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
156796149|NCT02471144|566007983|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
156796150|NCT02471144|566007984|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
156796151|NCT02471144|566007985|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
156796152|NCT02471144|566007986|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
156796153|NCT02471144|566007987|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
156796154|NCT02471144|566007988|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
156796155|NCT02471144|566007989|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
156796156|NCT02471144|566007979|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796157|NCT02471144|566007980|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796158|NCT02471144|566007981|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796159|NCT02471144|566007982|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
156796160|NCT02471144|566007983|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796161|NCT02471144|566007984|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796162|NCT02471144|566007985|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796163|NCT02471144|566007986|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796164|NCT02471144|566007987|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796165|NCT02471144|566007988|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156454910|NCT04719832|564759338|FG000|Overall Study|Randomized, not treated|0|||
156454911|NCT04719832|564759339|FG001|Overall Study|Randomized, not treated|2|||
156454912|NCT04719832|564759338|FG000|Overall Study|GCP violations|4|||
156796166|NCT02471144|566007989|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796167|NCT02471144|566007979|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796168|NCT02471144|566007980|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796169|NCT02471144|566007981|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
156796170|NCT02471144|566007982|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796171|NCT02471144|566007983|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796172|NCT02471144|566007984|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796173|NCT02471144|566007985|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796174|NCT02471144|566007986|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796175|NCT02471144|566007987|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796176|NCT02471144|566007988|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796177|NCT02471144|566007989|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796178|NCT02471144|566007979|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
156796179|NCT02471144|566007980|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
156796180|NCT02471144|566007981|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796181|NCT02471144|566007982|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796182|NCT02471144|566007983|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796183|NCT02471144|566007984|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796184|NCT02471144|566007985|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796185|NCT02471144|566007986|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796186|NCT02471144|566007987|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796187|NCT02471144|566007988|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156454913|NCT04719832|564759339|FG001|Overall Study|GCP violations|7|||
156454914|NCT05704543|564759343|FG000|Overall Study|Withdrawal by Subject|1|||
156796188|NCT02471144|566007989|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796189|NCT02471144|566007979|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796190|NCT02471144|566007980|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796191|NCT02471144|566007981|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796192|NCT02471144|566007982|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796193|NCT02471144|566007983|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
156796194|NCT02471144|566007984|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796195|NCT02471144|566007985|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
156454915|NCT05704543|564759344|FG001|Overall Study|Withdrawal by Subject|1|||
156728880|NCT00086619|565756002|FG001|Overall Study|Withdrawal by Subject|6|||
156728881|NCT00086619|565756001|FG000|Overall Study|Adverse Event|8|||
156728882|NCT00086619|565756002|FG001|Overall Study|Adverse Event|10|||
156728883|NCT00086619|565756001|FG000|Overall Study|Protocol Violation|1|||
156728884|NCT00086619|565756002|FG001|Overall Study|Protocol Violation|1|||
156728885|NCT02644668|565756003|FG000|Overall Study|Adverse Event|2|||
156728886|NCT02644668|565756004|FG001|Overall Study|Adverse Event|0|||
156728887|NCT02644668|565756005|FG002|Overall Study|Adverse Event|1|||
156728888|NCT02644668|565756003|FG000|Overall Study|Protocol Violation|0|||
156728889|NCT02644668|565756004|FG001|Overall Study|Protocol Violation|0|||
156728890|NCT02644668|565756005|FG002|Overall Study|Protocol Violation|1|||
156728891|NCT02644668|565756003|FG000|Overall Study|Withdrawal by Subject|0|||
156728892|NCT02644668|565756004|FG001|Overall Study|Withdrawal by Subject|0|||
156728893|NCT02644668|565756005|FG002|Overall Study|Withdrawal by Subject|1|||
156728894|NCT01209520|565756006|FG000|Overall Study|Withdrawal by Subject|3|||
156728895|NCT00961350|565756007|FG000|Overall Study|Adverse Event|18|||
156728896|NCT00961350|565756008|FG001|Overall Study|Adverse Event|33|||
156728897|NCT00961350|565756007|FG000|Overall Study|Withdrawal by Subject|10|||
156728898|NCT00961350|565756008|FG001|Overall Study|Withdrawal by Subject|10|||
156728899|NCT00961350|565756007|FG000|Overall Study|Lost to Follow-up|3|||
156728900|NCT00961350|565756008|FG001|Overall Study|Lost to Follow-up|3|||
156728901|NCT00961350|565756007|FG000|Overall Study|Misc|16|||
156728902|NCT00961350|565756008|FG001|Overall Study|Misc|21|||
156728903|NCT06868654|565756009|FG000|Overall Study|Death|4|||
156728904|NCT06868654|565756010|FG001|Overall Study|Death|14|||
156728905|NCT06868654|565756009|FG000|Overall Study|Lost to Follow-up|0|||
156728906|NCT06868654|565756010|FG001|Overall Study|Lost to Follow-up|1|||
156728907|NCT06868654|565756009|FG000|Overall Study|Withdrawal by Subject|5|||
156728908|NCT06868654|565756010|FG001|Overall Study|Withdrawal by Subject|3|||
156728909|NCT06868654|565756009|FG000|Overall Study|Physician Decision|0|||
156728910|NCT06868654|565756010|FG001|Overall Study|Physician Decision|1|||
156728911|NCT06868654|565756009|FG000|Overall Study|Ongoing|23|||
156728912|NCT06868654|565756010|FG001|Overall Study|Ongoing|21|||
156728913|NCT04015518|565756011|FG000|Overall Study|Adverse Event|6|||
156728914|NCT04015518|565756012|FG001|Overall Study|Adverse Event|1|||
156728915|NCT04015518|565756013|FG002|Overall Study|Adverse Event|1|||
156728916|NCT04015518|565756014|FG003|Overall Study|Adverse Event|3|||
156728917|NCT04015518|565756015|FG004|Overall Study|Adverse Event|3|||
156728918|NCT04015518|565756011|FG000|Overall Study|Lack of Efficacy|1|||
156728919|NCT04015518|565756012|FG001|Overall Study|Lack of Efficacy|0|||
156728920|NCT04015518|565756013|FG002|Overall Study|Lack of Efficacy|1|||
156728921|NCT04015518|565756014|FG003|Overall Study|Lack of Efficacy|0|||
156728922|NCT04015518|565756015|FG004|Overall Study|Lack of Efficacy|4|||
156728923|NCT04015518|565756011|FG000|Overall Study|Lost to Follow-up|0|||
156728924|NCT04015518|565756012|FG001|Overall Study|Lost to Follow-up|0|||
156454916|NCT05704543|564759345|FG002|Overall Study|Withdrawal by Subject|0|||
156454917|NCT05704543|564759346|FG003|Overall Study|Withdrawal by Subject|2|||
156728925|NCT04015518|565756013|FG002|Overall Study|Lost to Follow-up|0|||
156728926|NCT04015518|565756014|FG003|Overall Study|Lost to Follow-up|0|||
156728927|NCT04015518|565756015|FG004|Overall Study|Lost to Follow-up|1|||
156728928|NCT04015518|565756011|FG000|Overall Study|Withdrawal by Subject|0|||
156728929|NCT04015518|565756012|FG001|Overall Study|Withdrawal by Subject|1|||
156728930|NCT04015518|565756013|FG002|Overall Study|Withdrawal by Subject|0|||
156728931|NCT04015518|565756014|FG003|Overall Study|Withdrawal by Subject|1|||
156728932|NCT04015518|565756015|FG004|Overall Study|Withdrawal by Subject|1|||
156728933|NCT04015518|565756011|FG000|Overall Study|Patient did not come for consecutive visits|0|||
156728934|NCT04015518|565756012|FG001|Overall Study|Patient did not come for consecutive visits|1|||
156728935|NCT04015518|565756013|FG002|Overall Study|Patient did not come for consecutive visits|0|||
156728936|NCT04015518|565756014|FG003|Overall Study|Patient did not come for consecutive visits|0|||
156728937|NCT04015518|565756015|FG004|Overall Study|Patient did not come for consecutive visits|0|||
156728938|NCT04015518|565756011|FG000|Overall Study|not willing to travel due to Covid-19|0|||
156728939|NCT04015518|565756012|FG001|Overall Study|not willing to travel due to Covid-19|0|||
156728940|NCT04015518|565756013|FG002|Overall Study|not willing to travel due to Covid-19|1|||
156454918|NCT05704543|564759343|FG000|Overall Study|Lost to Follow-up|1|||
156454919|NCT05704543|564759344|FG001|Overall Study|Lost to Follow-up|2|||
156728941|NCT04015518|565756014|FG003|Overall Study|not willing to travel due to Covid-19|0|||
156728942|NCT04015518|565756015|FG004|Overall Study|not willing to travel due to Covid-19|0|||
156728943|NCT04015518|565756011|FG000|Overall Study|Patient wants to discontinue treatment|0|||
156728944|NCT04015518|565756012|FG001|Overall Study|Patient wants to discontinue treatment|0|||
156728945|NCT04015518|565756013|FG002|Overall Study|Patient wants to discontinue treatment|0|||
156728946|NCT04015518|565756014|FG003|Overall Study|Patient wants to discontinue treatment|1|||
156728947|NCT04015518|565756015|FG004|Overall Study|Patient wants to discontinue treatment|0|||
156728948|NCT04015518|565756011|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
156728949|NCT04015518|565756012|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
156454920|NCT05704543|564759345|FG002|Overall Study|Lost to Follow-up|0|||
156728950|NCT04015518|565756013|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
156876410|NCT00200356|566305828|FG001|Overall Study|Lack of Efficacy|3|||
156876411|NCT00200356|566305827|FG000|Overall Study|Protocol Violation|4|||
156728951|NCT04015518|565756014|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
156728952|NCT04015518|565756015|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
156728953|NCT04015518|565756011|FG000|Overall Study|Pregnancy|0|||
156728954|NCT04015518|565756012|FG001|Overall Study|Pregnancy|0|||
156876412|NCT00200356|566305828|FG001|Overall Study|Protocol Violation|4|||
156728955|NCT04015518|565756013|FG002|Overall Study|Pregnancy|0|||
156728956|NCT04015518|565756014|FG003|Overall Study|Pregnancy|0|||
156728957|NCT04015518|565756015|FG004|Overall Study|Pregnancy|1|||
156728958|NCT04015518|565756011|FG000|Overall Study|Personal reasons|1|||
156728959|NCT04015518|565756012|FG001|Overall Study|Personal reasons|0|||
156728960|NCT04015518|565756013|FG002|Overall Study|Personal reasons|0|||
156728961|NCT04015518|565756014|FG003|Overall Study|Personal reasons|0|||
156728962|NCT04015518|565756015|FG004|Overall Study|Personal reasons|1|||
156728963|NCT04015518|565756011|FG000|Overall Study|Withdrew consent|1|||
156728964|NCT04015518|565756012|FG001|Overall Study|Withdrew consent|0|||
156728965|NCT04015518|565756013|FG002|Overall Study|Withdrew consent|0|||
156728966|NCT04015518|565756014|FG003|Overall Study|Withdrew consent|0|||
156728967|NCT04015518|565756015|FG004|Overall Study|Withdrew consent|0|||
156728968|NCT04015518|565756011|FG000|Overall Study|Prostate carcinoma|1|||
156728969|NCT04015518|565756012|FG001|Overall Study|Prostate carcinoma|0|||
156728970|NCT04015518|565756013|FG002|Overall Study|Prostate carcinoma|0|||
156728971|NCT04015518|565756014|FG003|Overall Study|Prostate carcinoma|0|||
156728972|NCT04015518|565756015|FG004|Overall Study|Prostate carcinoma|0|||
156728973|NCT04015518|565756011|FG000|Overall Study|Could not keep appointments due to work|1|||
156728974|NCT04015518|565756012|FG001|Overall Study|Could not keep appointments due to work|0|||
156728975|NCT04015518|565756013|FG002|Overall Study|Could not keep appointments due to work|0|||
156728976|NCT04015518|565756014|FG003|Overall Study|Could not keep appointments due to work|0|||
156728977|NCT04015518|565756015|FG004|Overall Study|Could not keep appointments due to work|0|||
156728978|NCT02186873|565757223|FG000|Overall Study|Adverse Event|1|||
156728979|NCT02186873|565757224|FG001|Overall Study|Adverse Event|3|||
156728980|NCT02186873|565757223|FG000|Overall Study|Lack of Efficacy|0|||
156728981|NCT02186873|565757224|FG001|Overall Study|Lack of Efficacy|1|||
156728982|NCT02186873|565757223|FG000|Overall Study|Lost to Follow-up|1|||
156728983|NCT02186873|565757224|FG001|Overall Study|Lost to Follow-up|2|||
156728984|NCT02186873|565757223|FG000|Overall Study|Withdrawal by Subject|7|||
156728985|NCT02186873|565757224|FG001|Overall Study|Withdrawal by Subject|2|||
156728986|NCT03694002|565757225|FG000|Overall Study|Progression|4|||
156728987|NCT03694002|565757226|FG001|Overall Study|Progression|2|||
156728988|NCT03694002|565757225|FG000|Overall Study|Adverse Event|2|||
156728989|NCT03694002|565757226|FG001|Overall Study|Adverse Event|0|||
156728990|NCT03694002|565757225|FG000|Overall Study|Other not protocol specified|1|||
156728991|NCT03694002|565757226|FG001|Overall Study|Other not protocol specified|0|||
156728992|NCT03694002|565757225|FG000|Overall Study|Ineligible|0|||
156728993|NCT03694002|565757226|FG001|Overall Study|Ineligible|1|||
156728994|NCT03694002|565757225|FG000|Overall Study|Withdrew consent before starting treatment|0|||
156728995|NCT03694002|565757226|FG001|Overall Study|Withdrew consent before starting treatment|3|||
156728996|NCT01760655|565757227|FG000|Overall Study|Death|18|||
156728997|NCT01760655|565757227|FG000|Overall Study|Physician Decision|1|||
156728998|NCT03056638|565757232|FG000|Overall Study|Death|1|||
156728999|NCT03056638|565757233|FG001|Overall Study|Death|0|||
156729000|NCT02530125|565757234|FG000|Completed Treatment|Early termination of study|1|||
156729001|NCT02530125|565757234|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
156729002|NCT00468481|565757235|FG000|Overall Study|Adverse Event|13|||
156729003|NCT00468481|565757236|FG001|Overall Study|Adverse Event|3|||
156729004|NCT00468481|565757235|FG000|Overall Study|Lost to Follow-up|25|||
156729005|NCT00468481|565757236|FG001|Overall Study|Lost to Follow-up|8|||
156729006|NCT00468481|565757235|FG000|Overall Study|Pregnancy|2|||
156729007|NCT00468481|565757236|FG001|Overall Study|Pregnancy|0|||
156729008|NCT00468481|565757235|FG000|Overall Study|Protocol Violation|18|||
156876413|NCT00200356|566305827|FG000|Overall Study|Nontreatment|1|||
156876414|NCT00200356|566305828|FG001|Overall Study|Nontreatment|0|||
156876415|NCT00035932|566305833|FG000|Overall Study|Adverse Event|10|||
156876416|NCT00035932|566305834|FG001|Overall Study|Adverse Event|9|||
156729009|NCT00468481|565757236|FG001|Overall Study|Protocol Violation|8|||
156729010|NCT00468481|565757235|FG000|Overall Study|Withdrawal by Subject|12|||
156729011|NCT00468481|565757236|FG001|Overall Study|Withdrawal by Subject|3|||
156729012|NCT00468481|565757235|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
156729013|NCT00468481|565757236|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
156729014|NCT00468481|565757235|FG000|Overall Study|Prohibited Medication|1|||
156729015|NCT00468481|565757236|FG001|Overall Study|Prohibited Medication|1|||
156729016|NCT00468481|565757235|FG000|Overall Study|Egg Donor|1|||
156729017|NCT00468481|565757236|FG001|Overall Study|Egg Donor|0|||
156729018|NCT00468481|565757235|FG000|Overall Study|Moved out of area|4|||
156729019|NCT00468481|565757236|FG001|Overall Study|Moved out of area|1|||
156729020|NCT00468481|565757235|FG000|Overall Study|Non-Compliance|5|||
156876417|NCT00035932|566305835|FG002|Overall Study|Adverse Event|9|||
156729021|NCT00468481|565757236|FG001|Overall Study|Non-Compliance|0|||
156729022|NCT00468481|565757235|FG000|Overall Study|Other|6|||
156729023|NCT00468481|565757236|FG001|Overall Study|Other|0|||
156729024|NCT00728468|565757238|FG000|Overall Study|Enrolled but not treated|1|||
156729025|NCT00728468|565757238|FG000|Overall Study|Death|1|||
156729026|NCT00728468|565757238|FG000|Overall Study|Protocol Violation|4|||
156729027|NCT00728468|565757238|FG000|Overall Study|Objective progression or relapse|9|||
156729028|NCT00728468|565757238|FG000|Overall Study|Study terminated by sponsor|1|||
156729029|NCT01568034|565757239|FG000|Overall Study|Withdrawal by Subject|1|||
156729030|NCT01568034|565757240|FG001|Overall Study|Withdrawal by Subject|0|||
156729031|NCT01568034|565757241|FG002|Overall Study|Withdrawal by Subject|0|||
156729032|NCT01568034|565757242|FG003|Overall Study|Withdrawal by Subject|0|||
156729033|NCT00596687|565757243|FG000|Overall Study|< 24 hours of insulin treatment|8|||
156729034|NCT00596687|565757244|FG001|Overall Study|< 24 hours of insulin treatment|6|||
156729035|NCT00596687|565757243|FG000|Overall Study|continuous insulin infusion during TPN|2|||
156729036|NCT00596687|565757244|FG001|Overall Study|continuous insulin infusion during TPN|1|||
156729037|NCT00596687|565757243|FG000|Overall Study|Withdrawal by Subject|3|||
156729038|NCT00596687|565757244|FG001|Overall Study|Withdrawal by Subject|1|||
156729039|NCT00596687|565757243|FG000|Overall Study|cancelled surgery|1|||
156729040|NCT00596687|565757244|FG001|Overall Study|cancelled surgery|1|||
156729041|NCT06098339|565757245|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
156729042|NCT06098339|565757246|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
156729043|NCT06098339|565757245|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
156729044|NCT06098339|565757246|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
156729045|NCT03831113|565757247|FG000|Overall Study|Withdrawal by Subject|0|||
156729046|NCT03831113|565757248|FG001|Overall Study|Withdrawal by Subject|2|||
156729047|NCT03831113|565757247|FG000|Overall Study|Protocol Violation|0|||
156729048|NCT03831113|565757248|FG001|Overall Study|Protocol Violation|9|||
156729049|NCT02510664|565757259|FG000|Overall Study|Transferred Care|9|||
156729050|NCT02510664|565757260|FG001|Overall Study|Transferred Care|9|||
156729051|NCT02510664|565757261|FG002|Overall Study|Transferred Care|0|||
156729052|NCT02510664|565757259|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
156729053|NCT02510664|565757260|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
156729054|NCT02510664|565757261|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
156729055|NCT02510664|565757259|FG000|Overall Study|Time Constraints|1|||
156729056|NCT02510664|565757260|FG001|Overall Study|Time Constraints|1|||
156729057|NCT02510664|565757261|FG002|Overall Study|Time Constraints|0|||
156729058|NCT01718535|565757277|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
156729059|NCT01718535|565757278|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
156729060|NCT01718535|565757279|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
156729061|NCT01718535|565757280|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
156729062|NCT01718535|565757281|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
156729063|NCT01718535|565757282|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
156729064|NCT01718535|565757283|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
156729065|NCT01718535|565757284|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
156729066|NCT01718535|565757285|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
156729067|NCT01718535|565757286|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
156729068|NCT02476578|565757287|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
156729069|NCT02476578|565757288|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
156729070|NCT02476578|565757287|FG000|Overall Study|Lost to Follow-up|6|||
156729071|NCT02476578|565757288|FG001|Overall Study|Lost to Follow-up|13|||
156729072|NCT04747886|565757289|FG000|Overall Study|Withdrawal by Subject|1|||
156729073|NCT04747886|565757290|FG001|Overall Study|Withdrawal by Subject|4|||
156729074|NCT00820248|565757291|FG000|Overall Study|No treated|4|||
156729075|NCT00820248|565757292|FG001|Overall Study|No treated|1|||
156729076|NCT01057810|565757293|FG000|Overall Study|Disease progression|156|||
156729077|NCT01057810|565757294|FG001|Overall Study|Disease progression|197|||
156729078|NCT01057810|565757293|FG000|Overall Study|Study drug toxicity|5|||
156796196|NCT02471144|566007986|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796197|NCT02471144|566007987|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
156796198|NCT02471144|566007988|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156729079|NCT01057810|565757294|FG001|Overall Study|Study drug toxicity|114|||
156729080|NCT01057810|565757293|FG000|Overall Study|Adverse event unrelated to study drug|13|||
156729081|NCT01057810|565757294|FG001|Overall Study|Adverse event unrelated to study drug|29|||
156729082|NCT01057810|565757293|FG000|Overall Study|Withdrawal by Subject|10|||
156729083|NCT01057810|565757294|FG001|Overall Study|Withdrawal by Subject|25|||
156729084|NCT01057810|565757293|FG000|Overall Study|Death|2|||
156729085|NCT01057810|565757294|FG001|Overall Study|Death|12|||
156729086|NCT01057810|565757293|FG000|Overall Study|Maximum clinical benefit|5|||
156729087|NCT01057810|565757294|FG001|Overall Study|Maximum clinical benefit|5|||
156729088|NCT01057810|565757293|FG000|Overall Study|Poor/non-compliance|0|||
156729089|NCT01057810|565757294|FG001|Overall Study|Poor/non-compliance|1|||
156454921|NCT05704543|564759346|FG003|Overall Study|Lost to Follow-up|0|||
156454922|NCT04830800|564759351|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
156454923|NCT04830800|564759352|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
156454924|NCT04830800|564759353|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
156729090|NCT01057810|565757293|FG000|Overall Study|No longer met study criteria|0|||
156729091|NCT01057810|565757294|FG001|Overall Study|No longer met study criteria|1|||
156729092|NCT01057810|565757293|FG000|Overall Study|Other|7|||
156729093|NCT01057810|565757294|FG001|Overall Study|Other|14|||
156729094|NCT00267969|565757295|FG000|Controlled Period|Adverse Event|6|||
156729095|NCT00267969|565757296|FG001|Controlled Period|Adverse Event|0|||
156729096|NCT00267969|565757297|FG002|Controlled Period|Adverse Event|2|||
156729097|NCT00267969|565757298|FG003|Controlled Period|Adverse Event|0|||
156729098|NCT00267969|565757299|FG004|Controlled Period|Adverse Event|0|||
156729099|NCT00267969|565757300|FG005|Controlled Period|Adverse Event|0|||
156729100|NCT00267969|565757301|FG006|Controlled Period|Adverse Event|0|||
156729101|NCT00267969|565757295|FG000|Controlled Period|Lack of Efficacy|3|||
156729102|NCT00267969|565757296|FG001|Controlled Period|Lack of Efficacy|0|||
156729103|NCT00267969|565757297|FG002|Controlled Period|Lack of Efficacy|1|||
156729104|NCT00267969|565757298|FG003|Controlled Period|Lack of Efficacy|0|||
156729105|NCT00267969|565757299|FG004|Controlled Period|Lack of Efficacy|0|||
156729106|NCT00267969|565757300|FG005|Controlled Period|Lack of Efficacy|0|||
156729107|NCT00267969|565757301|FG006|Controlled Period|Lack of Efficacy|0|||
156729108|NCT00267969|565757295|FG000|Controlled Period|Lost to Follow-up|1|||
156729109|NCT00267969|565757296|FG001|Controlled Period|Lost to Follow-up|0|||
156729110|NCT00267969|565757297|FG002|Controlled Period|Lost to Follow-up|1|||
156729111|NCT00267969|565757298|FG003|Controlled Period|Lost to Follow-up|0|||
156729112|NCT00267969|565757299|FG004|Controlled Period|Lost to Follow-up|0|||
156729113|NCT00267969|565757300|FG005|Controlled Period|Lost to Follow-up|0|||
156729114|NCT00267969|565757301|FG006|Controlled Period|Lost to Follow-up|0|||
156729115|NCT00267969|565757295|FG000|Controlled Period|Randomized but not treated|0|||
156729116|NCT00267969|565757296|FG001|Controlled Period|Randomized but not treated|0|||
156729117|NCT00267969|565757297|FG002|Controlled Period|Randomized but not treated|1|||
156729118|NCT00267969|565757298|FG003|Controlled Period|Randomized but not treated|0|||
156729119|NCT00267969|565757299|FG004|Controlled Period|Randomized but not treated|0|||
156729120|NCT00267969|565757300|FG005|Controlled Period|Randomized but not treated|0|||
156729121|NCT00267969|565757301|FG006|Controlled Period|Randomized but not treated|0|||
156729122|NCT00267969|565757295|FG000|Controlled Period|Other|2|||
156729123|NCT00267969|565757296|FG001|Controlled Period|Other|1|||
156729124|NCT00267969|565757297|FG002|Controlled Period|Other|6|||
156729125|NCT00267969|565757298|FG003|Controlled Period|Other|0|||
156729126|NCT00267969|565757299|FG004|Controlled Period|Other|0|||
156729127|NCT00267969|565757300|FG005|Controlled Period|Other|0|||
156729128|NCT00267969|565757301|FG006|Controlled Period|Other|0|||
156729129|NCT00267969|565757295|FG000|After Controlled Period|Adverse Event|0|||
156729130|NCT00267969|565757296|FG001|After Controlled Period|Adverse Event|0|||
156729131|NCT00267969|565757297|FG002|After Controlled Period|Adverse Event|0|||
156729132|NCT00267969|565757298|FG003|After Controlled Period|Adverse Event|7|||
156729133|NCT00267969|565757299|FG004|After Controlled Period|Adverse Event|8|||
156729134|NCT00267969|565757300|FG005|After Controlled Period|Adverse Event|23|||
156729135|NCT00267969|565757301|FG006|After Controlled Period|Adverse Event|21|||
156729136|NCT00267969|565757295|FG000|After Controlled Period|Death|0|||
156729137|NCT00267969|565757296|FG001|After Controlled Period|Death|0|||
156729138|NCT00267969|565757297|FG002|After Controlled Period|Death|0|||
156729139|NCT00267969|565757298|FG003|After Controlled Period|Death|1|||
156729140|NCT00267969|565757299|FG004|After Controlled Period|Death|2|||
156729141|NCT00267969|565757300|FG005|After Controlled Period|Death|0|||
156729142|NCT00267969|565757301|FG006|After Controlled Period|Death|1|||
156729143|NCT00267969|565757295|FG000|After Controlled Period|Lack of Efficacy|0|||
156729144|NCT00267969|565757296|FG001|After Controlled Period|Lack of Efficacy|0|||
156729145|NCT00267969|565757297|FG002|After Controlled Period|Lack of Efficacy|0|||
156729146|NCT00267969|565757298|FG003|After Controlled Period|Lack of Efficacy|10|||
156729147|NCT00267969|565757299|FG004|After Controlled Period|Lack of Efficacy|6|||
156729148|NCT00267969|565757300|FG005|After Controlled Period|Lack of Efficacy|28|||
156729149|NCT00267969|565757301|FG006|After Controlled Period|Lack of Efficacy|15|||
156729150|NCT00267969|565757295|FG000|After Controlled Period|Lost to Follow-up|0|||
156729151|NCT00267969|565757296|FG001|After Controlled Period|Lost to Follow-up|0|||
156729152|NCT00267969|565757297|FG002|After Controlled Period|Lost to Follow-up|0|||
156336245|NCT01387789|564328210|FG000|Overall Study|Lack of Efficacy|2|||
156729153|NCT00267969|565757298|FG003|After Controlled Period|Lost to Follow-up|5|||
156729154|NCT00267969|565757299|FG004|After Controlled Period|Lost to Follow-up|8|||
156729155|NCT00267969|565757300|FG005|After Controlled Period|Lost to Follow-up|9|||
156729156|NCT00267969|565757301|FG006|After Controlled Period|Lost to Follow-up|10|||
156729157|NCT00267969|565757295|FG000|After Controlled Period|Other|0|||
156729158|NCT00267969|565757296|FG001|After Controlled Period|Other|0|||
156729159|NCT00267969|565757297|FG002|After Controlled Period|Other|0|||
156729160|NCT00267969|565757298|FG003|After Controlled Period|Other|13|||
156729161|NCT00267969|565757299|FG004|After Controlled Period|Other|11|||
156729162|NCT00267969|565757300|FG005|After Controlled Period|Other|22|||
156729163|NCT00267969|565757301|FG006|After Controlled Period|Other|25|||
156729164|NCT00887315|565757302|FG000|Overall Study|Study termination|7|||
156729165|NCT00887315|565757303|FG001|Overall Study|Study termination|4|||
156729166|NCT00619892|565757304|FG000|Overall Study|Adverse Event|3|||
156729167|NCT00619892|565757305|FG001|Overall Study|Adverse Event|0|||
156729168|NCT00619892|565757304|FG000|Overall Study|Lost to Follow-up|0|||
156729169|NCT00619892|565757305|FG001|Overall Study|Lost to Follow-up|1|||
156729170|NCT00619892|565757304|FG000|Overall Study|Intercurrent illness|0|||
156729171|NCT00619892|565757305|FG001|Overall Study|Intercurrent illness|1|||
156729172|NCT01091662|565757309|FG000|Overall Study|Adverse Event|1|||
156729173|NCT01091662|565757310|FG001|Overall Study|Adverse Event|9|||
156729174|NCT01091662|565757309|FG000|Overall Study|Physician Decision|1|||
156729175|NCT01091662|565757310|FG001|Overall Study|Physician Decision|1|||
156729176|NCT01091662|565757309|FG000|Overall Study|Withdrawal by Subject|7|||
156729177|NCT01091662|565757310|FG001|Overall Study|Withdrawal by Subject|6|||
156729178|NCT01091662|565757309|FG000|Overall Study|met exit criteria|7|||
156729179|NCT01091662|565757310|FG001|Overall Study|met exit criteria|13|||
156729180|NCT01091662|565757309|FG000|Overall Study|met exclusion criteria|1|||
156729181|NCT01091662|565757310|FG001|Overall Study|met exclusion criteria|0|||
156729182|NCT01091662|565757309|FG000|Overall Study|Lost to Follow-up|0|||
156729183|NCT01091662|565757310|FG001|Overall Study|Lost to Follow-up|1|||
156729184|NCT01091662|565757309|FG000|Overall Study|Pregnancy|0|||
156729185|NCT01091662|565757310|FG001|Overall Study|Pregnancy|1|||
156729186|NCT01091662|565757309|FG000|Overall Study|Protocol Violation|0|||
156729187|NCT01091662|565757310|FG001|Overall Study|Protocol Violation|2|||
156729188|NCT01091662|565757309|FG000|Overall Study|unable to swallow capsule|0|||
156729189|NCT01091662|565757310|FG001|Overall Study|unable to swallow capsule|1|||
156729190|NCT00443079|565757313|FG000|Overall Study|Lost to Follow-up|0|||
156729191|NCT00443079|565757314|FG001|Overall Study|Lost to Follow-up|1|||
156729192|NCT02649439|565757315|FG000|Overall Study|Switched to alternative treatment|6|||
156729193|NCT02649439|565757316|FG001|Overall Study|Switched to alternative treatment|4|||
156729194|NCT02649439|565757315|FG000|Overall Study|Patient decision|1|||
156729195|NCT02649439|565757316|FG001|Overall Study|Patient decision|0|||
156729196|NCT02649439|565757315|FG000|Overall Study|Patient going out of country|1|||
156729197|NCT02649439|565757316|FG001|Overall Study|Patient going out of country|0|||
156729198|NCT02649439|565757315|FG000|Overall Study|To start finasteride|1|||
156729199|NCT02649439|565757316|FG001|Overall Study|To start finasteride|0|||
156729200|NCT02649439|565757315|FG000|Overall Study|Physician Decision|1|||
156729201|NCT02649439|565757316|FG001|Overall Study|Physician Decision|0|||
156729202|NCT02649439|565757315|FG000|Overall Study|Disease progression on study|12|||
156729203|NCT02649439|565757316|FG001|Overall Study|Disease progression on study|13|||
156729204|NCT02649439|565757315|FG000|Overall Study|Refused further treatment|1|||
156729205|NCT02649439|565757316|FG001|Overall Study|Refused further treatment|0|||
156729206|NCT02649439|565757315|FG000|Overall Study|Refused further follow up|2|||
156729207|NCT02649439|565757316|FG001|Overall Study|Refused further follow up|7|||
156729208|NCT02649439|565757315|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
156729209|NCT02649439|565757316|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
156729210|NCT02649439|565757315|FG000|Overall Study|No treatment, per protocol|1|||
156729211|NCT02649439|565757316|FG001|Overall Study|No treatment, per protocol|0|||
156729212|NCT02649439|565757315|FG000|Overall Study|PSA DT makes ineligible|0|||
156729213|NCT02649439|565757316|FG001|Overall Study|PSA DT makes ineligible|1|||
156729214|NCT02649439|565757315|FG000|Overall Study|Rising PSA No Mets|0|||
156729215|NCT02649439|565757316|FG001|Overall Study|Rising PSA No Mets|1|||
156729216|NCT02649439|565757315|FG000|Overall Study|Rising PSA|0|||
156729217|NCT02649439|565757316|FG001|Overall Study|Rising PSA|1|||
156533581|NCT00578786|565048865|FG000|Overall Study|Withdrawal by Subject|7|||
156533582|NCT00578786|565048866|FG001|Overall Study|Withdrawal by Subject|8|||
156533583|NCT00578786|565048867|FG002|Overall Study|Withdrawal by Subject|5|||
156533584|NCT00578786|565048865|FG000|Overall Study|Protocol Violation|0|||
156533585|NCT00578786|565048866|FG001|Overall Study|Protocol Violation|3|||
156533586|NCT00578786|565048867|FG002|Overall Study|Protocol Violation|1|||
156729218|NCT02649439|565757315|FG000|Overall Study|Signed follow up protocol|0|||
156729219|NCT02649439|565757316|FG001|Overall Study|Signed follow up protocol|1|||
156729220|NCT02677922|565757319|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
156729221|NCT02677922|565757320|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
156729222|NCT02677922|565757321|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
156729223|NCT02677922|565757322|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
156729224|NCT02677922|565757323|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
156729225|NCT02677922|565757324|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
156729226|NCT02677922|565757319|FG000|Treatment Period|Adverse Event|0|||
156729227|NCT02677922|565757320|FG001|Treatment Period|Adverse Event|0|||
156729228|NCT02677922|565757321|FG002|Treatment Period|Adverse Event|1|||
156729229|NCT02677922|565757322|FG003|Treatment Period|Adverse Event|3|||
156729230|NCT02677922|565757323|FG004|Treatment Period|Adverse Event|5|||
156729231|NCT02677922|565757324|FG005|Treatment Period|Adverse Event|2|||
156729232|NCT02677922|565757319|FG000|Treatment Period|Progressive Disease|1|||
156729233|NCT02677922|565757320|FG001|Treatment Period|Progressive Disease|1|||
156729234|NCT02677922|565757321|FG002|Treatment Period|Progressive Disease|0|||
156729235|NCT02677922|565757322|FG003|Treatment Period|Progressive Disease|0|||
156729236|NCT02677922|565757323|FG004|Treatment Period|Progressive Disease|8|||
156729237|NCT02677922|565757324|FG005|Treatment Period|Progressive Disease|7|||
156729238|NCT02677922|565757319|FG000|Treatment Period|Lack of Efficacy|0|||
156729239|NCT02677922|565757320|FG001|Treatment Period|Lack of Efficacy|0|||
156729240|NCT02677922|565757321|FG002|Treatment Period|Lack of Efficacy|0|||
156729241|NCT02677922|565757322|FG003|Treatment Period|Lack of Efficacy|1|||
156729242|NCT02677922|565757323|FG004|Treatment Period|Lack of Efficacy|1|||
156729243|NCT02677922|565757324|FG005|Treatment Period|Lack of Efficacy|6|||
156729244|NCT02677922|565757319|FG000|Treatment Period|Withdrawal by Subject|0|||
156729245|NCT02677922|565757320|FG001|Treatment Period|Withdrawal by Subject|0|||
156729246|NCT02677922|565757321|FG002|Treatment Period|Withdrawal by Subject|1|||
156729247|NCT02677922|565757322|FG003|Treatment Period|Withdrawal by Subject|3|||
156729248|NCT02677922|565757323|FG004|Treatment Period|Withdrawal by Subject|5|||
156729249|NCT02677922|565757324|FG005|Treatment Period|Withdrawal by Subject|5|||
156729250|NCT02677922|565757319|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
156729251|NCT02677922|565757320|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
156729252|NCT02677922|565757321|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
156729253|NCT02677922|565757322|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
156729254|NCT02677922|565757323|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
156729255|NCT02677922|565757324|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
156729256|NCT02677922|565757319|FG000|Treatment Period|Disease Relapse|0|||
156729257|NCT02677922|565757320|FG001|Treatment Period|Disease Relapse|0|||
156729258|NCT02677922|565757321|FG002|Treatment Period|Disease Relapse|0|||
156729259|NCT02677922|565757322|FG003|Treatment Period|Disease Relapse|3|||
156729260|NCT02677922|565757323|FG004|Treatment Period|Disease Relapse|6|||
156729261|NCT02677922|565757324|FG005|Treatment Period|Disease Relapse|1|||
156729262|NCT02677922|565757319|FG000|Treatment Period|Allogeneic HSCT|1|||
156729263|NCT02677922|565757320|FG001|Treatment Period|Allogeneic HSCT|0|||
156729264|NCT02677922|565757321|FG002|Treatment Period|Allogeneic HSCT|0|||
156729265|NCT02677922|565757322|FG003|Treatment Period|Allogeneic HSCT|1|||
156729266|NCT02677922|565757323|FG004|Treatment Period|Allogeneic HSCT|4|||
156729267|NCT02677922|565757324|FG005|Treatment Period|Allogeneic HSCT|1|||
156729268|NCT02677922|565757319|FG000|Treatment Period|Other Reasons|0|||
156729269|NCT02677922|565757320|FG001|Treatment Period|Other Reasons|0|||
156729270|NCT02677922|565757321|FG002|Treatment Period|Other Reasons|0|||
156729271|NCT02677922|565757322|FG003|Treatment Period|Other Reasons|1|||
156729272|NCT02677922|565757323|FG004|Treatment Period|Other Reasons|3|||
156729273|NCT02677922|565757324|FG005|Treatment Period|Other Reasons|5|||
156729274|NCT02677922|565757319|FG000|Treatment Period|Death|0|||
156729275|NCT02677922|565757320|FG001|Treatment Period|Death|0|||
156729276|NCT02677922|565757321|FG002|Treatment Period|Death|0|||
156796199|NCT02471144|566007989|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156729277|NCT02677922|565757322|FG003|Treatment Period|Death|0|||
156729278|NCT02677922|565757323|FG004|Treatment Period|Death|12|||
156729279|NCT02677922|565757324|FG005|Treatment Period|Death|1|||
156729280|NCT02677922|565757319|FG000|Treatment Period|Non-compliance with Study Drug|0|||
156729281|NCT02677922|565757320|FG001|Treatment Period|Non-compliance with Study Drug|0|||
156729282|NCT02677922|565757321|FG002|Treatment Period|Non-compliance with Study Drug|0|||
156729283|NCT02677922|565757322|FG003|Treatment Period|Non-compliance with Study Drug|0|||
156729284|NCT02677922|565757323|FG004|Treatment Period|Non-compliance with Study Drug|1|||
156729285|NCT02677922|565757324|FG005|Treatment Period|Non-compliance with Study Drug|0|||
156796200|NCT02471144|566007979|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796201|NCT02471144|566007980|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796202|NCT02471144|566007981|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796203|NCT02471144|566007982|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796204|NCT02471144|566007983|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796205|NCT02471144|566007984|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
156729286|NCT02677922|565757319|FG000|Treatment Period|Physician Decision|0|||
156729287|NCT02677922|565757320|FG001|Treatment Period|Physician Decision|0|||
156729288|NCT02677922|565757321|FG002|Treatment Period|Physician Decision|0|||
156729289|NCT02677922|565757322|FG003|Treatment Period|Physician Decision|0|||
156729290|NCT02677922|565757323|FG004|Treatment Period|Physician Decision|0|||
156796206|NCT02471144|566007985|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796207|NCT02471144|566007986|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156729291|NCT02677922|565757324|FG005|Treatment Period|Physician Decision|1|||
156729292|NCT02677922|565757319|FG000|Treatment Period|Symptomatic Deterioration|0|||
156729293|NCT02677922|565757320|FG001|Treatment Period|Symptomatic Deterioration|0|||
156729294|NCT02677922|565757321|FG002|Treatment Period|Symptomatic Deterioration|0|||
156729295|NCT02677922|565757322|FG003|Treatment Period|Symptomatic Deterioration|0|||
156729296|NCT02677922|565757323|FG004|Treatment Period|Symptomatic Deterioration|1|||
156796208|NCT02471144|566007987|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
156796209|NCT02471144|566007988|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796210|NCT02471144|566007989|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796211|NCT02471144|566007979|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796212|NCT02471144|566007980|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796213|NCT02471144|566007981|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796214|NCT02471144|566007982|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796215|NCT02471144|566007983|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796216|NCT02471144|566007984|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156336246|NCT01387789|564328210|FG000|Overall Study|Lost to Follow-up|1|||
156336247|NCT02187744|564328215|FG000|Study|Participant refused further follow-up|1|||
156336248|NCT02187744|564328216|FG001|Study|Participant refused further follow-up|0|||
156336249|NCT02187744|564328215|FG000|Study|Other|2|||
156454925|NCT04830800|564759354|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
156454926|NCT04830800|564759355|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
156454927|NCT05192109|564759360|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
156454928|NCT05192109|564759361|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
156454929|NCT05192109|564759362|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156454930|NCT05192109|564759363|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156454931|NCT05192109|564759360|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
156454932|NCT05192109|564759361|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
156454933|NCT05192109|564759362|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156454934|NCT05192109|564759363|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156454935|NCT03287817|564761521|FG000|Overall Study|Progressive disease|4|||
156454936|NCT03287817|564761522|FG001|Overall Study|Progressive disease|2|||
156454937|NCT03287817|564761523|FG002|Overall Study|Progressive disease|3|||
156454938|NCT03287817|564761524|FG003|Overall Study|Progressive disease|10|||
156454939|NCT03287817|564761525|FG004|Overall Study|Progressive disease|8|||
156454940|NCT03287817|564761521|FG000|Overall Study|Death|0|||
156729297|NCT02677922|565757324|FG005|Treatment Period|Symptomatic Deterioration|0|||
156729298|NCT05708976|565757327|FG000|Overall Study|Withdrawal by Subject|0|||
156729299|NCT05708976|565757328|FG001|Overall Study|Withdrawal by Subject|1|||
156729300|NCT00403481|565757329|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
156729301|NCT00403481|565757329|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
156729302|NCT00403481|565757329|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
156729303|NCT00403481|565757329|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
156729304|NCT00403481|565757329|FG000|Olm 40 mg|Adverse Event|2|||
156729305|NCT00403481|565757329|FG000|Olm 40 mg|Protocol Violation|1|||
156729306|NCT00403481|565757329|FG000|Olm 40 mg|Withdrawal by Subject|1|||
156729307|NCT00403481|565757329|FG000|Olm 40 mg|Other|1|||
156729308|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
156729309|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
156729310|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
156729311|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
156729312|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
156729313|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
156729314|NCT02929589|565757331|FG000|Overall Study|Withdrawal by Subject|1|||
156729315|NCT02929589|565757332|FG001|Overall Study|Withdrawal by Subject|0|||
156729316|NCT02929589|565757333|FG002|Overall Study|Withdrawal by Subject|0|||
156729317|NCT02929589|565757334|FG003|Overall Study|Withdrawal by Subject|0|||
156729318|NCT02929589|565757331|FG000|Overall Study|Physician Decision|2|||
156729319|NCT02929589|565757332|FG001|Overall Study|Physician Decision|0|||
156729320|NCT02929589|565757333|FG002|Overall Study|Physician Decision|0|||
156729321|NCT02929589|565757334|FG003|Overall Study|Physician Decision|0|||
156729322|NCT00396656|565757335|FG000|First Treatment Period|Withdrawal by Subject|0|||
156729323|NCT00396656|565757336|FG001|First Treatment Period|Withdrawal by Subject|2|||
156796217|NCT02471144|566007985|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796218|NCT02471144|566007986|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796219|NCT02471144|566007987|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
156796220|NCT02471144|566007988|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796221|NCT02471144|566007989|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156336250|NCT02187744|564328216|FG001|Study|Other|1|||
156454941|NCT03287817|564761522|FG001|Overall Study|Death|0|||
156454942|NCT03287817|564761523|FG002|Overall Study|Death|2|||
156454943|NCT03287817|564761524|FG003|Overall Study|Death|3|||
156729324|NCT00396656|565757335|FG000|Second Treatment Period|Adverse Event|0|||
156729325|NCT00396656|565757336|FG001|Second Treatment Period|Adverse Event|1|||
156729326|NCT02343939|565757338|FG000|Overall Study|Death|0|||
156729327|NCT02343939|565757339|FG001|Overall Study|Death|15|||
156729328|NCT02343939|565757340|FG002|Overall Study|Death|4|||
156533587|NCT00578786|565048865|FG000|Overall Study|Physician Decision|1|||
156336251|NCT02187744|564328215|FG000|Study|Lost to Follow-up|0|||
156729329|NCT02343939|565757341|FG003|Overall Study|Death|2|||
156729330|NCT02343939|565757342|FG004|Overall Study|Death|5|||
156729331|NCT02343939|565757343|FG005|Overall Study|Death|11|||
156729332|NCT02343939|565757344|FG006|Overall Study|Death|8|||
156729333|NCT02343939|565757345|FG007|Overall Study|Death|22|||
156729334|NCT02343939|565757346|FG008|Overall Study|Death|1|||
156729335|NCT02343939|565757338|FG000|Overall Study|Study terminated by sponsor|0|||
156729336|NCT02343939|565757339|FG001|Overall Study|Study terminated by sponsor|27|||
156796222|NCT02471144|566007979|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796223|NCT02471144|566007980|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796224|NCT02471144|566007981|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796225|NCT02471144|566007982|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796226|NCT02471144|566007983|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796227|NCT02471144|566007984|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156729337|NCT02343939|565757340|FG002|Overall Study|Study terminated by sponsor|0|||
156729338|NCT02343939|565757341|FG003|Overall Study|Study terminated by sponsor|1|||
156729339|NCT02343939|565757342|FG004|Overall Study|Study terminated by sponsor|1|||
156729340|NCT02343939|565757343|FG005|Overall Study|Study terminated by sponsor|5|||
156729341|NCT02343939|565757344|FG006|Overall Study|Study terminated by sponsor|3|||
156729342|NCT02343939|565757345|FG007|Overall Study|Study terminated by sponsor|4|||
156729343|NCT02343939|565757346|FG008|Overall Study|Study terminated by sponsor|0|||
156796228|NCT02471144|566007985|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796229|NCT02471144|566007986|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
156796230|NCT02471144|566007987|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
156796231|NCT02471144|566007988|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796232|NCT02471144|566007989|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796233|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796234|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796235|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796236|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796237|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796238|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156876418|NCT00035932|566305833|FG000|Overall Study|Death|0|||
156876419|NCT00035932|566305834|FG001|Overall Study|Death|0|||
156876420|NCT00035932|566305835|FG002|Overall Study|Death|1|||
156876421|NCT00035932|566305833|FG000|Overall Study|Disease Progression / Relapse|1|||
156876422|NCT00035932|566305834|FG001|Overall Study|Disease Progression / Relapse|1|||
156876423|NCT00035932|566305835|FG002|Overall Study|Disease Progression / Relapse|0|||
156876424|NCT00035932|566305833|FG000|Overall Study|Lost to Follow-up|4|||
156876425|NCT00035932|566305834|FG001|Overall Study|Lost to Follow-up|4|||
156876426|NCT00035932|566305835|FG002|Overall Study|Lost to Follow-up|3|||
156876427|NCT00035932|566305833|FG000|Overall Study|Noncompliance|6|||
156876428|NCT00035932|566305834|FG001|Overall Study|Noncompliance|7|||
156876429|NCT00035932|566305835|FG002|Overall Study|Noncompliance|6|||
156876430|NCT00035932|566305833|FG000|Overall Study|Protocol Violation While on Study|0|||
156876431|NCT00035932|566305834|FG001|Overall Study|Protocol Violation While on Study|1|||
156876432|NCT00035932|566305835|FG002|Overall Study|Protocol Violation While on Study|2|||
156876433|NCT00035932|566305833|FG000|Overall Study|Withdrawal by Subject|1|||
156876434|NCT00035932|566305834|FG001|Overall Study|Withdrawal by Subject|5|||
156876435|NCT00035932|566305835|FG002|Overall Study|Withdrawal by Subject|0|||
156876436|NCT00035932|566305833|FG000|Overall Study|Study Termination by Sponsor|1|||
156876437|NCT00035932|566305834|FG001|Overall Study|Study Termination by Sponsor|0|||
156876438|NCT00035932|566305835|FG002|Overall Study|Study Termination by Sponsor|0|||
156876439|NCT00035932|566305833|FG000|Overall Study|Lack of Efficacy|33|||
156876440|NCT00035932|566305834|FG001|Overall Study|Lack of Efficacy|33|||
156876441|NCT00035932|566305835|FG002|Overall Study|Lack of Efficacy|28|||
156533588|NCT00578786|565048866|FG001|Overall Study|Physician Decision|0|||
156533589|NCT00578786|565048867|FG002|Overall Study|Physician Decision|1|||
156729344|NCT02343939|565757338|FG000|Overall Study|Withdrew consent|3|||
156729345|NCT02343939|565757339|FG001|Overall Study|Withdrew consent|6|||
156729346|NCT02343939|565757340|FG002|Overall Study|Withdrew consent|1|||
156729347|NCT02343939|565757341|FG003|Overall Study|Withdrew consent|2|||
156796239|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796240|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796241|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156729348|NCT02343939|565757342|FG004|Overall Study|Withdrew consent|2|||
156729349|NCT02343939|565757343|FG005|Overall Study|Withdrew consent|0|||
156796242|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
156796243|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
156876442|NCT00889720|566305838|FG000|Overall Study|Withdrawal by Subject|4|||
156876443|NCT00889720|566305838|FG000|Overall Study|Other|4|||
156876444|NCT04080167|566305839|FG000|Overall Study|Lost to Follow-up-Patients|7|||
156876445|NCT04080167|566305840|FG001|Overall Study|Lost to Follow-up-Patients|14|||
156454944|NCT03287817|564761525|FG004|Overall Study|Death|4|||
156454945|NCT03287817|564761521|FG000|Overall Study|Physician Decision|0|||
156454946|NCT03287817|564761522|FG001|Overall Study|Physician Decision|0|||
156454947|NCT03287817|564761523|FG002|Overall Study|Physician Decision|0|||
156729350|NCT02343939|565757344|FG006|Overall Study|Withdrew consent|0|||
156729351|NCT02343939|565757345|FG007|Overall Study|Withdrew consent|8|||
156729352|NCT02343939|565757346|FG008|Overall Study|Withdrew consent|6|||
156729353|NCT02343939|565757338|FG000|Overall Study|Treatment failure|0|||
156729354|NCT02343939|565757339|FG001|Overall Study|Treatment failure|0|||
156729355|NCT02343939|565757340|FG002|Overall Study|Treatment failure|0|||
156729356|NCT02343939|565757341|FG003|Overall Study|Treatment failure|0|||
156729357|NCT02343939|565757342|FG004|Overall Study|Treatment failure|0|||
156729358|NCT02343939|565757343|FG005|Overall Study|Treatment failure|0|||
156729359|NCT02343939|565757344|FG006|Overall Study|Treatment failure|2|||
156729360|NCT02343939|565757345|FG007|Overall Study|Treatment failure|1|||
156729361|NCT02343939|565757346|FG008|Overall Study|Treatment failure|0|||
156729362|NCT02343939|565757338|FG000|Overall Study|Investigator's discretion|0|||
156729363|NCT02343939|565757339|FG001|Overall Study|Investigator's discretion|0|||
156729364|NCT02343939|565757340|FG002|Overall Study|Investigator's discretion|0|||
156729365|NCT02343939|565757341|FG003|Overall Study|Investigator's discretion|1|||
156729366|NCT02343939|565757342|FG004|Overall Study|Investigator's discretion|0|||
156729367|NCT02343939|565757343|FG005|Overall Study|Investigator's discretion|0|||
156729368|NCT02343939|565757344|FG006|Overall Study|Investigator's discretion|1|||
156729369|NCT02343939|565757345|FG007|Overall Study|Investigator's discretion|0|||
156729370|NCT02343939|565757346|FG008|Overall Study|Investigator's discretion|0|||
156729371|NCT02343939|565757338|FG000|Overall Study|Adverse Event|0|||
156729372|NCT02343939|565757339|FG001|Overall Study|Adverse Event|0|||
156729373|NCT02343939|565757340|FG002|Overall Study|Adverse Event|0|||
156729374|NCT02343939|565757341|FG003|Overall Study|Adverse Event|0|||
156729375|NCT02343939|565757342|FG004|Overall Study|Adverse Event|0|||
156729376|NCT02343939|565757343|FG005|Overall Study|Adverse Event|1|||
156729377|NCT02343939|565757344|FG006|Overall Study|Adverse Event|0|||
156729378|NCT02343939|565757345|FG007|Overall Study|Adverse Event|0|||
156729379|NCT02343939|565757346|FG008|Overall Study|Adverse Event|0|||
156729380|NCT02343939|565757338|FG000|Overall Study|Never Treated With ENTO|0|||
156729381|NCT02343939|565757339|FG001|Overall Study|Never Treated With ENTO|0|||
156729382|NCT02343939|565757340|FG002|Overall Study|Never Treated With ENTO|0|||
156729383|NCT02343939|565757341|FG003|Overall Study|Never Treated With ENTO|0|||
156729384|NCT02343939|565757342|FG004|Overall Study|Never Treated With ENTO|0|||
156729385|NCT02343939|565757343|FG005|Overall Study|Never Treated With ENTO|0|||
156729386|NCT02343939|565757344|FG006|Overall Study|Never Treated With ENTO|1|||
156729387|NCT02343939|565757345|FG007|Overall Study|Never Treated With ENTO|2|||
156729388|NCT02343939|565757346|FG008|Overall Study|Never Treated With ENTO|0|||
156729389|NCT01303172|565757347|FG000|Overall Study|Physician Decision|9|||
156729390|NCT01303172|565757348|FG001|Overall Study|Physician Decision|6|||
156729391|NCT01303172|565757347|FG000|Overall Study|Adverse Event|5|||
156729392|NCT01303172|565757348|FG001|Overall Study|Adverse Event|2|||
156729393|NCT01303172|565757347|FG000|Overall Study|Withdrawal by Subject|4|||
156729394|NCT01303172|565757348|FG001|Overall Study|Withdrawal by Subject|2|||
156729395|NCT01303172|565757347|FG000|Overall Study|Death|20|||
156729396|NCT01303172|565757348|FG001|Overall Study|Death|7|||
156729397|NCT01303172|565757347|FG000|Overall Study|Lack of Efficacy|25|||
156729398|NCT01303172|565757348|FG001|Overall Study|Lack of Efficacy|17|||
156729399|NCT02099110|565757353|FG000|Overall Study|Protocol Violation|2|||
156729400|NCT02099110|565757354|FG001|Overall Study|Protocol Violation|1|||
156729401|NCT02099110|565757355|FG002|Overall Study|Protocol Violation|0|||
156729402|NCT02099110|565757356|FG003|Overall Study|Protocol Violation|3|||
156729403|NCT02099110|565757357|FG004|Overall Study|Protocol Violation|1|||
156336252|NCT02187744|564328216|FG001|Study|Lost to Follow-up|2|||
156454948|NCT03287817|564761524|FG003|Overall Study|Physician Decision|1|||
156454949|NCT03287817|564761525|FG004|Overall Study|Physician Decision|0|||
156454950|NCT03287817|564761521|FG000|Overall Study|Withdrawal by Subject|0|||
156454951|NCT03287817|564761522|FG001|Overall Study|Withdrawal by Subject|0|||
156454952|NCT03287817|564761523|FG002|Overall Study|Withdrawal by Subject|0|||
156729404|NCT02099110|565757353|FG000|Overall Study|Participant moved|1|||
156729405|NCT02099110|565757354|FG001|Overall Study|Participant moved|1|||
156729406|NCT02099110|565757355|FG002|Overall Study|Participant moved|1|||
156729407|NCT02099110|565757356|FG003|Overall Study|Participant moved|0|||
156729408|NCT02099110|565757357|FG004|Overall Study|Participant moved|2|||
156729409|NCT02099110|565757353|FG000|Overall Study|Withdrawal by Subject|7|||
156729410|NCT02099110|565757354|FG001|Overall Study|Withdrawal by Subject|11|||
156729411|NCT02099110|565757355|FG002|Overall Study|Withdrawal by Subject|13|||
156454953|NCT03287817|564761524|FG003|Overall Study|Withdrawal by Subject|0|||
156729412|NCT02099110|565757356|FG003|Overall Study|Withdrawal by Subject|9|||
156454954|NCT03287817|564761525|FG004|Overall Study|Withdrawal by Subject|4|||
156729413|NCT02099110|565757357|FG004|Overall Study|Withdrawal by Subject|13|||
156729414|NCT02099110|565757353|FG000|Overall Study|Adverse Event|3|||
156460622|NCT04625725|564781648|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
156729415|NCT02099110|565757354|FG001|Overall Study|Adverse Event|5|||
156533590|NCT00578786|565048865|FG000|Overall Study|Sponsor Decision|0|||
156533591|NCT00578786|565048866|FG001|Overall Study|Sponsor Decision|0|||
156729416|NCT02099110|565757355|FG002|Overall Study|Adverse Event|2|||
156729417|NCT02099110|565757356|FG003|Overall Study|Adverse Event|3|||
156729418|NCT02099110|565757357|FG004|Overall Study|Adverse Event|2|||
156729419|NCT02099110|565757353|FG000|Overall Study|Lost to Follow-up|6|||
156729420|NCT02099110|565757354|FG001|Overall Study|Lost to Follow-up|12|||
156729421|NCT02099110|565757355|FG002|Overall Study|Lost to Follow-up|11|||
156729422|NCT02099110|565757356|FG003|Overall Study|Lost to Follow-up|5|||
156729423|NCT02099110|565757357|FG004|Overall Study|Lost to Follow-up|6|||
156729424|NCT02099110|565757353|FG000|Overall Study|Death|0|||
156729425|NCT02099110|565757354|FG001|Overall Study|Death|1|||
156729426|NCT02099110|565757355|FG002|Overall Study|Death|0|||
156729427|NCT02099110|565757356|FG003|Overall Study|Death|0|||
156729428|NCT02099110|565757357|FG004|Overall Study|Death|0|||
156729429|NCT02099110|565757353|FG000|Overall Study|Screen failure|0|||
156729430|NCT02099110|565757354|FG001|Overall Study|Screen failure|0|||
156729431|NCT02099110|565757355|FG002|Overall Study|Screen failure|0|||
156729432|NCT02099110|565757356|FG003|Overall Study|Screen failure|0|||
156729433|NCT02099110|565757357|FG004|Overall Study|Screen failure|1|||
156729434|NCT02099110|565757353|FG000|Overall Study|Non-compliance with study drug|2|||
156729435|NCT02099110|565757354|FG001|Overall Study|Non-compliance with study drug|0|||
156729436|NCT02099110|565757355|FG002|Overall Study|Non-compliance with study drug|0|||
156729437|NCT02099110|565757356|FG003|Overall Study|Non-compliance with study drug|0|||
156729438|NCT02099110|565757357|FG004|Overall Study|Non-compliance with study drug|1|||
156729439|NCT02099110|565757353|FG000|Overall Study|Physician Decision|3|||
156729440|NCT02099110|565757354|FG001|Overall Study|Physician Decision|0|||
156729441|NCT02099110|565757355|FG002|Overall Study|Physician Decision|1|||
156729442|NCT02099110|565757356|FG003|Overall Study|Physician Decision|2|||
156729443|NCT02099110|565757357|FG004|Overall Study|Physician Decision|1|||
156729444|NCT00994461|565757363|FG000|Overall Study|Adverse Event|2|||
156729445|NCT00994461|565757364|FG001|Overall Study|Adverse Event|1|||
156729446|NCT00994461|565757365|FG002|Overall Study|Adverse Event|0|||
156729447|NCT03291431|565757367|FG000|Overall Study|Protocol Violation|2|||
156729448|NCT03291431|565757368|FG001|Overall Study|Protocol Violation|1|||
156729449|NCT03291431|565757367|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
156729450|NCT03291431|565757368|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
156729451|NCT03291431|565757367|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
156729452|NCT03291431|565757368|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
156729453|NCT00068393|565758987|FG000|Overall Study|Adverse Event|2|||
156729454|NCT00068393|565758987|FG000|Overall Study|Death|3|||
156729455|NCT00068393|565758987|FG000|Overall Study|Withdrawal by Subject|3|||
156729456|NCT00068393|565758987|FG000|Overall Study|Alternative treatment|1|||
156729457|NCT00068393|565758987|FG000|Overall Study|Quality of life worsening|1|||
156729458|NCT01399047|565758988|FG000|Overall Study|Withdrawal by Subject|0|||
156729459|NCT01399047|565758989|FG001|Overall Study|Withdrawal by Subject|1|||
156729460|NCT03300505|565759009|FG000|Overall Study|Death|0|||
156729461|NCT03300505|565759010|FG001|Overall Study|Death|1|||
156729462|NCT03300505|565759011|FG002|Overall Study|Death|0|||
156729463|NCT03300505|565759009|FG000|Overall Study|Withdrawal by Subject|0|||
156729464|NCT03300505|565759010|FG001|Overall Study|Withdrawal by Subject|1|||
156729465|NCT03300505|565759011|FG002|Overall Study|Withdrawal by Subject|1|||
156729466|NCT03300505|565759009|FG000|Overall Study|Sponsor Termination|0|||
156729467|NCT03300505|565759010|FG001|Overall Study|Sponsor Termination|1|||
156729468|NCT03300505|565759011|FG002|Overall Study|Sponsor Termination|0|||
156729469|NCT03300505|565759009|FG000|Overall Study|Adverse Event|0|||
156729470|NCT03300505|565759010|FG001|Overall Study|Adverse Event|0|||
156729471|NCT03300505|565759011|FG002|Overall Study|Adverse Event|2|||
156729472|NCT05119595|565759012|FG000|Overall Study|Death|1|||
156729473|NCT05119595|565759012|FG000|Overall Study|Lost to Follow-up|7|||
156729474|NCT01806961|565759013|FG000|Overall Study|sponsor decision|16|||
156729475|NCT01108341|565759017|FG000|Overall Study|Death|2|||
156729476|NCT01108341|565759017|FG000|Overall Study|Withdrawal by Subject|1|||
156729477|NCT01108341|565759017|FG000|Overall Study|Lost to Follow-up|1|||
156729478|NCT01108341|565759017|FG000|Overall Study|Other|1|||
156729479|NCT02498444|565759023|FG000|Overall Study|Withdrawal by Subject|3|||
156729480|NCT02498444|565759024|FG001|Overall Study|Withdrawal by Subject|0|||
156729481|NCT02498444|565759023|FG000|Overall Study|Physician Decision|1|||
156729482|NCT02498444|565759024|FG001|Overall Study|Physician Decision|0|||
156729483|NCT03656692|565759025|FG000|Overall Study|Worsening of disease activity|2|||
156729484|NCT03656692|565759025|FG000|Overall Study|Physician Decision|1|||
156729485|NCT00912743|565759032|FG000|Overall Study|Adverse Event|3|||
156729486|NCT00912743|565759033|FG001|Overall Study|Adverse Event|1|||
156729487|NCT00912743|565759032|FG000|Overall Study|Lack of Efficacy|9|||
156729488|NCT00912743|565759033|FG001|Overall Study|Lack of Efficacy|18|||
156796244|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156729489|NCT00912743|565759032|FG000|Overall Study|Toxicity|0|||
156729490|NCT00912743|565759033|FG001|Overall Study|Toxicity|1|||
156454955|NCT05251909|564761530|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
156454956|NCT05251909|564761531|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
156454957|NCT03869866|564761537|FG000|Overall Study|Protocol Violation|1|||
156454958|NCT03869866|564761537|FG000|Overall Study|Withdrawal by Subject|3|||
156454959|NCT06181227|564761538|FG000|Overall Study|Study terminated by sponsor|7|||
156454960|NCT06181227|564761539|FG001|Overall Study|Study terminated by sponsor|9|||
156454961|NCT05543915|564761540|FG000|Overall Study|Lost to Follow-up|0|||
156454962|NCT05543915|564761541|FG001|Overall Study|Lost to Follow-up|1|||
156454963|NCT06516705|564761548|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
156454964|NCT06516705|564761549|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
156454965|NCT06516705|564761548|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
156454966|NCT06516705|564761549|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
156454967|NCT06516705|564761548|FG000|T3 ( 3 Month After Education)|covid-19|1|||
156454968|NCT06516705|564761549|FG001|T3 ( 3 Month After Education)|covid-19|2|||
156454969|NCT06516705|564761548|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
156454970|NCT06516705|564761549|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
156454971|NCT06516705|564761548|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
156454972|NCT06516705|564761549|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
156454973|NCT06516705|564761548|FG000|T4 ( 6 Month After Education)|covid-19|3|||
156454974|NCT06516705|564761549|FG001|T4 ( 6 Month After Education)|covid-19|2|||
156454975|NCT06516705|564761548|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
156454976|NCT06516705|564761549|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
156454977|NCT02485938|564761551|FG000|Overall Study|Withdrawal of consent|2|||
156454978|NCT02485938|564761552|FG001|Overall Study|Withdrawal of consent|0|||
156454979|NCT03241745|564761553|FG000|Overall Study|Adverse Event|7|||
156454980|NCT03241745|564761553|FG000|Overall Study|Death|1|||
156454981|NCT03241745|564761553|FG000|Overall Study|Withdrawal by Subject|5|||
156454982|NCT03241745|564761553|FG000|Overall Study|Treatment delay >28 days|2|||
156454983|NCT03241745|564761553|FG000|Overall Study|Lack of Efficacy|14|||
156454984|NCT00470704|564761554|FG000|Overall Study|Withdrawal by Subject|4|||
156454985|NCT00470704|564761555|FG001|Overall Study|Withdrawal by Subject|3|||
156533592|NCT00578786|565048867|FG002|Overall Study|Sponsor Decision|1|||
156729491|NCT00912743|565759032|FG000|Overall Study|End of treatment form was not collected|1|||
156729492|NCT00912743|565759033|FG001|Overall Study|End of treatment form was not collected|0|||
156729493|NCT01136356|565759034|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
156729494|NCT01136356|565759035|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
156729495|NCT01136356|565759034|FG000|First 18-day Withdrawal|Physician Decision|1|||
156729496|NCT01136356|565759035|FG001|First 18-day Withdrawal|Physician Decision|0|||
156729497|NCT01136356|565759034|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
156729498|NCT01136356|565759035|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
156729499|NCT00178685|565759036|FG000|Overall Study|Death|3|||
156729500|NCT00178685|565759037|FG001|Overall Study|Death|3|||
156729501|NCT00178685|565759038|FG002|Overall Study|Death|6|||
156729502|NCT00178685|565759036|FG000|Overall Study|Lost to Follow-up|100|||
156729503|NCT00178685|565759037|FG001|Overall Study|Lost to Follow-up|187|||
156729504|NCT00178685|565759038|FG002|Overall Study|Lost to Follow-up|183|||
156729505|NCT00178685|565759036|FG000|Overall Study|Withdrawal by Subject|8|||
156729506|NCT00178685|565759037|FG001|Overall Study|Withdrawal by Subject|14|||
156729507|NCT00178685|565759038|FG002|Overall Study|Withdrawal by Subject|7|||
156729508|NCT02237196|565759039|FG000|Overall Study|Adverse Event|0|||
156729509|NCT02237196|565759040|FG001|Overall Study|Adverse Event|1|||
156729510|NCT02237196|565759041|FG002|Overall Study|Adverse Event|1|||
156729511|NCT02237196|565759042|FG003|Overall Study|Adverse Event|0|||
156729512|NCT02237196|565759039|FG000|Overall Study|Lost to Follow-up|4|||
156729513|NCT02237196|565759040|FG001|Overall Study|Lost to Follow-up|2|||
156729514|NCT02237196|565759041|FG002|Overall Study|Lost to Follow-up|4|||
156729515|NCT02237196|565759042|FG003|Overall Study|Lost to Follow-up|6|||
156729516|NCT02237196|565759039|FG000|Overall Study|Physician Decision|2|||
156729517|NCT02237196|565759040|FG001|Overall Study|Physician Decision|0|||
156729518|NCT02237196|565759041|FG002|Overall Study|Physician Decision|0|||
156729519|NCT02237196|565759042|FG003|Overall Study|Physician Decision|1|||
156729520|NCT02237196|565759039|FG000|Overall Study|Pregnancy|0|||
156454986|NCT00470704|564761554|FG000|Overall Study|Relapse/Progression|37|||
156729521|NCT02237196|565759040|FG001|Overall Study|Pregnancy|0|||
156729522|NCT02237196|565759041|FG002|Overall Study|Pregnancy|1|||
156729523|NCT02237196|565759042|FG003|Overall Study|Pregnancy|1|||
156729524|NCT02237196|565759039|FG000|Overall Study|Withdrawal by Subject|1|||
156729525|NCT02237196|565759040|FG001|Overall Study|Withdrawal by Subject|1|||
156454987|NCT00470704|564761555|FG001|Overall Study|Relapse/Progression|42|||
156454988|NCT00470704|564761554|FG000|Overall Study|toxicity|0|||
156729526|NCT02237196|565759041|FG002|Overall Study|Withdrawal by Subject|4|||
156729527|NCT02237196|565759042|FG003|Overall Study|Withdrawal by Subject|1|||
156729528|NCT02237196|565759039|FG000|Overall Study|Site Error|1|||
156729529|NCT02237196|565759040|FG001|Overall Study|Site Error|2|||
156729530|NCT02237196|565759041|FG002|Overall Study|Site Error|0|||
156729531|NCT02237196|565759042|FG003|Overall Study|Site Error|2|||
156729532|NCT00862823|565759043|FG000|First Intervention|Withdrawal by Subject|1|||
156729533|NCT00862823|565759044|FG001|First Intervention|Withdrawal by Subject|1|||
156729534|NCT02049814|565759051|FG000|Overall Study|Reason not Specified|4|||
156729535|NCT02049814|565759052|FG001|Overall Study|Reason not Specified|3|||
156729536|NCT02049814|565759051|FG000|Overall Study|Pregnancy|1|||
156729537|NCT02049814|565759052|FG001|Overall Study|Pregnancy|0|||
156729538|NCT02049814|565759051|FG000|Overall Study|Lost to Follow-up|2|||
156729539|NCT02049814|565759052|FG001|Overall Study|Lost to Follow-up|3|||
156729540|NCT02049814|565759051|FG000|Overall Study|Serious Protocol Violation|5|||
156729541|NCT02049814|565759052|FG001|Overall Study|Serious Protocol Violation|7|||
156729542|NCT02049814|565759051|FG000|Overall Study|Study Termination|0|||
156729543|NCT02049814|565759052|FG001|Overall Study|Study Termination|1|||
156729544|NCT02049814|565759051|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
156729545|NCT02049814|565759052|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
156729546|NCT02049814|565759051|FG000|Overall Study|Voluntary withdrawal|9|||
156729547|NCT02049814|565759052|FG001|Overall Study|Voluntary withdrawal|8|||
156729548|NCT00713258|565759053|FG000|Overall Study|Adverse Event|2|||
156729549|NCT00713258|565759054|FG001|Overall Study|Adverse Event|4|||
156729550|NCT00713258|565759053|FG000|Overall Study|Non-Compliance|2|||
156729551|NCT00713258|565759054|FG001|Overall Study|Non-Compliance|1|||
156729552|NCT00713258|565759053|FG000|Overall Study|Other|1|||
156729553|NCT00713258|565759054|FG001|Overall Study|Other|1|||
156729554|NCT02484456|565759057|FG000|Washout Period|Withdrawal by Subject|0|||
156729555|NCT02484456|565759058|FG001|Washout Period|Withdrawal by Subject|1|||
156729556|NCT02484456|565759057|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
156729557|NCT02484456|565759058|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
156729558|NCT02484456|565759057|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
156729559|NCT02484456|565759058|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
156729560|NCT02484456|565759057|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
156729561|NCT02484456|565759058|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
156729562|NCT00708214|565759059|FG000|Overall Study|Other Adverse Event|3|||
156729563|NCT00708214|565759060|FG001|Overall Study|Other Adverse Event|6|||
156729564|NCT00708214|565759061|FG002|Overall Study|Other Adverse Event|2|||
156729565|NCT00708214|565759059|FG000|Overall Study|Other|0|||
156729566|NCT00708214|565759060|FG001|Overall Study|Other|1|||
156729567|NCT00708214|565759061|FG002|Overall Study|Other|1|||
156729568|NCT00708214|565759059|FG000|Overall Study|Progressive Disease|4|||
156729569|NCT00708214|565759060|FG001|Overall Study|Progressive Disease|6|||
156729570|NCT00708214|565759061|FG002|Overall Study|Progressive Disease|5|||
156729571|NCT02199795|565759062|FG000|Overall Study|no longer met inclusion criteria|1|||
156729572|NCT02199795|565759063|FG001|Overall Study|no longer met inclusion criteria|0|||
156729573|NCT02199795|565759062|FG000|Overall Study|withdrew due to shoulder pain|1|||
156729574|NCT02199795|565759063|FG001|Overall Study|withdrew due to shoulder pain|0|||
156729575|NCT05310071|565759067|FG000|Overall Study|Death|0|||
156729576|NCT05310071|565759068|FG001|Overall Study|Death|3|||
156729577|NCT05310071|565759067|FG000|Overall Study|Adverse Event|4|||
156729578|NCT05310071|565759068|FG001|Overall Study|Adverse Event|31|||
156729579|NCT05310071|565759067|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
156729580|NCT05310071|565759068|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
156729581|NCT05310071|565759067|FG000|Overall Study|Protocol Deviation|2|||
156729582|NCT05310071|565759068|FG001|Overall Study|Protocol Deviation|0|||
156729583|NCT05310071|565759067|FG000|Overall Study|Randomized by Mistake|0|||
156729584|NCT05310071|565759068|FG001|Overall Study|Randomized by Mistake|1|||
156729585|NCT05310071|565759067|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
156729586|NCT05310071|565759068|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
156729587|NCT05310071|565759067|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
156729588|NCT05310071|565759068|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
156729589|NCT05310071|565759067|FG000|Overall Study|Site Terminated by Sponsor|0|||
156729590|NCT05310071|565759068|FG001|Overall Study|Site Terminated by Sponsor|2|||
156729591|NCT05310071|565759067|FG000|Overall Study|Study Terminated by Sponsor|282|||
156729592|NCT05310071|565759068|FG001|Overall Study|Study Terminated by Sponsor|559|||
156729593|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
156454989|NCT00470704|564761555|FG001|Overall Study|toxicity|1|||
156729594|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
156729595|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
156729596|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
156729597|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
156729598|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
156729599|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
156729600|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
156729601|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant - Other|25|||
156729602|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant - Other|30|||
156729603|NCT05310071|565759067|FG000|Overall Study|Lost to Follow-up|2|||
156729604|NCT05310071|565759068|FG001|Overall Study|Lost to Follow-up|4|||
156729605|NCT05310071|565759067|FG000|Overall Study|Reason Not Specified|1|||
156729606|NCT05310071|565759068|FG001|Overall Study|Reason Not Specified|3|||
156729607|NCT02418949|565759069|FG000|Overall Study|Withdrawal by Subject|1|||
156729608|NCT02418949|565759070|FG001|Overall Study|Withdrawal by Subject|0|||
156729609|NCT02418949|565759071|FG002|Overall Study|Withdrawal by Subject|1|||
156729610|NCT02418949|565759072|FG003|Overall Study|Withdrawal by Subject|1|||
156729611|NCT02418949|565759069|FG000|Overall Study|Lost to Follow-up|1|||
156729612|NCT02418949|565759070|FG001|Overall Study|Lost to Follow-up|0|||
156729613|NCT02418949|565759071|FG002|Overall Study|Lost to Follow-up|1|||
156729614|NCT02418949|565759072|FG003|Overall Study|Lost to Follow-up|0|||
156729615|NCT02418949|565759069|FG000|Overall Study|Physician Decision|1|||
156729616|NCT02418949|565759070|FG001|Overall Study|Physician Decision|1|||
156729617|NCT02418949|565759071|FG002|Overall Study|Physician Decision|1|||
156729618|NCT02418949|565759072|FG003|Overall Study|Physician Decision|0|||
156729619|NCT00014495|565759073|FG000|Overall Study|Death|0|||
156729620|NCT00014495|565759074|FG001|Overall Study|Death|0|||
156729621|NCT00014495|565759075|FG002|Overall Study|Death|1|||
156729622|NCT00014495|565759076|FG003|Overall Study|Death|0|||
156729623|NCT00014495|565759073|FG000|Overall Study|Clinical deterioration|0|||
156729624|NCT00014495|565759074|FG001|Overall Study|Clinical deterioration|0|||
156729625|NCT00014495|565759075|FG002|Overall Study|Clinical deterioration|0|||
156729626|NCT00014495|565759076|FG003|Overall Study|Clinical deterioration|1|||
156729627|NCT00828568|565759077|FG000|Randomized|Withdrawal by Subject|1|||
156729628|NCT00828568|565759078|FG001|Randomized|Withdrawal by Subject|0|||
156729629|NCT00828568|565759079|FG002|Randomized|Withdrawal by Subject|2|||
156729630|NCT00828568|565759077|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
156729631|NCT00828568|565759078|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
156729632|NCT00828568|565759079|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
156729633|NCT00828568|565759077|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
156729634|NCT00828568|565759078|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
156729635|NCT00828568|565759079|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
156729636|NCT00828568|565759077|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
156729637|NCT00828568|565759078|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
156729638|NCT00828568|565759079|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
156729639|NCT00828568|565759077|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
156729640|NCT00828568|565759078|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
156729641|NCT00828568|565759079|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
156729642|NCT02091089|565759114|FG000|Overall Study|Lost to Follow-up|2|||
156729643|NCT00460811|565759119|FG000|Overall Study|Adverse Event|4|||
156729644|NCT00460811|565759120|FG001|Overall Study|Adverse Event|6|||
156729645|NCT00460811|565759121|FG002|Overall Study|Adverse Event|3|||
156729646|NCT00460811|565759122|FG003|Overall Study|Adverse Event|10|||
156729647|NCT00460811|565759123|FG004|Overall Study|Adverse Event|2|||
156729648|NCT00460811|565759119|FG000|Overall Study|Noncompliance|1|||
156729649|NCT00460811|565759120|FG001|Overall Study|Noncompliance|0|||
156729650|NCT00460811|565759121|FG002|Overall Study|Noncompliance|0|||
156729651|NCT00460811|565759122|FG003|Overall Study|Noncompliance|2|||
156729652|NCT00460811|565759123|FG004|Overall Study|Noncompliance|1|||
156729653|NCT00460811|565759119|FG000|Overall Study|Withdrawal by Subject|7|||
156454990|NCT04802967|564761557|FG000|Part B|Withdrawal by Subject|0|||
156454991|NCT04802967|564761558|FG001|Part B|Withdrawal by Subject|0|||
156729654|NCT00460811|565759120|FG001|Overall Study|Withdrawal by Subject|7|||
156729655|NCT00460811|565759121|FG002|Overall Study|Withdrawal by Subject|6|||
156729656|NCT00460811|565759122|FG003|Overall Study|Withdrawal by Subject|3|||
156729657|NCT00460811|565759123|FG004|Overall Study|Withdrawal by Subject|11|||
156729658|NCT00460811|565759119|FG000|Overall Study|Physician Decision|1|||
156729659|NCT00460811|565759120|FG001|Overall Study|Physician Decision|0|||
156729660|NCT00460811|565759121|FG002|Overall Study|Physician Decision|0|||
156729661|NCT00460811|565759122|FG003|Overall Study|Physician Decision|0|||
156729662|NCT00460811|565759123|FG004|Overall Study|Physician Decision|0|||
156729663|NCT00460811|565759119|FG000|Overall Study|Lost to Follow-up|3|||
156454992|NCT04802967|564761559|FG002|Part B|Withdrawal by Subject|0|||
156729664|NCT00460811|565759120|FG001|Overall Study|Lost to Follow-up|2|||
156729665|NCT00460811|565759121|FG002|Overall Study|Lost to Follow-up|5|||
156729666|NCT00460811|565759122|FG003|Overall Study|Lost to Follow-up|3|||
156454993|NCT04802967|564761560|FG003|Part B|Withdrawal by Subject|0|||
156729667|NCT00460811|565759123|FG004|Overall Study|Lost to Follow-up|6|||
156729668|NCT02821754|565759124|FG000|Overall Study|Procedure not required prior to amendment change|13|||
156729669|NCT02821754|565759125|FG001|Overall Study|Procedure not required prior to amendment change|11|||
156729670|NCT02821754|565759126|FG002|Overall Study|Procedure not required prior to amendment change|0|||
156729671|NCT02821754|565759124|FG000|Overall Study|Participant's Clinical status|2|||
156729672|NCT02821754|565759125|FG001|Overall Study|Participant's Clinical status|0|||
156454994|NCT04802967|564761561|FG004|Part B|Withdrawal by Subject|0|||
156796245|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796246|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156729673|NCT02821754|565759126|FG002|Overall Study|Participant's Clinical status|0|||
156729674|NCT02821754|565759124|FG000|Overall Study|Participant removed for noncompliance|1|||
156729675|NCT02821754|565759125|FG001|Overall Study|Participant removed for noncompliance|0|||
156729676|NCT02821754|565759126|FG002|Overall Study|Participant removed for noncompliance|0|||
156796247|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796248|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796249|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796250|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796251|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796252|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796253|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
156796254|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796255|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796256|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796257|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796258|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796259|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796260|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796261|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796262|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796263|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796264|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796265|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
156796266|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156729677|NCT02821754|565759124|FG000|Overall Study|Drug not available.|0|||
156729678|NCT02821754|565759125|FG001|Overall Study|Drug not available.|0|||
156729679|NCT02821754|565759126|FG002|Overall Study|Drug not available.|1|||
156729680|NCT02821754|565759124|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
156729681|NCT02821754|565759125|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
156729682|NCT02821754|565759126|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
156729683|NCT02977572|565759131|FG000|Overall Study|Exclusion criterion|2|||
156729684|NCT02977572|565759132|FG001|Overall Study|Exclusion criterion|2|||
156729685|NCT01166438|565759135|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
156729686|NCT01166438|565759136|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
156729687|NCT01166438|565759135|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
156729688|NCT01166438|565759136|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
156729689|NCT01166438|565759135|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
156729690|NCT01166438|565759136|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
156729691|NCT01166438|565759135|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
156729692|NCT01166438|565759136|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
156729693|NCT01166438|565759135|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
156729694|NCT01166438|565759136|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
156729695|NCT01166438|565759135|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
156796267|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796268|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796269|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796270|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796271|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796272|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796273|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796274|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796275|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
156796276|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
156796277|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796278|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796279|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796280|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796281|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156454995|NCT04802967|564761562|FG005|Part B|Withdrawal by Subject|1|||
156454996|NCT04802967|564761563|FG006|Part B|Withdrawal by Subject|0|||
156454997|NCT04802967|564761564|FG007|Part B|Withdrawal by Subject|0|||
156454998|NCT04802967|564761565|FG008|Part B|Withdrawal by Subject|0|||
156454999|NCT04802967|564761566|FG009|Part B|Withdrawal by Subject|0|||
156455000|NCT03339713|564761571|FG000|Overall Study|Lost to Follow-up|2|||
156455001|NCT03339713|564761572|FG001|Overall Study|Lost to Follow-up|1|||
156455002|NCT03339713|564761571|FG000|Overall Study|Protocol Violation|1|||
156729696|NCT01166438|565759136|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
156729697|NCT03502070|565759137|FG000|Overall Study|Withdrawal by Subject|1|||
156729698|NCT03502070|565759137|FG000|Overall Study|Screen Failure|1|||
156729699|NCT00454363|565759145|FG000|Overall Study|Adverse Event|1|||
156729700|NCT00454363|565759146|FG001|Overall Study|Adverse Event|2|||
156729701|NCT00454363|565759145|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
156729702|NCT00454363|565759146|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
156729703|NCT01863667|565759148|FG000|Overall Study|Adverse Event|1|||
156729704|NCT01863667|565759149|FG001|Overall Study|Adverse Event|0|||
156729705|NCT01863667|565759148|FG000|Overall Study|Study terminated by Sponsor|30|||
156729706|NCT01863667|565759149|FG001|Overall Study|Study terminated by Sponsor|30|||
156729707|NCT01863667|565759148|FG000|Overall Study|Withdrawal by Subject|2|||
156729708|NCT01863667|565759149|FG001|Overall Study|Withdrawal by Subject|2|||
156729709|NCT03627546|565759152|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
156729710|NCT03627546|565759153|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
156729711|NCT03627546|565759154|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
156729712|NCT03627546|565759152|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
156729713|NCT03627546|565759153|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
156729714|NCT03627546|565759154|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
156729715|NCT01537042|565759156|FG000|Overall Study|Adverse Event|0|||
156729716|NCT01537042|565759157|FG001|Overall Study|Adverse Event|2|||
156729717|NCT01537042|565759156|FG000|Overall Study|Lack of Efficacy|0|||
156729718|NCT01537042|565759157|FG001|Overall Study|Lack of Efficacy|1|||
156729719|NCT01537042|565759156|FG000|Overall Study|Protocol Violation|0|||
156729720|NCT01537042|565759157|FG001|Overall Study|Protocol Violation|1|||
156729721|NCT01537042|565759156|FG000|Overall Study|Other|0|||
156729722|NCT01537042|565759157|FG001|Overall Study|Other|1|||
156729723|NCT02837731|565759158|FG000|Allocation|Admitted to General Floor|3|||
156729724|NCT02837731|565759159|FG001|Allocation|Admitted to General Floor|4|||
156729725|NCT02837731|565759158|FG000|Allocation|Immediate surgery/withdrew|2|||
156729726|NCT02837731|565759159|FG001|Allocation|Immediate surgery/withdrew|0|||
156729727|NCT02837731|565759158|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
156729728|NCT02837731|565759159|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
156729729|NCT02837731|565759158|FG000|Allocation|Withdrawal by Subject|2|||
156729730|NCT02837731|565759159|FG001|Allocation|Withdrawal by Subject|0|||
156729731|NCT02837731|565759158|FG000|Allocation|Device not available|1|||
156729732|NCT02837731|565759159|FG001|Allocation|Device not available|0|||
156729733|NCT02837731|565759158|FG000|Allocation|Protocol not implemented|7|||
156729734|NCT02837731|565759159|FG001|Allocation|Protocol not implemented|0|||
156729735|NCT02837731|565759158|FG000|Allocation|Moribund/Do not resuscitate|2|||
156729736|NCT02837731|565759159|FG001|Allocation|Moribund/Do not resuscitate|0|||
156729737|NCT02837731|565759158|FG000|Allocation|Did not meet sepsis criteria|1|||
156729738|NCT02837731|565759159|FG001|Allocation|Did not meet sepsis criteria|2|||
156729739|NCT02837731|565759158|FG000|Allocation|Known aortic abnormalities|0|||
156729740|NCT02837731|565759159|FG001|Allocation|Known aortic abnormalities|1|||
156729741|NCT02965573|565759161|FG000|Overall Study|Lack of Efficacy|1|||
156729742|NCT02965573|565759162|FG001|Overall Study|Lack of Efficacy|0|||
156729743|NCT00315458|565759163|FG000|Overall Study|Administrative|0|||
156729744|NCT00315458|565759164|FG001|Overall Study|Administrative|3|||
156729745|NCT00315458|565759165|FG002|Overall Study|Administrative|8|||
156729746|NCT00315458|565759166|FG003|Overall Study|Administrative|21|||
156729747|NCT00315458|565759163|FG000|Overall Study|Adverse Event|2|||
156729748|NCT00315458|565759164|FG001|Overall Study|Adverse Event|4|||
156729749|NCT00315458|565759165|FG002|Overall Study|Adverse Event|23|||
156729750|NCT00315458|565759166|FG003|Overall Study|Adverse Event|3|||
156729751|NCT00315458|565759163|FG000|Overall Study|Lost to Follow-up|1|||
156729752|NCT00315458|565759164|FG001|Overall Study|Lost to Follow-up|2|||
156729753|NCT00315458|565759165|FG002|Overall Study|Lost to Follow-up|0|||
156729754|NCT00315458|565759166|FG003|Overall Study|Lost to Follow-up|2|||
156729755|NCT00315458|565759163|FG000|Overall Study|Withdrawal by Subject|0|||
156729756|NCT00315458|565759164|FG001|Overall Study|Withdrawal by Subject|3|||
156729757|NCT00315458|565759165|FG002|Overall Study|Withdrawal by Subject|0|||
156729758|NCT00315458|565759166|FG003|Overall Study|Withdrawal by Subject|2|||
156729759|NCT00315458|565759163|FG000|Overall Study|Lack of Efficacy|0|||
156729760|NCT00315458|565759164|FG001|Overall Study|Lack of Efficacy|0|||
156455003|NCT03339713|564761572|FG001|Overall Study|Protocol Violation|0|||
156729761|NCT00315458|565759165|FG002|Overall Study|Lack of Efficacy|20|||
156455004|NCT03339713|564761571|FG000|Overall Study|Withdrawal by Subject|1|||
156455005|NCT03339713|564761572|FG001|Overall Study|Withdrawal by Subject|1|||
156455006|NCT02268253|564761573|FG000|Stage 1|Withdrawal by Subject|1|||
156729762|NCT00315458|565759166|FG003|Overall Study|Lack of Efficacy|1|||
156729763|NCT00315458|565759163|FG000|Overall Study|Did not qualify|0|||
156729764|NCT00315458|565759164|FG001|Overall Study|Did not qualify|0|||
156729765|NCT00315458|565759165|FG002|Overall Study|Did not qualify|1|||
156729766|NCT00315458|565759166|FG003|Overall Study|Did not qualify|0|||
156729767|NCT00523848|565759168|FG000|Overall Study|Adverse Event|11|||
156729768|NCT00523848|565759168|FG000|Overall Study|Withdrawal by Subject|2|||
156729769|NCT00523848|565759168|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
156729770|NCT00523848|565759168|FG000|Overall Study|Disease Progression|5|||
156729771|NCT00523848|565759168|FG000|Overall Study|Other, unspecified|4|||
156729772|NCT00489918|565759170|FG000|Overall Study|Withdrawal by Subject|2|||
156729773|NCT00489918|565759171|FG001|Overall Study|Withdrawal by Subject|1|||
156729774|NCT00489918|565759172|FG002|Overall Study|Withdrawal by Subject|1|||
156729775|NCT00489918|565759173|FG003|Overall Study|Withdrawal by Subject|0|||
156729776|NCT00489918|565759174|FG004|Overall Study|Withdrawal by Subject|1|||
156729777|NCT00489918|565759170|FG000|Overall Study|Adverse Event|0|||
156729778|NCT00489918|565759171|FG001|Overall Study|Adverse Event|1|||
156729779|NCT00489918|565759172|FG002|Overall Study|Adverse Event|1|||
156729780|NCT00489918|565759173|FG003|Overall Study|Adverse Event|0|||
156729781|NCT00489918|565759174|FG004|Overall Study|Adverse Event|0|||
156729782|NCT00489918|565759170|FG000|Overall Study|Lost to Follow-up|0|||
156729783|NCT00489918|565759171|FG001|Overall Study|Lost to Follow-up|0|||
156729784|NCT00489918|565759172|FG002|Overall Study|Lost to Follow-up|1|||
156729785|NCT00489918|565759173|FG003|Overall Study|Lost to Follow-up|1|||
156729786|NCT00489918|565759174|FG004|Overall Study|Lost to Follow-up|0|||
156729787|NCT00489918|565759170|FG000|Overall Study|Physician Decision|0|||
156729788|NCT00489918|565759171|FG001|Overall Study|Physician Decision|0|||
156729789|NCT00489918|565759172|FG002|Overall Study|Physician Decision|1|||
156729790|NCT00489918|565759173|FG003|Overall Study|Physician Decision|0|||
156729791|NCT00489918|565759174|FG004|Overall Study|Physician Decision|0|||
156729792|NCT02748213|565759175|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
156729793|NCT02748213|565759176|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
156729794|NCT02748213|565759175|FG000|Overall Study|Abnormal Laboratory Test|1|||
156729795|NCT02748213|565759176|FG001|Overall Study|Abnormal Laboratory Test|0|||
156729796|NCT02748213|565759175|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
156729797|NCT02748213|565759176|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
156729798|NCT02748213|565759175|FG000|Overall Study|Death|5|||
156729799|NCT02748213|565759176|FG001|Overall Study|Death|3|||
156729800|NCT02748213|565759175|FG000|Overall Study|Insufficient Therapeutic Response|56|||
156729801|NCT02748213|565759176|FG001|Overall Study|Insufficient Therapeutic Response|57|||
156729802|NCT02748213|565759175|FG000|Overall Study|Violation of Selection Criteria|2|||
156729803|NCT02748213|565759176|FG001|Overall Study|Violation of Selection Criteria|0|||
156729804|NCT02748213|565759175|FG000|Overall Study|Protocol Violation|6|||
156729805|NCT02748213|565759176|FG001|Overall Study|Protocol Violation|4|||
156729806|NCT02748213|565759175|FG000|Overall Study|Refused Treatment*|6|||
156729807|NCT02748213|565759176|FG001|Overall Study|Refused Treatment*|6|||
156729808|NCT02748213|565759175|FG000|Overall Study|Failure to Return|1|||
156729809|NCT02748213|565759176|FG001|Overall Study|Failure to Return|0|||
156729810|NCT02748213|565759175|FG000|Overall Study|Other|30|||
156729811|NCT02748213|565759176|FG001|Overall Study|Other|29|||
156729812|NCT03850483|565759180|FG000|Treatment for Stage 1|Adverse Event|1|||
156729813|NCT03850483|565759181|FG001|Treatment for Stage 1|Adverse Event|1|||
156729814|NCT03850483|565759182|FG002|Treatment for Stage 1|Adverse Event|3|||
156729815|NCT03850483|565759183|FG003|Treatment for Stage 1|Adverse Event|0|||
156729816|NCT03850483|565759184|FG004|Treatment for Stage 1|Adverse Event|2|||
156729817|NCT03850483|565759185|FG005|Treatment for Stage 1|Adverse Event|0|||
156729818|NCT03850483|565759186|FG006|Treatment for Stage 1|Adverse Event|2|||
156729819|NCT03850483|565759187|FG007|Treatment for Stage 1|Adverse Event|2|||
156729820|NCT03850483|565759188|FG008|Treatment for Stage 1|Adverse Event|0|||
156729821|NCT03850483|565759189|FG009|Treatment for Stage 1|Adverse Event|0|||
156729822|NCT03850483|565759180|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
156729823|NCT03850483|565759181|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
156729824|NCT03850483|565759182|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
156729825|NCT03850483|565759183|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
156729826|NCT03850483|565759184|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
156729827|NCT03850483|565759185|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
156729828|NCT03850483|565759186|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
156455007|NCT02268253|564761574|FG001|Stage 1|Withdrawal by Subject|0|||
156729829|NCT03850483|565759187|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
156729830|NCT03850483|565759188|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
156729831|NCT03850483|565759189|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
156455008|NCT02268253|564761575|FG002|Stage 1|Withdrawal by Subject|0|||
156729832|NCT03850483|565759180|FG000|Treatment for Stage 1|Protocol Violation|1|||
156729833|NCT03850483|565759181|FG001|Treatment for Stage 1|Protocol Violation|0|||
156729834|NCT03850483|565759182|FG002|Treatment for Stage 1|Protocol Violation|0|||
156729835|NCT03850483|565759183|FG003|Treatment for Stage 1|Protocol Violation|0|||
156729836|NCT03850483|565759184|FG004|Treatment for Stage 1|Protocol Violation|0|||
156729837|NCT03850483|565759185|FG005|Treatment for Stage 1|Protocol Violation|0|||
156455009|NCT02268253|564761576|FG003|Stage 1|Withdrawal by Subject|0|||
156455010|NCT02268253|564761577|FG004|Stage 1|Withdrawal by Subject|0|||
156729838|NCT03850483|565759186|FG006|Treatment for Stage 1|Protocol Violation|1|||
156729839|NCT03850483|565759187|FG007|Treatment for Stage 1|Protocol Violation|0|||
156455011|NCT02268253|564761578|FG005|Stage 1|Withdrawal by Subject|0|||
156455012|NCT02268253|564761579|FG006|Stage 1|Withdrawal by Subject|0|||
156455013|NCT02268253|564761573|FG000|Stage 1|Death|0|||
156455014|NCT02268253|564761574|FG001|Stage 1|Death|2|||
156455015|NCT02268253|564761575|FG002|Stage 1|Death|2|||
156455016|NCT02268253|564761576|FG003|Stage 1|Death|2|||
156455017|NCT02268253|564761577|FG004|Stage 1|Death|1|||
156729840|NCT03850483|565759188|FG008|Treatment for Stage 1|Protocol Violation|0|||
156729841|NCT03850483|565759189|FG009|Treatment for Stage 1|Protocol Violation|0|||
156729842|NCT03850483|565759180|FG000|Treatment for Stage 1|Physician Decision|0|||
156729843|NCT03850483|565759181|FG001|Treatment for Stage 1|Physician Decision|0|||
156729844|NCT03850483|565759182|FG002|Treatment for Stage 1|Physician Decision|0|||
156729845|NCT03850483|565759183|FG003|Treatment for Stage 1|Physician Decision|0|||
156729846|NCT03850483|565759184|FG004|Treatment for Stage 1|Physician Decision|0|||
156729847|NCT03850483|565759185|FG005|Treatment for Stage 1|Physician Decision|1|||
156729848|NCT03850483|565759186|FG006|Treatment for Stage 1|Physician Decision|0|||
156729849|NCT03850483|565759187|FG007|Treatment for Stage 1|Physician Decision|0|||
156729850|NCT03850483|565759188|FG008|Treatment for Stage 1|Physician Decision|0|||
156729851|NCT03850483|565759189|FG009|Treatment for Stage 1|Physician Decision|0|||
156729852|NCT03850483|565759180|FG000|Treatment for Stage 1|Other|0|||
156729853|NCT03850483|565759181|FG001|Treatment for Stage 1|Other|0|||
156729854|NCT03850483|565759182|FG002|Treatment for Stage 1|Other|0|||
156729855|NCT03850483|565759183|FG003|Treatment for Stage 1|Other|0|||
156729856|NCT03850483|565759184|FG004|Treatment for Stage 1|Other|2|||
156729857|NCT03850483|565759185|FG005|Treatment for Stage 1|Other|1|||
156729858|NCT03850483|565759186|FG006|Treatment for Stage 1|Other|0|||
156729859|NCT03850483|565759187|FG007|Treatment for Stage 1|Other|0|||
156729860|NCT03850483|565759188|FG008|Treatment for Stage 1|Other|0|||
156729861|NCT03850483|565759189|FG009|Treatment for Stage 1|Other|0|||
156729862|NCT03850483|565759180|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729863|NCT03850483|565759181|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729864|NCT03850483|565759182|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
156729865|NCT03850483|565759183|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729866|NCT03850483|565759184|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729867|NCT03850483|565759185|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729868|NCT03850483|565759186|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729869|NCT03850483|565759187|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729870|NCT03850483|565759188|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729871|NCT03850483|565759189|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729872|NCT03850483|565759180|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729873|NCT03850483|565759181|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729874|NCT03850483|565759182|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729875|NCT03850483|565759183|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729876|NCT03850483|565759184|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729877|NCT03850483|565759185|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
156729878|NCT03850483|565759186|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729879|NCT03850483|565759187|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729880|NCT03850483|565759188|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729881|NCT03850483|565759189|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729882|NCT03850483|565759180|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
156729883|NCT03850483|565759181|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
156729884|NCT03850483|565759182|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
156729885|NCT03850483|565759183|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
156729886|NCT03850483|565759184|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
156796282|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796283|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796284|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796285|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796286|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
156796287|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796288|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796289|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796290|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796291|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796292|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156808809|NCT01484496|566054474|FG001|Period 1|Physician Decision|1|||
156336253|NCT02187744|564328215|FG000|Study|Related adverse event, not serious|0|||
156336254|NCT02187744|564328216|FG001|Study|Related adverse event, not serious|2|||
156729887|NCT03850483|565759185|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
156455018|NCT02268253|564761578|FG005|Stage 1|Death|1|||
156455019|NCT02268253|564761579|FG006|Stage 1|Death|0|||
156455020|NCT02268253|564761573|FG000|Stage 2|Disease Recurrence/ Progression|0|||
156336255|NCT02187744|564328215|FG000|Study|Death|1|||
156455021|NCT02268253|564761574|FG001|Stage 2|Disease Recurrence/ Progression|0|||
156729888|NCT03850483|565759186|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
156729889|NCT03850483|565759187|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
156729890|NCT03850483|565759188|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
156729891|NCT03850483|565759189|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
156729892|NCT03850483|565759180|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
156729893|NCT03850483|565759181|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
156729894|NCT03850483|565759182|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
156729895|NCT03850483|565759183|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
156729896|NCT03850483|565759184|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
156729897|NCT03850483|565759185|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
156729898|NCT03850483|565759186|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
156729899|NCT03850483|565759187|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
156729900|NCT03850483|565759188|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
156729901|NCT03850483|565759189|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
156729902|NCT03850483|565759180|FG000|Treatment for Stage 1|Death|0|||
156729903|NCT03850483|565759181|FG001|Treatment for Stage 1|Death|0|||
156729904|NCT03850483|565759182|FG002|Treatment for Stage 1|Death|0|||
156729905|NCT03850483|565759183|FG003|Treatment for Stage 1|Death|0|||
156729906|NCT03850483|565759184|FG004|Treatment for Stage 1|Death|0|||
156729907|NCT03850483|565759185|FG005|Treatment for Stage 1|Death|1|||
156729908|NCT03850483|565759186|FG006|Treatment for Stage 1|Death|0|||
156729909|NCT03850483|565759187|FG007|Treatment for Stage 1|Death|0|||
156729910|NCT03850483|565759188|FG008|Treatment for Stage 1|Death|0|||
156729911|NCT03850483|565759189|FG009|Treatment for Stage 1|Death|0|||
156729912|NCT03850483|565759180|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
156729913|NCT03850483|565759181|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
156729914|NCT03850483|565759182|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
156729915|NCT03850483|565759183|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
156729916|NCT03850483|565759184|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
156729917|NCT03850483|565759185|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
156729918|NCT03850483|565759186|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
156729919|NCT03850483|565759187|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
156729920|NCT03850483|565759188|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
156729921|NCT03850483|565759189|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
156729922|NCT03850483|565759180|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
156729923|NCT03850483|565759181|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
156729924|NCT03850483|565759182|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
156729925|NCT03850483|565759183|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
156796293|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796294|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796295|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796296|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796297|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
156796298|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
156796299|NCT00791648|566007993|FG000|Overall Study|Physician Decision|0|||
156796300|NCT00791648|566007994|FG001|Overall Study|Physician Decision|1|||
156796301|NCT00791648|566007993|FG000|Overall Study|Withdrawal by Subject|0|||
156796302|NCT00791648|566007994|FG001|Overall Study|Withdrawal by Subject|1|||
156796303|NCT00462826|566007995|FG000|Overall Study|Ineligible - second primary|1|||
156796304|NCT00462826|566007995|FG000|Overall Study|Ineligible - wrong cell type|1|||
156796305|NCT00462826|566007995|FG000|Overall Study|Ineligible - wrong primary|2|||
156796306|NCT00462826|566007995|FG000|Overall Study|Never treated|1|||
156796307|NCT04123704|566008008|FG000|Overall Study|Disease progression|2|||
156796308|NCT00939185|566008009|FG000|Overall Study|Adverse Event|3|||
156796309|NCT00939185|566008009|FG000|Overall Study|Lack of Efficacy|1|||
156796310|NCT00939185|566008009|FG000|Overall Study|Lost to Follow-up|6|||
156796311|NCT00939185|566008009|FG000|Overall Study|Other|3|||
156796312|NCT00939185|566008009|FG000|Overall Study|Withdrawal by Subject|2|||
156796313|NCT00939185|566008009|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
156796314|NCT02374255|566008010|FG000|Overall Study|Withdrawal by Subject|2|||
156876446|NCT04080167|566305841|FG002|Overall Study|Lost to Follow-up-Patients|0|||
156876447|NCT04080167|566305839|FG000|Overall Study|Lost to Follow-up-Providers|2|||
156336256|NCT02187744|564328216|FG001|Study|Death|0|||
156729926|NCT03850483|565759184|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
156729927|NCT03850483|565759185|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
156729928|NCT03850483|565759186|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
156729929|NCT03850483|565759187|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
156729930|NCT03850483|565759188|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
156729931|NCT03850483|565759189|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
156729932|NCT03850483|565759180|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729933|NCT03850483|565759181|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729934|NCT03850483|565759182|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729935|NCT03850483|565759183|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
156455022|NCT02268253|564761575|FG002|Stage 2|Disease Recurrence/ Progression|1|||
156455023|NCT02268253|564761576|FG003|Stage 2|Disease Recurrence/ Progression|0|||
156455024|NCT02268253|564761577|FG004|Stage 2|Disease Recurrence/ Progression|0|||
156455025|NCT02268253|564761578|FG005|Stage 2|Disease Recurrence/ Progression|0|||
156455026|NCT02268253|564761579|FG006|Stage 2|Disease Recurrence/ Progression|0|||
156455027|NCT02268253|564761573|FG000|Stage 2|Withdrawal by Subject|0|||
156455028|NCT02268253|564761574|FG001|Stage 2|Withdrawal by Subject|0|||
156729936|NCT03850483|565759184|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
156455029|NCT02268253|564761575|FG002|Stage 2|Withdrawal by Subject|2|||
156455030|NCT02268253|564761576|FG003|Stage 2|Withdrawal by Subject|0|||
156729937|NCT03850483|565759185|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729938|NCT03850483|565759186|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
156729939|NCT03850483|565759187|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
156729940|NCT03850483|565759188|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729941|NCT03850483|565759189|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729942|NCT03850483|565759180|FG000|Follow-up for Stage 1|Physician Decision|0|||
156729943|NCT03850483|565759181|FG001|Follow-up for Stage 1|Physician Decision|0|||
156729944|NCT03850483|565759182|FG002|Follow-up for Stage 1|Physician Decision|0|||
156729945|NCT03850483|565759183|FG003|Follow-up for Stage 1|Physician Decision|0|||
156729946|NCT03850483|565759184|FG004|Follow-up for Stage 1|Physician Decision|1|||
156729947|NCT03850483|565759185|FG005|Follow-up for Stage 1|Physician Decision|0|||
156729948|NCT03850483|565759186|FG006|Follow-up for Stage 1|Physician Decision|1|||
156729949|NCT03850483|565759187|FG007|Follow-up for Stage 1|Physician Decision|0|||
156729950|NCT03850483|565759188|FG008|Follow-up for Stage 1|Physician Decision|0|||
156729951|NCT03850483|565759189|FG009|Follow-up for Stage 1|Physician Decision|0|||
156729952|NCT03850483|565759180|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
156729953|NCT03850483|565759181|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
156729954|NCT03850483|565759182|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
156729955|NCT03850483|565759183|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
156729956|NCT03850483|565759184|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
156729957|NCT03850483|565759185|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
156729958|NCT03850483|565759186|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
156729959|NCT03850483|565759187|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
156729960|NCT03850483|565759188|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
156729961|NCT03850483|565759189|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
156729962|NCT03850483|565759180|FG000|Follow-up for Stage 1|Adverse Event|0|||
156729963|NCT03850483|565759181|FG001|Follow-up for Stage 1|Adverse Event|0|||
156729964|NCT03850483|565759182|FG002|Follow-up for Stage 1|Adverse Event|1|||
156729965|NCT03850483|565759183|FG003|Follow-up for Stage 1|Adverse Event|0|||
156729966|NCT03850483|565759184|FG004|Follow-up for Stage 1|Adverse Event|0|||
156729967|NCT03850483|565759185|FG005|Follow-up for Stage 1|Adverse Event|1|||
156729968|NCT03850483|565759186|FG006|Follow-up for Stage 1|Adverse Event|0|||
156729969|NCT03850483|565759187|FG007|Follow-up for Stage 1|Adverse Event|0|||
156729970|NCT03850483|565759188|FG008|Follow-up for Stage 1|Adverse Event|0|||
156729971|NCT03850483|565759189|FG009|Follow-up for Stage 1|Adverse Event|0|||
156729972|NCT03850483|565759180|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729973|NCT03850483|565759181|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
156729974|NCT03850483|565759182|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729975|NCT03850483|565759183|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729976|NCT03850483|565759184|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
156729977|NCT03850483|565759185|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
156729978|NCT03850483|565759186|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729979|NCT03850483|565759187|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729980|NCT03850483|565759188|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729981|NCT03850483|565759189|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729982|NCT03850483|565759180|FG000|Follow-up for Stage 1|Other|0|||
156455031|NCT02268253|564761577|FG004|Stage 2|Withdrawal by Subject|0|||
156455032|NCT02268253|564761578|FG005|Stage 2|Withdrawal by Subject|2|||
156455033|NCT02268253|564761579|FG006|Stage 2|Withdrawal by Subject|0|||
156533593|NCT00578786|565048865|FG000|Overall Study|Lost to Follow-up|0|||
156533594|NCT00578786|565048866|FG001|Overall Study|Lost to Follow-up|4|||
156729983|NCT03850483|565759181|FG001|Follow-up for Stage 1|Other|2|||
156729984|NCT03850483|565759182|FG002|Follow-up for Stage 1|Other|0|||
156729985|NCT03850483|565759183|FG003|Follow-up for Stage 1|Other|2|||
156729986|NCT03850483|565759184|FG004|Follow-up for Stage 1|Other|0|||
156729987|NCT03850483|565759185|FG005|Follow-up for Stage 1|Other|1|||
156729988|NCT03850483|565759186|FG006|Follow-up for Stage 1|Other|0|||
156729989|NCT03850483|565759187|FG007|Follow-up for Stage 1|Other|0|||
156729990|NCT03850483|565759188|FG008|Follow-up for Stage 1|Other|0|||
156729991|NCT03850483|565759189|FG009|Follow-up for Stage 1|Other|0|||
156729992|NCT03850483|565759180|FG000|Treatment for Stage 2|Adverse Event|0|||
156729993|NCT03850483|565759181|FG001|Treatment for Stage 2|Adverse Event|0|||
156729994|NCT03850483|565759182|FG002|Treatment for Stage 2|Adverse Event|0|||
156729995|NCT03850483|565759183|FG003|Treatment for Stage 2|Adverse Event|0|||
156533595|NCT00578786|565048867|FG002|Overall Study|Lost to Follow-up|0|||
156729996|NCT03850483|565759184|FG004|Treatment for Stage 2|Adverse Event|0|||
156729997|NCT03850483|565759185|FG005|Treatment for Stage 2|Adverse Event|0|||
156729998|NCT03850483|565759186|FG006|Treatment for Stage 2|Adverse Event|0|||
156729999|NCT03850483|565759187|FG007|Treatment for Stage 2|Adverse Event|0|||
156730000|NCT03850483|565759188|FG008|Treatment for Stage 2|Adverse Event|0|||
156730001|NCT03850483|565759189|FG009|Treatment for Stage 2|Adverse Event|1|||
156455034|NCT02268253|564761573|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
156455035|NCT02268253|564761574|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
156455036|NCT02268253|564761575|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
156455037|NCT02268253|564761576|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
156455038|NCT02268253|564761577|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
156455039|NCT02268253|564761578|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
156455040|NCT02268253|564761579|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
156455041|NCT02268253|564761573|FG000|Stage 2|Death|0|||
156455042|NCT02268253|564761574|FG001|Stage 2|Death|0|||
156455043|NCT02268253|564761575|FG002|Stage 2|Death|19|||
156455044|NCT02268253|564761576|FG003|Stage 2|Death|0|||
156455045|NCT02268253|564761577|FG004|Stage 2|Death|0|||
156455046|NCT02268253|564761578|FG005|Stage 2|Death|20|||
156533596|NCT00578786|565048865|FG000|Overall Study|Pregnancy|0|||
156730002|NCT03850483|565759180|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
156730003|NCT03850483|565759181|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
156730004|NCT03850483|565759182|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
156730005|NCT03850483|565759183|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
156730006|NCT03850483|565759184|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
156730007|NCT03850483|565759185|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
156730008|NCT03850483|565759186|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
156730009|NCT03850483|565759187|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
156730010|NCT03850483|565759188|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
156730011|NCT03850483|565759189|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
156730012|NCT03850483|565759180|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
156730013|NCT03850483|565759181|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
156796315|NCT02374255|566008011|FG001|Overall Study|Withdrawal by Subject|0|||
156796316|NCT02374255|566008012|FG002|Overall Study|Withdrawal by Subject|0|||
156796317|NCT02374255|566008013|FG003|Overall Study|Withdrawal by Subject|0|||
156796318|NCT03360344|566008016|FG000|Overall Study|Withdrawal by Subject|0|||
156796319|NCT03360344|566008017|FG001|Overall Study|Withdrawal by Subject|1|||
156796320|NCT03360344|566008018|FG002|Overall Study|Withdrawal by Subject|1|||
156796321|NCT00133705|566008019|FG000|Overall Study|Withdrawal by Subject|2|||
156796322|NCT00133705|566008020|FG001|Overall Study|Withdrawal by Subject|3|||
156796323|NCT00959049|566008021|FG000|Overall Study|Adverse Event|1|||
156796324|NCT00959049|566008022|FG001|Overall Study|Adverse Event|0|||
156796325|NCT00959049|566008023|FG002|Overall Study|Adverse Event|0|||
156796326|NCT00959049|566008024|FG003|Overall Study|Adverse Event|0|||
156796327|NCT00959049|566008025|FG004|Overall Study|Adverse Event|0|||
156796328|NCT00959049|566008026|FG005|Overall Study|Adverse Event|0|||
156796329|NCT00959049|566008021|FG000|Overall Study|Lost to Follow-up|17|||
156796330|NCT00959049|566008022|FG001|Overall Study|Lost to Follow-up|5|||
156796331|NCT00959049|566008023|FG002|Overall Study|Lost to Follow-up|1|||
156796332|NCT00959049|566008024|FG003|Overall Study|Lost to Follow-up|10|||
156796333|NCT00959049|566008025|FG004|Overall Study|Lost to Follow-up|9|||
156796334|NCT00959049|566008026|FG005|Overall Study|Lost to Follow-up|1|||
156796335|NCT00959049|566008021|FG000|Overall Study|Contraindicated medication|0|||
156796336|NCT00959049|566008022|FG001|Overall Study|Contraindicated medication|0|||
156796337|NCT00959049|566008023|FG002|Overall Study|Contraindicated medication|0|||
156796338|NCT00959049|566008024|FG003|Overall Study|Contraindicated medication|1|||
156796339|NCT00959049|566008025|FG004|Overall Study|Contraindicated medication|0|||
156796340|NCT00959049|566008026|FG005|Overall Study|Contraindicated medication|0|||
156796341|NCT00959049|566008021|FG000|Overall Study|Withdrawal by Subject|0|||
156796342|NCT00959049|566008022|FG001|Overall Study|Withdrawal by Subject|2|||
156796343|NCT00959049|566008023|FG002|Overall Study|Withdrawal by Subject|0|||
156796344|NCT00959049|566008024|FG003|Overall Study|Withdrawal by Subject|0|||
156796345|NCT00959049|566008025|FG004|Overall Study|Withdrawal by Subject|0|||
156796346|NCT00959049|566008026|FG005|Overall Study|Withdrawal by Subject|0|||
156796347|NCT00836706|566008035|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
156796348|NCT00836706|566008036|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
156455047|NCT02268253|564761579|FG006|Stage 2|Death|1|||
156455048|NCT02268253|564761573|FG000|Stage 2|Lost to Follow-up|0|||
156455049|NCT02268253|564761574|FG001|Stage 2|Lost to Follow-up|0|||
156533597|NCT00578786|565048866|FG001|Overall Study|Pregnancy|1|||
156455050|NCT02268253|564761575|FG002|Stage 2|Lost to Follow-up|0|||
156730014|NCT03850483|565759182|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
156730015|NCT03850483|565759183|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
156796349|NCT01992757|566008037|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
156796350|NCT00863304|566008039|FG000|Overall Study|Adverse Event|10|||
156796351|NCT00863304|566008040|FG001|Overall Study|Adverse Event|4|||
156455051|NCT02268253|564761576|FG003|Stage 2|Lost to Follow-up|0|||
156533598|NCT00578786|565048867|FG002|Overall Study|Pregnancy|0|||
156730016|NCT03850483|565759184|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
156730017|NCT03850483|565759185|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
156730018|NCT03850483|565759186|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
156730019|NCT03850483|565759187|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
156730020|NCT03850483|565759188|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
156730021|NCT03850483|565759189|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
156730022|NCT03850483|565759180|FG000|Treatment for Stage 2|Physician Decision|0|||
156730023|NCT03850483|565759181|FG001|Treatment for Stage 2|Physician Decision|0|||
156730024|NCT03850483|565759182|FG002|Treatment for Stage 2|Physician Decision|0|||
156730025|NCT03850483|565759183|FG003|Treatment for Stage 2|Physician Decision|0|||
156730026|NCT03850483|565759184|FG004|Treatment for Stage 2|Physician Decision|0|||
156730027|NCT03850483|565759185|FG005|Treatment for Stage 2|Physician Decision|0|||
156730028|NCT03850483|565759186|FG006|Treatment for Stage 2|Physician Decision|0|||
156730029|NCT03850483|565759187|FG007|Treatment for Stage 2|Physician Decision|0|||
156730030|NCT03850483|565759188|FG008|Treatment for Stage 2|Physician Decision|0|||
156730031|NCT03850483|565759189|FG009|Treatment for Stage 2|Physician Decision|1|||
156730032|NCT03850483|565759180|FG000|Treatment for Stage 2|Protocol Violation|0|||
156730033|NCT03850483|565759181|FG001|Treatment for Stage 2|Protocol Violation|0|||
156730034|NCT03850483|565759182|FG002|Treatment for Stage 2|Protocol Violation|0|||
156730035|NCT03850483|565759183|FG003|Treatment for Stage 2|Protocol Violation|0|||
156730036|NCT03850483|565759184|FG004|Treatment for Stage 2|Protocol Violation|0|||
156730037|NCT03850483|565759185|FG005|Treatment for Stage 2|Protocol Violation|0|||
156730038|NCT03850483|565759186|FG006|Treatment for Stage 2|Protocol Violation|0|||
156730039|NCT03850483|565759187|FG007|Treatment for Stage 2|Protocol Violation|0|||
156730040|NCT03850483|565759188|FG008|Treatment for Stage 2|Protocol Violation|1|||
156730041|NCT03850483|565759189|FG009|Treatment for Stage 2|Protocol Violation|0|||
156730042|NCT03850483|565759180|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
156730043|NCT03850483|565759181|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
156730044|NCT03850483|565759182|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
156730045|NCT03850483|565759183|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
156796352|NCT00863304|566008041|FG002|Overall Study|Adverse Event|14|||
156796353|NCT00863304|566008042|FG003|Overall Study|Adverse Event|16|||
156796354|NCT00863304|566008039|FG000|Overall Study|Lost to Follow-up|1|||
156796355|NCT00863304|566008040|FG001|Overall Study|Lost to Follow-up|5|||
156796356|NCT00863304|566008041|FG002|Overall Study|Lost to Follow-up|4|||
156796357|NCT00863304|566008042|FG003|Overall Study|Lost to Follow-up|2|||
156796358|NCT00863304|566008039|FG000|Overall Study|Lack of Efficacy|57|||
156455052|NCT02268253|564761577|FG004|Stage 2|Lost to Follow-up|0|||
156796359|NCT00863304|566008040|FG001|Overall Study|Lack of Efficacy|26|||
156796360|NCT00863304|566008041|FG002|Overall Study|Lack of Efficacy|30|||
156796361|NCT00863304|566008042|FG003|Overall Study|Lack of Efficacy|28|||
156796362|NCT00863304|566008039|FG000|Overall Study|Withdrawal by Subject|19|||
156796363|NCT00863304|566008040|FG001|Overall Study|Withdrawal by Subject|14|||
156796364|NCT00863304|566008041|FG002|Overall Study|Withdrawal by Subject|20|||
156796365|NCT00863304|566008042|FG003|Overall Study|Withdrawal by Subject|18|||
156796366|NCT00863304|566008039|FG000|Overall Study|Other|1|||
156796367|NCT00863304|566008040|FG001|Overall Study|Other|0|||
156796368|NCT00863304|566008041|FG002|Overall Study|Other|0|||
156796369|NCT00863304|566008042|FG003|Overall Study|Other|1|||
156796370|NCT00863304|566008039|FG000|Overall Study|Protocol Violation|2|||
156796371|NCT00863304|566008040|FG001|Overall Study|Protocol Violation|6|||
156796372|NCT00863304|566008041|FG002|Overall Study|Protocol Violation|2|||
156796373|NCT00863304|566008042|FG003|Overall Study|Protocol Violation|0|||
156796374|NCT00863304|566008039|FG000|Overall Study|Randomized, but not Treated|3|||
156796375|NCT00863304|566008040|FG001|Overall Study|Randomized, but not Treated|1|||
156796376|NCT00863304|566008041|FG002|Overall Study|Randomized, but not Treated|4|||
156796377|NCT00863304|566008042|FG003|Overall Study|Randomized, but not Treated|1|||
156796378|NCT00863304|566008039|FG000|Overall Study|Entered extension study|101|||
156455053|NCT02268253|564761578|FG005|Stage 2|Lost to Follow-up|4|||
156455054|NCT02268253|564761579|FG006|Stage 2|Lost to Follow-up|0|||
156730046|NCT03850483|565759184|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
156730047|NCT03850483|565759185|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
156730048|NCT03850483|565759186|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
156730049|NCT03850483|565759187|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
156730050|NCT03850483|565759188|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
156730051|NCT03850483|565759189|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
156730052|NCT03850483|565759180|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730053|NCT03850483|565759181|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730054|NCT03850483|565759182|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730055|NCT03850483|565759183|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156796379|NCT00863304|566008040|FG001|Overall Study|Entered extension study|129|||
156796380|NCT00863304|566008041|FG002|Overall Study|Entered extension study|113|||
156796381|NCT00863304|566008042|FG003|Overall Study|Entered extension study|125|||
156796382|NCT00478257|566008043|FG000|Overall Study|Withdrawal by Subject|8|||
156796383|NCT00478257|566008044|FG001|Overall Study|Withdrawal by Subject|3|||
156455055|NCT02268253|564761573|FG000|Stage 2|Transferred to Hospice|0|||
156730056|NCT03850483|565759184|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730057|NCT03850483|565759185|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730058|NCT03850483|565759186|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730059|NCT03850483|565759187|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730060|NCT03850483|565759188|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730061|NCT03850483|565759189|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
156730062|NCT03850483|565759180|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
156730063|NCT03850483|565759181|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
156730064|NCT03850483|565759182|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
156730065|NCT03850483|565759183|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
156730066|NCT03850483|565759184|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
156730067|NCT03850483|565759185|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
156730068|NCT03850483|565759186|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
156730069|NCT03850483|565759187|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
156730070|NCT03850483|565759188|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
156730071|NCT03850483|565759189|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
156730072|NCT03850483|565759180|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
156730073|NCT03850483|565759181|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
156730074|NCT03850483|565759182|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
156730075|NCT03850483|565759183|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
156730076|NCT03850483|565759184|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
156730077|NCT03850483|565759185|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
156730078|NCT03850483|565759186|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
156730079|NCT03850483|565759187|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
156730080|NCT03850483|565759188|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
156730081|NCT03850483|565759189|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
156730082|NCT03850483|565759180|FG000|Follow-up For Stage 2|Other|0|||
156730083|NCT03850483|565759181|FG001|Follow-up For Stage 2|Other|0|||
156730084|NCT03850483|565759182|FG002|Follow-up For Stage 2|Other|0|||
156730085|NCT03850483|565759183|FG003|Follow-up For Stage 2|Other|0|||
156730086|NCT03850483|565759184|FG004|Follow-up For Stage 2|Other|0|||
156730087|NCT03850483|565759185|FG005|Follow-up For Stage 2|Other|0|||
156730088|NCT03850483|565759186|FG006|Follow-up For Stage 2|Other|0|||
156730089|NCT03850483|565759187|FG007|Follow-up For Stage 2|Other|0|||
156730090|NCT03850483|565759188|FG008|Follow-up For Stage 2|Other|0|||
156730091|NCT03850483|565759189|FG009|Follow-up For Stage 2|Other|1|||
156730092|NCT01283334|565760728|FG000|Overall Study|Withdrawal by Subject|1|||
156730093|NCT01283334|565760728|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
156730094|NCT01283334|565760728|FG000|Overall Study|Adverse Event|4|||
156730095|NCT01283334|565760728|FG000|Overall Study|Physician Decision|1|||
156730096|NCT03467217|565760729|FG000|Overall Study|Trial stopped early|5|||
156730097|NCT03467217|565760730|FG001|Overall Study|Trial stopped early|2|||
156730098|NCT03467217|565760729|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
156730099|NCT03467217|565760730|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
156730100|NCT03467217|565760729|FG000|Overall Study|Lost to Follow-up|0|||
156730101|NCT03467217|565760730|FG001|Overall Study|Lost to Follow-up|2|||
156730102|NCT00769067|565760731|FG000|Overall Study|Death|89|||
156730103|NCT00769067|565760732|FG001|Overall Study|Death|86|||
156730104|NCT00769067|565760731|FG000|Overall Study|Lost to Follow-up|3|||
156730105|NCT00769067|565760732|FG001|Overall Study|Lost to Follow-up|1|||
156730106|NCT00769067|565760731|FG000|Overall Study|Study terminated by sponsor|1|||
156730107|NCT00769067|565760732|FG001|Overall Study|Study terminated by sponsor|3|||
156730108|NCT00769067|565760731|FG000|Overall Study|Other|1|||
156730109|NCT00769067|565760732|FG001|Overall Study|Other|3|||
156730110|NCT00769067|565760731|FG000|Overall Study|Withdrawal by Subject|0|||
156730111|NCT00769067|565760732|FG001|Overall Study|Withdrawal by Subject|1|||
156455056|NCT02268253|564761574|FG001|Stage 2|Transferred to Hospice|0|||
156455057|NCT02268253|564761575|FG002|Stage 2|Transferred to Hospice|0|||
156455058|NCT02268253|564761576|FG003|Stage 2|Transferred to Hospice|0|||
156455059|NCT02268253|564761577|FG004|Stage 2|Transferred to Hospice|0|||
156455060|NCT02268253|564761578|FG005|Stage 2|Transferred to Hospice|2|||
156455061|NCT02268253|564761579|FG006|Stage 2|Transferred to Hospice|0|||
156455062|NCT02268253|564761573|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
156730112|NCT04981470|565760735|FG000|Overall Study|Device failure in all 4 patients|4|||
156730113|NCT04402138|565760736|FG000|Overall Study|Progressive Disease|2|||
156730114|NCT04402138|565760736|FG000|Overall Study|Adverse Event|1|||
156730115|NCT00784238|565760737|FG000|Overall Study|Adverse Event|14|||
156730116|NCT00784238|565760737|FG000|Overall Study|Death|2|||
156730117|NCT00784238|565760737|FG000|Overall Study|Lack of Efficacy|33|||
156730118|NCT00784238|565760737|FG000|Overall Study|Lost to Follow-up|29|||
156730119|NCT00784238|565760737|FG000|Overall Study|Pregnancy|1|||
156455063|NCT02268253|564761574|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
156730120|NCT00784238|565760737|FG000|Overall Study|Withdrawal by Subject|26|||
156730121|NCT00784238|565760737|FG000|Overall Study|Other|14|||
156730122|NCT04390503|565760739|FG000|Overall Study|Physician Decision|2|||
156730123|NCT04390503|565760740|FG001|Overall Study|Physician Decision|1|||
156730124|NCT04390503|565760739|FG000|Overall Study|Adverse Event|1|||
156730125|NCT04390503|565760740|FG001|Overall Study|Adverse Event|0|||
156730126|NCT00078767|565760741|FG000|Overall Study|Withdrawal by Subject|1|||
156730127|NCT00078767|565760742|FG001|Overall Study|Withdrawal by Subject|1|||
156730128|NCT01068730|565760743|FG000|Period 3|Personal reason|1|||
156730129|NCT01068730|565760744|FG001|Period 3|Personal reason|0|||
156730130|NCT01068730|565760745|FG002|Period 3|Personal reason|0|||
156730131|NCT01068730|565760746|FG003|Period 3|Personal reason|0|||
156730132|NCT01068730|565760743|FG000|Period 4|Family emergency|0|||
156730133|NCT01068730|565760744|FG001|Period 4|Family emergency|1|||
156730134|NCT01068730|565760745|FG002|Period 4|Family emergency|0|||
156730135|NCT01068730|565760746|FG003|Period 4|Family emergency|0|||
156730136|NCT03508726|565760747|FG000|Overall Study|Withdrawal by Subject|0|||
156730137|NCT03508726|565760748|FG001|Overall Study|Withdrawal by Subject|1|||
156730138|NCT03233529|565760752|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
156730139|NCT03233529|565760752|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
156730140|NCT01177293|565760753|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
156730141|NCT01177293|565760754|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
156730142|NCT00594100|565760755|FG000|Procedure|Technical Failure|9|||
156730143|NCT00594100|565760755|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
156730144|NCT00594100|565760755|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
156730145|NCT00594100|565760755|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
156730146|NCT02448537|565760756|FG000|Overall Study|Withdrawal by Subject|1|||
156730147|NCT02448537|565760757|FG001|Overall Study|Withdrawal by Subject|1|||
156730148|NCT02448537|565760758|FG002|Overall Study|Withdrawal by Subject|1|||
156730149|NCT03528369|565760761|FG000|Overall Study|Withdrawal by Subject|2|||
156730150|NCT03528369|565760762|FG001|Overall Study|Withdrawal by Subject|0|||
156730151|NCT03528369|565760763|FG002|Overall Study|Withdrawal by Subject|0|||
156730152|NCT03528369|565760761|FG000|Overall Study|Lost to Follow-up|1|||
156730153|NCT03528369|565760762|FG001|Overall Study|Lost to Follow-up|0|||
156730154|NCT03528369|565760763|FG002|Overall Study|Lost to Follow-up|0|||
156730155|NCT03528369|565760761|FG000|Overall Study|Adverse Event|0|||
156730156|NCT03528369|565760762|FG001|Overall Study|Adverse Event|1|||
156730157|NCT03528369|565760763|FG002|Overall Study|Adverse Event|0|||
156730158|NCT04725812|565760764|FG000|Overall Study|Withdrawal by Subject|1|||
156730159|NCT05656534|565760766|FG000|Overall Study|Withdrawal by Subject|1|||
156730160|NCT05656534|565760767|FG001|Overall Study|Withdrawal by Subject|1|||
156730161|NCT05656534|565760768|FG002|Overall Study|Withdrawal by Subject|0|||
156730162|NCT05656534|565760769|FG003|Overall Study|Withdrawal by Subject|0|||
156730163|NCT05656534|565760766|FG000|Overall Study|Physician Decision|1|||
156730164|NCT05656534|565760767|FG001|Overall Study|Physician Decision|1|||
156730165|NCT05656534|565760768|FG002|Overall Study|Physician Decision|0|||
156730166|NCT05656534|565760769|FG003|Overall Study|Physician Decision|0|||
156730167|NCT00839800|565760770|FG000|Overall Study|Adverse Event|8|||
156730168|NCT00839800|565760771|FG001|Overall Study|Adverse Event|12|||
156730169|NCT00839800|565760770|FG000|Overall Study|Lost to Follow-up|31|||
156730170|NCT00839800|565760771|FG001|Overall Study|Lost to Follow-up|26|||
156730171|NCT00839800|565760770|FG000|Overall Study|Withdrawal by Subject|28|||
156730172|NCT00839800|565760771|FG001|Overall Study|Withdrawal by Subject|34|||
156730173|NCT00839800|565760770|FG000|Overall Study|Incorrect Enrolment|3|||
156730174|NCT00839800|565760771|FG001|Overall Study|Incorrect Enrolment|3|||
156730175|NCT00839800|565760770|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
156730176|NCT00839800|565760771|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
156730177|NCT00839800|565760770|FG000|Overall Study|Safety Reasons|2|||
156730178|NCT00839800|565760771|FG001|Overall Study|Safety Reasons|1|||
156730179|NCT00839800|565760770|FG000|Overall Study|Other|8|||
156730180|NCT00839800|565760771|FG001|Overall Study|Other|14|||
156730181|NCT00839800|565760770|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
156730182|NCT00839800|565760771|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
156730183|NCT02801617|565760772|FG000|Overall Study|Protocol Violation|2|||
156796384|NCT01182350|566008045|FG000|Overall Study|Adverse Event|5|||
156796385|NCT01182350|566008046|FG001|Overall Study|Adverse Event|0|||
156796386|NCT01182350|566008047|FG002|Overall Study|Adverse Event|0|||
156796387|NCT01182350|566008048|FG003|Overall Study|Adverse Event|0|||
156796388|NCT01182350|566008049|FG004|Overall Study|Adverse Event|0|||
156730184|NCT02801617|565760773|FG001|Overall Study|Protocol Violation|6|||
156730185|NCT00302328|565760774|FG000|Overall Study|Physician Decision|0|||
156730186|NCT00302328|565760775|FG001|Overall Study|Physician Decision|1|||
156730187|NCT00302328|565760776|FG002|Overall Study|Physician Decision|0|||
156730188|NCT01288937|565760777|FG000|Overall Study|Adverse Event|1|||
156730189|NCT01288937|565760778|FG001|Overall Study|Adverse Event|0|||
156730190|NCT00857896|565760781|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
156730191|NCT01431716|565760785|FG000|Overall Study|Withdrawal of consent|1|||
156730192|NCT01996254|565760786|FG000|Overall Study|Change in Eligibility|0|||
156730193|NCT01996254|565760787|FG001|Overall Study|Change in Eligibility|2|||
156730194|NCT01996254|565760788|FG002|Overall Study|Change in Eligibility|0|||
156730195|NCT01996254|565760786|FG000|Overall Study|Withdrawal by Subject|0|||
156796389|NCT01182350|566008045|FG000|Overall Study|Disease Progression|15|||
156796390|NCT01182350|566008046|FG001|Overall Study|Disease Progression|12|||
156796391|NCT01182350|566008047|FG002|Overall Study|Disease Progression|0|||
156796392|NCT01182350|566008048|FG003|Overall Study|Disease Progression|1|||
156796393|NCT01182350|566008049|FG004|Overall Study|Disease Progression|0|||
156796394|NCT01182350|566008045|FG000|Overall Study|Death|0|||
156796395|NCT01182350|566008046|FG001|Overall Study|Death|1|||
156796396|NCT01182350|566008047|FG002|Overall Study|Death|1|||
156796397|NCT01182350|566008048|FG003|Overall Study|Death|0|||
156796398|NCT01182350|566008049|FG004|Overall Study|Death|0|||
156730196|NCT01996254|565760787|FG001|Overall Study|Withdrawal by Subject|3|||
156796399|NCT01182350|566008045|FG000|Overall Study|Withdrawal by Subject|3|||
156796400|NCT01182350|566008046|FG001|Overall Study|Withdrawal by Subject|1|||
156796401|NCT01182350|566008047|FG002|Overall Study|Withdrawal by Subject|0|||
156796402|NCT01182350|566008048|FG003|Overall Study|Withdrawal by Subject|1|||
156796403|NCT01182350|566008049|FG004|Overall Study|Withdrawal by Subject|0|||
156796404|NCT01182350|566008045|FG000|Overall Study|Alternative Therapy|2|||
156796405|NCT01182350|566008046|FG001|Overall Study|Alternative Therapy|0|||
156796406|NCT01182350|566008047|FG002|Overall Study|Alternative Therapy|1|||
156796407|NCT01182350|566008048|FG003|Overall Study|Alternative Therapy|0|||
156796408|NCT01182350|566008049|FG004|Overall Study|Alternative Therapy|0|||
156796409|NCT01182350|566008045|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
156796410|NCT01182350|566008046|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
156796411|NCT01182350|566008047|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
156796412|NCT01182350|566008048|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
156796413|NCT01182350|566008049|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
156730197|NCT01996254|565760788|FG002|Overall Study|Withdrawal by Subject|4|||
156730198|NCT01996254|565760786|FG000|Overall Study|Lost to Follow-up|1|||
156730199|NCT01996254|565760787|FG001|Overall Study|Lost to Follow-up|0|||
156730200|NCT01996254|565760788|FG002|Overall Study|Lost to Follow-up|4|||
156730201|NCT03852264|565760791|FG000|Third Research Visit|Lost to Follow-up|1|||
156730202|NCT03852264|565760792|FG001|Third Research Visit|Lost to Follow-up|0|||
156730203|NCT02411396|565760796|FG000|Overall Study|Lost to Follow-up|31|||
156730204|NCT02411396|565760796|FG000|Overall Study|Death|10|||
156730205|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
156796414|NCT01182350|566008045|FG000|Overall Study|Unevaluable for Biopsy|0|||
156796415|NCT01182350|566008046|FG001|Overall Study|Unevaluable for Biopsy|0|||
156796416|NCT01182350|566008047|FG002|Overall Study|Unevaluable for Biopsy|0|||
156796417|NCT01182350|566008048|FG003|Overall Study|Unevaluable for Biopsy|0|||
156796418|NCT01182350|566008049|FG004|Overall Study|Unevaluable for Biopsy|3|||
156796419|NCT01381679|566008052|FG000|Overall Study|Adverse Event|3|||
156796420|NCT01381679|566008052|FG000|Overall Study|Lost to Follow-up|885|||
156796421|NCT05473715|566008053|FG000|Overall Study|Trial terminate|2|||
156796422|NCT05473715|566008054|FG001|Overall Study|Trial terminate|1|||
156796423|NCT03528902|566008055|FG000|Overall Study|Adverse Event|1|||
156796424|NCT03528902|566008056|FG001|Overall Study|Adverse Event|0|||
156796425|NCT04770285|566008057|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
156796426|NCT04770285|566008058|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
156796427|NCT04770285|566008057|FG000|Overall Study|Lack of Efficacy|0|||
156796428|NCT04770285|566008058|FG001|Overall Study|Lack of Efficacy|1|||
156796429|NCT04770285|566008057|FG000|Overall Study|Lost to Follow-up|11|||
156796430|NCT04770285|566008058|FG001|Overall Study|Lost to Follow-up|8|||
156796431|NCT04770285|566008057|FG000|Overall Study|Protocol Deviation|6|||
156796432|NCT04770285|566008058|FG001|Overall Study|Protocol Deviation|6|||
156796433|NCT04770285|566008057|FG000|Overall Study|Technical Problem|0|||
156796434|NCT04770285|566008058|FG001|Overall Study|Technical Problem|1|||
156796435|NCT04770285|566008057|FG000|Overall Study|Withdrawal by Subject|9|||
156796436|NCT04770285|566008058|FG001|Overall Study|Withdrawal by Subject|8|||
156796437|NCT04770285|566008057|FG000|Overall Study|Reason Not Specified|0|||
156796438|NCT04770285|566008058|FG001|Overall Study|Reason Not Specified|1|||
156796439|NCT03232567|566008059|FG000|Overall Study|Withdrawal by Subject|0|||
156796440|NCT03232567|566008060|FG001|Overall Study|Withdrawal by Subject|1|||
156796441|NCT03232567|566008061|FG002|Overall Study|Withdrawal by Subject|0|||
156796442|NCT03232567|566008062|FG003|Overall Study|Withdrawal by Subject|0|||
156796443|NCT05837481|566008063|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
156730206|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
156730207|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
156730208|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
156796444|NCT05837481|566008064|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
156796445|NCT00427700|566008065|FG000|Overall Study|Lost to Follow-up|2|||
156796446|NCT00427700|566008066|FG001|Overall Study|Lost to Follow-up|5|||
156730209|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
156796447|NCT00427700|566008065|FG000|Overall Study|no induction of menses|1|||
156796448|NCT00427700|566008066|FG001|Overall Study|no induction of menses|4|||
156796449|NCT00427700|566008065|FG000|Overall Study|Pregnancy|0|||
156730210|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
156730211|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
156730212|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
156730213|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
156730214|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
156730215|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
156730216|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
156730217|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
156730218|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
156730219|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
156730220|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
156730221|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
156730222|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
156730223|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
156730224|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
156730225|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
156730226|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
156730227|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
156730228|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
156730229|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
156730230|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
156730231|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
156730232|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
156730233|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
156730234|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
156730235|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
156730236|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
156730237|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
156730238|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
156730239|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
156730240|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
156730241|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
156730242|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
156730243|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
156730244|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
156730245|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
156730246|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
156730247|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730248|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730249|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730250|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730251|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730252|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
156730253|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
156730254|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
156730255|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
156730256|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
156730257|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
156730258|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
156730259|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
156730260|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
156730261|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
156730262|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
156730263|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
156730264|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
156730265|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Death|0|||
156730266|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Death|0|||
156730267|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Death|0|||
156730268|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Death|0|||
156730269|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Death|0|||
156730270|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Death|1|||
156730271|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
156730272|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
156730273|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
156730274|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
156730275|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
156730276|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
156730277|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
156730278|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
156730279|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
156730280|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
156730281|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
156730282|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
156730283|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
156730284|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
156730285|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
156730286|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
156796450|NCT00427700|566008066|FG001|Overall Study|Pregnancy|2|||
156730287|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
156730288|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
156730289|NCT02016105|565760801|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
156730290|NCT02016105|565760802|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
156730291|NCT02016105|565760803|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
156730292|NCT02016105|565760804|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
156730293|NCT02016105|565760805|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
156730294|NCT02016105|565760806|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
156730295|NCT02016105|565760801|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
156730296|NCT02016105|565760802|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
156730297|NCT02016105|565760803|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
156730298|NCT02016105|565760804|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
156730299|NCT02016105|565760805|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
156730300|NCT02016105|565760806|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
156730301|NCT02016105|565760801|FG000|EXTENSION PERIOD|Adverse Event|0|||
156730302|NCT02016105|565760802|FG001|EXTENSION PERIOD|Adverse Event|0|||
156730303|NCT02016105|565760803|FG002|EXTENSION PERIOD|Adverse Event|2|||
156730304|NCT02016105|565760804|FG003|EXTENSION PERIOD|Adverse Event|0|||
156730305|NCT02016105|565760805|FG004|EXTENSION PERIOD|Adverse Event|1|||
156730306|NCT02016105|565760806|FG005|EXTENSION PERIOD|Adverse Event|0|||
156730307|NCT02016105|565760801|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
156730308|NCT02016105|565760802|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
156730309|NCT02016105|565760803|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
156730310|NCT02016105|565760804|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
156730311|NCT02016105|565760805|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
156730312|NCT02016105|565760806|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
156730313|NCT02016105|565760801|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730314|NCT02016105|565760802|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730315|NCT02016105|565760803|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730316|NCT02016105|565760804|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730317|NCT02016105|565760805|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
156730318|NCT02016105|565760806|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730319|NCT02016105|565760801|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
156730320|NCT02016105|565760802|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
156730321|NCT02016105|565760803|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
156730322|NCT02016105|565760804|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
156730323|NCT02016105|565760805|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
156730324|NCT02016105|565760806|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
156730325|NCT01908829|565760810|FG000|Overall Study|Adverse Event|13|||
156730326|NCT01908829|565760811|FG001|Overall Study|Adverse Event|11|||
156730327|NCT01908829|565760812|FG002|Overall Study|Adverse Event|13|||
156730328|NCT01908829|565760810|FG000|Overall Study|Lost to Follow-up|4|||
156730329|NCT01908829|565760811|FG001|Overall Study|Lost to Follow-up|2|||
156730330|NCT01908829|565760812|FG002|Overall Study|Lost to Follow-up|1|||
156730331|NCT01908829|565760810|FG000|Overall Study|Randomized no double-blind drug received|1|||
156730332|NCT01908829|565760811|FG001|Overall Study|Randomized no double-blind drug received|0|||
156730333|NCT01908829|565760812|FG002|Overall Study|Randomized no double-blind drug received|1|||
156730334|NCT01908829|565760810|FG000|Overall Study|Discontinued (no EoT page)|2|||
156730335|NCT01908829|565760811|FG001|Overall Study|Discontinued (no EoT page)|0|||
156730336|NCT01908829|565760812|FG002|Overall Study|Discontinued (no EoT page)|0|||
156730337|NCT01908829|565760810|FG000|Overall Study|Miscellaneous|0|||
156730338|NCT01908829|565760811|FG001|Overall Study|Miscellaneous|2|||
156730339|NCT01908829|565760812|FG002|Overall Study|Miscellaneous|0|||
156730340|NCT01908829|565760810|FG000|Overall Study|Protocol Violation|2|||
156730341|NCT01908829|565760811|FG001|Overall Study|Protocol Violation|2|||
156730342|NCT01908829|565760812|FG002|Overall Study|Protocol Violation|0|||
156730343|NCT01908829|565760810|FG000|Overall Study|Lack of Efficacy|1|||
156730344|NCT01908829|565760811|FG001|Overall Study|Lack of Efficacy|3|||
156730345|NCT01908829|565760812|FG002|Overall Study|Lack of Efficacy|2|||
156730346|NCT01908829|565760810|FG000|Overall Study|Withdrawal by Subject|26|||
156730347|NCT01908829|565760811|FG001|Overall Study|Withdrawal by Subject|29|||
156730348|NCT01908829|565760812|FG002|Overall Study|Withdrawal by Subject|22|||
156730349|NCT02865499|565760813|FG000|Baseline|Adverse Event|1|||
156730350|NCT02865499|565760813|FG000|Baseline|Withdrawal by Subject|1|||
156730351|NCT02792192|565760814|FG000|Overall Study|Death|1|||
156730352|NCT02792192|565760815|FG001|Overall Study|Death|0|||
156730353|NCT02792192|565760816|FG002|Overall Study|Death|0|||
156730354|NCT02792192|565760817|FG003|Overall Study|Death|0|||
156730355|NCT02792192|565760814|FG000|Overall Study|Informed Consent Withdrawn|4|||
156730356|NCT02792192|565760815|FG001|Overall Study|Informed Consent Withdrawn|0|||
156730357|NCT02792192|565760816|FG002|Overall Study|Informed Consent Withdrawn|0|||
156730358|NCT02792192|565760817|FG003|Overall Study|Informed Consent Withdrawn|0|||
156730359|NCT02792192|565760814|FG000|Overall Study|Physician Decision|1|||
156730360|NCT02792192|565760815|FG001|Overall Study|Physician Decision|0|||
156730361|NCT02792192|565760816|FG002|Overall Study|Physician Decision|0|||
156730362|NCT02792192|565760817|FG003|Overall Study|Physician Decision|0|||
156730363|NCT02792192|565760814|FG000|Overall Study|Progressive Disease|0|||
156455064|NCT02268253|564761575|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
156730364|NCT02792192|565760815|FG001|Overall Study|Progressive Disease|1|||
156730365|NCT02792192|565760816|FG002|Overall Study|Progressive Disease|0|||
156730366|NCT02792192|565760817|FG003|Overall Study|Progressive Disease|0|||
156730367|NCT02792192|565760814|FG000|Overall Study|Study Terminated By Sponsor|6|||
156730368|NCT02792192|565760815|FG001|Overall Study|Study Terminated By Sponsor|10|||
156730369|NCT02792192|565760816|FG002|Overall Study|Study Terminated By Sponsor|0|||
156730370|NCT02792192|565760817|FG003|Overall Study|Study Terminated By Sponsor|0|||
156730371|NCT02320058|565760818|FG000|Overall Study|Death|25|||
156730372|NCT02320058|565760819|FG001|Overall Study|Death|10|||
156730373|NCT02320058|565760818|FG000|Overall Study|Lost to Follow-up|4|||
156730374|NCT02320058|565760819|FG001|Overall Study|Lost to Follow-up|0|||
156730375|NCT02320058|565760818|FG000|Overall Study|Other reasons|4|||
156730376|NCT02320058|565760819|FG001|Overall Study|Other reasons|1|||
156730377|NCT02320058|565760818|FG000|Overall Study|Withdrawal by Subject|8|||
156730378|NCT02320058|565760819|FG001|Overall Study|Withdrawal by Subject|2|||
156730379|NCT02320058|565760818|FG000|Overall Study|Not reported|1|||
156730380|NCT02320058|565760819|FG001|Overall Study|Not reported|0|||
156730381|NCT01339923|565760820|FG000|Overall Study|Adverse Event|1|||
156730382|NCT01339923|565760821|FG001|Overall Study|Adverse Event|1|||
156730383|NCT01339923|565760822|FG002|Overall Study|Adverse Event|1|||
156730384|NCT01339923|565760823|FG003|Overall Study|Adverse Event|0|||
156730385|NCT01339923|565760824|FG004|Overall Study|Adverse Event|0|||
156730386|NCT01339923|565760825|FG005|Overall Study|Adverse Event|0|||
156730387|NCT01339923|565760826|FG006|Overall Study|Adverse Event|1|||
156730388|NCT01339923|565760820|FG000|Overall Study|Inappropriate Enrollment|1|||
156730389|NCT01339923|565760821|FG001|Overall Study|Inappropriate Enrollment|0|||
156730390|NCT01339923|565760822|FG002|Overall Study|Inappropriate Enrollment|0|||
156730391|NCT01339923|565760823|FG003|Overall Study|Inappropriate Enrollment|0|||
156730392|NCT01339923|565760824|FG004|Overall Study|Inappropriate Enrollment|0|||
156730393|NCT01339923|565760825|FG005|Overall Study|Inappropriate Enrollment|1|||
156730394|NCT01339923|565760826|FG006|Overall Study|Inappropriate Enrollment|0|||
156730395|NCT01339923|565760820|FG000|Overall Study|Lost to Follow-up|4|||
156730396|NCT01339923|565760821|FG001|Overall Study|Lost to Follow-up|4|||
156730397|NCT01339923|565760822|FG002|Overall Study|Lost to Follow-up|0|||
156730398|NCT01339923|565760823|FG003|Overall Study|Lost to Follow-up|3|||
156730399|NCT01339923|565760824|FG004|Overall Study|Lost to Follow-up|1|||
156730400|NCT01339923|565760825|FG005|Overall Study|Lost to Follow-up|1|||
156730401|NCT01339923|565760826|FG006|Overall Study|Lost to Follow-up|5|||
156730402|NCT01339923|565760820|FG000|Overall Study|Protocol Violation|0|||
156730403|NCT01339923|565760821|FG001|Overall Study|Protocol Violation|0|||
156730404|NCT01339923|565760822|FG002|Overall Study|Protocol Violation|0|||
156730405|NCT01339923|565760823|FG003|Overall Study|Protocol Violation|0|||
156730406|NCT01339923|565760824|FG004|Overall Study|Protocol Violation|0|||
156730407|NCT01339923|565760825|FG005|Overall Study|Protocol Violation|3|||
156730408|NCT01339923|565760826|FG006|Overall Study|Protocol Violation|1|||
156730409|NCT01339923|565760820|FG000|Overall Study|Unable to Classify|1|||
156730410|NCT01339923|565760821|FG001|Overall Study|Unable to Classify|0|||
156730411|NCT01339923|565760822|FG002|Overall Study|Unable to Classify|1|||
156730412|NCT01339923|565760823|FG003|Overall Study|Unable to Classify|0|||
156730413|NCT01339923|565760824|FG004|Overall Study|Unable to Classify|0|||
156730414|NCT01339923|565760825|FG005|Overall Study|Unable to Classify|1|||
156730415|NCT01339923|565760826|FG006|Overall Study|Unable to Classify|5|||
156730416|NCT01339923|565760820|FG000|Overall Study|Withdrawal by Subject|7|||
156730417|NCT01339923|565760821|FG001|Overall Study|Withdrawal by Subject|11|||
156730418|NCT01339923|565760822|FG002|Overall Study|Withdrawal by Subject|6|||
156730419|NCT01339923|565760823|FG003|Overall Study|Withdrawal by Subject|1|||
156730420|NCT01339923|565760824|FG004|Overall Study|Withdrawal by Subject|4|||
156455065|NCT02268253|564761576|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
156730421|NCT01339923|565760825|FG005|Overall Study|Withdrawal by Subject|3|||
156730422|NCT01339923|565760826|FG006|Overall Study|Withdrawal by Subject|2|||
156730423|NCT01430403|565760827|FG000|Overall Study|Lost to Follow-up|5|||
156730424|NCT01430403|565760828|FG001|Overall Study|Lost to Follow-up|5|||
156796451|NCT04581395|566008067|FG000|Overall Study|Protocol Violation|4|||
156796452|NCT04581395|566008068|FG001|Overall Study|Protocol Violation|3|||
156796453|NCT04581395|566008069|FG002|Overall Study|Protocol Violation|2|||
156796454|NCT04581395|566008067|FG000|Overall Study|Physician Decision|0|||
156455066|NCT02268253|564761577|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
156455067|NCT02268253|564761578|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
156730425|NCT01430403|565760829|FG002|Overall Study|Lost to Follow-up|3|||
156730426|NCT01430403|565760827|FG000|Overall Study|Physician Decision|1|||
156730427|NCT01430403|565760828|FG001|Overall Study|Physician Decision|0|||
156730428|NCT01430403|565760829|FG002|Overall Study|Physician Decision|0|||
156796455|NCT04581395|566008068|FG001|Overall Study|Physician Decision|1|||
156730429|NCT01430403|565760827|FG000|Overall Study|Protocol Violation|2|||
156730430|NCT01430403|565760828|FG001|Overall Study|Protocol Violation|3|||
156730431|NCT01430403|565760829|FG002|Overall Study|Protocol Violation|2|||
156796456|NCT04581395|566008069|FG002|Overall Study|Physician Decision|0|||
156730432|NCT01430403|565760827|FG000|Overall Study|Withdrawal by Subject|9|||
156730433|NCT01430403|565760828|FG001|Overall Study|Withdrawal by Subject|1|||
156730434|NCT01430403|565760829|FG002|Overall Study|Withdrawal by Subject|3|||
156730435|NCT02477826|565760850|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
156730436|NCT02477826|565760851|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
156730437|NCT02477826|565760852|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
156730438|NCT02477826|565760853|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
156730439|NCT02477826|565760854|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
156730440|NCT02477826|565760855|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
156455068|NCT02268253|564761579|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
156455069|NCT02268253|564761573|FG000|Stage 3A|Withdrawal by Subject|0|||
156455070|NCT02268253|564761574|FG001|Stage 3A|Withdrawal by Subject|0|||
156455071|NCT02268253|564761575|FG002|Stage 3A|Withdrawal by Subject|2|||
156730441|NCT02477826|565760856|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
156730442|NCT02477826|565760857|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
156730443|NCT02477826|565760858|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
156730444|NCT02477826|565760859|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
156730445|NCT02477826|565760850|FG000|Pre-Treatment|Other reasons|4|||
156730446|NCT02477826|565760851|FG001|Pre-Treatment|Other reasons|1|||
156730447|NCT02477826|565760852|FG002|Pre-Treatment|Other reasons|4|||
156730448|NCT02477826|565760853|FG003|Pre-Treatment|Other reasons|1|||
156730449|NCT02477826|565760854|FG004|Pre-Treatment|Other reasons|4|||
156730450|NCT02477826|565760855|FG005|Pre-Treatment|Other reasons|2|||
156730451|NCT02477826|565760856|FG006|Pre-Treatment|Other reasons|0|||
156730452|NCT02477826|565760857|FG007|Pre-Treatment|Other reasons|0|||
156730453|NCT02477826|565760858|FG008|Pre-Treatment|Other reasons|0|||
156730454|NCT02477826|565760859|FG009|Pre-Treatment|Other reasons|0|||
156730455|NCT02477826|565760850|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
156730456|NCT02477826|565760851|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
156730457|NCT02477826|565760852|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
156730458|NCT02477826|565760853|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
156730459|NCT02477826|565760854|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
156730460|NCT02477826|565760855|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
156730461|NCT02477826|565760856|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
156730462|NCT02477826|565760857|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
156730463|NCT02477826|565760858|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
156730464|NCT02477826|565760859|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
156730465|NCT02477826|565760850|FG000|Pre-Treatment|Subject withdrew consent|0|||
156730466|NCT02477826|565760851|FG001|Pre-Treatment|Subject withdrew consent|0|||
156730467|NCT02477826|565760852|FG002|Pre-Treatment|Subject withdrew consent|3|||
156730468|NCT02477826|565760853|FG003|Pre-Treatment|Subject withdrew consent|0|||
156730469|NCT02477826|565760854|FG004|Pre-Treatment|Subject withdrew consent|0|||
156730470|NCT02477826|565760855|FG005|Pre-Treatment|Subject withdrew consent|1|||
156730471|NCT02477826|565760856|FG006|Pre-Treatment|Subject withdrew consent|0|||
156730472|NCT02477826|565760857|FG007|Pre-Treatment|Subject withdrew consent|1|||
156730473|NCT02477826|565760858|FG008|Pre-Treatment|Subject withdrew consent|0|||
156730474|NCT02477826|565760859|FG009|Pre-Treatment|Subject withdrew consent|3|||
156730475|NCT02477826|565760850|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730476|NCT02477826|565760851|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
156730477|NCT02477826|565760852|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730478|NCT02477826|565760853|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730479|NCT02477826|565760854|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730480|NCT02477826|565760855|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730481|NCT02477826|565760856|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730482|NCT02477826|565760857|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
156796457|NCT00815633|566008074|FG000|Overall Study|study terminated|1|||
156796458|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
156796459|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796460|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796461|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796462|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796463|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796464|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796465|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
156796466|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
156796467|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
156796468|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
156796469|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
156796470|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
156796471|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
156730483|NCT02477826|565760858|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730484|NCT02477826|565760859|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
156730485|NCT02477826|565760850|FG000|Pre-Treatment|Death|0|||
156730486|NCT02477826|565760851|FG001|Pre-Treatment|Death|0|||
156730487|NCT02477826|565760852|FG002|Pre-Treatment|Death|0|||
156730488|NCT02477826|565760853|FG003|Pre-Treatment|Death|0|||
156730489|NCT02477826|565760854|FG004|Pre-Treatment|Death|0|||
156730490|NCT02477826|565760855|FG005|Pre-Treatment|Death|0|||
156730491|NCT02477826|565760856|FG006|Pre-Treatment|Death|1|||
156730492|NCT02477826|565760857|FG007|Pre-Treatment|Death|0|||
156730493|NCT02477826|565760858|FG008|Pre-Treatment|Death|0|||
156730494|NCT02477826|565760859|FG009|Pre-Treatment|Death|0|||
156730495|NCT02477826|565760850|FG000|Treatment Period|Not reported|8|||
156730496|NCT02477826|565760851|FG001|Treatment Period|Not reported|6|||
156730497|NCT02477826|565760852|FG002|Treatment Period|Not reported|4|||
156730498|NCT02477826|565760853|FG003|Treatment Period|Not reported|4|||
156730499|NCT02477826|565760854|FG004|Treatment Period|Not reported|2|||
156730500|NCT02477826|565760855|FG005|Treatment Period|Not reported|1|||
156730501|NCT02477826|565760856|FG006|Treatment Period|Not reported|14|||
156730502|NCT02477826|565760857|FG007|Treatment Period|Not reported|8|||
156730503|NCT02477826|565760858|FG008|Treatment Period|Not reported|5|||
156730504|NCT02477826|565760859|FG009|Treatment Period|Not reported|2|||
156730505|NCT02477826|565760850|FG000|Treatment Period|Other reasons|5|||
156730506|NCT02477826|565760851|FG001|Treatment Period|Other reasons|6|||
156730507|NCT02477826|565760852|FG002|Treatment Period|Other reasons|12|||
156730508|NCT02477826|565760853|FG003|Treatment Period|Other reasons|7|||
156730509|NCT02477826|565760854|FG004|Treatment Period|Other reasons|5|||
156730510|NCT02477826|565760855|FG005|Treatment Period|Other reasons|1|||
156730511|NCT02477826|565760856|FG006|Treatment Period|Other reasons|8|||
156730512|NCT02477826|565760857|FG007|Treatment Period|Other reasons|8|||
156730513|NCT02477826|565760858|FG008|Treatment Period|Other reasons|21|||
156730514|NCT02477826|565760859|FG009|Treatment Period|Other reasons|1|||
156730515|NCT02477826|565760850|FG000|Treatment Period|Administrative reason by sponsor|0|||
156730516|NCT02477826|565760851|FG001|Treatment Period|Administrative reason by sponsor|3|||
156730517|NCT02477826|565760852|FG002|Treatment Period|Administrative reason by sponsor|0|||
156730518|NCT02477826|565760853|FG003|Treatment Period|Administrative reason by sponsor|0|||
156730519|NCT02477826|565760854|FG004|Treatment Period|Administrative reason by sponsor|0|||
156730520|NCT02477826|565760855|FG005|Treatment Period|Administrative reason by sponsor|0|||
156730521|NCT02477826|565760856|FG006|Treatment Period|Administrative reason by sponsor|0|||
156730522|NCT02477826|565760857|FG007|Treatment Period|Administrative reason by sponsor|0|||
156730523|NCT02477826|565760858|FG008|Treatment Period|Administrative reason by sponsor|0|||
156730524|NCT02477826|565760859|FG009|Treatment Period|Administrative reason by sponsor|0|||
156730525|NCT02477826|565760850|FG000|Treatment Period|Participant meet no longer study criteria|1|||
156730526|NCT02477826|565760851|FG001|Treatment Period|Participant meet no longer study criteria|1|||
156730527|NCT02477826|565760852|FG002|Treatment Period|Participant meet no longer study criteria|0|||
156730528|NCT02477826|565760853|FG003|Treatment Period|Participant meet no longer study criteria|0|||
156730529|NCT02477826|565760854|FG004|Treatment Period|Participant meet no longer study criteria|1|||
156730530|NCT02477826|565760855|FG005|Treatment Period|Participant meet no longer study criteria|1|||
156730531|NCT02477826|565760856|FG006|Treatment Period|Participant meet no longer study criteria|0|||
156730532|NCT02477826|565760857|FG007|Treatment Period|Participant meet no longer study criteria|1|||
156730533|NCT02477826|565760858|FG008|Treatment Period|Participant meet no longer study criteria|0|||
156730534|NCT02477826|565760859|FG009|Treatment Period|Participant meet no longer study criteria|0|||
156730535|NCT02477826|565760850|FG000|Treatment Period|Poor/Non Compliance|1|||
156730536|NCT02477826|565760851|FG001|Treatment Period|Poor/Non Compliance|0|||
156730537|NCT02477826|565760852|FG002|Treatment Period|Poor/Non Compliance|2|||
156730538|NCT02477826|565760853|FG003|Treatment Period|Poor/Non Compliance|0|||
156730539|NCT02477826|565760854|FG004|Treatment Period|Poor/Non Compliance|0|||
156730540|NCT02477826|565760855|FG005|Treatment Period|Poor/Non Compliance|1|||
156730541|NCT02477826|565760856|FG006|Treatment Period|Poor/Non Compliance|1|||
156730542|NCT02477826|565760857|FG007|Treatment Period|Poor/Non Compliance|0|||
156796472|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
156730543|NCT02477826|565760858|FG008|Treatment Period|Poor/Non Compliance|0|||
156730544|NCT02477826|565760859|FG009|Treatment Period|Poor/Non Compliance|1|||
156730545|NCT02477826|565760850|FG000|Treatment Period|Maximum Clinical Benefit|3|||
156730546|NCT02477826|565760851|FG001|Treatment Period|Maximum Clinical Benefit|3|||
156730547|NCT02477826|565760852|FG002|Treatment Period|Maximum Clinical Benefit|1|||
156796473|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
156730548|NCT02477826|565760853|FG003|Treatment Period|Maximum Clinical Benefit|1|||
156730549|NCT02477826|565760854|FG004|Treatment Period|Maximum Clinical Benefit|3|||
156730550|NCT02477826|565760855|FG005|Treatment Period|Maximum Clinical Benefit|0|||
156730551|NCT02477826|565760856|FG006|Treatment Period|Maximum Clinical Benefit|3|||
156730552|NCT02477826|565760857|FG007|Treatment Period|Maximum Clinical Benefit|2|||
156730553|NCT02477826|565760858|FG008|Treatment Period|Maximum Clinical Benefit|2|||
156730554|NCT02477826|565760859|FG009|Treatment Period|Maximum Clinical Benefit|2|||
156730555|NCT02477826|565760850|FG000|Treatment Period|Lost to Follow-up|0|||
156730556|NCT02477826|565760851|FG001|Treatment Period|Lost to Follow-up|0|||
156730557|NCT02477826|565760852|FG002|Treatment Period|Lost to Follow-up|1|||
156730558|NCT02477826|565760853|FG003|Treatment Period|Lost to Follow-up|1|||
156730559|NCT02477826|565760854|FG004|Treatment Period|Lost to Follow-up|0|||
156730560|NCT02477826|565760855|FG005|Treatment Period|Lost to Follow-up|0|||
156730561|NCT02477826|565760856|FG006|Treatment Period|Lost to Follow-up|2|||
156730562|NCT02477826|565760857|FG007|Treatment Period|Lost to Follow-up|2|||
156730563|NCT02477826|565760858|FG008|Treatment Period|Lost to Follow-up|0|||
156730564|NCT02477826|565760859|FG009|Treatment Period|Lost to Follow-up|0|||
156730565|NCT02477826|565760850|FG000|Treatment Period|Participant withdrew Consent|5|||
156730566|NCT02477826|565760851|FG001|Treatment Period|Participant withdrew Consent|5|||
156730567|NCT02477826|565760852|FG002|Treatment Period|Participant withdrew Consent|3|||
156730568|NCT02477826|565760853|FG003|Treatment Period|Participant withdrew Consent|3|||
156730569|NCT02477826|565760854|FG004|Treatment Period|Participant withdrew Consent|1|||
156876448|NCT04080167|566305840|FG001|Overall Study|Lost to Follow-up-Providers|2|||
156730570|NCT02477826|565760855|FG005|Treatment Period|Participant withdrew Consent|3|||
156730571|NCT02477826|565760856|FG006|Treatment Period|Participant withdrew Consent|3|||
156730572|NCT02477826|565760857|FG007|Treatment Period|Participant withdrew Consent|3|||
156730573|NCT02477826|565760858|FG008|Treatment Period|Participant withdrew Consent|2|||
156730574|NCT02477826|565760859|FG009|Treatment Period|Participant withdrew Consent|3|||
156730575|NCT02477826|565760850|FG000|Treatment Period|Participant request to discontinue treatment|5|||
156730576|NCT02477826|565760851|FG001|Treatment Period|Participant request to discontinue treatment|3|||
156730577|NCT02477826|565760852|FG002|Treatment Period|Participant request to discontinue treatment|15|||
156730578|NCT02477826|565760853|FG003|Treatment Period|Participant request to discontinue treatment|5|||
156730579|NCT02477826|565760854|FG004|Treatment Period|Participant request to discontinue treatment|3|||
156730580|NCT02477826|565760855|FG005|Treatment Period|Participant request to discontinue treatment|6|||
156730581|NCT02477826|565760856|FG006|Treatment Period|Participant request to discontinue treatment|13|||
156730582|NCT02477826|565760857|FG007|Treatment Period|Participant request to discontinue treatment|15|||
156730583|NCT02477826|565760858|FG008|Treatment Period|Participant request to discontinue treatment|4|||
156730584|NCT02477826|565760859|FG009|Treatment Period|Participant request to discontinue treatment|18|||
156730585|NCT02477826|565760850|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
156730586|NCT02477826|565760851|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
156730587|NCT02477826|565760852|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
156730588|NCT02477826|565760853|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
156730589|NCT02477826|565760854|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
156730590|NCT02477826|565760855|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
156730591|NCT02477826|565760856|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
156730592|NCT02477826|565760857|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
156730593|NCT02477826|565760858|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
156730594|NCT02477826|565760859|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
156730595|NCT02477826|565760850|FG000|Treatment Period|Death|4|||
156730596|NCT02477826|565760851|FG001|Treatment Period|Death|7|||
156876449|NCT04080167|566305841|FG002|Overall Study|Lost to Follow-up-Providers|0|||
156876450|NCT04080167|566305839|FG000|Overall Study|Withdrawal by Subject|1|||
156876451|NCT04080167|566305840|FG001|Overall Study|Withdrawal by Subject|2|||
156876452|NCT04080167|566305841|FG002|Overall Study|Withdrawal by Subject|0|||
156876453|NCT04080167|566305839|FG000|Overall Study|Withdrawal by Provider|0|||
156876454|NCT04080167|566305840|FG001|Overall Study|Withdrawal by Provider|0|||
156876455|NCT04080167|566305841|FG002|Overall Study|Withdrawal by Provider|4|||
156876456|NCT04080167|566305839|FG000|Overall Study|Death-Patient|2|||
156876457|NCT04080167|566305840|FG001|Overall Study|Death-Patient|1|||
156876458|NCT04080167|566305841|FG002|Overall Study|Death-Patient|0|||
156876459|NCT04080167|566305839|FG000|Overall Study|Hydroxyurea New Starts|0|||
156876460|NCT04080167|566305840|FG001|Overall Study|Hydroxyurea New Starts|0|||
156876461|NCT04080167|566305841|FG002|Overall Study|Hydroxyurea New Starts|1|||
156876462|NCT04080167|566305839|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
156876463|NCT04080167|566305840|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
156730597|NCT02477826|565760852|FG002|Treatment Period|Death|0|||
156730598|NCT02477826|565760853|FG003|Treatment Period|Death|0|||
156730599|NCT02477826|565760854|FG004|Treatment Period|Death|1|||
156730600|NCT02477826|565760855|FG005|Treatment Period|Death|2|||
156876464|NCT04080167|566305841|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
156876465|NCT02067676|566305842|FG000|Overall Study|Withdrawal by Subject|1|||
156876466|NCT02067676|566305843|FG001|Overall Study|Withdrawal by Subject|0|||
156336257|NCT02187744|564328215|FG000|Study|Related adverse event, serious non-fatal|0|||
156336258|NCT02187744|564328216|FG001|Study|Related adverse event, serious non-fatal|1|||
156730601|NCT02477826|565760856|FG006|Treatment Period|Death|6|||
156730602|NCT02477826|565760857|FG007|Treatment Period|Death|5|||
156730603|NCT02477826|565760858|FG008|Treatment Period|Death|9|||
156730604|NCT02477826|565760859|FG009|Treatment Period|Death|0|||
156876467|NCT02067676|566305844|FG002|Overall Study|Withdrawal by Subject|0|||
156876468|NCT02067676|566305845|FG003|Overall Study|Withdrawal by Subject|0|||
156455072|NCT02268253|564761576|FG003|Stage 3A|Withdrawal by Subject|0|||
156455073|NCT02268253|564761577|FG004|Stage 3A|Withdrawal by Subject|0|||
156455074|NCT02268253|564761578|FG005|Stage 3A|Withdrawal by Subject|0|||
156455075|NCT02268253|564761579|FG006|Stage 3A|Withdrawal by Subject|0|||
156730605|NCT02477826|565760850|FG000|Treatment Period|Study Drug Toxicity|79|||
156730606|NCT02477826|565760851|FG001|Treatment Period|Study Drug Toxicity|51|||
156730607|NCT02477826|565760852|FG002|Treatment Period|Study Drug Toxicity|31|||
156730608|NCT02477826|565760853|FG003|Treatment Period|Study Drug Toxicity|39|||
156730609|NCT02477826|565760854|FG004|Treatment Period|Study Drug Toxicity|12|||
156730610|NCT02477826|565760855|FG005|Treatment Period|Study Drug Toxicity|25|||
156730611|NCT02477826|565760856|FG006|Treatment Period|Study Drug Toxicity|52|||
156730612|NCT02477826|565760857|FG007|Treatment Period|Study Drug Toxicity|30|||
156730613|NCT02477826|565760858|FG008|Treatment Period|Study Drug Toxicity|20|||
156730614|NCT02477826|565760859|FG009|Treatment Period|Study Drug Toxicity|9|||
156730615|NCT02477826|565760850|FG000|Treatment Period|Disease progression|212|||
156730616|NCT02477826|565760851|FG001|Treatment Period|Disease progression|240|||
156730617|NCT02477826|565760852|FG002|Treatment Period|Disease progression|202|||
156730618|NCT02477826|565760853|FG003|Treatment Period|Disease progression|93|||
156730619|NCT02477826|565760854|FG004|Treatment Period|Disease progression|113|||
156730620|NCT02477826|565760855|FG005|Treatment Period|Disease progression|96|||
156730621|NCT02477826|565760856|FG006|Treatment Period|Disease progression|208|||
156730622|NCT02477826|565760857|FG007|Treatment Period|Disease progression|195|||
156730623|NCT02477826|565760858|FG008|Treatment Period|Disease progression|59|||
156730624|NCT02477826|565760859|FG009|Treatment Period|Disease progression|46|||
156730625|NCT02477826|565760850|FG000|Treatment Period|Pregnancy|0|||
156730626|NCT02477826|565760851|FG001|Treatment Period|Pregnancy|0|||
156730627|NCT02477826|565760852|FG002|Treatment Period|Pregnancy|0|||
156730628|NCT02477826|565760853|FG003|Treatment Period|Pregnancy|0|||
156730629|NCT02477826|565760854|FG004|Treatment Period|Pregnancy|0|||
156730630|NCT02477826|565760855|FG005|Treatment Period|Pregnancy|0|||
156730631|NCT02477826|565760856|FG006|Treatment Period|Pregnancy|0|||
156730632|NCT02477826|565760857|FG007|Treatment Period|Pregnancy|0|||
156730633|NCT02477826|565760858|FG008|Treatment Period|Pregnancy|0|||
156730634|NCT02477826|565760859|FG009|Treatment Period|Pregnancy|1|||
156730635|NCT02477826|565760850|FG000|Treatment Period|Other|0|||
156730636|NCT02477826|565760851|FG001|Treatment Period|Other|0|||
156730637|NCT02477826|565760852|FG002|Treatment Period|Other|0|||
156730638|NCT02477826|565760853|FG003|Treatment Period|Other|0|||
156730639|NCT02477826|565760854|FG004|Treatment Period|Other|0|||
156730640|NCT02477826|565760855|FG005|Treatment Period|Other|0|||
156730641|NCT02477826|565760856|FG006|Treatment Period|Other|0|||
156730642|NCT02477826|565760857|FG007|Treatment Period|Other|0|||
156730643|NCT02477826|565760858|FG008|Treatment Period|Other|0|||
156730644|NCT02477826|565760859|FG009|Treatment Period|Other|1|||
156730645|NCT00183885|565760862|FG000|Overall Study|Adverse Event|11|||
156730646|NCT00183885|565760862|FG000|Overall Study|Death|1|||
156730647|NCT00183885|565760862|FG000|Overall Study|Lost to Follow-up|3|||
156730648|NCT00183885|565760862|FG000|Overall Study|Physician Decision|6|||
156730649|NCT00183885|565760862|FG000|Overall Study|Withdrawal by Subject|5|||
156730650|NCT00183885|565760862|FG000|Overall Study|Switched to alternative treatment|8|||
156730651|NCT00183885|565760862|FG000|Overall Study|Treatment delayed too long|4|||
156730652|NCT00183885|565760862|FG000|Overall Study|Developed second malignancy|1|||
156730653|NCT01075256|565760878|FG000|Overall Study|Withdrawal by Subject|1|||
156730654|NCT01075256|565760879|FG001|Overall Study|Withdrawal by Subject|0|||
156730655|NCT01075256|565760880|FG002|Overall Study|Withdrawal by Subject|0|||
156730656|NCT00591565|565760888|FG000|Overall Study|lost follow up, withdrawn|5|||
156730657|NCT01052480|565760889|FG000|Overall Study|Lost to Follow-up|3|||
156730658|NCT01052480|565760890|FG001|Overall Study|Lost to Follow-up|3|||
156730659|NCT01052480|565760889|FG000|Overall Study|Protocol Violation|1|||
156455076|NCT02268253|564761573|FG000|Stage 3A|Physician Decision|0|||
156455077|NCT02268253|564761574|FG001|Stage 3A|Physician Decision|0|||
156730660|NCT01052480|565760890|FG001|Overall Study|Protocol Violation|0|||
156730661|NCT01052480|565760889|FG000|Overall Study|Withdrawal by Subject|3|||
156730662|NCT01052480|565760890|FG001|Overall Study|Withdrawal by Subject|7|||
156730663|NCT01052480|565760889|FG000|Overall Study|Physician Decision|0|||
156730664|NCT01052480|565760890|FG001|Overall Study|Physician Decision|2|||
156336259|NCT02187744|564328215|FG000|Treatment|Death|1|||
156730665|NCT01052480|565760889|FG000|Overall Study|Death|1|||
156730666|NCT01052480|565760890|FG001|Overall Study|Death|5|||
156730667|NCT03232931|565762067|FG000|Overall Study|Physician Decision|1|||
156730668|NCT03232931|565762068|FG001|Overall Study|Physician Decision|1|||
156730669|NCT03232931|565762067|FG000|Overall Study|Withdrawal by Subject|6|||
156730670|NCT03232931|565762068|FG001|Overall Study|Withdrawal by Subject|0|||
156730671|NCT03232931|565762067|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
156730672|NCT03232931|565762068|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
156730673|NCT03232931|565762067|FG000|Overall Study|Parent did not record voice|1|||
156730674|NCT03232931|565762068|FG001|Overall Study|Parent did not record voice|2|||
156730675|NCT03232931|565762067|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
156455078|NCT02268253|564761575|FG002|Stage 3A|Physician Decision|2|||
156455079|NCT02268253|564761576|FG003|Stage 3A|Physician Decision|0|||
156455080|NCT02268253|564761577|FG004|Stage 3A|Physician Decision|0|||
156455081|NCT02268253|564761578|FG005|Stage 3A|Physician Decision|0|||
156455082|NCT02268253|564761579|FG006|Stage 3A|Physician Decision|0|||
156455083|NCT02268253|564761573|FG000|Stage 3A|Study Terminated by Sponsor|0|||
156455084|NCT02268253|564761574|FG001|Stage 3A|Study Terminated by Sponsor|0|||
156455085|NCT02268253|564761575|FG002|Stage 3A|Study Terminated by Sponsor|2|||
156455086|NCT02268253|564761576|FG003|Stage 3A|Study Terminated by Sponsor|0|||
156455087|NCT02268253|564761577|FG004|Stage 3A|Study Terminated by Sponsor|0|||
156455088|NCT02268253|564761578|FG005|Stage 3A|Study Terminated by Sponsor|0|||
156455089|NCT02268253|564761579|FG006|Stage 3A|Study Terminated by Sponsor|0|||
156455090|NCT02268253|564761573|FG000|Stage 3A|Lost to Follow-up|0|||
156455091|NCT02268253|564761574|FG001|Stage 3A|Lost to Follow-up|0|||
156455092|NCT02268253|564761575|FG002|Stage 3A|Lost to Follow-up|1|||
156455093|NCT02268253|564761576|FG003|Stage 3A|Lost to Follow-up|0|||
156455094|NCT02268253|564761577|FG004|Stage 3A|Lost to Follow-up|0|||
156455095|NCT02268253|564761578|FG005|Stage 3A|Lost to Follow-up|0|||
156455096|NCT02268253|564761579|FG006|Stage 3A|Lost to Follow-up|0|||
156455097|NCT02268253|564761573|FG000|Stage 3A|Death|0|||
156455098|NCT02268253|564761574|FG001|Stage 3A|Death|0|||
156455099|NCT02268253|564761575|FG002|Stage 3A|Death|5|||
156455100|NCT02268253|564761576|FG003|Stage 3A|Death|0|||
156455101|NCT02268253|564761577|FG004|Stage 3A|Death|0|||
156455102|NCT02268253|564761578|FG005|Stage 3A|Death|0|||
156455103|NCT02268253|564761579|FG006|Stage 3A|Death|0|||
156455104|NCT05714761|564761580|FG000|Overall Study|Lost to Follow-up|3|||
156455105|NCT05714761|564761580|FG000|Overall Study|Withdrawal by Subject|3|||
156455106|NCT05714761|564761580|FG000|Overall Study|unblinding of sensor data|1|||
156455107|NCT05714761|564761580|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
156455108|NCT05714761|564761580|FG000|Overall Study|did not return second CGM sensor|4|||
156455109|NCT05672069|564761581|FG000|Overall Study|Implant removal|1|||
156455110|NCT05672069|564761581|FG000|Overall Study|Lost to Follow-up|2|||
156455111|NCT03544281|564761584|FG000|Main Study Phase|Death|3|||
156455112|NCT03544281|564761585|FG001|Main Study Phase|Death|2|||
156455113|NCT03544281|564761586|FG002|Main Study Phase|Death|6|||
156455114|NCT03544281|564761587|FG003|Main Study Phase|Death|8|||
156455115|NCT03544281|564761588|FG004|Main Study Phase|Death|4|||
156455116|NCT03544281|564761589|FG005|Main Study Phase|Death|2|||
156455117|NCT03544281|564761590|FG006|Main Study Phase|Death|4|||
156455118|NCT03544281|564761591|FG007|Main Study Phase|Death|5|||
156455119|NCT03544281|564761592|FG008|Main Study Phase|Death|5|||
156455120|NCT03544281|564761593|FG009|Main Study Phase|Death|8|||
156455121|NCT03544281|564761594|FG010|Main Study Phase|Death|6|||
156455122|NCT03544281|564761595|FG011|Main Study Phase|Death|4|||
156455123|NCT03544281|564761596|FG012|Main Study Phase|Death|0|||
156455124|NCT03544281|564761597|FG013|Main Study Phase|Death|0|||
156455125|NCT03544281|564761598|FG014|Main Study Phase|Death|0|||
156455126|NCT03544281|564761599|FG015|Main Study Phase|Death|0|||
156455127|NCT03544281|564761600|FG016|Main Study Phase|Death|0|||
156455128|NCT03544281|564761601|FG017|Main Study Phase|Death|0|||
156730676|NCT03232931|565762068|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
156730677|NCT04925557|565762069|FG000|Overall Study|Study closed|5|||
156730678|NCT04925557|565762070|FG001|Overall Study|Study closed|3|||
156730679|NCT05488470|565762071|FG000|Overall Study|Physician Decision|2|||
156730680|NCT05488470|565762071|FG000|Overall Study|Withdrawal by Subject|1|||
156730681|NCT05488470|565762071|FG000|Overall Study|Death|1|||
156730682|NCT01190410|565762072|FG000|Overall Study|Adverse Event|0|||
156730683|NCT01190410|565762073|FG001|Overall Study|Adverse Event|3|||
156730684|NCT01190410|565762072|FG000|Overall Study|Lack of Efficacy|0|||
156730685|NCT01190410|565762073|FG001|Overall Study|Lack of Efficacy|2|||
156336260|NCT02187744|564328216|FG001|Treatment|Death|0|||
156455129|NCT03544281|564761602|FG018|Main Study Phase|Death|0|||
156455130|NCT03544281|564761603|FG019|Main Study Phase|Death|0|||
156455131|NCT03544281|564761604|FG020|Main Study Phase|Death|0|||
156730686|NCT01190410|565762072|FG000|Overall Study|Withdrawal by Subject|0|||
156455132|NCT03544281|564761605|FG021|Main Study Phase|Death|0|||
156455133|NCT03544281|564761584|FG000|Main Study Phase|Lost to Follow-up|0|||
156455134|NCT03544281|564761585|FG001|Main Study Phase|Lost to Follow-up|0|||
156455135|NCT03544281|564761586|FG002|Main Study Phase|Lost to Follow-up|0|||
156455136|NCT03544281|564761587|FG003|Main Study Phase|Lost to Follow-up|0|||
156730687|NCT01190410|565762073|FG001|Overall Study|Withdrawal by Subject|2|||
156455137|NCT03544281|564761588|FG004|Main Study Phase|Lost to Follow-up|0|||
156455138|NCT03544281|564761589|FG005|Main Study Phase|Lost to Follow-up|0|||
156455139|NCT03544281|564761590|FG006|Main Study Phase|Lost to Follow-up|0|||
156455140|NCT03544281|564761591|FG007|Main Study Phase|Lost to Follow-up|0|||
156455141|NCT03544281|564761592|FG008|Main Study Phase|Lost to Follow-up|0|||
156455142|NCT03544281|564761593|FG009|Main Study Phase|Lost to Follow-up|0|||
156455143|NCT03544281|564761594|FG010|Main Study Phase|Lost to Follow-up|1|||
156455144|NCT03544281|564761595|FG011|Main Study Phase|Lost to Follow-up|0|||
156730688|NCT01190410|565762072|FG000|Overall Study|Administrative decision|1|||
156455145|NCT03544281|564761596|FG012|Main Study Phase|Lost to Follow-up|0|||
156455146|NCT03544281|564761597|FG013|Main Study Phase|Lost to Follow-up|0|||
156455147|NCT03544281|564761598|FG014|Main Study Phase|Lost to Follow-up|0|||
156455148|NCT03544281|564761599|FG015|Main Study Phase|Lost to Follow-up|0|||
156455149|NCT03544281|564761600|FG016|Main Study Phase|Lost to Follow-up|0|||
156455150|NCT03544281|564761601|FG017|Main Study Phase|Lost to Follow-up|0|||
156455151|NCT03544281|564761602|FG018|Main Study Phase|Lost to Follow-up|0|||
156455152|NCT03544281|564761603|FG019|Main Study Phase|Lost to Follow-up|0|||
156455153|NCT03544281|564761604|FG020|Main Study Phase|Lost to Follow-up|0|||
156455154|NCT03544281|564761605|FG021|Main Study Phase|Lost to Follow-up|0|||
156455155|NCT03544281|564761584|FG000|Main Study Phase|Physician Decision|0|||
156455156|NCT03544281|564761585|FG001|Main Study Phase|Physician Decision|0|||
156455157|NCT03544281|564761586|FG002|Main Study Phase|Physician Decision|0|||
156455158|NCT03544281|564761587|FG003|Main Study Phase|Physician Decision|0|||
156455159|NCT03544281|564761588|FG004|Main Study Phase|Physician Decision|0|||
156455160|NCT03544281|564761589|FG005|Main Study Phase|Physician Decision|0|||
156455161|NCT03544281|564761590|FG006|Main Study Phase|Physician Decision|0|||
156455162|NCT03544281|564761591|FG007|Main Study Phase|Physician Decision|1|||
156455163|NCT03544281|564761592|FG008|Main Study Phase|Physician Decision|0|||
156730689|NCT01190410|565762073|FG001|Overall Study|Administrative decision|0|||
156730690|NCT01190410|565762072|FG000|Overall Study|PI discretion|0|||
156730691|NCT01190410|565762073|FG001|Overall Study|PI discretion|2|||
156730692|NCT01270464|565762080|FG000|Overall Study|Protocol Violation|4|||
156730693|NCT01270464|565762081|FG001|Overall Study|Protocol Violation|3|||
156730694|NCT01270464|565762082|FG002|Overall Study|Protocol Violation|2|||
156730695|NCT01270464|565762080|FG000|Overall Study|Lack of Efficacy|2|||
156730696|NCT01270464|565762081|FG001|Overall Study|Lack of Efficacy|3|||
156730697|NCT01270464|565762082|FG002|Overall Study|Lack of Efficacy|1|||
156730698|NCT01270464|565762080|FG000|Overall Study|Adverse Event|9|||
156730699|NCT01270464|565762081|FG001|Overall Study|Adverse Event|1|||
156730700|NCT01270464|565762082|FG002|Overall Study|Adverse Event|7|||
156730701|NCT01270464|565762080|FG000|Overall Study|Withdrawal by Subject|2|||
156730702|NCT01270464|565762081|FG001|Overall Study|Withdrawal by Subject|1|||
156730703|NCT01270464|565762082|FG002|Overall Study|Withdrawal by Subject|4|||
156730704|NCT01270464|565762080|FG000|Overall Study|Lost to Follow-up|2|||
156730705|NCT01270464|565762081|FG001|Overall Study|Lost to Follow-up|3|||
156730706|NCT01270464|565762082|FG002|Overall Study|Lost to Follow-up|1|||
156730707|NCT01270464|565762080|FG000|Overall Study|Other|1|||
156730708|NCT01270464|565762081|FG001|Overall Study|Other|1|||
156730709|NCT01270464|565762082|FG002|Overall Study|Other|3|||
156730710|NCT02875613|565762088|FG000|Overall Study|Withdrawal by Subject|1|||
156730711|NCT02875613|565762088|FG000|Overall Study|Screen Failure|1|||
156730712|NCT02347774|565762089|FG000|Study Participation|Lost to Follow-up|3|||
156730713|NCT02347774|565762090|FG001|Study Participation|Lost to Follow-up|6|||
156730714|NCT02347774|565762091|FG002|Study Participation|Lost to Follow-up|2|||
156730715|NCT02347774|565762089|FG000|Study Participation|Withdrawal by Subject|8|||
156730716|NCT02347774|565762090|FG001|Study Participation|Withdrawal by Subject|9|||
156730717|NCT02347774|565762091|FG002|Study Participation|Withdrawal by Subject|15|||
156730718|NCT02347774|565762089|FG000|Study Participation|Adverse Event|1|||
156730719|NCT02347774|565762090|FG001|Study Participation|Adverse Event|4|||
156730720|NCT02347774|565762091|FG002|Study Participation|Adverse Event|6|||
156730721|NCT02347774|565762089|FG000|Study Participation|withdrew consent|1|||
156730722|NCT02347774|565762090|FG001|Study Participation|withdrew consent|1|||
156730723|NCT02347774|565762091|FG002|Study Participation|withdrew consent|1|||
156730724|NCT02347774|565762089|FG000|Study Participation|Met Prolonged QT criteria|1|||
156730725|NCT02347774|565762090|FG001|Study Participation|Met Prolonged QT criteria|0|||
156730726|NCT02347774|565762091|FG002|Study Participation|Met Prolonged QT criteria|0|||
156796474|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
156455164|NCT03544281|564761593|FG009|Main Study Phase|Physician Decision|0|||
156455165|NCT03544281|564761594|FG010|Main Study Phase|Physician Decision|0|||
156796475|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
156808810|NCT01484496|566054475|FG002|Period 1|Physician Decision|0|||
156455166|NCT03544281|564761595|FG011|Main Study Phase|Physician Decision|0|||
156730727|NCT02347774|565762089|FG000|Study Participation|non-compliance with study drug|0|||
156730728|NCT02347774|565762090|FG001|Study Participation|non-compliance with study drug|1|||
156455167|NCT03544281|564761596|FG012|Main Study Phase|Physician Decision|0|||
156455168|NCT03544281|564761597|FG013|Main Study Phase|Physician Decision|0|||
156455169|NCT03544281|564761598|FG014|Main Study Phase|Physician Decision|0|||
156455170|NCT03544281|564761599|FG015|Main Study Phase|Physician Decision|0|||
156455171|NCT03544281|564761600|FG016|Main Study Phase|Physician Decision|0|||
156730729|NCT02347774|565762091|FG002|Study Participation|non-compliance with study drug|0|||
156730730|NCT02347774|565762089|FG000|Study Participation|incarceration|1|||
156730731|NCT02347774|565762090|FG001|Study Participation|incarceration|0|||
156730732|NCT02347774|565762091|FG002|Study Participation|incarceration|0|||
156730733|NCT02347774|565762089|FG000|Study Participation|randomized in error|0|||
156730734|NCT02347774|565762090|FG001|Study Participation|randomized in error|0|||
156730735|NCT02347774|565762091|FG002|Study Participation|randomized in error|1|||
156730736|NCT02347774|565762089|FG000|On Study Treatment|Adverse Event|9|||
156730737|NCT02347774|565762090|FG001|On Study Treatment|Adverse Event|15|||
156730738|NCT02347774|565762091|FG002|On Study Treatment|Adverse Event|19|||
156730739|NCT02347774|565762089|FG000|On Study Treatment|Lack of Efficacy|3|||
156730740|NCT02347774|565762090|FG001|On Study Treatment|Lack of Efficacy|0|||
156730741|NCT02347774|565762091|FG002|On Study Treatment|Lack of Efficacy|2|||
156730742|NCT02347774|565762089|FG000|On Study Treatment|non-complicance with study medication|0|||
156730743|NCT02347774|565762090|FG001|On Study Treatment|non-complicance with study medication|2|||
156730744|NCT02347774|565762091|FG002|On Study Treatment|non-complicance with study medication|0|||
156730745|NCT02347774|565762089|FG000|On Study Treatment|Protocol Violation|0|||
156730746|NCT02347774|565762090|FG001|On Study Treatment|Protocol Violation|0|||
156730747|NCT02347774|565762091|FG002|On Study Treatment|Protocol Violation|1|||
156730748|NCT02347774|565762089|FG000|On Study Treatment|withdrew consent|9|||
156730749|NCT02347774|565762090|FG001|On Study Treatment|withdrew consent|8|||
156730750|NCT02347774|565762091|FG002|On Study Treatment|withdrew consent|12|||
156730751|NCT02347774|565762089|FG000|On Study Treatment|Lost to Follow-up|2|||
156730752|NCT02347774|565762090|FG001|On Study Treatment|Lost to Follow-up|6|||
156730753|NCT02347774|565762091|FG002|On Study Treatment|Lost to Follow-up|1|||
156730754|NCT02347774|565762089|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
156730755|NCT02347774|565762090|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
156730756|NCT02347774|565762091|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
156730757|NCT02347774|565762089|FG000|On Study Treatment|ranomized in error|0|||
156730758|NCT02347774|565762090|FG001|On Study Treatment|ranomized in error|0|||
156730759|NCT02347774|565762091|FG002|On Study Treatment|ranomized in error|1|||
156730760|NCT04112043|565762093|FG000|Overall Study|Withdrawal by Subject|1|||
156730761|NCT04112043|565762094|FG001|Overall Study|Withdrawal by Subject|1|||
156730762|NCT04112043|565762095|FG002|Overall Study|Withdrawal by Subject|1|||
156730763|NCT04112043|565762093|FG000|Overall Study|Taking NR supplement|1|||
156730764|NCT04112043|565762094|FG001|Overall Study|Taking NR supplement|0|||
156730765|NCT04112043|565762095|FG002|Overall Study|Taking NR supplement|0|||
156730766|NCT04112043|565762093|FG000|Overall Study|Adverse Event|0|||
156730767|NCT04112043|565762094|FG001|Overall Study|Adverse Event|1|||
156730768|NCT04112043|565762095|FG002|Overall Study|Adverse Event|0|||
156730769|NCT01750697|565762098|FG000|Overall Study|Transferred Back to Local Hospital|1|||
156730770|NCT01750697|565762098|FG000|Overall Study|Physician and Family Decision|1|||
156730771|NCT01750697|565762098|FG000|Overall Study|Transferred to Adult Services|5|||
156730772|NCT01750697|565762098|FG000|Overall Study|Physician Decision|1|||
156730773|NCT01750697|565762098|FG000|Overall Study|Withdrawal by Subject|1|||
156730774|NCT02285166|565762099|FG000|Overall Study|Case Report Forms Uncollected|564|||
156730775|NCT02285166|565762099|FG000|Overall Study|Protocol Deviation|402|||
156730776|NCT00384839|565762104|FG000|Overall Study|Adverse Event|4|||
156730777|NCT00384839|565762104|FG000|Overall Study|Investigator Request|1|||
156730778|NCT00384839|565762104|FG000|Overall Study|Patient Request|1|||
156730779|NCT00384839|565762104|FG000|Overall Study|Ineligible|2|||
156336261|NCT02187744|564328215|FG000|Treatment|Related adverse event, serious non-fatal|0|||
156730780|NCT01421225|565762107|FG000|Overall Study|Withdrawal by Subject|0|||
156730781|NCT01421225|565762108|FG001|Overall Study|Withdrawal by Subject|1|||
156730782|NCT02714595|565762109|FG000|Overall Study|Lost to Follow-up|1|||
156730783|NCT02714595|565762110|FG001|Overall Study|Lost to Follow-up|0|||
156730784|NCT02714595|565762109|FG000|Overall Study|Withdrawal by Subject|1|||
156730785|NCT02714595|565762110|FG001|Overall Study|Withdrawal by Subject|2|||
156730786|NCT02714595|565762109|FG000|Overall Study|Lack of Efficacy|0|||
156730787|NCT02714595|565762110|FG001|Overall Study|Lack of Efficacy|1|||
156730788|NCT02714595|565762109|FG000|Overall Study|Death|30|||
156730789|NCT02714595|565762110|FG001|Overall Study|Death|9|||
156730790|NCT02714595|565762109|FG000|Overall Study|Other-Miscellaneous|0|||
156455172|NCT03544281|564761601|FG017|Main Study Phase|Physician Decision|0|||
156730791|NCT02714595|565762110|FG001|Overall Study|Other-Miscellaneous|1|||
156730792|NCT01322490|565762111|FG000|Treatment Period|Adverse Event|12|||
156730793|NCT01322490|565762112|FG001|Treatment Period|Adverse Event|18|||
156455173|NCT03544281|564761602|FG018|Main Study Phase|Physician Decision|0|||
156455174|NCT03544281|564761603|FG019|Main Study Phase|Physician Decision|0|||
156455175|NCT03544281|564761604|FG020|Main Study Phase|Physician Decision|0|||
156455176|NCT03544281|564761605|FG021|Main Study Phase|Physician Decision|0|||
156730794|NCT01322490|565762113|FG002|Treatment Period|Adverse Event|15|||
156730795|NCT01322490|565762111|FG000|Treatment Period|Death|5|||
156730796|NCT01322490|565762112|FG001|Treatment Period|Death|7|||
156730797|NCT01322490|565762113|FG002|Treatment Period|Death|3|||
156730798|NCT01322490|565762111|FG000|Treatment Period|Lack of Efficacy|89|||
156730799|NCT01322490|565762112|FG001|Treatment Period|Lack of Efficacy|100|||
156730800|NCT01322490|565762113|FG002|Treatment Period|Lack of Efficacy|112|||
156730801|NCT01322490|565762111|FG000|Treatment Period|Physician Decision|0|||
156730802|NCT01322490|565762112|FG001|Treatment Period|Physician Decision|2|||
156730803|NCT01322490|565762113|FG002|Treatment Period|Physician Decision|1|||
156730804|NCT01322490|565762111|FG000|Treatment Period|Protocol Violation|7|||
156730805|NCT01322490|565762112|FG001|Treatment Period|Protocol Violation|5|||
156730806|NCT01322490|565762113|FG002|Treatment Period|Protocol Violation|4|||
156796476|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
156796477|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
156796478|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
156796479|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
156796480|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
156796481|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
156796482|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
156796483|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
156796484|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
156796485|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
156796486|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
156796487|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
156796488|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
156796489|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
156796490|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
156796491|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
156796492|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
156796493|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
156796494|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
156796495|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
156796496|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
156796497|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
156796498|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
156796499|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
156796500|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
156796501|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796502|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796503|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796504|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796505|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796506|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796507|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796508|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
156796509|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796510|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796511|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796512|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796513|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796514|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Death on study|0|||
156796515|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Death on study|0|||
156796516|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Death on study|0|||
156796517|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Death on study|1|||
156796518|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Death on study|0|||
156796519|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Death on study|0|||
156796520|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Death on study|0|||
156796521|NCT01362790|566008075|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
156796522|NCT01362790|566008076|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
156796523|NCT01362790|566008077|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
156796524|NCT01362790|566008078|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
156796525|NCT01362790|566008079|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
156796526|NCT01362790|566008080|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
156796527|NCT01362790|566008081|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
156796528|NCT01362790|566008075|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796529|NCT01362790|566008076|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796530|NCT01362790|566008077|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796531|NCT01362790|566008078|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796532|NCT01362790|566008079|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
156796533|NCT01362790|566008080|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796534|NCT01362790|566008081|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796535|NCT01362790|566008075|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
156796536|NCT01362790|566008076|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
156796537|NCT01362790|566008077|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
156796538|NCT01362790|566008078|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
156796539|NCT01362790|566008079|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
156796540|NCT01362790|566008080|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
156796541|NCT01362790|566008081|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
156796542|NCT02457065|566008082|FG000|Overall Study|Lost to Follow-up|9|||
156796543|NCT02457065|566008083|FG001|Overall Study|Lost to Follow-up|11|||
156796544|NCT03038087|566008084|FG000|Overall Study|lost data|1|||
156796545|NCT00654355|566008085|FG000|Overall Study|Lost to Follow-up|2|||
156730807|NCT01322490|565762111|FG000|Treatment Period|Withdrawal by Subject|14|||
156730808|NCT01322490|565762112|FG001|Treatment Period|Withdrawal by Subject|16|||
156730809|NCT01322490|565762113|FG002|Treatment Period|Withdrawal by Subject|11|||
156455177|NCT03544281|564761584|FG000|Main Study Phase|Withdrawal by Subject|2|||
156455178|NCT03544281|564761585|FG001|Main Study Phase|Withdrawal by Subject|0|||
156455179|NCT03544281|564761586|FG002|Main Study Phase|Withdrawal by Subject|1|||
156455180|NCT03544281|564761587|FG003|Main Study Phase|Withdrawal by Subject|2|||
156455181|NCT03544281|564761588|FG004|Main Study Phase|Withdrawal by Subject|0|||
156455182|NCT03544281|564761589|FG005|Main Study Phase|Withdrawal by Subject|0|||
156455183|NCT03544281|564761590|FG006|Main Study Phase|Withdrawal by Subject|0|||
156455184|NCT03544281|564761591|FG007|Main Study Phase|Withdrawal by Subject|0|||
156455185|NCT03544281|564761592|FG008|Main Study Phase|Withdrawal by Subject|2|||
156730810|NCT01322490|565762111|FG000|Treatment Period|Non-compliance with study drug|0|||
156730811|NCT01322490|565762112|FG001|Treatment Period|Non-compliance with study drug|0|||
156730812|NCT01322490|565762113|FG002|Treatment Period|Non-compliance with study drug|1|||
156730813|NCT01322490|565762111|FG000|Treatment Period|Other per report|2|||
156730814|NCT01322490|565762112|FG001|Treatment Period|Other per report|2|||
156730815|NCT01322490|565762113|FG002|Treatment Period|Other per report|1|||
156730816|NCT01322490|565762111|FG000|Treatment Period|Randomized but Not Treated|3|||
156730817|NCT01322490|565762112|FG001|Treatment Period|Randomized but Not Treated|3|||
156730818|NCT01322490|565762113|FG002|Treatment Period|Randomized but Not Treated|5|||
156730819|NCT01322490|565762111|FG000|Long Term Follow-up Period|Death|235|||
156730820|NCT01322490|565762112|FG001|Long Term Follow-up Period|Death|239|||
156730821|NCT01322490|565762113|FG002|Long Term Follow-up Period|Death|236|||
156730822|NCT01322490|565762111|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
156730823|NCT01322490|565762112|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
156730824|NCT01322490|565762113|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
156730825|NCT01322490|565762111|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
156730826|NCT01322490|565762112|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
156730827|NCT01322490|565762113|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
156730828|NCT01322490|565762111|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
156730829|NCT01322490|565762112|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
156730830|NCT01322490|565762113|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
156730831|NCT01322490|565762111|FG000|Long Term Follow-up Period|Other per report|3|||
156730832|NCT01322490|565762112|FG001|Long Term Follow-up Period|Other per report|2|||
156730833|NCT01322490|565762113|FG002|Long Term Follow-up Period|Other per report|2|||
156730834|NCT01322490|565762111|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
156730835|NCT01322490|565762112|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
156730836|NCT01322490|565762113|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
156730837|NCT02257489|565762114|FG000|Overall Study|Withdrawal by Subject|0|||
156730838|NCT02257489|565762115|FG001|Overall Study|Withdrawal by Subject|0|||
156730839|NCT02257489|565762116|FG002|Overall Study|Withdrawal by Subject|0|||
156730840|NCT02257489|565762117|FG003|Overall Study|Withdrawal by Subject|1|||
156730841|NCT02257489|565762118|FG004|Overall Study|Withdrawal by Subject|0|||
156730842|NCT02257489|565762119|FG005|Overall Study|Withdrawal by Subject|0|||
156730843|NCT02257489|565762120|FG006|Overall Study|Withdrawal by Subject|0|||
156730844|NCT02257489|565762121|FG007|Overall Study|Withdrawal by Subject|0|||
156730845|NCT02257489|565762122|FG008|Overall Study|Withdrawal by Subject|0|||
156730846|NCT01896128|565762123|FG000|Overall Study|Withdrawal by Subject|3|||
156730847|NCT01896128|565762124|FG001|Overall Study|Withdrawal by Subject|3|||
156730848|NCT02920008|565762128|FG000|Overall Study|Death|117|||
156730849|NCT02920008|565762129|FG001|Overall Study|Death|127|||
156730850|NCT02920008|565762128|FG000|Overall Study|Withdrawal by Subject|3|||
156730851|NCT02920008|565762129|FG001|Overall Study|Withdrawal by Subject|6|||
156730852|NCT02920008|565762128|FG000|Overall Study|Lost to Follow-up|0|||
156730853|NCT02920008|565762129|FG001|Overall Study|Lost to Follow-up|1|||
156796546|NCT00654355|566008086|FG001|Overall Study|Lost to Follow-up|2|||
156455186|NCT03544281|564761593|FG009|Main Study Phase|Withdrawal by Subject|3|||
156455187|NCT03544281|564761594|FG010|Main Study Phase|Withdrawal by Subject|0|||
156730854|NCT01862250|565762130|FG000|Overall Study|Adverse Event|4|||
156730855|NCT00090493|565762133|FG000|Overall Study|Physician Decision|2|||
156730856|NCT02071706|565762134|FG000|Overall Study|Adverse Event|1|||
156730857|NCT02071706|565762134|FG000|Overall Study|Withdrawal by Subject|2|||
156730858|NCT02247440|565762137|FG000|Overall Study|Withdrawal by Subject|1|||
156730859|NCT02247440|565762137|FG000|Overall Study|Lack of Efficacy|3|||
156730860|NCT00661609|565762138|FG000|Overall Study|Adverse Event|4|||
156730861|NCT00661609|565762138|FG000|Overall Study|Death|20|||
156730862|NCT00661609|565762138|FG000|Overall Study|Withdrawal by Subject|2|||
156730863|NCT00661609|565762138|FG000|Overall Study|PI Decision|1|||
156730864|NCT00661609|565762138|FG000|Overall Study|Survival follow up stage discontinued|11|||
156730865|NCT00661609|565762138|FG000|Overall Study|Disease progression|3|||
156730866|NCT01769508|565762141|FG000|Overall Study|Death|3|||
156730867|NCT01769508|565762141|FG000|Overall Study|Withdrawal by Subject|1|||
156730868|NCT01769508|565762141|FG000|Overall Study|Adverse Event|1|||
156730869|NCT01769508|565762141|FG000|Overall Study|Lost to Follow-up|1|||
156730870|NCT02593097|565762149|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
156730871|NCT02593097|565762150|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
156730872|NCT02593097|565762149|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
156730873|NCT02593097|565762150|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
156730874|NCT02593097|565762149|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
156730875|NCT02593097|565762150|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
156730876|NCT02593097|565762149|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
156730877|NCT02593097|565762150|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
156730878|NCT02593097|565762149|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
156730879|NCT02593097|565762150|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
156730880|NCT02858583|565762151|FG000|Overall Study|Declined consent|1|||
156730881|NCT02858583|565762152|FG001|Overall Study|Declined consent|1|||
156730882|NCT03759587|565762154|FG000|Overall Study|Adverse Event|5|||
156730883|NCT03759587|565762154|FG000|Overall Study|Progressive Disease|10|||
156730884|NCT03759587|565762154|FG000|Overall Study|Site Terminated by Sponsor|3|||
156730885|NCT03759587|565762154|FG000|Overall Study|Withdrawal by Subject|1|||
156730886|NCT01218087|565762156|FG000|Overall Study|Death|2|||
156730887|NCT01218087|565762157|FG001|Overall Study|Death|1|||
156730888|NCT01218087|565762156|FG000|Overall Study|Withdrawal by Subject|5|||
156730889|NCT01218087|565762157|FG001|Overall Study|Withdrawal by Subject|0|||
156730890|NCT01218087|565762156|FG000|Overall Study|Transferred|8|||
156730891|NCT01218087|565762157|FG001|Overall Study|Transferred|5|||
156730892|NCT00552396|565762158|FG000|Overall Study|protocol withdrawal criteria|3|||
156730893|NCT00552396|565762159|FG001|Overall Study|protocol withdrawal criteria|3|||
156730894|NCT00552396|565762160|FG002|Overall Study|protocol withdrawal criteria|3|||
156730895|NCT00552396|565762161|FG003|Overall Study|protocol withdrawal criteria|6|||
156730896|NCT00552396|565762162|FG004|Overall Study|protocol withdrawal criteria|3|||
156730897|NCT00552396|565762163|FG005|Overall Study|protocol withdrawal criteria|3|||
156730898|NCT00552396|565762164|FG006|Overall Study|protocol withdrawal criteria|9|||
156730899|NCT03170362|565762165|FG000|Overall Study|Death|2|||
156730900|NCT03170362|565762166|FG001|Overall Study|Death|2|||
156730901|NCT03170362|565762165|FG000|Overall Study|Withdrawal by Subject|23|||
156730902|NCT03170362|565762166|FG001|Overall Study|Withdrawal by Subject|22|||
156730903|NCT03170362|565762165|FG000|Overall Study|Lost to Follow-up|187|||
156730904|NCT03170362|565762166|FG001|Overall Study|Lost to Follow-up|167|||
156730905|NCT04615403|565762167|FG000|Overall Study|Death|1|||
156730906|NCT00665431|565762168|FG000|Overall Study|Adverse Event|16|||
156730907|NCT00665431|565762169|FG001|Overall Study|Adverse Event|22|||
156730908|NCT00665431|565762170|FG002|Overall Study|Adverse Event|6|||
156730909|NCT00665431|565762168|FG000|Overall Study|Withdrawal by Subject|17|||
156730910|NCT00665431|565762169|FG001|Overall Study|Withdrawal by Subject|25|||
156730911|NCT00665431|565762170|FG002|Overall Study|Withdrawal by Subject|15|||
156730912|NCT00665431|565762168|FG000|Overall Study|Lost to Follow-up|3|||
156730913|NCT00665431|565762169|FG001|Overall Study|Lost to Follow-up|3|||
156730914|NCT00665431|565762170|FG002|Overall Study|Lost to Follow-up|1|||
156730915|NCT00665431|565762168|FG000|Overall Study|Other|4|||
156730916|NCT00665431|565762169|FG001|Overall Study|Other|7|||
156730917|NCT00665431|565762170|FG002|Overall Study|Other|2|||
156730918|NCT04185220|565762181|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
156730919|NCT04185220|565762182|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
156876469|NCT02067676|566305846|FG004|Overall Study|Withdrawal by Subject|0|||
156876470|NCT02067676|566305847|FG005|Overall Study|Withdrawal by Subject|0|||
156876471|NCT00476229|566305848|FG000|Overall Study|Progressive shortness of breath|1|||
156876472|NCT01262820|566305850|FG000|Overall Study|Adverse Event|5|||
156876473|NCT01262820|566305850|FG000|Overall Study|Lack of Efficacy|9|||
156876474|NCT01262820|566305850|FG000|Overall Study|Drug held for 21+ days|1|||
156876475|NCT00452361|566305851|FG000|Overall Study|Adverse Event|8|||
156876476|NCT00452361|566305852|FG001|Overall Study|Adverse Event|0|||
156336262|NCT02187744|564328216|FG001|Treatment|Related adverse event, serious non-fatal|1|||
156730920|NCT04185220|565762181|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
156730921|NCT04185220|565762182|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
156730922|NCT03260244|565763822|FG000|Overall Study|Death|19|||
156730923|NCT03260244|565763822|FG000|Overall Study|Lost to Follow-up|60|||
156730924|NCT03260244|565763822|FG000|Overall Study|Withdrawal by Subject|48|||
156336263|NCT02187744|564328215|FG000|Treatment|Related adverse event, not serious|0|||
156336264|NCT02187744|564328216|FG001|Treatment|Related adverse event, not serious|2|||
156336265|NCT02187744|564328215|FG000|Treatment|Lost to Follow-up|0|||
156730925|NCT03260244|565763822|FG000|Overall Study|Procedure Not Performed|21|||
156730926|NCT03260244|565763822|FG000|Overall Study|Enrollment Criteria Not Met|31|||
156730927|NCT03260244|565763822|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
156730928|NCT03260244|565763822|FG000|Overall Study|Subject Noncompliance|6|||
156730929|NCT03260244|565763822|FG000|Overall Study|No inducible Arrhythmia|2|||
156876477|NCT00452361|566305851|FG000|Overall Study|Withdrawal by Subject|0|||
156730930|NCT03260244|565763822|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
156730931|NCT03260244|565763822|FG000|Overall Study|Screen Failure|2|||
156730932|NCT03260244|565763822|FG000|Overall Study|Treated Off Label|69|||
156730933|NCT03260244|565763822|FG000|Overall Study|No Radiofrequency Ablation|14|||
156730934|NCT00892151|565763823|FG000|Overall Study|Protocol Violation|1|||
156730935|NCT01222520|565763826|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
156730936|NCT01222520|565763827|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
156730937|NCT01222520|565763826|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
156730938|NCT01222520|565763827|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
156730939|NCT01222520|565763826|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
156730940|NCT01222520|565763827|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
156730941|NCT01222520|565763826|FG000|Double-blind Period|Adverse Event|0|||
156730942|NCT01222520|565763827|FG001|Double-blind Period|Adverse Event|1|||
156730943|NCT01222520|565763826|FG000|Double-blind Period|Lack of Efficacy|0|||
156730944|NCT01222520|565763827|FG001|Double-blind Period|Lack of Efficacy|1|||
156730945|NCT01222520|565763826|FG000|Double-blind Period|Study medication stolen|1|||
156730946|NCT01222520|565763827|FG001|Double-blind Period|Study medication stolen|0|||
156730947|NCT04606394|565763832|FG000|Overall Study|Withdrawal by Subject|3|||
156730948|NCT04606394|565763832|FG000|Overall Study|Exclusion criteria screen failure|12|||
156730949|NCT00954941|565763833|FG000|Overall Study|Received treatment at home|1|||
156730950|NCT00954941|565763834|FG001|Overall Study|Received treatment at home|0|||
156730951|NCT00954941|565763833|FG000|Overall Study|Withdrawal by Subject|1|||
156730952|NCT00954941|565763834|FG001|Overall Study|Withdrawal by Subject|0|||
156730953|NCT00954941|565763833|FG000|Overall Study|Insurance Denial|2|||
156730954|NCT00954941|565763834|FG001|Overall Study|Insurance Denial|2|||
156730955|NCT00954941|565763833|FG000|Overall Study|Physician Decision|2|||
156730956|NCT00954941|565763834|FG001|Overall Study|Physician Decision|2|||
156730957|NCT00954941|565763833|FG000|Overall Study|Ineligible|2|||
156730958|NCT00954941|565763834|FG001|Overall Study|Ineligible|2|||
156730959|NCT00954941|565763833|FG000|Overall Study|Adverse Event|0|||
156730960|NCT00954941|565763834|FG001|Overall Study|Adverse Event|1|||
156730961|NCT00637000|565763835|FG000|Overall Study|Withdrawal by Subject|4|||
156730962|NCT00637000|565763836|FG001|Overall Study|Withdrawal by Subject|3|||
156730963|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
156730964|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
156730965|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
156730966|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
156730967|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
156730968|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
156730969|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
156730970|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
156730971|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
156730972|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
156730973|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
156730974|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
156730975|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
156730976|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
156730977|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
156533599|NCT00578786|565048865|FG000|Overall Study|Not Otherwise Specified|0|||
156533600|NCT00578786|565048866|FG001|Overall Study|Not Otherwise Specified|4|||
156533601|NCT00578786|565048867|FG002|Overall Study|Not Otherwise Specified|1|||
156730978|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
156730979|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
156730980|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
156730981|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
156730982|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
156730983|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
156730984|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
156730985|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
156730986|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
156730987|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
156730988|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
156730989|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
156730990|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
156730991|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
156730992|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
156730993|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
156730994|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
156730995|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
156730996|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
156808811|NCT01484496|566054476|FG003|Period 1|Physician Decision|0|||
156730997|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
156730998|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
156730999|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
156731000|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
156731001|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
156731002|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
156731003|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
156731004|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
156731005|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
156731006|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
156731007|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
156731008|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
156731009|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
156731010|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
156731011|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
156731012|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
156731013|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
156731014|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
156731015|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
156731016|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
156731017|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
156731018|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
156731019|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
156731020|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
156731021|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
156731022|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
156731023|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
156731024|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
156731025|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
156731026|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
156731027|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
156731028|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
156731029|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
156731030|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
156731031|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
156731032|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
156731033|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
156731034|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
156731035|NCT02751450|565763840|FG000|Overall Study|Adverse Event|1|||
156731036|NCT02751450|565763841|FG001|Overall Study|Adverse Event|0|||
156731037|NCT00562302|565763842|FG000|Overall Study|Lost to Follow-up|3|||
156731038|NCT00562302|565763843|FG001|Overall Study|Lost to Follow-up|3|||
156731039|NCT00562302|565763842|FG000|Overall Study|Adverse Event|0|||
156731040|NCT00562302|565763843|FG001|Overall Study|Adverse Event|6|||
156731041|NCT00562302|565763842|FG000|Overall Study|Non-compliance|1|||
156731042|NCT00562302|565763843|FG001|Overall Study|Non-compliance|2|||
156731043|NCT00562302|565763842|FG000|Overall Study|Withdrawal by Subject|7|||
156731044|NCT00562302|565763843|FG001|Overall Study|Withdrawal by Subject|8|||
156731045|NCT00562302|565763842|FG000|Overall Study|Death|1|||
156731046|NCT00562302|565763843|FG001|Overall Study|Death|2|||
156731047|NCT00562302|565763842|FG000|Overall Study|Lung resection prior to study completion|7|||
156731048|NCT00562302|565763843|FG001|Overall Study|Lung resection prior to study completion|7|||
156731049|NCT00562302|565763842|FG000|Overall Study|Not stated|1|||
156731050|NCT00562302|565763843|FG001|Overall Study|Not stated|4|||
156731051|NCT01855243|565763844|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
156731052|NCT01855243|565763845|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
156731053|NCT01855243|565763846|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
156731054|NCT03615144|565763847|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
156731055|NCT03615144|565763848|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
156731056|NCT02587598|565763851|FG000|Overall Study|Death|4|||
156731057|NCT02587598|565763852|FG001|Overall Study|Death|8|||
156796547|NCT03485157|566008088|FG000|Double Blind Phase|Lost to Follow-up|4|||
156731058|NCT02587598|565763853|FG002|Overall Study|Death|4|||
156731059|NCT02587598|565763854|FG003|Overall Study|Death|16|||
156731060|NCT02587598|565763855|FG004|Overall Study|Death|9|||
156731061|NCT02587598|565763856|FG005|Overall Study|Death|4|||
156731062|NCT02587598|565763857|FG006|Overall Study|Death|6|||
156731063|NCT02587598|565763858|FG007|Overall Study|Death|7|||
156731064|NCT02587598|565763859|FG008|Overall Study|Death|9|||
156796548|NCT03485157|566008089|FG001|Double Blind Phase|Lost to Follow-up|4|||
156731065|NCT02587598|565763860|FG009|Overall Study|Death|1|||
156731066|NCT02587598|565763861|FG010|Overall Study|Death|3|||
156731067|NCT02587598|565763851|FG000|Overall Study|Study Terminated by the Sponsor|0|||
156731068|NCT02587598|565763852|FG001|Overall Study|Study Terminated by the Sponsor|1|||
156731069|NCT02587598|565763853|FG002|Overall Study|Study Terminated by the Sponsor|0|||
156731070|NCT02587598|565763854|FG003|Overall Study|Study Terminated by the Sponsor|3|||
156731071|NCT02587598|565763855|FG004|Overall Study|Study Terminated by the Sponsor|0|||
156731072|NCT02587598|565763856|FG005|Overall Study|Study Terminated by the Sponsor|1|||
156731073|NCT02587598|565763857|FG006|Overall Study|Study Terminated by the Sponsor|0|||
156731074|NCT02587598|565763858|FG007|Overall Study|Study Terminated by the Sponsor|0|||
156731075|NCT02587598|565763859|FG008|Overall Study|Study Terminated by the Sponsor|0|||
156731076|NCT02587598|565763860|FG009|Overall Study|Study Terminated by the Sponsor|1|||
156731077|NCT02587598|565763861|FG010|Overall Study|Study Terminated by the Sponsor|6|||
156731078|NCT02587598|565763851|FG000|Overall Study|Reason for study withdrawal not specified|0|||
156731079|NCT02587598|565763852|FG001|Overall Study|Reason for study withdrawal not specified|1|||
156731080|NCT02587598|565763853|FG002|Overall Study|Reason for study withdrawal not specified|0|||
156731081|NCT02587598|565763854|FG003|Overall Study|Reason for study withdrawal not specified|0|||
156731082|NCT02587598|565763855|FG004|Overall Study|Reason for study withdrawal not specified|0|||
156731083|NCT02587598|565763856|FG005|Overall Study|Reason for study withdrawal not specified|0|||
156731084|NCT02587598|565763857|FG006|Overall Study|Reason for study withdrawal not specified|0|||
156731085|NCT02587598|565763858|FG007|Overall Study|Reason for study withdrawal not specified|0|||
156731086|NCT02587598|565763859|FG008|Overall Study|Reason for study withdrawal not specified|0|||
156731087|NCT02587598|565763860|FG009|Overall Study|Reason for study withdrawal not specified|0|||
156731088|NCT02587598|565763861|FG010|Overall Study|Reason for study withdrawal not specified|0|||
156731089|NCT02587598|565763851|FG000|Overall Study|Withdrawal by Subject|0|||
156731090|NCT02587598|565763852|FG001|Overall Study|Withdrawal by Subject|1|||
156731091|NCT02587598|565763853|FG002|Overall Study|Withdrawal by Subject|0|||
156731092|NCT02587598|565763854|FG003|Overall Study|Withdrawal by Subject|2|||
156731093|NCT02587598|565763855|FG004|Overall Study|Withdrawal by Subject|3|||
156731094|NCT02587598|565763856|FG005|Overall Study|Withdrawal by Subject|1|||
156731095|NCT02587598|565763857|FG006|Overall Study|Withdrawal by Subject|0|||
156731096|NCT02587598|565763858|FG007|Overall Study|Withdrawal by Subject|0|||
156731097|NCT02587598|565763859|FG008|Overall Study|Withdrawal by Subject|0|||
156731098|NCT02587598|565763860|FG009|Overall Study|Withdrawal by Subject|1|||
156731099|NCT02587598|565763861|FG010|Overall Study|Withdrawal by Subject|2|||
156731100|NCT02587598|565763851|FG000|Overall Study|Physician Decision|0|||
156731101|NCT02587598|565763852|FG001|Overall Study|Physician Decision|0|||
156731102|NCT02587598|565763853|FG002|Overall Study|Physician Decision|0|||
156731103|NCT02587598|565763854|FG003|Overall Study|Physician Decision|0|||
156731104|NCT02587598|565763855|FG004|Overall Study|Physician Decision|0|||
156731105|NCT02587598|565763856|FG005|Overall Study|Physician Decision|0|||
156731106|NCT02587598|565763857|FG006|Overall Study|Physician Decision|0|||
156731107|NCT02587598|565763858|FG007|Overall Study|Physician Decision|0|||
156731108|NCT02587598|565763859|FG008|Overall Study|Physician Decision|0|||
156731109|NCT02587598|565763860|FG009|Overall Study|Physician Decision|0|||
156731110|NCT02587598|565763861|FG010|Overall Study|Physician Decision|3|||
156731111|NCT01704651|565763862|FG000|Overall Study|Pre-op withdrawal by subject|1|||
156731112|NCT01704651|565763863|FG001|Overall Study|Pre-op withdrawal by subject|1|||
156731113|NCT01704651|565763862|FG000|Overall Study|Pre-op change in treatment plan|1|||
156731114|NCT01704651|565763863|FG001|Overall Study|Pre-op change in treatment plan|4|||
156731115|NCT01704651|565763862|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
156731116|NCT01704651|565763863|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
156731117|NCT01704651|565763862|FG000|Overall Study|Post-op did not have laparotomy|2|||
156731118|NCT01704651|565763863|FG001|Overall Study|Post-op did not have laparotomy|1|||
156731119|NCT01860040|565763864|FG000|Overall Study|Withdrawal by Subject|1|||
156731120|NCT01860040|565763865|FG001|Overall Study|Withdrawal by Subject|0|||
156731121|NCT01931995|565763866|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
156731122|NCT01931995|565763867|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
156731123|NCT01931995|565763866|FG000|First Intervention (1 Day)|Physician Decision|1|||
156731124|NCT01931995|565763867|FG001|First Intervention (1 Day)|Physician Decision|1|||
156731125|NCT01931995|565763866|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
156731126|NCT01931995|565763867|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
156533602|NCT00578786|565048865|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
156731127|NCT00791661|565763868|FG000|7 Day Wash-out|Adverse Event|0|||
156731128|NCT00791661|565763869|FG001|7 Day Wash-out|Adverse Event|0|||
156731129|NCT00791661|565763870|FG002|7 Day Wash-out|Adverse Event|1|||
156731130|NCT00791661|565763868|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
156731131|NCT00791661|565763869|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
156731132|NCT00791661|565763870|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
156731133|NCT00679289|565763871|FG000|Overall Study|Progressive disease|4|||
156731134|NCT00679289|565763872|FG001|Overall Study|Progressive disease|5|||
156731135|NCT00679289|565763873|FG002|Overall Study|Progressive disease|18|||
156796549|NCT03485157|566008088|FG000|Double Blind Phase|Adverse Event|2|||
156731136|NCT00679289|565763871|FG000|Overall Study|Withdrawal by Subject|0|||
156731137|NCT00679289|565763872|FG001|Overall Study|Withdrawal by Subject|1|||
156731138|NCT00679289|565763873|FG002|Overall Study|Withdrawal by Subject|1|||
156731139|NCT00679289|565763871|FG000|Overall Study|Adverse Event|0|||
156731140|NCT00679289|565763872|FG001|Overall Study|Adverse Event|0|||
156731141|NCT00679289|565763873|FG002|Overall Study|Adverse Event|3|||
156731142|NCT00679289|565763871|FG000|Overall Study|Physician Decision|1|||
156731143|NCT00679289|565763872|FG001|Overall Study|Physician Decision|0|||
156731144|NCT00679289|565763873|FG002|Overall Study|Physician Decision|1|||
156731145|NCT00937040|565763874|FG000|Overall Study|Adverse Event|5|||
156731146|NCT00937040|565763875|FG001|Overall Study|Adverse Event|8|||
156731147|NCT00937040|565763874|FG000|Overall Study|Lost to Follow-up|12|||
156731148|NCT00937040|565763875|FG001|Overall Study|Lost to Follow-up|12|||
156731149|NCT00937040|565763874|FG000|Overall Study|Protocol Violation|3|||
156731150|NCT00937040|565763875|FG001|Overall Study|Protocol Violation|0|||
156731151|NCT00937040|565763874|FG000|Overall Study|Withdrawal by Subject|13|||
156731152|NCT00937040|565763875|FG001|Overall Study|Withdrawal by Subject|7|||
156731153|NCT00937040|565763874|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
156731154|NCT00937040|565763875|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
156731155|NCT00937040|565763874|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
156731156|NCT00937040|565763875|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
156731157|NCT00554515|565763880|FG000|Overall Study|Withdrawal by Subject|3|||
156731158|NCT00554515|565763880|FG000|Overall Study|Disease progression|52|||
156731159|NCT00554515|565763880|FG000|Overall Study|Physician Decision|18|||
156731160|NCT00554515|565763880|FG000|Overall Study|Withdrawal by Subject|11|||
156731161|NCT00554515|565763880|FG000|Overall Study|Adverse Event|9|||
156731162|NCT00554515|565763880|FG000|Overall Study|Death|2|||
156731163|NCT00554515|565763880|FG000|Overall Study|Achieved Stable Disease|7|||
156731164|NCT00554515|565763880|FG000|Overall Study|Other|1|||
156731165|NCT00554515|565763880|FG000|Overall Study|Misc|15|||
156731166|NCT02477332|565763883|FG000|Overall Study|Adverse Event|0|||
156731167|NCT02477332|565763884|FG001|Overall Study|Adverse Event|1|||
156731168|NCT02477332|565763885|FG002|Overall Study|Adverse Event|1|||
156731169|NCT02477332|565763886|FG003|Overall Study|Adverse Event|2|||
156731170|NCT02477332|565763887|FG004|Overall Study|Adverse Event|1|||
156731171|NCT02477332|565763888|FG005|Overall Study|Adverse Event|2|||
156731172|NCT02477332|565763883|FG000|Overall Study|Lack of Efficacy|1|||
156731173|NCT02477332|565763884|FG001|Overall Study|Lack of Efficacy|2|||
156731174|NCT02477332|565763885|FG002|Overall Study|Lack of Efficacy|1|||
156731175|NCT02477332|565763886|FG003|Overall Study|Lack of Efficacy|2|||
156731176|NCT02477332|565763887|FG004|Overall Study|Lack of Efficacy|1|||
156731177|NCT02477332|565763888|FG005|Overall Study|Lack of Efficacy|1|||
156731178|NCT02477332|565763883|FG000|Overall Study|Non-compliance with study treatment|0|||
156731179|NCT02477332|565763884|FG001|Overall Study|Non-compliance with study treatment|1|||
156731180|NCT02477332|565763885|FG002|Overall Study|Non-compliance with study treatment|2|||
156731181|NCT02477332|565763886|FG003|Overall Study|Non-compliance with study treatment|0|||
156731182|NCT02477332|565763887|FG004|Overall Study|Non-compliance with study treatment|0|||
156731183|NCT02477332|565763888|FG005|Overall Study|Non-compliance with study treatment|0|||
156731184|NCT02477332|565763883|FG000|Overall Study|Pregnancy|0|||
156731185|NCT02477332|565763884|FG001|Overall Study|Pregnancy|0|||
156731186|NCT02477332|565763885|FG002|Overall Study|Pregnancy|0|||
156731187|NCT02477332|565763886|FG003|Overall Study|Pregnancy|1|||
156731188|NCT02477332|565763887|FG004|Overall Study|Pregnancy|0|||
156731189|NCT02477332|565763888|FG005|Overall Study|Pregnancy|0|||
156731190|NCT02477332|565763883|FG000|Overall Study|Protocol Violation|2|||
156731191|NCT02477332|565763884|FG001|Overall Study|Protocol Violation|0|||
156731192|NCT02477332|565763885|FG002|Overall Study|Protocol Violation|3|||
156731193|NCT02477332|565763886|FG003|Overall Study|Protocol Violation|3|||
156876478|NCT00452361|566305852|FG001|Overall Study|Withdrawal by Subject|1|||
156876479|NCT00452361|566305851|FG000|Overall Study|Premature termination|13|||
156336266|NCT02187744|564328216|FG001|Treatment|Lost to Follow-up|1|||
156731194|NCT02477332|565763887|FG004|Overall Study|Protocol Violation|1|||
156731195|NCT02477332|565763888|FG005|Overall Study|Protocol Violation|1|||
156731196|NCT02477332|565763883|FG000|Overall Study|Technical problems|0|||
156731197|NCT02477332|565763884|FG001|Overall Study|Technical problems|0|||
156731198|NCT02477332|565763885|FG002|Overall Study|Technical problems|1|||
156336267|NCT02187744|564328215|FG000|Treatment|Other|2|||
156731199|NCT02477332|565763886|FG003|Overall Study|Technical problems|0|||
156731200|NCT02477332|565763887|FG004|Overall Study|Technical problems|0|||
156731201|NCT02477332|565763888|FG005|Overall Study|Technical problems|0|||
156731202|NCT02477332|565763883|FG000|Overall Study|Lost to Follow-up|0|||
156731203|NCT02477332|565763884|FG001|Overall Study|Lost to Follow-up|0|||
156731204|NCT02477332|565763885|FG002|Overall Study|Lost to Follow-up|2|||
156731205|NCT02477332|565763886|FG003|Overall Study|Lost to Follow-up|0|||
156731206|NCT02477332|565763887|FG004|Overall Study|Lost to Follow-up|0|||
156731207|NCT02477332|565763888|FG005|Overall Study|Lost to Follow-up|0|||
156731208|NCT02477332|565763883|FG000|Overall Study|Physician Decision|0|||
156731209|NCT02477332|565763884|FG001|Overall Study|Physician Decision|0|||
156731210|NCT02477332|565763885|FG002|Overall Study|Physician Decision|1|||
156796550|NCT03485157|566008089|FG001|Double Blind Phase|Adverse Event|1|||
156796551|NCT03485157|566008088|FG000|Double Blind Phase|Withdrawal by Subject|6|||
156796552|NCT03485157|566008089|FG001|Double Blind Phase|Withdrawal by Subject|9|||
156796553|NCT03485157|566008088|FG000|Double Blind Phase|Removal by PI|3|||
156796554|NCT03485157|566008089|FG001|Double Blind Phase|Removal by PI|7|||
156796555|NCT03485157|566008088|FG000|Open Label Phase|Lost to Follow-up|1|||
156796556|NCT03485157|566008089|FG001|Open Label Phase|Lost to Follow-up|2|||
156796557|NCT03485157|566008088|FG000|Open Label Phase|Adverse Event|0|||
156796558|NCT03485157|566008089|FG001|Open Label Phase|Adverse Event|1|||
156796559|NCT03485157|566008088|FG000|Open Label Phase|Withdrawal by Subject|1|||
156796560|NCT03485157|566008089|FG001|Open Label Phase|Withdrawal by Subject|2|||
156796561|NCT03485157|566008088|FG000|Open Label Phase|Removal by PI|2|||
156796562|NCT03485157|566008089|FG001|Open Label Phase|Removal by PI|0|||
156796563|NCT01849276|566008090|FG000|Followed for Survival for 5 Years|Death|1|||
156796564|NCT01849276|566008090|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
156796565|NCT02011542|566008095|FG000|Overall Study|Physician Decision|1|||
156796566|NCT01813357|566008096|FG000|Overall Study|Lost to Follow-up|5|||
156796567|NCT01813357|566008097|FG001|Overall Study|Lost to Follow-up|6|||
156796568|NCT02607722|566008108|FG000|Overall Study|No data reliability|1|||
156796569|NCT02607722|566008108|FG000|Overall Study|no patient visit|18|||
156796570|NCT02607722|566008108|FG000|Overall Study|missing info in CRF|13|||
156796571|NCT02607722|566008108|FG000|Overall Study|Withdrawal by Subject|616|||
156796572|NCT02607722|566008108|FG000|Overall Study|Lost to Follow-up|312|||
156796573|NCT02607722|566008108|FG000|Overall Study|Improved|22|||
156796574|NCT02607722|566008108|FG000|Overall Study|Lack of Efficacy|316|||
156796575|NCT02607722|566008108|FG000|Overall Study|Adverse Event|2553|||
156796576|NCT02607722|566008108|FG000|Overall Study|Not treated|1|||
156796577|NCT02607722|566008108|FG000|Overall Study|No CRF collected|138|||
156796578|NCT02607722|566008108|FG000|Overall Study|without CRF|4225|||
156796579|NCT02607722|566008108|FG000|Overall Study|Physician Decision|367|||
156796580|NCT04347538|566008109|FG000|Overall Study|Lost to Follow-up|4|||
156796581|NCT04347538|566008110|FG001|Overall Study|Lost to Follow-up|5|||
156796582|NCT04347538|566008111|FG002|Overall Study|Lost to Follow-up|7|||
156455188|NCT03544281|564761595|FG011|Main Study Phase|Withdrawal by Subject|4|||
156455189|NCT03544281|564761596|FG012|Main Study Phase|Withdrawal by Subject|0|||
156455190|NCT03544281|564761597|FG013|Main Study Phase|Withdrawal by Subject|0|||
156455191|NCT03544281|564761598|FG014|Main Study Phase|Withdrawal by Subject|0|||
156455192|NCT03544281|564761599|FG015|Main Study Phase|Withdrawal by Subject|0|||
156455193|NCT03544281|564761600|FG016|Main Study Phase|Withdrawal by Subject|0|||
156455194|NCT03544281|564761601|FG017|Main Study Phase|Withdrawal by Subject|0|||
156455195|NCT03544281|564761602|FG018|Main Study Phase|Withdrawal by Subject|0|||
156455196|NCT03544281|564761603|FG019|Main Study Phase|Withdrawal by Subject|0|||
156455197|NCT03544281|564761604|FG020|Main Study Phase|Withdrawal by Subject|0|||
156455198|NCT03544281|564761605|FG021|Main Study Phase|Withdrawal by Subject|0|||
156455199|NCT03544281|564761584|FG000|Main Study Phase|Ongoing|3|||
156455200|NCT03544281|564761585|FG001|Main Study Phase|Ongoing|1|||
156455201|NCT03544281|564761586|FG002|Main Study Phase|Ongoing|2|||
156455202|NCT03544281|564761587|FG003|Main Study Phase|Ongoing|4|||
156455203|NCT03544281|564761588|FG004|Main Study Phase|Ongoing|2|||
156455204|NCT03544281|564761589|FG005|Main Study Phase|Ongoing|4|||
156455205|NCT03544281|564761590|FG006|Main Study Phase|Ongoing|4|||
156455206|NCT03544281|564761591|FG007|Main Study Phase|Ongoing|0|||
156455207|NCT03544281|564761592|FG008|Main Study Phase|Ongoing|2|||
156455208|NCT03544281|564761593|FG009|Main Study Phase|Ongoing|2|||
156455209|NCT03544281|564761594|FG010|Main Study Phase|Ongoing|1|||
156455210|NCT03544281|564761595|FG011|Main Study Phase|Ongoing|0|||
156455211|NCT03544281|564761596|FG012|Main Study Phase|Ongoing|0|||
156455212|NCT03544281|564761597|FG013|Main Study Phase|Ongoing|0|||
156455213|NCT03544281|564761598|FG014|Main Study Phase|Ongoing|0|||
156455214|NCT03544281|564761599|FG015|Main Study Phase|Ongoing|0|||
156455215|NCT03544281|564761600|FG016|Main Study Phase|Ongoing|0|||
156455216|NCT03544281|564761601|FG017|Main Study Phase|Ongoing|0|||
156455217|NCT03544281|564761602|FG018|Main Study Phase|Ongoing|0|||
156455218|NCT03544281|564761603|FG019|Main Study Phase|Ongoing|0|||
156455219|NCT03544281|564761604|FG020|Main Study Phase|Ongoing|0|||
156455220|NCT03544281|564761605|FG021|Main Study Phase|Ongoing|0|||
156455221|NCT03544281|564761584|FG000|Main Study Phase|Investigator Site Closed|0|||
156455222|NCT03544281|564761585|FG001|Main Study Phase|Investigator Site Closed|0|||
156455223|NCT03544281|564761586|FG002|Main Study Phase|Investigator Site Closed|0|||
156796583|NCT02135133|566008112|FG000|Overall Study|Adverse Event|10|||
156796584|NCT02135133|566008112|FG000|Overall Study|regulatory mandate|5|||
156796585|NCT02259231|566008113|FG000|Overall Study|Adverse Event|1|||
156796586|NCT02259231|566008114|FG001|Overall Study|Adverse Event|1|||
156796587|NCT02259231|566008115|FG002|Overall Study|Adverse Event|2|||
156455224|NCT03544281|564761587|FG003|Main Study Phase|Investigator Site Closed|0|||
156796588|NCT02259231|566008116|FG003|Overall Study|Adverse Event|0|||
156796589|NCT02259231|566008117|FG004|Overall Study|Adverse Event|0|||
156796590|NCT02259231|566008118|FG005|Overall Study|Adverse Event|0|||
156796591|NCT02259231|566008119|FG006|Overall Study|Adverse Event|0|||
156455225|NCT03544281|564761588|FG004|Main Study Phase|Investigator Site Closed|0|||
156796592|NCT02259231|566008113|FG000|Overall Study|Progressive Disease|4|||
156336268|NCT02187744|564328216|FG001|Treatment|Other|0|||
156336269|NCT02187744|564328215|FG000|Treatment|Participant refused continued treatment|1|||
156336270|NCT02187744|564328216|FG001|Treatment|Participant refused continued treatment|1|||
156336271|NCT01972568|564328217|FG000|Overall Study|Other events|3|||
156336272|NCT01972568|564328218|FG001|Overall Study|Other events|0|||
156336273|NCT01972568|564328219|FG002|Overall Study|Other events|0|||
156336274|NCT01972568|564328217|FG000|Overall Study|Lack of Efficacy|0|||
156336275|NCT01972568|564328218|FG001|Overall Study|Lack of Efficacy|1|||
156336276|NCT01972568|564328219|FG002|Overall Study|Lack of Efficacy|2|||
156336277|NCT01972568|564328217|FG000|Overall Study|Protocol Violation|1|||
156336278|NCT01972568|564328218|FG001|Overall Study|Protocol Violation|2|||
156336279|NCT01972568|564328219|FG002|Overall Study|Protocol Violation|2|||
156336280|NCT01972568|564328217|FG000|Overall Study|Withdrawal by Subject|6|||
156336281|NCT01972568|564328218|FG001|Overall Study|Withdrawal by Subject|3|||
156336282|NCT01972568|564328219|FG002|Overall Study|Withdrawal by Subject|7|||
156336283|NCT01972568|564328217|FG000|Overall Study|Lost to Follow-up|1|||
156336284|NCT01972568|564328218|FG001|Overall Study|Lost to Follow-up|0|||
156336285|NCT01972568|564328219|FG002|Overall Study|Lost to Follow-up|0|||
156336286|NCT01972568|564328217|FG000|Overall Study|Adverse Event|5|||
156336287|NCT01972568|564328218|FG001|Overall Study|Adverse Event|6|||
156336288|NCT01972568|564328219|FG002|Overall Study|Adverse Event|5|||
156455226|NCT03544281|564761589|FG005|Main Study Phase|Investigator Site Closed|0|||
156455227|NCT03544281|564761590|FG006|Main Study Phase|Investigator Site Closed|0|||
156455228|NCT03544281|564761591|FG007|Main Study Phase|Investigator Site Closed|0|||
156455229|NCT03544281|564761592|FG008|Main Study Phase|Investigator Site Closed|0|||
156731211|NCT02477332|565763886|FG003|Overall Study|Physician Decision|3|||
156731212|NCT02477332|565763887|FG004|Overall Study|Physician Decision|0|||
156731213|NCT02477332|565763888|FG005|Overall Study|Physician Decision|1|||
156731214|NCT02477332|565763883|FG000|Overall Study|Withdrawal by Subject|0|||
156731215|NCT02477332|565763884|FG001|Overall Study|Withdrawal by Subject|3|||
156731216|NCT02477332|565763885|FG002|Overall Study|Withdrawal by Subject|1|||
156731217|NCT02477332|565763886|FG003|Overall Study|Withdrawal by Subject|2|||
156731218|NCT02477332|565763887|FG004|Overall Study|Withdrawal by Subject|1|||
156731219|NCT02477332|565763888|FG005|Overall Study|Withdrawal by Subject|0|||
156731220|NCT03793842|565763889|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
156731221|NCT03793842|565763890|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
156731222|NCT03793842|565763889|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
156731223|NCT03793842|565763890|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
156731224|NCT04657198|565763891|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
156731225|NCT04657198|565763892|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
156731226|NCT04657198|565763893|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
156731227|NCT02549287|565763894|FG000|Overall Study|Lost to Follow-up|65|||
156731228|NCT02549287|565763895|FG001|Overall Study|Lost to Follow-up|26|||
156731229|NCT02549287|565763894|FG000|Overall Study|Withdrawal by Subject|15|||
156731230|NCT02549287|565763895|FG001|Overall Study|Withdrawal by Subject|6|||
156731231|NCT00427921|565763899|FG000|Overall Study|Adverse Event|26|||
156731232|NCT00427921|565763899|FG000|Overall Study|Withdrawal by Subject|4|||
156731233|NCT00427921|565763899|FG000|Overall Study|Lost to Follow-up|2|||
156731234|NCT00427921|565763899|FG000|Overall Study|Other reason not specified|10|||
156731235|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Hospitalization|1|||
156731236|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
156731237|NCT00427921|565763899|FG000|Overall Study|Adverse Event + No Response|1|||
156731238|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
156731239|NCT00427921|565763899|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
156731240|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Lost Response|1|||
156731241|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
156731242|NCT00427921|565763899|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
156731243|NCT00900159|565763900|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
156731244|NCT00900159|565763901|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
156731245|NCT00520533|565763902|FG000|Overall Study|Death|1|||
156731246|NCT00520533|565763902|FG000|Overall Study|Suspension of the study for safety reasons|1|||
156336289|NCT02059408|564328222|FG000|Overall Study|Did not get tested|0|||
156336290|NCT02059408|564328223|FG001|Overall Study|Did not get tested|330|||
156336291|NCT02059408|564328224|FG002|Overall Study|Did not get tested|358|||
156731247|NCT00520533|565763902|FG000|Overall Study|Withdrawal by Subject|1|||
156731248|NCT00520533|565763902|FG000|Overall Study|Physician Decision|1|||
156336292|NCT00508755|564328225|FG000|Overall Study|Withdrawal by Subject|1|||
156336293|NCT00957580|564328226|FG000|Overall Study|Ongoing at data cut-off|0|||
156455230|NCT03544281|564761593|FG009|Main Study Phase|Investigator Site Closed|1|||
156455231|NCT03544281|564761594|FG010|Main Study Phase|Investigator Site Closed|0|||
156336294|NCT00957580|564328227|FG001|Overall Study|Ongoing at data cut-off|1|||
156336295|NCT00957580|564328228|FG002|Overall Study|Ongoing at data cut-off|0|||
156336296|NCT00957580|564328226|FG000|Overall Study|Enrolled but not treated|0|||
156455232|NCT03544281|564761595|FG011|Main Study Phase|Investigator Site Closed|0|||
156455233|NCT03544281|564761596|FG012|Main Study Phase|Investigator Site Closed|0|||
156455234|NCT03544281|564761597|FG013|Main Study Phase|Investigator Site Closed|0|||
156455235|NCT03544281|564761598|FG014|Main Study Phase|Investigator Site Closed|0|||
156455236|NCT03544281|564761599|FG015|Main Study Phase|Investigator Site Closed|0|||
156455237|NCT03544281|564761600|FG016|Main Study Phase|Investigator Site Closed|0|||
156455238|NCT03544281|564761601|FG017|Main Study Phase|Investigator Site Closed|0|||
156455239|NCT03544281|564761602|FG018|Main Study Phase|Investigator Site Closed|0|||
156455240|NCT03544281|564761603|FG019|Main Study Phase|Investigator Site Closed|0|||
156455241|NCT03544281|564761604|FG020|Main Study Phase|Investigator Site Closed|0|||
156455242|NCT03544281|564761605|FG021|Main Study Phase|Investigator Site Closed|0|||
156455243|NCT03544281|564761584|FG000|Main Study Phase|Did not receive study treatment|0|||
156455244|NCT03544281|564761585|FG001|Main Study Phase|Did not receive study treatment|0|||
156455245|NCT03544281|564761586|FG002|Main Study Phase|Did not receive study treatment|0|||
156455246|NCT03544281|564761587|FG003|Main Study Phase|Did not receive study treatment|0|||
156455247|NCT03544281|564761588|FG004|Main Study Phase|Did not receive study treatment|0|||
156455248|NCT03544281|564761589|FG005|Main Study Phase|Did not receive study treatment|0|||
156455249|NCT03544281|564761590|FG006|Main Study Phase|Did not receive study treatment|1|||
156455250|NCT03544281|564761591|FG007|Main Study Phase|Did not receive study treatment|0|||
156455251|NCT03544281|564761592|FG008|Main Study Phase|Did not receive study treatment|0|||
156455252|NCT03544281|564761593|FG009|Main Study Phase|Did not receive study treatment|0|||
156455253|NCT03544281|564761594|FG010|Main Study Phase|Did not receive study treatment|0|||
156455254|NCT03544281|564761595|FG011|Main Study Phase|Did not receive study treatment|0|||
156455255|NCT03544281|564761596|FG012|Main Study Phase|Did not receive study treatment|0|||
156455256|NCT03544281|564761597|FG013|Main Study Phase|Did not receive study treatment|0|||
156455257|NCT03544281|564761598|FG014|Main Study Phase|Did not receive study treatment|0|||
156455258|NCT03544281|564761599|FG015|Main Study Phase|Did not receive study treatment|0|||
156455259|NCT03544281|564761600|FG016|Main Study Phase|Did not receive study treatment|0|||
156455260|NCT03544281|564761601|FG017|Main Study Phase|Did not receive study treatment|0|||
156455261|NCT03544281|564761602|FG018|Main Study Phase|Did not receive study treatment|0|||
156455262|NCT03544281|564761603|FG019|Main Study Phase|Did not receive study treatment|0|||
156455263|NCT03544281|564761604|FG020|Main Study Phase|Did not receive study treatment|0|||
156455264|NCT03544281|564761605|FG021|Main Study Phase|Did not receive study treatment|0|||
156455265|NCT03544281|564761584|FG000|PACT Phase|Adverse Event|0|||
156455266|NCT03544281|564761585|FG001|PACT Phase|Adverse Event|0|||
156455267|NCT03544281|564761586|FG002|PACT Phase|Adverse Event|0|||
156455268|NCT03544281|564761587|FG003|PACT Phase|Adverse Event|0|||
156455269|NCT03544281|564761588|FG004|PACT Phase|Adverse Event|0|||
156455270|NCT03544281|564761589|FG005|PACT Phase|Adverse Event|0|||
156455271|NCT03544281|564761590|FG006|PACT Phase|Adverse Event|0|||
156455272|NCT03544281|564761591|FG007|PACT Phase|Adverse Event|0|||
156455273|NCT03544281|564761592|FG008|PACT Phase|Adverse Event|0|||
156455274|NCT03544281|564761593|FG009|PACT Phase|Adverse Event|0|||
156533603|NCT00578786|565048866|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
156533604|NCT00578786|565048867|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
156533605|NCT00312221|565048868|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
156533606|NCT00312221|565048869|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
156731249|NCT03340454|565763903|FG000|Overall Study|Lost to Follow-up|0|||
156731250|NCT03340454|565763904|FG001|Overall Study|Lost to Follow-up|4|||
156731251|NCT02568189|565763910|FG000|Overall Study|Protocol Violation|0|||
156731252|NCT02568189|565763911|FG001|Overall Study|Protocol Violation|0|||
156731253|NCT02568189|565763912|FG002|Overall Study|Protocol Violation|19|||
156731254|NCT02568189|565763913|FG003|Overall Study|Protocol Violation|18|||
156731255|NCT00529373|565763914|FG000|Base Study|Adverse Event|525|||
156731256|NCT00529373|565763915|FG001|Base Study|Adverse Event|470|||
156731257|NCT00529373|565763914|FG000|Base Study|Lack of Efficacy|16|||
156731258|NCT00529373|565763915|FG001|Base Study|Lack of Efficacy|75|||
156731259|NCT00529373|565763914|FG000|Base Study|Lost to Follow-up|221|||
156731260|NCT00529373|565763915|FG001|Base Study|Lost to Follow-up|208|||
156731261|NCT00529373|565763914|FG000|Base Study|Other Protocol Specified Criteria|19|||
156731262|NCT00529373|565763915|FG001|Base Study|Other Protocol Specified Criteria|20|||
156876480|NCT00452361|566305852|FG001|Overall Study|Premature termination|9|||
156876481|NCT02954172|566305853|FG000|Overall Study|Protocol Violation|3|||
156455275|NCT03544281|564761594|FG010|PACT Phase|Adverse Event|0|||
156731263|NCT00529373|565763914|FG000|Base Study|Physician Decision|60|||
156731264|NCT00529373|565763915|FG001|Base Study|Physician Decision|52|||
156731265|NCT00529373|565763914|FG000|Base Study|Protocol Violation|48|||
156455276|NCT03544281|564761595|FG011|PACT Phase|Adverse Event|0|||
156455277|NCT03544281|564761596|FG012|PACT Phase|Adverse Event|1|||
156455278|NCT03544281|564761597|FG013|PACT Phase|Adverse Event|0|||
156455279|NCT03544281|564761598|FG014|PACT Phase|Adverse Event|0|||
156455280|NCT03544281|564761599|FG015|PACT Phase|Adverse Event|0|||
156455281|NCT03544281|564761600|FG016|PACT Phase|Adverse Event|0|||
156455282|NCT03544281|564761601|FG017|PACT Phase|Adverse Event|1|||
156455283|NCT03544281|564761602|FG018|PACT Phase|Adverse Event|1|||
156731266|NCT00529373|565763915|FG001|Base Study|Protocol Violation|38|||
156731267|NCT00529373|565763914|FG000|Base Study|Withdrawal by Subject|1062|||
156731268|NCT00529373|565763915|FG001|Base Study|Withdrawal by Subject|967|||
156731269|NCT00529373|565763914|FG000|Base Study|Did not continue into Extension|1795|||
156731270|NCT00529373|565763915|FG001|Base Study|Did not continue into Extension|2238|||
156731271|NCT00529373|565763914|FG000|First Extension Study|Adverse Event|162|||
156731272|NCT00529373|565763915|FG001|First Extension Study|Adverse Event|142|||
156731273|NCT00529373|565763914|FG000|First Extension Study|Lack of Efficacy|65|||
156731274|NCT00529373|565763915|FG001|First Extension Study|Lack of Efficacy|427|||
156731275|NCT00529373|565763914|FG000|First Extension Study|Lost to Follow-up|41|||
156731276|NCT00529373|565763915|FG001|First Extension Study|Lost to Follow-up|37|||
156731277|NCT00529373|565763914|FG000|First Extension Study|Other|27|||
156731278|NCT00529373|565763915|FG001|First Extension Study|Other|47|||
156731279|NCT00529373|565763914|FG000|First Extension Study|Physician Decision|50|||
156731280|NCT00529373|565763915|FG001|First Extension Study|Physician Decision|45|||
156731281|NCT00529373|565763914|FG000|First Extension Study|Protocol Violation|16|||
156731282|NCT00529373|565763915|FG001|First Extension Study|Protocol Violation|13|||
156876482|NCT02954172|566305854|FG001|Overall Study|Protocol Violation|0|||
156876483|NCT02954172|566305853|FG000|Overall Study|allergic reaction|2|||
156876484|NCT02954172|566305854|FG001|Overall Study|allergic reaction|1|||
156876485|NCT02954172|566305853|FG000|Overall Study|non-measurable lesions at baseline|1|||
156876486|NCT02954172|566305854|FG001|Overall Study|non-measurable lesions at baseline|2|||
156876487|NCT02621151|566305855|FG000|Overall Study|Not eligible for trial|6|||
156876488|NCT04198714|566305856|FG000|Overall Study|Physician Decision|0|||
156876489|NCT04198714|566305857|FG001|Overall Study|Physician Decision|1|||
156876490|NCT02529553|566305858|FG000|Overall Study|Progressive Disease|1|||
156876491|NCT02529553|566305859|FG001|Overall Study|Progressive Disease|0|||
156876492|NCT02529553|566305860|FG002|Overall Study|Progressive Disease|1|||
156876493|NCT02529553|566305861|FG003|Overall Study|Progressive Disease|3|||
156876494|NCT02529553|566305862|FG004|Overall Study|Progressive Disease|2|||
156876495|NCT02529553|566305863|FG005|Overall Study|Progressive Disease|3|||
156876496|NCT02529553|566305864|FG006|Overall Study|Progressive Disease|3|||
156731283|NCT00529373|565763914|FG000|First Extension Study|Withdrawal by Subject|296|||
156731284|NCT00529373|565763915|FG001|First Extension Study|Withdrawal by Subject|287|||
156731285|NCT00529373|565763914|FG000|First Extension Study|Disposition record non-existing|0|||
156731286|NCT00529373|565763915|FG001|First Extension Study|Disposition record non-existing|1|||
156731287|NCT00529373|565763914|FG000|First Extension Study|Discontinued after 5 years completion|208|||
156731288|NCT00529373|565763915|FG001|First Extension Study|Discontinued after 5 years completion|346|||
156731289|NCT00529373|565763914|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
156731290|NCT00529373|565763915|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
156731291|NCT00529373|565763914|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
156731292|NCT00529373|565763915|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
156731293|NCT00529373|565763914|FG000|Second Extension Study|Adverse Event|101|||
156731294|NCT00529373|565763915|FG001|Second Extension Study|Adverse Event|51|||
156731295|NCT00529373|565763914|FG000|Second Extension Study|Lack of Efficacy|7|||
156731296|NCT00529373|565763915|FG001|Second Extension Study|Lack of Efficacy|15|||
156731297|NCT00529373|565763914|FG000|Second Extension Study|Lost to Follow-up|18|||
156731298|NCT00529373|565763915|FG001|Second Extension Study|Lost to Follow-up|12|||
156731299|NCT00529373|565763914|FG000|Second Extension Study|Other|7|||
156731300|NCT00529373|565763915|FG001|Second Extension Study|Other|12|||
156731301|NCT00529373|565763914|FG000|Second Extension Study|Physician Decision|63|||
156876497|NCT02529553|566305865|FG007|Overall Study|Progressive Disease|5|||
156876498|NCT02529553|566305866|FG008|Overall Study|Progressive Disease|3|||
156876499|NCT02529553|566305858|FG000|Overall Study|Physician Decision|0|||
156876500|NCT02529553|566305859|FG001|Overall Study|Physician Decision|1|||
156876501|NCT02529553|566305860|FG002|Overall Study|Physician Decision|0|||
156876502|NCT02529553|566305861|FG003|Overall Study|Physician Decision|0|||
156731302|NCT00529373|565763915|FG001|Second Extension Study|Physician Decision|26|||
156731303|NCT00529373|565763914|FG000|Second Extension Study|Protocol Violation|2|||
156731304|NCT00529373|565763915|FG001|Second Extension Study|Protocol Violation|1|||
156731305|NCT00529373|565763914|FG000|Second Extension Study|Withdrawal by Subject|97|||
156731306|NCT00529373|565763915|FG001|Second Extension Study|Withdrawal by Subject|75|||
156731307|NCT00529373|565763914|FG000|Second Extension Study|Status Missing|5|||
156731308|NCT00529373|565763915|FG001|Second Extension Study|Status Missing|5|||
156731309|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
156731310|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
156876503|NCT02529553|566305862|FG004|Overall Study|Physician Decision|1|||
156336297|NCT00957580|564328227|FG001|Overall Study|Enrolled but not treated|1|||
156336298|NCT00957580|564328228|FG002|Overall Study|Enrolled but not treated|0|||
156336299|NCT00945893|564328229|FG000|Overall Study|Lost to Follow-up|2|||
156336300|NCT00945893|564328230|FG001|Overall Study|Lost to Follow-up|8|||
156455284|NCT03544281|564761603|FG019|PACT Phase|Adverse Event|0|||
156731311|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
156731312|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
156731313|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
156876504|NCT02529553|566305863|FG005|Overall Study|Physician Decision|0|||
156876505|NCT02529553|566305864|FG006|Overall Study|Physician Decision|0|||
156876506|NCT02529553|566305865|FG007|Overall Study|Physician Decision|0|||
156731314|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
156731315|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
156731316|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
156731317|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
156731318|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
156731319|NCT01074268|565763916|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
156731320|NCT01074268|565763917|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
156731321|NCT01074268|565763916|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
156731322|NCT01074268|565763917|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
156731323|NCT01074268|565763916|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
156731324|NCT01074268|565763917|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
156731325|NCT01074268|565763916|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
156731326|NCT01074268|565763917|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
156731327|NCT01578239|565763918|FG000|Treatment Period|Progressive Disease|19|||
156731328|NCT01578239|565763919|FG001|Treatment Period|Progressive Disease|64|||
156731329|NCT01578239|565763918|FG000|Treatment Period|Physician Decision|17|||
156731330|NCT01578239|565763919|FG001|Treatment Period|Physician Decision|17|||
156731331|NCT01578239|565763918|FG000|Treatment Period|Adverse Event|13|||
156731332|NCT01578239|565763919|FG001|Treatment Period|Adverse Event|10|||
156731333|NCT01578239|565763918|FG000|Treatment Period|Non-compliance|2|||
156731334|NCT01578239|565763919|FG001|Treatment Period|Non-compliance|0|||
156731335|NCT01578239|565763918|FG000|Treatment Period|Withdrawal by Subject|10|||
156731336|NCT01578239|565763919|FG001|Treatment Period|Withdrawal by Subject|9|||
156731337|NCT01578239|565763918|FG000|Treatment Period|Other|6|||
156731338|NCT01578239|565763919|FG001|Treatment Period|Other|1|||
156731339|NCT01578239|565763918|FG000|Long-term Follow-Up Period|Death|69|||
156876507|NCT02529553|566305866|FG008|Overall Study|Physician Decision|0|||
156876508|NCT02529553|566305858|FG000|Overall Study|Withdrawal by Subject|0|||
156876509|NCT02529553|566305859|FG001|Overall Study|Withdrawal by Subject|0|||
156876510|NCT02529553|566305860|FG002|Overall Study|Withdrawal by Subject|0|||
156876511|NCT02529553|566305861|FG003|Overall Study|Withdrawal by Subject|0|||
156876512|NCT02529553|566305862|FG004|Overall Study|Withdrawal by Subject|0|||
156876513|NCT02529553|566305863|FG005|Overall Study|Withdrawal by Subject|1|||
156876514|NCT02529553|566305864|FG006|Overall Study|Withdrawal by Subject|0|||
156876515|NCT02529553|566305865|FG007|Overall Study|Withdrawal by Subject|1|||
156876516|NCT02529553|566305866|FG008|Overall Study|Withdrawal by Subject|0|||
156876517|NCT00924027|566305871|FG000|Overall Study|Lost to Further Follow-Up|4|||
156876518|NCT00924027|566305872|FG001|Overall Study|Lost to Further Follow-Up|0|||
156876519|NCT00924027|566305873|FG002|Overall Study|Lost to Further Follow-Up|0|||
156876520|NCT00924027|566305874|FG003|Overall Study|Lost to Further Follow-Up|0|||
156876521|NCT00924027|566305871|FG000|Overall Study|Physician Decision|1|||
156876522|NCT00924027|566305872|FG001|Overall Study|Physician Decision|0|||
156731340|NCT01578239|565763919|FG001|Long-term Follow-Up Period|Death|64|||
156731341|NCT01578239|565763918|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
156731342|NCT01578239|565763919|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
156731343|NCT01578239|565763918|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
156731344|NCT01578239|565763919|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
156731345|NCT01578239|565763918|FG000|Long-term Follow-Up Period|Other|2|||
156876523|NCT00924027|566305873|FG002|Overall Study|Physician Decision|0|||
156876524|NCT00924027|566305874|FG003|Overall Study|Physician Decision|1|||
156876525|NCT00924027|566305871|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
156876526|NCT00924027|566305872|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
156876527|NCT00924027|566305873|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
156876528|NCT00924027|566305874|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
156455285|NCT03544281|564761604|FG020|PACT Phase|Adverse Event|0|||
156455286|NCT03544281|564761605|FG021|PACT Phase|Adverse Event|0|||
156455287|NCT02547233|564761606|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
156455288|NCT02547233|564761607|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
156455289|NCT02547233|564761606|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
156455290|NCT02547233|564761607|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
156455291|NCT02547233|564761606|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
156455292|NCT02547233|564761607|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
156455293|NCT02547233|564761606|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
156455294|NCT02547233|564761607|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
156731346|NCT01578239|565763919|FG001|Long-term Follow-Up Period|Other|2|||
156876529|NCT00924027|566305871|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
156876530|NCT00924027|566305872|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
156876531|NCT00924027|566305873|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
156876532|NCT00924027|566305874|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
156455295|NCT02547233|564761606|FG000|12-month Follow-up|Withdrawal by Subject|10|||
156455296|NCT02547233|564761607|FG001|12-month Follow-up|Withdrawal by Subject|10|||
156876533|NCT00924027|566305871|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
156876534|NCT00924027|566305872|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
156876535|NCT00924027|566305873|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
156731347|NCT02347813|565763922|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
156731348|NCT02347813|565763923|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
156731349|NCT02347813|565763922|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
156731350|NCT02347813|565763923|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
156731351|NCT01119859|565763926|FG000|Overall Study|Adverse Event|9|||
156731352|NCT01119859|565763927|FG001|Overall Study|Adverse Event|10|||
156876536|NCT00924027|566305874|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
156876537|NCT01217307|566307621|FG000|Overall Study|Withdrawal by Subject|0|||
156876538|NCT01217307|566307622|FG001|Overall Study|Withdrawal by Subject|1|||
156731353|NCT01119859|565763926|FG000|Overall Study|Death|2|||
156731354|NCT01119859|565763927|FG001|Overall Study|Death|0|||
156731355|NCT01119859|565763926|FG000|Overall Study|Insufficient therapeutic response|7|||
156731356|NCT01119859|565763927|FG001|Overall Study|Insufficient therapeutic response|14|||
156731357|NCT01119859|565763926|FG000|Overall Study|Refused treatment|3|||
156731358|NCT01119859|565763927|FG001|Overall Study|Refused treatment|6|||
156731359|NCT01119859|565763926|FG000|Overall Study|Failure to return|3|||
156731360|NCT01119859|565763927|FG001|Overall Study|Failure to return|0|||
156731361|NCT00603473|565763928|FG000|Overall Study|Adverse Event|4|||
156731362|NCT00603473|565763928|FG000|Overall Study|Lack of Efficacy|4|||
156731363|NCT00603473|565763928|FG000|Overall Study|Protocol Violation|1|||
156731364|NCT01134939|565763932|FG000|Overall Study|Adverse Event|9|||
156731365|NCT01134939|565763933|FG001|Overall Study|Adverse Event|3|||
156731366|NCT01134939|565763934|FG002|Overall Study|Adverse Event|4|||
156731367|NCT01134939|565763935|FG003|Overall Study|Adverse Event|5|||
156731368|NCT01134939|565763936|FG004|Overall Study|Adverse Event|5|||
156731369|NCT01134939|565763937|FG005|Overall Study|Adverse Event|5|||
156731370|NCT01134939|565763938|FG006|Overall Study|Adverse Event|1|||
156731371|NCT01134939|565763939|FG007|Overall Study|Adverse Event|0|||
156731372|NCT01134939|565763932|FG000|Overall Study|Lack of Efficacy|2|||
156731373|NCT01134939|565763933|FG001|Overall Study|Lack of Efficacy|5|||
156731374|NCT01134939|565763934|FG002|Overall Study|Lack of Efficacy|1|||
156731375|NCT01134939|565763935|FG003|Overall Study|Lack of Efficacy|0|||
156731376|NCT01134939|565763936|FG004|Overall Study|Lack of Efficacy|3|||
156731377|NCT01134939|565763937|FG005|Overall Study|Lack of Efficacy|0|||
156731378|NCT01134939|565763938|FG006|Overall Study|Lack of Efficacy|1|||
156731379|NCT01134939|565763939|FG007|Overall Study|Lack of Efficacy|0|||
156731380|NCT01134939|565763932|FG000|Overall Study|Lost to Follow-up|2|||
156731381|NCT01134939|565763933|FG001|Overall Study|Lost to Follow-up|3|||
156731382|NCT01134939|565763934|FG002|Overall Study|Lost to Follow-up|0|||
156731383|NCT01134939|565763935|FG003|Overall Study|Lost to Follow-up|1|||
156731384|NCT01134939|565763936|FG004|Overall Study|Lost to Follow-up|2|||
156731385|NCT01134939|565763937|FG005|Overall Study|Lost to Follow-up|1|||
156731386|NCT01134939|565763938|FG006|Overall Study|Lost to Follow-up|0|||
156731387|NCT01134939|565763939|FG007|Overall Study|Lost to Follow-up|0|||
156731388|NCT01134939|565763932|FG000|Overall Study|Death|0|||
156731389|NCT01134939|565763933|FG001|Overall Study|Death|1|||
156731390|NCT01134939|565763934|FG002|Overall Study|Death|0|||
156731391|NCT01134939|565763935|FG003|Overall Study|Death|0|||
156731392|NCT01134939|565763936|FG004|Overall Study|Death|0|||
156731393|NCT01134939|565763937|FG005|Overall Study|Death|0|||
156731394|NCT01134939|565763938|FG006|Overall Study|Death|0|||
156731395|NCT01134939|565763939|FG007|Overall Study|Death|0|||
156731396|NCT01134939|565763932|FG000|Overall Study|Termination page not available|4|||
156731397|NCT01134939|565763933|FG001|Overall Study|Termination page not available|6|||
156731398|NCT01134939|565763934|FG002|Overall Study|Termination page not available|5|||
156731399|NCT01134939|565763935|FG003|Overall Study|Termination page not available|8|||
156731400|NCT01134939|565763936|FG004|Overall Study|Termination page not available|0|||
156731401|NCT01134939|565763937|FG005|Overall Study|Termination page not available|3|||
156731402|NCT01134939|565763938|FG006|Overall Study|Termination page not available|7|||
156731403|NCT01134939|565763939|FG007|Overall Study|Termination page not available|0|||
156731404|NCT00733421|565763940|FG000|Overall Study|Withdrawal by Subject|1|||
156731405|NCT00733421|565763941|FG001|Overall Study|Withdrawal by Subject|1|||
156731406|NCT01029782|565763944|FG000|Overall Study|Lost to Follow-up|2|||
156731407|NCT01029782|565763945|FG001|Overall Study|Lost to Follow-up|2|||
156731408|NCT01029782|565763944|FG000|Overall Study|Diagnosis changed|1|||
156731409|NCT01029782|565763945|FG001|Overall Study|Diagnosis changed|1|||
156876539|NCT01868542|566307623|FG000|Overall Study|Protocol Violation|0|||
156876540|NCT01868542|566307624|FG001|Overall Study|Protocol Violation|1|||
156876541|NCT01868542|566307623|FG000|Overall Study|Unclassified|0|||
156731410|NCT01029782|565763944|FG000|Overall Study|Adverse Event|0|||
156731411|NCT01029782|565763945|FG001|Overall Study|Adverse Event|1|||
156731412|NCT01029782|565763944|FG000|Overall Study|Physician Decision|0|||
156731413|NCT01029782|565763945|FG001|Overall Study|Physician Decision|1|||
156731414|NCT01029782|565763944|FG000|Overall Study|Protocol Violation|0|||
156731415|NCT01029782|565763945|FG001|Overall Study|Protocol Violation|2|||
156731416|NCT01029782|565763944|FG000|Overall Study|Withdrawal by Subject|0|||
156731417|NCT01029782|565763945|FG001|Overall Study|Withdrawal by Subject|1|||
156731418|NCT02195869|565763949|FG000|Overall Study|cGVHD Progression|5|||
156731419|NCT02195869|565763949|FG000|Overall Study|Malignancy Progression/relapse|2|||
156731420|NCT02195869|565763949|FG000|Overall Study|Adverse Event|15|||
156731421|NCT02195869|565763949|FG000|Overall Study|Withdrawal by Subject|7|||
156731422|NCT02195869|565763949|FG000|Overall Study|Physician Decision|4|||
156731423|NCT02195869|565763949|FG000|Overall Study|Study Terminated by Sponsor|7|||
156731424|NCT02195869|565763949|FG000|Overall Study|Noncompliance with study drug|2|||
156731425|NCT00757042|565763950|FG000|Overall Study|Lost to Follow-up|0|||
156533607|NCT00312221|565048870|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
156336301|NCT00945893|564328229|FG000|Overall Study|Withdrawal of consent|1|||
156336302|NCT00945893|564328230|FG001|Overall Study|Withdrawal of consent|2|||
156336303|NCT04502433|564328231|FG000|Overall Study|Death|2|||
156336304|NCT04502433|564328232|FG001|Overall Study|Death|4|||
156336305|NCT04502433|564328231|FG000|Overall Study|Lost to Follow-up|1|||
156336306|NCT04502433|564328232|FG001|Overall Study|Lost to Follow-up|0|||
156336307|NCT04502433|564328231|FG000|Overall Study|Physician Decision|0|||
156336308|NCT04502433|564328232|FG001|Overall Study|Physician Decision|1|||
156336309|NCT04203797|564328240|FG000|Overall Study|Adverse Event|1|||
156336310|NCT04203797|564328241|FG001|Overall Study|Adverse Event|0|||
156336311|NCT04203797|564328240|FG000|Overall Study|Did not complete End of Study follow-up|1|||
156336312|NCT04203797|564328241|FG001|Overall Study|Did not complete End of Study follow-up|0|||
156336313|NCT00300274|564328242|FG000|Overall Study|Withdrawal by Subject|12|||
156336314|NCT00300274|564328243|FG001|Overall Study|Withdrawal by Subject|3|||
156336315|NCT00300274|564328244|FG002|Overall Study|Withdrawal by Subject|14|||
156336316|NCT00300274|564328242|FG000|Overall Study|Lost to Follow-up|3|||
156336317|NCT00300274|564328243|FG001|Overall Study|Lost to Follow-up|4|||
156336318|NCT00300274|564328244|FG002|Overall Study|Lost to Follow-up|5|||
156336319|NCT00300274|564328242|FG000|Overall Study|Death|31|||
156336320|NCT00300274|564328243|FG001|Overall Study|Death|20|||
156336321|NCT00300274|564328244|FG002|Overall Study|Death|25|||
156336322|NCT00300274|564328242|FG000|Overall Study|Re-transplant|0|||
156336323|NCT00300274|564328243|FG001|Overall Study|Re-transplant|0|||
156533608|NCT00312221|565048871|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
156533609|NCT00312221|565048868|FG000|Open-label Run-in Period|Adverse Event|74|||
156533610|NCT00312221|565048869|FG001|Open-label Run-in Period|Adverse Event|0|||
156533611|NCT00312221|565048870|FG002|Open-label Run-in Period|Adverse Event|0|||
156533612|NCT00312221|565048871|FG003|Open-label Run-in Period|Adverse Event|0|||
156533613|NCT00312221|565048868|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
156533614|NCT00312221|565048869|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
156533615|NCT00312221|565048870|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
156533616|NCT00312221|565048871|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
156533617|NCT00312221|565048868|FG000|Open-label Run-in Period|Administrative|42|||
156533618|NCT00312221|565048869|FG001|Open-label Run-in Period|Administrative|0|||
156533619|NCT00312221|565048870|FG002|Open-label Run-in Period|Administrative|0|||
156533620|NCT00312221|565048871|FG003|Open-label Run-in Period|Administrative|0|||
156731426|NCT00757042|565763951|FG001|Overall Study|Lost to Follow-up|0|||
156731427|NCT00757042|565763952|FG002|Overall Study|Lost to Follow-up|0|||
156731428|NCT00757042|565763953|FG003|Overall Study|Lost to Follow-up|0|||
156731429|NCT00757042|565763954|FG004|Overall Study|Lost to Follow-up|0|||
156731430|NCT00757042|565763955|FG005|Overall Study|Lost to Follow-up|0|||
156731431|NCT00757042|565763956|FG006|Overall Study|Lost to Follow-up|0|||
156731432|NCT00757042|565763957|FG007|Overall Study|Lost to Follow-up|0|||
156731433|NCT00757042|565763958|FG008|Overall Study|Lost to Follow-up|1|||
156731434|NCT00757042|565763959|FG009|Overall Study|Lost to Follow-up|0|||
156731435|NCT00757042|565763960|FG010|Overall Study|Lost to Follow-up|0|||
156731436|NCT00757042|565763950|FG000|Overall Study|Ineligibility Determined|0|||
156731437|NCT00757042|565763951|FG001|Overall Study|Ineligibility Determined|0|||
156731438|NCT00757042|565763952|FG002|Overall Study|Ineligibility Determined|0|||
156731439|NCT00757042|565763953|FG003|Overall Study|Ineligibility Determined|0|||
156731440|NCT00757042|565763954|FG004|Overall Study|Ineligibility Determined|0|||
156731441|NCT00757042|565763955|FG005|Overall Study|Ineligibility Determined|0|||
156731442|NCT00757042|565763956|FG006|Overall Study|Ineligibility Determined|0|||
156731443|NCT00757042|565763957|FG007|Overall Study|Ineligibility Determined|0|||
156731444|NCT00757042|565763958|FG008|Overall Study|Ineligibility Determined|0|||
156731445|NCT00757042|565763959|FG009|Overall Study|Ineligibility Determined|0|||
156731446|NCT00757042|565763960|FG010|Overall Study|Ineligibility Determined|1|||
156336324|NCT00300274|564328244|FG002|Overall Study|Re-transplant|1|||
156336325|NCT00242216|564328245|FG000|Overall Study|Lost to Follow-up|12|||
156336326|NCT00242216|564328246|FG001|Overall Study|Lost to Follow-up|17|||
156336327|NCT00242216|564328245|FG000|Overall Study|Death|4|||
156336328|NCT00242216|564328246|FG001|Overall Study|Death|2|||
156533621|NCT00312221|565048868|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
156731447|NCT00757042|565763950|FG000|Overall Study|Withdrawal by Subject|0|||
156731448|NCT00757042|565763951|FG001|Overall Study|Withdrawal by Subject|0|||
156731449|NCT00757042|565763952|FG002|Overall Study|Withdrawal by Subject|0|||
156731450|NCT00757042|565763953|FG003|Overall Study|Withdrawal by Subject|0|||
156731451|NCT00757042|565763954|FG004|Overall Study|Withdrawal by Subject|0|||
156731452|NCT00757042|565763955|FG005|Overall Study|Withdrawal by Subject|0|||
156731453|NCT00757042|565763956|FG006|Overall Study|Withdrawal by Subject|0|||
156731454|NCT00757042|565763957|FG007|Overall Study|Withdrawal by Subject|0|||
156731455|NCT00757042|565763958|FG008|Overall Study|Withdrawal by Subject|0|||
156731456|NCT00757042|565763959|FG009|Overall Study|Withdrawal by Subject|1|||
156731457|NCT00757042|565763960|FG010|Overall Study|Withdrawal by Subject|0|||
156731458|NCT02654977|565763962|FG000|Overall Study|Death|1|||
156731459|NCT02654977|565763962|FG000|Overall Study|Lost to Follow-up|1|||
156731460|NCT02654977|565763962|FG000|Overall Study|Adverse Event|1|||
156731461|NCT02654977|565763962|FG000|Overall Study|Withdrawal by Subject|1|||
156731462|NCT02654977|565763962|FG000|Overall Study|Lack of Efficacy|3|||
156731463|NCT01921101|565763963|FG000|Overall Study|Death|16|||
156731464|NCT01921101|565763964|FG001|Overall Study|Death|6|||
156731465|NCT02729051|565763970|FG000|Overall Study|Adverse Event|21|||
156731466|NCT02729051|565763971|FG001|Overall Study|Adverse Event|11|||
156731467|NCT02729051|565763970|FG000|Overall Study|Lack of Efficacy|1|||
156731468|NCT02729051|565763971|FG001|Overall Study|Lack of Efficacy|1|||
156731469|NCT02729051|565763970|FG000|Overall Study|Lost to Follow-up|1|||
156731470|NCT02729051|565763971|FG001|Overall Study|Lost to Follow-up|2|||
156731471|NCT02729051|565763970|FG000|Overall Study|Physician Decision|1|||
156731472|NCT02729051|565763971|FG001|Overall Study|Physician Decision|1|||
156731473|NCT02729051|565763970|FG000|Overall Study|Withdrawal by Subject|6|||
156731474|NCT02729051|565763971|FG001|Overall Study|Withdrawal by Subject|17|||
156731475|NCT03225105|565763975|FG000|Overall Study|Withdrawal by Subject|1|||
156731476|NCT03225105|565763976|FG001|Overall Study|Withdrawal by Subject|0|||
156731477|NCT03225105|565763977|FG002|Overall Study|Withdrawal by Subject|0|||
156731478|NCT03225105|565763978|FG003|Overall Study|Withdrawal by Subject|0|||
156731479|NCT03225105|565763975|FG000|Overall Study|Death|0|||
156731480|NCT03225105|565763976|FG001|Overall Study|Death|4|||
156731481|NCT03225105|565763977|FG002|Overall Study|Death|2|||
156731482|NCT03225105|565763978|FG003|Overall Study|Death|0|||
156731483|NCT03225105|565763975|FG000|Overall Study|Study termination per Sponsor Decision|2|||
156731484|NCT03225105|565763976|FG001|Overall Study|Study termination per Sponsor Decision|0|||
156731485|NCT03225105|565763977|FG002|Overall Study|Study termination per Sponsor Decision|3|||
156731486|NCT03225105|565763978|FG003|Overall Study|Study termination per Sponsor Decision|3|||
156731487|NCT03652636|565765827|FG000|Overall Study|Withdrawal by Subject|7|||
156731488|NCT03806933|565765831|FG000|Main Period|Physician Decision|0|||
156731489|NCT03806933|565765832|FG001|Main Period|Physician Decision|0|||
156731490|NCT03806933|565765833|FG002|Main Period|Physician Decision|0|||
156731491|NCT03806933|565765834|FG003|Main Period|Physician Decision|1|||
156731492|NCT03806933|565765831|FG000|Main Period|Pregnancy|0|||
156731493|NCT03806933|565765832|FG001|Main Period|Pregnancy|0|||
156731494|NCT03806933|565765833|FG002|Main Period|Pregnancy|1|||
156731495|NCT03806933|565765834|FG003|Main Period|Pregnancy|0|||
156731496|NCT03806933|565765831|FG000|Main Period|Withdrawal by Subject|2|||
156731497|NCT03806933|565765832|FG001|Main Period|Withdrawal by Subject|1|||
156731498|NCT03806933|565765833|FG002|Main Period|Withdrawal by Subject|1|||
156731499|NCT03806933|565765834|FG003|Main Period|Withdrawal by Subject|2|||
156731500|NCT03806933|565765831|FG000|Main Period|Lost to Follow-up|2|||
156731501|NCT03806933|565765832|FG001|Main Period|Lost to Follow-up|2|||
156731502|NCT03806933|565765833|FG002|Main Period|Lost to Follow-up|0|||
156731503|NCT03806933|565765834|FG003|Main Period|Lost to Follow-up|0|||
156731504|NCT03806933|565765831|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
156731505|NCT03806933|565765832|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
156731506|NCT03806933|565765833|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
156731507|NCT03806933|565765834|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
156731508|NCT01736397|565765835|FG000|Overall Study|Lack of Efficacy|1|||
156731509|NCT01736397|565765836|FG001|Overall Study|Lack of Efficacy|11|||
156731510|NCT01736397|565765835|FG000|Overall Study|Withdrawal by Subject|6|||
156731511|NCT01736397|565765836|FG001|Overall Study|Withdrawal by Subject|5|||
156731512|NCT01736397|565765835|FG000|Overall Study|Lost to Follow-up|0|||
156731513|NCT01736397|565765836|FG001|Overall Study|Lost to Follow-up|1|||
156796593|NCT02259231|566008114|FG001|Overall Study|Progressive Disease|5|||
156796594|NCT02259231|566008115|FG002|Overall Study|Progressive Disease|4|||
156731514|NCT01736397|565765835|FG000|Overall Study|Adverse Event|6|||
156731515|NCT01736397|565765836|FG001|Overall Study|Adverse Event|3|||
156731516|NCT01736397|565765835|FG000|Overall Study|Not stated|1|||
156731517|NCT01736397|565765836|FG001|Overall Study|Not stated|4|||
156731518|NCT05088603|565765837|FG000|Overall Study|Protocol Violation|6|||
156731519|NCT05088603|565765838|FG001|Overall Study|Protocol Violation|1|||
156731520|NCT01868438|565765839|FG000|First Intervention|Withdrawal by Subject|5|||
156731521|NCT01868438|565765840|FG001|First Intervention|Withdrawal by Subject|1|||
156731522|NCT01868438|565765839|FG000|First Intervention|Lost to Follow-up|2|||
156731523|NCT01868438|565765840|FG001|First Intervention|Lost to Follow-up|3|||
156731524|NCT01868438|565765839|FG000|First Intervention|Meeting the non-redosing criteria|0|||
156731525|NCT01868438|565765840|FG001|First Intervention|Meeting the non-redosing criteria|1|||
156455297|NCT02547233|564761606|FG000|12-month Follow-up|Lost to Follow-up|3|||
156455298|NCT02547233|564761607|FG001|12-month Follow-up|Lost to Follow-up|3|||
156455299|NCT02547233|564761606|FG000|12-month Follow-up|Lack of Efficacy|1|||
156455300|NCT02547233|564761607|FG001|12-month Follow-up|Lack of Efficacy|2|||
156455301|NCT02547233|564761606|FG000|12-month Follow-up|Protocol Violation|0|||
156455302|NCT02547233|564761607|FG001|12-month Follow-up|Protocol Violation|1|||
156455303|NCT02547233|564761606|FG000|12-month Follow-up|Other|0|||
156455304|NCT02547233|564761607|FG001|12-month Follow-up|Other|1|||
156455305|NCT06019559|564761609|FG000|Overall Study|Withdrawal by Subject|7|||
156455306|NCT06019559|564761610|FG001|Overall Study|Withdrawal by Subject|6|||
156455307|NCT06019559|564761611|FG002|Overall Study|Withdrawal by Subject|5|||
156455308|NCT06019559|564761609|FG000|Overall Study|Lost to Follow-up|2|||
156455309|NCT06019559|564761610|FG001|Overall Study|Lost to Follow-up|0|||
156455310|NCT06019559|564761611|FG002|Overall Study|Lost to Follow-up|3|||
156455311|NCT05949788|564761612|FG000|Overall Study|severe birth deformity|2|||
156455312|NCT05949788|564761613|FG001|Overall Study|severe birth deformity|7|||
156455313|NCT05949788|564761612|FG000|Overall Study|twin-twin transfusion syndrome|2|||
156455314|NCT05949788|564761613|FG001|Overall Study|twin-twin transfusion syndrome|7|||
156455315|NCT05949788|564761612|FG000|Overall Study|neonatal hemolytic disease|3|||
156455316|NCT05949788|564761613|FG001|Overall Study|neonatal hemolytic disease|8|||
156455317|NCT05949788|564761612|FG000|Overall Study|death within 14 days after birth|2|||
156455318|NCT05949788|564761613|FG001|Overall Study|death within 14 days after birth|6|||
156455319|NCT05949788|564761612|FG000|Overall Study|transfer to another hospital|2|||
156455320|NCT05949788|564761613|FG001|Overall Study|transfer to another hospital|6|||
156455321|NCT05213390|564761614|FG000|Overall Study|Withdrawal by Subject|2|||
156455322|NCT05213390|564761614|FG000|Overall Study|Lost to Follow-up|12|||
156455323|NCT05213390|564761614|FG000|Overall Study|Protocol Violation|9|||
156455324|NCT05362487|564761615|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
156455325|NCT03603600|564761617|FG000|Overall Study|Withdrawal by Subject|5|||
156455326|NCT03603600|564761618|FG001|Overall Study|Withdrawal by Subject|7|||
156455327|NCT03603600|564761617|FG000|Overall Study|Lost to Follow-up|2|||
156455328|NCT03603600|564761618|FG001|Overall Study|Lost to Follow-up|3|||
156455329|NCT03603600|564761617|FG000|Overall Study|Death|3|||
156455330|NCT03603600|564761618|FG001|Overall Study|Death|1|||
156455331|NCT03603600|564761617|FG000|Overall Study|Physician Decision|2|||
156455332|NCT03603600|564761618|FG001|Overall Study|Physician Decision|1|||
156455333|NCT03603600|564761617|FG000|Overall Study|Other reason|1|||
156455334|NCT03603600|564761618|FG001|Overall Study|Other reason|0|||
156731526|NCT01868438|565765839|FG000|Second Intervention|Adverse Event|3|||
156731527|NCT01868438|565765840|FG001|Second Intervention|Adverse Event|3|||
156731528|NCT03555565|565765843|FG000|Overall Study|Case Report Forms Uncollected|2|||
156796595|NCT02259231|566008116|FG003|Overall Study|Progressive Disease|5|||
156731529|NCT03555565|565765843|FG000|Overall Study|Protocol Deviation|13|||
156731530|NCT00076752|565765844|FG000|Overall Study|Death|2|||
156731531|NCT00076752|565765844|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
156731532|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
156731533|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
156731534|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
156731535|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
156731536|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
156731537|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
156731538|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
156731539|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
156796596|NCT02259231|566008117|FG004|Overall Study|Progressive Disease|4|||
156796597|NCT02259231|566008118|FG005|Overall Study|Progressive Disease|5|||
156796598|NCT02259231|566008119|FG006|Overall Study|Progressive Disease|4|||
156796599|NCT02259231|566008113|FG000|Overall Study|Sponsor termination of study|1|||
156796600|NCT02259231|566008114|FG001|Overall Study|Sponsor termination of study|0|||
156796601|NCT02259231|566008115|FG002|Overall Study|Sponsor termination of study|0|||
156796602|NCT02259231|566008116|FG003|Overall Study|Sponsor termination of study|1|||
156796603|NCT02259231|566008117|FG004|Overall Study|Sponsor termination of study|2|||
156796604|NCT02259231|566008118|FG005|Overall Study|Sponsor termination of study|1|||
156796605|NCT02259231|566008119|FG006|Overall Study|Sponsor termination of study|1|||
156796606|NCT05081843|566008120|FG000|Overall Study|Lost to Follow-up|135|||
156336329|NCT00242216|564328245|FG000|Overall Study|Lack of Efficacy|1|||
156455335|NCT03031470|564761624|FG000|Overall Study|Adverse Event|3|||
156731540|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Death|0|||
156731541|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Death|1|||
156731542|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
156731543|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
156796607|NCT05081843|566008121|FG001|Overall Study|Lost to Follow-up|145|||
156455336|NCT03031470|564761625|FG001|Overall Study|Adverse Event|0|||
156455337|NCT03031470|564761624|FG000|Overall Study|Death|3|||
156455338|NCT03031470|564761625|FG001|Overall Study|Death|1|||
156455339|NCT03031470|564761624|FG000|Overall Study|Lost to Follow-up|1|||
156455340|NCT03031470|564761625|FG001|Overall Study|Lost to Follow-up|1|||
156533622|NCT00312221|565048869|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
156533623|NCT00312221|565048870|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
156533624|NCT00312221|565048871|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
156533625|NCT00312221|565048868|FG000|Open-label Run-in Period|Did not qualify|5|||
156533626|NCT00312221|565048869|FG001|Open-label Run-in Period|Did not qualify|0|||
156533627|NCT00312221|565048870|FG002|Open-label Run-in Period|Did not qualify|0|||
156533628|NCT00312221|565048871|FG003|Open-label Run-in Period|Did not qualify|0|||
156533629|NCT00312221|565048868|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156533630|NCT00312221|565048869|FG001|Double-blind Phase|Withdrawal by Subject|6|||
156533631|NCT00312221|565048870|FG002|Double-blind Phase|Withdrawal by Subject|8|||
156533632|NCT00312221|565048871|FG003|Double-blind Phase|Withdrawal by Subject|7|||
156336330|NCT00242216|564328246|FG001|Overall Study|Lack of Efficacy|2|||
156336331|NCT00242216|564328245|FG000|Overall Study|no medicaiton dispensed|1|||
156336332|NCT00242216|564328246|FG001|Overall Study|no medicaiton dispensed|1|||
156533633|NCT00312221|565048868|FG000|Double-blind Phase|Adverse Event|0|||
156796608|NCT03312543|566008123|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
156796609|NCT03312543|566008124|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
156796610|NCT03312543|566008123|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
156796611|NCT03312543|566008124|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
156796612|NCT03312543|566008123|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
156336333|NCT01453361|564328247|FG000|Overall Study|Disease Progression|6|||
156336334|NCT01453361|564328247|FG000|Overall Study|Screen-Failures|10|||
156533634|NCT00312221|565048869|FG001|Double-blind Phase|Adverse Event|10|||
156533635|NCT00312221|565048870|FG002|Double-blind Phase|Adverse Event|19|||
156533636|NCT00312221|565048871|FG003|Double-blind Phase|Adverse Event|18|||
156533637|NCT00312221|565048868|FG000|Double-blind Phase|Lost to Follow-up|0|||
156533638|NCT00312221|565048869|FG001|Double-blind Phase|Lost to Follow-up|0|||
156533639|NCT00312221|565048870|FG002|Double-blind Phase|Lost to Follow-up|2|||
156533640|NCT00312221|565048871|FG003|Double-blind Phase|Lost to Follow-up|2|||
156533641|NCT00312221|565048868|FG000|Double-blind Phase|Administrative|0|||
156533642|NCT00312221|565048869|FG001|Double-blind Phase|Administrative|26|||
156533643|NCT00312221|565048870|FG002|Double-blind Phase|Administrative|37|||
156533644|NCT00312221|565048871|FG003|Double-blind Phase|Administrative|33|||
156533645|NCT00312221|565048868|FG000|Double-blind Phase|Lack of Efficacy|0|||
156533646|NCT00312221|565048869|FG001|Double-blind Phase|Lack of Efficacy|17|||
156533647|NCT00312221|565048870|FG002|Double-blind Phase|Lack of Efficacy|6|||
156533648|NCT00312221|565048871|FG003|Double-blind Phase|Lack of Efficacy|10|||
156533649|NCT02060721|565048872|FG000|Overall Study|Lost to Follow-up|1|||
156533650|NCT02060721|565048872|FG000|Overall Study|Physician Decision|2|||
156533651|NCT02060721|565048872|FG000|Overall Study|Death|14|||
156533652|NCT02060721|565048872|FG000|Overall Study|Withdrawal by Subject|2|||
156533653|NCT02060721|565048872|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
156533654|NCT05105789|565048873|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
156533655|NCT02558231|565048877|FG000|Overall Study|Death|4|||
156533656|NCT02558231|565048878|FG001|Overall Study|Death|12|||
156533657|NCT02558231|565048877|FG000|Overall Study|Lost to Follow-up|7|||
156533658|NCT02558231|565048878|FG001|Overall Study|Lost to Follow-up|4|||
156533659|NCT02558231|565048877|FG000|Overall Study|Withdrawal by Subject|7|||
156533660|NCT02558231|565048878|FG001|Overall Study|Withdrawal by Subject|4|||
156533661|NCT02558231|565048877|FG000|Overall Study|Physician Decision|7|||
156533662|NCT02558231|565048878|FG001|Overall Study|Physician Decision|5|||
156533663|NCT02558231|565048877|FG000|Overall Study|Sponsor Decision|0|||
156796613|NCT03312543|566008124|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
156796614|NCT03312543|566008123|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
156796615|NCT03312543|566008124|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
156796616|NCT03312543|566008123|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
156796617|NCT03312543|566008124|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
156796618|NCT03312543|566008123|FG000|Regression (Week 12 to Week 24)|Death|0|||
156796619|NCT03312543|566008124|FG001|Regression (Week 12 to Week 24)|Death|1|||
156796620|NCT04507269|566008125|FG000|Overall Study|Withdrawal by Subject|1|||
156796621|NCT04507269|566008126|FG001|Overall Study|Withdrawal by Subject|1|||
156796622|NCT04507269|566008127|FG002|Overall Study|Withdrawal by Subject|0|||
156796623|NCT04507269|566008128|FG003|Overall Study|Withdrawal by Subject|0|||
156796624|NCT04507269|566008129|FG004|Overall Study|Withdrawal by Subject|0|||
156796625|NCT04507269|566008130|FG005|Overall Study|Withdrawal by Subject|0|||
156796626|NCT04507269|566008125|FG000|Overall Study|Lost to Follow-up|0|||
156796627|NCT04507269|566008126|FG001|Overall Study|Lost to Follow-up|0|||
156796628|NCT04507269|566008127|FG002|Overall Study|Lost to Follow-up|0|||
156796629|NCT04507269|566008128|FG003|Overall Study|Lost to Follow-up|0|||
156796630|NCT04507269|566008129|FG004|Overall Study|Lost to Follow-up|1|||
156796631|NCT04507269|566008130|FG005|Overall Study|Lost to Follow-up|0|||
156796632|NCT05852340|566008131|FG000|Period 5|Not completing the meal|0|||
156796633|NCT05852340|566008132|FG001|Period 5|Not completing the meal|1|||
156796634|NCT05852340|566008133|FG002|Period 5|Not completing the meal|0|||
156796635|NCT05852340|566008134|FG003|Period 5|Not completing the meal|0|||
156796636|NCT05852340|566008131|FG000|Period 5|Adverse Event|0|||
156731544|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
156731545|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
156731546|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
156731547|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
156455341|NCT03031470|564761624|FG000|Overall Study|Withdrawal by Subject|1|||
156731548|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
156731549|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
156731550|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
156455342|NCT03031470|564761625|FG001|Overall Study|Withdrawal by Subject|0|||
156731551|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
156731552|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Non compliance|0|||
156731553|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Non compliance|1|||
156731554|NCT00394836|565765847|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
156731555|NCT00394836|565765848|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
156731556|NCT00394836|565765847|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
156731557|NCT00394836|565765848|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
156731558|NCT00394836|565765847|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
156731559|NCT00394836|565765848|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
156731560|NCT00394836|565765847|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
156731561|NCT00394836|565765848|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
156731562|NCT01560234|565765849|FG000|Overall Study|Lost to Follow-up|3|||
156731563|NCT01560234|565765850|FG001|Overall Study|Lost to Follow-up|0|||
156731564|NCT01560234|565765851|FG002|Overall Study|Lost to Follow-up|1|||
156731565|NCT01560234|565765852|FG003|Overall Study|Lost to Follow-up|0|||
156731566|NCT01560234|565765853|FG004|Overall Study|Lost to Follow-up|0|||
156731567|NCT01560234|565765854|FG005|Overall Study|Lost to Follow-up|2|||
156731568|NCT01560234|565765855|FG006|Overall Study|Lost to Follow-up|0|||
156731569|NCT01560234|565765856|FG007|Overall Study|Lost to Follow-up|2|||
156731570|NCT02028767|565765857|FG000|Treatment Period 2|Non compliant with protocol|1|||
156731571|NCT02028767|565765858|FG001|Treatment Period 2|Non compliant with protocol|0|||
156731572|NCT02028767|565765857|FG000|Treatment Period 2|Reason other than those specified above|1|||
156731573|NCT02028767|565765858|FG001|Treatment Period 2|Reason other than those specified above|0|||
156731574|NCT01284348|565765859|FG000|Overall Study|Death|1|||
156731575|NCT01284348|565765860|FG001|Overall Study|Death|1|||
156731576|NCT01284348|565765859|FG000|Overall Study|Withdrew consent|0|||
156731577|NCT01284348|565765860|FG001|Overall Study|Withdrew consent|1|||
156731578|NCT01284348|565765859|FG000|Overall Study|Status not recorded|9|||
156731579|NCT01284348|565765860|FG001|Overall Study|Status not recorded|10|||
156731580|NCT04075682|565765865|FG000|Overall Study|Lost to Follow-up|5|||
156731581|NCT04075682|565765866|FG001|Overall Study|Lost to Follow-up|5|||
156731582|NCT04075682|565765867|FG002|Overall Study|Lost to Follow-up|2|||
156731583|NCT04075682|565765868|FG003|Overall Study|Lost to Follow-up|2|||
156731584|NCT04075682|565765865|FG000|Overall Study|Withdrawal by Subject|1|||
156731585|NCT04075682|565765866|FG001|Overall Study|Withdrawal by Subject|0|||
156731586|NCT04075682|565765867|FG002|Overall Study|Withdrawal by Subject|1|||
156731587|NCT04075682|565765868|FG003|Overall Study|Withdrawal by Subject|0|||
156731588|NCT04075682|565765865|FG000|Overall Study|Protocol Violation|0|||
156731589|NCT04075682|565765866|FG001|Overall Study|Protocol Violation|1|||
156731590|NCT04075682|565765867|FG002|Overall Study|Protocol Violation|1|||
156731591|NCT04075682|565765868|FG003|Overall Study|Protocol Violation|0|||
156731592|NCT04075682|565765865|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
156731593|NCT04075682|565765866|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
156731594|NCT04075682|565765867|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
156731595|NCT04075682|565765868|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
156731596|NCT04075682|565765865|FG000|Overall Study|Lost study phone the first day of study participation|0|||
156731597|NCT04075682|565765866|FG001|Overall Study|Lost study phone the first day of study participation|1|||
156731598|NCT04075682|565765867|FG002|Overall Study|Lost study phone the first day of study participation|0|||
156731599|NCT04075682|565765868|FG003|Overall Study|Lost study phone the first day of study participation|0|||
156731600|NCT04292912|565765869|FG000|Overall Study|Physician Decision|1|||
156731601|NCT04292912|565765869|FG000|Overall Study|Protocol Violation|6|||
156731602|NCT00955955|565765870|FG000|Overall Study|Lost to Follow-up|2|||
156731603|NCT00955955|565765871|FG001|Overall Study|Lost to Follow-up|0|||
156731604|NCT00955955|565765872|FG002|Overall Study|Lost to Follow-up|0|||
156731605|NCT03423173|565765873|FG000|Overall Study|Randomized but not vaccinated|1|||
156455343|NCT03031470|564761624|FG000|Overall Study|Protocol entry criteria not met|0|||
156731606|NCT03423173|565765874|FG001|Overall Study|Randomized but not vaccinated|0|||
156731607|NCT03423173|565765875|FG002|Overall Study|Randomized but not vaccinated|2|||
156796637|NCT05852340|566008132|FG001|Period 5|Adverse Event|0|||
156796638|NCT05852340|566008133|FG002|Period 5|Adverse Event|0|||
156796639|NCT05852340|566008134|FG003|Period 5|Adverse Event|1|||
156731608|NCT03423173|565765876|FG003|Overall Study|Randomized but not vaccinated|1|||
156796640|NCT04976777|566009619|FG000|Overall Study|COVID-19 Infection|1|||
156731609|NCT03423173|565765873|FG000|Overall Study|Adverse Event|1|||
156731610|NCT03423173|565765874|FG001|Overall Study|Adverse Event|1|||
156731611|NCT03423173|565765875|FG002|Overall Study|Adverse Event|1|||
156731612|NCT03423173|565765876|FG003|Overall Study|Adverse Event|1|||
156731613|NCT03423173|565765873|FG000|Overall Study|Lost to Follow-up|10|||
156731614|NCT03423173|565765874|FG001|Overall Study|Lost to Follow-up|19|||
156731615|NCT03423173|565765875|FG002|Overall Study|Lost to Follow-up|17|||
156731616|NCT03423173|565765876|FG003|Overall Study|Lost to Follow-up|22|||
156731617|NCT03423173|565765873|FG000|Overall Study|Withdrawal of consent|4|||
156731618|NCT03423173|565765874|FG001|Overall Study|Withdrawal of consent|10|||
156731619|NCT03423173|565765875|FG002|Overall Study|Withdrawal of consent|4|||
156731620|NCT03423173|565765876|FG003|Overall Study|Withdrawal of consent|5|||
156731621|NCT03423173|565765873|FG000|Overall Study|Death|1|||
156731622|NCT03423173|565765874|FG001|Overall Study|Death|0|||
156731623|NCT03423173|565765875|FG002|Overall Study|Death|0|||
156731624|NCT03423173|565765876|FG003|Overall Study|Death|0|||
156731625|NCT03423173|565765873|FG000|Overall Study|Reason not Specified|2|||
156731626|NCT03423173|565765874|FG001|Overall Study|Reason not Specified|5|||
156731627|NCT03423173|565765875|FG002|Overall Study|Reason not Specified|3|||
156731628|NCT03423173|565765876|FG003|Overall Study|Reason not Specified|1|||
156731629|NCT03348930|565765877|FG000|Washout (1 Week)|Lost to Follow-up|1|||
156731630|NCT03348930|565765878|FG001|Washout (1 Week)|Lost to Follow-up|1|||
156731631|NCT01053663|565765879|FG000|Overall Study|Death|2|||
156731632|NCT01053663|565765879|FG000|Overall Study|Lost to Follow-up|1|||
156731633|NCT01053663|565765879|FG000|Overall Study|Poor IV Access|1|||
156731634|NCT01053663|565765879|FG000|Overall Study|Transferred to Another Hospital|1|||
156731635|NCT01053663|565765879|FG000|Overall Study|Negative Influenza Diagnosis|1|||
156731636|NCT03533114|565765880|FG000|Overall|Adverse Event|16|||
156731637|NCT03533114|565765881|FG001|Overall|Adverse Event|11|||
156731638|NCT03533114|565765880|FG000|Overall|Consent Withdrawal by Participant|7|||
156731639|NCT03533114|565765881|FG001|Overall|Consent Withdrawal by Participant|6|||
156731640|NCT03533114|565765880|FG000|Overall|Lack of Efficacy|5|||
156731641|NCT03533114|565765881|FG001|Overall|Lack of Efficacy|3|||
156731642|NCT03533114|565765880|FG000|Overall|Lost to Follow-up|1|||
156731643|NCT03533114|565765881|FG001|Overall|Lost to Follow-up|1|||
156731644|NCT03533114|565765880|FG000|Overall|Physician Decision|0|||
156731645|NCT03533114|565765881|FG001|Overall|Physician Decision|2|||
156731646|NCT03533114|565765880|FG000|Overall|Protocol deviation|1|||
156731647|NCT03533114|565765881|FG001|Overall|Protocol deviation|1|||
156731648|NCT03533114|565765880|FG000|Overall|Failure to meet randomization criteria|1|||
156731649|NCT03533114|565765881|FG001|Overall|Failure to meet randomization criteria|2|||
156731650|NCT03533114|565765880|FG000|Overall|Non-Compliance with study drug|0|||
156731651|NCT03533114|565765881|FG001|Overall|Non-Compliance with study drug|1|||
156731652|NCT03533114|565765880|FG000|Overall|Other|0|||
156731653|NCT03533114|565765881|FG001|Overall|Other|1|||
156731654|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Adverse Event|11|||
156731655|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Adverse Event|8|||
156731656|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
156731657|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
156731658|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
156731659|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
156731660|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
156731661|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
156731662|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
156731663|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
156731664|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
156731665|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
156731666|NCT03533114|565765880|FG000|Stable Dose|Adverse Event|0|||
156731667|NCT03533114|565765881|FG001|Stable Dose|Adverse Event|2|||
156731668|NCT03533114|565765880|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
156731669|NCT03533114|565765881|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
156731670|NCT03533114|565765880|FG000|Stable Dose|Lack of Efficacy|1|||
156731671|NCT03533114|565765881|FG001|Stable Dose|Lack of Efficacy|0|||
156731672|NCT03533114|565765880|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
156455344|NCT03031470|564761625|FG001|Overall Study|Protocol entry criteria not met|1|||
156731673|NCT03533114|565765881|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
156731674|NCT03533114|565765880|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
156731675|NCT03533114|565765881|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
156731676|NCT03533114|565765880|FG000|Open-Label Safety Extension|Adverse Event|3|||
156731677|NCT03533114|565765881|FG001|Open-Label Safety Extension|Adverse Event|0|||
156731678|NCT03533114|565765880|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
156731679|NCT03533114|565765881|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
156731680|NCT03533114|565765880|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
156731681|NCT03533114|565765881|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
156796641|NCT04976777|566009620|FG001|Overall Study|COVID-19 Infection|0|||
156455345|NCT03031470|564761624|FG000|Overall Study|Cancel the operation|0|||
156455346|NCT03031470|564761625|FG001|Overall Study|Cancel the operation|1|||
156455347|NCT03461276|564761626|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
156455348|NCT03461276|564761627|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
156455349|NCT03461276|564761626|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
156455350|NCT03461276|564761627|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
156455351|NCT03461276|564761626|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
156455352|NCT03461276|564761627|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
156455353|NCT03461276|564761626|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
156455354|NCT03461276|564761627|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
156455355|NCT03461276|564761626|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
156455356|NCT03461276|564761627|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
156455357|NCT03461276|564761626|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
156455358|NCT03461276|564761627|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
156731682|NCT03533114|565765880|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
156455359|NCT03461276|564761626|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
156455360|NCT03461276|564761627|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
156455361|NCT03461276|564761626|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
156455362|NCT03461276|564761627|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
156455363|NCT03461276|564761626|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
156455364|NCT03461276|564761627|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
156455365|NCT03461276|564761626|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
156455366|NCT03461276|564761627|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
156455367|NCT01943409|564761632|FG000|Overall Study|resumed oral/entral|24|||
156455368|NCT01943409|564761633|FG001|Overall Study|resumed oral/entral|20|||
156455369|NCT01943409|564761632|FG000|Overall Study|Protocol Violation|14|||
156455370|NCT01943409|564761633|FG001|Overall Study|Protocol Violation|24|||
156455371|NCT01943409|564761632|FG000|Overall Study|Death|3|||
156455372|NCT01943409|564761633|FG001|Overall Study|Death|1|||
156455373|NCT01943409|564761632|FG000|Overall Study|Withdrawal by Subject|4|||
156731683|NCT03533114|565765881|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
156731684|NCT03533114|565765880|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
156731685|NCT03533114|565765881|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
156731686|NCT03575793|565765882|FG000|Overall Study|Withdrawal by Subject|0|||
156336335|NCT01752985|564328248|FG000|Treatment Period|Subject request to discontinue treatment|1|||
156336336|NCT01752985|564328249|FG001|Treatment Period|Subject request to discontinue treatment|0|||
156336337|NCT01752985|564328250|FG002|Treatment Period|Subject request to discontinue treatment|1|||
156336338|NCT01752985|564328248|FG000|Treatment Period|Subject no longer meets study criteria|0|||
156336339|NCT01752985|564328249|FG001|Treatment Period|Subject no longer meets study criteria|1|||
156336340|NCT01752985|564328250|FG002|Treatment Period|Subject no longer meets study criteria|1|||
156336341|NCT01752985|564328248|FG000|Treatment Period|Adverse Event|2|||
156336342|NCT01752985|564328249|FG001|Treatment Period|Adverse Event|1|||
156336343|NCT01752985|564328250|FG002|Treatment Period|Adverse Event|2|||
156336344|NCT01752985|564328248|FG000|Treatment Period|Withdrawal by Subject|1|||
156336345|NCT01752985|564328249|FG001|Treatment Period|Withdrawal by Subject|1|||
156336346|NCT01752985|564328250|FG002|Treatment Period|Withdrawal by Subject|0|||
156336347|NCT01752985|564328248|FG000|Treatment Period|Lost to Follow-up|0|||
156336348|NCT01752985|564328249|FG001|Treatment Period|Lost to Follow-up|0|||
156455374|NCT01943409|564761633|FG001|Overall Study|Withdrawal by Subject|3|||
156455375|NCT04542317|564761634|FG000|Overall Study|Care recipients passed away|18|||
156455376|NCT04542317|564761635|FG001|Overall Study|Care recipients passed away|13|||
156455377|NCT04542317|564761634|FG000|Overall Study|No longer a primary caregiver|5|||
156455378|NCT04542317|564761635|FG001|Overall Study|No longer a primary caregiver|1|||
156455379|NCT04542317|564761634|FG000|Overall Study|Withdrawal by Subject|4|||
156455380|NCT04542317|564761635|FG001|Overall Study|Withdrawal by Subject|2|||
156455381|NCT04542317|564761634|FG000|Overall Study|Caregivers passed away|0|||
156533664|NCT02558231|565048878|FG001|Overall Study|Sponsor Decision|1|||
156731687|NCT03575793|565765883|FG001|Overall Study|Withdrawal by Subject|1|||
156731688|NCT03575793|565765882|FG000|Overall Study|Never Treated|0|||
156336349|NCT01752985|564328250|FG002|Treatment Period|Lost to Follow-up|1|||
156336350|NCT02400333|564329565|FG000|Overall Study|Withdrawal by Subject|0|||
156336351|NCT02400333|564329566|FG001|Overall Study|Withdrawal by Subject|1|||
156336352|NCT02400333|564329567|FG002|Overall Study|Withdrawal by Subject|0|||
156336353|NCT02400333|564329568|FG003|Overall Study|Withdrawal by Subject|1|||
156336354|NCT02400333|564329565|FG000|Overall Study|Protocol Violation|1|||
156336355|NCT02400333|564329566|FG001|Overall Study|Protocol Violation|0|||
156455382|NCT04542317|564761635|FG001|Overall Study|Caregivers passed away|2|||
156455383|NCT02310646|564761636|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
156455384|NCT02310646|564761637|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
156455385|NCT02310646|564761636|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
156731689|NCT03575793|565765883|FG001|Overall Study|Never Treated|2|||
156731690|NCT01062113|565765884|FG000|Overall Study|Adverse Event|1|||
156731691|NCT01062113|565765885|FG001|Overall Study|Adverse Event|0|||
156731692|NCT01062113|565765886|FG002|Overall Study|Adverse Event|0|||
156731693|NCT01062113|565765884|FG000|Overall Study|Lack of Efficacy|38|||
156731694|NCT01062113|565765885|FG001|Overall Study|Lack of Efficacy|22|||
156731695|NCT01062113|565765886|FG002|Overall Study|Lack of Efficacy|31|||
156731696|NCT01062113|565765884|FG000|Overall Study|Withdrawal by Subject|1|||
156731697|NCT01062113|565765885|FG001|Overall Study|Withdrawal by Subject|0|||
156731698|NCT01062113|565765886|FG002|Overall Study|Withdrawal by Subject|0|||
156731699|NCT00634803|565765890|FG000|Overall Study|Lost to Follow-up|6|||
156731700|NCT00634803|565765891|FG001|Overall Study|Lost to Follow-up|7|||
156731701|NCT00634803|565765892|FG002|Overall Study|Lost to Follow-up|7|||
156731702|NCT00364923|565765893|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
156731703|NCT00364923|565765893|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
156731704|NCT00766636|565765903|FG000|Overall Study|Withdrawal by Subject|1|||
156731705|NCT00766636|565765904|FG001|Overall Study|Withdrawal by Subject|1|||
156731706|NCT00766636|565765903|FG000|Overall Study|Incomplete Treatment|0|||
156731707|NCT00766636|565765904|FG001|Overall Study|Incomplete Treatment|1|||
156731708|NCT00766636|565765903|FG000|Overall Study|Adverse Event|1|||
156731709|NCT00766636|565765904|FG001|Overall Study|Adverse Event|0|||
156731710|NCT00766636|565765903|FG000|Overall Study|Disease Progression|1|||
156731711|NCT00766636|565765904|FG001|Overall Study|Disease Progression|0|||
156731712|NCT01355575|565765909|FG000|Overall Study|Withdrawal by Subject|2|||
156731713|NCT04087720|565765910|FG000|Overall Study|Withdrawal by Subject|2|||
156731714|NCT04087720|565765910|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
156731715|NCT00765336|565765915|FG000|Overall Study|Protocol Violation|4|||
156731716|NCT00765336|565765916|FG001|Overall Study|Protocol Violation|2|||
156731717|NCT00765336|565765915|FG000|Overall Study|Withdrawal by Subject|6|||
156731718|NCT00765336|565765916|FG001|Overall Study|Withdrawal by Subject|4|||
156731719|NCT00765336|565765915|FG000|Overall Study|Lost to Follow-up|7|||
156731720|NCT00765336|565765916|FG001|Overall Study|Lost to Follow-up|9|||
156731721|NCT00765336|565765915|FG000|Overall Study|Adverse Event|2|||
156731722|NCT00765336|565765916|FG001|Overall Study|Adverse Event|1|||
156731723|NCT00478777|565765917|FG000|Overall Study|Adverse Event|29|||
156731724|NCT00478777|565765917|FG000|Overall Study|Lack of Efficacy|23|||
156731725|NCT00478777|565765917|FG000|Overall Study|Withdrawal by Subject|4|||
156731726|NCT00478777|565765917|FG000|Overall Study|Death|3|||
156731727|NCT00478777|565765917|FG000|Overall Study|Protocol Violation|3|||
156731728|NCT00478777|565765917|FG000|Overall Study|Lost to Follow-up|3|||
156731729|NCT00478777|565765917|FG000|Overall Study|Physician Decision|1|||
156731730|NCT00478777|565765917|FG000|Overall Study|Intolerance of therapy|1|||
156731731|NCT00478777|565765917|FG000|Overall Study|Lack of compliance|1|||
156731732|NCT00478777|565765917|FG000|Overall Study|Lymphocytes infusion|1|||
156731733|NCT00478777|565765917|FG000|Overall Study|End of therapy|2|||
156731734|NCT00478777|565765917|FG000|Overall Study|Not treated with lenalidomide|6|||
156731735|NCT01377922|565765918|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
156731736|NCT01377922|565765919|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
156731737|NCT02553499|565765927|FG000|Overall Study|Adverse Event|0|||
156731738|NCT02553499|565765928|FG001|Overall Study|Adverse Event|0|||
156731739|NCT02553499|565765929|FG002|Overall Study|Adverse Event|0|||
156731740|NCT02553499|565765930|FG003|Overall Study|Adverse Event|0|||
156731741|NCT02553499|565765931|FG004|Overall Study|Adverse Event|0|||
156731742|NCT02553499|565765932|FG005|Overall Study|Adverse Event|0|||
156731743|NCT02553499|565765933|FG006|Overall Study|Adverse Event|1|||
156731744|NCT02553499|565765934|FG007|Overall Study|Adverse Event|1|||
156731745|NCT02553499|565765935|FG008|Overall Study|Adverse Event|0|||
156731746|NCT02553499|565765936|FG009|Overall Study|Adverse Event|0|||
156731747|NCT02553499|565765937|FG010|Overall Study|Adverse Event|0|||
156731748|NCT02553499|565765938|FG011|Overall Study|Adverse Event|0|||
156731749|NCT02553499|565765939|FG012|Overall Study|Adverse Event|0|||
156533665|NCT03933397|565048879|FG000|Overall Study|No emergency department visit|65|||
156533666|NCT03933397|565048880|FG001|Overall Study|No emergency department visit|71|||
156533667|NCT03933397|565048879|FG000|Overall Study|Missed emergency department visit|25|||
156533668|NCT03933397|565048880|FG001|Overall Study|Missed emergency department visit|30|||
156533669|NCT03933397|565048879|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
156533670|NCT03933397|565048880|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
156731750|NCT02553499|565765940|FG013|Overall Study|Adverse Event|1|||
156731751|NCT02553499|565765927|FG000|Overall Study|Death|0|||
156731752|NCT02553499|565765928|FG001|Overall Study|Death|1|||
156731753|NCT02553499|565765929|FG002|Overall Study|Death|1|||
156731754|NCT02553499|565765930|FG003|Overall Study|Death|0|||
156731755|NCT02553499|565765931|FG004|Overall Study|Death|1|||
156731756|NCT02553499|565765932|FG005|Overall Study|Death|2|||
156731757|NCT02553499|565765933|FG006|Overall Study|Death|0|||
156731758|NCT02553499|565765934|FG007|Overall Study|Death|0|||
156731759|NCT02553499|565765935|FG008|Overall Study|Death|0|||
156731760|NCT02553499|565765936|FG009|Overall Study|Death|0|||
156731761|NCT02553499|565765937|FG010|Overall Study|Death|1|||
156731762|NCT02553499|565765938|FG011|Overall Study|Death|0|||
156455386|NCT02310646|564761637|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
156455387|NCT00613106|564761646|FG000|Overall Study|Adverse Event|3|||
156455388|NCT00613106|564761647|FG001|Overall Study|Adverse Event|1|||
156731763|NCT02553499|565765939|FG012|Overall Study|Death|0|||
156731764|NCT02553499|565765940|FG013|Overall Study|Death|0|||
156731765|NCT02553499|565765927|FG000|Overall Study|Lost to Follow-up|0|||
156731766|NCT02553499|565765928|FG001|Overall Study|Lost to Follow-up|0|||
156731767|NCT02553499|565765929|FG002|Overall Study|Lost to Follow-up|0|||
156731768|NCT02553499|565765930|FG003|Overall Study|Lost to Follow-up|0|||
156731769|NCT02553499|565765931|FG004|Overall Study|Lost to Follow-up|0|||
156731770|NCT02553499|565765932|FG005|Overall Study|Lost to Follow-up|0|||
156731771|NCT02553499|565765933|FG006|Overall Study|Lost to Follow-up|1|||
156731772|NCT02553499|565765934|FG007|Overall Study|Lost to Follow-up|0|||
156731773|NCT02553499|565765935|FG008|Overall Study|Lost to Follow-up|0|||
156731774|NCT02553499|565765936|FG009|Overall Study|Lost to Follow-up|0|||
156731775|NCT02553499|565765937|FG010|Overall Study|Lost to Follow-up|0|||
156731776|NCT02553499|565765938|FG011|Overall Study|Lost to Follow-up|0|||
156731777|NCT02553499|565765939|FG012|Overall Study|Lost to Follow-up|0|||
156731778|NCT02553499|565765940|FG013|Overall Study|Lost to Follow-up|0|||
156731779|NCT02553499|565765927|FG000|Overall Study|Physician Decision|0|||
156731780|NCT02553499|565765928|FG001|Overall Study|Physician Decision|1|||
156731781|NCT02553499|565765929|FG002|Overall Study|Physician Decision|1|||
156731782|NCT02553499|565765930|FG003|Overall Study|Physician Decision|0|||
156731783|NCT02553499|565765931|FG004|Overall Study|Physician Decision|1|||
156731784|NCT02553499|565765932|FG005|Overall Study|Physician Decision|0|||
156731785|NCT02553499|565765933|FG006|Overall Study|Physician Decision|0|||
156731786|NCT02553499|565765934|FG007|Overall Study|Physician Decision|1|||
156731787|NCT02553499|565765935|FG008|Overall Study|Physician Decision|1|||
156731788|NCT02553499|565765936|FG009|Overall Study|Physician Decision|2|||
156731789|NCT02553499|565765937|FG010|Overall Study|Physician Decision|1|||
156731790|NCT02553499|565765938|FG011|Overall Study|Physician Decision|3|||
156731791|NCT02553499|565765939|FG012|Overall Study|Physician Decision|1|||
156731792|NCT02553499|565765940|FG013|Overall Study|Physician Decision|0|||
156731793|NCT02553499|565765927|FG000|Overall Study|Progressive Disease|0|||
156731794|NCT02553499|565765928|FG001|Overall Study|Progressive Disease|0|||
156731795|NCT02553499|565765929|FG002|Overall Study|Progressive Disease|0|||
156731796|NCT02553499|565765930|FG003|Overall Study|Progressive Disease|2|||
156731797|NCT02553499|565765931|FG004|Overall Study|Progressive Disease|1|||
156731798|NCT02553499|565765932|FG005|Overall Study|Progressive Disease|1|||
156731799|NCT02553499|565765933|FG006|Overall Study|Progressive Disease|1|||
156731800|NCT02553499|565765934|FG007|Overall Study|Progressive Disease|0|||
156731801|NCT02553499|565765935|FG008|Overall Study|Progressive Disease|0|||
156731802|NCT02553499|565765936|FG009|Overall Study|Progressive Disease|1|||
156731803|NCT02553499|565765937|FG010|Overall Study|Progressive Disease|0|||
156731804|NCT02553499|565765938|FG011|Overall Study|Progressive Disease|0|||
156731805|NCT02553499|565765939|FG012|Overall Study|Progressive Disease|2|||
156731806|NCT02553499|565765940|FG013|Overall Study|Progressive Disease|1|||
156731807|NCT02553499|565765927|FG000|Overall Study|Study Terminated by Sponsor|0|||
156731808|NCT02553499|565765928|FG001|Overall Study|Study Terminated by Sponsor|0|||
156731809|NCT02553499|565765929|FG002|Overall Study|Study Terminated by Sponsor|0|||
156731810|NCT02553499|565765930|FG003|Overall Study|Study Terminated by Sponsor|0|||
156731811|NCT02553499|565765931|FG004|Overall Study|Study Terminated by Sponsor|0|||
156731812|NCT02553499|565765932|FG005|Overall Study|Study Terminated by Sponsor|0|||
156731813|NCT02553499|565765933|FG006|Overall Study|Study Terminated by Sponsor|0|||
156455389|NCT00613106|564761646|FG000|Overall Study|Withdrawal by Subject|6|||
156455390|NCT00613106|564761647|FG001|Overall Study|Withdrawal by Subject|3|||
156455391|NCT00613106|564761646|FG000|Overall Study|Lost to Follow-up|7|||
156455392|NCT00613106|564761647|FG001|Overall Study|Lost to Follow-up|2|||
156455393|NCT00613106|564761646|FG000|Overall Study|misc|4|||
156455394|NCT00613106|564761647|FG001|Overall Study|misc|3|||
156455395|NCT03496168|564761648|FG000|Overall Study|Other Reasons|1|||
156455396|NCT03496168|564761648|FG000|Overall Study|Adverse Event|1|||
156455397|NCT02043678|564761653|FG000|Overall Study|Never treated|11|||
156731814|NCT02553499|565765934|FG007|Overall Study|Study Terminated by Sponsor|0|||
156731815|NCT02553499|565765935|FG008|Overall Study|Study Terminated by Sponsor|1|||
156455398|NCT02043678|564761654|FG001|Overall Study|Never treated|9|||
156455399|NCT02043678|564761653|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
156455400|NCT02043678|564761654|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
156455401|NCT02043678|564761653|FG000|Overall Study|AE without clinical PD|54|||
156731816|NCT02553499|565765936|FG009|Overall Study|Study Terminated by Sponsor|0|||
156731817|NCT02553499|565765937|FG010|Overall Study|Study Terminated by Sponsor|0|||
156731818|NCT02553499|565765938|FG011|Overall Study|Study Terminated by Sponsor|0|||
156731819|NCT02553499|565765939|FG012|Overall Study|Study Terminated by Sponsor|0|||
156731820|NCT02553499|565765940|FG013|Overall Study|Study Terminated by Sponsor|0|||
156731821|NCT02553499|565765927|FG000|Overall Study|Withdrawal by Subject|2|||
156731822|NCT02553499|565765928|FG001|Overall Study|Withdrawal by Subject|0|||
156731823|NCT02553499|565765929|FG002|Overall Study|Withdrawal by Subject|0|||
156731824|NCT02553499|565765930|FG003|Overall Study|Withdrawal by Subject|0|||
156731825|NCT02553499|565765931|FG004|Overall Study|Withdrawal by Subject|0|||
156731826|NCT02553499|565765932|FG005|Overall Study|Withdrawal by Subject|0|||
156731827|NCT02553499|565765933|FG006|Overall Study|Withdrawal by Subject|0|||
156731828|NCT02553499|565765934|FG007|Overall Study|Withdrawal by Subject|1|||
156731829|NCT02553499|565765935|FG008|Overall Study|Withdrawal by Subject|1|||
156731830|NCT02553499|565765936|FG009|Overall Study|Withdrawal by Subject|0|||
156731831|NCT02553499|565765937|FG010|Overall Study|Withdrawal by Subject|1|||
156731832|NCT02553499|565765938|FG011|Overall Study|Withdrawal by Subject|0|||
156731833|NCT02553499|565765939|FG012|Overall Study|Withdrawal by Subject|0|||
156731834|NCT02553499|565765940|FG013|Overall Study|Withdrawal by Subject|0|||
156731835|NCT01582178|565765941|FG000|Overall Study|Physician Decision|6|||
156731836|NCT01582178|565765942|FG001|Overall Study|Physician Decision|5|||
156731837|NCT01726270|565765945|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
156731838|NCT01726270|565765945|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
156731839|NCT01726270|565765945|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
156731840|NCT01726270|565765945|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
156731841|NCT01726270|565765945|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
156731842|NCT01726270|565765945|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
156731843|NCT01323387|565765946|FG000|Overall Study|Withdrawal by Subject|41|||
156731844|NCT01323387|565765946|FG000|Overall Study|Radiographic Data Unavailable|1|||
156731845|NCT01323387|565765946|FG000|Overall Study|Revision|14|||
156731846|NCT01323387|565765946|FG000|Overall Study|Protocol Violation|12|||
156731847|NCT01323387|565765946|FG000|Overall Study|Randomized but Never Treated|16|||
156731848|NCT01464164|565765948|FG000|Overall Study|Screen failure|0|||
156731849|NCT01464164|565765949|FG001|Overall Study|Screen failure|1|||
156731850|NCT01464164|565765950|FG002|Overall Study|Screen failure|2|||
156731851|NCT01464164|565765951|FG003|Overall Study|Screen failure|0|||
156731852|NCT01464164|565765952|FG004|Overall Study|Screen failure|0|||
156731853|NCT01464164|565765953|FG005|Overall Study|Screen failure|0|||
156731854|NCT01464164|565765954|FG006|Overall Study|Screen failure|0|||
156731855|NCT01464164|565765948|FG000|Overall Study|Physician Decision|0|||
156731856|NCT01464164|565765949|FG001|Overall Study|Physician Decision|1|||
156731857|NCT01464164|565765950|FG002|Overall Study|Physician Decision|0|||
156731858|NCT01464164|565765951|FG003|Overall Study|Physician Decision|0|||
156731859|NCT01464164|565765952|FG004|Overall Study|Physician Decision|0|||
156455402|NCT02043678|564761654|FG001|Overall Study|AE without clinical PD|36|||
156731860|NCT01464164|565765953|FG005|Overall Study|Physician Decision|0|||
156731861|NCT01464164|565765954|FG006|Overall Study|Physician Decision|2|||
156731862|NCT01972438|565765955|FG000|Baseline-Month 3 Crossover Period|Death|1|||
156731863|NCT01972438|565765956|FG001|Baseline-Month 3 Crossover Period|Death|0|||
156731864|NCT01972438|565765955|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
156731865|NCT01972438|565765956|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
156731866|NCT01972438|565765955|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
156731867|NCT01972438|565765956|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
156731868|NCT01972438|565765955|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
156731869|NCT01972438|565765956|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
156731870|NCT01972438|565765955|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
156731871|NCT01972438|565765956|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
156455403|NCT02043678|564761653|FG000|Overall Study|Lost to Follow-up|1|||
156455404|NCT02043678|564761654|FG001|Overall Study|Lost to Follow-up|1|||
156455405|NCT02043678|564761653|FG000|Overall Study|Other|10|||
156455406|NCT02043678|564761654|FG001|Overall Study|Other|14|||
156455407|NCT02043678|564761653|FG000|Overall Study|Clinical PD|114|||
156455408|NCT02043678|564761654|FG001|Overall Study|Clinical PD|148|||
156455409|NCT02043678|564761653|FG000|Overall Study|Radiological PD|100|||
156455410|NCT02043678|564761654|FG001|Overall Study|Radiological PD|90|||
156455411|NCT02043678|564761653|FG000|Overall Study|Protocol-driven decision point|59|||
156455412|NCT02043678|564761654|FG001|Overall Study|Protocol-driven decision point|58|||
156533671|NCT03933397|565048879|FG000|Overall Study|Withdrawal by Subject|1|||
156731872|NCT01972438|565765955|FG000|Months 6-12 Study Period|Death|1|||
156731873|NCT01972438|565765956|FG001|Months 6-12 Study Period|Death|0|||
156731874|NCT01972438|565765955|FG000|Months 6-12 Study Period|Early Study Closure|2|||
156731875|NCT01972438|565765956|FG001|Months 6-12 Study Period|Early Study Closure|2|||
156731876|NCT01972438|565765955|FG000|Post Month 12 Study Period|Early Study Closure|3|||
156455413|NCT02043678|564761653|FG000|Overall Study|Withdrawal by Subject|16|||
156455414|NCT02043678|564761654|FG001|Overall Study|Withdrawal by Subject|20|||
156455415|NCT02043678|564761653|FG000|Overall Study|Protocol Violation|1|||
156533672|NCT03933397|565048880|FG001|Overall Study|Withdrawal by Subject|0|||
156731877|NCT01972438|565765956|FG001|Post Month 12 Study Period|Early Study Closure|4|||
156731878|NCT00570063|565765959|FG000|Overall Study|Adverse Event|4|||
156731879|NCT00570063|565765960|FG001|Overall Study|Adverse Event|1|||
156731880|NCT00570063|565765959|FG000|Overall Study|Lack of Efficacy|0|||
156731881|NCT00570063|565765960|FG001|Overall Study|Lack of Efficacy|1|||
156731882|NCT00570063|565765959|FG000|Overall Study|Withdrawal by Subject|4|||
156731883|NCT00570063|565765960|FG001|Overall Study|Withdrawal by Subject|3|||
156731884|NCT00570063|565765959|FG000|Overall Study|Sponsor's Decision|7|||
156533673|NCT03933397|565048879|FG000|Overall Study|Physician Decision|1|||
156533674|NCT03933397|565048880|FG001|Overall Study|Physician Decision|1|||
156533675|NCT03933397|565048879|FG000|Overall Study|missing pain score|1|||
156533676|NCT03933397|565048880|FG001|Overall Study|missing pain score|1|||
156533677|NCT03933397|565048879|FG000|Overall Study|Confirmed COVID-19|1|||
156533678|NCT03933397|565048880|FG001|Overall Study|Confirmed COVID-19|2|||
156533679|NCT02066051|565048884|FG000|Overall Study|Subject developed active GVHD|1|||
156533680|NCT01610687|565048885|FG000|Overall Study|Lack of Efficacy|26|||
156533681|NCT01610687|565048885|FG000|Overall Study|Adverse Event|18|||
156533682|NCT01610687|565048885|FG000|Overall Study|Moved out of area|6|||
156533683|NCT01610687|565048885|FG000|Overall Study|Withdrawal by Subject|7|||
156533684|NCT01610687|565048885|FG000|Overall Study|Lost to Follow-up|4|||
156533685|NCT01610687|565048885|FG000|Overall Study|Symptom control without study medication|2|||
156533686|NCT01610687|565048885|FG000|Overall Study|Unable to make journey|1|||
156533687|NCT01610687|565048885|FG000|Overall Study|Death|1|||
156533688|NCT01610687|565048885|FG000|Overall Study|Cannabis affecting job|1|||
156533689|NCT01610687|565048885|FG000|Overall Study|Felt more alter without study medication|1|||
156533690|NCT01294150|565048886|FG000|Overall Study|Physician Decision|2|||
156533691|NCT01294150|565048887|FG001|Overall Study|Physician Decision|2|||
156533692|NCT03675776|565048888|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
156533693|NCT03675776|565048889|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
156533694|NCT03675776|565048890|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
156533695|NCT03675776|565048888|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
156533696|NCT03675776|565048889|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
156533697|NCT03675776|565048890|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
156876542|NCT01868542|566307624|FG001|Overall Study|Unclassified|1|||
156876543|NCT00130247|566307625|FG000|Overall Study|Pregnancy|1|||
156876544|NCT00130247|566307626|FG001|Overall Study|Pregnancy|0|||
156876545|NCT00130247|566307625|FG000|Overall Study|Post-randomization exclusion|1|||
156876546|NCT00130247|566307626|FG001|Overall Study|Post-randomization exclusion|2|||
156876547|NCT00130247|566307625|FG000|Overall Study|Not compliant with DOT|0|||
156876548|NCT00130247|566307626|FG001|Overall Study|Not compliant with DOT|2|||
156876549|NCT00843284|566307629|FG000|Overall Study|Adverse Event|39|||
156876550|NCT00843284|566307629|FG000|Overall Study|Lack of Efficacy|5|||
156876551|NCT00843284|566307629|FG000|Overall Study|Lost to Follow-up|11|||
156876552|NCT00843284|566307629|FG000|Overall Study|Other|10|||
156876553|NCT00843284|566307629|FG000|Overall Study|Withdrawal by Subject|4|||
156455416|NCT02043678|564761654|FG001|Overall Study|Protocol Violation|0|||
156455417|NCT02043678|564761653|FG000|Overall Study|Deterioration of general conditions|1|||
156455418|NCT02043678|564761654|FG001|Overall Study|Deterioration of general conditions|1|||
156455419|NCT02043678|564761653|FG000|Overall Study|Logistical difficulties|2|||
156455420|NCT02043678|564761654|FG001|Overall Study|Logistical difficulties|0|||
156455421|NCT02043678|564761653|FG000|Overall Study|Non-compliance with study drug|3|||
156876554|NCT00843284|566307629|FG000|Overall Study|Death|3|||
156876555|NCT02160899|566307632|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
156876556|NCT02160899|566307633|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
156876557|NCT02160899|566307634|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
156876558|NCT02160899|566307635|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
156876559|NCT02160899|566307636|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
156876560|NCT02160899|566307637|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
156876561|NCT04129151|566307638|FG000|Overall Study|Adverse Event|1|||
156876562|NCT04129151|566307638|FG000|Overall Study|Disease Progression|7|||
156876563|NCT04129151|566307638|FG000|Overall Study|Study closure|1|||
156876564|NCT04473235|566307639|FG000|Overall Study|Lost to Follow-up|6|||
156876565|NCT04473235|566307640|FG001|Overall Study|Lost to Follow-up|5|||
156876566|NCT04473235|566307639|FG000|Overall Study|Declined continuation|2|||
156876567|NCT04473235|566307640|FG001|Overall Study|Declined continuation|0|||
156336356|NCT02400333|564329567|FG002|Overall Study|Protocol Violation|2|||
156455422|NCT02043678|564761654|FG001|Overall Study|Non-compliance with study drug|1|||
156455423|NCT02043678|564761653|FG000|Overall Study|Physician Decision|4|||
156455424|NCT02043678|564761654|FG001|Overall Study|Physician Decision|3|||
156455425|NCT02043678|564761653|FG000|Overall Study|Subject decision|0|||
156533698|NCT01093625|565048891|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
156533699|NCT01093625|565048892|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
156455426|NCT02043678|564761654|FG001|Overall Study|Subject decision|1|||
156455427|NCT02043678|564761653|FG000|Overall Study|Switching to other therapy|3|||
156533700|NCT01093625|565048891|FG000|2-Week Visit|Withdrawal by Subject|1|||
156533701|NCT01093625|565048892|FG001|2-Week Visit|Withdrawal by Subject|0|||
156533702|NCT01093625|565048891|FG000|1-Month Visit|Lost to Follow-up|2|||
156876568|NCT04473235|566307639|FG000|Overall Study|Physician Decision|1|||
156876569|NCT04473235|566307640|FG001|Overall Study|Physician Decision|1|||
156876570|NCT04473235|566307639|FG000|Overall Study|Protocol Violation|10|||
156876571|NCT04473235|566307640|FG001|Overall Study|Protocol Violation|6|||
156876572|NCT00798759|566307641|FG000|Overall Study|Adverse Event|3|||
156336357|NCT02400333|564329568|FG003|Overall Study|Protocol Violation|1|||
156533703|NCT01093625|565048892|FG001|1-Month Visit|Lost to Follow-up|0|||
156731885|NCT00570063|565765960|FG001|Overall Study|Sponsor's Decision|3|||
156731886|NCT00697463|565765961|FG000|Overall Study|Withdrawal by Subject|1|||
156731887|NCT03307252|565765962|FG000|Part 2, Period 1|Treatment not received|0|||
156731888|NCT03307252|565765963|FG001|Part 2, Period 1|Treatment not received|0|||
156731889|NCT03307252|565765964|FG002|Part 2, Period 1|Treatment not received|0|||
156731890|NCT03307252|565765965|FG003|Part 2, Period 1|Treatment not received|0|||
156731891|NCT03307252|565765966|FG004|Part 2, Period 1|Treatment not received|0|||
156731892|NCT03307252|565765967|FG005|Part 2, Period 1|Treatment not received|1|||
156731893|NCT03307252|565765968|FG006|Part 2, Period 1|Treatment not received|0|||
156731894|NCT03307252|565765969|FG007|Part 2, Period 1|Treatment not received|0|||
156731895|NCT03307252|565765970|FG008|Part 2, Period 1|Treatment not received|0|||
156731896|NCT03307252|565765971|FG009|Part 2, Period 1|Treatment not received|0|||
156731897|NCT03307252|565765972|FG010|Part 2, Period 1|Treatment not received|0|||
156731898|NCT03307252|565765962|FG000|Part 2, Period 3|Other than listed|0|||
156731899|NCT03307252|565765963|FG001|Part 2, Period 3|Other than listed|0|||
156731900|NCT03307252|565765964|FG002|Part 2, Period 3|Other than listed|0|||
156731901|NCT03307252|565765965|FG003|Part 2, Period 3|Other than listed|0|||
156731902|NCT03307252|565765966|FG004|Part 2, Period 3|Other than listed|1|||
156731903|NCT03307252|565765967|FG005|Part 2, Period 3|Other than listed|0|||
156731904|NCT03307252|565765968|FG006|Part 2, Period 3|Other than listed|0|||
156731905|NCT03307252|565765969|FG007|Part 2, Period 3|Other than listed|0|||
156731906|NCT03307252|565765970|FG008|Part 2, Period 3|Other than listed|0|||
156731907|NCT03307252|565765971|FG009|Part 2, Period 3|Other than listed|0|||
156731908|NCT03307252|565765972|FG010|Part 2, Period 3|Other than listed|0|||
156731909|NCT03307252|565765962|FG000|Part 2, Period 4|Other than listed|0|||
156731910|NCT03307252|565765963|FG001|Part 2, Period 4|Other than listed|0|||
156731911|NCT03307252|565765964|FG002|Part 2, Period 4|Other than listed|0|||
156731912|NCT03307252|565765965|FG003|Part 2, Period 4|Other than listed|0|||
156731913|NCT03307252|565765966|FG004|Part 2, Period 4|Other than listed|0|||
156731914|NCT03307252|565765967|FG005|Part 2, Period 4|Other than listed|0|||
156731915|NCT03307252|565765968|FG006|Part 2, Period 4|Other than listed|1|||
156731916|NCT03307252|565765969|FG007|Part 2, Period 4|Other than listed|0|||
156731917|NCT03307252|565765970|FG008|Part 2, Period 4|Other than listed|0|||
156731918|NCT03307252|565765971|FG009|Part 2, Period 4|Other than listed|0|||
156731919|NCT03307252|565765972|FG010|Part 2, Period 4|Other than listed|0|||
156731920|NCT03307252|565765962|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731921|NCT03307252|565765963|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731922|NCT03307252|565765964|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731923|NCT03307252|565765965|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731924|NCT03307252|565765966|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731925|NCT03307252|565765967|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731926|NCT03307252|565765968|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731927|NCT03307252|565765969|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731928|NCT03307252|565765970|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731929|NCT03307252|565765971|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731930|NCT03307252|565765972|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
156731931|NCT01554527|565765973|FG000|Overall Study|Withdrawal by Subject|1|||
156731932|NCT01554527|565765974|FG001|Overall Study|Withdrawal by Subject|0|||
156731933|NCT01554527|565765975|FG002|Overall Study|Withdrawal by Subject|3|||
156731934|NCT01554527|565765973|FG000|Overall Study|Lost to Follow-up|0|||
156731935|NCT01554527|565765974|FG001|Overall Study|Lost to Follow-up|0|||
156731936|NCT01554527|565765975|FG002|Overall Study|Lost to Follow-up|4|||
156731937|NCT01554527|565765973|FG000|Overall Study|Physician Decision|0|||
156731938|NCT01554527|565765974|FG001|Overall Study|Physician Decision|0|||
156731939|NCT01554527|565765975|FG002|Overall Study|Physician Decision|1|||
156731940|NCT03817229|565765978|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
156533704|NCT01093625|565048891|FG000|3-Month Visit|Lost to Follow-up|2|||
156731941|NCT03817229|565765979|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
156731942|NCT03817229|565765980|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
156731943|NCT03817229|565765981|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
156731944|NCT03817229|565765978|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
156731945|NCT03817229|565765979|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
156731946|NCT03817229|565765980|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
156731947|NCT03817229|565765981|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
156731948|NCT03817229|565765978|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
156533705|NCT01093625|565048892|FG001|3-Month Visit|Lost to Follow-up|0|||
156731949|NCT03817229|565765979|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
156731950|NCT03817229|565765980|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
156731951|NCT03817229|565765981|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
156731952|NCT03817229|565765978|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
156533706|NCT01093625|565048891|FG000|6-Month Visit|Withdrawal by Subject|6|||
156731953|NCT03817229|565765979|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
156731954|NCT03817229|565765980|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
156731955|NCT03817229|565765981|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
156731956|NCT03817229|565765978|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
156731957|NCT03817229|565765979|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
156731958|NCT03817229|565765980|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
156731959|NCT03817229|565765981|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
156731960|NCT03817229|565765978|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
156731961|NCT03817229|565765979|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
156731962|NCT03817229|565765980|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
156731963|NCT03817229|565765981|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
156731964|NCT03817229|565765978|FG000|Post-Intervention|Withdrawal by Subject|6|||
156336358|NCT02468674|564329569|FG000|Overall Study|Adverse Event|0|||
156336359|NCT02468674|564329570|FG001|Overall Study|Adverse Event|0|||
156336360|NCT02468674|564329571|FG002|Overall Study|Adverse Event|0|||
156336361|NCT02468674|564329572|FG003|Overall Study|Adverse Event|1|||
156336362|NCT02468674|564329573|FG004|Overall Study|Adverse Event|0|||
156336363|NCT02468674|564329574|FG005|Overall Study|Adverse Event|1|||
156336364|NCT02468674|564329575|FG006|Overall Study|Adverse Event|0|||
156336365|NCT02468674|564329576|FG007|Overall Study|Adverse Event|0|||
156336366|NCT02468674|564329577|FG008|Overall Study|Adverse Event|0|||
156336367|NCT02468674|564329569|FG000|Overall Study|Lost to Follow-up|1|||
156336368|NCT02468674|564329570|FG001|Overall Study|Lost to Follow-up|0|||
156336369|NCT02468674|564329571|FG002|Overall Study|Lost to Follow-up|0|||
156336370|NCT02468674|564329572|FG003|Overall Study|Lost to Follow-up|0|||
156336371|NCT02468674|564329573|FG004|Overall Study|Lost to Follow-up|0|||
156336372|NCT02468674|564329574|FG005|Overall Study|Lost to Follow-up|0|||
156336373|NCT02468674|564329575|FG006|Overall Study|Lost to Follow-up|0|||
156336374|NCT02468674|564329576|FG007|Overall Study|Lost to Follow-up|1|||
156336375|NCT02468674|564329577|FG008|Overall Study|Lost to Follow-up|1|||
156336376|NCT02468674|564329569|FG000|Overall Study|Physician Decision|0|||
156336377|NCT02468674|564329570|FG001|Overall Study|Physician Decision|0|||
156336378|NCT02468674|564329571|FG002|Overall Study|Physician Decision|0|||
156336379|NCT02468674|564329572|FG003|Overall Study|Physician Decision|0|||
156336380|NCT02468674|564329573|FG004|Overall Study|Physician Decision|0|||
156336381|NCT02468674|564329574|FG005|Overall Study|Physician Decision|0|||
156336382|NCT02468674|564329575|FG006|Overall Study|Physician Decision|1|||
156336383|NCT02468674|564329576|FG007|Overall Study|Physician Decision|0|||
156455428|NCT02043678|564761654|FG001|Overall Study|Switching to other therapy|2|||
156455429|NCT02043678|564761653|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
156455430|NCT02043678|564761654|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
156455431|NCT02043678|564761653|FG000|Overall Study|Missing|1|||
156731965|NCT03817229|565765979|FG001|Post-Intervention|Withdrawal by Subject|0|||
156731966|NCT03817229|565765980|FG002|Post-Intervention|Withdrawal by Subject|2|||
156731967|NCT03817229|565765981|FG003|Post-Intervention|Withdrawal by Subject|2|||
156731968|NCT03817229|565765978|FG000|Post-Intervention|Withdrawal by Study Team|3|||
156731969|NCT03817229|565765979|FG001|Post-Intervention|Withdrawal by Study Team|1|||
156731970|NCT03817229|565765980|FG002|Post-Intervention|Withdrawal by Study Team|1|||
156731971|NCT03817229|565765981|FG003|Post-Intervention|Withdrawal by Study Team|4|||
156731972|NCT03817229|565765978|FG000|Post-Intervention|Weaned from medication|3|||
156731973|NCT03817229|565765979|FG001|Post-Intervention|Weaned from medication|0|||
156731974|NCT03817229|565765980|FG002|Post-Intervention|Weaned from medication|2|||
156731975|NCT03817229|565765981|FG003|Post-Intervention|Weaned from medication|1|||
156731976|NCT03817229|565765978|FG000|Post-Intervention|Transferred care to another institution|1|||
156336384|NCT02468674|564329577|FG008|Overall Study|Physician Decision|0|||
156336385|NCT02468674|564329569|FG000|Overall Study|Patient/Guardian Decision|0|||
156336386|NCT02468674|564329570|FG001|Overall Study|Patient/Guardian Decision|0|||
156336387|NCT02468674|564329571|FG002|Overall Study|Patient/Guardian Decision|0|||
156336388|NCT02468674|564329572|FG003|Overall Study|Patient/Guardian Decision|0|||
156336389|NCT02468674|564329573|FG004|Overall Study|Patient/Guardian Decision|1|||
156336390|NCT02468674|564329574|FG005|Overall Study|Patient/Guardian Decision|0|||
156336391|NCT02468674|564329575|FG006|Overall Study|Patient/Guardian Decision|0|||
156336392|NCT02468674|564329576|FG007|Overall Study|Patient/Guardian Decision|2|||
156336393|NCT02468674|564329577|FG008|Overall Study|Patient/Guardian Decision|1|||
156336394|NCT02468674|564329569|FG000|Overall Study|Protocol Deviation|0|||
156455432|NCT02043678|564761654|FG001|Overall Study|Missing|0|||
156336395|NCT02468674|564329570|FG001|Overall Study|Protocol Deviation|0|||
156336396|NCT02468674|564329571|FG002|Overall Study|Protocol Deviation|0|||
156336397|NCT02468674|564329572|FG003|Overall Study|Protocol Deviation|0|||
156455433|NCT02043678|564761653|FG000|Overall Study|Adverse Event|0|||
156336398|NCT02468674|564329573|FG004|Overall Study|Protocol Deviation|0|||
156336399|NCT02468674|564329574|FG005|Overall Study|Protocol Deviation|0|||
156336400|NCT02468674|564329575|FG006|Overall Study|Protocol Deviation|0|||
156336401|NCT02468674|564329576|FG007|Overall Study|Protocol Deviation|1|||
156336402|NCT02468674|564329577|FG008|Overall Study|Protocol Deviation|1|||
156731977|NCT03817229|565765979|FG001|Post-Intervention|Transferred care to another institution|0|||
156731978|NCT03817229|565765980|FG002|Post-Intervention|Transferred care to another institution|0|||
156731979|NCT03817229|565765981|FG003|Post-Intervention|Transferred care to another institution|0|||
156731980|NCT03817229|565765978|FG000|Post-Intervention|Change in parental guardianship|0|||
156731981|NCT03817229|565765979|FG001|Post-Intervention|Change in parental guardianship|0|||
156731982|NCT03817229|565765980|FG002|Post-Intervention|Change in parental guardianship|1|||
156731983|NCT03817229|565765981|FG003|Post-Intervention|Change in parental guardianship|0|||
156731984|NCT03817229|565765978|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
156731985|NCT03817229|565765979|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
156731986|NCT03817229|565765980|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
156731987|NCT03817229|565765981|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
156731988|NCT03817229|565765978|FG000|Follow-up 1|Withdrawal by Subject|1|||
156731989|NCT03817229|565765979|FG001|Follow-up 1|Withdrawal by Subject|2|||
156731990|NCT03817229|565765980|FG002|Follow-up 1|Withdrawal by Subject|0|||
156731991|NCT03817229|565765981|FG003|Follow-up 1|Withdrawal by Subject|0|||
156731992|NCT03817229|565765978|FG000|Follow-up 1|Withdrawal by Study Team|3|||
156731993|NCT03817229|565765979|FG001|Follow-up 1|Withdrawal by Study Team|1|||
156731994|NCT03817229|565765980|FG002|Follow-up 1|Withdrawal by Study Team|0|||
156731995|NCT03817229|565765981|FG003|Follow-up 1|Withdrawal by Study Team|0|||
156731996|NCT03817229|565765978|FG000|Follow-up 1|Wean from medication|3|||
156731997|NCT03817229|565765979|FG001|Follow-up 1|Wean from medication|4|||
156731998|NCT03817229|565765980|FG002|Follow-up 1|Wean from medication|0|||
156731999|NCT03817229|565765981|FG003|Follow-up 1|Wean from medication|1|||
156732000|NCT03817229|565765978|FG000|Follow-up 1|Transferred care to another hospital|1|||
156732001|NCT03817229|565765979|FG001|Follow-up 1|Transferred care to another hospital|0|||
156732002|NCT03817229|565765980|FG002|Follow-up 1|Transferred care to another hospital|0|||
156732003|NCT03817229|565765981|FG003|Follow-up 1|Transferred care to another hospital|0|||
156732004|NCT03817229|565765978|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
156732005|NCT03817229|565765979|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
156732006|NCT03817229|565765980|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
156732007|NCT03817229|565765981|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
156732008|NCT03817229|565765978|FG000|Follow-up 2|Withdrawal by Subject|2|||
156732009|NCT03817229|565765979|FG001|Follow-up 2|Withdrawal by Subject|0|||
156732010|NCT03817229|565765980|FG002|Follow-up 2|Withdrawal by Subject|1|||
156732011|NCT03817229|565765981|FG003|Follow-up 2|Withdrawal by Subject|1|||
156732012|NCT03817229|565765978|FG000|Follow-up 2|Withdrawal by Study Team|2|||
156732013|NCT03817229|565765979|FG001|Follow-up 2|Withdrawal by Study Team|0|||
156732014|NCT03817229|565765980|FG002|Follow-up 2|Withdrawal by Study Team|1|||
156732015|NCT03817229|565765981|FG003|Follow-up 2|Withdrawal by Study Team|0|||
156732016|NCT03817229|565765978|FG000|Follow-up 2|Wean from medication|1|||
156732017|NCT03817229|565765979|FG001|Follow-up 2|Wean from medication|0|||
156732018|NCT03817229|565765980|FG002|Follow-up 2|Wean from medication|0|||
156732019|NCT03817229|565765981|FG003|Follow-up 2|Wean from medication|0|||
156732020|NCT03817229|565765978|FG000|Follow-up 2|Transferred care|0|||
156732021|NCT03817229|565765979|FG001|Follow-up 2|Transferred care|0|||
156732022|NCT03817229|565765980|FG002|Follow-up 2|Transferred care|1|||
156732023|NCT03817229|565765981|FG003|Follow-up 2|Transferred care|0|||
156732024|NCT02887183|565765982|FG000|Overall Study|Adverse Event|44|||
156732025|NCT02887183|565765982|FG000|Overall Study|Death|30|||
156732026|NCT02887183|565765982|FG000|Overall Study|Pregnancy|1|||
156732027|NCT02887183|565765982|FG000|Overall Study|Protocol Violation|6|||
156732028|NCT02887183|565765982|FG000|Overall Study|Technical Problems|2|||
156732029|NCT02887183|565765982|FG000|Overall Study|Lost to Follow-up|13|||
156732030|NCT02887183|565765982|FG000|Overall Study|Physician Decision|10|||
156732031|NCT02887183|565765982|FG000|Overall Study|Withdrawal by Subject|35|||
156533707|NCT01093625|565048892|FG001|6-Month Visit|Withdrawal by Subject|7|||
156732032|NCT01031680|565765983|FG000|Overall Study|Adverse Event|8|||
156732033|NCT01031680|565765984|FG001|Overall Study|Adverse Event|3|||
156732034|NCT01031680|565765983|FG000|Overall Study|Lost to Follow-up|2|||
156732035|NCT01031680|565765984|FG001|Overall Study|Lost to Follow-up|10|||
156732036|NCT01031680|565765983|FG000|Overall Study|Withdrawal by Subject|12|||
156732037|NCT01031680|565765984|FG001|Overall Study|Withdrawal by Subject|16|||
156732038|NCT01031680|565765983|FG000|Overall Study|Death|2|||
156732039|NCT01031680|565765984|FG001|Overall Study|Death|1|||
156732040|NCT01031680|565765983|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
156732041|NCT01031680|565765984|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
156732042|NCT01031680|565765983|FG000|Overall Study|Poor/Non-compliance|5|||
156732043|NCT01031680|565765984|FG001|Overall Study|Poor/Non-compliance|6|||
156732044|NCT01031680|565765983|FG000|Overall Study|Safety|1|||
156732045|NCT01031680|565765984|FG001|Overall Study|Safety|0|||
156732046|NCT01031680|565765983|FG000|Overall Study|Incorrect Enrolment|1|||
156732047|NCT01031680|565765984|FG001|Overall Study|Incorrect Enrolment|2|||
156732048|NCT01031680|565765983|FG000|Overall Study|Administrative Reason by Sponsor|0|||
156732049|NCT01031680|565765984|FG001|Overall Study|Administrative Reason by Sponsor|1|||
156533708|NCT01093625|565048891|FG000|6-Month Visit|Lost to Follow-up|2|||
156732050|NCT01031680|565765983|FG000|Overall Study|Various|0|||
156732051|NCT01031680|565765984|FG001|Overall Study|Various|2|||
156732052|NCT01186692|565765987|FG000|Overall Study|Not Catheterized|11|||
156732053|NCT01186692|565765987|FG000|Overall Study|Futher testing contraindicated implant|19|||
156732054|NCT01186692|565765987|FG000|Overall Study|Adverse Event|2|||
156732055|NCT03319732|565765988|FG000|Overall Study|Adverse Event|40|||
156732056|NCT03319732|565765988|FG000|Overall Study|Withdrawal by Subject|50|||
156732057|NCT03319732|565765988|FG000|Overall Study|MS relapse|10|||
156732058|NCT03319732|565765988|FG000|Overall Study|reason not specified|5|||
156455434|NCT02043678|564761654|FG001|Overall Study|Adverse Event|1|||
156732059|NCT01266291|565765990|FG000|Overall Study|Adverse Event|1|||
156732060|NCT02702388|565765991|FG000|Overall Study|Disease Progression|18|||
156732061|NCT02702388|565765992|FG001|Overall Study|Disease Progression|25|||
156732062|NCT02702388|565765991|FG000|Overall Study|Withdrawal by Subject|9|||
156732063|NCT02702388|565765992|FG001|Overall Study|Withdrawal by Subject|7|||
156732064|NCT02702388|565765991|FG000|Overall Study|Adverse Event|11|||
156732065|NCT02702388|565765992|FG001|Overall Study|Adverse Event|15|||
156732066|NCT02702388|565765991|FG000|Overall Study|Other|2|||
156732067|NCT02702388|565765992|FG001|Overall Study|Other|4|||
156732068|NCT04250350|565767525|FG000|Overall Study|Withdrawal by Subject|13|||
156732069|NCT04250350|565767525|FG000|Overall Study|Lost to Follow-up|8|||
156732070|NCT04250350|565767525|FG000|Overall Study|Adverse Event|5|||
156732071|NCT04250350|565767525|FG000|Overall Study|Lack of Efficacy|4|||
156732072|NCT04250350|565767525|FG000|Overall Study|Physician Decision|1|||
156732073|NCT04250350|565767525|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
156732074|NCT00679029|565767529|FG000|Overall Study|Adverse Event|3|||
156732075|NCT00679029|565767529|FG000|Overall Study|Withdrawal by Subject|1|||
156732076|NCT00679029|565767529|FG000|Overall Study|Lost to Follow-up|1|||
156732077|NCT00956592|565767533|FG000|Overall Study|Protocol Violation|1|||
156732078|NCT00956592|565767534|FG001|Overall Study|Protocol Violation|3|||
156732079|NCT00160706|565767535|FG000|Overall Study|Adverse Event|53|||
156732080|NCT00160706|565767535|FG000|Overall Study|Adverse Event and Other Reason|105|||
156732081|NCT00160706|565767535|FG000|Overall Study|Protocol Violation|3|||
156732082|NCT00160706|565767535|FG000|Overall Study|Withdrawal by Subject|41|||
156732083|NCT00160706|565767535|FG000|Overall Study|Withdrawal by Subject and Other|12|||
156732084|NCT00160706|565767535|FG000|Overall Study|Physician Decision|10|||
156732085|NCT00160706|565767535|FG000|Overall Study|Physician Decision and Other|3|||
156732086|NCT00160706|565767535|FG000|Overall Study|Lost to Follow-up|4|||
156732087|NCT00160706|565767535|FG000|Overall Study|Lost to Follow-up and Other|1|||
156732088|NCT00160706|565767535|FG000|Overall Study|Lack of Efficacy|42|||
156732089|NCT00160706|565767535|FG000|Overall Study|Lack of Efficacy and Other|1|||
156732090|NCT00160706|565767535|FG000|Overall Study|Other Reason|11|||
156732091|NCT02162719|565767536|FG000|Overall Study|Death|41|||
156455435|NCT04137367|564761657|FG000|Overall Study|Lost to Follow-up|8|||
156732092|NCT02162719|565767537|FG001|Overall Study|Death|46|||
156732093|NCT02162719|565767536|FG000|Overall Study|Lost to Follow-up|1|||
156732094|NCT02162719|565767537|FG001|Overall Study|Lost to Follow-up|3|||
156732095|NCT02162719|565767536|FG000|Overall Study|Disease Progression|2|||
156732096|NCT02162719|565767537|FG001|Overall Study|Disease Progression|1|||
156732097|NCT02162719|565767536|FG000|Overall Study|Withdrawal by Subject|8|||
156732098|NCT02162719|565767537|FG001|Overall Study|Withdrawal by Subject|2|||
156732099|NCT02162719|565767536|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
156732100|NCT02162719|565767537|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
156732101|NCT03214380|565767538|FG000|Lead-in|Adverse Event|3|||
156732102|NCT03214380|565767539|FG001|Lead-in|Adverse Event|0|||
156732103|NCT03214380|565767540|FG002|Lead-in|Adverse Event|0|||
156732104|NCT03214380|565767541|FG003|Lead-in|Adverse Event|1|||
156732105|NCT03214380|565767542|FG004|Lead-in|Adverse Event|0|||
156732106|NCT03214380|565767543|FG005|Lead-in|Adverse Event|0|||
156732107|NCT03214380|565767538|FG000|Lead-in|Lost to Follow-up|4|||
156732108|NCT03214380|565767539|FG001|Lead-in|Lost to Follow-up|0|||
156732109|NCT03214380|565767540|FG002|Lead-in|Lost to Follow-up|0|||
156732110|NCT03214380|565767541|FG003|Lead-in|Lost to Follow-up|1|||
156732111|NCT03214380|565767542|FG004|Lead-in|Lost to Follow-up|0|||
156732112|NCT03214380|565767543|FG005|Lead-in|Lost to Follow-up|0|||
156732113|NCT03214380|565767538|FG000|Lead-in|Eligibility Criteria|3|||
156732114|NCT03214380|565767539|FG001|Lead-in|Eligibility Criteria|0|||
156732115|NCT03214380|565767540|FG002|Lead-in|Eligibility Criteria|0|||
156732116|NCT03214380|565767541|FG003|Lead-in|Eligibility Criteria|0|||
156732117|NCT03214380|565767542|FG004|Lead-in|Eligibility Criteria|0|||
156732118|NCT03214380|565767543|FG005|Lead-in|Eligibility Criteria|0|||
156732119|NCT03214380|565767538|FG000|Lead-in|Physician Decision|6|||
156732120|NCT03214380|565767539|FG001|Lead-in|Physician Decision|0|||
156732121|NCT03214380|565767540|FG002|Lead-in|Physician Decision|0|||
156732122|NCT03214380|565767541|FG003|Lead-in|Physician Decision|0|||
156732123|NCT03214380|565767542|FG004|Lead-in|Physician Decision|0|||
156732124|NCT03214380|565767543|FG005|Lead-in|Physician Decision|0|||
156732125|NCT03214380|565767538|FG000|Lead-in|Protocol Deviation|7|||
156455436|NCT04137367|564761658|FG001|Overall Study|Lost to Follow-up|6|||
156732126|NCT03214380|565767539|FG001|Lead-in|Protocol Deviation|0|||
156732127|NCT03214380|565767540|FG002|Lead-in|Protocol Deviation|0|||
156732128|NCT03214380|565767541|FG003|Lead-in|Protocol Deviation|3|||
156732129|NCT03214380|565767542|FG004|Lead-in|Protocol Deviation|0|||
156732130|NCT03214380|565767543|FG005|Lead-in|Protocol Deviation|0|||
156732131|NCT03214380|565767538|FG000|Lead-in|Withdrawal by Subject|41|||
156336403|NCT01644565|564329584|FG000|Overall Study|Undisclosed Medical History|1|||
156336404|NCT01644565|564329585|FG001|Overall Study|Undisclosed Medical History|0|||
156336405|NCT01644565|564329586|FG002|Overall Study|Undisclosed Medical History|0|||
156336406|NCT01644565|564329587|FG003|Overall Study|Undisclosed Medical History|0|||
156336407|NCT01644565|564329588|FG004|Overall Study|Undisclosed Medical History|0|||
156336408|NCT01644565|564329589|FG005|Overall Study|Undisclosed Medical History|0|||
156336409|NCT01644565|564329590|FG006|Overall Study|Undisclosed Medical History|0|||
156336410|NCT01644565|564329591|FG007|Overall Study|Undisclosed Medical History|0|||
156336411|NCT01644565|564329592|FG008|Overall Study|Undisclosed Medical History|0|||
156336412|NCT01644565|564329584|FG000|Overall Study|Lost to Follow-up|0|||
156336413|NCT01644565|564329585|FG001|Overall Study|Lost to Follow-up|0|||
156336414|NCT01644565|564329586|FG002|Overall Study|Lost to Follow-up|0|||
156336415|NCT01644565|564329587|FG003|Overall Study|Lost to Follow-up|1|||
156336416|NCT01644565|564329588|FG004|Overall Study|Lost to Follow-up|0|||
156336417|NCT01644565|564329589|FG005|Overall Study|Lost to Follow-up|0|||
156336418|NCT01644565|564329590|FG006|Overall Study|Lost to Follow-up|0|||
156336419|NCT01644565|564329591|FG007|Overall Study|Lost to Follow-up|2|||
156336420|NCT01644565|564329592|FG008|Overall Study|Lost to Follow-up|0|||
156336421|NCT01644565|564329584|FG000|Overall Study|Family emergency|0|||
156732132|NCT03214380|565767539|FG001|Lead-in|Withdrawal by Subject|0|||
156732133|NCT03214380|565767540|FG002|Lead-in|Withdrawal by Subject|0|||
156336422|NCT01644565|564329585|FG001|Overall Study|Family emergency|0|||
156336423|NCT01644565|564329586|FG002|Overall Study|Family emergency|0|||
156336424|NCT01644565|564329587|FG003|Overall Study|Family emergency|0|||
156336425|NCT01644565|564329588|FG004|Overall Study|Family emergency|1|||
156336426|NCT01644565|564329589|FG005|Overall Study|Family emergency|0|||
156336427|NCT01644565|564329590|FG006|Overall Study|Family emergency|0|||
156336428|NCT01644565|564329591|FG007|Overall Study|Family emergency|0|||
156336429|NCT01644565|564329592|FG008|Overall Study|Family emergency|0|||
156336430|NCT01644565|564329584|FG000|Overall Study|Relocation|0|||
156336431|NCT01644565|564329585|FG001|Overall Study|Relocation|0|||
156336432|NCT01644565|564329586|FG002|Overall Study|Relocation|0|||
156336433|NCT01644565|564329587|FG003|Overall Study|Relocation|0|||
156336434|NCT01644565|564329588|FG004|Overall Study|Relocation|0|||
156336435|NCT01644565|564329589|FG005|Overall Study|Relocation|0|||
156336436|NCT01644565|564329590|FG006|Overall Study|Relocation|0|||
156336437|NCT01644565|564329591|FG007|Overall Study|Relocation|0|||
156336438|NCT01644565|564329592|FG008|Overall Study|Relocation|1|||
156336439|NCT01687998|564329593|FG000|Overall Study|Withdrawal by Subject|49|||
156336440|NCT01687998|564329594|FG001|Overall Study|Withdrawal by Subject|51|||
156533709|NCT01093625|565048892|FG001|6-Month Visit|Lost to Follow-up|2|||
156533710|NCT01093625|565048891|FG000|1-Year Visit|Lost to Follow-up|5|||
156732134|NCT03214380|565767541|FG003|Lead-in|Withdrawal by Subject|14|||
156732135|NCT03214380|565767542|FG004|Lead-in|Withdrawal by Subject|0|||
156732136|NCT03214380|565767543|FG005|Lead-in|Withdrawal by Subject|0|||
156732137|NCT03214380|565767538|FG000|Lead-in|Family Emergency|1|||
156732138|NCT03214380|565767539|FG001|Lead-in|Family Emergency|0|||
156336441|NCT01687998|564329593|FG000|Overall Study|Known to be Alive at Study End|54|||
156336442|NCT01687998|564329594|FG001|Overall Study|Known to be Alive at Study End|62|||
156336443|NCT01687998|564329593|FG000|Overall Study|Lost to Follow-up|9|||
156336444|NCT01687998|564329594|FG001|Overall Study|Lost to Follow-up|7|||
156336445|NCT00443261|564329595|FG000|Overall Study|Death|1|||
156336446|NCT01663532|564329596|FG000|Overall Study|Lost to Follow-up|9|||
156336447|NCT01663532|564329597|FG001|Overall Study|Lost to Follow-up|10|||
156336448|NCT01663532|564329596|FG000|Overall Study|Adverse Event|7|||
156336449|NCT01663532|564329597|FG001|Overall Study|Adverse Event|13|||
156336450|NCT01663532|564329596|FG000|Overall Study|Met Withdrawal Criteria|7|||
156336451|NCT01663532|564329597|FG001|Overall Study|Met Withdrawal Criteria|6|||
156336452|NCT01663532|564329596|FG000|Overall Study|Physician Decision|1|||
156336453|NCT01663532|564329597|FG001|Overall Study|Physician Decision|1|||
156336454|NCT01663532|564329596|FG000|Overall Study|Withdrawal by Subject|35|||
156336455|NCT01663532|564329597|FG001|Overall Study|Withdrawal by Subject|17|||
156336456|NCT01663532|564329596|FG000|Overall Study|Lack of Efficacy|15|||
156336457|NCT01663532|564329597|FG001|Overall Study|Lack of Efficacy|60|||
156533711|NCT01093625|565048892|FG001|1-Year Visit|Lost to Follow-up|3|||
156732139|NCT03214380|565767540|FG002|Lead-in|Family Emergency|0|||
156732140|NCT03214380|565767541|FG003|Lead-in|Family Emergency|0|||
156732141|NCT03214380|565767542|FG004|Lead-in|Family Emergency|0|||
156876573|NCT00798759|566307642|FG001|Overall Study|Adverse Event|3|||
156336458|NCT01560403|564329601|FG000|Overall Study|Lost to Follow-up|0|||
156336459|NCT01560403|564329602|FG001|Overall Study|Lost to Follow-up|1|||
156336460|NCT00354744|564329603|FG000|Overall Study|Adverse Event|2|||
156336461|NCT00354744|564329603|FG000|Overall Study|Death|2|||
156336462|NCT00354744|564329603|FG000|Overall Study|Lack of Efficacy|11|||
156336463|NCT00354744|564329603|FG000|Overall Study|Lost to Follow-up|2|||
156732142|NCT03214380|565767543|FG005|Lead-in|Family Emergency|0|||
156732143|NCT03214380|565767538|FG000|Lead-in|Natural Disaster|9|||
156732144|NCT03214380|565767539|FG001|Lead-in|Natural Disaster|0|||
156732145|NCT03214380|565767540|FG002|Lead-in|Natural Disaster|0|||
156732146|NCT03214380|565767541|FG003|Lead-in|Natural Disaster|0|||
156732147|NCT03214380|565767542|FG004|Lead-in|Natural Disaster|0|||
156732148|NCT03214380|565767543|FG005|Lead-in|Natural Disaster|0|||
156732149|NCT03214380|565767538|FG000|Lead-in|Non Compliance|1|||
156732150|NCT03214380|565767539|FG001|Lead-in|Non Compliance|0|||
156732151|NCT03214380|565767540|FG002|Lead-in|Non Compliance|0|||
156732152|NCT03214380|565767541|FG003|Lead-in|Non Compliance|0|||
156732153|NCT03214380|565767542|FG004|Lead-in|Non Compliance|0|||
156732154|NCT03214380|565767543|FG005|Lead-in|Non Compliance|0|||
156732155|NCT03214380|565767538|FG000|Lead-in|Participant Schedule|2|||
156732156|NCT03214380|565767539|FG001|Lead-in|Participant Schedule|0|||
156732157|NCT03214380|565767540|FG002|Lead-in|Participant Schedule|0|||
156732158|NCT03214380|565767541|FG003|Lead-in|Participant Schedule|0|||
156732159|NCT03214380|565767542|FG004|Lead-in|Participant Schedule|0|||
156732160|NCT03214380|565767543|FG005|Lead-in|Participant Schedule|0|||
156732161|NCT03214380|565767538|FG000|Treatment Period|Adverse Event|0|||
156732162|NCT03214380|565767539|FG001|Treatment Period|Adverse Event|1|||
156732163|NCT03214380|565767540|FG002|Treatment Period|Adverse Event|1|||
156732164|NCT03214380|565767541|FG003|Treatment Period|Adverse Event|0|||
156732165|NCT03214380|565767542|FG004|Treatment Period|Adverse Event|1|||
156732166|NCT03214380|565767543|FG005|Treatment Period|Adverse Event|0|||
156732167|NCT03214380|565767538|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
156732168|NCT03214380|565767539|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
156732169|NCT03214380|565767540|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
156732170|NCT03214380|565767541|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
156732171|NCT03214380|565767542|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
156732172|NCT03214380|565767543|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
156732173|NCT03214380|565767538|FG000|Treatment Period|Withdrawal by Subject|0|||
156732174|NCT03214380|565767539|FG001|Treatment Period|Withdrawal by Subject|10|||
156732175|NCT03214380|565767540|FG002|Treatment Period|Withdrawal by Subject|8|||
156732176|NCT03214380|565767541|FG003|Treatment Period|Withdrawal by Subject|0|||
156732177|NCT03214380|565767542|FG004|Treatment Period|Withdrawal by Subject|7|||
156732178|NCT03214380|565767543|FG005|Treatment Period|Withdrawal by Subject|11|||
156732179|NCT03214380|565767538|FG000|Treatment Period|Death|0|||
156732180|NCT03214380|565767539|FG001|Treatment Period|Death|1|||
156732181|NCT03214380|565767540|FG002|Treatment Period|Death|2|||
156732182|NCT03214380|565767541|FG003|Treatment Period|Death|0|||
156732183|NCT03214380|565767542|FG004|Treatment Period|Death|0|||
156732184|NCT03214380|565767543|FG005|Treatment Period|Death|0|||
156732185|NCT03214380|565767538|FG000|Treatment Period|Lost to Follow-up|0|||
156876574|NCT00798759|566307641|FG000|Overall Study|Lost to Follow-up|1|||
156336464|NCT00354744|564329603|FG000|Overall Study|Physician Decision|11|||
156455437|NCT04137367|564761659|FG002|Overall Study|Lost to Follow-up|4|||
156455438|NCT05144009|564761660|FG000|Overall Study|Lost to Follow-up|0|||
156455439|NCT05144009|564761661|FG001|Overall Study|Lost to Follow-up|1|||
156455440|NCT05144009|564761660|FG000|Overall Study|Study Termination by the Sponsor|11|||
156455441|NCT05144009|564761661|FG001|Overall Study|Study Termination by the Sponsor|11|||
156455442|NCT05144009|564761660|FG000|Overall Study|Disease Progression|1|||
156455443|NCT05144009|564761661|FG001|Overall Study|Disease Progression|0|||
156455444|NCT05144009|564761660|FG000|Overall Study|Participant Decision|0|||
156455445|NCT05144009|564761661|FG001|Overall Study|Participant Decision|2|||
156455446|NCT05144009|564761660|FG000|Overall Study|Death|5|||
156455447|NCT05144009|564761661|FG001|Overall Study|Death|10|||
156455448|NCT04307355|564761662|FG000|Overall Study|Non-Compliance|3|||
156455449|NCT04307355|564761663|FG001|Overall Study|Non-Compliance|3|||
156455450|NCT04307355|564761664|FG002|Overall Study|Non-Compliance|0|||
156455451|NCT05269667|564761667|FG000|Overall Study|Study Terminated by Sponsor|4|||
156455452|NCT01175356|564761672|FG000|Overall Study|Death|1|||
156455453|NCT01175356|564761672|FG000|Overall Study|Lack of Efficacy|12|||
156455454|NCT01175356|564761672|FG000|Overall Study|Lost to Follow-up|1|||
156455455|NCT01175356|564761672|FG000|Overall Study|Physician Decision|23|||
156455456|NCT01175356|564761672|FG000|Overall Study|Ineligible|1|||
156455457|NCT01175356|564761672|FG000|Overall Study|Treatment Slot Not Available|18|||
156455458|NCT01175356|564761672|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
156732186|NCT03214380|565767539|FG001|Treatment Period|Lost to Follow-up|6|||
156732187|NCT03214380|565767540|FG002|Treatment Period|Lost to Follow-up|3|||
156732188|NCT03214380|565767541|FG003|Treatment Period|Lost to Follow-up|0|||
156732189|NCT03214380|565767542|FG004|Treatment Period|Lost to Follow-up|0|||
156732190|NCT03214380|565767543|FG005|Treatment Period|Lost to Follow-up|0|||
156732191|NCT03214380|565767538|FG000|Treatment Period|Participant schedule|0|||
156732192|NCT03214380|565767539|FG001|Treatment Period|Participant schedule|0|||
156732193|NCT03214380|565767540|FG002|Treatment Period|Participant schedule|1|||
156732194|NCT03214380|565767541|FG003|Treatment Period|Participant schedule|0|||
156455459|NCT01175356|564761672|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
156455460|NCT01175356|564761672|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
156533712|NCT02608879|565048893|FG000|Overall Study|Lost to Follow-up|1|||
156455461|NCT01175356|564761672|FG000|Overall Study|Inadequate stem cell for transplant|1|||
156455462|NCT01175356|564761672|FG000|Overall Study|Initiation other tx prior to completion|9|||
156455463|NCT05792085|564761673|FG000|Overall Study|Death|0|||
156455464|NCT05792085|564761674|FG001|Overall Study|Death|0|||
156455465|NCT05792085|564761675|FG002|Overall Study|Death|0|||
156455466|NCT05792085|564761676|FG003|Overall Study|Death|0|||
156455467|NCT05792085|564761677|FG004|Overall Study|Death|1|||
156455468|NCT04898673|564761678|FG000|Overall Study|Screenfail|1|||
156455469|NCT04898673|564761679|FG001|Overall Study|Screenfail|0|||
156455470|NCT04797897|564761680|FG000|Overall Study|Study Termination by Sponsor|1|||
156455471|NCT04797897|564761681|FG001|Overall Study|Study Termination by Sponsor|1|||
156455472|NCT03628924|564763112|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
156455473|NCT03628924|564763113|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
156455474|NCT03628924|564763114|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
156455475|NCT03628924|564763115|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
156455476|NCT03628924|564763116|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
156455477|NCT03628924|564763117|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
156455478|NCT03628924|564763118|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
156455479|NCT03628924|564763112|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156455480|NCT03628924|564763113|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156455481|NCT03628924|564763114|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
156455482|NCT03628924|564763115|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156796642|NCT00363298|566009621|FG000|First Study Week|Lack of Efficacy|6|||
156796643|NCT00363298|566009622|FG001|First Study Week|Lack of Efficacy|5|||
156796644|NCT00363298|566009621|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
156796645|NCT00363298|566009622|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
156796646|NCT03332056|566009629|FG000|Overall Study|Incomplete questionnaires|8|||
156796647|NCT03332056|566009630|FG001|Overall Study|Incomplete questionnaires|9|||
156796648|NCT03332056|566009629|FG000|Overall Study|Passed stone prior to surgery date|1|||
156796649|NCT03332056|566009630|FG001|Overall Study|Passed stone prior to surgery date|0|||
156796650|NCT03332056|566009629|FG000|Overall Study|Did not require a ureteral stent|0|||
156796651|NCT03332056|566009630|FG001|Overall Study|Did not require a ureteral stent|1|||
156796652|NCT00730327|566009631|FG000|Overall Study|Lost to Follow-up|14|||
156796653|NCT00730327|566009632|FG001|Overall Study|Lost to Follow-up|16|||
156796654|NCT00730327|566009631|FG000|Overall Study|Adverse Event|8|||
156796655|NCT00730327|566009632|FG001|Overall Study|Adverse Event|1|||
156796656|NCT00730327|566009631|FG000|Overall Study|Withdrawal by Subject|3|||
156796657|NCT00730327|566009632|FG001|Overall Study|Withdrawal by Subject|13|||
156796658|NCT00730327|566009631|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
156796659|NCT00730327|566009632|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
156796660|NCT02989857|566009638|FG000|Randomization Phase|Not Treated|3|||
156796661|NCT02989857|566009639|FG001|Randomization Phase|Not Treated|2|||
156796662|NCT02989857|566009640|FG002|Randomization Phase|Not Treated|0|||
156796663|NCT00688740|566009641|FG000|Overall Study|Adverse Event|45|||
156796664|NCT00688740|566009642|FG001|Overall Study|Adverse Event|8|||
156796665|NCT00688740|566009641|FG000|Overall Study|Death|2|||
156796666|NCT00688740|566009642|FG001|Overall Study|Death|2|||
156796667|NCT00688740|566009641|FG000|Overall Study|Lost to Follow-up|0|||
156796668|NCT00688740|566009642|FG001|Overall Study|Lost to Follow-up|1|||
156455483|NCT03628924|564763116|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156455484|NCT03628924|564763117|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156455485|NCT03628924|564763118|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156455486|NCT03628924|564763112|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
156455487|NCT03628924|564763113|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
156455488|NCT03628924|564763114|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
156455489|NCT03628924|564763115|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
156455490|NCT03628924|564763116|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
156455491|NCT03628924|564763117|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
156455492|NCT03628924|564763118|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
156455493|NCT03628924|564763112|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156455494|NCT03628924|564763113|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
156455495|NCT03628924|564763114|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156455496|NCT03628924|564763115|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156796669|NCT00688740|566009641|FG000|Overall Study|Consent Withdrawn|17|||
156796670|NCT00688740|566009642|FG001|Overall Study|Consent Withdrawn|17|||
156796671|NCT00688740|566009641|FG000|Overall Study|Breast Cancer Relapse|1|||
156796672|NCT00688740|566009642|FG001|Overall Study|Breast Cancer Relapse|4|||
156796673|NCT00688740|566009641|FG000|Overall Study|Violation of Inclusion Criteria|1|||
156796674|NCT00688740|566009642|FG001|Overall Study|Violation of Inclusion Criteria|3|||
156796675|NCT00095576|566009643|FG000|Overall Study|Adverse Event|5|||
156796676|NCT00095576|566009644|FG001|Overall Study|Adverse Event|3|||
156796677|NCT00095576|566009643|FG000|Overall Study|Lost to Follow-up|233|||
156732195|NCT03214380|565767542|FG004|Treatment Period|Participant schedule|0|||
156732196|NCT03214380|565767543|FG005|Treatment Period|Participant schedule|0|||
156732197|NCT03214380|565767538|FG000|Treatment Period|Treatment Interruption|0|||
156732198|NCT03214380|565767539|FG001|Treatment Period|Treatment Interruption|0|||
156732199|NCT03214380|565767540|FG002|Treatment Period|Treatment Interruption|1|||
156732200|NCT03214380|565767541|FG003|Treatment Period|Treatment Interruption|0|||
156732201|NCT03214380|565767542|FG004|Treatment Period|Treatment Interruption|0|||
156732202|NCT03214380|565767543|FG005|Treatment Period|Treatment Interruption|0|||
156732203|NCT03692325|565767546|FG000|Overall Study|Adverse Event|2|||
156455497|NCT03628924|564763116|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156455498|NCT03628924|564763117|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156455499|NCT03628924|564763118|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156455500|NCT03628924|564763112|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
156455501|NCT03628924|564763113|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
156732204|NCT03692325|565767546|FG000|Overall Study|Progression/Recurrence|2|||
156732205|NCT02817516|565767547|FG000|Overall Study|Other|0|||
156732206|NCT02817516|565767548|FG001|Overall Study|Other|0|||
156732207|NCT02817516|565767549|FG002|Overall Study|Other|1|||
156732208|NCT02817516|565767550|FG003|Overall Study|Other|0|||
156732209|NCT01920958|565767552|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
156732210|NCT00083759|565767556|FG000|Overall Study|Adverse Event|5|||
156732211|NCT00083759|565767557|FG001|Overall Study|Adverse Event|3|||
156732212|NCT00083759|565767556|FG000|Overall Study|Lost to Follow-up|1|||
156732213|NCT00083759|565767557|FG001|Overall Study|Lost to Follow-up|0|||
156732214|NCT00083759|565767556|FG000|Overall Study|Death|1|||
156732215|NCT00083759|565767557|FG001|Overall Study|Death|1|||
156732216|NCT00083759|565767556|FG000|Overall Study|Inadequate Therapeutic Response|32|||
156732217|NCT00083759|565767557|FG001|Overall Study|Inadequate Therapeutic Response|35|||
156732218|NCT00083759|565767556|FG000|Overall Study|Subject Withdrew Consent|2|||
156732219|NCT00083759|565767557|FG001|Overall Study|Subject Withdrew Consent|2|||
156732220|NCT00083759|565767556|FG000|Overall Study|Non-Compliance|1|||
156796678|NCT00095576|566009644|FG001|Overall Study|Lost to Follow-up|229|||
156796679|NCT00095576|566009643|FG000|Overall Study|Protocol Violation|1|||
156796680|NCT00095576|566009644|FG001|Overall Study|Protocol Violation|0|||
156796681|NCT00095576|566009643|FG000|Overall Study|Withdrawal by Subject|34|||
156796682|NCT00095576|566009644|FG001|Overall Study|Withdrawal by Subject|47|||
156796683|NCT00095576|566009643|FG000|Overall Study|Option to switch to a rollover study|1097|||
156455502|NCT03628924|564763114|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
156455503|NCT03628924|564763115|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
156455504|NCT03628924|564763116|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
156455505|NCT03628924|564763117|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
156455506|NCT03628924|564763118|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
156455507|NCT03628924|564763112|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
156455508|NCT03628924|564763113|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
156455509|NCT03628924|564763114|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
156455510|NCT03628924|564763115|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
156455511|NCT03628924|564763116|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
156455512|NCT03628924|564763117|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
156455513|NCT03628924|564763118|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
156455514|NCT03628924|564763112|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
156455515|NCT03628924|564763113|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
156455516|NCT03628924|564763114|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
156455517|NCT03628924|564763115|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
156455518|NCT03628924|564763116|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
156455519|NCT03628924|564763117|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
156455520|NCT03628924|564763118|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
156455521|NCT03628924|564763112|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
156455522|NCT03628924|564763113|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
156455523|NCT03628924|564763114|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
156455524|NCT03628924|564763115|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
156732221|NCT00083759|565767557|FG001|Overall Study|Non-Compliance|0|||
156732222|NCT00083759|565767556|FG000|Overall Study|Sponsor's Discretion|28|||
156732223|NCT00083759|565767557|FG001|Overall Study|Sponsor's Discretion|29|||
156732224|NCT00083759|565767556|FG000|Overall Study|Other|14|||
156732225|NCT00083759|565767557|FG001|Overall Study|Other|13|||
156796684|NCT00095576|566009644|FG001|Overall Study|Option to switch to a rollover study|1099|||
156732226|NCT01089608|565767560|FG000|Overall Study|Adverse Event|0|||
156796685|NCT00095576|566009643|FG000|Overall Study|Site terminated|75|||
156732227|NCT01089608|565767561|FG001|Overall Study|Adverse Event|4|||
156732228|NCT01089608|565767560|FG000|Overall Study|Lost to Follow-up|0|||
156796686|NCT00095576|566009644|FG001|Overall Study|Site terminated|67|||
156796687|NCT00095576|566009643|FG000|Overall Study|Subject moved|30|||
156796688|NCT00095576|566009644|FG001|Overall Study|Subject moved|36|||
156455525|NCT03628924|564763116|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
156455526|NCT03628924|564763117|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
156455527|NCT03628924|564763118|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
156455528|NCT03628924|564763112|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
156455529|NCT03628924|564763113|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
156455530|NCT03628924|564763114|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
156455531|NCT03628924|564763115|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
156732229|NCT01089608|565767561|FG001|Overall Study|Lost to Follow-up|2|||
156732230|NCT00729157|565767562|FG000|Overall Study|Withdrawal by Subject|1|||
156732231|NCT03521115|565767570|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
156732232|NCT03521115|565767571|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
156732233|NCT03521115|565767570|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
156732234|NCT03521115|565767571|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
156455532|NCT03628924|564763116|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
156455533|NCT03628924|564763117|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
156455534|NCT03628924|564763118|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
156455535|NCT03628924|564763112|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
156455536|NCT03628924|564763113|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
156455537|NCT03628924|564763114|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
156455538|NCT03628924|564763115|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
156455539|NCT03628924|564763116|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
156455540|NCT03628924|564763117|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
156455541|NCT03628924|564763118|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
156455542|NCT02191618|564763126|FG000|Overall Study|Withdrawal by Subject|3|||
156455543|NCT02191618|564763126|FG000|Overall Study|Missed Visit|4|||
156732235|NCT03655470|565767572|FG000|Overall Study|Lost to Follow-up|6|||
156732236|NCT03655470|565767573|FG001|Overall Study|Lost to Follow-up|7|||
156732237|NCT05481125|565767574|FG000|Overall Study|Adverse Event|1|||
156732238|NCT05481125|565767575|FG001|Overall Study|Adverse Event|0|||
156732239|NCT05481125|565767574|FG000|Overall Study|Lost to Follow-up|0|||
156732240|NCT05481125|565767575|FG001|Overall Study|Lost to Follow-up|1|||
156732241|NCT05481125|565767574|FG000|Overall Study|Withdrawal by Subject|0|||
156732242|NCT05481125|565767575|FG001|Overall Study|Withdrawal by Subject|1|||
156732243|NCT02244463|565767578|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
156455544|NCT02683447|564763128|FG000|Overall Study|Lost to Follow-up|2|||
156455545|NCT02489903|564763132|FG000|Screening|Screen Failure|24|||
156455546|NCT02489903|564763133|FG001|Screening|Screen Failure|0|||
156455547|NCT02489903|564763134|FG002|Screening|Screen Failure|0|||
156732244|NCT02244463|565767579|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732245|NCT02244463|565767580|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732246|NCT02244463|565767581|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732247|NCT02244463|565767582|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732248|NCT02244463|565767583|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732249|NCT02244463|565767578|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
156732250|NCT02244463|565767579|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
156732251|NCT02244463|565767580|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
156732252|NCT02244463|565767581|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
156732253|NCT02244463|565767582|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
156732254|NCT02244463|565767583|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
156732255|NCT02244463|565767578|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156732256|NCT02244463|565767579|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
156732257|NCT02244463|565767580|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156732258|NCT02244463|565767581|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156796689|NCT01822925|566009649|FG000|Overall Study|Adverse Event|1|||
156796690|NCT01822925|566009650|FG001|Overall Study|Adverse Event|1|||
156796691|NCT01822925|566009651|FG002|Overall Study|Adverse Event|1|||
156796692|NCT01822925|566009652|FG003|Overall Study|Adverse Event|1|||
156796693|NCT01822925|566009649|FG000|Overall Study|Lost to Follow-up|0|||
156796694|NCT01822925|566009650|FG001|Overall Study|Lost to Follow-up|1|||
156796695|NCT01822925|566009651|FG002|Overall Study|Lost to Follow-up|0|||
156796696|NCT01822925|566009652|FG003|Overall Study|Lost to Follow-up|0|||
156796697|NCT01822925|566009649|FG000|Overall Study|Protocol Violation|1|||
156796698|NCT01822925|566009650|FG001|Overall Study|Protocol Violation|0|||
156796699|NCT01822925|566009651|FG002|Overall Study|Protocol Violation|0|||
156336465|NCT00354744|564329603|FG000|Overall Study|Withdrawal by Subject|14|||
156732259|NCT02244463|565767582|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156732260|NCT02244463|565767583|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156796700|NCT01822925|566009652|FG003|Overall Study|Protocol Violation|1|||
156796701|NCT01822925|566009649|FG000|Overall Study|Withdrawal by Subject|2|||
156796702|NCT01822925|566009650|FG001|Overall Study|Withdrawal by Subject|0|||
156455548|NCT02489903|564763135|FG003|Screening|Screen Failure|8|||
156455549|NCT02489903|564763132|FG000|Randomized and Received Treatment|Protocol Violation|0|||
156732261|NCT02244463|565767578|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732262|NCT02244463|565767579|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732263|NCT02244463|565767580|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
156732264|NCT02244463|565767581|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732265|NCT02244463|565767582|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732266|NCT02244463|565767583|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732267|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732268|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732269|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732270|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
156732271|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732272|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732273|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732274|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732275|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732276|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
156732277|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732278|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732279|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732280|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732281|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732282|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
156732283|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732284|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732285|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732286|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732287|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732288|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
156732289|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732290|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732291|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732292|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732293|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732294|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
156732295|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732296|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732297|NCT02244463|565767578|FG000|Period 5: Phase II|Disease Progression|0|||
156732298|NCT02244463|565767579|FG001|Period 5: Phase II|Disease Progression|0|||
156732299|NCT02244463|565767580|FG002|Period 5: Phase II|Disease Progression|0|||
156732300|NCT02244463|565767581|FG003|Period 5: Phase II|Disease Progression|0|||
156732301|NCT02244463|565767582|FG004|Period 5: Phase II|Disease Progression|10|||
156732302|NCT02244463|565767583|FG005|Period 5: Phase II|Disease Progression|11|||
156732303|NCT02244463|565767578|FG000|Period 5: Phase II|Physician Decision|0|||
156732304|NCT02244463|565767579|FG001|Period 5: Phase II|Physician Decision|0|||
156732305|NCT02244463|565767580|FG002|Period 5: Phase II|Physician Decision|0|||
156732306|NCT02244463|565767581|FG003|Period 5: Phase II|Physician Decision|0|||
156732307|NCT02244463|565767582|FG004|Period 5: Phase II|Physician Decision|3|||
156732308|NCT02244463|565767583|FG005|Period 5: Phase II|Physician Decision|2|||
156732309|NCT02244463|565767578|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
156732310|NCT02244463|565767579|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
156732311|NCT02244463|565767580|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
156732312|NCT02244463|565767581|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
156732313|NCT02244463|565767582|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
156732314|NCT02244463|565767583|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
156732315|NCT02244463|565767578|FG000|Period 5: Phase II|Intercurrent Illness|0|||
156732316|NCT02244463|565767579|FG001|Period 5: Phase II|Intercurrent Illness|0|||
156732317|NCT02244463|565767580|FG002|Period 5: Phase II|Intercurrent Illness|0|||
156732318|NCT02244463|565767581|FG003|Period 5: Phase II|Intercurrent Illness|0|||
156732319|NCT02244463|565767582|FG004|Period 5: Phase II|Intercurrent Illness|2|||
156732320|NCT02244463|565767583|FG005|Period 5: Phase II|Intercurrent Illness|0|||
156732321|NCT02244463|565767578|FG000|Period 5: Phase II|Adverse Event|0|||
156732322|NCT02244463|565767579|FG001|Period 5: Phase II|Adverse Event|0|||
156732323|NCT02244463|565767580|FG002|Period 5: Phase II|Adverse Event|0|||
156732324|NCT02244463|565767581|FG003|Period 5: Phase II|Adverse Event|0|||
156732325|NCT02244463|565767582|FG004|Period 5: Phase II|Adverse Event|0|||
156732326|NCT02244463|565767583|FG005|Period 5: Phase II|Adverse Event|2|||
156732327|NCT02244463|565767578|FG000|Period 5: Phase II|Still On treatment|0|||
156732328|NCT02244463|565767579|FG001|Period 5: Phase II|Still On treatment|0|||
156732329|NCT02244463|565767580|FG002|Period 5: Phase II|Still On treatment|0|||
156732330|NCT02244463|565767581|FG003|Period 5: Phase II|Still On treatment|0|||
156732331|NCT02244463|565767582|FG004|Period 5: Phase II|Still On treatment|0|||
156732332|NCT02244463|565767583|FG005|Period 5: Phase II|Still On treatment|3|||
156732333|NCT03702010|565767586|FG000|Follow-up (30days)|Lack of Efficacy|2|||
156732334|NCT03702010|565767587|FG001|Follow-up (30days)|Lack of Efficacy|2|||
156732335|NCT02295020|565767599|FG000|Overall Study|Adverse Event|0|||
156732336|NCT02295020|565767600|FG001|Overall Study|Adverse Event|1|||
156732337|NCT02295020|565767599|FG000|Overall Study|Withdrawal by Subject|3|||
156732338|NCT02295020|565767600|FG001|Overall Study|Withdrawal by Subject|2|||
156732339|NCT01290679|565767601|FG000|Overall Study|Adverse Event|2|||
156732340|NCT01290679|565767602|FG001|Overall Study|Adverse Event|0|||
156732341|NCT01290679|565767601|FG000|Overall Study|Lost to Follow-up|8|||
156732342|NCT01290679|565767602|FG001|Overall Study|Lost to Follow-up|10|||
156732343|NCT01290679|565767601|FG000|Overall Study|Protocol Violation|0|||
156732344|NCT01290679|565767602|FG001|Overall Study|Protocol Violation|1|||
156732345|NCT01290679|565767601|FG000|Overall Study|Withdrawal by Subject|6|||
156732346|NCT01290679|565767602|FG001|Overall Study|Withdrawal by Subject|5|||
156732347|NCT01290679|565767601|FG000|Overall Study|Subject Entered Another Trial|0|||
156732348|NCT01290679|565767602|FG001|Overall Study|Subject Entered Another Trial|5|||
156732349|NCT01598090|565767603|FG000|Treatment Period|Poor/non-compliance|0|||
156732350|NCT01598090|565767604|FG001|Treatment Period|Poor/non-compliance|2|||
156732351|NCT01598090|565767605|FG002|Treatment Period|Poor/non-compliance|0|||
156732352|NCT01598090|565767603|FG000|Treatment Period|No longer meet study criteria|0|||
156732353|NCT01598090|565767604|FG001|Treatment Period|No longer meet study criteria|1|||
156732354|NCT01598090|565767605|FG002|Treatment Period|No longer meet study criteria|0|||
156732355|NCT01598090|565767603|FG000|Treatment Period|Lack of Efficacy|5|||
156732356|NCT01598090|565767604|FG001|Treatment Period|Lack of Efficacy|14|||
156732357|NCT01598090|565767605|FG002|Treatment Period|Lack of Efficacy|6|||
156732358|NCT01598090|565767603|FG000|Treatment Period|Adverse Event|2|||
156732359|NCT01598090|565767604|FG001|Treatment Period|Adverse Event|33|||
156732360|NCT01598090|565767605|FG002|Treatment Period|Adverse Event|17|||
156732361|NCT01598090|565767603|FG000|Treatment Period|Other reasons|0|||
156732362|NCT01598090|565767604|FG001|Treatment Period|Other reasons|4|||
156732363|NCT01598090|565767605|FG002|Treatment Period|Other reasons|1|||
156732364|NCT01598090|565767603|FG000|Treatment Period|Withdrawal by Subject|3|||
156732365|NCT01598090|565767604|FG001|Treatment Period|Withdrawal by Subject|13|||
156732366|NCT01598090|565767605|FG002|Treatment Period|Withdrawal by Subject|10|||
156732367|NCT01598090|565767603|FG000|Treatment Period|Lost to Follow-up|1|||
156732368|NCT01598090|565767604|FG001|Treatment Period|Lost to Follow-up|5|||
156732369|NCT01598090|565767605|FG002|Treatment Period|Lost to Follow-up|1|||
156732370|NCT01598090|565767603|FG000|Follow-up Period|Death|0|||
156732371|NCT01598090|565767604|FG001|Follow-up Period|Death|1|||
156732372|NCT01598090|565767605|FG002|Follow-up Period|Death|0|||
156732373|NCT01598090|565767603|FG000|Follow-up Period|No longer required per protocol|1|||
156455550|NCT02489903|564763133|FG001|Randomized and Received Treatment|Protocol Violation|1|||
156455551|NCT02489903|564763134|FG002|Randomized and Received Treatment|Protocol Violation|0|||
156455552|NCT02489903|564763135|FG003|Randomized and Received Treatment|Protocol Violation|0|||
156455553|NCT02489903|564763132|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
156455554|NCT02489903|564763133|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
156455555|NCT02489903|564763134|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
156455556|NCT02489903|564763135|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
156455557|NCT02489903|564763132|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
156455558|NCT02489903|564763133|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
156455559|NCT02489903|564763134|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
156455560|NCT02489903|564763135|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
156455561|NCT02489903|564763132|FG000|Randomized and Received Treatment|Death|10|||
156455562|NCT02489903|564763133|FG001|Randomized and Received Treatment|Death|1|||
156455563|NCT02489903|564763134|FG002|Randomized and Received Treatment|Death|0|||
156455564|NCT02489903|564763135|FG003|Randomized and Received Treatment|Death|0|||
156455565|NCT03768505|564763144|FG000|Overall Study|sponsor decision|76|||
156455566|NCT03768505|564763144|FG000|Overall Study|Death|35|||
156455567|NCT03768505|564763144|FG000|Overall Study|Other -Various|30|||
156455568|NCT03768505|564763144|FG000|Overall Study|Withdrawal by Subject|22|||
156533713|NCT02608879|565048894|FG001|Overall Study|Lost to Follow-up|0|||
156732374|NCT01598090|565767604|FG001|Follow-up Period|No longer required per protocol|3|||
156732375|NCT01598090|565767605|FG002|Follow-up Period|No longer required per protocol|2|||
156732376|NCT01598090|565767603|FG000|Follow-up Period|Not reported|0|||
156732377|NCT01598090|565767604|FG001|Follow-up Period|Not reported|10|||
156732378|NCT01598090|565767605|FG002|Follow-up Period|Not reported|4|||
156796703|NCT01822925|566009651|FG002|Overall Study|Withdrawal by Subject|2|||
156796704|NCT01822925|566009652|FG003|Overall Study|Withdrawal by Subject|2|||
156732379|NCT01598090|565767603|FG000|Follow-up Period|Withdrawal by Subject|0|||
156732380|NCT01598090|565767604|FG001|Follow-up Period|Withdrawal by Subject|3|||
156732381|NCT01598090|565767605|FG002|Follow-up Period|Withdrawal by Subject|2|||
156796705|NCT01822925|566009649|FG000|Overall Study|Taking prohibited medication|2|||
156796706|NCT01822925|566009650|FG001|Overall Study|Taking prohibited medication|0|||
156455569|NCT03768505|564763144|FG000|Overall Study|Lost to Follow-up|6|||
156455570|NCT04948697|564763145|FG000|Overall Study|Progressive disease|27|||
156732382|NCT01598090|565767603|FG000|Follow-up Period|Other reasons|2|||
156732383|NCT01598090|565767604|FG001|Follow-up Period|Other reasons|8|||
156732384|NCT01598090|565767605|FG002|Follow-up Period|Other reasons|8|||
156732385|NCT01598090|565767603|FG000|Follow-up Period|Lost to Follow-up|2|||
156732386|NCT01598090|565767604|FG001|Follow-up Period|Lost to Follow-up|10|||
156732387|NCT01598090|565767605|FG002|Follow-up Period|Lost to Follow-up|12|||
156732388|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
156732389|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
156732390|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
156732391|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
156732392|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732393|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732394|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732395|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732396|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732397|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732398|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732399|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
156732400|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732401|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
156732402|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
156732403|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732404|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732405|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732406|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732407|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732408|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732409|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732410|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
156732411|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
156732412|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
156732413|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
156732414|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732415|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732416|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732417|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732418|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732419|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732420|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732421|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
156732422|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
156732423|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
156732424|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
156732425|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732426|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732427|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732428|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732429|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732430|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732431|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732432|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732433|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732434|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732435|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
156732436|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732437|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732438|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732439|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732440|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732441|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156455571|NCT04948697|564763146|FG001|Overall Study|Progressive disease|18|||
156455572|NCT04948697|564763145|FG000|Overall Study|Adverse Event|14|||
156455573|NCT04948697|564763146|FG001|Overall Study|Adverse Event|4|||
156336466|NCT00094172|564329605|FG000|Overall Study|Adverse Event|0|||
156336467|NCT00094172|564329606|FG001|Overall Study|Adverse Event|1|||
156336468|NCT00094172|564329605|FG000|Overall Study|Lost to Follow-up|2|||
156336469|NCT00094172|564329606|FG001|Overall Study|Lost to Follow-up|0|||
156336470|NCT00094172|564329605|FG000|Overall Study|Protocol Violation|0|||
156336471|NCT00094172|564329606|FG001|Overall Study|Protocol Violation|1|||
156336472|NCT00094172|564329605|FG000|Overall Study|Withdrawal by Subject|10|||
156336473|NCT00094172|564329606|FG001|Overall Study|Withdrawal by Subject|5|||
156455574|NCT04948697|564763145|FG000|Overall Study|Participant moved to long term extension study|7|||
156455575|NCT04948697|564763146|FG001|Overall Study|Participant moved to long term extension study|4|||
156336474|NCT00094172|564329605|FG000|Overall Study|Primary endpoint met.|1|||
156336475|NCT00094172|564329606|FG001|Overall Study|Primary endpoint met.|0|||
156455576|NCT04948697|564763145|FG000|Overall Study|Withdrawal by Subject|10|||
156455577|NCT04948697|564763146|FG001|Overall Study|Withdrawal by Subject|0|||
156455578|NCT04948697|564763145|FG000|Overall Study|Closed by Sponsor|3|||
156455579|NCT04948697|564763146|FG001|Overall Study|Closed by Sponsor|2|||
156455580|NCT04948697|564763145|FG000|Overall Study|Physician Decision|0|||
156455581|NCT04948697|564763146|FG001|Overall Study|Physician Decision|2|||
156455582|NCT04948697|564763145|FG000|Overall Study|Lost to Follow-up|0|||
156455583|NCT04948697|564763146|FG001|Overall Study|Lost to Follow-up|1|||
156455584|NCT04948697|564763145|FG000|Overall Study|Other-Miscellaneous|1|||
156455585|NCT04948697|564763146|FG001|Overall Study|Other-Miscellaneous|0|||
156455586|NCT04948697|564763145|FG000|Overall Study|Randomized but not treated|0|||
156455587|NCT04948697|564763146|FG001|Overall Study|Randomized but not treated|1|||
156455588|NCT02815566|564763147|FG000|Overall Study|Adverse Event|1|||
156455589|NCT02815566|564763148|FG001|Overall Study|Adverse Event|1|||
156455590|NCT02815566|564763147|FG000|Overall Study|Withdrawal by Subject|1|||
156732442|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732443|NCT04791319|565767606|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732444|NCT04791319|565767607|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732445|NCT04791319|565767608|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732446|NCT04791319|565767609|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732447|NCT04791319|565767610|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
156732448|NCT04791319|565767611|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
156732449|NCT04791319|565767612|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
156732450|NCT04791319|565767613|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732451|NCT04791319|565767614|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732452|NCT04791319|565767615|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732453|NCT04791319|565767616|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
156732454|NCT04791319|565767606|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732455|NCT04791319|565767607|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732456|NCT04791319|565767608|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732457|NCT04791319|565767609|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732458|NCT04791319|565767610|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732459|NCT04791319|565767611|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732460|NCT04791319|565767612|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732461|NCT04791319|565767613|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732462|NCT04791319|565767614|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732463|NCT04791319|565767615|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
156732464|NCT04791319|565767616|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732465|NCT04791319|565767606|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732466|NCT04791319|565767607|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732467|NCT04791319|565767608|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732468|NCT04791319|565767609|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732469|NCT04791319|565767610|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
156732470|NCT04791319|565767611|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
156455591|NCT02815566|564763148|FG001|Overall Study|Withdrawal by Subject|0|||
156455592|NCT02815566|564763147|FG000|Overall Study|Lost to Follow-up|0|||
156336476|NCT00094172|564329605|FG000|Overall Study|Started other MS therapy due to disease|1|||
156336477|NCT00094172|564329606|FG001|Overall Study|Started other MS therapy due to disease|0|||
156336478|NCT00289133|564329611|FG000|Overall Study|Non-study device implanted|12|||
156336479|NCT00289133|564329612|FG001|Overall Study|Non-study device implanted|0|||
156455593|NCT02815566|564763148|FG001|Overall Study|Lost to Follow-up|1|||
156455594|NCT02861300|564763153|FG000|Overall Study|Death|0|||
156455595|NCT02861300|564763154|FG001|Overall Study|Death|0|||
156455596|NCT02861300|564763155|FG002|Overall Study|Death|0|||
156455597|NCT02861300|564763156|FG003|Overall Study|Death|0|||
156455598|NCT02861300|564763157|FG004|Overall Study|Death|0|||
156455599|NCT02861300|564763158|FG005|Overall Study|Death|0|||
156455600|NCT02861300|564763159|FG006|Overall Study|Death|24|||
156455601|NCT02861300|564763153|FG000|Overall Study|Delay in treatment|0|||
156455602|NCT02861300|564763154|FG001|Overall Study|Delay in treatment|0|||
156455603|NCT02861300|564763155|FG002|Overall Study|Delay in treatment|0|||
156455604|NCT02861300|564763156|FG003|Overall Study|Delay in treatment|0|||
156455605|NCT02861300|564763157|FG004|Overall Study|Delay in treatment|0|||
156732471|NCT04791319|565767612|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
156732472|NCT04791319|565767613|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732473|NCT04791319|565767614|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
156732474|NCT04791319|565767615|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
156732475|NCT04791319|565767616|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
156732476|NCT04791319|565767606|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
156732477|NCT04791319|565767607|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
156732478|NCT04791319|565767608|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
156732479|NCT04791319|565767609|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
156732480|NCT04791319|565767610|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
156732481|NCT04791319|565767611|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
156732482|NCT04791319|565767612|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
156732483|NCT04791319|565767613|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
156732484|NCT04791319|565767614|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
156732485|NCT04791319|565767615|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
156732486|NCT04791319|565767616|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
156732487|NCT00355147|565767625|FG000|Overall Study|Lost to Follow-up|10|||
156732488|NCT00355147|565767626|FG001|Overall Study|Lost to Follow-up|8|||
156732489|NCT00355147|565767625|FG000|Overall Study|Withdrawal by Subject|8|||
156732490|NCT00355147|565767626|FG001|Overall Study|Withdrawal by Subject|12|||
156732491|NCT03557931|565767633|FG000|Overall Study|Adverse Event|4|||
156732492|NCT03557931|565767634|FG001|Overall Study|Adverse Event|6|||
156732493|NCT03557931|565767635|FG002|Overall Study|Adverse Event|1|||
156732494|NCT03557931|565767633|FG000|Overall Study|Lost to Follow-up|4|||
156732495|NCT03557931|565767634|FG001|Overall Study|Lost to Follow-up|4|||
156732496|NCT03557931|565767635|FG002|Overall Study|Lost to Follow-up|1|||
156732497|NCT03557931|565767633|FG000|Overall Study|Protocol Violation|1|||
156732498|NCT03557931|565767634|FG001|Overall Study|Protocol Violation|4|||
156732499|NCT03557931|565767635|FG002|Overall Study|Protocol Violation|1|||
156732500|NCT03557931|565767633|FG000|Overall Study|Withdrawal by Subject|14|||
156732501|NCT03557931|565767634|FG001|Overall Study|Withdrawal by Subject|0|||
156732502|NCT03557931|565767635|FG002|Overall Study|Withdrawal by Subject|7|||
156732503|NCT03557931|565767633|FG000|Overall Study|Miscellaneous|8|||
156732504|NCT03557931|565767634|FG001|Overall Study|Miscellaneous|5|||
156732505|NCT03557931|565767635|FG002|Overall Study|Miscellaneous|3|||
156732506|NCT02394340|565767636|FG000|Overall Study|Failed drug screen test|1|||
156732507|NCT02394340|565767636|FG000|Overall Study|Adverse Event|1|||
156732508|NCT03605862|565767639|FG000|Overall Study|Withdrawal by Subject|12|||
156732509|NCT03605862|565767640|FG001|Overall Study|Withdrawal by Subject|9|||
156732510|NCT03605862|565767639|FG000|Overall Study|Adverse Event|2|||
156732511|NCT03605862|565767640|FG001|Overall Study|Adverse Event|1|||
156732512|NCT03605862|565767639|FG000|Overall Study|Physician Decision|3|||
156732513|NCT03605862|565767640|FG001|Overall Study|Physician Decision|1|||
156732514|NCT03605862|565767639|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
156732515|NCT03605862|565767640|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
156732516|NCT02157376|565767647|FG000|Overall Study|Death|10|||
156732517|NCT02157376|565767648|FG001|Overall Study|Death|4|||
156732518|NCT02157376|565767647|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156732519|NCT02157376|565767648|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156732520|NCT02157376|565767647|FG000|Overall Study|Withdrawal by Subject|3|||
156732521|NCT02157376|565767648|FG001|Overall Study|Withdrawal by Subject|8|||
156732522|NCT02157376|565767647|FG000|Overall Study|Not treated|8|||
156732523|NCT02157376|565767648|FG001|Overall Study|Not treated|3|||
156732524|NCT02157376|565767647|FG000|Overall Study|Investigator's misjudgement|1|||
156732525|NCT02157376|565767648|FG001|Overall Study|Investigator's misjudgement|2|||
156732526|NCT04200651|565767649|FG000|Overall Study|Moved to another country during follow-up|2|||
156732527|NCT04200651|565767650|FG001|Overall Study|Moved to another country during follow-up|2|||
156732528|NCT04200651|565767649|FG000|Overall Study|Lost to Follow-up|1|||
156455606|NCT02861300|564763158|FG005|Overall Study|Delay in treatment|1|||
156455607|NCT02861300|564763159|FG006|Overall Study|Delay in treatment|0|||
156455608|NCT02861300|564763153|FG000|Overall Study|Disease Progression|0|||
156533714|NCT02608879|565048895|FG002|Overall Study|Lost to Follow-up|0|||
156455609|NCT02861300|564763154|FG001|Overall Study|Disease Progression|1|||
156455610|NCT02861300|564763155|FG002|Overall Study|Disease Progression|0|||
156455611|NCT02861300|564763156|FG003|Overall Study|Disease Progression|0|||
156732529|NCT04200651|565767650|FG001|Overall Study|Lost to Follow-up|3|||
156732530|NCT02547220|565767657|FG000|Overall Study|Withdrawal by Subject|1|||
156732531|NCT02547220|565767658|FG001|Overall Study|Withdrawal by Subject|0|||
156732532|NCT02547220|565767657|FG000|Overall Study|Study terminated by sponsor|18|||
156732533|NCT02547220|565767658|FG001|Overall Study|Study terminated by sponsor|20|||
156455612|NCT02861300|564763157|FG004|Overall Study|Disease Progression|0|||
156455613|NCT02861300|564763158|FG005|Overall Study|Disease Progression|0|||
156732534|NCT00789698|565767663|FG000|Overall Study|Lack of Efficacy|10|||
156732535|NCT00789698|565767664|FG001|Overall Study|Lack of Efficacy|4|||
156732536|NCT00789698|565767665|FG002|Overall Study|Lack of Efficacy|5|||
156732537|NCT00789698|565767666|FG003|Overall Study|Lack of Efficacy|18|||
156732538|NCT00789698|565767663|FG000|Overall Study|Adverse Event|5|||
156732539|NCT00789698|565767664|FG001|Overall Study|Adverse Event|5|||
156732540|NCT00789698|565767665|FG002|Overall Study|Adverse Event|3|||
156732541|NCT00789698|565767666|FG003|Overall Study|Adverse Event|4|||
156732542|NCT00789698|565767663|FG000|Overall Study|Lost to Follow-up|5|||
156732543|NCT00789698|565767664|FG001|Overall Study|Lost to Follow-up|5|||
156732544|NCT00789698|565767665|FG002|Overall Study|Lost to Follow-up|2|||
156732545|NCT00789698|565767666|FG003|Overall Study|Lost to Follow-up|9|||
156732546|NCT00789698|565767663|FG000|Overall Study|Protocol Violation|6|||
156732547|NCT00789698|565767664|FG001|Overall Study|Protocol Violation|1|||
156732548|NCT00789698|565767665|FG002|Overall Study|Protocol Violation|2|||
156732549|NCT00789698|565767666|FG003|Overall Study|Protocol Violation|1|||
156732550|NCT00789698|565767663|FG000|Overall Study|Withdrawal by Subject|14|||
156732551|NCT00789698|565767664|FG001|Overall Study|Withdrawal by Subject|15|||
156732552|NCT00789698|565767665|FG002|Overall Study|Withdrawal by Subject|12|||
156732553|NCT00789698|565767666|FG003|Overall Study|Withdrawal by Subject|19|||
156732554|NCT00789698|565767663|FG000|Overall Study|Administrative|0|||
156732555|NCT00789698|565767664|FG001|Overall Study|Administrative|3|||
156732556|NCT00789698|565767665|FG002|Overall Study|Administrative|3|||
156732557|NCT00789698|565767666|FG003|Overall Study|Administrative|1|||
156732558|NCT02981082|565767668|FG000|Overall Study|Withdrawal by Subject|2|||
156732559|NCT02981082|565767669|FG001|Overall Study|Withdrawal by Subject|0|||
156732560|NCT02981082|565767668|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
156732561|NCT02981082|565767669|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
156732562|NCT02981082|565767668|FG000|Overall Study|Adverse Event|0|||
156732563|NCT02981082|565767669|FG001|Overall Study|Adverse Event|1|||
156732564|NCT00596817|565767670|FG000|Open-label Period|Adverse Event|0|||
156732565|NCT00596817|565767671|FG001|Open-label Period|Adverse Event|49|||
156732566|NCT00596817|565767670|FG000|Open-label Period|Lack of Efficacy|0|||
156732567|NCT00596817|565767671|FG001|Open-label Period|Lack of Efficacy|33|||
156876575|NCT00798759|566307642|FG001|Overall Study|Lost to Follow-up|1|||
156876576|NCT00798759|566307641|FG000|Overall Study|Protocol Violation|4|||
156876577|NCT00798759|566307642|FG001|Overall Study|Protocol Violation|8|||
156876578|NCT00798759|566307641|FG000|Overall Study|Other|0|||
156876579|NCT00798759|566307642|FG001|Overall Study|Other|1|||
156876580|NCT03387111|566307643|FG000|Overall Study|Progressive Disease|3|||
156876581|NCT03387111|566307643|FG000|Overall Study|Other|1|||
156876582|NCT01945710|566307644|FG000|Overall Study|Progressive Disease|5|||
156876583|NCT01945710|566307645|FG001|Overall Study|Progressive Disease|4|||
156876584|NCT01945710|566307646|FG002|Overall Study|Progressive Disease|3|||
156876585|NCT01945710|566307647|FG003|Overall Study|Progressive Disease|2|||
156876586|NCT01945710|566307648|FG004|Overall Study|Progressive Disease|7|||
156876587|NCT01945710|566307649|FG005|Overall Study|Progressive Disease|3|||
156876588|NCT01945710|566307650|FG006|Overall Study|Progressive Disease|19|||
156876589|NCT01945710|566307644|FG000|Overall Study|Adverse Event|0|||
156455614|NCT02861300|564763159|FG006|Overall Study|Disease Progression|2|||
156455615|NCT02861300|564763153|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
156455616|NCT02861300|564763154|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
156455617|NCT02861300|564763155|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
156732568|NCT00596817|565767670|FG000|Open-label Period|Other Reasons|0|||
156732569|NCT00596817|565767671|FG001|Open-label Period|Other Reasons|65|||
156732570|NCT00596817|565767670|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
156732571|NCT00596817|565767671|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
156732572|NCT00596817|565767670|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
156876590|NCT01945710|566307645|FG001|Overall Study|Adverse Event|1|||
156455618|NCT02861300|564763156|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
156455619|NCT02861300|564763157|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
156732573|NCT00596817|565767671|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
156732574|NCT00596817|565767670|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
156732575|NCT00596817|565767671|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
156732576|NCT00596817|565767670|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
156876591|NCT01945710|566307646|FG002|Overall Study|Adverse Event|0|||
156876592|NCT01945710|566307647|FG003|Overall Study|Adverse Event|0|||
156876593|NCT01945710|566307648|FG004|Overall Study|Adverse Event|0|||
156876594|NCT01945710|566307649|FG005|Overall Study|Adverse Event|0|||
156876595|NCT01945710|566307650|FG006|Overall Study|Adverse Event|0|||
156732577|NCT00596817|565767671|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
156732578|NCT00596817|565767670|FG000|Double-blind Period|Adverse Event|5|||
156732579|NCT00596817|565767671|FG001|Double-blind Period|Adverse Event|16|||
156732580|NCT00596817|565767670|FG000|Double-blind Period|Lack of Efficacy|52|||
156732581|NCT00596817|565767671|FG001|Double-blind Period|Lack of Efficacy|28|||
156732582|NCT00596817|565767670|FG000|Double-blind Period|Non-compliance With Study Product|3|||
156732583|NCT00596817|565767671|FG001|Double-blind Period|Non-compliance With Study Product|4|||
156732584|NCT00596817|565767670|FG000|Double-blind Period|Protocol Violation|11|||
156732585|NCT00596817|565767671|FG001|Double-blind Period|Protocol Violation|8|||
156732586|NCT00596817|565767670|FG000|Double-blind Period|Withdrawal of Consent|7|||
156732587|NCT00596817|565767671|FG001|Double-blind Period|Withdrawal of Consent|3|||
156732588|NCT00596817|565767670|FG000|Double-blind Period|Lost to Follow-up|0|||
156732589|NCT00596817|565767671|FG001|Double-blind Period|Lost to Follow-up|2|||
156732590|NCT00596817|565767670|FG000|Double-blind Period|Other Reasons|10|||
156732591|NCT00596817|565767671|FG001|Double-blind Period|Other Reasons|18|||
156732592|NCT01314872|565767680|FG000|Treatment Period 1|Protocol Violation|2|||
156732593|NCT01314872|565767681|FG001|Treatment Period 1|Protocol Violation|1|||
156732594|NCT01314872|565767682|FG002|Treatment Period 1|Protocol Violation|1|||
156732595|NCT01314872|565767683|FG003|Treatment Period 1|Protocol Violation|0|||
156732596|NCT01314872|565767684|FG004|Treatment Period 1|Protocol Violation|1|||
156732597|NCT01314872|565767685|FG005|Treatment Period 1|Protocol Violation|0|||
156732598|NCT01314872|565767686|FG006|Treatment Period 1|Protocol Violation|0|||
156732599|NCT01314872|565767687|FG007|Treatment Period 1|Protocol Violation|0|||
156732600|NCT01314872|565767688|FG008|Treatment Period 1|Protocol Violation|0|||
156732601|NCT01314872|565767689|FG009|Treatment Period 1|Protocol Violation|1|||
156732602|NCT01314872|565767690|FG010|Treatment Period 1|Protocol Violation|1|||
156732603|NCT01314872|565767691|FG011|Treatment Period 1|Protocol Violation|0|||
156732604|NCT01314872|565767692|FG012|Treatment Period 1|Protocol Violation|0|||
156732605|NCT01314872|565767693|FG013|Treatment Period 1|Protocol Violation|0|||
156732606|NCT01314872|565767694|FG014|Treatment Period 1|Protocol Violation|0|||
156732607|NCT01314872|565767680|FG000|Treatment Period 1|Physician Decision|0|||
156732608|NCT01314872|565767681|FG001|Treatment Period 1|Physician Decision|1|||
156732609|NCT01314872|565767682|FG002|Treatment Period 1|Physician Decision|0|||
156732610|NCT01314872|565767683|FG003|Treatment Period 1|Physician Decision|1|||
156732611|NCT01314872|565767684|FG004|Treatment Period 1|Physician Decision|0|||
156732612|NCT01314872|565767685|FG005|Treatment Period 1|Physician Decision|0|||
156732613|NCT01314872|565767686|FG006|Treatment Period 1|Physician Decision|0|||
156732614|NCT01314872|565767687|FG007|Treatment Period 1|Physician Decision|0|||
156732615|NCT01314872|565767688|FG008|Treatment Period 1|Physician Decision|0|||
156732616|NCT01314872|565767689|FG009|Treatment Period 1|Physician Decision|1|||
156732617|NCT01314872|565767690|FG010|Treatment Period 1|Physician Decision|0|||
156732618|NCT01314872|565767691|FG011|Treatment Period 1|Physician Decision|0|||
156732619|NCT01314872|565767692|FG012|Treatment Period 1|Physician Decision|0|||
156732620|NCT01314872|565767693|FG013|Treatment Period 1|Physician Decision|0|||
156732621|NCT01314872|565767694|FG014|Treatment Period 1|Physician Decision|0|||
156732622|NCT01314872|565767680|FG000|Treatment Period 1|Lack of Efficacy|1|||
156732623|NCT01314872|565767681|FG001|Treatment Period 1|Lack of Efficacy|0|||
156732624|NCT01314872|565767682|FG002|Treatment Period 1|Lack of Efficacy|0|||
156732625|NCT01314872|565767683|FG003|Treatment Period 1|Lack of Efficacy|0|||
156732626|NCT01314872|565767684|FG004|Treatment Period 1|Lack of Efficacy|0|||
156732627|NCT01314872|565767685|FG005|Treatment Period 1|Lack of Efficacy|1|||
156732628|NCT01314872|565767686|FG006|Treatment Period 1|Lack of Efficacy|0|||
156732629|NCT01314872|565767687|FG007|Treatment Period 1|Lack of Efficacy|2|||
156732630|NCT01314872|565767688|FG008|Treatment Period 1|Lack of Efficacy|0|||
156732631|NCT01314872|565767689|FG009|Treatment Period 1|Lack of Efficacy|0|||
156732632|NCT01314872|565767690|FG010|Treatment Period 1|Lack of Efficacy|0|||
156732633|NCT01314872|565767691|FG011|Treatment Period 1|Lack of Efficacy|0|||
156732634|NCT01314872|565767692|FG012|Treatment Period 1|Lack of Efficacy|0|||
156732635|NCT01314872|565767693|FG013|Treatment Period 1|Lack of Efficacy|0|||
156732636|NCT01314872|565767694|FG014|Treatment Period 1|Lack of Efficacy|0|||
156732637|NCT01314872|565767680|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
156732638|NCT01314872|565767681|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
156732639|NCT01314872|565767682|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
156732640|NCT01314872|565767683|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
156732641|NCT01314872|565767684|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
156732642|NCT01314872|565767685|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
156732643|NCT01314872|565767686|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
156732644|NCT01314872|565767687|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
156732645|NCT01314872|565767688|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
156732646|NCT01314872|565767689|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
156732647|NCT01314872|565767690|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
156796707|NCT01822925|566009651|FG002|Overall Study|Taking prohibited medication|0|||
156732648|NCT01314872|565767691|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
156732649|NCT01314872|565767692|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
156732650|NCT01314872|565767693|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
156732651|NCT01314872|565767694|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
156732652|NCT01314872|565767680|FG000|Treatment Period 1|Withdrawal by Subject|3|||
156732653|NCT01314872|565767681|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156732654|NCT01314872|565767682|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156732655|NCT01314872|565767683|FG003|Treatment Period 1|Withdrawal by Subject|2|||
156732656|NCT01314872|565767684|FG004|Treatment Period 1|Withdrawal by Subject|3|||
156732657|NCT01314872|565767685|FG005|Treatment Period 1|Withdrawal by Subject|1|||
156732658|NCT01314872|565767686|FG006|Treatment Period 1|Withdrawal by Subject|3|||
156732659|NCT01314872|565767687|FG007|Treatment Period 1|Withdrawal by Subject|2|||
156732660|NCT01314872|565767688|FG008|Treatment Period 1|Withdrawal by Subject|2|||
156732661|NCT01314872|565767689|FG009|Treatment Period 1|Withdrawal by Subject|2|||
156732662|NCT01314872|565767690|FG010|Treatment Period 1|Withdrawal by Subject|1|||
156732663|NCT01314872|565767691|FG011|Treatment Period 1|Withdrawal by Subject|0|||
156732664|NCT01314872|565767692|FG012|Treatment Period 1|Withdrawal by Subject|0|||
156732665|NCT01314872|565767693|FG013|Treatment Period 1|Withdrawal by Subject|0|||
156732666|NCT01314872|565767694|FG014|Treatment Period 1|Withdrawal by Subject|0|||
156732667|NCT01314872|565767680|FG000|Treatment Period 1|Lost to Follow-up|0|||
156732668|NCT01314872|565767681|FG001|Treatment Period 1|Lost to Follow-up|1|||
156732669|NCT01314872|565767682|FG002|Treatment Period 1|Lost to Follow-up|2|||
156732670|NCT01314872|565767683|FG003|Treatment Period 1|Lost to Follow-up|2|||
156732671|NCT01314872|565767684|FG004|Treatment Period 1|Lost to Follow-up|1|||
156732672|NCT01314872|565767685|FG005|Treatment Period 1|Lost to Follow-up|1|||
156732673|NCT01314872|565767686|FG006|Treatment Period 1|Lost to Follow-up|1|||
156732674|NCT01314872|565767687|FG007|Treatment Period 1|Lost to Follow-up|1|||
156732675|NCT01314872|565767688|FG008|Treatment Period 1|Lost to Follow-up|1|||
156732676|NCT01314872|565767689|FG009|Treatment Period 1|Lost to Follow-up|0|||
156732677|NCT01314872|565767690|FG010|Treatment Period 1|Lost to Follow-up|0|||
156732678|NCT01314872|565767691|FG011|Treatment Period 1|Lost to Follow-up|0|||
156732679|NCT01314872|565767692|FG012|Treatment Period 1|Lost to Follow-up|0|||
156732680|NCT01314872|565767693|FG013|Treatment Period 1|Lost to Follow-up|0|||
156732681|NCT01314872|565767694|FG014|Treatment Period 1|Lost to Follow-up|0|||
156732682|NCT01314872|565767680|FG000|Period 2|Protocol Violation|0|||
156732683|NCT01314872|565767681|FG001|Period 2|Protocol Violation|0|||
156732684|NCT01314872|565767682|FG002|Period 2|Protocol Violation|0|||
156732685|NCT01314872|565767683|FG003|Period 2|Protocol Violation|0|||
156732686|NCT01314872|565767684|FG004|Period 2|Protocol Violation|0|||
156732687|NCT01314872|565767685|FG005|Period 2|Protocol Violation|0|||
156732688|NCT01314872|565767686|FG006|Period 2|Protocol Violation|0|||
156732689|NCT01314872|565767687|FG007|Period 2|Protocol Violation|0|||
156732690|NCT01314872|565767688|FG008|Period 2|Protocol Violation|0|||
156732691|NCT01314872|565767689|FG009|Period 2|Protocol Violation|0|||
156732692|NCT01314872|565767690|FG010|Period 2|Protocol Violation|0|||
156732693|NCT01314872|565767691|FG011|Period 2|Protocol Violation|3|||
156732694|NCT01314872|565767692|FG012|Period 2|Protocol Violation|3|||
156732695|NCT01314872|565767693|FG013|Period 2|Protocol Violation|2|||
156732696|NCT01314872|565767694|FG014|Period 2|Protocol Violation|0|||
156732697|NCT01314872|565767680|FG000|Period 2|Non-compliance with study drug|0|||
156732698|NCT01314872|565767681|FG001|Period 2|Non-compliance with study drug|0|||
156732699|NCT01314872|565767682|FG002|Period 2|Non-compliance with study drug|0|||
156732700|NCT01314872|565767683|FG003|Period 2|Non-compliance with study drug|0|||
156732701|NCT01314872|565767684|FG004|Period 2|Non-compliance with study drug|0|||
156732702|NCT01314872|565767685|FG005|Period 2|Non-compliance with study drug|0|||
156732703|NCT01314872|565767686|FG006|Period 2|Non-compliance with study drug|0|||
156732704|NCT01314872|565767687|FG007|Period 2|Non-compliance with study drug|0|||
156732705|NCT01314872|565767688|FG008|Period 2|Non-compliance with study drug|0|||
156732706|NCT01314872|565767689|FG009|Period 2|Non-compliance with study drug|0|||
156732707|NCT01314872|565767690|FG010|Period 2|Non-compliance with study drug|0|||
156732708|NCT01314872|565767691|FG011|Period 2|Non-compliance with study drug|3|||
156732709|NCT01314872|565767692|FG012|Period 2|Non-compliance with study drug|3|||
156732710|NCT01314872|565767693|FG013|Period 2|Non-compliance with study drug|1|||
156732711|NCT01314872|565767694|FG014|Period 2|Non-compliance with study drug|2|||
156732712|NCT01314872|565767680|FG000|Period 2|Lack of Efficacy|0|||
156732713|NCT01314872|565767681|FG001|Period 2|Lack of Efficacy|0|||
156732714|NCT01314872|565767682|FG002|Period 2|Lack of Efficacy|0|||
156732715|NCT01314872|565767683|FG003|Period 2|Lack of Efficacy|0|||
156732716|NCT01314872|565767684|FG004|Period 2|Lack of Efficacy|0|||
156732717|NCT01314872|565767685|FG005|Period 2|Lack of Efficacy|0|||
156732718|NCT01314872|565767686|FG006|Period 2|Lack of Efficacy|0|||
156732719|NCT01314872|565767687|FG007|Period 2|Lack of Efficacy|0|||
156732720|NCT01314872|565767688|FG008|Period 2|Lack of Efficacy|0|||
156732721|NCT01314872|565767689|FG009|Period 2|Lack of Efficacy|0|||
156732722|NCT01314872|565767690|FG010|Period 2|Lack of Efficacy|0|||
156336480|NCT00289133|564329611|FG000|Overall Study|Protocol Violation|32|||
156732723|NCT01314872|565767691|FG011|Period 2|Lack of Efficacy|7|||
156732724|NCT01314872|565767692|FG012|Period 2|Lack of Efficacy|12|||
156732725|NCT01314872|565767693|FG013|Period 2|Lack of Efficacy|9|||
156732726|NCT01314872|565767694|FG014|Period 2|Lack of Efficacy|2|||
156732727|NCT01314872|565767680|FG000|Period 2|Pregnancy|0|||
156732728|NCT01314872|565767681|FG001|Period 2|Pregnancy|0|||
156732729|NCT01314872|565767682|FG002|Period 2|Pregnancy|0|||
156732730|NCT01314872|565767683|FG003|Period 2|Pregnancy|0|||
156732731|NCT01314872|565767684|FG004|Period 2|Pregnancy|0|||
156732732|NCT01314872|565767685|FG005|Period 2|Pregnancy|0|||
156732733|NCT01314872|565767686|FG006|Period 2|Pregnancy|0|||
156732734|NCT01314872|565767687|FG007|Period 2|Pregnancy|0|||
156732735|NCT01314872|565767688|FG008|Period 2|Pregnancy|0|||
156732736|NCT01314872|565767689|FG009|Period 2|Pregnancy|0|||
156732737|NCT01314872|565767690|FG010|Period 2|Pregnancy|0|||
156732738|NCT01314872|565767691|FG011|Period 2|Pregnancy|0|||
156732739|NCT01314872|565767692|FG012|Period 2|Pregnancy|0|||
156732740|NCT01314872|565767693|FG013|Period 2|Pregnancy|0|||
156732741|NCT01314872|565767694|FG014|Period 2|Pregnancy|1|||
156732742|NCT01314872|565767680|FG000|Period 2|Study terminated by Sponsor|0|||
156732743|NCT01314872|565767681|FG001|Period 2|Study terminated by Sponsor|0|||
156732744|NCT01314872|565767682|FG002|Period 2|Study terminated by Sponsor|0|||
156732745|NCT01314872|565767683|FG003|Period 2|Study terminated by Sponsor|0|||
156732746|NCT01314872|565767684|FG004|Period 2|Study terminated by Sponsor|0|||
156732747|NCT01314872|565767685|FG005|Period 2|Study terminated by Sponsor|0|||
156732748|NCT01314872|565767686|FG006|Period 2|Study terminated by Sponsor|0|||
156732749|NCT01314872|565767687|FG007|Period 2|Study terminated by Sponsor|0|||
156732750|NCT01314872|565767688|FG008|Period 2|Study terminated by Sponsor|0|||
156732751|NCT01314872|565767689|FG009|Period 2|Study terminated by Sponsor|0|||
156732752|NCT01314872|565767690|FG010|Period 2|Study terminated by Sponsor|0|||
156732753|NCT01314872|565767691|FG011|Period 2|Study terminated by Sponsor|2|||
156732754|NCT01314872|565767692|FG012|Period 2|Study terminated by Sponsor|2|||
156732755|NCT01314872|565767693|FG013|Period 2|Study terminated by Sponsor|3|||
156732756|NCT01314872|565767694|FG014|Period 2|Study terminated by Sponsor|0|||
156732757|NCT01314872|565767680|FG000|Period 2|Adverse event, non-fatal|0|||
156732758|NCT01314872|565767681|FG001|Period 2|Adverse event, non-fatal|0|||
156732759|NCT01314872|565767682|FG002|Period 2|Adverse event, non-fatal|0|||
156732760|NCT01314872|565767683|FG003|Period 2|Adverse event, non-fatal|0|||
156732761|NCT01314872|565767684|FG004|Period 2|Adverse event, non-fatal|0|||
156732762|NCT01314872|565767685|FG005|Period 2|Adverse event, non-fatal|0|||
156732763|NCT01314872|565767686|FG006|Period 2|Adverse event, non-fatal|0|||
156732764|NCT01314872|565767687|FG007|Period 2|Adverse event, non-fatal|0|||
156732765|NCT01314872|565767688|FG008|Period 2|Adverse event, non-fatal|0|||
156732766|NCT01314872|565767689|FG009|Period 2|Adverse event, non-fatal|0|||
156732767|NCT01314872|565767690|FG010|Period 2|Adverse event, non-fatal|0|||
156732768|NCT01314872|565767691|FG011|Period 2|Adverse event, non-fatal|13|||
156732769|NCT01314872|565767692|FG012|Period 2|Adverse event, non-fatal|16|||
156732770|NCT01314872|565767693|FG013|Period 2|Adverse event, non-fatal|24|||
156732771|NCT01314872|565767694|FG014|Period 2|Adverse event, non-fatal|9|||
156732772|NCT01314872|565767680|FG000|Period 2|Withdrawal by Subject|0|||
156732773|NCT01314872|565767681|FG001|Period 2|Withdrawal by Subject|0|||
156732774|NCT01314872|565767682|FG002|Period 2|Withdrawal by Subject|0|||
156732775|NCT01314872|565767683|FG003|Period 2|Withdrawal by Subject|0|||
156732776|NCT01314872|565767684|FG004|Period 2|Withdrawal by Subject|0|||
156732777|NCT01314872|565767685|FG005|Period 2|Withdrawal by Subject|0|||
156732778|NCT01314872|565767686|FG006|Period 2|Withdrawal by Subject|0|||
156732779|NCT01314872|565767687|FG007|Period 2|Withdrawal by Subject|0|||
156732780|NCT01314872|565767688|FG008|Period 2|Withdrawal by Subject|0|||
156732781|NCT01314872|565767689|FG009|Period 2|Withdrawal by Subject|0|||
156732782|NCT01314872|565767690|FG010|Period 2|Withdrawal by Subject|0|||
156732783|NCT01314872|565767691|FG011|Period 2|Withdrawal by Subject|14|||
156732784|NCT01314872|565767692|FG012|Period 2|Withdrawal by Subject|17|||
156732785|NCT01314872|565767693|FG013|Period 2|Withdrawal by Subject|12|||
156732786|NCT01314872|565767694|FG014|Period 2|Withdrawal by Subject|4|||
156732787|NCT01314872|565767680|FG000|Period 2|Lost to Follow-up|0|||
156732788|NCT01314872|565767681|FG001|Period 2|Lost to Follow-up|0|||
156732789|NCT01314872|565767682|FG002|Period 2|Lost to Follow-up|0|||
156732790|NCT01314872|565767683|FG003|Period 2|Lost to Follow-up|0|||
156732791|NCT01314872|565767684|FG004|Period 2|Lost to Follow-up|0|||
156732792|NCT01314872|565767685|FG005|Period 2|Lost to Follow-up|0|||
156732793|NCT01314872|565767686|FG006|Period 2|Lost to Follow-up|0|||
156732794|NCT01314872|565767687|FG007|Period 2|Lost to Follow-up|0|||
156732795|NCT01314872|565767688|FG008|Period 2|Lost to Follow-up|0|||
156732796|NCT01314872|565767689|FG009|Period 2|Lost to Follow-up|0|||
156732797|NCT01314872|565767690|FG010|Period 2|Lost to Follow-up|0|||
156732798|NCT01314872|565767691|FG011|Period 2|Lost to Follow-up|6|||
156732799|NCT01314872|565767692|FG012|Period 2|Lost to Follow-up|7|||
156732800|NCT01314872|565767693|FG013|Period 2|Lost to Follow-up|2|||
156732801|NCT01314872|565767694|FG014|Period 2|Lost to Follow-up|6|||
156732802|NCT00199797|565769032|FG000|Overall Study|Progressive Disease|1|||
156732803|NCT00199797|565769032|FG000|Overall Study|Adverse Event|1|||
156732804|NCT00199797|565769032|FG000|Overall Study|Physician Decision|1|||
156732805|NCT00504725|565769035|FG000|Overall Study|Protocol Violation|1|||
156732806|NCT00504725|565769036|FG001|Overall Study|Protocol Violation|0|||
156732807|NCT01435018|565769037|FG000|Overall Study|Death|37|||
156732808|NCT01435018|565769038|FG001|Overall Study|Death|18|||
156732809|NCT01435018|565769039|FG002|Overall Study|Death|25|||
156732810|NCT01435018|565769037|FG000|Overall Study|Site is closing|4|||
156732811|NCT01435018|565769038|FG001|Overall Study|Site is closing|9|||
156732812|NCT01435018|565769039|FG002|Overall Study|Site is closing|7|||
156732813|NCT01435018|565769037|FG000|Overall Study|Withdrew consent|0|||
156732814|NCT01435018|565769038|FG001|Overall Study|Withdrew consent|3|||
156732815|NCT01435018|565769039|FG002|Overall Study|Withdrew consent|1|||
156732816|NCT01435018|565769037|FG000|Overall Study|Not willing to adhere to requirements|0|||
156732817|NCT01435018|565769038|FG001|Overall Study|Not willing to adhere to requirements|2|||
156732818|NCT01435018|565769039|FG002|Overall Study|Not willing to adhere to requirements|3|||
156732819|NCT01435018|565769037|FG000|Overall Study|Not able to get to clinic|2|||
156732820|NCT01435018|565769038|FG001|Overall Study|Not able to get to clinic|0|||
156732821|NCT01435018|565769039|FG002|Overall Study|Not able to get to clinic|2|||
156732822|NCT01435018|565769037|FG000|Overall Study|Severe debilitation, unable to continue|0|||
156732823|NCT01435018|565769038|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156732824|NCT01435018|565769039|FG002|Overall Study|Severe debilitation, unable to continue|1|||
156732825|NCT01435018|565769037|FG000|Overall Study|Unable to contact participant/parent|1|||
156732826|NCT01435018|565769038|FG001|Overall Study|Unable to contact participant/parent|1|||
156732827|NCT01435018|565769039|FG002|Overall Study|Unable to contact participant/parent|1|||
156732828|NCT01435018|565769037|FG000|Overall Study|Enrollment Violation|0|||
156732829|NCT01435018|565769038|FG001|Overall Study|Enrollment Violation|1|||
156732830|NCT01435018|565769039|FG002|Overall Study|Enrollment Violation|0|||
156732831|NCT01435018|565769037|FG000|Overall Study|Never started chemotherapy|3|||
156732832|NCT01435018|565769038|FG001|Overall Study|Never started chemotherapy|0|||
156732833|NCT01435018|565769039|FG002|Overall Study|Never started chemotherapy|1|||
156732834|NCT00378508|565769040|FG000|Overall Study|Withdrawal by Subject|1|||
156732835|NCT00378508|565769041|FG001|Overall Study|Withdrawal by Subject|3|||
156732836|NCT00378508|565769040|FG000|Overall Study|Lost to Follow-up|1|||
156732837|NCT00378508|565769041|FG001|Overall Study|Lost to Follow-up|0|||
156732838|NCT03205761|565769042|FG000|Overall Study|Withdrawal by Subject|1|||
156732839|NCT03205761|565769042|FG000|Overall Study|Progressive Disease|10|||
156732840|NCT00636194|565769043|FG000|Overall Study|Study related symptoms and complaints|1|||
156732841|NCT00636194|565769044|FG001|Overall Study|Study related symptoms and complaints|0|||
156732842|NCT00636194|565769043|FG000|Overall Study|Protocol Violation|2|||
156732843|NCT00636194|565769044|FG001|Overall Study|Protocol Violation|0|||
156732844|NCT00972816|565769046|FG000|Overall Study|Adverse Event|0|||
156732845|NCT00972816|565769047|FG001|Overall Study|Adverse Event|0|||
156732846|NCT00972816|565769048|FG002|Overall Study|Adverse Event|1|||
156732847|NCT00972816|565769049|FG003|Overall Study|Adverse Event|0|||
156732848|NCT00972816|565769050|FG004|Overall Study|Adverse Event|0|||
156732849|NCT00972816|565769051|FG005|Overall Study|Adverse Event|0|||
156732850|NCT00972816|565769052|FG006|Overall Study|Adverse Event|0|||
156732851|NCT00972816|565769053|FG007|Overall Study|Adverse Event|0|||
156732852|NCT00972816|565769046|FG000|Overall Study|Withdrawal by Subject|4|||
156732853|NCT00972816|565769047|FG001|Overall Study|Withdrawal by Subject|2|||
156732854|NCT00972816|565769048|FG002|Overall Study|Withdrawal by Subject|1|||
156732855|NCT00972816|565769049|FG003|Overall Study|Withdrawal by Subject|3|||
156732856|NCT00972816|565769050|FG004|Overall Study|Withdrawal by Subject|0|||
156732857|NCT00972816|565769051|FG005|Overall Study|Withdrawal by Subject|1|||
156732858|NCT00972816|565769052|FG006|Overall Study|Withdrawal by Subject|1|||
156732859|NCT00972816|565769053|FG007|Overall Study|Withdrawal by Subject|2|||
156732860|NCT00972816|565769046|FG000|Overall Study|Lost to Follow-up|11|||
156732861|NCT00972816|565769047|FG001|Overall Study|Lost to Follow-up|9|||
156732862|NCT00972816|565769048|FG002|Overall Study|Lost to Follow-up|7|||
156732863|NCT00972816|565769049|FG003|Overall Study|Lost to Follow-up|5|||
156732864|NCT00972816|565769050|FG004|Overall Study|Lost to Follow-up|11|||
156732865|NCT00972816|565769051|FG005|Overall Study|Lost to Follow-up|10|||
156732866|NCT00972816|565769052|FG006|Overall Study|Lost to Follow-up|7|||
156732867|NCT00972816|565769053|FG007|Overall Study|Lost to Follow-up|7|||
156732868|NCT00972816|565769046|FG000|Overall Study|Inappropriate enrolment|0|||
156732869|NCT00972816|565769047|FG001|Overall Study|Inappropriate enrolment|0|||
156732870|NCT00972816|565769048|FG002|Overall Study|Inappropriate enrolment|0|||
156732871|NCT00972816|565769049|FG003|Overall Study|Inappropriate enrolment|0|||
156732872|NCT00972816|565769050|FG004|Overall Study|Inappropriate enrolment|0|||
156732873|NCT00972816|565769051|FG005|Overall Study|Inappropriate enrolment|0|||
156732874|NCT00972816|565769052|FG006|Overall Study|Inappropriate enrolment|2|||
156732875|NCT00972816|565769053|FG007|Overall Study|Inappropriate enrolment|0|||
156732876|NCT00972816|565769046|FG000|Overall Study|Unable to classify|2|||
156732877|NCT00972816|565769047|FG001|Overall Study|Unable to classify|0|||
156732878|NCT00972816|565769048|FG002|Overall Study|Unable to classify|0|||
156732879|NCT00972816|565769049|FG003|Overall Study|Unable to classify|0|||
156732880|NCT00972816|565769050|FG004|Overall Study|Unable to classify|1|||
156732881|NCT00972816|565769051|FG005|Overall Study|Unable to classify|0|||
156732882|NCT00972816|565769052|FG006|Overall Study|Unable to classify|0|||
156336481|NCT00289133|564329612|FG001|Overall Study|Protocol Violation|38|||
156732883|NCT00972816|565769053|FG007|Overall Study|Unable to classify|0|||
156732884|NCT02163226|565769054|FG000|Overall Study|Death|2|||
156732885|NCT02163226|565769055|FG001|Overall Study|Death|1|||
156732886|NCT02163226|565769054|FG000|Overall Study|Withdrawal by Subject|5|||
156732887|NCT02163226|565769055|FG001|Overall Study|Withdrawal by Subject|2|||
156732888|NCT02163226|565769054|FG000|Overall Study|Returned home, local radiotherapy|3|||
156732889|NCT02163226|565769055|FG001|Overall Study|Returned home, local radiotherapy|0|||
156732890|NCT02163226|565769054|FG000|Overall Study|Repeat imaging showed no disease|2|||
156732891|NCT02163226|565769055|FG001|Overall Study|Repeat imaging showed no disease|0|||
156732892|NCT02163226|565769054|FG000|Overall Study|Incomplete radiotherapy|3|||
156732893|NCT02163226|565769055|FG001|Overall Study|Incomplete radiotherapy|0|||
156732894|NCT02163226|565769054|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
156732895|NCT02163226|565769055|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
156732896|NCT02163226|565769054|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
156732897|NCT02163226|565769055|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
156732898|NCT02163226|565769054|FG000|Overall Study|ineligible|0|||
156732899|NCT02163226|565769055|FG001|Overall Study|ineligible|3|||
156732900|NCT00593684|565769058|FG000|Overall Study|Death|2|||
156732901|NCT00593684|565769059|FG001|Overall Study|Death|1|||
156732902|NCT03625466|565769060|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
156732903|NCT03625466|565769061|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
156732904|NCT03625466|565769062|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
156732905|NCT03625466|565769060|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
156732906|NCT03625466|565769061|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
156732907|NCT03625466|565769062|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
156732908|NCT03625466|565769060|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
156732909|NCT03625466|565769061|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
156732910|NCT03625466|565769062|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
156732911|NCT05318092|565769064|FG000|Overall Study|Lost to Follow-up|3|||
156732912|NCT05318092|565769064|FG000|Overall Study|Withdrawal by Subject|1|||
156732913|NCT01905553|565769069|FG000|Period 2|Adverse Event|1|||
156732914|NCT01905553|565769070|FG001|Period 2|Adverse Event|0|||
156732915|NCT04696055|565769072|FG000|Overall Study|Adverse Event|10|||
156732916|NCT04696055|565769073|FG001|Overall Study|Adverse Event|2|||
156732917|NCT04696055|565769072|FG000|Overall Study|Death|4|||
156732918|NCT04696055|565769073|FG001|Overall Study|Death|0|||
156732919|NCT04696055|565769072|FG000|Overall Study|Other|7|||
156732920|NCT04696055|565769073|FG001|Overall Study|Other|2|||
156732921|NCT04696055|565769072|FG000|Overall Study|Physician Decision|3|||
156732922|NCT04696055|565769073|FG001|Overall Study|Physician Decision|0|||
156732923|NCT04696055|565769072|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
156732924|NCT04696055|565769073|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
156732925|NCT04696055|565769072|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
156732926|NCT04696055|565769073|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
156732927|NCT04696055|565769072|FG000|Overall Study|Subject Decision|1|||
156732928|NCT04696055|565769073|FG001|Overall Study|Subject Decision|2|||
156732929|NCT03969901|565769074|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156732930|NCT03969901|565769075|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156732931|NCT03969901|565769076|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156732932|NCT03969901|565769077|FG003|Overall Study|Withdrawal by parent/guardian|0|||
156732933|NCT03969901|565769078|FG004|Overall Study|Withdrawal by parent/guardian|1|||
156732934|NCT03969901|565769079|FG005|Overall Study|Withdrawal by parent/guardian|0|||
156732935|NCT03969901|565769080|FG006|Overall Study|Withdrawal by parent/guardian|0|||
156732936|NCT03969901|565769081|FG007|Overall Study|Withdrawal by parent/guardian|1|||
156732937|NCT03969901|565769082|FG008|Overall Study|Withdrawal by parent/guardian|1|||
156876596|NCT01945710|566307644|FG000|Overall Study|Other|2|||
156876597|NCT01945710|566307645|FG001|Overall Study|Other|0|||
156732938|NCT03969901|565769083|FG009|Overall Study|Withdrawal by parent/guardian|0|||
156732939|NCT00348595|565769084|FG000|Overall Study|Adverse Event|5|||
156732940|NCT00348595|565769085|FG001|Overall Study|Adverse Event|8|||
156732941|NCT00610155|565769090|FG000|Period 1|Withdrawal by Subject|0|||
156732942|NCT00610155|565769091|FG001|Period 1|Withdrawal by Subject|0|||
156876598|NCT01945710|566307646|FG002|Overall Study|Other|3|||
156876599|NCT01945710|566307647|FG003|Overall Study|Other|1|||
156732943|NCT00610155|565769092|FG002|Period 1|Withdrawal by Subject|1|||
156732944|NCT00610155|565769093|FG003|Period 1|Withdrawal by Subject|0|||
156732945|NCT00610155|565769094|FG004|Period 1|Withdrawal by Subject|0|||
156732946|NCT00610155|565769095|FG005|Period 1|Withdrawal by Subject|0|||
156732947|NCT00610155|565769090|FG000|Period 3|Adverse Event|1|||
156732948|NCT00610155|565769091|FG001|Period 3|Adverse Event|0|||
156732949|NCT00610155|565769092|FG002|Period 3|Adverse Event|0|||
156732950|NCT00610155|565769093|FG003|Period 3|Adverse Event|0|||
156732951|NCT00610155|565769094|FG004|Period 3|Adverse Event|0|||
156732952|NCT00610155|565769095|FG005|Period 3|Adverse Event|0|||
156876600|NCT01945710|566307648|FG004|Overall Study|Other|1|||
156876601|NCT01945710|566307649|FG005|Overall Study|Other|0|||
156732953|NCT03192306|565769100|FG000|Overall Study|Did not treat cold sore during study|149|||
156732954|NCT03192306|565769101|FG001|Overall Study|Did not treat cold sore during study|143|||
156732955|NCT03192306|565769100|FG000|Overall Study|Withdrawal by Subject|1|||
156732956|NCT03192306|565769101|FG001|Overall Study|Withdrawal by Subject|1|||
156732957|NCT03192306|565769100|FG000|Overall Study|Lost to Follow-up|1|||
156732958|NCT03192306|565769101|FG001|Overall Study|Lost to Follow-up|0|||
156732959|NCT03192306|565769100|FG000|Overall Study|Protocol Violation|1|||
156732960|NCT03192306|565769101|FG001|Overall Study|Protocol Violation|1|||
156732961|NCT02589626|565769106|FG000|Overall Study|Other than the reason specified|1|||
156732962|NCT02589626|565769107|FG001|Overall Study|Other than the reason specified|0|||
156732963|NCT02589626|565769106|FG000|Overall Study|Withdrawal by Subject|1|||
156732964|NCT02589626|565769107|FG001|Overall Study|Withdrawal by Subject|1|||
156732965|NCT02589626|565769106|FG000|Overall Study|Adverse Event|1|||
156732966|NCT02589626|565769107|FG001|Overall Study|Adverse Event|1|||
156732967|NCT03645395|565769108|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
156732968|NCT03645395|565769109|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
156732969|NCT03645395|565769110|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
156732970|NCT03645395|565769111|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
156732971|NCT03645395|565769108|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
156732972|NCT03645395|565769109|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
156732973|NCT03645395|565769110|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
156732974|NCT03645395|565769111|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
156732975|NCT03645395|565769108|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
156732976|NCT03645395|565769109|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
156732977|NCT03645395|565769110|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
156732978|NCT03645395|565769111|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
156732979|NCT03645395|565769108|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
156732980|NCT03645395|565769109|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
156732981|NCT03645395|565769110|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
156732982|NCT03645395|565769111|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
156732983|NCT00379080|565769112|FG000|Overall Study|Withdrawal by Subject|0|||
156732984|NCT00379080|565769113|FG001|Overall Study|Withdrawal by Subject|4|||
156732985|NCT00379080|565769114|FG002|Overall Study|Withdrawal by Subject|0|||
156732986|NCT01250873|565769126|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
156732987|NCT01250873|565769126|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
156732988|NCT01127451|565769130|FG000|Overall Study|Other|2|||
156732989|NCT01127451|565769131|FG001|Overall Study|Other|1|||
156732990|NCT01127451|565769130|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
156732991|NCT01127451|565769131|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
156732992|NCT01127451|565769130|FG000|Overall Study|Death|22|||
156732993|NCT01127451|565769131|FG001|Overall Study|Death|17|||
156732994|NCT01127451|565769130|FG000|Overall Study|Lost to Follow-up|3|||
156732995|NCT01127451|565769131|FG001|Overall Study|Lost to Follow-up|0|||
156732996|NCT01127451|565769130|FG000|Overall Study|Administrative Reason by Sponsor|2|||
156732997|NCT01127451|565769131|FG001|Overall Study|Administrative Reason by Sponsor|2|||
156732998|NCT02429778|565769133|FG000|Overall Study|Lost to Follow-up|2|||
156732999|NCT02429778|565769134|FG001|Overall Study|Lost to Follow-up|0|||
156733000|NCT02429778|565769133|FG000|Overall Study|Withdrawal by Subject|5|||
156733001|NCT02429778|565769134|FG001|Overall Study|Withdrawal by Subject|0|||
156733002|NCT02475265|565769135|FG000|Overall Study|Physician Decision|1|||
156733003|NCT02475265|565769135|FG000|Overall Study|Withdrawal by Subject|2|||
156733004|NCT03499899|565769136|FG000|Overall Study|Adverse Event|2|||
156733005|NCT03499899|565769137|FG001|Overall Study|Adverse Event|3|||
156733006|NCT03499899|565769138|FG002|Overall Study|Adverse Event|3|||
156733007|NCT03499899|565769136|FG000|Overall Study|Death|0|||
156733008|NCT03499899|565769137|FG001|Overall Study|Death|0|||
156733009|NCT03499899|565769138|FG002|Overall Study|Death|1|||
156533715|NCT02608879|565048893|FG000|Overall Study|Did not meet continuation criteria|0|||
156533716|NCT02608879|565048894|FG001|Overall Study|Did not meet continuation criteria|0|||
156533717|NCT02608879|565048895|FG002|Overall Study|Did not meet continuation criteria|3|||
156733010|NCT03499899|565769136|FG000|Overall Study|Physician Decision|3|||
156733011|NCT03499899|565769137|FG001|Overall Study|Physician Decision|6|||
156733012|NCT03499899|565769138|FG002|Overall Study|Physician Decision|6|||
156733013|NCT03499899|565769136|FG000|Overall Study|Progressive disease|15|||
156733014|NCT03499899|565769137|FG001|Overall Study|Progressive disease|23|||
156733015|NCT03499899|565769138|FG002|Overall Study|Progressive disease|23|||
156733016|NCT03499899|565769136|FG000|Overall Study|Patient decision|0|||
156733017|NCT03499899|565769137|FG001|Overall Study|Patient decision|1|||
156733018|NCT03499899|565769138|FG002|Overall Study|Patient decision|1|||
156733019|NCT03499899|565769136|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
156733020|NCT03499899|565769137|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
156733021|NCT03499899|565769138|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
156733022|NCT04590586|565769143|FG000|Overall Study|Death|7|||
156533718|NCT01840605|565048896|FG000|Overall Study|Adverse Event|0|||
156455620|NCT02861300|564763158|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
156455621|NCT02861300|564763159|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
156733023|NCT04590586|565769144|FG001|Overall Study|Death|1|||
156733024|NCT04590586|565769145|FG002|Overall Study|Death|37|||
156733025|NCT04590586|565769146|FG003|Overall Study|Death|34|||
156733026|NCT04590586|565769147|FG004|Overall Study|Death|19|||
156733027|NCT04590586|565769148|FG005|Overall Study|Death|3|||
156733028|NCT04590586|565769143|FG000|Overall Study|Lost to Follow-up|3|||
156733029|NCT04590586|565769144|FG001|Overall Study|Lost to Follow-up|0|||
156733030|NCT04590586|565769145|FG002|Overall Study|Lost to Follow-up|11|||
156733031|NCT04590586|565769146|FG003|Overall Study|Lost to Follow-up|11|||
156733032|NCT04590586|565769147|FG004|Overall Study|Lost to Follow-up|6|||
156733033|NCT04590586|565769148|FG005|Overall Study|Lost to Follow-up|0|||
156733034|NCT04590586|565769143|FG000|Overall Study|Withdrawal by Subject|0|||
156733035|NCT04590586|565769144|FG001|Overall Study|Withdrawal by Subject|0|||
156733036|NCT04590586|565769145|FG002|Overall Study|Withdrawal by Subject|6|||
156733037|NCT04590586|565769146|FG003|Overall Study|Withdrawal by Subject|0|||
156733038|NCT04590586|565769147|FG004|Overall Study|Withdrawal by Subject|3|||
156733039|NCT04590586|565769148|FG005|Overall Study|Withdrawal by Subject|0|||
156733040|NCT04590586|565769143|FG000|Overall Study|Other|3|||
156733041|NCT04590586|565769144|FG001|Overall Study|Other|0|||
156733042|NCT04590586|565769145|FG002|Overall Study|Other|1|||
156733043|NCT04590586|565769146|FG003|Overall Study|Other|1|||
156733044|NCT04590586|565769147|FG004|Overall Study|Other|2|||
156733045|NCT04590586|565769148|FG005|Overall Study|Other|1|||
156733046|NCT03063086|565769149|FG000|Overall Study|technical problems|1|||
156733047|NCT03063086|565769150|FG001|Overall Study|technical problems|0|||
156733048|NCT03063086|565769151|FG002|Overall Study|technical problems|0|||
156733049|NCT03063086|565769152|FG003|Overall Study|technical problems|0|||
156733050|NCT03063086|565769153|FG004|Overall Study|technical problems|0|||
156733051|NCT03063086|565769154|FG005|Overall Study|technical problems|0|||
156733052|NCT03063086|565769149|FG000|Overall Study|Adverse Event|1|||
156733053|NCT03063086|565769150|FG001|Overall Study|Adverse Event|1|||
156733054|NCT03063086|565769151|FG002|Overall Study|Adverse Event|1|||
156733055|NCT03063086|565769152|FG003|Overall Study|Adverse Event|1|||
156733056|NCT03063086|565769153|FG004|Overall Study|Adverse Event|0|||
156733057|NCT03063086|565769154|FG005|Overall Study|Adverse Event|0|||
156733058|NCT03063086|565769149|FG000|Overall Study|subject/guardian decision|1|||
156733059|NCT03063086|565769150|FG001|Overall Study|subject/guardian decision|0|||
156733060|NCT03063086|565769151|FG002|Overall Study|subject/guardian decision|0|||
156733061|NCT03063086|565769152|FG003|Overall Study|subject/guardian decision|0|||
156733062|NCT03063086|565769153|FG004|Overall Study|subject/guardian decision|0|||
156733063|NCT03063086|565769154|FG005|Overall Study|subject/guardian decision|0|||
156733064|NCT03063086|565769149|FG000|Overall Study|Non-compliance with study treatment|0|||
156733065|NCT03063086|565769150|FG001|Overall Study|Non-compliance with study treatment|0|||
156733066|NCT03063086|565769151|FG002|Overall Study|Non-compliance with study treatment|0|||
156733067|NCT03063086|565769152|FG003|Overall Study|Non-compliance with study treatment|1|||
156733068|NCT03063086|565769153|FG004|Overall Study|Non-compliance with study treatment|0|||
156733069|NCT03063086|565769154|FG005|Overall Study|Non-compliance with study treatment|1|||
156733070|NCT03063086|565769149|FG000|Overall Study|Physician Decision|0|||
156733071|NCT03063086|565769150|FG001|Overall Study|Physician Decision|0|||
156733072|NCT03063086|565769151|FG002|Overall Study|Physician Decision|0|||
156733073|NCT03063086|565769152|FG003|Overall Study|Physician Decision|1|||
156733074|NCT03063086|565769153|FG004|Overall Study|Physician Decision|0|||
156733075|NCT03063086|565769154|FG005|Overall Study|Physician Decision|0|||
156733076|NCT01893281|565769155|FG000|Overall Study|Adverse Event|1|||
156733077|NCT01893281|565769155|FG000|Overall Study|Protocol Violation|1|||
156733078|NCT01893281|565769155|FG000|Overall Study|Withdrawal by Subject|1|||
156733079|NCT03474731|565769159|FG000|Overall Study|Withdrawal by Subject|36|||
156733080|NCT03474731|565769160|FG001|Overall Study|Withdrawal by Subject|29|||
156733081|NCT03474731|565769161|FG002|Overall Study|Withdrawal by Subject|11|||
156733082|NCT03474731|565769162|FG003|Overall Study|Withdrawal by Subject|27|||
156455622|NCT02861300|564763153|FG000|Overall Study|Clinical Complications|0|||
156455623|NCT02861300|564763154|FG001|Overall Study|Clinical Complications|0|||
156455624|NCT02861300|564763155|FG002|Overall Study|Clinical Complications|0|||
156455625|NCT02861300|564763156|FG003|Overall Study|Clinical Complications|0|||
156455626|NCT02861300|564763157|FG004|Overall Study|Clinical Complications|0|||
156733083|NCT03474731|565769159|FG000|Overall Study|COVID|0|||
156733084|NCT03474731|565769160|FG001|Overall Study|COVID|23|||
156733085|NCT03474731|565769161|FG002|Overall Study|COVID|0|||
156733086|NCT03474731|565769162|FG003|Overall Study|COVID|0|||
156733087|NCT03474731|565769159|FG000|Overall Study|Participant moved from area|1|||
156733088|NCT03474731|565769160|FG001|Overall Study|Participant moved from area|0|||
156733089|NCT03474731|565769161|FG002|Overall Study|Participant moved from area|0|||
156733090|NCT03474731|565769162|FG003|Overall Study|Participant moved from area|0|||
156733091|NCT03474731|565769159|FG000|Overall Study|Lost to Follow-up|11|||
156733092|NCT03474731|565769160|FG001|Overall Study|Lost to Follow-up|3|||
156733093|NCT03474731|565769161|FG002|Overall Study|Lost to Follow-up|18|||
156733094|NCT03474731|565769162|FG003|Overall Study|Lost to Follow-up|17|||
156733095|NCT03474731|565769159|FG000|Overall Study|Death|0|||
156733096|NCT03474731|565769160|FG001|Overall Study|Death|1|||
156733097|NCT03474731|565769161|FG002|Overall Study|Death|0|||
156733098|NCT03474731|565769162|FG003|Overall Study|Death|0|||
156733099|NCT03474731|565769159|FG000|Overall Study|Participant Removed|0|||
156733100|NCT03474731|565769160|FG001|Overall Study|Participant Removed|0|||
156733101|NCT03474731|565769161|FG002|Overall Study|Participant Removed|0|||
156733102|NCT03474731|565769162|FG003|Overall Study|Participant Removed|1|||
156733103|NCT00675428|565769164|FG000|Overall Study|Disease Progression|2|||
156733104|NCT00675428|565769165|FG001|Overall Study|Disease Progression|2|||
156733105|NCT00675428|565769164|FG000|Overall Study|No Disease Response After Cycle 6|0|||
156733106|NCT00675428|565769165|FG001|Overall Study|No Disease Response After Cycle 6|1|||
156733107|NCT00675428|565769164|FG000|Overall Study|Physician Decision|1|||
156733108|NCT00675428|565769165|FG001|Overall Study|Physician Decision|0|||
156733109|NCT00886743|565769167|FG000|Overall Study|Adverse Event|3|||
156733110|NCT00886743|565769167|FG000|Overall Study|Other|1|||
156733111|NCT04105218|565769168|FG000|Overall Study|Withdrawal by Subject|3|||
156733112|NCT04105218|565769169|FG001|Overall Study|Withdrawal by Subject|2|||
156733113|NCT04105218|565769168|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
156733114|NCT04105218|565769169|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
156733115|NCT04105218|565769168|FG000|Overall Study|Failed screening tests|2|||
156733116|NCT04105218|565769169|FG001|Overall Study|Failed screening tests|1|||
156733117|NCT00550043|565769170|FG000|Overall Study|Adverse Event|0|||
156733118|NCT00550043|565769171|FG001|Overall Study|Adverse Event|0|||
156733119|NCT00550043|565769172|FG002|Overall Study|Adverse Event|0|||
156733120|NCT00550043|565769173|FG003|Overall Study|Adverse Event|1|||
156733121|NCT00550043|565769174|FG004|Overall Study|Adverse Event|1|||
156733122|NCT00550043|565769170|FG000|Overall Study|Subject Withdrew Consent|0|||
156733123|NCT00550043|565769171|FG001|Overall Study|Subject Withdrew Consent|2|||
156733124|NCT00550043|565769172|FG002|Overall Study|Subject Withdrew Consent|1|||
156733125|NCT00550043|565769173|FG003|Overall Study|Subject Withdrew Consent|0|||
156733126|NCT00550043|565769174|FG004|Overall Study|Subject Withdrew Consent|0|||
156733127|NCT00550043|565769170|FG000|Overall Study|Other Reasons- Unspecified|0|||
156733128|NCT00550043|565769171|FG001|Overall Study|Other Reasons- Unspecified|1|||
156733129|NCT00550043|565769172|FG002|Overall Study|Other Reasons- Unspecified|0|||
156733130|NCT00550043|565769173|FG003|Overall Study|Other Reasons- Unspecified|1|||
156733131|NCT00550043|565769174|FG004|Overall Study|Other Reasons- Unspecified|0|||
156733132|NCT01870973|565769175|FG000|Overall Study|Lost to Follow-up|10|||
156733133|NCT01870973|565769176|FG001|Overall Study|Lost to Follow-up|3|||
156733134|NCT04310397|565771010|FG000|Overall Study|Lack of Efficacy|3|||
156733135|NCT04310397|565771010|FG000|Overall Study|Withdrawal by Subject|1|||
156733136|NCT00723255|565771013|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
156733137|NCT00723255|565771013|FG000|Overall Study|Ineligible: Second primary|1|||
156733138|NCT00723255|565771013|FG000|Overall Study|Ineligible: Wrong Primary|2|||
156733139|NCT00614523|565771016|FG000|Overall Study|Adverse Event|4|||
156733140|NCT00614523|565771017|FG001|Overall Study|Adverse Event|20|||
156733141|NCT00614523|565771016|FG000|Overall Study|Death|5|||
156733142|NCT00614523|565771017|FG001|Overall Study|Death|8|||
156733143|NCT00614523|565771016|FG000|Overall Study|Lack of Efficacy|9|||
156733144|NCT00614523|565771017|FG001|Overall Study|Lack of Efficacy|11|||
156733145|NCT00614523|565771016|FG000|Overall Study|Lost to Follow-up|0|||
156733146|NCT00614523|565771017|FG001|Overall Study|Lost to Follow-up|1|||
156733147|NCT00614523|565771016|FG000|Overall Study|Protocol Violation|3|||
156733148|NCT00614523|565771017|FG001|Overall Study|Protocol Violation|2|||
156733149|NCT00614523|565771016|FG000|Overall Study|Withdrawal by Subject|12|||
156796708|NCT01822925|566009652|FG003|Overall Study|Taking prohibited medication|1|||
156796709|NCT01905540|566009655|FG000|Period 3|Other|1|||
156336482|NCT00289133|564329611|FG000|Overall Study|Withdrawal by Subject|9|||
156533719|NCT01840605|565048897|FG001|Overall Study|Adverse Event|1|||
156533720|NCT01840605|565048896|FG000|Overall Study|Physician Decision|2|||
156533721|NCT01840605|565048897|FG001|Overall Study|Physician Decision|1|||
156533722|NCT03739437|565048898|FG000|Overall Study|Lost to Follow-up|2|||
156733150|NCT00614523|565771017|FG001|Overall Study|Withdrawal by Subject|22|||
156733151|NCT00614523|565771016|FG000|Overall Study|Other|6|||
156733152|NCT00614523|565771017|FG001|Overall Study|Other|11|||
156733153|NCT00614523|565771016|FG000|Overall Study|Ineligibility Determined|1|||
156733154|NCT00614523|565771017|FG001|Overall Study|Ineligibility Determined|2|||
156533723|NCT03739437|565048899|FG001|Overall Study|Lost to Follow-up|5|||
156733155|NCT00614523|565771016|FG000|Overall Study|Disease Progression|0|||
156733156|NCT00614523|565771017|FG001|Overall Study|Disease Progression|8|||
156733157|NCT00614523|565771016|FG000|Overall Study|Administrative Decision|23|||
156733158|NCT00614523|565771017|FG001|Overall Study|Administrative Decision|46|||
156733159|NCT03962790|565771018|FG000|Period 1|Adverse Event|0|||
156733160|NCT03962790|565771019|FG001|Period 1|Adverse Event|1|||
156733161|NCT03962790|565771018|FG000|Period 1|Failed to meet all eligibility criteria|1|||
156733162|NCT03962790|565771019|FG001|Period 1|Failed to meet all eligibility criteria|1|||
156733163|NCT03962790|565771018|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
156733164|NCT03962790|565771019|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
156733165|NCT03962790|565771018|FG000|Period 1|Withdrawal by Subject|1|||
156733166|NCT03962790|565771019|FG001|Period 1|Withdrawal by Subject|0|||
156733167|NCT03854370|565771029|FG000|Overall Study|samples not collected|1|||
156733168|NCT03854370|565771030|FG001|Overall Study|samples not collected|1|||
156733169|NCT03854370|565771031|FG002|Overall Study|samples not collected|1|||
156733170|NCT03854370|565771032|FG003|Overall Study|samples not collected|1|||
156733171|NCT00452673|565771036|FG000|Dose Escalation Period|Disease Progression|6|||
156733172|NCT00452673|565771037|FG001|Dose Escalation Period|Disease Progression|6|||
156733173|NCT00452673|565771038|FG002|Dose Escalation Period|Disease Progression|2|||
156733174|NCT00452673|565771039|FG003|Dose Escalation Period|Disease Progression|6|||
156733175|NCT00452673|565771040|FG004|Dose Escalation Period|Disease Progression|0|||
156733176|NCT00452673|565771036|FG000|Dose Escalation Period|study drug toxicity|1|||
156733177|NCT00452673|565771037|FG001|Dose Escalation Period|study drug toxicity|3|||
156733178|NCT00452673|565771038|FG002|Dose Escalation Period|study drug toxicity|3|||
156733179|NCT00452673|565771039|FG003|Dose Escalation Period|study drug toxicity|1|||
156733180|NCT00452673|565771040|FG004|Dose Escalation Period|study drug toxicity|0|||
156733181|NCT00452673|565771036|FG000|Dose Escalation Period|Other|0|||
156733182|NCT00452673|565771037|FG001|Dose Escalation Period|Other|0|||
156733183|NCT00452673|565771038|FG002|Dose Escalation Period|Other|1|||
156733184|NCT00452673|565771039|FG003|Dose Escalation Period|Other|0|||
156733185|NCT00452673|565771040|FG004|Dose Escalation Period|Other|0|||
156733186|NCT00452673|565771036|FG000|Dose Escalation Period|Adverse Event|0|||
156733187|NCT00452673|565771037|FG001|Dose Escalation Period|Adverse Event|0|||
156733188|NCT00452673|565771038|FG002|Dose Escalation Period|Adverse Event|0|||
156733189|NCT00452673|565771039|FG003|Dose Escalation Period|Adverse Event|1|||
156733190|NCT00452673|565771040|FG004|Dose Escalation Period|Adverse Event|0|||
156733191|NCT00452673|565771036|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
156733192|NCT00452673|565771037|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
156733193|NCT00452673|565771038|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
156733194|NCT00452673|565771039|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
156733195|NCT00452673|565771040|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
156733196|NCT00452673|565771036|FG000|Dose Expansion Period|Disease Progression|0|||
156733197|NCT00452673|565771037|FG001|Dose Expansion Period|Disease Progression|0|||
156733198|NCT00452673|565771038|FG002|Dose Expansion Period|Disease Progression|0|||
156733199|NCT00452673|565771039|FG003|Dose Expansion Period|Disease Progression|0|||
156733200|NCT00452673|565771040|FG004|Dose Expansion Period|Disease Progression|19|||
156733201|NCT00452673|565771036|FG000|Dose Expansion Period|Other|0|||
156733202|NCT00452673|565771037|FG001|Dose Expansion Period|Other|0|||
156733203|NCT00452673|565771038|FG002|Dose Expansion Period|Other|0|||
156733204|NCT00452673|565771039|FG003|Dose Expansion Period|Other|0|||
156733205|NCT00452673|565771040|FG004|Dose Expansion Period|Other|2|||
156733206|NCT02656290|565771041|FG000|Overall Study|Lost to Follow-up|1|||
156733207|NCT02656290|565771041|FG000|Overall Study|Reintervention|3|||
156733208|NCT00664859|565771044|FG000|Overall Study|Adverse Event|2|||
156733209|NCT00664859|565771045|FG001|Overall Study|Adverse Event|1|||
156733210|NCT00664859|565771046|FG002|Overall Study|Adverse Event|3|||
156733211|NCT00664859|565771044|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
156733212|NCT00664859|565771045|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
156733213|NCT00664859|565771046|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
156733214|NCT00664859|565771044|FG000|Overall Study|Noncompliance with protocol|1|||
156733215|NCT00664859|565771045|FG001|Overall Study|Noncompliance with protocol|0|||
156876602|NCT01945710|566307650|FG006|Overall Study|Other|4|||
156876603|NCT01945710|566307644|FG000|Overall Study|Withdrawal by Subject|0|||
156876604|NCT01945710|566307645|FG001|Overall Study|Withdrawal by Subject|1|||
156876605|NCT01945710|566307646|FG002|Overall Study|Withdrawal by Subject|1|||
156876606|NCT01945710|566307647|FG003|Overall Study|Withdrawal by Subject|0|||
156876607|NCT01945710|566307648|FG004|Overall Study|Withdrawal by Subject|1|||
156876608|NCT01945710|566307649|FG005|Overall Study|Withdrawal by Subject|0|||
156876609|NCT01945710|566307650|FG006|Overall Study|Withdrawal by Subject|0|||
156876610|NCT02730195|566307653|FG000|Overall Study|Withdrawal by Subject|1|||
156876611|NCT01239992|566307655|FG000|Overall Study|Withdrawal by Subject|2|||
156876612|NCT00535288|566307656|FG000|Overall Study|Adverse Event|20|||
156733216|NCT00664859|565771046|FG002|Overall Study|Noncompliance with protocol|4|||
156733217|NCT00664859|565771044|FG000|Overall Study|Laboratory abnormality|2|||
156733218|NCT00664859|565771045|FG001|Overall Study|Laboratory abnormality|1|||
156733219|NCT00664859|565771046|FG002|Overall Study|Laboratory abnormality|4|||
156733220|NCT00664859|565771044|FG000|Overall Study|Withdrawal by Subject|4|||
156733221|NCT00664859|565771045|FG001|Overall Study|Withdrawal by Subject|1|||
156733222|NCT00664859|565771046|FG002|Overall Study|Withdrawal by Subject|3|||
156876613|NCT00535288|566307657|FG001|Overall Study|Adverse Event|19|||
156876614|NCT00535288|566307658|FG002|Overall Study|Adverse Event|25|||
156876615|NCT00535288|566307659|FG003|Overall Study|Adverse Event|20|||
156733223|NCT00664859|565771044|FG000|Overall Study|Lost to Follow-up|2|||
156733224|NCT00664859|565771045|FG001|Overall Study|Lost to Follow-up|2|||
156733225|NCT00664859|565771046|FG002|Overall Study|Lost to Follow-up|1|||
156876616|NCT00535288|566307660|FG004|Overall Study|Adverse Event|30|||
156733226|NCT00664859|565771044|FG000|Overall Study|Other|0|||
156733227|NCT00664859|565771045|FG001|Overall Study|Other|1|||
156733228|NCT00664859|565771046|FG002|Overall Study|Other|2|||
156733229|NCT00748189|565771047|FG000|Overall Study|Death|99|||
156733230|NCT00748189|565771048|FG001|Overall Study|Death|84|||
156733231|NCT00748189|565771047|FG000|Overall Study|Withdrawal by Subject|23|||
156733232|NCT00748189|565771048|FG001|Overall Study|Withdrawal by Subject|29|||
156733233|NCT00748189|565771047|FG000|Overall Study|Physician Decision|16|||
156733234|NCT00748189|565771048|FG001|Overall Study|Physician Decision|5|||
156733235|NCT00748189|565771047|FG000|Overall Study|Lost to Follow-up|8|||
156733236|NCT00748189|565771048|FG001|Overall Study|Lost to Follow-up|15|||
156733237|NCT00748189|565771047|FG000|Overall Study|Study terminated by Sponsor|70|||
156733238|NCT00748189|565771048|FG001|Overall Study|Study terminated by Sponsor|79|||
156733239|NCT04481191|565771055|FG000|Overall Study|Withdrawn by parent/guardian|15|||
156733240|NCT04481191|565771056|FG001|Overall Study|Withdrawn by parent/guardian|10|||
156733241|NCT00546117|565771061|FG000|Overall Study|Withdrawal by Subject|3|||
156733242|NCT00546117|565771062|FG001|Overall Study|Withdrawal by Subject|0|||
156733243|NCT00546117|565771061|FG000|Overall Study|Inability to schedule follow-up visit|1|||
156733244|NCT00546117|565771062|FG001|Overall Study|Inability to schedule follow-up visit|0|||
156733245|NCT04984278|565771068|FG000|Period 1|Withdrawal by Subject|1|||
156733246|NCT04984278|565771069|FG001|Period 1|Withdrawal by Subject|0|||
156733247|NCT04984278|565771068|FG000|Period 1|Other|0|||
156733248|NCT04984278|565771069|FG001|Period 1|Other|1|||
156733249|NCT04984278|565771068|FG000|Period 2|Adverse Event|1|||
156733250|NCT04984278|565771069|FG001|Period 2|Adverse Event|0|||
156733251|NCT04984278|565771068|FG000|Period 2|Other|0|||
156733252|NCT04984278|565771069|FG001|Period 2|Other|1|||
156733253|NCT02564900|565771070|FG000|Dose Escalation|Progressive disease per RECIST|2|||
156733254|NCT02564900|565771071|FG001|Dose Escalation|Progressive disease per RECIST|3|||
156733255|NCT02564900|565771072|FG002|Dose Escalation|Progressive disease per RECIST|3|||
156733256|NCT02564900|565771073|FG003|Dose Escalation|Progressive disease per RECIST|3|||
156733257|NCT02564900|565771074|FG004|Dose Escalation|Progressive disease per RECIST|3|||
156733258|NCT02564900|565771075|FG005|Dose Escalation|Progressive disease per RECIST|1|||
156733259|NCT02564900|565771076|FG006|Dose Escalation|Progressive disease per RECIST|0|||
156733260|NCT02564900|565771077|FG007|Dose Escalation|Progressive disease per RECIST|0|||
156733261|NCT02564900|565771078|FG008|Dose Escalation|Progressive disease per RECIST|0|||
156733262|NCT02564900|565771079|FG009|Dose Escalation|Progressive disease per RECIST|0|||
156733263|NCT02564900|565771080|FG010|Dose Escalation|Progressive disease per RECIST|0|||
156733264|NCT02564900|565771081|FG011|Dose Escalation|Progressive disease per RECIST|0|||
156733265|NCT02564900|565771082|FG012|Dose Escalation|Progressive disease per RECIST|0|||
156733266|NCT02564900|565771083|FG013|Dose Escalation|Progressive disease per RECIST|0|||
156733267|NCT02564900|565771084|FG014|Dose Escalation|Progressive disease per RECIST|0|||
156733268|NCT02564900|565771070|FG000|Dose Escalation|Ongoing|1|||
156733269|NCT02564900|565771071|FG001|Dose Escalation|Ongoing|0|||
156733270|NCT02564900|565771072|FG002|Dose Escalation|Ongoing|0|||
156733271|NCT02564900|565771073|FG003|Dose Escalation|Ongoing|2|||
156733272|NCT02564900|565771074|FG004|Dose Escalation|Ongoing|2|||
156733273|NCT02564900|565771075|FG005|Dose Escalation|Ongoing|2|||
156733274|NCT02564900|565771076|FG006|Dose Escalation|Ongoing|0|||
156733275|NCT02564900|565771077|FG007|Dose Escalation|Ongoing|0|||
156733276|NCT02564900|565771078|FG008|Dose Escalation|Ongoing|0|||
156733277|NCT02564900|565771079|FG009|Dose Escalation|Ongoing|0|||
156733278|NCT02564900|565771080|FG010|Dose Escalation|Ongoing|0|||
156733279|NCT02564900|565771081|FG011|Dose Escalation|Ongoing|0|||
156733280|NCT02564900|565771082|FG012|Dose Escalation|Ongoing|0|||
156733281|NCT02564900|565771083|FG013|Dose Escalation|Ongoing|0|||
156733282|NCT02564900|565771084|FG014|Dose Escalation|Ongoing|0|||
156733283|NCT02564900|565771070|FG000|Dose Escalation|Adverse Event|0|||
156733284|NCT02564900|565771071|FG001|Dose Escalation|Adverse Event|0|||
156733285|NCT02564900|565771072|FG002|Dose Escalation|Adverse Event|0|||
156733286|NCT02564900|565771073|FG003|Dose Escalation|Adverse Event|1|||
156733287|NCT02564900|565771074|FG004|Dose Escalation|Adverse Event|1|||
156733288|NCT02564900|565771075|FG005|Dose Escalation|Adverse Event|3|||
156733289|NCT02564900|565771076|FG006|Dose Escalation|Adverse Event|0|||
156733290|NCT02564900|565771077|FG007|Dose Escalation|Adverse Event|0|||
156733291|NCT02564900|565771078|FG008|Dose Escalation|Adverse Event|0|||
156733292|NCT02564900|565771079|FG009|Dose Escalation|Adverse Event|0|||
156733293|NCT02564900|565771080|FG010|Dose Escalation|Adverse Event|0|||
156733294|NCT02564900|565771081|FG011|Dose Escalation|Adverse Event|0|||
156733295|NCT02564900|565771082|FG012|Dose Escalation|Adverse Event|0|||
156733296|NCT02564900|565771083|FG013|Dose Escalation|Adverse Event|0|||
156733297|NCT02564900|565771084|FG014|Dose Escalation|Adverse Event|0|||
156733298|NCT02564900|565771070|FG000|Dose Expansion|Progressive disease per RECIST|0|||
156733299|NCT02564900|565771071|FG001|Dose Expansion|Progressive disease per RECIST|0|||
156733300|NCT02564900|565771072|FG002|Dose Expansion|Progressive disease per RECIST|0|||
156733301|NCT02564900|565771073|FG003|Dose Expansion|Progressive disease per RECIST|0|||
156733302|NCT02564900|565771074|FG004|Dose Expansion|Progressive disease per RECIST|0|||
156733303|NCT02564900|565771075|FG005|Dose Expansion|Progressive disease per RECIST|0|||
156733304|NCT02564900|565771076|FG006|Dose Expansion|Progressive disease per RECIST|19|||
156336483|NCT00289133|564329612|FG001|Overall Study|Withdrawal by Subject|10|||
156336484|NCT00289133|564329611|FG000|Overall Study|Death|5|||
156336485|NCT00289133|564329612|FG001|Overall Study|Death|10|||
156336486|NCT00289133|564329611|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
156733305|NCT02564900|565771077|FG007|Dose Expansion|Progressive disease per RECIST|17|||
156733306|NCT02564900|565771078|FG008|Dose Expansion|Progressive disease per RECIST|8|||
156733307|NCT02564900|565771079|FG009|Dose Expansion|Progressive disease per RECIST|16|||
156733308|NCT02564900|565771080|FG010|Dose Expansion|Progressive disease per RECIST|13|||
156733309|NCT02564900|565771081|FG011|Dose Expansion|Progressive disease per RECIST|19|||
156733310|NCT02564900|565771082|FG012|Dose Expansion|Progressive disease per RECIST|10|||
156733311|NCT02564900|565771083|FG013|Dose Expansion|Progressive disease per RECIST|13|||
156733312|NCT02564900|565771084|FG014|Dose Expansion|Progressive disease per RECIST|11|||
156733313|NCT02564900|565771070|FG000|Dose Expansion|Clinical progression|0|||
156733314|NCT02564900|565771071|FG001|Dose Expansion|Clinical progression|0|||
156733315|NCT02564900|565771072|FG002|Dose Expansion|Clinical progression|0|||
156733316|NCT02564900|565771073|FG003|Dose Expansion|Clinical progression|0|||
156733317|NCT02564900|565771074|FG004|Dose Expansion|Clinical progression|0|||
156733318|NCT02564900|565771075|FG005|Dose Expansion|Clinical progression|0|||
156733319|NCT02564900|565771076|FG006|Dose Expansion|Clinical progression|5|||
156733320|NCT02564900|565771077|FG007|Dose Expansion|Clinical progression|12|||
156733321|NCT02564900|565771078|FG008|Dose Expansion|Clinical progression|0|||
156733322|NCT02564900|565771079|FG009|Dose Expansion|Clinical progression|3|||
156796710|NCT01905540|566009656|FG001|Period 3|Other|0|||
156796711|NCT01905540|566009657|FG002|Period 3|Other|1|||
156533724|NCT01130974|565048900|FG000|Overall Study|Protocol Violation|10|||
156533725|NCT01130974|565048901|FG001|Overall Study|Protocol Violation|10|||
156533726|NCT01130974|565048900|FG000|Overall Study|Withdrawal by Subject|0|||
156533727|NCT01130974|565048901|FG001|Overall Study|Withdrawal by Subject|1|||
156533728|NCT01130974|565048900|FG000|Overall Study|Ineligibility criteria|5|||
156533729|NCT01130974|565048901|FG001|Overall Study|Ineligibility criteria|2|||
156533730|NCT02966223|565048902|FG000|Overall Study|Physician Decision|3|||
156533731|NCT02966223|565048902|FG000|Overall Study|Withdrawal by Subject|11|||
156533732|NCT02966223|565048902|FG000|Overall Study|Lost to Follow-up|1|||
156533733|NCT01557348|565048903|FG000|Overall Study|Adverse Event|6|||
156533734|NCT01557348|565048904|FG001|Overall Study|Adverse Event|16|||
156533735|NCT01557348|565048903|FG000|Overall Study|Infusion reaction event|5|||
156533736|NCT01557348|565048904|FG001|Overall Study|Infusion reaction event|5|||
156533737|NCT01557348|565048903|FG000|Overall Study|Death|7|||
156533738|NCT01557348|565048904|FG001|Overall Study|Death|4|||
156533739|NCT01557348|565048903|FG000|Overall Study|Insufficient Therapeutic Response|13|||
156533740|NCT01557348|565048904|FG001|Overall Study|Insufficient Therapeutic Response|28|||
156533741|NCT01557348|565048903|FG000|Overall Study|Withdrawal by Subject|5|||
156533742|NCT01557348|565048904|FG001|Overall Study|Withdrawal by Subject|4|||
156533743|NCT01557348|565048903|FG000|Overall Study|Lost to Follow-up|26|||
156533744|NCT01557348|565048904|FG001|Overall Study|Lost to Follow-up|22|||
156533745|NCT01557348|565048903|FG000|Overall Study|Administrative|18|||
156533746|NCT01557348|565048904|FG001|Overall Study|Administrative|11|||
156733323|NCT02564900|565771080|FG010|Dose Expansion|Clinical progression|2|||
156733324|NCT02564900|565771081|FG011|Dose Expansion|Clinical progression|0|||
156733325|NCT02564900|565771082|FG012|Dose Expansion|Clinical progression|1|||
156733326|NCT02564900|565771083|FG013|Dose Expansion|Clinical progression|3|||
156733327|NCT02564900|565771084|FG014|Dose Expansion|Clinical progression|1|||
156733328|NCT02564900|565771070|FG000|Dose Expansion|Adverse Event|0|||
156733329|NCT02564900|565771071|FG001|Dose Expansion|Adverse Event|0|||
156733330|NCT02564900|565771072|FG002|Dose Expansion|Adverse Event|0|||
156733331|NCT02564900|565771073|FG003|Dose Expansion|Adverse Event|0|||
156796712|NCT01905540|566009658|FG003|Period 3|Other|1|||
156336487|NCT00289133|564329612|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
156533747|NCT06132425|565048905|FG000|Overall Study|Withdrawal by Subject|3|||
156533748|NCT06132425|565048906|FG001|Overall Study|Withdrawal by Subject|0|||
156533749|NCT06132425|565048905|FG000|Overall Study|Did not follow study instructions|0|||
156533750|NCT06132425|565048906|FG001|Overall Study|Did not follow study instructions|2|||
156533751|NCT06132425|565048905|FG000|Overall Study|Lost to Follow-up|3|||
156533752|NCT06132425|565048906|FG001|Overall Study|Lost to Follow-up|5|||
156533753|NCT04409353|565048909|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
156533754|NCT04409353|565048910|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
156533755|NCT04409353|565048911|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
156533756|NCT04409353|565048909|FG000|Overall Study|Lost to Follow-up|6|||
156533757|NCT04409353|565048910|FG001|Overall Study|Lost to Follow-up|8|||
156533758|NCT04409353|565048911|FG002|Overall Study|Lost to Follow-up|7|||
156533759|NCT04409353|565048909|FG000|Overall Study|Major surgery during participation window|4|||
156533760|NCT04409353|565048910|FG001|Overall Study|Major surgery during participation window|3|||
156533761|NCT04409353|565048911|FG002|Overall Study|Major surgery during participation window|3|||
156533762|NCT04409353|565048909|FG000|Overall Study|Life event occurred during participation window|3|||
156533763|NCT04409353|565048910|FG001|Overall Study|Life event occurred during participation window|2|||
156455627|NCT02861300|564763158|FG005|Overall Study|Clinical Complications|0|||
156455628|NCT02861300|564763159|FG006|Overall Study|Clinical Complications|1|||
156455629|NCT04992520|564763167|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
156455630|NCT04992520|564763168|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
156455631|NCT04992520|564763169|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
156455632|NCT04992520|564763170|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
156455633|NCT04992520|564763171|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
156455634|NCT04992520|564763172|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
156455635|NCT04992520|564763167|FG000|Part A: First Challenge|Non-compliance|0|||
156455636|NCT04992520|564763168|FG001|Part A: First Challenge|Non-compliance|0|||
156455637|NCT04992520|564763169|FG002|Part A: First Challenge|Non-compliance|0|||
156455638|NCT04992520|564763170|FG003|Part A: First Challenge|Non-compliance|1|||
156455639|NCT04992520|564763171|FG004|Part A: First Challenge|Non-compliance|0|||
156455640|NCT04992520|564763172|FG005|Part A: First Challenge|Non-compliance|0|||
156455641|NCT04992520|564763167|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
156455642|NCT04992520|564763168|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
156455643|NCT04992520|564763169|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
156455644|NCT04992520|564763170|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
156455645|NCT04992520|564763171|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
156455646|NCT04992520|564763172|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
156733332|NCT02564900|565771074|FG004|Dose Expansion|Adverse Event|0|||
156733333|NCT02564900|565771075|FG005|Dose Expansion|Adverse Event|0|||
156455647|NCT04992520|564763167|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
156733334|NCT02564900|565771076|FG006|Dose Expansion|Adverse Event|9|||
156733335|NCT02564900|565771077|FG007|Dose Expansion|Adverse Event|22|||
156733336|NCT02564900|565771078|FG008|Dose Expansion|Adverse Event|0|||
156733337|NCT02564900|565771079|FG009|Dose Expansion|Adverse Event|11|||
156733338|NCT02564900|565771080|FG010|Dose Expansion|Adverse Event|0|||
156733339|NCT02564900|565771081|FG011|Dose Expansion|Adverse Event|5|||
156733340|NCT02564900|565771082|FG012|Dose Expansion|Adverse Event|2|||
156733341|NCT02564900|565771083|FG013|Dose Expansion|Adverse Event|2|||
156733342|NCT02564900|565771084|FG014|Dose Expansion|Adverse Event|1|||
156733343|NCT02564900|565771070|FG000|Dose Expansion|Ongoing|0|||
156733344|NCT02564900|565771071|FG001|Dose Expansion|Ongoing|0|||
156733345|NCT02564900|565771072|FG002|Dose Expansion|Ongoing|0|||
156455648|NCT04992520|564763168|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
156733346|NCT02564900|565771073|FG003|Dose Expansion|Ongoing|0|||
156733347|NCT02564900|565771074|FG004|Dose Expansion|Ongoing|0|||
156733348|NCT02564900|565771075|FG005|Dose Expansion|Ongoing|0|||
156733349|NCT02564900|565771076|FG006|Dose Expansion|Ongoing|9|||
156733350|NCT02564900|565771077|FG007|Dose Expansion|Ongoing|10|||
156733351|NCT02564900|565771078|FG008|Dose Expansion|Ongoing|11|||
156733352|NCT02564900|565771079|FG009|Dose Expansion|Ongoing|3|||
156733353|NCT02564900|565771080|FG010|Dose Expansion|Ongoing|0|||
156455649|NCT04992520|564763169|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
156455650|NCT04992520|564763170|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
156455651|NCT04992520|564763171|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
156455652|NCT04992520|564763172|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
156455653|NCT03020199|564763182|FG000|Treatment Period|Adverse Event|0|||
156455654|NCT03020199|564763183|FG001|Treatment Period|Adverse Event|2|||
156455655|NCT03020199|564763182|FG000|Treatment Period|Lack of Efficacy|1|||
156455656|NCT03020199|564763183|FG001|Treatment Period|Lack of Efficacy|6|||
156455657|NCT03020199|564763182|FG000|Treatment Period|Lost to Follow-up|1|||
156455658|NCT03020199|564763183|FG001|Treatment Period|Lost to Follow-up|6|||
156455659|NCT03020199|564763182|FG000|Treatment Period|Physician Decision|0|||
156455660|NCT03020199|564763183|FG001|Treatment Period|Physician Decision|1|||
156455661|NCT03020199|564763182|FG000|Treatment Period|Subject/guardian decision|8|||
156733354|NCT02564900|565771081|FG011|Dose Expansion|Ongoing|0|||
156733355|NCT02564900|565771082|FG012|Dose Expansion|Ongoing|4|||
156733356|NCT02564900|565771083|FG013|Dose Expansion|Ongoing|0|||
156733357|NCT02564900|565771084|FG014|Dose Expansion|Ongoing|6|||
156733358|NCT02564900|565771070|FG000|Dose Expansion|Death|0|||
156336488|NCT00289133|564329611|FG000|Overall Study|Physician Decision|41|||
156455662|NCT03020199|564763183|FG001|Treatment Period|Subject/guardian decision|15|||
156455663|NCT03020199|564763182|FG000|Treatment Period|Subjects not treated|3|||
156455664|NCT03020199|564763183|FG001|Treatment Period|Subjects not treated|4|||
156733359|NCT02564900|565771071|FG001|Dose Expansion|Death|0|||
156733360|NCT02564900|565771072|FG002|Dose Expansion|Death|0|||
156455665|NCT03020199|564763182|FG000|Follow-up Period|Disease relapse|32|||
156455666|NCT03020199|564763183|FG001|Follow-up Period|Disease relapse|7|||
156455667|NCT03020199|564763182|FG000|Follow-up Period|Lack of Efficacy|1|||
156733361|NCT02564900|565771073|FG003|Dose Expansion|Death|0|||
156733362|NCT02564900|565771074|FG004|Dose Expansion|Death|0|||
156733363|NCT02564900|565771075|FG005|Dose Expansion|Death|0|||
156733364|NCT02564900|565771076|FG006|Dose Expansion|Death|1|||
156733365|NCT02564900|565771077|FG007|Dose Expansion|Death|0|||
156733366|NCT02564900|565771078|FG008|Dose Expansion|Death|0|||
156733367|NCT02564900|565771079|FG009|Dose Expansion|Death|0|||
156733368|NCT02564900|565771080|FG010|Dose Expansion|Death|1|||
156733369|NCT02564900|565771081|FG011|Dose Expansion|Death|0|||
156733370|NCT02564900|565771082|FG012|Dose Expansion|Death|1|||
156733371|NCT02564900|565771083|FG013|Dose Expansion|Death|1|||
156733372|NCT02564900|565771084|FG014|Dose Expansion|Death|0|||
156733373|NCT02564900|565771070|FG000|Dose Expansion|Withdrawal by Subject|0|||
156733374|NCT02564900|565771071|FG001|Dose Expansion|Withdrawal by Subject|0|||
156733375|NCT02564900|565771072|FG002|Dose Expansion|Withdrawal by Subject|0|||
156733376|NCT02564900|565771073|FG003|Dose Expansion|Withdrawal by Subject|0|||
156733377|NCT02564900|565771074|FG004|Dose Expansion|Withdrawal by Subject|0|||
156733378|NCT02564900|565771075|FG005|Dose Expansion|Withdrawal by Subject|0|||
156733379|NCT02564900|565771076|FG006|Dose Expansion|Withdrawal by Subject|4|||
156733380|NCT02564900|565771077|FG007|Dose Expansion|Withdrawal by Subject|0|||
156733381|NCT02564900|565771078|FG008|Dose Expansion|Withdrawal by Subject|0|||
156733382|NCT02564900|565771079|FG009|Dose Expansion|Withdrawal by Subject|0|||
156733383|NCT02564900|565771080|FG010|Dose Expansion|Withdrawal by Subject|1|||
156733384|NCT02564900|565771081|FG011|Dose Expansion|Withdrawal by Subject|0|||
156733385|NCT02564900|565771082|FG012|Dose Expansion|Withdrawal by Subject|0|||
156733386|NCT02564900|565771083|FG013|Dose Expansion|Withdrawal by Subject|1|||
156733387|NCT02564900|565771084|FG014|Dose Expansion|Withdrawal by Subject|1|||
156733388|NCT02564900|565771070|FG000|Dose Expansion|Other|0|||
156733389|NCT02564900|565771071|FG001|Dose Expansion|Other|0|||
156733390|NCT02564900|565771072|FG002|Dose Expansion|Other|0|||
156733391|NCT02564900|565771073|FG003|Dose Expansion|Other|0|||
156733392|NCT02564900|565771074|FG004|Dose Expansion|Other|0|||
156733393|NCT02564900|565771075|FG005|Dose Expansion|Other|0|||
156733394|NCT02564900|565771076|FG006|Dose Expansion|Other|1|||
156733395|NCT02564900|565771077|FG007|Dose Expansion|Other|0|||
156733396|NCT02564900|565771078|FG008|Dose Expansion|Other|1|||
156733397|NCT02564900|565771079|FG009|Dose Expansion|Other|0|||
156733398|NCT02564900|565771080|FG010|Dose Expansion|Other|0|||
156733399|NCT02564900|565771081|FG011|Dose Expansion|Other|0|||
156733400|NCT02564900|565771082|FG012|Dose Expansion|Other|0|||
156733401|NCT02564900|565771083|FG013|Dose Expansion|Other|0|||
156733402|NCT02564900|565771084|FG014|Dose Expansion|Other|1|||
156733403|NCT02564900|565771070|FG000|Dose Expansion|Did not receive treatment|0|||
156733404|NCT02564900|565771071|FG001|Dose Expansion|Did not receive treatment|0|||
156733405|NCT02564900|565771072|FG002|Dose Expansion|Did not receive treatment|0|||
156733406|NCT02564900|565771073|FG003|Dose Expansion|Did not receive treatment|0|||
156733407|NCT02564900|565771074|FG004|Dose Expansion|Did not receive treatment|0|||
156733408|NCT02564900|565771075|FG005|Dose Expansion|Did not receive treatment|0|||
156733409|NCT02564900|565771076|FG006|Dose Expansion|Did not receive treatment|1|||
156733410|NCT02564900|565771077|FG007|Dose Expansion|Did not receive treatment|1|||
156733411|NCT02564900|565771078|FG008|Dose Expansion|Did not receive treatment|0|||
156733412|NCT02564900|565771079|FG009|Dose Expansion|Did not receive treatment|0|||
156733413|NCT02564900|565771080|FG010|Dose Expansion|Did not receive treatment|0|||
156733414|NCT02564900|565771081|FG011|Dose Expansion|Did not receive treatment|0|||
156733415|NCT02564900|565771082|FG012|Dose Expansion|Did not receive treatment|0|||
156733416|NCT02564900|565771083|FG013|Dose Expansion|Did not receive treatment|0|||
156796713|NCT02743962|566009659|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
156796714|NCT02743962|566009660|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
156796715|NCT02314923|566009661|FG000|Overall Study|Death|0|||
156796716|NCT02314923|566009662|FG001|Overall Study|Death|0|||
156533764|NCT04409353|565048911|FG002|Overall Study|Life event occurred during participation window|4|||
156533765|NCT04409353|565048909|FG000|Overall Study|Lack of Efficacy|4|||
156533766|NCT04409353|565048910|FG001|Overall Study|Lack of Efficacy|1|||
156533767|NCT04409353|565048911|FG002|Overall Study|Lack of Efficacy|3|||
156533768|NCT04409353|565048909|FG000|Overall Study|Adverse Event|2|||
156733417|NCT02564900|565771084|FG014|Dose Expansion|Did not receive treatment|1|||
156733418|NCT01289639|565771086|FG000|Overall Study|Lost to Follow-up|1|||
156336489|NCT00289133|564329612|FG001|Overall Study|Physician Decision|45|||
156336490|NCT00289133|564329611|FG000|Overall Study|Revision|8|||
156733419|NCT01289639|565771087|FG001|Overall Study|Lost to Follow-up|0|||
156733420|NCT01289639|565771088|FG002|Overall Study|Lost to Follow-up|0|||
156733421|NCT02780713|565771089|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
156733422|NCT02780713|565771090|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
156796717|NCT02314923|566009663|FG002|Overall Study|Death|0|||
156533769|NCT04409353|565048910|FG001|Overall Study|Adverse Event|1|||
156533770|NCT04409353|565048911|FG002|Overall Study|Adverse Event|1|||
156733423|NCT02780713|565771091|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
156733424|NCT02780713|565771092|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
156733425|NCT02780713|565771093|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
156733426|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
156733427|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
156336491|NCT00289133|564329612|FG001|Overall Study|Revision|6|||
156533771|NCT04409353|565048909|FG000|Overall Study|Disease burden - unable to participate|0|||
156733428|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
156796718|NCT02314923|566009664|FG003|Overall Study|Death|1|||
156336492|NCT00289133|564329611|FG000|Overall Study|Lost to Follow-up|92|||
156336493|NCT00289133|564329612|FG001|Overall Study|Lost to Follow-up|115|||
156336494|NCT03372096|564329613|FG000|Overall Study|Study Closed|8|||
156336495|NCT00541931|564329614|FG000|Overall Study|Adverse Event|1|||
156336496|NCT00541931|564329615|FG001|Overall Study|Adverse Event|0|||
156336497|NCT00541931|564329614|FG000|Overall Study|Lost to Follow-up|3|||
156336498|NCT00541931|564329615|FG001|Overall Study|Lost to Follow-up|3|||
156336499|NCT00541931|564329614|FG000|Overall Study|Withdrawal by Subject|1|||
156336500|NCT00541931|564329615|FG001|Overall Study|Withdrawal by Subject|0|||
156336501|NCT00541931|564329614|FG000|Overall Study|Transportation Issue|0|||
156336502|NCT00541931|564329615|FG001|Overall Study|Transportation Issue|1|||
156336503|NCT02555683|564329619|FG000|Overall Study|Physician Decision|1|||
156336504|NCT02555683|564329620|FG001|Overall Study|Physician Decision|0|||
156336505|NCT02555683|564329621|FG002|Overall Study|Physician Decision|2|||
156336506|NCT02555683|564329619|FG000|Overall Study|Lost to Follow-up|2|||
156336507|NCT02555683|564329620|FG001|Overall Study|Lost to Follow-up|1|||
156336508|NCT02555683|564329621|FG002|Overall Study|Lost to Follow-up|2|||
156336509|NCT02555683|564329619|FG000|Overall Study|Technical Problems|1|||
156336510|NCT02555683|564329620|FG001|Overall Study|Technical Problems|1|||
156336511|NCT02555683|564329621|FG002|Overall Study|Technical Problems|0|||
156336512|NCT02555683|564329619|FG000|Overall Study|Protocol deviation|0|||
156336513|NCT02555683|564329620|FG001|Overall Study|Protocol deviation|1|||
156336514|NCT02555683|564329621|FG002|Overall Study|Protocol deviation|0|||
156336515|NCT02555683|564329619|FG000|Overall Study|Lack of Efficacy|2|||
156733429|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
156733430|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
156733431|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
156336516|NCT02555683|564329620|FG001|Overall Study|Lack of Efficacy|0|||
156336517|NCT02555683|564329621|FG002|Overall Study|Lack of Efficacy|0|||
156336518|NCT02555683|564329619|FG000|Overall Study|Death|0|||
156336519|NCT02555683|564329620|FG001|Overall Study|Death|1|||
156733432|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
156733433|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
156733434|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
156733435|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
156733436|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
156733437|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
156733438|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
156733439|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
156733440|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
156733441|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
156733442|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
156733443|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
156733444|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
156733445|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
156733446|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
156733447|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
156733448|NCT00280397|565771096|FG000|Overall Study|Adverse Event|1|||
156733449|NCT01028014|565771097|FG000|Overall Study|Lost to Follow-up|1|||
156733450|NCT01028014|565771098|FG001|Overall Study|Lost to Follow-up|2|||
156733451|NCT01028014|565771099|FG002|Overall Study|Lost to Follow-up|0|||
156733452|NCT01028014|565771100|FG003|Overall Study|Lost to Follow-up|1|||
156733453|NCT01028014|565771101|FG004|Overall Study|Lost to Follow-up|1|||
156733454|NCT01028014|565771102|FG005|Overall Study|Lost to Follow-up|2|||
156733455|NCT05338502|565771103|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
156733456|NCT05338502|565771104|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
156876617|NCT00535288|566307656|FG000|Overall Study|Lost to Follow-up|0|||
156336520|NCT02555683|564329621|FG002|Overall Study|Death|2|||
156336521|NCT02555683|564329619|FG000|Overall Study|Adverse Event|1|||
156336522|NCT02555683|564329620|FG001|Overall Study|Adverse Event|0|||
156336523|NCT02555683|564329621|FG002|Overall Study|Adverse Event|1|||
156733457|NCT05338502|565771105|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
156733458|NCT05338502|565771103|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
156336524|NCT02555683|564329619|FG000|Overall Study|Subject/guardian decision|12|||
156336525|NCT02555683|564329620|FG001|Overall Study|Subject/guardian decision|12|||
156336526|NCT02555683|564329621|FG002|Overall Study|Subject/guardian decision|22|||
156336527|NCT02555683|564329619|FG000|Overall Study|Death post Treatment/safety period|0|||
156733459|NCT05338502|565771104|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
156733460|NCT05338502|565771105|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
156733461|NCT02423343|565771108|FG000|Overall Study|Withdrawal by Subject|0|||
156876618|NCT00535288|566307657|FG001|Overall Study|Lost to Follow-up|3|||
156876619|NCT00535288|566307658|FG002|Overall Study|Lost to Follow-up|0|||
156336528|NCT02555683|564329620|FG001|Overall Study|Death post Treatment/safety period|1|||
156336529|NCT02555683|564329621|FG002|Overall Study|Death post Treatment/safety period|0|||
156336530|NCT00612040|564329626|FG000|Overall Study|Adverse Event|0|||
156336531|NCT00612040|564329627|FG001|Overall Study|Adverse Event|2|||
156336532|NCT00612040|564329628|FG002|Overall Study|Adverse Event|1|||
156455668|NCT03020199|564763183|FG001|Follow-up Period|Lack of Efficacy|2|||
156455669|NCT03020199|564763182|FG000|Follow-up Period|Lost to Follow-up|4|||
156455670|NCT03020199|564763183|FG001|Follow-up Period|Lost to Follow-up|6|||
156455671|NCT03020199|564763182|FG000|Follow-up Period|Physician Decision|2|||
156455672|NCT03020199|564763183|FG001|Follow-up Period|Physician Decision|2|||
156455673|NCT03020199|564763182|FG000|Follow-up Period|Protocol Violation|1|||
156455674|NCT03020199|564763183|FG001|Follow-up Period|Protocol Violation|2|||
156455675|NCT03020199|564763182|FG000|Follow-up Period|Study terminated by Sponsor|6|||
156455676|NCT03020199|564763183|FG001|Follow-up Period|Study terminated by Sponsor|3|||
156455677|NCT03020199|564763182|FG000|Follow-up Period|Subject/guardian decision|14|||
156455678|NCT03020199|564763183|FG001|Follow-up Period|Subject/guardian decision|9|||
156733462|NCT02423343|565771109|FG001|Overall Study|Withdrawal by Subject|1|||
156733463|NCT02423343|565771110|FG002|Overall Study|Withdrawal by Subject|0|||
156733464|NCT02423343|565771111|FG003|Overall Study|Withdrawal by Subject|0|||
156733465|NCT02423343|565771112|FG004|Overall Study|Withdrawal by Subject|0|||
156733466|NCT02423343|565771113|FG005|Overall Study|Withdrawal by Subject|0|||
156733467|NCT02423343|565771108|FG000|Overall Study|Progressive Disease|0|||
156733468|NCT02423343|565771109|FG001|Overall Study|Progressive Disease|0|||
156733469|NCT02423343|565771110|FG002|Overall Study|Progressive Disease|0|||
156733470|NCT02423343|565771111|FG003|Overall Study|Progressive Disease|0|||
156733471|NCT02423343|565771112|FG004|Overall Study|Progressive Disease|2|||
156733472|NCT02423343|565771113|FG005|Overall Study|Progressive Disease|0|||
156733473|NCT02423343|565771108|FG000|Overall Study|Adverse Event|0|||
156733474|NCT02423343|565771109|FG001|Overall Study|Adverse Event|0|||
156733475|NCT02423343|565771110|FG002|Overall Study|Adverse Event|0|||
156733476|NCT02423343|565771111|FG003|Overall Study|Adverse Event|0|||
156733477|NCT02423343|565771112|FG004|Overall Study|Adverse Event|2|||
156733478|NCT02423343|565771113|FG005|Overall Study|Adverse Event|0|||
156733479|NCT02423343|565771108|FG000|Overall Study|Death|0|||
156733480|NCT02423343|565771109|FG001|Overall Study|Death|0|||
156733481|NCT02423343|565771110|FG002|Overall Study|Death|0|||
156733482|NCT02423343|565771111|FG003|Overall Study|Death|0|||
156733483|NCT02423343|565771112|FG004|Overall Study|Death|1|||
156733484|NCT02423343|565771113|FG005|Overall Study|Death|0|||
156733485|NCT02111577|565771116|FG000|Overall Study|Protocol Violation|2|||
156733486|NCT02111577|565771117|FG001|Overall Study|Protocol Violation|0|||
156733487|NCT02111577|565771116|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
156733488|NCT02111577|565771117|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
156733489|NCT02111577|565771116|FG000|Overall Study|Failure to produce study treatment|6|||
156733490|NCT02111577|565771117|FG001|Overall Study|Failure to produce study treatment|0|||
156733491|NCT02111577|565771116|FG000|Overall Study|Death|518|||
156733492|NCT02111577|565771117|FG001|Overall Study|Death|254|||
156733493|NCT02111577|565771116|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
156733494|NCT02111577|565771117|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
156733495|NCT02111577|565771116|FG000|Overall Study|Adverse Event|1|||
156733496|NCT02111577|565771117|FG001|Overall Study|Adverse Event|1|||
156733497|NCT02111577|565771116|FG000|Overall Study|Withdrawal by Subject|51|||
156733498|NCT02111577|565771117|FG001|Overall Study|Withdrawal by Subject|23|||
156733499|NCT02111577|565771116|FG000|Overall Study|Disease progression|0|||
156733500|NCT02111577|565771117|FG001|Overall Study|Disease progression|1|||
156733501|NCT02111577|565771116|FG000|Overall Study|Lost to Follow-up|19|||
156733502|NCT02111577|565771117|FG001|Overall Study|Lost to Follow-up|10|||
156733503|NCT04967885|565771118|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
156733504|NCT04967885|565771119|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
156733505|NCT04967885|565771118|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
156733506|NCT04967885|565771119|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
156733507|NCT04967885|565771118|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
156733508|NCT04967885|565771119|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
156733509|NCT04967885|565771118|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
156733510|NCT04967885|565771119|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
156733511|NCT04967885|565771118|FG000|EMI-II Intervention|Lost to Follow-up|14|||
156733512|NCT04967885|565771119|FG001|EMI-II Intervention|Lost to Follow-up|10|||
156733513|NCT00654875|565771120|FG000|Overall Study|Adverse Event|5|||
156733514|NCT00654875|565771121|FG001|Overall Study|Adverse Event|5|||
156733515|NCT00654875|565771120|FG000|Overall Study|Withdrawal by Subject|4|||
156733516|NCT00654875|565771121|FG001|Overall Study|Withdrawal by Subject|4|||
156733517|NCT00654875|565771120|FG000|Overall Study|Protocol Violation|3|||
156796719|NCT02314923|566009665|FG004|Overall Study|Death|0|||
156455679|NCT04313972|564763184|FG000|Overall Study|Withdrawal by Subject|0|||
156455680|NCT04313972|564763185|FG001|Overall Study|Withdrawal by Subject|1|||
156733518|NCT00654875|565771121|FG001|Overall Study|Protocol Violation|3|||
156733519|NCT00654875|565771120|FG000|Overall Study|Lack of Efficacy|2|||
156733520|NCT00654875|565771121|FG001|Overall Study|Lack of Efficacy|2|||
156733521|NCT00654875|565771120|FG000|Overall Study|Lost to Follow-up|1|||
156733522|NCT00654875|565771121|FG001|Overall Study|Lost to Follow-up|3|||
156733523|NCT00654875|565771120|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
156733524|NCT00654875|565771121|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156733525|NCT00654875|565771120|FG000|Overall Study|Administrative Problems|1|||
156733526|NCT00654875|565771121|FG001|Overall Study|Administrative Problems|0|||
156733527|NCT01011465|565771122|FG000|Overall Study|Withdrawal by Subject|2|||
156733528|NCT01011465|565771123|FG001|Overall Study|Withdrawal by Subject|1|||
156733529|NCT01011465|565771124|FG002|Overall Study|Withdrawal by Subject|0|||
156733530|NCT01011465|565771125|FG003|Overall Study|Withdrawal by Subject|0|||
156733531|NCT01011465|565771126|FG004|Overall Study|Withdrawal by Subject|1|||
156733532|NCT01011465|565771127|FG005|Overall Study|Withdrawal by Subject|0|||
156733533|NCT01011465|565771128|FG006|Overall Study|Withdrawal by Subject|1|||
156733534|NCT01011465|565771129|FG007|Overall Study|Withdrawal by Subject|0|||
156733535|NCT02042950|565771132|FG000|Overall Study|Progressive Disease|4|||
156733536|NCT01014988|565771135|FG000|Overall Study|Adverse Event|20|||
156733537|NCT01014988|565771136|FG001|Overall Study|Adverse Event|0|||
156733538|NCT01014988|565771137|FG002|Overall Study|Adverse Event|1|||
156733539|NCT01014988|565771138|FG003|Overall Study|Adverse Event|0|||
156733540|NCT01014988|565771139|FG004|Overall Study|Adverse Event|1|||
156733541|NCT01014988|565771140|FG005|Overall Study|Adverse Event|3|||
156733542|NCT01014988|565771135|FG000|Overall Study|Lost to Follow-up|1|||
156733543|NCT01014988|565771136|FG001|Overall Study|Lost to Follow-up|0|||
156733544|NCT01014988|565771137|FG002|Overall Study|Lost to Follow-up|1|||
156733545|NCT01014988|565771138|FG003|Overall Study|Lost to Follow-up|0|||
156733546|NCT01014988|565771139|FG004|Overall Study|Lost to Follow-up|0|||
156733547|NCT01014988|565771140|FG005|Overall Study|Lost to Follow-up|0|||
156733548|NCT01014988|565771135|FG000|Overall Study|Physician Decision|1|||
156733549|NCT01014988|565771136|FG001|Overall Study|Physician Decision|0|||
156733550|NCT01014988|565771137|FG002|Overall Study|Physician Decision|0|||
156733551|NCT01014988|565771138|FG003|Overall Study|Physician Decision|0|||
156733552|NCT01014988|565771139|FG004|Overall Study|Physician Decision|0|||
156733553|NCT01014988|565771140|FG005|Overall Study|Physician Decision|0|||
156733554|NCT01014988|565771135|FG000|Overall Study|Withdrawal by Subject|1|||
156733555|NCT01014988|565771136|FG001|Overall Study|Withdrawal by Subject|0|||
156733556|NCT01014988|565771137|FG002|Overall Study|Withdrawal by Subject|0|||
156733557|NCT01014988|565771138|FG003|Overall Study|Withdrawal by Subject|0|||
156733558|NCT01014988|565771139|FG004|Overall Study|Withdrawal by Subject|0|||
156733559|NCT01014988|565771140|FG005|Overall Study|Withdrawal by Subject|0|||
156733560|NCT01683266|565771143|FG000|Overall Study|Adverse Event|5|||
156733561|NCT01683266|565771144|FG001|Overall Study|Adverse Event|4|||
156733562|NCT01683266|565771143|FG000|Overall Study|Lack of Efficacy|5|||
156733563|NCT01683266|565771144|FG001|Overall Study|Lack of Efficacy|2|||
156733564|NCT01683266|565771143|FG000|Overall Study|Protocol Violation|13|||
156733565|NCT01683266|565771144|FG001|Overall Study|Protocol Violation|6|||
156733566|NCT01683266|565771143|FG000|Overall Study|Personal Reason|17|||
156733567|NCT01683266|565771144|FG001|Overall Study|Personal Reason|25|||
156733568|NCT01683266|565771143|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
156733569|NCT01683266|565771144|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
156733570|NCT01683266|565771143|FG000|Overall Study|Lost to Follow-up|5|||
156733571|NCT01683266|565771144|FG001|Overall Study|Lost to Follow-up|0|||
156733572|NCT01683266|565771143|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
156733573|NCT01683266|565771144|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
156733574|NCT01683266|565771143|FG000|Overall Study|Nonserious Hypoglycemia|0|||
156733575|NCT01683266|565771144|FG001|Overall Study|Nonserious Hypoglycemia|3|||
156733576|NCT01683266|565771143|FG000|Overall Study|Perceived Lack of Efficacy|1|||
156733577|NCT01683266|565771144|FG001|Overall Study|Perceived Lack of Efficacy|1|||
156733578|NCT01683266|565771143|FG000|Overall Study|Possibly Hypoglycemia|1|||
156733579|NCT01683266|565771144|FG001|Overall Study|Possibly Hypoglycemia|0|||
156733580|NCT01683266|565771143|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
156733581|NCT01683266|565771144|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
156733582|NCT02217410|565771147|FG000|Overall Study|Graft Loss|0|||
156733583|NCT02217410|565771148|FG001|Overall Study|Graft Loss|0|||
156733584|NCT02217410|565771149|FG002|Overall Study|Graft Loss|2|||
156733585|NCT02217410|565771147|FG000|Overall Study|Withdrawal by Subject|0|||
156733586|NCT02217410|565771148|FG001|Overall Study|Withdrawal by Subject|0|||
156733587|NCT02217410|565771149|FG002|Overall Study|Withdrawal by Subject|2|||
156733588|NCT02217410|565771147|FG000|Overall Study|Lost to Follow-up|0|||
156733589|NCT02217410|565771148|FG001|Overall Study|Lost to Follow-up|0|||
156733590|NCT02217410|565771149|FG002|Overall Study|Lost to Follow-up|1|||
156733591|NCT02217410|565771147|FG000|Overall Study|Lack of Efficacy|0|||
156733592|NCT02217410|565771148|FG001|Overall Study|Lack of Efficacy|1|||
156733593|NCT02217410|565771149|FG002|Overall Study|Lack of Efficacy|0|||
156733594|NCT02217410|565771147|FG000|Overall Study|Physician Decision|1|||
156733595|NCT02217410|565771148|FG001|Overall Study|Physician Decision|3|||
156733596|NCT02217410|565771149|FG002|Overall Study|Physician Decision|0|||
156733597|NCT01940887|565771150|FG000|Year 1|Protocol Violation|0|||
156733598|NCT01940887|565771151|FG001|Year 1|Protocol Violation|1|||
156733599|NCT01940887|565771150|FG000|Year 1|Physician Decision|7|||
156733600|NCT01940887|565771151|FG001|Year 1|Physician Decision|3|||
156733601|NCT01940887|565771150|FG000|Year 1|Death|5|||
156733602|NCT01940887|565771151|FG001|Year 1|Death|3|||
156733603|NCT01940887|565771150|FG000|Year 1|Adverse Event|7|||
156733604|NCT01940887|565771151|FG001|Year 1|Adverse Event|6|||
156733605|NCT01940887|565771150|FG000|Year 1|Withdrawal by Subject|18|||
156733606|NCT01940887|565771151|FG001|Year 1|Withdrawal by Subject|9|||
156733607|NCT01940887|565771150|FG000|Year 1|Lost to Follow-up|2|||
156733608|NCT01940887|565771151|FG001|Year 1|Lost to Follow-up|1|||
156733609|NCT01940887|565771150|FG000|Year 2|Physician Decision|8|||
156733610|NCT01940887|565771151|FG001|Year 2|Physician Decision|1|||
156733611|NCT01940887|565771150|FG000|Year 2|Death|0|||
156733612|NCT01940887|565771151|FG001|Year 2|Death|2|||
156733613|NCT01940887|565771150|FG000|Year 2|Sponsor Decision, early termination|192|||
156733614|NCT01940887|565771151|FG001|Year 2|Sponsor Decision, early termination|203|||
156733615|NCT01940887|565771150|FG000|Year 2|Adverse Event|8|||
156733616|NCT01940887|565771151|FG001|Year 2|Adverse Event|2|||
156733617|NCT01940887|565771150|FG000|Year 2|Withdrawal by Subject|8|||
156733618|NCT01940887|565771151|FG001|Year 2|Withdrawal by Subject|8|||
156733619|NCT01940887|565771150|FG000|Year 2|Lost to Follow-up|1|||
156733620|NCT01940887|565771151|FG001|Year 2|Lost to Follow-up|6|||
156733621|NCT00090220|565771152|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
156733622|NCT00090220|565771153|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
156733623|NCT00090220|565771154|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156733624|NCT00090220|565771155|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156733625|NCT00090220|565771156|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156733626|NCT00090220|565771157|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156733627|NCT00090220|565771152|FG000|Base Study Vaccination Period|Adverse Event|6|||
156733628|NCT00090220|565771153|FG001|Base Study Vaccination Period|Adverse Event|1|||
156733629|NCT00090220|565771154|FG002|Base Study Vaccination Period|Adverse Event|0|||
156733630|NCT00090220|565771155|FG003|Base Study Vaccination Period|Adverse Event|0|||
156733631|NCT00090220|565771156|FG004|Base Study Vaccination Period|Adverse Event|0|||
156733632|NCT00090220|565771157|FG005|Base Study Vaccination Period|Adverse Event|0|||
156733633|NCT00090220|565771152|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
156733634|NCT00090220|565771153|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
156733635|NCT00090220|565771154|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
156733636|NCT00090220|565771155|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
156733637|NCT00090220|565771156|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
156733638|NCT00090220|565771157|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
156733639|NCT00090220|565771152|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
156733640|NCT00090220|565771153|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
156733641|NCT00090220|565771154|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
156733642|NCT00090220|565771155|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
156733643|NCT00090220|565771156|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
156733644|NCT00090220|565771157|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
156733645|NCT00090220|565771152|FG000|Base Study Vaccination Period|Patient Moved|6|||
156733646|NCT00090220|565771153|FG001|Base Study Vaccination Period|Patient Moved|2|||
156733647|NCT00090220|565771154|FG002|Base Study Vaccination Period|Patient Moved|0|||
156733648|NCT00090220|565771155|FG003|Base Study Vaccination Period|Patient Moved|0|||
156733649|NCT00090220|565771156|FG004|Base Study Vaccination Period|Patient Moved|0|||
156733650|NCT00090220|565771157|FG005|Base Study Vaccination Period|Patient Moved|0|||
156733651|NCT00090220|565771152|FG000|Base Study Vaccination Period|Other|4|||
156733652|NCT00090220|565771153|FG001|Base Study Vaccination Period|Other|4|||
156733653|NCT00090220|565771154|FG002|Base Study Vaccination Period|Other|0|||
156733654|NCT00090220|565771155|FG003|Base Study Vaccination Period|Other|0|||
156733655|NCT00090220|565771156|FG004|Base Study Vaccination Period|Other|0|||
156733656|NCT00090220|565771157|FG005|Base Study Vaccination Period|Other|0|||
156733657|NCT00090220|565771152|FG000|Base Study Follow-up Period|Adverse Event|6|||
156733658|NCT00090220|565771153|FG001|Base Study Follow-up Period|Adverse Event|1|||
156733659|NCT00090220|565771154|FG002|Base Study Follow-up Period|Adverse Event|0|||
156733660|NCT00090220|565771155|FG003|Base Study Follow-up Period|Adverse Event|0|||
156733661|NCT00090220|565771156|FG004|Base Study Follow-up Period|Adverse Event|0|||
156733662|NCT00090220|565771157|FG005|Base Study Follow-up Period|Adverse Event|0|||
156733663|NCT00090220|565771152|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
156733664|NCT00090220|565771153|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
156733665|NCT00090220|565771154|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
156733666|NCT00090220|565771155|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
156733667|NCT00090220|565771156|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
156733668|NCT00090220|565771157|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
156733669|NCT00090220|565771152|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
156733670|NCT00090220|565771153|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
156733671|NCT00090220|565771154|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
156733672|NCT00090220|565771155|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
156733673|NCT00090220|565771156|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
156733674|NCT00090220|565771157|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
156733675|NCT00090220|565771152|FG000|Base Study Follow-up Period|Patient Moved|20|||
156336533|NCT00612040|564329626|FG000|Overall Study|Protocol Violation|1|||
156336534|NCT00612040|564329627|FG001|Overall Study|Protocol Violation|2|||
156336535|NCT00612040|564329628|FG002|Overall Study|Protocol Violation|1|||
156336536|NCT00612040|564329626|FG000|Overall Study|Lack of Efficacy|2|||
156336537|NCT00612040|564329627|FG001|Overall Study|Lack of Efficacy|1|||
156336538|NCT00612040|564329628|FG002|Overall Study|Lack of Efficacy|0|||
156336539|NCT00612040|564329626|FG000|Overall Study|Unclassified|2|||
156336540|NCT00612040|564329627|FG001|Overall Study|Unclassified|2|||
156336541|NCT00612040|564329628|FG002|Overall Study|Unclassified|5|||
156336542|NCT02835820|564329629|FG000|Overall Study|Baseline Screen Failure|0|||
156336543|NCT02835820|564329630|FG001|Overall Study|Baseline Screen Failure|3|||
156336544|NCT01397890|564329639|FG000|Overall Study|Withdrawal by Subject|7|||
156336545|NCT01397890|564329640|FG001|Overall Study|Withdrawal by Subject|11|||
156336546|NCT01397890|564329639|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
156336547|NCT01397890|564329640|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
156455681|NCT05201079|564763199|FG000|Overall Study|Adverse Event|7|||
156733676|NCT00090220|565771153|FG001|Base Study Follow-up Period|Patient Moved|28|||
156733677|NCT00090220|565771154|FG002|Base Study Follow-up Period|Patient Moved|0|||
156733678|NCT00090220|565771155|FG003|Base Study Follow-up Period|Patient Moved|0|||
156733679|NCT00090220|565771156|FG004|Base Study Follow-up Period|Patient Moved|0|||
156733680|NCT00090220|565771157|FG005|Base Study Follow-up Period|Patient Moved|0|||
156733681|NCT00090220|565771152|FG000|Base Study Follow-up Period|Other|19|||
156733682|NCT00090220|565771153|FG001|Base Study Follow-up Period|Other|21|||
156733683|NCT00090220|565771154|FG002|Base Study Follow-up Period|Other|0|||
156733684|NCT00090220|565771155|FG003|Base Study Follow-up Period|Other|0|||
156733685|NCT00090220|565771156|FG004|Base Study Follow-up Period|Other|0|||
156733686|NCT00090220|565771157|FG005|Base Study Follow-up Period|Other|0|||
156733687|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Adverse Event|0|||
156733688|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Adverse Event|0|||
156733689|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Adverse Event|4|||
156733690|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Adverse Event|0|||
156733691|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Adverse Event|0|||
156733692|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Adverse Event|0|||
156733693|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733694|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733695|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
156733696|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733697|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733698|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733699|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Moved|0|||
156733700|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Moved|0|||
156733701|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Moved|2|||
156733702|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Moved|1|||
156733703|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Moved|0|||
156733704|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Moved|0|||
156733705|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733706|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733707|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
156733708|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733709|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733710|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733711|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
156733712|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
156733713|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
156733714|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
156733715|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
156733716|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
156733717|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Other reason|0|||
156733718|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Other reason|0|||
156733719|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Other reason|2|||
156733720|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Other reason|0|||
156733721|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Other reason|0|||
156733722|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Other reason|0|||
156733723|NCT00090220|565771152|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156455682|NCT05201079|564763200|FG001|Overall Study|Adverse Event|11|||
156455683|NCT05201079|564763199|FG000|Overall Study|Death|1|||
156455684|NCT05201079|564763200|FG001|Overall Study|Death|1|||
156733724|NCT00090220|565771153|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156733725|NCT00090220|565771154|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156733726|NCT00090220|565771155|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156733727|NCT00090220|565771156|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
156733728|NCT00090220|565771157|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
156733729|NCT00090220|565771152|FG000|Long-term Follow-up (EXT2)|Death|0|||
156733730|NCT00090220|565771153|FG001|Long-term Follow-up (EXT2)|Death|0|||
156336548|NCT01397890|564329639|FG000|Overall Study|Death|2|||
156336549|NCT01397890|564329640|FG001|Overall Study|Death|3|||
156336550|NCT01397890|564329639|FG000|Overall Study|Lost to Follow-up|1|||
156455685|NCT05201079|564763199|FG000|Overall Study|Lack of Efficacy|0|||
156733731|NCT00090220|565771154|FG002|Long-term Follow-up (EXT2)|Death|0|||
156733732|NCT00090220|565771155|FG003|Long-term Follow-up (EXT2)|Death|0|||
156733733|NCT00090220|565771156|FG004|Long-term Follow-up (EXT2)|Death|1|||
156733734|NCT00090220|565771157|FG005|Long-term Follow-up (EXT2)|Death|1|||
156733735|NCT00090220|565771152|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156733736|NCT00090220|565771153|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156733737|NCT00090220|565771154|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156733738|NCT00090220|565771155|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156733739|NCT00090220|565771156|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
156733740|NCT00090220|565771157|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
156733741|NCT00090220|565771152|FG000|Long-term Follow-up (EXT2)|Other|0|||
156733742|NCT00090220|565771153|FG001|Long-term Follow-up (EXT2)|Other|0|||
156733743|NCT00090220|565771154|FG002|Long-term Follow-up (EXT2)|Other|0|||
156733744|NCT00090220|565771155|FG003|Long-term Follow-up (EXT2)|Other|0|||
156733745|NCT00090220|565771156|FG004|Long-term Follow-up (EXT2)|Other|1|||
156733746|NCT00090220|565771157|FG005|Long-term Follow-up (EXT2)|Other|0|||
156733747|NCT01609543|565771160|FG000|Overall Study|Disease Progression|28|||
156733748|NCT01609543|565771160|FG000|Overall Study|Adverse Event|5|||
156733749|NCT01609543|565771160|FG000|Overall Study|Withdrawal by Subject|1|||
156733750|NCT01609543|565771160|FG000|Overall Study|Protocol Violation|1|||
156733751|NCT01609543|565771160|FG000|Overall Study|Death|7|||
156733752|NCT01254318|565771162|FG000|Overall Study|Lost to Follow-up|5|||
156455686|NCT05201079|564763200|FG001|Overall Study|Lack of Efficacy|2|||
156455687|NCT05201079|564763199|FG000|Overall Study|Lost to Follow-up|0|||
156455688|NCT05201079|564763200|FG001|Overall Study|Lost to Follow-up|1|||
156455689|NCT05201079|564763199|FG000|Overall Study|Physician Decision|1|||
156455690|NCT05201079|564763200|FG001|Overall Study|Physician Decision|1|||
156455691|NCT05201079|564763199|FG000|Overall Study|Protocol Violation|1|||
156455692|NCT05201079|564763200|FG001|Overall Study|Protocol Violation|0|||
156455693|NCT05201079|564763199|FG000|Overall Study|Withdrawal by Subject|1|||
156455694|NCT05201079|564763200|FG001|Overall Study|Withdrawal by Subject|0|||
156455695|NCT05201079|564763199|FG000|Overall Study|Forbidden medication|9|||
156455696|NCT05201079|564763200|FG001|Overall Study|Forbidden medication|5|||
156455697|NCT05201079|564763199|FG000|Overall Study|Transfer to another hospital|0|||
156455698|NCT05201079|564763200|FG001|Overall Study|Transfer to another hospital|1|||
156455699|NCT05201079|564763199|FG000|Overall Study|Clinical condition|1|||
156455700|NCT05201079|564763200|FG001|Overall Study|Clinical condition|0|||
156455701|NCT05201079|564763199|FG000|Overall Study|SAE and sepsis|1|||
156455702|NCT05201079|564763200|FG001|Overall Study|SAE and sepsis|0|||
156455703|NCT01210807|564763207|FG000|Overall Study|Lost to Follow-up|1|||
156455704|NCT01210807|564763208|FG001|Overall Study|Lost to Follow-up|2|||
156455705|NCT01210807|564763207|FG000|Overall Study|Not implanted bilaterally|2|||
156455706|NCT01210807|564763208|FG001|Overall Study|Not implanted bilaterally|1|||
156533772|NCT04409353|565048910|FG001|Overall Study|Disease burden - unable to participate|1|||
156733753|NCT01254318|565771162|FG000|Overall Study|Death|47|||
156733754|NCT01137110|565771169|FG000|Overall Study|Protocol Violation|1|||
156733755|NCT01137110|565771170|FG001|Overall Study|Protocol Violation|0|||
156796720|NCT02314923|566009666|FG005|Overall Study|Death|0|||
156796721|NCT02314923|566009667|FG006|Overall Study|Death|0|||
156796722|NCT02314923|566009668|FG007|Overall Study|Death|0|||
156796723|NCT02314923|566009669|FG008|Overall Study|Death|0|||
156796724|NCT02314923|566009670|FG009|Overall Study|Death|0|||
156796725|NCT02314923|566009661|FG000|Overall Study|Lost to Follow-up|2|||
156796726|NCT02314923|566009662|FG001|Overall Study|Lost to Follow-up|3|||
156796727|NCT02314923|566009663|FG002|Overall Study|Lost to Follow-up|1|||
156796728|NCT02314923|566009664|FG003|Overall Study|Lost to Follow-up|0|||
156796729|NCT02314923|566009665|FG004|Overall Study|Lost to Follow-up|0|||
156796730|NCT02314923|566009666|FG005|Overall Study|Lost to Follow-up|0|||
156796731|NCT02314923|566009667|FG006|Overall Study|Lost to Follow-up|3|||
156796732|NCT02314923|566009668|FG007|Overall Study|Lost to Follow-up|4|||
156796733|NCT02314923|566009669|FG008|Overall Study|Lost to Follow-up|2|||
156796734|NCT02314923|566009670|FG009|Overall Study|Lost to Follow-up|0|||
156796735|NCT02314923|566009661|FG000|Overall Study|Withdrawal by Subject|0|||
156796736|NCT02314923|566009662|FG001|Overall Study|Withdrawal by Subject|0|||
156796737|NCT02314923|566009663|FG002|Overall Study|Withdrawal by Subject|1|||
156796738|NCT02314923|566009664|FG003|Overall Study|Withdrawal by Subject|0|||
156796739|NCT02314923|566009665|FG004|Overall Study|Withdrawal by Subject|1|||
156796740|NCT02314923|566009666|FG005|Overall Study|Withdrawal by Subject|0|||
156796741|NCT02314923|566009667|FG006|Overall Study|Withdrawal by Subject|1|||
156796742|NCT02314923|566009668|FG007|Overall Study|Withdrawal by Subject|0|||
156796743|NCT02314923|566009669|FG008|Overall Study|Withdrawal by Subject|0|||
156796744|NCT02314923|566009670|FG009|Overall Study|Withdrawal by Subject|0|||
156796745|NCT02314923|566009661|FG000|Overall Study|Physician Decision|0|||
156796746|NCT02314923|566009662|FG001|Overall Study|Physician Decision|1|||
156796747|NCT02314923|566009663|FG002|Overall Study|Physician Decision|0|||
156796748|NCT02314923|566009664|FG003|Overall Study|Physician Decision|0|||
156796749|NCT02314923|566009665|FG004|Overall Study|Physician Decision|0|||
156733756|NCT00582608|565771173|FG000|Overall Study|Not Treated|7|||
156796750|NCT02314923|566009666|FG005|Overall Study|Physician Decision|0|||
156455707|NCT05281562|564763209|FG000|Overall Study|Ineligible patient|1|||
156455708|NCT05281562|564763210|FG001|Overall Study|Ineligible patient|0|||
156455709|NCT00324805|564763211|FG000|Overall Study|Adverse Event|62|||
156455710|NCT00324805|564763212|FG001|Overall Study|Adverse Event|203|||
156455711|NCT00324805|564763211|FG000|Overall Study|Progression|7|||
156455712|NCT00324805|564763212|FG001|Overall Study|Progression|35|||
156455713|NCT00324805|564763211|FG000|Overall Study|Withdrawal by Subject|51|||
156455714|NCT00324805|564763212|FG001|Overall Study|Withdrawal by Subject|174|||
156455715|NCT00324805|564763211|FG000|Overall Study|Death|6|||
156455716|NCT00324805|564763212|FG001|Overall Study|Death|9|||
156455717|NCT00324805|564763211|FG000|Overall Study|Alternative therapy|4|||
156455718|NCT00324805|564763212|FG001|Overall Study|Alternative therapy|8|||
156455719|NCT00324805|564763211|FG000|Overall Study|Other complicating disease|1|||
156455720|NCT00324805|564763212|FG001|Overall Study|Other complicating disease|9|||
156455721|NCT00324805|564763211|FG000|Overall Study|Other reasons|7|||
156455722|NCT00324805|564763212|FG001|Overall Study|Other reasons|26|||
156455723|NCT00324805|564763211|FG000|Overall Study|Other|0|||
156455724|NCT00324805|564763212|FG001|Overall Study|Other|2|||
156455725|NCT00324805|564763211|FG000|Overall Study|Did not start therapy|12|||
156455726|NCT00324805|564763212|FG001|Overall Study|Did not start therapy|17|||
156455727|NCT05526430|564763222|FG000|Overall Study|Withdrawal by Subject|0|||
156455728|NCT05526430|564763223|FG001|Overall Study|Withdrawal by Subject|2|||
156455729|NCT05526430|564763224|FG002|Overall Study|Withdrawal by Subject|0|||
156455730|NCT05526430|564763225|FG003|Overall Study|Withdrawal by Subject|0|||
156455731|NCT03085810|564763226|FG000|Main Study|Withdrawal by Subject|77|||
156455732|NCT03085810|564763227|FG001|Main Study|Withdrawal by Subject|0|||
156455733|NCT03085810|564763228|FG002|Main Study|Withdrawal by Subject|0|||
156455734|NCT03085810|564763226|FG000|Main Study|Terminated By Sponsor|14|||
156733757|NCT00582608|565771173|FG000|Overall Study|Patient Ineligible|1|||
156733758|NCT00582608|565771173|FG000|Overall Study|Lack of accrual|4|||
156733759|NCT03634033|565773564|FG000|Overall Study|Did not have a post-assessment|384|||
156733760|NCT03634033|565773565|FG001|Overall Study|Did not have a post-assessment|291|||
156733761|NCT03634033|565773566|FG002|Overall Study|Did not have a post-assessment|114|||
156733762|NCT03634033|565773567|FG003|Overall Study|Did not have a post-assessment|161|||
156733763|NCT03634033|565773568|FG004|Overall Study|Did not have a post-assessment|5|||
156733764|NCT03634033|565773569|FG005|Overall Study|Did not have a post-assessment|0|||
156733765|NCT03634033|565773570|FG006|Overall Study|Did not have a post-assessment|0|||
156733766|NCT03634033|565773564|FG000|Overall Study|Death|0|||
156733767|NCT03634033|565773565|FG001|Overall Study|Death|0|||
156733768|NCT03634033|565773566|FG002|Overall Study|Death|0|||
156733769|NCT03634033|565773567|FG003|Overall Study|Death|0|||
156733770|NCT03634033|565773568|FG004|Overall Study|Death|0|||
156733771|NCT03634033|565773569|FG005|Overall Study|Death|7|||
156733772|NCT03634033|565773570|FG006|Overall Study|Death|7|||
156733773|NCT03634033|565773564|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733774|NCT03634033|565773565|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733775|NCT03634033|565773566|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733776|NCT03634033|565773567|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733777|NCT03634033|565773568|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733778|NCT03634033|565773569|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
156733779|NCT03634033|565773570|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
156733780|NCT03634033|565773564|FG000|Overall Study|Lost to Follow-up|0|||
156733781|NCT03634033|565773565|FG001|Overall Study|Lost to Follow-up|0|||
156733782|NCT03634033|565773566|FG002|Overall Study|Lost to Follow-up|0|||
156796751|NCT02314923|566009667|FG006|Overall Study|Physician Decision|0|||
156796752|NCT02314923|566009668|FG007|Overall Study|Physician Decision|0|||
156796753|NCT02314923|566009669|FG008|Overall Study|Physician Decision|0|||
156796754|NCT02314923|566009670|FG009|Overall Study|Physician Decision|0|||
156796755|NCT02314923|566009661|FG000|Overall Study|Participant unavailable|0|||
156796756|NCT02314923|566009662|FG001|Overall Study|Participant unavailable|0|||
156796757|NCT02314923|566009663|FG002|Overall Study|Participant unavailable|0|||
156796758|NCT02314923|566009664|FG003|Overall Study|Participant unavailable|0|||
156796759|NCT02314923|566009665|FG004|Overall Study|Participant unavailable|0|||
156455735|NCT03085810|564763227|FG001|Main Study|Terminated By Sponsor|0|||
156455736|NCT03085810|564763228|FG002|Main Study|Terminated By Sponsor|0|||
156733783|NCT03634033|565773567|FG003|Overall Study|Lost to Follow-up|0|||
156733784|NCT03634033|565773568|FG004|Overall Study|Lost to Follow-up|0|||
156455737|NCT03085810|564763226|FG000|Main Study|Protocol Violation|15|||
156455738|NCT03085810|564763227|FG001|Main Study|Protocol Violation|0|||
156455739|NCT03085810|564763228|FG002|Main Study|Protocol Violation|0|||
156733785|NCT03634033|565773569|FG005|Overall Study|Lost to Follow-up|1|||
156796760|NCT02314923|566009666|FG005|Overall Study|Participant unavailable|1|||
156336551|NCT01397890|564329640|FG001|Overall Study|Lost to Follow-up|4|||
156733786|NCT03634033|565773570|FG006|Overall Study|Lost to Follow-up|2|||
156455740|NCT03085810|564763226|FG000|Main Study|Physician Decision|13|||
156733787|NCT03634033|565773564|FG000|Overall Study|Withdrawal by Subject|0|||
156733788|NCT03634033|565773565|FG001|Overall Study|Withdrawal by Subject|0|||
156796761|NCT02314923|566009667|FG006|Overall Study|Participant unavailable|0|||
156733789|NCT03634033|565773566|FG002|Overall Study|Withdrawal by Subject|0|||
156733790|NCT03634033|565773567|FG003|Overall Study|Withdrawal by Subject|0|||
156733791|NCT03634033|565773568|FG004|Overall Study|Withdrawal by Subject|0|||
156733792|NCT03634033|565773569|FG005|Overall Study|Withdrawal by Subject|0|||
156733793|NCT03634033|565773570|FG006|Overall Study|Withdrawal by Subject|1|||
156733794|NCT02836236|565773572|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
156733795|NCT02836236|565773573|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
156733796|NCT02836236|565773574|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
156733797|NCT02836236|565773575|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
156733798|NCT02836236|565773572|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
156733799|NCT02836236|565773573|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
156733800|NCT02836236|565773574|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
156733801|NCT02836236|565773575|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
156733802|NCT02836236|565773572|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156733803|NCT02836236|565773573|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
156733804|NCT02836236|565773574|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
156733805|NCT02836236|565773575|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
156733806|NCT02836236|565773572|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
156733807|NCT02836236|565773573|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156733808|NCT02836236|565773574|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156733809|NCT02836236|565773575|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156733810|NCT02836236|565773572|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
156733811|NCT02836236|565773573|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
156733812|NCT02836236|565773574|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
156733813|NCT02836236|565773575|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
156733814|NCT02836236|565773572|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
156733815|NCT02836236|565773573|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
156733816|NCT02836236|565773574|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
156733817|NCT02836236|565773575|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
156733818|NCT02836236|565773572|FG000|Open-Label TAF Treatment Phase|Death|0|||
156733819|NCT02836236|565773573|FG001|Open-Label TAF Treatment Phase|Death|0|||
156733820|NCT02836236|565773574|FG002|Open-Label TAF Treatment Phase|Death|1|||
156733821|NCT02836236|565773575|FG003|Open-Label TAF Treatment Phase|Death|1|||
156733822|NCT02836236|565773572|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
156733823|NCT02836236|565773573|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
156733824|NCT02836236|565773574|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
156733825|NCT02836236|565773575|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
156733826|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
156733827|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
156733828|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
156733829|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
156733830|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Death|0|||
156733831|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Death|0|||
156733832|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Death|1|||
156733833|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Death|0|||
156733834|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
156733835|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
156733836|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
156733837|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
156733838|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
156733839|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
156733840|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
156733841|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
156733842|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
156733843|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
156733844|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
156733845|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
156733846|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
156733847|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
156733848|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
156733849|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
156733850|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
156733851|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
156733852|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
156733853|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
156733854|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
156733855|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
156808812|NCT01484496|566054473|FG000|Period 1|Lack of Efficacy|10|||
156808813|NCT01484496|566054474|FG001|Period 1|Lack of Efficacy|15|||
156733856|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
156733857|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
156733858|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
156733859|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
156733860|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156733861|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156733862|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
156733863|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
156733864|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
156733865|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
156733866|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
156733867|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
156733868|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
156733869|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
156733870|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Other|8|||
156733871|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Other|14|||
156733872|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Other|8|||
156733873|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Other|23|||
156733874|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
156733875|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
156733876|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
156733877|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
156733878|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156733879|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156733880|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
156733881|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
156733882|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Death|0|||
156733883|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Death|0|||
156733884|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Death|0|||
156733885|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Death|1|||
156733886|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
156733887|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
156733888|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
156733889|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
156733890|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156733891|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
156733892|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
156733893|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
156733894|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156733895|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
156733896|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156733897|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
156733898|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156733899|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156733900|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156733901|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156733902|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156733903|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
156733904|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
156733905|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156733906|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
156733907|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
156733908|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
156733909|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
156733910|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156733911|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156733912|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156733913|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156733914|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Other|6|||
156733915|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Other|5|||
156733916|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Other|8|||
156733917|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Other|5|||
156733918|NCT03937908|565773583|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
156733919|NCT03937908|565773584|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
156733920|NCT03875092|565773585|FG000|Overall Study|Adverse Event|2|||
156733921|NCT03875092|565773586|FG001|Overall Study|Adverse Event|5|||
156733922|NCT03875092|565773585|FG000|Overall Study|Death|44|||
156733923|NCT03875092|565773586|FG001|Overall Study|Death|51|||
156733924|NCT03875092|565773585|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
156733925|NCT03875092|565773586|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
156733926|NCT04114357|565773587|FG000|Baseline-Randomization|Adverse Event|2|||
156733927|NCT04114357|565773588|FG001|Baseline-Randomization|Adverse Event|1|||
156733928|NCT04114357|565773587|FG000|Baseline-Randomization|Lost to Follow-up|1|||
156733929|NCT04114357|565773588|FG001|Baseline-Randomization|Lost to Follow-up|1|||
156733930|NCT04114357|565773587|FG000|Cross-over|Adverse Event|0|||
156733931|NCT04114357|565773588|FG001|Cross-over|Adverse Event|1|||
156733932|NCT03693612|565773592|FG000|Overall Study|Lost to Follow-up|0|||
156733933|NCT03693612|565773593|FG001|Overall Study|Lost to Follow-up|0|||
156733934|NCT03693612|565773594|FG002|Overall Study|Lost to Follow-up|0|||
156733935|NCT03693612|565773595|FG003|Overall Study|Lost to Follow-up|0|||
156733936|NCT03693612|565773596|FG004|Overall Study|Lost to Follow-up|1|||
156733937|NCT03693612|565773597|FG005|Overall Study|Lost to Follow-up|0|||
156733938|NCT03693612|565773598|FG006|Overall Study|Lost to Follow-up|0|||
156733939|NCT03693612|565773592|FG000|Overall Study|Withdrawal by Subject|0|||
156733940|NCT03693612|565773593|FG001|Overall Study|Withdrawal by Subject|0|||
156733941|NCT03693612|565773594|FG002|Overall Study|Withdrawal by Subject|1|||
156733942|NCT03693612|565773595|FG003|Overall Study|Withdrawal by Subject|0|||
156733943|NCT03693612|565773596|FG004|Overall Study|Withdrawal by Subject|2|||
156733944|NCT03693612|565773597|FG005|Overall Study|Withdrawal by Subject|0|||
156733945|NCT03693612|565773598|FG006|Overall Study|Withdrawal by Subject|0|||
156733946|NCT03693612|565773592|FG000|Overall Study|Study Terminated by Sponsor|0|||
156733947|NCT03693612|565773593|FG001|Overall Study|Study Terminated by Sponsor|1|||
156733948|NCT03693612|565773594|FG002|Overall Study|Study Terminated by Sponsor|0|||
156733949|NCT03693612|565773595|FG003|Overall Study|Study Terminated by Sponsor|0|||
156733950|NCT03693612|565773596|FG004|Overall Study|Study Terminated by Sponsor|3|||
156733951|NCT03693612|565773597|FG005|Overall Study|Study Terminated by Sponsor|0|||
156733952|NCT03693612|565773598|FG006|Overall Study|Study Terminated by Sponsor|0|||
156733953|NCT00809471|565773599|FG000|Overall Study|Protocol non-compliance|15|||
156733954|NCT00809471|565773600|FG001|Overall Study|Protocol non-compliance|15|||
156733955|NCT00809471|565773601|FG002|Overall Study|Protocol non-compliance|6|||
156733956|NCT00809471|565773599|FG000|Overall Study|Lost to Follow-up|4|||
156733957|NCT00809471|565773600|FG001|Overall Study|Lost to Follow-up|2|||
156733958|NCT00809471|565773601|FG002|Overall Study|Lost to Follow-up|9|||
156733959|NCT00809471|565773599|FG000|Overall Study|Adverse Event|0|||
156733960|NCT00809471|565773600|FG001|Overall Study|Adverse Event|2|||
156733961|NCT00809471|565773601|FG002|Overall Study|Adverse Event|2|||
156733962|NCT00809471|565773599|FG000|Overall Study|Requirement for restricted medication|1|||
156733963|NCT00809471|565773600|FG001|Overall Study|Requirement for restricted medication|1|||
156733964|NCT00809471|565773601|FG002|Overall Study|Requirement for restricted medication|0|||
156733965|NCT00831311|565773603|FG000|Overall Study|Definitive Contraindication|3|||
156733966|NCT00831311|565773604|FG001|Overall Study|Definitive Contraindication|3|||
156733967|NCT00831311|565773603|FG000|Overall Study|Lost to Follow-up|3|||
156733968|NCT00831311|565773604|FG001|Overall Study|Lost to Follow-up|0|||
156733969|NCT00831311|565773603|FG000|Overall Study|Physician Decision|0|||
156733970|NCT00831311|565773604|FG001|Overall Study|Physician Decision|1|||
156733971|NCT00831311|565773603|FG000|Overall Study|Withdrawal by Subject|6|||
156733972|NCT00831311|565773604|FG001|Overall Study|Withdrawal by Subject|4|||
156733973|NCT01669174|565773614|FG000|Overall Study|Subject withdrew consent|2|||
156733974|NCT01669174|565773615|FG001|Overall Study|Subject withdrew consent|2|||
156733975|NCT01669174|565773614|FG000|Overall Study|Lost to Follow-up|1|||
156733976|NCT01669174|565773615|FG001|Overall Study|Lost to Follow-up|0|||
156733977|NCT01669174|565773614|FG000|Overall Study|Adverse Event|2|||
156733978|NCT01669174|565773615|FG001|Overall Study|Adverse Event|2|||
156733979|NCT01669174|565773614|FG000|Overall Study|Administrative problems|1|||
156733980|NCT01669174|565773615|FG001|Overall Study|Administrative problems|2|||
156733981|NCT01953601|565773619|FG000|Part 1 (Base Study)|Adverse Event|24|||
156733982|NCT01953601|565773620|FG001|Part 1 (Base Study)|Adverse Event|37|||
156733983|NCT01953601|565773621|FG002|Part 1 (Base Study)|Adverse Event|15|||
156733984|NCT01953601|565773619|FG000|Part 1 (Base Study)|Death|2|||
156733985|NCT01953601|565773620|FG001|Part 1 (Base Study)|Death|0|||
156733986|NCT01953601|565773621|FG002|Part 1 (Base Study)|Death|3|||
156733987|NCT01953601|565773619|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
156733988|NCT01953601|565773620|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
156733989|NCT01953601|565773621|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
156733990|NCT01953601|565773619|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
156796762|NCT02314923|566009668|FG007|Overall Study|Participant unavailable|0|||
156733991|NCT01953601|565773620|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
156733992|NCT01953601|565773621|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
156733993|NCT01953601|565773619|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
156733994|NCT01953601|565773620|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
156733995|NCT01953601|565773621|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
156733996|NCT01953601|565773619|FG000|Part 1 (Base Study)|Physician Decision|3|||
156733997|NCT01953601|565773620|FG001|Part 1 (Base Study)|Physician Decision|7|||
156733998|NCT01953601|565773621|FG002|Part 1 (Base Study)|Physician Decision|4|||
156733999|NCT01953601|565773619|FG000|Part 1 (Base Study)|Screen failure|1|||
156734000|NCT01953601|565773620|FG001|Part 1 (Base Study)|Screen failure|0|||
156734001|NCT01953601|565773621|FG002|Part 1 (Base Study)|Screen failure|1|||
156734002|NCT01953601|565773619|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
156734003|NCT01953601|565773620|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
156734004|NCT01953601|565773621|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
156734005|NCT01953601|565773619|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
156734006|NCT01953601|565773620|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
156734007|NCT01953601|565773621|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
156734008|NCT01953601|565773619|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
156734009|NCT01953601|565773620|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
156734010|NCT01953601|565773621|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
156734011|NCT01953601|565773619|FG000|Part 1 (Base Study)|Subject moved|2|||
156734012|NCT01953601|565773620|FG001|Part 1 (Base Study)|Subject moved|2|||
156734013|NCT01953601|565773621|FG002|Part 1 (Base Study)|Subject moved|1|||
156734014|NCT01953601|565773619|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
156734015|NCT01953601|565773620|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
156734016|NCT01953601|565773621|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
156734017|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Adverse Event|1|||
156734018|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Adverse Event|1|||
156734019|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Adverse Event|10|||
156734020|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Death|0|||
156734021|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Death|3|||
156734022|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Death|0|||
156734023|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
156734024|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
156734025|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
156734026|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
156734027|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
156734028|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
156734029|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Physician Decision|2|||
156734030|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Physician Decision|0|||
156734031|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Physician Decision|2|||
156734032|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
156734033|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
156734034|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
156734035|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
156734036|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
156734037|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
156734038|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
156734039|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
156734040|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
156734041|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Subject moved|0|||
156734042|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Subject moved|0|||
156734043|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Subject moved|1|||
156796763|NCT02314923|566009669|FG008|Overall Study|Participant unavailable|0|||
156796764|NCT02314923|566009670|FG009|Overall Study|Participant unavailable|0|||
156796765|NCT02314923|566009661|FG000|Overall Study|Screen failure|0|||
156796766|NCT02314923|566009662|FG001|Overall Study|Screen failure|0|||
156796767|NCT02314923|566009663|FG002|Overall Study|Screen failure|0|||
156796768|NCT02314923|566009664|FG003|Overall Study|Screen failure|0|||
156796769|NCT02314923|566009665|FG004|Overall Study|Screen failure|0|||
156533773|NCT04409353|565048911|FG002|Overall Study|Disease burden - unable to participate|1|||
156533774|NCT04409353|565048909|FG000|Overall Study|Intervention too complicated|1|||
156533775|NCT04409353|565048910|FG001|Overall Study|Intervention too complicated|0|||
156533776|NCT04409353|565048911|FG002|Overall Study|Intervention too complicated|1|||
156533777|NCT04252287|565048913|FG000|Overall Study|Death|5|||
156533778|NCT04252287|565048914|FG001|Overall Study|Death|3|||
156533779|NCT04252287|565048913|FG000|Overall Study|Lost to Follow-up|4|||
156533780|NCT04252287|565048914|FG001|Overall Study|Lost to Follow-up|6|||
156734044|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
156734045|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
156734046|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
156796770|NCT02314923|566009666|FG005|Overall Study|Screen failure|0|||
156796771|NCT02314923|566009667|FG006|Overall Study|Screen failure|1|||
156796772|NCT02314923|566009668|FG007|Overall Study|Screen failure|0|||
156796773|NCT02314923|566009669|FG008|Overall Study|Screen failure|0|||
156796774|NCT02314923|566009670|FG009|Overall Study|Screen failure|0|||
156533781|NCT04252287|565048913|FG000|Overall Study|Withdrawal by Subject|19|||
156533782|NCT04252287|565048914|FG001|Overall Study|Withdrawal by Subject|16|||
156734047|NCT01608087|565773622|FG000|Overall Study|Lost to Follow-up|0|||
156734048|NCT01608087|565773623|FG001|Overall Study|Lost to Follow-up|1|||
156734049|NCT01608087|565773624|FG002|Overall Study|Lost to Follow-up|0|||
156734050|NCT01608087|565773622|FG000|Overall Study|Other Reason|0|||
156734051|NCT01608087|565773623|FG001|Overall Study|Other Reason|1|||
156734052|NCT01608087|565773624|FG002|Overall Study|Other Reason|0|||
156734053|NCT01300338|565773631|FG000|Overall Study|Lost to Follow-up|5|||
156734054|NCT01300338|565773632|FG001|Overall Study|Lost to Follow-up|0|||
156734055|NCT02461524|565773636|FG000|Overall Study|Death|16|||
156734056|NCT02461524|565773636|FG000|Overall Study|Withdrawal by Subject|4|||
156734057|NCT02461524|565773636|FG000|Overall Study|Device Explanted|5|||
156734058|NCT02461524|565773636|FG000|Overall Study|Missed Visit|6|||
156734059|NCT01943851|565773638|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734060|NCT01943851|565773639|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734061|NCT01943851|565773640|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734062|NCT01943851|565773641|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
156734063|NCT01943851|565773642|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734064|NCT01943851|565773643|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734065|NCT01943851|565773644|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
156734066|NCT01943851|565773645|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
156734067|NCT01943851|565773646|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
156796775|NCT02314923|566009661|FG000|Overall Study|Participant relocation|1|||
156796776|NCT02314923|566009662|FG001|Overall Study|Participant relocation|0|||
156796777|NCT02314923|566009663|FG002|Overall Study|Participant relocation|0|||
156533783|NCT04252287|565048913|FG000|Overall Study|Protocol Violation|3|||
156796778|NCT02314923|566009664|FG003|Overall Study|Participant relocation|0|||
156796779|NCT02314923|566009665|FG004|Overall Study|Participant relocation|0|||
156796780|NCT02314923|566009666|FG005|Overall Study|Participant relocation|0|||
156796781|NCT02314923|566009667|FG006|Overall Study|Participant relocation|0|||
156796782|NCT02314923|566009668|FG007|Overall Study|Participant relocation|1|||
156796783|NCT02314923|566009669|FG008|Overall Study|Participant relocation|0|||
156796784|NCT02314923|566009670|FG009|Overall Study|Participant relocation|0|||
156796785|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Adverse Event|20|||
156533784|NCT04252287|565048914|FG001|Overall Study|Protocol Violation|4|||
156533785|NCT02499770|565048918|FG000|Overall Study|Death|17|||
156533786|NCT02499770|565048919|FG001|Overall Study|Death|56|||
156533787|NCT02499770|565048918|FG000|Overall Study|Study completion|1|||
156533788|NCT02499770|565048919|FG001|Overall Study|Study completion|10|||
156533789|NCT02499770|565048918|FG000|Overall Study|Withdrawal by Subject|0|||
156533790|NCT02499770|565048919|FG001|Overall Study|Withdrawal by Subject|7|||
156533791|NCT02499770|565048918|FG000|Overall Study|Lost to Follow-up|0|||
156533792|NCT02499770|565048919|FG001|Overall Study|Lost to Follow-up|2|||
156533793|NCT02499770|565048918|FG000|Overall Study|Subject declined further treatment|1|||
156533794|NCT02499770|565048919|FG001|Overall Study|Subject declined further treatment|0|||
156533795|NCT02499770|565048918|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
156533796|NCT02499770|565048919|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
156533797|NCT02499770|565048918|FG000|Overall Study|Randomized but not enrolled|0|||
156533798|NCT02499770|565048919|FG001|Overall Study|Randomized but not enrolled|1|||
156533799|NCT00671554|565048922|FG000|Overall Study|Disease progression|3|||
156533800|NCT04275297|565048924|FG000|Overall Study|Lost to Follow-up|1|||
156533801|NCT04275297|565048925|FG001|Overall Study|Lost to Follow-up|1|||
156533802|NCT01093326|565048928|FG000|Overall Study|Death|0|||
156533803|NCT01093326|565048929|FG001|Overall Study|Death|1|||
156533804|NCT01093326|565048930|FG002|Overall Study|Death|0|||
156533805|NCT01093326|565048928|FG000|Overall Study|Lack of Efficacy|7|||
156533806|NCT01093326|565048929|FG001|Overall Study|Lack of Efficacy|6|||
156533807|NCT01093326|565048930|FG002|Overall Study|Lack of Efficacy|3|||
156533808|NCT01093326|565048928|FG000|Overall Study|Lost to Follow-up|2|||
156533809|NCT01093326|565048929|FG001|Overall Study|Lost to Follow-up|5|||
156533810|NCT01093326|565048930|FG002|Overall Study|Lost to Follow-up|4|||
156533811|NCT01093326|565048928|FG000|Overall Study|Physician Decision|3|||
156796786|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Adverse Event|10|||
156796787|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Adverse Event|5|||
156533812|NCT01093326|565048929|FG001|Overall Study|Physician Decision|1|||
156533813|NCT01093326|565048930|FG002|Overall Study|Physician Decision|3|||
156734068|NCT01943851|565773647|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734069|NCT01943851|565773648|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734070|NCT01943851|565773649|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156796788|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Adverse Event|0|||
156796789|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Adverse Event|0|||
156796790|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Adverse Event|0|||
156533814|NCT01093326|565048928|FG000|Overall Study|Withdrawal by Subject|30|||
156533815|NCT01093326|565048929|FG001|Overall Study|Withdrawal by Subject|27|||
156533816|NCT01093326|565048930|FG002|Overall Study|Withdrawal by Subject|26|||
156533817|NCT01093326|565048928|FG000|Overall Study|Adverse Event|2|||
156533818|NCT01093326|565048929|FG001|Overall Study|Adverse Event|1|||
156455741|NCT03085810|564763227|FG001|Main Study|Physician Decision|0|||
156734071|NCT01943851|565773650|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734072|NCT01943851|565773651|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734073|NCT01943851|565773652|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734074|NCT01943851|565773653|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734075|NCT01943851|565773654|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734076|NCT01943851|565773655|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734077|NCT01943851|565773638|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734078|NCT01943851|565773639|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734079|NCT01943851|565773640|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734080|NCT01943851|565773641|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734081|NCT01943851|565773642|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
156734082|NCT01943851|565773643|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734083|NCT01943851|565773644|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734084|NCT01943851|565773645|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
156734085|NCT01943851|565773646|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734086|NCT01943851|565773647|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734087|NCT01943851|565773648|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734088|NCT01943851|565773649|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734089|NCT01943851|565773650|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734090|NCT01943851|565773651|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734091|NCT01943851|565773652|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734092|NCT01943851|565773653|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734093|NCT01943851|565773654|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734094|NCT01943851|565773655|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734095|NCT01943851|565773638|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734096|NCT01943851|565773639|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734097|NCT01943851|565773640|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734098|NCT01943851|565773641|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734099|NCT01943851|565773642|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734100|NCT01943851|565773643|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734101|NCT01943851|565773644|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734102|NCT01943851|565773645|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734103|NCT01943851|565773646|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734104|NCT01943851|565773647|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734105|NCT01943851|565773648|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734106|NCT01943851|565773649|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734107|NCT01943851|565773650|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734108|NCT01943851|565773651|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
156734109|NCT01943851|565773652|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734110|NCT01943851|565773653|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734111|NCT01943851|565773654|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734112|NCT01943851|565773655|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734113|NCT01943851|565773638|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734114|NCT01943851|565773639|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734115|NCT01943851|565773640|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734116|NCT01943851|565773641|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734117|NCT01943851|565773642|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734118|NCT01943851|565773643|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734119|NCT01943851|565773644|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734120|NCT01943851|565773645|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734121|NCT01943851|565773646|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734122|NCT01943851|565773647|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734123|NCT01943851|565773648|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734124|NCT01943851|565773649|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734125|NCT01943851|565773650|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734126|NCT01943851|565773651|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734127|NCT01943851|565773652|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734128|NCT01943851|565773653|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
156734129|NCT01943851|565773654|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734130|NCT01943851|565773655|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734131|NCT01943851|565773638|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734132|NCT01943851|565773639|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734133|NCT01943851|565773640|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734134|NCT01943851|565773641|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156455742|NCT03085810|564763228|FG002|Main Study|Physician Decision|0|||
156455743|NCT03085810|564763226|FG000|Main Study|Lost to Follow-up|17|||
156455744|NCT03085810|564763227|FG001|Main Study|Lost to Follow-up|0|||
156455745|NCT03085810|564763228|FG002|Main Study|Lost to Follow-up|0|||
156455746|NCT03085810|564763226|FG000|Main Study|Adverse Event|25|||
156455747|NCT03085810|564763227|FG001|Main Study|Adverse Event|0|||
156734135|NCT01943851|565773642|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156455748|NCT03085810|564763228|FG002|Main Study|Adverse Event|0|||
156455749|NCT03085810|564763226|FG000|Main Study|Pregnancy|7|||
156455750|NCT03085810|564763227|FG001|Main Study|Pregnancy|0|||
156455751|NCT03085810|564763228|FG002|Main Study|Pregnancy|0|||
156455752|NCT03085810|564763226|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
156455753|NCT03085810|564763227|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
156455754|NCT03085810|564763228|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
156455755|NCT03085810|564763226|FG000|Main Study|Lack of Efficacy|10|||
156455756|NCT03085810|564763227|FG001|Main Study|Lack of Efficacy|0|||
156455757|NCT03085810|564763228|FG002|Main Study|Lack of Efficacy|0|||
156455758|NCT03085810|564763226|FG000|Main Study|Death|12|||
156455759|NCT03085810|564763227|FG001|Main Study|Death|0|||
156455760|NCT03085810|564763228|FG002|Main Study|Death|0|||
156455761|NCT03085810|564763226|FG000|Main Study|Disease progression|1|||
156734136|NCT01943851|565773643|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734137|NCT01943851|565773644|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734138|NCT01943851|565773645|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734139|NCT01943851|565773646|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734140|NCT01943851|565773647|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734141|NCT01943851|565773648|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734142|NCT01943851|565773649|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734143|NCT01943851|565773650|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734144|NCT01943851|565773651|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734145|NCT01943851|565773652|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156796791|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Adverse Event|0|||
156796792|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Adverse Event|0|||
156796793|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Adverse Event|0|||
156796794|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Adverse Event|0|||
156455762|NCT03085810|564763227|FG001|Main Study|Disease progression|0|||
156455763|NCT03085810|564763228|FG002|Main Study|Disease progression|0|||
156455764|NCT03085810|564763226|FG000|Main Study|Site Closure|3|||
156455765|NCT03085810|564763227|FG001|Main Study|Site Closure|0|||
156455766|NCT03085810|564763228|FG002|Main Study|Site Closure|0|||
156455767|NCT03085810|564763226|FG000|Main Study|Planned pregnancy|17|||
156455768|NCT03085810|564763227|FG001|Main Study|Planned pregnancy|0|||
156455769|NCT03085810|564763228|FG002|Main Study|Planned pregnancy|0|||
156455770|NCT03085810|564763226|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
156455771|NCT03085810|564763227|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
156455772|NCT03085810|564763228|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
156455773|NCT03085810|564763226|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
156796795|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Adverse Event|0|||
156796796|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Adverse Event|0|||
156796797|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796798|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796799|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
156796800|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796801|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796802|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796803|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796804|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796805|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796806|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796807|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796808|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796809|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
156796810|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
156796811|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
156796812|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
156455774|NCT03085810|564763227|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
156455775|NCT03085810|564763228|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
156455776|NCT03085810|564763226|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
156455777|NCT03085810|564763227|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
156455778|NCT03085810|564763228|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
156455779|NCT03085810|564763226|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
156734146|NCT01943851|565773653|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
156734147|NCT01943851|565773654|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
156734148|NCT01943851|565773655|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
156734149|NCT00401544|565773660|FG000|Overall Study|Adverse Event|5|||
156734150|NCT00401544|565773661|FG001|Overall Study|Adverse Event|1|||
156796813|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
156455780|NCT03085810|564763227|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
156336552|NCT01397890|564329639|FG000|Overall Study|Condition under Investigation Worsened|1|||
156336553|NCT01397890|564329640|FG001|Overall Study|Condition under Investigation Worsened|3|||
156336554|NCT01397890|564329639|FG000|Overall Study|Adverse Event|1|||
156336555|NCT01397890|564329640|FG001|Overall Study|Adverse Event|2|||
156336556|NCT01397890|564329639|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
156336557|NCT01397890|564329640|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
156455781|NCT03085810|564763228|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
156455782|NCT03701763|564763229|FG000|Placebo-controlled Phase|Adverse Event|1|||
156734151|NCT00401544|565773662|FG002|Overall Study|Adverse Event|1|||
156734152|NCT00401544|565773663|FG003|Overall Study|Adverse Event|1|||
156734153|NCT00401544|565773660|FG000|Overall Study|Death|3|||
156734154|NCT00401544|565773661|FG001|Overall Study|Death|6|||
156734155|NCT00401544|565773662|FG002|Overall Study|Death|2|||
156734156|NCT00401544|565773663|FG003|Overall Study|Death|5|||
156734157|NCT00401544|565773660|FG000|Overall Study|Lost to Follow-up|2|||
156734158|NCT00401544|565773661|FG001|Overall Study|Lost to Follow-up|0|||
156734159|NCT00401544|565773662|FG002|Overall Study|Lost to Follow-up|1|||
156734160|NCT00401544|565773663|FG003|Overall Study|Lost to Follow-up|1|||
156734161|NCT00401544|565773660|FG000|Overall Study|Withdrawal by Subject|7|||
156734162|NCT00401544|565773661|FG001|Overall Study|Withdrawal by Subject|6|||
156734163|NCT00401544|565773662|FG002|Overall Study|Withdrawal by Subject|6|||
156734164|NCT00401544|565773663|FG003|Overall Study|Withdrawal by Subject|5|||
156734165|NCT00401544|565773660|FG000|Overall Study|Physician Decision|1|||
156734166|NCT00401544|565773661|FG001|Overall Study|Physician Decision|3|||
156734167|NCT00401544|565773662|FG002|Overall Study|Physician Decision|0|||
156734168|NCT00401544|565773663|FG003|Overall Study|Physician Decision|0|||
156734169|NCT00401544|565773660|FG000|Overall Study|Ineligibility determined|0|||
156734170|NCT00401544|565773661|FG001|Overall Study|Ineligibility determined|1|||
156734171|NCT00401544|565773662|FG002|Overall Study|Ineligibility determined|0|||
156734172|NCT00401544|565773663|FG003|Overall Study|Ineligibility determined|2|||
156734173|NCT00401544|565773660|FG000|Overall Study|Disease progression|0|||
156734174|NCT00401544|565773661|FG001|Overall Study|Disease progression|1|||
156734175|NCT00401544|565773662|FG002|Overall Study|Disease progression|0|||
156734176|NCT00401544|565773663|FG003|Overall Study|Disease progression|0|||
156734177|NCT00401544|565773660|FG000|Overall Study|Other|0|||
156734178|NCT00401544|565773661|FG001|Overall Study|Other|0|||
156734179|NCT00401544|565773662|FG002|Overall Study|Other|2|||
156734180|NCT00401544|565773663|FG003|Overall Study|Other|2|||
156734181|NCT03991299|565773666|FG000|Overall Study|Study closed, sponsor decision|3|||
156336558|NCT01397890|564329639|FG000|Overall Study|Others|2|||
156455783|NCT03701763|564763230|FG001|Placebo-controlled Phase|Adverse Event|5|||
156455784|NCT03701763|564763231|FG002|Placebo-controlled Phase|Adverse Event|0|||
156455785|NCT03701763|564763232|FG003|Placebo-controlled Phase|Adverse Event|0|||
156455786|NCT03701763|564763229|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
156455787|NCT03701763|564763230|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
156455788|NCT03701763|564763231|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
156455789|NCT03701763|564763232|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
156455790|NCT03701763|564763229|FG000|Placebo-controlled Phase|Miscellaneous|2|||
156455791|NCT03701763|564763230|FG001|Placebo-controlled Phase|Miscellaneous|0|||
156533819|NCT01093326|565048930|FG002|Overall Study|Adverse Event|4|||
156734182|NCT03991299|565773666|FG000|Overall Study|Withdrawal by Subject|1|||
156734183|NCT00723008|565773667|FG000|Enrollment|Lost to Follow-up|1|||
156734184|NCT00723008|565773668|FG001|Enrollment|Lost to Follow-up|0|||
156734185|NCT00723008|565773667|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
156734186|NCT00723008|565773668|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
156734187|NCT00723008|565773667|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
156734188|NCT00723008|565773668|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
156336559|NCT01397890|564329640|FG001|Overall Study|Others|1|||
156734189|NCT00723008|565773667|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
156734190|NCT00723008|565773668|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
156734191|NCT00723008|565773667|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
156734192|NCT00723008|565773668|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
156336560|NCT03094169|564329641|FG000|Overall Study|Lack of Efficacy|0|||
156455792|NCT03701763|564763231|FG002|Placebo-controlled Phase|Miscellaneous|0|||
156455793|NCT03701763|564763232|FG003|Placebo-controlled Phase|Miscellaneous|0|||
156533820|NCT01093326|565048928|FG000|Overall Study|Other|0|||
156734193|NCT00723008|565773667|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
156734194|NCT00723008|565773668|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
156734195|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
156734196|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
156734197|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
156734198|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
156734199|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
156734200|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
156734201|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
156808814|NCT01484496|566054475|FG002|Period 1|Lack of Efficacy|0|||
156533821|NCT01093326|565048929|FG001|Overall Study|Other|0|||
156455794|NCT03701763|564763229|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
156734202|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
156734203|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
156734204|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
156734205|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
156455795|NCT03701763|564763230|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
156455796|NCT03701763|564763231|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
156455797|NCT03701763|564763232|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
156455798|NCT03701763|564763229|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
156455799|NCT03701763|564763230|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
156455800|NCT03701763|564763231|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
156455801|NCT03701763|564763232|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
156455802|NCT03701763|564763229|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
156455803|NCT03701763|564763230|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
156455804|NCT03701763|564763231|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
156455805|NCT03701763|564763232|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
156455806|NCT03701763|564763229|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
156455807|NCT03701763|564763230|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
156455808|NCT03701763|564763231|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
156455809|NCT03701763|564763232|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
156455810|NCT03701763|564763229|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
156455811|NCT03701763|564763230|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
156455812|NCT03701763|564763231|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
156455813|NCT03701763|564763232|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
156455814|NCT03701763|564763229|FG000|Apremilast Extension Phase|Adverse Event|0|||
156455815|NCT03701763|564763230|FG001|Apremilast Extension Phase|Adverse Event|0|||
156455816|NCT03701763|564763231|FG002|Apremilast Extension Phase|Adverse Event|3|||
156455817|NCT03701763|564763232|FG003|Apremilast Extension Phase|Adverse Event|1|||
156455818|NCT03701763|564763229|FG000|Apremilast Extension Phase|Miscellaneous|0|||
156455819|NCT03701763|564763230|FG001|Apremilast Extension Phase|Miscellaneous|0|||
156455820|NCT03701763|564763231|FG002|Apremilast Extension Phase|Miscellaneous|2|||
156455821|NCT03701763|564763232|FG003|Apremilast Extension Phase|Miscellaneous|1|||
156455822|NCT03701763|564763229|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
156455823|NCT03701763|564763230|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
156455824|NCT03701763|564763231|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
156455825|NCT03701763|564763232|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
156455826|NCT03701763|564763229|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
156455827|NCT03701763|564763230|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
156455828|NCT03701763|564763231|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
156455829|NCT03701763|564763232|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
156455830|NCT03701763|564763229|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
156455831|NCT03701763|564763230|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
156455832|NCT03701763|564763231|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
156455833|NCT03701763|564763232|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
156455834|NCT03701763|564763229|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
156455835|NCT03701763|564763230|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
156455836|NCT03701763|564763231|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
156455837|NCT03701763|564763232|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
156455838|NCT03701763|564763229|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
156455839|NCT03701763|564763230|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
156455840|NCT03701763|564763231|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
156455841|NCT03701763|564763232|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
156455842|NCT03701763|564763229|FG000|14-Week Observational Follow-up Phase|Other|0|||
156455843|NCT03701763|564763230|FG001|14-Week Observational Follow-up Phase|Other|0|||
156455844|NCT03701763|564763231|FG002|14-Week Observational Follow-up Phase|Other|1|||
156455845|NCT03701763|564763232|FG003|14-Week Observational Follow-up Phase|Other|0|||
156455846|NCT03701763|564763229|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
156455847|NCT03701763|564763230|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
156455848|NCT03701763|564763231|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
156455849|NCT03701763|564763232|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
156455850|NCT03701763|564763229|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
156455851|NCT03701763|564763230|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
156455852|NCT03701763|564763231|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
156808815|NCT01484496|566054476|FG003|Period 1|Lack of Efficacy|0|||
156808816|NCT01484496|566054473|FG000|Period 1|Adverse Event|25|||
156808817|NCT01484496|566054474|FG001|Period 1|Adverse Event|40|||
156808818|NCT01484496|566054475|FG002|Period 1|Adverse Event|0|||
156808819|NCT01484496|566054476|FG003|Period 1|Adverse Event|0|||
156808820|NCT01484496|566054473|FG000|Period 1|Withdrawal by Subject|15|||
156734206|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
156734207|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
156734208|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
156734209|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
156734210|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Death|0|||
156734211|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Death|0|||
156734212|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Death|1|||
156734213|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Death|2|||
156734214|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Death|7|||
156336561|NCT03094169|564329642|FG001|Overall Study|Lack of Efficacy|0|||
156336562|NCT03094169|564329643|FG002|Overall Study|Lack of Efficacy|0|||
156336563|NCT03094169|564329644|FG003|Overall Study|Lack of Efficacy|0|||
156336564|NCT03094169|564329645|FG004|Overall Study|Lack of Efficacy|0|||
156336565|NCT03094169|564329646|FG005|Overall Study|Lack of Efficacy|0|||
156336566|NCT03094169|564329647|FG006|Overall Study|Lack of Efficacy|0|||
156336567|NCT03094169|564329648|FG007|Overall Study|Lack of Efficacy|21|||
156336568|NCT03094169|564329641|FG000|Overall Study|Adverse Event|0|||
156336569|NCT03094169|564329642|FG001|Overall Study|Adverse Event|0|||
156336570|NCT03094169|564329643|FG002|Overall Study|Adverse Event|0|||
156336571|NCT03094169|564329644|FG003|Overall Study|Adverse Event|0|||
156336572|NCT03094169|564329645|FG004|Overall Study|Adverse Event|0|||
156336573|NCT03094169|564329646|FG005|Overall Study|Adverse Event|0|||
156336574|NCT03094169|564329647|FG006|Overall Study|Adverse Event|0|||
156336575|NCT03094169|564329648|FG007|Overall Study|Adverse Event|2|||
156336576|NCT03094169|564329641|FG000|Overall Study|Withdrawal by Subject|0|||
156336577|NCT03094169|564329642|FG001|Overall Study|Withdrawal by Subject|0|||
156336578|NCT03094169|564329643|FG002|Overall Study|Withdrawal by Subject|0|||
156336579|NCT03094169|564329644|FG003|Overall Study|Withdrawal by Subject|0|||
156336580|NCT03094169|564329645|FG004|Overall Study|Withdrawal by Subject|0|||
156336581|NCT03094169|564329646|FG005|Overall Study|Withdrawal by Subject|0|||
156336582|NCT03094169|564329647|FG006|Overall Study|Withdrawal by Subject|1|||
156336583|NCT03094169|564329648|FG007|Overall Study|Withdrawal by Subject|1|||
156336584|NCT03094169|564329641|FG000|Overall Study|Trial Termination|0|||
156336585|NCT03094169|564329642|FG001|Overall Study|Trial Termination|0|||
156336586|NCT03094169|564329643|FG002|Overall Study|Trial Termination|0|||
156336587|NCT03094169|564329644|FG003|Overall Study|Trial Termination|0|||
156455853|NCT03701763|564763232|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
156455854|NCT04515849|564763235|FG000|Overall Study|Adverse Event|0|||
156455855|NCT04515849|564763236|FG001|Overall Study|Adverse Event|0|||
156455856|NCT04515849|564763237|FG002|Overall Study|Adverse Event|0|||
156455857|NCT04515849|564763238|FG003|Overall Study|Adverse Event|1|||
156455858|NCT04515849|564763239|FG004|Overall Study|Adverse Event|2|||
156455859|NCT04515849|564763235|FG000|Overall Study|Death|2|||
156455860|NCT04515849|564763236|FG001|Overall Study|Death|0|||
156455861|NCT04515849|564763237|FG002|Overall Study|Death|0|||
156455862|NCT04515849|564763238|FG003|Overall Study|Death|0|||
156455863|NCT04515849|564763239|FG004|Overall Study|Death|0|||
156455864|NCT04515849|564763235|FG000|Overall Study|Other:family emergency|0|||
156455865|NCT04515849|564763236|FG001|Overall Study|Other:family emergency|0|||
156455866|NCT04515849|564763237|FG002|Overall Study|Other:family emergency|0|||
156455867|NCT04515849|564763238|FG003|Overall Study|Other:family emergency|1|||
156455868|NCT04515849|564763239|FG004|Overall Study|Other:family emergency|0|||
156455869|NCT04515849|564763235|FG000|Overall Study|Other:randomised by error|0|||
156455870|NCT04515849|564763236|FG001|Overall Study|Other:randomised by error|1|||
156455871|NCT04515849|564763237|FG002|Overall Study|Other:randomised by error|0|||
156455872|NCT04515849|564763238|FG003|Overall Study|Other:randomised by error|0|||
156455873|NCT04515849|564763239|FG004|Overall Study|Other:randomised by error|0|||
156734215|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
156734216|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
156734217|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
156734218|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
156734219|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
156336588|NCT03094169|564329645|FG004|Overall Study|Trial Termination|0|||
156455874|NCT04515849|564763235|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
156455875|NCT04515849|564763236|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
156533822|NCT01093326|565048930|FG002|Overall Study|Other|1|||
156336589|NCT03094169|564329646|FG005|Overall Study|Trial Termination|0|||
156336590|NCT03094169|564329647|FG006|Overall Study|Trial Termination|0|||
156336591|NCT03094169|564329648|FG007|Overall Study|Trial Termination|1|||
156734220|NCT00941863|565773669|FG000|Continued After PCD|Withdrawal by Subject|0|||
156734221|NCT00941863|565773670|FG001|Continued After PCD|Withdrawal by Subject|0|||
156336592|NCT04645953|564329649|FG000|Overall Study|Lost to Follow-up|2|||
156336593|NCT04645953|564329650|FG001|Overall Study|Lost to Follow-up|1|||
156336594|NCT04645953|564329651|FG002|Overall Study|Lost to Follow-up|1|||
156455876|NCT04515849|564763237|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
156734222|NCT00941863|565773671|FG002|Continued After PCD|Withdrawal by Subject|0|||
156734223|NCT00941863|565773672|FG003|Continued After PCD|Withdrawal by Subject|0|||
156734224|NCT00941863|565773673|FG004|Continued After PCD|Withdrawal by Subject|1|||
156734225|NCT00941863|565773669|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
156734226|NCT00941863|565773670|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
156734227|NCT00941863|565773671|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
156734228|NCT00941863|565773672|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
156734229|NCT00941863|565773673|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
156734230|NCT01471340|565773674|FG000|Overall Study|Death|5|||
156734231|NCT01471340|565773675|FG001|Overall Study|Death|4|||
156734232|NCT01471340|565773674|FG000|Overall Study|Lost to Follow-up|0|||
156734233|NCT01471340|565773675|FG001|Overall Study|Lost to Follow-up|1|||
156734234|NCT01471340|565773674|FG000|Overall Study|Investigational site closure|0|||
156734235|NCT01471340|565773675|FG001|Overall Study|Investigational site closure|1|||
156734236|NCT01471340|565773674|FG000|Overall Study|Invalid informed consent|1|||
156734237|NCT01471340|565773675|FG001|Overall Study|Invalid informed consent|0|||
156734238|NCT00179673|565773682|FG000|Overall Study|Adverse Event|7|||
156734239|NCT00179673|565773682|FG000|Overall Study|Lack of Efficacy|15|||
156734240|NCT00179673|565773682|FG000|Overall Study|Withdrawal by Subject|3|||
156734241|NCT00179673|565773682|FG000|Overall Study|Death|4|||
156734242|NCT00179673|565773682|FG000|Overall Study|Other Observations and options|14|||
156734243|NCT00492648|565773683|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
156734244|NCT00492648|565773684|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
156734245|NCT00282113|565773685|FG000|Overall Study|Removed at parents request|1|||
156734246|NCT00282113|565773686|FG001|Overall Study|Removed at parents request|0|||
156734247|NCT00282113|565773687|FG002|Overall Study|Removed at parents request|0|||
156734248|NCT02120833|565773688|FG000|Overall Study|Adverse Event|1|||
156734249|NCT02120833|565773689|FG001|Overall Study|Adverse Event|0|||
156734250|NCT02120833|565773688|FG000|Overall Study|Withdrawal by Subject|2|||
156734251|NCT02120833|565773689|FG001|Overall Study|Withdrawal by Subject|0|||
156734252|NCT02120833|565773688|FG000|Overall Study|Lost to Follow-up|1|||
156734253|NCT02120833|565773689|FG001|Overall Study|Lost to Follow-up|1|||
156734254|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
156734255|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
156734256|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
156734257|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
156734258|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
156734259|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156734260|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156734261|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156734262|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
156734263|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
156734264|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156734265|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156734266|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
156734267|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
156734268|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
156734269|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
156734270|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
156734271|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
156734272|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
156734273|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
156876620|NCT00535288|566307659|FG003|Overall Study|Lost to Follow-up|0|||
156876621|NCT00535288|566307660|FG004|Overall Study|Lost to Follow-up|0|||
156876622|NCT00535288|566307656|FG000|Overall Study|Lack of Efficacy|26|||
156876623|NCT00535288|566307657|FG001|Overall Study|Lack of Efficacy|3|||
156876624|NCT00535288|566307658|FG002|Overall Study|Lack of Efficacy|4|||
156876625|NCT00535288|566307659|FG003|Overall Study|Lack of Efficacy|4|||
156876626|NCT00535288|566307660|FG004|Overall Study|Lack of Efficacy|7|||
156876627|NCT00535288|566307656|FG000|Overall Study|Unwilling to cooperate|6|||
156876628|NCT00535288|566307657|FG001|Overall Study|Unwilling to cooperate|6|||
156734274|NCT02438826|565773690|FG000|Open-Label Treatment Phase|Adverse Event|11|||
156734275|NCT02438826|565773691|FG001|Open-Label Treatment Phase|Adverse Event|6|||
156336595|NCT04645953|564329649|FG000|Overall Study|Withdrawal by Subject|0|||
156734276|NCT02438826|565773692|FG002|Open-Label Treatment Phase|Adverse Event|0|||
156734277|NCT02438826|565773693|FG003|Open-Label Treatment Phase|Adverse Event|0|||
156734278|NCT02438826|565773690|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
156734279|NCT02438826|565773691|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
156734280|NCT02438826|565773692|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
156876629|NCT00535288|566307658|FG002|Overall Study|Unwilling to cooperate|3|||
156455877|NCT04515849|564763238|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
156460623|NCT04625725|564781649|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
156734281|NCT02438826|565773693|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
156734282|NCT02438826|565773690|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
156734283|NCT02438826|565773691|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
156734284|NCT02438826|565773692|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
156734285|NCT02438826|565773693|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
156734286|NCT02438826|565773690|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
156734287|NCT02438826|565773691|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
156734288|NCT02438826|565773692|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
156734289|NCT02438826|565773693|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
156734290|NCT02438826|565773690|FG000|Post-Treatment Phase|Adverse Event|3|||
156734291|NCT02438826|565773691|FG001|Post-Treatment Phase|Adverse Event|0|||
156734292|NCT02438826|565773692|FG002|Post-Treatment Phase|Adverse Event|0|||
156734293|NCT02438826|565773693|FG003|Post-Treatment Phase|Adverse Event|0|||
156734294|NCT02438826|565773690|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
156734295|NCT02438826|565773691|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
156734296|NCT02438826|565773692|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
156734297|NCT02438826|565773693|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
156734298|NCT02438826|565773690|FG000|Post-Treatment Phase|Physician Decision|1|||
156734299|NCT02438826|565773691|FG001|Post-Treatment Phase|Physician Decision|0|||
156734300|NCT02438826|565773692|FG002|Post-Treatment Phase|Physician Decision|0|||
156734301|NCT02438826|565773693|FG003|Post-Treatment Phase|Physician Decision|0|||
156734302|NCT02438826|565773690|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
156734303|NCT02438826|565773691|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
156734304|NCT02438826|565773692|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
156734305|NCT02438826|565773693|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
156734306|NCT03482453|565773712|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734307|NCT03482453|565773713|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156455878|NCT04515849|564763239|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
156734308|NCT03482453|565773714|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734309|NCT03482453|565773715|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734310|NCT03482453|565773716|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734311|NCT03482453|565773717|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734312|NCT03482453|565773718|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734313|NCT03482453|565773719|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734314|NCT03482453|565773720|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734315|NCT03482453|565773721|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734316|NCT03482453|565773722|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
156734317|NCT03482453|565773723|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734318|NCT03478644|565773726|FG000|Phase 2|Withdrawal by Subject|2|||
156734319|NCT03478644|565773727|FG001|Phase 2|Withdrawal by Subject|1|||
156734320|NCT03478644|565773726|FG000|Phase 2|Lost to Follow-up|1|||
156734321|NCT03478644|565773727|FG001|Phase 2|Lost to Follow-up|0|||
156734322|NCT04152837|565773728|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
156734323|NCT04152837|565773728|FG000|Maintenance Period|Adverse Event|1|||
156734324|NCT04152837|565773728|FG000|Maintenance Period|Withdrawal by Subject|1|||
156734325|NCT04152837|565773728|FG000|Maintenance Period|Sponsor Termination of Study|2|||
156734326|NCT00586820|565773729|FG000|Overall Study|Unsuccessful PCI|1|||
156734327|NCT00586820|565773730|FG001|Overall Study|Unsuccessful PCI|0|||
156734328|NCT02073929|565773731|FG000|Overall Study|Lost to Follow-up|2|||
156734329|NCT02073929|565773732|FG001|Overall Study|Lost to Follow-up|1|||
156734330|NCT02073929|565773731|FG000|Overall Study|Adverse Event|2|||
156734331|NCT02073929|565773732|FG001|Overall Study|Adverse Event|1|||
156734332|NCT02073929|565773731|FG000|Overall Study|Withdrawal by Subject|0|||
156734333|NCT02073929|565773732|FG001|Overall Study|Withdrawal by Subject|1|||
156734334|NCT00767455|565773733|FG000|Overall Study|Investigator error|19|||
156734335|NCT01483027|565773734|FG000|Overall Study|Administrative Reasons|2|||
156734336|NCT01483027|565773735|FG001|Overall Study|Administrative Reasons|1|||
156734337|NCT01483027|565773734|FG000|Overall Study|Withdrawal by Subject|21|||
156734338|NCT01483027|565773735|FG001|Overall Study|Withdrawal by Subject|32|||
156734339|NCT01483027|565773734|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
156734340|NCT01483027|565773735|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
156796814|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
156796815|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
156796816|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
156796817|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
156796818|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
156796819|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
156796820|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
156796821|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
156734341|NCT01483027|565773734|FG000|Overall Study|Lost to Follow-up|1|||
156734342|NCT01483027|565773735|FG001|Overall Study|Lost to Follow-up|1|||
156734343|NCT01483027|565773734|FG000|Overall Study|Adverse Event|0|||
156734344|NCT01483027|565773735|FG001|Overall Study|Adverse Event|1|||
156734345|NCT01483027|565773734|FG000|Overall Study|Withdrawal by Subject|0|||
156734346|NCT01483027|565773735|FG001|Overall Study|Withdrawal by Subject|1|||
156734347|NCT02504827|565773738|FG000|Overall Study|Could not produce sputum|1|||
156734348|NCT00686829|565773739|FG000|Overall Study|Adverse Event|5|||
156455879|NCT04515849|564763235|FG000|Overall Study|Physician Decision|0|||
156455880|NCT04515849|564763236|FG001|Overall Study|Physician Decision|1|||
156455881|NCT04515849|564763237|FG002|Overall Study|Physician Decision|0|||
156455882|NCT04515849|564763238|FG003|Overall Study|Physician Decision|0|||
156455883|NCT04515849|564763239|FG004|Overall Study|Physician Decision|0|||
156734349|NCT00686829|565773739|FG000|Overall Study|Lack of Efficacy|6|||
156734350|NCT00686829|565773739|FG000|Overall Study|Lost to Follow-up|4|||
156734351|NCT00686829|565773739|FG000|Overall Study|Withdrawal by Subject|14|||
156734352|NCT00686829|565773739|FG000|Overall Study|Protocol Violation|3|||
156734353|NCT00686829|565773739|FG000|Overall Study|Sponsor discontinued VCV|47|||
156734354|NCT01732640|565773740|FG000|Overall Study|Adverse Event|0|||
156734355|NCT01732640|565773741|FG001|Overall Study|Adverse Event|1|||
156734356|NCT01732640|565773740|FG000|Overall Study|Death|0|||
156734357|NCT01732640|565773741|FG001|Overall Study|Death|1|||
156734358|NCT06366087|565776359|FG000|Overall Study|Withdrawal by Subject|0|||
156734359|NCT06366087|565776360|FG001|Overall Study|Withdrawal by Subject|1|||
156734360|NCT01397786|565776363|FG000|Phase A|Lost to Follow-up|0|||
156734361|NCT01397786|565776364|FG001|Phase A|Lost to Follow-up|0|||
156734362|NCT01397786|565776365|FG002|Phase A|Lost to Follow-up|6|||
156734363|NCT01397786|565776363|FG000|Phase A|Adverse Event|0|||
156734364|NCT01397786|565776364|FG001|Phase A|Adverse Event|0|||
156734365|NCT01397786|565776365|FG002|Phase A|Adverse Event|8|||
156734366|NCT01397786|565776363|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
156734367|NCT01397786|565776364|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
156734368|NCT01397786|565776365|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
156734369|NCT01397786|565776363|FG000|Phase A|Physician Decision|0|||
156734370|NCT01397786|565776364|FG001|Phase A|Physician Decision|0|||
156734371|NCT01397786|565776365|FG002|Phase A|Physician Decision|1|||
156734372|NCT01397786|565776363|FG000|Phase A|Withdrawal by Subject|0|||
156734373|NCT01397786|565776364|FG001|Phase A|Withdrawal by Subject|0|||
156734374|NCT01397786|565776365|FG002|Phase A|Withdrawal by Subject|5|||
156734375|NCT01397786|565776363|FG000|Phase A|Lack of Efficacy|0|||
156734376|NCT01397786|565776364|FG001|Phase A|Lack of Efficacy|0|||
156734377|NCT01397786|565776365|FG002|Phase A|Lack of Efficacy|1|||
156734378|NCT01397786|565776363|FG000|Phase B|Lost to Follow-up|22|||
156734379|NCT01397786|565776364|FG001|Phase B|Lost to Follow-up|12|||
156734380|NCT01397786|565776365|FG002|Phase B|Lost to Follow-up|22|||
156734381|NCT01397786|565776363|FG000|Phase B|Adverse Event|109|||
156734382|NCT01397786|565776364|FG001|Phase B|Adverse Event|23|||
156734383|NCT01397786|565776365|FG002|Phase B|Adverse Event|27|||
156734384|NCT01397786|565776363|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
156734385|NCT01397786|565776364|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
156734386|NCT01397786|565776365|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
156734387|NCT01397786|565776363|FG000|Phase B|Physician Decision|9|||
156734388|NCT01397786|565776364|FG001|Phase B|Physician Decision|1|||
156734389|NCT01397786|565776365|FG002|Phase B|Physician Decision|3|||
156734390|NCT01397786|565776363|FG000|Phase B|Withdrawal by Subject|102|||
156734391|NCT01397786|565776364|FG001|Phase B|Withdrawal by Subject|45|||
156734392|NCT01397786|565776365|FG002|Phase B|Withdrawal by Subject|30|||
156734393|NCT01397786|565776363|FG000|Phase B|Protocol Deviation|1|||
156734394|NCT01397786|565776364|FG001|Phase B|Protocol Deviation|2|||
156734395|NCT01397786|565776365|FG002|Phase B|Protocol Deviation|4|||
156455884|NCT04515849|564763235|FG000|Overall Study|Withdrawal by Subject|1|||
156455885|NCT04515849|564763236|FG001|Overall Study|Withdrawal by Subject|2|||
156455886|NCT04515849|564763237|FG002|Overall Study|Withdrawal by Subject|1|||
156455887|NCT04515849|564763238|FG003|Overall Study|Withdrawal by Subject|0|||
156455888|NCT04515849|564763239|FG004|Overall Study|Withdrawal by Subject|0|||
156455889|NCT04049643|564763247|FG000|Overall Study|Lack of Efficacy|1|||
156455890|NCT04049643|564763248|FG001|Overall Study|Lack of Efficacy|1|||
156455891|NCT04049643|564763249|FG002|Overall Study|Lack of Efficacy|0|||
156734396|NCT01397786|565776363|FG000|Phase B|Lack of Efficacy|22|||
156734397|NCT01397786|565776364|FG001|Phase B|Lack of Efficacy|7|||
156734398|NCT01397786|565776365|FG002|Phase B|Lack of Efficacy|14|||
156734399|NCT00860249|565776369|FG000|Overall Study|trial was terminated prior to completion|21|||
156734400|NCT00860249|565776370|FG001|Overall Study|trial was terminated prior to completion|18|||
156734401|NCT00860249|565776371|FG002|Overall Study|trial was terminated prior to completion|21|||
156734402|NCT00743288|565776372|FG000|Overall Study|Adverse Event|1|||
156734403|NCT00743288|565776373|FG001|Overall Study|Adverse Event|1|||
156876630|NCT00535288|566307659|FG003|Overall Study|Unwilling to cooperate|3|||
156455892|NCT04049643|564763247|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
156734404|NCT00743288|565776374|FG002|Overall Study|Adverse Event|2|||
156734405|NCT00743288|565776375|FG003|Overall Study|Adverse Event|2|||
156734406|NCT00743288|565776376|FG004|Overall Study|Adverse Event|1|||
156734407|NCT00743288|565776377|FG005|Overall Study|Adverse Event|1|||
156796822|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
156796823|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
156796824|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
156796825|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
156796826|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
156796827|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
156796828|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
156796829|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
156796830|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
156796831|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
156796832|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
156796833|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Other|50|||
156796834|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Other|38|||
156876631|NCT00535288|566307660|FG004|Overall Study|Unwilling to cooperate|4|||
156876632|NCT00535288|566307656|FG000|Overall Study|Other|2|||
156876633|NCT00535288|566307657|FG001|Overall Study|Other|1|||
156876634|NCT00535288|566307658|FG002|Overall Study|Other|1|||
156876635|NCT00535288|566307659|FG003|Overall Study|Other|2|||
156876636|NCT00535288|566307660|FG004|Overall Study|Other|1|||
156876637|NCT01754727|566307661|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
156876638|NCT02848729|566307667|FG000|Overall Study|Withdrawal by Subject|1|||
156876639|NCT02848729|566307668|FG001|Overall Study|Withdrawal by Subject|0|||
156876640|NCT02848729|566307667|FG000|Overall Study|Emesis|15|||
156876641|NCT02848729|566307668|FG001|Overall Study|Emesis|11|||
156876642|NCT04518995|566307669|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
156876643|NCT04518995|566307670|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
156876644|NCT04518995|566307671|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
156876645|NCT04518995|566307669|FG000|Overall Study|Lack of Efficacy|2|||
156876646|NCT04518995|566307670|FG001|Overall Study|Lack of Efficacy|1|||
156876647|NCT04518995|566307671|FG002|Overall Study|Lack of Efficacy|0|||
156876648|NCT04518995|566307669|FG000|Overall Study|Non-compliance With Study Drug|0|||
156876649|NCT04518995|566307670|FG001|Overall Study|Non-compliance With Study Drug|3|||
156876650|NCT04518995|566307671|FG002|Overall Study|Non-compliance With Study Drug|2|||
156876651|NCT04518995|566307669|FG000|Overall Study|Pregnancy|0|||
156455893|NCT04049643|564763248|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
156455894|NCT04049643|564763249|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
156455895|NCT04081103|564763250|FG000|Overall Study|Adverse Event|1|||
156455896|NCT04081103|564763251|FG001|Overall Study|Adverse Event|1|||
156455897|NCT04081103|564763252|FG002|Overall Study|Adverse Event|1|||
156533823|NCT04435782|565048931|FG000|Overall Study|Study terminated by sponsor|4|||
156533824|NCT03672461|565048932|FG000|Overall Study|COVID Related|4|||
156734408|NCT00743288|565776378|FG006|Overall Study|Adverse Event|2|||
156734409|NCT00743288|565776372|FG000|Overall Study|Withdrawal by Subject|0|||
156734410|NCT00743288|565776373|FG001|Overall Study|Withdrawal by Subject|0|||
156734411|NCT00743288|565776374|FG002|Overall Study|Withdrawal by Subject|1|||
156796835|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Other|24|||
156796836|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Other|0|||
156796837|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Other|0|||
156876652|NCT04518995|566307670|FG001|Overall Study|Pregnancy|0|||
156734412|NCT00743288|565776375|FG003|Overall Study|Withdrawal by Subject|0|||
156734413|NCT00743288|565776376|FG004|Overall Study|Withdrawal by Subject|0|||
156734414|NCT00743288|565776377|FG005|Overall Study|Withdrawal by Subject|1|||
156734415|NCT00743288|565776378|FG006|Overall Study|Withdrawal by Subject|1|||
156734416|NCT00743288|565776372|FG000|Overall Study|Progressive disease (PD)|2|||
156734417|NCT00743288|565776373|FG001|Overall Study|Progressive disease (PD)|0|||
156734418|NCT00743288|565776374|FG002|Overall Study|Progressive disease (PD)|1|||
156734419|NCT00743288|565776375|FG003|Overall Study|Progressive disease (PD)|4|||
156734420|NCT00743288|565776376|FG004|Overall Study|Progressive disease (PD)|5|||
156734421|NCT00743288|565776377|FG005|Overall Study|Progressive disease (PD)|3|||
156734422|NCT00743288|565776378|FG006|Overall Study|Progressive disease (PD)|6|||
156734423|NCT00743288|565776372|FG000|Overall Study|Worsening of condition (Not PD)|0|||
156796838|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Other|0|||
156796839|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Other|0|||
156876653|NCT04518995|566307671|FG002|Overall Study|Pregnancy|1|||
156876654|NCT04518995|566307669|FG000|Overall Study|Protocol Violation|2|||
156876655|NCT04518995|566307670|FG001|Overall Study|Protocol Violation|0|||
156876656|NCT04518995|566307671|FG002|Overall Study|Protocol Violation|1|||
156455898|NCT04081103|564763250|FG000|Overall Study|Physician Decision|0|||
156455899|NCT04081103|564763251|FG001|Overall Study|Physician Decision|0|||
156455900|NCT04081103|564763252|FG002|Overall Study|Physician Decision|1|||
156533825|NCT03672461|565048933|FG001|Overall Study|COVID Related|2|||
156533826|NCT03672461|565048932|FG000|Overall Study|Adverse Event|2|||
156734424|NCT00743288|565776373|FG001|Overall Study|Worsening of condition (Not PD)|2|||
156734425|NCT00743288|565776374|FG002|Overall Study|Worsening of condition (Not PD)|1|||
156796840|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Other|0|||
156876657|NCT04518995|566307669|FG000|Overall Study|Reason not Specified|4|||
156455901|NCT03365882|564763255|FG000|Randomization|Still Receiving Protocol Treatment|2|||
156455902|NCT03365882|564763256|FG001|Randomization|Still Receiving Protocol Treatment|0|||
156455903|NCT03365882|564763255|FG000|Randomization|Adverse Event|1|||
156455904|NCT03365882|564763256|FG001|Randomization|Adverse Event|2|||
156455905|NCT03365882|564763255|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
156455906|NCT03365882|564763256|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
156455907|NCT03365882|564763255|FG000|Randomization|Progression/Relapse|21|||
156734426|NCT00743288|565776375|FG003|Overall Study|Worsening of condition (Not PD)|1|||
156734427|NCT00743288|565776376|FG004|Overall Study|Worsening of condition (Not PD)|0|||
156734428|NCT00743288|565776377|FG005|Overall Study|Worsening of condition (Not PD)|0|||
156734429|NCT00743288|565776378|FG006|Overall Study|Worsening of condition (Not PD)|0|||
156734430|NCT00519428|565776379|FG000|Overall Study|Adverse Event|5|||
156734431|NCT00519428|565776380|FG001|Overall Study|Adverse Event|2|||
156734432|NCT00519428|565776381|FG002|Overall Study|Adverse Event|10|||
156734433|NCT00519428|565776379|FG000|Overall Study|Lost to Follow-up|7|||
156734434|NCT00519428|565776380|FG001|Overall Study|Lost to Follow-up|7|||
156734435|NCT00519428|565776381|FG002|Overall Study|Lost to Follow-up|6|||
156734436|NCT00519428|565776379|FG000|Overall Study|Withdrawal by Subject|8|||
156734437|NCT00519428|565776380|FG001|Overall Study|Withdrawal by Subject|3|||
156734438|NCT00519428|565776381|FG002|Overall Study|Withdrawal by Subject|7|||
156734439|NCT00519428|565776379|FG000|Overall Study|unstated|1|||
156734440|NCT00519428|565776380|FG001|Overall Study|unstated|3|||
156734441|NCT00519428|565776381|FG002|Overall Study|unstated|2|||
156734442|NCT00688701|565776382|FG000|Overall Study|Adverse Event|1|||
156734443|NCT00688701|565776383|FG001|Overall Study|Adverse Event|0|||
156734444|NCT00688701|565776384|FG002|Overall Study|Adverse Event|5|||
156734445|NCT00688701|565776385|FG003|Overall Study|Adverse Event|3|||
156734446|NCT00688701|565776382|FG000|Overall Study|Lack of Efficacy|0|||
156734447|NCT00688701|565776383|FG001|Overall Study|Lack of Efficacy|1|||
156734448|NCT00688701|565776384|FG002|Overall Study|Lack of Efficacy|0|||
156455908|NCT03365882|564763256|FG001|Randomization|Progression/Relapse|3|||
156455909|NCT03365882|564763255|FG000|Randomization|Death|1|||
156455910|NCT03365882|564763256|FG001|Randomization|Death|0|||
156455911|NCT03365882|564763255|FG000|Randomization|Other - Not Protocol Specified|1|||
156455912|NCT03365882|564763256|FG001|Randomization|Other - Not Protocol Specified|1|||
156455913|NCT03365882|564763255|FG000|Randomization|Major Protocol Deviation|0|||
156455914|NCT03365882|564763256|FG001|Randomization|Major Protocol Deviation|1|||
156455915|NCT03365882|564763255|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
156455916|NCT03365882|564763256|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
156455917|NCT03365882|564763255|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
156455918|NCT03365882|564763256|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
156455919|NCT03365882|564763255|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
156455920|NCT03365882|564763256|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
156455921|NCT03365882|564763255|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
156455922|NCT03365882|564763256|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
156455923|NCT04437615|564763257|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
156455924|NCT04828005|564763258|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
156455925|NCT04828005|564763259|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
156455926|NCT04828005|564763260|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
156455927|NCT04828005|564763261|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
156455928|NCT04828005|564763258|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
156455929|NCT04828005|564763259|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
156734449|NCT00688701|565776385|FG003|Overall Study|Lack of Efficacy|0|||
156734450|NCT00688701|565776382|FG000|Overall Study|Withdrawal by Subject|3|||
156734451|NCT00688701|565776383|FG001|Overall Study|Withdrawal by Subject|3|||
156734452|NCT00688701|565776384|FG002|Overall Study|Withdrawal by Subject|4|||
156734453|NCT00688701|565776385|FG003|Overall Study|Withdrawal by Subject|8|||
156734454|NCT00688701|565776382|FG000|Overall Study|Poor compliance to protocol|0|||
156734455|NCT00688701|565776383|FG001|Overall Study|Poor compliance to protocol|1|||
156734456|NCT00688701|565776384|FG002|Overall Study|Poor compliance to protocol|1|||
156734457|NCT00688701|565776385|FG003|Overall Study|Poor compliance to protocol|0|||
156734458|NCT01275755|565776395|FG000|Double-blind Treatment Period|Adverse Event|0|||
156455930|NCT04828005|564763260|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
156455931|NCT04828005|564763261|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
156455932|NCT04828005|564763258|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
156455933|NCT04828005|564763259|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
156734459|NCT01275755|565776396|FG001|Double-blind Treatment Period|Adverse Event|2|||
156734460|NCT01275755|565776395|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
156734461|NCT01275755|565776396|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
156455934|NCT04828005|564763260|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
156734462|NCT01275755|565776395|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
156734463|NCT01275755|565776396|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
156734464|NCT01275755|565776395|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
156734465|NCT01275755|565776396|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
156734466|NCT00381238|565776401|FG000|Overall Study|Adverse Event|3|||
156455935|NCT04828005|564763261|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
156455936|NCT04828005|564763258|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
156455937|NCT04828005|564763259|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
156455938|NCT04828005|564763260|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
156455939|NCT04828005|564763261|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
156455940|NCT04828005|564763258|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
156455941|NCT04828005|564763259|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
156455942|NCT04828005|564763260|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
156455943|NCT04828005|564763261|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
156455944|NCT04828005|564763258|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
156455945|NCT04828005|564763259|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
156455946|NCT04828005|564763260|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
156455947|NCT04828005|564763261|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
156455948|NCT04828005|564763258|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
156455949|NCT04828005|564763259|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
156455950|NCT04828005|564763260|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
156455951|NCT04828005|564763261|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
156455952|NCT04828005|564763258|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
156455953|NCT04828005|564763259|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
156455954|NCT04828005|564763260|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
156455955|NCT04828005|564763261|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
156455956|NCT04828005|564763258|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
156455957|NCT04828005|564763259|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
156455958|NCT04828005|564763260|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
156455959|NCT04828005|564763261|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
156455960|NCT05579899|564765387|FG000|Overall Study|Lost to Follow-up|3|||
156455961|NCT05579899|564765388|FG001|Overall Study|Lost to Follow-up|1|||
156455962|NCT05579899|564765387|FG000|Overall Study|Adverse Event|0|||
156455963|NCT05579899|564765388|FG001|Overall Study|Adverse Event|3|||
156455964|NCT05579899|564765387|FG000|Overall Study|Pregnancy|0|||
156455965|NCT05579899|564765388|FG001|Overall Study|Pregnancy|1|||
156455966|NCT05579899|564765387|FG000|Overall Study|Withdrawal by Subject|0|||
156455967|NCT05579899|564765388|FG001|Overall Study|Withdrawal by Subject|3|||
156455968|NCT03023410|564765389|FG000|Overall Study|study termination|0|||
156455969|NCT03023410|564765390|FG001|Overall Study|study termination|1|||
156455970|NCT04987320|564765396|FG000|Overall Study|Withdrawal by Subject|0|||
156455971|NCT04987320|564765397|FG001|Overall Study|Withdrawal by Subject|1|||
156455972|NCT00085735|564765398|FG000|Overall Study|Adverse Event|1|||
156455973|NCT00085735|564765399|FG001|Overall Study|Adverse Event|0|||
156455974|NCT00085735|564765400|FG002|Overall Study|Adverse Event|0|||
156455975|NCT00085735|564765401|FG003|Overall Study|Adverse Event|0|||
156455976|NCT00085735|564765402|FG004|Overall Study|Adverse Event|0|||
156455977|NCT00085735|564765403|FG005|Overall Study|Adverse Event|0|||
156455978|NCT00085735|564765398|FG000|Overall Study|Lack of Efficacy|2|||
156455979|NCT00085735|564765399|FG001|Overall Study|Lack of Efficacy|4|||
156455980|NCT00085735|564765400|FG002|Overall Study|Lack of Efficacy|6|||
156455981|NCT00085735|564765401|FG003|Overall Study|Lack of Efficacy|3|||
156455982|NCT00085735|564765402|FG004|Overall Study|Lack of Efficacy|4|||
156455983|NCT00085735|564765403|FG005|Overall Study|Lack of Efficacy|3|||
156455984|NCT00085735|564765398|FG000|Overall Study|Lost to Follow-up|0|||
156455985|NCT00085735|564765399|FG001|Overall Study|Lost to Follow-up|1|||
156455986|NCT00085735|564765400|FG002|Overall Study|Lost to Follow-up|0|||
156455987|NCT00085735|564765401|FG003|Overall Study|Lost to Follow-up|0|||
156455988|NCT00085735|564765402|FG004|Overall Study|Lost to Follow-up|1|||
156455989|NCT00085735|564765403|FG005|Overall Study|Lost to Follow-up|0|||
156455990|NCT00085735|564765398|FG000|Overall Study|Physician Decision|2|||
156455991|NCT00085735|564765399|FG001|Overall Study|Physician Decision|3|||
156455992|NCT00085735|564765400|FG002|Overall Study|Physician Decision|2|||
156734467|NCT00381238|565776401|FG000|Overall Study|Protocol Violation|1|||
156734468|NCT00381238|565776401|FG000|Overall Study|Withdrawal by Subject|4|||
156734469|NCT00381238|565776401|FG000|Overall Study|Lack of Efficacy|2|||
156734470|NCT00381238|565776401|FG000|Overall Study|Withdrew by physician|1|||
156734471|NCT00381238|565776401|FG000|Overall Study|Disease progression|1|||
156455993|NCT00085735|564765401|FG003|Overall Study|Physician Decision|3|||
156455994|NCT00085735|564765402|FG004|Overall Study|Physician Decision|11|||
156455995|NCT00085735|564765403|FG005|Overall Study|Physician Decision|8|||
156455996|NCT00085735|564765398|FG000|Overall Study|Protocol Violation|1|||
156455997|NCT00085735|564765399|FG001|Overall Study|Protocol Violation|0|||
156455998|NCT00085735|564765400|FG002|Overall Study|Protocol Violation|0|||
156455999|NCT00085735|564765401|FG003|Overall Study|Protocol Violation|0|||
156734472|NCT00843037|565776405|FG000|Overall Study|Lost to Follow-up|1|||
156456000|NCT00085735|564765402|FG004|Overall Study|Protocol Violation|0|||
156734473|NCT03535194|565776406|FG000|Induction Period|Adverse Event|2|||
156734474|NCT03535194|565776407|FG001|Induction Period|Adverse Event|2|||
156734475|NCT03535194|565776408|FG002|Induction Period|Adverse Event|1|||
156456001|NCT00085735|564765403|FG005|Overall Study|Protocol Violation|0|||
156734476|NCT03535194|565776409|FG003|Induction Period|Adverse Event|3|||
156734477|NCT03535194|565776410|FG004|Induction Period|Adverse Event|0|||
156734478|NCT03535194|565776406|FG000|Induction Period|Death|0|||
156734479|NCT03535194|565776407|FG001|Induction Period|Death|1|||
156734480|NCT03535194|565776408|FG002|Induction Period|Death|0|||
156734481|NCT03535194|565776409|FG003|Induction Period|Death|0|||
156734482|NCT03535194|565776410|FG004|Induction Period|Death|0|||
156456002|NCT00085735|564765398|FG000|Overall Study|Withdrawal by Subject|1|||
156456003|NCT00085735|564765399|FG001|Overall Study|Withdrawal by Subject|0|||
156456004|NCT00085735|564765400|FG002|Overall Study|Withdrawal by Subject|4|||
156456005|NCT00085735|564765401|FG003|Overall Study|Withdrawal by Subject|5|||
156456006|NCT00085735|564765402|FG004|Overall Study|Withdrawal by Subject|7|||
156456007|NCT00085735|564765403|FG005|Overall Study|Withdrawal by Subject|8|||
156456008|NCT00085735|564765398|FG000|Overall Study|Patient ineligible|1|||
156456009|NCT00085735|564765399|FG001|Overall Study|Patient ineligible|0|||
156456010|NCT00085735|564765400|FG002|Overall Study|Patient ineligible|3|||
156456011|NCT00085735|564765401|FG003|Overall Study|Patient ineligible|7|||
156456012|NCT00085735|564765402|FG004|Overall Study|Patient ineligible|17|||
156456013|NCT00085735|564765403|FG005|Overall Study|Patient ineligible|8|||
156456014|NCT00085735|564765398|FG000|Overall Study|Excess residual disease|2|||
156456015|NCT00085735|564765399|FG001|Overall Study|Excess residual disease|2|||
156456016|NCT00085735|564765400|FG002|Overall Study|Excess residual disease|1|||
156456017|NCT00085735|564765401|FG003|Overall Study|Excess residual disease|1|||
156456018|NCT00085735|564765402|FG004|Overall Study|Excess residual disease|1|||
156456019|NCT00085735|564765403|FG005|Overall Study|Excess residual disease|4|||
156456020|NCT00085735|564765398|FG000|Overall Study|Reason not documented|1|||
156456021|NCT00085735|564765399|FG001|Overall Study|Reason not documented|0|||
156456022|NCT00085735|564765400|FG002|Overall Study|Reason not documented|1|||
156456023|NCT00085735|564765401|FG003|Overall Study|Reason not documented|0|||
156456024|NCT00085735|564765402|FG004|Overall Study|Reason not documented|1|||
156456025|NCT00085735|564765403|FG005|Overall Study|Reason not documented|0|||
156456026|NCT00085735|564765398|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
156456027|NCT00085735|564765399|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
156456028|NCT00085735|564765400|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
156456029|NCT00085735|564765401|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
156456030|NCT00085735|564765402|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
156456031|NCT00085735|564765403|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
156456032|NCT01824875|564765404|FG000|Overall Study|Disease progression|22|||
156456033|NCT01824875|564765405|FG001|Overall Study|Disease progression|15|||
156456034|NCT01824875|564765404|FG000|Overall Study|Withdrawal by Subject|5|||
156456035|NCT01824875|564765405|FG001|Overall Study|Withdrawal by Subject|4|||
156456036|NCT01824875|564765404|FG000|Overall Study|Adverse Event|4|||
156456037|NCT01824875|564765405|FG001|Overall Study|Adverse Event|10|||
156456038|NCT01824875|564765404|FG000|Overall Study|Alternative therapy|3|||
156456039|NCT01824875|564765405|FG001|Overall Study|Alternative therapy|0|||
156456040|NCT01824875|564765404|FG000|Overall Study|Complicating disease|1|||
156456041|NCT01824875|564765405|FG001|Overall Study|Complicating disease|0|||
156456042|NCT01824875|564765404|FG000|Overall Study|Physician Decision|0|||
156456043|NCT01824875|564765405|FG001|Overall Study|Physician Decision|1|||
156456044|NCT01824875|564765404|FG000|Overall Study|Non-compliance|1|||
156456045|NCT01824875|564765405|FG001|Overall Study|Non-compliance|1|||
156456046|NCT01824875|564765404|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
156456047|NCT01824875|564765405|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
156533827|NCT03672461|565048933|FG001|Overall Study|Adverse Event|0|||
156734483|NCT03535194|565776406|FG000|Induction Period|Lack of Efficacy|1|||
156734484|NCT03535194|565776407|FG001|Induction Period|Lack of Efficacy|3|||
156734485|NCT03535194|565776408|FG002|Induction Period|Lack of Efficacy|2|||
156734486|NCT03535194|565776409|FG003|Induction Period|Lack of Efficacy|2|||
156734487|NCT03535194|565776410|FG004|Induction Period|Lack of Efficacy|0|||
156734488|NCT03535194|565776406|FG000|Induction Period|Lost to Follow-up|3|||
156734489|NCT03535194|565776407|FG001|Induction Period|Lost to Follow-up|5|||
156734490|NCT03535194|565776408|FG002|Induction Period|Lost to Follow-up|2|||
156734491|NCT03535194|565776409|FG003|Induction Period|Lost to Follow-up|3|||
156456048|NCT01824875|564765404|FG000|Overall Study|Administrative issues|0|||
156456049|NCT01824875|564765405|FG001|Overall Study|Administrative issues|2|||
156456050|NCT01824875|564765404|FG000|Overall Study|Ineligible or never started treatment|9|||
156734492|NCT03535194|565776410|FG004|Induction Period|Lost to Follow-up|0|||
156734493|NCT03535194|565776406|FG000|Induction Period|Physician Decision|1|||
156456051|NCT01824875|564765405|FG001|Overall Study|Ineligible or never started treatment|5|||
156456052|NCT01824875|564765404|FG000|Overall Study|Other|0|||
156456053|NCT01824875|564765405|FG001|Overall Study|Other|2|||
156456054|NCT00433329|564765408|FG000|Overall Study|Adverse Event|9|||
156456055|NCT00433329|564765408|FG000|Overall Study|Death|4|||
156734494|NCT03535194|565776407|FG001|Induction Period|Physician Decision|1|||
156734495|NCT03535194|565776408|FG002|Induction Period|Physician Decision|0|||
156796841|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Other|0|||
156533828|NCT03672461|565048932|FG000|Overall Study|Serious Adverse Event|0|||
156533829|NCT03672461|565048933|FG001|Overall Study|Serious Adverse Event|1|||
156533830|NCT03672461|565048932|FG000|Overall Study|Too Busy|3|||
156533831|NCT03672461|565048933|FG001|Overall Study|Too Busy|1|||
156533832|NCT03672461|565048932|FG000|Overall Study|Lost to Follow-up|1|||
156533833|NCT03672461|565048933|FG001|Overall Study|Lost to Follow-up|2|||
156533834|NCT03672461|565048932|FG000|Overall Study|Family|2|||
156533835|NCT03672461|565048933|FG001|Overall Study|Family|2|||
156533836|NCT03672461|565048932|FG000|Overall Study|No remote technology access|0|||
156533837|NCT03672461|565048933|FG001|Overall Study|No remote technology access|1|||
156533838|NCT03672461|565048932|FG000|Overall Study|Withdrawal by Subject|1|||
156533839|NCT03672461|565048933|FG001|Overall Study|Withdrawal by Subject|0|||
156533840|NCT03672461|565048932|FG000|Overall Study|Cannot tolerate intervention|1|||
156533841|NCT03672461|565048933|FG001|Overall Study|Cannot tolerate intervention|0|||
156533842|NCT03672461|565048932|FG000|Overall Study|Incomplete outcome data|6|||
156533843|NCT03672461|565048933|FG001|Overall Study|Incomplete outcome data|1|||
156533844|NCT04225806|565048934|FG000|Overall Study|Trial termination|15|||
156336596|NCT04645953|564329650|FG001|Overall Study|Withdrawal by Subject|1|||
156336597|NCT04645953|564329651|FG002|Overall Study|Withdrawal by Subject|0|||
156336598|NCT04645953|564329649|FG000|Overall Study|Physician Decision|0|||
156336599|NCT04645953|564329650|FG001|Overall Study|Physician Decision|1|||
156456056|NCT00433329|564765408|FG000|Overall Study|Withdrew consent|3|||
156456057|NCT00433329|564765408|FG000|Overall Study|Discontinued sildenafil|2|||
156456058|NCT00433329|564765408|FG000|Overall Study|Moved out of state|1|||
156456059|NCT00433329|564765408|FG000|Overall Study|Lost to Follow-up|1|||
156456060|NCT00433329|564765408|FG000|Overall Study|Physician Decision|1|||
156456061|NCT04195698|564765409|FG000|Overall Study|Adverse Event|4|||
156456062|NCT04195698|564765410|FG001|Overall Study|Adverse Event|11|||
156456063|NCT04195698|564765409|FG000|Overall Study|Withdrawal by Subject|9|||
156456064|NCT04195698|564765410|FG001|Overall Study|Withdrawal by Subject|10|||
156456065|NCT04195698|564765409|FG000|Overall Study|Lost to Follow-up|5|||
156456066|NCT04195698|564765410|FG001|Overall Study|Lost to Follow-up|4|||
156456067|NCT04195698|564765409|FG000|Overall Study|Lack of Efficacy|2|||
156456068|NCT04195698|564765410|FG001|Overall Study|Lack of Efficacy|10|||
156456069|NCT04195698|564765409|FG000|Overall Study|Other|5|||
156456070|NCT04195698|564765410|FG001|Overall Study|Other|4|||
156456071|NCT05459688|564765411|FG000|Overall Study|Lost to Follow-up|6|||
156456072|NCT05459688|564765411|FG000|Overall Study|Physician Decision|1|||
156456073|NCT05459688|564765411|FG000|Overall Study|Withdrawal by Subject|19|||
156456074|NCT05459688|564765411|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
156456075|NCT05540665|564765412|FG000|Overall Study|Study terminated by sponsor|6|||
156456076|NCT05540665|564765413|FG001|Overall Study|Study terminated by sponsor|6|||
156456077|NCT05540665|564765414|FG002|Overall Study|Study terminated by sponsor|7|||
156456078|NCT03462030|564765415|FG000|Overall Study|Withdrawal by Subject|1|||
156456079|NCT03462030|564765416|FG001|Overall Study|Withdrawal by Subject|1|||
156456080|NCT02675751|564765417|FG000|Overall Study|Lost to Follow-up|16|||
156456081|NCT03371381|564765418|FG000|Overall Study|Death|5|||
156456082|NCT03371381|564765418|FG000|Overall Study|Study terminated by sponsor|3|||
156456083|NCT03371381|564765418|FG000|Overall Study|Other|4|||
156456084|NCT01593917|564765421|FG000|Overall Study|Death|67|||
156456085|NCT01593917|564765421|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
156456086|NCT01593917|564765421|FG000|Overall Study|Withdrawal by Subject|23|||
156456087|NCT01593917|564765421|FG000|Overall Study|Lost to Follow-up|12|||
156456088|NCT01593917|564765421|FG000|Overall Study|Protocol Violation|5|||
156456089|NCT01593917|564765421|FG000|Overall Study|Physician Decision|3|||
156456090|NCT04663737|564765422|FG000|Overall Study|Withdrawal by Subject|2|||
156456091|NCT04663737|564765423|FG001|Overall Study|Withdrawal by Subject|0|||
156456092|NCT04016662|564765424|FG000|Run-In Phase|Death|1|||
156456093|NCT04016662|564765424|FG000|Run-In Phase|Withdrawal by Subject|11|||
156456094|NCT04016662|564765424|FG000|Run-In Phase|Not meeting screening eligibility|9|||
156456095|NCT04016662|564765424|FG000|Run-In Phase|Physician Decision|3|||
156456096|NCT04016662|564765424|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
156456097|NCT04016662|564765424|FG000|PLGS (12 Weeks)|Death|1|||
156456098|NCT04016662|564765424|FG000|SAP (12 Weeks)|Death|1|||
156456099|NCT03216057|564765425|FG000|Overall Study|Lost to Follow-up|2|||
156456100|NCT03216057|564765426|FG001|Overall Study|Lost to Follow-up|2|||
156456101|NCT05126433|564765427|FG000|Overall Study|Withdrawal by Subject|3|||
156456102|NCT05126433|564765428|FG001|Overall Study|Withdrawal by Subject|0|||
156456103|NCT05126433|564765429|FG002|Overall Study|Withdrawal by Subject|4|||
156456104|NCT05126433|564765427|FG000|Overall Study|Death|9|||
156336600|NCT04645953|564329651|FG002|Overall Study|Physician Decision|0|||
156456105|NCT05126433|564765428|FG001|Overall Study|Death|3|||
156533845|NCT00977574|565048937|FG000|Overall Study|Never Treated|4|||
156533846|NCT00977574|565048938|FG001|Overall Study|Never Treated|2|||
156533847|NCT00977574|565048939|FG002|Overall Study|Never Treated|4|||
156734496|NCT03535194|565776409|FG003|Induction Period|Physician Decision|0|||
156456106|NCT05126433|564765429|FG002|Overall Study|Death|5|||
156456107|NCT05126433|564765427|FG000|Overall Study|Study Terminated by sponsor|0|||
156533848|NCT04223791|565048940|FG000|Overall Study|Lost to Follow-up|0|||
156533849|NCT04223791|565048941|FG001|Overall Study|Lost to Follow-up|4|||
156533850|NCT04223791|565048940|FG000|Overall Study|Physician Decision|5|||
156533851|NCT04223791|565048941|FG001|Overall Study|Physician Decision|1|||
156533852|NCT04223791|565048940|FG000|Overall Study|Protocol Violation|1|||
156533853|NCT04223791|565048941|FG001|Overall Study|Protocol Violation|1|||
156533854|NCT04223791|565048940|FG000|Overall Study|Withdrawal by Subject|10|||
156533855|NCT04223791|565048941|FG001|Overall Study|Withdrawal by Subject|12|||
156533856|NCT04223791|565048940|FG000|Overall Study|Pregnancy|1|||
156533857|NCT04223791|565048941|FG001|Overall Study|Pregnancy|1|||
156533858|NCT04223791|565048940|FG000|Overall Study|Ongoing in Study|305|||
156533859|NCT04223791|565048941|FG001|Overall Study|Ongoing in Study|302|||
156533860|NCT04667247|565048942|FG000|Overall Study|Withdrawal by Subject|0|||
156533861|NCT04667247|565048943|FG001|Overall Study|Withdrawal by Subject|1|||
156456108|NCT05126433|564765428|FG001|Overall Study|Study Terminated by sponsor|1|||
156456109|NCT05126433|564765429|FG002|Overall Study|Study Terminated by sponsor|2|||
156456110|NCT05126433|564765427|FG000|Overall Study|Progressive Disease|1|||
156456111|NCT05126433|564765428|FG001|Overall Study|Progressive Disease|4|||
156456112|NCT05126433|564765429|FG002|Overall Study|Progressive Disease|3|||
156456113|NCT05126433|564765427|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
156456114|NCT05126433|564765428|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
156456115|NCT05126433|564765429|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
156456116|NCT04599062|564765433|FG000|Overall Study|Physician Decision|1|||
156456117|NCT04599062|564765434|FG001|Overall Study|Physician Decision|0|||
156456118|NCT04032704|564765435|FG000|Part A|Withdrawal by Subject|0|||
156456119|NCT04032704|564765436|FG001|Part A|Withdrawal by Subject|0|||
156456120|NCT04032704|564765437|FG002|Part A|Withdrawal by Subject|3|||
156533862|NCT05460273|565048944|FG000|Overall Study|Death|43|||
156533863|NCT05460273|565048945|FG001|Overall Study|Death|9|||
156533864|NCT05460273|565048944|FG000|Overall Study|Lost to Follow-up|7|||
156533865|NCT05460273|565048945|FG001|Overall Study|Lost to Follow-up|0|||
156533866|NCT05460273|565048944|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
156533867|NCT05460273|565048945|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
156533868|NCT04124614|565048946|FG000|Placebo Run-in Period|Not Randomized|34|||
156533869|NCT04124614|565048947|FG001|Placebo Run-in Period|Not Randomized|0|||
156533870|NCT04124614|565048948|FG002|Placebo Run-in Period|Not Randomized|0|||
156533871|NCT04124614|565048946|FG000|Double Blind Treatment Period|Adverse Event|0|||
156533872|NCT04124614|565048947|FG001|Double Blind Treatment Period|Adverse Event|7|||
156533873|NCT04124614|565048948|FG002|Double Blind Treatment Period|Adverse Event|22|||
156533874|NCT04124614|565048946|FG000|Double Blind Treatment Period|Death|0|||
156533875|NCT04124614|565048947|FG001|Double Blind Treatment Period|Death|0|||
156533876|NCT04124614|565048948|FG002|Double Blind Treatment Period|Death|1|||
156533877|NCT04124614|565048946|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
156533878|NCT04124614|565048947|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
156533879|NCT04124614|565048948|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
156533880|NCT04124614|565048946|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
156533881|NCT04124614|565048947|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
156533882|NCT04124614|565048948|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
156533883|NCT04124614|565048946|FG000|Double Blind Treatment Period|Physician Decision|0|||
156533884|NCT04124614|565048947|FG001|Double Blind Treatment Period|Physician Decision|0|||
156533885|NCT04124614|565048948|FG002|Double Blind Treatment Period|Physician Decision|3|||
156533886|NCT04124614|565048946|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
156533887|NCT04124614|565048947|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
156533888|NCT04124614|565048948|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
156533889|NCT04124614|565048946|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
156533890|NCT04124614|565048947|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
156533891|NCT04124614|565048948|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
156533892|NCT04124614|565048946|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
156533893|NCT04124614|565048947|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
156533894|NCT04124614|565048948|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
156533895|NCT00332839|565050831|FG000|Core (Months 0 - 12)|Administrative problems|1|||
156533896|NCT00332839|565050832|FG001|Core (Months 0 - 12)|Administrative problems|1|||
156533897|NCT00332839|565050831|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
156533898|NCT00332839|565050832|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
156456121|NCT04032704|564765438|FG003|Part A|Withdrawal by Subject|0|||
156456122|NCT04032704|564765439|FG004|Part A|Withdrawal by Subject|1|||
156456123|NCT04032704|564765440|FG005|Part A|Withdrawal by Subject|7|||
156533899|NCT00332839|565050831|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
156533900|NCT00332839|565050832|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
156533901|NCT00332839|565050831|FG000|Core (Months 0 - 12)|Adverse Event|5|||
156533902|NCT00332839|565050832|FG001|Core (Months 0 - 12)|Adverse Event|15|||
156533903|NCT00332839|565050831|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
156533904|NCT00332839|565050832|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
156734497|NCT03535194|565776410|FG004|Induction Period|Physician Decision|0|||
156734498|NCT03535194|565776406|FG000|Induction Period|Protocol Violation|1|||
156734499|NCT03535194|565776407|FG001|Induction Period|Protocol Violation|0|||
156734500|NCT03535194|565776408|FG002|Induction Period|Protocol Violation|0|||
156734501|NCT03535194|565776409|FG003|Induction Period|Protocol Violation|1|||
156734502|NCT03535194|565776410|FG004|Induction Period|Protocol Violation|0|||
156734503|NCT03535194|565776406|FG000|Induction Period|Screen Failure|0|||
156734504|NCT03535194|565776407|FG001|Induction Period|Screen Failure|1|||
156734505|NCT03535194|565776408|FG002|Induction Period|Screen Failure|0|||
156734506|NCT03535194|565776409|FG003|Induction Period|Screen Failure|0|||
156336601|NCT04645953|564329649|FG000|Overall Study|Discontinued Prior to Dosing|0|||
156336602|NCT04645953|564329650|FG001|Overall Study|Discontinued Prior to Dosing|0|||
156456124|NCT04032704|564765441|FG006|Part A|Withdrawal by Subject|0|||
156456125|NCT04032704|564765442|FG007|Part A|Withdrawal by Subject|0|||
156456126|NCT04032704|564765443|FG008|Part A|Withdrawal by Subject|0|||
156456127|NCT04032704|564765444|FG009|Part A|Withdrawal by Subject|0|||
156456128|NCT04032704|564765445|FG010|Part A|Withdrawal by Subject|0|||
156456129|NCT04032704|564765446|FG011|Part A|Withdrawal by Subject|0|||
156456130|NCT04032704|564765447|FG012|Part A|Withdrawal by Subject|0|||
156456131|NCT04032704|564765448|FG013|Part A|Withdrawal by Subject|0|||
156456132|NCT04032704|564765449|FG014|Part A|Withdrawal by Subject|0|||
156456133|NCT04032704|564765450|FG015|Part A|Withdrawal by Subject|0|||
156456134|NCT04032704|564765451|FG016|Part A|Withdrawal by Subject|0|||
156456135|NCT04032704|564765452|FG017|Part A|Withdrawal by Subject|0|||
156456136|NCT04032704|564765435|FG000|Part A|Lost to Follow-up|1|||
156456137|NCT04032704|564765436|FG001|Part A|Lost to Follow-up|0|||
156456138|NCT04032704|564765437|FG002|Part A|Lost to Follow-up|0|||
156456139|NCT04032704|564765438|FG003|Part A|Lost to Follow-up|0|||
156456140|NCT04032704|564765439|FG004|Part A|Lost to Follow-up|0|||
156456141|NCT04032704|564765440|FG005|Part A|Lost to Follow-up|0|||
156456142|NCT04032704|564765441|FG006|Part A|Lost to Follow-up|0|||
156456143|NCT04032704|564765442|FG007|Part A|Lost to Follow-up|0|||
156456144|NCT04032704|564765443|FG008|Part A|Lost to Follow-up|0|||
156456145|NCT04032704|564765444|FG009|Part A|Lost to Follow-up|0|||
156456146|NCT04032704|564765445|FG010|Part A|Lost to Follow-up|0|||
156456147|NCT04032704|564765446|FG011|Part A|Lost to Follow-up|0|||
156456148|NCT04032704|564765447|FG012|Part A|Lost to Follow-up|0|||
156456149|NCT04032704|564765448|FG013|Part A|Lost to Follow-up|0|||
156456150|NCT04032704|564765449|FG014|Part A|Lost to Follow-up|0|||
156456151|NCT04032704|564765450|FG015|Part A|Lost to Follow-up|0|||
156456152|NCT04032704|564765451|FG016|Part A|Lost to Follow-up|0|||
156456153|NCT04032704|564765452|FG017|Part A|Lost to Follow-up|0|||
156456154|NCT04032704|564765435|FG000|Part A|Death|9|||
156456155|NCT04032704|564765436|FG001|Part A|Death|2|||
156456156|NCT04032704|564765437|FG002|Part A|Death|10|||
156456157|NCT04032704|564765438|FG003|Part A|Death|7|||
156456158|NCT04032704|564765439|FG004|Part A|Death|4|||
156456159|NCT04032704|564765440|FG005|Part A|Death|5|||
156456160|NCT04032704|564765441|FG006|Part A|Death|0|||
156456161|NCT04032704|564765442|FG007|Part A|Death|0|||
156456162|NCT04032704|564765443|FG008|Part A|Death|0|||
156456163|NCT04032704|564765444|FG009|Part A|Death|0|||
156456164|NCT04032704|564765445|FG010|Part A|Death|0|||
156456165|NCT04032704|564765446|FG011|Part A|Death|0|||
156456166|NCT04032704|564765447|FG012|Part A|Death|0|||
156456167|NCT04032704|564765448|FG013|Part A|Death|0|||
156456168|NCT04032704|564765449|FG014|Part A|Death|0|||
156456169|NCT04032704|564765450|FG015|Part A|Death|0|||
156456170|NCT04032704|564765451|FG016|Part A|Death|0|||
156456171|NCT04032704|564765452|FG017|Part A|Death|0|||
156456172|NCT04032704|564765435|FG000|Part B|Other|0|||
156456173|NCT04032704|564765436|FG001|Part B|Other|0|||
156456174|NCT04032704|564765437|FG002|Part B|Other|0|||
156456175|NCT04032704|564765438|FG003|Part B|Other|0|||
156456176|NCT04032704|564765439|FG004|Part B|Other|0|||
156456177|NCT04032704|564765440|FG005|Part B|Other|0|||
156456178|NCT04032704|564765441|FG006|Part B|Other|0|||
156456179|NCT04032704|564765442|FG007|Part B|Other|1|||
156456180|NCT04032704|564765443|FG008|Part B|Other|2|||
156456181|NCT04032704|564765444|FG009|Part B|Other|1|||
156456182|NCT04032704|564765445|FG010|Part B|Other|1|||
156456183|NCT04032704|564765446|FG011|Part B|Other|1|||
156456184|NCT04032704|564765447|FG012|Part B|Other|5|||
156456185|NCT04032704|564765448|FG013|Part B|Other|13|||
156456186|NCT04032704|564765449|FG014|Part B|Other|0|||
156456187|NCT04032704|564765450|FG015|Part B|Other|0|||
156456188|NCT04032704|564765451|FG016|Part B|Other|0|||
156456189|NCT04032704|564765452|FG017|Part B|Other|0|||
156456190|NCT04032704|564765435|FG000|Part B|Study termination by Sponsor|0|||
156456191|NCT04032704|564765436|FG001|Part B|Study termination by Sponsor|0|||
156456192|NCT04032704|564765437|FG002|Part B|Study termination by Sponsor|0|||
156456193|NCT04032704|564765438|FG003|Part B|Study termination by Sponsor|0|||
156456194|NCT04032704|564765439|FG004|Part B|Study termination by Sponsor|0|||
156456195|NCT04032704|564765440|FG005|Part B|Study termination by Sponsor|0|||
156456196|NCT04032704|564765441|FG006|Part B|Study termination by Sponsor|0|||
156456197|NCT04032704|564765442|FG007|Part B|Study termination by Sponsor|0|||
156734507|NCT03535194|565776410|FG004|Induction Period|Screen Failure|0|||
156456198|NCT04032704|564765443|FG008|Part B|Study termination by Sponsor|1|||
156456199|NCT04032704|564765444|FG009|Part B|Study termination by Sponsor|0|||
156456200|NCT04032704|564765445|FG010|Part B|Study termination by Sponsor|0|||
156456201|NCT04032704|564765446|FG011|Part B|Study termination by Sponsor|0|||
156456202|NCT04032704|564765447|FG012|Part B|Study termination by Sponsor|0|||
156456203|NCT04032704|564765448|FG013|Part B|Study termination by Sponsor|0|||
156456204|NCT04032704|564765449|FG014|Part B|Study termination by Sponsor|0|||
156456205|NCT04032704|564765450|FG015|Part B|Study termination by Sponsor|0|||
156456206|NCT04032704|564765451|FG016|Part B|Study termination by Sponsor|0|||
156456207|NCT04032704|564765452|FG017|Part B|Study termination by Sponsor|0|||
156456208|NCT04032704|564765435|FG000|Part B|Withdrawal by Subject|0|||
156456209|NCT04032704|564765436|FG001|Part B|Withdrawal by Subject|0|||
156456210|NCT04032704|564765437|FG002|Part B|Withdrawal by Subject|0|||
156456211|NCT04032704|564765438|FG003|Part B|Withdrawal by Subject|0|||
156533905|NCT00332839|565050831|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
156734508|NCT03535194|565776406|FG000|Induction Period|Withdrawal by Subject|3|||
156734509|NCT03535194|565776407|FG001|Induction Period|Withdrawal by Subject|4|||
156734510|NCT03535194|565776408|FG002|Induction Period|Withdrawal by Subject|3|||
156734511|NCT03535194|565776409|FG003|Induction Period|Withdrawal by Subject|2|||
156734512|NCT03535194|565776410|FG004|Induction Period|Withdrawal by Subject|0|||
156734513|NCT03535194|565776406|FG000|Maintenance Period|Adverse Event|6|||
156734514|NCT03535194|565776407|FG001|Maintenance Period|Adverse Event|5|||
156734515|NCT03535194|565776408|FG002|Maintenance Period|Adverse Event|1|||
156734516|NCT03535194|565776409|FG003|Maintenance Period|Adverse Event|11|||
156734517|NCT03535194|565776410|FG004|Maintenance Period|Adverse Event|4|||
156734518|NCT03535194|565776406|FG000|Maintenance Period|Lack of Efficacy|3|||
156734519|NCT03535194|565776407|FG001|Maintenance Period|Lack of Efficacy|2|||
156734520|NCT03535194|565776408|FG002|Maintenance Period|Lack of Efficacy|5|||
156734521|NCT03535194|565776409|FG003|Maintenance Period|Lack of Efficacy|9|||
156734522|NCT03535194|565776410|FG004|Maintenance Period|Lack of Efficacy|0|||
156734523|NCT03535194|565776406|FG000|Maintenance Period|Lost to Follow-up|4|||
156734524|NCT03535194|565776407|FG001|Maintenance Period|Lost to Follow-up|2|||
156734525|NCT03535194|565776408|FG002|Maintenance Period|Lost to Follow-up|1|||
156734526|NCT03535194|565776409|FG003|Maintenance Period|Lost to Follow-up|5|||
156734527|NCT03535194|565776410|FG004|Maintenance Period|Lost to Follow-up|2|||
156734528|NCT03535194|565776406|FG000|Maintenance Period|Other|1|||
156734529|NCT03535194|565776407|FG001|Maintenance Period|Other|2|||
156734530|NCT03535194|565776408|FG002|Maintenance Period|Other|0|||
156734531|NCT03535194|565776409|FG003|Maintenance Period|Other|0|||
156734532|NCT03535194|565776410|FG004|Maintenance Period|Other|0|||
156734533|NCT03535194|565776406|FG000|Maintenance Period|Physician Decision|1|||
156734534|NCT03535194|565776407|FG001|Maintenance Period|Physician Decision|2|||
156734535|NCT03535194|565776408|FG002|Maintenance Period|Physician Decision|0|||
156734536|NCT03535194|565776409|FG003|Maintenance Period|Physician Decision|2|||
156734537|NCT03535194|565776410|FG004|Maintenance Period|Physician Decision|0|||
156734538|NCT03535194|565776406|FG000|Maintenance Period|Pregnancy|0|||
156734539|NCT03535194|565776407|FG001|Maintenance Period|Pregnancy|0|||
156734540|NCT03535194|565776408|FG002|Maintenance Period|Pregnancy|0|||
156734541|NCT03535194|565776409|FG003|Maintenance Period|Pregnancy|2|||
156734542|NCT03535194|565776410|FG004|Maintenance Period|Pregnancy|0|||
156734543|NCT03535194|565776406|FG000|Maintenance Period|Protocol Violation|0|||
156734544|NCT03535194|565776407|FG001|Maintenance Period|Protocol Violation|1|||
156734545|NCT03535194|565776408|FG002|Maintenance Period|Protocol Violation|0|||
156734546|NCT03535194|565776409|FG003|Maintenance Period|Protocol Violation|0|||
156734547|NCT03535194|565776410|FG004|Maintenance Period|Protocol Violation|0|||
156734548|NCT03535194|565776406|FG000|Maintenance Period|Withdrawal by Subject|7|||
156734549|NCT03535194|565776407|FG001|Maintenance Period|Withdrawal by Subject|2|||
156734550|NCT03535194|565776408|FG002|Maintenance Period|Withdrawal by Subject|1|||
156734551|NCT03535194|565776409|FG003|Maintenance Period|Withdrawal by Subject|8|||
156734552|NCT03535194|565776410|FG004|Maintenance Period|Withdrawal by Subject|0|||
156734553|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Adverse Event|4|||
156734554|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Adverse Event|5|||
156734555|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Adverse Event|1|||
156734556|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Adverse Event|8|||
156734557|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Adverse Event|0|||
156734558|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
156876658|NCT04518995|566307670|FG001|Overall Study|Reason not Specified|11|||
156734559|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
156734560|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
156734561|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
156456212|NCT04032704|564765439|FG004|Part B|Withdrawal by Subject|0|||
156456213|NCT04032704|564765440|FG005|Part B|Withdrawal by Subject|0|||
156734562|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
156336603|NCT04645953|564329651|FG002|Overall Study|Discontinued Prior to Dosing|2|||
156456214|NCT04032704|564765441|FG006|Part B|Withdrawal by Subject|3|||
156533906|NCT00332839|565050832|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
156456215|NCT04032704|564765442|FG007|Part B|Withdrawal by Subject|2|||
156456216|NCT04032704|564765443|FG008|Part B|Withdrawal by Subject|2|||
156456217|NCT04032704|564765444|FG009|Part B|Withdrawal by Subject|1|||
156456218|NCT04032704|564765445|FG010|Part B|Withdrawal by Subject|4|||
156456219|NCT04032704|564765446|FG011|Part B|Withdrawal by Subject|6|||
156456220|NCT04032704|564765447|FG012|Part B|Withdrawal by Subject|2|||
156456221|NCT04032704|564765448|FG013|Part B|Withdrawal by Subject|1|||
156456222|NCT04032704|564765449|FG014|Part B|Withdrawal by Subject|0|||
156456223|NCT04032704|564765450|FG015|Part B|Withdrawal by Subject|1|||
156456224|NCT04032704|564765451|FG016|Part B|Withdrawal by Subject|0|||
156456225|NCT04032704|564765452|FG017|Part B|Withdrawal by Subject|0|||
156456226|NCT04032704|564765435|FG000|Part B|Lost to Follow-up|0|||
156456227|NCT04032704|564765436|FG001|Part B|Lost to Follow-up|0|||
156456228|NCT04032704|564765437|FG002|Part B|Lost to Follow-up|0|||
156456229|NCT04032704|564765438|FG003|Part B|Lost to Follow-up|0|||
156456230|NCT04032704|564765439|FG004|Part B|Lost to Follow-up|0|||
156456231|NCT04032704|564765440|FG005|Part B|Lost to Follow-up|0|||
156456232|NCT04032704|564765441|FG006|Part B|Lost to Follow-up|0|||
156456233|NCT04032704|564765442|FG007|Part B|Lost to Follow-up|0|||
156456234|NCT04032704|564765443|FG008|Part B|Lost to Follow-up|0|||
156456235|NCT04032704|564765444|FG009|Part B|Lost to Follow-up|0|||
156456236|NCT04032704|564765445|FG010|Part B|Lost to Follow-up|0|||
156456237|NCT04032704|564765446|FG011|Part B|Lost to Follow-up|1|||
156456238|NCT04032704|564765447|FG012|Part B|Lost to Follow-up|0|||
156456239|NCT04032704|564765448|FG013|Part B|Lost to Follow-up|0|||
156456240|NCT04032704|564765449|FG014|Part B|Lost to Follow-up|0|||
156456241|NCT04032704|564765450|FG015|Part B|Lost to Follow-up|0|||
156456242|NCT04032704|564765451|FG016|Part B|Lost to Follow-up|0|||
156456243|NCT04032704|564765452|FG017|Part B|Lost to Follow-up|0|||
156456244|NCT04032704|564765435|FG000|Part B|Death|0|||
156456245|NCT04032704|564765436|FG001|Part B|Death|0|||
156456246|NCT04032704|564765437|FG002|Part B|Death|0|||
156456247|NCT04032704|564765438|FG003|Part B|Death|0|||
156456248|NCT04032704|564765439|FG004|Part B|Death|0|||
156456249|NCT04032704|564765440|FG005|Part B|Death|0|||
156876659|NCT04518995|566307671|FG002|Overall Study|Reason not Specified|2|||
156876660|NCT04518995|566307669|FG000|Overall Study|Lost to Follow-up|1|||
156876661|NCT04518995|566307670|FG001|Overall Study|Lost to Follow-up|10|||
156456250|NCT04032704|564765441|FG006|Part B|Death|13|||
156456251|NCT04032704|564765442|FG007|Part B|Death|13|||
156456252|NCT04032704|564765443|FG008|Part B|Death|14|||
156456253|NCT04032704|564765444|FG009|Part B|Death|12|||
156456254|NCT04032704|564765445|FG010|Part B|Death|12|||
156456255|NCT04032704|564765446|FG011|Part B|Death|13|||
156456256|NCT04032704|564765447|FG012|Part B|Death|7|||
156456257|NCT04032704|564765448|FG013|Part B|Death|17|||
156456258|NCT04032704|564765449|FG014|Part B|Death|2|||
156456259|NCT04032704|564765450|FG015|Part B|Death|1|||
156456260|NCT04032704|564765451|FG016|Part B|Death|2|||
156456261|NCT04032704|564765452|FG017|Part B|Death|2|||
156456262|NCT03133546|564765454|FG000|Overall Study|Death|46|||
156456263|NCT03133546|564765455|FG001|Overall Study|Death|43|||
156456264|NCT03133546|564765454|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
156456265|NCT03133546|564765455|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
156456266|NCT02993159|564765456|FG000|Overall Study|Withdrawal by Subject|1|||
156456267|NCT02993159|564765457|FG001|Overall Study|Withdrawal by Subject|3|||
156456268|NCT02993159|564765456|FG000|Overall Study|Protocol Violation|1|||
156456269|NCT02993159|564765457|FG001|Overall Study|Protocol Violation|0|||
156456270|NCT02993159|564765456|FG000|Overall Study|Opted out of surgery|2|||
156456271|NCT02993159|564765457|FG001|Overall Study|Opted out of surgery|0|||
156456272|NCT02993159|564765456|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
156456273|NCT02993159|564765457|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
156456274|NCT02993159|564765456|FG000|Overall Study|Physician Decision|0|||
156456275|NCT02993159|564765457|FG001|Overall Study|Physician Decision|1|||
156456276|NCT05034328|564765458|FG000|Overall Study|Protocol Violation|1|||
156456277|NCT05034328|564765459|FG001|Overall Study|Protocol Violation|0|||
156456278|NCT05034328|564765458|FG000|Overall Study|Lost to Follow-up|0|||
156456279|NCT05034328|564765459|FG001|Overall Study|Lost to Follow-up|10|||
156876662|NCT04518995|566307671|FG002|Overall Study|Lost to Follow-up|6|||
156456280|NCT05399459|564765462|FG000|Overall Study|Randomized but not treated|29|||
156456281|NCT05399459|564765463|FG001|Overall Study|Randomized but not treated|30|||
156456282|NCT05399459|564765464|FG002|Overall Study|Randomized but not treated|38|||
156456283|NCT05399459|564765462|FG000|Overall Study|Lost to Follow-up|1|||
156876663|NCT04590248|566307674|FG000|Overall Study|Lost to Follow-up|1|||
156456284|NCT05399459|564765463|FG001|Overall Study|Lost to Follow-up|0|||
156456285|NCT05399459|564765464|FG002|Overall Study|Lost to Follow-up|0|||
156456286|NCT02231164|564765465|FG000|Overall Study|Adverse Event|1|||
156456287|NCT02231164|564765466|FG001|Overall Study|Adverse Event|1|||
156456288|NCT02231164|564765465|FG000|Overall Study|Lack of Efficacy|4|||
156456289|NCT02231164|564765466|FG001|Overall Study|Lack of Efficacy|3|||
156456290|NCT02231164|564765465|FG000|Overall Study|Withdrawal by Subject|1|||
156456291|NCT02231164|564765466|FG001|Overall Study|Withdrawal by Subject|2|||
156456292|NCT02969707|564765467|FG000|Overall Study|Withdrawal by Subject|6|||
156456293|NCT02969707|564765468|FG001|Overall Study|Withdrawal by Subject|5|||
156456294|NCT02969707|564765467|FG000|Overall Study|Severe anxiety|0|||
156456295|NCT02969707|564765468|FG001|Overall Study|Severe anxiety|1|||
156456296|NCT02969707|564765467|FG000|Overall Study|Positive toxicology screen|0|||
156456297|NCT02969707|564765468|FG001|Overall Study|Positive toxicology screen|2|||
156456298|NCT02969707|564765467|FG000|Overall Study|Claustrophobia|2|||
156456299|NCT02969707|564765468|FG001|Overall Study|Claustrophobia|2|||
156456300|NCT02969707|564765467|FG000|Overall Study|Non-compliance|1|||
156456301|NCT02969707|564765468|FG001|Overall Study|Non-compliance|2|||
156456302|NCT05583578|564765475|FG000|Overall Study|Withdrawal by Subject|2|||
156456303|NCT05583578|564765476|FG001|Overall Study|Withdrawal by Subject|0|||
156456304|NCT00248287|564765477|FG000|Overall Study|Adverse Event|11|||
156456305|NCT00248287|564765478|FG001|Overall Study|Adverse Event|10|||
156456306|NCT00248287|564765477|FG000|Overall Study|Death|1|||
156456307|NCT00248287|564765478|FG001|Overall Study|Death|0|||
156456308|NCT00248287|564765477|FG000|Overall Study|Lost to Follow-up|0|||
156456309|NCT00248287|564765478|FG001|Overall Study|Lost to Follow-up|1|||
156456310|NCT00248287|564765477|FG000|Overall Study|Investigator Request|4|||
156456311|NCT00248287|564765478|FG001|Overall Study|Investigator Request|3|||
156456312|NCT00248287|564765477|FG000|Overall Study|Patient Request|5|||
156456313|NCT00248287|564765478|FG001|Overall Study|Patient Request|3|||
156456314|NCT00248287|564765477|FG000|Overall Study|Other|3|||
156456315|NCT00248287|564765478|FG001|Overall Study|Other|2|||
156456316|NCT02714257|564765479|FG000|Overall Study|Withdrawal by Subject|6|||
156456317|NCT02714257|564765480|FG001|Overall Study|Withdrawal by Subject|11|||
156456318|NCT02714257|564765479|FG000|Overall Study|Death|3|||
156456319|NCT02714257|564765480|FG001|Overall Study|Death|4|||
156456320|NCT02714257|564765479|FG000|Overall Study|Lost to Follow-up|1|||
156456321|NCT02714257|564765480|FG001|Overall Study|Lost to Follow-up|6|||
156456322|NCT04103580|564765481|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
156456323|NCT04103580|564765482|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
156456324|NCT04103580|564765481|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
156456325|NCT04103580|564765482|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
156456326|NCT04103580|564765481|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
156456327|NCT04103580|564765482|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
156456328|NCT04103580|564765481|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
156456329|NCT04103580|564765482|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
156456330|NCT04103580|564765481|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
156734563|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
156734564|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
156734565|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
156734566|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
156734567|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
156734568|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Other|1|||
156734569|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Other|0|||
156734570|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Other|0|||
156734571|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Other|5|||
156734572|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Other|0|||
156734573|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Physician Decision|0|||
156734574|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Physician Decision|2|||
156734575|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Physician Decision|1|||
156734576|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Physician Decision|1|||
156734577|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Physician Decision|0|||
156734578|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
156734579|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
156734580|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
156734581|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
156734582|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156734583|NCT04411810|565776411|FG000|Overall Study|Screen failure|1|||
156734584|NCT04411810|565776411|FG000|Overall Study|Withdrawal by Subject|1|||
156734585|NCT04304235|565776415|FG000|Overall Study|incomplete triage data|0|||
156734586|NCT04304235|565776416|FG001|Overall Study|incomplete triage data|69|||
156734587|NCT04304235|565776417|FG002|Overall Study|incomplete triage data|0|||
156734588|NCT04304235|565776418|FG003|Overall Study|incomplete triage data|0|||
156734589|NCT04304235|565776419|FG004|Overall Study|incomplete triage data|289|||
156734590|NCT04304235|565776420|FG005|Overall Study|incomplete triage data|123|||
156456331|NCT04103580|564765482|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
156456332|NCT04103580|564765481|FG000|Phase 1 Active Caregiving|Other|3|||
156456333|NCT04103580|564765482|FG001|Phase 1 Active Caregiving|Other|3|||
156456334|NCT04103580|564765481|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
156456335|NCT04103580|564765482|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
156456336|NCT04103580|564765481|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
156456337|NCT04103580|564765482|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
156533907|NCT00332839|565050831|FG000|Follow-up (Months 12 - 60)|Death|1|||
156734591|NCT04304235|565776421|FG006|Overall Study|incomplete triage data|65|||
156533908|NCT00332839|565050832|FG001|Follow-up (Months 12 - 60)|Death|1|||
156533909|NCT00594516|565050836|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
156533910|NCT00594516|565050837|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
156533911|NCT00594516|565050838|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
156533912|NCT00594516|565050836|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
156533913|NCT00594516|565050837|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
156533914|NCT00594516|565050838|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
156533915|NCT00594516|565050836|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
156533916|NCT00594516|565050837|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
156533917|NCT00594516|565050838|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
156533918|NCT00594516|565050836|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
156533919|NCT00594516|565050837|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
156734592|NCT02278939|565776426|FG000|Overall Study|lack of time|1|||
156734593|NCT02278939|565776427|FG001|Overall Study|lack of time|0|||
156734594|NCT02278939|565776426|FG000|Overall Study|Lost to Follow-up|1|||
156734595|NCT02278939|565776427|FG001|Overall Study|Lost to Follow-up|1|||
156734596|NCT02278939|565776426|FG000|Overall Study|death in family|1|||
156734597|NCT02278939|565776427|FG001|Overall Study|death in family|0|||
156734598|NCT02278939|565776426|FG000|Overall Study|family emergency unable to commit|2|||
156734599|NCT02278939|565776427|FG001|Overall Study|family emergency unable to commit|0|||
156734600|NCT04429555|565776430|FG000|Overall Study|Death|0|||
156734601|NCT04429555|565776431|FG001|Overall Study|Death|2|||
156734602|NCT04429555|565776430|FG000|Overall Study|Other|2|||
156734603|NCT04429555|565776431|FG001|Overall Study|Other|0|||
156734604|NCT00930774|565776432|FG000|Overall Study|Withdrawal by Subject|1|||
156734605|NCT00930774|565776433|FG001|Overall Study|Withdrawal by Subject|9|||
156734606|NCT00930774|565776434|FG002|Overall Study|Withdrawal by Subject|2|||
156734607|NCT00930774|565776435|FG003|Overall Study|Withdrawal by Subject|0|||
156734608|NCT03200704|565776436|FG000|Overall Study|Withdrawal by Subject|1|||
156734609|NCT00425061|565776437|FG000|Overall Study|Adverse Event|1|||
156734610|NCT00425061|565776438|FG001|Overall Study|Adverse Event|0|||
156734611|NCT00425061|565776439|FG002|Overall Study|Adverse Event|0|||
156734612|NCT00425061|565776440|FG003|Overall Study|Adverse Event|2|||
156734613|NCT00425061|565776441|FG004|Overall Study|Adverse Event|2|||
156734614|NCT00425061|565776442|FG005|Overall Study|Adverse Event|0|||
156734615|NCT00425061|565776443|FG006|Overall Study|Adverse Event|0|||
156734616|NCT00425061|565776437|FG000|Overall Study|Lost to Follow-up|0|||
156734617|NCT00425061|565776438|FG001|Overall Study|Lost to Follow-up|1|||
156734618|NCT00425061|565776439|FG002|Overall Study|Lost to Follow-up|0|||
156734619|NCT00425061|565776440|FG003|Overall Study|Lost to Follow-up|0|||
156734620|NCT00425061|565776441|FG004|Overall Study|Lost to Follow-up|0|||
156734621|NCT00425061|565776442|FG005|Overall Study|Lost to Follow-up|0|||
156734622|NCT00425061|565776443|FG006|Overall Study|Lost to Follow-up|0|||
156734623|NCT00425061|565776437|FG000|Overall Study|Protocol Violation|1|||
156734624|NCT00425061|565776438|FG001|Overall Study|Protocol Violation|0|||
156734625|NCT00425061|565776439|FG002|Overall Study|Protocol Violation|0|||
156734626|NCT00425061|565776440|FG003|Overall Study|Protocol Violation|0|||
156734627|NCT00425061|565776441|FG004|Overall Study|Protocol Violation|0|||
156734628|NCT00425061|565776442|FG005|Overall Study|Protocol Violation|0|||
156734629|NCT00425061|565776443|FG006|Overall Study|Protocol Violation|0|||
156734630|NCT00425061|565776437|FG000|Overall Study|Withdrawal by Subject|0|||
156734631|NCT00425061|565776438|FG001|Overall Study|Withdrawal by Subject|1|||
156734632|NCT00425061|565776439|FG002|Overall Study|Withdrawal by Subject|0|||
156734633|NCT00425061|565776440|FG003|Overall Study|Withdrawal by Subject|0|||
156734634|NCT00425061|565776441|FG004|Overall Study|Withdrawal by Subject|1|||
156734635|NCT00425061|565776442|FG005|Overall Study|Withdrawal by Subject|0|||
156734636|NCT00425061|565776443|FG006|Overall Study|Withdrawal by Subject|3|||
156734637|NCT00425061|565776437|FG000|Overall Study|Sponsor's request|0|||
156734638|NCT00425061|565776438|FG001|Overall Study|Sponsor's request|0|||
156734639|NCT00425061|565776439|FG002|Overall Study|Sponsor's request|0|||
156734640|NCT00425061|565776440|FG003|Overall Study|Sponsor's request|0|||
156734641|NCT00425061|565776441|FG004|Overall Study|Sponsor's request|19|||
156876664|NCT04590248|566307674|FG000|Overall Study|Withdrawal by Subject|16|||
156876665|NCT04590248|566307674|FG000|Overall Study|Other|2|||
156533920|NCT00594516|565050838|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
156533921|NCT00594516|565050836|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
156533922|NCT00594516|565050837|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
156734642|NCT00425061|565776442|FG005|Overall Study|Sponsor's request|4|||
156734643|NCT00425061|565776443|FG006|Overall Study|Sponsor's request|15|||
156734644|NCT00425061|565776437|FG000|Overall Study|Physician Decision|0|||
156734645|NCT00425061|565776438|FG001|Overall Study|Physician Decision|0|||
156734646|NCT00425061|565776439|FG002|Overall Study|Physician Decision|0|||
156734647|NCT00425061|565776440|FG003|Overall Study|Physician Decision|0|||
156734648|NCT00425061|565776441|FG004|Overall Study|Physician Decision|1|||
156734649|NCT00425061|565776442|FG005|Overall Study|Physician Decision|0|||
156734650|NCT00425061|565776443|FG006|Overall Study|Physician Decision|0|||
156734651|NCT00425061|565776437|FG000|Overall Study|Other|0|||
156876666|NCT02052414|566307675|FG000|Overall Study|Adverse Event|12|||
156456338|NCT04103580|564765481|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
156456339|NCT04103580|564765482|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
156456340|NCT04103580|564765481|FG000|Phase 2 Bereavement|Other|8|||
156456341|NCT04103580|564765482|FG001|Phase 2 Bereavement|Other|6|||
156456342|NCT05808257|564765485|FG000|Overall Study|Lost to Follow-up|8|||
156456343|NCT05808257|564765486|FG001|Overall Study|Lost to Follow-up|8|||
156456344|NCT04568486|564765487|FG000|Overall Study|Withdrawal by Subject|26|||
156456345|NCT04568486|564765487|FG000|Overall Study|Lost to Follow-up|7|||
156456346|NCT04042233|564765488|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
156456347|NCT04042233|564765489|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
156456348|NCT04042233|564765488|FG000|Overall Study|Protocol Violation|0|||
156456349|NCT04042233|564765489|FG001|Overall Study|Protocol Violation|2|||
156456350|NCT04248725|564765499|FG000|Post-Treatment|Lost to Follow-up|6|||
156456351|NCT04248725|564765500|FG001|Post-Treatment|Lost to Follow-up|5|||
156456352|NCT04248725|564765499|FG000|6-Month Follow Up|Lost to Follow-up|9|||
156456353|NCT04248725|564765500|FG001|6-Month Follow Up|Lost to Follow-up|8|||
156456354|NCT04436276|564765503|FG000|Overall Study|Adverse Event|0|||
156456355|NCT04436276|564765504|FG001|Overall Study|Adverse Event|0|||
156456356|NCT04436276|564765505|FG002|Overall Study|Adverse Event|0|||
156456357|NCT04436276|564765506|FG003|Overall Study|Adverse Event|0|||
156456358|NCT04436276|564765507|FG004|Overall Study|Adverse Event|0|||
156456359|NCT04436276|564765508|FG005|Overall Study|Adverse Event|0|||
156456360|NCT04436276|564765509|FG006|Overall Study|Adverse Event|0|||
156456361|NCT04436276|564765510|FG007|Overall Study|Adverse Event|0|||
156456362|NCT04436276|564765511|FG008|Overall Study|Adverse Event|0|||
156456363|NCT04436276|564765512|FG009|Overall Study|Adverse Event|0|||
156456364|NCT04436276|564765513|FG010|Overall Study|Adverse Event|0|||
156456365|NCT04436276|564765514|FG011|Overall Study|Adverse Event|0|||
156456366|NCT04436276|564765515|FG012|Overall Study|Adverse Event|0|||
156456367|NCT04436276|564765516|FG013|Overall Study|Adverse Event|0|||
156456368|NCT04436276|564765517|FG014|Overall Study|Adverse Event|0|||
156456369|NCT04436276|564765518|FG015|Overall Study|Adverse Event|0|||
156456370|NCT04436276|564765519|FG016|Overall Study|Adverse Event|1|||
156456371|NCT04436276|564765520|FG017|Overall Study|Adverse Event|0|||
156456372|NCT04436276|564765521|FG018|Overall Study|Adverse Event|0|||
156456373|NCT04436276|564765522|FG019|Overall Study|Adverse Event|0|||
156456374|NCT04436276|564765523|FG020|Overall Study|Adverse Event|0|||
156456375|NCT04436276|564765524|FG021|Overall Study|Adverse Event|0|||
156456376|NCT04436276|564765525|FG022|Overall Study|Adverse Event|0|||
156456377|NCT04436276|564765503|FG000|Overall Study|Death|0|||
156456378|NCT04436276|564765504|FG001|Overall Study|Death|0|||
156456379|NCT04436276|564765505|FG002|Overall Study|Death|0|||
156456380|NCT04436276|564765506|FG003|Overall Study|Death|0|||
156456381|NCT04436276|564765507|FG004|Overall Study|Death|0|||
156456382|NCT04436276|564765508|FG005|Overall Study|Death|0|||
156456383|NCT04436276|564765509|FG006|Overall Study|Death|0|||
156456384|NCT04436276|564765510|FG007|Overall Study|Death|0|||
156456385|NCT04436276|564765511|FG008|Overall Study|Death|0|||
156456386|NCT04436276|564765512|FG009|Overall Study|Death|0|||
156456387|NCT04436276|564765513|FG010|Overall Study|Death|0|||
156456388|NCT04436276|564765514|FG011|Overall Study|Death|0|||
156456389|NCT04436276|564765515|FG012|Overall Study|Death|1|||
156456390|NCT04436276|564765516|FG013|Overall Study|Death|0|||
156456391|NCT04436276|564765517|FG014|Overall Study|Death|1|||
156456392|NCT04436276|564765518|FG015|Overall Study|Death|0|||
156456393|NCT04436276|564765519|FG016|Overall Study|Death|0|||
156456394|NCT04436276|564765520|FG017|Overall Study|Death|0|||
156456395|NCT04436276|564765521|FG018|Overall Study|Death|0|||
156456396|NCT04436276|564765522|FG019|Overall Study|Death|2|||
156456397|NCT04436276|564765523|FG020|Overall Study|Death|0|||
156456398|NCT04436276|564765524|FG021|Overall Study|Death|1|||
156456399|NCT04436276|564765525|FG022|Overall Study|Death|0|||
156456400|NCT04436276|564765503|FG000|Overall Study|Lost to Follow-up|0|||
156456401|NCT04436276|564765504|FG001|Overall Study|Lost to Follow-up|2|||
156456402|NCT04436276|564765505|FG002|Overall Study|Lost to Follow-up|2|||
156456403|NCT04436276|564765506|FG003|Overall Study|Lost to Follow-up|1|||
156456404|NCT04436276|564765507|FG004|Overall Study|Lost to Follow-up|4|||
156456405|NCT04436276|564765508|FG005|Overall Study|Lost to Follow-up|1|||
156456406|NCT04436276|564765509|FG006|Overall Study|Lost to Follow-up|0|||
156734652|NCT00425061|565776438|FG001|Overall Study|Other|0|||
156734653|NCT00425061|565776439|FG002|Overall Study|Other|0|||
156456407|NCT04436276|564765510|FG007|Overall Study|Lost to Follow-up|0|||
156456408|NCT04436276|564765511|FG008|Overall Study|Lost to Follow-up|1|||
156456409|NCT04436276|564765512|FG009|Overall Study|Lost to Follow-up|0|||
156456410|NCT04436276|564765513|FG010|Overall Study|Lost to Follow-up|5|||
156456411|NCT04436276|564765514|FG011|Overall Study|Lost to Follow-up|5|||
156456412|NCT04436276|564765515|FG012|Overall Study|Lost to Follow-up|4|||
156456413|NCT04436276|564765516|FG013|Overall Study|Lost to Follow-up|1|||
156456414|NCT04436276|564765517|FG014|Overall Study|Lost to Follow-up|7|||
156456415|NCT04436276|564765518|FG015|Overall Study|Lost to Follow-up|7|||
156734654|NCT00425061|565776440|FG003|Overall Study|Other|0|||
156533923|NCT00594516|565050838|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
156533924|NCT00594516|565050836|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
156533925|NCT00594516|565050837|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
156533926|NCT00594516|565050838|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
156533927|NCT00594516|565050836|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
156533928|NCT00594516|565050837|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
156533929|NCT00594516|565050838|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
156533930|NCT00594516|565050836|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
156533931|NCT00594516|565050837|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
156533932|NCT00594516|565050838|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
156533933|NCT00594516|565050836|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
156533934|NCT00594516|565050837|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
156533935|NCT00594516|565050838|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
156533936|NCT01493557|565050839|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
156533937|NCT01493557|565050840|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
156533938|NCT01493557|565050841|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
156533939|NCT01493557|565050839|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
156533940|NCT01493557|565050840|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
156533941|NCT01493557|565050841|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
156533942|NCT01493557|565050839|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
156533943|NCT01493557|565050840|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
156456416|NCT04436276|564765519|FG016|Overall Study|Lost to Follow-up|1|||
156456417|NCT04436276|564765520|FG017|Overall Study|Lost to Follow-up|0|||
156456418|NCT04436276|564765521|FG018|Overall Study|Lost to Follow-up|1|||
156456419|NCT04436276|564765522|FG019|Overall Study|Lost to Follow-up|1|||
156456420|NCT04436276|564765523|FG020|Overall Study|Lost to Follow-up|2|||
156456421|NCT04436276|564765524|FG021|Overall Study|Lost to Follow-up|1|||
156456422|NCT04436276|564765525|FG022|Overall Study|Lost to Follow-up|1|||
156456423|NCT04436276|564765503|FG000|Overall Study|Physician Decision|1|||
156456424|NCT04436276|564765504|FG001|Overall Study|Physician Decision|0|||
156456425|NCT04436276|564765505|FG002|Overall Study|Physician Decision|2|||
156456426|NCT04436276|564765506|FG003|Overall Study|Physician Decision|1|||
156456427|NCT04436276|564765507|FG004|Overall Study|Physician Decision|0|||
156456428|NCT04436276|564765508|FG005|Overall Study|Physician Decision|0|||
156456429|NCT04436276|564765509|FG006|Overall Study|Physician Decision|0|||
156456430|NCT04436276|564765510|FG007|Overall Study|Physician Decision|0|||
156456431|NCT04436276|564765511|FG008|Overall Study|Physician Decision|0|||
156456432|NCT04436276|564765512|FG009|Overall Study|Physician Decision|0|||
156456433|NCT04436276|564765513|FG010|Overall Study|Physician Decision|0|||
156456434|NCT04436276|564765514|FG011|Overall Study|Physician Decision|1|||
156456435|NCT04436276|564765515|FG012|Overall Study|Physician Decision|2|||
156456436|NCT04436276|564765516|FG013|Overall Study|Physician Decision|0|||
156456437|NCT04436276|564765517|FG014|Overall Study|Physician Decision|0|||
156456438|NCT04436276|564765518|FG015|Overall Study|Physician Decision|0|||
156456439|NCT04436276|564765519|FG016|Overall Study|Physician Decision|0|||
156456440|NCT04436276|564765520|FG017|Overall Study|Physician Decision|0|||
156456441|NCT04436276|564765521|FG018|Overall Study|Physician Decision|0|||
156456442|NCT04436276|564765522|FG019|Overall Study|Physician Decision|0|||
156456443|NCT04436276|564765523|FG020|Overall Study|Physician Decision|1|||
156456444|NCT04436276|564765524|FG021|Overall Study|Physician Decision|2|||
156456445|NCT04436276|564765525|FG022|Overall Study|Physician Decision|0|||
156456446|NCT04436276|564765503|FG000|Overall Study|Protocol Violation|0|||
156456447|NCT04436276|564765504|FG001|Overall Study|Protocol Violation|0|||
156456448|NCT04436276|564765505|FG002|Overall Study|Protocol Violation|0|||
156456449|NCT04436276|564765506|FG003|Overall Study|Protocol Violation|0|||
156456450|NCT04436276|564765507|FG004|Overall Study|Protocol Violation|0|||
156456451|NCT04436276|564765508|FG005|Overall Study|Protocol Violation|0|||
156456452|NCT04436276|564765509|FG006|Overall Study|Protocol Violation|0|||
156456453|NCT04436276|564765510|FG007|Overall Study|Protocol Violation|0|||
156456454|NCT04436276|564765511|FG008|Overall Study|Protocol Violation|0|||
156456455|NCT04436276|564765512|FG009|Overall Study|Protocol Violation|0|||
156456456|NCT04436276|564765513|FG010|Overall Study|Protocol Violation|0|||
156456457|NCT04436276|564765514|FG011|Overall Study|Protocol Violation|0|||
156533944|NCT01493557|565050841|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
156533945|NCT01493557|565050839|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
156456458|NCT04436276|564765515|FG012|Overall Study|Protocol Violation|0|||
156456459|NCT04436276|564765516|FG013|Overall Study|Protocol Violation|1|||
156456460|NCT04436276|564765517|FG014|Overall Study|Protocol Violation|0|||
156456461|NCT04436276|564765518|FG015|Overall Study|Protocol Violation|1|||
156456462|NCT04436276|564765519|FG016|Overall Study|Protocol Violation|0|||
156456463|NCT04436276|564765520|FG017|Overall Study|Protocol Violation|0|||
156456464|NCT04436276|564765521|FG018|Overall Study|Protocol Violation|0|||
156456465|NCT04436276|564765522|FG019|Overall Study|Protocol Violation|0|||
156456466|NCT04436276|564765523|FG020|Overall Study|Protocol Violation|0|||
156336604|NCT04613375|564329652|FG000|Overall Study|Death|198|||
156456467|NCT04436276|564765524|FG021|Overall Study|Protocol Violation|0|||
156456468|NCT04436276|564765525|FG022|Overall Study|Protocol Violation|0|||
156456469|NCT04436276|564765503|FG000|Overall Study|Withdrawal by Subject|25|||
156456470|NCT04436276|564765504|FG001|Overall Study|Withdrawal by Subject|22|||
156456471|NCT04436276|564765505|FG002|Overall Study|Withdrawal by Subject|24|||
156456472|NCT04436276|564765506|FG003|Overall Study|Withdrawal by Subject|23|||
156456473|NCT04436276|564765507|FG004|Overall Study|Withdrawal by Subject|14|||
156456474|NCT04436276|564765508|FG005|Overall Study|Withdrawal by Subject|0|||
156456475|NCT04436276|564765509|FG006|Overall Study|Withdrawal by Subject|0|||
156456476|NCT04436276|564765510|FG007|Overall Study|Withdrawal by Subject|1|||
156456477|NCT04436276|564765511|FG008|Overall Study|Withdrawal by Subject|0|||
156456478|NCT04436276|564765512|FG009|Overall Study|Withdrawal by Subject|1|||
156456479|NCT04436276|564765513|FG010|Overall Study|Withdrawal by Subject|17|||
156456480|NCT04436276|564765514|FG011|Overall Study|Withdrawal by Subject|7|||
156456481|NCT04436276|564765515|FG012|Overall Study|Withdrawal by Subject|10|||
156456482|NCT04436276|564765516|FG013|Overall Study|Withdrawal by Subject|6|||
156456483|NCT04436276|564765517|FG014|Overall Study|Withdrawal by Subject|20|||
156456484|NCT04436276|564765518|FG015|Overall Study|Withdrawal by Subject|6|||
156456485|NCT04436276|564765519|FG016|Overall Study|Withdrawal by Subject|11|||
156456486|NCT04436276|564765520|FG017|Overall Study|Withdrawal by Subject|4|||
156456487|NCT04436276|564765521|FG018|Overall Study|Withdrawal by Subject|14|||
156456488|NCT04436276|564765522|FG019|Overall Study|Withdrawal by Subject|24|||
156456489|NCT04436276|564765523|FG020|Overall Study|Withdrawal by Subject|24|||
156456490|NCT04436276|564765524|FG021|Overall Study|Withdrawal by Subject|16|||
156456491|NCT04436276|564765525|FG022|Overall Study|Withdrawal by Subject|14|||
156456492|NCT04436276|564765503|FG000|Overall Study|Other|3|||
156456493|NCT04436276|564765504|FG001|Overall Study|Other|2|||
156456494|NCT04436276|564765505|FG002|Overall Study|Other|5|||
156456495|NCT04436276|564765506|FG003|Overall Study|Other|9|||
156456496|NCT04436276|564765507|FG004|Overall Study|Other|23|||
156456497|NCT04436276|564765508|FG005|Overall Study|Other|1|||
156456498|NCT04436276|564765509|FG006|Overall Study|Other|0|||
156456499|NCT04436276|564765510|FG007|Overall Study|Other|0|||
156456500|NCT04436276|564765511|FG008|Overall Study|Other|0|||
156456501|NCT04436276|564765512|FG009|Overall Study|Other|0|||
156456502|NCT04436276|564765513|FG010|Overall Study|Other|3|||
156456503|NCT04436276|564765514|FG011|Overall Study|Other|1|||
156456504|NCT04436276|564765515|FG012|Overall Study|Other|1|||
156456505|NCT04436276|564765516|FG013|Overall Study|Other|2|||
156456506|NCT04436276|564765517|FG014|Overall Study|Other|3|||
156456507|NCT04436276|564765518|FG015|Overall Study|Other|0|||
156456508|NCT04436276|564765519|FG016|Overall Study|Other|0|||
156456509|NCT04436276|564765520|FG017|Overall Study|Other|6|||
156456510|NCT04436276|564765521|FG018|Overall Study|Other|1|||
156456511|NCT04436276|564765522|FG019|Overall Study|Other|0|||
156456512|NCT04436276|564765523|FG020|Overall Study|Other|2|||
156456513|NCT04436276|564765524|FG021|Overall Study|Other|2|||
156456514|NCT04436276|564765525|FG022|Overall Study|Other|60|||
156734655|NCT00425061|565776441|FG004|Overall Study|Other|3|||
156734656|NCT00425061|565776442|FG005|Overall Study|Other|0|||
156734657|NCT00425061|565776443|FG006|Overall Study|Other|1|||
156456515|NCT05977530|564765533|FG000|Overall Study|Withdrawal by Subject|1|||
156456516|NCT05977530|564765533|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
156456517|NCT04524442|564765534|FG000|Overall Study|Subject Decision|1|||
156456518|NCT04880863|564765545|FG000|Overall Study|Adverse Event|1|||
156734658|NCT03436693|565776444|FG000|Overall Study|Adverse Event|22|||
156734659|NCT03436693|565776445|FG001|Overall Study|Adverse Event|10|||
156734660|NCT03436693|565776444|FG000|Overall Study|Physician Decision|3|||
156734661|NCT03436693|565776445|FG001|Overall Study|Physician Decision|3|||
156734662|NCT03436693|565776444|FG000|Overall Study|Withdrawal by Subject|4|||
156734663|NCT03436693|565776445|FG001|Overall Study|Withdrawal by Subject|13|||
156734664|NCT03436693|565776444|FG000|Overall Study|Progressive Disease|1|||
156734665|NCT03436693|565776445|FG001|Overall Study|Progressive Disease|1|||
156734666|NCT05835011|565776446|FG000|Overall Study|Study Terminated by the Sponsor|1|||
156734667|NCT05835011|565776446|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
156734668|NCT00626821|565776449|FG000|Overall Study|Adverse Event|44|||
156734669|NCT00626821|565776449|FG000|Overall Study|Protocol Violation|33|||
156734670|NCT00626821|565776449|FG000|Overall Study|Withdrawal by Subject|10|||
156533946|NCT01493557|565050840|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
156734671|NCT00626821|565776449|FG000|Overall Study|Physician Decision|9|||
156456519|NCT04880863|564765545|FG000|Overall Study|Patient decision|2|||
156456520|NCT04880863|564765545|FG000|Overall Study|Confirmed Disease Progression|15|||
156456521|NCT04880863|564765545|FG000|Overall Study|Death|3|||
156456522|NCT04880863|564765545|FG000|Overall Study|Physician Decision|4|||
156456523|NCT04880863|564765545|FG000|Overall Study|Unconfirmed Disease Progression|4|||
156456524|NCT04880863|564765545|FG000|Overall Study|Withdrawal by Subject|2|||
156456525|NCT04880863|564765545|FG000|Overall Study|Study discontinuation by the sponsor|4|||
156734672|NCT00626821|565776449|FG000|Overall Study|Product dysfunction|21|||
156456526|NCT04880863|564765545|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
156456527|NCT04880863|564765545|FG000|Overall Study|Not received study drug NAP|2|||
156456528|NCT03899259|564765546|FG000|Overall Study|Adverse Event|5|||
156456529|NCT03899259|564765547|FG001|Overall Study|Adverse Event|4|||
156456530|NCT03899259|564765548|FG002|Overall Study|Adverse Event|6|||
156456531|NCT03899259|564765546|FG000|Overall Study|Lack of Efficacy|5|||
156456532|NCT03899259|564765547|FG001|Overall Study|Lack of Efficacy|0|||
156456533|NCT03899259|564765548|FG002|Overall Study|Lack of Efficacy|2|||
156456534|NCT03899259|564765546|FG000|Overall Study|Pregnancy|3|||
156456535|NCT03899259|564765547|FG001|Overall Study|Pregnancy|0|||
156456536|NCT03899259|564765548|FG002|Overall Study|Pregnancy|1|||
156456537|NCT03899259|564765546|FG000|Overall Study|Physician Decision|0|||
156456538|NCT03899259|564765547|FG001|Overall Study|Physician Decision|1|||
156456539|NCT03899259|564765548|FG002|Overall Study|Physician Decision|0|||
156456540|NCT03899259|564765546|FG000|Overall Study|Protocol Deviation|1|||
156456541|NCT03899259|564765547|FG001|Overall Study|Protocol Deviation|1|||
156456542|NCT03899259|564765548|FG002|Overall Study|Protocol Deviation|1|||
156456543|NCT03899259|564765546|FG000|Overall Study|Withdrawal by Subject|8|||
156456544|NCT03899259|564765547|FG001|Overall Study|Withdrawal by Subject|10|||
156456545|NCT03899259|564765548|FG002|Overall Study|Withdrawal by Subject|12|||
156456546|NCT03899259|564765546|FG000|Overall Study|Lost to Follow-up|5|||
156456547|NCT03899259|564765547|FG001|Overall Study|Lost to Follow-up|6|||
156456548|NCT03899259|564765548|FG002|Overall Study|Lost to Follow-up|2|||
156456549|NCT03899259|564765546|FG000|Overall Study|Lack of Adherence|1|||
156456550|NCT03899259|564765547|FG001|Overall Study|Lack of Adherence|0|||
156456551|NCT03899259|564765548|FG002|Overall Study|Lack of Adherence|0|||
156456552|NCT03899259|564765546|FG000|Overall Study|Screen Failure|1|||
156456553|NCT03899259|564765547|FG001|Overall Study|Screen Failure|0|||
156456554|NCT03899259|564765548|FG002|Overall Study|Screen Failure|0|||
156456555|NCT03899259|564765546|FG000|Overall Study|Ongoing Study Participation|127|||
156456556|NCT03899259|564765547|FG001|Overall Study|Ongoing Study Participation|134|||
156456557|NCT03899259|564765548|FG002|Overall Study|Ongoing Study Participation|210|||
156456558|NCT04508309|564765549|FG000|Overall Study|Death|0|||
156456559|NCT04508309|564765550|FG001|Overall Study|Death|0|||
156456560|NCT04508309|564765551|FG002|Overall Study|Death|0|||
156456561|NCT04508309|564765552|FG003|Overall Study|Death|0|||
156456562|NCT04508309|564765553|FG004|Overall Study|Death|1|||
156456563|NCT04508309|564765549|FG000|Overall Study|Lost to Follow-up|0|||
156456564|NCT04508309|564765550|FG001|Overall Study|Lost to Follow-up|0|||
156456565|NCT04508309|564765551|FG002|Overall Study|Lost to Follow-up|1|||
156456566|NCT04508309|564765552|FG003|Overall Study|Lost to Follow-up|1|||
156456567|NCT04508309|564765553|FG004|Overall Study|Lost to Follow-up|0|||
156456568|NCT04508309|564765549|FG000|Overall Study|Withdrawal by Subject|0|||
156456569|NCT04508309|564765550|FG001|Overall Study|Withdrawal by Subject|0|||
156456570|NCT04508309|564765551|FG002|Overall Study|Withdrawal by Subject|0|||
156456571|NCT04508309|564765552|FG003|Overall Study|Withdrawal by Subject|0|||
156456572|NCT04508309|564765553|FG004|Overall Study|Withdrawal by Subject|1|||
156456573|NCT03058289|564765554|FG000|Overall Study|Radiographic Deterioration|0|||
156456574|NCT03058289|564765555|FG001|Overall Study|Radiographic Deterioration|3|||
156456575|NCT03058289|564765556|FG002|Overall Study|Radiographic Deterioration|1|||
156456576|NCT03058289|564765557|FG003|Overall Study|Radiographic Deterioration|2|||
156456577|NCT03058289|564765558|FG004|Overall Study|Radiographic Deterioration|6|||
156456578|NCT03058289|564765559|FG005|Overall Study|Radiographic Deterioration|3|||
156456579|NCT03058289|564765560|FG006|Overall Study|Radiographic Deterioration|0|||
156456580|NCT03058289|564765561|FG007|Overall Study|Radiographic Deterioration|4|||
156456581|NCT03058289|564765562|FG008|Overall Study|Radiographic Deterioration|2|||
156456582|NCT03058289|564765554|FG000|Overall Study|Adverse Event|2|||
156456583|NCT03058289|564765555|FG001|Overall Study|Adverse Event|0|||
156456584|NCT03058289|564765556|FG002|Overall Study|Adverse Event|1|||
156456585|NCT03058289|564765557|FG003|Overall Study|Adverse Event|3|||
156456586|NCT03058289|564765558|FG004|Overall Study|Adverse Event|1|||
156734673|NCT00626821|565776449|FG000|Overall Study|other/unknown reason|104|||
156456587|NCT03058289|564765559|FG005|Overall Study|Adverse Event|0|||
156456588|NCT03058289|564765560|FG006|Overall Study|Adverse Event|1|||
156456589|NCT03058289|564765561|FG007|Overall Study|Adverse Event|3|||
156456590|NCT03058289|564765562|FG008|Overall Study|Adverse Event|0|||
156456591|NCT03058289|564765554|FG000|Overall Study|Withdrawal by Subject|0|||
156456592|NCT03058289|564765555|FG001|Overall Study|Withdrawal by Subject|0|||
156456593|NCT03058289|564765556|FG002|Overall Study|Withdrawal by Subject|0|||
156456594|NCT03058289|564765557|FG003|Overall Study|Withdrawal by Subject|2|||
156456595|NCT03058289|564765558|FG004|Overall Study|Withdrawal by Subject|0|||
156456596|NCT03058289|564765559|FG005|Overall Study|Withdrawal by Subject|2|||
156456597|NCT03058289|564765560|FG006|Overall Study|Withdrawal by Subject|0|||
156456598|NCT03058289|564765561|FG007|Overall Study|Withdrawal by Subject|4|||
156456599|NCT03058289|564765562|FG008|Overall Study|Withdrawal by Subject|1|||
156456600|NCT03058289|564765554|FG000|Overall Study|Physician Decision|1|||
156456601|NCT03058289|564765555|FG001|Overall Study|Physician Decision|0|||
156456602|NCT03058289|564765556|FG002|Overall Study|Physician Decision|0|||
156456603|NCT03058289|564765557|FG003|Overall Study|Physician Decision|2|||
156456604|NCT03058289|564765558|FG004|Overall Study|Physician Decision|1|||
156456605|NCT03058289|564765559|FG005|Overall Study|Physician Decision|0|||
156456606|NCT03058289|564765560|FG006|Overall Study|Physician Decision|2|||
156456607|NCT03058289|564765561|FG007|Overall Study|Physician Decision|3|||
156456608|NCT03058289|564765562|FG008|Overall Study|Physician Decision|0|||
156456609|NCT03058289|564765554|FG000|Overall Study|Clinical Deterioration|2|||
156456610|NCT03058289|564765555|FG001|Overall Study|Clinical Deterioration|0|||
156456611|NCT03058289|564765556|FG002|Overall Study|Clinical Deterioration|0|||
156456612|NCT03058289|564765557|FG003|Overall Study|Clinical Deterioration|2|||
156456613|NCT03058289|564765558|FG004|Overall Study|Clinical Deterioration|1|||
156456614|NCT03058289|564765559|FG005|Overall Study|Clinical Deterioration|1|||
156456615|NCT03058289|564765560|FG006|Overall Study|Clinical Deterioration|0|||
156456616|NCT03058289|564765561|FG007|Overall Study|Clinical Deterioration|3|||
156456617|NCT03058289|564765562|FG008|Overall Study|Clinical Deterioration|2|||
156456618|NCT03058289|564765554|FG000|Overall Study|Lost to Follow-up|0|||
156456619|NCT03058289|564765555|FG001|Overall Study|Lost to Follow-up|0|||
156456620|NCT03058289|564765556|FG002|Overall Study|Lost to Follow-up|0|||
156456621|NCT03058289|564765557|FG003|Overall Study|Lost to Follow-up|0|||
156456622|NCT03058289|564765558|FG004|Overall Study|Lost to Follow-up|1|||
156456623|NCT03058289|564765559|FG005|Overall Study|Lost to Follow-up|0|||
156456624|NCT03058289|564765560|FG006|Overall Study|Lost to Follow-up|0|||
156456625|NCT03058289|564765561|FG007|Overall Study|Lost to Follow-up|0|||
156456626|NCT03058289|564765562|FG008|Overall Study|Lost to Follow-up|0|||
156456627|NCT03058289|564765554|FG000|Overall Study|Refused Further Treatment|0|||
156734674|NCT01981954|565776453|FG000|Titration Period|Protocol Deviation|1|||
156734675|NCT01981954|565776453|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
156734676|NCT04016779|565776455|FG000|Overall Study|Adverse Event|9|||
156734677|NCT04016779|565776456|FG001|Overall Study|Adverse Event|17|||
156456628|NCT03058289|564765555|FG001|Overall Study|Refused Further Treatment|0|||
156456629|NCT03058289|564765556|FG002|Overall Study|Refused Further Treatment|1|||
156456630|NCT03058289|564765557|FG003|Overall Study|Refused Further Treatment|0|||
156456631|NCT03058289|564765558|FG004|Overall Study|Refused Further Treatment|1|||
156456632|NCT03058289|564765559|FG005|Overall Study|Refused Further Treatment|0|||
156456633|NCT03058289|564765560|FG006|Overall Study|Refused Further Treatment|0|||
156456634|NCT03058289|564765561|FG007|Overall Study|Refused Further Treatment|0|||
156456635|NCT03058289|564765562|FG008|Overall Study|Refused Further Treatment|0|||
156456636|NCT03058289|564765554|FG000|Overall Study|Rapid Progression of Disease|0|||
156734678|NCT04016779|565776455|FG000|Overall Study|Lack of Efficacy|4|||
156734679|NCT04016779|565776456|FG001|Overall Study|Lack of Efficacy|1|||
156734680|NCT04016779|565776455|FG000|Overall Study|Lost to Follow-up|5|||
156734681|NCT04016779|565776456|FG001|Overall Study|Lost to Follow-up|14|||
156734682|NCT04016779|565776455|FG000|Overall Study|Physician Decision|1|||
156734683|NCT04016779|565776456|FG001|Overall Study|Physician Decision|3|||
156734684|NCT04016779|565776455|FG000|Overall Study|Withdrawal by Subject|6|||
156734685|NCT04016779|565776456|FG001|Overall Study|Withdrawal by Subject|8|||
156734686|NCT04016779|565776455|FG000|Overall Study|Non-compliance with Study Drug|2|||
156734687|NCT04016779|565776456|FG001|Overall Study|Non-compliance with Study Drug|3|||
156734688|NCT04016779|565776455|FG000|Overall Study|Other, Multiple categories|17|||
156734689|NCT04016779|565776456|FG001|Overall Study|Other, Multiple categories|17|||
156734690|NCT00623935|565776457|FG000|Overall Study|Death|1|||
156734691|NCT00623935|565776457|FG000|Overall Study|Patient Declined Transplant|1|||
156734692|NCT03315286|565776458|FG000|Overall Study|Lost to Follow-up|0|||
156734693|NCT03315286|565776459|FG001|Overall Study|Lost to Follow-up|3|||
156734694|NCT03315286|565776458|FG000|Overall Study|Withdrawal by Subject|1|||
156734695|NCT03315286|565776459|FG001|Overall Study|Withdrawal by Subject|0|||
156734696|NCT03315286|565776458|FG000|Overall Study|Protocol Violation|0|||
156734697|NCT03315286|565776459|FG001|Overall Study|Protocol Violation|1|||
156734698|NCT02828124|565776460|FG000|Overall Study|Disease Progression|1|||
156734699|NCT02828124|565776461|FG001|Overall Study|Disease Progression|2|||
156734700|NCT02828124|565776462|FG002|Overall Study|Disease Progression|1|||
156734701|NCT02828124|565776463|FG003|Overall Study|Disease Progression|4|||
156734702|NCT02828124|565776460|FG000|Overall Study|AE Unrelated to Study Drug|0|||
156734703|NCT02828124|565776461|FG001|Overall Study|AE Unrelated to Study Drug|0|||
156734704|NCT02828124|565776462|FG002|Overall Study|AE Unrelated to Study Drug|0|||
156734705|NCT02828124|565776463|FG003|Overall Study|AE Unrelated to Study Drug|1|||
156734706|NCT02828124|565776460|FG000|Overall Study|Subject Withdrew Consent|0|||
156734707|NCT02828124|565776461|FG001|Overall Study|Subject Withdrew Consent|0|||
156734708|NCT02828124|565776462|FG002|Overall Study|Subject Withdrew Consent|0|||
156734709|NCT02828124|565776463|FG003|Overall Study|Subject Withdrew Consent|1|||
156456637|NCT03058289|564765555|FG001|Overall Study|Rapid Progression of Disease|0|||
156456638|NCT03058289|564765556|FG002|Overall Study|Rapid Progression of Disease|0|||
156734710|NCT00747474|565776464|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734711|NCT00747474|565776465|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734712|NCT00747474|565776466|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734713|NCT00747474|565776467|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734714|NCT00747474|565776468|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156533947|NCT01493557|565050841|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
156533948|NCT01493557|565050839|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
156533949|NCT01493557|565050840|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
156533950|NCT01493557|565050841|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
156533951|NCT01493557|565050839|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
156533952|NCT01493557|565050840|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
156533953|NCT01493557|565050841|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
156533954|NCT01493557|565050839|FG000|Not Randomized to Management Strategies|Early termination|0|||
156734715|NCT00747474|565776469|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734716|NCT00747474|565776470|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734717|NCT00747474|565776471|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
156734718|NCT00747474|565776472|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734719|NCT00747474|565776473|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734720|NCT00747474|565776474|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734721|NCT00747474|565776475|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734722|NCT02829723|565776477|FG000|Overall Study|Adverse Event|0|||
156734723|NCT02829723|565776478|FG001|Overall Study|Adverse Event|0|||
156734724|NCT02829723|565776479|FG002|Overall Study|Adverse Event|1|||
156734725|NCT02829723|565776480|FG003|Overall Study|Adverse Event|1|||
156734726|NCT02829723|565776481|FG004|Overall Study|Adverse Event|0|||
156734727|NCT02829723|565776482|FG005|Overall Study|Adverse Event|0|||
156734728|NCT02829723|565776483|FG006|Overall Study|Adverse Event|0|||
156734729|NCT02829723|565776484|FG007|Overall Study|Adverse Event|1|||
156734730|NCT02829723|565776485|FG008|Overall Study|Adverse Event|0|||
156734731|NCT02829723|565776486|FG009|Overall Study|Adverse Event|0|||
156734732|NCT02829723|565776487|FG010|Overall Study|Adverse Event|0|||
156734733|NCT02829723|565776488|FG011|Overall Study|Adverse Event|0|||
156734734|NCT02829723|565776489|FG012|Overall Study|Adverse Event|0|||
156734735|NCT02829723|565776490|FG013|Overall Study|Adverse Event|0|||
156456639|NCT03058289|564765557|FG003|Overall Study|Rapid Progression of Disease|1|||
156456640|NCT03058289|564765558|FG004|Overall Study|Rapid Progression of Disease|0|||
156456641|NCT03058289|564765559|FG005|Overall Study|Rapid Progression of Disease|0|||
156456642|NCT03058289|564765560|FG006|Overall Study|Rapid Progression of Disease|0|||
156456643|NCT03058289|564765561|FG007|Overall Study|Rapid Progression of Disease|0|||
156456644|NCT03058289|564765562|FG008|Overall Study|Rapid Progression of Disease|0|||
156456645|NCT02601313|564765563|FG000|Overall Study|Death|2|||
156456646|NCT02601313|564765564|FG001|Overall Study|Death|41|||
156456647|NCT02601313|564765565|FG002|Overall Study|Death|6|||
156456648|NCT02601313|564765563|FG000|Overall Study|Enrolled but never treated|0|||
156456649|NCT02601313|564765564|FG001|Overall Study|Enrolled but never treated|6|||
156456650|NCT02601313|564765565|FG002|Overall Study|Enrolled but never treated|3|||
156456651|NCT02601313|564765563|FG000|Overall Study|Enrolled, did not initiate AC|4|||
156456652|NCT02601313|564765564|FG001|Overall Study|Enrolled, did not initiate AC|0|||
156456653|NCT02601313|564765565|FG002|Overall Study|Enrolled, did not initiate AC|0|||
156456654|NCT02601313|564765563|FG000|Overall Study|Full consent withdrawal|0|||
156456655|NCT02601313|564765564|FG001|Overall Study|Full consent withdrawal|3|||
156456656|NCT02601313|564765565|FG002|Overall Study|Full consent withdrawal|2|||
156456657|NCT02601313|564765563|FG000|Overall Study|Lost to Follow-up|0|||
156456658|NCT02601313|564765564|FG001|Overall Study|Lost to Follow-up|1|||
156456659|NCT02601313|564765565|FG002|Overall Study|Lost to Follow-up|1|||
156456660|NCT05239455|564765571|FG000|Overall Study|Adverse Event|1|||
156456661|NCT05239455|564765571|FG000|Overall Study|Sponsor Decision|5|||
156456662|NCT05239455|564765571|FG000|Overall Study|Incomplete Blood Collection|1|||
156456663|NCT03800654|564765572|FG000|Overall Study|Time constraints|3|||
156456664|NCT03800654|564765573|FG001|Overall Study|Time constraints|3|||
156456665|NCT03800654|564765574|FG002|Overall Study|Time constraints|3|||
156456666|NCT03800654|564765572|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
156456667|NCT03800654|564765573|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
156456668|NCT03800654|564765574|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
156456669|NCT03800654|564765572|FG000|Overall Study|Lost to Follow-up|2|||
156456670|NCT03800654|564765573|FG001|Overall Study|Lost to Follow-up|1|||
156456671|NCT03800654|564765574|FG002|Overall Study|Lost to Follow-up|6|||
156456672|NCT03800654|564765572|FG000|Overall Study|Medical Health Issue|0|||
156456673|NCT03800654|564765573|FG001|Overall Study|Medical Health Issue|0|||
156456674|NCT03800654|564765574|FG002|Overall Study|Medical Health Issue|1|||
156456675|NCT03800654|564765572|FG000|Overall Study|Personal Issues|0|||
156456676|NCT03800654|564765573|FG001|Overall Study|Personal Issues|2|||
156456677|NCT03800654|564765574|FG002|Overall Study|Personal Issues|0|||
156734736|NCT02829723|565776491|FG014|Overall Study|Adverse Event|1|||
156734737|NCT02829723|565776492|FG015|Overall Study|Adverse Event|1|||
156734738|NCT02829723|565776493|FG016|Overall Study|Adverse Event|1|||
156734739|NCT02829723|565776494|FG017|Overall Study|Adverse Event|2|||
156734740|NCT02829723|565776495|FG018|Overall Study|Adverse Event|1|||
156456678|NCT03800654|564765572|FG000|Overall Study|Protocol Violation|0|||
156533955|NCT01493557|565050840|FG001|Not Randomized to Management Strategies|Early termination|0|||
156533956|NCT01493557|565050841|FG002|Not Randomized to Management Strategies|Early termination|34|||
156533957|NCT01493557|565050839|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
156533958|NCT01493557|565050840|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
156533959|NCT01493557|565050841|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
156533960|NCT01493557|565050839|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
156533961|NCT01493557|565050840|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
156533962|NCT01493557|565050841|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
156533963|NCT01493557|565050839|FG000|Randomized to Management Strategies|Other adverse event|8|||
156533964|NCT01493557|565050840|FG001|Randomized to Management Strategies|Other adverse event|5|||
156533965|NCT01493557|565050841|FG002|Randomized to Management Strategies|Other adverse event|0|||
156734741|NCT02829723|565776496|FG019|Overall Study|Adverse Event|1|||
156734742|NCT02829723|565776497|FG020|Overall Study|Adverse Event|3|||
156734743|NCT02829723|565776498|FG021|Overall Study|Adverse Event|0|||
156734744|NCT02829723|565776499|FG022|Overall Study|Adverse Event|0|||
156734745|NCT02829723|565776500|FG023|Overall Study|Adverse Event|1|||
156734746|NCT02829723|565776501|FG024|Overall Study|Adverse Event|1|||
156734747|NCT02829723|565776502|FG025|Overall Study|Adverse Event|3|||
156734748|NCT02829723|565776503|FG026|Overall Study|Adverse Event|5|||
156734749|NCT02829723|565776477|FG000|Overall Study|Death|1|||
156734750|NCT02829723|565776478|FG001|Overall Study|Death|0|||
156734751|NCT02829723|565776479|FG002|Overall Study|Death|1|||
156734752|NCT02829723|565776480|FG003|Overall Study|Death|1|||
156734753|NCT02829723|565776481|FG004|Overall Study|Death|0|||
156734754|NCT02829723|565776482|FG005|Overall Study|Death|0|||
156734755|NCT02829723|565776483|FG006|Overall Study|Death|2|||
156734756|NCT02829723|565776484|FG007|Overall Study|Death|0|||
156734757|NCT02829723|565776485|FG008|Overall Study|Death|1|||
156734758|NCT02829723|565776486|FG009|Overall Study|Death|0|||
156734759|NCT02829723|565776487|FG010|Overall Study|Death|0|||
156734760|NCT02829723|565776488|FG011|Overall Study|Death|0|||
156734761|NCT02829723|565776489|FG012|Overall Study|Death|2|||
156734762|NCT02829723|565776490|FG013|Overall Study|Death|1|||
156734763|NCT02829723|565776491|FG014|Overall Study|Death|0|||
156734764|NCT02829723|565776492|FG015|Overall Study|Death|0|||
156734765|NCT02829723|565776493|FG016|Overall Study|Death|0|||
156734766|NCT02829723|565776494|FG017|Overall Study|Death|0|||
156734767|NCT02829723|565776495|FG018|Overall Study|Death|0|||
156734768|NCT02829723|565776496|FG019|Overall Study|Death|0|||
156734769|NCT02829723|565776497|FG020|Overall Study|Death|0|||
156734770|NCT02829723|565776498|FG021|Overall Study|Death|2|||
156734771|NCT02829723|565776499|FG022|Overall Study|Death|0|||
156734772|NCT02829723|565776500|FG023|Overall Study|Death|0|||
156734773|NCT02829723|565776501|FG024|Overall Study|Death|0|||
156533966|NCT01493557|565050839|FG000|Randomized to Management Strategies|Protocol Violation|3|||
156533967|NCT01493557|565050840|FG001|Randomized to Management Strategies|Protocol Violation|0|||
156533968|NCT01493557|565050841|FG002|Randomized to Management Strategies|Protocol Violation|0|||
156533969|NCT01493557|565050839|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
156533970|NCT01493557|565050840|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
156533971|NCT01493557|565050841|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
156533972|NCT01493557|565050839|FG000|Randomized to Management Strategies|Other than stated above|1|||
156533973|NCT01493557|565050840|FG001|Randomized to Management Strategies|Other than stated above|3|||
156533974|NCT01493557|565050841|FG002|Randomized to Management Strategies|Other than stated above|0|||
156533975|NCT01493557|565050839|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
156533976|NCT01493557|565050840|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
156533977|NCT01493557|565050841|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
156533978|NCT01493557|565050839|FG000|Adding the Second Strategy|Other adverse event|1|||
156533979|NCT01493557|565050840|FG001|Adding the Second Strategy|Other adverse event|2|||
156734774|NCT02829723|565776502|FG025|Overall Study|Death|1|||
156734775|NCT02829723|565776503|FG026|Overall Study|Death|2|||
156734776|NCT02829723|565776477|FG000|Overall Study|Physician Decision|0|||
156336605|NCT04613375|564329652|FG000|Overall Study|Withdrawal by Subject|3|||
156734777|NCT02829723|565776478|FG001|Overall Study|Physician Decision|0|||
156734778|NCT02829723|565776479|FG002|Overall Study|Physician Decision|0|||
156734779|NCT02829723|565776480|FG003|Overall Study|Physician Decision|0|||
156796842|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Other|0|||
156336606|NCT00002651|564329653|FG000|Induction|Adverse Event|44|||
156734780|NCT02829723|565776481|FG004|Overall Study|Physician Decision|0|||
156734781|NCT02829723|565776482|FG005|Overall Study|Physician Decision|0|||
156734782|NCT02829723|565776483|FG006|Overall Study|Physician Decision|0|||
156734783|NCT02829723|565776484|FG007|Overall Study|Physician Decision|0|||
156734784|NCT02829723|565776485|FG008|Overall Study|Physician Decision|0|||
156734785|NCT02829723|565776486|FG009|Overall Study|Physician Decision|1|||
156734786|NCT02829723|565776487|FG010|Overall Study|Physician Decision|1|||
156734787|NCT02829723|565776488|FG011|Overall Study|Physician Decision|0|||
156734788|NCT02829723|565776489|FG012|Overall Study|Physician Decision|0|||
156734789|NCT02829723|565776490|FG013|Overall Study|Physician Decision|1|||
156734790|NCT02829723|565776491|FG014|Overall Study|Physician Decision|0|||
156734791|NCT02829723|565776492|FG015|Overall Study|Physician Decision|0|||
156734792|NCT02829723|565776493|FG016|Overall Study|Physician Decision|2|||
156734793|NCT02829723|565776494|FG017|Overall Study|Physician Decision|0|||
156734794|NCT02829723|565776495|FG018|Overall Study|Physician Decision|0|||
156876667|NCT02052414|566307675|FG000|Overall Study|Lack of Efficacy|2|||
156876668|NCT02052414|566307675|FG000|Overall Study|Withdrawal by Subject|3|||
156876669|NCT05367492|566307681|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
156876670|NCT05367492|566307682|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
156876671|NCT05367492|566307683|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
156876672|NCT05367492|566307681|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
156876673|NCT05367492|566307682|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
156876674|NCT05367492|566307683|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
156876675|NCT05367492|566307681|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
156876676|NCT05367492|566307682|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
156876677|NCT05367492|566307683|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
156876678|NCT05367492|566307681|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
156456679|NCT03800654|564765573|FG001|Overall Study|Protocol Violation|1|||
156456680|NCT03800654|564765574|FG002|Overall Study|Protocol Violation|0|||
156456681|NCT03459729|564765575|FG000|Overall Study|Physician Decision|2|||
156456682|NCT06182033|564765576|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
156456683|NCT06182033|564765577|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
156456684|NCT06182033|564765576|FG000|Overall Study|Target child relocation|1|||
156456685|NCT06182033|564765577|FG001|Overall Study|Target child relocation|1|||
156456686|NCT06182033|564765576|FG000|Overall Study|Withdrawal by Subject|1|||
156456687|NCT06182033|564765577|FG001|Overall Study|Withdrawal by Subject|0|||
156456688|NCT02626533|564765579|FG000|Overall Study|Protocol Violation|14|||
156456689|NCT02626533|564765579|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
156456690|NCT02626533|564765579|FG000|Overall Study|Withdrawal by Subject|1|||
156456691|NCT05576155|564765582|FG000|Overall Study|Withdrawal by Subject|1|||
156456692|NCT05576155|564765583|FG001|Overall Study|Withdrawal by Subject|1|||
156456693|NCT05623228|564765586|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
156456694|NCT05623228|564765587|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156456695|NCT05623228|564765588|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156456696|NCT05623228|564765589|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156456697|NCT05623228|564765590|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156456698|NCT05623228|564765591|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156456699|NCT05623228|564765592|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156456700|NCT05623228|564765593|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156456701|NCT05623228|564765586|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
156456702|NCT05623228|564765587|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
156456703|NCT05623228|564765588|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
156456704|NCT05623228|564765589|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
156456705|NCT05623228|564765590|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
156456706|NCT05623228|564765591|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
156456707|NCT05623228|564765592|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
156456708|NCT05623228|564765593|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
156456709|NCT03379675|564767101|FG000|Overall Study|Lost to Follow-up|0|||
156456710|NCT03379675|564767102|FG001|Overall Study|Lost to Follow-up|1|||
156456711|NCT03379675|564767103|FG002|Overall Study|Lost to Follow-up|0|||
156456712|NCT03379675|564767101|FG000|Overall Study|Adverse Event|2|||
156456713|NCT03379675|564767102|FG001|Overall Study|Adverse Event|0|||
156456714|NCT03379675|564767103|FG002|Overall Study|Adverse Event|0|||
156456715|NCT03379675|564767101|FG000|Overall Study|Withdrawal by Subject|2|||
156456716|NCT03379675|564767102|FG001|Overall Study|Withdrawal by Subject|1|||
156456717|NCT03379675|564767103|FG002|Overall Study|Withdrawal by Subject|2|||
156456718|NCT02817776|564767104|FG000|Overall Study|Excluded|33|||
156456719|NCT02817776|564767104|FG000|Overall Study|Lost to Follow-up|20|||
156456720|NCT02817776|564767104|FG000|Overall Study|Withdrawal by Subject|33|||
156456721|NCT02817776|564767104|FG000|Overall Study|Death|2|||
156876679|NCT05367492|566307682|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
156456722|NCT02359890|564767110|FG000|Overall Study|Not meeting eligibility|4|||
156876680|NCT05367492|566307683|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
156336607|NCT00002651|564329654|FG001|Induction|Adverse Event|0|||
156336608|NCT00002651|564329655|FG002|Induction|Adverse Event|0|||
156456723|NCT02359890|564767110|FG000|Overall Study|Never treated with study catheter|6|||
156456724|NCT01574274|564767112|FG000|Overall Study|Ineligible|0|||
156456725|NCT01574274|564767113|FG001|Overall Study|Ineligible|1|||
156456726|NCT01574274|564767112|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
156456727|NCT01574274|564767113|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
156456728|NCT01574274|564767112|FG000|Overall Study|Ph+ B-ALL|3|||
156734795|NCT02829723|565776496|FG019|Overall Study|Physician Decision|0|||
156734796|NCT02829723|565776497|FG020|Overall Study|Physician Decision|0|||
156456729|NCT01574274|564767113|FG001|Overall Study|Ph+ B-ALL|4|||
156456730|NCT01574274|564767112|FG000|Overall Study|Induction Death|2|||
156734797|NCT02829723|565776498|FG021|Overall Study|Physician Decision|0|||
156734798|NCT02829723|565776499|FG022|Overall Study|Physician Decision|1|||
156734799|NCT02829723|565776500|FG023|Overall Study|Physician Decision|1|||
156734800|NCT02829723|565776501|FG024|Overall Study|Physician Decision|1|||
156734801|NCT02829723|565776502|FG025|Overall Study|Physician Decision|1|||
156734802|NCT02829723|565776503|FG026|Overall Study|Physician Decision|3|||
156734803|NCT02829723|565776477|FG000|Overall Study|Progressive disease|4|||
156734804|NCT02829723|565776478|FG001|Overall Study|Progressive disease|6|||
156734805|NCT02829723|565776479|FG002|Overall Study|Progressive disease|3|||
156734806|NCT02829723|565776480|FG003|Overall Study|Progressive disease|3|||
156734807|NCT02829723|565776481|FG004|Overall Study|Progressive disease|3|||
156456731|NCT01574274|564767113|FG001|Overall Study|Induction Death|0|||
156456732|NCT01574274|564767112|FG000|Overall Study|Induction Failure|4|||
156456733|NCT01574274|564767113|FG001|Overall Study|Induction Failure|1|||
156456734|NCT01574274|564767112|FG000|Overall Study|Adverse Event|16|||
156456735|NCT01574274|564767113|FG001|Overall Study|Adverse Event|13|||
156456736|NCT01574274|564767112|FG000|Overall Study|Remission Death|1|||
156456737|NCT01574274|564767113|FG001|Overall Study|Remission Death|0|||
156456738|NCT01574274|564767112|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
156456739|NCT01574274|564767113|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
156456740|NCT01574274|564767112|FG000|Overall Study|Other, unknown|3|||
156456741|NCT01574274|564767113|FG001|Overall Study|Other, unknown|2|||
156456742|NCT03907878|564767120|FG000|Treatment Period|Withdrawal by Subject|5|||
156456743|NCT03907878|564767120|FG000|Treatment Period|Adverse Event|4|||
156456744|NCT03907878|564767120|FG000|Treatment Period|Lack of Efficacy|1|||
156456745|NCT03907878|564767120|FG000|Treatment Period|Protocol Violation|1|||
156456746|NCT03907878|564767120|FG000|Follow-up Period|Adverse Event|3|||
156456747|NCT03907878|564767120|FG000|Follow-up Period|Withdrawal by Subject|3|||
156456748|NCT03904147|564767125|FG000|Overall Study|Death|15|||
156456749|NCT03904147|564767126|FG001|Overall Study|Death|13|||
156456750|NCT03904147|564767127|FG002|Overall Study|Death|15|||
156456751|NCT03904147|564767125|FG000|Overall Study|Withdrawal by Subject|7|||
156456752|NCT03904147|564767126|FG001|Overall Study|Withdrawal by Subject|12|||
156456753|NCT03904147|564767127|FG002|Overall Study|Withdrawal by Subject|1|||
156734808|NCT02829723|565776482|FG005|Overall Study|Progressive disease|5|||
156734809|NCT02829723|565776483|FG006|Overall Study|Progressive disease|4|||
156734810|NCT02829723|565776484|FG007|Overall Study|Progressive disease|6|||
156734811|NCT02829723|565776485|FG008|Overall Study|Progressive disease|8|||
156734812|NCT02829723|565776486|FG009|Overall Study|Progressive disease|4|||
156734813|NCT02829723|565776487|FG010|Overall Study|Progressive disease|9|||
156734814|NCT02829723|565776488|FG011|Overall Study|Progressive disease|0|||
156734815|NCT02829723|565776489|FG012|Overall Study|Progressive disease|3|||
156734816|NCT02829723|565776490|FG013|Overall Study|Progressive disease|4|||
156734817|NCT02829723|565776491|FG014|Overall Study|Progressive disease|2|||
156734818|NCT02829723|565776492|FG015|Overall Study|Progressive disease|4|||
156734819|NCT02829723|565776493|FG016|Overall Study|Progressive disease|5|||
156734820|NCT02829723|565776494|FG017|Overall Study|Progressive disease|3|||
156734821|NCT02829723|565776495|FG018|Overall Study|Progressive disease|4|||
156734822|NCT02829723|565776496|FG019|Overall Study|Progressive disease|4|||
156734823|NCT02829723|565776497|FG020|Overall Study|Progressive disease|7|||
156734824|NCT02829723|565776498|FG021|Overall Study|Progressive disease|6|||
156734825|NCT02829723|565776499|FG022|Overall Study|Progressive disease|3|||
156734826|NCT02829723|565776500|FG023|Overall Study|Progressive disease|3|||
156734827|NCT02829723|565776501|FG024|Overall Study|Progressive disease|3|||
156734828|NCT02829723|565776502|FG025|Overall Study|Progressive disease|16|||
156734829|NCT02829723|565776503|FG026|Overall Study|Progressive disease|10|||
156734830|NCT02829723|565776477|FG000|Overall Study|Subject/guardian decision|0|||
156734831|NCT02829723|565776478|FG001|Overall Study|Subject/guardian decision|1|||
156734832|NCT02829723|565776479|FG002|Overall Study|Subject/guardian decision|0|||
156734833|NCT02829723|565776480|FG003|Overall Study|Subject/guardian decision|1|||
156796843|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Other|0|||
156456754|NCT03904147|564767125|FG000|Overall Study|1Y visit completed after 365 days|1|||
156456755|NCT03904147|564767126|FG001|Overall Study|1Y visit completed after 365 days|1|||
156456756|NCT03904147|564767127|FG002|Overall Study|1Y visit completed after 365 days|0|||
156456757|NCT03625167|564767129|FG000|Overall Study|Protocol Violation|5|||
156734834|NCT02829723|565776481|FG004|Overall Study|Subject/guardian decision|0|||
156734835|NCT02829723|565776482|FG005|Overall Study|Subject/guardian decision|0|||
156734836|NCT02829723|565776483|FG006|Overall Study|Subject/guardian decision|0|||
156734837|NCT02829723|565776484|FG007|Overall Study|Subject/guardian decision|1|||
156734838|NCT02829723|565776485|FG008|Overall Study|Subject/guardian decision|0|||
156734839|NCT02829723|565776486|FG009|Overall Study|Subject/guardian decision|0|||
156734840|NCT02829723|565776487|FG010|Overall Study|Subject/guardian decision|0|||
156734841|NCT02829723|565776488|FG011|Overall Study|Subject/guardian decision|0|||
156734842|NCT02829723|565776489|FG012|Overall Study|Subject/guardian decision|0|||
156456758|NCT06103188|564767130|FG000|Overall Study|Lost to Follow-up|1|||
156456759|NCT06103188|564767131|FG001|Overall Study|Lost to Follow-up|6|||
156734843|NCT02829723|565776490|FG013|Overall Study|Subject/guardian decision|0|||
156734844|NCT02829723|565776491|FG014|Overall Study|Subject/guardian decision|1|||
156734845|NCT02829723|565776492|FG015|Overall Study|Subject/guardian decision|0|||
156734846|NCT02829723|565776493|FG016|Overall Study|Subject/guardian decision|1|||
156734847|NCT02829723|565776494|FG017|Overall Study|Subject/guardian decision|0|||
156734848|NCT02829723|565776495|FG018|Overall Study|Subject/guardian decision|1|||
156734849|NCT02829723|565776496|FG019|Overall Study|Subject/guardian decision|0|||
156734850|NCT02829723|565776497|FG020|Overall Study|Subject/guardian decision|1|||
156734851|NCT02829723|565776498|FG021|Overall Study|Subject/guardian decision|0|||
156734852|NCT02829723|565776499|FG022|Overall Study|Subject/guardian decision|0|||
156734853|NCT02829723|565776500|FG023|Overall Study|Subject/guardian decision|1|||
156734854|NCT02829723|565776501|FG024|Overall Study|Subject/guardian decision|0|||
156734855|NCT02829723|565776502|FG025|Overall Study|Subject/guardian decision|1|||
156734856|NCT02829723|565776503|FG026|Overall Study|Subject/guardian decision|1|||
156734857|NCT02829723|565776477|FG000|Overall Study|Study terminated by sponsor|0|||
156734858|NCT02829723|565776478|FG001|Overall Study|Study terminated by sponsor|0|||
156734859|NCT02829723|565776479|FG002|Overall Study|Study terminated by sponsor|0|||
156734860|NCT02829723|565776480|FG003|Overall Study|Study terminated by sponsor|0|||
156734861|NCT02829723|565776481|FG004|Overall Study|Study terminated by sponsor|0|||
156734862|NCT02829723|565776482|FG005|Overall Study|Study terminated by sponsor|0|||
156734863|NCT02829723|565776483|FG006|Overall Study|Study terminated by sponsor|0|||
156456760|NCT06103188|564767132|FG002|Overall Study|Lost to Follow-up|4|||
156456761|NCT04145440|564767135|FG000|Overall Study|Physician Decision|3|||
156456762|NCT04145440|564767136|FG001|Overall Study|Physician Decision|0|||
156456763|NCT04145440|564767135|FG000|Overall Study|Use of prohibited therapy|2|||
156456764|NCT04145440|564767136|FG001|Overall Study|Use of prohibited therapy|3|||
156456765|NCT06457802|564767152|FG000|Overall Study|Early termination of study prior to participant completion|2|||
156456766|NCT06457802|564767153|FG001|Overall Study|Early termination of study prior to participant completion|2|||
156734864|NCT02829723|565776484|FG007|Overall Study|Study terminated by sponsor|0|||
156734865|NCT02829723|565776485|FG008|Overall Study|Study terminated by sponsor|0|||
156734866|NCT02829723|565776486|FG009|Overall Study|Study terminated by sponsor|0|||
156734867|NCT02829723|565776487|FG010|Overall Study|Study terminated by sponsor|0|||
156734868|NCT02829723|565776488|FG011|Overall Study|Study terminated by sponsor|0|||
156734869|NCT02829723|565776489|FG012|Overall Study|Study terminated by sponsor|0|||
156734870|NCT02829723|565776490|FG013|Overall Study|Study terminated by sponsor|0|||
156734871|NCT02829723|565776491|FG014|Overall Study|Study terminated by sponsor|0|||
156734872|NCT02829723|565776492|FG015|Overall Study|Study terminated by sponsor|0|||
156734873|NCT02829723|565776493|FG016|Overall Study|Study terminated by sponsor|0|||
156734874|NCT02829723|565776494|FG017|Overall Study|Study terminated by sponsor|0|||
156734875|NCT02829723|565776495|FG018|Overall Study|Study terminated by sponsor|0|||
156734876|NCT02829723|565776496|FG019|Overall Study|Study terminated by sponsor|0|||
156734877|NCT02829723|565776497|FG020|Overall Study|Study terminated by sponsor|0|||
156734878|NCT02829723|565776498|FG021|Overall Study|Study terminated by sponsor|1|||
156734879|NCT02829723|565776499|FG022|Overall Study|Study terminated by sponsor|0|||
156734880|NCT02829723|565776500|FG023|Overall Study|Study terminated by sponsor|0|||
156734881|NCT02829723|565776501|FG024|Overall Study|Study terminated by sponsor|0|||
156734882|NCT02829723|565776502|FG025|Overall Study|Study terminated by sponsor|0|||
156734883|NCT02829723|565776503|FG026|Overall Study|Study terminated by sponsor|0|||
156734884|NCT02989649|565776504|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
156734885|NCT02989649|565776504|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
156734886|NCT02989649|565776504|FG000|Overall Study|Lost For Observation During Study|3|||
156734887|NCT02989649|565776504|FG000|Overall Study|Reason Not Specified|13|||
156734888|NCT00330343|565776505|FG000|Overall Study|Lost to Follow-up|5|||
156734889|NCT00256854|565776506|FG000|Overall Study|Withdrawal by Subject|2|||
156734890|NCT00256854|565776507|FG001|Overall Study|Withdrawal by Subject|3|||
156734891|NCT00256854|565776508|FG002|Overall Study|Withdrawal by Subject|0|||
156734892|NCT00256854|565776509|FG003|Overall Study|Withdrawal by Subject|0|||
156456767|NCT05496231|564767154|FG000|Overall Study|Adverse Event|1|||
156456768|NCT05496231|564767155|FG001|Overall Study|Adverse Event|1|||
156456769|NCT05496231|564767156|FG002|Overall Study|Adverse Event|0|||
156456770|NCT05496231|564767157|FG003|Overall Study|Adverse Event|4|||
156456771|NCT05496231|564767154|FG000|Overall Study|Withdrawal by Subject|5|||
156456772|NCT05496231|564767155|FG001|Overall Study|Withdrawal by Subject|5|||
156734893|NCT00256854|565776510|FG004|Overall Study|Withdrawal by Subject|0|||
156734894|NCT00256854|565776511|FG005|Overall Study|Withdrawal by Subject|0|||
156734895|NCT00256854|565776506|FG000|Overall Study|Lack of Efficacy|1|||
156734896|NCT00256854|565776507|FG001|Overall Study|Lack of Efficacy|0|||
156734897|NCT00256854|565776508|FG002|Overall Study|Lack of Efficacy|0|||
156734898|NCT00256854|565776509|FG003|Overall Study|Lack of Efficacy|0|||
156734899|NCT00256854|565776510|FG004|Overall Study|Lack of Efficacy|0|||
156734900|NCT00256854|565776511|FG005|Overall Study|Lack of Efficacy|0|||
156734901|NCT00256854|565776506|FG000|Overall Study|Protocol Violation|0|||
156456773|NCT05496231|564767156|FG002|Overall Study|Withdrawal by Subject|4|||
156734902|NCT00256854|565776507|FG001|Overall Study|Protocol Violation|1|||
156734903|NCT00256854|565776508|FG002|Overall Study|Protocol Violation|1|||
156734904|NCT00256854|565776509|FG003|Overall Study|Protocol Violation|1|||
156734905|NCT00256854|565776510|FG004|Overall Study|Protocol Violation|0|||
156533980|NCT01493557|565050841|FG002|Adding the Second Strategy|Other adverse event|0|||
156533981|NCT01493557|565050839|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
156533982|NCT01493557|565050840|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
156533983|NCT01493557|565050841|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
156533984|NCT01876251|565050842|FG000|Overall Study|Clinical progression|1|||
156533985|NCT01876251|565050843|FG001|Overall Study|Clinical progression|0|||
156533986|NCT01876251|565050844|FG002|Overall Study|Clinical progression|0|||
156533987|NCT01876251|565050842|FG000|Overall Study|Death|2|||
156533988|NCT01876251|565050843|FG001|Overall Study|Death|0|||
156533989|NCT01876251|565050844|FG002|Overall Study|Death|1|||
156533990|NCT01876251|565050842|FG000|Overall Study|Participant started new treatment|1|||
156533991|NCT01876251|565050843|FG001|Overall Study|Participant started new treatment|0|||
156533992|NCT01876251|565050844|FG002|Overall Study|Participant started new treatment|1|||
156533993|NCT01876251|565050842|FG000|Overall Study|Participant refused further follow-up|0|||
156734906|NCT00256854|565776511|FG005|Overall Study|Protocol Violation|0|||
156734907|NCT00256854|565776506|FG000|Overall Study|Adverse Event|0|||
156734908|NCT00256854|565776507|FG001|Overall Study|Adverse Event|0|||
156734909|NCT00256854|565776508|FG002|Overall Study|Adverse Event|2|||
156734910|NCT00256854|565776509|FG003|Overall Study|Adverse Event|2|||
156734911|NCT00256854|565776510|FG004|Overall Study|Adverse Event|0|||
156734912|NCT00256854|565776511|FG005|Overall Study|Adverse Event|1|||
156734913|NCT00256854|565776506|FG000|Overall Study|Not compliant with the study drug|0|||
156734914|NCT00256854|565776507|FG001|Overall Study|Not compliant with the study drug|0|||
156734915|NCT00256854|565776508|FG002|Overall Study|Not compliant with the study drug|0|||
156734916|NCT00256854|565776509|FG003|Overall Study|Not compliant with the study drug|0|||
156734917|NCT00256854|565776510|FG004|Overall Study|Not compliant with the study drug|1|||
156734918|NCT00256854|565776511|FG005|Overall Study|Not compliant with the study drug|0|||
156734919|NCT06586788|565776512|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
156734920|NCT03990571|565776513|FG000|Overall Study|Withdrawal by Subject|1|||
156734921|NCT03990571|565776513|FG000|Overall Study|Insurance Issues|3|||
156734922|NCT03990571|565776513|FG000|Overall Study|Covid Restrictions|2|||
156734923|NCT03514485|565776514|FG000|Overall Study|Lost to Follow-up|5|||
156734924|NCT03514485|565776515|FG001|Overall Study|Lost to Follow-up|3|||
156734925|NCT03514485|565776516|FG002|Overall Study|Lost to Follow-up|2|||
156734926|NCT03514485|565776517|FG003|Overall Study|Lost to Follow-up|0|||
156734927|NCT03514485|565776518|FG004|Overall Study|Lost to Follow-up|1|||
156336609|NCT00002651|564329653|FG000|Induction|Refusal unrelated to adverse event|50|||
156336610|NCT00002651|564329654|FG001|Induction|Refusal unrelated to adverse event|0|||
156336611|NCT00002651|564329655|FG002|Induction|Refusal unrelated to adverse event|0|||
156456774|NCT05496231|564767157|FG003|Overall Study|Withdrawal by Subject|11|||
156456775|NCT05496231|564767154|FG000|Overall Study|Migrated/moved from the study area|3|||
156456776|NCT05496231|564767155|FG001|Overall Study|Migrated/moved from the study area|5|||
156456777|NCT05496231|564767156|FG002|Overall Study|Migrated/moved from the study area|3|||
156456778|NCT05496231|564767157|FG003|Overall Study|Migrated/moved from the study area|3|||
156456779|NCT05496231|564767154|FG000|Overall Study|Lost to Follow-up|13|||
156456780|NCT05496231|564767155|FG001|Overall Study|Lost to Follow-up|6|||
156456781|NCT05496231|564767156|FG002|Overall Study|Lost to Follow-up|11|||
156456782|NCT05496231|564767157|FG003|Overall Study|Lost to Follow-up|6|||
156456783|NCT05496231|564767154|FG000|Overall Study|Other|9|||
156456784|NCT05496231|564767155|FG001|Overall Study|Other|7|||
156456785|NCT05496231|564767156|FG002|Overall Study|Other|7|||
156456786|NCT05496231|564767157|FG003|Overall Study|Other|8|||
156456787|NCT03819153|564767160|FG000|Overall Study|Withdrawal by Subject|20|||
156456788|NCT03819153|564767161|FG001|Overall Study|Withdrawal by Subject|28|||
156456789|NCT03819153|564767160|FG000|Overall Study|Lost to Follow-up|23|||
156456790|NCT03819153|564767161|FG001|Overall Study|Lost to Follow-up|30|||
156456791|NCT03974178|564767162|FG000|Overall Study|Death|0|||
156456792|NCT03974178|564767163|FG001|Overall Study|Death|1|||
156456793|NCT01152450|564767164|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
156456794|NCT01152450|564767165|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
156456795|NCT01152450|564767166|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
156456796|NCT01152450|564767167|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
156456797|NCT01152450|564767168|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
156456798|NCT01152450|564767169|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
156456799|NCT01152450|564767164|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
156533994|NCT01876251|565050843|FG001|Overall Study|Participant refused further follow-up|0|||
156734928|NCT03514485|565776519|FG005|Overall Study|Lost to Follow-up|4|||
156456800|NCT01152450|564767165|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
156456801|NCT01152450|564767166|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
156456802|NCT01152450|564767167|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
156456803|NCT01152450|564767168|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
156734929|NCT03514485|565776514|FG000|Overall Study|Withdrawal by Subject|0|||
156734930|NCT03514485|565776515|FG001|Overall Study|Withdrawal by Subject|1|||
156734931|NCT03514485|565776516|FG002|Overall Study|Withdrawal by Subject|3|||
156876681|NCT03539549|566307690|FG000|Overall Study|Adverse Event|12|||
156456804|NCT01152450|564767169|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
156336612|NCT00002651|564329653|FG000|Induction|Progression/relapse|274|||
156336613|NCT00002651|564329654|FG001|Induction|Progression/relapse|0|||
156336614|NCT00002651|564329655|FG002|Induction|Progression/relapse|0|||
156336615|NCT00002651|564329653|FG000|Induction|Death|62|||
156336616|NCT00002651|564329654|FG001|Induction|Death|0|||
156336617|NCT00002651|564329655|FG002|Induction|Death|0|||
156336618|NCT00002651|564329653|FG000|Induction|Other|823|||
156336619|NCT00002651|564329654|FG001|Induction|Other|0|||
156336620|NCT00002651|564329655|FG002|Induction|Other|0|||
156336621|NCT00002651|564329653|FG000|Induction|not eligible|90|||
156336622|NCT00002651|564329654|FG001|Induction|not eligible|0|||
156336623|NCT00002651|564329655|FG002|Induction|not eligible|0|||
156336624|NCT00002651|564329653|FG000|Consolidation and Randomization|Adverse Event|0|||
156336625|NCT00002651|564329654|FG001|Consolidation and Randomization|Adverse Event|36|||
156336626|NCT00002651|564329655|FG002|Consolidation and Randomization|Adverse Event|14|||
156336627|NCT00002651|564329653|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
156336628|NCT00002651|564329654|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
156336629|NCT00002651|564329655|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
156336630|NCT00002651|564329653|FG000|Consolidation and Randomization|Progression/relapse|0|||
156336631|NCT00002651|564329654|FG001|Consolidation and Randomization|Progression/relapse|295|||
156336632|NCT00002651|564329655|FG002|Consolidation and Randomization|Progression/relapse|298|||
156336633|NCT00002651|564329653|FG000|Consolidation and Randomization|Death|0|||
156336634|NCT00002651|564329654|FG001|Consolidation and Randomization|Death|38|||
156336635|NCT00002651|564329655|FG002|Consolidation and Randomization|Death|48|||
156336636|NCT00002651|564329653|FG000|Consolidation and Randomization|Other|0|||
156336637|NCT00002651|564329654|FG001|Consolidation and Randomization|Other|314|||
156336638|NCT00002651|564329655|FG002|Consolidation and Randomization|Other|313|||
156336639|NCT00002651|564329653|FG000|Consolidation and Randomization|not eligible|0|||
156336640|NCT00002651|564329654|FG001|Consolidation and Randomization|not eligible|102|||
156336641|NCT00002651|564329655|FG002|Consolidation and Randomization|not eligible|112|||
156336642|NCT01705730|564329656|FG000|Overall Study|Lack of Efficacy|1|||
156336643|NCT01705730|564329656|FG000|Overall Study|Adverse Event|3|||
156336644|NCT01705730|564329656|FG000|Overall Study|Lost to Follow-up|1|||
156336645|NCT01705730|564329656|FG000|Overall Study|Reason not Specified|4|||
156336646|NCT01773733|564329657|FG000|Overall Study|Adverse Event|3286|||
156336647|NCT01773733|564329658|FG001|Overall Study|Adverse Event|540|||
156336648|NCT01773733|564329657|FG000|Overall Study|Pregnancy|28|||
156456805|NCT01152450|564767164|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
156456806|NCT01152450|564767165|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
156456807|NCT01152450|564767166|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
156456808|NCT01152450|564767167|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
156456809|NCT01152450|564767168|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
156456810|NCT01152450|564767169|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
156456811|NCT05670587|564767170|FG000|Overall Study|Withdrawal by Subject|3|||
156456812|NCT01544114|564767176|FG000|Overall Study|Withdrawal by Subject|0|||
156456813|NCT01544114|564767177|FG001|Overall Study|Withdrawal by Subject|0|||
156456814|NCT01544114|564767178|FG002|Overall Study|Withdrawal by Subject|3|||
156456815|NCT01544114|564767176|FG000|Overall Study|Lost to Follow-up|0|||
156456816|NCT01544114|564767177|FG001|Overall Study|Lost to Follow-up|2|||
156456817|NCT01544114|564767178|FG002|Overall Study|Lost to Follow-up|0|||
156456818|NCT01544114|564767176|FG000|Overall Study|Adverse Event|1|||
156456819|NCT01544114|564767177|FG001|Overall Study|Adverse Event|1|||
156456820|NCT01544114|564767178|FG002|Overall Study|Adverse Event|2|||
156456821|NCT01544114|564767176|FG000|Overall Study|Protocol Violation|0|||
156456822|NCT01544114|564767177|FG001|Overall Study|Protocol Violation|1|||
156456823|NCT01544114|564767178|FG002|Overall Study|Protocol Violation|0|||
156456824|NCT01733316|564767181|FG000|RP103 Phase|Non-compliance|1|||
156456825|NCT01733316|564767181|FG000|Long Term Extension Phase|Adverse Event|1|||
156456826|NCT01733316|564767181|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
156456827|NCT01733316|564767181|FG000|Long Term Extension Phase|Sponsor Decision|2|||
156456828|NCT05940194|564767188|FG000|Overall Study|Adverse Event|0|||
156456829|NCT05940194|564767189|FG001|Overall Study|Adverse Event|1|||
156456830|NCT05940194|564767190|FG002|Overall Study|Adverse Event|0|||
156734932|NCT03514485|565776517|FG003|Overall Study|Withdrawal by Subject|1|||
156734933|NCT03514485|565776518|FG004|Overall Study|Withdrawal by Subject|2|||
156336649|NCT01773733|564329658|FG001|Overall Study|Pregnancy|0|||
156336650|NCT01773733|564329657|FG000|Overall Study|Other different categories of not compl|55415|||
156336651|NCT01773733|564329658|FG001|Overall Study|Other different categories of not compl|7781|||
156456831|NCT05940194|564767188|FG000|Overall Study|Migrated/Moved from the study area|2|||
156456832|NCT05940194|564767189|FG001|Overall Study|Migrated/Moved from the study area|2|||
156336652|NCT03345914|564329660|FG000|Overall Study|Transition to another study at week 16|80|||
156336653|NCT03345914|564329661|FG001|Overall Study|Transition to another study at week 16|86|||
156456833|NCT05940194|564767190|FG002|Overall Study|Migrated/Moved from the study area|4|||
156336654|NCT03345914|564329662|FG002|Overall Study|Transition to another study at week 16|78|||
156336655|NCT03345914|564329660|FG000|Overall Study|Transition to OLE during follow-up|37|||
156336656|NCT03345914|564329661|FG001|Overall Study|Transition to OLE during follow-up|33|||
156456834|NCT04625465|564767191|FG000|Overall Study|Lost to Follow-up|2|||
156533995|NCT01876251|565050844|FG002|Overall Study|Participant refused further follow-up|1|||
156533996|NCT01876251|565050842|FG000|Overall Study|Study terminated|1|||
156533997|NCT01876251|565050843|FG001|Overall Study|Study terminated|0|||
156533998|NCT01876251|565050844|FG002|Overall Study|Study terminated|0|||
156533999|NCT01876251|565050842|FG000|Overall Study|Objective progression or relapse|10|||
156534000|NCT01876251|565050843|FG001|Overall Study|Objective progression or relapse|3|||
156534001|NCT01876251|565050844|FG002|Overall Study|Objective progression or relapse|8|||
156534002|NCT02460497|565050853|FG000|Overall Study|Participant Requested Withdrawal|4|||
156534003|NCT02460497|565050853|FG000|Overall Study|Non-Compliance|1|||
156534004|NCT02460497|565050853|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
156534005|NCT02460497|565050853|FG000|Overall Study|Lost to Follow-up|2|||
156534006|NCT02460497|565050853|FG000|Overall Study|Investigator Decision|1|||
156734934|NCT03514485|565776519|FG005|Overall Study|Withdrawal by Subject|1|||
156734935|NCT03075891|565776520|FG000|Overall Study|Withdrawal by Subject|3|||
156734936|NCT03075891|565776521|FG001|Overall Study|Withdrawal by Subject|6|||
156734937|NCT03075891|565776520|FG000|Overall Study|Lost to Follow-up|1|||
156734938|NCT03075891|565776521|FG001|Overall Study|Lost to Follow-up|0|||
156734939|NCT03075891|565776520|FG000|Overall Study|Pregnancy|3|||
156876682|NCT03539549|566307690|FG000|Overall Study|Lost to Follow-up|1|||
156456835|NCT04625465|564767192|FG001|Overall Study|Lost to Follow-up|2|||
156456836|NCT04625465|564767193|FG002|Overall Study|Lost to Follow-up|1|||
156456837|NCT04625465|564767194|FG003|Overall Study|Lost to Follow-up|0|||
156456838|NCT04625465|564767195|FG004|Overall Study|Lost to Follow-up|0|||
156456839|NCT04625465|564767196|FG005|Overall Study|Lost to Follow-up|2|||
156456840|NCT04625465|564767197|FG006|Overall Study|Lost to Follow-up|0|||
156456841|NCT04625465|564767198|FG007|Overall Study|Lost to Follow-up|0|||
156456842|NCT04625465|564767191|FG000|Overall Study|Death|1|||
156456843|NCT04625465|564767192|FG001|Overall Study|Death|0|||
156456844|NCT04625465|564767193|FG002|Overall Study|Death|0|||
156456845|NCT04625465|564767194|FG003|Overall Study|Death|0|||
156456846|NCT04625465|564767195|FG004|Overall Study|Death|0|||
156456847|NCT04625465|564767196|FG005|Overall Study|Death|0|||
156456848|NCT04625465|564767197|FG006|Overall Study|Death|0|||
156456849|NCT04625465|564767198|FG007|Overall Study|Death|0|||
156456850|NCT04625465|564767191|FG000|Overall Study|Withdrawal by Subject|1|||
156456851|NCT04625465|564767192|FG001|Overall Study|Withdrawal by Subject|0|||
156456852|NCT04625465|564767193|FG002|Overall Study|Withdrawal by Subject|4|||
156456853|NCT04625465|564767194|FG003|Overall Study|Withdrawal by Subject|4|||
156456854|NCT04625465|564767195|FG004|Overall Study|Withdrawal by Subject|4|||
156456855|NCT04625465|564767196|FG005|Overall Study|Withdrawal by Subject|0|||
156456856|NCT04625465|564767197|FG006|Overall Study|Withdrawal by Subject|0|||
156456857|NCT04625465|564767198|FG007|Overall Study|Withdrawal by Subject|0|||
156456858|NCT04753697|564767201|FG000|Induction Phase|Withdrawal by Subject|12|||
156456859|NCT04753697|564767202|FG001|Induction Phase|Withdrawal by Subject|5|||
156456860|NCT04753697|564767203|FG002|Induction Phase|Withdrawal by Subject|6|||
156456861|NCT04753697|564767201|FG000|Induction Phase|Physician Decision|1|||
156456862|NCT04753697|564767202|FG001|Induction Phase|Physician Decision|0|||
156456863|NCT04753697|564767203|FG002|Induction Phase|Physician Decision|0|||
156456864|NCT04753697|564767201|FG000|Induction Phase|Lost to Follow-up|2|||
156456865|NCT04753697|564767202|FG001|Induction Phase|Lost to Follow-up|2|||
156456866|NCT04753697|564767203|FG002|Induction Phase|Lost to Follow-up|1|||
156456867|NCT04753697|564767201|FG000|Induction Phase|Lack of Efficacy|1|||
156456868|NCT04753697|564767202|FG001|Induction Phase|Lack of Efficacy|0|||
156456869|NCT04753697|564767203|FG002|Induction Phase|Lack of Efficacy|0|||
156456870|NCT04753697|564767201|FG000|Maintenance Phase|Physician Decision|0|||
156456871|NCT04753697|564767202|FG001|Maintenance Phase|Physician Decision|0|||
156456872|NCT04753697|564767203|FG002|Maintenance Phase|Physician Decision|1|||
156456873|NCT04753697|564767201|FG000|Maintenance Phase|Withdrawal by Subject|3|||
156456874|NCT04753697|564767202|FG001|Maintenance Phase|Withdrawal by Subject|4|||
156456875|NCT04753697|564767203|FG002|Maintenance Phase|Withdrawal by Subject|6|||
156456876|NCT04753697|564767201|FG000|Maintenance Phase|Lost to Follow-up|2|||
156456877|NCT04753697|564767202|FG001|Maintenance Phase|Lost to Follow-up|2|||
156456878|NCT04753697|564767203|FG002|Maintenance Phase|Lost to Follow-up|0|||
156534007|NCT02012296|565050854|FG000|Overall Study|Lack of Efficacy|0|||
156734940|NCT03075891|565776521|FG001|Overall Study|Pregnancy|1|||
156456879|NCT04753697|564767201|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
156456880|NCT04753697|564767202|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
156534008|NCT02012296|565050855|FG001|Overall Study|Lack of Efficacy|0|||
156534009|NCT02012296|565050856|FG002|Overall Study|Lack of Efficacy|15|||
156734941|NCT03075891|565776520|FG000|Overall Study|visits not performed (no time)|1|||
156456881|NCT04753697|564767203|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
156456882|NCT04753697|564767201|FG000|Maintenance Phase|Adverse Event|0|||
156456883|NCT04753697|564767202|FG001|Maintenance Phase|Adverse Event|1|||
156456884|NCT04753697|564767203|FG002|Maintenance Phase|Adverse Event|1|||
156456885|NCT04753697|564767201|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
156534010|NCT02012296|565050854|FG000|Overall Study|Adverse Event|0|||
156534011|NCT02012296|565050855|FG001|Overall Study|Adverse Event|0|||
156534012|NCT02012296|565050856|FG002|Overall Study|Adverse Event|2|||
156534013|NCT02012296|565050854|FG000|Overall Study|Early study closure|0|||
156534014|NCT02012296|565050855|FG001|Overall Study|Early study closure|0|||
156734942|NCT03075891|565776521|FG001|Overall Study|visits not performed (no time)|0|||
156734943|NCT03075891|565776520|FG000|Overall Study|Drug abuse relapse issue|0|||
156534015|NCT02012296|565050856|FG002|Overall Study|Early study closure|5|||
156534016|NCT02012296|565050854|FG000|Overall Study|Protocol Violation|0|||
156734944|NCT03075891|565776521|FG001|Overall Study|Drug abuse relapse issue|1|||
156734945|NCT03075891|565776520|FG000|Overall Study|Participant requiring study withdrawal|0|||
156734946|NCT03075891|565776521|FG001|Overall Study|Participant requiring study withdrawal|1|||
156734947|NCT03075891|565776520|FG000|Overall Study|Adverse event, non-fatal|1|||
156734948|NCT03075891|565776521|FG001|Overall Study|Adverse event, non-fatal|4|||
156734949|NCT02387957|565776525|FG000|Overall Study|The study was discontinued|21|||
156534017|NCT02012296|565050855|FG001|Overall Study|Protocol Violation|1|||
156534018|NCT02012296|565050856|FG002|Overall Study|Protocol Violation|0|||
156534019|NCT03876171|565050857|FG000|Overall Study|Withdrawal by Subject|3|||
156534020|NCT03876171|565050858|FG001|Overall Study|Withdrawal by Subject|3|||
156534021|NCT03876171|565050857|FG000|Overall Study|Re-arrest|0|||
156534022|NCT03876171|565050858|FG001|Overall Study|Re-arrest|4|||
156534023|NCT00727649|565050861|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
156534024|NCT00727649|565050862|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
156534025|NCT00727649|565050861|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
156534026|NCT00727649|565050862|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
156534027|NCT00727649|565050861|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
156734950|NCT02387957|565776526|FG001|Overall Study|The study was discontinued|21|||
156734951|NCT02387957|565776527|FG002|Overall Study|The study was discontinued|20|||
156534028|NCT00727649|565050862|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
156534029|NCT00727649|565050861|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
156534030|NCT00727649|565050862|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
156534031|NCT00727649|565050861|FG000|Second Intervention (4-weeks)|Death|1|||
156534032|NCT00727649|565050862|FG001|Second Intervention (4-weeks)|Death|0|||
156534033|NCT00727649|565050861|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
156534034|NCT00727649|565050862|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
156534035|NCT00727649|565050861|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
156534036|NCT00727649|565050862|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
156534037|NCT02953639|565050866|FG000|Overall Study|Adverse Event|2|||
156534038|NCT02953639|565050867|FG001|Overall Study|Adverse Event|0|||
156534039|NCT02953639|565050868|FG002|Overall Study|Adverse Event|1|||
156734952|NCT02887248|565776528|FG000|Overall Study|Withdrawal by Subject|1|||
156734953|NCT02887248|565776528|FG000|Overall Study|Adverse Event|1|||
156734954|NCT02887248|565776528|FG000|Overall Study|Progressive Disease|1|||
156734955|NCT02294396|565776529|FG000|Overall Study|Adverse Event|26|||
156734956|NCT02294396|565776530|FG001|Overall Study|Adverse Event|25|||
156734957|NCT02294396|565776531|FG002|Overall Study|Adverse Event|21|||
156734958|NCT02294396|565776532|FG003|Overall Study|Adverse Event|24|||
156734959|NCT02294396|565776529|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
156734960|NCT02294396|565776530|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
156734961|NCT02294396|565776531|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
156734962|NCT02294396|565776532|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
156734963|NCT02294396|565776529|FG000|Overall Study|Withdrawal by Subject|8|||
156734964|NCT02294396|565776530|FG001|Overall Study|Withdrawal by Subject|6|||
156734965|NCT02294396|565776531|FG002|Overall Study|Withdrawal by Subject|6|||
156734966|NCT02294396|565776532|FG003|Overall Study|Withdrawal by Subject|8|||
156734967|NCT02294396|565776529|FG000|Overall Study|Lost to Follow-up|0|||
156734968|NCT02294396|565776530|FG001|Overall Study|Lost to Follow-up|0|||
156734969|NCT02294396|565776531|FG002|Overall Study|Lost to Follow-up|1|||
156734970|NCT02294396|565776532|FG003|Overall Study|Lost to Follow-up|1|||
156734971|NCT02294396|565776529|FG000|Overall Study|Protocol Deviation|3|||
156734972|NCT02294396|565776530|FG001|Overall Study|Protocol Deviation|2|||
156734973|NCT02294396|565776531|FG002|Overall Study|Protocol Deviation|2|||
156876683|NCT03539549|566307690|FG000|Overall Study|Death|2|||
156534040|NCT02953639|565050866|FG000|Overall Study|Lost to Follow-up|8|||
156534041|NCT02953639|565050867|FG001|Overall Study|Lost to Follow-up|4|||
156534042|NCT02953639|565050868|FG002|Overall Study|Lost to Follow-up|3|||
156534043|NCT02953639|565050866|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156734974|NCT02294396|565776532|FG003|Overall Study|Protocol Deviation|1|||
156876684|NCT03539549|566307690|FG000|Overall Study|Progressive Disease|1|||
156534044|NCT02953639|565050867|FG001|Overall Study|Non-Compliance With Study Drug|2|||
156534045|NCT02953639|565050868|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156734975|NCT02294396|565776529|FG000|Overall Study|Miscellaneous|2|||
156734976|NCT02294396|565776530|FG001|Overall Study|Miscellaneous|0|||
156734977|NCT02294396|565776531|FG002|Overall Study|Miscellaneous|5|||
156734978|NCT02294396|565776532|FG003|Overall Study|Miscellaneous|2|||
156734979|NCT01500187|565776535|FG000|Overall Study|Lost to Follow-up|6|||
156734980|NCT01500187|565776536|FG001|Overall Study|Lost to Follow-up|0|||
156534046|NCT02953639|565050866|FG000|Overall Study|Multiple Reasons|1|||
156456886|NCT04753697|564767202|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
156456887|NCT04753697|564767203|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
156456888|NCT02151981|564767204|FG000|Overall Study|Death|184|||
156734981|NCT03070002|565776548|FG000|Follow up for 2 Years|Death|1|||
156734982|NCT00712543|565776551|FG000|Day 8-14|Lost to Follow-up|0|||
156734983|NCT00712543|565776552|FG001|Day 8-14|Lost to Follow-up|2|||
156734984|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
156734985|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
156734986|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
156734987|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
156734988|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
156734989|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
156734990|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
156734991|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
156734992|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
156734993|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
156734994|NCT04740827|565776553|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
156734995|NCT04740827|565776554|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
156734996|NCT02147158|565776555|FG000|Treatment Course 1|Adverse Event|1|||
156734997|NCT02147158|565776556|FG001|Treatment Course 1|Adverse Event|4|||
156734998|NCT02147158|565776557|FG002|Treatment Course 1|Adverse Event|3|||
156734999|NCT02147158|565776558|FG003|Treatment Course 1|Adverse Event|4|||
156735000|NCT02147158|565776559|FG004|Treatment Course 1|Adverse Event|1|||
156735001|NCT02147158|565776560|FG005|Treatment Course 1|Adverse Event|2|||
156735002|NCT02147158|565776555|FG000|Treatment Course 1|Lost to Follow-up|2|||
156735003|NCT02147158|565776556|FG001|Treatment Course 1|Lost to Follow-up|4|||
156735004|NCT02147158|565776557|FG002|Treatment Course 1|Lost to Follow-up|3|||
156735005|NCT02147158|565776558|FG003|Treatment Course 1|Lost to Follow-up|3|||
156735006|NCT02147158|565776559|FG004|Treatment Course 1|Lost to Follow-up|2|||
156735007|NCT02147158|565776560|FG005|Treatment Course 1|Lost to Follow-up|4|||
156735008|NCT02147158|565776555|FG000|Treatment Course 1|Protocol Violation|0|||
156735009|NCT02147158|565776556|FG001|Treatment Course 1|Protocol Violation|0|||
156735010|NCT02147158|565776557|FG002|Treatment Course 1|Protocol Violation|1|||
156735011|NCT02147158|565776558|FG003|Treatment Course 1|Protocol Violation|1|||
156735012|NCT02147158|565776559|FG004|Treatment Course 1|Protocol Violation|0|||
156735013|NCT02147158|565776560|FG005|Treatment Course 1|Protocol Violation|0|||
156735014|NCT02147158|565776555|FG000|Treatment Course 1|Withdrawal of Consent|1|||
156456889|NCT02151981|564767205|FG001|Overall Study|Death|88|||
156456890|NCT02151981|564767204|FG000|Overall Study|Lost to Follow-up|7|||
156735015|NCT02147158|565776556|FG001|Treatment Course 1|Withdrawal of Consent|1|||
156456891|NCT02151981|564767205|FG001|Overall Study|Lost to Follow-up|1|||
156735016|NCT02147158|565776557|FG002|Treatment Course 1|Withdrawal of Consent|1|||
156735017|NCT02147158|565776558|FG003|Treatment Course 1|Withdrawal of Consent|5|||
156735018|NCT02147158|565776559|FG004|Treatment Course 1|Withdrawal of Consent|3|||
156735019|NCT02147158|565776560|FG005|Treatment Course 1|Withdrawal of Consent|2|||
156735020|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Adverse Event|1|||
156735021|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Adverse Event|0|||
156735022|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Adverse Event|0|||
156735023|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Adverse Event|1|||
156735024|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Adverse Event|0|||
156735025|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Adverse Event|0|||
156735026|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
156735027|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
156735028|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
156735029|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
156735030|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
156735031|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
156735032|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
156735033|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
156735034|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
156456892|NCT02151981|564767204|FG000|Overall Study|Withdrawal by Subject|27|||
156735035|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
156735036|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
156735037|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
156735038|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
156735039|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
156735040|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
156735041|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
156735042|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
156796844|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Other|0|||
156796845|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796846|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796847|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156735043|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
156735044|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
156735045|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
156735046|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
156735047|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
156735048|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
156735049|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
156735050|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
156735051|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
156735052|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
156735053|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
156735054|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
156735055|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
156735056|NCT02147158|565776555|FG000|Treatment Course 2|Adverse Event|0|||
156735057|NCT02147158|565776556|FG001|Treatment Course 2|Adverse Event|4|||
156735058|NCT02147158|565776557|FG002|Treatment Course 2|Adverse Event|2|||
156735059|NCT02147158|565776558|FG003|Treatment Course 2|Adverse Event|1|||
156735060|NCT02147158|565776559|FG004|Treatment Course 2|Adverse Event|0|||
156735061|NCT02147158|565776560|FG005|Treatment Course 2|Adverse Event|1|||
156735062|NCT02147158|565776555|FG000|Treatment Course 2|Withdrawal of Consent|0|||
156735063|NCT02147158|565776556|FG001|Treatment Course 2|Withdrawal of Consent|1|||
156735064|NCT02147158|565776557|FG002|Treatment Course 2|Withdrawal of Consent|2|||
156735065|NCT02147158|565776558|FG003|Treatment Course 2|Withdrawal of Consent|3|||
156735066|NCT02147158|565776559|FG004|Treatment Course 2|Withdrawal of Consent|0|||
156735067|NCT02147158|565776560|FG005|Treatment Course 2|Withdrawal of Consent|0|||
156735068|NCT02147158|565776555|FG000|Treatment Course 2|Lost to Follow-up|1|||
156735069|NCT02147158|565776556|FG001|Treatment Course 2|Lost to Follow-up|0|||
156735070|NCT02147158|565776557|FG002|Treatment Course 2|Lost to Follow-up|1|||
156735071|NCT02147158|565776558|FG003|Treatment Course 2|Lost to Follow-up|1|||
156735072|NCT02147158|565776559|FG004|Treatment Course 2|Lost to Follow-up|0|||
156735073|NCT02147158|565776560|FG005|Treatment Course 2|Lost to Follow-up|1|||
156735074|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
156735075|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
156735076|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
156735077|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
156735078|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
156735079|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
156735080|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
156735081|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
156735082|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
156735083|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
156735084|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
156735085|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
156735086|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
156735087|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
156735088|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
156735089|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
156735090|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
156735091|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
156735092|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
156735093|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
156735094|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
156735095|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
156735096|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
156735097|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
156735098|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
156735099|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
156735100|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
156735101|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
156735102|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
156735103|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
156735104|NCT00940823|565776561|FG000|Overall Study|Death|8|||
156735105|NCT00940823|565776562|FG001|Overall Study|Death|12|||
156735106|NCT00940823|565776561|FG000|Overall Study|Lost to Follow-up|27|||
156735107|NCT00940823|565776562|FG001|Overall Study|Lost to Follow-up|20|||
156534047|NCT02953639|565050867|FG001|Overall Study|Multiple Reasons|0|||
156735108|NCT04520997|565776565|FG000|Overall Study|Lost to Follow-up|1|||
156735109|NCT04520997|565776566|FG001|Overall Study|Lost to Follow-up|1|||
156735110|NCT04520997|565776565|FG000|Overall Study|Withdrawal by Subject|1|||
156735111|NCT04520997|565776566|FG001|Overall Study|Withdrawal by Subject|0|||
156735112|NCT04520997|565776565|FG000|Overall Study|Not Treated|0|||
156735113|NCT04520997|565776566|FG001|Overall Study|Not Treated|1|||
156735114|NCT03689374|565776567|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
156735115|NCT03689374|565776568|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
156735116|NCT03689374|565776569|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
156735117|NCT03689374|565776567|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
156735118|NCT03689374|565776568|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
156534048|NCT02953639|565050868|FG002|Overall Study|Multiple Reasons|1|||
156534049|NCT02953639|565050866|FG000|Overall Study|Physician Decision|1|||
156534050|NCT02953639|565050867|FG001|Overall Study|Physician Decision|0|||
156534051|NCT02953639|565050868|FG002|Overall Study|Physician Decision|0|||
156534052|NCT02953639|565050866|FG000|Overall Study|Withdrawal by Subject|7|||
156534053|NCT02953639|565050867|FG001|Overall Study|Withdrawal by Subject|8|||
156534054|NCT02953639|565050868|FG002|Overall Study|Withdrawal by Subject|10|||
156534055|NCT02953639|565050866|FG000|Overall Study|Completed or Discontinued information is missing|1|||
156534056|NCT02953639|565050867|FG001|Overall Study|Completed or Discontinued information is missing|0|||
156534057|NCT02953639|565050868|FG002|Overall Study|Completed or Discontinued information is missing|0|||
156534058|NCT01830855|565050869|FG000|Overall Study|Other|7|||
156534059|NCT01830855|565050870|FG001|Overall Study|Other|1|||
156534060|NCT01830855|565050871|FG002|Overall Study|Other|4|||
156534061|NCT01830855|565050872|FG003|Overall Study|Other|4|||
156534062|NCT01830855|565050869|FG000|Overall Study|Medication error without associated AE|1|||
156534063|NCT01830855|565050870|FG001|Overall Study|Medication error without associated AE|0|||
156534064|NCT01830855|565050871|FG002|Overall Study|Medication error without associated AE|0|||
156534065|NCT01830855|565050872|FG003|Overall Study|Medication error without associated AE|1|||
156534066|NCT01830855|565050869|FG000|Overall Study|Pregnancy|3|||
156534067|NCT01830855|565050870|FG001|Overall Study|Pregnancy|1|||
156534068|NCT01830855|565050871|FG002|Overall Study|Pregnancy|2|||
156534069|NCT01830855|565050872|FG003|Overall Study|Pregnancy|1|||
156534070|NCT01830855|565050869|FG000|Overall Study|No longer meets eligibility criteria|11|||
156534071|NCT01830855|565050870|FG001|Overall Study|No longer meets eligibility criteria|2|||
156534072|NCT01830855|565050871|FG002|Overall Study|No longer meets eligibility criteria|3|||
156534073|NCT01830855|565050872|FG003|Overall Study|No longer meets eligibility criteria|5|||
156534074|NCT01830855|565050869|FG000|Overall Study|Adverse Event|11|||
156534075|NCT01830855|565050870|FG001|Overall Study|Adverse Event|5|||
156534076|NCT01830855|565050871|FG002|Overall Study|Adverse Event|6|||
156534077|NCT01830855|565050872|FG003|Overall Study|Adverse Event|3|||
156534078|NCT01830855|565050869|FG000|Overall Study|Protocol deviation|10|||
156534079|NCT01830855|565050870|FG001|Overall Study|Protocol deviation|5|||
156534080|NCT01830855|565050871|FG002|Overall Study|Protocol deviation|6|||
156534081|NCT01830855|565050872|FG003|Overall Study|Protocol deviation|6|||
156534082|NCT01830855|565050869|FG000|Overall Study|Withdrawal by Subject|33|||
156534083|NCT01830855|565050870|FG001|Overall Study|Withdrawal by Subject|14|||
156534084|NCT01830855|565050871|FG002|Overall Study|Withdrawal by Subject|10|||
156534085|NCT01830855|565050872|FG003|Overall Study|Withdrawal by Subject|12|||
156534086|NCT01830855|565050869|FG000|Overall Study|No longer willing to participate|32|||
156534087|NCT01830855|565050870|FG001|Overall Study|No longer willing to participate|13|||
156534088|NCT01830855|565050871|FG002|Overall Study|No longer willing to participate|12|||
156534089|NCT01830855|565050872|FG003|Overall Study|No longer willing to participate|17|||
156534090|NCT01830855|565050869|FG000|Overall Study|Lost to Follow-up|47|||
156534091|NCT01830855|565050870|FG001|Overall Study|Lost to Follow-up|20|||
156534092|NCT01830855|565050871|FG002|Overall Study|Lost to Follow-up|23|||
156534093|NCT01830855|565050872|FG003|Overall Study|Lost to Follow-up|33|||
156534094|NCT01667081|565050873|FG000|Overall Study|Death|43|||
156735119|NCT03689374|565776569|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
156735120|NCT03689374|565776567|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
156735121|NCT03689374|565776568|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
156735122|NCT03689374|565776569|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
156735123|NCT03689374|565776567|FG000|Treatment Period (Week 0 to 52)|Death|0|||
156735124|NCT03689374|565776568|FG001|Treatment Period (Week 0 to 52)|Death|11|||
156735125|NCT03689374|565776569|FG002|Treatment Period (Week 0 to 52)|Death|1|||
156735126|NCT04420585|565778357|FG000|Overall Study|Adverse Event|1|||
156735127|NCT04420585|565778357|FG000|Overall Study|Never initiated medication|2|||
156735128|NCT00477750|565778359|FG000|Overall Study|Currently Receiving Treatment|11|||
156735129|NCT00601172|565778360|FG000|Overall Study|Adverse Event|43|||
156735130|NCT00601172|565778361|FG001|Overall Study|Adverse Event|32|||
156735131|NCT00601172|565778360|FG000|Overall Study|Lack of Efficacy|11|||
156534095|NCT01667081|565050874|FG001|Overall Study|Death|3|||
156534096|NCT01667081|565050873|FG000|Overall Study|Lost to Follow-up|99|||
156735132|NCT00601172|565778361|FG001|Overall Study|Lack of Efficacy|12|||
156336657|NCT03345914|564329662|FG002|Overall Study|Transition to OLE during follow-up|39|||
156534097|NCT01667081|565050874|FG001|Overall Study|Lost to Follow-up|48|||
156534098|NCT01667081|565050873|FG000|Overall Study|Physician Decision|16|||
156534099|NCT01667081|565050874|FG001|Overall Study|Physician Decision|2|||
156735133|NCT00601172|565778360|FG000|Overall Study|Protocol Violation|2|||
156534100|NCT01667081|565050873|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
156534101|NCT01667081|565050874|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
156876685|NCT03539549|566307690|FG000|Overall Study|Reason not Specified|1|||
156876686|NCT04027608|566307691|FG000|Overall Study|Withdrawal by Subject|13|||
156876687|NCT04027608|566307692|FG001|Overall Study|Withdrawal by Subject|2|||
156876688|NCT04027608|566307691|FG000|Overall Study|Protocol Violation|2|||
156876689|NCT04027608|566307692|FG001|Overall Study|Protocol Violation|1|||
156876690|NCT04027608|566307691|FG000|Overall Study|Physician Decision|1|||
156876691|NCT04027608|566307692|FG001|Overall Study|Physician Decision|0|||
156876692|NCT04027608|566307691|FG000|Overall Study|Lost to Follow-up|20|||
156876693|NCT04027608|566307692|FG001|Overall Study|Lost to Follow-up|4|||
156876694|NCT01652469|566307696|FG000|Overall Study|Withdrawal by Subject|1|||
156876695|NCT01652469|566307697|FG001|Overall Study|Withdrawal by Subject|4|||
156876696|NCT01652469|566307696|FG000|Overall Study|Lost to Follow-up|0|||
156876697|NCT01652469|566307697|FG001|Overall Study|Lost to Follow-up|2|||
156876698|NCT01049009|566307698|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
156876699|NCT01049009|566307699|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
156876700|NCT01049009|566307698|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156876701|NCT01049009|566307699|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156876702|NCT01049009|566307698|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
156876703|NCT01049009|566307699|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
156876704|NCT01049009|566307698|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
156876705|NCT01049009|566307699|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
156876706|NCT01667419|566307704|FG000|Overall Study|Reason Not Specified|1|||
156456893|NCT02151981|564767205|FG001|Overall Study|Withdrawal by Subject|21|||
156456894|NCT02151981|564767204|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156456895|NCT02151981|564767205|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156456896|NCT02151981|564767204|FG000|Overall Study|Other reasons|1|||
156456897|NCT02151981|564767205|FG001|Overall Study|Other reasons|2|||
156456898|NCT05446168|564767206|FG000|Overall Study|Physician Decision|0|||
156456899|NCT05446168|564767207|FG001|Overall Study|Physician Decision|1|||
156456900|NCT01129102|564769854|FG000|Overall Study|No study drug treatment|2|||
156456901|NCT01129102|564769855|FG001|Overall Study|No study drug treatment|3|||
156456902|NCT01129102|564769856|FG002|Overall Study|No study drug treatment|1|||
156456903|NCT01129102|564769854|FG000|Overall Study|Withdrawal by Subject|2|||
156456904|NCT01129102|564769855|FG001|Overall Study|Withdrawal by Subject|0|||
156456905|NCT01129102|564769856|FG002|Overall Study|Withdrawal by Subject|3|||
156456906|NCT01129102|564769854|FG000|Overall Study|Protocol Violation|0|||
156456907|NCT01129102|564769855|FG001|Overall Study|Protocol Violation|1|||
156456908|NCT01129102|564769856|FG002|Overall Study|Protocol Violation|1|||
156456909|NCT01129102|564769854|FG000|Overall Study|Pregnancy|0|||
156456910|NCT01129102|564769855|FG001|Overall Study|Pregnancy|0|||
156456911|NCT01129102|564769856|FG002|Overall Study|Pregnancy|1|||
156456912|NCT01129102|564769854|FG000|Overall Study|Adverse Event|2|||
156456913|NCT01129102|564769855|FG001|Overall Study|Adverse Event|2|||
156456914|NCT01129102|564769856|FG002|Overall Study|Adverse Event|1|||
156456915|NCT01129102|564769854|FG000|Overall Study|Lost to Follow-up|2|||
156456916|NCT01129102|564769855|FG001|Overall Study|Lost to Follow-up|0|||
156456917|NCT01129102|564769856|FG002|Overall Study|Lost to Follow-up|0|||
156456918|NCT03381196|564769857|FG000|Overall Study|Withdrawal by Subject|7|||
156456919|NCT03381196|564769858|FG001|Overall Study|Withdrawal by Subject|7|||
156456920|NCT03381196|564769857|FG000|Overall Study|Other|0|||
156456921|NCT03381196|564769858|FG001|Overall Study|Other|1|||
156456922|NCT03381196|564769857|FG000|Overall Study|Lost to Follow-up|5|||
156456923|NCT03381196|564769858|FG001|Overall Study|Lost to Follow-up|4|||
156456924|NCT03381196|564769857|FG000|Overall Study|Death|0|||
156456925|NCT03381196|564769858|FG001|Overall Study|Death|1|||
156456926|NCT03381196|564769857|FG000|Overall Study|Adverse Event|1|||
156456927|NCT03381196|564769858|FG001|Overall Study|Adverse Event|0|||
156456928|NCT03381196|564769857|FG000|Overall Study|Randomized, not treated|3|||
156456929|NCT03381196|564769858|FG001|Overall Study|Randomized, not treated|6|||
156456930|NCT03854227|564769862|FG000|Overall Study|Adverse Event|0|||
156456931|NCT03854227|564769863|FG001|Overall Study|Adverse Event|0|||
156456932|NCT03854227|564769864|FG002|Overall Study|Adverse Event|0|||
156456933|NCT03854227|564769865|FG003|Overall Study|Adverse Event|1|||
156456934|NCT03854227|564769866|FG004|Overall Study|Adverse Event|0|||
156456935|NCT03854227|564769867|FG005|Overall Study|Adverse Event|0|||
156456936|NCT03854227|564769868|FG006|Overall Study|Adverse Event|1|||
156456937|NCT03854227|564769869|FG007|Overall Study|Adverse Event|0|||
156456938|NCT03854227|564769870|FG008|Overall Study|Adverse Event|0|||
156456939|NCT03854227|564769871|FG009|Overall Study|Adverse Event|3|||
156534102|NCT01667081|565050873|FG000|Overall Study|Withdrawal by Subject|90|||
156456940|NCT03854227|564769872|FG010|Overall Study|Adverse Event|0|||
156456941|NCT03854227|564769873|FG011|Overall Study|Adverse Event|1|||
156876707|NCT01667419|566307705|FG001|Overall Study|Reason Not Specified|0|||
156876708|NCT01667419|566307706|FG002|Overall Study|Reason Not Specified|0|||
156876709|NCT01667419|566307707|FG003|Overall Study|Reason Not Specified|0|||
156456942|NCT03854227|564769862|FG000|Overall Study|Death|0|||
156456943|NCT03854227|564769863|FG001|Overall Study|Death|0|||
156876710|NCT01667419|566307704|FG000|Overall Study|Withdrawal by Subject|16|||
156456944|NCT03854227|564769864|FG002|Overall Study|Death|0|||
156456945|NCT03854227|564769865|FG003|Overall Study|Death|0|||
156456946|NCT03854227|564769866|FG004|Overall Study|Death|0|||
156456947|NCT03854227|564769867|FG005|Overall Study|Death|1|||
156456948|NCT03854227|564769868|FG006|Overall Study|Death|0|||
156456949|NCT03854227|564769869|FG007|Overall Study|Death|0|||
156456950|NCT03854227|564769870|FG008|Overall Study|Death|0|||
156735134|NCT00601172|565778361|FG001|Overall Study|Protocol Violation|5|||
156735135|NCT00601172|565778360|FG000|Overall Study|Lost to Follow-up|4|||
156735136|NCT00601172|565778361|FG001|Overall Study|Lost to Follow-up|3|||
156735137|NCT00601172|565778360|FG000|Overall Study|Physician Decision|27|||
156735138|NCT00601172|565778361|FG001|Overall Study|Physician Decision|28|||
156735139|NCT00601172|565778360|FG000|Overall Study|Withdrawal by Subject|35|||
156456951|NCT03854227|564769871|FG009|Overall Study|Death|1|||
156456952|NCT03854227|564769872|FG010|Overall Study|Death|0|||
156456953|NCT03854227|564769873|FG011|Overall Study|Death|1|||
156456954|NCT03854227|564769862|FG000|Overall Study|Physician Decision|0|||
156456955|NCT03854227|564769863|FG001|Overall Study|Physician Decision|0|||
156456956|NCT03854227|564769864|FG002|Overall Study|Physician Decision|0|||
156456957|NCT03854227|564769865|FG003|Overall Study|Physician Decision|0|||
156456958|NCT03854227|564769866|FG004|Overall Study|Physician Decision|0|||
156456959|NCT03854227|564769867|FG005|Overall Study|Physician Decision|1|||
156456960|NCT03854227|564769868|FG006|Overall Study|Physician Decision|0|||
156456961|NCT03854227|564769869|FG007|Overall Study|Physician Decision|0|||
156456962|NCT03854227|564769870|FG008|Overall Study|Physician Decision|1|||
156456963|NCT03854227|564769871|FG009|Overall Study|Physician Decision|1|||
156456964|NCT03854227|564769872|FG010|Overall Study|Physician Decision|0|||
156456965|NCT03854227|564769873|FG011|Overall Study|Physician Decision|1|||
156456966|NCT03854227|564769862|FG000|Overall Study|Progressive disease|1|||
156456967|NCT03854227|564769863|FG001|Overall Study|Progressive disease|1|||
156456968|NCT03854227|564769864|FG002|Overall Study|Progressive disease|1|||
156456969|NCT03854227|564769865|FG003|Overall Study|Progressive disease|2|||
156456970|NCT03854227|564769866|FG004|Overall Study|Progressive disease|3|||
156456971|NCT03854227|564769867|FG005|Overall Study|Progressive disease|1|||
156456972|NCT03854227|564769868|FG006|Overall Study|Progressive disease|2|||
156456973|NCT03854227|564769869|FG007|Overall Study|Progressive disease|5|||
156456974|NCT03854227|564769870|FG008|Overall Study|Progressive disease|2|||
156456975|NCT03854227|564769871|FG009|Overall Study|Progressive disease|5|||
156456976|NCT03854227|564769872|FG010|Overall Study|Progressive disease|1|||
156456977|NCT03854227|564769873|FG011|Overall Study|Progressive disease|6|||
156456978|NCT03854227|564769862|FG000|Overall Study|Study terminated by sponsor|0|||
156456979|NCT03854227|564769863|FG001|Overall Study|Study terminated by sponsor|0|||
156456980|NCT03854227|564769864|FG002|Overall Study|Study terminated by sponsor|0|||
156456981|NCT03854227|564769865|FG003|Overall Study|Study terminated by sponsor|0|||
156456982|NCT03854227|564769866|FG004|Overall Study|Study terminated by sponsor|0|||
156456983|NCT03854227|564769867|FG005|Overall Study|Study terminated by sponsor|0|||
156456984|NCT03854227|564769868|FG006|Overall Study|Study terminated by sponsor|0|||
156456985|NCT03854227|564769869|FG007|Overall Study|Study terminated by sponsor|0|||
156456986|NCT03854227|564769870|FG008|Overall Study|Study terminated by sponsor|0|||
156456987|NCT03854227|564769871|FG009|Overall Study|Study terminated by sponsor|1|||
156456988|NCT03854227|564769872|FG010|Overall Study|Study terminated by sponsor|0|||
156456989|NCT03854227|564769873|FG011|Overall Study|Study terminated by sponsor|0|||
156456990|NCT03854227|564769862|FG000|Overall Study|Withdrawal by Subject|0|||
156456991|NCT03854227|564769863|FG001|Overall Study|Withdrawal by Subject|0|||
156456992|NCT03854227|564769864|FG002|Overall Study|Withdrawal by Subject|1|||
156456993|NCT03854227|564769865|FG003|Overall Study|Withdrawal by Subject|0|||
156456994|NCT03854227|564769866|FG004|Overall Study|Withdrawal by Subject|0|||
156456995|NCT03854227|564769867|FG005|Overall Study|Withdrawal by Subject|0|||
156456996|NCT03854227|564769868|FG006|Overall Study|Withdrawal by Subject|0|||
156456997|NCT03854227|564769869|FG007|Overall Study|Withdrawal by Subject|0|||
156456998|NCT03854227|564769870|FG008|Overall Study|Withdrawal by Subject|0|||
156456999|NCT03854227|564769871|FG009|Overall Study|Withdrawal by Subject|1|||
156457000|NCT03854227|564769872|FG010|Overall Study|Withdrawal by Subject|1|||
156735140|NCT00601172|565778361|FG001|Overall Study|Withdrawal by Subject|27|||
156735141|NCT00601172|565778360|FG000|Overall Study|Did not meet continuation criteria|19|||
156735142|NCT00601172|565778361|FG001|Overall Study|Did not meet continuation criteria|20|||
156735143|NCT04434469|565778362|FG000|Overall Study|Death|2|||
156457001|NCT03854227|564769873|FG011|Overall Study|Withdrawal by Subject|0|||
156457002|NCT03854227|564769862|FG000|Overall Study|Disease relapse|0|||
156457003|NCT03854227|564769863|FG001|Overall Study|Disease relapse|0|||
156457004|NCT03854227|564769864|FG002|Overall Study|Disease relapse|0|||
156457005|NCT03854227|564769865|FG003|Overall Study|Disease relapse|0|||
156457006|NCT03854227|564769866|FG004|Overall Study|Disease relapse|0|||
156457007|NCT03854227|564769867|FG005|Overall Study|Disease relapse|0|||
156735144|NCT04434469|565778363|FG001|Overall Study|Death|3|||
156457008|NCT03854227|564769868|FG006|Overall Study|Disease relapse|0|||
156808821|NCT01484496|566054474|FG001|Period 1|Withdrawal by Subject|12|||
156457009|NCT03854227|564769869|FG007|Overall Study|Disease relapse|0|||
156457010|NCT03854227|564769870|FG008|Overall Study|Disease relapse|1|||
156735145|NCT04434469|565778364|FG002|Overall Study|Death|2|||
156457011|NCT03854227|564769871|FG009|Overall Study|Disease relapse|0|||
156735146|NCT04434469|565778365|FG003|Overall Study|Death|2|||
156735147|NCT04434469|565778366|FG004|Overall Study|Death|2|||
156735148|NCT04434469|565778367|FG005|Overall Study|Death|0|||
156735149|NCT04434469|565778362|FG000|Overall Study|Lost to Follow-up|0|||
156735150|NCT04434469|565778363|FG001|Overall Study|Lost to Follow-up|0|||
156735151|NCT04434469|565778364|FG002|Overall Study|Lost to Follow-up|0|||
156735152|NCT04434469|565778365|FG003|Overall Study|Lost to Follow-up|1|||
156735153|NCT04434469|565778366|FG004|Overall Study|Lost to Follow-up|1|||
156735154|NCT04434469|565778367|FG005|Overall Study|Lost to Follow-up|0|||
156735155|NCT04434469|565778362|FG000|Overall Study|Study terminated by sponsor|1|||
156735156|NCT04434469|565778363|FG001|Overall Study|Study terminated by sponsor|1|||
156735157|NCT04434469|565778364|FG002|Overall Study|Study terminated by sponsor|1|||
156735158|NCT04434469|565778365|FG003|Overall Study|Study terminated by sponsor|2|||
156735159|NCT04434469|565778366|FG004|Overall Study|Study terminated by sponsor|3|||
156735160|NCT04434469|565778367|FG005|Overall Study|Study terminated by sponsor|3|||
156735161|NCT04434469|565778362|FG000|Overall Study|Withdrawal by Subject|0|||
156735162|NCT04434469|565778363|FG001|Overall Study|Withdrawal by Subject|0|||
156735163|NCT04434469|565778364|FG002|Overall Study|Withdrawal by Subject|1|||
156735164|NCT04434469|565778365|FG003|Overall Study|Withdrawal by Subject|0|||
156735165|NCT04434469|565778366|FG004|Overall Study|Withdrawal by Subject|0|||
156735166|NCT04434469|565778367|FG005|Overall Study|Withdrawal by Subject|0|||
156735167|NCT02703272|565778371|FG000|Overall Study|Death|4|||
156735168|NCT02703272|565778372|FG001|Overall Study|Death|9|||
156735169|NCT02703272|565778373|FG002|Overall Study|Death|19|||
156735170|NCT02703272|565778374|FG003|Overall Study|Death|10|||
156735171|NCT02703272|565778371|FG000|Overall Study|Withdrawal by Subject|0|||
156735172|NCT02703272|565778372|FG001|Overall Study|Withdrawal by Subject|0|||
156735173|NCT02703272|565778373|FG002|Overall Study|Withdrawal by Subject|4|||
156457012|NCT03854227|564769872|FG010|Overall Study|Disease relapse|0|||
156457013|NCT03854227|564769873|FG011|Overall Study|Disease relapse|0|||
156457014|NCT03854227|564769862|FG000|Overall Study|Global deterioration of health status|0|||
156457015|NCT03854227|564769863|FG001|Overall Study|Global deterioration of health status|0|||
156457016|NCT03854227|564769864|FG002|Overall Study|Global deterioration of health status|0|||
156457017|NCT03854227|564769865|FG003|Overall Study|Global deterioration of health status|0|||
156457018|NCT03854227|564769866|FG004|Overall Study|Global deterioration of health status|0|||
156457019|NCT03854227|564769867|FG005|Overall Study|Global deterioration of health status|1|||
156457020|NCT03854227|564769868|FG006|Overall Study|Global deterioration of health status|0|||
156457021|NCT03854227|564769869|FG007|Overall Study|Global deterioration of health status|1|||
156457022|NCT03854227|564769870|FG008|Overall Study|Global deterioration of health status|0|||
156457023|NCT03854227|564769871|FG009|Overall Study|Global deterioration of health status|0|||
156457024|NCT03854227|564769872|FG010|Overall Study|Global deterioration of health status|0|||
156457025|NCT03854227|564769873|FG011|Overall Study|Global deterioration of health status|0|||
156457026|NCT03854227|564769862|FG000|Overall Study|Refused further treatment|0|||
156457027|NCT03854227|564769863|FG001|Overall Study|Refused further treatment|0|||
156457028|NCT03854227|564769864|FG002|Overall Study|Refused further treatment|0|||
156457029|NCT03854227|564769865|FG003|Overall Study|Refused further treatment|0|||
156457030|NCT03854227|564769866|FG004|Overall Study|Refused further treatment|0|||
156457031|NCT03854227|564769867|FG005|Overall Study|Refused further treatment|0|||
156457032|NCT03854227|564769868|FG006|Overall Study|Refused further treatment|0|||
156457033|NCT03854227|564769869|FG007|Overall Study|Refused further treatment|0|||
156457034|NCT03854227|564769870|FG008|Overall Study|Refused further treatment|0|||
156457035|NCT03854227|564769871|FG009|Overall Study|Refused further treatment|1|||
156457036|NCT03854227|564769872|FG010|Overall Study|Refused further treatment|0|||
156735174|NCT02703272|565778374|FG003|Overall Study|Withdrawal by Subject|2|||
156735175|NCT02703272|565778371|FG000|Overall Study|Study Terminated by Sponsor|6|||
156735176|NCT02703272|565778372|FG001|Overall Study|Study Terminated by Sponsor|1|||
156735177|NCT02703272|565778373|FG002|Overall Study|Study Terminated by Sponsor|12|||
156735178|NCT02703272|565778374|FG003|Overall Study|Study Terminated by Sponsor|4|||
156735179|NCT02703272|565778371|FG000|Overall Study|Other|1|||
156735180|NCT02703272|565778372|FG001|Overall Study|Other|0|||
156735181|NCT02703272|565778373|FG002|Overall Study|Other|0|||
156457037|NCT03854227|564769873|FG011|Overall Study|Refused further treatment|1|||
156457038|NCT03854227|564769862|FG000|Overall Study|Other|0|||
156457039|NCT03854227|564769863|FG001|Overall Study|Other|0|||
156457040|NCT03854227|564769864|FG002|Overall Study|Other|0|||
156457041|NCT03854227|564769865|FG003|Overall Study|Other|0|||
156735182|NCT02703272|565778374|FG003|Overall Study|Other|0|||
156735183|NCT04470544|565778377|FG000|Overall Study|Withdrawal by Subject|4|||
156735184|NCT04470544|565778378|FG001|Overall Study|Withdrawal by Subject|6|||
156735185|NCT00712881|565778379|FG000|Overall Study|Adverse Event|3|||
156735186|NCT00712881|565778380|FG001|Overall Study|Adverse Event|3|||
156735187|NCT00712881|565778379|FG000|Overall Study|Withdrawal by Subject|1|||
156735188|NCT00712881|565778380|FG001|Overall Study|Withdrawal by Subject|1|||
156735189|NCT00712881|565778379|FG000|Overall Study|Disease Progression|2|||
156735190|NCT00712881|565778380|FG001|Overall Study|Disease Progression|1|||
156735191|NCT00712881|565778379|FG000|Overall Study|Lost to Follow-up|1|||
156534103|NCT01667081|565050874|FG001|Overall Study|Withdrawal by Subject|35|||
156534104|NCT03034460|565050875|FG000|Overall Study|Adverse Event|0|||
156534105|NCT03034460|565050876|FG001|Overall Study|Adverse Event|1|||
156534106|NCT03034460|565050875|FG000|Overall Study|Withdrawal by Subject|2|||
156534107|NCT03034460|565050876|FG001|Overall Study|Withdrawal by Subject|2|||
156534108|NCT03034460|565050875|FG000|Overall Study|Personal Reasons|1|||
156534109|NCT03034460|565050876|FG001|Overall Study|Personal Reasons|0|||
156534110|NCT00295633|565050879|FG000|Overall Study|Lack of Efficacy|19|||
156534111|NCT00295633|565050880|FG001|Overall Study|Lack of Efficacy|7|||
156534112|NCT00295633|565050881|FG002|Overall Study|Lack of Efficacy|16|||
156534113|NCT00295633|565050879|FG000|Overall Study|Withdrawal of consent by subject|16|||
156534114|NCT00295633|565050880|FG001|Overall Study|Withdrawal of consent by subject|16|||
156534115|NCT00295633|565050881|FG002|Overall Study|Withdrawal of consent by subject|26|||
156534116|NCT00295633|565050879|FG000|Overall Study|Adverse Event|9|||
156534117|NCT00295633|565050880|FG001|Overall Study|Adverse Event|17|||
156534118|NCT00295633|565050881|FG002|Overall Study|Adverse Event|9|||
156534119|NCT00295633|565050879|FG000|Overall Study|Lost to Follow-up|6|||
156534120|NCT00295633|565050880|FG001|Overall Study|Lost to Follow-up|11|||
156534121|NCT00295633|565050881|FG002|Overall Study|Lost to Follow-up|7|||
156534122|NCT00295633|565050879|FG000|Overall Study|Physician Decision|9|||
156534123|NCT00295633|565050880|FG001|Overall Study|Physician Decision|10|||
156534124|NCT00295633|565050881|FG002|Overall Study|Physician Decision|8|||
156534125|NCT00295633|565050879|FG000|Overall Study|Poor/Noncompliance|2|||
156534126|NCT00295633|565050880|FG001|Overall Study|Poor/Noncompliance|2|||
156735192|NCT00712881|565778380|FG001|Overall Study|Lost to Follow-up|1|||
156735193|NCT00712881|565778379|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
156735194|NCT00712881|565778380|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
156735195|NCT00712881|565778379|FG000|Overall Study|Protocol Violation|1|||
156735196|NCT00712881|565778380|FG001|Overall Study|Protocol Violation|1|||
156735197|NCT00712881|565778379|FG000|Overall Study|Randomized but not treated|1|||
156735198|NCT00712881|565778380|FG001|Overall Study|Randomized but not treated|0|||
156735199|NCT01680861|565778381|FG000|Early Post-transplant Period|Protocol Violation|1|||
156735200|NCT01680861|565778382|FG001|Early Post-transplant Period|Protocol Violation|1|||
156735201|NCT04720911|565778385|FG000|Overall Study|Withdrawal by Subject|0|||
156735202|NCT04720911|565778386|FG001|Overall Study|Withdrawal by Subject|1|||
156735203|NCT04720911|565778387|FG002|Overall Study|Withdrawal by Subject|0|||
156735204|NCT00537316|565778389|FG000|Part 1|Adverse Event|7|||
156735205|NCT00537316|565778390|FG001|Part 1|Adverse Event|11|||
156534127|NCT00295633|565050881|FG002|Overall Study|Poor/Noncompliance|6|||
156534128|NCT00295633|565050879|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
156534129|NCT00295633|565050880|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
156534130|NCT00295633|565050881|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
156534131|NCT00295633|565050879|FG000|Overall Study|Death|1|||
156534132|NCT00295633|565050880|FG001|Overall Study|Death|1|||
156534133|NCT00295633|565050881|FG002|Overall Study|Death|0|||
156534134|NCT00295633|565050879|FG000|Overall Study|Administrative reason by sponsor|0|||
156534135|NCT00295633|565050880|FG001|Overall Study|Administrative reason by sponsor|0|||
156534136|NCT00295633|565050881|FG002|Overall Study|Administrative reason by sponsor|1|||
156534137|NCT01798992|565050882|FG000|Overall Study|Administrative withdrawal|0|||
156534138|NCT01798992|565050883|FG001|Overall Study|Administrative withdrawal|1|||
156534139|NCT01798992|565050884|FG002|Overall Study|Administrative withdrawal|0|||
156534140|NCT01798992|565050885|FG003|Overall Study|Administrative withdrawal|1|||
156735206|NCT00537316|565778391|FG002|Part 1|Adverse Event|8|||
156735207|NCT00537316|565778392|FG003|Part 1|Adverse Event|0|||
156735208|NCT00537316|565778393|FG004|Part 1|Adverse Event|0|||
156735209|NCT00537316|565778394|FG005|Part 1|Adverse Event|0|||
156735210|NCT00537316|565778395|FG006|Part 1|Adverse Event|0|||
156735211|NCT00537316|565778389|FG000|Part 1|Protocol defined clinical event|1|||
156735212|NCT00537316|565778390|FG001|Part 1|Protocol defined clinical event|0|||
156735213|NCT00537316|565778391|FG002|Part 1|Protocol defined clinical event|0|||
156808822|NCT01484496|566054475|FG002|Period 1|Withdrawal by Subject|0|||
156534141|NCT01798992|565050882|FG000|Overall Study|Lost to Follow-up|0|||
156534142|NCT01798992|565050883|FG001|Overall Study|Lost to Follow-up|1|||
156534143|NCT01798992|565050884|FG002|Overall Study|Lost to Follow-up|1|||
156534144|NCT01798992|565050885|FG003|Overall Study|Lost to Follow-up|0|||
156534145|NCT01798992|565050882|FG000|Overall Study|Insufficient biopsy tissue|0|||
156534146|NCT01798992|565050883|FG001|Overall Study|Insufficient biopsy tissue|0|||
156808823|NCT01484496|566054476|FG003|Period 1|Withdrawal by Subject|0|||
156808824|NCT01484496|566054473|FG000|Period 1|Lost to Follow-up|2|||
156808825|NCT01484496|566054474|FG001|Period 1|Lost to Follow-up|6|||
156808826|NCT01484496|566054475|FG002|Period 1|Lost to Follow-up|0|||
156808827|NCT01484496|566054476|FG003|Period 1|Lost to Follow-up|0|||
156808828|NCT01484496|566054473|FG000|Period 1|Positive Pregnancy|1|||
156808829|NCT01484496|566054474|FG001|Period 1|Positive Pregnancy|6|||
156808830|NCT01484496|566054475|FG002|Period 1|Positive Pregnancy|0|||
156808831|NCT01484496|566054476|FG003|Period 1|Positive Pregnancy|0|||
156808832|NCT01484496|566054473|FG000|Period 1|Treatment Failure|3|||
156808833|NCT01484496|566054474|FG001|Period 1|Treatment Failure|6|||
156534147|NCT01798992|565050884|FG002|Overall Study|Insufficient biopsy tissue|1|||
156735214|NCT00537316|565778392|FG003|Part 1|Protocol defined clinical event|0|||
156735215|NCT00537316|565778393|FG004|Part 1|Protocol defined clinical event|0|||
156735216|NCT00537316|565778394|FG005|Part 1|Protocol defined clinical event|0|||
156735217|NCT00537316|565778395|FG006|Part 1|Protocol defined clinical event|0|||
156457042|NCT03854227|564769866|FG004|Overall Study|Other|0|||
156457043|NCT03854227|564769867|FG005|Overall Study|Other|0|||
156457044|NCT03854227|564769868|FG006|Overall Study|Other|0|||
156457045|NCT03854227|564769869|FG007|Overall Study|Other|0|||
156457046|NCT03854227|564769870|FG008|Overall Study|Other|1|||
156457047|NCT03854227|564769871|FG009|Overall Study|Other|1|||
156457048|NCT03854227|564769872|FG010|Overall Study|Other|0|||
156735218|NCT00537316|565778389|FG000|Part 1|Lost to Follow-up|1|||
156735219|NCT00537316|565778390|FG001|Part 1|Lost to Follow-up|0|||
156735220|NCT00537316|565778391|FG002|Part 1|Lost to Follow-up|0|||
156735221|NCT00537316|565778392|FG003|Part 1|Lost to Follow-up|0|||
156735222|NCT00537316|565778393|FG004|Part 1|Lost to Follow-up|0|||
156735223|NCT00537316|565778394|FG005|Part 1|Lost to Follow-up|0|||
156735224|NCT00537316|565778395|FG006|Part 1|Lost to Follow-up|0|||
156735225|NCT00537316|565778389|FG000|Part 1|Withdrawal by Subject|3|||
156735226|NCT00537316|565778390|FG001|Part 1|Withdrawal by Subject|8|||
156735227|NCT00537316|565778391|FG002|Part 1|Withdrawal by Subject|4|||
156735228|NCT00537316|565778392|FG003|Part 1|Withdrawal by Subject|0|||
156735229|NCT00537316|565778393|FG004|Part 1|Withdrawal by Subject|0|||
156735230|NCT00537316|565778394|FG005|Part 1|Withdrawal by Subject|0|||
156735231|NCT00537316|565778395|FG006|Part 1|Withdrawal by Subject|0|||
156735232|NCT00537316|565778389|FG000|Part 1|Protocol Violation|1|||
156735233|NCT00537316|565778390|FG001|Part 1|Protocol Violation|5|||
156735234|NCT00537316|565778391|FG002|Part 1|Protocol Violation|1|||
156735235|NCT00537316|565778392|FG003|Part 1|Protocol Violation|0|||
156735236|NCT00537316|565778393|FG004|Part 1|Protocol Violation|0|||
156735237|NCT00537316|565778394|FG005|Part 1|Protocol Violation|0|||
156735238|NCT00537316|565778395|FG006|Part 1|Protocol Violation|0|||
156735239|NCT00537316|565778389|FG000|Part 1|Did not meet protocol eligibility|1|||
156735240|NCT00537316|565778390|FG001|Part 1|Did not meet protocol eligibility|3|||
156735241|NCT00537316|565778391|FG002|Part 1|Did not meet protocol eligibility|2|||
156735242|NCT00537316|565778392|FG003|Part 1|Did not meet protocol eligibility|0|||
156735243|NCT00537316|565778393|FG004|Part 1|Did not meet protocol eligibility|0|||
156735244|NCT00537316|565778394|FG005|Part 1|Did not meet protocol eligibility|0|||
156457049|NCT03854227|564769873|FG011|Overall Study|Other|0|||
156457050|NCT04676763|564769874|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
156457051|NCT04676763|564769875|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
156457052|NCT04676763|564769876|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
156457053|NCT04676763|564769874|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
156457054|NCT04676763|564769875|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
156457055|NCT04676763|564769876|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
156457056|NCT04676763|564769874|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
156457057|NCT04676763|564769875|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
156457058|NCT04676763|564769876|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
156457059|NCT04119843|564769883|FG000|Overall Study|Adverse Event|3|||
156457060|NCT04119843|564769883|FG000|Overall Study|Death|1|||
156457061|NCT04499924|564769884|FG000|Overall Study|Study termination by sponsor|4|||
156457062|NCT04499924|564769885|FG001|Overall Study|Study termination by sponsor|6|||
156457063|NCT04499924|564769884|FG000|Overall Study|Withdrawal by Subject|1|||
156457064|NCT04499924|564769885|FG001|Overall Study|Withdrawal by Subject|3|||
156457065|NCT04225273|564769886|FG000|Overall Study|Lost to Follow-up|3|||
156457066|NCT03652389|564769887|FG000|Overall Study|Lost to Follow-up|1|||
156457067|NCT03652389|564769888|FG001|Overall Study|Lost to Follow-up|5|||
156735245|NCT00537316|565778395|FG006|Part 1|Did not meet protocol eligibility|0|||
156735246|NCT00537316|565778389|FG000|Part 1|Administrative|0|||
156735247|NCT00537316|565778390|FG001|Part 1|Administrative|0|||
156735248|NCT00537316|565778391|FG002|Part 1|Administrative|2|||
156735249|NCT00537316|565778392|FG003|Part 1|Administrative|0|||
156735250|NCT00537316|565778393|FG004|Part 1|Administrative|0|||
156735251|NCT00537316|565778394|FG005|Part 1|Administrative|0|||
156735252|NCT00537316|565778395|FG006|Part 1|Administrative|0|||
156735253|NCT00537316|565778389|FG000|Part 2|Never entered follow-up|0|||
156735254|NCT00537316|565778390|FG001|Part 2|Never entered follow-up|0|||
156735255|NCT00537316|565778391|FG002|Part 2|Never entered follow-up|0|||
156735256|NCT00537316|565778392|FG003|Part 2|Never entered follow-up|0|||
156735257|NCT00537316|565778393|FG004|Part 2|Never entered follow-up|0|||
156735258|NCT00537316|565778394|FG005|Part 2|Never entered follow-up|0|||
156457068|NCT03652389|564769887|FG000|Overall Study|Withdrawal by Subject|5|||
156457069|NCT03652389|564769888|FG001|Overall Study|Withdrawal by Subject|1|||
156457070|NCT03652389|564769887|FG000|Overall Study|New diagnosis|2|||
156457071|NCT03652389|564769888|FG001|Overall Study|New diagnosis|0|||
156457072|NCT04413708|564769889|FG000|Overall Study|Lost to Follow-up|1|||
156457073|NCT04413708|564769890|FG001|Overall Study|Lost to Follow-up|2|||
156735259|NCT00537316|565778395|FG006|Part 2|Never entered follow-up|1|||
156735260|NCT00537316|565778389|FG000|Part 2|Adverse Event|4|||
156735261|NCT00537316|565778390|FG001|Part 2|Adverse Event|0|||
156876711|NCT01667419|566307705|FG001|Overall Study|Withdrawal by Subject|8|||
156876712|NCT01667419|566307706|FG002|Overall Study|Withdrawal by Subject|9|||
156876713|NCT01667419|566307707|FG003|Overall Study|Withdrawal by Subject|8|||
156336658|NCT03345914|564329660|FG000|Overall Study|Physician Decision|0|||
156336659|NCT03345914|564329661|FG001|Overall Study|Physician Decision|1|||
156336660|NCT03345914|564329662|FG002|Overall Study|Physician Decision|1|||
156735262|NCT00537316|565778391|FG002|Part 2|Adverse Event|2|||
156735263|NCT00537316|565778392|FG003|Part 2|Adverse Event|0|||
156336661|NCT03345914|564329660|FG000|Overall Study|Withdrawal by Subject|5|||
156336662|NCT03345914|564329661|FG001|Overall Study|Withdrawal by Subject|1|||
156457074|NCT04231149|564769891|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
156457075|NCT04231149|564769892|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
156457076|NCT04231149|564769893|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
156457077|NCT04231149|564769894|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
156735264|NCT00537316|565778393|FG004|Part 2|Adverse Event|0|||
156735265|NCT00537316|565778394|FG005|Part 2|Adverse Event|0|||
156735266|NCT00537316|565778395|FG006|Part 2|Adverse Event|0|||
156735267|NCT00537316|565778389|FG000|Part 2|Lost to Follow-up|1|||
156735268|NCT00537316|565778390|FG001|Part 2|Lost to Follow-up|0|||
156735269|NCT00537316|565778391|FG002|Part 2|Lost to Follow-up|2|||
156735270|NCT00537316|565778392|FG003|Part 2|Lost to Follow-up|0|||
156735271|NCT00537316|565778393|FG004|Part 2|Lost to Follow-up|0|||
156735272|NCT00537316|565778394|FG005|Part 2|Lost to Follow-up|0|||
156735273|NCT00537316|565778395|FG006|Part 2|Lost to Follow-up|0|||
156457078|NCT04231149|564769895|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
156457079|NCT01501955|564769898|FG000|Overall Study|Withdrawal by Subject|1|||
156457080|NCT01501955|564769899|FG001|Overall Study|Withdrawal by Subject|0|||
156735274|NCT00537316|565778389|FG000|Part 2|Withdrawal by Subject|5|||
156735275|NCT00537316|565778390|FG001|Part 2|Withdrawal by Subject|1|||
156735276|NCT00537316|565778391|FG002|Part 2|Withdrawal by Subject|4|||
156735277|NCT00537316|565778392|FG003|Part 2|Withdrawal by Subject|0|||
156735278|NCT00537316|565778393|FG004|Part 2|Withdrawal by Subject|0|||
156735279|NCT00537316|565778394|FG005|Part 2|Withdrawal by Subject|0|||
156735280|NCT00537316|565778395|FG006|Part 2|Withdrawal by Subject|0|||
156735281|NCT00537316|565778389|FG000|Part 2|Administrative|16|||
156735282|NCT00537316|565778390|FG001|Part 2|Administrative|8|||
156735283|NCT00537316|565778391|FG002|Part 2|Administrative|24|||
156735284|NCT00537316|565778392|FG003|Part 2|Administrative|3|||
156735285|NCT00537316|565778393|FG004|Part 2|Administrative|1|||
156735286|NCT00537316|565778394|FG005|Part 2|Administrative|4|||
156735287|NCT00537316|565778395|FG006|Part 2|Administrative|1|||
156735288|NCT02651155|565778398|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156735289|NCT02651155|565778399|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
156735290|NCT02651155|565778398|FG000|Overall Study|Voluntary Withdrawal|5|||
156735291|NCT02651155|565778399|FG001|Overall Study|Voluntary Withdrawal|0|||
156735292|NCT01867710|565778400|FG000|Overall Study|Death|25|||
156735293|NCT01867710|565778401|FG001|Overall Study|Death|15|||
156735294|NCT01867710|565778402|FG002|Overall Study|Death|27|||
156796848|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
156796849|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
156796850|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
156796851|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796852|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796853|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796854|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796855|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796856|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796857|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Death|0|||
156796858|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Death|0|||
156796859|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Death|0|||
156796860|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Death|0|||
156796861|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Death|1|||
156796862|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Death|0|||
156796863|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Death|0|||
156796864|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Death|0|||
156336663|NCT03345914|564329662|FG002|Overall Study|Withdrawal by Subject|2|||
156336664|NCT03345914|564329660|FG000|Overall Study|Other|1|||
156457081|NCT01501955|564769898|FG000|Overall Study|Adverse Event|1|||
156457082|NCT01501955|564769899|FG001|Overall Study|Adverse Event|3|||
156457083|NCT05877976|564769900|FG000|Overall Study|Lost to Follow-up|31|||
156457084|NCT04314713|564769901|FG000|Overall Study|Lost to Follow-up|0|||
156457085|NCT04314713|564769902|FG001|Overall Study|Lost to Follow-up|0|||
156457086|NCT04314713|564769903|FG002|Overall Study|Lost to Follow-up|0|||
156457087|NCT04314713|564769904|FG003|Overall Study|Lost to Follow-up|1|||
156457088|NCT04314713|564769905|FG004|Overall Study|Lost to Follow-up|0|||
156457089|NCT04314713|564769906|FG005|Overall Study|Lost to Follow-up|0|||
156457090|NCT04907851|564769907|FG000|Overall Study|Consent withdrawn|1|||
156735295|NCT01867710|565778403|FG003|Overall Study|Death|20|||
156735296|NCT01867710|565778400|FG000|Overall Study|Lost to Follow-up|3|||
156735297|NCT01867710|565778401|FG001|Overall Study|Lost to Follow-up|4|||
156457091|NCT04907851|564769908|FG001|Overall Study|Consent withdrawn|2|||
156457092|NCT04907851|564769909|FG002|Overall Study|Consent withdrawn|0|||
156457093|NCT04907851|564769907|FG000|Overall Study|Death|5|||
156457094|NCT04907851|564769908|FG001|Overall Study|Death|15|||
156457095|NCT04907851|564769909|FG002|Overall Study|Death|10|||
156457096|NCT03656510|564769920|FG000|Overall Study|Lost to Follow-up|1|||
156457097|NCT03656510|564769921|FG001|Overall Study|Lost to Follow-up|0|||
156534148|NCT01798992|565050885|FG003|Overall Study|Insufficient biopsy tissue|0|||
156534149|NCT02294682|565050886|FG000|Overall Study|Could not swallow pills|1|||
156534150|NCT02294682|565050887|FG001|Overall Study|Could not swallow pills|0|||
156534151|NCT01516970|565050888|FG000|Overall Study|Lost to Follow-up|7|||
156534152|NCT01516970|565050889|FG001|Overall Study|Lost to Follow-up|8|||
156534153|NCT01516970|565050888|FG000|Overall Study|Adverse Event|1|||
156534154|NCT01516970|565050889|FG001|Overall Study|Adverse Event|5|||
156534155|NCT01516970|565050888|FG000|Overall Study|Withdrawal by Subject|1|||
156534156|NCT01516970|565050889|FG001|Overall Study|Withdrawal by Subject|1|||
156534157|NCT01516970|565050888|FG000|Overall Study|Other|9|||
156735298|NCT01867710|565778402|FG002|Overall Study|Lost to Follow-up|3|||
156735299|NCT01867710|565778403|FG003|Overall Study|Lost to Follow-up|2|||
156735300|NCT01867710|565778400|FG000|Overall Study|Withdrawal of consent|2|||
156735301|NCT01867710|565778401|FG001|Overall Study|Withdrawal of consent|5|||
156735302|NCT01867710|565778402|FG002|Overall Study|Withdrawal of consent|1|||
156735303|NCT01867710|565778403|FG003|Overall Study|Withdrawal of consent|2|||
156735304|NCT01867710|565778400|FG000|Overall Study|Study Terminated by Sponsor|9|||
156735305|NCT01867710|565778401|FG001|Overall Study|Study Terminated by Sponsor|13|||
156735306|NCT01867710|565778402|FG002|Overall Study|Study Terminated by Sponsor|8|||
156735307|NCT01867710|565778403|FG003|Overall Study|Study Terminated by Sponsor|16|||
156735308|NCT01867710|565778400|FG000|Overall Study|Biochemical progression|0|||
156876714|NCT01667419|566307704|FG000|Overall Study|Non-compliance|0|||
156876715|NCT01667419|566307705|FG001|Overall Study|Non-compliance|0|||
156876716|NCT01667419|566307706|FG002|Overall Study|Non-compliance|0|||
156876717|NCT01667419|566307707|FG003|Overall Study|Non-compliance|1|||
156876718|NCT01667419|566307704|FG000|Overall Study|Protocol Violation|1|||
156876719|NCT01667419|566307705|FG001|Overall Study|Protocol Violation|0|||
156876720|NCT01667419|566307706|FG002|Overall Study|Protocol Violation|0|||
156876721|NCT01667419|566307707|FG003|Overall Study|Protocol Violation|0|||
156876722|NCT01667419|566307704|FG000|Overall Study|Lost to Follow-up|7|||
156876723|NCT01667419|566307705|FG001|Overall Study|Lost to Follow-up|6|||
156876724|NCT01667419|566307706|FG002|Overall Study|Lost to Follow-up|2|||
156876725|NCT01667419|566307707|FG003|Overall Study|Lost to Follow-up|4|||
156876726|NCT01667419|566307704|FG000|Overall Study|Death|18|||
156876727|NCT01667419|566307705|FG001|Overall Study|Death|33|||
156876728|NCT01667419|566307706|FG002|Overall Study|Death|25|||
156457098|NCT03656510|564769922|FG002|Overall Study|Lost to Follow-up|0|||
156457099|NCT03656510|564769923|FG003|Overall Study|Lost to Follow-up|0|||
156457100|NCT03656510|564769924|FG004|Overall Study|Lost to Follow-up|0|||
156457101|NCT03656510|564769925|FG005|Overall Study|Lost to Follow-up|0|||
156457102|NCT03656510|564769920|FG000|Overall Study|Withdrawal by Subject|1|||
156457103|NCT03656510|564769921|FG001|Overall Study|Withdrawal by Subject|1|||
156534158|NCT01516970|565050889|FG001|Overall Study|Other|7|||
156534159|NCT01205438|565050890|FG000|Overall Study|Adverse Event|19|||
156735309|NCT01867710|565778401|FG001|Overall Study|Biochemical progression|1|||
156735310|NCT01867710|565778402|FG002|Overall Study|Biochemical progression|0|||
156735311|NCT01867710|565778403|FG003|Overall Study|Biochemical progression|0|||
156735312|NCT01867710|565778400|FG000|Overall Study|Clinical progression|0|||
156735313|NCT01867710|565778401|FG001|Overall Study|Clinical progression|0|||
156735314|NCT01867710|565778402|FG002|Overall Study|Clinical progression|1|||
156735315|NCT01867710|565778403|FG003|Overall Study|Clinical progression|0|||
156735316|NCT01867710|565778400|FG000|Overall Study|Disease progression|1|||
156735317|NCT01867710|565778401|FG001|Overall Study|Disease progression|0|||
156735318|NCT01867710|565778402|FG002|Overall Study|Disease progression|0|||
156735319|NCT01867710|565778403|FG003|Overall Study|Disease progression|0|||
156735320|NCT01867710|565778400|FG000|Overall Study|Patient decision|0|||
156735321|NCT01867710|565778401|FG001|Overall Study|Patient decision|0|||
156735322|NCT01867710|565778402|FG002|Overall Study|Patient decision|0|||
156735323|NCT01867710|565778403|FG003|Overall Study|Patient decision|1|||
156735324|NCT01867710|565778400|FG000|Overall Study|Patient to follow subsequent treatment|0|||
156735325|NCT01867710|565778401|FG001|Overall Study|Patient to follow subsequent treatment|1|||
156735326|NCT01867710|565778402|FG002|Overall Study|Patient to follow subsequent treatment|0|||
156735327|NCT01867710|565778403|FG003|Overall Study|Patient to follow subsequent treatment|0|||
156735328|NCT01867710|565778400|FG000|Overall Study|Progressive disease|1|||
156735329|NCT01867710|565778401|FG001|Overall Study|Progressive disease|0|||
156876729|NCT01667419|566307707|FG003|Overall Study|Death|26|||
156457104|NCT03656510|564769922|FG002|Overall Study|Withdrawal by Subject|0|||
156457105|NCT03656510|564769923|FG003|Overall Study|Withdrawal by Subject|1|||
156457106|NCT03656510|564769924|FG004|Overall Study|Withdrawal by Subject|0|||
156735330|NCT01867710|565778402|FG002|Overall Study|Progressive disease|0|||
156876730|NCT00856518|566307708|FG000|Overall Study|Lost to Follow-up|4|||
156876731|NCT00856518|566307709|FG001|Overall Study|Lost to Follow-up|2|||
156796865|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Death|0|||
156796866|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Death|0|||
156796867|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Death|0|||
156796868|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Death|0|||
156796869|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796870|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796871|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796872|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
156796873|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796874|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796875|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796876|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796877|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796878|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796879|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796880|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796881|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796882|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796883|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796884|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
156457107|NCT03656510|564769925|FG005|Overall Study|Withdrawal by Subject|0|||
156457108|NCT05477186|564769928|FG000|Overall Study|Vaccine not administered|0|||
156457109|NCT05477186|564769929|FG001|Overall Study|Vaccine not administered|2|||
156457110|NCT05477186|564769930|FG002|Overall Study|Vaccine not administered|1|||
156457111|NCT05477186|564769931|FG003|Overall Study|Vaccine not administered|0|||
156457112|NCT05477186|564769932|FG004|Overall Study|Vaccine not administered|1|||
156457113|NCT05477186|564769933|FG005|Overall Study|Vaccine not administered|0|||
156457114|NCT05477186|564769934|FG006|Overall Study|Vaccine not administered|0|||
156457115|NCT05477186|564769928|FG000|Overall Study|Withdrawal by Subject|1|||
156457116|NCT05477186|564769929|FG001|Overall Study|Withdrawal by Subject|0|||
156457117|NCT05477186|564769930|FG002|Overall Study|Withdrawal by Subject|0|||
156457118|NCT05477186|564769931|FG003|Overall Study|Withdrawal by Subject|0|||
156457119|NCT05477186|564769932|FG004|Overall Study|Withdrawal by Subject|0|||
156457120|NCT05477186|564769933|FG005|Overall Study|Withdrawal by Subject|1|||
156457121|NCT05477186|564769934|FG006|Overall Study|Withdrawal by Subject|0|||
156457122|NCT05477186|564769928|FG000|Overall Study|Lost to Follow-up|1|||
156457123|NCT05477186|564769929|FG001|Overall Study|Lost to Follow-up|0|||
156457124|NCT05477186|564769930|FG002|Overall Study|Lost to Follow-up|2|||
156457125|NCT05477186|564769931|FG003|Overall Study|Lost to Follow-up|1|||
156457126|NCT05477186|564769932|FG004|Overall Study|Lost to Follow-up|1|||
156457127|NCT05477186|564769933|FG005|Overall Study|Lost to Follow-up|0|||
156457128|NCT05477186|564769934|FG006|Overall Study|Lost to Follow-up|2|||
156457129|NCT03852472|564769937|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
156457130|NCT03852472|564769938|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
156457131|NCT03852472|564769939|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
156457132|NCT03852472|564769940|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
156457133|NCT03852472|564769941|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
156457134|NCT03852472|564769937|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
156457135|NCT03852472|564769938|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
156457136|NCT03852472|564769939|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
156457137|NCT03852472|564769940|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
156457138|NCT03852472|564769941|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
156457139|NCT03852472|564769937|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
156457140|NCT03852472|564769938|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
156457141|NCT03852472|564769939|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
156457142|NCT03852472|564769940|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
156457143|NCT03852472|564769941|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
156457144|NCT03852472|564769937|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
156457145|NCT03852472|564769938|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
156457146|NCT03852472|564769939|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
156457147|NCT03852472|564769940|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
156457148|NCT03852472|564769941|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
156457149|NCT03852472|564769937|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
156457150|NCT03852472|564769938|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
156457151|NCT03852472|564769939|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
156534160|NCT01205438|565050891|FG001|Overall Study|Adverse Event|17|||
156796885|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796886|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
156796887|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
156457152|NCT03852472|564769940|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
156457153|NCT03852472|564769941|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
156796888|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
156457154|NCT03852472|564769937|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
156457155|NCT03852472|564769938|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
156457156|NCT03852472|564769939|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
156457157|NCT03852472|564769940|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
156457158|NCT03852472|564769941|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
156457159|NCT03852472|564769937|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
156457160|NCT03852472|564769938|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
156457161|NCT03852472|564769939|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
156457162|NCT03852472|564769940|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
156457163|NCT03852472|564769941|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
156457164|NCT03852472|564769937|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
156457165|NCT03852472|564769938|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
156457166|NCT03852472|564769939|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
156457167|NCT03852472|564769940|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
156457168|NCT03852472|564769941|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
156876732|NCT03860259|566307719|FG000|Overall Study|Lost to Follow-up|5|||
156876733|NCT03860259|566307720|FG001|Overall Study|Lost to Follow-up|5|||
156876734|NCT03860259|566307719|FG000|Overall Study|Protocol Violation|1|||
156876735|NCT03860259|566307720|FG001|Overall Study|Protocol Violation|0|||
156876736|NCT01068600|566307721|FG000|Overall Study|Withdrawal by Subject|5|||
156876737|NCT01068600|566307722|FG001|Overall Study|Withdrawal by Subject|6|||
156876738|NCT01068600|566307721|FG000|Overall Study|Adverse Event|3|||
156876739|NCT01068600|566307722|FG001|Overall Study|Adverse Event|3|||
156876740|NCT01068600|566307721|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156876741|NCT01068600|566307722|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156876742|NCT01068600|566307721|FG000|Overall Study|Lost to Follow-up|1|||
156876743|NCT01068600|566307722|FG001|Overall Study|Lost to Follow-up|2|||
156876744|NCT01068600|566307721|FG000|Overall Study|Protocol deviation|1|||
156876745|NCT01068600|566307722|FG001|Overall Study|Protocol deviation|1|||
156876746|NCT01068600|566307721|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156876747|NCT01068600|566307722|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156876748|NCT01068600|566307721|FG000|Overall Study|Administrative problems|0|||
156876749|NCT01068600|566307722|FG001|Overall Study|Administrative problems|1|||
156876750|NCT02644109|566307723|FG000|Overall Study|Adverse Event|0|||
156876751|NCT02644109|566307724|FG001|Overall Study|Adverse Event|4|||
156876752|NCT02474069|566307725|FG000|Selection Phase (SP)|Adverse Event|8|||
156457169|NCT03852472|564769937|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
156457170|NCT03852472|564769938|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
156457171|NCT03852472|564769939|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
156457172|NCT03852472|564769940|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
156457173|NCT03852472|564769941|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
156457174|NCT03852472|564769937|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
156457175|NCT03852472|564769938|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
156457176|NCT03852472|564769939|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
156457177|NCT03852472|564769940|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
156457178|NCT03852472|564769941|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
156457179|NCT03852472|564769937|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
156457180|NCT03852472|564769938|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
156457181|NCT03852472|564769939|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
156457182|NCT03852472|564769940|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
156457183|NCT03852472|564769941|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
156457184|NCT03852472|564769937|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
156457185|NCT03852472|564769938|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
156457186|NCT03852472|564769939|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
156457187|NCT03852472|564769940|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
156457188|NCT03852472|564769941|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
156457189|NCT03852472|564769937|FG000|Period 2 - Week 44|Adverse Event|0|||
156457190|NCT03852472|564769938|FG001|Period 2 - Week 44|Adverse Event|3|||
156457191|NCT03852472|564769939|FG002|Period 2 - Week 44|Adverse Event|1|||
156735331|NCT01867710|565778403|FG003|Overall Study|Progressive disease|0|||
156735332|NCT01867710|565778400|FG000|Overall Study|Protocol Violation|0|||
156735333|NCT01867710|565778401|FG001|Overall Study|Protocol Violation|0|||
156735334|NCT01867710|565778402|FG002|Overall Study|Protocol Violation|0|||
156735335|NCT01867710|565778403|FG003|Overall Study|Protocol Violation|1|||
156876753|NCT02474069|566307726|FG001|Selection Phase (SP)|Adverse Event|0|||
156457192|NCT03852472|564769940|FG003|Period 2 - Week 44|Adverse Event|2|||
156876754|NCT02474069|566307727|FG002|Selection Phase (SP)|Adverse Event|0|||
156876755|NCT02474069|566307725|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
156876756|NCT02474069|566307726|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
156457193|NCT03852472|564769941|FG004|Period 2 - Week 44|Adverse Event|2|||
156457194|NCT03852472|564769937|FG000|Period 2 - Week 44|COVID-19 Related|0|||
156735336|NCT01867710|565778400|FG000|Overall Study|PSA-progression|0|||
156457195|NCT03852472|564769938|FG001|Period 2 - Week 44|COVID-19 Related|0|||
156457196|NCT03852472|564769939|FG002|Period 2 - Week 44|COVID-19 Related|0|||
156457197|NCT03852472|564769940|FG003|Period 2 - Week 44|COVID-19 Related|1|||
156457198|NCT03852472|564769941|FG004|Period 2 - Week 44|COVID-19 Related|0|||
156457199|NCT03852472|564769937|FG000|Period 2 - Week 44|Reason not stated|0|||
156457200|NCT03852472|564769938|FG001|Period 2 - Week 44|Reason not stated|0|||
156457201|NCT03852472|564769939|FG002|Period 2 - Week 44|Reason not stated|0|||
156457202|NCT03852472|564769940|FG003|Period 2 - Week 44|Reason not stated|0|||
156457203|NCT03852472|564769941|FG004|Period 2 - Week 44|Reason not stated|1|||
156457204|NCT01919554|564769942|FG000|Overall Study|Withdrawal by Subject|0|||
156457205|NCT01919554|564769943|FG001|Overall Study|Withdrawal by Subject|0|||
156457206|NCT01919554|564769944|FG002|Overall Study|Withdrawal by Subject|1|||
156457207|NCT01919554|564769945|FG003|Overall Study|Withdrawal by Subject|1|||
156457208|NCT02305888|564769949|FG000|Overall Study|Lost to Follow-up|0|||
156735337|NCT01867710|565778401|FG001|Overall Study|PSA-progression|1|||
156735338|NCT01867710|565778402|FG002|Overall Study|PSA-progression|0|||
156735339|NCT01867710|565778403|FG003|Overall Study|PSA-progression|0|||
156735340|NCT01867710|565778400|FG000|Overall Study|Study medication no longer effective|0|||
156735341|NCT01867710|565778401|FG001|Overall Study|Study medication no longer effective|1|||
156735342|NCT01867710|565778402|FG002|Overall Study|Study medication no longer effective|0|||
156735343|NCT01867710|565778403|FG003|Overall Study|Study medication no longer effective|0|||
156735344|NCT02048826|565778404|FG000|Overall Study|Withdrawal by Subject|1|||
156735345|NCT02048826|565778405|FG001|Overall Study|Withdrawal by Subject|0|||
156735346|NCT00526669|565778406|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
156735347|NCT00526669|565778407|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
156735348|NCT00526669|565778406|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
156735349|NCT00526669|565778407|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
156735350|NCT00526669|565778406|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
156336665|NCT03345914|564329661|FG001|Overall Study|Other|1|||
156457209|NCT02305888|564769950|FG001|Overall Study|Lost to Follow-up|0|||
156457210|NCT02305888|564769951|FG002|Overall Study|Lost to Follow-up|1|||
156457211|NCT02305888|564769949|FG000|Overall Study|Adverse Event|0|||
156457212|NCT02305888|564769950|FG001|Overall Study|Adverse Event|1|||
156457213|NCT02305888|564769951|FG002|Overall Study|Adverse Event|0|||
156457214|NCT05139810|564769952|FG000|Overall Study|Voluntary Withdrawal|2|||
156457215|NCT05139810|564769953|FG001|Overall Study|Voluntary Withdrawal|1|||
156457216|NCT05139810|564769954|FG002|Overall Study|Voluntary Withdrawal|0|||
156457217|NCT05139810|564769952|FG000|Overall Study|Pregnancy|1|||
156457218|NCT05139810|564769953|FG001|Overall Study|Pregnancy|0|||
156457219|NCT05139810|564769954|FG002|Overall Study|Pregnancy|0|||
156457220|NCT05139810|564769952|FG000|Overall Study|Roll Over to CS7|19|||
156457221|NCT05139810|564769953|FG001|Overall Study|Roll Over to CS7|44|||
156457222|NCT05139810|564769954|FG002|Overall Study|Roll Over to CS7|20|||
156457223|NCT04914676|564769959|FG000|Overall Study|Study termination|3|||
156457224|NCT04914676|564769960|FG001|Overall Study|Study termination|0|||
156457225|NCT03024437|564769961|FG000|Overall Study|Adverse Event|0|||
156457226|NCT03024437|564769962|FG001|Overall Study|Adverse Event|1|||
156457227|NCT03024437|564769963|FG002|Overall Study|Adverse Event|3|||
156457228|NCT03024437|564769964|FG003|Overall Study|Adverse Event|5|||
156457229|NCT03024437|564769965|FG004|Overall Study|Adverse Event|0|||
156457230|NCT03024437|564769961|FG000|Overall Study|Physician Decision|1|||
156457231|NCT03024437|564769962|FG001|Overall Study|Physician Decision|0|||
156457232|NCT03024437|564769963|FG002|Overall Study|Physician Decision|0|||
156457233|NCT03024437|564769964|FG003|Overall Study|Physician Decision|1|||
156457234|NCT03024437|564769965|FG004|Overall Study|Physician Decision|0|||
156457235|NCT03024437|564769961|FG000|Overall Study|Disease progression, relapse|1|||
156457236|NCT03024437|564769962|FG001|Overall Study|Disease progression, relapse|0|||
156457237|NCT03024437|564769963|FG002|Overall Study|Disease progression, relapse|0|||
156457238|NCT03024437|564769964|FG003|Overall Study|Disease progression, relapse|3|||
156457239|NCT03024437|564769965|FG004|Overall Study|Disease progression, relapse|0|||
156457240|NCT03024437|564769961|FG000|Overall Study|Disease progression, refractory disease|4|||
156457241|NCT03024437|564769962|FG001|Overall Study|Disease progression, refractory disease|4|||
156457242|NCT03024437|564769963|FG002|Overall Study|Disease progression, refractory disease|2|||
156457243|NCT03024437|564769964|FG003|Overall Study|Disease progression, refractory disease|2|||
156457244|NCT03024437|564769965|FG004|Overall Study|Disease progression, refractory disease|1|||
156534161|NCT01205438|565050892|FG002|Overall Study|Adverse Event|24|||
156534162|NCT01205438|565050890|FG000|Overall Study|Death|1|||
156735351|NCT00526669|565778407|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
156735352|NCT00526669|565778406|FG000|Combined Treatment Phase|Death|0|||
156796889|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
156336666|NCT03345914|564329662|FG002|Overall Study|Other|1|||
156336667|NCT03345914|564329660|FG000|Overall Study|Ongoing|0|||
156336668|NCT03345914|564329661|FG001|Overall Study|Ongoing|0|||
156457245|NCT03024437|564769961|FG000|Overall Study|Newly diagnosed cancer|0|||
156457246|NCT03024437|564769962|FG001|Overall Study|Newly diagnosed cancer|0|||
156534163|NCT01205438|565050891|FG001|Overall Study|Death|1|||
156336669|NCT03345914|564329662|FG002|Overall Study|Ongoing|1|||
156336670|NCT01145625|564329665|FG000|Overall Study|Lost to Follow-up|8|||
156336671|NCT01145625|564329666|FG001|Overall Study|Lost to Follow-up|9|||
156457247|NCT03024437|564769963|FG002|Overall Study|Newly diagnosed cancer|0|||
156457248|NCT03024437|564769964|FG003|Overall Study|Newly diagnosed cancer|1|||
156457249|NCT03024437|564769965|FG004|Overall Study|Newly diagnosed cancer|0|||
156457250|NCT03024437|564769961|FG000|Overall Study|Moved out of state|0|||
156457251|NCT03024437|564769962|FG001|Overall Study|Moved out of state|1|||
156457252|NCT03024437|564769963|FG002|Overall Study|Moved out of state|0|||
156457253|NCT03024437|564769964|FG003|Overall Study|Moved out of state|0|||
156457254|NCT03024437|564769965|FG004|Overall Study|Moved out of state|0|||
156457255|NCT03024437|564769961|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
156735353|NCT00526669|565778407|FG001|Combined Treatment Phase|Death|2|||
156735354|NCT02218736|565778419|FG000|Overall Study|Withdrawal by Subject|10|||
156735355|NCT02218736|565778420|FG001|Overall Study|Withdrawal by Subject|9|||
156735356|NCT02218736|565778419|FG000|Overall Study|Protocol Violation|2|||
156735357|NCT02218736|565778420|FG001|Overall Study|Protocol Violation|0|||
156457256|NCT03024437|564769962|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
156457257|NCT03024437|564769963|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
156457258|NCT03024437|564769964|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
156457259|NCT03024437|564769965|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
156457260|NCT03240016|564769968|FG000|Overall Study|Adverse Event|9|||
156457261|NCT03240016|564769968|FG000|Overall Study|Withdrawal by Subject|7|||
156457262|NCT03240016|564769968|FG000|Overall Study|Death|1|||
156457263|NCT03240016|564769968|FG000|Overall Study|Physician Decision|2|||
156457264|NCT05200403|564769969|FG000|Overall Study|Withdrawal by Subject|4|||
156457265|NCT05200403|564769970|FG001|Overall Study|Withdrawal by Subject|2|||
156457266|NCT05200403|564769971|FG002|Overall Study|Withdrawal by Subject|6|||
156457267|NCT05546411|564769972|FG000|Overall Study|Progressive Disease|1|||
156457268|NCT05546411|564769973|FG001|Overall Study|Progressive Disease|0|||
156457269|NCT05546411|564769972|FG000|Overall Study|Adverse Event|0|||
156457270|NCT05546411|564769973|FG001|Overall Study|Adverse Event|1|||
156457271|NCT05546411|564769972|FG000|Overall Study|Metastatic disease|1|||
156457272|NCT05546411|564769973|FG001|Overall Study|Metastatic disease|0|||
156457273|NCT02606422|564769974|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
156457274|NCT02606422|564769975|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
156457275|NCT02606422|564769974|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
156457276|NCT02606422|564769975|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
156457277|NCT02606422|564769974|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
156735358|NCT03452488|565778421|FG000|Overall Study|Adverse Event|4|||
156735359|NCT03452488|565778422|FG001|Overall Study|Adverse Event|6|||
156735360|NCT03452488|565778423|FG002|Overall Study|Adverse Event|1|||
156735361|NCT03452488|565778421|FG000|Overall Study|Death|0|||
156735362|NCT03452488|565778422|FG001|Overall Study|Death|0|||
156735363|NCT03452488|565778423|FG002|Overall Study|Death|1|||
156735364|NCT03452488|565778421|FG000|Overall Study|Lost to Follow-up|1|||
156735365|NCT03452488|565778422|FG001|Overall Study|Lost to Follow-up|2|||
156735366|NCT03452488|565778423|FG002|Overall Study|Lost to Follow-up|0|||
156735367|NCT03452488|565778421|FG000|Overall Study|PI Decision|1|||
156735368|NCT03452488|565778422|FG001|Overall Study|PI Decision|0|||
156796890|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796891|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796892|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796893|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Other|0|||
156796894|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Other|0|||
156796895|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Other|0|||
156796896|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Other|15|||
156796897|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Other|20|||
156796898|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Other|44|||
156796899|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Other|0|||
156796900|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Other|0|||
156796901|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Other|0|||
156796902|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Other|0|||
156796903|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Other|0|||
156796904|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Other|0|||
156796905|NCT00725985|566009671|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156336672|NCT01145625|564329665|FG000|Overall Study|Adverse Event|6|||
156457278|NCT02606422|564769975|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
156457279|NCT02606422|564769974|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
156457280|NCT02606422|564769975|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
156457281|NCT05566639|564769977|FG000|Overall Study|Adverse Event|1|||
156534164|NCT01205438|565050892|FG002|Overall Study|Death|3|||
156735369|NCT03452488|565778423|FG002|Overall Study|PI Decision|0|||
156735370|NCT03452488|565778421|FG000|Overall Study|Withdrew consent|4|||
156735371|NCT03452488|565778422|FG001|Overall Study|Withdrew consent|2|||
156796906|NCT00725985|566009672|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156808834|NCT01484496|566054475|FG002|Period 1|Treatment Failure|0|||
156457282|NCT05566639|564769978|FG001|Overall Study|Adverse Event|1|||
156457283|NCT05566639|564769977|FG000|Overall Study|Serious Adverse Event|1|||
156457284|NCT05566639|564769978|FG001|Overall Study|Serious Adverse Event|3|||
156457285|NCT05566639|564769977|FG000|Overall Study|Death|44|||
156457286|NCT05566639|564769978|FG001|Overall Study|Death|45|||
156457287|NCT05566639|564769977|FG000|Overall Study|Lost to Follow-up|467|||
156457288|NCT05566639|564769978|FG001|Overall Study|Lost to Follow-up|461|||
156457289|NCT05566639|564769977|FG000|Overall Study|Physician Decision|45|||
156457290|NCT05566639|564769978|FG001|Overall Study|Physician Decision|44|||
156457291|NCT05566639|564769977|FG000|Overall Study|Protocol Deviation|4|||
156457292|NCT05566639|564769978|FG001|Overall Study|Protocol Deviation|4|||
156457293|NCT05566639|564769977|FG000|Overall Study|Withdrawal by Subject|277|||
156457294|NCT05566639|564769978|FG001|Overall Study|Withdrawal by Subject|271|||
156457295|NCT05566639|564769977|FG000|Overall Study|Other Than Specified|52|||
156457296|NCT05566639|564769978|FG001|Overall Study|Other Than Specified|64|||
156457297|NCT04054193|564769986|FG000|Cycle 1|Physician Decision|1|||
156457298|NCT04054193|564769986|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
156457299|NCT04054193|564769986|FG000|Cycle 1|Allocated but not treated|3|||
156457300|NCT04054193|564769986|FG000|Cycles 2-3|Physician Decision|2|||
156457301|NCT04054193|564769986|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
156457302|NCT04054193|564769986|FG000|Cycles 2-3|Various reasons|17|||
156457303|NCT02966873|564769987|FG000|Overall Study|Lost to Follow-up|16|||
156457304|NCT02966873|564769988|FG001|Overall Study|Lost to Follow-up|15|||
156457305|NCT03235544|564769997|FG000|Overall Study|Death|11|||
156457306|NCT03235544|564769998|FG001|Overall Study|Death|31|||
156457307|NCT03235544|564769999|FG002|Overall Study|Death|19|||
156457308|NCT03235544|564770000|FG003|Overall Study|Death|34|||
156457309|NCT03235544|564769997|FG000|Overall Study|Lost to Follow-up|0|||
156457310|NCT03235544|564769998|FG001|Overall Study|Lost to Follow-up|1|||
156457311|NCT03235544|564769999|FG002|Overall Study|Lost to Follow-up|1|||
156457312|NCT03235544|564770000|FG003|Overall Study|Lost to Follow-up|1|||
156457313|NCT03235544|564769997|FG000|Overall Study|Withdrawal by Subject|0|||
156457314|NCT03235544|564769998|FG001|Overall Study|Withdrawal by Subject|3|||
156457315|NCT03235544|564769999|FG002|Overall Study|Withdrawal by Subject|1|||
156457316|NCT03235544|564770000|FG003|Overall Study|Withdrawal by Subject|5|||
156457317|NCT03235544|564769997|FG000|Overall Study|Disease Progression|0|||
156457318|NCT03235544|564769998|FG001|Overall Study|Disease Progression|1|||
156457319|NCT03235544|564769999|FG002|Overall Study|Disease Progression|0|||
156457320|NCT03235544|564770000|FG003|Overall Study|Disease Progression|2|||
156457321|NCT03235544|564769997|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
156457322|NCT03235544|564769998|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
156457323|NCT03235544|564769999|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
156457324|NCT03235544|564770000|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
156457325|NCT03235544|564769997|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
156457326|NCT03235544|564769998|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
156457327|NCT03235544|564769999|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
156457328|NCT03235544|564770000|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
156457329|NCT00950742|564770001|FG000|Overall Study|Other Adverse Event|1|||
156457330|NCT00950742|564770002|FG001|Overall Study|Other Adverse Event|0|||
156457331|NCT00950742|564770001|FG000|Overall Study|Withdrawal by Subject|3|||
156457332|NCT00950742|564770002|FG001|Overall Study|Withdrawal by Subject|0|||
156457333|NCT00950742|564770001|FG000|Overall Study|Progressive Disease|6|||
156457334|NCT00950742|564770002|FG001|Overall Study|Progressive Disease|2|||
156457335|NCT00950742|564770001|FG000|Overall Study|Dose limiting toxicity|6|||
156457336|NCT00950742|564770002|FG001|Overall Study|Dose limiting toxicity|0|||
156457337|NCT05436262|564770004|FG000|Pre-Randomization|Withdrawal by Subject|1|||
156457338|NCT05436262|564770005|FG001|Pre-Randomization|Withdrawal by Subject|0|||
156457339|NCT05436262|564770006|FG002|Pre-Randomization|Withdrawal by Subject|0|||
156457340|NCT05436262|564770004|FG000|Randomization|Withdrawal by Subject|0|||
156735372|NCT03452488|565778423|FG002|Overall Study|Withdrew consent|2|||
156735373|NCT03452488|565778421|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
156735374|NCT03452488|565778422|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
156735375|NCT03452488|565778423|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
156735376|NCT03452488|565778421|FG000|Overall Study|Other|0|||
156735377|NCT03452488|565778422|FG001|Overall Study|Other|2|||
156735378|NCT03452488|565778423|FG002|Overall Study|Other|2|||
156336673|NCT01145625|564329666|FG001|Overall Study|Adverse Event|4|||
156457341|NCT05436262|564770005|FG001|Randomization|Withdrawal by Subject|1|||
156457342|NCT05436262|564770006|FG002|Randomization|Withdrawal by Subject|0|||
156457343|NCT01456949|564770007|FG000|Enrollment|PI death- incomplete data|6|||
156457344|NCT01456949|564770007|FG000|Enrollment|Death|1|||
156457345|NCT01456949|564770007|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
156457346|NCT01456949|564770007|FG000|Enrollment|Physician Decision|10|||
156457347|NCT01456949|564770007|FG000|Enrollment|Withdrawal by Subject|7|||
156457348|NCT01456949|564770007|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
156735379|NCT00281632|565778426|FG000|Overall Study|Adverse Event|7|||
156735380|NCT00281632|565778426|FG000|Overall Study|Withdrawal by Subject|2|||
156735381|NCT00281632|565778426|FG000|Overall Study|Disease Progression|22|||
156735382|NCT00281632|565778426|FG000|Overall Study|Death|1|||
156735383|NCT00281632|565778426|FG000|Overall Study|Physician Decision|1|||
156735384|NCT00281632|565778426|FG000|Overall Study|Ongoing|3|||
156735385|NCT01878084|565778431|FG000|Overall Study|Physician Decision|2|||
156735386|NCT03696108|565778432|FG000|Overall Study|Physician Decision|1|||
156735387|NCT03696108|565778433|FG001|Overall Study|Physician Decision|0|||
156735388|NCT03696108|565778432|FG000|Overall Study|Withdrawal by Subject|3|||
156735389|NCT03696108|565778433|FG001|Overall Study|Withdrawal by Subject|6|||
156735390|NCT04143594|565778434|FG000|Overall Study|Withdrew consent|3|||
156735391|NCT04143594|565778435|FG001|Overall Study|Withdrew consent|10|||
156735392|NCT04143594|565778436|FG002|Overall Study|Withdrew consent|3|||
156735393|NCT04143594|565778437|FG003|Overall Study|Withdrew consent|1|||
156735394|NCT04143594|565778434|FG000|Overall Study|Lost to Follow-up|3|||
156735395|NCT04143594|565778435|FG001|Overall Study|Lost to Follow-up|5|||
156735396|NCT04143594|565778436|FG002|Overall Study|Lost to Follow-up|11|||
156735397|NCT04143594|565778437|FG003|Overall Study|Lost to Follow-up|0|||
156735398|NCT04143594|565778434|FG000|Overall Study|Investigator's discretion|2|||
156735399|NCT04143594|565778435|FG001|Overall Study|Investigator's discretion|2|||
156534165|NCT01205438|565050890|FG000|Overall Study|Entry Criteria Not Met|16|||
156534166|NCT01205438|565050891|FG001|Overall Study|Entry Criteria Not Met|15|||
156534167|NCT01205438|565050892|FG002|Overall Study|Entry Criteria Not Met|13|||
156534168|NCT01205438|565050890|FG000|Overall Study|Lack of Efficacy|14|||
156534169|NCT01205438|565050891|FG001|Overall Study|Lack of Efficacy|11|||
156534170|NCT01205438|565050892|FG002|Overall Study|Lack of Efficacy|14|||
156534171|NCT01205438|565050890|FG000|Overall Study|Lost to Follow-up|6|||
156534172|NCT01205438|565050891|FG001|Overall Study|Lost to Follow-up|7|||
156534173|NCT01205438|565050892|FG002|Overall Study|Lost to Follow-up|8|||
156534174|NCT01205438|565050890|FG000|Overall Study|Withdrawal by Subject|19|||
156534175|NCT01205438|565050891|FG001|Overall Study|Withdrawal by Subject|25|||
156534176|NCT01205438|565050892|FG002|Overall Study|Withdrawal by Subject|19|||
156534177|NCT01205438|565050890|FG000|Overall Study|Physician Decision|0|||
156534178|NCT01205438|565050891|FG001|Overall Study|Physician Decision|3|||
156534179|NCT01205438|565050892|FG002|Overall Study|Physician Decision|2|||
156457349|NCT01456949|564770007|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
156457350|NCT01456949|564770007|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
156457351|NCT01456949|564770007|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
156457352|NCT01456949|564770007|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
156457353|NCT01456949|564770007|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
156457354|NCT01456949|564770007|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
156457355|NCT01456949|564770007|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
156457356|NCT04200456|564770010|FG000|Overall Study|Physician Decision|0|||
156457357|NCT04200456|564770011|FG001|Overall Study|Physician Decision|1|||
156457358|NCT04200456|564770010|FG000|Overall Study|Withdrawal by Subject|2|||
156457359|NCT04200456|564770011|FG001|Overall Study|Withdrawal by Subject|2|||
156457360|NCT04200456|564770010|FG000|Overall Study|Lack of Efficacy|1|||
156457361|NCT04200456|564770011|FG001|Overall Study|Lack of Efficacy|1|||
156457362|NCT04200456|564770010|FG000|Overall Study|Adverse event, non-fatal|0|||
156457363|NCT04200456|564770011|FG001|Overall Study|Adverse event, non-fatal|1|||
156457364|NCT04200456|564770010|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
156534180|NCT01205438|565050890|FG000|Overall Study|Protocol Violation|2|||
156534181|NCT01205438|565050891|FG001|Overall Study|Protocol Violation|7|||
156534182|NCT01205438|565050892|FG002|Overall Study|Protocol Violation|4|||
156534183|NCT01205438|565050890|FG000|Overall Study|Sponsor Decision|0|||
156534184|NCT01205438|565050891|FG001|Overall Study|Sponsor Decision|1|||
156534185|NCT01205438|565050892|FG002|Overall Study|Sponsor Decision|1|||
156534186|NCT03823404|565050893|FG000|Overall Study|Lost to Follow-up|1|||
156534187|NCT03823404|565050894|FG001|Overall Study|Lost to Follow-up|2|||
156735400|NCT04143594|565778436|FG002|Overall Study|Investigator's discretion|0|||
156735401|NCT04143594|565778437|FG003|Overall Study|Investigator's discretion|0|||
156735402|NCT04143594|565778434|FG000|Overall Study|Randomized but never treated|0|||
156735403|NCT04143594|565778435|FG001|Overall Study|Randomized but never treated|0|||
156735404|NCT04143594|565778436|FG002|Overall Study|Randomized but never treated|0|||
156735405|NCT04143594|565778437|FG003|Overall Study|Randomized but never treated|1|||
156735406|NCT04143594|565778434|FG000|Overall Study|Death|1|||
156735407|NCT04143594|565778435|FG001|Overall Study|Death|0|||
156735408|NCT04143594|565778436|FG002|Overall Study|Death|1|||
156796907|NCT00725985|566009673|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796908|NCT00725985|566009674|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796909|NCT00725985|566009675|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796910|NCT00725985|566009676|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156534188|NCT03823404|565050895|FG002|Overall Study|Lost to Follow-up|3|||
156735409|NCT04143594|565778437|FG003|Overall Study|Death|0|||
156735410|NCT04143594|565778434|FG000|Overall Study|Adverse Event|1|||
156735411|NCT04143594|565778435|FG001|Overall Study|Adverse Event|0|||
156735412|NCT04143594|565778436|FG002|Overall Study|Adverse Event|0|||
156735413|NCT04143594|565778437|FG003|Overall Study|Adverse Event|0|||
156735414|NCT04143594|565778434|FG000|Overall Study|Pregnancy|0|||
156735415|NCT04143594|565778435|FG001|Overall Study|Pregnancy|0|||
156735416|NCT04143594|565778436|FG002|Overall Study|Pregnancy|1|||
156735417|NCT04143594|565778437|FG003|Overall Study|Pregnancy|0|||
156735418|NCT04143594|565778434|FG000|Overall Study|Lack of Efficacy|1|||
156735419|NCT04143594|565778435|FG001|Overall Study|Lack of Efficacy|1|||
156735420|NCT04143594|565778436|FG002|Overall Study|Lack of Efficacy|0|||
156735421|NCT04143594|565778437|FG003|Overall Study|Lack of Efficacy|0|||
156735422|NCT03047720|565778440|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
156735423|NCT03047720|565778441|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
156735424|NCT01475851|565778442|FG000|Overall Study|Protocol defined stopping criteria|1|||
156735425|NCT01475851|565778443|FG001|Overall Study|Protocol defined stopping criteria|0|||
156735426|NCT04603482|565778444|FG000|Overall Study|Lost to Follow-up|15|||
156735427|NCT04603482|565778445|FG001|Overall Study|Lost to Follow-up|15|||
156735428|NCT04603482|565778446|FG002|Overall Study|Lost to Follow-up|15|||
156735429|NCT00732758|565778447|FG000|Overall Study|Lost to Follow-up|8|||
156735430|NCT00732758|565778448|FG001|Overall Study|Lost to Follow-up|16|||
156735431|NCT00373958|565778449|FG000|Infant Series|Withdrawal by Subject|13|||
156735432|NCT00373958|565778450|FG001|Infant Series|Withdrawal by Subject|15|||
156735433|NCT00373958|565778449|FG000|Infant Series|Failed to return|8|||
156735434|NCT00373958|565778450|FG001|Infant Series|Failed to return|13|||
156735435|NCT00373958|565778449|FG000|Infant Series|Lost to Follow-up|6|||
156735436|NCT00373958|565778450|FG001|Infant Series|Lost to Follow-up|5|||
156735437|NCT00373958|565778449|FG000|Infant Series|Protocol Violation|3|||
156735438|NCT00373958|565778450|FG001|Infant Series|Protocol Violation|7|||
156735439|NCT00373958|565778449|FG000|Infant Series|Lost Kaiser coverage|4|||
156735440|NCT00373958|565778450|FG001|Infant Series|Lost Kaiser coverage|0|||
156735441|NCT00373958|565778449|FG000|Infant Series|Child relocated|1|||
156735442|NCT00373958|565778450|FG001|Infant Series|Child relocated|0|||
156457365|NCT04200456|564770011|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
156457366|NCT05002088|564770013|FG000|Overall Study|Withdrawal by Subject|9|||
156457367|NCT05002088|564770014|FG001|Overall Study|Withdrawal by Subject|0|||
156457368|NCT05002088|564770013|FG000|Overall Study|Lost to Follow-up|0|||
156457369|NCT05002088|564770014|FG001|Overall Study|Lost to Follow-up|1|||
156457370|NCT05002088|564770013|FG000|Overall Study|Death|16|||
156457371|NCT05002088|564770014|FG001|Overall Study|Death|2|||
156457372|NCT05002088|564770013|FG000|Overall Study|Protocol Violation|25|||
156457373|NCT05002088|564770014|FG001|Overall Study|Protocol Violation|7|||
156457374|NCT04068181|564770015|FG000|Overall Study|Death|17|||
156457375|NCT04068181|564770016|FG001|Overall Study|Death|12|||
156457376|NCT04068181|564770017|FG002|Overall Study|Death|4|||
156457377|NCT04068181|564770018|FG003|Overall Study|Death|7|||
156457378|NCT04068181|564770015|FG000|Overall Study|Lost to Follow-up|1|||
156457379|NCT04068181|564770016|FG001|Overall Study|Lost to Follow-up|0|||
156457380|NCT04068181|564770017|FG002|Overall Study|Lost to Follow-up|0|||
156457381|NCT04068181|564770018|FG003|Overall Study|Lost to Follow-up|0|||
156457382|NCT04068181|564770015|FG000|Overall Study|Withdrawal of consent from study|3|||
156457383|NCT04068181|564770016|FG001|Overall Study|Withdrawal of consent from study|0|||
156457384|NCT04068181|564770017|FG002|Overall Study|Withdrawal of consent from study|0|||
156457385|NCT04068181|564770018|FG003|Overall Study|Withdrawal of consent from study|0|||
156534189|NCT03823404|565050893|FG000|Overall Study|Protocol Violation|2|||
156534190|NCT03823404|565050894|FG001|Overall Study|Protocol Violation|0|||
156457386|NCT03785964|564770021|FG000|Overall Study|Adverse Event|14|||
156457387|NCT03785964|564770022|FG001|Overall Study|Adverse Event|1|||
156457388|NCT03785964|564770021|FG000|Overall Study|Unqualified Clinical Progression|1|||
156457389|NCT03785964|564770022|FG001|Overall Study|Unqualified Clinical Progression|1|||
156457390|NCT03785964|564770021|FG000|Overall Study|Participant non-compliance|1|||
156735443|NCT00373958|565778449|FG000|Infant Series|Consent was not received|1|||
156735444|NCT00373958|565778450|FG001|Infant Series|Consent was not received|0|||
156457391|NCT03785964|564770022|FG001|Overall Study|Participant non-compliance|1|||
156735445|NCT00373958|565778449|FG000|Infant Series|Adverse Event|3|||
156735446|NCT00373958|565778450|FG001|Infant Series|Adverse Event|1|||
156735447|NCT00373958|565778449|FG000|Infant Series|Physician Decision|1|||
156735448|NCT00373958|565778450|FG001|Infant Series|Physician Decision|1|||
156735449|NCT00373958|565778449|FG000|Toddler Dose|Lost to Follow-up|5|||
156735450|NCT00373958|565778450|FG001|Toddler Dose|Lost to Follow-up|8|||
156457392|NCT03785964|564770021|FG000|Overall Study|Not treated|1|||
156457393|NCT03785964|564770022|FG001|Overall Study|Not treated|0|||
156457394|NCT03785964|564770021|FG000|Overall Study|Other reason|5|||
156457395|NCT03785964|564770022|FG001|Overall Study|Other reason|11|||
156457396|NCT03785964|564770021|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
156735451|NCT00373958|565778449|FG000|Toddler Dose|Withdrawal by Subject|2|||
156735452|NCT00373958|565778450|FG001|Toddler Dose|Withdrawal by Subject|2|||
156735453|NCT00373958|565778449|FG000|Toddler Dose|Failed to return|1|||
156735454|NCT00373958|565778450|FG001|Toddler Dose|Failed to return|2|||
156735455|NCT00373958|565778449|FG000|Toddler Dose|Protocol Violation|0|||
156735456|NCT00373958|565778450|FG001|Toddler Dose|Protocol Violation|1|||
156735457|NCT00373958|565778449|FG000|Toddler Dose|Withdrawn after infant series|22|||
156735458|NCT00373958|565778450|FG001|Toddler Dose|Withdrawn after infant series|25|||
156735459|NCT03382834|565778453|FG000|Step 1|Lost to Follow-up|0|||
156735460|NCT03382834|565778454|FG001|Step 1|Lost to Follow-up|1|||
156735461|NCT03382834|565778453|FG000|Step 2|Death|1|||
156735462|NCT03382834|565778454|FG001|Step 2|Death|0|||
156735463|NCT03382834|565778453|FG000|Step 2|Lost to Follow-up|2|||
156735464|NCT03382834|565778454|FG001|Step 2|Lost to Follow-up|2|||
156735465|NCT03382834|565778453|FG000|Step 2|Site Terminated by Sponsor|1|||
156735466|NCT03382834|565778454|FG001|Step 2|Site Terminated by Sponsor|0|||
156735467|NCT02949843|565778455|FG000|Overall Study|Withdrawal by Subject|0|||
156735468|NCT02949843|565778456|FG001|Overall Study|Withdrawal by Subject|1|||
156735469|NCT02949843|565778457|FG002|Overall Study|Withdrawal by Subject|1|||
156735470|NCT03613649|565778458|FG000|Second Treatment|Lost to Follow-up|0|||
156735471|NCT03613649|565778459|FG001|Second Treatment|Lost to Follow-up|0|||
156735472|NCT03613649|565778460|FG002|Second Treatment|Lost to Follow-up|1|||
156735473|NCT03613649|565778461|FG003|Second Treatment|Lost to Follow-up|0|||
156735474|NCT03613649|565778462|FG004|Second Treatment|Lost to Follow-up|0|||
156735475|NCT03613649|565778463|FG005|Second Treatment|Lost to Follow-up|0|||
156457397|NCT03785964|564770022|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
156457398|NCT05070728|564770023|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
156457399|NCT05070728|564770024|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
156457400|NCT03924635|564770041|FG000|Overall Study|Withdrawal by Subject|2|||
156457401|NCT03924635|564770042|FG001|Overall Study|Withdrawal by Subject|4|||
156457402|NCT04568434|564770045|FG000|Overall Study|Voluntary Withdrawal|0|||
156457403|NCT04568434|564770046|FG001|Overall Study|Voluntary Withdrawal|1|||
156457404|NCT04568434|564770047|FG002|Overall Study|Voluntary Withdrawal|1|||
156457405|NCT04568434|564770045|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
156735476|NCT03613649|565778464|FG006|Second Treatment|Lost to Follow-up|0|||
156457406|NCT04568434|564770046|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
156457407|NCT04568434|564770047|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
156457408|NCT04568434|564770045|FG000|Overall Study|Investigator Judgement|1|||
156457409|NCT04568434|564770046|FG001|Overall Study|Investigator Judgement|0|||
156457410|NCT04568434|564770047|FG002|Overall Study|Investigator Judgement|0|||
156457411|NCT05469464|564770048|FG000|Overall Study|Withdrawal by Subject|8|||
156457412|NCT05469464|564770049|FG001|Overall Study|Withdrawal by Subject|7|||
156457413|NCT05469464|564770050|FG002|Overall Study|Withdrawal by Subject|4|||
156457414|NCT05469464|564770051|FG003|Overall Study|Withdrawal by Subject|5|||
156457415|NCT05469464|564770048|FG000|Overall Study|Adverse Event|8|||
156457416|NCT05469464|564770049|FG001|Overall Study|Adverse Event|14|||
156457417|NCT05469464|564770050|FG002|Overall Study|Adverse Event|13|||
156457418|NCT05469464|564770051|FG003|Overall Study|Adverse Event|2|||
156457419|NCT05469464|564770048|FG000|Overall Study|Lost to Follow-up|2|||
156457420|NCT05469464|564770049|FG001|Overall Study|Lost to Follow-up|5|||
156457421|NCT05469464|564770050|FG002|Overall Study|Lost to Follow-up|3|||
156457422|NCT05469464|564770051|FG003|Overall Study|Lost to Follow-up|3|||
156457423|NCT05469464|564770048|FG000|Overall Study|Lack of Efficacy|4|||
156457424|NCT05469464|564770049|FG001|Overall Study|Lack of Efficacy|1|||
156457425|NCT05469464|564770050|FG002|Overall Study|Lack of Efficacy|2|||
156534191|NCT03823404|565050895|FG002|Overall Study|Protocol Violation|2|||
156534192|NCT03823404|565050893|FG000|Overall Study|Adverse Event|35|||
156534193|NCT03823404|565050894|FG001|Overall Study|Adverse Event|38|||
156534194|NCT03823404|565050895|FG002|Overall Study|Adverse Event|8|||
156534195|NCT03823404|565050893|FG000|Overall Study|Withdrawal by Subject|38|||
156534196|NCT03823404|565050894|FG001|Overall Study|Withdrawal by Subject|40|||
156534197|NCT03823404|565050895|FG002|Overall Study|Withdrawal by Subject|35|||
156735477|NCT03613649|565778465|FG007|Second Treatment|Lost to Follow-up|0|||
156735478|NCT03613649|565778466|FG008|Second Treatment|Lost to Follow-up|0|||
156457426|NCT05469464|564770051|FG003|Overall Study|Lack of Efficacy|2|||
156735479|NCT03613649|565778467|FG009|Second Treatment|Lost to Follow-up|0|||
156735480|NCT03613649|565778468|FG010|Second Treatment|Lost to Follow-up|0|||
156457427|NCT05469464|564770048|FG000|Overall Study|Physician Decision|0|||
156457428|NCT05469464|564770049|FG001|Overall Study|Physician Decision|0|||
156457429|NCT05469464|564770050|FG002|Overall Study|Physician Decision|0|||
156457430|NCT05469464|564770051|FG003|Overall Study|Physician Decision|1|||
156735481|NCT03613649|565778469|FG011|Second Treatment|Lost to Follow-up|0|||
156735482|NCT03613649|565778458|FG000|Second Treatment|Withdrawal by Subject|0|||
156808835|NCT01484496|566054476|FG003|Period 1|Treatment Failure|0|||
156808836|NCT01484496|566054473|FG000|Period 1|Lack of Compliance|2|||
156808837|NCT01484496|566054474|FG001|Period 1|Lack of Compliance|1|||
156808838|NCT01484496|566054475|FG002|Period 1|Lack of Compliance|0|||
156808839|NCT01484496|566054476|FG003|Period 1|Lack of Compliance|0|||
156808840|NCT01484496|566054473|FG000|Period 1|Unable to Visit Site|0|||
156808841|NCT01484496|566054474|FG001|Period 1|Unable to Visit Site|2|||
156808842|NCT01484496|566054475|FG002|Period 1|Unable to Visit Site|0|||
156457431|NCT05374798|564770054|FG000|Overall Study|Lost to Follow-up|2|||
156457432|NCT05374798|564770054|FG000|Overall Study|Withdrawal by Subject|2|||
156735483|NCT03613649|565778459|FG001|Second Treatment|Withdrawal by Subject|0|||
156735484|NCT03613649|565778460|FG002|Second Treatment|Withdrawal by Subject|0|||
156735485|NCT03613649|565778461|FG003|Second Treatment|Withdrawal by Subject|0|||
156735486|NCT03613649|565778462|FG004|Second Treatment|Withdrawal by Subject|1|||
156735487|NCT03613649|565778463|FG005|Second Treatment|Withdrawal by Subject|0|||
156735488|NCT03613649|565778464|FG006|Second Treatment|Withdrawal by Subject|0|||
156735489|NCT03613649|565778465|FG007|Second Treatment|Withdrawal by Subject|0|||
156457433|NCT05374798|564770054|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
156457434|NCT03463044|564770055|FG000|Overall Study|Lost to Follow-up|0|||
156457435|NCT03463044|564770056|FG001|Overall Study|Lost to Follow-up|0|||
156457436|NCT03463044|564770057|FG002|Overall Study|Lost to Follow-up|0|||
156457437|NCT03463044|564770058|FG003|Overall Study|Lost to Follow-up|0|||
156457438|NCT03463044|564770059|FG004|Overall Study|Lost to Follow-up|0|||
156457439|NCT03463044|564770060|FG005|Overall Study|Lost to Follow-up|0|||
156457440|NCT03463044|564770061|FG006|Overall Study|Lost to Follow-up|0|||
156457441|NCT03463044|564770062|FG007|Overall Study|Lost to Follow-up|1|||
156457442|NCT03463044|564770063|FG008|Overall Study|Lost to Follow-up|0|||
156457443|NCT04471246|564770064|FG000|Overall Study|Lost to Follow-up|2|||
156457444|NCT04471246|564770065|FG001|Overall Study|Lost to Follow-up|2|||
156457445|NCT04079218|564770070|FG000|Overall Study|Death|1|||
156457446|NCT04079218|564770071|FG001|Overall Study|Death|0|||
156457447|NCT04079218|564770070|FG000|Overall Study|Withdrawal by Subject|3|||
156457448|NCT04079218|564770071|FG001|Overall Study|Withdrawal by Subject|0|||
156457449|NCT04079218|564770070|FG000|Overall Study|Physician Decision|4|||
156457450|NCT04079218|564770071|FG001|Overall Study|Physician Decision|0|||
156457451|NCT04079218|564770070|FG000|Overall Study|Lost to Follow-up|0|||
156457452|NCT04079218|564770071|FG001|Overall Study|Lost to Follow-up|1|||
156457453|NCT05093842|564770077|FG000|Overall Study|Pregnancy loss|1|||
156457454|NCT05093842|564770078|FG001|Overall Study|Pregnancy loss|1|||
156457455|NCT05093842|564770077|FG000|Overall Study|Lost to Follow-up|6|||
156457456|NCT05093842|564770078|FG001|Overall Study|Lost to Follow-up|0|||
156457457|NCT05093842|564770077|FG000|Overall Study|Physician Decision|0|||
156457458|NCT05093842|564770078|FG001|Overall Study|Physician Decision|1|||
156457459|NCT03910478|564770084|FG000|Overall Study|Death|13|||
156457460|NCT03910478|564770085|FG001|Overall Study|Death|6|||
156457461|NCT03910478|564770084|FG000|Overall Study|Withdrawal by Subject|23|||
156457462|NCT03910478|564770085|FG001|Overall Study|Withdrawal by Subject|2|||
156457463|NCT03910478|564770084|FG000|Overall Study|Physician Decision|5|||
156457464|NCT03910478|564770085|FG001|Overall Study|Physician Decision|0|||
156457465|NCT03910478|564770084|FG000|Overall Study|Protocol Violation|1|||
156457466|NCT03910478|564770085|FG001|Overall Study|Protocol Violation|0|||
156457467|NCT03910478|564770084|FG000|Overall Study|Failure to meet continuation criteria|2|||
156457468|NCT03910478|564770085|FG001|Overall Study|Failure to meet continuation criteria|0|||
156457469|NCT03910478|564770084|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
156735490|NCT03613649|565778466|FG008|Second Treatment|Withdrawal by Subject|0|||
156735491|NCT03613649|565778467|FG009|Second Treatment|Withdrawal by Subject|0|||
156735492|NCT03613649|565778468|FG010|Second Treatment|Withdrawal by Subject|0|||
156735493|NCT03613649|565778469|FG011|Second Treatment|Withdrawal by Subject|0|||
156735494|NCT03613649|565778458|FG000|Third Treatment|Lost to Follow-up|0|||
156735495|NCT03613649|565778459|FG001|Third Treatment|Lost to Follow-up|0|||
156735496|NCT03613649|565778460|FG002|Third Treatment|Lost to Follow-up|0|||
156735497|NCT03613649|565778461|FG003|Third Treatment|Lost to Follow-up|0|||
156735498|NCT03613649|565778462|FG004|Third Treatment|Lost to Follow-up|1|||
156735499|NCT03613649|565778463|FG005|Third Treatment|Lost to Follow-up|0|||
156735500|NCT03613649|565778464|FG006|Third Treatment|Lost to Follow-up|0|||
156735501|NCT03613649|565778465|FG007|Third Treatment|Lost to Follow-up|0|||
156735502|NCT03613649|565778466|FG008|Third Treatment|Lost to Follow-up|0|||
156735503|NCT03613649|565778467|FG009|Third Treatment|Lost to Follow-up|0|||
156735504|NCT03613649|565778468|FG010|Third Treatment|Lost to Follow-up|0|||
156735505|NCT03613649|565778469|FG011|Third Treatment|Lost to Follow-up|1|||
156735506|NCT03613649|565778458|FG000|Third Treatment|Protocol Violation|0|||
156735507|NCT03613649|565778459|FG001|Third Treatment|Protocol Violation|0|||
156457470|NCT03910478|564770085|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
156457471|NCT03478956|564770087|FG000|Randomized Treatment Period|Adverse Event|1|||
156457472|NCT03478956|564770088|FG001|Randomized Treatment Period|Adverse Event|0|||
156457473|NCT03478956|564770089|FG002|Randomized Treatment Period|Adverse Event|0|||
156457474|NCT03478956|564770090|FG003|Randomized Treatment Period|Adverse Event|0|||
156457475|NCT03478956|564770087|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
156457476|NCT03478956|564770088|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
156457477|NCT03478956|564770089|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
156457478|NCT03478956|564770090|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
156457479|NCT03478956|564770087|FG000|Open Label Extension Period|Adverse Event|0|||
156457480|NCT03478956|564770088|FG001|Open Label Extension Period|Adverse Event|0|||
156534198|NCT03823404|565050893|FG000|Overall Study|Death|4|||
156735508|NCT03613649|565778460|FG002|Third Treatment|Protocol Violation|0|||
156735509|NCT03613649|565778461|FG003|Third Treatment|Protocol Violation|0|||
156735510|NCT03613649|565778462|FG004|Third Treatment|Protocol Violation|0|||
156735511|NCT03613649|565778463|FG005|Third Treatment|Protocol Violation|0|||
156735512|NCT03613649|565778464|FG006|Third Treatment|Protocol Violation|1|||
156735513|NCT03613649|565778465|FG007|Third Treatment|Protocol Violation|0|||
156735514|NCT03613649|565778466|FG008|Third Treatment|Protocol Violation|0|||
156735515|NCT03613649|565778467|FG009|Third Treatment|Protocol Violation|0|||
156735516|NCT03613649|565778468|FG010|Third Treatment|Protocol Violation|0|||
156735517|NCT03613649|565778469|FG011|Third Treatment|Protocol Violation|1|||
156457481|NCT03478956|564770089|FG002|Open Label Extension Period|Adverse Event|4|||
156457482|NCT03478956|564770090|FG003|Open Label Extension Period|Adverse Event|0|||
156457483|NCT03478956|564770087|FG000|Open Label Extension Period|Lack of Efficacy|0|||
156457484|NCT03478956|564770088|FG001|Open Label Extension Period|Lack of Efficacy|0|||
156457485|NCT03478956|564770089|FG002|Open Label Extension Period|Lack of Efficacy|8|||
156457486|NCT03478956|564770090|FG003|Open Label Extension Period|Lack of Efficacy|0|||
156457487|NCT03478956|564770087|FG000|Open Label Extension Period|Reason Not Provided|0|||
156457488|NCT03478956|564770088|FG001|Open Label Extension Period|Reason Not Provided|0|||
156457489|NCT03478956|564770089|FG002|Open Label Extension Period|Reason Not Provided|1|||
156457490|NCT03478956|564770090|FG003|Open Label Extension Period|Reason Not Provided|0|||
156457491|NCT03478956|564770087|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
156457492|NCT03478956|564770088|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
156457493|NCT03478956|564770089|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
156457494|NCT03478956|564770090|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
156457495|NCT03478956|564770087|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
156457496|NCT03478956|564770088|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
156457497|NCT03478956|564770089|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
156457498|NCT03478956|564770090|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
156457499|NCT03478956|564770087|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
156457500|NCT03478956|564770088|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
156457501|NCT03478956|564770089|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
156457502|NCT03478956|564770090|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
156457503|NCT04800211|564770093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
156457504|NCT04800211|564770094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
156457505|NCT04800211|564770095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
156457506|NCT04800211|564770093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
156457507|NCT04800211|564770094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
156457508|NCT04800211|564770095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
156457509|NCT04800211|564770093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
156457510|NCT04800211|564770094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
156457511|NCT04800211|564770095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
156457512|NCT04800211|564770093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
156457513|NCT04800211|564770094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
156457514|NCT04800211|564770095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
156457515|NCT04800211|564770093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
156534199|NCT03823404|565050894|FG001|Overall Study|Death|0|||
156534200|NCT03823404|565050895|FG002|Overall Study|Death|0|||
156534201|NCT03823404|565050893|FG000|Overall Study|Other: Various reasons provided|5|||
156534202|NCT03823404|565050894|FG001|Overall Study|Other: Various reasons provided|5|||
156735518|NCT03613649|565778458|FG000|Fourth Treatment|Protocol Violation|1|||
156735519|NCT03613649|565778459|FG001|Fourth Treatment|Protocol Violation|0|||
156735520|NCT03613649|565778460|FG002|Fourth Treatment|Protocol Violation|0|||
156735521|NCT03613649|565778461|FG003|Fourth Treatment|Protocol Violation|0|||
156735522|NCT03613649|565778462|FG004|Fourth Treatment|Protocol Violation|1|||
156735523|NCT03613649|565778463|FG005|Fourth Treatment|Protocol Violation|0|||
156735524|NCT03613649|565778464|FG006|Fourth Treatment|Protocol Violation|0|||
156735525|NCT03613649|565778465|FG007|Fourth Treatment|Protocol Violation|0|||
156735526|NCT03613649|565778466|FG008|Fourth Treatment|Protocol Violation|0|||
156735527|NCT03613649|565778467|FG009|Fourth Treatment|Protocol Violation|0|||
156735528|NCT03613649|565778468|FG010|Fourth Treatment|Protocol Violation|0|||
156735529|NCT03613649|565778469|FG011|Fourth Treatment|Protocol Violation|0|||
156735530|NCT03613649|565778458|FG000|Fourth Treatment|Physician Decision|0|||
156735531|NCT03613649|565778459|FG001|Fourth Treatment|Physician Decision|0|||
156735532|NCT03613649|565778460|FG002|Fourth Treatment|Physician Decision|0|||
156735533|NCT03613649|565778461|FG003|Fourth Treatment|Physician Decision|0|||
156735534|NCT03613649|565778462|FG004|Fourth Treatment|Physician Decision|0|||
156735535|NCT03613649|565778463|FG005|Fourth Treatment|Physician Decision|0|||
156735536|NCT03613649|565778464|FG006|Fourth Treatment|Physician Decision|1|||
156735537|NCT03613649|565778465|FG007|Fourth Treatment|Physician Decision|0|||
156457516|NCT04800211|564770094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
156735538|NCT03613649|565778466|FG008|Fourth Treatment|Physician Decision|0|||
156735539|NCT03613649|565778467|FG009|Fourth Treatment|Physician Decision|0|||
156735540|NCT03613649|565778468|FG010|Fourth Treatment|Physician Decision|0|||
156735541|NCT03613649|565778469|FG011|Fourth Treatment|Physician Decision|0|||
156735542|NCT02693171|565778470|FG000|Overall Study|Adverse Event|1|||
156735543|NCT02693171|565778470|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
156735544|NCT00319592|565778472|FG000|Overall Study|Protocol Violation|1|||
156735545|NCT00319592|565778473|FG001|Overall Study|Protocol Violation|0|||
156735546|NCT00319592|565778472|FG000|Overall Study|Physician Decision|0|||
156735547|NCT00319592|565778473|FG001|Overall Study|Physician Decision|1|||
156735548|NCT03429244|565778474|FG000|Overall Study|Withdrawal by Subject|2|||
156735549|NCT03429244|565778475|FG001|Overall Study|Withdrawal by Subject|1|||
156735550|NCT03429244|565778476|FG002|Overall Study|Withdrawal by Subject|1|||
156735551|NCT00430573|565778481|FG000|Overall Study|Withdrawal by Subject|5|||
156735552|NCT04463251|565778488|FG000|Overall Study|Death|1|||
156735553|NCT04463251|565778489|FG001|Overall Study|Death|0|||
156735554|NCT04463251|565778490|FG002|Overall Study|Death|1|||
156735555|NCT04463251|565778488|FG000|Overall Study|Adverse Event|0|||
156735556|NCT04463251|565778489|FG001|Overall Study|Adverse Event|1|||
156735557|NCT04463251|565778490|FG002|Overall Study|Adverse Event|0|||
156735558|NCT04463251|565778488|FG000|Overall Study|Lost to Follow-up|0|||
156735559|NCT04463251|565778489|FG001|Overall Study|Lost to Follow-up|1|||
156735560|NCT04463251|565778490|FG002|Overall Study|Lost to Follow-up|0|||
156735561|NCT04463251|565778488|FG000|Overall Study|Withdrawal by Subject|0|||
156735562|NCT04463251|565778489|FG001|Overall Study|Withdrawal by Subject|2|||
156735563|NCT04463251|565778490|FG002|Overall Study|Withdrawal by Subject|2|||
156735564|NCT05020665|565778491|FG000|Overall Study|Study terminated by Sponsor|5|||
156735565|NCT05020665|565778492|FG001|Overall Study|Study terminated by Sponsor|4|||
156735566|NCT05020665|565778491|FG000|Overall Study|Death|2|||
156735567|NCT05020665|565778492|FG001|Overall Study|Death|1|||
156735568|NCT05020665|565778491|FG000|Overall Study|Physician Decision|0|||
156735569|NCT05020665|565778492|FG001|Overall Study|Physician Decision|1|||
156735570|NCT05020665|565778491|FG000|Overall Study|Withdrawal by Subject|0|||
156735571|NCT05020665|565778492|FG001|Overall Study|Withdrawal by Subject|1|||
156735572|NCT05020665|565778491|FG000|Overall Study|Reason not specified|1|||
156735573|NCT05020665|565778492|FG001|Overall Study|Reason not specified|0|||
156735574|NCT01628198|565778493|FG000|Overall Study|Lost to Follow-up|7|||
156735575|NCT01628198|565778493|FG000|Overall Study|Withdrawal by Subject|10|||
156735576|NCT01628198|565778493|FG000|Overall Study|Screen failure|1|||
156735577|NCT03386994|565778498|FG000|Overall Study|Lung transplant|1|||
156735578|NCT03386994|565778498|FG000|Overall Study|Adverse Event|14|||
156735579|NCT03386994|565778498|FG000|Overall Study|Lost to Follow-up|4|||
156735580|NCT03386994|565778498|FG000|Overall Study|Withdrawal by Subject|3|||
156735581|NCT03386994|565778498|FG000|Overall Study|Death|16|||
156735582|NCT01743560|565778499|FG000|Overall Study|Disease progression|26|||
156735583|NCT01743560|565778499|FG000|Overall Study|Adverse Event|8|||
156735584|NCT01743560|565778499|FG000|Overall Study|Death|3|||
156735585|NCT01743560|565778499|FG000|Overall Study|Withdrawal by Subject|2|||
156735586|NCT01743560|565778499|FG000|Overall Study|Protocol Violation|1|||
156735587|NCT01743560|565778499|FG000|Overall Study|>1 dose of study drug|3|||
156735588|NCT01827267|565778505|FG000|Overall Study|Did not receive study drug|1|||
156735589|NCT01827267|565778506|FG001|Overall Study|Did not receive study drug|1|||
156735590|NCT01827267|565778505|FG000|Overall Study|Physician Decision|1|||
156735591|NCT01827267|565778506|FG001|Overall Study|Physician Decision|0|||
156735592|NCT01827267|565778505|FG000|Overall Study|Disease Progression|1|||
156735593|NCT01827267|565778506|FG001|Overall Study|Disease Progression|1|||
156735594|NCT01827267|565778505|FG000|Overall Study|Sponsor Discontinued Study|2|||
156735595|NCT01827267|565778506|FG001|Overall Study|Sponsor Discontinued Study|8|||
156735596|NCT01827267|565778505|FG000|Overall Study|Still on study|0|||
156735597|NCT01827267|565778506|FG001|Overall Study|Still on study|2|||
156336674|NCT01145625|564329665|FG000|Overall Study|Protocol Violation|3|||
156336675|NCT01145625|564329666|FG001|Overall Study|Protocol Violation|1|||
156735598|NCT00877487|565778507|FG000|Open-label Treatment Phase|Adverse Event|1|||
156735599|NCT00877487|565778508|FG001|Open-label Treatment Phase|Adverse Event|0|||
156735600|NCT00877487|565778507|FG000|Open-label Treatment Phase|Protocol Violation|3|||
156735601|NCT00877487|565778508|FG001|Open-label Treatment Phase|Protocol Violation|0|||
156735602|NCT00877487|565778507|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
156735603|NCT00877487|565778508|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
156336676|NCT01145625|564329665|FG000|Overall Study|Withdrawal by Subject|7|||
156735604|NCT00877487|565778507|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
156735605|NCT00877487|565778508|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
156735606|NCT00877487|565778507|FG000|Open-label Treatment Phase|Out of country for business|1|||
156735607|NCT00877487|565778508|FG001|Open-label Treatment Phase|Out of country for business|0|||
156735608|NCT00877487|565778507|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
156735609|NCT00877487|565778508|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
156735610|NCT00877487|565778507|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
156735611|NCT00877487|565778508|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
156735612|NCT00877487|565778507|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
156735613|NCT00877487|565778508|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
156735614|NCT00877487|565778507|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
156735615|NCT00877487|565778508|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
156735616|NCT03425396|565778511|FG000|Overall Study|Lost to Follow-up|2|||
156735617|NCT03425396|565778512|FG001|Overall Study|Lost to Follow-up|5|||
156735618|NCT03425396|565778513|FG002|Overall Study|Lost to Follow-up|2|||
156735619|NCT03425396|565778514|FG003|Overall Study|Lost to Follow-up|0|||
156735620|NCT03425396|565778515|FG004|Overall Study|Lost to Follow-up|0|||
156735621|NCT03425396|565778511|FG000|Overall Study|Withdrawal by Subject|0|||
156735622|NCT03425396|565778512|FG001|Overall Study|Withdrawal by Subject|1|||
156735623|NCT03425396|565778513|FG002|Overall Study|Withdrawal by Subject|0|||
156735624|NCT03425396|565778514|FG003|Overall Study|Withdrawal by Subject|1|||
156735625|NCT03425396|565778515|FG004|Overall Study|Withdrawal by Subject|0|||
156735626|NCT03425396|565778511|FG000|Overall Study|Other|0|||
156735627|NCT03425396|565778512|FG001|Overall Study|Other|1|||
156735628|NCT03425396|565778513|FG002|Overall Study|Other|1|||
156735629|NCT03425396|565778514|FG003|Overall Study|Other|0|||
156735630|NCT03425396|565778515|FG004|Overall Study|Other|1|||
156735631|NCT02122887|565778519|FG000|Overall Study|Withdrawal by Subject|20|||
156735632|NCT02122887|565778520|FG001|Overall Study|Withdrawal by Subject|2|||
156735633|NCT04999163|565778521|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
156735634|NCT04999163|565778522|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
156735635|NCT04999163|565778521|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
156735636|NCT04999163|565778522|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
156735637|NCT04999163|565778521|FG000|Overall Study|Withdrawal by Subject|1|||
156735638|NCT04999163|565778522|FG001|Overall Study|Withdrawal by Subject|0|||
156735639|NCT00784550|565780376|FG000|Overall Study|Adverse Event|12|||
156735640|NCT00784550|565780377|FG001|Overall Study|Adverse Event|10|||
156735641|NCT00784550|565780376|FG000|Overall Study|Lack of Efficacy|0|||
156735642|NCT00784550|565780377|FG001|Overall Study|Lack of Efficacy|1|||
156735643|NCT00784550|565780376|FG000|Overall Study|Protocol Violation|10|||
156735644|NCT00784550|565780377|FG001|Overall Study|Protocol Violation|10|||
156735645|NCT00784550|565780376|FG000|Overall Study|Lost to Follow-up|8|||
156735646|NCT00784550|565780377|FG001|Overall Study|Lost to Follow-up|5|||
156735647|NCT00784550|565780376|FG000|Overall Study|Physician Decision|2|||
156735648|NCT00784550|565780377|FG001|Overall Study|Physician Decision|3|||
156735649|NCT00784550|565780376|FG000|Overall Study|Withdrawal by Subject|4|||
156735650|NCT00784550|565780377|FG001|Overall Study|Withdrawal by Subject|13|||
156735651|NCT03558152|565780378|FG000|Overall Study|Adverse Event|0|||
156735652|NCT03558152|565780379|FG001|Overall Study|Adverse Event|0|||
156735653|NCT03558152|565780380|FG002|Overall Study|Adverse Event|1|||
156735654|NCT03558152|565780381|FG003|Overall Study|Adverse Event|1|||
156735655|NCT03558152|565780382|FG004|Overall Study|Adverse Event|2|||
156735656|NCT03558152|565780383|FG005|Overall Study|Adverse Event|1|||
156735657|NCT03558152|565780384|FG006|Overall Study|Adverse Event|1|||
156735658|NCT03558152|565780385|FG007|Overall Study|Adverse Event|0|||
156735659|NCT03558152|565780378|FG000|Overall Study|Death|0|||
156735660|NCT03558152|565780379|FG001|Overall Study|Death|0|||
156735661|NCT03558152|565780380|FG002|Overall Study|Death|0|||
156735662|NCT03558152|565780381|FG003|Overall Study|Death|0|||
156735663|NCT03558152|565780382|FG004|Overall Study|Death|1|||
156735664|NCT03558152|565780383|FG005|Overall Study|Death|0|||
156735665|NCT03558152|565780384|FG006|Overall Study|Death|0|||
156735666|NCT03558152|565780385|FG007|Overall Study|Death|0|||
156735667|NCT03558152|565780378|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
156735668|NCT03558152|565780379|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735669|NCT03558152|565780380|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735670|NCT03558152|565780381|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735671|NCT03558152|565780382|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735672|NCT03558152|565780383|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735673|NCT03558152|565780384|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735674|NCT03558152|565780385|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735675|NCT03558152|565780378|FG000|Overall Study|Miscalculation in mmcs|0|||
156735676|NCT03558152|565780379|FG001|Overall Study|Miscalculation in mmcs|0|||
156735677|NCT03558152|565780380|FG002|Overall Study|Miscalculation in mmcs|0|||
156735678|NCT03558152|565780381|FG003|Overall Study|Miscalculation in mmcs|0|||
156735679|NCT03558152|565780382|FG004|Overall Study|Miscalculation in mmcs|0|||
156735680|NCT03558152|565780383|FG005|Overall Study|Miscalculation in mmcs|0|||
156735681|NCT03558152|565780384|FG006|Overall Study|Miscalculation in mmcs|1|||
156735682|NCT03558152|565780385|FG007|Overall Study|Miscalculation in mmcs|0|||
156735683|NCT03558152|565780378|FG000|Overall Study|Mistake in calculation|0|||
156735684|NCT03558152|565780379|FG001|Overall Study|Mistake in calculation|0|||
156534203|NCT03823404|565050895|FG002|Overall Study|Other: Various reasons provided|6|||
156735685|NCT03558152|565780380|FG002|Overall Study|Mistake in calculation|0|||
156735686|NCT03558152|565780381|FG003|Overall Study|Mistake in calculation|1|||
156735687|NCT03558152|565780382|FG004|Overall Study|Mistake in calculation|0|||
156808843|NCT01484496|566054476|FG003|Period 1|Unable to Visit Site|0|||
156735688|NCT03558152|565780383|FG005|Overall Study|Mistake in calculation|0|||
156735689|NCT03558152|565780384|FG006|Overall Study|Mistake in calculation|0|||
156735690|NCT03558152|565780385|FG007|Overall Study|Mistake in calculation|0|||
156735691|NCT03558152|565780378|FG000|Overall Study|Mistake in evaluation of disease status|0|||
156735692|NCT03558152|565780379|FG001|Overall Study|Mistake in evaluation of disease status|0|||
156735693|NCT03558152|565780380|FG002|Overall Study|Mistake in evaluation of disease status|0|||
156735694|NCT03558152|565780381|FG003|Overall Study|Mistake in evaluation of disease status|0|||
156735695|NCT03558152|565780382|FG004|Overall Study|Mistake in evaluation of disease status|0|||
156735696|NCT03558152|565780383|FG005|Overall Study|Mistake in evaluation of disease status|0|||
156735697|NCT03558152|565780384|FG006|Overall Study|Mistake in evaluation of disease status|0|||
156735698|NCT03558152|565780385|FG007|Overall Study|Mistake in evaluation of disease status|1|||
156735699|NCT03558152|565780378|FG000|Overall Study|Physician Decision|0|||
156735700|NCT03558152|565780379|FG001|Overall Study|Physician Decision|0|||
156735701|NCT03558152|565780380|FG002|Overall Study|Physician Decision|0|||
156735702|NCT03558152|565780381|FG003|Overall Study|Physician Decision|0|||
156735703|NCT03558152|565780382|FG004|Overall Study|Physician Decision|0|||
156735704|NCT03558152|565780383|FG005|Overall Study|Physician Decision|0|||
156735705|NCT03558152|565780384|FG006|Overall Study|Physician Decision|1|||
156735706|NCT03558152|565780385|FG007|Overall Study|Physician Decision|0|||
156735707|NCT03558152|565780378|FG000|Overall Study|Withdrawal by Subject|2|||
156735708|NCT03558152|565780379|FG001|Overall Study|Withdrawal by Subject|3|||
156735709|NCT03558152|565780380|FG002|Overall Study|Withdrawal by Subject|2|||
156735710|NCT03558152|565780381|FG003|Overall Study|Withdrawal by Subject|1|||
156735711|NCT03558152|565780382|FG004|Overall Study|Withdrawal by Subject|1|||
156735712|NCT03558152|565780383|FG005|Overall Study|Withdrawal by Subject|1|||
156735713|NCT03558152|565780384|FG006|Overall Study|Withdrawal by Subject|3|||
156735714|NCT03558152|565780385|FG007|Overall Study|Withdrawal by Subject|2|||
156735715|NCT03558152|565780378|FG000|Overall Study|Lack of Efficacy|11|||
156735716|NCT03558152|565780379|FG001|Overall Study|Lack of Efficacy|11|||
156735717|NCT03558152|565780380|FG002|Overall Study|Lack of Efficacy|10|||
156735718|NCT03558152|565780381|FG003|Overall Study|Lack of Efficacy|11|||
156735719|NCT03558152|565780382|FG004|Overall Study|Lack of Efficacy|14|||
156735720|NCT03558152|565780383|FG005|Overall Study|Lack of Efficacy|12|||
156735721|NCT03558152|565780384|FG006|Overall Study|Lack of Efficacy|14|||
156735722|NCT03558152|565780385|FG007|Overall Study|Lack of Efficacy|13|||
156735723|NCT03558152|565780378|FG000|Overall Study|Protocol Violation|1|||
156735724|NCT03558152|565780379|FG001|Overall Study|Protocol Violation|1|||
156735725|NCT03558152|565780380|FG002|Overall Study|Protocol Violation|0|||
156735726|NCT03558152|565780381|FG003|Overall Study|Protocol Violation|1|||
156735727|NCT03558152|565780382|FG004|Overall Study|Protocol Violation|1|||
156735728|NCT03558152|565780383|FG005|Overall Study|Protocol Violation|0|||
156735729|NCT03558152|565780384|FG006|Overall Study|Protocol Violation|2|||
156735730|NCT03558152|565780385|FG007|Overall Study|Protocol Violation|0|||
156735731|NCT04166591|565780386|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
156735732|NCT04166591|565780387|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
156534204|NCT03842163|565050896|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
156534205|NCT03842163|565050896|FG000|Overall Study|Scintigraphy was not performed|44|||
156534206|NCT03829241|565050900|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
156735733|NCT04166591|565780388|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156735734|NCT04166591|565780389|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156735735|NCT04166591|565780386|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
156735736|NCT04166591|565780387|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
156735737|NCT04166591|565780388|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156735738|NCT04166591|565780389|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156735739|NCT03960021|565780390|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
156735740|NCT01936181|565780395|FG000|Randomised, Double-blind|Adverse Event|27|||
156735741|NCT01936181|565780396|FG001|Randomised, Double-blind|Adverse Event|21|||
156735742|NCT01936181|565780397|FG002|Randomised, Double-blind|Adverse Event|0|||
156735743|NCT01936181|565780398|FG003|Randomised, Double-blind|Adverse Event|0|||
156735744|NCT01936181|565780395|FG000|Randomised, Double-blind|Protocol Violation|1|||
156735745|NCT01936181|565780396|FG001|Randomised, Double-blind|Protocol Violation|5|||
156735746|NCT01936181|565780397|FG002|Randomised, Double-blind|Protocol Violation|0|||
156735747|NCT01936181|565780398|FG003|Randomised, Double-blind|Protocol Violation|0|||
156735748|NCT01936181|565780395|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
156534207|NCT03829241|565050901|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
156735749|NCT01936181|565780396|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
156735750|NCT01936181|565780397|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
156735751|NCT01936181|565780398|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
156735752|NCT01936181|565780395|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
156735753|NCT01936181|565780396|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
156735754|NCT01936181|565780397|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
156735755|NCT01936181|565780398|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
156735756|NCT01936181|565780395|FG000|Randomised, Double-blind|Pregnancy|0|||
156735757|NCT01936181|565780396|FG001|Randomised, Double-blind|Pregnancy|1|||
156735758|NCT01936181|565780397|FG002|Randomised, Double-blind|Pregnancy|0|||
156735759|NCT01936181|565780398|FG003|Randomised, Double-blind|Pregnancy|0|||
156735760|NCT01936181|565780395|FG000|Randomised, Double-blind|Physician Decision|4|||
156336677|NCT01145625|564329666|FG001|Overall Study|Withdrawal by Subject|16|||
156336678|NCT01145625|564329665|FG000|Overall Study|Pregnancy|0|||
156336679|NCT01145625|564329666|FG001|Overall Study|Pregnancy|1|||
156735761|NCT01936181|565780396|FG001|Randomised, Double-blind|Physician Decision|4|||
156735762|NCT01936181|565780397|FG002|Randomised, Double-blind|Physician Decision|0|||
156735763|NCT01936181|565780398|FG003|Randomised, Double-blind|Physician Decision|0|||
156735764|NCT01936181|565780395|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
156735765|NCT01936181|565780396|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
156735766|NCT01936181|565780397|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
156735767|NCT01936181|565780398|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
156735768|NCT01936181|565780395|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
156735769|NCT01936181|565780396|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
156735770|NCT01936181|565780397|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
156735771|NCT01936181|565780398|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
156735772|NCT01936181|565780395|FG000|Transition-extension|Adverse Event|3|||
156735773|NCT01936181|565780396|FG001|Transition-extension|Adverse Event|0|||
156735774|NCT01936181|565780397|FG002|Transition-extension|Adverse Event|3|||
156735775|NCT01936181|565780398|FG003|Transition-extension|Adverse Event|1|||
156735776|NCT01936181|565780395|FG000|Transition-extension|Lost to Follow-up|3|||
156735777|NCT01936181|565780396|FG001|Transition-extension|Lost to Follow-up|0|||
156735778|NCT01936181|565780397|FG002|Transition-extension|Lost to Follow-up|1|||
156735779|NCT01936181|565780398|FG003|Transition-extension|Lost to Follow-up|2|||
156735780|NCT01936181|565780395|FG000|Transition-extension|Physician Decision|2|||
156735781|NCT01936181|565780396|FG001|Transition-extension|Physician Decision|0|||
156735782|NCT01936181|565780397|FG002|Transition-extension|Physician Decision|0|||
156735783|NCT01936181|565780398|FG003|Transition-extension|Physician Decision|1|||
156735784|NCT01936181|565780395|FG000|Transition-extension|Withdrawal by Subject|7|||
156735785|NCT01936181|565780396|FG001|Transition-extension|Withdrawal by Subject|0|||
156735786|NCT01936181|565780397|FG002|Transition-extension|Withdrawal by Subject|2|||
156735787|NCT01936181|565780398|FG003|Transition-extension|Withdrawal by Subject|1|||
156735788|NCT01346189|565780399|FG000|Overall Study|Withdrawal by Subject|7|||
156735789|NCT01346189|565780400|FG001|Overall Study|Withdrawal by Subject|5|||
156735790|NCT01346189|565780401|FG002|Overall Study|Withdrawal by Subject|3|||
156735791|NCT01346189|565780402|FG003|Overall Study|Withdrawal by Subject|5|||
156735792|NCT01346189|565780399|FG000|Overall Study|Physician Decision|4|||
156735793|NCT01346189|565780400|FG001|Overall Study|Physician Decision|0|||
156735794|NCT01346189|565780401|FG002|Overall Study|Physician Decision|0|||
156735795|NCT01346189|565780402|FG003|Overall Study|Physician Decision|0|||
156735796|NCT01346189|565780399|FG000|Overall Study|Moved|3|||
156735797|NCT01346189|565780400|FG001|Overall Study|Moved|0|||
156735798|NCT01346189|565780401|FG002|Overall Study|Moved|4|||
156735799|NCT01346189|565780402|FG003|Overall Study|Moved|0|||
156735800|NCT01346189|565780399|FG000|Overall Study|Other|2|||
156735801|NCT01346189|565780400|FG001|Overall Study|Other|4|||
156735802|NCT01346189|565780401|FG002|Overall Study|Other|7|||
156336680|NCT01751178|564329667|FG000|Overall Study|Adverse Event|2|||
156336681|NCT01751178|564329668|FG001|Overall Study|Adverse Event|0|||
156336682|NCT01751178|564329669|FG002|Overall Study|Adverse Event|0|||
156336683|NCT01751178|564329667|FG000|Overall Study|Other Reason (unknown)|1|||
156336684|NCT01751178|564329668|FG001|Overall Study|Other Reason (unknown)|0|||
156336685|NCT01751178|564329669|FG002|Overall Study|Other Reason (unknown)|2|||
156336686|NCT00885846|564329670|FG000|Overall Study|Withdrawal by Subject|2|||
156336687|NCT00885846|564329671|FG001|Overall Study|Withdrawal by Subject|5|||
156336688|NCT00885846|564329672|FG002|Overall Study|Withdrawal by Subject|2|||
156336689|NCT00493025|564329676|FG000|Overall Study|Physician Decision|19|||
156735803|NCT01346189|565780402|FG003|Overall Study|Other|3|||
156336690|NCT01781975|564329677|FG000|Overall Study|Death|1|||
156336691|NCT01781975|564329678|FG001|Overall Study|Death|0|||
156735804|NCT01346189|565780399|FG000|Overall Study|Death|0|||
156735805|NCT01346189|565780400|FG001|Overall Study|Death|3|||
156735806|NCT01346189|565780401|FG002|Overall Study|Death|0|||
156735807|NCT01346189|565780402|FG003|Overall Study|Death|0|||
156735808|NCT01346189|565780399|FG000|Overall Study|Non-health system primary care physician|0|||
156735809|NCT01346189|565780400|FG001|Overall Study|Non-health system primary care physician|5|||
156735810|NCT01346189|565780401|FG002|Overall Study|Non-health system primary care physician|0|||
156735811|NCT01346189|565780402|FG003|Overall Study|Non-health system primary care physician|0|||
156336692|NCT01781975|564329677|FG000|Overall Study|Withdrawal by Subject|1|||
156735812|NCT01346189|565780399|FG000|Overall Study|Travel|0|||
156336693|NCT01781975|564329678|FG001|Overall Study|Withdrawal by Subject|1|||
156735813|NCT01346189|565780400|FG001|Overall Study|Travel|0|||
156735814|NCT01346189|565780401|FG002|Overall Study|Travel|0|||
156336694|NCT00839852|564329680|FG000|Overall Study|Adverse Event|10|||
156735815|NCT01346189|565780402|FG003|Overall Study|Travel|3|||
156735816|NCT00900757|565780403|FG000|Overall Study|screen failure|19|||
156735817|NCT05113979|565780408|FG000|Overall Study|Death|2|||
156735818|NCT05113979|565780408|FG000|Overall Study|Lost to Follow-up|1|||
156735819|NCT00976820|565780409|FG000|Overall Study|Lost to Follow-up|5|||
156735820|NCT00976820|565780410|FG001|Overall Study|Lost to Follow-up|16|||
156735821|NCT00976820|565780411|FG002|Overall Study|Lost to Follow-up|2|||
156735822|NCT00976820|565780412|FG003|Overall Study|Lost to Follow-up|3|||
156735823|NCT00976820|565780409|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
156735824|NCT00976820|565780410|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
156735825|NCT00976820|565780411|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
156735826|NCT00976820|565780412|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
156735827|NCT00976820|565780409|FG000|Overall Study|Withdrawal by Subject|2|||
156735828|NCT00976820|565780410|FG001|Overall Study|Withdrawal by Subject|4|||
156735829|NCT00976820|565780411|FG002|Overall Study|Withdrawal by Subject|1|||
156735830|NCT00976820|565780412|FG003|Overall Study|Withdrawal by Subject|4|||
156735831|NCT00968981|565780413|FG000|Overall Study|Adverse Event|2|||
156735832|NCT00968981|565780414|FG001|Overall Study|Adverse Event|0|||
156735833|NCT00968981|565780415|FG002|Overall Study|Adverse Event|0|||
156735834|NCT00968981|565780413|FG000|Overall Study|Disease Progression|14|||
156735835|NCT00968981|565780414|FG001|Overall Study|Disease Progression|16|||
156735836|NCT00968981|565780415|FG002|Overall Study|Disease Progression|13|||
156735837|NCT00968981|565780413|FG000|Overall Study|Lost to Follow-up|0|||
156735838|NCT00968981|565780414|FG001|Overall Study|Lost to Follow-up|0|||
156735839|NCT00968981|565780415|FG002|Overall Study|Lost to Follow-up|1|||
156735840|NCT00968981|565780413|FG000|Overall Study|Physician Decision|5|||
156735841|NCT00968981|565780414|FG001|Overall Study|Physician Decision|3|||
156735842|NCT00968981|565780415|FG002|Overall Study|Physician Decision|5|||
156735843|NCT00968981|565780413|FG000|Overall Study|Withdrawal by Subject|1|||
156735844|NCT00968981|565780414|FG001|Overall Study|Withdrawal by Subject|3|||
156735845|NCT00968981|565780415|FG002|Overall Study|Withdrawal by Subject|3|||
156735846|NCT01489254|565780416|FG000|Double-blind Part|Adverse Event|7|||
156735847|NCT01489254|565780417|FG001|Double-blind Part|Adverse Event|2|||
156735848|NCT01489254|565780418|FG002|Double-blind Part|Adverse Event|2|||
156735849|NCT01489254|565780419|FG003|Double-blind Part|Adverse Event|0|||
156735850|NCT01489254|565780416|FG000|Double-blind Part|Pregnancy|1|||
156735851|NCT01489254|565780417|FG001|Double-blind Part|Pregnancy|3|||
156735852|NCT01489254|565780418|FG002|Double-blind Part|Pregnancy|0|||
156735853|NCT01489254|565780419|FG003|Double-blind Part|Pregnancy|0|||
156735854|NCT01489254|565780416|FG000|Double-blind Part|Withdrawal by Subject|12|||
156735855|NCT01489254|565780417|FG001|Double-blind Part|Withdrawal by Subject|20|||
156735856|NCT01489254|565780418|FG002|Double-blind Part|Withdrawal by Subject|1|||
156735857|NCT01489254|565780419|FG003|Double-blind Part|Withdrawal by Subject|0|||
156735858|NCT01489254|565780416|FG000|Double-blind Part|Lost to Follow-up|1|||
156735859|NCT01489254|565780417|FG001|Double-blind Part|Lost to Follow-up|2|||
156735860|NCT01489254|565780418|FG002|Double-blind Part|Lost to Follow-up|0|||
156735861|NCT01489254|565780419|FG003|Double-blind Part|Lost to Follow-up|0|||
156735862|NCT01489254|565780416|FG000|Double-blind Part|Other reasons for not completing study|4|||
156735863|NCT01489254|565780417|FG001|Double-blind Part|Other reasons for not completing study|6|||
156735864|NCT01489254|565780418|FG002|Double-blind Part|Other reasons for not completing study|0|||
156735865|NCT01489254|565780419|FG003|Double-blind Part|Other reasons for not completing study|0|||
156735866|NCT01489254|565780416|FG000|Open-label Extension Part|Adverse Event|0|||
156735867|NCT01489254|565780417|FG001|Open-label Extension Part|Adverse Event|0|||
156735868|NCT01489254|565780418|FG002|Open-label Extension Part|Adverse Event|0|||
156735869|NCT01489254|565780419|FG003|Open-label Extension Part|Adverse Event|10|||
156735870|NCT01489254|565780416|FG000|Open-label Extension Part|Pregnancy|0|||
156735871|NCT01489254|565780417|FG001|Open-label Extension Part|Pregnancy|0|||
156735872|NCT01489254|565780418|FG002|Open-label Extension Part|Pregnancy|0|||
156735873|NCT01489254|565780419|FG003|Open-label Extension Part|Pregnancy|3|||
156735874|NCT01489254|565780416|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
156735875|NCT01489254|565780417|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
156735876|NCT01489254|565780418|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
156735877|NCT01489254|565780419|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
156735878|NCT01489254|565780416|FG000|Open-label Extension Part|Protocol Violation|0|||
156735879|NCT01489254|565780417|FG001|Open-label Extension Part|Protocol Violation|0|||
156735880|NCT01489254|565780418|FG002|Open-label Extension Part|Protocol Violation|0|||
156735881|NCT01489254|565780419|FG003|Open-label Extension Part|Protocol Violation|1|||
156735882|NCT01489254|565780416|FG000|Open-label Extension Part|Lost to Follow-up|0|||
156735883|NCT01489254|565780417|FG001|Open-label Extension Part|Lost to Follow-up|0|||
156735884|NCT01489254|565780418|FG002|Open-label Extension Part|Lost to Follow-up|0|||
156534208|NCT03829241|565050900|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
156735885|NCT01489254|565780419|FG003|Open-label Extension Part|Lost to Follow-up|9|||
156735886|NCT01489254|565780416|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
156735887|NCT01489254|565780417|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
156808844|NCT01484496|566054473|FG000|Period 2|Lack of Efficacy|0|||
156735888|NCT01489254|565780418|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
156735889|NCT01489254|565780419|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
156735890|NCT02980341|565780424|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
156735891|NCT02980341|565780425|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
156735892|NCT02980341|565780426|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
156735893|NCT02980341|565780427|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
156735894|NCT02980341|565780428|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
156735895|NCT02980341|565780429|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735896|NCT02980341|565780430|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735897|NCT02980341|565780431|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735898|NCT02980341|565780432|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735899|NCT02980341|565780433|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735900|NCT02980341|565780434|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735901|NCT02980341|565780424|FG000|Dose Escalation|Clinical progression|0|||
156735902|NCT02980341|565780425|FG001|Dose Escalation|Clinical progression|0|||
156735903|NCT02980341|565780426|FG002|Dose Escalation|Clinical progression|2|||
156735904|NCT02980341|565780427|FG003|Dose Escalation|Clinical progression|1|||
156735905|NCT02980341|565780428|FG004|Dose Escalation|Clinical progression|0|||
156735906|NCT02980341|565780429|FG005|Dose Escalation|Clinical progression|0|||
156735907|NCT02980341|565780430|FG006|Dose Escalation|Clinical progression|0|||
156534209|NCT03829241|565050901|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
156534210|NCT03829241|565050900|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
156534211|NCT03829241|565050901|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
156534212|NCT03829241|565050900|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
156534213|NCT03829241|565050901|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
156534214|NCT03829241|565050900|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
156735908|NCT02980341|565780431|FG007|Dose Escalation|Clinical progression|0|||
156735909|NCT02980341|565780432|FG008|Dose Escalation|Clinical progression|0|||
156735910|NCT02980341|565780433|FG009|Dose Escalation|Clinical progression|0|||
156735911|NCT02980341|565780434|FG010|Dose Escalation|Clinical progression|0|||
156735912|NCT02980341|565780424|FG000|Dose Escalation|Adverse Event|0|||
156735913|NCT02980341|565780425|FG001|Dose Escalation|Adverse Event|0|||
156735914|NCT02980341|565780426|FG002|Dose Escalation|Adverse Event|1|||
156735915|NCT02980341|565780427|FG003|Dose Escalation|Adverse Event|2|||
156735916|NCT02980341|565780428|FG004|Dose Escalation|Adverse Event|2|||
156735917|NCT02980341|565780429|FG005|Dose Escalation|Adverse Event|0|||
156735918|NCT02980341|565780430|FG006|Dose Escalation|Adverse Event|0|||
156735919|NCT02980341|565780431|FG007|Dose Escalation|Adverse Event|0|||
156735920|NCT02980341|565780432|FG008|Dose Escalation|Adverse Event|0|||
156735921|NCT02980341|565780433|FG009|Dose Escalation|Adverse Event|0|||
156735922|NCT02980341|565780434|FG010|Dose Escalation|Adverse Event|0|||
156735923|NCT02980341|565780424|FG000|Dose Escalation|Withdrawal by Subject|0|||
156735924|NCT02980341|565780425|FG001|Dose Escalation|Withdrawal by Subject|0|||
156735925|NCT02980341|565780426|FG002|Dose Escalation|Withdrawal by Subject|1|||
156735926|NCT02980341|565780427|FG003|Dose Escalation|Withdrawal by Subject|0|||
156735927|NCT02980341|565780428|FG004|Dose Escalation|Withdrawal by Subject|0|||
156735928|NCT02980341|565780429|FG005|Dose Escalation|Withdrawal by Subject|0|||
156735929|NCT02980341|565780430|FG006|Dose Escalation|Withdrawal by Subject|0|||
156735930|NCT02980341|565780431|FG007|Dose Escalation|Withdrawal by Subject|0|||
156735931|NCT02980341|565780432|FG008|Dose Escalation|Withdrawal by Subject|0|||
156735932|NCT02980341|565780433|FG009|Dose Escalation|Withdrawal by Subject|0|||
156735933|NCT02980341|565780434|FG010|Dose Escalation|Withdrawal by Subject|0|||
156735934|NCT02980341|565780424|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735935|NCT02980341|565780425|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735936|NCT02980341|565780426|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735937|NCT02980341|565780427|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
156735938|NCT02980341|565780428|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735939|NCT02980341|565780429|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735940|NCT02980341|565780430|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735941|NCT02980341|565780431|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
156336695|NCT00839852|564329680|FG000|Overall Study|Insufficient Therapeutic Response|3|||
156336696|NCT00839852|564329680|FG000|Overall Study|Protocol Violation|9|||
156534215|NCT03829241|565050901|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
156534216|NCT03829241|565050900|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
156534217|NCT03829241|565050901|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
156735942|NCT02980341|565780432|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735943|NCT02980341|565780433|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735944|NCT02980341|565780434|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735945|NCT02980341|565780424|FG000|Dose Escalation|Due to investigator's decision|0|||
156735946|NCT02980341|565780425|FG001|Dose Escalation|Due to investigator's decision|0|||
156735947|NCT02980341|565780426|FG002|Dose Escalation|Due to investigator's decision|0|||
156735948|NCT02980341|565780427|FG003|Dose Escalation|Due to investigator's decision|0|||
156735949|NCT02980341|565780428|FG004|Dose Escalation|Due to investigator's decision|1|||
156735950|NCT02980341|565780429|FG005|Dose Escalation|Due to investigator's decision|0|||
156735951|NCT02980341|565780430|FG006|Dose Escalation|Due to investigator's decision|0|||
156735952|NCT02980341|565780431|FG007|Dose Escalation|Due to investigator's decision|0|||
156735953|NCT02980341|565780432|FG008|Dose Escalation|Due to investigator's decision|0|||
156735954|NCT02980341|565780433|FG009|Dose Escalation|Due to investigator's decision|0|||
156735955|NCT02980341|565780434|FG010|Dose Escalation|Due to investigator's decision|0|||
156735956|NCT02980341|565780424|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735957|NCT02980341|565780425|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735958|NCT02980341|565780426|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735959|NCT02980341|565780427|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735960|NCT02980341|565780428|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735961|NCT02980341|565780429|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
156735962|NCT02980341|565780430|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
156735963|NCT02980341|565780431|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735964|NCT02980341|565780432|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735965|NCT02980341|565780433|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735966|NCT02980341|565780434|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735967|NCT02980341|565780424|FG000|Dose Finding|Adverse Event|0|||
156735968|NCT02980341|565780425|FG001|Dose Finding|Adverse Event|0|||
156735969|NCT02980341|565780426|FG002|Dose Finding|Adverse Event|0|||
156735970|NCT02980341|565780427|FG003|Dose Finding|Adverse Event|0|||
156735971|NCT02980341|565780428|FG004|Dose Finding|Adverse Event|0|||
156735972|NCT02980341|565780429|FG005|Dose Finding|Adverse Event|3|||
156735973|NCT02980341|565780430|FG006|Dose Finding|Adverse Event|0|||
156735974|NCT02980341|565780431|FG007|Dose Finding|Adverse Event|0|||
156735975|NCT02980341|565780432|FG008|Dose Finding|Adverse Event|0|||
156735976|NCT02980341|565780433|FG009|Dose Finding|Adverse Event|0|||
156735977|NCT02980341|565780434|FG010|Dose Finding|Adverse Event|0|||
156735978|NCT02980341|565780424|FG000|Dose Finding|Withdrawal by Subject|0|||
156735979|NCT02980341|565780425|FG001|Dose Finding|Withdrawal by Subject|0|||
156735980|NCT02980341|565780426|FG002|Dose Finding|Withdrawal by Subject|0|||
156735981|NCT02980341|565780427|FG003|Dose Finding|Withdrawal by Subject|0|||
156735982|NCT02980341|565780428|FG004|Dose Finding|Withdrawal by Subject|0|||
156735983|NCT02980341|565780429|FG005|Dose Finding|Withdrawal by Subject|1|||
156735984|NCT02980341|565780430|FG006|Dose Finding|Withdrawal by Subject|1|||
156735985|NCT02980341|565780431|FG007|Dose Finding|Withdrawal by Subject|0|||
156735986|NCT02980341|565780432|FG008|Dose Finding|Withdrawal by Subject|0|||
156735987|NCT02980341|565780433|FG009|Dose Finding|Withdrawal by Subject|0|||
156735988|NCT02980341|565780434|FG010|Dose Finding|Withdrawal by Subject|0|||
156735989|NCT02980341|565780424|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735990|NCT02980341|565780425|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735991|NCT02980341|565780426|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735992|NCT02980341|565780427|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735993|NCT02980341|565780428|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735994|NCT02980341|565780429|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735995|NCT02980341|565780430|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735996|NCT02980341|565780431|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
156735997|NCT02980341|565780432|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
156735998|NCT02980341|565780433|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
156735999|NCT02980341|565780434|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
156736000|NCT02980341|565780424|FG000|Dose Expansion|Clinical progression|0|||
156736001|NCT02980341|565780425|FG001|Dose Expansion|Clinical progression|0|||
156736002|NCT02980341|565780426|FG002|Dose Expansion|Clinical progression|0|||
156736003|NCT02980341|565780427|FG003|Dose Expansion|Clinical progression|0|||
156736004|NCT02980341|565780428|FG004|Dose Expansion|Clinical progression|0|||
156736005|NCT02980341|565780429|FG005|Dose Expansion|Clinical progression|0|||
156736006|NCT02980341|565780430|FG006|Dose Expansion|Clinical progression|0|||
156736007|NCT02980341|565780431|FG007|Dose Expansion|Clinical progression|4|||
156736008|NCT02980341|565780432|FG008|Dose Expansion|Clinical progression|3|||
156736009|NCT02980341|565780433|FG009|Dose Expansion|Clinical progression|1|||
156736010|NCT02980341|565780434|FG010|Dose Expansion|Clinical progression|4|||
156736011|NCT02980341|565780424|FG000|Dose Expansion|Adverse Event|0|||
156736012|NCT02980341|565780425|FG001|Dose Expansion|Adverse Event|0|||
156736013|NCT02980341|565780426|FG002|Dose Expansion|Adverse Event|0|||
156736014|NCT02980341|565780427|FG003|Dose Expansion|Adverse Event|0|||
156736015|NCT02980341|565780428|FG004|Dose Expansion|Adverse Event|0|||
156736016|NCT02980341|565780429|FG005|Dose Expansion|Adverse Event|0|||
156736017|NCT02980341|565780430|FG006|Dose Expansion|Adverse Event|0|||
156736018|NCT02980341|565780431|FG007|Dose Expansion|Adverse Event|3|||
156736019|NCT02980341|565780432|FG008|Dose Expansion|Adverse Event|0|||
156736020|NCT02980341|565780433|FG009|Dose Expansion|Adverse Event|1|||
156736021|NCT02980341|565780434|FG010|Dose Expansion|Adverse Event|3|||
156736022|NCT02980341|565780424|FG000|Dose Expansion|Death|0|||
156736023|NCT02980341|565780425|FG001|Dose Expansion|Death|0|||
156736024|NCT02980341|565780426|FG002|Dose Expansion|Death|0|||
156736025|NCT02980341|565780427|FG003|Dose Expansion|Death|0|||
156736026|NCT02980341|565780428|FG004|Dose Expansion|Death|0|||
156736027|NCT02980341|565780429|FG005|Dose Expansion|Death|0|||
156736028|NCT02980341|565780430|FG006|Dose Expansion|Death|0|||
156736029|NCT02980341|565780431|FG007|Dose Expansion|Death|0|||
156736030|NCT02980341|565780432|FG008|Dose Expansion|Death|2|||
156736031|NCT02980341|565780433|FG009|Dose Expansion|Death|1|||
156736032|NCT02980341|565780434|FG010|Dose Expansion|Death|0|||
156736033|NCT02980341|565780424|FG000|Dose Expansion|Withdrawal by Subject|0|||
156736034|NCT02980341|565780425|FG001|Dose Expansion|Withdrawal by Subject|0|||
156736035|NCT02980341|565780426|FG002|Dose Expansion|Withdrawal by Subject|0|||
156736036|NCT02980341|565780427|FG003|Dose Expansion|Withdrawal by Subject|0|||
156736037|NCT02980341|565780428|FG004|Dose Expansion|Withdrawal by Subject|0|||
156736038|NCT02980341|565780429|FG005|Dose Expansion|Withdrawal by Subject|0|||
156736039|NCT02980341|565780430|FG006|Dose Expansion|Withdrawal by Subject|0|||
156736040|NCT02980341|565780431|FG007|Dose Expansion|Withdrawal by Subject|2|||
156736041|NCT02980341|565780432|FG008|Dose Expansion|Withdrawal by Subject|0|||
156736042|NCT02980341|565780433|FG009|Dose Expansion|Withdrawal by Subject|1|||
156736043|NCT02980341|565780434|FG010|Dose Expansion|Withdrawal by Subject|0|||
156736044|NCT02980341|565780424|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736045|NCT02980341|565780425|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736046|NCT02980341|565780426|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736047|NCT02980341|565780427|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736048|NCT02980341|565780428|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736049|NCT02980341|565780429|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736050|NCT02980341|565780430|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736051|NCT02980341|565780431|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
156736052|NCT02980341|565780432|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736053|NCT02980341|565780433|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736054|NCT02980341|565780434|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736055|NCT02980341|565780424|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736056|NCT02980341|565780425|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736057|NCT02980341|565780426|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736058|NCT02980341|565780427|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736059|NCT02980341|565780428|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736060|NCT02980341|565780429|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736061|NCT02980341|565780430|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736062|NCT02980341|565780431|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736063|NCT02980341|565780432|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
156876757|NCT02474069|566307727|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
156876758|NCT02474069|566307725|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
156876759|NCT02474069|566307726|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
156876760|NCT02474069|566307727|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
156736064|NCT02980341|565780433|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736065|NCT02980341|565780434|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736066|NCT02980341|565780424|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736067|NCT02980341|565780425|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736068|NCT02980341|565780426|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736069|NCT02980341|565780427|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736070|NCT02980341|565780428|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736071|NCT02980341|565780429|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736072|NCT02980341|565780430|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736073|NCT02980341|565780431|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736074|NCT02980341|565780432|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
156736075|NCT02980341|565780433|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736076|NCT02980341|565780434|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156457517|NCT04800211|564770095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
156457518|NCT04800211|564770093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
156736077|NCT02980341|565780424|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736078|NCT02980341|565780425|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736079|NCT02980341|565780426|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736080|NCT02980341|565780427|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736081|NCT02980341|565780428|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736082|NCT02980341|565780429|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736083|NCT02980341|565780430|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736084|NCT02980341|565780431|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736085|NCT02980341|565780432|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736086|NCT02980341|565780433|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736087|NCT02980341|565780434|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
156736088|NCT01895608|565780436|FG000|Overall Study|change in health status|0|||
156736089|NCT01895608|565780437|FG001|Overall Study|change in health status|1|||
156736090|NCT01895608|565780438|FG002|Overall Study|change in health status|1|||
156736091|NCT01895608|565780439|FG003|Overall Study|change in health status|0|||
156736092|NCT01895608|565780436|FG000|Overall Study|Withdrawal by Subject|0|||
156736093|NCT01895608|565780437|FG001|Overall Study|Withdrawal by Subject|0|||
156736094|NCT01895608|565780438|FG002|Overall Study|Withdrawal by Subject|2|||
156736095|NCT01895608|565780439|FG003|Overall Study|Withdrawal by Subject|0|||
156736096|NCT02691936|565780440|FG000|Overall Study|Withdrawal by Subject|2|||
156736097|NCT02691936|565780441|FG001|Overall Study|Withdrawal by Subject|5|||
156736098|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
156736099|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
156736100|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
156736101|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
156736102|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
156736103|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
156736104|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
156736105|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
156736106|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
156736107|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
156736108|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Death|1|||
156736109|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Death|0|||
156736110|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
156736111|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
156736112|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
156736113|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
156736114|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
156796911|NCT00725985|566009677|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796912|NCT00725985|566009678|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
156796913|NCT00725985|566009679|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796914|NCT00725985|566009680|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156457519|NCT04800211|564770094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
156457520|NCT04800211|564770095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
156796915|NCT00725985|566009681|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796916|NCT00725985|566009682|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796917|NCT00725985|566009671|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796918|NCT00725985|566009672|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796919|NCT00725985|566009673|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796920|NCT00725985|566009674|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796921|NCT00725985|566009675|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796922|NCT00725985|566009676|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796923|NCT00725985|566009677|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796924|NCT00725985|566009678|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796925|NCT00725985|566009679|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
156796926|NCT00725985|566009680|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796927|NCT00725985|566009681|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796928|NCT00725985|566009682|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796929|NCT00725985|566009671|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796930|NCT00725985|566009672|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796931|NCT00725985|566009673|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796932|NCT00725985|566009674|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796933|NCT00725985|566009675|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796934|NCT00725985|566009676|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796935|NCT00725985|566009677|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
156736115|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
156736116|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
156736117|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
156736118|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Adverse Event|2|||
156736119|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Adverse Event|6|||
156736120|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
156736121|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
156736122|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Progressive disease|4|||
156736123|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Progressive disease|35|||
156736124|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
156736125|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
156736126|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
156736127|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
156736128|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Death|0|||
156736129|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Death|1|||
156736130|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Other than specified above|9|||
156736131|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Other than specified above|18|||
156736132|NCT00749684|565780444|FG000|Overall Study|Death|1|||
156736133|NCT00749684|565780444|FG000|Overall Study|Adverse Event|27|||
156736134|NCT00749684|565780444|FG000|Overall Study|Participant's Wish|10|||
156736135|NCT00749684|565780444|FG000|Overall Study|Not Documented|1|||
156736136|NCT00749684|565780444|FG000|Overall Study|Progressive Desease|31|||
156736137|NCT00749684|565780444|FG000|Overall Study|Therapy according to protocol + AE|2|||
156736138|NCT00749684|565780444|FG000|Overall Study|AE+discontinuation on participants wish|1|||
156736139|NCT00749684|565780444|FG000|Overall Study|Missing|9|||
156736140|NCT01194531|565780446|FG000|Overall Study|Withdrawal by Subject|1|||
156736141|NCT01194531|565780447|FG001|Overall Study|Withdrawal by Subject|0|||
156736142|NCT01194531|565780446|FG000|Overall Study|Protocol Violation|4|||
156736143|NCT01194531|565780447|FG001|Overall Study|Protocol Violation|1|||
156736144|NCT01194531|565780446|FG000|Overall Study|Physician Decision|0|||
156736145|NCT01194531|565780447|FG001|Overall Study|Physician Decision|2|||
156736146|NCT03891862|565780448|FG000|Open-label Period|Adverse Event|2|||
156736147|NCT03891862|565780449|FG001|Open-label Period|Adverse Event|0|||
156736148|NCT03891862|565780450|FG002|Open-label Period|Adverse Event|0|||
156736149|NCT03891862|565780448|FG000|Open-label Period|Protocol Violation|5|||
156736150|NCT03891862|565780449|FG001|Open-label Period|Protocol Violation|0|||
156736151|NCT03891862|565780450|FG002|Open-label Period|Protocol Violation|0|||
156736152|NCT03891862|565780448|FG000|Open-label Period|Withdrawal by Subject|6|||
156736153|NCT03891862|565780449|FG001|Open-label Period|Withdrawal by Subject|0|||
156736154|NCT03891862|565780450|FG002|Open-label Period|Withdrawal by Subject|0|||
156736155|NCT03891862|565780448|FG000|Open-label Period|Death|1|||
156736156|NCT03891862|565780449|FG001|Open-label Period|Death|0|||
156736157|NCT03891862|565780450|FG002|Open-label Period|Death|0|||
156736158|NCT03891862|565780448|FG000|Open-label Period|Lost to Follow-up|2|||
156736159|NCT03891862|565780449|FG001|Open-label Period|Lost to Follow-up|0|||
156736160|NCT03891862|565780450|FG002|Open-label Period|Lost to Follow-up|0|||
156736161|NCT03891862|565780448|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
156736162|NCT03891862|565780449|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
156736163|NCT03891862|565780450|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
156736164|NCT03891862|565780448|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
156736165|NCT03891862|565780449|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
156736166|NCT03891862|565780450|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
156736167|NCT03891862|565780448|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
156736168|NCT03891862|565780449|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
156736169|NCT03891862|565780450|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
156736170|NCT03891862|565780448|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
156736171|NCT03891862|565780449|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
156736172|NCT03891862|565780450|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
156736173|NCT01053962|565780451|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
156736174|NCT01053962|565780452|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
156736175|NCT01053962|565780453|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
156736176|NCT01053962|565780454|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
156736177|NCT01053962|565780455|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
156736178|NCT01053962|565780451|FG000|Pretreatment Period|Venipuncture Failure|0|||
156736179|NCT01053962|565780452|FG001|Pretreatment Period|Venipuncture Failure|0|||
156736180|NCT01053962|565780453|FG002|Pretreatment Period|Venipuncture Failure|1|||
156736181|NCT01053962|565780454|FG003|Pretreatment Period|Venipuncture Failure|0|||
156736182|NCT01053962|565780455|FG004|Pretreatment Period|Venipuncture Failure|0|||
156736183|NCT01053962|565780451|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
156736184|NCT01053962|565780452|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
156736185|NCT01053962|565780453|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
156457521|NCT04800211|564770093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
156457522|NCT04800211|564770094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
156457523|NCT04800211|564770095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
156457524|NCT04800211|564770093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
156457525|NCT04800211|564770094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
156736186|NCT01053962|565780454|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
156736187|NCT01053962|565780455|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
156736188|NCT01053962|565780451|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
156736189|NCT01053962|565780452|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
156736190|NCT01053962|565780453|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
156736191|NCT01053962|565780454|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
156736192|NCT01053962|565780455|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
156736193|NCT01053962|565780451|FG000|Treatment Period|Lack of Efficacy|0|||
156736194|NCT01053962|565780452|FG001|Treatment Period|Lack of Efficacy|0|||
156736195|NCT01053962|565780453|FG002|Treatment Period|Lack of Efficacy|0|||
156736196|NCT01053962|565780454|FG003|Treatment Period|Lack of Efficacy|0|||
156736197|NCT01053962|565780455|FG004|Treatment Period|Lack of Efficacy|1|||
156736198|NCT01053962|565780451|FG000|Treatment Period|Adverse Event|0|||
156736199|NCT01053962|565780452|FG001|Treatment Period|Adverse Event|0|||
156736200|NCT01053962|565780453|FG002|Treatment Period|Adverse Event|0|||
156736201|NCT01053962|565780454|FG003|Treatment Period|Adverse Event|0|||
156736202|NCT01053962|565780455|FG004|Treatment Period|Adverse Event|1|||
156736203|NCT01053962|565780451|FG000|Treatment Period|Withdrawal by Subject|0|||
156736204|NCT01053962|565780452|FG001|Treatment Period|Withdrawal by Subject|0|||
156736205|NCT01053962|565780453|FG002|Treatment Period|Withdrawal by Subject|0|||
156736206|NCT01053962|565780454|FG003|Treatment Period|Withdrawal by Subject|0|||
156876761|NCT02474069|566307725|FG000|Selection Phase (SP)|Physician Decision|1|||
156876762|NCT02474069|566307726|FG001|Selection Phase (SP)|Physician Decision|0|||
156876763|NCT02474069|566307727|FG002|Selection Phase (SP)|Physician Decision|0|||
156876764|NCT02474069|566307725|FG000|Selection Phase (SP)|Protocol Violation|1|||
156876765|NCT02474069|566307726|FG001|Selection Phase (SP)|Protocol Violation|0|||
156876766|NCT02474069|566307727|FG002|Selection Phase (SP)|Protocol Violation|0|||
156876767|NCT02474069|566307725|FG000|Selection Phase (SP)|No longer requires treatment|1|||
156876768|NCT02474069|566307726|FG001|Selection Phase (SP)|No longer requires treatment|0|||
156876769|NCT02474069|566307727|FG002|Selection Phase (SP)|No longer requires treatment|0|||
156876770|NCT02474069|566307725|FG000|Selection Phase (SP)|Technical Problem|1|||
156876771|NCT02474069|566307726|FG001|Selection Phase (SP)|Technical Problem|0|||
156876772|NCT02474069|566307727|FG002|Selection Phase (SP)|Technical Problem|0|||
156876773|NCT02474069|566307725|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
156876774|NCT02474069|566307726|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
156876775|NCT02474069|566307727|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
156876776|NCT02474069|566307725|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
156876777|NCT02474069|566307726|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
156876778|NCT02474069|566307727|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
156876779|NCT02474069|566307725|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
156876780|NCT02474069|566307726|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
156876781|NCT02474069|566307727|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
156876782|NCT02474069|566307725|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
156876783|NCT02474069|566307726|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
156876784|NCT02474069|566307727|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
156876785|NCT02474069|566307725|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
156876786|NCT02474069|566307726|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
156876787|NCT02474069|566307727|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
156876788|NCT02474069|566307725|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
156876789|NCT02474069|566307726|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
156876790|NCT02474069|566307727|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
156876791|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
156457526|NCT04800211|564770095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
156457527|NCT04800211|564770093|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
156736207|NCT01053962|565780455|FG004|Treatment Period|Withdrawal by Subject|1|||
156736208|NCT01053962|565780451|FG000|Treatment Period|Noncompliance with protocol|1|||
156736209|NCT01053962|565780452|FG001|Treatment Period|Noncompliance with protocol|0|||
156736210|NCT01053962|565780453|FG002|Treatment Period|Noncompliance with protocol|0|||
156876792|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
156876793|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
156876794|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
156876795|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
156736211|NCT01053962|565780454|FG003|Treatment Period|Noncompliance with protocol|0|||
156876796|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
156736212|NCT01053962|565780455|FG004|Treatment Period|Noncompliance with protocol|0|||
156736213|NCT03089697|565780458|FG000|Overall Study|Adverse Event|1|||
156736214|NCT03089697|565780459|FG001|Overall Study|Adverse Event|2|||
156736215|NCT03089697|565780458|FG000|Overall Study|Withdrawal by Subject|1|||
156736216|NCT03089697|565780459|FG001|Overall Study|Withdrawal by Subject|0|||
156736217|NCT00638443|565780460|FG000|First Intervention|Adverse Event|2|||
156736218|NCT00638443|565780461|FG001|First Intervention|Adverse Event|1|||
156736219|NCT01044290|565780462|FG000|Follow-up 1|Death|3|||
156736220|NCT01044290|565780463|FG001|Follow-up 1|Death|3|||
156736221|NCT01044290|565780464|FG002|Follow-up 1|Death|1|||
156736222|NCT01044290|565780462|FG000|Follow-up 1|Withdrawal by Subject|2|||
156736223|NCT01044290|565780463|FG001|Follow-up 1|Withdrawal by Subject|2|||
156736224|NCT01044290|565780464|FG002|Follow-up 1|Withdrawal by Subject|0|||
156736225|NCT01044290|565780462|FG000|Follow-Up 2|Death|0|||
156736226|NCT01044290|565780463|FG001|Follow-Up 2|Death|1|||
156736227|NCT01044290|565780464|FG002|Follow-Up 2|Death|1|||
156736228|NCT01044290|565780462|FG000|Follow-Up 2|Withdrawal by Subject|0|||
156736229|NCT01044290|565780463|FG001|Follow-Up 2|Withdrawal by Subject|1|||
156736230|NCT01044290|565780464|FG002|Follow-Up 2|Withdrawal by Subject|1|||
156736231|NCT01646021|565780465|FG000|Overall Study|Death|77|||
156736232|NCT01646021|565780466|FG001|Overall Study|Death|83|||
156736233|NCT01646021|565780465|FG000|Overall Study|Study Terminated by Sponsor|50|||
156736234|NCT01646021|565780466|FG001|Overall Study|Study Terminated by Sponsor|41|||
156736235|NCT01646021|565780465|FG000|Overall Study|Lost to Follow-up|2|||
156736236|NCT01646021|565780466|FG001|Overall Study|Lost to Follow-up|2|||
156736237|NCT01646021|565780465|FG000|Overall Study|Withdrawal by Subject|10|||
156736238|NCT01646021|565780466|FG001|Overall Study|Withdrawal by Subject|15|||
156736239|NCT01967706|565780469|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
156736240|NCT01967706|565780470|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
156736241|NCT01967706|565780471|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
156736242|NCT01967706|565780472|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
156736243|NCT01552915|565780483|FG000|Overall Study|Adverse Event|3|||
156736244|NCT01552915|565780484|FG001|Overall Study|Adverse Event|14|||
156736245|NCT01552915|565780485|FG002|Overall Study|Adverse Event|3|||
156736246|NCT01552915|565780483|FG000|Overall Study|Lost to Follow-up|4|||
156736247|NCT01552915|565780484|FG001|Overall Study|Lost to Follow-up|6|||
156736248|NCT01552915|565780485|FG002|Overall Study|Lost to Follow-up|5|||
156736249|NCT01552915|565780483|FG000|Overall Study|Withdrawal by Subject|6|||
156736250|NCT01552915|565780484|FG001|Overall Study|Withdrawal by Subject|4|||
156736251|NCT01552915|565780485|FG002|Overall Study|Withdrawal by Subject|5|||
156736252|NCT01552915|565780483|FG000|Overall Study|Protocol Violation|0|||
156736253|NCT01552915|565780484|FG001|Overall Study|Protocol Violation|4|||
156736254|NCT01552915|565780485|FG002|Overall Study|Protocol Violation|4|||
156736255|NCT01552915|565780483|FG000|Overall Study|Lack of Efficacy|8|||
156736256|NCT01552915|565780484|FG001|Overall Study|Lack of Efficacy|1|||
156736257|NCT01552915|565780485|FG002|Overall Study|Lack of Efficacy|4|||
156736258|NCT01552915|565780483|FG000|Overall Study|Other|2|||
156736259|NCT01552915|565780484|FG001|Overall Study|Other|0|||
156736260|NCT01552915|565780485|FG002|Overall Study|Other|6|||
156736261|NCT00750139|565780494|FG000|Overall Study|Adverse Event|1|||
156736262|NCT00750139|565780495|FG001|Overall Study|Adverse Event|2|||
156736263|NCT00750139|565780496|FG002|Overall Study|Adverse Event|0|||
156736264|NCT00750139|565780497|FG003|Overall Study|Adverse Event|1|||
156736265|NCT00750139|565780494|FG000|Overall Study|Lost to Follow-up|17|||
156736266|NCT00750139|565780495|FG001|Overall Study|Lost to Follow-up|12|||
156736267|NCT00750139|565780496|FG002|Overall Study|Lost to Follow-up|15|||
156736268|NCT00750139|565780497|FG003|Overall Study|Lost to Follow-up|6|||
156736269|NCT00750139|565780494|FG000|Overall Study|Withdrawal by Subject|3|||
156736270|NCT00750139|565780495|FG001|Overall Study|Withdrawal by Subject|2|||
156736271|NCT00750139|565780496|FG002|Overall Study|Withdrawal by Subject|6|||
156736272|NCT00750139|565780497|FG003|Overall Study|Withdrawal by Subject|2|||
156736273|NCT00750139|565780494|FG000|Overall Study|Physician Decision|1|||
156736274|NCT00750139|565780495|FG001|Overall Study|Physician Decision|1|||
156736275|NCT00750139|565780496|FG002|Overall Study|Physician Decision|0|||
156457528|NCT04800211|564770094|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
156736276|NCT00750139|565780497|FG003|Overall Study|Physician Decision|0|||
156736277|NCT00750139|565780494|FG000|Overall Study|Non-compliance|1|||
156736278|NCT00750139|565780495|FG001|Overall Study|Non-compliance|0|||
156736279|NCT00750139|565780496|FG002|Overall Study|Non-compliance|1|||
156736280|NCT00750139|565780497|FG003|Overall Study|Non-compliance|3|||
156736281|NCT00750139|565780494|FG000|Overall Study|Termination by sponsor|4|||
156736282|NCT00750139|565780495|FG001|Overall Study|Termination by sponsor|0|||
156736283|NCT00750139|565780496|FG002|Overall Study|Termination by sponsor|0|||
156736284|NCT00750139|565780497|FG003|Overall Study|Termination by sponsor|1|||
156736285|NCT00750139|565780494|FG000|Overall Study|Non-specific|62|||
156736286|NCT00750139|565780495|FG001|Overall Study|Non-specific|42|||
156736287|NCT00750139|565780496|FG002|Overall Study|Non-specific|79|||
156736288|NCT00750139|565780497|FG003|Overall Study|Non-specific|33|||
156736289|NCT00658775|565780498|FG000|Overall Study|Adverse Event|4|||
156736290|NCT00658775|565780499|FG001|Overall Study|Adverse Event|6|||
156736291|NCT00658775|565780498|FG000|Overall Study|Lost to Follow-up|17|||
156736292|NCT00658775|565780499|FG001|Overall Study|Lost to Follow-up|18|||
156876797|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
156876798|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
156876799|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
156876800|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
156457529|NCT04800211|564770095|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
156736293|NCT00658775|565780498|FG000|Overall Study|Withdrawal by Subject|6|||
156457530|NCT04800211|564770093|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
156457531|NCT04800211|564770094|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
156457532|NCT04800211|564770095|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
156457533|NCT04800211|564770093|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
156457534|NCT04800211|564770094|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
156457535|NCT04800211|564770095|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
156457536|NCT05256017|564772366|FG000|Treatment Period|Withdrawal by Subject|1|||
156736294|NCT00658775|565780499|FG001|Overall Study|Withdrawal by Subject|4|||
156736295|NCT00658775|565780498|FG000|Overall Study|Withdrawal of consent|8|||
156736296|NCT00658775|565780499|FG001|Overall Study|Withdrawal of consent|7|||
156736297|NCT00658775|565780498|FG000|Overall Study|Other|7|||
156736298|NCT00658775|565780499|FG001|Overall Study|Other|8|||
156736299|NCT01992653|565780502|FG000|Overall Study|Death|0|||
156736300|NCT01992653|565780503|FG001|Overall Study|Death|0|||
156736301|NCT01992653|565780504|FG002|Overall Study|Death|1|||
156736302|NCT01992653|565780505|FG003|Overall Study|Death|0|||
156736303|NCT01992653|565780506|FG004|Overall Study|Death|1|||
156736304|NCT01992653|565780507|FG005|Overall Study|Death|0|||
156457537|NCT05256017|564772367|FG001|Treatment Period|Withdrawal by Subject|1|||
156457538|NCT05256017|564772366|FG000|Follow-up|Lost to Follow-up|7|||
156457539|NCT05256017|564772367|FG001|Follow-up|Lost to Follow-up|1|||
156457540|NCT05256017|564772366|FG000|Follow-up|Withdrawal by Subject|1|||
156457541|NCT05256017|564772367|FG001|Follow-up|Withdrawal by Subject|0|||
156457542|NCT05256017|564772366|FG000|Follow-up|Death|0|||
156457543|NCT05256017|564772367|FG001|Follow-up|Death|1|||
156457544|NCT03668236|564772370|FG000|90-day Follow-up|Withdrawal by Subject|3|||
156457545|NCT03668236|564772371|FG001|90-day Follow-up|Withdrawal by Subject|2|||
156457546|NCT03668236|564772370|FG000|90-day Follow-up|Lost to Follow-up|3|||
156457547|NCT03668236|564772371|FG001|90-day Follow-up|Lost to Follow-up|1|||
156457548|NCT03668236|564772370|FG000|Baseline Characteristics|Lost to Follow-up|9|||
156457549|NCT03668236|564772371|FG001|Baseline Characteristics|Lost to Follow-up|5|||
156457550|NCT03668236|564772370|FG000|1-year Follow-up|Withdrawal by Subject|17|||
156457551|NCT03668236|564772371|FG001|1-year Follow-up|Withdrawal by Subject|15|||
156457552|NCT06132282|564772372|FG000|Overall Study|Lost to Follow-up|31|||
156457553|NCT03748953|564772376|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
156457554|NCT03748953|564772377|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
156457555|NCT03748953|564772376|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
156457556|NCT03748953|564772377|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
156457557|NCT03748953|564772376|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
156457558|NCT03748953|564772377|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
156457559|NCT03748953|564772376|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
156457560|NCT03748953|564772377|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
156457561|NCT03748953|564772376|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
156457562|NCT03748953|564772377|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
156457563|NCT04858451|564772378|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
156457564|NCT04858451|564772379|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
156457565|NCT04858451|564772380|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
156457566|NCT04858451|564772381|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
156457567|NCT04858451|564772382|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
156457568|NCT04858451|564772383|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
156457569|NCT04858451|564772384|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
156457570|NCT04858451|564772385|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
156736305|NCT01992653|565780508|FG006|Overall Study|Death|4|||
156736306|NCT01992653|565780509|FG007|Overall Study|Death|2|||
156736307|NCT01992653|565780502|FG000|Overall Study|Lost to Follow-up|0|||
156736308|NCT01992653|565780503|FG001|Overall Study|Lost to Follow-up|0|||
156736309|NCT01992653|565780504|FG002|Overall Study|Lost to Follow-up|0|||
156736310|NCT01992653|565780505|FG003|Overall Study|Lost to Follow-up|0|||
156736311|NCT01992653|565780506|FG004|Overall Study|Lost to Follow-up|0|||
156736312|NCT01992653|565780507|FG005|Overall Study|Lost to Follow-up|0|||
156876801|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
156457571|NCT04858451|564772386|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
156736313|NCT01992653|565780508|FG006|Overall Study|Lost to Follow-up|0|||
156736314|NCT01992653|565780509|FG007|Overall Study|Lost to Follow-up|1|||
156736315|NCT01992653|565780502|FG000|Overall Study|Study Completed|0|||
156736316|NCT01992653|565780503|FG001|Overall Study|Study Completed|0|||
156736317|NCT01992653|565780504|FG002|Overall Study|Study Completed|0|||
156736318|NCT01992653|565780505|FG003|Overall Study|Study Completed|0|||
156736319|NCT01992653|565780506|FG004|Overall Study|Study Completed|0|||
156336697|NCT00839852|564329680|FG000|Overall Study|Withdrawal of Consent|16|||
156336698|NCT00839852|564329680|FG000|Overall Study|Lost to Follow-up|7|||
156336699|NCT00839852|564329680|FG000|Overall Study|Lack of Compliance While in Jail|1|||
156336700|NCT00839852|564329680|FG000|Overall Study|Pregnancy|1|||
156336701|NCT02846324|564329682|FG000|Overall Study|Other|1|||
156336702|NCT02846324|564329683|FG001|Overall Study|Other|0|||
156336703|NCT02846324|564329684|FG002|Overall Study|Other|0|||
156336704|NCT02846324|564329685|FG003|Overall Study|Other|0|||
156336705|NCT02846324|564329682|FG000|Overall Study|Withdrawal by Subject|1|||
156336706|NCT02846324|564329683|FG001|Overall Study|Withdrawal by Subject|0|||
156336707|NCT02846324|564329684|FG002|Overall Study|Withdrawal by Subject|4|||
156336708|NCT02846324|564329685|FG003|Overall Study|Withdrawal by Subject|0|||
156336709|NCT00003487|564329694|FG000|Overall Study|Not evaluable|2|||
156336710|NCT04154930|564329695|FG000|Overall Study|Withdrawal by Subject|15|||
156336711|NCT04154930|564329696|FG001|Overall Study|Withdrawal by Subject|6|||
156336712|NCT04154930|564329695|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
156336713|NCT04154930|564329696|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
156336714|NCT04154930|564329695|FG000|Overall Study|Lost to Follow-up|14|||
156336715|NCT04154930|564329696|FG001|Overall Study|Lost to Follow-up|6|||
156336716|NCT04154930|564329695|FG000|Overall Study|Other|6|||
156336717|NCT04154930|564329696|FG001|Overall Study|Other|0|||
156336718|NCT00657358|564329697|FG000|Overall Study|Lack of Efficacy|6|||
156336719|NCT02130297|564329701|FG000|Overall Study|Lost to Follow-up|4|||
156336720|NCT01999179|564329702|FG000|Overall Study|Adverse Event|1|||
156336721|NCT01999179|564329702|FG000|Overall Study|Lost to Follow-up|1|||
156457572|NCT04858451|564772378|FG000|Part 2|Discontinued|0|||
156457573|NCT04858451|564772379|FG001|Part 2|Discontinued|0|||
156457574|NCT04858451|564772380|FG002|Part 2|Discontinued|0|||
156457575|NCT04858451|564772381|FG003|Part 2|Discontinued|0|||
156736320|NCT01992653|565780507|FG005|Overall Study|Study Completed|0|||
156736321|NCT01992653|565780508|FG006|Overall Study|Study Completed|0|||
156736322|NCT01992653|565780509|FG007|Overall Study|Study Completed|1|||
156736323|NCT01992653|565780502|FG000|Overall Study|Disease Progression|0|||
156736324|NCT01992653|565780503|FG001|Overall Study|Disease Progression|0|||
156736325|NCT01992653|565780504|FG002|Overall Study|Disease Progression|0|||
156736326|NCT01992653|565780505|FG003|Overall Study|Disease Progression|0|||
156736327|NCT01992653|565780506|FG004|Overall Study|Disease Progression|0|||
156736328|NCT01992653|565780507|FG005|Overall Study|Disease Progression|0|||
156736329|NCT01992653|565780508|FG006|Overall Study|Disease Progression|4|||
156736330|NCT01992653|565780509|FG007|Overall Study|Disease Progression|0|||
156736331|NCT01435460|565780510|FG000|Overall Study|Adverse Event|2|||
156736332|NCT01435460|565780511|FG001|Overall Study|Adverse Event|1|||
156736333|NCT01435460|565780510|FG000|Overall Study|Lost to Follow-up|6|||
156736334|NCT01435460|565780511|FG001|Overall Study|Lost to Follow-up|1|||
156736335|NCT01435460|565780510|FG000|Overall Study|Withdrawal by Subject|1|||
156736336|NCT01435460|565780511|FG001|Overall Study|Withdrawal by Subject|3|||
156736337|NCT01435460|565780510|FG000|Overall Study|Protocol Violation|0|||
156736338|NCT01435460|565780511|FG001|Overall Study|Protocol Violation|1|||
156736339|NCT01435460|565780510|FG000|Overall Study|Did not meet eligibility criteria|2|||
156736340|NCT01435460|565780511|FG001|Overall Study|Did not meet eligibility criteria|0|||
156736341|NCT01706939|565780512|FG000|Pre Randomization|Screen Failure|1|||
156736342|NCT01706939|565780513|FG001|Pre Randomization|Screen Failure|0|||
156736343|NCT01706939|565780514|FG002|Pre Randomization|Screen Failure|0|||
156736344|NCT01706939|565780512|FG000|Pre Randomization|Ineligible for Randomization|1|||
156736345|NCT01706939|565780513|FG001|Pre Randomization|Ineligible for Randomization|0|||
156736346|NCT01706939|565780514|FG002|Pre Randomization|Ineligible for Randomization|0|||
156457576|NCT04858451|564772382|FG004|Part 2|Discontinued|0|||
156736347|NCT01706939|565780512|FG000|Pre Randomization|Withdrawal by Subject|1|||
156457577|NCT04858451|564772383|FG005|Part 2|Discontinued|0|||
156457578|NCT04858451|564772384|FG006|Part 2|Discontinued|0|||
156457579|NCT04858451|564772385|FG007|Part 2|Discontinued|0|||
156457580|NCT04858451|564772386|FG008|Part 2|Discontinued|63|||
156457581|NCT03314454|564772387|FG000|Overall Study|Protocol Violation|1|||
156457582|NCT02841579|564772396|FG000|Overall Study|Death|1|||
156457583|NCT02841579|564772396|FG000|Overall Study|Adverse Event|1|||
156736348|NCT01706939|565780513|FG001|Pre Randomization|Withdrawal by Subject|0|||
156736349|NCT01706939|565780514|FG002|Pre Randomization|Withdrawal by Subject|0|||
156736350|NCT01706939|565780512|FG000|Randomization|Insufficient QoL survey compliance|0|||
156736351|NCT01706939|565780513|FG001|Randomization|Insufficient QoL survey compliance|1|||
156736352|NCT01706939|565780514|FG002|Randomization|Insufficient QoL survey compliance|1|||
156736353|NCT01706939|565780512|FG000|Randomization|Progression of disease|0|||
156336722|NCT01999179|564329702|FG000|Overall Study|Change in Therapy|3|||
156336723|NCT01999179|564329702|FG000|Overall Study|New catheter|2|||
156336724|NCT00678080|564329706|FG000|Overall Study|Physician Decision|2|||
156336725|NCT00678080|564329707|FG001|Overall Study|Physician Decision|0|||
156336726|NCT00678080|564329706|FG000|Overall Study|Lost to Follow-up|1|||
156336727|NCT00678080|564329707|FG001|Overall Study|Lost to Follow-up|0|||
156336728|NCT00678080|564329706|FG000|Overall Study|Withdrawal by Subject|0|||
156457584|NCT02841579|564772396|FG000|Overall Study|Lack of Efficacy|9|||
156457585|NCT03011333|564772399|FG000|Overall Study|Lost to Follow-up|0|||
156457586|NCT03011333|564772400|FG001|Overall Study|Lost to Follow-up|1|||
156457587|NCT03011333|564772401|FG002|Overall Study|Lost to Follow-up|0|||
156457588|NCT03011333|564772402|FG003|Overall Study|Lost to Follow-up|1|||
156457589|NCT03011333|564772403|FG004|Overall Study|Lost to Follow-up|4|||
156457590|NCT03011333|564772404|FG005|Overall Study|Lost to Follow-up|4|||
156457591|NCT03011333|564772405|FG006|Overall Study|Lost to Follow-up|5|||
156457592|NCT04233216|564772406|FG000|Overall Study|Lost to Follow-up|1|||
156457593|NCT04233216|564772407|FG001|Overall Study|Lost to Follow-up|0|||
156736354|NCT01706939|565780513|FG001|Randomization|Progression of disease|2|||
156736355|NCT01706939|565780514|FG002|Randomization|Progression of disease|1|||
156736356|NCT01046903|565780515|FG000|Overall Study|Lost to Follow-up|16|||
156736357|NCT01046903|565780515|FG000|Overall Study|Adverse Event|4|||
156736358|NCT01046903|565780515|FG000|Overall Study|Withdrawal by Subject|3|||
156736359|NCT01046903|565780515|FG000|Overall Study|Other|5|||
156736360|NCT04013672|565780517|FG000|Overall Study|Withdrawal by Subject|3|||
156736361|NCT04013672|565780518|FG001|Overall Study|Withdrawal by Subject|0|||
156736362|NCT04013672|565780517|FG000|Overall Study|Death|1|||
156736363|NCT04013672|565780518|FG001|Overall Study|Death|0|||
156736364|NCT04013672|565780517|FG000|Overall Study|Physician Decision|5|||
156736365|NCT04013672|565780518|FG001|Overall Study|Physician Decision|0|||
156736366|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
156736367|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
156736368|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
156736369|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
156736370|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
156736371|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
156736372|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
156736373|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
156736374|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
156736375|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
156736376|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
156736377|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
156736378|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
156736379|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
156736380|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
156736381|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
156736382|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
156736383|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
156736384|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
156457594|NCT04233216|564772408|FG002|Overall Study|Lost to Follow-up|2|||
156457595|NCT04233216|564772409|FG003|Overall Study|Lost to Follow-up|0|||
156457596|NCT04233216|564772406|FG000|Overall Study|Physician Decision|0|||
156457597|NCT04233216|564772407|FG001|Overall Study|Physician Decision|3|||
156736385|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
156736386|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
156736387|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
156736388|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
156736389|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
156736390|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
156736391|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
156736392|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
156736393|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
156736394|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
156876802|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
156876803|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
156876804|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
156876805|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
156876806|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
156876807|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
156876808|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
156876809|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
156457598|NCT04233216|564772408|FG002|Overall Study|Physician Decision|0|||
156457599|NCT04233216|564772409|FG003|Overall Study|Physician Decision|2|||
156457600|NCT04233216|564772406|FG000|Overall Study|Withdrawal by Subject|0|||
156457601|NCT04233216|564772407|FG001|Overall Study|Withdrawal by Subject|2|||
156736395|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
156336729|NCT00678080|564329707|FG001|Overall Study|Withdrawal by Subject|1|||
156457602|NCT04233216|564772408|FG002|Overall Study|Withdrawal by Subject|1|||
156457603|NCT04233216|564772409|FG003|Overall Study|Withdrawal by Subject|0|||
156336730|NCT01385566|564331331|FG000|Overall Study|Lost to Follow-up|1|||
156736396|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
156736397|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
156736398|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
156736399|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
156736400|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
156736401|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
156736402|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
156736403|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
156736404|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
156534218|NCT03829241|565050900|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
156534219|NCT03829241|565050901|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
156534220|NCT03829241|565050900|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
156534221|NCT03829241|565050901|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
156534222|NCT03829241|565050900|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
156534223|NCT03829241|565050901|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
156534224|NCT03829241|565050900|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
156534225|NCT03829241|565050901|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
156534226|NCT03829241|565050900|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
156534227|NCT03829241|565050901|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
156534228|NCT03829241|565050900|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
156534229|NCT03829241|565050901|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
156534230|NCT03829241|565050900|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
156534231|NCT03829241|565050901|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
156534232|NCT03829241|565050900|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
156534233|NCT03829241|565050901|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
156534234|NCT00698451|565050902|FG000|Overall Study|Adverse Event|22|||
156534235|NCT00698451|565050902|FG000|Overall Study|Physician Decision|2|||
156736405|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
156736406|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Death|0|||
156736407|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Death|0|||
156736408|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Death|0|||
156736409|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Death|1|||
156736410|NCT03887442|565780523|FG000|Overall Study|Adverse Event|1|||
156736411|NCT03887442|565780524|FG001|Overall Study|Adverse Event|0|||
156736412|NCT05367973|565780527|FG000|Overall Study|Adverse Event|0|||
156736413|NCT05367973|565780528|FG001|Overall Study|Adverse Event|2|||
156736414|NCT00986921|565780529|FG000|Overall Study|Physician Decision|1|||
156736415|NCT00986921|565780530|FG001|Overall Study|Physician Decision|0|||
156736416|NCT01758731|565780531|FG000|Overall Study|Physician Decision|1|||
156736417|NCT04445714|565780532|FG000|Overall Study|Discontinuation of the study|14|||
156736418|NCT04445714|565780532|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
156736419|NCT04445714|565780532|FG000|Overall Study|Withdrawal of Informed Consent|8|||
156736420|NCT02396420|565780537|FG000|Overall Study|Death|1|||
156736421|NCT01273623|565780539|FG000|Overall Study|did not meet IVUS criteria|29|||
156736422|NCT02086448|565782818|FG000|Overall Study|Withdrawal by Subject|1|||
156736423|NCT02086448|565782819|FG001|Overall Study|Withdrawal by Subject|0|||
156736424|NCT02086448|565782820|FG002|Overall Study|Withdrawal by Subject|0|||
156736425|NCT02086448|565782821|FG003|Overall Study|Withdrawal by Subject|2|||
156736426|NCT01871402|565782830|FG000|Overall Study|Lost to Follow-up|1|||
156736427|NCT01871402|565782831|FG001|Overall Study|Lost to Follow-up|0|||
156736428|NCT01871402|565782830|FG000|Overall Study|Withdrawal by Subject|0|||
156736429|NCT01871402|565782831|FG001|Overall Study|Withdrawal by Subject|2|||
156736430|NCT01871402|565782830|FG000|Overall Study|Non-compliance|0|||
156736431|NCT01871402|565782831|FG001|Overall Study|Non-compliance|1|||
156736432|NCT04594941|565782832|FG000|Overall Study|Other|0|||
156736433|NCT04594941|565782833|FG001|Overall Study|Other|3|||
156736434|NCT04594941|565782834|FG002|Overall Study|Other|1|||
156736435|NCT04594941|565782835|FG003|Overall Study|Other|0|||
156736436|NCT00231114|565782836|FG000|Randomized|Withdrawal by Subject|6|||
156736437|NCT00231114|565782837|FG001|Randomized|Withdrawal by Subject|3|||
156736438|NCT00231114|565782836|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
156736439|NCT00231114|565782837|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
156736440|NCT00231114|565782836|FG000|Post-Treatment Period|Lost to Follow-up|6|||
156736441|NCT00231114|565782837|FG001|Post-Treatment Period|Lost to Follow-up|1|||
156736442|NCT00231114|565782836|FG000|Post-Treatment Period|Physician Decision|1|||
156736443|NCT00231114|565782837|FG001|Post-Treatment Period|Physician Decision|0|||
156736444|NCT00231114|565782836|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
156736445|NCT00231114|565782837|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
156736446|NCT02031640|565782841|FG000|Screening Period|Adverse Event|1|||
156736447|NCT02031640|565782842|FG001|Screening Period|Adverse Event|0|||
156534236|NCT00698451|565050902|FG000|Overall Study|Protocol Violation|6|||
156736448|NCT02031640|565782843|FG002|Screening Period|Adverse Event|0|||
156736449|NCT02031640|565782844|FG003|Screening Period|Adverse Event|0|||
156736450|NCT02031640|565782845|FG004|Screening Period|Adverse Event|0|||
156736451|NCT02031640|565782846|FG005|Screening Period|Adverse Event|0|||
156736452|NCT02031640|565782841|FG000|Screening Period|Withdrawal by Subject|29|||
156736453|NCT02031640|565782842|FG001|Screening Period|Withdrawal by Subject|0|||
156736454|NCT02031640|565782843|FG002|Screening Period|Withdrawal by Subject|0|||
156736455|NCT02031640|565782844|FG003|Screening Period|Withdrawal by Subject|0|||
156736456|NCT02031640|565782845|FG004|Screening Period|Withdrawal by Subject|0|||
156736457|NCT02031640|565782846|FG005|Screening Period|Withdrawal by Subject|0|||
156736458|NCT02031640|565782841|FG000|Screening Period|Inclusion criteria not met|312|||
156736459|NCT02031640|565782842|FG001|Screening Period|Inclusion criteria not met|0|||
156736460|NCT02031640|565782843|FG002|Screening Period|Inclusion criteria not met|0|||
156736461|NCT02031640|565782844|FG003|Screening Period|Inclusion criteria not met|0|||
156736462|NCT02031640|565782845|FG004|Screening Period|Inclusion criteria not met|0|||
156736463|NCT02031640|565782846|FG005|Screening Period|Inclusion criteria not met|0|||
156736464|NCT02031640|565782841|FG000|Screening Period|Exclusion criteria met|30|||
156736465|NCT02031640|565782842|FG001|Screening Period|Exclusion criteria met|0|||
156736466|NCT02031640|565782843|FG002|Screening Period|Exclusion criteria met|0|||
156736467|NCT02031640|565782844|FG003|Screening Period|Exclusion criteria met|0|||
156736468|NCT02031640|565782845|FG004|Screening Period|Exclusion criteria met|0|||
156736469|NCT02031640|565782846|FG005|Screening Period|Exclusion criteria met|0|||
156736470|NCT02031640|565782841|FG000|Screening Period|Lost to Follow-up|14|||
156736471|NCT02031640|565782842|FG001|Screening Period|Lost to Follow-up|0|||
156736472|NCT02031640|565782843|FG002|Screening Period|Lost to Follow-up|0|||
156736473|NCT02031640|565782844|FG003|Screening Period|Lost to Follow-up|0|||
156736474|NCT02031640|565782845|FG004|Screening Period|Lost to Follow-up|0|||
156736475|NCT02031640|565782846|FG005|Screening Period|Lost to Follow-up|0|||
156736476|NCT02031640|565782841|FG000|Screening Period|Enrollment closed|26|||
156736477|NCT02031640|565782842|FG001|Screening Period|Enrollment closed|0|||
156736478|NCT02031640|565782843|FG002|Screening Period|Enrollment closed|0|||
156736479|NCT02031640|565782844|FG003|Screening Period|Enrollment closed|0|||
156736480|NCT02031640|565782845|FG004|Screening Period|Enrollment closed|0|||
156736481|NCT02031640|565782846|FG005|Screening Period|Enrollment closed|0|||
156736482|NCT02031640|565782841|FG000|Run-In Period|Adverse Event|4|||
156736483|NCT02031640|565782842|FG001|Run-In Period|Adverse Event|0|||
156736484|NCT02031640|565782843|FG002|Run-In Period|Adverse Event|0|||
156736485|NCT02031640|565782844|FG003|Run-In Period|Adverse Event|0|||
156736486|NCT02031640|565782845|FG004|Run-In Period|Adverse Event|0|||
156736487|NCT02031640|565782846|FG005|Run-In Period|Adverse Event|0|||
156736488|NCT02031640|565782841|FG000|Run-In Period|Withdrawal by Subject|17|||
156736489|NCT02031640|565782842|FG001|Run-In Period|Withdrawal by Subject|0|||
156736490|NCT02031640|565782843|FG002|Run-In Period|Withdrawal by Subject|0|||
156736491|NCT02031640|565782844|FG003|Run-In Period|Withdrawal by Subject|0|||
156736492|NCT02031640|565782845|FG004|Run-In Period|Withdrawal by Subject|0|||
156736493|NCT02031640|565782846|FG005|Run-In Period|Withdrawal by Subject|0|||
156736494|NCT02031640|565782841|FG000|Run-In Period|Inclusion criteria not met|38|||
156736495|NCT02031640|565782842|FG001|Run-In Period|Inclusion criteria not met|0|||
156736496|NCT02031640|565782843|FG002|Run-In Period|Inclusion criteria not met|0|||
156736497|NCT02031640|565782844|FG003|Run-In Period|Inclusion criteria not met|0|||
156736498|NCT02031640|565782845|FG004|Run-In Period|Inclusion criteria not met|0|||
156736499|NCT02031640|565782846|FG005|Run-In Period|Inclusion criteria not met|0|||
156457604|NCT02998268|564772410|FG000|Overall Study|Adverse Event|0|||
156457605|NCT02998268|564772411|FG001|Overall Study|Adverse Event|2|||
156457606|NCT02998268|564772410|FG000|Overall Study|Withdrawal by Subject|0|||
156457607|NCT02998268|564772411|FG001|Overall Study|Withdrawal by Subject|1|||
156736500|NCT02031640|565782841|FG000|Run-In Period|Exclusion criteria met|8|||
156736501|NCT02031640|565782842|FG001|Run-In Period|Exclusion criteria met|0|||
156736502|NCT02031640|565782843|FG002|Run-In Period|Exclusion criteria met|0|||
156796936|NCT00725985|566009678|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
156796937|NCT00725985|566009679|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
156796938|NCT00725985|566009680|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796939|NCT00725985|566009681|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796940|NCT00725985|566009682|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156457608|NCT03252847|564772412|FG000|Overall Study|Withdrawal by Subject|0|||
156457609|NCT03252847|564772413|FG001|Overall Study|Withdrawal by Subject|0|||
156457610|NCT03252847|564772414|FG002|Overall Study|Withdrawal by Subject|1|||
156736503|NCT02031640|565782844|FG003|Run-In Period|Exclusion criteria met|0|||
156736504|NCT02031640|565782845|FG004|Run-In Period|Exclusion criteria met|0|||
156736505|NCT02031640|565782846|FG005|Run-In Period|Exclusion criteria met|0|||
156736506|NCT02031640|565782841|FG000|Run-In Period|Randomization criteria not met|85|||
156736507|NCT02031640|565782842|FG001|Run-In Period|Randomization criteria not met|0|||
156736508|NCT02031640|565782843|FG002|Run-In Period|Randomization criteria not met|0|||
156796941|NCT00725985|566009671|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156457611|NCT03252847|564772415|FG003|Overall Study|Withdrawal by Subject|0|||
156796942|NCT00725985|566009672|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796943|NCT00725985|566009673|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156736509|NCT02031640|565782844|FG003|Run-In Period|Randomization criteria not met|0|||
156736510|NCT02031640|565782845|FG004|Run-In Period|Randomization criteria not met|0|||
156736511|NCT02031640|565782846|FG005|Run-In Period|Randomization criteria not met|0|||
156736512|NCT02031640|565782841|FG000|Run-In Period|Various administrative reasons|17|||
156736513|NCT02031640|565782842|FG001|Run-In Period|Various administrative reasons|0|||
156736514|NCT02031640|565782843|FG002|Run-In Period|Various administrative reasons|0|||
156736515|NCT02031640|565782844|FG003|Run-In Period|Various administrative reasons|0|||
156736516|NCT02031640|565782845|FG004|Run-In Period|Various administrative reasons|0|||
156736517|NCT02031640|565782846|FG005|Run-In Period|Various administrative reasons|0|||
156736518|NCT02031640|565782841|FG000|Double-blind Treatment Period|Protocol deviation|0|||
156736519|NCT02031640|565782842|FG001|Double-blind Treatment Period|Protocol deviation|2|||
156457612|NCT03252847|564772416|FG004|Overall Study|Withdrawal by Subject|0|||
156457613|NCT03252847|564772417|FG005|Overall Study|Withdrawal by Subject|0|||
156736520|NCT02031640|565782843|FG002|Double-blind Treatment Period|Protocol deviation|0|||
156736521|NCT02031640|565782844|FG003|Double-blind Treatment Period|Protocol deviation|1|||
156736522|NCT02031640|565782845|FG004|Double-blind Treatment Period|Protocol deviation|3|||
156736523|NCT02031640|565782846|FG005|Double-blind Treatment Period|Protocol deviation|1|||
156736524|NCT02031640|565782841|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
156736525|NCT02031640|565782842|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
156736526|NCT02031640|565782843|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
156736527|NCT02031640|565782844|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
156736528|NCT02031640|565782845|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
156736529|NCT02031640|565782846|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
156736530|NCT02031640|565782841|FG000|Double-blind Treatment Period|Non-compliance|0|||
156736531|NCT02031640|565782842|FG001|Double-blind Treatment Period|Non-compliance|1|||
156736532|NCT02031640|565782843|FG002|Double-blind Treatment Period|Non-compliance|0|||
156736533|NCT02031640|565782844|FG003|Double-blind Treatment Period|Non-compliance|1|||
156736534|NCT02031640|565782845|FG004|Double-blind Treatment Period|Non-compliance|1|||
156736535|NCT02031640|565782846|FG005|Double-blind Treatment Period|Non-compliance|0|||
156736536|NCT02031640|565782841|FG000|Double-blind Treatment Period|Adverse Event|0|||
156736537|NCT02031640|565782842|FG001|Double-blind Treatment Period|Adverse Event|0|||
156736538|NCT02031640|565782843|FG002|Double-blind Treatment Period|Adverse Event|0|||
156736539|NCT02031640|565782844|FG003|Double-blind Treatment Period|Adverse Event|2|||
156736540|NCT02031640|565782845|FG004|Double-blind Treatment Period|Adverse Event|0|||
156736541|NCT02031640|565782846|FG005|Double-blind Treatment Period|Adverse Event|0|||
156736542|NCT02031640|565782841|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
156736543|NCT02031640|565782842|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
156736544|NCT02031640|565782843|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
156736545|NCT02031640|565782844|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
156736546|NCT02031640|565782845|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
156736547|NCT02031640|565782846|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
156736548|NCT02031640|565782841|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156736549|NCT02031640|565782842|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
156736550|NCT02031640|565782843|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
156457614|NCT03252847|564772418|FG006|Overall Study|Withdrawal by Subject|0|||
156457615|NCT03252847|564772412|FG000|Overall Study|Other: Patient decision|0|||
156457616|NCT03252847|564772413|FG001|Overall Study|Other: Patient decision|0|||
156457617|NCT03252847|564772414|FG002|Overall Study|Other: Patient decision|0|||
156736551|NCT02031640|565782844|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
156736552|NCT02031640|565782845|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
156457618|NCT03252847|564772415|FG003|Overall Study|Other: Patient decision|0|||
156457619|NCT03252847|564772416|FG004|Overall Study|Other: Patient decision|1|||
156457620|NCT03252847|564772417|FG005|Overall Study|Other: Patient decision|0|||
156457621|NCT03252847|564772418|FG006|Overall Study|Other: Patient decision|0|||
156457622|NCT04298983|564772421|FG000|Overall Study|Adverse Event|4|||
156736553|NCT02031640|565782846|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
156736554|NCT02005692|565782847|FG000|Overall Study|Protocol Violation|1|||
156736555|NCT02005692|565782847|FG000|Overall Study|Withdrawal by Subject|1|||
156808845|NCT01484496|566054474|FG001|Period 2|Lack of Efficacy|0|||
156808846|NCT01484496|566054475|FG002|Period 2|Lack of Efficacy|1|||
156808847|NCT01484496|566054476|FG003|Period 2|Lack of Efficacy|3|||
156808848|NCT01484496|566054473|FG000|Period 2|Adverse Event|0|||
156808849|NCT01484496|566054474|FG001|Period 2|Adverse Event|0|||
156457623|NCT04298983|564772421|FG000|Overall Study|Lack of Efficacy|3|||
156808850|NCT01484496|566054475|FG002|Period 2|Adverse Event|5|||
156808851|NCT01484496|566054476|FG003|Period 2|Adverse Event|13|||
156808852|NCT01484496|566054473|FG000|Period 2|Other|0|||
156808853|NCT01484496|566054474|FG001|Period 2|Other|0|||
156808854|NCT01484496|566054475|FG002|Period 2|Other|9|||
156808855|NCT01484496|566054476|FG003|Period 2|Other|6|||
156808856|NCT01645735|566054477|FG000|Overall Study|Physician Decision|2|||
156808857|NCT01645735|566054478|FG001|Overall Study|Physician Decision|0|||
156808858|NCT01645735|566054477|FG000|Overall Study|Withdrawal by Subject|1|||
156457624|NCT02723591|564772424|FG000|Overall Study|Adverse Event|48|||
156736556|NCT02005692|565782847|FG000|Overall Study|Discharged earlier than anticipated|5|||
156736557|NCT01194999|565782848|FG000|Overall Study|Lost to Follow-up|17|||
156736558|NCT01895270|565782849|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
156736559|NCT01895270|565782850|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
156736560|NCT01895270|565782849|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
156736561|NCT01895270|565782850|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
156736562|NCT01895270|565782849|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
156736563|NCT01895270|565782850|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
156736564|NCT01895270|565782849|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
156736565|NCT01895270|565782850|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
156736566|NCT01895270|565782849|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
156736567|NCT01895270|565782850|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
156736568|NCT01895270|565782849|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
156736569|NCT01895270|565782850|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
156736570|NCT01895270|565782849|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
156736571|NCT01895270|565782850|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
156736572|NCT02091375|565782853|FG000|Overall Study|Adverse Event|8|||
156736573|NCT02091375|565782854|FG001|Overall Study|Adverse Event|1|||
156736574|NCT02091375|565782853|FG000|Overall Study|Lost to Follow-up|0|||
156736575|NCT02091375|565782854|FG001|Overall Study|Lost to Follow-up|1|||
156736576|NCT02091375|565782853|FG000|Overall Study|Withdrawal by Subject|0|||
156736577|NCT02091375|565782854|FG001|Overall Study|Withdrawal by Subject|1|||
156736578|NCT02091375|565782853|FG000|Overall Study|Withdrawn by the investigator|1|||
156736579|NCT02091375|565782854|FG001|Overall Study|Withdrawn by the investigator|0|||
156736580|NCT02682823|565782856|FG000|Overall Study|Withdrawal by Subject|0|||
156736581|NCT02682823|565782857|FG001|Overall Study|Withdrawal by Subject|0|||
156736582|NCT02682823|565782858|FG002|Overall Study|Withdrawal by Subject|1|||
156736583|NCT02682823|565782859|FG003|Overall Study|Withdrawal by Subject|0|||
156736584|NCT02682823|565782860|FG004|Overall Study|Withdrawal by Subject|1|||
156736585|NCT02682823|565782856|FG000|Overall Study|Protocol Deviation|0|||
156736586|NCT02682823|565782857|FG001|Overall Study|Protocol Deviation|1|||
156736587|NCT02682823|565782858|FG002|Overall Study|Protocol Deviation|0|||
156736588|NCT02682823|565782859|FG003|Overall Study|Protocol Deviation|0|||
156736589|NCT02682823|565782860|FG004|Overall Study|Protocol Deviation|0|||
156736590|NCT02682823|565782856|FG000|Overall Study|Adverse Event|0|||
156736591|NCT02682823|565782857|FG001|Overall Study|Adverse Event|0|||
156736592|NCT02682823|565782858|FG002|Overall Study|Adverse Event|0|||
156736593|NCT02682823|565782859|FG003|Overall Study|Adverse Event|1|||
156736594|NCT02682823|565782860|FG004|Overall Study|Adverse Event|0|||
156736595|NCT05896527|565782861|FG000|Overall Study|Withdrawal by Subject|11|||
156736596|NCT05896527|565782862|FG001|Overall Study|Withdrawal by Subject|10|||
156736597|NCT05896527|565782863|FG002|Overall Study|Withdrawal by Subject|4|||
156736598|NCT05896527|565782864|FG003|Overall Study|Withdrawal by Subject|3|||
156736599|NCT05896527|565782865|FG004|Overall Study|Withdrawal by Subject|2|||
156736600|NCT05896527|565782861|FG000|Overall Study|Lost to Follow-up|0|||
156736601|NCT05896527|565782862|FG001|Overall Study|Lost to Follow-up|2|||
156736602|NCT05896527|565782863|FG002|Overall Study|Lost to Follow-up|2|||
156736603|NCT05896527|565782864|FG003|Overall Study|Lost to Follow-up|2|||
156736604|NCT05896527|565782865|FG004|Overall Study|Lost to Follow-up|1|||
156736605|NCT05896527|565782861|FG000|Overall Study|Significant protocol noncompliance|0|||
156796944|NCT00725985|566009674|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796945|NCT00725985|566009675|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796946|NCT00725985|566009676|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796947|NCT00725985|566009677|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796948|NCT00725985|566009678|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156457625|NCT02723591|564772425|FG001|Overall Study|Adverse Event|40|||
156736606|NCT05896527|565782862|FG001|Overall Study|Significant protocol noncompliance|1|||
156736607|NCT05896527|565782863|FG002|Overall Study|Significant protocol noncompliance|0|||
156736608|NCT05896527|565782864|FG003|Overall Study|Significant protocol noncompliance|0|||
156736609|NCT05896527|565782865|FG004|Overall Study|Significant protocol noncompliance|0|||
156736610|NCT05896527|565782861|FG000|Overall Study|Eligibility criteria not met|1|||
156796949|NCT00725985|566009679|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796950|NCT00725985|566009680|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
156796951|NCT00725985|566009681|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
156796952|NCT00725985|566009682|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
156796953|NCT04476784|566009683|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
156796954|NCT04476784|566009684|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
156796955|NCT01055028|566009689|FG000|Screening|Screen Failure|1|||
156736611|NCT05896527|565782862|FG001|Overall Study|Eligibility criteria not met|0|||
156736612|NCT05896527|565782863|FG002|Overall Study|Eligibility criteria not met|0|||
156796956|NCT01055028|566009690|FG001|Screening|Screen Failure|1|||
156796957|NCT01055028|566009689|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
156457626|NCT02723591|564772424|FG000|Overall Study|Death|2|||
156457627|NCT02723591|564772425|FG001|Overall Study|Death|2|||
156457628|NCT02723591|564772424|FG000|Overall Study|Lack of Efficacy|4|||
156457629|NCT02723591|564772425|FG001|Overall Study|Lack of Efficacy|3|||
156736613|NCT05896527|565782864|FG003|Overall Study|Eligibility criteria not met|0|||
156736614|NCT05896527|565782865|FG004|Overall Study|Eligibility criteria not met|0|||
156736615|NCT05896527|565782861|FG000|Overall Study|Sponsor's decision|0|||
156736616|NCT05896527|565782862|FG001|Overall Study|Sponsor's decision|0|||
156736617|NCT05896527|565782863|FG002|Overall Study|Sponsor's decision|0|||
156736618|NCT05896527|565782864|FG003|Overall Study|Sponsor's decision|1|||
156736619|NCT05896527|565782865|FG004|Overall Study|Sponsor's decision|0|||
156736620|NCT05896527|565782861|FG000|Overall Study|Investigator's decision|0|||
156736621|NCT05896527|565782862|FG001|Overall Study|Investigator's decision|1|||
156736622|NCT05896527|565782863|FG002|Overall Study|Investigator's decision|0|||
156534237|NCT00698451|565050902|FG000|Overall Study|Withdrawal by Subject|6|||
156457630|NCT02723591|564772424|FG000|Overall Study|Lost to Follow-up|1|||
156457631|NCT02723591|564772425|FG001|Overall Study|Lost to Follow-up|7|||
156534238|NCT00698451|565050902|FG000|Overall Study|Disease progression|3|||
156736623|NCT05896527|565782864|FG003|Overall Study|Investigator's decision|0|||
156457632|NCT02723591|564772424|FG000|Overall Study|Protocol Violation|20|||
156534239|NCT02224599|565050906|FG000|Overall Study|Physician Decision|1|||
156534240|NCT02224599|565050906|FG000|Overall Study|Progression of Disease|1|||
156534241|NCT00129623|565050907|FG000|Overall Study|Adverse Event|3|||
156534242|NCT00129623|565050908|FG001|Overall Study|Adverse Event|7|||
156534243|NCT00129623|565050907|FG000|Overall Study|Refused Treatment|5|||
156534244|NCT00129623|565050908|FG001|Overall Study|Refused Treatment|3|||
156534245|NCT00129623|565050907|FG000|Overall Study|Failure to Return|1|||
156534246|NCT00129623|565050908|FG001|Overall Study|Failure to Return|1|||
156534247|NCT00129623|565050907|FG000|Overall Study|Relocated job out of state|1|||
156534248|NCT00129623|565050908|FG001|Overall Study|Relocated job out of state|0|||
156534249|NCT00129623|565050907|FG000|Overall Study|Uncertainty to return|0|||
156534250|NCT00129623|565050908|FG001|Overall Study|Uncertainty to return|1|||
156534251|NCT00596934|565050909|FG000|Overall Study|Protocol Violation|1|||
156534252|NCT00596934|565050909|FG000|Overall Study|Withdrawal by Subject|1|||
156534253|NCT02315898|565050910|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
156534254|NCT02315898|565050911|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
156534255|NCT02315898|565050912|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
156534256|NCT02315898|565050913|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
156534257|NCT02445755|565050914|FG000|Overall Study|Withdrawal by Subject|2|||
156534258|NCT02445755|565050914|FG000|Overall Study|Protocol Violation|6|||
156534259|NCT02445755|565050914|FG000|Overall Study|Screen Failure|5|||
156534260|NCT01674712|565050916|FG000|Overall Study|Adverse Event|5|||
156534261|NCT01674712|565050917|FG001|Overall Study|Adverse Event|6|||
156534262|NCT01674712|565050918|FG002|Overall Study|Adverse Event|3|||
156534263|NCT01674712|565050919|FG003|Overall Study|Adverse Event|4|||
156534264|NCT01674712|565050920|FG004|Overall Study|Adverse Event|6|||
156534265|NCT01674712|565050916|FG000|Overall Study|Lost to Follow-up|1|||
156534266|NCT01674712|565050917|FG001|Overall Study|Lost to Follow-up|0|||
156534267|NCT01674712|565050918|FG002|Overall Study|Lost to Follow-up|0|||
156534268|NCT01674712|565050919|FG003|Overall Study|Lost to Follow-up|0|||
156534269|NCT01674712|565050920|FG004|Overall Study|Lost to Follow-up|0|||
156534270|NCT01674712|565050916|FG000|Overall Study|Protocol Violation|2|||
156534271|NCT01674712|565050917|FG001|Overall Study|Protocol Violation|0|||
156534272|NCT01674712|565050918|FG002|Overall Study|Protocol Violation|0|||
156534273|NCT01674712|565050919|FG003|Overall Study|Protocol Violation|0|||
156534274|NCT01674712|565050920|FG004|Overall Study|Protocol Violation|0|||
156534275|NCT01674712|565050916|FG000|Overall Study|Withdrawal by Subject|2|||
156534276|NCT01674712|565050917|FG001|Overall Study|Withdrawal by Subject|2|||
156736624|NCT05896527|565782865|FG004|Overall Study|Investigator's decision|0|||
156457633|NCT02723591|564772425|FG001|Overall Study|Protocol Violation|23|||
156457634|NCT02723591|564772424|FG000|Overall Study|Withdrawal by Subject|4|||
156457635|NCT02723591|564772425|FG001|Overall Study|Withdrawal by Subject|8|||
156457636|NCT02723591|564772424|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
156457637|NCT02723591|564772425|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
156457638|NCT02723591|564772424|FG000|Overall Study|Miscellaneous|5|||
156457639|NCT02723591|564772425|FG001|Overall Study|Miscellaneous|6|||
156457640|NCT04770402|564772426|FG000|Overall Study|Lost to Follow-up|1|||
156457641|NCT04770402|564772427|FG001|Overall Study|Lost to Follow-up|2|||
156534277|NCT01674712|565050918|FG002|Overall Study|Withdrawal by Subject|5|||
156534278|NCT01674712|565050919|FG003|Overall Study|Withdrawal by Subject|4|||
156534279|NCT01674712|565050920|FG004|Overall Study|Withdrawal by Subject|3|||
156534280|NCT01674712|565050916|FG000|Overall Study|Administrative|0|||
156736625|NCT05896527|565782861|FG000|Overall Study|Pregnancy of his partner|0|||
156534281|NCT01674712|565050917|FG001|Overall Study|Administrative|1|||
156457642|NCT04770402|564772426|FG000|Overall Study|Non-compliance|1|||
156457643|NCT04770402|564772427|FG001|Overall Study|Non-compliance|0|||
156736626|NCT05896527|565782862|FG001|Overall Study|Pregnancy of his partner|0|||
156736627|NCT05896527|565782863|FG002|Overall Study|Pregnancy of his partner|0|||
156736628|NCT05896527|565782864|FG003|Overall Study|Pregnancy of his partner|1|||
156736629|NCT05896527|565782865|FG004|Overall Study|Pregnancy of his partner|0|||
156736630|NCT01279070|565782867|FG000|Overall Study|Withdrawal by Subject|2|||
156736631|NCT01279070|565782868|FG001|Overall Study|Withdrawal by Subject|3|||
156736632|NCT01279070|565782867|FG000|Overall Study|Acute exacerbation|3|||
156736633|NCT01279070|565782868|FG001|Overall Study|Acute exacerbation|1|||
156736634|NCT03781583|565782869|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
156736635|NCT03781583|565782870|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
156736636|NCT03781583|565782871|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
156736637|NCT03781583|565782872|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
156736638|NCT03781583|565782869|FG000|Overall Study|Technology did not work for that person in that environment|1|||
156736639|NCT03781583|565782870|FG001|Overall Study|Technology did not work for that person in that environment|0|||
156736640|NCT03781583|565782871|FG002|Overall Study|Technology did not work for that person in that environment|0|||
156736641|NCT03781583|565782872|FG003|Overall Study|Technology did not work for that person in that environment|0|||
156736642|NCT03781583|565782869|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
156736643|NCT03781583|565782870|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
156736644|NCT03781583|565782871|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
156736645|NCT03781583|565782872|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
156736646|NCT03781583|565782869|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
156736647|NCT03781583|565782870|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
156736648|NCT03781583|565782871|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
156736649|NCT03781583|565782872|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
156736650|NCT02222545|565782873|FG000|Overall Study|Adverse Event|1|||
156876810|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
156876811|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
156876812|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
156876813|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
156876814|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
156876815|NCT00202878|566307735|FG000|Overall Study|Death|964|||
156876816|NCT00202878|566307736|FG001|Overall Study|Death|968|||
156876817|NCT00202878|566307735|FG000|Overall Study|Only Vital Status Known|357|||
156876818|NCT00202878|566307736|FG001|Overall Study|Only Vital Status Known|356|||
156876819|NCT00202878|566307735|FG000|Overall Study|Lost to Follow-up|44|||
156876820|NCT00202878|566307736|FG001|Overall Study|Lost to Follow-up|49|||
156876821|NCT00202878|566307735|FG000|Overall Study|Site Closure|39|||
156876822|NCT00202878|566307736|FG001|Overall Study|Site Closure|36|||
156876823|NCT00202878|566307735|FG000|Overall Study|Withdrawal by Subject|795|||
156876824|NCT00202878|566307736|FG001|Overall Study|Withdrawal by Subject|808|||
156876825|NCT00918736|566307737|FG000|Overall Study|Withdrawal by Subject|4|||
156876826|NCT01474018|566307738|FG000|Overall Study|Lost to Follow-up|0|||
156876827|NCT01474018|566307739|FG001|Overall Study|Lost to Follow-up|1|||
156876828|NCT01474018|566307738|FG000|Overall Study|Withdrawal by Subject|0|||
156534282|NCT01674712|565050918|FG002|Overall Study|Administrative|0|||
156534283|NCT01674712|565050919|FG003|Overall Study|Administrative|0|||
156876829|NCT01474018|566307739|FG001|Overall Study|Withdrawal by Subject|2|||
156876830|NCT02433080|566307741|FG000|Overall Study|Lost to Follow-up|1|||
156534284|NCT01674712|565050920|FG004|Overall Study|Administrative|1|||
156534285|NCT01674712|565050916|FG000|Overall Study|Lack of Efficacy|0|||
156534286|NCT01674712|565050917|FG001|Overall Study|Lack of Efficacy|0|||
156534287|NCT01674712|565050918|FG002|Overall Study|Lack of Efficacy|1|||
156534288|NCT01674712|565050919|FG003|Overall Study|Lack of Efficacy|0|||
156534289|NCT01674712|565050920|FG004|Overall Study|Lack of Efficacy|1|||
156534290|NCT05372653|565050927|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
156534291|NCT05372653|565050928|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
156534292|NCT05372653|565050927|FG000|Overall Study|Adverse Event|0|||
156534293|NCT05372653|565050928|FG001|Overall Study|Adverse Event|1|||
156534294|NCT00117507|565050929|FG000|Overall Study|Adverse Event|4|||
156534295|NCT00117507|565050929|FG000|Overall Study|Abnormal laboratory values|3|||
156876831|NCT02433080|566307742|FG001|Overall Study|Lost to Follow-up|2|||
156876832|NCT02433080|566307741|FG000|Overall Study|Withdrawal by Subject|0|||
156534296|NCT00117507|565050929|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156534297|NCT00117507|565050929|FG000|Overall Study|Patient withdrew consent|4|||
156534298|NCT00117507|565050929|FG000|Overall Study|Death|3|||
156534299|NCT00866723|565050930|FG000|Overall Study|Withdrawal by Subject|1|||
156534300|NCT00866723|565050930|FG000|Overall Study|Disease Progression|4|||
156876833|NCT02433080|566307742|FG001|Overall Study|Withdrawal by Subject|2|||
156534301|NCT03740997|565050933|FG000|Overall Study|Withdrawal by Subject|1|||
156534302|NCT03740997|565050934|FG001|Overall Study|Withdrawal by Subject|0|||
156736651|NCT02222545|565782874|FG001|Overall Study|Adverse Event|0|||
156736652|NCT02222545|565782875|FG002|Overall Study|Adverse Event|2|||
156736653|NCT02222545|565782873|FG000|Overall Study|Death|0|||
156736654|NCT02222545|565782874|FG001|Overall Study|Death|0|||
156736655|NCT02222545|565782875|FG002|Overall Study|Death|9|||
156736656|NCT02222545|565782873|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
156736657|NCT02222545|565782874|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
156736658|NCT02222545|565782875|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
156736659|NCT02222545|565782873|FG000|Overall Study|Withdrawal by Subject|0|||
156736660|NCT02222545|565782874|FG001|Overall Study|Withdrawal by Subject|0|||
156736661|NCT02222545|565782875|FG002|Overall Study|Withdrawal by Subject|3|||
156736662|NCT02222545|565782873|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
156534303|NCT03740997|565050933|FG000|Overall Study|Participant was unable to complete study procedures|1|||
156534304|NCT03740997|565050934|FG001|Overall Study|Participant was unable to complete study procedures|0|||
156534305|NCT01003990|565050935|FG000|Overall Study|Adverse Event|8|||
156534306|NCT01003990|565050936|FG001|Overall Study|Adverse Event|5|||
156534307|NCT01003990|565050937|FG002|Overall Study|Adverse Event|11|||
156534308|NCT01003990|565050935|FG000|Overall Study|Death|0|||
156534309|NCT01003990|565050936|FG001|Overall Study|Death|8|||
156534310|NCT01003990|565050937|FG002|Overall Study|Death|1|||
156534311|NCT01003990|565050935|FG000|Overall Study|Lack of Efficacy|10|||
156534312|NCT01003990|565050936|FG001|Overall Study|Lack of Efficacy|2|||
156534313|NCT01003990|565050937|FG002|Overall Study|Lack of Efficacy|3|||
156534314|NCT01003990|565050935|FG000|Overall Study|Lost to Follow-up|30|||
156534315|NCT01003990|565050936|FG001|Overall Study|Lost to Follow-up|12|||
156534316|NCT01003990|565050937|FG002|Overall Study|Lost to Follow-up|7|||
156534317|NCT01003990|565050935|FG000|Overall Study|Reasons Not Identified|14|||
156534318|NCT01003990|565050936|FG001|Overall Study|Reasons Not Identified|13|||
156534319|NCT01003990|565050937|FG002|Overall Study|Reasons Not Identified|8|||
156534320|NCT01003990|565050935|FG000|Overall Study|Poor/Non-compliance|4|||
156534321|NCT01003990|565050936|FG001|Overall Study|Poor/Non-compliance|3|||
156534322|NCT01003990|565050937|FG002|Overall Study|Poor/Non-compliance|2|||
156534323|NCT01003990|565050935|FG000|Overall Study|Pregnancy|10|||
156534324|NCT01003990|565050936|FG001|Overall Study|Pregnancy|2|||
156534325|NCT01003990|565050937|FG002|Overall Study|Pregnancy|4|||
156534326|NCT01003990|565050935|FG000|Overall Study|No Longer Met Study Criteria|4|||
156534327|NCT01003990|565050936|FG001|Overall Study|No Longer Met Study Criteria|1|||
156534328|NCT01003990|565050937|FG002|Overall Study|No Longer Met Study Criteria|0|||
156534329|NCT01003990|565050935|FG000|Overall Study|Subject Withdrew Consent|12|||
156534330|NCT01003990|565050936|FG001|Overall Study|Subject Withdrew Consent|5|||
156534331|NCT01003990|565050937|FG002|Overall Study|Subject Withdrew Consent|7|||
156534332|NCT01271803|565050938|FG000|Overall Study|Progressive disease|0|||
156534333|NCT01271803|565050939|FG001|Overall Study|Progressive disease|0|||
156534334|NCT01271803|565050940|FG002|Overall Study|Progressive disease|2|||
156534335|NCT01271803|565050938|FG000|Overall Study|Death|53|||
156534336|NCT01271803|565050939|FG001|Overall Study|Death|34|||
156534337|NCT01271803|565050940|FG002|Overall Study|Death|0|||
156534338|NCT01271803|565050938|FG000|Overall Study|Withdrawal by Subject|1|||
156534339|NCT01271803|565050939|FG001|Overall Study|Withdrawal by Subject|5|||
156534340|NCT01271803|565050940|FG002|Overall Study|Withdrawal by Subject|0|||
156534341|NCT01271803|565050938|FG000|Overall Study|Lost to Follow-up|1|||
156534342|NCT01271803|565050939|FG001|Overall Study|Lost to Follow-up|0|||
156534343|NCT01271803|565050940|FG002|Overall Study|Lost to Follow-up|0|||
156534344|NCT01975428|565050944|FG000|Overall Study|Lost to Follow-up|17|||
156534345|NCT01975428|565050945|FG001|Overall Study|Lost to Follow-up|4|||
156534346|NCT01975428|565050944|FG000|Overall Study|Withdrawal by Subject|3|||
156534347|NCT01975428|565050945|FG001|Overall Study|Withdrawal by Subject|10|||
156534348|NCT01505010|565050946|FG000|Overall Study|Protocol Violation|0|||
156534349|NCT01505010|565050947|FG001|Overall Study|Protocol Violation|1|||
156534350|NCT01505010|565050946|FG000|Overall Study|Lost to Follow-up|0|||
156534351|NCT01505010|565050947|FG001|Overall Study|Lost to Follow-up|1|||
156534352|NCT00995007|565050952|FG000|Overall Study|Withdrew consent|1|||
156534353|NCT00995007|565050953|FG001|Overall Study|Withdrew consent|0|||
156534354|NCT00995007|565050952|FG000|Overall Study|Refused further treatment|8|||
156534355|NCT00995007|565050953|FG001|Overall Study|Refused further treatment|2|||
156736663|NCT02222545|565782874|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
156534356|NCT00995007|565050952|FG000|Overall Study|Toxicity|8|||
156534357|NCT00995007|565050953|FG001|Overall Study|Toxicity|0|||
156534358|NCT01368042|565050954|FG000|Overall Study|Death|14|||
156534359|NCT01368042|565050954|FG000|Overall Study|Protocol Violation|11|||
156534360|NCT01368042|565050954|FG000|Overall Study|Lost to Follow-up|4|||
156534361|NCT01368042|565050954|FG000|Overall Study|Transplanted|1|||
156534362|NCT01621542|565050955|FG000|Overall Study|Adverse Event|0|||
156534363|NCT01621542|565050956|FG001|Overall Study|Adverse Event|0|||
156534364|NCT01621542|565050957|FG002|Overall Study|Adverse Event|1|||
156534365|NCT01621542|565050958|FG003|Overall Study|Adverse Event|3|||
156534366|NCT01621542|565050959|FG004|Overall Study|Adverse Event|0|||
156534367|NCT01621542|565050960|FG005|Overall Study|Adverse Event|0|||
156736664|NCT02222545|565782875|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
156736665|NCT01938430|565782876|FG000|Overall Study|Randomized but Not Treated|0|||
156736666|NCT01938430|565782877|FG001|Overall Study|Randomized but Not Treated|0|||
156736667|NCT01938430|565782878|FG002|Overall Study|Randomized but Not Treated|0|||
156736668|NCT01938430|565782879|FG003|Overall Study|Randomized but Not Treated|0|||
156736669|NCT01938430|565782880|FG004|Overall Study|Randomized but Not Treated|0|||
156736670|NCT01938430|565782881|FG005|Overall Study|Randomized but Not Treated|0|||
156736671|NCT01938430|565782882|FG006|Overall Study|Randomized but Not Treated|0|||
156736672|NCT01938430|565782883|FG007|Overall Study|Randomized but Not Treated|0|||
156736673|NCT01938430|565782884|FG008|Overall Study|Randomized but Not Treated|0|||
156736674|NCT01938430|565782885|FG009|Overall Study|Randomized but Not Treated|0|||
156736675|NCT01938430|565782886|FG010|Overall Study|Randomized but Not Treated|1|||
156736676|NCT01938430|565782887|FG011|Overall Study|Randomized but Not Treated|0|||
156736677|NCT01938430|565782888|FG012|Overall Study|Randomized but Not Treated|0|||
156736678|NCT01938430|565782889|FG013|Overall Study|Randomized but Not Treated|1|||
156736679|NCT01938430|565782876|FG000|Overall Study|Adverse Event|0|||
156736680|NCT01938430|565782877|FG001|Overall Study|Adverse Event|0|||
156736681|NCT01938430|565782878|FG002|Overall Study|Adverse Event|0|||
156736682|NCT01938430|565782879|FG003|Overall Study|Adverse Event|0|||
156736683|NCT01938430|565782880|FG004|Overall Study|Adverse Event|0|||
156736684|NCT01938430|565782881|FG005|Overall Study|Adverse Event|0|||
156736685|NCT01938430|565782882|FG006|Overall Study|Adverse Event|1|||
156736686|NCT01938430|565782883|FG007|Overall Study|Adverse Event|0|||
156736687|NCT01938430|565782884|FG008|Overall Study|Adverse Event|0|||
156736688|NCT01938430|565782885|FG009|Overall Study|Adverse Event|0|||
156736689|NCT01938430|565782886|FG010|Overall Study|Adverse Event|0|||
156736690|NCT01938430|565782887|FG011|Overall Study|Adverse Event|0|||
156736691|NCT01938430|565782888|FG012|Overall Study|Adverse Event|0|||
156736692|NCT01938430|565782889|FG013|Overall Study|Adverse Event|0|||
156736693|NCT01938430|565782876|FG000|Overall Study|Death|1|||
156736694|NCT01938430|565782877|FG001|Overall Study|Death|2|||
156876834|NCT01942733|566307744|FG000|Overall Study|Lost to Follow-up|1|||
156876835|NCT01942733|566307744|FG000|Overall Study|Non-compliance with IMP|1|||
156457644|NCT04770402|564772426|FG000|Overall Study|Withdrawal by Subject|0|||
156457645|NCT04770402|564772427|FG001|Overall Study|Withdrawal by Subject|1|||
156457646|NCT02589795|564772428|FG000|Overall Study|Lost to Follow-up|1|||
156457647|NCT02589795|564772429|FG001|Overall Study|Lost to Follow-up|0|||
156457648|NCT02589795|564772430|FG002|Overall Study|Lost to Follow-up|0|||
156457649|NCT02589795|564772428|FG000|Overall Study|Withdrawal by Subject|0|||
156457650|NCT02589795|564772429|FG001|Overall Study|Withdrawal by Subject|0|||
156457651|NCT02589795|564772430|FG002|Overall Study|Withdrawal by Subject|2|||
156457652|NCT02589795|564772428|FG000|Overall Study|Protocol Violation|0|||
156457653|NCT02589795|564772429|FG001|Overall Study|Protocol Violation|0|||
156457654|NCT02589795|564772430|FG002|Overall Study|Protocol Violation|1|||
156457655|NCT03599661|564772432|FG000|Overall Study|Lost to Follow-up|9|||
156457656|NCT04811040|564772433|FG000|Overall Study|Lost to Follow-up|2|||
156457657|NCT04811040|564772434|FG001|Overall Study|Lost to Follow-up|0|||
156457658|NCT04811040|564772435|FG002|Overall Study|Lost to Follow-up|0|||
156457659|NCT04811040|564772436|FG003|Overall Study|Lost to Follow-up|0|||
156457660|NCT04811040|564772433|FG000|Overall Study|Withdrew consent|1|||
156457661|NCT04811040|564772434|FG001|Overall Study|Withdrew consent|1|||
156457662|NCT04811040|564772435|FG002|Overall Study|Withdrew consent|0|||
156457663|NCT04811040|564772436|FG003|Overall Study|Withdrew consent|0|||
156457664|NCT01828099|564772437|FG000|Treatment Period|Adverse Event|24|||
156457665|NCT01828099|564772438|FG001|Treatment Period|Adverse Event|23|||
156457666|NCT01828099|564772437|FG000|Treatment Period|Death|10|||
156876836|NCT01942733|566307744|FG000|Overall Study|Administrative|1|||
156876837|NCT00486291|566307748|FG000|Overall Study|Adverse Event|3|||
156876838|NCT00486291|566307749|FG001|Overall Study|Adverse Event|4|||
156876839|NCT00486291|566307748|FG000|Overall Study|Lost to Follow-up|3|||
156876840|NCT00486291|566307749|FG001|Overall Study|Lost to Follow-up|7|||
156876841|NCT00486291|566307748|FG000|Overall Study|protocol non-compliance|10|||
156457667|NCT01828099|564772438|FG001|Treatment Period|Death|12|||
156736695|NCT01938430|565782878|FG002|Overall Study|Death|2|||
156457668|NCT01828099|564772437|FG000|Treatment Period|Lost to Follow-up|2|||
156457669|NCT01828099|564772438|FG001|Treatment Period|Lost to Follow-up|1|||
156457670|NCT01828099|564772437|FG000|Treatment Period|Non-compliance with study treatment|1|||
156457671|NCT01828099|564772438|FG001|Treatment Period|Non-compliance with study treatment|0|||
156736696|NCT01938430|565782879|FG003|Overall Study|Death|1|||
156736697|NCT01938430|565782880|FG004|Overall Study|Death|0|||
156876842|NCT00486291|566307749|FG001|Overall Study|protocol non-compliance|15|||
156736698|NCT01938430|565782881|FG005|Overall Study|Death|0|||
156876843|NCT00486291|566307748|FG000|Overall Study|requirement for restricted medication|0|||
156736699|NCT01938430|565782882|FG006|Overall Study|Death|1|||
156876844|NCT00486291|566307749|FG001|Overall Study|requirement for restricted medication|3|||
156457672|NCT01828099|564772437|FG000|Treatment Period|Physician Decision|17|||
156736700|NCT01938430|565782883|FG007|Overall Study|Death|1|||
156736701|NCT01938430|565782884|FG008|Overall Study|Death|2|||
156736702|NCT01938430|565782885|FG009|Overall Study|Death|3|||
156736703|NCT01938430|565782886|FG010|Overall Study|Death|0|||
156736704|NCT01938430|565782887|FG011|Overall Study|Death|0|||
156736705|NCT01938430|565782888|FG012|Overall Study|Death|0|||
156736706|NCT01938430|565782889|FG013|Overall Study|Death|0|||
156736707|NCT01938430|565782876|FG000|Overall Study|Investigator's Discretion|0|||
156736708|NCT01938430|565782877|FG001|Overall Study|Investigator's Discretion|0|||
156736709|NCT01938430|565782878|FG002|Overall Study|Investigator's Discretion|1|||
156736710|NCT01938430|565782879|FG003|Overall Study|Investigator's Discretion|0|||
156736711|NCT01938430|565782880|FG004|Overall Study|Investigator's Discretion|0|||
156457673|NCT01828099|564772438|FG001|Treatment Period|Physician Decision|16|||
156457674|NCT01828099|564772437|FG000|Treatment Period|Progressive disease|99|||
156736712|NCT01938430|565782881|FG005|Overall Study|Investigator's Discretion|0|||
156736713|NCT01938430|565782882|FG006|Overall Study|Investigator's Discretion|0|||
156457675|NCT01828099|564772438|FG001|Treatment Period|Progressive disease|107|||
156457676|NCT01828099|564772437|FG000|Treatment Period|Subject/guardian decision|22|||
156457677|NCT01828099|564772438|FG001|Treatment Period|Subject/guardian decision|26|||
156457678|NCT01828099|564772437|FG000|Treatment Period|Study terminated by Sponsor|13|||
156457679|NCT01828099|564772438|FG001|Treatment Period|Study terminated by Sponsor|1|||
156457680|NCT01828099|564772437|FG000|Treatment Period|Protocol deviation|1|||
156457681|NCT01828099|564772438|FG001|Treatment Period|Protocol deviation|0|||
156457682|NCT01828099|564772437|FG000|Treatment Period|No longer requires treatment|0|||
156457683|NCT01828099|564772438|FG001|Treatment Period|No longer requires treatment|1|||
156457684|NCT01828099|564772437|FG000|Extension-treatment Phase|Adverse Event|0|||
156457685|NCT01828099|564772438|FG001|Extension-treatment Phase|Adverse Event|17|||
156457686|NCT01828099|564772437|FG000|Extension-treatment Phase|Death|0|||
156457687|NCT01828099|564772438|FG001|Extension-treatment Phase|Death|11|||
156457688|NCT01828099|564772437|FG000|Extension-treatment Phase|Physician Decision|0|||
156457689|NCT01828099|564772438|FG001|Extension-treatment Phase|Physician Decision|5|||
156457690|NCT01828099|564772437|FG000|Extension-treatment Phase|Progressive disease|0|||
156457691|NCT01828099|564772438|FG001|Extension-treatment Phase|Progressive disease|54|||
156457692|NCT01828099|564772437|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
156457693|NCT01828099|564772438|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
156457694|NCT01828099|564772437|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
156457695|NCT01828099|564772438|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
156457696|NCT05934942|564772440|FG000|Run-in Period|Not treated|1|||
156457697|NCT05934942|564772440|FG000|Run-in Period|Withdrawal by Subject|1|||
156457698|NCT05645757|564772441|FG000|Overall Study|Enrolled but treatment not administered|0|||
156457699|NCT05645757|564772442|FG001|Overall Study|Enrolled but treatment not administered|0|||
156457700|NCT05645757|564772443|FG002|Overall Study|Enrolled but treatment not administered|0|||
156457701|NCT05645757|564772444|FG003|Overall Study|Enrolled but treatment not administered|0|||
156457702|NCT05645757|564772445|FG004|Overall Study|Enrolled but treatment not administered|1|||
156457703|NCT05645757|564772446|FG005|Overall Study|Enrolled but treatment not administered|1|||
156457704|NCT05645757|564772447|FG006|Overall Study|Enrolled but treatment not administered|0|||
156457705|NCT05645757|564772448|FG007|Overall Study|Enrolled but treatment not administered|0|||
156457706|NCT03905798|564772449|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
156457707|NCT04826471|564772450|FG000|Overall Study|Lost to Follow-up|2|||
156457708|NCT04826471|564772450|FG000|Overall Study|Protocol Violation|3|||
156457709|NCT04826471|564772450|FG000|Overall Study|Withdrawal by Subject|1|||
156457710|NCT05764525|564772451|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
156457711|NCT05764525|564772452|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
156457712|NCT05764525|564772451|FG000|Overall Study|Withdrawal by Subject|4|||
156457713|NCT05764525|564772452|FG001|Overall Study|Withdrawal by Subject|8|||
156457714|NCT05764525|564772451|FG000|Overall Study|Physician Decision|1|||
156457715|NCT05764525|564772452|FG001|Overall Study|Physician Decision|0|||
156457716|NCT03334630|564772453|FG000|Overall Study|Withdrawal by Subject|7|||
156457717|NCT03334630|564772454|FG001|Overall Study|Withdrawal by Subject|7|||
156457718|NCT03334630|564772453|FG000|Overall Study|Lost to Follow-up|3|||
156457719|NCT03334630|564772454|FG001|Overall Study|Lost to Follow-up|1|||
156457720|NCT03334630|564772453|FG000|Overall Study|Adverse Event|0|||
156457721|NCT03334630|564772454|FG001|Overall Study|Adverse Event|1|||
156457722|NCT03334630|564772453|FG000|Overall Study|Physician Decision|1|||
156457723|NCT03334630|564772454|FG001|Overall Study|Physician Decision|1|||
156457724|NCT03334630|564772453|FG000|Overall Study|Enrollment closed|2|||
156457725|NCT03334630|564772454|FG001|Overall Study|Enrollment closed|1|||
156457726|NCT03334630|564772453|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
156457727|NCT03334630|564772454|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
156457728|NCT03334630|564772453|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
156457729|NCT03334630|564772454|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
156457730|NCT05907174|564772455|FG000|3-Month Assessment|Withdrawal by Subject|0|||
156457731|NCT05907174|564772456|FG001|3-Month Assessment|Withdrawal by Subject|0|||
156457732|NCT05907174|564772457|FG002|3-Month Assessment|Withdrawal by Subject|0|||
156736714|NCT01938430|565782883|FG007|Overall Study|Investigator's Discretion|0|||
156736715|NCT01938430|565782884|FG008|Overall Study|Investigator's Discretion|0|||
156736716|NCT01938430|565782885|FG009|Overall Study|Investigator's Discretion|0|||
156736717|NCT01938430|565782886|FG010|Overall Study|Investigator's Discretion|0|||
156736718|NCT01938430|565782887|FG011|Overall Study|Investigator's Discretion|0|||
156736719|NCT01938430|565782888|FG012|Overall Study|Investigator's Discretion|0|||
156736720|NCT01938430|565782889|FG013|Overall Study|Investigator's Discretion|0|||
156736721|NCT01938430|565782876|FG000|Overall Study|Lack of Efficacy|3|||
156736722|NCT01938430|565782877|FG001|Overall Study|Lack of Efficacy|1|||
156736723|NCT01938430|565782878|FG002|Overall Study|Lack of Efficacy|1|||
156736724|NCT01938430|565782879|FG003|Overall Study|Lack of Efficacy|1|||
156736725|NCT01938430|565782880|FG004|Overall Study|Lack of Efficacy|0|||
156736726|NCT01938430|565782881|FG005|Overall Study|Lack of Efficacy|0|||
156736727|NCT01938430|565782882|FG006|Overall Study|Lack of Efficacy|0|||
156736728|NCT01938430|565782883|FG007|Overall Study|Lack of Efficacy|0|||
156736729|NCT01938430|565782884|FG008|Overall Study|Lack of Efficacy|1|||
156736730|NCT01938430|565782885|FG009|Overall Study|Lack of Efficacy|0|||
156736731|NCT01938430|565782886|FG010|Overall Study|Lack of Efficacy|2|||
156736732|NCT01938430|565782887|FG011|Overall Study|Lack of Efficacy|1|||
156736733|NCT01938430|565782888|FG012|Overall Study|Lack of Efficacy|0|||
156736734|NCT01938430|565782889|FG013|Overall Study|Lack of Efficacy|0|||
156736735|NCT01938430|565782876|FG000|Overall Study|Lost to Follow-up|0|||
156736736|NCT01938430|565782877|FG001|Overall Study|Lost to Follow-up|0|||
156736737|NCT01938430|565782878|FG002|Overall Study|Lost to Follow-up|1|||
156736738|NCT01938430|565782879|FG003|Overall Study|Lost to Follow-up|0|||
156736739|NCT01938430|565782880|FG004|Overall Study|Lost to Follow-up|0|||
156736740|NCT01938430|565782881|FG005|Overall Study|Lost to Follow-up|1|||
156736741|NCT01938430|565782882|FG006|Overall Study|Lost to Follow-up|0|||
156736742|NCT01938430|565782883|FG007|Overall Study|Lost to Follow-up|0|||
156736743|NCT01938430|565782884|FG008|Overall Study|Lost to Follow-up|0|||
156736744|NCT01938430|565782885|FG009|Overall Study|Lost to Follow-up|0|||
156736745|NCT01938430|565782886|FG010|Overall Study|Lost to Follow-up|0|||
156736746|NCT01938430|565782887|FG011|Overall Study|Lost to Follow-up|0|||
156736747|NCT01938430|565782888|FG012|Overall Study|Lost to Follow-up|0|||
156736748|NCT01938430|565782889|FG013|Overall Study|Lost to Follow-up|0|||
156736749|NCT01938430|565782876|FG000|Overall Study|Withdrew Consent|0|||
156736750|NCT01938430|565782877|FG001|Overall Study|Withdrew Consent|0|||
156736751|NCT01938430|565782878|FG002|Overall Study|Withdrew Consent|0|||
156736752|NCT01938430|565782879|FG003|Overall Study|Withdrew Consent|0|||
156736753|NCT01938430|565782880|FG004|Overall Study|Withdrew Consent|0|||
156736754|NCT01938430|565782881|FG005|Overall Study|Withdrew Consent|0|||
156736755|NCT01938430|565782882|FG006|Overall Study|Withdrew Consent|0|||
156736756|NCT01938430|565782883|FG007|Overall Study|Withdrew Consent|0|||
156736757|NCT01938430|565782884|FG008|Overall Study|Withdrew Consent|1|||
156736758|NCT01938430|565782885|FG009|Overall Study|Withdrew Consent|0|||
156736759|NCT01938430|565782886|FG010|Overall Study|Withdrew Consent|0|||
156736760|NCT01938430|565782887|FG011|Overall Study|Withdrew Consent|0|||
156736761|NCT01938430|565782888|FG012|Overall Study|Withdrew Consent|0|||
156736762|NCT01938430|565782889|FG013|Overall Study|Withdrew Consent|0|||
156736763|NCT04533412|565782890|FG000|Overall Study|Withdrawal by Subject|1|||
156736764|NCT04533412|565782891|FG001|Overall Study|Withdrawal by Subject|1|||
156736765|NCT04533412|565782890|FG000|Overall Study|Lost to Follow-up|1|||
156736766|NCT04533412|565782891|FG001|Overall Study|Lost to Follow-up|4|||
156736767|NCT02738879|565782896|FG000|Overall Study|Adverse Event|1|||
156457733|NCT05907174|564772458|FG003|3-Month Assessment|Withdrawal by Subject|1|||
156736768|NCT02738879|565782897|FG001|Overall Study|Adverse Event|1|||
156736769|NCT02738879|565782896|FG000|Overall Study|Death|0|||
156736770|NCT02738879|565782897|FG001|Overall Study|Death|2|||
156736771|NCT02738879|565782896|FG000|Overall Study|Lost to Follow-up|1|||
156736772|NCT02738879|565782897|FG001|Overall Study|Lost to Follow-up|5|||
156736773|NCT02738879|565782896|FG000|Overall Study|Protocol Violation|1|||
156736774|NCT02738879|565782897|FG001|Overall Study|Protocol Violation|3|||
156336731|NCT01385566|564331332|FG001|Overall Study|Lost to Follow-up|0|||
156736775|NCT02738879|565782896|FG000|Overall Study|Physician Decision|3|||
156736776|NCT02738879|565782897|FG001|Overall Study|Physician Decision|4|||
156736777|NCT02738879|565782896|FG000|Overall Study|Pregnancy|0|||
156736778|NCT02738879|565782897|FG001|Overall Study|Pregnancy|1|||
156457734|NCT05907174|564772455|FG000|3-Month Assessment|Lost to Follow-up|1|||
156457735|NCT05907174|564772456|FG001|3-Month Assessment|Lost to Follow-up|1|||
156457736|NCT05907174|564772457|FG002|3-Month Assessment|Lost to Follow-up|1|||
156457737|NCT05907174|564772458|FG003|3-Month Assessment|Lost to Follow-up|1|||
156457738|NCT05907174|564772455|FG000|6-Month Assessment|Death|0|||
156457739|NCT05907174|564772456|FG001|6-Month Assessment|Death|0|||
156736779|NCT02738879|565782896|FG000|Overall Study|Screen Failure|1|||
156736780|NCT02738879|565782897|FG001|Overall Study|Screen Failure|2|||
156736781|NCT02738879|565782896|FG000|Overall Study|Site Discontinued Study Participation|1|||
156736782|NCT02738879|565782897|FG001|Overall Study|Site Discontinued Study Participation|0|||
156736783|NCT02738879|565782896|FG000|Overall Study|Withdrawal by Subject|5|||
156736784|NCT02738879|565782897|FG001|Overall Study|Withdrawal by Subject|7|||
156736785|NCT00890084|565782898|FG000|Overall Study|Adverse Event|16|||
156736786|NCT00890084|565782898|FG000|Overall Study|Lost to Follow-up|126|||
156736787|NCT01730534|565782900|FG000|Overall Study|Withdrawal by Subject|97|||
156736788|NCT01730534|565782901|FG001|Overall Study|Withdrawal by Subject|127|||
156736789|NCT01730534|565782900|FG000|Overall Study|Lost to Follow-up|12|||
156736790|NCT01730534|565782901|FG001|Overall Study|Lost to Follow-up|18|||
156736791|NCT02892422|565782905|FG000|Overall Study|Enrolled not treated|4|||
156736792|NCT02892422|565782905|FG000|Overall Study|Adverse Event|38|||
156736793|NCT02892422|565782905|FG000|Overall Study|Lack of Efficacy|32|||
156736794|NCT02892422|565782905|FG000|Overall Study|Non-compliance with study drug|11|||
156457740|NCT05907174|564772457|FG002|6-Month Assessment|Death|3|||
156457741|NCT05907174|564772458|FG003|6-Month Assessment|Death|0|||
156457742|NCT05907174|564772455|FG000|6-Month Assessment|Withdrawal by Subject|0|||
156457743|NCT05907174|564772456|FG001|6-Month Assessment|Withdrawal by Subject|0|||
156457744|NCT05907174|564772457|FG002|6-Month Assessment|Withdrawal by Subject|1|||
156457745|NCT05907174|564772458|FG003|6-Month Assessment|Withdrawal by Subject|1|||
156457746|NCT05907174|564772455|FG000|6-Month Assessment|Lost to Follow-up|0|||
156457747|NCT05907174|564772456|FG001|6-Month Assessment|Lost to Follow-up|1|||
156457748|NCT05907174|564772457|FG002|6-Month Assessment|Lost to Follow-up|1|||
156457749|NCT05907174|564772458|FG003|6-Month Assessment|Lost to Follow-up|1|||
156457750|NCT04498390|564772459|FG000|Overall Study|Adverse Event|0|||
156457751|NCT04498390|564772460|FG001|Overall Study|Adverse Event|0|||
156457752|NCT04498390|564772461|FG002|Overall Study|Adverse Event|1|||
156457753|NCT04498390|564772462|FG003|Overall Study|Adverse Event|0|||
156457754|NCT04498390|564772463|FG004|Overall Study|Adverse Event|0|||
156457755|NCT04498390|564772459|FG000|Overall Study|Withdrawal by Subject|0|||
156457756|NCT04498390|564772460|FG001|Overall Study|Withdrawal by Subject|0|||
156457757|NCT04498390|564772461|FG002|Overall Study|Withdrawal by Subject|0|||
156457758|NCT04498390|564772462|FG003|Overall Study|Withdrawal by Subject|1|||
156457759|NCT04498390|564772463|FG004|Overall Study|Withdrawal by Subject|0|||
156457760|NCT01275677|564772473|FG000|Overall Study|Not at risk for recurrence.|1|||
156457761|NCT01275677|564772474|FG001|Overall Study|Not at risk for recurrence.|1|||
156457762|NCT01275677|564772473|FG000|Overall Study|No follow-up|26|||
156457763|NCT01275677|564772474|FG001|Overall Study|No follow-up|37|||
156457764|NCT01275677|564772473|FG000|Overall Study|No clinical follow up.|1|||
156736795|NCT02892422|565782905|FG000|Overall Study|Protocol Violation|4|||
156736796|NCT02892422|565782905|FG000|Overall Study|Withdrawal by Subject|56|||
156736797|NCT02892422|565782905|FG000|Overall Study|Lost to Follow-up|5|||
156736798|NCT02892422|565782905|FG000|Overall Study|sponsor information 16159A results|21|||
156736799|NCT02892422|565782905|FG000|Overall Study|withdrawal of consent|13|||
156736800|NCT02892422|565782905|FG000|Overall Study|exclusion criteria met|3|||
156736801|NCT02892422|565782905|FG000|Overall Study|moving elsewhere|4|||
156736802|NCT02892422|565782905|FG000|Overall Study|non-compliance|10|||
156736803|NCT02892422|565782905|FG000|Overall Study|patient legally incapable|1|||
156736804|NCT02892422|565782905|FG000|Overall Study|patient decision|7|||
156736805|NCT02892422|565782905|FG000|Overall Study|Investigator decision|1|||
156736806|NCT00725608|565782910|FG000|Overall Study|Lost to Follow-up|60|||
156736807|NCT00725608|565782910|FG000|Overall Study|Adverse Event|14|||
156736808|NCT00725608|565782910|FG000|Overall Study|Individual reasons|86|||
156736809|NCT00725608|565782910|FG000|Overall Study|Other|7|||
156736810|NCT00614120|565782914|FG000|Overall Study|Adverse Event|9|||
156736811|NCT00614120|565782915|FG001|Overall Study|Adverse Event|22|||
156736812|NCT00614120|565782916|FG002|Overall Study|Adverse Event|30|||
156736813|NCT00614120|565782917|FG003|Overall Study|Adverse Event|3|||
156736814|NCT00614120|565782914|FG000|Overall Study|Lack of Efficacy|3|||
156736815|NCT00614120|565782915|FG001|Overall Study|Lack of Efficacy|3|||
156736816|NCT00614120|565782916|FG002|Overall Study|Lack of Efficacy|2|||
156736817|NCT00614120|565782917|FG003|Overall Study|Lack of Efficacy|2|||
156736818|NCT00614120|565782914|FG000|Overall Study|Protocol Violation|2|||
156736819|NCT00614120|565782915|FG001|Overall Study|Protocol Violation|5|||
156736820|NCT00614120|565782916|FG002|Overall Study|Protocol Violation|3|||
156736821|NCT00614120|565782917|FG003|Overall Study|Protocol Violation|1|||
156736822|NCT00614120|565782914|FG000|Overall Study|Withdrawal criteria|1|||
156736823|NCT00614120|565782915|FG001|Overall Study|Withdrawal criteria|0|||
156736824|NCT00614120|565782916|FG002|Overall Study|Withdrawal criteria|0|||
156736825|NCT00614120|565782917|FG003|Overall Study|Withdrawal criteria|0|||
156736826|NCT00614120|565782914|FG000|Overall Study|Withdrawal by Subject|9|||
156736827|NCT00614120|565782915|FG001|Overall Study|Withdrawal by Subject|10|||
156736828|NCT00614120|565782916|FG002|Overall Study|Withdrawal by Subject|16|||
156736829|NCT00614120|565782917|FG003|Overall Study|Withdrawal by Subject|3|||
156736830|NCT00614120|565782914|FG000|Overall Study|Did not meet trial criteria|0|||
156457765|NCT01275677|564772474|FG001|Overall Study|No clinical follow up.|4|||
156457766|NCT03734679|564772482|FG000|Overall Study|Missed Visit|1|||
156457767|NCT02733159|564772487|FG000|Overall Study|Adverse Event|1|||
156457768|NCT02733159|564772487|FG000|Overall Study|Lack of disease progression|1|||
156457769|NCT03088878|564772497|FG000|Overall Study|Adverse Event|0|||
156457770|NCT03088878|564772498|FG001|Overall Study|Adverse Event|0|||
156736831|NCT00614120|565782915|FG001|Overall Study|Did not meet trial criteria|1|||
156736832|NCT00614120|565782916|FG002|Overall Study|Did not meet trial criteria|1|||
156457771|NCT03088878|564772499|FG002|Overall Study|Adverse Event|0|||
156736833|NCT00614120|565782917|FG003|Overall Study|Did not meet trial criteria|1|||
156736834|NCT00614120|565782914|FG000|Overall Study|hCG positive (not pregnant)|0|||
156736835|NCT00614120|565782915|FG001|Overall Study|hCG positive (not pregnant)|0|||
156736836|NCT00614120|565782916|FG002|Overall Study|hCG positive (not pregnant)|1|||
156736837|NCT00614120|565782917|FG003|Overall Study|hCG positive (not pregnant)|0|||
156736838|NCT00614120|565782914|FG000|Overall Study|Hypoglycaemia|0|||
156736839|NCT00614120|565782915|FG001|Overall Study|Hypoglycaemia|0|||
156736840|NCT00614120|565782916|FG002|Overall Study|Hypoglycaemia|0|||
156736841|NCT00614120|565782917|FG003|Overall Study|Hypoglycaemia|1|||
156736842|NCT00614120|565782914|FG000|Overall Study|Lack of trial product|3|||
156736843|NCT00614120|565782915|FG001|Overall Study|Lack of trial product|3|||
156736844|NCT00614120|565782916|FG002|Overall Study|Lack of trial product|2|||
156736845|NCT00614120|565782917|FG003|Overall Study|Lack of trial product|0|||
156736846|NCT00614120|565782914|FG000|Overall Study|Late syphilis, latent|1|||
156736847|NCT00614120|565782915|FG001|Overall Study|Late syphilis, latent|0|||
156736848|NCT00614120|565782916|FG002|Overall Study|Late syphilis, latent|0|||
156736849|NCT00614120|565782917|FG003|Overall Study|Late syphilis, latent|0|||
156736850|NCT00614120|565782914|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
156736851|NCT00614120|565782915|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
156736852|NCT00614120|565782916|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
156736853|NCT00614120|565782917|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
156736854|NCT00614120|565782914|FG000|Overall Study|Lost to Follow-up|1|||
156736855|NCT00614120|565782915|FG001|Overall Study|Lost to Follow-up|2|||
156736856|NCT00614120|565782916|FG002|Overall Study|Lost to Follow-up|3|||
156736857|NCT00614120|565782917|FG003|Overall Study|Lost to Follow-up|4|||
156736858|NCT01154088|565782918|FG000|Overall Study|Lost to Follow-up|4|||
156736859|NCT01154088|565782919|FG001|Overall Study|Lost to Follow-up|6|||
156736860|NCT01154088|565782920|FG002|Overall Study|Lost to Follow-up|7|||
156736861|NCT05129137|565782922|FG000|Second Period|Adverse Event|1|||
156736862|NCT05129137|565782923|FG001|Second Period|Adverse Event|0|||
156736863|NCT05129137|565782924|FG002|Second Period|Adverse Event|0|||
156736864|NCT05129137|565782925|FG003|Second Period|Adverse Event|0|||
156736865|NCT05129137|565782922|FG000|Second Period|Protocol Violation|0|||
156736866|NCT05129137|565782923|FG001|Second Period|Protocol Violation|0|||
156736867|NCT05129137|565782924|FG002|Second Period|Protocol Violation|0|||
156736868|NCT05129137|565782925|FG003|Second Period|Protocol Violation|1|||
156736869|NCT05129137|565782922|FG000|Third Period|Protocol Violation|0|||
156736870|NCT05129137|565782923|FG001|Third Period|Protocol Violation|0|||
156736871|NCT05129137|565782924|FG002|Third Period|Protocol Violation|0|||
156736872|NCT05129137|565782925|FG003|Third Period|Protocol Violation|1|||
156736873|NCT05129137|565782922|FG000|Forth Period|Protocol Violation|0|||
156736874|NCT05129137|565782923|FG001|Forth Period|Protocol Violation|1|||
156736875|NCT05129137|565782924|FG002|Forth Period|Protocol Violation|0|||
156736876|NCT05129137|565782925|FG003|Forth Period|Protocol Violation|0|||
156736877|NCT05129137|565782922|FG000|Forth Period|Withdrawal by Subject|0|||
156736878|NCT05129137|565782923|FG001|Forth Period|Withdrawal by Subject|0|||
156736879|NCT05129137|565782924|FG002|Forth Period|Withdrawal by Subject|1|||
156736880|NCT05129137|565782925|FG003|Forth Period|Withdrawal by Subject|0|||
156736881|NCT01084668|565782926|FG000|Overall Study|Lack of Efficacy|5|||
156736882|NCT01084668|565782926|FG000|Overall Study|Withdrawal by Subject|2|||
156736883|NCT01084668|565782926|FG000|Overall Study|Pregnancy|1|||
156736884|NCT01084668|565782926|FG000|Overall Study|Non-compliance|1|||
156736885|NCT00979420|565782927|FG000|Overall Study|Adverse Event|1|||
156736886|NCT00979420|565782928|FG001|Overall Study|Adverse Event|0|||
156736887|NCT00979420|565782929|FG002|Overall Study|Adverse Event|0|||
156736888|NCT00979420|565782930|FG003|Overall Study|Adverse Event|0|||
156736889|NCT00979420|565782927|FG000|Overall Study|Lack of Efficacy|3|||
156736890|NCT00979420|565782928|FG001|Overall Study|Lack of Efficacy|0|||
156457772|NCT03088878|564772500|FG003|Overall Study|Adverse Event|0|||
156457773|NCT03088878|564772501|FG004|Overall Study|Adverse Event|4|||
156457774|NCT03088878|564772502|FG005|Overall Study|Adverse Event|2|||
156457775|NCT03088878|564772503|FG006|Overall Study|Adverse Event|1|||
156457776|NCT03088878|564772504|FG007|Overall Study|Adverse Event|0|||
156736891|NCT00979420|565782929|FG002|Overall Study|Lack of Efficacy|1|||
156736892|NCT00979420|565782930|FG003|Overall Study|Lack of Efficacy|1|||
156736893|NCT00979420|565782927|FG000|Overall Study|Other reasons not related to Viramune|3|||
156736894|NCT00979420|565782928|FG001|Overall Study|Other reasons not related to Viramune|0|||
156736895|NCT00979420|565782929|FG002|Overall Study|Other reasons not related to Viramune|0|||
156736896|NCT00979420|565782930|FG003|Overall Study|Other reasons not related to Viramune|1|||
156736897|NCT01054196|565782931|FG000|Overall Study|Physician Decision|0|||
156736898|NCT01054196|565782932|FG001|Overall Study|Physician Decision|0|||
156736899|NCT01054196|565782933|FG002|Overall Study|Physician Decision|0|||
156736900|NCT01054196|565782934|FG003|Overall Study|Physician Decision|1|||
156736901|NCT01054196|565782935|FG004|Overall Study|Physician Decision|0|||
156736902|NCT01054196|565782936|FG005|Overall Study|Physician Decision|0|||
156736903|NCT01054196|565782937|FG006|Overall Study|Physician Decision|1|||
156457777|NCT03088878|564772505|FG008|Overall Study|Adverse Event|0|||
156736904|NCT01820572|565782942|FG000|Randomization|Not Treated|2|||
156736905|NCT01820572|565782943|FG001|Randomization|Not Treated|1|||
156736906|NCT01820572|565782942|FG000|Treatment Period|Adverse Event|12|||
156736907|NCT01820572|565782943|FG001|Treatment Period|Adverse Event|7|||
156736908|NCT01820572|565782942|FG000|Treatment Period|Death|3|||
156736909|NCT01820572|565782943|FG001|Treatment Period|Death|3|||
156736910|NCT01820572|565782942|FG000|Treatment Period|Lack of Efficacy|1|||
156736911|NCT01820572|565782943|FG001|Treatment Period|Lack of Efficacy|0|||
156736912|NCT01820572|565782942|FG000|Treatment Period|poor/non compliance|0|||
156736913|NCT01820572|565782943|FG001|Treatment Period|poor/non compliance|3|||
156736914|NCT01820572|565782942|FG000|Treatment Period|request to discontinue|6|||
156736915|NCT01820572|565782943|FG001|Treatment Period|request to discontinue|11|||
156736916|NCT01820572|565782942|FG000|Treatment Period|No longer meets study criteria|3|||
156736917|NCT01820572|565782943|FG001|Treatment Period|No longer meets study criteria|10|||
156736918|NCT01820572|565782942|FG000|Treatment Period|withdrew consent|1|||
156736919|NCT01820572|565782943|FG001|Treatment Period|withdrew consent|2|||
156736920|NCT00595517|565782944|FG000|Overall Study|Adverse Event|6|||
156736921|NCT00595517|565782944|FG000|Overall Study|Withdrawal by Subject|4|||
156736922|NCT00595517|565782944|FG000|Overall Study|Protocol Violation|2|||
156736923|NCT00595517|565782944|FG000|Overall Study|Recurrence of ulcer|5|||
156736924|NCT00595517|565782944|FG000|Overall Study|usage of prohibited treatment|1|||
156736925|NCT00595517|565782944|FG000|Overall Study|No intention to attend regularly|1|||
156736926|NCT01167881|565782945|FG000|Overall Study|Adverse Event|47|||
156736927|NCT01167881|565782946|FG001|Overall Study|Adverse Event|51|||
156736928|NCT01167881|565782945|FG000|Overall Study|Lack of Efficacy|4|||
156736929|NCT01167881|565782946|FG001|Overall Study|Lack of Efficacy|7|||
156736930|NCT01167881|565782945|FG000|Overall Study|Non compliant with protocol|9|||
156736931|NCT01167881|565782946|FG001|Overall Study|Non compliant with protocol|18|||
156736932|NCT01167881|565782945|FG000|Overall Study|Lost to Follow-up|19|||
156736933|NCT01167881|565782946|FG001|Overall Study|Lost to Follow-up|20|||
156736934|NCT01167881|565782945|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
156736935|NCT01167881|565782946|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
156736936|NCT01167881|565782945|FG000|Overall Study|Not treated|4|||
156736937|NCT01167881|565782946|FG001|Overall Study|Not treated|0|||
156736938|NCT01167881|565782945|FG000|Overall Study|Other not defined above|31|||
156736939|NCT01167881|565782946|FG001|Overall Study|Other not defined above|55|||
156736940|NCT00977314|565782947|FG000|Overall Study|Withdrawal by Subject|1|||
156736941|NCT00977314|565782948|FG001|Overall Study|Withdrawal by Subject|0|||
156736942|NCT00977314|565782947|FG000|Overall Study|Physician Decision|1|||
156736943|NCT00977314|565782948|FG001|Overall Study|Physician Decision|0|||
156736944|NCT02107859|565782949|FG000|Overall Study|Withdrawal by Subject|14|||
156736945|NCT02107859|565782949|FG000|Overall Study|Adverse Event|3|||
156736946|NCT02107859|565782949|FG000|Overall Study|Study closure|41|||
156736947|NCT02107859|565782949|FG000|Overall Study|Other than specified|3|||
156736948|NCT01343277|565782950|FG000|Overall Study|Other|3|||
156736949|NCT01343277|565782951|FG001|Overall Study|Other|3|||
156736950|NCT01343277|565782950|FG000|Overall Study|Withdrawal by Subject|18|||
156736951|NCT01343277|565782951|FG001|Overall Study|Withdrawal by Subject|13|||
156736952|NCT01343277|565782950|FG000|Overall Study|Physician Decision|1|||
156736953|NCT01343277|565782951|FG001|Overall Study|Physician Decision|2|||
156736954|NCT01343277|565782950|FG000|Overall Study|Death|10|||
156736955|NCT01343277|565782951|FG001|Overall Study|Death|1|||
156736956|NCT01343277|565782950|FG000|Overall Study|Adverse Event|67|||
156736957|NCT01343277|565782951|FG001|Overall Study|Adverse Event|13|||
156736958|NCT01343277|565782950|FG000|Overall Study|Disease progression|270|||
156736959|NCT01343277|565782951|FG001|Overall Study|Disease progression|138|||
156736960|NCT01343277|565782950|FG000|Overall Study|Randomized not treated|6|||
156736961|NCT01343277|565782951|FG001|Overall Study|Randomized not treated|21|||
156736962|NCT01343277|565782950|FG000|Overall Study|Treatment ongoing|8|||
156736963|NCT01343277|565782951|FG001|Overall Study|Treatment ongoing|2|||
156736964|NCT01343277|565782950|FG000|Overall Study|Subsequent anticancer therapy|1|||
156736965|NCT01343277|565782951|FG001|Overall Study|Subsequent anticancer therapy|0|||
156736966|NCT01894100|565782954|FG000|Overall Study|Lost to Follow-up|0|||
156736967|NCT01894100|565782955|FG001|Overall Study|Lost to Follow-up|1|||
156736968|NCT01894100|565782954|FG000|Overall Study|Withdrawal by Subject|3|||
156736969|NCT01894100|565782955|FG001|Overall Study|Withdrawal by Subject|0|||
156736970|NCT01094301|565782958|FG000|Trial Stage|Withdrawal by Subject|1|||
156796958|NCT01055028|566009690|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
156796959|NCT01055028|566009689|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
156796960|NCT01055028|566009690|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
156796961|NCT01055028|566009689|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
156796962|NCT01055028|566009690|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
156796963|NCT04620668|566009691|FG000|Overall Study|Withdrawal by Subject|2|||
156796964|NCT04620668|566009692|FG001|Overall Study|Withdrawal by Subject|0|||
156796965|NCT04620668|566009691|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
156796966|NCT04620668|566009692|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
156336732|NCT01385566|564331333|FG002|Overall Study|Lost to Follow-up|0|||
156736971|NCT01094301|565782958|FG000|Implant Stage|Adverse Event|1|||
156736972|NCT01094301|565782958|FG000|Implant Stage|Protocol Violation|1|||
156736973|NCT01094301|565782958|FG000|Implant Stage|Withdrawal by Subject|2|||
156736974|NCT01094301|565782958|FG000|Implant Stage|No return of pain|4|||
156736975|NCT00135512|565782959|FG000|Overall Study|Adverse Event|56|||
156736976|NCT00135512|565782959|FG000|Overall Study|Lack of Efficacy|25|||
156736977|NCT00135512|565782959|FG000|Overall Study|Other|42|||
156736978|NCT04439214|565782963|FG000|Overall Study|Adverse Event|13|||
156736979|NCT04439214|565782963|FG000|Overall Study|Disease progression|16|||
156736980|NCT04439214|565782963|FG000|Overall Study|Death|1|||
156736981|NCT04439214|565782963|FG000|Overall Study|Withdrawal by Subject|2|||
156736982|NCT04439214|565782963|FG000|Overall Study|Declining health|1|||
156736983|NCT04439214|565782963|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
156736984|NCT04439214|565782963|FG000|Overall Study|Ineligible|5|||
156736985|NCT02235077|565782964|FG000|Overall Study|Death|5|||
156736986|NCT02235077|565782965|FG001|Overall Study|Death|7|||
156736987|NCT02235077|565782964|FG000|Overall Study|Lost to Follow-up|5|||
156736988|NCT02235077|565782965|FG001|Overall Study|Lost to Follow-up|6|||
156736989|NCT02235077|565782964|FG000|Overall Study|Withdrawal by Subject|8|||
156736990|NCT02235077|565782965|FG001|Overall Study|Withdrawal by Subject|5|||
156736991|NCT02235077|565782964|FG000|Overall Study|Physician Decision|0|||
156736992|NCT02235077|565782965|FG001|Overall Study|Physician Decision|1|||
156736993|NCT03852628|565782966|FG000|Overall Study|Lost to Follow-up|7|||
156736994|NCT03852628|565782967|FG001|Overall Study|Lost to Follow-up|6|||
156736995|NCT03852628|565782966|FG000|Overall Study|Lack of Efficacy|6|||
156736996|NCT03852628|565782967|FG001|Overall Study|Lack of Efficacy|6|||
156736997|NCT02964208|565782968|FG000|Overall Study|Death|103|||
156736998|NCT02964208|565782968|FG000|Overall Study|Withdrawal by Subject|6|||
156736999|NCT02964208|565782968|FG000|Overall Study|Lost to Follow-up|6|||
156737000|NCT02964208|565782968|FG000|Overall Study|Unsuccessful Procedure|5|||
156737001|NCT02964208|565782968|FG000|Overall Study|Device Explant|1|||
156737002|NCT02964208|565782968|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
156737003|NCT01668173|565782975|FG000|Overall Study|Adverse Event|3|||
156737004|NCT01668173|565782975|FG000|Overall Study|Trial suspension|4|||
156737005|NCT01295827|565782976|FG000|Overall Study|Adverse Event|1|||
156737006|NCT01295827|565782977|FG001|Overall Study|Adverse Event|2|||
156737007|NCT01295827|565782978|FG002|Overall Study|Adverse Event|2|||
156737008|NCT01295827|565782979|FG003|Overall Study|Adverse Event|1|||
156737009|NCT01295827|565782980|FG004|Overall Study|Adverse Event|1|||
156737010|NCT01295827|565782981|FG005|Overall Study|Adverse Event|4|||
156737011|NCT01295827|565782982|FG006|Overall Study|Adverse Event|15|||
156737012|NCT01295827|565782983|FG007|Overall Study|Adverse Event|49|||
156737013|NCT01295827|565782984|FG008|Overall Study|Adverse Event|22|||
156737014|NCT01295827|565782985|FG009|Overall Study|Adverse Event|7|||
156737015|NCT01295827|565782986|FG010|Overall Study|Adverse Event|50|||
156737016|NCT01295827|565782987|FG011|Overall Study|Adverse Event|21|||
156737017|NCT01295827|565782988|FG012|Overall Study|Adverse Event|0|||
156737018|NCT01295827|565782989|FG013|Overall Study|Adverse Event|0|||
156737019|NCT01295827|565782990|FG014|Overall Study|Adverse Event|0|||
156737020|NCT01295827|565782976|FG000|Overall Study|Lost to Follow-up|0|||
156737021|NCT01295827|565782977|FG001|Overall Study|Lost to Follow-up|0|||
156737022|NCT01295827|565782978|FG002|Overall Study|Lost to Follow-up|3|||
156737023|NCT01295827|565782979|FG003|Overall Study|Lost to Follow-up|0|||
156737024|NCT01295827|565782980|FG004|Overall Study|Lost to Follow-up|1|||
156737025|NCT01295827|565782981|FG005|Overall Study|Lost to Follow-up|0|||
156737026|NCT01295827|565782982|FG006|Overall Study|Lost to Follow-up|4|||
156737027|NCT01295827|565782983|FG007|Overall Study|Lost to Follow-up|8|||
156737028|NCT01295827|565782984|FG008|Overall Study|Lost to Follow-up|7|||
156737029|NCT01295827|565782985|FG009|Overall Study|Lost to Follow-up|4|||
156534368|NCT01621542|565050955|FG000|Overall Study|Death|0|||
156534369|NCT01621542|565050956|FG001|Overall Study|Death|1|||
156534370|NCT01621542|565050957|FG002|Overall Study|Death|0|||
156534371|NCT01621542|565050958|FG003|Overall Study|Death|0|||
156876845|NCT03462511|566307754|FG000|Overall Study|Withdrawal by Subject|2|||
156336733|NCT01385566|564331334|FG003|Overall Study|Lost to Follow-up|0|||
156534372|NCT01621542|565050959|FG004|Overall Study|Death|0|||
156534373|NCT01621542|565050960|FG005|Overall Study|Death|0|||
156737030|NCT01295827|565782986|FG010|Overall Study|Lost to Follow-up|7|||
156737031|NCT01295827|565782987|FG011|Overall Study|Lost to Follow-up|3|||
156737032|NCT01295827|565782988|FG012|Overall Study|Lost to Follow-up|0|||
156737033|NCT01295827|565782989|FG013|Overall Study|Lost to Follow-up|0|||
156737034|NCT01295827|565782990|FG014|Overall Study|Lost to Follow-up|0|||
156737035|NCT01295827|565782976|FG000|Overall Study|Not Reported|0|||
156737036|NCT01295827|565782977|FG001|Overall Study|Not Reported|0|||
156737037|NCT01295827|565782978|FG002|Overall Study|Not Reported|0|||
156534374|NCT01621542|565050955|FG000|Overall Study|Physician Decision|1|||
156534375|NCT01621542|565050956|FG001|Overall Study|Physician Decision|0|||
156737038|NCT01295827|565782979|FG003|Overall Study|Not Reported|1|||
156737039|NCT01295827|565782980|FG004|Overall Study|Not Reported|0|||
156737040|NCT01295827|565782981|FG005|Overall Study|Not Reported|0|||
156534376|NCT01621542|565050957|FG002|Overall Study|Physician Decision|1|||
156534377|NCT01621542|565050958|FG003|Overall Study|Physician Decision|13|||
156534378|NCT01621542|565050959|FG004|Overall Study|Physician Decision|3|||
156534379|NCT01621542|565050960|FG005|Overall Study|Physician Decision|1|||
156534380|NCT01621542|565050955|FG000|Overall Study|Withdrawal by Subject|2|||
156534381|NCT01621542|565050956|FG001|Overall Study|Withdrawal by Subject|0|||
156534382|NCT01621542|565050957|FG002|Overall Study|Withdrawal by Subject|1|||
156534383|NCT01621542|565050958|FG003|Overall Study|Withdrawal by Subject|3|||
156534384|NCT01621542|565050959|FG004|Overall Study|Withdrawal by Subject|3|||
156534385|NCT01621542|565050960|FG005|Overall Study|Withdrawal by Subject|3|||
156534386|NCT01621542|565050955|FG000|Overall Study|progression/treatment failure|2|||
156534387|NCT01621542|565050956|FG001|Overall Study|progression/treatment failure|4|||
156534388|NCT01621542|565050957|FG002|Overall Study|progression/treatment failure|3|||
156534389|NCT01621542|565050958|FG003|Overall Study|progression/treatment failure|7|||
156534390|NCT01621542|565050959|FG004|Overall Study|progression/treatment failure|3|||
156534391|NCT01621542|565050960|FG005|Overall Study|progression/treatment failure|5|||
156534392|NCT01621542|565050955|FG000|Overall Study|Protocol Violation|0|||
156534393|NCT01621542|565050956|FG001|Overall Study|Protocol Violation|0|||
156737041|NCT01295827|565782982|FG006|Overall Study|Not Reported|24|||
156737042|NCT01295827|565782983|FG007|Overall Study|Not Reported|58|||
156737043|NCT01295827|565782984|FG008|Overall Study|Not Reported|41|||
156737044|NCT01295827|565782985|FG009|Overall Study|Not Reported|2|||
156737045|NCT01295827|565782986|FG010|Overall Study|Not Reported|23|||
156737046|NCT01295827|565782987|FG011|Overall Study|Not Reported|13|||
156737047|NCT01295827|565782988|FG012|Overall Study|Not Reported|0|||
156737048|NCT01295827|565782989|FG013|Overall Study|Not Reported|0|||
156737049|NCT01295827|565782990|FG014|Overall Study|Not Reported|0|||
156737050|NCT01295827|565782976|FG000|Overall Study|Progressive Disease|2|||
156737051|NCT01295827|565782977|FG001|Overall Study|Progressive Disease|1|||
156737052|NCT01295827|565782978|FG002|Overall Study|Progressive Disease|5|||
156737053|NCT01295827|565782979|FG003|Overall Study|Progressive Disease|2|||
156737054|NCT01295827|565782980|FG004|Overall Study|Progressive Disease|0|||
156737055|NCT01295827|565782981|FG005|Overall Study|Progressive Disease|1|||
156737056|NCT01295827|565782982|FG006|Overall Study|Progressive Disease|87|||
156737057|NCT01295827|565782983|FG007|Overall Study|Progressive Disease|144|||
156737058|NCT01295827|565782984|FG008|Overall Study|Progressive Disease|85|||
156737059|NCT01295827|565782985|FG009|Overall Study|Progressive Disease|40|||
156737060|NCT01295827|565782986|FG010|Overall Study|Progressive Disease|175|||
156737061|NCT01295827|565782987|FG011|Overall Study|Progressive Disease|136|||
156737062|NCT01295827|565782988|FG012|Overall Study|Progressive Disease|0|||
156737063|NCT01295827|565782989|FG013|Overall Study|Progressive Disease|0|||
156737064|NCT01295827|565782990|FG014|Overall Study|Progressive Disease|0|||
156737065|NCT01295827|565782976|FG000|Overall Study|Screen Failure|0|||
156737066|NCT01295827|565782977|FG001|Overall Study|Screen Failure|0|||
156737067|NCT01295827|565782978|FG002|Overall Study|Screen Failure|0|||
156737068|NCT01295827|565782979|FG003|Overall Study|Screen Failure|0|||
156737069|NCT01295827|565782980|FG004|Overall Study|Screen Failure|0|||
156737070|NCT01295827|565782981|FG005|Overall Study|Screen Failure|0|||
156737071|NCT01295827|565782982|FG006|Overall Study|Screen Failure|2|||
156737072|NCT01295827|565782983|FG007|Overall Study|Screen Failure|2|||
156737073|NCT01295827|565782984|FG008|Overall Study|Screen Failure|2|||
156737074|NCT01295827|565782985|FG009|Overall Study|Screen Failure|0|||
156737075|NCT01295827|565782986|FG010|Overall Study|Screen Failure|1|||
156737076|NCT01295827|565782987|FG011|Overall Study|Screen Failure|0|||
156737077|NCT01295827|565782988|FG012|Overall Study|Screen Failure|0|||
156737078|NCT01295827|565782989|FG013|Overall Study|Screen Failure|0|||
156737079|NCT01295827|565782990|FG014|Overall Study|Screen Failure|0|||
156796967|NCT04620668|566009691|FG000|Overall Study|Removed before analysis: missing data|2|||
156796968|NCT04620668|566009692|FG001|Overall Study|Removed before analysis: missing data|0|||
156796969|NCT04620668|566009691|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
156796970|NCT04620668|566009692|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
156534394|NCT01621542|565050957|FG002|Overall Study|Protocol Violation|0|||
156737080|NCT01295827|565782976|FG000|Overall Study|Withdrawal by Subject|1|||
156796971|NCT04620668|566009691|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
156796972|NCT04620668|566009692|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
156737081|NCT01295827|565782977|FG001|Overall Study|Withdrawal by Subject|0|||
156737082|NCT01295827|565782978|FG002|Overall Study|Withdrawal by Subject|2|||
156336734|NCT01385566|564331335|FG004|Overall Study|Lost to Follow-up|0|||
156737083|NCT01295827|565782979|FG003|Overall Study|Withdrawal by Subject|0|||
156737084|NCT01295827|565782980|FG004|Overall Study|Withdrawal by Subject|0|||
156796973|NCT03559530|566009693|FG000|Overall Study|non-location of medical records|44|||
156534395|NCT01621542|565050958|FG003|Overall Study|Protocol Violation|1|||
156534396|NCT01621542|565050959|FG004|Overall Study|Protocol Violation|0|||
156534397|NCT01621542|565050960|FG005|Overall Study|Protocol Violation|0|||
156534398|NCT01621542|565050955|FG000|Overall Study|study stopped by sponsor|0|||
156737085|NCT01295827|565782981|FG005|Overall Study|Withdrawal by Subject|1|||
156737086|NCT01295827|565782982|FG006|Overall Study|Withdrawal by Subject|13|||
156737087|NCT01295827|565782983|FG007|Overall Study|Withdrawal by Subject|35|||
156737088|NCT01295827|565782984|FG008|Overall Study|Withdrawal by Subject|11|||
156737089|NCT01295827|565782985|FG009|Overall Study|Withdrawal by Subject|2|||
156737090|NCT01295827|565782986|FG010|Overall Study|Withdrawal by Subject|18|||
156737091|NCT01295827|565782987|FG011|Overall Study|Withdrawal by Subject|13|||
156737092|NCT01295827|565782988|FG012|Overall Study|Withdrawal by Subject|0|||
156737093|NCT01295827|565782989|FG013|Overall Study|Withdrawal by Subject|0|||
156737094|NCT01295827|565782990|FG014|Overall Study|Withdrawal by Subject|0|||
156737095|NCT01295827|565782976|FG000|Overall Study|Other|0|||
156737096|NCT01295827|565782977|FG001|Overall Study|Other|0|||
156737097|NCT01295827|565782978|FG002|Overall Study|Other|0|||
156737098|NCT01295827|565782979|FG003|Overall Study|Other|0|||
156737099|NCT01295827|565782980|FG004|Overall Study|Other|0|||
156737100|NCT01295827|565782981|FG005|Overall Study|Other|0|||
156737101|NCT01295827|565782982|FG006|Overall Study|Other|1|||
156737102|NCT01295827|565782983|FG007|Overall Study|Other|1|||
156737103|NCT01295827|565782984|FG008|Overall Study|Other|1|||
156737104|NCT01295827|565782985|FG009|Overall Study|Other|0|||
156737105|NCT01295827|565782986|FG010|Overall Study|Other|2|||
156737106|NCT01295827|565782987|FG011|Overall Study|Other|0|||
156737107|NCT01295827|565782988|FG012|Overall Study|Other|0|||
156737108|NCT01295827|565782989|FG013|Overall Study|Other|0|||
156737109|NCT01295827|565782990|FG014|Overall Study|Other|0|||
156737110|NCT00101166|565782991|FG000|Overall Study|progressive disease|10|||
156737111|NCT01868022|565782992|FG000|Overall Study|Withdrawal by Subject|0|||
156737112|NCT01868022|565782993|FG001|Overall Study|Withdrawal by Subject|0|||
156737113|NCT01868022|565782994|FG002|Overall Study|Withdrawal by Subject|1|||
156737114|NCT01868022|565782995|FG003|Overall Study|Withdrawal by Subject|1|||
156737115|NCT01868022|565782996|FG004|Overall Study|Withdrawal by Subject|0|||
156737116|NCT01868022|565782997|FG005|Overall Study|Withdrawal by Subject|0|||
156737117|NCT01868022|565782998|FG006|Overall Study|Withdrawal by Subject|0|||
156737118|NCT01868022|565782999|FG007|Overall Study|Withdrawal by Subject|1|||
156737119|NCT01868022|565783000|FG008|Overall Study|Withdrawal by Subject|0|||
156737120|NCT01868022|565782992|FG000|Overall Study|Adverse Event|0|||
156737121|NCT01868022|565782993|FG001|Overall Study|Adverse Event|0|||
156737122|NCT01868022|565782994|FG002|Overall Study|Adverse Event|0|||
156737123|NCT01868022|565782995|FG003|Overall Study|Adverse Event|0|||
156737124|NCT01868022|565782996|FG004|Overall Study|Adverse Event|2|||
156737125|NCT01868022|565782997|FG005|Overall Study|Adverse Event|0|||
156737126|NCT01868022|565782998|FG006|Overall Study|Adverse Event|0|||
156737127|NCT01868022|565782999|FG007|Overall Study|Adverse Event|2|||
156737128|NCT01868022|565783000|FG008|Overall Study|Adverse Event|2|||
156737129|NCT01868022|565782992|FG000|Overall Study|Physician Decision|0|||
156737130|NCT01868022|565782993|FG001|Overall Study|Physician Decision|0|||
156737131|NCT01868022|565782994|FG002|Overall Study|Physician Decision|0|||
156737132|NCT01868022|565782995|FG003|Overall Study|Physician Decision|0|||
156737133|NCT01868022|565782996|FG004|Overall Study|Physician Decision|0|||
156737134|NCT01868022|565782997|FG005|Overall Study|Physician Decision|1|||
156737135|NCT01868022|565782998|FG006|Overall Study|Physician Decision|0|||
156737136|NCT01868022|565782999|FG007|Overall Study|Physician Decision|2|||
156737137|NCT01868022|565783000|FG008|Overall Study|Physician Decision|0|||
156737138|NCT01868022|565782992|FG000|Overall Study|Study closed/terminated|0|||
156737139|NCT01868022|565782993|FG001|Overall Study|Study closed/terminated|0|||
156737140|NCT01868022|565782994|FG002|Overall Study|Study closed/terminated|0|||
156737141|NCT01868022|565782995|FG003|Overall Study|Study closed/terminated|0|||
156737142|NCT01868022|565782996|FG004|Overall Study|Study closed/terminated|0|||
156737143|NCT01868022|565782997|FG005|Overall Study|Study closed/terminated|0|||
156737144|NCT01868022|565782998|FG006|Overall Study|Study closed/terminated|0|||
156737145|NCT01868022|565782999|FG007|Overall Study|Study closed/terminated|1|||
156737146|NCT01868022|565783000|FG008|Overall Study|Study closed/terminated|0|||
156737147|NCT01868022|565782992|FG000|Overall Study|Ongoing|0|||
156737148|NCT01868022|565782993|FG001|Overall Study|Ongoing|0|||
156737149|NCT01868022|565782994|FG002|Overall Study|Ongoing|0|||
156737150|NCT01868022|565782995|FG003|Overall Study|Ongoing|0|||
156737151|NCT01868022|565782996|FG004|Overall Study|Ongoing|0|||
156737152|NCT01868022|565782997|FG005|Overall Study|Ongoing|0|||
156737153|NCT01868022|565782998|FG006|Overall Study|Ongoing|0|||
156737154|NCT01868022|565782999|FG007|Overall Study|Ongoing|3|||
156737155|NCT01868022|565783000|FG008|Overall Study|Ongoing|0|||
156737156|NCT00746564|565783001|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
156336735|NCT01385566|564331336|FG005|Overall Study|Lost to Follow-up|0|||
156336736|NCT01385566|564331331|FG000|Overall Study|Withdrawal by Subject|0|||
156737157|NCT00022698|565783002|FG000|Overall Study|Adverse Event|5|||
156737158|NCT00022698|565783003|FG001|Overall Study|Adverse Event|9|||
156737159|NCT00022698|565783002|FG000|Overall Study|Death|0|||
156737160|NCT00022698|565783003|FG001|Overall Study|Death|2|||
156336737|NCT01385566|564331332|FG001|Overall Study|Withdrawal by Subject|0|||
156336738|NCT01385566|564331333|FG002|Overall Study|Withdrawal by Subject|0|||
156737161|NCT00022698|565783002|FG000|Overall Study|Failure to return|0|||
156737162|NCT00022698|565783003|FG001|Overall Study|Failure to return|1|||
156737163|NCT00022698|565783002|FG000|Overall Study|Refused treatment|0|||
156737164|NCT00022698|565783003|FG001|Overall Study|Refused treatment|2|||
156737165|NCT00022698|565783002|FG000|Overall Study|Insufficient therapeutic response|2|||
156737166|NCT00022698|565783003|FG001|Overall Study|Insufficient therapeutic response|14|||
156737167|NCT00022698|565783002|FG000|Overall Study|Administrative /other|1|||
156737168|NCT00022698|565783003|FG001|Overall Study|Administrative /other|7|||
156336739|NCT01385566|564331334|FG003|Overall Study|Withdrawal by Subject|1|||
156336740|NCT01385566|564331335|FG004|Overall Study|Withdrawal by Subject|0|||
156336741|NCT01385566|564331336|FG005|Overall Study|Withdrawal by Subject|0|||
156336742|NCT00967668|564331337|FG000|Overall Study|Withdrawal by Subject|13|||
156336743|NCT00967668|564331338|FG001|Overall Study|Withdrawal by Subject|8|||
156336744|NCT00967668|564331339|FG002|Overall Study|Withdrawal by Subject|8|||
156336745|NCT00967668|564331337|FG000|Overall Study|Death|0|||
156457778|NCT03088878|564772506|FG009|Overall Study|Adverse Event|0|||
156457779|NCT03088878|564772507|FG010|Overall Study|Adverse Event|0|||
156457780|NCT03088878|564772508|FG011|Overall Study|Adverse Event|0|||
156457781|NCT03088878|564772509|FG012|Overall Study|Adverse Event|5|||
156737169|NCT01217476|565783008|FG000|Overall Study|Adverse Event|6|||
156737170|NCT01217476|565783009|FG001|Overall Study|Adverse Event|1|||
156737171|NCT01217476|565783008|FG000|Overall Study|Physician Decision|0|||
156737172|NCT01217476|565783009|FG001|Overall Study|Physician Decision|1|||
156737173|NCT01217476|565783008|FG000|Overall Study|Withdrawal by Subject|3|||
156737174|NCT01217476|565783009|FG001|Overall Study|Withdrawal by Subject|3|||
156737175|NCT01217476|565783008|FG000|Overall Study|Surgery on the Target Limb|0|||
156737176|NCT01217476|565783009|FG001|Overall Study|Surgery on the Target Limb|2|||
156737177|NCT01217476|565783008|FG000|Overall Study|Protocol Deviation|1|||
156737178|NCT01217476|565783009|FG001|Overall Study|Protocol Deviation|0|||
156737179|NCT01217476|565783008|FG000|Overall Study|Other|2|||
156737180|NCT01217476|565783009|FG001|Overall Study|Other|0|||
156737181|NCT03033602|565783010|FG000|Overall Study|Withdrawal by Subject|11|||
156737182|NCT03033602|565783011|FG001|Overall Study|Withdrawal by Subject|21|||
156737183|NCT03033602|565783010|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
156737184|NCT03033602|565783011|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
156737185|NCT01441765|565783012|FG000|Overall Study|Death|1|||
156737186|NCT01441765|565783013|FG001|Overall Study|Death|0|||
156737187|NCT01493284|565783018|FG000|Overall Study|Death|29|||
156737188|NCT01493284|565783018|FG000|Overall Study|Withdrawal by Subject|32|||
156737189|NCT03489707|565783019|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
156737190|NCT03489707|565783020|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
156737191|NCT03489707|565783019|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
156737192|NCT03489707|565783020|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
156737193|NCT00325156|565783021|FG000|Overall Study|Protocol Violation|8|||
156737194|NCT00325156|565783021|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
156876846|NCT03462511|566307755|FG001|Overall Study|Withdrawal by Subject|3|||
156457782|NCT03088878|564772510|FG013|Overall Study|Adverse Event|3|||
156457783|NCT03088878|564772497|FG000|Overall Study|Clinical Progression|0|||
156457784|NCT03088878|564772498|FG001|Overall Study|Clinical Progression|0|||
156457785|NCT03088878|564772499|FG002|Overall Study|Clinical Progression|0|||
156737195|NCT00325156|565783021|FG000|Overall Study|Migrated/moved from study area|12|||
156737196|NCT00325156|565783021|FG000|Overall Study|Adverse event, non-fatal|3|||
156737197|NCT00325156|565783021|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
156737198|NCT00325156|565783021|FG000|Overall Study|Other|1|||
156737199|NCT00325156|565783021|FG000|Overall Study|Withdrawal by Subject|31|||
156876847|NCT02925416|566307756|FG000|Overall Study|Adverse Event|2|||
156876848|NCT02925416|566307757|FG001|Overall Study|Adverse Event|0|||
156876849|NCT02625909|566307758|FG000|Overall Study|Death|2|||
156876850|NCT02625909|566307759|FG001|Overall Study|Death|0|||
156876851|NCT02625909|566307758|FG000|Overall Study|Lost to Follow-up|3|||
156876852|NCT02625909|566307759|FG001|Overall Study|Lost to Follow-up|5|||
156876853|NCT02625909|566307758|FG000|Overall Study|Lack of Efficacy|9|||
156876854|NCT02625909|566307759|FG001|Overall Study|Lack of Efficacy|2|||
156457786|NCT03088878|564772500|FG003|Overall Study|Clinical Progression|0|||
156457787|NCT03088878|564772501|FG004|Overall Study|Clinical Progression|2|||
156457788|NCT03088878|564772502|FG005|Overall Study|Clinical Progression|0|||
156876855|NCT02625909|566307758|FG000|Overall Study|Reinfection|3|||
156457789|NCT03088878|564772503|FG006|Overall Study|Clinical Progression|0|||
156457790|NCT03088878|564772504|FG007|Overall Study|Clinical Progression|0|||
156737200|NCT01082211|565783025|FG000|Overall Study|Protocol Violation|4|||
156737201|NCT01082211|565783025|FG000|Overall Study|No protocol treatment received|3|||
156737202|NCT03725761|565783026|FG000|Overall Study|still on study|1|||
156876856|NCT02625909|566307759|FG001|Overall Study|Reinfection|2|||
156336746|NCT00967668|564331338|FG001|Overall Study|Death|2|||
156336747|NCT00967668|564331339|FG002|Overall Study|Death|4|||
156336748|NCT00967668|564331337|FG000|Overall Study|Removed due to behavior|1|||
156336749|NCT00967668|564331338|FG001|Overall Study|Removed due to behavior|1|||
156457791|NCT03088878|564772505|FG008|Overall Study|Clinical Progression|0|||
156737203|NCT05903924|565784777|FG000|Overall Study|Lost to Follow-up|1|||
156737204|NCT05903924|565784778|FG001|Overall Study|Lost to Follow-up|0|||
156737205|NCT05903924|565784779|FG002|Overall Study|Lost to Follow-up|0|||
156737206|NCT00174967|565784780|FG000|Overall Study|Adverse Event|1|||
156737207|NCT00174967|565784781|FG001|Overall Study|Adverse Event|2|||
156737208|NCT00174967|565784782|FG002|Overall Study|Adverse Event|2|||
156737209|NCT00174967|565784783|FG003|Overall Study|Adverse Event|1|||
156737210|NCT00174967|565784780|FG000|Overall Study|Gout Flare|0|||
156737211|NCT00174967|565784781|FG001|Overall Study|Gout Flare|0|||
156737212|NCT00174967|565784782|FG002|Overall Study|Gout Flare|0|||
156737213|NCT00174967|565784783|FG003|Overall Study|Gout Flare|1|||
156737214|NCT00174967|565784780|FG000|Overall Study|Other|0|||
156737215|NCT00174967|565784781|FG001|Overall Study|Other|1|||
156737216|NCT00174967|565784782|FG002|Overall Study|Other|0|||
156737217|NCT00174967|565784783|FG003|Overall Study|Other|0|||
156737218|NCT03030989|565784784|FG000|Overall Study|Fever|2|||
156737219|NCT03030989|565784785|FG001|Overall Study|Fever|2|||
156737220|NCT03030989|565784784|FG000|Overall Study|Rash|2|||
156737221|NCT03030989|565784785|FG001|Overall Study|Rash|1|||
156737222|NCT03030989|565784784|FG000|Overall Study|Fatigue/Overwhelmed|1|||
156876857|NCT02367833|566307760|FG000|Overall Study|Withdrawal by Subject|1|||
156737223|NCT03030989|565784785|FG001|Overall Study|Fatigue/Overwhelmed|5|||
156737224|NCT03030989|565784784|FG000|Overall Study|Positive Blood Cultures|2|||
156876858|NCT02367833|566307761|FG001|Overall Study|Withdrawal by Subject|1|||
156876859|NCT02367833|566307762|FG002|Overall Study|Withdrawal by Subject|0|||
156876860|NCT02167139|566307763|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
156876861|NCT02167139|566307764|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
156876862|NCT02167139|566307765|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
156876863|NCT02167139|566307766|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
156876864|NCT02167139|566307763|FG000|Randomised, Double-blind|Adverse Event|2|||
156876865|NCT02167139|566307764|FG001|Randomised, Double-blind|Adverse Event|9|||
156876866|NCT02167139|566307765|FG002|Randomised, Double-blind|Adverse Event|0|||
156876867|NCT02167139|566307766|FG003|Randomised, Double-blind|Adverse Event|0|||
156876868|NCT02167139|566307763|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
156876869|NCT02167139|566307764|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
156876870|NCT02167139|566307765|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
156876871|NCT02167139|566307766|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
156876872|NCT02167139|566307763|FG000|Randomised, Double-blind|Other|3|||
156876873|NCT02167139|566307764|FG001|Randomised, Double-blind|Other|0|||
156876874|NCT02167139|566307765|FG002|Randomised, Double-blind|Other|0|||
156876875|NCT02167139|566307766|FG003|Randomised, Double-blind|Other|0|||
156876876|NCT02167139|566307763|FG000|Transition-extension|Adverse Event|2|||
156876877|NCT02167139|566307764|FG001|Transition-extension|Adverse Event|0|||
156876878|NCT02167139|566307765|FG002|Transition-extension|Adverse Event|2|||
156876879|NCT02167139|566307766|FG003|Transition-extension|Adverse Event|3|||
156876880|NCT02167139|566307763|FG000|Transition-extension|Withdrawal by Subject|2|||
156876881|NCT02167139|566307764|FG001|Transition-extension|Withdrawal by Subject|0|||
156876882|NCT02167139|566307765|FG002|Transition-extension|Withdrawal by Subject|4|||
156876883|NCT02167139|566307766|FG003|Transition-extension|Withdrawal by Subject|1|||
156876884|NCT02167139|566307763|FG000|Transition-extension|Lack of Efficacy|0|||
156876885|NCT02167139|566307764|FG001|Transition-extension|Lack of Efficacy|0|||
156876886|NCT02167139|566307765|FG002|Transition-extension|Lack of Efficacy|1|||
156876887|NCT02167139|566307766|FG003|Transition-extension|Lack of Efficacy|1|||
156876888|NCT02167139|566307763|FG000|Transition-extension|Other|1|||
156876889|NCT02167139|566307764|FG001|Transition-extension|Other|0|||
156876890|NCT02167139|566307765|FG002|Transition-extension|Other|1|||
156737225|NCT03030989|565784785|FG001|Overall Study|Positive Blood Cultures|1|||
156737226|NCT03030989|565784784|FG000|Overall Study|Line Removed|0|||
156737227|NCT03030989|565784785|FG001|Overall Study|Line Removed|2|||
156737228|NCT03030989|565784784|FG000|Overall Study|No longer interested|5|||
156737229|NCT03030989|565784785|FG001|Overall Study|No longer interested|3|||
156876891|NCT02167139|566307766|FG003|Transition-extension|Other|0|||
156457792|NCT03088878|564772506|FG009|Overall Study|Clinical Progression|0|||
156737230|NCT02730377|565784786|FG000|Overall Study|Other|5|||
156737231|NCT02730377|565784787|FG001|Overall Study|Other|4|||
156737232|NCT02730377|565784786|FG000|Overall Study|Death|1|||
156737233|NCT02730377|565784787|FG001|Overall Study|Death|8|||
156876892|NCT02167139|566307763|FG000|Transition-extension|Lost to Follow-up|1|||
156876893|NCT02167139|566307764|FG001|Transition-extension|Lost to Follow-up|0|||
156876894|NCT02167139|566307765|FG002|Transition-extension|Lost to Follow-up|0|||
156876895|NCT02167139|566307766|FG003|Transition-extension|Lost to Follow-up|0|||
156876896|NCT00996333|566307767|FG000|Overall Study|Screen failure|1|||
156876897|NCT00996333|566307767|FG000|Overall Study|Withdrawal by Subject|1|||
156876898|NCT00996333|566307767|FG000|Overall Study|Death|4|||
156876899|NCT00996333|566307767|FG000|Overall Study|Adverse Event|1|||
156737234|NCT02730377|565784786|FG000|Overall Study|Inadequate glycaemic control|368|||
156876900|NCT00996333|566307767|FG000|Overall Study|Physician Decision|1|||
156737235|NCT02730377|565784787|FG001|Overall Study|Inadequate glycaemic control|473|||
156737236|NCT02730377|565784786|FG000|Overall Study|Adverse Event|79|||
156336750|NCT00967668|564331339|FG002|Overall Study|Removed due to behavior|2|||
156336751|NCT00967668|564331337|FG000|Overall Study|Refused Year 2|11|||
156336752|NCT00967668|564331338|FG001|Overall Study|Refused Year 2|6|||
156336753|NCT00967668|564331339|FG002|Overall Study|Refused Year 2|4|||
156336754|NCT00967668|564331337|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
156336755|NCT00967668|564331338|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
156336756|NCT00967668|564331339|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
156336757|NCT00967668|564331337|FG000|Overall Study|Lost to Follow-up|15|||
156336758|NCT00967668|564331338|FG001|Overall Study|Lost to Follow-up|9|||
156336759|NCT00967668|564331339|FG002|Overall Study|Lost to Follow-up|16|||
156534399|NCT01621542|565050956|FG001|Overall Study|study stopped by sponsor|0|||
156737237|NCT02730377|565784787|FG001|Overall Study|Adverse Event|41|||
156336760|NCT00967668|564331337|FG000|Overall Study|Refused 12-mo assessment|3|||
156336761|NCT00967668|564331338|FG001|Overall Study|Refused 12-mo assessment|1|||
156336762|NCT00967668|564331339|FG002|Overall Study|Refused 12-mo assessment|9|||
156336763|NCT00967668|564331337|FG000|Overall Study|Pregnancy|1|||
156336764|NCT00967668|564331338|FG001|Overall Study|Pregnancy|0|||
156534400|NCT01621542|565050957|FG002|Overall Study|study stopped by sponsor|0|||
156534401|NCT01621542|565050958|FG003|Overall Study|study stopped by sponsor|1|||
156534402|NCT01621542|565050959|FG004|Overall Study|study stopped by sponsor|0|||
156534403|NCT01621542|565050960|FG005|Overall Study|study stopped by sponsor|0|||
156737238|NCT02730377|565784786|FG000|Overall Study|Protocol Violation|23|||
156737239|NCT02730377|565784787|FG001|Overall Study|Protocol Violation|30|||
156737240|NCT02730377|565784786|FG000|Overall Study|Lack of Efficacy|4|||
156737241|NCT02730377|565784787|FG001|Overall Study|Lack of Efficacy|13|||
156737242|NCT02730377|565784786|FG000|Overall Study|Pregnancy|0|||
156737243|NCT02730377|565784787|FG001|Overall Study|Pregnancy|1|||
156737244|NCT02730377|565784786|FG000|Overall Study|Withdrawal by Subject|45|||
156737245|NCT02730377|565784787|FG001|Overall Study|Withdrawal by Subject|42|||
156737246|NCT02730377|565784786|FG000|Overall Study|Lost to Follow-up|25|||
156737247|NCT02730377|565784787|FG001|Overall Study|Lost to Follow-up|21|||
156737248|NCT02706886|565784788|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
156737249|NCT02706886|565784789|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
156737250|NCT02706886|565784790|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
156737251|NCT02706886|565784791|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
156737252|NCT02706886|565784792|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
156737253|NCT02706886|565784793|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
156737254|NCT02706886|565784794|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
156737255|NCT02706886|565784795|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
156737256|NCT02706886|565784796|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
156737257|NCT03917472|565784797|FG000|Overall Study|Physician Decision|4|||
156737258|NCT03917472|565784798|FG001|Overall Study|Physician Decision|0|||
156737259|NCT03917472|565784797|FG000|Overall Study|Adverse Event|3|||
156737260|NCT03917472|565784798|FG001|Overall Study|Adverse Event|1|||
156737261|NCT03917472|565784797|FG000|Overall Study|Death|7|||
156737262|NCT03917472|565784798|FG001|Overall Study|Death|5|||
156737263|NCT03917472|565784797|FG000|Overall Study|Withdrawal by Subject|11|||
156737264|NCT03917472|565784798|FG001|Overall Study|Withdrawal by Subject|4|||
156737265|NCT03917472|565784797|FG000|Overall Study|Lost to Follow-up|10|||
156737266|NCT03917472|565784798|FG001|Overall Study|Lost to Follow-up|5|||
156737267|NCT01154296|565784799|FG000|Randomization and Intervention|Decided to decline|1|||
156737268|NCT01154296|565784800|FG001|Randomization and Intervention|Decided to decline|1|||
156737269|NCT01154296|565784799|FG000|Randomization and Intervention|Declined by staff|1|||
156737270|NCT01154296|565784800|FG001|Randomization and Intervention|Declined by staff|0|||
156737271|NCT01154296|565784799|FG000|Randomization and Intervention|Did not return|1|||
156737272|NCT01154296|565784800|FG001|Randomization and Intervention|Did not return|0|||
156737273|NCT01154296|565784799|FG000|Randomization and Intervention|Left before test|0|||
156737274|NCT01154296|565784800|FG001|Randomization and Intervention|Left before test|1|||
156737275|NCT01154296|565784799|FG000|Randomization and Intervention|Left clinic early|2|||
156737276|NCT01154296|565784800|FG001|Randomization and Intervention|Left clinic early|0|||
156737277|NCT01154296|565784799|FG000|6-month Follow-up|Lost contact|269|||
156534404|NCT00544648|565050965|FG000|Overall Study|Withdrawal by Subject|1|||
156534405|NCT00544648|565050966|FG001|Overall Study|Withdrawal by Subject|0|||
156534406|NCT00544648|565050965|FG000|Overall Study|Adverse Event|1|||
156737278|NCT01154296|565784800|FG001|6-month Follow-up|Lost contact|275|||
156737279|NCT01154296|565784799|FG000|6-month Follow-up|Incarcerated|37|||
156737280|NCT01154296|565784800|FG001|6-month Follow-up|Incarcerated|32|||
156737281|NCT01154296|565784799|FG000|6-month Follow-up|Withdrew consent|14|||
156737282|NCT01154296|565784800|FG001|6-month Follow-up|Withdrew consent|15|||
156737283|NCT01154296|565784799|FG000|6-month Follow-up|Death|3|||
156737284|NCT01154296|565784800|FG001|6-month Follow-up|Death|2|||
156534407|NCT00544648|565050966|FG001|Overall Study|Adverse Event|1|||
156336765|NCT00967668|564331339|FG002|Overall Study|Pregnancy|0|||
156336766|NCT01594281|564331340|FG000|Interventional Core Phase|Protocol Deviation|1|||
156336767|NCT01594281|564331341|FG001|Interventional Core Phase|Protocol Deviation|0|||
156336768|NCT01594281|564331342|FG002|Interventional Core Phase|Protocol Deviation|0|||
156336769|NCT01594281|564331340|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
156336770|NCT01594281|564331341|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
156336771|NCT01594281|564331342|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
156336772|NCT01594281|564331340|FG000|Interventional Core Phase|Death|1|||
156336773|NCT01594281|564331341|FG001|Interventional Core Phase|Death|1|||
156336774|NCT01594281|564331342|FG002|Interventional Core Phase|Death|2|||
156336775|NCT01594281|564331340|FG000|Interventional Core Phase|Lost to Follow-up|1|||
156336776|NCT01594281|564331341|FG001|Interventional Core Phase|Lost to Follow-up|4|||
156336777|NCT01594281|564331342|FG002|Interventional Core Phase|Lost to Follow-up|1|||
156336778|NCT01594281|564331340|FG000|Interventional Core Phase|Adverse Event|4|||
156336779|NCT01594281|564331341|FG001|Interventional Core Phase|Adverse Event|4|||
156336780|NCT01594281|564331342|FG002|Interventional Core Phase|Adverse Event|4|||
156336781|NCT01594281|564331340|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
156336782|NCT01594281|564331341|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
156336783|NCT01594281|564331342|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
156336784|NCT01594281|564331340|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
156336785|NCT01594281|564331341|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
156336786|NCT01594281|564331342|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
156336787|NCT01594281|564331340|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
156336788|NCT01594281|564331341|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
156336789|NCT01594281|564331342|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
156336790|NCT00283400|564331343|FG000|Overall Study|Withdrawal by Subject|1|||
156336791|NCT00283400|564331344|FG001|Overall Study|Withdrawal by Subject|1|||
156336792|NCT00283400|564331345|FG002|Overall Study|Withdrawal by Subject|0|||
156336793|NCT00283400|564331346|FG003|Overall Study|Withdrawal by Subject|0|||
156336794|NCT00283400|564331343|FG000|Overall Study|Death|1|||
156336795|NCT00283400|564331344|FG001|Overall Study|Death|0|||
156336796|NCT00283400|564331345|FG002|Overall Study|Death|1|||
156737285|NCT01154296|565784799|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
156737286|NCT01154296|565784800|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
156737287|NCT02203851|565784801|FG000|Overall Study|Lost to Follow-up|4|||
156737288|NCT02203851|565784801|FG000|Overall Study|Withdrawal by Subject|6|||
156737289|NCT02203851|565784801|FG000|Overall Study|Other|1|||
156737290|NCT04934189|565784802|FG000|Overall Study|Lost to Follow-up|4|||
156737291|NCT04934189|565784802|FG000|Overall Study|Withdrawal by Subject|17|||
156737292|NCT03320850|565784805|FG000|Overall Study|Lost to Follow-up|0|||
156737293|NCT03320850|565784806|FG001|Overall Study|Lost to Follow-up|0|||
156737294|NCT03320850|565784807|FG002|Overall Study|Lost to Follow-up|0|||
156737295|NCT03320850|565784808|FG003|Overall Study|Lost to Follow-up|0|||
156737296|NCT03320850|565784809|FG004|Overall Study|Lost to Follow-up|1|||
156737297|NCT03320850|565784810|FG005|Overall Study|Lost to Follow-up|2|||
156737298|NCT03320850|565784811|FG006|Overall Study|Lost to Follow-up|2|||
156737299|NCT03320850|565784812|FG007|Overall Study|Lost to Follow-up|0|||
156737300|NCT03320850|565784813|FG008|Overall Study|Lost to Follow-up|6|||
156737301|NCT03320850|565784814|FG009|Overall Study|Lost to Follow-up|4|||
156737302|NCT03320850|565784805|FG000|Overall Study|Withdrawal by Subject|0|||
156737303|NCT03320850|565784806|FG001|Overall Study|Withdrawal by Subject|0|||
156737304|NCT03320850|565784807|FG002|Overall Study|Withdrawal by Subject|0|||
156737305|NCT03320850|565784808|FG003|Overall Study|Withdrawal by Subject|0|||
156737306|NCT03320850|565784809|FG004|Overall Study|Withdrawal by Subject|1|||
156737307|NCT03320850|565784810|FG005|Overall Study|Withdrawal by Subject|2|||
156737308|NCT03320850|565784811|FG006|Overall Study|Withdrawal by Subject|4|||
156737309|NCT03320850|565784812|FG007|Overall Study|Withdrawal by Subject|5|||
156737310|NCT03320850|565784813|FG008|Overall Study|Withdrawal by Subject|2|||
156737311|NCT03320850|565784814|FG009|Overall Study|Withdrawal by Subject|1|||
156737312|NCT03320850|565784805|FG000|Overall Study|Lack of Efficacy|0|||
156737313|NCT03320850|565784806|FG001|Overall Study|Lack of Efficacy|0|||
156737314|NCT03320850|565784807|FG002|Overall Study|Lack of Efficacy|0|||
156737315|NCT03320850|565784808|FG003|Overall Study|Lack of Efficacy|1|||
156737316|NCT03320850|565784809|FG004|Overall Study|Lack of Efficacy|0|||
156737317|NCT03320850|565784810|FG005|Overall Study|Lack of Efficacy|1|||
156737318|NCT03320850|565784811|FG006|Overall Study|Lack of Efficacy|0|||
156737319|NCT03320850|565784812|FG007|Overall Study|Lack of Efficacy|2|||
156336797|NCT00283400|564331346|FG003|Overall Study|Death|0|||
156737320|NCT03320850|565784813|FG008|Overall Study|Lack of Efficacy|0|||
156737321|NCT03320850|565784814|FG009|Overall Study|Lack of Efficacy|3|||
156737322|NCT03320850|565784805|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
156336798|NCT02550106|564331350|FG000|Overall Study|Adverse Event|1|||
156336799|NCT02550106|564331350|FG000|Overall Study|Lack of Efficacy|3|||
156336800|NCT02550106|564331350|FG000|Overall Study|Protocol Violation|6|||
156336801|NCT02550106|564331350|FG000|Overall Study|Withdrawal by Subject|2|||
156737323|NCT03320850|565784806|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
156737324|NCT03320850|565784807|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
156737325|NCT03320850|565784808|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
156737326|NCT03320850|565784809|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
156737327|NCT03320850|565784810|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
156737328|NCT03320850|565784811|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
156737329|NCT03320850|565784812|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
156737330|NCT03320850|565784813|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
156737331|NCT03320850|565784814|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
156737332|NCT03320850|565784805|FG000|Overall Study|Adverse Event|0|||
156737333|NCT03320850|565784806|FG001|Overall Study|Adverse Event|0|||
156737334|NCT03320850|565784807|FG002|Overall Study|Adverse Event|0|||
156737335|NCT03320850|565784808|FG003|Overall Study|Adverse Event|0|||
156737336|NCT03320850|565784809|FG004|Overall Study|Adverse Event|0|||
156737337|NCT03320850|565784810|FG005|Overall Study|Adverse Event|2|||
156737338|NCT03320850|565784811|FG006|Overall Study|Adverse Event|1|||
156737339|NCT03320850|565784812|FG007|Overall Study|Adverse Event|0|||
156737340|NCT03320850|565784813|FG008|Overall Study|Adverse Event|2|||
156737341|NCT03320850|565784814|FG009|Overall Study|Adverse Event|0|||
156737342|NCT03320850|565784805|FG000|Overall Study|Reason Not Specified|0|||
156737343|NCT03320850|565784806|FG001|Overall Study|Reason Not Specified|0|||
156737344|NCT03320850|565784807|FG002|Overall Study|Reason Not Specified|0|||
156534408|NCT00544648|565050965|FG000|Overall Study|progression of disease|1|||
156534409|NCT00544648|565050966|FG001|Overall Study|progression of disease|0|||
156534410|NCT02663271|565050967|FG000|Overall Study|Withdrawal by Subject|5|||
156534411|NCT02663271|565050967|FG000|Overall Study|Lack of Efficacy|1|||
156534412|NCT00999713|565050968|FG000|Overall Study|Physician Decision|2|||
156534413|NCT00999713|565050969|FG001|Overall Study|Physician Decision|0|||
156534414|NCT01351623|565050971|FG000|Overall Study|Protocol Violation|2|||
156534415|NCT01351623|565050971|FG000|Overall Study|Adverse Event|4|||
156534416|NCT01351623|565050971|FG000|Overall Study|Withdrawal by Subject|1|||
156534417|NCT01351623|565050971|FG000|Overall Study|Death|2|||
156534418|NCT04399122|565050974|FG000|Overall Study|Lost to Follow-up|2|||
156534419|NCT04399122|565050975|FG001|Overall Study|Lost to Follow-up|0|||
156876901|NCT00996333|566307767|FG000|Overall Study|Other|5|||
156876902|NCT02164461|566307768|FG000|Overall Study|Adverse Event|0|||
156534420|NCT04399122|565050974|FG000|Overall Study|Withdrawal by Subject|1|||
156737345|NCT03320850|565784808|FG003|Overall Study|Reason Not Specified|0|||
156737346|NCT03320850|565784809|FG004|Overall Study|Reason Not Specified|0|||
156737347|NCT03320850|565784810|FG005|Overall Study|Reason Not Specified|1|||
156737348|NCT03320850|565784811|FG006|Overall Study|Reason Not Specified|0|||
156737349|NCT03320850|565784812|FG007|Overall Study|Reason Not Specified|0|||
156737350|NCT03320850|565784813|FG008|Overall Study|Reason Not Specified|0|||
156737351|NCT03320850|565784814|FG009|Overall Study|Reason Not Specified|1|||
156737352|NCT03261674|565784816|FG000|Overall Study|Lost to Follow-up|6|||
156737353|NCT03261674|565784817|FG001|Overall Study|Lost to Follow-up|7|||
156737354|NCT03261674|565784816|FG000|Overall Study|Protocol Violation|1|||
156737355|NCT03261674|565784817|FG001|Overall Study|Protocol Violation|4|||
156737356|NCT03261674|565784816|FG000|Overall Study|Withdrawal by Subject|1|||
156737357|NCT03261674|565784817|FG001|Overall Study|Withdrawal by Subject|4|||
156737358|NCT03261674|565784816|FG000|Overall Study|Physician Decision|1|||
156737359|NCT03261674|565784817|FG001|Overall Study|Physician Decision|0|||
156737360|NCT02353442|565784818|FG000|Overall Study|Withdrawal by Subject|3|||
156737361|NCT02353442|565784819|FG001|Overall Study|Withdrawal by Subject|4|||
156737362|NCT00782184|565784832|FG000|Overall Study|Adverse Event|1|||
156737363|NCT00782184|565784833|FG001|Overall Study|Adverse Event|2|||
156737364|NCT00782184|565784832|FG000|Overall Study|Protocol Violation|0|||
156737365|NCT00782184|565784833|FG001|Overall Study|Protocol Violation|1|||
156737366|NCT00782184|565784832|FG000|Overall Study|Withdrawal by Subject|3|||
156737367|NCT00782184|565784833|FG001|Overall Study|Withdrawal by Subject|2|||
156737368|NCT01438294|565784834|FG000|Overall Study|Lost to Follow-up|3|||
156737369|NCT01438294|565784835|FG001|Overall Study|Lost to Follow-up|7|||
156737370|NCT01075646|565784838|FG000|Overall Study|Lost to Follow-up|4|||
156737371|NCT01075646|565784839|FG001|Overall Study|Lost to Follow-up|3|||
156737372|NCT01075646|565784840|FG002|Overall Study|Lost to Follow-up|1|||
156737373|NCT01075646|565784841|FG003|Overall Study|Lost to Follow-up|2|||
156737374|NCT01676896|565784845|FG000|Overall Study|Withdrawal by Subject|12|||
156876903|NCT02164461|566307769|FG001|Overall Study|Adverse Event|0|||
156876904|NCT02164461|566307770|FG002|Overall Study|Adverse Event|1|||
156534421|NCT04399122|565050975|FG001|Overall Study|Withdrawal by Subject|0|||
156737375|NCT01676896|565784846|FG001|Overall Study|Withdrawal by Subject|7|||
156737376|NCT01676896|565784847|FG002|Overall Study|Withdrawal by Subject|19|||
156737377|NCT01647516|565784848|FG000|Induction Period (IP)|Physician Decision|2|||
156737378|NCT01647516|565784849|FG001|Induction Period (IP)|Physician Decision|0|||
156737379|NCT01647516|565784850|FG002|Induction Period (IP)|Physician Decision|0|||
156737380|NCT01647516|565784851|FG003|Induction Period (IP)|Physician Decision|0|||
156737381|NCT01647516|565784852|FG004|Induction Period (IP)|Physician Decision|0|||
156876905|NCT02164461|566307768|FG000|Overall Study|Disease Progression|1|||
156534422|NCT02322229|565050976|FG000|Overall Study|Physician Decision|2|||
156534423|NCT00705432|565050977|FG000|Treatment Period|Adverse Event|45|||
156534424|NCT00705432|565050978|FG001|Treatment Period|Adverse Event|37|||
156534425|NCT00705432|565050979|FG002|Treatment Period|Adverse Event|51|||
156534426|NCT00705432|565050980|FG003|Treatment Period|Adverse Event|12|||
156737382|NCT01647516|565784853|FG005|Induction Period (IP)|Physician Decision|0|||
156737383|NCT01647516|565784848|FG000|Induction Period (IP)|Adverse Event|1|||
156737384|NCT01647516|565784849|FG001|Induction Period (IP)|Adverse Event|2|||
156737385|NCT01647516|565784850|FG002|Induction Period (IP)|Adverse Event|0|||
156737386|NCT01647516|565784851|FG003|Induction Period (IP)|Adverse Event|0|||
156737387|NCT01647516|565784852|FG004|Induction Period (IP)|Adverse Event|0|||
156737388|NCT01647516|565784853|FG005|Induction Period (IP)|Adverse Event|0|||
156737389|NCT01647516|565784848|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
156737390|NCT01647516|565784849|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
156737391|NCT01647516|565784850|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
156737392|NCT01647516|565784851|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
156737393|NCT01647516|565784852|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
156737394|NCT01647516|565784853|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
156737395|NCT01647516|565784848|FG000|Induction Period (IP)|Participant Choice|0|||
156737396|NCT01647516|565784849|FG001|Induction Period (IP)|Participant Choice|0|||
156737397|NCT01647516|565784850|FG002|Induction Period (IP)|Participant Choice|1|||
156737398|NCT01647516|565784851|FG003|Induction Period (IP)|Participant Choice|0|||
156737399|NCT01647516|565784852|FG004|Induction Period (IP)|Participant Choice|0|||
156737400|NCT01647516|565784853|FG005|Induction Period (IP)|Participant Choice|0|||
156737401|NCT01647516|565784848|FG000|Induction Period (IP)|Lack of Efficacy|1|||
156737402|NCT01647516|565784849|FG001|Induction Period (IP)|Lack of Efficacy|0|||
156737403|NCT01647516|565784850|FG002|Induction Period (IP)|Lack of Efficacy|0|||
156737404|NCT01647516|565784851|FG003|Induction Period (IP)|Lack of Efficacy|0|||
156737405|NCT01647516|565784852|FG004|Induction Period (IP)|Lack of Efficacy|0|||
156737406|NCT01647516|565784853|FG005|Induction Period (IP)|Lack of Efficacy|0|||
156737407|NCT01647516|565784848|FG000|Induction Period (IP)|No study drug received|1|||
156737408|NCT01647516|565784849|FG001|Induction Period (IP)|No study drug received|1|||
156737409|NCT01647516|565784850|FG002|Induction Period (IP)|No study drug received|0|||
156737410|NCT01647516|565784851|FG003|Induction Period (IP)|No study drug received|0|||
156737411|NCT01647516|565784852|FG004|Induction Period (IP)|No study drug received|0|||
156737412|NCT01647516|565784853|FG005|Induction Period (IP)|No study drug received|0|||
156737413|NCT01647516|565784848|FG000|Maintenance Period (MP)|Adverse Event|2|||
156876906|NCT02164461|566307769|FG001|Overall Study|Disease Progression|3|||
156876907|NCT02164461|566307770|FG002|Overall Study|Disease Progression|4|||
156876908|NCT02164461|566307768|FG000|Overall Study|Withdrawal by Subject|0|||
156876909|NCT02164461|566307769|FG001|Overall Study|Withdrawal by Subject|3|||
156876910|NCT02164461|566307770|FG002|Overall Study|Withdrawal by Subject|0|||
156876911|NCT02355184|566307771|FG000|Overall Study|Lost to Follow-up|2|||
156876912|NCT02355184|566307771|FG000|Overall Study|Study Terminated|10|||
156876913|NCT05091567|566309693|FG000|Enrollment Phase|Death|37|||
156876914|NCT05091567|566309694|FG001|Enrollment Phase|Death|0|||
156876915|NCT05091567|566309695|FG002|Enrollment Phase|Death|0|||
156876916|NCT05091567|566309693|FG000|Enrollment Phase|Adverse Event|21|||
156876917|NCT05091567|566309694|FG001|Enrollment Phase|Adverse Event|0|||
156876918|NCT05091567|566309695|FG002|Enrollment Phase|Adverse Event|0|||
156876919|NCT05091567|566309693|FG000|Enrollment Phase|Progressive Disease|10|||
156876920|NCT05091567|566309694|FG001|Enrollment Phase|Progressive Disease|0|||
156876921|NCT05091567|566309695|FG002|Enrollment Phase|Progressive Disease|0|||
156876922|NCT05091567|566309693|FG000|Enrollment Phase|Withdrawal by Subject|8|||
156876923|NCT05091567|566309694|FG001|Enrollment Phase|Withdrawal by Subject|0|||
156876924|NCT05091567|566309695|FG002|Enrollment Phase|Withdrawal by Subject|0|||
156876925|NCT05091567|566309693|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
156876926|NCT05091567|566309694|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
156876927|NCT05091567|566309695|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
156876928|NCT05091567|566309693|FG000|Enrollment Phase|Physician Decision|3|||
156876929|NCT05091567|566309694|FG001|Enrollment Phase|Physician Decision|0|||
156876930|NCT05091567|566309695|FG002|Enrollment Phase|Physician Decision|0|||
156876931|NCT05091567|566309693|FG000|Enrollment Phase|Protocol Violation|2|||
156876932|NCT05091567|566309694|FG001|Enrollment Phase|Protocol Violation|0|||
156876933|NCT05091567|566309695|FG002|Enrollment Phase|Protocol Violation|0|||
156876934|NCT05091567|566309693|FG000|Enrollment Phase|Reason not Specified|1|||
156876935|NCT05091567|566309694|FG001|Enrollment Phase|Reason not Specified|0|||
156876936|NCT05091567|566309695|FG002|Enrollment Phase|Reason not Specified|0|||
156737414|NCT01647516|565784849|FG001|Maintenance Period (MP)|Adverse Event|1|||
156737415|NCT01647516|565784850|FG002|Maintenance Period (MP)|Adverse Event|0|||
156737416|NCT01647516|565784851|FG003|Maintenance Period (MP)|Adverse Event|0|||
156737417|NCT01647516|565784852|FG004|Maintenance Period (MP)|Adverse Event|0|||
156876937|NCT05091567|566309693|FG000|Randomized Phase|Death|0|||
156876938|NCT05091567|566309694|FG001|Randomized Phase|Death|135|||
156876939|NCT05091567|566309695|FG002|Randomized Phase|Death|112|||
156876940|NCT05091567|566309693|FG000|Randomized Phase|Progressive Disease|0|||
156876941|NCT05091567|566309694|FG001|Randomized Phase|Progressive Disease|2|||
156876942|NCT05091567|566309695|FG002|Randomized Phase|Progressive Disease|0|||
156876943|NCT05091567|566309693|FG000|Randomized Phase|Withdrawal by Subject|0|||
156876944|NCT05091567|566309694|FG001|Randomized Phase|Withdrawal by Subject|1|||
156457793|NCT03088878|564772507|FG010|Overall Study|Clinical Progression|0|||
156457794|NCT03088878|564772508|FG011|Overall Study|Clinical Progression|0|||
156457795|NCT03088878|564772509|FG012|Overall Study|Clinical Progression|0|||
156457796|NCT03088878|564772510|FG013|Overall Study|Clinical Progression|0|||
156457797|NCT03088878|564772497|FG000|Overall Study|Death|0|||
156457798|NCT03088878|564772498|FG001|Overall Study|Death|0|||
156457799|NCT03088878|564772499|FG002|Overall Study|Death|0|||
156534427|NCT00705432|565050981|FG004|Treatment Period|Adverse Event|8|||
156534428|NCT00705432|565050982|FG005|Treatment Period|Adverse Event|9|||
156534429|NCT00705432|565050977|FG000|Treatment Period|Treatment failure|92|||
156534430|NCT00705432|565050978|FG001|Treatment Period|Treatment failure|42|||
156534431|NCT00705432|565050979|FG002|Treatment Period|Treatment failure|33|||
156534432|NCT00705432|565050980|FG003|Treatment Period|Treatment failure|25|||
156534433|NCT00705432|565050981|FG004|Treatment Period|Treatment failure|13|||
156534434|NCT00705432|565050982|FG005|Treatment Period|Treatment failure|14|||
156534435|NCT00705432|565050977|FG000|Treatment Period|Non medical reason|26|||
156534436|NCT00705432|565050978|FG001|Treatment Period|Non medical reason|32|||
156534437|NCT00705432|565050979|FG002|Treatment Period|Non medical reason|37|||
156534438|NCT00705432|565050980|FG003|Treatment Period|Non medical reason|4|||
156534439|NCT00705432|565050981|FG004|Treatment Period|Non medical reason|7|||
156534440|NCT00705432|565050982|FG005|Treatment Period|Non medical reason|7|||
156534441|NCT00705432|565050977|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
156534442|NCT00705432|565050978|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
156534443|NCT00705432|565050979|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
156534444|NCT00705432|565050980|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
156534445|NCT00705432|565050981|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
156534446|NCT00705432|565050982|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
156534447|NCT00705432|565050977|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
156534448|NCT00705432|565050978|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
156534449|NCT00705432|565050979|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
156534450|NCT00705432|565050980|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
156534451|NCT00705432|565050981|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
156534452|NCT00705432|565050982|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
156534453|NCT00521053|565050983|FG000|Observation Phase|Disease Progression|55|||
156534454|NCT00521053|565050983|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
156534455|NCT00521053|565050983|FG000|Observation Phase|Death|2|||
156534456|NCT00521053|565050983|FG000|Observation Phase|Adverse Event|1|||
156534457|NCT00521053|565050983|FG000|Observation Phase|Other non-study melanoma treatment|1|||
156534458|NCT00521053|565050983|FG000|Observation Phase|Physician Decision|1|||
156534459|NCT05749952|565050988|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
156534460|NCT03426787|565052372|FG000|Overall Study|Withdrawal by Subject|6|||
156534461|NCT03426787|565052372|FG000|Overall Study|Lost to Follow-up|7|||
156534462|NCT03426787|565052372|FG000|Overall Study|Unrelated to intervention death|1|||
156534463|NCT02592551|565052373|FG000|Overall Study|Not evaluable|1|||
156534464|NCT02592551|565052374|FG001|Overall Study|Not evaluable|3|||
156534465|NCT02592551|565052375|FG002|Overall Study|Not evaluable|0|||
156534466|NCT00908583|565052379|FG000|Phase 1|Withdrawal by Subject|1|||
156534467|NCT00908583|565052379|FG000|Phase 1|Adverse Event|4|||
156534468|NCT00908583|565052379|FG000|Phase 2|Physician Decision|1|||
156534469|NCT00908583|565052379|FG000|Phase 2|Adverse Event|1|||
156534470|NCT00908583|565052379|FG000|Phase 3|Adverse Event|2|||
156534471|NCT00908583|565052379|FG000|Phase 4|Adverse Event|1|||
156534472|NCT00908583|565052379|FG000|Phase 4|Physician Decision|1|||
156534473|NCT00908583|565052379|FG000|Phase 5|Adverse Event|3|||
156534474|NCT00993954|565052380|FG000|Overall Study|Protocol Violation|21|||
156534475|NCT00993954|565052381|FG001|Overall Study|Protocol Violation|2|||
156534476|NCT00860951|565052382|FG000|Overall Study|Withdrawal by Subject|2|||
156534477|NCT00860951|565052382|FG000|Overall Study|Lost to Follow-up|5|||
156534478|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
156534479|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
156534480|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
156534481|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
156534482|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
156534483|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
156876945|NCT05091567|566309695|FG002|Randomized Phase|Withdrawal by Subject|3|||
156534484|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
156534485|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
156534486|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
156534487|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
156534488|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
156534489|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
156534490|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
156457800|NCT03088878|564772500|FG003|Overall Study|Death|0|||
156457801|NCT03088878|564772501|FG004|Overall Study|Death|2|||
156876946|NCT05091567|566309693|FG000|Randomized Phase|Lost to Follow-up|0|||
156876947|NCT05091567|566309694|FG001|Randomized Phase|Lost to Follow-up|1|||
156876948|NCT05091567|566309695|FG002|Randomized Phase|Lost to Follow-up|1|||
156876949|NCT05091567|566309693|FG000|Randomized Phase|Ongoing in Study|0|||
156876950|NCT05091567|566309694|FG001|Randomized Phase|Ongoing in Study|102|||
156876951|NCT05091567|566309695|FG002|Randomized Phase|Ongoing in Study|126|||
156876952|NCT05568615|566309696|FG000|Overall Study|Death|1|||
156336802|NCT02195583|564331351|FG000|Overall Study|Lost to Follow-up|1|||
156336803|NCT02195583|564331351|FG000|Overall Study|Withdrawal by Subject|4|||
156737418|NCT01647516|565784853|FG005|Maintenance Period (MP)|Adverse Event|0|||
156737419|NCT01647516|565784848|FG000|Maintenance Period (MP)|Non-compliance|1|||
156737420|NCT01647516|565784849|FG001|Maintenance Period (MP)|Non-compliance|0|||
156737421|NCT01647516|565784850|FG002|Maintenance Period (MP)|Non-compliance|0|||
156737422|NCT01647516|565784851|FG003|Maintenance Period (MP)|Non-compliance|0|||
156737423|NCT01647516|565784852|FG004|Maintenance Period (MP)|Non-compliance|0|||
156737424|NCT01647516|565784853|FG005|Maintenance Period (MP)|Non-compliance|0|||
156737425|NCT01647516|565784848|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
156737426|NCT01647516|565784849|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
156737427|NCT01647516|565784850|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
156737428|NCT01647516|565784851|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
156737429|NCT01647516|565784852|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
156737430|NCT01647516|565784853|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
156737431|NCT01647516|565784848|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
156737432|NCT01647516|565784849|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
156737433|NCT01647516|565784850|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
156737434|NCT01647516|565784851|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
156737435|NCT01647516|565784852|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
156737436|NCT01647516|565784853|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
156737437|NCT01647516|565784848|FG000|Open-Label Period|Adverse Event|0|||
156737438|NCT01647516|565784849|FG001|Open-Label Period|Adverse Event|0|||
156336804|NCT02195583|564331351|FG000|Overall Study|Adverse Event|2|||
156457802|NCT03088878|564772502|FG005|Overall Study|Death|0|||
156457803|NCT03088878|564772503|FG006|Overall Study|Death|0|||
156457804|NCT03088878|564772504|FG007|Overall Study|Death|0|||
156457805|NCT03088878|564772505|FG008|Overall Study|Death|0|||
156457806|NCT03088878|564772506|FG009|Overall Study|Death|0|||
156457807|NCT03088878|564772507|FG010|Overall Study|Death|0|||
156457808|NCT03088878|564772508|FG011|Overall Study|Death|1|||
156457809|NCT03088878|564772509|FG012|Overall Study|Death|0|||
156457810|NCT03088878|564772510|FG013|Overall Study|Death|0|||
156457811|NCT03088878|564772497|FG000|Overall Study|Disease Progression|1|||
156457812|NCT03088878|564772498|FG001|Overall Study|Disease Progression|2|||
156457813|NCT03088878|564772499|FG002|Overall Study|Disease Progression|3|||
156457814|NCT03088878|564772500|FG003|Overall Study|Disease Progression|0|||
156457815|NCT03088878|564772501|FG004|Overall Study|Disease Progression|3|||
156457816|NCT03088878|564772502|FG005|Overall Study|Disease Progression|0|||
156457817|NCT03088878|564772503|FG006|Overall Study|Disease Progression|0|||
156457818|NCT03088878|564772504|FG007|Overall Study|Disease Progression|0|||
156457819|NCT03088878|564772505|FG008|Overall Study|Disease Progression|0|||
156457820|NCT03088878|564772506|FG009|Overall Study|Disease Progression|0|||
156457821|NCT03088878|564772507|FG010|Overall Study|Disease Progression|0|||
156457822|NCT03088878|564772508|FG011|Overall Study|Disease Progression|0|||
156457823|NCT03088878|564772509|FG012|Overall Study|Disease Progression|1|||
156457824|NCT03088878|564772510|FG013|Overall Study|Disease Progression|1|||
156457825|NCT03088878|564772497|FG000|Overall Study|Initiation of Alternative Treatment|0|||
156457826|NCT03088878|564772498|FG001|Overall Study|Initiation of Alternative Treatment|0|||
156457827|NCT03088878|564772499|FG002|Overall Study|Initiation of Alternative Treatment|0|||
156457828|NCT03088878|564772500|FG003|Overall Study|Initiation of Alternative Treatment|1|||
156457829|NCT03088878|564772501|FG004|Overall Study|Initiation of Alternative Treatment|0|||
156457830|NCT03088878|564772502|FG005|Overall Study|Initiation of Alternative Treatment|0|||
156737439|NCT01647516|565784850|FG002|Open-Label Period|Adverse Event|0|||
156737440|NCT01647516|565784851|FG003|Open-Label Period|Adverse Event|5|||
156737441|NCT01647516|565784852|FG004|Open-Label Period|Adverse Event|6|||
156737442|NCT01647516|565784853|FG005|Open-Label Period|Adverse Event|3|||
156876953|NCT05568615|566309696|FG000|Overall Study|Physician Decision|1|||
156876954|NCT05440097|566309698|FG000|Overall Study|Withdrawal by Subject|154|||
156876955|NCT05440097|566309698|FG000|Overall Study|Death|2|||
156336805|NCT02195583|564331351|FG000|Overall Study|Other Reason|2|||
156457831|NCT03088878|564772503|FG006|Overall Study|Initiation of Alternative Treatment|0|||
156457832|NCT03088878|564772504|FG007|Overall Study|Initiation of Alternative Treatment|1|||
156457833|NCT03088878|564772505|FG008|Overall Study|Initiation of Alternative Treatment|1|||
156457834|NCT03088878|564772506|FG009|Overall Study|Initiation of Alternative Treatment|0|||
156457835|NCT03088878|564772507|FG010|Overall Study|Initiation of Alternative Treatment|0|||
156457836|NCT03088878|564772508|FG011|Overall Study|Initiation of Alternative Treatment|0|||
156457837|NCT03088878|564772509|FG012|Overall Study|Initiation of Alternative Treatment|0|||
156457838|NCT03088878|564772510|FG013|Overall Study|Initiation of Alternative Treatment|0|||
156457839|NCT03088878|564772497|FG000|Overall Study|Withdrawal by Subject|0|||
156876956|NCT05440097|566309698|FG000|Overall Study|Physician Decision|2|||
156876957|NCT05440097|566309698|FG000|Overall Study|Lost to Follow-up|56|||
156876958|NCT05440097|566309698|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
156737443|NCT01647516|565784848|FG000|Open-Label Period|Pregnancy|0|||
156737444|NCT01647516|565784849|FG001|Open-Label Period|Pregnancy|0|||
156737445|NCT01647516|565784850|FG002|Open-Label Period|Pregnancy|0|||
156737446|NCT01647516|565784851|FG003|Open-Label Period|Pregnancy|0|||
156737447|NCT01647516|565784852|FG004|Open-Label Period|Pregnancy|0|||
156737448|NCT01647516|565784853|FG005|Open-Label Period|Pregnancy|1|||
156737449|NCT01647516|565784848|FG000|Open-Label Period|Non-compliance|0|||
156737450|NCT01647516|565784849|FG001|Open-Label Period|Non-compliance|0|||
156737451|NCT01647516|565784850|FG002|Open-Label Period|Non-compliance|0|||
156737452|NCT01647516|565784851|FG003|Open-Label Period|Non-compliance|1|||
156737453|NCT01647516|565784852|FG004|Open-Label Period|Non-compliance|0|||
156737454|NCT01647516|565784853|FG005|Open-Label Period|Non-compliance|1|||
156737455|NCT01647516|565784848|FG000|Open-Label Period|Physician Decision|0|||
156737456|NCT01647516|565784849|FG001|Open-Label Period|Physician Decision|0|||
156737457|NCT01647516|565784850|FG002|Open-Label Period|Physician Decision|0|||
156737458|NCT01647516|565784851|FG003|Open-Label Period|Physician Decision|1|||
156737459|NCT01647516|565784852|FG004|Open-Label Period|Physician Decision|1|||
156737460|NCT01647516|565784853|FG005|Open-Label Period|Physician Decision|0|||
156737461|NCT01647516|565784848|FG000|Open-Label Period|Withdrawal by Subject|0|||
156737462|NCT01647516|565784849|FG001|Open-Label Period|Withdrawal by Subject|0|||
156737463|NCT01647516|565784850|FG002|Open-Label Period|Withdrawal by Subject|0|||
156737464|NCT01647516|565784851|FG003|Open-Label Period|Withdrawal by Subject|9|||
156737465|NCT01647516|565784852|FG004|Open-Label Period|Withdrawal by Subject|11|||
156737466|NCT01647516|565784853|FG005|Open-Label Period|Withdrawal by Subject|6|||
156737467|NCT01647516|565784848|FG000|Open-Label Period|Lost to Follow-up|0|||
156737468|NCT01647516|565784849|FG001|Open-Label Period|Lost to Follow-up|0|||
156737469|NCT01647516|565784850|FG002|Open-Label Period|Lost to Follow-up|0|||
156737470|NCT01647516|565784851|FG003|Open-Label Period|Lost to Follow-up|1|||
156737471|NCT01647516|565784852|FG004|Open-Label Period|Lost to Follow-up|0|||
156737472|NCT01647516|565784853|FG005|Open-Label Period|Lost to Follow-up|1|||
156737473|NCT01647516|565784848|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
156737474|NCT01647516|565784849|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
156737475|NCT01647516|565784850|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
156737476|NCT01647516|565784851|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
156737477|NCT01647516|565784852|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
156737478|NCT01647516|565784853|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
156737479|NCT01647516|565784848|FG000|Open-Label Period|Lack of Efficacy|0|||
156737480|NCT01647516|565784849|FG001|Open-Label Period|Lack of Efficacy|0|||
156737481|NCT01647516|565784850|FG002|Open-Label Period|Lack of Efficacy|0|||
156876959|NCT00565851|566309699|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
156876960|NCT00565851|566309700|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
156876961|NCT00565851|566309701|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
156876962|NCT00565851|566309702|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
156876963|NCT00565851|566309703|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
156876964|NCT00565851|566309704|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
156876965|NCT00565851|566309705|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
156876966|NCT00565851|566309706|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
156876967|NCT00565851|566309699|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
156876968|NCT00565851|566309700|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
156876969|NCT00565851|566309701|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
156876970|NCT00565851|566309702|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
156876971|NCT00565851|566309703|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
156876972|NCT00565851|566309704|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
156876973|NCT00565851|566309705|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
156876974|NCT00565851|566309706|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
156876975|NCT03291067|566309707|FG000|Overall Study|Adverse Event|0|||
156876976|NCT03291067|566309708|FG001|Overall Study|Adverse Event|2|||
156876977|NCT03291067|566309709|FG002|Overall Study|Adverse Event|17|||
156876978|NCT03291067|566309710|FG003|Overall Study|Adverse Event|3|||
156876979|NCT03291067|566309707|FG000|Overall Study|Lost to Follow-up|2|||
156737482|NCT01647516|565784851|FG003|Open-Label Period|Lack of Efficacy|7|||
156737483|NCT01647516|565784852|FG004|Open-Label Period|Lack of Efficacy|9|||
156737484|NCT01647516|565784853|FG005|Open-Label Period|Lack of Efficacy|10|||
156876980|NCT03291067|566309708|FG001|Overall Study|Lost to Follow-up|1|||
156876981|NCT03291067|566309709|FG002|Overall Study|Lost to Follow-up|0|||
156876982|NCT03291067|566309710|FG003|Overall Study|Lost to Follow-up|1|||
156876983|NCT03291067|566309707|FG000|Overall Study|Physician Decision|0|||
156876984|NCT03291067|566309708|FG001|Overall Study|Physician Decision|0|||
156876985|NCT03291067|566309709|FG002|Overall Study|Physician Decision|1|||
156876986|NCT03291067|566309710|FG003|Overall Study|Physician Decision|0|||
156876987|NCT03291067|566309707|FG000|Overall Study|Protocol Violation|5|||
156737485|NCT01647516|565784848|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
156737486|NCT01647516|565784849|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
156737487|NCT01647516|565784850|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
156737488|NCT01647516|565784851|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
156737489|NCT01647516|565784852|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
156737490|NCT01647516|565784853|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
156737491|NCT01647516|565784848|FG000|Open-Label Period|No completion / discontinuation visit|0|||
156737492|NCT01647516|565784849|FG001|Open-Label Period|No completion / discontinuation visit|0|||
156737493|NCT01647516|565784850|FG002|Open-Label Period|No completion / discontinuation visit|0|||
156737494|NCT01647516|565784851|FG003|Open-Label Period|No completion / discontinuation visit|0|||
156737495|NCT01647516|565784852|FG004|Open-Label Period|No completion / discontinuation visit|2|||
156737496|NCT01647516|565784853|FG005|Open-Label Period|No completion / discontinuation visit|1|||
156336806|NCT01020981|564331355|FG000|Overall Study|Did not return mailed survey|74|||
156336807|NCT01020981|564331356|FG001|Overall Study|Did not return mailed survey|58|||
156336808|NCT01020981|564331355|FG000|Overall Study|Survey returned undeliverable|8|||
156336809|NCT01020981|564331356|FG001|Overall Study|Survey returned undeliverable|32|||
156336810|NCT01020981|564331355|FG000|Overall Study|Participant declined to complete survey|2|||
156336811|NCT01020981|564331356|FG001|Overall Study|Participant declined to complete survey|0|||
156336812|NCT00040365|564331363|FG000|Overall Study|Death|1|||
156336813|NCT00040365|564331363|FG000|Overall Study|Progressive disease|7|||
156336814|NCT00040365|564331363|FG000|Overall Study|Lost to Follow-up|3|||
156336815|NCT00680017|564331364|FG000|Overall Study|Adverse Event|13|||
156336816|NCT00680017|564331365|FG001|Overall Study|Adverse Event|7|||
156737497|NCT03614078|565784856|FG000|Overall Study|Withdrawal by Subject|2|||
156737498|NCT03614078|565784857|FG001|Overall Study|Withdrawal by Subject|2|||
156737499|NCT03614078|565784858|FG002|Overall Study|Withdrawal by Subject|3|||
156737500|NCT03614078|565784856|FG000|Overall Study|Participant Did Not Return for Visit|0|||
156737501|NCT03614078|565784857|FG001|Overall Study|Participant Did Not Return for Visit|1|||
156737502|NCT03614078|565784858|FG002|Overall Study|Participant Did Not Return for Visit|0|||
156737503|NCT03614078|565784856|FG000|Overall Study|High Neutrophils|0|||
156737504|NCT03614078|565784857|FG001|Overall Study|High Neutrophils|0|||
156737505|NCT03614078|565784858|FG002|Overall Study|High Neutrophils|2|||
156737506|NCT03614078|565784856|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
156737507|NCT03614078|565784857|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
156737508|NCT03614078|565784858|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
156737509|NCT03614078|565784856|FG000|Overall Study|Exacerbation of Psoriasis|0|||
156336817|NCT00680017|564331364|FG000|Overall Study|Withdrawal by Subject|2|||
156336818|NCT00680017|564331365|FG001|Overall Study|Withdrawal by Subject|5|||
156336819|NCT00680017|564331364|FG000|Overall Study|Lost to Follow-up|2|||
156336820|NCT00680017|564331365|FG001|Overall Study|Lost to Follow-up|0|||
156336821|NCT01947582|564331366|FG000|Overall Study|Withdrawal by Subject|1|||
156336822|NCT02279420|564331367|FG000|Overall Study|Lost to Follow-up|23|||
156336823|NCT03535844|564331368|FG000|Overall Study|Withdrawal by Subject|0|||
156336824|NCT03535844|564331369|FG001|Overall Study|Withdrawal by Subject|1|||
156336825|NCT00297830|564331372|FG000|6 Month Visit|Death|1|||
156336826|NCT00297830|564331373|FG001|6 Month Visit|Death|0|||
156336827|NCT00297830|564331374|FG002|6 Month Visit|Death|2|||
156336828|NCT00297830|564331372|FG000|6 Month Visit|Withdrawal by Subject|2|||
156457840|NCT03088878|564772498|FG001|Overall Study|Withdrawal by Subject|0|||
156457841|NCT03088878|564772499|FG002|Overall Study|Withdrawal by Subject|0|||
156457842|NCT03088878|564772500|FG003|Overall Study|Withdrawal by Subject|1|||
156457843|NCT03088878|564772501|FG004|Overall Study|Withdrawal by Subject|4|||
156457844|NCT03088878|564772502|FG005|Overall Study|Withdrawal by Subject|1|||
156457845|NCT03088878|564772503|FG006|Overall Study|Withdrawal by Subject|1|||
156457846|NCT03088878|564772504|FG007|Overall Study|Withdrawal by Subject|0|||
156737510|NCT03614078|565784857|FG001|Overall Study|Exacerbation of Psoriasis|1|||
156336829|NCT00297830|564331373|FG001|6 Month Visit|Withdrawal by Subject|1|||
156737511|NCT03614078|565784858|FG002|Overall Study|Exacerbation of Psoriasis|0|||
156737512|NCT03614078|565784856|FG000|Overall Study|Adverse Event|0|||
156737513|NCT03614078|565784857|FG001|Overall Study|Adverse Event|2|||
156737514|NCT03614078|565784858|FG002|Overall Study|Adverse Event|0|||
156737515|NCT03614078|565784856|FG000|Overall Study|Dizziness and Rash|0|||
156336830|NCT00297830|564331374|FG002|6 Month Visit|Withdrawal by Subject|1|||
156336831|NCT00297830|564331372|FG000|6 Month Visit|Adverse Event|0|||
156336832|NCT00297830|564331373|FG001|6 Month Visit|Adverse Event|1|||
156336833|NCT00297830|564331374|FG002|6 Month Visit|Adverse Event|0|||
156336834|NCT00297830|564331372|FG000|12 Month Visit|Lost to Follow-up|1|||
156336835|NCT00297830|564331373|FG001|12 Month Visit|Lost to Follow-up|0|||
156457847|NCT03088878|564772505|FG008|Overall Study|Withdrawal by Subject|1|||
156457848|NCT03088878|564772506|FG009|Overall Study|Withdrawal by Subject|2|||
156457849|NCT03088878|564772507|FG010|Overall Study|Withdrawal by Subject|0|||
156457850|NCT03088878|564772508|FG011|Overall Study|Withdrawal by Subject|2|||
156737516|NCT03614078|565784857|FG001|Overall Study|Dizziness and Rash|1|||
156457851|NCT03088878|564772509|FG012|Overall Study|Withdrawal by Subject|1|||
156457852|NCT03088878|564772510|FG013|Overall Study|Withdrawal by Subject|0|||
156457853|NCT03088878|564772497|FG000|Overall Study|Terminated by Sponsor|2|||
156457854|NCT03088878|564772498|FG001|Overall Study|Terminated by Sponsor|1|||
156737517|NCT03614078|565784858|FG002|Overall Study|Dizziness and Rash|0|||
156737518|NCT02004886|565784859|FG000|Overall Study|Adverse Event|0|||
156737519|NCT02004886|565784860|FG001|Overall Study|Adverse Event|1|||
156737520|NCT02004886|565784861|FG002|Overall Study|Adverse Event|0|||
156737521|NCT02004886|565784862|FG003|Overall Study|Adverse Event|0|||
156737522|NCT02004886|565784859|FG000|Overall Study|Unable to attend future visits|1|||
156737523|NCT02004886|565784860|FG001|Overall Study|Unable to attend future visits|0|||
156737524|NCT02004886|565784861|FG002|Overall Study|Unable to attend future visits|0|||
156737525|NCT02004886|565784862|FG003|Overall Study|Unable to attend future visits|0|||
156737526|NCT04964544|565784865|FG000|Overall Study|Screen failure or other uncategorised|10|||
156737527|NCT04964544|565784865|FG000|Overall Study|Physician Decision|4|||
156737528|NCT04964544|565784865|FG000|Overall Study|Lost to Follow-up|9|||
156737529|NCT04964544|565784865|FG000|Overall Study|Withdrawal by Subject|18|||
156737530|NCT04964544|565784865|FG000|Overall Study|Death|1|||
156737531|NCT01613222|565784868|FG000|Overall Study|Physician Decision|1|||
156737532|NCT01613222|565784868|FG000|Overall Study|Unable to place arterial line|1|||
156737533|NCT01613222|565784868|FG000|Overall Study|Reused disposable sensors|10|||
156737534|NCT03505593|565784869|FG000|Overall Study|Withdrawal by Subject|1|||
156737535|NCT03505593|565784869|FG000|Overall Study|Died before procedure|1|||
156737536|NCT03505593|565784869|FG000|Overall Study|Anatomical abnormality|1|||
156737537|NCT03505593|565784869|FG000|Overall Study|Unable to pass through esophagus|1|||
156737538|NCT03505593|565784869|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
156737539|NCT05239494|565784870|FG000|Overall Study|Lost to Follow-up|1|||
156737540|NCT02822573|565784872|FG000|Overall Study|Lost to Follow-up|5|||
156737541|NCT02822573|565784873|FG001|Overall Study|Lost to Follow-up|3|||
156737542|NCT02822573|565784872|FG000|Overall Study|Physician Decision|1|||
156737543|NCT02822573|565784873|FG001|Overall Study|Physician Decision|1|||
156737544|NCT02822573|565784872|FG000|Overall Study|Withdrawal by Subject|9|||
156737545|NCT02822573|565784873|FG001|Overall Study|Withdrawal by Subject|5|||
156737546|NCT02822573|565784872|FG000|Overall Study|Protocol Violation|6|||
156737547|NCT02822573|565784873|FG001|Overall Study|Protocol Violation|4|||
156737548|NCT02822573|565784872|FG000|Overall Study|Too sick or ill|2|||
156737549|NCT02822573|565784873|FG001|Overall Study|Too sick or ill|1|||
156737550|NCT02822573|565784872|FG000|Overall Study|Disease Progression|1|||
156737551|NCT02822573|565784873|FG001|Overall Study|Disease Progression|1|||
156737552|NCT02822573|565784872|FG000|Overall Study|No reason given|6|||
156737553|NCT02822573|565784873|FG001|Overall Study|No reason given|4|||
156737554|NCT02855359|565784874|FG000|Overall Study|Death|2|||
156737555|NCT02855359|565784875|FG001|Overall Study|Death|2|||
156737556|NCT02855359|565784876|FG002|Overall Study|Death|0|||
156737557|NCT02855359|565784877|FG003|Overall Study|Death|0|||
156876988|NCT03291067|566309708|FG001|Overall Study|Protocol Violation|3|||
156876989|NCT03291067|566309709|FG002|Overall Study|Protocol Violation|4|||
156876990|NCT03291067|566309710|FG003|Overall Study|Protocol Violation|2|||
156876991|NCT03291067|566309707|FG000|Overall Study|Withdrawal by Subject|3|||
156876992|NCT03291067|566309708|FG001|Overall Study|Withdrawal by Subject|4|||
156876993|NCT03291067|566309709|FG002|Overall Study|Withdrawal by Subject|7|||
156876994|NCT03291067|566309710|FG003|Overall Study|Withdrawal by Subject|5|||
156876995|NCT03291067|566309707|FG000|Overall Study|Other|0|||
156876996|NCT03291067|566309708|FG001|Overall Study|Other|4|||
156876997|NCT03291067|566309709|FG002|Overall Study|Other|4|||
156876998|NCT03291067|566309710|FG003|Overall Study|Other|6|||
156876999|NCT02255435|566309712|FG000|Overall Study|Patient's Limited Time Availability|0|||
156877000|NCT02255435|566309713|FG001|Overall Study|Patient's Limited Time Availability|0|||
156877001|NCT02255435|566309714|FG002|Overall Study|Patient's Limited Time Availability|0|||
156877002|NCT02255435|566309715|FG003|Overall Study|Patient's Limited Time Availability|0|||
156877003|NCT02255435|566309716|FG004|Overall Study|Patient's Limited Time Availability|0|||
156336836|NCT00297830|564331374|FG002|12 Month Visit|Lost to Follow-up|0|||
156336837|NCT00297830|564331372|FG000|12 Month Visit|Adverse Event|0|||
156336838|NCT00297830|564331373|FG001|12 Month Visit|Adverse Event|3|||
156457855|NCT03088878|564772499|FG002|Overall Study|Terminated by Sponsor|0|||
156336839|NCT00297830|564331374|FG002|12 Month Visit|Adverse Event|0|||
156457856|NCT03088878|564772500|FG003|Overall Study|Terminated by Sponsor|1|||
156457857|NCT03088878|564772501|FG004|Overall Study|Terminated by Sponsor|6|||
156737558|NCT02855359|565784874|FG000|Overall Study|Study Termination by Sponsor|9|||
156737559|NCT02855359|565784875|FG001|Overall Study|Study Termination by Sponsor|11|||
156737560|NCT02855359|565784876|FG002|Overall Study|Study Termination by Sponsor|0|||
156737561|NCT02855359|565784877|FG003|Overall Study|Study Termination by Sponsor|0|||
156737562|NCT03155178|565784878|FG000|Overall Study|Did not meet treatment day baseline|7|||
156737563|NCT03155178|565784879|FG001|Overall Study|Did not meet treatment day baseline|7|||
156737564|NCT03155178|565784880|FG002|Overall Study|Did not meet treatment day baseline|7|||
156737565|NCT03155178|565784881|FG003|Overall Study|Did not meet treatment day baseline|7|||
156737566|NCT01023256|565784882|FG000|Overall Study|Protocol Violation|2|||
156877004|NCT02255435|566309717|FG005|Overall Study|Patient's Limited Time Availability|0|||
156336840|NCT00297830|564331372|FG000|12 Month Visit|Withdrawal by Subject|0|||
156336841|NCT00297830|564331373|FG001|12 Month Visit|Withdrawal by Subject|3|||
156336842|NCT00297830|564331374|FG002|12 Month Visit|Withdrawal by Subject|0|||
156336843|NCT05096221|564331375|FG000|Part 2|Physician Decision|0|||
156336844|NCT05096221|564331376|FG001|Part 2|Physician Decision|1|||
156336845|NCT02478632|564331379|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
156336846|NCT02478632|564331380|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
156336847|NCT02478632|564331379|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
156457858|NCT03088878|564772502|FG005|Overall Study|Terminated by Sponsor|0|||
156457859|NCT03088878|564772503|FG006|Overall Study|Terminated by Sponsor|0|||
156457860|NCT03088878|564772504|FG007|Overall Study|Terminated by Sponsor|0|||
156457861|NCT03088878|564772505|FG008|Overall Study|Terminated by Sponsor|0|||
156457862|NCT03088878|564772506|FG009|Overall Study|Terminated by Sponsor|0|||
156457863|NCT03088878|564772507|FG010|Overall Study|Terminated by Sponsor|3|||
156737567|NCT01023256|565784883|FG001|Overall Study|Protocol Violation|3|||
156737568|NCT01023256|565784884|FG002|Overall Study|Protocol Violation|0|||
156737569|NCT01023256|565784885|FG003|Overall Study|Protocol Violation|0|||
156737570|NCT01023256|565784882|FG000|Overall Study|Randomized but not treated|1|||
156877005|NCT02255435|566309718|FG006|Overall Study|Patient's Limited Time Availability|0|||
156877006|NCT02255435|566309719|FG007|Overall Study|Patient's Limited Time Availability|1|||
156877007|NCT02255435|566309720|FG008|Overall Study|Patient's Limited Time Availability|0|||
156877008|NCT02255435|566309721|FG009|Overall Study|Patient's Limited Time Availability|0|||
156877009|NCT02255435|566309712|FG000|Overall Study|Withdrawal by Subject|0|||
156877010|NCT02255435|566309713|FG001|Overall Study|Withdrawal by Subject|0|||
156877011|NCT02255435|566309714|FG002|Overall Study|Withdrawal by Subject|0|||
156877012|NCT02255435|566309715|FG003|Overall Study|Withdrawal by Subject|0|||
156877013|NCT02255435|566309716|FG004|Overall Study|Withdrawal by Subject|0|||
156877014|NCT02255435|566309717|FG005|Overall Study|Withdrawal by Subject|0|||
156877015|NCT02255435|566309718|FG006|Overall Study|Withdrawal by Subject|0|||
156877016|NCT02255435|566309719|FG007|Overall Study|Withdrawal by Subject|0|||
156877017|NCT02255435|566309720|FG008|Overall Study|Withdrawal by Subject|1|||
156877018|NCT02255435|566309721|FG009|Overall Study|Withdrawal by Subject|4|||
156877019|NCT02255435|566309712|FG000|Overall Study|Administrative reasons|0|||
156877020|NCT02255435|566309713|FG001|Overall Study|Administrative reasons|0|||
156877021|NCT02255435|566309714|FG002|Overall Study|Administrative reasons|0|||
156877022|NCT02255435|566309715|FG003|Overall Study|Administrative reasons|0|||
156877023|NCT02255435|566309716|FG004|Overall Study|Administrative reasons|0|||
156877024|NCT02255435|566309717|FG005|Overall Study|Administrative reasons|0|||
156877025|NCT02255435|566309718|FG006|Overall Study|Administrative reasons|0|||
156877026|NCT02255435|566309719|FG007|Overall Study|Administrative reasons|0|||
156877027|NCT02255435|566309720|FG008|Overall Study|Administrative reasons|0|||
156877028|NCT02255435|566309721|FG009|Overall Study|Administrative reasons|2|||
156877029|NCT03596905|566309726|FG000|Overall Study|Protocol Violation|0|||
156877030|NCT03596905|566309727|FG001|Overall Study|Protocol Violation|0|||
156877031|NCT03596905|566309728|FG002|Overall Study|Protocol Violation|0|||
156877032|NCT03596905|566309729|FG003|Overall Study|Protocol Violation|0|||
156877033|NCT03596905|566309730|FG004|Overall Study|Protocol Violation|1|||
156877034|NCT03596905|566309731|FG005|Overall Study|Protocol Violation|0|||
156877035|NCT03596905|566309732|FG006|Overall Study|Protocol Violation|0|||
156877036|NCT03596905|566309726|FG000|Overall Study|Withdrawal by Subject|0|||
156877037|NCT03596905|566309727|FG001|Overall Study|Withdrawal by Subject|2|||
156877038|NCT03596905|566309728|FG002|Overall Study|Withdrawal by Subject|1|||
156877039|NCT03596905|566309729|FG003|Overall Study|Withdrawal by Subject|0|||
156877040|NCT03596905|566309730|FG004|Overall Study|Withdrawal by Subject|2|||
156877041|NCT03596905|566309731|FG005|Overall Study|Withdrawal by Subject|0|||
156877042|NCT03596905|566309732|FG006|Overall Study|Withdrawal by Subject|0|||
156877043|NCT03596905|566309726|FG000|Overall Study|Participant moved and was unable to complete study|0|||
156877044|NCT03596905|566309727|FG001|Overall Study|Participant moved and was unable to complete study|1|||
156877045|NCT03596905|566309728|FG002|Overall Study|Participant moved and was unable to complete study|0|||
156877046|NCT03596905|566309729|FG003|Overall Study|Participant moved and was unable to complete study|0|||
156877047|NCT03596905|566309730|FG004|Overall Study|Participant moved and was unable to complete study|0|||
156877048|NCT03596905|566309731|FG005|Overall Study|Participant moved and was unable to complete study|0|||
156877049|NCT03596905|566309732|FG006|Overall Study|Participant moved and was unable to complete study|0|||
156877050|NCT03596905|566309726|FG000|Overall Study|Adverse Event|0|||
156877051|NCT03596905|566309727|FG001|Overall Study|Adverse Event|0|||
156877052|NCT03596905|566309728|FG002|Overall Study|Adverse Event|0|||
156877053|NCT03596905|566309729|FG003|Overall Study|Adverse Event|0|||
156877054|NCT03596905|566309730|FG004|Overall Study|Adverse Event|0|||
156877055|NCT03596905|566309731|FG005|Overall Study|Adverse Event|0|||
156457864|NCT03088878|564772508|FG011|Overall Study|Terminated by Sponsor|13|||
156457865|NCT03088878|564772509|FG012|Overall Study|Terminated by Sponsor|2|||
156457866|NCT03088878|564772510|FG013|Overall Study|Terminated by Sponsor|1|||
156737571|NCT01023256|565784883|FG001|Overall Study|Randomized but not treated|0|||
156737572|NCT01023256|565784884|FG002|Overall Study|Randomized but not treated|1|||
156877056|NCT03596905|566309732|FG006|Overall Study|Adverse Event|1|||
156877057|NCT03596905|566309726|FG000|Overall Study|Non-Compliance with eDiary|1|||
156877058|NCT03596905|566309727|FG001|Overall Study|Non-Compliance with eDiary|0|||
156877059|NCT03596905|566309728|FG002|Overall Study|Non-Compliance with eDiary|0|||
156877060|NCT03596905|566309729|FG003|Overall Study|Non-Compliance with eDiary|0|||
156737573|NCT01023256|565784885|FG003|Overall Study|Randomized but not treated|0|||
156737574|NCT01023256|565784882|FG000|Overall Study|Other|1|||
156737575|NCT01023256|565784883|FG001|Overall Study|Other|0|||
156737576|NCT01023256|565784884|FG002|Overall Study|Other|0|||
156737577|NCT01023256|565784885|FG003|Overall Study|Other|2|||
156737578|NCT01023256|565784882|FG000|Overall Study|Adverse Event|0|||
156737579|NCT01023256|565784883|FG001|Overall Study|Adverse Event|0|||
156737580|NCT01023256|565784884|FG002|Overall Study|Adverse Event|0|||
156737581|NCT01023256|565784885|FG003|Overall Study|Adverse Event|1|||
156737582|NCT01023256|565784882|FG000|Overall Study|Withdrawal by Subject|0|||
156737583|NCT01023256|565784883|FG001|Overall Study|Withdrawal by Subject|0|||
156737584|NCT01023256|565784884|FG002|Overall Study|Withdrawal by Subject|0|||
156737585|NCT01023256|565784885|FG003|Overall Study|Withdrawal by Subject|2|||
156737586|NCT02833844|565784886|FG000|Double-Blind Period|Withdrawal by Subject|2|||
156737587|NCT02833844|565784887|FG001|Double-Blind Period|Withdrawal by Subject|3|||
156737588|NCT02833844|565784886|FG000|Double-Blind Period|Protocol Violation|0|||
156737589|NCT02833844|565784887|FG001|Double-Blind Period|Protocol Violation|4|||
156737590|NCT02833844|565784886|FG000|Open-Label Period|Death|0|||
156737591|NCT02833844|565784887|FG001|Open-Label Period|Death|2|||
156737592|NCT02833844|565784886|FG000|Open-Label Period|Lost to Follow-up|1|||
156737593|NCT02833844|565784887|FG001|Open-Label Period|Lost to Follow-up|0|||
156737594|NCT02833844|565784886|FG000|Open-Label Period|Withdrawal by Subject|1|||
156737595|NCT02833844|565784887|FG001|Open-Label Period|Withdrawal by Subject|0|||
156737596|NCT00308087|565784888|FG000|Overall Study|Progressive Disease|19|||
156737597|NCT00308087|565784889|FG001|Overall Study|Progressive Disease|21|||
156737598|NCT00308087|565784888|FG000|Overall Study|Study Closure|11|||
156737599|NCT00308087|565784889|FG001|Overall Study|Study Closure|12|||
156737600|NCT00308087|565784888|FG000|Overall Study|Withdrawal by Subject|2|||
156737601|NCT00308087|565784889|FG001|Overall Study|Withdrawal by Subject|1|||
156737602|NCT00308087|565784888|FG000|Overall Study|Other|4|||
156796974|NCT03559530|566009694|FG001|Overall Study|non-location of medical records|0|||
156796975|NCT03559530|566009693|FG000|Overall Study|culture results not considered for treat|29|||
156796976|NCT03559530|566009694|FG001|Overall Study|culture results not considered for treat|0|||
156796977|NCT03559530|566009693|FG000|Overall Study|duplicate cases|8|||
156796978|NCT03559530|566009694|FG001|Overall Study|duplicate cases|0|||
156796979|NCT03559530|566009693|FG000|Overall Study|other species of Acinetobacte|7|||
156796980|NCT03559530|566009694|FG001|Overall Study|other species of Acinetobacte|0|||
156796981|NCT03559530|566009693|FG000|Overall Study|contamination / colonization|3|||
156796982|NCT03559530|566009694|FG001|Overall Study|contamination / colonization|0|||
156796983|NCT01472185|566009699|FG000|Overall Study|Randomized but Not Treated|0|||
156796984|NCT01472185|566009700|FG001|Overall Study|Randomized but Not Treated|1|||
156796985|NCT01472185|566009699|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
156796986|NCT01472185|566009700|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
156796987|NCT01472185|566009699|FG000|Overall Study|Hyperglycemia|5|||
156796988|NCT01472185|566009700|FG001|Overall Study|Hyperglycemia|2|||
156796989|NCT01472185|566009699|FG000|Overall Study|Investigator's Discretion|3|||
156796990|NCT01472185|566009700|FG001|Overall Study|Investigator's Discretion|1|||
156796991|NCT01472185|566009699|FG000|Overall Study|Lost to Follow-up|4|||
156796992|NCT01472185|566009700|FG001|Overall Study|Lost to Follow-up|1|||
156796993|NCT01472185|566009699|FG000|Overall Study|Protocol Violation|5|||
156796994|NCT01472185|566009700|FG001|Overall Study|Protocol Violation|1|||
156796995|NCT01472185|566009699|FG000|Overall Study|Subject Noncompliance|8|||
156796996|NCT01472185|566009700|FG001|Overall Study|Subject Noncompliance|15|||
156796997|NCT01472185|566009699|FG000|Overall Study|Subject Withdrew Consent|6|||
156796998|NCT01472185|566009700|FG001|Overall Study|Subject Withdrew Consent|3|||
156796999|NCT01767987|566009703|FG000|Overall Study|Physician Decision|4|||
156797000|NCT01767987|566009704|FG001|Overall Study|Physician Decision|1|||
156797001|NCT01153516|566009705|FG000|Overall Study|Both subjects refused surgery|2|||
156877061|NCT03596905|566309730|FG004|Overall Study|Non-Compliance with eDiary|1|||
156534491|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
156737603|NCT00308087|565784889|FG001|Overall Study|Other|3|||
156797002|NCT01153516|566009706|FG001|Overall Study|Both subjects refused surgery|0|||
156797003|NCT00635050|566009709|FG000|Overall Study|Withdrawal by Subject|1|||
156797004|NCT04875533|566009713|FG000|Overall Study|Adverse Event|6|||
156797005|NCT04875533|566009714|FG001|Overall Study|Adverse Event|4|||
156797006|NCT04875533|566009713|FG000|Overall Study|Protocol Violation|4|||
156737604|NCT04323306|565784890|FG000|Overall Study|Physician Decision|1|||
156737605|NCT04323306|565784891|FG001|Overall Study|Physician Decision|0|||
156737606|NCT04323306|565784892|FG002|Overall Study|Physician Decision|0|||
156737607|NCT04323306|565784893|FG003|Overall Study|Physician Decision|0|||
156797007|NCT04875533|566009714|FG001|Overall Study|Protocol Violation|0|||
156797008|NCT04875533|566009713|FG000|Overall Study|Withdrawal by Subject|8|||
156737608|NCT04323306|565784894|FG004|Overall Study|Physician Decision|0|||
156737609|NCT04323306|565784895|FG005|Overall Study|Physician Decision|0|||
156737610|NCT04323306|565784896|FG006|Overall Study|Physician Decision|0|||
156737611|NCT04323306|565784897|FG007|Overall Study|Physician Decision|0|||
156737612|NCT04323306|565784898|FG008|Overall Study|Physician Decision|0|||
156737613|NCT04323306|565784890|FG000|Overall Study|Withdrawal by Subject|0|||
156737614|NCT04323306|565784891|FG001|Overall Study|Withdrawal by Subject|0|||
156737615|NCT04323306|565784892|FG002|Overall Study|Withdrawal by Subject|0|||
156737616|NCT04323306|565784893|FG003|Overall Study|Withdrawal by Subject|0|||
156737617|NCT04323306|565784894|FG004|Overall Study|Withdrawal by Subject|0|||
156737618|NCT04323306|565784895|FG005|Overall Study|Withdrawal by Subject|1|||
156737619|NCT04323306|565784896|FG006|Overall Study|Withdrawal by Subject|3|||
156737620|NCT04323306|565784897|FG007|Overall Study|Withdrawal by Subject|0|||
156737621|NCT04323306|565784898|FG008|Overall Study|Withdrawal by Subject|1|||
156737622|NCT00089778|565784900|FG000|Overall Study|Protocol Violation|0|||
156737623|NCT00089778|565784901|FG001|Overall Study|Protocol Violation|0|||
156737624|NCT00089778|565784902|FG002|Overall Study|Protocol Violation|1|||
156737625|NCT04712019|565784903|FG000|Overall Study|Withdrawal by Subject|2|||
156737626|NCT04712019|565784904|FG001|Overall Study|Withdrawal by Subject|2|||
156737627|NCT04712019|565784903|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
156737628|NCT04712019|565784904|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
156737629|NCT03729570|565784912|FG000|Overall Study|Lost to Follow-up|16|||
156737630|NCT03729570|565784913|FG001|Overall Study|Lost to Follow-up|20|||
156737631|NCT03729570|565784912|FG000|Overall Study|Seroconversion|5|||
156737632|NCT03729570|565784913|FG001|Overall Study|Seroconversion|0|||
156737633|NCT03729570|565784912|FG000|Overall Study|Moved out of the city|1|||
156737634|NCT03729570|565784913|FG001|Overall Study|Moved out of the city|0|||
156737635|NCT03729570|565784912|FG000|Overall Study|Time Conflict|1|||
156737636|NCT03729570|565784913|FG001|Overall Study|Time Conflict|0|||
156737637|NCT03729570|565784912|FG000|Overall Study|Time Commitment|2|||
156737638|NCT03729570|565784913|FG001|Overall Study|Time Commitment|0|||
156737639|NCT03729570|565784912|FG000|Overall Study|Bad Experience|0|||
156737640|NCT03729570|565784913|FG001|Overall Study|Bad Experience|1|||
156737641|NCT03729570|565784912|FG000|Overall Study|No reason provided|2|||
156737642|NCT03729570|565784913|FG001|Overall Study|No reason provided|1|||
156737643|NCT03729570|565784912|FG000|Overall Study|Family Conflict|0|||
156737644|NCT03729570|565784913|FG001|Overall Study|Family Conflict|1|||
156737645|NCT03729570|565784912|FG000|Overall Study|Did not want to continue taking medications|0|||
156737646|NCT03729570|565784913|FG001|Overall Study|Did not want to continue taking medications|1|||
156737647|NCT03729570|565784912|FG000|Overall Study|Found another PrEP provider|1|||
156737648|NCT03729570|565784913|FG001|Overall Study|Found another PrEP provider|0|||
156737649|NCT03729570|565784912|FG000|Overall Study|Did not enjoy being in the control group|0|||
156737650|NCT03729570|565784913|FG001|Overall Study|Did not enjoy being in the control group|1|||
156737651|NCT00631410|565784918|FG000|Overall Study|Adverse Event|1|||
156737652|NCT00631410|565784919|FG001|Overall Study|Adverse Event|3|||
156737653|NCT00631410|565784918|FG000|Overall Study|Objective Progression or Relapse|4|||
156737654|NCT00631410|565784919|FG001|Overall Study|Objective Progression or Relapse|3|||
156737655|NCT00631410|565784918|FG000|Overall Study|Surgery|1|||
156737656|NCT00631410|565784919|FG001|Overall Study|Surgery|0|||
156737657|NCT02447497|565784921|FG000|Overall Study|Did not meet treatment day baseline.|6|||
156737658|NCT02447497|565784922|FG001|Overall Study|Did not meet treatment day baseline.|5|||
156737659|NCT02447497|565784923|FG002|Overall Study|Did not meet treatment day baseline.|2|||
156737660|NCT02447497|565784924|FG003|Overall Study|Did not meet treatment day baseline.|2|||
156737661|NCT02447497|565784921|FG000|Overall Study|Dressing was compromised|0|||
156737662|NCT02447497|565784922|FG001|Overall Study|Dressing was compromised|1|||
156737663|NCT02447497|565784923|FG002|Overall Study|Dressing was compromised|0|||
156737664|NCT02447497|565784924|FG003|Overall Study|Dressing was compromised|0|||
156737665|NCT00727844|565784925|FG000|Initial Randomization|Physician Decision|2|||
156737666|NCT00727844|565784926|FG001|Initial Randomization|Physician Decision|0|||
156737667|NCT00727844|565784927|FG002|Initial Randomization|Physician Decision|0|||
156797009|NCT04875533|566009714|FG001|Overall Study|Withdrawal by Subject|5|||
156797010|NCT04875533|566009713|FG000|Overall Study|No longer meets eligibility criteria|1|||
156737668|NCT00727844|565784928|FG003|Initial Randomization|Physician Decision|0|||
156797011|NCT04875533|566009714|FG001|Overall Study|No longer meets eligibility criteria|0|||
156797012|NCT04875533|566009713|FG000|Overall Study|Other|0|||
156797013|NCT04875533|566009714|FG001|Overall Study|Other|2|||
156797014|NCT01299961|566009716|FG000|Overall Study|Adverse Event|3|||
156797015|NCT01299961|566009716|FG000|Overall Study|Lack of Efficacy|2|||
156737669|NCT04240457|565784939|FG000|Overall Study|Lost to Follow-up|5|||
156737670|NCT04240457|565784940|FG001|Overall Study|Lost to Follow-up|1|||
156797016|NCT01299961|566009716|FG000|Overall Study|Lost to Follow-up|1|||
156797017|NCT02904096|566009717|FG000|Overall Study|Adverse Event|1|||
156737671|NCT00985959|565784941|FG000|Overall Study|Adverse Event|0|||
156737672|NCT00985959|565784942|FG001|Overall Study|Adverse Event|0|||
156737673|NCT00985959|565784943|FG002|Overall Study|Adverse Event|19|||
156737674|NCT00985959|565784941|FG000|Overall Study|Withdrawal by Subject|0|||
156737675|NCT00985959|565784942|FG001|Overall Study|Withdrawal by Subject|0|||
156737676|NCT00985959|565784943|FG002|Overall Study|Withdrawal by Subject|8|||
156737677|NCT00985959|565784941|FG000|Overall Study|Progressive disease|1|||
156737678|NCT00985959|565784942|FG001|Overall Study|Progressive disease|2|||
156737679|NCT00985959|565784943|FG002|Overall Study|Progressive disease|8|||
156737680|NCT00985959|565784941|FG000|Overall Study|Unrecovered toxicity|0|||
156737681|NCT00985959|565784942|FG001|Overall Study|Unrecovered toxicity|0|||
156737682|NCT00985959|565784943|FG002|Overall Study|Unrecovered toxicity|7|||
156737683|NCT00985959|565784941|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
156737684|NCT00985959|565784942|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
156737685|NCT00985959|565784943|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
156737686|NCT00985959|565784941|FG000|Overall Study|Complete response observed over 2 cycles|0|||
156737687|NCT00985959|565784942|FG001|Overall Study|Complete response observed over 2 cycles|1|||
156737688|NCT00985959|565784943|FG002|Overall Study|Complete response observed over 2 cycles|4|||
156737689|NCT00985959|565784941|FG000|Overall Study|Other|0|||
156737690|NCT00985959|565784942|FG001|Overall Study|Other|0|||
156737691|NCT00985959|565784943|FG002|Overall Study|Other|11|||
156737692|NCT00844480|565784944|FG000|Overall Study|Withdrawal by Subject|2|||
156737693|NCT00844480|565784945|FG001|Overall Study|Withdrawal by Subject|3|||
156737694|NCT02858180|565784946|FG000|Overall Study|Lost to Follow-up|0|||
156737695|NCT02858180|565784947|FG001|Overall Study|Lost to Follow-up|2|||
156737696|NCT03843632|565784956|FG000|Overall Study|Withdrawal by Subject|1|||
156737697|NCT03843632|565784957|FG001|Overall Study|Withdrawal by Subject|0|||
156737698|NCT03843632|565784958|FG002|Overall Study|Withdrawal by Subject|0|||
156737699|NCT03843632|565784959|FG003|Overall Study|Withdrawal by Subject|0|||
156737700|NCT00813813|565784969|FG000|Overall Study|Withdrawal by Subject|1|||
156737701|NCT00813813|565784970|FG001|Overall Study|Withdrawal by Subject|1|||
156737702|NCT00813813|565784969|FG000|Overall Study|Lost to Follow-up|2|||
156737703|NCT00813813|565784970|FG001|Overall Study|Lost to Follow-up|7|||
156737704|NCT00813813|565784969|FG000|Overall Study|Other|0|||
156737705|NCT00813813|565784970|FG001|Overall Study|Other|1|||
156737706|NCT03197467|565786748|FG000|Overall Study|Withdrawal by Subject|1|||
156737707|NCT03666533|565786749|FG000|Overall Study|Lost to Follow-up|2|||
156737708|NCT03666533|565786750|FG001|Overall Study|Lost to Follow-up|2|||
156737709|NCT04743804|565786751|FG000|Overall Study|Other|1|||
156737710|NCT04743804|565786752|FG001|Overall Study|Other|0|||
156737711|NCT04743804|565786751|FG000|Overall Study|Withdrawal by Subject|0|||
156797018|NCT02904096|566009718|FG001|Overall Study|Adverse Event|0|||
156797019|NCT02904096|566009717|FG000|Overall Study|Withdrawal by Subject|4|||
156797020|NCT02904096|566009718|FG001|Overall Study|Withdrawal by Subject|3|||
156797021|NCT02904096|566009717|FG000|Overall Study|Lost to Follow-up|10|||
156797022|NCT02904096|566009718|FG001|Overall Study|Lost to Follow-up|17|||
156797023|NCT02904096|566009717|FG000|Overall Study|Non-compliant|3|||
156797024|NCT02904096|566009718|FG001|Overall Study|Non-compliant|1|||
156797025|NCT02904096|566009717|FG000|Overall Study|Sponsor instructed|1|||
156797026|NCT02904096|566009718|FG001|Overall Study|Sponsor instructed|0|||
156797027|NCT00663260|566009720|FG000|Overall Study|Lack of Efficacy|2|||
156797028|NCT00663260|566009721|FG001|Overall Study|Lack of Efficacy|0|||
156797029|NCT00663260|566009722|FG002|Overall Study|Lack of Efficacy|0|||
156797030|NCT00663260|566009720|FG000|Overall Study|Adverse Event|12|||
156797031|NCT00663260|566009721|FG001|Overall Study|Adverse Event|7|||
156797032|NCT00663260|566009722|FG002|Overall Study|Adverse Event|6|||
156797033|NCT00663260|566009720|FG000|Overall Study|Withdrawal by Subject|3|||
156797034|NCT00663260|566009721|FG001|Overall Study|Withdrawal by Subject|1|||
156797035|NCT00663260|566009722|FG002|Overall Study|Withdrawal by Subject|6|||
156797036|NCT00663260|566009720|FG000|Overall Study|Death|1|||
156797037|NCT00663260|566009721|FG001|Overall Study|Death|0|||
156797038|NCT00663260|566009722|FG002|Overall Study|Death|1|||
156797039|NCT00663260|566009720|FG000|Overall Study|Lost to Follow-up|0|||
156797040|NCT00663260|566009721|FG001|Overall Study|Lost to Follow-up|1|||
156797041|NCT00663260|566009722|FG002|Overall Study|Lost to Follow-up|0|||
156797042|NCT00663260|566009720|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
156797043|NCT00663260|566009721|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
156797044|NCT00663260|566009722|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
156877062|NCT03596905|566309731|FG005|Overall Study|Non-Compliance with eDiary|0|||
156737712|NCT04743804|565786752|FG001|Overall Study|Withdrawal by Subject|1|||
156797045|NCT01979185|566009723|FG000|Period 2|Other|0|||
156797046|NCT01979185|566009724|FG001|Period 2|Other|1|||
156797047|NCT00980798|566009725|FG000|Overall Study|Adverse Event|7|||
156797048|NCT00980798|566009726|FG001|Overall Study|Adverse Event|36|||
156797049|NCT00980798|566009725|FG000|Overall Study|Lack of Efficacy|16|||
156797050|NCT00980798|566009726|FG001|Overall Study|Lack of Efficacy|5|||
156737713|NCT04743804|565786751|FG000|Overall Study|Study Terminated by Sponsor|1|||
156737714|NCT04743804|565786752|FG001|Overall Study|Study Terminated by Sponsor|4|||
156737715|NCT04743804|565786751|FG000|Overall Study|Physician Decision|0|||
156737716|NCT04743804|565786752|FG001|Overall Study|Physician Decision|1|||
156737717|NCT04743804|565786751|FG000|Overall Study|Death|3|||
156797051|NCT00980798|566009725|FG000|Overall Study|Lost to Follow-up|0|||
156737718|NCT04743804|565786752|FG001|Overall Study|Death|0|||
156737719|NCT04338269|565786753|FG000|Overall Study|Death|86|||
156737720|NCT04338269|565786754|FG001|Overall Study|Death|89|||
156737721|NCT04338269|565786753|FG000|Overall Study|Lost to Follow-up|1|||
156737722|NCT04338269|565786754|FG001|Overall Study|Lost to Follow-up|2|||
156737723|NCT04338269|565786753|FG000|Overall Study|Physician Decision|1|||
156737724|NCT04338269|565786754|FG001|Overall Study|Physician Decision|0|||
156737725|NCT04338269|565786753|FG000|Overall Study|Withdrawal by Subject|14|||
156737726|NCT04338269|565786754|FG001|Overall Study|Withdrawal by Subject|11|||
156737727|NCT01424514|565786760|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
156737728|NCT01424514|565786761|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
156737729|NCT01424514|565786760|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
156737730|NCT01424514|565786761|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
156737731|NCT02002533|565786764|FG000|Overall Study|Withdrawal by Subject|6|||
156737732|NCT02002533|565786765|FG001|Overall Study|Withdrawal by Subject|13|||
156737733|NCT02002533|565786764|FG000|Overall Study|Protocol Violation|0|||
156737734|NCT02002533|565786765|FG001|Overall Study|Protocol Violation|1|||
156737735|NCT02002533|565786764|FG000|Overall Study|Adverse Event|0|||
156737736|NCT02002533|565786765|FG001|Overall Study|Adverse Event|3|||
156737737|NCT02002533|565786764|FG000|Overall Study|Lost to Follow-up|0|||
156737738|NCT02002533|565786765|FG001|Overall Study|Lost to Follow-up|1|||
156737739|NCT03408444|565786774|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
156737740|NCT03408444|565786775|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
156737741|NCT03408444|565786776|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
156737742|NCT03408444|565786777|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
156737743|NCT03408444|565786774|FG000|Overall Study|Lens Discomfort|0|||
156737744|NCT03408444|565786775|FG001|Overall Study|Lens Discomfort|1|||
156737745|NCT03408444|565786776|FG002|Overall Study|Lens Discomfort|0|||
156737746|NCT03408444|565786777|FG003|Overall Study|Lens Discomfort|0|||
156737747|NCT03408444|565786774|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
156737748|NCT03408444|565786775|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
156534492|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
156534493|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
156534494|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
156534495|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
156534496|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
156534497|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
156534498|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
156534499|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
156534500|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
156534501|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
156534502|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
156534503|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
156534504|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
156534505|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
156534506|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
156534507|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
156534508|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
156534509|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
156534510|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
156534511|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
156534512|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
156737749|NCT03408444|565786776|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
156737750|NCT03408444|565786777|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
156797052|NCT00980798|566009726|FG001|Overall Study|Lost to Follow-up|1|||
156797053|NCT00980798|566009725|FG000|Overall Study|Physician Decision|2|||
156797054|NCT00980798|566009726|FG001|Overall Study|Physician Decision|1|||
156797055|NCT00980798|566009725|FG000|Overall Study|Withdrawal by Subject|8|||
156797056|NCT00980798|566009726|FG001|Overall Study|Withdrawal by Subject|11|||
156797057|NCT00980798|566009725|FG000|Overall Study|Other|0|||
156797058|NCT00980798|566009726|FG001|Overall Study|Other|1|||
156797059|NCT00522379|566009727|FG000|Overall Study|Adverse Event|12|||
156797060|NCT00522379|566009728|FG001|Overall Study|Adverse Event|15|||
156797061|NCT00522379|566009729|FG002|Overall Study|Adverse Event|12|||
156797062|NCT00522379|566009730|FG003|Overall Study|Adverse Event|5|||
156797063|NCT00522379|566009731|FG004|Overall Study|Adverse Event|17|||
156797064|NCT00522379|566009727|FG000|Overall Study|Lack of Efficacy|3|||
156797065|NCT00522379|566009728|FG001|Overall Study|Lack of Efficacy|0|||
156797066|NCT00522379|566009729|FG002|Overall Study|Lack of Efficacy|2|||
156877063|NCT03596905|566309732|FG006|Overall Study|Non-Compliance with eDiary|2|||
156877064|NCT03596905|566309726|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156877065|NCT03596905|566309727|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156737751|NCT03408444|565786774|FG000|Overall Study|Withdrawal by Subject|0|||
156737752|NCT03408444|565786775|FG001|Overall Study|Withdrawal by Subject|2|||
156737753|NCT03408444|565786776|FG002|Overall Study|Withdrawal by Subject|3|||
156737754|NCT03408444|565786777|FG003|Overall Study|Withdrawal by Subject|0|||
156737755|NCT03408444|565786774|FG000|Overall Study|Lost to Follow-up|0|||
156737756|NCT03408444|565786775|FG001|Overall Study|Lost to Follow-up|0|||
156737757|NCT03408444|565786776|FG002|Overall Study|Lost to Follow-up|1|||
156737758|NCT03408444|565786777|FG003|Overall Study|Lost to Follow-up|0|||
156737759|NCT03408444|565786774|FG000|Overall Study|Adverse Event|0|||
156737760|NCT03408444|565786775|FG001|Overall Study|Adverse Event|0|||
156737761|NCT03408444|565786776|FG002|Overall Study|Adverse Event|0|||
156737762|NCT03408444|565786777|FG003|Overall Study|Adverse Event|1|||
156737763|NCT03408444|565786774|FG000|Overall Study|Lens Handling Difficulties|0|||
156737764|NCT03408444|565786775|FG001|Overall Study|Lens Handling Difficulties|0|||
156737765|NCT03408444|565786776|FG002|Overall Study|Lens Handling Difficulties|1|||
156737766|NCT03408444|565786777|FG003|Overall Study|Lens Handling Difficulties|0|||
156737767|NCT03408444|565786774|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
156737768|NCT03408444|565786775|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
156737769|NCT03408444|565786776|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
156737770|NCT03408444|565786777|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
156737771|NCT01741792|565786778|FG000|Overall Study|Death|6|||
156877066|NCT03596905|566309728|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156737772|NCT01741792|565786779|FG001|Overall Study|Death|1|||
156737773|NCT01741792|565786780|FG002|Overall Study|Death|12|||
156737774|NCT05139303|565786781|FG000|Overall Study|Lost to Follow-up|3|||
156737775|NCT05139303|565786782|FG001|Overall Study|Lost to Follow-up|0|||
156877067|NCT03596905|566309729|FG003|Overall Study|Non-Compliance with Study Drug|0|||
156737776|NCT05139303|565786781|FG000|Overall Study|Adverse Event|1|||
156737777|NCT05139303|565786782|FG001|Overall Study|Adverse Event|0|||
156737778|NCT03875482|565786783|FG000|Overall Study|Adverse Event|0|||
156737779|NCT03875482|565786784|FG001|Overall Study|Adverse Event|1|||
156737780|NCT03875482|565786783|FG000|Overall Study|Withdrew consent|5|||
156737781|NCT03875482|565786784|FG001|Overall Study|Withdrew consent|6|||
156737782|NCT03875482|565786783|FG000|Overall Study|Lost to Follow-up|8|||
156797067|NCT00522379|566009730|FG003|Overall Study|Lack of Efficacy|2|||
156797068|NCT00522379|566009731|FG004|Overall Study|Lack of Efficacy|7|||
156797069|NCT00522379|566009727|FG000|Overall Study|Withdrawal by Subject|2|||
156797070|NCT00522379|566009728|FG001|Overall Study|Withdrawal by Subject|3|||
156534513|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
156797071|NCT00522379|566009729|FG002|Overall Study|Withdrawal by Subject|1|||
156797072|NCT00522379|566009730|FG003|Overall Study|Withdrawal by Subject|2|||
156797073|NCT00522379|566009731|FG004|Overall Study|Withdrawal by Subject|0|||
156797074|NCT00522379|566009727|FG000|Overall Study|Protocol Violation|1|||
156797075|NCT00522379|566009728|FG001|Overall Study|Protocol Violation|1|||
156797076|NCT00522379|566009729|FG002|Overall Study|Protocol Violation|2|||
156797077|NCT00522379|566009730|FG003|Overall Study|Protocol Violation|0|||
156797078|NCT00522379|566009731|FG004|Overall Study|Protocol Violation|0|||
156797079|NCT00522379|566009727|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
156797080|NCT00522379|566009728|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
156797081|NCT00522379|566009729|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
156797082|NCT00522379|566009730|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
156797083|NCT00522379|566009731|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
156797084|NCT00522379|566009727|FG000|Overall Study|Lost to Follow-up|1|||
156797085|NCT00522379|566009728|FG001|Overall Study|Lost to Follow-up|0|||
156534514|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
156737783|NCT03875482|565786784|FG001|Overall Study|Lost to Follow-up|2|||
156737784|NCT03875482|565786783|FG000|Overall Study|Lack of Efficacy|0|||
156737785|NCT03875482|565786784|FG001|Overall Study|Lack of Efficacy|11|||
156737786|NCT03197870|565786788|FG000|Overall Study|Adverse Event|9|||
156737787|NCT03197870|565786789|FG001|Overall Study|Adverse Event|4|||
156737788|NCT03197870|565786790|FG002|Overall Study|Adverse Event|6|||
156797086|NCT00522379|566009729|FG002|Overall Study|Lost to Follow-up|4|||
156797087|NCT00522379|566009730|FG003|Overall Study|Lost to Follow-up|2|||
156737789|NCT03197870|565786788|FG000|Overall Study|Withdrawal by Subject|2|||
156737790|NCT03197870|565786789|FG001|Overall Study|Withdrawal by Subject|3|||
156737791|NCT03197870|565786790|FG002|Overall Study|Withdrawal by Subject|0|||
156737792|NCT03197870|565786788|FG000|Overall Study|Lost to Follow-up|2|||
156737793|NCT03197870|565786789|FG001|Overall Study|Lost to Follow-up|2|||
156737794|NCT03197870|565786790|FG002|Overall Study|Lost to Follow-up|0|||
156797088|NCT00522379|566009731|FG004|Overall Study|Lost to Follow-up|2|||
156737795|NCT03197870|565786788|FG000|Overall Study|data not available|1|||
156797089|NCT00522379|566009727|FG000|Overall Study|Randomization error|0|||
156797090|NCT00522379|566009728|FG001|Overall Study|Randomization error|0|||
156877068|NCT03596905|566309730|FG004|Overall Study|Non-Compliance with Study Drug|1|||
156737796|NCT03197870|565786789|FG001|Overall Study|data not available|1|||
156737797|NCT03197870|565786790|FG002|Overall Study|data not available|0|||
156737798|NCT01618019|565786791|FG000|Overall Study|Withdrawal by Subject|14|||
156737799|NCT01618019|565786792|FG001|Overall Study|Withdrawal by Subject|14|||
156737800|NCT01508130|565786793|FG000|Overall Study|Adverse Event|81|||
156737801|NCT01508130|565786794|FG001|Overall Study|Adverse Event|28|||
156737802|NCT01508130|565786793|FG000|Overall Study|Death|3|||
156737803|NCT01508130|565786794|FG001|Overall Study|Death|1|||
156737804|NCT01508130|565786793|FG000|Overall Study|Protocol Violation|2|||
156737805|NCT01508130|565786794|FG001|Overall Study|Protocol Violation|0|||
156737806|NCT01508130|565786793|FG000|Overall Study|Lost to Follow-up|25|||
156737807|NCT01508130|565786794|FG001|Overall Study|Lost to Follow-up|2|||
156737808|NCT01508130|565786793|FG000|Overall Study|Withdrawal by Subject|3|||
156737809|NCT01508130|565786794|FG001|Overall Study|Withdrawal by Subject|3|||
156737810|NCT01508130|565786793|FG000|Overall Study|Subject's substantial non-compliance|25|||
156737811|NCT01508130|565786794|FG001|Overall Study|Subject's substantial non-compliance|9|||
156737812|NCT01508130|565786793|FG000|Overall Study|Insufficient therapeutic response|74|||
156737813|NCT01508130|565786794|FG001|Overall Study|Insufficient therapeutic response|23|||
156737814|NCT01508130|565786793|FG000|Overall Study|Administrative|14|||
156737815|NCT01508130|565786794|FG001|Overall Study|Administrative|3|||
156737816|NCT01680159|565786795|FG000|Screening Period|Not meet criteria for dose-up period|7|||
156737817|NCT01680159|565786795|FG000|Increased Dose Period|Adverse Event|6|||
156737818|NCT01680159|565786795|FG000|Increased Dose Period|Withdrawal by Subject|2|||
156737819|NCT02783729|565786799|FG000|Overall Study|Lack of Efficacy|1|||
156737820|NCT02783729|565786800|FG001|Overall Study|Lack of Efficacy|0|||
156737821|NCT02783729|565786801|FG002|Overall Study|Lack of Efficacy|0|||
156737822|NCT02783729|565786802|FG003|Overall Study|Lack of Efficacy|0|||
156737823|NCT02783729|565786799|FG000|Overall Study|Adverse Event|2|||
156737824|NCT02783729|565786800|FG001|Overall Study|Adverse Event|6|||
156737825|NCT02783729|565786801|FG002|Overall Study|Adverse Event|2|||
156737826|NCT02783729|565786802|FG003|Overall Study|Adverse Event|3|||
156737827|NCT02783729|565786799|FG000|Overall Study|Other|1|||
156737828|NCT02783729|565786800|FG001|Overall Study|Other|6|||
156737829|NCT02783729|565786801|FG002|Overall Study|Other|2|||
156737830|NCT02783729|565786802|FG003|Overall Study|Other|3|||
156737831|NCT02783729|565786799|FG000|Overall Study|Withdrawal by Subject|2|||
156737832|NCT02783729|565786800|FG001|Overall Study|Withdrawal by Subject|3|||
156737833|NCT02783729|565786801|FG002|Overall Study|Withdrawal by Subject|1|||
156737834|NCT02783729|565786802|FG003|Overall Study|Withdrawal by Subject|2|||
156737835|NCT02783729|565786799|FG000|Overall Study|Participant's choice|2|||
156737836|NCT02783729|565786800|FG001|Overall Study|Participant's choice|1|||
156737837|NCT02783729|565786801|FG002|Overall Study|Participant's choice|2|||
156737838|NCT02783729|565786802|FG003|Overall Study|Participant's choice|1|||
156737839|NCT02783729|565786799|FG000|Overall Study|Lost to Follow-up|2|||
156737840|NCT02783729|565786800|FG001|Overall Study|Lost to Follow-up|1|||
156737841|NCT02783729|565786801|FG002|Overall Study|Lost to Follow-up|1|||
156737842|NCT02783729|565786802|FG003|Overall Study|Lost to Follow-up|0|||
156737843|NCT02288091|565786804|FG000|Overall Study|Lost to Follow-up|1|||
156737844|NCT02288091|565786804|FG000|Overall Study|Screen fail|7|||
156737845|NCT03403751|565786805|FG000|Overall Study|Death|5|||
156737846|NCT03403751|565786806|FG001|Overall Study|Death|6|||
156737847|NCT03403751|565786805|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
156737848|NCT03403751|565786806|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
156737849|NCT00387010|565786810|FG000|Dose Titration Period|Adverse Event|12|||
156737850|NCT00387010|565786810|FG000|Dose Titration Period|Lack of Efficacy|5|||
156737851|NCT00387010|565786810|FG000|Dose Titration Period|Withdrawal by Subject|3|||
156737852|NCT00387010|565786810|FG000|Dose Titration Period|Protocol Violation|1|||
156737853|NCT00387010|565786810|FG000|Dose Titration Period|Lost to Follow-up|2|||
156737854|NCT00387010|565786810|FG000|Dose Titration Period|Noncompliance with study medication|8|||
156737855|NCT00387010|565786810|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
156737856|NCT00387010|565786810|FG000|Treatment Period|Adverse Event|4|||
156737857|NCT00387010|565786810|FG000|Treatment Period|Withdrawal by Subject|1|||
156737858|NCT00387010|565786810|FG000|Treatment Period|Noncompliance with study medication|2|||
156737859|NCT00387010|565786810|FG000|Treatment Period|Noncompliance with study procedures|3|||
156534515|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
156737860|NCT00387010|565786810|FG000|Treatment Period|Participant reported study drug stolen|1|||
156737861|NCT03085238|565786817|FG000|Overall Study|Adverse Event|2|||
156737862|NCT03085238|565786817|FG000|Overall Study|Death|2|||
156737863|NCT01931956|565786818|FG000|Overall Study|Death|42|||
156737864|NCT01931956|565786819|FG001|Overall Study|Death|7|||
156737865|NCT01931956|565786820|FG002|Overall Study|Death|379|||
156797091|NCT00522379|566009729|FG002|Overall Study|Randomization error|0|||
156797092|NCT00522379|566009730|FG003|Overall Study|Randomization error|0|||
156737866|NCT01931956|565786821|FG003|Overall Study|Death|96|||
156737867|NCT01931956|565786818|FG000|Overall Study|Withdrawal by Subject|5|||
156737868|NCT01931956|565786819|FG001|Overall Study|Withdrawal by Subject|0|||
156797093|NCT00522379|566009731|FG004|Overall Study|Randomization error|1|||
156737869|NCT01931956|565786820|FG002|Overall Study|Withdrawal by Subject|70|||
156737870|NCT01931956|565786821|FG003|Overall Study|Withdrawal by Subject|30|||
156737871|NCT01931956|565786818|FG000|Overall Study|Lost to Follow-up|2|||
156737872|NCT01931956|565786819|FG001|Overall Study|Lost to Follow-up|0|||
156737873|NCT01931956|565786820|FG002|Overall Study|Lost to Follow-up|11|||
156737874|NCT01931956|565786821|FG003|Overall Study|Lost to Follow-up|7|||
156737875|NCT01931956|565786818|FG000|Overall Study|Expected|2|||
156737876|NCT01931956|565786819|FG001|Overall Study|Expected|0|||
156737877|NCT01931956|565786820|FG002|Overall Study|Expected|6|||
156737878|NCT01931956|565786821|FG003|Overall Study|Expected|0|||
156737879|NCT01931956|565786818|FG000|Overall Study|Not due|0|||
156737880|NCT01931956|565786819|FG001|Overall Study|Not due|0|||
156737881|NCT01931956|565786820|FG002|Overall Study|Not due|21|||
156737882|NCT01931956|565786821|FG003|Overall Study|Not due|0|||
156737883|NCT02847494|565786822|FG000|Overall Study|Lost to Follow-up|8|||
156737884|NCT02847494|565786823|FG001|Overall Study|Lost to Follow-up|5|||
156737885|NCT02294175|565786824|FG000|Overall Study|Withdrawal by Subject|1|||
156737886|NCT02294175|565786825|FG001|Overall Study|Withdrawal by Subject|2|||
156737887|NCT02294175|565786824|FG000|Overall Study|pt taking excluded medication|3|||
156737888|NCT02294175|565786825|FG001|Overall Study|pt taking excluded medication|1|||
156737889|NCT02294175|565786824|FG000|Overall Study|Protocol Violation|1|||
156737890|NCT02294175|565786825|FG001|Overall Study|Protocol Violation|0|||
156737891|NCT02294175|565786824|FG000|Overall Study|Lost to Follow-up|0|||
156737892|NCT02294175|565786825|FG001|Overall Study|Lost to Follow-up|1|||
156737893|NCT02294175|565786824|FG000|Overall Study|wound healed|0|||
156737894|NCT02294175|565786825|FG001|Overall Study|wound healed|2|||
156737895|NCT02548351|565786826|FG000|Overall Study|Withdrawal by Subject|149|||
156737896|NCT02548351|565786827|FG001|Overall Study|Withdrawal by Subject|154|||
156737897|NCT02548351|565786828|FG002|Overall Study|Withdrawal by Subject|152|||
156737898|NCT02548351|565786826|FG000|Overall Study|Death|11|||
156737899|NCT02548351|565786827|FG001|Overall Study|Death|15|||
156737900|NCT02548351|565786828|FG002|Overall Study|Death|12|||
156737901|NCT02548351|565786826|FG000|Overall Study|Adverse Event|22|||
156737902|NCT02548351|565786827|FG001|Overall Study|Adverse Event|56|||
156737903|NCT02548351|565786828|FG002|Overall Study|Adverse Event|36|||
156737904|NCT02548351|565786826|FG000|Overall Study|Study Terminated by Sponsor|549|||
156737905|NCT02548351|565786827|FG001|Overall Study|Study Terminated by Sponsor|509|||
156737906|NCT02548351|565786828|FG002|Overall Study|Study Terminated by Sponsor|528|||
156737907|NCT02548351|565786826|FG000|Overall Study|Site Closure|14|||
156737908|NCT02548351|565786827|FG001|Overall Study|Site Closure|5|||
156737909|NCT02548351|565786828|FG002|Overall Study|Site Closure|7|||
156737910|NCT02548351|565786826|FG000|Overall Study|Non-compliance with Study Drug|4|||
156737911|NCT02548351|565786827|FG001|Overall Study|Non-compliance with Study Drug|2|||
156737912|NCT02548351|565786828|FG002|Overall Study|Non-compliance with Study Drug|0|||
156737913|NCT02548351|565786826|FG000|Overall Study|Protocol Violation|2|||
156737914|NCT02548351|565786827|FG001|Overall Study|Protocol Violation|1|||
156737915|NCT02548351|565786828|FG002|Overall Study|Protocol Violation|2|||
156737916|NCT02548351|565786826|FG000|Overall Study|Physician Decision|11|||
156737917|NCT02548351|565786827|FG001|Overall Study|Physician Decision|18|||
156737918|NCT02548351|565786828|FG002|Overall Study|Physician Decision|11|||
156737919|NCT02548351|565786826|FG000|Overall Study|Lost to Follow-up|43|||
156737920|NCT02548351|565786827|FG001|Overall Study|Lost to Follow-up|50|||
156737921|NCT02548351|565786828|FG002|Overall Study|Lost to Follow-up|57|||
156737922|NCT02548351|565786826|FG000|Overall Study|Other|19|||
156737923|NCT02548351|565786827|FG001|Overall Study|Other|16|||
156737924|NCT02548351|565786828|FG002|Overall Study|Other|20|||
156737925|NCT02548351|565786826|FG000|Overall Study|Missing|1|||
156737926|NCT02548351|565786827|FG001|Overall Study|Missing|1|||
156737927|NCT02548351|565786828|FG002|Overall Study|Missing|0|||
156737928|NCT01901653|565786829|FG000|Overall Study|Death|2|||
156737929|NCT01901653|565786830|FG001|Overall Study|Death|1|||
156737930|NCT01901653|565786831|FG002|Overall Study|Death|8|||
156737931|NCT01901653|565786832|FG003|Overall Study|Death|3|||
156737932|NCT01901653|565786833|FG004|Overall Study|Death|2|||
156737933|NCT01901653|565786834|FG005|Overall Study|Death|2|||
156737934|NCT01901653|565786835|FG006|Overall Study|Death|6|||
156737935|NCT01901653|565786836|FG007|Overall Study|Death|9|||
156737936|NCT01901653|565786837|FG008|Overall Study|Death|1|||
156336848|NCT02478632|564331380|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
156336849|NCT02478632|564331379|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
156737937|NCT01901653|565786838|FG009|Overall Study|Death|16|||
156737938|NCT01901653|565786839|FG010|Overall Study|Death|2|||
156737939|NCT01901653|565786840|FG011|Overall Study|Death|15|||
156737940|NCT01901653|565786841|FG012|Overall Study|Death|4|||
156737941|NCT01901653|565786829|FG000|Overall Study|Lost to Follow-up|1|||
156737942|NCT01901653|565786830|FG001|Overall Study|Lost to Follow-up|0|||
156737943|NCT01901653|565786831|FG002|Overall Study|Lost to Follow-up|2|||
156737944|NCT01901653|565786832|FG003|Overall Study|Lost to Follow-up|0|||
156737945|NCT01901653|565786833|FG004|Overall Study|Lost to Follow-up|0|||
156737946|NCT01901653|565786834|FG005|Overall Study|Lost to Follow-up|1|||
156737947|NCT01901653|565786835|FG006|Overall Study|Lost to Follow-up|0|||
156737948|NCT01901653|565786836|FG007|Overall Study|Lost to Follow-up|1|||
156737949|NCT01901653|565786837|FG008|Overall Study|Lost to Follow-up|0|||
156737950|NCT01901653|565786838|FG009|Overall Study|Lost to Follow-up|0|||
156737951|NCT01901653|565786839|FG010|Overall Study|Lost to Follow-up|0|||
156737952|NCT01901653|565786840|FG011|Overall Study|Lost to Follow-up|0|||
156737953|NCT01901653|565786841|FG012|Overall Study|Lost to Follow-up|0|||
156737954|NCT01901653|565786829|FG000|Overall Study|Withdrawal by Subject|0|||
156737955|NCT01901653|565786830|FG001|Overall Study|Withdrawal by Subject|0|||
156737956|NCT01901653|565786831|FG002|Overall Study|Withdrawal by Subject|0|||
156737957|NCT01901653|565786832|FG003|Overall Study|Withdrawal by Subject|0|||
156737958|NCT01901653|565786833|FG004|Overall Study|Withdrawal by Subject|0|||
156737959|NCT01901653|565786834|FG005|Overall Study|Withdrawal by Subject|0|||
156737960|NCT01901653|565786835|FG006|Overall Study|Withdrawal by Subject|1|||
156737961|NCT01901653|565786836|FG007|Overall Study|Withdrawal by Subject|0|||
156737962|NCT01901653|565786837|FG008|Overall Study|Withdrawal by Subject|0|||
156737963|NCT01901653|565786838|FG009|Overall Study|Withdrawal by Subject|0|||
156737964|NCT01901653|565786839|FG010|Overall Study|Withdrawal by Subject|0|||
156737965|NCT01901653|565786840|FG011|Overall Study|Withdrawal by Subject|0|||
156737966|NCT01901653|565786841|FG012|Overall Study|Withdrawal by Subject|0|||
156737967|NCT01901653|565786829|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
156737968|NCT01901653|565786830|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
156737969|NCT01901653|565786831|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
156737970|NCT01901653|565786832|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
156737971|NCT01901653|565786833|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
156737972|NCT01901653|565786834|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
156737973|NCT01901653|565786835|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
156737974|NCT01901653|565786836|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
156737975|NCT01901653|565786837|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
156737976|NCT01901653|565786838|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
156737977|NCT01901653|565786839|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
156737978|NCT01901653|565786840|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
156737979|NCT01901653|565786841|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
156737980|NCT03226769|565786847|FG000|Overall Study|Withdrawal by Subject|0|||
156737981|NCT03226769|565786848|FG001|Overall Study|Withdrawal by Subject|1|||
156737982|NCT02640677|565786849|FG000|Overall Study|Lost to Follow-up|1|||
156737983|NCT02640677|565786849|FG000|Overall Study|Withdrawal by Subject|1|||
156737984|NCT01516008|565786856|FG000|Overall Study|Adverse Event|0|||
156737985|NCT01516008|565786857|FG001|Overall Study|Adverse Event|2|||
156737986|NCT01516008|565786858|FG002|Overall Study|Adverse Event|7|||
156737987|NCT01516008|565786856|FG000|Overall Study|Lack of Efficacy|44|||
156737988|NCT01516008|565786857|FG001|Overall Study|Lack of Efficacy|14|||
156737989|NCT01516008|565786858|FG002|Overall Study|Lack of Efficacy|10|||
156737990|NCT01516008|565786856|FG000|Overall Study|Protocol Violation|1|||
156534516|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
156534517|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
156534518|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
156534519|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
156534520|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
156534521|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
156534522|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
156534523|NCT03627767|565052384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
156534524|NCT03627767|565052385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
156534525|NCT03627767|565052386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
156534526|NCT03627767|565052387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
156534527|NCT03627767|565052388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
156534528|NCT03627767|565052384|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
156534529|NCT03627767|565052385|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
156534530|NCT03627767|565052386|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
156534531|NCT03627767|565052387|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
156534532|NCT03627767|565052388|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
156534533|NCT03627767|565052384|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156534534|NCT03627767|565052385|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156534535|NCT03627767|565052386|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
156534536|NCT03627767|565052387|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
156534537|NCT03627767|565052388|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156737991|NCT01516008|565786857|FG001|Overall Study|Protocol Violation|0|||
156737992|NCT01516008|565786858|FG002|Overall Study|Protocol Violation|0|||
156737993|NCT01516008|565786856|FG000|Overall Study|Reason not specified|0|||
156737994|NCT01516008|565786857|FG001|Overall Study|Reason not specified|0|||
156797094|NCT00522379|566009727|FG000|Overall Study|Dispensing error|1|||
156336850|NCT02478632|564331380|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
156336851|NCT01086033|564331381|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
156336852|NCT01086033|564331381|FG000|Overall Study|Lost to Follow-up|86|||
156336853|NCT01086033|564331381|FG000|Overall Study|Adverse Event|42|||
156336854|NCT01086033|564331381|FG000|Overall Study|Withdrawal by Subject|41|||
156336855|NCT01086033|564331381|FG000|Overall Study|Other|14|||
156336856|NCT01086033|564331381|FG000|Overall Study|Other|13|||
156336857|NCT01086033|564331381|FG000|Overall Study|AE and Withdrew Consent|5|||
156336858|NCT01086033|564331381|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
156336859|NCT01086033|564331381|FG000|Overall Study|Withdrew consent and Other Reason|4|||
156336860|NCT01086033|564331381|FG000|Overall Study|AE and Lack of Efficacy|4|||
156336861|NCT01086033|564331381|FG000|Overall Study|Death|1|||
156336862|NCT01086033|564331381|FG000|Overall Study|AE and Lost to Follow-up|1|||
156336863|NCT01086033|564331381|FG000|Overall Study|AE and Other Reason|1|||
156336864|NCT01086033|564331381|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
156336865|NCT02193867|564331383|FG000|Overall Study|Death|2|||
156737995|NCT01516008|565786858|FG002|Overall Study|Reason not specified|1|||
156737996|NCT04553471|565786859|FG000|Overall Study|Did not start treatment on protocol|3|||
156737997|NCT04553471|565786859|FG000|Overall Study|Death|1|||
156737998|NCT02805660|565786861|FG000|Overall Study|Death|5|||
156737999|NCT02805660|565786862|FG001|Overall Study|Death|2|||
156738000|NCT02805660|565786863|FG002|Overall Study|Death|9|||
156738001|NCT02805660|565786864|FG003|Overall Study|Death|5|||
156738002|NCT02805660|565786865|FG004|Overall Study|Death|0|||
156738003|NCT02805660|565786866|FG005|Overall Study|Death|14|||
156738004|NCT02805660|565786867|FG006|Overall Study|Death|12|||
156738005|NCT02805660|565786861|FG000|Overall Study|Lost to Follow-up|0|||
156738006|NCT02805660|565786862|FG001|Overall Study|Lost to Follow-up|1|||
156738007|NCT02805660|565786863|FG002|Overall Study|Lost to Follow-up|1|||
156738008|NCT02805660|565786864|FG003|Overall Study|Lost to Follow-up|2|||
156738009|NCT02805660|565786865|FG004|Overall Study|Lost to Follow-up|0|||
156738010|NCT02805660|565786866|FG005|Overall Study|Lost to Follow-up|0|||
156738011|NCT02805660|565786867|FG006|Overall Study|Lost to Follow-up|0|||
156738012|NCT02805660|565786861|FG000|Overall Study|Withdrawal by Subject|0|||
156738013|NCT02805660|565786862|FG001|Overall Study|Withdrawal by Subject|0|||
156738014|NCT02805660|565786863|FG002|Overall Study|Withdrawal by Subject|0|||
156738015|NCT02805660|565786864|FG003|Overall Study|Withdrawal by Subject|3|||
156738016|NCT02805660|565786865|FG004|Overall Study|Withdrawal by Subject|1|||
156738017|NCT02805660|565786866|FG005|Overall Study|Withdrawal by Subject|0|||
156738018|NCT02805660|565786867|FG006|Overall Study|Withdrawal by Subject|2|||
156738019|NCT02805660|565786861|FG000|Overall Study|Study terminated by Sponsor|0|||
156797095|NCT00522379|566009728|FG001|Overall Study|Dispensing error|0|||
156797096|NCT00522379|566009729|FG002|Overall Study|Dispensing error|0|||
156797097|NCT00522379|566009730|FG003|Overall Study|Dispensing error|1|||
156797098|NCT00522379|566009731|FG004|Overall Study|Dispensing error|0|||
156797099|NCT00522379|566009727|FG000|Overall Study|Subject Moved|1|||
156797100|NCT00522379|566009728|FG001|Overall Study|Subject Moved|1|||
156797101|NCT00522379|566009729|FG002|Overall Study|Subject Moved|0|||
156797102|NCT00522379|566009730|FG003|Overall Study|Subject Moved|0|||
156797103|NCT00522379|566009731|FG004|Overall Study|Subject Moved|0|||
156797104|NCT00522379|566009727|FG000|Overall Study|Sponsor Request|0|||
156797105|NCT00522379|566009728|FG001|Overall Study|Sponsor Request|1|||
156797106|NCT00522379|566009729|FG002|Overall Study|Sponsor Request|0|||
156797107|NCT00522379|566009730|FG003|Overall Study|Sponsor Request|0|||
156797108|NCT00522379|566009731|FG004|Overall Study|Sponsor Request|0|||
156797109|NCT00522379|566009727|FG000|Overall Study|Family Problem|0|||
156797110|NCT00522379|566009728|FG001|Overall Study|Family Problem|0|||
156797111|NCT00522379|566009729|FG002|Overall Study|Family Problem|1|||
156797112|NCT00522379|566009730|FG003|Overall Study|Family Problem|0|||
156797113|NCT00522379|566009731|FG004|Overall Study|Family Problem|0|||
156797114|NCT00522379|566009727|FG000|Overall Study|Site Closed|0|||
156797115|NCT00522379|566009728|FG001|Overall Study|Site Closed|0|||
156797116|NCT00522379|566009729|FG002|Overall Study|Site Closed|0|||
156797117|NCT00522379|566009730|FG003|Overall Study|Site Closed|1|||
156797118|NCT00522379|566009731|FG004|Overall Study|Site Closed|0|||
156797119|NCT00522379|566009727|FG000|Overall Study|Subject Withdrawal|0|||
156797120|NCT00522379|566009728|FG001|Overall Study|Subject Withdrawal|0|||
156797121|NCT00522379|566009729|FG002|Overall Study|Subject Withdrawal|0|||
156797122|NCT00522379|566009730|FG003|Overall Study|Subject Withdrawal|1|||
156797123|NCT00522379|566009731|FG004|Overall Study|Subject Withdrawal|0|||
156797124|NCT03238196|566009734|FG000|Overall Study|Adverse Event|3|||
156797125|NCT03238196|566009735|FG001|Overall Study|Adverse Event|0|||
156336866|NCT02193867|564331383|FG000|Overall Study|Sponsor Study Termination|2|||
156738020|NCT02805660|565786862|FG001|Overall Study|Study terminated by Sponsor|0|||
156738021|NCT02805660|565786863|FG002|Overall Study|Study terminated by Sponsor|1|||
156738022|NCT02805660|565786864|FG003|Overall Study|Study terminated by Sponsor|4|||
156738023|NCT02805660|565786865|FG004|Overall Study|Study terminated by Sponsor|2|||
156797126|NCT03238196|566009736|FG002|Overall Study|Adverse Event|2|||
156797127|NCT03238196|566009737|FG003|Overall Study|Adverse Event|2|||
156797128|NCT03238196|566009734|FG000|Overall Study|Withdrawal by Subject|4|||
156738024|NCT02805660|565786866|FG005|Overall Study|Study terminated by Sponsor|3|||
156738025|NCT02805660|565786867|FG006|Overall Study|Study terminated by Sponsor|1|||
156738026|NCT02805660|565786861|FG000|Overall Study|Miscellaneous|0|||
156738027|NCT02805660|565786862|FG001|Overall Study|Miscellaneous|1|||
156738028|NCT02805660|565786863|FG002|Overall Study|Miscellaneous|0|||
156738029|NCT02805660|565786864|FG003|Overall Study|Miscellaneous|4|||
156738030|NCT02805660|565786865|FG004|Overall Study|Miscellaneous|0|||
156738031|NCT02805660|565786866|FG005|Overall Study|Miscellaneous|6|||
156738032|NCT02805660|565786867|FG006|Overall Study|Miscellaneous|4|||
156738033|NCT02572076|565786869|FG000|Overall Study|Protocol Violation|1|||
156738034|NCT02778074|565786870|FG000|Overall Study|Lost to Follow-up|7|||
156738035|NCT02778074|565786871|FG001|Overall Study|Lost to Follow-up|10|||
156738036|NCT01684943|565786874|FG000|Overall Study|Inadequate Venous Access|3|||
156738037|NCT01684943|565786875|FG001|Overall Study|Inadequate Venous Access|0|||
156738038|NCT01684943|565786876|FG002|Overall Study|Inadequate Venous Access|0|||
156738039|NCT01684943|565786874|FG000|Overall Study|Principal Investigator Determination|1|||
156738040|NCT01684943|565786875|FG001|Overall Study|Principal Investigator Determination|0|||
156738041|NCT01684943|565786876|FG002|Overall Study|Principal Investigator Determination|0|||
156738042|NCT01684943|565786874|FG000|Overall Study|Excluded from Analysis|1|||
156738043|NCT01684943|565786875|FG001|Overall Study|Excluded from Analysis|1|||
156738044|NCT01684943|565786876|FG002|Overall Study|Excluded from Analysis|1|||
156738045|NCT01684943|565786874|FG000|Overall Study|Lost to Follow-up|3|||
156738046|NCT01684943|565786875|FG001|Overall Study|Lost to Follow-up|0|||
156738047|NCT01684943|565786876|FG002|Overall Study|Lost to Follow-up|0|||
156738048|NCT01684943|565786874|FG000|Overall Study|Planning Pregnancy|1|||
156738049|NCT01684943|565786875|FG001|Overall Study|Planning Pregnancy|0|||
156738050|NCT01684943|565786876|FG002|Overall Study|Planning Pregnancy|0|||
156738051|NCT04064411|565786877|FG000|Overall Study|Adverse Event|29|||
156738052|NCT04064411|565786878|FG001|Overall Study|Adverse Event|19|||
156738053|NCT04064411|565786877|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
156738054|NCT04064411|565786878|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
156738055|NCT04064411|565786877|FG000|Overall Study|Protocol Deviation|0|||
156738056|NCT04064411|565786878|FG001|Overall Study|Protocol Deviation|2|||
156738057|NCT04064411|565786877|FG000|Overall Study|Withdrawal by Subject|25|||
156738058|NCT04064411|565786878|FG001|Overall Study|Withdrawal by Subject|29|||
156738059|NCT04064411|565786877|FG000|Overall Study|Lost to Follow-up|5|||
156738060|NCT04064411|565786878|FG001|Overall Study|Lost to Follow-up|2|||
156738061|NCT04064411|565786877|FG000|Overall Study|Other than Specified|4|||
156738062|NCT04064411|565786878|FG001|Overall Study|Other than Specified|1|||
156738063|NCT04064411|565786877|FG000|Overall Study|Death|1|||
156738064|NCT04064411|565786878|FG001|Overall Study|Death|0|||
156738065|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
156738066|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
156738067|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
156738068|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
156738069|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
156738070|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
156738071|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
156738072|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738073|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
156738074|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
156738075|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738076|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738077|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738078|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738079|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
156738080|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
156738081|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738082|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738083|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738084|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738085|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738086|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738087|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
156738088|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738089|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738090|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738091|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738092|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738093|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
156738094|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738095|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
156738096|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738097|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738098|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738099|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738100|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
156738101|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
156738102|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
156738103|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
156738104|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
156738105|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
156534538|NCT03627767|565052384|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
156534539|NCT03627767|565052385|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
156534540|NCT03627767|565052386|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
156534541|NCT03627767|565052387|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
156534542|NCT03627767|565052388|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
156534543|NCT03627767|565052384|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
156534544|NCT03627767|565052385|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
156534545|NCT03627767|565052386|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
156534546|NCT03627767|565052387|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
156534547|NCT03627767|565052388|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
156534548|NCT03627767|565052384|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
156534549|NCT03627767|565052385|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
156534550|NCT03627767|565052386|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
156534551|NCT03627767|565052387|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
156534552|NCT03627767|565052388|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
156534553|NCT03627767|565052384|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
156534554|NCT03627767|565052385|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
156534555|NCT03627767|565052386|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
156534556|NCT03627767|565052387|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
156534557|NCT03627767|565052388|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
156534558|NCT03627767|565052384|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
156534559|NCT03627767|565052385|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
156534560|NCT03627767|565052386|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
156534561|NCT03627767|565052387|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
156534562|NCT03627767|565052388|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
156534563|NCT03627767|565052384|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
156534564|NCT03627767|565052385|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
156534565|NCT03627767|565052386|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
156534566|NCT03627767|565052387|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
156534567|NCT03627767|565052388|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
156534568|NCT03627767|565052384|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
156534569|NCT03627767|565052385|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
156534570|NCT03627767|565052386|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
156534571|NCT03627767|565052387|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
156534572|NCT03627767|565052388|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
156534573|NCT03627767|565052384|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
156534574|NCT03627767|565052385|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
156534575|NCT03627767|565052386|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
156534576|NCT03627767|565052387|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
156534577|NCT03627767|565052388|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
156534578|NCT01950247|565052391|FG000|Overall Study|Withdrawal by Subject|28|||
156534579|NCT01950247|565052392|FG001|Overall Study|Withdrawal by Subject|13|||
156534580|NCT01950247|565052391|FG000|Overall Study|Lost to Follow-up|18|||
156534581|NCT01950247|565052392|FG001|Overall Study|Lost to Follow-up|16|||
156534582|NCT01950247|565052391|FG000|Overall Study|Physician Decision|3|||
156534583|NCT01950247|565052392|FG001|Overall Study|Physician Decision|4|||
156534584|NCT01950247|565052391|FG000|Overall Study|Adverse Event|3|||
156738106|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
156738107|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
156738108|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
156534585|NCT01950247|565052392|FG001|Overall Study|Adverse Event|2|||
156534586|NCT01950247|565052391|FG000|Overall Study|Death|1|||
156534587|NCT01950247|565052392|FG001|Overall Study|Death|1|||
156534588|NCT01950247|565052391|FG000|Overall Study|Not Defined|4|||
156738109|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
156738110|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
156738111|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
156738112|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
156738113|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
156738114|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
156738115|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
156738116|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
156738117|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
156738118|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
156738119|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
156738120|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
156738121|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738122|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738123|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738124|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738125|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
156738126|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738127|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738128|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
156738129|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
156738130|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
156738131|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
156738132|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
156738133|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
156738134|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
156797129|NCT03238196|566009735|FG001|Overall Study|Withdrawal by Subject|1|||
156797130|NCT03238196|566009736|FG002|Overall Study|Withdrawal by Subject|1|||
156797131|NCT03238196|566009737|FG003|Overall Study|Withdrawal by Subject|0|||
156797132|NCT03238196|566009734|FG000|Overall Study|Disease progression|14|||
156797133|NCT03238196|566009735|FG001|Overall Study|Disease progression|2|||
156797134|NCT03238196|566009736|FG002|Overall Study|Disease progression|3|||
156797135|NCT03238196|566009737|FG003|Overall Study|Disease progression|2|||
156797136|NCT03238196|566009734|FG000|Overall Study|Still on treatment|1|||
156797137|NCT03238196|566009735|FG001|Overall Study|Still on treatment|0|||
156797138|NCT03238196|566009736|FG002|Overall Study|Still on treatment|0|||
156797139|NCT03238196|566009737|FG003|Overall Study|Still on treatment|0|||
156797140|NCT04562090|566009738|FG000|Overall Study|Withdrawal by Subject|3|||
156797141|NCT04562090|566009739|FG001|Overall Study|Withdrawal by Subject|4|||
156797142|NCT04562090|566009738|FG000|Overall Study|Protocol Violation|2|||
156797143|NCT04562090|566009739|FG001|Overall Study|Protocol Violation|0|||
156797144|NCT04562090|566009738|FG000|Overall Study|Lack of Efficacy|0|||
156797145|NCT04562090|566009739|FG001|Overall Study|Lack of Efficacy|1|||
156797146|NCT04562090|566009738|FG000|Overall Study|Adverse Event|1|||
156797147|NCT04562090|566009739|FG001|Overall Study|Adverse Event|4|||
156797148|NCT04562090|566009738|FG000|Overall Study|Miscellaneous|0|||
156797149|NCT04562090|566009739|FG001|Overall Study|Miscellaneous|3|||
156797150|NCT00847730|566009740|FG000|Overall Study|Multiple interruptions in therapy|8|||
156797151|NCT04938427|566009743|FG000|Overall Study|Adverse Event|5|||
156797152|NCT04938427|566009744|FG001|Overall Study|Adverse Event|19|||
156797153|NCT04938427|566009743|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156797154|NCT04938427|566009744|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156797155|NCT04938427|566009743|FG000|Overall Study|Withdrawal by Subject|1|||
156797156|NCT04938427|566009744|FG001|Overall Study|Withdrawal by Subject|0|||
156797157|NCT04938427|566009743|FG000|Overall Study|Reason Not Specified|2|||
156797158|NCT04938427|566009744|FG001|Overall Study|Reason Not Specified|1|||
156797159|NCT02402647|566009755|FG000|Overall Study|Lost to Follow-up|13|||
156797160|NCT02402647|566009756|FG001|Overall Study|Lost to Follow-up|7|||
156797161|NCT02402647|566009755|FG000|Overall Study|Protocol Violation|1|||
156797162|NCT02402647|566009756|FG001|Overall Study|Protocol Violation|1|||
156797163|NCT02402647|566009755|FG000|Overall Study|scheduled and timed out|2|||
156797164|NCT02402647|566009756|FG001|Overall Study|scheduled and timed out|1|||
156797165|NCT02402647|566009755|FG000|Overall Study|medical illness|2|||
156797166|NCT02402647|566009756|FG001|Overall Study|medical illness|4|||
156797167|NCT02402647|566009755|FG000|Overall Study|Moved|2|||
156797168|NCT02402647|566009756|FG001|Overall Study|Moved|0|||
156877069|NCT03596905|566309731|FG005|Overall Study|Non-Compliance with Study Drug|0|||
156877070|NCT03596905|566309732|FG006|Overall Study|Non-Compliance with Study Drug|0|||
156336867|NCT02924571|564331384|FG000|Overall Study|Lost to Follow-up|1|||
156534589|NCT01950247|565052392|FG001|Overall Study|Not Defined|10|||
156797169|NCT02402647|566009755|FG000|Overall Study|loved one illness|1|||
156797170|NCT02402647|566009756|FG001|Overall Study|loved one illness|0|||
156797171|NCT02402647|566009755|FG000|Overall Study|deceased preexisting condition|2|||
156797172|NCT02402647|566009756|FG001|Overall Study|deceased preexisting condition|0|||
156797173|NCT02402647|566009755|FG000|Overall Study|Other|2|||
156797174|NCT02402647|566009756|FG001|Overall Study|Other|1|||
156534590|NCT01069120|565052395|FG000|Overall Study|Study prematurely terminated|27|||
156738135|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738136|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738137|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738138|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
156738139|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738140|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
156738141|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738142|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
156738143|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
156738144|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
156738145|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
156738146|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
156738147|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
156738148|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
156738149|NCT00356135|565786889|FG000|Overall Study|Protocol Violation|1|||
156738150|NCT00356135|565786890|FG001|Overall Study|Protocol Violation|0|||
156738151|NCT00356135|565786891|FG002|Overall Study|Protocol Violation|0|||
156738152|NCT00356135|565786889|FG000|Overall Study|Adverse Event|1|||
156738153|NCT00356135|565786890|FG001|Overall Study|Adverse Event|0|||
156738154|NCT00356135|565786891|FG002|Overall Study|Adverse Event|0|||
156738155|NCT00356135|565786889|FG000|Overall Study|Lost to Follow-up|0|||
156738156|NCT00356135|565786890|FG001|Overall Study|Lost to Follow-up|0|||
156738157|NCT00356135|565786891|FG002|Overall Study|Lost to Follow-up|1|||
156738158|NCT00356135|565786889|FG000|Overall Study|Physician Decision|1|||
156738159|NCT00356135|565786890|FG001|Overall Study|Physician Decision|1|||
156738160|NCT00356135|565786891|FG002|Overall Study|Physician Decision|1|||
156738161|NCT00356135|565786889|FG000|Overall Study|Subject non-compliance|1|||
156738162|NCT00356135|565786890|FG001|Overall Study|Subject non-compliance|1|||
156738163|NCT00356135|565786891|FG002|Overall Study|Subject non-compliance|3|||
156738164|NCT03617770|565786892|FG000|Overall Study|Lost to Follow-up|1|||
156738165|NCT03617770|565786893|FG001|Overall Study|Lost to Follow-up|0|||
156738166|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156738167|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
156738168|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
156738169|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
156738170|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
156738171|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
156738172|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
156738173|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
156738174|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
156738175|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
156738176|NCT03963232|565786894|FG000|Open-Label Treatment Phase|Adverse Event|1|||
156738177|NCT03963232|565786895|FG001|Open-Label Treatment Phase|Adverse Event|2|||
156877071|NCT03596905|566309726|FG000|Overall Study|Lost to Follow-up|0|||
156877072|NCT03596905|566309727|FG001|Overall Study|Lost to Follow-up|0|||
156877073|NCT03596905|566309728|FG002|Overall Study|Lost to Follow-up|0|||
156877074|NCT03596905|566309729|FG003|Overall Study|Lost to Follow-up|0|||
156877075|NCT03596905|566309730|FG004|Overall Study|Lost to Follow-up|0|||
156877076|NCT03596905|566309731|FG005|Overall Study|Lost to Follow-up|1|||
156877077|NCT03596905|566309732|FG006|Overall Study|Lost to Follow-up|0|||
156877078|NCT02081599|566309733|FG000|Period 1：Double-blind Period|Adverse Event|3|||
156877079|NCT02081599|566309734|FG001|Period 1：Double-blind Period|Adverse Event|0|||
156877080|NCT02081599|566309733|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
156877081|NCT02081599|566309734|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
156877082|NCT02081599|566309733|FG000|Period 1：Double-blind Period|Physician Decision|1|||
156336868|NCT02924571|564331385|FG001|Overall Study|Lost to Follow-up|1|||
156877083|NCT02081599|566309734|FG001|Period 1：Double-blind Period|Physician Decision|0|||
156877084|NCT02081599|566309733|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
156877085|NCT02081599|566309734|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
156738178|NCT03963232|565786894|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
156738179|NCT03963232|565786895|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
156877086|NCT02081599|566309733|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
156877087|NCT02081599|566309734|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
156336869|NCT02924571|564331386|FG002|Overall Study|Lost to Follow-up|0|||
156877088|NCT02081599|566309733|FG000|Period 1：Double-blind Period|stopping criteria|1|||
156877089|NCT02081599|566309734|FG001|Period 1：Double-blind Period|stopping criteria|0|||
156877090|NCT02081599|566309733|FG000|Period 2：Open-label Period|Adverse Event|1|||
156336870|NCT00434954|564331390|FG000|Overall Study|Adverse Event|17|||
156738180|NCT03963232|565786894|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
156738181|NCT03963232|565786895|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
156336871|NCT00434954|564331391|FG001|Overall Study|Adverse Event|2|||
156738182|NCT03963232|565786894|FG000|Open-Label Treatment Phase|Pregnancy|1|||
156738183|NCT03963232|565786895|FG001|Open-Label Treatment Phase|Pregnancy|0|||
156738184|NCT03963232|565786894|FG000|Follow-up Phase|Withdrawal by Subject|7|||
156738185|NCT03963232|565786895|FG001|Follow-up Phase|Withdrawal by Subject|5|||
156738186|NCT03963232|565786894|FG000|Follow-up Phase|Protocol Violation|0|||
156738187|NCT03963232|565786895|FG001|Follow-up Phase|Protocol Violation|2|||
156738188|NCT03963232|565786894|FG000|Follow-up Phase|Adverse Event|0|||
156738189|NCT03963232|565786895|FG001|Follow-up Phase|Adverse Event|1|||
156738190|NCT03963232|565786894|FG000|Follow-up Phase|Lost to Follow-up|0|||
156738191|NCT03963232|565786895|FG001|Follow-up Phase|Lost to Follow-up|1|||
156738192|NCT03512210|565786896|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
156738193|NCT03512210|565786896|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
156738194|NCT03512210|565786896|FG000|Step 2:Post-MINMON|Death|2|||
156738195|NCT03512210|565786896|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
156738196|NCT03512210|565786896|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
156738197|NCT01672710|565786897|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
156738198|NCT01672710|565786898|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
156738199|NCT01672710|565786897|FG000|3 Month Follow up|Lost to Follow-up|2|||
156738200|NCT01672710|565786898|FG001|3 Month Follow up|Lost to Follow-up|3|||
156738201|NCT01672710|565786897|FG000|3 Month Follow up|follow up due after termination date|4|||
156738202|NCT01672710|565786898|FG001|3 Month Follow up|follow up due after termination date|1|||
156738203|NCT05033262|565786904|FG000|Overall Study|Lost to Follow-up|1|||
156738204|NCT05033262|565786905|FG001|Overall Study|Lost to Follow-up|0|||
156738205|NCT05033262|565786906|FG002|Overall Study|Lost to Follow-up|0|||
156738206|NCT05033262|565786907|FG003|Overall Study|Lost to Follow-up|1|||
156738207|NCT05270395|565786908|FG000|Overall Study|Lost to Follow-up|2|||
156738208|NCT05270395|565786909|FG001|Overall Study|Lost to Follow-up|2|||
156738209|NCT05270395|565786908|FG000|Overall Study|Death|1|||
156738210|NCT05270395|565786909|FG001|Overall Study|Death|2|||
156738211|NCT05270395|565786908|FG000|Overall Study|Study Team Withdrew|1|||
156738212|NCT05270395|565786909|FG001|Overall Study|Study Team Withdrew|0|||
156738213|NCT00970632|565788914|FG000|Overall Study|Adverse Event|2|||
156738214|NCT00970632|565788915|FG001|Overall Study|Adverse Event|2|||
156877091|NCT02081599|566309734|FG001|Period 2：Open-label Period|Adverse Event|0|||
156877092|NCT02081599|566309733|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
156877093|NCT02081599|566309734|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
156877094|NCT02081599|566309733|FG000|Period 2：Open-label Period|Physician Decision|1|||
156877095|NCT02081599|566309734|FG001|Period 2：Open-label Period|Physician Decision|0|||
156877096|NCT02081599|566309733|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
156877097|NCT02081599|566309734|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
156877098|NCT04307134|566309735|FG000|Overall Study|Lost to Follow-up|2|||
156877099|NCT04307134|566309735|FG000|Overall Study|Withdrawal by Subject|3|||
156877100|NCT04307134|566309735|FG000|Overall Study|Other|3|||
156877101|NCT04307134|566309735|FG000|Overall Study|Death|21|||
156877102|NCT04307134|566309735|FG000|Overall Study|Enrolled but not Treated|1|||
156877103|NCT00255346|566309748|FG000|Overall Study|Adverse Event|1|||
156877104|NCT00255346|566309749|FG001|Overall Study|Adverse Event|0|||
156877105|NCT00255346|566309750|FG002|Overall Study|Adverse Event|0|||
156877106|NCT00255346|566309751|FG003|Overall Study|Adverse Event|0|||
156877107|NCT00255346|566309752|FG004|Overall Study|Adverse Event|0|||
156877108|NCT04402489|566309754|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
156877109|NCT04402489|566309755|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
156877110|NCT04402489|566309756|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
156877111|NCT04402489|566309757|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
156877112|NCT04402489|566309758|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
156877113|NCT04402489|566309754|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
156877114|NCT04402489|566309755|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
156877115|NCT04402489|566309756|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
156738215|NCT00970632|565788916|FG002|Overall Study|Adverse Event|1|||
156738216|NCT00970632|565788914|FG000|Overall Study|Lack of Efficacy|3|||
156738217|NCT00970632|565788915|FG001|Overall Study|Lack of Efficacy|0|||
156738218|NCT00970632|565788916|FG002|Overall Study|Lack of Efficacy|0|||
156738219|NCT00970632|565788914|FG000|Overall Study|Lost to Follow-up|3|||
156738220|NCT00970632|565788915|FG001|Overall Study|Lost to Follow-up|0|||
156877116|NCT04402489|566309757|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
156877117|NCT04402489|566309758|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
156877118|NCT04402489|566309754|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
156877119|NCT04402489|566309755|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
156877120|NCT04402489|566309756|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
156877121|NCT04402489|566309757|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
156877122|NCT04402489|566309758|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
156738221|NCT00970632|565788916|FG002|Overall Study|Lost to Follow-up|2|||
156738222|NCT00970632|565788914|FG000|Overall Study|Protocol Violation|8|||
156738223|NCT00970632|565788915|FG001|Overall Study|Protocol Violation|5|||
156738224|NCT00970632|565788916|FG002|Overall Study|Protocol Violation|8|||
156738225|NCT00970632|565788914|FG000|Overall Study|Withdrawal by Subject|7|||
156877123|NCT04402489|566309754|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
156336872|NCT00434954|564331390|FG000|Overall Study|Entry criteria not met|14|||
156336873|NCT00434954|564331391|FG001|Overall Study|Entry criteria not met|16|||
156336874|NCT00434954|564331390|FG000|Overall Study|Lost to Follow-up|0|||
156336875|NCT00434954|564331391|FG001|Overall Study|Lost to Follow-up|1|||
156336876|NCT00434954|564331390|FG000|Overall Study|Physician Decision|6|||
156336877|NCT00434954|564331391|FG001|Overall Study|Physician Decision|3|||
156336878|NCT00434954|564331390|FG000|Overall Study|Protocol Violation|36|||
156336879|NCT00434954|564331391|FG001|Overall Study|Protocol Violation|27|||
156336880|NCT00434954|564331390|FG000|Overall Study|Sponsor decision|1|||
156336881|NCT00434954|564331391|FG001|Overall Study|Sponsor decision|0|||
156336882|NCT00434954|564331390|FG000|Overall Study|Subject decision|8|||
156336883|NCT00434954|564331391|FG001|Overall Study|Subject decision|22|||
156336884|NCT03741062|564331394|FG000|Overall Study|Protocol Violation|1|||
156336885|NCT03741062|564331395|FG001|Overall Study|Protocol Violation|0|||
156336886|NCT01986907|564331400|FG000|Overall Study|Adverse Event|11|||
156336887|NCT01986907|564331400|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
156457867|NCT03088878|564772497|FG000|Overall Study|Completed 2 years of Treatment|0|||
156797178|NCT03559556|566009761|FG000|Overall Study|Withdrawal by Subject|1|||
156797179|NCT02457793|566009762|FG000|Overall Study|Reason not specified|0|||
156797180|NCT02457793|566009763|FG001|Overall Study|Reason not specified|0|||
156797181|NCT02457793|566009764|FG002|Overall Study|Reason not specified|0|||
156797182|NCT02457793|566009765|FG003|Overall Study|Reason not specified|1|||
156797183|NCT02457793|566009766|FG004|Overall Study|Reason not specified|1|||
156797184|NCT02457793|566009767|FG005|Overall Study|Reason not specified|1|||
156797185|NCT02457793|566009762|FG000|Overall Study|Withdrawal by Subject|0|||
156797186|NCT02457793|566009763|FG001|Overall Study|Withdrawal by Subject|4|||
156797187|NCT02457793|566009764|FG002|Overall Study|Withdrawal by Subject|2|||
156797188|NCT02457793|566009765|FG003|Overall Study|Withdrawal by Subject|2|||
156797189|NCT02457793|566009766|FG004|Overall Study|Withdrawal by Subject|2|||
156797190|NCT02457793|566009767|FG005|Overall Study|Withdrawal by Subject|2|||
156797191|NCT02457793|566009762|FG000|Overall Study|Adverse Event|0|||
156797192|NCT02457793|566009763|FG001|Overall Study|Adverse Event|0|||
156797193|NCT02457793|566009764|FG002|Overall Study|Adverse Event|0|||
156797194|NCT02457793|566009765|FG003|Overall Study|Adverse Event|1|||
156797195|NCT02457793|566009766|FG004|Overall Study|Adverse Event|0|||
156797196|NCT02457793|566009767|FG005|Overall Study|Adverse Event|0|||
156797197|NCT02457793|566009762|FG000|Overall Study|Physician Decision|1|||
156797198|NCT02457793|566009763|FG001|Overall Study|Physician Decision|0|||
156797199|NCT02457793|566009764|FG002|Overall Study|Physician Decision|1|||
156797200|NCT02457793|566009765|FG003|Overall Study|Physician Decision|1|||
156797201|NCT02457793|566009766|FG004|Overall Study|Physician Decision|1|||
156797202|NCT02457793|566009767|FG005|Overall Study|Physician Decision|3|||
156797203|NCT00835172|566009772|FG000|Washout|Protocol Violation|0|||
156797204|NCT00835172|566009773|FG001|Washout|Protocol Violation|1|||
156797205|NCT03941093|566009774|FG000|Overall Study|Protocol Violation|0|||
156797206|NCT03941093|566009775|FG001|Overall Study|Protocol Violation|1|||
156797207|NCT03941093|566009774|FG000|Overall Study|Withdrawal by Subject|9|||
156797208|NCT03941093|566009775|FG001|Overall Study|Withdrawal by Subject|6|||
156797209|NCT01344356|566011236|FG000|Overall Study|Physician Decision|0|||
156797210|NCT01344356|566011237|FG001|Overall Study|Physician Decision|3|||
156797211|NCT01344356|566011236|FG000|Overall Study|Lost to Follow-up|0|||
156797212|NCT01344356|566011237|FG001|Overall Study|Lost to Follow-up|6|||
156797213|NCT02390076|566011239|FG000|Overall Study|Lost to Follow-up|2|||
156797214|NCT02390076|566011240|FG001|Overall Study|Lost to Follow-up|1|||
156797215|NCT02390076|566011241|FG002|Overall Study|Lost to Follow-up|4|||
156797216|NCT01206517|566011242|FG000|Overall Study|Withdrawal by Subject|0|||
156797217|NCT01206517|566011243|FG001|Overall Study|Withdrawal by Subject|0|||
156797218|NCT01206517|566011244|FG002|Overall Study|Withdrawal by Subject|2|||
156797219|NCT01206517|566011245|FG003|Overall Study|Withdrawal by Subject|0|||
156797220|NCT01206517|566011246|FG004|Overall Study|Withdrawal by Subject|1|||
156797221|NCT01206517|566011247|FG005|Overall Study|Withdrawal by Subject|0|||
156797222|NCT00553254|566011250|FG000|Overall Study|Death|3|||
156797223|NCT00553254|566011251|FG001|Overall Study|Death|6|||
156797224|NCT00553254|566011252|FG002|Overall Study|Death|25|||
156797225|NCT00553254|566011250|FG000|Overall Study|Lost to Follow-up|0|||
156797226|NCT00553254|566011251|FG001|Overall Study|Lost to Follow-up|0|||
156797227|NCT00553254|566011252|FG002|Overall Study|Lost to Follow-up|2|||
156797228|NCT00553254|566011250|FG000|Overall Study|Withdrawal by Subject|2|||
156797229|NCT00553254|566011251|FG001|Overall Study|Withdrawal by Subject|0|||
156797230|NCT00553254|566011252|FG002|Overall Study|Withdrawal by Subject|2|||
156336888|NCT01986907|564331400|FG000|Overall Study|Protocol Violation|4|||
156797231|NCT00553254|566011250|FG000|Overall Study|Study terminated by Sponsor|0|||
156797232|NCT00553254|566011251|FG001|Overall Study|Study terminated by Sponsor|0|||
156797233|NCT00553254|566011252|FG002|Overall Study|Study terminated by Sponsor|1|||
156336889|NCT01986907|564331400|FG000|Overall Study|Withdrawal by Subject|76|||
156797234|NCT00553254|566011250|FG000|Overall Study|Other|1|||
156797235|NCT00553254|566011251|FG001|Overall Study|Other|0|||
156336890|NCT01986907|564331400|FG000|Overall Study|Lost to Follow-up|38|||
156738226|NCT00970632|565788915|FG001|Overall Study|Withdrawal by Subject|6|||
156738227|NCT00970632|565788916|FG002|Overall Study|Withdrawal by Subject|4|||
156738228|NCT00970632|565788914|FG000|Overall Study|Entry criteria not met|0|||
156738229|NCT00970632|565788915|FG001|Overall Study|Entry criteria not met|2|||
156738230|NCT00970632|565788916|FG002|Overall Study|Entry criteria not met|2|||
156738231|NCT00970632|565788914|FG000|Overall Study|Sponsor decision|1|||
156738232|NCT00970632|565788915|FG001|Overall Study|Sponsor decision|0|||
156738233|NCT00970632|565788916|FG002|Overall Study|Sponsor decision|1|||
156797236|NCT00553254|566011252|FG002|Overall Study|Other|13|||
156877124|NCT04402489|566309755|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
156877125|NCT04402489|566309756|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
156877126|NCT04402489|566309757|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
156877127|NCT04402489|566309758|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
156877128|NCT04402489|566309754|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
156877129|NCT04402489|566309755|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
156877130|NCT04402489|566309756|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
156877131|NCT04402489|566309757|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
156877132|NCT04402489|566309758|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
156877133|NCT04402489|566309754|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
156877134|NCT04402489|566309755|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
156877135|NCT04402489|566309756|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
156877136|NCT04402489|566309757|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
156877137|NCT04402489|566309758|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
156877138|NCT03192891|566309759|FG000|Overall Study|Lost to Follow-up|55|||
156877139|NCT05223868|566309760|FG000|Overall Study|Lost to Follow-up|1|||
156877140|NCT05223868|566309761|FG001|Overall Study|Lost to Follow-up|3|||
156877141|NCT05223868|566309762|FG002|Overall Study|Lost to Follow-up|0|||
156877142|NCT05223868|566309763|FG003|Overall Study|Lost to Follow-up|0|||
156877143|NCT05223868|566309764|FG004|Overall Study|Lost to Follow-up|0|||
156877144|NCT05223868|566309765|FG005|Overall Study|Lost to Follow-up|1|||
156877145|NCT05223868|566309760|FG000|Overall Study|Withdrawal by Subject|6|||
156877146|NCT05223868|566309761|FG001|Overall Study|Withdrawal by Subject|2|||
156877147|NCT05223868|566309762|FG002|Overall Study|Withdrawal by Subject|3|||
156877148|NCT05223868|566309763|FG003|Overall Study|Withdrawal by Subject|1|||
156877149|NCT05223868|566309764|FG004|Overall Study|Withdrawal by Subject|1|||
156877150|NCT05223868|566309765|FG005|Overall Study|Withdrawal by Subject|2|||
156877151|NCT05223868|566309760|FG000|Overall Study|Other|0|||
156877152|NCT05223868|566309761|FG001|Overall Study|Other|2|||
156877153|NCT05223868|566309762|FG002|Overall Study|Other|0|||
156877154|NCT05223868|566309763|FG003|Overall Study|Other|0|||
156877155|NCT05223868|566309764|FG004|Overall Study|Other|1|||
156877156|NCT05223868|566309765|FG005|Overall Study|Other|1|||
156877157|NCT05590585|566309766|FG000|Overall Study|Lost to Follow-up|3|||
156877158|NCT05590585|566309766|FG000|Overall Study|Withdrawal by Subject|1|||
156877159|NCT03760731|566309767|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
156877160|NCT03760731|566309768|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
156877161|NCT03760731|566309767|FG000|Treatment|Attended less than 70% of sessions|10|||
156877162|NCT03760731|566309768|FG001|Treatment|Attended less than 70% of sessions|15|||
156877163|NCT01970358|566309769|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
156877164|NCT01970358|566309769|FG000|Overall Study|Ineligible at time of second consent|4|||
156877165|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
156877166|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
156877167|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
156797237|NCT02546323|566011253|FG000|Overall Study|Withdrawal by Subject|36|||
156797238|NCT02546323|566011254|FG001|Overall Study|Withdrawal by Subject|33|||
156797239|NCT02546323|566011253|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
156797240|NCT02546323|566011254|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
156797241|NCT02546323|566011253|FG000|Overall Study|Adverse Event|17|||
156797242|NCT02546323|566011254|FG001|Overall Study|Adverse Event|11|||
156797243|NCT02546323|566011253|FG000|Overall Study|Patient Specific Reasons|1|||
156797244|NCT02546323|566011254|FG001|Overall Study|Patient Specific Reasons|2|||
156797245|NCT02546323|566011253|FG000|Overall Study|Lost to Follow-up|2|||
156797246|NCT02546323|566011254|FG001|Overall Study|Lost to Follow-up|3|||
156797247|NCT02546323|566011253|FG000|Overall Study|Non-compliance with Study Drug|2|||
156877168|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
156877169|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
156877170|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
156877171|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
156877172|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
156738234|NCT01286168|565788919|FG000|Overall Study|Withdrawal by Subject|1|||
156738235|NCT01286168|565788919|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
156797248|NCT02546323|566011254|FG001|Overall Study|Non-compliance with Study Drug|2|||
156738236|NCT02487771|565788920|FG000|Overall Study|Lost to Follow-up|2|||
156877173|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
156877174|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
156877175|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
156877176|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
156877177|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
156877178|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
156877179|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
156877180|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
156877181|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
156877182|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
156877183|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
156877184|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
156877185|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
156877186|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
156877187|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
156877188|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
156877189|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
156877190|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
156877191|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
156877192|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
156877193|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
156877194|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
156877195|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
156877196|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
156877197|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
156877198|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
156877199|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
156877200|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
156877201|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
156877202|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
156877203|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
156877204|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
156877205|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
156877206|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
156877207|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
156877208|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
156877209|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
156877210|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
156877211|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
156877212|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
156877213|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
156877214|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
156877215|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
156877216|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
156877217|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
156877218|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
156877219|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
156877220|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
156738237|NCT02487771|565788921|FG001|Overall Study|Lost to Follow-up|3|||
156738238|NCT02487771|565788920|FG000|Overall Study|Moved out of area|5|||
156738239|NCT02487771|565788921|FG001|Overall Study|Moved out of area|6|||
156738240|NCT02487771|565788920|FG000|Overall Study|Withdrawal by Subject|3|||
156738241|NCT02487771|565788921|FG001|Overall Study|Withdrawal by Subject|5|||
156738242|NCT02653170|565788922|FG000|Overall Study|Withdrawal by Subject|3|||
156738243|NCT02653170|565788923|FG001|Overall Study|Withdrawal by Subject|8|||
156738244|NCT02653170|565788924|FG002|Overall Study|Withdrawal by Subject|3|||
156738245|NCT02653170|565788922|FG000|Overall Study|withdrawn by study team|2|||
156738246|NCT02653170|565788923|FG001|Overall Study|withdrawn by study team|4|||
156738247|NCT02653170|565788924|FG002|Overall Study|withdrawn by study team|5|||
156738248|NCT02653170|565788922|FG000|Overall Study|Lost to Follow-up|12|||
156738249|NCT02653170|565788923|FG001|Overall Study|Lost to Follow-up|4|||
156738250|NCT02653170|565788924|FG002|Overall Study|Lost to Follow-up|10|||
156534591|NCT01446016|565052396|FG000|Overall Study|Lost to Follow-up|3|||
156738251|NCT01482065|565788925|FG000|Overall Study|Withdrawal by Subject|0|||
156738252|NCT01482065|565788926|FG001|Overall Study|Withdrawal by Subject|1|||
156738253|NCT01942486|565788927|FG000|Overall Study|Lost to Follow-up|27|||
156738254|NCT03728426|565788928|FG000|Overall Study|Death|3|||
156738255|NCT02424630|565788931|FG000|Overall Study|No rotator cuff tear|1|||
156738256|NCT02424630|565788932|FG001|Overall Study|No rotator cuff tear|2|||
156738257|NCT02424630|565788931|FG000|Overall Study|Open procedure|0|||
156738258|NCT02424630|565788932|FG001|Overall Study|Open procedure|1|||
156738259|NCT01995175|565788933|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
156738260|NCT01995175|565788933|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
156738261|NCT01995175|565788933|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
156738262|NCT01995175|565788933|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
156738263|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
156738264|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
156738265|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
156738266|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
156738267|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
156738268|NCT00984061|565788934|FG000|Clarithromycin Alone|Protocol Violation|1|||
156738269|NCT00761280|565788935|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
156738270|NCT00761280|565788936|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
156877221|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
156877222|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
156877223|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
156877224|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
156738271|NCT00761280|565788935|FG000|Randomization to First Dose|Sponsor decision|1|||
156738272|NCT00761280|565788936|FG001|Randomization to First Dose|Sponsor decision|0|||
156738273|NCT00761280|565788935|FG000|Randomization to First Dose|Other|1|||
156738274|NCT00761280|565788936|FG001|Randomization to First Dose|Other|0|||
156738275|NCT00761280|565788935|FG000|First Dose to End of Study|End of trial|5|||
156738276|NCT00761280|565788936|FG001|First Dose to End of Study|End of trial|5|||
156738277|NCT00761280|565788935|FG000|First Dose to End of Study|Progressive disease|5|||
156738278|NCT00761280|565788936|FG001|First Dose to End of Study|Progressive disease|3|||
156738279|NCT00761280|565788935|FG000|First Dose to End of Study|Sponsor decision|1|||
156738280|NCT00761280|565788936|FG001|First Dose to End of Study|Sponsor decision|2|||
156738281|NCT00761280|565788935|FG000|First Dose to End of Study|Death|1|||
156738282|NCT00761280|565788936|FG001|First Dose to End of Study|Death|0|||
156738283|NCT00761280|565788935|FG000|First Dose to End of Study|Lost to Follow-up|0|||
156738284|NCT00761280|565788936|FG001|First Dose to End of Study|Lost to Follow-up|1|||
156738285|NCT04777201|565788940|FG000|Main Study|Withdrawal by Subject|19|||
156738286|NCT04777201|565788941|FG001|Main Study|Withdrawal by Subject|27|||
156738287|NCT04777201|565788942|FG002|Main Study|Withdrawal by Subject|0|||
156738288|NCT04777201|565788940|FG000|Main Study|Death|13|||
156738289|NCT04777201|565788941|FG001|Main Study|Death|27|||
156738290|NCT04777201|565788942|FG002|Main Study|Death|0|||
156738291|NCT04777201|565788940|FG000|Main Study|Subject missed the safety follow-up visit|9|||
156738292|NCT04777201|565788941|FG001|Main Study|Subject missed the safety follow-up visit|10|||
156738293|NCT04777201|565788942|FG002|Main Study|Subject missed the safety follow-up visit|0|||
156738294|NCT04777201|565788940|FG000|Main Study|Physician Decision|8|||
156738295|NCT04777201|565788941|FG001|Main Study|Physician Decision|10|||
156738296|NCT04777201|565788942|FG002|Main Study|Physician Decision|0|||
156738297|NCT04777201|565788940|FG000|Main Study|Adverse Event|8|||
156797249|NCT02546323|566011253|FG000|Overall Study|Met Withdrawal Criteria|2|||
156797250|NCT02546323|566011254|FG001|Overall Study|Met Withdrawal Criteria|14|||
156797251|NCT04023487|566011256|FG000|Overall Study|Lost to Follow-up|5|||
156797252|NCT04023487|566011257|FG001|Overall Study|Lost to Follow-up|4|||
156797253|NCT04023487|566011256|FG000|Overall Study|Pregnancy|1|||
156797254|NCT04023487|566011257|FG001|Overall Study|Pregnancy|2|||
156797255|NCT04023487|566011256|FG000|Overall Study|Withdrawal by Subject|4|||
156797256|NCT04023487|566011257|FG001|Overall Study|Withdrawal by Subject|5|||
156797257|NCT04023487|566011256|FG000|Overall Study|Partially completed testing|8|||
156877225|NCT03395197|566309770|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
156877226|NCT03395197|566309771|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
156877227|NCT03395197|566309772|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
156877228|NCT03395197|566309773|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
156877229|NCT03395197|566309774|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
156877230|NCT03395197|566309775|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
156738298|NCT04777201|565788941|FG001|Main Study|Adverse Event|8|||
156738299|NCT04777201|565788942|FG002|Main Study|Adverse Event|0|||
156738300|NCT04777201|565788940|FG000|Main Study|Lost to Follow-up|9|||
156738301|NCT04777201|565788941|FG001|Main Study|Lost to Follow-up|4|||
156738302|NCT04777201|565788942|FG002|Main Study|Lost to Follow-up|0|||
156797258|NCT04023487|566011257|FG001|Overall Study|Partially completed testing|4|||
156797259|NCT03898180|566011258|FG000|Overall Study|Death|178|||
156797260|NCT03898180|566011259|FG001|Overall Study|Death|173|||
156877231|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|Death|0|||
156877232|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|Death|0|||
156738303|NCT04777201|565788940|FG000|Main Study|Reason not specified|3|||
156738304|NCT04777201|565788941|FG001|Main Study|Reason not specified|3|||
156738305|NCT04777201|565788942|FG002|Main Study|Reason not specified|0|||
156738306|NCT04777201|565788940|FG000|Main Study|Lack of Efficacy|1|||
156738307|NCT04777201|565788941|FG001|Main Study|Lack of Efficacy|1|||
156738308|NCT04777201|565788942|FG002|Main Study|Lack of Efficacy|0|||
156738309|NCT04777201|565788940|FG000|Main Study|Protocol Violation|1|||
156738310|NCT04777201|565788941|FG001|Main Study|Protocol Violation|0|||
156738311|NCT04777201|565788942|FG002|Main Study|Protocol Violation|0|||
156738312|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
156738313|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
156738314|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
156738315|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
156738316|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
156738317|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
156738318|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
156738319|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
156738320|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
156738321|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
156738322|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
156738323|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
156738324|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
156738325|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
156738326|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
156738327|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
156738328|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
156738329|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
156738330|NCT00507819|565788945|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
156738331|NCT00507819|565788946|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
156738332|NCT02045862|565788949|FG000|Overall Study|Death|0|||
156738333|NCT02045862|565788950|FG001|Overall Study|Death|0|||
156738334|NCT02045862|565788951|FG002|Overall Study|Death|1|||
156738335|NCT02045862|565788949|FG000|Overall Study|Miscellaneous|5|||
156738336|NCT02045862|565788950|FG001|Overall Study|Miscellaneous|0|||
156877233|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|Death|0|||
156738337|NCT02045862|565788951|FG002|Overall Study|Miscellaneous|8|||
156738338|NCT02045862|565788949|FG000|Overall Study|Withdrawal by Patient|18|||
156738339|NCT02045862|565788950|FG001|Overall Study|Withdrawal by Patient|27|||
156797261|NCT03898180|566011258|FG000|Overall Study|Physician Decision|1|||
156797262|NCT03898180|566011259|FG001|Overall Study|Physician Decision|0|||
156797263|NCT03898180|566011258|FG000|Overall Study|Sponsor Decision|3|||
156797264|NCT03898180|566011259|FG001|Overall Study|Sponsor Decision|0|||
156797265|NCT03898180|566011258|FG000|Overall Study|Lost to Follow-up|1|||
156797266|NCT03898180|566011259|FG001|Overall Study|Lost to Follow-up|0|||
156797267|NCT03898180|566011258|FG000|Overall Study|Withdrawal by Subject|5|||
156797268|NCT03898180|566011259|FG001|Overall Study|Withdrawal by Subject|4|||
156877234|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|Death|0|||
156877235|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|Death|1|||
156877236|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|Death|4|||
156877237|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
156877238|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
156877239|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
156877240|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
156877241|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
156877242|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
156877243|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
156877244|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
156534592|NCT01446016|565052396|FG000|Overall Study|Withdrawal by Subject|1|||
156738340|NCT02045862|565788951|FG002|Overall Study|Withdrawal by Patient|57|||
156738341|NCT02045862|565788949|FG000|Overall Study|Protocol Violation|0|||
156797269|NCT00645658|566011260|FG000|Overall Study|Withdrawal by Subject|1|||
156877245|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
156877246|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
156738342|NCT02045862|565788950|FG001|Overall Study|Protocol Violation|0|||
156738343|NCT02045862|565788951|FG002|Overall Study|Protocol Violation|6|||
156738344|NCT02045862|565788949|FG000|Overall Study|Lack of Efficacy|8|||
156738345|NCT02045862|565788950|FG001|Overall Study|Lack of Efficacy|4|||
156797270|NCT00645658|566011261|FG001|Overall Study|Withdrawal by Subject|0|||
156797271|NCT00645658|566011260|FG000|Overall Study|Did not complete all assesments|0|||
156877247|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
156877248|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
156738346|NCT02045862|565788951|FG002|Overall Study|Lack of Efficacy|13|||
156877249|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
156877250|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
156877251|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
156877252|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
156877253|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
156877254|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
156738347|NCT02045862|565788949|FG000|Overall Study|Randomized but not Received Study Drug|0|||
156738348|NCT02045862|565788950|FG001|Overall Study|Randomized but not Received Study Drug|2|||
156877255|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
156877256|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
156877257|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
156877258|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
156877259|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
156877260|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
156877261|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
156877262|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
156877263|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
156877264|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
156877265|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
156877266|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
156877267|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
156877268|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
156877269|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
156877270|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
156877271|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
156877272|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
156877273|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|Other|0|||
156877274|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|Other|0|||
156877275|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|Other|0|||
156877276|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|Other|0|||
156877277|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|Other|3|||
156877278|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|Other|3|||
156877279|NCT03395197|566309770|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
156877280|NCT03395197|566309771|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
156877281|NCT03395197|566309772|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
156877282|NCT03395197|566309773|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
156877283|NCT03395197|566309774|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
156877284|NCT03395197|566309775|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
156877285|NCT03869216|566309776|FG000|Overall Study|prostate removed during the study|1|||
156877286|NCT03869216|566309777|FG001|Overall Study|prostate removed during the study|1|||
156877287|NCT03869216|566309776|FG000|Overall Study|Withdrawal by Subject|0|||
156877288|NCT03869216|566309777|FG001|Overall Study|Withdrawal by Subject|1|||
156877289|NCT03869216|566309776|FG000|Overall Study|Lost to Follow-up|3|||
156877290|NCT03869216|566309777|FG001|Overall Study|Lost to Follow-up|12|||
156877291|NCT03869216|566309776|FG000|Overall Study|Changed clinical site or moved out of city|5|||
156738349|NCT02045862|565788951|FG002|Overall Study|Randomized but not Received Study Drug|8|||
156738350|NCT02045862|565788949|FG000|Overall Study|Adverse Event|7|||
156738351|NCT02045862|565788950|FG001|Overall Study|Adverse Event|5|||
156738352|NCT02045862|565788951|FG002|Overall Study|Adverse Event|27|||
156738353|NCT02045862|565788949|FG000|Overall Study|Lost to Follow-up|1|||
156738354|NCT02045862|565788950|FG001|Overall Study|Lost to Follow-up|2|||
156738355|NCT02045862|565788951|FG002|Overall Study|Lost to Follow-up|6|||
156738356|NCT02691013|565788956|FG000|Overall Study|Withdrawal by Subject|3|||
156738357|NCT02691013|565788957|FG001|Overall Study|Withdrawal by Subject|0|||
156738358|NCT04507256|565788958|FG000|Overall Study|Withdrawal by Subject|1|||
156738359|NCT04507256|565788959|FG001|Overall Study|Withdrawal by Subject|0|||
156738360|NCT04507256|565788960|FG002|Overall Study|Withdrawal by Subject|0|||
156738361|NCT04507256|565788961|FG003|Overall Study|Withdrawal by Subject|1|||
156877292|NCT03869216|566309777|FG001|Overall Study|Changed clinical site or moved out of city|9|||
156877293|NCT03869216|566309776|FG000|Overall Study|No primary care appointment scheduled|10|||
156877294|NCT03869216|566309777|FG001|Overall Study|No primary care appointment scheduled|4|||
156877295|NCT03869216|566309776|FG000|Overall Study|Death|1|||
156738362|NCT04507256|565788962|FG004|Overall Study|Withdrawal by Subject|0|||
156738363|NCT04507256|565788963|FG005|Overall Study|Withdrawal by Subject|0|||
156797272|NCT00645658|566011261|FG001|Overall Study|Did not complete all assesments|2|||
156797273|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
156797274|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
156797275|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
156797276|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
156797277|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
156797278|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
156797279|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
156797280|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
156797281|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
156797282|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
156797283|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
156797284|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
156797285|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
156797286|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
156797287|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
156797288|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
156797289|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
156797290|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
156797291|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
156797292|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
156797293|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
156797294|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
156797295|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
156797296|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
156797297|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
156797298|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
156797299|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
156797300|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
156797301|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
156797302|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
156797303|NCT03093415|566011264|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
156797304|NCT03093415|566011265|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
156797305|NCT03093415|566011266|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
156797306|NCT01605097|566011272|FG000|Overall Study|Protocol Violation|1|||
156797307|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Adverse Event|3|||
156797308|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Adverse Event|0|||
156797309|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Adverse Event|0|||
156797310|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
156797311|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
156797312|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
156797313|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
156797314|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
156797315|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
156797316|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
156797317|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
156797318|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
156797319|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
156797320|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
156797321|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
156797322|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
156797323|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
156797324|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
156797325|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156797326|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156797327|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Adverse Event|14|||
156797328|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
156797329|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
156797330|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
156797331|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156797332|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
156797333|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
156797334|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
156877296|NCT03869216|566309777|FG001|Overall Study|Death|1|||
156738364|NCT02111785|565788964|FG000|Overall Study|Death|0|||
156738365|NCT02111785|565788965|FG001|Overall Study|Death|1|||
156738366|NCT02111785|565788966|FG002|Overall Study|Death|0|||
156738367|NCT02111785|565788967|FG003|Overall Study|Death|0|||
156738368|NCT02256982|565788970|FG000|Overall Study|Disease Progression|0|||
156738369|NCT02256982|565788971|FG001|Overall Study|Disease Progression|1|||
156738370|NCT01899742|565788972|FG000|Overall Study|Adverse Event|5|||
156738371|NCT01899742|565788973|FG001|Overall Study|Adverse Event|4|||
156877297|NCT03609944|566309778|FG000|Overall Study|Lost to Follow-up|1|||
156877298|NCT03609944|566309779|FG001|Overall Study|Lost to Follow-up|5|||
156457868|NCT03088878|564772498|FG001|Overall Study|Completed 2 years of Treatment|0|||
156457869|NCT03088878|564772499|FG002|Overall Study|Completed 2 years of Treatment|0|||
156738372|NCT01899742|565788972|FG000|Overall Study|Lack of Efficacy|1|||
156738373|NCT01899742|565788973|FG001|Overall Study|Lack of Efficacy|5|||
156738374|NCT01899742|565788972|FG000|Overall Study|Protocol Violation|2|||
156738375|NCT01899742|565788973|FG001|Overall Study|Protocol Violation|2|||
156738376|NCT01899742|565788972|FG000|Overall Study|Withdrawal by Subject|9|||
156738377|NCT01899742|565788973|FG001|Overall Study|Withdrawal by Subject|5|||
156738378|NCT02662764|565788974|FG000|Overall Study|Adverse Event|6|||
156738379|NCT02662764|565788974|FG000|Overall Study|Lack of Efficacy|8|||
156738380|NCT02662764|565788974|FG000|Overall Study|Protocol Violation|1|||
156457870|NCT03088878|564772500|FG003|Overall Study|Completed 2 years of Treatment|0|||
156457871|NCT03088878|564772501|FG004|Overall Study|Completed 2 years of Treatment|0|||
156457872|NCT03088878|564772502|FG005|Overall Study|Completed 2 years of Treatment|0|||
156457873|NCT03088878|564772503|FG006|Overall Study|Completed 2 years of Treatment|1|||
156738381|NCT02662764|565788974|FG000|Overall Study|Withdrawal by Subject|5|||
156738382|NCT02662764|565788974|FG000|Overall Study|Device failure|4|||
156738383|NCT02662764|565788974|FG000|Overall Study|Patient changed treatment|1|||
156738384|NCT02662764|565788974|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
156738385|NCT00759785|565788979|FG000|Overall Study|Participant sample not evaluable|11|||
156738386|NCT00759785|565788980|FG001|Overall Study|Participant sample not evaluable|2|||
156738387|NCT00759785|565788979|FG000|Overall Study|Participant sample lost|0|||
156738388|NCT00759785|565788980|FG001|Overall Study|Participant sample lost|1|||
156738389|NCT00759785|565788979|FG000|Overall Study|Protocol Violation|1|||
156738390|NCT00759785|565788980|FG001|Overall Study|Protocol Violation|0|||
156738391|NCT00759785|565788979|FG000|Overall Study|Physician Decision|0|||
156738392|NCT00759785|565788980|FG001|Overall Study|Physician Decision|1|||
156738393|NCT00759785|565788979|FG000|Overall Study|Withdrawal by Subject|0|||
156738394|NCT00759785|565788980|FG001|Overall Study|Withdrawal by Subject|1|||
156738395|NCT02677038|565788981|FG000|Overall Study|Physician Decision|1|||
156738396|NCT02677038|565788981|FG000|Overall Study|Withdrawal by Subject|1|||
156738397|NCT02777970|565788988|FG000|Overall Study|Lost to Follow-up|0|||
156738398|NCT02777970|565788989|FG001|Overall Study|Lost to Follow-up|1|||
156738399|NCT02777970|565788990|FG002|Overall Study|Lost to Follow-up|0|||
156877299|NCT03609944|566309778|FG000|Overall Study|Withdrawal by Subject|1|||
156457874|NCT03088878|564772504|FG007|Overall Study|Completed 2 years of Treatment|0|||
156457875|NCT03088878|564772505|FG008|Overall Study|Completed 2 years of Treatment|0|||
156457876|NCT03088878|564772506|FG009|Overall Study|Completed 2 years of Treatment|1|||
156457877|NCT03088878|564772507|FG010|Overall Study|Completed 2 years of Treatment|0|||
156457878|NCT03088878|564772508|FG011|Overall Study|Completed 2 years of Treatment|0|||
156457879|NCT03088878|564772509|FG012|Overall Study|Completed 2 years of Treatment|8|||
156457880|NCT03088878|564772510|FG013|Overall Study|Completed 2 years of Treatment|3|||
156457881|NCT03088878|564772497|FG000|Overall Study|Physician Decision|0|||
156457882|NCT03088878|564772498|FG001|Overall Study|Physician Decision|0|||
156457883|NCT03088878|564772499|FG002|Overall Study|Physician Decision|0|||
156457884|NCT03088878|564772500|FG003|Overall Study|Physician Decision|0|||
156457885|NCT03088878|564772501|FG004|Overall Study|Physician Decision|0|||
156457886|NCT03088878|564772502|FG005|Overall Study|Physician Decision|0|||
156457887|NCT03088878|564772503|FG006|Overall Study|Physician Decision|0|||
156457888|NCT03088878|564772504|FG007|Overall Study|Physician Decision|2|||
156457889|NCT03088878|564772505|FG008|Overall Study|Physician Decision|1|||
156534593|NCT01446016|565052396|FG000|Overall Study|Toxicity|3|||
156738400|NCT02777970|565788988|FG000|Overall Study|Protocol Violation|1|||
156738401|NCT02777970|565788989|FG001|Overall Study|Protocol Violation|0|||
156738402|NCT02777970|565788990|FG002|Overall Study|Protocol Violation|0|||
156877300|NCT03609944|566309779|FG001|Overall Study|Withdrawal by Subject|1|||
156877301|NCT06041646|566309782|FG000|Overall Study|Withdrawal by Subject|1|||
156877302|NCT05330975|566309783|FG000|Primary|Lost to Follow-up|12|||
156457890|NCT03088878|564772506|FG009|Overall Study|Physician Decision|0|||
156457891|NCT03088878|564772507|FG010|Overall Study|Physician Decision|0|||
156738403|NCT02347891|565788991|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
156738404|NCT02347891|565788992|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
156738405|NCT02347891|565788991|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
156738406|NCT02347891|565788992|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
156738407|NCT02541669|565788998|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
156738408|NCT02541669|565788999|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
156877303|NCT05330975|566309784|FG001|Primary|Lost to Follow-up|21|||
156457892|NCT03088878|564772508|FG011|Overall Study|Physician Decision|0|||
156457893|NCT03088878|564772509|FG012|Overall Study|Physician Decision|0|||
156457894|NCT03088878|564772510|FG013|Overall Study|Physician Decision|1|||
156457895|NCT03088878|564772497|FG000|Overall Study|COVID Related noncompliance|0|||
156457896|NCT03088878|564772498|FG001|Overall Study|COVID Related noncompliance|0|||
156457897|NCT03088878|564772499|FG002|Overall Study|COVID Related noncompliance|0|||
156457898|NCT03088878|564772500|FG003|Overall Study|COVID Related noncompliance|0|||
156457899|NCT03088878|564772501|FG004|Overall Study|COVID Related noncompliance|0|||
156457900|NCT03088878|564772502|FG005|Overall Study|COVID Related noncompliance|0|||
156457901|NCT03088878|564772503|FG006|Overall Study|COVID Related noncompliance|0|||
156457902|NCT03088878|564772504|FG007|Overall Study|COVID Related noncompliance|0|||
156457903|NCT03088878|564772505|FG008|Overall Study|COVID Related noncompliance|0|||
156457904|NCT03088878|564772506|FG009|Overall Study|COVID Related noncompliance|0|||
156457905|NCT03088878|564772507|FG010|Overall Study|COVID Related noncompliance|0|||
156457906|NCT03088878|564772508|FG011|Overall Study|COVID Related noncompliance|0|||
156457907|NCT03088878|564772509|FG012|Overall Study|COVID Related noncompliance|0|||
156457908|NCT03088878|564772510|FG013|Overall Study|COVID Related noncompliance|1|||
156457909|NCT03088878|564772497|FG000|Overall Study|Drug or Study Noncompliance|0|||
156457910|NCT03088878|564772498|FG001|Overall Study|Drug or Study Noncompliance|0|||
156457911|NCT03088878|564772499|FG002|Overall Study|Drug or Study Noncompliance|0|||
156457912|NCT03088878|564772500|FG003|Overall Study|Drug or Study Noncompliance|0|||
156457913|NCT03088878|564772501|FG004|Overall Study|Drug or Study Noncompliance|0|||
156457914|NCT03088878|564772502|FG005|Overall Study|Drug or Study Noncompliance|0|||
156457915|NCT03088878|564772503|FG006|Overall Study|Drug or Study Noncompliance|0|||
156457916|NCT03088878|564772504|FG007|Overall Study|Drug or Study Noncompliance|0|||
156457917|NCT03088878|564772505|FG008|Overall Study|Drug or Study Noncompliance|0|||
156457918|NCT03088878|564772506|FG009|Overall Study|Drug or Study Noncompliance|0|||
156457919|NCT03088878|564772507|FG010|Overall Study|Drug or Study Noncompliance|0|||
156457920|NCT03088878|564772508|FG011|Overall Study|Drug or Study Noncompliance|0|||
156457921|NCT03088878|564772509|FG012|Overall Study|Drug or Study Noncompliance|1|||
156457922|NCT03088878|564772510|FG013|Overall Study|Drug or Study Noncompliance|0|||
156457923|NCT04690582|564772511|FG000|Overall Study|Withdrawal by Subject|6|||
156457924|NCT04690582|564772512|FG001|Overall Study|Withdrawal by Subject|4|||
156457925|NCT04032847|564772518|FG000|Overall Study|Study termination by sponsor|8|||
156457926|NCT04032847|564772519|FG001|Overall Study|Study termination by sponsor|0|||
156457927|NCT04032847|564772520|FG002|Overall Study|Study termination by sponsor|4|||
156457928|NCT04032847|564772518|FG000|Overall Study|Death|12|||
156738409|NCT02541669|565789000|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
156738410|NCT02541669|565789001|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
156738411|NCT02541669|565789002|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
156738412|NCT00834639|565789003|FG000|Second Intervention|Physician Decision|0|||
156738413|NCT00834639|565789004|FG001|Second Intervention|Physician Decision|2|||
156738414|NCT04739722|565789005|FG000|Overall Study|Lost to Follow-up|5301|||
156738415|NCT04739722|565789005|FG000|Overall Study|Withdrawal by Subject|42|||
156738416|NCT04739722|565789005|FG000|Overall Study|Non Average-risk|1157|||
156738417|NCT05178641|565789009|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
156738418|NCT05178641|565789010|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
156738419|NCT05178641|565789009|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
156738420|NCT05178641|565789010|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
156738421|NCT01869699|565789011|FG000|Overall Study|Withdrawal by Subject|1|||
156738422|NCT01869699|565789012|FG001|Overall Study|Withdrawal by Subject|0|||
156738423|NCT01083186|565789014|FG000|Overall Study|Lost to Follow-up|48|||
156738424|NCT01083186|565789014|FG000|Overall Study|Consent Withdrawal|7|||
156738425|NCT01083186|565789014|FG000|Overall Study|Death|3|||
156738426|NCT01083186|565789014|FG000|Overall Study|Adverse Event|3|||
156738427|NCT01083186|565789014|FG000|Overall Study|Lack of Efficacy|2|||
156738428|NCT01083186|565789014|FG000|Overall Study|Hemodialysis Initiation|28|||
156797335|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
156797336|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
156797337|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
156797338|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
156797339|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
156738429|NCT01083186|565789014|FG000|Overall Study|Administrative Reasons|2|||
156797340|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
156797341|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
156797342|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
156457929|NCT04032847|564772519|FG001|Overall Study|Death|0|||
156457930|NCT04032847|564772520|FG002|Overall Study|Death|0|||
156457931|NCT04032847|564772518|FG000|Overall Study|Progressive disease|2|||
156457932|NCT04032847|564772519|FG001|Overall Study|Progressive disease|0|||
156534594|NCT00404066|565052403|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
156534595|NCT00404066|565052403|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
156457933|NCT04032847|564772520|FG002|Overall Study|Progressive disease|1|||
156738430|NCT01083186|565789014|FG000|Overall Study|Non-compliance to Study Treatment|1|||
156738431|NCT01867294|565789024|FG000|Overall Study|Withdrawal by Subject|1|||
156738432|NCT01867294|565789025|FG001|Overall Study|Withdrawal by Subject|1|||
156738433|NCT01867294|565789026|FG002|Overall Study|Withdrawal by Subject|0|||
156738434|NCT01867294|565789027|FG003|Overall Study|Withdrawal by Subject|0|||
156738435|NCT00278148|565789028|FG000|Phase II - Expansion Phase|Disease progression|0|||
156738436|NCT00278148|565789029|FG001|Phase II - Expansion Phase|Disease progression|0|||
156738437|NCT00278148|565789030|FG002|Phase II - Expansion Phase|Disease progression|4|||
156738438|NCT00278148|565789028|FG000|Phase II - Expansion Phase|Adverse Event|0|||
156738439|NCT00278148|565789029|FG001|Phase II - Expansion Phase|Adverse Event|0|||
156738440|NCT00278148|565789030|FG002|Phase II - Expansion Phase|Adverse Event|2|||
156457934|NCT03056573|564772521|FG000|Overall Study|Death|2|||
156457935|NCT03056573|564772522|FG001|Overall Study|Death|4|||
156457936|NCT03056573|564772521|FG000|Overall Study|Withdrawal by Subject|2|||
156457937|NCT03056573|564772522|FG001|Overall Study|Withdrawal by Subject|0|||
156457938|NCT03056573|564772521|FG000|Overall Study|Lost to Follow-up|1|||
156457939|NCT03056573|564772522|FG001|Overall Study|Lost to Follow-up|1|||
156457940|NCT05104463|564772523|FG000|Overall Study|Adverse Event|1|||
156457941|NCT05104463|564772524|FG001|Overall Study|Adverse Event|1|||
156457942|NCT05104463|564772523|FG000|Overall Study|Lost to Follow-up|1|||
156457943|NCT05104463|564772524|FG001|Overall Study|Lost to Follow-up|1|||
156738441|NCT03419598|565789031|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
156738442|NCT00380081|565789034|FG000|Overall Study|Withdrawal by Subject|0|||
156738443|NCT00380081|565789035|FG001|Overall Study|Withdrawal by Subject|0|||
156738444|NCT00380081|565789036|FG002|Overall Study|Withdrawal by Subject|0|||
156738445|NCT00380081|565789037|FG003|Overall Study|Withdrawal by Subject|0|||
156738446|NCT00380081|565789038|FG004|Overall Study|Withdrawal by Subject|1|||
156738447|NCT00380081|565789039|FG005|Overall Study|Withdrawal by Subject|0|||
156738448|NCT00380081|565789034|FG000|Overall Study|Family Emergency|0|||
156738449|NCT00380081|565789035|FG001|Overall Study|Family Emergency|0|||
156457944|NCT05104463|564772523|FG000|Overall Study|Physician Decision|1|||
156457945|NCT05104463|564772524|FG001|Overall Study|Physician Decision|0|||
156457946|NCT05104463|564772523|FG000|Overall Study|Protocol Violation|0|||
156457947|NCT05104463|564772524|FG001|Overall Study|Protocol Violation|2|||
156457948|NCT05104463|564772523|FG000|Overall Study|Withdrawal by Subject|1|||
156738450|NCT00380081|565789036|FG002|Overall Study|Family Emergency|0|||
156738451|NCT00380081|565789037|FG003|Overall Study|Family Emergency|0|||
156457949|NCT05104463|564772524|FG001|Overall Study|Withdrawal by Subject|1|||
156457950|NCT05267470|564772525|FG000|Overall Study|Decision by sponsor|0|||
156457951|NCT05267470|564772526|FG001|Overall Study|Decision by sponsor|3|||
156457952|NCT05267470|564772527|FG002|Overall Study|Decision by sponsor|19|||
156457953|NCT05267470|564772528|FG003|Overall Study|Decision by sponsor|7|||
156457954|NCT05267470|564772529|FG004|Overall Study|Decision by sponsor|3|||
156457955|NCT05267470|564772525|FG000|Overall Study|Withdrawal by Subject|1|||
156457956|NCT05267470|564772526|FG001|Overall Study|Withdrawal by Subject|1|||
156457957|NCT05267470|564772527|FG002|Overall Study|Withdrawal by Subject|2|||
156457958|NCT05267470|564772528|FG003|Overall Study|Withdrawal by Subject|2|||
156457959|NCT05267470|564772529|FG004|Overall Study|Withdrawal by Subject|0|||
156457960|NCT05267470|564772525|FG000|Overall Study|Death|3|||
156457961|NCT05267470|564772526|FG001|Overall Study|Death|5|||
156457962|NCT05267470|564772527|FG002|Overall Study|Death|8|||
156457963|NCT05267470|564772528|FG003|Overall Study|Death|18|||
156738452|NCT00380081|565789038|FG004|Overall Study|Family Emergency|0|||
156738453|NCT00380081|565789039|FG005|Overall Study|Family Emergency|1|||
156738454|NCT00459706|565789040|FG000|Overall Study|Adverse Event|19|||
156738455|NCT00459706|565789041|FG001|Overall Study|Adverse Event|13|||
156738456|NCT00459706|565789040|FG000|Overall Study|Withdrawal by Subject|1|||
156738457|NCT00459706|565789041|FG001|Overall Study|Withdrawal by Subject|6|||
156738458|NCT00459706|565789040|FG000|Overall Study|Physician Decision|2|||
156738459|NCT00459706|565789041|FG001|Overall Study|Physician Decision|0|||
156738460|NCT00459706|565789040|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
156457964|NCT05267470|564772529|FG004|Overall Study|Death|1|||
156457965|NCT05267470|564772525|FG000|Overall Study|Lost to Follow-up|0|||
156457966|NCT05267470|564772526|FG001|Overall Study|Lost to Follow-up|0|||
156457967|NCT05267470|564772527|FG002|Overall Study|Lost to Follow-up|0|||
156457968|NCT05267470|564772528|FG003|Overall Study|Lost to Follow-up|1|||
156738461|NCT00459706|565789041|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
156738462|NCT00459706|565789040|FG000|Overall Study|Protocol Violation|2|||
156738463|NCT00459706|565789041|FG001|Overall Study|Protocol Violation|1|||
156738464|NCT00459706|565789040|FG000|Overall Study|Failed to Return|1|||
156738465|NCT00459706|565789041|FG001|Overall Study|Failed to Return|0|||
156457969|NCT05267470|564772529|FG004|Overall Study|Lost to Follow-up|0|||
156457970|NCT04428203|564772530|FG000|Overall Study|Adverse Event|1|||
156457971|NCT04428203|564772531|FG001|Overall Study|Adverse Event|0|||
156457972|NCT04428203|564772532|FG002|Overall Study|Adverse Event|0|||
156457973|NCT04428203|564772530|FG000|Overall Study|Withdrawal by Subject|1|||
156457974|NCT04428203|564772531|FG001|Overall Study|Withdrawal by Subject|0|||
156457975|NCT04428203|564772532|FG002|Overall Study|Withdrawal by Subject|1|||
156738466|NCT00459706|565789040|FG000|Overall Study|Other|0|||
156738467|NCT00459706|565789041|FG001|Overall Study|Other|1|||
156738468|NCT00189306|565789042|FG000|Treatment Period|Withdrawal by Subject|2|||
156738469|NCT00189306|565789042|FG000|Treatment Period|Adverse Event|2|||
156738470|NCT00189306|565789042|FG000|Treatment Period|Protocol Violation|1|||
156738471|NCT00189306|565789042|FG000|Posttreatment Period|Death|1|||
156738472|NCT00189306|565789042|FG000|Posttreatment Period|Withdrawal by Subject|2|||
156738473|NCT00189306|565789042|FG000|Posttreatment Period|Noncompliance|1|||
156738474|NCT00189306|565789042|FG000|Posttreatment Period|Target lesion excised|1|||
156738475|NCT00189306|565789042|FG000|Posttreatment Period|Protocol Violation|1|||
156738476|NCT00189306|565789042|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
156457976|NCT02823145|564772533|FG000|Enrollment|Other|1|||
156457977|NCT02823145|564772534|FG001|Enrollment|Other|0|||
156457978|NCT02823145|564772533|FG000|Treatment|Adverse Event|0|||
156457979|NCT02823145|564772534|FG001|Treatment|Adverse Event|11|||
156738477|NCT00189306|565789042|FG000|Posttreatment Period|Local skin reaction/sign|1|||
156738478|NCT00189306|565789042|FG000|Long-Term Follow-up|Adverse Event|2|||
156457980|NCT02823145|564772533|FG000|Treatment|Death|0|||
156457981|NCT02823145|564772534|FG001|Treatment|Death|3|||
156457982|NCT02823145|564772533|FG000|Treatment|Family Decision|0|||
156457983|NCT02823145|564772534|FG001|Treatment|Family Decision|1|||
156797343|NCT00209131|566011287|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
156797344|NCT00209131|566011288|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
156797345|NCT05360784|566011289|FG000|Overall Study|Discontinued|25|||
156797346|NCT05360784|566011290|FG001|Overall Study|Discontinued|11|||
156797347|NCT00437073|566011291|FG000|Overall Study|Sponsor Terminated Study|1|||
156797348|NCT00437073|566011292|FG001|Overall Study|Sponsor Terminated Study|0|||
156797349|NCT00437073|566011291|FG000|Overall Study|Physician Decision|0|||
156797350|NCT00437073|566011292|FG001|Overall Study|Physician Decision|1|||
156797351|NCT04918771|566011293|FG000|Overall Study|Withdrawal by Subject|4|||
156797352|NCT04918771|566011294|FG001|Overall Study|Withdrawal by Subject|5|||
156797353|NCT04918771|566011293|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
156797354|NCT04918771|566011294|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
156797355|NCT00539500|566011295|FG000|Overall Study|Disease Progression|1|||
156797356|NCT00539500|566011295|FG000|Overall Study|Lost to Follow-up|2|||
156797357|NCT02657343|566011298|FG000|Overall Study|Death|0|||
156797358|NCT02657343|566011299|FG001|Overall Study|Death|2|||
156797359|NCT02657343|566011300|FG002|Overall Study|Death|0|||
156797360|NCT02657343|566011301|FG003|Overall Study|Death|0|||
156797361|NCT02657343|566011302|FG004|Overall Study|Death|0|||
156797362|NCT02657343|566011303|FG005|Overall Study|Death|0|||
156797363|NCT02657343|566011298|FG000|Overall Study|Patient went to hospice|1|||
156797364|NCT02657343|566011299|FG001|Overall Study|Patient went to hospice|0|||
156797365|NCT02657343|566011300|FG002|Overall Study|Patient went to hospice|0|||
156797366|NCT02657343|566011301|FG003|Overall Study|Patient went to hospice|0|||
156797367|NCT02657343|566011302|FG004|Overall Study|Patient went to hospice|0|||
156797368|NCT02657343|566011303|FG005|Overall Study|Patient went to hospice|0|||
156797369|NCT02657343|566011298|FG000|Overall Study|Withdrawal by Subject|0|||
156797370|NCT02657343|566011299|FG001|Overall Study|Withdrawal by Subject|0|||
156797371|NCT02657343|566011300|FG002|Overall Study|Withdrawal by Subject|0|||
156797372|NCT02657343|566011301|FG003|Overall Study|Withdrawal by Subject|0|||
156797373|NCT02657343|566011302|FG004|Overall Study|Withdrawal by Subject|1|||
156797374|NCT02657343|566011303|FG005|Overall Study|Withdrawal by Subject|0|||
156797375|NCT01506726|566011306|FG000|Overall Study|Adverse Event|1|||
156797376|NCT01506726|566011307|FG001|Overall Study|Adverse Event|2|||
156797377|NCT00210132|566011308|FG000|Overall Study|Protocol Violation|1|||
156797378|NCT00210132|566011309|FG001|Overall Study|Protocol Violation|4|||
156797379|NCT03633058|566011310|FG000|Overall Study|Adverse Event|0|||
156797380|NCT03633058|566011311|FG001|Overall Study|Adverse Event|0|||
156797381|NCT03633058|566011312|FG002|Overall Study|Adverse Event|1|||
156797382|NCT03633058|566011313|FG003|Overall Study|Adverse Event|0|||
156797383|NCT00432965|566011314|FG000|Overall Study|Lost to Follow-up|22|||
156797384|NCT00432965|566011315|FG001|Overall Study|Lost to Follow-up|19|||
156797385|NCT00432965|566011314|FG000|Overall Study|Withdrawal by Subject|13|||
156797386|NCT00432965|566011315|FG001|Overall Study|Withdrawal by Subject|13|||
156797387|NCT00432965|566011314|FG000|Overall Study|Physician Decision|14|||
156797388|NCT00432965|566011315|FG001|Overall Study|Physician Decision|13|||
156797389|NCT00432965|566011314|FG000|Overall Study|Lack of Efficacy|8|||
156457984|NCT02823145|564772533|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
156738479|NCT00189306|565789042|FG000|Long-Term Follow-up|Death|4|||
156797390|NCT00432965|566011315|FG001|Overall Study|Lack of Efficacy|13|||
156797391|NCT00432965|566011314|FG000|Overall Study|Non-compliance|7|||
156797392|NCT00432965|566011315|FG001|Overall Study|Non-compliance|0|||
156797393|NCT00432965|566011314|FG000|Overall Study|Adverse Event|22|||
156797394|NCT00432965|566011315|FG001|Overall Study|Adverse Event|19|||
156797395|NCT00432965|566011314|FG000|Overall Study|Death|3|||
156797396|NCT00432965|566011315|FG001|Overall Study|Death|4|||
156457985|NCT02823145|564772534|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
156457986|NCT02823145|564772533|FG000|Treatment|Lack of Efficacy|0|||
156457987|NCT02823145|564772534|FG001|Treatment|Lack of Efficacy|48|||
156457988|NCT02823145|564772533|FG000|Treatment|Non-Compliance With E-Diary|0|||
156457989|NCT02823145|564772534|FG001|Treatment|Non-Compliance With E-Diary|1|||
156457990|NCT02823145|564772533|FG000|Treatment|Physician Decision|0|||
156457991|NCT02823145|564772534|FG001|Treatment|Physician Decision|2|||
156457992|NCT02823145|564772533|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
156457993|NCT02823145|564772534|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
156457994|NCT02823145|564772533|FG000|Treatment|Subject needed to take prohibited medication|0|||
156457995|NCT02823145|564772534|FG001|Treatment|Subject needed to take prohibited medication|1|||
156457996|NCT02823145|564772533|FG000|Treatment|Subject transferred to direct access programme|0|||
156457997|NCT02823145|564772534|FG001|Treatment|Subject transferred to direct access programme|1|||
156457998|NCT02823145|564772533|FG000|Treatment|Switching to commercially available drug|0|||
156457999|NCT02823145|564772534|FG001|Treatment|Switching to commercially available drug|11|||
156458000|NCT02823145|564772533|FG000|Treatment|Transitioned to commercial supply of medication|0|||
156458001|NCT02823145|564772534|FG001|Treatment|Transitioned to commercial supply of medication|1|||
156458002|NCT02823145|564772533|FG000|Treatment|Withdrawal By Caregiver|0|||
156458003|NCT02823145|564772534|FG001|Treatment|Withdrawal By Caregiver|1|||
156458004|NCT02823145|564772533|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
156458005|NCT02823145|564772534|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
156458006|NCT02823145|564772533|FG000|Treatment|Withdrawal by Subject|0|||
156458007|NCT02823145|564772534|FG001|Treatment|Withdrawal by Subject|16|||
156458008|NCT02823145|564772533|FG000|Treatment|Reason unknown|0|||
156458009|NCT02823145|564772534|FG001|Treatment|Reason unknown|1|||
156458010|NCT03257410|564774598|FG000|Overall Study|Adverse Event|2|||
156458011|NCT03257410|564774599|FG001|Overall Study|Adverse Event|3|||
156458012|NCT03257410|564774598|FG000|Overall Study|Protocol Violation|1|||
156458013|NCT03257410|564774599|FG001|Overall Study|Protocol Violation|2|||
156458014|NCT03257410|564774598|FG000|Overall Study|Lost to Follow-up|1|||
156458015|NCT03257410|564774599|FG001|Overall Study|Lost to Follow-up|0|||
156458016|NCT03257410|564774598|FG000|Overall Study|Withdrawal by Subject|1|||
156458017|NCT03257410|564774599|FG001|Overall Study|Withdrawal by Subject|2|||
156458018|NCT03257410|564774598|FG000|Overall Study|Physician Decision|1|||
156458019|NCT03257410|564774599|FG001|Overall Study|Physician Decision|1|||
156458020|NCT03257410|564774598|FG000|Overall Study|Renal transplantation|2|||
156458021|NCT03257410|564774599|FG001|Overall Study|Renal transplantation|0|||
156458022|NCT03257410|564774598|FG000|Overall Study|Switch to peritoneal dialysis|1|||
156458023|NCT03257410|564774599|FG001|Overall Study|Switch to peritoneal dialysis|0|||
156458024|NCT03257410|564774598|FG000|Overall Study|Death|3|||
156458025|NCT03257410|564774599|FG001|Overall Study|Death|2|||
156458026|NCT03257410|564774598|FG000|Overall Study|Change to another dialysis center|2|||
156458027|NCT03257410|564774599|FG001|Overall Study|Change to another dialysis center|2|||
156458028|NCT03257410|564774598|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
156458029|NCT03257410|564774599|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
156458030|NCT03257410|564774598|FG000|Overall Study|Miscellaneous|2|||
156458031|NCT03257410|564774599|FG001|Overall Study|Miscellaneous|2|||
156458032|NCT03257410|564774598|FG000|Overall Study|Other|0|||
156458033|NCT03257410|564774599|FG001|Overall Study|Other|1|||
156458034|NCT02598388|564774600|FG000|Overall Study|Lost to Follow-up|1|||
156458035|NCT02598388|564774601|FG001|Overall Study|Lost to Follow-up|0|||
156458036|NCT02598388|564774602|FG002|Overall Study|Lost to Follow-up|1|||
156458037|NCT02598388|564774603|FG003|Overall Study|Lost to Follow-up|0|||
156458038|NCT02598388|564774604|FG004|Overall Study|Lost to Follow-up|5|||
156458039|NCT02598388|564774605|FG005|Overall Study|Lost to Follow-up|1|||
156458040|NCT02598388|564774606|FG006|Overall Study|Lost to Follow-up|2|||
156458041|NCT02598388|564774607|FG007|Overall Study|Lost to Follow-up|1|||
156458042|NCT02598388|564774608|FG008|Overall Study|Lost to Follow-up|0|||
156458043|NCT02598388|564774609|FG009|Overall Study|Lost to Follow-up|0|||
156458044|NCT02598388|564774610|FG010|Overall Study|Lost to Follow-up|1|||
156458045|NCT02598388|564774611|FG011|Overall Study|Lost to Follow-up|0|||
156458046|NCT02598388|564774600|FG000|Overall Study|Withdrawal by Subject|0|||
156458047|NCT02598388|564774601|FG001|Overall Study|Withdrawal by Subject|0|||
156534596|NCT01399190|565052406|FG000|Overall Study|Not Eligible for Final Analysis|5|||
156797397|NCT00432965|566011314|FG000|Overall Study|Exclusionary Methods|1|||
156797398|NCT00432965|566011315|FG001|Overall Study|Exclusionary Methods|2|||
156797399|NCT00432965|566011314|FG000|Overall Study|Incomplete Data|4|||
156797400|NCT00432965|566011315|FG001|Overall Study|Incomplete Data|3|||
156797401|NCT01889251|566011316|FG000|Overall Study|Adverse Event|1|||
156797402|NCT01889251|566011317|FG001|Overall Study|Adverse Event|0|||
156797403|NCT00071032|566011318|FG000|Overall Study|Lost to Follow-up|1|||
156458048|NCT02598388|564774602|FG002|Overall Study|Withdrawal by Subject|0|||
156458049|NCT02598388|564774603|FG003|Overall Study|Withdrawal by Subject|0|||
156458050|NCT02598388|564774604|FG004|Overall Study|Withdrawal by Subject|2|||
156458051|NCT02598388|564774605|FG005|Overall Study|Withdrawal by Subject|0|||
156458052|NCT02598388|564774606|FG006|Overall Study|Withdrawal by Subject|2|||
156458053|NCT02598388|564774607|FG007|Overall Study|Withdrawal by Subject|0|||
156458054|NCT02598388|564774608|FG008|Overall Study|Withdrawal by Subject|0|||
156458055|NCT02598388|564774609|FG009|Overall Study|Withdrawal by Subject|1|||
156458056|NCT02598388|564774610|FG010|Overall Study|Withdrawal by Subject|0|||
156458057|NCT02598388|564774611|FG011|Overall Study|Withdrawal by Subject|0|||
156458058|NCT02598388|564774600|FG000|Overall Study|Other|0|||
156458059|NCT02598388|564774601|FG001|Overall Study|Other|0|||
156458060|NCT02598388|564774602|FG002|Overall Study|Other|1|||
156458061|NCT02598388|564774603|FG003|Overall Study|Other|0|||
156458062|NCT02598388|564774604|FG004|Overall Study|Other|3|||
156458063|NCT02598388|564774605|FG005|Overall Study|Other|0|||
156458064|NCT02598388|564774606|FG006|Overall Study|Other|1|||
156458065|NCT02598388|564774607|FG007|Overall Study|Other|0|||
156458066|NCT02598388|564774608|FG008|Overall Study|Other|0|||
156458067|NCT02598388|564774609|FG009|Overall Study|Other|0|||
156458068|NCT02598388|564774610|FG010|Overall Study|Other|0|||
156738480|NCT00189306|565789042|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
156738481|NCT00189306|565789042|FG000|Long-Term Follow-up|Intercurrent disease|2|||
156738482|NCT00189306|565789042|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
156738483|NCT00189306|565789042|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
156738484|NCT02017912|565789043|FG000|Overall Study|Withdrawal by Subject|2|||
156738485|NCT02017912|565789044|FG001|Overall Study|Withdrawal by Subject|1|||
156738486|NCT02017912|565789043|FG000|Overall Study|miscellaneous|1|||
156738487|NCT02017912|565789044|FG001|Overall Study|miscellaneous|1|||
156738488|NCT01322035|565789045|FG000|Overall Study|Lost to Follow-up|8|||
156738489|NCT01322035|565789046|FG001|Overall Study|Lost to Follow-up|3|||
156738490|NCT00535847|565789047|FG000|Overall Study|Adverse Event|5|||
156738491|NCT00535847|565789048|FG001|Overall Study|Adverse Event|3|||
156738492|NCT00535847|565789049|FG002|Overall Study|Adverse Event|2|||
156738493|NCT00535847|565789047|FG000|Overall Study|Non compliance|1|||
156738494|NCT00535847|565789048|FG001|Overall Study|Non compliance|1|||
156738495|NCT00535847|565789049|FG002|Overall Study|Non compliance|0|||
156738496|NCT00535847|565789047|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
156738497|NCT00535847|565789048|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
156738498|NCT00535847|565789049|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
156738499|NCT04569968|565789050|FG000|Overall Study|Lost to Follow-up|2|||
156738500|NCT04569968|565789051|FG001|Overall Study|Lost to Follow-up|5|||
156738501|NCT04569968|565789050|FG000|Overall Study|Story of head and/or neck surgery|2|||
156738502|NCT04569968|565789051|FG001|Overall Study|Story of head and/or neck surgery|2|||
156738503|NCT04569968|565789050|FG000|Overall Study|Time of stroke onset|8|||
156738504|NCT04569968|565789051|FG001|Overall Study|Time of stroke onset|7|||
156738505|NCT04569968|565789050|FG000|Overall Study|Type of strokr|12|||
156458069|NCT02598388|564774611|FG011|Overall Study|Other|0|||
156458070|NCT04171141|564774614|FG000|Overall Study|Adverse Event|0|||
156458071|NCT04171141|564774615|FG001|Overall Study|Adverse Event|0|||
156458072|NCT04171141|564774616|FG002|Overall Study|Adverse Event|2|||
156458073|NCT04171141|564774617|FG003|Overall Study|Adverse Event|0|||
156458074|NCT04171141|564774618|FG004|Overall Study|Adverse Event|0|||
156458075|NCT04171141|564774619|FG005|Overall Study|Adverse Event|0|||
156458076|NCT04171141|564774620|FG006|Overall Study|Adverse Event|0|||
156458077|NCT04171141|564774621|FG007|Overall Study|Adverse Event|0|||
156458078|NCT04171141|564774622|FG008|Overall Study|Adverse Event|0|||
156458079|NCT04171141|564774623|FG009|Overall Study|Adverse Event|0|||
156458080|NCT04171141|564774624|FG010|Overall Study|Adverse Event|0|||
156458081|NCT04171141|564774625|FG011|Overall Study|Adverse Event|0|||
156458082|NCT04171141|564774626|FG012|Overall Study|Adverse Event|0|||
156458083|NCT04171141|564774627|FG013|Overall Study|Adverse Event|2|||
156458084|NCT04171141|564774628|FG014|Overall Study|Adverse Event|0|||
156458085|NCT04171141|564774629|FG015|Overall Study|Adverse Event|0|||
156458086|NCT04171141|564774614|FG000|Overall Study|Physician Decision|0|||
156458087|NCT04171141|564774615|FG001|Overall Study|Physician Decision|0|||
156458088|NCT04171141|564774616|FG002|Overall Study|Physician Decision|0|||
156458089|NCT04171141|564774617|FG003|Overall Study|Physician Decision|0|||
156458090|NCT04171141|564774618|FG004|Overall Study|Physician Decision|1|||
156458091|NCT04171141|564774619|FG005|Overall Study|Physician Decision|0|||
156458092|NCT04171141|564774620|FG006|Overall Study|Physician Decision|0|||
156458093|NCT04171141|564774621|FG007|Overall Study|Physician Decision|0|||
156458094|NCT04171141|564774622|FG008|Overall Study|Physician Decision|0|||
156458095|NCT04171141|564774623|FG009|Overall Study|Physician Decision|0|||
156458096|NCT04171141|564774624|FG010|Overall Study|Physician Decision|0|||
156458097|NCT04171141|564774625|FG011|Overall Study|Physician Decision|0|||
156458098|NCT04171141|564774626|FG012|Overall Study|Physician Decision|0|||
156738506|NCT04569968|565789051|FG001|Overall Study|Type of strokr|8|||
156738507|NCT04569968|565789050|FG000|Overall Study|Cooperation|8|||
156738508|NCT04569968|565789051|FG001|Overall Study|Cooperation|8|||
156738509|NCT04569968|565789050|FG000|Overall Study|Age interval|17|||
156738510|NCT04569968|565789051|FG001|Overall Study|Age interval|6|||
156458099|NCT04171141|564774627|FG013|Overall Study|Physician Decision|0|||
156458100|NCT04171141|564774628|FG014|Overall Study|Physician Decision|0|||
156458101|NCT04171141|564774629|FG015|Overall Study|Physician Decision|1|||
156458102|NCT04171141|564774614|FG000|Overall Study|Progressive disease|2|||
156458103|NCT04171141|564774615|FG001|Overall Study|Progressive disease|3|||
156458104|NCT04171141|564774616|FG002|Overall Study|Progressive disease|4|||
156458105|NCT04171141|564774617|FG003|Overall Study|Progressive disease|7|||
156458106|NCT04171141|564774618|FG004|Overall Study|Progressive disease|1|||
156458107|NCT04171141|564774619|FG005|Overall Study|Progressive disease|8|||
156458108|NCT04171141|564774620|FG006|Overall Study|Progressive disease|4|||
156458109|NCT04171141|564774621|FG007|Overall Study|Progressive disease|6|||
156458110|NCT04171141|564774622|FG008|Overall Study|Progressive disease|7|||
156458111|NCT04171141|564774623|FG009|Overall Study|Progressive disease|3|||
156458112|NCT04171141|564774624|FG010|Overall Study|Progressive disease|4|||
156458113|NCT04171141|564774625|FG011|Overall Study|Progressive disease|3|||
156458114|NCT04171141|564774626|FG012|Overall Study|Progressive disease|4|||
156458115|NCT04171141|564774627|FG013|Overall Study|Progressive disease|2|||
156738511|NCT04569968|565789050|FG000|Overall Study|Denial of participation to the study|0|||
156738512|NCT04569968|565789051|FG001|Overall Study|Denial of participation to the study|3|||
156738513|NCT04569968|565789050|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
156738514|NCT04569968|565789051|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
156738515|NCT04569968|565789050|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
156738516|NCT04569968|565789051|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
156738517|NCT04569968|565789050|FG000|Overall Study|Quarantine|1|||
156738518|NCT04569968|565789051|FG001|Overall Study|Quarantine|0|||
156738519|NCT04569968|565789050|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
156738520|NCT04569968|565789051|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
156738521|NCT04569968|565789050|FG000|Overall Study|Repetitive stroke|8|||
156738522|NCT04569968|565789051|FG001|Overall Study|Repetitive stroke|0|||
156738523|NCT04569968|565789050|FG000|Overall Study|Insufficient mastication|1|||
156738524|NCT04569968|565789051|FG001|Overall Study|Insufficient mastication|0|||
156738525|NCT04569968|565789050|FG000|Overall Study|Infection|1|||
156738526|NCT04569968|565789051|FG001|Overall Study|Infection|0|||
156738527|NCT00520481|565789063|FG000|Overall Study|Adverse Event|4|||
156738528|NCT00520481|565789064|FG001|Overall Study|Adverse Event|1|||
156738529|NCT00520481|565789063|FG000|Overall Study|Withdrawal by Subject|3|||
156738530|NCT00520481|565789064|FG001|Overall Study|Withdrawal by Subject|0|||
156738531|NCT00471718|565789067|FG000|Overall Study|Adverse Event|3|||
156738532|NCT00471718|565789067|FG000|Overall Study|other complicating disease|1|||
156738533|NCT00471718|565789067|FG000|Overall Study|disease progression|22|||
156738534|NCT00471718|565789067|FG000|Overall Study|Withdrawal by Subject|1|||
156738535|NCT01817582|565789073|FG000|Overall Study|Withdrawal by Subject|0|||
156738536|NCT01817582|565789074|FG001|Overall Study|Withdrawal by Subject|1|||
156738537|NCT01817582|565789075|FG002|Overall Study|Withdrawal by Subject|0|||
156738538|NCT01817582|565789073|FG000|Overall Study|Participant revealed masked treatment|1|||
156738539|NCT01817582|565789074|FG001|Overall Study|Participant revealed masked treatment|0|||
156738540|NCT01817582|565789075|FG002|Overall Study|Participant revealed masked treatment|0|||
156738541|NCT01817582|565789073|FG000|Overall Study|Randomized but exclusion criteria met|1|||
156738542|NCT01817582|565789074|FG001|Overall Study|Randomized but exclusion criteria met|0|||
156738543|NCT01817582|565789075|FG002|Overall Study|Randomized but exclusion criteria met|0|||
156738544|NCT03053063|565789081|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
156738545|NCT03053063|565789082|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
156738546|NCT03053063|565789083|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
156738547|NCT03053063|565789084|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
156738548|NCT03053063|565789081|FG000|Randomized Phase|Withdrew consent|8|||
156738549|NCT03053063|565789082|FG001|Randomized Phase|Withdrew consent|11|||
156738550|NCT03053063|565789083|FG002|Randomized Phase|Withdrew consent|5|||
156738551|NCT03053063|565789084|FG003|Randomized Phase|Withdrew consent|0|||
156738552|NCT03053063|565789081|FG000|Randomized Phase|Investigator's Discretion|8|||
156738553|NCT03053063|565789082|FG001|Randomized Phase|Investigator's Discretion|6|||
156738554|NCT03053063|565789083|FG002|Randomized Phase|Investigator's Discretion|2|||
156738555|NCT03053063|565789084|FG003|Randomized Phase|Investigator's Discretion|0|||
156738556|NCT03053063|565789081|FG000|Randomized Phase|Lost to Follow-up|3|||
156738557|NCT03053063|565789082|FG001|Randomized Phase|Lost to Follow-up|5|||
156738558|NCT03053063|565789083|FG002|Randomized Phase|Lost to Follow-up|1|||
156797404|NCT00071032|566011319|FG001|Overall Study|Lost to Follow-up|1|||
156458116|NCT04171141|564774628|FG014|Overall Study|Progressive disease|4|||
156458117|NCT04171141|564774629|FG015|Overall Study|Progressive disease|1|||
156458118|NCT04171141|564774614|FG000|Overall Study|Withdrawal by Subject|0|||
156458119|NCT04171141|564774615|FG001|Overall Study|Withdrawal by Subject|0|||
156458120|NCT04171141|564774616|FG002|Overall Study|Withdrawal by Subject|0|||
156458121|NCT04171141|564774617|FG003|Overall Study|Withdrawal by Subject|1|||
156458122|NCT04171141|564774618|FG004|Overall Study|Withdrawal by Subject|0|||
156738559|NCT03053063|565789084|FG003|Randomized Phase|Lost to Follow-up|0|||
156738560|NCT03053063|565789081|FG000|Randomized Phase|Adverse Event|0|||
156738561|NCT03053063|565789082|FG001|Randomized Phase|Adverse Event|1|||
156738562|NCT03053063|565789083|FG002|Randomized Phase|Adverse Event|0|||
156738563|NCT03053063|565789084|FG003|Randomized Phase|Adverse Event|0|||
156738564|NCT03053063|565789081|FG000|Randomized Phase|Randomized but Never Treated|1|||
156458123|NCT04171141|564774619|FG005|Overall Study|Withdrawal by Subject|0|||
156458124|NCT04171141|564774620|FG006|Overall Study|Withdrawal by Subject|1|||
156458125|NCT04171141|564774621|FG007|Overall Study|Withdrawal by Subject|0|||
156738565|NCT03053063|565789082|FG001|Randomized Phase|Randomized but Never Treated|3|||
156738566|NCT03053063|565789083|FG002|Randomized Phase|Randomized but Never Treated|2|||
156458126|NCT04171141|564774622|FG008|Overall Study|Withdrawal by Subject|0|||
156458127|NCT04171141|564774623|FG009|Overall Study|Withdrawal by Subject|1|||
156458128|NCT04171141|564774624|FG010|Overall Study|Withdrawal by Subject|0|||
156458129|NCT04171141|564774625|FG011|Overall Study|Withdrawal by Subject|0|||
156458130|NCT04171141|564774626|FG012|Overall Study|Withdrawal by Subject|0|||
156458131|NCT04171141|564774627|FG013|Overall Study|Withdrawal by Subject|0|||
156458132|NCT04171141|564774628|FG014|Overall Study|Withdrawal by Subject|0|||
156458133|NCT04171141|564774629|FG015|Overall Study|Withdrawal by Subject|0|||
156458134|NCT04171141|564774614|FG000|Overall Study|Global deterioration of health status|0|||
156458135|NCT04171141|564774615|FG001|Overall Study|Global deterioration of health status|0|||
156458136|NCT04171141|564774616|FG002|Overall Study|Global deterioration of health status|0|||
156458137|NCT04171141|564774617|FG003|Overall Study|Global deterioration of health status|1|||
156458138|NCT04171141|564774618|FG004|Overall Study|Global deterioration of health status|0|||
156458139|NCT04171141|564774619|FG005|Overall Study|Global deterioration of health status|2|||
156458140|NCT04171141|564774620|FG006|Overall Study|Global deterioration of health status|1|||
156458141|NCT04171141|564774621|FG007|Overall Study|Global deterioration of health status|0|||
156458142|NCT04171141|564774622|FG008|Overall Study|Global deterioration of health status|1|||
156458143|NCT04171141|564774623|FG009|Overall Study|Global deterioration of health status|0|||
156458144|NCT04171141|564774624|FG010|Overall Study|Global deterioration of health status|0|||
156738567|NCT03053063|565789084|FG003|Randomized Phase|Randomized but Never Treated|0|||
156738568|NCT03053063|565789081|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
156738569|NCT03053063|565789082|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
156458145|NCT04171141|564774625|FG011|Overall Study|Global deterioration of health status|0|||
156458146|NCT04171141|564774626|FG012|Overall Study|Global deterioration of health status|0|||
156458147|NCT04171141|564774627|FG013|Overall Study|Global deterioration of health status|0|||
156738570|NCT03053063|565789083|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
156336891|NCT01986907|564331400|FG000|Overall Study|Death|9|||
156738571|NCT03053063|565789084|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
156738572|NCT03053063|565789081|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
156738573|NCT03053063|565789082|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
156738574|NCT03053063|565789083|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
156738575|NCT03053063|565789084|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
156738576|NCT03053063|565789081|FG000|Open-Label Phase|Death|0|||
156738577|NCT03053063|565789082|FG001|Open-Label Phase|Death|0|||
156738578|NCT03053063|565789083|FG002|Open-Label Phase|Death|0|||
156738579|NCT03053063|565789084|FG003|Open-Label Phase|Death|2|||
156738580|NCT03053063|565789081|FG000|Open-Label Phase|Investigator's discretion|0|||
156738581|NCT03053063|565789082|FG001|Open-Label Phase|Investigator's discretion|0|||
156738582|NCT03053063|565789083|FG002|Open-Label Phase|Investigator's discretion|0|||
156738583|NCT03053063|565789084|FG003|Open-Label Phase|Investigator's discretion|2|||
156738584|NCT02600845|565789085|FG000|Overall Study|Reason Not Specified|3|||
156738585|NCT02600845|565789085|FG000|Overall Study|Non-compliance with Study Procedures|10|||
156738586|NCT02600845|565789085|FG000|Overall Study|Consent Withdrawal|5|||
156738587|NCT03055494|565791129|FG000|Overall Study|Lost to Follow-up|6|||
156738588|NCT03055494|565791130|FG001|Overall Study|Lost to Follow-up|0|||
156738589|NCT03055494|565791129|FG000|Overall Study|Physician Decision|2|||
156738590|NCT03055494|565791130|FG001|Overall Study|Physician Decision|0|||
156738591|NCT03055494|565791129|FG000|Overall Study|Withdrawal by Subject|1|||
156738592|NCT03055494|565791130|FG001|Overall Study|Withdrawal by Subject|0|||
156738593|NCT03055494|565791129|FG000|Overall Study|Adverse Event|0|||
156738594|NCT03055494|565791130|FG001|Overall Study|Adverse Event|1|||
156738595|NCT03055494|565791129|FG000|Overall Study|Non-compliance with study treatment|1|||
156738596|NCT03055494|565791130|FG001|Overall Study|Non-compliance with study treatment|0|||
156797405|NCT00071032|566011318|FG000|Overall Study|Withdrawal by Subject|8|||
156797406|NCT00071032|566011319|FG001|Overall Study|Withdrawal by Subject|6|||
156458148|NCT04171141|564774628|FG014|Overall Study|Global deterioration of health status|1|||
156458149|NCT04171141|564774629|FG015|Overall Study|Global deterioration of health status|1|||
156458150|NCT03663569|564774630|FG000|Overall Study|Discontinuation of study|11|||
156336892|NCT03800173|564331404|FG000|Overall Study|Lost to Follow-up|0|||
156458151|NCT03663569|564774630|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
156458152|NCT03663569|564774630|FG000|Overall Study|Deceased patient|6|||
156458153|NCT03663569|564774630|FG000|Overall Study|Lost to Follow-up|18|||
156458154|NCT03663569|564774630|FG000|Overall Study|Withdrawal of consent|5|||
156738597|NCT02017717|565791131|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738598|NCT02017717|565791132|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738599|NCT02017717|565791133|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738600|NCT02017717|565791134|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738601|NCT02017717|565791135|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156877304|NCT05330975|566309785|FG002|Primary|Lost to Follow-up|38|||
156877305|NCT05330975|566309786|FG003|Primary|Lost to Follow-up|30|||
156877306|NCT05330975|566309787|FG004|Primary|Lost to Follow-up|25|||
156877307|NCT05330975|566309788|FG005|Primary|Lost to Follow-up|28|||
156877308|NCT05330975|566309789|FG006|Primary|Lost to Follow-up|0|||
156877309|NCT05330975|566309783|FG000|Primary|Withdrawal by Subject|4|||
156877310|NCT05330975|566309784|FG001|Primary|Withdrawal by Subject|11|||
156877311|NCT05330975|566309785|FG002|Primary|Withdrawal by Subject|8|||
156877312|NCT05330975|566309786|FG003|Primary|Withdrawal by Subject|23|||
156877313|NCT05330975|566309787|FG004|Primary|Withdrawal by Subject|20|||
156877314|NCT05330975|566309788|FG005|Primary|Withdrawal by Subject|19|||
156336893|NCT03800173|564331405|FG001|Overall Study|Lost to Follow-up|0|||
156336894|NCT03800173|564331406|FG002|Overall Study|Lost to Follow-up|0|||
156458155|NCT03663569|564774630|FG000|Overall Study|Patient's request|11|||
156458156|NCT03663569|564774630|FG000|Overall Study|Adverse Event|4|||
156458157|NCT03663569|564774630|FG000|Overall Study|Not come to second visit|3|||
156458158|NCT03663569|564774630|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
156458159|NCT03663569|564774630|FG000|Overall Study|Serious adverse event|1|||
156458160|NCT04979442|564774631|FG000|Overall Study|Death|43|||
156458161|NCT04979442|564774632|FG001|Overall Study|Death|30|||
156458162|NCT04979442|564774631|FG000|Overall Study|Withdrawal by Subject|8|||
156458163|NCT04979442|564774632|FG001|Overall Study|Withdrawal by Subject|13|||
156458164|NCT04979442|564774631|FG000|Overall Study|Physician Decision|1|||
156458165|NCT04979442|564774632|FG001|Overall Study|Physician Decision|1|||
156458166|NCT04979442|564774631|FG000|Overall Study|Lost to Follow-up|0|||
156458167|NCT04979442|564774632|FG001|Overall Study|Lost to Follow-up|2|||
156458168|NCT04979442|564774631|FG000|Overall Study|do not want to continue|0|||
156458169|NCT04979442|564774632|FG001|Overall Study|do not want to continue|1|||
156458170|NCT04005794|564774634|FG000|Overall Study|Lost to Follow-up|0|||
156458171|NCT04005794|564774635|FG001|Overall Study|Lost to Follow-up|4|||
156458172|NCT04005794|564774636|FG002|Overall Study|Lost to Follow-up|0|||
156458173|NCT00104676|564774640|FG000|Overall Study|Death|3|||
156458174|NCT00104676|564774641|FG001|Overall Study|Death|2|||
156458175|NCT00104676|564774640|FG000|Overall Study|Withdrawal by Subject|0|||
156458176|NCT00104676|564774641|FG001|Overall Study|Withdrawal by Subject|2|||
156458177|NCT00104676|564774640|FG000|Overall Study|treatment interruption|4|||
156458178|NCT00104676|564774641|FG001|Overall Study|treatment interruption|10|||
156458179|NCT05622812|564774642|FG000|Overall Study|Withdrawal by Subject|1|||
156458180|NCT05622812|564774643|FG001|Overall Study|Withdrawal by Subject|4|||
156458181|NCT05622812|564774642|FG000|Overall Study|Lost to Follow-up|2|||
156877315|NCT05330975|566309789|FG006|Primary|Withdrawal by Subject|0|||
156877316|NCT05330975|566309783|FG000|Primary|Protocol Violation|0|||
156877317|NCT05330975|566309784|FG001|Primary|Protocol Violation|2|||
156877318|NCT05330975|566309785|FG002|Primary|Protocol Violation|0|||
156877319|NCT05330975|566309786|FG003|Primary|Protocol Violation|4|||
156877320|NCT05330975|566309787|FG004|Primary|Protocol Violation|0|||
156877321|NCT05330975|566309788|FG005|Primary|Protocol Violation|3|||
156336895|NCT03800173|564331407|FG003|Overall Study|Lost to Follow-up|0|||
156458182|NCT05622812|564774643|FG001|Overall Study|Lost to Follow-up|1|||
156458183|NCT02116530|564774644|FG000|Overall Study|Withdrawal by Subject|1|||
156458184|NCT02116530|564774645|FG001|Overall Study|Withdrawal by Subject|2|||
156458185|NCT02116530|564774644|FG000|Overall Study|Adverse Event|4|||
156458186|NCT02116530|564774645|FG001|Overall Study|Adverse Event|0|||
156458187|NCT02116530|564774644|FG000|Overall Study|Physician Decision|1|||
156458188|NCT02116530|564774645|FG001|Overall Study|Physician Decision|0|||
156458189|NCT02116530|564774644|FG000|Overall Study|Lost to Follow-up|1|||
156458190|NCT02116530|564774645|FG001|Overall Study|Lost to Follow-up|0|||
156458191|NCT02116530|564774644|FG000|Overall Study|Other Medical Problems|2|||
156458192|NCT02116530|564774645|FG001|Overall Study|Other Medical Problems|2|||
156458193|NCT02927236|564774646|FG000|Characterization Phase|Physician Decision|0|||
156458194|NCT02927236|564774647|FG001|Characterization Phase|Physician Decision|3|||
156458195|NCT02927236|564774648|FG002|Characterization Phase|Physician Decision|0|||
156738602|NCT02017717|565791136|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738603|NCT02017717|565791137|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738604|NCT02017717|565791138|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
156877322|NCT05330975|566309789|FG006|Primary|Protocol Violation|0|||
156877323|NCT05330975|566309783|FG000|Primary|Death|0|||
156877324|NCT05330975|566309784|FG001|Primary|Death|3|||
156458196|NCT02927236|564774649|FG003|Characterization Phase|Physician Decision|2|||
156458197|NCT02927236|564774646|FG000|Characterization Phase|Lost to Follow-up|0|||
156458198|NCT02927236|564774647|FG001|Characterization Phase|Lost to Follow-up|0|||
156458199|NCT02927236|564774648|FG002|Characterization Phase|Lost to Follow-up|0|||
156458200|NCT02927236|564774649|FG003|Characterization Phase|Lost to Follow-up|3|||
156877325|NCT05330975|566309785|FG002|Primary|Death|1|||
156877326|NCT05330975|566309786|FG003|Primary|Death|1|||
156877327|NCT05330975|566309787|FG004|Primary|Death|0|||
156336896|NCT03800173|564331408|FG004|Overall Study|Lost to Follow-up|1|||
156877328|NCT05330975|566309788|FG005|Primary|Death|0|||
156877329|NCT05330975|566309789|FG006|Primary|Death|0|||
156877330|NCT05330975|566309783|FG000|Primary|Other Than Specified|0|||
156738605|NCT02017717|565791139|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738606|NCT02017717|565791131|FG000|Before Treatment Period|Participant request to stop therapy|0|||
156738607|NCT02017717|565791132|FG001|Before Treatment Period|Participant request to stop therapy|0|||
156738608|NCT02017717|565791133|FG002|Before Treatment Period|Participant request to stop therapy|0|||
156738609|NCT02017717|565791134|FG003|Before Treatment Period|Participant request to stop therapy|0|||
156738610|NCT02017717|565791135|FG004|Before Treatment Period|Participant request to stop therapy|0|||
156738611|NCT02017717|565791136|FG005|Before Treatment Period|Participant request to stop therapy|0|||
156738612|NCT02017717|565791137|FG006|Before Treatment Period|Participant request to stop therapy|0|||
156738613|NCT02017717|565791138|FG007|Before Treatment Period|Participant request to stop therapy|0|||
156738614|NCT02017717|565791139|FG008|Before Treatment Period|Participant request to stop therapy|5|||
156738615|NCT02017717|565791131|FG000|Before Treatment Period|Participant withdrew consent|0|||
156738616|NCT02017717|565791132|FG001|Before Treatment Period|Participant withdrew consent|0|||
156738617|NCT02017717|565791133|FG002|Before Treatment Period|Participant withdrew consent|0|||
156738618|NCT02017717|565791134|FG003|Before Treatment Period|Participant withdrew consent|0|||
156738619|NCT02017717|565791135|FG004|Before Treatment Period|Participant withdrew consent|0|||
156738620|NCT02017717|565791136|FG005|Before Treatment Period|Participant withdrew consent|0|||
156738621|NCT02017717|565791137|FG006|Before Treatment Period|Participant withdrew consent|2|||
156738622|NCT02017717|565791138|FG007|Before Treatment Period|Participant withdrew consent|0|||
156738623|NCT02017717|565791139|FG008|Before Treatment Period|Participant withdrew consent|11|||
156738624|NCT02017717|565791131|FG000|Before Treatment Period|Lost to Follow-up|0|||
156738625|NCT02017717|565791132|FG001|Before Treatment Period|Lost to Follow-up|0|||
156738626|NCT02017717|565791133|FG002|Before Treatment Period|Lost to Follow-up|0|||
156738627|NCT02017717|565791134|FG003|Before Treatment Period|Lost to Follow-up|0|||
156738628|NCT02017717|565791135|FG004|Before Treatment Period|Lost to Follow-up|0|||
156738629|NCT02017717|565791136|FG005|Before Treatment Period|Lost to Follow-up|0|||
156738630|NCT02017717|565791137|FG006|Before Treatment Period|Lost to Follow-up|0|||
156738631|NCT02017717|565791138|FG007|Before Treatment Period|Lost to Follow-up|0|||
156738632|NCT02017717|565791139|FG008|Before Treatment Period|Lost to Follow-up|1|||
156738633|NCT02017717|565791131|FG000|Before Treatment Period|Participant no longer met criteria|0|||
156738634|NCT02017717|565791132|FG001|Before Treatment Period|Participant no longer met criteria|0|||
156738635|NCT02017717|565791133|FG002|Before Treatment Period|Participant no longer met criteria|0|||
156738636|NCT02017717|565791134|FG003|Before Treatment Period|Participant no longer met criteria|0|||
156738637|NCT02017717|565791135|FG004|Before Treatment Period|Participant no longer met criteria|0|||
156458201|NCT02927236|564774646|FG000|Characterization Phase|Withdrawal by Subject|1|||
156458202|NCT02927236|564774647|FG001|Characterization Phase|Withdrawal by Subject|0|||
156458203|NCT02927236|564774648|FG002|Characterization Phase|Withdrawal by Subject|0|||
156458204|NCT02927236|564774649|FG003|Characterization Phase|Withdrawal by Subject|1|||
156458205|NCT02927236|564774646|FG000|Treatment Phase|Adverse Event|1|||
156458206|NCT02927236|564774647|FG001|Treatment Phase|Adverse Event|0|||
156458207|NCT02927236|564774648|FG002|Treatment Phase|Adverse Event|1|||
156458208|NCT02927236|564774649|FG003|Treatment Phase|Adverse Event|1|||
156458209|NCT02927236|564774646|FG000|Treatment Phase|Protocol Violation|3|||
156458210|NCT02927236|564774647|FG001|Treatment Phase|Protocol Violation|0|||
156458211|NCT02927236|564774648|FG002|Treatment Phase|Protocol Violation|0|||
156458212|NCT02927236|564774649|FG003|Treatment Phase|Protocol Violation|1|||
156458213|NCT02927236|564774646|FG000|Treatment Phase|Lost to Follow-up|1|||
156458214|NCT02927236|564774647|FG001|Treatment Phase|Lost to Follow-up|0|||
156458215|NCT02927236|564774648|FG002|Treatment Phase|Lost to Follow-up|0|||
156458216|NCT02927236|564774649|FG003|Treatment Phase|Lost to Follow-up|0|||
156738638|NCT02017717|565791136|FG005|Before Treatment Period|Participant no longer met criteria|1|||
156738639|NCT02017717|565791137|FG006|Before Treatment Period|Participant no longer met criteria|0|||
156738640|NCT02017717|565791138|FG007|Before Treatment Period|Participant no longer met criteria|1|||
156738641|NCT02017717|565791139|FG008|Before Treatment Period|Participant no longer met criteria|2|||
156738642|NCT02017717|565791131|FG000|Before Treatment Period|other reason|0|||
156738643|NCT02017717|565791132|FG001|Before Treatment Period|other reason|0|||
156738644|NCT02017717|565791133|FG002|Before Treatment Period|other reason|0|||
156738645|NCT02017717|565791134|FG003|Before Treatment Period|other reason|0|||
156738646|NCT02017717|565791135|FG004|Before Treatment Period|other reason|0|||
156738647|NCT02017717|565791136|FG005|Before Treatment Period|other reason|0|||
156738648|NCT02017717|565791137|FG006|Before Treatment Period|other reason|0|||
156738649|NCT02017717|565791138|FG007|Before Treatment Period|other reason|0|||
156738650|NCT02017717|565791139|FG008|Before Treatment Period|other reason|1|||
156738651|NCT02017717|565791131|FG000|Treatment Period|Disease progression|7|||
156738652|NCT02017717|565791132|FG001|Treatment Period|Disease progression|9|||
156458217|NCT02927236|564774646|FG000|Follow-up Phase|Lost to Follow-up|1|||
156458218|NCT02927236|564774647|FG001|Follow-up Phase|Lost to Follow-up|0|||
156458219|NCT02927236|564774648|FG002|Follow-up Phase|Lost to Follow-up|1|||
156458220|NCT02927236|564774649|FG003|Follow-up Phase|Lost to Follow-up|0|||
156738653|NCT02017717|565791133|FG002|Treatment Period|Disease progression|12|||
156738654|NCT02017717|565791134|FG003|Treatment Period|Disease progression|20|||
156738655|NCT02017717|565791135|FG004|Treatment Period|Disease progression|26|||
156738656|NCT02017717|565791136|FG005|Treatment Period|Disease progression|16|||
156738657|NCT02017717|565791137|FG006|Treatment Period|Disease progression|22|||
156738658|NCT02017717|565791138|FG007|Treatment Period|Disease progression|165|||
156738659|NCT02017717|565791139|FG008|Treatment Period|Disease progression|135|||
156738660|NCT02017717|565791131|FG000|Treatment Period|Study drug toxicity|3|||
156738661|NCT02017717|565791132|FG001|Treatment Period|Study drug toxicity|0|||
156738662|NCT02017717|565791133|FG002|Treatment Period|Study drug toxicity|1|||
156738663|NCT02017717|565791134|FG003|Treatment Period|Study drug toxicity|4|||
156738664|NCT02017717|565791135|FG004|Treatment Period|Study drug toxicity|4|||
156738665|NCT02017717|565791136|FG005|Treatment Period|Study drug toxicity|5|||
156458221|NCT05297565|564774650|FG000|Overall Study|Other Reasons|0|||
156458222|NCT05297565|564774651|FG001|Overall Study|Other Reasons|1|||
156458223|NCT05297565|564774650|FG000|Overall Study|Physician Decision|0|||
156458224|NCT05297565|564774651|FG001|Overall Study|Physician Decision|1|||
156458225|NCT05297565|564774650|FG000|Overall Study|Disease recurrence|1|||
156458226|NCT05297565|564774651|FG001|Overall Study|Disease recurrence|0|||
156458227|NCT01959607|564774652|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
156458228|NCT01959607|564774653|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
156458229|NCT01959607|564774654|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
156458230|NCT01959607|564774655|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
156458231|NCT03913442|564774656|FG000|Overall Study|Adverse Event|0|||
156458232|NCT03913442|564774657|FG001|Overall Study|Adverse Event|3|||
156458233|NCT03913442|564774656|FG000|Overall Study|Withdrawal by Subject|5|||
156458234|NCT03913442|564774657|FG001|Overall Study|Withdrawal by Subject|5|||
156458235|NCT03913442|564774656|FG000|Overall Study|Terminations|2|||
156458236|NCT03913442|564774657|FG001|Overall Study|Terminations|1|||
156458237|NCT03913442|564774656|FG000|Overall Study|Lost to Follow-up|2|||
156458238|NCT03913442|564774657|FG001|Overall Study|Lost to Follow-up|2|||
156458239|NCT02433379|564774661|FG000|Overall Study|Screen Failures|55|||
156458240|NCT02433379|564774661|FG000|Overall Study|Death|57|||
156458241|NCT02433379|564774661|FG000|Overall Study|Total Withdrawals|209|||
156458242|NCT03952338|564774662|FG000|Overall Study|Lost to Follow-up|11|||
156458243|NCT03952338|564774663|FG001|Overall Study|Lost to Follow-up|17|||
156458244|NCT03952338|564774662|FG000|Overall Study|Withdrawal by Subject|1|||
156458245|NCT03952338|564774663|FG001|Overall Study|Withdrawal by Subject|1|||
156458246|NCT03952338|564774662|FG000|Overall Study|Protocol Violation|1|||
156458247|NCT03952338|564774663|FG001|Overall Study|Protocol Violation|0|||
156458248|NCT03710603|564774664|FG000|Overall Study|Adverse Event|1|||
156458249|NCT03710603|564774665|FG001|Overall Study|Adverse Event|0|||
156458250|NCT03710603|564774664|FG000|Overall Study|Death|44|||
156458251|NCT03710603|564774665|FG001|Overall Study|Death|34|||
156458252|NCT03710603|564774664|FG000|Overall Study|Lost to Follow-up|3|||
156458253|NCT03710603|564774665|FG001|Overall Study|Lost to Follow-up|5|||
156458254|NCT03710603|564774664|FG000|Overall Study|Withdrawal by Subject|11|||
156458255|NCT03710603|564774665|FG001|Overall Study|Withdrawal by Subject|10|||
156458256|NCT03691935|564774666|FG000|Overall Study|Physician Decision|2|||
156458257|NCT03691935|564774667|FG001|Overall Study|Physician Decision|1|||
156458258|NCT03691935|564774666|FG000|Overall Study|Adverse Event|3|||
156458259|NCT03691935|564774667|FG001|Overall Study|Adverse Event|0|||
156458260|NCT01946789|564774673|FG000|Overall Study|Death|0|||
156458261|NCT01946789|564774674|FG001|Overall Study|Death|2|||
156458262|NCT01946789|564774675|FG002|Overall Study|Death|1|||
156458263|NCT01946789|564774676|FG003|Overall Study|Death|1|||
156458264|NCT01946789|564774677|FG004|Overall Study|Death|1|||
156458265|NCT01946789|564774678|FG005|Overall Study|Death|1|||
156458266|NCT01946789|564774679|FG006|Overall Study|Death|3|||
156458267|NCT01946789|564774680|FG007|Overall Study|Death|1|||
156458268|NCT01946789|564774681|FG008|Overall Study|Death|2|||
156458269|NCT01946789|564774673|FG000|Overall Study|Progressive Disease|0|||
156458270|NCT01946789|564774674|FG001|Overall Study|Progressive Disease|0|||
156458271|NCT01946789|564774675|FG002|Overall Study|Progressive Disease|1|||
156738666|NCT02017717|565791137|FG006|Treatment Period|Study drug toxicity|3|||
156738667|NCT02017717|565791138|FG007|Treatment Period|Study drug toxicity|7|||
156458272|NCT01946789|564774676|FG003|Overall Study|Progressive Disease|0|||
156458273|NCT01946789|564774677|FG004|Overall Study|Progressive Disease|0|||
156458274|NCT01946789|564774678|FG005|Overall Study|Progressive Disease|2|||
156458275|NCT01946789|564774679|FG006|Overall Study|Progressive Disease|0|||
156458276|NCT01946789|564774680|FG007|Overall Study|Progressive Disease|0|||
156458277|NCT01946789|564774681|FG008|Overall Study|Progressive Disease|0|||
156458278|NCT01946789|564774673|FG000|Overall Study|Withdrawal by Subject|0|||
156458279|NCT01946789|564774674|FG001|Overall Study|Withdrawal by Subject|0|||
156458280|NCT01946789|564774675|FG002|Overall Study|Withdrawal by Subject|0|||
156458281|NCT01946789|564774676|FG003|Overall Study|Withdrawal by Subject|2|||
156458282|NCT01946789|564774677|FG004|Overall Study|Withdrawal by Subject|1|||
156458283|NCT01946789|564774678|FG005|Overall Study|Withdrawal by Subject|0|||
156458284|NCT01946789|564774679|FG006|Overall Study|Withdrawal by Subject|1|||
156458285|NCT01946789|564774680|FG007|Overall Study|Withdrawal by Subject|0|||
156458286|NCT01946789|564774681|FG008|Overall Study|Withdrawal by Subject|0|||
156877331|NCT05330975|566309784|FG001|Primary|Other Than Specified|1|||
156738668|NCT02017717|565791139|FG008|Treatment Period|Study drug toxicity|11|||
156738669|NCT02017717|565791131|FG000|Treatment Period|Death|0|||
156738670|NCT02017717|565791132|FG001|Treatment Period|Death|0|||
156738671|NCT02017717|565791133|FG002|Treatment Period|Death|1|||
156738672|NCT02017717|565791134|FG003|Treatment Period|Death|0|||
156738673|NCT02017717|565791135|FG004|Treatment Period|Death|0|||
156738674|NCT02017717|565791136|FG005|Treatment Period|Death|2|||
156738675|NCT02017717|565791137|FG006|Treatment Period|Death|0|||
156738676|NCT02017717|565791138|FG007|Treatment Period|Death|0|||
156738677|NCT02017717|565791139|FG008|Treatment Period|Death|0|||
156738678|NCT02017717|565791131|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
156738679|NCT02017717|565791132|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
156738680|NCT02017717|565791133|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
156738681|NCT02017717|565791134|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
156738682|NCT02017717|565791135|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
156738683|NCT02017717|565791136|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
156738684|NCT02017717|565791137|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
156738685|NCT02017717|565791138|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
156738686|NCT02017717|565791139|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
156738687|NCT02017717|565791131|FG000|Treatment Period|Participant request to stop therapy|0|||
156738688|NCT02017717|565791132|FG001|Treatment Period|Participant request to stop therapy|0|||
156738689|NCT02017717|565791133|FG002|Treatment Period|Participant request to stop therapy|3|||
156738690|NCT02017717|565791134|FG003|Treatment Period|Participant request to stop therapy|6|||
156738691|NCT02017717|565791135|FG004|Treatment Period|Participant request to stop therapy|0|||
156738692|NCT02017717|565791136|FG005|Treatment Period|Participant request to stop therapy|2|||
156738693|NCT02017717|565791137|FG006|Treatment Period|Participant request to stop therapy|1|||
156738694|NCT02017717|565791138|FG007|Treatment Period|Participant request to stop therapy|4|||
156738695|NCT02017717|565791139|FG008|Treatment Period|Participant request to stop therapy|7|||
156738696|NCT02017717|565791131|FG000|Treatment Period|Participant withdrew consent|0|||
156738697|NCT02017717|565791132|FG001|Treatment Period|Participant withdrew consent|0|||
156738698|NCT02017717|565791133|FG002|Treatment Period|Participant withdrew consent|1|||
156877332|NCT05330975|566309785|FG002|Primary|Other Than Specified|2|||
156877333|NCT05330975|566309786|FG003|Primary|Other Than Specified|1|||
156458287|NCT04707625|564774682|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
156738699|NCT02017717|565791134|FG003|Treatment Period|Participant withdrew consent|0|||
156738700|NCT02017717|565791135|FG004|Treatment Period|Participant withdrew consent|0|||
156738701|NCT02017717|565791136|FG005|Treatment Period|Participant withdrew consent|2|||
156738702|NCT02017717|565791137|FG006|Treatment Period|Participant withdrew consent|0|||
156738703|NCT02017717|565791138|FG007|Treatment Period|Participant withdrew consent|1|||
156738704|NCT02017717|565791139|FG008|Treatment Period|Participant withdrew consent|4|||
156738705|NCT02017717|565791131|FG000|Treatment Period|Participant no longer met criteria|0|||
156738706|NCT02017717|565791132|FG001|Treatment Period|Participant no longer met criteria|0|||
156738707|NCT02017717|565791133|FG002|Treatment Period|Participant no longer met criteria|0|||
156738708|NCT02017717|565791134|FG003|Treatment Period|Participant no longer met criteria|0|||
156738709|NCT02017717|565791135|FG004|Treatment Period|Participant no longer met criteria|0|||
156738710|NCT02017717|565791136|FG005|Treatment Period|Participant no longer met criteria|0|||
156738711|NCT02017717|565791137|FG006|Treatment Period|Participant no longer met criteria|0|||
156738712|NCT02017717|565791138|FG007|Treatment Period|Participant no longer met criteria|0|||
156738713|NCT02017717|565791139|FG008|Treatment Period|Participant no longer met criteria|1|||
156738714|NCT02017717|565791131|FG000|Treatment Period|Other reasons|0|||
156738715|NCT02017717|565791132|FG001|Treatment Period|Other reasons|0|||
156738716|NCT02017717|565791133|FG002|Treatment Period|Other reasons|0|||
156738717|NCT02017717|565791134|FG003|Treatment Period|Other reasons|1|||
156738718|NCT02017717|565791135|FG004|Treatment Period|Other reasons|0|||
156738719|NCT02017717|565791136|FG005|Treatment Period|Other reasons|1|||
156738720|NCT02017717|565791137|FG006|Treatment Period|Other reasons|1|||
156738721|NCT02017717|565791138|FG007|Treatment Period|Other reasons|1|||
156738722|NCT02017717|565791139|FG008|Treatment Period|Other reasons|1|||
156738723|NCT02017717|565791131|FG000|Treatment Period|Maximum clinical benefit|0|||
156738724|NCT02017717|565791132|FG001|Treatment Period|Maximum clinical benefit|0|||
156738725|NCT02017717|565791133|FG002|Treatment Period|Maximum clinical benefit|0|||
156738726|NCT02017717|565791134|FG003|Treatment Period|Maximum clinical benefit|0|||
156738727|NCT02017717|565791135|FG004|Treatment Period|Maximum clinical benefit|0|||
156738728|NCT02017717|565791136|FG005|Treatment Period|Maximum clinical benefit|0|||
156738729|NCT02017717|565791137|FG006|Treatment Period|Maximum clinical benefit|0|||
156738730|NCT02017717|565791138|FG007|Treatment Period|Maximum clinical benefit|0|||
156738731|NCT02017717|565791139|FG008|Treatment Period|Maximum clinical benefit|1|||
156738732|NCT02017717|565791131|FG000|Treatment Period|Not reported|0|||
156738733|NCT02017717|565791132|FG001|Treatment Period|Not reported|1|||
156738734|NCT02017717|565791133|FG002|Treatment Period|Not reported|0|||
156738735|NCT02017717|565791134|FG003|Treatment Period|Not reported|0|||
156738736|NCT02017717|565791135|FG004|Treatment Period|Not reported|0|||
156877334|NCT05330975|566309787|FG004|Primary|Other Than Specified|2|||
156877335|NCT05330975|566309788|FG005|Primary|Other Than Specified|2|||
156877336|NCT05330975|566309789|FG006|Primary|Other Than Specified|0|||
156877337|NCT05330975|566309783|FG000|Primary|Adverse Event|0|||
156877338|NCT05330975|566309784|FG001|Primary|Adverse Event|0|||
156877339|NCT05330975|566309785|FG002|Primary|Adverse Event|0|||
156877340|NCT05330975|566309786|FG003|Primary|Adverse Event|1|||
156877341|NCT05330975|566309787|FG004|Primary|Adverse Event|0|||
156877342|NCT05330975|566309788|FG005|Primary|Adverse Event|0|||
156877343|NCT05330975|566309789|FG006|Primary|Adverse Event|0|||
156877344|NCT05330975|566309783|FG000|Primary|Physician Decision|0|||
156877345|NCT05330975|566309784|FG001|Primary|Physician Decision|0|||
156877346|NCT05330975|566309785|FG002|Primary|Physician Decision|0|||
156877347|NCT05330975|566309786|FG003|Primary|Physician Decision|0|||
156877348|NCT05330975|566309787|FG004|Primary|Physician Decision|1|||
156877349|NCT05330975|566309788|FG005|Primary|Physician Decision|0|||
156877350|NCT05330975|566309789|FG006|Primary|Physician Decision|0|||
156877351|NCT05330975|566309783|FG000|Revaccination|Adverse Event|0|||
156877352|NCT05330975|566309784|FG001|Revaccination|Adverse Event|0|||
156877353|NCT05330975|566309785|FG002|Revaccination|Adverse Event|0|||
156877354|NCT05330975|566309786|FG003|Revaccination|Adverse Event|0|||
156877355|NCT05330975|566309787|FG004|Revaccination|Adverse Event|0|||
156877356|NCT05330975|566309788|FG005|Revaccination|Adverse Event|0|||
156877357|NCT05330975|566309789|FG006|Revaccination|Adverse Event|3|||
156877358|NCT05330975|566309783|FG000|Revaccination|Lost to Follow-up|0|||
156877359|NCT05330975|566309784|FG001|Revaccination|Lost to Follow-up|0|||
156877360|NCT05330975|566309785|FG002|Revaccination|Lost to Follow-up|0|||
156877361|NCT05330975|566309786|FG003|Revaccination|Lost to Follow-up|0|||
156877362|NCT05330975|566309787|FG004|Revaccination|Lost to Follow-up|0|||
156877363|NCT05330975|566309788|FG005|Revaccination|Lost to Follow-up|0|||
156877364|NCT05330975|566309789|FG006|Revaccination|Lost to Follow-up|10|||
156877365|NCT05330975|566309783|FG000|Revaccination|Withdrawal by Subject|0|||
156877366|NCT05330975|566309784|FG001|Revaccination|Withdrawal by Subject|0|||
156877367|NCT05330975|566309785|FG002|Revaccination|Withdrawal by Subject|0|||
156877368|NCT05330975|566309786|FG003|Revaccination|Withdrawal by Subject|0|||
156877369|NCT05330975|566309787|FG004|Revaccination|Withdrawal by Subject|0|||
156877370|NCT05330975|566309788|FG005|Revaccination|Withdrawal by Subject|0|||
156877371|NCT05330975|566309789|FG006|Revaccination|Withdrawal by Subject|2|||
156877372|NCT05330975|566309783|FG000|Revaccination|Death|0|||
156877373|NCT05330975|566309784|FG001|Revaccination|Death|0|||
156877374|NCT05330975|566309785|FG002|Revaccination|Death|0|||
156877375|NCT05330975|566309786|FG003|Revaccination|Death|0|||
156877376|NCT05330975|566309787|FG004|Revaccination|Death|0|||
156877377|NCT05330975|566309788|FG005|Revaccination|Death|0|||
156877378|NCT05330975|566309789|FG006|Revaccination|Death|3|||
156877379|NCT04903288|566309790|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
156877380|NCT04903288|566309790|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
156877381|NCT04903288|566309790|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
156877382|NCT04903288|566309790|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
156458288|NCT00321048|564774683|FG000|Overall Study|Withdrawal by Subject|6|||
156458289|NCT00321048|564774684|FG001|Overall Study|Withdrawal by Subject|8|||
156458290|NCT06473662|564774685|FG000|Overall Study|Withdrawal by Subject|1|||
156738737|NCT02017717|565791136|FG005|Treatment Period|Not reported|0|||
156738738|NCT02017717|565791137|FG006|Treatment Period|Not reported|0|||
156738739|NCT02017717|565791138|FG007|Treatment Period|Not reported|0|||
156738740|NCT02017717|565791139|FG008|Treatment Period|Not reported|0|||
156738741|NCT05072106|565791142|FG000|Overall Study|Progressive disease|3|||
156738742|NCT05072106|565791143|FG001|Overall Study|Progressive disease|3|||
156738743|NCT05072106|565791142|FG000|Overall Study|Compassionate use|3|||
156738744|NCT05072106|565791143|FG001|Overall Study|Compassionate use|1|||
156738745|NCT05072106|565791142|FG000|Overall Study|Withdrawal by Subject|1|||
156738746|NCT05072106|565791143|FG001|Overall Study|Withdrawal by Subject|0|||
156877383|NCT02531126|566309794|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
156877384|NCT02531126|566309795|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
156877385|NCT02531126|566309796|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
156458291|NCT06473662|564774686|FG001|Overall Study|Withdrawal by Subject|6|||
156738747|NCT03839459|565791144|FG000|Overall Study|Withdrawal by Subject|2|||
156738748|NCT03839459|565791144|FG000|Overall Study|progression of disease|3|||
156877386|NCT02531126|566309797|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
156738749|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
156738750|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
156877387|NCT02531126|566309794|FG000|Overall Study|Adverse Event|16|||
156877388|NCT02531126|566309795|FG001|Overall Study|Adverse Event|13|||
156877389|NCT02531126|566309796|FG002|Overall Study|Adverse Event|27|||
156877390|NCT02531126|566309797|FG003|Overall Study|Adverse Event|4|||
156877391|NCT02531126|566309794|FG000|Overall Study|Lack of Efficacy|50|||
156877392|NCT02531126|566309795|FG001|Overall Study|Lack of Efficacy|32|||
156877393|NCT02531126|566309796|FG002|Overall Study|Lack of Efficacy|121|||
156877394|NCT02531126|566309797|FG003|Overall Study|Lack of Efficacy|0|||
156877395|NCT02531126|566309794|FG000|Overall Study|Withdrawal by Subject|38|||
156877396|NCT02531126|566309795|FG001|Overall Study|Withdrawal by Subject|31|||
156877397|NCT02531126|566309796|FG002|Overall Study|Withdrawal by Subject|96|||
156877398|NCT02531126|566309797|FG003|Overall Study|Withdrawal by Subject|6|||
156877399|NCT02531126|566309794|FG000|Overall Study|Pregnancy|2|||
156877400|NCT02531126|566309795|FG001|Overall Study|Pregnancy|3|||
156877401|NCT02531126|566309796|FG002|Overall Study|Pregnancy|2|||
156877402|NCT02531126|566309797|FG003|Overall Study|Pregnancy|0|||
156877403|NCT02531126|566309794|FG000|Overall Study|Switched to commercial drug|2|||
156877404|NCT02531126|566309795|FG001|Overall Study|Switched to commercial drug|4|||
156877405|NCT02531126|566309796|FG002|Overall Study|Switched to commercial drug|4|||
156877406|NCT02531126|566309797|FG003|Overall Study|Switched to commercial drug|0|||
156877407|NCT02531126|566309794|FG000|Overall Study|Other reasons|23|||
156877408|NCT02531126|566309795|FG001|Overall Study|Other reasons|29|||
156877409|NCT02531126|566309796|FG002|Overall Study|Other reasons|27|||
156877410|NCT02531126|566309797|FG003|Overall Study|Other reasons|15|||
156877411|NCT02531126|566309794|FG000|Overall Study|Physician Decision|6|||
156877412|NCT02531126|566309795|FG001|Overall Study|Physician Decision|6|||
156877413|NCT02531126|566309796|FG002|Overall Study|Physician Decision|28|||
156877414|NCT02531126|566309797|FG003|Overall Study|Physician Decision|0|||
156877415|NCT02531126|566309794|FG000|Overall Study|Non-compliance with investigational drug|1|||
156877416|NCT02531126|566309795|FG001|Overall Study|Non-compliance with investigational drug|0|||
156877417|NCT02531126|566309796|FG002|Overall Study|Non-compliance with investigational drug|0|||
156877418|NCT02531126|566309797|FG003|Overall Study|Non-compliance with investigational drug|0|||
156877419|NCT01809691|566309798|FG000|Overall Study|Currently on Treatment|192|||
156877420|NCT01809691|566309799|FG001|Overall Study|Currently on Treatment|100|||
156877421|NCT01809691|566309798|FG000|Overall Study|No Protocol Treatment|10|||
156877422|NCT01809691|566309799|FG001|Overall Study|No Protocol Treatment|11|||
156877423|NCT01809691|566309798|FG000|Overall Study|Adverse Event|80|||
156877424|NCT01809691|566309799|FG001|Overall Study|Adverse Event|21|||
156877425|NCT01809691|566309798|FG000|Overall Study|Disease Progression|226|||
156877426|NCT01809691|566309799|FG001|Overall Study|Disease Progression|372|||
156877427|NCT01809691|566309798|FG000|Overall Study|Death|26|||
156877428|NCT01809691|566309799|FG001|Overall Study|Death|13|||
156877429|NCT01809691|566309798|FG000|Overall Study|Participant Refusal|70|||
156877430|NCT01809691|566309799|FG001|Overall Study|Participant Refusal|72|||
156877431|NCT01809691|566309798|FG000|Overall Study|Other, Not Specified|34|||
156877432|NCT01809691|566309799|FG001|Overall Study|Other, Not Specified|52|||
156877433|NCT05267106|566309800|FG000|Overall Study|Death|50|||
156877434|NCT05267106|566309801|FG001|Overall Study|Death|2|||
156877435|NCT05267106|566309800|FG000|Overall Study|Study terminated by Sponsor|24|||
156877436|NCT05267106|566309801|FG001|Overall Study|Study terminated by Sponsor|6|||
156877437|NCT05267106|566309800|FG000|Overall Study|Withdrawal by Subject|0|||
156877438|NCT05267106|566309801|FG001|Overall Study|Withdrawal by Subject|1|||
156877439|NCT04165824|566309802|FG000|Overall Study|Adverse Event|23|||
156877440|NCT04165824|566309802|FG000|Overall Study|Physician Decision|1|||
156877441|NCT04165824|566309802|FG000|Overall Study|Withdrawal by Subject|17|||
156877442|NCT04165824|566309802|FG000|Overall Study|Other|5|||
156458292|NCT06473662|564774687|FG002|Overall Study|Withdrawal by Subject|5|||
156458293|NCT06473662|564774685|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
156458294|NCT06473662|564774686|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
156458295|NCT06473662|564774687|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
156738751|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
156877443|NCT03085433|566309803|FG000|Overall Study|Withdrawal by Subject|2|||
156877444|NCT03085433|566309804|FG001|Overall Study|Withdrawal by Subject|4|||
156877445|NCT03085433|566309803|FG000|Overall Study|Physician Decision|33|||
156877446|NCT03085433|566309804|FG001|Overall Study|Physician Decision|50|||
156877447|NCT03809039|566309807|FG000|Part 1|Withdrawal by Subject|1|||
156877448|NCT03809039|566309808|FG001|Part 1|Withdrawal by Subject|0|||
156877449|NCT03809039|566309809|FG002|Part 1|Withdrawal by Subject|0|||
156877450|NCT03809039|566309810|FG003|Part 1|Withdrawal by Subject|1|||
156877451|NCT03809039|566309811|FG004|Part 1|Withdrawal by Subject|0|||
156877452|NCT03809039|566309812|FG005|Part 1|Withdrawal by Subject|0|||
156877453|NCT03809039|566309813|FG006|Part 1|Withdrawal by Subject|0|||
156738752|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
156877454|NCT03809039|566309814|FG007|Part 1|Withdrawal by Subject|0|||
156877455|NCT03809039|566309815|FG008|Part 1|Withdrawal by Subject|0|||
156877456|NCT03809039|566309807|FG000|Part 3|Withdrawn by study termination|0|||
156877457|NCT03809039|566309808|FG001|Part 3|Withdrawn by study termination|0|||
156877458|NCT03809039|566309809|FG002|Part 3|Withdrawn by study termination|0|||
156458296|NCT06473662|564774685|FG000|Overall Study|Starting HbA1c below 7%|0|||
156877459|NCT03809039|566309810|FG003|Part 3|Withdrawn by study termination|0|||
156877460|NCT03809039|566309811|FG004|Part 3|Withdrawn by study termination|0|||
156877461|NCT03809039|566309812|FG005|Part 3|Withdrawn by study termination|0|||
156877462|NCT03809039|566309813|FG006|Part 3|Withdrawn by study termination|0|||
156877463|NCT03809039|566309814|FG007|Part 3|Withdrawn by study termination|2|||
156877464|NCT03809039|566309815|FG008|Part 3|Withdrawn by study termination|6|||
156458297|NCT06473662|564774686|FG001|Overall Study|Starting HbA1c below 7%|1|||
156458298|NCT06473662|564774687|FG002|Overall Study|Starting HbA1c below 7%|1|||
156458299|NCT06473662|564774685|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
156458300|NCT06473662|564774686|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
156458301|NCT06473662|564774687|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
156458302|NCT06473662|564774685|FG000|Overall Study|Did not take medication|2|||
156458303|NCT06473662|564774686|FG001|Overall Study|Did not take medication|3|||
156458304|NCT06473662|564774687|FG002|Overall Study|Did not take medication|2|||
156458305|NCT05485779|564774690|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
156458306|NCT05485779|564774691|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
156738753|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
156738754|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
156738755|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
156738756|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
156738757|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
156738758|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
156738759|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
156738760|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
156738761|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
156738762|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
156738763|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
156738764|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
156738765|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
156738766|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
156738767|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
156738768|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
156738769|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
156738770|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
156738771|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
156738772|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
156738773|NCT04488419|565791146|FG000|Primary Analysis Population|Adverse Event|6|||
156738774|NCT04488419|565791147|FG001|Primary Analysis Population|Adverse Event|9|||
156738775|NCT04488419|565791148|FG002|Primary Analysis Population|Adverse Event|0|||
156738776|NCT04488419|565791146|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
156738777|NCT04488419|565791147|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
156738778|NCT04488419|565791148|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
156738779|NCT04488419|565791146|FG000|Primary Analysis Population|Protocol Violation|1|||
156738780|NCT04488419|565791147|FG001|Primary Analysis Population|Protocol Violation|1|||
156738781|NCT04488419|565791148|FG002|Primary Analysis Population|Protocol Violation|0|||
156738782|NCT04488419|565791146|FG000|Primary Analysis Population|Undetermined|7|||
156738783|NCT04488419|565791147|FG001|Primary Analysis Population|Undetermined|3|||
156738784|NCT04488419|565791148|FG002|Primary Analysis Population|Undetermined|0|||
156738785|NCT04488419|565791146|FG000|Primary Analysis Population|>1 Reason|2|||
156738786|NCT04488419|565791147|FG001|Primary Analysis Population|>1 Reason|4|||
156738787|NCT04488419|565791148|FG002|Primary Analysis Population|>1 Reason|0|||
156738788|NCT04598451|565791151|FG000|Overall Study|Adverse Event|3|||
156738789|NCT04598451|565791152|FG001|Overall Study|Adverse Event|2|||
156738790|NCT04598451|565791151|FG000|Overall Study|Withdrawal by Subject|3|||
156738791|NCT04598451|565791152|FG001|Overall Study|Withdrawal by Subject|7|||
156738792|NCT04598451|565791151|FG000|Overall Study|Lost to Follow-up|2|||
156738793|NCT04598451|565791152|FG001|Overall Study|Lost to Follow-up|0|||
156458307|NCT05485779|564774692|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
156458308|NCT05485779|564774693|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
156458309|NCT05485779|564774694|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
156458310|NCT05485779|564774695|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
156738794|NCT04598451|565791151|FG000|Overall Study|Physician Decision|4|||
156738795|NCT04598451|565791152|FG001|Overall Study|Physician Decision|1|||
156738796|NCT04598451|565791151|FG000|Overall Study|Requires Prohibited Medication|1|||
156797407|NCT00071032|566011318|FG000|Overall Study|Missing Primary Outcome|0|||
156797408|NCT00071032|566011319|FG001|Overall Study|Missing Primary Outcome|1|||
156797409|NCT02255656|566011327|FG000|Overall Study|Adverse Event|11|||
156797410|NCT02255656|566011327|FG000|Overall Study|Poor compliance to protocol|3|||
156797411|NCT02255656|566011327|FG000|Overall Study|Lost to Follow-up|30|||
156458311|NCT05485779|564774696|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
156738797|NCT04598451|565791152|FG001|Overall Study|Requires Prohibited Medication|0|||
156738798|NCT04598451|565791151|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
156797412|NCT02255656|566011327|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
156797413|NCT02255656|566011327|FG000|Overall Study|Other|126|||
156458312|NCT05485779|564774697|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
156458313|NCT05485779|564774698|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
156738799|NCT04598451|565791152|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
156877465|NCT03036930|566309816|FG000|Overall Study|Lost to Follow-up|7|||
156877466|NCT03036930|566309816|FG000|Overall Study|Withdrawal by Subject|3|||
156458314|NCT05485779|564774699|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
156458315|NCT05485779|564774700|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
156738800|NCT01632150|565791155|FG000|Overall Study|Disease progression|27|||
156738801|NCT01632150|565791155|FG000|Overall Study|Study drug toxicity|1|||
156738802|NCT01632150|565791155|FG000|Overall Study|Unrelated adverse event|7|||
156738803|NCT01632150|565791155|FG000|Overall Study|Withdrawal by Subject|2|||
156738804|NCT01632150|565791155|FG000|Overall Study|Patient underwent autologous transplant|1|||
156738805|NCT01632150|565791155|FG000|Overall Study|Moved to compassionate program|2|||
156738806|NCT04327661|565791160|FG000|Overall Study|Withdrawal by Subject|1|||
156738807|NCT04327661|565791161|FG001|Overall Study|Withdrawal by Subject|0|||
156738808|NCT04327661|565791162|FG002|Overall Study|Withdrawal by Subject|0|||
156738809|NCT01473394|565791163|FG000|Overall Study|Adverse Event|13|||
156738810|NCT01473394|565791164|FG001|Overall Study|Adverse Event|16|||
156738811|NCT01473394|565791163|FG000|Overall Study|Insufficient Therapeutic Response|4|||
156877467|NCT03036930|566309816|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
156877468|NCT05271552|566309817|FG000|Overall Study|Adverse Event|4|||
156738812|NCT01473394|565791164|FG001|Overall Study|Insufficient Therapeutic Response|1|||
156797414|NCT03909971|566011328|FG000|Overall Study|Participant transition to rollover study|26|||
156797415|NCT03909971|566011329|FG001|Overall Study|Participant transition to rollover study|9|||
156797416|NCT03909971|566011328|FG000|Overall Study|Global Deterioration of Health Status|2|||
156877469|NCT05271552|566309818|FG001|Overall Study|Adverse Event|6|||
156458316|NCT05485779|564774690|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458317|NCT05485779|564774691|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458318|NCT05485779|564774692|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458319|NCT05485779|564774693|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458320|NCT05485779|564774694|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458321|NCT05485779|564774695|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458322|NCT05485779|564774696|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458323|NCT05485779|564774697|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458324|NCT05485779|564774698|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458325|NCT05485779|564774699|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
156458326|NCT05485779|564774700|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
156458327|NCT05485779|564774690|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458328|NCT05485779|564774691|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458329|NCT05485779|564774692|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458330|NCT05485779|564774693|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
156458331|NCT05485779|564774694|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458332|NCT05485779|564774695|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458333|NCT05485779|564774696|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458334|NCT05485779|564774697|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156460624|NCT04625725|564781650|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
156460625|NCT04625725|564781651|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
156797417|NCT03909971|566011329|FG001|Overall Study|Global Deterioration of Health Status|2|||
156797418|NCT03909971|566011328|FG000|Overall Study|Progressive Disease|28|||
156797419|NCT03909971|566011329|FG001|Overall Study|Progressive Disease|21|||
156797420|NCT03909971|566011328|FG000|Overall Study|Death|6|||
156797421|NCT03909971|566011329|FG001|Overall Study|Death|6|||
156797422|NCT03909971|566011328|FG000|Overall Study|Adverse Event|1|||
156797423|NCT03909971|566011329|FG001|Overall Study|Adverse Event|2|||
156797424|NCT03909971|566011328|FG000|Overall Study|Withdrawal by Subject|2|||
156797425|NCT03909971|566011329|FG001|Overall Study|Withdrawal by Subject|1|||
156797426|NCT03909971|566011328|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
156797427|NCT03909971|566011329|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
156797428|NCT03909971|566011328|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
156797429|NCT03909971|566011329|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
156797430|NCT01877278|566011330|FG000|Overall Study|Lost to Follow-up|3|||
156797431|NCT01877278|566011331|FG001|Overall Study|Lost to Follow-up|3|||
156797432|NCT01969058|566011332|FG000|Overall Study|Withdrawal by Subject|2|||
156797433|NCT01969058|566011333|FG001|Overall Study|Withdrawal by Subject|0|||
156797434|NCT01969058|566011332|FG000|Overall Study|Adverse Event|1|||
156797435|NCT01969058|566011333|FG001|Overall Study|Adverse Event|0|||
156797436|NCT04090749|566011336|FG000|Open Label Pilot|Lost to Follow-up|1|||
156797437|NCT04090749|566011337|FG001|Open Label Pilot|Lost to Follow-up|0|||
156877470|NCT05271552|566309819|FG002|Overall Study|Adverse Event|3|||
156458335|NCT05485779|564774698|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458336|NCT05485779|564774699|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458337|NCT05485779|564774700|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156458338|NCT02038777|564774701|FG000|Overall Study|Death|0|||
156458339|NCT02038777|564774702|FG001|Overall Study|Death|2|||
156458340|NCT02038777|564774703|FG002|Overall Study|Death|0|||
156458341|NCT02038777|564774704|FG003|Overall Study|Death|1|||
156458342|NCT02038777|564774705|FG004|Overall Study|Death|2|||
156458343|NCT02038777|564774706|FG005|Overall Study|Death|4|||
156458344|NCT02038777|564774707|FG006|Overall Study|Death|0|||
156458345|NCT02038777|564774708|FG007|Overall Study|Death|11|||
156458346|NCT02038777|564774701|FG000|Overall Study|Lost to Follow-up|0|||
156458347|NCT02038777|564774702|FG001|Overall Study|Lost to Follow-up|0|||
156458348|NCT02038777|564774703|FG002|Overall Study|Lost to Follow-up|0|||
156458349|NCT02038777|564774704|FG003|Overall Study|Lost to Follow-up|1|||
156458350|NCT02038777|564774705|FG004|Overall Study|Lost to Follow-up|0|||
156458351|NCT02038777|564774706|FG005|Overall Study|Lost to Follow-up|0|||
156458352|NCT02038777|564774707|FG006|Overall Study|Lost to Follow-up|0|||
156458353|NCT02038777|564774708|FG007|Overall Study|Lost to Follow-up|0|||
156458354|NCT02038777|564774701|FG000|Overall Study|Other|0|||
156458355|NCT02038777|564774702|FG001|Overall Study|Other|1|||
156458356|NCT02038777|564774703|FG002|Overall Study|Other|0|||
156458357|NCT02038777|564774704|FG003|Overall Study|Other|2|||
156458358|NCT02038777|564774705|FG004|Overall Study|Other|1|||
156458359|NCT02038777|564774706|FG005|Overall Study|Other|0|||
156458360|NCT02038777|564774707|FG006|Overall Study|Other|0|||
156458361|NCT02038777|564774708|FG007|Overall Study|Other|0|||
156458362|NCT02038777|564774701|FG000|Overall Study|Randomized but not treated|0|||
156458363|NCT02038777|564774702|FG001|Overall Study|Randomized but not treated|1|||
156458364|NCT02038777|564774703|FG002|Overall Study|Randomized but not treated|0|||
156458365|NCT02038777|564774704|FG003|Overall Study|Randomized but not treated|0|||
156458366|NCT02038777|564774705|FG004|Overall Study|Randomized but not treated|0|||
156458367|NCT02038777|564774706|FG005|Overall Study|Randomized but not treated|0|||
156738813|NCT01473394|565791163|FG000|Overall Study|Protocol Violation|7|||
156738814|NCT01473394|565791164|FG001|Overall Study|Protocol Violation|5|||
156738815|NCT01473394|565791163|FG000|Overall Study|Withdrew Consent|12|||
156738816|NCT01473394|565791164|FG001|Overall Study|Withdrew Consent|10|||
156738817|NCT01473394|565791163|FG000|Overall Study|Lost to Follow-up|9|||
156877471|NCT05271552|566309817|FG000|Overall Study|Death|1|||
156458368|NCT02038777|564774707|FG006|Overall Study|Randomized but not treated|0|||
156458369|NCT02038777|564774708|FG007|Overall Study|Randomized but not treated|0|||
156458370|NCT02038777|564774701|FG000|Overall Study|Started Chemotherapy|1|||
156458371|NCT02038777|564774702|FG001|Overall Study|Started Chemotherapy|0|||
156458372|NCT02038777|564774703|FG002|Overall Study|Started Chemotherapy|3|||
156458373|NCT02038777|564774704|FG003|Overall Study|Started Chemotherapy|0|||
156458374|NCT02038777|564774705|FG004|Overall Study|Started Chemotherapy|0|||
156458375|NCT02038777|564774706|FG005|Overall Study|Started Chemotherapy|0|||
156458376|NCT02038777|564774707|FG006|Overall Study|Started Chemotherapy|0|||
156458377|NCT02038777|564774708|FG007|Overall Study|Started Chemotherapy|0|||
156458378|NCT02038777|564774701|FG000|Overall Study|participation terminated by sponsor|0|||
156458379|NCT02038777|564774702|FG001|Overall Study|participation terminated by sponsor|0|||
156458380|NCT02038777|564774703|FG002|Overall Study|participation terminated by sponsor|0|||
156458381|NCT02038777|564774704|FG003|Overall Study|participation terminated by sponsor|0|||
156458382|NCT02038777|564774705|FG004|Overall Study|participation terminated by sponsor|0|||
156458383|NCT02038777|564774706|FG005|Overall Study|participation terminated by sponsor|0|||
156458384|NCT02038777|564774707|FG006|Overall Study|participation terminated by sponsor|1|||
156458385|NCT02038777|564774708|FG007|Overall Study|participation terminated by sponsor|1|||
156458386|NCT04299464|564774709|FG000|Overall Study|Adverse Event|1|||
156458387|NCT04299464|564774710|FG001|Overall Study|Adverse Event|0|||
156458388|NCT04299464|564774711|FG002|Overall Study|Adverse Event|2|||
156458389|NCT04299464|564774709|FG000|Overall Study|Non-compliance with Study Drug|1|||
156458390|NCT04299464|564774710|FG001|Overall Study|Non-compliance with Study Drug|0|||
156877472|NCT05271552|566309818|FG001|Overall Study|Death|1|||
156877473|NCT05271552|566309819|FG002|Overall Study|Death|1|||
156458391|NCT04299464|564774711|FG002|Overall Study|Non-compliance with Study Drug|0|||
156458392|NCT04299464|564774709|FG000|Overall Study|Reason not Specified|0|||
156458393|NCT04299464|564774710|FG001|Overall Study|Reason not Specified|1|||
156458394|NCT04299464|564774711|FG002|Overall Study|Reason not Specified|3|||
156458395|NCT04299464|564774709|FG000|Overall Study|Physician Decision|0|||
156458396|NCT04299464|564774710|FG001|Overall Study|Physician Decision|1|||
156458397|NCT04299464|564774711|FG002|Overall Study|Physician Decision|1|||
156458398|NCT04299464|564774709|FG000|Overall Study|Withdrawal by Subject|0|||
156738818|NCT01473394|565791164|FG001|Overall Study|Lost to Follow-up|11|||
156458399|NCT04299464|564774710|FG001|Overall Study|Withdrawal by Subject|2|||
156534597|NCT01399190|565052406|FG000|Overall Study|Adverse Event|8|||
156738819|NCT03391232|565791165|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
156458400|NCT04299464|564774711|FG002|Overall Study|Withdrawal by Subject|1|||
156458401|NCT03030261|564774714|FG000|Overall Study|Still receiving continuation therapy|5|||
156458402|NCT05293171|564774721|FG000|Washout 5 to 7 Days|Adverse Event|1|||
156458403|NCT05293171|564774722|FG001|Washout 5 to 7 Days|Adverse Event|1|||
156458404|NCT05293171|564774723|FG002|Washout 5 to 7 Days|Adverse Event|0|||
156458405|NCT05293171|564774724|FG003|Washout 5 to 7 Days|Adverse Event|0|||
156458406|NCT05293171|564774725|FG004|Washout 5 to 7 Days|Adverse Event|0|||
156458407|NCT05293171|564774726|FG005|Washout 5 to 7 Days|Adverse Event|0|||
156458408|NCT05293171|564774727|FG006|Washout 5 to 7 Days|Adverse Event|0|||
156458409|NCT05293171|564774728|FG007|Washout 5 to 7 Days|Adverse Event|0|||
156458410|NCT05293171|564774729|FG008|Washout 5 to 7 Days|Adverse Event|0|||
156458411|NCT05293171|564774730|FG009|Washout 5 to 7 Days|Adverse Event|0|||
156458412|NCT05293171|564774731|FG010|Washout 5 to 7 Days|Adverse Event|0|||
156458413|NCT05293171|564774732|FG011|Washout 5 to 7 Days|Adverse Event|0|||
156738820|NCT03391232|565791166|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
156738821|NCT03391232|565791165|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
156877474|NCT05271552|566309817|FG000|Overall Study|Lost to Follow-up|1|||
156877475|NCT05271552|566309818|FG001|Overall Study|Lost to Follow-up|5|||
156877476|NCT05271552|566309819|FG002|Overall Study|Lost to Follow-up|4|||
156877477|NCT05271552|566309817|FG000|Overall Study|Withdrawal by Subject|0|||
156877478|NCT05271552|566309818|FG001|Overall Study|Withdrawal by Subject|4|||
156877479|NCT05271552|566309819|FG002|Overall Study|Withdrawal by Subject|7|||
156877480|NCT05271552|566309817|FG000|Overall Study|Other medical reason.|1|||
156877481|NCT05271552|566309818|FG001|Overall Study|Other medical reason.|2|||
156877482|NCT05271552|566309819|FG002|Overall Study|Other medical reason.|0|||
156877483|NCT05271552|566309817|FG000|Overall Study|Other|3|||
156877484|NCT05271552|566309818|FG001|Overall Study|Other|3|||
156877485|NCT05271552|566309819|FG002|Overall Study|Other|6|||
156877486|NCT04227899|566309828|FG000|Overall Study|Withdrawal by Subject|6|||
156877487|NCT04227899|566309829|FG001|Overall Study|Withdrawal by Subject|3|||
156877488|NCT04227899|566309828|FG000|Overall Study|Death|12|||
156877489|NCT04227899|566309829|FG001|Overall Study|Death|6|||
156877490|NCT04227899|566309828|FG000|Overall Study|Lost to Follow-up|2|||
156877491|NCT04227899|566309829|FG001|Overall Study|Lost to Follow-up|1|||
156877492|NCT05151471|566309830|FG000|Overall Study|Adverse Event|21|||
156877493|NCT05151471|566309831|FG001|Overall Study|Adverse Event|16|||
156738822|NCT03391232|565791166|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
156877494|NCT05151471|566309830|FG000|Overall Study|Death|1|||
156877495|NCT05151471|566309831|FG001|Overall Study|Death|0|||
156877496|NCT05151471|566309830|FG000|Overall Study|Lost to Follow-up|0|||
156877497|NCT05151471|566309831|FG001|Overall Study|Lost to Follow-up|1|||
156877498|NCT05151471|566309830|FG000|Overall Study|Withdrawal by Subject|7|||
156877499|NCT05151471|566309831|FG001|Overall Study|Withdrawal by Subject|9|||
156877500|NCT05151471|566309830|FG000|Overall Study|Study terminated by sponsor|49|||
156877501|NCT05151471|566309831|FG001|Overall Study|Study terminated by sponsor|47|||
156877502|NCT05151471|566309830|FG000|Overall Study|Other|2|||
156877503|NCT05151471|566309831|FG001|Overall Study|Other|1|||
156877504|NCT03988608|566309832|FG000|Overall Study|Adverse Event|1|||
156877505|NCT03988608|566309832|FG000|Overall Study|Lost to Follow-up|1|||
156877506|NCT03988608|566309832|FG000|Overall Study|Withdrawal by Subject|3|||
156738823|NCT02091960|565791167|FG000|Overall Study|Death|7|||
156738824|NCT02091960|565791167|FG000|Overall Study|Withdrawal by Subject|1|||
156738825|NCT02091960|565791167|FG000|Overall Study|Miscellaneous Reasons|37|||
156738826|NCT02637895|565791181|FG000|Overall Study|Lost to Follow-up|4|||
156738827|NCT02637895|565791182|FG001|Overall Study|Lost to Follow-up|0|||
156738828|NCT02637895|565791181|FG000|Overall Study|Protocol Violation|0|||
156738829|NCT02637895|565791182|FG001|Overall Study|Protocol Violation|1|||
156738830|NCT02637895|565791181|FG000|Overall Study|Lack of Efficacy|1|||
156877507|NCT03988608|566309832|FG000|Overall Study|Death|1|||
156877508|NCT03840993|566309834|FG000|Overall Study|Adverse Event|1|||
156877509|NCT03840993|566309835|FG001|Overall Study|Adverse Event|0|||
156877510|NCT03840993|566309834|FG000|Overall Study|Lost to Follow-up|4|||
156877511|NCT03840993|566309835|FG001|Overall Study|Lost to Follow-up|0|||
156877512|NCT03840993|566309834|FG000|Overall Study|Physician Decision|0|||
156877513|NCT03840993|566309835|FG001|Overall Study|Physician Decision|1|||
156877514|NCT03840993|566309834|FG000|Overall Study|Pregnancy|0|||
156877515|NCT03840993|566309835|FG001|Overall Study|Pregnancy|1|||
156877516|NCT03840993|566309834|FG000|Overall Study|Withdrawal by Subject|1|||
156877517|NCT03840993|566309835|FG001|Overall Study|Withdrawal by Subject|3|||
156877518|NCT03840993|566309834|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
156458414|NCT05293171|564774721|FG000|Washout 5 to 7 Days|Adverse Event|0|||
156458415|NCT05293171|564774722|FG001|Washout 5 to 7 Days|Adverse Event|0|||
156458416|NCT05293171|564774723|FG002|Washout 5 to 7 Days|Adverse Event|0|||
156458417|NCT05293171|564774724|FG003|Washout 5 to 7 Days|Adverse Event|0|||
156738831|NCT02637895|565791182|FG001|Overall Study|Lack of Efficacy|0|||
156738832|NCT02637895|565791181|FG000|Overall Study|Withdrawal by Subject|1|||
156877519|NCT03840993|566309835|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
156877520|NCT00998881|566309846|FG000|Overall Study|Adverse Event|2|||
156877521|NCT00998881|566309847|FG001|Overall Study|Adverse Event|2|||
156877522|NCT00998881|566309846|FG000|Overall Study|Lack of Efficacy|1|||
156877523|NCT00998881|566309847|FG001|Overall Study|Lack of Efficacy|0|||
156877524|NCT00998881|566309846|FG000|Overall Study|Physician Decision|3|||
156738833|NCT02637895|565791182|FG001|Overall Study|Withdrawal by Subject|1|||
156738834|NCT02637895|565791181|FG000|Overall Study|Abnormal baseline lab|0|||
156738835|NCT02637895|565791182|FG001|Overall Study|Abnormal baseline lab|1|||
156738836|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Adverse Event|6|||
156738837|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Adverse Event|14|||
156738838|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Death|3|||
156738839|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Death|1|||
156738840|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
156738841|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
156738842|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
156738843|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
156738844|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
156738845|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
156738846|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
156738847|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
156738848|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
156738849|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
156738850|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Physician Decision|2|||
156738851|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Physician Decision|4|||
156738852|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Pregnancy|2|||
156738853|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Pregnancy|1|||
156738854|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
156738855|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
156738856|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
156738857|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
156738858|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
156738859|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
156738860|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
156738861|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
156738862|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
156738863|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
156738864|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
156738865|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
156738866|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
156738867|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
156738868|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
156738869|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
156738870|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
156738871|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
156738872|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
156738873|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
156738874|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
156738875|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
156738876|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
156738877|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
156738878|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
156738879|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
156738880|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
156877525|NCT00998881|566309847|FG001|Overall Study|Physician Decision|0|||
156877526|NCT00998881|566309846|FG000|Overall Study|Withdrawal by Subject|1|||
156877527|NCT00998881|566309847|FG001|Overall Study|Withdrawal by Subject|0|||
156877528|NCT00998881|566309846|FG000|Overall Study|Personal matter|1|||
156738881|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
156738882|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
156738883|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
156738884|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
156738885|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
156738886|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
156738887|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
156738888|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
156738889|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
156738890|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
156738891|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
156877529|NCT00998881|566309847|FG001|Overall Study|Personal matter|0|||
156877530|NCT03292458|566309848|FG000|Period 1|Adverse Event|2|||
156738892|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
156738893|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
156738894|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
156738895|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
156738896|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
156738897|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
156738898|NCT01054300|565791194|FG000|Period 1|Adverse Event|1|||
156738899|NCT01054300|565791195|FG001|Period 1|Adverse Event|0|||
156738900|NCT01054300|565791196|FG002|Period 1|Adverse Event|0|||
156738901|NCT01054300|565791197|FG003|Period 1|Adverse Event|0|||
156738902|NCT01054300|565791194|FG000|Period 2|Withdrawal by Subject|0|||
156738903|NCT01054300|565791195|FG001|Period 2|Withdrawal by Subject|0|||
156738904|NCT01054300|565791196|FG002|Period 2|Withdrawal by Subject|1|||
156738905|NCT01054300|565791197|FG003|Period 2|Withdrawal by Subject|0|||
156738906|NCT00738881|565791205|FG000|Overall Study|Withdrawal by Subject|0|||
156738907|NCT00738881|565791206|FG001|Overall Study|Withdrawal by Subject|2|||
156738908|NCT00177307|565791210|FG000|Overall Study|Withdrawal by Subject|1|||
156738909|NCT01282164|565791211|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
156738910|NCT01282164|565791212|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
156738911|NCT04521621|565791213|FG000|Overall Study|Death|17|||
156738912|NCT04521621|565791214|FG001|Overall Study|Death|8|||
156738913|NCT04521621|565791215|FG002|Overall Study|Death|8|||
156738914|NCT04521621|565791216|FG003|Overall Study|Death|5|||
156738915|NCT04521621|565791217|FG004|Overall Study|Death|2|||
156738916|NCT04521621|565791218|FG005|Overall Study|Death|7|||
156738917|NCT04521621|565791219|FG006|Overall Study|Death|0|||
156738918|NCT04521621|565791220|FG007|Overall Study|Death|0|||
156738919|NCT04521621|565791213|FG000|Overall Study|Study Terminated by Sponsor|4|||
156738920|NCT04521621|565791214|FG001|Overall Study|Study Terminated by Sponsor|6|||
156738921|NCT04521621|565791215|FG002|Overall Study|Study Terminated by Sponsor|8|||
156738922|NCT04521621|565791216|FG003|Overall Study|Study Terminated by Sponsor|0|||
156738923|NCT04521621|565791217|FG004|Overall Study|Study Terminated by Sponsor|1|||
156738924|NCT04521621|565791218|FG005|Overall Study|Study Terminated by Sponsor|7|||
156738925|NCT04521621|565791219|FG006|Overall Study|Study Terminated by Sponsor|0|||
156738926|NCT04521621|565791220|FG007|Overall Study|Study Terminated by Sponsor|0|||
156738927|NCT04521621|565791213|FG000|Overall Study|Withdrawal by Subject|0|||
156738928|NCT04521621|565791214|FG001|Overall Study|Withdrawal by Subject|0|||
156738929|NCT04521621|565791215|FG002|Overall Study|Withdrawal by Subject|1|||
156738930|NCT04521621|565791216|FG003|Overall Study|Withdrawal by Subject|1|||
156738931|NCT04521621|565791217|FG004|Overall Study|Withdrawal by Subject|0|||
156738932|NCT04521621|565791218|FG005|Overall Study|Withdrawal by Subject|0|||
156877531|NCT03292458|566309849|FG001|Period 1|Adverse Event|0|||
156877532|NCT04927364|566309850|FG000|Overall Study|Withdrawal by Subject|3|||
156877533|NCT04927364|566309850|FG000|Overall Study|Unable to complete preassessment MRI|1|||
156738933|NCT04521621|565791219|FG006|Overall Study|Withdrawal by Subject|0|||
156738934|NCT04521621|565791220|FG007|Overall Study|Withdrawal by Subject|0|||
156738935|NCT04521621|565791213|FG000|Overall Study|Allocated in error without study intervention|1|||
156797438|NCT04090749|566011338|FG002|Open Label Pilot|Lost to Follow-up|0|||
156877534|NCT04281485|566309851|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
156877535|NCT04281485|566309852|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
156877536|NCT04281485|566309851|FG000|Overall Study|Ongoing (Safety data collection)|10|||
156877537|NCT04281485|566309852|FG001|Overall Study|Ongoing (Safety data collection)|5|||
156877538|NCT04203160|566309853|FG000|Overall Study|Alternative Therapy|3|||
156797439|NCT04090749|566011336|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
156797440|NCT04090749|566011337|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
156797441|NCT04090749|566011338|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
156797442|NCT04090749|566011336|FG000|Pilot Trial|Lost to Follow-up|0|||
156797443|NCT04090749|566011337|FG001|Pilot Trial|Lost to Follow-up|1|||
156797444|NCT04090749|566011338|FG002|Pilot Trial|Lost to Follow-up|1|||
156797445|NCT03510715|566011339|FG000|Overall Study|Adverse Event|1|||
156797446|NCT03510715|566011340|FG001|Overall Study|Adverse Event|0|||
156797447|NCT05185453|566011352|FG000|Overall Study|Lost to Follow-up|13|||
156797448|NCT05185453|566011353|FG001|Overall Study|Lost to Follow-up|3|||
156797449|NCT04144517|566011357|FG000|Overall Study|Physician Decision|0|||
156877539|NCT04203160|566309854|FG001|Overall Study|Alternative Therapy|0|||
156738936|NCT04521621|565791214|FG001|Overall Study|Allocated in error without study intervention|0|||
156738937|NCT04521621|565791215|FG002|Overall Study|Allocated in error without study intervention|0|||
156738938|NCT04521621|565791216|FG003|Overall Study|Allocated in error without study intervention|0|||
156738939|NCT04521621|565791217|FG004|Overall Study|Allocated in error without study intervention|0|||
156738940|NCT04521621|565791218|FG005|Overall Study|Allocated in error without study intervention|0|||
156738941|NCT04521621|565791219|FG006|Overall Study|Allocated in error without study intervention|0|||
156797450|NCT04144517|566011358|FG001|Overall Study|Physician Decision|1|||
156797451|NCT04144517|566011357|FG000|Overall Study|Other|2|||
156797452|NCT04144517|566011358|FG001|Overall Study|Other|2|||
156877540|NCT04203160|566309855|FG002|Overall Study|Alternative Therapy|1|||
156877541|NCT04203160|566309856|FG003|Overall Study|Alternative Therapy|0|||
156877542|NCT04203160|566309857|FG004|Overall Study|Alternative Therapy|0|||
156738942|NCT04521621|565791220|FG007|Overall Study|Allocated in error without study intervention|0|||
156738943|NCT03671564|565791221|FG000|Overall Study|Progressive Disease|3|||
156738944|NCT03671564|565791222|FG001|Overall Study|Progressive Disease|5|||
156738945|NCT03671564|565791223|FG002|Overall Study|Progressive Disease|3|||
156738946|NCT03671564|565791221|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
156738947|NCT03671564|565791222|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
156738948|NCT03671564|565791223|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
156738949|NCT03671564|565791221|FG000|Overall Study|Withdrawal by Subject|1|||
156738950|NCT03671564|565791222|FG001|Overall Study|Withdrawal by Subject|1|||
156738951|NCT03671564|565791223|FG002|Overall Study|Withdrawal by Subject|0|||
156738952|NCT01968707|565791228|FG000|Overall Study|Did not meet treatment day baseline|49|||
156738953|NCT01968707|565791229|FG001|Overall Study|Did not meet treatment day baseline|12|||
156738954|NCT01968707|565791230|FG002|Overall Study|Did not meet treatment day baseline|41|||
156738955|NCT01968707|565791231|FG003|Overall Study|Did not meet treatment day baseline|44|||
156738956|NCT01968707|565791232|FG004|Overall Study|Did not meet treatment day baseline|36|||
156738957|NCT01968707|565791233|FG005|Overall Study|Did not meet treatment day baseline|11|||
156738958|NCT01968707|565791234|FG006|Overall Study|Did not meet treatment day baseline|34|||
156738959|NCT01968707|565791235|FG007|Overall Study|Did not meet treatment day baseline|35|||
156738960|NCT01104246|565791240|FG000|Overall Study|Withdrawal by Subject|1|||
156738961|NCT01104246|565791240|FG000|Overall Study|did not meet inclusion criteria|4|||
156738962|NCT03640481|565791243|FG000|Overall Study|Death|14|||
156738963|NCT03640481|565791244|FG001|Overall Study|Death|14|||
156738964|NCT03640481|565791245|FG002|Overall Study|Death|0|||
156738965|NCT03640481|565791246|FG003|Overall Study|Death|0|||
156738966|NCT03640481|565791243|FG000|Overall Study|Lost to Follow-up|2|||
156738967|NCT03640481|565791244|FG001|Overall Study|Lost to Follow-up|0|||
156738968|NCT03640481|565791245|FG002|Overall Study|Lost to Follow-up|0|||
156738969|NCT03640481|565791246|FG003|Overall Study|Lost to Follow-up|0|||
156738970|NCT03640481|565791243|FG000|Overall Study|Site terminated by sponsor|1|||
156738971|NCT03640481|565791244|FG001|Overall Study|Site terminated by sponsor|3|||
156738972|NCT03640481|565791245|FG002|Overall Study|Site terminated by sponsor|0|||
156738973|NCT03640481|565791246|FG003|Overall Study|Site terminated by sponsor|0|||
156738974|NCT03640481|565791243|FG000|Overall Study|Study terminated by sponsor|29|||
156738975|NCT03640481|565791244|FG001|Overall Study|Study terminated by sponsor|42|||
156738976|NCT03640481|565791245|FG002|Overall Study|Study terminated by sponsor|1|||
156738977|NCT03640481|565791246|FG003|Overall Study|Study terminated by sponsor|0|||
156738978|NCT03640481|565791243|FG000|Overall Study|Withdrawal by Subject|5|||
156738979|NCT03640481|565791244|FG001|Overall Study|Withdrawal by Subject|4|||
156738980|NCT03640481|565791245|FG002|Overall Study|Withdrawal by Subject|0|||
156738981|NCT03640481|565791246|FG003|Overall Study|Withdrawal by Subject|1|||
156738982|NCT03640481|565791243|FG000|Overall Study|Other|26|||
156738983|NCT03640481|565791244|FG001|Overall Study|Other|12|||
156738984|NCT03640481|565791245|FG002|Overall Study|Other|1|||
156738985|NCT03640481|565791246|FG003|Overall Study|Other|0|||
156738986|NCT03640481|565791243|FG000|Overall Study|Randomized, but not treated|1|||
156738987|NCT03640481|565791244|FG001|Overall Study|Randomized, but not treated|3|||
156738988|NCT03640481|565791245|FG002|Overall Study|Randomized, but not treated|0|||
156738989|NCT03640481|565791246|FG003|Overall Study|Randomized, but not treated|0|||
156738990|NCT01546168|565791247|FG000|Overall Study|Lost to Follow-up|1|||
156797453|NCT04144517|566011357|FG000|Overall Study|Death|6|||
156797454|NCT04144517|566011358|FG001|Overall Study|Death|3|||
156797455|NCT05929326|566011376|FG000|Overall Study|unqualified sample|2|||
156797456|NCT05929326|566011377|FG001|Overall Study|unqualified sample|3|||
156797457|NCT05929326|566011378|FG002|Overall Study|unqualified sample|7|||
156877543|NCT04203160|566309858|FG005|Overall Study|Alternative Therapy|2|||
156877544|NCT04203160|566309853|FG000|Overall Study|Withdrawal by Subject|4|||
156877545|NCT04203160|566309854|FG001|Overall Study|Withdrawal by Subject|5|||
156738991|NCT01546168|565791248|FG001|Overall Study|Lost to Follow-up|0|||
156738992|NCT01546168|565791247|FG000|Overall Study|Withdrawal by Subject|1|||
156738993|NCT01546168|565791248|FG001|Overall Study|Withdrawal by Subject|0|||
156797458|NCT02495883|566011385|FG000|Overall Study|Excessive head motion|1|||
156797459|NCT02495883|566011386|FG001|Overall Study|Excessive head motion|0|||
156336897|NCT01313312|564331409|FG000|Overall Study|Adverse Event|5|||
156738994|NCT01546168|565791247|FG000|Overall Study|ineligible after signing consent|2|||
156738995|NCT01546168|565791248|FG001|Overall Study|ineligible after signing consent|0|||
156738996|NCT02850016|565791251|FG000|Overall Study|Withdrawal by Subject|1|||
156738997|NCT02850016|565791252|FG001|Overall Study|Withdrawal by Subject|2|||
156738998|NCT00070018|565791255|FG000|Overall Study|Adverse Event|2|||
156738999|NCT00070018|565791255|FG000|Overall Study|Lack of Efficacy|1|||
156739000|NCT00070018|565791255|FG000|Overall Study|Withdrawal by Subject|1|||
156797460|NCT00964678|566011387|FG000|Overall Study|Physician Decision|4|||
156877546|NCT04203160|566309855|FG002|Overall Study|Withdrawal by Subject|0|||
156877547|NCT04203160|566309856|FG003|Overall Study|Withdrawal by Subject|0|||
156797461|NCT03359395|566011388|FG000|First Intervention A / B|Withdrawal by Subject|1|||
156877548|NCT04203160|566309857|FG004|Overall Study|Withdrawal by Subject|0|||
156877549|NCT04203160|566309858|FG005|Overall Study|Withdrawal by Subject|4|||
156877550|NCT04203160|566309853|FG000|Overall Study|Adverse Event|7|||
156797462|NCT03359395|566011389|FG001|First Intervention A / B|Withdrawal by Subject|0|||
156797463|NCT03359395|566011388|FG000|First Intervention A / B|Lost to Follow-up|2|||
156797464|NCT03359395|566011389|FG001|First Intervention A / B|Lost to Follow-up|3|||
156797465|NCT03359395|566011388|FG000|Second Intervention B/A|Exclusion criteria|0|||
156797466|NCT03359395|566011389|FG001|Second Intervention B/A|Exclusion criteria|1|||
156797467|NCT03359395|566011388|FG000|Second Intervention B/A|Lost to Follow-up|3|||
156797468|NCT03359395|566011389|FG001|Second Intervention B/A|Lost to Follow-up|2|||
156797469|NCT03164356|566011390|FG000|Overall Study|Lost to Follow-up|1|||
156797470|NCT03164356|566011391|FG001|Overall Study|Lost to Follow-up|1|||
156797471|NCT03164356|566011392|FG002|Overall Study|Lost to Follow-up|2|||
156797472|NCT03164356|566011393|FG003|Overall Study|Lost to Follow-up|1|||
156797473|NCT03164356|566011390|FG000|Overall Study|Physician Decision|0|||
156797474|NCT03164356|566011391|FG001|Overall Study|Physician Decision|0|||
156797475|NCT03164356|566011392|FG002|Overall Study|Physician Decision|3|||
156797476|NCT03164356|566011393|FG003|Overall Study|Physician Decision|0|||
156797477|NCT03164356|566011390|FG000|Overall Study|Protocol Violation|2|||
156797478|NCT03164356|566011391|FG001|Overall Study|Protocol Violation|1|||
156797479|NCT03164356|566011392|FG002|Overall Study|Protocol Violation|0|||
156797480|NCT03164356|566011393|FG003|Overall Study|Protocol Violation|0|||
156877551|NCT04203160|566309854|FG001|Overall Study|Adverse Event|5|||
156877552|NCT04203160|566309855|FG002|Overall Study|Adverse Event|0|||
156877553|NCT04203160|566309856|FG003|Overall Study|Adverse Event|0|||
156877554|NCT04203160|566309857|FG004|Overall Study|Adverse Event|0|||
156877555|NCT04203160|566309858|FG005|Overall Study|Adverse Event|0|||
156877556|NCT04203160|566309853|FG000|Overall Study|Sponsor Termination|1|||
156877557|NCT04203160|566309854|FG001|Overall Study|Sponsor Termination|0|||
156877558|NCT04203160|566309855|FG002|Overall Study|Sponsor Termination|0|||
156739001|NCT02939716|565791256|FG000|Overall Study|scanner failure|0|||
156739002|NCT02939716|565791257|FG001|Overall Study|scanner failure|0|||
156739003|NCT02939716|565791258|FG002|Overall Study|scanner failure|0|||
156739004|NCT02939716|565791259|FG003|Overall Study|scanner failure|1|||
156739005|NCT02939716|565791260|FG004|Overall Study|scanner failure|1|||
156739006|NCT02939716|565791261|FG005|Overall Study|scanner failure|1|||
156739007|NCT04442269|565791264|FG000|Overall Study|Adverse Event|1|||
156739008|NCT04442269|565791265|FG001|Overall Study|Adverse Event|0|||
156739009|NCT04442269|565791264|FG000|Overall Study|Death|0|||
156739010|NCT04442269|565791265|FG001|Overall Study|Death|1|||
156739011|NCT04442269|565791264|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
156739012|NCT04442269|565791265|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
156739013|NCT04442269|565791264|FG000|Overall Study|Lost to Follow-up|1|||
156739014|NCT04442269|565791265|FG001|Overall Study|Lost to Follow-up|0|||
156739015|NCT04442269|565791264|FG000|Overall Study|Withdrawal by Subject|3|||
156739016|NCT04442269|565791265|FG001|Overall Study|Withdrawal by Subject|2|||
156739017|NCT04442269|565791264|FG000|Overall Study|Protocol Deviation|0|||
156739018|NCT04442269|565791265|FG001|Overall Study|Protocol Deviation|1|||
156739019|NCT04442269|565791264|FG000|Overall Study|Travel Limitations|1|||
156739020|NCT04442269|565791265|FG001|Overall Study|Travel Limitations|1|||
156739021|NCT03802565|565791269|FG000|Overall Study|Adverse Event|0|||
156739022|NCT03802565|565791270|FG001|Overall Study|Adverse Event|1|||
156739023|NCT03802565|565791271|FG002|Overall Study|Adverse Event|2|||
156739024|NCT03802565|565791272|FG003|Overall Study|Adverse Event|1|||
156739025|NCT03802565|565791273|FG004|Overall Study|Adverse Event|1|||
156739026|NCT03802565|565791269|FG000|Overall Study|Withdrawal by Subject|2|||
156797481|NCT03164356|566011390|FG000|Overall Study|Withdrawal by Subject|1|||
156877559|NCT04203160|566309856|FG003|Overall Study|Sponsor Termination|0|||
156877560|NCT04203160|566309857|FG004|Overall Study|Sponsor Termination|0|||
156877561|NCT04203160|566309858|FG005|Overall Study|Sponsor Termination|0|||
156877562|NCT04203160|566309853|FG000|Overall Study|Physician Decision|3|||
156739027|NCT03802565|565791270|FG001|Overall Study|Withdrawal by Subject|2|||
156739028|NCT03802565|565791271|FG002|Overall Study|Withdrawal by Subject|2|||
156797482|NCT03164356|566011391|FG001|Overall Study|Withdrawal by Subject|0|||
156797483|NCT03164356|566011392|FG002|Overall Study|Withdrawal by Subject|0|||
156797484|NCT03164356|566011393|FG003|Overall Study|Withdrawal by Subject|0|||
156739029|NCT03802565|565791272|FG003|Overall Study|Withdrawal by Subject|0|||
156797485|NCT03164356|566011390|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
156797486|NCT03164356|566011391|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
156797487|NCT03164356|566011392|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
156877563|NCT04203160|566309854|FG001|Overall Study|Physician Decision|2|||
156877564|NCT04203160|566309855|FG002|Overall Study|Physician Decision|0|||
156877565|NCT04203160|566309856|FG003|Overall Study|Physician Decision|0|||
156877566|NCT04203160|566309857|FG004|Overall Study|Physician Decision|0|||
156739030|NCT03802565|565791273|FG004|Overall Study|Withdrawal by Subject|1|||
156739031|NCT03802565|565791269|FG000|Overall Study|Protocol Violation|2|||
156739032|NCT03802565|565791270|FG001|Overall Study|Protocol Violation|1|||
156739033|NCT03802565|565791271|FG002|Overall Study|Protocol Violation|4|||
156739034|NCT03802565|565791272|FG003|Overall Study|Protocol Violation|5|||
156739035|NCT03802565|565791273|FG004|Overall Study|Protocol Violation|1|||
156739036|NCT03802565|565791269|FG000|Overall Study|Lost to Follow-up|0|||
156739037|NCT03802565|565791270|FG001|Overall Study|Lost to Follow-up|0|||
156739038|NCT03802565|565791271|FG002|Overall Study|Lost to Follow-up|1|||
156739039|NCT03802565|565791272|FG003|Overall Study|Lost to Follow-up|0|||
156739040|NCT03802565|565791273|FG004|Overall Study|Lost to Follow-up|0|||
156739041|NCT03802565|565791269|FG000|Overall Study|Subjects Related to Each Other|1|||
156739042|NCT03802565|565791270|FG001|Overall Study|Subjects Related to Each Other|0|||
156739043|NCT03802565|565791271|FG002|Overall Study|Subjects Related to Each Other|0|||
156739044|NCT03802565|565791272|FG003|Overall Study|Subjects Related to Each Other|2|||
156739045|NCT03802565|565791273|FG004|Overall Study|Subjects Related to Each Other|1|||
156739046|NCT03802565|565791269|FG000|Overall Study|Elevated Enzymes|0|||
156739047|NCT03802565|565791270|FG001|Overall Study|Elevated Enzymes|0|||
156739048|NCT03802565|565791271|FG002|Overall Study|Elevated Enzymes|0|||
156739049|NCT03802565|565791272|FG003|Overall Study|Elevated Enzymes|0|||
156739050|NCT03802565|565791273|FG004|Overall Study|Elevated Enzymes|2|||
156739051|NCT00430352|565791274|FG000|Overall Study|Disease progression|58|||
156739052|NCT00430352|565791274|FG000|Overall Study|Withdrawal by Subject|11|||
156739053|NCT00430352|565791274|FG000|Overall Study|Adverse Event|16|||
156739054|NCT00430352|565791274|FG000|Overall Study|Death|5|||
156739055|NCT00430352|565791274|FG000|Overall Study|Other|48|||
156739056|NCT03099694|565791275|FG000|Overall Study|Withdrawal by Subject|11|||
156739057|NCT03099694|565791276|FG001|Overall Study|Withdrawal by Subject|13|||
156739058|NCT03099694|565791275|FG000|Overall Study|Lost to Follow-up|9|||
156739059|NCT03099694|565791276|FG001|Overall Study|Lost to Follow-up|5|||
156739060|NCT04326439|565791277|FG000|Overall Study|Withdrawal by Subject|1|||
156739061|NCT04326439|565791278|FG001|Overall Study|Withdrawal by Subject|0|||
156739062|NCT04326439|565791277|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
156739063|NCT04326439|565791278|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
156739064|NCT04326439|565791277|FG000|Overall Study|Relapse after Induction 2|0|||
156739065|NCT04326439|565791278|FG001|Overall Study|Relapse after Induction 2|1|||
156739066|NCT04326439|565791277|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
156739067|NCT04326439|565791278|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
156739068|NCT01446237|565791281|FG000|Overall Study|Adverse Event|1|||
156739069|NCT01446237|565791281|FG000|Overall Study|Lost to Follow-up|2|||
156739070|NCT01446237|565791281|FG000|Overall Study|Withdrawal by Subject|7|||
156739071|NCT01744184|565791296|FG000|Overall Study|Adverse Event|1|||
156739072|NCT01744184|565791297|FG001|Overall Study|Adverse Event|0|||
156739073|NCT01744184|565791296|FG000|Overall Study|Withdrawal by Subject|0|||
156739074|NCT01744184|565791297|FG001|Overall Study|Withdrawal by Subject|1|||
156739075|NCT00072280|565791298|FG000|Treatment|Found ineligible|1|||
156739076|NCT00072280|565791299|FG001|Treatment|Found ineligible|2|||
156739077|NCT00072280|565791298|FG000|Follow-up|Early termination of study|2|||
156739078|NCT00072280|565791299|FG001|Follow-up|Early termination of study|2|||
156739079|NCT02841280|565791300|FG000|Overall Study|Adverse Event|2|||
156739080|NCT02841280|565791301|FG001|Overall Study|Adverse Event|1|||
156739081|NCT02841280|565791300|FG000|Overall Study|Death|1|||
156739082|NCT02841280|565791301|FG001|Overall Study|Death|0|||
156739083|NCT02841280|565791300|FG000|Overall Study|Lost to Follow-up|2|||
156739084|NCT02841280|565791301|FG001|Overall Study|Lost to Follow-up|2|||
156739085|NCT02841280|565791300|FG000|Overall Study|Withdrawal by Subject|7|||
156739086|NCT02841280|565791301|FG001|Overall Study|Withdrawal by Subject|3|||
156739087|NCT02841280|565791300|FG000|Overall Study|Stop Point: BP above threshold|2|||
156739088|NCT02841280|565791301|FG001|Overall Study|Stop Point: BP above threshold|0|||
156739089|NCT00957268|565791302|FG000|Overall Study|Voluntary Withdrawal|0|||
156739090|NCT00957268|565791303|FG001|Overall Study|Voluntary Withdrawal|0|||
156739091|NCT00957268|565791304|FG002|Overall Study|Voluntary Withdrawal|1|||
156739092|NCT00957268|565791305|FG003|Overall Study|Voluntary Withdrawal|0|||
156739093|NCT00957268|565791306|FG004|Overall Study|Voluntary Withdrawal|0|||
156739094|NCT01340027|565791308|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
156739095|NCT01340027|565791309|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
156739096|NCT01340027|565791310|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
156739097|NCT01340027|565791311|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
156739098|NCT01340027|565791312|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
156739099|NCT01340027|565791313|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
156739100|NCT01340027|565791314|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
156739101|NCT01340027|565791315|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
156739102|NCT01340027|565791316|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
156739103|NCT01340027|565791317|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
156739104|NCT01340027|565791318|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
156739105|NCT01340027|565791319|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
156739106|NCT01340027|565791308|FG000|Overall Study|Adverse Event|0|||
156739107|NCT01340027|565791309|FG001|Overall Study|Adverse Event|1|||
156739108|NCT01340027|565791310|FG002|Overall Study|Adverse Event|2|||
156739109|NCT01340027|565791311|FG003|Overall Study|Adverse Event|0|||
156739110|NCT01340027|565791312|FG004|Overall Study|Adverse Event|1|||
156739111|NCT01340027|565791313|FG005|Overall Study|Adverse Event|2|||
156739112|NCT01340027|565791314|FG006|Overall Study|Adverse Event|2|||
156739113|NCT01340027|565791315|FG007|Overall Study|Adverse Event|1|||
156739114|NCT01340027|565791316|FG008|Overall Study|Adverse Event|4|||
156739115|NCT01340027|565791317|FG009|Overall Study|Adverse Event|1|||
156739116|NCT01340027|565791318|FG010|Overall Study|Adverse Event|1|||
156739117|NCT01340027|565791319|FG011|Overall Study|Adverse Event|3|||
156739118|NCT01340027|565791308|FG000|Overall Study|Lack of Efficacy|0|||
156739119|NCT01340027|565791309|FG001|Overall Study|Lack of Efficacy|0|||
156739120|NCT01340027|565791310|FG002|Overall Study|Lack of Efficacy|0|||
156739121|NCT01340027|565791311|FG003|Overall Study|Lack of Efficacy|0|||
156739122|NCT01340027|565791312|FG004|Overall Study|Lack of Efficacy|0|||
156739123|NCT01340027|565791313|FG005|Overall Study|Lack of Efficacy|0|||
156739124|NCT01340027|565791314|FG006|Overall Study|Lack of Efficacy|1|||
156739125|NCT01340027|565791315|FG007|Overall Study|Lack of Efficacy|1|||
156739126|NCT01340027|565791316|FG008|Overall Study|Lack of Efficacy|1|||
156739127|NCT01340027|565791317|FG009|Overall Study|Lack of Efficacy|0|||
156739128|NCT01340027|565791318|FG010|Overall Study|Lack of Efficacy|0|||
156739129|NCT01340027|565791319|FG011|Overall Study|Lack of Efficacy|0|||
156739130|NCT01340027|565791308|FG000|Overall Study|Lost to Follow-up|0|||
156739131|NCT01340027|565791309|FG001|Overall Study|Lost to Follow-up|1|||
156739132|NCT01340027|565791310|FG002|Overall Study|Lost to Follow-up|0|||
156739133|NCT01340027|565791311|FG003|Overall Study|Lost to Follow-up|0|||
156739134|NCT01340027|565791312|FG004|Overall Study|Lost to Follow-up|0|||
156739135|NCT01340027|565791313|FG005|Overall Study|Lost to Follow-up|0|||
156739136|NCT01340027|565791314|FG006|Overall Study|Lost to Follow-up|1|||
156739137|NCT01340027|565791315|FG007|Overall Study|Lost to Follow-up|0|||
156739138|NCT01340027|565791316|FG008|Overall Study|Lost to Follow-up|0|||
156739139|NCT01340027|565791317|FG009|Overall Study|Lost to Follow-up|1|||
156739140|NCT01340027|565791318|FG010|Overall Study|Lost to Follow-up|0|||
156739141|NCT01340027|565791319|FG011|Overall Study|Lost to Follow-up|0|||
156739142|NCT01340027|565791308|FG000|Overall Study|Protocol Violation|1|||
156739143|NCT01340027|565791309|FG001|Overall Study|Protocol Violation|2|||
156739144|NCT01340027|565791310|FG002|Overall Study|Protocol Violation|0|||
156739145|NCT01340027|565791311|FG003|Overall Study|Protocol Violation|0|||
156739146|NCT01340027|565791312|FG004|Overall Study|Protocol Violation|6|||
156739147|NCT01340027|565791313|FG005|Overall Study|Protocol Violation|0|||
156739148|NCT01340027|565791314|FG006|Overall Study|Protocol Violation|0|||
156739149|NCT01340027|565791315|FG007|Overall Study|Protocol Violation|1|||
156739150|NCT01340027|565791316|FG008|Overall Study|Protocol Violation|2|||
156739151|NCT01340027|565791317|FG009|Overall Study|Protocol Violation|2|||
156739152|NCT01340027|565791318|FG010|Overall Study|Protocol Violation|0|||
156739153|NCT01340027|565791319|FG011|Overall Study|Protocol Violation|0|||
156739154|NCT01340027|565791308|FG000|Overall Study|Withdrawal by Subject|4|||
156739155|NCT01340027|565791309|FG001|Overall Study|Withdrawal by Subject|3|||
156739156|NCT01340027|565791310|FG002|Overall Study|Withdrawal by Subject|1|||
156739157|NCT01340027|565791311|FG003|Overall Study|Withdrawal by Subject|3|||
156739158|NCT01340027|565791312|FG004|Overall Study|Withdrawal by Subject|3|||
156739159|NCT01340027|565791313|FG005|Overall Study|Withdrawal by Subject|2|||
156739160|NCT01340027|565791314|FG006|Overall Study|Withdrawal by Subject|3|||
156739161|NCT01340027|565791315|FG007|Overall Study|Withdrawal by Subject|4|||
156739162|NCT01340027|565791316|FG008|Overall Study|Withdrawal by Subject|1|||
156739163|NCT01340027|565791317|FG009|Overall Study|Withdrawal by Subject|2|||
156739164|NCT01340027|565791318|FG010|Overall Study|Withdrawal by Subject|0|||
156739165|NCT01340027|565791319|FG011|Overall Study|Withdrawal by Subject|1|||
156739166|NCT01340027|565791308|FG000|Overall Study|Miscellaneous|0|||
156739167|NCT01340027|565791309|FG001|Overall Study|Miscellaneous|0|||
156739168|NCT01340027|565791310|FG002|Overall Study|Miscellaneous|0|||
156739169|NCT01340027|565791311|FG003|Overall Study|Miscellaneous|1|||
156739170|NCT01340027|565791312|FG004|Overall Study|Miscellaneous|0|||
156739171|NCT01340027|565791313|FG005|Overall Study|Miscellaneous|0|||
156739172|NCT01340027|565791314|FG006|Overall Study|Miscellaneous|0|||
156739173|NCT01340027|565791315|FG007|Overall Study|Miscellaneous|0|||
156739174|NCT01340027|565791316|FG008|Overall Study|Miscellaneous|0|||
156739175|NCT01340027|565791317|FG009|Overall Study|Miscellaneous|0|||
156739176|NCT01340027|565791318|FG010|Overall Study|Miscellaneous|1|||
156739177|NCT01340027|565791319|FG011|Overall Study|Miscellaneous|0|||
156739178|NCT00833482|565791320|FG000|Days 11-20|Adverse Event|0|||
156739179|NCT00833482|565791321|FG001|Days 11-20|Adverse Event|2|||
156739180|NCT00833482|565791322|FG002|Days 11-20|Adverse Event|0|||
156739181|NCT00833482|565791323|FG003|Days 11-20|Adverse Event|0|||
156739182|NCT00833482|565791324|FG004|Days 11-20|Adverse Event|0|||
156739183|NCT00833482|565791325|FG005|Days 11-20|Adverse Event|0|||
156739184|NCT00833482|565791320|FG000|Days 11-20|Withdrawal by Subject|0|||
156739185|NCT00833482|565791321|FG001|Days 11-20|Withdrawal by Subject|1|||
156739186|NCT00833482|565791322|FG002|Days 11-20|Withdrawal by Subject|0|||
156739187|NCT00833482|565791323|FG003|Days 11-20|Withdrawal by Subject|0|||
156739188|NCT00833482|565791324|FG004|Days 11-20|Withdrawal by Subject|0|||
156797488|NCT03164356|566011393|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
156797489|NCT03164356|566011390|FG000|Overall Study|Subject Incarcerated|0|||
156797490|NCT03164356|566011391|FG001|Overall Study|Subject Incarcerated|1|||
156797491|NCT03164356|566011392|FG002|Overall Study|Subject Incarcerated|0|||
156336898|NCT01313312|564331409|FG000|Overall Study|Withdrawal by Subject|18|||
156336899|NCT01313312|564331409|FG000|Overall Study|Lack of Efficacy|3|||
156336900|NCT01313312|564331409|FG000|Overall Study|Investigator Decision|1|||
156739189|NCT00833482|565791325|FG005|Days 11-20|Withdrawal by Subject|0|||
156739190|NCT00833482|565791320|FG000|Days 21-30|Adverse Event|0|||
156739191|NCT00833482|565791321|FG001|Days 21-30|Adverse Event|0|||
156739192|NCT00833482|565791322|FG002|Days 21-30|Adverse Event|1|||
156739193|NCT00833482|565791323|FG003|Days 21-30|Adverse Event|0|||
156739194|NCT00833482|565791324|FG004|Days 21-30|Adverse Event|0|||
156739195|NCT00833482|565791325|FG005|Days 21-30|Adverse Event|0|||
156739196|NCT00833482|565791320|FG000|Days 21-30|Withdrawal by Subject|0|||
156739197|NCT00833482|565791321|FG001|Days 21-30|Withdrawal by Subject|0|||
156739198|NCT00833482|565791322|FG002|Days 21-30|Withdrawal by Subject|0|||
156739199|NCT00833482|565791323|FG003|Days 21-30|Withdrawal by Subject|0|||
156739200|NCT00833482|565791324|FG004|Days 21-30|Withdrawal by Subject|1|||
156739201|NCT00833482|565791325|FG005|Days 21-30|Withdrawal by Subject|0|||
156739202|NCT02496091|565791326|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156739203|NCT02234596|565791330|FG000|Overall Study|Participant not treated|2|||
156739204|NCT00197002|565793102|FG000|Overall Study|Adverse Event|0|||
156739205|NCT00197002|565793103|FG001|Overall Study|Adverse Event|1|||
156739206|NCT00197002|565793104|FG002|Overall Study|Adverse Event|0|||
156739207|NCT00197002|565793102|FG000|Overall Study|Protocol Violation|1|||
156739208|NCT00197002|565793103|FG001|Overall Study|Protocol Violation|0|||
156739209|NCT00197002|565793104|FG002|Overall Study|Protocol Violation|2|||
156739210|NCT00197002|565793102|FG000|Overall Study|Withdrawal by Subject|9|||
156739211|NCT00197002|565793103|FG001|Overall Study|Withdrawal by Subject|5|||
156739212|NCT00197002|565793104|FG002|Overall Study|Withdrawal by Subject|7|||
156739213|NCT00197002|565793102|FG000|Overall Study|Migrated/moved from study area|3|||
156739214|NCT00197002|565793103|FG001|Overall Study|Migrated/moved from study area|5|||
156739215|NCT00197002|565793104|FG002|Overall Study|Migrated/moved from study area|1|||
156739216|NCT00197002|565793102|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
156739217|NCT00197002|565793103|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
156739218|NCT00197002|565793104|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
156739219|NCT00197002|565793102|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
156739220|NCT00197002|565793103|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
156739221|NCT00197002|565793104|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
156739222|NCT00197002|565793102|FG000|Overall Study|Others|3|||
156739223|NCT00197002|565793103|FG001|Overall Study|Others|1|||
156739224|NCT00197002|565793104|FG002|Overall Study|Others|1|||
156739225|NCT05376241|565793105|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
156739226|NCT05376241|565793105|FG000|Overall Study|103 did not complete the survey|103|||
156739227|NCT05376241|565793105|FG000|Overall Study|17 failed 2 attention check questions|17|||
156739228|NCT03036098|565793106|FG000|Pre-Treatment|Other Reasons|1|||
156739229|NCT03036098|565793107|FG001|Pre-Treatment|Other Reasons|2|||
156739230|NCT03036098|565793108|FG002|Pre-Treatment|Other Reasons|0|||
156739231|NCT03036098|565793109|FG003|Pre-Treatment|Other Reasons|5|||
156739232|NCT03036098|565793106|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
156739233|NCT03036098|565793107|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
156739234|NCT03036098|565793108|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
156739235|NCT03036098|565793109|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
156739236|NCT03036098|565793106|FG000|Pre-Treatment|Withdrawal by Subject|1|||
156739237|NCT03036098|565793107|FG001|Pre-Treatment|Withdrawal by Subject|14|||
156739238|NCT03036098|565793108|FG002|Pre-Treatment|Withdrawal by Subject|0|||
156739239|NCT03036098|565793109|FG003|Pre-Treatment|Withdrawal by Subject|5|||
156739240|NCT03036098|565793106|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
156739241|NCT03036098|565793107|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
156739242|NCT03036098|565793108|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
156739243|NCT03036098|565793109|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
156739244|NCT03036098|565793106|FG000|Treatment|Disease Progression|130|||
156739245|NCT03036098|565793107|FG001|Treatment|Disease Progression|77|||
156739246|NCT03036098|565793108|FG002|Treatment|Disease Progression|168|||
156739247|NCT03036098|565793109|FG003|Treatment|Disease Progression|50|||
156739248|NCT03036098|565793106|FG000|Treatment|Study Drug Toxicity|95|||
156739249|NCT03036098|565793107|FG001|Treatment|Study Drug Toxicity|45|||
156739250|NCT03036098|565793108|FG002|Treatment|Study Drug Toxicity|26|||
156739251|NCT03036098|565793109|FG003|Treatment|Study Drug Toxicity|22|||
156739252|NCT03036098|565793106|FG000|Treatment|Death|9|||
156739253|NCT03036098|565793107|FG001|Treatment|Death|3|||
156739254|NCT03036098|565793108|FG002|Treatment|Death|1|||
156797492|NCT03164356|566011393|FG003|Overall Study|Subject Incarcerated|0|||
156739255|NCT03036098|565793109|FG003|Treatment|Death|2|||
156739256|NCT03036098|565793106|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
156739257|NCT03036098|565793107|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
156739258|NCT03036098|565793108|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
156739259|NCT03036098|565793109|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
156739260|NCT03036098|565793106|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
156739261|NCT03036098|565793107|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
156739262|NCT03036098|565793108|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
156739263|NCT03036098|565793109|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
156739264|NCT03036098|565793106|FG000|Treatment|Withdrawal by Subject|2|||
156739265|NCT03036098|565793107|FG001|Treatment|Withdrawal by Subject|9|||
156739266|NCT03036098|565793108|FG002|Treatment|Withdrawal by Subject|2|||
156739267|NCT03036098|565793109|FG003|Treatment|Withdrawal by Subject|4|||
156739268|NCT03036098|565793106|FG000|Treatment|Maximum Clinical Benefit|6|||
156739269|NCT03036098|565793107|FG001|Treatment|Maximum Clinical Benefit|1|||
156739270|NCT03036098|565793108|FG002|Treatment|Maximum Clinical Benefit|6|||
156739271|NCT03036098|565793109|FG003|Treatment|Maximum Clinical Benefit|10|||
156739272|NCT03036098|565793106|FG000|Treatment|Poor/Non Compliance|1|||
156739273|NCT03036098|565793107|FG001|Treatment|Poor/Non Compliance|2|||
156739274|NCT03036098|565793108|FG002|Treatment|Poor/Non Compliance|0|||
156739275|NCT03036098|565793109|FG003|Treatment|Poor/Non Compliance|1|||
156739276|NCT03036098|565793106|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
156739277|NCT03036098|565793107|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
156739278|NCT03036098|565793108|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
156739279|NCT03036098|565793109|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
156739280|NCT03036098|565793106|FG000|Treatment|Administrative Reason by Sponsor|1|||
156739281|NCT03036098|565793107|FG001|Treatment|Administrative Reason by Sponsor|0|||
156739282|NCT03036098|565793108|FG002|Treatment|Administrative Reason by Sponsor|2|||
156739283|NCT03036098|565793109|FG003|Treatment|Administrative Reason by Sponsor|1|||
156739284|NCT03036098|565793106|FG000|Treatment|Other Reasons|31|||
156739285|NCT03036098|565793107|FG001|Treatment|Other Reasons|5|||
156739286|NCT03036098|565793108|FG002|Treatment|Other Reasons|21|||
156739287|NCT03036098|565793109|FG003|Treatment|Other Reasons|8|||
156739288|NCT03036098|565793106|FG000|Treatment|Ongoing Treatment|0|||
156739289|NCT03036098|565793107|FG001|Treatment|Ongoing Treatment|0|||
156739290|NCT03036098|565793108|FG002|Treatment|Ongoing Treatment|23|||
156739291|NCT03036098|565793109|FG003|Treatment|Ongoing Treatment|0|||
156739292|NCT04240886|565793112|FG000|Treatment Phase|Death|4|||
156739293|NCT04240886|565793112|FG000|Treatment Phase|Discontinuation by Subject|1|||
156739294|NCT04240886|565793112|FG000|Treatment Phase|Adverse Event|5|||
156739295|NCT04240886|565793112|FG000|Follow-up Phase|Withdrawal by Subject|1|||
156739296|NCT04240886|565793112|FG000|Follow-up Phase|Discontinuation by Subject|1|||
156739297|NCT04240886|565793112|FG000|Follow-up Phase|Death|2|||
156739298|NCT01632904|565793113|FG000|Overall Study|Adverse Event|4|||
156739299|NCT01632904|565793114|FG001|Overall Study|Adverse Event|1|||
156739300|NCT01632904|565793113|FG000|Overall Study|Physician Decision|0|||
156739301|NCT01632904|565793114|FG001|Overall Study|Physician Decision|1|||
156739302|NCT01632904|565793113|FG000|Overall Study|Subject decision|3|||
156739303|NCT01632904|565793114|FG001|Overall Study|Subject decision|2|||
156739304|NCT01632904|565793113|FG000|Overall Study|Disease Progression|0|||
156739305|NCT01632904|565793114|FG001|Overall Study|Disease Progression|1|||
156739306|NCT01632904|565793113|FG000|Overall Study|Reason for discontinuation not available|0|||
156739307|NCT01632904|565793114|FG001|Overall Study|Reason for discontinuation not available|1|||
156739308|NCT01944670|565793117|FG000|Overall Study|Lost to Follow-up|2|||
156739309|NCT03339726|565793121|FG000|Overall Study|Withdrawal by Subject|1|||
156739310|NCT03339726|565793122|FG001|Overall Study|Withdrawal by Subject|0|||
156739311|NCT03339726|565793123|FG002|Overall Study|Withdrawal by Subject|0|||
156739312|NCT03339726|565793121|FG000|Overall Study|Lost to Follow-up|0|||
156739313|NCT03339726|565793122|FG001|Overall Study|Lost to Follow-up|1|||
156739314|NCT03339726|565793123|FG002|Overall Study|Lost to Follow-up|0|||
156739315|NCT04542499|565793130|FG000|Overall Study|Adverse Event|23|||
156739316|NCT04542499|565793131|FG001|Overall Study|Adverse Event|43|||
156739317|NCT04542499|565793130|FG000|Overall Study|Lack of Efficacy|5|||
156739318|NCT04542499|565793131|FG001|Overall Study|Lack of Efficacy|2|||
156739319|NCT04542499|565793130|FG000|Overall Study|Lost to Follow-up|3|||
156739320|NCT04542499|565793131|FG001|Overall Study|Lost to Follow-up|4|||
156739321|NCT04542499|565793130|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
156739322|NCT04542499|565793131|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
156739323|NCT04542499|565793130|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
156797493|NCT03164356|566011390|FG000|Overall Study|Prosthetist unable to participate|0|||
156336901|NCT01313312|564331409|FG000|Overall Study|Observational Phase|1|||
156739324|NCT04542499|565793131|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
156739325|NCT04542499|565793130|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156739326|NCT04542499|565793131|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156739327|NCT04542499|565793130|FG000|Overall Study|Physician Decision|0|||
156739328|NCT04542499|565793131|FG001|Overall Study|Physician Decision|1|||
156739329|NCT04542499|565793130|FG000|Overall Study|Site Terminated by Sponsor|3|||
156739330|NCT04542499|565793131|FG001|Overall Study|Site Terminated by Sponsor|5|||
156739331|NCT04542499|565793130|FG000|Overall Study|Withdrawal by Subject|12|||
156739332|NCT04542499|565793131|FG001|Overall Study|Withdrawal by Subject|33|||
156739333|NCT04542499|565793130|FG000|Overall Study|Other|2|||
156739334|NCT04542499|565793131|FG001|Overall Study|Other|2|||
156739335|NCT04035434|565793137|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739336|NCT04035434|565793138|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739337|NCT04035434|565793139|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739338|NCT04035434|565793140|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
156739339|NCT04035434|565793141|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739340|NCT04035434|565793142|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739341|NCT04035434|565793143|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739342|NCT04035434|565793144|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739343|NCT04035434|565793145|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739344|NCT04035434|565793146|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739345|NCT04035434|565793147|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739346|NCT04035434|565793148|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739347|NCT04035434|565793149|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739348|NCT04035434|565793137|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739349|NCT04035434|565793138|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
156739350|NCT04035434|565793139|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
156739351|NCT04035434|565793140|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739352|NCT04035434|565793141|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
156739353|NCT04035434|565793142|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739354|NCT04035434|565793143|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
156739355|NCT04035434|565793144|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
156739356|NCT04035434|565793145|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739357|NCT04035434|565793146|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
156739358|NCT04035434|565793147|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739359|NCT04035434|565793148|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
156739360|NCT04035434|565793149|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
156739361|NCT04035434|565793137|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739362|NCT04035434|565793138|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
156739363|NCT04035434|565793139|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
156739364|NCT04035434|565793140|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739365|NCT04035434|565793141|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
156739366|NCT04035434|565793142|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
156739367|NCT04035434|565793143|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739368|NCT04035434|565793144|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739369|NCT04035434|565793145|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
156739370|NCT04035434|565793146|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
156739371|NCT04035434|565793147|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739372|NCT04035434|565793148|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
156739373|NCT04035434|565793149|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
156739374|NCT04035434|565793137|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739375|NCT04035434|565793138|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739376|NCT04035434|565793139|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739377|NCT04035434|565793140|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
156739378|NCT04035434|565793141|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156797494|NCT03164356|566011391|FG001|Overall Study|Prosthetist unable to participate|2|||
156797495|NCT03164356|566011392|FG002|Overall Study|Prosthetist unable to participate|1|||
156797496|NCT03164356|566011393|FG003|Overall Study|Prosthetist unable to participate|0|||
156797497|NCT04490278|566013339|FG000|Overall Study|Lost to Follow-up|6|||
156797498|NCT03243084|566013341|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
156797499|NCT03243084|566013342|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
156797500|NCT02507934|566013348|FG000|Overall Study|Lost to Follow-up|2|||
156797501|NCT02507934|566013349|FG001|Overall Study|Lost to Follow-up|0|||
156797502|NCT02507934|566013348|FG000|Overall Study|Withdrawal by Subject|2|||
156797503|NCT02507934|566013349|FG001|Overall Study|Withdrawal by Subject|0|||
156797504|NCT03766399|566013351|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156336902|NCT01313312|564331409|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
156336903|NCT01313312|564331409|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
156797505|NCT03766399|566013352|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797506|NCT03766399|566013353|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156336904|NCT00932126|564331414|FG000|Overall Study|Adverse Event|0|||
156336905|NCT00932126|564331415|FG001|Overall Study|Adverse Event|0|||
156739379|NCT04035434|565793142|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739380|NCT04035434|565793143|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739381|NCT04035434|565793144|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739382|NCT04035434|565793145|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739383|NCT04035434|565793146|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739384|NCT04035434|565793147|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739385|NCT04035434|565793148|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739386|NCT04035434|565793149|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739387|NCT04035434|565793137|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739388|NCT04035434|565793138|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739389|NCT04035434|565793139|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739390|NCT04035434|565793140|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739391|NCT04035434|565793141|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739392|NCT04035434|565793142|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
156739393|NCT04035434|565793143|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
156739394|NCT04035434|565793144|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739395|NCT04035434|565793145|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739396|NCT04035434|565793146|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739397|NCT04035434|565793147|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739398|NCT04035434|565793148|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739399|NCT04035434|565793149|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739400|NCT04035434|565793137|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739401|NCT04035434|565793138|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739402|NCT04035434|565793139|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739403|NCT04035434|565793140|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739404|NCT04035434|565793141|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739405|NCT04035434|565793142|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739406|NCT04035434|565793143|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739407|NCT04035434|565793144|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739408|NCT04035434|565793145|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739409|NCT04035434|565793146|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739410|NCT04035434|565793147|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739411|NCT04035434|565793148|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739412|NCT04035434|565793149|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739413|NCT04035434|565793137|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739414|NCT04035434|565793138|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739415|NCT04035434|565793139|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739416|NCT04035434|565793140|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739417|NCT04035434|565793141|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739418|NCT04035434|565793142|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
156739419|NCT04035434|565793143|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
156739420|NCT04035434|565793144|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739421|NCT04035434|565793145|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739422|NCT04035434|565793146|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739423|NCT04035434|565793147|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739424|NCT04035434|565793148|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739425|NCT04035434|565793149|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156877567|NCT04203160|566309858|FG005|Overall Study|Physician Decision|0|||
156877568|NCT04317599|566309859|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
156877569|NCT04317599|566309859|FG000|Overall Study|treatment outside standard of care|4|||
156877570|NCT02276885|566309860|FG000|Overall Study|Withdrawal by Subject|2|||
156877571|NCT02276885|566309861|FG001|Overall Study|Withdrawal by Subject|0|||
156877572|NCT02276885|566309860|FG000|Overall Study|Lost to Follow-up|5|||
156877573|NCT02276885|566309861|FG001|Overall Study|Lost to Follow-up|2|||
156877574|NCT04569032|566309865|FG000|Overall Study|Death|10|||
156877575|NCT04569032|566309866|FG001|Overall Study|Death|13|||
156877576|NCT04569032|566309865|FG000|Overall Study|Withdrawal by Subject|2|||
156739426|NCT02759055|565793150|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
156739427|NCT02759055|565793151|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
156739428|NCT04161079|565793152|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
156877577|NCT04569032|566309866|FG001|Overall Study|Withdrawal by Subject|0|||
156877578|NCT04569032|566309865|FG000|Overall Study|Lost to Follow-up|0|||
156877579|NCT04569032|566309866|FG001|Overall Study|Lost to Follow-up|1|||
156877580|NCT04569032|566309865|FG000|Overall Study|In long term follow up|22|||
156877581|NCT04569032|566309866|FG001|Overall Study|In long term follow up|34|||
156877582|NCT03541200|566309867|FG000|Overall Study|Adverse Event|19|||
156739429|NCT02515994|565793153|FG000|Overall Study|Protocol Violation|3|||
156739430|NCT02515994|565793154|FG001|Overall Study|Protocol Violation|5|||
156739431|NCT02515994|565793153|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
156739432|NCT02515994|565793154|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
156739433|NCT02515994|565793153|FG000|Overall Study|Adverse Event|3|||
156739434|NCT02515994|565793154|FG001|Overall Study|Adverse Event|1|||
156739435|NCT02515994|565793153|FG000|Overall Study|Withdrawal by Subject|2|||
156739436|NCT02515994|565793154|FG001|Overall Study|Withdrawal by Subject|0|||
156739437|NCT04045132|565793158|FG000|Overall Study|Lost to Follow-up|3|||
156739438|NCT04045132|565793159|FG001|Overall Study|Lost to Follow-up|6|||
156739439|NCT02879994|565793160|FG000|Overall Study|off treatment early|7|||
156739440|NCT02879994|565793160|FG000|Overall Study|Adverse Event|2|||
156739441|NCT02879994|565793160|FG000|Overall Study|Death|2|||
156739442|NCT02143791|565793161|FG000|Enrolled|Withdrawal by Subject|4|||
156739443|NCT02143791|565793161|FG000|Trial Stimulation|Lack of Efficacy|21|||
156739444|NCT02143791|565793161|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
156739445|NCT02143791|565793161|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
156739446|NCT02143791|565793161|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
156739447|NCT02143791|565793161|FG000|Any Programming (3-6 Months)|Missing Data|1|||
156739448|NCT02143791|565793161|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
156739449|NCT04984681|565793167|FG000|Overall Study|Lost to Follow-up|3|||
156739450|NCT04984681|565793168|FG001|Overall Study|Lost to Follow-up|1|||
156739451|NCT01214252|565793169|FG000|Overall Study|Not eligible per protocol|82|||
156739452|NCT00552032|565793171|FG000|Overall Study|Withdrawal by Subject|2|||
156739453|NCT00552032|565793172|FG001|Overall Study|Withdrawal by Subject|2|||
156739454|NCT00552032|565793171|FG000|Overall Study|Protocol Violation|7|||
156739455|NCT00552032|565793172|FG001|Overall Study|Protocol Violation|12|||
156739456|NCT00552032|565793171|FG000|Overall Study|Lost to Follow-up|8|||
156739457|NCT00552032|565793172|FG001|Overall Study|Lost to Follow-up|5|||
156739458|NCT05845567|565793175|FG000|Overall Study|Withdrawal by Subject|1|||
156739459|NCT02062944|565793180|FG000|Overall Study|Lost to Follow-up|1|||
156739460|NCT02062944|565793180|FG000|Overall Study|New hemotological disorder identified|1|||
156739461|NCT02062944|565793180|FG000|Overall Study|Uncontrolled Hypertension|1|||
156739462|NCT02062944|565793180|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
156739463|NCT02035748|565793181|FG000|Overall Study|Adverse Event|5|||
156739464|NCT02035748|565793181|FG000|Overall Study|Death|3|||
156739465|NCT02035748|565793181|FG000|Overall Study|Lost to Follow-up|2|||
156739466|NCT02035748|565793181|FG000|Overall Study|Physician Decision|3|||
156739467|NCT02035748|565793181|FG000|Overall Study|Withdrawal by Subject|6|||
156739468|NCT02035748|565793181|FG000|Overall Study|Progressive Disease|1|||
156739469|NCT02083185|565793182|FG000|Overall Study|Lost to Follow-up|0|||
156739470|NCT02083185|565793183|FG001|Overall Study|Lost to Follow-up|3|||
156739471|NCT02083185|565793184|FG002|Overall Study|Lost to Follow-up|0|||
156739472|NCT02083185|565793182|FG000|Overall Study|Withdrawal by Subject|9|||
156739473|NCT02083185|565793183|FG001|Overall Study|Withdrawal by Subject|15|||
156739474|NCT02083185|565793184|FG002|Overall Study|Withdrawal by Subject|1|||
156739475|NCT02083185|565793182|FG000|Overall Study|Death|2|||
156739476|NCT02083185|565793183|FG001|Overall Study|Death|2|||
156739477|NCT02083185|565793184|FG002|Overall Study|Death|1|||
156739478|NCT02083185|565793182|FG000|Overall Study|Reason not Specified|9|||
156739479|NCT02083185|565793183|FG001|Overall Study|Reason not Specified|6|||
156739480|NCT02083185|565793184|FG002|Overall Study|Reason not Specified|5|||
156739481|NCT02083185|565793182|FG000|Overall Study|Study Terminated by Sponsor|0|||
156739482|NCT02083185|565793183|FG001|Overall Study|Study Terminated by Sponsor|1|||
156739483|NCT02083185|565793184|FG002|Overall Study|Study Terminated by Sponsor|0|||
156739484|NCT02083185|565793182|FG000|Overall Study|Did not Receive Study Drug|0|||
156739485|NCT02083185|565793183|FG001|Overall Study|Did not Receive Study Drug|2|||
156739486|NCT02083185|565793184|FG002|Overall Study|Did not Receive Study Drug|0|||
156739487|NCT01740128|565793185|FG000|Overall Study|Pregnancy|0|||
156739488|NCT01740128|565793186|FG001|Overall Study|Pregnancy|1|||
156739489|NCT01740128|565793185|FG000|Overall Study|Protocol Violation|1|||
156739490|NCT01740128|565793186|FG001|Overall Study|Protocol Violation|2|||
156739491|NCT01740128|565793185|FG000|Overall Study|Lost to Follow-up|2|||
156739492|NCT01740128|565793186|FG001|Overall Study|Lost to Follow-up|2|||
156739493|NCT01740128|565793185|FG000|Overall Study|Withdrawal by Subject|1|||
156739494|NCT01740128|565793186|FG001|Overall Study|Withdrawal by Subject|0|||
156739495|NCT01740128|565793185|FG000|Overall Study|Insufficient protocol compliance|2|||
156739496|NCT01740128|565793186|FG001|Overall Study|Insufficient protocol compliance|2|||
156797507|NCT03766399|566013354|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797508|NCT03766399|566013355|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797509|NCT03766399|566013356|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797510|NCT03766399|566013357|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156877583|NCT03541200|566309867|FG000|Overall Study|Death|1|||
156739497|NCT02474589|565793187|FG000|Overall Study|Adverse Event|6|||
156739498|NCT02474589|565793188|FG001|Overall Study|Adverse Event|2|||
156739499|NCT02474589|565793187|FG000|Overall Study|Lost to Follow-up|6|||
156739500|NCT02474589|565793188|FG001|Overall Study|Lost to Follow-up|1|||
156739501|NCT02474589|565793187|FG000|Overall Study|Protocol Violation|4|||
156739502|NCT02474589|565793188|FG001|Overall Study|Protocol Violation|1|||
156739503|NCT02474589|565793187|FG000|Overall Study|Withdrawal by Subject|4|||
156739504|NCT02474589|565793188|FG001|Overall Study|Withdrawal by Subject|0|||
156739505|NCT02474589|565793187|FG000|Overall Study|Inability to complete study procedures|5|||
156739506|NCT02474589|565793188|FG001|Overall Study|Inability to complete study procedures|1|||
156739507|NCT02231879|565793189|FG000|Overall Study|Adverse Event|2|||
156739508|NCT02231879|565793190|FG001|Overall Study|Adverse Event|1|||
156739509|NCT02231879|565793189|FG000|Overall Study|Lack of Efficacy|0|||
156739510|NCT02231879|565793190|FG001|Overall Study|Lack of Efficacy|1|||
156739511|NCT05007041|565793191|FG000|Overall Study|Missing Diary Entries|0|||
156739512|NCT05007041|565793192|FG001|Overall Study|Missing Diary Entries|1|||
156739513|NCT00705718|565793193|FG000|Overall Study|Death|6|||
156739514|NCT00705718|565793194|FG001|Overall Study|Death|6|||
156739515|NCT00705718|565793193|FG000|Overall Study|Not due for Visit|0|||
156739516|NCT00705718|565793194|FG001|Overall Study|Not due for Visit|12|||
156739517|NCT00705718|565793193|FG000|Overall Study|Follow up not done|1|||
156739518|NCT00705718|565793194|FG001|Overall Study|Follow up not done|4|||
156739519|NCT00423189|565793196|FG000|Overall Study|Death|0|||
156739520|NCT00423189|565793197|FG001|Overall Study|Death|1|||
156739521|NCT00423189|565793198|FG002|Overall Study|Death|0|||
156739522|NCT01459718|565793205|FG000|Overall Study|Physician Decision|1|||
156739523|NCT01459718|565793205|FG000|Overall Study|Lost to Follow-up|1|||
156739524|NCT01459718|565793205|FG000|Overall Study|Adverse Event|1|||
156739525|NCT01258075|565793206|FG000|Overall Study|Adverse Event|8|||
156739526|NCT01258075|565793207|FG001|Overall Study|Adverse Event|3|||
156739527|NCT01258075|565793206|FG000|Overall Study|Lost to Follow-up|11|||
156739528|NCT01258075|565793207|FG001|Overall Study|Lost to Follow-up|6|||
156739529|NCT01258075|565793206|FG000|Overall Study|Withdrawal by Subject|10|||
156739530|NCT01258075|565793207|FG001|Overall Study|Withdrawal by Subject|7|||
156739531|NCT01258075|565793206|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
156739532|NCT01258075|565793207|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
156739533|NCT01258075|565793206|FG000|Overall Study|Other|12|||
156739534|NCT01258075|565793207|FG001|Overall Study|Other|5|||
156739535|NCT00976209|565793208|FG000|Treatment Period 1|Protocol Violation|1|||
156739536|NCT00976209|565793209|FG001|Treatment Period 1|Protocol Violation|0|||
156739537|NCT00976209|565793208|FG000|Treatment Period 1|Lost to Follow-up|2|||
156739538|NCT00976209|565793209|FG001|Treatment Period 1|Lost to Follow-up|0|||
156739539|NCT00976209|565793208|FG000|Treatment Period 1|Other|0|||
156739540|NCT00976209|565793209|FG001|Treatment Period 1|Other|1|||
156739541|NCT00976209|565793208|FG000|Wash-out Period|Adverse Event|1|||
156739542|NCT00976209|565793209|FG001|Wash-out Period|Adverse Event|2|||
156739543|NCT00976209|565793208|FG000|Wash-out Period|Lost to Follow-up|1|||
156797511|NCT03766399|566013358|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797512|NCT03766399|566013359|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797513|NCT03766399|566013360|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797514|NCT03766399|566013361|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797515|NCT03766399|566013362|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797516|NCT03766399|566013363|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797517|NCT03766399|566013364|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
156797518|NCT03766399|566013365|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797519|NCT03766399|566013366|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797520|NCT03766399|566013367|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797521|NCT03766399|566013368|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797522|NCT05030766|566013369|FG000|Phase 1 Participants|Lost to Follow-up|12|||
156797523|NCT05030766|566013370|FG001|Phase 1 Participants|Lost to Follow-up|22|||
156797524|NCT05030766|566013371|FG002|Phase 1 Participants|Lost to Follow-up|0|||
156797525|NCT05030766|566013372|FG003|Phase 1 Participants|Lost to Follow-up|0|||
156797526|NCT05030766|566013369|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
156797527|NCT05030766|566013370|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
156797528|NCT05030766|566013371|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
156797529|NCT05030766|566013372|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
156797530|NCT05030766|566013369|FG000|Phase 2 Participants|Lost to Follow-up|0|||
156797531|NCT05030766|566013370|FG001|Phase 2 Participants|Lost to Follow-up|0|||
156797532|NCT05030766|566013371|FG002|Phase 2 Participants|Lost to Follow-up|6|||
156739544|NCT00976209|565793209|FG001|Wash-out Period|Lost to Follow-up|0|||
156739545|NCT00976209|565793208|FG000|Wash-out Period|Protocol Violation|1|||
156739546|NCT00976209|565793209|FG001|Wash-out Period|Protocol Violation|0|||
156739547|NCT00976209|565793208|FG000|Wash-out Period|Other|1|||
156739548|NCT00976209|565793209|FG001|Wash-out Period|Other|0|||
156739549|NCT00976209|565793208|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156739550|NCT00976209|565793209|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156739551|NCT00976209|565793208|FG000|Treatment Period 2|Lost to Follow-up|0|||
156739552|NCT00976209|565793209|FG001|Treatment Period 2|Lost to Follow-up|1|||
156739553|NCT00574249|565793210|FG000|Overall Study|Adverse Event|6|||
156739554|NCT00574249|565793211|FG001|Overall Study|Adverse Event|18|||
156739555|NCT00574249|565793210|FG000|Overall Study|Lack of Efficacy|5|||
156739556|NCT00574249|565793211|FG001|Overall Study|Lack of Efficacy|3|||
156739557|NCT00574249|565793210|FG000|Overall Study|Lost to Follow-up|4|||
156739558|NCT00574249|565793211|FG001|Overall Study|Lost to Follow-up|3|||
156739559|NCT00574249|565793210|FG000|Overall Study|Protocol Violation|5|||
156739560|NCT00574249|565793211|FG001|Overall Study|Protocol Violation|2|||
156739561|NCT00574249|565793210|FG000|Overall Study|History of carcinoma|1|||
156739562|NCT00574249|565793211|FG001|Overall Study|History of carcinoma|0|||
156739563|NCT00574249|565793210|FG000|Overall Study|Withdrawal by Subject|3|||
156739564|NCT00574249|565793211|FG001|Overall Study|Withdrawal by Subject|0|||
156739565|NCT00574249|565793210|FG000|Overall Study|Physician Decision|1|||
156739566|NCT00574249|565793211|FG001|Overall Study|Physician Decision|0|||
156739567|NCT00574249|565793210|FG000|Overall Study|Pregnancy|1|||
156739568|NCT00574249|565793211|FG001|Overall Study|Pregnancy|0|||
156739569|NCT00574249|565793210|FG000|Overall Study|Excluded by company|0|||
156739570|NCT00574249|565793211|FG001|Overall Study|Excluded by company|1|||
156739571|NCT00574249|565793210|FG000|Overall Study|PPD test taken twice|0|||
156739572|NCT00574249|565793211|FG001|Overall Study|PPD test taken twice|1|||
156739573|NCT01542034|565793215|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
156739574|NCT01542034|565793216|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
156739575|NCT01542034|565793215|FG000|Overall Study|Administrative decision|0|||
156739576|NCT01542034|565793216|FG001|Overall Study|Administrative decision|3|||
156739577|NCT01542034|565793215|FG000|Overall Study|Subject Noncompliance|1|||
156739578|NCT01542034|565793216|FG001|Overall Study|Subject Noncompliance|0|||
156739579|NCT01542034|565793215|FG000|Overall Study|Adverse Event|2|||
156739580|NCT01542034|565793216|FG001|Overall Study|Adverse Event|2|||
156739581|NCT01542034|565793215|FG000|Overall Study|Lost to Follow-up|7|||
156739582|NCT01542034|565793216|FG001|Overall Study|Lost to Follow-up|6|||
156739583|NCT02612610|565793217|FG000|Overall Study|Withdrawal by Subject|1|||
156739584|NCT02612610|565793218|FG001|Overall Study|Withdrawal by Subject|1|||
156739585|NCT02612610|565793219|FG002|Overall Study|Withdrawal by Subject|0|||
156739586|NCT02612610|565793220|FG003|Overall Study|Withdrawal by Subject|2|||
156739587|NCT02612610|565793217|FG000|Overall Study|Adverse Event|2|||
156739588|NCT02612610|565793218|FG001|Overall Study|Adverse Event|2|||
156739589|NCT02612610|565793219|FG002|Overall Study|Adverse Event|3|||
156739590|NCT02612610|565793220|FG003|Overall Study|Adverse Event|10|||
156739591|NCT02612610|565793217|FG000|Overall Study|Lost to Follow-up|0|||
156739592|NCT02612610|565793218|FG001|Overall Study|Lost to Follow-up|1|||
156739593|NCT02612610|565793219|FG002|Overall Study|Lost to Follow-up|0|||
156739594|NCT02612610|565793220|FG003|Overall Study|Lost to Follow-up|0|||
156739595|NCT02612610|565793217|FG000|Overall Study|Protocol Violation|0|||
156739596|NCT02612610|565793218|FG001|Overall Study|Protocol Violation|1|||
156739597|NCT02612610|565793219|FG002|Overall Study|Protocol Violation|1|||
156739598|NCT02612610|565793220|FG003|Overall Study|Protocol Violation|0|||
156739599|NCT02612610|565793217|FG000|Overall Study|Lack of Efficacy|1|||
156739600|NCT02612610|565793218|FG001|Overall Study|Lack of Efficacy|2|||
156739601|NCT02612610|565793219|FG002|Overall Study|Lack of Efficacy|0|||
156739602|NCT02612610|565793220|FG003|Overall Study|Lack of Efficacy|1|||
156739603|NCT02612610|565793217|FG000|Overall Study|Physician Decision|0|||
156739604|NCT02612610|565793218|FG001|Overall Study|Physician Decision|1|||
156739605|NCT02612610|565793219|FG002|Overall Study|Physician Decision|0|||
156739606|NCT02612610|565793220|FG003|Overall Study|Physician Decision|0|||
156739607|NCT02612610|565793217|FG000|Overall Study|Noncompliance|1|||
156739608|NCT02612610|565793218|FG001|Overall Study|Noncompliance|0|||
156739609|NCT02612610|565793219|FG002|Overall Study|Noncompliance|0|||
156797533|NCT05030766|566013372|FG003|Phase 2 Participants|Lost to Follow-up|2|||
156797534|NCT01559935|566013375|FG000|Car Phase|Toxicity|4|||
156797535|NCT01559935|566013375|FG000|Car Phase|Death|1|||
156739610|NCT02612610|565793220|FG003|Overall Study|Noncompliance|0|||
156739611|NCT02612610|565793217|FG000|Overall Study|Cough Improvement|0|||
156739612|NCT02612610|565793218|FG001|Overall Study|Cough Improvement|0|||
156739613|NCT02612610|565793219|FG002|Overall Study|Cough Improvement|1|||
156797536|NCT01559935|566013375|FG000|Car Phase|Lack of Efficacy|2|||
156797537|NCT01559935|566013375|FG000|Car Phase|Lost to Follow-up|1|||
156797538|NCT01559935|566013375|FG000|Car Phase|Physician Decision|1|||
156797539|NCT01559935|566013375|FG000|Car Phase|Withdrawal by Subject|2|||
156739614|NCT02612610|565793220|FG003|Overall Study|Cough Improvement|0|||
156739615|NCT01546571|565793223|FG000|Overall Study|Adverse Event|1|||
156739616|NCT01546571|565793224|FG001|Overall Study|Adverse Event|0|||
156739617|NCT01546571|565793225|FG002|Overall Study|Adverse Event|0|||
156739618|NCT01546571|565793226|FG003|Overall Study|Adverse Event|1|||
156739619|NCT01546571|565793227|FG004|Overall Study|Adverse Event|0|||
156739620|NCT01546571|565793223|FG000|Overall Study|assigned placebo in Part A|0|||
156739621|NCT01546571|565793224|FG001|Overall Study|assigned placebo in Part A|0|||
156739622|NCT01546571|565793225|FG002|Overall Study|assigned placebo in Part A|22|||
156739623|NCT01546571|565793226|FG003|Overall Study|assigned placebo in Part A|0|||
156797540|NCT01559935|566013375|FG000|Car Phase|Per protocol|1|||
156797541|NCT01559935|566013375|FG000|Car Phase|Insurance|1|||
156739624|NCT01546571|565793227|FG004|Overall Study|assigned placebo in Part A|0|||
156739625|NCT01546571|565793223|FG000|Overall Study|Death|0|||
156739626|NCT01546571|565793224|FG001|Overall Study|Death|1|||
156739627|NCT01546571|565793225|FG002|Overall Study|Death|0|||
156739628|NCT01546571|565793226|FG003|Overall Study|Death|0|||
156739629|NCT01546571|565793227|FG004|Overall Study|Death|0|||
156739630|NCT01546571|565793223|FG000|Overall Study|Lost to Follow-up|0|||
156739631|NCT01546571|565793224|FG001|Overall Study|Lost to Follow-up|0|||
156739632|NCT01546571|565793225|FG002|Overall Study|Lost to Follow-up|2|||
156739633|NCT01546571|565793226|FG003|Overall Study|Lost to Follow-up|2|||
156739634|NCT01546571|565793227|FG004|Overall Study|Lost to Follow-up|3|||
156739635|NCT01546571|565793223|FG000|Overall Study|Pregnancy|0|||
156739636|NCT01546571|565793224|FG001|Overall Study|Pregnancy|0|||
156739637|NCT01546571|565793225|FG002|Overall Study|Pregnancy|0|||
156739638|NCT01546571|565793226|FG003|Overall Study|Pregnancy|1|||
156739639|NCT01546571|565793227|FG004|Overall Study|Pregnancy|0|||
156797542|NCT01559935|566013375|FG000|Car Phase|non-compliance|1|||
156797543|NCT01559935|566013375|FG000|BiRD Phase|Toxicity|1|||
156797544|NCT01559935|566013375|FG000|BiRD Phase|Lack of Efficacy|1|||
156877584|NCT03541200|566309867|FG000|Overall Study|Lost to Follow-up|10|||
156877585|NCT03541200|566309867|FG000|Overall Study|Physician Decision|1|||
156877586|NCT03541200|566309867|FG000|Overall Study|Protocol Violation|51|||
156877587|NCT03541200|566309867|FG000|Overall Study|Withdrawal by Subject|23|||
156877588|NCT03541200|566309867|FG000|Overall Study|other|8|||
156877589|NCT05714345|566309868|FG000|Overall Study|Death|1|||
156877590|NCT05714345|566309869|FG001|Overall Study|Death|1|||
156877591|NCT03837626|566309875|FG000|Overall Study|Adverse Event|3|||
156877592|NCT03837626|566309876|FG001|Overall Study|Adverse Event|3|||
156877593|NCT03837626|566309875|FG000|Overall Study|Withdrawal by Subject|2|||
156877594|NCT03837626|566309876|FG001|Overall Study|Withdrawal by Subject|4|||
156877595|NCT03837626|566309875|FG000|Overall Study|Physician Decision|2|||
156877596|NCT03837626|566309876|FG001|Overall Study|Physician Decision|3|||
156877597|NCT03837626|566309875|FG000|Overall Study|Lost to Follow-up|3|||
156877598|NCT03837626|566309876|FG001|Overall Study|Lost to Follow-up|1|||
156877599|NCT04601857|566309877|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
156877600|NCT04601857|566309878|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
156877601|NCT04601857|566309877|FG000|Overall Study|Disease Progression|2|||
156877602|NCT04601857|566309878|FG001|Overall Study|Disease Progression|4|||
156797545|NCT01559935|566013375|FG000|BiRD Phase|Withdrawal by Subject|2|||
156797546|NCT01559935|566013375|FG000|Maintenance Phase|Remains on study|28|||
156797547|NCT01559935|566013375|FG000|Maintenance Phase|Toxicity|1|||
156797548|NCT01559935|566013375|FG000|Maintenance Phase|Lack of Efficacy|18|||
156797549|NCT01559935|566013375|FG000|Maintenance Phase|Withdrawal by Subject|5|||
156797550|NCT01559935|566013375|FG000|Maintenance Phase|Non-compliance|2|||
156797551|NCT05889468|566013377|FG000|Overall Study|Lost to Follow-up|9|||
156797552|NCT05889468|566013378|FG001|Overall Study|Lost to Follow-up|2|||
156797553|NCT05889468|566013377|FG000|Overall Study|Withdrawal by Subject|2|||
156797554|NCT05889468|566013378|FG001|Overall Study|Withdrawal by Subject|2|||
156797555|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797556|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
156797557|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797558|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
156797559|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
156797560|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
156797561|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
156797562|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797563|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797564|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797565|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156877603|NCT04601857|566309877|FG000|Overall Study|Clinical Disease Progression|2|||
156458418|NCT05293171|564774725|FG004|Washout 5 to 7 Days|Adverse Event|0|||
156458419|NCT05293171|564774726|FG005|Washout 5 to 7 Days|Adverse Event|1|||
156458420|NCT05293171|564774727|FG006|Washout 5 to 7 Days|Adverse Event|0|||
156458421|NCT05293171|564774728|FG007|Washout 5 to 7 Days|Adverse Event|0|||
156739640|NCT01546571|565793223|FG000|Overall Study|Disease Progression|20|||
156458422|NCT05293171|564774729|FG008|Washout 5 to 7 Days|Adverse Event|0|||
156739641|NCT01546571|565793224|FG001|Overall Study|Disease Progression|18|||
156739642|NCT01546571|565793225|FG002|Overall Study|Disease Progression|15|||
156797566|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797567|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797568|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156877604|NCT04601857|566309878|FG001|Overall Study|Clinical Disease Progression|1|||
156877605|NCT04601857|566309877|FG000|Overall Study|Radiological Progression|4|||
156877606|NCT04601857|566309878|FG001|Overall Study|Radiological Progression|11|||
156877607|NCT04601857|566309877|FG000|Overall Study|Death|1|||
156877608|NCT04601857|566309878|FG001|Overall Study|Death|0|||
156739643|NCT01546571|565793226|FG003|Overall Study|Disease Progression|73|||
156739644|NCT01546571|565793227|FG004|Overall Study|Disease Progression|37|||
156739645|NCT01546571|565793223|FG000|Overall Study|Withdrawal by Subject|1|||
156458423|NCT05293171|564774730|FG009|Washout 5 to 7 Days|Adverse Event|0|||
156458424|NCT05293171|564774731|FG010|Washout 5 to 7 Days|Adverse Event|0|||
156458425|NCT05293171|564774732|FG011|Washout 5 to 7 Days|Adverse Event|0|||
156458426|NCT04066205|564774733|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
156877609|NCT04601857|566309877|FG000|Overall Study|Reason Not Specified|0|||
156877610|NCT04601857|566309878|FG001|Overall Study|Reason Not Specified|1|||
156877611|NCT04601857|566309877|FG000|Overall Study|At the Participant's Request|0|||
156877612|NCT04601857|566309878|FG001|Overall Study|At the Participant's Request|1|||
156877613|NCT03933202|566309879|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
156877614|NCT03933202|566309880|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
156458427|NCT04066205|564774734|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
156739646|NCT01546571|565793224|FG001|Overall Study|Withdrawal by Subject|2|||
156877615|NCT03933202|566309879|FG000|Overall Study|Participant transferred care|1|||
156877616|NCT03933202|566309880|FG001|Overall Study|Participant transferred care|0|||
156877617|NCT03933202|566309879|FG000|Overall Study|Site research department closing|1|||
156877618|NCT03933202|566309880|FG001|Overall Study|Site research department closing|0|||
156877619|NCT03933202|566309879|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
156877620|NCT03933202|566309880|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
156877621|NCT03933202|566309879|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
156877622|NCT03933202|566309880|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
156877623|NCT03933202|566309879|FG000|Overall Study|Participant changed primary neurology provider|1|||
156877624|NCT03933202|566309880|FG001|Overall Study|Participant changed primary neurology provider|0|||
156877625|NCT03933202|566309879|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
156877626|NCT03933202|566309880|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
156877627|NCT03933202|566309879|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
156877628|NCT03933202|566309880|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
156877629|NCT03933202|566309879|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
156877630|NCT03933202|566309880|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
156877631|NCT03933202|566309879|FG000|Overall Study|Missed visit|0|||
156877632|NCT03933202|566309880|FG001|Overall Study|Missed visit|1|||
156877633|NCT03933202|566309879|FG000|Overall Study|Investigator decision|4|||
156877634|NCT03933202|566309880|FG001|Overall Study|Investigator decision|0|||
156877635|NCT03933202|566309879|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
156877636|NCT03933202|566309880|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
156877637|NCT03933202|566309879|FG000|Overall Study|Withdrawal by Subject|10|||
156739647|NCT01546571|565793225|FG002|Overall Study|Withdrawal by Subject|4|||
156739648|NCT01546571|565793226|FG003|Overall Study|Withdrawal by Subject|9|||
156739649|NCT01546571|565793227|FG004|Overall Study|Withdrawal by Subject|2|||
156739650|NCT01546571|565793223|FG000|Overall Study|Intercurrent Illness|1|||
156739651|NCT01546571|565793224|FG001|Overall Study|Intercurrent Illness|2|||
156739652|NCT01546571|565793225|FG002|Overall Study|Intercurrent Illness|0|||
156739653|NCT01546571|565793226|FG003|Overall Study|Intercurrent Illness|0|||
156739654|NCT01546571|565793227|FG004|Overall Study|Intercurrent Illness|0|||
156739655|NCT01546571|565793223|FG000|Overall Study|Other Cancers|0|||
156739656|NCT01546571|565793224|FG001|Overall Study|Other Cancers|0|||
156739657|NCT01546571|565793225|FG002|Overall Study|Other Cancers|0|||
156739658|NCT01546571|565793226|FG003|Overall Study|Other Cancers|3|||
156739659|NCT01546571|565793227|FG004|Overall Study|Other Cancers|1|||
156739660|NCT01546571|565793223|FG000|Overall Study|Other|0|||
156739661|NCT01546571|565793224|FG001|Overall Study|Other|0|||
156739662|NCT01546571|565793225|FG002|Overall Study|Other|3|||
156739663|NCT01546571|565793226|FG003|Overall Study|Other|0|||
156739664|NCT01546571|565793227|FG004|Overall Study|Other|0|||
156739665|NCT00478699|565793228|FG000|Overall Study|Inclusion Error|1|||
156739666|NCT00478699|565793229|FG001|Overall Study|Inclusion Error|7|||
156739667|NCT00478699|565793228|FG000|Overall Study|Not receive study treatment|6|||
156739668|NCT00478699|565793229|FG001|Overall Study|Not receive study treatment|30|||
156739669|NCT01252563|565793233|FG000|Overall Study|Contract Deviation|41|||
156739670|NCT01252563|565793233|FG000|Overall Study|Centralized Registration Deviation|30|||
156739671|NCT01252563|565793233|FG000|Overall Study|Lost to Follow-up|161|||
156739672|NCT01252563|565793233|FG000|Overall Study|No visit after first day of treatment|194|||
156739673|NCT01252563|565793233|FG000|Overall Study|No drug administration|6|||
156739674|NCT01866657|565793234|FG000|Overall Study|Surgery canceled|2|||
156739675|NCT01866657|565793235|FG001|Overall Study|Surgery canceled|0|||
156877638|NCT03933202|566309880|FG001|Overall Study|Withdrawal by Subject|8|||
156877639|NCT03933202|566309879|FG000|Overall Study|Death|2|||
156739676|NCT01880086|565793241|FG000|Overall Study|Lost to Follow-up|1|||
156739677|NCT01880086|565793242|FG001|Overall Study|Lost to Follow-up|1|||
156739678|NCT04063657|565795019|FG000|Overall Study|Lost to Follow-up|1|||
156739679|NCT04063657|565795020|FG001|Overall Study|Lost to Follow-up|0|||
156739680|NCT01041976|565795021|FG000|Overall Study|Withdrawal by Subject|3|||
156739681|NCT01041976|565795022|FG001|Overall Study|Withdrawal by Subject|0|||
156739682|NCT01041976|565795021|FG000|Overall Study|Incarceration|2|||
156739683|NCT01041976|565795022|FG001|Overall Study|Incarceration|0|||
156739684|NCT01041976|565795021|FG000|Overall Study|Death|0|||
156739685|NCT01041976|565795022|FG001|Overall Study|Death|4|||
156739686|NCT02658734|565795023|FG000|Overall Study|Adverse Event|2|||
156739687|NCT02658734|565795023|FG000|Overall Study|Death|4|||
156739688|NCT02658734|565795023|FG000|Overall Study|Lost to Follow-up|7|||
156739689|NCT02658734|565795023|FG000|Overall Study|Withdrawal of Consent|16|||
156739690|NCT02658734|565795023|FG000|Overall Study|Disease Progression|28|||
156739691|NCT04021121|565795038|FG000|Overall Study|Death|3|||
156739692|NCT04021121|565795039|FG001|Overall Study|Death|3|||
156739693|NCT04021121|565795040|FG002|Overall Study|Death|5|||
156739694|NCT04021121|565795041|FG003|Overall Study|Death|4|||
156739695|NCT00978250|565795043|FG000|Overall Study|Late determination of ineligibility|0|||
156739696|NCT00978250|565795044|FG001|Overall Study|Late determination of ineligibility|1|||
156739697|NCT00978250|565795045|FG002|Overall Study|Late determination of ineligibility|0|||
156739698|NCT00978250|565795046|FG003|Overall Study|Late determination of ineligibility|1|||
156739699|NCT02951533|565795052|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
156739700|NCT02951533|565795053|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
156739701|NCT02951533|565795054|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
156739702|NCT02951533|565795052|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
156739703|NCT02951533|565795053|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
156739704|NCT02951533|565795054|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
156739705|NCT02951533|565795052|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
156739706|NCT02951533|565795053|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
156739707|NCT02951533|565795054|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
156739708|NCT02951533|565795052|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
156739709|NCT02951533|565795053|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
156739710|NCT02951533|565795054|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
156739711|NCT02951533|565795052|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
156739712|NCT02951533|565795053|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
156739713|NCT02951533|565795054|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
156739714|NCT02951533|565795052|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
156739715|NCT02951533|565795053|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
156739716|NCT02951533|565795054|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
156739717|NCT02951533|565795052|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
156739718|NCT02951533|565795053|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
156739719|NCT02951533|565795054|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
156739720|NCT02951533|565795052|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
156739721|NCT02951533|565795053|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
156739722|NCT02951533|565795054|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
156739723|NCT02951533|565795052|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
156739724|NCT02951533|565795053|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
156739725|NCT02951533|565795054|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
156739726|NCT02951533|565795052|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
156739727|NCT02951533|565795053|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
156739728|NCT02951533|565795054|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
156739729|NCT02951533|565795052|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
156739730|NCT02951533|565795053|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
156739731|NCT02951533|565795054|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
156739732|NCT05174949|565795055|FG000|Overall Study|Physician Decision|1|||
156739733|NCT05174949|565795056|FG001|Overall Study|Physician Decision|2|||
156739734|NCT05174949|565795057|FG002|Overall Study|Physician Decision|0|||
156739735|NCT05174949|565795058|FG003|Overall Study|Physician Decision|1|||
156739736|NCT05174949|565795059|FG004|Overall Study|Physician Decision|0|||
156739737|NCT05174949|565795060|FG005|Overall Study|Physician Decision|0|||
156739738|NCT05174949|565795055|FG000|Overall Study|Withdrawal by Subject|0|||
156739739|NCT05174949|565795056|FG001|Overall Study|Withdrawal by Subject|1|||
156739740|NCT05174949|565795057|FG002|Overall Study|Withdrawal by Subject|0|||
156739741|NCT05174949|565795058|FG003|Overall Study|Withdrawal by Subject|0|||
156797569|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156739742|NCT05174949|565795059|FG004|Overall Study|Withdrawal by Subject|0|||
156797570|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797571|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
156797572|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
156797573|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
156797574|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
156739743|NCT05174949|565795060|FG005|Overall Study|Withdrawal by Subject|0|||
156739744|NCT05174949|565795055|FG000|Overall Study|Lost to Follow-up|0|||
156739745|NCT05174949|565795056|FG001|Overall Study|Lost to Follow-up|0|||
156739746|NCT05174949|565795057|FG002|Overall Study|Lost to Follow-up|0|||
156739747|NCT05174949|565795058|FG003|Overall Study|Lost to Follow-up|1|||
156739748|NCT05174949|565795059|FG004|Overall Study|Lost to Follow-up|0|||
156739749|NCT05174949|565795060|FG005|Overall Study|Lost to Follow-up|0|||
156739750|NCT02029989|565795061|FG000|Overall Study|Withdrawal by Subject|1|||
156739751|NCT02029989|565795062|FG001|Overall Study|Withdrawal by Subject|0|||
156739752|NCT02029989|565795061|FG000|Overall Study|Withdrawal: Fear of needles|1|||
156739753|NCT02029989|565795062|FG001|Overall Study|Withdrawal: Fear of needles|0|||
156739754|NCT02029989|565795061|FG000|Overall Study|Change of location|2|||
156739755|NCT02029989|565795062|FG001|Overall Study|Change of location|3|||
156739756|NCT02029989|565795061|FG000|Overall Study|Physician Decision|2|||
156739757|NCT02029989|565795062|FG001|Overall Study|Physician Decision|0|||
156739758|NCT02029989|565795061|FG000|Overall Study|Lost to Follow-up|9|||
156739759|NCT02029989|565795062|FG001|Overall Study|Lost to Follow-up|7|||
156739760|NCT02029989|565795061|FG000|Overall Study|Death|0|||
156739761|NCT02029989|565795062|FG001|Overall Study|Death|1|||
156739762|NCT02029989|565795061|FG000|Overall Study|Protocol Violation|1|||
156739763|NCT02029989|565795062|FG001|Overall Study|Protocol Violation|0|||
156739764|NCT04351373|565795063|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
156739765|NCT01123941|565795069|FG000|Overall Study|Lost to Follow-up|2|||
156739766|NCT01123941|565795070|FG001|Overall Study|Lost to Follow-up|1|||
156739767|NCT05036668|565795071|FG000|Overall Study|lost to follow Up|0|||
156739768|NCT05036668|565795072|FG001|Overall Study|lost to follow Up|0|||
156739769|NCT05036668|565795073|FG002|Overall Study|lost to follow Up|1|||
156739770|NCT04601103|565795075|FG000|Overall Study|Needed crown & cleaning|0|||
156739771|NCT04601103|565795076|FG001|Overall Study|Needed crown & cleaning|0|||
156739772|NCT04601103|565795077|FG002|Overall Study|Needed crown & cleaning|1|||
156739773|NCT04601103|565795075|FG000|Overall Study|study was terminated|18|||
156739774|NCT04601103|565795076|FG001|Overall Study|study was terminated|18|||
156739775|NCT04601103|565795077|FG002|Overall Study|study was terminated|16|||
156739776|NCT05083923|565795082|FG000|Overall Study|Adverse Event|2|||
156739777|NCT05083923|565795083|FG001|Overall Study|Adverse Event|0|||
156739778|NCT05083923|565795082|FG000|Overall Study|Lack of Efficacy|1|||
156739779|NCT05083923|565795083|FG001|Overall Study|Lack of Efficacy|3|||
156739780|NCT05083923|565795082|FG000|Overall Study|Withdrawal by Subject|2|||
156739781|NCT05083923|565795083|FG001|Overall Study|Withdrawal by Subject|6|||
156739782|NCT05083923|565795082|FG000|Overall Study|Reason Not Specified|0|||
156739783|NCT05083923|565795083|FG001|Overall Study|Reason Not Specified|1|||
156739784|NCT01537068|565795088|FG000|Overall Study|Lost to Follow-up|2|||
156739785|NCT01537068|565795089|FG001|Overall Study|Lost to Follow-up|1|||
156739786|NCT01537068|565795088|FG000|Overall Study|Adverse Event|0|||
156739787|NCT01537068|565795089|FG001|Overall Study|Adverse Event|1|||
156739788|NCT01537068|565795088|FG000|Overall Study|Withdrawal by Subject|1|||
156739789|NCT01537068|565795089|FG001|Overall Study|Withdrawal by Subject|1|||
156739790|NCT01537068|565795088|FG000|Overall Study|Lack of Efficacy|1|||
156739791|NCT01537068|565795089|FG001|Overall Study|Lack of Efficacy|0|||
156739792|NCT06011161|565795090|FG000|Overall Study|Withdrawal by Subject|2|||
156739793|NCT06011161|565795090|FG000|Overall Study|Lost to Follow-up|5|||
156739794|NCT02291601|565795093|FG000|Abdomen|Did not qualify|333|||
156739795|NCT02291601|565795094|FG001|Abdomen|Did not qualify|54|||
156739796|NCT02291601|565795095|FG002|Abdomen|Did not qualify|339|||
156739797|NCT02291601|565795093|FG000|Groin|Did not qualify|183|||
156739798|NCT02291601|565795094|FG001|Groin|Did not qualify|30|||
156739799|NCT02291601|565795095|FG002|Groin|Did not qualify|177|||
156739800|NCT00381043|565795096|FG000|Overall Study|Lost to Follow-up|8|||
156739801|NCT00381043|565795097|FG001|Overall Study|Lost to Follow-up|6|||
156336906|NCT00932126|564331416|FG002|Overall Study|Adverse Event|0|||
156336907|NCT00932126|564331417|FG003|Overall Study|Adverse Event|0|||
156336908|NCT00932126|564331418|FG004|Overall Study|Adverse Event|0|||
156739802|NCT00381043|565795096|FG000|Overall Study|Withdrawal by Subject|3|||
156739803|NCT00381043|565795097|FG001|Overall Study|Withdrawal by Subject|1|||
156739804|NCT00381043|565795096|FG000|Overall Study|wanted more care|0|||
156739805|NCT00381043|565795097|FG001|Overall Study|wanted more care|1|||
156739806|NCT00381043|565795096|FG000|Overall Study|incarcerated|1|||
156877640|NCT03933202|566309880|FG001|Overall Study|Death|0|||
156336909|NCT00932126|564331419|FG005|Overall Study|Adverse Event|0|||
156458428|NCT04066205|564774733|FG000|T2 Immediate Post-Intervention|did not respond|5|||
156739807|NCT00381043|565795097|FG001|Overall Study|incarcerated|0|||
156739808|NCT02880865|565795105|FG000|Overall Study|Adverse Event|1|||
156739809|NCT02880865|565795106|FG001|Overall Study|Adverse Event|0|||
156739810|NCT02880865|565795105|FG000|Overall Study|Withdrawal by Subject|0|||
156739811|NCT02880865|565795106|FG001|Overall Study|Withdrawal by Subject|2|||
156739812|NCT02880865|565795105|FG000|Overall Study|Physician Decision|0|||
156739813|NCT02880865|565795106|FG001|Overall Study|Physician Decision|1|||
156739814|NCT03045276|565795109|FG000|Intervention Phase|Withdrawal by Subject|7|||
156739815|NCT03045276|565795110|FG001|Intervention Phase|Withdrawal by Subject|2|||
156739816|NCT03045276|565795111|FG002|Intervention Phase|Withdrawal by Subject|3|||
156739817|NCT03045276|565795112|FG003|Intervention Phase|Withdrawal by Subject|7|||
156739818|NCT03045276|565795109|FG000|Intervention Phase|Developed exclusionary criteria|3|||
156739819|NCT03045276|565795110|FG001|Intervention Phase|Developed exclusionary criteria|3|||
156739820|NCT03045276|565795111|FG002|Intervention Phase|Developed exclusionary criteria|0|||
156739821|NCT03045276|565795112|FG003|Intervention Phase|Developed exclusionary criteria|0|||
156739822|NCT03045276|565795109|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
156739823|NCT03045276|565795110|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
156739824|NCT03045276|565795111|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
156739825|NCT03045276|565795112|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
156739826|NCT03045276|565795109|FG000|Follow-Up Phase|Lost to Follow-up|0|||
156739827|NCT03045276|565795110|FG001|Follow-Up Phase|Lost to Follow-up|1|||
156739828|NCT03045276|565795111|FG002|Follow-Up Phase|Lost to Follow-up|0|||
156739829|NCT03045276|565795112|FG003|Follow-Up Phase|Lost to Follow-up|1|||
156739830|NCT03045276|565795109|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
156739831|NCT03045276|565795110|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
156739832|NCT03045276|565795111|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
156739833|NCT03045276|565795112|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
156739834|NCT01597375|565795113|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
156739835|NCT01597375|565795114|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
156739836|NCT01597375|565795113|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
156739837|NCT01597375|565795114|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
156739838|NCT01597375|565795113|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
156739839|NCT01597375|565795114|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
156739840|NCT01597375|565795113|FG000|Washout (2 Weeks)|Adverse Event|1|||
156739841|NCT01597375|565795114|FG001|Washout (2 Weeks)|Adverse Event|0|||
156739842|NCT01597375|565795113|FG000|Second Intervention|Failed to react at both Aspirin|1|||
156739843|NCT01597375|565795114|FG001|Second Intervention|Failed to react at both Aspirin|1|||
156739844|NCT01190267|565795119|FG000|Overall Study|Adverse Event|10|||
156739845|NCT01190267|565795120|FG001|Overall Study|Adverse Event|0|||
156739846|NCT01190267|565795119|FG000|Overall Study|Treatment Failure|8|||
156739847|NCT01190267|565795120|FG001|Overall Study|Treatment Failure|2|||
156739848|NCT01190267|565795119|FG000|Overall Study|Lost to Follow-up|2|||
156739849|NCT01190267|565795120|FG001|Overall Study|Lost to Follow-up|0|||
156739850|NCT01190267|565795119|FG000|Overall Study|Withdrawal by Subject|13|||
156739851|NCT01190267|565795120|FG001|Overall Study|Withdrawal by Subject|1|||
156739852|NCT01190267|565795119|FG000|Overall Study|Protocol Violation|8|||
156739853|NCT01190267|565795120|FG001|Overall Study|Protocol Violation|1|||
156739854|NCT04017832|565795121|FG000|Overall Study|Withdrawal by Subject|13|||
156739855|NCT04017832|565795122|FG001|Overall Study|Withdrawal by Subject|12|||
156739856|NCT04017832|565795123|FG002|Overall Study|Withdrawal by Subject|21|||
156739857|NCT04017832|565795124|FG003|Overall Study|Withdrawal by Subject|7|||
156739858|NCT04017832|565795121|FG000|Overall Study|Lost to Follow-up|0|||
156739859|NCT04017832|565795122|FG001|Overall Study|Lost to Follow-up|3|||
156739860|NCT04017832|565795123|FG002|Overall Study|Lost to Follow-up|3|||
156739861|NCT04017832|565795124|FG003|Overall Study|Lost to Follow-up|1|||
156739862|NCT04017832|565795121|FG000|Overall Study|Physician Decision|1|||
156739863|NCT04017832|565795122|FG001|Overall Study|Physician Decision|1|||
156739864|NCT04017832|565795123|FG002|Overall Study|Physician Decision|1|||
156739865|NCT04017832|565795124|FG003|Overall Study|Physician Decision|1|||
156739866|NCT04017832|565795121|FG000|Overall Study|Death|2|||
156739867|NCT04017832|565795122|FG001|Overall Study|Death|2|||
156739868|NCT04017832|565795123|FG002|Overall Study|Death|1|||
156739869|NCT04017832|565795124|FG003|Overall Study|Death|0|||
156739870|NCT02375555|565795134|FG000|Induction Period|Adverse Event|7|||
156739871|NCT02375555|565795134|FG000|Induction Period|Withdrawal by Subject|2|||
156739872|NCT02375555|565795134|FG000|Induction Period|Other|1|||
156739873|NCT02375555|565795134|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
156739874|NCT02375555|565795134|FG000|Maintenance Period|Adverse Event|2|||
156739875|NCT02375555|565795134|FG000|Maintenance Period|Withdrawal by Subject|4|||
156739876|NCT02375555|565795134|FG000|Maintenance Period|Death|1|||
156797575|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
156797576|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
156797577|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
156797578|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
156797579|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
156797580|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
156797581|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
156797582|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
156797583|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
156797584|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
156739877|NCT02375555|565795134|FG000|Maintenance Period|Disease Progression|5|||
156739878|NCT02375555|565795134|FG000|Maintenance Period|Patient Non-compliance|1|||
156739879|NCT02375555|565795134|FG000|Maintenance Period|Still on maintenance|16|||
156739880|NCT02091986|565795138|FG000|Overall Study|7 rand in error 1 patient decision|2|||
156739881|NCT02091986|565795139|FG001|Overall Study|7 rand in error 1 patient decision|3|||
156739882|NCT02091986|565795140|FG002|Overall Study|7 rand in error 1 patient decision|3|||
156739883|NCT02091986|565795138|FG000|Overall Study|Lost to Follow-up|1|||
156739884|NCT02091986|565795139|FG001|Overall Study|Lost to Follow-up|0|||
156739885|NCT02091986|565795140|FG002|Overall Study|Lost to Follow-up|0|||
156739886|NCT02091986|565795138|FG000|Overall Study|Withdrawal by Subject|4|||
156739887|NCT02091986|565795139|FG001|Overall Study|Withdrawal by Subject|8|||
156739888|NCT02091986|565795140|FG002|Overall Study|Withdrawal by Subject|3|||
156739889|NCT02091986|565795138|FG000|Overall Study|Adverse Event|0|||
156739890|NCT02091986|565795139|FG001|Overall Study|Adverse Event|0|||
156739891|NCT02091986|565795140|FG002|Overall Study|Adverse Event|2|||
156739892|NCT00125242|565795141|FG000|Overall Study|did not qualify|7|||
156739893|NCT00125242|565795142|FG001|Overall Study|did not qualify|2|||
156739894|NCT01664949|565795145|FG000|Overall Study|Adverse Event|11|||
156739895|NCT01664949|565795146|FG001|Overall Study|Adverse Event|12|||
156739896|NCT01664949|565795145|FG000|Overall Study|Lack of Efficacy|1|||
156739897|NCT01664949|565795146|FG001|Overall Study|Lack of Efficacy|1|||
156739898|NCT01664949|565795145|FG000|Overall Study|Lost to Follow-up|1|||
156739899|NCT01664949|565795146|FG001|Overall Study|Lost to Follow-up|2|||
156739900|NCT01664949|565795145|FG000|Overall Study|Personal Reasons|3|||
156739901|NCT01664949|565795146|FG001|Overall Study|Personal Reasons|4|||
156739902|NCT01664949|565795145|FG000|Overall Study|Protocol Violation|5|||
156739903|NCT01664949|565795146|FG001|Overall Study|Protocol Violation|5|||
156739904|NCT01664949|565795145|FG000|Overall Study|Other Miscellaneous Reasons|3|||
156739905|NCT01664949|565795146|FG001|Overall Study|Other Miscellaneous Reasons|1|||
156739906|NCT02727777|565795153|FG000|Overall Study|Screen Failure|2|||
156739907|NCT02727777|565795154|FG001|Overall Study|Screen Failure|0|||
156739908|NCT02727777|565795155|FG002|Overall Study|Screen Failure|0|||
156739909|NCT02727777|565795153|FG000|Overall Study|Progressive disease|2|||
156739910|NCT02727777|565795154|FG001|Overall Study|Progressive disease|0|||
156739911|NCT02727777|565795155|FG002|Overall Study|Progressive disease|0|||
156739912|NCT03003494|565795156|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
156739913|NCT01738503|565795157|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
156739914|NCT01738503|565795158|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739915|NCT01738503|565795159|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739916|NCT01738503|565795160|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739917|NCT01738503|565795161|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739918|NCT01738503|565795162|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739919|NCT01738503|565795163|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739920|NCT01738503|565795157|FG000|Treatment Period|Adverse Event|0|||
156739921|NCT01738503|565795158|FG001|Treatment Period|Adverse Event|1|||
156739922|NCT01738503|565795159|FG002|Treatment Period|Adverse Event|0|||
156739923|NCT01738503|565795160|FG003|Treatment Period|Adverse Event|1|||
156739924|NCT01738503|565795161|FG004|Treatment Period|Adverse Event|2|||
156739925|NCT01738503|565795162|FG005|Treatment Period|Adverse Event|2|||
156739926|NCT01738503|565795163|FG006|Treatment Period|Adverse Event|2|||
156739927|NCT01738503|565795157|FG000|Treatment Period|Lost to Follow-up|0|||
156739928|NCT01738503|565795158|FG001|Treatment Period|Lost to Follow-up|0|||
156739929|NCT01738503|565795159|FG002|Treatment Period|Lost to Follow-up|3|||
156739930|NCT01738503|565795160|FG003|Treatment Period|Lost to Follow-up|4|||
156739931|NCT01738503|565795161|FG004|Treatment Period|Lost to Follow-up|1|||
156739932|NCT01738503|565795162|FG005|Treatment Period|Lost to Follow-up|1|||
156739933|NCT01738503|565795163|FG006|Treatment Period|Lost to Follow-up|5|||
156739934|NCT01738503|565795157|FG000|Treatment Period|Withdrawal by Subject|0|||
156739935|NCT01738503|565795158|FG001|Treatment Period|Withdrawal by Subject|1|||
156739936|NCT01738503|565795159|FG002|Treatment Period|Withdrawal by Subject|0|||
156739937|NCT01738503|565795160|FG003|Treatment Period|Withdrawal by Subject|1|||
156739938|NCT01738503|565795161|FG004|Treatment Period|Withdrawal by Subject|1|||
156739939|NCT01738503|565795162|FG005|Treatment Period|Withdrawal by Subject|1|||
156739940|NCT01738503|565795163|FG006|Treatment Period|Withdrawal by Subject|1|||
156739941|NCT01738503|565795157|FG000|Treatment Period|Protocol Violation|0|||
156739942|NCT01738503|565795158|FG001|Treatment Period|Protocol Violation|3|||
156739943|NCT01738503|565795159|FG002|Treatment Period|Protocol Violation|1|||
156739944|NCT01738503|565795160|FG003|Treatment Period|Protocol Violation|0|||
156739945|NCT01738503|565795161|FG004|Treatment Period|Protocol Violation|4|||
156739946|NCT01738503|565795162|FG005|Treatment Period|Protocol Violation|2|||
156739947|NCT01738503|565795163|FG006|Treatment Period|Protocol Violation|0|||
156739948|NCT01738503|565795157|FG000|Treatment Period|Other|0|||
156739949|NCT01738503|565795158|FG001|Treatment Period|Other|0|||
156739950|NCT01738503|565795159|FG002|Treatment Period|Other|1|||
156739951|NCT01738503|565795160|FG003|Treatment Period|Other|0|||
156739952|NCT01738503|565795161|FG004|Treatment Period|Other|0|||
156739953|NCT01738503|565795162|FG005|Treatment Period|Other|0|||
156739954|NCT01738503|565795163|FG006|Treatment Period|Other|0|||
156739955|NCT01738503|565795157|FG000|PET Imaging Sub-study|Adverse Event|0|||
156739956|NCT01738503|565795158|FG001|PET Imaging Sub-study|Adverse Event|0|||
156739957|NCT01738503|565795159|FG002|PET Imaging Sub-study|Adverse Event|0|||
156739958|NCT01738503|565795160|FG003|PET Imaging Sub-study|Adverse Event|0|||
156739959|NCT01738503|565795161|FG004|PET Imaging Sub-study|Adverse Event|0|||
156739960|NCT01738503|565795162|FG005|PET Imaging Sub-study|Adverse Event|1|||
156739961|NCT01738503|565795163|FG006|PET Imaging Sub-study|Adverse Event|0|||
156739962|NCT01738503|565795157|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739963|NCT01738503|565795158|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739964|NCT01738503|565795159|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739965|NCT01738503|565795160|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739966|NCT01738503|565795161|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739967|NCT01738503|565795162|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
156739968|NCT01738503|565795163|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
156739969|NCT03005327|565795164|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
156739970|NCT03005327|565795165|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
156739971|NCT03005327|565795166|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
156739972|NCT03005327|565795167|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
156739973|NCT03005327|565795164|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156739974|NCT03005327|565795165|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
156739975|NCT03005327|565795166|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156739976|NCT03005327|565795167|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156739977|NCT04687072|565795169|FG000|Overall Study|Adverse Event|2|||
156739978|NCT04687072|565795170|FG001|Overall Study|Adverse Event|0|||
156739979|NCT04687072|565795169|FG000|Overall Study|Death|1|||
156739980|NCT04687072|565795170|FG001|Overall Study|Death|0|||
156739981|NCT04687072|565795169|FG000|Overall Study|Lack of Efficacy|2|||
156739982|NCT04687072|565795170|FG001|Overall Study|Lack of Efficacy|1|||
156739983|NCT04687072|565795169|FG000|Overall Study|Physician Decision|1|||
156739984|NCT04687072|565795170|FG001|Overall Study|Physician Decision|0|||
156739985|NCT04687072|565795169|FG000|Overall Study|Pregnancy|1|||
156739986|NCT04687072|565795170|FG001|Overall Study|Pregnancy|0|||
156739987|NCT04687072|565795169|FG000|Overall Study|Requires Prohibited Medication|2|||
156739988|NCT04687072|565795170|FG001|Overall Study|Requires Prohibited Medication|0|||
156739989|NCT04687072|565795169|FG000|Overall Study|Withdrawal of Consent|11|||
156739990|NCT04687072|565795170|FG001|Overall Study|Withdrawal of Consent|6|||
156739991|NCT04687072|565795169|FG000|Overall Study|Miscellaneous|4|||
156739992|NCT04687072|565795170|FG001|Overall Study|Miscellaneous|1|||
156739993|NCT01263782|565795171|FG000|Overall Study|Death|0|||
156739994|NCT01263782|565795172|FG001|Overall Study|Death|0|||
156739995|NCT01263782|565795173|FG002|Overall Study|Death|1|||
156739996|NCT01263782|565795174|FG003|Overall Study|Death|0|||
156739997|NCT01263782|565795171|FG000|Overall Study|Progressive disease|0|||
156739998|NCT01263782|565795172|FG001|Overall Study|Progressive disease|0|||
156739999|NCT01263782|565795173|FG002|Overall Study|Progressive disease|0|||
156740000|NCT01263782|565795174|FG003|Overall Study|Progressive disease|1|||
156740001|NCT01263782|565795171|FG000|Overall Study|Too early|0|||
156740002|NCT01263782|565795172|FG001|Overall Study|Too early|0|||
156740003|NCT01263782|565795173|FG002|Overall Study|Too early|1|||
156740004|NCT01263782|565795174|FG003|Overall Study|Too early|0|||
156740005|NCT01263782|565795171|FG000|Overall Study|Inevaluable|0|||
156740006|NCT01263782|565795172|FG001|Overall Study|Inevaluable|0|||
156740007|NCT01263782|565795173|FG002|Overall Study|Inevaluable|1|||
156740008|NCT01263782|565795174|FG003|Overall Study|Inevaluable|0|||
156740009|NCT00915876|565795175|FG000|Overall Study|Adverse Event|0|||
156740010|NCT00915876|565795176|FG001|Overall Study|Adverse Event|1|||
156740011|NCT04545567|565795182|FG000|Overall Study|tested positive for SARS-co-V2|1|||
156740012|NCT04545567|565795183|FG001|Overall Study|tested positive for SARS-co-V2|1|||
156740013|NCT04545567|565795182|FG000|Overall Study|Withdrawal by Subject|0|||
156740014|NCT04545567|565795183|FG001|Overall Study|Withdrawal by Subject|1|||
156740015|NCT02272842|565795184|FG000|Overall Study|Lost to Follow-up|8|||
156740016|NCT02272842|565795185|FG001|Overall Study|Lost to Follow-up|8|||
156877641|NCT03933202|566309879|FG000|Overall Study|Progressive disease|0|||
156877642|NCT03933202|566309880|FG001|Overall Study|Progressive disease|3|||
156877643|NCT03933202|566309879|FG000|Overall Study|Protocol non-compliance|6|||
156877644|NCT03933202|566309880|FG001|Overall Study|Protocol non-compliance|3|||
156877645|NCT03933202|566309879|FG000|Overall Study|Lost to Follow-up|16|||
156877646|NCT03933202|566309880|FG001|Overall Study|Lost to Follow-up|8|||
156877647|NCT03933202|566309879|FG000|Overall Study|Adverse Event|3|||
156877648|NCT03933202|566309880|FG001|Overall Study|Adverse Event|0|||
156877649|NCT00980954|566309881|FG000|Overall Study|Protocol Violation|9|||
156740017|NCT02272842|565795184|FG000|Overall Study|Withdrawal by Subject|8|||
156740018|NCT02272842|565795185|FG001|Overall Study|Withdrawal by Subject|2|||
156740019|NCT01294696|565795194|FG000|Overall Study|Screening failures|7|||
156740020|NCT01294696|565795194|FG000|Overall Study|Protocol Violation|8|||
156740021|NCT01294696|565795194|FG000|Overall Study|Missing BPI Response|7|||
156336910|NCT00932126|564331420|FG006|Overall Study|Adverse Event|1|||
156740022|NCT01294696|565795194|FG000|Overall Study|Site closure|52|||
156740023|NCT05897827|565796747|FG000|Overall Study|Lost to Follow-up|33|||
156740024|NCT05897827|565796748|FG001|Overall Study|Lost to Follow-up|14|||
156740025|NCT05897827|565796747|FG000|Overall Study|Withdrawal by Subject|1|||
156740026|NCT05897827|565796748|FG001|Overall Study|Withdrawal by Subject|1|||
156740027|NCT03569293|565796749|FG000|Overall Study|Adverse Event|4|||
156877650|NCT00980954|566309882|FG001|Overall Study|Protocol Violation|15|||
156877651|NCT04115319|566309885|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
156877652|NCT04115319|566309886|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
156740028|NCT03569293|565796750|FG001|Overall Study|Adverse Event|1|||
156740029|NCT03569293|565796751|FG002|Overall Study|Adverse Event|5|||
156740030|NCT03569293|565796752|FG003|Overall Study|Adverse Event|1|||
156740031|NCT03569293|565796753|FG004|Overall Study|Adverse Event|0|||
156740032|NCT03569293|565796754|FG005|Overall Study|Adverse Event|0|||
156740033|NCT03569293|565796749|FG000|Overall Study|Withdrawal by Subject|16|||
156740034|NCT03569293|565796750|FG001|Overall Study|Withdrawal by Subject|2|||
156740035|NCT03569293|565796751|FG002|Overall Study|Withdrawal by Subject|4|||
156740036|NCT03569293|565796752|FG003|Overall Study|Withdrawal by Subject|1|||
156740037|NCT03569293|565796753|FG004|Overall Study|Withdrawal by Subject|0|||
156740038|NCT03569293|565796754|FG005|Overall Study|Withdrawal by Subject|0|||
156740039|NCT03569293|565796749|FG000|Overall Study|Lost to Follow-up|1|||
156740040|NCT03569293|565796750|FG001|Overall Study|Lost to Follow-up|3|||
156740041|NCT03569293|565796751|FG002|Overall Study|Lost to Follow-up|1|||
156740042|NCT03569293|565796752|FG003|Overall Study|Lost to Follow-up|1|||
156740043|NCT03569293|565796753|FG004|Overall Study|Lost to Follow-up|0|||
156740044|NCT03569293|565796754|FG005|Overall Study|Lost to Follow-up|0|||
156740045|NCT03569293|565796749|FG000|Overall Study|Other|8|||
156740046|NCT03569293|565796750|FG001|Overall Study|Other|2|||
156740047|NCT03569293|565796751|FG002|Overall Study|Other|1|||
156740048|NCT03569293|565796752|FG003|Overall Study|Other|1|||
156740049|NCT03569293|565796753|FG004|Overall Study|Other|0|||
156740050|NCT03569293|565796754|FG005|Overall Study|Other|0|||
156740051|NCT03569293|565796749|FG000|Overall Study|Ongoing at Time of Analysis|8|||
156740052|NCT03569293|565796750|FG001|Overall Study|Ongoing at Time of Analysis|1|||
156740053|NCT03569293|565796751|FG002|Overall Study|Ongoing at Time of Analysis|3|||
156740054|NCT03569293|565796752|FG003|Overall Study|Ongoing at Time of Analysis|0|||
156740055|NCT03569293|565796753|FG004|Overall Study|Ongoing at Time of Analysis|0|||
156740056|NCT03569293|565796754|FG005|Overall Study|Ongoing at Time of Analysis|0|||
156740057|NCT02276053|565796765|FG000|Overall Study|Death|2|||
156740058|NCT02276053|565796765|FG000|Overall Study|Adverse Event|5|||
156740059|NCT02276053|565796765|FG000|Overall Study|Lack of Efficacy|2|||
156740060|NCT02276053|565796765|FG000|Overall Study|Withdrawal by Subject|1|||
156740061|NCT02276053|565796765|FG000|Overall Study|Patient does not meet selection criteria|3|||
156740062|NCT02276053|565796765|FG000|Overall Study|Patient needs to increase baseline AED|1|||
156740063|NCT02059434|565796766|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
156740064|NCT02059434|565796767|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
156740065|NCT02059434|565796768|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
156740066|NCT02059434|565796769|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
156740067|NCT02059434|565796770|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
156740068|NCT02059434|565796771|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
156740069|NCT02059434|565796772|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
156740070|NCT02059434|565796773|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
156740071|NCT02059434|565796774|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
156740072|NCT02059434|565796766|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
156740073|NCT02059434|565796767|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
156740074|NCT02059434|565796768|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
156740075|NCT02059434|565796769|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
156740076|NCT02059434|565796770|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
156740077|NCT02059434|565796771|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
156740078|NCT02059434|565796772|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
156740079|NCT02059434|565796773|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
156740080|NCT02059434|565796774|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
156740081|NCT02059434|565796766|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
156740082|NCT02059434|565796767|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
156740083|NCT02059434|565796768|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
156740084|NCT02059434|565796769|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
156740085|NCT02059434|565796770|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
156740086|NCT02059434|565796771|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
156740087|NCT02059434|565796772|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
156740088|NCT02059434|565796773|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
156740089|NCT02059434|565796774|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
156740090|NCT02059434|565796766|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
156740091|NCT02059434|565796767|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
156740092|NCT02059434|565796768|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
156740093|NCT02059434|565796769|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
156740094|NCT02059434|565796770|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
156740095|NCT02059434|565796771|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
156740096|NCT02059434|565796772|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
156740097|NCT02059434|565796773|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
156740098|NCT02059434|565796774|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
156740099|NCT02059434|565796766|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740100|NCT02059434|565796767|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740101|NCT02059434|565796768|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740102|NCT02059434|565796769|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740103|NCT02059434|565796770|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740104|NCT02059434|565796771|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740105|NCT02059434|565796772|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740106|NCT02059434|565796773|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740107|NCT02059434|565796774|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
156740108|NCT01004406|565796777|FG000|Overall Study|Withdrawal by Subject|2|||
156740109|NCT01004406|565796778|FG001|Overall Study|Withdrawal by Subject|0|||
156740110|NCT01004406|565796777|FG000|Overall Study|Lost to Follow-up|1|||
156740111|NCT01004406|565796778|FG001|Overall Study|Lost to Follow-up|0|||
156740112|NCT02928770|565796779|FG000|Overall Study|Withdrawal by Subject|2|||
156740113|NCT03201874|565796782|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
156740114|NCT03201874|565796783|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
156740115|NCT03201874|565796782|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
156740116|NCT03201874|565796783|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
156740117|NCT02907593|565796784|FG000|Overall Study|Withdrawal by Subject|0|||
156740118|NCT02907593|565796785|FG001|Overall Study|Withdrawal by Subject|0|||
156740119|NCT02907593|565796786|FG002|Overall Study|Withdrawal by Subject|1|||
156740120|NCT02907593|565796787|FG003|Overall Study|Withdrawal by Subject|0|||
156740121|NCT04488497|565796795|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
156740122|NCT04488497|565796796|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
156740123|NCT04488497|565796795|FG000|Intervention|Physician Decision|2|||
156740124|NCT04488497|565796796|FG001|Intervention|Physician Decision|1|||
156740125|NCT04488497|565796795|FG000|Intervention|Withdrawal by Subject|5|||
156740126|NCT04488497|565796796|FG001|Intervention|Withdrawal by Subject|6|||
156740127|NCT04488497|565796795|FG000|Intervention|Lost to Follow-up|2|||
156740128|NCT04488497|565796796|FG001|Intervention|Lost to Follow-up|0|||
156740129|NCT04488497|565796795|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
156740130|NCT04488497|565796796|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
156740131|NCT04488497|565796795|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
156740132|NCT04488497|565796796|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
156740133|NCT04322539|565796797|FG000|Overall Study|Adverse Event|2|||
156740134|NCT04322539|565796798|FG001|Overall Study|Adverse Event|0|||
156740135|NCT04322539|565796797|FG000|Overall Study|Death|411|||
156740136|NCT04322539|565796798|FG001|Overall Study|Death|203|||
156740137|NCT04322539|565796797|FG000|Overall Study|Lost to Follow-up|3|||
156740138|NCT04322539|565796798|FG001|Overall Study|Lost to Follow-up|1|||
156740139|NCT04322539|565796797|FG000|Overall Study|Withdrawal of consent|14|||
156740140|NCT04322539|565796798|FG001|Overall Study|Withdrawal of consent|8|||
156740141|NCT04322539|565796797|FG000|Overall Study|Radiological Disease Progression|6|||
156740142|NCT04322539|565796798|FG001|Overall Study|Radiological Disease Progression|0|||
156740143|NCT04322539|565796797|FG000|Overall Study|Sponsor Decision|19|||
156740144|NCT04322539|565796798|FG001|Overall Study|Sponsor Decision|14|||
156740145|NCT04322539|565796797|FG000|Overall Study|Other|6|||
156740146|NCT04322539|565796798|FG001|Overall Study|Other|4|||
156740147|NCT01877551|565796799|FG000|Overall Study|Physician Decision|0|||
156740148|NCT01877551|565796800|FG001|Overall Study|Physician Decision|1|||
156740149|NCT02659514|565796801|FG000|Overall Study|Adverse Event|3|||
156740150|NCT02659514|565796802|FG001|Overall Study|Adverse Event|12|||
156740151|NCT02659514|565796801|FG000|Overall Study|Disease Progression|23|||
156740152|NCT02659514|565796802|FG001|Overall Study|Disease Progression|13|||
156740153|NCT02659514|565796801|FG000|Overall Study|Withdrawal by Subject|0|||
156740154|NCT02659514|565796802|FG001|Overall Study|Withdrawal by Subject|4|||
156740155|NCT02659514|565796801|FG000|Overall Study|Lost to Follow-up|0|||
156740156|NCT02659514|565796802|FG001|Overall Study|Lost to Follow-up|1|||
156740157|NCT02659514|565796801|FG000|Overall Study|Death|6|||
156740158|NCT02659514|565796802|FG001|Overall Study|Death|1|||
156740159|NCT02659514|565796801|FG000|Overall Study|Reason Unspecified|0|||
156740160|NCT02659514|565796802|FG001|Overall Study|Reason Unspecified|3|||
156740161|NCT00348790|565796803|FG000|Completed Treatment|Withdrawal by Subject|4|||
156740162|NCT00348790|565796803|FG000|Completed Treatment|Disease progression|14|||
156740163|NCT00348790|565796803|FG000|Completed Treatment|Adverse Event|4|||
156740164|NCT00348790|565796803|FG000|Completed Treatment|Required surgery|2|||
156740165|NCT00348790|565796803|FG000|Completed Treatment|Unable to travel to study site|1|||
156740166|NCT03409107|565796807|FG000|Overall Study|Withdrawal by Subject|4|||
156740167|NCT03409107|565796808|FG001|Overall Study|Withdrawal by Subject|2|||
156740168|NCT03409107|565796807|FG000|Overall Study|Physician Decision|1|||
156740169|NCT03409107|565796808|FG001|Overall Study|Physician Decision|0|||
156740170|NCT03409107|565796807|FG000|Overall Study|Lost to Follow-up|7|||
156740171|NCT03409107|565796808|FG001|Overall Study|Lost to Follow-up|2|||
156740172|NCT03409107|565796807|FG000|Overall Study|Adverse Event|5|||
156740173|NCT03409107|565796808|FG001|Overall Study|Adverse Event|3|||
156740174|NCT01185509|565796809|FG000|Overall Study|Progression/Relapse|9|||
156877653|NCT04115319|566309885|FG000|Overall Study|Withdrawal by participant|17|||
156877654|NCT04115319|566309886|FG001|Overall Study|Withdrawal by participant|9|||
156877655|NCT04115319|566309885|FG000|Overall Study|Geopolitical Conflict Related|2|||
156877656|NCT04115319|566309886|FG001|Overall Study|Geopolitical Conflict Related|1|||
156877657|NCT04115319|566309885|FG000|Overall Study|COVID-19 Related|1|||
156534598|NCT01399190|565052406|FG000|Overall Study|Participant's Request|5|||
156534599|NCT01399190|565052406|FG000|Overall Study|Physician Decision|2|||
156534600|NCT05395104|565052407|FG000|Overall Study|Met Liver Stopping Criteria|1|||
156534601|NCT05395104|565052407|FG000|Overall Study|Withdrawal by Subject|1|||
156534602|NCT00381563|565052408|FG000|Overall Study|Withdrawal by Subject|5|||
156534603|NCT00381563|565052409|FG001|Overall Study|Withdrawal by Subject|5|||
156534604|NCT00381563|565052408|FG000|Overall Study|Lost to Follow-up|2|||
156534605|NCT00381563|565052409|FG001|Overall Study|Lost to Follow-up|0|||
156534606|NCT00381563|565052408|FG000|Overall Study|Protocol Violation|0|||
156534607|NCT00381563|565052409|FG001|Overall Study|Protocol Violation|1|||
156534608|NCT01287364|565052410|FG000|Overall Study|Adverse Event|0|||
156534609|NCT01287364|565052411|FG001|Overall Study|Adverse Event|3|||
156534610|NCT01287364|565052410|FG000|Overall Study|Protocol Violation|5|||
156534611|NCT01287364|565052411|FG001|Overall Study|Protocol Violation|5|||
156534612|NCT01287364|565052410|FG000|Overall Study|Other Reason|4|||
156534613|NCT01287364|565052411|FG001|Overall Study|Other Reason|2|||
156534614|NCT04422990|565052412|FG000|Overall Study|Withdrawal by Subject|0|||
156534615|NCT04422990|565052413|FG001|Overall Study|Withdrawal by Subject|1|||
156534616|NCT04422990|565052412|FG000|Overall Study|Travel|3|||
156534617|NCT04422990|565052413|FG001|Overall Study|Travel|0|||
156534618|NCT01829425|565052422|FG000|Overall Study|Withdrawal by Subject|4|||
156534619|NCT01829425|565052423|FG001|Overall Study|Withdrawal by Subject|3|||
156534620|NCT01829425|565052422|FG000|Overall Study|Lost to Follow-up|2|||
156534621|NCT01829425|565052423|FG001|Overall Study|Lost to Follow-up|1|||
156534622|NCT03681951|565052424|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
156534623|NCT03681951|565052425|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156534624|NCT03681951|565052426|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156534625|NCT03681951|565052427|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156534626|NCT03681951|565052428|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156534627|NCT03681951|565052429|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156534628|NCT03681951|565052430|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156534629|NCT03681951|565052431|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156534630|NCT03681951|565052424|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
156534631|NCT03681951|565052425|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
156534632|NCT03681951|565052426|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
156534633|NCT03681951|565052427|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
156534634|NCT03681951|565052428|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
156534635|NCT03681951|565052429|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
156534636|NCT03681951|565052430|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
156534637|NCT03681951|565052431|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
156534638|NCT03681951|565052424|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
156534639|NCT03681951|565052425|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156534640|NCT03681951|565052426|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156534641|NCT03681951|565052427|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156534642|NCT03681951|565052428|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156534643|NCT03681951|565052429|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156534644|NCT03681951|565052430|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156534645|NCT03681951|565052431|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156534646|NCT02187809|565052432|FG000|Overall Study|The study was terminated|3|||
156534647|NCT01020448|565052433|FG000|Pre-assignment|Adverse Event|6|||
156534648|NCT01020448|565052433|FG000|Pre-assignment|Withdrawal by Subject|5|||
156534649|NCT01020448|565052433|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
156534650|NCT01020448|565052433|FG000|Treatment|Adverse Event|11|||
156534651|NCT01020448|565052433|FG000|Treatment|Consent Withdrawn|3|||
156534652|NCT01020448|565052433|FG000|Treatment|Disease Progression|2|||
156534653|NCT01020448|565052433|FG000|Treatment|Lack of Efficacy|8|||
156740175|NCT01185509|565796810|FG001|Overall Study|Progression/Relapse|15|||
156534654|NCT01020448|565052433|FG000|Treatment|Lost to Follow-up|2|||
156534655|NCT01230554|565052434|FG000|Overall Study|Lost to Follow-up|2|||
156534656|NCT01230554|565052434|FG000|Overall Study|Inability to maintain visit schedule|1|||
156534657|NCT00698932|565052439|FG000|Overall Study|Adverse Event|0|||
156534658|NCT00698932|565052440|FG001|Overall Study|Adverse Event|2|||
156534659|NCT00698932|565052439|FG000|Overall Study|Incorrect enrollment|0|||
156534660|NCT00698932|565052440|FG001|Overall Study|Incorrect enrollment|2|||
156534661|NCT00698932|565052439|FG000|Overall Study|Study specific discontinuation criteria|3|||
156740176|NCT01185509|565796809|FG000|Overall Study|Physician Decision|2|||
156877658|NCT04115319|566309886|FG001|Overall Study|COVID-19 Related|0|||
156877659|NCT04115319|566309885|FG000|Overall Study|Adverse Event|48|||
156740177|NCT01185509|565796810|FG001|Overall Study|Physician Decision|2|||
156740178|NCT01185509|565796809|FG000|Overall Study|Withdrawal by Subject|0|||
156740179|NCT01185509|565796810|FG001|Overall Study|Withdrawal by Subject|1|||
156740180|NCT01185509|565796809|FG000|Overall Study|Death|0|||
156740181|NCT01185509|565796810|FG001|Overall Study|Death|1|||
156740182|NCT01185509|565796809|FG000|Overall Study|Intercurrent Illness|0|||
156740183|NCT01185509|565796810|FG001|Overall Study|Intercurrent Illness|1|||
156740184|NCT03687372|565796811|FG000|Overall Study|Lost to Follow-up|12|||
156740185|NCT03687372|565796812|FG001|Overall Study|Lost to Follow-up|21|||
156740186|NCT03687372|565796811|FG000|Overall Study|Withdrawal by Subject|4|||
156740187|NCT03687372|565796812|FG001|Overall Study|Withdrawal by Subject|17|||
156740188|NCT03687372|565796811|FG000|Overall Study|Investigator Decision|1|||
156740189|NCT03687372|565796812|FG001|Overall Study|Investigator Decision|1|||
156740190|NCT02370667|565796820|FG000|Overall Study|Lost to Follow-up|0|||
156740191|NCT02370667|565796821|FG001|Overall Study|Lost to Follow-up|1|||
156740192|NCT02370667|565796822|FG002|Overall Study|Lost to Follow-up|0|||
156740193|NCT03536949|565796823|FG000|Overall Study|Adverse Event|4|||
156740194|NCT03536949|565796824|FG001|Overall Study|Adverse Event|0|||
156740195|NCT03536949|565796823|FG000|Overall Study|Lost to Follow-up|2|||
156740196|NCT03536949|565796824|FG001|Overall Study|Lost to Follow-up|1|||
156740197|NCT03536949|565796823|FG000|Overall Study|Withdrawal by Subject|6|||
156740198|NCT03536949|565796824|FG001|Overall Study|Withdrawal by Subject|0|||
156740199|NCT03536949|565796823|FG000|Overall Study|Non-compliance|2|||
156740200|NCT03536949|565796824|FG001|Overall Study|Non-compliance|1|||
156740201|NCT02954653|565796826|FG000|Overall Study|Death|3|||
156740202|NCT02954653|565796827|FG001|Overall Study|Death|1|||
156740203|NCT02954653|565796828|FG002|Overall Study|Death|0|||
156740204|NCT02954653|565796829|FG003|Overall Study|Death|0|||
156740205|NCT02954653|565796830|FG004|Overall Study|Death|0|||
156740206|NCT02954653|565796831|FG005|Overall Study|Death|0|||
156740207|NCT02954653|565796832|FG006|Overall Study|Death|0|||
156740208|NCT02954653|565796833|FG007|Overall Study|Death|0|||
156740209|NCT02954653|565796834|FG008|Overall Study|Death|0|||
156534662|NCT00698932|565052440|FG001|Overall Study|Study specific discontinuation criteria|4|||
156534663|NCT00698932|565052439|FG000|Overall Study|Withdrawal by Subject|11|||
156534664|NCT00698932|565052440|FG001|Overall Study|Withdrawal by Subject|23|||
156534665|NCT00698932|565052439|FG000|Overall Study|Lost to Follow-up|6|||
156534666|NCT00698932|565052440|FG001|Overall Study|Lost to Follow-up|1|||
156534667|NCT00698932|565052439|FG000|Overall Study|Severe non-compliance to protocol|1|||
156534668|NCT00698932|565052440|FG001|Overall Study|Severe non-compliance to protocol|2|||
156534669|NCT00698932|565052439|FG000|Overall Study|Safety reasons|0|||
156534670|NCT00698932|565052440|FG001|Overall Study|Safety reasons|2|||
156534671|NCT00698932|565052439|FG000|Overall Study|Death|1|||
156534672|NCT00698932|565052440|FG001|Overall Study|Death|0|||
156534673|NCT01245387|565052441|FG000|Overall Study|Lost to Follow-up|106|||
156534674|NCT01245387|565052441|FG000|Overall Study|Lack of Efficacy|195|||
156534675|NCT01245387|565052441|FG000|Overall Study|Adverse Event|9|||
156534676|NCT01245387|565052441|FG000|Overall Study|Death|3|||
156740210|NCT02954653|565796826|FG000|Overall Study|Randomized but did not receive treatment|1|||
156740211|NCT02954653|565796827|FG001|Overall Study|Randomized but did not receive treatment|0|||
156797585|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
156797586|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
156797587|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
156797588|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
156797589|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797590|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156740212|NCT02954653|565796828|FG002|Overall Study|Randomized but did not receive treatment|0|||
156740213|NCT02954653|565796829|FG003|Overall Study|Randomized but did not receive treatment|0|||
156740214|NCT02954653|565796830|FG004|Overall Study|Randomized but did not receive treatment|0|||
156740215|NCT02954653|565796831|FG005|Overall Study|Randomized but did not receive treatment|0|||
156740216|NCT02954653|565796832|FG006|Overall Study|Randomized but did not receive treatment|0|||
156797591|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797592|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797593|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797594|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797595|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156534677|NCT01245387|565052441|FG000|Overall Study|Other|131|||
156534678|NCT01245387|565052441|FG000|Overall Study|Missing discontinuation status|369|||
156534679|NCT00601705|565052442|FG000|Overall Study|Withdrawal by Subject|1|||
156740217|NCT02954653|565796833|FG007|Overall Study|Randomized but did not receive treatment|0|||
156740218|NCT02954653|565796834|FG008|Overall Study|Randomized but did not receive treatment|0|||
156740219|NCT02954653|565796826|FG000|Overall Study|Started another anti-cancer therapy|0|||
156740220|NCT02954653|565796827|FG001|Overall Study|Started another anti-cancer therapy|1|||
156534680|NCT04513665|565052443|FG000|Overall Study|Adverse Event|2|||
156534681|NCT04513665|565052444|FG001|Overall Study|Adverse Event|0|||
156534682|NCT04513665|565052443|FG000|Overall Study|Lack of Efficacy|14|||
156740221|NCT02954653|565796828|FG002|Overall Study|Started another anti-cancer therapy|0|||
156740222|NCT02954653|565796829|FG003|Overall Study|Started another anti-cancer therapy|0|||
156740223|NCT02954653|565796830|FG004|Overall Study|Started another anti-cancer therapy|0|||
156740224|NCT02954653|565796831|FG005|Overall Study|Started another anti-cancer therapy|0|||
156740225|NCT02954653|565796832|FG006|Overall Study|Started another anti-cancer therapy|0|||
156740226|NCT02954653|565796833|FG007|Overall Study|Started another anti-cancer therapy|0|||
156740227|NCT02954653|565796834|FG008|Overall Study|Started another anti-cancer therapy|0|||
156740228|NCT02954653|565796826|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
156740229|NCT02954653|565796827|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
156740230|NCT02954653|565796828|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
156740231|NCT02954653|565796829|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
156740232|NCT02954653|565796830|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
156740233|NCT02954653|565796831|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
156740234|NCT02954653|565796832|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
156740235|NCT02954653|565796833|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
156740236|NCT02954653|565796834|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
156740237|NCT03054064|565796835|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
156740238|NCT03054064|565796835|FG000|Overall Study|Investigator Decision|2|||
156740239|NCT03054064|565796835|FG000|Overall Study|Bladder Issue|1|||
156740240|NCT03054064|565796835|FG000|Overall Study|High Blood Pressure|1|||
156740241|NCT03054064|565796835|FG000|Overall Study|Change in Status|1|||
156740242|NCT04329091|565796836|FG000|Overall Study|Physician Decision|5|||
156740243|NCT03787303|565796839|FG000|Overall Study|Death|1|||
156740244|NCT03787303|565796839|FG000|Overall Study|Premature Termination of Study|1|||
156740245|NCT05020366|565796844|FG000|Overall Study|Lost to Follow-up|2|||
156740246|NCT05020366|565796845|FG001|Overall Study|Lost to Follow-up|0|||
156740247|NCT05020366|565796844|FG000|Overall Study|Withdrawal by Subject|2|||
156740248|NCT05020366|565796845|FG001|Overall Study|Withdrawal by Subject|0|||
156740249|NCT00794040|565796849|FG000|Overall Study|Withdrawal by Subject|3|||
156740250|NCT00794040|565796850|FG001|Overall Study|Withdrawal by Subject|4|||
156740251|NCT00794040|565796849|FG000|Overall Study|Physician Decision|0|||
156740252|NCT00794040|565796850|FG001|Overall Study|Physician Decision|1|||
156740253|NCT04696354|565796851|FG000|Overall Study|Study termination|6|||
156740254|NCT04696354|565796852|FG001|Overall Study|Study termination|6|||
156740255|NCT03626363|565796855|FG000|Overall Study|Protocol Violation|4|||
156740256|NCT03626363|565796856|FG001|Overall Study|Protocol Violation|0|||
156740257|NCT03626363|565796855|FG000|Overall Study|Lost to Follow-up|5|||
156740258|NCT03626363|565796856|FG001|Overall Study|Lost to Follow-up|7|||
156740259|NCT00965341|565796862|FG000|Overall Study|Withdrew consent|1|||
156740260|NCT00965341|565796863|FG001|Overall Study|Withdrew consent|5|||
156740261|NCT00965341|565796862|FG000|Overall Study|Lost to Follow-up|1|||
156740262|NCT00965341|565796863|FG001|Overall Study|Lost to Follow-up|0|||
156740263|NCT00965341|565796862|FG000|Overall Study|Transportation issues|4|||
156740264|NCT00965341|565796863|FG001|Overall Study|Transportation issues|3|||
156740265|NCT01970475|565796864|FG000|Overall Study|Withdrawal by Subject|11|||
156740266|NCT01970475|565796865|FG001|Overall Study|Withdrawal by Subject|6|||
156740267|NCT01970475|565796864|FG000|Overall Study|Adverse Event|7|||
156740268|NCT01970475|565796865|FG001|Overall Study|Adverse Event|3|||
156740269|NCT01970475|565796864|FG000|Overall Study|Lost to Follow-up|2|||
156740270|NCT01970475|565796865|FG001|Overall Study|Lost to Follow-up|2|||
156740271|NCT01970475|565796864|FG000|Overall Study|Protocol Violation|1|||
156740272|NCT01970475|565796865|FG001|Overall Study|Protocol Violation|0|||
156740273|NCT01077739|565796866|FG000|Overall Study|Premature withdrawal|1|||
156740274|NCT01077739|565796867|FG001|Overall Study|Premature withdrawal|3|||
156740275|NCT01077739|565796866|FG000|Overall Study|Withdrawal by Subject|1|||
156740276|NCT01077739|565796867|FG001|Overall Study|Withdrawal by Subject|0|||
156740277|NCT01077739|565796866|FG000|Overall Study|Death|0|||
156740278|NCT01077739|565796867|FG001|Overall Study|Death|3|||
156740279|NCT01077739|565796866|FG000|Overall Study|Unacceptable toxicity|1|||
156740280|NCT01077739|565796867|FG001|Overall Study|Unacceptable toxicity|2|||
156740281|NCT01077739|565796866|FG000|Overall Study|Other|2|||
156740282|NCT01077739|565796867|FG001|Overall Study|Other|2|||
156740283|NCT00960986|565796868|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
156740284|NCT00960986|565796869|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
156740285|NCT00960986|565796870|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
156740286|NCT00960986|565796871|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
156740287|NCT00960986|565796868|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
156740288|NCT00960986|565796869|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
156740289|NCT00960986|565796870|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
156740290|NCT00960986|565796871|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
156740291|NCT00960986|565796868|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
156740292|NCT00960986|565796869|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
156740293|NCT00960986|565796870|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
156740294|NCT00960986|565796871|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
156740295|NCT00960986|565796868|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
156740296|NCT00960986|565796869|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
156740297|NCT00960986|565796870|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
156740298|NCT00960986|565796871|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
156534683|NCT04513665|565052444|FG001|Overall Study|Lack of Efficacy|0|||
156534684|NCT02146599|565052448|FG000|Overall Study|Failed to meet inclusion criteria|5|||
156534685|NCT04246801|565052449|FG000|Overall Study|Adverse Event|1|||
156534686|NCT04246801|565052450|FG001|Overall Study|Adverse Event|1|||
156534687|NCT04246801|565052449|FG000|Overall Study|Protocol Violation|1|||
156534688|NCT04246801|565052450|FG001|Overall Study|Protocol Violation|1|||
156534689|NCT04246801|565052449|FG000|Overall Study|Lack of Efficacy|0|||
156534690|NCT04246801|565052450|FG001|Overall Study|Lack of Efficacy|2|||
156534691|NCT04246801|565052449|FG000|Overall Study|Lost to Follow-up|1|||
156740299|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
156740300|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
156740301|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
156740302|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
156740303|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Death|0|||
156740304|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Death|0|||
156740305|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Death|1|||
156740306|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Death|0|||
156740307|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
156740308|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
156740309|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
156740310|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
156534692|NCT04246801|565052450|FG001|Overall Study|Lost to Follow-up|1|||
156534693|NCT04246801|565052449|FG000|Overall Study|Withdrawal by Subject|2|||
156534694|NCT04246801|565052450|FG001|Overall Study|Withdrawal by Subject|1|||
156534695|NCT02632721|565052456|FG000|Overall Study|Adverse Event|0|||
156534696|NCT02632721|565052457|FG001|Overall Study|Adverse Event|0|||
156534697|NCT02632721|565052458|FG002|Overall Study|Adverse Event|2|||
156534698|NCT02632721|565052459|FG003|Overall Study|Adverse Event|5|||
156534699|NCT02632721|565052460|FG004|Overall Study|Adverse Event|3|||
156534700|NCT02632721|565052456|FG000|Overall Study|Dose limiting toxicity|0|||
156534701|NCT02632721|565052457|FG001|Overall Study|Dose limiting toxicity|0|||
156534702|NCT02632721|565052458|FG002|Overall Study|Dose limiting toxicity|0|||
156534703|NCT02632721|565052459|FG003|Overall Study|Dose limiting toxicity|1|||
156534704|NCT02632721|565052460|FG004|Overall Study|Dose limiting toxicity|0|||
156534705|NCT02632721|565052456|FG000|Overall Study|Progressive disease|3|||
156534706|NCT02632721|565052457|FG001|Overall Study|Progressive disease|0|||
156534707|NCT02632721|565052458|FG002|Overall Study|Progressive disease|4|||
156534708|NCT02632721|565052459|FG003|Overall Study|Progressive disease|6|||
156534709|NCT02632721|565052460|FG004|Overall Study|Progressive disease|5|||
156534710|NCT02632721|565052456|FG000|Overall Study|Refused to continue taking trial medication|0|||
156534711|NCT02632721|565052457|FG001|Overall Study|Refused to continue taking trial medication|1|||
156534712|NCT02632721|565052458|FG002|Overall Study|Refused to continue taking trial medication|1|||
156740311|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
156740312|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
156740313|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
156534713|NCT02632721|565052459|FG003|Overall Study|Refused to continue taking trial medication|1|||
156534714|NCT02632721|565052460|FG004|Overall Study|Refused to continue taking trial medication|2|||
156740314|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
156740315|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
156740316|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
156740317|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
156740318|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
156740319|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
156740320|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
156740321|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
156740322|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
156740323|NCT00877071|565796872|FG000|Overall Study|disease progression|2|||
156740324|NCT01984892|565796873|FG000|Overall Study|Progressive disease|7|||
156797596|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156534715|NCT02632721|565052456|FG000|Overall Study|Inadequate clinical condition|0|||
156534716|NCT02632721|565052457|FG001|Overall Study|Inadequate clinical condition|0|||
156797597|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156877660|NCT04115319|566309886|FG001|Overall Study|Adverse Event|21|||
156534717|NCT02632721|565052458|FG002|Overall Study|Inadequate clinical condition|0|||
156534718|NCT02632721|565052459|FG003|Overall Study|Inadequate clinical condition|0|||
156534719|NCT02632721|565052460|FG004|Overall Study|Inadequate clinical condition|1|||
156534720|NCT02632721|565052456|FG000|Overall Study|No meet eligibility|0|||
156534721|NCT02632721|565052457|FG001|Overall Study|No meet eligibility|0|||
156534722|NCT02632721|565052458|FG002|Overall Study|No meet eligibility|0|||
156740325|NCT04464720|565796874|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
156740326|NCT04413552|565796880|FG000|Overall Study|Adverse Event|0|||
156740327|NCT04413552|565796881|FG001|Overall Study|Adverse Event|0|||
156740328|NCT04413552|565796882|FG002|Overall Study|Adverse Event|0|||
156740329|NCT04413552|565796883|FG003|Overall Study|Adverse Event|0|||
156740330|NCT04413552|565796884|FG004|Overall Study|Adverse Event|0|||
156740331|NCT04413552|565796885|FG005|Overall Study|Adverse Event|0|||
156740332|NCT04413552|565796886|FG006|Overall Study|Adverse Event|1|||
156740333|NCT04413552|565796887|FG007|Overall Study|Adverse Event|0|||
156740334|NCT04413552|565796888|FG008|Overall Study|Adverse Event|0|||
156740335|NCT04413552|565796889|FG009|Overall Study|Adverse Event|0|||
156740336|NCT05723328|565796890|FG000|Overall Study|Investigator's Decision|5|||
156740337|NCT05723328|565796891|FG001|Overall Study|Investigator's Decision|2|||
156740338|NCT01794793|565796894|FG000|Treatment Period|Withdrawal by Subject|24|||
156740339|NCT01794793|565796894|FG000|Treatment Period|Lack of Efficacy|22|||
156740340|NCT01794793|565796894|FG000|Treatment Period|Adverse Event|17|||
156740341|NCT01794793|565796894|FG000|Treatment Period|Physician Decision|14|||
156740342|NCT01794793|565796894|FG000|Treatment Period|Lost to Follow-up|7|||
156740343|NCT01794793|565796894|FG000|Treatment Period|Death|6|||
156740344|NCT01794793|565796894|FG000|Treatment Period|Protocol Violation|5|||
156740345|NCT01794793|565796894|FG000|Treatment Period|administrative problem|3|||
156740346|NCT01794793|565796894|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
156740347|NCT01794793|565796894|FG000|Post-treatment Follow-up|Adverse Event|8|||
156740348|NCT01794793|565796894|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
156740349|NCT01794793|565796894|FG000|Post-treatment Follow-up|administrative problem|5|||
156740350|NCT01794793|565796894|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
156740351|NCT01794793|565796894|FG000|Post-treatment Follow-up|Protocol Violation|3|||
156740352|NCT03495154|565796895|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
156740353|NCT03495154|565796895|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
156740354|NCT03495154|565796895|FG000|Overall Study|Screen Failures During Surgery|6|||
156740355|NCT03495154|565796895|FG000|Overall Study|Death|2|||
156740356|NCT03495154|565796895|FG000|Overall Study|Lost to Follow-up|16|||
156740357|NCT03495154|565796895|FG000|Overall Study|Withdrawal by Subject|2|||
156740358|NCT03495154|565796895|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
156740359|NCT04852679|565796898|FG000|Main Intervention Period|Withdrawal by Subject|3|||
156740360|NCT04852679|565796898|FG000|Main Intervention Period|Adverse Event|1|||
156740361|NCT04852679|565796898|FG000|Main Intervention Period|Progressive Disease|16|||
156740362|NCT04852679|565796898|FG000|Main Intervention Period|Refused study visit|1|||
156740363|NCT04852679|565796898|FG000|Independent Injection Period|Missed study visit|1|||
156740364|NCT02000882|565798664|FG000|Overall Study|Adverse Event|3|||
156740365|NCT02000882|565798664|FG000|Overall Study|Physician Decision|2|||
156740366|NCT02000882|565798664|FG000|Overall Study|Withdrawal by Subject|1|||
156740367|NCT02417961|565798668|FG000|Overall Study|Adverse Event|1|||
156740368|NCT02417961|565798668|FG000|Overall Study|Lost to Follow-up|1|||
156740369|NCT02417961|565798668|FG000|Overall Study|Withdrawal by Subject|2|||
156740370|NCT01390428|565798669|FG000|Overall Study|Elective Surgery|0|||
156740371|NCT01390428|565798670|FG001|Overall Study|Elective Surgery|0|||
156740372|NCT01390428|565798671|FG002|Overall Study|Elective Surgery|0|||
156740373|NCT01390428|565798672|FG003|Overall Study|Elective Surgery|0|||
156740374|NCT01390428|565798673|FG004|Overall Study|Elective Surgery|1|||
156740375|NCT01390428|565798674|FG005|Overall Study|Elective Surgery|0|||
156740376|NCT01390428|565798669|FG000|Overall Study|Withdrawal by Subject|0|||
156740377|NCT01390428|565798670|FG001|Overall Study|Withdrawal by Subject|0|||
156740378|NCT01390428|565798671|FG002|Overall Study|Withdrawal by Subject|1|||
156740379|NCT01390428|565798672|FG003|Overall Study|Withdrawal by Subject|0|||
156740380|NCT01390428|565798673|FG004|Overall Study|Withdrawal by Subject|0|||
156740381|NCT01390428|565798674|FG005|Overall Study|Withdrawal by Subject|0|||
156797598|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797599|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156534723|NCT02632721|565052459|FG003|Overall Study|No meet eligibility|0|||
156534724|NCT02632721|565052460|FG004|Overall Study|No meet eligibility|1|||
156534725|NCT02632721|565052456|FG000|Overall Study|Allergic reaction|0|||
156740382|NCT05079750|565798675|FG000|Overall Study|Lost to Follow-up|0|||
156740383|NCT05079750|565798676|FG001|Overall Study|Lost to Follow-up|0|||
156740384|NCT05079750|565798677|FG002|Overall Study|Lost to Follow-up|1|||
156740385|NCT05091346|565798680|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
156740386|NCT05091346|565798681|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
156740387|NCT05091346|565798682|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
156740388|NCT05091346|565798683|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
156740389|NCT05091346|565798684|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
156740390|NCT05091346|565798680|FG000|Overall Study|Death|6|||
156740391|NCT05091346|565798681|FG001|Overall Study|Death|5|||
156534726|NCT02632721|565052457|FG001|Overall Study|Allergic reaction|0|||
156740392|NCT05091346|565798682|FG002|Overall Study|Death|8|||
156740393|NCT05091346|565798683|FG003|Overall Study|Death|16|||
156740394|NCT05091346|565798684|FG004|Overall Study|Death|26|||
156740395|NCT05091346|565798680|FG000|Overall Study|Lost to Follow-up|0|||
156740396|NCT05091346|565798681|FG001|Overall Study|Lost to Follow-up|0|||
156740397|NCT05091346|565798682|FG002|Overall Study|Lost to Follow-up|0|||
156740398|NCT05091346|565798683|FG003|Overall Study|Lost to Follow-up|1|||
156740399|NCT05091346|565798684|FG004|Overall Study|Lost to Follow-up|0|||
156740400|NCT05091346|565798680|FG000|Overall Study|Withdrawal by Subject|0|||
156740401|NCT05091346|565798681|FG001|Overall Study|Withdrawal by Subject|1|||
156740402|NCT05091346|565798682|FG002|Overall Study|Withdrawal by Subject|2|||
156740403|NCT05091346|565798683|FG003|Overall Study|Withdrawal by Subject|2|||
156740404|NCT05091346|565798684|FG004|Overall Study|Withdrawal by Subject|1|||
156740405|NCT05128773|565798696|FG000|Overall Study|Sponsor decision to terminate study|3|||
156740406|NCT04250714|565798697|FG000|Overall Study|Treatment - withdrawal by subject|14|||
156740407|NCT04250714|565798697|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
156740408|NCT04250714|565798697|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
156740409|NCT04250714|565798697|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
156740410|NCT04250714|565798697|FG000|Overall Study|Treatment - Death|1|||
156740411|NCT04250714|565798697|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
156740412|NCT04250714|565798697|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
156740413|NCT04250714|565798697|FG000|Overall Study|Attempt|2|||
156740414|NCT04250714|565798697|FG000|Overall Study|Intent|7|||
156740415|NCT04697056|565798698|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
156740416|NCT04697056|565798699|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
156740417|NCT03617861|565798700|FG000|Second Intervention (1 Day)|Adverse Event|0|||
156740418|NCT03617861|565798701|FG001|Second Intervention (1 Day)|Adverse Event|0|||
156740419|NCT03617861|565798702|FG002|Second Intervention (1 Day)|Adverse Event|1|||
156740420|NCT03617861|565798703|FG003|Second Intervention (1 Day)|Adverse Event|0|||
156740421|NCT01702532|565798704|FG000|Overall Study|Adverse Event|0|||
156740422|NCT01702532|565798705|FG001|Overall Study|Adverse Event|1|||
156740423|NCT00623597|565798706|FG000|Overall Study|Failed to return|1|||
156740424|NCT00623597|565798707|FG001|Overall Study|Failed to return|0|||
156740425|NCT01451164|565798708|FG000|Overall Study|Adverse Event|19|||
156740426|NCT01451164|565798709|FG001|Overall Study|Adverse Event|12|||
156740427|NCT01451164|565798710|FG002|Overall Study|Adverse Event|18|||
156740428|NCT01451164|565798711|FG003|Overall Study|Adverse Event|21|||
156740429|NCT01451164|565798708|FG000|Overall Study|Withdrawal Criteria|1|||
156740430|NCT01451164|565798709|FG001|Overall Study|Withdrawal Criteria|1|||
156740431|NCT01451164|565798710|FG002|Overall Study|Withdrawal Criteria|1|||
156740432|NCT01451164|565798711|FG003|Overall Study|Withdrawal Criteria|1|||
156740433|NCT01451164|565798708|FG000|Overall Study|Physician Decision|2|||
156740434|NCT01451164|565798709|FG001|Overall Study|Physician Decision|0|||
156740435|NCT01451164|565798710|FG002|Overall Study|Physician Decision|1|||
156740436|NCT01451164|565798711|FG003|Overall Study|Physician Decision|0|||
156740437|NCT01451164|565798708|FG000|Overall Study|Withdrawal by Subject|14|||
156740438|NCT01451164|565798709|FG001|Overall Study|Withdrawal by Subject|11|||
156740439|NCT01451164|565798710|FG002|Overall Study|Withdrawal by Subject|16|||
156740440|NCT01451164|565798711|FG003|Overall Study|Withdrawal by Subject|17|||
156740441|NCT01451164|565798708|FG000|Overall Study|Protocol Violation|0|||
156740442|NCT01451164|565798709|FG001|Overall Study|Protocol Violation|1|||
156740443|NCT01451164|565798710|FG002|Overall Study|Protocol Violation|0|||
156740444|NCT01451164|565798711|FG003|Overall Study|Protocol Violation|0|||
156740445|NCT01451164|565798708|FG000|Overall Study|Lack of Efficacy|7|||
156877661|NCT04115319|566309885|FG000|Overall Study|Noncompliance with Study Drug|5|||
156877662|NCT04115319|566309886|FG001|Overall Study|Noncompliance with Study Drug|1|||
156877663|NCT04115319|566309885|FG000|Overall Study|Lack of Efficacy|6|||
156877664|NCT04115319|566309886|FG001|Overall Study|Lack of Efficacy|2|||
156740446|NCT01451164|565798709|FG001|Overall Study|Lack of Efficacy|9|||
156740447|NCT01451164|565798710|FG002|Overall Study|Lack of Efficacy|9|||
156740448|NCT01451164|565798711|FG003|Overall Study|Lack of Efficacy|7|||
156797600|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797601|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797602|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797603|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
156797604|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797605|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
156797606|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
156797607|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
156877665|NCT04115319|566309885|FG000|Overall Study|Lost to Follow-up|6|||
156740449|NCT00345878|565798714|FG000|Overall Study|Adverse Event|1|||
156740450|NCT00345878|565798715|FG001|Overall Study|Adverse Event|0|||
156740451|NCT00345878|565798714|FG000|Overall Study|Lost to Follow-up|2|||
156740452|NCT00345878|565798715|FG001|Overall Study|Lost to Follow-up|1|||
156740453|NCT00345878|565798714|FG000|Overall Study|Other|1|||
156740454|NCT00345878|565798715|FG001|Overall Study|Other|0|||
156740455|NCT00308750|565798716|FG000|Overall Study|Adverse Event|9|||
156877666|NCT04115319|566309886|FG001|Overall Study|Lost to Follow-up|7|||
156877667|NCT04115319|566309885|FG000|Overall Study|Protocol Deviation|5|||
156877668|NCT04115319|566309886|FG001|Overall Study|Protocol Deviation|1|||
156877669|NCT04115319|566309885|FG000|Overall Study|Participant relocated|5|||
156877670|NCT04115319|566309886|FG001|Overall Study|Participant relocated|2|||
156877671|NCT04115319|566309885|FG000|Overall Study|Personal Reasons|0|||
156877672|NCT04115319|566309886|FG001|Overall Study|Personal Reasons|1|||
156877673|NCT04115319|566309885|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
156877674|NCT04115319|566309886|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
156740456|NCT00308750|565798717|FG001|Overall Study|Adverse Event|9|||
156740457|NCT00308750|565798718|FG002|Overall Study|Adverse Event|13|||
156740458|NCT00308750|565798716|FG000|Overall Study|Withdrawal by Subject|6|||
156740459|NCT00308750|565798717|FG001|Overall Study|Withdrawal by Subject|2|||
156740460|NCT00308750|565798718|FG002|Overall Study|Withdrawal by Subject|3|||
156740461|NCT00308750|565798716|FG000|Overall Study|Physician Decision|3|||
156740462|NCT00308750|565798717|FG001|Overall Study|Physician Decision|4|||
156740463|NCT00308750|565798718|FG002|Overall Study|Physician Decision|3|||
156740464|NCT00308750|565798716|FG000|Overall Study|Sponsor Decision|1|||
156740465|NCT00308750|565798717|FG001|Overall Study|Sponsor Decision|0|||
156740466|NCT00308750|565798718|FG002|Overall Study|Sponsor Decision|0|||
156740467|NCT00308750|565798716|FG000|Overall Study|Disease Progression|47|||
156740468|NCT00308750|565798717|FG001|Overall Study|Disease Progression|24|||
156740469|NCT00308750|565798718|FG002|Overall Study|Disease Progression|28|||
156740470|NCT00308750|565798716|FG000|Overall Study|Unrelated Complication|3|||
156740471|NCT00308750|565798717|FG001|Overall Study|Unrelated Complication|0|||
156740472|NCT00308750|565798718|FG002|Overall Study|Unrelated Complication|1|||
156740473|NCT00308750|565798716|FG000|Overall Study|Death|1|||
156740474|NCT00308750|565798717|FG001|Overall Study|Death|0|||
156740475|NCT00308750|565798718|FG002|Overall Study|Death|1|||
156740476|NCT00308750|565798716|FG000|Overall Study|Protocol Violation|1|||
156740477|NCT00308750|565798717|FG001|Overall Study|Protocol Violation|0|||
156740478|NCT00308750|565798718|FG002|Overall Study|Protocol Violation|0|||
156740479|NCT00308750|565798716|FG000|Overall Study|New Primary Disease Identified|1|||
156740480|NCT00308750|565798717|FG001|Overall Study|New Primary Disease Identified|1|||
156740481|NCT00308750|565798718|FG002|Overall Study|New Primary Disease Identified|0|||
156740482|NCT01358578|565798719|FG000|Induction Period|Adverse Event|2|||
156740483|NCT01358578|565798720|FG001|Induction Period|Adverse Event|4|||
156740484|NCT01358578|565798721|FG002|Induction Period|Adverse Event|2|||
156740485|NCT01358578|565798722|FG003|Induction Period|Adverse Event|6|||
156740486|NCT01358578|565798723|FG004|Induction Period|Adverse Event|0|||
156740487|NCT01358578|565798724|FG005|Induction Period|Adverse Event|0|||
156740488|NCT01358578|565798719|FG000|Induction Period|Lack of Efficacy|0|||
156740489|NCT01358578|565798720|FG001|Induction Period|Lack of Efficacy|0|||
156740490|NCT01358578|565798721|FG002|Induction Period|Lack of Efficacy|9|||
156740491|NCT01358578|565798722|FG003|Induction Period|Lack of Efficacy|1|||
156740492|NCT01358578|565798723|FG004|Induction Period|Lack of Efficacy|0|||
156740493|NCT01358578|565798724|FG005|Induction Period|Lack of Efficacy|0|||
156740494|NCT01358578|565798719|FG000|Induction Period|Lost to Follow-up|0|||
156740495|NCT01358578|565798720|FG001|Induction Period|Lost to Follow-up|0|||
156740496|NCT01358578|565798721|FG002|Induction Period|Lost to Follow-up|1|||
156740497|NCT01358578|565798722|FG003|Induction Period|Lost to Follow-up|4|||
156740498|NCT01358578|565798723|FG004|Induction Period|Lost to Follow-up|0|||
156740499|NCT01358578|565798724|FG005|Induction Period|Lost to Follow-up|0|||
156740500|NCT01358578|565798719|FG000|Induction Period|Physician Decision|2|||
156740501|NCT01358578|565798720|FG001|Induction Period|Physician Decision|1|||
156740502|NCT01358578|565798721|FG002|Induction Period|Physician Decision|2|||
156740503|NCT01358578|565798722|FG003|Induction Period|Physician Decision|0|||
156740504|NCT01358578|565798723|FG004|Induction Period|Physician Decision|0|||
156740505|NCT01358578|565798724|FG005|Induction Period|Physician Decision|0|||
156740506|NCT01358578|565798719|FG000|Induction Period|Protocol Deviation|3|||
156877675|NCT05422638|566309887|FG000|Overall Study|Withdrawal by Subject|8|||
156877676|NCT05422638|566309888|FG001|Overall Study|Withdrawal by Subject|2|||
156740507|NCT01358578|565798720|FG001|Induction Period|Protocol Deviation|5|||
156877677|NCT05658523|566309889|FG000|Baseline|No blood draw|1|||
156877678|NCT05658523|566309890|FG001|Baseline|No blood draw|0|||
156740508|NCT01358578|565798721|FG002|Induction Period|Protocol Deviation|0|||
156877679|NCT05658523|566309891|FG002|Baseline|No blood draw|0|||
156458429|NCT04066205|564774734|FG001|T2 Immediate Post-Intervention|did not respond|3|||
156458430|NCT02052882|564774735|FG000|Overall Study|Not treated|11|||
156740509|NCT01358578|565798722|FG003|Induction Period|Protocol Deviation|3|||
156740510|NCT01358578|565798723|FG004|Induction Period|Protocol Deviation|0|||
156740511|NCT01358578|565798724|FG005|Induction Period|Protocol Deviation|0|||
156740512|NCT01358578|565798719|FG000|Induction Period|technical problems|0|||
156740513|NCT01358578|565798720|FG001|Induction Period|technical problems|0|||
156740514|NCT01358578|565798721|FG002|Induction Period|technical problems|1|||
156877680|NCT05658523|566309889|FG000|28 Days|Lost to Follow-up|1|||
156877681|NCT05658523|566309890|FG001|28 Days|Lost to Follow-up|0|||
156877682|NCT05658523|566309891|FG002|28 Days|Lost to Follow-up|0|||
156877683|NCT05658523|566309889|FG000|28 Days|Withdrawal by Subject|1|||
156740515|NCT01358578|565798722|FG003|Induction Period|technical problems|1|||
156740516|NCT01358578|565798723|FG004|Induction Period|technical problems|0|||
156740517|NCT01358578|565798724|FG005|Induction Period|technical problems|0|||
156740518|NCT01358578|565798719|FG000|Induction Period|Withdrawal by Subject|5|||
156740519|NCT01358578|565798720|FG001|Induction Period|Withdrawal by Subject|5|||
156740520|NCT01358578|565798721|FG002|Induction Period|Withdrawal by Subject|10|||
156740521|NCT01358578|565798722|FG003|Induction Period|Withdrawal by Subject|6|||
156740522|NCT01358578|565798723|FG004|Induction Period|Withdrawal by Subject|0|||
156740523|NCT01358578|565798724|FG005|Induction Period|Withdrawal by Subject|0|||
156740524|NCT01358578|565798719|FG000|Maintenance Period|Adverse Event|2|||
156740525|NCT01358578|565798720|FG001|Maintenance Period|Adverse Event|7|||
156740526|NCT01358578|565798721|FG002|Maintenance Period|Adverse Event|0|||
156740527|NCT01358578|565798722|FG003|Maintenance Period|Adverse Event|6|||
156740528|NCT01358578|565798723|FG004|Maintenance Period|Adverse Event|4|||
156740529|NCT01358578|565798724|FG005|Maintenance Period|Adverse Event|3|||
156740530|NCT01358578|565798719|FG000|Maintenance Period|Lack of Efficacy|10|||
156740531|NCT01358578|565798720|FG001|Maintenance Period|Lack of Efficacy|2|||
156740532|NCT01358578|565798721|FG002|Maintenance Period|Lack of Efficacy|0|||
156740533|NCT01358578|565798722|FG003|Maintenance Period|Lack of Efficacy|11|||
156740534|NCT01358578|565798723|FG004|Maintenance Period|Lack of Efficacy|3|||
156740535|NCT01358578|565798724|FG005|Maintenance Period|Lack of Efficacy|0|||
156740536|NCT01358578|565798719|FG000|Maintenance Period|Lost to Follow-up|4|||
156740537|NCT01358578|565798720|FG001|Maintenance Period|Lost to Follow-up|0|||
156740538|NCT01358578|565798721|FG002|Maintenance Period|Lost to Follow-up|0|||
156740539|NCT01358578|565798722|FG003|Maintenance Period|Lost to Follow-up|5|||
156740540|NCT01358578|565798723|FG004|Maintenance Period|Lost to Follow-up|1|||
156740541|NCT01358578|565798724|FG005|Maintenance Period|Lost to Follow-up|1|||
156740542|NCT01358578|565798719|FG000|Maintenance Period|Non-compliance with study treatment|3|||
156740543|NCT01358578|565798720|FG001|Maintenance Period|Non-compliance with study treatment|1|||
156740544|NCT01358578|565798721|FG002|Maintenance Period|Non-compliance with study treatment|0|||
156740545|NCT01358578|565798722|FG003|Maintenance Period|Non-compliance with study treatment|2|||
156740546|NCT01358578|565798723|FG004|Maintenance Period|Non-compliance with study treatment|1|||
156740547|NCT01358578|565798724|FG005|Maintenance Period|Non-compliance with study treatment|2|||
156740548|NCT01358578|565798719|FG000|Maintenance Period|Physician Decision|0|||
156740549|NCT01358578|565798720|FG001|Maintenance Period|Physician Decision|1|||
156740550|NCT01358578|565798721|FG002|Maintenance Period|Physician Decision|0|||
156740551|NCT01358578|565798722|FG003|Maintenance Period|Physician Decision|1|||
156740552|NCT01358578|565798723|FG004|Maintenance Period|Physician Decision|0|||
156740553|NCT01358578|565798724|FG005|Maintenance Period|Physician Decision|0|||
156740554|NCT01358578|565798719|FG000|Maintenance Period|Pregnancy|1|||
156740555|NCT01358578|565798720|FG001|Maintenance Period|Pregnancy|0|||
156740556|NCT01358578|565798721|FG002|Maintenance Period|Pregnancy|0|||
156740557|NCT01358578|565798722|FG003|Maintenance Period|Pregnancy|0|||
156740558|NCT01358578|565798723|FG004|Maintenance Period|Pregnancy|0|||
156740559|NCT01358578|565798724|FG005|Maintenance Period|Pregnancy|0|||
156740560|NCT01358578|565798719|FG000|Maintenance Period|Protocol deviation|7|||
156740561|NCT01358578|565798720|FG001|Maintenance Period|Protocol deviation|4|||
156740562|NCT01358578|565798721|FG002|Maintenance Period|Protocol deviation|0|||
156740563|NCT01358578|565798722|FG003|Maintenance Period|Protocol deviation|2|||
156740564|NCT01358578|565798723|FG004|Maintenance Period|Protocol deviation|2|||
156740565|NCT01358578|565798724|FG005|Maintenance Period|Protocol deviation|2|||
156740566|NCT01358578|565798719|FG000|Maintenance Period|Withdrawal by Subject|12|||
156740567|NCT01358578|565798720|FG001|Maintenance Period|Withdrawal by Subject|7|||
156740568|NCT01358578|565798721|FG002|Maintenance Period|Withdrawal by Subject|2|||
156740569|NCT01358578|565798722|FG003|Maintenance Period|Withdrawal by Subject|15|||
156740570|NCT01358578|565798723|FG004|Maintenance Period|Withdrawal by Subject|6|||
156740571|NCT01358578|565798724|FG005|Maintenance Period|Withdrawal by Subject|3|||
156740572|NCT01358578|565798719|FG000|Follow-up Period|Adverse Event|1|||
156740573|NCT01358578|565798720|FG001|Follow-up Period|Adverse Event|1|||
156740574|NCT01358578|565798721|FG002|Follow-up Period|Adverse Event|0|||
156740575|NCT01358578|565798722|FG003|Follow-up Period|Adverse Event|0|||
156740576|NCT01358578|565798723|FG004|Follow-up Period|Adverse Event|0|||
156740577|NCT01358578|565798724|FG005|Follow-up Period|Adverse Event|0|||
156740578|NCT01358578|565798719|FG000|Follow-up Period|Lack of Efficacy|3|||
156740579|NCT01358578|565798720|FG001|Follow-up Period|Lack of Efficacy|0|||
156740580|NCT01358578|565798721|FG002|Follow-up Period|Lack of Efficacy|4|||
156740581|NCT01358578|565798722|FG003|Follow-up Period|Lack of Efficacy|1|||
156740582|NCT01358578|565798723|FG004|Follow-up Period|Lack of Efficacy|0|||
156877684|NCT05658523|566309890|FG001|28 Days|Withdrawal by Subject|1|||
156740583|NCT01358578|565798724|FG005|Follow-up Period|Lack of Efficacy|0|||
156740584|NCT01358578|565798719|FG000|Follow-up Period|Lost to Follow-up|0|||
156740585|NCT01358578|565798720|FG001|Follow-up Period|Lost to Follow-up|1|||
156740586|NCT01358578|565798721|FG002|Follow-up Period|Lost to Follow-up|0|||
156740587|NCT01358578|565798722|FG003|Follow-up Period|Lost to Follow-up|4|||
156740588|NCT01358578|565798723|FG004|Follow-up Period|Lost to Follow-up|0|||
156740589|NCT01358578|565798724|FG005|Follow-up Period|Lost to Follow-up|0|||
156740590|NCT01358578|565798719|FG000|Follow-up Period|non- compliance with study treatment|1|||
156740591|NCT01358578|565798720|FG001|Follow-up Period|non- compliance with study treatment|0|||
156740592|NCT01358578|565798721|FG002|Follow-up Period|non- compliance with study treatment|0|||
156740593|NCT01358578|565798722|FG003|Follow-up Period|non- compliance with study treatment|0|||
156740594|NCT01358578|565798723|FG004|Follow-up Period|non- compliance with study treatment|0|||
156740595|NCT01358578|565798724|FG005|Follow-up Period|non- compliance with study treatment|0|||
156740596|NCT01358578|565798719|FG000|Follow-up Period|Pregnancy|1|||
156740597|NCT01358578|565798720|FG001|Follow-up Period|Pregnancy|0|||
156740598|NCT01358578|565798721|FG002|Follow-up Period|Pregnancy|0|||
156740599|NCT01358578|565798722|FG003|Follow-up Period|Pregnancy|0|||
156740600|NCT01358578|565798723|FG004|Follow-up Period|Pregnancy|0|||
156740601|NCT01358578|565798724|FG005|Follow-up Period|Pregnancy|0|||
156740602|NCT01358578|565798719|FG000|Follow-up Period|Withdrawal by Subject|3|||
156740603|NCT01358578|565798720|FG001|Follow-up Period|Withdrawal by Subject|3|||
156740604|NCT01358578|565798721|FG002|Follow-up Period|Withdrawal by Subject|1|||
156740605|NCT01358578|565798722|FG003|Follow-up Period|Withdrawal by Subject|12|||
156740606|NCT01358578|565798723|FG004|Follow-up Period|Withdrawal by Subject|0|||
156740607|NCT01358578|565798724|FG005|Follow-up Period|Withdrawal by Subject|0|||
156740608|NCT01358578|565798719|FG000|Follow-up Period|Physician Decision|1|||
156740609|NCT01358578|565798720|FG001|Follow-up Period|Physician Decision|1|||
156740610|NCT01358578|565798721|FG002|Follow-up Period|Physician Decision|0|||
156740611|NCT01358578|565798722|FG003|Follow-up Period|Physician Decision|2|||
156740612|NCT01358578|565798723|FG004|Follow-up Period|Physician Decision|0|||
156740613|NCT01358578|565798724|FG005|Follow-up Period|Physician Decision|0|||
156740614|NCT01643798|565798725|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
156740615|NCT01643798|565798726|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
156740616|NCT03605849|565798727|FG000|Overall Study|Adverse Event|20|||
156740617|NCT03605849|565798728|FG001|Overall Study|Adverse Event|21|||
156740618|NCT03605849|565798729|FG002|Overall Study|Adverse Event|29|||
156740619|NCT03605849|565798730|FG003|Overall Study|Adverse Event|11|||
156740620|NCT03605849|565798727|FG000|Overall Study|Lack of Efficacy|4|||
156740621|NCT03605849|565798728|FG001|Overall Study|Lack of Efficacy|7|||
156740622|NCT03605849|565798729|FG002|Overall Study|Lack of Efficacy|9|||
156740623|NCT03605849|565798730|FG003|Overall Study|Lack of Efficacy|2|||
156740624|NCT03605849|565798727|FG000|Overall Study|Lost to Follow-up|8|||
156740625|NCT03605849|565798728|FG001|Overall Study|Lost to Follow-up|8|||
156740626|NCT03605849|565798729|FG002|Overall Study|Lost to Follow-up|14|||
156740627|NCT03605849|565798730|FG003|Overall Study|Lost to Follow-up|11|||
156336911|NCT00932126|564331421|FG007|Overall Study|Adverse Event|2|||
156534727|NCT02632721|565052458|FG002|Overall Study|Allergic reaction|0|||
156534728|NCT02632721|565052459|FG003|Overall Study|Allergic reaction|1|||
156534729|NCT02632721|565052460|FG004|Overall Study|Allergic reaction|0|||
156534730|NCT02632721|565052456|FG000|Overall Study|Receiving Decitabine locally|0|||
156534731|NCT02632721|565052457|FG001|Overall Study|Receiving Decitabine locally|0|||
156534732|NCT02632721|565052458|FG002|Overall Study|Receiving Decitabine locally|1|||
156534733|NCT02632721|565052459|FG003|Overall Study|Receiving Decitabine locally|0|||
156534734|NCT02632721|565052460|FG004|Overall Study|Receiving Decitabine locally|0|||
156534735|NCT02632721|565052456|FG000|Overall Study|No benefit from study treatment|1|||
156534736|NCT02632721|565052457|FG001|Overall Study|No benefit from study treatment|1|||
156534737|NCT02632721|565052458|FG002|Overall Study|No benefit from study treatment|0|||
156534738|NCT02632721|565052459|FG003|Overall Study|No benefit from study treatment|0|||
156534739|NCT02632721|565052460|FG004|Overall Study|No benefit from study treatment|1|||
156534740|NCT02632721|565052456|FG000|Overall Study|Patient wish for other treatment|0|||
156534741|NCT02632721|565052457|FG001|Overall Study|Patient wish for other treatment|1|||
156534742|NCT02632721|565052458|FG002|Overall Study|Patient wish for other treatment|0|||
156534743|NCT02632721|565052459|FG003|Overall Study|Patient wish for other treatment|0|||
156534744|NCT02632721|565052460|FG004|Overall Study|Patient wish for other treatment|0|||
156740628|NCT03605849|565798727|FG000|Overall Study|Non-compliance With IMP|6|||
156740629|NCT03605849|565798728|FG001|Overall Study|Non-compliance With IMP|5|||
156740630|NCT03605849|565798729|FG002|Overall Study|Non-compliance With IMP|2|||
156740631|NCT03605849|565798730|FG003|Overall Study|Non-compliance With IMP|1|||
156740632|NCT03605849|565798727|FG000|Overall Study|Protocol Deviation|1|||
156740633|NCT03605849|565798728|FG001|Overall Study|Protocol Deviation|2|||
156740634|NCT03605849|565798729|FG002|Overall Study|Protocol Deviation|1|||
156740635|NCT03605849|565798730|FG003|Overall Study|Protocol Deviation|3|||
156740636|NCT03605849|565798727|FG000|Overall Study|Withdrawal by Subject|33|||
156740637|NCT03605849|565798728|FG001|Overall Study|Withdrawal by Subject|28|||
156740638|NCT03605849|565798729|FG002|Overall Study|Withdrawal by Subject|30|||
156740639|NCT03605849|565798730|FG003|Overall Study|Withdrawal by Subject|28|||
156740640|NCT03605849|565798727|FG000|Overall Study|Site Terminated by Sponsor|0|||
156740641|NCT03605849|565798728|FG001|Overall Study|Site Terminated by Sponsor|0|||
156534745|NCT02632721|565052456|FG000|Overall Study|Relapsed Pneumonia|0|||
156740642|NCT03605849|565798729|FG002|Overall Study|Site Terminated by Sponsor|0|||
156740643|NCT03605849|565798730|FG003|Overall Study|Site Terminated by Sponsor|1|||
156534746|NCT02632721|565052457|FG001|Overall Study|Relapsed Pneumonia|0|||
156740644|NCT03605849|565798727|FG000|Overall Study|Physician Decision|2|||
156740645|NCT03605849|565798728|FG001|Overall Study|Physician Decision|1|||
156740646|NCT03605849|565798729|FG002|Overall Study|Physician Decision|2|||
156740647|NCT03605849|565798730|FG003|Overall Study|Physician Decision|1|||
156740648|NCT03605849|565798727|FG000|Overall Study|Enrolled, but not Treated|2|||
156740649|NCT03605849|565798728|FG001|Overall Study|Enrolled, but not Treated|2|||
156740650|NCT03605849|565798729|FG002|Overall Study|Enrolled, but not Treated|3|||
156740651|NCT03605849|565798730|FG003|Overall Study|Enrolled, but not Treated|2|||
156740652|NCT03605849|565798727|FG000|Overall Study|Other (COVID-19 Related)|0|||
156740653|NCT03605849|565798728|FG001|Overall Study|Other (COVID-19 Related)|1|||
156740654|NCT03605849|565798729|FG002|Overall Study|Other (COVID-19 Related)|1|||
156740655|NCT03605849|565798730|FG003|Overall Study|Other (COVID-19 Related)|0|||
156740656|NCT03605849|565798727|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
156740657|NCT03605849|565798728|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
156740658|NCT03605849|565798729|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
156740659|NCT03605849|565798730|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
156740660|NCT02045732|565798735|FG000|Overall Study|At the discretion of the investigator|1|||
156740661|NCT02045732|565798736|FG001|Overall Study|At the discretion of the investigator|1|||
156740662|NCT05014815|565798737|FG000|Overall Study|Death|63|||
156740663|NCT05014815|565798738|FG001|Overall Study|Death|70|||
156740664|NCT05014815|565798737|FG000|Overall Study|Withdrawal by Subject|10|||
156740665|NCT05014815|565798738|FG001|Overall Study|Withdrawal by Subject|10|||
156740666|NCT05014815|565798737|FG000|Overall Study|Lost to Follow-up|4|||
156740667|NCT05014815|565798738|FG001|Overall Study|Lost to Follow-up|2|||
156740668|NCT05014815|565798737|FG000|Overall Study|Physician Decision|2|||
156740669|NCT05014815|565798738|FG001|Overall Study|Physician Decision|4|||
156740670|NCT06303167|565798749|FG000|Overall Study|Ineligible|1|||
156740671|NCT06303167|565798749|FG000|Overall Study|Never start protocol therapy|2|||
156740672|NCT06303167|565798749|FG000|Overall Study|Disease progression|16|||
156740673|NCT00916344|565798750|FG000|Overall Study|Death|2|||
156740674|NCT00916344|565798750|FG000|Overall Study|ICD upgrade|1|||
156740675|NCT00916344|565798750|FG000|Overall Study|Drop-out|5|||
156740676|NCT03602391|565798751|FG000|Overall Study|COVID-19|7|||
156740677|NCT03602391|565798752|FG001|Overall Study|COVID-19|6|||
156740678|NCT01088243|565798760|FG000|Overall Study|Adverse Event|1|||
156740679|NCT01088243|565798761|FG001|Overall Study|Adverse Event|0|||
156740680|NCT02122770|565798764|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
156740681|NCT02122770|565798765|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
156740682|NCT02122770|565798766|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
156740683|NCT02122770|565798767|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
156740684|NCT02122770|565798768|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
156740685|NCT02122770|565798769|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
156740686|NCT02122770|565798764|FG000|Part A: Drug-drug Interaction 2|Other|0|||
156740687|NCT02122770|565798765|FG001|Part A: Drug-drug Interaction 2|Other|0|||
156740688|NCT02122770|565798766|FG002|Part A: Drug-drug Interaction 2|Other|1|||
156740689|NCT02122770|565798767|FG003|Part A: Drug-drug Interaction 2|Other|0|||
156740690|NCT02122770|565798768|FG004|Part A: Drug-drug Interaction 2|Other|0|||
156740691|NCT02122770|565798769|FG005|Part A: Drug-drug Interaction 2|Other|0|||
156740692|NCT02122770|565798764|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740693|NCT02122770|565798765|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
156740694|NCT02122770|565798766|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740695|NCT02122770|565798767|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740696|NCT02122770|565798768|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740697|NCT02122770|565798769|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740698|NCT02122770|565798764|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
156740699|NCT02122770|565798765|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
156740700|NCT02122770|565798766|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
156740701|NCT02122770|565798767|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
156877685|NCT05658523|566309891|FG002|28 Days|Withdrawal by Subject|0|||
156877686|NCT05658523|566309889|FG000|28 Days|Visit missed|0|||
156877687|NCT05658523|566309890|FG001|28 Days|Visit missed|4|||
156877688|NCT05658523|566309891|FG002|28 Days|Visit missed|0|||
156877689|NCT05658523|566309889|FG000|6 Months|Lost to Follow-up|1|||
156877690|NCT05658523|566309890|FG001|6 Months|Lost to Follow-up|7|||
156740702|NCT02122770|565798768|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
156740703|NCT02122770|565798769|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
156740704|NCT02122770|565798764|FG000|Part B: Standard of Care|Adverse Event|0|||
156877691|NCT05658523|566309891|FG002|6 Months|Lost to Follow-up|2|||
156877692|NCT05658523|566309889|FG000|6 Months|Withdrawal by Subject|1|||
156740705|NCT02122770|565798765|FG001|Part B: Standard of Care|Adverse Event|0|||
156336912|NCT00932126|564331414|FG000|Overall Study|Protocol Violation|0|||
156740706|NCT02122770|565798766|FG002|Part B: Standard of Care|Adverse Event|0|||
156740707|NCT02122770|565798767|FG003|Part B: Standard of Care|Adverse Event|0|||
156877693|NCT05658523|566309890|FG001|6 Months|Withdrawal by Subject|3|||
156877694|NCT05658523|566309891|FG002|6 Months|Withdrawal by Subject|4|||
156740708|NCT02122770|565798768|FG004|Part B: Standard of Care|Adverse Event|4|||
156740709|NCT02122770|565798769|FG005|Part B: Standard of Care|Adverse Event|1|||
156740710|NCT02122770|565798764|FG000|Part B: Standard of Care|Other|0|||
156740711|NCT02122770|565798765|FG001|Part B: Standard of Care|Other|0|||
156740712|NCT02122770|565798766|FG002|Part B: Standard of Care|Other|0|||
156740713|NCT02122770|565798767|FG003|Part B: Standard of Care|Other|0|||
156740714|NCT02122770|565798768|FG004|Part B: Standard of Care|Other|0|||
156740715|NCT02122770|565798769|FG005|Part B: Standard of Care|Other|2|||
156740716|NCT02122770|565798764|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
156740717|NCT02122770|565798765|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
156740718|NCT02122770|565798766|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
156740719|NCT02122770|565798767|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
156740720|NCT02122770|565798768|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
156740721|NCT02122770|565798769|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
156740722|NCT02122770|565798764|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740723|NCT02122770|565798765|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740724|NCT02122770|565798766|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740725|NCT02122770|565798767|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740726|NCT02122770|565798768|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
156740727|NCT02122770|565798769|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740728|NCT02122770|565798764|FG000|Part B: Standard of Care|Progressive Disease|0|||
156740729|NCT02122770|565798765|FG001|Part B: Standard of Care|Progressive Disease|0|||
156740730|NCT02122770|565798766|FG002|Part B: Standard of Care|Progressive Disease|0|||
156740731|NCT02122770|565798767|FG003|Part B: Standard of Care|Progressive Disease|0|||
156740732|NCT02122770|565798768|FG004|Part B: Standard of Care|Progressive Disease|10|||
156740733|NCT02122770|565798769|FG005|Part B: Standard of Care|Progressive Disease|8|||
156740734|NCT04495816|565798772|FG000|Overall Study|Lost to Follow-up|10|||
156740735|NCT04495816|565798773|FG001|Overall Study|Lost to Follow-up|4|||
156740736|NCT04495816|565798772|FG000|Overall Study|Withdrawal by Subject|3|||
156740737|NCT04495816|565798773|FG001|Overall Study|Withdrawal by Subject|5|||
156740738|NCT01210495|565798776|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
156740739|NCT01210495|565798777|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
156740740|NCT01210495|565798778|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
156740741|NCT01210495|565798779|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
156740742|NCT01210495|565798776|FG000|Overall Study|Death|14|||
156740743|NCT01210495|565798777|FG001|Overall Study|Death|7|||
156740744|NCT01210495|565798778|FG002|Overall Study|Death|112|||
156740745|NCT01210495|565798779|FG003|Overall Study|Death|54|||
156740746|NCT01210495|565798776|FG000|Overall Study|Study Terminated by Sponsor|0|||
156740747|NCT01210495|565798777|FG001|Overall Study|Study Terminated by Sponsor|0|||
156740748|NCT01210495|565798778|FG002|Overall Study|Study Terminated by Sponsor|4|||
156740749|NCT01210495|565798779|FG003|Overall Study|Study Terminated by Sponsor|11|||
156740750|NCT01210495|565798776|FG000|Overall Study|Lost to Follow-up|0|||
156740751|NCT01210495|565798777|FG001|Overall Study|Lost to Follow-up|0|||
156740752|NCT01210495|565798778|FG002|Overall Study|Lost to Follow-up|1|||
156740753|NCT01210495|565798779|FG003|Overall Study|Lost to Follow-up|1|||
156740754|NCT01210495|565798776|FG000|Overall Study|Other unspecified|0|||
156740755|NCT01210495|565798777|FG001|Overall Study|Other unspecified|0|||
156740756|NCT01210495|565798778|FG002|Overall Study|Other unspecified|6|||
156740757|NCT01210495|565798779|FG003|Overall Study|Other unspecified|0|||
156740758|NCT01384019|565798780|FG000|Overall Study|Withdrawal by Subject|3|||
156740759|NCT01384019|565798781|FG001|Overall Study|Withdrawal by Subject|0|||
156740760|NCT01384019|565798780|FG000|Overall Study|Death|1|||
156740761|NCT01384019|565798781|FG001|Overall Study|Death|0|||
156740762|NCT01384019|565798780|FG000|Overall Study|MRI refusal|6|||
156740763|NCT01384019|565798781|FG001|Overall Study|MRI refusal|6|||
156740764|NCT01826370|565798786|FG000|Overall Study|Protocol Violation|6|||
156740765|NCT01826370|565798786|FG000|Overall Study|Lost to Follow-up|12|||
156740766|NCT01826370|565798786|FG000|Overall Study|Other reason not defined above|2|||
156740767|NCT04416737|565798787|FG000|Week 1 (First Injection)|Physician Decision|0|||
156740768|NCT04416737|565798788|FG001|Week 1 (First Injection)|Physician Decision|1|||
156740769|NCT03332628|565798789|FG000|Overall Study|Physician Decision|2|||
156740770|NCT04489381|565798801|FG000|Overall Study|Lost to Follow-up|2|||
156740771|NCT04489381|565798802|FG001|Overall Study|Lost to Follow-up|3|||
156740772|NCT04489381|565798801|FG000|Overall Study|Withdrawal by Subject|1|||
156740773|NCT04489381|565798802|FG001|Overall Study|Withdrawal by Subject|0|||
156740774|NCT01500213|565798803|FG000|Overall Study|Adverse Event|35|||
156740775|NCT01500213|565798804|FG001|Overall Study|Adverse Event|35|||
156740776|NCT01500213|565798803|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
156740777|NCT01500213|565798804|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
156740778|NCT01500213|565798803|FG000|Overall Study|Withdrawal by Subject|28|||
156740779|NCT01500213|565798804|FG001|Overall Study|Withdrawal by Subject|37|||
156740780|NCT01500213|565798803|FG000|Overall Study|Death|7|||
156740781|NCT01500213|565798804|FG001|Overall Study|Death|3|||
156740782|NCT01500213|565798803|FG000|Overall Study|Disease Progression|13|||
156740783|NCT01500213|565798804|FG001|Overall Study|Disease Progression|21|||
156740784|NCT01500213|565798803|FG000|Overall Study|Protocol Violation|19|||
156740785|NCT01500213|565798804|FG001|Overall Study|Protocol Violation|19|||
156740786|NCT01500213|565798803|FG000|Overall Study|Physician Decision|12|||
156740787|NCT01500213|565798804|FG001|Overall Study|Physician Decision|10|||
156740788|NCT01500213|565798803|FG000|Overall Study|Lack of Efficacy|9|||
156740789|NCT01500213|565798804|FG001|Overall Study|Lack of Efficacy|7|||
156740790|NCT01500213|565798803|FG000|Overall Study|Lost to Follow-up|3|||
156740791|NCT01500213|565798804|FG001|Overall Study|Lost to Follow-up|6|||
156740792|NCT01500213|565798803|FG000|Overall Study|Other Reasons|7|||
156740793|NCT01500213|565798804|FG001|Overall Study|Other Reasons|5|||
156740794|NCT00785213|565798805|FG000|Quinine Sulfate Alone|Adverse Event|4|||
156740795|NCT00785213|565798805|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
156740796|NCT02386345|565798806|FG000|Overall Study|Not treated|14|||
156740797|NCT02386345|565798806|FG000|Overall Study|Lost to Follow-up|1|||
156740798|NCT02386345|565798806|FG000|Overall Study|Adverse Event|5|||
156740799|NCT02386345|565798806|FG000|Overall Study|Repeat Procedure|10|||
156740800|NCT02386345|565798806|FG000|Overall Study|Did not complete 12-month follow-up|72|||
156740801|NCT01043705|565798809|FG000|Overall Study|Death|28|||
156740802|NCT01043705|565798810|FG001|Overall Study|Death|60|||
156740803|NCT01043705|565798811|FG002|Overall Study|Death|26|||
156740804|NCT01043705|565798809|FG000|Overall Study|Lost to Follow-up|27|||
156740805|NCT01043705|565798810|FG001|Overall Study|Lost to Follow-up|12|||
156740806|NCT01043705|565798811|FG002|Overall Study|Lost to Follow-up|0|||
156740807|NCT01043705|565798809|FG000|Overall Study|Multiple Reasons|4|||
156740808|NCT01043705|565798810|FG001|Overall Study|Multiple Reasons|7|||
156740809|NCT01043705|565798811|FG002|Overall Study|Multiple Reasons|0|||
156740810|NCT01043705|565798809|FG000|Overall Study|Protocol Violation|2|||
156740811|NCT01043705|565798810|FG001|Overall Study|Protocol Violation|1|||
156740812|NCT01043705|565798811|FG002|Overall Study|Protocol Violation|0|||
156740813|NCT01043705|565798809|FG000|Overall Study|Withdrawal by Subject|8|||
156740814|NCT01043705|565798810|FG001|Overall Study|Withdrawal by Subject|6|||
156534747|NCT02632721|565052458|FG002|Overall Study|Relapsed Pneumonia|0|||
156534748|NCT02632721|565052459|FG003|Overall Study|Relapsed Pneumonia|0|||
156534749|NCT02632721|565052460|FG004|Overall Study|Relapsed Pneumonia|1|||
156534750|NCT02632721|565052456|FG000|Overall Study|Therapy refractory AML|0|||
156534751|NCT02632721|565052457|FG001|Overall Study|Therapy refractory AML|0|||
156534752|NCT02632721|565052458|FG002|Overall Study|Therapy refractory AML|0|||
156534753|NCT02632721|565052459|FG003|Overall Study|Therapy refractory AML|0|||
156534754|NCT02632721|565052460|FG004|Overall Study|Therapy refractory AML|1|||
156534755|NCT02632721|565052456|FG000|Overall Study|Increase of white blood cell count|0|||
156534756|NCT02632721|565052457|FG001|Overall Study|Increase of white blood cell count|0|||
156534757|NCT02632721|565052458|FG002|Overall Study|Increase of white blood cell count|0|||
156740815|NCT01043705|565798811|FG002|Overall Study|Withdrawal by Subject|0|||
156740816|NCT01043705|565798809|FG000|Overall Study|Site Closure|8|||
156740817|NCT01043705|565798810|FG001|Overall Study|Site Closure|0|||
156740818|NCT01043705|565798811|FG002|Overall Study|Site Closure|0|||
156740819|NCT01043705|565798809|FG000|Overall Study|Subsequent Procedure|9|||
156740820|NCT01043705|565798810|FG001|Overall Study|Subsequent Procedure|24|||
156740821|NCT01043705|565798811|FG002|Overall Study|Subsequent Procedure|29|||
156740822|NCT01043705|565798809|FG000|Overall Study|Adverse Event|0|||
156740823|NCT01043705|565798810|FG001|Overall Study|Adverse Event|2|||
156740824|NCT01043705|565798811|FG002|Overall Study|Adverse Event|0|||
156740825|NCT01043705|565798809|FG000|Overall Study|Screen Fail|21|||
156740826|NCT01043705|565798810|FG001|Overall Study|Screen Fail|0|||
156797608|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
156797609|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
156797610|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797611|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797612|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797613|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797614|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797615|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797616|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797617|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797618|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797619|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797620|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156877695|NCT05658523|566309889|FG000|6 Months|Visit missed|5|||
156877696|NCT05658523|566309890|FG001|6 Months|Visit missed|7|||
156534758|NCT02632721|565052459|FG003|Overall Study|Increase of white blood cell count|0|||
156534759|NCT02632721|565052460|FG004|Overall Study|Increase of white blood cell count|1|||
156740827|NCT01043705|565798811|FG002|Overall Study|Screen Fail|0|||
156740828|NCT01043705|565798809|FG000|Overall Study|Other|0|||
156740829|NCT01043705|565798810|FG001|Overall Study|Other|19|||
156740830|NCT01043705|565798811|FG002|Overall Study|Other|25|||
156740831|NCT02003963|565798813|FG000|Overall Study|Lost to Follow-up|2|||
156740832|NCT02003963|565798814|FG001|Overall Study|Lost to Follow-up|1|||
156740833|NCT00581542|565798815|FG000|Overall Study|they met an exclusion criteria|2|||
156740834|NCT00581542|565798816|FG001|Overall Study|they met an exclusion criteria|2|||
156740835|NCT00581542|565798815|FG000|Overall Study|Lost to Follow-up|9|||
156740836|NCT00581542|565798816|FG001|Overall Study|Lost to Follow-up|21|||
156740837|NCT00176644|565798817|FG000|Overall Study|Withdrawal by Subject|1|||
156740838|NCT01801280|565798818|FG000|Period 1|Withdrawal by Subject|0|||
156740839|NCT01801280|565798819|FG001|Period 1|Withdrawal by Subject|1|||
156740840|NCT01801280|565798820|FG002|Period 1|Withdrawal by Subject|0|||
156740841|NCT01801280|565798821|FG003|Period 1|Withdrawal by Subject|0|||
156740842|NCT01801280|565798818|FG000|Period 2|Withdrawal by Subject|1|||
156740843|NCT01801280|565798819|FG001|Period 2|Withdrawal by Subject|0|||
156740844|NCT01801280|565798820|FG002|Period 2|Withdrawal by Subject|0|||
156740845|NCT01801280|565798821|FG003|Period 2|Withdrawal by Subject|0|||
156740846|NCT01801280|565798818|FG000|Period 4|Protocol Violation|0|||
156740847|NCT01801280|565798819|FG001|Period 4|Protocol Violation|0|||
156740848|NCT01801280|565798820|FG002|Period 4|Protocol Violation|1|||
156740849|NCT01801280|565798821|FG003|Period 4|Protocol Violation|0|||
156740850|NCT03973918|565798822|FG000|Overall Study|Adverse Event|0|||
156740851|NCT03973918|565798823|FG001|Overall Study|Adverse Event|0|||
156740852|NCT03973918|565798824|FG002|Overall Study|Adverse Event|0|||
156740853|NCT03973918|565798825|FG003|Overall Study|Adverse Event|1|||
156740854|NCT03973918|565798822|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
156740855|NCT03973918|565798823|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
156740856|NCT03973918|565798824|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
156740857|NCT03973918|565798825|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
156740858|NCT04050124|565798830|FG000|Overall Study|Death|1|||
156740859|NCT04050124|565798831|FG001|Overall Study|Death|0|||
156740860|NCT00347919|565798838|FG000|Overall Study|Lost to Follow-up|11|||
156740861|NCT00347919|565798839|FG001|Overall Study|Lost to Follow-up|13|||
156740862|NCT00347919|565798840|FG002|Overall Study|Lost to Follow-up|0|||
156740863|NCT00347919|565798838|FG000|Overall Study|Withdrawal by Subject|6|||
156740864|NCT00347919|565798839|FG001|Overall Study|Withdrawal by Subject|8|||
156740865|NCT00347919|565798840|FG002|Overall Study|Withdrawal by Subject|0|||
156740866|NCT00347919|565798838|FG000|Overall Study|Physician Decision|1|||
156740867|NCT00347919|565798839|FG001|Overall Study|Physician Decision|1|||
156877697|NCT05658523|566309891|FG002|6 Months|Visit missed|0|||
156740868|NCT00347919|565798840|FG002|Overall Study|Physician Decision|0|||
156740869|NCT00347919|565798838|FG000|Overall Study|Sponsor terminated study|15|||
156740870|NCT00347919|565798839|FG001|Overall Study|Sponsor terminated study|10|||
156740871|NCT00347919|565798840|FG002|Overall Study|Sponsor terminated study|16|||
156740872|NCT00347919|565798838|FG000|Overall Study|Death|35|||
156740873|NCT00347919|565798839|FG001|Overall Study|Death|42|||
156740874|NCT00347919|565798840|FG002|Overall Study|Death|19|||
156740875|NCT00347919|565798838|FG000|Overall Study|Par. Started Other Treatment|1|||
156740876|NCT00347919|565798839|FG001|Overall Study|Par. Started Other Treatment|1|||
156740877|NCT00347919|565798840|FG002|Overall Study|Par. Started Other Treatment|1|||
156740878|NCT00347919|565798838|FG000|Overall Study|Missing|2|||
156740879|NCT00347919|565798839|FG001|Overall Study|Missing|1|||
156740880|NCT00347919|565798840|FG002|Overall Study|Missing|2|||
156740881|NCT04450407|565798841|FG000|Overall Study|Withdrawal by Subject|10|||
156740882|NCT04450407|565798842|FG001|Overall Study|Withdrawal by Subject|1|||
156740883|NCT04450407|565798843|FG002|Overall Study|Withdrawal by Subject|4|||
156740884|NCT04450407|565798841|FG000|Overall Study|Adverse Event|0|||
156740885|NCT04450407|565798842|FG001|Overall Study|Adverse Event|0|||
156740886|NCT04450407|565798843|FG002|Overall Study|Adverse Event|1|||
156740887|NCT04450407|565798841|FG000|Overall Study|Lost to Follow-up|1|||
156740888|NCT04450407|565798842|FG001|Overall Study|Lost to Follow-up|0|||
156740889|NCT04450407|565798843|FG002|Overall Study|Lost to Follow-up|0|||
156740890|NCT04450407|565798841|FG000|Overall Study|Physician Decision|0|||
156740891|NCT04450407|565798842|FG001|Overall Study|Physician Decision|0|||
156740892|NCT04450407|565798843|FG002|Overall Study|Physician Decision|1|||
156534760|NCT02632721|565052456|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
156534761|NCT02632721|565052457|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
156740893|NCT04450407|565798841|FG000|Overall Study|Pregnancy|1|||
156740894|NCT04450407|565798842|FG001|Overall Study|Pregnancy|0|||
156740895|NCT04450407|565798843|FG002|Overall Study|Pregnancy|0|||
156740896|NCT04450407|565798841|FG000|Overall Study|Protocol Violation|2|||
156740897|NCT04450407|565798842|FG001|Overall Study|Protocol Violation|0|||
156740898|NCT04450407|565798843|FG002|Overall Study|Protocol Violation|0|||
156740899|NCT04450407|565798841|FG000|Overall Study|Investigational site terminated by sponsor|3|||
156740900|NCT04450407|565798842|FG001|Overall Study|Investigational site terminated by sponsor|0|||
156740901|NCT04450407|565798843|FG002|Overall Study|Investigational site terminated by sponsor|2|||
156740902|NCT02419612|565798851|FG000|Short-term Treatment Period|Adverse Event|1|||
156740903|NCT02419612|565798852|FG001|Short-term Treatment Period|Adverse Event|1|||
156336913|NCT00932126|564331415|FG001|Overall Study|Protocol Violation|0|||
156740904|NCT02419612|565798851|FG000|Short-term Treatment Period|Death|0|||
156740905|NCT02419612|565798852|FG001|Short-term Treatment Period|Death|2|||
156740906|NCT02419612|565798851|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
156740907|NCT02419612|565798852|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
156740908|NCT02419612|565798851|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
156740909|NCT02419612|565798852|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
156740910|NCT02419612|565798851|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
156740911|NCT02419612|565798852|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
156740912|NCT02419612|565798851|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
156740913|NCT02419612|565798852|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
156740914|NCT02419612|565798851|FG000|Short-term Treatment Period|Worsening of liver function|0|||
156740915|NCT02419612|565798852|FG001|Short-term Treatment Period|Worsening of liver function|1|||
156740916|NCT02419612|565798851|FG000|Short-term Treatment Period|Subject moved out of state|0|||
156740917|NCT02419612|565798852|FG001|Short-term Treatment Period|Subject moved out of state|1|||
156740918|NCT02419612|565798851|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
156740919|NCT02419612|565798852|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
156740920|NCT02419612|565798851|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
156740921|NCT02419612|565798852|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
156740922|NCT02419612|565798851|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
156740923|NCT02419612|565798852|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
156740924|NCT02419612|565798851|FG000|Long-term Treatment Period|Death|0|||
156740925|NCT02419612|565798852|FG001|Long-term Treatment Period|Death|1|||
156740926|NCT02419612|565798851|FG000|Long-term Treatment Period|Adverse Event|0|||
156740927|NCT02419612|565798852|FG001|Long-term Treatment Period|Adverse Event|5|||
156740928|NCT02419612|565798851|FG000|Long-term Treatment Period|Other|4|||
156740929|NCT02419612|565798852|FG001|Long-term Treatment Period|Other|4|||
156740930|NCT02419612|565798851|FG000|Long-term Treatment Period|Subject Decision|2|||
156740931|NCT02419612|565798852|FG001|Long-term Treatment Period|Subject Decision|4|||
156740932|NCT02419612|565798851|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
156740933|NCT02419612|565798852|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
156740934|NCT00533702|565798853|FG000|Overall Study|Withdrawal by Subject|3|||
156740935|NCT00533702|565798854|FG001|Overall Study|Withdrawal by Subject|1|||
156740936|NCT00533702|565798853|FG000|Overall Study|Found ineligible after randomization|2|||
156740937|NCT00533702|565798854|FG001|Overall Study|Found ineligible after randomization|1|||
156740938|NCT01095978|565798855|FG000|Overall Study|Did not take Klacid SR|2|||
156740939|NCT01095978|565798855|FG000|Overall Study|Adverse Event|1|||
156740940|NCT01752634|565800480|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
156740941|NCT01752634|565800481|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
156740942|NCT01752634|565800482|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
156740943|NCT01752634|565800483|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
156740944|NCT01752634|565800484|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
156740945|NCT01752634|565800485|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
156740946|NCT01752634|565800480|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740947|NCT01752634|565800481|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
156740948|NCT01752634|565800482|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740949|NCT01752634|565800483|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740950|NCT01752634|565800484|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740951|NCT01752634|565800485|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740952|NCT01752634|565800480|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
156740953|NCT01752634|565800481|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
156740954|NCT01752634|565800482|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
156740955|NCT01752634|565800483|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
156740956|NCT01752634|565800484|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
156740957|NCT01752634|565800485|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
156740958|NCT01752634|565800480|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
156740959|NCT01752634|565800481|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
156740960|NCT01752634|565800482|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
156740961|NCT01752634|565800483|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
156740962|NCT01752634|565800484|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
156740963|NCT01752634|565800485|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
156740964|NCT01752634|565800480|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
156740965|NCT01752634|565800481|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
156740966|NCT01752634|565800482|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
156740967|NCT01752634|565800483|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
156740968|NCT01752634|565800484|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
156740969|NCT01752634|565800485|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
156740970|NCT01752634|565800480|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
156740971|NCT01752634|565800481|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
156740972|NCT01752634|565800482|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
156740973|NCT01752634|565800483|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
156740974|NCT01752634|565800484|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
156740975|NCT01752634|565800485|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
156740976|NCT01752634|565800480|FG000|Week 24 to Week 260|Physician Decision|1|||
156740977|NCT01752634|565800481|FG001|Week 24 to Week 260|Physician Decision|2|||
156740978|NCT01752634|565800482|FG002|Week 24 to Week 260|Physician Decision|4|||
156740979|NCT01752634|565800483|FG003|Week 24 to Week 260|Physician Decision|2|||
156740980|NCT01752634|565800484|FG004|Week 24 to Week 260|Physician Decision|1|||
156740981|NCT01752634|565800485|FG005|Week 24 to Week 260|Physician Decision|0|||
156740982|NCT01752634|565800480|FG000|Week 24 to Week 260|Death|0|||
156740983|NCT01752634|565800481|FG001|Week 24 to Week 260|Death|1|||
156740984|NCT01752634|565800482|FG002|Week 24 to Week 260|Death|0|||
156740985|NCT01752634|565800483|FG003|Week 24 to Week 260|Death|0|||
156740986|NCT01752634|565800484|FG004|Week 24 to Week 260|Death|0|||
156740987|NCT01752634|565800485|FG005|Week 24 to Week 260|Death|0|||
156740988|NCT01752634|565800480|FG000|Week 24 to Week 260|Pregnancy|0|||
156740989|NCT01752634|565800481|FG001|Week 24 to Week 260|Pregnancy|0|||
156740990|NCT01752634|565800482|FG002|Week 24 to Week 260|Pregnancy|1|||
156740991|NCT01752634|565800483|FG003|Week 24 to Week 260|Pregnancy|0|||
156740992|NCT01752634|565800484|FG004|Week 24 to Week 260|Pregnancy|0|||
156740993|NCT01752634|565800485|FG005|Week 24 to Week 260|Pregnancy|0|||
156740994|NCT01752634|565800480|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
156740995|NCT01752634|565800481|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
156740996|NCT01752634|565800482|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
156740997|NCT01752634|565800483|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
156740998|NCT01752634|565800484|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
156877698|NCT05658523|566309889|FG000|6 Months|No blood draw|0|||
156877699|NCT05658523|566309890|FG001|6 Months|No blood draw|0|||
156877700|NCT05658523|566309891|FG002|6 Months|No blood draw|1|||
156740999|NCT01752634|565800485|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
156741000|NCT01752634|565800480|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
156741001|NCT01752634|565800481|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
156741002|NCT01752634|565800482|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
156741003|NCT01752634|565800483|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
156741004|NCT01752634|565800484|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
156741005|NCT01752634|565800485|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
156741006|NCT01752634|565800480|FG000|Week 24 to Week 260|Adverse Event|4|||
156741007|NCT01752634|565800481|FG001|Week 24 to Week 260|Adverse Event|8|||
156741008|NCT01752634|565800482|FG002|Week 24 to Week 260|Adverse Event|8|||
156741009|NCT01752634|565800483|FG003|Week 24 to Week 260|Adverse Event|4|||
156741010|NCT01752634|565800484|FG004|Week 24 to Week 260|Adverse Event|2|||
156741011|NCT01752634|565800485|FG005|Week 24 to Week 260|Adverse Event|0|||
156741012|NCT05562934|565800486|FG000|Overall Study|Adverse Event|0|||
156741013|NCT05562934|565800487|FG001|Overall Study|Adverse Event|2|||
156741014|NCT05562934|565800488|FG002|Overall Study|Adverse Event|0|||
156741015|NCT05562934|565800489|FG003|Overall Study|Adverse Event|0|||
156741016|NCT05562934|565800490|FG004|Overall Study|Adverse Event|2|||
156741017|NCT05562934|565800486|FG000|Overall Study|Lost to Follow-up|0|||
156741018|NCT05562934|565800487|FG001|Overall Study|Lost to Follow-up|0|||
156741019|NCT05562934|565800488|FG002|Overall Study|Lost to Follow-up|0|||
156741020|NCT05562934|565800489|FG003|Overall Study|Lost to Follow-up|0|||
156741021|NCT05562934|565800490|FG004|Overall Study|Lost to Follow-up|1|||
156741022|NCT05562934|565800486|FG000|Overall Study|Protocol Violation|0|||
156741023|NCT05562934|565800487|FG001|Overall Study|Protocol Violation|0|||
156741024|NCT05562934|565800488|FG002|Overall Study|Protocol Violation|0|||
156741025|NCT05562934|565800489|FG003|Overall Study|Protocol Violation|1|||
156741026|NCT05562934|565800490|FG004|Overall Study|Protocol Violation|1|||
156741027|NCT05562934|565800486|FG000|Overall Study|Withdrawal by Subject|0|||
156741028|NCT05562934|565800487|FG001|Overall Study|Withdrawal by Subject|0|||
156741029|NCT05562934|565800488|FG002|Overall Study|Withdrawal by Subject|1|||
156741030|NCT05562934|565800489|FG003|Overall Study|Withdrawal by Subject|1|||
156741031|NCT05562934|565800490|FG004|Overall Study|Withdrawal by Subject|0|||
156741032|NCT05906836|565800493|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
156741033|NCT05906836|565800493|FG000|Overall Study|Lost to Follow-up|1|||
156741034|NCT01846221|565800494|FG000|Overall Study|Catheter Failure|2|||
156741035|NCT01846221|565800495|FG001|Overall Study|Catheter Failure|0|||
156741036|NCT01846221|565800494|FG000|Overall Study|Age Exclusion|1|||
156741037|NCT01846221|565800495|FG001|Overall Study|Age Exclusion|0|||
156741038|NCT04599933|565800496|FG000|Overall Study|Adverse Event|4|||
156741039|NCT04599933|565800497|FG001|Overall Study|Adverse Event|1|||
156741040|NCT04599933|565800496|FG000|Overall Study|Withdrawal by Subject|4|||
156741041|NCT04599933|565800497|FG001|Overall Study|Withdrawal by Subject|2|||
156741042|NCT04599933|565800496|FG000|Overall Study|Lost to Follow-up|0|||
156741043|NCT04599933|565800497|FG001|Overall Study|Lost to Follow-up|1|||
156741044|NCT04599933|565800496|FG000|Overall Study|Physician Decision|0|||
156741045|NCT04599933|565800497|FG001|Overall Study|Physician Decision|1|||
156741046|NCT04599933|565800496|FG000|Overall Study|Screen Failure|1|||
156741047|NCT04599933|565800497|FG001|Overall Study|Screen Failure|2|||
156877701|NCT05658523|566309889|FG000|12 Months|Lost to Follow-up|2|||
156336914|NCT00932126|564331416|FG002|Overall Study|Protocol Violation|0|||
156336915|NCT00932126|564331417|FG003|Overall Study|Protocol Violation|0|||
156741048|NCT02963558|565800505|FG000|Overall Study|Withdrawn by investigator|1|||
156741049|NCT02963558|565800506|FG001|Overall Study|Withdrawn by investigator|0|||
156741050|NCT02963558|565800505|FG000|Overall Study|Withdrawal by Subject|0|||
156741051|NCT02963558|565800506|FG001|Overall Study|Withdrawal by Subject|1|||
156741052|NCT02339155|565800507|FG000|Overall Study|Adverse Event|0|||
156741053|NCT02339155|565800508|FG001|Overall Study|Adverse Event|6|||
156741054|NCT02339155|565800507|FG000|Overall Study|Death|1|||
156741055|NCT02339155|565800508|FG001|Overall Study|Death|1|||
156741056|NCT02339155|565800507|FG000|Overall Study|Lost to Follow-up|8|||
156741057|NCT02339155|565800508|FG001|Overall Study|Lost to Follow-up|9|||
156741058|NCT02339155|565800507|FG000|Overall Study|Physician Decision|2|||
156741059|NCT02339155|565800508|FG001|Overall Study|Physician Decision|1|||
156741060|NCT02339155|565800507|FG000|Overall Study|Withdrawal by Subject|4|||
156741061|NCT02339155|565800508|FG001|Overall Study|Withdrawal by Subject|4|||
156741062|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Adverse Event|0|||
156741063|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Adverse Event|1|||
156741064|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Adverse Event|0|||
156741065|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Adverse Event|0|||
156741066|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Adverse Event|0|||
156741067|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Adverse Event|0|||
156741068|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Death|0|||
156741069|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Death|0|||
156741070|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Death|1|||
156741071|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Death|0|||
156741072|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Death|0|||
156741073|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Death|0|||
156741074|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741075|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
156741076|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741077|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741078|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741079|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741080|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741081|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741082|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
156741083|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741084|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741085|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741086|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741087|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741088|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741089|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
156741090|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741091|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741092|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
156741093|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
156741094|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
156741095|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
156741096|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
156741097|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
156741098|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
156741099|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
156741100|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
156741101|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
156741102|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
156741103|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
156741104|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Death|0|||
156741105|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Death|0|||
156741106|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Death|0|||
156877702|NCT05658523|566309890|FG001|12 Months|Lost to Follow-up|6|||
156877703|NCT05658523|566309891|FG002|12 Months|Lost to Follow-up|3|||
156877704|NCT05658523|566309889|FG000|12 Months|Withdrawal by Subject|4|||
156877705|NCT05658523|566309890|FG001|12 Months|Withdrawal by Subject|4|||
156877706|NCT05658523|566309891|FG002|12 Months|Withdrawal by Subject|2|||
156877707|NCT05658523|566309889|FG000|12 Months|Visit missed|4|||
156877708|NCT05658523|566309890|FG001|12 Months|Visit missed|8|||
156877709|NCT05658523|566309891|FG002|12 Months|Visit missed|8|||
156877710|NCT05658523|566309889|FG000|18 Months|Lost to Follow-up|5|||
156336916|NCT00932126|564331418|FG004|Overall Study|Protocol Violation|1|||
156336917|NCT00932126|564331419|FG005|Overall Study|Protocol Violation|0|||
156877711|NCT05658523|566309890|FG001|18 Months|Lost to Follow-up|8|||
156877712|NCT05658523|566309891|FG002|18 Months|Lost to Follow-up|2|||
156877713|NCT05658523|566309889|FG000|18 Months|Withdrawal by Subject|17|||
156741107|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Death|0|||
156741108|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Death|0|||
156741109|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Death|1|||
156741110|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741111|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741112|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741113|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741114|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741115|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
156741116|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
156741117|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
156741118|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
156741119|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
156741120|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
156741121|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
156741122|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741123|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741124|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741125|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741126|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741127|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
156741128|NCT01371877|565800521|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
156741129|NCT01371877|565800522|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
156741130|NCT05932225|565800525|FG000|Overall Study|Lost to Follow-up|0|||
156741131|NCT05932225|565800526|FG001|Overall Study|Lost to Follow-up|1|||
156741132|NCT05932225|565800527|FG002|Overall Study|Lost to Follow-up|0|||
156741133|NCT05932225|565800525|FG000|Overall Study|Withdrawal by Subject|1|||
156741134|NCT05932225|565800526|FG001|Overall Study|Withdrawal by Subject|0|||
156741135|NCT05932225|565800527|FG002|Overall Study|Withdrawal by Subject|0|||
156741136|NCT05932225|565800525|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
156741137|NCT05932225|565800526|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
156741138|NCT05932225|565800527|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
156741139|NCT03427268|565800528|FG000|Overall Study|Progressive disease|25|||
156741140|NCT03427268|565800528|FG000|Overall Study|Never treated|2|||
156741141|NCT03427268|565800528|FG000|Overall Study|Compassionate use|1|||
156741142|NCT03427268|565800528|FG000|Overall Study|Withdrawal by Subject|1|||
156741143|NCT03427268|565800528|FG000|Overall Study|Adverse Event|3|||
156741144|NCT01911780|565800534|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
156741145|NCT01911780|565800535|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
156741146|NCT01911780|565800534|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
156741147|NCT01911780|565800535|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
156741148|NCT01911780|565800534|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
156797621|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797622|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
156797623|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156741149|NCT01911780|565800535|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
156741150|NCT01911780|565800534|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
156797624|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156741151|NCT01911780|565800535|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
156741152|NCT01911780|565800534|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
156741153|NCT01911780|565800535|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
156797625|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
156797626|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797627|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797628|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797629|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797630|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797631|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797632|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797633|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797634|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797635|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797636|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797637|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
156797638|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156877714|NCT05658523|566309890|FG001|18 Months|Withdrawal by Subject|9|||
156741154|NCT01911780|565800534|FG000|Extension Period (52 Weeks)|Personal reason|1|||
156741155|NCT01911780|565800535|FG001|Extension Period (52 Weeks)|Personal reason|1|||
156741156|NCT04247880|565800536|FG000|Overall Study|Lost to Follow-up|24|||
156741157|NCT04247880|565800537|FG001|Overall Study|Lost to Follow-up|17|||
156741158|NCT04247880|565800536|FG000|Overall Study|Withdrawal by Subject|3|||
156741159|NCT04247880|565800537|FG001|Overall Study|Withdrawal by Subject|0|||
156741160|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Death|117|||
156741161|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Death|197|||
156741162|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
156741163|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
156741164|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
156741165|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
156741166|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
156741167|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
156741168|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
156741169|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
156741170|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
156741171|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
156741172|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
156741173|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
156741174|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
156741175|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
156741176|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
156741177|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
156741178|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
156741179|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
156741180|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
156741181|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
156741182|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
156741183|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
156741184|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
156741185|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
156741186|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
156741187|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
156741188|NCT00108485|565800548|FG000|Overall Study|Withdrawal by Subject|3|||
156741189|NCT00108485|565800549|FG001|Overall Study|Withdrawal by Subject|0|||
156741190|NCT00108485|565800548|FG000|Overall Study|Lost to Follow-up|0|||
156741191|NCT00108485|565800549|FG001|Overall Study|Lost to Follow-up|2|||
156741192|NCT00878969|565800551|FG000|Overall Study|Physician Decision|5|||
156741193|NCT00878969|565800552|FG001|Overall Study|Physician Decision|3|||
156741194|NCT00878969|565800553|FG002|Overall Study|Physician Decision|2|||
156741195|NCT00878969|565800551|FG000|Overall Study|Withdrawal by Subject|1|||
156741196|NCT00878969|565800552|FG001|Overall Study|Withdrawal by Subject|6|||
156741197|NCT00878969|565800553|FG002|Overall Study|Withdrawal by Subject|3|||
156741198|NCT00878969|565800551|FG000|Overall Study|kidney transplant|2|||
156741199|NCT00878969|565800552|FG001|Overall Study|kidney transplant|3|||
156741200|NCT00878969|565800553|FG002|Overall Study|kidney transplant|2|||
156741201|NCT00878969|565800551|FG000|Overall Study|Adverse Event|3|||
156741202|NCT00878969|565800552|FG001|Overall Study|Adverse Event|1|||
156741203|NCT00878969|565800553|FG002|Overall Study|Adverse Event|2|||
156741204|NCT00878969|565800551|FG000|Overall Study|Lost to Follow-up|2|||
156741205|NCT00878969|565800552|FG001|Overall Study|Lost to Follow-up|1|||
156741206|NCT00878969|565800553|FG002|Overall Study|Lost to Follow-up|0|||
156741207|NCT00878969|565800551|FG000|Overall Study|Protocol Violation|2|||
156741208|NCT00878969|565800552|FG001|Overall Study|Protocol Violation|0|||
156741209|NCT00878969|565800553|FG002|Overall Study|Protocol Violation|0|||
156741210|NCT00878969|565800551|FG000|Overall Study|Death|0|||
156741211|NCT00878969|565800552|FG001|Overall Study|Death|0|||
156741212|NCT00878969|565800553|FG002|Overall Study|Death|2|||
156741213|NCT00878969|565800551|FG000|Overall Study|Pregnancy|0|||
156741214|NCT00878969|565800552|FG001|Overall Study|Pregnancy|1|||
156741215|NCT00878969|565800553|FG002|Overall Study|Pregnancy|0|||
156741216|NCT00655733|565800554|FG000|Overall Study|Lost to Follow-up|2|||
156741217|NCT00655733|565800555|FG001|Overall Study|Lost to Follow-up|2|||
156741218|NCT00655733|565800554|FG000|Overall Study|Adverse Event|2|||
156741219|NCT00655733|565800555|FG001|Overall Study|Adverse Event|2|||
156741220|NCT00655733|565800554|FG000|Overall Study|Withdrawal by Subject|3|||
156741221|NCT00655733|565800555|FG001|Overall Study|Withdrawal by Subject|3|||
156741222|NCT00655733|565800554|FG000|Overall Study|Physician Decision|0|||
156741223|NCT00655733|565800555|FG001|Overall Study|Physician Decision|1|||
156741224|NCT01701193|565800559|FG000|Overall Study|Withdrawal by Subject|2|||
156741225|NCT01701193|565800560|FG001|Overall Study|Withdrawal by Subject|2|||
156741226|NCT01701193|565800561|FG002|Overall Study|Withdrawal by Subject|1|||
156741227|NCT01701193|565800562|FG003|Overall Study|Withdrawal by Subject|2|||
156741228|NCT01701193|565800559|FG000|Overall Study|Adverse Event|1|||
156741229|NCT01701193|565800560|FG001|Overall Study|Adverse Event|0|||
156741230|NCT01701193|565800561|FG002|Overall Study|Adverse Event|0|||
156741231|NCT01701193|565800562|FG003|Overall Study|Adverse Event|0|||
156741232|NCT01482962|565800563|FG000|Overall Study|Progressive Disease|65|||
156741233|NCT01482962|565800564|FG001|Overall Study|Progressive Disease|53|||
156741234|NCT01482962|565800563|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
156741235|NCT01482962|565800564|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
156741236|NCT01482962|565800563|FG000|Overall Study|Adverse Event|18|||
156741237|NCT01482962|565800564|FG001|Overall Study|Adverse Event|22|||
156741238|NCT01482962|565800563|FG000|Overall Study|Withdrawal by Participant|8|||
156741239|NCT01482962|565800564|FG001|Overall Study|Withdrawal by Participant|13|||
156741240|NCT01482962|565800563|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
156741241|NCT01482962|565800564|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
156741242|NCT01482962|565800563|FG000|Overall Study|Other Reason|1|||
156741243|NCT01482962|565800564|FG001|Overall Study|Other Reason|5|||
156741244|NCT01482962|565800563|FG000|Overall Study|Study Terminated by Sponsor|5|||
156741245|NCT01482962|565800564|FG001|Overall Study|Study Terminated by Sponsor|2|||
156741246|NCT01482962|565800563|FG000|Overall Study|Did not Receive Study Drug|1|||
156741247|NCT01482962|565800564|FG001|Overall Study|Did not Receive Study Drug|6|||
156741248|NCT02407457|565800565|FG000|1 Month|Death|3|||
156741249|NCT02407457|565800566|FG001|1 Month|Death|0|||
156741250|NCT02407457|565800565|FG000|1 Month|Lost to Follow-up|1|||
156741251|NCT02407457|565800566|FG001|1 Month|Lost to Follow-up|1|||
156741252|NCT02407457|565800565|FG000|1 Month|missed visit|2|||
156741253|NCT02407457|565800566|FG001|1 Month|missed visit|5|||
156741254|NCT02407457|565800565|FG000|6-Month|Death|2|||
156741255|NCT02407457|565800566|FG001|6-Month|Death|8|||
156741256|NCT02407457|565800565|FG000|6-Month|Lost to Follow-up|2|||
156741257|NCT02407457|565800566|FG001|6-Month|Lost to Follow-up|2|||
156741258|NCT02407457|565800565|FG000|6-Month|missed visit|16|||
156741259|NCT02407457|565800566|FG001|6-Month|missed visit|14|||
156741260|NCT02407457|565800565|FG000|6-Month|Open Repair|0|||
156741261|NCT02407457|565800566|FG001|6-Month|Open Repair|1|||
156741262|NCT02407457|565800565|FG000|1 Year|Death|6|||
156741263|NCT02407457|565800566|FG001|1 Year|Death|11|||
156741264|NCT02407457|565800565|FG000|1 Year|Lost to Follow-up|3|||
156741265|NCT02407457|565800566|FG001|1 Year|Lost to Follow-up|2|||
156741266|NCT02407457|565800565|FG000|1 Year|Missed Visit|24|||
156741267|NCT02407457|565800566|FG001|1 Year|Missed Visit|14|||
156741268|NCT02407457|565800565|FG000|1 Year|Open Repair|0|||
156741269|NCT02407457|565800566|FG001|1 Year|Open Repair|1|||
156741270|NCT02407457|565800565|FG000|2-year|Death|14|||
156741271|NCT02407457|565800566|FG001|2-year|Death|8|||
156741272|NCT02407457|565800565|FG000|2-year|Lost to Follow-up|7|||
156741273|NCT02407457|565800566|FG001|2-year|Lost to Follow-up|10|||
156741274|NCT02407457|565800565|FG000|2-year|Missed Visit|13|||
156741275|NCT02407457|565800566|FG001|2-year|Missed Visit|15|||
156741276|NCT02407457|565800565|FG000|2-year|Open Repair|0|||
156741277|NCT02407457|565800566|FG001|2-year|Open Repair|2|||
156741278|NCT02407457|565800565|FG000|3-year|Death|11|||
156741279|NCT02407457|565800566|FG001|3-year|Death|10|||
156741280|NCT02407457|565800565|FG000|3-year|Lost to Follow-up|9|||
156741281|NCT02407457|565800566|FG001|3-year|Lost to Follow-up|10|||
156741282|NCT02407457|565800565|FG000|3-year|Missed Visit|19|||
156741283|NCT02407457|565800566|FG001|3-year|Missed Visit|16|||
156741284|NCT02407457|565800565|FG000|4-year|Death|18|||
156741285|NCT02407457|565800566|FG001|4-year|Death|10|||
156741286|NCT02407457|565800565|FG000|4-year|Lost to Follow-up|10|||
156741287|NCT02407457|565800566|FG001|4-year|Lost to Follow-up|12|||
156741288|NCT02407457|565800565|FG000|4-year|Missed Visit|18|||
156741289|NCT02407457|565800566|FG001|4-year|Missed Visit|16|||
156741290|NCT02407457|565800565|FG000|5-year|Death|10|||
156741291|NCT02407457|565800566|FG001|5-year|Death|3|||
156741292|NCT02407457|565800565|FG000|5-year|Lost to Follow-up|22|||
156741293|NCT02407457|565800566|FG001|5-year|Lost to Follow-up|13|||
156741294|NCT02407457|565800565|FG000|5-year|Missed Visit|9|||
156741295|NCT02407457|565800566|FG001|5-year|Missed Visit|1|||
156741296|NCT01549041|565800569|FG000|Overall Study|Lack of Efficacy|2|||
156741297|NCT01549041|565800570|FG001|Overall Study|Lack of Efficacy|4|||
156741298|NCT01549041|565800569|FG000|Overall Study|Adverse Event|0|||
156741299|NCT01549041|565800570|FG001|Overall Study|Adverse Event|4|||
156741300|NCT03199612|565800571|FG000|Overall Study|Adverse Event|1|||
156741301|NCT03199612|565800572|FG001|Overall Study|Adverse Event|0|||
156741302|NCT02543892|565800573|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
156741303|NCT02543892|565800574|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
156741304|NCT02543892|565800575|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
156741305|NCT02543892|565800576|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
156741306|NCT02543892|565800577|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
156741307|NCT02543892|565800578|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
156741308|NCT02543892|565800579|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
156741309|NCT02543892|565800580|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
156741310|NCT02543892|565800573|FG000|Received Vaccination 2|Physician Decision|0|||
156741311|NCT02543892|565800574|FG001|Received Vaccination 2|Physician Decision|0|||
156741312|NCT02543892|565800575|FG002|Received Vaccination 2|Physician Decision|0|||
156741313|NCT02543892|565800576|FG003|Received Vaccination 2|Physician Decision|0|||
156741314|NCT02543892|565800577|FG004|Received Vaccination 2|Physician Decision|0|||
156741315|NCT02543892|565800578|FG005|Received Vaccination 2|Physician Decision|1|||
156741316|NCT02543892|565800579|FG006|Received Vaccination 2|Physician Decision|0|||
156741317|NCT02543892|565800580|FG007|Received Vaccination 2|Physician Decision|0|||
156741318|NCT02543892|565800573|FG000|Received Vaccination 2|Adverse Event|0|||
156741319|NCT02543892|565800574|FG001|Received Vaccination 2|Adverse Event|1|||
156741320|NCT02543892|565800575|FG002|Received Vaccination 2|Adverse Event|0|||
156741321|NCT02543892|565800576|FG003|Received Vaccination 2|Adverse Event|0|||
156741322|NCT02543892|565800577|FG004|Received Vaccination 2|Adverse Event|0|||
156741323|NCT02543892|565800578|FG005|Received Vaccination 2|Adverse Event|0|||
156741324|NCT02543892|565800579|FG006|Received Vaccination 2|Adverse Event|0|||
156741325|NCT02543892|565800580|FG007|Received Vaccination 2|Adverse Event|0|||
156741326|NCT02543892|565800573|FG000|Had Immunology Data|Withdrawal by Subject|0|||
156741327|NCT02543892|565800574|FG001|Had Immunology Data|Withdrawal by Subject|0|||
156741328|NCT02543892|565800575|FG002|Had Immunology Data|Withdrawal by Subject|0|||
156741329|NCT02543892|565800576|FG003|Had Immunology Data|Withdrawal by Subject|0|||
156741330|NCT02543892|565800577|FG004|Had Immunology Data|Withdrawal by Subject|0|||
156741331|NCT02543892|565800578|FG005|Had Immunology Data|Withdrawal by Subject|0|||
156741332|NCT02543892|565800579|FG006|Had Immunology Data|Withdrawal by Subject|1|||
156741333|NCT02543892|565800580|FG007|Had Immunology Data|Withdrawal by Subject|0|||
156741334|NCT01199822|565800581|FG000|Overall Study|Investigator discontinued therapy|0|||
156741335|NCT01199822|565800582|FG001|Overall Study|Investigator discontinued therapy|1|||
156741336|NCT01199822|565800583|FG002|Overall Study|Investigator discontinued therapy|0|||
156741337|NCT04027075|565800584|FG000|Overall Study|Lost to Follow-up|41|||
156741338|NCT04027075|565800585|FG001|Overall Study|Lost to Follow-up|22|||
156741339|NCT00526331|565800586|FG000|Overall Study|Sponsor Termination|55|||
156741340|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
156741341|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
156741342|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
156741343|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
156741344|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Death|1|||
156741345|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Death|1|||
156741346|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
156741347|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
156741348|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
156741349|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
156741350|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
156741351|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
156534762|NCT02632721|565052458|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
156534763|NCT02632721|565052459|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
156534764|NCT02632721|565052460|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
156534765|NCT01572675|565052461|FG000|Overall Study|End of prescribed treatment|140|||
156534766|NCT01572675|565052462|FG001|Overall Study|End of prescribed treatment|118|||
156534767|NCT01572675|565052461|FG000|Overall Study|Recovery|16|||
156534768|NCT01572675|565052462|FG001|Overall Study|Recovery|23|||
156534769|NCT01572675|565052461|FG000|Overall Study|Lack of Efficacy|31|||
156534770|NCT01572675|565052462|FG001|Overall Study|Lack of Efficacy|31|||
156534771|NCT01572675|565052461|FG000|Overall Study|Intolerance|6|||
156534772|NCT01572675|565052462|FG001|Overall Study|Intolerance|5|||
156534773|NCT01572675|565052461|FG000|Overall Study|Improved symptoms|8|||
156534774|NCT01572675|565052462|FG001|Overall Study|Improved symptoms|2|||
156534775|NCT01572675|565052461|FG000|Overall Study|Surgical intervention|3|||
156534776|NCT01572675|565052462|FG001|Overall Study|Surgical intervention|6|||
156534777|NCT01572675|565052461|FG000|Overall Study|Withdrawal by Subject|5|||
156534778|NCT01572675|565052462|FG001|Overall Study|Withdrawal by Subject|1|||
156534779|NCT01572675|565052461|FG000|Overall Study|Physician Decision|2|||
156741352|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
156534780|NCT01572675|565052462|FG001|Overall Study|Physician Decision|2|||
156534781|NCT01572675|565052461|FG000|Overall Study|Death unrelated to coxibs|1|||
156534782|NCT01572675|565052462|FG001|Overall Study|Death unrelated to coxibs|1|||
156534783|NCT01572675|565052461|FG000|Overall Study|Other disease detected|1|||
156534784|NCT01572675|565052462|FG001|Overall Study|Other disease detected|1|||
156534785|NCT01572675|565052461|FG000|Overall Study|Unknown reason|1|||
156741353|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
156741354|NCT00033657|565800588|FG000|Surgical Resection|not complete resection|0|||
156741355|NCT00033657|565800589|FG001|Surgical Resection|not complete resection|3|||
156741356|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
156741357|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
156741358|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
156741359|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
156741360|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Death|2|||
156741361|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Death|1|||
156877715|NCT05658523|566309891|FG002|18 Months|Withdrawal by Subject|16|||
156877716|NCT05658523|566309889|FG000|18 Months|Visit missed|12|||
156877717|NCT05658523|566309890|FG001|18 Months|Visit missed|14|||
156877718|NCT05658523|566309891|FG002|18 Months|Visit missed|6|||
156877719|NCT03212170|566309892|FG000|Overall Study|Withdrawal by Subject|1|||
156877720|NCT01827956|566309902|FG000|Overall Study|Protocol Violation|3|||
156877721|NCT05029687|566310683|FG000|Overall Study|Withdrawal by Subject|4|||
156877722|NCT05029687|566310684|FG001|Overall Study|Withdrawal by Subject|0|||
156741362|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
156741363|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
156741364|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
156741365|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
156877723|NCT05029687|566310685|FG002|Overall Study|Withdrawal by Subject|2|||
156877724|NCT05029687|566310683|FG000|Overall Study|Lost to Follow-up|4|||
156877725|NCT05029687|566310684|FG001|Overall Study|Lost to Follow-up|0|||
156877726|NCT05029687|566310685|FG002|Overall Study|Lost to Follow-up|2|||
156741366|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Other|0|||
156741367|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Other|2|||
156741368|NCT03448939|565800590|FG000|Overall Study|Adverse Event|5|||
156741369|NCT03448939|565800591|FG001|Overall Study|Adverse Event|1|||
156741370|NCT03448939|565800590|FG000|Overall Study|Lost to Follow-up|6|||
156741371|NCT03448939|565800591|FG001|Overall Study|Lost to Follow-up|6|||
156741372|NCT03448939|565800590|FG000|Overall Study|Pregnancy|1|||
156741373|NCT03448939|565800591|FG001|Overall Study|Pregnancy|1|||
156741374|NCT03448939|565800590|FG000|Overall Study|Withdrawal by Subject|9|||
156741375|NCT03448939|565800591|FG001|Overall Study|Withdrawal by Subject|3|||
156741376|NCT01259375|565800592|FG000|Overall Study|Adverse Event|1|||
156877727|NCT04803214|566310686|FG000|Overall Study|Adverse Event|1|||
156741377|NCT00986986|565800593|FG000|Overall Study|Lost to Follow-up|0|||
156741378|NCT00986986|565800594|FG001|Overall Study|Lost to Follow-up|1|||
156741379|NCT00628095|565800595|FG000|Overall Study|Adverse Event|5|||
156741380|NCT00628095|565800596|FG001|Overall Study|Adverse Event|3|||
156741381|NCT00628095|565800595|FG000|Overall Study|Lack of Efficacy|0|||
156741382|NCT00628095|565800596|FG001|Overall Study|Lack of Efficacy|3|||
156741383|NCT00628095|565800595|FG000|Overall Study|Withdrawal by Subject|2|||
156741384|NCT00628095|565800596|FG001|Overall Study|Withdrawal by Subject|0|||
156741385|NCT00628095|565800595|FG000|Overall Study|Other|0|||
156741386|NCT00628095|565800596|FG001|Overall Study|Other|1|||
156741387|NCT00656851|565800603|FG000|Overall Study|Withdrawal by Subject|0|||
156741388|NCT00656851|565800604|FG001|Overall Study|Withdrawal by Subject|4|||
156741389|NCT03932331|565800607|FG000|Overall Study|Death|0|||
156741390|NCT03932331|565800608|FG001|Overall Study|Death|7|||
156741391|NCT03932331|565800609|FG002|Overall Study|Death|2|||
156877728|NCT04803214|566310687|FG001|Overall Study|Adverse Event|0|||
156877729|NCT04803214|566310686|FG000|Overall Study|Withdrawal by Subject|1|||
156877730|NCT04803214|566310687|FG001|Overall Study|Withdrawal by Subject|2|||
156877731|NCT04803214|566310686|FG000|Overall Study|Lost to Follow-up|2|||
156741392|NCT03932331|565800607|FG000|Overall Study|Withdrawal by Subject|0|||
156741393|NCT03932331|565800608|FG001|Overall Study|Withdrawal by Subject|3|||
156741394|NCT03932331|565800609|FG002|Overall Study|Withdrawal by Subject|0|||
156741395|NCT03932331|565800607|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
156741396|NCT03932331|565800608|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
156741397|NCT03932331|565800609|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
156741398|NCT03932331|565800607|FG000|Overall Study|Progressive disease|3|||
156741399|NCT03932331|565800608|FG001|Overall Study|Progressive disease|0|||
156741400|NCT03932331|565800609|FG002|Overall Study|Progressive disease|0|||
156741401|NCT03932331|565800607|FG000|Overall Study|Lung infection|1|||
156741402|NCT03932331|565800608|FG001|Overall Study|Lung infection|0|||
156741403|NCT03932331|565800609|FG002|Overall Study|Lung infection|0|||
156741404|NCT03932331|565800607|FG000|Overall Study|Other|0|||
156877732|NCT04803214|566310687|FG001|Overall Study|Lost to Follow-up|4|||
156336918|NCT00932126|564331420|FG006|Overall Study|Protocol Violation|0|||
156741405|NCT03932331|565800608|FG001|Overall Study|Other|0|||
156741406|NCT03932331|565800609|FG002|Overall Study|Other|58|||
156741407|NCT03379753|565800610|FG000|Overall Study|Withdrawal by Subject|2|||
156741408|NCT03379753|565800611|FG001|Overall Study|Withdrawal by Subject|1|||
156741409|NCT03379753|565800610|FG000|Overall Study|not having correct procedure|1|||
156741410|NCT03379753|565800611|FG001|Overall Study|not having correct procedure|2|||
156741411|NCT03379753|565800610|FG000|Overall Study|No primary outcome|12|||
156741412|NCT03379753|565800611|FG001|Overall Study|No primary outcome|22|||
156741413|NCT02225366|565800618|FG000|Overall Study|Lack of Efficacy|1|||
156741414|NCT02225366|565800619|FG001|Overall Study|Lack of Efficacy|0|||
156877733|NCT04803214|566310686|FG000|Overall Study|Physician Decision|1|||
156877734|NCT04803214|566310687|FG001|Overall Study|Physician Decision|1|||
156877735|NCT04803214|566310686|FG000|Overall Study|Missed 12 month visit|0|||
156877736|NCT04803214|566310687|FG001|Overall Study|Missed 12 month visit|3|||
156877737|NCT03345420|566310688|FG000|Overall Study|Withdrawal by Subject|1|||
156877738|NCT00628212|566310694|FG000|Overall Study|Adverse Event|2|||
156877739|NCT00628212|566310695|FG001|Overall Study|Adverse Event|0|||
156741415|NCT02431806|565800620|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
156741416|NCT02431806|565800621|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
156741417|NCT02431806|565800622|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
156741418|NCT02431806|565800623|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
156741419|NCT02431806|565800620|FG000|Double-blind Treatment Period|Adverse Event|4|||
156741420|NCT02431806|565800621|FG001|Double-blind Treatment Period|Adverse Event|7|||
156741421|NCT02431806|565800622|FG002|Double-blind Treatment Period|Adverse Event|11|||
156741422|NCT02431806|565800623|FG003|Double-blind Treatment Period|Adverse Event|7|||
156741423|NCT02431806|565800620|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
156741424|NCT02431806|565800621|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
156741425|NCT02431806|565800622|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
156741426|NCT02431806|565800623|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
156741427|NCT02431806|565800620|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
156741428|NCT02431806|565800621|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
156741429|NCT02431806|565800622|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
156741430|NCT02431806|565800623|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
156741431|NCT02431806|565800620|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
156741432|NCT02431806|565800621|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
156741433|NCT02431806|565800622|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
156741434|NCT02431806|565800623|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
156741435|NCT02431806|565800620|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
156741436|NCT02431806|565800621|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
156741437|NCT02431806|565800622|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
156741438|NCT02431806|565800623|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
156797639|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797640|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797641|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797642|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797643|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797644|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797645|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797646|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156458431|NCT02052882|564774735|FG000|Overall Study|Protocol Violation|1|||
156458432|NCT02052882|564774735|FG000|Overall Study|Inadequate testing|1|||
156458433|NCT03987022|564774739|FG000|Overall Study|Lost to Follow-up|2|||
156797647|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797648|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797649|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797650|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797651|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
156797652|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
156797653|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
156797654|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797655|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797656|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797657|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797658|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797659|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797660|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797661|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797662|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797663|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797664|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797665|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797666|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797667|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
156797668|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
156797669|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
156797670|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
156797671|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
156797672|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
156797673|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
156797674|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
156797675|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
156797676|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
156797677|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
156458434|NCT03987022|564774740|FG001|Overall Study|Lost to Follow-up|2|||
156458435|NCT03987022|564774739|FG000|Overall Study|Withdrawal by Subject|1|||
156741439|NCT02431806|565800620|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
156741440|NCT02431806|565800621|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
156741441|NCT02431806|565800622|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
156741442|NCT02431806|565800623|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
156741443|NCT01419080|565800626|FG000|Overall Study|Withdrawal by Subject|75|||
156741444|NCT01419080|565800626|FG000|Overall Study|Death|30|||
156741445|NCT01419080|565800626|FG000|Overall Study|Lost to Follow-up|23|||
156741446|NCT01419080|565800626|FG000|Overall Study|Too Ill|3|||
156741447|NCT00710684|565800627|FG000|Overall Study|Adverse Event|11|||
156741448|NCT00710684|565800628|FG001|Overall Study|Adverse Event|19|||
156741449|NCT00710684|565800629|FG002|Overall Study|Adverse Event|16|||
156741450|NCT00710684|565800627|FG000|Overall Study|Lack of Efficacy|4|||
156741451|NCT00710684|565800628|FG001|Overall Study|Lack of Efficacy|3|||
156741452|NCT00710684|565800629|FG002|Overall Study|Lack of Efficacy|5|||
156741453|NCT00710684|565800627|FG000|Overall Study|Protocol Violation|5|||
156741454|NCT00710684|565800628|FG001|Overall Study|Protocol Violation|5|||
156741455|NCT00710684|565800629|FG002|Overall Study|Protocol Violation|5|||
156741456|NCT00710684|565800627|FG000|Overall Study|Lost to Follow-up|4|||
156741457|NCT00710684|565800628|FG001|Overall Study|Lost to Follow-up|6|||
156741458|NCT00710684|565800629|FG002|Overall Study|Lost to Follow-up|7|||
156741459|NCT00710684|565800627|FG000|Overall Study|Physician Decision|0|||
156336919|NCT00932126|564331421|FG007|Overall Study|Protocol Violation|0|||
156336920|NCT00932126|564331414|FG000|Overall Study|Withdrawal by Subject|0|||
156336921|NCT00932126|564331415|FG001|Overall Study|Withdrawal by Subject|0|||
156336922|NCT00932126|564331416|FG002|Overall Study|Withdrawal by Subject|1|||
156336923|NCT00932126|564331417|FG003|Overall Study|Withdrawal by Subject|0|||
156336924|NCT00932126|564331418|FG004|Overall Study|Withdrawal by Subject|0|||
156336925|NCT00932126|564331419|FG005|Overall Study|Withdrawal by Subject|0|||
156336926|NCT00932126|564331420|FG006|Overall Study|Withdrawal by Subject|0|||
156336927|NCT00932126|564331421|FG007|Overall Study|Withdrawal by Subject|1|||
156741460|NCT00710684|565800628|FG001|Overall Study|Physician Decision|2|||
156741461|NCT00710684|565800629|FG002|Overall Study|Physician Decision|4|||
156741462|NCT00710684|565800627|FG000|Overall Study|Withdrawal by Subject|24|||
156741463|NCT00710684|565800628|FG001|Overall Study|Withdrawal by Subject|18|||
156741464|NCT00710684|565800629|FG002|Overall Study|Withdrawal by Subject|11|||
156741465|NCT00710684|565800627|FG000|Overall Study|Missing|1|||
156741466|NCT00710684|565800628|FG001|Overall Study|Missing|0|||
156741467|NCT00710684|565800629|FG002|Overall Study|Missing|0|||
156741468|NCT00710684|565800627|FG000|Overall Study|Did not continue after week 24|25|||
156741469|NCT00710684|565800628|FG001|Overall Study|Did not continue after week 24|21|||
156741470|NCT00710684|565800629|FG002|Overall Study|Did not continue after week 24|16|||
156741471|NCT04778059|565800630|FG000|Overall Study|Death|2|||
156741472|NCT04778059|565800631|FG001|Overall Study|Death|2|||
156741473|NCT04778059|565800632|FG002|Overall Study|Death|1|||
156741474|NCT04778059|565800633|FG003|Overall Study|Death|1|||
156741475|NCT04778059|565800634|FG004|Overall Study|Death|1|||
156741476|NCT04778059|565800630|FG000|Overall Study|Lost to Follow-up|0|||
156741477|NCT04778059|565800631|FG001|Overall Study|Lost to Follow-up|0|||
156741478|NCT04778059|565800632|FG002|Overall Study|Lost to Follow-up|0|||
156741479|NCT04778059|565800633|FG003|Overall Study|Lost to Follow-up|0|||
156741480|NCT04778059|565800634|FG004|Overall Study|Lost to Follow-up|1|||
156741481|NCT04778059|565800630|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
156741482|NCT04778059|565800631|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
156741483|NCT04778059|565800632|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
156534786|NCT01572675|565052462|FG001|Overall Study|Unknown reason|1|||
156534787|NCT01572675|565052461|FG000|Overall Study|Rheumatologist new evaluation|0|||
156741484|NCT04778059|565800633|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
156741485|NCT04778059|565800634|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
156741486|NCT02832375|565800635|FG000|Overall Study|Lost to Follow-up|1|||
156797678|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
156797679|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
156797680|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
156797681|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
156336928|NCT00932126|564331414|FG000|Overall Study|Objective progression or relapse|3|||
156741487|NCT02832375|565800636|FG001|Overall Study|Lost to Follow-up|0|||
156741488|NCT02832375|565800635|FG000|Overall Study|Withdrawal of Consent|1|||
156741489|NCT02832375|565800636|FG001|Overall Study|Withdrawal of Consent|0|||
156336929|NCT00932126|564331415|FG001|Overall Study|Objective progression or relapse|3|||
156741490|NCT00514904|565800637|FG000|Overall Study|Withdrawal by Subject|3|||
156336930|NCT00932126|564331416|FG002|Overall Study|Objective progression or relapse|2|||
156336931|NCT00932126|564331417|FG003|Overall Study|Objective progression or relapse|3|||
156534788|NCT01572675|565052462|FG001|Overall Study|Rheumatologist new evaluation|1|||
156741491|NCT00514904|565800638|FG001|Overall Study|Withdrawal by Subject|2|||
156741492|NCT00514904|565800637|FG000|Overall Study|Lost to Follow-up|21|||
156741493|NCT00514904|565800638|FG001|Overall Study|Lost to Follow-up|3|||
156741494|NCT00084318|565800639|FG000|Overall Study|Withdrawal by Subject|5|||
156741495|NCT00084318|565800640|FG001|Overall Study|Withdrawal by Subject|2|||
156741496|NCT00084318|565800639|FG000|Overall Study|Protocol Violation|15|||
156741497|NCT00084318|565800640|FG001|Overall Study|Protocol Violation|11|||
156741498|NCT00084318|565800639|FG000|Overall Study|No protocol treatment|2|||
156741499|NCT00084318|565800640|FG001|Overall Study|No protocol treatment|0|||
156741500|NCT01317797|565800641|FG000|Overall Study|Other|0|||
156741501|NCT01317797|565800642|FG001|Overall Study|Other|1|||
156741502|NCT01317797|565800643|FG002|Overall Study|Other|0|||
156741503|NCT01317797|565800641|FG000|Overall Study|Withdrawal of Patient|0|||
156741504|NCT01317797|565800642|FG001|Overall Study|Withdrawal of Patient|0|||
156741505|NCT01317797|565800643|FG002|Overall Study|Withdrawal of Patient|1|||
156741506|NCT03026530|565800647|FG000|Overall Study|Lost to Follow-up|19|||
156534789|NCT01572675|565052461|FG000|Overall Study|Missing data|1|||
156534790|NCT01572675|565052462|FG001|Overall Study|Missing data|4|||
156534791|NCT01572675|565052461|FG000|Overall Study|Lost to Follow-up|22|||
156741507|NCT03026530|565800648|FG001|Overall Study|Lost to Follow-up|24|||
156741508|NCT03026530|565800647|FG000|Overall Study|Protocol Violation|2|||
156741509|NCT03026530|565800648|FG001|Overall Study|Protocol Violation|5|||
156741510|NCT03721835|565800649|FG000|Overall Study|Participant not able to return|1|||
156741511|NCT03721835|565800649|FG000|Overall Study|Lost to Follow-up|1|||
156741512|NCT03721835|565800649|FG000|Overall Study|Revision of the components of the study device|2|||
156741513|NCT03721835|565800649|FG000|Overall Study|Sponsor terminated study|6|||
156741514|NCT03721835|565800649|FG000|Overall Study|Death|1|||
156741515|NCT03721835|565800649|FG000|Overall Study|Sponsor decision|1|||
156741516|NCT02100670|565800650|FG000|Overall Study|Adverse Event|10|||
156741517|NCT02100670|565800651|FG001|Overall Study|Adverse Event|3|||
156741518|NCT02100670|565800652|FG002|Overall Study|Adverse Event|3|||
156741519|NCT02100670|565800653|FG003|Overall Study|Adverse Event|0|||
156741520|NCT02100670|565800650|FG000|Overall Study|Lost to Follow-up|1|||
156741521|NCT02100670|565800651|FG001|Overall Study|Lost to Follow-up|0|||
156741522|NCT02100670|565800652|FG002|Overall Study|Lost to Follow-up|0|||
156741523|NCT02100670|565800653|FG003|Overall Study|Lost to Follow-up|0|||
156741524|NCT02100670|565800650|FG000|Overall Study|Protocol Violation|0|||
156741525|NCT02100670|565800651|FG001|Overall Study|Protocol Violation|1|||
156741526|NCT02100670|565800652|FG002|Overall Study|Protocol Violation|0|||
156741527|NCT02100670|565800653|FG003|Overall Study|Protocol Violation|1|||
156741528|NCT02100670|565800650|FG000|Overall Study|Withdrawal of Consent|0|||
156741529|NCT02100670|565800651|FG001|Overall Study|Withdrawal of Consent|1|||
156741530|NCT02100670|565800652|FG002|Overall Study|Withdrawal of Consent|1|||
156741531|NCT02100670|565800653|FG003|Overall Study|Withdrawal of Consent|0|||
156741532|NCT02100670|565800650|FG000|Overall Study|No swelling no pain|1|||
156741533|NCT02100670|565800651|FG001|Overall Study|No swelling no pain|0|||
156741534|NCT02100670|565800652|FG002|Overall Study|No swelling no pain|0|||
156534792|NCT01572675|565052462|FG001|Overall Study|Lost to Follow-up|27|||
156534793|NCT05390580|565052463|FG000|Overall Study|Physician Decision|3|||
156534794|NCT05390580|565052464|FG001|Overall Study|Physician Decision|2|||
156741535|NCT02100670|565800653|FG003|Overall Study|No swelling no pain|0|||
156797682|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
156797683|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797684|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797685|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797686|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797687|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
156797688|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797689|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797690|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797691|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797692|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797693|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797694|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797695|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797696|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797697|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797698|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156741536|NCT02100670|565800650|FG000|Overall Study|Poor Efficacy|0|||
156741537|NCT02100670|565800651|FG001|Overall Study|Poor Efficacy|1|||
156741538|NCT02100670|565800652|FG002|Overall Study|Poor Efficacy|0|||
156741539|NCT02100670|565800653|FG003|Overall Study|Poor Efficacy|0|||
156741540|NCT02100670|565800650|FG000|Overall Study|Physician Decision|0|||
156741541|NCT02100670|565800651|FG001|Overall Study|Physician Decision|1|||
156797699|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156336932|NCT00932126|564331418|FG004|Overall Study|Objective progression or relapse|3|||
156534795|NCT04448756|565052465|FG000|Overall Study|Adverse Event|0|||
156741542|NCT02100670|565800652|FG002|Overall Study|Physician Decision|0|||
156741543|NCT02100670|565800653|FG003|Overall Study|Physician Decision|0|||
156741544|NCT02100670|565800650|FG000|Overall Study|Withdrawal by Subject|1|||
156741545|NCT02100670|565800651|FG001|Overall Study|Withdrawal by Subject|0|||
156741546|NCT02100670|565800652|FG002|Overall Study|Withdrawal by Subject|0|||
156741547|NCT02100670|565800653|FG003|Overall Study|Withdrawal by Subject|0|||
156741548|NCT05741346|565802421|FG000|Overall Study|Withdrawn due to termination of study|28|||
156877740|NCT00628212|566310696|FG002|Overall Study|Adverse Event|1|||
156877741|NCT00628212|566310697|FG003|Overall Study|Adverse Event|2|||
156877742|NCT00628212|566310694|FG000|Overall Study|Physician Decision|1|||
156877743|NCT00628212|566310695|FG001|Overall Study|Physician Decision|1|||
156741549|NCT04439357|565802425|FG000|Overall Study|Disease Progression|4|||
156741550|NCT01458951|565802440|FG000|Overall Study|Other|1|||
156741551|NCT01458951|565802441|FG001|Overall Study|Other|0|||
156741552|NCT01458951|565802442|FG002|Overall Study|Other|0|||
156741553|NCT01458951|565802440|FG000|Overall Study|Protocol Violation|5|||
156741554|NCT01458951|565802441|FG001|Overall Study|Protocol Violation|1|||
156741555|NCT01458951|565802442|FG002|Overall Study|Protocol Violation|0|||
156741556|NCT01458951|565802440|FG000|Overall Study|Withdrawal by Subject|2|||
156741557|NCT01458951|565802441|FG001|Overall Study|Withdrawal by Subject|0|||
156741558|NCT01458951|565802442|FG002|Overall Study|Withdrawal by Subject|2|||
156741559|NCT01458951|565802440|FG000|Overall Study|Adverse Event|7|||
156741560|NCT01458951|565802441|FG001|Overall Study|Adverse Event|0|||
156741561|NCT01458951|565802442|FG002|Overall Study|Adverse Event|2|||
156741562|NCT01458951|565802440|FG000|Overall Study|Insufficient Clinical Response|17|||
156741563|NCT01458951|565802441|FG001|Overall Study|Insufficient Clinical Response|0|||
156741564|NCT01458951|565802442|FG002|Overall Study|Insufficient Clinical Response|11|||
156741565|NCT01668966|565802447|FG000|Overall Study|Withdrawal by Subject|1|||
156741566|NCT01668966|565802447|FG000|Overall Study|Death|1|||
156741567|NCT01668966|565802447|FG000|Overall Study|Not treated|2|||
156741568|NCT04392167|565802449|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
156741569|NCT01573767|565802450|FG000|Overall Study|Adverse Event|0|||
156741570|NCT01573767|565802451|FG001|Overall Study|Adverse Event|1|||
156741571|NCT01573767|565802452|FG002|Overall Study|Adverse Event|0|||
156741572|NCT01573767|565802453|FG003|Overall Study|Adverse Event|1|||
156741573|NCT01573767|565802450|FG000|Overall Study|Lack of Efficacy|18|||
156741574|NCT01573767|565802451|FG001|Overall Study|Lack of Efficacy|15|||
156741575|NCT01573767|565802452|FG002|Overall Study|Lack of Efficacy|12|||
156741576|NCT01573767|565802453|FG003|Overall Study|Lack of Efficacy|17|||
156741577|NCT01573767|565802450|FG000|Overall Study|Protocol Violation|3|||
156741578|NCT01573767|565802451|FG001|Overall Study|Protocol Violation|1|||
156741579|NCT01573767|565802452|FG002|Overall Study|Protocol Violation|1|||
156741580|NCT01573767|565802453|FG003|Overall Study|Protocol Violation|3|||
156741581|NCT01573767|565802450|FG000|Overall Study|Lost to Follow-up|0|||
156741582|NCT01573767|565802451|FG001|Overall Study|Lost to Follow-up|1|||
156741583|NCT01573767|565802452|FG002|Overall Study|Lost to Follow-up|1|||
156741584|NCT01573767|565802453|FG003|Overall Study|Lost to Follow-up|1|||
156741585|NCT01573767|565802450|FG000|Overall Study|Physician Decision|1|||
156741586|NCT01573767|565802451|FG001|Overall Study|Physician Decision|2|||
156741587|NCT01573767|565802452|FG002|Overall Study|Physician Decision|0|||
156741588|NCT01573767|565802453|FG003|Overall Study|Physician Decision|2|||
156741589|NCT01573767|565802450|FG000|Overall Study|Withdrawal by Subject|0|||
156741590|NCT01573767|565802451|FG001|Overall Study|Withdrawal by Subject|1|||
156741591|NCT01573767|565802452|FG002|Overall Study|Withdrawal by Subject|0|||
156741592|NCT01573767|565802453|FG003|Overall Study|Withdrawal by Subject|0|||
156741593|NCT04076059|565802456|FG000|Double Blind Phase|Progressive disease|22|||
156741594|NCT04076059|565802457|FG001|Double Blind Phase|Progressive disease|26|||
156741595|NCT04076059|565802458|FG002|Double Blind Phase|Progressive disease|0|||
156741596|NCT04076059|565802456|FG000|Double Blind Phase|Withdrawal by Subject|4|||
156741597|NCT04076059|565802457|FG001|Double Blind Phase|Withdrawal by Subject|11|||
156741598|NCT04076059|565802458|FG002|Double Blind Phase|Withdrawal by Subject|0|||
156741599|NCT04076059|565802456|FG000|Double Blind Phase|Death|1|||
156741600|NCT04076059|565802457|FG001|Double Blind Phase|Death|1|||
156741601|NCT04076059|565802458|FG002|Double Blind Phase|Death|0|||
156741602|NCT04076059|565802456|FG000|Double Blind Phase|Lost to Follow-up|1|||
156741603|NCT04076059|565802457|FG001|Double Blind Phase|Lost to Follow-up|0|||
156741604|NCT04076059|565802458|FG002|Double Blind Phase|Lost to Follow-up|0|||
156877744|NCT00628212|566310696|FG002|Overall Study|Physician Decision|2|||
156877745|NCT00628212|566310697|FG003|Overall Study|Physician Decision|3|||
156877746|NCT05740371|566310701|FG000|Overall Study|Death|1|||
156877747|NCT04930445|566310702|FG000|Overall Study|Adverse Event|7|||
156877748|NCT04930445|566310702|FG000|Overall Study|Lost to Follow-up|1|||
156336933|NCT00932126|564331419|FG005|Overall Study|Objective progression or relapse|3|||
156741605|NCT04076059|565802456|FG000|Double Blind Phase|Adverse Event|5|||
156741606|NCT04076059|565802457|FG001|Double Blind Phase|Adverse Event|1|||
156741607|NCT04076059|565802458|FG002|Double Blind Phase|Adverse Event|0|||
156741608|NCT04076059|565802456|FG000|Double Blind Phase|Ongoing Participants|82|||
156741609|NCT04076059|565802457|FG001|Double Blind Phase|Ongoing Participants|18|||
156877749|NCT04930445|566310702|FG000|Overall Study|Physician Decision|1|||
156877750|NCT04930445|566310702|FG000|Overall Study|Lack of Efficacy|1|||
156877751|NCT04930445|566310702|FG000|Overall Study|Study Terminated by Sponsor|245|||
156877752|NCT04930445|566310702|FG000|Overall Study|Screen Failure|8|||
156534796|NCT04448756|565052466|FG001|Overall Study|Adverse Event|1|||
156534797|NCT04448756|565052467|FG002|Overall Study|Adverse Event|0|||
156534798|NCT04448756|565052465|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
156534799|NCT04448756|565052466|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
156534800|NCT04448756|565052467|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
156534801|NCT04448756|565052465|FG000|Overall Study|Withdrawal by Subject|0|||
156534802|NCT04448756|565052466|FG001|Overall Study|Withdrawal by Subject|3|||
156534803|NCT04448756|565052467|FG002|Overall Study|Withdrawal by Subject|1|||
156534804|NCT04448756|565052465|FG000|Overall Study|Death|2|||
156534805|NCT04448756|565052466|FG001|Overall Study|Death|1|||
156534806|NCT04448756|565052467|FG002|Overall Study|Death|0|||
156534807|NCT02733185|565052468|FG000|Overall Study|Withdrawal by Subject|12|||
156534808|NCT02733185|565052469|FG001|Overall Study|Withdrawal by Subject|10|||
156534809|NCT02733185|565052470|FG002|Overall Study|Withdrawal by Subject|17|||
156534810|NCT02733185|565052471|FG003|Overall Study|Withdrawal by Subject|21|||
156534811|NCT02733185|565052468|FG000|Overall Study|Death|46|||
156534812|NCT02733185|565052469|FG001|Overall Study|Death|34|||
156534813|NCT02733185|565052470|FG002|Overall Study|Death|35|||
156534814|NCT02733185|565052471|FG003|Overall Study|Death|43|||
156534815|NCT02733185|565052468|FG000|Overall Study|Lost to Follow-up|17|||
156534816|NCT02733185|565052469|FG001|Overall Study|Lost to Follow-up|18|||
156534817|NCT02733185|565052470|FG002|Overall Study|Lost to Follow-up|16|||
156534818|NCT02733185|565052471|FG003|Overall Study|Lost to Follow-up|11|||
156534819|NCT02129205|565052472|FG000|Overall Study|Withdrawal by Subject|0|||
156534820|NCT02129205|565052473|FG001|Overall Study|Withdrawal by Subject|0|||
156534821|NCT02129205|565052474|FG002|Overall Study|Withdrawal by Subject|0|||
156534822|NCT02129205|565052475|FG003|Overall Study|Withdrawal by Subject|0|||
156534823|NCT02129205|565052476|FG004|Overall Study|Withdrawal by Subject|1|||
156534824|NCT02129205|565052477|FG005|Overall Study|Withdrawal by Subject|1|||
156534825|NCT02129205|565052478|FG006|Overall Study|Withdrawal by Subject|1|||
156534826|NCT02129205|565052479|FG007|Overall Study|Withdrawal by Subject|0|||
156534827|NCT02129205|565052480|FG008|Overall Study|Withdrawal by Subject|1|||
156534828|NCT02129205|565052481|FG009|Overall Study|Withdrawal by Subject|0|||
156534829|NCT02129205|565052472|FG000|Overall Study|Other|1|||
156534830|NCT02129205|565052473|FG001|Overall Study|Other|0|||
156534831|NCT02129205|565052474|FG002|Overall Study|Other|0|||
156534832|NCT02129205|565052475|FG003|Overall Study|Other|0|||
156534833|NCT02129205|565052476|FG004|Overall Study|Other|2|||
156534834|NCT02129205|565052477|FG005|Overall Study|Other|3|||
156534835|NCT02129205|565052478|FG006|Overall Study|Other|3|||
156534836|NCT02129205|565052479|FG007|Overall Study|Other|2|||
156534837|NCT02129205|565052480|FG008|Overall Study|Other|1|||
156534838|NCT02129205|565052481|FG009|Overall Study|Other|0|||
156534839|NCT02877927|565052482|FG000|Overall Study|Adverse Event|1|||
156534840|NCT02877927|565052483|FG001|Overall Study|Adverse Event|0|||
156534841|NCT02877927|565052482|FG000|Overall Study|Lost to Follow-up|37|||
156534842|NCT02877927|565052483|FG001|Overall Study|Lost to Follow-up|38|||
156534843|NCT02877927|565052482|FG000|Overall Study|Withdrawal by Subject|11|||
156534844|NCT02877927|565052483|FG001|Overall Study|Withdrawal by Subject|12|||
156534845|NCT02877927|565052482|FG000|Overall Study|Physician Decision|0|||
156534846|NCT02877927|565052483|FG001|Overall Study|Physician Decision|1|||
156534847|NCT02877927|565052482|FG000|Overall Study|Missed EOT/PTE Visit|5|||
156534848|NCT02877927|565052483|FG001|Overall Study|Missed EOT/PTE Visit|6|||
156534849|NCT00601250|565052484|FG000|Overall Study|Adverse Event|3|||
156534850|NCT00601250|565052485|FG001|Overall Study|Adverse Event|9|||
156741610|NCT04076059|565802458|FG002|Double Blind Phase|Ongoing Participants|0|||
156741611|NCT04076059|565802456|FG000|Double Blind Phase|Miscellaneous|3|||
156741612|NCT04076059|565802457|FG001|Double Blind Phase|Miscellaneous|1|||
156741613|NCT04076059|565802458|FG002|Double Blind Phase|Miscellaneous|0|||
156741614|NCT04076059|565802456|FG000|Double Blind Phase|Protocol Deviation|1|||
156741615|NCT04076059|565802457|FG001|Double Blind Phase|Protocol Deviation|1|||
156741616|NCT04076059|565802458|FG002|Double Blind Phase|Protocol Deviation|0|||
156741617|NCT04076059|565802456|FG000|Double Blind Phase|Did not take study drug|1|||
156741618|NCT04076059|565802457|FG001|Double Blind Phase|Did not take study drug|1|||
156741619|NCT04076059|565802458|FG002|Double Blind Phase|Did not take study drug|0|||
156741620|NCT04076059|565802456|FG000|Open Label Phase|Progressive disease|0|||
156741621|NCT04076059|565802457|FG001|Open Label Phase|Progressive disease|0|||
156534851|NCT00601250|565052484|FG000|Overall Study|Protocol Violation|3|||
156534852|NCT00601250|565052485|FG001|Overall Study|Protocol Violation|2|||
156534853|NCT00601250|565052484|FG000|Overall Study|Lost to Follow-up|2|||
156534854|NCT00601250|565052485|FG001|Overall Study|Lost to Follow-up|6|||
156534855|NCT00601250|565052484|FG000|Overall Study|Withdrawal by Subject|4|||
156534856|NCT00601250|565052485|FG001|Overall Study|Withdrawal by Subject|13|||
156534857|NCT00601250|565052484|FG000|Overall Study|Other incl. lack of efficacy|2|||
156534858|NCT00601250|565052485|FG001|Overall Study|Other incl. lack of efficacy|9|||
156534859|NCT04376060|565052486|FG000|Overall Study|Physician Decision|1|||
156534860|NCT01791803|565052487|FG000|Overall Study|Withdrawal by Subject|0|||
156534861|NCT01791803|565052488|FG001|Overall Study|Withdrawal by Subject|0|||
156877753|NCT04930445|566310702|FG000|Overall Study|Other|2|||
156336934|NCT00932126|564331420|FG006|Overall Study|Objective progression or relapse|3|||
156797700|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797701|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797702|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797703|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797704|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797705|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797706|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797707|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797708|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
156797709|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797710|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797711|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
156797712|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797713|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797714|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
156797715|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797716|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797717|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797718|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797719|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797720|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797721|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797722|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797723|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
156797724|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
156797725|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797726|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
156797727|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797728|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
156797729|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797730|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
156797731|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797732|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797733|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797734|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797735|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797736|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797737|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797738|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156877754|NCT03211416|566310703|FG000|Overall Study|Adverse Event|7|||
156336935|NCT00932126|564331421|FG007|Overall Study|Objective progression or relapse|5|||
156877755|NCT03211416|566310703|FG000|Overall Study|Lack of Efficacy|2|||
156877756|NCT03211416|566310703|FG000|Overall Study|Physician Decision|1|||
156877757|NCT03199274|566310707|FG000|Overall Study|Withdrawal by Subject|4|||
156877758|NCT03199274|566310708|FG001|Overall Study|Withdrawal by Subject|0|||
156877759|NCT03199274|566310707|FG000|Overall Study|Lost to Follow-up|0|||
156877760|NCT03199274|566310708|FG001|Overall Study|Lost to Follow-up|1|||
156877761|NCT03199274|566310707|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
156877762|NCT03199274|566310708|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
156877763|NCT05550532|566310716|FG000|Overall Study|Withdrawal by Subject|8|||
156877764|NCT05550532|566310717|FG001|Overall Study|Withdrawal by Subject|3|||
156877765|NCT05550532|566310716|FG000|Overall Study|Adverse Event|2|||
156877766|NCT05550532|566310717|FG001|Overall Study|Adverse Event|3|||
156877767|NCT05550532|566310716|FG000|Overall Study|Lost to Follow-up|4|||
156877768|NCT05550532|566310717|FG001|Overall Study|Lost to Follow-up|0|||
156877769|NCT05550532|566310716|FG000|Overall Study|Other|0|||
156877770|NCT05550532|566310717|FG001|Overall Study|Other|4|||
156877771|NCT06475729|566310718|FG000|Overall Study|Withdrawal by Subject|2|||
156877772|NCT06475729|566310719|FG001|Overall Study|Withdrawal by Subject|1|||
156877773|NCT06475729|566310718|FG000|Overall Study|Randomized but did not receive any dose|3|||
156877774|NCT06475729|566310719|FG001|Overall Study|Randomized but did not receive any dose|2|||
156877775|NCT06475729|566310718|FG000|Overall Study|Lost to Follow-up|1|||
156877776|NCT06475729|566310719|FG001|Overall Study|Lost to Follow-up|2|||
156877777|NCT06475729|566310718|FG000|Overall Study|Physician Decision|5|||
156877778|NCT06475729|566310719|FG001|Overall Study|Physician Decision|2|||
156877779|NCT06475729|566310718|FG000|Overall Study|Adverse Event|1|||
156877780|NCT06475729|566310719|FG001|Overall Study|Adverse Event|1|||
156336936|NCT00932126|564331414|FG000|Overall Study|Other|0|||
156877781|NCT03520036|566310720|FG000|Overall Study|Adverse Event|1|||
156336937|NCT00932126|564331415|FG001|Overall Study|Other|0|||
156336938|NCT00932126|564331416|FG002|Overall Study|Other|0|||
156458436|NCT03987022|564774740|FG001|Overall Study|Withdrawal by Subject|0|||
156741622|NCT04076059|565802458|FG002|Open Label Phase|Progressive disease|7|||
156741623|NCT04076059|565802456|FG000|Open Label Phase|Withdrawal by Subject|0|||
156741624|NCT04076059|565802457|FG001|Open Label Phase|Withdrawal by Subject|0|||
156741625|NCT04076059|565802458|FG002|Open Label Phase|Withdrawal by Subject|3|||
156741626|NCT04076059|565802456|FG000|Open Label Phase|Death|0|||
156741627|NCT04076059|565802457|FG001|Open Label Phase|Death|0|||
156741628|NCT04076059|565802458|FG002|Open Label Phase|Death|2|||
156741629|NCT04076059|565802456|FG000|Open Label Phase|Ongoing Participants|0|||
156741630|NCT04076059|565802457|FG001|Open Label Phase|Ongoing Participants|0|||
156741631|NCT04076059|565802458|FG002|Open Label Phase|Ongoing Participants|11|||
156741632|NCT04186806|565802459|FG000|Period 1: 7 Days|Adverse Event|1|||
156741633|NCT04186806|565802460|FG001|Period 1: 7 Days|Adverse Event|0|||
156741634|NCT02720744|565802464|FG000|Overall Study|Protocol Violation|0|||
156741635|NCT02720744|565802465|FG001|Overall Study|Protocol Violation|2|||
156741636|NCT02720744|565802464|FG000|Overall Study|Pregnancy|2|||
156741637|NCT02720744|565802465|FG001|Overall Study|Pregnancy|0|||
156741638|NCT02720744|565802464|FG000|Overall Study|Lack of Efficacy|2|||
156741639|NCT02720744|565802465|FG001|Overall Study|Lack of Efficacy|8|||
156741640|NCT02720744|565802464|FG000|Overall Study|Adverse Event|21|||
156741641|NCT02720744|565802465|FG001|Overall Study|Adverse Event|3|||
156741642|NCT02720744|565802464|FG000|Overall Study|Withdrawal by Subject|11|||
156741643|NCT02720744|565802465|FG001|Overall Study|Withdrawal by Subject|11|||
156741644|NCT02720744|565802464|FG000|Overall Study|Lost to follow up|2|||
156741645|NCT02720744|565802465|FG001|Overall Study|Lost to follow up|0|||
156741646|NCT02720744|565802464|FG000|Overall Study|Non Compliance with Investigational Product|0|||
156741647|NCT02720744|565802465|FG001|Overall Study|Non Compliance with Investigational Product|1|||
156741648|NCT02720744|565802464|FG000|Overall Study|Excluded Concomitant Medication|0|||
156741649|NCT02720744|565802465|FG001|Overall Study|Excluded Concomitant Medication|1|||
156741650|NCT06137703|565802466|FG000|Overall Study|Other|0|||
156797739|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797740|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
156797741|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797742|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797743|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797744|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797745|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797746|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
156797747|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797748|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797749|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797750|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797751|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797752|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797753|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797754|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797755|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797756|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156458437|NCT05170841|564774742|FG000|Single Dose Phase|Adverse Event|1|||
156458438|NCT05170841|564774743|FG001|Single Dose Phase|Adverse Event|2|||
156458439|NCT05170841|564774744|FG002|Single Dose Phase|Adverse Event|0|||
156458440|NCT05170841|564774745|FG003|Single Dose Phase|Adverse Event|2|||
156458441|NCT05170841|564774742|FG000|Multiple Dose Phase|Adverse Event|1|||
156458442|NCT05170841|564774743|FG001|Multiple Dose Phase|Adverse Event|2|||
156458443|NCT05170841|564774744|FG002|Multiple Dose Phase|Adverse Event|1|||
156458444|NCT05170841|564774745|FG003|Multiple Dose Phase|Adverse Event|4|||
156458445|NCT05170841|564774742|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
156458446|NCT05170841|564774743|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
156458447|NCT05170841|564774744|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
156458448|NCT05170841|564774745|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
156458449|NCT05123586|564774748|FG000|Overall Study|Physician Decision|1|||
156458450|NCT05123586|564774749|FG001|Overall Study|Physician Decision|1|||
156458451|NCT05123586|564774748|FG000|Overall Study|Withdrawal by Subject|0|||
156458452|NCT05123586|564774749|FG001|Overall Study|Withdrawal by Subject|3|||
156458453|NCT06122194|564774765|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
156741651|NCT06137703|565802467|FG001|Overall Study|Other|1|||
156741652|NCT06137703|565802468|FG002|Overall Study|Other|0|||
156741653|NCT06137703|565802469|FG003|Overall Study|Other|0|||
156458454|NCT06122194|564774766|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
156458455|NCT06122194|564774767|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
156458456|NCT06122194|564774768|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
156458457|NCT05218096|564774769|FG000|Primary Evaluation|Withdrawal by Subject|0|||
156741654|NCT06137703|565802466|FG000|Overall Study|Adverse Event|0|||
156741655|NCT06137703|565802467|FG001|Overall Study|Adverse Event|0|||
156741656|NCT06137703|565802468|FG002|Overall Study|Adverse Event|1|||
156877782|NCT03520036|566310721|FG001|Overall Study|Adverse Event|2|||
156877783|NCT03520036|566310722|FG002|Overall Study|Adverse Event|0|||
156877784|NCT03520036|566310720|FG000|Overall Study|Protocol Violation|1|||
156877785|NCT03520036|566310721|FG001|Overall Study|Protocol Violation|0|||
156877786|NCT03520036|566310722|FG002|Overall Study|Protocol Violation|0|||
156877787|NCT03520036|566310720|FG000|Overall Study|Withdrawal by Subject|0|||
156877788|NCT03520036|566310721|FG001|Overall Study|Withdrawal by Subject|1|||
156877789|NCT03520036|566310722|FG002|Overall Study|Withdrawal by Subject|4|||
156877790|NCT03520036|566310720|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
156877791|NCT03520036|566310721|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
156877792|NCT03520036|566310722|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
156877793|NCT00006436|566310723|FG000|Overall Study|Refused further treatment|2|||
156877794|NCT00006436|566310723|FG000|Overall Study|Declined to participate (before treatment started)|1|||
156877795|NCT03926117|566310726|FG000|Overall Study|Unclassified|1|||
156877796|NCT03926117|566310727|FG001|Overall Study|Unclassified|4|||
156741657|NCT06137703|565802469|FG003|Overall Study|Adverse Event|0|||
156741658|NCT00741091|565802470|FG000|Overall Study|Death|13|||
156741659|NCT00741091|565802470|FG000|Overall Study|Lost to Follow-up|16|||
156741660|NCT00741091|565802470|FG000|Overall Study|Withdrawal by Subject|6|||
156741661|NCT00741091|565802470|FG000|Overall Study|Missed Visit|22|||
156741662|NCT01801358|565802471|FG000|Overall Study|Adverse Event|0|||
156741663|NCT01801358|565802472|FG001|Overall Study|Adverse Event|2|||
156741664|NCT01801358|565802473|FG002|Overall Study|Adverse Event|1|||
156741665|NCT01801358|565802474|FG003|Overall Study|Adverse Event|0|||
156741666|NCT01801358|565802475|FG004|Overall Study|Adverse Event|0|||
156741667|NCT01801358|565802476|FG005|Overall Study|Adverse Event|1|||
156741668|NCT01801358|565802471|FG000|Overall Study|Physician Decision|0|||
156741669|NCT01801358|565802472|FG001|Overall Study|Physician Decision|0|||
156741670|NCT01801358|565802473|FG002|Overall Study|Physician Decision|1|||
156741671|NCT01801358|565802474|FG003|Overall Study|Physician Decision|0|||
156741672|NCT01801358|565802475|FG004|Overall Study|Physician Decision|0|||
156741673|NCT01801358|565802476|FG005|Overall Study|Physician Decision|0|||
156741674|NCT01801358|565802471|FG000|Overall Study|Progressive Disease|6|||
156741675|NCT01801358|565802472|FG001|Overall Study|Progressive Disease|4|||
156741676|NCT01801358|565802473|FG002|Overall Study|Progressive Disease|4|||
156741677|NCT01801358|565802474|FG003|Overall Study|Progressive Disease|5|||
156741678|NCT01801358|565802475|FG004|Overall Study|Progressive Disease|6|||
156741679|NCT01801358|565802476|FG005|Overall Study|Progressive Disease|5|||
156877797|NCT03926117|566310728|FG002|Overall Study|Unclassified|1|||
156877798|NCT03926117|566310729|FG003|Overall Study|Unclassified|4|||
156877799|NCT03926117|566310726|FG000|Overall Study|Withdrawal by Subject|3|||
156877800|NCT03926117|566310727|FG001|Overall Study|Withdrawal by Subject|0|||
156877801|NCT03926117|566310728|FG002|Overall Study|Withdrawal by Subject|1|||
156877802|NCT03926117|566310729|FG003|Overall Study|Withdrawal by Subject|1|||
156877803|NCT03926117|566310726|FG000|Overall Study|Lost to Follow-up|0|||
156877804|NCT03926117|566310727|FG001|Overall Study|Lost to Follow-up|2|||
156877805|NCT03926117|566310728|FG002|Overall Study|Lost to Follow-up|1|||
156877806|NCT03926117|566310729|FG003|Overall Study|Lost to Follow-up|0|||
156877807|NCT03926117|566310726|FG000|Overall Study|Adverse Event|1|||
156877808|NCT03926117|566310727|FG001|Overall Study|Adverse Event|2|||
156877809|NCT03926117|566310728|FG002|Overall Study|Adverse Event|3|||
156877810|NCT03926117|566310729|FG003|Overall Study|Adverse Event|1|||
156877811|NCT03926117|566310726|FG000|Overall Study|Randomized but not treated|1|||
156877812|NCT03926117|566310727|FG001|Overall Study|Randomized but not treated|1|||
156877813|NCT03926117|566310728|FG002|Overall Study|Randomized but not treated|0|||
156877814|NCT03926117|566310729|FG003|Overall Study|Randomized but not treated|1|||
156877815|NCT04071769|566310732|FG000|Overall Study|Lost to Follow-up|3|||
156877816|NCT04071769|566310732|FG000|Overall Study|Physician Decision|2|||
156877817|NCT04071769|566310732|FG000|Overall Study|Withdrawal by Subject|8|||
156877818|NCT02938520|566310733|FG000|Overall Study|On-going at the time of analysis|258|||
156877819|NCT02938520|566310734|FG001|Overall Study|On-going at the time of analysis|261|||
156741680|NCT01801358|565802471|FG000|Overall Study|Withdrawal by Subject|0|||
156741681|NCT01801358|565802472|FG001|Overall Study|Withdrawal by Subject|0|||
156741682|NCT01801358|565802473|FG002|Overall Study|Withdrawal by Subject|0|||
156741683|NCT01801358|565802474|FG003|Overall Study|Withdrawal by Subject|1|||
156741684|NCT01801358|565802475|FG004|Overall Study|Withdrawal by Subject|0|||
156877820|NCT02938520|566310733|FG000|Overall Study|Physician Decision|2|||
156877821|NCT02938520|566310734|FG001|Overall Study|Physician Decision|5|||
156877822|NCT02938520|566310733|FG000|Overall Study|Lost to Follow-up|2|||
156877823|NCT02938520|566310734|FG001|Overall Study|Lost to Follow-up|2|||
156877824|NCT02938520|566310733|FG000|Overall Study|Withdrawal by Subject|7|||
156877825|NCT02938520|566310734|FG001|Overall Study|Withdrawal by Subject|7|||
156741685|NCT01801358|565802476|FG005|Overall Study|Withdrawal by Subject|2|||
156877826|NCT02938520|566310733|FG000|Overall Study|Protocol Violation|0|||
156877827|NCT02938520|566310734|FG001|Overall Study|Protocol Violation|1|||
156877828|NCT02938520|566310733|FG000|Overall Study|Lack of Efficacy|5|||
156877829|NCT02938520|566310734|FG001|Overall Study|Lack of Efficacy|3|||
156877830|NCT02938520|566310733|FG000|Overall Study|Adverse Event|9|||
156741686|NCT01527487|565802477|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
156741687|NCT01527487|565802478|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
156741688|NCT01527487|565802477|FG000|Overall Study|Disease Progression|4|||
156741689|NCT01527487|565802478|FG001|Overall Study|Disease Progression|1|||
156741690|NCT01527487|565802477|FG000|Overall Study|Adverse Event|1|||
156741691|NCT01527487|565802478|FG001|Overall Study|Adverse Event|1|||
156741692|NCT01527487|565802477|FG000|Overall Study|Death|0|||
156741693|NCT01527487|565802478|FG001|Overall Study|Death|1|||
156741694|NCT01472757|565802481|FG000|Overall Study|Withdrawal by Subject|1|||
156741695|NCT01472757|565802482|FG001|Overall Study|Withdrawal by Subject|2|||
156741696|NCT01472757|565802483|FG002|Overall Study|Withdrawal by Subject|2|||
156741697|NCT01472757|565802484|FG003|Overall Study|Withdrawal by Subject|0|||
156741698|NCT01472757|565802481|FG000|Overall Study|Asthma exacerbation|4|||
156741699|NCT01472757|565802482|FG001|Overall Study|Asthma exacerbation|1|||
156741700|NCT01472757|565802483|FG002|Overall Study|Asthma exacerbation|2|||
156741701|NCT01472757|565802484|FG003|Overall Study|Asthma exacerbation|1|||
156741702|NCT01472757|565802481|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
156741703|NCT01472757|565802482|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
156741704|NCT01472757|565802483|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
156741705|NCT01472757|565802484|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
156741706|NCT01472757|565802481|FG000|Overall Study|Protocol Violation|3|||
156741707|NCT01472757|565802482|FG001|Overall Study|Protocol Violation|2|||
156741708|NCT01472757|565802483|FG002|Overall Study|Protocol Violation|4|||
156741709|NCT01472757|565802484|FG003|Overall Study|Protocol Violation|4|||
156741710|NCT01472757|565802481|FG000|Overall Study|Other reasons|1|||
156741711|NCT01472757|565802482|FG001|Overall Study|Other reasons|0|||
156741712|NCT01472757|565802483|FG002|Overall Study|Other reasons|2|||
156741713|NCT01472757|565802484|FG003|Overall Study|Other reasons|2|||
156741714|NCT02505334|565802485|FG000|Main Treatment Period|Adverse Event|3|||
156741715|NCT02505334|565802486|FG001|Main Treatment Period|Adverse Event|3|||
156741716|NCT02505334|565802485|FG000|Main Treatment Period|Lack of Efficacy|7|||
156741717|NCT02505334|565802486|FG001|Main Treatment Period|Lack of Efficacy|17|||
156741718|NCT02505334|565802485|FG000|Main Treatment Period|Protocol Violation|0|||
156741719|NCT02505334|565802486|FG001|Main Treatment Period|Protocol Violation|1|||
156741720|NCT02505334|565802485|FG000|Main Treatment Period|Withdrawal by Subject|1|||
156741721|NCT02505334|565802486|FG001|Main Treatment Period|Withdrawal by Subject|8|||
156741722|NCT02505334|565802485|FG000|Main Treatment Period|Unclassified|4|||
156741723|NCT02505334|565802486|FG001|Main Treatment Period|Unclassified|10|||
156797757|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797758|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
156797759|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
156797760|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
156797761|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
156797762|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
156797763|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
156797764|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
156797765|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
156797766|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
156797767|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
156797768|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
156797769|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
156797770|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
156797771|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
156797772|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
156797773|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
156797774|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
156797775|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
156797776|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
156797777|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
156797778|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
156797779|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797780|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797781|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797782|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156741724|NCT02505334|565802485|FG000|Extension Treatment Period|Adverse Event|5|||
156741725|NCT02505334|565802486|FG001|Extension Treatment Period|Adverse Event|0|||
156741726|NCT02505334|565802485|FG000|Extension Treatment Period|Lack of Efficacy|4|||
156741727|NCT02505334|565802486|FG001|Extension Treatment Period|Lack of Efficacy|0|||
156741728|NCT02505334|565802485|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
156741729|NCT02505334|565802486|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
156741730|NCT02505334|565802485|FG000|Extension Treatment Period|Unclassified|3|||
156797783|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156741731|NCT02505334|565802486|FG001|Extension Treatment Period|Unclassified|0|||
156877831|NCT02938520|566310734|FG001|Overall Study|Adverse Event|4|||
156741732|NCT00597506|565802489|FG000|Overall Study|Subject is being followed for survival|1|||
156741733|NCT00081731|565802492|FG000|Overall Study|scientific integrity issue|8|||
156741734|NCT00081731|565802493|FG001|Overall Study|scientific integrity issue|8|||
156741735|NCT01629823|565802494|FG000|Trial Period|Missed visit|11|||
156741736|NCT01629823|565802495|FG001|Trial Period|Missed visit|9|||
156741737|NCT01629823|565802496|FG002|Trial Period|Missed visit|8|||
156741738|NCT01629823|565802494|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
156741739|NCT01629823|565802495|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
156741740|NCT01629823|565802496|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
156741741|NCT01629823|565802494|FG000|Trial Period|Pregnancy|1|||
156741742|NCT01629823|565802495|FG001|Trial Period|Pregnancy|0|||
156741743|NCT01629823|565802496|FG002|Trial Period|Pregnancy|0|||
156741744|NCT01629823|565802494|FG000|Trial Period|Adverse Event|0|||
156741745|NCT01629823|565802495|FG001|Trial Period|Adverse Event|1|||
156741746|NCT01629823|565802496|FG002|Trial Period|Adverse Event|0|||
156741747|NCT01629823|565802494|FG000|Trial Period|Out-of-window visit|0|||
156741748|NCT01629823|565802495|FG001|Trial Period|Out-of-window visit|2|||
156741749|NCT01629823|565802496|FG002|Trial Period|Out-of-window visit|0|||
156741750|NCT01629823|565802494|FG000|Trial Period|Failed to hold medication|0|||
156741751|NCT01629823|565802495|FG001|Trial Period|Failed to hold medication|0|||
156741752|NCT01629823|565802496|FG002|Trial Period|Failed to hold medication|1|||
156741753|NCT01629823|565802494|FG000|Washout Period|Safety|2|||
156741754|NCT01629823|565802495|FG001|Washout Period|Safety|5|||
156741755|NCT01629823|565802496|FG002|Washout Period|Safety|0|||
156741756|NCT01629823|565802494|FG000|Washout Period|Pregnancy|1|||
156741757|NCT01629823|565802495|FG001|Washout Period|Pregnancy|0|||
156741758|NCT01629823|565802496|FG002|Washout Period|Pregnancy|0|||
156741759|NCT01629823|565802494|FG000|Washout Period|Protocol Violation|0|||
156741760|NCT01629823|565802495|FG001|Washout Period|Protocol Violation|1|||
156741761|NCT01629823|565802496|FG002|Washout Period|Protocol Violation|0|||
156741762|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
156741763|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
156741764|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
156741765|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
156741766|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
156741767|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
156741768|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
156741769|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
156741770|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
156741771|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
156741772|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|All other|33|||
156741773|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|All other|0|||
156741774|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
156741775|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
156741776|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
156741777|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
156741778|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
156741779|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
156741780|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
156741781|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
156741782|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
156741783|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
156741784|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
156741785|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
156741786|NCT03235115|565802502|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741787|NCT03235115|565802503|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741788|NCT03235115|565802504|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741789|NCT03235115|565802505|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741790|NCT03235115|565802506|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741791|NCT03235115|565802507|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
156741792|NCT00503997|565802509|FG000|Overall Study|disease progression|1|||
156741793|NCT00503997|565802509|FG000|Overall Study|Adverse Event|5|||
156741794|NCT00503997|565802509|FG000|Overall Study|Death|1|||
156741795|NCT00503997|565802509|FG000|Overall Study|Withdrawal by Subject|1|||
156741796|NCT01195844|565802510|FG000|Overall Study|Fecal sample not collected|40|||
156741797|NCT05020899|565802511|FG000|8 Week Follow-up|Lost to Follow-up|3|||
156458458|NCT05218096|564774770|FG001|Primary Evaluation|Withdrawal by Subject|0|||
156741798|NCT05020899|565802512|FG001|8 Week Follow-up|Lost to Follow-up|6|||
156741799|NCT05020899|565802511|FG000|12 Week Follow-up|Lost to Follow-up|1|||
156741800|NCT05020899|565802512|FG001|12 Week Follow-up|Lost to Follow-up|0|||
156741801|NCT05020899|565802511|FG000|12 Week Follow-up|Death|0|||
156741802|NCT05020899|565802512|FG001|12 Week Follow-up|Death|1|||
156336939|NCT00932126|564331417|FG003|Overall Study|Other|0|||
156877832|NCT05379023|566311207|FG000|Overall Study|Lost to Follow-up|1|||
156877833|NCT05379023|566311208|FG001|Overall Study|Lost to Follow-up|0|||
156877834|NCT05379023|566311209|FG002|Overall Study|Lost to Follow-up|0|||
156877835|NCT05379023|566311207|FG000|Overall Study|Withdrawal by Subject|2|||
156877836|NCT05379023|566311208|FG001|Overall Study|Withdrawal by Subject|0|||
156877837|NCT05379023|566311209|FG002|Overall Study|Withdrawal by Subject|0|||
156877838|NCT04569084|566311213|FG000|Overall Study|Adverse Event|10|||
156877839|NCT04569084|566311214|FG001|Overall Study|Adverse Event|14|||
156877840|NCT04569084|566311213|FG000|Overall Study|Death|2|||
156877841|NCT04569084|566311214|FG001|Overall Study|Death|3|||
156877842|NCT04569084|566311213|FG000|Overall Study|Lost to Follow-up|1|||
156877843|NCT04569084|566311214|FG001|Overall Study|Lost to Follow-up|1|||
156877844|NCT04569084|566311213|FG000|Overall Study|Physician Decision|3|||
156877845|NCT04569084|566311214|FG001|Overall Study|Physician Decision|3|||
156877846|NCT04569084|566311213|FG000|Overall Study|Protocol Violation|2|||
156877847|NCT04569084|566311214|FG001|Overall Study|Protocol Violation|1|||
156877848|NCT04569084|566311213|FG000|Overall Study|Withdrawal by Subject|20|||
156877849|NCT04569084|566311214|FG001|Overall Study|Withdrawal by Subject|21|||
156877850|NCT04569084|566311213|FG000|Overall Study|Study terminated by sponsor|26|||
156877851|NCT04569084|566311214|FG001|Overall Study|Study terminated by sponsor|23|||
156877852|NCT04569084|566311213|FG000|Overall Study|Other|3|||
156877853|NCT04569084|566311214|FG001|Overall Study|Other|5|||
156877854|NCT05147662|566311215|FG000|Overall Study|Withdrawal by parent/guardian|3|||
156877855|NCT05147662|566311215|FG000|Overall Study|Assigned to treatment but never treated|1|||
156877856|NCT02951052|566311218|FG000|Overall Study|Adverse Event|13|||
156877857|NCT02951052|566311219|FG001|Overall Study|Adverse Event|5|||
156877858|NCT02951052|566311218|FG000|Overall Study|Withdrawal by Subject|1|||
156741803|NCT01068626|565802515|FG000|Overall Study|Adverse Event|3|||
156877859|NCT02951052|566311219|FG001|Overall Study|Withdrawal by Subject|5|||
156741804|NCT01068626|565802516|FG001|Overall Study|Adverse Event|0|||
156741805|NCT01068626|565802515|FG000|Overall Study|Withdrawal by Subject|0|||
156741806|NCT01068626|565802516|FG001|Overall Study|Withdrawal by Subject|2|||
156741807|NCT01785849|565802517|FG000|Overall Study|Death|7|||
156741808|NCT01785849|565802518|FG001|Overall Study|Death|9|||
156741809|NCT01785849|565802517|FG000|Overall Study|Protocol Specified Criteria|29|||
156741810|NCT01785849|565802518|FG001|Overall Study|Protocol Specified Criteria|1|||
156741811|NCT01785849|565802517|FG000|Overall Study|Withdrawal by Subject|15|||
156741812|NCT01785849|565802518|FG001|Overall Study|Withdrawal by Subject|12|||
156741813|NCT01785849|565802517|FG000|Overall Study|Sponsor Decision|0|||
156877860|NCT02951052|566311218|FG000|Overall Study|Physician Decision|2|||
156877861|NCT02951052|566311219|FG001|Overall Study|Physician Decision|0|||
156877862|NCT02951052|566311218|FG000|Overall Study|Lost to Follow-up|1|||
156877863|NCT02951052|566311219|FG001|Overall Study|Lost to Follow-up|1|||
156877864|NCT02951052|566311218|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
156877865|NCT02951052|566311219|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
156877866|NCT02951052|566311218|FG000|Overall Study|Protocol Violation|5|||
156877867|NCT02951052|566311219|FG001|Overall Study|Protocol Violation|3|||
156877868|NCT02951052|566311218|FG000|Overall Study|Lack of Efficacy|3|||
156877869|NCT02951052|566311219|FG001|Overall Study|Lack of Efficacy|4|||
156877870|NCT02951052|566311218|FG000|Overall Study|Ongoing|1|||
156877871|NCT02951052|566311219|FG001|Overall Study|Ongoing|0|||
156877872|NCT04577404|566311220|FG000|Overall Study|Adverse Event|31|||
156877873|NCT04577404|566311220|FG000|Overall Study|Death|1|||
156877874|NCT04577404|566311220|FG000|Overall Study|Lack of Efficacy|3|||
156877875|NCT04577404|566311220|FG000|Overall Study|Physician Decision|7|||
156877876|NCT04577404|566311220|FG000|Overall Study|Withdrawal by Subject|21|||
156877877|NCT04577404|566311220|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
156877878|NCT05468320|566311221|FG000|Overall Study|Other|1|||
156877879|NCT05468320|566311221|FG000|Overall Study|Adverse Event|1|||
156877880|NCT03921554|566311222|FG000|Overall Study|Adverse Event|2|||
156877881|NCT03921554|566311222|FG000|Overall Study|Withdrawal by Subject|1|||
156877882|NCT03921554|566311222|FG000|Overall Study|Death|3|||
156458459|NCT05218096|564774771|FG002|Primary Evaluation|Withdrawal by Subject|2|||
156458460|NCT05218096|564774772|FG003|Primary Evaluation|Withdrawal by Subject|0|||
156741814|NCT01785849|565802518|FG001|Overall Study|Sponsor Decision|1|||
156741815|NCT01785849|565802517|FG000|Overall Study|Lost to Follow-up|10|||
156741816|NCT01785849|565802518|FG001|Overall Study|Lost to Follow-up|11|||
156741817|NCT01032239|565802519|FG000|Overall Study|Lost to Follow-up|3|||
156877883|NCT04440592|566311223|FG000|Overall Study|Adverse Event|8|||
156877884|NCT04440592|566311224|FG001|Overall Study|Adverse Event|0|||
156877885|NCT04440592|566311223|FG000|Overall Study|Lost to Follow-up|1|||
156877886|NCT04440592|566311224|FG001|Overall Study|Lost to Follow-up|0|||
156877887|NCT04440592|566311223|FG000|Overall Study|Withdrawal by Subject|1|||
156877888|NCT04440592|566311224|FG001|Overall Study|Withdrawal by Subject|1|||
156877889|NCT04440592|566311223|FG000|Overall Study|Other therapy needed|0|||
156877890|NCT04440592|566311224|FG001|Overall Study|Other therapy needed|1|||
156877891|NCT06173063|566311225|FG000|Overall Study|Withdrawal by Subject|2|||
156877892|NCT03820947|566311226|FG000|Overall Study|Physician Decision|0|||
156877893|NCT03820947|566311227|FG001|Overall Study|Physician Decision|1|||
156336940|NCT00932126|564331418|FG004|Overall Study|Other|1|||
156336941|NCT00932126|564331419|FG005|Overall Study|Other|0|||
156336942|NCT00932126|564331420|FG006|Overall Study|Other|1|||
156336943|NCT00932126|564331421|FG007|Overall Study|Other|2|||
156336944|NCT02716805|564331422|FG000|Overall Study|Progressive disease|2|||
156336945|NCT02716805|564331423|FG001|Overall Study|Progressive disease|0|||
156336946|NCT02716805|564331424|FG002|Overall Study|Progressive disease|0|||
156336947|NCT02716805|564331425|FG003|Overall Study|Progressive disease|0|||
156336948|NCT00066365|564331426|FG000|Overall Study|Adverse Event|1|||
156336949|NCT00066365|564331427|FG001|Overall Study|Adverse Event|0|||
156741818|NCT01032239|565802520|FG001|Overall Study|Lost to Follow-up|2|||
156741819|NCT01032239|565802519|FG000|Overall Study|Withdrawal by Subject|2|||
156741820|NCT01032239|565802520|FG001|Overall Study|Withdrawal by Subject|3|||
156741821|NCT01032239|565802519|FG000|Overall Study|Death|1|||
156741822|NCT01032239|565802520|FG001|Overall Study|Death|0|||
156741823|NCT01032239|565802519|FG000|Overall Study|Protocol Violation|1|||
156741824|NCT01032239|565802520|FG001|Overall Study|Protocol Violation|0|||
156741825|NCT01940900|565802521|FG000|Overall Study|Physician Decision|4|||
156741826|NCT01940900|565802522|FG001|Overall Study|Physician Decision|0|||
156741827|NCT01940900|565802521|FG000|Overall Study|Adverse Event|10|||
156741828|NCT01940900|565802522|FG001|Overall Study|Adverse Event|15|||
156741829|NCT01940900|565802521|FG000|Overall Study|Withdrawal by Subject|11|||
156741830|NCT01940900|565802522|FG001|Overall Study|Withdrawal by Subject|15|||
156741831|NCT01940900|565802521|FG000|Overall Study|Lost to Follow-up|1|||
156741832|NCT01940900|565802522|FG001|Overall Study|Lost to Follow-up|0|||
156741833|NCT01940900|565802521|FG000|Overall Study|Sponsor Decision|1|||
156741834|NCT01940900|565802522|FG001|Overall Study|Sponsor Decision|0|||
156797784|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797785|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797786|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797787|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797788|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797789|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797790|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797791|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797792|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
156797793|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797794|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797795|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797796|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797797|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797798|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797799|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797800|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797801|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797802|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797803|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797804|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797805|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797806|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797807|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797808|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
156797809|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797810|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797811|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797812|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797813|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797814|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797815|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797816|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797817|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797818|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156336950|NCT00066365|564331426|FG000|Overall Study|Lack of Efficacy|15|||
156336951|NCT00066365|564331427|FG001|Overall Study|Lack of Efficacy|12|||
156336952|NCT00066365|564331426|FG000|Overall Study|Physician Decision|1|||
156336953|NCT00066365|564331427|FG001|Overall Study|Physician Decision|0|||
156336954|NCT00066365|564331426|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
156741835|NCT01940900|565802521|FG000|Overall Study|subject non-compliance|1|||
156741836|NCT01940900|565802522|FG001|Overall Study|subject non-compliance|1|||
156741837|NCT01940900|565802521|FG000|Overall Study|other|1|||
156877894|NCT03820947|566311228|FG002|Overall Study|Physician Decision|1|||
156877895|NCT03820947|566311229|FG003|Overall Study|Physician Decision|0|||
156877896|NCT03820947|566311230|FG004|Overall Study|Physician Decision|3|||
156877897|NCT03820947|566311226|FG000|Overall Study|Withdrawal by Subject|6|||
156877898|NCT03820947|566311227|FG001|Overall Study|Withdrawal by Subject|10|||
156877899|NCT03820947|566311228|FG002|Overall Study|Withdrawal by Subject|3|||
156877900|NCT03820947|566311229|FG003|Overall Study|Withdrawal by Subject|8|||
156877901|NCT03820947|566311230|FG004|Overall Study|Withdrawal by Subject|5|||
156877902|NCT03820947|566311226|FG000|Overall Study|Procedure Not Attempted|0|||
156877903|NCT03820947|566311227|FG001|Overall Study|Procedure Not Attempted|2|||
156877904|NCT03820947|566311228|FG002|Overall Study|Procedure Not Attempted|1|||
156877905|NCT03820947|566311229|FG003|Overall Study|Procedure Not Attempted|0|||
156877906|NCT03820947|566311230|FG004|Overall Study|Procedure Not Attempted|0|||
156877907|NCT03820947|566311226|FG000|Overall Study|Other Exit|1|||
156877908|NCT03820947|566311227|FG001|Overall Study|Other Exit|3|||
156877909|NCT03820947|566311228|FG002|Overall Study|Other Exit|3|||
156877910|NCT03820947|566311229|FG003|Overall Study|Other Exit|3|||
156877911|NCT03820947|566311230|FG004|Overall Study|Other Exit|0|||
156877912|NCT03820947|566311226|FG000|Overall Study|Follow-up Not Done|10|||
156877913|NCT03820947|566311227|FG001|Overall Study|Follow-up Not Done|13|||
156877914|NCT03820947|566311228|FG002|Overall Study|Follow-up Not Done|2|||
156877915|NCT03820947|566311229|FG003|Overall Study|Follow-up Not Done|3|||
156877916|NCT03820947|566311230|FG004|Overall Study|Follow-up Not Done|12|||
156877917|NCT03820947|566311226|FG000|Overall Study|Death|0|||
156877918|NCT03820947|566311227|FG001|Overall Study|Death|0|||
156877919|NCT03820947|566311228|FG002|Overall Study|Death|0|||
156877920|NCT03820947|566311229|FG003|Overall Study|Death|0|||
156877921|NCT03820947|566311230|FG004|Overall Study|Death|9|||
156877922|NCT03820947|566311226|FG000|Overall Study|Lost to Follow-up|4|||
156877923|NCT03820947|566311227|FG001|Overall Study|Lost to Follow-up|6|||
156877924|NCT03820947|566311228|FG002|Overall Study|Lost to Follow-up|0|||
156877925|NCT03820947|566311229|FG003|Overall Study|Lost to Follow-up|0|||
156877926|NCT03820947|566311230|FG004|Overall Study|Lost to Follow-up|9|||
156877927|NCT03626857|566311346|FG000|Overall Study|Adverse Event|9|||
156877928|NCT03626857|566311347|FG001|Overall Study|Adverse Event|7|||
156877929|NCT03626857|566311346|FG000|Overall Study|Lost to Follow-up|8|||
156877930|NCT03626857|566311347|FG001|Overall Study|Lost to Follow-up|8|||
156877931|NCT03626857|566311346|FG000|Overall Study|Withdrawal by Subject|2|||
156877932|NCT03626857|566311347|FG001|Overall Study|Withdrawal by Subject|2|||
156877933|NCT03626857|566311346|FG000|Overall Study|Protocol Violation|1|||
156877934|NCT03626857|566311347|FG001|Overall Study|Protocol Violation|3|||
156877935|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
156877936|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
156877937|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
156877938|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
156877939|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
156877940|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
156877941|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
156877942|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
156877943|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
156877944|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
156877945|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
156877946|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
156877947|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
156877948|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
156534862|NCT01791803|565052489|FG002|Overall Study|Withdrawal by Subject|0|||
156534863|NCT01791803|565052490|FG003|Overall Study|Withdrawal by Subject|2|||
156534864|NCT01791803|565052487|FG000|Overall Study|Physician Decision|0|||
156534865|NCT01791803|565052488|FG001|Overall Study|Physician Decision|2|||
156534866|NCT01791803|565052489|FG002|Overall Study|Physician Decision|0|||
156534867|NCT01791803|565052490|FG003|Overall Study|Physician Decision|1|||
156534868|NCT01791803|565052487|FG000|Overall Study|Death|0|||
156534869|NCT01791803|565052488|FG001|Overall Study|Death|0|||
156534870|NCT01791803|565052489|FG002|Overall Study|Death|2|||
156534871|NCT01791803|565052490|FG003|Overall Study|Death|2|||
156534872|NCT04572854|565052491|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
156534873|NCT04572854|565052492|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
156534874|NCT04572854|565052493|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
156534875|NCT04572854|565052494|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
156534876|NCT04572854|565052491|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
156741838|NCT01940900|565802522|FG001|Overall Study|other|0|||
156877949|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
156877950|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
156877951|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
156741839|NCT00204477|565802523|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
156741840|NCT00204477|565802524|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
156741841|NCT00204477|565802523|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
156741842|NCT00204477|565802524|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
156741843|NCT04713592|565802527|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
156741844|NCT04713592|565802528|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
156741845|NCT04713592|565802529|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
156741846|NCT04713592|565802530|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
156741847|NCT04713592|565802527|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
156741848|NCT04713592|565802528|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
156741849|NCT04713592|565802529|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
156741850|NCT04713592|565802530|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
156741851|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
156741852|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
156741853|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
156741854|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
156741855|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156741856|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156741857|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
156741858|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
156741859|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
156741860|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
156741861|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
156741862|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
156741863|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156741864|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156741865|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
156741866|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
156741867|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
156741868|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
156741869|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
156741870|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
156741871|NCT03782298|565802535|FG000|Overall Study|Protocol Deviation|4|||
156741872|NCT00742508|565802536|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
156741873|NCT00742508|565802537|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
156741874|NCT00742508|565802536|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
156741875|NCT00742508|565802537|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
156741876|NCT00742508|565802536|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
156741877|NCT00742508|565802537|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
156741878|NCT00742508|565802536|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
156741879|NCT00742508|565802537|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
156741880|NCT00742508|565802536|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
156741881|NCT00742508|565802537|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
156741882|NCT01382225|565802538|FG000|Overall Study|Adverse Event|3|||
156741883|NCT01382225|565802539|FG001|Overall Study|Adverse Event|2|||
156741884|NCT01382225|565802538|FG000|Overall Study|Protocol Violation|2|||
156741885|NCT01382225|565802539|FG001|Overall Study|Protocol Violation|1|||
156741886|NCT01382225|565802538|FG000|Overall Study|Subject Withdrew Consent|5|||
156741887|NCT01382225|565802539|FG001|Overall Study|Subject Withdrew Consent|2|||
156741888|NCT01382225|565802538|FG000|Overall Study|Other|4|||
156741889|NCT01382225|565802539|FG001|Overall Study|Other|2|||
156741890|NCT01797081|565802540|FG000|Overall Study|Adverse Event|1|||
156741891|NCT01797081|565802541|FG001|Overall Study|Adverse Event|0|||
156741892|NCT01797081|565802542|FG002|Overall Study|Adverse Event|1|||
156741893|NCT01797081|565802543|FG003|Overall Study|Adverse Event|0|||
156741894|NCT01797081|565802540|FG000|Overall Study|Pregnancy|1|||
156741895|NCT01797081|565802541|FG001|Overall Study|Pregnancy|0|||
156741896|NCT01797081|565802542|FG002|Overall Study|Pregnancy|0|||
156741897|NCT01797081|565802543|FG003|Overall Study|Pregnancy|0|||
156741898|NCT01797081|565802540|FG000|Overall Study|Personal Reasons|12|||
156797819|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797820|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
156797821|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797822|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797823|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156336955|NCT00066365|564331427|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
156336956|NCT00066365|564331426|FG000|Overall Study|Ineligible|4|||
156741899|NCT01797081|565802541|FG001|Overall Study|Personal Reasons|4|||
156741900|NCT01797081|565802542|FG002|Overall Study|Personal Reasons|4|||
156741901|NCT01797081|565802543|FG003|Overall Study|Personal Reasons|8|||
156741902|NCT01797081|565802540|FG000|Overall Study|Protocol Violation|0|||
156741903|NCT01797081|565802541|FG001|Overall Study|Protocol Violation|0|||
156741904|NCT01797081|565802542|FG002|Overall Study|Protocol Violation|0|||
156741905|NCT01797081|565802543|FG003|Overall Study|Protocol Violation|1|||
156741906|NCT05513703|565802552|FG000|Overall Study|Death|4|||
156797824|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797825|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797826|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797827|NCT01309230|566013395|FG000|Overall Study|Withdrawal by Subject|0|||
156797828|NCT01309230|566013396|FG001|Overall Study|Withdrawal by Subject|2|||
156797829|NCT01309230|566013395|FG000|Overall Study|Observation arm closed|0|||
156797830|NCT01309230|566013396|FG001|Overall Study|Observation arm closed|2|||
156797831|NCT02661815|566013397|FG000|Overall Study|Withdrawal by Subject|1|||
156797832|NCT02661815|566013398|FG001|Overall Study|Withdrawal by Subject|0|||
156797833|NCT02661815|566013399|FG002|Overall Study|Withdrawal by Subject|0|||
156797834|NCT02661815|566013400|FG003|Overall Study|Withdrawal by Subject|0|||
156797835|NCT03078868|566013406|FG000|Overall Study|Physician Decision|3|||
156797836|NCT03038620|566013407|FG000|Overall Study|Lost to Follow-up|18|||
156797837|NCT03038620|566013408|FG001|Overall Study|Lost to Follow-up|23|||
156797838|NCT03038620|566013407|FG000|Overall Study|Withdrawal by Subject|0|||
156797839|NCT03038620|566013408|FG001|Overall Study|Withdrawal by Subject|15|||
156797840|NCT03038620|566013407|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
156797841|NCT03038620|566013408|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
156797842|NCT00105066|566013409|FG000|Overall Study|Adverse Event|2|||
156797843|NCT00105066|566013410|FG001|Overall Study|Adverse Event|5|||
156797844|NCT03261505|566013419|FG000|Overall Study|Withdrawal by Subject|2|||
156877952|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
156877953|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
156877954|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
156877955|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
156877956|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
156877957|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
156877958|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
156877959|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
156877960|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
156877961|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
156877962|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
156877963|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
156877964|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
156877965|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
156877966|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
156877967|NCT03602859|566311348|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
156877968|NCT03602859|566311349|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
156877969|NCT03602859|566311350|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
156877970|NCT03602859|566311351|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
156877971|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
156877972|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
156877973|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
156877974|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
156877975|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
156877976|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
156877977|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
156877978|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
156877979|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
156741907|NCT05513703|565802552|FG000|Overall Study|Study terminated by sponsor|5|||
156741908|NCT02484651|565802554|FG000|Overall Study|Patients' data files were corrupted.|1|||
156741909|NCT02484651|565802555|FG001|Overall Study|Patients' data files were corrupted.|1|||
156741910|NCT02484651|565802554|FG000|Overall Study|BIS monitoring failed.|1|||
156741911|NCT02484651|565802555|FG001|Overall Study|BIS monitoring failed.|1|||
156741912|NCT02484651|565802554|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
156797845|NCT03261505|566013420|FG001|Overall Study|Withdrawal by Subject|3|||
156797846|NCT03261505|566013421|FG002|Overall Study|Withdrawal by Subject|4|||
156797847|NCT03261505|566013422|FG003|Overall Study|Withdrawal by Subject|3|||
156797848|NCT03261505|566013419|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
156797849|NCT03261505|566013420|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
156797850|NCT03261505|566013421|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
156741913|NCT02484651|565802555|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
156741914|NCT03619902|565802557|FG000|Overall Study|Termination of Study by Investigator|1|||
156741915|NCT03619902|565802557|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
156741916|NCT02537431|565802560|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
156741917|NCT02278120|565802562|FG000|Treatment Period|Progressive disease|234|||
156741918|NCT02278120|565802563|FG001|Treatment Period|Progressive disease|260|||
156741919|NCT02278120|565802562|FG000|Treatment Period|Subject/guardian decision|23|||
156741920|NCT02278120|565802563|FG001|Treatment Period|Subject/guardian decision|20|||
156741921|NCT02278120|565802562|FG000|Treatment Period|Adverse Event|16|||
156741922|NCT02278120|565802563|FG001|Treatment Period|Adverse Event|14|||
156741923|NCT02278120|565802562|FG000|Treatment Period|Physician Decision|14|||
156741924|NCT02278120|565802563|FG001|Treatment Period|Physician Decision|27|||
156741925|NCT02278120|565802562|FG000|Treatment Period|Death|3|||
156741926|NCT02278120|565802563|FG001|Treatment Period|Death|3|||
156741927|NCT02278120|565802562|FG000|Treatment Period|Lost to Follow-up|2|||
156741928|NCT02278120|565802563|FG001|Treatment Period|Lost to Follow-up|0|||
156741929|NCT02278120|565802562|FG000|Treatment Period|Protocol deviation|0|||
156741930|NCT02278120|565802563|FG001|Treatment Period|Protocol deviation|2|||
156741931|NCT02278120|565802562|FG000|Treatment Period|Study terminated as per protocol|43|||
156741932|NCT02278120|565802563|FG001|Treatment Period|Study terminated as per protocol|11|||
156741933|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Death|0|||
156741934|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Death|1|||
156741935|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
156741936|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156741937|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
156741938|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
156741939|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
156741940|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
156741941|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156741942|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156741943|NCT03197324|565802567|FG000|Overall Study|Adverse Event|0|||
156741944|NCT03197324|565802568|FG001|Overall Study|Adverse Event|1|||
156741945|NCT00102531|565802569|FG000|Overall Study|Adverse Event|0|||
156741946|NCT00102531|565802570|FG001|Overall Study|Adverse Event|1|||
156741947|NCT00102531|565802569|FG000|Overall Study|Disease Progression|5|||
156741948|NCT00102531|565802570|FG001|Overall Study|Disease Progression|9|||
156741949|NCT00102531|565802569|FG000|Overall Study|Physician Decision|0|||
156741950|NCT00102531|565802570|FG001|Overall Study|Physician Decision|1|||
156741951|NCT04216589|565802575|FG000|Overall Study|Withdrawal by Subject|2|||
156741952|NCT04216589|565802575|FG000|Overall Study|Protocol Violation|1|||
156741953|NCT04216589|565802575|FG000|Overall Study|Incarceration|1|||
156741954|NCT04676412|565803839|FG000|Overall Study|Death|28|||
156741955|NCT04676412|565803840|FG001|Overall Study|Death|31|||
156741956|NCT04676412|565803839|FG000|Overall Study|Lost to Follow-up|1|||
156741957|NCT04676412|565803840|FG001|Overall Study|Lost to Follow-up|2|||
156741958|NCT04676412|565803839|FG000|Overall Study|Sponsor Decision|20|||
156741959|NCT04676412|565803840|FG001|Overall Study|Sponsor Decision|23|||
156741960|NCT04676412|565803839|FG000|Overall Study|Withdrawal by Subject|0|||
156741961|NCT04676412|565803840|FG001|Overall Study|Withdrawal by Subject|2|||
156741962|NCT00250458|565803842|FG000|Overall Study|Lost to Follow-up|4|||
156741963|NCT00250458|565803843|FG001|Overall Study|Lost to Follow-up|2|||
156741964|NCT00250458|565803842|FG000|Overall Study|Protocol Violation|0|||
156741965|NCT00250458|565803843|FG001|Overall Study|Protocol Violation|1|||
156741966|NCT00250458|565803842|FG000|Overall Study|Withdrawal by Subject|4|||
156741967|NCT00250458|565803843|FG001|Overall Study|Withdrawal by Subject|2|||
156741968|NCT00250458|565803842|FG000|Overall Study|Lack of Migraine Attack|20|||
156741969|NCT00250458|565803843|FG001|Overall Study|Lack of Migraine Attack|9|||
156741970|NCT00250458|565803842|FG000|Overall Study|Qualifying migraine but did not treat|3|||
156741971|NCT00250458|565803843|FG001|Overall Study|Qualifying migraine but did not treat|3|||
156741972|NCT00250458|565803842|FG000|Overall Study|Other|1|||
156741973|NCT00250458|565803843|FG001|Overall Study|Other|0|||
156741974|NCT01892085|565803846|FG000|Overall Study|Death|4|||
156741975|NCT01892085|565803847|FG001|Overall Study|Death|1|||
156741976|NCT01892085|565803848|FG002|Overall Study|Death|3|||
156741977|NCT01892085|565803846|FG000|Overall Study|Withdrawal by Subject|2|||
156741978|NCT01892085|565803847|FG001|Overall Study|Withdrawal by Subject|0|||
156741979|NCT01892085|565803848|FG002|Overall Study|Withdrawal by Subject|2|||
156741980|NCT00767039|565803849|FG000|Overall Study|Death|5|||
156741981|NCT00767039|565803850|FG001|Overall Study|Death|2|||
156741982|NCT00525902|565803854|FG000|Overall Study|Lack of Efficacy|1|||
156741983|NCT03747302|565803855|FG000|Overall Study|Withdrawal by Subject|1|||
156741984|NCT03747302|565803856|FG001|Overall Study|Withdrawal by Subject|2|||
156741985|NCT00738062|565803859|FG000|Open Label Treatment|Lack of Efficacy|5|||
156741986|NCT00738062|565803860|FG001|Open Label Treatment|Lack of Efficacy|0|||
156336957|NCT00066365|564331427|FG001|Overall Study|Ineligible|2|||
156877980|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
156877981|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
156877982|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
156877983|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
156877984|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
156877985|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
156336958|NCT00467857|564331430|FG000|Overall Study|Adverse Event|1|||
156336959|NCT00467857|564331431|FG001|Overall Study|Adverse Event|0|||
156336960|NCT00467857|564331430|FG000|Overall Study|Withdrew consent|2|||
156336961|NCT00467857|564331431|FG001|Overall Study|Withdrew consent|0|||
156336962|NCT00467857|564331430|FG000|Overall Study|Death|0|||
156336963|NCT00467857|564331431|FG001|Overall Study|Death|1|||
156336964|NCT00467857|564331430|FG000|Overall Study|Discharged from court service|0|||
156336965|NCT00467857|564331431|FG001|Overall Study|Discharged from court service|1|||
156336966|NCT00467857|564331430|FG000|Overall Study|Emergency care required|0|||
156336967|NCT00467857|564331431|FG001|Overall Study|Emergency care required|1|||
156336968|NCT00467857|564331430|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
156336969|NCT00467857|564331431|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
156336970|NCT00467857|564331430|FG000|Overall Study|Discontinuation reason missing|0|||
156336971|NCT00467857|564331431|FG001|Overall Study|Discontinuation reason missing|3|||
156336972|NCT03576495|564331435|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
156336973|NCT03576495|564331436|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
156336974|NCT00516074|564331440|FG000|Overall Study|Adverse Event|0|||
156336975|NCT00516074|564331441|FG001|Overall Study|Adverse Event|1|||
156336976|NCT00516074|564331440|FG000|Overall Study|Subject Decision|4|||
156534877|NCT04572854|565052492|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
156534878|NCT04572854|565052493|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
156741987|NCT00738062|565803861|FG002|Open Label Treatment|Lack of Efficacy|0|||
156877986|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
156741988|NCT00738062|565803859|FG000|Open Label Treatment|Adverse Event|11|||
156741989|NCT00738062|565803860|FG001|Open Label Treatment|Adverse Event|0|||
156741990|NCT00738062|565803861|FG002|Open Label Treatment|Adverse Event|0|||
156741991|NCT00738062|565803859|FG000|Open Label Treatment|Protocol Violation|2|||
156741992|NCT00738062|565803860|FG001|Open Label Treatment|Protocol Violation|0|||
156741993|NCT00738062|565803861|FG002|Open Label Treatment|Protocol Violation|0|||
156741994|NCT00738062|565803859|FG000|Open Label Treatment|Withdrawal by Subject|9|||
156741995|NCT00738062|565803860|FG001|Open Label Treatment|Withdrawal by Subject|0|||
156741996|NCT00738062|565803861|FG002|Open Label Treatment|Withdrawal by Subject|0|||
156741997|NCT00738062|565803859|FG000|Open Label Treatment|Investigator Decision|1|||
156741998|NCT00738062|565803860|FG001|Open Label Treatment|Investigator Decision|0|||
156741999|NCT00738062|565803861|FG002|Open Label Treatment|Investigator Decision|0|||
156742000|NCT00738062|565803859|FG000|Open-Label Extension|Adverse Event|5|||
156742001|NCT00738062|565803860|FG001|Open-Label Extension|Adverse Event|0|||
156742002|NCT00738062|565803861|FG002|Open-Label Extension|Adverse Event|0|||
156797851|NCT03261505|566013422|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
156797852|NCT03261505|566013419|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
156797853|NCT03261505|566013420|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
156797854|NCT03261505|566013421|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
156797855|NCT03261505|566013422|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
156797856|NCT03261505|566013419|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
156797857|NCT03261505|566013420|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
156797858|NCT03261505|566013421|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
156797859|NCT03261505|566013422|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
156797860|NCT02231580|566013423|FG000|Overall Study|Adverse Event|5|||
156797861|NCT02231580|566013424|FG001|Overall Study|Adverse Event|0|||
156797862|NCT04079738|566013425|FG000|Study Treatment|Death|1|||
156797863|NCT04079738|566013426|FG001|Study Treatment|Death|0|||
156797864|NCT04079738|566013427|FG002|Study Treatment|Death|0|||
156797865|NCT04079738|566013428|FG003|Study Treatment|Death|0|||
156797866|NCT04079738|566013425|FG000|Study Treatment|Adverse Event|2|||
156797867|NCT04079738|566013426|FG001|Study Treatment|Adverse Event|0|||
156797868|NCT04079738|566013427|FG002|Study Treatment|Adverse Event|0|||
156797869|NCT04079738|566013428|FG003|Study Treatment|Adverse Event|0|||
156797870|NCT04079738|566013425|FG000|Study Treatment|withdrawal before treatment|1|||
156797871|NCT04079738|566013426|FG001|Study Treatment|withdrawal before treatment|0|||
156797872|NCT04079738|566013427|FG002|Study Treatment|withdrawal before treatment|0|||
156797873|NCT04079738|566013428|FG003|Study Treatment|withdrawal before treatment|0|||
156877987|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
156336977|NCT00516074|564331441|FG001|Overall Study|Subject Decision|2|||
156742003|NCT00738062|565803859|FG000|Open-Label Extension|Physician Decision|1|||
156877988|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
156877989|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
156877990|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
156877991|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
156877992|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
156877993|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
156877994|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
156877995|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
156877996|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
156877997|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
156877998|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
156877999|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
156878000|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
156878001|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
156878002|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
156878003|NCT03602859|566311348|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
156878004|NCT03602859|566311349|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
156878005|NCT03602859|566311350|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
156878006|NCT03602859|566311351|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
156878007|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
156878008|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
156878009|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
156878010|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
156878011|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
156878012|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
156878013|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
156878014|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
156878015|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
156878016|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
156878017|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
156878018|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
156878019|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
156878020|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
156878021|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
156878022|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
156878023|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
156878024|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
156878025|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
156878026|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
156878027|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
156878028|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
156878029|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
156742004|NCT00738062|565803860|FG001|Open-Label Extension|Physician Decision|0|||
156742005|NCT00738062|565803861|FG002|Open-Label Extension|Physician Decision|0|||
156742006|NCT00738062|565803859|FG000|Open-Label Extension|Lack of Efficacy|2|||
156742007|NCT00738062|565803860|FG001|Open-Label Extension|Lack of Efficacy|0|||
156742008|NCT00738062|565803861|FG002|Open-Label Extension|Lack of Efficacy|0|||
156742009|NCT00738062|565803859|FG000|Open-Label Extension|Withdrawal by Subject|6|||
156742010|NCT00738062|565803860|FG001|Open-Label Extension|Withdrawal by Subject|0|||
156742011|NCT00738062|565803861|FG002|Open-Label Extension|Withdrawal by Subject|0|||
156878030|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
156878031|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
156878032|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
156878033|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
156878034|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
156878035|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
156878036|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
156878037|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
156878038|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
156878039|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
156878040|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
156878041|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
156878042|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
156878043|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
156534879|NCT04572854|565052494|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
156534880|NCT00972777|565052497|FG000|Overall Study|Adverse Event|3|||
156534881|NCT00972777|565052498|FG001|Overall Study|Adverse Event|2|||
156534882|NCT00972777|565052497|FG000|Overall Study|Lost to Follow-up|0|||
156534883|NCT00972777|565052498|FG001|Overall Study|Lost to Follow-up|4|||
156534884|NCT00972777|565052497|FG000|Overall Study|Withdrawal by Subject|4|||
156534885|NCT00972777|565052498|FG001|Overall Study|Withdrawal by Subject|5|||
156534886|NCT00972777|565052497|FG000|Overall Study|Physician Decision|4|||
156534887|NCT00972777|565052498|FG001|Overall Study|Physician Decision|0|||
156534888|NCT00972777|565052497|FG000|Overall Study|Protocol Violation|0|||
156534889|NCT00972777|565052498|FG001|Overall Study|Protocol Violation|2|||
156534890|NCT00972777|565052497|FG000|Overall Study|Screening Failure|2|||
156534891|NCT00972777|565052498|FG001|Overall Study|Screening Failure|1|||
156534892|NCT00972777|565052497|FG000|Overall Study|Missed visit|1|||
156534893|NCT00972777|565052498|FG001|Overall Study|Missed visit|0|||
156534894|NCT07052682|565052501|FG000|Overall Study|Withdrawal by Subject|4|||
156534895|NCT02246582|565054003|FG000|Overall Study|Withdrawal by Subject|3|||
156534896|NCT02246582|565054004|FG001|Overall Study|Withdrawal by Subject|4|||
156534897|NCT02229539|565054005|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
156534898|NCT02229539|565054006|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
156742012|NCT00738062|565803859|FG000|Open-Label Extension|Protocol Violation|1|||
156742013|NCT00738062|565803860|FG001|Open-Label Extension|Protocol Violation|0|||
156742014|NCT00738062|565803861|FG002|Open-Label Extension|Protocol Violation|0|||
156742015|NCT00738062|565803859|FG000|Open-Label Extension|Study Terminated|2|||
156742016|NCT00738062|565803860|FG001|Open-Label Extension|Study Terminated|0|||
156742017|NCT00738062|565803861|FG002|Open-Label Extension|Study Terminated|0|||
156742018|NCT03488225|565803862|FG000|Overall Study|Off Protocol Therapy|2|||
156742019|NCT03488225|565803862|FG000|Overall Study|Stem Cell Transplant|2|||
156742020|NCT01711619|565803863|FG000|Overall Study|Early study termination|10|||
156742021|NCT01711619|565803864|FG001|Overall Study|Early study termination|14|||
156742022|NCT01711619|565803863|FG000|Overall Study|Withdrawal by Subject|3|||
156742023|NCT01711619|565803864|FG001|Overall Study|Withdrawal by Subject|7|||
156742024|NCT01711619|565803863|FG000|Overall Study|Protocol Violation|2|||
156742025|NCT01711619|565803864|FG001|Overall Study|Protocol Violation|3|||
156742026|NCT01711619|565803863|FG000|Overall Study|Adverse Event|2|||
156742027|NCT01711619|565803864|FG001|Overall Study|Adverse Event|0|||
156742028|NCT01711619|565803863|FG000|Overall Study|Lost to Follow-up|1|||
156742029|NCT01711619|565803864|FG001|Overall Study|Lost to Follow-up|0|||
156742030|NCT00087126|565803868|FG000|Overall Study|Ineligible - second primary|1|||
156742031|NCT00087126|565803868|FG000|Overall Study|Never treated|1|||
156742032|NCT00096993|565803871|FG000|Overall Study|Death|1|||
156742033|NCT00096993|565803872|FG001|Overall Study|Death|0|||
156742034|NCT00096993|565803871|FG000|Overall Study|Disease progression|56|||
156742035|NCT00096993|565803872|FG001|Overall Study|Disease progression|53|||
156742036|NCT00096993|565803871|FG000|Overall Study|Adverse Event|2|||
156742037|NCT00096993|565803872|FG001|Overall Study|Adverse Event|8|||
156742038|NCT00096993|565803871|FG000|Overall Study|Subject's decision|3|||
156742039|NCT00096993|565803872|FG001|Overall Study|Subject's decision|1|||
156742040|NCT00096993|565803871|FG000|Overall Study|Physician Decision|2|||
156742041|NCT00096993|565803872|FG001|Overall Study|Physician Decision|1|||
156742042|NCT00096993|565803871|FG000|Overall Study|Non-compliance|0|||
156742043|NCT00096993|565803872|FG001|Overall Study|Non-compliance|1|||
156742044|NCT00096993|565803871|FG000|Overall Study|Other unspecified|1|||
156742045|NCT00096993|565803872|FG001|Overall Study|Other unspecified|1|||
156742046|NCT01438814|565803875|FG000|Overall Study|Adverse Event|3|||
156742047|NCT01438814|565803876|FG001|Overall Study|Adverse Event|3|||
156742048|NCT01438814|565803875|FG000|Overall Study|Protocol Violation|1|||
156742049|NCT01438814|565803876|FG001|Overall Study|Protocol Violation|2|||
156742050|NCT01438814|565803875|FG000|Overall Study|Lost to Follow-up|4|||
156742051|NCT01438814|565803876|FG001|Overall Study|Lost to Follow-up|3|||
156742052|NCT01438814|565803875|FG000|Overall Study|Withdrawal by Subject|4|||
156742053|NCT01438814|565803876|FG001|Overall Study|Withdrawal by Subject|2|||
156742054|NCT01438814|565803875|FG000|Overall Study|Other|2|||
156742055|NCT01438814|565803876|FG001|Overall Study|Other|4|||
156742056|NCT00195494|565803879|FG000|Year 1|Adverse Event|0|||
156742057|NCT00195494|565803880|FG001|Year 1|Adverse Event|0|||
156742058|NCT00195494|565803881|FG002|Year 1|Adverse Event|0|||
156534899|NCT02229539|565054007|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
156534900|NCT02229539|565054005|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
156534901|NCT02229539|565054006|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
156742059|NCT00195494|565803882|FG003|Year 1|Adverse Event|0|||
156742060|NCT00195494|565803883|FG004|Year 1|Adverse Event|34|||
156742061|NCT00195494|565803884|FG005|Year 1|Adverse Event|27|||
156742062|NCT00195494|565803879|FG000|Year 1|System Toxicity|0|||
156742063|NCT00195494|565803880|FG001|Year 1|System Toxicity|0|||
156742064|NCT00195494|565803881|FG002|Year 1|System Toxicity|0|||
156742065|NCT00195494|565803882|FG003|Year 1|System Toxicity|0|||
156742066|NCT00195494|565803883|FG004|Year 1|System Toxicity|0|||
156742067|NCT00195494|565803884|FG005|Year 1|System Toxicity|1|||
156742068|NCT00195494|565803879|FG000|Year 1|Lack of Efficacy|0|||
156742069|NCT00195494|565803880|FG001|Year 1|Lack of Efficacy|0|||
156742070|NCT00195494|565803881|FG002|Year 1|Lack of Efficacy|0|||
156742071|NCT00195494|565803882|FG003|Year 1|Lack of Efficacy|0|||
156742072|NCT00195494|565803883|FG004|Year 1|Lack of Efficacy|24|||
156742073|NCT00195494|565803884|FG005|Year 1|Lack of Efficacy|9|||
156742074|NCT00195494|565803879|FG000|Year 1|Compliance|0|||
156742075|NCT00195494|565803880|FG001|Year 1|Compliance|0|||
156742076|NCT00195494|565803881|FG002|Year 1|Compliance|0|||
156742077|NCT00195494|565803882|FG003|Year 1|Compliance|0|||
156742078|NCT00195494|565803883|FG004|Year 1|Compliance|5|||
156742079|NCT00195494|565803884|FG005|Year 1|Compliance|1|||
156742080|NCT00195494|565803879|FG000|Year 1|Lost to Follow-up|0|||
156742081|NCT00195494|565803880|FG001|Year 1|Lost to Follow-up|0|||
156742082|NCT00195494|565803881|FG002|Year 1|Lost to Follow-up|0|||
156742083|NCT00195494|565803882|FG003|Year 1|Lost to Follow-up|0|||
156742084|NCT00195494|565803883|FG004|Year 1|Lost to Follow-up|1|||
156742085|NCT00195494|565803884|FG005|Year 1|Lost to Follow-up|0|||
156742086|NCT00195494|565803879|FG000|Year 1|Missed >4 consecutive doses|0|||
156742087|NCT00195494|565803880|FG001|Year 1|Missed >4 consecutive doses|0|||
156742088|NCT00195494|565803881|FG002|Year 1|Missed >4 consecutive doses|0|||
156742089|NCT00195494|565803882|FG003|Year 1|Missed >4 consecutive doses|0|||
156742090|NCT00195494|565803883|FG004|Year 1|Missed >4 consecutive doses|3|||
156742091|NCT00195494|565803884|FG005|Year 1|Missed >4 consecutive doses|2|||
156742092|NCT00195494|565803879|FG000|Year 1|Protocol deviation|0|||
156742093|NCT00195494|565803880|FG001|Year 1|Protocol deviation|0|||
156742094|NCT00195494|565803881|FG002|Year 1|Protocol deviation|0|||
156742095|NCT00195494|565803882|FG003|Year 1|Protocol deviation|0|||
156742096|NCT00195494|565803883|FG004|Year 1|Protocol deviation|2|||
156742097|NCT00195494|565803884|FG005|Year 1|Protocol deviation|3|||
156742098|NCT00195494|565803879|FG000|Year 1|Physician Decision|0|||
156742099|NCT00195494|565803880|FG001|Year 1|Physician Decision|0|||
156742100|NCT00195494|565803881|FG002|Year 1|Physician Decision|0|||
156797874|NCT04079738|566013425|FG000|Study Treatment|symptomatic deterioration|2|||
156797875|NCT04079738|566013426|FG001|Study Treatment|symptomatic deterioration|0|||
156797876|NCT04079738|566013427|FG002|Study Treatment|symptomatic deterioration|0|||
156797877|NCT04079738|566013428|FG003|Study Treatment|symptomatic deterioration|0|||
156797878|NCT04079738|566013425|FG000|Study Treatment|Disease Progression|1|||
156797879|NCT04079738|566013426|FG001|Study Treatment|Disease Progression|0|||
156797880|NCT04079738|566013427|FG002|Study Treatment|Disease Progression|0|||
156797881|NCT04079738|566013428|FG003|Study Treatment|Disease Progression|0|||
156797882|NCT04079738|566013425|FG000|Study Treatment|withdrawal after treatment|1|||
156797883|NCT04079738|566013426|FG001|Study Treatment|withdrawal after treatment|0|||
156797884|NCT04079738|566013427|FG002|Study Treatment|withdrawal after treatment|0|||
156797885|NCT04079738|566013428|FG003|Study Treatment|withdrawal after treatment|0|||
156797886|NCT04079738|566013425|FG000|Follow up|Withdrawal by Subject|3|||
156797887|NCT04079738|566013426|FG001|Follow up|Withdrawal by Subject|0|||
156797888|NCT04079738|566013427|FG002|Follow up|Withdrawal by Subject|0|||
156797889|NCT04079738|566013428|FG003|Follow up|Withdrawal by Subject|0|||
156797890|NCT04079738|566013425|FG000|Follow up|Death|5|||
156742101|NCT00195494|565803882|FG003|Year 1|Physician Decision|0|||
156742102|NCT00195494|565803883|FG004|Year 1|Physician Decision|1|||
156797891|NCT04079738|566013426|FG001|Follow up|Death|0|||
156797892|NCT04079738|566013427|FG002|Follow up|Death|0|||
156797893|NCT04079738|566013428|FG003|Follow up|Death|0|||
156808859|NCT01645735|566054478|FG001|Overall Study|Withdrawal by Subject|0|||
156742103|NCT00195494|565803884|FG005|Year 1|Physician Decision|0|||
156742104|NCT00195494|565803879|FG000|Year 1|Withdrawal by Subject|0|||
156742105|NCT00195494|565803880|FG001|Year 1|Withdrawal by Subject|0|||
156742106|NCT00195494|565803881|FG002|Year 1|Withdrawal by Subject|0|||
156742107|NCT00195494|565803882|FG003|Year 1|Withdrawal by Subject|0|||
156742108|NCT00195494|565803883|FG004|Year 1|Withdrawal by Subject|8|||
156742109|NCT00195494|565803884|FG005|Year 1|Withdrawal by Subject|9|||
156742110|NCT00195494|565803879|FG000|Year 1|Protocol Violation|0|||
156742111|NCT00195494|565803880|FG001|Year 1|Protocol Violation|0|||
156808860|NCT01645735|566054477|FG000|Overall Study|Protocol Violation|1|||
156808861|NCT01645735|566054478|FG001|Overall Study|Protocol Violation|0|||
156808862|NCT01645735|566054477|FG000|Overall Study|Adverse Event|0|||
156808863|NCT01645735|566054478|FG001|Overall Study|Adverse Event|1|||
156808864|NCT03369665|566054489|FG000|Overall Study|Adverse Event|3|||
156808865|NCT03369665|566054489|FG000|Overall Study|Lost to Follow-up|7|||
156808866|NCT03369665|566054489|FG000|Overall Study|Withdrawal by Subject|15|||
156808867|NCT03369665|566054489|FG000|Overall Study|Progression Disease|2|||
156808868|NCT03369665|566054489|FG000|Overall Study|Not classified|3|||
156808869|NCT02168101|566054490|FG000|Overall Study|Death|2|||
156808870|NCT02168101|566054491|FG001|Overall Study|Death|2|||
156808871|NCT02168101|566054492|FG002|Overall Study|Death|1|||
156808872|NCT00589797|566054493|FG000|Overall Study|Death|1|||
156808873|NCT00589797|566054494|FG001|Overall Study|Death|0|||
156808874|NCT00589797|566054493|FG000|Overall Study|Lost to Follow-up|12|||
156808875|NCT00589797|566054494|FG001|Overall Study|Lost to Follow-up|9|||
156808876|NCT00589797|566054493|FG000|Overall Study|Physician Decision|8|||
156808877|NCT00589797|566054494|FG001|Overall Study|Physician Decision|3|||
156808878|NCT00589797|566054493|FG000|Overall Study|Withdrawal by Subject|6|||
156878044|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
156878045|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
156878046|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
156878047|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
156878048|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
156878049|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
156878050|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
156878051|NCT03602859|566311348|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
156878052|NCT03602859|566311349|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
156878053|NCT03602859|566311350|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
156878054|NCT03602859|566311351|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
156878055|NCT01301833|566311352|FG000|Overall Study|Adverse Event|7|||
156878056|NCT01301833|566311353|FG001|Overall Study|Adverse Event|5|||
156878057|NCT01301833|566311354|FG002|Overall Study|Adverse Event|5|||
156878058|NCT01301833|566311355|FG003|Overall Study|Adverse Event|5|||
156878059|NCT01301833|566311352|FG000|Overall Study|Lack of Efficacy|1|||
156878060|NCT01301833|566311353|FG001|Overall Study|Lack of Efficacy|1|||
156878061|NCT01301833|566311354|FG002|Overall Study|Lack of Efficacy|0|||
156878062|NCT01301833|566311355|FG003|Overall Study|Lack of Efficacy|0|||
156878063|NCT01301833|566311352|FG000|Overall Study|Physician Decision|3|||
156878064|NCT01301833|566311353|FG001|Overall Study|Physician Decision|1|||
156878065|NCT01301833|566311354|FG002|Overall Study|Physician Decision|1|||
156878066|NCT01301833|566311355|FG003|Overall Study|Physician Decision|0|||
156878067|NCT01301833|566311352|FG000|Overall Study|Withdrawal by Subject|3|||
156878068|NCT01301833|566311353|FG001|Overall Study|Withdrawal by Subject|1|||
156878069|NCT01301833|566311354|FG002|Overall Study|Withdrawal by Subject|1|||
156878070|NCT01301833|566311355|FG003|Overall Study|Withdrawal by Subject|2|||
156878071|NCT01301833|566311352|FG000|Overall Study|Personal matter|1|||
156878072|NCT01301833|566311353|FG001|Overall Study|Personal matter|0|||
156878073|NCT01301833|566311354|FG002|Overall Study|Personal matter|0|||
156878074|NCT01301833|566311355|FG003|Overall Study|Personal matter|0|||
156742112|NCT00195494|565803881|FG002|Year 1|Protocol Violation|0|||
156742113|NCT00195494|565803882|FG003|Year 1|Protocol Violation|0|||
156742114|NCT00195494|565803883|FG004|Year 1|Protocol Violation|1|||
156742115|NCT00195494|565803884|FG005|Year 1|Protocol Violation|1|||
156742116|NCT00195494|565803879|FG000|Year 2|Adverse Event|3|||
156742117|NCT00195494|565803880|FG001|Year 2|Adverse Event|7|||
156742118|NCT00195494|565803881|FG002|Year 2|Adverse Event|5|||
156742119|NCT00195494|565803882|FG003|Year 2|Adverse Event|9|||
156742120|NCT00195494|565803883|FG004|Year 2|Adverse Event|0|||
156742121|NCT00195494|565803884|FG005|Year 2|Adverse Event|0|||
156742122|NCT00195494|565803879|FG000|Year 2|Lack of Efficacy|0|||
156742123|NCT00195494|565803880|FG001|Year 2|Lack of Efficacy|1|||
156742124|NCT00195494|565803881|FG002|Year 2|Lack of Efficacy|7|||
156742125|NCT00195494|565803882|FG003|Year 2|Lack of Efficacy|7|||
156742126|NCT00195494|565803883|FG004|Year 2|Lack of Efficacy|0|||
156742127|NCT00195494|565803884|FG005|Year 2|Lack of Efficacy|0|||
156742128|NCT00195494|565803879|FG000|Year 2|Compliance|1|||
156742129|NCT00195494|565803880|FG001|Year 2|Compliance|0|||
156742130|NCT00195494|565803881|FG002|Year 2|Compliance|0|||
156742131|NCT00195494|565803882|FG003|Year 2|Compliance|2|||
156742132|NCT00195494|565803883|FG004|Year 2|Compliance|0|||
156742133|NCT00195494|565803884|FG005|Year 2|Compliance|0|||
156742134|NCT00195494|565803879|FG000|Year 2|Lost to Follow-up|0|||
156742135|NCT00195494|565803880|FG001|Year 2|Lost to Follow-up|0|||
156742136|NCT00195494|565803881|FG002|Year 2|Lost to Follow-up|1|||
156742137|NCT00195494|565803882|FG003|Year 2|Lost to Follow-up|1|||
156797894|NCT05552859|566013429|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
156797895|NCT05552859|566013430|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
156797896|NCT01380080|566013431|FG000|Overall Study|Death|36|||
156797897|NCT01380080|566013432|FG001|Overall Study|Death|44|||
156797898|NCT01380080|566013431|FG000|Overall Study|Site is closing|28|||
156797899|NCT01380080|566013432|FG001|Overall Study|Site is closing|31|||
156797900|NCT01380080|566013431|FG000|Overall Study|Not able to get to clinic|7|||
156797901|NCT01380080|566013432|FG001|Overall Study|Not able to get to clinic|1|||
156797902|NCT01380080|566013431|FG000|Overall Study|Not willing to adhere to requirements|6|||
156797903|NCT01380080|566013432|FG001|Overall Study|Not willing to adhere to requirements|2|||
156797904|NCT01380080|566013431|FG000|Overall Study|Withdrawal by Subject|5|||
156797905|NCT01380080|566013432|FG001|Overall Study|Withdrawal by Subject|2|||
156797906|NCT01380080|566013431|FG000|Overall Study|Lost to Follow-up|3|||
156797907|NCT01380080|566013432|FG001|Overall Study|Lost to Follow-up|3|||
156797908|NCT02711202|566013433|FG000|Overall Study|Adverse Event|3|||
156797909|NCT02711202|566013434|FG001|Overall Study|Adverse Event|0|||
156797910|NCT02711202|566013433|FG000|Overall Study|graft loss|1|||
156797911|NCT02711202|566013434|FG001|Overall Study|graft loss|0|||
156797912|NCT05852470|566013436|FG000|Overall Study|Withdrawal by Subject|0|||
156797913|NCT05852470|566013437|FG001|Overall Study|Withdrawal by Subject|1|||
156797914|NCT01903863|566013438|FG000|Overall Study|Physician Decision|2|||
156797915|NCT01903863|566013439|FG001|Overall Study|Physician Decision|0|||
156797916|NCT01722669|566013442|FG000|Overall Study|Withdrawal by Subject|0|||
156797917|NCT01722669|566013443|FG001|Overall Study|Withdrawal by Subject|0|||
156797918|NCT01722669|566013444|FG002|Overall Study|Withdrawal by Subject|0|||
156797919|NCT01722669|566013445|FG003|Overall Study|Withdrawal by Subject|0|||
156797920|NCT01722669|566013446|FG004|Overall Study|Withdrawal by Subject|0|||
156797921|NCT01722669|566013447|FG005|Overall Study|Withdrawal by Subject|2|||
156797922|NCT01107496|566013448|FG000|Overall Study|Adverse Event|1|||
156797923|NCT01107496|566013449|FG001|Overall Study|Adverse Event|0|||
156797924|NCT01107496|566013448|FG000|Overall Study|Lack of Efficacy|1|||
156797925|NCT01107496|566013449|FG001|Overall Study|Lack of Efficacy|0|||
156797926|NCT01107496|566013448|FG000|Overall Study|Protocol Violation|0|||
156797927|NCT01107496|566013449|FG001|Overall Study|Protocol Violation|1|||
156797928|NCT01107496|566013448|FG000|Overall Study|Lost to Follow-up|0|||
156797929|NCT01107496|566013449|FG001|Overall Study|Lost to Follow-up|1|||
156797930|NCT02496000|566013454|FG000|Overall Study|Withdrawal by Subject|1|||
156797931|NCT02496000|566013455|FG001|Overall Study|Withdrawal by Subject|2|||
156797932|NCT02496000|566013456|FG002|Overall Study|Withdrawal by Subject|0|||
156797933|NCT02496000|566013454|FG000|Overall Study|Lost to Follow-up|1|||
156797934|NCT02496000|566013455|FG001|Overall Study|Lost to Follow-up|0|||
156797935|NCT02496000|566013456|FG002|Overall Study|Lost to Follow-up|1|||
156797936|NCT02496000|566013454|FG000|Overall Study|Protocol Violation|0|||
156797937|NCT02496000|566013455|FG001|Overall Study|Protocol Violation|0|||
156797938|NCT02496000|566013456|FG002|Overall Study|Protocol Violation|1|||
156797939|NCT02496000|566013454|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
156797940|NCT02496000|566013455|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
156797941|NCT02496000|566013456|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
156797942|NCT02496000|566013454|FG000|Overall Study|undetermined|0|||
156797943|NCT02496000|566013455|FG001|Overall Study|undetermined|1|||
156797944|NCT02496000|566013456|FG002|Overall Study|undetermined|0|||
156797945|NCT03734536|566013457|FG000|Overall Study|Withdrew Consent|1|||
156797946|NCT03734536|566013458|FG001|Overall Study|Withdrew Consent|5|||
156797947|NCT03734536|566013457|FG000|Overall Study|Lost to Follow-up|10|||
156742138|NCT00195494|565803883|FG004|Year 2|Lost to Follow-up|0|||
156742139|NCT00195494|565803884|FG005|Year 2|Lost to Follow-up|0|||
156797948|NCT03734536|566013458|FG001|Overall Study|Lost to Follow-up|7|||
156742140|NCT00195494|565803879|FG000|Year 2|Missed >4 consecutive doses|1|||
156742141|NCT00195494|565803880|FG001|Year 2|Missed >4 consecutive doses|1|||
156742142|NCT00195494|565803881|FG002|Year 2|Missed >4 consecutive doses|1|||
156742143|NCT00195494|565803882|FG003|Year 2|Missed >4 consecutive doses|0|||
156797949|NCT04727151|566013462|FG000|Overall Study|Death|0|||
156797950|NCT04727151|566013463|FG001|Overall Study|Death|0|||
156797951|NCT04727151|566013464|FG002|Overall Study|Death|0|||
156797952|NCT04727151|566013465|FG003|Overall Study|Death|0|||
156797953|NCT04727151|566013466|FG004|Overall Study|Death|3|||
156742144|NCT00195494|565803883|FG004|Year 2|Missed >4 consecutive doses|0|||
156336978|NCT00516074|564331440|FG000|Overall Study|Loss of Glucose Control|2|||
156336979|NCT00516074|564331441|FG001|Overall Study|Loss of Glucose Control|0|||
156797954|NCT04727151|566013462|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
156797955|NCT04727151|566013463|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
156797956|NCT04727151|566013464|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
156797957|NCT04727151|566013465|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
156797958|NCT04727151|566013466|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
156797959|NCT03448393|566013467|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156742145|NCT00195494|565803884|FG005|Year 2|Missed >4 consecutive doses|0|||
156742146|NCT00195494|565803879|FG000|Year 2|Protocol deviation|0|||
156742147|NCT00195494|565803880|FG001|Year 2|Protocol deviation|1|||
156742148|NCT00195494|565803881|FG002|Year 2|Protocol deviation|0|||
156742149|NCT00195494|565803882|FG003|Year 2|Protocol deviation|0|||
156742150|NCT00195494|565803883|FG004|Year 2|Protocol deviation|0|||
156742151|NCT00195494|565803884|FG005|Year 2|Protocol deviation|0|||
156742152|NCT00195494|565803879|FG000|Year 2|Physician Decision|1|||
156742153|NCT00195494|565803880|FG001|Year 2|Physician Decision|1|||
156742154|NCT00195494|565803881|FG002|Year 2|Physician Decision|0|||
156742155|NCT00195494|565803882|FG003|Year 2|Physician Decision|0|||
156742156|NCT00195494|565803883|FG004|Year 2|Physician Decision|0|||
156742157|NCT00195494|565803884|FG005|Year 2|Physician Decision|0|||
156742158|NCT00195494|565803879|FG000|Year 2|Withdrawal by Subject|1|||
156742159|NCT00195494|565803880|FG001|Year 2|Withdrawal by Subject|5|||
156742160|NCT00195494|565803881|FG002|Year 2|Withdrawal by Subject|4|||
156742161|NCT00195494|565803882|FG003|Year 2|Withdrawal by Subject|3|||
156742162|NCT00195494|565803883|FG004|Year 2|Withdrawal by Subject|0|||
156742163|NCT00195494|565803884|FG005|Year 2|Withdrawal by Subject|0|||
156742164|NCT00195494|565803879|FG000|Year 2|System toxicity|0|||
156742165|NCT00195494|565803880|FG001|Year 2|System toxicity|0|||
156742166|NCT00195494|565803881|FG002|Year 2|System toxicity|0|||
156742167|NCT00195494|565803882|FG003|Year 2|System toxicity|1|||
156742168|NCT00195494|565803883|FG004|Year 2|System toxicity|0|||
156742169|NCT00195494|565803884|FG005|Year 2|System toxicity|0|||
156742170|NCT00513357|565803885|FG000|Overall Study|did not receive allocated placebo|2|||
156742171|NCT00513357|565803886|FG001|Overall Study|did not receive allocated placebo|3|||
156742172|NCT00513357|565803885|FG000|Overall Study|Adverse Event|4|||
156742173|NCT00513357|565803886|FG001|Overall Study|Adverse Event|2|||
156742174|NCT00513357|565803885|FG000|Overall Study|Death|2|||
156742175|NCT00513357|565803886|FG001|Overall Study|Death|0|||
156742176|NCT00513357|565803885|FG000|Overall Study|Withdrawal by Subject|5|||
156742177|NCT00513357|565803886|FG001|Overall Study|Withdrawal by Subject|4|||
156742178|NCT00513357|565803885|FG000|Overall Study|Disease Progression|2|||
156742179|NCT00513357|565803886|FG001|Overall Study|Disease Progression|1|||
156742180|NCT01162122|565803887|FG000|Overall Study|Withdrawal by Subject|52|||
156742181|NCT01162122|565803888|FG001|Overall Study|Withdrawal by Subject|43|||
156742182|NCT01162122|565803887|FG000|Overall Study|Lost to Follow-up|73|||
156742183|NCT01162122|565803888|FG001|Overall Study|Lost to Follow-up|91|||
156742184|NCT01162122|565803887|FG000|Overall Study|Adverse Event|3|||
156742185|NCT01162122|565803888|FG001|Overall Study|Adverse Event|2|||
156742186|NCT01162122|565803887|FG000|Overall Study|Death|51|||
156742187|NCT01162122|565803888|FG001|Overall Study|Death|46|||
156742188|NCT01162122|565803887|FG000|Overall Study|Protocol Violation|2|||
156742189|NCT01162122|565803888|FG001|Overall Study|Protocol Violation|2|||
156742190|NCT01162122|565803887|FG000|Overall Study|Inappropriate enrollment|5|||
156742191|NCT01162122|565803888|FG001|Overall Study|Inappropriate enrollment|4|||
156742192|NCT01162122|565803887|FG000|Overall Study|Administrative reason|1|||
156742193|NCT01162122|565803888|FG001|Overall Study|Administrative reason|1|||
156742194|NCT01162122|565803887|FG000|Overall Study|Unable to classify|3|||
156742195|NCT01162122|565803888|FG001|Overall Study|Unable to classify|7|||
156742196|NCT01162122|565803887|FG000|Overall Study|Missing primary reason|1|||
156742197|NCT01162122|565803888|FG001|Overall Study|Missing primary reason|0|||
156742198|NCT02020512|565803889|FG000|Overall Study|Adverse Event|1|||
156742199|NCT02020512|565803889|FG000|Overall Study|Lost to Follow-up|3|||
156742200|NCT02020512|565803889|FG000|Overall Study|Protocol Violation|4|||
156797960|NCT03448393|566013468|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156742201|NCT00435487|565803892|FG000|Overall Study|Death|3|||
156742202|NCT00435487|565803893|FG001|Overall Study|Death|4|||
156742203|NCT00435487|565803892|FG000|Overall Study|Adverse Event|0|||
156742204|NCT00435487|565803893|FG001|Overall Study|Adverse Event|3|||
156742205|NCT00435487|565803892|FG000|Overall Study|Lost to Follow-up|2|||
156742206|NCT00435487|565803893|FG001|Overall Study|Lost to Follow-up|2|||
156742207|NCT00435487|565803892|FG000|Overall Study|Other|5|||
156742208|NCT00435487|565803893|FG001|Overall Study|Other|2|||
156742209|NCT00435487|565803892|FG000|Overall Study|Withdrawal by Subject|2|||
156742210|NCT00435487|565803893|FG001|Overall Study|Withdrawal by Subject|1|||
156742211|NCT00435487|565803892|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
156742212|NCT00435487|565803893|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
156742213|NCT00435487|565803892|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
156742214|NCT00435487|565803893|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
156742215|NCT00835679|565803895|FG000|Overall Study|Withdrawal by Subject|1|||
156742216|NCT00835679|565803896|FG001|Overall Study|Withdrawal by Subject|0|||
156742217|NCT00835679|565803897|FG002|Overall Study|Withdrawal by Subject|0|||
156742218|NCT00835679|565803898|FG003|Overall Study|Withdrawal by Subject|0|||
156742219|NCT00955968|565803902|FG000|Overall Study|Death|2|||
156742220|NCT00955968|565803903|FG001|Overall Study|Death|4|||
156742221|NCT00955968|565803902|FG000|Overall Study|Withdrawal by Subject|35|||
156742222|NCT00955968|565803903|FG001|Overall Study|Withdrawal by Subject|31|||
156742223|NCT00955968|565803902|FG000|Overall Study|Lost to Follow-up|45|||
156742224|NCT00955968|565803903|FG001|Overall Study|Lost to Follow-up|39|||
156742225|NCT00955968|565803902|FG000|Overall Study|Site closed|55|||
156742226|NCT00955968|565803903|FG001|Overall Study|Site closed|52|||
156742227|NCT04972968|565803907|FG000|Overall Study|Adverse Event|3|||
156742228|NCT04972968|565803908|FG001|Overall Study|Adverse Event|1|||
156742229|NCT04972968|565803909|FG002|Overall Study|Adverse Event|1|||
156742230|NCT04972968|565803910|FG003|Overall Study|Adverse Event|7|||
156742231|NCT04972968|565803907|FG000|Overall Study|Lack of Efficacy|2|||
156742232|NCT04972968|565803908|FG001|Overall Study|Lack of Efficacy|1|||
156742233|NCT04972968|565803909|FG002|Overall Study|Lack of Efficacy|0|||
156742234|NCT04972968|565803910|FG003|Overall Study|Lack of Efficacy|0|||
156742235|NCT04972968|565803907|FG000|Overall Study|Withdrawal by Subject|7|||
156742236|NCT04972968|565803908|FG001|Overall Study|Withdrawal by Subject|4|||
156742237|NCT04972968|565803909|FG002|Overall Study|Withdrawal by Subject|3|||
156742238|NCT04972968|565803910|FG003|Overall Study|Withdrawal by Subject|2|||
156742239|NCT04972968|565803907|FG000|Overall Study|Study Terminated by Sponsor|25|||
156742240|NCT04972968|565803908|FG001|Overall Study|Study Terminated by Sponsor|28|||
156742241|NCT04972968|565803909|FG002|Overall Study|Study Terminated by Sponsor|32|||
156742242|NCT04972968|565803910|FG003|Overall Study|Study Terminated by Sponsor|27|||
156797961|NCT03448393|566013469|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
156797962|NCT03448393|566013470|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797963|NCT03448393|566013471|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797964|NCT03448393|566013472|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797965|NCT03448393|566013473|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797966|NCT03448393|566013474|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797967|NCT03448393|566013475|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
156797968|NCT03448393|566013467|FG000|Dose Expansion|Not treated - screen failure|0|||
156797969|NCT03448393|566013468|FG001|Dose Expansion|Not treated - screen failure|0|||
156797970|NCT03448393|566013469|FG002|Dose Expansion|Not treated - screen failure|0|||
156797971|NCT03448393|566013470|FG003|Dose Expansion|Not treated - screen failure|0|||
156797972|NCT03448393|566013471|FG004|Dose Expansion|Not treated - screen failure|0|||
156797973|NCT03448393|566013472|FG005|Dose Expansion|Not treated - screen failure|0|||
156797974|NCT03448393|566013473|FG006|Dose Expansion|Not treated - screen failure|0|||
156797975|NCT03448393|566013474|FG007|Dose Expansion|Not treated - screen failure|0|||
156797976|NCT03448393|566013475|FG008|Dose Expansion|Not treated - screen failure|7|||
156797977|NCT01587196|566013476|FG000|Overall Study|Lost to Follow-up|50|||
156797978|NCT01587196|566013476|FG000|Overall Study|Withdrawal by Subject|4|||
156797979|NCT00642759|566013477|FG000|Overall Study|Protocol Violation|1|||
156797980|NCT03612570|566013482|FG000|Overall Study|Lost to Follow-up|1|||
156797981|NCT05318287|566013483|FG000|Overall Study|Lost to Follow-up|8|||
156797982|NCT03537508|566013486|FG000|Overall Study|Adverse Event|2|||
156797983|NCT03537508|566013487|FG001|Overall Study|Adverse Event|1|||
156797984|NCT03537508|566013486|FG000|Overall Study|Protocol Violation|65|||
156797985|NCT03537508|566013487|FG001|Overall Study|Protocol Violation|48|||
156797986|NCT03537508|566013486|FG000|Overall Study|Lost to Follow-up|86|||
156797987|NCT03537508|566013487|FG001|Overall Study|Lost to Follow-up|60|||
156797988|NCT03537508|566013486|FG000|Overall Study|Withdrawal by parent/guardian|263|||
156797989|NCT03537508|566013487|FG001|Overall Study|Withdrawal by parent/guardian|149|||
156797990|NCT01972659|566013500|FG000|Overall Study|Protocol Violation|2|||
156797991|NCT01972659|566013501|FG001|Overall Study|Protocol Violation|2|||
156797992|NCT01972659|566013500|FG000|Overall Study|problems realted to acceleromyograph|2|||
156797993|NCT01972659|566013501|FG001|Overall Study|problems realted to acceleromyograph|1|||
156797994|NCT03814044|566013509|FG000|Overall Study|Protocol deviation|1|||
156797995|NCT02757768|566013510|FG000|Overall Study|Randomized Never Received Study Drug|3|||
156797996|NCT02757768|566013511|FG001|Overall Study|Randomized Never Received Study Drug|4|||
156797997|NCT02757768|566013510|FG000|Overall Study|Adverse Event|5|||
156797998|NCT02757768|566013511|FG001|Overall Study|Adverse Event|3|||
156797999|NCT02757768|566013510|FG000|Overall Study|Lack of Efficacy|2|||
156798000|NCT02757768|566013511|FG001|Overall Study|Lack of Efficacy|1|||
156534902|NCT02229539|565054007|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
156742243|NCT04972968|565803907|FG000|Overall Study|Other|1|||
156742244|NCT04972968|565803908|FG001|Overall Study|Other|0|||
156742245|NCT04972968|565803909|FG002|Overall Study|Other|1|||
156742246|NCT04972968|565803910|FG003|Overall Study|Other|1|||
156742247|NCT01698879|565803911|FG000|Overall Study|Withdrawal by Subject|1|||
156742248|NCT01698879|565803912|FG001|Overall Study|Withdrawal by Subject|0|||
156742249|NCT01698879|565803913|FG002|Overall Study|Withdrawal by Subject|0|||
156742250|NCT03649178|565803914|FG000|Overall Study|Adverse Event|1|||
156742251|NCT03649178|565803915|FG001|Overall Study|Adverse Event|2|||
156742252|NCT03649178|565803914|FG000|Overall Study|Withdrawal by Subject|0|||
156742253|NCT03649178|565803915|FG001|Overall Study|Withdrawal by Subject|2|||
156742254|NCT03649178|565803914|FG000|Overall Study|COVID regulation required halt in protocol|1|||
156742255|NCT03649178|565803915|FG001|Overall Study|COVID regulation required halt in protocol|0|||
156742256|NCT05238025|565803916|FG000|Overall Study|Adverse Event|2|||
156742257|NCT05238025|565803917|FG001|Overall Study|Adverse Event|2|||
156742258|NCT05238025|565803916|FG000|Overall Study|Lost to Follow-up|334|||
156742259|NCT05238025|565803917|FG001|Overall Study|Lost to Follow-up|339|||
156742260|NCT05238025|565803916|FG000|Overall Study|Withdrawal by Subject|203|||
156742261|NCT05238025|565803917|FG001|Overall Study|Withdrawal by Subject|222|||
156742262|NCT05238025|565803916|FG000|Overall Study|Physician Decision|20|||
156742263|NCT05238025|565803917|FG001|Overall Study|Physician Decision|8|||
156742264|NCT05238025|565803916|FG000|Overall Study|Protocol Violation|6|||
156742265|NCT05238025|565803917|FG001|Overall Study|Protocol Violation|2|||
156742266|NCT05238025|565803916|FG000|Overall Study|Death|38|||
156742267|NCT05238025|565803917|FG001|Overall Study|Death|32|||
156742268|NCT05238025|565803916|FG000|Overall Study|Study terminated by Sponsor|6358|||
156742269|NCT05238025|565803917|FG001|Overall Study|Study terminated by Sponsor|6358|||
156798001|NCT02757768|566013510|FG000|Overall Study|Lost to Follow-up|1|||
156798002|NCT02757768|566013511|FG001|Overall Study|Lost to Follow-up|0|||
156798003|NCT02757768|566013510|FG000|Overall Study|Protocol Deviation|2|||
156798004|NCT02757768|566013511|FG001|Overall Study|Protocol Deviation|9|||
156798005|NCT02757768|566013510|FG000|Overall Study|Withdrawal by Subject|16|||
156798006|NCT02757768|566013511|FG001|Overall Study|Withdrawal by Subject|9|||
156798007|NCT02757768|566013510|FG000|Overall Study|Miscellaneous|4|||
156798008|NCT02757768|566013511|FG001|Overall Study|Miscellaneous|2|||
156798009|NCT00835367|566013512|FG000|Washout|Adverse Event|2|||
156798010|NCT00835367|566013513|FG001|Washout|Adverse Event|0|||
156798011|NCT00835367|566013512|FG000|Washout|Withdrawal by Subject|1|||
156798012|NCT00835367|566013513|FG001|Washout|Withdrawal by Subject|0|||
156798013|NCT00835367|566013512|FG000|Second Intervention|Adverse Event|1|||
156798014|NCT00835367|566013513|FG001|Second Intervention|Adverse Event|1|||
156798015|NCT03557502|566013515|FG000|Protocol 2|Withdrawal by Subject|1|||
156798016|NCT03557502|566013516|FG001|Protocol 2|Withdrawal by Subject|1|||
156798017|NCT03557502|566013515|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
156798018|NCT03557502|566013516|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
156798019|NCT02333799|566015633|FG000|Treatment Period|Withdrawal by Subject|1|||
156798020|NCT02333799|566015633|FG000|Treatment Period|Death|6|||
156798021|NCT02333799|566015633|FG000|6 Month Follow Up Period|Physician Decision|1|||
156798022|NCT02333799|566015633|FG000|6 Month Follow Up Period|Death|1|||
156798023|NCT02333799|566015633|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
156798024|NCT02333799|566015633|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
156798025|NCT03716830|566015634|FG000|Overall Study|Withdrawal by Subject|2|||
156798026|NCT03716830|566015635|FG001|Overall Study|Withdrawal by Subject|2|||
156798027|NCT03716830|566015636|FG002|Overall Study|Withdrawal by Subject|6|||
156798028|NCT03716830|566015637|FG003|Overall Study|Withdrawal by Subject|5|||
156798029|NCT03716830|566015634|FG000|Overall Study|Adverse Event|1|||
156798030|NCT03716830|566015635|FG001|Overall Study|Adverse Event|2|||
156742270|NCT05238025|565803916|FG000|Overall Study|Other Reason|669|||
156742271|NCT05238025|565803917|FG001|Overall Study|Other Reason|690|||
156742272|NCT03814720|565803920|FG000|Overall Study|Lost to Follow-up|0|||
156742273|NCT03814720|565803921|FG001|Overall Study|Lost to Follow-up|1|||
156798031|NCT03716830|566015636|FG002|Overall Study|Adverse Event|0|||
156534903|NCT02229539|565054005|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
156534904|NCT02229539|565054006|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
156534905|NCT02229539|565054007|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
156798032|NCT03716830|566015637|FG003|Overall Study|Adverse Event|1|||
156798033|NCT03716830|566015634|FG000|Overall Study|Lost to Follow-up|1|||
156798034|NCT03716830|566015635|FG001|Overall Study|Lost to Follow-up|1|||
156798035|NCT03716830|566015636|FG002|Overall Study|Lost to Follow-up|0|||
156798036|NCT03716830|566015637|FG003|Overall Study|Lost to Follow-up|0|||
156798037|NCT05484895|566015638|FG000|Overall Study|Lost to Follow-up|63|||
156798038|NCT05484895|566015639|FG001|Overall Study|Lost to Follow-up|64|||
156798039|NCT04795531|566015640|FG000|Overall Study|Withdrawal by Subject|4|||
156798040|NCT04795531|566015641|FG001|Overall Study|Withdrawal by Subject|4|||
156798041|NCT04795531|566015640|FG000|Overall Study|Lost to Follow-up|0|||
156798042|NCT04795531|566015641|FG001|Overall Study|Lost to Follow-up|1|||
156798043|NCT04795531|566015640|FG000|Overall Study|Physician Decision|0|||
156798044|NCT04795531|566015641|FG001|Overall Study|Physician Decision|2|||
156798045|NCT04795531|566015640|FG000|Overall Study|Death|2|||
156798046|NCT04795531|566015641|FG001|Overall Study|Death|1|||
156798047|NCT04887831|566015642|FG000|Overall Study|Death|26|||
156798048|NCT04887831|566015643|FG001|Overall Study|Death|26|||
156798049|NCT04887831|566015642|FG000|Overall Study|Lost to Follow-up|0|||
156798050|NCT04887831|566015643|FG001|Overall Study|Lost to Follow-up|1|||
156798051|NCT04887831|566015642|FG000|Overall Study|Withdrawal by Subject|2|||
156798052|NCT04887831|566015643|FG001|Overall Study|Withdrawal by Subject|1|||
156798053|NCT04887831|566015642|FG000|Overall Study|Study Terminated by Sponsor|18|||
156798054|NCT04887831|566015643|FG001|Overall Study|Study Terminated by Sponsor|17|||
156798055|NCT04887831|566015642|FG000|Overall Study|Other|1|||
156798056|NCT04887831|566015643|FG001|Overall Study|Other|0|||
156798057|NCT03396445|566015644|FG000|Treatment Period|Death|2|||
156798058|NCT03396445|566015645|FG001|Treatment Period|Death|2|||
156798059|NCT03396445|566015646|FG002|Treatment Period|Death|1|||
156798060|NCT03396445|566015647|FG003|Treatment Period|Death|1|||
156798061|NCT03396445|566015648|FG004|Treatment Period|Death|3|||
156798062|NCT03396445|566015649|FG005|Treatment Period|Death|2|||
156798063|NCT03396445|566015650|FG006|Treatment Period|Death|5|||
156798064|NCT03396445|566015651|FG007|Treatment Period|Death|3|||
156798065|NCT03396445|566015652|FG008|Treatment Period|Death|3|||
156798066|NCT03396445|566015653|FG009|Treatment Period|Death|3|||
156798067|NCT03396445|566015654|FG010|Treatment Period|Death|7|||
156798068|NCT03396445|566015655|FG011|Treatment Period|Death|12|||
156798069|NCT03396445|566015656|FG012|Treatment Period|Death|28|||
156798070|NCT03396445|566015657|FG013|Treatment Period|Death|14|||
156798071|NCT03396445|566015658|FG014|Treatment Period|Death|10|||
156798072|NCT03396445|566015659|FG015|Treatment Period|Death|8|||
156798073|NCT03396445|566015660|FG016|Treatment Period|Death|18|||
156798074|NCT03396445|566015661|FG017|Treatment Period|Death|0|||
156798075|NCT03396445|566015662|FG018|Treatment Period|Death|0|||
156798076|NCT03396445|566015663|FG019|Treatment Period|Death|0|||
156798077|NCT03396445|566015664|FG020|Treatment Period|Death|0|||
156798078|NCT03396445|566015665|FG021|Treatment Period|Death|0|||
156798079|NCT03396445|566015666|FG022|Treatment Period|Death|0|||
156798080|NCT03396445|566015667|FG023|Treatment Period|Death|0|||
156798081|NCT03396445|566015668|FG024|Treatment Period|Death|0|||
156798082|NCT03396445|566015669|FG025|Treatment Period|Death|0|||
156798083|NCT03396445|566015644|FG000|Treatment Period|Lost to Follow-up|0|||
156798084|NCT03396445|566015645|FG001|Treatment Period|Lost to Follow-up|0|||
156798085|NCT03396445|566015646|FG002|Treatment Period|Lost to Follow-up|0|||
156798086|NCT03396445|566015647|FG003|Treatment Period|Lost to Follow-up|0|||
156798087|NCT03396445|566015648|FG004|Treatment Period|Lost to Follow-up|0|||
156798088|NCT03396445|566015649|FG005|Treatment Period|Lost to Follow-up|0|||
156798089|NCT03396445|566015650|FG006|Treatment Period|Lost to Follow-up|0|||
156798090|NCT03396445|566015651|FG007|Treatment Period|Lost to Follow-up|0|||
156798091|NCT03396445|566015652|FG008|Treatment Period|Lost to Follow-up|0|||
156798092|NCT03396445|566015653|FG009|Treatment Period|Lost to Follow-up|0|||
156798093|NCT03396445|566015654|FG010|Treatment Period|Lost to Follow-up|0|||
156798094|NCT03396445|566015655|FG011|Treatment Period|Lost to Follow-up|0|||
156798095|NCT03396445|566015656|FG012|Treatment Period|Lost to Follow-up|1|||
156798096|NCT03396445|566015657|FG013|Treatment Period|Lost to Follow-up|0|||
156798097|NCT03396445|566015658|FG014|Treatment Period|Lost to Follow-up|1|||
156798098|NCT03396445|566015659|FG015|Treatment Period|Lost to Follow-up|0|||
156798099|NCT03396445|566015660|FG016|Treatment Period|Lost to Follow-up|0|||
156798100|NCT03396445|566015661|FG017|Treatment Period|Lost to Follow-up|0|||
156798101|NCT03396445|566015662|FG018|Treatment Period|Lost to Follow-up|0|||
156798102|NCT03396445|566015663|FG019|Treatment Period|Lost to Follow-up|0|||
156798103|NCT03396445|566015664|FG020|Treatment Period|Lost to Follow-up|0|||
156798104|NCT03396445|566015665|FG021|Treatment Period|Lost to Follow-up|0|||
156798105|NCT03396445|566015666|FG022|Treatment Period|Lost to Follow-up|0|||
156798106|NCT03396445|566015667|FG023|Treatment Period|Lost to Follow-up|0|||
156798107|NCT03396445|566015668|FG024|Treatment Period|Lost to Follow-up|0|||
156798108|NCT03396445|566015669|FG025|Treatment Period|Lost to Follow-up|0|||
156798109|NCT03396445|566015644|FG000|Treatment Period|Physician Decision|0|||
156742274|NCT03814720|565803922|FG002|Overall Study|Lost to Follow-up|0|||
156742275|NCT03814720|565803923|FG003|Overall Study|Lost to Follow-up|0|||
156742276|NCT03814720|565803924|FG004|Overall Study|Lost to Follow-up|0|||
156742277|NCT00474045|565803925|FG000|Overall Study|Adverse Event|18|||
156742278|NCT00474045|565803926|FG001|Overall Study|Adverse Event|8|||
156742279|NCT00474045|565803925|FG000|Overall Study|Unclassified|1|||
156742280|NCT00474045|565803926|FG001|Overall Study|Unclassified|3|||
156742281|NCT00474045|565803925|FG000|Overall Study|Lack of Efficacy|0|||
156742282|NCT00474045|565803926|FG001|Overall Study|Lack of Efficacy|9|||
156742283|NCT00474045|565803925|FG000|Overall Study|Lost to Follow-up|1|||
156742284|NCT00474045|565803926|FG001|Overall Study|Lost to Follow-up|1|||
156742285|NCT00474045|565803925|FG000|Overall Study|Protocol Violation|10|||
156742286|NCT00474045|565803926|FG001|Overall Study|Protocol Violation|12|||
156742287|NCT00474045|565803925|FG000|Overall Study|Withdrawal by Subject|16|||
156742288|NCT00474045|565803926|FG001|Overall Study|Withdrawal by Subject|18|||
156742289|NCT00474045|565803925|FG000|Overall Study|Withdrawal criteria|60|||
156742290|NCT00474045|565803926|FG001|Overall Study|Withdrawal criteria|50|||
156742291|NCT02135107|565803933|FG000|Treatment Period|Withdrawal by Subject|11|||
156742292|NCT02135107|565803934|FG001|Treatment Period|Withdrawal by Subject|0|||
156742293|NCT02135107|565803935|FG002|Treatment Period|Withdrawal by Subject|0|||
156742294|NCT02135107|565803936|FG003|Treatment Period|Withdrawal by Subject|0|||
156742295|NCT02135107|565803933|FG000|Treatment Period|Adverse Event|5|||
156742296|NCT02135107|565803934|FG001|Treatment Period|Adverse Event|2|||
156742297|NCT02135107|565803935|FG002|Treatment Period|Adverse Event|0|||
156742298|NCT02135107|565803936|FG003|Treatment Period|Adverse Event|0|||
156742299|NCT02135107|565803933|FG000|Treatment Period|Pregnancy|1|||
156742300|NCT02135107|565803934|FG001|Treatment Period|Pregnancy|0|||
156742301|NCT02135107|565803935|FG002|Treatment Period|Pregnancy|0|||
156742302|NCT02135107|565803936|FG003|Treatment Period|Pregnancy|0|||
156742303|NCT02135107|565803933|FG000|Treatment Period|Other|115|||
156742304|NCT02135107|565803934|FG001|Treatment Period|Other|24|||
156742305|NCT02135107|565803935|FG002|Treatment Period|Other|0|||
156742306|NCT02135107|565803936|FG003|Treatment Period|Other|0|||
156742307|NCT02135107|565803933|FG000|Maintenance Therapy Period|Adverse Event|0|||
156742308|NCT02135107|565803934|FG001|Maintenance Therapy Period|Adverse Event|0|||
156742309|NCT02135107|565803935|FG002|Maintenance Therapy Period|Adverse Event|3|||
156742310|NCT02135107|565803936|FG003|Maintenance Therapy Period|Adverse Event|7|||
156742311|NCT02135107|565803933|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
156742312|NCT02135107|565803934|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
156742313|NCT02135107|565803935|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
156742314|NCT02135107|565803936|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
156742315|NCT02135107|565803933|FG000|Maintenance Therapy Period|Pregnancy|0|||
156742316|NCT02135107|565803934|FG001|Maintenance Therapy Period|Pregnancy|0|||
156742317|NCT02135107|565803935|FG002|Maintenance Therapy Period|Pregnancy|0|||
156742318|NCT02135107|565803936|FG003|Maintenance Therapy Period|Pregnancy|1|||
156742319|NCT02135107|565803933|FG000|Maintenance Therapy Period|Other|0|||
156742320|NCT02135107|565803934|FG001|Maintenance Therapy Period|Other|0|||
156742321|NCT02135107|565803935|FG002|Maintenance Therapy Period|Other|7|||
156742322|NCT02135107|565803936|FG003|Maintenance Therapy Period|Other|8|||
156742323|NCT02009397|565803939|FG000|Overall Study|Protocol Violation|6|||
156742324|NCT02009397|565803939|FG000|Overall Study|Death|8|||
156742325|NCT02009397|565803939|FG000|Overall Study|Lost to Follow-up|6|||
156742326|NCT01966068|565803941|FG000|Overall Study|Withdrawal by Subject|57|||
156742327|NCT01966068|565803941|FG000|Overall Study|Lost to Follow-up|81|||
156742328|NCT00808639|565803942|FG000|Overall Study|Disease progression before surgery.|1|||
156742329|NCT00191282|565803943|FG000|Overall Study|Adverse Event|5|||
156742330|NCT00191282|565803944|FG001|Overall Study|Adverse Event|6|||
156742331|NCT00191282|565803943|FG000|Overall Study|Death|51|||
156742332|NCT00191282|565803944|FG001|Overall Study|Death|51|||
156742333|NCT00191282|565803943|FG000|Overall Study|Lack of Efficacy|11|||
156742334|NCT00191282|565803944|FG001|Overall Study|Lack of Efficacy|6|||
156742335|NCT00191282|565803943|FG000|Overall Study|Noncompliance|14|||
156742336|NCT00191282|565803944|FG001|Overall Study|Noncompliance|17|||
156742337|NCT00191282|565803943|FG000|Overall Study|Patient moved|11|||
156742338|NCT00191282|565803944|FG001|Overall Study|Patient moved|14|||
156742339|NCT00191282|565803943|FG000|Overall Study|Withdrawal by Subject|59|||
156742340|NCT00191282|565803944|FG001|Overall Study|Withdrawal by Subject|44|||
156742341|NCT00191282|565803943|FG000|Overall Study|Physician Decision|18|||
156742342|NCT00191282|565803944|FG001|Overall Study|Physician Decision|15|||
156742343|NCT00191282|565803943|FG000|Overall Study|Protocol entry criteria not met|14|||
156742344|NCT00191282|565803944|FG001|Overall Study|Protocol entry criteria not met|9|||
156742345|NCT00191282|565803943|FG000|Overall Study|Protocol Violation|9|||
156742346|NCT00191282|565803944|FG001|Overall Study|Protocol Violation|12|||
156742347|NCT00191282|565803943|FG000|Overall Study|Severity of outcome|2|||
156742348|NCT00191282|565803944|FG001|Overall Study|Severity of outcome|5|||
156742349|NCT00191282|565803943|FG000|Overall Study|Sponsor's decision|2|||
156742350|NCT00191282|565803944|FG001|Overall Study|Sponsor's decision|2|||
156742351|NCT00191282|565803943|FG000|Overall Study|Lost to Follow-up|24|||
156742352|NCT00191282|565803944|FG001|Overall Study|Lost to Follow-up|31|||
156742353|NCT01790828|565803945|FG000|Overall Study|Other|34|||
156742354|NCT03589976|565803947|FG000|Overall Study|Death|5|||
156742355|NCT03589976|565803948|FG001|Overall Study|Death|1|||
156742356|NCT03589976|565803947|FG000|Overall Study|Adverse Event|5|||
156742357|NCT03589976|565803948|FG001|Overall Study|Adverse Event|1|||
156742358|NCT03589976|565803947|FG000|Overall Study|Withdrawal by Subject|4|||
156742359|NCT03589976|565803948|FG001|Overall Study|Withdrawal by Subject|1|||
156742360|NCT03589976|565803947|FG000|Overall Study|Lost to Follow-up|1|||
156742361|NCT03589976|565803948|FG001|Overall Study|Lost to Follow-up|0|||
156742362|NCT03589976|565803947|FG000|Overall Study|Other|4|||
156742363|NCT03589976|565803948|FG001|Overall Study|Other|3|||
156742364|NCT02089334|565803949|FG000|Overall Study|Withdrawal by Subject|0|||
156742365|NCT02089334|565803950|FG001|Overall Study|Withdrawal by Subject|0|||
156742366|NCT02089334|565803951|FG002|Overall Study|Withdrawal by Subject|0|||
156742367|NCT02089334|565803952|FG003|Overall Study|Withdrawal by Subject|2|||
156742368|NCT02089334|565803949|FG000|Overall Study|Adverse Event|0|||
156742369|NCT02089334|565803950|FG001|Overall Study|Adverse Event|0|||
156742370|NCT02089334|565803951|FG002|Overall Study|Adverse Event|0|||
156742371|NCT02089334|565803952|FG003|Overall Study|Adverse Event|2|||
156742372|NCT02089334|565803949|FG000|Overall Study|Progressive disease|0|||
156742373|NCT02089334|565803950|FG001|Overall Study|Progressive disease|0|||
156742374|NCT02089334|565803951|FG002|Overall Study|Progressive disease|0|||
156742375|NCT02089334|565803952|FG003|Overall Study|Progressive disease|2|||
156742376|NCT02089334|565803949|FG000|Overall Study|Physician Decision|0|||
156742377|NCT02089334|565803950|FG001|Overall Study|Physician Decision|0|||
156742378|NCT02089334|565803951|FG002|Overall Study|Physician Decision|1|||
156742379|NCT02089334|565803952|FG003|Overall Study|Physician Decision|1|||
156742380|NCT00954512|565803955|FG000|Overall Study|Withdrawal by Subject|0|||
156742381|NCT00954512|565803956|FG001|Overall Study|Withdrawal by Subject|0|||
156742382|NCT00954512|565803957|FG002|Overall Study|Withdrawal by Subject|0|||
156742383|NCT00954512|565803958|FG003|Overall Study|Withdrawal by Subject|0|||
156742384|NCT00954512|565803959|FG004|Overall Study|Withdrawal by Subject|0|||
156742385|NCT00954512|565803960|FG005|Overall Study|Withdrawal by Subject|1|||
156742386|NCT00954512|565803955|FG000|Overall Study|Adverse Event|0|||
156742387|NCT00954512|565803956|FG001|Overall Study|Adverse Event|0|||
156742388|NCT00954512|565803957|FG002|Overall Study|Adverse Event|0|||
156742389|NCT00954512|565803958|FG003|Overall Study|Adverse Event|0|||
156742390|NCT00954512|565803959|FG004|Overall Study|Adverse Event|1|||
156742391|NCT00954512|565803960|FG005|Overall Study|Adverse Event|2|||
156742392|NCT00954512|565803955|FG000|Overall Study|Physician Decision|0|||
156742393|NCT00954512|565803956|FG001|Overall Study|Physician Decision|1|||
156742394|NCT00954512|565803957|FG002|Overall Study|Physician Decision|0|||
156742395|NCT00954512|565803958|FG003|Overall Study|Physician Decision|1|||
156742396|NCT00954512|565803959|FG004|Overall Study|Physician Decision|0|||
156742397|NCT00954512|565803960|FG005|Overall Study|Physician Decision|0|||
156742398|NCT00954512|565803955|FG000|Overall Study|Symptomatic Deterioration|0|||
156742399|NCT00954512|565803956|FG001|Overall Study|Symptomatic Deterioration|1|||
156742400|NCT00954512|565803957|FG002|Overall Study|Symptomatic Deterioration|0|||
156742401|NCT00954512|565803958|FG003|Overall Study|Symptomatic Deterioration|0|||
156742402|NCT00954512|565803959|FG004|Overall Study|Symptomatic Deterioration|2|||
156742403|NCT00954512|565803960|FG005|Overall Study|Symptomatic Deterioration|0|||
156742404|NCT00954512|565803955|FG000|Overall Study|Progression of Disease|2|||
156742405|NCT00954512|565803956|FG001|Overall Study|Progression of Disease|1|||
156742406|NCT00954512|565803957|FG002|Overall Study|Progression of Disease|0|||
156742407|NCT00954512|565803958|FG003|Overall Study|Progression of Disease|1|||
156742408|NCT00954512|565803959|FG004|Overall Study|Progression of Disease|1|||
156742409|NCT00954512|565803960|FG005|Overall Study|Progression of Disease|1|||
156742410|NCT04814368|565803961|FG000|Overall Study|Study Terminated by Sponsor|0|||
156742411|NCT04814368|565803962|FG001|Overall Study|Study Terminated by Sponsor|3|||
156742412|NCT04814368|565803963|FG002|Overall Study|Study Terminated by Sponsor|0|||
156742413|NCT04814368|565803964|FG003|Overall Study|Study Terminated by Sponsor|2|||
156742414|NCT04814368|565803961|FG000|Overall Study|Subject Decision|1|||
156742415|NCT04814368|565803962|FG001|Overall Study|Subject Decision|2|||
156742416|NCT04814368|565803963|FG002|Overall Study|Subject Decision|0|||
156336980|NCT02628938|564331442|FG000|Overall Study|Did not attend the follow up recall|2|||
156742417|NCT04814368|565803964|FG003|Overall Study|Subject Decision|0|||
156742418|NCT00224406|565806318|FG000|Overall Study|Re-transplant|0|||
156742419|NCT00224406|565806319|FG001|Overall Study|Re-transplant|2|||
156742420|NCT00224406|565806318|FG000|Overall Study|Death|0|||
156742421|NCT00224406|565806319|FG001|Overall Study|Death|1|||
156742422|NCT00224406|565806318|FG000|Overall Study|Transplant cancelled|0|||
156742423|NCT00224406|565806319|FG001|Overall Study|Transplant cancelled|4|||
156742424|NCT00224406|565806318|FG000|Overall Study|Drug not delivered|2|||
156742425|NCT00224406|565806319|FG001|Overall Study|Drug not delivered|0|||
156798110|NCT03396445|566015645|FG001|Treatment Period|Physician Decision|0|||
156798111|NCT03396445|566015646|FG002|Treatment Period|Physician Decision|0|||
156798112|NCT03396445|566015647|FG003|Treatment Period|Physician Decision|0|||
156798113|NCT03396445|566015648|FG004|Treatment Period|Physician Decision|1|||
156798114|NCT03396445|566015649|FG005|Treatment Period|Physician Decision|0|||
156798115|NCT03396445|566015650|FG006|Treatment Period|Physician Decision|0|||
156798116|NCT03396445|566015651|FG007|Treatment Period|Physician Decision|0|||
156798117|NCT03396445|566015652|FG008|Treatment Period|Physician Decision|0|||
156798118|NCT03396445|566015653|FG009|Treatment Period|Physician Decision|1|||
156798119|NCT03396445|566015654|FG010|Treatment Period|Physician Decision|0|||
156798120|NCT03396445|566015655|FG011|Treatment Period|Physician Decision|0|||
156798121|NCT03396445|566015656|FG012|Treatment Period|Physician Decision|0|||
156798122|NCT03396445|566015657|FG013|Treatment Period|Physician Decision|0|||
156798123|NCT03396445|566015658|FG014|Treatment Period|Physician Decision|0|||
156798124|NCT03396445|566015659|FG015|Treatment Period|Physician Decision|0|||
156798125|NCT03396445|566015660|FG016|Treatment Period|Physician Decision|0|||
156798126|NCT03396445|566015661|FG017|Treatment Period|Physician Decision|0|||
156798127|NCT03396445|566015662|FG018|Treatment Period|Physician Decision|0|||
156798128|NCT03396445|566015663|FG019|Treatment Period|Physician Decision|0|||
156798129|NCT03396445|566015664|FG020|Treatment Period|Physician Decision|0|||
156798130|NCT03396445|566015665|FG021|Treatment Period|Physician Decision|0|||
156798131|NCT03396445|566015666|FG022|Treatment Period|Physician Decision|0|||
156798132|NCT03396445|566015667|FG023|Treatment Period|Physician Decision|0|||
156798133|NCT03396445|566015668|FG024|Treatment Period|Physician Decision|0|||
156798134|NCT03396445|566015669|FG025|Treatment Period|Physician Decision|0|||
156798135|NCT03396445|566015644|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798136|NCT03396445|566015645|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798137|NCT03396445|566015646|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798138|NCT03396445|566015647|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798139|NCT03396445|566015648|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798140|NCT03396445|566015649|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798141|NCT03396445|566015650|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798142|NCT03396445|566015651|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798143|NCT03396445|566015652|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798144|NCT03396445|566015653|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798145|NCT03396445|566015654|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798146|NCT03396445|566015655|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798147|NCT03396445|566015656|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
156798148|NCT03396445|566015657|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798149|NCT03396445|566015658|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
156798150|NCT03396445|566015659|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798151|NCT03396445|566015660|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798152|NCT03396445|566015661|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798153|NCT03396445|566015662|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798154|NCT03396445|566015663|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798155|NCT03396445|566015664|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798156|NCT03396445|566015665|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798157|NCT03396445|566015666|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798158|NCT03396445|566015667|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798159|NCT03396445|566015668|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798160|NCT03396445|566015669|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798161|NCT03396445|566015644|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
156336981|NCT02628938|564331443|FG001|Overall Study|Did not attend the follow up recall|2|||
156336982|NCT02628938|564331444|FG002|Overall Study|Did not attend the follow up recall|1|||
156336983|NCT02628938|564331442|FG000|Overall Study|Failure to comply with the instructions|3|||
156742426|NCT00224406|565806318|FG000|Overall Study|Other|4|||
156798162|NCT03396445|566015645|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
156742427|NCT00224406|565806319|FG001|Overall Study|Other|0|||
156336984|NCT02628938|564331443|FG001|Overall Study|Failure to comply with the instructions|0|||
156336985|NCT02628938|564331444|FG002|Overall Study|Failure to comply with the instructions|3|||
156336986|NCT02058693|564331445|FG000|Phase 1|Withdrawal by Subject|3|||
156336987|NCT02058693|564331446|FG001|Phase 1|Withdrawal by Subject|2|||
156336988|NCT02058693|564331445|FG000|Phase 1|Adverse Event|0|||
156336989|NCT02058693|564331446|FG001|Phase 1|Adverse Event|1|||
156336990|NCT02058693|564331445|FG000|Phase 1|Lack of Efficacy|1|||
156336991|NCT02058693|564331446|FG001|Phase 1|Lack of Efficacy|0|||
156336992|NCT02058693|564331445|FG000|Phase 1|Physician Decision|1|||
156798163|NCT03396445|566015646|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
156798164|NCT03396445|566015647|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
156798165|NCT03396445|566015648|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
156798166|NCT03396445|566015649|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156336993|NCT02058693|564331446|FG001|Phase 1|Physician Decision|1|||
156336994|NCT02058693|564331445|FG000|Phase 2|Withdrawal by Subject|0|||
156336995|NCT02058693|564331446|FG001|Phase 2|Withdrawal by Subject|2|||
156336996|NCT03855228|564331447|FG000|Overall Study|Adverse Event|2|||
156336997|NCT03855228|564331448|FG001|Overall Study|Adverse Event|4|||
156798167|NCT03396445|566015650|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
156798168|NCT03396445|566015651|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798169|NCT03396445|566015652|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798170|NCT03396445|566015653|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798171|NCT03396445|566015654|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798172|NCT03396445|566015655|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798173|NCT03396445|566015656|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156534906|NCT02229539|565054005|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
156336998|NCT03855228|564331449|FG002|Overall Study|Adverse Event|4|||
156336999|NCT03855228|564331450|FG003|Overall Study|Adverse Event|8|||
156534907|NCT02229539|565054006|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
156534908|NCT02229539|565054007|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
156534909|NCT02229539|565054005|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
156534910|NCT02229539|565054006|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
156337000|NCT03855228|564331447|FG000|Overall Study|Treatment Failure|1|||
156337001|NCT03855228|564331448|FG001|Overall Study|Treatment Failure|2|||
156337002|NCT03855228|564331449|FG002|Overall Study|Treatment Failure|1|||
156337003|NCT03855228|564331450|FG003|Overall Study|Treatment Failure|8|||
156337004|NCT03855228|564331447|FG000|Overall Study|Lost to Follow-up|0|||
156337005|NCT03855228|564331448|FG001|Overall Study|Lost to Follow-up|0|||
156742428|NCT00224406|565806318|FG000|Overall Study|Transplant cancelled|3|||
156742429|NCT00224406|565806319|FG001|Overall Study|Transplant cancelled|0|||
156742430|NCT04823130|565806320|FG000|Overall Study|Withdrawal by Subject|2|||
156742431|NCT04823130|565806321|FG001|Overall Study|Withdrawal by Subject|3|||
156742432|NCT04823130|565806320|FG000|Overall Study|Failure to meet inclusion criteria|6|||
156742433|NCT04823130|565806321|FG001|Overall Study|Failure to meet inclusion criteria|4|||
156742434|NCT04823130|565806320|FG000|Overall Study|Other-unspecified|1|||
156742435|NCT04823130|565806321|FG001|Overall Study|Other-unspecified|0|||
156742436|NCT03315455|565806322|FG000|Overall Study|Ongoing in the Study|13|||
156742437|NCT03315455|565806323|FG001|Overall Study|Ongoing in the Study|24|||
156742438|NCT03315455|565806324|FG002|Overall Study|Ongoing in the Study|17|||
156742439|NCT03315455|565806325|FG003|Overall Study|Ongoing in the Study|15|||
156742440|NCT03315455|565806322|FG000|Overall Study|Withdrawal by Subject|0|||
156742441|NCT03315455|565806323|FG001|Overall Study|Withdrawal by Subject|1|||
156742442|NCT03315455|565806324|FG002|Overall Study|Withdrawal by Subject|0|||
156742443|NCT03315455|565806325|FG003|Overall Study|Withdrawal by Subject|0|||
156742444|NCT03117881|565806328|FG000|Baseline|Withdrawal by Subject|21|||
156742445|NCT03117881|565806329|FG001|Baseline|Withdrawal by Subject|10|||
156742446|NCT03117881|565806330|FG002|Baseline|Withdrawal by Subject|0|||
156742447|NCT03117881|565806328|FG000|Baseline|Lost to Follow-up|22|||
156742448|NCT03117881|565806329|FG001|Baseline|Lost to Follow-up|25|||
156742449|NCT03117881|565806330|FG002|Baseline|Lost to Follow-up|0|||
156742450|NCT03117881|565806328|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
156742451|NCT03117881|565806329|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
156742452|NCT03117881|565806330|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
156742453|NCT03117881|565806328|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
156742454|NCT03117881|565806329|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
156742455|NCT03117881|565806330|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
156742456|NCT03117881|565806328|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
156742457|NCT03117881|565806329|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
156742458|NCT03117881|565806330|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
156742459|NCT03117881|565806328|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
156742460|NCT03117881|565806329|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
156742461|NCT03117881|565806330|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
156742462|NCT03117881|565806328|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
156742463|NCT03117881|565806329|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
156742464|NCT03117881|565806330|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
156742465|NCT03117881|565806328|FG000|6-Month Follow-Up|Did not complete test|53|||
156742466|NCT03117881|565806329|FG001|6-Month Follow-Up|Did not complete test|25|||
156742467|NCT03117881|565806330|FG002|6-Month Follow-Up|Did not complete test|7|||
156742468|NCT03117881|565806328|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
156742469|NCT03117881|565806329|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
156742470|NCT03117881|565806330|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
156742471|NCT03117881|565806328|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
156742472|NCT03117881|565806329|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
156742473|NCT03117881|565806330|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
156742474|NCT03117881|565806328|FG000|12-Month Follow-Up|Did not complete test|40|||
156742475|NCT03117881|565806329|FG001|12-Month Follow-Up|Did not complete test|0|||
156742476|NCT03117881|565806330|FG002|12-Month Follow-Up|Did not complete test|0|||
156742477|NCT02304380|565806332|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742478|NCT02304380|565806333|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742479|NCT02304380|565806334|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742480|NCT02304380|565806335|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
156742481|NCT02304380|565806336|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742482|NCT02304380|565806337|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742483|NCT01027897|565806338|FG000|Overall Study|Protocol Violation|1|||
156742484|NCT01027897|565806338|FG000|Overall Study|Withdrawal by Subject|1|||
156742485|NCT00473824|565806339|FG000|Overall Study|Virologic Breakthrough|1|||
156742486|NCT00473824|565806340|FG001|Overall Study|Virologic Breakthrough|0|||
156742487|NCT00473824|565806339|FG000|Overall Study|Adverse Event|1|||
156742488|NCT00473824|565806340|FG001|Overall Study|Adverse Event|0|||
156798174|NCT03396445|566015657|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798175|NCT03396445|566015658|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156808879|NCT00589797|566054494|FG001|Overall Study|Withdrawal by Subject|5|||
156742489|NCT00473824|565806339|FG000|Overall Study|Death|1|||
156742490|NCT00473824|565806340|FG001|Overall Study|Death|0|||
156742491|NCT00473824|565806339|FG000|Overall Study|Lost to Follow-up|1|||
156742492|NCT00473824|565806340|FG001|Overall Study|Lost to Follow-up|0|||
156742493|NCT00473824|565806339|FG000|Overall Study|Withdrawal by physician|1|||
156742494|NCT00473824|565806340|FG001|Overall Study|Withdrawal by physician|0|||
156742495|NCT01349322|565806341|FG000|Overall Study|Protocol Violation|45|||
156742496|NCT01349322|565806342|FG001|Overall Study|Protocol Violation|47|||
156742497|NCT00985426|565806346|FG000|Overall Study|Adverse Event|0|||
156742498|NCT00985426|565806347|FG001|Overall Study|Adverse Event|1|||
156742499|NCT00985426|565806346|FG000|Overall Study|Subject Non-Compliance|3|||
156742500|NCT00985426|565806347|FG001|Overall Study|Subject Non-Compliance|3|||
156742501|NCT00985426|565806346|FG000|Overall Study|Withdrawal by Subject|12|||
156742502|NCT00985426|565806347|FG001|Overall Study|Withdrawal by Subject|16|||
156742503|NCT00985426|565806346|FG000|Overall Study|Lost to Follow-up|8|||
156742504|NCT00985426|565806347|FG001|Overall Study|Lost to Follow-up|10|||
156742505|NCT00985426|565806346|FG000|Overall Study|Death|7|||
156742506|NCT00985426|565806347|FG001|Overall Study|Death|3|||
156742507|NCT00985426|565806346|FG000|Overall Study|Protocol Violation|2|||
156742508|NCT00985426|565806347|FG001|Overall Study|Protocol Violation|0|||
156742509|NCT00985426|565806346|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
156742510|NCT00985426|565806347|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
156742511|NCT01661933|565806348|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
156742512|NCT01661933|565806348|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
156742513|NCT03385304|565806349|FG000|Overall Study|Death|19|||
156742514|NCT03385304|565806350|FG001|Overall Study|Death|7|||
156742515|NCT03385304|565806349|FG000|Overall Study|Lost to Follow-up|17|||
156742516|NCT03385304|565806350|FG001|Overall Study|Lost to Follow-up|14|||
156742517|NCT03385304|565806349|FG000|Overall Study|Withdrawal by Subject|3|||
156742518|NCT03385304|565806350|FG001|Overall Study|Withdrawal by Subject|2|||
156742519|NCT03385304|565806349|FG000|Overall Study|Incarceration|2|||
156534911|NCT02229539|565054007|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
156742520|NCT03385304|565806350|FG001|Overall Study|Incarceration|3|||
156742521|NCT00723190|565806351|FG000|Overall Study|Withdrawal by Subject|45|||
156742522|NCT00723190|565806351|FG000|Overall Study|Lost to Follow-up|37|||
156742523|NCT00723190|565806351|FG000|Overall Study|Adverse Event|18|||
156742524|NCT00723190|565806351|FG000|Overall Study|Lack of Efficacy|16|||
156742525|NCT00723190|565806351|FG000|Overall Study|Protocol Violation|15|||
156742526|NCT00723190|565806351|FG000|Overall Study|Other-Premature Discontinuation|9|||
156742527|NCT00723190|565806351|FG000|Overall Study|Other-Not included in safety population|2|||
156742528|NCT00480493|565806356|FG000|Overall Study|moved|2|||
156742529|NCT00480493|565806357|FG001|Overall Study|moved|7|||
156742530|NCT03769675|565806358|FG000|Overall Study|Lost to Follow-up|1|||
156742531|NCT02844907|565806359|FG000|With Dexamethasone|No IV access|1|||
156742532|NCT02772276|565806360|FG000|Overall Study|Lost to Follow-up|0|||
156742533|NCT02772276|565806361|FG001|Overall Study|Lost to Follow-up|0|||
156742534|NCT02772276|565806362|FG002|Overall Study|Lost to Follow-up|0|||
156742535|NCT02772276|565806363|FG003|Overall Study|Lost to Follow-up|0|||
156742536|NCT02772276|565806364|FG004|Overall Study|Lost to Follow-up|0|||
156742537|NCT02772276|565806365|FG005|Overall Study|Lost to Follow-up|0|||
156742538|NCT02772276|565806366|FG006|Overall Study|Lost to Follow-up|1|||
156742539|NCT02772276|565806367|FG007|Overall Study|Lost to Follow-up|0|||
156742540|NCT02772276|565806368|FG008|Overall Study|Lost to Follow-up|0|||
156742541|NCT02772276|565806369|FG009|Overall Study|Lost to Follow-up|0|||
156742542|NCT02772276|565806370|FG010|Overall Study|Lost to Follow-up|0|||
156742543|NCT02772276|565806371|FG011|Overall Study|Lost to Follow-up|0|||
156742544|NCT02772276|565806372|FG012|Overall Study|Lost to Follow-up|0|||
156742545|NCT02772276|565806360|FG000|Overall Study|Withdrew consent|0|||
156742546|NCT02772276|565806361|FG001|Overall Study|Withdrew consent|0|||
156742547|NCT02772276|565806362|FG002|Overall Study|Withdrew consent|0|||
156742548|NCT02772276|565806363|FG003|Overall Study|Withdrew consent|0|||
156742549|NCT02772276|565806364|FG004|Overall Study|Withdrew consent|0|||
156742550|NCT02772276|565806365|FG005|Overall Study|Withdrew consent|0|||
156742551|NCT02772276|565806366|FG006|Overall Study|Withdrew consent|0|||
156742552|NCT02772276|565806367|FG007|Overall Study|Withdrew consent|1|||
156742553|NCT02772276|565806368|FG008|Overall Study|Withdrew consent|0|||
156742554|NCT02772276|565806369|FG009|Overall Study|Withdrew consent|0|||
156742555|NCT02772276|565806370|FG010|Overall Study|Withdrew consent|0|||
156742556|NCT02772276|565806371|FG011|Overall Study|Withdrew consent|0|||
156742557|NCT02772276|565806372|FG012|Overall Study|Withdrew consent|0|||
156742558|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
156742559|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
156742560|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
156742561|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
156742562|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
156742563|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
156742564|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
156742565|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
156742566|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
156742567|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
156742568|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
156742569|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
156742570|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
156742571|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
156742572|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
156742573|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
156742574|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
156742575|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
156742576|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
156742577|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
156742578|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
156742579|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
156742580|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
156742581|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
156742582|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
156742583|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
156742584|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
156798176|NCT03396445|566015659|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798177|NCT03396445|566015660|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798178|NCT03396445|566015661|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798179|NCT03396445|566015662|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798180|NCT03396445|566015663|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798181|NCT03396445|566015664|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156808880|NCT00589797|566054493|FG000|Overall Study|Non-Randomized Training Subjects|46|||
156742585|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
156742586|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
156742587|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
156742588|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
156742589|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
156742590|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
156742591|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
156742592|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
156742593|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
156742594|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
156742595|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
156742596|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
156742597|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
156742598|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
156742599|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
156742600|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
156742601|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
156742602|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
156742603|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
156742604|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
156742605|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
156742606|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
156798182|NCT03396445|566015665|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798183|NCT03396445|566015666|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798184|NCT03396445|566015667|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798185|NCT03396445|566015668|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798186|NCT03396445|566015669|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798187|NCT03396445|566015644|FG000|Treatment Period|Withdrawal by Subject|0|||
156798188|NCT03396445|566015645|FG001|Treatment Period|Withdrawal by Subject|0|||
156798189|NCT03396445|566015646|FG002|Treatment Period|Withdrawal by Subject|0|||
156798190|NCT03396445|566015647|FG003|Treatment Period|Withdrawal by Subject|0|||
156798191|NCT03396445|566015648|FG004|Treatment Period|Withdrawal by Subject|0|||
156742607|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
156742608|NCT02248974|565806381|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
156742609|NCT02248974|565806382|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
156742610|NCT02248974|565806381|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
156742611|NCT02248974|565806382|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
156742612|NCT02248974|565806381|FG000|1-Day Follow-Up|Enrolled in another study|1|||
156742613|NCT02248974|565806382|FG001|1-Day Follow-Up|Enrolled in another study|0|||
156742614|NCT02248974|565806381|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
156742615|NCT02248974|565806382|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
156742616|NCT02248974|565806381|FG000|1-Week Follow-Up|Enrolled in another study|1|||
156742617|NCT02248974|565806382|FG001|1-Week Follow-Up|Enrolled in another study|1|||
156742618|NCT02248974|565806381|FG000|1-Week Follow-Up|Transferred to another facility|1|||
156742619|NCT02248974|565806382|FG001|1-Week Follow-Up|Transferred to another facility|0|||
156742620|NCT02248974|565806381|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
156742621|NCT02248974|565806382|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
156742622|NCT02248974|565806381|FG000|1-Week Follow-Up|Death|1|||
156742623|NCT02248974|565806382|FG001|1-Week Follow-Up|Death|1|||
156742624|NCT02248974|565806381|FG000|1-Week Follow-Up|Excluded because of age|0|||
156742625|NCT02248974|565806382|FG001|1-Week Follow-Up|Excluded because of age|1|||
156742626|NCT02248974|565806381|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
156742627|NCT02248974|565806382|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
156742628|NCT02248974|565806381|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
156742629|NCT02248974|565806382|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
156742630|NCT02248974|565806381|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
156742631|NCT02248974|565806382|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
156742632|NCT02248974|565806381|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
156742633|NCT02248974|565806382|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
156742634|NCT02248974|565806381|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
156742635|NCT02248974|565806382|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
156742636|NCT04093492|565806383|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
156742637|NCT04093492|565806384|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
156742638|NCT04093492|565806385|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
156742639|NCT04093492|565806386|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
156742640|NCT04093492|565806383|FG000|25 Weeks Gestational Age (GA)|No response|5|||
156742641|NCT04093492|565806384|FG001|25 Weeks Gestational Age (GA)|No response|5|||
156742642|NCT04093492|565806385|FG002|25 Weeks Gestational Age (GA)|No response|5|||
156742643|NCT04093492|565806386|FG003|25 Weeks Gestational Age (GA)|No response|2|||
156742644|NCT04093492|565806383|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
156742645|NCT04093492|565806384|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
156742646|NCT04093492|565806385|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
156742647|NCT04093492|565806386|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
156742648|NCT04093492|565806383|FG000|30 Weeks GA|Delivered before assessment|1|||
156742649|NCT04093492|565806384|FG001|30 Weeks GA|Delivered before assessment|2|||
156742650|NCT04093492|565806385|FG002|30 Weeks GA|Delivered before assessment|0|||
156742651|NCT04093492|565806386|FG003|30 Weeks GA|Delivered before assessment|0|||
156742652|NCT04093492|565806383|FG000|30 Weeks GA|No response|7|||
156742653|NCT04093492|565806384|FG001|30 Weeks GA|No response|5|||
156742654|NCT04093492|565806385|FG002|30 Weeks GA|No response|5|||
156742655|NCT04093492|565806386|FG003|30 Weeks GA|No response|2|||
156742656|NCT04093492|565806383|FG000|30 Weeks GA|Lost to Follow-up|0|||
156742657|NCT04093492|565806384|FG001|30 Weeks GA|Lost to Follow-up|1|||
156742658|NCT04093492|565806385|FG002|30 Weeks GA|Lost to Follow-up|0|||
156742659|NCT04093492|565806386|FG003|30 Weeks GA|Lost to Follow-up|0|||
156742660|NCT04093492|565806383|FG000|34 Weeks GA|Delivered before assessment|6|||
156742661|NCT04093492|565806384|FG001|34 Weeks GA|Delivered before assessment|3|||
156742662|NCT04093492|565806385|FG002|34 Weeks GA|Delivered before assessment|0|||
156742663|NCT04093492|565806386|FG003|34 Weeks GA|Delivered before assessment|0|||
156742664|NCT04093492|565806383|FG000|34 Weeks GA|No response|0|||
156742665|NCT04093492|565806384|FG001|34 Weeks GA|No response|7|||
156742666|NCT04093492|565806385|FG002|34 Weeks GA|No response|5|||
156742667|NCT04093492|565806386|FG003|34 Weeks GA|No response|3|||
156742668|NCT04093492|565806383|FG000|34 Weeks GA|Lost to Follow-up|0|||
156742669|NCT04093492|565806384|FG001|34 Weeks GA|Lost to Follow-up|1|||
156742670|NCT04093492|565806385|FG002|34 Weeks GA|Lost to Follow-up|0|||
156742671|NCT04093492|565806386|FG003|34 Weeks GA|Lost to Follow-up|0|||
156798192|NCT03396445|566015649|FG005|Treatment Period|Withdrawal by Subject|0|||
156742672|NCT02945254|565806393|FG000|Overall Study|Lost to Follow-up|1|||
156798193|NCT03396445|566015650|FG006|Treatment Period|Withdrawal by Subject|0|||
156337006|NCT03855228|564331449|FG002|Overall Study|Lost to Follow-up|0|||
156742673|NCT02945254|565806394|FG001|Overall Study|Lost to Follow-up|0|||
156742674|NCT02945254|565806393|FG000|Overall Study|Withdrawal by Subject|1|||
156742675|NCT02945254|565806394|FG001|Overall Study|Withdrawal by Subject|0|||
156742676|NCT00783224|565806395|FG000|Overall Study|Adverse Event|0|||
156742677|NCT00783224|565806396|FG001|Overall Study|Adverse Event|0|||
156798194|NCT03396445|566015651|FG007|Treatment Period|Withdrawal by Subject|0|||
156742678|NCT00783224|565806397|FG002|Overall Study|Adverse Event|1|||
156742679|NCT00783224|565806398|FG003|Overall Study|Adverse Event|0|||
156742680|NCT00783224|565806395|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
156742681|NCT00783224|565806396|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
156742682|NCT00783224|565806397|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
156742683|NCT00783224|565806398|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
156742684|NCT00783224|565806395|FG000|Overall Study|Inappropriate as a study subject|0|||
156742685|NCT00783224|565806396|FG001|Overall Study|Inappropriate as a study subject|0|||
156742686|NCT00783224|565806397|FG002|Overall Study|Inappropriate as a study subject|0|||
156742687|NCT00783224|565806398|FG003|Overall Study|Inappropriate as a study subject|1|||
156742688|NCT04631107|565806399|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
156742689|NCT04631107|565806399|FG000|Second Intervention (1 Night)|Adverse Event|1|||
156742690|NCT04631107|565806399|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
156742691|NCT04631107|565806399|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
156742692|NCT00772005|565806401|FG000|Overall Study|Adverse Event|9|||
156742693|NCT00772005|565806402|FG001|Overall Study|Adverse Event|14|||
156742694|NCT00772005|565806403|FG002|Overall Study|Adverse Event|10|||
156742695|NCT00772005|565806404|FG003|Overall Study|Adverse Event|13|||
156798195|NCT03396445|566015652|FG008|Treatment Period|Withdrawal by Subject|0|||
156798196|NCT03396445|566015653|FG009|Treatment Period|Withdrawal by Subject|0|||
156798197|NCT03396445|566015654|FG010|Treatment Period|Withdrawal by Subject|0|||
156798198|NCT03396445|566015655|FG011|Treatment Period|Withdrawal by Subject|0|||
156798199|NCT03396445|566015656|FG012|Treatment Period|Withdrawal by Subject|0|||
156798200|NCT03396445|566015657|FG013|Treatment Period|Withdrawal by Subject|0|||
156798201|NCT03396445|566015658|FG014|Treatment Period|Withdrawal by Subject|1|||
156798202|NCT03396445|566015659|FG015|Treatment Period|Withdrawal by Subject|0|||
156798203|NCT03396445|566015660|FG016|Treatment Period|Withdrawal by Subject|1|||
156798204|NCT03396445|566015661|FG017|Treatment Period|Withdrawal by Subject|0|||
156798205|NCT03396445|566015662|FG018|Treatment Period|Withdrawal by Subject|0|||
156798206|NCT03396445|566015663|FG019|Treatment Period|Withdrawal by Subject|0|||
156798207|NCT03396445|566015664|FG020|Treatment Period|Withdrawal by Subject|0|||
156798208|NCT03396445|566015665|FG021|Treatment Period|Withdrawal by Subject|0|||
156798209|NCT03396445|566015666|FG022|Treatment Period|Withdrawal by Subject|0|||
156798210|NCT03396445|566015667|FG023|Treatment Period|Withdrawal by Subject|0|||
156798211|NCT03396445|566015668|FG024|Treatment Period|Withdrawal by Subject|0|||
156798212|NCT03396445|566015669|FG025|Treatment Period|Withdrawal by Subject|0|||
156798213|NCT03396445|566015644|FG000|Switch-over Period|Death|0|||
156798214|NCT03396445|566015645|FG001|Switch-over Period|Death|0|||
156798215|NCT03396445|566015646|FG002|Switch-over Period|Death|0|||
156798216|NCT03396445|566015647|FG003|Switch-over Period|Death|0|||
156798217|NCT03396445|566015648|FG004|Switch-over Period|Death|0|||
156798218|NCT03396445|566015649|FG005|Switch-over Period|Death|0|||
156798219|NCT03396445|566015650|FG006|Switch-over Period|Death|0|||
156798220|NCT03396445|566015651|FG007|Switch-over Period|Death|0|||
156798221|NCT03396445|566015652|FG008|Switch-over Period|Death|0|||
156798222|NCT03396445|566015653|FG009|Switch-over Period|Death|0|||
156798223|NCT03396445|566015654|FG010|Switch-over Period|Death|0|||
156798224|NCT03396445|566015655|FG011|Switch-over Period|Death|0|||
156798225|NCT03396445|566015656|FG012|Switch-over Period|Death|0|||
156798226|NCT03396445|566015657|FG013|Switch-over Period|Death|0|||
156798227|NCT03396445|566015658|FG014|Switch-over Period|Death|0|||
156798228|NCT03396445|566015659|FG015|Switch-over Period|Death|0|||
156798229|NCT03396445|566015660|FG016|Switch-over Period|Death|0|||
156798230|NCT03396445|566015661|FG017|Switch-over Period|Death|0|||
156798231|NCT03396445|566015662|FG018|Switch-over Period|Death|1|||
156798232|NCT03396445|566015663|FG019|Switch-over Period|Death|2|||
156798233|NCT03396445|566015664|FG020|Switch-over Period|Death|2|||
156798234|NCT03396445|566015665|FG021|Switch-over Period|Death|1|||
156798235|NCT03396445|566015666|FG022|Switch-over Period|Death|2|||
156742696|NCT00772005|565806401|FG000|Overall Study|Lack of Efficacy|0|||
156742697|NCT00772005|565806402|FG001|Overall Study|Lack of Efficacy|1|||
156742698|NCT00772005|565806403|FG002|Overall Study|Lack of Efficacy|0|||
156798236|NCT03396445|566015667|FG023|Switch-over Period|Death|0|||
156798237|NCT03396445|566015668|FG024|Switch-over Period|Death|1|||
156798238|NCT03396445|566015669|FG025|Switch-over Period|Death|6|||
156742699|NCT00772005|565806404|FG003|Overall Study|Lack of Efficacy|0|||
156742700|NCT00772005|565806401|FG000|Overall Study|Withdrawal by Subject|3|||
156742701|NCT00772005|565806402|FG001|Overall Study|Withdrawal by Subject|7|||
156742702|NCT00772005|565806403|FG002|Overall Study|Withdrawal by Subject|10|||
156798239|NCT03396445|566015644|FG000|Switch-over Period|Lost to Follow-up|0|||
156798240|NCT03396445|566015645|FG001|Switch-over Period|Lost to Follow-up|0|||
156798241|NCT03396445|566015646|FG002|Switch-over Period|Lost to Follow-up|0|||
156798242|NCT03396445|566015647|FG003|Switch-over Period|Lost to Follow-up|0|||
156798243|NCT03396445|566015648|FG004|Switch-over Period|Lost to Follow-up|0|||
156742703|NCT00772005|565806404|FG003|Overall Study|Withdrawal by Subject|2|||
156798244|NCT03396445|566015649|FG005|Switch-over Period|Lost to Follow-up|0|||
156798245|NCT03396445|566015650|FG006|Switch-over Period|Lost to Follow-up|0|||
156798246|NCT03396445|566015651|FG007|Switch-over Period|Lost to Follow-up|0|||
156742704|NCT00772005|565806401|FG000|Overall Study|Protocol Violation|2|||
156742705|NCT00772005|565806402|FG001|Overall Study|Protocol Violation|4|||
156742706|NCT00772005|565806403|FG002|Overall Study|Protocol Violation|1|||
156742707|NCT00772005|565806404|FG003|Overall Study|Protocol Violation|6|||
156742708|NCT00772005|565806401|FG000|Overall Study|Lost to Follow-up|7|||
156742709|NCT00772005|565806402|FG001|Overall Study|Lost to Follow-up|3|||
156742710|NCT00772005|565806403|FG002|Overall Study|Lost to Follow-up|6|||
156742711|NCT00772005|565806404|FG003|Overall Study|Lost to Follow-up|3|||
156742712|NCT00772005|565806401|FG000|Overall Study|Non-compliance with study procedures|1|||
156742713|NCT00772005|565806402|FG001|Overall Study|Non-compliance with study procedures|1|||
156742714|NCT00772005|565806403|FG002|Overall Study|Non-compliance with study procedures|0|||
156742715|NCT00772005|565806404|FG003|Overall Study|Non-compliance with study procedures|1|||
156742716|NCT00772005|565806401|FG000|Overall Study|Non-compliance with drug administration|3|||
156742717|NCT00772005|565806402|FG001|Overall Study|Non-compliance with drug administration|0|||
156742718|NCT00772005|565806403|FG002|Overall Study|Non-compliance with drug administration|1|||
156742719|NCT00772005|565806404|FG003|Overall Study|Non-compliance with drug administration|1|||
156742720|NCT01440569|565806409|FG000|Main Study|Enrolled but not treated|1|||
156742721|NCT01440569|565806410|FG001|Main Study|Enrolled but not treated|0|||
156742722|NCT01440569|565806409|FG000|Main Study|Adverse Event|9|||
156798247|NCT03396445|566015652|FG008|Switch-over Period|Lost to Follow-up|0|||
156798248|NCT03396445|566015653|FG009|Switch-over Period|Lost to Follow-up|0|||
156798249|NCT03396445|566015654|FG010|Switch-over Period|Lost to Follow-up|0|||
156798250|NCT03396445|566015655|FG011|Switch-over Period|Lost to Follow-up|0|||
156798251|NCT03396445|566015656|FG012|Switch-over Period|Lost to Follow-up|0|||
156798252|NCT03396445|566015657|FG013|Switch-over Period|Lost to Follow-up|0|||
156798253|NCT03396445|566015658|FG014|Switch-over Period|Lost to Follow-up|0|||
156798254|NCT03396445|566015659|FG015|Switch-over Period|Lost to Follow-up|0|||
156798255|NCT03396445|566015660|FG016|Switch-over Period|Lost to Follow-up|0|||
156798256|NCT03396445|566015661|FG017|Switch-over Period|Lost to Follow-up|0|||
156798257|NCT03396445|566015662|FG018|Switch-over Period|Lost to Follow-up|0|||
156798258|NCT03396445|566015663|FG019|Switch-over Period|Lost to Follow-up|0|||
156798259|NCT03396445|566015664|FG020|Switch-over Period|Lost to Follow-up|0|||
156798260|NCT03396445|566015665|FG021|Switch-over Period|Lost to Follow-up|0|||
156798261|NCT03396445|566015666|FG022|Switch-over Period|Lost to Follow-up|0|||
156798262|NCT03396445|566015667|FG023|Switch-over Period|Lost to Follow-up|1|||
156798263|NCT03396445|566015668|FG024|Switch-over Period|Lost to Follow-up|0|||
156798264|NCT03396445|566015669|FG025|Switch-over Period|Lost to Follow-up|0|||
156798265|NCT03552029|566015673|FG000|Overall Study|Death|3|||
156798266|NCT03552029|566015674|FG001|Overall Study|Death|0|||
156798267|NCT03552029|566015673|FG000|Overall Study|Adverse Event|1|||
156798268|NCT03552029|566015674|FG001|Overall Study|Adverse Event|0|||
156798269|NCT03552029|566015673|FG000|Overall Study|Lack of Efficacy|0|||
156798270|NCT03552029|566015674|FG001|Overall Study|Lack of Efficacy|2|||
156798271|NCT03552029|566015673|FG000|Overall Study|Physician Decision|0|||
156798272|NCT03552029|566015674|FG001|Overall Study|Physician Decision|1|||
156798273|NCT03552029|566015673|FG000|Overall Study|Study terminated by Sponsor|0|||
156798274|NCT03552029|566015674|FG001|Overall Study|Study terminated by Sponsor|1|||
156798275|NCT03552029|566015673|FG000|Overall Study|Other|0|||
156798276|NCT03552029|566015674|FG001|Overall Study|Other|2|||
156798277|NCT02552225|566015675|FG000|Overall Study|Withdrawal by Subject|1|||
156798278|NCT02552225|566015676|FG001|Overall Study|Withdrawal by Subject|0|||
156798279|NCT03122184|566015677|FG000|Overall Study|Lost to Follow-up|4|||
156798280|NCT03122184|566015678|FG001|Overall Study|Lost to Follow-up|6|||
156798281|NCT03122184|566015677|FG000|Overall Study|Withdrawal by Subject|3|||
156798282|NCT03122184|566015678|FG001|Overall Study|Withdrawal by Subject|0|||
156798283|NCT03122184|566015677|FG000|Overall Study|Terminated due to cognitive problem|1|||
156798284|NCT03122184|566015678|FG001|Overall Study|Terminated due to cognitive problem|0|||
156798285|NCT00633126|566015679|FG000|Overall Study|Did not receive full dose|1|||
156798286|NCT01168596|566015687|FG000|Overall Study|Withdrawal by Subject|3|||
156798287|NCT01168596|566015688|FG001|Overall Study|Withdrawal by Subject|1|||
156798288|NCT00876447|566015689|FG000|Overall Study|Other miscellaneous reasons|3|||
156798289|NCT00876447|566015690|FG001|Overall Study|Other miscellaneous reasons|8|||
156798290|NCT00876447|566015689|FG000|Overall Study|Site closure|19|||
156798291|NCT00876447|566015690|FG001|Overall Study|Site closure|14|||
156798292|NCT00876447|566015689|FG000|Overall Study|Protocol Violation|9|||
156798293|NCT00876447|566015690|FG001|Overall Study|Protocol Violation|3|||
156798294|NCT00876447|566015689|FG000|Overall Study|Personal reasons|30|||
156798295|NCT00876447|566015690|FG001|Overall Study|Personal reasons|28|||
156742723|NCT01440569|565806410|FG001|Main Study|Adverse Event|0|||
156798296|NCT00876447|566015689|FG000|Overall Study|Lost to Follow-up|6|||
156798297|NCT00876447|566015690|FG001|Overall Study|Lost to Follow-up|15|||
156798298|NCT00876447|566015689|FG000|Overall Study|Pregnancy|4|||
156798299|NCT00876447|566015690|FG001|Overall Study|Pregnancy|2|||
156798300|NCT00876447|566015689|FG000|Overall Study|Lack of Efficacy|5|||
156798301|NCT00876447|566015690|FG001|Overall Study|Lack of Efficacy|3|||
156798302|NCT00876447|566015689|FG000|Overall Study|Adverse Event|4|||
156798303|NCT00876447|566015690|FG001|Overall Study|Adverse Event|8|||
156337007|NCT03855228|564331450|FG003|Overall Study|Lost to Follow-up|1|||
156742724|NCT01440569|565806409|FG000|Main Study|Pregnancy|1|||
156742725|NCT01440569|565806410|FG001|Main Study|Pregnancy|0|||
156742726|NCT01440569|565806409|FG000|Main Study|Investigator's Discretion|1|||
156742727|NCT01440569|565806410|FG001|Main Study|Investigator's Discretion|1|||
156742728|NCT01440569|565806409|FG000|Main Study|Withdrew Consent|7|||
156742729|NCT01440569|565806410|FG001|Main Study|Withdrew Consent|1|||
156742730|NCT01440569|565806409|FG000|Main Study|Lost to Follow-up|13|||
156742731|NCT01440569|565806410|FG001|Main Study|Lost to Follow-up|2|||
156742732|NCT01440569|565806409|FG000|Main Study|Subject Non-Compliance|3|||
156742733|NCT01440569|565806410|FG001|Main Study|Subject Non-Compliance|0|||
156742734|NCT01440569|565806409|FG000|Main Study|Protocol Violation|1|||
156742735|NCT01440569|565806410|FG001|Main Study|Protocol Violation|0|||
156742736|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Adverse Event|3|||
156742737|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Adverse Event|0|||
156742738|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Pregnancy|1|||
156742739|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Pregnancy|0|||
156742740|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
156742741|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
156742742|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
156742743|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
156742744|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
156742745|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
156742746|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
156742747|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
156742748|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
156742749|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
156742750|NCT02584959|565806419|FG000|Period 1|Withdrawn from study|3|||
156742751|NCT02584959|565806420|FG001|Period 1|Withdrawn from study|4|||
156742752|NCT02584959|565806421|FG002|Period 1|Withdrawn from study|0|||
156742753|NCT02584959|565806419|FG000|Period 2|Withdrawn from study|6|||
156742754|NCT02584959|565806420|FG001|Period 2|Withdrawn from study|1|||
156742755|NCT02584959|565806421|FG002|Period 2|Withdrawn from study|2|||
156742756|NCT01793688|565806430|FG000|Overall Study|Protocol Violation|2|||
156742757|NCT00150800|565806431|FG000|Overall Study|Adverse Event|89|||
156742758|NCT00150800|565806431|FG000|Overall Study|Death|18|||
156742759|NCT00150800|565806431|FG000|Overall Study|Lack of Efficacy|166|||
156742760|NCT00150800|565806431|FG000|Overall Study|Lost to Follow-up|58|||
156742761|NCT00150800|565806431|FG000|Overall Study|Subject's choice|90|||
156742762|NCT00150800|565806431|FG000|Overall Study|No compliance|18|||
156742763|NCT00150800|565806431|FG000|Overall Study|IP misshandling|1|||
156742764|NCT00150800|565806431|FG000|Overall Study|Site closure|24|||
156742765|NCT00150800|565806431|FG000|Overall Study|Protocol non-adherence|2|||
156742766|NCT00150800|565806431|FG000|Overall Study|Nobody to accompany patient|1|||
156742767|NCT00150800|565806431|FG000|Overall Study|Distance too long for patient|1|||
156742768|NCT00150800|565806431|FG000|Overall Study|Neurosurgery|2|||
156337008|NCT03855228|564331447|FG000|Overall Study|Protocol Violation|0|||
156742769|NCT00150800|565806431|FG000|Overall Study|BRV monotherapy|1|||
156742770|NCT00150800|565806431|FG000|Overall Study|Visit refusal|3|||
156742771|NCT00150800|565806431|FG000|Overall Study|Sponsor's request|2|||
156742772|NCT00150800|565806431|FG000|Overall Study|Generalized Epilepsy|1|||
156742773|NCT00150800|565806431|FG000|Overall Study|Moved from area/country|8|||
156337009|NCT03855228|564331448|FG001|Overall Study|Protocol Violation|1|||
156742774|NCT00150800|565806431|FG000|Overall Study|PI retiring|2|||
156742775|NCT00150800|565806431|FG000|Overall Study|PI leaving site|2|||
156742776|NCT00150800|565806431|FG000|Overall Study|Patient insurance|1|||
156742777|NCT00150800|565806431|FG000|Overall Study|Surgical intervention|4|||
156337010|NCT03855228|564331449|FG002|Overall Study|Protocol Violation|2|||
156742778|NCT00150800|565806431|FG000|Overall Study|Pregnancy planned|1|||
156742779|NCT00150800|565806431|FG000|Overall Study|PI discontinuation request|1|||
156742780|NCT04756154|565806442|FG000|Overall Study|Did not meet treatment day baseline|30|||
156742781|NCT04756154|565806443|FG001|Overall Study|Did not meet treatment day baseline|28|||
156742782|NCT04756154|565806444|FG002|Overall Study|Did not meet treatment day baseline|7|||
156742783|NCT04756154|565806442|FG000|Overall Study|Did not return for final sample collection|1|||
156742784|NCT04756154|565806443|FG001|Overall Study|Did not return for final sample collection|1|||
156742785|NCT04756154|565806444|FG002|Overall Study|Did not return for final sample collection|0|||
156742786|NCT03430895|565806451|FG000|Overall Study|Not Treated|2|||
156742787|NCT01645891|565806457|FG000|Overall Study|Adverse Event|6|||
156742788|NCT01645891|565806458|FG001|Overall Study|Adverse Event|10|||
156742789|NCT01645891|565806457|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
156742790|NCT01645891|565806458|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
156742791|NCT01645891|565806457|FG000|Overall Study|Withdrawal by Subject|3|||
156742792|NCT01645891|565806458|FG001|Overall Study|Withdrawal by Subject|3|||
156742793|NCT01645891|565806457|FG000|Overall Study|Protocol Violation|4|||
156742794|NCT01645891|565806458|FG001|Overall Study|Protocol Violation|0|||
156742795|NCT01645891|565806457|FG000|Overall Study|Lost to Follow-up|4|||
156742796|NCT01645891|565806458|FG001|Overall Study|Lost to Follow-up|1|||
156742797|NCT01645891|565806457|FG000|Overall Study|Death|0|||
156742798|NCT01645891|565806458|FG001|Overall Study|Death|2|||
156742799|NCT00138073|565806459|FG000|Overall Study|lack of resources|55|||
156742800|NCT03301740|565806460|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
156742801|NCT03301740|565806461|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
156742802|NCT03301740|565806460|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
156742803|NCT03301740|565806461|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
156742804|NCT01173055|565806466|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
156742805|NCT01173055|565806467|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
156742806|NCT01173055|565806466|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
156742807|NCT01173055|565806467|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
156742808|NCT04253782|565806468|FG000|Overall Study|Death|2|||
156742809|NCT04253782|565806469|FG001|Overall Study|Death|0|||
156742810|NCT01306045|565806474|FG000|Met General Eligibility Criteria|Screen failures|193|||
156742811|NCT01306045|565806475|FG001|Met General Eligibility Criteria|Screen failures|11|||
156742812|NCT01306045|565806476|FG002|Met General Eligibility Criteria|Screen failures|8|||
156742813|NCT05685732|565806477|FG000|Overall Study|Withdrawal by Subject|2|||
156742814|NCT05685732|565806478|FG001|Overall Study|Withdrawal by Subject|0|||
156742815|NCT05685732|565806479|FG002|Overall Study|Withdrawal by Subject|2|||
156742816|NCT05685732|565806480|FG003|Overall Study|Withdrawal by Subject|3|||
156742817|NCT05685732|565806477|FG000|Overall Study|Protocol Violation|1|||
156742818|NCT05685732|565806478|FG001|Overall Study|Protocol Violation|2|||
156742819|NCT05685732|565806479|FG002|Overall Study|Protocol Violation|4|||
156742820|NCT05685732|565806480|FG003|Overall Study|Protocol Violation|1|||
156742821|NCT05685732|565806477|FG000|Overall Study|Lost to Follow-up|5|||
156742822|NCT05685732|565806478|FG001|Overall Study|Lost to Follow-up|1|||
156742823|NCT05685732|565806479|FG002|Overall Study|Lost to Follow-up|3|||
156742824|NCT05685732|565806480|FG003|Overall Study|Lost to Follow-up|1|||
156742825|NCT05685732|565806477|FG000|Overall Study|Adverse Event|2|||
156742826|NCT05685732|565806478|FG001|Overall Study|Adverse Event|1|||
156742827|NCT05685732|565806479|FG002|Overall Study|Adverse Event|0|||
156742828|NCT05685732|565806480|FG003|Overall Study|Adverse Event|0|||
156742829|NCT05685732|565806477|FG000|Overall Study|Physician Decision|1|||
156742830|NCT05685732|565806478|FG001|Overall Study|Physician Decision|0|||
156742831|NCT05685732|565806479|FG002|Overall Study|Physician Decision|0|||
156742832|NCT05685732|565806480|FG003|Overall Study|Physician Decision|0|||
156742833|NCT02640404|565806481|FG000|Overall Study|Protocol Violation|1|||
156742834|NCT02640404|565806482|FG001|Overall Study|Protocol Violation|0|||
156742835|NCT02640404|565806481|FG000|Overall Study|Withdrawal by Subject|1|||
156742836|NCT02640404|565806482|FG001|Overall Study|Withdrawal by Subject|0|||
156742837|NCT04908202|565806483|FG000|Pre-Treatment Period|OTHER REASONS|3|||
156742838|NCT04908202|565806484|FG001|Pre-Treatment Period|OTHER REASONS|1|||
156742839|NCT04908202|565806485|FG002|Pre-Treatment Period|OTHER REASONS|0|||
156742840|NCT04908202|565806486|FG003|Pre-Treatment Period|OTHER REASONS|0|||
156742841|NCT04908202|565806483|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
156742842|NCT04908202|565806484|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742843|NCT04908202|565806485|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742844|NCT04908202|565806486|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156337011|NCT03855228|564331450|FG003|Overall Study|Protocol Violation|1|||
156742845|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
156742846|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
156742847|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
156742848|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
156742849|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
156742850|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
156742851|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
156742852|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
156742853|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
156742854|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
156742855|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
156742856|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
156742857|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
156742858|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
156742859|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742860|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742861|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
156742862|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
156742863|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
156742864|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
156742865|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742866|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
156742867|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742868|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742869|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
156742870|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
156742871|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
156742872|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
156742873|NCT04908202|565806483|FG000|Active Treatment Period|OTHER REASONS|0|||
156742874|NCT04908202|565806484|FG001|Active Treatment Period|OTHER REASONS|0|||
156742875|NCT04908202|565806485|FG002|Active Treatment Period|OTHER REASONS|1|||
156742876|NCT04908202|565806486|FG003|Active Treatment Period|OTHER REASONS|3|||
156742877|NCT04908202|565806483|FG000|Active Treatment Period|Lack of Efficacy|0|||
156742878|NCT04908202|565806484|FG001|Active Treatment Period|Lack of Efficacy|0|||
156742879|NCT04908202|565806485|FG002|Active Treatment Period|Lack of Efficacy|4|||
156742880|NCT04908202|565806486|FG003|Active Treatment Period|Lack of Efficacy|5|||
156742881|NCT04908202|565806483|FG000|Active Treatment Period|Adverse Event|0|||
156742882|NCT04908202|565806484|FG001|Active Treatment Period|Adverse Event|0|||
156742883|NCT04908202|565806485|FG002|Active Treatment Period|Adverse Event|5|||
156742884|NCT04908202|565806486|FG003|Active Treatment Period|Adverse Event|8|||
156742885|NCT04908202|565806483|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
156742886|NCT04908202|565806484|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
156742887|NCT04908202|565806485|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
156742888|NCT04908202|565806486|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
156742889|NCT04908202|565806483|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742890|NCT04908202|565806484|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742891|NCT04908202|565806485|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
156742892|NCT04908202|565806486|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
156742893|NCT04908202|565806483|FG000|Active Treatment Period|Lost to Follow-up|0|||
156742894|NCT04908202|565806484|FG001|Active Treatment Period|Lost to Follow-up|0|||
156742895|NCT04908202|565806485|FG002|Active Treatment Period|Lost to Follow-up|2|||
156742896|NCT04908202|565806486|FG003|Active Treatment Period|Lost to Follow-up|2|||
156742897|NCT04908202|565806483|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
156742898|NCT04908202|565806484|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
156742899|NCT04908202|565806485|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
156742900|NCT04908202|565806486|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
156742901|NCT04908202|565806483|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742902|NCT04908202|565806484|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742903|NCT04908202|565806485|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
156742904|NCT04908202|565806486|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
156742905|NCT04908202|565806483|FG000|Active Treatment Period|ONGOING Treatment|0|||
156742906|NCT04908202|565806484|FG001|Active Treatment Period|ONGOING Treatment|0|||
156742907|NCT04908202|565806485|FG002|Active Treatment Period|ONGOING Treatment|117|||
156742908|NCT04908202|565806486|FG003|Active Treatment Period|ONGOING Treatment|114|||
156742909|NCT05397171|565806487|FG000|Overall Study|Death|2|||
156742910|NCT05397171|565806488|FG001|Overall Study|Death|3|||
156742911|NCT05397171|565806489|FG002|Overall Study|Death|3|||
156742912|NCT05397171|565806487|FG000|Overall Study|Study Terminated By Sponsor|1|||
156742913|NCT05397171|565806488|FG001|Overall Study|Study Terminated By Sponsor|2|||
156742914|NCT05397171|565806489|FG002|Overall Study|Study Terminated By Sponsor|3|||
156742915|NCT05397171|565806487|FG000|Overall Study|Withdrawal by Subject|0|||
156742916|NCT05397171|565806488|FG001|Overall Study|Withdrawal by Subject|1|||
156742917|NCT05397171|565806489|FG002|Overall Study|Withdrawal by Subject|1|||
156742918|NCT00549601|565808164|FG000|Randomized|Protocol Violation|0|||
156742919|NCT00549601|565808165|FG001|Randomized|Protocol Violation|0|||
156742920|NCT00549601|565808166|FG002|Randomized|Protocol Violation|1|||
156742921|NCT00549601|565808164|FG000|Randomized|Withdrawal by Subject|0|||
156742922|NCT00549601|565808165|FG001|Randomized|Withdrawal by Subject|1|||
156742923|NCT00549601|565808166|FG002|Randomized|Withdrawal by Subject|1|||
156742924|NCT00549601|565808164|FG000|Received Study Drug|Adverse Event|2|||
156742925|NCT00549601|565808165|FG001|Received Study Drug|Adverse Event|5|||
156742926|NCT00549601|565808166|FG002|Received Study Drug|Adverse Event|1|||
156742927|NCT00549601|565808164|FG000|Received Study Drug|Death|0|||
156742928|NCT00549601|565808165|FG001|Received Study Drug|Death|1|||
156742929|NCT00549601|565808166|FG002|Received Study Drug|Death|0|||
156742930|NCT00549601|565808164|FG000|Received Study Drug|Lost to Follow-up|0|||
156742931|NCT00549601|565808165|FG001|Received Study Drug|Lost to Follow-up|1|||
156742932|NCT00549601|565808166|FG002|Received Study Drug|Lost to Follow-up|1|||
156742933|NCT00549601|565808164|FG000|Received Study Drug|Protocol Violation|3|||
156742934|NCT00549601|565808165|FG001|Received Study Drug|Protocol Violation|4|||
156742935|NCT00549601|565808166|FG002|Received Study Drug|Protocol Violation|1|||
156742936|NCT00549601|565808164|FG000|Received Study Drug|Withdrawal by Subject|2|||
156742937|NCT00549601|565808165|FG001|Received Study Drug|Withdrawal by Subject|0|||
156742938|NCT00549601|565808166|FG002|Received Study Drug|Withdrawal by Subject|1|||
156742939|NCT01250171|565808170|FG000|Overall Study|Administrative reasons|1|||
156742940|NCT01250171|565808171|FG001|Overall Study|Administrative reasons|0|||
156742941|NCT01250171|565808172|FG002|Overall Study|Administrative reasons|0|||
156742942|NCT04550832|565808173|FG000|Overall Study|Adverse Event|0|||
156742943|NCT04550832|565808174|FG001|Overall Study|Adverse Event|0|||
156742944|NCT04550832|565808175|FG002|Overall Study|Adverse Event|2|||
156742945|NCT04550832|565808176|FG003|Overall Study|Adverse Event|0|||
156742946|NCT04550832|565808177|FG004|Overall Study|Adverse Event|1|||
156742947|NCT00328094|565808183|FG000|Overall Study|Physician Decision|3|||
156742948|NCT00328094|565808184|FG001|Overall Study|Physician Decision|3|||
156742949|NCT01143064|565808185|FG000|Overall Study|Death|109|||
156742950|NCT01143064|565808186|FG001|Overall Study|Death|91|||
156742951|NCT01143064|565808185|FG000|Overall Study|Adverse Event|0|||
156742952|NCT01143064|565808186|FG001|Overall Study|Adverse Event|1|||
156742953|NCT01143064|565808185|FG000|Overall Study|Withdrawal by Subject|7|||
156742954|NCT01143064|565808186|FG001|Overall Study|Withdrawal by Subject|5|||
156742955|NCT01143064|565808185|FG000|Overall Study|Lost to Follow-up|17|||
156742956|NCT01143064|565808186|FG001|Overall Study|Lost to Follow-up|14|||
156742957|NCT01143064|565808185|FG000|Overall Study|Physician Decision|0|||
156742958|NCT01143064|565808186|FG001|Overall Study|Physician Decision|4|||
156742959|NCT02453282|565808187|FG000|Overall Study|Death|275|||
156742960|NCT02453282|565808188|FG001|Overall Study|Death|277|||
156742961|NCT02453282|565808189|FG002|Overall Study|Death|296|||
156742962|NCT02453282|565808187|FG000|Overall Study|Lost to Follow-up|1|||
156742963|NCT02453282|565808188|FG001|Overall Study|Lost to Follow-up|0|||
156742964|NCT02453282|565808189|FG002|Overall Study|Lost to Follow-up|2|||
156742965|NCT02453282|565808187|FG000|Overall Study|Withdrawal by Subject|12|||
156742966|NCT02453282|565808188|FG001|Overall Study|Withdrawal by Subject|10|||
156742967|NCT02453282|565808189|FG002|Overall Study|Withdrawal by Subject|11|||
156742968|NCT02453282|565808187|FG000|Overall Study|Participants ongoing at data cut-off|85|||
156798304|NCT00567502|566015693|FG000|Overall Study|Lost to Follow-up|91|||
156798305|NCT00567502|566015694|FG001|Overall Study|Lost to Follow-up|14|||
156798306|NCT00567502|566015695|FG002|Overall Study|Lost to Follow-up|351|||
156798307|NCT00567502|566015696|FG003|Overall Study|Lost to Follow-up|2|||
156798308|NCT00567502|566015693|FG000|Overall Study|Death|65|||
156798309|NCT00567502|566015694|FG001|Overall Study|Death|16|||
156742969|NCT02453282|565808188|FG001|Overall Study|Participants ongoing at data cut-off|84|||
156742970|NCT02453282|565808189|FG002|Overall Study|Participants ongoing at data cut-off|62|||
156742971|NCT02453282|565808187|FG000|Overall Study|Other|1|||
156742972|NCT02453282|565808188|FG001|Overall Study|Other|1|||
156742973|NCT02453282|565808189|FG002|Overall Study|Other|1|||
156742974|NCT02327013|565808192|FG000|Overall Study|Adverse Event|4|||
156742975|NCT02327013|565808193|FG001|Overall Study|Adverse Event|4|||
156742976|NCT02327013|565808194|FG002|Overall Study|Adverse Event|3|||
156798310|NCT00567502|566015695|FG002|Overall Study|Death|360|||
156742977|NCT02327013|565808195|FG003|Overall Study|Adverse Event|0|||
156742978|NCT02327013|565808196|FG004|Overall Study|Adverse Event|1|||
156742979|NCT02327013|565808192|FG000|Overall Study|Lack of Efficacy|2|||
156742980|NCT02327013|565808193|FG001|Overall Study|Lack of Efficacy|0|||
156742981|NCT02327013|565808194|FG002|Overall Study|Lack of Efficacy|5|||
156798311|NCT00567502|566015696|FG003|Overall Study|Death|5|||
156798312|NCT00567502|566015693|FG000|Overall Study|Other|64|||
156337012|NCT03855228|564331447|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
156337013|NCT03855228|564331448|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
156337014|NCT03855228|564331449|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
156337015|NCT03855228|564331450|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
156337016|NCT02993757|564331451|FG000|Overall Study|Non compliance with the protocol|155|||
156337017|NCT02993757|564331452|FG001|Overall Study|Non compliance with the protocol|170|||
156337018|NCT02993757|564331451|FG000|Overall Study|Lost to Follow-up|1|||
156337019|NCT02993757|564331452|FG001|Overall Study|Lost to Follow-up|0|||
156337020|NCT02993757|564331451|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
156337021|NCT02993757|564331452|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
156337022|NCT01611155|564331454|FG000|Overall Study|Adverse Event|1|||
156337023|NCT01611155|564331455|FG001|Overall Study|Adverse Event|1|||
156337024|NCT01611155|564331454|FG000|Overall Study|Refused further treatment|6|||
156337025|NCT01611155|564331455|FG001|Overall Study|Refused further treatment|4|||
156337026|NCT01611155|564331454|FG000|Overall Study|Disease progression|1|||
156337027|NCT01611155|564331455|FG001|Overall Study|Disease progression|0|||
156337028|NCT01611155|564331454|FG000|Overall Study|Withdrawal by Subject|1|||
156337029|NCT01611155|564331455|FG001|Overall Study|Withdrawal by Subject|0|||
156337030|NCT01611155|564331454|FG000|Overall Study|Alternative treatment|0|||
156337031|NCT01611155|564331455|FG001|Overall Study|Alternative treatment|1|||
156337032|NCT01611155|564331454|FG000|Overall Study|Ineligible patient|0|||
156337033|NCT01611155|564331455|FG001|Overall Study|Ineligible patient|1|||
156337034|NCT00190671|564331458|FG000|Overall Study|Satisfactory Response|4|||
156337035|NCT00190671|564331459|FG001|Overall Study|Satisfactory Response|7|||
156337036|NCT00190671|564331458|FG000|Overall Study|Lack of Efficacy|19|||
156337037|NCT00190671|564331459|FG001|Overall Study|Lack of Efficacy|24|||
156337038|NCT00190671|564331458|FG000|Overall Study|Death from Study Disease|1|||
156337039|NCT00190671|564331459|FG001|Overall Study|Death from Study Disease|1|||
156337040|NCT00190671|564331458|FG000|Overall Study|Adverse Event|3|||
156337041|NCT00190671|564331459|FG001|Overall Study|Adverse Event|2|||
156337042|NCT00190671|564331458|FG000|Overall Study|Clinical Relapse|0|||
156337043|NCT00190671|564331459|FG001|Overall Study|Clinical Relapse|1|||
156337044|NCT00190671|564331458|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
156337045|NCT00190671|564331459|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
156337046|NCT00190671|564331458|FG000|Overall Study|Death from Other Causes|0|||
156337047|NCT00190671|564331459|FG001|Overall Study|Death from Other Causes|2|||
156337048|NCT00190671|564331458|FG000|Overall Study|Protocol Violation|0|||
156337049|NCT00190671|564331459|FG001|Overall Study|Protocol Violation|1|||
156337050|NCT00190671|564331458|FG000|Overall Study|Withdrawal by Subject|0|||
156337051|NCT00190671|564331459|FG001|Overall Study|Withdrawal by Subject|2|||
156337052|NCT00087607|564331460|FG000|Overall Study|Adverse Event|14|||
156337053|NCT00087607|564331461|FG001|Overall Study|Adverse Event|24|||
156798313|NCT00567502|566015694|FG001|Overall Study|Other|2|||
156798314|NCT00567502|566015695|FG002|Overall Study|Other|134|||
156798315|NCT00567502|566015696|FG003|Overall Study|Other|6|||
156798316|NCT00567502|566015693|FG000|Overall Study|Participant request|12|||
156798317|NCT00567502|566015694|FG001|Overall Study|Participant request|1|||
156798318|NCT00567502|566015695|FG002|Overall Study|Participant request|33|||
156798319|NCT00567502|566015696|FG003|Overall Study|Participant request|1|||
156798320|NCT00567502|566015693|FG000|Overall Study|Sponsor request|9|||
156798321|NCT00567502|566015694|FG001|Overall Study|Sponsor request|0|||
156798322|NCT00567502|566015695|FG002|Overall Study|Sponsor request|30|||
156798323|NCT00567502|566015696|FG003|Overall Study|Sponsor request|1|||
156798324|NCT00567502|566015693|FG000|Overall Study|Never Initiated Treatment|0|||
156798325|NCT00567502|566015694|FG001|Overall Study|Never Initiated Treatment|0|||
156798326|NCT00567502|566015695|FG002|Overall Study|Never Initiated Treatment|0|||
156798327|NCT00567502|566015696|FG003|Overall Study|Never Initiated Treatment|72|||
156798328|NCT02297516|566015697|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
156798329|NCT02297516|566015698|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
156798330|NCT02297516|566015697|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
156798331|NCT02297516|566015698|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
156798332|NCT02297516|566015697|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
156798333|NCT02297516|566015698|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
156798334|NCT00710593|566015699|FG000|Overall Study|Incarceration|1|||
156798335|NCT00710593|566015700|FG001|Overall Study|Incarceration|0|||
156798336|NCT00710593|566015699|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
156798337|NCT00710593|566015700|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
156798338|NCT00710593|566015699|FG000|Overall Study|Lost to Follow-up|3|||
156798339|NCT00710593|566015700|FG001|Overall Study|Lost to Follow-up|1|||
156798340|NCT00710593|566015699|FG000|Overall Study|Moved out of area|1|||
156798341|NCT00710593|566015700|FG001|Overall Study|Moved out of area|0|||
156798342|NCT00710593|566015699|FG000|Overall Study|Failure to adhere or complete study eval|1|||
156798343|NCT00710593|566015700|FG001|Overall Study|Failure to adhere or complete study eval|1|||
156798344|NCT00710593|566015699|FG000|Overall Study|Protocol Violation|1|||
156798345|NCT00710593|566015700|FG001|Overall Study|Protocol Violation|1|||
156798346|NCT00710593|566015699|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
156798347|NCT00710593|566015700|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
156798348|NCT00366457|566015704|FG000|Overall Study|never began study therapy|2|||
156798349|NCT02538614|566015705|FG000|Overall Study|Progressive Disease|2|||
156798350|NCT02829996|566015706|FG000|Overall Study|Withdrawal by Subject|1|||
156798351|NCT02829996|566015707|FG001|Overall Study|Withdrawal by Subject|0|||
156798352|NCT02829996|566015708|FG002|Overall Study|Withdrawal by Subject|0|||
156798353|NCT02829996|566015709|FG003|Overall Study|Withdrawal by Subject|0|||
156798354|NCT02829996|566015710|FG004|Overall Study|Withdrawal by Subject|0|||
156798355|NCT00189423|566015721|FG000|Overall Study|Death|746|||
156798356|NCT00189423|566015722|FG001|Overall Study|Death|747|||
156798357|NCT00189423|566015721|FG000|Overall Study|Withdrawal by Subject|9|||
156798358|NCT00189423|566015722|FG001|Overall Study|Withdrawal by Subject|9|||
156798359|NCT00189423|566015721|FG000|Overall Study|Lost to Follow-up|10|||
156798360|NCT00189423|566015722|FG001|Overall Study|Lost to Follow-up|10|||
156798361|NCT00183248|566015732|FG000|Overall Study|Lost to Follow-up|0|||
156798362|NCT00183248|566015733|FG001|Overall Study|Lost to Follow-up|1|||
156798363|NCT00183248|566015732|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
156798364|NCT00183248|566015733|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
156798365|NCT04734210|566015734|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
156798366|NCT04734210|566015735|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
156798367|NCT04734210|566015736|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
156798368|NCT04734210|566015734|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
156798369|NCT04734210|566015735|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
156798370|NCT04734210|566015736|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
156798371|NCT04734210|566015734|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
156798372|NCT04734210|566015735|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
156798373|NCT04734210|566015736|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
156798374|NCT04734210|566015734|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
156808881|NCT00589797|566054494|FG001|Overall Study|Non-Randomized Training Subjects|6|||
156808882|NCT04011735|566054499|FG000|Overall Study|Withdrawal by Subject|1|||
156808883|NCT04011735|566054500|FG001|Overall Study|Withdrawal by Subject|0|||
156808884|NCT04011735|566054501|FG002|Overall Study|Withdrawal by Subject|1|||
156808885|NCT04011735|566054499|FG000|Overall Study|Met exclusion criteria after study entry|0|||
156808886|NCT04011735|566054500|FG001|Overall Study|Met exclusion criteria after study entry|1|||
156808887|NCT04011735|566054501|FG002|Overall Study|Met exclusion criteria after study entry|0|||
156808888|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
156742982|NCT02327013|565808195|FG003|Overall Study|Lack of Efficacy|0|||
156742983|NCT02327013|565808196|FG004|Overall Study|Lack of Efficacy|1|||
156742984|NCT02327013|565808192|FG000|Overall Study|Non-compliance with IMP|1|||
156742985|NCT02327013|565808193|FG001|Overall Study|Non-compliance with IMP|2|||
156742986|NCT02327013|565808194|FG002|Overall Study|Non-compliance with IMP|7|||
156742987|NCT02327013|565808195|FG003|Overall Study|Non-compliance with IMP|0|||
156742988|NCT02327013|565808196|FG004|Overall Study|Non-compliance with IMP|0|||
156742989|NCT02327013|565808192|FG000|Overall Study|Withdrawal of Consent|1|||
156742990|NCT02327013|565808193|FG001|Overall Study|Withdrawal of Consent|0|||
156742991|NCT02327013|565808194|FG002|Overall Study|Withdrawal of Consent|3|||
156742992|NCT02327013|565808195|FG003|Overall Study|Withdrawal of Consent|0|||
156742993|NCT02327013|565808196|FG004|Overall Study|Withdrawal of Consent|0|||
156742994|NCT02327013|565808192|FG000|Overall Study|Lost to Follow-up|2|||
156742995|NCT02327013|565808193|FG001|Overall Study|Lost to Follow-up|4|||
156742996|NCT02327013|565808194|FG002|Overall Study|Lost to Follow-up|5|||
156742997|NCT02327013|565808195|FG003|Overall Study|Lost to Follow-up|0|||
156742998|NCT02327013|565808196|FG004|Overall Study|Lost to Follow-up|0|||
156742999|NCT02327013|565808192|FG000|Overall Study|Administrative or other reason(s)|1|||
156743000|NCT02327013|565808193|FG001|Overall Study|Administrative or other reason(s)|5|||
156743001|NCT02327013|565808194|FG002|Overall Study|Administrative or other reason(s)|11|||
156337054|NCT00087607|564331460|FG000|Overall Study|Death|0|||
156743002|NCT02327013|565808195|FG003|Overall Study|Administrative or other reason(s)|1|||
156743003|NCT02327013|565808196|FG004|Overall Study|Administrative or other reason(s)|1|||
156743004|NCT02327013|565808192|FG000|Overall Study|Protocol Violation|0|||
156743005|NCT02327013|565808193|FG001|Overall Study|Protocol Violation|0|||
156743006|NCT02327013|565808194|FG002|Overall Study|Protocol Violation|3|||
156743007|NCT02327013|565808195|FG003|Overall Study|Protocol Violation|0|||
156743008|NCT02327013|565808196|FG004|Overall Study|Protocol Violation|1|||
156743009|NCT02327013|565808192|FG000|Overall Study|Withdrawal before treatment|2|||
156743010|NCT02327013|565808193|FG001|Overall Study|Withdrawal before treatment|1|||
156743011|NCT02327013|565808194|FG002|Overall Study|Withdrawal before treatment|5|||
156743012|NCT02327013|565808195|FG003|Overall Study|Withdrawal before treatment|0|||
156743013|NCT02327013|565808196|FG004|Overall Study|Withdrawal before treatment|0|||
156743014|NCT02380859|565808197|FG000|Overall Study|Withdrawal by Subject|2|||
156743015|NCT02380859|565808198|FG001|Overall Study|Withdrawal by Subject|0|||
156743016|NCT01565668|565808199|FG000|Overall Study|Death|2|||
156743017|NCT01565668|565808200|FG001|Overall Study|Death|1|||
156743018|NCT01565668|565808199|FG000|Overall Study|Lack of Efficacy|4|||
156743019|NCT01565668|565808200|FG001|Overall Study|Lack of Efficacy|2|||
156743020|NCT01565668|565808199|FG000|Overall Study|Participant went on Hospice Care|1|||
156534912|NCT02229539|565054005|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
156743021|NCT01565668|565808200|FG001|Overall Study|Participant went on Hospice Care|0|||
156534913|NCT02229539|565054006|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
156534914|NCT02229539|565054007|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
156743022|NCT01565668|565808199|FG000|Overall Study|Adverse Event|6|||
156743023|NCT01565668|565808200|FG001|Overall Study|Adverse Event|1|||
156743024|NCT01565668|565808199|FG000|Overall Study|Randomized, but never received drug|0|||
156458461|NCT05218096|564774773|FG004|Primary Evaluation|Withdrawal by Subject|0|||
156458462|NCT05218096|564774769|FG000|Primary Evaluation|Physician Decision|1|||
156458463|NCT05218096|564774770|FG001|Primary Evaluation|Physician Decision|0|||
156458464|NCT05218096|564774771|FG002|Primary Evaluation|Physician Decision|0|||
156458465|NCT05218096|564774772|FG003|Primary Evaluation|Physician Decision|0|||
156458466|NCT05218096|564774773|FG004|Primary Evaluation|Physician Decision|0|||
156743025|NCT01565668|565808200|FG001|Overall Study|Randomized, but never received drug|2|||
156743026|NCT01565668|565808199|FG000|Overall Study|Progressive disease|13|||
156743027|NCT01565668|565808200|FG001|Overall Study|Progressive disease|14|||
156743028|NCT01565668|565808199|FG000|Overall Study|Withdrawal by Subject|1|||
156743029|NCT01565668|565808200|FG001|Overall Study|Withdrawal by Subject|3|||
156743030|NCT01565668|565808199|FG000|Overall Study|HSCT Transplant|11|||
156743031|NCT01565668|565808200|FG001|Overall Study|HSCT Transplant|15|||
156743032|NCT01097421|565808201|FG000|Overall Study|Adverse Event|8|||
156743033|NCT01097421|565808201|FG000|Overall Study|Protocol Violation|2|||
156743034|NCT01097421|565808201|FG000|Overall Study|Lost to Follow-up|1|||
156743035|NCT01097421|565808201|FG000|Overall Study|Withdrawal by Subject|3|||
156743036|NCT04258254|565808202|FG000|Overall Study|Withdrawal by Subject|0|||
156743037|NCT04258254|565808203|FG001|Overall Study|Withdrawal by Subject|1|||
156743038|NCT04258254|565808204|FG002|Overall Study|Withdrawal by Subject|0|||
156743039|NCT01120249|565808205|FG000|Overall Study|No protocol treatment received|21|||
156743040|NCT01120249|565808206|FG001|Overall Study|No protocol treatment received|15|||
156743041|NCT01120249|565808205|FG000|Overall Study|Disease recurrence|107|||
156743042|NCT01120249|565808206|FG001|Overall Study|Disease recurrence|57|||
156743043|NCT01120249|565808205|FG000|Overall Study|Death|1|||
156743044|NCT01120249|565808206|FG001|Overall Study|Death|0|||
156743045|NCT01120249|565808205|FG000|Overall Study|Adverse Event|40|||
156743046|NCT01120249|565808206|FG001|Overall Study|Adverse Event|276|||
156743047|NCT01120249|565808205|FG000|Overall Study|Participant refusal|34|||
156743048|NCT01120249|565808206|FG001|Overall Study|Participant refusal|42|||
156743049|NCT01120249|565808205|FG000|Overall Study|Other reasons, not protocol specified|29|||
156743050|NCT01120249|565808206|FG001|Overall Study|Other reasons, not protocol specified|22|||
156743051|NCT02052596|565808207|FG000|Active Phase|Adverse Event|3|||
156743052|NCT02052596|565808208|FG001|Active Phase|Adverse Event|2|||
156743053|NCT02052596|565808207|FG000|Active Phase|Lost to Follow-up|8|||
156743054|NCT02052596|565808208|FG001|Active Phase|Lost to Follow-up|11|||
156743055|NCT02052596|565808207|FG000|Active Phase|Protocol Violation|1|||
156743056|NCT02052596|565808208|FG001|Active Phase|Protocol Violation|2|||
156743057|NCT02052596|565808207|FG000|Active Phase|Withdrawal by Subject|3|||
156743058|NCT02052596|565808208|FG001|Active Phase|Withdrawal by Subject|4|||
156743059|NCT02052596|565808207|FG000|Active Phase|Enrolled in error|1|||
156743060|NCT02052596|565808208|FG001|Active Phase|Enrolled in error|0|||
156743061|NCT02052596|565808207|FG000|Active Phase|Lost due to Crohn's disease|0|||
156743062|NCT02052596|565808208|FG001|Active Phase|Lost due to Crohn's disease|1|||
156743063|NCT02052596|565808207|FG000|Safety Phase|Adverse Event|6|||
156743064|NCT02052596|565808208|FG001|Safety Phase|Adverse Event|3|||
156458467|NCT05218096|564774769|FG000|Extended Treatment|Clinical Deterioration|1|||
156743065|NCT02052596|565808207|FG000|Safety Phase|Lost to Follow-up|11|||
156743066|NCT02052596|565808208|FG001|Safety Phase|Lost to Follow-up|18|||
156743067|NCT02052596|565808207|FG000|Safety Phase|Protocol Violation|1|||
156743068|NCT02052596|565808208|FG001|Safety Phase|Protocol Violation|2|||
156743069|NCT02052596|565808207|FG000|Safety Phase|Withdrawal by Subject|8|||
156743070|NCT02052596|565808208|FG001|Safety Phase|Withdrawal by Subject|11|||
156743071|NCT02052596|565808207|FG000|Safety Phase|Enrolled in error|1|||
156743072|NCT02052596|565808208|FG001|Safety Phase|Enrolled in error|0|||
156743073|NCT02052596|565808207|FG000|Safety Phase|Lost due to Crohn's disease|0|||
156743074|NCT02052596|565808208|FG001|Safety Phase|Lost due to Crohn's disease|1|||
156743075|NCT00558896|565808209|FG000|Overall Study|Adverse Event|1|||
156743076|NCT00558896|565808210|FG001|Overall Study|Adverse Event|1|||
156743077|NCT00558896|565808211|FG002|Overall Study|Adverse Event|1|||
156743078|NCT00558896|565808212|FG003|Overall Study|Adverse Event|3|||
156743079|NCT00558896|565808213|FG004|Overall Study|Adverse Event|4|||
156743080|NCT00558896|565808214|FG005|Overall Study|Adverse Event|10|||
156743081|NCT00558896|565808215|FG006|Overall Study|Adverse Event|3|||
156458468|NCT05218096|564774770|FG001|Extended Treatment|Clinical Deterioration|1|||
156458469|NCT05218096|564774771|FG002|Extended Treatment|Clinical Deterioration|0|||
156458470|NCT05218096|564774772|FG003|Extended Treatment|Clinical Deterioration|0|||
156458471|NCT05218096|564774773|FG004|Extended Treatment|Clinical Deterioration|0|||
156458472|NCT05218096|564774769|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
156458473|NCT05218096|564774770|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
156458474|NCT05218096|564774771|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
156743082|NCT00558896|565808209|FG000|Overall Study|Death|3|||
156743083|NCT00558896|565808210|FG001|Overall Study|Death|0|||
156337055|NCT00087607|564331461|FG001|Overall Study|Death|1|||
156458475|NCT05218096|564774772|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
156743084|NCT00558896|565808211|FG002|Overall Study|Death|2|||
156743085|NCT00558896|565808212|FG003|Overall Study|Death|3|||
156743086|NCT00558896|565808213|FG004|Overall Study|Death|2|||
156743087|NCT00558896|565808214|FG005|Overall Study|Death|2|||
156743088|NCT00558896|565808215|FG006|Overall Study|Death|6|||
156743089|NCT00558896|565808209|FG000|Overall Study|Withdrawal by Subject|2|||
156743090|NCT00558896|565808210|FG001|Overall Study|Withdrawal by Subject|1|||
156743091|NCT00558896|565808211|FG002|Overall Study|Withdrawal by Subject|1|||
156743092|NCT00558896|565808212|FG003|Overall Study|Withdrawal by Subject|1|||
156743093|NCT00558896|565808213|FG004|Overall Study|Withdrawal by Subject|1|||
156743094|NCT00558896|565808214|FG005|Overall Study|Withdrawal by Subject|5|||
156743095|NCT00558896|565808215|FG006|Overall Study|Withdrawal by Subject|5|||
156743096|NCT00558896|565808209|FG000|Overall Study|Alternative Treatment|2|||
156743097|NCT00558896|565808210|FG001|Overall Study|Alternative Treatment|2|||
156743098|NCT00558896|565808211|FG002|Overall Study|Alternative Treatment|0|||
156743099|NCT00558896|565808212|FG003|Overall Study|Alternative Treatment|2|||
156743100|NCT00558896|565808213|FG004|Overall Study|Alternative Treatment|6|||
156743101|NCT00558896|565808214|FG005|Overall Study|Alternative Treatment|7|||
156743102|NCT00558896|565808215|FG006|Overall Study|Alternative Treatment|1|||
156743103|NCT00558896|565808209|FG000|Overall Study|Physician discretion|3|||
156743104|NCT00558896|565808210|FG001|Overall Study|Physician discretion|2|||
156743105|NCT00558896|565808211|FG002|Overall Study|Physician discretion|1|||
156743106|NCT00558896|565808212|FG003|Overall Study|Physician discretion|2|||
156743107|NCT00558896|565808213|FG004|Overall Study|Physician discretion|1|||
156743108|NCT00558896|565808214|FG005|Overall Study|Physician discretion|3|||
156743109|NCT00558896|565808215|FG006|Overall Study|Physician discretion|3|||
156743110|NCT00558896|565808209|FG000|Overall Study|Continues on treatment|10|||
156743111|NCT00558896|565808210|FG001|Overall Study|Continues on treatment|1|||
156743112|NCT00558896|565808211|FG002|Overall Study|Continues on treatment|0|||
156743113|NCT00558896|565808212|FG003|Overall Study|Continues on treatment|1|||
156743114|NCT00558896|565808213|FG004|Overall Study|Continues on treatment|9|||
156743115|NCT00558896|565808214|FG005|Overall Study|Continues on treatment|25|||
156743116|NCT00558896|565808215|FG006|Overall Study|Continues on treatment|6|||
156743117|NCT04472026|565808222|FG000|Overall Study|Lost to Follow-up|5|||
156743118|NCT01404208|565808223|FG000|Overall Study|Discontinued|3|||
156798375|NCT04734210|566015735|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
156798376|NCT04734210|566015736|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
156798377|NCT01358734|566015737|FG000|Overall Study|Adverse Event|4|||
156798378|NCT01358734|566015738|FG001|Overall Study|Adverse Event|7|||
156798379|NCT01358734|566015739|FG002|Overall Study|Adverse Event|3|||
156798380|NCT01358734|566015737|FG000|Overall Study|Lack of Efficacy|0|||
156798381|NCT01358734|566015738|FG001|Overall Study|Lack of Efficacy|1|||
156798382|NCT01358734|566015739|FG002|Overall Study|Lack of Efficacy|3|||
156798383|NCT01358734|566015737|FG000|Overall Study|Withdrawal by Subject|1|||
156798384|NCT01358734|566015738|FG001|Overall Study|Withdrawal by Subject|6|||
156798385|NCT01358734|566015739|FG002|Overall Study|Withdrawal by Subject|3|||
156798386|NCT01358734|566015737|FG000|Overall Study|Death|3|||
156798387|NCT01358734|566015738|FG001|Overall Study|Death|7|||
156798388|NCT01358734|566015739|FG002|Overall Study|Death|2|||
156798389|NCT01358734|566015737|FG000|Overall Study|Progressive Disease|5|||
156798390|NCT01358734|566015738|FG001|Overall Study|Progressive Disease|13|||
156798391|NCT01358734|566015739|FG002|Overall Study|Progressive Disease|16|||
156798392|NCT01358734|566015737|FG000|Overall Study|Non-compliance with study drug|0|||
156798393|NCT01358734|566015738|FG001|Overall Study|Non-compliance with study drug|0|||
156798394|NCT01358734|566015739|FG002|Overall Study|Non-compliance with study drug|1|||
156798395|NCT01358734|566015737|FG000|Overall Study|Other|2|||
156798396|NCT01358734|566015738|FG001|Overall Study|Other|5|||
156798397|NCT01358734|566015739|FG002|Overall Study|Other|4|||
156798398|NCT01358734|566015737|FG000|Overall Study|Protocol Violation|0|||
156798399|NCT01358734|566015738|FG001|Overall Study|Protocol Violation|0|||
156743119|NCT01404208|565808224|FG001|Overall Study|Discontinued|0|||
156743120|NCT00334802|565808227|FG000|Overall Study|Progressive Disease|2|||
156743121|NCT00334802|565808228|FG001|Overall Study|Progressive Disease|24|||
156798400|NCT01358734|566015739|FG002|Overall Study|Protocol Violation|2|||
156798401|NCT03847519|566015744|FG000|Overall Study|Death|5|||
156458476|NCT05218096|564774773|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
156458477|NCT05218096|564774769|FG000|Extended Treatment|Withdrawal by Subject|1|||
156743122|NCT00334802|565808227|FG000|Overall Study|Toxicity|1|||
156743123|NCT00334802|565808228|FG001|Overall Study|Toxicity|5|||
156743124|NCT00334802|565808227|FG000|Overall Study|Lack of Efficacy|1|||
156743125|NCT00334802|565808228|FG001|Overall Study|Lack of Efficacy|3|||
156743126|NCT00334802|565808227|FG000|Overall Study|Patient Condition Aggrevated|1|||
156743127|NCT00334802|565808228|FG001|Overall Study|Patient Condition Aggrevated|0|||
156743128|NCT00334802|565808227|FG000|Overall Study|Physician Decision|1|||
156743129|NCT00334802|565808228|FG001|Overall Study|Physician Decision|0|||
156743130|NCT00334802|565808227|FG000|Overall Study|Withdrawal by Subject|0|||
156743131|NCT00334802|565808228|FG001|Overall Study|Withdrawal by Subject|4|||
156743132|NCT00334802|565808227|FG000|Overall Study|Adverse Event|0|||
156743133|NCT00334802|565808228|FG001|Overall Study|Adverse Event|3|||
156743134|NCT00334802|565808227|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
156743135|NCT00334802|565808228|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
156743136|NCT03422159|565808229|FG000|Overall Study|Exclusion due to terminal disease|2|||
156743137|NCT03422159|565808230|FG001|Overall Study|Exclusion due to terminal disease|1|||
156743138|NCT03436199|565808231|FG000|Overall Study|Adverse Event|15|||
156743139|NCT03436199|565808232|FG001|Overall Study|Adverse Event|40|||
156743140|NCT03436199|565808233|FG002|Overall Study|Adverse Event|7|||
156743141|NCT03436199|565808231|FG000|Overall Study|Withdrawal by Subject|4|||
156743142|NCT03436199|565808232|FG001|Overall Study|Withdrawal by Subject|10|||
156743143|NCT03436199|565808233|FG002|Overall Study|Withdrawal by Subject|3|||
156743144|NCT03436199|565808231|FG000|Overall Study|Lost to Follow-up|1|||
156743145|NCT03436199|565808232|FG001|Overall Study|Lost to Follow-up|0|||
156743146|NCT03436199|565808233|FG002|Overall Study|Lost to Follow-up|2|||
156743147|NCT03436199|565808231|FG000|Overall Study|Protocol Violation|1|||
156743148|NCT03436199|565808232|FG001|Overall Study|Protocol Violation|1|||
156743149|NCT03436199|565808233|FG002|Overall Study|Protocol Violation|0|||
156743150|NCT03436199|565808231|FG000|Overall Study|Physician Decision|0|||
156743151|NCT03436199|565808232|FG001|Overall Study|Physician Decision|1|||
156743152|NCT03436199|565808233|FG002|Overall Study|Physician Decision|0|||
156743153|NCT03436199|565808231|FG000|Overall Study|Could not return to clinic|1|||
156743154|NCT03436199|565808232|FG001|Overall Study|Could not return to clinic|0|||
156743155|NCT03436199|565808233|FG002|Overall Study|Could not return to clinic|0|||
156743156|NCT03436199|565808231|FG000|Overall Study|Withdrawn per physician|0|||
156743157|NCT03436199|565808232|FG001|Overall Study|Withdrawn per physician|1|||
156743158|NCT03436199|565808233|FG002|Overall Study|Withdrawn per physician|0|||
156743159|NCT00085098|565808234|FG000|Overall Study|Withdrawal by Subject|0|||
156743160|NCT00085098|565808235|FG001|Overall Study|Withdrawal by Subject|1|||
156743161|NCT00085098|565808234|FG000|Overall Study|Ineligible|1|||
156743162|NCT00085098|565808235|FG001|Overall Study|Ineligible|1|||
156743163|NCT01886781|565808240|FG000|Overall Study|Protocol Violation|5|||
156743164|NCT01886781|565808241|FG001|Overall Study|Protocol Violation|0|||
156743165|NCT01886781|565808240|FG000|Overall Study|Adverse Event|1|||
156743166|NCT01886781|565808241|FG001|Overall Study|Adverse Event|0|||
156743167|NCT01886781|565808240|FG000|Overall Study|Lost to Follow-up|5|||
156743168|NCT01886781|565808241|FG001|Overall Study|Lost to Follow-up|0|||
156743169|NCT01886781|565808240|FG000|Overall Study|Withdrawal by Subject|2|||
156743170|NCT01886781|565808241|FG001|Overall Study|Withdrawal by Subject|1|||
156743171|NCT01886781|565808240|FG000|Overall Study|Worsening of symptoms|1|||
156743172|NCT01886781|565808241|FG001|Overall Study|Worsening of symptoms|1|||
156743173|NCT01432275|565808243|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
156743174|NCT01432275|565808244|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
156743175|NCT01432275|565808243|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
156743176|NCT01432275|565808244|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
156743177|NCT01432275|565808243|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
156743178|NCT01432275|565808244|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
156743179|NCT01432275|565808243|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
156743180|NCT01432275|565808244|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
156743181|NCT01432275|565808243|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
156743182|NCT01432275|565808244|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
156743183|NCT01432275|565808243|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
156743184|NCT01432275|565808244|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
156743185|NCT01432275|565808243|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
156743186|NCT01432275|565808244|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
156743187|NCT01432275|565808243|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
156743188|NCT01432275|565808244|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
156743189|NCT01432275|565808243|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
156458478|NCT05218096|564774770|FG001|Extended Treatment|Withdrawal by Subject|3|||
156743190|NCT01432275|565808244|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
156743191|NCT01935700|565808249|FG000|Overall Study|Withdrawal by Subject|1|||
156743192|NCT01935700|565808250|FG001|Overall Study|Withdrawal by Subject|0|||
156458479|NCT05218096|564774771|FG002|Extended Treatment|Withdrawal by Subject|0|||
156458480|NCT05218096|564774772|FG003|Extended Treatment|Withdrawal by Subject|2|||
156458481|NCT05218096|564774773|FG004|Extended Treatment|Withdrawal by Subject|2|||
156458482|NCT05218096|564774769|FG000|Extended Treatment|Lack of Efficacy|3|||
156458483|NCT05218096|564774770|FG001|Extended Treatment|Lack of Efficacy|0|||
156458484|NCT05218096|564774771|FG002|Extended Treatment|Lack of Efficacy|0|||
156458485|NCT05218096|564774772|FG003|Extended Treatment|Lack of Efficacy|0|||
156458486|NCT05218096|564774773|FG004|Extended Treatment|Lack of Efficacy|0|||
156458487|NCT05218096|564774769|FG000|Extended Treatment|Physician Decision|0|||
156458488|NCT05218096|564774770|FG001|Extended Treatment|Physician Decision|1|||
156743193|NCT01935700|565808249|FG000|Overall Study|Physician Decision|4|||
156743194|NCT01935700|565808250|FG001|Overall Study|Physician Decision|0|||
156743195|NCT01935128|565808251|FG000|Overall Study|Death|1|||
156743196|NCT01935128|565808251|FG000|Overall Study|Adverse Event|6|||
156743197|NCT01273155|565808253|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
156743198|NCT01273155|565808254|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
156743199|NCT01273155|565808255|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
156743200|NCT01273155|565808256|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
156743201|NCT01273155|565808257|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
156743202|NCT01273155|565808258|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
156743203|NCT01273155|565808259|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
156743204|NCT01273155|565808253|FG000|Overall Study|Change in liver function/no longer eval.|0|||
156743205|NCT01273155|565808254|FG001|Overall Study|Change in liver function/no longer eval.|1|||
156743206|NCT01273155|565808255|FG002|Overall Study|Change in liver function/no longer eval.|0|||
156743207|NCT01273155|565808256|FG003|Overall Study|Change in liver function/no longer eval.|0|||
156743208|NCT01273155|565808257|FG004|Overall Study|Change in liver function/no longer eval.|1|||
156743209|NCT01273155|565808258|FG005|Overall Study|Change in liver function/no longer eval.|0|||
156743210|NCT01273155|565808259|FG006|Overall Study|Change in liver function/no longer eval.|0|||
156743211|NCT01273155|565808253|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
156743212|NCT01273155|565808254|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
156743213|NCT01273155|565808255|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
156743214|NCT01273155|565808256|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
156743215|NCT01273155|565808257|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
156743216|NCT01273155|565808258|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
156743217|NCT01273155|565808259|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
156743218|NCT01273155|565808253|FG000|Overall Study|Died during Cycle 1|0|||
156743219|NCT01273155|565808254|FG001|Overall Study|Died during Cycle 1|0|||
156743220|NCT01273155|565808255|FG002|Overall Study|Died during Cycle 1|1|||
156743221|NCT01273155|565808256|FG003|Overall Study|Died during Cycle 1|1|||
156743222|NCT01273155|565808257|FG004|Overall Study|Died during Cycle 1|0|||
156743223|NCT01273155|565808258|FG005|Overall Study|Died during Cycle 1|2|||
156743224|NCT01273155|565808259|FG006|Overall Study|Died during Cycle 1|2|||
156743225|NCT01273155|565808253|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
156743226|NCT01273155|565808254|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
156743227|NCT01273155|565808255|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
156743228|NCT01273155|565808256|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
156743229|NCT01273155|565808257|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
156743230|NCT01273155|565808258|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
156743231|NCT01273155|565808259|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
156743232|NCT03887117|565808260|FG000|Overall Study|Discontinued prematurely|0|||
156743233|NCT03887117|565808261|FG001|Overall Study|Discontinued prematurely|1|||
156743234|NCT03887117|565808262|FG002|Overall Study|Discontinued prematurely|1|||
156743235|NCT03887117|565808263|FG003|Overall Study|Discontinued prematurely|2|||
156743236|NCT04908475|565808264|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
156743237|NCT04908475|565808265|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743238|NCT04908475|565808266|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743239|NCT04908475|565808267|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743240|NCT04908475|565808268|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743241|NCT04908475|565808269|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743242|NCT04908475|565808264|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
156743243|NCT04908475|565808265|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156743244|NCT04908475|565808266|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156743245|NCT04908475|565808267|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156743246|NCT04908475|565808268|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156798402|NCT03847519|566015745|FG001|Overall Study|Death|8|||
156798403|NCT03847519|566015746|FG002|Overall Study|Death|1|||
156458489|NCT05218096|564774771|FG002|Extended Treatment|Physician Decision|0|||
156798404|NCT03847519|566015744|FG000|Overall Study|Lost to Follow-up|1|||
156798405|NCT03847519|566015745|FG001|Overall Study|Lost to Follow-up|2|||
156458490|NCT05218096|564774772|FG003|Extended Treatment|Physician Decision|0|||
156337056|NCT00087607|564331460|FG000|Overall Study|Insufficient Therapeutic Response|53|||
156337057|NCT00087607|564331461|FG001|Overall Study|Insufficient Therapeutic Response|42|||
156337058|NCT00087607|564331460|FG000|Overall Study|Failure to return|21|||
156458491|NCT05218096|564774773|FG004|Extended Treatment|Physician Decision|0|||
156458492|NCT05218096|564774769|FG000|Open-label Extension|Adverse Event|1|||
156458493|NCT05218096|564774770|FG001|Open-label Extension|Adverse Event|0|||
156458494|NCT05218096|564774771|FG002|Open-label Extension|Adverse Event|0|||
156458495|NCT05218096|564774772|FG003|Open-label Extension|Adverse Event|0|||
156458496|NCT05218096|564774773|FG004|Open-label Extension|Adverse Event|1|||
156458497|NCT05218096|564774769|FG000|Open-label Extension|Pregnancy|0|||
156458498|NCT05218096|564774770|FG001|Open-label Extension|Pregnancy|0|||
156458499|NCT05218096|564774771|FG002|Open-label Extension|Pregnancy|0|||
156458500|NCT05218096|564774772|FG003|Open-label Extension|Pregnancy|0|||
156458501|NCT05218096|564774773|FG004|Open-label Extension|Pregnancy|1|||
156458502|NCT05218096|564774769|FG000|Open-label Extension|Lack of Efficacy|1|||
156743247|NCT04908475|565808269|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156743248|NCT04908475|565808264|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
156743249|NCT04908475|565808265|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743250|NCT04908475|565808266|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743251|NCT04908475|565808267|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743252|NCT04908475|565808268|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743253|NCT04908475|565808269|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743254|NCT04908475|565808264|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156743255|NCT04908475|565808265|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
156743256|NCT04908475|565808266|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
156743257|NCT04908475|565808267|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
156743258|NCT04908475|565808268|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156743259|NCT04908475|565808269|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156743260|NCT04908475|565808264|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
156743261|NCT04908475|565808265|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
156743262|NCT04908475|565808266|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
156743263|NCT04908475|565808267|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
156743264|NCT04908475|565808268|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
156743265|NCT04908475|565808269|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
156743266|NCT04908475|565808264|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
156743267|NCT04908475|565808265|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
156743268|NCT04908475|565808266|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
156743269|NCT04908475|565808267|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
156743270|NCT04908475|565808268|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
156743271|NCT04908475|565808269|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
156743272|NCT01739764|565808270|FG000|Overall Study|Adverse Event|0|||
156743273|NCT01739764|565808271|FG001|Overall Study|Adverse Event|3|||
156743274|NCT01739764|565808272|FG002|Overall Study|Adverse Event|4|||
156743275|NCT01739764|565808270|FG000|Overall Study|Death|4|||
156743276|NCT01739764|565808271|FG001|Overall Study|Death|6|||
156743277|NCT01739764|565808272|FG002|Overall Study|Death|38|||
156743278|NCT01739764|565808270|FG000|Overall Study|Lost to Follow-up|0|||
156743279|NCT01739764|565808271|FG001|Overall Study|Lost to Follow-up|0|||
156743280|NCT01739764|565808272|FG002|Overall Study|Lost to Follow-up|5|||
156743281|NCT01739764|565808270|FG000|Overall Study|Non-Compliance|0|||
156743282|NCT01739764|565808271|FG001|Overall Study|Non-Compliance|0|||
156743283|NCT01739764|565808272|FG002|Overall Study|Non-Compliance|1|||
156743284|NCT01739764|565808270|FG000|Overall Study|Multiple Reasons|3|||
156743285|NCT01739764|565808271|FG001|Overall Study|Multiple Reasons|2|||
156743286|NCT01739764|565808272|FG002|Overall Study|Multiple Reasons|3|||
156743287|NCT01739764|565808270|FG000|Overall Study|Physician Decision|2|||
156743288|NCT01739764|565808271|FG001|Overall Study|Physician Decision|2|||
156743289|NCT01739764|565808272|FG002|Overall Study|Physician Decision|4|||
156743290|NCT01739764|565808270|FG000|Overall Study|Progressive Disease|3|||
156743291|NCT01739764|565808271|FG001|Overall Study|Progressive Disease|5|||
156743292|NCT01739764|565808272|FG002|Overall Study|Progressive Disease|16|||
156743293|NCT01739764|565808270|FG000|Overall Study|Protocol Violation|0|||
156743294|NCT01739764|565808271|FG001|Overall Study|Protocol Violation|0|||
156743295|NCT01739764|565808272|FG002|Overall Study|Protocol Violation|2|||
156337059|NCT00087607|564331461|FG001|Overall Study|Failure to return|17|||
156337060|NCT00087607|564331460|FG000|Overall Study|Withdrew Consent|12|||
156458503|NCT05218096|564774770|FG001|Open-label Extension|Lack of Efficacy|2|||
156458504|NCT05218096|564774771|FG002|Open-label Extension|Lack of Efficacy|0|||
156743296|NCT01739764|565808270|FG000|Overall Study|Study Terminated by Sponsor|8|||
156743297|NCT01739764|565808271|FG001|Overall Study|Study Terminated by Sponsor|13|||
156458505|NCT05218096|564774772|FG003|Open-label Extension|Lack of Efficacy|0|||
156743298|NCT01739764|565808272|FG002|Overall Study|Study Terminated by Sponsor|26|||
156743299|NCT01739764|565808270|FG000|Overall Study|Withdrawal by Subject|6|||
156743300|NCT01739764|565808271|FG001|Overall Study|Withdrawal by Subject|5|||
156743301|NCT01739764|565808272|FG002|Overall Study|Withdrawal by Subject|27|||
156743302|NCT00404924|565808273|FG000|Overall Study|Adverse Event|75|||
156743303|NCT00404924|565808274|FG001|Overall Study|Adverse Event|16|||
156743304|NCT00404924|565808273|FG000|Overall Study|Condition under investigation worsened|475|||
156743305|NCT00404924|565808274|FG001|Overall Study|Condition under investigation worsened|264|||
156743306|NCT00404924|565808273|FG000|Overall Study|Lost to Follow-up|1|||
156743307|NCT00404924|565808274|FG001|Overall Study|Lost to Follow-up|1|||
156743308|NCT00404924|565808273|FG000|Overall Study|Withdrawal by Subject|26|||
156743309|NCT00404924|565808274|FG001|Overall Study|Withdrawal by Subject|13|||
156743310|NCT00404924|565808273|FG000|Overall Study|Other|25|||
156743311|NCT00404924|565808274|FG001|Overall Study|Other|11|||
156743312|NCT00404924|565808273|FG000|Overall Study|Randomised but not received treatment|1|||
156743313|NCT00404924|565808274|FG001|Overall Study|Randomised but not received treatment|1|||
156743314|NCT05087966|565808279|FG000|Overall Study|Lost to Follow-up|1|||
156743315|NCT05087966|565808279|FG000|Overall Study|Withdrawal by Subject|5|||
156743316|NCT01037127|565808282|FG000|Overall Study|Lost to Follow-up|2|||
156743317|NCT01037127|565808283|FG001|Overall Study|Lost to Follow-up|4|||
156743318|NCT01037127|565808282|FG000|Overall Study|Physician Decision|1|||
156743319|NCT01037127|565808283|FG001|Overall Study|Physician Decision|0|||
156743320|NCT01037127|565808282|FG000|Overall Study|Study Closed Terminated|2|||
156743321|NCT01037127|565808283|FG001|Overall Study|Study Closed Terminated|17|||
156743322|NCT04325698|565808290|FG000|Overall Study|Study Terminated By Sponsor|1|||
156743323|NCT04325698|565808291|FG001|Overall Study|Study Terminated By Sponsor|1|||
156743324|NCT04325698|565808290|FG000|Overall Study|Withdrawal by Subject|0|||
156743325|NCT04325698|565808291|FG001|Overall Study|Withdrawal by Subject|2|||
156743326|NCT02044874|565808292|FG000|Overall Study|Adverse Event|5|||
156743327|NCT02044874|565808293|FG001|Overall Study|Adverse Event|6|||
156743328|NCT02044874|565808294|FG002|Overall Study|Adverse Event|6|||
156743329|NCT02044874|565808292|FG000|Overall Study|Withdrawal by Subject|8|||
156743330|NCT02044874|565808293|FG001|Overall Study|Withdrawal by Subject|16|||
156743331|NCT02044874|565808294|FG002|Overall Study|Withdrawal by Subject|23|||
156743332|NCT02044874|565808292|FG000|Overall Study|Physician Decision|0|||
156743333|NCT02044874|565808293|FG001|Overall Study|Physician Decision|2|||
156798406|NCT03847519|566015746|FG002|Overall Study|Lost to Follow-up|0|||
156798407|NCT03847519|566015744|FG000|Overall Study|Study Terminated by Sponsor|0|||
156798408|NCT03847519|566015745|FG001|Overall Study|Study Terminated by Sponsor|3|||
156458506|NCT05218096|564774773|FG004|Open-label Extension|Lack of Efficacy|0|||
156458507|NCT05218096|564774769|FG000|Open-label Extension|Lost to Follow-up|1|||
156458508|NCT05218096|564774770|FG001|Open-label Extension|Lost to Follow-up|0|||
156458509|NCT05218096|564774771|FG002|Open-label Extension|Lost to Follow-up|0|||
156458510|NCT05218096|564774772|FG003|Open-label Extension|Lost to Follow-up|0|||
156798409|NCT03847519|566015746|FG002|Overall Study|Study Terminated by Sponsor|2|||
156798410|NCT02095106|566015747|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
156798411|NCT02095106|566015748|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
156798412|NCT00806585|566015761|FG000|Overall Study|Study terminated by Sponsor|0|||
156798413|NCT00806585|566015762|FG001|Overall Study|Study terminated by Sponsor|0|||
156798414|NCT00806585|566015763|FG002|Overall Study|Study terminated by Sponsor|1|||
156798415|NCT00806585|566015764|FG003|Overall Study|Study terminated by Sponsor|2|||
156798416|NCT00806585|566015765|FG004|Overall Study|Study terminated by Sponsor|0|||
156798417|NCT00806585|566015761|FG000|Overall Study|Protocol Violation|3|||
156798418|NCT00806585|566015762|FG001|Overall Study|Protocol Violation|1|||
156798419|NCT00806585|566015763|FG002|Overall Study|Protocol Violation|2|||
156798420|NCT00806585|566015764|FG003|Overall Study|Protocol Violation|0|||
156798421|NCT00806585|566015765|FG004|Overall Study|Protocol Violation|0|||
156798422|NCT00806585|566015761|FG000|Overall Study|Physician Decision|0|||
156798423|NCT00806585|566015762|FG001|Overall Study|Physician Decision|2|||
156798424|NCT00806585|566015763|FG002|Overall Study|Physician Decision|3|||
156798425|NCT00806585|566015764|FG003|Overall Study|Physician Decision|0|||
156798426|NCT00806585|566015765|FG004|Overall Study|Physician Decision|1|||
156798427|NCT00806585|566015761|FG000|Overall Study|Lost to Follow-up|2|||
156798428|NCT00806585|566015762|FG001|Overall Study|Lost to Follow-up|1|||
156798429|NCT00806585|566015763|FG002|Overall Study|Lost to Follow-up|2|||
156458511|NCT05218096|564774773|FG004|Open-label Extension|Lost to Follow-up|0|||
156458512|NCT05218096|564774769|FG000|Open-label Extension|Death|0|||
156743334|NCT02044874|565808294|FG002|Overall Study|Physician Decision|1|||
156743335|NCT02044874|565808292|FG000|Overall Study|Lost to Follow-up|10|||
156798430|NCT00806585|566015764|FG003|Overall Study|Lost to Follow-up|2|||
156458513|NCT05218096|564774770|FG001|Open-label Extension|Death|0|||
156743336|NCT02044874|565808293|FG001|Overall Study|Lost to Follow-up|27|||
156743337|NCT02044874|565808294|FG002|Overall Study|Lost to Follow-up|21|||
156743338|NCT02044874|565808292|FG000|Overall Study|Sponsor Decision|0|||
156743339|NCT02044874|565808293|FG001|Overall Study|Sponsor Decision|1|||
156743340|NCT02044874|565808294|FG002|Overall Study|Sponsor Decision|1|||
156798431|NCT00806585|566015765|FG004|Overall Study|Lost to Follow-up|5|||
156798432|NCT00806585|566015761|FG000|Overall Study|Lack of Efficacy|1|||
156798433|NCT00806585|566015762|FG001|Overall Study|Lack of Efficacy|0|||
156798434|NCT00806585|566015763|FG002|Overall Study|Lack of Efficacy|0|||
156458514|NCT05218096|564774771|FG002|Open-label Extension|Death|0|||
156743341|NCT02044874|565808292|FG000|Overall Study|Other|7|||
156743342|NCT02044874|565808293|FG001|Overall Study|Other|3|||
156743343|NCT02044874|565808294|FG002|Overall Study|Other|8|||
156743344|NCT02889835|565808295|FG000|Overall Study|Lost to Follow-up|13|||
156743345|NCT02889835|565808296|FG001|Overall Study|Lost to Follow-up|13|||
156743346|NCT02889835|565808297|FG002|Overall Study|Lost to Follow-up|13|||
156743347|NCT02889835|565808295|FG000|Overall Study|Withdrawal by Subject|2|||
156743348|NCT02889835|565808296|FG001|Overall Study|Withdrawal by Subject|2|||
156743349|NCT02889835|565808297|FG002|Overall Study|Withdrawal by Subject|2|||
156743350|NCT02889835|565808295|FG000|Overall Study|Protocol Violation|1|||
156743351|NCT02889835|565808296|FG001|Overall Study|Protocol Violation|1|||
156743352|NCT02889835|565808297|FG002|Overall Study|Protocol Violation|1|||
156743353|NCT02889835|565808295|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
156743354|NCT02889835|565808296|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
156743355|NCT02889835|565808297|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
156743356|NCT02889835|565808295|FG000|Overall Study|Death|1|||
156743357|NCT02889835|565808296|FG001|Overall Study|Death|1|||
156743358|NCT02889835|565808297|FG002|Overall Study|Death|1|||
156743359|NCT01047332|565808300|FG000|Overall Study|SEMS Obstruction|11|||
156743360|NCT01047332|565808301|FG001|Overall Study|SEMS Obstruction|20|||
156743361|NCT01047332|565808300|FG000|Overall Study|Died Unobstructed|38|||
156743362|NCT01047332|565808301|FG001|Overall Study|Died Unobstructed|41|||
156743363|NCT01047332|565808300|FG000|Overall Study|Lost to Follow-up|8|||
156743364|NCT01047332|565808301|FG001|Overall Study|Lost to Follow-up|3|||
156743365|NCT00787917|565808302|FG000|Blinded Treatment|Adverse Event|1|||
156743366|NCT00787917|565808303|FG001|Blinded Treatment|Adverse Event|0|||
156743367|NCT00787917|565808302|FG000|Blinded Treatment|Lack of Efficacy|1|||
156743368|NCT00787917|565808303|FG001|Blinded Treatment|Lack of Efficacy|0|||
156743369|NCT00787917|565808302|FG000|Blinded Treatment|Administrative problems|3|||
156743370|NCT00787917|565808303|FG001|Blinded Treatment|Administrative problems|2|||
156743371|NCT00787917|565808302|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
156743372|NCT00787917|565808303|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
156743373|NCT00787917|565808302|FG000|Open Label|Administrative problems|3|||
156743374|NCT00787917|565808303|FG001|Open Label|Administrative problems|0|||
156743375|NCT03521817|565808304|FG000|Overall Study|Protocol Violation|0|||
156743376|NCT03521817|565808305|FG001|Overall Study|Protocol Violation|1|||
156743377|NCT00778102|565808307|FG000|Overall Study|Adverse Event|8|||
156743378|NCT00778102|565808308|FG001|Overall Study|Adverse Event|5|||
156743379|NCT00778102|565808307|FG000|Overall Study|Death|1|||
156743380|NCT00778102|565808308|FG001|Overall Study|Death|1|||
156743381|NCT00778102|565808307|FG000|Overall Study|Lost to Follow-up|1|||
156743382|NCT00778102|565808308|FG001|Overall Study|Lost to Follow-up|0|||
156743383|NCT00778102|565808307|FG000|Overall Study|Violation of Selection Criteria|1|||
156743384|NCT00778102|565808308|FG001|Overall Study|Violation of Selection Criteria|1|||
156743385|NCT00778102|565808307|FG000|Overall Study|Protocol Violation|0|||
156743386|NCT00778102|565808308|FG001|Overall Study|Protocol Violation|1|||
156743387|NCT00778102|565808307|FG000|Overall Study|Refused Treatment|2|||
156743388|NCT00778102|565808308|FG001|Overall Study|Refused Treatment|3|||
156743389|NCT00778102|565808307|FG000|Overall Study|Withdrawal by Subject|1|||
156743390|NCT00778102|565808308|FG001|Overall Study|Withdrawal by Subject|1|||
156743391|NCT00778102|565808307|FG000|Overall Study|Administrative Reason|7|||
156743392|NCT00778102|565808308|FG001|Overall Study|Administrative Reason|10|||
156743393|NCT01328548|565808309|FG000|Overall Study|Death|3|||
156743394|NCT01328548|565808310|FG001|Overall Study|Death|0|||
156743395|NCT01328548|565808309|FG000|Overall Study|Protocol Violation|1|||
156743396|NCT01328548|565808310|FG001|Overall Study|Protocol Violation|0|||
156743397|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
156743398|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
156743399|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
156743400|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
156743401|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
156743402|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
156743403|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
156743404|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
156743405|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
156798435|NCT00806585|566015764|FG003|Overall Study|Lack of Efficacy|0|||
156798436|NCT00806585|566015765|FG004|Overall Study|Lack of Efficacy|0|||
156798437|NCT00806585|566015761|FG000|Overall Study|Adverse Event|1|||
156798438|NCT00806585|566015762|FG001|Overall Study|Adverse Event|5|||
156458515|NCT05218096|564774772|FG003|Open-label Extension|Death|1|||
156743406|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
156743407|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
156743408|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
156743409|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
156743410|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
156798439|NCT00806585|566015763|FG002|Overall Study|Adverse Event|3|||
156743411|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
156743412|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
156743413|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
156743414|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
156743415|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
156743416|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
156743417|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
156743418|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
156743419|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
156743420|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
156743421|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
156743422|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
156743423|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
156743424|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
156743425|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
156743426|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
156743427|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
156743428|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
156743429|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
156743430|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
156743431|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
156743432|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
156743433|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
156798440|NCT00806585|566015764|FG003|Overall Study|Adverse Event|4|||
156798441|NCT00806585|566015765|FG004|Overall Study|Adverse Event|2|||
156798442|NCT00806585|566015761|FG000|Overall Study|Withdrawal by Subject|10|||
156798443|NCT00806585|566015762|FG001|Overall Study|Withdrawal by Subject|8|||
156798444|NCT00806585|566015763|FG002|Overall Study|Withdrawal by Subject|9|||
156798445|NCT00806585|566015764|FG003|Overall Study|Withdrawal by Subject|3|||
156798446|NCT00806585|566015765|FG004|Overall Study|Withdrawal by Subject|11|||
156798447|NCT00806585|566015761|FG000|Overall Study|Completion status unknown|15|||
156798448|NCT00806585|566015762|FG001|Overall Study|Completion status unknown|14|||
156798449|NCT00806585|566015763|FG002|Overall Study|Completion status unknown|12|||
156798450|NCT00806585|566015764|FG003|Overall Study|Completion status unknown|4|||
156798451|NCT00806585|566015765|FG004|Overall Study|Completion status unknown|12|||
156798452|NCT00023595|566015766|FG000|5 Year Follow up|Lost to Follow-up|2|||
156798453|NCT00023595|566015767|FG001|5 Year Follow up|Lost to Follow-up|2|||
156798454|NCT00023595|566015768|FG002|5 Year Follow up|Lost to Follow-up|1|||
156798455|NCT00023595|566015769|FG003|5 Year Follow up|Lost to Follow-up|7|||
156798456|NCT00023595|566015770|FG004|5 Year Follow up|Lost to Follow-up|3|||
156798457|NCT00023595|566015766|FG000|10 Year Follow up|Lost to Follow-up|12|||
156798458|NCT00023595|566015767|FG001|10 Year Follow up|Lost to Follow-up|10|||
156798459|NCT00023595|566015768|FG002|10 Year Follow up|Lost to Follow-up|3|||
156798460|NCT00023595|566015769|FG003|10 Year Follow up|Lost to Follow-up|0|||
156798461|NCT00023595|566015770|FG004|10 Year Follow up|Lost to Follow-up|0|||
156798462|NCT02284893|566015771|FG000|26 Week (Short Term)|Adverse Event|1|||
156798463|NCT02284893|566015772|FG001|26 Week (Short Term)|Adverse Event|9|||
156798464|NCT02284893|566015771|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
156798465|NCT02284893|566015772|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
156798466|NCT02284893|566015771|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
156798467|NCT02284893|566015772|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
156798468|NCT02284893|566015771|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
156798469|NCT02284893|566015772|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
156798470|NCT02284893|566015771|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
156798471|NCT02284893|566015772|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
156798472|NCT02284893|566015771|FG000|26 Week (Short Term)|Other|1|||
156798473|NCT02284893|566015772|FG001|26 Week (Short Term)|Other|1|||
156798474|NCT02284893|566015771|FG000|52 Week (Long Term)|Adverse Event|3|||
156798475|NCT02284893|566015772|FG001|52 Week (Long Term)|Adverse Event|1|||
156798476|NCT02284893|566015771|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
156798477|NCT02284893|566015772|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
156798478|NCT02284893|566015771|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
156798479|NCT02284893|566015772|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
156798480|NCT02284893|566015771|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
156743434|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
156743435|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
156743436|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
156743437|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
156743438|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
156743439|NCT00908596|565809812|FG000|Overall Study|Other reasons|46|||
156743440|NCT00908596|565809813|FG001|Overall Study|Other reasons|6|||
156743441|NCT00908596|565809814|FG002|Overall Study|Other reasons|2|||
156743442|NCT00908596|565809815|FG003|Overall Study|Other reasons|0|||
156743443|NCT00908596|565809812|FG000|Overall Study|Lost to Follow-up|0|||
156743444|NCT00908596|565809813|FG001|Overall Study|Lost to Follow-up|1|||
156743445|NCT00908596|565809814|FG002|Overall Study|Lost to Follow-up|12|||
156743446|NCT00908596|565809815|FG003|Overall Study|Lost to Follow-up|4|||
156743447|NCT00908596|565809812|FG000|Overall Study|Death|0|||
156743448|NCT00908596|565809813|FG001|Overall Study|Death|5|||
156458516|NCT05218096|564774773|FG004|Open-label Extension|Death|0|||
156458517|NCT05218096|564774769|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
156458518|NCT05218096|564774770|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
156458519|NCT05218096|564774771|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
156458520|NCT05218096|564774772|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
156458521|NCT05218096|564774773|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
156743449|NCT00908596|565809814|FG002|Overall Study|Death|57|||
156743450|NCT00908596|565809815|FG003|Overall Study|Death|32|||
156743451|NCT00908596|565809812|FG000|Overall Study|Protocol Violation|1|||
156743452|NCT00908596|565809813|FG001|Overall Study|Protocol Violation|0|||
156743453|NCT00908596|565809814|FG002|Overall Study|Protocol Violation|0|||
156743454|NCT00908596|565809815|FG003|Overall Study|Protocol Violation|0|||
156743455|NCT00908596|565809812|FG000|Overall Study|Withdrawal by Subject|0|||
156743456|NCT00908596|565809813|FG001|Overall Study|Withdrawal by Subject|1|||
156743457|NCT00908596|565809814|FG002|Overall Study|Withdrawal by Subject|3|||
156743458|NCT00908596|565809815|FG003|Overall Study|Withdrawal by Subject|1|||
156743459|NCT01556997|565809816|FG000|Overall Study|Adverse Event|10|||
156743460|NCT01556997|565809817|FG001|Overall Study|Adverse Event|12|||
156743461|NCT01556997|565809818|FG002|Overall Study|Adverse Event|12|||
156743462|NCT01556997|565809816|FG000|Overall Study|Lost to Follow-up|6|||
156743463|NCT01556997|565809817|FG001|Overall Study|Lost to Follow-up|6|||
156743464|NCT01556997|565809818|FG002|Overall Study|Lost to Follow-up|4|||
156743465|NCT01556997|565809816|FG000|Overall Study|Physician Decision|1|||
156743466|NCT01556997|565809817|FG001|Overall Study|Physician Decision|1|||
156743467|NCT01556997|565809818|FG002|Overall Study|Physician Decision|1|||
156743468|NCT01556997|565809816|FG000|Overall Study|Withdrawal by Subject|7|||
156743469|NCT01556997|565809817|FG001|Overall Study|Withdrawal by Subject|6|||
156743470|NCT01556997|565809818|FG002|Overall Study|Withdrawal by Subject|8|||
156743471|NCT01556997|565809816|FG000|Overall Study|Other|2|||
156743472|NCT01556997|565809817|FG001|Overall Study|Other|3|||
156743473|NCT01556997|565809818|FG002|Overall Study|Other|7|||
156743474|NCT00078949|565809822|FG000|Overall Study|No treated|4|||
156743475|NCT00078949|565809823|FG001|Overall Study|No treated|5|||
156743476|NCT00078949|565809824|FG002|Overall Study|No treated|3|||
156743477|NCT00078949|565809825|FG003|Overall Study|No treated|3|||
156798481|NCT02284893|566015772|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
156798482|NCT02284893|566015771|FG000|52 Week (Long Term)|Non-Compliance|2|||
156798483|NCT02284893|566015772|FG001|52 Week (Long Term)|Non-Compliance|3|||
156798484|NCT01983111|566015777|FG000|Overall Study|Withdrawal by Subject|8|||
156798485|NCT01983111|566015778|FG001|Overall Study|Withdrawal by Subject|6|||
156798486|NCT01983111|566015777|FG000|Overall Study|Adverse Event|4|||
156798487|NCT01983111|566015778|FG001|Overall Study|Adverse Event|0|||
156798488|NCT01983111|566015777|FG000|Overall Study|Protocol Violation|0|||
156798489|NCT01983111|566015778|FG001|Overall Study|Protocol Violation|1|||
156798490|NCT00855335|566015779|FG000|Overall Study|Lost to Follow-up|0|||
156798491|NCT00855335|566015780|FG001|Overall Study|Lost to Follow-up|0|||
156798492|NCT00855335|566015781|FG002|Overall Study|Lost to Follow-up|3|||
156798493|NCT00855335|566015782|FG003|Overall Study|Lost to Follow-up|1|||
156798494|NCT00855335|566015783|FG004|Overall Study|Lost to Follow-up|0|||
156798495|NCT00855335|566015779|FG000|Overall Study|Withdrawal by Subject|0|||
156798496|NCT00855335|566015780|FG001|Overall Study|Withdrawal by Subject|0|||
156798497|NCT00855335|566015781|FG002|Overall Study|Withdrawal by Subject|0|||
156798498|NCT00855335|566015782|FG003|Overall Study|Withdrawal by Subject|1|||
156798499|NCT00855335|566015783|FG004|Overall Study|Withdrawal by Subject|0|||
156798500|NCT00855335|566015779|FG000|Overall Study|Adverse Event|2|||
156798501|NCT00855335|566015780|FG001|Overall Study|Adverse Event|0|||
156798502|NCT00855335|566015781|FG002|Overall Study|Adverse Event|0|||
156798503|NCT00855335|566015782|FG003|Overall Study|Adverse Event|0|||
156798504|NCT00855335|566015783|FG004|Overall Study|Adverse Event|0|||
156798505|NCT00855335|566015779|FG000|Overall Study|Physician Decision|1|||
156798506|NCT00855335|566015780|FG001|Overall Study|Physician Decision|1|||
156798507|NCT00855335|566015781|FG002|Overall Study|Physician Decision|0|||
156798508|NCT00855335|566015782|FG003|Overall Study|Physician Decision|0|||
156743478|NCT00577005|565809826|FG000|Overall Study|Lost to Follow-up|3|||
156798509|NCT00855335|566015783|FG004|Overall Study|Physician Decision|0|||
156798510|NCT00855335|566015779|FG000|Overall Study|Other|2|||
156798511|NCT00855335|566015780|FG001|Overall Study|Other|1|||
156798512|NCT00855335|566015781|FG002|Overall Study|Other|2|||
156798513|NCT00855335|566015782|FG003|Overall Study|Other|5|||
156798514|NCT00855335|566015783|FG004|Overall Study|Other|1|||
156798515|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
156798516|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
156798517|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
156743479|NCT00577005|565809827|FG001|Overall Study|Lost to Follow-up|2|||
156743480|NCT00577005|565809826|FG000|Overall Study|Withdrawal by Subject|2|||
156743481|NCT00577005|565809827|FG001|Overall Study|Withdrawal by Subject|1|||
156743482|NCT02667626|565809828|FG000|Overall Study|Withdrawal by Subject|0|||
156743483|NCT02667626|565809829|FG001|Overall Study|Withdrawal by Subject|1|||
156798518|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
156798519|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
156798520|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
156798521|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
156743484|NCT02309723|565809830|FG000|Overall Study|Withdrawal by Subject|24|||
156798522|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
156743485|NCT02309723|565809831|FG001|Overall Study|Withdrawal by Subject|23|||
156798523|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
156743486|NCT02309723|565809832|FG002|Overall Study|Withdrawal by Subject|24|||
156743487|NCT02560623|565809833|FG000|Overall Study|Unable to swallow sponge|0|||
156743488|NCT02560623|565809834|FG001|Overall Study|Unable to swallow sponge|1|||
156743489|NCT02560623|565809835|FG002|Overall Study|Unable to swallow sponge|0|||
156743490|NCT02560623|565809836|FG003|Overall Study|Unable to swallow sponge|0|||
156743491|NCT02560623|565809833|FG000|Overall Study|Intervention prior to sponge administration|0|||
156743492|NCT02560623|565809834|FG001|Overall Study|Intervention prior to sponge administration|1|||
156743493|NCT02560623|565809835|FG002|Overall Study|Intervention prior to sponge administration|0|||
156743494|NCT02560623|565809836|FG003|Overall Study|Intervention prior to sponge administration|0|||
156743495|NCT01125813|565809837|FG000|Overall Study|Death|1|||
156743496|NCT01125813|565809837|FG000|Overall Study|Withdrawal by Subject|1|||
156743497|NCT01125813|565809837|FG000|Overall Study|Screen Failures|4|||
156743498|NCT02255552|565809840|FG000|Overall Study|Participants enrolled into another study|0|||
156743499|NCT02255552|565809841|FG001|Overall Study|Participants enrolled into another study|11|||
156743500|NCT02255552|565809840|FG000|Overall Study|Withdrawal by Subject|1|||
156743501|NCT02255552|565809841|FG001|Overall Study|Withdrawal by Subject|4|||
156743502|NCT01447446|565809842|FG000|Overall Study|Death|6|||
156743503|NCT01447446|565809843|FG001|Overall Study|Death|3|||
156743504|NCT01447446|565809844|FG002|Overall Study|Death|2|||
156743505|NCT01447446|565809845|FG003|Overall Study|Death|1|||
156743506|NCT01447446|565809846|FG004|Overall Study|Death|7|||
156743507|NCT01447446|565809847|FG005|Overall Study|Death|0|||
156743508|NCT01447446|565809842|FG000|Overall Study|Adverse Event|3|||
156743509|NCT01447446|565809843|FG001|Overall Study|Adverse Event|0|||
156743510|NCT01447446|565809844|FG002|Overall Study|Adverse Event|1|||
156743511|NCT01447446|565809845|FG003|Overall Study|Adverse Event|0|||
156743512|NCT01447446|565809846|FG004|Overall Study|Adverse Event|2|||
156743513|NCT01447446|565809847|FG005|Overall Study|Adverse Event|0|||
156798524|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
156798525|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798526|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798527|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798528|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798529|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798530|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798531|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798532|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
156798533|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798534|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798535|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798536|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798537|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798538|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798539|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798540|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
156798541|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798542|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798543|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798544|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798545|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798546|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798547|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798548|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798549|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
156798550|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
156798551|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
156798552|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
156798553|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
156798554|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798555|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798556|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798557|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798558|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798559|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798560|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156458522|NCT05863156|564774781|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
156743514|NCT01447446|565809842|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
156798561|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156743515|NCT01447446|565809843|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
156743516|NCT01447446|565809844|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
156798562|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
156798563|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156743517|NCT01447446|565809845|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
156337061|NCT00087607|564331461|FG001|Overall Study|Withdrew Consent|16|||
156743518|NCT01447446|565809846|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
156743519|NCT01447446|565809847|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
156743520|NCT01447446|565809842|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
156743521|NCT01447446|565809843|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
156743522|NCT01447446|565809844|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
156743523|NCT01447446|565809845|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
156743524|NCT01447446|565809846|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
156743525|NCT01447446|565809847|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
156743526|NCT01447446|565809842|FG000|Overall Study|Administrative/Other|34|||
156743527|NCT01447446|565809843|FG001|Overall Study|Administrative/Other|9|||
156743528|NCT01447446|565809844|FG002|Overall Study|Administrative/Other|10|||
156743529|NCT01447446|565809845|FG003|Overall Study|Administrative/Other|2|||
156743530|NCT01447446|565809846|FG004|Overall Study|Administrative/Other|33|||
156743531|NCT01447446|565809847|FG005|Overall Study|Administrative/Other|4|||
156743532|NCT01447446|565809842|FG000|Overall Study|SVR12 Assessment|13|||
156743533|NCT01447446|565809843|FG001|Overall Study|SVR12 Assessment|1|||
156743534|NCT01447446|565809844|FG002|Overall Study|SVR12 Assessment|2|||
156743535|NCT01447446|565809845|FG003|Overall Study|SVR12 Assessment|1|||
156743536|NCT01447446|565809846|FG004|Overall Study|SVR12 Assessment|5|||
156743537|NCT01447446|565809847|FG005|Overall Study|SVR12 Assessment|5|||
156743538|NCT01447446|565809842|FG000|Overall Study|New Treatment Started|8|||
156743539|NCT01447446|565809843|FG001|Overall Study|New Treatment Started|2|||
156743540|NCT01447446|565809844|FG002|Overall Study|New Treatment Started|1|||
156743541|NCT01447446|565809845|FG003|Overall Study|New Treatment Started|0|||
156743542|NCT01447446|565809846|FG004|Overall Study|New Treatment Started|2|||
156743543|NCT01447446|565809847|FG005|Overall Study|New Treatment Started|0|||
156743544|NCT01447446|565809842|FG000|Overall Study|Reason not Specified|1|||
156743545|NCT01447446|565809843|FG001|Overall Study|Reason not Specified|1|||
156743546|NCT01447446|565809844|FG002|Overall Study|Reason not Specified|1|||
156743547|NCT01447446|565809845|FG003|Overall Study|Reason not Specified|1|||
156743548|NCT01447446|565809846|FG004|Overall Study|Reason not Specified|1|||
156743549|NCT01447446|565809847|FG005|Overall Study|Reason not Specified|0|||
156743550|NCT04829331|565809850|FG000|Overall Study|Lost to Follow-up|1|||
156743551|NCT04829331|565809851|FG001|Overall Study|Lost to Follow-up|0|||
156743552|NCT05323994|565809852|FG000|Overall Study|Protocol Violation|1|||
156743553|NCT00454818|565809856|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
156743554|NCT00454818|565809857|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
156743555|NCT00454818|565809858|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
156743556|NCT00454818|565809859|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
156743557|NCT00454818|565809860|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
156743558|NCT00454818|565809856|FG000|Phase I: Open-label Dose-escalation|Death|0|||
156743559|NCT00454818|565809857|FG001|Phase I: Open-label Dose-escalation|Death|1|||
156743560|NCT00454818|565809858|FG002|Phase I: Open-label Dose-escalation|Death|0|||
156743561|NCT00454818|565809859|FG003|Phase I: Open-label Dose-escalation|Death|0|||
156743562|NCT00454818|565809860|FG004|Phase I: Open-label Dose-escalation|Death|0|||
156743563|NCT00454818|565809856|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
156743564|NCT00454818|565809857|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
156798564|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798565|NCT02106832|566015796|FG000|Overall Study|Adverse Event|1|||
156798566|NCT02106832|566015797|FG001|Overall Study|Adverse Event|2|||
156798567|NCT02106832|566015798|FG002|Overall Study|Adverse Event|3|||
156798568|NCT02106832|566015799|FG003|Overall Study|Adverse Event|0|||
156798569|NCT02106832|566015796|FG000|Overall Study|Death|4|||
156798570|NCT02106832|566015797|FG001|Overall Study|Death|4|||
156798571|NCT02106832|566015798|FG002|Overall Study|Death|1|||
156798572|NCT02106832|566015799|FG003|Overall Study|Death|4|||
156798573|NCT02106832|566015796|FG000|Overall Study|Deterioration of general conditions|0|||
156798574|NCT02106832|566015797|FG001|Overall Study|Deterioration of general conditions|0|||
156798575|NCT02106832|566015798|FG002|Overall Study|Deterioration of general conditions|1|||
156798576|NCT02106832|566015799|FG003|Overall Study|Deterioration of general conditions|0|||
156798577|NCT02106832|566015796|FG000|Overall Study|Lost to Follow-up|0|||
156798578|NCT02106832|566015797|FG001|Overall Study|Lost to Follow-up|1|||
156798579|NCT02106832|566015798|FG002|Overall Study|Lost to Follow-up|1|||
156798580|NCT02106832|566015799|FG003|Overall Study|Lost to Follow-up|3|||
156798581|NCT02106832|566015796|FG000|Overall Study|Physician Decision|1|||
156534915|NCT02060383|565054008|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
156743565|NCT00454818|565809858|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
156743566|NCT00454818|565809859|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
156798582|NCT02106832|566015797|FG001|Overall Study|Physician Decision|0|||
156798583|NCT02106832|566015798|FG002|Overall Study|Physician Decision|0|||
156798584|NCT02106832|566015799|FG003|Overall Study|Physician Decision|0|||
156534916|NCT02060383|565054009|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
156534917|NCT02060383|565054010|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
156534918|NCT02060383|565054011|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
156534919|NCT02060383|565054012|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
156798585|NCT02106832|566015796|FG000|Overall Study|Protocol Violation|0|||
156337062|NCT00087607|564331460|FG000|Overall Study|Administrative|12|||
156337063|NCT00087607|564331461|FG001|Overall Study|Administrative|12|||
156798586|NCT02106832|566015797|FG001|Overall Study|Protocol Violation|0|||
156337064|NCT00087607|564331460|FG000|Overall Study|Refused Treatment|5|||
156798587|NCT02106832|566015798|FG002|Overall Study|Protocol Violation|0|||
156798588|NCT02106832|566015799|FG003|Overall Study|Protocol Violation|1|||
156798589|NCT02106832|566015796|FG000|Overall Study|Withdrawal by Subject|17|||
156798590|NCT02106832|566015797|FG001|Overall Study|Withdrawal by Subject|17|||
156798591|NCT02106832|566015798|FG002|Overall Study|Withdrawal by Subject|10|||
156798592|NCT02106832|566015799|FG003|Overall Study|Withdrawal by Subject|7|||
156798593|NCT02106832|566015796|FG000|Overall Study|Technical problems|0|||
156798594|NCT02106832|566015797|FG001|Overall Study|Technical problems|1|||
156798595|NCT02106832|566015798|FG002|Overall Study|Technical problems|0|||
156798596|NCT02106832|566015799|FG003|Overall Study|Technical problems|0|||
156798597|NCT00619866|566015816|FG000|Weeks 1 - 12|Adverse Event|0|||
156798598|NCT00619866|566015817|FG001|Weeks 1 - 12|Adverse Event|1|||
156798599|NCT00619866|566015818|FG002|Weeks 1 - 12|Adverse Event|2|||
156798600|NCT00619866|566015819|FG003|Weeks 1 - 12|Adverse Event|0|||
156798601|NCT00619866|566015820|FG004|Weeks 1 - 12|Adverse Event|0|||
156798602|NCT00619866|566015816|FG000|Weeks 1 - 12|Non-compliance|0|||
156798603|NCT00619866|566015817|FG001|Weeks 1 - 12|Non-compliance|0|||
156798604|NCT00619866|566015818|FG002|Weeks 1 - 12|Non-compliance|1|||
156798605|NCT00619866|566015819|FG003|Weeks 1 - 12|Non-compliance|0|||
156798606|NCT00619866|566015820|FG004|Weeks 1 - 12|Non-compliance|0|||
156798607|NCT00619866|566015816|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
156798608|NCT00619866|566015817|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
156798609|NCT00619866|566015818|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
156798610|NCT00619866|566015819|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
156798611|NCT00619866|566015820|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
156798612|NCT00619866|566015816|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
156798613|NCT00619866|566015817|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
156798614|NCT00619866|566015818|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
156798615|NCT00619866|566015819|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
156798616|NCT00619866|566015820|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
156798617|NCT00619866|566015816|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
156798618|NCT00619866|566015817|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
156798619|NCT00619866|566015818|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
156798620|NCT00619866|566015819|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
156798621|NCT00619866|566015820|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
156798622|NCT00619866|566015816|FG000|Weeks 1 - 12|Sponsor Decision|0|||
156798623|NCT00619866|566015817|FG001|Weeks 1 - 12|Sponsor Decision|1|||
156798624|NCT00619866|566015818|FG002|Weeks 1 - 12|Sponsor Decision|0|||
156798625|NCT00619866|566015819|FG003|Weeks 1 - 12|Sponsor Decision|0|||
156798626|NCT00619866|566015820|FG004|Weeks 1 - 12|Sponsor Decision|0|||
156798627|NCT00619866|566015816|FG000|Weeks 13 - 24|Adverse Event|0|||
156798628|NCT00619866|566015817|FG001|Weeks 13 - 24|Adverse Event|0|||
156798629|NCT00619866|566015818|FG002|Weeks 13 - 24|Adverse Event|2|||
156798630|NCT00619866|566015819|FG003|Weeks 13 - 24|Adverse Event|1|||
156798631|NCT00619866|566015820|FG004|Weeks 13 - 24|Adverse Event|0|||
156798632|NCT00619866|566015816|FG000|Weeks 13 - 24|Protocol Deviation|0|||
156798633|NCT00619866|566015817|FG001|Weeks 13 - 24|Protocol Deviation|0|||
156798634|NCT00619866|566015818|FG002|Weeks 13 - 24|Protocol Deviation|0|||
156798635|NCT00619866|566015819|FG003|Weeks 13 - 24|Protocol Deviation|1|||
156798636|NCT00619866|566015820|FG004|Weeks 13 - 24|Protocol Deviation|0|||
156798637|NCT00619866|566015816|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
156798638|NCT00619866|566015817|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
156798639|NCT00619866|566015818|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
156798640|NCT00619866|566015819|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
156798641|NCT00619866|566015820|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
156798642|NCT00619866|566015816|FG000|Weeks 13 - 24|Non-compliance|0|||
156798643|NCT00619866|566015817|FG001|Weeks 13 - 24|Non-compliance|1|||
156798644|NCT00619866|566015818|FG002|Weeks 13 - 24|Non-compliance|1|||
156798645|NCT00619866|566015819|FG003|Weeks 13 - 24|Non-compliance|0|||
156798646|NCT00619866|566015820|FG004|Weeks 13 - 24|Non-compliance|0|||
156798647|NCT00619866|566015816|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
156798648|NCT00619866|566015817|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
156798649|NCT00619866|566015818|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
156798650|NCT00619866|566015819|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
156798651|NCT00619866|566015820|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
156798652|NCT02520154|566015833|FG000|Overall Study|Death|1|||
156798653|NCT02520154|566015833|FG000|Overall Study|Withdrawal by Subject|2|||
156798654|NCT02520154|566015833|FG000|Overall Study|Physician Decision|2|||
156743567|NCT00454818|565809860|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
156743568|NCT00454818|565809856|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
156743569|NCT00454818|565809857|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
156743570|NCT00454818|565809858|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
156743571|NCT00454818|565809859|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
156743572|NCT00454818|565809860|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
156743573|NCT00454818|565809856|FG000|Phase 2: Randomized Double-blind|Death|0|||
156743574|NCT00454818|565809857|FG001|Phase 2: Randomized Double-blind|Death|1|||
156743575|NCT00454818|565809858|FG002|Phase 2: Randomized Double-blind|Death|0|||
156743576|NCT00454818|565809859|FG003|Phase 2: Randomized Double-blind|Death|0|||
156743577|NCT00454818|565809860|FG004|Phase 2: Randomized Double-blind|Death|1|||
156743578|NCT00454818|565809856|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
156743579|NCT00454818|565809857|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
156743580|NCT00454818|565809858|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
156743581|NCT00454818|565809859|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
156743582|NCT00454818|565809860|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
156743583|NCT00454818|565809856|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
156743584|NCT00454818|565809857|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
156743585|NCT00454818|565809858|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
156743586|NCT00454818|565809859|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
156743587|NCT00454818|565809860|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
156743588|NCT03181503|565809861|FG000|Overall Study|Adverse Event|2|||
156743589|NCT03181503|565809862|FG001|Overall Study|Adverse Event|2|||
156743590|NCT03181503|565809861|FG000|Overall Study|Protocol Violation|1|||
156743591|NCT03181503|565809862|FG001|Overall Study|Protocol Violation|0|||
156743592|NCT03181503|565809861|FG000|Overall Study|Withdrawal by Subject|3|||
156743593|NCT03181503|565809862|FG001|Overall Study|Withdrawal by Subject|0|||
156743594|NCT03181503|565809861|FG000|Overall Study|Lost to Follow-up|1|||
156743595|NCT03181503|565809862|FG001|Overall Study|Lost to Follow-up|1|||
156743596|NCT03435224|565809866|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
156743597|NCT03077659|565809869|FG000|Overall Study|Withdrawal by Subject|0|||
156743598|NCT03077659|565809870|FG001|Overall Study|Withdrawal by Subject|0|||
156743599|NCT03077659|565809871|FG002|Overall Study|Withdrawal by Subject|1|||
156743600|NCT02258542|565809878|FG000|Overall Study|eg. not made to the visit|7|||
156743601|NCT02258542|565809879|FG001|Overall Study|eg. not made to the visit|4|||
156743602|NCT02258542|565809880|FG002|Overall Study|eg. not made to the visit|0|||
156743603|NCT02258542|565809881|FG003|Overall Study|eg. not made to the visit|1|||
156743604|NCT02258542|565809878|FG000|Overall Study|study specific discount. criteria|1|||
156743605|NCT02258542|565809879|FG001|Overall Study|study specific discount. criteria|1|||
156743606|NCT02258542|565809880|FG002|Overall Study|study specific discount. criteria|0|||
156743607|NCT02258542|565809881|FG003|Overall Study|study specific discount. criteria|0|||
156743608|NCT02258542|565809878|FG000|Overall Study|Withdrawal by Subject|20|||
156743609|NCT02258542|565809879|FG001|Overall Study|Withdrawal by Subject|20|||
156743610|NCT02258542|565809880|FG002|Overall Study|Withdrawal by Subject|7|||
156743611|NCT02258542|565809881|FG003|Overall Study|Withdrawal by Subject|1|||
156743612|NCT02258542|565809878|FG000|Overall Study|Lost to Follow-up|5|||
156743613|NCT02258542|565809879|FG001|Overall Study|Lost to Follow-up|12|||
156743614|NCT02258542|565809880|FG002|Overall Study|Lost to Follow-up|1|||
156743615|NCT02258542|565809881|FG003|Overall Study|Lost to Follow-up|2|||
156743616|NCT02258542|565809878|FG000|Overall Study|Death|5|||
156743617|NCT02258542|565809879|FG001|Overall Study|Death|4|||
156743618|NCT02258542|565809880|FG002|Overall Study|Death|0|||
156798655|NCT06022107|566015834|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
156743619|NCT02258542|565809881|FG003|Overall Study|Death|1|||
156743620|NCT02258542|565809878|FG000|Overall Study|Adverse Event|3|||
156743621|NCT02258542|565809879|FG001|Overall Study|Adverse Event|4|||
156743622|NCT02258542|565809880|FG002|Overall Study|Adverse Event|0|||
156743623|NCT02258542|565809881|FG003|Overall Study|Adverse Event|0|||
156743624|NCT02258542|565809878|FG000|Overall Study|Protocol Violation|1|||
156743625|NCT02258542|565809879|FG001|Overall Study|Protocol Violation|2|||
156798656|NCT06022107|566015834|FG000|Overall Study|Dropped out of study for higher level of care|1|||
156798657|NCT06022107|566015834|FG000|Overall Study|Lost to Follow-up|2|||
156798658|NCT05943990|566015835|FG000|Overall Study|Study Terminated by Sponsor|0|||
156798659|NCT05943990|566015836|FG001|Overall Study|Study Terminated by Sponsor|0|||
156798660|NCT05943990|566015837|FG002|Overall Study|Study Terminated by Sponsor|1|||
156798661|NCT02038647|566017164|FG000|Overall Study|Progressive Disease|50|||
156743626|NCT02258542|565809880|FG002|Overall Study|Protocol Violation|0|||
156743627|NCT02258542|565809881|FG003|Overall Study|Protocol Violation|0|||
156743628|NCT02258542|565809878|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156743629|NCT02258542|565809879|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
156743630|NCT02258542|565809880|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
156743631|NCT02258542|565809881|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
156743632|NCT01032070|565809882|FG000|Overall Study|Disease progression|13|||
156743633|NCT01032070|565809883|FG001|Overall Study|Disease progression|8|||
156743634|NCT01032070|565809882|FG000|Overall Study|Medical or ethical reasons|0|||
156743635|NCT01032070|565809883|FG001|Overall Study|Medical or ethical reasons|2|||
156743636|NCT01032070|565809882|FG000|Overall Study|Withdrawal by Subject|0|||
156743637|NCT01032070|565809883|FG001|Overall Study|Withdrawal by Subject|2|||
156743638|NCT02554318|565809884|FG000|Overall Study|Withdrawal by Subject|10|||
156743639|NCT02554318|565809885|FG001|Overall Study|Withdrawal by Subject|8|||
156743640|NCT02332239|565809888|FG000|Overall Study|Lost to Follow-up|4|||
156743641|NCT02332239|565809889|FG001|Overall Study|Lost to Follow-up|6|||
156743642|NCT00894790|565809890|FG000|Overall Study|Protocol Violation|0|||
156743643|NCT00894790|565809891|FG001|Overall Study|Protocol Violation|1|||
156743644|NCT00894790|565809890|FG000|Overall Study|Lost to Follow-up|0|||
156743645|NCT00894790|565809891|FG001|Overall Study|Lost to Follow-up|1|||
156743646|NCT00894790|565809890|FG000|Overall Study|Did not meet entrance criteria|1|||
156743647|NCT00894790|565809891|FG001|Overall Study|Did not meet entrance criteria|0|||
156743648|NCT01472965|565809892|FG000|Overall Study|Withdrawal by Subject|1|||
156743649|NCT01472965|565809893|FG001|Overall Study|Withdrawal by Subject|0|||
156743650|NCT00980018|565809897|FG000|Overall Study|Adverse Event|8|||
156743651|NCT00980018|565809897|FG000|Overall Study|Patient withdrew consent|3|||
156798662|NCT02038647|566017165|FG001|Overall Study|Progressive Disease|59|||
156798663|NCT02038647|566017164|FG000|Overall Study|Adverse Event|18|||
156798664|NCT02038647|566017165|FG001|Overall Study|Adverse Event|10|||
156798665|NCT02038647|566017164|FG000|Overall Study|Symptomatic Deterioration|7|||
156798666|NCT02038647|566017165|FG001|Overall Study|Symptomatic Deterioration|7|||
156798667|NCT02038647|566017164|FG000|Overall Study|Withdrawal by Subject|5|||
156798668|NCT02038647|566017165|FG001|Overall Study|Withdrawal by Subject|2|||
156798669|NCT02038647|566017164|FG000|Overall Study|Not Reported|0|||
156798670|NCT02038647|566017165|FG001|Overall Study|Not Reported|1|||
156798671|NCT02038647|566017164|FG000|Overall Study|Ongoing at Datacut|9|||
156798672|NCT02038647|566017165|FG001|Overall Study|Ongoing at Datacut|10|||
156798673|NCT04462471|566017166|FG000|Overall Study|Adverse Event|0|||
156798674|NCT04462471|566017167|FG001|Overall Study|Adverse Event|1|||
156798675|NCT04462471|566017168|FG002|Overall Study|Adverse Event|0|||
156798676|NCT04462471|566017169|FG003|Overall Study|Adverse Event|0|||
156798677|NCT04462471|566017166|FG000|Overall Study|Disease progression|1|||
156798678|NCT04462471|566017167|FG001|Overall Study|Disease progression|0|||
156798679|NCT04462471|566017168|FG002|Overall Study|Disease progression|0|||
156798680|NCT04462471|566017169|FG003|Overall Study|Disease progression|0|||
156798681|NCT02526290|566017170|FG000|Overall Study|Adverse Event|3|||
156798682|NCT02526290|566017170|FG000|Overall Study|Withdrawal by Subject|4|||
156798683|NCT02526290|566017170|FG000|Overall Study|Physician Decision|1|||
156798684|NCT02706392|566017176|FG000|Overall Study|Death|1|||
156798685|NCT02706392|566017177|FG001|Overall Study|Death|0|||
156798686|NCT02706392|566017178|FG002|Overall Study|Death|2|||
156798687|NCT02706392|566017179|FG003|Overall Study|Death|2|||
156798688|NCT02706392|566017180|FG004|Overall Study|Death|5|||
156798689|NCT02706392|566017181|FG005|Overall Study|Death|2|||
156798690|NCT00265122|566017183|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
156798691|NCT00265122|566017184|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
156798692|NCT00265122|566017185|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
156798693|NCT00265122|566017186|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
156798694|NCT00265122|566017187|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
156798695|NCT00265122|566017188|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
156798696|NCT00265122|566017183|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
156798697|NCT00265122|566017184|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
156798698|NCT00265122|566017185|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
156798699|NCT00265122|566017186|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
156798700|NCT00265122|566017187|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
156798701|NCT00265122|566017188|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
156798702|NCT00265122|566017183|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
156798703|NCT00265122|566017184|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
156798704|NCT00265122|566017185|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
156798705|NCT00265122|566017186|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
156798706|NCT00265122|566017187|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
156337065|NCT00087607|564331461|FG001|Overall Study|Refused Treatment|7|||
156743652|NCT00980018|565809897|FG000|Overall Study|Lost to Follow-up|1|||
156798707|NCT00265122|566017188|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
156798708|NCT00265122|566017183|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
156798709|NCT00265122|566017184|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
156798710|NCT00265122|566017185|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
156743653|NCT00551161|565809898|FG000|Overall Study|Withdrawal by Subject|1|||
156743654|NCT01256385|565809899|FG000|Overall Study|Physician Decision|1|||
156743655|NCT01256385|565809900|FG001|Overall Study|Physician Decision|1|||
156743656|NCT01256385|565809899|FG000|Overall Study|Withdrawal by Subject|2|||
156743657|NCT01256385|565809900|FG001|Overall Study|Withdrawal by Subject|2|||
156743658|NCT00926536|565809901|FG000|Overall Study|Physician Decision|1|||
156743659|NCT00926536|565809902|FG001|Overall Study|Physician Decision|2|||
156743660|NCT03301844|565809903|FG000|Overall Study|suspected colon cancer|1|||
156743661|NCT03301844|565809904|FG001|Overall Study|suspected colon cancer|1|||
156743662|NCT01267201|565809905|FG000|First Intervention Period|Withdrawal by Subject|1|||
156743663|NCT01267201|565809906|FG001|First Intervention Period|Withdrawal by Subject|0|||
156743664|NCT01267201|565809907|FG002|First Intervention Period|Withdrawal by Subject|0|||
156743665|NCT01267201|565809908|FG003|First Intervention Period|Withdrawal by Subject|0|||
156743666|NCT01267201|565809909|FG004|First Intervention Period|Withdrawal by Subject|0|||
156743667|NCT01267201|565809910|FG005|First Intervention Period|Withdrawal by Subject|0|||
156743668|NCT01267201|565809905|FG000|Second Intervention Period|Withdrawal by Subject|0|||
156743669|NCT01267201|565809906|FG001|Second Intervention Period|Withdrawal by Subject|1|||
156743670|NCT01267201|565809907|FG002|Second Intervention Period|Withdrawal by Subject|0|||
156743671|NCT01267201|565809908|FG003|Second Intervention Period|Withdrawal by Subject|0|||
156743672|NCT01267201|565809909|FG004|Second Intervention Period|Withdrawal by Subject|0|||
156743673|NCT01267201|565809910|FG005|Second Intervention Period|Withdrawal by Subject|0|||
156743674|NCT00483704|565809911|FG000|Randomization|Withdrawal by Subject|19|||
156743675|NCT00483704|565809912|FG001|Randomization|Withdrawal by Subject|28|||
156743676|NCT00483704|565809913|FG002|Randomization|Withdrawal by Subject|18|||
156743677|NCT00483704|565809911|FG000|Randomization|Protocol Violation|14|||
156743678|NCT00483704|565809912|FG001|Randomization|Protocol Violation|25|||
156743679|NCT00483704|565809913|FG002|Randomization|Protocol Violation|22|||
156743680|NCT00483704|565809911|FG000|Randomization|Lost to Follow-up|14|||
156743681|NCT00483704|565809912|FG001|Randomization|Lost to Follow-up|14|||
156743682|NCT00483704|565809913|FG002|Randomization|Lost to Follow-up|19|||
156743683|NCT00483704|565809911|FG000|Randomization|Pregnancy|1|||
156743684|NCT00483704|565809912|FG001|Randomization|Pregnancy|0|||
156743685|NCT00483704|565809913|FG002|Randomization|Pregnancy|0|||
156743686|NCT00483704|565809911|FG000|Randomization|Physician Decision|2|||
156743687|NCT00483704|565809912|FG001|Randomization|Physician Decision|4|||
156743688|NCT00483704|565809913|FG002|Randomization|Physician Decision|0|||
156743689|NCT00483704|565809911|FG000|Randomization|Progressive disease|0|||
156743690|NCT00483704|565809912|FG001|Randomization|Progressive disease|0|||
156743691|NCT00483704|565809913|FG002|Randomization|Progressive disease|1|||
156743692|NCT00483704|565809911|FG000|Randomization|Lack of qualifying migraines|21|||
156743693|NCT00483704|565809912|FG001|Randomization|Lack of qualifying migraines|25|||
156743694|NCT00483704|565809913|FG002|Randomization|Lack of qualifying migraines|31|||
156743695|NCT00483704|565809911|FG000|Treatment|Lack of qualifying migraines|101|||
156743696|NCT00483704|565809912|FG001|Treatment|Lack of qualifying migraines|99|||
156743697|NCT00483704|565809913|FG002|Treatment|Lack of qualifying migraines|116|||
156743698|NCT00483704|565809911|FG000|Treatment|Adverse Event|3|||
156743699|NCT00483704|565809912|FG001|Treatment|Adverse Event|5|||
156743700|NCT00483704|565809913|FG002|Treatment|Adverse Event|4|||
156743701|NCT00483704|565809911|FG000|Treatment|Withdrawal by Subject|16|||
156743702|NCT00483704|565809912|FG001|Treatment|Withdrawal by Subject|12|||
156743703|NCT00483704|565809913|FG002|Treatment|Withdrawal by Subject|21|||
156743704|NCT00483704|565809911|FG000|Treatment|Protocol Violation|6|||
156743705|NCT00483704|565809912|FG001|Treatment|Protocol Violation|3|||
156743706|NCT00483704|565809913|FG002|Treatment|Protocol Violation|5|||
156743707|NCT00483704|565809911|FG000|Treatment|Lost to Follow-up|2|||
156743708|NCT00483704|565809912|FG001|Treatment|Lost to Follow-up|7|||
156743709|NCT00483704|565809913|FG002|Treatment|Lost to Follow-up|5|||
156743710|NCT00483704|565809911|FG000|Treatment|Lack of Efficacy|1|||
156743711|NCT00483704|565809912|FG001|Treatment|Lack of Efficacy|1|||
156743712|NCT00483704|565809913|FG002|Treatment|Lack of Efficacy|1|||
156743713|NCT00483704|565809911|FG000|Treatment|Pregnancy|0|||
156743714|NCT00483704|565809912|FG001|Treatment|Pregnancy|1|||
156743715|NCT00483704|565809913|FG002|Treatment|Pregnancy|0|||
156743716|NCT00483704|565809911|FG000|Treatment|Physician Decision|0|||
156743717|NCT00483704|565809912|FG001|Treatment|Physician Decision|1|||
156743718|NCT00483704|565809913|FG002|Treatment|Physician Decision|4|||
156798711|NCT00265122|566017186|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
156337066|NCT00087607|564331460|FG000|Overall Study|Other Protocol Violation|5|||
156743719|NCT00819780|565809914|FG000|Overall Study|Did not receive study drug|3|||
156743720|NCT00819780|565809915|FG001|Overall Study|Did not receive study drug|4|||
156743721|NCT00819780|565809914|FG000|Overall Study|Still in treatment|25|||
156743722|NCT00819780|565809915|FG001|Overall Study|Still in treatment|17|||
156743723|NCT02637713|565809917|FG000|Overall Study|Screen Failure|2|||
156743724|NCT02847182|565809918|FG000|Overall Study|Withdrawal by Subject|0|||
156743725|NCT02847182|565809919|FG001|Overall Study|Withdrawal by Subject|1|||
156743726|NCT02345889|565809920|FG000|Overall Study|Inadequate Bowel Prep|17|||
156743727|NCT02345889|565809921|FG001|Overall Study|Inadequate Bowel Prep|16|||
156743728|NCT02345889|565809922|FG002|Overall Study|Inadequate Bowel Prep|18|||
156743729|NCT02345889|565809923|FG003|Overall Study|Inadequate Bowel Prep|14|||
156743730|NCT02345889|565809920|FG000|Overall Study|Polyposis identified during procedure|1|||
156743731|NCT02345889|565809921|FG001|Overall Study|Polyposis identified during procedure|1|||
156743732|NCT02345889|565809922|FG002|Overall Study|Polyposis identified during procedure|0|||
156743733|NCT02345889|565809923|FG003|Overall Study|Polyposis identified during procedure|1|||
156743734|NCT02345889|565809920|FG000|Overall Study|Recognized ineligible post-randomization|1|||
156743735|NCT02345889|565809921|FG001|Overall Study|Recognized ineligible post-randomization|0|||
156743736|NCT02345889|565809922|FG002|Overall Study|Recognized ineligible post-randomization|2|||
156743737|NCT02345889|565809923|FG003|Overall Study|Recognized ineligible post-randomization|1|||
156743738|NCT02345889|565809920|FG000|Overall Study|Ulcerative Colitis identified|1|||
156743739|NCT02345889|565809921|FG001|Overall Study|Ulcerative Colitis identified|0|||
156743740|NCT02345889|565809922|FG002|Overall Study|Ulcerative Colitis identified|0|||
156743741|NCT02345889|565809923|FG003|Overall Study|Ulcerative Colitis identified|0|||
156743742|NCT02345889|565809920|FG000|Overall Study|Cecum not intubated|1|||
156743743|NCT02345889|565809921|FG001|Overall Study|Cecum not intubated|0|||
156743744|NCT02345889|565809922|FG002|Overall Study|Cecum not intubated|0|||
156743745|NCT02345889|565809923|FG003|Overall Study|Cecum not intubated|0|||
156743746|NCT05072964|565809929|FG000|Overall Study|Withdrawal by Subject|4|||
156743747|NCT05072964|565809929|FG000|Overall Study|Death|1|||
156743748|NCT02987972|565809930|FG000|Overall Study|Adverse Event|1|||
156743749|NCT02987972|565809931|FG001|Overall Study|Adverse Event|1|||
156743750|NCT02987972|565809932|FG002|Overall Study|Adverse Event|0|||
156743751|NCT02987972|565809930|FG000|Overall Study|Death|1|||
156743752|NCT02987972|565809931|FG001|Overall Study|Death|0|||
156743753|NCT02987972|565809932|FG002|Overall Study|Death|0|||
156743754|NCT02987972|565809930|FG000|Overall Study|Lack of Efficacy|9|||
156743755|NCT02987972|565809931|FG001|Overall Study|Lack of Efficacy|12|||
156743756|NCT02987972|565809932|FG002|Overall Study|Lack of Efficacy|12|||
156743757|NCT02987972|565809930|FG000|Overall Study|Lost to Follow-up|7|||
156743758|NCT02987972|565809931|FG001|Overall Study|Lost to Follow-up|8|||
156743759|NCT02987972|565809932|FG002|Overall Study|Lost to Follow-up|4|||
156743760|NCT02987972|565809930|FG000|Overall Study|Physician Decision|1|||
156743761|NCT02987972|565809931|FG001|Overall Study|Physician Decision|6|||
156743762|NCT02987972|565809932|FG002|Overall Study|Physician Decision|0|||
156743763|NCT02987972|565809930|FG000|Overall Study|Protocol Violation|2|||
156743764|NCT02987972|565809931|FG001|Overall Study|Protocol Violation|1|||
156743765|NCT02987972|565809932|FG002|Overall Study|Protocol Violation|5|||
156743766|NCT02987972|565809930|FG000|Overall Study|Withdrawal by Subject|22|||
156743767|NCT02987972|565809931|FG001|Overall Study|Withdrawal by Subject|17|||
156743768|NCT02987972|565809932|FG002|Overall Study|Withdrawal by Subject|21|||
156743769|NCT02342548|565809933|FG000|Overall Study|Adverse Event|12|||
156743770|NCT02342548|565809934|FG001|Overall Study|Adverse Event|17|||
156743771|NCT02342548|565809935|FG002|Overall Study|Adverse Event|13|||
156743772|NCT02342548|565809933|FG000|Overall Study|Lost to Follow-up|0|||
156743773|NCT02342548|565809934|FG001|Overall Study|Lost to Follow-up|1|||
156743774|NCT02342548|565809935|FG002|Overall Study|Lost to Follow-up|0|||
156743775|NCT02342548|565809933|FG000|Overall Study|Study terminated by sponsor|20|||
156743776|NCT02342548|565809934|FG001|Overall Study|Study terminated by sponsor|39|||
156743777|NCT02342548|565809935|FG002|Overall Study|Study terminated by sponsor|25|||
156743778|NCT02342548|565809933|FG000|Overall Study|Protocol Violation|0|||
156743779|NCT02342548|565809934|FG001|Overall Study|Protocol Violation|1|||
156743780|NCT02342548|565809935|FG002|Overall Study|Protocol Violation|0|||
156743781|NCT02342548|565809933|FG000|Overall Study|Withdrawal by Subject|1|||
156743782|NCT02342548|565809934|FG001|Overall Study|Withdrawal by Subject|3|||
156743783|NCT02342548|565809935|FG002|Overall Study|Withdrawal by Subject|4|||
156743784|NCT02342548|565809933|FG000|Overall Study|Other|1|||
156743785|NCT02342548|565809934|FG001|Overall Study|Other|1|||
156743786|NCT02342548|565809935|FG002|Overall Study|Other|1|||
156743787|NCT02172040|565809937|FG000|Overall Study|Adverse Event|0|||
156743788|NCT02172040|565809938|FG001|Overall Study|Adverse Event|2|||
156743789|NCT02172040|565809939|FG002|Overall Study|Adverse Event|0|||
156743790|NCT02172040|565809940|FG003|Overall Study|Adverse Event|0|||
156743791|NCT02172040|565809937|FG000|Overall Study|Protocol Violation|0|||
156743792|NCT02172040|565809938|FG001|Overall Study|Protocol Violation|1|||
156743793|NCT02172040|565809939|FG002|Overall Study|Protocol Violation|0|||
156337067|NCT00087607|564331461|FG001|Overall Study|Other Protocol Violation|2|||
156337068|NCT00087607|564331460|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
156337069|NCT00087607|564331461|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156743794|NCT02172040|565809940|FG003|Overall Study|Protocol Violation|0|||
156337070|NCT02699593|564331462|FG000|Period 1|Unsatisfactory Visual Response|0|||
156337071|NCT02699593|564331463|FG001|Period 1|Unsatisfactory Visual Response|1|||
156337072|NCT02699593|564331462|FG000|Period 1|Torn Contact Len|4|||
156337073|NCT02699593|564331463|FG001|Period 1|Torn Contact Len|3|||
156743795|NCT02172040|565809937|FG000|Overall Study|Withdrawal by Subject|0|||
156337074|NCT02699593|564331462|FG000|Period 1|Protocol Violation|0|||
156743796|NCT02172040|565809938|FG001|Overall Study|Withdrawal by Subject|0|||
156743797|NCT02172040|565809939|FG002|Overall Study|Withdrawal by Subject|1|||
156743798|NCT02172040|565809940|FG003|Overall Study|Withdrawal by Subject|0|||
156743799|NCT02172040|565809937|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
156743800|NCT02172040|565809938|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
156743801|NCT02172040|565809939|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
156743802|NCT02172040|565809940|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
156743803|NCT02172040|565809937|FG000|Overall Study|Family emergency abroad|0|||
156743804|NCT02172040|565809938|FG001|Overall Study|Family emergency abroad|0|||
156743805|NCT02172040|565809939|FG002|Overall Study|Family emergency abroad|0|||
156743806|NCT02172040|565809940|FG003|Overall Study|Family emergency abroad|1|||
156743807|NCT03976323|565809947|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
156743808|NCT03976323|565809948|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
156743809|NCT03976323|565809949|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
156743810|NCT03976323|565809947|FG000|Induction Phase|Death|80|||
156743811|NCT03976323|565809948|FG001|Induction Phase|Death|0|||
156743812|NCT03976323|565809949|FG002|Induction Phase|Death|0|||
156743813|NCT03976323|565809947|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
156743814|NCT03976323|565809948|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
156743815|NCT03976323|565809949|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
156743816|NCT03976323|565809947|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156743817|NCT03976323|565809948|FG001|Maintenance Phase|Withdrawal by Subject|9|||
156743818|NCT03976323|565809949|FG002|Maintenance Phase|Withdrawal by Subject|3|||
156743819|NCT03976323|565809947|FG000|Maintenance Phase|Physician Decision|0|||
156743820|NCT03976323|565809948|FG001|Maintenance Phase|Physician Decision|0|||
156743821|NCT03976323|565809949|FG002|Maintenance Phase|Physician Decision|1|||
156743822|NCT03976323|565809947|FG000|Maintenance Phase|Death|0|||
156743823|NCT03976323|565809948|FG001|Maintenance Phase|Death|228|||
156743824|NCT03976323|565809949|FG002|Maintenance Phase|Death|234|||
156743825|NCT02824562|565811429|FG000|Overall Study|Lost to Follow-up|3|||
156743826|NCT02824562|565811430|FG001|Overall Study|Lost to Follow-up|4|||
156743827|NCT02824562|565811429|FG000|Overall Study|Death|0|||
156743828|NCT02824562|565811430|FG001|Overall Study|Death|1|||
156743829|NCT05459558|565811431|FG000|Overall Study|Adverse Event|1|||
156743830|NCT05459558|565811432|FG001|Overall Study|Adverse Event|0|||
156743831|NCT05459558|565811433|FG002|Overall Study|Adverse Event|0|||
156743832|NCT05459558|565811431|FG000|Overall Study|Scheduling issue|0|||
156743833|NCT05459558|565811432|FG001|Overall Study|Scheduling issue|1|||
156743834|NCT05459558|565811433|FG002|Overall Study|Scheduling issue|3|||
156743835|NCT05459558|565811431|FG000|Overall Study|Withdrawal by Subject|0|||
156743836|NCT05459558|565811432|FG001|Overall Study|Withdrawal by Subject|0|||
156743837|NCT05459558|565811433|FG002|Overall Study|Withdrawal by Subject|2|||
156743838|NCT01887288|565811439|FG000|Overall Study|The study was terminated and the PI has|16|||
156743839|NCT01092637|565811440|FG000|Overall Study|Death|47|||
156743840|NCT01092637|565811441|FG001|Overall Study|Death|49|||
156743841|NCT02921750|565811442|FG000|Overall Study|Adverse Event|1|||
156743842|NCT02921750|565811443|FG001|Overall Study|Adverse Event|2|||
156743843|NCT02921750|565811442|FG000|Overall Study|Withdrawal by Subject|1|||
156743844|NCT02921750|565811443|FG001|Overall Study|Withdrawal by Subject|1|||
156743845|NCT02921750|565811442|FG000|Overall Study|Lost to Follow-up|3|||
156743846|NCT02921750|565811443|FG001|Overall Study|Lost to Follow-up|3|||
156743847|NCT02921750|565811442|FG000|Overall Study|Wound healed|3|||
156743848|NCT02921750|565811443|FG001|Overall Study|Wound healed|3|||
156743849|NCT02921750|565811442|FG000|Overall Study|Serious Adverse Event|1|||
156743850|NCT02921750|565811443|FG001|Overall Study|Serious Adverse Event|2|||
156743851|NCT03309696|565811448|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
156743852|NCT03309696|565811449|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
156743853|NCT03309696|565811450|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
156743854|NCT03309696|565811451|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
156743855|NCT04643964|565811452|FG000|Overall Study|Lost to Follow-up|55|||
156743856|NCT04643964|565811453|FG001|Overall Study|Lost to Follow-up|59|||
156743857|NCT04643964|565811454|FG002|Overall Study|Lost to Follow-up|54|||
156743858|NCT04643964|565811455|FG003|Overall Study|Lost to Follow-up|129|||
156743859|NCT04643964|565811456|FG004|Overall Study|Lost to Follow-up|48|||
156743860|NCT04643964|565811452|FG000|Overall Study|Failed attention check|1|||
156743861|NCT04643964|565811453|FG001|Overall Study|Failed attention check|8|||
156743862|NCT04643964|565811454|FG002|Overall Study|Failed attention check|2|||
156743863|NCT04643964|565811455|FG003|Overall Study|Failed attention check|14|||
156743864|NCT04643964|565811456|FG004|Overall Study|Failed attention check|11|||
156743865|NCT02638129|565811457|FG000|Overall Study|Study terminated|28|||
156743866|NCT02638129|565811458|FG001|Overall Study|Study terminated|30|||
156743867|NCT02949908|565811459|FG000|Overall Study|Study termination|2|||
156743868|NCT02368210|565811462|FG000|Overall Study|Withdrawal by Subject|1|||
156743869|NCT02368210|565811463|FG001|Overall Study|Withdrawal by Subject|0|||
156743870|NCT02368210|565811462|FG000|Overall Study|Adverse Event|0|||
156743871|NCT02368210|565811463|FG001|Overall Study|Adverse Event|1|||
156743872|NCT00590538|565811464|FG000|Overall Study|Study terminated before completed|2|||
156743873|NCT02539134|565811465|FG000|Overall Study|Lost to Follow-up|1|||
156743874|NCT02539134|565811466|FG001|Overall Study|Lost to Follow-up|0|||
156743875|NCT02539134|565811467|FG002|Overall Study|Lost to Follow-up|0|||
156743876|NCT02539134|565811468|FG003|Overall Study|Lost to Follow-up|0|||
156743877|NCT02539134|565811469|FG004|Overall Study|Lost to Follow-up|0|||
156743878|NCT02539134|565811470|FG005|Overall Study|Lost to Follow-up|0|||
156743879|NCT02604550|565811472|FG000|Overall Study|Lost to Follow-up|7|||
156743880|NCT02604550|565811473|FG001|Overall Study|Lost to Follow-up|6|||
156743881|NCT02604550|565811472|FG000|Overall Study|Withdrawal by Subject|0|||
156743882|NCT02604550|565811473|FG001|Overall Study|Withdrawal by Subject|1|||
156743883|NCT02604550|565811472|FG000|Overall Study|Incomplete data using paper journal|18|||
156743884|NCT02604550|565811473|FG001|Overall Study|Incomplete data using paper journal|19|||
156743885|NCT00908076|565811474|FG000|Overall Study|Lack of Efficacy|1|||
156743886|NCT00908076|565811475|FG001|Overall Study|Lack of Efficacy|1|||
156743887|NCT02609724|565811476|FG000|Overall Study|Death|2|||
156743888|NCT02609724|565811477|FG001|Overall Study|Death|0|||
156743889|NCT02609724|565811478|FG002|Overall Study|Death|1|||
156743890|NCT02609724|565811476|FG000|Overall Study|Withdrawal by Subject|1|||
156743891|NCT02609724|565811477|FG001|Overall Study|Withdrawal by Subject|2|||
156743892|NCT02609724|565811478|FG002|Overall Study|Withdrawal by Subject|3|||
156743893|NCT02609724|565811476|FG000|Overall Study|Illness|2|||
156743894|NCT02609724|565811477|FG001|Overall Study|Illness|1|||
156743895|NCT02609724|565811478|FG002|Overall Study|Illness|0|||
156743896|NCT02382796|565811479|FG000|Overall Study|Global deterioration of health status|1|||
156743897|NCT02382796|565811479|FG000|Overall Study|Objective progression or relapse|3|||
156743898|NCT02382796|565811479|FG000|Overall Study|Commercial dacomitinib became available|3|||
156743899|NCT04007107|565811480|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
156743900|NCT04007107|565811481|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
156743901|NCT04007107|565811482|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
156743902|NCT04007107|565811483|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
156743903|NCT04068688|565811484|FG000|Overall Study|Lost to Follow-up|1|||
156743904|NCT04068688|565811485|FG001|Overall Study|Lost to Follow-up|1|||
156743905|NCT04068688|565811486|FG002|Overall Study|Lost to Follow-up|0|||
156743906|NCT04068688|565811487|FG003|Overall Study|Lost to Follow-up|0|||
156743907|NCT04068688|565811488|FG004|Overall Study|Lost to Follow-up|5|||
156743908|NCT04068688|565811489|FG005|Overall Study|Lost to Follow-up|5|||
156743909|NCT04068688|565811490|FG006|Overall Study|Lost to Follow-up|0|||
156743910|NCT04068688|565811491|FG007|Overall Study|Lost to Follow-up|0|||
156743911|NCT04068688|565811492|FG008|Overall Study|Lost to Follow-up|1|||
156743912|NCT04068688|565811493|FG009|Overall Study|Lost to Follow-up|0|||
156743913|NCT04068688|565811484|FG000|Overall Study|Withdrawal by Subject|1|||
156743914|NCT04068688|565811485|FG001|Overall Study|Withdrawal by Subject|1|||
156743915|NCT04068688|565811486|FG002|Overall Study|Withdrawal by Subject|0|||
156743916|NCT04068688|565811487|FG003|Overall Study|Withdrawal by Subject|0|||
156743917|NCT04068688|565811488|FG004|Overall Study|Withdrawal by Subject|0|||
156743918|NCT04068688|565811489|FG005|Overall Study|Withdrawal by Subject|0|||
156743919|NCT04068688|565811490|FG006|Overall Study|Withdrawal by Subject|0|||
156743920|NCT04068688|565811491|FG007|Overall Study|Withdrawal by Subject|0|||
156743921|NCT04068688|565811492|FG008|Overall Study|Withdrawal by Subject|0|||
156743922|NCT04068688|565811493|FG009|Overall Study|Withdrawal by Subject|0|||
156743923|NCT04068688|565811484|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
156743924|NCT04068688|565811485|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
156743925|NCT04068688|565811486|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743926|NCT04068688|565811487|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743927|NCT04068688|565811488|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743928|NCT04068688|565811489|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743929|NCT04068688|565811490|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743930|NCT04068688|565811491|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156337075|NCT02699593|564331463|FG001|Period 1|Protocol Violation|1|||
156743931|NCT04068688|565811492|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743932|NCT04068688|565811493|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743933|NCT04679051|565811494|FG000|Overall Study|felt tired after restricted time in bed|3|||
156743934|NCT04679051|565811495|FG001|Overall Study|felt tired after restricted time in bed|0|||
156743935|NCT04679051|565811494|FG000|Overall Study|discomfort with blood pressure cuff|2|||
156743936|NCT04679051|565811495|FG001|Overall Study|discomfort with blood pressure cuff|0|||
156743937|NCT04679051|565811494|FG000|Overall Study|scheduling conflict|1|||
156743938|NCT04679051|565811495|FG001|Overall Study|scheduling conflict|1|||
156743939|NCT04679051|565811494|FG000|Overall Study|Protocol Violation|0|||
156743940|NCT04679051|565811495|FG001|Overall Study|Protocol Violation|4|||
156743941|NCT00396877|565811496|FG000|Overall Study|Lost to Follow-up|2|||
156743942|NCT00396877|565811497|FG001|Overall Study|Lost to Follow-up|1|||
156743943|NCT00396877|565811496|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
156743944|NCT00396877|565811497|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
156743945|NCT00934856|565811503|FG000|Feasibility Part|Progressive disease|4|||
156743946|NCT00934856|565811504|FG001|Feasibility Part|Progressive disease|4|||
156743947|NCT00934856|565811505|FG002|Feasibility Part|Progressive disease|2|||
156743948|NCT00934856|565811506|FG003|Feasibility Part|Progressive disease|3|||
156743949|NCT00934856|565811507|FG004|Feasibility Part|Progressive disease|0|||
156743950|NCT00934856|565811508|FG005|Feasibility Part|Progressive disease|0|||
156743951|NCT00934856|565811503|FG000|Feasibility Part|Physician Decision|0|||
156743952|NCT00934856|565811504|FG001|Feasibility Part|Physician Decision|0|||
156743953|NCT00934856|565811505|FG002|Feasibility Part|Physician Decision|1|||
156743954|NCT00934856|565811506|FG003|Feasibility Part|Physician Decision|0|||
156743955|NCT00934856|565811507|FG004|Feasibility Part|Physician Decision|0|||
156534920|NCT02060383|565054008|FG000|Core Phase|Adverse Event|2|||
156534921|NCT02060383|565054009|FG001|Core Phase|Adverse Event|0|||
156534922|NCT02060383|565054010|FG002|Core Phase|Adverse Event|0|||
156534923|NCT02060383|565054011|FG003|Core Phase|Adverse Event|2|||
156534924|NCT02060383|565054012|FG004|Core Phase|Adverse Event|6|||
156534925|NCT02060383|565054008|FG000|Core Phase|Administrative problems|0|||
156534926|NCT02060383|565054009|FG001|Core Phase|Administrative problems|1|||
156534927|NCT02060383|565054010|FG002|Core Phase|Administrative problems|0|||
156743956|NCT00934856|565811508|FG005|Feasibility Part|Physician Decision|0|||
156743957|NCT00934856|565811503|FG000|Feasibility Part|Adverse Event|1|||
156743958|NCT00934856|565811504|FG001|Feasibility Part|Adverse Event|1|||
156743959|NCT00934856|565811505|FG002|Feasibility Part|Adverse Event|0|||
156743960|NCT00934856|565811506|FG003|Feasibility Part|Adverse Event|1|||
156743961|NCT00934856|565811507|FG004|Feasibility Part|Adverse Event|0|||
156534928|NCT02060383|565054011|FG003|Core Phase|Administrative problems|0|||
156534929|NCT02060383|565054012|FG004|Core Phase|Administrative problems|0|||
156534930|NCT02060383|565054008|FG000|Core Phase|Protocol Violation|0|||
156534931|NCT02060383|565054009|FG001|Core Phase|Protocol Violation|0|||
156534932|NCT02060383|565054010|FG002|Core Phase|Protocol Violation|0|||
156743962|NCT00934856|565811508|FG005|Feasibility Part|Adverse Event|2|||
156743963|NCT00934856|565811503|FG000|Feasibility Part|Withdrawal by Subject|0|||
156743964|NCT00934856|565811504|FG001|Feasibility Part|Withdrawal by Subject|0|||
156743965|NCT00934856|565811505|FG002|Feasibility Part|Withdrawal by Subject|0|||
156743966|NCT00934856|565811506|FG003|Feasibility Part|Withdrawal by Subject|1|||
156743967|NCT00934856|565811507|FG004|Feasibility Part|Withdrawal by Subject|0|||
156743968|NCT00934856|565811508|FG005|Feasibility Part|Withdrawal by Subject|1|||
156743969|NCT00934856|565811503|FG000|Extension Part|Adverse Event|0|||
156743970|NCT00934856|565811504|FG001|Extension Part|Adverse Event|0|||
156743971|NCT00934856|565811505|FG002|Extension Part|Adverse Event|0|||
156743972|NCT00934856|565811506|FG003|Extension Part|Adverse Event|1|||
156743973|NCT00934856|565811507|FG004|Extension Part|Adverse Event|4|||
156743974|NCT00934856|565811508|FG005|Extension Part|Adverse Event|4|||
156743975|NCT00934856|565811503|FG000|Extension Part|Progressive disease|0|||
156743976|NCT00934856|565811504|FG001|Extension Part|Progressive disease|0|||
156743977|NCT00934856|565811505|FG002|Extension Part|Progressive disease|0|||
156743978|NCT00934856|565811506|FG003|Extension Part|Progressive disease|1|||
156743979|NCT00934856|565811507|FG004|Extension Part|Progressive disease|0|||
156743980|NCT00934856|565811508|FG005|Extension Part|Progressive disease|0|||
156743981|NCT00934856|565811503|FG000|Extension Part|Non-compliance with drug|0|||
156743982|NCT00934856|565811504|FG001|Extension Part|Non-compliance with drug|0|||
156743983|NCT00934856|565811505|FG002|Extension Part|Non-compliance with drug|0|||
156743984|NCT00934856|565811506|FG003|Extension Part|Non-compliance with drug|0|||
156743985|NCT00934856|565811507|FG004|Extension Part|Non-compliance with drug|0|||
156743986|NCT00934856|565811508|FG005|Extension Part|Non-compliance with drug|1|||
156743987|NCT00932451|565811516|FG000|Overall Study|Withdrawal by Subject|69|||
156743988|NCT00932451|565811516|FG000|Overall Study|Lost to Follow-up|22|||
156798712|NCT00265122|566017187|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
156798713|NCT00265122|566017188|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
156798714|NCT00265122|566017183|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
156534933|NCT02060383|565054011|FG003|Core Phase|Protocol Violation|1|||
156743989|NCT00932451|565811516|FG000|Overall Study|Death|726|||
156743990|NCT00932451|565811516|FG000|Overall Study|Other reasons|5|||
156743991|NCT04272606|565811517|FG000|Overall Study|Protocol Violation|1|||
156798715|NCT00265122|566017184|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
156534934|NCT02060383|565054012|FG004|Core Phase|Protocol Violation|0|||
156743992|NCT04272606|565811518|FG001|Overall Study|Protocol Violation|1|||
156743993|NCT04272606|565811517|FG000|Overall Study|Physician Decision|0|||
156743994|NCT04272606|565811518|FG001|Overall Study|Physician Decision|1|||
156534935|NCT02060383|565054008|FG000|Core Phase|Withdrawal by Subject|0|||
156534936|NCT02060383|565054009|FG001|Core Phase|Withdrawal by Subject|0|||
156534937|NCT02060383|565054010|FG002|Core Phase|Withdrawal by Subject|0|||
156534938|NCT02060383|565054011|FG003|Core Phase|Withdrawal by Subject|4|||
156534939|NCT02060383|565054012|FG004|Core Phase|Withdrawal by Subject|2|||
156743995|NCT00725101|565811519|FG000|Overall Study|Death|3|||
156743996|NCT00725101|565811519|FG000|Overall Study|Lost to Follow-up|353|||
156743997|NCT00725101|565811519|FG000|Overall Study|Protocol Violation|1|||
156743998|NCT00725101|565811519|FG000|Overall Study|Withdrawal by Subject|127|||
156743999|NCT00725101|565811519|FG000|Overall Study|not specified/no reason given|11|||
156744000|NCT03912428|565811522|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
156744001|NCT03912428|565811523|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
156744002|NCT03912428|565811524|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
156744003|NCT03912428|565811525|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
156744004|NCT03912428|565811522|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
156744005|NCT03912428|565811523|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
156744006|NCT03912428|565811524|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
156744007|NCT03912428|565811525|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
156744008|NCT03912428|565811522|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
156744009|NCT03912428|565811523|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
156744010|NCT03912428|565811524|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
156744011|NCT03912428|565811525|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
156744012|NCT00962091|565811526|FG000|Overall Study|Withdrawal by Subject|1|||
156744013|NCT00962091|565811527|FG001|Overall Study|Withdrawal by Subject|2|||
156744014|NCT00962091|565811528|FG002|Overall Study|Withdrawal by Subject|1|||
156744015|NCT00962091|565811529|FG003|Overall Study|Withdrawal by Subject|1|||
156744016|NCT00962091|565811530|FG004|Overall Study|Withdrawal by Subject|0|||
156744017|NCT00962091|565811531|FG005|Overall Study|Withdrawal by Subject|1|||
156744018|NCT00962091|565811532|FG006|Overall Study|Withdrawal by Subject|0|||
156744019|NCT00962091|565811526|FG000|Overall Study|Adverse Event|0|||
156744020|NCT00962091|565811527|FG001|Overall Study|Adverse Event|0|||
156744021|NCT00962091|565811528|FG002|Overall Study|Adverse Event|0|||
156744022|NCT00962091|565811529|FG003|Overall Study|Adverse Event|0|||
156744023|NCT00962091|565811530|FG004|Overall Study|Adverse Event|0|||
156744024|NCT00962091|565811531|FG005|Overall Study|Adverse Event|0|||
156744025|NCT00962091|565811532|FG006|Overall Study|Adverse Event|1|||
156744026|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744027|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744028|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
156744029|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744030|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744031|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744032|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744033|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744034|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744035|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744036|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744037|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744038|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744039|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744040|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
156744041|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744042|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744043|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744044|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744045|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744046|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744047|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744048|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744049|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744050|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744051|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156798716|NCT00265122|566017185|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
156798717|NCT00265122|566017186|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
156798718|NCT00265122|566017187|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
156798719|NCT00265122|566017188|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
156798720|NCT00265122|566017183|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
156798721|NCT00265122|566017184|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
156798722|NCT00265122|566017185|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
156798723|NCT00265122|566017186|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
156744052|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744053|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744054|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
156744055|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
156744056|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744057|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744058|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744059|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744060|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744061|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156534940|NCT02060383|565054008|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
156534941|NCT02060383|565054009|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
156534942|NCT02060383|565054010|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
156534943|NCT02060383|565054011|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
156534944|NCT02060383|565054012|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
156744062|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744063|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744064|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744065|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744066|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744067|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744068|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
156744069|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
156744070|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744071|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744072|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744073|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744074|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744075|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744076|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744077|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744078|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744079|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744080|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744081|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744082|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744083|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744084|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
156744085|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744086|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744087|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744088|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744089|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744090|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744091|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744092|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744093|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744094|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744095|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744096|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744097|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744098|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744099|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744100|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744101|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156798724|NCT00265122|566017187|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
156798725|NCT00265122|566017188|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
156798726|NCT04716894|566017189|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
156798727|NCT04716894|566017189|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
156798728|NCT05205616|566017196|FG000|Overall Study|Lost to Follow-up|4|||
156798729|NCT05205616|566017197|FG001|Overall Study|Lost to Follow-up|4|||
156798730|NCT01467466|566017206|FG000|Overall Study|Withdrawal by Subject|15|||
156798731|NCT01467466|566017207|FG001|Overall Study|Withdrawal by Subject|18|||
156798732|NCT01467466|566017208|FG002|Overall Study|Withdrawal by Subject|13|||
156798733|NCT01467466|566017209|FG003|Overall Study|Withdrawal by Subject|11|||
156798734|NCT01467466|566017206|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
156798735|NCT01467466|566017207|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
156798736|NCT01467466|566017208|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
156798737|NCT01467466|566017209|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
156798738|NCT01467466|566017206|FG000|Overall Study|Procedure Cancelled|46|||
156798739|NCT01467466|566017207|FG001|Overall Study|Procedure Cancelled|45|||
156337076|NCT02699593|564331462|FG000|Period 1|Withdrawal by Subject|0|||
156337077|NCT02699593|564331463|FG001|Period 1|Withdrawal by Subject|1|||
156534945|NCT02060383|565054008|FG000|Extension Phase|Adverse Event|1|||
156337078|NCT02699593|564331462|FG000|Period 1|Adverse Event|1|||
156798740|NCT01467466|566017208|FG002|Overall Study|Procedure Cancelled|25|||
156798741|NCT01467466|566017209|FG003|Overall Study|Procedure Cancelled|29|||
156798742|NCT01467466|566017206|FG000|Overall Study|No Endpoint Blood Draw|38|||
156798743|NCT01467466|566017207|FG001|Overall Study|No Endpoint Blood Draw|32|||
156798744|NCT01467466|566017208|FG002|Overall Study|No Endpoint Blood Draw|51|||
156798745|NCT01467466|566017209|FG003|Overall Study|No Endpoint Blood Draw|43|||
156798746|NCT00982280|566017220|FG000|Observation Period|Not eligible to be dosed|19|||
156798747|NCT00982280|566017220|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
156798748|NCT00982280|566017220|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
156798749|NCT00982280|566017220|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
156798750|NCT00982280|566017220|FG000|Maintenance Period|Adverse Event|1|||
156798751|NCT04724837|566017221|FG000|Overall Study|Other|4|||
156798752|NCT04724837|566017222|FG001|Overall Study|Other|16|||
156798753|NCT04724837|566017223|FG002|Overall Study|Other|0|||
156798754|NCT04724837|566017221|FG000|Overall Study|Withdrawal by Subject|2|||
156798755|NCT04724837|566017222|FG001|Overall Study|Withdrawal by Subject|9|||
156798756|NCT04724837|566017223|FG002|Overall Study|Withdrawal by Subject|9|||
156798757|NCT04724837|566017221|FG000|Overall Study|Adverse Event|2|||
156798758|NCT04724837|566017222|FG001|Overall Study|Adverse Event|7|||
156798759|NCT04724837|566017223|FG002|Overall Study|Adverse Event|4|||
156798760|NCT04724837|566017221|FG000|Overall Study|Lost to Follow-up|0|||
156798761|NCT04724837|566017222|FG001|Overall Study|Lost to Follow-up|1|||
156798762|NCT04724837|566017223|FG002|Overall Study|Lost to Follow-up|3|||
156798763|NCT04724837|566017221|FG000|Overall Study|Physician Decision|1|||
156798764|NCT04724837|566017222|FG001|Overall Study|Physician Decision|2|||
156798765|NCT04724837|566017223|FG002|Overall Study|Physician Decision|0|||
156798766|NCT04724837|566017221|FG000|Overall Study|Death|0|||
156798767|NCT04724837|566017222|FG001|Overall Study|Death|0|||
156798768|NCT04724837|566017223|FG002|Overall Study|Death|1|||
156798769|NCT04724837|566017221|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
156798770|NCT04724837|566017222|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
156798771|NCT04724837|566017223|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
156798772|NCT04724837|566017221|FG000|Overall Study|Study Terminated by Sponsor|0|||
156798773|NCT04724837|566017222|FG001|Overall Study|Study Terminated by Sponsor|1|||
156798774|NCT04724837|566017223|FG002|Overall Study|Study Terminated by Sponsor|0|||
156798775|NCT03213509|566017224|FG000|Overall Study|Did not consent for verbal autopsy|4|||
156798776|NCT03213509|566017225|FG001|Overall Study|Did not consent for verbal autopsy|5|||
156798777|NCT03620981|566017226|FG000|Overall Study|Adverse Event|14|||
156798778|NCT03620981|566017227|FG001|Overall Study|Adverse Event|38|||
156798779|NCT03620981|566017228|FG002|Overall Study|Adverse Event|25|||
156798780|NCT03620981|566017226|FG000|Overall Study|Lack of Efficacy|2|||
156798781|NCT03620981|566017227|FG001|Overall Study|Lack of Efficacy|1|||
156744102|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
156744103|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156744104|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156744105|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156744106|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744107|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744108|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744109|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744110|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744111|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744112|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744113|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744114|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744115|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
156744116|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
156744117|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156337079|NCT02699593|564331463|FG001|Period 1|Adverse Event|1|||
156460626|NCT00429364|564781665|FG000|Overall Study|Withdrawal by Subject|11|||
156744118|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
156798782|NCT03620981|566017228|FG002|Overall Study|Lack of Efficacy|1|||
156798783|NCT03620981|566017226|FG000|Overall Study|Physician Decision|7|||
156798784|NCT03620981|566017227|FG001|Overall Study|Physician Decision|4|||
156798785|NCT03620981|566017228|FG002|Overall Study|Physician Decision|4|||
156798786|NCT03620981|566017226|FG000|Overall Study|Protocol Violation|1|||
156798787|NCT03620981|566017227|FG001|Overall Study|Protocol Violation|2|||
156798788|NCT03620981|566017228|FG002|Overall Study|Protocol Violation|1|||
156744119|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744120|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744121|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744122|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744123|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744124|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744125|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744126|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744127|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744128|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744129|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
156744130|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744131|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744132|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744133|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744134|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744135|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744136|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744137|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744138|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744139|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744140|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744141|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744142|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744143|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744144|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
156744145|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744146|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744147|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744148|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744149|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744150|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744151|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744152|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744153|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744154|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744155|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744156|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744157|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744158|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744159|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
156744160|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744161|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744162|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744163|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744164|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744165|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744166|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744167|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744168|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744169|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744170|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744171|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744172|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
156744173|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
156744174|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744175|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744176|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744177|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744178|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744179|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744180|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744181|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744182|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744183|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744184|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744185|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744186|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744187|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156744188|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744189|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744190|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744191|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744192|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744193|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744194|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744195|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744196|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744197|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744198|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744199|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
156744200|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744201|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744202|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744203|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744204|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744205|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744206|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744207|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744208|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
156744209|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
156744210|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
156744211|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
156744212|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
156744213|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
156744214|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
156744215|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
156744216|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
156744217|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
156744218|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
156744219|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
156744220|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
156744221|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
156744222|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156458523|NCT05863156|564774782|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
156534946|NCT02060383|565054009|FG001|Extension Phase|Adverse Event|1|||
156744223|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744224|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744225|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744226|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156337080|NCT02699593|564331462|FG000|Period 2|Adverse Event|1|||
156744227|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744228|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744229|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744230|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744231|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744232|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744233|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
156744234|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
156744235|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744236|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744237|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744238|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744239|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744240|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744241|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744242|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744243|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744244|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744245|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744246|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744247|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156744248|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156744249|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744250|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744251|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744252|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744253|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744254|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744255|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744256|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744257|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744258|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744259|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744260|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744261|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744262|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744263|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
156744264|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744265|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744266|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744267|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744268|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744269|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744270|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744271|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744272|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744273|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744274|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744275|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
156744276|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
156744277|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
156744278|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744279|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744280|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744281|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744282|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744283|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744284|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744285|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744286|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744287|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744288|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156798789|NCT03620981|566017226|FG000|Overall Study|Withdrawal by Legal Representative|2|||
156744289|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
156744290|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
156744291|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
156744292|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744293|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744294|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744295|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744296|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744297|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744298|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744299|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744300|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744301|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744302|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744303|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
156744304|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
156744305|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
156744306|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744307|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744308|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744309|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744310|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744311|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
156744312|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744313|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744314|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744315|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744316|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744317|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
156744318|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Adverse Event|0|||
156744319|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Adverse Event|0|||
156744320|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Adverse Event|0|||
156744321|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Adverse Event|0|||
156744322|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Adverse Event|0|||
156744323|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Adverse Event|2|||
156744324|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744325|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744326|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744327|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744328|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744329|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
156744330|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744331|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744332|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744333|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744334|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744335|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
156744336|NCT03191864|565811547|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
156744337|NCT03191864|565811548|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
156744338|NCT03191864|565811549|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
156744339|NCT03191864|565811550|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
156744340|NCT03191864|565811551|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
156744341|NCT03191864|565811552|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
156744342|NCT03191864|565811547|FG000|Part 1 - Induction|Adverse Event|0|||
156744343|NCT03191864|565811548|FG001|Part 1 - Induction|Adverse Event|2|||
156744344|NCT03191864|565811549|FG002|Part 1 - Induction|Adverse Event|0|||
156744345|NCT03191864|565811550|FG003|Part 1 - Induction|Adverse Event|1|||
156744346|NCT03191864|565811551|FG004|Part 1 - Induction|Adverse Event|0|||
156744347|NCT03191864|565811552|FG005|Part 1 - Induction|Adverse Event|2|||
156744348|NCT03191864|565811547|FG000|Part 1 - Induction|Randomized but never dosed|0|||
156744349|NCT03191864|565811548|FG001|Part 1 - Induction|Randomized but never dosed|0|||
156744350|NCT03191864|565811549|FG002|Part 1 - Induction|Randomized but never dosed|1|||
156744351|NCT03191864|565811550|FG003|Part 1 - Induction|Randomized but never dosed|0|||
156744352|NCT03191864|565811551|FG004|Part 1 - Induction|Randomized but never dosed|0|||
156744353|NCT03191864|565811552|FG005|Part 1 - Induction|Randomized but never dosed|0|||
156744354|NCT03191864|565811547|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
156744355|NCT03191864|565811548|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
156744356|NCT03191864|565811549|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
156744357|NCT03191864|565811550|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
156744358|NCT03191864|565811551|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
156744359|NCT03191864|565811552|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
156744360|NCT03191864|565811547|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744361|NCT03191864|565811548|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744362|NCT03191864|565811549|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
156744363|NCT03191864|565811550|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744364|NCT03191864|565811551|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744365|NCT03191864|565811552|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744366|NCT03191864|565811547|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
156744367|NCT03191864|565811548|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744368|NCT03191864|565811549|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744369|NCT03191864|565811550|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744370|NCT03191864|565811551|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744371|NCT03191864|565811552|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744372|NCT03191864|565811547|FG000|Part 2 - Maintenance|Physician Decision|1|||
156744373|NCT03191864|565811548|FG001|Part 2 - Maintenance|Physician Decision|0|||
156744374|NCT03191864|565811549|FG002|Part 2 - Maintenance|Physician Decision|0|||
156744375|NCT03191864|565811550|FG003|Part 2 - Maintenance|Physician Decision|0|||
156744376|NCT03191864|565811551|FG004|Part 2 - Maintenance|Physician Decision|0|||
156744377|NCT03191864|565811552|FG005|Part 2 - Maintenance|Physician Decision|0|||
156744378|NCT03191864|565811547|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
156744379|NCT03191864|565811548|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
156744380|NCT03191864|565811549|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
156744381|NCT03191864|565811550|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
156744382|NCT03191864|565811551|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
156744383|NCT03191864|565811552|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
156744384|NCT03191864|565811547|FG000|Part 2 - Maintenance|Adverse Event|0|||
156744385|NCT03191864|565811548|FG001|Part 2 - Maintenance|Adverse Event|0|||
156744386|NCT03191864|565811549|FG002|Part 2 - Maintenance|Adverse Event|0|||
156744387|NCT03191864|565811550|FG003|Part 2 - Maintenance|Adverse Event|0|||
156744388|NCT03191864|565811551|FG004|Part 2 - Maintenance|Adverse Event|1|||
156744389|NCT03191864|565811552|FG005|Part 2 - Maintenance|Adverse Event|0|||
156744390|NCT03191864|565811547|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
156744391|NCT03191864|565811548|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
156744392|NCT03191864|565811549|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
156744393|NCT03191864|565811550|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
156744394|NCT03191864|565811551|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
156744395|NCT03191864|565811552|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
156744396|NCT03191864|565811547|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744397|NCT03191864|565811548|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744398|NCT03191864|565811549|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744399|NCT03191864|565811550|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744400|NCT03191864|565811551|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
156744401|NCT03191864|565811552|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744402|NCT00415597|565811555|FG000|Enrollment|Withdrawal by Subject|1|||
156744403|NCT00415597|565811555|FG000|Enrollment|Protocol Violation|1|||
156744404|NCT00415597|565811555|FG000|Treatment|Adverse Event|110|||
156744405|NCT00415597|565811555|FG000|Treatment|Lack of Efficacy|39|||
156744406|NCT00415597|565811555|FG000|Treatment|Protocol Violation|67|||
156744407|NCT00415597|565811555|FG000|Treatment|Physician Decision|3|||
156798790|NCT03620981|566017227|FG001|Overall Study|Withdrawal by Legal Representative|1|||
156798791|NCT03620981|566017228|FG002|Overall Study|Withdrawal by Legal Representative|1|||
156798792|NCT03620981|566017226|FG000|Overall Study|Withdrawal by Care Giver|2|||
156798793|NCT03620981|566017227|FG001|Overall Study|Withdrawal by Care Giver|0|||
156744408|NCT00415597|565811555|FG000|Treatment|Withdrawal by Subject|51|||
156798794|NCT03620981|566017228|FG002|Overall Study|Withdrawal by Care Giver|1|||
156798795|NCT03620981|566017226|FG000|Overall Study|Non-compliance with Study Drug|1|||
156798796|NCT03620981|566017227|FG001|Overall Study|Non-compliance with Study Drug|1|||
156798797|NCT03620981|566017228|FG002|Overall Study|Non-compliance with Study Drug|0|||
156798798|NCT06071104|566017229|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
156798799|NCT01344226|566017234|FG000|Overall Study|Protocol Violation|2|||
156798800|NCT01344226|566017234|FG000|Overall Study|Withdrawal by Subject|3|||
156798801|NCT01344226|566017234|FG000|Overall Study|Lack of Efficacy|3|||
156798802|NCT02420717|566017240|FG000|Overall Study|Did not receive all study medication|2|||
156534947|NCT02060383|565054010|FG002|Extension Phase|Adverse Event|2|||
156744409|NCT00415597|565811555|FG000|Treatment|Lost to Follow-up|28|||
156744410|NCT00415597|565811555|FG000|Treatment|Drug Screen|2|||
156744411|NCT00415597|565811555|FG000|Treatment|Administrative|3|||
156744412|NCT00415597|565811555|FG000|Treatment|Sponsor Decision|1|||
156744413|NCT00415597|565811555|FG000|Treatment|Multiple Reasons|1|||
156744414|NCT01447927|565811556|FG000|Overall Study|Adverse Event|4|||
156744415|NCT01447927|565811557|FG001|Overall Study|Adverse Event|3|||
156744416|NCT01447927|565811556|FG000|Overall Study|Withdrawal by Subject|1|||
156744417|NCT01447927|565811557|FG001|Overall Study|Withdrawal by Subject|0|||
156744418|NCT04102865|565811558|FG000|Overall Study|Adverse Event|4|||
156744419|NCT04102865|565811559|FG001|Overall Study|Adverse Event|0|||
156744420|NCT04102865|565811558|FG000|Overall Study|Lost to Follow-up|1|||
156744421|NCT04102865|565811559|FG001|Overall Study|Lost to Follow-up|0|||
156744422|NCT04102865|565811558|FG000|Overall Study|Withdrawal by Subject|2|||
156744423|NCT04102865|565811559|FG001|Overall Study|Withdrawal by Subject|0|||
156744424|NCT04506905|565811567|FG000|Overall Study|Lost to Follow-up|1|||
156744425|NCT04506905|565811568|FG001|Overall Study|Lost to Follow-up|0|||
156744426|NCT04506905|565811569|FG002|Overall Study|Lost to Follow-up|0|||
156744427|NCT04506905|565811570|FG003|Overall Study|Lost to Follow-up|1|||
156744428|NCT04506905|565811571|FG004|Overall Study|Lost to Follow-up|0|||
156744429|NCT04506905|565811572|FG005|Overall Study|Lost to Follow-up|0|||
156744430|NCT04506905|565811573|FG006|Overall Study|Lost to Follow-up|0|||
156744431|NCT04506905|565811574|FG007|Overall Study|Lost to Follow-up|0|||
156744432|NCT04506905|565811575|FG008|Overall Study|Lost to Follow-up|0|||
156744433|NCT04506905|565811567|FG000|Overall Study|Withdrawal by Subject|0|||
156744434|NCT04506905|565811568|FG001|Overall Study|Withdrawal by Subject|0|||
156744435|NCT04506905|565811569|FG002|Overall Study|Withdrawal by Subject|0|||
156744436|NCT04506905|565811570|FG003|Overall Study|Withdrawal by Subject|2|||
156744437|NCT04506905|565811571|FG004|Overall Study|Withdrawal by Subject|0|||
156744438|NCT04506905|565811572|FG005|Overall Study|Withdrawal by Subject|0|||
156744439|NCT04506905|565811573|FG006|Overall Study|Withdrawal by Subject|0|||
156744440|NCT04506905|565811574|FG007|Overall Study|Withdrawal by Subject|0|||
156744441|NCT04506905|565811575|FG008|Overall Study|Withdrawal by Subject|0|||
156744442|NCT02093390|565811576|FG000|Overall Study|Withdrawal by Subject|0|||
156744443|NCT02093390|565811577|FG001|Overall Study|Withdrawal by Subject|1|||
156744444|NCT00073983|565811578|FG000|Overall Study|not evaluable|1|||
156744445|NCT03800836|565811579|FG000|Overall Study|Other|2|||
156744446|NCT03800836|565811580|FG001|Overall Study|Other|1|||
156744447|NCT03800836|565811581|FG002|Overall Study|Other|0|||
156744448|NCT03800836|565811582|FG003|Overall Study|Other|2|||
156744449|NCT03800836|565811583|FG004|Overall Study|Other|0|||
156744450|NCT03800836|565811584|FG005|Overall Study|Other|1|||
156744451|NCT03800836|565811579|FG000|Overall Study|Lost to Follow-up|2|||
156744452|NCT03800836|565811580|FG001|Overall Study|Lost to Follow-up|0|||
156744453|NCT03800836|565811581|FG002|Overall Study|Lost to Follow-up|1|||
156744454|NCT03800836|565811582|FG003|Overall Study|Lost to Follow-up|1|||
156744455|NCT03800836|565811583|FG004|Overall Study|Lost to Follow-up|3|||
156744456|NCT03800836|565811584|FG005|Overall Study|Lost to Follow-up|0|||
156744457|NCT03800836|565811579|FG000|Overall Study|Withdrawal by Subject|1|||
156744458|NCT03800836|565811580|FG001|Overall Study|Withdrawal by Subject|0|||
156744459|NCT03800836|565811581|FG002|Overall Study|Withdrawal by Subject|0|||
156744460|NCT03800836|565811582|FG003|Overall Study|Withdrawal by Subject|0|||
156744461|NCT03800836|565811583|FG004|Overall Study|Withdrawal by Subject|0|||
156744462|NCT03800836|565811584|FG005|Overall Study|Withdrawal by Subject|0|||
156744463|NCT03800836|565811579|FG000|Overall Study|Physician Decision|31|||
156744464|NCT03800836|565811580|FG001|Overall Study|Physician Decision|3|||
156744465|NCT03800836|565811581|FG002|Overall Study|Physician Decision|6|||
156744466|NCT03800836|565811582|FG003|Overall Study|Physician Decision|4|||
156744467|NCT03800836|565811583|FG004|Overall Study|Physician Decision|4|||
156744468|NCT03800836|565811584|FG005|Overall Study|Physician Decision|5|||
156744469|NCT03800836|565811579|FG000|Overall Study|Death|34|||
156744470|NCT03800836|565811580|FG001|Overall Study|Death|16|||
156798803|NCT02420717|566017241|FG001|Overall Study|Did not receive all study medication|0|||
156744471|NCT03800836|565811581|FG002|Overall Study|Death|5|||
156744472|NCT03800836|565811582|FG003|Overall Study|Death|5|||
156744473|NCT03800836|565811583|FG004|Overall Study|Death|10|||
156744474|NCT03800836|565811584|FG005|Overall Study|Death|0|||
156744475|NCT03800836|565811579|FG000|Overall Study|Symptomatic Deterioration|1|||
156744476|NCT03800836|565811580|FG001|Overall Study|Symptomatic Deterioration|0|||
156744477|NCT03800836|565811581|FG002|Overall Study|Symptomatic Deterioration|1|||
156744478|NCT03800836|565811582|FG003|Overall Study|Symptomatic Deterioration|0|||
156744479|NCT03800836|565811583|FG004|Overall Study|Symptomatic Deterioration|0|||
156744480|NCT03800836|565811584|FG005|Overall Study|Symptomatic Deterioration|0|||
156744481|NCT01709864|565813219|FG000|Overall Study|Physician Decision|0|||
156744482|NCT01709864|565813220|FG001|Overall Study|Physician Decision|1|||
156744483|NCT01709864|565813219|FG000|Overall Study|subject/guardian decision|5|||
156744484|NCT01709864|565813220|FG001|Overall Study|subject/guardian decision|6|||
156744485|NCT01709864|565813219|FG000|Overall Study|Lost to Follow-up|1|||
156744486|NCT01709864|565813220|FG001|Overall Study|Lost to Follow-up|0|||
156744487|NCT01709864|565813219|FG000|Overall Study|non-compliance with study treatment|1|||
156744488|NCT01709864|565813220|FG001|Overall Study|non-compliance with study treatment|1|||
156744489|NCT01709864|565813219|FG000|Overall Study|Adverse Event|0|||
156798804|NCT02420717|566017242|FG002|Overall Study|Did not receive all study medication|0|||
156798805|NCT03781570|566017243|FG000|Overall Study|Technical Issues (equipment failure)|31|||
156798806|NCT03781570|566017243|FG000|Overall Study|Withdrawal by Subject|7|||
156798807|NCT03781570|566017243|FG000|Overall Study|Physical Constraints|11|||
156798808|NCT06028464|566017247|FG000|Washout|Positive drug test.|1|||
156798809|NCT03636022|566017248|FG000|Overall Study|Withdrawal by Subject|1|||
156798810|NCT03636022|566017249|FG001|Overall Study|Withdrawal by Subject|3|||
156798811|NCT03330847|566017252|FG000|Overall Study|Patients ongoing study|62|||
156744490|NCT01709864|565813220|FG001|Overall Study|Adverse Event|2|||
156744491|NCT01709864|565813219|FG000|Overall Study|Death|0|||
156744492|NCT01709864|565813220|FG001|Overall Study|Death|1|||
156744493|NCT01066793|565813221|FG000|Overall Study|Death|4|||
156744494|NCT01066793|565813222|FG001|Overall Study|Death|1|||
156744495|NCT01066793|565813223|FG002|Overall Study|Death|1|||
156744496|NCT01066793|565813224|FG003|Overall Study|Death|0|||
156744497|NCT01066793|565813225|FG004|Overall Study|Death|0|||
156744498|NCT01066793|565813226|FG005|Overall Study|Death|0|||
156744499|NCT01066793|565813221|FG000|Overall Study|Lack of Efficacy|2|||
156744500|NCT01066793|565813222|FG001|Overall Study|Lack of Efficacy|1|||
156798812|NCT03330847|566017253|FG001|Overall Study|Patients ongoing study|65|||
156744501|NCT01066793|565813223|FG002|Overall Study|Lack of Efficacy|0|||
156744502|NCT01066793|565813224|FG003|Overall Study|Lack of Efficacy|0|||
156744503|NCT01066793|565813225|FG004|Overall Study|Lack of Efficacy|0|||
156744504|NCT01066793|565813226|FG005|Overall Study|Lack of Efficacy|0|||
156744505|NCT01066793|565813221|FG000|Overall Study|Lost to Follow-up|180|||
156744506|NCT01066793|565813222|FG001|Overall Study|Lost to Follow-up|39|||
156744507|NCT01066793|565813223|FG002|Overall Study|Lost to Follow-up|82|||
156744508|NCT01066793|565813224|FG003|Overall Study|Lost to Follow-up|16|||
156744509|NCT01066793|565813225|FG004|Overall Study|Lost to Follow-up|0|||
156744510|NCT01066793|565813226|FG005|Overall Study|Lost to Follow-up|1|||
156744511|NCT01066793|565813221|FG000|Overall Study|Physician Decision|3|||
156744512|NCT01066793|565813222|FG001|Overall Study|Physician Decision|0|||
156744513|NCT01066793|565813223|FG002|Overall Study|Physician Decision|0|||
156798813|NCT03330847|566017254|FG002|Overall Study|Patients ongoing study|15|||
156798814|NCT02769481|566017257|FG000|Overall Study|Protocol Violation|1|||
156798815|NCT02769481|566017258|FG001|Overall Study|Protocol Violation|0|||
156798816|NCT02769481|566017257|FG000|Overall Study|Adverse Event|3|||
156798817|NCT02769481|566017258|FG001|Overall Study|Adverse Event|6|||
156798818|NCT02769481|566017257|FG000|Overall Study|Entry Criteria Not Met|1|||
156798819|NCT02769481|566017258|FG001|Overall Study|Entry Criteria Not Met|2|||
156798820|NCT02769481|566017257|FG000|Overall Study|Withdrawal by Subject|14|||
156798821|NCT02769481|566017258|FG001|Overall Study|Withdrawal by Subject|16|||
156337081|NCT02699593|564331463|FG001|Period 2|Adverse Event|1|||
156337082|NCT02699593|564331462|FG000|Period 2|Lost Contact Lens|0|||
156337083|NCT02699593|564331463|FG001|Period 2|Lost Contact Lens|1|||
156744514|NCT01066793|565813224|FG003|Overall Study|Physician Decision|0|||
156744515|NCT01066793|565813225|FG004|Overall Study|Physician Decision|0|||
156744516|NCT01066793|565813226|FG005|Overall Study|Physician Decision|0|||
156744517|NCT01066793|565813221|FG000|Overall Study|Protocol Violation|3|||
156744518|NCT01066793|565813222|FG001|Overall Study|Protocol Violation|2|||
156744519|NCT01066793|565813223|FG002|Overall Study|Protocol Violation|2|||
156744520|NCT01066793|565813224|FG003|Overall Study|Protocol Violation|0|||
156744521|NCT01066793|565813225|FG004|Overall Study|Protocol Violation|0|||
156744522|NCT01066793|565813226|FG005|Overall Study|Protocol Violation|0|||
156744523|NCT01066793|565813221|FG000|Overall Study|Withdrawal by Subject|7|||
156744524|NCT01066793|565813222|FG001|Overall Study|Withdrawal by Subject|4|||
156798822|NCT02769481|566017257|FG000|Overall Study|Lost to Follow-up|9|||
156744525|NCT01066793|565813223|FG002|Overall Study|Withdrawal by Subject|1|||
156337084|NCT02699593|564331462|FG000|Period 2|Torn Contact Lens|1|||
156744526|NCT01066793|565813224|FG003|Overall Study|Withdrawal by Subject|0|||
156744527|NCT01066793|565813225|FG004|Overall Study|Withdrawal by Subject|0|||
156744528|NCT01066793|565813226|FG005|Overall Study|Withdrawal by Subject|0|||
156744529|NCT01066793|565813221|FG000|Overall Study|Early Termination|3|||
156744530|NCT01066793|565813222|FG001|Overall Study|Early Termination|0|||
156744531|NCT01066793|565813223|FG002|Overall Study|Early Termination|0|||
156744532|NCT01066793|565813224|FG003|Overall Study|Early Termination|0|||
156744533|NCT01066793|565813225|FG004|Overall Study|Early Termination|0|||
156798823|NCT02769481|566017258|FG001|Overall Study|Lost to Follow-up|9|||
156798824|NCT02769481|566017257|FG000|Overall Study|Physician Decision|0|||
156744534|NCT01066793|565813226|FG005|Overall Study|Early Termination|0|||
156744535|NCT01066793|565813221|FG000|Overall Study|Lab test not done|7|||
156744536|NCT01066793|565813222|FG001|Overall Study|Lab test not done|0|||
156744537|NCT01066793|565813223|FG002|Overall Study|Lab test not done|0|||
156744538|NCT01066793|565813224|FG003|Overall Study|Lab test not done|1|||
156744539|NCT01066793|565813225|FG004|Overall Study|Lab test not done|0|||
156744540|NCT01066793|565813226|FG005|Overall Study|Lab test not done|0|||
156744541|NCT01066793|565813221|FG000|Overall Study|Miscellaneous|4|||
156744542|NCT01066793|565813222|FG001|Overall Study|Miscellaneous|5|||
156744543|NCT01066793|565813223|FG002|Overall Study|Miscellaneous|6|||
156744544|NCT01066793|565813224|FG003|Overall Study|Miscellaneous|0|||
156744545|NCT01066793|565813225|FG004|Overall Study|Miscellaneous|0|||
156744546|NCT01066793|565813226|FG005|Overall Study|Miscellaneous|0|||
156744547|NCT01066793|565813221|FG000|Overall Study|Non-responders|104|||
156744548|NCT01066793|565813222|FG001|Overall Study|Non-responders|5|||
156744549|NCT01066793|565813223|FG002|Overall Study|Non-responders|11|||
156744550|NCT01066793|565813224|FG003|Overall Study|Non-responders|25|||
156744551|NCT01066793|565813225|FG004|Overall Study|Non-responders|0|||
156744552|NCT01066793|565813226|FG005|Overall Study|Non-responders|0|||
156744553|NCT01066793|565813221|FG000|Overall Study|Other|15|||
156744554|NCT01066793|565813222|FG001|Overall Study|Other|5|||
156744555|NCT01066793|565813223|FG002|Overall Study|Other|6|||
156744556|NCT01066793|565813224|FG003|Overall Study|Other|2|||
156744557|NCT01066793|565813225|FG004|Overall Study|Other|0|||
156744558|NCT01066793|565813226|FG005|Overall Study|Other|0|||
156744559|NCT01066793|565813221|FG000|Overall Study|Relapse|20|||
156744560|NCT01066793|565813222|FG001|Overall Study|Relapse|8|||
156744561|NCT01066793|565813223|FG002|Overall Study|Relapse|2|||
156744562|NCT01066793|565813224|FG003|Overall Study|Relapse|3|||
156744563|NCT01066793|565813225|FG004|Overall Study|Relapse|0|||
156744564|NCT01066793|565813226|FG005|Overall Study|Relapse|0|||
156744565|NCT01066793|565813221|FG000|Overall Study|Result Not Available|1|||
156744566|NCT01066793|565813222|FG001|Overall Study|Result Not Available|0|||
156744567|NCT01066793|565813223|FG002|Overall Study|Result Not Available|0|||
156744568|NCT01066793|565813224|FG003|Overall Study|Result Not Available|0|||
156744569|NCT01066793|565813225|FG004|Overall Study|Result Not Available|0|||
156744570|NCT01066793|565813226|FG005|Overall Study|Result Not Available|0|||
156744571|NCT01066793|565813221|FG000|Overall Study|Treatment Interrupted|1|||
156744572|NCT01066793|565813222|FG001|Overall Study|Treatment Interrupted|1|||
156744573|NCT01066793|565813223|FG002|Overall Study|Treatment Interrupted|0|||
156337085|NCT02699593|564331463|FG001|Period 2|Torn Contact Lens|0|||
156744574|NCT01066793|565813224|FG003|Overall Study|Treatment Interrupted|0|||
156744575|NCT01066793|565813225|FG004|Overall Study|Treatment Interrupted|0|||
156744576|NCT01066793|565813226|FG005|Overall Study|Treatment Interrupted|0|||
156337086|NCT02369016|564331464|FG000|Overall Study|AE associated with clinical disease progression|2|||
156337087|NCT02369016|564331465|FG001|Overall Study|AE associated with clinical disease progression|1|||
156337088|NCT02369016|564331464|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
156337089|NCT02369016|564331465|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
156337090|NCT02369016|564331464|FG000|Overall Study|Progressive disease - clinical progression|1|||
156337091|NCT02369016|564331465|FG001|Overall Study|Progressive disease - clinical progression|4|||
156337092|NCT02369016|564331464|FG000|Overall Study|withdrawal by patient|4|||
156337093|NCT02369016|564331465|FG001|Overall Study|withdrawal by patient|0|||
156337094|NCT02369016|564331464|FG000|Overall Study|Progressive disease - radiological progression|6|||
156337095|NCT02369016|564331465|FG001|Overall Study|Progressive disease - radiological progression|2|||
156337096|NCT02229383|564331468|FG000|Overall Study|Adverse Event|7|||
156337097|NCT02229383|564331469|FG001|Overall Study|Adverse Event|4|||
156337098|NCT02229383|564331468|FG000|Overall Study|Death|0|||
156337099|NCT02229383|564331469|FG001|Overall Study|Death|1|||
156458524|NCT05863156|564774783|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
156458525|NCT03362476|564774784|FG000|Overall Study|Withdrawal by Subject|0|||
156458526|NCT03362476|564774785|FG001|Overall Study|Withdrawal by Subject|1|||
156458527|NCT05216406|564774788|FG000|Overall Study|Lost to Follow-up|8|||
156458528|NCT05216406|564774789|FG001|Overall Study|Lost to Follow-up|9|||
156458529|NCT04270942|564774790|FG000|Overall Study|Death|1|||
156458530|NCT04741776|564774798|FG000|Overall Study|Withdrawal by Subject|7|||
156458531|NCT04741776|564774799|FG001|Overall Study|Withdrawal by Subject|10|||
156458532|NCT04741776|564774800|FG002|Overall Study|Withdrawal by Subject|10|||
156458533|NCT04741776|564774801|FG003|Overall Study|Withdrawal by Subject|17|||
156458534|NCT04741776|564774798|FG000|Overall Study|Death|0|||
156458535|NCT04741776|564774799|FG001|Overall Study|Death|0|||
156458536|NCT04741776|564774800|FG002|Overall Study|Death|1|||
156458537|NCT04741776|564774801|FG003|Overall Study|Death|0|||
156744577|NCT01066793|565813221|FG000|Overall Study|Treatment Never Started|18|||
156744578|NCT01066793|565813222|FG001|Overall Study|Treatment Never Started|5|||
156744579|NCT01066793|565813223|FG002|Overall Study|Treatment Never Started|4|||
156744580|NCT01066793|565813224|FG003|Overall Study|Treatment Never Started|1|||
156744581|NCT01066793|565813225|FG004|Overall Study|Treatment Never Started|0|||
156744582|NCT01066793|565813226|FG005|Overall Study|Treatment Never Started|0|||
156744583|NCT01066793|565813221|FG000|Overall Study|Treatment Stopped|2|||
156744584|NCT01066793|565813222|FG001|Overall Study|Treatment Stopped|1|||
156534948|NCT02060383|565054011|FG003|Extension Phase|Adverse Event|0|||
156534949|NCT02060383|565054012|FG004|Extension Phase|Adverse Event|1|||
156534950|NCT02060383|565054008|FG000|Extension Phase|Withdrawal by Subject|0|||
156534951|NCT02060383|565054009|FG001|Extension Phase|Withdrawal by Subject|1|||
156534952|NCT02060383|565054010|FG002|Extension Phase|Withdrawal by Subject|0|||
156534953|NCT02060383|565054011|FG003|Extension Phase|Withdrawal by Subject|0|||
156534954|NCT02060383|565054012|FG004|Extension Phase|Withdrawal by Subject|2|||
156534955|NCT02060383|565054008|FG000|Extension Phase|Administrative problems|1|||
156534956|NCT02060383|565054009|FG001|Extension Phase|Administrative problems|0|||
156534957|NCT02060383|565054010|FG002|Extension Phase|Administrative problems|0|||
156534958|NCT02060383|565054011|FG003|Extension Phase|Administrative problems|0|||
156534959|NCT02060383|565054012|FG004|Extension Phase|Administrative problems|0|||
156534960|NCT02060383|565054008|FG000|Extension Phase|Death|0|||
156534961|NCT02060383|565054009|FG001|Extension Phase|Death|0|||
156534962|NCT02060383|565054010|FG002|Extension Phase|Death|1|||
156534963|NCT02060383|565054011|FG003|Extension Phase|Death|0|||
156534964|NCT02060383|565054012|FG004|Extension Phase|Death|1|||
156534965|NCT02060383|565054008|FG000|Extension Phase|Protocol Violation|0|||
156534966|NCT02060383|565054009|FG001|Extension Phase|Protocol Violation|0|||
156534967|NCT02060383|565054010|FG002|Extension Phase|Protocol Violation|0|||
156534968|NCT02060383|565054011|FG003|Extension Phase|Protocol Violation|0|||
156534969|NCT02060383|565054012|FG004|Extension Phase|Protocol Violation|1|||
156534970|NCT03441334|565054013|FG000|Overall Study|Withdrawal by Subject|1|||
156534971|NCT03441334|565054014|FG001|Overall Study|Withdrawal by Subject|0|||
156534972|NCT00088907|565054015|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
156534973|NCT00088907|565054016|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
156534974|NCT00088907|565054015|FG000|Randomized Study (Step 1)|Adverse Event|14|||
156534975|NCT00088907|565054016|FG001|Randomized Study (Step 1)|Adverse Event|19|||
156534976|NCT00088907|565054015|FG000|Randomized Study (Step 1)|Death|11|||
156534977|NCT00088907|565054016|FG001|Randomized Study (Step 1)|Death|12|||
156534978|NCT00088907|565054015|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
156534979|NCT00088907|565054016|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
156534980|NCT00088907|565054015|FG000|Randomized Study (Step 1)|complicating disease|3|||
156534981|NCT00088907|565054016|FG001|Randomized Study (Step 1)|complicating disease|1|||
156534982|NCT00088907|565054015|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
156534983|NCT00088907|565054016|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
156534984|NCT00088907|565054015|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
156534985|NCT00088907|565054016|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
156534986|NCT00088907|565054015|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
156534987|NCT00088907|565054016|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
156534988|NCT00088907|565054015|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
156534989|NCT00088907|565054016|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
156534990|NCT00088907|565054015|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
156534991|NCT00088907|565054016|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
156534992|NCT00088907|565054015|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
156534993|NCT00088907|565054016|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
156534994|NCT00257166|565054020|FG000|Overall Study|Adverse Event|18|||
156534995|NCT00257166|565054021|FG001|Overall Study|Adverse Event|13|||
156534996|NCT00257166|565054020|FG000|Overall Study|Laboratory abnormality|1|||
156534997|NCT00257166|565054021|FG001|Overall Study|Laboratory abnormality|0|||
156534998|NCT00257166|565054020|FG000|Overall Study|Lost to Follow-up|8|||
156534999|NCT00257166|565054021|FG001|Overall Study|Lost to Follow-up|1|||
156535000|NCT00257166|565054020|FG000|Overall Study|Withdrawal by Subject|9|||
156535001|NCT00257166|565054021|FG001|Overall Study|Withdrawal by Subject|2|||
156535002|NCT00257166|565054020|FG000|Overall Study|Other|16|||
156535003|NCT00257166|565054021|FG001|Overall Study|Other|21|||
156535004|NCT00257166|565054020|FG000|Overall Study|Randomized, but not treated|1|||
156535005|NCT00257166|565054021|FG001|Overall Study|Randomized, but not treated|0|||
156535006|NCT02553265|565054022|FG000|Enrollment|Death|0|||
156535007|NCT02553265|565054023|FG001|Enrollment|Death|0|||
156535008|NCT02553265|565054024|FG002|Enrollment|Death|1|||
156535009|NCT02553265|565054022|FG000|First Intervention (28 Days)|Adverse Event|1|||
156535010|NCT02553265|565054023|FG001|First Intervention (28 Days)|Adverse Event|0|||
156535011|NCT02553265|565054024|FG002|First Intervention (28 Days)|Adverse Event|0|||
156535012|NCT02553265|565054022|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
156535013|NCT02553265|565054023|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
156798825|NCT02769481|566017258|FG001|Overall Study|Physician Decision|1|||
156535014|NCT02553265|565054024|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
156535015|NCT02553265|565054022|FG000|Second Intervention (28 Days)|Adverse Event|1|||
156535016|NCT02553265|565054023|FG001|Second Intervention (28 Days)|Adverse Event|0|||
156535017|NCT02553265|565054024|FG002|Second Intervention (28 Days)|Adverse Event|0|||
156535018|NCT02553265|565054022|FG000|Third Intervention (28 Days)|Adverse Event|1|||
156535019|NCT02553265|565054023|FG001|Third Intervention (28 Days)|Adverse Event|0|||
156535020|NCT02553265|565054024|FG002|Third Intervention (28 Days)|Adverse Event|0|||
156535021|NCT02553265|565054022|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
156535022|NCT02553265|565054023|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
156535023|NCT02553265|565054024|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
156535024|NCT00659529|565054033|FG000|Overall Study|Withdrawal by Subject|4|||
156535025|NCT00659529|565054033|FG000|Overall Study|Protocol Violation|3|||
156535026|NCT00659529|565054033|FG000|Overall Study|Screen failure|9|||
156535027|NCT00283049|565054037|FG000|Overall Study|Adverse Event|6|||
156535028|NCT00283049|565054038|FG001|Overall Study|Adverse Event|1|||
156535029|NCT00283049|565054039|FG002|Overall Study|Adverse Event|4|||
156535030|NCT00283049|565054037|FG000|Overall Study|Protocol Violation|3|||
156535031|NCT00283049|565054038|FG001|Overall Study|Protocol Violation|0|||
156535032|NCT00283049|565054039|FG002|Overall Study|Protocol Violation|3|||
156535033|NCT00283049|565054037|FG000|Overall Study|Death|1|||
156535034|NCT00283049|565054038|FG001|Overall Study|Death|1|||
156535035|NCT00283049|565054039|FG002|Overall Study|Death|1|||
156535036|NCT00283049|565054037|FG000|Overall Study|Lack of Efficacy|0|||
156535037|NCT00283049|565054038|FG001|Overall Study|Lack of Efficacy|1|||
156535038|NCT00283049|565054039|FG002|Overall Study|Lack of Efficacy|1|||
156535039|NCT00283049|565054037|FG000|Overall Study|Lost to Follow-up|4|||
156535040|NCT00283049|565054038|FG001|Overall Study|Lost to Follow-up|2|||
156535041|NCT00283049|565054039|FG002|Overall Study|Lost to Follow-up|5|||
156535042|NCT00283049|565054037|FG000|Overall Study|Withdrawal by Subject|26|||
156535043|NCT00283049|565054038|FG001|Overall Study|Withdrawal by Subject|24|||
156535044|NCT00283049|565054039|FG002|Overall Study|Withdrawal by Subject|19|||
156535045|NCT00283049|565054037|FG000|Overall Study|Discontinuation of Study|18|||
156535046|NCT00283049|565054038|FG001|Overall Study|Discontinuation of Study|16|||
156535047|NCT00283049|565054039|FG002|Overall Study|Discontinuation of Study|20|||
156535048|NCT00283049|565054037|FG000|Overall Study|No longer requires study treatment|0|||
156535049|NCT00283049|565054038|FG001|Overall Study|No longer requires study treatment|0|||
156535050|NCT00283049|565054039|FG002|Overall Study|No longer requires study treatment|1|||
156535051|NCT00763971|565054040|FG000|Overall Study|Adverse Event|5|||
156535052|NCT00763971|565054041|FG001|Overall Study|Adverse Event|2|||
156535053|NCT00763971|565054042|FG002|Overall Study|Adverse Event|4|||
156535054|NCT00763971|565054040|FG000|Overall Study|Protocol Violation|3|||
156535055|NCT00763971|565054041|FG001|Overall Study|Protocol Violation|3|||
156535056|NCT00763971|565054042|FG002|Overall Study|Protocol Violation|2|||
156535057|NCT00763971|565054040|FG000|Overall Study|Withdrawal by Subject|4|||
156535058|NCT00763971|565054041|FG001|Overall Study|Withdrawal by Subject|5|||
156535059|NCT00763971|565054042|FG002|Overall Study|Withdrawal by Subject|5|||
156535060|NCT00763971|565054040|FG000|Overall Study|Lost to Follow-up|0|||
156535061|NCT00763971|565054041|FG001|Overall Study|Lost to Follow-up|1|||
156535062|NCT00763971|565054042|FG002|Overall Study|Lost to Follow-up|0|||
156535063|NCT00763971|565054040|FG000|Overall Study|Lack of Efficacy|11|||
156535064|NCT00763971|565054041|FG001|Overall Study|Lack of Efficacy|22|||
156535065|NCT00763971|565054042|FG002|Overall Study|Lack of Efficacy|54|||
156535066|NCT00763971|565054040|FG000|Overall Study|Unable to swallow capsule|2|||
156535067|NCT00763971|565054041|FG001|Overall Study|Unable to swallow capsule|1|||
156535068|NCT00763971|565054042|FG002|Overall Study|Unable to swallow capsule|1|||
156535069|NCT00763971|565054040|FG000|Overall Study|Personal reason|3|||
156535070|NCT00763971|565054041|FG001|Overall Study|Personal reason|0|||
156535071|NCT00763971|565054042|FG002|Overall Study|Personal reason|0|||
156535072|NCT00763971|565054040|FG000|Overall Study|Exclusion criteria met|1|||
156535073|NCT00763971|565054041|FG001|Overall Study|Exclusion criteria met|0|||
156535074|NCT00763971|565054042|FG002|Overall Study|Exclusion criteria met|0|||
156535075|NCT00763971|565054040|FG000|Overall Study|Sponsor decision|1|||
156535076|NCT00763971|565054041|FG001|Overall Study|Sponsor decision|0|||
156535077|NCT00763971|565054042|FG002|Overall Study|Sponsor decision|0|||
156535078|NCT00763971|565054040|FG000|Overall Study|Due to holiday season|2|||
156535079|NCT00763971|565054041|FG001|Overall Study|Due to holiday season|0|||
156535080|NCT00763971|565054042|FG002|Overall Study|Due to holiday season|1|||
156535081|NCT00763971|565054040|FG000|Overall Study|Randomization error|0|||
156535082|NCT00763971|565054041|FG001|Overall Study|Randomization error|0|||
156535083|NCT00763971|565054042|FG002|Overall Study|Randomization error|1|||
156535084|NCT00763971|565054040|FG000|Overall Study|Medical monitor decision|0|||
156535085|NCT00763971|565054041|FG001|Overall Study|Medical monitor decision|0|||
156798826|NCT02769481|566017257|FG000|Overall Study|Terminated by Sponsor|1|||
156535086|NCT00763971|565054042|FG002|Overall Study|Medical monitor decision|1|||
156535087|NCT00763971|565054040|FG000|Overall Study|Moved to another country|0|||
156535088|NCT00763971|565054041|FG001|Overall Study|Moved to another country|1|||
156535089|NCT00763971|565054042|FG002|Overall Study|Moved to another country|0|||
156535090|NCT00763971|565054040|FG000|Overall Study|Subject wanted dose reduction|0|||
156535091|NCT00763971|565054041|FG001|Overall Study|Subject wanted dose reduction|1|||
156535092|NCT00763971|565054042|FG002|Overall Study|Subject wanted dose reduction|0|||
156535093|NCT00763971|565054040|FG000|Overall Study|Lack of availability|0|||
156535094|NCT00763971|565054041|FG001|Overall Study|Lack of availability|1|||
156535095|NCT00763971|565054042|FG002|Overall Study|Lack of availability|0|||
156535096|NCT00763971|565054040|FG000|Overall Study|Performed final visit on phone|0|||
156744585|NCT01066793|565813223|FG002|Overall Study|Treatment Stopped|0|||
156744586|NCT01066793|565813224|FG003|Overall Study|Treatment Stopped|1|||
156744587|NCT01066793|565813225|FG004|Overall Study|Treatment Stopped|0|||
156744588|NCT01066793|565813226|FG005|Overall Study|Treatment Stopped|0|||
156744589|NCT03334422|565813228|FG000|Overall Study|Adverse Event|1|||
156744590|NCT03334422|565813229|FG001|Overall Study|Adverse Event|3|||
156744591|NCT03334422|565813230|FG002|Overall Study|Adverse Event|2|||
156744592|NCT03334422|565813231|FG003|Overall Study|Adverse Event|2|||
156744593|NCT03334422|565813228|FG000|Overall Study|Lack of Efficacy|10|||
156744594|NCT03334422|565813229|FG001|Overall Study|Lack of Efficacy|2|||
156744595|NCT03334422|565813230|FG002|Overall Study|Lack of Efficacy|7|||
156744596|NCT03334422|565813231|FG003|Overall Study|Lack of Efficacy|3|||
156744597|NCT03334422|565813228|FG000|Overall Study|Withdrawal by Subject|8|||
156744598|NCT03334422|565813229|FG001|Overall Study|Withdrawal by Subject|3|||
156744599|NCT03334422|565813230|FG002|Overall Study|Withdrawal by Subject|1|||
156744600|NCT03334422|565813231|FG003|Overall Study|Withdrawal by Subject|0|||
156744601|NCT03334422|565813228|FG000|Overall Study|Lost to Follow-up|0|||
156744602|NCT03334422|565813229|FG001|Overall Study|Lost to Follow-up|0|||
156744603|NCT03334422|565813230|FG002|Overall Study|Lost to Follow-up|0|||
156744604|NCT03334422|565813231|FG003|Overall Study|Lost to Follow-up|1|||
156744605|NCT03334422|565813228|FG000|Overall Study|Inability to obtain laboratory samples|0|||
156744606|NCT03334422|565813229|FG001|Overall Study|Inability to obtain laboratory samples|1|||
156744607|NCT03334422|565813230|FG002|Overall Study|Inability to obtain laboratory samples|0|||
156744608|NCT03334422|565813231|FG003|Overall Study|Inability to obtain laboratory samples|0|||
156744609|NCT03334422|565813228|FG000|Overall Study|Pregnancy|0|||
156744610|NCT03334422|565813229|FG001|Overall Study|Pregnancy|1|||
156744611|NCT03334422|565813230|FG002|Overall Study|Pregnancy|0|||
156744612|NCT03334422|565813231|FG003|Overall Study|Pregnancy|0|||
156798827|NCT02769481|566017258|FG001|Overall Study|Terminated by Sponsor|0|||
156798828|NCT02769481|566017257|FG000|Overall Study|Death|0|||
156798829|NCT02769481|566017258|FG001|Overall Study|Death|1|||
156798830|NCT02769481|566017257|FG000|Overall Study|Undefined|4|||
156798831|NCT02769481|566017258|FG001|Overall Study|Undefined|1|||
156798832|NCT01346592|566017259|FG000|Overall Study|Lost to Follow-up|62|||
156798833|NCT01346592|566017260|FG001|Overall Study|Lost to Follow-up|29|||
156798834|NCT01346592|566017261|FG002|Overall Study|Lost to Follow-up|29|||
156798835|NCT01346592|566017259|FG000|Overall Study|Protocol Violation|2|||
156798836|NCT01346592|566017260|FG001|Overall Study|Protocol Violation|1|||
156798837|NCT01346592|566017261|FG002|Overall Study|Protocol Violation|0|||
156798838|NCT01346592|566017259|FG000|Overall Study|Death|1|||
156798839|NCT01346592|566017260|FG001|Overall Study|Death|3|||
156798840|NCT01346592|566017261|FG002|Overall Study|Death|4|||
156798841|NCT01346592|566017259|FG000|Overall Study|Adverse Event|0|||
156798842|NCT01346592|566017260|FG001|Overall Study|Adverse Event|1|||
156798843|NCT01346592|566017261|FG002|Overall Study|Adverse Event|0|||
156798844|NCT01346592|566017259|FG000|Overall Study|Withdrawal by Subject|77|||
156798845|NCT01346592|566017260|FG001|Overall Study|Withdrawal by Subject|51|||
156798846|NCT01346592|566017261|FG002|Overall Study|Withdrawal by Subject|38|||
156798847|NCT01346592|566017259|FG000|Overall Study|Inappropriate enrollment|3|||
156798848|NCT01346592|566017260|FG001|Overall Study|Inappropriate enrollment|1|||
156798849|NCT01346592|566017261|FG002|Overall Study|Inappropriate enrollment|1|||
156798850|NCT01346592|566017259|FG000|Overall Study|Administrative reason|1|||
156798851|NCT01346592|566017260|FG001|Overall Study|Administrative reason|0|||
156798852|NCT01346592|566017261|FG002|Overall Study|Administrative reason|0|||
156798853|NCT01346592|566017259|FG000|Overall Study|Unable to Classify|7|||
156798854|NCT01346592|566017260|FG001|Overall Study|Unable to Classify|3|||
156798855|NCT01346592|566017261|FG002|Overall Study|Unable to Classify|6|||
156798856|NCT00643279|566017264|FG000|Overall Study|Death|13|||
156798857|NCT00643279|566017265|FG001|Overall Study|Death|11|||
156798858|NCT00643279|566017264|FG000|Overall Study|Withdrawal by Subject|3|||
156798859|NCT00643279|566017265|FG001|Overall Study|Withdrawal by Subject|0|||
156798860|NCT00643279|566017264|FG000|Overall Study|Lost to Follow-up|0|||
156798861|NCT00643279|566017265|FG001|Overall Study|Lost to Follow-up|1|||
156798862|NCT00643279|566017264|FG000|Overall Study|Physician Decision|0|||
156798863|NCT00643279|566017265|FG001|Overall Study|Physician Decision|1|||
156798864|NCT06272383|566017266|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
156744613|NCT01313221|565813232|FG000|Overall Study|Protocol Violation|0|||
156798865|NCT06272383|566017267|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
156744614|NCT01313221|565813233|FG001|Overall Study|Protocol Violation|1|||
156744615|NCT01313221|565813234|FG002|Overall Study|Protocol Violation|1|||
156744616|NCT01313221|565813232|FG000|Overall Study|Non-compliance|3|||
156744617|NCT01313221|565813233|FG001|Overall Study|Non-compliance|0|||
156744618|NCT01313221|565813234|FG002|Overall Study|Non-compliance|2|||
156798866|NCT05715827|566017268|FG000|Overall Study|Physician Decision|0|||
156337100|NCT02229383|564331468|FG000|Overall Study|Lost to Follow-up|5|||
156744619|NCT01313221|565813232|FG000|Overall Study|Withdrawal by Subject|2|||
156744620|NCT01313221|565813233|FG001|Overall Study|Withdrawal by Subject|3|||
156744621|NCT01313221|565813234|FG002|Overall Study|Withdrawal by Subject|5|||
156744622|NCT01313221|565813232|FG000|Overall Study|Requirement for alternative therapy|0|||
156744623|NCT01313221|565813233|FG001|Overall Study|Requirement for alternative therapy|1|||
156744624|NCT01313221|565813234|FG002|Overall Study|Requirement for alternative therapy|1|||
156337101|NCT02229383|564331469|FG001|Overall Study|Lost to Follow-up|3|||
156337102|NCT02229383|564331468|FG000|Overall Study|Withdrawal by Subject|4|||
156458538|NCT02852655|564774817|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
156337103|NCT02229383|564331469|FG001|Overall Study|Withdrawal by Subject|6|||
156458539|NCT02852655|564774818|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
156458540|NCT02852655|564774819|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
156458541|NCT02852655|564774817|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
156458542|NCT02852655|564774818|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
156458543|NCT02852655|564774819|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
156458544|NCT02852655|564774817|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
156458545|NCT02852655|564774818|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
156458546|NCT02852655|564774819|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
156458547|NCT02852655|564774817|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
156458548|NCT02852655|564774818|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
156460627|NCT00429364|564781666|FG001|Overall Study|Withdrawal by Subject|5|||
156460628|NCT00429364|564781665|FG000|Overall Study|Physician Decision|4|||
156744625|NCT01313221|565813232|FG000|Overall Study|Lost to Follow-up|6|||
156744626|NCT01313221|565813233|FG001|Overall Study|Lost to Follow-up|3|||
156744627|NCT01313221|565813234|FG002|Overall Study|Lost to Follow-up|1|||
156744628|NCT01313221|565813232|FG000|Overall Study|Other|1|||
156744629|NCT01313221|565813233|FG001|Overall Study|Other|0|||
156744630|NCT01313221|565813234|FG002|Overall Study|Other|0|||
156744631|NCT01313221|565813232|FG000|Overall Study|Adverse Event|0|||
156744632|NCT01313221|565813233|FG001|Overall Study|Adverse Event|0|||
156744633|NCT01313221|565813234|FG002|Overall Study|Adverse Event|7|||
156798867|NCT05715827|566017269|FG001|Overall Study|Physician Decision|1|||
156798868|NCT05715827|566017268|FG000|Overall Study|console communication error|0|||
156798869|NCT05715827|566017269|FG001|Overall Study|console communication error|1|||
156798870|NCT04846868|566017270|FG000|Overall Study|Adverse Event|12|||
156798871|NCT04846868|566017271|FG001|Overall Study|Adverse Event|11|||
156798872|NCT04846868|566017270|FG000|Overall Study|Protocol deviation|6|||
156798873|NCT04846868|566017271|FG001|Overall Study|Protocol deviation|2|||
156798874|NCT04846868|566017270|FG000|Overall Study|Perceived lack of efficacy|3|||
156798875|NCT04846868|566017271|FG001|Overall Study|Perceived lack of efficacy|2|||
156798876|NCT04846868|566017270|FG000|Overall Study|Change of residence|2|||
156798877|NCT04846868|566017271|FG001|Overall Study|Change of residence|3|||
156798878|NCT04846868|566017270|FG000|Overall Study|Burden of study procedures|1|||
156798879|NCT04846868|566017271|FG001|Overall Study|Burden of study procedures|1|||
156798880|NCT04846868|566017270|FG000|Overall Study|No reason available|2|||
156798881|NCT04846868|566017271|FG001|Overall Study|No reason available|5|||
156798882|NCT04846868|566017270|FG000|Overall Study|Other reason listed|20|||
156798883|NCT04846868|566017271|FG001|Overall Study|Other reason listed|10|||
156798884|NCT04846868|566017270|FG000|Overall Study|Not treated|0|||
156798885|NCT04846868|566017271|FG001|Overall Study|Not treated|1|||
156798886|NCT04890509|566017272|FG000|Overall Study|Death|4|||
156798887|NCT04890509|566017273|FG001|Overall Study|Death|4|||
156744634|NCT01313221|565813232|FG000|Overall Study|Disease progression|0|||
156744635|NCT01313221|565813233|FG001|Overall Study|Disease progression|0|||
156744636|NCT01313221|565813234|FG002|Overall Study|Disease progression|2|||
156744637|NCT01313221|565813232|FG000|Overall Study|Physician Decision|0|||
156744638|NCT01313221|565813233|FG001|Overall Study|Physician Decision|0|||
156744639|NCT01313221|565813234|FG002|Overall Study|Physician Decision|2|||
156744640|NCT01313221|565813232|FG000|Overall Study|Pregnancy|0|||
156744641|NCT01313221|565813233|FG001|Overall Study|Pregnancy|0|||
156744642|NCT01313221|565813234|FG002|Overall Study|Pregnancy|2|||
156744643|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
156744644|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
156744645|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
156744646|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
156744647|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
156744648|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
156744649|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
156744650|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
156744651|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
156744652|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
156744653|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
156744654|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
156744655|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
156744656|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
156744657|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
156744658|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
156744659|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
156744660|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
156744661|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
156744662|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
156744663|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
156744664|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
156744665|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
156744666|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
156744667|NCT03246061|565813239|FG000|Overall Study|Still in follow-up|15|||
156744668|NCT03246061|565813240|FG001|Overall Study|Still in follow-up|21|||
156744669|NCT02864316|565813245|FG000|Overall Study|Progressive Disease|2|||
156744670|NCT02864316|565813246|FG001|Overall Study|Progressive Disease|1|||
156744671|NCT02864316|565813245|FG000|Overall Study|Adverse Event|0|||
156744672|NCT02864316|565813246|FG001|Overall Study|Adverse Event|1|||
156744673|NCT04710368|565813247|FG000|Overall Study|Withdrawal by Subject|9|||
156744674|NCT04710368|565813247|FG000|Overall Study|Lost to Follow-up|4|||
156744675|NCT04710368|565813247|FG000|Overall Study|Death|2|||
156744676|NCT04710368|565813247|FG000|Overall Study|Patient preference|11|||
156744677|NCT04710368|565813247|FG000|Overall Study|Treatment discontinuation|1|||
156744678|NCT05625477|565813248|FG000|Overall Study|Lost to Follow-up|2|||
156744679|NCT05625477|565813249|FG001|Overall Study|Lost to Follow-up|2|||
156744680|NCT05625477|565813250|FG002|Overall Study|Lost to Follow-up|1|||
156744681|NCT05625477|565813251|FG003|Overall Study|Lost to Follow-up|1|||
156744682|NCT05625477|565813252|FG004|Overall Study|Lost to Follow-up|0|||
156744683|NCT05625477|565813248|FG000|Overall Study|Covid quarantine|1|||
156744684|NCT05625477|565813249|FG001|Overall Study|Covid quarantine|0|||
156744685|NCT05625477|565813250|FG002|Overall Study|Covid quarantine|0|||
156744686|NCT05625477|565813251|FG003|Overall Study|Covid quarantine|0|||
156744687|NCT05625477|565813252|FG004|Overall Study|Covid quarantine|0|||
156744688|NCT05916131|565813253|FG000|Overall Study|Lost to Follow-up|0|||
156744689|NCT05916131|565813254|FG001|Overall Study|Lost to Follow-up|0|||
156744690|NCT05916131|565813255|FG002|Overall Study|Lost to Follow-up|1|||
156744691|NCT05916131|565813256|FG003|Overall Study|Lost to Follow-up|0|||
156744692|NCT03030118|565813257|FG000|Overall Study|Achieved SLE Diagnosis|11|||
156744693|NCT03030118|565813258|FG001|Overall Study|Achieved SLE Diagnosis|10|||
156744694|NCT03030118|565813257|FG000|Overall Study|Adverse Event|1|||
156798888|NCT05212168|566017274|FG000|Overall Study|Lost to Follow-up|0|||
156798889|NCT05212168|566017275|FG001|Overall Study|Lost to Follow-up|3|||
156798890|NCT05212168|566017274|FG000|Overall Study|Study terminated by sponsor|30|||
156798891|NCT05212168|566017275|FG001|Overall Study|Study terminated by sponsor|27|||
156460629|NCT00429364|564781666|FG001|Overall Study|Physician Decision|2|||
156744695|NCT03030118|565813258|FG001|Overall Study|Adverse Event|1|||
156744696|NCT03030118|565813257|FG000|Overall Study|Pregnancy|2|||
156744697|NCT03030118|565813258|FG001|Overall Study|Pregnancy|2|||
156744698|NCT03030118|565813257|FG000|Overall Study|Lost to Follow-up|5|||
156744699|NCT03030118|565813258|FG001|Overall Study|Lost to Follow-up|6|||
156744700|NCT03030118|565813257|FG000|Overall Study|Concomitant Medications|1|||
156744701|NCT03030118|565813258|FG001|Overall Study|Concomitant Medications|1|||
156744702|NCT03030118|565813257|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
156798892|NCT05212168|566017274|FG000|Overall Study|Other|4|||
156744703|NCT03030118|565813258|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
156744704|NCT03030118|565813257|FG000|Overall Study|Other|2|||
156744705|NCT03030118|565813258|FG001|Overall Study|Other|0|||
156744706|NCT03030118|565813257|FG000|Overall Study|Withdrawal by Subject|26|||
156744707|NCT03030118|565813258|FG001|Overall Study|Withdrawal by Subject|21|||
156744708|NCT03030118|565813257|FG000|Overall Study|Protocol Violation|1|||
156744709|NCT03030118|565813258|FG001|Overall Study|Protocol Violation|6|||
156744710|NCT02607280|565813260|FG000|Overall Study|Adverse Event|4|||
156744711|NCT02607280|565813261|FG001|Overall Study|Adverse Event|0|||
156744712|NCT02607280|565813260|FG000|Overall Study|Decrease in CrCl <15|0|||
156744713|NCT02607280|565813261|FG001|Overall Study|Decrease in CrCl <15|1|||
156744714|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
156744715|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
156744716|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
156744717|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
156798893|NCT05212168|566017275|FG001|Overall Study|Other|7|||
156798894|NCT03274466|566017276|FG000|Overall Study|Withdrawal by Subject|7|||
156798895|NCT03274466|566017277|FG001|Overall Study|Withdrawal by Subject|3|||
156798896|NCT03274466|566017276|FG000|Overall Study|Protocol Specified Withdrawal|5|||
156798897|NCT03274466|566017277|FG001|Overall Study|Protocol Specified Withdrawal|11|||
156798898|NCT03274466|566017276|FG000|Overall Study|Lost to Follow-up|5|||
156798899|NCT03274466|566017277|FG001|Overall Study|Lost to Follow-up|7|||
156798900|NCT03274466|566017276|FG000|Overall Study|Subject Non-compliance|0|||
156798901|NCT03274466|566017277|FG001|Overall Study|Subject Non-compliance|1|||
156798902|NCT03274466|566017276|FG000|Overall Study|Adverse Event|3|||
156798903|NCT03274466|566017277|FG001|Overall Study|Adverse Event|3|||
156798904|NCT03274466|566017276|FG000|Overall Study|Physician Decision|0|||
156798905|NCT03274466|566017277|FG001|Overall Study|Physician Decision|1|||
156798906|NCT03274466|566017276|FG000|Overall Study|Protocol Violation|3|||
156798907|NCT03274466|566017277|FG001|Overall Study|Protocol Violation|3|||
156458549|NCT02852655|564774819|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
156458550|NCT02852655|564774817|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
156458551|NCT02852655|564774818|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
156458552|NCT02852655|564774819|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
156798908|NCT00618787|566017280|FG000|Overall Study|Adverse Event|0|||
156798909|NCT00618787|566017281|FG001|Overall Study|Adverse Event|1|||
156798910|NCT00618787|566017280|FG000|Overall Study|Withdrawal by Subject|2|||
156798911|NCT00618787|566017281|FG001|Overall Study|Withdrawal by Subject|1|||
156798912|NCT00618787|566017280|FG000|Overall Study|Lost to Follow-up|1|||
156798913|NCT00618787|566017281|FG001|Overall Study|Lost to Follow-up|0|||
156798914|NCT01107886|566017282|FG000|Overall Study|Lost to Follow-up|15|||
156798915|NCT01107886|566017283|FG001|Overall Study|Lost to Follow-up|13|||
156798916|NCT01107886|566017282|FG000|Overall Study|Withdrawal by Subject|180|||
156798917|NCT01107886|566017283|FG001|Overall Study|Withdrawal by Subject|196|||
156798918|NCT01107886|566017282|FG000|Overall Study|Administrative withdrawal of consent|7|||
156798919|NCT01107886|566017283|FG001|Overall Study|Administrative withdrawal of consent|5|||
156798920|NCT01346176|566017284|FG000|Recruited|Protocol Violation|1|||
156798921|NCT01346176|566017285|FG001|Recruited|Protocol Violation|0|||
156798922|NCT01346176|566017286|FG002|Recruited|Protocol Violation|0|||
156798923|NCT01346176|566017284|FG000|Completed Advance Directive|Death|3|||
156798924|NCT01346176|566017285|FG001|Completed Advance Directive|Death|2|||
156798925|NCT01346176|566017286|FG002|Completed Advance Directive|Death|2|||
156798926|NCT01346176|566017284|FG000|Completed Advance Directive|Became Ineligible|3|||
156798927|NCT01346176|566017285|FG001|Completed Advance Directive|Became Ineligible|0|||
156798928|NCT01346176|566017286|FG002|Completed Advance Directive|Became Ineligible|1|||
156798929|NCT01346176|566017284|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
156798930|NCT01346176|566017285|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
156798931|NCT01346176|566017286|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
156458553|NCT02852655|564774817|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
156458554|NCT02852655|564774818|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
156798932|NCT01346176|566017284|FG000|Completed Satisfaction Survey|Death|3|||
156798933|NCT01346176|566017285|FG001|Completed Satisfaction Survey|Death|0|||
156798934|NCT01346176|566017286|FG002|Completed Satisfaction Survey|Death|2|||
156798935|NCT01346176|566017284|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
156798936|NCT01346176|566017285|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
156798937|NCT01346176|566017286|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
156798938|NCT01994876|566017287|FG000|Test Period 1|Withdrawal by Subject|0|||
156744718|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
156798939|NCT01994876|566017288|FG001|Test Period 1|Withdrawal by Subject|1|||
156744719|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
156535097|NCT00763971|565054041|FG001|Overall Study|Performed final visit on phone|1|||
156535098|NCT00763971|565054042|FG002|Overall Study|Performed final visit on phone|0|||
156535099|NCT00763971|565054040|FG000|Overall Study|Participation in 489-326 required|1|||
156535100|NCT00763971|565054041|FG001|Overall Study|Participation in 489-326 required|0|||
156535101|NCT00763971|565054042|FG002|Overall Study|Participation in 489-326 required|0|||
156535102|NCT02713542|565054050|FG000|Overall Study|Use of prohibited medication|14|||
156535103|NCT02713542|565054051|FG001|Overall Study|Use of prohibited medication|5|||
156535104|NCT02713542|565054050|FG000|Overall Study|Withdrawal by Subject|4|||
156535105|NCT02713542|565054051|FG001|Overall Study|Withdrawal by Subject|1|||
156535106|NCT03631667|565054052|FG000|Overall Study|Withdrawal by Subject|3|||
156535107|NCT03383289|565054053|FG000|Overall Study|Death|83|||
156535108|NCT03383289|565054054|FG001|Overall Study|Death|78|||
156535109|NCT03383289|565054053|FG000|Overall Study|discharge from facility|84|||
156535110|NCT03383289|565054054|FG001|Overall Study|discharge from facility|84|||
156535111|NCT03383289|565054053|FG000|Overall Study|Withdrawal by Subject|4|||
156535112|NCT03383289|565054054|FG001|Overall Study|Withdrawal by Subject|1|||
156535113|NCT00884325|565054055|FG000|Overall Study|Lost to Follow-up|1|||
156535114|NCT00884325|565054056|FG001|Overall Study|Lost to Follow-up|2|||
156535115|NCT00884325|565054055|FG000|Overall Study|Lack of Efficacy|0|||
156535116|NCT00884325|565054056|FG001|Overall Study|Lack of Efficacy|1|||
156535117|NCT00884325|565054055|FG000|Overall Study|Withdrawal by Subject|1|||
156535118|NCT00884325|565054056|FG001|Overall Study|Withdrawal by Subject|1|||
156535119|NCT00884325|565054055|FG000|Overall Study|Not provided|1|||
156535120|NCT00884325|565054056|FG001|Overall Study|Not provided|0|||
156535121|NCT01641237|565054068|FG000|Period II|Withdrawal by Subject|1|||
156535122|NCT01641237|565054069|FG001|Period II|Withdrawal by Subject|0|||
156535123|NCT01641237|565054070|FG002|Period II|Withdrawal by Subject|0|||
156535124|NCT01641237|565054071|FG003|Period II|Withdrawal by Subject|0|||
156535125|NCT01641237|565054068|FG000|Period III|Lost to Follow-up|1|||
156535126|NCT01641237|565054069|FG001|Period III|Lost to Follow-up|0|||
156535127|NCT01641237|565054070|FG002|Period III|Lost to Follow-up|0|||
156535128|NCT01641237|565054071|FG003|Period III|Lost to Follow-up|0|||
156535129|NCT00832117|565054072|FG000|Overall Study|Death|1|||
156535130|NCT00832117|565054072|FG000|Overall Study|Disease Progression|11|||
156535131|NCT01301456|565054073|FG000|Stage 1|Withdrawal by Subject|0|||
156535132|NCT01301456|565054074|FG001|Stage 1|Withdrawal by Subject|0|||
156535133|NCT01301456|565054075|FG002|Stage 1|Withdrawal by Subject|1|||
156535134|NCT01301456|565054076|FG003|Stage 1|Withdrawal by Subject|0|||
156535135|NCT01301456|565054077|FG004|Stage 1|Withdrawal by Subject|1|||
156535136|NCT01301456|565054078|FG005|Stage 1|Withdrawal by Subject|0|||
156535137|NCT01301456|565054079|FG006|Stage 1|Withdrawal by Subject|0|||
156535138|NCT01301456|565054080|FG007|Stage 1|Withdrawal by Subject|0|||
156535139|NCT01301456|565054081|FG008|Stage 1|Withdrawal by Subject|0|||
156535140|NCT01301456|565054082|FG009|Stage 1|Withdrawal by Subject|0|||
156535141|NCT01301456|565054083|FG010|Stage 1|Withdrawal by Subject|0|||
156535142|NCT01301456|565054084|FG011|Stage 1|Withdrawal by Subject|0|||
156535143|NCT01301456|565054073|FG000|Stage 1|Randomized but not treated|0|||
156535144|NCT01301456|565054074|FG001|Stage 1|Randomized but not treated|0|||
156535145|NCT01301456|565054075|FG002|Stage 1|Randomized but not treated|0|||
156535146|NCT01301456|565054076|FG003|Stage 1|Randomized but not treated|0|||
156535147|NCT01301456|565054077|FG004|Stage 1|Randomized but not treated|0|||
156535148|NCT01301456|565054078|FG005|Stage 1|Randomized but not treated|0|||
156535149|NCT01301456|565054079|FG006|Stage 1|Randomized but not treated|1|||
156535150|NCT01301456|565054080|FG007|Stage 1|Randomized but not treated|0|||
156535151|NCT01301456|565054081|FG008|Stage 1|Randomized but not treated|0|||
156744720|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
156744721|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
156744722|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
156744723|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
156744724|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
156744725|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
156744726|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
156744727|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
156744728|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
156744729|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
156798940|NCT01994876|566017287|FG000|Test Period 1|Adverse Event|0|||
156798941|NCT01994876|566017288|FG001|Test Period 1|Adverse Event|1|||
156535152|NCT01301456|565054082|FG009|Stage 1|Randomized but not treated|0|||
156535153|NCT01301456|565054083|FG010|Stage 1|Randomized but not treated|0|||
156535154|NCT01301456|565054084|FG011|Stage 1|Randomized but not treated|0|||
156535155|NCT01301456|565054073|FG000|Stage 2|Adverse Event|0|||
156535156|NCT01301456|565054074|FG001|Stage 2|Adverse Event|0|||
156535157|NCT01301456|565054075|FG002|Stage 2|Adverse Event|0|||
156535158|NCT01301456|565054076|FG003|Stage 2|Adverse Event|0|||
156535159|NCT01301456|565054077|FG004|Stage 2|Adverse Event|0|||
156535160|NCT01301456|565054078|FG005|Stage 2|Adverse Event|0|||
156337104|NCT02229383|564331468|FG000|Overall Study|Did not receive treatment|1|||
156458555|NCT02852655|564774819|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
156744730|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
156744731|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
156744732|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
156744733|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
156744734|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
156744735|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
156744736|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
156744737|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
156458556|NCT02852655|564774817|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
156458557|NCT02852655|564774818|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
156458558|NCT02852655|564774819|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
156458559|NCT02852655|564774817|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
156458560|NCT02852655|564774818|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
156744738|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
156744739|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
156535161|NCT01301456|565054079|FG006|Stage 2|Adverse Event|0|||
156535162|NCT01301456|565054080|FG007|Stage 2|Adverse Event|0|||
156535163|NCT01301456|565054081|FG008|Stage 2|Adverse Event|0|||
156535164|NCT01301456|565054082|FG009|Stage 2|Adverse Event|0|||
156535165|NCT01301456|565054083|FG010|Stage 2|Adverse Event|1|||
156535166|NCT01301456|565054084|FG011|Stage 2|Adverse Event|0|||
156744740|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
156744741|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
156744742|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
156744743|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
156744744|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
156535167|NCT03239483|565054085|FG000|Overall Study|Lost to Follow-up|1|||
156535168|NCT03239483|565054086|FG001|Overall Study|Lost to Follow-up|0|||
156535169|NCT03239483|565054085|FG000|Overall Study|Withdrawal by Subject|1|||
156535170|NCT03239483|565054086|FG001|Overall Study|Withdrawal by Subject|0|||
156535171|NCT03678103|565054087|FG000|Overall Study|Withdrawn prior to completion|4|||
156535172|NCT00770770|565054092|FG000|Overall Study|Lost to Follow-up|1|||
156744745|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
156535173|NCT00770770|565054093|FG001|Overall Study|Lost to Follow-up|0|||
156535174|NCT00770770|565054092|FG000|Overall Study|Withdrawal by Subject|1|||
156535175|NCT00770770|565054093|FG001|Overall Study|Withdrawal by Subject|0|||
156535176|NCT00770770|565054092|FG000|Overall Study|Death|0|||
156535177|NCT00770770|565054093|FG001|Overall Study|Death|1|||
156744746|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
156535178|NCT00770770|565054092|FG000|Overall Study|Study Terminated|8|||
156535179|NCT00770770|565054093|FG001|Overall Study|Study Terminated|0|||
156744747|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
156744748|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
156744749|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
156744750|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
156744751|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
156744752|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
156744753|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
156744754|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
156744755|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
156744756|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
156744757|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
156798942|NCT01994876|566017287|FG000|Test Period 2|Adverse Event|1|||
156798943|NCT01994876|566017288|FG001|Test Period 2|Adverse Event|0|||
156798944|NCT01994876|566017287|FG000|Test Period 2|Protocol Violation|0|||
156798945|NCT01994876|566017288|FG001|Test Period 2|Protocol Violation|1|||
156798946|NCT05819398|566017289|FG000|Overall Study|Withdrawal by Subject|11|||
156798947|NCT05819398|566017290|FG001|Overall Study|Withdrawal by Subject|7|||
156798948|NCT05819398|566017291|FG002|Overall Study|Withdrawal by Subject|6|||
156798949|NCT05819398|566017292|FG003|Overall Study|Withdrawal by Subject|6|||
156798950|NCT05819398|566017289|FG000|Overall Study|Lost to Follow-up|0|||
156798951|NCT05819398|566017290|FG001|Overall Study|Lost to Follow-up|2|||
156798952|NCT05819398|566017291|FG002|Overall Study|Lost to Follow-up|0|||
156798953|NCT05819398|566017292|FG003|Overall Study|Lost to Follow-up|1|||
156798954|NCT05819398|566017289|FG000|Overall Study|Adverse Event|1|||
156798955|NCT05819398|566017290|FG001|Overall Study|Adverse Event|3|||
156798956|NCT05819398|566017291|FG002|Overall Study|Adverse Event|4|||
156798957|NCT05819398|566017292|FG003|Overall Study|Adverse Event|5|||
156798958|NCT05819398|566017289|FG000|Overall Study|Other than listed|0|||
156798959|NCT05819398|566017290|FG001|Overall Study|Other than listed|2|||
156798960|NCT05819398|566017291|FG002|Overall Study|Other than listed|2|||
156798961|NCT05819398|566017292|FG003|Overall Study|Other than listed|0|||
156798962|NCT05819398|566017289|FG000|Overall Study|Lack of Efficacy|0|||
156798963|NCT05819398|566017290|FG001|Overall Study|Lack of Efficacy|1|||
156798964|NCT05819398|566017291|FG002|Overall Study|Lack of Efficacy|0|||
156798965|NCT05819398|566017292|FG003|Overall Study|Lack of Efficacy|0|||
156798966|NCT05819398|566017289|FG000|Overall Study|Study terminated by sponsor|20|||
156798967|NCT05819398|566017290|FG001|Overall Study|Study terminated by sponsor|18|||
156798968|NCT05819398|566017291|FG002|Overall Study|Study terminated by sponsor|20|||
156798969|NCT05819398|566017292|FG003|Overall Study|Study terminated by sponsor|22|||
156798970|NCT02776735|566017293|FG000|Overall Study|Adverse Event|0|||
156798971|NCT02776735|566017294|FG001|Overall Study|Adverse Event|0|||
156458561|NCT02852655|564774819|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
156458562|NCT02852655|564774817|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
156458563|NCT02852655|564774818|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
156458564|NCT02852655|564774819|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
156458565|NCT03916185|564776603|FG000|Overall Study|Lost to Follow-up|0|||
156458566|NCT03916185|564776604|FG001|Overall Study|Lost to Follow-up|1|||
156458567|NCT03916185|564776605|FG002|Overall Study|Lost to Follow-up|0|||
156458568|NCT03916185|564776606|FG003|Overall Study|Lost to Follow-up|0|||
156458569|NCT03916185|564776603|FG000|Overall Study|Moved|1|||
156458570|NCT03916185|564776604|FG001|Overall Study|Moved|0|||
156458571|NCT03916185|564776605|FG002|Overall Study|Moved|0|||
156458572|NCT03916185|564776606|FG003|Overall Study|Moved|1|||
156458573|NCT03916185|564776603|FG000|Overall Study|Not Able to Get to Clinic|1|||
156458574|NCT03916185|564776604|FG001|Overall Study|Not Able to Get to Clinic|0|||
156458575|NCT03916185|564776605|FG002|Overall Study|Not Able to Get to Clinic|0|||
156458576|NCT03916185|564776606|FG003|Overall Study|Not Able to Get to Clinic|0|||
156458577|NCT03766685|564776607|FG000|Overall Study|Lost to Follow-up|1|||
156458578|NCT03766685|564776608|FG001|Overall Study|Lost to Follow-up|1|||
156458579|NCT03766685|564776609|FG002|Overall Study|Lost to Follow-up|0|||
156458580|NCT03766685|564776610|FG003|Overall Study|Lost to Follow-up|0|||
156458581|NCT03766685|564776607|FG000|Overall Study|Adverse Event, not fatal|0|||
156798972|NCT02776735|566017295|FG002|Overall Study|Adverse Event|0|||
156798973|NCT02776735|566017296|FG003|Overall Study|Adverse Event|1|||
156798974|NCT02776735|566017297|FG004|Overall Study|Adverse Event|0|||
156458582|NCT03766685|564776608|FG001|Overall Study|Adverse Event, not fatal|1|||
156458583|NCT03766685|564776609|FG002|Overall Study|Adverse Event, not fatal|0|||
156798975|NCT02776735|566017298|FG005|Overall Study|Adverse Event|1|||
156798976|NCT02776735|566017293|FG000|Overall Study|Lost to Follow-up|0|||
156798977|NCT02776735|566017294|FG001|Overall Study|Lost to Follow-up|0|||
156337105|NCT02229383|564331469|FG001|Overall Study|Did not receive treatment|0|||
156458584|NCT03766685|564776610|FG003|Overall Study|Adverse Event, not fatal|1|||
156458585|NCT03766685|564776607|FG000|Overall Study|Withdrawal by Subject|0|||
156458586|NCT03766685|564776608|FG001|Overall Study|Withdrawal by Subject|2|||
156458587|NCT03766685|564776609|FG002|Overall Study|Withdrawal by Subject|0|||
156458588|NCT03766685|564776610|FG003|Overall Study|Withdrawal by Subject|0|||
156458589|NCT03766685|564776607|FG000|Overall Study|Protocol Violation|0|||
156458590|NCT03766685|564776608|FG001|Overall Study|Protocol Violation|1|||
156458591|NCT03766685|564776609|FG002|Overall Study|Protocol Violation|0|||
156458592|NCT03766685|564776610|FG003|Overall Study|Protocol Violation|0|||
156458593|NCT03766685|564776607|FG000|Overall Study|Non-compliance|0|||
156458594|NCT03766685|564776608|FG001|Overall Study|Non-compliance|2|||
156458595|NCT03766685|564776609|FG002|Overall Study|Non-compliance|0|||
156458596|NCT03766685|564776610|FG003|Overall Study|Non-compliance|0|||
156458597|NCT02844465|564776616|FG000|Overall Study|Screen Failure|36|||
156458598|NCT02844465|564776616|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
156458599|NCT02844465|564776616|FG000|Overall Study|Withdrawal by Subject|5|||
156337106|NCT02229383|564331468|FG000|Overall Study|Other|3|||
156458600|NCT02844465|564776616|FG000|Overall Study|Lost to Follow-up|1|||
156458601|NCT02844465|564776616|FG000|Overall Study|Retreatment|1|||
156535180|NCT02486653|565054097|FG000|Overall Study|Withdrawal by Subject|1|||
156535181|NCT02486653|565054098|FG001|Overall Study|Withdrawal by Subject|3|||
156535182|NCT02486653|565054097|FG000|Overall Study|Protocol Violation|1|||
156535183|NCT02486653|565054098|FG001|Overall Study|Protocol Violation|0|||
156535184|NCT02486653|565054097|FG000|Overall Study|surgery cancelled|4|||
156535185|NCT02486653|565054098|FG001|Overall Study|surgery cancelled|1|||
156535186|NCT01006265|565054099|FG000|Overall Study|Lost to Follow-up|1|||
156535187|NCT01006265|565054100|FG001|Overall Study|Lost to Follow-up|0|||
156535188|NCT01006265|565054101|FG002|Overall Study|Lost to Follow-up|1|||
156535189|NCT01006265|565054102|FG003|Overall Study|Lost to Follow-up|0|||
156535190|NCT01006265|565054099|FG000|Overall Study|Withdrawal by Subject|4|||
156535191|NCT01006265|565054100|FG001|Overall Study|Withdrawal by Subject|7|||
156535192|NCT01006265|565054101|FG002|Overall Study|Withdrawal by Subject|5|||
156535193|NCT01006265|565054102|FG003|Overall Study|Withdrawal by Subject|5|||
156744758|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
156744759|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
156744760|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
156744761|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
156744762|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
156744763|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
156744764|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
156535194|NCT01006265|565054099|FG000|Overall Study|Administrative reason|1|||
156535195|NCT01006265|565054100|FG001|Overall Study|Administrative reason|2|||
156744765|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
156744766|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
156744767|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
156744768|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
156744769|NCT01004432|565813262|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
156458602|NCT05029622|564776618|FG000|Overall Study|Lost to Follow-up|1|||
156458603|NCT06232590|564776619|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
156458604|NCT06232590|564776620|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
156458605|NCT05299723|564776621|FG000|Overall Study|Withdrawal by Subject|0|||
156458606|NCT05299723|564776622|FG001|Overall Study|Withdrawal by Subject|2|||
156458607|NCT05299723|564776623|FG002|Overall Study|Withdrawal by Subject|0|||
156458608|NCT02460458|564776624|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
156458609|NCT02460458|564776624|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
156458610|NCT02460458|564776624|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
156458611|NCT02460458|564776624|FG000|First Prospective Phase|Lost to Follow-up|84|||
156458612|NCT02460458|564776624|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
156458613|NCT05299073|564776625|FG000|Overall Study|Withdrawal by Subject|0|||
156458614|NCT05299073|564776626|FG001|Overall Study|Withdrawal by Subject|0|||
156458615|NCT05299073|564776627|FG002|Overall Study|Withdrawal by Subject|1|||
156458616|NCT05299073|564776625|FG000|Overall Study|Adverse Event|0|||
156458617|NCT05299073|564776626|FG001|Overall Study|Adverse Event|1|||
156458618|NCT05299073|564776627|FG002|Overall Study|Adverse Event|0|||
156458619|NCT05299073|564776625|FG000|Overall Study|Lost to Follow-up|0|||
156458620|NCT05299073|564776626|FG001|Overall Study|Lost to Follow-up|1|||
156458621|NCT05299073|564776627|FG002|Overall Study|Lost to Follow-up|0|||
156458622|NCT00592852|564776628|FG000|Overall Study|Non-compliance|1|||
156458623|NCT00592852|564776628|FG000|Overall Study|Adverse Event|3|||
156458624|NCT00592852|564776628|FG000|Overall Study|Found ineligible|1|||
156458625|NCT00592852|564776628|FG000|Overall Study|Withdrawal by Subject|1|||
156458626|NCT02505984|564776632|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
156458627|NCT02505984|564776633|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
156458628|NCT02505984|564776632|FG000|Overall Study|Unreliable self-report data|1|||
156458629|NCT02505984|564776633|FG001|Overall Study|Unreliable self-report data|0|||
156458630|NCT02505984|564776632|FG000|Overall Study|Study blind opened during assessment|0|||
156458631|NCT02505984|564776633|FG001|Overall Study|Study blind opened during assessment|1|||
156458632|NCT02505984|564776632|FG000|Overall Study|Noncompliance with study protocol|0|||
156458633|NCT02505984|564776633|FG001|Overall Study|Noncompliance with study protocol|1|||
156458634|NCT03511664|564776644|FG000|Overall Study|Death|457|||
156458635|NCT03511664|564776645|FG001|Overall Study|Death|201|||
156458636|NCT03511664|564776646|FG002|Overall Study|Death|21|||
156458637|NCT03511664|564776644|FG000|Overall Study|Withdrew consent|40|||
156458638|NCT03511664|564776645|FG001|Overall Study|Withdrew consent|63|||
156458639|NCT03511664|564776646|FG002|Overall Study|Withdrew consent|3|||
156458640|NCT03511664|564776644|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
156458641|NCT03511664|564776645|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
156458642|NCT03511664|564776646|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
156458643|NCT03511664|564776644|FG000|Overall Study|Lost to Follow-up|8|||
156458644|NCT03511664|564776645|FG001|Overall Study|Lost to Follow-up|5|||
156458645|NCT03511664|564776646|FG002|Overall Study|Lost to Follow-up|0|||
156458646|NCT03511664|564776644|FG000|Overall Study|Physician Decision|2|||
156458647|NCT03511664|564776645|FG001|Overall Study|Physician Decision|1|||
156458648|NCT03511664|564776646|FG002|Overall Study|Physician Decision|0|||
156458649|NCT03511664|564776644|FG000|Overall Study|Patient non-compliance|1|||
156458650|NCT03511664|564776645|FG001|Overall Study|Patient non-compliance|0|||
156535196|NCT01006265|565054101|FG002|Overall Study|Administrative reason|3|||
156535197|NCT01006265|565054102|FG003|Overall Study|Administrative reason|0|||
156744770|NCT01004432|565813263|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
156744771|NCT01004432|565813264|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
156744772|NCT01004432|565813265|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
156744773|NCT01004432|565813266|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
156744774|NCT01004432|565813262|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
156744775|NCT01004432|565813263|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
156744776|NCT01004432|565813264|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
156744777|NCT01004432|565813265|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
156744778|NCT01004432|565813266|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
156798978|NCT02776735|566017295|FG002|Overall Study|Lost to Follow-up|0|||
156458651|NCT03511664|564776646|FG002|Overall Study|Patient non-compliance|0|||
156458652|NCT04362254|564776650|FG000|Overall Study|Adverse Event|1|||
156535198|NCT02101021|565054103|FG000|Overall Study|Death|4|||
156744779|NCT01004432|565813262|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
156458653|NCT04362254|564776650|FG000|Overall Study|Protocol Violation|1|||
156535199|NCT02101021|565054104|FG001|Overall Study|Death|3|||
156535200|NCT02101021|565054105|FG002|Overall Study|Death|6|||
156535201|NCT02101021|565054106|FG003|Overall Study|Death|0|||
156535202|NCT02101021|565054107|FG004|Overall Study|Death|3|||
156535203|NCT02101021|565054103|FG000|Overall Study|Withdrew Consent from study|1|||
156535204|NCT02101021|565054104|FG001|Overall Study|Withdrew Consent from study|1|||
156535205|NCT02101021|565054105|FG002|Overall Study|Withdrew Consent from study|0|||
156535206|NCT02101021|565054106|FG003|Overall Study|Withdrew Consent from study|2|||
156535207|NCT02101021|565054107|FG004|Overall Study|Withdrew Consent from study|0|||
156535208|NCT02101021|565054103|FG000|Overall Study|Lost to Follow-up|1|||
156535209|NCT02101021|565054104|FG001|Overall Study|Lost to Follow-up|0|||
156535210|NCT02101021|565054105|FG002|Overall Study|Lost to Follow-up|0|||
156535211|NCT02101021|565054106|FG003|Overall Study|Lost to Follow-up|0|||
156535212|NCT02101021|565054107|FG004|Overall Study|Lost to Follow-up|0|||
156535213|NCT02101021|565054103|FG000|Overall Study|Study Terminated by Sponsor|1|||
156535214|NCT02101021|565054104|FG001|Overall Study|Study Terminated by Sponsor|0|||
156535215|NCT02101021|565054105|FG002|Overall Study|Study Terminated by Sponsor|1|||
156535216|NCT02101021|565054106|FG003|Overall Study|Study Terminated by Sponsor|1|||
156535217|NCT02101021|565054107|FG004|Overall Study|Study Terminated by Sponsor|1|||
156535218|NCT03346057|565054110|FG000|Overall Study|Death|1|||
156535219|NCT03346057|565054111|FG001|Overall Study|Death|2|||
156535220|NCT03346057|565054112|FG002|Overall Study|Death|0|||
156535221|NCT03346057|565054113|FG003|Overall Study|Death|0|||
156535222|NCT03346057|565054110|FG000|Overall Study|Lost to Follow-up|0|||
156535223|NCT03346057|565054111|FG001|Overall Study|Lost to Follow-up|2|||
156535224|NCT03346057|565054112|FG002|Overall Study|Lost to Follow-up|1|||
156535225|NCT03346057|565054113|FG003|Overall Study|Lost to Follow-up|0|||
156535226|NCT03346057|565054110|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
156535227|NCT03346057|565054111|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
156535228|NCT03346057|565054112|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
156535229|NCT03346057|565054113|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
156535230|NCT03346057|565054110|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
156535231|NCT03346057|565054111|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
156535232|NCT03346057|565054112|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
156535233|NCT03346057|565054113|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
156535234|NCT03346057|565054110|FG000|Overall Study|Physician Decision|3|||
156535235|NCT03346057|565054111|FG001|Overall Study|Physician Decision|2|||
156535236|NCT03346057|565054112|FG002|Overall Study|Physician Decision|0|||
156535237|NCT03346057|565054113|FG003|Overall Study|Physician Decision|2|||
156535238|NCT03346057|565054110|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
156535239|NCT03346057|565054111|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
156535240|NCT03346057|565054112|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
156535241|NCT03346057|565054113|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
156535242|NCT03346057|565054110|FG000|Overall Study|Withdrawal by Subject|1|||
156535243|NCT03346057|565054111|FG001|Overall Study|Withdrawal by Subject|0|||
156535244|NCT03346057|565054112|FG002|Overall Study|Withdrawal by Subject|0|||
156535245|NCT03346057|565054113|FG003|Overall Study|Withdrawal by Subject|0|||
156535246|NCT02921269|565054114|FG000|Overall Study|Did not complete DLT period|1|||
156535247|NCT01326728|565054115|FG000|Overall Study|Death|13|||
156535248|NCT01326728|565054116|FG001|Overall Study|Death|0|||
156535249|NCT01326728|565054115|FG000|Overall Study|Early closure of study|34|||
156535250|NCT01326728|565054116|FG001|Overall Study|Early closure of study|9|||
156535251|NCT01184053|565054117|FG000|Overall Study|progression while on treatment|3|||
156535252|NCT02536755|565054121|FG000|Overall Study|Adverse Event|4|||
156535253|NCT02301936|565054122|FG000|Overall Study|Lost to Follow-up|1|||
156535254|NCT02301936|565054123|FG001|Overall Study|Lost to Follow-up|0|||
156535255|NCT03065023|565054124|FG000|Overall Study|Progressive Disease|0|||
156535256|NCT03065023|565054125|FG001|Overall Study|Progressive Disease|1|||
156535257|NCT03065023|565054126|FG002|Overall Study|Progressive Disease|0|||
156535258|NCT03065023|565054127|FG003|Overall Study|Progressive Disease|0|||
156535259|NCT03065023|565054128|FG004|Overall Study|Progressive Disease|0|||
156535260|NCT03065023|565054124|FG000|Overall Study|Death|2|||
156535261|NCT03065023|565054125|FG001|Overall Study|Death|0|||
156535262|NCT03065023|565054126|FG002|Overall Study|Death|1|||
156535263|NCT03065023|565054127|FG003|Overall Study|Death|1|||
156535264|NCT03065023|565054128|FG004|Overall Study|Death|0|||
156744780|NCT01004432|565813263|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
156744781|NCT01004432|565813264|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
156535265|NCT03065023|565054124|FG000|Overall Study|Lost to Follow-up|0|||
156535266|NCT03065023|565054125|FG001|Overall Study|Lost to Follow-up|1|||
156535267|NCT03065023|565054126|FG002|Overall Study|Lost to Follow-up|0|||
156535268|NCT03065023|565054127|FG003|Overall Study|Lost to Follow-up|0|||
156535269|NCT03065023|565054128|FG004|Overall Study|Lost to Follow-up|0|||
156535270|NCT03065023|565054124|FG000|Overall Study|Participant Decision|0|||
156744782|NCT01004432|565813265|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
156535271|NCT03065023|565054125|FG001|Overall Study|Participant Decision|0|||
156535272|NCT03065023|565054126|FG002|Overall Study|Participant Decision|0|||
156535273|NCT03065023|565054127|FG003|Overall Study|Participant Decision|1|||
156535274|NCT03065023|565054128|FG004|Overall Study|Participant Decision|0|||
156535275|NCT03065023|565054124|FG000|Overall Study|Withdrawal by Subject|0|||
156535276|NCT03065023|565054125|FG001|Overall Study|Withdrawal by Subject|0|||
156535277|NCT03065023|565054126|FG002|Overall Study|Withdrawal by Subject|0|||
156535278|NCT03065023|565054127|FG003|Overall Study|Withdrawal by Subject|1|||
156535279|NCT03065023|565054128|FG004|Overall Study|Withdrawal by Subject|0|||
156535280|NCT01102803|565054129|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
156535281|NCT01102803|565054130|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
156535282|NCT01102803|565054129|FG000|Post to Follow-Up|Lost to Follow-up|1|||
156535283|NCT01102803|565054130|FG001|Post to Follow-Up|Lost to Follow-up|3|||
156535284|NCT01667107|565054131|FG000|Overall Study|Adverse Event|4|||
156535285|NCT01667107|565054132|FG001|Overall Study|Adverse Event|3|||
156535286|NCT01667107|565054131|FG000|Overall Study|Tolerability issues|0|||
156535287|NCT01667107|565054132|FG001|Overall Study|Tolerability issues|2|||
156535288|NCT01667107|565054131|FG000|Overall Study|Protocol Violation|0|||
156535289|NCT01667107|565054132|FG001|Overall Study|Protocol Violation|1|||
156535290|NCT01667107|565054131|FG000|Overall Study|Lack of Efficacy|0|||
156535291|NCT01667107|565054132|FG001|Overall Study|Lack of Efficacy|1|||
156535292|NCT03427125|565054133|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
156535293|NCT03427125|565054134|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
156535294|NCT03427125|565054135|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
156535295|NCT02281357|565054136|FG000|Overall Study|Adverse Event|2|||
156535296|NCT02281357|565054137|FG001|Overall Study|Adverse Event|1|||
156535297|NCT02281357|565054136|FG000|Overall Study|Lost to Follow-up|1|||
156535298|NCT02281357|565054137|FG001|Overall Study|Lost to Follow-up|0|||
156535299|NCT02281357|565054136|FG000|Overall Study|Withdrawal by Subject|4|||
156535300|NCT02281357|565054137|FG001|Overall Study|Withdrawal by Subject|3|||
156535301|NCT01162239|565054138|FG000|Treatment Phase|Withdrawal by Subject|1|||
156535302|NCT01162239|565054139|FG001|Treatment Phase|Withdrawal by Subject|3|||
156535303|NCT01162239|565054140|FG002|Treatment Phase|Withdrawal by Subject|2|||
156535304|NCT01162239|565054141|FG003|Treatment Phase|Withdrawal by Subject|3|||
156535305|NCT01162239|565054138|FG000|Treatment Phase|Death|0|||
156535306|NCT01162239|565054139|FG001|Treatment Phase|Death|0|||
156535307|NCT01162239|565054140|FG002|Treatment Phase|Death|0|||
156535308|NCT01162239|565054141|FG003|Treatment Phase|Death|1|||
156535309|NCT01162239|565054138|FG000|Treatment Phase|Lost to Follow-up|5|||
156535310|NCT01162239|565054139|FG001|Treatment Phase|Lost to Follow-up|4|||
156535311|NCT01162239|565054140|FG002|Treatment Phase|Lost to Follow-up|2|||
156535312|NCT01162239|565054141|FG003|Treatment Phase|Lost to Follow-up|1|||
156535313|NCT01162239|565054138|FG000|Extended Follow-up|Lost to Follow-up|8|||
156535314|NCT01162239|565054139|FG001|Extended Follow-up|Lost to Follow-up|13|||
156535315|NCT01162239|565054140|FG002|Extended Follow-up|Lost to Follow-up|8|||
156535316|NCT01162239|565054141|FG003|Extended Follow-up|Lost to Follow-up|6|||
156535317|NCT00232141|565054144|FG000|Overall Study|Adverse Event|9|||
156535318|NCT00232141|565054145|FG001|Overall Study|Adverse Event|4|||
156535319|NCT00232141|565054144|FG000|Overall Study|Lack of Efficacy|0|||
156535320|NCT00232141|565054145|FG001|Overall Study|Lack of Efficacy|3|||
156535321|NCT00232141|565054144|FG000|Overall Study|Lost to Follow-up|9|||
156535322|NCT00232141|565054145|FG001|Overall Study|Lost to Follow-up|6|||
156535323|NCT00232141|565054144|FG000|Overall Study|Other|8|||
156535324|NCT00232141|565054145|FG001|Overall Study|Other|10|||
156535325|NCT00232141|565054144|FG000|Overall Study|Withdrawal by Subject|5|||
156535326|NCT00232141|565054145|FG001|Overall Study|Withdrawal by Subject|3|||
156535327|NCT01810016|565054151|FG000|Overall Study|Progressive disease|1|||
156535328|NCT01810016|565054152|FG001|Overall Study|Progressive disease|1|||
156535329|NCT01810016|565054153|FG002|Overall Study|Progressive disease|0|||
156535330|NCT01810016|565054151|FG000|Overall Study|Death|0|||
156535331|NCT01810016|565054152|FG001|Overall Study|Death|0|||
156535332|NCT01810016|565054153|FG002|Overall Study|Death|1|||
156535333|NCT04263896|565054154|FG000|Overall Study|Withdrawal by Subject|2|||
156535334|NCT04263896|565054155|FG001|Overall Study|Withdrawal by Subject|4|||
156535335|NCT04263896|565054154|FG000|Overall Study|converted to open procedure|0|||
156535336|NCT04263896|565054155|FG001|Overall Study|converted to open procedure|1|||
156535337|NCT04263896|565054154|FG000|Overall Study|Lost to Follow-up|9|||
156535338|NCT04263896|565054155|FG001|Overall Study|Lost to Follow-up|11|||
156744783|NCT01004432|565813266|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
156744784|NCT01004432|565813262|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
156744785|NCT01004432|565813263|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
156535339|NCT04263896|565054154|FG000|Overall Study|surveys lost in mail|5|||
156535340|NCT04263896|565054155|FG001|Overall Study|surveys lost in mail|3|||
156535341|NCT04263896|565054154|FG000|Overall Study|excluded from analysis|1|||
156535342|NCT04263896|565054155|FG001|Overall Study|excluded from analysis|0|||
156535343|NCT06950879|565054156|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
156535344|NCT00682448|565055515|FG000|Overall Study|Adverse Event|1|||
156744786|NCT01004432|565813264|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
156535345|NCT00682448|565055516|FG001|Overall Study|Adverse Event|2|||
156535346|NCT00682448|565055515|FG000|Overall Study|Lack of Efficacy|1|||
156535347|NCT00682448|565055516|FG001|Overall Study|Lack of Efficacy|0|||
156535348|NCT00682448|565055515|FG000|Overall Study|Lost to Follow-up|1|||
156535349|NCT00682448|565055516|FG001|Overall Study|Lost to Follow-up|3|||
156535350|NCT00682448|565055515|FG000|Overall Study|Pregnancy|0|||
156535351|NCT00682448|565055516|FG001|Overall Study|Pregnancy|1|||
156535352|NCT00682448|565055515|FG000|Overall Study|Withdrawal by Subject|2|||
156535353|NCT00682448|565055516|FG001|Overall Study|Withdrawal by Subject|0|||
156535354|NCT04050670|565055519|FG000|Period 3|Physician Decision|0|||
156535355|NCT04050670|565055520|FG001|Period 3|Physician Decision|1|||
156535356|NCT04050670|565055521|FG002|Period 3|Physician Decision|0|||
156535357|NCT00761306|565055522|FG000|Overall Study|Adverse Event|5|||
156535358|NCT00761306|565055522|FG000|Overall Study|Lack of Efficacy|4|||
156535359|NCT00761306|565055522|FG000|Overall Study|Protocol Violation|2|||
156535360|NCT00761306|565055522|FG000|Overall Study|Withdrawal of Consent|3|||
156535361|NCT00761306|565055522|FG000|Overall Study|Lost to Follow-up|1|||
156535362|NCT00761306|565055522|FG000|Overall Study|Administrative or Other Reasons|5|||
156535363|NCT00268437|565055523|FG000|Overall Study|Ineligible|1|||
156535364|NCT05162027|565055524|FG000|Overall Study|Adverse Event|1|||
156535365|NCT05162027|565055525|FG001|Overall Study|Adverse Event|0|||
156535366|NCT00525044|565055526|FG000|Overall Study|Lost to Follow-up|0|||
156535367|NCT00525044|565055527|FG001|Overall Study|Lost to Follow-up|1|||
156535368|NCT02982239|565055528|FG000|Overall Study|Lost to Follow-up|3|||
156535369|NCT02982239|565055529|FG001|Overall Study|Lost to Follow-up|2|||
156535370|NCT01650285|565055530|FG000|Overall Study|Adverse Event|1|||
156535371|NCT00907257|565055531|FG000|Overall Study|Adverse Event|0|||
156535372|NCT00907257|565055532|FG001|Overall Study|Adverse Event|4|||
156535373|NCT00907257|565055531|FG000|Overall Study|Protocol Violation|1|||
156535374|NCT00907257|565055532|FG001|Overall Study|Protocol Violation|2|||
156535375|NCT00907257|565055531|FG000|Overall Study|Lost to Follow-up|3|||
156535376|NCT00907257|565055532|FG001|Overall Study|Lost to Follow-up|3|||
156535377|NCT00907257|565055531|FG000|Overall Study|Withdrawal by Subject|1|||
156535378|NCT00907257|565055532|FG001|Overall Study|Withdrawal by Subject|2|||
156535379|NCT00907257|565055531|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
156535380|NCT00907257|565055532|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
156535381|NCT00907257|565055531|FG000|Overall Study|Moved|1|||
156535382|NCT00907257|565055532|FG001|Overall Study|Moved|0|||
156535383|NCT00907257|565055531|FG000|Overall Study|Personal Reasons|6|||
156535384|NCT00907257|565055532|FG001|Overall Study|Personal Reasons|1|||
156535385|NCT00880555|565055533|FG000|Overall Study|Physician Decision|0|||
156535386|NCT00880555|565055534|FG001|Overall Study|Physician Decision|8|||
156535387|NCT00880555|565055535|FG002|Overall Study|Physician Decision|0|||
156535388|NCT00880555|565055536|FG003|Overall Study|Physician Decision|2|||
156535389|NCT00880555|565055537|FG004|Overall Study|Physician Decision|1|||
156535390|NCT00880555|565055538|FG005|Overall Study|Physician Decision|0|||
156535391|NCT00880555|565055533|FG000|Overall Study|Withdrawal by Subject|1|||
156535392|NCT00880555|565055534|FG001|Overall Study|Withdrawal by Subject|1|||
156535393|NCT00880555|565055535|FG002|Overall Study|Withdrawal by Subject|0|||
156535394|NCT00880555|565055536|FG003|Overall Study|Withdrawal by Subject|0|||
156535395|NCT00880555|565055537|FG004|Overall Study|Withdrawal by Subject|0|||
156535396|NCT00880555|565055538|FG005|Overall Study|Withdrawal by Subject|0|||
156535397|NCT00880555|565055533|FG000|Overall Study|Lack of resources (hired rater)|9|||
156535398|NCT00880555|565055534|FG001|Overall Study|Lack of resources (hired rater)|7|||
156535399|NCT00880555|565055535|FG002|Overall Study|Lack of resources (hired rater)|5|||
156535400|NCT00880555|565055536|FG003|Overall Study|Lack of resources (hired rater)|0|||
156535401|NCT00880555|565055537|FG004|Overall Study|Lack of resources (hired rater)|0|||
156535402|NCT00880555|565055538|FG005|Overall Study|Lack of resources (hired rater)|0|||
156798979|NCT02776735|566017296|FG003|Overall Study|Lost to Follow-up|1|||
156798980|NCT02776735|566017297|FG004|Overall Study|Lost to Follow-up|0|||
156798981|NCT02776735|566017298|FG005|Overall Study|Lost to Follow-up|0|||
156798982|NCT02776735|566017293|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156535403|NCT00880555|565055533|FG000|Overall Study|Death|0|||
156535404|NCT00880555|565055534|FG001|Overall Study|Death|0|||
156535405|NCT00880555|565055535|FG002|Overall Study|Death|0|||
156535406|NCT00880555|565055536|FG003|Overall Study|Death|0|||
156535407|NCT00880555|565055537|FG004|Overall Study|Death|0|||
156535408|NCT00880555|565055538|FG005|Overall Study|Death|1|||
156535409|NCT00880555|565055533|FG000|Overall Study|Lost to Follow-up|0|||
156535410|NCT00880555|565055534|FG001|Overall Study|Lost to Follow-up|1|||
156535411|NCT00880555|565055535|FG002|Overall Study|Lost to Follow-up|0|||
156798983|NCT02776735|566017294|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156337107|NCT02229383|564331469|FG001|Overall Study|Other|8|||
156535412|NCT00880555|565055536|FG003|Overall Study|Lost to Follow-up|0|||
156535413|NCT00880555|565055537|FG004|Overall Study|Lost to Follow-up|0|||
156535414|NCT00880555|565055538|FG005|Overall Study|Lost to Follow-up|0|||
156535415|NCT04163900|565055539|FG000|Overall Study|Radiological disease progression|112|||
156535416|NCT04163900|565055540|FG001|Overall Study|Radiological disease progression|127|||
156535417|NCT04163900|565055539|FG000|Overall Study|Study closure|98|||
156535418|NCT04163900|565055540|FG001|Overall Study|Study closure|133|||
156798984|NCT02776735|566017295|FG002|Overall Study|Withdrawal by parent/guardian|2|||
156798985|NCT02776735|566017296|FG003|Overall Study|Withdrawal by parent/guardian|2|||
156798986|NCT02776735|566017297|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156798987|NCT02776735|566017298|FG005|Overall Study|Withdrawal by parent/guardian|0|||
156798988|NCT02776735|566017293|FG000|Overall Study|Withdrawal by Subject|1|||
156798989|NCT02776735|566017294|FG001|Overall Study|Withdrawal by Subject|0|||
156798990|NCT02776735|566017295|FG002|Overall Study|Withdrawal by Subject|0|||
156798991|NCT02776735|566017296|FG003|Overall Study|Withdrawal by Subject|0|||
156798992|NCT02776735|566017297|FG004|Overall Study|Withdrawal by Subject|0|||
156798993|NCT02776735|566017298|FG005|Overall Study|Withdrawal by Subject|1|||
156798994|NCT02776735|566017293|FG000|Overall Study|Other|0|||
156798995|NCT02776735|566017294|FG001|Overall Study|Other|0|||
156798996|NCT02776735|566017295|FG002|Overall Study|Other|3|||
156798997|NCT02776735|566017296|FG003|Overall Study|Other|0|||
156798998|NCT02776735|566017297|FG004|Overall Study|Other|0|||
156798999|NCT02776735|566017298|FG005|Overall Study|Other|0|||
156799000|NCT05847686|566018879|FG000|Overall Study|Withdrawal by Subject|3|||
156799001|NCT01323192|566018880|FG000|Overall Study|Adverse Event|6|||
156799002|NCT01323192|566018881|FG001|Overall Study|Adverse Event|1|||
156799003|NCT01323192|566018880|FG000|Overall Study|Withdrawal by Subject|3|||
156799004|NCT01323192|566018881|FG001|Overall Study|Withdrawal by Subject|1|||
156799005|NCT01323192|566018880|FG000|Overall Study|Noncompliance with study medication|0|||
156799006|NCT01323192|566018881|FG001|Overall Study|Noncompliance with study medication|3|||
156799007|NCT01323192|566018880|FG000|Overall Study|Nonmedical reasons|0|||
156799008|NCT01323192|566018881|FG001|Overall Study|Nonmedical reasons|1|||
156799009|NCT03698279|566018882|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156799010|NCT03698279|566018883|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156799011|NCT03698279|566018884|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156799012|NCT03698279|566018885|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156799013|NCT03698279|566018886|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156799014|NCT03698279|566018887|FG005|Overall Study|Withdrawal by parent/guardian|0|||
156799015|NCT03698279|566018882|FG000|Overall Study|Protocol deviation|1|||
156799016|NCT03698279|566018883|FG001|Overall Study|Protocol deviation|0|||
156799017|NCT03698279|566018884|FG002|Overall Study|Protocol deviation|1|||
156799018|NCT03698279|566018885|FG003|Overall Study|Protocol deviation|0|||
156799019|NCT03698279|566018886|FG004|Overall Study|Protocol deviation|0|||
156799020|NCT03698279|566018887|FG005|Overall Study|Protocol deviation|0|||
156799021|NCT03698279|566018882|FG000|Overall Study|Withdrawal by Subject|0|||
156799022|NCT03698279|566018883|FG001|Overall Study|Withdrawal by Subject|0|||
156799023|NCT03698279|566018884|FG002|Overall Study|Withdrawal by Subject|1|||
156799024|NCT03698279|566018885|FG003|Overall Study|Withdrawal by Subject|0|||
156799025|NCT03698279|566018886|FG004|Overall Study|Withdrawal by Subject|0|||
156799026|NCT03698279|566018887|FG005|Overall Study|Withdrawal by Subject|0|||
156799027|NCT03698279|566018882|FG000|Overall Study|Lost to Follow-up|3|||
156799028|NCT03698279|566018883|FG001|Overall Study|Lost to Follow-up|1|||
156799029|NCT03698279|566018884|FG002|Overall Study|Lost to Follow-up|4|||
156799030|NCT03698279|566018885|FG003|Overall Study|Lost to Follow-up|5|||
156799031|NCT03698279|566018886|FG004|Overall Study|Lost to Follow-up|0|||
156799032|NCT03698279|566018887|FG005|Overall Study|Lost to Follow-up|0|||
156799033|NCT03309202|566018891|FG000|Overall Study|Lost to Follow-up|1|||
156799034|NCT03309202|566018892|FG001|Overall Study|Lost to Follow-up|0|||
156799035|NCT03309202|566018893|FG002|Overall Study|Lost to Follow-up|0|||
156799036|NCT03309202|566018894|FG003|Overall Study|Lost to Follow-up|0|||
156799037|NCT00573768|566018895|FG000|Overall Study|Adverse Event|1|||
156799038|NCT00573768|566018896|FG001|Overall Study|Adverse Event|1|||
156799039|NCT00573768|566018897|FG002|Overall Study|Adverse Event|2|||
156799040|NCT00573768|566018895|FG000|Overall Study|Protocol Violation|1|||
156799041|NCT00573768|566018896|FG001|Overall Study|Protocol Violation|0|||
156799042|NCT00573768|566018897|FG002|Overall Study|Protocol Violation|1|||
156799043|NCT00573768|566018895|FG000|Overall Study|Withdrawal by Subject|0|||
156799044|NCT00573768|566018896|FG001|Overall Study|Withdrawal by Subject|1|||
156799045|NCT00573768|566018897|FG002|Overall Study|Withdrawal by Subject|0|||
156799046|NCT00573768|566018895|FG000|Overall Study|Lost to Follow-up|0|||
156799047|NCT00573768|566018896|FG001|Overall Study|Lost to Follow-up|0|||
156799048|NCT00573768|566018897|FG002|Overall Study|Lost to Follow-up|1|||
156799049|NCT01500317|566018902|FG000|Overall Study|Withdrawal by Subject|3|||
156799050|NCT01500317|566018903|FG001|Overall Study|Withdrawal by Subject|2|||
156799051|NCT01500317|566018904|FG002|Overall Study|Withdrawal by Subject|0|||
156799052|NCT00976456|566018905|FG000|Overall Study|Adverse Event|17|||
156799053|NCT00976456|566018906|FG001|Overall Study|Adverse Event|22|||
156799054|NCT00976456|566018905|FG000|Overall Study|Death|7|||
156799055|NCT00976456|566018906|FG001|Overall Study|Death|9|||
156458654|NCT04362254|564776650|FG000|Overall Study|Due to early termination of the trial|10|||
156535419|NCT04163900|565055539|FG000|Overall Study|Adverse Event|78|||
156535420|NCT04163900|565055540|FG001|Overall Study|Adverse Event|32|||
156535421|NCT04163900|565055539|FG000|Overall Study|Withdrawal by Subject|37|||
156535422|NCT04163900|565055540|FG001|Overall Study|Withdrawal by Subject|34|||
156535423|NCT04163900|565055539|FG000|Overall Study|Death|29|||
156535424|NCT04163900|565055540|FG001|Overall Study|Death|16|||
156535425|NCT04163900|565055539|FG000|Overall Study|Physician Decision|17|||
156535426|NCT04163900|565055540|FG001|Overall Study|Physician Decision|25|||
156535427|NCT04163900|565055539|FG000|Overall Study|Clinical disease progression|14|||
156535428|NCT04163900|565055540|FG001|Overall Study|Clinical disease progression|13|||
156535429|NCT04163900|565055539|FG000|Overall Study|Protocol Violation|3|||
156535430|NCT04163900|565055540|FG001|Overall Study|Protocol Violation|4|||
156535431|NCT04163900|565055539|FG000|Overall Study|Lost to Follow-up|0|||
156535432|NCT04163900|565055540|FG001|Overall Study|Lost to Follow-up|1|||
156535433|NCT01873417|565055542|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
156535434|NCT01873417|565055542|FG000|Overall Study|Adverse Event|24|||
156535435|NCT01873417|565055542|FG000|Overall Study|Lost to Follow-up|2|||
156535436|NCT01873417|565055542|FG000|Overall Study|Withdrawal by Subject|2|||
156535437|NCT01873417|565055542|FG000|Overall Study|Physician Decision|3|||
156535438|NCT00785044|565055543|FG000|Overall Study|Dosed at non-participating sites|152|||
156535439|NCT00785044|565055543|FG000|Overall Study|Death|77|||
156535440|NCT00785044|565055543|FG000|Overall Study|Lost to Follow-up|266|||
156535441|NCT00785044|565055543|FG000|Overall Study|Withdrawal by Subject|1|||
156535442|NCT01628107|565055544|FG000|Overall Study|Withdrawal by Subject|17|||
156535443|NCT01628107|565055544|FG000|Overall Study|Lost to Follow-up|4|||
156535444|NCT01628107|565055544|FG000|Overall Study|Adverse Event|33|||
156535445|NCT01628107|565055544|FG000|Overall Study|Physician Decision|2|||
156535446|NCT01628107|565055544|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
156535447|NCT01628107|565055544|FG000|Overall Study|Non-compliant with Study Procedures|10|||
156535448|NCT01628107|565055544|FG000|Overall Study|Not Treated|8|||
156535449|NCT01628107|565055544|FG000|Overall Study|Sponsor Decision|11|||
156535450|NCT01628107|565055544|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
156535451|NCT01628107|565055544|FG000|Overall Study|Relocated|8|||
156535452|NCT01628107|565055544|FG000|Overall Study|Kidney Transplant|9|||
156535453|NCT01628107|565055544|FG000|Overall Study|Use of Standard of Care|9|||
156535454|NCT01086410|565055545|FG000|Overall Study|Adverse Event|1|||
156535455|NCT01086410|565055546|FG001|Overall Study|Adverse Event|0|||
156535456|NCT01086410|565055547|FG002|Overall Study|Adverse Event|0|||
156535457|NCT01086410|565055548|FG003|Overall Study|Adverse Event|2|||
156535458|NCT01086410|565055545|FG000|Overall Study|Lack of Efficacy|1|||
156535459|NCT01086410|565055546|FG001|Overall Study|Lack of Efficacy|1|||
156535460|NCT01086410|565055547|FG002|Overall Study|Lack of Efficacy|0|||
156535461|NCT01086410|565055548|FG003|Overall Study|Lack of Efficacy|0|||
156535462|NCT01086410|565055545|FG000|Overall Study|Protocol Violation|1|||
156535463|NCT01086410|565055546|FG001|Overall Study|Protocol Violation|1|||
156535464|NCT01086410|565055547|FG002|Overall Study|Protocol Violation|0|||
156535465|NCT01086410|565055548|FG003|Overall Study|Protocol Violation|0|||
156535466|NCT01086410|565055545|FG000|Overall Study|Lost to Follow-up|0|||
156535467|NCT01086410|565055546|FG001|Overall Study|Lost to Follow-up|0|||
156535468|NCT01086410|565055547|FG002|Overall Study|Lost to Follow-up|1|||
156535469|NCT01086410|565055548|FG003|Overall Study|Lost to Follow-up|0|||
156535470|NCT00621751|565055549|FG000|Overall Study|Adverse Event|0|||
156535471|NCT00621751|565055550|FG001|Overall Study|Adverse Event|1|||
156535472|NCT02023242|565055551|FG000|Overall Study|Lost to Follow-up|3|||
156535473|NCT02023242|565055552|FG001|Overall Study|Lost to Follow-up|1|||
156535474|NCT02023242|565055551|FG000|Overall Study|Death|0|||
156535475|NCT02023242|565055552|FG001|Overall Study|Death|1|||
156535476|NCT00710879|565055556|FG000|Overall Study|Lost to Follow-up|2|||
156535477|NCT00710879|565055557|FG001|Overall Study|Lost to Follow-up|1|||
156535478|NCT00710879|565055556|FG000|Overall Study|Protocol Violation|0|||
156535479|NCT00710879|565055557|FG001|Overall Study|Protocol Violation|3|||
156535480|NCT01809132|565055558|FG000|Overall Study|Withdrawal by Subject|0|||
156535481|NCT01809132|565055559|FG001|Overall Study|Withdrawal by Subject|0|||
156744787|NCT01004432|565813265|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
156535482|NCT01809132|565055560|FG002|Overall Study|Withdrawal by Subject|1|||
156535483|NCT04854434|565055561|FG000|Overall Study|Death|1|||
156535484|NCT04854434|565055562|FG001|Overall Study|Death|3|||
156535485|NCT04854434|565055563|FG002|Overall Study|Death|4|||
156535486|NCT04854434|565055561|FG000|Overall Study|Study Terminated by Sponsor|2|||
156744788|NCT01004432|565813266|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
156744789|NCT04526574|565813268|FG000|Overall Study|Protocol Violation|3|||
156535487|NCT04854434|565055562|FG001|Overall Study|Study Terminated by Sponsor|0|||
156535488|NCT04854434|565055563|FG002|Overall Study|Study Terminated by Sponsor|0|||
156535489|NCT04854434|565055561|FG000|Overall Study|Other|1|||
156535490|NCT04854434|565055562|FG001|Overall Study|Other|1|||
156535491|NCT04854434|565055563|FG002|Overall Study|Other|0|||
156535492|NCT03349775|565055564|FG000|Overall Study|Side Effects|1|||
156535493|NCT03349775|565055565|FG001|Overall Study|Side Effects|2|||
156535494|NCT03349775|565055564|FG000|Overall Study|Withdrawal by Subject|1|||
156744790|NCT04526574|565813269|FG001|Overall Study|Protocol Violation|1|||
156799056|NCT00976456|566018905|FG000|Overall Study|Lack of Efficacy|5|||
156799057|NCT00976456|566018906|FG001|Overall Study|Lack of Efficacy|2|||
156799058|NCT00976456|566018905|FG000|Overall Study|Withdrawal by Subject|3|||
156799059|NCT00976456|566018906|FG001|Overall Study|Withdrawal by Subject|1|||
156799060|NCT00976456|566018905|FG000|Overall Study|screening failure, unknown|11|||
156799061|NCT00976456|566018906|FG001|Overall Study|screening failure, unknown|4|||
156799062|NCT00335829|566018907|FG000|Overall Study|Withdrawal by Subject|1|||
156799063|NCT00335829|566018907|FG000|Overall Study|Lost to Follow-up|1|||
156799064|NCT00335829|566018907|FG000|Overall Study|Adverse Event|1|||
156799065|NCT02090764|566018910|FG000|Overall Study|Adverse Event|1|||
156799066|NCT02090764|566018911|FG001|Overall Study|Adverse Event|3|||
156799067|NCT02090764|566018910|FG000|Overall Study|Lack of Efficacy|0|||
156799068|NCT02090764|566018911|FG001|Overall Study|Lack of Efficacy|13|||
156799069|NCT02090764|566018910|FG000|Overall Study|Withdrawal by Subject|2|||
156799070|NCT02090764|566018911|FG001|Overall Study|Withdrawal by Subject|1|||
156799071|NCT02090764|566018910|FG000|Overall Study|Intercurrent illness and other|1|||
156799072|NCT02090764|566018911|FG001|Overall Study|Intercurrent illness and other|1|||
156799073|NCT02090764|566018910|FG000|Overall Study|Lost to Follow-up|2|||
156799074|NCT02090764|566018911|FG001|Overall Study|Lost to Follow-up|2|||
156799075|NCT04617860|566018912|FG000|Overall Study|Adverse Event|0|||
156799076|NCT04617860|566018913|FG001|Overall Study|Adverse Event|2|||
156799077|NCT04617860|566018914|FG002|Overall Study|Adverse Event|2|||
156799078|NCT04617860|566018912|FG000|Overall Study|Withdrawal by Subject|0|||
156799079|NCT04617860|566018913|FG001|Overall Study|Withdrawal by Subject|0|||
156799080|NCT04617860|566018914|FG002|Overall Study|Withdrawal by Subject|2|||
156799081|NCT04617860|566018912|FG000|Overall Study|Physician Decision|0|||
156799082|NCT04617860|566018913|FG001|Overall Study|Physician Decision|1|||
156799083|NCT04617860|566018914|FG002|Overall Study|Physician Decision|0|||
156799084|NCT04617860|566018912|FG000|Overall Study|Sponsor Decision|0|||
156799085|NCT04617860|566018913|FG001|Overall Study|Sponsor Decision|3|||
156799086|NCT04617860|566018914|FG002|Overall Study|Sponsor Decision|1|||
156799087|NCT04617860|566018912|FG000|Overall Study|Termination of Study by Sponsor|8|||
156799088|NCT04617860|566018913|FG001|Overall Study|Termination of Study by Sponsor|4|||
156799089|NCT04617860|566018914|FG002|Overall Study|Termination of Study by Sponsor|13|||
156799090|NCT00673920|566018925|FG000|Baseline up to Week 48|Withdrew consent|1|||
156799091|NCT00673920|566018926|FG001|Baseline up to Week 48|Withdrew consent|0|||
156799092|NCT00673920|566018927|FG002|Baseline up to Week 48|Withdrew consent|2|||
156799093|NCT00673920|566018928|FG003|Baseline up to Week 48|Withdrew consent|0|||
156799094|NCT00673920|566018929|FG004|Baseline up to Week 48|Withdrew consent|0|||
156799095|NCT00673920|566018930|FG005|Baseline up to Week 48|Withdrew consent|0|||
156799096|NCT00673920|566018931|FG006|Baseline up to Week 48|Withdrew consent|0|||
156799097|NCT00673920|566018932|FG007|Baseline up to Week 48|Withdrew consent|0|||
156799098|NCT00673920|566018925|FG000|Baseline up to Week 48|Refused treatment|1|||
156799099|NCT00673920|566018926|FG001|Baseline up to Week 48|Refused treatment|0|||
156799100|NCT00673920|566018927|FG002|Baseline up to Week 48|Refused treatment|0|||
156799101|NCT00673920|566018928|FG003|Baseline up to Week 48|Refused treatment|0|||
156799102|NCT00673920|566018929|FG004|Baseline up to Week 48|Refused treatment|0|||
156799103|NCT00673920|566018930|FG005|Baseline up to Week 48|Refused treatment|0|||
156799104|NCT00673920|566018931|FG006|Baseline up to Week 48|Refused treatment|0|||
156799105|NCT00673920|566018932|FG007|Baseline up to Week 48|Refused treatment|0|||
156799106|NCT00673920|566018925|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
156799107|NCT00673920|566018926|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
156799108|NCT00673920|566018927|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799109|NCT00673920|566018928|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799110|NCT00673920|566018929|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799111|NCT00673920|566018930|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799112|NCT00673920|566018931|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799113|NCT00673920|566018932|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799114|NCT00673920|566018925|FG000|Baseline up to Week 48|Protocol Violation|0|||
156799115|NCT00673920|566018926|FG001|Baseline up to Week 48|Protocol Violation|0|||
156799116|NCT00673920|566018927|FG002|Baseline up to Week 48|Protocol Violation|1|||
156799117|NCT00673920|566018928|FG003|Baseline up to Week 48|Protocol Violation|0|||
156799118|NCT00673920|566018929|FG004|Baseline up to Week 48|Protocol Violation|0|||
156799119|NCT00673920|566018930|FG005|Baseline up to Week 48|Protocol Violation|0|||
156799120|NCT00673920|566018931|FG006|Baseline up to Week 48|Protocol Violation|0|||
156799121|NCT00673920|566018932|FG007|Baseline up to Week 48|Protocol Violation|0|||
156799122|NCT00673920|566018925|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799123|NCT00673920|566018926|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799124|NCT00673920|566018927|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
156799125|NCT00673920|566018928|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799126|NCT00673920|566018929|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799127|NCT00673920|566018930|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799128|NCT00673920|566018931|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156535495|NCT03349775|565055565|FG001|Overall Study|Withdrawal by Subject|1|||
156535496|NCT03349775|565055564|FG000|Overall Study|No primary outcome measurements|0|||
156535497|NCT03349775|565055565|FG001|Overall Study|No primary outcome measurements|1|||
156535498|NCT04439071|565055572|FG000|Overall Study|Lost to Follow-up|0|||
156535499|NCT04439071|565055573|FG001|Overall Study|Lost to Follow-up|3|||
156535500|NCT04439071|565055572|FG000|Overall Study|Withdrawal by Subject|3|||
156535501|NCT04439071|565055573|FG001|Overall Study|Withdrawal by Subject|8|||
156535502|NCT04439071|565055572|FG000|Overall Study|Death|6|||
156535503|NCT04439071|565055573|FG001|Overall Study|Death|4|||
156535504|NCT04439071|565055572|FG000|Overall Study|Other than specified|3|||
156535505|NCT04439071|565055573|FG001|Overall Study|Other than specified|3|||
156535506|NCT04439071|565055572|FG000|Overall Study|Randomized but not treated|2|||
156535507|NCT04439071|565055573|FG001|Overall Study|Randomized but not treated|0|||
156535508|NCT00892177|565055574|FG000|Phase II|Ineligible|0|||
156535509|NCT00892177|565055575|FG001|Phase II|Ineligible|0|||
156535510|NCT00892177|565055576|FG002|Phase II|Ineligible|0|||
156535511|NCT00892177|565055577|FG003|Phase II|Ineligible|0|||
156535512|NCT00892177|565055578|FG004|Phase II|Ineligible|1|||
156535513|NCT00892177|565055579|FG005|Phase II|Ineligible|1|||
156535514|NCT00892177|565055574|FG000|Phase II|Withdrawal by Subject|0|||
156535515|NCT00892177|565055575|FG001|Phase II|Withdrawal by Subject|0|||
156535516|NCT00892177|565055576|FG002|Phase II|Withdrawal by Subject|0|||
156535517|NCT00892177|565055577|FG003|Phase II|Withdrawal by Subject|0|||
156535518|NCT00892177|565055578|FG004|Phase II|Withdrawal by Subject|4|||
156535519|NCT00892177|565055579|FG005|Phase II|Withdrawal by Subject|1|||
156535520|NCT03583450|565055580|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
156535521|NCT03583450|565055581|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
156337108|NCT01696071|564331475|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
156337109|NCT01696071|564331476|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
156535522|NCT05097716|565055586|FG000|Period 1|Adverse Event|1|||
156535523|NCT05097716|565055586|FG000|Period 1|Close contact with highly-transmissible infection|1|||
156535524|NCT00698204|565055587|FG000|Overall Study|Withdrawal by Subject|1|||
156535525|NCT00698204|565055588|FG001|Overall Study|Withdrawal by Subject|0|||
156535526|NCT01949155|565055589|FG000|Overall Study|Lost to Follow-up|1|||
156337110|NCT03298867|564331495|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
156535527|NCT01949155|565055590|FG001|Overall Study|Lost to Follow-up|0|||
156535528|NCT01949155|565055589|FG000|Overall Study|Protocol Violation|1|||
156535529|NCT01949155|565055590|FG001|Overall Study|Protocol Violation|0|||
156535530|NCT00851682|565055595|FG000|Overall Study|screen failure|5|||
156535531|NCT00851682|565055596|FG001|Overall Study|screen failure|0|||
156535532|NCT00800436|565055602|FG000|Overall Study|Withdrawal by Subject|0|||
156535533|NCT00800436|565055603|FG001|Overall Study|Withdrawal by Subject|0|||
156535534|NCT00800436|565055604|FG002|Overall Study|Withdrawal by Subject|1|||
156535535|NCT00800436|565055605|FG003|Overall Study|Withdrawal by Subject|1|||
156535536|NCT00800436|565055606|FG004|Overall Study|Withdrawal by Subject|0|||
156535537|NCT00800436|565055607|FG005|Overall Study|Withdrawal by Subject|0|||
156535538|NCT00800436|565055608|FG006|Overall Study|Withdrawal by Subject|0|||
156535539|NCT00711529|565055615|FG000|Overall Study|Protocol Violation|2|||
156535540|NCT00711529|565055616|FG001|Overall Study|Protocol Violation|0|||
156535541|NCT00711529|565055615|FG000|Overall Study|Withdrawal by Subject|2|||
156535542|NCT00711529|565055616|FG001|Overall Study|Withdrawal by Subject|6|||
156535543|NCT01177384|565055622|FG000|Overall Study|Adverse Event|6|||
156535544|NCT01177384|565055623|FG001|Overall Study|Adverse Event|4|||
156535545|NCT01177384|565055622|FG000|Overall Study|Lack of Efficacy|0|||
156535546|NCT01177384|565055623|FG001|Overall Study|Lack of Efficacy|1|||
156535547|NCT01177384|565055622|FG000|Overall Study|Lost to Follow-up|3|||
156535548|NCT01177384|565055623|FG001|Overall Study|Lost to Follow-up|4|||
156535549|NCT01177384|565055622|FG000|Overall Study|Physician Decision|0|||
156535550|NCT01177384|565055623|FG001|Overall Study|Physician Decision|3|||
156535551|NCT01177384|565055622|FG000|Overall Study|Protocol Violation|0|||
156535552|NCT01177384|565055623|FG001|Overall Study|Protocol Violation|2|||
156535553|NCT01177384|565055622|FG000|Overall Study|Withdrawal by Subject|5|||
156535554|NCT01177384|565055623|FG001|Overall Study|Withdrawal by Subject|12|||
156535555|NCT03606980|565055624|FG000|Overall Study|Lost to Follow-up|3|||
156535556|NCT03606980|565055625|FG001|Overall Study|Lost to Follow-up|2|||
156535557|NCT03606980|565055626|FG002|Overall Study|Lost to Follow-up|3|||
156535558|NCT03606980|565055624|FG000|Overall Study|Withdrawal by Subject|1|||
156535559|NCT03606980|565055625|FG001|Overall Study|Withdrawal by Subject|0|||
156535560|NCT03606980|565055626|FG002|Overall Study|Withdrawal by Subject|4|||
156535561|NCT01849497|565055627|FG000|Overall Study|Withdrawal by Subject|1|||
156535562|NCT01849497|565055628|FG001|Overall Study|Withdrawal by Subject|2|||
156535563|NCT01849497|565055627|FG000|Overall Study|Sponsor Decision|0|||
156535564|NCT01849497|565055628|FG001|Overall Study|Sponsor Decision|1|||
156535565|NCT01849497|565055627|FG000|Overall Study|Lost to Follow-up|0|||
156535566|NCT01849497|565055628|FG001|Overall Study|Lost to Follow-up|1|||
156535567|NCT03044886|565055629|FG000|Overall Study|Lost to Follow-up|15|||
156535568|NCT03044886|565055630|FG001|Overall Study|Lost to Follow-up|10|||
156535569|NCT03044886|565055631|FG002|Overall Study|Lost to Follow-up|12|||
156535570|NCT01174238|565055634|FG000|Overall Study|Lost to Follow-up|2|||
156535571|NCT00732251|565055638|FG000|Overall Study|Lost to Follow-up|3|||
156535572|NCT00732251|565055638|FG000|Overall Study|Withdrawal by Subject|3|||
156535573|NCT00732251|565055638|FG000|Overall Study|Early Term due to Site Closure|1|||
156535574|NCT02684279|565055641|FG000|Overall Study|Adverse Event|87|||
156535575|NCT02684279|565055641|FG000|Overall Study|Lack of Efficacy|4|||
156535576|NCT02684279|565055641|FG000|Overall Study|Lost to Follow-up|61|||
156535577|NCT02684279|565055641|FG000|Overall Study|Protocol Violation|6|||
156535578|NCT02684279|565055641|FG000|Overall Study|Pregnancy|8|||
156535579|NCT02684279|565055641|FG000|Overall Study|Withdrawal by Subject|92|||
156535580|NCT02684279|565055641|FG000|Overall Study|non-compliance with study drug|9|||
156535581|NCT02684279|565055641|FG000|Overall Study|non compliance with study visits|2|||
156535582|NCT02684279|565055641|FG000|Overall Study|subject to have surgery|1|||
156535583|NCT02684279|565055641|FG000|Overall Study|family emergency|1|||
156535584|NCT02684279|565055641|FG000|Overall Study|Site closures|7|||
156535585|NCT02684279|565055641|FG000|Overall Study|Physician Decision|1|||
156535586|NCT00228566|565055642|FG000|Overall Study|Adverse Event|31|||
156535587|NCT00228566|565055642|FG000|Overall Study|Lack of Efficacy|14|||
156535588|NCT00228566|565055642|FG000|Overall Study|Lost to Follow-up|16|||
156535589|NCT00228566|565055642|FG000|Overall Study|Physician Decision|5|||
156535590|NCT00228566|565055642|FG000|Overall Study|Withdrawal by Subject|4|||
156535591|NCT00228566|565055642|FG000|Overall Study|Miscellaneous|1|||
156535592|NCT05975840|565055643|FG000|Overall Study|Other|1|||
156535593|NCT05975840|565055644|FG001|Overall Study|Other|0|||
156535594|NCT05975840|565055645|FG002|Overall Study|Other|0|||
156535595|NCT05975840|565055646|FG003|Overall Study|Other|0|||
156535596|NCT05975840|565055647|FG004|Overall Study|Other|1|||
156535597|NCT05975840|565055648|FG005|Overall Study|Other|0|||
156535598|NCT05975840|565055649|FG006|Overall Study|Other|0|||
156535599|NCT05975840|565055650|FG007|Overall Study|Other|0|||
156535600|NCT05975840|565055643|FG000|Overall Study|Lost to Follow-up|3|||
156535601|NCT05975840|565055644|FG001|Overall Study|Lost to Follow-up|6|||
156535602|NCT05975840|565055645|FG002|Overall Study|Lost to Follow-up|3|||
156535603|NCT05975840|565055646|FG003|Overall Study|Lost to Follow-up|1|||
156535604|NCT05975840|565055647|FG004|Overall Study|Lost to Follow-up|4|||
156535605|NCT05975840|565055648|FG005|Overall Study|Lost to Follow-up|1|||
156535606|NCT05975840|565055649|FG006|Overall Study|Lost to Follow-up|2|||
156535607|NCT05975840|565055650|FG007|Overall Study|Lost to Follow-up|4|||
156535608|NCT05975840|565055643|FG000|Overall Study|Migrated/moved from the study area|1|||
156535609|NCT05975840|565055644|FG001|Overall Study|Migrated/moved from the study area|0|||
156337111|NCT03298867|564331496|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
156337112|NCT03298867|564331495|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
156458655|NCT04076618|564776651|FG000|Overall Study|Lost to Follow-up|2|||
156458656|NCT04076618|564776652|FG001|Overall Study|Lost to Follow-up|1|||
156458657|NCT04076618|564776653|FG002|Overall Study|Lost to Follow-up|3|||
156458658|NCT04076618|564776651|FG000|Overall Study|Withdrawal by Subject|3|||
156458659|NCT04076618|564776652|FG001|Overall Study|Withdrawal by Subject|1|||
156458660|NCT04076618|564776653|FG002|Overall Study|Withdrawal by Subject|2|||
156458661|NCT04076618|564776651|FG000|Overall Study|Relocated out of state|0|||
156458662|NCT04076618|564776652|FG001|Overall Study|Relocated out of state|2|||
156460630|NCT00429364|564781665|FG000|Overall Study|Lost to Follow-up|7|||
156460631|NCT00429364|564781666|FG001|Overall Study|Lost to Follow-up|6|||
156460632|NCT00429364|564781665|FG000|Overall Study|Death|0|||
156460633|NCT00429364|564781666|FG001|Overall Study|Death|1|||
156460634|NCT00429364|564781665|FG000|Overall Study|Underwent aortic root surgery|10|||
156460635|NCT00429364|564781666|FG001|Overall Study|Underwent aortic root surgery|18|||
156460636|NCT00429364|564781665|FG000|Overall Study|Pregnancy|0|||
156460637|NCT00429364|564781666|FG001|Overall Study|Pregnancy|1|||
156460638|NCT04871529|564781667|FG000|Overall Study|Withdrawal by Subject|0|||
156460639|NCT04871529|564781668|FG001|Overall Study|Withdrawal by Subject|1|||
156460640|NCT04871529|564781667|FG000|Overall Study|Death|0|||
156460641|NCT04871529|564781668|FG001|Overall Study|Death|1|||
156460642|NCT04871529|564781667|FG000|Overall Study|Not protocol specified|0|||
156460643|NCT04871529|564781668|FG001|Overall Study|Not protocol specified|1|||
156460644|NCT05184452|564781669|FG000|Overall Study|Lost to Follow-up|0|||
156460645|NCT05184452|564781670|FG001|Overall Study|Lost to Follow-up|0|||
156460646|NCT05184452|564781671|FG002|Overall Study|Lost to Follow-up|0|||
156460647|NCT05184452|564781672|FG003|Overall Study|Lost to Follow-up|0|||
156460648|NCT05184452|564781673|FG004|Overall Study|Lost to Follow-up|0|||
156460649|NCT05184452|564781674|FG005|Overall Study|Lost to Follow-up|2|||
156460650|NCT05184452|564781675|FG006|Overall Study|Lost to Follow-up|0|||
156460651|NCT05184452|564781676|FG007|Overall Study|Lost to Follow-up|0|||
156460652|NCT05184452|564781677|FG008|Overall Study|Lost to Follow-up|0|||
156460653|NCT05184452|564781678|FG009|Overall Study|Lost to Follow-up|1|||
156460654|NCT05184452|564781669|FG000|Overall Study|Withdrawal by Subject|0|||
156460655|NCT05184452|564781670|FG001|Overall Study|Withdrawal by Subject|0|||
156460656|NCT05184452|564781671|FG002|Overall Study|Withdrawal by Subject|0|||
156460657|NCT05184452|564781672|FG003|Overall Study|Withdrawal by Subject|0|||
156460658|NCT05184452|564781673|FG004|Overall Study|Withdrawal by Subject|0|||
156460659|NCT05184452|564781674|FG005|Overall Study|Withdrawal by Subject|1|||
156460660|NCT05184452|564781675|FG006|Overall Study|Withdrawal by Subject|0|||
156460661|NCT05184452|564781676|FG007|Overall Study|Withdrawal by Subject|0|||
156460662|NCT05184452|564781677|FG008|Overall Study|Withdrawal by Subject|0|||
156460663|NCT05184452|564781678|FG009|Overall Study|Withdrawal by Subject|1|||
156460664|NCT05586490|564781679|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
156460665|NCT05586490|564781680|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
156460666|NCT05586490|564781681|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
156460667|NCT05586490|564781682|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
156460668|NCT05586490|564781683|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
156460669|NCT05586490|564781679|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
156460670|NCT05586490|564781680|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
156460671|NCT05586490|564781681|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
156460672|NCT05586490|564781682|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
156460673|NCT05586490|564781683|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
156460674|NCT05586490|564781679|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
156460675|NCT05586490|564781680|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
156460676|NCT05586490|564781681|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
156460677|NCT05586490|564781682|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
156460678|NCT05586490|564781683|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
156460679|NCT05873556|564781684|FG000|Overall Study|Lost to Follow-up|4|||
156460680|NCT05873556|564781685|FG001|Overall Study|Lost to Follow-up|1|||
156460681|NCT03606408|564781687|FG000|Overall Study|Adverse Event|13|||
156460682|NCT03606408|564781687|FG000|Overall Study|Withdrawal by Subject|7|||
156460683|NCT03606408|564781687|FG000|Overall Study|Physician Decision|4|||
156460684|NCT03606408|564781687|FG000|Overall Study|Lack of Efficacy|2|||
156460685|NCT03606408|564781687|FG000|Overall Study|Death|1|||
156460686|NCT03606408|564781687|FG000|Overall Study|new therapy for study indication|1|||
156460687|NCT04689256|564781688|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
156535610|NCT05975840|565055645|FG002|Overall Study|Migrated/moved from the study area|0|||
156535611|NCT05975840|565055646|FG003|Overall Study|Migrated/moved from the study area|0|||
156535612|NCT05975840|565055647|FG004|Overall Study|Migrated/moved from the study area|0|||
156535613|NCT05975840|565055648|FG005|Overall Study|Migrated/moved from the study area|0|||
156535614|NCT05975840|565055649|FG006|Overall Study|Migrated/moved from the study area|0|||
156535615|NCT05975840|565055650|FG007|Overall Study|Migrated/moved from the study area|0|||
156535616|NCT05975840|565055643|FG000|Overall Study|Withdrawal by Subject|0|||
156535617|NCT05975840|565055644|FG001|Overall Study|Withdrawal by Subject|5|||
156535618|NCT05975840|565055645|FG002|Overall Study|Withdrawal by Subject|2|||
156535619|NCT05975840|565055646|FG003|Overall Study|Withdrawal by Subject|2|||
156535620|NCT05975840|565055647|FG004|Overall Study|Withdrawal by Subject|0|||
156535621|NCT05975840|565055648|FG005|Overall Study|Withdrawal by Subject|2|||
156535622|NCT05975840|565055649|FG006|Overall Study|Withdrawal by Subject|2|||
156535623|NCT05975840|565055650|FG007|Overall Study|Withdrawal by Subject|1|||
156535624|NCT05975840|565055643|FG000|Overall Study|Protocol Violation|0|||
156535625|NCT05975840|565055644|FG001|Overall Study|Protocol Violation|1|||
156535626|NCT05975840|565055645|FG002|Overall Study|Protocol Violation|0|||
156535627|NCT05975840|565055646|FG003|Overall Study|Protocol Violation|0|||
156535628|NCT05975840|565055647|FG004|Overall Study|Protocol Violation|0|||
156535629|NCT05975840|565055648|FG005|Overall Study|Protocol Violation|0|||
156535630|NCT05975840|565055649|FG006|Overall Study|Protocol Violation|0|||
156535631|NCT05975840|565055650|FG007|Overall Study|Protocol Violation|0|||
156535632|NCT05975840|565055643|FG000|Overall Study|Adverse Event|0|||
156535633|NCT05975840|565055644|FG001|Overall Study|Adverse Event|0|||
156535634|NCT05975840|565055645|FG002|Overall Study|Adverse Event|0|||
156535635|NCT05975840|565055646|FG003|Overall Study|Adverse Event|1|||
156535636|NCT05975840|565055647|FG004|Overall Study|Adverse Event|0|||
156535637|NCT05975840|565055648|FG005|Overall Study|Adverse Event|0|||
156535638|NCT05975840|565055649|FG006|Overall Study|Adverse Event|0|||
156535639|NCT05975840|565055650|FG007|Overall Study|Adverse Event|0|||
156535640|NCT05975840|565055643|FG000|Overall Study|Death|0|||
156535641|NCT05975840|565055644|FG001|Overall Study|Death|1|||
156535642|NCT05975840|565055645|FG002|Overall Study|Death|0|||
156535643|NCT05975840|565055646|FG003|Overall Study|Death|0|||
156535644|NCT05975840|565055647|FG004|Overall Study|Death|0|||
156535645|NCT05975840|565055648|FG005|Overall Study|Death|0|||
156535646|NCT05975840|565055649|FG006|Overall Study|Death|0|||
156535647|NCT05975840|565055650|FG007|Overall Study|Death|1|||
156535648|NCT04196803|565057557|FG000|Overall Study|Withdrawal by Subject|1|||
156535649|NCT04196803|565057558|FG001|Overall Study|Withdrawal by Subject|3|||
156535650|NCT04196803|565057557|FG000|Overall Study|Adverse Event|4|||
156535651|NCT04196803|565057558|FG001|Overall Study|Adverse Event|2|||
156535652|NCT04196803|565057557|FG000|Overall Study|Lost to Follow-up|0|||
156535653|NCT04196803|565057558|FG001|Overall Study|Lost to Follow-up|1|||
156535654|NCT01022996|565057559|FG000|Overall Study|Adverse Event|14|||
156535655|NCT01022996|565057559|FG000|Overall Study|Withdrawal by Subject|3|||
156535656|NCT01022996|565057559|FG000|Overall Study|Lost to Follow-up|1|||
156535657|NCT01022996|565057559|FG000|Overall Study|Administrative problems|6|||
156535658|NCT01022996|565057559|FG000|Overall Study|Disease Progression|32|||
156535659|NCT01022996|565057559|FG000|Overall Study|Protocol Violation|1|||
156535660|NCT02767323|565057560|FG000|Overall Study|Withdrawal by Subject|17|||
156535661|NCT02767323|565057561|FG001|Overall Study|Withdrawal by Subject|5|||
156535662|NCT02767323|565057562|FG002|Overall Study|Withdrawal by Subject|13|||
156535663|NCT02767323|565057563|FG003|Overall Study|Withdrawal by Subject|0|||
156535664|NCT02767323|565057560|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
156535665|NCT02767323|565057561|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
156535666|NCT02767323|565057562|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
156535667|NCT02767323|565057563|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
156535668|NCT00930722|565057564|FG000|Overall Study|Lost to Follow-up|16|||
156535669|NCT00930722|565057564|FG000|Overall Study|No longer willing to participate|9|||
156535670|NCT00930722|565057564|FG000|Overall Study|Study terminated by sponsor|2|||
156535671|NCT02230254|565057565|FG000|Overall Study|Lost to Follow-up|3|||
156535672|NCT03523728|565057566|FG000|Stage 1 (24 Months)|Adverse Event|2|||
156535673|NCT03523728|565057567|FG001|Stage 1 (24 Months)|Adverse Event|2|||
156535674|NCT03523728|565057568|FG002|Stage 1 (24 Months)|Adverse Event|4|||
156744791|NCT04526574|565813268|FG000|Overall Study|Withdrawal by Subject|12|||
156744792|NCT04526574|565813269|FG001|Overall Study|Withdrawal by Subject|9|||
156744793|NCT04526574|565813268|FG000|Overall Study|Other|1|||
156744794|NCT04526574|565813269|FG001|Overall Study|Other|2|||
156744795|NCT04526574|565813268|FG000|Overall Study|Adverse Event|1|||
156535675|NCT03523728|565057569|FG003|Stage 1 (24 Months)|Adverse Event|0|||
156535676|NCT03523728|565057570|FG004|Stage 1 (24 Months)|Adverse Event|0|||
156535677|NCT03523728|565057566|FG000|Stage 1 (24 Months)|Progressive disease|0|||
156535678|NCT03523728|565057567|FG001|Stage 1 (24 Months)|Progressive disease|0|||
156535679|NCT03523728|565057568|FG002|Stage 1 (24 Months)|Progressive disease|1|||
156535680|NCT03523728|565057569|FG003|Stage 1 (24 Months)|Progressive disease|0|||
156535681|NCT03523728|565057570|FG004|Stage 1 (24 Months)|Progressive disease|0|||
156535682|NCT03523728|565057566|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
156535683|NCT03523728|565057567|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
156535684|NCT03523728|565057568|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
156535685|NCT03523728|565057569|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
156535686|NCT03523728|565057570|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
156535687|NCT03523728|565057566|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
156535688|NCT03523728|565057567|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
156535689|NCT03523728|565057568|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
156535690|NCT03523728|565057569|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
156535691|NCT03523728|565057570|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
156535692|NCT03523728|565057566|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
156535693|NCT03523728|565057567|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
156535694|NCT03523728|565057568|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
156535695|NCT03523728|565057569|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
156535696|NCT03523728|565057570|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
156535697|NCT03523728|565057566|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
156535698|NCT03523728|565057567|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
156535699|NCT03523728|565057568|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
156535700|NCT03523728|565057569|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
156535701|NCT03523728|565057570|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
156535702|NCT03523728|565057566|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
156535703|NCT03523728|565057567|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
156535704|NCT03523728|565057568|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
156535705|NCT03523728|565057569|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
156535706|NCT03523728|565057570|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
156535707|NCT03523728|565057566|FG000|Stage 2 (24 Months)|Adverse Event|0|||
156535708|NCT03523728|565057567|FG001|Stage 2 (24 Months)|Adverse Event|0|||
156535709|NCT03523728|565057568|FG002|Stage 2 (24 Months)|Adverse Event|0|||
156535710|NCT03523728|565057569|FG003|Stage 2 (24 Months)|Adverse Event|1|||
156535711|NCT03523728|565057570|FG004|Stage 2 (24 Months)|Adverse Event|2|||
156535712|NCT03523728|565057566|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
156535713|NCT03523728|565057567|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
156535714|NCT03523728|565057568|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
156535715|NCT03523728|565057569|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
156535716|NCT03523728|565057570|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
156535717|NCT03523728|565057566|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
156535718|NCT03523728|565057567|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
156535719|NCT03523728|565057568|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
156535720|NCT03523728|565057569|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
156535721|NCT03523728|565057570|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
156535722|NCT03523728|565057566|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
156535723|NCT03523728|565057567|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
156535724|NCT03523728|565057568|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
156535725|NCT03523728|565057569|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
156535726|NCT03523728|565057570|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
156535727|NCT03523728|565057566|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
156535728|NCT03523728|565057567|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
156535729|NCT03523728|565057568|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
156535730|NCT03523728|565057569|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
156535731|NCT03523728|565057570|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
156535732|NCT00419120|565057573|FG000|Long Term Follow up Period|study ongoing|10|||
156535733|NCT02667275|565057576|FG000|Overall Study|Protocol Violation|11|||
156535734|NCT02667275|565057577|FG001|Overall Study|Protocol Violation|7|||
156535735|NCT02667275|565057576|FG000|Overall Study|Lost to Follow-up|0|||
156535736|NCT02667275|565057577|FG001|Overall Study|Lost to Follow-up|2|||
156535737|NCT02667275|565057576|FG000|Overall Study|Withdrawal by Subject|0|||
156535738|NCT02667275|565057577|FG001|Overall Study|Withdrawal by Subject|5|||
156535739|NCT02667275|565057576|FG000|Overall Study|Discontinued early without completing|0|||
156535740|NCT02667275|565057577|FG001|Overall Study|Discontinued early without completing|1|||
156535741|NCT01756040|565057578|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
156535742|NCT01756040|565057578|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
156535743|NCT01756040|565057578|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
156535744|NCT01274715|565057579|FG000|Overall Study|Lost to Follow-up|1|||
156535745|NCT01274715|565057579|FG000|Overall Study|After consent, met exclusion criteria.|1|||
156535746|NCT01274715|565057579|FG000|Overall Study|After consent, met exclusion criteria.|1|||
156535747|NCT01274715|565057579|FG000|Overall Study|After consent, met exclusion criteria.|1|||
156744796|NCT04526574|565813269|FG001|Overall Study|Adverse Event|1|||
156744797|NCT04526574|565813268|FG000|Overall Study|Death|2|||
156535748|NCT04479436|565057580|FG000|Overall Study|Progressive disease|26|||
156535749|NCT04479436|565057581|FG001|Overall Study|Progressive disease|1|||
156535750|NCT04479436|565057580|FG000|Overall Study|Adverse Event|6|||
156535751|NCT04479436|565057581|FG001|Overall Study|Adverse Event|0|||
156535752|NCT04479436|565057580|FG000|Overall Study|Withdrawal by Subject|5|||
156535753|NCT04479436|565057581|FG001|Overall Study|Withdrawal by Subject|0|||
156458663|NCT04076618|564776653|FG002|Overall Study|Relocated out of state|0|||
156458664|NCT04076618|564776651|FG000|Overall Study|COVID concerns|0|||
156458665|NCT04076618|564776652|FG001|Overall Study|COVID concerns|1|||
156458666|NCT04076618|564776653|FG002|Overall Study|COVID concerns|0|||
156458667|NCT04076618|564776651|FG000|Overall Study|Adverse Event|0|||
156458668|NCT04076618|564776652|FG001|Overall Study|Adverse Event|0|||
156458669|NCT04076618|564776653|FG002|Overall Study|Adverse Event|2|||
156458670|NCT01928394|564776654|FG000|Treatment Period|Disease progression|17|||
156458671|NCT01928394|564776655|FG001|Treatment Period|Disease progression|2|||
156458672|NCT01928394|564776656|FG002|Treatment Period|Disease progression|12|||
156458673|NCT01928394|564776657|FG003|Treatment Period|Disease progression|48|||
156458674|NCT01928394|564776658|FG004|Treatment Period|Disease progression|3|||
156458675|NCT01928394|564776659|FG005|Treatment Period|Disease progression|25|||
156458676|NCT01928394|564776660|FG006|Treatment Period|Disease progression|38|||
156458677|NCT01928394|564776661|FG007|Treatment Period|Disease progression|16|||
156458678|NCT01928394|564776662|FG008|Treatment Period|Disease progression|3|||
156458679|NCT01928394|564776663|FG009|Treatment Period|Disease progression|11|||
156458680|NCT01928394|564776664|FG010|Treatment Period|Disease progression|22|||
156458681|NCT01928394|564776665|FG011|Treatment Period|Disease progression|73|||
156458682|NCT01928394|564776666|FG012|Treatment Period|Disease progression|38|||
156458683|NCT01928394|564776667|FG013|Treatment Period|Disease progression|118|||
156458684|NCT01928394|564776668|FG014|Treatment Period|Disease progression|59|||
156458685|NCT01928394|564776669|FG015|Treatment Period|Disease progression|1|||
156458686|NCT01928394|564776670|FG016|Treatment Period|Disease progression|43|||
156458687|NCT01928394|564776671|FG017|Treatment Period|Disease progression|56|||
156458688|NCT01928394|564776672|FG018|Treatment Period|Disease progression|50|||
156458689|NCT01928394|564776673|FG019|Treatment Period|Disease progression|71|||
156458690|NCT01928394|564776674|FG020|Treatment Period|Disease progression|30|||
156458691|NCT01928394|564776675|FG021|Treatment Period|Disease progression|31|||
156458692|NCT01928394|564776676|FG022|Treatment Period|Disease progression|31|||
156458693|NCT01928394|564776654|FG000|Treatment Period|Study drug toxicity|1|||
156458694|NCT01928394|564776655|FG001|Treatment Period|Study drug toxicity|1|||
156458695|NCT01928394|564776656|FG002|Treatment Period|Study drug toxicity|3|||
156458696|NCT01928394|564776657|FG003|Treatment Period|Study drug toxicity|3|||
156458697|NCT01928394|564776658|FG004|Treatment Period|Study drug toxicity|0|||
156458698|NCT01928394|564776659|FG005|Treatment Period|Study drug toxicity|9|||
156458699|NCT01928394|564776660|FG006|Treatment Period|Study drug toxicity|7|||
156458700|NCT01928394|564776661|FG007|Treatment Period|Study drug toxicity|1|||
156458701|NCT01928394|564776662|FG008|Treatment Period|Study drug toxicity|0|||
156458702|NCT01928394|564776663|FG009|Treatment Period|Study drug toxicity|5|||
156458703|NCT01928394|564776664|FG010|Treatment Period|Study drug toxicity|2|||
156458704|NCT01928394|564776665|FG011|Treatment Period|Study drug toxicity|3|||
156458705|NCT01928394|564776666|FG012|Treatment Period|Study drug toxicity|7|||
156458706|NCT01928394|564776667|FG013|Treatment Period|Study drug toxicity|5|||
156458707|NCT01928394|564776668|FG014|Treatment Period|Study drug toxicity|12|||
156458708|NCT01928394|564776669|FG015|Treatment Period|Study drug toxicity|0|||
156458709|NCT01928394|564776670|FG016|Treatment Period|Study drug toxicity|3|||
156458710|NCT01928394|564776671|FG017|Treatment Period|Study drug toxicity|3|||
156458711|NCT01928394|564776672|FG018|Treatment Period|Study drug toxicity|12|||
156458712|NCT01928394|564776673|FG019|Treatment Period|Study drug toxicity|15|||
156458713|NCT01928394|564776674|FG020|Treatment Period|Study drug toxicity|4|||
156458714|NCT01928394|564776675|FG021|Treatment Period|Study drug toxicity|7|||
156458715|NCT01928394|564776676|FG022|Treatment Period|Study drug toxicity|4|||
156458716|NCT01928394|564776654|FG000|Treatment Period|AE unrelated to study drug|0|||
156458717|NCT01928394|564776655|FG001|Treatment Period|AE unrelated to study drug|0|||
156458718|NCT01928394|564776656|FG002|Treatment Period|AE unrelated to study drug|2|||
156458719|NCT01928394|564776657|FG003|Treatment Period|AE unrelated to study drug|3|||
156458720|NCT01928394|564776658|FG004|Treatment Period|AE unrelated to study drug|0|||
156458721|NCT01928394|564776659|FG005|Treatment Period|AE unrelated to study drug|5|||
156458722|NCT01928394|564776660|FG006|Treatment Period|AE unrelated to study drug|1|||
156458723|NCT01928394|564776661|FG007|Treatment Period|AE unrelated to study drug|0|||
156458724|NCT01928394|564776662|FG008|Treatment Period|AE unrelated to study drug|0|||
156458725|NCT01928394|564776663|FG009|Treatment Period|AE unrelated to study drug|2|||
156458726|NCT01928394|564776664|FG010|Treatment Period|AE unrelated to study drug|0|||
156458727|NCT01928394|564776665|FG011|Treatment Period|AE unrelated to study drug|12|||
156458728|NCT01928394|564776666|FG012|Treatment Period|AE unrelated to study drug|6|||
156458729|NCT01928394|564776667|FG013|Treatment Period|AE unrelated to study drug|13|||
156458730|NCT01928394|564776668|FG014|Treatment Period|AE unrelated to study drug|6|||
156458731|NCT01928394|564776669|FG015|Treatment Period|AE unrelated to study drug|1|||
156458732|NCT01928394|564776670|FG016|Treatment Period|AE unrelated to study drug|1|||
156458733|NCT01928394|564776671|FG017|Treatment Period|AE unrelated to study drug|6|||
156458734|NCT01928394|564776672|FG018|Treatment Period|AE unrelated to study drug|3|||
156458735|NCT01928394|564776673|FG019|Treatment Period|AE unrelated to study drug|5|||
156458736|NCT01928394|564776674|FG020|Treatment Period|AE unrelated to study drug|1|||
156458737|NCT01928394|564776675|FG021|Treatment Period|AE unrelated to study drug|1|||
156458738|NCT01928394|564776676|FG022|Treatment Period|AE unrelated to study drug|0|||
156458739|NCT01928394|564776654|FG000|Treatment Period|Participant request to stop therapy|0|||
156458740|NCT01928394|564776655|FG001|Treatment Period|Participant request to stop therapy|0|||
156458741|NCT01928394|564776656|FG002|Treatment Period|Participant request to stop therapy|0|||
156458742|NCT01928394|564776657|FG003|Treatment Period|Participant request to stop therapy|0|||
156458743|NCT01928394|564776658|FG004|Treatment Period|Participant request to stop therapy|0|||
156458744|NCT01928394|564776659|FG005|Treatment Period|Participant request to stop therapy|3|||
156458745|NCT01928394|564776660|FG006|Treatment Period|Participant request to stop therapy|3|||
156458746|NCT01928394|564776661|FG007|Treatment Period|Participant request to stop therapy|0|||
156458747|NCT01928394|564776662|FG008|Treatment Period|Participant request to stop therapy|0|||
156458748|NCT01928394|564776663|FG009|Treatment Period|Participant request to stop therapy|0|||
156458749|NCT01928394|564776664|FG010|Treatment Period|Participant request to stop therapy|3|||
156458750|NCT01928394|564776665|FG011|Treatment Period|Participant request to stop therapy|2|||
156458751|NCT01928394|564776666|FG012|Treatment Period|Participant request to stop therapy|1|||
156458752|NCT01928394|564776667|FG013|Treatment Period|Participant request to stop therapy|2|||
156458753|NCT01928394|564776668|FG014|Treatment Period|Participant request to stop therapy|4|||
156458754|NCT01928394|564776669|FG015|Treatment Period|Participant request to stop therapy|0|||
156458755|NCT01928394|564776670|FG016|Treatment Period|Participant request to stop therapy|1|||
156458756|NCT01928394|564776671|FG017|Treatment Period|Participant request to stop therapy|3|||
156458757|NCT01928394|564776672|FG018|Treatment Period|Participant request to stop therapy|1|||
156458758|NCT01928394|564776673|FG019|Treatment Period|Participant request to stop therapy|1|||
156744798|NCT04526574|565813269|FG001|Overall Study|Death|3|||
156744799|NCT04526574|565813268|FG000|Overall Study|Lost to Follow-up|9|||
156535754|NCT04479436|565057580|FG000|Overall Study|Clinical progression|1|||
156535755|NCT04479436|565057581|FG001|Overall Study|Clinical progression|0|||
156535756|NCT04479436|565057580|FG000|Overall Study|Physician Decision|1|||
156535757|NCT04479436|565057581|FG001|Overall Study|Physician Decision|0|||
156535758|NCT01186939|565057586|FG000|Overall Study|Death|7|||
156535759|NCT01186939|565057586|FG000|Overall Study|Withdrawal by Subject|2|||
156535760|NCT01186939|565057586|FG000|Overall Study|No longer receiving clinical benefit|17|||
156535761|NCT01186939|565057586|FG000|Overall Study|Program closed|5|||
156535762|NCT01186939|565057586|FG000|Overall Study|Sponsor decision|4|||
156535763|NCT01186939|565057586|FG000|Overall Study|Started additional treatment|1|||
156535764|NCT01186939|565057586|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
156535765|NCT01186939|565057586|FG000|Overall Study|Myocardial infarction|1|||
156535766|NCT01186939|565057586|FG000|Overall Study|Bone marrow transplant|1|||
156535767|NCT01186939|565057586|FG000|Overall Study|Transformation to AML|1|||
156535768|NCT03945591|565057589|FG000|Overall Study|Participant not transplanted|1|||
156535769|NCT03945591|565057589|FG000|Overall Study|Change in treatment plan|3|||
156535770|NCT03945591|565057589|FG000|Overall Study|Adverse Event|1|||
156535771|NCT00791258|565057592|FG000|Overall Study|Adverse Event|87|||
156535772|NCT00791258|565057592|FG000|Overall Study|Lost to Follow-up|18|||
156535773|NCT00791258|565057592|FG000|Overall Study|Protocol Violation|109|||
156535774|NCT00791258|565057592|FG000|Overall Study|Withdrawal by Subject|40|||
156535775|NCT00791258|565057592|FG000|Overall Study|Did not take medication for >3 days|1|||
156535776|NCT00791258|565057592|FG000|Overall Study|subject left area|2|||
156535777|NCT00791258|565057592|FG000|Overall Study|non-compliance|3|||
156535778|NCT00791258|565057592|FG000|Overall Study|Subject incarcerated|1|||
156535779|NCT00791258|565057592|FG000|Overall Study|Subject required restricted medication|1|||
156535780|NCT00791258|565057592|FG000|Overall Study|Lack of Efficacy|1|||
156535781|NCT00436618|565057593|FG000|Overall Study|Withdrawal by Subject|5|||
156535782|NCT00436618|565057594|FG001|Overall Study|Withdrawal by Subject|8|||
156535783|NCT00436618|565057595|FG002|Overall Study|Withdrawal by Subject|11|||
156535784|NCT00436618|565057593|FG000|Overall Study|Adverse Event|8|||
156535785|NCT00436618|565057594|FG001|Overall Study|Adverse Event|8|||
156535786|NCT00436618|565057595|FG002|Overall Study|Adverse Event|9|||
156535787|NCT00436618|565057593|FG000|Overall Study|Alternate Treatment|3|||
156535788|NCT00436618|565057594|FG001|Overall Study|Alternate Treatment|4|||
156535789|NCT00436618|565057595|FG002|Overall Study|Alternate Treatment|12|||
156535790|NCT00436618|565057593|FG000|Overall Study|Other Medical Problems|3|||
156535791|NCT00436618|565057594|FG001|Overall Study|Other Medical Problems|1|||
156535792|NCT00436618|565057595|FG002|Overall Study|Other Medical Problems|7|||
156535793|NCT00436618|565057593|FG000|Overall Study|Death|4|||
156535794|NCT00436618|565057594|FG001|Overall Study|Death|2|||
156535795|NCT00436618|565057595|FG002|Overall Study|Death|3|||
156535796|NCT00436618|565057593|FG000|Overall Study|New Primary or Other Reasons|6|||
156535797|NCT00436618|565057594|FG001|Overall Study|New Primary or Other Reasons|2|||
156535798|NCT00436618|565057595|FG002|Overall Study|New Primary or Other Reasons|12|||
156535799|NCT00436618|565057593|FG000|Overall Study|Still on treatment|1|||
156535800|NCT00436618|565057594|FG001|Overall Study|Still on treatment|2|||
156535801|NCT00436618|565057595|FG002|Overall Study|Still on treatment|7|||
156535802|NCT01179672|565057596|FG000|Overall Study|Adverse Event|17|||
156535803|NCT01179672|565057597|FG001|Overall Study|Adverse Event|8|||
156535804|NCT01179672|565057596|FG000|Overall Study|Withdrawal by Subject|10|||
156535805|NCT01179672|565057597|FG001|Overall Study|Withdrawal by Subject|12|||
156535806|NCT01179672|565057596|FG000|Overall Study|Entry Criteria Not Met|0|||
156535807|NCT01179672|565057597|FG001|Overall Study|Entry Criteria Not Met|2|||
156535808|NCT01179672|565057596|FG000|Overall Study|Lost to Follow-up|0|||
156535809|NCT01179672|565057597|FG001|Overall Study|Lost to Follow-up|1|||
156535810|NCT01179672|565057596|FG000|Overall Study|Protocol Violation|2|||
156535811|NCT01179672|565057597|FG001|Overall Study|Protocol Violation|2|||
156535812|NCT01179672|565057596|FG000|Overall Study|Physician Decision|1|||
156535813|NCT01179672|565057597|FG001|Overall Study|Physician Decision|1|||
156535814|NCT01994382|565057598|FG000|Overall Study|Informed consent withdrawn|0|||
156535815|NCT01994382|565057599|FG001|Overall Study|Informed consent withdrawn|0|||
156535816|NCT01994382|565057600|FG002|Overall Study|Informed consent withdrawn|0|||
156535817|NCT01994382|565057601|FG003|Overall Study|Informed consent withdrawn|0|||
156535818|NCT01994382|565057602|FG004|Overall Study|Informed consent withdrawn|0|||
156535819|NCT01994382|565057603|FG005|Overall Study|Informed consent withdrawn|0|||
156535820|NCT01994382|565057604|FG006|Overall Study|Informed consent withdrawn|1|||
156535821|NCT01994382|565057605|FG007|Overall Study|Informed consent withdrawn|0|||
156535822|NCT01994382|565057606|FG008|Overall Study|Informed consent withdrawn|0|||
156535823|NCT01994382|565057607|FG009|Overall Study|Informed consent withdrawn|0|||
156535824|NCT01994382|565057608|FG010|Overall Study|Informed consent withdrawn|0|||
156535825|NCT01994382|565057609|FG011|Overall Study|Informed consent withdrawn|0|||
156535826|NCT01994382|565057610|FG012|Overall Study|Informed consent withdrawn|0|||
156535827|NCT01994382|565057611|FG013|Overall Study|Informed consent withdrawn|0|||
156535828|NCT01994382|565057612|FG014|Overall Study|Informed consent withdrawn|0|||
156535829|NCT01994382|565057613|FG015|Overall Study|Informed consent withdrawn|0|||
156535830|NCT01994382|565057614|FG016|Overall Study|Informed consent withdrawn|0|||
156535831|NCT01994382|565057598|FG000|Overall Study|Progressive disease|3|||
156535832|NCT01994382|565057599|FG001|Overall Study|Progressive disease|4|||
156535833|NCT01994382|565057600|FG002|Overall Study|Progressive disease|4|||
156535834|NCT01994382|565057601|FG003|Overall Study|Progressive disease|3|||
156535835|NCT01994382|565057602|FG004|Overall Study|Progressive disease|2|||
156337113|NCT03298867|564331496|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
156337114|NCT03298867|564331495|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
156535836|NCT01994382|565057603|FG005|Overall Study|Progressive disease|3|||
156744800|NCT04526574|565813269|FG001|Overall Study|Lost to Follow-up|9|||
156744801|NCT04526574|565813268|FG000|Overall Study|No longer meets eligibility criteria|8|||
156744802|NCT04526574|565813269|FG001|Overall Study|No longer meets eligibility criteria|8|||
156744803|NCT00006305|565813270|FG000|Overall Study|Withdrawal by Subject|17|||
156744804|NCT00006305|565813271|FG001|Overall Study|Withdrawal by Subject|10|||
156744805|NCT00006305|565813272|FG002|Overall Study|Withdrawal by Subject|15|||
156744806|NCT00006305|565813273|FG003|Overall Study|Withdrawal by Subject|14|||
156744807|NCT00662558|565813274|FG000|Overall Study|Adverse Event|21|||
156744808|NCT00662558|565813275|FG001|Overall Study|Adverse Event|59|||
156799129|NCT00673920|566018932|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799130|NCT00673920|566018925|FG000|Baseline up to Week 48|Administrative/Other|0|||
156799131|NCT00673920|566018926|FG001|Baseline up to Week 48|Administrative/Other|1|||
156799132|NCT00673920|566018927|FG002|Baseline up to Week 48|Administrative/Other|2|||
156799133|NCT00673920|566018928|FG003|Baseline up to Week 48|Administrative/Other|0|||
156799134|NCT00673920|566018929|FG004|Baseline up to Week 48|Administrative/Other|0|||
156799135|NCT00673920|566018930|FG005|Baseline up to Week 48|Administrative/Other|0|||
156799136|NCT00673920|566018931|FG006|Baseline up to Week 48|Administrative/Other|0|||
156799137|NCT00673920|566018932|FG007|Baseline up to Week 48|Administrative/Other|0|||
156799138|NCT00673920|566018925|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799139|NCT00673920|566018926|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
156799140|NCT00673920|566018927|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
156799141|NCT00673920|566018928|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799142|NCT00673920|566018929|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799143|NCT00673920|566018930|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799144|NCT00673920|566018931|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799145|NCT00673920|566018932|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799146|NCT00673920|566018925|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799147|NCT00673920|566018926|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799148|NCT00673920|566018927|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799149|NCT00673920|566018928|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799150|NCT00673920|566018929|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799151|NCT00673920|566018930|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799152|NCT00673920|566018931|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
156799153|NCT00673920|566018932|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799154|NCT00673920|566018925|FG000|Week 24 to Week 48|Failure to return|0|||
156799155|NCT00673920|566018926|FG001|Week 24 to Week 48|Failure to return|0|||
156799156|NCT00673920|566018927|FG002|Week 24 to Week 48|Failure to return|0|||
156799157|NCT00673920|566018928|FG003|Week 24 to Week 48|Failure to return|0|||
156799158|NCT00673920|566018929|FG004|Week 24 to Week 48|Failure to return|0|||
156799159|NCT00673920|566018930|FG005|Week 24 to Week 48|Failure to return|1|||
156799160|NCT00673920|566018931|FG006|Week 24 to Week 48|Failure to return|0|||
156799161|NCT00673920|566018932|FG007|Week 24 to Week 48|Failure to return|0|||
156799162|NCT00673920|566018925|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799163|NCT00673920|566018926|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799164|NCT00673920|566018927|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799165|NCT00673920|566018928|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799166|NCT00673920|566018929|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799167|NCT00673920|566018930|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
156799168|NCT00673920|566018931|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799169|NCT00673920|566018932|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799170|NCT00673920|566018925|FG000|Week 24 to Week 48|Death|0|||
156799171|NCT00673920|566018926|FG001|Week 24 to Week 48|Death|0|||
156799172|NCT00673920|566018927|FG002|Week 24 to Week 48|Death|0|||
156799173|NCT00673920|566018928|FG003|Week 24 to Week 48|Death|0|||
156799174|NCT00673920|566018929|FG004|Week 24 to Week 48|Death|0|||
156799175|NCT00673920|566018930|FG005|Week 24 to Week 48|Death|1|||
156799176|NCT00673920|566018931|FG006|Week 24 to Week 48|Death|0|||
156799177|NCT00673920|566018932|FG007|Week 24 to Week 48|Death|0|||
156799178|NCT00673920|566018925|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
156799179|NCT00673920|566018926|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
156799180|NCT00673920|566018927|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
156535837|NCT01994382|565057604|FG006|Overall Study|Progressive disease|3|||
156535838|NCT01994382|565057605|FG007|Overall Study|Progressive disease|6|||
156535839|NCT01994382|565057606|FG008|Overall Study|Progressive disease|2|||
156535840|NCT01994382|565057607|FG009|Overall Study|Progressive disease|2|||
156535841|NCT01994382|565057608|FG010|Overall Study|Progressive disease|13|||
156535842|NCT01994382|565057609|FG011|Overall Study|Progressive disease|8|||
156535843|NCT01994382|565057610|FG012|Overall Study|Progressive disease|7|||
156535844|NCT01994382|565057611|FG013|Overall Study|Progressive disease|3|||
156535845|NCT01994382|565057612|FG014|Overall Study|Progressive disease|6|||
156535846|NCT01994382|565057613|FG015|Overall Study|Progressive disease|44|||
156535847|NCT01994382|565057614|FG016|Overall Study|Progressive disease|28|||
156535848|NCT01994382|565057598|FG000|Overall Study|Physician Decision|0|||
156535849|NCT01994382|565057599|FG001|Overall Study|Physician Decision|1|||
156535850|NCT01994382|565057600|FG002|Overall Study|Physician Decision|0|||
156535851|NCT01994382|565057601|FG003|Overall Study|Physician Decision|0|||
156535852|NCT01994382|565057602|FG004|Overall Study|Physician Decision|0|||
156535853|NCT01994382|565057603|FG005|Overall Study|Physician Decision|0|||
156535854|NCT01994382|565057604|FG006|Overall Study|Physician Decision|0|||
156535855|NCT01994382|565057605|FG007|Overall Study|Physician Decision|0|||
156535856|NCT01994382|565057606|FG008|Overall Study|Physician Decision|0|||
156535857|NCT01994382|565057607|FG009|Overall Study|Physician Decision|0|||
156535858|NCT01994382|565057608|FG010|Overall Study|Physician Decision|3|||
156535859|NCT01994382|565057609|FG011|Overall Study|Physician Decision|1|||
156535860|NCT01994382|565057610|FG012|Overall Study|Physician Decision|1|||
156535861|NCT01994382|565057611|FG013|Overall Study|Physician Decision|0|||
156535862|NCT01994382|565057612|FG014|Overall Study|Physician Decision|1|||
156535863|NCT01994382|565057613|FG015|Overall Study|Physician Decision|4|||
156535864|NCT01994382|565057614|FG016|Overall Study|Physician Decision|2|||
156535865|NCT01994382|565057598|FG000|Overall Study|Death|0|||
156535866|NCT01994382|565057599|FG001|Overall Study|Death|0|||
156535867|NCT01994382|565057600|FG002|Overall Study|Death|0|||
156535868|NCT01994382|565057601|FG003|Overall Study|Death|0|||
156535869|NCT01994382|565057602|FG004|Overall Study|Death|1|||
156535870|NCT01994382|565057603|FG005|Overall Study|Death|0|||
156535871|NCT01994382|565057604|FG006|Overall Study|Death|0|||
156535872|NCT01994382|565057605|FG007|Overall Study|Death|0|||
156535873|NCT01994382|565057606|FG008|Overall Study|Death|1|||
156535874|NCT01994382|565057607|FG009|Overall Study|Death|1|||
156535875|NCT01994382|565057608|FG010|Overall Study|Death|0|||
156535876|NCT01994382|565057609|FG011|Overall Study|Death|0|||
156535877|NCT01994382|565057610|FG012|Overall Study|Death|0|||
156535878|NCT01994382|565057611|FG013|Overall Study|Death|0|||
156535879|NCT01994382|565057612|FG014|Overall Study|Death|0|||
156535880|NCT01994382|565057613|FG015|Overall Study|Death|1|||
156535881|NCT01994382|565057614|FG016|Overall Study|Death|0|||
156535882|NCT01994382|565057598|FG000|Overall Study|Adverse Event|0|||
156535883|NCT01994382|565057599|FG001|Overall Study|Adverse Event|1|||
156535884|NCT01994382|565057600|FG002|Overall Study|Adverse Event|2|||
156535885|NCT01994382|565057601|FG003|Overall Study|Adverse Event|0|||
156535886|NCT01994382|565057602|FG004|Overall Study|Adverse Event|0|||
156535887|NCT01994382|565057603|FG005|Overall Study|Adverse Event|0|||
156535888|NCT01994382|565057604|FG006|Overall Study|Adverse Event|0|||
156535889|NCT01994382|565057605|FG007|Overall Study|Adverse Event|0|||
156535890|NCT01994382|565057606|FG008|Overall Study|Adverse Event|0|||
156799181|NCT00673920|566018928|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
156799182|NCT00673920|566018929|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
156799183|NCT00673920|566018930|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
156799184|NCT00673920|566018931|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
156799185|NCT00673920|566018932|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
156799186|NCT02300233|566018936|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
156799187|NCT02300233|566018937|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
156799188|NCT02300233|566018938|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
156799189|NCT02300233|566018936|FG000|Overall Study|Withdrawal by Subject|1|||
156799190|NCT02300233|566018937|FG001|Overall Study|Withdrawal by Subject|0|||
156799191|NCT02300233|566018938|FG002|Overall Study|Withdrawal by Subject|3|||
156799192|NCT02300233|566018936|FG000|Overall Study|Investigator Judgement|0|||
156799193|NCT02300233|566018937|FG001|Overall Study|Investigator Judgement|0|||
156535891|NCT01994382|565057607|FG009|Overall Study|Adverse Event|0|||
156535892|NCT01994382|565057608|FG010|Overall Study|Adverse Event|15|||
156535893|NCT01994382|565057609|FG011|Overall Study|Adverse Event|2|||
156535894|NCT01994382|565057610|FG012|Overall Study|Adverse Event|7|||
156535895|NCT01994382|565057611|FG013|Overall Study|Adverse Event|3|||
156535896|NCT01994382|565057612|FG014|Overall Study|Adverse Event|17|||
156535897|NCT01994382|565057613|FG015|Overall Study|Adverse Event|6|||
156535898|NCT01994382|565057614|FG016|Overall Study|Adverse Event|3|||
156535899|NCT01994382|565057598|FG000|Overall Study|Other than specified|0|||
156535900|NCT01994382|565057599|FG001|Overall Study|Other than specified|0|||
156535901|NCT01994382|565057600|FG002|Overall Study|Other than specified|0|||
156535902|NCT01994382|565057601|FG003|Overall Study|Other than specified|0|||
156799194|NCT02300233|566018938|FG002|Overall Study|Investigator Judgement|1|||
156799195|NCT02300233|566018936|FG000|Overall Study|Reason Not Specified|0|||
156799196|NCT02300233|566018937|FG001|Overall Study|Reason Not Specified|0|||
156799197|NCT02300233|566018938|FG002|Overall Study|Reason Not Specified|5|||
156799198|NCT00833690|566018939|FG000|Overall Study|Withdrawal by Subject|1|||
156799199|NCT00833690|566018940|FG001|Overall Study|Withdrawal by Subject|0|||
156799200|NCT00833690|566018941|FG002|Overall Study|Withdrawal by Subject|0|||
156799201|NCT00833690|566018939|FG000|Overall Study|Discontinued study drug|3|||
156799202|NCT00833690|566018940|FG001|Overall Study|Discontinued study drug|2|||
156799203|NCT00833690|566018941|FG002|Overall Study|Discontinued study drug|0|||
156799204|NCT05448950|566018947|FG000|Overall Study|Death|2|||
156799205|NCT05448950|566018947|FG000|Overall Study|Withdrawal by Subject|1|||
156799206|NCT05448950|566018947|FG000|Overall Study|AVG abandoned|4|||
156799207|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156799208|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
156799209|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156799210|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156799211|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
156799212|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
156799213|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
156799214|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
156799215|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
156799216|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
156799217|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
156799218|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
156799219|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156799220|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156799221|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156799222|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156799223|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
156799224|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
156799225|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
156799226|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
156799227|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
156799228|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
156799229|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
156799230|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
156799231|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
156799232|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
156799233|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
156799234|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
156799235|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
156744809|NCT00662558|565813274|FG000|Overall Study|Lack of Efficacy|4|||
156744810|NCT00662558|565813275|FG001|Overall Study|Lack of Efficacy|7|||
156744811|NCT00662558|565813274|FG000|Overall Study|Lost to Follow-up|13|||
156744812|NCT00662558|565813275|FG001|Overall Study|Lost to Follow-up|10|||
156744813|NCT00662558|565813274|FG000|Overall Study|Other|9|||
156744814|NCT00662558|565813275|FG001|Overall Study|Other|14|||
156744815|NCT00662558|565813274|FG000|Overall Study|Withdrawal by Subject|7|||
156744816|NCT00662558|565813275|FG001|Overall Study|Withdrawal by Subject|12|||
156744817|NCT00662558|565813274|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
156744818|NCT00662558|565813275|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
156744819|NCT00329641|565813276|FG000|Overall Study|Did not start treatment|1|||
156744820|NCT00329641|565813276|FG000|Overall Study|Not eligible|1|||
156744821|NCT00329641|565813276|FG000|Overall Study|Adverse Event|3|||
156744822|NCT00329641|565813276|FG000|Overall Study|Other reason, not protocol specified|1|||
156744823|NCT02631070|565813286|FG000|Overall Study|Withdrawal by Subject|35|||
156744824|NCT02631070|565813287|FG001|Overall Study|Withdrawal by Subject|13|||
156744825|NCT02631070|565813286|FG000|Overall Study|Death|45|||
156799236|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
156799237|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
156799238|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
156799239|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Death|0|||
156799240|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Death|0|||
156744826|NCT02631070|565813287|FG001|Overall Study|Death|24|||
156799241|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Death|1|||
156799242|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Death|0|||
156799243|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
156799244|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
156799245|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
156744827|NCT02631070|565813286|FG000|Overall Study|Lost to Follow-up|5|||
156799246|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
156799247|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
156744828|NCT02631070|565813287|FG001|Overall Study|Lost to Follow-up|1|||
156744829|NCT02631070|565813286|FG000|Overall Study|Transition to rollover protocol|52|||
156744830|NCT02631070|565813287|FG001|Overall Study|Transition to rollover protocol|21|||
156744831|NCT02631070|565813286|FG000|Overall Study|Other reasons|12|||
156744832|NCT02631070|565813287|FG001|Overall Study|Other reasons|5|||
156744833|NCT03329248|565813288|FG000|Overall Study|Progressive Disease|6|||
156744834|NCT00987402|565813289|FG000|Overall Study|Insufficient data entry|86|||
156744835|NCT00987402|565813290|FG001|Overall Study|Insufficient data entry|98|||
156744836|NCT03000530|565813291|FG000|Overall Study|Adverse Event|0|||
156744837|NCT03000530|565813292|FG001|Overall Study|Adverse Event|0|||
156744838|NCT03000530|565813293|FG002|Overall Study|Adverse Event|2|||
156744839|NCT03000530|565813291|FG000|Overall Study|Lost to Follow-up|0|||
156744840|NCT03000530|565813292|FG001|Overall Study|Lost to Follow-up|3|||
156744841|NCT03000530|565813293|FG002|Overall Study|Lost to Follow-up|1|||
156744842|NCT03000530|565813291|FG000|Overall Study|Withdrawal by Subject|0|||
156744843|NCT03000530|565813292|FG001|Overall Study|Withdrawal by Subject|2|||
156799248|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
156799249|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
156799250|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
156799251|NCT03605693|566018952|FG000|Overall Study|Lost to Follow-up|4|||
156799252|NCT03605693|566018953|FG001|Overall Study|Lost to Follow-up|0|||
156799253|NCT03605693|566018952|FG000|Overall Study|Physician Decision|1|||
156799254|NCT03605693|566018953|FG001|Overall Study|Physician Decision|0|||
156799255|NCT04752566|566018954|FG000|Overall Study|Protocol Violation|0|||
156799256|NCT04752566|566018955|FG001|Overall Study|Protocol Violation|1|||
156799257|NCT04752566|566018954|FG000|Overall Study|Death|1|||
156799258|NCT04752566|566018955|FG001|Overall Study|Death|0|||
156799259|NCT04752566|566018954|FG000|Overall Study|Adverse Event|1|||
156799260|NCT04752566|566018955|FG001|Overall Study|Adverse Event|0|||
156799261|NCT04752566|566018954|FG000|Overall Study|Withdrawal by Subject|2|||
156744844|NCT03000530|565813293|FG002|Overall Study|Withdrawal by Subject|1|||
156744845|NCT01672294|565813300|FG000|Overall Study|Withdrawal by Subject|4|||
156744846|NCT01672294|565813301|FG001|Overall Study|Withdrawal by Subject|4|||
156744847|NCT01672294|565813302|FG002|Overall Study|Withdrawal by Subject|4|||
156744848|NCT01672294|565813303|FG003|Overall Study|Withdrawal by Subject|4|||
156744849|NCT01672294|565813300|FG000|Overall Study|Excluded by study|1|||
156744850|NCT01672294|565813301|FG001|Overall Study|Excluded by study|1|||
156744851|NCT01672294|565813302|FG002|Overall Study|Excluded by study|0|||
156744852|NCT01672294|565813303|FG003|Overall Study|Excluded by study|0|||
156744853|NCT01672294|565813300|FG000|Overall Study|Lost to Follow-up|1|||
156744854|NCT01672294|565813301|FG001|Overall Study|Lost to Follow-up|16|||
156744855|NCT01672294|565813302|FG002|Overall Study|Lost to Follow-up|7|||
156744856|NCT01672294|565813303|FG003|Overall Study|Lost to Follow-up|9|||
156744857|NCT01285492|565813304|FG000|Overall Study|Adverse Event|11|||
156744858|NCT01285492|565813305|FG001|Overall Study|Adverse Event|0|||
156744859|NCT01285492|565813304|FG000|Overall Study|Protocol Violation|3|||
156744860|NCT01285492|565813305|FG001|Overall Study|Protocol Violation|0|||
156744861|NCT01285492|565813304|FG000|Overall Study|Withdrawal by Subject|2|||
156744862|NCT01285492|565813305|FG001|Overall Study|Withdrawal by Subject|1|||
156744863|NCT01285492|565813304|FG000|Overall Study|Death|1|||
156744864|NCT01285492|565813305|FG001|Overall Study|Death|0|||
156744865|NCT01606202|565813307|FG000|Overall Study|Adverse Event|5|||
156744866|NCT01606202|565813308|FG001|Overall Study|Adverse Event|0|||
156744867|NCT01606202|565813307|FG000|Overall Study|Withdrawal by Subject|2|||
156744868|NCT01606202|565813308|FG001|Overall Study|Withdrawal by Subject|1|||
156744869|NCT01606202|565813307|FG000|Overall Study|Personal problems|0|||
156744870|NCT01606202|565813308|FG001|Overall Study|Personal problems|1|||
156744871|NCT01606202|565813307|FG000|Overall Study|Problems with administration|0|||
156799262|NCT04752566|566018955|FG001|Overall Study|Withdrawal by Subject|0|||
156799263|NCT04752566|566018954|FG000|Overall Study|Physician Decision|1|||
156799264|NCT04752566|566018955|FG001|Overall Study|Physician Decision|1|||
156458759|NCT01928394|564776674|FG020|Treatment Period|Participant request to stop therapy|3|||
156744872|NCT01606202|565813308|FG001|Overall Study|Problems with administration|1|||
156458760|NCT01928394|564776675|FG021|Treatment Period|Participant request to stop therapy|1|||
156458761|NCT01928394|564776676|FG022|Treatment Period|Participant request to stop therapy|3|||
156744873|NCT02273908|565813309|FG000|Overall Study|Adverse Event|16|||
156744874|NCT02273908|565813310|FG001|Overall Study|Adverse Event|0|||
156799265|NCT04562116|566018956|FG000|Overall Study|Lost to Follow-up|1|||
156799266|NCT04562116|566018956|FG000|Overall Study|Withdrawal by Subject|3|||
156799267|NCT03331354|566018957|FG000|Overall Study|Withdrawal by Subject|1|||
156799268|NCT03331354|566018958|FG001|Overall Study|Withdrawal by Subject|3|||
156799269|NCT03331354|566018957|FG000|Overall Study|Lost to Follow-up|3|||
156744875|NCT02273908|565813309|FG000|Overall Study|Lost to Follow-up|10|||
156744876|NCT02273908|565813310|FG001|Overall Study|Lost to Follow-up|1|||
156744877|NCT02273908|565813309|FG000|Overall Study|Did not meet entrance criteria|3|||
156799270|NCT03331354|566018958|FG001|Overall Study|Lost to Follow-up|3|||
156744878|NCT02273908|565813310|FG001|Overall Study|Did not meet entrance criteria|2|||
156744879|NCT02273908|565813309|FG000|Overall Study|Withdrawal by Subject|4|||
156744880|NCT02273908|565813310|FG001|Overall Study|Withdrawal by Subject|2|||
156744881|NCT00369161|565813311|FG000|Overall Study|Adverse Event|15|||
156744882|NCT00369161|565813312|FG001|Overall Study|Adverse Event|13|||
156744883|NCT00369161|565813311|FG000|Overall Study|Abnormal laboratory value|0|||
156744884|NCT00369161|565813312|FG001|Overall Study|Abnormal laboratory value|1|||
156744885|NCT00369161|565813311|FG000|Overall Study|Lack of Efficacy|3|||
156744886|NCT00369161|565813312|FG001|Overall Study|Lack of Efficacy|1|||
156744887|NCT00369161|565813311|FG000|Overall Study|Protocol Violation|0|||
156744888|NCT00369161|565813312|FG001|Overall Study|Protocol Violation|2|||
156744889|NCT00369161|565813311|FG000|Overall Study|Withdrawal by Subject|2|||
156744890|NCT00369161|565813312|FG001|Overall Study|Withdrawal by Subject|3|||
156744891|NCT00369161|565813311|FG000|Overall Study|Death|1|||
156744892|NCT00369161|565813312|FG001|Overall Study|Death|2|||
156744893|NCT00369161|565813311|FG000|Overall Study|Graft loss|4|||
156744894|NCT00369161|565813312|FG001|Overall Study|Graft loss|0|||
156744895|NCT00369161|565813311|FG000|Overall Study|Administrative Problem|2|||
156744896|NCT00369161|565813312|FG001|Overall Study|Administrative Problem|2|||
156744897|NCT01870297|565813315|FG000|Overall Study|Adverse Event|0|||
156744898|NCT01870297|565813316|FG001|Overall Study|Adverse Event|0|||
156744899|NCT01870297|565813317|FG002|Overall Study|Adverse Event|0|||
156744900|NCT01870297|565813318|FG003|Overall Study|Adverse Event|0|||
156744901|NCT01870297|565813319|FG004|Overall Study|Adverse Event|2|||
156744902|NCT01870297|565813320|FG005|Overall Study|Adverse Event|0|||
156744903|NCT01870297|565813321|FG006|Overall Study|Adverse Event|0|||
156744904|NCT01870297|565813315|FG000|Overall Study|Lost to Follow-up|0|||
156744905|NCT01870297|565813316|FG001|Overall Study|Lost to Follow-up|1|||
156744906|NCT01870297|565813317|FG002|Overall Study|Lost to Follow-up|1|||
156744907|NCT01870297|565813318|FG003|Overall Study|Lost to Follow-up|0|||
156744908|NCT01870297|565813319|FG004|Overall Study|Lost to Follow-up|0|||
156744909|NCT01870297|565813320|FG005|Overall Study|Lost to Follow-up|0|||
156744910|NCT01870297|565813321|FG006|Overall Study|Lost to Follow-up|0|||
156744911|NCT01870297|565813315|FG000|Overall Study|Withdrawal by Subject|0|||
156744912|NCT01870297|565813316|FG001|Overall Study|Withdrawal by Subject|0|||
156744913|NCT01870297|565813317|FG002|Overall Study|Withdrawal by Subject|0|||
156744914|NCT01870297|565813318|FG003|Overall Study|Withdrawal by Subject|0|||
156744915|NCT01870297|565813319|FG004|Overall Study|Withdrawal by Subject|1|||
156744916|NCT01870297|565813320|FG005|Overall Study|Withdrawal by Subject|1|||
156744917|NCT01870297|565813321|FG006|Overall Study|Withdrawal by Subject|1|||
156744918|NCT01870297|565813315|FG000|Overall Study|Sponsor Decision|0|||
156744919|NCT01870297|565813316|FG001|Overall Study|Sponsor Decision|6|||
156744920|NCT01870297|565813317|FG002|Overall Study|Sponsor Decision|0|||
156744921|NCT01870297|565813318|FG003|Overall Study|Sponsor Decision|0|||
156744922|NCT01870297|565813319|FG004|Overall Study|Sponsor Decision|0|||
156744923|NCT01870297|565813320|FG005|Overall Study|Sponsor Decision|0|||
156744924|NCT01870297|565813321|FG006|Overall Study|Sponsor Decision|1|||
156744925|NCT00422422|565813322|FG000|Overall Study|Lack of Efficacy|1|||
156744926|NCT00422422|565813322|FG000|Overall Study|Protocol Violation|1|||
156744927|NCT00422422|565813322|FG000|Overall Study|Withdrawal by Subject|2|||
156744928|NCT00422422|565813322|FG000|Overall Study|SAE, non-fatal|1|||
156744929|NCT00422422|565813322|FG000|Overall Study|AE, non-serious non-fatal|5|||
156744930|NCT01593254|565813323|FG000|Overall Study|Disease progression|2|||
156744931|NCT01593254|565813324|FG001|Overall Study|Disease progression|7|||
156744932|NCT01593254|565813323|FG000|Overall Study|Study drug toxicity|6|||
156744933|NCT01593254|565813324|FG001|Overall Study|Study drug toxicity|20|||
156744934|NCT01593254|565813323|FG000|Overall Study|Death|3|||
156744935|NCT01593254|565813324|FG001|Overall Study|Death|3|||
156744936|NCT01593254|565813323|FG000|Overall Study|AE unrelated to study drug|0|||
156744937|NCT01593254|565813324|FG001|Overall Study|AE unrelated to study drug|1|||
156744938|NCT01593254|565813323|FG000|Overall Study|participant request to discontinue study treatment|1|||
156744939|NCT01593254|565813324|FG001|Overall Study|participant request to discontinue study treatment|3|||
156744940|NCT01593254|565813323|FG000|Overall Study|participant withdrew consent|0|||
156744941|NCT01593254|565813324|FG001|Overall Study|participant withdrew consent|9|||
156744942|NCT01593254|565813323|FG000|Overall Study|lost to follow up|1|||
156744943|NCT01593254|565813324|FG001|Overall Study|lost to follow up|6|||
156744944|NCT01593254|565813323|FG000|Overall Study|maximum clinical benefit|1|||
156744945|NCT01593254|565813324|FG001|Overall Study|maximum clinical benefit|2|||
156744946|NCT01593254|565813323|FG000|Overall Study|Poor/non compliance|1|||
156744947|NCT01593254|565813324|FG001|Overall Study|Poor/non compliance|1|||
156744948|NCT01593254|565813323|FG000|Overall Study|Pregnancy|0|||
156744949|NCT01593254|565813324|FG001|Overall Study|Pregnancy|3|||
156744950|NCT01593254|565813323|FG000|Overall Study|participant no longer meets study criteria|1|||
156744951|NCT01593254|565813324|FG001|Overall Study|participant no longer meets study criteria|1|||
156744952|NCT01593254|565813323|FG000|Overall Study|Admin reason by sponsor|7|||
156744953|NCT01593254|565813324|FG001|Overall Study|Admin reason by sponsor|3|||
156744954|NCT01593254|565813323|FG000|Overall Study|Imatinib treatment failure|2|||
156744955|NCT01593254|565813324|FG001|Overall Study|Imatinib treatment failure|0|||
156535903|NCT01994382|565057602|FG004|Overall Study|Other than specified|0|||
156535904|NCT01994382|565057603|FG005|Overall Study|Other than specified|0|||
156535905|NCT01994382|565057604|FG006|Overall Study|Other than specified|0|||
156535906|NCT01994382|565057605|FG007|Overall Study|Other than specified|0|||
156535907|NCT01994382|565057606|FG008|Overall Study|Other than specified|0|||
156535908|NCT01994382|565057607|FG009|Overall Study|Other than specified|0|||
156744956|NCT01593254|565813323|FG000|Overall Study|Other Reasons|61|||
156744957|NCT01593254|565813324|FG001|Overall Study|Other Reasons|115|||
156535909|NCT01994382|565057608|FG010|Overall Study|Other than specified|2|||
156535910|NCT01994382|565057609|FG011|Overall Study|Other than specified|0|||
156535911|NCT01994382|565057610|FG012|Overall Study|Other than specified|2|||
156744958|NCT00501059|565813325|FG000|Overall Study|Protocol Violation|80|||
156744959|NCT00501059|565813326|FG001|Overall Study|Protocol Violation|69|||
156744960|NCT00501059|565813325|FG000|Overall Study|Death|140|||
156744961|NCT00501059|565813326|FG001|Overall Study|Death|137|||
156744962|NCT00501059|565813325|FG000|Overall Study|Other|236|||
156744963|NCT00501059|565813326|FG001|Overall Study|Other|239|||
156744964|NCT00501059|565813325|FG000|Overall Study|Missing end-of-study page|91|||
156744965|NCT00501059|565813326|FG001|Overall Study|Missing end-of-study page|92|||
156744966|NCT00501059|565813325|FG000|Overall Study|Clinical endpoint reached|110|||
156744967|NCT00501059|565813326|FG001|Overall Study|Clinical endpoint reached|123|||
156744968|NCT00501059|565813325|FG000|Overall Study|Insufficient therapeutic effect|4|||
156744969|NCT00501059|565813326|FG001|Overall Study|Insufficient therapeutic effect|5|||
156744970|NCT00501059|565813325|FG000|Overall Study|Consent withdrawn by subject|817|||
156744971|NCT00501059|565813326|FG001|Overall Study|Consent withdrawn by subject|873|||
156744972|NCT00501059|565813325|FG000|Overall Study|Non-compliant with study treatment|23|||
156744973|NCT00501059|565813326|FG001|Overall Study|Non-compliant with study treatment|16|||
156744974|NCT00501059|565813325|FG000|Overall Study|Reason not given|3|||
156744975|NCT00501059|565813326|FG001|Overall Study|Reason not given|1|||
156744976|NCT00501059|565813325|FG000|Overall Study|Adverse Event|129|||
156744977|NCT00501059|565813326|FG001|Overall Study|Adverse Event|122|||
156744978|NCT00501059|565813325|FG000|Overall Study|Lost to Follow-up|210|||
156744979|NCT00501059|565813326|FG001|Overall Study|Lost to Follow-up|198|||
156744980|NCT00501059|565813325|FG000|Overall Study|Not treated|25|||
156744981|NCT00501059|565813326|FG001|Overall Study|Not treated|17|||
156744982|NCT04249622|565813329|FG000|Overall Study|Withdrawal by Subject|1|||
156744983|NCT04249622|565813330|FG001|Overall Study|Withdrawal by Subject|1|||
156744984|NCT04249622|565813329|FG000|Overall Study|Alternative therapy|1|||
156744985|NCT04249622|565813330|FG001|Overall Study|Alternative therapy|0|||
156744986|NCT04249622|565813329|FG000|Overall Study|Discontinuation of pertuzumab|1|||
156744987|NCT04249622|565813330|FG001|Overall Study|Discontinuation of pertuzumab|0|||
156744988|NCT03689543|565813333|FG000|Overall Study|Adverse Event|0|||
156744989|NCT03689543|565813334|FG001|Overall Study|Adverse Event|0|||
156744990|NCT03689543|565813335|FG002|Overall Study|Adverse Event|1|||
156744991|NCT01294371|565813336|FG000|Overall Study|Adverse Event|1|||
156744992|NCT01294371|565813336|FG000|Overall Study|Withdrawal by Subject|12|||
156744993|NCT01294371|565813336|FG000|Overall Study|Lost to Follow-up|6|||
156744994|NCT01294371|565813336|FG000|Overall Study|Administrative Reason|1|||
156744995|NCT01294371|565813336|FG000|Overall Study|Other|14|||
156744996|NCT05619536|565813337|FG000|Overall Study|Withdrawal by Subject|0|||
156744997|NCT05619536|565813338|FG001|Overall Study|Withdrawal by Subject|1|||
156744998|NCT05619536|565813339|FG002|Overall Study|Withdrawal by Subject|0|||
156744999|NCT05619536|565813340|FG003|Overall Study|Withdrawal by Subject|1|||
156745000|NCT05619536|565813337|FG000|Overall Study|Lost to Follow-up|0|||
156745001|NCT05619536|565813338|FG001|Overall Study|Lost to Follow-up|1|||
156745002|NCT05619536|565813339|FG002|Overall Study|Lost to Follow-up|1|||
156745003|NCT05619536|565813340|FG003|Overall Study|Lost to Follow-up|0|||
156745004|NCT00622336|565813343|FG000|Treatment Phase|Progression of Disease|181|||
156745005|NCT00622336|565813343|FG000|Treatment Phase|Adverse Event|46|||
156745006|NCT00622336|565813343|FG000|Treatment Phase|Other|40|||
156745007|NCT00622336|565813343|FG000|Treatment Phase|Death|14|||
156745008|NCT00622336|565813343|FG000|Treatment Phase|Lack of therapeutic effect|13|||
156745009|NCT00622336|565813343|FG000|Treatment Phase|Withdrawal by Subject|13|||
156745010|NCT00622336|565813343|FG000|Treatment Phase|Lost to Follow-up|2|||
156745011|NCT00622336|565813343|FG000|Extension Phase|Adverse Event|2|||
156745012|NCT00622336|565813343|FG000|Extension Phase|Progressive Disease|6|||
156745013|NCT00622336|565813343|FG000|Extension Phase|Lack of therapeutic effect|2|||
156745014|NCT00622336|565813343|FG000|Extension Phase|Withdrawal by Subject|1|||
156745015|NCT00622336|565813343|FG000|Extension Phase|Lost to Follow-up|1|||
156745016|NCT00622336|565813343|FG000|Extension Phase|Other|9|||
156745017|NCT00157248|565813348|FG000|Overall Study|Adverse Event|36|||
156745018|NCT00157248|565813349|FG001|Overall Study|Adverse Event|25|||
156745019|NCT00157248|565813350|FG002|Overall Study|Adverse Event|13|||
156535912|NCT01994382|565057611|FG013|Overall Study|Other than specified|0|||
156745020|NCT00157248|565813351|FG003|Overall Study|Adverse Event|33|||
156745021|NCT00157248|565813348|FG000|Overall Study|Protocol Violation|4|||
156745022|NCT00157248|565813349|FG001|Overall Study|Protocol Violation|0|||
156745023|NCT00157248|565813350|FG002|Overall Study|Protocol Violation|2|||
156535913|NCT01994382|565057612|FG014|Overall Study|Other than specified|0|||
156535914|NCT01994382|565057613|FG015|Overall Study|Other than specified|4|||
156745024|NCT00157248|565813351|FG003|Overall Study|Protocol Violation|2|||
156745025|NCT00157248|565813348|FG000|Overall Study|Lost to Follow-up|0|||
156745026|NCT00157248|565813349|FG001|Overall Study|Lost to Follow-up|1|||
156745027|NCT00157248|565813350|FG002|Overall Study|Lost to Follow-up|0|||
156745028|NCT00157248|565813351|FG003|Overall Study|Lost to Follow-up|0|||
156745029|NCT00157248|565813348|FG000|Overall Study|Withdrawal by Subject|1|||
156745030|NCT00157248|565813349|FG001|Overall Study|Withdrawal by Subject|4|||
156535915|NCT01994382|565057614|FG016|Overall Study|Other than specified|4|||
156535916|NCT01994382|565057598|FG000|Overall Study|Withdrawal by Subject|0|||
156535917|NCT01994382|565057599|FG001|Overall Study|Withdrawal by Subject|0|||
156535918|NCT01994382|565057600|FG002|Overall Study|Withdrawal by Subject|0|||
156535919|NCT01994382|565057601|FG003|Overall Study|Withdrawal by Subject|0|||
156535920|NCT01994382|565057602|FG004|Overall Study|Withdrawal by Subject|0|||
156535921|NCT01994382|565057603|FG005|Overall Study|Withdrawal by Subject|0|||
156535922|NCT01994382|565057604|FG006|Overall Study|Withdrawal by Subject|0|||
156535923|NCT01994382|565057605|FG007|Overall Study|Withdrawal by Subject|0|||
156535924|NCT01994382|565057606|FG008|Overall Study|Withdrawal by Subject|0|||
156535925|NCT01994382|565057607|FG009|Overall Study|Withdrawal by Subject|0|||
156535926|NCT01994382|565057608|FG010|Overall Study|Withdrawal by Subject|6|||
156535927|NCT01994382|565057609|FG011|Overall Study|Withdrawal by Subject|0|||
156535928|NCT01994382|565057610|FG012|Overall Study|Withdrawal by Subject|2|||
156535929|NCT01994382|565057611|FG013|Overall Study|Withdrawal by Subject|0|||
156535930|NCT01994382|565057612|FG014|Overall Study|Withdrawal by Subject|4|||
156535931|NCT01994382|565057613|FG015|Overall Study|Withdrawal by Subject|3|||
156535932|NCT01994382|565057614|FG016|Overall Study|Withdrawal by Subject|0|||
156535933|NCT01994382|565057598|FG000|Overall Study|Lost to Follow-up|0|||
156745031|NCT00157248|565813350|FG002|Overall Study|Withdrawal by Subject|3|||
156745032|NCT00157248|565813351|FG003|Overall Study|Withdrawal by Subject|3|||
156745033|NCT00157248|565813348|FG000|Overall Study|site closures, subject moving|7|||
156745034|NCT00157248|565813349|FG001|Overall Study|site closures, subject moving|7|||
156745035|NCT00157248|565813350|FG002|Overall Study|site closures, subject moving|3|||
156535934|NCT01994382|565057599|FG001|Overall Study|Lost to Follow-up|0|||
156535935|NCT01994382|565057600|FG002|Overall Study|Lost to Follow-up|0|||
156535936|NCT01994382|565057601|FG003|Overall Study|Lost to Follow-up|0|||
156535937|NCT01994382|565057602|FG004|Overall Study|Lost to Follow-up|0|||
156535938|NCT01994382|565057603|FG005|Overall Study|Lost to Follow-up|0|||
156535939|NCT01994382|565057604|FG006|Overall Study|Lost to Follow-up|0|||
156745036|NCT00157248|565813351|FG003|Overall Study|site closures, subject moving|9|||
156745037|NCT01911793|565815603|FG000|Overall Study|Physician Decision|1|||
156745038|NCT01911793|565815604|FG001|Overall Study|Physician Decision|5|||
156745039|NCT03774394|565815605|FG000|Overall Study|Withdrawal by Subject|2|||
156745040|NCT03774394|565815606|FG001|Overall Study|Withdrawal by Subject|0|||
156745041|NCT02697916|565815607|FG000|Overall Study|Death|357|||
156745042|NCT02697916|565815608|FG001|Overall Study|Death|315|||
156745043|NCT02697916|565815607|FG000|Overall Study|Withdrawal by Subject|221|||
156745044|NCT02697916|565815608|FG001|Overall Study|Withdrawal by Subject|393|||
156745045|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
156745046|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
156745047|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
156745048|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
156745049|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
156745050|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
156745051|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
156745052|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
156745053|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
156745054|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
156745055|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
156745056|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
156745057|NCT01777139|565815609|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
156745058|NCT01777139|565815610|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
156745059|NCT01777139|565815609|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
156745060|NCT01777139|565815610|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
156745061|NCT00290693|565815612|FG000|Overall Study|Withdrawal by Subject|2|||
156745062|NCT04849416|565815613|FG000|Overall Study|Ongoing Treatment|12|||
156745063|NCT04849416|565815614|FG001|Overall Study|Ongoing Treatment|5|||
156745064|NCT04849416|565815615|FG002|Overall Study|Ongoing Treatment|3|||
156745065|NCT04849416|565815613|FG000|Overall Study|On Post-Treatment Follow-up|8|||
156745066|NCT04849416|565815614|FG001|Overall Study|On Post-Treatment Follow-up|9|||
156745067|NCT04849416|565815615|FG002|Overall Study|On Post-Treatment Follow-up|10|||
156745068|NCT04849416|565815613|FG000|Overall Study|Withdrawal by Subject|0|||
156458762|NCT01928394|564776654|FG000|Treatment Period|Participant withdrew consent|0|||
156458763|NCT01928394|564776655|FG001|Treatment Period|Participant withdrew consent|0|||
156458764|NCT01928394|564776656|FG002|Treatment Period|Participant withdrew consent|1|||
156535940|NCT01994382|565057605|FG007|Overall Study|Lost to Follow-up|0|||
156535941|NCT01994382|565057606|FG008|Overall Study|Lost to Follow-up|0|||
156535942|NCT01994382|565057607|FG009|Overall Study|Lost to Follow-up|0|||
156535943|NCT01994382|565057608|FG010|Overall Study|Lost to Follow-up|1|||
156535944|NCT01994382|565057609|FG011|Overall Study|Lost to Follow-up|0|||
156535945|NCT01994382|565057610|FG012|Overall Study|Lost to Follow-up|0|||
156535946|NCT01994382|565057611|FG013|Overall Study|Lost to Follow-up|0|||
156535947|NCT01994382|565057612|FG014|Overall Study|Lost to Follow-up|0|||
156535948|NCT01994382|565057613|FG015|Overall Study|Lost to Follow-up|0|||
156535949|NCT01994382|565057614|FG016|Overall Study|Lost to Follow-up|0|||
156535950|NCT01994382|565057598|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535951|NCT01994382|565057599|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535952|NCT01994382|565057600|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535953|NCT01994382|565057601|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535954|NCT01994382|565057602|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535955|NCT01994382|565057603|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156745069|NCT04849416|565815614|FG001|Overall Study|Withdrawal by Subject|0|||
156745070|NCT04849416|565815615|FG002|Overall Study|Withdrawal by Subject|1|||
156745071|NCT04849416|565815613|FG000|Overall Study|Lost to Follow-up|1|||
156745072|NCT04849416|565815614|FG001|Overall Study|Lost to Follow-up|0|||
156745073|NCT04849416|565815615|FG002|Overall Study|Lost to Follow-up|0|||
156745074|NCT00981058|565815626|FG000|Overall Study|Progressive Disease|38|||
156745075|NCT00981058|565815627|FG001|Overall Study|Progressive Disease|31|||
156745076|NCT00981058|565815626|FG000|Overall Study|Lost to Follow-up|3|||
156745077|NCT00981058|565815627|FG001|Overall Study|Lost to Follow-up|2|||
156745078|NCT00981058|565815626|FG000|Overall Study|Physician Decision|4|||
156745079|NCT00981058|565815627|FG001|Overall Study|Physician Decision|5|||
156745080|NCT00981058|565815626|FG000|Overall Study|Randomization Error|0|||
156745081|NCT00981058|565815627|FG001|Overall Study|Randomization Error|1|||
156745082|NCT00981058|565815626|FG000|Overall Study|Withdrawal by Subject|24|||
156745083|NCT00981058|565815627|FG001|Overall Study|Withdrawal by Subject|22|||
156745084|NCT02667587|565815628|FG000|Pre-Treatment|Not reported|1|||
156745085|NCT02667587|565815629|FG001|Pre-Treatment|Not reported|0|||
156745086|NCT02667587|565815628|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
156745087|NCT02667587|565815629|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
156745088|NCT02667587|565815628|FG000|Pre-Treatment|Participant withdrew consent|0|||
156745089|NCT02667587|565815629|FG001|Pre-Treatment|Participant withdrew consent|1|||
156745090|NCT02667587|565815628|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
156745091|NCT02667587|565815629|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
156799271|NCT03331354|566018957|FG000|Overall Study|Found employment before initiated active intervention|0|||
156799272|NCT03331354|566018958|FG001|Overall Study|Found employment before initiated active intervention|4|||
156799273|NCT01646827|566018959|FG000|Overall Study|Lost to Follow-up|0|||
156799274|NCT01646827|566018960|FG001|Overall Study|Lost to Follow-up|3|||
156799275|NCT01646827|566018959|FG000|Overall Study|Physician Decision|1|||
156799276|NCT01646827|566018960|FG001|Overall Study|Physician Decision|2|||
156799277|NCT01646827|566018959|FG000|Overall Study|Withdrawal by Subject|1|||
156799278|NCT01646827|566018960|FG001|Overall Study|Withdrawal by Subject|0|||
156799279|NCT05134649|566018961|FG000|Overall Study|Lost to Follow-up|12|||
156799280|NCT05134649|566018961|FG000|Overall Study|Withdrawal by Subject|14|||
156799281|NCT05134649|566018961|FG000|Overall Study|Pregnancy|1|||
156799282|NCT05134649|566018961|FG000|Overall Study|Other, not specified|3|||
156799283|NCT00928668|566018962|FG000|Overall Study|Adverse Event|1|||
156799284|NCT00928668|566018963|FG001|Overall Study|Adverse Event|0|||
156799285|NCT00928668|566018964|FG002|Overall Study|Adverse Event|0|||
156799286|NCT00928668|566018965|FG003|Overall Study|Adverse Event|0|||
156799287|NCT00928668|566018966|FG004|Overall Study|Adverse Event|0|||
156799288|NCT00928668|566018962|FG000|Overall Study|Protocol Violation|0|||
156799289|NCT00928668|566018963|FG001|Overall Study|Protocol Violation|0|||
156799290|NCT00928668|566018964|FG002|Overall Study|Protocol Violation|0|||
156799291|NCT00928668|566018965|FG003|Overall Study|Protocol Violation|0|||
156799292|NCT00928668|566018966|FG004|Overall Study|Protocol Violation|1|||
156799293|NCT00928668|566018962|FG000|Overall Study|Withdrawal by Subject|0|||
156799294|NCT00928668|566018963|FG001|Overall Study|Withdrawal by Subject|1|||
156799295|NCT00928668|566018964|FG002|Overall Study|Withdrawal by Subject|1|||
156799296|NCT00928668|566018965|FG003|Overall Study|Withdrawal by Subject|0|||
156799297|NCT00928668|566018966|FG004|Overall Study|Withdrawal by Subject|0|||
156799298|NCT00928668|566018962|FG000|Overall Study|Other reasons not listed above|0|||
156799299|NCT00928668|566018963|FG001|Overall Study|Other reasons not listed above|0|||
156799300|NCT00928668|566018964|FG002|Overall Study|Other reasons not listed above|0|||
156799301|NCT00928668|566018965|FG003|Overall Study|Other reasons not listed above|1|||
156799302|NCT00928668|566018966|FG004|Overall Study|Other reasons not listed above|0|||
156799303|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
156799304|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
156799305|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
156799306|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
156799307|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
156799308|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
156799309|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
156799310|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
156799311|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
156799312|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
156799313|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
156799314|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
156799315|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
156799316|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
156799317|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
156799318|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
156799319|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
156799320|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
156799321|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
156799322|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
156799323|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
156799324|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
156799325|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
156799326|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
156799327|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
156799328|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
156799329|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
156799330|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
156799331|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
156799332|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
156799333|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
156799334|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
156799335|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
156799336|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
156799337|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
156799338|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
156799339|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
156799340|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
156799341|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
156799342|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
156799343|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
156799344|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
156799345|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
156799346|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
156799347|NCT04392154|566018967|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
156799348|NCT04392154|566018968|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
156799349|NCT04392154|566018969|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
156799350|NCT04392154|566018970|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
156799351|NCT04392154|566018967|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
156799352|NCT04392154|566018968|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
156799353|NCT04392154|566018969|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
156799354|NCT04392154|566018970|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
156799355|NCT04392154|566018967|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
156799356|NCT04392154|566018968|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
156799357|NCT04392154|566018969|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
156799358|NCT04392154|566018970|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
156799359|NCT02757430|566018981|FG000|Overall Study|Physician Decision|6|||
156799360|NCT02757430|566018981|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
156745092|NCT02667587|565815628|FG000|End of Treatment|Disease Progression|193|||
156745093|NCT02667587|565815629|FG001|End of Treatment|Disease Progression|226|||
156745094|NCT02667587|565815628|FG000|End of Treatment|Study Drug Toxicity|75|||
156745095|NCT02667587|565815629|FG001|End of Treatment|Study Drug Toxicity|19|||
156745096|NCT02667587|565815628|FG000|End of Treatment|Death|2|||
156745097|NCT02667587|565815629|FG001|End of Treatment|Death|1|||
156745098|NCT02667587|565815628|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
156745099|NCT02667587|565815629|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
156745100|NCT02667587|565815628|FG000|End of Treatment|participant request to discontinue treatment|33|||
156745101|NCT02667587|565815629|FG001|End of Treatment|participant request to discontinue treatment|35|||
156745102|NCT02667587|565815628|FG000|End of Treatment|participant withdrew consent|5|||
156745103|NCT02667587|565815629|FG001|End of Treatment|participant withdrew consent|6|||
156745104|NCT02667587|565815628|FG000|End of Treatment|Lost to Follow-up|1|||
156745105|NCT02667587|565815629|FG001|End of Treatment|Lost to Follow-up|2|||
156745106|NCT02667587|565815628|FG000|End of Treatment|maximum clinical benefit|4|||
156745107|NCT02667587|565815629|FG001|End of Treatment|maximum clinical benefit|4|||
156745108|NCT02667587|565815628|FG000|End of Treatment|poor or non compliant|0|||
156745109|NCT02667587|565815629|FG001|End of Treatment|poor or non compliant|1|||
156745110|NCT02667587|565815628|FG000|End of Treatment|participant no longer meets study criteria|1|||
156745111|NCT02667587|565815629|FG001|End of Treatment|participant no longer meets study criteria|1|||
156745112|NCT02667587|565815628|FG000|End of Treatment|administrative reason by sponsor|1|||
156745113|NCT02667587|565815629|FG001|End of Treatment|administrative reason by sponsor|29|||
156745114|NCT02667587|565815628|FG000|End of Treatment|other reasonse|21|||
156745115|NCT02667587|565815629|FG001|End of Treatment|other reasonse|10|||
156745116|NCT02542293|565815630|FG000|Overall Study|Death|367|||
156745117|NCT02542293|565815631|FG001|Overall Study|Death|377|||
156745118|NCT02542293|565815630|FG000|Overall Study|Withdrawal by Subject|8|||
156745119|NCT02542293|565815631|FG001|Overall Study|Withdrawal by Subject|19|||
156745120|NCT04529850|565815632|FG000|Overall Study|Death|2|||
156745121|NCT04529850|565815632|FG000|Overall Study|Physician Decision|1|||
156745122|NCT04529850|565815632|FG000|Overall Study|Withdrawal by Subject|2|||
156745123|NCT02278367|565815635|FG000|Overall Study|Physician Decision|5|||
156745124|NCT02278367|565815636|FG001|Overall Study|Physician Decision|0|||
156745125|NCT02278367|565815635|FG000|Overall Study|Withdrawal by Subject|5|||
156745126|NCT02278367|565815636|FG001|Overall Study|Withdrawal by Subject|0|||
156745127|NCT01472939|565815640|FG000|Overall Study|Adverse Event|3|||
156745128|NCT01472939|565815641|FG001|Overall Study|Adverse Event|7|||
156745129|NCT01472939|565815642|FG002|Overall Study|Adverse Event|7|||
156745130|NCT01472939|565815643|FG003|Overall Study|Adverse Event|14|||
156745131|NCT01472939|565815640|FG000|Overall Study|Lack of Efficacy|1|||
156745132|NCT01472939|565815641|FG001|Overall Study|Lack of Efficacy|0|||
156745133|NCT01472939|565815642|FG002|Overall Study|Lack of Efficacy|0|||
156745134|NCT01472939|565815643|FG003|Overall Study|Lack of Efficacy|1|||
156745135|NCT01472939|565815640|FG000|Overall Study|Lost to Follow-up|3|||
156745136|NCT01472939|565815641|FG001|Overall Study|Lost to Follow-up|0|||
156745137|NCT01472939|565815642|FG002|Overall Study|Lost to Follow-up|2|||
156745138|NCT01472939|565815643|FG003|Overall Study|Lost to Follow-up|0|||
156745139|NCT01472939|565815640|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
156745140|NCT01472939|565815641|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
156458765|NCT01928394|564776657|FG003|Treatment Period|Participant withdrew consent|1|||
156745141|NCT01472939|565815642|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
156745142|NCT01472939|565815643|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
156745143|NCT01472939|565815640|FG000|Overall Study|Prohibited Medication|0|||
156745144|NCT01472939|565815641|FG001|Overall Study|Prohibited Medication|1|||
156745145|NCT01472939|565815642|FG002|Overall Study|Prohibited Medication|0|||
156745146|NCT01472939|565815643|FG003|Overall Study|Prohibited Medication|0|||
156745147|NCT01472939|565815640|FG000|Overall Study|Withdrawal By PI|1|||
156745148|NCT01472939|565815641|FG001|Overall Study|Withdrawal By PI|0|||
156799361|NCT02757430|566018981|FG000|Overall Study|No informed consent|1|||
156799362|NCT02757430|566018981|FG000|Overall Study|No procedure performed|2|||
156799363|NCT03502200|566018982|FG000|Overall Study|Adverse Event|1|||
156799364|NCT03502200|566018983|FG001|Overall Study|Adverse Event|0|||
156799365|NCT03502200|566018982|FG000|Overall Study|Lost to Follow-up|36|||
156799366|NCT03502200|566018983|FG001|Overall Study|Lost to Follow-up|38|||
156799367|NCT03502200|566018982|FG000|Overall Study|Study Team Decision|1|||
156799368|NCT03502200|566018983|FG001|Overall Study|Study Team Decision|1|||
156799369|NCT03502200|566018982|FG000|Overall Study|Withdrawal by Subject|5|||
156799370|NCT03502200|566018983|FG001|Overall Study|Withdrawal by Subject|7|||
156745149|NCT01472939|565815642|FG002|Overall Study|Withdrawal By PI|0|||
156745150|NCT01472939|565815643|FG003|Overall Study|Withdrawal By PI|0|||
156745151|NCT01472939|565815640|FG000|Overall Study|Protocol Violation|3|||
156745152|NCT01472939|565815641|FG001|Overall Study|Protocol Violation|3|||
156745153|NCT01472939|565815642|FG002|Overall Study|Protocol Violation|0|||
156745154|NCT01472939|565815643|FG003|Overall Study|Protocol Violation|1|||
156799371|NCT03502200|566018982|FG000|Overall Study|Death|0|||
156799372|NCT03502200|566018983|FG001|Overall Study|Death|2|||
156799373|NCT03097289|566018985|FG000|Overall Study|Adverse Event|1|||
156799374|NCT03097289|566018985|FG000|Overall Study|Equipment failure|2|||
156799375|NCT03097289|566018985|FG000|Overall Study|Collected platelet product unusable|3|||
156337115|NCT03298867|564331496|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
156337116|NCT03298867|564331495|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
156337117|NCT03298867|564331496|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
156745155|NCT01472939|565815640|FG000|Overall Study|Withdrawal by Subject|9|||
156745156|NCT01472939|565815641|FG001|Overall Study|Withdrawal by Subject|3|||
156745157|NCT01472939|565815642|FG002|Overall Study|Withdrawal by Subject|1|||
156745158|NCT01472939|565815643|FG003|Overall Study|Withdrawal by Subject|4|||
156745159|NCT00114738|565815644|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
156745160|NCT00114738|565815645|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
156745161|NCT00114738|565815646|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
156745162|NCT00114738|565815644|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
156745163|NCT00114738|565815645|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
156745164|NCT00114738|565815646|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
156745165|NCT00114738|565815644|FG000|Screening for Randomization|Neuropathy|17|||
156337118|NCT03298867|564331495|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
156337119|NCT03298867|564331496|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
156337120|NCT03298867|564331495|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
156337121|NCT03298867|564331496|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
156337122|NCT03298867|564331495|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
156337123|NCT03298867|564331496|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
156337124|NCT03298867|564331495|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
156337125|NCT03298867|564331496|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
156337126|NCT03298867|564331495|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
156337127|NCT03298867|564331496|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
156337128|NCT01871532|564333546|FG000|Overall Study|Withdrawal by Subject|1|||
156337129|NCT01871532|564333547|FG001|Overall Study|Withdrawal by Subject|2|||
156337130|NCT01673867|564333549|FG000|Randomization|Adverse event unrelated to study drug|1|||
156337131|NCT01673867|564333550|FG001|Randomization|Adverse event unrelated to study drug|0|||
156337132|NCT01673867|564333549|FG000|Randomization|Participant request to discontinue study treatment|0|||
156337133|NCT01673867|564333550|FG001|Randomization|Participant request to discontinue study treatment|4|||
156337134|NCT01673867|564333549|FG000|Randomization|Withdrawal by participant|0|||
156337135|NCT01673867|564333550|FG001|Randomization|Withdrawal by participant|12|||
156337136|NCT01673867|564333549|FG000|Randomization|Lost to Follow-up|0|||
156337137|NCT01673867|564333550|FG001|Randomization|Lost to Follow-up|1|||
156337138|NCT01673867|564333549|FG000|Randomization|Participant no longer meets study criteria|4|||
156337139|NCT01673867|564333550|FG001|Randomization|Participant no longer meets study criteria|5|||
156337140|NCT01673867|564333549|FG000|Treatment|Disease Progression|208|||
156337141|NCT01673867|564333550|FG001|Treatment|Disease Progression|178|||
156337142|NCT01673867|564333549|FG000|Treatment|Study Drug Toxicity|23|||
156337143|NCT01673867|564333550|FG001|Treatment|Study Drug Toxicity|43|||
156337144|NCT01673867|564333549|FG000|Treatment|Death|2|||
156337145|NCT01673867|564333550|FG001|Treatment|Death|3|||
156337146|NCT01673867|564333549|FG000|Treatment|Adverse event unrelated to study drug|23|||
156337147|NCT01673867|564333550|FG001|Treatment|Adverse event unrelated to study drug|10|||
156337148|NCT01673867|564333549|FG000|Treatment|Participant request to discontinue study treatment|7|||
156745166|NCT00114738|565815645|FG001|Screening for Randomization|Neuropathy|0|||
156799376|NCT00049543|566018988|FG000|Overall Study|still on treatment|2|||
156799377|NCT00049543|566018989|FG001|Overall Study|still on treatment|9|||
156799378|NCT04251533|566018999|FG000|Overall Study|Progressive disease|33|||
156337149|NCT01673867|564333550|FG001|Treatment|Participant request to discontinue study treatment|17|||
156337150|NCT01673867|564333549|FG000|Treatment|Withdrawal by participant|5|||
156799379|NCT04251533|566019000|FG001|Overall Study|Progressive disease|29|||
156799380|NCT04251533|566019001|FG002|Overall Study|Progressive disease|22|||
156799381|NCT04251533|566018999|FG000|Overall Study|Death|5|||
156799382|NCT04251533|566019000|FG001|Overall Study|Death|1|||
156799383|NCT04251533|566019001|FG002|Overall Study|Death|3|||
156799384|NCT04251533|566018999|FG000|Overall Study|Physician Decision|3|||
156799385|NCT04251533|566019000|FG001|Overall Study|Physician Decision|2|||
156799386|NCT04251533|566019001|FG002|Overall Study|Physician Decision|4|||
156799387|NCT04251533|566018999|FG000|Overall Study|Participant decision|1|||
156799388|NCT04251533|566019000|FG001|Overall Study|Participant decision|3|||
156337151|NCT01673867|564333550|FG001|Treatment|Withdrawal by participant|5|||
156337152|NCT01673867|564333549|FG000|Treatment|Maximum clinical benefit|1|||
156745167|NCT00114738|565815646|FG002|Screening for Randomization|Neuropathy|0|||
156799389|NCT04251533|566019001|FG002|Overall Study|Participant decision|1|||
156799390|NCT04251533|566018999|FG000|Overall Study|Adverse Event|2|||
156799391|NCT04251533|566019000|FG001|Overall Study|Adverse Event|1|||
156799392|NCT04251533|566019001|FG002|Overall Study|Adverse Event|1|||
156745168|NCT00114738|565815644|FG000|Screening for Randomization|Progressive disease|2|||
156745169|NCT00114738|565815645|FG001|Screening for Randomization|Progressive disease|0|||
156745170|NCT00114738|565815646|FG002|Screening for Randomization|Progressive disease|0|||
156745171|NCT00114738|565815644|FG000|Screening for Randomization|CNS Hemorrhage|1|||
156745172|NCT00114738|565815645|FG001|Screening for Randomization|CNS Hemorrhage|0|||
156745173|NCT00114738|565815646|FG002|Screening for Randomization|CNS Hemorrhage|0|||
156745174|NCT00114738|565815644|FG000|Screening for Randomization|Other|1|||
156745175|NCT00114738|565815645|FG001|Screening for Randomization|Other|0|||
156745176|NCT00114738|565815646|FG002|Screening for Randomization|Other|0|||
156745177|NCT00316914|565815648|FG000|Overall Study|Withdrawal by Subject|5|||
156745178|NCT00316914|565815649|FG001|Overall Study|Withdrawal by Subject|3|||
156745179|NCT00316914|565815648|FG000|Overall Study|Adverse Event|8|||
156745180|NCT00316914|565815649|FG001|Overall Study|Adverse Event|7|||
156745181|NCT00316914|565815648|FG000|Overall Study|Other Problems|6|||
156745182|NCT00316914|565815649|FG001|Overall Study|Other Problems|11|||
156745183|NCT00316914|565815648|FG000|Overall Study|Missing end of treatment documentation|14|||
156745184|NCT00316914|565815649|FG001|Overall Study|Missing end of treatment documentation|15|||
156745185|NCT04105010|565815650|FG000|Overall Study|Death|3|||
156745186|NCT04105010|565815651|FG001|Overall Study|Death|1|||
156745187|NCT04105010|565815652|FG002|Overall Study|Death|1|||
156458766|NCT01928394|564776658|FG004|Treatment Period|Participant withdrew consent|0|||
156458767|NCT01928394|564776659|FG005|Treatment Period|Participant withdrew consent|1|||
156458768|NCT01928394|564776660|FG006|Treatment Period|Participant withdrew consent|0|||
156458769|NCT01928394|564776661|FG007|Treatment Period|Participant withdrew consent|1|||
156458770|NCT01928394|564776662|FG008|Treatment Period|Participant withdrew consent|0|||
156458771|NCT01928394|564776663|FG009|Treatment Period|Participant withdrew consent|0|||
156458772|NCT01928394|564776664|FG010|Treatment Period|Participant withdrew consent|1|||
156458773|NCT01928394|564776665|FG011|Treatment Period|Participant withdrew consent|1|||
156458774|NCT01928394|564776666|FG012|Treatment Period|Participant withdrew consent|1|||
156458775|NCT01928394|564776667|FG013|Treatment Period|Participant withdrew consent|0|||
156458776|NCT01928394|564776668|FG014|Treatment Period|Participant withdrew consent|2|||
156458777|NCT01928394|564776669|FG015|Treatment Period|Participant withdrew consent|0|||
156458778|NCT01928394|564776670|FG016|Treatment Period|Participant withdrew consent|2|||
156458779|NCT01928394|564776671|FG017|Treatment Period|Participant withdrew consent|1|||
156458780|NCT01928394|564776672|FG018|Treatment Period|Participant withdrew consent|1|||
156458781|NCT01928394|564776673|FG019|Treatment Period|Participant withdrew consent|1|||
156458782|NCT01928394|564776674|FG020|Treatment Period|Participant withdrew consent|0|||
156458783|NCT01928394|564776675|FG021|Treatment Period|Participant withdrew consent|2|||
156458784|NCT01928394|564776676|FG022|Treatment Period|Participant withdrew consent|0|||
156458785|NCT01928394|564776654|FG000|Treatment Period|Poor/non-compliance|0|||
156458786|NCT01928394|564776655|FG001|Treatment Period|Poor/non-compliance|0|||
156458787|NCT01928394|564776656|FG002|Treatment Period|Poor/non-compliance|0|||
156458788|NCT01928394|564776657|FG003|Treatment Period|Poor/non-compliance|1|||
156458789|NCT01928394|564776658|FG004|Treatment Period|Poor/non-compliance|0|||
156458790|NCT01928394|564776659|FG005|Treatment Period|Poor/non-compliance|0|||
156458791|NCT01928394|564776660|FG006|Treatment Period|Poor/non-compliance|0|||
156458792|NCT01928394|564776661|FG007|Treatment Period|Poor/non-compliance|0|||
156458793|NCT01928394|564776662|FG008|Treatment Period|Poor/non-compliance|0|||
156458794|NCT01928394|564776663|FG009|Treatment Period|Poor/non-compliance|0|||
156458795|NCT01928394|564776664|FG010|Treatment Period|Poor/non-compliance|0|||
156458796|NCT01928394|564776665|FG011|Treatment Period|Poor/non-compliance|0|||
156458797|NCT01928394|564776666|FG012|Treatment Period|Poor/non-compliance|1|||
156458798|NCT01928394|564776667|FG013|Treatment Period|Poor/non-compliance|0|||
156458799|NCT01928394|564776668|FG014|Treatment Period|Poor/non-compliance|1|||
156458800|NCT01928394|564776669|FG015|Treatment Period|Poor/non-compliance|0|||
156458801|NCT01928394|564776670|FG016|Treatment Period|Poor/non-compliance|0|||
156458802|NCT01928394|564776671|FG017|Treatment Period|Poor/non-compliance|1|||
156458803|NCT01928394|564776672|FG018|Treatment Period|Poor/non-compliance|0|||
156458804|NCT01928394|564776673|FG019|Treatment Period|Poor/non-compliance|1|||
156458805|NCT01928394|564776674|FG020|Treatment Period|Poor/non-compliance|0|||
156458806|NCT01928394|564776675|FG021|Treatment Period|Poor/non-compliance|0|||
156458807|NCT01928394|564776676|FG022|Treatment Period|Poor/non-compliance|0|||
156458808|NCT01928394|564776654|FG000|Treatment Period|other reason|0|||
156458809|NCT01928394|564776655|FG001|Treatment Period|other reason|0|||
156458810|NCT01928394|564776656|FG002|Treatment Period|other reason|0|||
156458811|NCT01928394|564776657|FG003|Treatment Period|other reason|0|||
156458812|NCT01928394|564776658|FG004|Treatment Period|other reason|0|||
156458813|NCT01928394|564776659|FG005|Treatment Period|other reason|0|||
156458814|NCT01928394|564776660|FG006|Treatment Period|other reason|0|||
156458815|NCT01928394|564776661|FG007|Treatment Period|other reason|0|||
156458816|NCT01928394|564776662|FG008|Treatment Period|other reason|0|||
156458817|NCT01928394|564776663|FG009|Treatment Period|other reason|0|||
156745188|NCT04105010|565815653|FG003|Overall Study|Death|54|||
156745189|NCT04105010|565815650|FG000|Overall Study|Lost to Follow-up|0|||
156745190|NCT04105010|565815651|FG001|Overall Study|Lost to Follow-up|0|||
156745191|NCT04105010|565815652|FG002|Overall Study|Lost to Follow-up|0|||
156745192|NCT04105010|565815653|FG003|Overall Study|Lost to Follow-up|4|||
156745193|NCT04105010|565815650|FG000|Overall Study|Withdrawal by Subject|8|||
156745194|NCT04105010|565815651|FG001|Overall Study|Withdrawal by Subject|1|||
156745195|NCT04105010|565815652|FG002|Overall Study|Withdrawal by Subject|1|||
156745196|NCT04105010|565815653|FG003|Overall Study|Withdrawal by Subject|4|||
156745197|NCT04105010|565815650|FG000|Overall Study|Other reason|4|||
156745198|NCT04105010|565815651|FG001|Overall Study|Other reason|7|||
156745199|NCT04105010|565815652|FG002|Overall Study|Other reason|0|||
156745200|NCT04105010|565815653|FG003|Overall Study|Other reason|19|||
156745201|NCT01211483|565815654|FG000|Phase 1b|Death|6|||
156745202|NCT01211483|565815655|FG001|Phase 1b|Death|0|||
156745203|NCT01211483|565815656|FG002|Phase 1b|Death|0|||
156799393|NCT02303821|566019004|FG000|Overall Study|Withdrawal by Subject|0|||
156799394|NCT02303821|566019005|FG001|Overall Study|Withdrawal by Subject|0|||
156799395|NCT02303821|566019006|FG002|Overall Study|Withdrawal by Subject|0|||
156799396|NCT02303821|566019007|FG003|Overall Study|Withdrawal by Subject|0|||
156799397|NCT02303821|566019008|FG004|Overall Study|Withdrawal by Subject|0|||
156799398|NCT02303821|566019009|FG005|Overall Study|Withdrawal by Subject|0|||
156799399|NCT02303821|566019010|FG006|Overall Study|Withdrawal by Subject|0|||
156799400|NCT02303821|566019011|FG007|Overall Study|Withdrawal by Subject|2|||
156799401|NCT02303821|566019004|FG000|Overall Study|Death|0|||
156799402|NCT02303821|566019005|FG001|Overall Study|Death|2|||
156799403|NCT02303821|566019006|FG002|Overall Study|Death|0|||
156799404|NCT02303821|566019007|FG003|Overall Study|Death|0|||
156799405|NCT02303821|566019008|FG004|Overall Study|Death|0|||
156799406|NCT02303821|566019009|FG005|Overall Study|Death|3|||
156799407|NCT02303821|566019010|FG006|Overall Study|Death|41|||
156799408|NCT02303821|566019011|FG007|Overall Study|Death|29|||
156799409|NCT02303821|566019004|FG000|Overall Study|Lost to Follow-up|0|||
156799410|NCT02303821|566019005|FG001|Overall Study|Lost to Follow-up|0|||
156799411|NCT02303821|566019006|FG002|Overall Study|Lost to Follow-up|0|||
156799412|NCT02303821|566019007|FG003|Overall Study|Lost to Follow-up|0|||
156458818|NCT01928394|564776664|FG010|Treatment Period|other reason|1|||
156458819|NCT01928394|564776665|FG011|Treatment Period|other reason|1|||
156458820|NCT01928394|564776666|FG012|Treatment Period|other reason|1|||
156458821|NCT01928394|564776667|FG013|Treatment Period|other reason|0|||
156458822|NCT01928394|564776668|FG014|Treatment Period|other reason|1|||
156458823|NCT01928394|564776669|FG015|Treatment Period|other reason|0|||
156458824|NCT01928394|564776670|FG016|Treatment Period|other reason|0|||
156458825|NCT01928394|564776671|FG017|Treatment Period|other reason|0|||
156458826|NCT01928394|564776672|FG018|Treatment Period|other reason|2|||
156458827|NCT01928394|564776673|FG019|Treatment Period|other reason|2|||
156458828|NCT01928394|564776674|FG020|Treatment Period|other reason|0|||
156458829|NCT01928394|564776675|FG021|Treatment Period|other reason|0|||
156458830|NCT01928394|564776676|FG022|Treatment Period|other reason|0|||
156458831|NCT01928394|564776654|FG000|Treatment Period|Maximum clinical benefit|0|||
156458832|NCT01928394|564776655|FG001|Treatment Period|Maximum clinical benefit|0|||
156458833|NCT01928394|564776656|FG002|Treatment Period|Maximum clinical benefit|0|||
156458834|NCT01928394|564776657|FG003|Treatment Period|Maximum clinical benefit|0|||
156458835|NCT01928394|564776658|FG004|Treatment Period|Maximum clinical benefit|0|||
156458836|NCT01928394|564776659|FG005|Treatment Period|Maximum clinical benefit|0|||
156458837|NCT01928394|564776660|FG006|Treatment Period|Maximum clinical benefit|0|||
156458838|NCT01928394|564776661|FG007|Treatment Period|Maximum clinical benefit|0|||
156458839|NCT01928394|564776662|FG008|Treatment Period|Maximum clinical benefit|0|||
156458840|NCT01928394|564776663|FG009|Treatment Period|Maximum clinical benefit|0|||
156458841|NCT01928394|564776664|FG010|Treatment Period|Maximum clinical benefit|1|||
156458842|NCT01928394|564776665|FG011|Treatment Period|Maximum clinical benefit|1|||
156458843|NCT01928394|564776666|FG012|Treatment Period|Maximum clinical benefit|0|||
156458844|NCT01928394|564776667|FG013|Treatment Period|Maximum clinical benefit|0|||
156458845|NCT01928394|564776668|FG014|Treatment Period|Maximum clinical benefit|1|||
156458846|NCT01928394|564776669|FG015|Treatment Period|Maximum clinical benefit|0|||
156458847|NCT01928394|564776670|FG016|Treatment Period|Maximum clinical benefit|0|||
156458848|NCT01928394|564776671|FG017|Treatment Period|Maximum clinical benefit|1|||
156458849|NCT01928394|564776672|FG018|Treatment Period|Maximum clinical benefit|1|||
156458850|NCT01928394|564776673|FG019|Treatment Period|Maximum clinical benefit|0|||
156458851|NCT01928394|564776674|FG020|Treatment Period|Maximum clinical benefit|2|||
156458852|NCT01928394|564776675|FG021|Treatment Period|Maximum clinical benefit|0|||
156458853|NCT01928394|564776676|FG022|Treatment Period|Maximum clinical benefit|0|||
156458854|NCT01928394|564776654|FG000|Treatment Period|Lost to Follow-up|0|||
156458855|NCT01928394|564776655|FG001|Treatment Period|Lost to Follow-up|0|||
156745204|NCT01211483|565815657|FG003|Phase 1b|Death|0|||
156799413|NCT02303821|566019008|FG004|Overall Study|Lost to Follow-up|0|||
156745205|NCT01211483|565815654|FG000|Phase 1b|Withdrawal by Subject|1|||
156799414|NCT02303821|566019009|FG005|Overall Study|Lost to Follow-up|0|||
156799415|NCT02303821|566019010|FG006|Overall Study|Lost to Follow-up|1|||
156799416|NCT02303821|566019011|FG007|Overall Study|Lost to Follow-up|0|||
156745206|NCT01211483|565815655|FG001|Phase 1b|Withdrawal by Subject|0|||
156745207|NCT01211483|565815656|FG002|Phase 1b|Withdrawal by Subject|0|||
156535956|NCT01994382|565057604|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535957|NCT01994382|565057605|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535958|NCT01994382|565057606|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535959|NCT01994382|565057607|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535960|NCT01994382|565057608|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
156535961|NCT01994382|565057609|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535962|NCT01994382|565057610|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
156535963|NCT01994382|565057611|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535964|NCT01994382|565057612|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
156535965|NCT01994382|565057613|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
156535966|NCT01994382|565057614|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
156535967|NCT01994382|565057598|FG000|Overall Study|Protocol violation/noncompliance|0|||
156535968|NCT01994382|565057599|FG001|Overall Study|Protocol violation/noncompliance|0|||
156535969|NCT01994382|565057600|FG002|Overall Study|Protocol violation/noncompliance|0|||
156535970|NCT01994382|565057601|FG003|Overall Study|Protocol violation/noncompliance|0|||
156535971|NCT01994382|565057602|FG004|Overall Study|Protocol violation/noncompliance|0|||
156535972|NCT01994382|565057603|FG005|Overall Study|Protocol violation/noncompliance|0|||
156535973|NCT01994382|565057604|FG006|Overall Study|Protocol violation/noncompliance|0|||
156535974|NCT01994382|565057605|FG007|Overall Study|Protocol violation/noncompliance|0|||
156535975|NCT01994382|565057606|FG008|Overall Study|Protocol violation/noncompliance|0|||
156535976|NCT01994382|565057607|FG009|Overall Study|Protocol violation/noncompliance|0|||
156535977|NCT01994382|565057608|FG010|Overall Study|Protocol violation/noncompliance|0|||
156535978|NCT01994382|565057609|FG011|Overall Study|Protocol violation/noncompliance|1|||
156535979|NCT01994382|565057610|FG012|Overall Study|Protocol violation/noncompliance|0|||
156535980|NCT01994382|565057611|FG013|Overall Study|Protocol violation/noncompliance|0|||
156535981|NCT01994382|565057612|FG014|Overall Study|Protocol violation/noncompliance|0|||
156535982|NCT01994382|565057613|FG015|Overall Study|Protocol violation/noncompliance|0|||
156535983|NCT01994382|565057614|FG016|Overall Study|Protocol violation/noncompliance|2|||
156535984|NCT01994382|565057598|FG000|Overall Study|Rolled over to Phase 2a|0|||
156535985|NCT01994382|565057599|FG001|Overall Study|Rolled over to Phase 2a|0|||
156337153|NCT01673867|564333550|FG001|Treatment|Maximum clinical benefit|10|||
156337154|NCT01673867|564333549|FG000|Treatment|Participant no longer meets study criteria|2|||
156535986|NCT01994382|565057600|FG002|Overall Study|Rolled over to Phase 2a|1|||
156535987|NCT01994382|565057601|FG003|Overall Study|Rolled over to Phase 2a|0|||
156535988|NCT01994382|565057602|FG004|Overall Study|Rolled over to Phase 2a|0|||
156535989|NCT01994382|565057603|FG005|Overall Study|Rolled over to Phase 2a|0|||
156535990|NCT01994382|565057604|FG006|Overall Study|Rolled over to Phase 2a|0|||
156535991|NCT01994382|565057605|FG007|Overall Study|Rolled over to Phase 2a|0|||
156535992|NCT01994382|565057606|FG008|Overall Study|Rolled over to Phase 2a|0|||
156535993|NCT01994382|565057607|FG009|Overall Study|Rolled over to Phase 2a|2|||
156535994|NCT01994382|565057608|FG010|Overall Study|Rolled over to Phase 2a|0|||
156535995|NCT01994382|565057609|FG011|Overall Study|Rolled over to Phase 2a|0|||
156535996|NCT01994382|565057610|FG012|Overall Study|Rolled over to Phase 2a|0|||
156535997|NCT01994382|565057611|FG013|Overall Study|Rolled over to Phase 2a|0|||
156535998|NCT01994382|565057612|FG014|Overall Study|Rolled over to Phase 2a|0|||
156535999|NCT01994382|565057613|FG015|Overall Study|Rolled over to Phase 2a|0|||
156536000|NCT01994382|565057614|FG016|Overall Study|Rolled over to Phase 2a|0|||
156536001|NCT00314249|565057615|FG000|Overall Study|Adverse Event|73|||
156536002|NCT00314249|565057616|FG001|Overall Study|Adverse Event|94|||
156536003|NCT00314249|565057615|FG000|Overall Study|Lack of Efficacy|33|||
156536004|NCT00314249|565057616|FG001|Overall Study|Lack of Efficacy|24|||
156536005|NCT00314249|565057615|FG000|Overall Study|Withdrawal by Subject|21|||
156536006|NCT00314249|565057616|FG001|Overall Study|Withdrawal by Subject|28|||
156536007|NCT00314249|565057615|FG000|Overall Study|Lost to Follow-up|15|||
156536008|NCT00314249|565057616|FG001|Overall Study|Lost to Follow-up|9|||
156536009|NCT00314249|565057615|FG000|Overall Study|Physician Decision|1|||
156536010|NCT00314249|565057616|FG001|Overall Study|Physician Decision|1|||
156536011|NCT00314249|565057615|FG000|Overall Study|Withdrawn for other reasons|4|||
156536012|NCT00314249|565057616|FG001|Overall Study|Withdrawn for other reasons|1|||
156536013|NCT00314249|565057615|FG000|Overall Study|Non-Compliant|5|||
156337155|NCT01673867|564333550|FG001|Treatment|Participant no longer meets study criteria|0|||
156536014|NCT00314249|565057616|FG001|Overall Study|Non-Compliant|6|||
156536015|NCT04667377|565057617|FG000|Dose Escalation Period|Other not specified below|3|||
156745208|NCT01211483|565815657|FG003|Phase 1b|Withdrawal by Subject|0|||
156745209|NCT01211483|565815654|FG000|Phase 2|Lost to Follow-up|0|||
156745210|NCT01211483|565815655|FG001|Phase 2|Lost to Follow-up|1|||
156536016|NCT04667377|565057618|FG001|Dose Escalation Period|Other not specified below|3|||
156536017|NCT04667377|565057619|FG002|Dose Escalation Period|Other not specified below|2|||
156745211|NCT01211483|565815656|FG002|Phase 2|Lost to Follow-up|1|||
156745212|NCT01211483|565815657|FG003|Phase 2|Lost to Follow-up|2|||
156745213|NCT01211483|565815654|FG000|Phase 2|Death|0|||
156536018|NCT04667377|565057620|FG003|Dose Escalation Period|Other not specified below|1|||
156536019|NCT04667377|565057621|FG004|Dose Escalation Period|Other not specified below|3|||
156536020|NCT04667377|565057617|FG000|Dose Escalation Period|Protocol Violation|2|||
156536021|NCT04667377|565057618|FG001|Dose Escalation Period|Protocol Violation|2|||
156536022|NCT04667377|565057619|FG002|Dose Escalation Period|Protocol Violation|0|||
156536023|NCT04667377|565057620|FG003|Dose Escalation Period|Protocol Violation|2|||
156536024|NCT04667377|565057621|FG004|Dose Escalation Period|Protocol Violation|1|||
156745214|NCT01211483|565815655|FG001|Phase 2|Death|64|||
156745215|NCT01211483|565815656|FG002|Phase 2|Death|53|||
156745216|NCT01211483|565815657|FG003|Phase 2|Death|53|||
156745217|NCT01211483|565815654|FG000|Phase 2|Withdrawal by Subject|0|||
156536025|NCT04667377|565057617|FG000|Dose Escalation Period|Burden of study procedures|2|||
156536026|NCT04667377|565057618|FG001|Dose Escalation Period|Burden of study procedures|1|||
156536027|NCT04667377|565057619|FG002|Dose Escalation Period|Burden of study procedures|1|||
156536028|NCT04667377|565057620|FG003|Dose Escalation Period|Burden of study procedures|1|||
156536029|NCT04667377|565057621|FG004|Dose Escalation Period|Burden of study procedures|5|||
156536030|NCT04667377|565057617|FG000|Dose Escalation Period|Change of residence|0|||
156745218|NCT01211483|565815655|FG001|Phase 2|Withdrawal by Subject|1|||
156745219|NCT01211483|565815656|FG002|Phase 2|Withdrawal by Subject|10|||
156745220|NCT01211483|565815657|FG003|Phase 2|Withdrawal by Subject|5|||
156745221|NCT01211483|565815654|FG000|Phase 2|Study terminated by Sponsor|0|||
156745222|NCT01211483|565815655|FG001|Phase 2|Study terminated by Sponsor|6|||
156745223|NCT01211483|565815656|FG002|Phase 2|Study terminated by Sponsor|8|||
156745224|NCT01211483|565815657|FG003|Phase 2|Study terminated by Sponsor|11|||
156745225|NCT01675154|565815658|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
156745226|NCT01675154|565815659|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
156745227|NCT01675154|565815660|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
156745228|NCT01675154|565815661|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
156745229|NCT02971800|565815664|FG000|Overall Study|Protocol Violation|1|||
156745230|NCT02971800|565815664|FG000|Overall Study|Withdrawal by Subject|1|||
156745231|NCT02971800|565815664|FG000|Overall Study|Exclusion criteria prior intervention|1|||
156745232|NCT02971800|565815664|FG000|Overall Study|Number evaluable participant already reached|4|||
156745233|NCT01149421|565815666|FG000|Overall Study|Adverse Event|22|||
156745234|NCT01149421|565815667|FG001|Overall Study|Adverse Event|6|||
156536031|NCT04667377|565057618|FG001|Dose Escalation Period|Change of residence|0|||
156536032|NCT04667377|565057619|FG002|Dose Escalation Period|Change of residence|1|||
156536033|NCT04667377|565057620|FG003|Dose Escalation Period|Change of residence|0|||
156536034|NCT04667377|565057621|FG004|Dose Escalation Period|Change of residence|0|||
156536035|NCT04667377|565057617|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
156536036|NCT04667377|565057618|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
156536037|NCT04667377|565057619|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
156536038|NCT04667377|565057620|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
156536039|NCT04667377|565057621|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
156536040|NCT04667377|565057617|FG000|Dose Escalation Period|Adverse Event|9|||
156745235|NCT01149421|565815668|FG002|Overall Study|Adverse Event|11|||
156745236|NCT01149421|565815666|FG000|Overall Study|Withdrawal by Subject|20|||
156745237|NCT01149421|565815667|FG001|Overall Study|Withdrawal by Subject|12|||
156745238|NCT01149421|565815668|FG002|Overall Study|Withdrawal by Subject|13|||
156745239|NCT01149421|565815666|FG000|Overall Study|Sponsor Decision|0|||
156745240|NCT01149421|565815667|FG001|Overall Study|Sponsor Decision|1|||
156745241|NCT01149421|565815668|FG002|Overall Study|Sponsor Decision|1|||
156745242|NCT01149421|565815666|FG000|Overall Study|Lost to Follow-up|2|||
156745243|NCT01149421|565815667|FG001|Overall Study|Lost to Follow-up|4|||
156745244|NCT01149421|565815668|FG002|Overall Study|Lost to Follow-up|5|||
156745245|NCT01149421|565815666|FG000|Overall Study|Physician Decision|5|||
156745246|NCT01149421|565815667|FG001|Overall Study|Physician Decision|3|||
156536041|NCT04667377|565057618|FG001|Dose Escalation Period|Adverse Event|10|||
156536042|NCT04667377|565057619|FG002|Dose Escalation Period|Adverse Event|12|||
156536043|NCT04667377|565057620|FG003|Dose Escalation Period|Adverse Event|17|||
156745247|NCT01149421|565815668|FG002|Overall Study|Physician Decision|6|||
156745248|NCT01149421|565815666|FG000|Overall Study|Entry Criteria Not Met|1|||
156745249|NCT01149421|565815667|FG001|Overall Study|Entry Criteria Not Met|1|||
156745250|NCT01149421|565815668|FG002|Overall Study|Entry Criteria Not Met|2|||
156745251|NCT01149421|565815666|FG000|Overall Study|Protocol Violation|2|||
156745252|NCT01149421|565815667|FG001|Overall Study|Protocol Violation|2|||
156745253|NCT01149421|565815668|FG002|Overall Study|Protocol Violation|6|||
156745254|NCT00616603|565815669|FG000|Overall Study|Physician Decision|2|||
156745255|NCT00616603|565815670|FG001|Overall Study|Physician Decision|0|||
156745256|NCT00616603|565815671|FG002|Overall Study|Physician Decision|2|||
156745257|NCT03570554|565815674|FG000|Overall Study|Non-compliance with study drug|0|||
156745258|NCT03570554|565815675|FG001|Overall Study|Non-compliance with study drug|0|||
156745259|NCT03570554|565815676|FG002|Overall Study|Non-compliance with study drug|1|||
156745260|NCT03570554|565815677|FG003|Overall Study|Non-compliance with study drug|0|||
156745261|NCT03570554|565815674|FG000|Overall Study|Adverse Event|0|||
156745262|NCT03570554|565815675|FG001|Overall Study|Adverse Event|0|||
156745263|NCT03570554|565815676|FG002|Overall Study|Adverse Event|0|||
156745264|NCT03570554|565815677|FG003|Overall Study|Adverse Event|1|||
156745265|NCT03738800|565815678|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
156745266|NCT03738800|565815679|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
156745267|NCT03738800|565815680|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156745268|NCT03738800|565815678|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
156745269|NCT03738800|565815679|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
156745270|NCT03738800|565815680|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
156745271|NCT03738800|565815678|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
156745272|NCT03738800|565815679|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
156745273|NCT03738800|565815680|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
156745274|NCT02719353|565815683|FG000|First Intervention|Physician Decision|0|||
156745275|NCT02719353|565815684|FG001|First Intervention|Physician Decision|1|||
156745276|NCT00766467|565815685|FG000|Overall Study|Withdrawal by Subject|7|||
156745277|NCT00766467|565815686|FG001|Overall Study|Withdrawal by Subject|2|||
156745278|NCT00766467|565815685|FG000|Overall Study|Adverse Event|1|||
156745279|NCT00766467|565815686|FG001|Overall Study|Adverse Event|1|||
156745280|NCT00766467|565815685|FG000|Overall Study|Protocol Violation|2|||
156745281|NCT00766467|565815686|FG001|Overall Study|Protocol Violation|4|||
156745282|NCT00766467|565815685|FG000|Overall Study|Tumor Progression on Study|0|||
156745283|NCT00766467|565815686|FG001|Overall Study|Tumor Progression on Study|1|||
156745284|NCT00766467|565815685|FG000|Overall Study|Physician Decision|1|||
156745285|NCT00766467|565815686|FG001|Overall Study|Physician Decision|0|||
156745286|NCT02223819|565815689|FG000|Overall Study|Lost to Follow-up|2|||
156745287|NCT01917344|565815692|FG000|Overall Study|Withdrawal by Subject|1|||
156745288|NCT00367484|565815693|FG000|Overall Study|Adverse Event|7|||
156745289|NCT00367484|565815693|FG000|Overall Study|Withdrew informed consent|5|||
156745290|NCT00367484|565815693|FG000|Overall Study|Travel to USA|1|||
156745291|NCT00367484|565815693|FG000|Overall Study|Lost to Follow-up|1|||
156745292|NCT00367484|565815693|FG000|Overall Study|Protocol Violation|1|||
156745293|NCT00367484|565815693|FG000|Overall Study|The choice of the patient|1|||
156745294|NCT00367484|565815693|FG000|Overall Study|Lack of Efficacy|1|||
156745295|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
156745296|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
156745297|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
156745298|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
156745299|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
156745300|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
156745301|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
156745302|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
156745303|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
156745304|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
156745305|NCT01777295|565815695|FG000|Overall Study|Withdrawal by Subject|2|||
156745306|NCT01777295|565815696|FG001|Overall Study|Withdrawal by Subject|2|||
156745307|NCT01777295|565815695|FG000|Overall Study|Pregnancy|0|||
156745308|NCT01777295|565815696|FG001|Overall Study|Pregnancy|1|||
156745309|NCT01777295|565815695|FG000|Overall Study|Personal problem|1|||
156745310|NCT01777295|565815696|FG001|Overall Study|Personal problem|0|||
156745311|NCT01777295|565815695|FG000|Overall Study|Investigator call for AEs check|1|||
156745312|NCT01777295|565815696|FG001|Overall Study|Investigator call for AEs check|0|||
156745313|NCT00426660|565815697|FG000|Overall Study|Death|14|||
156745314|NCT00426660|565815697|FG000|Overall Study|Adverse Event|23|||
156745315|NCT00426660|565815697|FG000|Overall Study|Insufficient Clinical Response|22|||
156745316|NCT00426660|565815697|FG000|Overall Study|Lost to Follow-up|15|||
156745317|NCT00426660|565815697|FG000|Overall Study|Other|23|||
156745318|NCT00426660|565815697|FG000|Overall Study|Withdrawal by Subject|18|||
156745319|NCT00426660|565815697|FG000|Overall Study|Protocol Violation|1|||
156745320|NCT00426660|565815697|FG000|Overall Study|Enrolled Not Treated|15|||
156745321|NCT01398410|565815698|FG000|Overall Study|Adverse Event|12|||
156745322|NCT01398410|565815699|FG001|Overall Study|Adverse Event|16|||
156745323|NCT01398410|565815698|FG000|Overall Study|Participants Choice|8|||
156745324|NCT01398410|565815699|FG001|Overall Study|Participants Choice|11|||
156745325|NCT01398410|565815698|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
156745326|NCT01398410|565815699|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
156745327|NCT01398410|565815698|FG000|Overall Study|Other|36|||
156745328|NCT01398410|565815699|FG001|Overall Study|Other|29|||
156745329|NCT02470403|565815700|FG000|Overall Study|Adverse Event|1|||
156745330|NCT02470403|565815701|FG001|Overall Study|Adverse Event|0|||
156745331|NCT02470403|565815702|FG002|Overall Study|Adverse Event|0|||
156745332|NCT02470403|565815703|FG003|Overall Study|Adverse Event|0|||
156745333|NCT02470403|565815704|FG004|Overall Study|Adverse Event|0|||
156337156|NCT01673867|564333549|FG000|Treatment|Administrative reason by sponsor|3|||
156337157|NCT01673867|564333550|FG001|Treatment|Administrative reason by sponsor|0|||
156337158|NCT01673867|564333549|FG000|Treatment|Other reason|11|||
156337159|NCT01673867|564333550|FG001|Treatment|Other reason|2|||
156337160|NCT04218695|564333553|FG000|Overall Study|Adverse Event|1|||
156745334|NCT02470403|565815700|FG000|Overall Study|Lost to Follow-up|0|||
156799417|NCT02303821|566019004|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156337161|NCT04218695|564333554|FG001|Overall Study|Adverse Event|0|||
156337162|NCT01890473|564333555|FG000|Overall Study|Lost to Follow-up|1|||
156745335|NCT02470403|565815701|FG001|Overall Study|Lost to Follow-up|1|||
156745336|NCT02470403|565815702|FG002|Overall Study|Lost to Follow-up|0|||
156745337|NCT02470403|565815703|FG003|Overall Study|Lost to Follow-up|0|||
156745338|NCT02470403|565815704|FG004|Overall Study|Lost to Follow-up|0|||
156745339|NCT02470403|565815700|FG000|Overall Study|Subject/guardian decision|1|||
156745340|NCT02470403|565815701|FG001|Overall Study|Subject/guardian decision|0|||
156745341|NCT02470403|565815702|FG002|Overall Study|Subject/guardian decision|0|||
156745342|NCT02470403|565815703|FG003|Overall Study|Subject/guardian decision|4|||
156745343|NCT02470403|565815704|FG004|Overall Study|Subject/guardian decision|0|||
156745344|NCT01522235|565815705|FG000|Overall Study|Physician Decision|1|||
156745345|NCT01522235|565815706|FG001|Overall Study|Physician Decision|1|||
156745346|NCT03769194|565815707|FG000|Overall Study|Withdrawal by Subject|0|||
156745347|NCT03769194|565815708|FG001|Overall Study|Withdrawal by Subject|7|||
156745348|NCT03769194|565815709|FG002|Overall Study|Withdrawal by Subject|4|||
156745349|NCT03769194|565815710|FG003|Overall Study|Withdrawal by Subject|1|||
156745350|NCT03769194|565815707|FG000|Overall Study|moved from study area|0|||
156745351|NCT03769194|565815708|FG001|Overall Study|moved from study area|2|||
156745352|NCT03769194|565815709|FG002|Overall Study|moved from study area|1|||
156745353|NCT03769194|565815710|FG003|Overall Study|moved from study area|1|||
156745354|NCT03769194|565815707|FG000|Overall Study|Lost to Follow-up|3|||
156745355|NCT03769194|565815708|FG001|Overall Study|Lost to Follow-up|6|||
156745356|NCT03769194|565815709|FG002|Overall Study|Lost to Follow-up|3|||
156745357|NCT03769194|565815710|FG003|Overall Study|Lost to Follow-up|6|||
156745358|NCT03769194|565815707|FG000|Overall Study|other|1|||
156745359|NCT03769194|565815708|FG001|Overall Study|other|3|||
156745360|NCT03769194|565815709|FG002|Overall Study|other|0|||
156745361|NCT03769194|565815710|FG003|Overall Study|other|1|||
156745362|NCT01430624|565815713|FG000|Overall Study|Lost to Follow-up|23|||
156799418|NCT02303821|566019005|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799419|NCT02303821|566019006|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799420|NCT02303821|566019007|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799421|NCT02303821|566019008|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799422|NCT02303821|566019009|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799423|NCT02303821|566019010|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
156799424|NCT02303821|566019011|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799425|NCT02303821|566019004|FG000|Overall Study|Decision by sponsor|0|||
156799426|NCT02303821|566019005|FG001|Overall Study|Decision by sponsor|0|||
156799427|NCT02303821|566019006|FG002|Overall Study|Decision by sponsor|0|||
156799428|NCT02303821|566019007|FG003|Overall Study|Decision by sponsor|0|||
156799429|NCT02303821|566019008|FG004|Overall Study|Decision by sponsor|0|||
156799430|NCT02303821|566019009|FG005|Overall Study|Decision by sponsor|1|||
156799431|NCT02303821|566019010|FG006|Overall Study|Decision by sponsor|0|||
156799432|NCT02303821|566019011|FG007|Overall Study|Decision by sponsor|0|||
156799433|NCT02303821|566019004|FG000|Overall Study|Protocol-specified criteria|0|||
156799434|NCT02303821|566019005|FG001|Overall Study|Protocol-specified criteria|1|||
156799435|NCT02303821|566019006|FG002|Overall Study|Protocol-specified criteria|0|||
156799436|NCT02303821|566019007|FG003|Overall Study|Protocol-specified criteria|0|||
156799437|NCT02303821|566019008|FG004|Overall Study|Protocol-specified criteria|0|||
156799438|NCT02303821|566019009|FG005|Overall Study|Protocol-specified criteria|1|||
156745363|NCT01430624|565815714|FG001|Overall Study|Lost to Follow-up|29|||
156745364|NCT01430624|565815715|FG002|Overall Study|Lost to Follow-up|27|||
156536044|NCT04667377|565057621|FG004|Dose Escalation Period|Adverse Event|3|||
156536045|NCT04667377|565057617|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
156745365|NCT01430624|565815713|FG000|Overall Study|technical or eligibility|5|||
156745366|NCT01430624|565815714|FG001|Overall Study|technical or eligibility|5|||
156745367|NCT01430624|565815715|FG002|Overall Study|technical or eligibility|2|||
156745368|NCT01362517|565815716|FG000|Overall Study|Protocol Violation|1|||
156745369|NCT01362517|565815716|FG000|Overall Study|Lost to Follow-up|1|||
156745370|NCT01133288|565815719|FG000|Eligibility Assessment|met exclusion criteria|5|||
156745371|NCT01133288|565815719|FG000|Intervention Allocation|study terminated|2|||
156745372|NCT02565706|565815724|FG000|Overall Study|Withdrawal by Subject|5|||
156745373|NCT02565706|565815725|FG001|Overall Study|Withdrawal by Subject|7|||
156745374|NCT02565706|565815726|FG002|Overall Study|Withdrawal by Subject|7|||
156745375|NCT02565706|565815727|FG003|Overall Study|Withdrawal by Subject|11|||
156745376|NCT02565706|565815724|FG000|Overall Study|Lost to Follow-up|72|||
156745377|NCT02565706|565815725|FG001|Overall Study|Lost to Follow-up|75|||
156745378|NCT02565706|565815726|FG002|Overall Study|Lost to Follow-up|82|||
156745379|NCT02565706|565815727|FG003|Overall Study|Lost to Follow-up|74|||
156745380|NCT03379792|565815729|FG000|Overall Study|Physician Decision|0|||
156745381|NCT03379792|565815730|FG001|Overall Study|Physician Decision|0|||
156745382|NCT03379792|565815731|FG002|Overall Study|Physician Decision|0|||
156745383|NCT03379792|565815732|FG003|Overall Study|Physician Decision|1|||
156745384|NCT03379792|565815733|FG004|Overall Study|Physician Decision|0|||
156745385|NCT03379792|565815734|FG005|Overall Study|Physician Decision|0|||
156745386|NCT03379792|565815729|FG000|Overall Study|Withdrawal by Subject|0|||
156745387|NCT03379792|565815730|FG001|Overall Study|Withdrawal by Subject|0|||
156745388|NCT03379792|565815731|FG002|Overall Study|Withdrawal by Subject|0|||
156745389|NCT03379792|565815732|FG003|Overall Study|Withdrawal by Subject|0|||
156745390|NCT03379792|565815733|FG004|Overall Study|Withdrawal by Subject|1|||
156745391|NCT03379792|565815734|FG005|Overall Study|Withdrawal by Subject|1|||
156745392|NCT01121536|565815735|FG000|Overall Study|Adverse Event|63|||
156745393|NCT01121536|565815735|FG000|Overall Study|Lack of Efficacy|35|||
156745394|NCT01121536|565815735|FG000|Overall Study|Withdrawal by Subject|65|||
156745395|NCT01121536|565815735|FG000|Overall Study|Protocol Violation|20|||
156745396|NCT01121536|565815735|FG000|Overall Study|Noncompliance with study medication|12|||
156745397|NCT01121536|565815735|FG000|Overall Study|Noncompliance with study procedures|9|||
156799439|NCT02303821|566019010|FG006|Overall Study|Protocol-specified criteria|0|||
156799440|NCT02303821|566019011|FG007|Overall Study|Protocol-specified criteria|0|||
156799441|NCT04116489|566019015|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
156799442|NCT04116489|566019015|FG000|Overall Study|Withdrawal by Subject|1|||
156536046|NCT04667377|565057618|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
156536047|NCT04667377|565057619|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
156536048|NCT04667377|565057620|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
156536049|NCT04667377|565057621|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
156536050|NCT04667377|565057617|FG000|Dose Escalation Period|Not treated|1|||
156536051|NCT04667377|565057618|FG001|Dose Escalation Period|Not treated|0|||
156536052|NCT04667377|565057619|FG002|Dose Escalation Period|Not treated|0|||
156536053|NCT04667377|565057620|FG003|Dose Escalation Period|Not treated|0|||
156536054|NCT04667377|565057621|FG004|Dose Escalation Period|Not treated|0|||
156536055|NCT04667377|565057617|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
156536056|NCT04667377|565057618|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
156536057|NCT04667377|565057619|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
156536058|NCT04667377|565057620|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
156536059|NCT04667377|565057621|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
156536060|NCT04667377|565057617|FG000|Dose Escalation Period|Lost to Follow-up|0|||
156536061|NCT04667377|565057618|FG001|Dose Escalation Period|Lost to Follow-up|1|||
156536062|NCT04667377|565057619|FG002|Dose Escalation Period|Lost to Follow-up|0|||
156536063|NCT04667377|565057620|FG003|Dose Escalation Period|Lost to Follow-up|0|||
156536064|NCT04667377|565057621|FG004|Dose Escalation Period|Lost to Follow-up|0|||
156536065|NCT04667377|565057617|FG000|Maintenance Period|Perceived lack of efficacy|0|||
156536066|NCT04667377|565057618|FG001|Maintenance Period|Perceived lack of efficacy|2|||
156745398|NCT01121536|565815735|FG000|Overall Study|Lost to Follow-up|39|||
156745399|NCT01121536|565815735|FG000|Overall Study|Other|118|||
156745400|NCT00401960|565815736|FG000|Overall Study|Lost to Follow-up|3|||
156745401|NCT00401960|565815737|FG001|Overall Study|Lost to Follow-up|0|||
156799443|NCT03138564|566019016|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
156799444|NCT03138564|566019017|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
156799445|NCT03138564|566019016|FG000|Overall Study|Lost to Follow-up|16|||
156536067|NCT04667377|565057619|FG002|Maintenance Period|Perceived lack of efficacy|1|||
156536068|NCT04667377|565057620|FG003|Maintenance Period|Perceived lack of efficacy|0|||
156536069|NCT04667377|565057621|FG004|Maintenance Period|Perceived lack of efficacy|1|||
156536070|NCT04667377|565057617|FG000|Maintenance Period|Adverse Event|2|||
156536071|NCT04667377|565057618|FG001|Maintenance Period|Adverse Event|8|||
156745402|NCT00401960|565815736|FG000|Overall Study|Death|2|||
156745403|NCT00401960|565815737|FG001|Overall Study|Death|0|||
156745404|NCT02649426|565815738|FG000|Overall Study|Follow-up on going|1|||
156536072|NCT04667377|565057619|FG002|Maintenance Period|Adverse Event|5|||
156536073|NCT04667377|565057620|FG003|Maintenance Period|Adverse Event|4|||
156536074|NCT04667377|565057621|FG004|Maintenance Period|Adverse Event|1|||
156536075|NCT04667377|565057617|FG000|Maintenance Period|Adverse event: COVID infection|0|||
156536076|NCT04667377|565057618|FG001|Maintenance Period|Adverse event: COVID infection|1|||
156536077|NCT04667377|565057619|FG002|Maintenance Period|Adverse event: COVID infection|0|||
156536078|NCT04667377|565057620|FG003|Maintenance Period|Adverse event: COVID infection|0|||
156536079|NCT04667377|565057621|FG004|Maintenance Period|Adverse event: COVID infection|0|||
156536080|NCT04667377|565057617|FG000|Maintenance Period|COVID-related|0|||
156536081|NCT04667377|565057618|FG001|Maintenance Period|COVID-related|0|||
156536082|NCT04667377|565057619|FG002|Maintenance Period|COVID-related|1|||
156536083|NCT04667377|565057620|FG003|Maintenance Period|COVID-related|1|||
156536084|NCT04667377|565057621|FG004|Maintenance Period|COVID-related|0|||
156536085|NCT04667377|565057617|FG000|Maintenance Period|Protocol Violation|1|||
156536086|NCT04667377|565057618|FG001|Maintenance Period|Protocol Violation|0|||
156536087|NCT04667377|565057619|FG002|Maintenance Period|Protocol Violation|0|||
156536088|NCT04667377|565057620|FG003|Maintenance Period|Protocol Violation|0|||
156536089|NCT04667377|565057621|FG004|Maintenance Period|Protocol Violation|1|||
156536090|NCT04667377|565057617|FG000|Maintenance Period|Burden of study procedures|1|||
156536091|NCT04667377|565057618|FG001|Maintenance Period|Burden of study procedures|2|||
156536092|NCT04667377|565057619|FG002|Maintenance Period|Burden of study procedures|0|||
156536093|NCT04667377|565057620|FG003|Maintenance Period|Burden of study procedures|1|||
156536094|NCT04667377|565057621|FG004|Maintenance Period|Burden of study procedures|0|||
156536095|NCT04667377|565057617|FG000|Maintenance Period|Change of residence|0|||
156536096|NCT04667377|565057618|FG001|Maintenance Period|Change of residence|1|||
156536097|NCT04667377|565057619|FG002|Maintenance Period|Change of residence|0|||
156536098|NCT04667377|565057620|FG003|Maintenance Period|Change of residence|0|||
156536099|NCT04667377|565057621|FG004|Maintenance Period|Change of residence|1|||
156536100|NCT04667377|565057617|FG000|Maintenance Period|Missing|1|||
156536101|NCT04667377|565057618|FG001|Maintenance Period|Missing|0|||
156536102|NCT04667377|565057619|FG002|Maintenance Period|Missing|0|||
156536103|NCT04667377|565057620|FG003|Maintenance Period|Missing|0|||
156536104|NCT04667377|565057621|FG004|Maintenance Period|Missing|0|||
156536105|NCT04667377|565057617|FG000|Maintenance Period|Other than listed above|2|||
156536106|NCT04667377|565057618|FG001|Maintenance Period|Other than listed above|0|||
156536107|NCT04667377|565057619|FG002|Maintenance Period|Other than listed above|3|||
156536108|NCT04667377|565057620|FG003|Maintenance Period|Other than listed above|2|||
156536109|NCT04667377|565057621|FG004|Maintenance Period|Other than listed above|6|||
156536110|NCT04667377|565057617|FG000|Maintenance Period|Withdrawal by Subject|0|||
156536111|NCT04667377|565057618|FG001|Maintenance Period|Withdrawal by Subject|1|||
156536112|NCT04667377|565057619|FG002|Maintenance Period|Withdrawal by Subject|0|||
156536113|NCT04667377|565057620|FG003|Maintenance Period|Withdrawal by Subject|0|||
156536114|NCT04667377|565057621|FG004|Maintenance Period|Withdrawal by Subject|0|||
156536115|NCT04667377|565057617|FG000|Maintenance Period|Lost to Follow-up|1|||
156536116|NCT04667377|565057618|FG001|Maintenance Period|Lost to Follow-up|0|||
156536117|NCT04667377|565057619|FG002|Maintenance Period|Lost to Follow-up|1|||
156536118|NCT04667377|565057620|FG003|Maintenance Period|Lost to Follow-up|0|||
156536119|NCT04667377|565057621|FG004|Maintenance Period|Lost to Follow-up|1|||
156536120|NCT00058552|565057622|FG000|Overall Study|Died prior to receiving treatment|4|||
156536121|NCT00058552|565057623|FG001|Overall Study|Died prior to receiving treatment|2|||
156536122|NCT00058552|565057622|FG000|Overall Study|Disease progression|52|||
156536123|NCT00058552|565057623|FG001|Overall Study|Disease progression|44|||
156536124|NCT00058552|565057622|FG000|Overall Study|Adverse Event|4|||
156536125|NCT00058552|565057623|FG001|Overall Study|Adverse Event|2|||
156536126|NCT00058552|565057622|FG000|Overall Study|Withdrawal by Subject|3|||
156536127|NCT00058552|565057623|FG001|Overall Study|Withdrawal by Subject|5|||
156536128|NCT00058552|565057622|FG000|Overall Study|Physician Decision|2|||
156536129|NCT00058552|565057623|FG001|Overall Study|Physician Decision|5|||
156799446|NCT03138564|566019017|FG001|Overall Study|Lost to Follow-up|2|||
156799447|NCT03138564|566019016|FG000|Overall Study|Withdrawal by Subject|48|||
156799448|NCT03138564|566019017|FG001|Overall Study|Withdrawal by Subject|4|||
156536130|NCT00058552|565057622|FG000|Overall Study|Clinical disease progression|0|||
156536131|NCT00058552|565057623|FG001|Overall Study|Clinical disease progression|4|||
156536132|NCT02428855|565057624|FG000|Overall Study|Withdrawal by Subject|2|||
156536133|NCT00210184|565057625|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
156536134|NCT03861936|565057626|FG000|Overall Study|Withdrawal by Subject|4|||
156799449|NCT03138564|566019016|FG000|Overall Study|No longer met eligibility criteria|2|||
156536135|NCT03861936|565057627|FG001|Overall Study|Withdrawal by Subject|1|||
156536136|NCT03861936|565057628|FG002|Overall Study|Withdrawal by Subject|3|||
156536137|NCT03861936|565057626|FG000|Overall Study|Lost to Follow-up|5|||
156536138|NCT03861936|565057627|FG001|Overall Study|Lost to Follow-up|3|||
156536139|NCT03861936|565057628|FG002|Overall Study|Lost to Follow-up|3|||
156536140|NCT03861936|565057626|FG000|Overall Study|Physician Decision|0|||
156536141|NCT03861936|565057627|FG001|Overall Study|Physician Decision|1|||
156536142|NCT03861936|565057628|FG002|Overall Study|Physician Decision|0|||
156799450|NCT03138564|566019017|FG001|Overall Study|No longer met eligibility criteria|0|||
156799451|NCT03138564|566019016|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
156799452|NCT03138564|566019017|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
156799453|NCT03138564|566019016|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
156799454|NCT03138564|566019017|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
156799455|NCT03138564|566019016|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
156799456|NCT03138564|566019017|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
156799457|NCT03138564|566019016|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
156799458|NCT03138564|566019017|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
156799459|NCT05177354|566019019|FG000|Implant to 30-day Visit|Physician Decision|1|||
156799460|NCT05177354|566019019|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
156799461|NCT05177354|566019019|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
156799462|NCT05177354|566019019|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
156799463|NCT02581930|566019027|FG000|Overall Study|Withdrawal by Subject|1|||
156799464|NCT02581930|566019027|FG000|Overall Study|patient declined further treatment|1|||
156799465|NCT01649869|566019028|FG000|Overall Study|Family member illness|1|||
156799466|NCT01649869|566019029|FG001|Overall Study|Family member illness|0|||
156799467|NCT01649869|566019028|FG000|Overall Study|Required treatment outside protocol|1|||
156799468|NCT01649869|566019029|FG001|Overall Study|Required treatment outside protocol|0|||
156799469|NCT01649869|566019028|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
156799470|NCT01649869|566019029|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
156799471|NCT02276040|566021309|FG000|Overall Study|Physician Decision|15|||
156799472|NCT02835690|566021310|FG000|Overall Study|Death|12|||
156799473|NCT02835690|566021311|FG001|Overall Study|Death|11|||
156799474|NCT02835690|566021312|FG002|Overall Study|Death|13|||
156799475|NCT02835690|566021310|FG000|Overall Study|Transferred to Extension Study|2|||
156799476|NCT02835690|566021311|FG001|Overall Study|Transferred to Extension Study|2|||
156799477|NCT02835690|566021312|FG002|Overall Study|Transferred to Extension Study|1|||
156799478|NCT02835690|566021310|FG000|Overall Study|Did Not Continue on Extension Study|0|||
156799479|NCT02835690|566021311|FG001|Overall Study|Did Not Continue on Extension Study|0|||
156799480|NCT02835690|566021312|FG002|Overall Study|Did Not Continue on Extension Study|1|||
156799481|NCT02835690|566021310|FG000|Overall Study|Not Treated|0|||
156799482|NCT02835690|566021311|FG001|Overall Study|Not Treated|2|||
156799483|NCT02835690|566021312|FG002|Overall Study|Not Treated|0|||
156799484|NCT00582907|566021313|FG000|1st Course|Withdrawal by Subject|1|||
156799485|NCT00582907|566021314|FG001|1st Course|Withdrawal by Subject|0|||
156799486|NCT00582907|566021315|FG002|1st Course|Withdrawal by Subject|0|||
156799487|NCT00582907|566021316|FG003|1st Course|Withdrawal by Subject|0|||
156799488|NCT00582907|566021313|FG000|1st Course|Lost to Follow-up|0|||
156799489|NCT00582907|566021314|FG001|1st Course|Lost to Follow-up|0|||
156799490|NCT00582907|566021315|FG002|1st Course|Lost to Follow-up|0|||
156799491|NCT00582907|566021316|FG003|1st Course|Lost to Follow-up|1|||
156799492|NCT00582907|566021313|FG000|2nd Course|Lack of Efficacy|1|||
156799493|NCT00582907|566021314|FG001|2nd Course|Lack of Efficacy|0|||
156799494|NCT00582907|566021315|FG002|2nd Course|Lack of Efficacy|0|||
156799495|NCT00582907|566021316|FG003|2nd Course|Lack of Efficacy|0|||
156799496|NCT04622592|566021317|FG000|Overall Study|Death|0|||
156799497|NCT04622592|566021318|FG001|Overall Study|Death|0|||
156799498|NCT04622592|566021319|FG002|Overall Study|Death|1|||
156799499|NCT04622592|566021320|FG003|Overall Study|Death|0|||
156799500|NCT04622592|566021321|FG004|Overall Study|Death|0|||
156799501|NCT04622592|566021322|FG005|Overall Study|Death|0|||
156799502|NCT04622592|566021323|FG006|Overall Study|Death|0|||
156799503|NCT04622592|566021324|FG007|Overall Study|Death|1|||
156745405|NCT02649426|565815739|FG001|Overall Study|Follow-up on going|26|||
156745406|NCT02649426|565815740|FG002|Overall Study|Follow-up on going|28|||
156745407|NCT02649426|565815741|FG003|Overall Study|Follow-up on going|31|||
156745408|NCT00306787|565815742|FG000|Overall Study|Discontinued without taking study drug|208|||
156745409|NCT00306787|565815743|FG001|Overall Study|Discontinued without taking study drug|215|||
156745410|NCT00306787|565815742|FG000|Overall Study|Adverse Event|1|||
156745411|NCT00306787|565815743|FG001|Overall Study|Adverse Event|1|||
156745412|NCT00306787|565815742|FG000|Overall Study|Lack of Efficacy|1|||
156745413|NCT00306787|565815743|FG001|Overall Study|Lack of Efficacy|0|||
156745414|NCT00306787|565815742|FG000|Overall Study|Protocol Violation|8|||
156745415|NCT00306787|565815743|FG001|Overall Study|Protocol Violation|10|||
156745416|NCT00306787|565815742|FG000|Overall Study|Withdrawal by Subject|2|||
156745417|NCT00306787|565815743|FG001|Overall Study|Withdrawal by Subject|9|||
156745418|NCT00306787|565815742|FG000|Overall Study|Lost to Follow-up|9|||
156745419|NCT00306787|565815743|FG001|Overall Study|Lost to Follow-up|6|||
156745420|NCT00306787|565815742|FG000|Overall Study|Administrative problems|4|||
156745421|NCT00306787|565815743|FG001|Overall Study|Administrative problems|0|||
156745422|NCT00306787|565815742|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156799504|NCT04622592|566021317|FG000|Overall Study|Lost to Follow-up|0|||
156799505|NCT04622592|566021318|FG001|Overall Study|Lost to Follow-up|0|||
156458856|NCT01928394|564776656|FG002|Treatment Period|Lost to Follow-up|0|||
156458857|NCT01928394|564776657|FG003|Treatment Period|Lost to Follow-up|0|||
156458858|NCT01928394|564776658|FG004|Treatment Period|Lost to Follow-up|0|||
156458859|NCT01928394|564776659|FG005|Treatment Period|Lost to Follow-up|0|||
156458860|NCT01928394|564776660|FG006|Treatment Period|Lost to Follow-up|0|||
156458861|NCT01928394|564776661|FG007|Treatment Period|Lost to Follow-up|0|||
156458862|NCT01928394|564776662|FG008|Treatment Period|Lost to Follow-up|0|||
156458863|NCT01928394|564776663|FG009|Treatment Period|Lost to Follow-up|0|||
156458864|NCT01928394|564776664|FG010|Treatment Period|Lost to Follow-up|0|||
156458865|NCT01928394|564776665|FG011|Treatment Period|Lost to Follow-up|0|||
156458866|NCT01928394|564776666|FG012|Treatment Period|Lost to Follow-up|0|||
156458867|NCT01928394|564776667|FG013|Treatment Period|Lost to Follow-up|0|||
156458868|NCT01928394|564776668|FG014|Treatment Period|Lost to Follow-up|0|||
156458869|NCT01928394|564776669|FG015|Treatment Period|Lost to Follow-up|0|||
156458870|NCT01928394|564776670|FG016|Treatment Period|Lost to Follow-up|0|||
156458871|NCT01928394|564776671|FG017|Treatment Period|Lost to Follow-up|0|||
156458872|NCT01928394|564776672|FG018|Treatment Period|Lost to Follow-up|0|||
156458873|NCT01928394|564776673|FG019|Treatment Period|Lost to Follow-up|0|||
156458874|NCT01928394|564776674|FG020|Treatment Period|Lost to Follow-up|0|||
156458875|NCT01928394|564776675|FG021|Treatment Period|Lost to Follow-up|0|||
156458876|NCT01928394|564776676|FG022|Treatment Period|Lost to Follow-up|1|||
156458877|NCT01928394|564776654|FG000|Treatment Period|Death|0|||
156458878|NCT01928394|564776655|FG001|Treatment Period|Death|0|||
156458879|NCT01928394|564776656|FG002|Treatment Period|Death|0|||
156458880|NCT01928394|564776657|FG003|Treatment Period|Death|0|||
156458881|NCT01928394|564776658|FG004|Treatment Period|Death|0|||
156458882|NCT01928394|564776659|FG005|Treatment Period|Death|0|||
156458883|NCT01928394|564776660|FG006|Treatment Period|Death|0|||
156458884|NCT01928394|564776661|FG007|Treatment Period|Death|0|||
156458885|NCT01928394|564776662|FG008|Treatment Period|Death|0|||
156458886|NCT01928394|564776663|FG009|Treatment Period|Death|0|||
156458887|NCT01928394|564776664|FG010|Treatment Period|Death|0|||
156458888|NCT01928394|564776665|FG011|Treatment Period|Death|0|||
156458889|NCT01928394|564776666|FG012|Treatment Period|Death|0|||
156458890|NCT01928394|564776667|FG013|Treatment Period|Death|1|||
156458891|NCT01928394|564776668|FG014|Treatment Period|Death|2|||
156458892|NCT01928394|564776669|FG015|Treatment Period|Death|0|||
156799506|NCT04622592|566021319|FG002|Overall Study|Lost to Follow-up|0|||
156799507|NCT04622592|566021320|FG003|Overall Study|Lost to Follow-up|3|||
156799508|NCT04622592|566021321|FG004|Overall Study|Lost to Follow-up|1|||
156799509|NCT04622592|566021322|FG005|Overall Study|Lost to Follow-up|0|||
156799510|NCT04622592|566021323|FG006|Overall Study|Lost to Follow-up|2|||
156799511|NCT04622592|566021324|FG007|Overall Study|Lost to Follow-up|2|||
156799512|NCT04622592|566021317|FG000|Overall Study|Physician Decision|0|||
156799513|NCT04622592|566021318|FG001|Overall Study|Physician Decision|0|||
156799514|NCT04622592|566021319|FG002|Overall Study|Physician Decision|0|||
156799515|NCT04622592|566021320|FG003|Overall Study|Physician Decision|0|||
156799516|NCT04622592|566021321|FG004|Overall Study|Physician Decision|1|||
156799517|NCT04622592|566021322|FG005|Overall Study|Physician Decision|0|||
156799518|NCT04622592|566021323|FG006|Overall Study|Physician Decision|0|||
156799519|NCT04622592|566021324|FG007|Overall Study|Physician Decision|0|||
156799520|NCT04622592|566021317|FG000|Overall Study|Withdrawal by Subject|1|||
156799521|NCT04622592|566021318|FG001|Overall Study|Withdrawal by Subject|0|||
156799522|NCT04622592|566021319|FG002|Overall Study|Withdrawal by Subject|2|||
156799523|NCT04622592|566021320|FG003|Overall Study|Withdrawal by Subject|0|||
156799524|NCT04622592|566021321|FG004|Overall Study|Withdrawal by Subject|0|||
156799525|NCT04622592|566021322|FG005|Overall Study|Withdrawal by Subject|0|||
156799526|NCT04622592|566021323|FG006|Overall Study|Withdrawal by Subject|1|||
156799527|NCT04622592|566021324|FG007|Overall Study|Withdrawal by Subject|4|||
156799528|NCT04622592|566021317|FG000|Overall Study|Other than specified above|0|||
156799529|NCT04622592|566021318|FG001|Overall Study|Other than specified above|0|||
156799530|NCT04622592|566021319|FG002|Overall Study|Other than specified above|1|||
156799531|NCT04622592|566021320|FG003|Overall Study|Other than specified above|0|||
156799532|NCT04622592|566021321|FG004|Overall Study|Other than specified above|0|||
156337163|NCT01890473|564333556|FG001|Overall Study|Lost to Follow-up|0|||
156458893|NCT01928394|564776670|FG016|Treatment Period|Death|0|||
156458894|NCT01928394|564776671|FG017|Treatment Period|Death|0|||
156458895|NCT01928394|564776672|FG018|Treatment Period|Death|0|||
156458896|NCT01928394|564776673|FG019|Treatment Period|Death|0|||
156458897|NCT01928394|564776674|FG020|Treatment Period|Death|0|||
156458898|NCT01928394|564776675|FG021|Treatment Period|Death|0|||
156458899|NCT01928394|564776676|FG022|Treatment Period|Death|0|||
156458900|NCT01928394|564776654|FG000|Follow-up Period|Participant withdrew consent|3|||
156458901|NCT01928394|564776655|FG001|Follow-up Period|Participant withdrew consent|0|||
156799533|NCT04622592|566021322|FG005|Overall Study|Other than specified above|0|||
156799534|NCT04622592|566021323|FG006|Overall Study|Other than specified above|0|||
156799535|NCT04622592|566021324|FG007|Overall Study|Other than specified above|0|||
156799536|NCT00415636|566021325|FG000|Overall Study|Symptomatic deterioration|1|||
156799537|NCT00415636|566021326|FG001|Overall Study|Symptomatic deterioration|0|||
156799538|NCT00415636|566021327|FG002|Overall Study|Symptomatic deterioration|1|||
156536143|NCT03861936|565057626|FG000|Overall Study|Protocol Deviation|0|||
156536144|NCT03861936|565057627|FG001|Overall Study|Protocol Deviation|0|||
156536145|NCT03861936|565057628|FG002|Overall Study|Protocol Deviation|1|||
156536146|NCT03861936|565057626|FG000|Overall Study|Reason not Specified|5|||
156536147|NCT03861936|565057627|FG001|Overall Study|Reason not Specified|5|||
156536148|NCT03861936|565057628|FG002|Overall Study|Reason not Specified|3|||
156536149|NCT02066311|565057629|FG000|Overall Study|Adverse Event|4|||
156536150|NCT02066311|565057629|FG000|Overall Study|Withdrawal by Subject|1|||
156536151|NCT00359021|565057630|FG000|Overall Study|Adverse Event|26|||
156536152|NCT00359021|565057631|FG001|Overall Study|Adverse Event|8|||
156536153|NCT00359021|565057630|FG000|Overall Study|Subject Non-Compliant|1|||
156536154|NCT00359021|565057631|FG001|Overall Study|Subject Non-Compliant|2|||
156536155|NCT00359021|565057630|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
156536156|NCT00359021|565057631|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
156536157|NCT00359021|565057630|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
156536158|NCT00359021|565057631|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
156536159|NCT00359021|565057630|FG000|Overall Study|Withdrawal by Subject|2|||
156536160|NCT00359021|565057631|FG001|Overall Study|Withdrawal by Subject|9|||
156536161|NCT00359021|565057630|FG000|Overall Study|Lost to Follow-up|1|||
156536162|NCT00359021|565057631|FG001|Overall Study|Lost to Follow-up|0|||
156536163|NCT00359021|565057630|FG000|Overall Study|Other|4|||
156536164|NCT00359021|565057631|FG001|Overall Study|Other|1|||
156536165|NCT00359021|565057630|FG000|Overall Study|Pregnancy|1|||
156536166|NCT00359021|565057631|FG001|Overall Study|Pregnancy|0|||
156536167|NCT01372150|565057634|FG000|Overall Study|Lack of Efficacy|3|||
156536168|NCT01372150|565057635|FG001|Overall Study|Lack of Efficacy|0|||
156536169|NCT01372150|565057636|FG002|Overall Study|Lack of Efficacy|1|||
156536170|NCT01372150|565057634|FG000|Overall Study|Lost to Follow-up|4|||
156536171|NCT01372150|565057635|FG001|Overall Study|Lost to Follow-up|5|||
156536172|NCT01372150|565057636|FG002|Overall Study|Lost to Follow-up|6|||
156536173|NCT01372150|565057634|FG000|Overall Study|Protocol Violation|1|||
156536174|NCT01372150|565057635|FG001|Overall Study|Protocol Violation|0|||
156536175|NCT01372150|565057636|FG002|Overall Study|Protocol Violation|3|||
156536176|NCT01372150|565057634|FG000|Overall Study|Withdrawal by Subject|2|||
156536177|NCT01372150|565057635|FG001|Overall Study|Withdrawal by Subject|7|||
156536178|NCT01372150|565057636|FG002|Overall Study|Withdrawal by Subject|2|||
156536179|NCT01372150|565057634|FG000|Overall Study|Other|1|||
156536180|NCT01372150|565057635|FG001|Overall Study|Other|0|||
156536181|NCT01372150|565057636|FG002|Overall Study|Other|2|||
156536182|NCT01372150|565057634|FG000|Overall Study|Adverse Event|2|||
156536183|NCT01372150|565057635|FG001|Overall Study|Adverse Event|1|||
156536184|NCT01372150|565057636|FG002|Overall Study|Adverse Event|2|||
156536185|NCT01372150|565057634|FG000|Overall Study|Randomized but not treated|0|||
156536186|NCT01372150|565057635|FG001|Overall Study|Randomized but not treated|1|||
156536187|NCT01372150|565057636|FG002|Overall Study|Randomized but not treated|0|||
156536188|NCT05418673|565057637|FG000|Overall Study|Study Terminated by Sponsor|2|||
156536189|NCT05418673|565057638|FG001|Overall Study|Study Terminated by Sponsor|4|||
156536190|NCT05418673|565057637|FG000|Overall Study|Lost to Follow-up|1|||
156536191|NCT05418673|565057638|FG001|Overall Study|Lost to Follow-up|0|||
156536192|NCT02316340|565057639|FG000|First Progression|Clinical progression|2|||
156536193|NCT02316340|565057640|FG001|First Progression|Clinical progression|1|||
156536194|NCT02316340|565057639|FG000|First Progression|Withdrawal by Subject|1|||
156536195|NCT02316340|565057640|FG001|First Progression|Withdrawal by Subject|0|||
156536196|NCT02234284|565057641|FG000|Overall Study|Death|4|||
156536197|NCT02234284|565057642|FG001|Overall Study|Death|2|||
156536198|NCT02234284|565057641|FG000|Overall Study|Withdrawal by Subject|1|||
156536199|NCT02234284|565057642|FG001|Overall Study|Withdrawal by Subject|0|||
156536200|NCT02234284|565057641|FG000|Overall Study|Lost to Follow-up|20|||
156536201|NCT02234284|565057642|FG001|Overall Study|Lost to Follow-up|7|||
156536202|NCT01835015|565057643|FG000|Overall Study|Adverse Event|0|||
156536203|NCT01835015|565057644|FG001|Overall Study|Adverse Event|0|||
156536204|NCT01835015|565057645|FG002|Overall Study|Adverse Event|1|||
156799539|NCT00415636|566021328|FG003|Overall Study|Symptomatic deterioration|2|||
156536205|NCT01835015|565057646|FG003|Overall Study|Adverse Event|0|||
156536206|NCT01835015|565057647|FG004|Overall Study|Adverse Event|0|||
156337164|NCT01890473|564333555|FG000|Overall Study|Poor/non-compliance|1|||
156536207|NCT03781323|565057650|FG000|Overall Study|Withdrawal by Subject|1|||
156536208|NCT00975715|565057654|FG000|Titration Period|Adverse Event|6|||
156536209|NCT00975715|565057655|FG001|Titration Period|Adverse Event|0|||
156536210|NCT00975715|565057654|FG000|Titration Period|Protocol Violation|1|||
156536211|NCT00975715|565057655|FG001|Titration Period|Protocol Violation|0|||
156536212|NCT00975715|565057654|FG000|Maintenance Period|Adverse Event|2|||
156536213|NCT00975715|565057655|FG001|Maintenance Period|Adverse Event|1|||
156536214|NCT01241552|565057656|FG000|Overall Study|Lack of Efficacy|1|||
156536215|NCT01241552|565057657|FG001|Overall Study|Lack of Efficacy|0|||
156536216|NCT01241552|565057658|FG002|Overall Study|Lack of Efficacy|0|||
156536217|NCT01241552|565057659|FG003|Overall Study|Lack of Efficacy|0|||
156536218|NCT01241552|565057656|FG000|Overall Study|Death|26|||
156536219|NCT01241552|565057657|FG001|Overall Study|Death|30|||
156536220|NCT01241552|565057658|FG002|Overall Study|Death|20|||
156536221|NCT01241552|565057659|FG003|Overall Study|Death|25|||
156536222|NCT01241552|565057656|FG000|Overall Study|Adverse Event|1|||
156536223|NCT01241552|565057657|FG001|Overall Study|Adverse Event|1|||
156536224|NCT01241552|565057658|FG002|Overall Study|Adverse Event|0|||
156536225|NCT01241552|565057659|FG003|Overall Study|Adverse Event|0|||
156536226|NCT01241552|565057656|FG000|Overall Study|Technical Problems|2|||
156536227|NCT01241552|565057657|FG001|Overall Study|Technical Problems|0|||
156536228|NCT01241552|565057658|FG002|Overall Study|Technical Problems|2|||
156536229|NCT01241552|565057659|FG003|Overall Study|Technical Problems|2|||
156536230|NCT01241552|565057656|FG000|Overall Study|Progressive Disease|0|||
156536231|NCT01241552|565057657|FG001|Overall Study|Progressive Disease|0|||
156536232|NCT01241552|565057658|FG002|Overall Study|Progressive Disease|1|||
156536233|NCT01241552|565057659|FG003|Overall Study|Progressive Disease|2|||
156536234|NCT01241552|565057656|FG000|Overall Study|Protocol Violation|0|||
156536235|NCT01241552|565057657|FG001|Overall Study|Protocol Violation|2|||
156536236|NCT01241552|565057658|FG002|Overall Study|Protocol Violation|6|||
156536237|NCT01241552|565057659|FG003|Overall Study|Protocol Violation|1|||
156536238|NCT01241552|565057656|FG000|Overall Study|Withdrawal by Subject|7|||
156536239|NCT01241552|565057657|FG001|Overall Study|Withdrawal by Subject|15|||
156536240|NCT01241552|565057658|FG002|Overall Study|Withdrawal by Subject|14|||
156536241|NCT01241552|565057659|FG003|Overall Study|Withdrawal by Subject|15|||
156536242|NCT01241552|565057656|FG000|Overall Study|Physician Decision|2|||
156536243|NCT01241552|565057657|FG001|Overall Study|Physician Decision|4|||
156536244|NCT01241552|565057658|FG002|Overall Study|Physician Decision|2|||
156536245|NCT01241552|565057659|FG003|Overall Study|Physician Decision|3|||
156536246|NCT01241552|565057656|FG000|Overall Study|Lost to Follow-up|2|||
156536247|NCT01241552|565057657|FG001|Overall Study|Lost to Follow-up|11|||
156536248|NCT01241552|565057658|FG002|Overall Study|Lost to Follow-up|15|||
156536249|NCT01241552|565057659|FG003|Overall Study|Lost to Follow-up|16|||
156536250|NCT04004429|565057660|FG000|Overall Study|Protocol Violation|1|||
156536251|NCT04004429|565057661|FG001|Overall Study|Protocol Violation|0|||
156536252|NCT04004429|565057662|FG002|Overall Study|Protocol Violation|0|||
156536253|NCT04004429|565057660|FG000|Overall Study|Physician Decision|0|||
156536254|NCT04004429|565057661|FG001|Overall Study|Physician Decision|1|||
156536255|NCT04004429|565057662|FG002|Overall Study|Physician Decision|1|||
156536256|NCT04004429|565057660|FG000|Overall Study|Withdrawal by Subject|1|||
156536257|NCT04004429|565057661|FG001|Overall Study|Withdrawal by Subject|1|||
156536258|NCT04004429|565057662|FG002|Overall Study|Withdrawal by Subject|1|||
156536259|NCT00718549|565057663|FG000|Induction Phase|Disease Progression|1|||
156799540|NCT00415636|566021329|FG004|Overall Study|Symptomatic deterioration|0|||
156458902|NCT01928394|564776656|FG002|Follow-up Period|Participant withdrew consent|1|||
156458903|NCT01928394|564776657|FG003|Follow-up Period|Participant withdrew consent|4|||
156458904|NCT01928394|564776658|FG004|Follow-up Period|Participant withdrew consent|0|||
156458905|NCT01928394|564776659|FG005|Follow-up Period|Participant withdrew consent|2|||
156458906|NCT01928394|564776660|FG006|Follow-up Period|Participant withdrew consent|5|||
156458907|NCT01928394|564776661|FG007|Follow-up Period|Participant withdrew consent|1|||
156458908|NCT01928394|564776662|FG008|Follow-up Period|Participant withdrew consent|0|||
156458909|NCT01928394|564776663|FG009|Follow-up Period|Participant withdrew consent|0|||
156458910|NCT01928394|564776664|FG010|Follow-up Period|Participant withdrew consent|5|||
156458911|NCT01928394|564776665|FG011|Follow-up Period|Participant withdrew consent|8|||
156458912|NCT01928394|564776666|FG012|Follow-up Period|Participant withdrew consent|2|||
156458913|NCT01928394|564776667|FG013|Follow-up Period|Participant withdrew consent|12|||
156458914|NCT01928394|564776668|FG014|Follow-up Period|Participant withdrew consent|7|||
156458915|NCT01928394|564776669|FG015|Follow-up Period|Participant withdrew consent|0|||
156458916|NCT01928394|564776670|FG016|Follow-up Period|Participant withdrew consent|5|||
156458917|NCT01928394|564776671|FG017|Follow-up Period|Participant withdrew consent|3|||
156458918|NCT01928394|564776672|FG018|Follow-up Period|Participant withdrew consent|2|||
156458919|NCT01928394|564776673|FG019|Follow-up Period|Participant withdrew consent|7|||
156458920|NCT01928394|564776674|FG020|Follow-up Period|Participant withdrew consent|4|||
156458921|NCT01928394|564776675|FG021|Follow-up Period|Participant withdrew consent|6|||
156458922|NCT01928394|564776676|FG022|Follow-up Period|Participant withdrew consent|2|||
156458923|NCT01928394|564776654|FG000|Follow-up Period|Death|0|||
156458924|NCT01928394|564776655|FG001|Follow-up Period|Death|0|||
156458925|NCT01928394|564776656|FG002|Follow-up Period|Death|2|||
156458926|NCT01928394|564776657|FG003|Follow-up Period|Death|6|||
156458927|NCT01928394|564776658|FG004|Follow-up Period|Death|0|||
156536260|NCT00718549|565057664|FG001|Induction Phase|Disease Progression|0|||
156458928|NCT01928394|564776659|FG005|Follow-up Period|Death|6|||
156458929|NCT01928394|564776660|FG006|Follow-up Period|Death|6|||
156458930|NCT01928394|564776661|FG007|Follow-up Period|Death|2|||
156458931|NCT01928394|564776662|FG008|Follow-up Period|Death|1|||
156536261|NCT00718549|565057665|FG002|Induction Phase|Disease Progression|0|||
156536262|NCT00718549|565057663|FG000|Induction Phase|Eligibility Criteria Violation|2|||
156536263|NCT00718549|565057664|FG001|Induction Phase|Eligibility Criteria Violation|0|||
156536264|NCT00718549|565057665|FG002|Induction Phase|Eligibility Criteria Violation|0|||
156536265|NCT00718549|565057663|FG000|Induction Phase|Early Termination - No Additional Info|59|||
156536266|NCT00718549|565057664|FG001|Induction Phase|Early Termination - No Additional Info|0|||
156536267|NCT00718549|565057665|FG002|Induction Phase|Early Termination - No Additional Info|0|||
156536268|NCT00718549|565057663|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
156536269|NCT00718549|565057664|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
156536270|NCT00718549|565057665|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
156536271|NCT00718549|565057663|FG000|Maintenance/ Observation Phase|Death|0|||
156536272|NCT00718549|565057664|FG001|Maintenance/ Observation Phase|Death|1|||
156536273|NCT00718549|565057665|FG002|Maintenance/ Observation Phase|Death|2|||
156536274|NCT00718549|565057663|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
156536275|NCT00718549|565057664|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
156536276|NCT00718549|565057665|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
156536277|NCT00718549|565057663|FG000|Maintenance/ Observation Phase|Progression|0|||
156536278|NCT00718549|565057664|FG001|Maintenance/ Observation Phase|Progression|5|||
156536279|NCT00718549|565057665|FG002|Maintenance/ Observation Phase|Progression|14|||
156536280|NCT00718549|565057663|FG000|Maintenance/ Observation Phase|Relapse|0|||
156536281|NCT00718549|565057664|FG001|Maintenance/ Observation Phase|Relapse|3|||
156536282|NCT00718549|565057665|FG002|Maintenance/ Observation Phase|Relapse|2|||
156536283|NCT02606461|565057666|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
156536284|NCT02606461|565057667|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
156536285|NCT02606461|565057668|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
156536286|NCT02606461|565057669|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
156536287|NCT02606461|565057670|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
156536288|NCT02606461|565057671|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
156536289|NCT00239226|565057672|FG000|Overall Study|permAF during stabilization period|0|||
156536290|NCT00239226|565057673|FG001|Overall Study|permAF during stabilization period|0|||
156536291|NCT00239226|565057674|FG002|Overall Study|permAF during stabilization period|0|||
156536292|NCT00239226|565057675|FG003|Overall Study|permAF during stabilization period|3|||
156536293|NCT00239226|565057672|FG000|Overall Study|Lost to Follow-up|1|||
156536294|NCT00239226|565057673|FG001|Overall Study|Lost to Follow-up|0|||
156536295|NCT00239226|565057674|FG002|Overall Study|Lost to Follow-up|1|||
156536296|NCT00239226|565057675|FG003|Overall Study|Lost to Follow-up|0|||
156536297|NCT01303965|565057678|FG000|Overall Study|Adverse Event|1|||
156536298|NCT01303965|565057679|FG001|Overall Study|Adverse Event|1|||
156536299|NCT01303965|565057678|FG000|Overall Study|Death|0|||
156536300|NCT01303965|565057679|FG001|Overall Study|Death|3|||
156536301|NCT01303965|565057678|FG000|Overall Study|Withdrawal by Subject|1|||
156536302|NCT01303965|565057679|FG001|Overall Study|Withdrawal by Subject|0|||
156536303|NCT01303965|565057678|FG000|Overall Study|Disease Progression|1|||
156536304|NCT01303965|565057679|FG001|Overall Study|Disease Progression|6|||
156536305|NCT02448225|565057680|FG000|Overall Study|Withdrawal by Subject|1|||
156536306|NCT02448225|565057680|FG000|Overall Study|Did not get FSPG scan|18|||
156536307|NCT02448225|565057680|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
156536308|NCT04060563|565057681|FG000|Overall Study|Lost to Follow-up|1|||
156536309|NCT04060563|565057682|FG001|Overall Study|Lost to Follow-up|1|||
156536310|NCT04060563|565057681|FG000|Overall Study|Physician Decision|0|||
156536311|NCT04060563|565057682|FG001|Overall Study|Physician Decision|1|||
156536312|NCT01379573|565057691|FG000|Overall Study|Lost to Follow-up|1|||
156536313|NCT01379573|565057691|FG000|Overall Study|Screen Failure|10|||
156536314|NCT02871778|565057692|FG000|Part A: Treatment Period 1|Adverse Event|1|||
156536315|NCT02871778|565057693|FG001|Part A: Treatment Period 1|Adverse Event|1|||
156536316|NCT02871778|565057694|FG002|Part A: Treatment Period 1|Adverse Event|1|||
156536317|NCT02871778|565057695|FG003|Part A: Treatment Period 1|Adverse Event|0|||
156536318|NCT02871778|565057696|FG004|Part A: Treatment Period 1|Adverse Event|0|||
156536319|NCT02871778|565057697|FG005|Part A: Treatment Period 1|Adverse Event|0|||
156536320|NCT02871778|565057698|FG006|Part A: Treatment Period 1|Adverse Event|0|||
156536321|NCT02871778|565057699|FG007|Part A: Treatment Period 1|Adverse Event|0|||
156536322|NCT02871778|565057692|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
156536323|NCT02871778|565057693|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
156536324|NCT02871778|565057694|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
156536325|NCT02871778|565057695|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
156536326|NCT02871778|565057696|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
156536327|NCT02871778|565057697|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
156536328|NCT02871778|565057698|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
156536329|NCT02871778|565057699|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
156536330|NCT02871778|565057692|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
156536331|NCT02871778|565057693|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
156536332|NCT02871778|565057694|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
156536333|NCT02871778|565057695|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
156536334|NCT02871778|565057696|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
156745423|NCT00306787|565815743|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156536335|NCT02871778|565057697|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
156536336|NCT02871778|565057698|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
156536337|NCT02871778|565057699|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
156536338|NCT02871778|565057692|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
156536339|NCT02871778|565057693|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
156536340|NCT02871778|565057694|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
156536341|NCT02871778|565057695|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
156536342|NCT02871778|565057696|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
156536343|NCT02871778|565057697|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
156536344|NCT02871778|565057698|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
156536345|NCT02871778|565057699|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
156536346|NCT02871778|565057692|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
156536347|NCT02871778|565057693|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
156536348|NCT02871778|565057694|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
156536349|NCT02871778|565057695|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
156536350|NCT02871778|565057696|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
156536351|NCT02871778|565057697|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
156536352|NCT02871778|565057698|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
156536353|NCT02871778|565057699|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
156536354|NCT02871778|565057692|FG000|Part A: Treatment Period 2|Adverse Event|2|||
156536355|NCT02871778|565057693|FG001|Part A: Treatment Period 2|Adverse Event|2|||
156536356|NCT02871778|565057694|FG002|Part A: Treatment Period 2|Adverse Event|0|||
156536357|NCT02871778|565057695|FG003|Part A: Treatment Period 2|Adverse Event|0|||
156536358|NCT02871778|565057696|FG004|Part A: Treatment Period 2|Adverse Event|0|||
156536359|NCT02871778|565057697|FG005|Part A: Treatment Period 2|Adverse Event|0|||
156536360|NCT02871778|565057698|FG006|Part A: Treatment Period 2|Adverse Event|0|||
156536361|NCT02871778|565057699|FG007|Part A: Treatment Period 2|Adverse Event|0|||
156536362|NCT02871778|565057692|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
156536363|NCT02871778|565057693|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
156536364|NCT02871778|565057694|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
156536365|NCT02871778|565057695|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
156536366|NCT02871778|565057696|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
156536367|NCT02871778|565057697|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
156536368|NCT02871778|565057698|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
156536369|NCT02871778|565057699|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
156536370|NCT02871778|565057692|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
156536371|NCT02871778|565057693|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
156536372|NCT02871778|565057694|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
156536373|NCT02871778|565057695|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
156536374|NCT02871778|565057696|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
156536375|NCT02871778|565057697|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
156536376|NCT02871778|565057698|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
156536377|NCT02871778|565057699|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
156536378|NCT02871778|565057692|FG000|Part B: Treatment Period 3|Adverse Event|0|||
156536379|NCT02871778|565057693|FG001|Part B: Treatment Period 3|Adverse Event|0|||
156536380|NCT02871778|565057694|FG002|Part B: Treatment Period 3|Adverse Event|0|||
156536381|NCT02871778|565057695|FG003|Part B: Treatment Period 3|Adverse Event|0|||
156536382|NCT02871778|565057696|FG004|Part B: Treatment Period 3|Adverse Event|1|||
156536383|NCT02871778|565057697|FG005|Part B: Treatment Period 3|Adverse Event|1|||
156536384|NCT02871778|565057698|FG006|Part B: Treatment Period 3|Adverse Event|1|||
156536385|NCT02871778|565057699|FG007|Part B: Treatment Period 3|Adverse Event|0|||
156536386|NCT02653300|565057700|FG000|Overall Study|Withdrawal by Subject|2|||
156536387|NCT02289352|565057709|FG000|Overall Study|Withdrawal by Subject|1|||
156536388|NCT02289352|565057710|FG001|Overall Study|Withdrawal by Subject|1|||
156536389|NCT02289352|565057711|FG002|Overall Study|Withdrawal by Subject|0|||
156536390|NCT01390272|565057712|FG000|Overall Study|Death|3|||
156536391|NCT01390272|565057713|FG001|Overall Study|Death|2|||
156536392|NCT01390272|565057712|FG000|Overall Study|Withdrawal by Subject|9|||
156536393|NCT01390272|565057713|FG001|Overall Study|Withdrawal by Subject|5|||
156536394|NCT01390272|565057712|FG000|Overall Study|Patient moved, no longer eligible|5|||
156536395|NCT01390272|565057713|FG001|Overall Study|Patient moved, no longer eligible|8|||
156536396|NCT00307333|565057714|FG000|Overall Study|Lost to Follow-up|11|||
156536397|NCT00307333|565057715|FG001|Overall Study|Lost to Follow-up|3|||
156536398|NCT04166383|565057716|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
156536399|NCT04166383|565057716|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
156536400|NCT04166383|565057716|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
156536401|NCT00387764|565057729|FG000|Overall Study|Adverse Event|12|||
156536402|NCT00387764|565057729|FG000|Overall Study|Withdrawal by Subject|8|||
156745424|NCT00337779|565815744|FG000|Overall Study|Withdrawal by Subject|10|||
156536403|NCT00387764|565057729|FG000|Overall Study|Sponsor Terminated Study|1|||
156536404|NCT00387764|565057729|FG000|Overall Study|Physician Decision|1|||
156536405|NCT00387764|565057729|FG000|Overall Study|Other|2|||
156536406|NCT00387764|565057729|FG000|Overall Study|Death|7|||
156536407|NCT00375219|565057731|FG000|Overall Study|Failure to achieve a response|16|||
156536408|NCT00375219|565057732|FG001|Overall Study|Failure to achieve a response|2|||
156536409|NCT00375219|565057733|FG002|Overall Study|Failure to achieve a response|0|||
156536410|NCT00375219|565057731|FG000|Overall Study|Adverse Event|8|||
156536411|NCT00375219|565057732|FG001|Overall Study|Adverse Event|2|||
156536412|NCT00375219|565057733|FG002|Overall Study|Adverse Event|1|||
156536413|NCT00375219|565057731|FG000|Overall Study|Protocol Violation|1|||
156536414|NCT00375219|565057732|FG001|Overall Study|Protocol Violation|0|||
156536415|NCT00375219|565057733|FG002|Overall Study|Protocol Violation|1|||
156536416|NCT00375219|565057731|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
156536417|NCT00375219|565057732|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
156536418|NCT00375219|565057733|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
156536419|NCT00375219|565057731|FG000|Overall Study|Lost to Follow-up|1|||
156536420|NCT00375219|565057732|FG001|Overall Study|Lost to Follow-up|1|||
156536421|NCT00375219|565057733|FG002|Overall Study|Lost to Follow-up|0|||
156536422|NCT00375219|565057731|FG000|Overall Study|Disease progression|18|||
156536423|NCT00375219|565057732|FG001|Overall Study|Disease progression|9|||
156536424|NCT00375219|565057733|FG002|Overall Study|Disease progression|12|||
156536425|NCT00375219|565057731|FG000|Overall Study|Death|4|||
156536426|NCT00375219|565057732|FG001|Overall Study|Death|3|||
156536427|NCT00375219|565057733|FG002|Overall Study|Death|7|||
156536428|NCT00375219|565057731|FG000|Overall Study|Hematologic resistance|1|||
156536429|NCT00375219|565057732|FG001|Overall Study|Hematologic resistance|0|||
156536430|NCT00375219|565057733|FG002|Overall Study|Hematologic resistance|0|||
156536431|NCT00375219|565057731|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
156536432|NCT00375219|565057732|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
156536433|NCT00375219|565057733|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
156536434|NCT00375219|565057731|FG000|Overall Study|Allograft|2|||
156536435|NCT00375219|565057732|FG001|Overall Study|Allograft|0|||
156536436|NCT00375219|565057733|FG002|Overall Study|Allograft|0|||
156536437|NCT00375219|565057731|FG000|Overall Study|Cord blood transplantation|1|||
156536438|NCT00375219|565057732|FG001|Overall Study|Cord blood transplantation|0|||
156536439|NCT00375219|565057733|FG002|Overall Study|Cord blood transplantation|0|||
156536440|NCT00375219|565057731|FG000|Overall Study|Withdrawal by Subject|1|||
156536441|NCT00375219|565057732|FG001|Overall Study|Withdrawal by Subject|0|||
156536442|NCT00375219|565057733|FG002|Overall Study|Withdrawal by Subject|0|||
156536443|NCT01624259|565057734|FG000|Overall Study|Adverse Event|18|||
156536444|NCT01624259|565057735|FG001|Overall Study|Adverse Event|18|||
156536445|NCT01624259|565057734|FG000|Overall Study|Protocol Violation|1|||
156536446|NCT01624259|565057735|FG001|Overall Study|Protocol Violation|2|||
156536447|NCT01624259|565057734|FG000|Overall Study|Withdrawal by Subject|5|||
156536448|NCT01624259|565057735|FG001|Overall Study|Withdrawal by Subject|7|||
156536449|NCT01624259|565057734|FG000|Overall Study|Physician Decision|1|||
156536450|NCT01624259|565057735|FG001|Overall Study|Physician Decision|1|||
156536451|NCT01624259|565057734|FG000|Overall Study|Lost to Follow-up|2|||
156536452|NCT01624259|565057735|FG001|Overall Study|Lost to Follow-up|3|||
156536453|NCT01624259|565057734|FG000|Overall Study|Abnormal laboratory measure|3|||
156536454|NCT01624259|565057735|FG001|Overall Study|Abnormal laboratory measure|0|||
156536455|NCT01298518|565057736|FG000|Overall Study|Withdrawal by Subject|0|||
156536456|NCT01298518|565057737|FG001|Overall Study|Withdrawal by Subject|0|||
156536457|NCT01298518|565057738|FG002|Overall Study|Withdrawal by Subject|1|||
156536458|NCT02273726|565057739|FG000|Overall Study|Death|70|||
156536459|NCT02273726|565057740|FG001|Overall Study|Death|62|||
156536460|NCT02273726|565057739|FG000|Overall Study|Withdrawal by Subject|41|||
156536461|NCT02273726|565057740|FG001|Overall Study|Withdrawal by Subject|29|||
156536462|NCT02273726|565057739|FG000|Overall Study|Kidney transplant|31|||
156536463|NCT02273726|565057740|FG001|Overall Study|Kidney transplant|39|||
156536464|NCT02273726|565057739|FG000|Overall Study|Physician Decision|30|||
156536465|NCT02273726|565057740|FG001|Overall Study|Physician Decision|15|||
156536466|NCT02273726|565057739|FG000|Overall Study|Adverse Event|27|||
156536467|NCT02273726|565057740|FG001|Overall Study|Adverse Event|9|||
156799541|NCT00415636|566021330|FG005|Overall Study|Symptomatic deterioration|1|||
156536468|NCT02273726|565057739|FG000|Overall Study|Lost to Follow-up|6|||
156536469|NCT02273726|565057740|FG001|Overall Study|Lost to Follow-up|3|||
156536470|NCT02273726|565057739|FG000|Overall Study|Lack of Efficacy|6|||
156536471|NCT02273726|565057740|FG001|Overall Study|Lack of Efficacy|1|||
156536472|NCT02273726|565057739|FG000|Overall Study|Protocol Violation|4|||
156536473|NCT02273726|565057740|FG001|Overall Study|Protocol Violation|0|||
156536474|NCT02273726|565057739|FG000|Overall Study|Other than specified|28|||
156536475|NCT02273726|565057740|FG001|Overall Study|Other than specified|30|||
156536476|NCT01979835|565057741|FG000|Primary Outcome SA Measurment|failed insertion|18|||
156536477|NCT01979835|565057741|FG000|Follow-up|Lost to Follow-up|32|||
156536478|NCT01479829|565057742|FG000|Overall Study|Withdrawal by Subject|8|||
156536479|NCT01479829|565057743|FG001|Overall Study|Withdrawal by Subject|10|||
156536480|NCT01986920|565058971|FG000|A- 101 25%|Withdrawal by Subject|1|||
156536481|NCT01986920|565058972|FG001|A- 101 25%|Withdrawal by Subject|0|||
156536482|NCT01986920|565058973|FG002|A- 101 25%|Withdrawal by Subject|0|||
156536483|NCT01986920|565058974|FG003|A- 101 25%|Withdrawal by Subject|0|||
156536484|NCT01986920|565058971|FG000|A-101 32.5%|Withdrawal by Subject|0|||
156536485|NCT01986920|565058972|FG001|A-101 32.5%|Withdrawal by Subject|1|||
156536486|NCT01986920|565058973|FG002|A-101 32.5%|Withdrawal by Subject|0|||
156536487|NCT01986920|565058974|FG003|A-101 32.5%|Withdrawal by Subject|0|||
156536488|NCT01986920|565058971|FG000|A-101 40%|Withdrawal by Subject|0|||
156536489|NCT01986920|565058972|FG001|A-101 40%|Withdrawal by Subject|0|||
156536490|NCT01986920|565058973|FG002|A-101 40%|Withdrawal by Subject|1|||
156536491|NCT01986920|565058974|FG003|A-101 40%|Withdrawal by Subject|0|||
156536492|NCT01986920|565058971|FG000|Placebo|Withdrawal by Subject|0|||
156536493|NCT01986920|565058972|FG001|Placebo|Withdrawal by Subject|0|||
156536494|NCT01986920|565058973|FG002|Placebo|Withdrawal by Subject|0|||
156536495|NCT01986920|565058974|FG003|Placebo|Withdrawal by Subject|1|||
156536496|NCT01338415|565058975|FG000|Core + Extension|Adverse Event|8|||
156799542|NCT00415636|566021325|FG000|Overall Study|Adverse Event|0|||
156799543|NCT00415636|566021326|FG001|Overall Study|Adverse Event|0|||
156799544|NCT00415636|566021327|FG002|Overall Study|Adverse Event|0|||
156799545|NCT00415636|566021328|FG003|Overall Study|Adverse Event|1|||
156799546|NCT00415636|566021329|FG004|Overall Study|Adverse Event|1|||
156799547|NCT00415636|566021330|FG005|Overall Study|Adverse Event|0|||
156536497|NCT01338415|565058976|FG001|Core + Extension|Adverse Event|6|||
156536498|NCT01338415|565058977|FG002|Core + Extension|Adverse Event|0|||
156536499|NCT01338415|565058975|FG000|Core + Extension|Withdrawal by Subject|1|||
156536500|NCT01338415|565058976|FG001|Core + Extension|Withdrawal by Subject|1|||
156536501|NCT01338415|565058977|FG002|Core + Extension|Withdrawal by Subject|0|||
156536502|NCT01338415|565058975|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
156536503|NCT01338415|565058976|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
156536504|NCT01338415|565058977|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
156536505|NCT01338415|565058975|FG000|Core + Extension|Other (administrative reason)|1|||
156536506|NCT01338415|565058976|FG001|Core + Extension|Other (administrative reason)|0|||
156536507|NCT01338415|565058977|FG002|Core + Extension|Other (administrative reason)|0|||
156536508|NCT01338415|565058975|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
156536509|NCT01338415|565058976|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
156799548|NCT00415636|566021325|FG000|Overall Study|Withdrawal by Subject|0|||
156799549|NCT00415636|566021326|FG001|Overall Study|Withdrawal by Subject|0|||
156799550|NCT00415636|566021327|FG002|Overall Study|Withdrawal by Subject|0|||
156799551|NCT00415636|566021328|FG003|Overall Study|Withdrawal by Subject|0|||
156799552|NCT00415636|566021329|FG004|Overall Study|Withdrawal by Subject|1|||
156799553|NCT00415636|566021330|FG005|Overall Study|Withdrawal by Subject|0|||
156799554|NCT00415636|566021325|FG000|Overall Study|Disease progression|0|||
156799555|NCT00415636|566021326|FG001|Overall Study|Disease progression|0|||
156799556|NCT00415636|566021327|FG002|Overall Study|Disease progression|0|||
156799557|NCT00415636|566021328|FG003|Overall Study|Disease progression|3|||
156799558|NCT00415636|566021329|FG004|Overall Study|Disease progression|0|||
156799559|NCT00415636|566021330|FG005|Overall Study|Disease progression|1|||
156799560|NCT02138825|566021331|FG000|Main Study Treatment|Adverse Event|11|||
156799561|NCT02138825|566021332|FG001|Main Study Treatment|Adverse Event|3|||
156799562|NCT02138825|566021331|FG000|Main Study Treatment|Death|1|||
156799563|NCT02138825|566021332|FG001|Main Study Treatment|Death|2|||
156799564|NCT02138825|566021331|FG000|Main Study Treatment|Protocol Violation|2|||
156799565|NCT02138825|566021332|FG001|Main Study Treatment|Protocol Violation|2|||
156799566|NCT02138825|566021331|FG000|Main Study Treatment|Sponsor decision|12|||
156799567|NCT02138825|566021332|FG001|Main Study Treatment|Sponsor decision|18|||
156799568|NCT02138825|566021331|FG000|Main Study Treatment|Study terminated by sponsor|10|||
156799569|NCT02138825|566021332|FG001|Main Study Treatment|Study terminated by sponsor|9|||
156799570|NCT02138825|566021331|FG000|Main Study Treatment|Withdrawal by Subject|3|||
156799571|NCT02138825|566021332|FG001|Main Study Treatment|Withdrawal by Subject|1|||
156799572|NCT02138825|566021331|FG000|Main Study Treatment|Medical decision|1|||
156799573|NCT02138825|566021332|FG001|Main Study Treatment|Medical decision|0|||
156799574|NCT02138825|566021331|FG000|Long-term Extension|Study termination by sponsor|32|||
156337165|NCT01890473|564333556|FG001|Overall Study|Poor/non-compliance|0|||
156337166|NCT04019288|564333557|FG000|Overall Study|Death|1|||
156799575|NCT02138825|566021332|FG001|Long-term Extension|Study termination by sponsor|38|||
156799576|NCT02138825|566021331|FG000|Safety Follow-up|Adverse Event|4|||
156337167|NCT04019288|564333558|FG001|Overall Study|Death|0|||
156337168|NCT04019288|564333559|FG002|Overall Study|Death|0|||
156536510|NCT01338415|565058977|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
156536511|NCT01338415|565058975|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
156536512|NCT01338415|565058976|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
156536513|NCT01338415|565058977|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
156799577|NCT02138825|566021332|FG001|Safety Follow-up|Adverse Event|3|||
156799578|NCT02138825|566021331|FG000|Safety Follow-up|Death|11|||
156799579|NCT02138825|566021332|FG001|Safety Follow-up|Death|5|||
156799580|NCT02138825|566021331|FG000|Safety Follow-up|Withdrawal by Subject|5|||
156536514|NCT01338415|565058975|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
156536515|NCT01338415|565058976|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
156536516|NCT01338415|565058977|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
156536517|NCT01338415|565058975|FG000|Exceptional Use Treatment Period|Death|0|||
156536518|NCT01338415|565058976|FG001|Exceptional Use Treatment Period|Death|0|||
156536519|NCT01338415|565058977|FG002|Exceptional Use Treatment Period|Death|1|||
156536520|NCT01118325|565058978|FG000|Overall Study|Adverse Event|1|||
156536521|NCT01118325|565058979|FG001|Overall Study|Adverse Event|0|||
156536522|NCT01118325|565058980|FG002|Overall Study|Adverse Event|1|||
156536523|NCT03334409|565058981|FG000|Overall Study|Did not meet inclusion criteria|1|||
156536524|NCT03334409|565058982|FG001|Overall Study|Did not meet inclusion criteria|0|||
156536525|NCT00233363|565058991|FG000|Overall Study|Adverse Event|1|||
156536526|NCT00233363|565058992|FG001|Overall Study|Adverse Event|2|||
156536527|NCT00233363|565058991|FG000|Overall Study|Lack of Efficacy|0|||
156536528|NCT00233363|565058992|FG001|Overall Study|Lack of Efficacy|2|||
156536529|NCT00233363|565058991|FG000|Overall Study|Withdrawal by Subject|1|||
156458932|NCT01928394|564776663|FG009|Follow-up Period|Death|2|||
156458933|NCT01928394|564776664|FG010|Follow-up Period|Death|4|||
156458934|NCT01928394|564776665|FG011|Follow-up Period|Death|12|||
156458935|NCT01928394|564776666|FG012|Follow-up Period|Death|11|||
156458936|NCT01928394|564776667|FG013|Follow-up Period|Death|25|||
156458937|NCT01928394|564776668|FG014|Follow-up Period|Death|18|||
156458938|NCT01928394|564776669|FG015|Follow-up Period|Death|0|||
156458939|NCT01928394|564776670|FG016|Follow-up Period|Death|6|||
156458940|NCT01928394|564776671|FG017|Follow-up Period|Death|5|||
156458941|NCT01928394|564776672|FG018|Follow-up Period|Death|13|||
156458942|NCT01928394|564776673|FG019|Follow-up Period|Death|13|||
156458943|NCT01928394|564776674|FG020|Follow-up Period|Death|5|||
156458944|NCT01928394|564776675|FG021|Follow-up Period|Death|3|||
156458945|NCT01928394|564776676|FG022|Follow-up Period|Death|2|||
156458946|NCT01928394|564776654|FG000|Follow-up Period|other reason|0|||
156458947|NCT01928394|564776655|FG001|Follow-up Period|other reason|0|||
156458948|NCT01928394|564776656|FG002|Follow-up Period|other reason|0|||
156458949|NCT01928394|564776657|FG003|Follow-up Period|other reason|0|||
156458950|NCT01928394|564776658|FG004|Follow-up Period|other reason|0|||
156458951|NCT01928394|564776659|FG005|Follow-up Period|other reason|0|||
156458952|NCT01928394|564776660|FG006|Follow-up Period|other reason|1|||
156458953|NCT01928394|564776661|FG007|Follow-up Period|other reason|3|||
156458954|NCT01928394|564776662|FG008|Follow-up Period|other reason|0|||
156458955|NCT01928394|564776663|FG009|Follow-up Period|other reason|0|||
156458956|NCT01928394|564776664|FG010|Follow-up Period|other reason|2|||
156458957|NCT01928394|564776665|FG011|Follow-up Period|other reason|1|||
156458958|NCT01928394|564776666|FG012|Follow-up Period|other reason|0|||
156458959|NCT01928394|564776667|FG013|Follow-up Period|other reason|1|||
156458960|NCT01928394|564776668|FG014|Follow-up Period|other reason|4|||
156458961|NCT01928394|564776669|FG015|Follow-up Period|other reason|0|||
156458962|NCT01928394|564776670|FG016|Follow-up Period|other reason|2|||
156458963|NCT01928394|564776671|FG017|Follow-up Period|other reason|0|||
156458964|NCT01928394|564776672|FG018|Follow-up Period|other reason|1|||
156458965|NCT01928394|564776673|FG019|Follow-up Period|other reason|1|||
156536530|NCT00233363|565058992|FG001|Overall Study|Withdrawal by Subject|1|||
156536531|NCT00233363|565058991|FG000|Overall Study|Aggravation of complication|1|||
156536532|NCT00233363|565058992|FG001|Overall Study|Aggravation of complication|0|||
156536533|NCT01526551|565058993|FG000|Overall Study|Lack of returned parental consent form|424|||
156745425|NCT00337779|565815745|FG001|Overall Study|Withdrawal by Subject|12|||
156745426|NCT00337779|565815744|FG000|Overall Study|Sponsor decision|1|||
156745427|NCT00337779|565815745|FG001|Overall Study|Sponsor decision|1|||
156745428|NCT00337779|565815744|FG000|Overall Study|Physician Decision|3|||
156745429|NCT00337779|565815745|FG001|Overall Study|Physician Decision|6|||
156745430|NCT00337779|565815744|FG000|Overall Study|Protocol Violation|1|||
156745431|NCT00337779|565815745|FG001|Overall Study|Protocol Violation|1|||
156745432|NCT00337779|565815744|FG000|Overall Study|Lost to Follow-up|6|||
156745433|NCT00337779|565815745|FG001|Overall Study|Lost to Follow-up|5|||
156745434|NCT00337779|565815744|FG000|Overall Study|Adverse Event|28|||
156745435|NCT00337779|565815745|FG001|Overall Study|Adverse Event|51|||
156745436|NCT00337779|565815744|FG000|Overall Study|Pregnancy|3|||
156745437|NCT00337779|565815745|FG001|Overall Study|Pregnancy|2|||
156745438|NCT00337779|565815744|FG000|Overall Study|Death|0|||
156745439|NCT00337779|565815745|FG001|Overall Study|Death|1|||
156745440|NCT03008278|565815748|FG000|Overall Study|Progressive Disease|0|||
156745441|NCT03008278|565815749|FG001|Overall Study|Progressive Disease|0|||
156745442|NCT03008278|565815750|FG002|Overall Study|Progressive Disease|32|||
156745443|NCT03008278|565815748|FG000|Overall Study|Adverse Event|0|||
156745444|NCT03008278|565815749|FG001|Overall Study|Adverse Event|0|||
156745445|NCT03008278|565815750|FG002|Overall Study|Adverse Event|4|||
156745446|NCT03008278|565815748|FG000|Overall Study|Withdrawal by Subject|0|||
156745447|NCT03008278|565815749|FG001|Overall Study|Withdrawal by Subject|0|||
156745448|NCT03008278|565815750|FG002|Overall Study|Withdrawal by Subject|3|||
156745449|NCT03008278|565815748|FG000|Overall Study|Physician Decision|0|||
156745450|NCT03008278|565815749|FG001|Overall Study|Physician Decision|2|||
156745451|NCT03008278|565815750|FG002|Overall Study|Physician Decision|0|||
156799581|NCT02138825|566021332|FG001|Safety Follow-up|Withdrawal by Subject|3|||
156799582|NCT02138825|566021331|FG000|Safety Follow-up|clinic worsening|1|||
156799583|NCT02138825|566021332|FG001|Safety Follow-up|clinic worsening|0|||
156799584|NCT02138825|566021331|FG000|Safety Follow-up|withdrawal by PI|1|||
156799585|NCT02138825|566021332|FG001|Safety Follow-up|withdrawal by PI|0|||
156799586|NCT02138825|566021331|FG000|Safety Follow-up|logistical difficulties|0|||
156799587|NCT02138825|566021332|FG001|Safety Follow-up|logistical difficulties|1|||
156799588|NCT02138825|566021331|FG000|Safety Follow-up|progressive disease|0|||
156799589|NCT02138825|566021332|FG001|Safety Follow-up|progressive disease|2|||
156799590|NCT02138825|566021331|FG000|Safety Follow-up|too unwell to attend the visit|0|||
156799591|NCT02138825|566021332|FG001|Safety Follow-up|too unwell to attend the visit|1|||
156799592|NCT02138825|566021331|FG000|Safety Follow-up|treatment unblinded|0|||
156799593|NCT02138825|566021332|FG001|Safety Follow-up|treatment unblinded|1|||
156799594|NCT02138825|566021331|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
156799595|NCT02138825|566021332|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
156799596|NCT01702298|566021335|FG000|Overall Study|Withdrawal by Subject|1|||
156799597|NCT01664624|566021341|FG000|Overall Study|Adverse Event|0|||
156799598|NCT01664624|566021342|FG001|Overall Study|Adverse Event|1|||
156799599|NCT01664624|566021343|FG002|Overall Study|Adverse Event|0|||
156799600|NCT01664624|566021344|FG003|Overall Study|Adverse Event|0|||
156745452|NCT01074255|565815751|FG000|Overall Study|Did not receive EMEND|2|||
156745453|NCT01389258|565815752|FG000|Overall Study|Lost to Follow-up|5|||
156745454|NCT03313310|565815753|FG000|Phase 2|Lost to Follow-up|4|||
156745455|NCT03313310|565815754|FG001|Phase 2|Lost to Follow-up|0|||
156745456|NCT03313310|565815753|FG000|Phase 3|Lost to Follow-up|0|||
156745457|NCT03313310|565815754|FG001|Phase 3|Lost to Follow-up|1|||
156745458|NCT02124759|565815760|FG000|Overall Study|Withdrawal by Subject|3|||
156745459|NCT02124759|565815761|FG001|Overall Study|Withdrawal by Subject|1|||
156745460|NCT02124759|565815762|FG002|Overall Study|Withdrawal by Subject|1|||
156745461|NCT02124759|565815760|FG000|Overall Study|Screen Fail|2|||
156745462|NCT02124759|565815761|FG001|Overall Study|Screen Fail|2|||
156745463|NCT02124759|565815762|FG002|Overall Study|Screen Fail|3|||
156745464|NCT00314132|565815765|FG000|Overall Study|Lost to Follow-up|3|||
156745465|NCT00314132|565815766|FG001|Overall Study|Lost to Follow-up|13|||
156536534|NCT00874770|565058994|FG000|Overall Study|Lack of Efficacy|2|||
156745466|NCT00314132|565815765|FG000|Overall Study|Withdrawal by Subject|3|||
156745467|NCT00314132|565815766|FG001|Overall Study|Withdrawal by Subject|5|||
156745468|NCT00314132|565815765|FG000|Overall Study|Adverse Event|1|||
156745469|NCT00314132|565815766|FG001|Overall Study|Adverse Event|0|||
156745470|NCT00314132|565815765|FG000|Overall Study|Physician Decision|1|||
156745471|NCT00314132|565815766|FG001|Overall Study|Physician Decision|0|||
156745472|NCT03627416|565815784|FG000|Overall Study|Adverse Event|0|||
156745473|NCT03627416|565815785|FG001|Overall Study|Adverse Event|1|||
156745474|NCT02968433|565815786|FG000|Overall Study|Withdrawal by Subject|1|||
156745475|NCT00875433|565815787|FG000|Overall Study|Progressive disease|41|||
156799601|NCT00560508|566021345|FG000|12 Week Double-blind Period|Adverse Event|3|||
156536535|NCT00874770|565058995|FG001|Overall Study|Lack of Efficacy|0|||
156536536|NCT00874770|565058996|FG002|Overall Study|Lack of Efficacy|0|||
156536537|NCT00874770|565058997|FG003|Overall Study|Lack of Efficacy|2|||
156536538|NCT00874770|565058994|FG000|Overall Study|Adverse Event|1|||
156536539|NCT00874770|565058995|FG001|Overall Study|Adverse Event|1|||
156536540|NCT00874770|565058996|FG002|Overall Study|Adverse Event|4|||
156536541|NCT00874770|565058997|FG003|Overall Study|Adverse Event|2|||
156536542|NCT00874770|565058994|FG000|Overall Study|Lost to Follow-up|1|||
156536543|NCT00874770|565058995|FG001|Overall Study|Lost to Follow-up|0|||
156536544|NCT00874770|565058996|FG002|Overall Study|Lost to Follow-up|0|||
156536545|NCT00874770|565058997|FG003|Overall Study|Lost to Follow-up|1|||
156536546|NCT00874770|565058994|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
156536547|NCT00874770|565058995|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
156536548|NCT00874770|565058996|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
156536549|NCT00874770|565058997|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
156745476|NCT00875433|565815787|FG000|Overall Study|Other Adverse Event|14|||
156745477|NCT00875433|565815787|FG000|Overall Study|Withdrawal by Subject|2|||
156745478|NCT00875433|565815787|FG000|Overall Study|Other|3|||
156745479|NCT00637806|565815788|FG000|Double-blind Phase|Study Discontinued|2|||
156745480|NCT00637806|565815789|FG001|Double-blind Phase|Study Discontinued|0|||
156745481|NCT00637806|565815790|FG002|Double-blind Phase|Study Discontinued|1|||
156745482|NCT00637806|565815791|FG003|Double-blind Phase|Study Discontinued|0|||
156745483|NCT00637806|565815788|FG000|Extension Phase|Study Discontinued|0|||
156745484|NCT00637806|565815789|FG001|Extension Phase|Study Discontinued|0|||
156745485|NCT00637806|565815790|FG002|Extension Phase|Study Discontinued|0|||
156745486|NCT00637806|565815791|FG003|Extension Phase|Study Discontinued|1|||
156745487|NCT04148287|565815793|FG000|Overall Study|Death|2|||
156745488|NCT02240069|565815795|FG000|Overall Study|Withdrawal by Subject|5|||
156745489|NCT02240069|565815796|FG001|Overall Study|Withdrawal by Subject|5|||
156745490|NCT02240069|565815797|FG002|Overall Study|Withdrawal by Subject|2|||
156745491|NCT00106639|565815798|FG000|Overall Study|Adverse Event|3|||
156745492|NCT00106639|565815799|FG001|Overall Study|Adverse Event|4|||
156745493|NCT00106639|565815800|FG002|Overall Study|Adverse Event|1|||
156745494|NCT00106639|565815798|FG000|Overall Study|Protocol Violation|0|||
156745495|NCT00106639|565815799|FG001|Overall Study|Protocol Violation|1|||
156745496|NCT00106639|565815800|FG002|Overall Study|Protocol Violation|0|||
156745497|NCT00106639|565815798|FG000|Overall Study|Withdrawal by Subject|0|||
156745498|NCT00106639|565815799|FG001|Overall Study|Withdrawal by Subject|1|||
156745499|NCT00106639|565815800|FG002|Overall Study|Withdrawal by Subject|0|||
156745500|NCT00106639|565815798|FG000|Overall Study|Participant defaulted|0|||
156745501|NCT00106639|565815799|FG001|Overall Study|Participant defaulted|1|||
156745502|NCT00106639|565815800|FG002|Overall Study|Participant defaulted|1|||
156536550|NCT05215262|565058998|FG000|Overall Study|Lost to Follow-up|12|||
156536551|NCT05215262|565058999|FG001|Overall Study|Lost to Follow-up|0|||
156536552|NCT04880447|565059000|FG000|Overall Study|No vaccination information|1|||
156536553|NCT04880447|565059000|FG000|Overall Study|No adverse event information (missing information)|1|||
156536554|NCT04880447|565059000|FG000|Overall Study|Disease not covered in this study|35|||
156536555|NCT01576172|565059002|FG000|Overall Study|Ineligible|2|||
156536556|NCT01576172|565059003|FG001|Overall Study|Ineligible|1|||
156536557|NCT01576172|565059002|FG000|Overall Study|Withdrawal by Subject|2|||
156536558|NCT01576172|565059003|FG001|Overall Study|Withdrawal by Subject|0|||
156536559|NCT01576172|565059002|FG000|Overall Study|Insurance issue|1|||
156536560|NCT01576172|565059003|FG001|Overall Study|Insurance issue|0|||
156536561|NCT02092350|565059008|FG000|Overall Study|Adverse Event|0|||
156536562|NCT02092350|565059009|FG001|Overall Study|Adverse Event|3|||
156536563|NCT02092350|565059008|FG000|Overall Study|Death|2|||
156536564|NCT02092350|565059009|FG001|Overall Study|Death|5|||
156745503|NCT01096589|565815801|FG000|Overall Study|Adverse Event|2|||
156337169|NCT01543958|564333560|FG000|Overall Study|Loss to follow-up|3|||
156536565|NCT02092350|565059008|FG000|Overall Study|Lost to Follow-up|3|||
156536566|NCT02092350|565059009|FG001|Overall Study|Lost to Follow-up|1|||
156536567|NCT02092350|565059008|FG000|Overall Study|Protocol Violation|1|||
156536568|NCT02092350|565059009|FG001|Overall Study|Protocol Violation|0|||
156536569|NCT02092350|565059008|FG000|Overall Study|Physician Decision|1|||
156536570|NCT02092350|565059009|FG001|Overall Study|Physician Decision|1|||
156745504|NCT01096589|565815802|FG001|Overall Study|Adverse Event|1|||
156745505|NCT01096589|565815803|FG002|Overall Study|Adverse Event|2|||
156745506|NCT01096589|565815804|FG003|Overall Study|Adverse Event|1|||
156745507|NCT01096589|565815801|FG000|Overall Study|Withdrawal by Subject|2|||
156745508|NCT01096589|565815802|FG001|Overall Study|Withdrawal by Subject|1|||
156745509|NCT01096589|565815803|FG002|Overall Study|Withdrawal by Subject|1|||
156745510|NCT01096589|565815804|FG003|Overall Study|Withdrawal by Subject|1|||
156337170|NCT01543958|564333560|FG000|Overall Study|ART initiation|1|||
156745511|NCT01096589|565815801|FG000|Overall Study|Compliance with protocol|0|||
156745512|NCT01096589|565815802|FG001|Overall Study|Compliance with protocol|0|||
156745513|NCT01096589|565815803|FG002|Overall Study|Compliance with protocol|1|||
156745514|NCT01096589|565815804|FG003|Overall Study|Compliance with protocol|0|||
156745515|NCT01096589|565815801|FG000|Overall Study|found treatment exhausting|0|||
156745516|NCT01096589|565815802|FG001|Overall Study|found treatment exhausting|0|||
156745517|NCT01096589|565815803|FG002|Overall Study|found treatment exhausting|0|||
156745518|NCT01096589|565815804|FG003|Overall Study|found treatment exhausting|1|||
156745519|NCT02923245|565815805|FG000|Overall Study|ultrasound order was cancelled|2|||
156745520|NCT02923245|565815806|FG001|Overall Study|ultrasound order was cancelled|1|||
156745521|NCT00948506|565815807|FG000|Overall Study|Withdrawal by Subject|3|||
156745522|NCT00948506|565815808|FG001|Overall Study|Withdrawal by Subject|1|||
156745523|NCT03233204|565815810|FG000|Overall Study|Adverse Event|1|||
156745524|NCT03233204|565815810|FG000|Overall Study|Death|1|||
156745525|NCT03233204|565815810|FG000|Overall Study|Withdrawal by Subject|1|||
156745526|NCT03233204|565815810|FG000|Overall Study|Progressive Disease|3|||
156745527|NCT02680834|565815811|FG000|Overall Study|Physician Decision|5|||
156745528|NCT02680834|565815812|FG001|Overall Study|Physician Decision|2|||
156745529|NCT02680834|565815811|FG000|Overall Study|Withdrawal by Subject|6|||
156745530|NCT02680834|565815812|FG001|Overall Study|Withdrawal by Subject|0|||
156745531|NCT02680834|565815811|FG000|Overall Study|Lost to Follow-up|0|||
156745532|NCT02680834|565815812|FG001|Overall Study|Lost to Follow-up|1|||
156745533|NCT02520427|565815813|FG000|Overall Study|Decision by sponsor|0|||
156745534|NCT02520427|565815814|FG001|Overall Study|Decision by sponsor|0|||
156745535|NCT02520427|565815815|FG002|Overall Study|Decision by sponsor|0|||
156745536|NCT02520427|565815816|FG003|Overall Study|Decision by sponsor|0|||
156745537|NCT02520427|565815817|FG004|Overall Study|Decision by sponsor|0|||
156745538|NCT02520427|565815818|FG005|Overall Study|Decision by sponsor|0|||
156745539|NCT02520427|565815819|FG006|Overall Study|Decision by sponsor|0|||
156745540|NCT02520427|565815820|FG007|Overall Study|Decision by sponsor|0|||
156745541|NCT02520427|565815821|FG008|Overall Study|Decision by sponsor|1|||
156745542|NCT02520427|565815822|FG009|Overall Study|Decision by sponsor|1|||
156745543|NCT02520427|565815823|FG010|Overall Study|Decision by sponsor|0|||
156745544|NCT02520427|565815824|FG011|Overall Study|Decision by sponsor|0|||
156745545|NCT02520427|565815825|FG012|Overall Study|Decision by sponsor|0|||
156745546|NCT02520427|565815826|FG013|Overall Study|Decision by sponsor|0|||
156745547|NCT02520427|565815827|FG014|Overall Study|Decision by sponsor|0|||
156745548|NCT02520427|565815828|FG015|Overall Study|Decision by sponsor|0|||
156745549|NCT02520427|565815829|FG016|Overall Study|Decision by sponsor|0|||
156745550|NCT02520427|565815830|FG017|Overall Study|Decision by sponsor|0|||
156745551|NCT02520427|565815831|FG018|Overall Study|Decision by sponsor|0|||
156745552|NCT02520427|565815832|FG019|Overall Study|Decision by sponsor|0|||
156745553|NCT02520427|565815833|FG020|Overall Study|Decision by sponsor|0|||
156745554|NCT02520427|565815834|FG021|Overall Study|Decision by sponsor|0|||
156745555|NCT02520427|565815835|FG022|Overall Study|Decision by sponsor|0|||
156745556|NCT02520427|565815836|FG023|Overall Study|Decision by sponsor|0|||
156745557|NCT02520427|565815837|FG024|Overall Study|Decision by sponsor|0|||
156745558|NCT02520427|565815838|FG025|Overall Study|Decision by sponsor|0|||
156745559|NCT02520427|565815813|FG000|Overall Study|Withdrawal by Subject|0|||
156745560|NCT02520427|565815814|FG001|Overall Study|Withdrawal by Subject|0|||
156745561|NCT02520427|565815815|FG002|Overall Study|Withdrawal by Subject|1|||
156745562|NCT02520427|565815816|FG003|Overall Study|Withdrawal by Subject|0|||
156745563|NCT02520427|565815817|FG004|Overall Study|Withdrawal by Subject|0|||
156745564|NCT02520427|565815818|FG005|Overall Study|Withdrawal by Subject|0|||
156745565|NCT02520427|565815819|FG006|Overall Study|Withdrawal by Subject|0|||
156745566|NCT02520427|565815820|FG007|Overall Study|Withdrawal by Subject|0|||
156745567|NCT02520427|565815821|FG008|Overall Study|Withdrawal by Subject|0|||
156745568|NCT02520427|565815822|FG009|Overall Study|Withdrawal by Subject|0|||
156745569|NCT02520427|565815823|FG010|Overall Study|Withdrawal by Subject|0|||
156745570|NCT02520427|565815824|FG011|Overall Study|Withdrawal by Subject|0|||
156745571|NCT02520427|565815825|FG012|Overall Study|Withdrawal by Subject|1|||
156745572|NCT02520427|565815826|FG013|Overall Study|Withdrawal by Subject|1|||
156745573|NCT02520427|565815827|FG014|Overall Study|Withdrawal by Subject|1|||
156745574|NCT02520427|565815828|FG015|Overall Study|Withdrawal by Subject|0|||
156745575|NCT02520427|565815829|FG016|Overall Study|Withdrawal by Subject|1|||
156745576|NCT02520427|565815830|FG017|Overall Study|Withdrawal by Subject|0|||
156745577|NCT02520427|565815831|FG018|Overall Study|Withdrawal by Subject|0|||
156745578|NCT02520427|565815832|FG019|Overall Study|Withdrawal by Subject|3|||
156745579|NCT02520427|565815833|FG020|Overall Study|Withdrawal by Subject|2|||
156745580|NCT02520427|565815834|FG021|Overall Study|Withdrawal by Subject|0|||
156745581|NCT02520427|565815835|FG022|Overall Study|Withdrawal by Subject|0|||
156745582|NCT02520427|565815836|FG023|Overall Study|Withdrawal by Subject|0|||
156745583|NCT02520427|565815837|FG024|Overall Study|Withdrawal by Subject|0|||
156745584|NCT02520427|565815838|FG025|Overall Study|Withdrawal by Subject|0|||
156745585|NCT02520427|565815813|FG000|Overall Study|Death|1|||
156745586|NCT02520427|565815814|FG001|Overall Study|Death|0|||
156745587|NCT02520427|565815815|FG002|Overall Study|Death|0|||
156745588|NCT02520427|565815816|FG003|Overall Study|Death|0|||
156745589|NCT02520427|565815817|FG004|Overall Study|Death|0|||
156745590|NCT02520427|565815818|FG005|Overall Study|Death|0|||
156745591|NCT02520427|565815819|FG006|Overall Study|Death|0|||
156745592|NCT02520427|565815820|FG007|Overall Study|Death|0|||
156745593|NCT02520427|565815821|FG008|Overall Study|Death|0|||
156745594|NCT02520427|565815822|FG009|Overall Study|Death|0|||
156745595|NCT02520427|565815823|FG010|Overall Study|Death|0|||
156745596|NCT02520427|565815824|FG011|Overall Study|Death|0|||
156745597|NCT02520427|565815825|FG012|Overall Study|Death|0|||
156745598|NCT02520427|565815826|FG013|Overall Study|Death|0|||
156745599|NCT02520427|565815827|FG014|Overall Study|Death|0|||
156745600|NCT02520427|565815828|FG015|Overall Study|Death|0|||
156745601|NCT02520427|565815829|FG016|Overall Study|Death|2|||
156745602|NCT02520427|565815830|FG017|Overall Study|Death|1|||
156745603|NCT02520427|565815831|FG018|Overall Study|Death|3|||
156745604|NCT02520427|565815832|FG019|Overall Study|Death|2|||
156745605|NCT02520427|565815833|FG020|Overall Study|Death|0|||
156745606|NCT02520427|565815834|FG021|Overall Study|Death|0|||
156745607|NCT02520427|565815835|FG022|Overall Study|Death|1|||
156745608|NCT02520427|565815836|FG023|Overall Study|Death|0|||
156745609|NCT02520427|565815837|FG024|Overall Study|Death|1|||
156745610|NCT02520427|565815838|FG025|Overall Study|Death|0|||
156745611|NCT02168777|565818149|FG000|Overall Study|Withdrawal by Subject|1|||
156745612|NCT02168777|565818150|FG001|Overall Study|Withdrawal by Subject|0|||
156745613|NCT02168777|565818151|FG002|Overall Study|Withdrawal by Subject|2|||
156745614|NCT02168777|565818149|FG000|Overall Study|Adverse Event|1|||
156745615|NCT02168777|565818150|FG001|Overall Study|Adverse Event|0|||
156745616|NCT02168777|565818151|FG002|Overall Study|Adverse Event|1|||
156745617|NCT02168777|565818149|FG000|Overall Study|Disease recurrence|0|||
156745618|NCT02168777|565818150|FG001|Overall Study|Disease recurrence|0|||
156745619|NCT02168777|565818151|FG002|Overall Study|Disease recurrence|1|||
156745620|NCT02168777|565818149|FG000|Overall Study|Radiological disease progression|0|||
156745621|NCT02168777|565818150|FG001|Overall Study|Radiological disease progression|5|||
156745622|NCT02168777|565818151|FG002|Overall Study|Radiological disease progression|5|||
156337171|NCT03166735|564333561|FG000|Overall Study|Not Treated|1|||
156458966|NCT01928394|564776674|FG020|Follow-up Period|other reason|0|||
156458967|NCT01928394|564776675|FG021|Follow-up Period|other reason|0|||
156458968|NCT01928394|564776676|FG022|Follow-up Period|other reason|1|||
156458969|NCT01928394|564776654|FG000|Follow-up Period|Lost to Follow-up|0|||
156458970|NCT01928394|564776655|FG001|Follow-up Period|Lost to Follow-up|0|||
156458971|NCT01928394|564776656|FG002|Follow-up Period|Lost to Follow-up|0|||
156458972|NCT01928394|564776657|FG003|Follow-up Period|Lost to Follow-up|0|||
156458973|NCT01928394|564776658|FG004|Follow-up Period|Lost to Follow-up|0|||
156458974|NCT01928394|564776659|FG005|Follow-up Period|Lost to Follow-up|0|||
156458975|NCT01928394|564776660|FG006|Follow-up Period|Lost to Follow-up|0|||
156458976|NCT01928394|564776661|FG007|Follow-up Period|Lost to Follow-up|0|||
156458977|NCT01928394|564776662|FG008|Follow-up Period|Lost to Follow-up|0|||
156458978|NCT01928394|564776663|FG009|Follow-up Period|Lost to Follow-up|0|||
156458979|NCT01928394|564776664|FG010|Follow-up Period|Lost to Follow-up|0|||
156458980|NCT01928394|564776665|FG011|Follow-up Period|Lost to Follow-up|1|||
156458981|NCT01928394|564776666|FG012|Follow-up Period|Lost to Follow-up|1|||
156458982|NCT01928394|564776667|FG013|Follow-up Period|Lost to Follow-up|0|||
156458983|NCT01928394|564776668|FG014|Follow-up Period|Lost to Follow-up|1|||
156458984|NCT01928394|564776669|FG015|Follow-up Period|Lost to Follow-up|0|||
156458985|NCT01928394|564776670|FG016|Follow-up Period|Lost to Follow-up|1|||
156458986|NCT01928394|564776671|FG017|Follow-up Period|Lost to Follow-up|0|||
156458987|NCT01928394|564776672|FG018|Follow-up Period|Lost to Follow-up|0|||
156458988|NCT01928394|564776673|FG019|Follow-up Period|Lost to Follow-up|0|||
156458989|NCT01928394|564776674|FG020|Follow-up Period|Lost to Follow-up|0|||
156458990|NCT01928394|564776675|FG021|Follow-up Period|Lost to Follow-up|0|||
156458991|NCT01928394|564776676|FG022|Follow-up Period|Lost to Follow-up|1|||
156458992|NCT03209973|564776680|FG000|Overall Study|Withdrawal by Subject|7|||
156458993|NCT03209973|564776680|FG000|Overall Study|Lost to Follow-up|2|||
156458994|NCT03209973|564776680|FG000|Overall Study|Death|8|||
156458995|NCT03209973|564776680|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
156458996|NCT03209973|564776680|FG000|Overall Study|Sponsor Decision|18|||
156458997|NCT03209973|564776680|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
156458998|NCT03209973|564776680|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
156458999|NCT02240238|564776692|FG000|Phase 1|Adverse Event|0|||
156459000|NCT02240238|564776693|FG001|Phase 1|Adverse Event|0|||
156459001|NCT02240238|564776694|FG002|Phase 1|Adverse Event|0|||
156459002|NCT02240238|564776695|FG003|Phase 1|Adverse Event|0|||
156459003|NCT02240238|564776696|FG004|Phase 1|Adverse Event|0|||
156459004|NCT02240238|564776697|FG005|Phase 1|Adverse Event|0|||
156459005|NCT02240238|564776698|FG006|Phase 1|Adverse Event|3|||
156745623|NCT02168777|565818149|FG000|Overall Study|Clinical disease progression|0|||
156745624|NCT02168777|565818150|FG001|Overall Study|Clinical disease progression|1|||
156745625|NCT02168777|565818151|FG002|Overall Study|Clinical disease progression|2|||
156745626|NCT02168777|565818149|FG000|Overall Study|Other reason|0|||
156745627|NCT02168777|565818150|FG001|Overall Study|Other reason|1|||
156745628|NCT02168777|565818151|FG002|Overall Study|Other reason|0|||
156745629|NCT00441363|565818152|FG000|Overall Study|Adverse Event|4|||
156745630|NCT00441363|565818153|FG001|Overall Study|Adverse Event|2|||
156745631|NCT00441363|565818152|FG000|Overall Study|Withdrawal by Subject|3|||
156745632|NCT00441363|565818153|FG001|Overall Study|Withdrawal by Subject|4|||
156745633|NCT00441363|565818152|FG000|Overall Study|Physician Decision|6|||
156745634|NCT00441363|565818153|FG001|Overall Study|Physician Decision|7|||
156745635|NCT00441363|565818152|FG000|Overall Study|Lost to Follow-up|2|||
156745636|NCT00441363|565818153|FG001|Overall Study|Lost to Follow-up|2|||
156745637|NCT00441363|565818152|FG000|Overall Study|Other|2|||
156745638|NCT00441363|565818153|FG001|Overall Study|Other|0|||
156745639|NCT02437188|565818154|FG000|Overall Study|Randomized but did not receive surgery|4|||
156745640|NCT02437188|565818155|FG001|Overall Study|Randomized but did not receive surgery|8|||
156745641|NCT02437188|565818154|FG000|Overall Study|Adverse Event|0|||
156745642|NCT02437188|565818155|FG001|Overall Study|Adverse Event|1|||
156745643|NCT00593606|565818166|FG000|Overall Study|Adverse Event|13|||
156745644|NCT00593606|565818166|FG000|Overall Study|Withdrawal by Subject|1|||
156745645|NCT00593606|565818166|FG000|Overall Study|Protocol Violation|3|||
156745646|NCT00593606|565818166|FG000|Overall Study|Lost to Follow-up|2|||
156745647|NCT00593606|565818166|FG000|Overall Study|Run-In Failure|5|||
156536571|NCT02092350|565059008|FG000|Overall Study|Screen Failure|1|||
156745648|NCT00593606|565818166|FG000|Overall Study|Screen Failure|3|||
156745649|NCT05940077|565818167|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
156745650|NCT00388297|565818168|FG000|Overall Study|Lost to Follow-up|16|||
156745651|NCT00388297|565818169|FG001|Overall Study|Lost to Follow-up|12|||
156745652|NCT00388297|565818170|FG002|Overall Study|Lost to Follow-up|11|||
156745653|NCT00388297|565818171|FG003|Overall Study|Lost to Follow-up|8|||
156745654|NCT01492101|565818172|FG000|Overall Study|Death|323|||
156745655|NCT01492101|565818173|FG001|Overall Study|Death|322|||
156745656|NCT01492101|565818172|FG000|Overall Study|Withdrawal by Subject|14|||
156745657|NCT01492101|565818173|FG001|Overall Study|Withdrawal by Subject|18|||
156745658|NCT01492101|565818172|FG000|Overall Study|Lost to Follow-up|0|||
156745659|NCT01492101|565818173|FG001|Overall Study|Lost to Follow-up|2|||
156745660|NCT00412217|565818179|FG000|Overall Study|Insufficient Data Available|8|||
156745661|NCT00412217|565818180|FG001|Overall Study|Insufficient Data Available|3|||
156745662|NCT00412217|565818179|FG000|Overall Study|Death|5|||
156745663|NCT00412217|565818180|FG001|Overall Study|Death|4|||
156745664|NCT00412217|565818179|FG000|Overall Study|Disease Progression|2|||
156745665|NCT00412217|565818180|FG001|Overall Study|Disease Progression|3|||
156745666|NCT00412217|565818179|FG000|Overall Study|Investigator Decision|1|||
156745667|NCT00412217|565818180|FG001|Overall Study|Investigator Decision|0|||
156745668|NCT00412217|565818179|FG000|Overall Study|Withdrawal by Subject|2|||
156745669|NCT00412217|565818180|FG001|Overall Study|Withdrawal by Subject|0|||
156745670|NCT00412217|565818179|FG000|Overall Study|Lost to Follow-up|1|||
156745671|NCT00412217|565818180|FG001|Overall Study|Lost to Follow-up|4|||
156745672|NCT00412217|565818179|FG000|Overall Study|Study Terminated by Sponsor|26|||
156745673|NCT00412217|565818180|FG001|Overall Study|Study Terminated by Sponsor|33|||
156745674|NCT00412217|565818179|FG000|Overall Study|Other|1|||
156745675|NCT00412217|565818180|FG001|Overall Study|Other|1|||
156745676|NCT00980174|565818190|FG000|Overall Study|Withdrawal by Subject|1|||
156745677|NCT00980174|565818191|FG001|Overall Study|Withdrawal by Subject|4|||
156536572|NCT02092350|565059009|FG001|Overall Study|Screen Failure|0|||
156536573|NCT02092350|565059008|FG000|Overall Study|Withdrawal by Subject|2|||
156745678|NCT00980174|565818190|FG000|Overall Study|Adverse Event|0|||
156745679|NCT00980174|565818191|FG001|Overall Study|Adverse Event|3|||
156745680|NCT00980174|565818190|FG000|Overall Study|Ineligibility determined|2|||
156745681|NCT00980174|565818191|FG001|Overall Study|Ineligibility determined|1|||
156745682|NCT00980174|565818190|FG000|Overall Study|Death|1|||
156745683|NCT00980174|565818191|FG001|Overall Study|Death|1|||
156745684|NCT00980174|565818190|FG000|Overall Study|Other|0|||
156745685|NCT00980174|565818191|FG001|Overall Study|Other|1|||
156536574|NCT02092350|565059009|FG001|Overall Study|Withdrawal by Subject|2|||
156536575|NCT00646906|565059010|FG000|Crossover Period 1|Withdrawal by Subject|1|||
156536576|NCT00646906|565059011|FG001|Crossover Period 1|Withdrawal by Subject|0|||
156745686|NCT03114657|565818192|FG000|Overall Study|Adverse Event|9|||
156745687|NCT03114657|565818193|FG001|Overall Study|Adverse Event|6|||
156745688|NCT03114657|565818192|FG000|Overall Study|Death|4|||
156745689|NCT03114657|565818193|FG001|Overall Study|Death|0|||
156745690|NCT03114657|565818192|FG000|Overall Study|Multiple Reasons|1|||
156745691|NCT03114657|565818193|FG001|Overall Study|Multiple Reasons|2|||
156745692|NCT03114657|565818192|FG000|Overall Study|Physician Decision|2|||
156745693|NCT03114657|565818193|FG001|Overall Study|Physician Decision|2|||
156745694|NCT03114657|565818192|FG000|Overall Study|Study Terminated By Sponsor|355|||
156536577|NCT00646906|565059012|FG002|Crossover Period 1|Withdrawal by Subject|0|||
156536578|NCT00646906|565059013|FG003|Crossover Period 1|Withdrawal by Subject|0|||
156745695|NCT03114657|565818193|FG001|Overall Study|Study Terminated By Sponsor|374|||
156745696|NCT03114657|565818192|FG000|Overall Study|Symptomatic Deterioration|0|||
156745697|NCT03114657|565818193|FG001|Overall Study|Symptomatic Deterioration|1|||
156745698|NCT03114657|565818192|FG000|Overall Study|Withdrawal by Subject|28|||
156745699|NCT03114657|565818193|FG001|Overall Study|Withdrawal by Subject|22|||
156745700|NCT00115037|565818194|FG000|Phase1|Lost to Follow-up|16|||
156745701|NCT00115037|565818195|FG001|Phase1|Lost to Follow-up|23|||
156745702|NCT00115037|565818196|FG002|Phase1|Lost to Follow-up|0|||
156745703|NCT00115037|565818197|FG003|Phase1|Lost to Follow-up|0|||
156745704|NCT00115037|565818198|FG004|Phase1|Lost to Follow-up|0|||
156745705|NCT00115037|565818199|FG005|Phase1|Lost to Follow-up|0|||
156745706|NCT00115037|565818194|FG000|Phase1|Withdrawal by Subject|9|||
156745707|NCT00115037|565818195|FG001|Phase1|Withdrawal by Subject|4|||
156745708|NCT00115037|565818196|FG002|Phase1|Withdrawal by Subject|0|||
156745709|NCT00115037|565818197|FG003|Phase1|Withdrawal by Subject|0|||
156745710|NCT00115037|565818198|FG004|Phase1|Withdrawal by Subject|0|||
156745711|NCT00115037|565818199|FG005|Phase1|Withdrawal by Subject|0|||
156745712|NCT00115037|565818194|FG000|Phase2|Death|0|||
156745713|NCT00115037|565818195|FG001|Phase2|Death|0|||
156745714|NCT00115037|565818196|FG002|Phase2|Death|1|||
156745715|NCT00115037|565818197|FG003|Phase2|Death|0|||
156745716|NCT00115037|565818198|FG004|Phase2|Death|0|||
156745717|NCT00115037|565818199|FG005|Phase2|Death|1|||
156745718|NCT00115037|565818194|FG000|Phase2|Withdrawal by Subject|0|||
156745719|NCT00115037|565818195|FG001|Phase2|Withdrawal by Subject|0|||
156745720|NCT00115037|565818196|FG002|Phase2|Withdrawal by Subject|2|||
156745721|NCT00115037|565818197|FG003|Phase2|Withdrawal by Subject|1|||
156745722|NCT00115037|565818198|FG004|Phase2|Withdrawal by Subject|2|||
156745723|NCT00115037|565818199|FG005|Phase2|Withdrawal by Subject|1|||
156745724|NCT00115037|565818194|FG000|Phase2|Lost to Follow-up|0|||
156745725|NCT00115037|565818195|FG001|Phase2|Lost to Follow-up|0|||
156745726|NCT00115037|565818196|FG002|Phase2|Lost to Follow-up|12|||
156745727|NCT00115037|565818197|FG003|Phase2|Lost to Follow-up|14|||
156745728|NCT00115037|565818198|FG004|Phase2|Lost to Follow-up|4|||
156745729|NCT00115037|565818199|FG005|Phase2|Lost to Follow-up|10|||
156745730|NCT01546038|565818200|FG000|Overall Study|Death|15|||
156459006|NCT02240238|564776699|FG007|Phase 1|Adverse Event|1|||
156459007|NCT02240238|564776700|FG008|Phase 1|Adverse Event|0|||
156459008|NCT02240238|564776701|FG009|Phase 1|Adverse Event|0|||
156459009|NCT02240238|564776702|FG010|Phase 1|Adverse Event|0|||
156459010|NCT02240238|564776703|FG011|Phase 1|Adverse Event|0|||
156459011|NCT02240238|564776692|FG000|Phase 1|Death|0|||
156459012|NCT02240238|564776693|FG001|Phase 1|Death|0|||
156459013|NCT02240238|564776694|FG002|Phase 1|Death|0|||
156459014|NCT02240238|564776695|FG003|Phase 1|Death|0|||
156459015|NCT02240238|564776696|FG004|Phase 1|Death|0|||
156459016|NCT02240238|564776697|FG005|Phase 1|Death|1|||
156459017|NCT02240238|564776698|FG006|Phase 1|Death|0|||
156459018|NCT02240238|564776699|FG007|Phase 1|Death|0|||
156459019|NCT02240238|564776700|FG008|Phase 1|Death|0|||
156459020|NCT02240238|564776701|FG009|Phase 1|Death|0|||
156459021|NCT02240238|564776702|FG010|Phase 1|Death|0|||
156459022|NCT02240238|564776703|FG011|Phase 1|Death|0|||
156459023|NCT02240238|564776692|FG000|Phase 1|Sponsor termination|0|||
156459024|NCT02240238|564776693|FG001|Phase 1|Sponsor termination|0|||
156459025|NCT02240238|564776694|FG002|Phase 1|Sponsor termination|0|||
156459026|NCT02240238|564776695|FG003|Phase 1|Sponsor termination|0|||
156459027|NCT02240238|564776696|FG004|Phase 1|Sponsor termination|0|||
156459028|NCT02240238|564776697|FG005|Phase 1|Sponsor termination|1|||
156459029|NCT02240238|564776698|FG006|Phase 1|Sponsor termination|0|||
156459030|NCT02240238|564776699|FG007|Phase 1|Sponsor termination|0|||
156459031|NCT02240238|564776700|FG008|Phase 1|Sponsor termination|0|||
156459032|NCT02240238|564776701|FG009|Phase 1|Sponsor termination|0|||
156459033|NCT02240238|564776702|FG010|Phase 1|Sponsor termination|0|||
156459034|NCT02240238|564776703|FG011|Phase 1|Sponsor termination|0|||
156459035|NCT02240238|564776692|FG000|Phase 1|Withdrawal by Subject|0|||
156459036|NCT02240238|564776693|FG001|Phase 1|Withdrawal by Subject|0|||
156459037|NCT02240238|564776694|FG002|Phase 1|Withdrawal by Subject|0|||
156459038|NCT02240238|564776695|FG003|Phase 1|Withdrawal by Subject|0|||
156745731|NCT01546038|565818201|FG001|Overall Study|Death|6|||
156459039|NCT02240238|564776696|FG004|Phase 1|Withdrawal by Subject|0|||
156459040|NCT02240238|564776697|FG005|Phase 1|Withdrawal by Subject|2|||
156459041|NCT02240238|564776698|FG006|Phase 1|Withdrawal by Subject|0|||
156459042|NCT02240238|564776699|FG007|Phase 1|Withdrawal by Subject|0|||
156459043|NCT02240238|564776700|FG008|Phase 1|Withdrawal by Subject|0|||
156459044|NCT02240238|564776701|FG009|Phase 1|Withdrawal by Subject|0|||
156459045|NCT02240238|564776702|FG010|Phase 1|Withdrawal by Subject|0|||
156536579|NCT00646906|565059014|FG004|Crossover Period 1|Withdrawal by Subject|0|||
156745732|NCT01546038|565818202|FG002|Overall Study|Death|4|||
156745733|NCT01546038|565818203|FG003|Overall Study|Death|2|||
156459046|NCT02240238|564776703|FG011|Phase 1|Withdrawal by Subject|0|||
156459047|NCT02240238|564776692|FG000|Phase 1|Physician Decision|0|||
156459048|NCT02240238|564776693|FG001|Phase 1|Physician Decision|0|||
156459049|NCT02240238|564776694|FG002|Phase 1|Physician Decision|0|||
156745734|NCT01546038|565818204|FG004|Overall Study|Death|9|||
156745735|NCT01546038|565818205|FG005|Overall Study|Death|3|||
156745736|NCT01546038|565818206|FG006|Overall Study|Death|46|||
156745737|NCT01546038|565818207|FG007|Overall Study|Death|76|||
156745738|NCT01546038|565818208|FG008|Overall Study|Death|39|||
156745739|NCT01546038|565818200|FG000|Overall Study|Lost to Follow-up|0|||
156745740|NCT01546038|565818201|FG001|Overall Study|Lost to Follow-up|0|||
156745741|NCT01546038|565818202|FG002|Overall Study|Lost to Follow-up|0|||
156745742|NCT01546038|565818203|FG003|Overall Study|Lost to Follow-up|0|||
156745743|NCT01546038|565818204|FG004|Overall Study|Lost to Follow-up|1|||
156745744|NCT01546038|565818205|FG005|Overall Study|Lost to Follow-up|0|||
156745745|NCT01546038|565818206|FG006|Overall Study|Lost to Follow-up|2|||
156745746|NCT01546038|565818207|FG007|Overall Study|Lost to Follow-up|1|||
156745747|NCT01546038|565818208|FG008|Overall Study|Lost to Follow-up|0|||
156745748|NCT01546038|565818200|FG000|Overall Study|Withdrawal by Subject|1|||
156745749|NCT01546038|565818201|FG001|Overall Study|Withdrawal by Subject|0|||
156745750|NCT01546038|565818202|FG002|Overall Study|Withdrawal by Subject|0|||
156745751|NCT01546038|565818203|FG003|Overall Study|Withdrawal by Subject|1|||
156745752|NCT01546038|565818204|FG004|Overall Study|Withdrawal by Subject|0|||
156745753|NCT01546038|565818205|FG005|Overall Study|Withdrawal by Subject|1|||
156745754|NCT01546038|565818206|FG006|Overall Study|Withdrawal by Subject|3|||
156745755|NCT01546038|565818207|FG007|Overall Study|Withdrawal by Subject|3|||
156745756|NCT01546038|565818208|FG008|Overall Study|Withdrawal by Subject|1|||
156745757|NCT01546038|565818200|FG000|Overall Study|: Randomized, not treated|0|||
156745758|NCT01546038|565818201|FG001|Overall Study|: Randomized, not treated|0|||
156745759|NCT01546038|565818202|FG002|Overall Study|: Randomized, not treated|0|||
156745760|NCT01546038|565818203|FG003|Overall Study|: Randomized, not treated|0|||
156745761|NCT01546038|565818204|FG004|Overall Study|: Randomized, not treated|0|||
156745762|NCT01546038|565818205|FG005|Overall Study|: Randomized, not treated|0|||
156745763|NCT01546038|565818206|FG006|Overall Study|: Randomized, not treated|2|||
156745764|NCT01546038|565818207|FG007|Overall Study|: Randomized, not treated|4|||
156745765|NCT01546038|565818208|FG008|Overall Study|: Randomized, not treated|3|||
156745766|NCT04245202|565818209|FG000|Overall Study|Lack of Efficacy|10|||
156745767|NCT04245202|565818210|FG001|Overall Study|Lack of Efficacy|1|||
156745768|NCT00717275|565818211|FG000|Overall Study|Premature study termination.|3|||
156745769|NCT03515629|565818215|FG000|Overall Study|Death|0|||
156745770|NCT03515629|565818216|FG001|Overall Study|Death|1|||
156745771|NCT03515629|565818217|FG002|Overall Study|Death|1|||
156745772|NCT03515629|565818215|FG000|Overall Study|Progressive disease|0|||
156745773|NCT03515629|565818216|FG001|Overall Study|Progressive disease|1|||
156745774|NCT03515629|565818217|FG002|Overall Study|Progressive disease|0|||
156745775|NCT01254721|565818218|FG000|Overall Study|Lost to Follow-up|0|||
156745776|NCT01254721|565818219|FG001|Overall Study|Lost to Follow-up|4|||
156745777|NCT01254721|565818218|FG000|Overall Study|Lack of Efficacy|4|||
156745778|NCT01254721|565818219|FG001|Overall Study|Lack of Efficacy|2|||
156745779|NCT01254721|565818218|FG000|Overall Study|Death|0|||
156745780|NCT01254721|565818219|FG001|Overall Study|Death|1|||
156745781|NCT01254721|565818218|FG000|Overall Study|technical problum|1|||
156745782|NCT01254721|565818219|FG001|Overall Study|technical problum|0|||
156745783|NCT01254721|565818218|FG000|Overall Study|Adverse Event|2|||
156745784|NCT01254721|565818219|FG001|Overall Study|Adverse Event|3|||
156745785|NCT01254721|565818218|FG000|Overall Study|Withdrawal by Subject|8|||
156745786|NCT01254721|565818219|FG001|Overall Study|Withdrawal by Subject|11|||
156745787|NCT01254721|565818218|FG000|Overall Study|Wrongly randomization|0|||
156745788|NCT01254721|565818219|FG001|Overall Study|Wrongly randomization|1|||
156745789|NCT00424021|565818220|FG000|NCT00046319 Study Period|Adverse Event|1|||
156745790|NCT00424021|565818221|FG001|NCT00046319 Study Period|Adverse Event|0|||
156745791|NCT00424021|565818222|FG002|NCT00046319 Study Period|Adverse Event|1|||
156745792|NCT00424021|565818223|FG003|NCT00046319 Study Period|Adverse Event|1|||
156745793|NCT00424021|565818220|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
156745794|NCT00424021|565818221|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
156745795|NCT00424021|565818222|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
156337172|NCT03166735|564333562|FG001|Overall Study|Not Treated|0|||
156337173|NCT03166735|564333563|FG002|Overall Study|Not Treated|0|||
156459050|NCT02240238|564776695|FG003|Phase 1|Physician Decision|0|||
156745796|NCT00424021|565818223|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
156745797|NCT00424021|565818220|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
156745798|NCT00424021|565818221|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
156745799|NCT00424021|565818222|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
156745800|NCT00424021|565818223|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
156745801|NCT00424021|565818220|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
156745802|NCT00424021|565818221|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
156745803|NCT00424021|565818222|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
156745804|NCT00424021|565818223|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
156745805|NCT00424021|565818220|FG000|AMB-220-E Study Period|Adverse Event|1|||
156745806|NCT00424021|565818221|FG001|AMB-220-E Study Period|Adverse Event|1|||
156745807|NCT00424021|565818222|FG002|AMB-220-E Study Period|Adverse Event|3|||
156745808|NCT00424021|565818223|FG003|AMB-220-E Study Period|Adverse Event|7|||
156745809|NCT00424021|565818220|FG000|AMB-220-E Study Period|Death|0|||
156745810|NCT00424021|565818221|FG001|AMB-220-E Study Period|Death|0|||
156745811|NCT00424021|565818222|FG002|AMB-220-E Study Period|Death|1|||
156337174|NCT03166735|564333564|FG003|Overall Study|Not Treated|0|||
156745812|NCT00424021|565818223|FG003|AMB-220-E Study Period|Death|1|||
156745813|NCT00424021|565818220|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
156745814|NCT00424021|565818221|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
156745815|NCT00424021|565818222|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
156745816|NCT00424021|565818223|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
156745817|NCT00424021|565818220|FG000|AMB-220-E Study Period|Physician Decision|0|||
156745818|NCT00424021|565818221|FG001|AMB-220-E Study Period|Physician Decision|0|||
156745819|NCT00424021|565818222|FG002|AMB-220-E Study Period|Physician Decision|0|||
156745820|NCT00424021|565818223|FG003|AMB-220-E Study Period|Physician Decision|1|||
156745821|NCT00312572|565818224|FG000|Overall Study|Adverse Event|10|||
156745822|NCT00312572|565818225|FG001|Overall Study|Adverse Event|16|||
156745823|NCT00312572|565818224|FG000|Overall Study|Lost to Follow-up|1|||
156745824|NCT00312572|565818225|FG001|Overall Study|Lost to Follow-up|1|||
156745825|NCT00312572|565818224|FG000|Overall Study|Administrative|4|||
156745826|NCT00312572|565818225|FG001|Overall Study|Administrative|2|||
156745827|NCT00312572|565818224|FG000|Overall Study|Lack of Efficacy|1|||
156745828|NCT00312572|565818225|FG001|Overall Study|Lack of Efficacy|2|||
156745829|NCT03597022|565818226|FG000|Overall Study|Premature termination of the study|7|||
156745830|NCT03597022|565818227|FG001|Overall Study|Premature termination of the study|7|||
156745831|NCT03597022|565818228|FG002|Overall Study|Premature termination of the study|8|||
156745832|NCT03597022|565818226|FG000|Overall Study|Serious adverse event|1|||
156745833|NCT03597022|565818227|FG001|Overall Study|Serious adverse event|1|||
156745834|NCT03597022|565818228|FG002|Overall Study|Serious adverse event|0|||
156745835|NCT05385224|565818229|FG000|Overall Study|Unable to swallow capsule|2|||
156745836|NCT05385224|565818229|FG000|Overall Study|Withdrawal by Subject|2|||
156745837|NCT05385224|565818229|FG000|Overall Study|Did not meet study criteria|1|||
156745838|NCT04521114|565818232|FG000|Overall Study|Lost to Follow-up|1|||
156745839|NCT04521114|565818233|FG001|Overall Study|Lost to Follow-up|2|||
156745840|NCT04521114|565818234|FG002|Overall Study|Lost to Follow-up|0|||
156745841|NCT04521114|565818232|FG000|Overall Study|Withdrawal by Subject|1|||
156745842|NCT04521114|565818233|FG001|Overall Study|Withdrawal by Subject|2|||
156745843|NCT04521114|565818234|FG002|Overall Study|Withdrawal by Subject|2|||
156745844|NCT04521114|565818232|FG000|Overall Study|Adverse Event|1|||
156745845|NCT04521114|565818233|FG001|Overall Study|Adverse Event|0|||
156745846|NCT04521114|565818234|FG002|Overall Study|Adverse Event|0|||
156745847|NCT04521114|565818232|FG000|Overall Study|Sponsor Wish|1|||
156745848|NCT04521114|565818233|FG001|Overall Study|Sponsor Wish|0|||
156745849|NCT04521114|565818234|FG002|Overall Study|Sponsor Wish|0|||
156745850|NCT04521114|565818232|FG000|Overall Study|Withdrawal of Consent|2|||
156745851|NCT04521114|565818233|FG001|Overall Study|Withdrawal of Consent|2|||
156745852|NCT04521114|565818234|FG002|Overall Study|Withdrawal of Consent|0|||
156745853|NCT02614131|565818235|FG000|Overall Study|Withdrawal by Subject|1|||
156536580|NCT00646906|565059015|FG005|Crossover Period 1|Withdrawal by Subject|1|||
156536581|NCT00646906|565059016|FG006|Crossover Period 1|Withdrawal by Subject|0|||
156536582|NCT00646906|565059010|FG000|Crossover Period 2|Withdrawal by Subject|0|||
156536583|NCT00646906|565059011|FG001|Crossover Period 2|Withdrawal by Subject|1|||
156536584|NCT00646906|565059012|FG002|Crossover Period 2|Withdrawal by Subject|2|||
156536585|NCT00646906|565059013|FG003|Crossover Period 2|Withdrawal by Subject|1|||
156536586|NCT00646906|565059014|FG004|Crossover Period 2|Withdrawal by Subject|0|||
156536587|NCT00646906|565059015|FG005|Crossover Period 2|Withdrawal by Subject|0|||
156536588|NCT00646906|565059016|FG006|Crossover Period 2|Withdrawal by Subject|0|||
156536589|NCT00646906|565059010|FG000|Crossover Period 2|Physician Decision|0|||
156536590|NCT00646906|565059011|FG001|Crossover Period 2|Physician Decision|0|||
156536591|NCT00646906|565059012|FG002|Crossover Period 2|Physician Decision|0|||
156745854|NCT02614131|565818236|FG001|Overall Study|Withdrawal by Subject|0|||
156745855|NCT02614131|565818237|FG002|Overall Study|Withdrawal by Subject|0|||
156745856|NCT02614131|565818238|FG003|Overall Study|Withdrawal by Subject|0|||
156745857|NCT02614131|565818239|FG004|Overall Study|Withdrawal by Subject|0|||
156745858|NCT02614131|565818240|FG005|Overall Study|Withdrawal by Subject|0|||
156745859|NCT02614131|565818241|FG006|Overall Study|Withdrawal by Subject|0|||
156745860|NCT02614131|565818235|FG000|Overall Study|Adverse Event|0|||
156799602|NCT00560508|566021346|FG001|12 Week Double-blind Period|Adverse Event|2|||
156799603|NCT00560508|566021345|FG000|12 Week Double-blind Period|Protocol Violation|1|||
156799604|NCT00560508|566021346|FG001|12 Week Double-blind Period|Protocol Violation|0|||
156536592|NCT00646906|565059013|FG003|Crossover Period 2|Physician Decision|0|||
156745861|NCT02614131|565818236|FG001|Overall Study|Adverse Event|0|||
156745862|NCT02614131|565818237|FG002|Overall Study|Adverse Event|0|||
156745863|NCT02614131|565818238|FG003|Overall Study|Adverse Event|0|||
156745864|NCT02614131|565818239|FG004|Overall Study|Adverse Event|0|||
156745865|NCT02614131|565818240|FG005|Overall Study|Adverse Event|0|||
156745866|NCT02614131|565818241|FG006|Overall Study|Adverse Event|1|||
156745867|NCT03209518|565818242|FG000|Overall Study|Case Report Forms Uncollected|1|||
156745868|NCT03209518|565818242|FG000|Overall Study|Protocol Deviation|1|||
156745869|NCT02854605|565818243|FG000|Overall Study|Adverse Event|1|||
156745870|NCT02854605|565818244|FG001|Overall Study|Adverse Event|5|||
156745871|NCT02854605|565818245|FG002|Overall Study|Adverse Event|2|||
156745872|NCT02854605|565818243|FG000|Overall Study|Lost to Follow-up|0|||
156536593|NCT00646906|565059014|FG004|Crossover Period 2|Physician Decision|0|||
156536594|NCT00646906|565059015|FG005|Crossover Period 2|Physician Decision|0|||
156536595|NCT00646906|565059016|FG006|Crossover Period 2|Physician Decision|1|||
156536596|NCT00962390|565059018|FG000|Overall Study|Adverse Event|0|||
156536597|NCT00962390|565059019|FG001|Overall Study|Adverse Event|0|||
156536598|NCT00962390|565059020|FG002|Overall Study|Adverse Event|3|||
156536599|NCT00962390|565059021|FG003|Overall Study|Adverse Event|1|||
156536600|NCT00962390|565059018|FG000|Overall Study|Lost to Follow-up|2|||
156536601|NCT00962390|565059019|FG001|Overall Study|Lost to Follow-up|2|||
156536602|NCT00962390|565059020|FG002|Overall Study|Lost to Follow-up|0|||
156745873|NCT02854605|565818244|FG001|Overall Study|Lost to Follow-up|2|||
156745874|NCT02854605|565818245|FG002|Overall Study|Lost to Follow-up|0|||
156745875|NCT02854605|565818243|FG000|Overall Study|Withdrew Consent|1|||
156745876|NCT02854605|565818244|FG001|Overall Study|Withdrew Consent|0|||
156745877|NCT02854605|565818245|FG002|Overall Study|Withdrew Consent|1|||
156745878|NCT02854605|565818243|FG000|Overall Study|Investigator's Discretion|1|||
156745879|NCT02854605|565818244|FG001|Overall Study|Investigator's Discretion|0|||
156745880|NCT02854605|565818245|FG002|Overall Study|Investigator's Discretion|0|||
156745881|NCT02854605|565818243|FG000|Overall Study|Protocol Violation|0|||
156799605|NCT00560508|566021345|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
156536603|NCT00962390|565059021|FG003|Overall Study|Lost to Follow-up|0|||
156536604|NCT00962390|565059018|FG000|Overall Study|Protocol Violation|1|||
156536605|NCT00962390|565059019|FG001|Overall Study|Protocol Violation|0|||
156536606|NCT00962390|565059020|FG002|Overall Study|Protocol Violation|0|||
156536607|NCT00962390|565059021|FG003|Overall Study|Protocol Violation|0|||
156536608|NCT00962390|565059018|FG000|Overall Study|Withdrawal by Subject|1|||
156536609|NCT00962390|565059019|FG001|Overall Study|Withdrawal by Subject|1|||
156536610|NCT00962390|565059020|FG002|Overall Study|Withdrawal by Subject|1|||
156536611|NCT00962390|565059021|FG003|Overall Study|Withdrawal by Subject|0|||
156536612|NCT02613884|565059022|FG000|Overall Study|Death|1|||
156536613|NCT02613884|565059022|FG000|Overall Study|Lost to Follow-up|1|||
156536614|NCT02844920|565059023|FG000|Overall Study|Lost to Follow-up|2|||
156536615|NCT04534491|565059024|FG000|Overall Study|Not completed end-of-study interview|24|||
156536616|NCT04534491|565059024|FG000|Overall Study|Non-users|70|||
156536617|NCT04534491|565059024|FG000|Overall Study|Non-verifiable users|58|||
156536618|NCT00766090|565059027|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536619|NCT00766090|565059028|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536620|NCT00766090|565059029|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536621|NCT00766090|565059030|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536622|NCT00766090|565059031|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536623|NCT00766090|565059032|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536624|NCT00766090|565059033|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536625|NCT00766090|565059034|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536626|NCT00766090|565059035|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
156536627|NCT00766090|565059036|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536628|NCT00766090|565059037|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536629|NCT00766090|565059038|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156536630|NCT00766090|565059027|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
156536631|NCT00766090|565059028|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536632|NCT00766090|565059029|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536633|NCT00766090|565059030|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536634|NCT00766090|565059031|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536635|NCT00766090|565059032|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536636|NCT00766090|565059033|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536637|NCT00766090|565059034|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536638|NCT00766090|565059035|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536639|NCT00766090|565059036|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536640|NCT00766090|565059037|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156536641|NCT00766090|565059038|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
156745882|NCT02854605|565818244|FG001|Overall Study|Protocol Violation|0|||
156745883|NCT02854605|565818245|FG002|Overall Study|Protocol Violation|1|||
156799606|NCT00560508|566021346|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
156799607|NCT00560508|566021345|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
156799608|NCT00560508|566021346|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
156799609|NCT00560508|566021345|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
156536642|NCT00766090|565059027|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
156536643|NCT00766090|565059028|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156536644|NCT00766090|565059029|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156536645|NCT00766090|565059030|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
156536646|NCT00766090|565059031|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156536647|NCT00766090|565059032|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156745884|NCT01897571|565818246|FG000|Overall Study|Lost to Follow-up|3|||
156799610|NCT00560508|566021346|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
156745885|NCT01897571|565818247|FG001|Overall Study|Lost to Follow-up|0|||
156745886|NCT01897571|565818248|FG002|Overall Study|Lost to Follow-up|0|||
156745887|NCT01897571|565818249|FG003|Overall Study|Lost to Follow-up|0|||
156745888|NCT01897571|565818250|FG004|Overall Study|Lost to Follow-up|2|||
156745889|NCT01897571|565818251|FG005|Overall Study|Lost to Follow-up|0|||
156745890|NCT01897571|565818252|FG006|Overall Study|Lost to Follow-up|0|||
156745891|NCT01897571|565818253|FG007|Overall Study|Lost to Follow-up|0|||
156745892|NCT01897571|565818254|FG008|Overall Study|Lost to Follow-up|1|||
156745893|NCT01897571|565818255|FG009|Overall Study|Lost to Follow-up|2|||
156745894|NCT01897571|565818256|FG010|Overall Study|Lost to Follow-up|4|||
156745895|NCT01897571|565818246|FG000|Overall Study|Withdrawal by Subject|0|||
156745896|NCT01897571|565818247|FG001|Overall Study|Withdrawal by Subject|0|||
156745897|NCT01897571|565818248|FG002|Overall Study|Withdrawal by Subject|0|||
156745898|NCT01897571|565818249|FG003|Overall Study|Withdrawal by Subject|0|||
156745899|NCT01897571|565818250|FG004|Overall Study|Withdrawal by Subject|0|||
156745900|NCT01897571|565818251|FG005|Overall Study|Withdrawal by Subject|0|||
156745901|NCT01897571|565818252|FG006|Overall Study|Withdrawal by Subject|0|||
156745902|NCT01897571|565818253|FG007|Overall Study|Withdrawal by Subject|1|||
156745903|NCT01897571|565818254|FG008|Overall Study|Withdrawal by Subject|4|||
156536648|NCT00766090|565059033|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156745904|NCT01897571|565818255|FG009|Overall Study|Withdrawal by Subject|3|||
156745905|NCT01897571|565818256|FG010|Overall Study|Withdrawal by Subject|1|||
156745906|NCT01897571|565818246|FG000|Overall Study|Other|1|||
156745907|NCT01897571|565818247|FG001|Overall Study|Other|0|||
156745908|NCT01897571|565818248|FG002|Overall Study|Other|0|||
156745909|NCT01897571|565818249|FG003|Overall Study|Other|3|||
156536649|NCT00766090|565059034|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156536650|NCT00766090|565059035|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156536651|NCT00766090|565059036|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156745910|NCT01897571|565818250|FG004|Overall Study|Other|3|||
156745911|NCT01897571|565818251|FG005|Overall Study|Other|4|||
156745912|NCT01897571|565818252|FG006|Overall Study|Other|7|||
156745913|NCT01897571|565818253|FG007|Overall Study|Other|0|||
156745914|NCT01897571|565818254|FG008|Overall Study|Other|0|||
156745915|NCT01897571|565818255|FG009|Overall Study|Other|0|||
156745916|NCT01897571|565818256|FG010|Overall Study|Other|0|||
156745917|NCT01897571|565818246|FG000|Overall Study|Enrolled in rollover study|0|||
156745918|NCT01897571|565818247|FG001|Overall Study|Enrolled in rollover study|0|||
156745919|NCT01897571|565818248|FG002|Overall Study|Enrolled in rollover study|0|||
156745920|NCT01897571|565818249|FG003|Overall Study|Enrolled in rollover study|0|||
156745921|NCT01897571|565818250|FG004|Overall Study|Enrolled in rollover study|0|||
156745922|NCT01897571|565818251|FG005|Overall Study|Enrolled in rollover study|0|||
156745923|NCT01897571|565818252|FG006|Overall Study|Enrolled in rollover study|0|||
156745924|NCT01897571|565818253|FG007|Overall Study|Enrolled in rollover study|9|||
156745925|NCT01897571|565818254|FG008|Overall Study|Enrolled in rollover study|7|||
156745926|NCT01897571|565818255|FG009|Overall Study|Enrolled in rollover study|9|||
156745927|NCT01897571|565818256|FG010|Overall Study|Enrolled in rollover study|1|||
156745928|NCT01897571|565818246|FG000|Overall Study|Death|2|||
156745929|NCT01897571|565818247|FG001|Overall Study|Death|2|||
156745930|NCT01897571|565818248|FG002|Overall Study|Death|3|||
156799611|NCT00560508|566021345|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
156799612|NCT00560508|566021346|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
156799613|NCT00560508|566021345|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
156799614|NCT00560508|566021346|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
156799615|NCT03493958|566021347|FG000|Overall Study|Withdrawal by Subject|6|||
156536652|NCT00766090|565059037|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156745931|NCT01897571|565818249|FG003|Overall Study|Death|6|||
156745932|NCT01897571|565818250|FG004|Overall Study|Death|7|||
156745933|NCT01897571|565818251|FG005|Overall Study|Death|9|||
156745934|NCT01897571|565818252|FG006|Overall Study|Death|5|||
156745935|NCT01897571|565818253|FG007|Overall Study|Death|22|||
156745936|NCT01897571|565818254|FG008|Overall Study|Death|23|||
156745937|NCT01897571|565818255|FG009|Overall Study|Death|129|||
156745938|NCT01897571|565818256|FG010|Overall Study|Death|59|||
156745939|NCT05268016|565818257|FG000|Overall Study|Unacceptable toxicity or AE|2|||
156745940|NCT05268016|565818258|FG001|Overall Study|Unacceptable toxicity or AE|2|||
156745941|NCT05268016|565818259|FG002|Overall Study|Unacceptable toxicity or AE|4|||
156745942|NCT05268016|565818260|FG003|Overall Study|Unacceptable toxicity or AE|3|||
156745943|NCT05268016|565818261|FG004|Overall Study|Unacceptable toxicity or AE|1|||
156745944|NCT05268016|565818257|FG000|Overall Study|Withdrawal by Subject|1|||
156745945|NCT05268016|565818258|FG001|Overall Study|Withdrawal by Subject|3|||
156745946|NCT05268016|565818259|FG002|Overall Study|Withdrawal by Subject|2|||
156745947|NCT05268016|565818260|FG003|Overall Study|Withdrawal by Subject|2|||
156745948|NCT05268016|565818261|FG004|Overall Study|Withdrawal by Subject|1|||
156745949|NCT05268016|565818257|FG000|Overall Study|Lost to Follow-up|4|||
156745950|NCT05268016|565818258|FG001|Overall Study|Lost to Follow-up|7|||
156745951|NCT05268016|565818259|FG002|Overall Study|Lost to Follow-up|1|||
156745952|NCT05268016|565818260|FG003|Overall Study|Lost to Follow-up|3|||
156745953|NCT05268016|565818261|FG004|Overall Study|Lost to Follow-up|5|||
156745954|NCT05268016|565818257|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
156745955|NCT05268016|565818258|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
156745956|NCT05268016|565818259|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
156745957|NCT05268016|565818260|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
156745958|NCT05268016|565818261|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
156745959|NCT05268016|565818257|FG000|Overall Study|Lack of Efficacy|0|||
156745960|NCT05268016|565818258|FG001|Overall Study|Lack of Efficacy|0|||
156745961|NCT05268016|565818259|FG002|Overall Study|Lack of Efficacy|0|||
156745962|NCT05268016|565818260|FG003|Overall Study|Lack of Efficacy|0|||
156745963|NCT05268016|565818261|FG004|Overall Study|Lack of Efficacy|4|||
156745964|NCT05268016|565818257|FG000|Overall Study|Physician Decision|0|||
156745965|NCT05268016|565818258|FG001|Overall Study|Physician Decision|0|||
156745966|NCT05268016|565818259|FG002|Overall Study|Physician Decision|0|||
156745967|NCT05268016|565818260|FG003|Overall Study|Physician Decision|1|||
156745968|NCT05268016|565818261|FG004|Overall Study|Physician Decision|0|||
156745969|NCT05268016|565818257|FG000|Overall Study|Other|1|||
156745970|NCT05268016|565818258|FG001|Overall Study|Other|0|||
156745971|NCT05268016|565818259|FG002|Overall Study|Other|1|||
156745972|NCT05268016|565818260|FG003|Overall Study|Other|2|||
156745973|NCT05268016|565818261|FG004|Overall Study|Other|0|||
156745974|NCT03170609|565818265|FG000|Overall Study|Death|0|||
156745975|NCT03170609|565818266|FG001|Overall Study|Death|0|||
156745976|NCT03170609|565818267|FG002|Overall Study|Death|1|||
156745977|NCT03170609|565818268|FG003|Overall Study|Death|0|||
156745978|NCT03170609|565818269|FG004|Overall Study|Death|0|||
156745979|NCT03170609|565818270|FG005|Overall Study|Death|0|||
156745980|NCT03170609|565818271|FG006|Overall Study|Death|0|||
156745981|NCT03170609|565818265|FG000|Overall Study|Withdrawal by Subject|1|||
156745982|NCT03170609|565818266|FG001|Overall Study|Withdrawal by Subject|2|||
156745983|NCT03170609|565818267|FG002|Overall Study|Withdrawal by Subject|0|||
156745984|NCT03170609|565818268|FG003|Overall Study|Withdrawal by Subject|0|||
156745985|NCT03170609|565818269|FG004|Overall Study|Withdrawal by Subject|0|||
156745986|NCT03170609|565818270|FG005|Overall Study|Withdrawal by Subject|0|||
156745987|NCT03170609|565818271|FG006|Overall Study|Withdrawal by Subject|1|||
156745988|NCT03170609|565818265|FG000|Overall Study|Lost to Follow-up|1|||
156745989|NCT03170609|565818266|FG001|Overall Study|Lost to Follow-up|0|||
156745990|NCT03170609|565818267|FG002|Overall Study|Lost to Follow-up|5|||
156745991|NCT03170609|565818268|FG003|Overall Study|Lost to Follow-up|2|||
156745992|NCT03170609|565818269|FG004|Overall Study|Lost to Follow-up|1|||
156745993|NCT03170609|565818270|FG005|Overall Study|Lost to Follow-up|1|||
156745994|NCT03170609|565818271|FG006|Overall Study|Lost to Follow-up|0|||
156745995|NCT03170609|565818265|FG000|Overall Study|Other|1|||
156745996|NCT03170609|565818266|FG001|Overall Study|Other|0|||
156745997|NCT03170609|565818267|FG002|Overall Study|Other|0|||
156745998|NCT03170609|565818268|FG003|Overall Study|Other|0|||
156745999|NCT03170609|565818269|FG004|Overall Study|Other|0|||
156746000|NCT03170609|565818270|FG005|Overall Study|Other|1|||
156746001|NCT03170609|565818271|FG006|Overall Study|Other|0|||
156746002|NCT01281956|565818272|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
156746003|NCT01281956|565818273|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
156746004|NCT00586508|565818287|FG000|Overall Study|Progressive disease|52|||
156746005|NCT00586508|565818288|FG001|Overall Study|Progressive disease|8|||
156746006|NCT00586508|565818287|FG000|Overall Study|Death|0|||
156746007|NCT00586508|565818288|FG001|Overall Study|Death|1|||
156746008|NCT00586508|565818287|FG000|Overall Study|Adverse Event|12|||
156746009|NCT00586508|565818288|FG001|Overall Study|Adverse Event|4|||
156746010|NCT00586508|565818287|FG000|Overall Study|Withdrawal by Subject|4|||
156746011|NCT00586508|565818288|FG001|Overall Study|Withdrawal by Subject|0|||
156746012|NCT02918552|565818289|FG000|Overall Study|Failed Pharmacokinetics|1|||
156746013|NCT02918552|565818290|FG001|Overall Study|Failed Pharmacokinetics|0|||
156746014|NCT02918552|565818289|FG000|Overall Study|Withdrawal by Subject|0|||
156746015|NCT02918552|565818290|FG001|Overall Study|Withdrawal by Subject|1|||
156746016|NCT02918552|565818289|FG000|Overall Study|Lost to Follow-up|0|||
156746017|NCT02918552|565818290|FG001|Overall Study|Lost to Follow-up|1|||
156746018|NCT03325894|565818291|FG000|Overall Study|Adverse Event|2|||
156746019|NCT03325894|565818292|FG001|Overall Study|Adverse Event|3|||
156746020|NCT03325894|565818291|FG000|Overall Study|Protocol Violation|1|||
156746021|NCT03325894|565818292|FG001|Overall Study|Protocol Violation|2|||
156746022|NCT03325894|565818291|FG000|Overall Study|Withdrawal by Subject|10|||
156746023|NCT03325894|565818292|FG001|Overall Study|Withdrawal by Subject|6|||
156746024|NCT03325894|565818291|FG000|Overall Study|Lost to Follow-up|4|||
156746025|NCT03325894|565818292|FG001|Overall Study|Lost to Follow-up|9|||
156746026|NCT03325894|565818291|FG000|Overall Study|Lack of Efficacy|8|||
156746027|NCT03325894|565818292|FG001|Overall Study|Lack of Efficacy|14|||
156746028|NCT03325894|565818291|FG000|Overall Study|Study Terminated by Sponsor|38|||
156746029|NCT03325894|565818292|FG001|Overall Study|Study Terminated by Sponsor|43|||
156746030|NCT03325894|565818291|FG000|Overall Study|Other (Not received Treatment)|1|||
156746031|NCT03325894|565818292|FG001|Overall Study|Other (Not received Treatment)|0|||
156746032|NCT01592292|565818293|FG000|Overall Study|Follow-up loss|3|||
156746033|NCT01592292|565818294|FG001|Overall Study|Follow-up loss|3|||
156746034|NCT01592292|565818295|FG002|Overall Study|Follow-up loss|1|||
156746035|NCT01592292|565818296|FG003|Overall Study|Follow-up loss|0|||
156746036|NCT01592292|565818293|FG000|Overall Study|Withdrew consent|2|||
156746037|NCT01592292|565818294|FG001|Overall Study|Withdrew consent|1|||
156746038|NCT01592292|565818295|FG002|Overall Study|Withdrew consent|0|||
156746039|NCT01592292|565818296|FG003|Overall Study|Withdrew consent|0|||
156746040|NCT01592292|565818293|FG000|Overall Study|Other|1|||
156746041|NCT01592292|565818294|FG001|Overall Study|Other|1|||
156746042|NCT01592292|565818295|FG002|Overall Study|Other|2|||
156746043|NCT01592292|565818296|FG003|Overall Study|Other|1|||
156746044|NCT00335959|565818299|FG000|Overall Study|Adverse Event|2|||
156746045|NCT00335959|565818299|FG000|Overall Study|Ineligible|1|||
156746046|NCT02028169|565818300|FG000|Overall Study|Lost to Follow-up|21|||
156746047|NCT02028169|565818300|FG000|Overall Study|Lack of Efficacy|2|||
156746048|NCT02028169|565818300|FG000|Overall Study|Withdrawal by Subject|2|||
156746049|NCT02028169|565818300|FG000|Overall Study|Adverse Event|1|||
156746050|NCT02028169|565818300|FG000|Overall Study|Cessation of Drug|1|||
156746051|NCT02028169|565818300|FG000|Overall Study|Concomitant Medication Usage|1|||
156746052|NCT03482167|565818301|FG000|Allocated to Intervention|Physician Decision|1|||
156746053|NCT03482167|565818302|FG001|Allocated to Intervention|Physician Decision|2|||
156746054|NCT03482167|565818301|FG000|Received Intervention|Adverse Event|3|||
156746055|NCT03482167|565818302|FG001|Received Intervention|Adverse Event|1|||
156746056|NCT03482167|565818301|FG000|Received Intervention|Physician Decision|1|||
156746057|NCT03482167|565818302|FG001|Received Intervention|Physician Decision|1|||
156746058|NCT03482167|565818301|FG000|Received Intervention|Withdrawal by Subject|1|||
156746059|NCT03482167|565818302|FG001|Received Intervention|Withdrawal by Subject|0|||
156746060|NCT01001598|565818303|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
156746061|NCT01001598|565818303|FG000|Overall Study|Adverse Event|1|||
156746062|NCT01876979|565818311|FG000|Overall Study|Physician Decision|2|||
156746063|NCT01876979|565818312|FG001|Overall Study|Physician Decision|3|||
156746064|NCT00824382|565818313|FG000|Overall Study|Adverse Event|4|||
156799616|NCT03493958|566021347|FG000|Overall Study|Lost to Follow-up|7|||
156799617|NCT03493958|566021347|FG000|Overall Study|Did not complete all required study procedures|2|||
156799618|NCT02367456|566021348|FG000|Overall Study|Death|8|||
156799619|NCT02367456|566021349|FG001|Overall Study|Death|24|||
156799620|NCT02367456|566021350|FG002|Overall Study|Death|17|||
156799621|NCT02367456|566021348|FG000|Overall Study|Lost to Follow-up|1|||
156799622|NCT02367456|566021349|FG001|Overall Study|Lost to Follow-up|3|||
156799623|NCT02367456|566021350|FG002|Overall Study|Lost to Follow-up|1|||
156799624|NCT02367456|566021348|FG000|Overall Study|Other reason|3|||
156799625|NCT02367456|566021349|FG001|Overall Study|Other reason|3|||
156799626|NCT02367456|566021350|FG002|Overall Study|Other reason|9|||
156799627|NCT02367456|566021348|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
156799628|NCT02367456|566021349|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
156799629|NCT02367456|566021350|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
156799630|NCT01645176|566021352|FG000|Overall Study|Lack of Efficacy|4|||
156799631|NCT01645176|566021352|FG000|Overall Study|did not complete final MRI|1|||
156799636|NCT00904371|566021356|FG000|Overall Study|Adverse Event|2|||
156799637|NCT00904371|566021356|FG000|Overall Study|Lost to Follow-up|4|||
156799638|NCT00904371|566021356|FG000|Overall Study|Discontinued at target blood pressure|2|||
156799639|NCT00904371|566021356|FG000|Overall Study|Continued with Tritace|1|||
156799640|NCT01668004|566021359|FG000|Overall Study|Adverse Event|7|||
156799641|NCT01668004|566021359|FG000|Overall Study|Withdrawal by Subject|2|||
156799642|NCT01668004|566021359|FG000|Overall Study|Lost to Follow-up|5|||
156799643|NCT01668004|566021359|FG000|Overall Study|Lack of Efficacy|9|||
156799644|NCT01668004|566021359|FG000|Overall Study|Non-compliance with treatment|2|||
156799645|NCT02735200|566021361|FG000|Overall Study|Lost to Follow-up|0|||
156799646|NCT02735200|566021362|FG001|Overall Study|Lost to Follow-up|5|||
156799647|NCT02735200|566021361|FG000|Overall Study|Withdrawal by Subject|8|||
156799648|NCT02735200|566021362|FG001|Overall Study|Withdrawal by Subject|0|||
156799649|NCT04856527|566021365|FG000|Overall Study|Unable to complete experimental task|2|||
156799650|NCT04856527|566021366|FG001|Overall Study|Unable to complete experimental task|0|||
156746065|NCT00824382|565818314|FG001|Overall Study|Adverse Event|1|||
156746066|NCT00824382|565818315|FG002|Overall Study|Adverse Event|1|||
156746067|NCT00824382|565818316|FG003|Overall Study|Adverse Event|4|||
156746068|NCT00824382|565818313|FG000|Overall Study|Protocol Violation|1|||
156746069|NCT00824382|565818314|FG001|Overall Study|Protocol Violation|0|||
156799651|NCT02115321|566021367|FG000|Overall Study|Death|1|||
156799652|NCT02115321|566021368|FG001|Overall Study|Death|0|||
156746070|NCT00824382|565818315|FG002|Overall Study|Protocol Violation|0|||
156746071|NCT00824382|565818316|FG003|Overall Study|Protocol Violation|1|||
156746072|NCT00824382|565818313|FG000|Overall Study|Investigator's decision|0|||
156746073|NCT00824382|565818314|FG001|Overall Study|Investigator's decision|1|||
156746074|NCT00824382|565818315|FG002|Overall Study|Investigator's decision|2|||
156746075|NCT00824382|565818316|FG003|Overall Study|Investigator's decision|0|||
156746076|NCT00793624|565818317|FG000|Overall Study|Adverse Event|18|||
156746077|NCT00793624|565818318|FG001|Overall Study|Adverse Event|16|||
156746078|NCT00793624|565818319|FG002|Overall Study|Adverse Event|15|||
156746079|NCT00793624|565818320|FG003|Overall Study|Adverse Event|20|||
156746080|NCT00793624|565818317|FG000|Overall Study|Lost to Follow-up|2|||
156746081|NCT00793624|565818318|FG001|Overall Study|Lost to Follow-up|2|||
156746082|NCT00793624|565818319|FG002|Overall Study|Lost to Follow-up|4|||
156746083|NCT00793624|565818320|FG003|Overall Study|Lost to Follow-up|0|||
156799653|NCT01463527|566021371|FG000|Overall Study|Protocol Violation|1|||
156799654|NCT01463527|566021372|FG001|Overall Study|Protocol Violation|1|||
156337175|NCT03166735|564333565|FG004|Overall Study|Not Treated|0|||
156459051|NCT02240238|564776696|FG004|Phase 1|Physician Decision|0|||
156799655|NCT01463527|566021371|FG000|Overall Study|Crying >20% of sedation|5|||
156799656|NCT01463527|566021372|FG001|Overall Study|Crying >20% of sedation|6|||
156799657|NCT01493414|566021373|FG000|Overall Study|Adverse Event|405|||
156799658|NCT01493414|566021373|FG000|Overall Study|Disease progression|204|||
156799659|NCT01493414|566021373|FG000|Overall Study|Death|101|||
156799660|NCT01493414|566021373|FG000|Overall Study|Physician Decision|93|||
156799661|NCT01493414|566021373|FG000|Overall Study|Withdrawal by Subject|79|||
156799662|NCT01493414|566021373|FG000|Overall Study|Protocol deviation|27|||
156799663|NCT01493414|566021373|FG000|Overall Study|Administrative problems|25|||
156799664|NCT01493414|566021373|FG000|Overall Study|Lost to Follow-up|16|||
156799665|NCT04403919|566021374|FG000|Overall Study|Lost to Follow-up|0|||
156799666|NCT04403919|566021375|FG001|Overall Study|Lost to Follow-up|0|||
156799667|NCT04403919|566021376|FG002|Overall Study|Lost to Follow-up|0|||
156799668|NCT04403919|566021377|FG003|Overall Study|Lost to Follow-up|1|||
156799669|NCT03746015|566021378|FG000|Overall Study|Withdrawal of Consent|1|||
156799670|NCT03746015|566021379|FG001|Overall Study|Withdrawal of Consent|0|||
156799671|NCT03746015|566021380|FG002|Overall Study|Withdrawal of Consent|0|||
156799672|NCT02303262|566021383|FG000|Overall Study|Withdrawal by Subject|2|||
156799673|NCT01143402|566021386|FG000|Overall Study|Rapid clinical decline|1|||
156799674|NCT01143402|566021387|FG001|Overall Study|Rapid clinical decline|1|||
156799675|NCT01143402|566021388|FG002|Overall Study|Rapid clinical decline|0|||
156799676|NCT01143402|566021386|FG000|Overall Study|Not Treated|0|||
156799677|NCT01143402|566021387|FG001|Overall Study|Not Treated|0|||
156799678|NCT01143402|566021388|FG002|Overall Study|Not Treated|1|||
156799679|NCT00397540|566021396|FG000|Overall Study|short follow-up duration < 12 months|1|||
156799680|NCT00397540|566021397|FG001|Overall Study|short follow-up duration < 12 months|0|||
156799681|NCT01656161|566021398|FG000|Overall Study|Death|3|||
156799682|NCT01656161|566021398|FG000|Overall Study|Adverse Event|2|||
156799683|NCT01656161|566021398|FG000|Overall Study|Protocol Violation|1|||
156799684|NCT01656161|566021398|FG000|Overall Study|Withdrawal by Subject|1|||
156799685|NCT01968980|566021405|FG000|Overall Study|Death|0|||
156799686|NCT01968980|566021406|FG001|Overall Study|Death|1|||
156799687|NCT01968980|566021405|FG000|Overall Study|Adverse Event|1|||
156799688|NCT01968980|566021406|FG001|Overall Study|Adverse Event|3|||
156799689|NCT01968980|566021405|FG000|Overall Study|Does not meet entry criteria|1|||
156799690|NCT01968980|566021406|FG001|Overall Study|Does not meet entry criteria|3|||
156799691|NCT01968980|566021405|FG000|Overall Study|Withdrawal by Subject|13|||
156799692|NCT01968980|566021406|FG001|Overall Study|Withdrawal by Subject|5|||
156799693|NCT01968980|566021405|FG000|Overall Study|Other unspecified|1|||
156799694|NCT01968980|566021406|FG001|Overall Study|Other unspecified|2|||
156799695|NCT00776230|566021407|FG000|Overall Study|Lost to Follow-up|2|||
156799696|NCT00776230|566021408|FG001|Overall Study|Lost to Follow-up|1|||
156799697|NCT00776230|566021409|FG002|Overall Study|Lost to Follow-up|5|||
156799698|NCT00776230|566021407|FG000|Overall Study|Not vaccinated at Day 0|1|||
156799699|NCT00776230|566021408|FG001|Overall Study|Not vaccinated at Day 0|0|||
156799700|NCT00776230|566021409|FG002|Overall Study|Not vaccinated at Day 0|0|||
156799701|NCT00776230|566021407|FG000|Overall Study|Withdrawal by Subject|0|||
156799702|NCT00776230|566021408|FG001|Overall Study|Withdrawal by Subject|1|||
156799703|NCT00776230|566021409|FG002|Overall Study|Withdrawal by Subject|0|||
156799704|NCT00776230|566021407|FG000|Overall Study|Subject missed Visit 4|0|||
156799705|NCT00776230|566021408|FG001|Overall Study|Subject missed Visit 4|1|||
156337176|NCT03166735|564333561|FG000|Overall Study|follow-up not completed as planned|0|||
156799706|NCT00776230|566021409|FG002|Overall Study|Subject missed Visit 4|0|||
156746084|NCT00793624|565818317|FG000|Overall Study|Withdrawal by Subject|20|||
156746085|NCT00793624|565818318|FG001|Overall Study|Withdrawal by Subject|9|||
156746086|NCT00793624|565818319|FG002|Overall Study|Withdrawal by Subject|11|||
156746087|NCT00793624|565818320|FG003|Overall Study|Withdrawal by Subject|14|||
156799707|NCT01215851|566021410|FG000|Treatment Period|Adverse Event|1|||
156799708|NCT01215851|566021411|FG001|Treatment Period|Adverse Event|1|||
156799709|NCT01215851|566021412|FG002|Treatment Period|Adverse Event|1|||
156746088|NCT00793624|565818317|FG000|Overall Study|Lack of Efficacy|9|||
156746089|NCT00793624|565818318|FG001|Overall Study|Lack of Efficacy|2|||
156746090|NCT00793624|565818319|FG002|Overall Study|Lack of Efficacy|1|||
156746091|NCT00793624|565818320|FG003|Overall Study|Lack of Efficacy|3|||
156746092|NCT00793624|565818317|FG000|Overall Study|Non compliance with protocol|2|||
156746093|NCT00793624|565818318|FG001|Overall Study|Non compliance with protocol|3|||
156746094|NCT00793624|565818319|FG002|Overall Study|Non compliance with protocol|2|||
156746095|NCT00793624|565818320|FG003|Overall Study|Non compliance with protocol|3|||
156746096|NCT00793624|565818317|FG000|Overall Study|Other reason not described above|6|||
156746097|NCT00793624|565818318|FG001|Overall Study|Other reason not described above|4|||
156746098|NCT00793624|565818319|FG002|Overall Study|Other reason not described above|6|||
156746099|NCT00793624|565818320|FG003|Overall Study|Other reason not described above|3|||
156746100|NCT03467763|565818323|FG000|Overall Study|Lost to Follow-up|1|||
156746101|NCT03467763|565818323|FG000|Overall Study|Protocol Violation|2|||
156746102|NCT02908074|565818324|FG000|Overall Study|sponsor/ICON decision|0|||
156746103|NCT02908074|565818325|FG001|Overall Study|sponsor/ICON decision|0|||
156746104|NCT02908074|565818326|FG002|Overall Study|sponsor/ICON decision|1|||
156746105|NCT02908074|565818327|FG003|Overall Study|sponsor/ICON decision|0|||
156746106|NCT02908074|565818328|FG004|Overall Study|sponsor/ICON decision|0|||
156746107|NCT02908074|565818329|FG005|Overall Study|sponsor/ICON decision|0|||
156746108|NCT02908074|565818324|FG000|Overall Study|Protocol Violation|0|||
156746109|NCT02908074|565818325|FG001|Overall Study|Protocol Violation|1|||
156746110|NCT02908074|565818326|FG002|Overall Study|Protocol Violation|0|||
156746111|NCT02908074|565818327|FG003|Overall Study|Protocol Violation|0|||
156746112|NCT02908074|565818328|FG004|Overall Study|Protocol Violation|0|||
156746113|NCT02908074|565818329|FG005|Overall Study|Protocol Violation|0|||
156746114|NCT02908074|565818324|FG000|Overall Study|Adverse Event|5|||
156536653|NCT00766090|565059038|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156536654|NCT00766090|565059027|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
156536655|NCT00766090|565059028|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
156536656|NCT00766090|565059029|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
156536657|NCT00766090|565059030|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
156536658|NCT00766090|565059031|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
156536659|NCT00766090|565059032|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
156536660|NCT00766090|565059033|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
156746115|NCT02908074|565818325|FG001|Overall Study|Adverse Event|2|||
156746116|NCT02908074|565818326|FG002|Overall Study|Adverse Event|0|||
156746117|NCT02908074|565818327|FG003|Overall Study|Adverse Event|0|||
156746118|NCT02908074|565818328|FG004|Overall Study|Adverse Event|1|||
156746119|NCT02908074|565818329|FG005|Overall Study|Adverse Event|0|||
156746120|NCT02908074|565818324|FG000|Overall Study|AESI|1|||
156746121|NCT02908074|565818325|FG001|Overall Study|AESI|0|||
156746122|NCT02908074|565818326|FG002|Overall Study|AESI|1|||
156746123|NCT02908074|565818327|FG003|Overall Study|AESI|0|||
156746124|NCT02908074|565818328|FG004|Overall Study|AESI|1|||
156746125|NCT02908074|565818329|FG005|Overall Study|AESI|0|||
156746126|NCT02908074|565818324|FG000|Overall Study|Discontinuation criteria per protocol|0|||
156746127|NCT02908074|565818325|FG001|Overall Study|Discontinuation criteria per protocol|0|||
156746128|NCT02908074|565818326|FG002|Overall Study|Discontinuation criteria per protocol|1|||
156746129|NCT02908074|565818327|FG003|Overall Study|Discontinuation criteria per protocol|0|||
156746130|NCT02908074|565818328|FG004|Overall Study|Discontinuation criteria per protocol|0|||
156746131|NCT02908074|565818329|FG005|Overall Study|Discontinuation criteria per protocol|1|||
156746132|NCT02908074|565818324|FG000|Overall Study|Withdrawal by Subject|3|||
156746133|NCT02908074|565818325|FG001|Overall Study|Withdrawal by Subject|2|||
156746134|NCT02908074|565818326|FG002|Overall Study|Withdrawal by Subject|2|||
156746135|NCT02908074|565818327|FG003|Overall Study|Withdrawal by Subject|2|||
156746136|NCT02908074|565818328|FG004|Overall Study|Withdrawal by Subject|2|||
156746137|NCT02908074|565818329|FG005|Overall Study|Withdrawal by Subject|2|||
156746138|NCT02908074|565818324|FG000|Overall Study|Lost to Follow-up|0|||
156746139|NCT02908074|565818325|FG001|Overall Study|Lost to Follow-up|1|||
156799710|NCT01215851|566021413|FG003|Treatment Period|Adverse Event|3|||
156799711|NCT01215851|566021414|FG004|Treatment Period|Adverse Event|0|||
156799712|NCT01215851|566021415|FG005|Treatment Period|Adverse Event|1|||
156536661|NCT00766090|565059034|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
156746140|NCT02908074|565818326|FG002|Overall Study|Lost to Follow-up|1|||
156746141|NCT02908074|565818327|FG003|Overall Study|Lost to Follow-up|1|||
156746142|NCT02908074|565818328|FG004|Overall Study|Lost to Follow-up|0|||
156746143|NCT02908074|565818329|FG005|Overall Study|Lost to Follow-up|1|||
156746144|NCT02073565|565818331|FG000|Cohort A|Withdrawal by Subject|1|||
156799713|NCT01215851|566021410|FG000|Follow up Period|Lost to Follow-up|0|||
156799714|NCT01215851|566021411|FG001|Follow up Period|Lost to Follow-up|0|||
156799715|NCT01215851|566021412|FG002|Follow up Period|Lost to Follow-up|0|||
156746145|NCT02073565|565818332|FG001|Cohort A|Withdrawal by Subject|0|||
156746146|NCT02073565|565818331|FG000|Cohort B|Withdrawal by Subject|1|||
156799716|NCT01215851|566021413|FG003|Follow up Period|Lost to Follow-up|0|||
156799717|NCT01215851|566021414|FG004|Follow up Period|Lost to Follow-up|0|||
156746147|NCT02073565|565818332|FG001|Cohort B|Withdrawal by Subject|2|||
156746148|NCT02073565|565818331|FG000|Cohort C|Withdrawal by Subject|0|||
156746149|NCT02073565|565818332|FG001|Cohort C|Withdrawal by Subject|2|||
156746150|NCT02073565|565818331|FG000|Cohort C|Lost to Follow-up|0|||
156746151|NCT02073565|565818332|FG001|Cohort C|Lost to Follow-up|2|||
156746152|NCT01764997|565818333|FG000|Run-in Period|Adverse Event|15|||
156746153|NCT01764997|565818334|FG001|Run-in Period|Adverse Event|0|||
156746154|NCT01764997|565818335|FG002|Run-in Period|Adverse Event|0|||
156746155|NCT01764997|565818336|FG003|Run-in Period|Adverse Event|0|||
156746156|NCT01764997|565818337|FG004|Run-in Period|Adverse Event|0|||
156746157|NCT01764997|565818333|FG000|Run-in Period|Lack of Efficacy|5|||
156746158|NCT01764997|565818334|FG001|Run-in Period|Lack of Efficacy|0|||
156746159|NCT01764997|565818335|FG002|Run-in Period|Lack of Efficacy|0|||
156746160|NCT01764997|565818336|FG003|Run-in Period|Lack of Efficacy|0|||
156746161|NCT01764997|565818337|FG004|Run-in Period|Lack of Efficacy|0|||
156746162|NCT01764997|565818333|FG000|Run-in Period|Poor compliance to protocol|1|||
156746163|NCT01764997|565818334|FG001|Run-in Period|Poor compliance to protocol|0|||
156746164|NCT01764997|565818335|FG002|Run-in Period|Poor compliance to protocol|0|||
156746165|NCT01764997|565818336|FG003|Run-in Period|Poor compliance to protocol|0|||
156746166|NCT01764997|565818337|FG004|Run-in Period|Poor compliance to protocol|0|||
156746167|NCT01764997|565818333|FG000|Run-in Period|Other than specified above|17|||
156746168|NCT01764997|565818334|FG001|Run-in Period|Other than specified above|0|||
156746169|NCT01764997|565818335|FG002|Run-in Period|Other than specified above|0|||
156746170|NCT01764997|565818336|FG003|Run-in Period|Other than specified above|0|||
156746171|NCT01764997|565818337|FG004|Run-in Period|Other than specified above|0|||
156746172|NCT01764997|565818333|FG000|Study Drug Treatment Period|Adverse Event|0|||
156746173|NCT01764997|565818334|FG001|Study Drug Treatment Period|Adverse Event|1|||
156746174|NCT01764997|565818335|FG002|Study Drug Treatment Period|Adverse Event|0|||
156746175|NCT01764997|565818336|FG003|Study Drug Treatment Period|Adverse Event|0|||
156746176|NCT01764997|565818337|FG004|Study Drug Treatment Period|Adverse Event|24|||
156746177|NCT01764997|565818333|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
156746178|NCT01764997|565818334|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
156746179|NCT01764997|565818335|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
156746180|NCT01764997|565818336|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
156746181|NCT01764997|565818337|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
156746182|NCT01764997|565818333|FG000|Study Drug Treatment Period|Other than specified above|0|||
156746183|NCT01764997|565818334|FG001|Study Drug Treatment Period|Other than specified above|0|||
156746184|NCT01764997|565818335|FG002|Study Drug Treatment Period|Other than specified above|0|||
156746185|NCT01764997|565818336|FG003|Study Drug Treatment Period|Other than specified above|0|||
156746186|NCT01764997|565818337|FG004|Study Drug Treatment Period|Other than specified above|10|||
156746187|NCT02227368|565819930|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
156746188|NCT02227368|565819931|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
156746189|NCT02227368|565819930|FG000|Overall Study|Lost to Follow-up|1|||
156746190|NCT02227368|565819931|FG001|Overall Study|Lost to Follow-up|0|||
156746191|NCT02227368|565819930|FG000|Overall Study|Adverse Event|1|||
156746192|NCT02227368|565819931|FG001|Overall Study|Adverse Event|0|||
156746193|NCT03046056|565819933|FG000|Overall Study|Non-responder at Week 10|6|||
156746194|NCT03046056|565819934|FG001|Overall Study|Non-responder at Week 10|6|||
156746195|NCT03046056|565819935|FG002|Overall Study|Non-responder at Week 10|4|||
156746196|NCT03046056|565819933|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
156746197|NCT03046056|565819934|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
156746198|NCT03046056|565819935|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
156746199|NCT03046056|565819933|FG000|Overall Study|Adverse Event|1|||
156746200|NCT03046056|565819934|FG001|Overall Study|Adverse Event|5|||
156746201|NCT03046056|565819935|FG002|Overall Study|Adverse Event|0|||
156746202|NCT03046056|565819933|FG000|Overall Study|Non-compliance With Study Drug|0|||
156746203|NCT03046056|565819934|FG001|Overall Study|Non-compliance With Study Drug|0|||
156746204|NCT03046056|565819935|FG002|Overall Study|Non-compliance With Study Drug|2|||
156746205|NCT03046056|565819933|FG000|Overall Study|Protocol Violation|1|||
156746206|NCT03046056|565819934|FG001|Overall Study|Protocol Violation|1|||
156746207|NCT03046056|565819935|FG002|Overall Study|Protocol Violation|0|||
156746208|NCT03046056|565819933|FG000|Overall Study|Investigator's Discretion|0|||
156746209|NCT03046056|565819934|FG001|Overall Study|Investigator's Discretion|1|||
156337177|NCT03166735|564333562|FG001|Overall Study|follow-up not completed as planned|1|||
156746210|NCT03046056|565819935|FG002|Overall Study|Investigator's Discretion|0|||
156337178|NCT03166735|564333563|FG002|Overall Study|follow-up not completed as planned|1|||
156459052|NCT02240238|564776697|FG005|Phase 1|Physician Decision|2|||
156459053|NCT02240238|564776698|FG006|Phase 1|Physician Decision|0|||
156746211|NCT03046056|565819933|FG000|Overall Study|Withdrew Consent|1|||
156746212|NCT03046056|565819934|FG001|Overall Study|Withdrew Consent|0|||
156746213|NCT03046056|565819935|FG002|Overall Study|Withdrew Consent|0|||
156746214|NCT02913105|565819936|FG000|Overall Study|Adverse Event|11|||
156337179|NCT03166735|564333564|FG003|Overall Study|follow-up not completed as planned|0|||
156746215|NCT02913105|565819937|FG001|Overall Study|Adverse Event|0|||
156337180|NCT03166735|564333565|FG004|Overall Study|follow-up not completed as planned|1|||
156746216|NCT02913105|565819938|FG002|Overall Study|Adverse Event|4|||
156746217|NCT02913105|565819936|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156746218|NCT02913105|565819937|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156746219|NCT02913105|565819938|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156746220|NCT02913105|565819936|FG000|Overall Study|Reason Not Specified|3|||
156746221|NCT02913105|565819937|FG001|Overall Study|Reason Not Specified|1|||
156746222|NCT02913105|565819938|FG002|Overall Study|Reason Not Specified|1|||
156746223|NCT02913105|565819936|FG000|Overall Study|Physician Decision|1|||
156746224|NCT02913105|565819937|FG001|Overall Study|Physician Decision|1|||
156746225|NCT02913105|565819938|FG002|Overall Study|Physician Decision|0|||
156746226|NCT02913105|565819936|FG000|Overall Study|Withdrawal by Subject|0|||
156746227|NCT02913105|565819937|FG001|Overall Study|Withdrawal by Subject|3|||
156746228|NCT02913105|565819938|FG002|Overall Study|Withdrawal by Subject|1|||
156746229|NCT05243563|565819939|FG000|Overall Study|Withdrawal by Subject|1|||
156746230|NCT05243563|565819940|FG001|Overall Study|Withdrawal by Subject|0|||
156746231|NCT05243563|565819939|FG000|Overall Study|Physician Decision|1|||
156746232|NCT05243563|565819940|FG001|Overall Study|Physician Decision|0|||
156746233|NCT01663857|565819943|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
156746234|NCT01663857|565819944|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
156746235|NCT01663857|565819945|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
156746236|NCT01663857|565819946|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
156746237|NCT01663857|565819943|FG000|Overall Study|Lost to Follow-up|0|||
156746238|NCT01663857|565819944|FG001|Overall Study|Lost to Follow-up|0|||
156746239|NCT01663857|565819945|FG002|Overall Study|Lost to Follow-up|3|||
156746240|NCT01663857|565819946|FG003|Overall Study|Lost to Follow-up|1|||
156746241|NCT01172808|565819949|FG000|Overall Study|Adverse Event|8|||
156746242|NCT01172808|565819950|FG001|Overall Study|Adverse Event|4|||
156746243|NCT01172808|565819951|FG002|Overall Study|Adverse Event|8|||
156746244|NCT01172808|565819952|FG003|Overall Study|Adverse Event|3|||
156746245|NCT01172808|565819949|FG000|Overall Study|Lack of Efficacy|1|||
156746246|NCT01172808|565819950|FG001|Overall Study|Lack of Efficacy|0|||
156746247|NCT01172808|565819951|FG002|Overall Study|Lack of Efficacy|0|||
156746248|NCT01172808|565819952|FG003|Overall Study|Lack of Efficacy|0|||
156746249|NCT01172808|565819949|FG000|Overall Study|Protocol Violation|2|||
156746250|NCT01172808|565819950|FG001|Overall Study|Protocol Violation|2|||
156746251|NCT01172808|565819951|FG002|Overall Study|Protocol Violation|2|||
156746252|NCT01172808|565819952|FG003|Overall Study|Protocol Violation|0|||
156746253|NCT01172808|565819949|FG000|Overall Study|Lost to Follow-up|0|||
156746254|NCT01172808|565819950|FG001|Overall Study|Lost to Follow-up|1|||
156746255|NCT01172808|565819951|FG002|Overall Study|Lost to Follow-up|1|||
156746256|NCT01172808|565819952|FG003|Overall Study|Lost to Follow-up|3|||
156746257|NCT01172808|565819949|FG000|Overall Study|Withdrawal by Subject|4|||
156746258|NCT01172808|565819950|FG001|Overall Study|Withdrawal by Subject|1|||
156746259|NCT01172808|565819951|FG002|Overall Study|Withdrawal by Subject|3|||
156746260|NCT01172808|565819952|FG003|Overall Study|Withdrawal by Subject|2|||
156746261|NCT01172808|565819949|FG000|Overall Study|Other|6|||
156746262|NCT01172808|565819950|FG001|Overall Study|Other|5|||
156746263|NCT01172808|565819951|FG002|Overall Study|Other|9|||
156746264|NCT01172808|565819952|FG003|Overall Study|Other|7|||
156746265|NCT00703326|565819953|FG000|Overall Study|Lost to Follow-up|47|||
156746266|NCT00703326|565819954|FG001|Overall Study|Lost to Follow-up|18|||
156746267|NCT00703326|565819953|FG000|Overall Study|Withdrawal by Subject|54|||
156746268|NCT00703326|565819954|FG001|Overall Study|Withdrawal by Subject|20|||
156459054|NCT02240238|564776699|FG007|Phase 1|Physician Decision|0|||
156459055|NCT02240238|564776700|FG008|Phase 1|Physician Decision|0|||
156459056|NCT02240238|564776701|FG009|Phase 1|Physician Decision|0|||
156459057|NCT02240238|564776702|FG010|Phase 1|Physician Decision|0|||
156459058|NCT02240238|564776703|FG011|Phase 1|Physician Decision|0|||
156459059|NCT02240238|564776692|FG000|Phase 2|Adverse Event|0|||
156459060|NCT02240238|564776693|FG001|Phase 2|Adverse Event|0|||
156459061|NCT02240238|564776694|FG002|Phase 2|Adverse Event|0|||
156459062|NCT02240238|564776695|FG003|Phase 2|Adverse Event|0|||
156459063|NCT02240238|564776696|FG004|Phase 2|Adverse Event|0|||
156459064|NCT02240238|564776697|FG005|Phase 2|Adverse Event|0|||
156459065|NCT02240238|564776698|FG006|Phase 2|Adverse Event|0|||
156746269|NCT00703326|565819953|FG000|Overall Study|Adverse Event|1|||
156746270|NCT00703326|565819954|FG001|Overall Study|Adverse Event|0|||
156746271|NCT02661061|565819956|FG000|Overall Study|Lack of Efficacy|1|||
156746272|NCT02661061|565819957|FG001|Overall Study|Lack of Efficacy|1|||
156746273|NCT02661061|565819956|FG000|Overall Study|Withdrawal by Subject|1|||
156746274|NCT02661061|565819957|FG001|Overall Study|Withdrawal by Subject|1|||
156746275|NCT02578940|565819958|FG000|Overall Study|Screening failure|5|||
156799718|NCT01215851|566021415|FG005|Follow up Period|Lost to Follow-up|1|||
156799719|NCT03510273|566021418|FG000|Overall Study|Withdrawal by Subject|2|||
156459066|NCT02240238|564776699|FG007|Phase 2|Adverse Event|0|||
156459067|NCT02240238|564776700|FG008|Phase 2|Adverse Event|0|||
156746276|NCT02578940|565819958|FG000|Overall Study|Lost to Follow-up|1|||
156746277|NCT03959488|565819967|FG000|Season 1|Other|6|||
156746278|NCT03959488|565819968|FG001|Season 1|Other|7|||
156746279|NCT03959488|565819969|FG002|Season 1|Other|0|||
156746280|NCT03959488|565819970|FG003|Season 1|Other|0|||
156746281|NCT03959488|565819971|FG004|Season 1|Other|0|||
156746282|NCT03959488|565819967|FG000|Season 1|Withdrawal by parent/guardian|43|||
156746283|NCT03959488|565819968|FG001|Season 1|Withdrawal by parent/guardian|28|||
156746284|NCT03959488|565819969|FG002|Season 1|Withdrawal by parent/guardian|0|||
156746285|NCT03959488|565819970|FG003|Season 1|Withdrawal by parent/guardian|0|||
156746286|NCT03959488|565819971|FG004|Season 1|Withdrawal by parent/guardian|0|||
156746287|NCT03959488|565819967|FG000|Season 1|Due to COVID-19 pandemic|2|||
156746288|NCT03959488|565819968|FG001|Season 1|Due to COVID-19 pandemic|3|||
156746289|NCT03959488|565819969|FG002|Season 1|Due to COVID-19 pandemic|0|||
156746290|NCT03959488|565819970|FG003|Season 1|Due to COVID-19 pandemic|0|||
156746291|NCT03959488|565819971|FG004|Season 1|Due to COVID-19 pandemic|0|||
156746292|NCT03959488|565819967|FG000|Season 1|Lost to Follow-up|17|||
156746293|NCT03959488|565819968|FG001|Season 1|Lost to Follow-up|7|||
156746294|NCT03959488|565819969|FG002|Season 1|Lost to Follow-up|0|||
156746295|NCT03959488|565819970|FG003|Season 1|Lost to Follow-up|0|||
156746296|NCT03959488|565819971|FG004|Season 1|Lost to Follow-up|0|||
156746297|NCT03959488|565819967|FG000|Season 1|Death|5|||
156746298|NCT03959488|565819968|FG001|Season 1|Death|1|||
156746299|NCT03959488|565819969|FG002|Season 1|Death|0|||
156746300|NCT03959488|565819970|FG003|Season 1|Death|0|||
156746301|NCT03959488|565819971|FG004|Season 1|Death|0|||
156746302|NCT03959488|565819967|FG000|Season 2|Other|0|||
156746303|NCT03959488|565819968|FG001|Season 2|Other|0|||
156746304|NCT03959488|565819969|FG002|Season 2|Other|2|||
156746305|NCT03959488|565819970|FG003|Season 2|Other|0|||
156746306|NCT03959488|565819971|FG004|Season 2|Other|0|||
156746307|NCT03959488|565819967|FG000|Season 2|Withdrawal by parent/guardian|0|||
156746308|NCT03959488|565819968|FG001|Season 2|Withdrawal by parent/guardian|0|||
156746309|NCT03959488|565819969|FG002|Season 2|Withdrawal by parent/guardian|3|||
156746310|NCT03959488|565819970|FG003|Season 2|Withdrawal by parent/guardian|1|||
156746311|NCT03959488|565819971|FG004|Season 2|Withdrawal by parent/guardian|1|||
156746312|NCT03959488|565819967|FG000|Season 2|Lost to Follow-up|0|||
156746313|NCT03959488|565819968|FG001|Season 2|Lost to Follow-up|0|||
156746314|NCT03959488|565819969|FG002|Season 2|Lost to Follow-up|1|||
156746315|NCT03959488|565819970|FG003|Season 2|Lost to Follow-up|0|||
156746316|NCT03959488|565819971|FG004|Season 2|Lost to Follow-up|1|||
156746317|NCT03341936|565819973|FG000|Overall Study|Ineligible|1|||
156746318|NCT03341936|565819973|FG000|Overall Study|Disease Progression|2|||
156746319|NCT03341936|565819973|FG000|Overall Study|Withdrew Consent|4|||
156746320|NCT03341936|565819973|FG000|Overall Study|Non-Compliance|1|||
156799720|NCT03510273|566021418|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
156799721|NCT03510273|566021418|FG000|Overall Study|Moved away from study area|4|||
156799722|NCT02589938|566021422|FG000|Overall Study|Withdrawal by Subject|11|||
156799723|NCT02589938|566021423|FG001|Overall Study|Withdrawal by Subject|5|||
156799724|NCT02589938|566021424|FG002|Overall Study|Withdrawal by Subject|6|||
156799725|NCT02589938|566021422|FG000|Overall Study|Lost to Follow-up|3|||
156799726|NCT02589938|566021423|FG001|Overall Study|Lost to Follow-up|3|||
156799727|NCT02589938|566021424|FG002|Overall Study|Lost to Follow-up|3|||
156799728|NCT02589938|566021422|FG000|Overall Study|Death|1|||
156799729|NCT02589938|566021423|FG001|Overall Study|Death|0|||
156799730|NCT02589938|566021424|FG002|Overall Study|Death|1|||
156799731|NCT02589938|566021422|FG000|Overall Study|Protocol Violation|6|||
156799732|NCT02589938|566021423|FG001|Overall Study|Protocol Violation|2|||
156799733|NCT02589938|566021424|FG002|Overall Study|Protocol Violation|3|||
156799734|NCT02589938|566021422|FG000|Overall Study|Physician Decision|1|||
156799735|NCT02589938|566021423|FG001|Overall Study|Physician Decision|0|||
156799736|NCT02589938|566021424|FG002|Overall Study|Physician Decision|0|||
156337181|NCT03166735|564333561|FG000|Overall Study|Withdrawal by Subject|0|||
156746321|NCT03341936|565819973|FG000|Overall Study|Physician Decision|1|||
156746322|NCT03341936|565819973|FG000|Overall Study|Withdrawal by Subject|1|||
156746323|NCT03341936|565819973|FG000|Overall Study|Other|1|||
156746324|NCT02290925|565819976|FG000|First Period of Three Months|Lost to Follow-up|2|||
156799737|NCT02589938|566021422|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
156799738|NCT02589938|566021423|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
156799739|NCT02589938|566021424|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
156337182|NCT03166735|564333562|FG001|Overall Study|Withdrawal by Subject|0|||
156746325|NCT02290925|565819977|FG001|First Period of Three Months|Lost to Follow-up|1|||
156746326|NCT02290925|565819976|FG000|First Period of Three Months|Death|1|||
156746327|NCT02290925|565819977|FG001|First Period of Three Months|Death|0|||
156746328|NCT02290925|565819976|FG000|First Period of Three Months|Insulin Started|1|||
156746329|NCT02290925|565819977|FG001|First Period of Three Months|Insulin Started|1|||
156746330|NCT02290925|565819976|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
156746331|NCT02290925|565819977|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
156746332|NCT02290925|565819976|FG000|Second Period of 3 Months|insulin started|0|||
156746333|NCT02290925|565819977|FG001|Second Period of 3 Months|insulin started|1|||
156746334|NCT01716520|565819978|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
156746335|NCT01716520|565819979|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746336|NCT01716520|565819980|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746337|NCT01716520|565819981|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746338|NCT01716520|565819982|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746339|NCT01716520|565819983|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746340|NCT01716520|565819978|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
156746341|NCT01716520|565819979|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
156799740|NCT01276106|566021425|FG000|Overall Study|Adverse Event|3|||
156799741|NCT01276106|566021426|FG001|Overall Study|Adverse Event|3|||
156799742|NCT01276106|566021427|FG002|Overall Study|Adverse Event|11|||
156799743|NCT01276106|566021428|FG003|Overall Study|Adverse Event|3|||
156799744|NCT01276106|566021425|FG000|Overall Study|Withdrawal by Subject|6|||
156799745|NCT01276106|566021426|FG001|Overall Study|Withdrawal by Subject|3|||
156799746|NCT01276106|566021427|FG002|Overall Study|Withdrawal by Subject|1|||
156799747|NCT01276106|566021428|FG003|Overall Study|Withdrawal by Subject|6|||
156337183|NCT03166735|564333563|FG002|Overall Study|Withdrawal by Subject|1|||
156459068|NCT02240238|564776701|FG009|Phase 2|Adverse Event|7|||
156459069|NCT02240238|564776702|FG010|Phase 2|Adverse Event|14|||
156459070|NCT02240238|564776703|FG011|Phase 2|Adverse Event|2|||
156459071|NCT02240238|564776692|FG000|Phase 2|Death|0|||
156459072|NCT02240238|564776693|FG001|Phase 2|Death|0|||
156459073|NCT02240238|564776694|FG002|Phase 2|Death|0|||
156459074|NCT02240238|564776695|FG003|Phase 2|Death|0|||
156459075|NCT02240238|564776696|FG004|Phase 2|Death|0|||
156459076|NCT02240238|564776697|FG005|Phase 2|Death|0|||
156459077|NCT02240238|564776698|FG006|Phase 2|Death|0|||
156459078|NCT02240238|564776699|FG007|Phase 2|Death|0|||
156459079|NCT02240238|564776700|FG008|Phase 2|Death|0|||
156459080|NCT02240238|564776701|FG009|Phase 2|Death|3|||
156459081|NCT02240238|564776702|FG010|Phase 2|Death|2|||
156459082|NCT02240238|564776703|FG011|Phase 2|Death|1|||
156459083|NCT02240238|564776692|FG000|Phase 2|Disease progression|0|||
156459084|NCT02240238|564776693|FG001|Phase 2|Disease progression|0|||
156459085|NCT02240238|564776694|FG002|Phase 2|Disease progression|0|||
156459086|NCT02240238|564776695|FG003|Phase 2|Disease progression|0|||
156459087|NCT02240238|564776696|FG004|Phase 2|Disease progression|0|||
156459088|NCT02240238|564776697|FG005|Phase 2|Disease progression|0|||
156459089|NCT02240238|564776698|FG006|Phase 2|Disease progression|0|||
156459090|NCT02240238|564776699|FG007|Phase 2|Disease progression|0|||
156459091|NCT02240238|564776700|FG008|Phase 2|Disease progression|0|||
156459092|NCT02240238|564776701|FG009|Phase 2|Disease progression|5|||
156459093|NCT02240238|564776702|FG010|Phase 2|Disease progression|11|||
156459094|NCT02240238|564776703|FG011|Phase 2|Disease progression|1|||
156459095|NCT02240238|564776692|FG000|Phase 2|Withdrawal by Subject|0|||
156459096|NCT02240238|564776693|FG001|Phase 2|Withdrawal by Subject|0|||
156459097|NCT02240238|564776694|FG002|Phase 2|Withdrawal by Subject|0|||
156459098|NCT02240238|564776695|FG003|Phase 2|Withdrawal by Subject|0|||
156459099|NCT02240238|564776696|FG004|Phase 2|Withdrawal by Subject|0|||
156459100|NCT02240238|564776697|FG005|Phase 2|Withdrawal by Subject|0|||
156459101|NCT02240238|564776698|FG006|Phase 2|Withdrawal by Subject|0|||
156459102|NCT02240238|564776699|FG007|Phase 2|Withdrawal by Subject|0|||
156459103|NCT02240238|564776700|FG008|Phase 2|Withdrawal by Subject|0|||
156459104|NCT02240238|564776701|FG009|Phase 2|Withdrawal by Subject|1|||
156459105|NCT02240238|564776702|FG010|Phase 2|Withdrawal by Subject|1|||
156459106|NCT02240238|564776703|FG011|Phase 2|Withdrawal by Subject|0|||
156459107|NCT02240238|564776692|FG000|Phase 2|Physician Decision|0|||
156459108|NCT02240238|564776693|FG001|Phase 2|Physician Decision|0|||
156459109|NCT02240238|564776694|FG002|Phase 2|Physician Decision|0|||
156459110|NCT02240238|564776695|FG003|Phase 2|Physician Decision|0|||
156459111|NCT02240238|564776696|FG004|Phase 2|Physician Decision|0|||
156459112|NCT02240238|564776697|FG005|Phase 2|Physician Decision|0|||
156459113|NCT02240238|564776698|FG006|Phase 2|Physician Decision|0|||
156459114|NCT02240238|564776699|FG007|Phase 2|Physician Decision|0|||
156459115|NCT02240238|564776700|FG008|Phase 2|Physician Decision|0|||
156746342|NCT01716520|565819980|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
156746343|NCT01716520|565819981|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
156746344|NCT01716520|565819982|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
156799748|NCT01276106|566021425|FG000|Overall Study|Lack of Efficacy|0|||
156459116|NCT02240238|564776701|FG009|Phase 2|Physician Decision|1|||
156459117|NCT02240238|564776702|FG010|Phase 2|Physician Decision|3|||
156459118|NCT02240238|564776703|FG011|Phase 2|Physician Decision|0|||
156459119|NCT02240238|564776692|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156459120|NCT02240238|564776693|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156459121|NCT02240238|564776694|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156459122|NCT02240238|564776695|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156459123|NCT02240238|564776696|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156746345|NCT01716520|565819983|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
156746346|NCT01716520|565819978|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746347|NCT01716520|565819979|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156746348|NCT01716520|565819980|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746349|NCT01716520|565819981|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746350|NCT01716520|565819982|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746351|NCT01716520|565819983|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746352|NCT01716520|565819978|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746353|NCT01716520|565819979|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
156746354|NCT01716520|565819980|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746355|NCT01716520|565819981|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746356|NCT01716520|565819982|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746357|NCT01716520|565819983|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746358|NCT01716520|565819978|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746359|NCT01716520|565819979|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746360|NCT01716520|565819980|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746361|NCT01716520|565819981|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746362|NCT01716520|565819982|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746363|NCT01716520|565819983|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
156746364|NCT01716520|565819978|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
156746365|NCT01716520|565819979|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
156746366|NCT01716520|565819980|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
156746367|NCT01716520|565819981|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
156746368|NCT01716520|565819982|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
156746369|NCT01716520|565819983|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
156746370|NCT01716520|565819978|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746371|NCT01716520|565819979|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746372|NCT01716520|565819980|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746373|NCT01716520|565819981|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746374|NCT01716520|565819982|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
156746375|NCT01716520|565819983|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746376|NCT01716520|565819978|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746377|NCT01716520|565819979|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746378|NCT01716520|565819980|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746379|NCT01716520|565819981|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746380|NCT01716520|565819982|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156746381|NCT01716520|565819983|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746382|NCT01716520|565819978|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746383|NCT01716520|565819979|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746384|NCT01716520|565819980|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746385|NCT01716520|565819981|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
156746386|NCT01716520|565819982|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746387|NCT01716520|565819983|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746388|NCT01716520|565819978|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
156746389|NCT01716520|565819979|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
156746390|NCT01716520|565819980|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
156746391|NCT01716520|565819981|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
156746392|NCT01716520|565819982|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
156746393|NCT01716520|565819983|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
156459124|NCT02240238|564776697|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156746394|NCT01716520|565819978|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
156746395|NCT01716520|565819979|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746396|NCT01716520|565819980|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746397|NCT01716520|565819981|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746398|NCT01716520|565819982|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746399|NCT01716520|565819983|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746400|NCT01716520|565819978|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746401|NCT01716520|565819979|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746402|NCT01716520|565819980|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746403|NCT01716520|565819981|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746404|NCT01716520|565819982|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746405|NCT01716520|565819983|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
156746406|NCT01716520|565819978|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156536662|NCT00766090|565059035|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
156746407|NCT01716520|565819979|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
156746408|NCT01716520|565819980|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156746409|NCT01716520|565819981|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156746410|NCT01716520|565819982|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156746411|NCT01716520|565819983|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156746412|NCT01716520|565819978|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746413|NCT01716520|565819979|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746414|NCT01716520|565819980|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746415|NCT01716520|565819981|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746416|NCT01716520|565819982|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746417|NCT01716520|565819983|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
156746418|NCT01716520|565819978|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746419|NCT01716520|565819979|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746420|NCT01716520|565819980|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
156746421|NCT01716520|565819981|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746422|NCT01716520|565819982|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746423|NCT01716520|565819983|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746424|NCT00869557|565819992|FG000|Randomized Phase|Lost to Follow-up|2|||
156746425|NCT00869557|565819993|FG001|Randomized Phase|Lost to Follow-up|1|||
156746426|NCT00869557|565819992|FG000|Randomized Phase|Investigator's Discretion|1|||
156746427|NCT00869557|565819993|FG001|Randomized Phase|Investigator's Discretion|0|||
156799749|NCT01276106|566021426|FG001|Overall Study|Lack of Efficacy|1|||
156799750|NCT01276106|566021427|FG002|Overall Study|Lack of Efficacy|0|||
156799751|NCT01276106|566021428|FG003|Overall Study|Lack of Efficacy|1|||
156799752|NCT01276106|566021425|FG000|Overall Study|Lost to Follow-up|2|||
156799753|NCT01276106|566021426|FG001|Overall Study|Lost to Follow-up|1|||
156799754|NCT01276106|566021427|FG002|Overall Study|Lost to Follow-up|1|||
156799755|NCT01276106|566021428|FG003|Overall Study|Lost to Follow-up|0|||
156799756|NCT01276106|566021425|FG000|Overall Study|Physician Decision|0|||
156799757|NCT01276106|566021426|FG001|Overall Study|Physician Decision|0|||
156799758|NCT01276106|566021427|FG002|Overall Study|Physician Decision|1|||
156799759|NCT01276106|566021428|FG003|Overall Study|Physician Decision|1|||
156799760|NCT01276106|566021425|FG000|Overall Study|Protocol Violation|1|||
156799761|NCT01276106|566021426|FG001|Overall Study|Protocol Violation|1|||
156799762|NCT01276106|566021427|FG002|Overall Study|Protocol Violation|0|||
156799763|NCT01276106|566021428|FG003|Overall Study|Protocol Violation|2|||
156799764|NCT01276106|566021425|FG000|Overall Study|Insufficient therapeutic effects|0|||
156799765|NCT01276106|566021426|FG001|Overall Study|Insufficient therapeutic effects|0|||
156799766|NCT01276106|566021427|FG002|Overall Study|Insufficient therapeutic effects|2|||
156799767|NCT01276106|566021428|FG003|Overall Study|Insufficient therapeutic effects|0|||
156799768|NCT01242514|566021431|FG000|Overall Study|e.g., project closure|1042|||
156799769|NCT01242514|566021432|FG001|Overall Study|e.g., project closure|305|||
156799770|NCT01242514|566021433|FG002|Overall Study|e.g., project closure|171|||
156799771|NCT01242514|566021431|FG000|Overall Study|Subject decision|33|||
156799772|NCT01242514|566021432|FG001|Overall Study|Subject decision|8|||
156799773|NCT01242514|566021433|FG002|Overall Study|Subject decision|2|||
156799774|NCT01242514|566021431|FG000|Overall Study|Severe non-compliance to protocol|5|||
156799775|NCT01242514|566021432|FG001|Overall Study|Severe non-compliance to protocol|2|||
156799776|NCT01242514|566021433|FG002|Overall Study|Severe non-compliance to protocol|1|||
156799777|NCT01242514|566021431|FG000|Overall Study|Lack of therapeutic response|99|||
156799778|NCT01242514|566021432|FG001|Overall Study|Lack of therapeutic response|16|||
156799779|NCT01242514|566021433|FG002|Overall Study|Lack of therapeutic response|10|||
156799780|NCT01242514|566021431|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
156799781|NCT01242514|566021432|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
156799782|NCT01242514|566021433|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
156799783|NCT01242514|566021431|FG000|Overall Study|Lost to Follow-up|14|||
156799784|NCT01242514|566021432|FG001|Overall Study|Lost to Follow-up|5|||
156799785|NCT01242514|566021433|FG002|Overall Study|Lost to Follow-up|4|||
156799786|NCT01242514|566021431|FG000|Overall Study|Adverse Event|129|||
156799787|NCT01242514|566021432|FG001|Overall Study|Adverse Event|18|||
156799788|NCT01242514|566021433|FG002|Overall Study|Adverse Event|19|||
156799789|NCT00862940|566021435|FG000|Overall Study|Adverse Event|15|||
156799790|NCT00862940|566021436|FG001|Overall Study|Adverse Event|12|||
156799791|NCT00862940|566021435|FG000|Overall Study|Lack of Efficacy|1|||
156799792|NCT00862940|566021436|FG001|Overall Study|Lack of Efficacy|3|||
156799793|NCT00862940|566021435|FG000|Overall Study|Protocol Violation|2|||
156799794|NCT00862940|566021436|FG001|Overall Study|Protocol Violation|5|||
156799795|NCT00862940|566021435|FG000|Overall Study|Withdrawal by Subject|4|||
156799796|NCT00862940|566021436|FG001|Overall Study|Withdrawal by Subject|6|||
156799797|NCT00862940|566021435|FG000|Overall Study|Non-compliance|4|||
156799798|NCT00862940|566021436|FG001|Overall Study|Non-compliance|0|||
156799799|NCT00862940|566021435|FG000|Overall Study|Lost to Follow-up|0|||
156799800|NCT00862940|566021436|FG001|Overall Study|Lost to Follow-up|1|||
156799801|NCT00862940|566021435|FG000|Overall Study|Administrative or other reason(s)|4|||
156746428|NCT00869557|565819992|FG000|Randomized Phase|Withdrew Consent|0|||
156746429|NCT00869557|565819993|FG001|Randomized Phase|Withdrew Consent|1|||
156746430|NCT00869557|565819992|FG000|Extension Phase|Adverse Event|2|||
156746431|NCT00869557|565819993|FG001|Extension Phase|Adverse Event|2|||
156746432|NCT00869557|565819992|FG000|Extension Phase|Lack of Efficacy|1|||
156746433|NCT00869557|565819993|FG001|Extension Phase|Lack of Efficacy|0|||
156746434|NCT00869557|565819992|FG000|Extension Phase|Lost to Follow-up|3|||
156746435|NCT00869557|565819993|FG001|Extension Phase|Lost to Follow-up|1|||
156746436|NCT00869557|565819992|FG000|Extension Phase|Investigator's Discretion|2|||
156746437|NCT00869557|565819993|FG001|Extension Phase|Investigator's Discretion|0|||
156746438|NCT00869557|565819992|FG000|Extension Phase|Withdrew Consent|2|||
156746439|NCT00869557|565819993|FG001|Extension Phase|Withdrew Consent|0|||
156746440|NCT02305446|565819994|FG000|Overall Study|Adverse Event|1|||
156746441|NCT02696434|565819999|FG000|Overall Study|Adverse Event|3|||
156746442|NCT02696434|565820000|FG001|Overall Study|Adverse Event|1|||
156746443|NCT02696434|565819999|FG000|Overall Study|Lost to Follow-up|5|||
156746444|NCT02696434|565820000|FG001|Overall Study|Lost to Follow-up|4|||
156746445|NCT02696434|565819999|FG000|Overall Study|Withdrawal by Subject|14|||
156746446|NCT02696434|565820000|FG001|Overall Study|Withdrawal by Subject|12|||
156746447|NCT02696434|565819999|FG000|Overall Study|Physician Decision|0|||
156746448|NCT02696434|565820000|FG001|Overall Study|Physician Decision|1|||
156746449|NCT02956057|565820010|FG000|Overall Study|Discontinued intervention|14|||
156746450|NCT02956057|565820011|FG001|Overall Study|Discontinued intervention|10|||
156746451|NCT02956057|565820012|FG002|Overall Study|Discontinued intervention|7|||
156746452|NCT02956057|565820013|FG003|Overall Study|Discontinued intervention|14|||
156746453|NCT02956057|565820014|FG004|Overall Study|Discontinued intervention|4|||
156746454|NCT02956057|565820015|FG005|Overall Study|Discontinued intervention|17|||
156746455|NCT02956057|565820010|FG000|Overall Study|Lost to Follow-up|0|||
156746456|NCT02956057|565820011|FG001|Overall Study|Lost to Follow-up|2|||
156746457|NCT02956057|565820012|FG002|Overall Study|Lost to Follow-up|1|||
156746458|NCT02956057|565820013|FG003|Overall Study|Lost to Follow-up|1|||
156746459|NCT02956057|565820014|FG004|Overall Study|Lost to Follow-up|1|||
156746460|NCT02956057|565820015|FG005|Overall Study|Lost to Follow-up|0|||
156746461|NCT01420679|565820020|FG000|Overall Study|Disease Progression|3|||
156746462|NCT01420679|565820021|FG001|Overall Study|Disease Progression|2|||
156746463|NCT01420679|565820020|FG000|Overall Study|Adverse Event|4|||
156746464|NCT01420679|565820021|FG001|Overall Study|Adverse Event|0|||
156746465|NCT01420679|565820020|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
156746466|NCT01420679|565820021|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
156746467|NCT01420679|565820020|FG000|Overall Study|Patient Decision|1|||
156746468|NCT01420679|565820021|FG001|Overall Study|Patient Decision|0|||
156746469|NCT01420679|565820020|FG000|Overall Study|Investigator Decision|1|||
156746470|NCT01420679|565820021|FG001|Overall Study|Investigator Decision|2|||
156746471|NCT01420679|565820020|FG000|Overall Study|Sponsor Decision|3|||
156746472|NCT01420679|565820021|FG001|Overall Study|Sponsor Decision|3|||
156746473|NCT01420679|565820020|FG000|Overall Study|Other|1|||
156746474|NCT01420679|565820021|FG001|Overall Study|Other|0|||
156746475|NCT03956615|565820022|FG000|Overall Study|No multiple myeloma confirmed|2|||
156746476|NCT03956615|565820022|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
156746477|NCT03956615|565820022|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
156746478|NCT03956615|565820022|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
156746479|NCT01069419|565820023|FG000|Overall Study|Adverse Event|233|||
156746480|NCT01069419|565820023|FG000|Overall Study|Lack of Efficacy|332|||
156746481|NCT01069419|565820023|FG000|Overall Study|Lost to Follow-up|49|||
156746482|NCT01069419|565820023|FG000|Overall Study|Remission of disease|11|||
156746483|NCT01069419|565820023|FG000|Overall Study|Withdrawal by Subject|34|||
156746484|NCT01069419|565820023|FG000|Overall Study|Other Reason|43|||
156799802|NCT00862940|566021436|FG001|Overall Study|Administrative or other reason(s)|3|||
156799803|NCT00787150|566021437|FG000|Overall Study|Adverse Event|4|||
156799804|NCT00787150|566021438|FG001|Overall Study|Adverse Event|4|||
156799805|NCT00787150|566021439|FG002|Overall Study|Adverse Event|4|||
156799806|NCT00787150|566021437|FG000|Overall Study|Physician Decision|1|||
156746485|NCT01069419|565820023|FG000|Overall Study|Missing termination information|13|||
156746486|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
156746487|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
156746488|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
156746489|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
156746490|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
156746491|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
156746492|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
156746493|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
156746494|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
156746495|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
156746496|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
156799807|NCT00787150|566021438|FG001|Overall Study|Physician Decision|2|||
156746497|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
156746498|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Death|0|||
156337184|NCT03166735|564333564|FG003|Overall Study|Withdrawal by Subject|1|||
156337185|NCT03166735|564333565|FG004|Overall Study|Withdrawal by Subject|2|||
156536663|NCT00766090|565059036|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
156746499|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Death|0|||
156746500|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Death|1|||
156746501|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Death|0|||
156746502|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
156746503|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
156746504|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
156746505|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
156746506|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
156746507|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
156746508|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
156746509|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
156746510|NCT01179737|565820027|FG000|Extension|The study was terminated|3|||
156746511|NCT01179737|565820028|FG001|Extension|The study was terminated|0|||
156746512|NCT01179737|565820029|FG002|Extension|The study was terminated|0|||
156746513|NCT01179737|565820030|FG003|Extension|The study was terminated|0|||
156746514|NCT00568334|565820032|FG000|Overall Study|Withdrawal by Subject|0|||
156746515|NCT00568334|565820033|FG001|Overall Study|Withdrawal by Subject|1|||
156746516|NCT00568334|565820032|FG000|Overall Study|Lost to Follow-up|1|||
156746517|NCT00568334|565820033|FG001|Overall Study|Lost to Follow-up|0|||
156746518|NCT03217968|565820036|FG000|Overall Study|Withdrawal by Subject|4|||
156746519|NCT03217968|565820036|FG000|Overall Study|Lost to Follow-up|1|||
156746520|NCT03217968|565820036|FG000|Overall Study|Protocol Violation|6|||
156746521|NCT01904903|565820037|FG000|Overall Study|Withdrawal by Subject|1|||
156746522|NCT03677934|565820038|FG000|Overall Study|Adverse Event|1|||
156746523|NCT03677934|565820039|FG001|Overall Study|Adverse Event|1|||
156746524|NCT03677934|565820038|FG000|Overall Study|Death|8|||
156746525|NCT03677934|565820039|FG001|Overall Study|Death|4|||
156746526|NCT03677934|565820038|FG000|Overall Study|Lost to Follow-up|3|||
156746527|NCT03677934|565820039|FG001|Overall Study|Lost to Follow-up|0|||
156746528|NCT03677934|565820038|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156746529|NCT03677934|565820039|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156746530|NCT03677934|565820038|FG000|Overall Study|Physician Decision|0|||
156746531|NCT03677934|565820039|FG001|Overall Study|Physician Decision|1|||
156746532|NCT03677934|565820038|FG000|Overall Study|Withdrawal by Subject|1|||
156746533|NCT03677934|565820039|FG001|Overall Study|Withdrawal by Subject|7|||
156746534|NCT04769739|565820056|FG000|Overall Study|Colorectal cancer obstruction|2|||
156746535|NCT04769739|565820057|FG001|Overall Study|Colorectal cancer obstruction|0|||
156746536|NCT04769739|565820058|FG002|Overall Study|Colorectal cancer obstruction|0|||
156746537|NCT04769739|565820059|FG003|Overall Study|Colorectal cancer obstruction|0|||
156746538|NCT04769739|565820056|FG000|Overall Study|Failed cecal intubation|1|||
156746539|NCT04769739|565820057|FG001|Overall Study|Failed cecal intubation|0|||
156746540|NCT04769739|565820058|FG002|Overall Study|Failed cecal intubation|0|||
156746541|NCT04769739|565820059|FG003|Overall Study|Failed cecal intubation|1|||
156746542|NCT04769739|565820056|FG000|Overall Study|Poor bowel preparation|0|||
156746543|NCT04769739|565820057|FG001|Overall Study|Poor bowel preparation|0|||
156746544|NCT04769739|565820058|FG002|Overall Study|Poor bowel preparation|0|||
156746545|NCT04769739|565820059|FG003|Overall Study|Poor bowel preparation|1|||
156746546|NCT01260584|565820060|FG000|Period 1|Protocol Violation|0|||
156746547|NCT01260584|565820061|FG001|Period 1|Protocol Violation|0|||
156746548|NCT01260584|565820062|FG002|Period 1|Protocol Violation|1|||
156746549|NCT01260584|565820063|FG003|Period 1|Protocol Violation|1|||
156746550|NCT01260584|565820060|FG000|Period 1|Adverse Event|0|||
156746551|NCT01260584|565820061|FG001|Period 1|Adverse Event|0|||
156746552|NCT01260584|565820062|FG002|Period 1|Adverse Event|1|||
156746553|NCT01260584|565820063|FG003|Period 1|Adverse Event|0|||
156746554|NCT01260584|565820060|FG000|Period 2|Protocol Violation|0|||
156746555|NCT01260584|565820061|FG001|Period 2|Protocol Violation|2|||
156746556|NCT01260584|565820062|FG002|Period 2|Protocol Violation|3|||
156746557|NCT01260584|565820063|FG003|Period 2|Protocol Violation|1|||
156746558|NCT01260584|565820060|FG000|Period 2|Adverse Event|1|||
156746559|NCT01260584|565820061|FG001|Period 2|Adverse Event|0|||
156746560|NCT01260584|565820062|FG002|Period 2|Adverse Event|2|||
156746561|NCT01260584|565820063|FG003|Period 2|Adverse Event|0|||
156746562|NCT01260584|565820060|FG000|Period 2|Withdrawal by Subject|0|||
156746563|NCT01260584|565820061|FG001|Period 2|Withdrawal by Subject|1|||
156746564|NCT01260584|565820062|FG002|Period 2|Withdrawal by Subject|0|||
156746565|NCT01260584|565820063|FG003|Period 2|Withdrawal by Subject|0|||
156746566|NCT00045734|565820064|FG000|Overall Study|Protocol Violation|1|||
156746567|NCT02069093|565820065|FG000|Overall Study|Disease progression|14|||
156746568|NCT02069093|565820065|FG000|Overall Study|New cancer therapy|1|||
156746569|NCT02069093|565820065|FG000|Overall Study|Death|1|||
156746570|NCT02069093|565820065|FG000|Overall Study|Administrative problems|1|||
156746571|NCT02069093|565820065|FG000|Overall Study|Withdrawal by Subject|2|||
156746572|NCT02069093|565820065|FG000|Overall Study|Abnormal laboratory values|1|||
156746573|NCT02069093|565820065|FG000|Overall Study|Adverse Event|10|||
156746574|NCT01634659|565820066|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
156746575|NCT01634659|565820067|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
156746576|NCT01634659|565820066|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
156746577|NCT01634659|565820067|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
156746578|NCT02079636|565820068|FG000|Overall Study|Death|2|||
156746579|NCT02079636|565820069|FG001|Overall Study|Death|1|||
156746580|NCT02079636|565820070|FG002|Overall Study|Death|0|||
156746581|NCT02079636|565820071|FG003|Overall Study|Death|5|||
156746582|NCT02079636|565820072|FG004|Overall Study|Death|1|||
156746583|NCT02079636|565820073|FG005|Overall Study|Death|2|||
156746584|NCT02079636|565820074|FG006|Overall Study|Death|1|||
156746585|NCT02079636|565820075|FG007|Overall Study|Death|0|||
156746586|NCT02079636|565820076|FG008|Overall Study|Death|0|||
156746587|NCT02079636|565820077|FG009|Overall Study|Death|0|||
156746588|NCT02079636|565820078|FG010|Overall Study|Death|0|||
156746589|NCT02079636|565820079|FG011|Overall Study|Death|1|||
156746590|NCT02079636|565820080|FG012|Overall Study|Death|1|||
156746591|NCT02079636|565820081|FG013|Overall Study|Death|0|||
156746592|NCT02079636|565820082|FG014|Overall Study|Death|2|||
156746593|NCT02079636|565820068|FG000|Overall Study|Adverse Event|1|||
156746594|NCT02079636|565820069|FG001|Overall Study|Adverse Event|1|||
156746595|NCT02079636|565820070|FG002|Overall Study|Adverse Event|0|||
156746596|NCT02079636|565820071|FG003|Overall Study|Adverse Event|1|||
156746597|NCT02079636|565820072|FG004|Overall Study|Adverse Event|1|||
156746598|NCT02079636|565820073|FG005|Overall Study|Adverse Event|2|||
156746599|NCT02079636|565820074|FG006|Overall Study|Adverse Event|0|||
156746600|NCT02079636|565820075|FG007|Overall Study|Adverse Event|0|||
156746601|NCT02079636|565820076|FG008|Overall Study|Adverse Event|0|||
156746602|NCT02079636|565820077|FG009|Overall Study|Adverse Event|0|||
156746603|NCT02079636|565820078|FG010|Overall Study|Adverse Event|0|||
156746604|NCT02079636|565820079|FG011|Overall Study|Adverse Event|0|||
156746605|NCT02079636|565820080|FG012|Overall Study|Adverse Event|0|||
156746606|NCT02079636|565820081|FG013|Overall Study|Adverse Event|0|||
156746607|NCT02079636|565820082|FG014|Overall Study|Adverse Event|0|||
156746608|NCT02079636|565820068|FG000|Overall Study|Progressive disease|0|||
156746609|NCT02079636|565820069|FG001|Overall Study|Progressive disease|0|||
156746610|NCT02079636|565820070|FG002|Overall Study|Progressive disease|0|||
156746611|NCT02079636|565820071|FG003|Overall Study|Progressive disease|2|||
156746612|NCT02079636|565820072|FG004|Overall Study|Progressive disease|0|||
156746613|NCT02079636|565820073|FG005|Overall Study|Progressive disease|0|||
156746614|NCT02079636|565820074|FG006|Overall Study|Progressive disease|0|||
156746615|NCT02079636|565820075|FG007|Overall Study|Progressive disease|0|||
156746616|NCT02079636|565820076|FG008|Overall Study|Progressive disease|0|||
156746617|NCT02079636|565820077|FG009|Overall Study|Progressive disease|0|||
156746618|NCT02079636|565820078|FG010|Overall Study|Progressive disease|0|||
156746619|NCT02079636|565820079|FG011|Overall Study|Progressive disease|0|||
156746620|NCT02079636|565820080|FG012|Overall Study|Progressive disease|1|||
156746621|NCT02079636|565820081|FG013|Overall Study|Progressive disease|0|||
156746622|NCT02079636|565820082|FG014|Overall Study|Progressive disease|0|||
156746623|NCT02079636|565820068|FG000|Overall Study|Withdrawal by Subject|0|||
156746624|NCT02079636|565820069|FG001|Overall Study|Withdrawal by Subject|0|||
156746625|NCT02079636|565820070|FG002|Overall Study|Withdrawal by Subject|0|||
156746626|NCT02079636|565820071|FG003|Overall Study|Withdrawal by Subject|4|||
156746627|NCT02079636|565820072|FG004|Overall Study|Withdrawal by Subject|0|||
156746628|NCT02079636|565820073|FG005|Overall Study|Withdrawal by Subject|1|||
156746629|NCT02079636|565820074|FG006|Overall Study|Withdrawal by Subject|0|||
156746630|NCT02079636|565820075|FG007|Overall Study|Withdrawal by Subject|0|||
156459125|NCT02240238|564776698|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156459126|NCT02240238|564776699|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156536664|NCT00766090|565059037|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
156746631|NCT02079636|565820076|FG008|Overall Study|Withdrawal by Subject|0|||
156746632|NCT02079636|565820077|FG009|Overall Study|Withdrawal by Subject|2|||
156746633|NCT02079636|565820078|FG010|Overall Study|Withdrawal by Subject|1|||
156746634|NCT02079636|565820079|FG011|Overall Study|Withdrawal by Subject|1|||
156746635|NCT02079636|565820080|FG012|Overall Study|Withdrawal by Subject|1|||
156746636|NCT02079636|565820081|FG013|Overall Study|Withdrawal by Subject|0|||
156746637|NCT02079636|565820082|FG014|Overall Study|Withdrawal by Subject|2|||
156746638|NCT02079636|565820068|FG000|Overall Study|Physician Decision|0|||
156746639|NCT02079636|565820069|FG001|Overall Study|Physician Decision|0|||
156746640|NCT02079636|565820070|FG002|Overall Study|Physician Decision|0|||
156746641|NCT02079636|565820071|FG003|Overall Study|Physician Decision|0|||
156536665|NCT00766090|565059038|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
156536666|NCT00766090|565059027|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536667|NCT00766090|565059028|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536668|NCT00766090|565059029|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536669|NCT00766090|565059030|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536670|NCT00766090|565059031|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
156337186|NCT03166735|564333561|FG000|Overall Study|Lost to Follow-up|0|||
156536671|NCT00766090|565059032|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536672|NCT00766090|565059033|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536673|NCT00766090|565059034|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536674|NCT00766090|565059035|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536675|NCT00766090|565059036|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536676|NCT00766090|565059037|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536677|NCT00766090|565059038|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156536678|NCT00766090|565059027|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536679|NCT00766090|565059028|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536680|NCT00766090|565059029|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
156536681|NCT00766090|565059030|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536682|NCT00766090|565059031|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536683|NCT00766090|565059032|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536684|NCT00766090|565059033|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536685|NCT00766090|565059034|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536686|NCT00766090|565059035|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536687|NCT00766090|565059036|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536688|NCT00766090|565059037|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536689|NCT00766090|565059038|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
156536690|NCT00766090|565059027|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
156536691|NCT00766090|565059028|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
156536692|NCT00766090|565059029|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
156536693|NCT00766090|565059030|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
156536694|NCT00766090|565059031|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
156536695|NCT00766090|565059032|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
156536696|NCT00766090|565059033|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
156536697|NCT00766090|565059034|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
156536698|NCT00766090|565059035|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
156536699|NCT00766090|565059036|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
156536700|NCT00766090|565059037|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
156337187|NCT03166735|564333562|FG001|Overall Study|Lost to Follow-up|2|||
156536701|NCT00766090|565059038|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
156536702|NCT00766090|565059027|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156536703|NCT00766090|565059028|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156799808|NCT00787150|566021439|FG002|Overall Study|Physician Decision|1|||
156799809|NCT00787150|566021437|FG000|Overall Study|Withdrawal by Subject|2|||
156799810|NCT00787150|566021438|FG001|Overall Study|Withdrawal by Subject|1|||
156799811|NCT00787150|566021439|FG002|Overall Study|Withdrawal by Subject|0|||
156799812|NCT00787150|566021437|FG000|Overall Study|Dosing incorrect study durg|2|||
156799813|NCT00787150|566021438|FG001|Overall Study|Dosing incorrect study durg|0|||
156799814|NCT00787150|566021439|FG002|Overall Study|Dosing incorrect study durg|0|||
156799815|NCT00879398|566021442|FG000|Overall Study|Visit Stop|399|||
156799816|NCT00879398|566021442|FG000|Overall Study|Lack of Efficacy|64|||
156799817|NCT00879398|566021442|FG000|Overall Study|Adverse Event|41|||
156799818|NCT00879398|566021442|FG000|Overall Study|Other Reasons|171|||
156799819|NCT01121757|566021450|FG000|First Drug|Death|1|||
156799820|NCT01121757|566021451|FG001|First Drug|Death|0|||
156799821|NCT01121757|566021450|FG000|First Drug|Disease Progression|0|||
156799822|NCT01121757|566021451|FG001|First Drug|Disease Progression|2|||
156799823|NCT01121757|566021450|FG000|Combination|Physician Decision|0|||
156799824|NCT01121757|566021451|FG001|Combination|Physician Decision|1|||
156799825|NCT01121757|566021450|FG000|Combination|Disease Progression|2|||
156799826|NCT01121757|566021451|FG001|Combination|Disease Progression|0|||
156799827|NCT03773484|566021452|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
156799828|NCT04222673|566021453|FG000|Overall Study|Lost to Follow-up|5|||
156799829|NCT04398706|566021464|FG000|Overall Study|Adverse Event|0|||
156799830|NCT04398706|566021465|FG001|Overall Study|Adverse Event|0|||
156799831|NCT04398706|566021466|FG002|Overall Study|Adverse Event|0|||
156799832|NCT04398706|566021467|FG003|Overall Study|Adverse Event|0|||
156799833|NCT04398706|566021468|FG004|Overall Study|Adverse Event|0|||
156799834|NCT04398706|566021469|FG005|Overall Study|Adverse Event|1|||
156799835|NCT04398706|566021470|FG006|Overall Study|Adverse Event|1|||
156799836|NCT04398706|566021471|FG007|Overall Study|Adverse Event|0|||
156799837|NCT04398706|566021464|FG000|Overall Study|Lost to Follow-up|0|||
156799838|NCT04398706|566021465|FG001|Overall Study|Lost to Follow-up|1|||
156799839|NCT04398706|566021466|FG002|Overall Study|Lost to Follow-up|2|||
156337188|NCT03166735|564333563|FG002|Overall Study|Lost to Follow-up|1|||
156746642|NCT02079636|565820072|FG004|Overall Study|Physician Decision|0|||
156746643|NCT02079636|565820073|FG005|Overall Study|Physician Decision|1|||
156746644|NCT02079636|565820074|FG006|Overall Study|Physician Decision|0|||
156746645|NCT02079636|565820075|FG007|Overall Study|Physician Decision|0|||
156746646|NCT02079636|565820076|FG008|Overall Study|Physician Decision|0|||
156746647|NCT02079636|565820077|FG009|Overall Study|Physician Decision|1|||
156746648|NCT02079636|565820078|FG010|Overall Study|Physician Decision|1|||
156746649|NCT02079636|565820079|FG011|Overall Study|Physician Decision|0|||
156746650|NCT02079636|565820080|FG012|Overall Study|Physician Decision|0|||
156746651|NCT02079636|565820081|FG013|Overall Study|Physician Decision|0|||
156337189|NCT03166735|564333564|FG003|Overall Study|Lost to Follow-up|0|||
156337190|NCT03166735|564333565|FG004|Overall Study|Lost to Follow-up|1|||
156746652|NCT02079636|565820082|FG014|Overall Study|Physician Decision|1|||
156746653|NCT02079636|565820068|FG000|Overall Study|Lost to Follow-up|0|||
156746654|NCT02079636|565820069|FG001|Overall Study|Lost to Follow-up|0|||
156746655|NCT02079636|565820070|FG002|Overall Study|Lost to Follow-up|0|||
156746656|NCT02079636|565820071|FG003|Overall Study|Lost to Follow-up|0|||
156746657|NCT02079636|565820072|FG004|Overall Study|Lost to Follow-up|0|||
156746658|NCT02079636|565820073|FG005|Overall Study|Lost to Follow-up|0|||
156746659|NCT02079636|565820074|FG006|Overall Study|Lost to Follow-up|0|||
156746660|NCT02079636|565820075|FG007|Overall Study|Lost to Follow-up|1|||
156746661|NCT02079636|565820076|FG008|Overall Study|Lost to Follow-up|0|||
156746662|NCT02079636|565820077|FG009|Overall Study|Lost to Follow-up|0|||
156746663|NCT02079636|565820078|FG010|Overall Study|Lost to Follow-up|0|||
156746664|NCT02079636|565820079|FG011|Overall Study|Lost to Follow-up|0|||
156746665|NCT02079636|565820080|FG012|Overall Study|Lost to Follow-up|0|||
156746666|NCT02079636|565820081|FG013|Overall Study|Lost to Follow-up|0|||
156746667|NCT02079636|565820082|FG014|Overall Study|Lost to Follow-up|0|||
156746668|NCT00561470|565820083|FG000|Overall Study|Adverse Event|74|||
156746669|NCT00561470|565820084|FG001|Overall Study|Adverse Event|163|||
156746670|NCT00561470|565820083|FG000|Overall Study|Disease progression|437|||
156746671|NCT00561470|565820084|FG001|Overall Study|Disease progression|305|||
156746672|NCT00561470|565820083|FG000|Overall Study|poor compliance to protocol|4|||
156799840|NCT04398706|566021467|FG003|Overall Study|Lost to Follow-up|1|||
156799841|NCT04398706|566021468|FG004|Overall Study|Lost to Follow-up|6|||
156799842|NCT04398706|566021469|FG005|Overall Study|Lost to Follow-up|3|||
156799843|NCT04398706|566021470|FG006|Overall Study|Lost to Follow-up|8|||
156799844|NCT04398706|566021471|FG007|Overall Study|Lost to Follow-up|2|||
156799845|NCT04398706|566021464|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156799846|NCT04398706|566021465|FG001|Overall Study|Withdrawal by parent/guardian|2|||
156799847|NCT04398706|566021466|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156799848|NCT04398706|566021467|FG003|Overall Study|Withdrawal by parent/guardian|2|||
156799849|NCT04398706|566021468|FG004|Overall Study|Withdrawal by parent/guardian|19|||
156799850|NCT04398706|566021469|FG005|Overall Study|Withdrawal by parent/guardian|23|||
156799851|NCT04398706|566021470|FG006|Overall Study|Withdrawal by parent/guardian|13|||
156799852|NCT04398706|566021471|FG007|Overall Study|Withdrawal by parent/guardian|11|||
156799853|NCT04398706|566021464|FG000|Overall Study|Protocol deviation|0|||
156337191|NCT01945281|564333566|FG000|Overall Study|Adverse Event|1|||
156337192|NCT01945281|564333567|FG001|Overall Study|Adverse Event|0|||
156799854|NCT04398706|566021465|FG001|Overall Study|Protocol deviation|1|||
156799855|NCT04398706|566021466|FG002|Overall Study|Protocol deviation|0|||
156799856|NCT04398706|566021467|FG003|Overall Study|Protocol deviation|0|||
156337193|NCT01945281|564333566|FG000|Overall Study|Death|3|||
156746673|NCT00561470|565820084|FG001|Overall Study|poor compliance to protocol|4|||
156746674|NCT00561470|565820083|FG000|Overall Study|Lost to Follow-up|2|||
156746675|NCT00561470|565820084|FG001|Overall Study|Lost to Follow-up|0|||
156746676|NCT00561470|565820083|FG000|Overall Study|Physician Decision|21|||
156746677|NCT00561470|565820084|FG001|Overall Study|Physician Decision|20|||
156746678|NCT00561470|565820083|FG000|Overall Study|Consent Withdrawn|2|||
156746679|NCT00561470|565820084|FG001|Overall Study|Consent Withdrawn|6|||
156799857|NCT04398706|566021468|FG004|Overall Study|Protocol deviation|6|||
156799858|NCT04398706|566021469|FG005|Overall Study|Protocol deviation|4|||
156799859|NCT04398706|566021470|FG006|Overall Study|Protocol deviation|6|||
156799860|NCT04398706|566021471|FG007|Overall Study|Protocol deviation|3|||
156799861|NCT04116853|566021472|FG000|Overall Study|Adverse Event|1|||
156799862|NCT04116853|566021473|FG001|Overall Study|Adverse Event|3|||
156799863|NCT04116853|566021472|FG000|Overall Study|Lost to Follow-up|2|||
156799864|NCT04116853|566021473|FG001|Overall Study|Lost to Follow-up|0|||
156799865|NCT04116853|566021472|FG000|Overall Study|Incarceration|0|||
156799866|NCT04116853|566021473|FG001|Overall Study|Incarceration|1|||
156799867|NCT04116853|566021472|FG000|Overall Study|Pregnancy|1|||
156799868|NCT04116853|566021473|FG001|Overall Study|Pregnancy|1|||
156799869|NCT04116853|566021472|FG000|Overall Study|Began Other Weight Loss program|4|||
156799870|NCT04116853|566021473|FG001|Overall Study|Began Other Weight Loss program|8|||
156799871|NCT04116853|566021472|FG000|Overall Study|Began Anti-Obesity Medication|3|||
156799872|NCT04116853|566021473|FG001|Overall Study|Began Anti-Obesity Medication|3|||
156799873|NCT04116853|566021472|FG000|Overall Study|Protocol Violation|0|||
156799874|NCT04116853|566021473|FG001|Overall Study|Protocol Violation|1|||
156799875|NCT04522973|566021475|FG000|Overall Study|Lost to Follow-up|4|||
156799876|NCT04522973|566021475|FG000|Overall Study|Could not adhere to study schedule|1|||
156799877|NCT04696146|566023288|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
156799878|NCT04696146|566023289|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
156799879|NCT04696146|566023288|FG000|Overall Study|Off hours issue with product|1|||
156799880|NCT04696146|566023289|FG001|Overall Study|Off hours issue with product|0|||
156799881|NCT03021486|566023291|FG000|Overall Study|Withdrawal by Subject|1|||
156799882|NCT03021486|566023292|FG001|Overall Study|Withdrawal by Subject|1|||
156799883|NCT03021486|566023293|FG002|Overall Study|Withdrawal by Subject|3|||
156799884|NCT03021486|566023291|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
156799885|NCT03021486|566023292|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
156799886|NCT03021486|566023293|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
156799887|NCT04043286|566023294|FG000|Overall Study|Withdrawal by Subject|2|||
156799888|NCT04043286|566023295|FG001|Overall Study|Withdrawal by Subject|2|||
156799889|NCT01276704|566023301|FG000|Overall Study|Lost to Follow-up|2|||
156799890|NCT01276704|566023302|FG001|Overall Study|Lost to Follow-up|3|||
156799891|NCT01276704|566023301|FG000|Overall Study|Non-compliant|2|||
156799892|NCT01276704|566023302|FG001|Overall Study|Non-compliant|2|||
156799893|NCT01276704|566023301|FG000|Overall Study|Withdrawal by Subject|7|||
156799894|NCT01276704|566023302|FG001|Overall Study|Withdrawal by Subject|1|||
156799895|NCT01276704|566023301|FG000|Overall Study|Physician Decision|3|||
156799896|NCT01276704|566023302|FG001|Overall Study|Physician Decision|5|||
156799897|NCT03728933|566023303|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156799898|NCT03728933|566023304|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156799899|NCT03728933|566023305|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156799900|NCT03728933|566023303|FG000|Overall Study|Withdrawal by Subject|0|||
156799901|NCT03728933|566023304|FG001|Overall Study|Withdrawal by Subject|0|||
156799902|NCT03728933|566023305|FG002|Overall Study|Withdrawal by Subject|1|||
156799903|NCT03728933|566023303|FG000|Overall Study|Lost to Follow-up|0|||
156799904|NCT03728933|566023304|FG001|Overall Study|Lost to Follow-up|1|||
156799905|NCT03728933|566023305|FG002|Overall Study|Lost to Follow-up|0|||
156799906|NCT03728933|566023303|FG000|Overall Study|Adverse Event|1|||
156799907|NCT03728933|566023304|FG001|Overall Study|Adverse Event|0|||
156799908|NCT03728933|566023305|FG002|Overall Study|Adverse Event|0|||
156799909|NCT03674281|566023306|FG000|Overall Study|screen failure|2|||
156799910|NCT03674281|566023307|FG001|Overall Study|screen failure|0|||
156799911|NCT03674281|566023308|FG002|Overall Study|screen failure|0|||
156799912|NCT03674281|566023306|FG000|Overall Study|Withdrawal by Subject|1|||
156799913|NCT03674281|566023307|FG001|Overall Study|Withdrawal by Subject|3|||
156799914|NCT03674281|566023308|FG002|Overall Study|Withdrawal by Subject|3|||
156799915|NCT01441960|566023309|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
156799916|NCT01441960|566023310|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
156799917|NCT01441960|566023309|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
156799918|NCT01441960|566023310|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
156799919|NCT01441960|566023309|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
156799920|NCT01441960|566023310|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
156799921|NCT00276419|566023314|FG000|First Intervention|Adverse Event|1|||
156799922|NCT00276419|566023315|FG001|First Intervention|Adverse Event|0|||
156799923|NCT00276419|566023314|FG000|First Intervention|Withdrawal by Subject|0|||
156799924|NCT00276419|566023315|FG001|First Intervention|Withdrawal by Subject|2|||
156799925|NCT03186638|566023316|FG000|Overall Study|Withdrawal by Subject|4|||
156799926|NCT03186638|566023317|FG001|Overall Study|Withdrawal by Subject|4|||
156799927|NCT03186638|566023316|FG000|Overall Study|Withdrawn due to medical problem|3|||
156799928|NCT03186638|566023317|FG001|Overall Study|Withdrawn due to medical problem|2|||
156799929|NCT03186638|566023316|FG000|Overall Study|Lost to Follow-up|1|||
156799930|NCT03186638|566023317|FG001|Overall Study|Lost to Follow-up|0|||
156799931|NCT03801525|566023318|FG000|Overall Study|Adverse Event|17|||
156799932|NCT03801525|566023319|FG001|Overall Study|Adverse Event|1|||
156799933|NCT03801525|566023320|FG002|Overall Study|Adverse Event|0|||
156799934|NCT03801525|566023318|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
156799935|NCT03801525|566023319|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
156799936|NCT03801525|566023320|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
156799937|NCT03801525|566023318|FG000|Overall Study|Death|29|||
156799938|NCT03801525|566023319|FG001|Overall Study|Death|1|||
156799939|NCT03801525|566023320|FG002|Overall Study|Death|4|||
156799940|NCT03801525|566023318|FG000|Overall Study|Disease Progression|6|||
156799941|NCT03801525|566023319|FG001|Overall Study|Disease Progression|0|||
156799942|NCT03801525|566023320|FG002|Overall Study|Disease Progression|1|||
156799943|NCT03801525|566023318|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
156799944|NCT03801525|566023319|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
156799945|NCT03801525|566023320|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
156799946|NCT03801525|566023318|FG000|Overall Study|Investigator Decision|18|||
156799947|NCT03801525|566023319|FG001|Overall Study|Investigator Decision|1|||
156799948|NCT03801525|566023320|FG002|Overall Study|Investigator Decision|0|||
156799949|NCT03801525|566023318|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
156799950|NCT03801525|566023319|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
156799951|NCT03801525|566023320|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
156799952|NCT03801525|566023318|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
156799953|NCT03801525|566023319|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
156799954|NCT03801525|566023320|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
156799955|NCT03801525|566023318|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
156799956|NCT03801525|566023319|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
156799957|NCT03801525|566023320|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
156799958|NCT03801525|566023318|FG000|Overall Study|Withdrawal of Subject Consent|38|||
156799959|NCT03801525|566023319|FG001|Overall Study|Withdrawal of Subject Consent|2|||
156799960|NCT03801525|566023320|FG002|Overall Study|Withdrawal of Subject Consent|1|||
156799961|NCT03801525|566023318|FG000|Overall Study|Reason not Specified|4|||
156799962|NCT03801525|566023319|FG001|Overall Study|Reason not Specified|0|||
156799963|NCT03801525|566023320|FG002|Overall Study|Reason not Specified|4|||
156799964|NCT01263119|566023321|FG000|Period 1|Protocol Violation|2|||
156799965|NCT01263119|566023321|FG000|Period 2|Adverse Event|2|||
156799966|NCT05201807|566023325|FG000|Overall Study|Adverse Event|1|||
156799967|NCT05201807|566023325|FG000|Overall Study|COVID-19 Related|1|||
156799968|NCT01029535|566023328|FG000|Overall Study|Lost to Follow-up|24|||
156746680|NCT00561470|565820083|FG000|Overall Study|Subject request|43|||
156746681|NCT00561470|565820084|FG001|Overall Study|Subject request|77|||
156746682|NCT00561470|565820083|FG000|Overall Study|Metastatic surgery|10|||
156746683|NCT00561470|565820084|FG001|Overall Study|Metastatic surgery|12|||
156746684|NCT00561470|565820083|FG000|Overall Study|Unauthorized procedure|3|||
156536704|NCT00766090|565059029|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156536705|NCT00766090|565059030|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156536706|NCT00766090|565059031|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156536707|NCT00766090|565059032|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
156536708|NCT00766090|565059033|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156536709|NCT00766090|565059034|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156536710|NCT00766090|565059035|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156536711|NCT00766090|565059036|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156746685|NCT00561470|565820084|FG001|Overall Study|Unauthorized procedure|1|||
156746686|NCT00561470|565820083|FG000|Overall Study|Randomized but not treated|5|||
156746687|NCT00561470|565820084|FG001|Overall Study|Randomized but not treated|5|||
156746688|NCT00561470|565820083|FG000|Overall Study|Missed visit window|1|||
156746689|NCT00561470|565820084|FG001|Overall Study|Missed visit window|4|||
156746690|NCT00561470|565820083|FG000|Overall Study|Planning surgery|1|||
156746691|NCT00561470|565820084|FG001|Overall Study|Planning surgery|1|||
156746692|NCT00561470|565820083|FG000|Overall Study|Ongoing Treatment|11|||
156746693|NCT00561470|565820084|FG001|Overall Study|Ongoing Treatment|14|||
156746694|NCT01362244|565820086|FG000|Overall Study|Adverse Event|3|||
156746695|NCT01362244|565820087|FG001|Overall Study|Adverse Event|5|||
156746696|NCT01362244|565820086|FG000|Overall Study|Lack of Efficacy|5|||
156746697|NCT01362244|565820087|FG001|Overall Study|Lack of Efficacy|11|||
156746698|NCT01362244|565820086|FG000|Overall Study|Lost to Follow-up|0|||
156746699|NCT01362244|565820087|FG001|Overall Study|Lost to Follow-up|2|||
156746700|NCT01362244|565820086|FG000|Overall Study|Protocol Violation|5|||
156746701|NCT01362244|565820087|FG001|Overall Study|Protocol Violation|1|||
156746702|NCT01362244|565820086|FG000|Overall Study|Withdrawal by Subject|2|||
156746703|NCT01362244|565820087|FG001|Overall Study|Withdrawal by Subject|1|||
156746704|NCT01362244|565820086|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
156746705|NCT01362244|565820087|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
156746706|NCT01362244|565820086|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
156746707|NCT01362244|565820087|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
156746708|NCT01712334|565820088|FG000|Treatment Period 1|Randomized in Error|0|||
156746709|NCT01712334|565820089|FG001|Treatment Period 1|Randomized in Error|2|||
156746710|NCT00232596|565820090|FG000|6-Week Titration Phase|Adverse Event|6|||
156746711|NCT00232596|565820091|FG001|6-Week Titration Phase|Adverse Event|19|||
156746712|NCT00232596|565820090|FG000|6-Week Titration Phase|Failed to Return|2|||
156746713|NCT00232596|565820091|FG001|6-Week Titration Phase|Failed to Return|1|||
156746714|NCT00232596|565820090|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
156746715|NCT00232596|565820091|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
156746716|NCT00232596|565820090|FG000|6-Week Titration Phase|Protocol Violation|1|||
156746717|NCT00232596|565820091|FG001|6-Week Titration Phase|Protocol Violation|3|||
156746718|NCT00232596|565820090|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
156746719|NCT00232596|565820091|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
156746720|NCT00232596|565820090|FG000|6-Week Titration Phase|Other|3|||
156746721|NCT00232596|565820091|FG001|6-Week Titration Phase|Other|3|||
156746722|NCT00232596|565820090|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
156746723|NCT00232596|565820091|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
156746724|NCT00232596|565820090|FG000|12-Week Maintenance Phase|Adverse Event|7|||
156746725|NCT00232596|565820091|FG001|12-Week Maintenance Phase|Adverse Event|22|||
156746726|NCT00232596|565820090|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
156746727|NCT00232596|565820091|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
156746728|NCT00232596|565820090|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
156746729|NCT00232596|565820091|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
156746730|NCT00232596|565820090|FG000|12-Week Maintenance Phase|Other|1|||
156746731|NCT00232596|565820091|FG001|12-Week Maintenance Phase|Other|3|||
156746732|NCT01253174|565820092|FG000|Period 1|Randomized but not treated|0|||
156746733|NCT01253174|565820093|FG001|Period 1|Randomized but not treated|1|||
156746734|NCT01253174|565820094|FG002|Period 1|Randomized but not treated|1|||
156746735|NCT01253174|565820095|FG003|Period 1|Randomized but not treated|0|||
156746736|NCT01253174|565820096|FG004|Period 1|Randomized but not treated|1|||
156746737|NCT01253174|565820097|FG005|Period 1|Randomized but not treated|0|||
156746738|NCT01253174|565820092|FG000|Period 2|Adverse Event|0|||
156746739|NCT01253174|565820093|FG001|Period 2|Adverse Event|0|||
156536712|NCT00766090|565059037|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156536713|NCT00766090|565059038|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
156746740|NCT01253174|565820094|FG002|Period 2|Adverse Event|1|||
156746741|NCT01253174|565820095|FG003|Period 2|Adverse Event|0|||
156746742|NCT01253174|565820096|FG004|Period 2|Adverse Event|0|||
156746743|NCT01253174|565820097|FG005|Period 2|Adverse Event|0|||
156746744|NCT01253174|565820092|FG000|Period 3|Withdrawal by Subject|0|||
156746745|NCT01253174|565820093|FG001|Period 3|Withdrawal by Subject|1|||
156746746|NCT01253174|565820094|FG002|Period 3|Withdrawal by Subject|0|||
156746747|NCT01253174|565820095|FG003|Period 3|Withdrawal by Subject|0|||
156746748|NCT01253174|565820096|FG004|Period 3|Withdrawal by Subject|1|||
156746749|NCT01253174|565820097|FG005|Period 3|Withdrawal by Subject|0|||
156746750|NCT01253174|565820092|FG000|Period 3|Pregnancy|0|||
156746751|NCT01253174|565820093|FG001|Period 3|Pregnancy|0|||
156746752|NCT01253174|565820094|FG002|Period 3|Pregnancy|1|||
156746753|NCT01253174|565820095|FG003|Period 3|Pregnancy|0|||
156746754|NCT01253174|565820096|FG004|Period 3|Pregnancy|0|||
156746755|NCT01253174|565820097|FG005|Period 3|Pregnancy|0|||
156746756|NCT02407054|565820098|FG000|Overall Study|Adverse Event|1|||
156746757|NCT02407054|565820099|FG001|Overall Study|Adverse Event|4|||
156746758|NCT02407054|565820100|FG002|Overall Study|Adverse Event|1|||
156746759|NCT02407054|565820098|FG000|Overall Study|Non-compliance with Study|0|||
156746760|NCT02407054|565820099|FG001|Overall Study|Non-compliance with Study|2|||
156746761|NCT02407054|565820100|FG002|Overall Study|Non-compliance with Study|1|||
156746762|NCT02407054|565820098|FG000|Overall Study|Physician Decision|1|||
156746763|NCT02407054|565820099|FG001|Overall Study|Physician Decision|3|||
156746764|NCT02407054|565820100|FG002|Overall Study|Physician Decision|3|||
156746765|NCT02407054|565820098|FG000|Overall Study|Withdrawal by Subject|5|||
156746766|NCT02407054|565820099|FG001|Overall Study|Withdrawal by Subject|9|||
156746767|NCT02407054|565820100|FG002|Overall Study|Withdrawal by Subject|2|||
156746768|NCT00932698|565820103|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
156746769|NCT00932698|565820104|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
156746770|NCT00932698|565820105|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
156746771|NCT00932698|565820106|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
156746772|NCT00932698|565820107|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
156746773|NCT00932698|565820108|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
156746774|NCT00932698|565820109|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
156799969|NCT01029535|566023328|FG000|Overall Study|Protocol Violation|2|||
156799970|NCT01029535|566023328|FG000|Overall Study|Participant Withdrew Consent|2|||
156799971|NCT01029535|566023328|FG000|Overall Study|Adverse Event|1|||
156799972|NCT01029535|566023328|FG000|Overall Study|Use of Another Treatment|1|||
156799973|NCT01029535|566023328|FG000|Overall Study|Death|1|||
156799974|NCT02862574|566023329|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156799975|NCT02862574|566023330|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156799976|NCT02862574|566023331|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156799977|NCT02862574|566023329|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
156799978|NCT02862574|566023330|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
156799979|NCT02862574|566023331|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
156799980|NCT02862574|566023329|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
156799981|NCT02862574|566023330|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
156799982|NCT02862574|566023331|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
156799983|NCT01870869|566023346|FG000|Overall Study|Implanted with nonstudy device|1|||
156459127|NCT02240238|564776700|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156459128|NCT02240238|564776701|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
156746775|NCT00932698|565820110|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
156746776|NCT00932698|565820111|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
156799984|NCT01870869|566023347|FG001|Overall Study|Implanted with nonstudy device|3|||
156799985|NCT01870869|566023348|FG002|Overall Study|Implanted with nonstudy device|14|||
156799986|NCT01870869|566023349|FG003|Overall Study|Implanted with nonstudy device|4|||
156799987|NCT01870869|566023346|FG000|Overall Study|Death|0|||
156799988|NCT01870869|566023347|FG001|Overall Study|Death|0|||
156799989|NCT01870869|566023348|FG002|Overall Study|Death|7|||
156799990|NCT01870869|566023349|FG003|Overall Study|Death|1|||
156746777|NCT00932698|565820112|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
156746778|NCT00932698|565820113|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
156746779|NCT00932698|565820103|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746780|NCT00932698|565820104|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
156746781|NCT00932698|565820105|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746782|NCT00932698|565820106|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
156746783|NCT00932698|565820107|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746784|NCT00932698|565820108|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
156746785|NCT00932698|565820109|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
156746786|NCT00932698|565820110|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746787|NCT00932698|565820111|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746788|NCT00932698|565820112|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746789|NCT00932698|565820113|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746790|NCT00932698|565820103|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
156746791|NCT00932698|565820104|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
156746792|NCT00932698|565820105|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
156746793|NCT00932698|565820106|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
156746794|NCT00932698|565820107|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
156746795|NCT00932698|565820108|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
156746796|NCT00932698|565820109|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
156746797|NCT00932698|565820110|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
156746798|NCT00932698|565820111|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
156746799|NCT00932698|565820112|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
156746800|NCT00932698|565820113|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
156746801|NCT00932698|565820103|FG000|Part 1 (Dose Escalation)|Other|0|||
156746802|NCT00932698|565820104|FG001|Part 1 (Dose Escalation)|Other|0|||
156746803|NCT00932698|565820105|FG002|Part 1 (Dose Escalation)|Other|1|||
156746804|NCT00932698|565820106|FG003|Part 1 (Dose Escalation)|Other|0|||
156746805|NCT00932698|565820107|FG004|Part 1 (Dose Escalation)|Other|0|||
156746806|NCT00932698|565820108|FG005|Part 1 (Dose Escalation)|Other|0|||
156746807|NCT00932698|565820109|FG006|Part 1 (Dose Escalation)|Other|1|||
156746808|NCT00932698|565820110|FG007|Part 1 (Dose Escalation)|Other|0|||
156746809|NCT00932698|565820111|FG008|Part 1 (Dose Escalation)|Other|0|||
156746810|NCT00932698|565820112|FG009|Part 1 (Dose Escalation)|Other|0|||
156746811|NCT00932698|565820113|FG010|Part 1 (Dose Escalation)|Other|0|||
156746812|NCT00932698|565820103|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746813|NCT00932698|565820104|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746814|NCT00932698|565820105|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746815|NCT00932698|565820106|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746816|NCT00932698|565820107|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746817|NCT00932698|565820108|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746818|NCT00932698|565820109|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746819|NCT00932698|565820110|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
156746820|NCT00932698|565820111|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
156746821|NCT00932698|565820112|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
156746822|NCT00932698|565820113|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
156746823|NCT00932698|565820103|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746824|NCT00932698|565820104|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746825|NCT00932698|565820105|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746826|NCT00932698|565820106|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746827|NCT00932698|565820107|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746828|NCT00932698|565820108|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746829|NCT00932698|565820109|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746830|NCT00932698|565820110|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
156746831|NCT00932698|565820111|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
156746832|NCT00932698|565820112|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
156746833|NCT00932698|565820113|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746834|NCT00932698|565820103|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
156746835|NCT00932698|565820104|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
156746836|NCT00932698|565820105|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
156746837|NCT00932698|565820106|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
156746838|NCT00932698|565820107|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
156746839|NCT00932698|565820108|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
156746840|NCT00932698|565820109|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
156746841|NCT00932698|565820110|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
156746842|NCT00932698|565820111|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
156746843|NCT00932698|565820112|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
156746844|NCT00932698|565820113|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
156746845|NCT02510820|565821864|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156746846|NCT02510820|565821865|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156746847|NCT02510820|565821864|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156746848|NCT02510820|565821865|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156746849|NCT03089853|565821866|FG000|Overall Study|Lost to Follow-up|2|||
156746850|NCT03089853|565821867|FG001|Overall Study|Lost to Follow-up|1|||
156746851|NCT04114656|565821872|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
156746852|NCT04114656|565821873|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
156746853|NCT04114656|565821872|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
156746854|NCT04114656|565821873|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
156746855|NCT04114656|565821872|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
156746856|NCT04114656|565821873|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
156746857|NCT04114656|565821872|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
156746858|NCT04114656|565821873|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
156746859|NCT04114656|565821872|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
156746860|NCT04114656|565821873|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
156746861|NCT01393106|565821874|FG000|Overall Study|Adverse Event|3|||
156746862|NCT01393106|565821874|FG000|Overall Study|Withdrawal by Subject|1|||
156746863|NCT01393106|565821874|FG000|Overall Study|Lack of Efficacy|1|||
156746864|NCT03052920|565821875|FG000|Overall Study|Withdrawal by Subject|1|||
156746865|NCT01698268|565821876|FG000|Overall Study|Physician Decision|2|||
156746866|NCT01698268|565821877|FG001|Overall Study|Physician Decision|1|||
156746867|NCT02263729|565821878|FG000|Overall Study|Lost to Follow-up|1|||
156746868|NCT02263729|565821879|FG001|Overall Study|Lost to Follow-up|1|||
156746869|NCT04591015|565821880|FG000|Overall Study|Death|6|||
156746870|NCT04591015|565821881|FG001|Overall Study|Death|4|||
156746871|NCT04591015|565821880|FG000|Overall Study|Withdrawal by Subject|6|||
156746872|NCT04591015|565821881|FG001|Overall Study|Withdrawal by Subject|3|||
156746873|NCT04591015|565821880|FG000|Overall Study|Lost to Follow-up|16|||
156746874|NCT04591015|565821881|FG001|Overall Study|Lost to Follow-up|11|||
156746875|NCT02509078|565821882|FG000|Overall Study|Protocol Violation|1|||
156746876|NCT02509078|565821883|FG001|Overall Study|Protocol Violation|1|||
156799991|NCT01870869|566023346|FG000|Overall Study|Subject choice|6|||
156799992|NCT01870869|566023347|FG001|Overall Study|Subject choice|2|||
156799993|NCT01870869|566023348|FG002|Overall Study|Subject choice|22|||
156799994|NCT01870869|566023349|FG003|Overall Study|Subject choice|8|||
156799995|NCT01870869|566023346|FG000|Overall Study|Lost to Follow-up|10|||
156799996|NCT01870869|566023347|FG001|Overall Study|Lost to Follow-up|2|||
156799997|NCT01870869|566023348|FG002|Overall Study|Lost to Follow-up|25|||
156799998|NCT01870869|566023349|FG003|Overall Study|Lost to Follow-up|3|||
156799999|NCT01870869|566023346|FG000|Overall Study|Reason not Specified|1|||
156800000|NCT01870869|566023347|FG001|Overall Study|Reason not Specified|2|||
156800001|NCT01870869|566023348|FG002|Overall Study|Reason not Specified|20|||
156800002|NCT01870869|566023349|FG003|Overall Study|Reason not Specified|4|||
156800003|NCT01870869|566023346|FG000|Overall Study|Not evaluable|10|||
156800004|NCT01870869|566023347|FG001|Overall Study|Not evaluable|5|||
156800005|NCT01870869|566023348|FG002|Overall Study|Not evaluable|42|||
156800006|NCT01870869|566023349|FG003|Overall Study|Not evaluable|10|||
156800007|NCT02569853|566023350|FG000|Overall Study|Adverse Event|2|||
156800008|NCT02569853|566023351|FG001|Overall Study|Adverse Event|0|||
156800009|NCT02569853|566023350|FG000|Overall Study|Withdrawal by Subject|3|||
156800010|NCT02569853|566023351|FG001|Overall Study|Withdrawal by Subject|2|||
156800011|NCT02569853|566023350|FG000|Overall Study|Lost to Follow-up|3|||
156800012|NCT02569853|566023351|FG001|Overall Study|Lost to Follow-up|3|||
156800013|NCT02569853|566023350|FG000|Overall Study|Protocol Violation|1|||
156800014|NCT02569853|566023351|FG001|Overall Study|Protocol Violation|1|||
156800015|NCT02569853|566023350|FG000|Overall Study|Did not experience migraine attack|10|||
156800016|NCT02569853|566023351|FG001|Overall Study|Did not experience migraine attack|7|||
156800017|NCT02569853|566023350|FG000|Overall Study|Physician Decision|1|||
156800018|NCT02569853|566023351|FG001|Overall Study|Physician Decision|1|||
156746877|NCT03594955|565821884|FG000|Overall Study|Adverse Event|1|||
156746878|NCT03594955|565821884|FG000|Overall Study|Progressive disease|5|||
156800019|NCT00402987|566023352|FG000|Overall Study|Lack of Efficacy|0|||
156800020|NCT00402987|566023353|FG001|Overall Study|Lack of Efficacy|0|||
156800021|NCT00402987|566023354|FG002|Overall Study|Lack of Efficacy|1|||
156800022|NCT00402987|566023355|FG003|Overall Study|Lack of Efficacy|0|||
156800023|NCT00419744|566023356|FG000|Overall Study|Adverse Event|39|||
156800024|NCT00419744|566023357|FG001|Overall Study|Adverse Event|40|||
156800025|NCT00419744|566023358|FG002|Overall Study|Adverse Event|50|||
156800026|NCT00419744|566023356|FG000|Overall Study|Withdrawal by Subject|45|||
156800027|NCT00419744|566023357|FG001|Overall Study|Withdrawal by Subject|49|||
156800028|NCT00419744|566023358|FG002|Overall Study|Withdrawal by Subject|52|||
156800029|NCT00419744|566023356|FG000|Overall Study|Lost to Follow-up|8|||
156800030|NCT00419744|566023357|FG001|Overall Study|Lost to Follow-up|10|||
156800031|NCT00419744|566023358|FG002|Overall Study|Lost to Follow-up|6|||
156800032|NCT00419744|566023356|FG000|Overall Study|Protocol Violation|4|||
156800033|NCT00419744|566023357|FG001|Overall Study|Protocol Violation|7|||
156800034|NCT00419744|566023358|FG002|Overall Study|Protocol Violation|8|||
156746879|NCT03594955|565821884|FG000|Overall Study|Sponsor's decision|1|||
156746880|NCT03539484|565821886|FG000|Overall Study|Death|1|||
156746881|NCT03539484|565821887|FG001|Overall Study|Death|0|||
156746882|NCT03539484|565821888|FG002|Overall Study|Death|0|||
156746883|NCT03539484|565821889|FG003|Overall Study|Death|2|||
156746884|NCT03539484|565821890|FG004|Overall Study|Death|8|||
156746885|NCT03539484|565821891|FG005|Overall Study|Death|3|||
156746886|NCT03539484|565821892|FG006|Overall Study|Death|0|||
156746887|NCT03539484|565821886|FG000|Overall Study|Lost to Follow-up|0|||
156746888|NCT03539484|565821887|FG001|Overall Study|Lost to Follow-up|1|||
156746889|NCT03539484|565821888|FG002|Overall Study|Lost to Follow-up|0|||
156746890|NCT03539484|565821889|FG003|Overall Study|Lost to Follow-up|0|||
156746891|NCT03539484|565821890|FG004|Overall Study|Lost to Follow-up|1|||
156746892|NCT03539484|565821891|FG005|Overall Study|Lost to Follow-up|0|||
156746893|NCT03539484|565821892|FG006|Overall Study|Lost to Follow-up|0|||
156746894|NCT03539484|565821886|FG000|Overall Study|Withdrawal by Subject|0|||
156746895|NCT03539484|565821887|FG001|Overall Study|Withdrawal by Subject|0|||
156746896|NCT03539484|565821888|FG002|Overall Study|Withdrawal by Subject|0|||
156746897|NCT03539484|565821889|FG003|Overall Study|Withdrawal by Subject|0|||
156746898|NCT03539484|565821890|FG004|Overall Study|Withdrawal by Subject|2|||
156746899|NCT03539484|565821891|FG005|Overall Study|Withdrawal by Subject|0|||
156746900|NCT03539484|565821892|FG006|Overall Study|Withdrawal by Subject|1|||
156746901|NCT03539484|565821886|FG000|Overall Study|Study Terminated by Sponsor|0|||
156746902|NCT03539484|565821887|FG001|Overall Study|Study Terminated by Sponsor|0|||
156746903|NCT03539484|565821888|FG002|Overall Study|Study Terminated by Sponsor|1|||
156746904|NCT03539484|565821889|FG003|Overall Study|Study Terminated by Sponsor|1|||
156746905|NCT03539484|565821890|FG004|Overall Study|Study Terminated by Sponsor|2|||
156746906|NCT03539484|565821891|FG005|Overall Study|Study Terminated by Sponsor|2|||
156746907|NCT03539484|565821892|FG006|Overall Study|Study Terminated by Sponsor|1|||
156746908|NCT02131636|565821896|FG000|Overall Study|Personal Reasons|4|||
156746909|NCT02131636|565821897|FG001|Overall Study|Personal Reasons|4|||
156746910|NCT02131636|565821896|FG000|Overall Study|Lost to Follow-up|4|||
156746911|NCT02131636|565821897|FG001|Overall Study|Lost to Follow-up|0|||
156746912|NCT02131636|565821896|FG000|Overall Study|Adverse Event|4|||
156746913|NCT02131636|565821897|FG001|Overall Study|Adverse Event|1|||
156746914|NCT02173379|565821898|FG000|Overall Study|Lost to Follow-up|89|||
156746915|NCT02173379|565821899|FG001|Overall Study|Lost to Follow-up|81|||
156746916|NCT02173379|565821898|FG000|Overall Study|Withdrawal by Subject|24|||
156746917|NCT02173379|565821899|FG001|Overall Study|Withdrawal by Subject|29|||
156746918|NCT02173379|565821898|FG000|Overall Study|Physician Decision|8|||
156746919|NCT02173379|565821899|FG001|Overall Study|Physician Decision|8|||
156746920|NCT02173379|565821898|FG000|Overall Study|Death|75|||
156746921|NCT02173379|565821899|FG001|Overall Study|Death|72|||
156746922|NCT02173379|565821898|FG000|Overall Study|Other Reason|1|||
156746923|NCT02173379|565821899|FG001|Overall Study|Other Reason|0|||
156746924|NCT06226649|565821901|FG000|Overall Study|Withdrawal by Subject|4|||
156746925|NCT06226649|565821902|FG001|Overall Study|Withdrawal by Subject|1|||
156746926|NCT00631163|565821907|FG000|Number of Participants in Year 1|Adverse Event|12|||
156746927|NCT00631163|565821907|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
156746928|NCT00631163|565821907|FG000|Number of Participants in Year 1|Death|6|||
156746929|NCT00631163|565821907|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
156746930|NCT00631163|565821907|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
156746931|NCT00631163|565821907|FG000|Number of Participants in Year 1|Administrative problems|6|||
156746932|NCT00631163|565821907|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
156746933|NCT00631163|565821907|FG000|Number of Participants in Year 2|Adverse Event|1|||
156746934|NCT00631163|565821907|FG000|Number of Participants in Year 2|Protocol Violation|1|||
156746935|NCT00631163|565821907|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
156746936|NCT01636947|565821911|FG000|Overall Study|Not Treated|2|||
156746937|NCT01636947|565821912|FG001|Overall Study|Not Treated|2|||
156746938|NCT01636947|565821911|FG000|Overall Study|Lost to Follow-up|4|||
156746939|NCT01636947|565821912|FG001|Overall Study|Lost to Follow-up|0|||
156746940|NCT01636947|565821911|FG000|Overall Study|Protocol Violation|1|||
156746941|NCT01636947|565821912|FG001|Overall Study|Protocol Violation|1|||
156746942|NCT01636947|565821911|FG000|Overall Study|Withdrawal by Subject|3|||
156746943|NCT01636947|565821912|FG001|Overall Study|Withdrawal by Subject|3|||
156746944|NCT01636947|565821911|FG000|Overall Study|Adverse Event|1|||
156746945|NCT01636947|565821912|FG001|Overall Study|Adverse Event|1|||
156746946|NCT01636947|565821911|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
156746947|NCT01636947|565821912|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
156536714|NCT00766090|565059027|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156746948|NCT00427999|565821935|FG000|Overall Study|Adverse Event|6|||
156746949|NCT00427999|565821935|FG000|Overall Study|Abnormal laboratory values|1|||
156746950|NCT00427999|565821935|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
156746951|NCT00427999|565821935|FG000|Overall Study|Protocol Violation|2|||
156746952|NCT00427999|565821935|FG000|Overall Study|Withdrawal by Subject|9|||
156746953|NCT00427999|565821935|FG000|Overall Study|Death|1|||
156746954|NCT02284568|565821936|FG000|Overall Study|Adverse Event|2|||
156746955|NCT02284568|565821937|FG001|Overall Study|Adverse Event|9|||
156746956|NCT02284568|565821938|FG002|Overall Study|Adverse Event|4|||
156746957|NCT02284568|565821936|FG000|Overall Study|Withdrawal by Subject|22|||
156746958|NCT02284568|565821937|FG001|Overall Study|Withdrawal by Subject|21|||
156746959|NCT02284568|565821938|FG002|Overall Study|Withdrawal by Subject|1|||
156746960|NCT02284568|565821936|FG000|Overall Study|Noncompliance with study drug admin|1|||
156746961|NCT02284568|565821937|FG001|Overall Study|Noncompliance with study drug admin|2|||
156746962|NCT02284568|565821938|FG002|Overall Study|Noncompliance with study drug admin|0|||
156746963|NCT02284568|565821936|FG000|Overall Study|Noncompliance|1|||
156746964|NCT02284568|565821937|FG001|Overall Study|Noncompliance|0|||
156746965|NCT02284568|565821938|FG002|Overall Study|Noncompliance|0|||
156746966|NCT02284568|565821936|FG000|Overall Study|Protocol Violation|0|||
156746967|NCT02284568|565821937|FG001|Overall Study|Protocol Violation|1|||
156746968|NCT02284568|565821938|FG002|Overall Study|Protocol Violation|0|||
156746969|NCT02284568|565821936|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
156746970|NCT02284568|565821937|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
156746971|NCT02284568|565821938|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
156746972|NCT02284568|565821936|FG000|Overall Study|Lost to Follow-up|0|||
156746973|NCT02284568|565821937|FG001|Overall Study|Lost to Follow-up|3|||
156746974|NCT02284568|565821938|FG002|Overall Study|Lost to Follow-up|0|||
156746975|NCT02284568|565821936|FG000|Overall Study|Lack of Efficacy|4|||
156746976|NCT02284568|565821937|FG001|Overall Study|Lack of Efficacy|7|||
156746977|NCT02284568|565821938|FG002|Overall Study|Lack of Efficacy|0|||
156746978|NCT02284568|565821936|FG000|Overall Study|Other|1|||
156746979|NCT02284568|565821937|FG001|Overall Study|Other|2|||
156746980|NCT02284568|565821938|FG002|Overall Study|Other|0|||
156746981|NCT02284568|565821936|FG000|Overall Study|Withdrew before taking study drug|0|||
156746982|NCT02284568|565821937|FG001|Overall Study|Withdrew before taking study drug|1|||
156746983|NCT02284568|565821938|FG002|Overall Study|Withdrew before taking study drug|0|||
156746984|NCT00460265|565821939|FG000|Overall Study|Lost to Follow-up|14|||
156746985|NCT00460265|565821940|FG001|Overall Study|Lost to Follow-up|15|||
156746986|NCT00460265|565821939|FG000|Overall Study|Physician Decision|1|||
156746987|NCT00460265|565821940|FG001|Overall Study|Physician Decision|2|||
156746988|NCT00460265|565821939|FG000|Overall Study|Withdrawal by Subject|10|||
156746989|NCT00460265|565821940|FG001|Overall Study|Withdrawal by Subject|25|||
156746990|NCT00460265|565821939|FG000|Overall Study|Ongoing|60|||
156746991|NCT00460265|565821940|FG001|Overall Study|Ongoing|47|||
156746992|NCT01955109|565821950|FG000|Overall Study|Adverse Event|2|||
156746993|NCT01955109|565821951|FG001|Overall Study|Adverse Event|0|||
156746994|NCT01955109|565821950|FG000|Overall Study|Participant unwilling to continue|35|||
156746995|NCT01955109|565821951|FG001|Overall Study|Participant unwilling to continue|7|||
156746996|NCT01955109|565821950|FG000|Overall Study|Physician Decision|2|||
156746997|NCT01955109|565821951|FG001|Overall Study|Physician Decision|0|||
156746998|NCT01955109|565821950|FG000|Overall Study|Lost to Follow-up|3|||
156746999|NCT01955109|565821951|FG001|Overall Study|Lost to Follow-up|1|||
156747000|NCT01955109|565821950|FG000|Overall Study|Non-compliance|3|||
156747001|NCT01955109|565821951|FG001|Overall Study|Non-compliance|1|||
156747002|NCT00904839|565821952|FG000|Overall Study|Adverse Event|0|||
156747003|NCT00904839|565821953|FG001|Overall Study|Adverse Event|5|||
156747004|NCT00904839|565821954|FG002|Overall Study|Adverse Event|4|||
156747005|NCT00904839|565821952|FG000|Overall Study|Protocol Violation|0|||
156747006|NCT00904839|565821953|FG001|Overall Study|Protocol Violation|1|||
156747007|NCT00904839|565821954|FG002|Overall Study|Protocol Violation|1|||
156747008|NCT00904839|565821952|FG000|Overall Study|Lost to Follow-up|0|||
156747009|NCT00904839|565821953|FG001|Overall Study|Lost to Follow-up|1|||
156747010|NCT00904839|565821954|FG002|Overall Study|Lost to Follow-up|2|||
156747011|NCT00904839|565821952|FG000|Overall Study|Withdrawal by Subject|0|||
156747012|NCT00904839|565821953|FG001|Overall Study|Withdrawal by Subject|2|||
156747013|NCT00904839|565821954|FG002|Overall Study|Withdrawal by Subject|0|||
156747014|NCT00904839|565821952|FG000|Overall Study|Not treated|1|||
156747015|NCT00904839|565821953|FG001|Overall Study|Not treated|0|||
156747016|NCT00904839|565821954|FG002|Overall Study|Not treated|1|||
156747017|NCT00904839|565821952|FG000|Overall Study|Other than above|0|||
156747018|NCT00904839|565821953|FG001|Overall Study|Other than above|9|||
156747019|NCT00904839|565821954|FG002|Overall Study|Other than above|7|||
156747020|NCT01853696|565821961|FG000|Overall Study|Withdrawal by Subject|1|||
156747021|NCT01853696|565821962|FG001|Overall Study|Withdrawal by Subject|1|||
156747022|NCT01853696|565821961|FG000|Overall Study|Lost to Follow-up|5|||
156747023|NCT01853696|565821962|FG001|Overall Study|Lost to Follow-up|4|||
156747024|NCT00553358|565821963|FG000|Overall Study|Randomized but did not receive treatment|3|||
156747025|NCT00553358|565821964|FG001|Overall Study|Randomized but did not receive treatment|3|||
156747026|NCT00553358|565821965|FG002|Overall Study|Randomized but did not receive treatment|1|||
156747027|NCT00553358|565821963|FG000|Overall Study|Lost to Follow-up|22|||
156747028|NCT00553358|565821964|FG001|Overall Study|Lost to Follow-up|26|||
156747029|NCT00553358|565821965|FG002|Overall Study|Lost to Follow-up|18|||
156747030|NCT00553358|565821963|FG000|Overall Study|Withdrew completely|23|||
156747031|NCT00553358|565821964|FG001|Overall Study|Withdrew completely|33|||
156747032|NCT00553358|565821965|FG002|Overall Study|Withdrew completely|34|||
156747033|NCT00553358|565821963|FG000|Overall Study|Died during clinical follow-up|25|||
156747034|NCT00553358|565821964|FG001|Overall Study|Died during clinical follow-up|29|||
156747035|NCT00553358|565821965|FG002|Overall Study|Died during clinical follow-up|32|||
156747036|NCT00553358|565821963|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
156747037|NCT00553358|565821964|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
156747038|NCT00553358|565821965|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
156747039|NCT00553358|565821963|FG000|Overall Study|Died after clinical follow-up ended|1|||
156747040|NCT00553358|565821964|FG001|Overall Study|Died after clinical follow-up ended|2|||
156747041|NCT00553358|565821965|FG002|Overall Study|Died after clinical follow-up ended|0|||
156747042|NCT00553358|565821963|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
156747043|NCT00553358|565821964|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
156747044|NCT00553358|565821965|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
156747045|NCT01832818|565821966|FG000|Overall Study|Lost to Follow-up|6|||
156747046|NCT00236899|565821967|FG000|Overall Study|Adverse Event (Study Related)|1|||
156747047|NCT00236899|565821968|FG001|Overall Study|Adverse Event (Study Related)|1|||
156747048|NCT00236899|565821969|FG002|Overall Study|Adverse Event (Study Related)|2|||
156747049|NCT00236899|565821970|FG003|Overall Study|Adverse Event (Study Related)|1|||
156747050|NCT00236899|565821967|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
156747051|NCT00236899|565821968|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
156747052|NCT00236899|565821969|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
156747053|NCT00236899|565821970|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
156747054|NCT00236899|565821967|FG000|Overall Study|Death (Study Disease)|1|||
156747055|NCT00236899|565821968|FG001|Overall Study|Death (Study Disease)|4|||
156747056|NCT00236899|565821969|FG002|Overall Study|Death (Study Disease)|0|||
156747057|NCT00236899|565821970|FG003|Overall Study|Death (Study Disease)|0|||
156747058|NCT00236899|565821967|FG000|Overall Study|Death (Not Study Related)|2|||
156747059|NCT00236899|565821968|FG001|Overall Study|Death (Not Study Related)|0|||
156747060|NCT00236899|565821969|FG002|Overall Study|Death (Not Study Related)|0|||
156747061|NCT00236899|565821970|FG003|Overall Study|Death (Not Study Related)|0|||
156747062|NCT00236899|565821967|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
156747063|NCT00236899|565821968|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
156747064|NCT00236899|565821969|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
156747065|NCT00236899|565821970|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
156747066|NCT00236899|565821967|FG000|Overall Study|Lost to Follow-up|0|||
156747067|NCT00236899|565821968|FG001|Overall Study|Lost to Follow-up|1|||
156747068|NCT00236899|565821969|FG002|Overall Study|Lost to Follow-up|0|||
156747069|NCT00236899|565821970|FG003|Overall Study|Lost to Follow-up|0|||
156747070|NCT00236899|565821967|FG000|Overall Study|Entry Criteria Exclusion|0|||
156747071|NCT00236899|565821968|FG001|Overall Study|Entry Criteria Exclusion|1|||
156747072|NCT00236899|565821969|FG002|Overall Study|Entry Criteria Exclusion|1|||
156747073|NCT00236899|565821970|FG003|Overall Study|Entry Criteria Exclusion|0|||
156747074|NCT00236899|565821967|FG000|Overall Study|Protocol Violation|1|||
156747075|NCT00236899|565821968|FG001|Overall Study|Protocol Violation|0|||
156747076|NCT00236899|565821969|FG002|Overall Study|Protocol Violation|0|||
156747077|NCT00236899|565821970|FG003|Overall Study|Protocol Violation|0|||
156747078|NCT00236899|565821967|FG000|Overall Study|Withdrawal by Subject|6|||
156747079|NCT00236899|565821968|FG001|Overall Study|Withdrawal by Subject|4|||
156747080|NCT00236899|565821969|FG002|Overall Study|Withdrawal by Subject|5|||
156747081|NCT00236899|565821970|FG003|Overall Study|Withdrawal by Subject|2|||
156747082|NCT00236899|565821967|FG000|Overall Study|Physician Decision|7|||
156747083|NCT00236899|565821968|FG001|Overall Study|Physician Decision|8|||
156747084|NCT00236899|565821969|FG002|Overall Study|Physician Decision|7|||
156747085|NCT00236899|565821970|FG003|Overall Study|Physician Decision|6|||
156747086|NCT00236899|565821967|FG000|Overall Study|Satisfactory Response|2|||
156747087|NCT00236899|565821968|FG001|Overall Study|Satisfactory Response|0|||
156747088|NCT00236899|565821969|FG002|Overall Study|Satisfactory Response|0|||
156800035|NCT00419744|566023356|FG000|Overall Study|Randomized in error|9|||
156800036|NCT00419744|566023357|FG001|Overall Study|Randomized in error|6|||
156800037|NCT00419744|566023358|FG002|Overall Study|Randomized in error|7|||
156800038|NCT00419744|566023356|FG000|Overall Study|Moving out of state|2|||
156800039|NCT00419744|566023357|FG001|Overall Study|Moving out of state|0|||
156800040|NCT00419744|566023358|FG002|Overall Study|Moving out of state|1|||
156800041|NCT00419744|566023356|FG000|Overall Study|Physician Decision|10|||
156800042|NCT00419744|566023357|FG001|Overall Study|Physician Decision|5|||
156800043|NCT00419744|566023358|FG002|Overall Study|Physician Decision|6|||
156800044|NCT00419744|566023356|FG000|Overall Study|Spirometry mouthpiece issues|0|||
156800045|NCT00419744|566023357|FG001|Overall Study|Spirometry mouthpiece issues|1|||
156800046|NCT00419744|566023358|FG002|Overall Study|Spirometry mouthpiece issues|2|||
156747089|NCT00236899|565821970|FG003|Overall Study|Satisfactory Response|1|||
156747090|NCT00236899|565821967|FG000|Overall Study|Lack of Efficacy|18|||
156747091|NCT00236899|565821968|FG001|Overall Study|Lack of Efficacy|18|||
156747092|NCT00236899|565821969|FG002|Overall Study|Lack of Efficacy|25|||
156747093|NCT00236899|565821970|FG003|Overall Study|Lack of Efficacy|23|||
156747094|NCT01797094|565821973|FG000|Overall Study|Adverse Event|1|||
156747095|NCT01797094|565821974|FG001|Overall Study|Adverse Event|1|||
156747096|NCT01797094|565821973|FG000|Overall Study|Personal Reasons|4|||
156747097|NCT01797094|565821974|FG001|Overall Study|Personal Reasons|0|||
156747098|NCT01797094|565821973|FG000|Overall Study|Protocol Violation|0|||
156747099|NCT01797094|565821974|FG001|Overall Study|Protocol Violation|1|||
156747100|NCT01797094|565821973|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156747101|NCT01797094|565821974|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156747102|NCT02147067|565821975|FG000|Overall Study|Withdrawal by Subject|2|||
156747103|NCT02147067|565821976|FG001|Overall Study|Withdrawal by Subject|2|||
156747104|NCT02943785|565821977|FG000|Overall Study|Adverse Event|112|||
156747105|NCT02943785|565821978|FG001|Overall Study|Adverse Event|97|||
156747106|NCT02943785|565821977|FG000|Overall Study|Withdrawal by Subject|63|||
156747107|NCT02943785|565821978|FG001|Overall Study|Withdrawal by Subject|126|||
156747108|NCT02943785|565821977|FG000|Overall Study|Physician Decision|23|||
156747109|NCT02943785|565821978|FG001|Overall Study|Physician Decision|47|||
156747110|NCT02943785|565821977|FG000|Overall Study|Death|46|||
156747111|NCT02943785|565821978|FG001|Overall Study|Death|46|||
156747112|NCT02943785|565821977|FG000|Overall Study|Lost to Follow-up|1|||
156747113|NCT02943785|565821978|FG001|Overall Study|Lost to Follow-up|0|||
156747114|NCT02943785|565821977|FG000|Overall Study|Other|16|||
156747115|NCT02943785|565821978|FG001|Overall Study|Other|19|||
156747116|NCT02943785|565821977|FG000|Overall Study|Did not receive any study medication|21|||
156747117|NCT02943785|565821978|FG001|Overall Study|Did not receive any study medication|28|||
156747118|NCT03578146|565821979|FG000|Overall Study|Did Not Receive Treatment|1|||
156747119|NCT03578146|565821980|FG001|Overall Study|Did Not Receive Treatment|0|||
156747120|NCT03578146|565821981|FG002|Overall Study|Did Not Receive Treatment|0|||
156747121|NCT03578146|565821982|FG003|Overall Study|Did Not Receive Treatment|0|||
156747122|NCT03578146|565821983|FG004|Overall Study|Did Not Receive Treatment|0|||
156747123|NCT03578146|565821984|FG005|Overall Study|Did Not Receive Treatment|2|||
156747124|NCT03578146|565821979|FG000|Overall Study|Lost to Follow-up|0|||
156747125|NCT03578146|565821980|FG001|Overall Study|Lost to Follow-up|1|||
156747126|NCT03578146|565821981|FG002|Overall Study|Lost to Follow-up|1|||
156747127|NCT03578146|565821982|FG003|Overall Study|Lost to Follow-up|0|||
156747128|NCT03578146|565821983|FG004|Overall Study|Lost to Follow-up|0|||
156747129|NCT03578146|565821984|FG005|Overall Study|Lost to Follow-up|1|||
156747130|NCT00634049|565821985|FG000|Overall Study|Never received study drug|1|||
156747131|NCT00634049|565821985|FG000|Overall Study|Died prior to receiving study drug|1|||
156747132|NCT00634049|565821985|FG000|Overall Study|Screening failure|1|||
156747133|NCT04395274|565821988|FG000|Overall Study|Lost to Follow-up|20|||
156747134|NCT04395274|565821989|FG001|Overall Study|Lost to Follow-up|11|||
156747135|NCT04395274|565821988|FG000|Overall Study|Withdrawal by Subject|13|||
156747136|NCT04395274|565821989|FG001|Overall Study|Withdrawal by Subject|10|||
156747137|NCT04395274|565821988|FG000|Overall Study|Moved Abroad|0|||
156747138|NCT04395274|565821989|FG001|Overall Study|Moved Abroad|1|||
156747139|NCT02919267|565821991|FG000|Overall Study|Protocol Violation|0|||
156747140|NCT02919267|565821992|FG001|Overall Study|Protocol Violation|3|||
156747141|NCT02919267|565821993|FG002|Overall Study|Protocol Violation|3|||
156747142|NCT02919267|565821994|FG003|Overall Study|Protocol Violation|4|||
156747143|NCT04438499|565821997|FG000|Overall Study|Lack of Efficacy|3|||
156747144|NCT00642954|565823873|FG000|Overall Study|Progressive Disease|3|||
156747145|NCT00642954|565823874|FG001|Overall Study|Progressive Disease|3|||
156747146|NCT00642954|565823875|FG002|Overall Study|Progressive Disease|3|||
156747147|NCT00642954|565823876|FG003|Overall Study|Progressive Disease|3|||
156747148|NCT00642954|565823877|FG004|Overall Study|Progressive Disease|9|||
156747149|NCT00642954|565823873|FG000|Overall Study|Withdrawal by Subject|0|||
156747150|NCT00642954|565823874|FG001|Overall Study|Withdrawal by Subject|0|||
156747151|NCT00642954|565823875|FG002|Overall Study|Withdrawal by Subject|0|||
156747152|NCT00642954|565823876|FG003|Overall Study|Withdrawal by Subject|0|||
156747153|NCT00642954|565823877|FG004|Overall Study|Withdrawal by Subject|1|||
156747154|NCT00642954|565823873|FG000|Overall Study|Adverse Event|1|||
156747155|NCT00642954|565823874|FG001|Overall Study|Adverse Event|1|||
156747156|NCT00642954|565823875|FG002|Overall Study|Adverse Event|0|||
156747157|NCT00642954|565823876|FG003|Overall Study|Adverse Event|0|||
156747158|NCT00642954|565823877|FG004|Overall Study|Adverse Event|6|||
156747159|NCT01317004|565823878|FG000|Overall Study|Withdrawal by Subject|1|||
156747160|NCT01317004|565823879|FG001|Overall Study|Withdrawal by Subject|4|||
156747161|NCT01317004|565823878|FG000|Overall Study|Protocol Violation|0|||
156747162|NCT01317004|565823879|FG001|Overall Study|Protocol Violation|2|||
156747163|NCT01317004|565823878|FG000|Overall Study|Adverse Event|3|||
156747164|NCT01317004|565823879|FG001|Overall Study|Adverse Event|3|||
156747165|NCT01890759|565823880|FG000|Overall Study|Protocol Violation|0|||
156747166|NCT01890759|565823881|FG001|Overall Study|Protocol Violation|2|||
156747167|NCT01890759|565823880|FG000|Overall Study|Lost to Follow-up|0|||
156747168|NCT01890759|565823881|FG001|Overall Study|Lost to Follow-up|2|||
156747169|NCT01890759|565823880|FG000|Overall Study|Withdrawal by Subject|2|||
156747170|NCT01890759|565823881|FG001|Overall Study|Withdrawal by Subject|8|||
156747171|NCT01344759|565823882|FG000|Overall Study|Patients failed to reach sedation level|0|||
156747172|NCT01344759|565823883|FG001|Overall Study|Patients failed to reach sedation level|2|||
156747173|NCT02732015|565823884|FG000|Overall Study|Lost to Follow-up|0|||
156747174|NCT02732015|565823885|FG001|Overall Study|Lost to Follow-up|1|||
156747175|NCT01980628|565823886|FG000|Overall Study|Adverse Event|12|||
156747176|NCT01980628|565823886|FG000|Overall Study|Physician Decision|5|||
156747177|NCT01980628|565823886|FG000|Overall Study|Withdrawal by Subject|4|||
156747178|NCT01980628|565823886|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
156747179|NCT05437640|565823889|FG000|Washout (1 Week)|Adverse Event|1|||
156747180|NCT05437640|565823890|FG001|Washout (1 Week)|Adverse Event|0|||
156747181|NCT02474355|565823891|FG000|Overall Study|Other|43|||
156747182|NCT02474355|565823891|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
156747183|NCT02474355|565823891|FG000|Overall Study|Lost to Follow-up|98|||
156747184|NCT02474355|565823891|FG000|Overall Study|Withdrawal by Subject|124|||
156747185|NCT02474355|565823891|FG000|Overall Study|Death|1361|||
156747186|NCT03015194|565823893|FG000|Overall Study|Death|10|||
156747187|NCT03015194|565823893|FG000|Overall Study|Withdrawal by Subject|2|||
156747188|NCT01937715|565823897|FG000|Overall Study|Death|0|||
156747189|NCT01937715|565823898|FG001|Overall Study|Death|0|||
156747190|NCT01937715|565823899|FG002|Overall Study|Death|0|||
156747191|NCT01937715|565823900|FG003|Overall Study|Death|1|||
156747192|NCT01937715|565823901|FG004|Overall Study|Death|0|||
156747193|NCT01937715|565823897|FG000|Overall Study|Withdrawal by Subject|0|||
156747194|NCT01937715|565823898|FG001|Overall Study|Withdrawal by Subject|1|||
156747195|NCT01937715|565823899|FG002|Overall Study|Withdrawal by Subject|0|||
156747196|NCT01937715|565823900|FG003|Overall Study|Withdrawal by Subject|0|||
156747197|NCT01937715|565823901|FG004|Overall Study|Withdrawal by Subject|2|||
156747198|NCT01937715|565823897|FG000|Overall Study|Other|0|||
156747199|NCT01937715|565823898|FG001|Overall Study|Other|0|||
156747200|NCT01937715|565823899|FG002|Overall Study|Other|0|||
156747201|NCT01937715|565823900|FG003|Overall Study|Other|3|||
156747202|NCT01937715|565823901|FG004|Overall Study|Other|0|||
156747203|NCT00433017|565823904|FG000|Overall Study|Adverse Event|5|||
156747204|NCT00433017|565823905|FG001|Overall Study|Adverse Event|3|||
156747205|NCT00433017|565823904|FG000|Overall Study|Withdrawal by Subject|4|||
156747206|NCT00433017|565823905|FG001|Overall Study|Withdrawal by Subject|5|||
156747207|NCT00433017|565823904|FG000|Overall Study|Lost to Follow-up|3|||
156747208|NCT00433017|565823905|FG001|Overall Study|Lost to Follow-up|4|||
156747209|NCT00433017|565823904|FG000|Overall Study|Administrative problems|80|||
156747210|NCT00433017|565823905|FG001|Overall Study|Administrative problems|86|||
156747211|NCT00433017|565823904|FG000|Overall Study|Protocol Violation|1|||
156747212|NCT00433017|565823905|FG001|Overall Study|Protocol Violation|0|||
156747213|NCT00433017|565823904|FG000|Overall Study|Death|2|||
156747214|NCT00433017|565823905|FG001|Overall Study|Death|2|||
156747215|NCT00433017|565823904|FG000|Overall Study|Subject no longer requires study drug|1|||
156747216|NCT00433017|565823905|FG001|Overall Study|Subject no longer requires study drug|1|||
156747217|NCT00153816|565823906|FG000|Overall Study|Death|6|||
156747218|NCT00153816|565823907|FG001|Overall Study|Death|5|||
156747219|NCT00153816|565823908|FG002|Overall Study|Death|4|||
156747220|NCT00153816|565823909|FG003|Overall Study|Death|6|||
156747221|NCT00153816|565823910|FG004|Overall Study|Death|0|||
156747222|NCT00153816|565823911|FG005|Overall Study|Death|2|||
156747223|NCT00153816|565823906|FG000|Overall Study|Lost to Follow-up|7|||
156747224|NCT00153816|565823907|FG001|Overall Study|Lost to Follow-up|8|||
156747225|NCT00153816|565823908|FG002|Overall Study|Lost to Follow-up|5|||
156747226|NCT00153816|565823909|FG003|Overall Study|Lost to Follow-up|8|||
156747227|NCT00153816|565823910|FG004|Overall Study|Lost to Follow-up|7|||
156747228|NCT00153816|565823911|FG005|Overall Study|Lost to Follow-up|9|||
156747229|NCT00153816|565823906|FG000|Overall Study|Withdrawal by Subject|9|||
156747230|NCT00153816|565823907|FG001|Overall Study|Withdrawal by Subject|9|||
156747231|NCT00153816|565823908|FG002|Overall Study|Withdrawal by Subject|9|||
156747232|NCT00153816|565823909|FG003|Overall Study|Withdrawal by Subject|4|||
156747233|NCT00153816|565823910|FG004|Overall Study|Withdrawal by Subject|1|||
156800047|NCT00419744|566023356|FG000|Overall Study|Incorrect medication kit dispensed|0|||
156800048|NCT00419744|566023357|FG001|Overall Study|Incorrect medication kit dispensed|0|||
156800049|NCT00419744|566023358|FG002|Overall Study|Incorrect medication kit dispensed|1|||
156800050|NCT02448381|566023360|FG000|Overall Study|Adverse Event|2|||
156800051|NCT02448381|566023361|FG001|Overall Study|Adverse Event|0|||
156800052|NCT02448381|566023360|FG000|Overall Study|Lost to Follow-up|16|||
156747234|NCT00153816|565823911|FG005|Overall Study|Withdrawal by Subject|5|||
156747235|NCT00153816|565823906|FG000|Overall Study|Follow-up exam not done|8|||
156747236|NCT00153816|565823907|FG001|Overall Study|Follow-up exam not done|7|||
156747237|NCT00153816|565823908|FG002|Overall Study|Follow-up exam not done|11|||
156747238|NCT00153816|565823909|FG003|Overall Study|Follow-up exam not done|10|||
156747239|NCT00153816|565823910|FG004|Overall Study|Follow-up exam not done|8|||
156747240|NCT00153816|565823911|FG005|Overall Study|Follow-up exam not done|9|||
156747241|NCT00153816|565823906|FG000|Overall Study|Follow-up exam done, histology missing|2|||
156747242|NCT00153816|565823907|FG001|Overall Study|Follow-up exam done, histology missing|3|||
156747243|NCT00153816|565823908|FG002|Overall Study|Follow-up exam done, histology missing|3|||
156800053|NCT02448381|566023361|FG001|Overall Study|Lost to Follow-up|9|||
156747244|NCT00153816|565823909|FG003|Overall Study|Follow-up exam done, histology missing|3|||
156747245|NCT00153816|565823910|FG004|Overall Study|Follow-up exam done, histology missing|1|||
156747246|NCT00153816|565823911|FG005|Overall Study|Follow-up exam done, histology missing|2|||
156747247|NCT01937884|565823914|FG000|Overall Study|Withdrawal by Subject|1|||
156747248|NCT01937884|565823915|FG001|Overall Study|Withdrawal by Subject|0|||
156747249|NCT01167634|565823922|FG000|Overall Study|Lost to Follow-up|1|||
156747250|NCT01167634|565823923|FG001|Overall Study|Lost to Follow-up|3|||
156747251|NCT01167634|565823924|FG002|Overall Study|Lost to Follow-up|3|||
156747252|NCT01167634|565823925|FG003|Overall Study|Lost to Follow-up|4|||
156747253|NCT01167634|565823922|FG000|Overall Study|Withdrawal by Subject|1|||
156747254|NCT01167634|565823923|FG001|Overall Study|Withdrawal by Subject|1|||
156747255|NCT01167634|565823924|FG002|Overall Study|Withdrawal by Subject|0|||
156747256|NCT01167634|565823925|FG003|Overall Study|Withdrawal by Subject|0|||
156747257|NCT00821015|565823930|FG000|Overall Study|Lost to Follow-up|12|||
156747258|NCT01887678|565823936|FG000|Overall Study|Adverse Event|4|||
156747259|NCT01887678|565823937|FG001|Overall Study|Adverse Event|6|||
156747260|NCT01887678|565823936|FG000|Overall Study|Exceeded rescue medication dosage|4|||
156747261|NCT01887678|565823937|FG001|Overall Study|Exceeded rescue medication dosage|5|||
156747262|NCT01887678|565823936|FG000|Overall Study|Withdrawal of consent|3|||
156747263|NCT01887678|565823937|FG001|Overall Study|Withdrawal of consent|4|||
156747264|NCT01887678|565823936|FG000|Overall Study|Lost to Follow-up|4|||
156747265|NCT01887678|565823937|FG001|Overall Study|Lost to Follow-up|2|||
156747266|NCT01887678|565823936|FG000|Overall Study|Deterioration of clinical condition|0|||
156747267|NCT01887678|565823937|FG001|Overall Study|Deterioration of clinical condition|4|||
156747268|NCT01887678|565823936|FG000|Overall Study|Lack of Efficacy|1|||
156747269|NCT01887678|565823937|FG001|Overall Study|Lack of Efficacy|2|||
156747270|NCT01887678|565823936|FG000|Overall Study|Non-compliance|0|||
156747271|NCT01887678|565823937|FG001|Overall Study|Non-compliance|3|||
156747272|NCT01887678|565823936|FG000|Overall Study|Specified|1|||
156747273|NCT01887678|565823937|FG001|Overall Study|Specified|2|||
156747274|NCT03013985|565823938|FG000|Overall Study|Protocol Violation|2|||
156747275|NCT03013985|565823939|FG001|Overall Study|Protocol Violation|2|||
156747276|NCT03013985|565823938|FG000|Overall Study|Withdrawal by Subject|14|||
156747277|NCT03013985|565823939|FG001|Overall Study|Withdrawal by Subject|17|||
156747278|NCT03411902|565823940|FG000|Overall Study|Lost to Follow-up|3|||
156747279|NCT03411902|565823941|FG001|Overall Study|Lost to Follow-up|0|||
156747280|NCT00791492|565823944|FG000|Overall Study|Withdrawal by Subject|1|||
156747281|NCT00791492|565823945|FG001|Overall Study|Withdrawal by Subject|2|||
156747282|NCT00791492|565823944|FG000|Overall Study|Liver transplantation|5|||
156747283|NCT00791492|565823945|FG001|Overall Study|Liver transplantation|1|||
156747284|NCT00076999|565823950|FG000|Overall Study|Adverse Event|2|||
156536715|NCT00766090|565059028|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
156536716|NCT00766090|565059029|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156536717|NCT00766090|565059030|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
156536718|NCT00766090|565059031|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156536719|NCT00766090|565059032|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156536720|NCT00766090|565059033|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156536721|NCT00766090|565059034|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156800054|NCT02448381|566023360|FG000|Overall Study|Physician Decision|1|||
156800055|NCT02448381|566023361|FG001|Overall Study|Physician Decision|1|||
156800056|NCT02448381|566023360|FG000|Overall Study|Pregnancy|1|||
156800057|NCT02448381|566023361|FG001|Overall Study|Pregnancy|0|||
156800058|NCT02448381|566023360|FG000|Overall Study|Withdrawal by Subject|13|||
156800059|NCT02448381|566023361|FG001|Overall Study|Withdrawal by Subject|9|||
156800060|NCT02448381|566023360|FG000|Overall Study|Noncompliance with Study Procedures|2|||
156536722|NCT00766090|565059035|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156536723|NCT00766090|565059036|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156536724|NCT00766090|565059037|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
156536725|NCT00766090|565059038|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
156536726|NCT00766090|565059027|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536727|NCT00766090|565059028|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536728|NCT00766090|565059029|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536729|NCT00766090|565059030|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536730|NCT00766090|565059031|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
156800061|NCT02448381|566023361|FG001|Overall Study|Noncompliance with Study Procedures|0|||
156536731|NCT00766090|565059032|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536732|NCT00766090|565059033|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536733|NCT00766090|565059034|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536734|NCT00766090|565059035|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536735|NCT00766090|565059036|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536736|NCT00766090|565059037|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156747285|NCT00076999|565823951|FG001|Overall Study|Adverse Event|8|||
156747286|NCT00076999|565823952|FG002|Overall Study|Adverse Event|6|||
156747287|NCT00076999|565823953|FG003|Overall Study|Adverse Event|0|||
156800062|NCT00583219|566023362|FG000|Phase 2|Withdrawal by Subject|1|||
156536737|NCT00766090|565059038|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
156536738|NCT03024970|565059044|FG000|First Intervention|Adverse Event|1|||
156536739|NCT03024970|565059045|FG001|First Intervention|Adverse Event|0|||
156536740|NCT03024970|565059044|FG000|Second Intervention|Lost to Follow-up|1|||
156536741|NCT03024970|565059045|FG001|Second Intervention|Lost to Follow-up|0|||
156536742|NCT00131469|565059046|FG000|Overall Study|Withdrawal by Subject|3|||
156536743|NCT00131469|565059047|FG001|Overall Study|Withdrawal by Subject|4|||
156536744|NCT00131469|565059046|FG000|Overall Study|Protocol Violation|3|||
156536745|NCT00131469|565059047|FG001|Overall Study|Protocol Violation|1|||
156747288|NCT00076999|565823954|FG004|Overall Study|Adverse Event|2|||
156536746|NCT00131469|565059046|FG000|Overall Study|Death|0|||
156536747|NCT00131469|565059047|FG001|Overall Study|Death|1|||
156536748|NCT00131469|565059046|FG000|Overall Study|Lost to Follow-up|0|||
156536749|NCT00131469|565059047|FG001|Overall Study|Lost to Follow-up|1|||
156536750|NCT00131469|565059046|FG000|Overall Study|scan not analyzable|3|||
156536751|NCT00131469|565059047|FG001|Overall Study|scan not analyzable|6|||
156536752|NCT00574288|565059048|FG000|Overall Study|Adverse Event|2|||
156536753|NCT00574288|565059049|FG001|Overall Study|Adverse Event|0|||
156536754|NCT00574288|565059050|FG002|Overall Study|Adverse Event|0|||
156536755|NCT00574288|565059051|FG003|Overall Study|Adverse Event|0|||
156536756|NCT00574288|565059052|FG004|Overall Study|Adverse Event|1|||
156536757|NCT00574288|565059053|FG005|Overall Study|Adverse Event|0|||
156536758|NCT00574288|565059054|FG006|Overall Study|Adverse Event|0|||
156536759|NCT00574288|565059048|FG000|Overall Study|Death|0|||
156536760|NCT00574288|565059049|FG001|Overall Study|Death|0|||
156536761|NCT00574288|565059050|FG002|Overall Study|Death|0|||
156536762|NCT00574288|565059051|FG003|Overall Study|Death|0|||
156536763|NCT00574288|565059052|FG004|Overall Study|Death|0|||
156536764|NCT00574288|565059053|FG005|Overall Study|Death|25|||
156536765|NCT00574288|565059054|FG006|Overall Study|Death|21|||
156536766|NCT00574288|565059048|FG000|Overall Study|Lost to Follow-up|0|||
156536767|NCT00574288|565059049|FG001|Overall Study|Lost to Follow-up|0|||
156536768|NCT00574288|565059050|FG002|Overall Study|Lost to Follow-up|0|||
156536769|NCT00574288|565059051|FG003|Overall Study|Lost to Follow-up|0|||
156536770|NCT00574288|565059052|FG004|Overall Study|Lost to Follow-up|0|||
156536771|NCT00574288|565059053|FG005|Overall Study|Lost to Follow-up|1|||
156536772|NCT00574288|565059054|FG006|Overall Study|Lost to Follow-up|2|||
156536773|NCT00574288|565059048|FG000|Overall Study|Study Terminated By Sponsor|0|||
156536774|NCT00574288|565059049|FG001|Overall Study|Study Terminated By Sponsor|0|||
156536775|NCT00574288|565059050|FG002|Overall Study|Study Terminated By Sponsor|0|||
156536776|NCT00574288|565059051|FG003|Overall Study|Study Terminated By Sponsor|0|||
156536777|NCT00574288|565059052|FG004|Overall Study|Study Terminated By Sponsor|0|||
156536778|NCT00574288|565059053|FG005|Overall Study|Study Terminated By Sponsor|0|||
156536779|NCT00574288|565059054|FG006|Overall Study|Study Terminated By Sponsor|5|||
156536780|NCT00574288|565059048|FG000|Overall Study|Progressive Disease|17|||
156536781|NCT00574288|565059049|FG001|Overall Study|Progressive Disease|2|||
156536782|NCT00574288|565059050|FG002|Overall Study|Progressive Disease|3|||
156536783|NCT00574288|565059051|FG003|Overall Study|Progressive Disease|2|||
156536784|NCT00574288|565059052|FG004|Overall Study|Progressive Disease|1|||
156536785|NCT00574288|565059053|FG005|Overall Study|Progressive Disease|0|||
156536786|NCT00574288|565059054|FG006|Overall Study|Progressive Disease|0|||
156536787|NCT00574288|565059048|FG000|Overall Study|Other|1|||
156536788|NCT00574288|565059049|FG001|Overall Study|Other|1|||
156536789|NCT00574288|565059050|FG002|Overall Study|Other|0|||
156536790|NCT00574288|565059051|FG003|Overall Study|Other|0|||
156536791|NCT00574288|565059052|FG004|Overall Study|Other|0|||
156536792|NCT00574288|565059053|FG005|Overall Study|Other|0|||
156536793|NCT00574288|565059054|FG006|Overall Study|Other|0|||
156536794|NCT01106027|565059055|FG000|Overall Study|Lost graft early, discontinued|1|||
156536795|NCT00356889|565059057|FG000|Overall Study|Protocol Violation|2|||
156536796|NCT00356889|565059057|FG000|Overall Study|Adverse Event|1|||
156536797|NCT02678416|565059058|FG000|Part 1|Withdrawal by Subject|1|||
156536798|NCT02678416|565059058|FG000|Part 2|Adverse Event|2|||
156536799|NCT02678416|565059058|FG000|Part 2|Withdrawal by Subject|1|||
156536800|NCT01910116|565059063|FG000|Overall Study|Adverse Event|0|||
156536801|NCT01910116|565059064|FG001|Overall Study|Adverse Event|3|||
156536802|NCT01910116|565059063|FG000|Overall Study|Lack of Efficacy|3|||
156536803|NCT01910116|565059064|FG001|Overall Study|Lack of Efficacy|4|||
156747289|NCT00076999|565823950|FG000|Overall Study|Protocol Violation|0|||
156747290|NCT00076999|565823951|FG001|Overall Study|Protocol Violation|3|||
156747291|NCT00076999|565823952|FG002|Overall Study|Protocol Violation|4|||
156747292|NCT00076999|565823953|FG003|Overall Study|Protocol Violation|0|||
156536804|NCT01910116|565059063|FG000|Overall Study|Lost to Follow-up|1|||
156536805|NCT01910116|565059064|FG001|Overall Study|Lost to Follow-up|0|||
156536806|NCT01910116|565059063|FG000|Overall Study|Protocol Violation|1|||
156536807|NCT01910116|565059064|FG001|Overall Study|Protocol Violation|2|||
156536808|NCT01910116|565059063|FG000|Overall Study|Withdrawal by Subject|8|||
156747293|NCT00076999|565823954|FG004|Overall Study|Protocol Violation|9|||
156536809|NCT01910116|565059064|FG001|Overall Study|Withdrawal by Subject|3|||
156536810|NCT01910116|565059063|FG000|Overall Study|uncertain allocation|1|||
156536811|NCT01910116|565059064|FG001|Overall Study|uncertain allocation|3|||
156747294|NCT00076999|565823950|FG000|Overall Study|Lost to Follow-up|2|||
156747295|NCT00076999|565823951|FG001|Overall Study|Lost to Follow-up|1|||
156747296|NCT00076999|565823952|FG002|Overall Study|Lost to Follow-up|0|||
156747297|NCT00076999|565823953|FG003|Overall Study|Lost to Follow-up|0|||
156747298|NCT00076999|565823954|FG004|Overall Study|Lost to Follow-up|0|||
156747299|NCT00076999|565823950|FG000|Overall Study|Withdrawal by Subject|0|||
156747300|NCT00076999|565823951|FG001|Overall Study|Withdrawal by Subject|4|||
156747301|NCT00076999|565823952|FG002|Overall Study|Withdrawal by Subject|3|||
156747302|NCT00076999|565823953|FG003|Overall Study|Withdrawal by Subject|0|||
156747303|NCT00076999|565823954|FG004|Overall Study|Withdrawal by Subject|1|||
156747304|NCT00076999|565823950|FG000|Overall Study|Other reason (not specified)|8|||
156747305|NCT00076999|565823951|FG001|Overall Study|Other reason (not specified)|8|||
156747306|NCT00076999|565823952|FG002|Overall Study|Other reason (not specified)|4|||
156747307|NCT00076999|565823953|FG003|Overall Study|Other reason (not specified)|1|||
156747308|NCT00076999|565823954|FG004|Overall Study|Other reason (not specified)|13|||
156747309|NCT01217385|565823957|FG000|Overall Study|Withdrawal by Subject|3|||
156747310|NCT01217385|565823957|FG000|Overall Study|DOSI not performed/not eval|12|||
156747311|NCT01217385|565823957|FG000|Overall Study|Central Path not Available|1|||
156747312|NCT01217385|565823957|FG000|Overall Study|Normal Breast TOI not available|10|||
156747313|NCT00090987|565823958|FG000|Overall Study|Adverse Event|5|||
156747314|NCT00090987|565823958|FG000|Overall Study|Lack of Efficacy|7|||
156747315|NCT00090987|565823958|FG000|Overall Study|Withdrawal by Subject|3|||
156747316|NCT00090987|565823958|FG000|Overall Study|alternative therapy|1|||
156747317|NCT00090987|565823958|FG000|Overall Study|Non-compliance|4|||
156747318|NCT00090987|565823958|FG000|Overall Study|Incarcerated|1|||
156747319|NCT00990665|565823963|FG000|Overall Study|Unsuccessful Implant|8|||
156747320|NCT00990665|565823963|FG000|Overall Study|Death|29|||
156747321|NCT00990665|565823963|FG000|Overall Study|Heart Transplant|1|||
156747322|NCT00990665|565823963|FG000|Overall Study|Withdrawal by Subject|6|||
156747323|NCT00990665|565823963|FG000|Overall Study|Lost to Follow-up|1|||
156747324|NCT00990665|565823963|FG000|Overall Study|System Explant|3|||
156747325|NCT02603562|565823964|FG000|Overall Study|Lost to Follow-up|1|||
156747326|NCT00270231|565823965|FG000|First Intervention|Lost to Follow-up|1|||
156747327|NCT00270231|565823966|FG001|First Intervention|Lost to Follow-up|1|||
156747328|NCT00270231|565823965|FG000|Washout Period|Lost to Follow-up|1|||
156747329|NCT00270231|565823966|FG001|Washout Period|Lost to Follow-up|0|||
156747330|NCT00270231|565823965|FG000|Second Intervention|Lost to Follow-up|0|||
156747331|NCT00270231|565823966|FG001|Second Intervention|Lost to Follow-up|1|||
156747332|NCT01534208|565823971|FG000|Overall Study|Lost to Follow-up|19|||
156747333|NCT01534208|565823972|FG001|Overall Study|Lost to Follow-up|14|||
156747334|NCT01534208|565823971|FG000|Overall Study|Withdrawal by Subject|6|||
156747335|NCT01534208|565823972|FG001|Overall Study|Withdrawal by Subject|20|||
156747336|NCT01534208|565823971|FG000|Overall Study|Adverse Event|15|||
156747337|NCT01534208|565823972|FG001|Overall Study|Adverse Event|8|||
156747338|NCT01534208|565823971|FG000|Overall Study|Physician Decision|2|||
156747339|NCT01534208|565823972|FG001|Overall Study|Physician Decision|0|||
156747340|NCT01534208|565823971|FG000|Overall Study|Lack of Efficacy|0|||
156747341|NCT01534208|565823972|FG001|Overall Study|Lack of Efficacy|3|||
156747342|NCT01534208|565823971|FG000|Overall Study|Protocol Violation|2|||
156747343|NCT01534208|565823972|FG001|Overall Study|Protocol Violation|2|||
156747344|NCT01534208|565823971|FG000|Overall Study|Sponsor decision|4|||
156747345|NCT01534208|565823972|FG001|Overall Study|Sponsor decision|1|||
156747346|NCT01534208|565823971|FG000|Overall Study|Subject relocation|2|||
156747347|NCT01534208|565823972|FG001|Overall Study|Subject relocation|0|||
156747348|NCT01534208|565823971|FG000|Overall Study|Lab assessment|2|||
156747349|NCT01534208|565823972|FG001|Overall Study|Lab assessment|1|||
156747350|NCT01534208|565823971|FG000|Overall Study|Eligibility error|3|||
156800063|NCT02037529|566023363|FG000|Overall Study|Withdrawal by Subject|1|||
156800064|NCT02037529|566023364|FG001|Overall Study|Withdrawal by Subject|3|||
156800065|NCT02037529|566023363|FG000|Overall Study|Adverse Event|0|||
156800066|NCT02037529|566023364|FG001|Overall Study|Adverse Event|1|||
156800067|NCT02131766|566023365|FG000|Overall Study|Withdrawal by Subject|4|||
156800068|NCT00754572|566023366|FG000|Overall Study|Adverse Event|19|||
156800069|NCT00754572|566023366|FG000|Overall Study|Other|39|||
156747351|NCT01534208|565823972|FG001|Overall Study|Eligibility error|0|||
156800070|NCT00754572|566023366|FG000|Overall Study|Protocol Violation|3|||
156536812|NCT01910116|565059063|FG000|Overall Study|incomplete data|0|||
156747352|NCT01534208|565823971|FG000|Overall Study|PCP decision|1|||
156747353|NCT01534208|565823972|FG001|Overall Study|PCP decision|0|||
156747354|NCT01534208|565823971|FG000|Overall Study|Needed prohibited meds|1|||
156747355|NCT01534208|565823972|FG001|Overall Study|Needed prohibited meds|0|||
156747356|NCT02117713|565823983|FG000|Week 48|Adverse Event|4|||
156747357|NCT02117713|565823983|FG000|Week 48|Withdrawal by caregiver|2|||
156747358|NCT02117713|565823983|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
156747359|NCT02117713|565823983|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
156747360|NCT02117713|565823983|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
156747361|NCT02117713|565823983|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
156800071|NCT00754572|566023366|FG000|Overall Study|Withdrawal by Subject|3|||
156800072|NCT00754572|566023366|FG000|Overall Study|Lack of Efficacy|2|||
156800073|NCT00754572|566023366|FG000|Overall Study|Death|1|||
156800074|NCT00754572|566023366|FG000|Overall Study|Administrative Reason|3|||
156800075|NCT00754572|566023366|FG000|Overall Study|Lost to Follow-up|1|||
156800076|NCT00718315|566023368|FG000|Overall Study|Adverse Event|1|||
156800077|NCT00718315|566023369|FG001|Overall Study|Adverse Event|2|||
156800078|NCT00718315|566023370|FG002|Overall Study|Adverse Event|3|||
156536813|NCT01910116|565059064|FG001|Overall Study|incomplete data|1|||
156747362|NCT00574795|565823984|FG000|Infant Series|Withdrawal by Subject|2|||
156747363|NCT00574795|565823984|FG000|Infant Series|Protocol Violation|2|||
156747364|NCT00574795|565823984|FG000|Infant Series|Adverse Event|1|||
156747365|NCT00574795|565823984|FG000|After Infant Series|Withdrawal by Subject|1|||
156747366|NCT00574795|565823984|FG000|After Infant Series|Adverse Event|2|||
156747367|NCT00574795|565823984|FG000|Toddler Dose|Withdrawal by Subject|1|||
156747368|NCT00672841|565823985|FG000|Overall Study|Comfort care|1|||
156747369|NCT00672841|565823986|FG001|Overall Study|Comfort care|4|||
156747370|NCT00672841|565823985|FG000|Overall Study|icteric specimens|0|||
156747371|NCT00672841|565823986|FG001|Overall Study|icteric specimens|3|||
156747372|NCT00672841|565823985|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
156747373|NCT00672841|565823986|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
156747374|NCT00672841|565823985|FG000|Overall Study|Adverse Event|0|||
156747375|NCT00672841|565823986|FG001|Overall Study|Adverse Event|3|||
156747376|NCT00672841|565823985|FG000|Overall Study|Pregnancy|0|||
156747377|NCT00672841|565823986|FG001|Overall Study|Pregnancy|1|||
156747378|NCT02638259|565823987|FG000|Treatment Period 1|Adverse Event|1|||
156747379|NCT02638259|565823988|FG001|Treatment Period 1|Adverse Event|5|||
156747380|NCT02638259|565823987|FG000|Treatment Period 1|Death|0|||
156747381|NCT02638259|565823988|FG001|Treatment Period 1|Death|1|||
156747382|NCT02638259|565823987|FG000|Treatment Period 1|Lack of Efficacy|0|||
156747383|NCT02638259|565823988|FG001|Treatment Period 1|Lack of Efficacy|1|||
156747384|NCT02638259|565823987|FG000|Treatment Period 1|Protocol Violation|0|||
156747385|NCT02638259|565823988|FG001|Treatment Period 1|Protocol Violation|3|||
156747386|NCT02638259|565823987|FG000|Treatment Period 1|Withdrawal by Subject|4|||
156747387|NCT02638259|565823988|FG001|Treatment Period 1|Withdrawal by Subject|6|||
156747388|NCT02638259|565823987|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
156747389|NCT02638259|565823988|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
156747390|NCT02638259|565823987|FG000|Treatment Period 2|Adverse Event|5|||
156747391|NCT02638259|565823988|FG001|Treatment Period 2|Adverse Event|4|||
156747392|NCT02638259|565823987|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156747393|NCT02638259|565823988|FG001|Treatment Period 2|Withdrawal by Subject|7|||
156747394|NCT04299048|565823989|FG000|Overall Study|Death|1|||
156747395|NCT04299048|565823989|FG000|Overall Study|Global deterioration of health status|2|||
156747396|NCT04299048|565823989|FG000|Overall Study|Enrolled and not treated|1|||
156747397|NCT01094782|565823991|FG000|Overall Study|Withdrawal by Subject|5|||
156747398|NCT01094782|565823992|FG001|Overall Study|Withdrawal by Subject|5|||
156747399|NCT01094782|565823993|FG002|Overall Study|Withdrawal by Subject|1|||
156747400|NCT01094782|565823994|FG003|Overall Study|Withdrawal by Subject|5|||
156747401|NCT01094782|565823995|FG004|Overall Study|Withdrawal by Subject|5|||
156747402|NCT01094782|565823996|FG005|Overall Study|Withdrawal by Subject|0|||
156747403|NCT01094782|565823991|FG000|Overall Study|Lost to Follow-up|1|||
156747404|NCT01094782|565823992|FG001|Overall Study|Lost to Follow-up|0|||
156747405|NCT01094782|565823993|FG002|Overall Study|Lost to Follow-up|0|||
156747406|NCT01094782|565823994|FG003|Overall Study|Lost to Follow-up|2|||
156747407|NCT01094782|565823995|FG004|Overall Study|Lost to Follow-up|1|||
156747408|NCT01094782|565823996|FG005|Overall Study|Lost to Follow-up|4|||
156747409|NCT01094782|565823991|FG000|Overall Study|Positive Drug Screen|2|||
156747410|NCT01094782|565823992|FG001|Overall Study|Positive Drug Screen|2|||
156747411|NCT01094782|565823993|FG002|Overall Study|Positive Drug Screen|1|||
156747412|NCT01094782|565823994|FG003|Overall Study|Positive Drug Screen|1|||
156747413|NCT01094782|565823995|FG004|Overall Study|Positive Drug Screen|3|||
156747414|NCT01094782|565823996|FG005|Overall Study|Positive Drug Screen|2|||
156747415|NCT01094782|565823991|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
156747416|NCT01094782|565823992|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
156747417|NCT01094782|565823993|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
156747418|NCT01094782|565823994|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
156800079|NCT00718315|566023368|FG000|Overall Study|Death|6|||
156747419|NCT01094782|565823995|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
156747420|NCT01094782|565823996|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
156747421|NCT01094782|565823991|FG000|Overall Study|Unable to Complete Questionnaires|0|||
156747422|NCT01094782|565823992|FG001|Overall Study|Unable to Complete Questionnaires|1|||
156747423|NCT01094782|565823993|FG002|Overall Study|Unable to Complete Questionnaires|0|||
156747424|NCT01094782|565823994|FG003|Overall Study|Unable to Complete Questionnaires|0|||
156747425|NCT01094782|565823995|FG004|Overall Study|Unable to Complete Questionnaires|0|||
156747426|NCT01094782|565823996|FG005|Overall Study|Unable to Complete Questionnaires|0|||
156747427|NCT01094782|565823991|FG000|Overall Study|Healthy Subject Had Pain|0|||
156747428|NCT01094782|565823992|FG001|Overall Study|Healthy Subject Had Pain|1|||
156800080|NCT00718315|566023369|FG001|Overall Study|Death|6|||
156459129|NCT02240238|564776702|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156747429|NCT01094782|565823993|FG002|Overall Study|Healthy Subject Had Pain|0|||
156747430|NCT01094782|565823994|FG003|Overall Study|Healthy Subject Had Pain|0|||
156747431|NCT01094782|565823995|FG004|Overall Study|Healthy Subject Had Pain|0|||
156747432|NCT01094782|565823996|FG005|Overall Study|Healthy Subject Had Pain|0|||
156747433|NCT01094782|565823991|FG000|Overall Study|Hypertension|0|||
156747434|NCT01094782|565823992|FG001|Overall Study|Hypertension|0|||
156747435|NCT01094782|565823993|FG002|Overall Study|Hypertension|1|||
156747436|NCT01094782|565823994|FG003|Overall Study|Hypertension|0|||
156747437|NCT01094782|565823995|FG004|Overall Study|Hypertension|0|||
156747438|NCT01094782|565823996|FG005|Overall Study|Hypertension|0|||
156747439|NCT01094782|565823991|FG000|Overall Study|Wrong Pain Condition|0|||
156747440|NCT01094782|565823992|FG001|Overall Study|Wrong Pain Condition|0|||
156747441|NCT01094782|565823993|FG002|Overall Study|Wrong Pain Condition|0|||
156747442|NCT01094782|565823994|FG003|Overall Study|Wrong Pain Condition|2|||
156747443|NCT01094782|565823995|FG004|Overall Study|Wrong Pain Condition|1|||
156747444|NCT01094782|565823996|FG005|Overall Study|Wrong Pain Condition|1|||
156747445|NCT01094782|565823991|FG000|Overall Study|Recent Interventional Injection|0|||
156747446|NCT01094782|565823992|FG001|Overall Study|Recent Interventional Injection|0|||
156747447|NCT01094782|565823993|FG002|Overall Study|Recent Interventional Injection|0|||
156747448|NCT01094782|565823994|FG003|Overall Study|Recent Interventional Injection|0|||
156747449|NCT01094782|565823995|FG004|Overall Study|Recent Interventional Injection|0|||
156747450|NCT01094782|565823996|FG005|Overall Study|Recent Interventional Injection|1|||
156747451|NCT01094782|565823991|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747452|NCT01094782|565823992|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747453|NCT01094782|565823993|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747454|NCT01094782|565823994|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747455|NCT01094782|565823995|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
156747456|NCT01094782|565823996|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747457|NCT01094782|565823991|FG000|Overall Study|Noncompliance With Study Schedule|0|||
156747458|NCT01094782|565823992|FG001|Overall Study|Noncompliance With Study Schedule|0|||
156747459|NCT01094782|565823993|FG002|Overall Study|Noncompliance With Study Schedule|0|||
156747460|NCT01094782|565823994|FG003|Overall Study|Noncompliance With Study Schedule|1|||
156747461|NCT01094782|565823995|FG004|Overall Study|Noncompliance With Study Schedule|0|||
156747462|NCT01094782|565823996|FG005|Overall Study|Noncompliance With Study Schedule|0|||
156747463|NCT01717391|565823999|FG000|Overall Study|Withdrawal by Subject|5|||
156747464|NCT01717391|565823999|FG000|Overall Study|Physician Decision|1|||
156747465|NCT01717391|565823999|FG000|Overall Study|FLT technical failure|3|||
156747466|NCT00957905|565824000|FG000|Part B|Not Treated|0|||
156747467|NCT00957905|565824001|FG001|Part B|Not Treated|1|||
156747468|NCT00957905|565824000|FG000|Part B|Physician Decision|0|||
156747469|NCT00957905|565824001|FG001|Part B|Physician Decision|1|||
156747470|NCT00957905|565824000|FG000|Part B|Death|0|||
156747471|NCT00957905|565824001|FG001|Part B|Death|1|||
156747472|NCT00957905|565824000|FG000|Part B|Protocol Violation|0|||
156747473|NCT00957905|565824001|FG001|Part B|Protocol Violation|1|||
156747474|NCT03434249|565824004|FG000|Overall Study|Adverse Event|1|||
156747475|NCT03434249|565824005|FG001|Overall Study|Adverse Event|0|||
156747476|NCT03434249|565824004|FG000|Overall Study|Lost to Follow-up|0|||
156747477|NCT03434249|565824005|FG001|Overall Study|Lost to Follow-up|1|||
156747478|NCT03434249|565824004|FG000|Overall Study|Non-compliance of family|2|||
156747479|NCT03434249|565824005|FG001|Overall Study|Non-compliance of family|1|||
156747480|NCT03434249|565824004|FG000|Overall Study|Difficulties in completing daily diary|2|||
156747481|NCT03434249|565824005|FG001|Overall Study|Difficulties in completing daily diary|1|||
156747482|NCT02450552|565824006|FG000|Overall Study|Withdrawal by Subject|4|||
156747483|NCT02450552|565824007|FG001|Overall Study|Withdrawal by Subject|0|||
156747484|NCT02450552|565824008|FG002|Overall Study|Withdrawal by Subject|4|||
156747485|NCT02450552|565824006|FG000|Overall Study|Physician Decision|1|||
156747486|NCT02450552|565824007|FG001|Overall Study|Physician Decision|0|||
156459130|NCT02240238|564776703|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
156747487|NCT02450552|565824008|FG002|Overall Study|Physician Decision|1|||
156747488|NCT01969084|565824012|FG000|Overall Study|Adverse Event|0|||
156747489|NCT01969084|565824013|FG001|Overall Study|Adverse Event|1|||
156747490|NCT05079230|565824014|FG000|Overall Study|Study Terminated by Sponsor|101|||
156747491|NCT05079230|565824015|FG001|Overall Study|Study Terminated by Sponsor|102|||
156747492|NCT05079230|565824014|FG000|Overall Study|Death|72|||
156800081|NCT00718315|566023370|FG002|Overall Study|Death|5|||
156800082|NCT00718315|566023368|FG000|Overall Study|Lost to Follow-up|2|||
156800083|NCT00718315|566023369|FG001|Overall Study|Lost to Follow-up|3|||
156800084|NCT00718315|566023370|FG002|Overall Study|Lost to Follow-up|4|||
156800085|NCT00718315|566023368|FG000|Overall Study|Protocol Violation|5|||
156459131|NCT02240238|564776692|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156800086|NCT00718315|566023369|FG001|Overall Study|Protocol Violation|5|||
156747493|NCT05079230|565824015|FG001|Overall Study|Death|66|||
156747494|NCT05079230|565824014|FG000|Overall Study|Withdrew Consent|16|||
156747495|NCT05079230|565824015|FG001|Overall Study|Withdrew Consent|18|||
156337194|NCT01945281|564333567|FG001|Overall Study|Death|3|||
156337195|NCT01945281|564333566|FG000|Overall Study|Physician Decision|1|||
156747496|NCT05079230|565824014|FG000|Overall Study|Lost to Follow-up|0|||
156747497|NCT05079230|565824015|FG001|Overall Study|Lost to Follow-up|3|||
156747498|NCT02920177|565824016|FG000|Overall Study|Withdrawal by Subject|1|||
156747499|NCT02920177|565824017|FG001|Overall Study|Withdrawal by Subject|1|||
156747500|NCT02920177|565824016|FG000|Overall Study|Physician Decision|1|||
156747501|NCT02920177|565824017|FG001|Overall Study|Physician Decision|0|||
156747502|NCT02920177|565824016|FG000|Overall Study|Lost to Follow-up|0|||
156747503|NCT02920177|565824017|FG001|Overall Study|Lost to Follow-up|1|||
156747504|NCT03164265|565824018|FG000|Overall Study|Physician Decision|3|||
156747505|NCT03053427|565824019|FG000|Overall Study|Adverse Event|4|||
156747506|NCT03053427|565824020|FG001|Overall Study|Adverse Event|4|||
156747507|NCT03053427|565824019|FG000|Overall Study|Lack of Efficacy|1|||
156747508|NCT03053427|565824020|FG001|Overall Study|Lack of Efficacy|3|||
156747509|NCT03053427|565824019|FG000|Overall Study|Lost to Follow-up|2|||
156747510|NCT03053427|565824020|FG001|Overall Study|Lost to Follow-up|2|||
156747511|NCT03053427|565824019|FG000|Overall Study|Worsening of the target disease|0|||
156747512|NCT03053427|565824020|FG001|Overall Study|Worsening of the target disease|1|||
156747513|NCT03053427|565824019|FG000|Overall Study|Protocol Deviation|3|||
156747514|NCT03053427|565824020|FG001|Overall Study|Protocol Deviation|3|||
156747515|NCT03053427|565824019|FG000|Overall Study|Withdrawal by Subject|3|||
156747516|NCT03053427|565824020|FG001|Overall Study|Withdrawal by Subject|2|||
156747517|NCT03053427|565824019|FG000|Overall Study|Miscellaneous|0|||
156747518|NCT03053427|565824020|FG001|Overall Study|Miscellaneous|1|||
156747519|NCT02607306|565824029|FG000|Overall Study|Adverse Event|8|||
156747520|NCT02607306|565824030|FG001|Overall Study|Adverse Event|6|||
156747521|NCT02607306|565824031|FG002|Overall Study|Adverse Event|6|||
156747522|NCT02607306|565824029|FG000|Overall Study|Unclassified|1|||
156747523|NCT02607306|565824030|FG001|Overall Study|Unclassified|4|||
156747524|NCT02607306|565824031|FG002|Overall Study|Unclassified|0|||
156747525|NCT02607306|565824029|FG000|Overall Study|Withdrawal by Subject|8|||
156747526|NCT02607306|565824030|FG001|Overall Study|Withdrawal by Subject|10|||
156747527|NCT02607306|565824031|FG002|Overall Study|Withdrawal by Subject|2|||
156747528|NCT02607306|565824029|FG000|Overall Study|Lack of Efficacy|0|||
156747529|NCT02607306|565824030|FG001|Overall Study|Lack of Efficacy|1|||
156747530|NCT02607306|565824031|FG002|Overall Study|Lack of Efficacy|1|||
156747531|NCT02607306|565824029|FG000|Overall Study|Protocol Violation|4|||
156747532|NCT02607306|565824030|FG001|Overall Study|Protocol Violation|2|||
156747533|NCT02607306|565824031|FG002|Overall Study|Protocol Violation|1|||
156747534|NCT02360475|565824032|FG000|Overall Study|Lost to Follow-up|4|||
156747535|NCT02360475|565824033|FG001|Overall Study|Lost to Follow-up|12|||
156747536|NCT02360475|565824034|FG002|Overall Study|Lost to Follow-up|6|||
156747537|NCT02360475|565824035|FG003|Overall Study|Lost to Follow-up|4|||
156747538|NCT02360475|565824032|FG000|Overall Study|Withdrawal by Subject|0|||
156747539|NCT02360475|565824033|FG001|Overall Study|Withdrawal by Subject|1|||
156747540|NCT02360475|565824034|FG002|Overall Study|Withdrawal by Subject|2|||
156747541|NCT02360475|565824035|FG003|Overall Study|Withdrawal by Subject|0|||
156747542|NCT02360475|565824032|FG000|Overall Study|Migrated/moved from study area|0|||
156747543|NCT02360475|565824033|FG001|Overall Study|Migrated/moved from study area|0|||
156747544|NCT02360475|565824034|FG002|Overall Study|Migrated/moved from study area|0|||
156747545|NCT02360475|565824035|FG003|Overall Study|Migrated/moved from study area|1|||
156747546|NCT03759366|565824037|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
156747547|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
156747548|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
156747549|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
156747550|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
156747551|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
156747552|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
156747553|NCT00539032|565824038|FG000|Overall Study|Withdrawal by Subject|2|||
156747554|NCT00539032|565824039|FG001|Overall Study|Withdrawal by Subject|1|||
156747555|NCT01760447|565825305|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
156747556|NCT01760447|565825306|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
156747557|NCT01760447|565825307|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
156747558|NCT01760447|565825308|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
156747559|NCT01760447|565825305|FG000|Weeks 0-20|Withdrawal by Subject|2|||
156747560|NCT01760447|565825306|FG001|Weeks 0-20|Withdrawal by Subject|0|||
156747561|NCT01760447|565825307|FG002|Weeks 0-20|Withdrawal by Subject|1|||
156747562|NCT01760447|565825308|FG003|Weeks 0-20|Withdrawal by Subject|0|||
156747563|NCT01760447|565825305|FG000|Weeks 0-20|Lost to Follow-up|1|||
156747564|NCT01760447|565825306|FG001|Weeks 0-20|Lost to Follow-up|0|||
156800087|NCT00718315|566023370|FG002|Overall Study|Protocol Violation|3|||
156800088|NCT00718315|566023368|FG000|Overall Study|Erlotinib dose decreased|4|||
156800089|NCT00718315|566023369|FG001|Overall Study|Erlotinib dose decreased|3|||
156337196|NCT01945281|564333567|FG001|Overall Study|Physician Decision|1|||
156337197|NCT01945281|564333566|FG000|Overall Study|Technical Problems|1|||
156800090|NCT00718315|566023370|FG002|Overall Study|Erlotinib dose decreased|1|||
156800091|NCT00718315|566023368|FG000|Overall Study|Use of Minocyclin|1|||
156800092|NCT00718315|566023369|FG001|Overall Study|Use of Minocyclin|1|||
156800093|NCT00718315|566023370|FG002|Overall Study|Use of Minocyclin|1|||
156800094|NCT00718315|566023368|FG000|Overall Study|Disease progression|0|||
156800095|NCT00718315|566023369|FG001|Overall Study|Disease progression|1|||
156800096|NCT00718315|566023370|FG002|Overall Study|Disease progression|1|||
156800097|NCT00718315|566023368|FG000|Overall Study|Other|0|||
156800098|NCT00718315|566023369|FG001|Overall Study|Other|0|||
156800099|NCT00718315|566023370|FG002|Overall Study|Other|1|||
156800100|NCT00718315|566023368|FG000|Overall Study|Use of ATB and Corticoids|0|||
156800101|NCT00718315|566023369|FG001|Overall Study|Use of ATB and Corticoids|1|||
156800102|NCT00718315|566023370|FG002|Overall Study|Use of ATB and Corticoids|2|||
156800103|NCT02271880|566023372|FG000|Overall Study|Premature discontinuation of study|3|||
156800104|NCT02271880|566023373|FG001|Overall Study|Premature discontinuation of study|4|||
156800105|NCT00474903|566023375|FG000|Overall Study|Protocol Violation|1|||
156800106|NCT00474903|566023376|FG001|Overall Study|Protocol Violation|5|||
156800107|NCT00474903|566023377|FG002|Overall Study|Protocol Violation|2|||
156800108|NCT02519842|566023378|FG000|Base Study: Cycle 1|Screening Failure|1|||
156800109|NCT02519842|566023379|FG001|Base Study: Cycle 1|Screening Failure|1|||
156800110|NCT02519842|566023380|FG002|Base Study: Cycle 1|Screening Failure|0|||
156800111|NCT02519842|566023378|FG000|Base Study: Cycle 1|Adverse Event|1|||
156800112|NCT02519842|566023379|FG001|Base Study: Cycle 1|Adverse Event|0|||
156800113|NCT02519842|566023380|FG002|Base Study: Cycle 1|Adverse Event|0|||
156800114|NCT02519842|566023378|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
156800115|NCT02519842|566023379|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
156800116|NCT02519842|566023380|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
156800117|NCT02519842|566023378|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
156800118|NCT02519842|566023379|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
156800119|NCT02519842|566023380|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
156800120|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
156747565|NCT01760447|565825307|FG002|Weeks 0-20|Lost to Follow-up|1|||
156747566|NCT01760447|565825308|FG003|Weeks 0-20|Lost to Follow-up|1|||
156747567|NCT01760447|565825305|FG000|Weeks 0-20|Randomized but not treated|0|||
156337198|NCT01945281|564333567|FG001|Overall Study|Technical Problems|0|||
156337199|NCT00934089|564333568|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
156337200|NCT00934089|564333569|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
156337201|NCT00934089|564333568|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
156337202|NCT00934089|564333569|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
156337203|NCT01434667|564333570|FG000|Overall Study|Lost to Follow-up|5|||
156747568|NCT01760447|565825306|FG001|Weeks 0-20|Randomized but not treated|0|||
156747569|NCT01760447|565825307|FG002|Weeks 0-20|Randomized but not treated|2|||
156747570|NCT01760447|565825308|FG003|Weeks 0-20|Randomized but not treated|0|||
156747571|NCT01760447|565825305|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
156747572|NCT01760447|565825306|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
156747573|NCT01760447|565825307|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
156747574|NCT01760447|565825308|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
156747575|NCT01760447|565825305|FG000|Weeks 20-54|Withdrawal by Subject|2|||
156747576|NCT01760447|565825306|FG001|Weeks 20-54|Withdrawal by Subject|1|||
156747577|NCT01760447|565825307|FG002|Weeks 20-54|Withdrawal by Subject|1|||
156747578|NCT01760447|565825308|FG003|Weeks 20-54|Withdrawal by Subject|2|||
156747579|NCT01760447|565825305|FG000|Weeks 20-54|Lost to Follow-up|0|||
156747580|NCT01760447|565825306|FG001|Weeks 20-54|Lost to Follow-up|0|||
156747581|NCT01760447|565825307|FG002|Weeks 20-54|Lost to Follow-up|1|||
156747582|NCT01760447|565825308|FG003|Weeks 20-54|Lost to Follow-up|2|||
156747583|NCT02636699|565825314|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
156747584|NCT02636699|565825315|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
156747585|NCT02636699|565825316|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
156337204|NCT01434667|564333571|FG001|Overall Study|Lost to Follow-up|10|||
156337205|NCT02165215|564333576|FG000|Induction Phase|Adverse Event|1|||
156747586|NCT02636699|565825314|FG000|Screening Period|Withdrawal by Subject|0|||
156747587|NCT02636699|565825315|FG001|Screening Period|Withdrawal by Subject|0|||
156747588|NCT02636699|565825316|FG002|Screening Period|Withdrawal by Subject|23|||
156747589|NCT02636699|565825314|FG000|Screening Period|Adverse Event|0|||
156747590|NCT02636699|565825315|FG001|Screening Period|Adverse Event|0|||
156747591|NCT02636699|565825316|FG002|Screening Period|Adverse Event|1|||
156747592|NCT02636699|565825314|FG000|Screening Period|Other not specified|0|||
156747593|NCT02636699|565825315|FG001|Screening Period|Other not specified|0|||
156747594|NCT02636699|565825316|FG002|Screening Period|Other not specified|3|||
156747595|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
156747596|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
156747597|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
156747598|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
156747599|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
156747600|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
156337206|NCT02165215|564333577|FG001|Induction Phase|Adverse Event|0|||
156337207|NCT02165215|564333578|FG002|Induction Phase|Adverse Event|0|||
156536814|NCT00736034|565059065|FG000|Overall Study|Adverse Event|2|||
156536815|NCT00911625|565059072|FG000|Overall Study|Lost to Follow-up|7|||
156536816|NCT00911625|565059073|FG001|Overall Study|Lost to Follow-up|0|||
156536817|NCT00590044|565059074|FG000|Overall Study|Withdrawal by Subject|2|||
156536818|NCT00590044|565059075|FG001|Overall Study|Withdrawal by Subject|2|||
156536819|NCT00590044|565059074|FG000|Overall Study|wrong insulin arm assigned|1|||
156536820|NCT00590044|565059075|FG001|Overall Study|wrong insulin arm assigned|0|||
156536821|NCT00590044|565059074|FG000|Overall Study|Protocol Violation|1|||
156536822|NCT00590044|565059075|FG001|Overall Study|Protocol Violation|0|||
156536823|NCT01514136|565059076|FG000|Test Period 1; Test A|Protocol Violation|1|||
156536824|NCT01514136|565059077|FG001|Test Period 1; Test A|Protocol Violation|0|||
156536825|NCT01514136|565059078|FG002|Test Period 1; Test A|Protocol Violation|0|||
156536826|NCT01514136|565059079|FG003|Test Period 1; Test A|Protocol Violation|0|||
156536827|NCT01514136|565059080|FG004|Test Period 1; Test A|Protocol Violation|0|||
156536828|NCT01514136|565059081|FG005|Test Period 1; Test A|Protocol Violation|0|||
156536829|NCT01514136|565059082|FG006|Test Period 1; Test A|Protocol Violation|0|||
156536830|NCT01514136|565059083|FG007|Test Period 1; Test A|Protocol Violation|0|||
156536831|NCT01514136|565059076|FG000|Test Period 1; Test A|Break from study holiday|2|||
156536832|NCT01514136|565059077|FG001|Test Period 1; Test A|Break from study holiday|0|||
156536833|NCT01514136|565059078|FG002|Test Period 1; Test A|Break from study holiday|0|||
156536834|NCT01514136|565059079|FG003|Test Period 1; Test A|Break from study holiday|0|||
156536835|NCT01514136|565059080|FG004|Test Period 1; Test A|Break from study holiday|0|||
156536836|NCT01514136|565059081|FG005|Test Period 1; Test A|Break from study holiday|0|||
156747601|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
156747602|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
156747603|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
156747604|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
156747605|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
156747606|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
156747607|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
156747608|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
156747609|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
156747610|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Other|3|||
156747611|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Other|1|||
156747612|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Other|0|||
156747613|NCT00624832|565825317|FG000|Overall Study|Adverse Event|0|||
156747614|NCT00624832|565825318|FG001|Overall Study|Adverse Event|1|||
156747615|NCT00624832|565825319|FG002|Overall Study|Adverse Event|0|||
156747616|NCT00624832|565825320|FG003|Overall Study|Adverse Event|1|||
156747617|NCT00624832|565825317|FG000|Overall Study|Abnormal Laboratory Value|2|||
156747618|NCT00624832|565825318|FG001|Overall Study|Abnormal Laboratory Value|0|||
156747619|NCT00624832|565825319|FG002|Overall Study|Abnormal Laboratory Value|0|||
156747620|NCT00624832|565825320|FG003|Overall Study|Abnormal Laboratory Value|0|||
156747621|NCT01939223|565825321|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
156747622|NCT01939223|565825322|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
156747623|NCT01939223|565825321|FG000|Overall Study|Disease recurrence (radiological)|1|||
156747624|NCT01939223|565825322|FG001|Overall Study|Disease recurrence (radiological)|3|||
156747625|NCT01939223|565825321|FG000|Overall Study|Study stopped by Sponsor|5|||
156747626|NCT01939223|565825322|FG001|Overall Study|Study stopped by Sponsor|7|||
156747627|NCT01939223|565825321|FG000|Overall Study|Withdrawal by Subject|6|||
156747628|NCT01939223|565825322|FG001|Overall Study|Withdrawal by Subject|0|||
156747629|NCT04379700|565825323|FG000|Overall Study|Withdrawal by Subject|10|||
156747630|NCT04379700|565825323|FG000|Overall Study|Screen Fail|4|||
156747631|NCT04379700|565825323|FG000|Overall Study|Lost to Follow-up|3|||
156747632|NCT03004924|565825326|FG000|Overall Study|Adverse Event|6|||
156747633|NCT03004924|565825327|FG001|Overall Study|Adverse Event|5|||
156747634|NCT03004924|565825328|FG002|Overall Study|Adverse Event|10|||
156747635|NCT03004924|565825326|FG000|Overall Study|Protocol Violation|4|||
156747636|NCT03004924|565825327|FG001|Overall Study|Protocol Violation|0|||
156536837|NCT01514136|565059082|FG006|Test Period 1; Test A|Break from study holiday|0|||
156536838|NCT01514136|565059083|FG007|Test Period 1; Test A|Break from study holiday|0|||
156536839|NCT01514136|565059076|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
156536840|NCT01514136|565059077|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
156747637|NCT03004924|565825328|FG002|Overall Study|Protocol Violation|1|||
156747638|NCT03004924|565825326|FG000|Overall Study|Withdrawal by Subject|5|||
156747639|NCT03004924|565825327|FG001|Overall Study|Withdrawal by Subject|3|||
156747640|NCT03004924|565825328|FG002|Overall Study|Withdrawal by Subject|5|||
156747641|NCT03004924|565825326|FG000|Overall Study|Lost to Follow-up|6|||
156747642|NCT03004924|565825327|FG001|Overall Study|Lost to Follow-up|1|||
156747643|NCT03004924|565825328|FG002|Overall Study|Lost to Follow-up|4|||
156747644|NCT03004924|565825326|FG000|Overall Study|Lack of Efficacy|2|||
156747645|NCT03004924|565825327|FG001|Overall Study|Lack of Efficacy|4|||
156747646|NCT03004924|565825328|FG002|Overall Study|Lack of Efficacy|2|||
156747647|NCT03004924|565825326|FG000|Overall Study|Physician Decision|1|||
156747648|NCT03004924|565825327|FG001|Overall Study|Physician Decision|0|||
156747649|NCT03004924|565825328|FG002|Overall Study|Physician Decision|1|||
156747650|NCT03004924|565825326|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156747651|NCT03004924|565825327|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156747652|NCT03004924|565825328|FG002|Overall Study|Withdrawal by parent/guardian|2|||
156747653|NCT03004924|565825326|FG000|Overall Study|Screen Failure|1|||
156747654|NCT03004924|565825327|FG001|Overall Study|Screen Failure|0|||
156747655|NCT03004924|565825328|FG002|Overall Study|Screen Failure|0|||
156747656|NCT03004924|565825326|FG000|Overall Study|Pregnancy|0|||
156747657|NCT03004924|565825327|FG001|Overall Study|Pregnancy|1|||
156747658|NCT03004924|565825328|FG002|Overall Study|Pregnancy|0|||
156800121|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
156800122|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
156800123|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
156800124|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
156800125|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
156800126|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156800127|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156800128|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
156800129|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
156800130|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
156800131|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
156800132|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Death|0|||
156800133|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Death|0|||
156800134|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Death|1|||
156800135|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
156800136|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
156800137|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
156800138|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
156800139|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
156800140|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
156800141|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
156800142|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
156800143|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
156800144|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
156800145|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
156800146|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
156800147|NCT00744861|566023381|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
156800148|NCT00744861|566023382|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
156800149|NCT00744861|566023383|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
156800150|NCT00744861|566023384|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
156800151|NCT00744861|566023381|FG000|Feasibility Stage 1|Pregnancy|0|||
156800152|NCT00744861|566023382|FG001|Feasibility Stage 1|Pregnancy|1|||
156800153|NCT00744861|566023383|FG002|Feasibility Stage 1|Pregnancy|0|||
156800154|NCT00744861|566023384|FG003|Feasibility Stage 1|Pregnancy|0|||
156800155|NCT00744861|566023381|FG000|Pivotal Stage 2|Adverse Event|0|||
156800156|NCT00744861|566023382|FG001|Pivotal Stage 2|Adverse Event|0|||
156800157|NCT00744861|566023383|FG002|Pivotal Stage 2|Adverse Event|6|||
156800158|NCT00744861|566023384|FG003|Pivotal Stage 2|Adverse Event|11|||
156800159|NCT00744861|566023381|FG000|Pivotal Stage 2|Death|0|||
156800160|NCT00744861|566023382|FG001|Pivotal Stage 2|Death|0|||
156800161|NCT00744861|566023383|FG002|Pivotal Stage 2|Death|0|||
156800162|NCT00744861|566023384|FG003|Pivotal Stage 2|Death|1|||
156800163|NCT00744861|566023381|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
156800164|NCT00744861|566023382|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
156747659|NCT03004924|565825326|FG000|Overall Study|Terminated by Sponsor|0|||
156747660|NCT03004924|565825327|FG001|Overall Study|Terminated by Sponsor|0|||
156800165|NCT00744861|566023383|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
156747661|NCT03004924|565825328|FG002|Overall Study|Terminated by Sponsor|1|||
156747662|NCT03004924|565825326|FG000|Overall Study|Missed Study Visit|0|||
156800166|NCT00744861|566023384|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
156800167|NCT00744861|566023381|FG000|Pivotal Stage 2|Physician Decision|0|||
156800168|NCT00744861|566023382|FG001|Pivotal Stage 2|Physician Decision|0|||
156800169|NCT00744861|566023383|FG002|Pivotal Stage 2|Physician Decision|3|||
156747663|NCT03004924|565825327|FG001|Overall Study|Missed Study Visit|0|||
156747664|NCT03004924|565825328|FG002|Overall Study|Missed Study Visit|2|||
156747665|NCT03004924|565825326|FG000|Overall Study|HSV1 Positive|1|||
156747666|NCT03004924|565825327|FG001|Overall Study|HSV1 Positive|0|||
156747667|NCT03004924|565825328|FG002|Overall Study|HSV1 Positive|0|||
156747668|NCT03003000|565825338|FG000|Overall Study|Adverse Event|1|||
156747669|NCT03003000|565825339|FG001|Overall Study|Adverse Event|2|||
156747670|NCT03003000|565825340|FG002|Overall Study|Adverse Event|3|||
156747671|NCT03003000|565825338|FG000|Overall Study|Lack of Efficacy|1|||
156747672|NCT03003000|565825339|FG001|Overall Study|Lack of Efficacy|0|||
156747673|NCT03003000|565825340|FG002|Overall Study|Lack of Efficacy|0|||
156747674|NCT03003000|565825338|FG000|Overall Study|Non-compliant with protocol|0|||
156747675|NCT03003000|565825339|FG001|Overall Study|Non-compliant with protocol|1|||
156747676|NCT03003000|565825340|FG002|Overall Study|Non-compliant with protocol|1|||
156747677|NCT03003000|565825338|FG000|Overall Study|Refused to continue medication|2|||
156747678|NCT03003000|565825339|FG001|Overall Study|Refused to continue medication|0|||
156747679|NCT03003000|565825340|FG002|Overall Study|Refused to continue medication|0|||
156747680|NCT03003000|565825338|FG000|Overall Study|Other than listed|1|||
156747681|NCT03003000|565825339|FG001|Overall Study|Other than listed|1|||
156747682|NCT03003000|565825340|FG002|Overall Study|Other than listed|1|||
156747683|NCT04933617|565825342|FG000|Dose Escalation|Early closure of study|0|||
156747684|NCT04933617|565825343|FG001|Dose Escalation|Early closure of study|3|||
156747685|NCT04933617|565825344|FG002|Dose Escalation|Early closure of study|0|||
156747686|NCT04933617|565825345|FG003|Dose Escalation|Early closure of study|0|||
156747687|NCT04933617|565825346|FG004|Dose Escalation|Early closure of study|0|||
156747688|NCT02191046|565825352|FG000|Overall Study|low compliance|5|||
156747689|NCT02191046|565825353|FG001|Overall Study|low compliance|1|||
156747690|NCT01964716|565825354|FG000|Overall Study|Withdrawal by Subject|2|||
156747691|NCT01964716|565825355|FG001|Overall Study|Withdrawal by Subject|3|||
156747692|NCT01964716|565825354|FG000|Overall Study|Lost to Follow-up|1|||
156747693|NCT01964716|565825355|FG001|Overall Study|Lost to Follow-up|2|||
156747694|NCT01964716|565825354|FG000|Overall Study|No longer met eligibility criteria|1|||
156747695|NCT01964716|565825355|FG001|Overall Study|No longer met eligibility criteria|1|||
156747696|NCT01964716|565825354|FG000|Overall Study|Death|1|||
156747697|NCT01964716|565825355|FG001|Overall Study|Death|0|||
156747698|NCT00089635|565825356|FG000|Overall Study|Adverse Event|2|||
156747699|NCT00089635|565825356|FG000|Overall Study|Death|17|||
156747700|NCT00089635|565825356|FG000|Overall Study|Disease Progression|12|||
156747701|NCT00089635|565825356|FG000|Overall Study|Lost to Follow-up|3|||
156747702|NCT00089635|565825356|FG000|Overall Study|Withdrawal by Subject|6|||
156747703|NCT00089635|565825356|FG000|Overall Study|Ineligibility determined|1|||
156747704|NCT00089635|565825356|FG000|Overall Study|Other|2|||
156747705|NCT02603107|565825357|FG000|Randomized Phase|Withdrew consent|8|||
156747706|NCT02603107|565825358|FG001|Randomized Phase|Withdrew consent|15|||
156747707|NCT02603107|565825357|FG000|Randomized Phase|Lost to Follow-up|1|||
156747708|NCT02603107|565825358|FG001|Randomized Phase|Lost to Follow-up|3|||
156747709|NCT02603107|565825357|FG000|Randomized Phase|Adverse Event|2|||
156747710|NCT02603107|565825358|FG001|Randomized Phase|Adverse Event|0|||
156747711|NCT02603107|565825357|FG000|Randomized Phase|Death|1|||
156747712|NCT02603107|565825358|FG001|Randomized Phase|Death|1|||
156747713|NCT02603107|565825357|FG000|Randomized Phase|Non-compliance with study drug|1|||
156747714|NCT02603107|565825358|FG001|Randomized Phase|Non-compliance with study drug|1|||
156747715|NCT02603107|565825357|FG000|Randomized Phase|Investigator's discretion|0|||
156747716|NCT02603107|565825358|FG001|Randomized Phase|Investigator's discretion|1|||
156747717|NCT02603107|565825357|FG000|Randomized Phase|Lack of Efficacy|1|||
156747718|NCT02603107|565825358|FG001|Randomized Phase|Lack of Efficacy|0|||
156747719|NCT02603107|565825357|FG000|Randomized Phase|Protocol Violation|1|||
156747720|NCT02603107|565825358|FG001|Randomized Phase|Protocol Violation|0|||
156747721|NCT02603107|565825357|FG000|Optional Extension Phase|Lost to Follow-up|3|||
156747722|NCT02603107|565825358|FG001|Optional Extension Phase|Lost to Follow-up|3|||
156747723|NCT02603107|565825357|FG000|Optional Extension Phase|Withdrew consent|3|||
156747724|NCT02603107|565825358|FG001|Optional Extension Phase|Withdrew consent|2|||
156747725|NCT02603107|565825357|FG000|Optional Extension Phase|Investigator's discretion|2|||
156747726|NCT02603107|565825358|FG001|Optional Extension Phase|Investigator's discretion|2|||
156747727|NCT02603107|565825357|FG000|Optional Extension Phase|Pregnancy|0|||
156747728|NCT02603107|565825358|FG001|Optional Extension Phase|Pregnancy|3|||
156337208|NCT02165215|564333576|FG000|Induction Phase|Withdrawal by Subject|10|||
156747729|NCT02603107|565825357|FG000|Optional Extension Phase|Adverse Event|0|||
156800170|NCT00744861|566023384|FG003|Pivotal Stage 2|Physician Decision|1|||
156747730|NCT02603107|565825358|FG001|Optional Extension Phase|Adverse Event|2|||
156747731|NCT02603107|565825357|FG000|Optional Extension Phase|Not treated in extension phase|0|||
156747732|NCT02603107|565825358|FG001|Optional Extension Phase|Not treated in extension phase|1|||
156747733|NCT02603107|565825357|FG000|Optional Extension Phase|Protocol Violation|1|||
156747734|NCT02603107|565825358|FG001|Optional Extension Phase|Protocol Violation|0|||
156747735|NCT01370616|565825360|FG000|Overall Study|Adverse Event|11|||
156747736|NCT01370616|565825361|FG001|Overall Study|Adverse Event|16|||
156747737|NCT01370616|565825360|FG000|Overall Study|Death|1|||
156747738|NCT01370616|565825361|FG001|Overall Study|Death|0|||
156747739|NCT01370616|565825360|FG000|Overall Study|Lack of Efficacy|6|||
156747740|NCT01370616|565825361|FG001|Overall Study|Lack of Efficacy|2|||
156747741|NCT01370616|565825360|FG000|Overall Study|Lost to Follow-up|0|||
156747742|NCT01370616|565825361|FG001|Overall Study|Lost to Follow-up|3|||
156747743|NCT01370616|565825360|FG000|Overall Study|Physician Decision|6|||
156747744|NCT01370616|565825361|FG001|Overall Study|Physician Decision|6|||
156747745|NCT01370616|565825360|FG000|Overall Study|Progressive Disease|0|||
156747746|NCT01370616|565825361|FG001|Overall Study|Progressive Disease|1|||
156747747|NCT01370616|565825360|FG000|Overall Study|Recovery|1|||
156747748|NCT01370616|565825361|FG001|Overall Study|Recovery|0|||
156747749|NCT01370616|565825360|FG000|Overall Study|Technical Problems|3|||
156747750|NCT01370616|565825361|FG001|Overall Study|Technical Problems|5|||
156747751|NCT01370616|565825360|FG000|Overall Study|Withdrawal by Subject|34|||
156747752|NCT01370616|565825361|FG001|Overall Study|Withdrawal by Subject|34|||
156747753|NCT00419159|565825362|FG000|Overall Study|Adverse Event|7|||
156747754|NCT00419159|565825363|FG001|Overall Study|Adverse Event|15|||
156747755|NCT00419159|565825362|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156747756|NCT00419159|565825363|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156747757|NCT00419159|565825362|FG000|Overall Study|Subject's no longer requires study drug|0|||
156747758|NCT00419159|565825363|FG001|Overall Study|Subject's no longer requires study drug|1|||
156747759|NCT00419159|565825362|FG000|Overall Study|Protocol Violation|1|||
156747760|NCT00419159|565825363|FG001|Overall Study|Protocol Violation|0|||
156747761|NCT00419159|565825362|FG000|Overall Study|Withdrawal by Subject|10|||
156747762|NCT00419159|565825363|FG001|Overall Study|Withdrawal by Subject|3|||
156747763|NCT00419159|565825362|FG000|Overall Study|Lost to Follow-up|0|||
156747764|NCT00419159|565825363|FG001|Overall Study|Lost to Follow-up|1|||
156747765|NCT00419159|565825362|FG000|Overall Study|Death|2|||
156747766|NCT00419159|565825363|FG001|Overall Study|Death|2|||
156747767|NCT00419159|565825362|FG000|Overall Study|Disease progression|79|||
156747768|NCT00419159|565825363|FG001|Overall Study|Disease progression|76|||
156747769|NCT01693185|565825364|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
156747770|NCT01693185|565825365|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
156747771|NCT01017601|565825368|FG000|Overall Study|Disease Progression|12|||
156747772|NCT01017601|565825369|FG001|Overall Study|Disease Progression|12|||
156747773|NCT01017601|565825368|FG000|Overall Study|Withdrawal by Subject|0|||
156747774|NCT01017601|565825369|FG001|Overall Study|Withdrawal by Subject|1|||
156747775|NCT01857102|565825370|FG000|Period 1|No longer meets Eligibility Criteria|0|||
156747776|NCT01857102|565825371|FG001|Period 1|No longer meets Eligibility Criteria|2|||
156747777|NCT01857102|565825370|FG000|Period 1|Lost to Follow-up|0|||
156747778|NCT01857102|565825371|FG001|Period 1|Lost to Follow-up|3|||
156747779|NCT01857102|565825370|FG000|Period 1|Unsatisfactory Lens Fit|1|||
156747780|NCT01857102|565825371|FG001|Period 1|Unsatisfactory Lens Fit|0|||
156747781|NCT01857102|565825370|FG000|Period 1|Unsatisfactory Visual Response|1|||
156747782|NCT01857102|565825371|FG001|Period 1|Unsatisfactory Visual Response|0|||
156747783|NCT01857102|565825370|FG000|Period 1|Physician Decision|1|||
156747784|NCT01857102|565825371|FG001|Period 1|Physician Decision|0|||
156747785|NCT01857102|565825370|FG000|Period 2|Lens Discomfort|1|||
156747786|NCT01857102|565825371|FG001|Period 2|Lens Discomfort|0|||
156747787|NCT01857102|565825370|FG000|Period 2|Unsatisfactory Lens Fit|1|||
156747788|NCT01857102|565825371|FG001|Period 2|Unsatisfactory Lens Fit|0|||
156747789|NCT02073656|565825374|FG000|Primary Study|Lost to Follow-up|6|||
156747790|NCT02073656|565825374|FG000|Primary Study|Death|1|||
156747791|NCT02073656|565825374|FG000|Primary Study|Withdrew Consent|1|||
156747792|NCT01524783|565825381|FG000|Blinded Period|Adverse Event|64|||
156747793|NCT01524783|565825382|FG001|Blinded Period|Adverse Event|7|||
156747794|NCT01524783|565825383|FG002|Blinded Period|Adverse Event|0|||
156747795|NCT01524783|565825381|FG000|Blinded Period|Disease Progression|89|||
156800171|NCT00744861|566023381|FG000|Pivotal Stage 2|Protocol Violation|0|||
156800172|NCT00744861|566023382|FG001|Pivotal Stage 2|Protocol Violation|0|||
156800173|NCT00744861|566023383|FG002|Pivotal Stage 2|Protocol Violation|0|||
156800174|NCT00744861|566023384|FG003|Pivotal Stage 2|Protocol Violation|1|||
156800175|NCT00744861|566023381|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
156800176|NCT00744861|566023382|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
156536841|NCT01514136|565059078|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
156536842|NCT01514136|565059079|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
156536843|NCT01514136|565059080|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
156536844|NCT01514136|565059081|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
156747796|NCT01524783|565825382|FG001|Blinded Period|Disease Progression|75|||
156747797|NCT01524783|565825383|FG002|Blinded Period|Disease Progression|0|||
156747798|NCT01524783|565825381|FG000|Blinded Period|Withdrawal by Subject|19|||
156747799|NCT01524783|565825382|FG001|Blinded Period|Withdrawal by Subject|6|||
156747800|NCT01524783|565825383|FG002|Blinded Period|Withdrawal by Subject|0|||
156747801|NCT01524783|565825381|FG000|Blinded Period|Protocol deviation|2|||
156747802|NCT01524783|565825382|FG001|Blinded Period|Protocol deviation|1|||
156747803|NCT01524783|565825383|FG002|Blinded Period|Protocol deviation|0|||
156747804|NCT01524783|565825381|FG000|Blinded Period|Death|5|||
156747805|NCT01524783|565825382|FG001|Blinded Period|Death|2|||
156747806|NCT01524783|565825383|FG002|Blinded Period|Death|0|||
156536845|NCT01514136|565059082|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
156536846|NCT01514136|565059083|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
156536847|NCT01514136|565059076|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
156747807|NCT01524783|565825381|FG000|Open-label Period|Disease progression|13|||
156747808|NCT01524783|565825382|FG001|Open-label Period|Disease progression|0|||
156747809|NCT01524783|565825383|FG002|Open-label Period|Disease progression|2|||
156747810|NCT01524783|565825381|FG000|Open-label Period|Administrative problems|5|||
156747811|NCT01524783|565825382|FG001|Open-label Period|Administrative problems|0|||
156747812|NCT01524783|565825383|FG002|Open-label Period|Administrative problems|2|||
156536848|NCT01514136|565059077|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
156536849|NCT01514136|565059078|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
156536850|NCT01514136|565059079|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
156536851|NCT01514136|565059080|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
156536852|NCT01514136|565059081|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
156536853|NCT01514136|565059082|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
156536854|NCT01514136|565059083|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
156536855|NCT01514136|565059076|FG000|Test Period 2; Test A*|Adverse Event|0|||
156536856|NCT01514136|565059077|FG001|Test Period 2; Test A*|Adverse Event|0|||
156536857|NCT01514136|565059078|FG002|Test Period 2; Test A*|Adverse Event|0|||
156536858|NCT01514136|565059079|FG003|Test Period 2; Test A*|Adverse Event|0|||
156536859|NCT01514136|565059080|FG004|Test Period 2; Test A*|Adverse Event|1|||
156536860|NCT01514136|565059081|FG005|Test Period 2; Test A*|Adverse Event|0|||
156536861|NCT01514136|565059082|FG006|Test Period 2; Test A*|Adverse Event|0|||
156536862|NCT01514136|565059083|FG007|Test Period 2; Test A*|Adverse Event|0|||
156536863|NCT01514136|565059076|FG000|Test Period 2; Test A*|Holiday|0|||
156536864|NCT01514136|565059077|FG001|Test Period 2; Test A*|Holiday|0|||
156536865|NCT01514136|565059078|FG002|Test Period 2; Test A*|Holiday|0|||
156536866|NCT01514136|565059079|FG003|Test Period 2; Test A*|Holiday|0|||
156536867|NCT01514136|565059080|FG004|Test Period 2; Test A*|Holiday|1|||
156536868|NCT01514136|565059081|FG005|Test Period 2; Test A*|Holiday|0|||
156536869|NCT01514136|565059082|FG006|Test Period 2; Test A*|Holiday|0|||
156536870|NCT01514136|565059083|FG007|Test Period 2; Test A*|Holiday|0|||
156536871|NCT01514136|565059076|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
156536872|NCT01514136|565059077|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
156536873|NCT01514136|565059078|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
156536874|NCT01514136|565059079|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
156536875|NCT01514136|565059080|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
156536876|NCT01514136|565059081|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
156747813|NCT01524783|565825381|FG000|Open-label Period|Adverse Event|5|||
156747814|NCT01524783|565825382|FG001|Open-label Period|Adverse Event|0|||
156747815|NCT01524783|565825383|FG002|Open-label Period|Adverse Event|1|||
156747816|NCT01524783|565825381|FG000|Open-label Period|Withdrawal by Subject|2|||
156747817|NCT01524783|565825382|FG001|Open-label Period|Withdrawal by Subject|0|||
156747818|NCT01524783|565825383|FG002|Open-label Period|Withdrawal by Subject|1|||
156747819|NCT01524783|565825381|FG000|Open-label Period|Protocol deviation|1|||
156747820|NCT01524783|565825382|FG001|Open-label Period|Protocol deviation|0|||
156747821|NCT01524783|565825383|FG002|Open-label Period|Protocol deviation|0|||
156747822|NCT02054910|565825385|FG000|Overall Study|Lost to Follow-up|4|||
156747823|NCT02054910|565825386|FG001|Overall Study|Lost to Follow-up|1|||
156747824|NCT01625689|565825387|FG000|Overall Study|Migration|2|||
156747825|NCT01625689|565825388|FG001|Overall Study|Migration|1|||
156747826|NCT04907227|565825393|FG000|Overall Study|Death|12|||
156747827|NCT04907227|565825394|FG001|Overall Study|Death|8|||
156747828|NCT04907227|565825393|FG000|Overall Study|Withdrawal by Subject|2|||
156747829|NCT04907227|565825394|FG001|Overall Study|Withdrawal by Subject|2|||
156747830|NCT04907227|565825393|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
156747831|NCT04907227|565825394|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
156747832|NCT04907227|565825393|FG000|Overall Study|Sponsor Decision|25|||
156747833|NCT04907227|565825394|FG001|Overall Study|Sponsor Decision|30|||
156536877|NCT01514136|565059082|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
156536878|NCT01514136|565059083|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
156536879|NCT01514136|565059076|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
156536880|NCT01514136|565059077|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
156536881|NCT01514136|565059078|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
156536882|NCT01514136|565059079|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
156747834|NCT04907227|565825393|FG000|Overall Study|Physician Decision|1|||
156747835|NCT04907227|565825394|FG001|Overall Study|Physician Decision|0|||
156747836|NCT03723070|565825395|FG000|Overall Study|Lost to Follow-up|2|||
156747837|NCT03723070|565825395|FG000|Overall Study|Physician Decision|1|||
156747838|NCT03723070|565825395|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
156747839|NCT02208050|565825396|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
156747840|NCT02208050|565825397|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
156747841|NCT00721279|565825401|FG000|Overall Study|Lack of Efficacy|6|||
156747842|NCT00721279|565825402|FG001|Overall Study|Lack of Efficacy|3|||
156747843|NCT00721279|565825401|FG000|Overall Study|Tolerability insufficient|5|||
156459132|NCT02240238|564776693|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156747844|NCT00721279|565825402|FG001|Overall Study|Tolerability insufficient|2|||
156747845|NCT00721279|565825401|FG000|Overall Study|Withdrawal by Subject|13|||
156747846|NCT00721279|565825402|FG001|Overall Study|Withdrawal by Subject|3|||
156747847|NCT00721279|565825401|FG000|Overall Study|Other|12|||
156747848|NCT00721279|565825402|FG001|Overall Study|Other|16|||
156747849|NCT03673345|565825403|FG000|Overall Study|Lost to Follow-up|1|||
156747850|NCT03673345|565825404|FG001|Overall Study|Lost to Follow-up|0|||
156747851|NCT03673345|565825405|FG002|Overall Study|Lost to Follow-up|3|||
156747852|NCT03673345|565825406|FG003|Overall Study|Lost to Follow-up|3|||
156747853|NCT03673345|565825407|FG004|Overall Study|Lost to Follow-up|2|||
156747854|NCT03673345|565825408|FG005|Overall Study|Lost to Follow-up|1|||
156747855|NCT03673345|565825409|FG006|Overall Study|Lost to Follow-up|0|||
156747856|NCT03673345|565825410|FG007|Overall Study|Lost to Follow-up|0|||
156747857|NCT03673345|565825403|FG000|Overall Study|Withdrawal by Subject|1|||
156747858|NCT03673345|565825404|FG001|Overall Study|Withdrawal by Subject|0|||
156747859|NCT03673345|565825405|FG002|Overall Study|Withdrawal by Subject|4|||
156747860|NCT03673345|565825406|FG003|Overall Study|Withdrawal by Subject|2|||
156747861|NCT03673345|565825407|FG004|Overall Study|Withdrawal by Subject|0|||
156747862|NCT03673345|565825408|FG005|Overall Study|Withdrawal by Subject|0|||
156747863|NCT03673345|565825409|FG006|Overall Study|Withdrawal by Subject|0|||
156747864|NCT03673345|565825410|FG007|Overall Study|Withdrawal by Subject|0|||
156747865|NCT03673345|565825403|FG000|Overall Study|Physician Decision|0|||
156747866|NCT03673345|565825404|FG001|Overall Study|Physician Decision|0|||
156747867|NCT03673345|565825405|FG002|Overall Study|Physician Decision|2|||
156747868|NCT03673345|565825406|FG003|Overall Study|Physician Decision|0|||
156747869|NCT03673345|565825407|FG004|Overall Study|Physician Decision|0|||
156747870|NCT03673345|565825408|FG005|Overall Study|Physician Decision|0|||
156747871|NCT03673345|565825409|FG006|Overall Study|Physician Decision|0|||
156747872|NCT03673345|565825410|FG007|Overall Study|Physician Decision|0|||
156747873|NCT05153148|565825411|FG000|Overall Study|Adverse Event|1|||
156747874|NCT05153148|565825412|FG001|Overall Study|Adverse Event|0|||
156747875|NCT05153148|565825413|FG002|Overall Study|Adverse Event|3|||
156747876|NCT05153148|565825414|FG003|Overall Study|Adverse Event|5|||
156747877|NCT05153148|565825411|FG000|Overall Study|Lost to Follow-up|1|||
156747878|NCT05153148|565825412|FG001|Overall Study|Lost to Follow-up|1|||
156747879|NCT05153148|565825413|FG002|Overall Study|Lost to Follow-up|2|||
156747880|NCT05153148|565825414|FG003|Overall Study|Lost to Follow-up|0|||
156747881|NCT05153148|565825411|FG000|Overall Study|Withdrawal by Subject|6|||
156747882|NCT05153148|565825412|FG001|Overall Study|Withdrawal by Subject|8|||
156747883|NCT05153148|565825413|FG002|Overall Study|Withdrawal by Subject|6|||
156747884|NCT05153148|565825414|FG003|Overall Study|Withdrawal by Subject|8|||
156747885|NCT05153148|565825411|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
156747886|NCT05153148|565825412|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
156747887|NCT05153148|565825413|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
156747888|NCT05153148|565825414|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
156747889|NCT05153148|565825411|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
156747890|NCT05153148|565825412|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
156747891|NCT05153148|565825413|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
156747892|NCT05153148|565825414|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
156747893|NCT05153148|565825411|FG000|Overall Study|Reason not Specified|1|||
156747894|NCT05153148|565825412|FG001|Overall Study|Reason not Specified|1|||
156747895|NCT05153148|565825413|FG002|Overall Study|Reason not Specified|1|||
156747896|NCT05153148|565825414|FG003|Overall Study|Reason not Specified|1|||
156747897|NCT02267135|565825415|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
156747898|NCT02267135|565825416|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
156747899|NCT02267135|565825415|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
156747900|NCT02267135|565825416|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
156747901|NCT02267135|565825415|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
156747902|NCT02267135|565825416|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
156747903|NCT02267135|565825415|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
156747904|NCT02267135|565825416|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
156747905|NCT02267135|565825415|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
156747906|NCT02267135|565825416|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
156747907|NCT03806231|565825417|FG000|Overall Study|Physician Decision|1|||
156747908|NCT03806231|565825418|FG001|Overall Study|Physician Decision|0|||
156747909|NCT03806231|565825417|FG000|Overall Study|Withdrawal by Subject|1|||
156747910|NCT03806231|565825418|FG001|Overall Study|Withdrawal by Subject|0|||
156747911|NCT00900731|565825419|FG000|Overall Study|Adverse Event|31|||
156800177|NCT00744861|566023383|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
156800178|NCT00744861|566023384|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
156747912|NCT00900731|565825420|FG001|Overall Study|Adverse Event|27|||
156747913|NCT00900731|565825419|FG000|Overall Study|Withdrawal by Subject|8|||
156747914|NCT00900731|565825420|FG001|Overall Study|Withdrawal by Subject|7|||
156747915|NCT00900731|565825419|FG000|Overall Study|Protocol Deviation|8|||
156747916|NCT00900731|565825420|FG001|Overall Study|Protocol Deviation|11|||
156747917|NCT00900731|565825419|FG000|Overall Study|Administrative Problems|5|||
156747918|NCT00900731|565825420|FG001|Overall Study|Administrative Problems|4|||
156747919|NCT00900731|565825419|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
156747920|NCT00900731|565825420|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156747921|NCT00900731|565825419|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
156747922|NCT00900731|565825420|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
156747923|NCT00900731|565825419|FG000|Overall Study|Lost to Follow-up|2|||
156747924|NCT00900731|565825420|FG001|Overall Study|Lost to Follow-up|3|||
156747925|NCT00900731|565825419|FG000|Overall Study|Lack of Efficacy|1|||
156747926|NCT00900731|565825420|FG001|Overall Study|Lack of Efficacy|3|||
156747927|NCT00900731|565825419|FG000|Overall Study|Death|0|||
156747928|NCT00900731|565825420|FG001|Overall Study|Death|2|||
156747929|NCT04608344|565825421|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
156747930|NCT04608344|565825422|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
156747931|NCT04608344|565825421|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
156747932|NCT04608344|565825422|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
156747933|NCT00131365|565825423|FG000|Overall Study|Withdrawal by Subject|1|||
156747934|NCT00131365|565825423|FG000|Overall Study|Alternative treatment|3|||
156747935|NCT00467961|565825424|FG000|Overall Study|Technical Failures|5|||
156747936|NCT00467961|565825424|FG000|Overall Study|Disease Progression|2|||
156747937|NCT05249127|565825425|FG000|Overall Study|Protocol Violation|13|||
156747938|NCT05249127|565825425|FG000|Overall Study|Physician Decision|4|||
156747939|NCT05249127|565825425|FG000|Overall Study|Withdrawal by Subject|2|||
156747940|NCT05249127|565825425|FG000|Overall Study|Participant Non-compliance|1|||
156747941|NCT02429310|565825427|FG000|Overall Study|Lost to Follow-up|1|||
156747942|NCT02429310|565825428|FG001|Overall Study|Lost to Follow-up|2|||
156747943|NCT02429310|565825427|FG000|Overall Study|Protocol Violation|1|||
156747944|NCT02429310|565825428|FG001|Overall Study|Protocol Violation|1|||
156747945|NCT00394433|565825429|FG000|Overall Study|Adverse Event|2|||
156747946|NCT00394433|565825429|FG000|Overall Study|Alternative Therapy|1|||
156747947|NCT03646305|565825430|FG000|Overall Study|Lost to Follow-up|4|||
156747948|NCT03646305|565825431|FG001|Overall Study|Lost to Follow-up|2|||
156747949|NCT03646305|565825432|FG002|Overall Study|Lost to Follow-up|2|||
156747950|NCT03646305|565825433|FG003|Overall Study|Lost to Follow-up|1|||
156747951|NCT03646305|565825430|FG000|Overall Study|Withdrawal by Subject|1|||
156747952|NCT03646305|565825431|FG001|Overall Study|Withdrawal by Subject|0|||
156747953|NCT03646305|565825432|FG002|Overall Study|Withdrawal by Subject|0|||
156747954|NCT03646305|565825433|FG003|Overall Study|Withdrawal by Subject|1|||
156747955|NCT01554176|565825434|FG000|Treatment Phase|Protocol Violation|1|||
156747956|NCT01554176|565825435|FG001|Treatment Phase|Protocol Violation|2|||
156747957|NCT01554176|565825436|FG002|Treatment Phase|Protocol Violation|0|||
156747958|NCT01554176|565825437|FG003|Treatment Phase|Protocol Violation|0|||
156747959|NCT01554176|565825438|FG004|Treatment Phase|Protocol Violation|0|||
156747960|NCT01554176|565825434|FG000|Treatment Phase|Physician Decision|1|||
156747961|NCT01554176|565825435|FG001|Treatment Phase|Physician Decision|1|||
156747962|NCT01554176|565825436|FG002|Treatment Phase|Physician Decision|0|||
156747963|NCT01554176|565825437|FG003|Treatment Phase|Physician Decision|0|||
156747964|NCT01554176|565825438|FG004|Treatment Phase|Physician Decision|0|||
156747965|NCT01554176|565825434|FG000|Treatment Phase|Lack of Efficacy|0|||
156747966|NCT01554176|565825435|FG001|Treatment Phase|Lack of Efficacy|1|||
156747967|NCT01554176|565825436|FG002|Treatment Phase|Lack of Efficacy|0|||
156747968|NCT01554176|565825437|FG003|Treatment Phase|Lack of Efficacy|0|||
156747969|NCT01554176|565825438|FG004|Treatment Phase|Lack of Efficacy|0|||
156747970|NCT01554176|565825434|FG000|Treatment Phase|Adverse event, non-fatal|1|||
156747971|NCT01554176|565825435|FG001|Treatment Phase|Adverse event, non-fatal|1|||
156747972|NCT01554176|565825436|FG002|Treatment Phase|Adverse event, non-fatal|0|||
156747973|NCT01554176|565825437|FG003|Treatment Phase|Adverse event, non-fatal|0|||
156747974|NCT01554176|565825438|FG004|Treatment Phase|Adverse event, non-fatal|0|||
156747975|NCT01554176|565825434|FG000|Treatment Phase|Non-compliance with study drug|1|||
156747976|NCT01554176|565825435|FG001|Treatment Phase|Non-compliance with study drug|0|||
156747977|NCT01554176|565825436|FG002|Treatment Phase|Non-compliance with study drug|0|||
156747978|NCT01554176|565825437|FG003|Treatment Phase|Non-compliance with study drug|0|||
156747979|NCT01554176|565825438|FG004|Treatment Phase|Non-compliance with study drug|0|||
156747980|NCT01554176|565825434|FG000|Treatment Phase|Withdrawal by Subject|1|||
156747981|NCT01554176|565825435|FG001|Treatment Phase|Withdrawal by Subject|0|||
156747982|NCT01554176|565825436|FG002|Treatment Phase|Withdrawal by Subject|0|||
156747983|NCT01554176|565825437|FG003|Treatment Phase|Withdrawal by Subject|0|||
156747984|NCT01554176|565825438|FG004|Treatment Phase|Withdrawal by Subject|0|||
156747985|NCT01554176|565825434|FG000|Treatment Phase|Lost to Follow-up|3|||
156747986|NCT01554176|565825435|FG001|Treatment Phase|Lost to Follow-up|0|||
156747987|NCT01554176|565825436|FG002|Treatment Phase|Lost to Follow-up|0|||
156747988|NCT01554176|565825437|FG003|Treatment Phase|Lost to Follow-up|0|||
156747989|NCT01554176|565825438|FG004|Treatment Phase|Lost to Follow-up|0|||
156747990|NCT01554176|565825434|FG000|Run-out Phase|Protocol Violation|0|||
156747991|NCT01554176|565825435|FG001|Run-out Phase|Protocol Violation|0|||
156747992|NCT01554176|565825436|FG002|Run-out Phase|Protocol Violation|0|||
156747993|NCT01554176|565825437|FG003|Run-out Phase|Protocol Violation|1|||
156747994|NCT01554176|565825438|FG004|Run-out Phase|Protocol Violation|0|||
156747995|NCT02678000|565825439|FG000|PART 2|Adverse Event|0|||
156747996|NCT02678000|565825440|FG001|PART 2|Adverse Event|0|||
156747997|NCT02678000|565825441|FG002|PART 2|Adverse Event|2|||
156747998|NCT02678000|565825442|FG003|PART 2|Adverse Event|1|||
156747999|NCT02678000|565825443|FG004|PART 2|Adverse Event|0|||
156748000|NCT02678000|565825439|FG000|PART 2|Withdrawal by Subject|0|||
156748001|NCT02678000|565825440|FG001|PART 2|Withdrawal by Subject|0|||
156748002|NCT02678000|565825441|FG002|PART 2|Withdrawal by Subject|1|||
156748003|NCT02678000|565825442|FG003|PART 2|Withdrawal by Subject|0|||
156748004|NCT02678000|565825443|FG004|PART 2|Withdrawal by Subject|0|||
156748005|NCT01859949|565827674|FG000|Overall Study|Family Matters|0|||
156748006|NCT01859949|565827675|FG001|Overall Study|Family Matters|1|||
156748007|NCT01859949|565827674|FG000|Overall Study|Physician Decision|2|||
156748008|NCT01859949|565827675|FG001|Overall Study|Physician Decision|4|||
156748009|NCT01859949|565827674|FG000|Overall Study|Withdrawal by Subject|11|||
156748010|NCT01859949|565827675|FG001|Overall Study|Withdrawal by Subject|10|||
156748011|NCT01859949|565827674|FG000|Overall Study|Protocol Violation|1|||
156748012|NCT01859949|565827675|FG001|Overall Study|Protocol Violation|1|||
156748013|NCT01859949|565827674|FG000|Overall Study|Adverse Event|0|||
156748014|NCT01859949|565827675|FG001|Overall Study|Adverse Event|1|||
156748015|NCT01153009|565827676|FG000|Overall Study|Adverse Event|4|||
156748016|NCT01153009|565827677|FG001|Overall Study|Adverse Event|14|||
156748017|NCT01153009|565827678|FG002|Overall Study|Adverse Event|14|||
156748018|NCT01153009|565827679|FG003|Overall Study|Adverse Event|10|||
156748019|NCT01153009|565827676|FG000|Overall Study|Lack of Efficacy|9|||
156748020|NCT01153009|565827677|FG001|Overall Study|Lack of Efficacy|0|||
156748021|NCT01153009|565827678|FG002|Overall Study|Lack of Efficacy|2|||
156748022|NCT01153009|565827679|FG003|Overall Study|Lack of Efficacy|1|||
156748023|NCT01153009|565827676|FG000|Overall Study|Noncompliance with Study Medication|1|||
156748024|NCT01153009|565827677|FG001|Overall Study|Noncompliance with Study Medication|3|||
156748025|NCT01153009|565827678|FG002|Overall Study|Noncompliance with Study Medication|4|||
156748026|NCT01153009|565827679|FG003|Overall Study|Noncompliance with Study Medication|1|||
156748027|NCT01153009|565827676|FG000|Overall Study|Protocol Deviations|4|||
156748028|NCT01153009|565827677|FG001|Overall Study|Protocol Deviations|3|||
156748029|NCT01153009|565827678|FG002|Overall Study|Protocol Deviations|3|||
156748030|NCT01153009|565827679|FG003|Overall Study|Protocol Deviations|2|||
156748031|NCT01153009|565827676|FG000|Overall Study|Withdrawal of Consent|5|||
156748032|NCT01153009|565827677|FG001|Overall Study|Withdrawal of Consent|5|||
156748033|NCT01153009|565827678|FG002|Overall Study|Withdrawal of Consent|4|||
156748034|NCT01153009|565827679|FG003|Overall Study|Withdrawal of Consent|6|||
156748035|NCT01153009|565827676|FG000|Overall Study|Lost to Follow-up|8|||
156748036|NCT01153009|565827677|FG001|Overall Study|Lost to Follow-up|8|||
156748037|NCT01153009|565827678|FG002|Overall Study|Lost to Follow-up|11|||
156748038|NCT01153009|565827679|FG003|Overall Study|Lost to Follow-up|15|||
156459133|NCT02240238|564776694|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156459134|NCT02240238|564776695|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156748039|NCT01153009|565827676|FG000|Overall Study|Other|1|||
156748040|NCT01153009|565827677|FG001|Overall Study|Other|1|||
156748041|NCT01153009|565827678|FG002|Overall Study|Other|3|||
156748042|NCT01153009|565827679|FG003|Overall Study|Other|2|||
156748043|NCT03307837|565827682|FG000|Overall Study|Withdrawal by Subject|0|||
156748044|NCT03307837|565827683|FG001|Overall Study|Withdrawal by Subject|0|||
156748045|NCT03307837|565827684|FG002|Overall Study|Withdrawal by Subject|1|||
156459135|NCT02240238|564776696|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156459136|NCT02240238|564776697|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156459137|NCT02240238|564776698|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156748046|NCT03307837|565827685|FG003|Overall Study|Withdrawal by Subject|0|||
156748047|NCT03307837|565827686|FG004|Overall Study|Withdrawal by Subject|0|||
156748048|NCT03307837|565827687|FG005|Overall Study|Withdrawal by Subject|1|||
156748049|NCT03307837|565827682|FG000|Overall Study|Lost to Follow-up|1|||
156748050|NCT03307837|565827683|FG001|Overall Study|Lost to Follow-up|1|||
156748051|NCT03307837|565827684|FG002|Overall Study|Lost to Follow-up|0|||
156748052|NCT03307837|565827685|FG003|Overall Study|Lost to Follow-up|0|||
156748053|NCT03307837|565827686|FG004|Overall Study|Lost to Follow-up|0|||
156748054|NCT03307837|565827687|FG005|Overall Study|Lost to Follow-up|1|||
156748055|NCT03041467|565827688|FG000|Overall Study|Death|46|||
156748056|NCT03041467|565827689|FG001|Overall Study|Death|39|||
156748057|NCT03041467|565827688|FG000|Overall Study|Withdrawal by Subject|36|||
156748058|NCT03041467|565827689|FG001|Overall Study|Withdrawal by Subject|37|||
156748059|NCT03041467|565827688|FG000|Overall Study|Lost to Follow-up|6|||
156748060|NCT03041467|565827689|FG001|Overall Study|Lost to Follow-up|8|||
156748061|NCT03041467|565827688|FG000|Overall Study|Declined consent for study extension|21|||
156748062|NCT03041467|565827689|FG001|Overall Study|Declined consent for study extension|33|||
156748063|NCT03041467|565827688|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
156748064|NCT03041467|565827689|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
156748065|NCT04228965|565827693|FG000|Overall Study|Lost to Follow-up|26|||
156748066|NCT04228965|565827694|FG001|Overall Study|Lost to Follow-up|11|||
156748067|NCT04228965|565827693|FG000|Overall Study|Withdrawal by Subject|18|||
156748068|NCT04228965|565827694|FG001|Overall Study|Withdrawal by Subject|5|||
156748069|NCT00734656|565827697|FG000|Lab Session 1|Withdrawal by Subject|2|||
156748070|NCT00734656|565827698|FG001|Lab Session 1|Withdrawal by Subject|0|||
156748071|NCT00734656|565827699|FG002|Lab Session 1|Withdrawal by Subject|0|||
156748072|NCT00734656|565827700|FG003|Lab Session 1|Withdrawal by Subject|0|||
156748073|NCT00734656|565827697|FG000|Washout 1|Withdrawal by Subject|1|||
156748074|NCT00734656|565827698|FG001|Washout 1|Withdrawal by Subject|5|||
156748075|NCT00734656|565827699|FG002|Washout 1|Withdrawal by Subject|2|||
156748076|NCT00734656|565827700|FG003|Washout 1|Withdrawal by Subject|3|||
156748077|NCT00734656|565827697|FG000|Lab Session 2|Withdrawal by Subject|1|||
156748078|NCT00734656|565827698|FG001|Lab Session 2|Withdrawal by Subject|0|||
156748079|NCT00734656|565827699|FG002|Lab Session 2|Withdrawal by Subject|0|||
156748080|NCT00734656|565827700|FG003|Lab Session 2|Withdrawal by Subject|1|||
156748081|NCT00734656|565827697|FG000|Washout 2|Withdrawal by Subject|1|||
156748082|NCT00734656|565827698|FG001|Washout 2|Withdrawal by Subject|1|||
156748083|NCT00734656|565827699|FG002|Washout 2|Withdrawal by Subject|1|||
156748084|NCT00734656|565827700|FG003|Washout 2|Withdrawal by Subject|0|||
156748085|NCT00734656|565827697|FG000|Washout 3|Withdrawal by Subject|1|||
156748086|NCT00734656|565827698|FG001|Washout 3|Withdrawal by Subject|0|||
156748087|NCT00734656|565827699|FG002|Washout 3|Withdrawal by Subject|0|||
156748088|NCT00734656|565827700|FG003|Washout 3|Withdrawal by Subject|1|||
156748089|NCT00734656|565827697|FG000|Lab Session 4|Withdrawal by Subject|0|||
156748090|NCT00734656|565827698|FG001|Lab Session 4|Withdrawal by Subject|0|||
156748091|NCT00734656|565827699|FG002|Lab Session 4|Withdrawal by Subject|0|||
156748092|NCT00734656|565827700|FG003|Lab Session 4|Withdrawal by Subject|1|||
156748093|NCT03214679|565827701|FG000|Overall Study|Lost to Follow-up|12|||
156748094|NCT03214679|565827702|FG001|Overall Study|Lost to Follow-up|14|||
156748095|NCT03214679|565827701|FG000|Overall Study|not eligible|2|||
156748096|NCT03214679|565827702|FG001|Overall Study|not eligible|0|||
156748097|NCT03915626|565827703|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
156748098|NCT01754766|565827711|FG000|Overall Study|Personal reasons|1|||
156748099|NCT01754766|565827712|FG001|Overall Study|Personal reasons|1|||
156748100|NCT01754766|565827713|FG002|Overall Study|Personal reasons|0|||
156748101|NCT02469168|565827714|FG000|Overall Study|Trial closed|1|||
156748102|NCT02469168|565827715|FG001|Overall Study|Trial closed|0|||
156748103|NCT00298363|565827716|FG000|Overall Study|Lost to Follow-up|0|||
156748104|NCT00298363|565827717|FG001|Overall Study|Lost to Follow-up|0|||
156748105|NCT00298363|565827718|FG002|Overall Study|Lost to Follow-up|1|||
156748106|NCT00298363|565827716|FG000|Overall Study|Physician Decision|4|||
156748107|NCT00298363|565827717|FG001|Overall Study|Physician Decision|1|||
156748108|NCT00298363|565827718|FG002|Overall Study|Physician Decision|0|||
156748109|NCT00298363|565827716|FG000|Overall Study|Protocol Violation|1|||
156748110|NCT00298363|565827717|FG001|Overall Study|Protocol Violation|1|||
156748111|NCT00298363|565827718|FG002|Overall Study|Protocol Violation|0|||
156748112|NCT00298363|565827716|FG000|Overall Study|Withdrawal by Subject|5|||
156748113|NCT00298363|565827717|FG001|Overall Study|Withdrawal by Subject|1|||
156748114|NCT00298363|565827718|FG002|Overall Study|Withdrawal by Subject|3|||
156748115|NCT00298363|565827716|FG000|Overall Study|Adverse Event|5|||
156748116|NCT00298363|565827717|FG001|Overall Study|Adverse Event|2|||
156748117|NCT00298363|565827718|FG002|Overall Study|Adverse Event|2|||
156748118|NCT00298363|565827716|FG000|Overall Study|Lack of Efficacy|2|||
156748119|NCT00298363|565827717|FG001|Overall Study|Lack of Efficacy|3|||
156748120|NCT00298363|565827718|FG002|Overall Study|Lack of Efficacy|0|||
156748121|NCT00135356|565827719|FG000|Overall Study|Adverse Event|6|||
156748122|NCT00135356|565827720|FG001|Overall Study|Adverse Event|2|||
156337209|NCT02165215|564333577|FG001|Induction Phase|Withdrawal by Subject|0|||
156337210|NCT02165215|564333578|FG002|Induction Phase|Withdrawal by Subject|0|||
156748123|NCT00135356|565827719|FG000|Overall Study|Lack of Efficacy|2|||
156748124|NCT00135356|565827720|FG001|Overall Study|Lack of Efficacy|0|||
156748125|NCT00135356|565827719|FG000|Overall Study|Lost to Follow-up|3|||
156748126|NCT00135356|565827720|FG001|Overall Study|Lost to Follow-up|1|||
156748127|NCT00135356|565827719|FG000|Overall Study|Surgery for abdominal fat|1|||
156748128|NCT00135356|565827720|FG001|Overall Study|Surgery for abdominal fat|0|||
156748129|NCT00135356|565827719|FG000|Overall Study|Change in antiviral regimen|0|||
156748130|NCT00135356|565827720|FG001|Overall Study|Change in antiviral regimen|1|||
156748131|NCT00135356|565827719|FG000|Overall Study|Poor/noncompliance|1|||
156748132|NCT00135356|565827720|FG001|Overall Study|Poor/noncompliance|1|||
156748133|NCT00135356|565827719|FG000|Overall Study|No longer meets study criteria|2|||
156748134|NCT00135356|565827720|FG001|Overall Study|No longer meets study criteria|0|||
156748135|NCT00135356|565827719|FG000|Overall Study|Withdrawal by Subject|2|||
156748136|NCT00135356|565827720|FG001|Overall Study|Withdrawal by Subject|4|||
156748137|NCT01533688|565827721|FG000|Overall Study|Withdrawal by Subject|5|||
156748138|NCT01533688|565827722|FG001|Overall Study|Withdrawal by Subject|4|||
156748139|NCT01533688|565827723|FG002|Overall Study|Withdrawal by Subject|3|||
156748140|NCT01533688|565827721|FG000|Overall Study|Medically unstable|1|||
156748141|NCT01533688|565827722|FG001|Overall Study|Medically unstable|3|||
156748142|NCT01533688|565827723|FG002|Overall Study|Medically unstable|3|||
156748143|NCT01533688|565827721|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
156748144|NCT01533688|565827722|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
156748145|NCT01533688|565827723|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
156748146|NCT01306214|565827725|FG000|Overall Study|Death|0|||
156748147|NCT01306214|565827726|FG001|Overall Study|Death|0|||
156748148|NCT01306214|565827727|FG002|Overall Study|Death|1|||
156748149|NCT01306214|565827725|FG000|Overall Study|Lost to Follow-up|3|||
156748150|NCT01306214|565827726|FG001|Overall Study|Lost to Follow-up|5|||
156748151|NCT01306214|565827727|FG002|Overall Study|Lost to Follow-up|4|||
156748152|NCT01306214|565827725|FG000|Overall Study|Withdrawal by Subject|24|||
156748153|NCT01306214|565827726|FG001|Overall Study|Withdrawal by Subject|22|||
156748154|NCT01306214|565827727|FG002|Overall Study|Withdrawal by Subject|16|||
156748155|NCT01306214|565827725|FG000|Overall Study|Not treated|1|||
156748156|NCT01306214|565827726|FG001|Overall Study|Not treated|1|||
156748157|NCT01306214|565827727|FG002|Overall Study|Not treated|1|||
156748158|NCT02686814|565827728|FG000|Overall Study|Physician Decision|14|||
156748159|NCT02686814|565827728|FG000|Overall Study|Withdrawal by Subject|4|||
156748160|NCT02686814|565827728|FG000|Overall Study|Death|1|||
156748161|NCT01026818|565827731|FG000|Screening Period|Entry Criteria Not Met|105|||
156748162|NCT01026818|565827732|FG001|Screening Period|Entry Criteria Not Met|0|||
156748163|NCT01026818|565827733|FG002|Screening Period|Entry Criteria Not Met|0|||
156748164|NCT01026818|565827734|FG003|Screening Period|Entry Criteria Not Met|0|||
156748165|NCT01026818|565827731|FG000|Screening Period|Withdrawal by Subject|49|||
156748166|NCT01026818|565827732|FG001|Screening Period|Withdrawal by Subject|0|||
156748167|NCT01026818|565827733|FG002|Screening Period|Withdrawal by Subject|0|||
156748168|NCT01026818|565827734|FG003|Screening Period|Withdrawal by Subject|0|||
156748169|NCT01026818|565827731|FG000|Screening Period|Protocol Deviation|3|||
156748170|NCT01026818|565827732|FG001|Screening Period|Protocol Deviation|0|||
156748171|NCT01026818|565827733|FG002|Screening Period|Protocol Deviation|0|||
156748172|NCT01026818|565827734|FG003|Screening Period|Protocol Deviation|0|||
156748173|NCT01026818|565827731|FG000|Screening Period|Adverse Event|2|||
156748174|NCT01026818|565827732|FG001|Screening Period|Adverse Event|0|||
156748175|NCT01026818|565827733|FG002|Screening Period|Adverse Event|0|||
156748176|NCT01026818|565827734|FG003|Screening Period|Adverse Event|0|||
156748177|NCT01026818|565827731|FG000|Screening Period|Physician Decision|1|||
156748178|NCT01026818|565827732|FG001|Screening Period|Physician Decision|0|||
156748179|NCT01026818|565827733|FG002|Screening Period|Physician Decision|0|||
156748180|NCT01026818|565827734|FG003|Screening Period|Physician Decision|0|||
156748181|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
156748182|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
156337211|NCT02165215|564333576|FG000|Induction Phase|Protocol Violation|1|||
156337212|NCT02165215|564333577|FG001|Induction Phase|Protocol Violation|0|||
156748183|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
156748184|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
156748185|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
156748186|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
156337213|NCT02165215|564333578|FG002|Induction Phase|Protocol Violation|0|||
156337214|NCT02165215|564333576|FG000|Induction Phase|Physician Decision|1|||
156748187|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
156748188|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
156748189|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
156748190|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
156748191|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
156748192|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
156459138|NCT02240238|564776699|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156748193|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
156748194|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
156748195|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
156748196|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
156748197|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
156748198|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
156748199|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
156748200|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
156748201|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
156748202|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
156748203|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
156748204|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
156748205|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
156748206|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
156748207|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
156748208|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
156748209|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
156748210|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
156748211|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
156748212|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
156748213|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
156748214|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
156748215|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
156748216|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
156748217|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
156748218|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
156748219|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
156748220|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
156748221|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
156748222|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
156536883|NCT01514136|565059080|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
156536884|NCT01514136|565059081|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
156536885|NCT01514136|565059082|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
156536886|NCT01514136|565059083|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
156536887|NCT01514136|565059076|FG000|Test Period 2; Test C*|holiday|0|||
156536888|NCT01514136|565059077|FG001|Test Period 2; Test C*|holiday|0|||
156536889|NCT01514136|565059078|FG002|Test Period 2; Test C*|holiday|0|||
156536890|NCT01514136|565059079|FG003|Test Period 2; Test C*|holiday|0|||
156536891|NCT01514136|565059080|FG004|Test Period 2; Test C*|holiday|0|||
156536892|NCT01514136|565059081|FG005|Test Period 2; Test C*|holiday|0|||
156536893|NCT01514136|565059082|FG006|Test Period 2; Test C*|holiday|1|||
156536894|NCT01514136|565059083|FG007|Test Period 2; Test C*|holiday|0|||
156536895|NCT01514136|565059076|FG000|Test Period 2; Test C*|Protocol Violation|0|||
156536896|NCT01514136|565059077|FG001|Test Period 2; Test C*|Protocol Violation|0|||
156536897|NCT01514136|565059078|FG002|Test Period 2; Test C*|Protocol Violation|0|||
156536898|NCT01514136|565059079|FG003|Test Period 2; Test C*|Protocol Violation|0|||
156536899|NCT01514136|565059080|FG004|Test Period 2; Test C*|Protocol Violation|0|||
156536900|NCT01514136|565059081|FG005|Test Period 2; Test C*|Protocol Violation|0|||
156536901|NCT01514136|565059082|FG006|Test Period 2; Test C*|Protocol Violation|1|||
156536902|NCT01514136|565059083|FG007|Test Period 2; Test C*|Protocol Violation|0|||
156536903|NCT02729740|565059088|FG000|Overall Study|Early Termination|130|||
156536904|NCT02729740|565059088|FG000|Overall Study|Other|1|||
156536905|NCT00888381|565059089|FG000|Overall Study|Lost to Follow-up|0|||
156536906|NCT00888381|565059090|FG001|Overall Study|Lost to Follow-up|1|||
156536907|NCT00757003|565059094|FG000|Overall Study|Death|33|||
156536908|NCT00757003|565059094|FG000|Overall Study|Lost to Follow-up|9|||
156536909|NCT00757003|565059094|FG000|Overall Study|Withdrawal by Subject|4|||
156536910|NCT00757003|565059094|FG000|Overall Study|Surgically explanted|2|||
156536911|NCT00757003|565059094|FG000|Overall Study|Not implanted|1|||
156536912|NCT03044249|565059097|FG000|Overall Study|Adverse Event|4|||
156536913|NCT03044249|565059098|FG001|Overall Study|Adverse Event|9|||
156536914|NCT03044249|565059097|FG000|Overall Study|Lost to Follow-up|1|||
156536915|NCT03044249|565059098|FG001|Overall Study|Lost to Follow-up|0|||
156536916|NCT03044249|565059097|FG000|Overall Study|Non-compliance with Study Drug|1|||
156536917|NCT03044249|565059098|FG001|Overall Study|Non-compliance with Study Drug|0|||
156536918|NCT03044249|565059097|FG000|Overall Study|Study Terminated by Sponsor|2|||
156536919|NCT03044249|565059098|FG001|Overall Study|Study Terminated by Sponsor|0|||
156536920|NCT03044249|565059097|FG000|Overall Study|Withdrawal by Subject|2|||
156536921|NCT03044249|565059098|FG001|Overall Study|Withdrawal by Subject|5|||
156536922|NCT00955279|565059099|FG000|Overall Study|Other|0|||
156536923|NCT00955279|565059100|FG001|Overall Study|Other|0|||
156536924|NCT00955279|565059101|FG002|Overall Study|Other|3|||
156536925|NCT00955279|565059099|FG000|Overall Study|Death|1|||
156536926|NCT00955279|565059100|FG001|Overall Study|Death|1|||
156536927|NCT00955279|565059101|FG002|Overall Study|Death|1|||
156536928|NCT00955279|565059099|FG000|Overall Study|Lost to Follow-up|0|||
156536929|NCT00955279|565059100|FG001|Overall Study|Lost to Follow-up|3|||
156536930|NCT00955279|565059101|FG002|Overall Study|Lost to Follow-up|1|||
156748223|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
156748224|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
156748225|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
156748226|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
156748227|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
156748228|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
156748229|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
156800179|NCT00744861|566023381|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
156800180|NCT00744861|566023382|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
156800181|NCT00744861|566023383|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
156800182|NCT00744861|566023384|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
156800183|NCT02493764|566023385|FG000|Overall Study|Adverse Event|2|||
156536931|NCT00955279|565059099|FG000|Overall Study|Withdrawal by Subject|2|||
156536932|NCT00955279|565059100|FG001|Overall Study|Withdrawal by Subject|0|||
156536933|NCT00955279|565059101|FG002|Overall Study|Withdrawal by Subject|3|||
156536934|NCT03785678|565059102|FG000|Overall Study|Death|44|||
156536935|NCT03785678|565059103|FG001|Overall Study|Death|42|||
156536936|NCT03785678|565059102|FG000|Overall Study|Lost to Follow-up|4|||
156536937|NCT03785678|565059103|FG001|Overall Study|Lost to Follow-up|2|||
156536938|NCT03785678|565059102|FG000|Overall Study|Physician Decision|0|||
156536939|NCT03785678|565059103|FG001|Overall Study|Physician Decision|2|||
156536940|NCT03785678|565059102|FG000|Overall Study|Withdrawal by Subject|5|||
156536941|NCT03785678|565059103|FG001|Overall Study|Withdrawal by Subject|3|||
156536942|NCT01159912|565059104|FG000|Overall Study|Adverse Event|2|||
156536943|NCT01159912|565059105|FG001|Overall Study|Adverse Event|2|||
156536944|NCT01159912|565059106|FG002|Overall Study|Adverse Event|3|||
156536945|NCT01159912|565059104|FG000|Overall Study|Lack of Efficacy|23|||
156536946|NCT01159912|565059105|FG001|Overall Study|Lack of Efficacy|15|||
156536947|NCT01159912|565059106|FG002|Overall Study|Lack of Efficacy|14|||
156748230|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
156748231|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
156748232|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
156748233|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
156748234|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
156748235|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
156748236|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
156748237|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
156748238|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
156748239|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
156748240|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
156748241|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
156748242|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
156748243|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
156748244|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
156748245|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
156748246|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
156748247|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
156748248|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
156748249|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
156748250|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
156748251|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
156748252|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
156748253|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
156748254|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
156748255|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
156748256|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
156748257|NCT03300050|565827737|FG000|Overall Study|Lost to Follow-up|2|||
156748258|NCT03300050|565827738|FG001|Overall Study|Lost to Follow-up|1|||
156748259|NCT03300050|565827739|FG002|Overall Study|Lost to Follow-up|0|||
156748260|NCT03300050|565827740|FG003|Overall Study|Lost to Follow-up|0|||
156748261|NCT03300050|565827741|FG004|Overall Study|Lost to Follow-up|1|||
156748262|NCT03300050|565827737|FG000|Overall Study|Withdrawal by Subject|1|||
156748263|NCT03300050|565827738|FG001|Overall Study|Withdrawal by Subject|1|||
156748264|NCT03300050|565827739|FG002|Overall Study|Withdrawal by Subject|1|||
156748265|NCT03300050|565827740|FG003|Overall Study|Withdrawal by Subject|0|||
156748266|NCT03300050|565827741|FG004|Overall Study|Withdrawal by Subject|0|||
156748267|NCT03300050|565827737|FG000|Overall Study|Death|0|||
156748268|NCT03300050|565827738|FG001|Overall Study|Death|0|||
156748269|NCT03300050|565827739|FG002|Overall Study|Death|1|||
156800184|NCT02493764|566023386|FG001|Overall Study|Adverse Event|2|||
156800185|NCT02493764|566023385|FG000|Overall Study|Death|44|||
156800186|NCT02493764|566023386|FG001|Overall Study|Death|58|||
156459139|NCT02240238|564776700|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156459140|NCT02240238|564776701|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
156459141|NCT02240238|564776702|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156459142|NCT02240238|564776703|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
156459143|NCT02240238|564776692|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459144|NCT02240238|564776693|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459145|NCT02240238|564776694|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459146|NCT02240238|564776695|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459147|NCT02240238|564776696|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459148|NCT02240238|564776697|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459149|NCT02240238|564776698|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459150|NCT02240238|564776699|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459151|NCT02240238|564776700|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459152|NCT02240238|564776701|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459153|NCT02240238|564776702|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
156459154|NCT02240238|564776703|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
156459155|NCT02240238|564776692|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156459156|NCT02240238|564776693|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156459157|NCT02240238|564776694|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156459158|NCT02240238|564776695|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156748270|NCT03300050|565827740|FG003|Overall Study|Death|0|||
156748271|NCT03300050|565827741|FG004|Overall Study|Death|0|||
156748272|NCT03300050|565827737|FG000|Overall Study|Not Eligible at Randomization|0|||
156748273|NCT03300050|565827738|FG001|Overall Study|Not Eligible at Randomization|0|||
156748274|NCT03300050|565827739|FG002|Overall Study|Not Eligible at Randomization|1|||
156748275|NCT03300050|565827740|FG003|Overall Study|Not Eligible at Randomization|1|||
156800187|NCT02493764|566023385|FG000|Overall Study|Lost to Follow-up|2|||
156337215|NCT02165215|564333577|FG001|Induction Phase|Physician Decision|0|||
156337216|NCT02165215|564333578|FG002|Induction Phase|Physician Decision|0|||
156337217|NCT02165215|564333576|FG000|Induction Phase|Lack of Efficacy|2|||
156337218|NCT02165215|564333577|FG001|Induction Phase|Lack of Efficacy|0|||
156337219|NCT02165215|564333578|FG002|Induction Phase|Lack of Efficacy|0|||
156337220|NCT02165215|564333576|FG000|Induction Phase|Non-Compliance|2|||
156748276|NCT03300050|565827741|FG004|Overall Study|Not Eligible at Randomization|0|||
156748277|NCT01214668|565827742|FG000|Overall Study|Adverse Event|0|||
156748278|NCT01214668|565827743|FG001|Overall Study|Adverse Event|1|||
156748279|NCT01214668|565827744|FG002|Overall Study|Adverse Event|0|||
156748280|NCT01214668|565827745|FG003|Overall Study|Adverse Event|2|||
156748281|NCT01214668|565827746|FG004|Overall Study|Adverse Event|1|||
156748282|NCT01214668|565827747|FG005|Overall Study|Adverse Event|1|||
156748283|NCT01214668|565827742|FG000|Overall Study|Death|0|||
156536948|NCT01159912|565059104|FG000|Overall Study|Protocol Violation|1|||
156748284|NCT01214668|565827743|FG001|Overall Study|Death|0|||
156536949|NCT01159912|565059105|FG001|Overall Study|Protocol Violation|2|||
156748285|NCT01214668|565827744|FG002|Overall Study|Death|1|||
156748286|NCT01214668|565827745|FG003|Overall Study|Death|0|||
156748287|NCT01214668|565827746|FG004|Overall Study|Death|0|||
156748288|NCT01214668|565827747|FG005|Overall Study|Death|0|||
156748289|NCT01214668|565827742|FG000|Overall Study|Progressive Disease|4|||
156748290|NCT01214668|565827743|FG001|Overall Study|Progressive Disease|2|||
156748291|NCT01214668|565827744|FG002|Overall Study|Progressive Disease|5|||
156748292|NCT01214668|565827745|FG003|Overall Study|Progressive Disease|4|||
156748293|NCT01214668|565827746|FG004|Overall Study|Progressive Disease|4|||
156748294|NCT01214668|565827747|FG005|Overall Study|Progressive Disease|5|||
156748295|NCT01214668|565827742|FG000|Overall Study|Withdrawal by Subject|0|||
156748296|NCT01214668|565827743|FG001|Overall Study|Withdrawal by Subject|0|||
156748297|NCT01214668|565827744|FG002|Overall Study|Withdrawal by Subject|0|||
156748298|NCT01214668|565827745|FG003|Overall Study|Withdrawal by Subject|0|||
156748299|NCT01214668|565827746|FG004|Overall Study|Withdrawal by Subject|1|||
156748300|NCT01214668|565827747|FG005|Overall Study|Withdrawal by Subject|0|||
156748301|NCT02907619|565827748|FG000|Overall Study|Study terminated by sponsor|18|||
156748302|NCT02907619|565827749|FG001|Overall Study|Study terminated by sponsor|18|||
156748303|NCT02907619|565827750|FG002|Overall Study|Study terminated by sponsor|19|||
156748304|NCT02907619|565827748|FG000|Overall Study|Death|0|||
156748305|NCT02907619|565827749|FG001|Overall Study|Death|0|||
156748306|NCT02907619|565827750|FG002|Overall Study|Death|1|||
156748307|NCT02907619|565827748|FG000|Overall Study|Withdrawal by Subject|1|||
156748308|NCT02907619|565827749|FG001|Overall Study|Withdrawal by Subject|1|||
156748309|NCT02907619|565827750|FG002|Overall Study|Withdrawal by Subject|0|||
156748310|NCT02907619|565827748|FG000|Overall Study|Other|0|||
156748311|NCT02907619|565827749|FG001|Overall Study|Other|1|||
156748312|NCT02907619|565827750|FG002|Overall Study|Other|0|||
156748313|NCT03326518|565827751|FG000|Overall Study|Protocol Violation|1|||
156748314|NCT03326518|565827752|FG001|Overall Study|Protocol Violation|0|||
156748315|NCT03326518|565827753|FG002|Overall Study|Protocol Violation|0|||
156748316|NCT03326518|565827751|FG000|Overall Study|Withdrawal by Subject|1|||
156748317|NCT03326518|565827752|FG001|Overall Study|Withdrawal by Subject|0|||
156748318|NCT03326518|565827753|FG002|Overall Study|Withdrawal by Subject|0|||
156748319|NCT03326518|565827751|FG000|Overall Study|Lost to Follow-up|1|||
156748320|NCT03326518|565827752|FG001|Overall Study|Lost to Follow-up|0|||
156748321|NCT03326518|565827753|FG002|Overall Study|Lost to Follow-up|1|||
156748322|NCT01375374|565827754|FG000|Overall Study|Adverse Event|1|||
156748323|NCT01908582|565827755|FG000|Period 2|Physician Decision|1|||
156748324|NCT01908582|565827755|FG000|Period 2|Withdrawal by Subject|1|||
156748325|NCT02065518|565827756|FG000|Overall Study|Lost to Follow-up|3|||
156748326|NCT02065518|565827757|FG001|Overall Study|Lost to Follow-up|4|||
156748327|NCT02065518|565827758|FG002|Overall Study|Lost to Follow-up|0|||
156748328|NCT02065518|565827759|FG003|Overall Study|Lost to Follow-up|3|||
156748329|NCT02065518|565827756|FG000|Overall Study|Withdrawal by Subject|3|||
156748330|NCT02065518|565827757|FG001|Overall Study|Withdrawal by Subject|4|||
156748331|NCT02065518|565827758|FG002|Overall Study|Withdrawal by Subject|9|||
156748332|NCT02065518|565827759|FG003|Overall Study|Withdrawal by Subject|2|||
156748333|NCT01066663|565827761|FG000|Overall Study|Adverse Event|0|||
156748334|NCT01066663|565827762|FG001|Overall Study|Adverse Event|0|||
156748335|NCT01066663|565827763|FG002|Overall Study|Adverse Event|1|||
156748336|NCT01090050|565827764|FG000|Overall Study|Lost to Follow-up|0|||
156748337|NCT01090050|565827765|FG001|Overall Study|Lost to Follow-up|1|||
156748338|NCT01090050|565827764|FG000|Overall Study|Lack of Efficacy|1|||
156748339|NCT01090050|565827765|FG001|Overall Study|Lack of Efficacy|5|||
156748340|NCT01090050|565827764|FG000|Overall Study|Physician Decision|0|||
156748341|NCT01090050|565827765|FG001|Overall Study|Physician Decision|1|||
156536950|NCT01159912|565059106|FG002|Overall Study|Protocol Violation|3|||
156748342|NCT02232061|565827766|FG000|Overall Study|Administrative problems|1|||
156748343|NCT02232061|565827766|FG000|Overall Study|Withdrawal by Subject|1|||
156748344|NCT00571103|565827767|FG000|Overall Study|Withdrawal by Subject|1|||
156536951|NCT01159912|565059104|FG000|Overall Study|Lost to Follow-up|4|||
156748345|NCT00571103|565827767|FG000|Overall Study|Lost to Follow-up|1|||
156748346|NCT06439095|565827768|FG000|Overall Study|Lost to Follow-up|2|||
156748347|NCT02368886|565827769|FG000|Overall Study|Cancel|1|||
156748348|NCT02368886|565827770|FG001|Overall Study|Cancel|1|||
156748349|NCT02368886|565827771|FG002|Overall Study|Cancel|1|||
156748350|NCT02368886|565827772|FG003|Overall Study|Cancel|3|||
156748351|NCT02368886|565827769|FG000|Overall Study|Ineligible|0|||
156748352|NCT02368886|565827770|FG001|Overall Study|Ineligible|0|||
156748353|NCT02368886|565827771|FG002|Overall Study|Ineligible|0|||
156748354|NCT02368886|565827772|FG003|Overall Study|Ineligible|1|||
156748355|NCT03484403|565827774|FG000|Overall Study|Withdrawal by Subject|6|||
156748356|NCT03484403|565827775|FG001|Overall Study|Withdrawal by Subject|4|||
156748357|NCT04278924|565827776|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
156748358|NCT04278924|565827777|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
156748359|NCT04278924|565827778|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
156748360|NCT04278924|565827779|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
156748361|NCT04278924|565827780|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
156748362|NCT04278924|565827781|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
156748363|NCT04278924|565827782|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
156748364|NCT04278924|565827776|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748365|NCT04278924|565827777|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
156748366|NCT04278924|565827778|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748367|NCT04278924|565827779|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748368|NCT04278924|565827780|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748369|NCT04278924|565827781|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748370|NCT04278924|565827782|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748371|NCT04767529|565827783|FG000|Overall Study|Adverse Event|0|||
156748372|NCT04767529|565827784|FG001|Overall Study|Adverse Event|4|||
156748373|NCT04767529|565827785|FG002|Overall Study|Adverse Event|3|||
156748374|NCT04767529|565827783|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
156748375|NCT04767529|565827784|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
156748376|NCT04767529|565827785|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
156748377|NCT04767529|565827783|FG000|Overall Study|Required use of a prohibited medication|0|||
156748378|NCT04767529|565827784|FG001|Overall Study|Required use of a prohibited medication|1|||
156748379|NCT04767529|565827785|FG002|Overall Study|Required use of a prohibited medication|0|||
156748380|NCT04767529|565827783|FG000|Overall Study|Withdrawal by Subject|7|||
156748381|NCT04767529|565827784|FG001|Overall Study|Withdrawal by Subject|5|||
156748382|NCT04767529|565827785|FG002|Overall Study|Withdrawal by Subject|4|||
156748383|NCT04767529|565827783|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
156748384|NCT04767529|565827784|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
156748385|NCT04767529|565827785|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
156748386|NCT04767529|565827783|FG000|Overall Study|Lost to Follow-up|0|||
156748387|NCT04767529|565827784|FG001|Overall Study|Lost to Follow-up|2|||
156748388|NCT04767529|565827785|FG002|Overall Study|Lost to Follow-up|3|||
156748389|NCT00253370|565827786|FG000|Overall Study|Adverse Event|18|||
156748390|NCT00253370|565827786|FG000|Overall Study|Disease progression|13|||
156748391|NCT00253370|565827786|FG000|Overall Study|Death|2|||
156748392|NCT00253370|565827786|FG000|Overall Study|Withdrawal by Subject|6|||
156748393|NCT00253370|565827786|FG000|Overall Study|Non-protocol therapy|1|||
156748394|NCT00253370|565827786|FG000|Overall Study|Physician Decision|1|||
156748395|NCT00253370|565827786|FG000|Overall Study|Protocol Violation|1|||
156748396|NCT00253370|565827786|FG000|Overall Study|Abdominal pain due to disease|1|||
156748397|NCT02697591|565827787|FG000|Overall Study|Lost to Follow-up|0|||
156748398|NCT02697591|565827788|FG001|Overall Study|Lost to Follow-up|0|||
156748399|NCT02697591|565827789|FG002|Overall Study|Lost to Follow-up|0|||
156748400|NCT02697591|565827790|FG003|Overall Study|Lost to Follow-up|0|||
156748401|NCT02697591|565827791|FG004|Overall Study|Lost to Follow-up|0|||
156748402|NCT02697591|565827792|FG005|Overall Study|Lost to Follow-up|1|||
156748403|NCT02697591|565827793|FG006|Overall Study|Lost to Follow-up|1|||
156748404|NCT02697591|565827794|FG007|Overall Study|Lost to Follow-up|0|||
156748405|NCT02697591|565827795|FG008|Overall Study|Lost to Follow-up|0|||
156748406|NCT02697591|565827796|FG009|Overall Study|Lost to Follow-up|1|||
156748407|NCT02697591|565827787|FG000|Overall Study|Withdrawal by Subject|1|||
156748408|NCT02697591|565827788|FG001|Overall Study|Withdrawal by Subject|1|||
156748409|NCT02697591|565827789|FG002|Overall Study|Withdrawal by Subject|2|||
156748410|NCT02697591|565827790|FG003|Overall Study|Withdrawal by Subject|1|||
156748411|NCT02697591|565827791|FG004|Overall Study|Withdrawal by Subject|7|||
156748412|NCT02697591|565827792|FG005|Overall Study|Withdrawal by Subject|6|||
156748413|NCT02697591|565827793|FG006|Overall Study|Withdrawal by Subject|9|||
156748414|NCT02697591|565827794|FG007|Overall Study|Withdrawal by Subject|1|||
156748415|NCT02697591|565827795|FG008|Overall Study|Withdrawal by Subject|6|||
156748416|NCT02697591|565827796|FG009|Overall Study|Withdrawal by Subject|10|||
156748417|NCT02697591|565827787|FG000|Overall Study|Physician Decision|1|||
156748418|NCT02697591|565827788|FG001|Overall Study|Physician Decision|0|||
156748419|NCT02697591|565827789|FG002|Overall Study|Physician Decision|0|||
156748420|NCT02697591|565827790|FG003|Overall Study|Physician Decision|0|||
156748421|NCT02697591|565827791|FG004|Overall Study|Physician Decision|1|||
156748422|NCT02697591|565827792|FG005|Overall Study|Physician Decision|2|||
156748423|NCT02697591|565827793|FG006|Overall Study|Physician Decision|0|||
156748424|NCT02697591|565827794|FG007|Overall Study|Physician Decision|0|||
156748425|NCT02697591|565827795|FG008|Overall Study|Physician Decision|1|||
156748426|NCT02697591|565827796|FG009|Overall Study|Physician Decision|1|||
156748427|NCT02697591|565827787|FG000|Overall Study|Death|2|||
156748428|NCT02697591|565827788|FG001|Overall Study|Death|3|||
156748429|NCT02697591|565827789|FG002|Overall Study|Death|1|||
156748430|NCT02697591|565827790|FG003|Overall Study|Death|1|||
156748431|NCT02697591|565827791|FG004|Overall Study|Death|4|||
156748432|NCT02697591|565827792|FG005|Overall Study|Death|5|||
156748433|NCT02697591|565827793|FG006|Overall Study|Death|3|||
156748434|NCT02697591|565827794|FG007|Overall Study|Death|1|||
156748435|NCT02697591|565827795|FG008|Overall Study|Death|1|||
156748436|NCT02697591|565827796|FG009|Overall Study|Death|5|||
156748437|NCT02697591|565827787|FG000|Overall Study|Reason not Specified|0|||
156748438|NCT02697591|565827788|FG001|Overall Study|Reason not Specified|0|||
156748439|NCT02697591|565827789|FG002|Overall Study|Reason not Specified|0|||
156748440|NCT02697591|565827790|FG003|Overall Study|Reason not Specified|1|||
156748441|NCT02697591|565827791|FG004|Overall Study|Reason not Specified|1|||
156748442|NCT02697591|565827792|FG005|Overall Study|Reason not Specified|2|||
156748443|NCT02697591|565827793|FG006|Overall Study|Reason not Specified|3|||
156748444|NCT02697591|565827794|FG007|Overall Study|Reason not Specified|1|||
156748445|NCT02697591|565827795|FG008|Overall Study|Reason not Specified|1|||
156748446|NCT02697591|565827796|FG009|Overall Study|Reason not Specified|3|||
156748447|NCT00004088|565827798|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
156748448|NCT00004088|565827798|FG000|Overall Study|Withdrawal by Subject|1|||
156748449|NCT00004088|565827798|FG000|Overall Study|Protocol Violation|3|||
156748450|NCT00004088|565827798|FG000|Overall Study|Physician Decision|1|||
156748451|NCT03624569|565827800|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156748452|NCT03624569|565827801|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
156748453|NCT03624569|565827800|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
156748454|NCT03624569|565827801|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
156748455|NCT00803205|565827802|FG000|Overall Study|Adverse Event|7|||
156748456|NCT00803205|565827803|FG001|Overall Study|Adverse Event|2|||
156748457|NCT00803205|565827802|FG000|Overall Study|Lost to Follow-up|1|||
156748458|NCT00803205|565827803|FG001|Overall Study|Lost to Follow-up|0|||
156748459|NCT00803205|565827802|FG000|Overall Study|Withdrawal by Subject|9|||
156337221|NCT02165215|564333577|FG001|Induction Phase|Non-Compliance|0|||
156748460|NCT00803205|565827803|FG001|Overall Study|Withdrawal by Subject|9|||
156748461|NCT00803205|565827802|FG000|Overall Study|Physician Decision|1|||
156748462|NCT00803205|565827803|FG001|Overall Study|Physician Decision|0|||
156748463|NCT00803205|565827802|FG000|Overall Study|Protocol Violation|1|||
156748464|NCT00803205|565827803|FG001|Overall Study|Protocol Violation|1|||
156748465|NCT00803205|565827802|FG000|Overall Study|Medical Monitor Decision|1|||
156748466|NCT00803205|565827803|FG001|Overall Study|Medical Monitor Decision|0|||
156748467|NCT00803205|565827802|FG000|Overall Study|Acquired a Lung Infection|0|||
156748468|NCT00803205|565827803|FG001|Overall Study|Acquired a Lung Infection|1|||
156748469|NCT00803205|565827802|FG000|Overall Study|Sponsor Decision|0|||
156748470|NCT00803205|565827803|FG001|Overall Study|Sponsor Decision|1|||
156748471|NCT02735096|565827809|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
156748472|NCT01080391|565827817|FG000|Overall Study|Randomized but not treated|7|||
156748473|NCT01080391|565827818|FG001|Overall Study|Randomized but not treated|4|||
156748474|NCT02083653|565827819|FG000|Overall Study|Randomized but not Treated|0|||
156748475|NCT02083653|565827820|FG001|Overall Study|Randomized but not Treated|2|||
156748476|NCT02083653|565827821|FG002|Overall Study|Randomized but not Treated|7|||
156748477|NCT02083653|565827819|FG000|Overall Study|Adverse Event|12|||
156748478|NCT02083653|565827820|FG001|Overall Study|Adverse Event|5|||
156748479|NCT02083653|565827821|FG002|Overall Study|Adverse Event|4|||
156748480|NCT02083653|565827819|FG000|Overall Study|Lost to Follow-up|1|||
156748481|NCT02083653|565827820|FG001|Overall Study|Lost to Follow-up|0|||
156748482|NCT02083653|565827821|FG002|Overall Study|Lost to Follow-up|0|||
156748483|NCT02083653|565827819|FG000|Overall Study|Death|2|||
156748484|NCT02083653|565827820|FG001|Overall Study|Death|2|||
156748485|NCT02083653|565827821|FG002|Overall Study|Death|2|||
156748486|NCT02083653|565827819|FG000|Overall Study|Progressive Disease|65|||
156748487|NCT02083653|565827820|FG001|Overall Study|Progressive Disease|73|||
156748488|NCT02083653|565827821|FG002|Overall Study|Progressive Disease|63|||
156748489|NCT02083653|565827819|FG000|Overall Study|Withdrawal by Subject|2|||
156748490|NCT02083653|565827820|FG001|Overall Study|Withdrawal by Subject|1|||
156748491|NCT02083653|565827821|FG002|Overall Study|Withdrawal by Subject|2|||
156748492|NCT02083653|565827819|FG000|Overall Study|Other Events|0|||
156748493|NCT02083653|565827820|FG001|Overall Study|Other Events|2|||
156748494|NCT02083653|565827821|FG002|Overall Study|Other Events|2|||
156748495|NCT02083653|565827819|FG000|Overall Study|Reason Missing|0|||
156748496|NCT02083653|565827820|FG001|Overall Study|Reason Missing|0|||
156748497|NCT02083653|565827821|FG002|Overall Study|Reason Missing|4|||
156748498|NCT02536781|565827822|FG000|Overall Study|Lost to Follow-up|2|||
156748499|NCT02536781|565827823|FG001|Overall Study|Lost to Follow-up|0|||
156748500|NCT03423147|565827824|FG000|Overall Study|Lost to Follow-up|5|||
156748501|NCT03423147|565827825|FG001|Overall Study|Lost to Follow-up|8|||
156748502|NCT03423147|565827824|FG000|Overall Study|Withdrawal by Subject|1|||
156748503|NCT03423147|565827825|FG001|Overall Study|Withdrawal by Subject|0|||
156748504|NCT03423147|565827824|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
156748505|NCT03423147|565827825|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
156748506|NCT03423147|565827824|FG000|Overall Study|Age < 18|1|||
156748507|NCT03423147|565827825|FG001|Overall Study|Age < 18|0|||
156748508|NCT03423147|565827824|FG000|Overall Study|No Trial of Labor|0|||
156748509|NCT03423147|565827825|FG001|Overall Study|No Trial of Labor|1|||
156748510|NCT01048099|565827826|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
156748511|NCT01048099|565827826|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
156748512|NCT00508157|565827827|FG000|Overall Study|Adverse Event|0|||
156748513|NCT00508157|565827828|FG001|Overall Study|Adverse Event|1|||
156748514|NCT00508157|565827827|FG000|Overall Study|Subject Withdrew Consent|1|||
156748515|NCT00508157|565827828|FG001|Overall Study|Subject Withdrew Consent|0|||
156748516|NCT00508157|565827827|FG000|Overall Study|Lost to Follow-up|1|||
156748517|NCT00508157|565827828|FG001|Overall Study|Lost to Follow-up|0|||
156748518|NCT00508157|565827827|FG000|Overall Study|Subject no longer met study criteria|0|||
156748519|NCT00508157|565827828|FG001|Overall Study|Subject no longer met study criteria|1|||
156748520|NCT00508157|565827827|FG000|Overall Study|Other known cause|0|||
156748521|NCT00508157|565827828|FG001|Overall Study|Other known cause|1|||
156748522|NCT01324570|565827829|FG000|Overall Study|Adverse Event|4|||
156748523|NCT01324570|565827830|FG001|Overall Study|Adverse Event|7|||
156748524|NCT01324570|565827829|FG000|Overall Study|Withdrawal by Subject|0|||
156748525|NCT01324570|565827830|FG001|Overall Study|Withdrawal by Subject|3|||
156748526|NCT01324570|565827829|FG000|Overall Study|Lack of Efficacy|0|||
156748527|NCT01324570|565827830|FG001|Overall Study|Lack of Efficacy|1|||
156748528|NCT01324570|565827829|FG000|Overall Study|Confirmed or suspected diversion|0|||
156748529|NCT01324570|565827830|FG001|Overall Study|Confirmed or suspected diversion|1|||
156748530|NCT01324570|565827829|FG000|Overall Study|Administrative|0|||
156748531|NCT01324570|565827830|FG001|Overall Study|Administrative|2|||
156748532|NCT00207727|565827831|FG000|Overall Study|Withdrawal by Subject|0|||
156748533|NCT00207727|565827832|FG001|Overall Study|Withdrawal by Subject|0|||
156748534|NCT00207727|565827833|FG002|Overall Study|Withdrawal by Subject|0|||
156748535|NCT00207727|565827834|FG003|Overall Study|Withdrawal by Subject|0|||
156748536|NCT00207727|565827835|FG004|Overall Study|Withdrawal by Subject|1|||
156748537|NCT00207727|565827831|FG000|Overall Study|Lost to Follow-up|0|||
156748538|NCT00207727|565827832|FG001|Overall Study|Lost to Follow-up|1|||
156748539|NCT00207727|565827833|FG002|Overall Study|Lost to Follow-up|0|||
156748540|NCT00207727|565827834|FG003|Overall Study|Lost to Follow-up|0|||
156748541|NCT00207727|565827835|FG004|Overall Study|Lost to Follow-up|0|||
156748542|NCT00207727|565827831|FG000|Overall Study|Other|38|||
156748543|NCT00207727|565827832|FG001|Overall Study|Other|41|||
156800188|NCT02493764|566023386|FG001|Overall Study|Lost to Follow-up|1|||
156800189|NCT02493764|566023385|FG000|Overall Study|Protocol Violation|6|||
156800190|NCT02493764|566023386|FG001|Overall Study|Protocol Violation|7|||
156800191|NCT02493764|566023385|FG000|Overall Study|Physician Decision|1|||
156748544|NCT00207727|565827833|FG002|Overall Study|Other|41|||
156748545|NCT00207727|565827834|FG003|Overall Study|Other|37|||
156748546|NCT00207727|565827835|FG004|Overall Study|Other|33|||
156748547|NCT03611582|565827841|FG000|Overall Study|Adverse Event|26|||
156748548|NCT03611582|565827842|FG001|Overall Study|Adverse Event|6|||
156748549|NCT03611582|565827841|FG000|Overall Study|Protocol Violation|0|||
156748550|NCT03611582|565827842|FG001|Overall Study|Protocol Violation|1|||
156748551|NCT03611582|565827841|FG000|Overall Study|Pregnancy|1|||
156748552|NCT03611582|565827842|FG001|Overall Study|Pregnancy|2|||
156800192|NCT02493764|566023386|FG001|Overall Study|Physician Decision|1|||
156748553|NCT03611582|565827841|FG000|Overall Study|Lack of Efficacy|0|||
156748554|NCT03611582|565827842|FG001|Overall Study|Lack of Efficacy|1|||
156800193|NCT02493764|566023385|FG000|Overall Study|Participant moved|17|||
156800194|NCT02493764|566023386|FG001|Overall Study|Participant moved|5|||
156800195|NCT02493764|566023385|FG000|Overall Study|Withdrawal parent/guardian|0|||
156800196|NCT02493764|566023386|FG001|Overall Study|Withdrawal parent/guardian|1|||
156800197|NCT02493764|566023385|FG000|Overall Study|Withdrawal by Subject|11|||
156800198|NCT02493764|566023386|FG001|Overall Study|Withdrawal by Subject|7|||
156800199|NCT01561976|566023387|FG000|Period 1|Adverse Event|0|||
156800200|NCT01561976|566023388|FG001|Period 1|Adverse Event|0|||
156800201|NCT01561976|566023389|FG002|Period 1|Adverse Event|1|||
156800202|NCT01561976|566023390|FG003|Period 1|Adverse Event|0|||
156800203|NCT01561976|566023391|FG004|Period 1|Adverse Event|0|||
156800204|NCT01561976|566023392|FG005|Period 1|Adverse Event|0|||
156800205|NCT01561976|566023387|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
156800206|NCT01561976|566023388|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
156800207|NCT01561976|566023389|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
156800208|NCT01561976|566023390|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
156800209|NCT01561976|566023391|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
156800210|NCT01561976|566023392|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
156800211|NCT01561976|566023387|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800212|NCT01561976|566023388|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800213|NCT01561976|566023389|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800214|NCT01561976|566023390|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800215|NCT01561976|566023391|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800216|NCT01561976|566023392|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156800217|NCT01561976|566023387|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
156800218|NCT01561976|566023388|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
156800219|NCT01561976|566023389|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
156800220|NCT01561976|566023390|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
156800221|NCT01561976|566023391|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
156800222|NCT01561976|566023392|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
156800223|NCT01977222|566023399|FG000|Overall Study|Withdrawal by Subject|1|||
156800224|NCT04846231|566023403|FG000|Overall Study|Lost to Follow-up|1|||
156800225|NCT04846231|566023404|FG001|Overall Study|Lost to Follow-up|0|||
156800226|NCT04846231|566023405|FG002|Overall Study|Lost to Follow-up|0|||
156800227|NCT04846231|566023406|FG003|Overall Study|Lost to Follow-up|0|||
156800228|NCT04846231|566023407|FG004|Overall Study|Lost to Follow-up|0|||
156800229|NCT04846231|566023408|FG005|Overall Study|Lost to Follow-up|0|||
156800230|NCT04846231|566023409|FG006|Overall Study|Lost to Follow-up|0|||
156800231|NCT04846231|566023410|FG007|Overall Study|Lost to Follow-up|1|||
156800232|NCT04846231|566023403|FG000|Overall Study|Withdrawal by Subject|0|||
156800233|NCT04846231|566023404|FG001|Overall Study|Withdrawal by Subject|1|||
156800234|NCT04846231|566023405|FG002|Overall Study|Withdrawal by Subject|2|||
156800235|NCT04846231|566023406|FG003|Overall Study|Withdrawal by Subject|1|||
156800236|NCT04846231|566023407|FG004|Overall Study|Withdrawal by Subject|0|||
156800237|NCT04846231|566023408|FG005|Overall Study|Withdrawal by Subject|0|||
156800238|NCT04846231|566023409|FG006|Overall Study|Withdrawal by Subject|0|||
156800239|NCT04846231|566023410|FG007|Overall Study|Withdrawal by Subject|0|||
156800240|NCT04846231|566023403|FG000|Overall Study|Protocol Violation|0|||
156800241|NCT04846231|566023404|FG001|Overall Study|Protocol Violation|1|||
156800242|NCT04846231|566023405|FG002|Overall Study|Protocol Violation|0|||
156800243|NCT04846231|566023406|FG003|Overall Study|Protocol Violation|0|||
156800244|NCT04846231|566023407|FG004|Overall Study|Protocol Violation|0|||
156800245|NCT04846231|566023408|FG005|Overall Study|Protocol Violation|0|||
156800246|NCT04846231|566023409|FG006|Overall Study|Protocol Violation|0|||
156800247|NCT04846231|566023410|FG007|Overall Study|Protocol Violation|0|||
156800248|NCT04846231|566023403|FG000|Overall Study|Adverse Event|0|||
156800249|NCT04846231|566023404|FG001|Overall Study|Adverse Event|0|||
156800250|NCT04846231|566023405|FG002|Overall Study|Adverse Event|0|||
156800251|NCT04846231|566023406|FG003|Overall Study|Adverse Event|0|||
156800252|NCT04846231|566023407|FG004|Overall Study|Adverse Event|0|||
156800253|NCT04846231|566023408|FG005|Overall Study|Adverse Event|0|||
156800254|NCT04846231|566023409|FG006|Overall Study|Adverse Event|1|||
156800255|NCT04846231|566023410|FG007|Overall Study|Adverse Event|1|||
156800256|NCT02980107|566023411|FG000|Overall Study|Withdrawal by Subject|51|||
156800257|NCT02980107|566023412|FG001|Overall Study|Withdrawal by Subject|62|||
156800258|NCT02412670|566023413|FG000|Overall Study|Adverse Event|4|||
156800259|NCT02412670|566023414|FG001|Overall Study|Adverse Event|1|||
156800260|NCT02412670|566023413|FG000|Overall Study|Physician Decision|1|||
156800261|NCT02412670|566023414|FG001|Overall Study|Physician Decision|0|||
156800262|NCT02412670|566023413|FG000|Overall Study|Withdrawal by Subject|1|||
156800263|NCT02412670|566023414|FG001|Overall Study|Withdrawal by Subject|0|||
156800264|NCT02412670|566023413|FG000|Overall Study|Ineligible|1|||
156800265|NCT02412670|566023414|FG001|Overall Study|Ineligible|0|||
156800266|NCT05901636|566023417|FG000|Overall Study|Lost to Follow-up|0|||
156800267|NCT05901636|566023418|FG001|Overall Study|Lost to Follow-up|1|||
156800268|NCT05901636|566023419|FG002|Overall Study|Lost to Follow-up|0|||
156800269|NCT05901636|566023420|FG003|Overall Study|Lost to Follow-up|1|||
156800270|NCT05901636|566023421|FG004|Overall Study|Lost to Follow-up|1|||
156800271|NCT05901636|566023422|FG005|Overall Study|Lost to Follow-up|3|||
156800272|NCT05901636|566023423|FG006|Overall Study|Lost to Follow-up|1|||
156337222|NCT02165215|564333578|FG002|Induction Phase|Non-Compliance|0|||
156337223|NCT02165215|564333576|FG000|Induction Phase|Lost to Follow-up|6|||
156337224|NCT02165215|564333577|FG001|Induction Phase|Lost to Follow-up|0|||
156337225|NCT02165215|564333578|FG002|Induction Phase|Lost to Follow-up|0|||
156748555|NCT03611582|565827841|FG000|Overall Study|At the discretion of the investigator|1|||
156748556|NCT03611582|565827842|FG001|Overall Study|At the discretion of the investigator|0|||
156748557|NCT03611582|565827841|FG000|Overall Study|Safety concern as judged by the investigator|1|||
156748558|NCT03611582|565827842|FG001|Overall Study|Safety concern as judged by the investigator|2|||
156748559|NCT03611582|565827841|FG000|Overall Study|Withdrawal by Subject|4|||
156748560|NCT03611582|565827842|FG001|Overall Study|Withdrawal by Subject|3|||
156748561|NCT03611582|565827841|FG000|Overall Study|Lost to Follow-up|18|||
156748562|NCT03611582|565827842|FG001|Overall Study|Lost to Follow-up|7|||
156748563|NCT03611582|565827841|FG000|Overall Study|other|17|||
156748564|NCT03611582|565827842|FG001|Overall Study|other|16|||
156748565|NCT01783821|565827843|FG000|Overall Study|Screen Failure|1|||
156748566|NCT01783821|565827844|FG001|Overall Study|Screen Failure|1|||
156748567|NCT02333383|565827845|FG000|Overall Study|Adalimumab discontinuation|21|||
156748568|NCT02333383|565827845|FG000|Overall Study|Lost to Follow-up|15|||
156748569|NCT02333383|565827845|FG000|Overall Study|Withdrawal by Subject|3|||
156748570|NCT02333383|565827845|FG000|Overall Study|Transfer to another hospital|2|||
156748571|NCT01653327|565827846|FG000|Overall Study|Withdrawal by Subject|1|||
156748572|NCT01744483|565829469|FG000|Overall Study|Death|9|||
156748573|NCT01744483|565829470|FG001|Overall Study|Death|4|||
156748574|NCT01744483|565829471|FG002|Overall Study|Death|11|||
156748575|NCT01744483|565829469|FG000|Overall Study|Lost to Follow-up|8|||
156748576|NCT01744483|565829470|FG001|Overall Study|Lost to Follow-up|9|||
156748577|NCT01744483|565829471|FG002|Overall Study|Lost to Follow-up|11|||
156748578|NCT01744483|565829469|FG000|Overall Study|Protocol Violation|1|||
156748579|NCT01744483|565829470|FG001|Overall Study|Protocol Violation|2|||
156748580|NCT01744483|565829471|FG002|Overall Study|Protocol Violation|1|||
156748581|NCT01744483|565829469|FG000|Overall Study|Withdrawal by Subject|4|||
156748582|NCT01744483|565829470|FG001|Overall Study|Withdrawal by Subject|6|||
156748583|NCT01744483|565829471|FG002|Overall Study|Withdrawal by Subject|2|||
156748584|NCT01744483|565829469|FG000|Overall Study|No ICU Admit|5|||
156748585|NCT01744483|565829470|FG001|Overall Study|No ICU Admit|1|||
156748586|NCT01744483|565829471|FG002|Overall Study|No ICU Admit|2|||
156337226|NCT02165215|564333576|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156748587|NCT01744483|565829469|FG000|Overall Study|Routed to OSH|2|||
156748588|NCT01744483|565829470|FG001|Overall Study|Routed to OSH|0|||
156748589|NCT01744483|565829471|FG002|Overall Study|Routed to OSH|1|||
156748590|NCT02335346|565829479|FG000|Overall Study|Adverse Event|11|||
156748591|NCT02335346|565829479|FG000|Overall Study|Withdrawal by Subject|1|||
156748592|NCT00560703|565829482|FG000|Overall Study|Adverse Event|0|||
156337227|NCT02165215|564333577|FG001|Maintenance Phase|Withdrawal by Subject|7|||
156748593|NCT00560703|565829483|FG001|Overall Study|Adverse Event|2|||
156748594|NCT00560703|565829482|FG000|Overall Study|Protocol Violation|0|||
156748595|NCT00560703|565829483|FG001|Overall Study|Protocol Violation|2|||
156337228|NCT02165215|564333578|FG002|Maintenance Phase|Withdrawal by Subject|3|||
156748596|NCT00560703|565829482|FG000|Overall Study|Withdrawal by Subject|0|||
156748597|NCT00560703|565829483|FG001|Overall Study|Withdrawal by Subject|1|||
156748598|NCT00560703|565829482|FG000|Overall Study|non-compliance|0|||
156748599|NCT00560703|565829483|FG001|Overall Study|non-compliance|1|||
156748600|NCT06010732|565829489|FG000|Crossover Period 1|Protocol Violation|0|||
156748601|NCT06010732|565829490|FG001|Crossover Period 1|Protocol Violation|0|||
156748602|NCT06010732|565829491|FG002|Crossover Period 1|Protocol Violation|1|||
156748603|NCT06010732|565829492|FG003|Crossover Period 1|Protocol Violation|0|||
156748604|NCT06010732|565829493|FG004|Crossover Period 1|Protocol Violation|1|||
156748605|NCT06010732|565829494|FG005|Crossover Period 1|Protocol Violation|0|||
156748606|NCT06010732|565829489|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748607|NCT06010732|565829490|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
156748608|NCT06010732|565829491|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748609|NCT06010732|565829492|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748610|NCT06010732|565829493|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748611|NCT06010732|565829494|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748612|NCT06010732|565829489|FG000|Crossover Period 2|Adverse Event|0|||
156748613|NCT06010732|565829490|FG001|Crossover Period 2|Adverse Event|1|||
156748614|NCT06010732|565829491|FG002|Crossover Period 2|Adverse Event|0|||
156748615|NCT06010732|565829492|FG003|Crossover Period 2|Adverse Event|0|||
156748616|NCT06010732|565829493|FG004|Crossover Period 2|Adverse Event|0|||
156748617|NCT06010732|565829494|FG005|Crossover Period 2|Adverse Event|0|||
156748618|NCT06010732|565829489|FG000|Crossover Period 2|broken denture|0|||
156748619|NCT06010732|565829490|FG001|Crossover Period 2|broken denture|0|||
156748620|NCT06010732|565829491|FG002|Crossover Period 2|broken denture|1|||
156748621|NCT06010732|565829492|FG003|Crossover Period 2|broken denture|0|||
156748622|NCT06010732|565829493|FG004|Crossover Period 2|broken denture|0|||
156748623|NCT06010732|565829494|FG005|Crossover Period 2|broken denture|0|||
156748624|NCT04942210|565829495|FG000|Overall Study|Adverse Event|0|||
156748625|NCT04942210|565829496|FG001|Overall Study|Adverse Event|1|||
156748626|NCT04942210|565829495|FG000|Overall Study|Protocol Deviation|4|||
156748627|NCT04942210|565829496|FG001|Overall Study|Protocol Deviation|1|||
156748628|NCT04942210|565829495|FG000|Overall Study|Withdrawal by Subject|5|||
156748629|NCT04942210|565829496|FG001|Overall Study|Withdrawal by Subject|2|||
156748630|NCT04942210|565829495|FG000|Overall Study|Lost to Follow-up|16|||
156748631|NCT04942210|565829496|FG001|Overall Study|Lost to Follow-up|7|||
156748632|NCT04942210|565829495|FG000|Overall Study|Ongoing at the time of DBL date|60|||
156748633|NCT04942210|565829496|FG001|Overall Study|Ongoing at the time of DBL date|25|||
156748634|NCT04942210|565829495|FG000|Overall Study|Randomized but did not receive vaccination|3|||
156748635|NCT04942210|565829496|FG001|Overall Study|Randomized but did not receive vaccination|0|||
156748636|NCT04122625|565829497|FG000|Part A (up to 2.92 Years)|Death|2|||
156748637|NCT04122625|565829498|FG001|Part A (up to 2.92 Years)|Death|4|||
156748638|NCT04122625|565829499|FG002|Part A (up to 2.92 Years)|Death|0|||
156748639|NCT04122625|565829500|FG003|Part A (up to 2.92 Years)|Death|0|||
156748640|NCT04122625|565829501|FG004|Part A (up to 2.92 Years)|Death|0|||
156748641|NCT04122625|565829502|FG005|Part A (up to 2.92 Years)|Death|0|||
156748642|NCT04122625|565829497|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
156748643|NCT04122625|565829498|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
156748644|NCT04122625|565829499|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
156748645|NCT04122625|565829500|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
156748646|NCT04122625|565829501|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
156748647|NCT04122625|565829502|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
156748648|NCT04122625|565829497|FG000|Part B (up to 2.33 Years)|Death|0|||
156748649|NCT04122625|565829498|FG001|Part B (up to 2.33 Years)|Death|0|||
156748650|NCT04122625|565829499|FG002|Part B (up to 2.33 Years)|Death|5|||
156748651|NCT04122625|565829500|FG003|Part B (up to 2.33 Years)|Death|7|||
156748652|NCT04122625|565829501|FG004|Part B (up to 2.33 Years)|Death|6|||
156748653|NCT04122625|565829502|FG005|Part B (up to 2.33 Years)|Death|7|||
156748654|NCT04348500|565829503|FG000|Overall Study|Death|2|||
156748655|NCT04348500|565829504|FG001|Overall Study|Death|2|||
156748656|NCT04348500|565829503|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
156748657|NCT04348500|565829504|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
156748658|NCT02776670|565829505|FG000|Overall Study|Adverse Event|0|||
156748659|NCT02776670|565829506|FG001|Overall Study|Adverse Event|2|||
156748660|NCT02776670|565829505|FG000|Overall Study|Protocol Violation|0|||
156748661|NCT02776670|565829506|FG001|Overall Study|Protocol Violation|2|||
156748662|NCT02776670|565829505|FG000|Overall Study|Withdrawal by Subject|0|||
156748663|NCT02776670|565829506|FG001|Overall Study|Withdrawal by Subject|1|||
156748664|NCT02776670|565829505|FG000|Overall Study|Other - Reason not given|0|||
156748665|NCT02776670|565829506|FG001|Overall Study|Other - Reason not given|1|||
156748666|NCT03699540|565829507|FG000|Overall Study|Lost to Follow-up|1|||
156748667|NCT01618916|565829510|FG000|Overall Study|Adverse Event|1|||
156748668|NCT01618916|565829511|FG001|Overall Study|Adverse Event|0|||
156748669|NCT01618916|565829512|FG002|Overall Study|Adverse Event|0|||
156748670|NCT01618916|565829513|FG003|Overall Study|Adverse Event|0|||
156748671|NCT01618916|565829514|FG004|Overall Study|Adverse Event|0|||
156748672|NCT01618916|565829515|FG005|Overall Study|Adverse Event|0|||
156748673|NCT01618916|565829510|FG000|Overall Study|Withdrawal by Subject|0|||
156748674|NCT01618916|565829511|FG001|Overall Study|Withdrawal by Subject|1|||
156748675|NCT01618916|565829512|FG002|Overall Study|Withdrawal by Subject|1|||
156748676|NCT01618916|565829513|FG003|Overall Study|Withdrawal by Subject|0|||
156748677|NCT01618916|565829514|FG004|Overall Study|Withdrawal by Subject|1|||
156748678|NCT01618916|565829515|FG005|Overall Study|Withdrawal by Subject|0|||
156748679|NCT01618916|565829510|FG000|Overall Study|Lost to Follow-up|1|||
156748680|NCT01618916|565829511|FG001|Overall Study|Lost to Follow-up|0|||
156748681|NCT01618916|565829512|FG002|Overall Study|Lost to Follow-up|0|||
156748682|NCT01618916|565829513|FG003|Overall Study|Lost to Follow-up|2|||
156748683|NCT01618916|565829514|FG004|Overall Study|Lost to Follow-up|0|||
156748684|NCT01618916|565829515|FG005|Overall Study|Lost to Follow-up|0|||
156748685|NCT04527978|565829524|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
156748686|NCT04527978|565829525|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
156748687|NCT00055497|565829526|FG000|Overall Study|Adverse Event|1|||
156800273|NCT05901636|566023417|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
156800274|NCT05901636|566023418|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
156800275|NCT05901636|566023419|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
156800276|NCT05901636|566023420|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
156800277|NCT05901636|566023421|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
156800278|NCT05901636|566023422|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
156800279|NCT05901636|566023423|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
156800280|NCT05901636|566023417|FG000|Overall Study|Withdrawal by Subject|1|||
156800281|NCT05901636|566023418|FG001|Overall Study|Withdrawal by Subject|1|||
156800282|NCT05901636|566023419|FG002|Overall Study|Withdrawal by Subject|0|||
156800283|NCT05901636|566023420|FG003|Overall Study|Withdrawal by Subject|0|||
156800284|NCT05901636|566023421|FG004|Overall Study|Withdrawal by Subject|1|||
156800285|NCT05901636|566023422|FG005|Overall Study|Withdrawal by Subject|1|||
156800286|NCT05901636|566023423|FG006|Overall Study|Withdrawal by Subject|0|||
156800287|NCT05901636|566023417|FG000|Overall Study|Other|0|||
156800288|NCT05901636|566023418|FG001|Overall Study|Other|0|||
156800289|NCT05901636|566023419|FG002|Overall Study|Other|1|||
156800290|NCT05901636|566023420|FG003|Overall Study|Other|1|||
156800291|NCT05901636|566023421|FG004|Overall Study|Other|0|||
156800292|NCT05901636|566023422|FG005|Overall Study|Other|0|||
156800293|NCT05901636|566023423|FG006|Overall Study|Other|0|||
156800294|NCT02302222|566023429|FG000|Overall Study|Physician Decision|0|||
156800295|NCT02302222|566023430|FG001|Overall Study|Physician Decision|4|||
156800296|NCT02302222|566023429|FG000|Overall Study|Lost to Follow-up|1|||
156800297|NCT02302222|566023430|FG001|Overall Study|Lost to Follow-up|0|||
156800298|NCT02302222|566023429|FG000|Overall Study|Treatment discontinued before day 5|0|||
156800299|NCT02302222|566023430|FG001|Overall Study|Treatment discontinued before day 5|1|||
156748688|NCT00055497|565829527|FG001|Overall Study|Adverse Event|1|||
156748689|NCT00055497|565829528|FG002|Overall Study|Adverse Event|1|||
156748690|NCT00055497|565829529|FG003|Overall Study|Adverse Event|28|||
156748691|NCT00055497|565829526|FG000|Overall Study|Withdrawal by Subject|3|||
156748692|NCT00055497|565829527|FG001|Overall Study|Withdrawal by Subject|1|||
156748693|NCT00055497|565829528|FG002|Overall Study|Withdrawal by Subject|1|||
156748694|NCT00055497|565829529|FG003|Overall Study|Withdrawal by Subject|15|||
156800300|NCT02302222|566023429|FG000|Overall Study|Withdrawn prior to any treatment|0|||
156800301|NCT02302222|566023430|FG001|Overall Study|Withdrawn prior to any treatment|1|||
156800302|NCT00016354|566023433|FG000|Overall Study|Lack of Efficacy|0|||
156800303|NCT00016354|566023434|FG001|Overall Study|Lack of Efficacy|0|||
156800304|NCT00016354|566023435|FG002|Overall Study|Lack of Efficacy|0|||
156800305|NCT00016354|566023436|FG003|Overall Study|Lack of Efficacy|0|||
156800306|NCT00016354|566023437|FG004|Overall Study|Lack of Efficacy|0|||
156800307|NCT00016354|566023438|FG005|Overall Study|Lack of Efficacy|0|||
156800308|NCT00016354|566023439|FG006|Overall Study|Lack of Efficacy|0|||
156800309|NCT00016354|566023440|FG007|Overall Study|Lack of Efficacy|1|||
156800310|NCT03110562|566023441|FG000|Initial Treatment Period|Disease Progression|1|||
156536952|NCT01159912|565059105|FG001|Overall Study|Lost to Follow-up|0|||
156536953|NCT01159912|565059106|FG002|Overall Study|Lost to Follow-up|0|||
156536954|NCT01159912|565059104|FG000|Overall Study|Physician Decision|0|||
156536955|NCT01159912|565059105|FG001|Overall Study|Physician Decision|0|||
156536956|NCT01159912|565059106|FG002|Overall Study|Physician Decision|3|||
156536957|NCT01159912|565059104|FG000|Overall Study|Withdrawal by Subject|10|||
156536958|NCT01159912|565059105|FG001|Overall Study|Withdrawal by Subject|3|||
156536959|NCT01159912|565059106|FG002|Overall Study|Withdrawal by Subject|3|||
156536960|NCT02374021|565059110|FG000|Overall Study|Adverse Event|1|||
156536961|NCT02374021|565059111|FG001|Overall Study|Adverse Event|0|||
156536962|NCT02374021|565059110|FG000|Overall Study|Lost to Follow-up|3|||
156536963|NCT02374021|565059111|FG001|Overall Study|Lost to Follow-up|2|||
156536964|NCT02374021|565059110|FG000|Overall Study|Physician Decision|0|||
156536965|NCT02374021|565059111|FG001|Overall Study|Physician Decision|3|||
156536966|NCT02374021|565059110|FG000|Overall Study|Withdrawal by Subject|6|||
156536967|NCT02374021|565059111|FG001|Overall Study|Withdrawal by Subject|5|||
156536968|NCT02374021|565059110|FG000|Overall Study|Poor Adherence|0|||
156536969|NCT02374021|565059111|FG001|Overall Study|Poor Adherence|1|||
156536970|NCT02374021|565059110|FG000|Overall Study|Scan protocol not followed|0|||
156536971|NCT02374021|565059111|FG001|Overall Study|Scan protocol not followed|1|||
156536972|NCT02374021|565059110|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
156536973|NCT02374021|565059111|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
156536974|NCT00688155|565059112|FG000|Overall Study|Withdrawal by Subject|2|||
156536975|NCT00688155|565059113|FG001|Overall Study|Withdrawal by Subject|2|||
156536976|NCT00688155|565059114|FG002|Overall Study|Withdrawal by Subject|1|||
156536977|NCT00688155|565059115|FG003|Overall Study|Withdrawal by Subject|1|||
156536978|NCT03007979|565059120|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
156536979|NCT03734016|565059121|FG000|Overall Study|Sponsor Ended Study|225|||
156536980|NCT03734016|565059122|FG001|Overall Study|Sponsor Ended Study|200|||
156536981|NCT03734016|565059121|FG000|Overall Study|Death|69|||
156536982|NCT03734016|565059122|FG001|Overall Study|Death|83|||
156536983|NCT03734016|565059121|FG000|Overall Study|Withdrawal by Subject|21|||
156536984|NCT03734016|565059122|FG001|Overall Study|Withdrawal by Subject|27|||
156536985|NCT03734016|565059121|FG000|Overall Study|Physician Decision|1|||
156536986|NCT03734016|565059122|FG001|Overall Study|Physician Decision|12|||
156536987|NCT03734016|565059121|FG000|Overall Study|Lost to Follow-up|6|||
156536988|NCT03734016|565059122|FG001|Overall Study|Lost to Follow-up|2|||
156536989|NCT03734016|565059121|FG000|Overall Study|Miscellaneous|5|||
156536990|NCT03734016|565059122|FG001|Overall Study|Miscellaneous|1|||
156536991|NCT01444456|565059123|FG000|Overall Study|Withdrawal by Subject|21|||
156536992|NCT01444456|565059123|FG000|Overall Study|Physician Decision|9|||
156536993|NCT01444456|565059123|FG000|Overall Study|Lost to Follow-up|37|||
156536994|NCT01444456|565059123|FG000|Overall Study|Death|73|||
156536995|NCT01444456|565059123|FG000|Overall Study|Ineligibility determined|23|||
156536996|NCT01444456|565059123|FG000|Overall Study|Other|18|||
156536997|NCT01444456|565059123|FG000|Overall Study|Not treated|104|||
156536998|NCT02142738|565061065|FG000|Overall Study|Adverse Event|13|||
156536999|NCT02142738|565061066|FG001|Overall Study|Adverse Event|9|||
156537000|NCT02142738|565061065|FG000|Overall Study|Death|92|||
156537001|NCT02142738|565061066|FG001|Overall Study|Death|112|||
156537002|NCT02142738|565061065|FG000|Overall Study|Lost to Follow-up|0|||
156537003|NCT02142738|565061066|FG001|Overall Study|Lost to Follow-up|3|||
156537004|NCT02142738|565061065|FG000|Overall Study|Withdrawal by Subject|6|||
156537005|NCT02142738|565061066|FG001|Overall Study|Withdrawal by Subject|7|||
156537006|NCT02142738|565061065|FG000|Overall Study|Follow up ended by sponsor|43|||
156537007|NCT02142738|565061066|FG001|Overall Study|Follow up ended by sponsor|20|||
156537008|NCT01168973|565061068|FG000|Overall Study|Progressive Disease|341|||
156537009|NCT01168973|565061069|FG001|Overall Study|Progressive Disease|429|||
156748695|NCT00055497|565829526|FG000|Overall Study|Lost to Follow-up|0|||
156748696|NCT00055497|565829527|FG001|Overall Study|Lost to Follow-up|1|||
156748697|NCT00055497|565829528|FG002|Overall Study|Lost to Follow-up|0|||
156748698|NCT00055497|565829529|FG003|Overall Study|Lost to Follow-up|5|||
156748699|NCT00055497|565829526|FG000|Overall Study|Protocol Violation|0|||
156748700|NCT00055497|565829527|FG001|Overall Study|Protocol Violation|0|||
156748701|NCT00055497|565829528|FG002|Overall Study|Protocol Violation|0|||
156748702|NCT00055497|565829529|FG003|Overall Study|Protocol Violation|3|||
156748703|NCT00055497|565829526|FG000|Overall Study|Lack of Efficacy|1|||
156748704|NCT00055497|565829527|FG001|Overall Study|Lack of Efficacy|0|||
156537010|NCT01168973|565061068|FG000|Overall Study|Adverse Event|94|||
156537011|NCT01168973|565061069|FG001|Overall Study|Adverse Event|55|||
156537012|NCT01168973|565061068|FG000|Overall Study|Withdrawal by Subject|90|||
156537013|NCT01168973|565061069|FG001|Overall Study|Withdrawal by Subject|53|||
156537014|NCT01168973|565061068|FG000|Overall Study|Death|42|||
156537015|NCT01168973|565061069|FG001|Overall Study|Death|45|||
156537016|NCT01168973|565061068|FG000|Overall Study|Physician Decision|37|||
156537017|NCT01168973|565061069|FG001|Overall Study|Physician Decision|19|||
156748705|NCT00055497|565829528|FG002|Overall Study|Lack of Efficacy|0|||
156748706|NCT00055497|565829529|FG003|Overall Study|Lack of Efficacy|27|||
156748707|NCT00055497|565829526|FG000|Overall Study|Administrative Reasons|0|||
156748708|NCT00055497|565829527|FG001|Overall Study|Administrative Reasons|0|||
156748709|NCT00055497|565829528|FG002|Overall Study|Administrative Reasons|0|||
156748710|NCT00055497|565829529|FG003|Overall Study|Administrative Reasons|1|||
156748711|NCT00055497|565829526|FG000|Overall Study|Other|0|||
156748712|NCT00055497|565829527|FG001|Overall Study|Other|0|||
156748713|NCT00055497|565829528|FG002|Overall Study|Other|0|||
156748714|NCT00055497|565829529|FG003|Overall Study|Other|11|||
156748715|NCT00048165|565829530|FG000|Completed 6 Months Study|Administration/Other|8|||
156748716|NCT00048165|565829531|FG001|Completed 6 Months Study|Administration/Other|8|||
156748717|NCT00048165|565829530|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
156748718|NCT00048165|565829531|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
156748719|NCT00048165|565829530|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
156748720|NCT00048165|565829531|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
156748721|NCT00048165|565829530|FG000|Completed 6 Months Study|Death|12|||
156748722|NCT00048165|565829531|FG001|Completed 6 Months Study|Death|6|||
156748723|NCT00048165|565829530|FG000|Completed 6 Months Study|Insufficient therapy|1|||
156748724|NCT00048165|565829531|FG001|Completed 6 Months Study|Insufficient therapy|4|||
156748725|NCT00048165|565829530|FG000|Completed 6 Months Study|Other violation|4|||
156748726|NCT00048165|565829531|FG001|Completed 6 Months Study|Other violation|6|||
156748727|NCT00048165|565829530|FG000|Completed 6 Months Study|Refused treatment|5|||
156800311|NCT03110562|566023442|FG001|Initial Treatment Period|Disease Progression|1|||
156800312|NCT03110562|566023443|FG002|Initial Treatment Period|Disease Progression|0|||
156800313|NCT03110562|566023444|FG003|Initial Treatment Period|Disease Progression|0|||
156800314|NCT03110562|566023441|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
156800315|NCT03110562|566023442|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
156800316|NCT03110562|566023443|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
156800317|NCT03110562|566023444|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
156800318|NCT03110562|566023441|FG000|Initial Treatment Period|Adverse Event|1|||
156800319|NCT03110562|566023442|FG001|Initial Treatment Period|Adverse Event|0|||
156800320|NCT03110562|566023443|FG002|Initial Treatment Period|Adverse Event|0|||
156800321|NCT03110562|566023444|FG003|Initial Treatment Period|Adverse Event|0|||
156800322|NCT03110562|566023441|FG000|Initial Treatment Period|Death|74|||
156800323|NCT03110562|566023442|FG001|Initial Treatment Period|Death|82|||
156800324|NCT03110562|566023443|FG002|Initial Treatment Period|Death|0|||
156800325|NCT03110562|566023444|FG003|Initial Treatment Period|Death|0|||
156800326|NCT03110562|566023441|FG000|Initial Treatment Period|Lost to Follow-up|13|||
156800327|NCT03110562|566023442|FG001|Initial Treatment Period|Lost to Follow-up|8|||
156800328|NCT03110562|566023443|FG002|Initial Treatment Period|Lost to Follow-up|0|||
156800329|NCT03110562|566023444|FG003|Initial Treatment Period|Lost to Follow-up|0|||
156800330|NCT03110562|566023441|FG000|Initial Treatment Period|Protocol Deviation|1|||
156800331|NCT03110562|566023442|FG001|Initial Treatment Period|Protocol Deviation|0|||
156800332|NCT03110562|566023443|FG002|Initial Treatment Period|Protocol Deviation|0|||
156800333|NCT03110562|566023444|FG003|Initial Treatment Period|Protocol Deviation|0|||
156800334|NCT03110562|566023441|FG000|Initial Treatment Period|Physician Decision|2|||
156800335|NCT03110562|566023442|FG001|Initial Treatment Period|Physician Decision|1|||
156800336|NCT03110562|566023443|FG002|Initial Treatment Period|Physician Decision|0|||
156800337|NCT03110562|566023444|FG003|Initial Treatment Period|Physician Decision|0|||
156800338|NCT03110562|566023441|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
156800339|NCT03110562|566023442|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
156748728|NCT00048165|565829531|FG001|Completed 6 Months Study|Refused treatment|5|||
156337229|NCT02165215|564333576|FG000|Maintenance Phase|Multiple reasons|0|||
156748729|NCT00048165|565829530|FG000|Completed 6 Months Study|Violation criteria|0|||
156748730|NCT00048165|565829531|FG001|Completed 6 Months Study|Violation criteria|2|||
156748731|NCT00048165|565829530|FG000|Completed 6 Months Study|Did not receive study drug|6|||
156748732|NCT00048165|565829531|FG001|Completed 6 Months Study|Did not receive study drug|6|||
156748733|NCT00048165|565829530|FG000|Completed 12 Months Study|Administration/Other|0|||
156748734|NCT00048165|565829531|FG001|Completed 12 Months Study|Administration/Other|2|||
156748735|NCT00048165|565829530|FG000|Completed 12 Months Study|Death|2|||
156748736|NCT00048165|565829531|FG001|Completed 12 Months Study|Death|1|||
156748737|NCT00048165|565829530|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
156748738|NCT00048165|565829531|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
156748739|NCT00731731|565829532|FG000|Overall Study|Protocol Violation|0|||
156748740|NCT00731731|565829533|FG001|Overall Study|Protocol Violation|0|||
156748741|NCT00731731|565829534|FG002|Overall Study|Protocol Violation|1|||
156748742|NCT00731731|565829532|FG000|Overall Study|Cancel prior to treatment|0|||
156748743|NCT00731731|565829533|FG001|Overall Study|Cancel prior to treatment|0|||
156748744|NCT00731731|565829534|FG002|Overall Study|Cancel prior to treatment|2|||
156748745|NCT01084538|565829536|FG000|Overall Study|Drug not available|30|||
156748746|NCT01084538|565829536|FG000|Overall Study|Adverse Event|9|||
156748747|NCT01084538|565829536|FG000|Overall Study|Kidney transplant|6|||
156748748|NCT01084538|565829536|FG000|Overall Study|Serious Adverse Event|3|||
156748749|NCT01084538|565829536|FG000|Overall Study|Lack of effectiveness|2|||
156748750|NCT01084538|565829536|FG000|Overall Study|Patient noncompliance|2|||
156748751|NCT01084538|565829536|FG000|Overall Study|Hyperphosphatemia|2|||
156748752|NCT01084538|565829536|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
156748753|NCT01084538|565829536|FG000|Overall Study|Change of residence|2|||
156748754|NCT01084538|565829536|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
156748755|NCT01084538|565829536|FG000|Overall Study|Reason unknown|8|||
156800340|NCT03110562|566023443|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
156800341|NCT03110562|566023444|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
156800342|NCT03110562|566023441|FG000|Initial Treatment Period|Other|5|||
156800343|NCT03110562|566023442|FG001|Initial Treatment Period|Other|4|||
156800344|NCT03110562|566023443|FG002|Initial Treatment Period|Other|0|||
156800345|NCT03110562|566023444|FG003|Initial Treatment Period|Other|0|||
156800346|NCT03110562|566023441|FG000|Initial Treatment Period|Randomized but never treated|0|||
156800347|NCT03110562|566023442|FG001|Initial Treatment Period|Randomized but never treated|3|||
156800348|NCT03110562|566023443|FG002|Initial Treatment Period|Randomized but never treated|0|||
156800349|NCT03110562|566023444|FG003|Initial Treatment Period|Randomized but never treated|0|||
156800350|NCT03110562|566023441|FG000|Crossover Period|Disease Progression|0|||
156800351|NCT03110562|566023442|FG001|Crossover Period|Disease Progression|0|||
156800352|NCT03110562|566023443|FG002|Crossover Period|Disease Progression|1|||
156800353|NCT03110562|566023444|FG003|Crossover Period|Disease Progression|0|||
156800354|NCT03110562|566023441|FG000|Crossover Period|Withdrawal by Subject|0|||
156800355|NCT03110562|566023442|FG001|Crossover Period|Withdrawal by Subject|0|||
156800356|NCT03110562|566023443|FG002|Crossover Period|Withdrawal by Subject|8|||
156800357|NCT03110562|566023444|FG003|Crossover Period|Withdrawal by Subject|6|||
156800358|NCT03110562|566023441|FG000|Crossover Period|Death|0|||
156800359|NCT03110562|566023442|FG001|Crossover Period|Death|0|||
156800360|NCT03110562|566023443|FG002|Crossover Period|Death|37|||
156748756|NCT00187278|565829537|FG000|Overall Study|Protocol Violation|10|||
156748757|NCT00187278|565829538|FG001|Overall Study|Protocol Violation|13|||
156748758|NCT01490697|565829545|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
156800361|NCT03110562|566023444|FG003|Crossover Period|Death|3|||
156800362|NCT03110562|566023441|FG000|Crossover Period|Lost to Follow-up|0|||
156337230|NCT02165215|564333577|FG001|Maintenance Phase|Multiple reasons|2|||
156337231|NCT02165215|564333578|FG002|Maintenance Phase|Multiple reasons|1|||
156337232|NCT02165215|564333576|FG000|Maintenance Phase|Lost to Follow-up|0|||
156748759|NCT01490697|565829546|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
156748760|NCT00090584|565829547|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
156748761|NCT00090584|565829548|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
156748762|NCT00090584|565829547|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
156748763|NCT00090584|565829548|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
156748764|NCT00379808|565829549|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
156748765|NCT00379808|565829550|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
156748766|NCT03742258|565829556|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
156748767|NCT03742258|565829557|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
156748768|NCT03742258|565829558|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
156748769|NCT03742258|565829556|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
156748770|NCT03742258|565829557|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
156748771|NCT03742258|565829558|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
156748772|NCT03742258|565829556|FG000|Survival Follow-Up|Still in Follow-up|0|||
156748773|NCT03742258|565829557|FG001|Survival Follow-Up|Still in Follow-up|0|||
156748774|NCT03742258|565829558|FG002|Survival Follow-Up|Still in Follow-up|2|||
156748775|NCT01987232|565829563|FG000|Overall Study|Ongoing in Study|0|||
156748776|NCT01987232|565829564|FG001|Overall Study|Ongoing in Study|0|||
156748777|NCT01987232|565829565|FG002|Overall Study|Ongoing in Study|0|||
156748778|NCT01987232|565829566|FG003|Overall Study|Ongoing in Study|1|||
156748779|NCT01987232|565829567|FG004|Overall Study|Ongoing in Study|0|||
156748780|NCT01731470|565829569|FG000|Overall Study|Withdrawal by Subject|1|||
156748781|NCT01731470|565829569|FG000|Overall Study|Did not meet study criteria|1|||
156748782|NCT02258334|565829572|FG000|Overall Study|Adverse Event|1|||
156748783|NCT02258334|565829573|FG001|Overall Study|Adverse Event|0|||
156748784|NCT02258334|565829574|FG002|Overall Study|Adverse Event|0|||
156748785|NCT02258334|565829575|FG003|Overall Study|Adverse Event|0|||
156748786|NCT03564795|565829578|FG000|Overall Study|Withdrawal by Subject|3|||
156748787|NCT03564795|565829578|FG000|Overall Study|Lost to Follow-up|6|||
156748788|NCT03564795|565829578|FG000|Overall Study|Physician Decision|2|||
156748789|NCT00564395|565829583|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
156748790|NCT00564395|565829584|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
156748791|NCT00564395|565829583|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
156748792|NCT00564395|565829584|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
156748793|NCT01333956|565829589|FG000|Overall Study|Lost to Follow-up|1|||
156748794|NCT01333956|565829590|FG001|Overall Study|Lost to Follow-up|2|||
156748795|NCT01333956|565829591|FG002|Overall Study|Lost to Follow-up|0|||
156748796|NCT01333956|565829592|FG003|Overall Study|Lost to Follow-up|1|||
156748797|NCT01333956|565829589|FG000|Overall Study|Unable to complete study procedure|1|||
156748798|NCT01333956|565829590|FG001|Overall Study|Unable to complete study procedure|0|||
156748799|NCT01333956|565829591|FG002|Overall Study|Unable to complete study procedure|0|||
156748800|NCT01333956|565829592|FG003|Overall Study|Unable to complete study procedure|1|||
156748801|NCT01333956|565829589|FG000|Overall Study|Withdrawal by Subject|0|||
156748802|NCT01333956|565829590|FG001|Overall Study|Withdrawal by Subject|2|||
156748803|NCT01333956|565829591|FG002|Overall Study|Withdrawal by Subject|1|||
156748804|NCT01333956|565829592|FG003|Overall Study|Withdrawal by Subject|0|||
156748805|NCT02134353|565829593|FG000|Overall Study|Adverse Event|10|||
156337233|NCT02165215|564333577|FG001|Maintenance Phase|Lost to Follow-up|2|||
156748806|NCT02134353|565829594|FG001|Overall Study|Adverse Event|6|||
156748807|NCT02134353|565829593|FG000|Overall Study|Lost to Follow-up|1|||
156748808|NCT02134353|565829594|FG001|Overall Study|Lost to Follow-up|1|||
156748809|NCT02134353|565829593|FG000|Overall Study|Lack of Efficacy|2|||
156748810|NCT02134353|565829594|FG001|Overall Study|Lack of Efficacy|1|||
156748811|NCT02134353|565829593|FG000|Overall Study|Withdrawal by Subject|12|||
156748812|NCT02134353|565829594|FG001|Overall Study|Withdrawal by Subject|13|||
156337234|NCT02165215|564333578|FG002|Maintenance Phase|Lost to Follow-up|0|||
156748813|NCT02134353|565829593|FG000|Overall Study|Death|0|||
156748814|NCT02134353|565829594|FG001|Overall Study|Death|1|||
156748815|NCT02134353|565829593|FG000|Overall Study|Pregnancy|0|||
156748816|NCT02134353|565829594|FG001|Overall Study|Pregnancy|1|||
156748817|NCT02134353|565829593|FG000|Overall Study|Relocation|1|||
156748818|NCT02134353|565829594|FG001|Overall Study|Relocation|0|||
156748819|NCT02134353|565829593|FG000|Overall Study|Other - Patient's Choice|0|||
156748820|NCT02134353|565829594|FG001|Overall Study|Other - Patient's Choice|1|||
156748821|NCT00477607|565829595|FG000|Overall Study|Lost to Follow-up|7|||
156748822|NCT00477607|565829596|FG001|Overall Study|Lost to Follow-up|7|||
156748823|NCT01732471|565829599|FG000|Overall Study|Withdrawal by Subject|1|||
156748824|NCT00474786|565829600|FG000|Overall Study|Not Meeting Study Criteria|0|||
156748825|NCT00474786|565829601|FG001|Overall Study|Not Meeting Study Criteria|1|||
156748826|NCT00474786|565829600|FG000|Overall Study|Investigator Request|2|||
156748827|NCT00474786|565829601|FG001|Overall Study|Investigator Request|1|||
156748828|NCT00474786|565829600|FG000|Overall Study|Death|189|||
156748829|NCT00474786|565829601|FG001|Overall Study|Death|170|||
156337235|NCT02165215|564333576|FG000|Maintenance Phase|Adverse Event|0|||
156337236|NCT02165215|564333577|FG001|Maintenance Phase|Adverse Event|1|||
156337237|NCT02165215|564333578|FG002|Maintenance Phase|Adverse Event|1|||
156337238|NCT05074667|564333579|FG000|Overall Study|Death|1|||
156337239|NCT05074667|564333579|FG000|Overall Study|Withdrawal by Subject|4|||
156337240|NCT05074667|564333579|FG000|Overall Study|Lost to Follow-up|10|||
156337241|NCT01153347|564333582|FG000|Overall Study|Withdrawal by Subject|7|||
156337242|NCT01153347|564333583|FG001|Overall Study|Withdrawal by Subject|7|||
156337243|NCT01153347|564333584|FG002|Overall Study|Withdrawal by Subject|7|||
156337244|NCT01153347|564333585|FG003|Overall Study|Withdrawal by Subject|7|||
156337245|NCT01153347|564333582|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156337246|NCT01153347|564333583|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156337247|NCT01153347|564333584|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
156337248|NCT01153347|564333585|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156337249|NCT01153347|564333582|FG000|Overall Study|Adverse Event|3|||
156537018|NCT01168973|565061068|FG000|Overall Study|Sponsor Decision|2|||
156537019|NCT01168973|565061069|FG001|Overall Study|Sponsor Decision|1|||
156748830|NCT00474786|565829600|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
156337250|NCT01153347|564333583|FG001|Overall Study|Adverse Event|9|||
156337251|NCT01153347|564333584|FG002|Overall Study|Adverse Event|21|||
156337252|NCT01153347|564333585|FG003|Overall Study|Adverse Event|7|||
156337253|NCT01153347|564333582|FG000|Overall Study|Severe non-compliance to protocol|6|||
156337254|NCT01153347|564333583|FG001|Overall Study|Severe non-compliance to protocol|7|||
156337255|NCT01153347|564333584|FG002|Overall Study|Severe non-compliance to protocol|4|||
156337256|NCT01153347|564333585|FG003|Overall Study|Severe non-compliance to protocol|3|||
156337257|NCT01153347|564333582|FG000|Overall Study|Condition under investigation worsened|1|||
156748831|NCT00474786|565829601|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
156748832|NCT00474786|565829600|FG000|Overall Study|Lost to Follow-up|4|||
156748833|NCT00474786|565829601|FG001|Overall Study|Lost to Follow-up|7|||
156748834|NCT00474786|565829600|FG000|Overall Study|Protocol Violation|2|||
156748835|NCT00474786|565829601|FG001|Overall Study|Protocol Violation|0|||
156748836|NCT00474786|565829600|FG000|Overall Study|Withdrawal by Subject|15|||
156748837|NCT00474786|565829601|FG001|Overall Study|Withdrawal by Subject|15|||
156748838|NCT00474786|565829600|FG000|Overall Study|Other|5|||
156748839|NCT00474786|565829601|FG001|Overall Study|Other|0|||
156748840|NCT02892513|565829602|FG000|Overall Study|Withdrawal by Subject|0|||
156748841|NCT02892513|565829603|FG001|Overall Study|Withdrawal by Subject|1|||
156748842|NCT00432276|565829604|FG000|Overall Study|Hyperglycemic Rescue|44|||
156748843|NCT00432276|565829605|FG001|Overall Study|Hyperglycemic Rescue|87|||
156748844|NCT00432276|565829604|FG000|Overall Study|Adverse Event|13|||
156748845|NCT00432276|565829605|FG001|Overall Study|Adverse Event|16|||
156748846|NCT00432276|565829604|FG000|Overall Study|Protocol Violation|25|||
156748847|NCT00432276|565829605|FG001|Overall Study|Protocol Violation|20|||
156748848|NCT00432276|565829604|FG000|Overall Study|Lost to Follow-up|6|||
156748849|NCT00432276|565829605|FG001|Overall Study|Lost to Follow-up|2|||
156748850|NCT00432276|565829604|FG000|Overall Study|Withdrawal by Subject|25|||
156748851|NCT00432276|565829605|FG001|Overall Study|Withdrawal by Subject|20|||
156748852|NCT00432276|565829604|FG000|Overall Study|Physician Decision|6|||
156748853|NCT00432276|565829605|FG001|Overall Study|Physician Decision|8|||
156748854|NCT00432276|565829604|FG000|Overall Study|Other|2|||
156748855|NCT00432276|565829605|FG001|Overall Study|Other|3|||
156337258|NCT01153347|564333583|FG001|Overall Study|Condition under investigation worsened|1|||
156337259|NCT01153347|564333584|FG002|Overall Study|Condition under investigation worsened|0|||
156337260|NCT01153347|564333585|FG003|Overall Study|Condition under investigation worsened|0|||
156337261|NCT01153347|564333582|FG000|Overall Study|Lack of Efficacy|2|||
156748856|NCT00594386|565829606|FG000|Overall Study|Major protocol violation|2|||
156748857|NCT00594386|565829606|FG000|Overall Study|Lack of Efficacy|12|||
156748858|NCT00594386|565829606|FG000|Overall Study|Adverse Event|68|||
156748859|NCT00594386|565829606|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
156748860|NCT00594386|565829606|FG000|Overall Study|Subject withdrew consent|35|||
156748861|NCT00594386|565829606|FG000|Overall Study|Study ended per sponsor|115|||
156748862|NCT00594386|565829606|FG000|Overall Study|Lost to Follow-up|6|||
156748863|NCT00594386|565829606|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
156748864|NCT00594386|565829606|FG000|Overall Study|Other: Subject moved to Seattle|1|||
156748865|NCT00594386|565829606|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
156748866|NCT00594386|565829606|FG000|Overall Study|Other: Study terminated per investigator|2|||
156748867|NCT00594386|565829606|FG000|Overall Study|Other: Sponsor closure of study|1|||
156748868|NCT00594386|565829606|FG000|Overall Study|Other: Site terminated participation|1|||
156748869|NCT00594386|565829606|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
156748870|NCT00594386|565829606|FG000|Overall Study|Other: Loss of drivers license|1|||
156748871|NCT04459598|565829611|FG000|Overall Study|Adverse Event|1|||
156748872|NCT04459598|565829612|FG001|Overall Study|Adverse Event|1|||
156748873|NCT00463840|565829614|FG000|Overall Study|Disease progression|7|||
156748874|NCT00463840|565829614|FG000|Overall Study|Withdrawal by Subject|2|||
156748875|NCT00463840|565829614|FG000|Overall Study|Adverse Event|3|||
156748876|NCT00866333|565829620|FG000|Overall Study|Withdrawal of consent|0|||
156748877|NCT00866333|565829621|FG001|Overall Study|Withdrawal of consent|1|||
156748878|NCT00866333|565829622|FG002|Overall Study|Withdrawal of consent|2|||
156748879|NCT00866333|565829620|FG000|Overall Study|Reason not Specified|3|||
156748880|NCT00866333|565829621|FG001|Overall Study|Reason not Specified|1|||
156748881|NCT00866333|565829622|FG002|Overall Study|Reason not Specified|1|||
156748882|NCT00866333|565829620|FG000|Overall Study|Study Terminated by Sponsor|2|||
156748883|NCT00866333|565829621|FG001|Overall Study|Study Terminated by Sponsor|5|||
156748884|NCT00866333|565829622|FG002|Overall Study|Study Terminated by Sponsor|9|||
156748885|NCT00422292|565829623|FG000|Overall Study|Serious adverse events|1|||
156748886|NCT00422292|565829624|FG001|Overall Study|Serious adverse events|4|||
156748887|NCT00422292|565829625|FG002|Overall Study|Serious adverse events|0|||
156748888|NCT00422292|565829626|FG003|Overall Study|Serious adverse events|0|||
156748889|NCT00422292|565829623|FG000|Overall Study|Adverse Event|1|||
156748890|NCT00422292|565829624|FG001|Overall Study|Adverse Event|0|||
156748891|NCT00422292|565829625|FG002|Overall Study|Adverse Event|1|||
156748892|NCT00422292|565829626|FG003|Overall Study|Adverse Event|0|||
156748893|NCT00422292|565829623|FG000|Overall Study|Protocol Violation|4|||
156748894|NCT00422292|565829624|FG001|Overall Study|Protocol Violation|25|||
156748895|NCT00422292|565829625|FG002|Overall Study|Protocol Violation|8|||
156748896|NCT00422292|565829626|FG003|Overall Study|Protocol Violation|5|||
156748897|NCT00422292|565829623|FG000|Overall Study|Lost to Follow-up|6|||
156748898|NCT00422292|565829624|FG001|Overall Study|Lost to Follow-up|12|||
156748899|NCT00422292|565829625|FG002|Overall Study|Lost to Follow-up|6|||
156748900|NCT00422292|565829626|FG003|Overall Study|Lost to Follow-up|6|||
156748901|NCT00422292|565829623|FG000|Overall Study|Withdrawal by Subject|6|||
156748902|NCT00422292|565829624|FG001|Overall Study|Withdrawal by Subject|25|||
156748903|NCT00422292|565829625|FG002|Overall Study|Withdrawal by Subject|7|||
156748904|NCT00422292|565829626|FG003|Overall Study|Withdrawal by Subject|13|||
156748905|NCT02669082|565829627|FG000|Overall Study|Adverse Event|1|||
156748906|NCT04918355|565829631|FG000|Overall Study|no qualifying health encounter|497|||
156748907|NCT04918355|565829632|FG001|Overall Study|no qualifying health encounter|192|||
156748908|NCT04918355|565829633|FG002|Overall Study|no qualifying health encounter|438|||
156748909|NCT04918355|565829634|FG003|Overall Study|no qualifying health encounter|424|||
156748910|NCT04683939|565829638|FG000|Overall Study|Study termination by the sponsor|0|||
156748911|NCT04683939|565829639|FG001|Overall Study|Study termination by the sponsor|1|||
156748912|NCT04683939|565829640|FG002|Overall Study|Study termination by the sponsor|2|||
156748913|NCT04683939|565829641|FG003|Overall Study|Study termination by the sponsor|2|||
156748914|NCT04683939|565829638|FG000|Overall Study|Death|1|||
156748915|NCT04683939|565829639|FG001|Overall Study|Death|1|||
156748916|NCT04683939|565829640|FG002|Overall Study|Death|2|||
156748917|NCT04683939|565829641|FG003|Overall Study|Death|1|||
156748918|NCT04683939|565829638|FG000|Overall Study|Withdrawal by Subject|1|||
156748919|NCT04683939|565829639|FG001|Overall Study|Withdrawal by Subject|0|||
156748920|NCT04683939|565829640|FG002|Overall Study|Withdrawal by Subject|0|||
156748921|NCT04683939|565829641|FG003|Overall Study|Withdrawal by Subject|0|||
156748922|NCT04683939|565829638|FG000|Overall Study|Physician Decision|1|||
156748923|NCT04683939|565829639|FG001|Overall Study|Physician Decision|0|||
156748924|NCT04683939|565829640|FG002|Overall Study|Physician Decision|0|||
156748925|NCT04683939|565829641|FG003|Overall Study|Physician Decision|0|||
156748926|NCT04683939|565829638|FG000|Overall Study|Lost to Follow-up|0|||
156748927|NCT04683939|565829639|FG001|Overall Study|Lost to Follow-up|1|||
156748928|NCT04683939|565829640|FG002|Overall Study|Lost to Follow-up|0|||
156748929|NCT04683939|565829641|FG003|Overall Study|Lost to Follow-up|0|||
156748930|NCT04852276|565829642|FG000|Overall Study|Death|2|||
156748931|NCT04852276|565829643|FG001|Overall Study|Death|0|||
156748932|NCT04852276|565829642|FG000|Overall Study|Lost to Follow-up|15|||
156748933|NCT04852276|565829643|FG001|Overall Study|Lost to Follow-up|9|||
156748934|NCT04852276|565829642|FG000|Overall Study|Withdrawal by Subject|26|||
156748935|NCT04852276|565829643|FG001|Overall Study|Withdrawal by Subject|6|||
156459159|NCT02240238|564776696|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156748936|NCT01687283|565831533|FG000|Overall Study|Adverse Event|11|||
156459160|NCT02240238|564776697|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156748937|NCT01687283|565831534|FG001|Overall Study|Adverse Event|4|||
156748938|NCT01687283|565831533|FG000|Overall Study|Lack of Efficacy|3|||
156748939|NCT01687283|565831534|FG001|Overall Study|Lack of Efficacy|1|||
156748940|NCT01687283|565831533|FG000|Overall Study|Protocol Violation|1|||
156748941|NCT01687283|565831534|FG001|Overall Study|Protocol Violation|3|||
156748942|NCT01687283|565831533|FG000|Overall Study|protocol defined stopping criteria|8|||
156748943|NCT01687283|565831534|FG001|Overall Study|protocol defined stopping criteria|10|||
156748944|NCT01687283|565831533|FG000|Overall Study|Lost to Follow-up|1|||
156748945|NCT01687283|565831534|FG001|Overall Study|Lost to Follow-up|1|||
156748946|NCT01687283|565831533|FG000|Overall Study|Investigator discretion|2|||
156748947|NCT01687283|565831534|FG001|Overall Study|Investigator discretion|0|||
156748948|NCT01687283|565831533|FG000|Overall Study|Withdrawal by Subject|9|||
156748949|NCT01687283|565831534|FG001|Overall Study|Withdrawal by Subject|8|||
156748950|NCT00410072|565831538|FG000|Day 1 to Week 48|Adverse Event|1|||
156748951|NCT00410072|565831539|FG001|Day 1 to Week 48|Adverse Event|2|||
156748952|NCT00410072|565831538|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
156748953|NCT00410072|565831539|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
156748954|NCT00410072|565831538|FG000|Day 1 to Week 48|Other|0|||
156748955|NCT00410072|565831539|FG001|Day 1 to Week 48|Other|1|||
156748956|NCT00410072|565831538|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
156748957|NCT00410072|565831539|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
156748958|NCT00410072|565831538|FG000|Day 1 to Week 48|Pregnancy|0|||
156748959|NCT00410072|565831539|FG001|Day 1 to Week 48|Pregnancy|2|||
156748960|NCT00410072|565831538|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
156748961|NCT00410072|565831539|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
156748962|NCT00410072|565831538|FG000|After Week 48 to Week 96|Adverse Event|1|||
156748963|NCT00410072|565831539|FG001|After Week 48 to Week 96|Adverse Event|2|||
156748964|NCT00410072|565831538|FG000|After Week 48 to Week 96|Death|0|||
156748965|NCT00410072|565831539|FG001|After Week 48 to Week 96|Death|1|||
156748966|NCT00410072|565831538|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
156748967|NCT00410072|565831539|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
156748968|NCT00410072|565831538|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
156748969|NCT00410072|565831539|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
156748970|NCT00410072|565831538|FG000|After Week 48 to Week 96|Other|2|||
156748971|NCT00410072|565831539|FG001|After Week 48 to Week 96|Other|0|||
156748972|NCT00410072|565831538|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
156748973|NCT00410072|565831539|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
156748974|NCT00410072|565831538|FG000|After Week 48 to Week 96|Pregnancy|0|||
156748975|NCT00410072|565831539|FG001|After Week 48 to Week 96|Pregnancy|2|||
156748976|NCT00410072|565831538|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
156748977|NCT00410072|565831539|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
156748978|NCT04494425|565831542|FG000|Overall Study|Death|160|||
156748979|NCT04494425|565831543|FG001|Overall Study|Death|166|||
156748980|NCT04494425|565831542|FG000|Overall Study|Withdrawal by Subject|10|||
156748981|NCT04494425|565831543|FG001|Overall Study|Withdrawal by Subject|40|||
156748982|NCT04494425|565831542|FG000|Overall Study|Other|1|||
156748983|NCT04494425|565831543|FG001|Overall Study|Other|1|||
156748984|NCT04494425|565831542|FG000|Overall Study|Ongoing at the time of PCD|265|||
156748985|NCT04494425|565831543|FG001|Overall Study|Ongoing at the time of PCD|223|||
156748986|NCT01270321|565831545|FG000|Overall Study|Death|3|||
156748987|NCT01270321|565831546|FG001|Overall Study|Death|1|||
156748988|NCT01270321|565831547|FG002|Overall Study|Death|4|||
156748989|NCT01270321|565831545|FG000|Overall Study|Adverse Event|7|||
156748990|NCT01270321|565831546|FG001|Overall Study|Adverse Event|9|||
156748991|NCT01270321|565831547|FG002|Overall Study|Adverse Event|5|||
156748992|NCT04003623|565831551|FG000|Overall Study|Withdrawal by Subject|1|||
156748993|NCT04003623|565831552|FG001|Overall Study|Withdrawal by Subject|0|||
156748994|NCT01190189|565831556|FG000|Overall Study|Lost to Follow-up|4|||
156748995|NCT01190189|565831556|FG000|Overall Study|Withdrawal by Subject|1|||
156748996|NCT01190189|565831556|FG000|Overall Study|Migrated/moved from study area|1|||
156748997|NCT00904917|565831558|FG000|Overall Study|Lost to Follow-up|2|||
156748998|NCT00904917|565831559|FG001|Overall Study|Lost to Follow-up|2|||
156748999|NCT00904917|565831560|FG002|Overall Study|Lost to Follow-up|2|||
156749000|NCT00904917|565831561|FG003|Overall Study|Lost to Follow-up|2|||
156749001|NCT02442206|565831562|FG000|Period 1|Adverse Event|1|||
156749002|NCT02442206|565831563|FG001|Period 1|Adverse Event|1|||
156749003|NCT02442206|565831562|FG000|Period 1|withdrew consent|0|||
156749004|NCT02442206|565831563|FG001|Period 1|withdrew consent|1|||
156749005|NCT02442206|565831562|FG000|Period 1|COPD exacerbation|0|||
156749006|NCT02442206|565831563|FG001|Period 1|COPD exacerbation|1|||
156749007|NCT02442206|565831562|FG000|Period 2|Adverse Event|1|||
156749008|NCT02442206|565831563|FG001|Period 2|Adverse Event|0|||
156749009|NCT01471444|565831564|FG000|Overall Study|Physician Decision|3|||
156749010|NCT01471444|565831565|FG001|Overall Study|Physician Decision|2|||
156749011|NCT01471444|565831564|FG000|Overall Study|Withdrawal by Subject|0|||
156749012|NCT01471444|565831565|FG001|Overall Study|Withdrawal by Subject|1|||
156749013|NCT01709409|565831570|FG000|Overall Study|Protocol Violation|1|||
156749014|NCT01709409|565831571|FG001|Overall Study|Protocol Violation|0|||
156749015|NCT02412878|565831572|FG000|Overall Study|Withdrawal by Subject|19|||
156749016|NCT02412878|565831573|FG001|Overall Study|Withdrawal by Subject|10|||
156749017|NCT02412878|565831572|FG000|Overall Study|Lost to Follow-up|2|||
156749018|NCT02412878|565831573|FG001|Overall Study|Lost to Follow-up|3|||
156749019|NCT02190721|565831574|FG000|Overall Study|Patient was out of the city|0|||
156749020|NCT02190721|565831575|FG001|Overall Study|Patient was out of the city|1|||
156749021|NCT02190721|565831576|FG002|Overall Study|Patient was out of the city|0|||
156749022|NCT05025332|565831577|FG000|Screening|Screen failure|12|||
156749023|NCT05025332|565831577|FG000|Treatment & Follow Up|Protocol Violation|1|||
156749024|NCT05025332|565831577|FG000|Treatment & Follow Up|Adverse Event|4|||
156749025|NCT04676152|565831578|FG000|Overall Study|screen fail|9|||
156749026|NCT01928199|565831579|FG000|Overall Study|Lost to Follow-up|2|||
156749027|NCT01928199|565831580|FG001|Overall Study|Lost to Follow-up|1|||
156749028|NCT01928199|565831579|FG000|Overall Study|Withdrawal by Subject|3|||
156749029|NCT01928199|565831580|FG001|Overall Study|Withdrawal by Subject|5|||
156749030|NCT02107313|565831582|FG000|Overall Study|One participant did not do the FED cohor|0|||
156749031|NCT02107313|565831583|FG001|Overall Study|One participant did not do the FED cohor|1|||
156749032|NCT01031004|565831586|FG000|Overall Study|Protocol Violation|0|||
156537020|NCT01168973|565061068|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
156537021|NCT01168973|565061069|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
156537022|NCT00388505|565061073|FG000|Overall Study|Adverse Event or Death|43|||
156537023|NCT00388505|565061074|FG001|Overall Study|Adverse Event or Death|17|||
156537024|NCT00388505|565061073|FG000|Overall Study|Withdrawal by Subject|24|||
156537025|NCT00388505|565061074|FG001|Overall Study|Withdrawal by Subject|9|||
156537026|NCT00388505|565061073|FG000|Overall Study|Lost to Follow-up|5|||
156537027|NCT00388505|565061074|FG001|Overall Study|Lost to Follow-up|3|||
156537028|NCT00388505|565061073|FG000|Overall Study|Inappropriate Enrollment|0|||
156537029|NCT00388505|565061074|FG001|Overall Study|Inappropriate Enrollment|1|||
156537030|NCT00388505|565061073|FG000|Overall Study|Administrative Reason|1|||
156537031|NCT00388505|565061074|FG001|Overall Study|Administrative Reason|0|||
156537032|NCT00388505|565061073|FG000|Overall Study|Protocol Violation|6|||
156537033|NCT00388505|565061074|FG001|Overall Study|Protocol Violation|5|||
156537034|NCT00388505|565061073|FG000|Overall Study|Unable to classify|4|||
156537035|NCT00388505|565061074|FG001|Overall Study|Unable to classify|3|||
156537036|NCT02163187|565061075|FG000|Overall Study|Device removed|1|||
156537037|NCT02163187|565061076|FG001|Overall Study|Device removed|0|||
156537038|NCT02163187|565061075|FG000|Overall Study|Progressive disease|1|||
156537039|NCT02163187|565061076|FG001|Overall Study|Progressive disease|0|||
156537040|NCT03281668|565061078|FG000|Overall Study|Physician Decision|1|||
156537041|NCT03281668|565061078|FG000|Overall Study|scheduling conflict, family circumstance|2|||
156537042|NCT03281668|565061078|FG000|Overall Study|Withdrawal by Subject|4|||
156537043|NCT03281668|565061078|FG000|Overall Study|Lost to Follow-up|1|||
156537044|NCT02285920|565061080|FG000|Overall Study|Kidney transplantation|2|||
156537045|NCT02285920|565061081|FG001|Overall Study|Kidney transplantation|2|||
156537046|NCT02285920|565061082|FG002|Overall Study|Kidney transplantation|2|||
156537047|NCT02285920|565061083|FG003|Overall Study|Kidney transplantation|0|||
156537048|NCT02285920|565061080|FG000|Overall Study|Change to peritoneal dialysis|0|||
156537049|NCT02285920|565061081|FG001|Overall Study|Change to peritoneal dialysis|0|||
156537050|NCT02285920|565061082|FG002|Overall Study|Change to peritoneal dialysis|1|||
156537051|NCT02285920|565061083|FG003|Overall Study|Change to peritoneal dialysis|0|||
156537052|NCT02285920|565061080|FG000|Overall Study|Transfer to non-participating unit|0|||
156537053|NCT02285920|565061081|FG001|Overall Study|Transfer to non-participating unit|1|||
156537054|NCT02285920|565061082|FG002|Overall Study|Transfer to non-participating unit|0|||
156537055|NCT02285920|565061083|FG003|Overall Study|Transfer to non-participating unit|0|||
156537056|NCT02285920|565061080|FG000|Overall Study|Dialysis discontinuation|0|||
156537057|NCT02285920|565061081|FG001|Overall Study|Dialysis discontinuation|1|||
156537058|NCT02285920|565061082|FG002|Overall Study|Dialysis discontinuation|0|||
156537059|NCT02285920|565061083|FG003|Overall Study|Dialysis discontinuation|0|||
156749033|NCT01031004|565831587|FG001|Overall Study|Protocol Violation|1|||
156749034|NCT01031004|565831586|FG000|Overall Study|Lost to Follow-up|1|||
156749035|NCT01031004|565831587|FG001|Overall Study|Lost to Follow-up|0|||
156749036|NCT01641471|565831588|FG000|Overall Study|Withdrawal by Subject|19|||
156749037|NCT01641471|565831589|FG001|Overall Study|Withdrawal by Subject|19|||
156749038|NCT01641471|565831588|FG000|Overall Study|Lost to Follow-up|2|||
156749039|NCT01641471|565831589|FG001|Overall Study|Lost to Follow-up|4|||
156749040|NCT01641471|565831588|FG000|Overall Study|Protocol Violation|2|||
156749041|NCT01641471|565831589|FG001|Overall Study|Protocol Violation|4|||
156749042|NCT04575584|565831590|FG000|Overall Study|Death|6|||
156749043|NCT04575584|565831591|FG001|Overall Study|Death|4|||
156749044|NCT04575584|565831592|FG002|Overall Study|Death|6|||
156749045|NCT04575584|565831593|FG003|Overall Study|Death|2|||
156749046|NCT04575584|565831594|FG004|Overall Study|Death|0|||
156749047|NCT04575584|565831595|FG005|Overall Study|Death|0|||
156749048|NCT04575584|565831590|FG000|Overall Study|Lost to Follow-up|1|||
156749049|NCT04575584|565831591|FG001|Overall Study|Lost to Follow-up|1|||
156749050|NCT04575584|565831592|FG002|Overall Study|Lost to Follow-up|1|||
156749051|NCT04575584|565831593|FG003|Overall Study|Lost to Follow-up|1|||
156749052|NCT04575584|565831594|FG004|Overall Study|Lost to Follow-up|0|||
156749053|NCT04575584|565831595|FG005|Overall Study|Lost to Follow-up|0|||
156537060|NCT02285920|565061080|FG000|Overall Study|Death|2|||
156537061|NCT02285920|565061081|FG001|Overall Study|Death|0|||
156537062|NCT02285920|565061082|FG002|Overall Study|Death|2|||
156537063|NCT02285920|565061083|FG003|Overall Study|Death|1|||
156537064|NCT01383096|565061086|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
156537065|NCT01383096|565061087|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
156537066|NCT01383096|565061088|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
156749054|NCT04575584|565831590|FG000|Overall Study|Physician Decision|0|||
156749055|NCT04575584|565831591|FG001|Overall Study|Physician Decision|1|||
156749056|NCT04575584|565831592|FG002|Overall Study|Physician Decision|1|||
156749057|NCT04575584|565831593|FG003|Overall Study|Physician Decision|1|||
156749058|NCT04575584|565831594|FG004|Overall Study|Physician Decision|0|||
156749059|NCT04575584|565831595|FG005|Overall Study|Physician Decision|0|||
156337262|NCT01153347|564333583|FG001|Overall Study|Lack of Efficacy|2|||
156337263|NCT01153347|564333584|FG002|Overall Study|Lack of Efficacy|0|||
156337264|NCT01153347|564333585|FG003|Overall Study|Lack of Efficacy|4|||
156337265|NCT01153347|564333582|FG000|Overall Study|Study-specific withdrawal criteria|4|||
156337266|NCT01153347|564333583|FG001|Overall Study|Study-specific withdrawal criteria|3|||
156337267|NCT01153347|564333584|FG002|Overall Study|Study-specific withdrawal criteria|1|||
156337268|NCT01153347|564333585|FG003|Overall Study|Study-specific withdrawal criteria|2|||
156337269|NCT01153347|564333582|FG000|Overall Study|Lost to Follow-up|4|||
156337270|NCT01153347|564333583|FG001|Overall Study|Lost to Follow-up|9|||
156337271|NCT01153347|564333584|FG002|Overall Study|Lost to Follow-up|11|||
156337272|NCT01153347|564333585|FG003|Overall Study|Lost to Follow-up|8|||
156337273|NCT01153347|564333582|FG000|Overall Study|Other|5|||
156337274|NCT01153347|564333583|FG001|Overall Study|Other|5|||
156337275|NCT01153347|564333584|FG002|Overall Study|Other|4|||
156337276|NCT01153347|564333585|FG003|Overall Study|Other|0|||
156337277|NCT01153347|564333582|FG000|Overall Study|Death|1|||
156337278|NCT01153347|564333583|FG001|Overall Study|Death|0|||
156337279|NCT01153347|564333584|FG002|Overall Study|Death|0|||
156337280|NCT01153347|564333585|FG003|Overall Study|Death|0|||
156337281|NCT00003473|564333588|FG000|Overall Study|Three patients were not evaluable.|3|||
156337282|NCT04401423|564333589|FG000|Overall Study|Withdrawal by Subject|3|||
156337283|NCT04401423|564333590|FG001|Overall Study|Withdrawal by Subject|1|||
156337284|NCT04401423|564333589|FG000|Overall Study|Physician Decision|2|||
156337285|NCT04401423|564333590|FG001|Overall Study|Physician Decision|1|||
156337286|NCT00827502|564333591|FG000|Overall Study|randomized but not treated|11|||
156337287|NCT00827502|564333591|FG000|Overall Study|Adverse Event|1|||
156337288|NCT00827502|564333591|FG000|Overall Study|Lost to Follow-up|4|||
156337289|NCT00827502|564333591|FG000|Overall Study|Withdrawal by Subject|5|||
156337290|NCT03417219|564333593|FG000|Overall Study|Lost to Follow-up|0|||
156749060|NCT04575584|565831590|FG000|Overall Study|Withdrawal by Subject|7|||
156749061|NCT04575584|565831591|FG001|Overall Study|Withdrawal by Subject|9|||
156749062|NCT04575584|565831592|FG002|Overall Study|Withdrawal by Subject|5|||
156749063|NCT04575584|565831593|FG003|Overall Study|Withdrawal by Subject|3|||
156749064|NCT04575584|565831594|FG004|Overall Study|Withdrawal by Subject|0|||
156749065|NCT04575584|565831595|FG005|Overall Study|Withdrawal by Subject|0|||
156749066|NCT04575584|565831590|FG000|Overall Study|Not recorded|0|||
156749067|NCT04575584|565831591|FG001|Overall Study|Not recorded|0|||
156749068|NCT04575584|565831592|FG002|Overall Study|Not recorded|0|||
156749069|NCT04575584|565831593|FG003|Overall Study|Not recorded|1|||
156749070|NCT04575584|565831594|FG004|Overall Study|Not recorded|0|||
156749071|NCT04575584|565831595|FG005|Overall Study|Not recorded|0|||
156749072|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
156749073|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
156749074|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
156749075|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
156749076|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
156749077|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
156749078|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
156749079|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
156749080|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
156749081|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
156749082|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
156749083|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
156749084|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
156749085|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
156749086|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
156749087|NCT02634801|565831596|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
156749088|NCT02634801|565831597|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
156749089|NCT02634801|565831598|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
156749090|NCT02634801|565831596|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
156749091|NCT02634801|565831597|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
156749092|NCT02634801|565831598|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
156749093|NCT02634801|565831596|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
156749094|NCT02634801|565831597|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
156749095|NCT02634801|565831598|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
156749096|NCT02634801|565831596|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
156749097|NCT02634801|565831597|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
156749098|NCT02634801|565831598|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
156749099|NCT02634801|565831596|FG000|Follow-up Period|Lost to Follow-up|3|||
156749100|NCT02634801|565831597|FG001|Follow-up Period|Lost to Follow-up|1|||
156749101|NCT02634801|565831598|FG002|Follow-up Period|Lost to Follow-up|2|||
156749102|NCT02634801|565831596|FG000|Follow-up Period|Physician Decision|0|||
156749103|NCT02634801|565831597|FG001|Follow-up Period|Physician Decision|0|||
156749104|NCT02634801|565831598|FG002|Follow-up Period|Physician Decision|1|||
156749105|NCT02634801|565831596|FG000|Follow-up Period|Withdrawal by Subject|1|||
156749106|NCT02634801|565831597|FG001|Follow-up Period|Withdrawal by Subject|2|||
156749107|NCT02634801|565831598|FG002|Follow-up Period|Withdrawal by Subject|5|||
156749108|NCT02634801|565831596|FG000|Follow-up Period|Adverse Event|1|||
156749109|NCT02634801|565831597|FG001|Follow-up Period|Adverse Event|5|||
156749110|NCT02634801|565831598|FG002|Follow-up Period|Adverse Event|0|||
156749111|NCT01548768|565831619|FG000|Overall Study|Withdrawal by Subject|0|||
156749112|NCT01548768|565831620|FG001|Overall Study|Withdrawal by Subject|2|||
156749113|NCT01548768|565831621|FG002|Overall Study|Withdrawal by Subject|1|||
156749114|NCT01548768|565831622|FG003|Overall Study|Withdrawal by Subject|0|||
156749115|NCT01548768|565831619|FG000|Overall Study|Physician Decision|1|||
156749116|NCT01548768|565831620|FG001|Overall Study|Physician Decision|0|||
156749117|NCT01548768|565831621|FG002|Overall Study|Physician Decision|0|||
156749118|NCT01548768|565831622|FG003|Overall Study|Physician Decision|0|||
156749119|NCT01548768|565831619|FG000|Overall Study|Adverse Event|0|||
156749120|NCT01548768|565831620|FG001|Overall Study|Adverse Event|0|||
156749121|NCT01548768|565831621|FG002|Overall Study|Adverse Event|0|||
156749122|NCT01548768|565831622|FG003|Overall Study|Adverse Event|1|||
156749123|NCT01548768|565831619|FG000|Overall Study|Non-Compliance|0|||
156749124|NCT01548768|565831620|FG001|Overall Study|Non-Compliance|0|||
156749125|NCT01548768|565831621|FG002|Overall Study|Non-Compliance|0|||
156749126|NCT01548768|565831622|FG003|Overall Study|Non-Compliance|3|||
156749127|NCT01108237|565831623|FG000|Overall Study|No alignment data|2|||
156749128|NCT01108237|565831624|FG001|Overall Study|No alignment data|15|||
156537067|NCT01383096|565061086|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
156749129|NCT01108237|565831623|FG000|Overall Study|Did not meet criteria for analysis|7|||
156749130|NCT01108237|565831624|FG001|Overall Study|Did not meet criteria for analysis|0|||
156749131|NCT02178358|565831627|FG000|Overall Study|Withdrawal by Subject|0|||
156749132|NCT02178358|565831628|FG001|Overall Study|Withdrawal by Subject|2|||
156537068|NCT01383096|565061087|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
156537069|NCT01383096|565061088|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
156537070|NCT01383096|565061086|FG000|Third Intervention (8 Days)|Elevated AST|0|||
156749133|NCT02178358|565831629|FG002|Overall Study|Withdrawal by Subject|2|||
156749134|NCT02178358|565831627|FG000|Overall Study|Lost to Follow-up|1|||
156749135|NCT02178358|565831628|FG001|Overall Study|Lost to Follow-up|0|||
156749136|NCT02178358|565831629|FG002|Overall Study|Lost to Follow-up|0|||
156749137|NCT03297021|565831630|FG000|Overall Study|Incomplete/illegible data sheet|4|||
156749138|NCT03297021|565831631|FG001|Overall Study|Incomplete/illegible data sheet|2|||
156749139|NCT03297021|565831632|FG002|Overall Study|Incomplete/illegible data sheet|3|||
156749140|NCT03297021|565831630|FG000|Overall Study|Missing Post-Op Data|1|||
156749141|NCT03297021|565831631|FG001|Overall Study|Missing Post-Op Data|2|||
156749142|NCT03297021|565831632|FG002|Overall Study|Missing Post-Op Data|1|||
156749143|NCT02784288|565831633|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
156749144|NCT02734862|565831634|FG000|Part A|Death|3|||
156749145|NCT02734862|565831635|FG001|Part A|Death|4|||
156749146|NCT02734862|565831636|FG002|Part A|Death|6|||
156749147|NCT02734862|565831634|FG000|Part A|Lost to Follow-up|2|||
156749148|NCT02734862|565831635|FG001|Part A|Lost to Follow-up|1|||
156749149|NCT02734862|565831636|FG002|Part A|Lost to Follow-up|1|||
156749150|NCT02734862|565831634|FG000|Part A|Withdrawal by Subject|1|||
156749151|NCT02734862|565831635|FG001|Part A|Withdrawal by Subject|1|||
156749152|NCT02734862|565831636|FG002|Part A|Withdrawal by Subject|2|||
156749153|NCT02734862|565831634|FG000|Part A|Physician Decision|2|||
156749154|NCT02734862|565831635|FG001|Part A|Physician Decision|0|||
156749155|NCT02734862|565831636|FG002|Part A|Physician Decision|1|||
156749156|NCT02734862|565831634|FG000|Part A|Adverse Event|2|||
156749157|NCT02734862|565831635|FG001|Part A|Adverse Event|0|||
156749158|NCT02734862|565831636|FG002|Part A|Adverse Event|1|||
156749159|NCT02734862|565831634|FG000|Part A|Noncompliance|1|||
156749160|NCT02734862|565831635|FG001|Part A|Noncompliance|1|||
156749161|NCT02734862|565831636|FG002|Part A|Noncompliance|0|||
156749162|NCT02734862|565831634|FG000|Part A|Other|1|||
156749163|NCT02734862|565831635|FG001|Part A|Other|1|||
156749164|NCT02734862|565831636|FG002|Part A|Other|3|||
156749165|NCT02734862|565831634|FG000|Part B|Death|8|||
156749166|NCT02734862|565831635|FG001|Part B|Death|3|||
156749167|NCT02734862|565831636|FG002|Part B|Death|5|||
156749168|NCT02734862|565831634|FG000|Part B|Lost to Follow-up|2|||
156749169|NCT02734862|565831635|FG001|Part B|Lost to Follow-up|2|||
156749170|NCT02734862|565831636|FG002|Part B|Lost to Follow-up|0|||
156749171|NCT02734862|565831634|FG000|Part B|Withdrawal by Subject|3|||
156749172|NCT02734862|565831635|FG001|Part B|Withdrawal by Subject|1|||
156749173|NCT02734862|565831636|FG002|Part B|Withdrawal by Subject|0|||
156749174|NCT02734862|565831634|FG000|Part B|Other|0|||
156749175|NCT02734862|565831635|FG001|Part B|Other|1|||
156749176|NCT02734862|565831636|FG002|Part B|Other|0|||
156749177|NCT02757625|565831637|FG000|Overall Study|Investigator's discretion|0|||
156749178|NCT02757625|565831638|FG001|Overall Study|Investigator's discretion|0|||
156749179|NCT02757625|565831639|FG002|Overall Study|Investigator's discretion|1|||
156749180|NCT02757625|565831640|FG003|Overall Study|Investigator's discretion|0|||
156749181|NCT02757625|565831637|FG000|Overall Study|Adverse Event|0|||
156749182|NCT02757625|565831638|FG001|Overall Study|Adverse Event|0|||
156749183|NCT02757625|565831639|FG002|Overall Study|Adverse Event|1|||
156749184|NCT02757625|565831640|FG003|Overall Study|Adverse Event|0|||
156749185|NCT00564278|565831641|FG000|Overall Study|Lost to Follow-up|35|||
156749186|NCT00564278|565831642|FG001|Overall Study|Lost to Follow-up|33|||
156537071|NCT01383096|565061087|FG001|Third Intervention (8 Days)|Elevated AST|1|||
156537072|NCT01383096|565061088|FG002|Third Intervention (8 Days)|Elevated AST|0|||
156537073|NCT01383096|565061086|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
156537074|NCT01383096|565061087|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
156749187|NCT00564278|565831641|FG000|Overall Study|Physician Decision|1|||
156749188|NCT00564278|565831642|FG001|Overall Study|Physician Decision|2|||
156749189|NCT00564278|565831641|FG000|Overall Study|Withdrawal by Subject|11|||
156749190|NCT00564278|565831642|FG001|Overall Study|Withdrawal by Subject|7|||
156749191|NCT00645671|565831643|FG000|Overall Study|Protocol Violation|1|||
156749192|NCT00645671|565831644|FG001|Overall Study|Protocol Violation|0|||
156749193|NCT00645671|565831643|FG000|Overall Study|Withdrawal by Subject|0|||
156749194|NCT00645671|565831644|FG001|Overall Study|Withdrawal by Subject|4|||
156749195|NCT00645671|565831643|FG000|Overall Study|Adverse Event|0|||
156749196|NCT00645671|565831644|FG001|Overall Study|Adverse Event|1|||
156800363|NCT03110562|566023442|FG001|Crossover Period|Lost to Follow-up|0|||
156537075|NCT01383096|565061088|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
156749197|NCT00645671|565831643|FG000|Overall Study|Physician Decision|0|||
156749198|NCT00645671|565831644|FG001|Overall Study|Physician Decision|1|||
156749199|NCT02095197|565831645|FG000|Overall Study|Lost to Follow-up|0|||
156749200|NCT02095197|565831646|FG001|Overall Study|Lost to Follow-up|3|||
156749201|NCT00493311|565831647|FG000|Overall Study|Need for rescue medication|2|||
156749202|NCT00493311|565831648|FG001|Overall Study|Need for rescue medication|2|||
156749203|NCT02779075|565831649|FG000|Overall Study|Withdrawal by Subject|1|||
156337291|NCT03417219|564333594|FG001|Overall Study|Lost to Follow-up|3|||
156337292|NCT01281865|564333595|FG000|Overall Study|Adverse Event|1|||
156337293|NCT01281865|564333596|FG001|Overall Study|Adverse Event|1|||
156337294|NCT01281865|564333595|FG000|Overall Study|Withdrawal by Subject|1|||
156337295|NCT01281865|564333596|FG001|Overall Study|Withdrawal by Subject|0|||
156337296|NCT01281865|564333595|FG000|Overall Study|Lack of Efficacy|1|||
156337297|NCT01281865|564333596|FG001|Overall Study|Lack of Efficacy|0|||
156459161|NCT02240238|564776698|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156459162|NCT02240238|564776699|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156459163|NCT02240238|564776700|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156459164|NCT02240238|564776701|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156459165|NCT02240238|564776702|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
156459166|NCT02240238|564776703|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
156459167|NCT02240238|564776692|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459168|NCT02240238|564776693|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459169|NCT02240238|564776694|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459170|NCT02240238|564776695|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459171|NCT02240238|564776696|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459172|NCT02240238|564776697|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459173|NCT02240238|564776698|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459174|NCT02240238|564776699|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459175|NCT02240238|564776700|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459176|NCT02240238|564776701|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459177|NCT02240238|564776702|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
156459178|NCT02240238|564776703|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
156459179|NCT02240238|564776692|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459180|NCT02240238|564776693|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459181|NCT02240238|564776694|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156749204|NCT02779075|565831650|FG001|Overall Study|Withdrawal by Subject|3|||
156749205|NCT02779075|565831649|FG000|Overall Study|IV lost during 2nd study|1|||
156749206|NCT02779075|565831650|FG001|Overall Study|IV lost during 2nd study|0|||
156337298|NCT03733470|564333597|FG000|Overall Study|PI Decision|1|||
156337299|NCT03733470|564333598|FG001|Overall Study|PI Decision|1|||
156459182|NCT02240238|564776695|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156749207|NCT00790556|565831651|FG000|Treatment Period 1|Physician Decision|1|||
156749208|NCT00790556|565831652|FG001|Treatment Period 1|Physician Decision|0|||
156337300|NCT01786668|564333601|FG000|Overall Study|Adverse Event|0|||
156537076|NCT01383096|565061086|FG000|Third Intervention (8 Days)|Adverse Event|1|||
156537077|NCT01383096|565061087|FG001|Third Intervention (8 Days)|Adverse Event|0|||
156537078|NCT01383096|565061088|FG002|Third Intervention (8 Days)|Adverse Event|0|||
156537079|NCT01383096|565061086|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
156537080|NCT01383096|565061087|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
156537081|NCT01383096|565061088|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
156537082|NCT01383096|565061086|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
156537083|NCT01383096|565061087|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
156537084|NCT01383096|565061088|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
156537085|NCT01383096|565061086|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
156537086|NCT01383096|565061087|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
156537087|NCT01383096|565061088|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
156537088|NCT01383096|565061086|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
156537089|NCT01383096|565061087|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
156537090|NCT01383096|565061088|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
156537091|NCT01383096|565061086|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
156537092|NCT01383096|565061087|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
156537093|NCT01383096|565061088|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
156537094|NCT01383096|565061086|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
156537095|NCT01383096|565061087|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
156537096|NCT01383096|565061088|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
156537097|NCT00616434|565061093|FG000|Overall Study|Adverse Event|5|||
156537098|NCT00616434|565061094|FG001|Overall Study|Adverse Event|2|||
156537099|NCT00616434|565061093|FG000|Overall Study|Physician Decision|0|||
156537100|NCT00616434|565061094|FG001|Overall Study|Physician Decision|4|||
156537101|NCT00616434|565061093|FG000|Overall Study|Withdrawal by Subject|1|||
156537102|NCT00616434|565061094|FG001|Overall Study|Withdrawal by Subject|1|||
156537103|NCT00616434|565061093|FG000|Overall Study|Protocol deviation|0|||
156537104|NCT00616434|565061094|FG001|Overall Study|Protocol deviation|1|||
156537105|NCT00467779|565061095|FG000|Stage 1|Adverse Event|1|||
156537106|NCT00467779|565061096|FG001|Stage 1|Adverse Event|0|||
156537107|NCT00467779|565061097|FG002|Stage 1|Adverse Event|0|||
156537108|NCT00467779|565061098|FG003|Stage 1|Adverse Event|0|||
156459183|NCT02240238|564776696|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459184|NCT02240238|564776697|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459185|NCT02240238|564776698|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459186|NCT02240238|564776699|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459187|NCT02240238|564776700|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459188|NCT02240238|564776701|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459189|NCT02240238|564776702|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
156459190|NCT02240238|564776703|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156459191|NCT02240238|564776692|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459192|NCT02240238|564776693|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459193|NCT02240238|564776694|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459194|NCT02240238|564776695|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459195|NCT02240238|564776696|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156537109|NCT00467779|565061099|FG004|Stage 1|Adverse Event|0|||
156537110|NCT00467779|565061100|FG005|Stage 1|Adverse Event|1|||
156537111|NCT00467779|565061101|FG006|Stage 1|Adverse Event|2|||
156537112|NCT00467779|565061102|FG007|Stage 1|Adverse Event|1|||
156537113|NCT00467779|565061103|FG008|Stage 1|Adverse Event|0|||
156537114|NCT00467779|565061104|FG009|Stage 1|Adverse Event|0|||
156537115|NCT00467779|565061105|FG010|Stage 1|Adverse Event|0|||
156537116|NCT00467779|565061106|FG011|Stage 1|Adverse Event|0|||
156459196|NCT02240238|564776697|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459197|NCT02240238|564776698|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459198|NCT02240238|564776699|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459199|NCT02240238|564776700|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459200|NCT02240238|564776701|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459201|NCT02240238|564776702|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
156459202|NCT02240238|564776703|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
156459203|NCT02240238|564776692|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459204|NCT02240238|564776693|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459205|NCT02240238|564776694|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459206|NCT02240238|564776695|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459207|NCT02240238|564776696|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459208|NCT02240238|564776697|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459209|NCT02240238|564776698|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459210|NCT02240238|564776699|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459211|NCT02240238|564776700|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459212|NCT02240238|564776701|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459213|NCT02240238|564776702|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
156459214|NCT02240238|564776703|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
156459215|NCT02724969|564776715|FG000|Overall Study|Lost to Follow-up|12|||
156459216|NCT02724969|564776716|FG001|Overall Study|Lost to Follow-up|6|||
156459217|NCT02724969|564776715|FG000|Overall Study|Withdrawal by Subject|3|||
156459218|NCT02724969|564776716|FG001|Overall Study|Withdrawal by Subject|3|||
156459219|NCT02724969|564776715|FG000|Overall Study|Infant demise|0|||
156459220|NCT02724969|564776716|FG001|Overall Study|Infant demise|2|||
156459221|NCT01346540|564776717|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
156459222|NCT01346540|564776718|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
156459223|NCT01346540|564776717|FG000|Overall Study|Adverse Event|0|||
156459224|NCT01346540|564776718|FG001|Overall Study|Adverse Event|4|||
156459225|NCT04797195|564776722|FG000|Overall Study|Death|8|||
156459226|NCT04797195|564776723|FG001|Overall Study|Death|15|||
156459227|NCT04797195|564776722|FG000|Overall Study|Change from PD|15|||
156459228|NCT04797195|564776723|FG001|Overall Study|Change from PD|15|||
156459229|NCT04797195|564776722|FG000|Overall Study|Withdrawal by Subject|3|||
156459230|NCT04797195|564776723|FG001|Overall Study|Withdrawal by Subject|2|||
156459231|NCT01236781|564776725|FG000|Overall Study|Ineligible|2|||
156459232|NCT01236781|564776726|FG001|Overall Study|Ineligible|1|||
156459233|NCT01236781|564776725|FG000|Overall Study|Did not complete study imaging|5|||
156459234|NCT01236781|564776726|FG001|Overall Study|Did not complete study imaging|0|||
156749209|NCT00790556|565831651|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156749210|NCT00790556|565831652|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156749211|NCT04847232|565831653|FG000|Overall Study|Death|123|||
156749212|NCT04847232|565831654|FG001|Overall Study|Death|115|||
156749213|NCT04847232|565831653|FG000|Overall Study|Lost to Follow-up|3|||
156749214|NCT04847232|565831654|FG001|Overall Study|Lost to Follow-up|10|||
156749215|NCT04847232|565831653|FG000|Overall Study|Withdrawal by Subject|73|||
156749216|NCT04847232|565831654|FG001|Overall Study|Withdrawal by Subject|101|||
156749217|NCT04847232|565831653|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
156749218|NCT04847232|565831654|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
156749219|NCT02476916|565831655|FG000|Core Period|Adverse Event|2|||
156749220|NCT02476916|565831656|FG001|Core Period|Adverse Event|2|||
156749221|NCT02476916|565831655|FG000|Core Period|Investigator decision|1|||
156749222|NCT02476916|565831656|FG001|Core Period|Investigator decision|1|||
156749223|NCT02476916|565831655|FG000|Core Period|Withdrawal by Subject|3|||
156749224|NCT02476916|565831656|FG001|Core Period|Withdrawal by Subject|0|||
156749225|NCT02476916|565831655|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
156749226|NCT02476916|565831656|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
156749227|NCT02476916|565831655|FG000|Extension Period|On Treatment|12|||
156749228|NCT02476916|565831656|FG001|Extension Period|On Treatment|17|||
156749229|NCT05600036|565831657|FG000|Overall Study|Adverse Event|0|||
156749230|NCT05600036|565831658|FG001|Overall Study|Adverse Event|2|||
156749231|NCT05600036|565831659|FG002|Overall Study|Adverse Event|1|||
156749232|NCT05600036|565831660|FG003|Overall Study|Adverse Event|0|||
156749233|NCT05600036|565831661|FG004|Overall Study|Adverse Event|1|||
156749234|NCT05600036|565831662|FG005|Overall Study|Adverse Event|0|||
156749235|NCT05600036|565831657|FG000|Overall Study|Lost to Follow-up|0|||
156749236|NCT05600036|565831658|FG001|Overall Study|Lost to Follow-up|2|||
156459235|NCT04577963|564776727|FG000|Part 2|Death|0|||
156459236|NCT04577963|564776728|FG001|Part 2|Death|1|||
156459237|NCT04577963|564776729|FG002|Part 2|Death|8|||
156459238|NCT04577963|564776730|FG003|Part 2|Death|0|||
156459239|NCT04577963|564776731|FG004|Part 2|Death|20|||
156459240|NCT04577963|564776727|FG000|Part 2|Lost to Follow-up|0|||
156749237|NCT05600036|565831659|FG002|Overall Study|Lost to Follow-up|1|||
156749238|NCT05600036|565831660|FG003|Overall Study|Lost to Follow-up|1|||
156749239|NCT05600036|565831661|FG004|Overall Study|Lost to Follow-up|0|||
156749240|NCT05600036|565831662|FG005|Overall Study|Lost to Follow-up|0|||
156749241|NCT05600036|565831657|FG000|Overall Study|Protocol Violation|0|||
156749242|NCT05600036|565831658|FG001|Overall Study|Protocol Violation|0|||
156749243|NCT05600036|565831659|FG002|Overall Study|Protocol Violation|2|||
156749244|NCT05600036|565831660|FG003|Overall Study|Protocol Violation|0|||
156749245|NCT05600036|565831661|FG004|Overall Study|Protocol Violation|0|||
156749246|NCT05600036|565831662|FG005|Overall Study|Protocol Violation|0|||
156749247|NCT05600036|565831657|FG000|Overall Study|Withdrawal by Subject|0|||
156749248|NCT05600036|565831658|FG001|Overall Study|Withdrawal by Subject|1|||
156749249|NCT05600036|565831659|FG002|Overall Study|Withdrawal by Subject|2|||
156749250|NCT05600036|565831660|FG003|Overall Study|Withdrawal by Subject|0|||
156749251|NCT05600036|565831661|FG004|Overall Study|Withdrawal by Subject|3|||
156749252|NCT05600036|565831662|FG005|Overall Study|Withdrawal by Subject|5|||
156749253|NCT05600036|565831657|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749254|NCT05600036|565831658|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749255|NCT05600036|565831659|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749256|NCT05600036|565831660|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
156749257|NCT05600036|565831661|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749258|NCT05600036|565831662|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749259|NCT05600036|565831657|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749260|NCT05600036|565831658|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
156749261|NCT05600036|565831659|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749262|NCT05600036|565831660|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749263|NCT05600036|565831661|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749264|NCT05600036|565831662|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749265|NCT05600036|565831657|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749266|NCT05600036|565831658|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749267|NCT05600036|565831659|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749268|NCT05600036|565831660|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
156749269|NCT05600036|565831661|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749270|NCT05600036|565831662|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749271|NCT04401202|565831663|FG000|Overall Study|Lost to Follow-up|2|||
156749272|NCT04401202|565831664|FG001|Overall Study|Lost to Follow-up|2|||
156749273|NCT04401202|565831663|FG000|Overall Study|Adverse Event|0|||
156749274|NCT04401202|565831664|FG001|Overall Study|Adverse Event|1|||
156749275|NCT04401202|565831663|FG000|Overall Study|Hospitalized|4|||
156749276|NCT04401202|565831664|FG001|Overall Study|Hospitalized|1|||
156749277|NCT02714036|565831666|FG000|Overall Study|Adverse Event|9|||
156749278|NCT02714036|565831667|FG001|Overall Study|Adverse Event|2|||
156749279|NCT02714036|565831666|FG000|Overall Study|Withdrawal by Subject|3|||
156749280|NCT02714036|565831667|FG001|Overall Study|Withdrawal by Subject|2|||
156749281|NCT00715520|565831669|FG000|Overall Study|Screen failure|8|||
156749282|NCT00715520|565831670|FG001|Overall Study|Screen failure|1|||
156749283|NCT00715520|565831671|FG002|Overall Study|Screen failure|1|||
156749284|NCT00715520|565831669|FG000|Overall Study|Withdrawal by Subject|2|||
156749285|NCT00715520|565831670|FG001|Overall Study|Withdrawal by Subject|0|||
156749286|NCT00715520|565831671|FG002|Overall Study|Withdrawal by Subject|1|||
156800364|NCT03110562|566023443|FG002|Crossover Period|Lost to Follow-up|0|||
156800365|NCT03110562|566023444|FG003|Crossover Period|Lost to Follow-up|1|||
156800366|NCT03110562|566023441|FG000|Crossover Period|Other|0|||
156800367|NCT03110562|566023442|FG001|Crossover Period|Other|0|||
156800368|NCT03110562|566023443|FG002|Crossover Period|Other|1|||
156800369|NCT03110562|566023444|FG003|Crossover Period|Other|1|||
156800370|NCT03110562|566023441|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
156800371|NCT03110562|566023442|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
156800372|NCT03110562|566023443|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
156800373|NCT03110562|566023444|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
156800374|NCT05211596|566023447|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
156800375|NCT05211596|566023447|FG000|Baseline to 6 Months|Death|1|||
156800376|NCT05211596|566023447|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
156800377|NCT05211596|566023447|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
156800378|NCT02293551|566023448|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
156800379|NCT02293551|566023449|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
156800380|NCT02293551|566023450|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
156749287|NCT01006590|565831672|FG000|Overall Study|Adverse Event|2|||
156749288|NCT01006590|565831673|FG001|Overall Study|Adverse Event|3|||
156800381|NCT02293551|566023451|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
156800382|NCT02293551|566023452|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
156800383|NCT02293551|566023453|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
156800384|NCT02293551|566023448|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
156749289|NCT01006590|565831672|FG000|Overall Study|Death|1|||
156749290|NCT01006590|565831673|FG001|Overall Study|Death|1|||
156749291|NCT01006590|565831672|FG000|Overall Study|Lost to Follow-up|1|||
156749292|NCT01006590|565831673|FG001|Overall Study|Lost to Follow-up|1|||
156749293|NCT01006590|565831672|FG000|Overall Study|Protocol Violation|1|||
156749294|NCT01006590|565831673|FG001|Overall Study|Protocol Violation|0|||
156749295|NCT01006590|565831672|FG000|Overall Study|Withdrawal by Subject|4|||
156749296|NCT01006590|565831673|FG001|Overall Study|Withdrawal by Subject|2|||
156749297|NCT01006590|565831672|FG000|Overall Study|Study specific discontinuation criteria|16|||
156749298|NCT01006590|565831673|FG001|Overall Study|Study specific discontinuation criteria|23|||
156749299|NCT01006590|565831672|FG000|Overall Study|Other|3|||
156749300|NCT01006590|565831673|FG001|Overall Study|Other|2|||
156749301|NCT03332095|565831674|FG000|Overall Study|Lost to Follow-up|1|||
156749302|NCT03332095|565831675|FG001|Overall Study|Lost to Follow-up|0|||
156749303|NCT03332095|565831674|FG000|Overall Study|Pregnancy|0|||
156749304|NCT03332095|565831675|FG001|Overall Study|Pregnancy|1|||
156749305|NCT05697627|565831681|FG000|Overall Study|Adverse Event|1|||
156749306|NCT02722746|565831686|FG000|Overall Study|Withdrawal by Subject|0|||
156749307|NCT02722746|565831687|FG001|Overall Study|Withdrawal by Subject|1|||
156749308|NCT02722746|565831688|FG002|Overall Study|Withdrawal by Subject|0|||
156749309|NCT02722746|565831686|FG000|Overall Study|Protocol Violation|8|||
156749310|NCT02722746|565831687|FG001|Overall Study|Protocol Violation|4|||
156749311|NCT02722746|565831688|FG002|Overall Study|Protocol Violation|6|||
156749312|NCT01038752|565831693|FG000|Overall Study|Tumor Progression|2|||
156749313|NCT01038752|565831694|FG001|Overall Study|Tumor Progression|2|||
156749314|NCT01038752|565831693|FG000|Overall Study|Lost to Follow-up|3|||
156749315|NCT01038752|565831694|FG001|Overall Study|Lost to Follow-up|3|||
156749316|NCT02700698|565831697|FG000|Overall Study|Withdrawal by Subject|1|||
156749317|NCT02700698|565831698|FG001|Overall Study|Withdrawal by Subject|0|||
156749318|NCT00703118|565831699|FG000|Overall Study|Adverse Event|1|||
156749319|NCT00703118|565831700|FG001|Overall Study|Adverse Event|2|||
156749320|NCT00703118|565831701|FG002|Overall Study|Adverse Event|2|||
156749321|NCT00703118|565831699|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
156749322|NCT00703118|565831700|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
156749323|NCT00703118|565831701|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
156749324|NCT00703118|565831699|FG000|Overall Study|Lost to Follow-up|6|||
156749325|NCT00703118|565831700|FG001|Overall Study|Lost to Follow-up|4|||
156749326|NCT00703118|565831701|FG002|Overall Study|Lost to Follow-up|4|||
156749327|NCT00703118|565831699|FG000|Overall Study|Withdrawal by Subject|8|||
156749328|NCT00703118|565831700|FG001|Overall Study|Withdrawal by Subject|7|||
156749329|NCT00703118|565831701|FG002|Overall Study|Withdrawal by Subject|13|||
156749330|NCT00703118|565831699|FG000|Overall Study|Other|0|||
156749331|NCT00703118|565831700|FG001|Overall Study|Other|0|||
156749332|NCT00703118|565831701|FG002|Overall Study|Other|1|||
156749333|NCT04165135|565831704|FG000|Overall Study|Protocol Violation|10|||
156749334|NCT04165135|565831704|FG000|Overall Study|Participants withdrawal of consent|5|||
156749335|NCT05053035|565831711|FG000|Overall Study|Withdrawal by Subject|1|||
156749336|NCT05053035|565831712|FG001|Overall Study|Withdrawal by Subject|0|||
156749337|NCT02243046|565831715|FG000|Overall Study|Lost to Follow-up|1|||
156749338|NCT02243046|565831716|FG001|Overall Study|Lost to Follow-up|1|||
156749339|NCT02243046|565831717|FG002|Overall Study|Lost to Follow-up|4|||
156749340|NCT00762034|565833504|FG000|Induction Period|Protocol Violation|1|||
156749341|NCT00762034|565833505|FG001|Induction Period|Protocol Violation|2|||
156749342|NCT00762034|565833504|FG000|Induction Period|Entry Criterion Not Met|12|||
156749343|NCT00762034|565833505|FG001|Induction Period|Entry Criterion Not Met|11|||
156749344|NCT00762034|565833504|FG000|Induction Period|Adverse Event|27|||
156749345|NCT00762034|565833505|FG001|Induction Period|Adverse Event|38|||
156800385|NCT02293551|566023449|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
156800386|NCT02293551|566023450|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
156800387|NCT02293551|566023451|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
156800388|NCT02293551|566023452|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
156800389|NCT02293551|566023453|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
156800390|NCT02293551|566023448|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
156800391|NCT02293551|566023449|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
156800392|NCT02293551|566023450|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
156800393|NCT02293551|566023451|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
156537117|NCT00467779|565061107|FG012|Stage 1|Adverse Event|0|||
156749346|NCT00762034|565833504|FG000|Induction Period|Lost to Follow-up|1|||
156537118|NCT00467779|565061108|FG013|Stage 1|Adverse Event|0|||
156749347|NCT00762034|565833505|FG001|Induction Period|Lost to Follow-up|1|||
156749348|NCT00762034|565833504|FG000|Induction Period|Progressive Disease|73|||
156749349|NCT00762034|565833505|FG001|Induction Period|Progressive Disease|55|||
156749350|NCT00762034|565833504|FG000|Induction Period|Physician Decision|21|||
156749351|NCT00762034|565833505|FG001|Induction Period|Physician Decision|20|||
156749352|NCT00762034|565833504|FG000|Induction Period|Withdrawal by Subject|15|||
156800394|NCT02293551|566023452|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
156800395|NCT02293551|566023453|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
156749353|NCT00762034|565833505|FG001|Induction Period|Withdrawal by Subject|19|||
156749354|NCT00762034|565833504|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
156749355|NCT00762034|565833505|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
156749356|NCT00762034|565833504|FG000|Induction Period|Deaths Due to Study Disease|9|||
156749357|NCT00762034|565833505|FG001|Induction Period|Deaths Due to Study Disease|9|||
156749358|NCT00762034|565833504|FG000|Maintenance Period|Protocol Violation|1|||
156749359|NCT00762034|565833505|FG001|Maintenance Period|Protocol Violation|3|||
156749360|NCT00762034|565833504|FG000|Maintenance Period|Entry Criterion Not Met|0|||
156749361|NCT00762034|565833505|FG001|Maintenance Period|Entry Criterion Not Met|2|||
156749362|NCT00762034|565833504|FG000|Maintenance Period|Adverse Event|42|||
156749363|NCT00762034|565833505|FG001|Maintenance Period|Adverse Event|26|||
156749364|NCT00762034|565833504|FG000|Maintenance Period|Progressive Disease|186|||
156749365|NCT00762034|565833505|FG001|Maintenance Period|Progressive Disease|224|||
156749366|NCT00762034|565833504|FG000|Maintenance Period|Physician Decision|25|||
156749367|NCT00762034|565833505|FG001|Maintenance Period|Physician Decision|20|||
156749368|NCT00762034|565833504|FG000|Maintenance Period|Withdrawal by Subject|34|||
156749369|NCT00762034|565833505|FG001|Maintenance Period|Withdrawal by Subject|14|||
156749370|NCT00762034|565833504|FG000|Maintenance Period|Death not due to study disease|2|||
156749371|NCT00762034|565833505|FG001|Maintenance Period|Death not due to study disease|5|||
156749372|NCT00762034|565833504|FG000|Maintenance Period|Death due to study disease|3|||
156749373|NCT00762034|565833505|FG001|Maintenance Period|Death due to study disease|3|||
156749374|NCT00762034|565833504|FG000|Maintenance Period|Other|1|||
156749375|NCT00762034|565833505|FG001|Maintenance Period|Other|1|||
156749376|NCT00497146|565833506|FG000|Treatment Period|Adverse Event|6|||
156749377|NCT00497146|565833507|FG001|Treatment Period|Adverse Event|2|||
156749378|NCT00497146|565833506|FG000|Treatment Period|Withdrawal by Subject|5|||
156749379|NCT00497146|565833507|FG001|Treatment Period|Withdrawal by Subject|9|||
156749380|NCT00497146|565833506|FG000|Treatment Period|Lost to Follow-up|1|||
156749381|NCT00497146|565833507|FG001|Treatment Period|Lost to Follow-up|3|||
156749382|NCT00497146|565833506|FG000|Treatment Period|Required dialysis|4|||
156749383|NCT00497146|565833507|FG001|Treatment Period|Required dialysis|1|||
156749384|NCT00497146|565833506|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
156749385|NCT00497146|565833507|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
156749386|NCT00497146|565833506|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
156749387|NCT00497146|565833507|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
156749388|NCT00497146|565833506|FG000|Treatment Period|Other Reason|2|||
156749389|NCT00497146|565833507|FG001|Treatment Period|Other Reason|3|||
156749390|NCT00497146|565833506|FG000|Long-term Follow-up Period|Adverse Event|2|||
156749391|NCT00497146|565833507|FG001|Long-term Follow-up Period|Adverse Event|2|||
156749392|NCT00497146|565833506|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
156749393|NCT00497146|565833507|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
156749394|NCT00497146|565833506|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
156749395|NCT00497146|565833507|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
156749396|NCT00497146|565833506|FG000|Long-term Follow-up Period|Other|0|||
156749397|NCT00497146|565833507|FG001|Long-term Follow-up Period|Other|1|||
156749398|NCT04571385|565833510|FG000|Overall Study|Participant non-compliance|1|||
156749399|NCT04571385|565833511|FG001|Overall Study|Participant non-compliance|0|||
156749400|NCT04571385|565833512|FG002|Overall Study|Participant non-compliance|0|||
156749401|NCT04571385|565833510|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
156749402|NCT04571385|565833511|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
156749403|NCT04571385|565833512|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
156749404|NCT04571385|565833510|FG000|Overall Study|Screen failure|0|||
156749405|NCT04571385|565833511|FG001|Overall Study|Screen failure|0|||
156749406|NCT04571385|565833512|FG002|Overall Study|Screen failure|1|||
156749407|NCT02499263|565833513|FG000|Overall Study|Lost to Follow-up|9|||
156749408|NCT02499263|565833513|FG000|Overall Study|Participant's withdrawal of consent|4|||
156749409|NCT02499263|565833513|FG000|Overall Study|Lack of Efficacy|22|||
156749410|NCT02499263|565833513|FG000|Overall Study|investigator's judgment|12|||
156749411|NCT02499263|565833513|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
156749412|NCT02499263|565833513|FG000|Overall Study|Participant's decision|3|||
156749413|NCT02499263|565833513|FG000|Overall Study|Pregnancy|1|||
156749414|NCT00424593|565833514|FG000|Acute Double-Blind Period|Adverse Event|16|||
156749415|NCT00424593|565833515|FG001|Acute Double-Blind Period|Adverse Event|7|||
156749416|NCT00424593|565833514|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
156749417|NCT00424593|565833515|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
156749418|NCT00424593|565833514|FG000|Acute Double-Blind Period|Protocol Violation|2|||
156749419|NCT00424593|565833515|FG001|Acute Double-Blind Period|Protocol Violation|2|||
156749420|NCT00424593|565833514|FG000|Acute Double-Blind Period|Physician Decision|1|||
156749421|NCT00424593|565833515|FG001|Acute Double-Blind Period|Physician Decision|2|||
156749422|NCT00424593|565833514|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
156537119|NCT00467779|565061109|FG014|Stage 1|Adverse Event|0|||
156749423|NCT00424593|565833515|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
156749424|NCT00424593|565833514|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
156749425|NCT00424593|565833515|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
156459241|NCT04577963|564776728|FG001|Part 2|Lost to Follow-up|0|||
156459242|NCT04577963|564776729|FG002|Part 2|Lost to Follow-up|0|||
156459243|NCT04577963|564776730|FG003|Part 2|Lost to Follow-up|0|||
156459244|NCT04577963|564776731|FG004|Part 2|Lost to Follow-up|2|||
156459245|NCT04577963|564776727|FG000|Part 2|Withdrawal by Subject|0|||
156459246|NCT04577963|564776728|FG001|Part 2|Withdrawal by Subject|0|||
156459247|NCT04577963|564776729|FG002|Part 2|Withdrawal by Subject|0|||
156459248|NCT04577963|564776730|FG003|Part 2|Withdrawal by Subject|0|||
156459249|NCT04577963|564776731|FG004|Part 2|Withdrawal by Subject|10|||
156459250|NCT04577963|564776727|FG000|Part 2|Progressive disease|0|||
156459251|NCT04577963|564776728|FG001|Part 2|Progressive disease|0|||
156459252|NCT04577963|564776729|FG002|Part 2|Progressive disease|0|||
156459253|NCT04577963|564776730|FG003|Part 2|Progressive disease|0|||
156337301|NCT01786668|564333602|FG001|Overall Study|Adverse Event|1|||
156337302|NCT01786668|564333603|FG002|Overall Study|Adverse Event|1|||
156337303|NCT01786668|564333604|FG003|Overall Study|Adverse Event|2|||
156337304|NCT01786668|564333601|FG000|Overall Study|Withdrawal by Subject|0|||
156459254|NCT04577963|564776731|FG004|Part 2|Progressive disease|2|||
156337305|NCT01786668|564333602|FG001|Overall Study|Withdrawal by Subject|0|||
156337306|NCT01786668|564333603|FG002|Overall Study|Withdrawal by Subject|3|||
156337307|NCT01786668|564333604|FG003|Overall Study|Withdrawal by Subject|1|||
156337308|NCT01786668|564333601|FG000|Overall Study|Pregnancy|0|||
156337309|NCT01786668|564333602|FG001|Overall Study|Pregnancy|0|||
156337310|NCT01786668|564333603|FG002|Overall Study|Pregnancy|0|||
156337311|NCT01786668|564333604|FG003|Overall Study|Pregnancy|1|||
156337312|NCT01786668|564333601|FG000|Overall Study|Lost to Follow-up|1|||
156337313|NCT01786668|564333602|FG001|Overall Study|Lost to Follow-up|0|||
156337314|NCT01786668|564333603|FG002|Overall Study|Lost to Follow-up|1|||
156337315|NCT01786668|564333604|FG003|Overall Study|Lost to Follow-up|0|||
156337316|NCT01776840|564333612|FG000|Overall Study|Lost to Follow-up|12|||
156337317|NCT01776840|564333613|FG001|Overall Study|Lost to Follow-up|7|||
156337318|NCT01776840|564333612|FG000|Overall Study|Withdrawal by Subject|32|||
156337319|NCT01776840|564333613|FG001|Overall Study|Withdrawal by Subject|48|||
156337320|NCT01776840|564333612|FG000|Overall Study|Sponsor decision|89|||
156337321|NCT01776840|564333613|FG001|Overall Study|Sponsor decision|87|||
156337322|NCT03641339|564333614|FG000|Overall Study|Physician Decision|1|||
156337323|NCT03641339|564333615|FG001|Overall Study|Physician Decision|0|||
156337324|NCT03641339|564333616|FG002|Overall Study|Physician Decision|0|||
156337325|NCT03641339|564333617|FG003|Overall Study|Physician Decision|0|||
156459255|NCT04577963|564776727|FG000|Part 2|Investigator decision|0|||
156459256|NCT04577963|564776728|FG001|Part 2|Investigator decision|0|||
156459257|NCT04577963|564776729|FG002|Part 2|Investigator decision|0|||
156459258|NCT04577963|564776730|FG003|Part 2|Investigator decision|0|||
156459259|NCT04577963|564776731|FG004|Part 2|Investigator decision|1|||
156459260|NCT04577963|564776727|FG000|Part 2|Sponsor terminated study|0|||
156459261|NCT04577963|564776728|FG001|Part 2|Sponsor terminated study|0|||
156459262|NCT04577963|564776729|FG002|Part 2|Sponsor terminated study|3|||
156459263|NCT04577963|564776730|FG003|Part 2|Sponsor terminated study|1|||
156459264|NCT04577963|564776731|FG004|Part 2|Sponsor terminated study|4|||
156459265|NCT02709161|564776736|FG000|Overall Study|Withdrawal by Subject|1|||
156459266|NCT02709161|564776737|FG001|Overall Study|Withdrawal by Subject|0|||
156459267|NCT05167864|564776740|FG000|Overall Study|Lost to Follow-up|7|||
156459268|NCT05167864|564776741|FG001|Overall Study|Lost to Follow-up|6|||
156459269|NCT05167864|564776742|FG002|Overall Study|Lost to Follow-up|7|||
156459270|NCT05167864|564776743|FG003|Overall Study|Lost to Follow-up|9|||
156459271|NCT04862416|564776744|FG000|Overall Study|Withdrawal by Subject|0|||
156459272|NCT04862416|564776745|FG001|Overall Study|Withdrawal by Subject|1|||
156459273|NCT04862416|564776746|FG002|Overall Study|Withdrawal by Subject|0|||
156459274|NCT04862416|564776747|FG003|Overall Study|Withdrawal by Subject|1|||
156459275|NCT04862416|564776748|FG004|Overall Study|Withdrawal by Subject|0|||
156459276|NCT04862416|564776749|FG005|Overall Study|Withdrawal by Subject|0|||
156459277|NCT04862416|564776750|FG006|Overall Study|Withdrawal by Subject|0|||
156459278|NCT04862416|564776751|FG007|Overall Study|Withdrawal by Subject|0|||
156459279|NCT00746096|564776754|FG000|Overall Study|Adverse Event|1|||
156749426|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
156749427|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
156749428|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Adverse Event|18|||
156749429|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Adverse Event|0|||
156749430|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
156749431|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
156749432|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
156749433|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
156749434|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
156749435|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
156749436|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Physician Decision|3|||
156749437|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Physician Decision|0|||
156749438|NCT02496039|565833516|FG000|Overall Study|Adverse Event|3|||
156749439|NCT02496039|565833516|FG000|Overall Study|Protocol Violation|1|||
156749440|NCT00255840|565833517|FG000|Overall Study|Lost to Follow-up|10|||
156459280|NCT00746096|564776755|FG001|Overall Study|Adverse Event|0|||
156459281|NCT00746096|564776754|FG000|Overall Study|Withdrawal by Subject|5|||
156459282|NCT00746096|564776755|FG001|Overall Study|Withdrawal by Subject|1|||
156749441|NCT00255840|565833518|FG001|Overall Study|Lost to Follow-up|14|||
156337326|NCT03641339|564333618|FG004|Overall Study|Physician Decision|0|||
156337327|NCT03641339|564333619|FG005|Overall Study|Physician Decision|0|||
156337328|NCT03641339|564333614|FG000|Overall Study|Withdrawal by Subject|0|||
156337329|NCT03641339|564333615|FG001|Overall Study|Withdrawal by Subject|2|||
156337330|NCT03641339|564333616|FG002|Overall Study|Withdrawal by Subject|0|||
156337331|NCT03641339|564333617|FG003|Overall Study|Withdrawal by Subject|2|||
156337332|NCT03641339|564333618|FG004|Overall Study|Withdrawal by Subject|0|||
156337333|NCT03641339|564333619|FG005|Overall Study|Withdrawal by Subject|1|||
156337334|NCT05338216|564333621|FG000|Overall Study|Withdrawal by Subject|1|||
156337335|NCT05338216|564333622|FG001|Overall Study|Withdrawal by Subject|1|||
156337336|NCT04457336|564333623|FG000|Period 2: Part A|Withdrawal by Subject|0|||
156337337|NCT04457336|564333624|FG001|Period 2: Part A|Withdrawal by Subject|1|||
156337338|NCT04457336|564333625|FG002|Period 2: Part A|Withdrawal by Subject|1|||
156337339|NCT04457336|564333626|FG003|Period 2: Part A|Withdrawal by Subject|1|||
156337340|NCT04457336|564333627|FG004|Period 2: Part A|Withdrawal by Subject|0|||
156337341|NCT04457336|564333628|FG005|Period 2: Part A|Withdrawal by Subject|0|||
156337342|NCT04457336|564333629|FG006|Period 2: Part A|Withdrawal by Subject|0|||
156337343|NCT04457336|564333630|FG007|Period 2: Part A|Withdrawal by Subject|0|||
156459283|NCT00746096|564776754|FG000|Overall Study|Lost to Follow-up|2|||
156459284|NCT00746096|564776755|FG001|Overall Study|Lost to Follow-up|1|||
156800396|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
156459285|NCT00746096|564776754|FG000|Overall Study|Protocol Violation|1|||
156800397|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
156800398|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
156800399|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
156800400|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
156800401|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
156800402|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
156800403|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
156800404|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
156800405|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
156800406|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
156800407|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
156800408|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
156800409|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
156800410|NCT04532749|566023454|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
156800411|NCT04532749|566023455|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
156800412|NCT04532749|566023454|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
156800413|NCT04532749|566023455|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
156800414|NCT04532749|566023454|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
156800415|NCT04532749|566023455|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
156800416|NCT02936323|566023456|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800417|NCT02936323|566023457|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
156800418|NCT02936323|566023458|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800419|NCT02936323|566023459|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
156800420|NCT02936323|566023460|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
156800421|NCT02936323|566023461|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
156800422|NCT02936323|566023462|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800423|NCT02936323|566023463|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800424|NCT02936323|566023464|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800425|NCT02936323|566023465|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800426|NCT02936323|566023456|FG000|Phase 1 Dose Escalation|Death|2|||
156800427|NCT02936323|566023457|FG001|Phase 1 Dose Escalation|Death|1|||
156800428|NCT02936323|566023458|FG002|Phase 1 Dose Escalation|Death|3|||
156800429|NCT02936323|566023459|FG003|Phase 1 Dose Escalation|Death|1|||
156800430|NCT02936323|566023460|FG004|Phase 1 Dose Escalation|Death|2|||
156800431|NCT02936323|566023461|FG005|Phase 1 Dose Escalation|Death|3|||
156800432|NCT02936323|566023462|FG006|Phase 1 Dose Escalation|Death|3|||
156800433|NCT02936323|566023463|FG007|Phase 1 Dose Escalation|Death|0|||
156800434|NCT02936323|566023464|FG008|Phase 1 Dose Escalation|Death|0|||
156800435|NCT02936323|566023465|FG009|Phase 1 Dose Escalation|Death|0|||
156800436|NCT02936323|566023456|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800437|NCT02936323|566023457|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800438|NCT02936323|566023458|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800439|NCT02936323|566023459|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800440|NCT02936323|566023460|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800441|NCT02936323|566023461|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
156800442|NCT02936323|566023462|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156337344|NCT04457336|564333623|FG000|Period 2: Part A|Adverse Event|0|||
156337345|NCT04457336|564333624|FG001|Period 2: Part A|Adverse Event|0|||
156459286|NCT00746096|564776755|FG001|Overall Study|Protocol Violation|0|||
156459287|NCT00746096|564776754|FG000|Overall Study|No study drug treatment|1|||
156459288|NCT00746096|564776755|FG001|Overall Study|No study drug treatment|1|||
156800443|NCT02936323|566023463|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800444|NCT02936323|566023464|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800445|NCT02936323|566023465|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800446|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156749442|NCT00255840|565833517|FG000|Overall Study|Discontinued intervention|53|||
156749443|NCT00255840|565833518|FG001|Overall Study|Discontinued intervention|56|||
156749444|NCT01005901|565833521|FG000|Overall Study|Withdrawal by Subject|38|||
156749445|NCT01005901|565833522|FG001|Overall Study|Withdrawal by Subject|14|||
156749446|NCT01005901|565833521|FG000|Overall Study|Adverse Event|30|||
156749447|NCT01005901|565833522|FG001|Overall Study|Adverse Event|16|||
156749448|NCT01005901|565833521|FG000|Overall Study|Administrative problems|21|||
156749449|NCT01005901|565833522|FG001|Overall Study|Administrative problems|13|||
156749450|NCT01005901|565833521|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
156749451|NCT01005901|565833522|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
156749452|NCT01005901|565833521|FG000|Overall Study|Protocol Violation|4|||
156749453|NCT01005901|565833522|FG001|Overall Study|Protocol Violation|3|||
156749454|NCT01005901|565833521|FG000|Overall Study|Death|2|||
156749455|NCT01005901|565833522|FG001|Overall Study|Death|3|||
156749456|NCT01005901|565833521|FG000|Overall Study|Lost to Follow-up|1|||
156749457|NCT01005901|565833522|FG001|Overall Study|Lost to Follow-up|2|||
156749458|NCT01005901|565833521|FG000|Overall Study|Patient's inability to use the device|1|||
156749459|NCT01005901|565833522|FG001|Overall Study|Patient's inability to use the device|1|||
156749460|NCT01005901|565833521|FG000|Overall Study|No longer requires study drug|0|||
156749461|NCT01005901|565833522|FG001|Overall Study|No longer requires study drug|1|||
156749462|NCT00957424|565833523|FG000|Overall Study|Lost to Follow-up|19|||
156749463|NCT00957424|565833523|FG000|Overall Study|Protocol Violation|3|||
156749464|NCT00957424|565833523|FG000|Overall Study|Withdrawal by Subject|1|||
156749465|NCT00530790|565833528|FG000|Overall Study|Adverse Event|2|||
156749466|NCT00530790|565833528|FG000|Overall Study|Withdrawal by Subject|2|||
156749467|NCT00530790|565833528|FG000|Overall Study|Physician Decision|1|||
156749468|NCT00438256|565833529|FG000|Overall Study|Ineligible for Resection|2|||
156749469|NCT00438256|565833530|FG001|Overall Study|Ineligible for Resection|1|||
156749470|NCT00438256|565833531|FG002|Overall Study|Ineligible for Resection|1|||
156749471|NCT00438256|565833532|FG003|Overall Study|Ineligible for Resection|7|||
156749472|NCT00438256|565833529|FG000|Overall Study|Excluded final Diagnosis|0|||
156749473|NCT00438256|565833530|FG001|Overall Study|Excluded final Diagnosis|0|||
156749474|NCT00438256|565833531|FG002|Overall Study|Excluded final Diagnosis|0|||
156749475|NCT00438256|565833532|FG003|Overall Study|Excluded final Diagnosis|2|||
156749476|NCT02005627|565833533|FG000|Overall Study|Lost to Follow-up|1|||
156749477|NCT02005627|565833534|FG001|Overall Study|Lost to Follow-up|2|||
156749478|NCT02005627|565833533|FG000|Overall Study|Withdrawal by Subject|1|||
156749479|NCT02005627|565833534|FG001|Overall Study|Withdrawal by Subject|2|||
156749480|NCT00849290|565833538|FG000|Overall Study|Adverse Event|3|||
156749481|NCT00849290|565833538|FG000|Overall Study|Death|14|||
156749482|NCT00849290|565833538|FG000|Overall Study|Withdrawal by Subject|11|||
156749483|NCT00849290|565833538|FG000|Overall Study|Lost to Follow-up|2|||
156749484|NCT00849290|565833538|FG000|Overall Study|Protocol Violation|5|||
156749485|NCT00849290|565833538|FG000|Overall Study|Disease Progression|20|||
156749486|NCT00938587|565833539|FG000|Overall Study|Adverse Event|2|||
156749487|NCT00938587|565833540|FG001|Overall Study|Adverse Event|0|||
156749488|NCT00938587|565833541|FG002|Overall Study|Adverse Event|0|||
156749489|NCT00938587|565833542|FG003|Overall Study|Adverse Event|2|||
156749490|NCT00938587|565833539|FG000|Overall Study|Did not meet entrance criteria|0|||
156749491|NCT00938587|565833540|FG001|Overall Study|Did not meet entrance criteria|0|||
156749492|NCT00938587|565833541|FG002|Overall Study|Did not meet entrance criteria|1|||
156749493|NCT00938587|565833542|FG003|Overall Study|Did not meet entrance criteria|0|||
156749494|NCT00938587|565833539|FG000|Overall Study|Withdrawal by Subject|1|||
156749495|NCT00938587|565833540|FG001|Overall Study|Withdrawal by Subject|1|||
156749496|NCT00938587|565833541|FG002|Overall Study|Withdrawal by Subject|0|||
156749497|NCT00938587|565833542|FG003|Overall Study|Withdrawal by Subject|0|||
156337346|NCT04457336|564333625|FG002|Period 2: Part A|Adverse Event|1|||
156337347|NCT04457336|564333626|FG003|Period 2: Part A|Adverse Event|1|||
156337348|NCT04457336|564333627|FG004|Period 2: Part A|Adverse Event|0|||
156337349|NCT04457336|564333628|FG005|Period 2: Part A|Adverse Event|0|||
156337350|NCT04457336|564333629|FG006|Period 2: Part A|Adverse Event|0|||
156337351|NCT04457336|564333630|FG007|Period 2: Part A|Adverse Event|0|||
156337352|NCT04457336|564333623|FG000|Period 2: Part A|Study Terminated|0|||
156749498|NCT01464619|565833549|FG000|Overall Study|Lost to Follow-up|3|||
156749499|NCT01464619|565833550|FG001|Overall Study|Lost to Follow-up|4|||
156749500|NCT03913104|565833551|FG000|Overall Study|Lost to Follow-up|20|||
156749501|NCT03913104|565833551|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
156749502|NCT03913104|565833551|FG000|Overall Study|Withdrawal by Subject|2|||
156749503|NCT00048997|565833554|FG000|Overall Study|Protocol Violation|7|||
156749504|NCT00048997|565833555|FG001|Overall Study|Protocol Violation|2|||
156749505|NCT00048997|565833554|FG000|Overall Study|Withdrawal by Subject|6|||
156749506|NCT00048997|565833555|FG001|Overall Study|Withdrawal by Subject|1|||
156749507|NCT02819440|565833556|FG000|Overall Study|Adverse Event|3|||
156749508|NCT02819440|565833557|FG001|Overall Study|Adverse Event|1|||
156749509|NCT02819440|565833556|FG000|Overall Study|Lost to Follow-up|1|||
156749510|NCT02819440|565833557|FG001|Overall Study|Lost to Follow-up|3|||
156337353|NCT04457336|564333624|FG001|Period 2: Part A|Study Terminated|0|||
156459289|NCT04059185|564776756|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
156459290|NCT04059185|564776757|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
156459291|NCT04059185|564776758|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
156459292|NCT04059185|564776756|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
156459293|NCT04059185|564776757|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
156459294|NCT04059185|564776758|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
156459295|NCT04059185|564776756|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
156459296|NCT04059185|564776757|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
156459297|NCT04059185|564776758|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
156459298|NCT04059185|564776756|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
156459299|NCT04059185|564776757|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
156459300|NCT04059185|564776758|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
156459301|NCT04059185|564776756|FG000|Longitudinal Assessment-Adults Only|Death|4|||
156459302|NCT04059185|564776757|FG001|Longitudinal Assessment-Adults Only|Death|4|||
156459303|NCT04059185|564776758|FG002|Longitudinal Assessment-Adults Only|Death|3|||
156459304|NCT04295512|564776764|FG000|Overall Study|Lack of family response to schedule assessment|0|||
156459305|NCT04295512|564776765|FG001|Overall Study|Lack of family response to schedule assessment|0|||
156459306|NCT04295512|564776766|FG002|Overall Study|Lack of family response to schedule assessment|0|||
156459307|NCT04295512|564776767|FG003|Overall Study|Lack of family response to schedule assessment|2|||
156459308|NCT04295512|564776764|FG000|Overall Study|Therapist did not refer eligible family|7|||
156459309|NCT04295512|564776765|FG001|Overall Study|Therapist did not refer eligible family|7|||
156459310|NCT04295512|564776766|FG002|Overall Study|Therapist did not refer eligible family|0|||
156459311|NCT04295512|564776767|FG003|Overall Study|Therapist did not refer eligible family|0|||
156459312|NCT05207956|564776776|FG000|Overall Study|Lost to follow up|1|||
156459313|NCT05207956|564776777|FG001|Overall Study|Lost to follow up|2|||
156459314|NCT01009788|564776780|FG000|Overall Study|Withdrawal by Subject|1|||
156459315|NCT01009788|564776781|FG001|Overall Study|Withdrawal by Subject|0|||
156749511|NCT02819440|565833556|FG000|Overall Study|Withdrawal by Subject|9|||
156749512|NCT02819440|565833557|FG001|Overall Study|Withdrawal by Subject|8|||
156749513|NCT00002525|565833563|FG000|Overall Study|Adverse Event|36|||
156749514|NCT00002525|565833564|FG001|Overall Study|Adverse Event|0|||
156749515|NCT00002525|565833563|FG000|Overall Study|Death|5|||
156749516|NCT00002525|565833564|FG001|Overall Study|Death|0|||
156749517|NCT00002525|565833563|FG000|Overall Study|Withdrawal by Subject|11|||
156749518|NCT00002525|565833564|FG001|Overall Study|Withdrawal by Subject|0|||
156749519|NCT00002525|565833563|FG000|Overall Study|Start non-protocol therapy|1|||
156749520|NCT00002525|565833564|FG001|Overall Study|Start non-protocol therapy|0|||
156749521|NCT00002525|565833563|FG000|Overall Study|Other complicating disease|1|||
156749522|NCT00002525|565833564|FG001|Overall Study|Other complicating disease|0|||
156749523|NCT00002525|565833563|FG000|Overall Study|Duke's A, B1, D disease|92|||
156749524|NCT00002525|565833564|FG001|Overall Study|Duke's A, B1, D disease|0|||
156749525|NCT00002525|565833563|FG000|Overall Study|Error|6|||
156749526|NCT00002525|565833564|FG001|Overall Study|Error|0|||
156749527|NCT00002525|565833563|FG000|Overall Study|Other|26|||
156749528|NCT00002525|565833564|FG001|Overall Study|Other|0|||
156749529|NCT00002525|565833563|FG000|Overall Study|Never start protocol therapy|8|||
156749530|NCT00002525|565833564|FG001|Overall Study|Never start protocol therapy|0|||
156749531|NCT03304184|565833565|FG000|Overall Study|Withdrawal by Subject|1|||
156749532|NCT03304184|565833566|FG001|Overall Study|Withdrawal by Subject|2|||
156749533|NCT03420222|565833571|FG000|Overall Study|Withdrawal by Subject|5|||
156749534|NCT03420222|565833572|FG001|Overall Study|Withdrawal by Subject|0|||
156749535|NCT03420222|565833571|FG000|Overall Study|Physician Decision|0|||
156749536|NCT03420222|565833572|FG001|Overall Study|Physician Decision|1|||
156749537|NCT02112877|565833575|FG000|Overall Study|Withdrawal by Subject|1|||
156749538|NCT02112877|565833576|FG001|Overall Study|Withdrawal by Subject|7|||
156749539|NCT02112877|565833575|FG000|Overall Study|Visit Missed|1|||
156749540|NCT02112877|565833576|FG001|Overall Study|Visit Missed|6|||
156749541|NCT01578499|565833589|FG000|Overall Study|Reason not Specified|0|||
156749542|NCT01578499|565833590|FG001|Overall Study|Reason not Specified|1|||
156749543|NCT01578499|565833589|FG000|Overall Study|Lost to Follow-up|2|||
156749544|NCT01578499|565833590|FG001|Overall Study|Lost to Follow-up|1|||
156459316|NCT04587453|564776782|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
156537120|NCT00467779|565061095|FG000|Stage 1|Disease Progression|2|||
156537121|NCT00467779|565061096|FG001|Stage 1|Disease Progression|2|||
156749545|NCT01578499|565833589|FG000|Overall Study|Withdrawal by Subject|10|||
156537122|NCT00467779|565061097|FG002|Stage 1|Disease Progression|2|||
156749546|NCT01578499|565833590|FG001|Overall Study|Withdrawal by Subject|16|||
156749547|NCT01578499|565833589|FG000|Overall Study|Death|20|||
156749548|NCT01578499|565833590|FG001|Overall Study|Death|25|||
156749549|NCT01578499|565833589|FG000|Overall Study|Died and End of Study Page not Completed|2|||
156749550|NCT01578499|565833590|FG001|Overall Study|Died and End of Study Page not Completed|0|||
156749551|NCT01606748|565833591|FG000|Overall Study|Adverse Event|1|||
156749552|NCT01606748|565833592|FG001|Overall Study|Adverse Event|0|||
156337354|NCT04457336|564333625|FG002|Period 2: Part A|Study Terminated|1|||
156749553|NCT01606748|565833591|FG000|Overall Study|Progressive Disease|1|||
156749554|NCT01606748|565833592|FG001|Overall Study|Progressive Disease|0|||
156749555|NCT01606748|565833591|FG000|Overall Study|Withdrawal by Subject|1|||
156749556|NCT01606748|565833592|FG001|Overall Study|Withdrawal by Subject|0|||
156749557|NCT01380691|565833593|FG000|Washout (7 Days)|Protocol Violation|0|||
156749558|NCT01380691|565833594|FG001|Washout (7 Days)|Protocol Violation|0|||
156749559|NCT01380691|565833595|FG002|Washout (7 Days)|Protocol Violation|0|||
156749560|NCT01380691|565833596|FG003|Washout (7 Days)|Protocol Violation|1|||
156749561|NCT01380691|565833593|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
156749562|NCT01380691|565833594|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
156749563|NCT01380691|565833595|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
156749564|NCT01380691|565833596|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
156749565|NCT01952080|565833598|FG000|Overall Study|Withdrawal by Subject|0|||
156749566|NCT01952080|565833599|FG001|Overall Study|Withdrawal by Subject|0|||
156749567|NCT01952080|565833600|FG002|Overall Study|Withdrawal by Subject|0|||
156749568|NCT01952080|565833601|FG003|Overall Study|Withdrawal by Subject|1|||
156749569|NCT01952080|565833598|FG000|Overall Study|Protocol Non-compliance|0|||
156749570|NCT01952080|565833599|FG001|Overall Study|Protocol Non-compliance|1|||
156749571|NCT01952080|565833600|FG002|Overall Study|Protocol Non-compliance|0|||
156749572|NCT01952080|565833601|FG003|Overall Study|Protocol Non-compliance|0|||
156749573|NCT03426436|565833602|FG000|Overall Study|Incorrect lead placement|12|||
156749574|NCT03426436|565833602|FG000|Overall Study|Withdrawal by Subject|2|||
156749575|NCT03426436|565833602|FG000|Overall Study|Consent issue|1|||
156749576|NCT03426436|565833602|FG000|Overall Study|ECGs not saved|4|||
156749577|NCT00655681|565833603|FG000|Overall Study|Lost to Follow-up|1|||
156749578|NCT00655681|565833604|FG001|Overall Study|Lost to Follow-up|1|||
156749579|NCT04776018|565833606|FG000|Overall Study|Death|0|||
156749580|NCT04776018|565833607|FG001|Overall Study|Death|1|||
156749581|NCT04776018|565833608|FG002|Overall Study|Death|4|||
156749582|NCT04776018|565833609|FG003|Overall Study|Death|1|||
156749583|NCT04776018|565833610|FG004|Overall Study|Death|4|||
156749584|NCT04776018|565833611|FG005|Overall Study|Death|0|||
156749585|NCT04776018|565833612|FG006|Overall Study|Death|0|||
156749586|NCT04776018|565833606|FG000|Overall Study|Study terminated by sponsor|2|||
156749587|NCT04776018|565833607|FG001|Overall Study|Study terminated by sponsor|1|||
156749588|NCT04776018|565833608|FG002|Overall Study|Study terminated by sponsor|4|||
156749589|NCT04776018|565833609|FG003|Overall Study|Study terminated by sponsor|0|||
156749590|NCT04776018|565833610|FG004|Overall Study|Study terminated by sponsor|3|||
156749591|NCT04776018|565833611|FG005|Overall Study|Study terminated by sponsor|0|||
156749592|NCT04776018|565833612|FG006|Overall Study|Study terminated by sponsor|0|||
156749593|NCT04776018|565833606|FG000|Overall Study|Withdrawal by Subject|1|||
156749594|NCT04776018|565833607|FG001|Overall Study|Withdrawal by Subject|0|||
156749595|NCT04776018|565833608|FG002|Overall Study|Withdrawal by Subject|0|||
156749596|NCT04776018|565833609|FG003|Overall Study|Withdrawal by Subject|2|||
156749597|NCT04776018|565833610|FG004|Overall Study|Withdrawal by Subject|1|||
156749598|NCT04776018|565833611|FG005|Overall Study|Withdrawal by Subject|0|||
156337355|NCT04457336|564333626|FG003|Period 2: Part A|Study Terminated|0|||
156337356|NCT04457336|564333627|FG004|Period 2: Part A|Study Terminated|0|||
156337357|NCT04457336|564333628|FG005|Period 2: Part A|Study Terminated|0|||
156337358|NCT04457336|564333629|FG006|Period 2: Part A|Study Terminated|0|||
156337359|NCT04457336|564333630|FG007|Period 2: Part A|Study Terminated|0|||
156749599|NCT04776018|565833612|FG006|Overall Study|Withdrawal by Subject|0|||
156749600|NCT04776018|565833606|FG000|Overall Study|Other|0|||
156749601|NCT04776018|565833607|FG001|Overall Study|Other|1|||
156749602|NCT04776018|565833608|FG002|Overall Study|Other|1|||
156749603|NCT04776018|565833609|FG003|Overall Study|Other|0|||
156749604|NCT04776018|565833610|FG004|Overall Study|Other|0|||
156749605|NCT04776018|565833611|FG005|Overall Study|Other|0|||
156749606|NCT04776018|565833612|FG006|Overall Study|Other|0|||
156749607|NCT04776018|565833606|FG000|Overall Study|Lost to Follow-up|0|||
156749608|NCT04776018|565833607|FG001|Overall Study|Lost to Follow-up|0|||
156749609|NCT04776018|565833608|FG002|Overall Study|Lost to Follow-up|1|||
156749610|NCT04776018|565833609|FG003|Overall Study|Lost to Follow-up|0|||
156749611|NCT04776018|565833610|FG004|Overall Study|Lost to Follow-up|0|||
156749612|NCT04776018|565833611|FG005|Overall Study|Lost to Follow-up|0|||
156749613|NCT04776018|565833612|FG006|Overall Study|Lost to Follow-up|0|||
156749614|NCT03417024|565833615|FG000|Overall Study|Study Termination prior to follow-up|11|||
156749615|NCT03417024|565833615|FG000|Overall Study|Physician Decision|2|||
156749616|NCT03168919|565833616|FG000|Overall Study|Withdrawal by Subject|2|||
156749617|NCT01085136|565833617|FG000|Part A|Other Adverse event|223|||
156749618|NCT01085136|565833618|FG001|Part A|Other Adverse event|0|||
156749619|NCT01085136|565833619|FG002|Part A|Other Adverse event|0|||
156749620|NCT01085136|565833617|FG000|Part A|Protocol Violation|3|||
156749621|NCT01085136|565833618|FG001|Part A|Protocol Violation|0|||
156749622|NCT01085136|565833619|FG002|Part A|Protocol Violation|0|||
156749623|NCT01085136|565833617|FG000|Part A|Lost to Follow-up|3|||
156749624|NCT01085136|565833618|FG001|Part A|Lost to Follow-up|0|||
156749625|NCT01085136|565833619|FG002|Part A|Lost to Follow-up|0|||
156749626|NCT01085136|565833617|FG000|Part A|Refusal to continue trial medication|64|||
156749627|NCT01085136|565833618|FG001|Part A|Refusal to continue trial medication|0|||
156749628|NCT01085136|565833619|FG002|Part A|Refusal to continue trial medication|0|||
156749629|NCT01085136|565833617|FG000|Part A|Other reason not defined above|30|||
156749630|NCT01085136|565833618|FG001|Part A|Other reason not defined above|0|||
156749631|NCT01085136|565833619|FG002|Part A|Other reason not defined above|0|||
156749632|NCT01085136|565833617|FG000|Part B|Other AE|0|||
156749633|NCT01085136|565833618|FG001|Part B|Other AE|29|||
156749634|NCT01085136|565833619|FG002|Part B|Other AE|8|||
156749635|NCT01085136|565833617|FG000|Part B|Refusal to continue trial medication|0|||
156749636|NCT01085136|565833618|FG001|Part B|Refusal to continue trial medication|12|||
156749637|NCT01085136|565833619|FG002|Part B|Refusal to continue trial medication|7|||
156749638|NCT01085136|565833617|FG000|Part B|Not treated|0|||
156749639|NCT01085136|565833618|FG001|Part B|Not treated|4|||
156749640|NCT01085136|565833619|FG002|Part B|Not treated|8|||
156749641|NCT01085136|565833617|FG000|Part B|Other reason not defined above|0|||
156749642|NCT01085136|565833618|FG001|Part B|Other reason not defined above|6|||
156749643|NCT01085136|565833619|FG002|Part B|Other reason not defined above|3|||
156749644|NCT02195427|565833620|FG000|Overall Study|Did not consent to study extension|13|||
156749645|NCT02195427|565833621|FG001|Overall Study|Did not consent to study extension|9|||
156749646|NCT02195427|565833620|FG000|Overall Study|Withdrawal by Subject|4|||
156749647|NCT02195427|565833621|FG001|Overall Study|Withdrawal by Subject|2|||
156749648|NCT02195427|565833620|FG000|Overall Study|Lost to Follow-up|0|||
156749649|NCT02195427|565833621|FG001|Overall Study|Lost to Follow-up|1|||
156749650|NCT02195427|565833620|FG000|Overall Study|Protocol Violation|7|||
156749651|NCT02195427|565833621|FG001|Overall Study|Protocol Violation|14|||
156749652|NCT02195427|565833620|FG000|Overall Study|Conditional re-treatment at W52|2|||
156749653|NCT02195427|565833621|FG001|Overall Study|Conditional re-treatment at W52|1|||
156749654|NCT01210144|565833625|FG000|Overall Study|Lack of ovarian response|1|||
156749655|NCT01210144|565833626|FG001|Overall Study|Lack of ovarian response|0|||
156749656|NCT01210144|565833625|FG000|Overall Study|No fertilization|1|||
156749657|NCT01210144|565833626|FG001|Overall Study|No fertilization|0|||
156749658|NCT01210144|565833625|FG000|Overall Study|No transfer|1|||
156749659|NCT01210144|565833626|FG001|Overall Study|No transfer|0|||
156749660|NCT00386425|565833627|FG000|Overall Study|Physician Decision|3|||
156749661|NCT00386425|565833628|FG001|Overall Study|Physician Decision|0|||
156749662|NCT00386425|565833629|FG002|Overall Study|Physician Decision|0|||
156749663|NCT00386425|565833627|FG000|Overall Study|Withdrawal by Subject|0|||
156749664|NCT00386425|565833628|FG001|Overall Study|Withdrawal by Subject|1|||
156749665|NCT00386425|565833629|FG002|Overall Study|Withdrawal by Subject|0|||
156749666|NCT02655419|565833630|FG000|Overall Study|Enrolled but not treated|1|||
156749667|NCT02655419|565833631|FG001|Overall Study|Enrolled but not treated|5|||
156749668|NCT02655419|565833630|FG000|Overall Study|Withdrawal by Subject|4|||
156749669|NCT02655419|565833631|FG001|Overall Study|Withdrawal by Subject|1|||
156749670|NCT02655419|565833630|FG000|Overall Study|Other|0|||
156749671|NCT02655419|565833631|FG001|Overall Study|Other|1|||
156749672|NCT04226495|565833635|FG000|Overall Study|Withdrawal by Subject|3|||
156749673|NCT04226495|565833636|FG001|Overall Study|Withdrawal by Subject|3|||
156749674|NCT04226495|565833635|FG000|Overall Study|PI discretion|3|||
156749675|NCT04226495|565833636|FG001|Overall Study|PI discretion|4|||
156749676|NCT02440854|565833637|FG000|Overall Study|Relocation of patient|1|||
156749677|NCT02440854|565833637|FG000|Overall Study|Death|6|||
156749678|NCT02440854|565833637|FG000|Overall Study|Lost to Follow-up|10|||
156749679|NCT02440854|565833637|FG000|Overall Study|Afatinib discontinuation|46|||
156749680|NCT02440854|565833637|FG000|Overall Study|stopped study at earlier timepoint|14|||
156537123|NCT00467779|565061098|FG003|Stage 1|Disease Progression|3|||
156749681|NCT02440854|565833637|FG000|Overall Study|Study medication not received|1|||
156749682|NCT02440854|565833637|FG000|Overall Study|Violation of inclusion criteria|2|||
156749683|NCT00660595|565835074|FG000|Overall Study|Lost to Follow-up|0|||
156537124|NCT00467779|565061099|FG004|Stage 1|Disease Progression|2|||
156749684|NCT00660595|565835075|FG001|Overall Study|Lost to Follow-up|1|||
156749685|NCT00660595|565835074|FG000|Overall Study|Did not consent to participate in study|12|||
156749686|NCT00660595|565835075|FG001|Overall Study|Did not consent to participate in study|8|||
156749687|NCT00660595|565835074|FG000|Overall Study|Participant left hospital|1|||
156749688|NCT00660595|565835075|FG001|Overall Study|Participant left hospital|0|||
156749689|NCT00660595|565835074|FG000|Overall Study|Non Specified reasons|5|||
156749690|NCT00660595|565835075|FG001|Overall Study|Non Specified reasons|0|||
156749691|NCT01148459|565835076|FG000|Overall Study|Serious Adverse Event|5|||
156749692|NCT01148459|565835077|FG001|Overall Study|Serious Adverse Event|4|||
156749693|NCT01148459|565835076|FG000|Overall Study|Withdrawal by Subject|1|||
156749694|NCT01148459|565835077|FG001|Overall Study|Withdrawal by Subject|0|||
156749695|NCT01148459|565835076|FG000|Overall Study|Migrated/moved from study area|3|||
156749696|NCT01148459|565835077|FG001|Overall Study|Migrated/moved from study area|6|||
156749697|NCT01148459|565835076|FG000|Overall Study|Lost to Follow-up|2|||
156749698|NCT01148459|565835077|FG001|Overall Study|Lost to Follow-up|0|||
156749699|NCT01148459|565835076|FG000|Overall Study|Refusal|1|||
156749700|NCT01148459|565835077|FG001|Overall Study|Refusal|0|||
156749701|NCT01148459|565835076|FG000|Overall Study|Failure to comply with study procedures|0|||
156749702|NCT01148459|565835077|FG001|Overall Study|Failure to comply with study procedures|1|||
156749703|NCT03077607|565835078|FG000|Period 1 (15 Days)|Adverse Event|1|||
156749704|NCT03077607|565835079|FG001|Period 1 (15 Days)|Adverse Event|0|||
156749705|NCT03077607|565835078|FG000|Period 1 (15 Days)|Death|1|||
156749706|NCT03077607|565835079|FG001|Period 1 (15 Days)|Death|0|||
156749707|NCT03077607|565835078|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
156749708|NCT03077607|565835079|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
156749709|NCT03077607|565835078|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
156749710|NCT03077607|565835079|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
156749711|NCT00080483|565835080|FG000|Overall Study|Lost to Follow-up|1|||
156749712|NCT00080483|565835081|FG001|Overall Study|Lost to Follow-up|1|||
156749713|NCT00080483|565835080|FG000|Overall Study|Physician Decision|1|||
156749714|NCT00080483|565835081|FG001|Overall Study|Physician Decision|1|||
156749715|NCT01119846|565835084|FG000|Overall Study|Adverse Event|1|||
156749716|NCT01119846|565835085|FG001|Overall Study|Adverse Event|0|||
156749717|NCT01119846|565835086|FG002|Overall Study|Adverse Event|6|||
156749718|NCT01119846|565835084|FG000|Overall Study|Physician Decision|1|||
156749719|NCT01119846|565835085|FG001|Overall Study|Physician Decision|0|||
156749720|NCT01119846|565835086|FG002|Overall Study|Physician Decision|0|||
156749721|NCT01119846|565835084|FG000|Overall Study|Protocol Violation|0|||
156749722|NCT01119846|565835085|FG001|Overall Study|Protocol Violation|0|||
156749723|NCT01119846|565835086|FG002|Overall Study|Protocol Violation|1|||
156749724|NCT01119846|565835084|FG000|Overall Study|Withdrawal by Subject|0|||
156749725|NCT01119846|565835085|FG001|Overall Study|Withdrawal by Subject|0|||
156749726|NCT01119846|565835086|FG002|Overall Study|Withdrawal by Subject|4|||
156749727|NCT01404949|565835087|FG000|Overall Study|Not Treated|1|||
156749728|NCT02334384|565835088|FG000|Overall Study|Lost to Follow-up|1|||
156749729|NCT02334384|565835089|FG001|Overall Study|Lost to Follow-up|1|||
156749730|NCT02651688|565835090|FG000|Overall Study|Non-compliance|0|||
156749731|NCT02651688|565835091|FG001|Overall Study|Non-compliance|0|||
156749732|NCT02651688|565835092|FG002|Overall Study|Non-compliance|1|||
156749733|NCT02651688|565835090|FG000|Overall Study|Principal Investigator (PI) decision|0|||
156459317|NCT04587453|564776783|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
156459318|NCT03571581|564776784|FG000|Overall Study|Death|2|||
156459319|NCT03571581|564776784|FG000|Overall Study|Withdrawal by Subject|2|||
156459320|NCT04737330|564776787|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
156459321|NCT04737330|564776788|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
156749734|NCT02651688|565835091|FG001|Overall Study|Principal Investigator (PI) decision|2|||
156749735|NCT02651688|565835092|FG002|Overall Study|Principal Investigator (PI) decision|0|||
156749736|NCT02651688|565835090|FG000|Overall Study|Lost to Follow-up|1|||
156749737|NCT02651688|565835091|FG001|Overall Study|Lost to Follow-up|3|||
156749738|NCT02651688|565835092|FG002|Overall Study|Lost to Follow-up|0|||
156749739|NCT02651688|565835090|FG000|Overall Study|Withdrawal by Subject|1|||
156749740|NCT02651688|565835091|FG001|Overall Study|Withdrawal by Subject|0|||
156749741|NCT02651688|565835092|FG002|Overall Study|Withdrawal by Subject|2|||
156749742|NCT00625183|565835093|FG000|Overall Study|Disease Progression|1|||
156459322|NCT04737330|564776787|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
156749743|NCT01863732|565835094|FG000|Overall Study|Adverse Event|2|||
156749744|NCT01863732|565835095|FG001|Overall Study|Adverse Event|0|||
156749745|NCT01863732|565835096|FG002|Overall Study|Adverse Event|3|||
156749746|NCT01863732|565835097|FG003|Overall Study|Adverse Event|3|||
156749747|NCT01863732|565835094|FG000|Overall Study|Lack of Efficacy|1|||
156749748|NCT01863732|565835095|FG001|Overall Study|Lack of Efficacy|0|||
156749749|NCT01863732|565835096|FG002|Overall Study|Lack of Efficacy|2|||
156749750|NCT01863732|565835097|FG003|Overall Study|Lack of Efficacy|1|||
156749751|NCT01863732|565835094|FG000|Overall Study|Lost to Follow-up|2|||
156749752|NCT01863732|565835095|FG001|Overall Study|Lost to Follow-up|2|||
156749753|NCT01863732|565835096|FG002|Overall Study|Lost to Follow-up|1|||
156749754|NCT01863732|565835097|FG003|Overall Study|Lost to Follow-up|1|||
156749755|NCT01863732|565835094|FG000|Overall Study|Physician Decision|1|||
156749756|NCT01863732|565835095|FG001|Overall Study|Physician Decision|0|||
156749757|NCT01863732|565835096|FG002|Overall Study|Physician Decision|1|||
156749758|NCT01863732|565835097|FG003|Overall Study|Physician Decision|0|||
156749759|NCT01863732|565835094|FG000|Overall Study|Pregnancy|0|||
156749760|NCT01863732|565835095|FG001|Overall Study|Pregnancy|0|||
156749761|NCT01863732|565835096|FG002|Overall Study|Pregnancy|0|||
156749762|NCT01863732|565835097|FG003|Overall Study|Pregnancy|1|||
156749763|NCT01863732|565835094|FG000|Overall Study|Technical problems|0|||
156749764|NCT01863732|565835095|FG001|Overall Study|Technical problems|1|||
156749765|NCT01863732|565835096|FG002|Overall Study|Technical problems|1|||
156749766|NCT01863732|565835097|FG003|Overall Study|Technical problems|0|||
156749767|NCT01863732|565835094|FG000|Overall Study|Subject/guardian decision|6|||
156749768|NCT01863732|565835095|FG001|Overall Study|Subject/guardian decision|9|||
156749769|NCT01863732|565835096|FG002|Overall Study|Subject/guardian decision|3|||
156749770|NCT01863732|565835097|FG003|Overall Study|Subject/guardian decision|1|||
156749771|NCT01863732|565835094|FG000|Overall Study|Death|1|||
156749772|NCT01863732|565835095|FG001|Overall Study|Death|0|||
156749773|NCT01863732|565835096|FG002|Overall Study|Death|0|||
156749774|NCT01863732|565835097|FG003|Overall Study|Death|1|||
156749775|NCT03084315|565835098|FG000|Overall Study|Lost to Follow-up|8|||
156749776|NCT03084315|565835099|FG001|Overall Study|Lost to Follow-up|7|||
156749777|NCT03084315|565835098|FG000|Overall Study|Withdrawal by Subject|2|||
156749778|NCT03084315|565835099|FG001|Overall Study|Withdrawal by Subject|2|||
156749779|NCT04424914|565835100|FG000|Overall Study|Other|0|||
156749780|NCT04424914|565835101|FG001|Overall Study|Other|0|||
156749781|NCT04424914|565835102|FG002|Overall Study|Other|28|||
156749782|NCT04424914|565835100|FG000|Overall Study|Withdrawal by Subject|3|||
156749783|NCT04424914|565835101|FG001|Overall Study|Withdrawal by Subject|0|||
156749784|NCT04424914|565835102|FG002|Overall Study|Withdrawal by Subject|0|||
156749785|NCT04424914|565835100|FG000|Overall Study|Study terminated by sponsor|23|||
156749786|NCT04424914|565835101|FG001|Overall Study|Study terminated by sponsor|7|||
156749787|NCT04424914|565835102|FG002|Overall Study|Study terminated by sponsor|0|||
156749788|NCT04424914|565835100|FG000|Overall Study|Lost to Follow-up|0|||
156749789|NCT04424914|565835101|FG001|Overall Study|Lost to Follow-up|0|||
156749790|NCT04424914|565835102|FG002|Overall Study|Lost to Follow-up|1|||
156749791|NCT04424914|565835100|FG000|Overall Study|Death|3|||
156749792|NCT04424914|565835101|FG001|Overall Study|Death|1|||
156749793|NCT04424914|565835102|FG002|Overall Study|Death|0|||
156749794|NCT00460746|565835103|FG000|Overall Study|Adverse Event|1|||
156459323|NCT04737330|564776788|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
156459324|NCT04737330|564776787|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
156749795|NCT00460746|565835103|FG000|Overall Study|Lost to Follow-up|1|||
156749796|NCT02791438|565835105|FG000|Treatment Period|Adverse Event|1|||
156749797|NCT02791438|565835106|FG001|Treatment Period|Adverse Event|0|||
156800447|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800448|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800449|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800450|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800451|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800452|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800453|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
156800454|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
156800455|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
156800456|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
156749798|NCT02791438|565835105|FG000|Treatment Period|Withdrawal by Subject|0|||
156749799|NCT02791438|565835106|FG001|Treatment Period|Withdrawal by Subject|1|||
156749800|NCT02791438|565835105|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
156749801|NCT02791438|565835106|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
156749802|NCT01603394|565835108|FG000|Overall Study|Adverse Event|1|||
156749803|NCT00394771|565835111|FG000|Overall Study|Did not meet protocol requirements|1|||
156749804|NCT00394771|565835112|FG001|Overall Study|Did not meet protocol requirements|0|||
156749805|NCT00394771|565835113|FG002|Overall Study|Did not meet protocol requirements|2|||
156749806|NCT00394771|565835114|FG003|Overall Study|Did not meet protocol requirements|0|||
156749807|NCT00394771|565835111|FG000|Overall Study|Protocol Violation|2|||
156749808|NCT00394771|565835112|FG001|Overall Study|Protocol Violation|4|||
156749809|NCT00394771|565835113|FG002|Overall Study|Protocol Violation|9|||
156749810|NCT00394771|565835114|FG003|Overall Study|Protocol Violation|7|||
156749811|NCT00394771|565835111|FG000|Overall Study|Withdrawal by Subject|10|||
156749812|NCT00394771|565835112|FG001|Overall Study|Withdrawal by Subject|6|||
156749813|NCT00394771|565835113|FG002|Overall Study|Withdrawal by Subject|8|||
156749814|NCT00394771|565835114|FG003|Overall Study|Withdrawal by Subject|12|||
156749815|NCT00394771|565835111|FG000|Overall Study|Adverse Event|10|||
156749816|NCT00394771|565835112|FG001|Overall Study|Adverse Event|5|||
156749817|NCT00394771|565835113|FG002|Overall Study|Adverse Event|12|||
156749818|NCT00394771|565835114|FG003|Overall Study|Adverse Event|8|||
156749819|NCT00394771|565835111|FG000|Overall Study|Participant pregnant|0|||
156749820|NCT00394771|565835112|FG001|Overall Study|Participant pregnant|1|||
156749821|NCT00394771|565835113|FG002|Overall Study|Participant pregnant|2|||
156749822|NCT00394771|565835114|FG003|Overall Study|Participant pregnant|2|||
156749823|NCT00394771|565835111|FG000|Overall Study|Lost to Follow-up|15|||
156749824|NCT00394771|565835112|FG001|Overall Study|Lost to Follow-up|15|||
156749825|NCT00394771|565835113|FG002|Overall Study|Lost to Follow-up|13|||
156749826|NCT00394771|565835114|FG003|Overall Study|Lost to Follow-up|10|||
156749827|NCT00394771|565835111|FG000|Overall Study|Other|3|||
156749828|NCT00394771|565835112|FG001|Overall Study|Other|3|||
156749829|NCT00394771|565835113|FG002|Overall Study|Other|1|||
156749830|NCT00394771|565835114|FG003|Overall Study|Other|0|||
156749831|NCT00862459|565835117|FG000|Overall Study|Lost to Follow-up|1|||
156749832|NCT00862459|565835118|FG001|Overall Study|Lost to Follow-up|2|||
156749833|NCT00862459|565835119|FG002|Overall Study|Lost to Follow-up|2|||
156749834|NCT00862459|565835117|FG000|Overall Study|Protocol Violation|1|||
156749835|NCT00862459|565835118|FG001|Overall Study|Protocol Violation|0|||
156749836|NCT00862459|565835119|FG002|Overall Study|Protocol Violation|0|||
156749837|NCT00862459|565835117|FG000|Overall Study|Withdrawal by Subject|1|||
156749838|NCT00862459|565835118|FG001|Overall Study|Withdrawal by Subject|1|||
156749839|NCT00862459|565835119|FG002|Overall Study|Withdrawal by Subject|3|||
156749840|NCT00862459|565835117|FG000|Overall Study|Adverse Event|0|||
156749841|NCT00862459|565835118|FG001|Overall Study|Adverse Event|1|||
156459325|NCT04737330|564776788|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
156459326|NCT04737330|564776787|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
156459327|NCT04737330|564776788|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
156459328|NCT04737330|564776787|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
156749842|NCT00862459|565835119|FG002|Overall Study|Adverse Event|0|||
156749843|NCT00862459|565835117|FG000|Overall Study|Personal reasons|1|||
156749844|NCT00862459|565835118|FG001|Overall Study|Personal reasons|0|||
156749845|NCT00862459|565835119|FG002|Overall Study|Personal reasons|0|||
156749846|NCT00862459|565835117|FG000|Overall Study|Operation|1|||
156749847|NCT00862459|565835118|FG001|Overall Study|Operation|1|||
156800457|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
156800458|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
156800459|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
156800460|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
156800461|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
156800462|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
156800463|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
156800464|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
156800465|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
156800466|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800467|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800468|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800469|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800470|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156749848|NCT00862459|565835119|FG002|Overall Study|Operation|0|||
156749849|NCT00862459|565835117|FG000|Overall Study|Intravenous (IV) site problems|1|||
156800471|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156749850|NCT00862459|565835118|FG001|Overall Study|Intravenous (IV) site problems|0|||
156749851|NCT00862459|565835119|FG002|Overall Study|Intravenous (IV) site problems|1|||
156749852|NCT00862459|565835117|FG000|Overall Study|Unable to hold still for imaging|0|||
156749853|NCT00862459|565835118|FG001|Overall Study|Unable to hold still for imaging|1|||
156749854|NCT00862459|565835119|FG002|Overall Study|Unable to hold still for imaging|0|||
156749855|NCT00862459|565835117|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
156749856|NCT00862459|565835118|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
156749857|NCT00862459|565835119|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
156749858|NCT00862459|565835117|FG000|Overall Study|Administrative problems|0|||
156749859|NCT00862459|565835118|FG001|Overall Study|Administrative problems|1|||
156749860|NCT00862459|565835119|FG002|Overall Study|Administrative problems|0|||
156749861|NCT02906033|565835120|FG000|Baseline|Protocol Violation|37|||
156749862|NCT02906033|565835121|FG001|Baseline|Protocol Violation|33|||
156749863|NCT02906033|565835120|FG000|Follow-up|Lost to Follow-up|46|||
156749864|NCT02906033|565835121|FG001|Follow-up|Lost to Follow-up|62|||
156749865|NCT00358956|565835132|FG000|Overall Study|Adverse Event|3|||
156749866|NCT00358956|565835132|FG000|Overall Study|condition under investigation worsened|4|||
156749867|NCT00358956|565835132|FG000|Overall Study|Withdrawal by Subject|1|||
156749868|NCT03782974|565835139|FG000|Overall Study|Withdrawal by Subject|7|||
156749869|NCT03782974|565835140|FG001|Overall Study|Withdrawal by Subject|7|||
156749870|NCT03782974|565835139|FG000|Overall Study|Pregnancy|1|||
156749871|NCT03782974|565835140|FG001|Overall Study|Pregnancy|0|||
156749872|NCT00505661|565835143|FG000|Overall Study|Not Eligible|4|||
156749873|NCT01907217|565835145|FG000|Overall Study|Withdrawal by Subject|0|||
156749874|NCT01907217|565835146|FG001|Overall Study|Withdrawal by Subject|2|||
156749875|NCT01764659|565835151|FG000|Overall Study|Death|1|||
156749876|NCT01764659|565835151|FG000|Overall Study|Physician Decision|1|||
156749877|NCT01210352|565835153|FG000|Overall Study|Adverse Event|0|||
156749878|NCT01210352|565835154|FG001|Overall Study|Adverse Event|0|||
156749879|NCT01210352|565835155|FG002|Overall Study|Adverse Event|0|||
156749880|NCT01210352|565835156|FG003|Overall Study|Adverse Event|0|||
156749881|NCT01210352|565835157|FG004|Overall Study|Adverse Event|0|||
156749882|NCT01210352|565835158|FG005|Overall Study|Adverse Event|0|||
156749883|NCT01210352|565835159|FG006|Overall Study|Adverse Event|0|||
156749884|NCT01210352|565835160|FG007|Overall Study|Adverse Event|2|||
156749885|NCT01210352|565835161|FG008|Overall Study|Adverse Event|1|||
156749886|NCT01210352|565835153|FG000|Overall Study|Lack of Efficacy|0|||
156749887|NCT01210352|565835154|FG001|Overall Study|Lack of Efficacy|0|||
156749888|NCT01210352|565835155|FG002|Overall Study|Lack of Efficacy|0|||
156749889|NCT01210352|565835156|FG003|Overall Study|Lack of Efficacy|0|||
156749890|NCT01210352|565835157|FG004|Overall Study|Lack of Efficacy|0|||
156749891|NCT01210352|565835158|FG005|Overall Study|Lack of Efficacy|0|||
156749892|NCT01210352|565835159|FG006|Overall Study|Lack of Efficacy|1|||
156749893|NCT01210352|565835160|FG007|Overall Study|Lack of Efficacy|0|||
156749894|NCT01210352|565835161|FG008|Overall Study|Lack of Efficacy|0|||
156749895|NCT01210352|565835153|FG000|Overall Study|Physician Decision|0|||
156749896|NCT01210352|565835154|FG001|Overall Study|Physician Decision|0|||
156749897|NCT01210352|565835155|FG002|Overall Study|Physician Decision|0|||
156749898|NCT01210352|565835156|FG003|Overall Study|Physician Decision|0|||
156749899|NCT01210352|565835157|FG004|Overall Study|Physician Decision|0|||
156749900|NCT01210352|565835158|FG005|Overall Study|Physician Decision|0|||
156749901|NCT01210352|565835159|FG006|Overall Study|Physician Decision|0|||
156749902|NCT01210352|565835160|FG007|Overall Study|Physician Decision|1|||
156749903|NCT01210352|565835161|FG008|Overall Study|Physician Decision|2|||
156749904|NCT01210352|565835153|FG000|Overall Study|Withdrawal by Subject|0|||
156749905|NCT01210352|565835154|FG001|Overall Study|Withdrawal by Subject|0|||
156749906|NCT01210352|565835155|FG002|Overall Study|Withdrawal by Subject|1|||
156749907|NCT01210352|565835156|FG003|Overall Study|Withdrawal by Subject|0|||
156749908|NCT01210352|565835157|FG004|Overall Study|Withdrawal by Subject|0|||
156749909|NCT01210352|565835158|FG005|Overall Study|Withdrawal by Subject|0|||
156749910|NCT01210352|565835159|FG006|Overall Study|Withdrawal by Subject|1|||
156749911|NCT01210352|565835160|FG007|Overall Study|Withdrawal by Subject|0|||
156800472|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800473|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
156800474|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
156800475|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156749912|NCT01210352|565835161|FG008|Overall Study|Withdrawal by Subject|1|||
156749913|NCT01210352|565835153|FG000|Overall Study|Patient Discharged Early|0|||
156749914|NCT01210352|565835154|FG001|Overall Study|Patient Discharged Early|0|||
156800476|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156749915|NCT01210352|565835155|FG002|Overall Study|Patient Discharged Early|1|||
156749916|NCT01210352|565835156|FG003|Overall Study|Patient Discharged Early|0|||
156749917|NCT01210352|565835157|FG004|Overall Study|Patient Discharged Early|0|||
156749918|NCT01210352|565835158|FG005|Overall Study|Patient Discharged Early|0|||
156749919|NCT01210352|565835159|FG006|Overall Study|Patient Discharged Early|0|||
156749920|NCT01210352|565835160|FG007|Overall Study|Patient Discharged Early|0|||
156800477|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156749921|NCT01210352|565835161|FG008|Overall Study|Patient Discharged Early|0|||
156749922|NCT03338569|565835162|FG000|Overall Study|Physician Decision|8|||
156749923|NCT03338569|565835163|FG001|Overall Study|Physician Decision|3|||
156749924|NCT03338569|565835162|FG000|Overall Study|Withdrawal by Subject|0|||
156749925|NCT03338569|565835163|FG001|Overall Study|Withdrawal by Subject|1|||
156749926|NCT03338569|565835162|FG000|Overall Study|Lost to Follow-up|0|||
156749927|NCT03338569|565835163|FG001|Overall Study|Lost to Follow-up|1|||
156749928|NCT04607980|565835164|FG000|Overall Study|Adverse Event|3|||
156749929|NCT04607980|565835165|FG001|Overall Study|Adverse Event|4|||
156749930|NCT04607980|565835164|FG000|Overall Study|Death|0|||
156749931|NCT04607980|565835165|FG001|Overall Study|Death|1|||
156749932|NCT04607980|565835164|FG000|Overall Study|Withdrawal by Subject|2|||
156749933|NCT04607980|565835165|FG001|Overall Study|Withdrawal by Subject|5|||
156749934|NCT04607980|565835164|FG000|Overall Study|Lost to Follow-up|4|||
156749935|NCT04607980|565835165|FG001|Overall Study|Lost to Follow-up|8|||
156749936|NCT04607980|565835164|FG000|Overall Study|Protocol Violation|0|||
156749937|NCT04607980|565835165|FG001|Overall Study|Protocol Violation|3|||
156749938|NCT04607980|565835164|FG000|Overall Study|Other|3|||
156749939|NCT04607980|565835165|FG001|Overall Study|Other|0|||
156749940|NCT00448812|565835167|FG000|Year 2|Missed visit but remained in study|4|||
156749941|NCT00448812|565835168|FG001|Year 2|Missed visit but remained in study|1|||
156749942|NCT00448812|565835167|FG000|Year 3|Withdrawal by Subject|1|||
156749943|NCT00448812|565835168|FG001|Year 3|Withdrawal by Subject|3|||
156749944|NCT00448812|565835167|FG000|Year 3|Lost to Follow-up|1|||
156749945|NCT00448812|565835168|FG001|Year 3|Lost to Follow-up|0|||
156800478|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800479|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800480|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800481|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800482|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800483|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800484|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800485|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
156800486|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Death|0|||
156800487|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Death|0|||
156800488|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Death|0|||
156800489|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Death|0|||
156800490|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Death|0|||
156800491|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Death|0|||
156800492|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Death|0|||
156800493|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Death|4|||
156800494|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Death|8|||
156800495|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Death|10|||
156800496|NCT05239221|566023466|FG000|Overall Study|Adverse Event|0|||
156800497|NCT05239221|566023467|FG001|Overall Study|Adverse Event|0|||
156800498|NCT05239221|566023468|FG002|Overall Study|Adverse Event|0|||
156800499|NCT05239221|566023469|FG003|Overall Study|Adverse Event|0|||
156800500|NCT05239221|566023470|FG004|Overall Study|Adverse Event|0|||
156800501|NCT05239221|566023471|FG005|Overall Study|Adverse Event|0|||
156800502|NCT05239221|566023472|FG006|Overall Study|Adverse Event|1|||
156800503|NCT05239221|566023473|FG007|Overall Study|Adverse Event|0|||
156800504|NCT05239221|566023474|FG008|Overall Study|Adverse Event|0|||
156800505|NCT05239221|566023475|FG009|Overall Study|Adverse Event|0|||
156800506|NCT05239221|566023476|FG010|Overall Study|Adverse Event|1|||
156800507|NCT05239221|566023477|FG011|Overall Study|Adverse Event|1|||
156800508|NCT05239221|566023478|FG012|Overall Study|Adverse Event|0|||
156800509|NCT05239221|566023479|FG013|Overall Study|Adverse Event|0|||
156800510|NCT05239221|566023480|FG014|Overall Study|Adverse Event|0|||
156800511|NCT05239221|566023481|FG015|Overall Study|Adverse Event|0|||
156800512|NCT05239221|566023466|FG000|Overall Study|Withdrawal by Subject|0|||
156800513|NCT05239221|566023467|FG001|Overall Study|Withdrawal by Subject|0|||
156800514|NCT05239221|566023468|FG002|Overall Study|Withdrawal by Subject|0|||
156800515|NCT05239221|566023469|FG003|Overall Study|Withdrawal by Subject|0|||
156800516|NCT05239221|566023470|FG004|Overall Study|Withdrawal by Subject|0|||
156800517|NCT05239221|566023471|FG005|Overall Study|Withdrawal by Subject|0|||
156800518|NCT05239221|566023472|FG006|Overall Study|Withdrawal by Subject|0|||
156749946|NCT00448812|565835167|FG000|Year 3|Missed visit but remained in study|2|||
156749947|NCT00448812|565835168|FG001|Year 3|Missed visit but remained in study|0|||
156800519|NCT05239221|566023473|FG007|Overall Study|Withdrawal by Subject|0|||
156337360|NCT04457336|564333623|FG000|Period 2: Part A|Protocol Violation|0|||
156749948|NCT00448812|565835167|FG000|Year 5|Missed visit but remained in study|1|||
156800520|NCT05239221|566023474|FG008|Overall Study|Withdrawal by Subject|0|||
156800521|NCT05239221|566023475|FG009|Overall Study|Withdrawal by Subject|0|||
156800522|NCT05239221|566023476|FG010|Overall Study|Withdrawal by Subject|1|||
156800523|NCT05239221|566023477|FG011|Overall Study|Withdrawal by Subject|0|||
156800524|NCT05239221|566023478|FG012|Overall Study|Withdrawal by Subject|0|||
156800525|NCT05239221|566023479|FG013|Overall Study|Withdrawal by Subject|0|||
156800526|NCT05239221|566023480|FG014|Overall Study|Withdrawal by Subject|0|||
156459329|NCT04737330|564776788|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
156459330|NCT04737330|564776787|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
156749949|NCT00448812|565835168|FG001|Year 5|Missed visit but remained in study|0|||
156749950|NCT01854879|565835171|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
156749951|NCT01854879|565835171|FG000|Overall Study|screen fail|3|||
156749952|NCT01854879|565835171|FG000|Overall Study|incomplete data set|1|||
156749953|NCT02012959|565835172|FG000|Treatment Phase A|Adverse Event|2|||
156749954|NCT02012959|565835173|FG001|Treatment Phase A|Adverse Event|0|||
156749955|NCT02012959|565835174|FG002|Treatment Phase A|Adverse Event|0|||
156749956|NCT02012959|565835175|FG003|Treatment Phase A|Adverse Event|0|||
156749957|NCT02012959|565835176|FG004|Treatment Phase A|Adverse Event|0|||
156800527|NCT05239221|566023481|FG015|Overall Study|Withdrawal by Subject|1|||
156800528|NCT01400412|566023482|FG000|Overall Study|Lost to Follow-up|4|||
156800529|NCT01400412|566023483|FG001|Overall Study|Lost to Follow-up|7|||
156800530|NCT01400412|566023482|FG000|Overall Study|Withdrawal by Subject|3|||
156800531|NCT01400412|566023483|FG001|Overall Study|Withdrawal by Subject|4|||
156800532|NCT01400412|566023482|FG000|Overall Study|Unable to complete|3|||
156800533|NCT01400412|566023483|FG001|Overall Study|Unable to complete|3|||
156800534|NCT01400412|566023482|FG000|Overall Study|Never started study treatment|0|||
156800535|NCT01400412|566023483|FG001|Overall Study|Never started study treatment|3|||
156800536|NCT01334918|566025314|FG000|Overall Study|Did not receive study drug|6|||
156800537|NCT01334918|566025315|FG001|Overall Study|Did not receive study drug|0|||
156800538|NCT01334918|566025314|FG000|Overall Study|Adverse Event|2|||
156800539|NCT01334918|566025315|FG001|Overall Study|Adverse Event|0|||
156800540|NCT01334918|566025314|FG000|Overall Study|Withdrawal by Subject|0|||
156800541|NCT01334918|566025315|FG001|Overall Study|Withdrawal by Subject|1|||
156800542|NCT01576783|566025319|FG000|Overall Study|Change in Medical Care|1|||
156800543|NCT01576783|566025320|FG001|Overall Study|Change in Medical Care|0|||
156800544|NCT01576783|566025319|FG000|Overall Study|Lost to Follow-up|14|||
156800545|NCT01576783|566025320|FG001|Overall Study|Lost to Follow-up|16|||
156800546|NCT01576783|566025319|FG000|Overall Study|Withdrawal by Subject|5|||
156800547|NCT01576783|566025320|FG001|Overall Study|Withdrawal by Subject|1|||
156800548|NCT05489328|566025322|FG000|Overall Study|Lost to Follow-up|0|||
156800549|NCT05489328|566025323|FG001|Overall Study|Lost to Follow-up|0|||
156800550|NCT05489328|566025324|FG002|Overall Study|Lost to Follow-up|1|||
156800551|NCT05489328|566025325|FG003|Overall Study|Lost to Follow-up|0|||
156800552|NCT05489328|566025326|FG004|Overall Study|Lost to Follow-up|2|||
156800553|NCT05489328|566025327|FG005|Overall Study|Lost to Follow-up|0|||
156800554|NCT05489328|566025328|FG006|Overall Study|Lost to Follow-up|0|||
156800555|NCT05489328|566025329|FG007|Overall Study|Lost to Follow-up|1|||
156800556|NCT05489328|566025330|FG008|Overall Study|Lost to Follow-up|0|||
156800557|NCT05489328|566025322|FG000|Overall Study|Withdrawal by Subject|0|||
156800558|NCT05489328|566025323|FG001|Overall Study|Withdrawal by Subject|0|||
156800559|NCT05489328|566025324|FG002|Overall Study|Withdrawal by Subject|0|||
156800560|NCT05489328|566025325|FG003|Overall Study|Withdrawal by Subject|0|||
156800561|NCT05489328|566025326|FG004|Overall Study|Withdrawal by Subject|0|||
156800562|NCT05489328|566025327|FG005|Overall Study|Withdrawal by Subject|0|||
156800563|NCT05489328|566025328|FG006|Overall Study|Withdrawal by Subject|1|||
156800564|NCT05489328|566025329|FG007|Overall Study|Withdrawal by Subject|1|||
156800565|NCT05489328|566025330|FG008|Overall Study|Withdrawal by Subject|0|||
156800566|NCT05489328|566025322|FG000|Overall Study|Other|0|||
156800567|NCT05489328|566025323|FG001|Overall Study|Other|0|||
156800568|NCT05489328|566025324|FG002|Overall Study|Other|0|||
156800569|NCT05489328|566025325|FG003|Overall Study|Other|0|||
156800570|NCT05489328|566025326|FG004|Overall Study|Other|0|||
156800571|NCT05489328|566025327|FG005|Overall Study|Other|0|||
156800572|NCT05489328|566025328|FG006|Overall Study|Other|0|||
156800573|NCT05489328|566025329|FG007|Overall Study|Other|1|||
156800574|NCT05489328|566025330|FG008|Overall Study|Other|1|||
156800575|NCT01083602|566025331|FG000|Overall Study|Adverse Event|11|||
156800576|NCT01083602|566025331|FG000|Overall Study|New Cancer Therapy|2|||
156800577|NCT01083602|566025331|FG000|Overall Study|Death|1|||
156800578|NCT01083602|566025331|FG000|Overall Study|Withdrawal by Subject|5|||
156800579|NCT01083602|566025331|FG000|Overall Study|Lack of Efficacy|36|||
156800580|NCT01657370|566025333|FG000|Overall Study|Withdrawal by Subject|0|||
156800581|NCT01657370|566025334|FG001|Overall Study|Withdrawal by Subject|0|||
156800582|NCT01657370|566025335|FG002|Overall Study|Withdrawal by Subject|1|||
156800583|NCT01657370|566025336|FG003|Overall Study|Withdrawal by Subject|0|||
156800584|NCT01657370|566025337|FG004|Overall Study|Withdrawal by Subject|0|||
156800585|NCT01657370|566025338|FG005|Overall Study|Withdrawal by Subject|1|||
156800586|NCT01657370|566025333|FG000|Overall Study|Physician Decision|2|||
156800587|NCT01657370|566025334|FG001|Overall Study|Physician Decision|3|||
156800588|NCT01657370|566025335|FG002|Overall Study|Physician Decision|1|||
156800589|NCT01657370|566025336|FG003|Overall Study|Physician Decision|2|||
156800590|NCT01657370|566025337|FG004|Overall Study|Physician Decision|5|||
156800591|NCT01657370|566025338|FG005|Overall Study|Physician Decision|0|||
156537125|NCT00467779|565061100|FG005|Stage 1|Disease Progression|2|||
156800592|NCT01657370|566025333|FG000|Overall Study|Lack of Qualifying Event|1|||
156337361|NCT04457336|564333624|FG001|Period 2: Part A|Protocol Violation|1|||
156337362|NCT04457336|564333625|FG002|Period 2: Part A|Protocol Violation|0|||
156337363|NCT04457336|564333626|FG003|Period 2: Part A|Protocol Violation|0|||
156337364|NCT04457336|564333627|FG004|Period 2: Part A|Protocol Violation|0|||
156337365|NCT04457336|564333628|FG005|Period 2: Part A|Protocol Violation|0|||
156337366|NCT04457336|564333629|FG006|Period 2: Part A|Protocol Violation|0|||
156337367|NCT04457336|564333630|FG007|Period 2: Part A|Protocol Violation|0|||
156337368|NCT04457336|564333623|FG000|Period 2: Part A|Lost to Follow-up|0|||
156337369|NCT04457336|564333624|FG001|Period 2: Part A|Lost to Follow-up|1|||
156337370|NCT04457336|564333625|FG002|Period 2: Part A|Lost to Follow-up|0|||
156337371|NCT04457336|564333626|FG003|Period 2: Part A|Lost to Follow-up|0|||
156337372|NCT04457336|564333627|FG004|Period 2: Part A|Lost to Follow-up|0|||
156337373|NCT04457336|564333628|FG005|Period 2: Part A|Lost to Follow-up|0|||
156337374|NCT04457336|564333629|FG006|Period 2: Part A|Lost to Follow-up|0|||
156337375|NCT04457336|564333630|FG007|Period 2: Part A|Lost to Follow-up|0|||
156337376|NCT04457336|564333623|FG000|Period 2: Part A|Other|0|||
156337377|NCT04457336|564333624|FG001|Period 2: Part A|Other|1|||
156337378|NCT04457336|564333625|FG002|Period 2: Part A|Other|0|||
156337379|NCT04457336|564333626|FG003|Period 2: Part A|Other|0|||
156337380|NCT04457336|564333627|FG004|Period 2: Part A|Other|0|||
156337381|NCT04457336|564333628|FG005|Period 2: Part A|Other|0|||
156337382|NCT04457336|564333629|FG006|Period 2: Part A|Other|0|||
156337383|NCT04457336|564333630|FG007|Period 2: Part A|Other|0|||
156337384|NCT04457336|564333623|FG000|Period 2: Part A|Physician Decision|0|||
156337385|NCT04457336|564333624|FG001|Period 2: Part A|Physician Decision|0|||
156337386|NCT04457336|564333625|FG002|Period 2: Part A|Physician Decision|0|||
156337387|NCT04457336|564333626|FG003|Period 2: Part A|Physician Decision|1|||
156337388|NCT04457336|564333627|FG004|Period 2: Part A|Physician Decision|0|||
156337389|NCT04457336|564333628|FG005|Period 2: Part A|Physician Decision|0|||
156337390|NCT04457336|564333629|FG006|Period 2: Part A|Physician Decision|0|||
156337391|NCT04457336|564333630|FG007|Period 2: Part A|Physician Decision|0|||
156337392|NCT04457336|564333623|FG000|Period 3: Part B|Study Terminated|0|||
156337393|NCT04457336|564333624|FG001|Period 3: Part B|Study Terminated|0|||
156337394|NCT04457336|564333625|FG002|Period 3: Part B|Study Terminated|0|||
156337395|NCT04457336|564333626|FG003|Period 3: Part B|Study Terminated|0|||
156337396|NCT04457336|564333627|FG004|Period 3: Part B|Study Terminated|1|||
156337397|NCT04457336|564333628|FG005|Period 3: Part B|Study Terminated|10|||
156337398|NCT04457336|564333629|FG006|Period 3: Part B|Study Terminated|13|||
156337399|NCT04457336|564333630|FG007|Period 3: Part B|Study Terminated|0|||
156337400|NCT04457336|564333623|FG000|Period 3: Part B|Withdrawal by Subject|0|||
156800593|NCT01657370|566025334|FG001|Overall Study|Lack of Qualifying Event|0|||
156800594|NCT01657370|566025335|FG002|Overall Study|Lack of Qualifying Event|3|||
156800595|NCT01657370|566025336|FG003|Overall Study|Lack of Qualifying Event|2|||
156800596|NCT01657370|566025337|FG004|Overall Study|Lack of Qualifying Event|1|||
156800597|NCT01657370|566025338|FG005|Overall Study|Lack of Qualifying Event|2|||
156800598|NCT01657370|566025333|FG000|Overall Study|Adverse Event|0|||
156800599|NCT01657370|566025334|FG001|Overall Study|Adverse Event|0|||
156800600|NCT01657370|566025335|FG002|Overall Study|Adverse Event|0|||
156800601|NCT01657370|566025336|FG003|Overall Study|Adverse Event|0|||
156800602|NCT01657370|566025337|FG004|Overall Study|Adverse Event|1|||
156337401|NCT04457336|564333624|FG001|Period 3: Part B|Withdrawal by Subject|0|||
156337402|NCT04457336|564333625|FG002|Period 3: Part B|Withdrawal by Subject|0|||
156337403|NCT04457336|564333626|FG003|Period 3: Part B|Withdrawal by Subject|0|||
156537126|NCT00467779|565061101|FG006|Stage 1|Disease Progression|4|||
156337404|NCT04457336|564333627|FG004|Period 3: Part B|Withdrawal by Subject|0|||
156337405|NCT04457336|564333628|FG005|Period 3: Part B|Withdrawal by Subject|1|||
156337406|NCT04457336|564333629|FG006|Period 3: Part B|Withdrawal by Subject|2|||
156337407|NCT04457336|564333630|FG007|Period 3: Part B|Withdrawal by Subject|0|||
156337408|NCT04457336|564333623|FG000|Period 4: Part C|Study Terminated|0|||
156337409|NCT04457336|564333624|FG001|Period 4: Part C|Study Terminated|0|||
156337410|NCT04457336|564333625|FG002|Period 4: Part C|Study Terminated|0|||
156800603|NCT01657370|566025338|FG005|Overall Study|Adverse Event|0|||
156800604|NCT01657370|566025333|FG000|Overall Study|Protocol Violation|1|||
156800605|NCT01657370|566025334|FG001|Overall Study|Protocol Violation|1|||
156800606|NCT01657370|566025335|FG002|Overall Study|Protocol Violation|1|||
156800607|NCT01657370|566025336|FG003|Overall Study|Protocol Violation|1|||
156800608|NCT01657370|566025337|FG004|Overall Study|Protocol Violation|0|||
156800609|NCT01657370|566025338|FG005|Overall Study|Protocol Violation|0|||
156800610|NCT01657370|566025333|FG000|Overall Study|Lost to Follow-up|2|||
156800611|NCT01657370|566025334|FG001|Overall Study|Lost to Follow-up|0|||
156800612|NCT01657370|566025335|FG002|Overall Study|Lost to Follow-up|1|||
156800613|NCT01657370|566025336|FG003|Overall Study|Lost to Follow-up|0|||
156800614|NCT01657370|566025337|FG004|Overall Study|Lost to Follow-up|0|||
156800615|NCT01657370|566025338|FG005|Overall Study|Lost to Follow-up|1|||
156800616|NCT02777086|566025339|FG000|Overall Study|Lost to Follow-up|96|||
156800617|NCT02777086|566025340|FG001|Overall Study|Lost to Follow-up|99|||
156800618|NCT01133665|566025341|FG000|Overall Study|Physician Decision|2|||
156800619|NCT01819272|566025342|FG000|Overall Study|Adverse Event|1|||
156800620|NCT01819272|566025343|FG001|Overall Study|Adverse Event|0|||
156800621|NCT01819272|566025344|FG002|Overall Study|Adverse Event|0|||
156800622|NCT01819272|566025345|FG003|Overall Study|Adverse Event|2|||
156800623|NCT01819272|566025346|FG004|Overall Study|Adverse Event|0|||
156800624|NCT01819272|566025347|FG005|Overall Study|Adverse Event|0|||
156800625|NCT01819272|566025342|FG000|Overall Study|Lost to Follow-up|3|||
156800626|NCT01819272|566025343|FG001|Overall Study|Lost to Follow-up|0|||
156800627|NCT01819272|566025344|FG002|Overall Study|Lost to Follow-up|1|||
156800628|NCT01819272|566025345|FG003|Overall Study|Lost to Follow-up|0|||
156800629|NCT01819272|566025346|FG004|Overall Study|Lost to Follow-up|0|||
156800630|NCT01819272|566025347|FG005|Overall Study|Lost to Follow-up|3|||
156800631|NCT01819272|566025342|FG000|Overall Study|Protocol Violation|0|||
156800632|NCT01819272|566025343|FG001|Overall Study|Protocol Violation|0|||
156800633|NCT01819272|566025344|FG002|Overall Study|Protocol Violation|0|||
156800634|NCT01819272|566025345|FG003|Overall Study|Protocol Violation|1|||
156800635|NCT01819272|566025346|FG004|Overall Study|Protocol Violation|2|||
156800636|NCT01819272|566025347|FG005|Overall Study|Protocol Violation|3|||
156800637|NCT01819272|566025342|FG000|Overall Study|Physician Decision|0|||
156800638|NCT01819272|566025343|FG001|Overall Study|Physician Decision|1|||
156800639|NCT01819272|566025344|FG002|Overall Study|Physician Decision|0|||
156800640|NCT01819272|566025345|FG003|Overall Study|Physician Decision|0|||
156800641|NCT01819272|566025346|FG004|Overall Study|Physician Decision|0|||
156800642|NCT01819272|566025347|FG005|Overall Study|Physician Decision|0|||
156800643|NCT01819272|566025342|FG000|Overall Study|Withdrawal of Consent|0|||
156800644|NCT01819272|566025343|FG001|Overall Study|Withdrawal of Consent|1|||
156800645|NCT01819272|566025344|FG002|Overall Study|Withdrawal of Consent|2|||
156800646|NCT01819272|566025345|FG003|Overall Study|Withdrawal of Consent|1|||
156800647|NCT01819272|566025346|FG004|Overall Study|Withdrawal of Consent|0|||
156800648|NCT01819272|566025347|FG005|Overall Study|Withdrawal of Consent|1|||
156800649|NCT01819272|566025342|FG000|Overall Study|Loss of Glucose Control|2|||
156800650|NCT01819272|566025343|FG001|Overall Study|Loss of Glucose Control|1|||
156800651|NCT01819272|566025344|FG002|Overall Study|Loss of Glucose Control|0|||
156800652|NCT01819272|566025345|FG003|Overall Study|Loss of Glucose Control|1|||
156800653|NCT01819272|566025346|FG004|Overall Study|Loss of Glucose Control|2|||
156800654|NCT01819272|566025347|FG005|Overall Study|Loss of Glucose Control|0|||
156800655|NCT00805389|566025348|FG000|Overall Study|Adverse Event|0|||
156800656|NCT00805389|566025349|FG001|Overall Study|Adverse Event|0|||
156800657|NCT00805389|566025350|FG002|Overall Study|Adverse Event|1|||
156800658|NCT00805389|566025351|FG003|Overall Study|Adverse Event|2|||
156800659|NCT00805389|566025352|FG004|Overall Study|Adverse Event|0|||
156800660|NCT00805389|566025348|FG000|Overall Study|Lost to Follow-up|4|||
156800661|NCT00805389|566025349|FG001|Overall Study|Lost to Follow-up|3|||
156800662|NCT00805389|566025350|FG002|Overall Study|Lost to Follow-up|6|||
156800663|NCT00805389|566025351|FG003|Overall Study|Lost to Follow-up|10|||
156800664|NCT00805389|566025352|FG004|Overall Study|Lost to Follow-up|9|||
156800665|NCT00805389|566025348|FG000|Overall Study|Protocol Violation|0|||
156800666|NCT00805389|566025349|FG001|Overall Study|Protocol Violation|0|||
156800667|NCT00805389|566025350|FG002|Overall Study|Protocol Violation|1|||
156800668|NCT00805389|566025351|FG003|Overall Study|Protocol Violation|0|||
156800669|NCT00805389|566025352|FG004|Overall Study|Protocol Violation|0|||
156800670|NCT00805389|566025348|FG000|Overall Study|Withdrawal by Subject|3|||
156800671|NCT00805389|566025349|FG001|Overall Study|Withdrawal by Subject|2|||
156800672|NCT00805389|566025350|FG002|Overall Study|Withdrawal by Subject|4|||
156800673|NCT00805389|566025351|FG003|Overall Study|Withdrawal by Subject|5|||
156800674|NCT00805389|566025352|FG004|Overall Study|Withdrawal by Subject|4|||
156800675|NCT01359956|566025355|FG000|Overall Study|Death|58|||
156800676|NCT01359956|566025356|FG001|Overall Study|Death|60|||
156800677|NCT01359956|566025357|FG002|Overall Study|Death|66|||
156800678|NCT01359956|566025358|FG003|Overall Study|Death|57|||
156800679|NCT01359956|566025355|FG000|Overall Study|Lost to Follow-up|3|||
156800680|NCT01359956|566025356|FG001|Overall Study|Lost to Follow-up|4|||
156800681|NCT01359956|566025357|FG002|Overall Study|Lost to Follow-up|1|||
156800682|NCT01359956|566025358|FG003|Overall Study|Lost to Follow-up|1|||
156800683|NCT01784029|566025359|FG000|Overall Study|Lost to Follow-up|19|||
156800684|NCT01784029|566025360|FG001|Overall Study|Lost to Follow-up|20|||
156800685|NCT01784029|566025361|FG002|Overall Study|Lost to Follow-up|22|||
156800686|NCT01209767|566025366|FG000|Overall Study|Withdrawal by Subject|1|||
156800687|NCT01209767|566025366|FG000|Overall Study|Lost to Follow-up|3|||
156800688|NCT02410772|566025370|FG000|Overall Study|Death|3|||
156800689|NCT02410772|566025371|FG001|Overall Study|Death|4|||
156800690|NCT02410772|566025372|FG002|Overall Study|Death|8|||
156800691|NCT02410772|566025370|FG000|Overall Study|Lost to Follow-up|31|||
156800692|NCT02410772|566025371|FG001|Overall Study|Lost to Follow-up|23|||
156800693|NCT02410772|566025372|FG002|Overall Study|Lost to Follow-up|22|||
156800694|NCT02410772|566025370|FG000|Overall Study|Pregnancy|8|||
156800695|NCT02410772|566025371|FG001|Overall Study|Pregnancy|4|||
156800696|NCT02410772|566025372|FG002|Overall Study|Pregnancy|5|||
156800697|NCT02410772|566025370|FG000|Overall Study|Protocol Violation|8|||
156800698|NCT02410772|566025371|FG001|Overall Study|Protocol Violation|8|||
156800699|NCT02410772|566025372|FG002|Overall Study|Protocol Violation|4|||
156800700|NCT02410772|566025370|FG000|Overall Study|Baseline Drug Resistance|49|||
156800701|NCT02410772|566025371|FG001|Overall Study|Baseline Drug Resistance|40|||
156800702|NCT02410772|566025372|FG002|Overall Study|Baseline Drug Resistance|51|||
156800703|NCT02410772|566025370|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
156800704|NCT02410772|566025371|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
156800705|NCT02410772|566025372|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
156800706|NCT02410772|566025370|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
156800707|NCT02410772|566025371|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
156800708|NCT02410772|566025372|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
156800709|NCT04573972|566025373|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
156800710|NCT04573972|566025374|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
156800711|NCT01517984|566025375|FG000|Overall Study|Lost to Follow-up|0|||
156800712|NCT01517984|566025376|FG001|Overall Study|Lost to Follow-up|1|||
156800713|NCT01517984|566025377|FG002|Overall Study|Lost to Follow-up|0|||
156800714|NCT01517984|566025378|FG003|Overall Study|Lost to Follow-up|0|||
156800715|NCT01517984|566025375|FG000|Overall Study|Withdrawal by Subject|1|||
156800716|NCT01517984|566025376|FG001|Overall Study|Withdrawal by Subject|8|||
156800717|NCT01517984|566025377|FG002|Overall Study|Withdrawal by Subject|4|||
156800718|NCT01517984|566025378|FG003|Overall Study|Withdrawal by Subject|1|||
156800719|NCT01517984|566025375|FG000|Overall Study|Screen Failure|4|||
156800720|NCT01517984|566025376|FG001|Overall Study|Screen Failure|0|||
156800721|NCT01517984|566025377|FG002|Overall Study|Screen Failure|0|||
156800722|NCT01517984|566025378|FG003|Overall Study|Screen Failure|0|||
156800723|NCT01517984|566025375|FG000|Overall Study|Ineligible for randomization|0|||
156337411|NCT04457336|564333626|FG003|Period 4: Part C|Study Terminated|0|||
156337412|NCT04457336|564333627|FG004|Period 4: Part C|Study Terminated|0|||
156800724|NCT01517984|566025376|FG001|Overall Study|Ineligible for randomization|14|||
156800725|NCT01517984|566025377|FG002|Overall Study|Ineligible for randomization|0|||
156800726|NCT01517984|566025378|FG003|Overall Study|Ineligible for randomization|0|||
156800727|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
156800728|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
156800729|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
156800730|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
156800731|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
156800732|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
156800733|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
156800734|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
156800735|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
156800736|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
156800737|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
156800738|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
156800739|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
156337413|NCT04457336|564333628|FG005|Period 4: Part C|Study Terminated|0|||
156459331|NCT04737330|564776788|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
156800740|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
156800741|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
156800742|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
156800743|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
156800744|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
156800745|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
156800746|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
156337414|NCT04457336|564333629|FG006|Period 4: Part C|Study Terminated|0|||
156337415|NCT04457336|564333630|FG007|Period 4: Part C|Study Terminated|30|||
156337416|NCT04457336|564333623|FG000|Period 4: Part C|Adverse Event|0|||
156337417|NCT04457336|564333624|FG001|Period 4: Part C|Adverse Event|0|||
156337418|NCT04457336|564333625|FG002|Period 4: Part C|Adverse Event|0|||
156337419|NCT04457336|564333626|FG003|Period 4: Part C|Adverse Event|0|||
156337420|NCT04457336|564333627|FG004|Period 4: Part C|Adverse Event|0|||
156337421|NCT04457336|564333628|FG005|Period 4: Part C|Adverse Event|0|||
156337422|NCT04457336|564333629|FG006|Period 4: Part C|Adverse Event|0|||
156337423|NCT04457336|564333630|FG007|Period 4: Part C|Adverse Event|2|||
156337424|NCT04457336|564333623|FG000|Period 4: Part C|Site Terminated|0|||
156337425|NCT04457336|564333624|FG001|Period 4: Part C|Site Terminated|0|||
156337426|NCT04457336|564333625|FG002|Period 4: Part C|Site Terminated|0|||
156337427|NCT04457336|564333626|FG003|Period 4: Part C|Site Terminated|0|||
156337428|NCT04457336|564333627|FG004|Period 4: Part C|Site Terminated|0|||
156337429|NCT04457336|564333628|FG005|Period 4: Part C|Site Terminated|0|||
156337430|NCT04457336|564333629|FG006|Period 4: Part C|Site Terminated|0|||
156337431|NCT04457336|564333630|FG007|Period 4: Part C|Site Terminated|1|||
156337432|NCT04457336|564333623|FG000|Period 4: Part C|Other|0|||
156337433|NCT04457336|564333624|FG001|Period 4: Part C|Other|0|||
156337434|NCT04457336|564333625|FG002|Period 4: Part C|Other|0|||
156337435|NCT04457336|564333626|FG003|Period 4: Part C|Other|0|||
156337436|NCT04457336|564333627|FG004|Period 4: Part C|Other|0|||
156337437|NCT04457336|564333628|FG005|Period 4: Part C|Other|0|||
156337438|NCT04457336|564333629|FG006|Period 4: Part C|Other|0|||
156337439|NCT04457336|564333630|FG007|Period 4: Part C|Other|2|||
156337440|NCT04457336|564333623|FG000|Period 4: Part C|Withdrawal by Subject|0|||
156337441|NCT04457336|564333624|FG001|Period 4: Part C|Withdrawal by Subject|0|||
156337442|NCT04457336|564333625|FG002|Period 4: Part C|Withdrawal by Subject|0|||
156337443|NCT04457336|564333626|FG003|Period 4: Part C|Withdrawal by Subject|0|||
156337444|NCT04457336|564333627|FG004|Period 4: Part C|Withdrawal by Subject|0|||
156337445|NCT04457336|564333628|FG005|Period 4: Part C|Withdrawal by Subject|0|||
156337446|NCT04457336|564333629|FG006|Period 4: Part C|Withdrawal by Subject|0|||
156337447|NCT04457336|564333630|FG007|Period 4: Part C|Withdrawal by Subject|3|||
156337448|NCT05379231|564333631|FG000|Home Visit|Withdrawal by Subject|2|||
156337449|NCT05379231|564333631|FG000|In-lab Visit|Withdrawal by Subject|2|||
156337450|NCT00446251|564333643|FG000|Overall Study|On-study Transplants|2|||
156337451|NCT00446251|564333643|FG000|Overall Study|Rituximab Infusion Reaction|2|||
156337452|NCT00446251|564333643|FG000|Overall Study|Lost to Follow-up|1|||
156337453|NCT02693119|564333644|FG000|Open-Label Period|Withdrawal by Subject|0|||
156337454|NCT02693119|564333645|FG001|Open-Label Period|Withdrawal by Subject|1|||
156337455|NCT01719783|564333646|FG000|Dose 2|Physician Decision|1|||
156337456|NCT01719783|564333647|FG001|Dose 2|Physician Decision|0|||
156337457|NCT02319837|564333648|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
156337458|NCT02319837|564333649|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
156337459|NCT02319837|564333650|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
156337460|NCT02319837|564333648|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
156337461|NCT02319837|564333649|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
156337462|NCT02319837|564333650|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
156337463|NCT02319837|564333648|FG000|Study Treatment Phase|Adverse Event|73|||
156337464|NCT02319837|564333649|FG001|Study Treatment Phase|Adverse Event|36|||
156337465|NCT02319837|564333650|FG002|Study Treatment Phase|Adverse Event|63|||
156337466|NCT02319837|564333648|FG000|Study Treatment Phase|Development of castration resistance|0|||
156337467|NCT02319837|564333649|FG001|Study Treatment Phase|Development of castration resistance|2|||
156337468|NCT02319837|564333650|FG002|Study Treatment Phase|Development of castration resistance|0|||
156337469|NCT02319837|564333648|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
156337470|NCT02319837|564333649|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
156337471|NCT02319837|564333650|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
156337472|NCT02319837|564333648|FG000|Study Treatment Phase|Protocol Violation|2|||
156337473|NCT02319837|564333649|FG001|Study Treatment Phase|Protocol Violation|2|||
156337474|NCT02319837|564333650|FG002|Study Treatment Phase|Protocol Violation|1|||
156337475|NCT02319837|564333648|FG000|Study Treatment Phase|Lost to Follow-up|0|||
156337476|NCT02319837|564333649|FG001|Study Treatment Phase|Lost to Follow-up|1|||
156337477|NCT02319837|564333650|FG002|Study Treatment Phase|Lost to Follow-up|0|||
156338249|NCT05248867|564336597|FG005|Open-label Period|Withdrawal by Subject|9|||
156800747|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
156800748|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
156800749|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
156800750|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
156800751|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
156800752|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
156800753|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
156800754|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
156800755|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
156800756|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
156800757|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
156800758|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
156800759|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
156800760|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
156800761|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
156800762|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
156800763|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
156800764|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
156800765|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
156800766|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
156800767|NCT02724839|566025383|FG000|Overall Study|Withdrawal by Subject|1|||
156800768|NCT02724839|566025384|FG001|Overall Study|Withdrawal by Subject|1|||
156800769|NCT02724839|566025385|FG002|Overall Study|Withdrawal by Subject|0|||
156800770|NCT02724839|566025383|FG000|Overall Study|Lost to Follow-up|0|||
156800771|NCT02724839|566025384|FG001|Overall Study|Lost to Follow-up|3|||
156800772|NCT02724839|566025385|FG002|Overall Study|Lost to Follow-up|2|||
156800773|NCT02724839|566025383|FG000|Overall Study|Physician Decision|0|||
156800774|NCT02724839|566025384|FG001|Overall Study|Physician Decision|0|||
156800775|NCT02724839|566025385|FG002|Overall Study|Physician Decision|3|||
156800776|NCT00949533|566025387|FG000|Overall Study|Lost to Follow-up|0|||
156800777|NCT00949533|566025388|FG001|Overall Study|Lost to Follow-up|1|||
156800778|NCT01948427|566025391|FG000|Overall Study|Serious Adverse Event|3|||
156800779|NCT01948427|566025392|FG001|Overall Study|Serious Adverse Event|0|||
156800780|NCT01948427|566025393|FG002|Overall Study|Serious Adverse Event|0|||
156800781|NCT01948427|566025394|FG003|Overall Study|Serious Adverse Event|0|||
156800782|NCT01948427|566025395|FG004|Overall Study|Serious Adverse Event|1|||
156800783|NCT01948427|566025391|FG000|Overall Study|Investigator Request|0|||
156800784|NCT01948427|566025392|FG001|Overall Study|Investigator Request|8|||
156800785|NCT01948427|566025393|FG002|Overall Study|Investigator Request|0|||
156800786|NCT01948427|566025394|FG003|Overall Study|Investigator Request|0|||
156800787|NCT01948427|566025395|FG004|Overall Study|Investigator Request|6|||
156800788|NCT01948427|566025391|FG000|Overall Study|Lost to Follow-up|1|||
156800789|NCT01948427|566025392|FG001|Overall Study|Lost to Follow-up|0|||
156800790|NCT01948427|566025393|FG002|Overall Study|Lost to Follow-up|0|||
156800791|NCT01948427|566025394|FG003|Overall Study|Lost to Follow-up|0|||
156800792|NCT01948427|566025395|FG004|Overall Study|Lost to Follow-up|4|||
156800793|NCT01948427|566025391|FG000|Overall Study|Withdrawal by Subject|2|||
156800794|NCT01948427|566025392|FG001|Overall Study|Withdrawal by Subject|0|||
156800795|NCT01948427|566025393|FG002|Overall Study|Withdrawal by Subject|0|||
156800796|NCT01948427|566025394|FG003|Overall Study|Withdrawal by Subject|0|||
156800797|NCT01948427|566025395|FG004|Overall Study|Withdrawal by Subject|1|||
156800798|NCT01948427|566025391|FG000|Overall Study|Other, Not Specified|1|||
156800799|NCT01948427|566025392|FG001|Overall Study|Other, Not Specified|9|||
156800800|NCT01948427|566025393|FG002|Overall Study|Other, Not Specified|0|||
156800801|NCT01948427|566025394|FG003|Overall Study|Other, Not Specified|0|||
156800802|NCT01948427|566025395|FG004|Overall Study|Other, Not Specified|2|||
156800803|NCT02434081|566025396|FG000|Overall Study|Death (never started treatment)|2|||
156800804|NCT02434081|566025396|FG000|Overall Study|Death|2|||
156800805|NCT02434081|566025396|FG000|Overall Study|Progression|20|||
156800806|NCT02434081|566025396|FG000|Overall Study|Adverse Event|20|||
156800807|NCT02434081|566025396|FG000|Overall Study|Physician Decision|2|||
156800808|NCT02434081|566025396|FG000|Overall Study|Withdrawal by Subject|1|||
156800809|NCT02434081|566025396|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
156800810|NCT02006927|566025403|FG000|Overall Study|Adverse Event|2|||
156800811|NCT02006927|566025403|FG000|Overall Study|Withdrawal by Subject|1|||
156459332|NCT03295721|564776792|FG000|Overall Study|Adverse Event|1|||
156459333|NCT03295721|564776793|FG001|Overall Study|Adverse Event|0|||
156800812|NCT02943473|566025410|FG000|Overall Study|enrolled but not dosed|1|||
156800813|NCT02943473|566025410|FG000|Overall Study|screen failure|1|||
156800814|NCT02943473|566025410|FG000|Overall Study|Physician Decision|4|||
156800815|NCT01728246|566025411|FG000|Overall Study|Participant needed rescue medication|1|||
156800816|NCT01728246|566025412|FG001|Overall Study|Participant needed rescue medication|5|||
156800817|NCT01728246|566025411|FG000|Overall Study|Protocol Violation|1|||
156800818|NCT01728246|566025412|FG001|Overall Study|Protocol Violation|0|||
156800819|NCT01728246|566025411|FG000|Overall Study|Withdrawal by Subject|2|||
156800820|NCT01728246|566025412|FG001|Overall Study|Withdrawal by Subject|3|||
156800821|NCT01728246|566025411|FG000|Overall Study|Lost to Follow-up|23|||
156800822|NCT01728246|566025412|FG001|Overall Study|Lost to Follow-up|22|||
156800823|NCT01728246|566025411|FG000|Overall Study|Lack of Efficacy|1|||
156800824|NCT01728246|566025412|FG001|Overall Study|Lack of Efficacy|1|||
156800825|NCT01728246|566025411|FG000|Overall Study|Adverse Event|8|||
156800826|NCT01728246|566025412|FG001|Overall Study|Adverse Event|5|||
156800827|NCT05805150|566025413|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
156800828|NCT05805150|566025414|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
156800829|NCT00431964|566025417|FG000|Overall Study|Adverse Event|1|||
156800830|NCT00431964|566025418|FG001|Overall Study|Adverse Event|0|||
156800831|NCT00431964|566025417|FG000|Overall Study|Lost to Follow-up|1|||
156800832|NCT00431964|566025418|FG001|Overall Study|Lost to Follow-up|2|||
156800833|NCT00431964|566025417|FG000|Overall Study|Physician Decision|2|||
156800834|NCT00431964|566025418|FG001|Overall Study|Physician Decision|2|||
156800835|NCT00431964|566025417|FG000|Overall Study|Withdrawal by Subject|2|||
156800836|NCT00431964|566025418|FG001|Overall Study|Withdrawal by Subject|1|||
156800837|NCT00431964|566025417|FG000|Overall Study|Parental Consent Withdrawn|0|||
156800838|NCT00431964|566025418|FG001|Overall Study|Parental Consent Withdrawn|2|||
156800839|NCT00431964|566025417|FG000|Overall Study|Due to Unstable Health|0|||
156800840|NCT00431964|566025418|FG001|Overall Study|Due to Unstable Health|1|||
156800841|NCT04138056|566025422|FG000|Primary Study|Lost to Follow-up|3|||
156800842|NCT04138056|566025423|FG001|Primary Study|Lost to Follow-up|4|||
156800843|NCT04138056|566025424|FG002|Primary Study|Lost to Follow-up|1|||
156800844|NCT04138056|566025425|FG003|Primary Study|Lost to Follow-up|1|||
156800845|NCT04138056|566025426|FG004|Primary Study|Lost to Follow-up|4|||
156800846|NCT04138056|566025422|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
156800847|NCT04138056|566025423|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
156800848|NCT04138056|566025424|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
156800849|NCT04138056|566025425|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
156800850|NCT04138056|566025426|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
156800851|NCT04138056|566025422|FG000|Extension Study|Lost to Follow-up|1|||
156800852|NCT04138056|566025423|FG001|Extension Study|Lost to Follow-up|2|||
156800853|NCT04138056|566025424|FG002|Extension Study|Lost to Follow-up|1|||
156800854|NCT04138056|566025425|FG003|Extension Study|Lost to Follow-up|0|||
156800855|NCT04138056|566025426|FG004|Extension Study|Lost to Follow-up|1|||
156800856|NCT01959932|566025428|FG000|Overall Study|Withdrawal by Subject|1|||
156800857|NCT01959932|566025429|FG001|Overall Study|Withdrawal by Subject|0|||
156800858|NCT01959932|566025430|FG002|Overall Study|Withdrawal by Subject|0|||
156800859|NCT00485173|566025438|FG000|Overall Study|Death|4|||
156800860|NCT00485173|566025439|FG001|Overall Study|Death|3|||
156800861|NCT00485173|566025438|FG000|Overall Study|Lost to Follow-up|32|||
156800862|NCT00485173|566025439|FG001|Overall Study|Lost to Follow-up|61|||
156800863|NCT00829244|566025442|FG000|Overall Study|Adverse Event|1|||
156800864|NCT00829244|566025443|FG001|Overall Study|Adverse Event|3|||
156800865|NCT00829244|566025442|FG000|Overall Study|Protocol Violation|1|||
156800866|NCT00829244|566025443|FG001|Overall Study|Protocol Violation|0|||
156800867|NCT00829244|566025442|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
156800868|NCT00829244|566025443|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
156800869|NCT00829244|566025442|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
156800870|NCT00829244|566025443|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
156800871|NCT00829244|566025442|FG000|Overall Study|No fertilization|2|||
156800872|NCT00829244|566025443|FG001|Overall Study|No fertilization|2|||
156800873|NCT00829244|566025442|FG000|Overall Study|All embryos discarded|0|||
156800874|NCT00829244|566025443|FG001|Overall Study|All embryos discarded|3|||
156800875|NCT00829244|566025442|FG000|Overall Study|No embryo cleavage|0|||
156800876|NCT00829244|566025443|FG001|Overall Study|No embryo cleavage|2|||
156800877|NCT02297412|566025444|FG000|Overall Study|Canceled|1|||
156800878|NCT02297412|566025445|FG001|Overall Study|Canceled|1|||
156800879|NCT04583618|566025452|FG000|Overall Study|Adverse Event|0|||
156800880|NCT04583618|566025453|FG001|Overall Study|Adverse Event|0|||
156800881|NCT04583618|566025454|FG002|Overall Study|Adverse Event|1|||
156800882|NCT04583618|566025455|FG003|Overall Study|Adverse Event|0|||
156800883|NCT04583618|566025456|FG004|Overall Study|Adverse Event|0|||
156800884|NCT04583618|566025452|FG000|Overall Study|Protocol deviation|1|||
156800885|NCT04583618|566025453|FG001|Overall Study|Protocol deviation|1|||
156800886|NCT04583618|566025454|FG002|Overall Study|Protocol deviation|1|||
156800887|NCT04583618|566025455|FG003|Overall Study|Protocol deviation|0|||
156800888|NCT04583618|566025456|FG004|Overall Study|Protocol deviation|0|||
156800889|NCT04583618|566025452|FG000|Overall Study|Withdrawal by Subject|2|||
156800890|NCT04583618|566025453|FG001|Overall Study|Withdrawal by Subject|1|||
156800891|NCT04583618|566025454|FG002|Overall Study|Withdrawal by Subject|3|||
156800892|NCT04583618|566025455|FG003|Overall Study|Withdrawal by Subject|1|||
156800893|NCT04583618|566025456|FG004|Overall Study|Withdrawal by Subject|1|||
156800894|NCT04583618|566025452|FG000|Overall Study|Lost to Follow-up|0|||
156800895|NCT04583618|566025453|FG001|Overall Study|Lost to Follow-up|1|||
156800896|NCT04583618|566025454|FG002|Overall Study|Lost to Follow-up|3|||
156800897|NCT04583618|566025455|FG003|Overall Study|Lost to Follow-up|1|||
156800898|NCT04583618|566025456|FG004|Overall Study|Lost to Follow-up|1|||
156800899|NCT03193801|566025461|FG000|Overall Study|Physician Decision|2|||
156800900|NCT03193801|566025461|FG000|Overall Study|Withdrawal by Subject|1|||
156800901|NCT00529633|566027207|FG000|Overall Study|Withdrawal by Subject|1|||
156800902|NCT00529633|566027208|FG001|Overall Study|Withdrawal by Subject|1|||
156800903|NCT02114177|566027209|FG000|Overall Study|Lost to Follow-up|1|||
156800904|NCT02114177|566027210|FG001|Overall Study|Lost to Follow-up|2|||
156800905|NCT02114177|566027209|FG000|Overall Study|Withdrawal by Subject|6|||
156800906|NCT02114177|566027210|FG001|Overall Study|Withdrawal by Subject|1|||
156800907|NCT02114177|566027209|FG000|Overall Study|Other|2|||
156800908|NCT02114177|566027210|FG001|Overall Study|Other|1|||
156800909|NCT01897493|566027211|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
156800910|NCT01732536|566027216|FG000|Overall Study|Withdrawal by Subject|1|||
156800911|NCT01732536|566027217|FG001|Overall Study|Withdrawal by Subject|1|||
156800912|NCT01246960|566027218|FG000|Overall Study|Lost to Follow-up|3|||
156800913|NCT01246960|566027219|FG001|Overall Study|Lost to Follow-up|1|||
156800914|NCT01246960|566027218|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
156800915|NCT01246960|566027219|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
156800916|NCT05111145|566027220|FG000|Overall Study|Commercial drug is available for participant|76|||
156800917|NCT05111145|566027220|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
156800918|NCT02336815|566027223|FG000|Overall Study|Disease Progression|45|||
156800919|NCT02336815|566027224|FG001|Overall Study|Disease Progression|70|||
156800920|NCT02336815|566027223|FG000|Overall Study|Adverse Event|18|||
156800921|NCT02336815|566027224|FG001|Overall Study|Adverse Event|39|||
156800922|NCT02336815|566027223|FG000|Overall Study|Physician Decision|11|||
156800923|NCT02336815|566027224|FG001|Overall Study|Physician Decision|4|||
156800924|NCT02336815|566027223|FG000|Overall Study|Withdrawal by Subject|3|||
156800925|NCT02336815|566027224|FG001|Overall Study|Withdrawal by Subject|2|||
156800926|NCT02336815|566027223|FG000|Overall Study|Lost to Follow-up|1|||
156800927|NCT02336815|566027224|FG001|Overall Study|Lost to Follow-up|3|||
156800928|NCT02336815|566027223|FG000|Overall Study|Other|1|||
156800929|NCT02336815|566027224|FG001|Overall Study|Other|5|||
156800930|NCT03376516|566027225|FG000|Overall Study|Not treated|1|||
156800931|NCT03376516|566027225|FG000|Overall Study|Consent withdrawn|1|||
156800932|NCT01581684|566027226|FG000|Overall Study|Other reason not defined|0|||
156800933|NCT01581684|566027227|FG001|Overall Study|Other reason not defined|0|||
156800934|NCT01581684|566027228|FG002|Overall Study|Other reason not defined|0|||
156800935|NCT01581684|566027229|FG003|Overall Study|Other reason not defined|0|||
156800936|NCT01581684|566027230|FG004|Overall Study|Other reason not defined|0|||
156800937|NCT01581684|566027231|FG005|Overall Study|Other reason not defined|0|||
156800938|NCT01581684|566027232|FG006|Overall Study|Other reason not defined|0|||
156800939|NCT01581684|566027233|FG007|Overall Study|Other reason not defined|0|||
156800940|NCT01581684|566027234|FG008|Overall Study|Other reason not defined|1|||
156800941|NCT01581684|566027235|FG009|Overall Study|Other reason not defined|0|||
156800942|NCT03235050|566027236|FG000|Overall Study|Adverse Event|0|||
156800943|NCT03235050|566027237|FG001|Overall Study|Adverse Event|0|||
156800944|NCT03235050|566027238|FG002|Overall Study|Adverse Event|1|||
156800945|NCT03235050|566027239|FG003|Overall Study|Adverse Event|4|||
156800946|NCT03235050|566027240|FG004|Overall Study|Adverse Event|1|||
156800947|NCT03235050|566027236|FG000|Overall Study|Death|0|||
156800948|NCT03235050|566027237|FG001|Overall Study|Death|0|||
156800949|NCT03235050|566027238|FG002|Overall Study|Death|0|||
156800950|NCT03235050|566027239|FG003|Overall Study|Death|2|||
156800951|NCT03235050|566027240|FG004|Overall Study|Death|1|||
156800952|NCT03235050|566027236|FG000|Overall Study|Lost to Follow-up|1|||
156800953|NCT03235050|566027237|FG001|Overall Study|Lost to Follow-up|2|||
156800954|NCT03235050|566027238|FG002|Overall Study|Lost to Follow-up|1|||
156800955|NCT03235050|566027239|FG003|Overall Study|Lost to Follow-up|2|||
156800956|NCT03235050|566027240|FG004|Overall Study|Lost to Follow-up|0|||
156800957|NCT03235050|566027236|FG000|Overall Study|Withdrawal by Subject|3|||
156800958|NCT03235050|566027237|FG001|Overall Study|Withdrawal by Subject|2|||
156800959|NCT03235050|566027238|FG002|Overall Study|Withdrawal by Subject|2|||
156337478|NCT02319837|564333648|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
156337479|NCT02319837|564333649|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
156337480|NCT02319837|564333650|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
156337481|NCT02319837|564333648|FG000|Study Treatment Phase|Other|0|||
156337482|NCT02319837|564333649|FG001|Study Treatment Phase|Other|1|||
156337483|NCT02319837|564333650|FG002|Study Treatment Phase|Other|0|||
156337484|NCT02319837|564333648|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
156337485|NCT02319837|564333649|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
156337486|NCT02319837|564333650|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
156337487|NCT02319837|564333648|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
156337488|NCT02319837|564333649|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
156459334|NCT03295721|564776794|FG002|Overall Study|Adverse Event|0|||
156459335|NCT03295721|564776792|FG000|Overall Study|Lost to Follow-up|1|||
156800960|NCT03235050|566027239|FG003|Overall Study|Withdrawal by Subject|5|||
156800961|NCT03235050|566027240|FG004|Overall Study|Withdrawal by Subject|7|||
156800962|NCT03235050|566027236|FG000|Overall Study|Other reasons|0|||
156800963|NCT03235050|566027237|FG001|Overall Study|Other reasons|1|||
156800964|NCT03235050|566027238|FG002|Overall Study|Other reasons|0|||
156800965|NCT03235050|566027239|FG003|Overall Study|Other reasons|1|||
156800966|NCT03235050|566027240|FG004|Overall Study|Other reasons|2|||
156800967|NCT00370292|566027241|FG000|Overall Study|Disease Progression|4|||
156800968|NCT00370292|566027241|FG000|Overall Study|Adverse Event|7|||
156800969|NCT00370292|566027241|FG000|Overall Study|Physician Decision|2|||
156800970|NCT02986074|566027242|FG000|First Trial Period|Adverse Event|1|||
156800971|NCT02986074|566027243|FG001|First Trial Period|Adverse Event|0|||
156800972|NCT02986074|566027244|FG002|First Trial Period|Adverse Event|0|||
156800973|NCT02986074|566027245|FG003|First Trial Period|Adverse Event|0|||
156800974|NCT02986074|566027242|FG000|Follow up Period|system explant|0|||
156800975|NCT02986074|566027243|FG001|Follow up Period|system explant|0|||
156800976|NCT02986074|566027244|FG002|Follow up Period|system explant|1|||
156800977|NCT02986074|566027245|FG003|Follow up Period|system explant|2|||
156800978|NCT02986074|566027242|FG000|Follow up Period|Physician Decision|0|||
156800979|NCT02986074|566027243|FG001|Follow up Period|Physician Decision|0|||
156800980|NCT02986074|566027244|FG002|Follow up Period|Physician Decision|0|||
156800981|NCT02986074|566027245|FG003|Follow up Period|Physician Decision|1|||
156800982|NCT00069641|566027248|FG000|Overall Study|Death|1|||
156800983|NCT00069641|566027249|FG001|Overall Study|Death|0|||
156800984|NCT00069641|566027250|FG002|Overall Study|Death|1|||
156800985|NCT02239926|566027251|FG000|Overall Study|Withdrawal by Subject|0|||
156800986|NCT02239926|566027252|FG001|Overall Study|Withdrawal by Subject|1|||
156800987|NCT02704208|566027253|FG000|Overall Study|Lost to Follow-up|42|||
156800988|NCT02704208|566027254|FG001|Overall Study|Lost to Follow-up|37|||
156800989|NCT04099277|566027255|FG000|Overall Study|Physician Decision|1|||
156800990|NCT04099277|566027255|FG000|Overall Study|Withdrawal by Subject|1|||
156800991|NCT00598650|566027256|FG000|Overall Study|Withdrawal by Subject|3|||
156800992|NCT00598650|566027256|FG000|Overall Study|Adverse Event|18|||
156800993|NCT00598650|566027256|FG000|Overall Study|No treatment for 3 weeks|1|||
156800994|NCT00598650|566027256|FG000|Overall Study|Not eligible|1|||
156800995|NCT00598650|566027256|FG000|Overall Study|Prohibited Concomitant Medication|2|||
156800996|NCT00598650|566027256|FG000|Overall Study|Physician Decision|2|||
156800997|NCT03545672|566027257|FG000|Overall Study|Uncertain diagnosis|2|||
156800998|NCT03545672|566027258|FG001|Overall Study|Uncertain diagnosis|1|||
156800999|NCT03545672|566027257|FG000|Overall Study|Protocol Violation|2|||
156801000|NCT03545672|566027258|FG001|Overall Study|Protocol Violation|2|||
156801001|NCT01628913|566027259|FG000|Overall Study|Adverse Event|12|||
156801002|NCT01628913|566027260|FG001|Overall Study|Adverse Event|5|||
156801003|NCT01628913|566027259|FG000|Overall Study|Disease Progression|11|||
156801004|NCT01628913|566027260|FG001|Overall Study|Disease Progression|14|||
156801005|NCT01628913|566027259|FG000|Overall Study|Protocol Violation|1|||
156801006|NCT01628913|566027260|FG001|Overall Study|Protocol Violation|0|||
156801007|NCT01628913|566027259|FG000|Overall Study|Death|1|||
156459336|NCT03295721|564776793|FG001|Overall Study|Lost to Follow-up|1|||
156801008|NCT01628913|566027260|FG001|Overall Study|Death|0|||
156801009|NCT01628913|566027259|FG000|Overall Study|study terminated by Sponsor|4|||
156801010|NCT01628913|566027260|FG001|Overall Study|study terminated by Sponsor|9|||
156801011|NCT01628913|566027259|FG000|Overall Study|Withdrawal by Subject|1|||
156801012|NCT01628913|566027260|FG001|Overall Study|Withdrawal by Subject|0|||
156801013|NCT01628913|566027259|FG000|Overall Study|Physician Decision|1|||
156801014|NCT01628913|566027260|FG001|Overall Study|Physician Decision|3|||
156801015|NCT02415556|566027264|FG000|Overall Study|Adverse Event|3|||
156801016|NCT02415556|566027265|FG001|Overall Study|Adverse Event|4|||
156801017|NCT02415556|566027266|FG002|Overall Study|Adverse Event|2|||
156801018|NCT02415556|566027267|FG003|Overall Study|Adverse Event|4|||
156801019|NCT02415556|566027264|FG000|Overall Study|Lost to Follow-up|4|||
156801020|NCT02415556|566027265|FG001|Overall Study|Lost to Follow-up|5|||
156801021|NCT02415556|566027266|FG002|Overall Study|Lost to Follow-up|4|||
156801022|NCT02415556|566027267|FG003|Overall Study|Lost to Follow-up|1|||
156801023|NCT02415556|566027264|FG000|Overall Study|Withdrawal by Subject|13|||
156801024|NCT02415556|566027265|FG001|Overall Study|Withdrawal by Subject|4|||
156801025|NCT02415556|566027266|FG002|Overall Study|Withdrawal by Subject|14|||
156801026|NCT02415556|566027267|FG003|Overall Study|Withdrawal by Subject|12|||
156801027|NCT02415556|566027264|FG000|Overall Study|Physician Decision|1|||
156801028|NCT02415556|566027265|FG001|Overall Study|Physician Decision|3|||
156801029|NCT02415556|566027266|FG002|Overall Study|Physician Decision|1|||
156801030|NCT02415556|566027267|FG003|Overall Study|Physician Decision|2|||
156801031|NCT02415556|566027264|FG000|Overall Study|Censored - study completion|4|||
156801032|NCT02415556|566027265|FG001|Overall Study|Censored - study completion|5|||
156801033|NCT02415556|566027266|FG002|Overall Study|Censored - study completion|1|||
156801034|NCT02415556|566027267|FG003|Overall Study|Censored - study completion|0|||
156801035|NCT02415556|566027264|FG000|Overall Study|Family-related issues|0|||
156801036|NCT02415556|566027265|FG001|Overall Study|Family-related issues|0|||
156801037|NCT02415556|566027266|FG002|Overall Study|Family-related issues|0|||
156801038|NCT02415556|566027267|FG003|Overall Study|Family-related issues|1|||
156801039|NCT01621178|566027268|FG000|Overall Study|Adverse Event|5|||
156801040|NCT01621178|566027269|FG001|Overall Study|Adverse Event|2|||
156801041|NCT01621178|566027270|FG002|Overall Study|Adverse Event|8|||
156801042|NCT01621178|566027268|FG000|Overall Study|Death|6|||
156801043|NCT01621178|566027269|FG001|Overall Study|Death|7|||
156801044|NCT01621178|566027270|FG002|Overall Study|Death|2|||
156801045|NCT01621178|566027268|FG000|Overall Study|Lost to Follow-up|1|||
156801046|NCT01621178|566027269|FG001|Overall Study|Lost to Follow-up|2|||
156801047|NCT01621178|566027270|FG002|Overall Study|Lost to Follow-up|1|||
156801048|NCT01621178|566027268|FG000|Overall Study|Withdrawal by Subject|14|||
156801049|NCT01621178|566027269|FG001|Overall Study|Withdrawal by Subject|17|||
156801050|NCT01621178|566027270|FG002|Overall Study|Withdrawal by Subject|18|||
156801051|NCT01621178|566027268|FG000|Overall Study|Physician Decision|5|||
156801052|NCT01621178|566027269|FG001|Overall Study|Physician Decision|2|||
156801053|NCT01621178|566027270|FG002|Overall Study|Physician Decision|7|||
156801054|NCT00105534|566027271|FG000|Overall Study|Adverse Event|2|||
156801055|NCT00105534|566027272|FG001|Overall Study|Adverse Event|5|||
156801056|NCT00105534|566027271|FG000|Overall Study|Protocol Violation|1|||
156801057|NCT00105534|566027272|FG001|Overall Study|Protocol Violation|4|||
156801058|NCT00105534|566027271|FG000|Overall Study|Withdrawal by Subject|6|||
156801059|NCT00105534|566027272|FG001|Overall Study|Withdrawal by Subject|6|||
156801060|NCT00105534|566027271|FG000|Overall Study|Lost to Follow-up|5|||
156801061|NCT00105534|566027272|FG001|Overall Study|Lost to Follow-up|1|||
156801062|NCT00105534|566027271|FG000|Overall Study|Lack of Efficacy|7|||
156801063|NCT00105534|566027272|FG001|Overall Study|Lack of Efficacy|15|||
156801064|NCT00105534|566027271|FG000|Overall Study|Treatment unmasked|1|||
156801065|NCT00105534|566027272|FG001|Overall Study|Treatment unmasked|0|||
156801066|NCT00105534|566027271|FG000|Overall Study|Other Reason|0|||
156801067|NCT00105534|566027272|FG001|Overall Study|Other Reason|2|||
156801068|NCT04102007|566027274|FG000|Overall Study|Adverse Event|4|||
156801069|NCT04102007|566027274|FG000|Overall Study|Lost to Follow-up|3|||
156801070|NCT04102007|566027274|FG000|Overall Study|Withdrawal by Subject|12|||
156801071|NCT04102007|566027274|FG000|Overall Study|Eligibility Violation|5|||
156801072|NCT04102007|566027274|FG000|Overall Study|Lack of Efficacy|6|||
156801073|NCT04102007|566027274|FG000|Overall Study|Protocol Deviation|5|||
156801074|NCT04102007|566027274|FG000|Overall Study|Protocol Compliance|1|||
156801075|NCT04102007|566027274|FG000|Overall Study|Withdrew Treatment|2|||
156801076|NCT04102007|566027274|FG000|Overall Study|Pregnancy|1|||
156801077|NCT05173974|566027275|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
156801078|NCT05173974|566027276|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
156801079|NCT05173974|566027277|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
156801080|NCT05173974|566027278|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
156801081|NCT05173974|566027275|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
156801082|NCT05173974|566027276|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
156801083|NCT05173974|566027277|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
156801084|NCT05173974|566027278|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
156801085|NCT03289143|566027279|FG000|Overall Study|Caregiver Unavailability|1|||
156801086|NCT03289143|566027280|FG001|Overall Study|Caregiver Unavailability|1|||
156801087|NCT03289143|566027281|FG002|Overall Study|Caregiver Unavailability|0|||
156801088|NCT03289143|566027282|FG003|Overall Study|Caregiver Unavailability|0|||
156801089|NCT03289143|566027279|FG000|Overall Study|Research Department Closure|0|||
156801090|NCT03289143|566027280|FG001|Overall Study|Research Department Closure|0|||
156801091|NCT03289143|566027281|FG002|Overall Study|Research Department Closure|1|||
156801092|NCT03289143|566027282|FG003|Overall Study|Research Department Closure|0|||
156801093|NCT03289143|566027279|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
156801094|NCT03289143|566027280|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
156801095|NCT03289143|566027281|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
156801096|NCT03289143|566027282|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
156801097|NCT03289143|566027279|FG000|Overall Study|Medical Monitor Decision|1|||
156801098|NCT03289143|566027280|FG001|Overall Study|Medical Monitor Decision|0|||
156801099|NCT03289143|566027281|FG002|Overall Study|Medical Monitor Decision|0|||
156801100|NCT03289143|566027282|FG003|Overall Study|Medical Monitor Decision|0|||
156801101|NCT03289143|566027279|FG000|Overall Study|Participant Non-Compliance|0|||
156801102|NCT03289143|566027280|FG001|Overall Study|Participant Non-Compliance|0|||
156801103|NCT03289143|566027281|FG002|Overall Study|Participant Non-Compliance|1|||
156801104|NCT03289143|566027282|FG003|Overall Study|Participant Non-Compliance|0|||
156801105|NCT03289143|566027279|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
156801106|NCT03289143|566027280|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
156801107|NCT03289143|566027281|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
156801108|NCT03289143|566027282|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
156801109|NCT03289143|566027279|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
156801110|NCT03289143|566027280|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
156801111|NCT03289143|566027281|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
156801112|NCT03289143|566027282|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
156801113|NCT03289143|566027279|FG000|Overall Study|Caregiver Passed Away|1|||
156801114|NCT03289143|566027280|FG001|Overall Study|Caregiver Passed Away|0|||
156801115|NCT03289143|566027281|FG002|Overall Study|Caregiver Passed Away|0|||
156801116|NCT03289143|566027282|FG003|Overall Study|Caregiver Passed Away|0|||
156801117|NCT03289143|566027279|FG000|Overall Study|Physician Decision|0|||
156801118|NCT03289143|566027280|FG001|Overall Study|Physician Decision|2|||
156801119|NCT03289143|566027281|FG002|Overall Study|Physician Decision|2|||
156801120|NCT03289143|566027282|FG003|Overall Study|Physician Decision|2|||
156801121|NCT03289143|566027279|FG000|Overall Study|Protocol Deviation|2|||
156801122|NCT03289143|566027280|FG001|Overall Study|Protocol Deviation|1|||
156801123|NCT03289143|566027281|FG002|Overall Study|Protocol Deviation|3|||
156801124|NCT03289143|566027282|FG003|Overall Study|Protocol Deviation|1|||
156801125|NCT03289143|566027279|FG000|Overall Study|Study Terminated By Sponsor|101|||
156801126|NCT03289143|566027280|FG001|Overall Study|Study Terminated By Sponsor|75|||
156801127|NCT03289143|566027281|FG002|Overall Study|Study Terminated By Sponsor|100|||
156801128|NCT03289143|566027282|FG003|Overall Study|Study Terminated By Sponsor|69|||
156801129|NCT03289143|566027279|FG000|Overall Study|Withdrawal by Subject|14|||
156801130|NCT03289143|566027280|FG001|Overall Study|Withdrawal by Subject|6|||
156801131|NCT03289143|566027281|FG002|Overall Study|Withdrawal by Subject|14|||
156801132|NCT03289143|566027282|FG003|Overall Study|Withdrawal by Subject|12|||
156801133|NCT03289143|566027279|FG000|Overall Study|Adverse Event|10|||
156801134|NCT03289143|566027280|FG001|Overall Study|Adverse Event|7|||
156801135|NCT03289143|566027281|FG002|Overall Study|Adverse Event|6|||
156801136|NCT03289143|566027282|FG003|Overall Study|Adverse Event|5|||
156801137|NCT03289143|566027279|FG000|Overall Study|Death|2|||
156801138|NCT03289143|566027280|FG001|Overall Study|Death|0|||
156801139|NCT03289143|566027281|FG002|Overall Study|Death|2|||
156801140|NCT03289143|566027282|FG003|Overall Study|Death|1|||
156801141|NCT03289143|566027279|FG000|Overall Study|Lost to Follow-up|2|||
156801142|NCT03289143|566027280|FG001|Overall Study|Lost to Follow-up|1|||
156801143|NCT03289143|566027281|FG002|Overall Study|Lost to Follow-up|1|||
156801144|NCT03289143|566027282|FG003|Overall Study|Lost to Follow-up|0|||
156801145|NCT03289143|566027279|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
156801146|NCT03289143|566027280|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
156801147|NCT03289143|566027281|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
156801148|NCT03289143|566027282|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
156801149|NCT03289143|566027279|FG000|Overall Study|Withdrawal by Caregiver|0|||
156801150|NCT03289143|566027280|FG001|Overall Study|Withdrawal by Caregiver|1|||
156801151|NCT03289143|566027281|FG002|Overall Study|Withdrawal by Caregiver|0|||
156801152|NCT03289143|566027282|FG003|Overall Study|Withdrawal by Caregiver|0|||
156801153|NCT03289143|566027279|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
156801154|NCT03289143|566027280|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
156801155|NCT03289143|566027281|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
156801156|NCT03289143|566027282|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
156801157|NCT03289143|566027279|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
156801158|NCT03289143|566027280|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
156801159|NCT03289143|566027281|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
156801160|NCT03289143|566027282|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
156337489|NCT02319837|564333650|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
156337490|NCT02319837|564333648|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
156801161|NCT00948688|566027283|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
156801162|NCT00948688|566027284|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
156801163|NCT00948688|566027283|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
156801164|NCT00948688|566027284|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
156801165|NCT00948688|566027283|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
156801166|NCT00948688|566027284|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
156801167|NCT00730756|566027285|FG000|Overall Study|Adverse Event|2|||
156801168|NCT00730756|566027286|FG001|Overall Study|Adverse Event|0|||
156801169|NCT00730756|566027285|FG000|Overall Study|Lack of Efficacy|1|||
156801170|NCT00730756|566027286|FG001|Overall Study|Lack of Efficacy|1|||
156801171|NCT00730756|566027285|FG000|Overall Study|Protocol Deviation|1|||
156337491|NCT02319837|564333649|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
156801172|NCT00730756|566027286|FG001|Overall Study|Protocol Deviation|2|||
156801173|NCT00730756|566027285|FG000|Overall Study|Lost to Follow-up|0|||
156801174|NCT00730756|566027286|FG001|Overall Study|Lost to Follow-up|1|||
156801175|NCT00730756|566027285|FG000|Overall Study|Withdrew Consent|0|||
156801176|NCT00730756|566027286|FG001|Overall Study|Withdrew Consent|1|||
156801177|NCT04388826|566027287|FG000|Overall Study|Lost to Follow-up|3|||
156801178|NCT04388826|566027288|FG001|Overall Study|Lost to Follow-up|2|||
156801179|NCT04388826|566027287|FG000|Overall Study|Adverse Event|1|||
156801180|NCT04388826|566027288|FG001|Overall Study|Adverse Event|0|||
156801181|NCT01146613|566027291|FG000|Overall Study|Lost to Follow-up|3|||
156801182|NCT01146613|566027292|FG001|Overall Study|Lost to Follow-up|8|||
156801183|NCT01146613|566027291|FG000|Overall Study|Lack of Efficacy|0|||
156801184|NCT01146613|566027292|FG001|Overall Study|Lack of Efficacy|1|||
156801185|NCT01146613|566027291|FG000|Overall Study|Death|1|||
156801186|NCT01146613|566027292|FG001|Overall Study|Death|0|||
156801187|NCT01146613|566027291|FG000|Overall Study|Physician Decision|1|||
156801188|NCT01146613|566027292|FG001|Overall Study|Physician Decision|0|||
156801189|NCT01146613|566027291|FG000|Overall Study|Withdrawal by Subject|0|||
156801190|NCT01146613|566027292|FG001|Overall Study|Withdrawal by Subject|3|||
156801191|NCT01146613|566027291|FG000|Overall Study|schedule conflict|1|||
156801192|NCT01146613|566027292|FG001|Overall Study|schedule conflict|0|||
156801193|NCT01146613|566027291|FG000|Overall Study|Outpatient detox|1|||
156801194|NCT01146613|566027292|FG001|Overall Study|Outpatient detox|0|||
156801195|NCT05878067|566027293|FG000|Overall Study|Lost to Follow-up|2|||
156801196|NCT01198587|566027296|FG000|Overall Study|Lost to Follow-up|8|||
156801197|NCT01198587|566027297|FG001|Overall Study|Lost to Follow-up|0|||
156801198|NCT01198587|566027298|FG002|Overall Study|Lost to Follow-up|9|||
156801199|NCT01198587|566027299|FG003|Overall Study|Lost to Follow-up|0|||
156801200|NCT01493089|566027300|FG000|Overall Study|Protocol Violation|2|||
156801201|NCT01493089|566027301|FG001|Overall Study|Protocol Violation|2|||
156801202|NCT01493089|566027300|FG000|Overall Study|Withdrawal by Subject|1|||
156801203|NCT01493089|566027301|FG001|Overall Study|Withdrawal by Subject|0|||
156801204|NCT01493089|566027300|FG000|Overall Study|Physician Decision|0|||
156801205|NCT01493089|566027301|FG001|Overall Study|Physician Decision|1|||
156801206|NCT02234362|566027302|FG000|Overall Study|Not eligible after first screening visit|17|||
156801207|NCT02234362|566027302|FG000|Overall Study|Lost to Follow-up|6|||
156801208|NCT02234362|566027302|FG000|Overall Study|Withdrawal by Subject|3|||
156801209|NCT01959529|566027303|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
156801210|NCT01959529|566027304|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
156801211|NCT01959529|566027303|FG000|Overall Study|Lost to Follow-up|4|||
156801212|NCT01959529|566027304|FG001|Overall Study|Lost to Follow-up|1|||
156801213|NCT01959529|566027303|FG000|Overall Study|Other|70|||
156801214|NCT01959529|566027304|FG001|Overall Study|Other|68|||
156801215|NCT01959529|566027303|FG000|Overall Study|Hypoglycaemia|1|||
156801216|NCT01959529|566027304|FG001|Overall Study|Hypoglycaemia|1|||
156801217|NCT01959529|566027303|FG000|Overall Study|Lack of glycaemic control|1|||
156801218|NCT01959529|566027304|FG001|Overall Study|Lack of glycaemic control|1|||
156801219|NCT00560417|566027312|FG000|Overall Study|Adverse Event|3|||
156459337|NCT03295721|564776794|FG002|Overall Study|Lost to Follow-up|1|||
156459338|NCT03295721|564776792|FG000|Overall Study|Withdrawal by Subject|1|||
156459339|NCT03295721|564776793|FG001|Overall Study|Withdrawal by Subject|0|||
156459340|NCT03295721|564776794|FG002|Overall Study|Withdrawal by Subject|1|||
156459341|NCT03295721|564776792|FG000|Overall Study|Death|0|||
156459342|NCT03295721|564776793|FG001|Overall Study|Death|0|||
156459343|NCT03295721|564776794|FG002|Overall Study|Death|1|||
156459344|NCT01651403|564776796|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
156459345|NCT01651403|564776797|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
156459346|NCT01651403|564776796|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
156459347|NCT01651403|564776797|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
156459348|NCT01651403|564776796|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
156459349|NCT01651403|564776797|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
156537127|NCT00467779|565061102|FG007|Stage 1|Disease Progression|5|||
156459350|NCT01651403|564776796|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
156459351|NCT01651403|564776797|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
156459352|NCT01651403|564776796|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
156459353|NCT01651403|564776797|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
156459354|NCT01651403|564776796|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
156459355|NCT01651403|564776797|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
156459356|NCT05090683|564776798|FG000|Overall Study|Lost to Follow-up|10|||
156459357|NCT05090683|564776799|FG001|Overall Study|Lost to Follow-up|2|||
156459358|NCT05090683|564776798|FG000|Overall Study|Withdrawal by Subject|15|||
156459359|NCT05090683|564776799|FG001|Overall Study|Withdrawal by Subject|0|||
156459360|NCT03325985|564776800|FG000|Overall Study|Lost to Follow-up|122|||
156459361|NCT03325985|564776801|FG001|Overall Study|Lost to Follow-up|26|||
156459362|NCT03325985|564776802|FG002|Overall Study|Lost to Follow-up|141|||
156459363|NCT03325985|564776803|FG003|Overall Study|Lost to Follow-up|28|||
156459364|NCT03325985|564776800|FG000|Overall Study|Death|99|||
156459365|NCT03325985|564776801|FG001|Overall Study|Death|36|||
156459366|NCT03325985|564776802|FG002|Overall Study|Death|94|||
156459367|NCT03325985|564776803|FG003|Overall Study|Death|32|||
156801220|NCT00560417|566027313|FG001|Overall Study|Adverse Event|2|||
156801221|NCT00560417|566027312|FG000|Overall Study|Entry Criteria Not Met|1|||
156801222|NCT00560417|566027313|FG001|Overall Study|Entry Criteria Not Met|0|||
156801223|NCT00560417|566027312|FG000|Overall Study|Lost to Follow-up|0|||
156801224|NCT00560417|566027313|FG001|Overall Study|Lost to Follow-up|1|||
156801225|NCT00560417|566027312|FG000|Overall Study|Physician Decision|2|||
156801226|NCT00560417|566027313|FG001|Overall Study|Physician Decision|6|||
156801227|NCT00560417|566027312|FG000|Overall Study|Protocol Violation|6|||
156801228|NCT00560417|566027313|FG001|Overall Study|Protocol Violation|5|||
156801229|NCT00560417|566027312|FG000|Overall Study|Sponsor Decision|2|||
156801230|NCT00560417|566027313|FG001|Overall Study|Sponsor Decision|0|||
156801231|NCT00560417|566027312|FG000|Overall Study|Withdrawal by Subject|3|||
156801232|NCT00560417|566027313|FG001|Overall Study|Withdrawal by Subject|3|||
156459368|NCT03213665|564776804|FG000|Overall Study|Adverse Event|1|||
156459369|NCT03213665|564776804|FG000|Overall Study|Physician Decision|2|||
156459370|NCT03213665|564776804|FG000|Overall Study|Withdrawal by Subject|3|||
156801233|NCT02164864|566027314|FG000|Overall Study|Trial disease worsening|7|||
156801234|NCT02164864|566027315|FG001|Overall Study|Trial disease worsening|5|||
156801235|NCT02164864|566027316|FG002|Overall Study|Trial disease worsening|1|||
156801236|NCT02164864|566027314|FG000|Overall Study|Other pre-existing disease worsening|6|||
156801237|NCT02164864|566027315|FG001|Overall Study|Other pre-existing disease worsening|4|||
156801238|NCT02164864|566027316|FG002|Overall Study|Other pre-existing disease worsening|9|||
156801239|NCT02164864|566027314|FG000|Overall Study|Other Adverse Event (AE)|52|||
156801240|NCT02164864|566027315|FG001|Overall Study|Other Adverse Event (AE)|32|||
156801241|NCT02164864|566027316|FG002|Overall Study|Other Adverse Event (AE)|49|||
156801242|NCT02164864|566027314|FG000|Overall Study|Protocol Violation|2|||
156801243|NCT02164864|566027315|FG001|Overall Study|Protocol Violation|4|||
156801244|NCT02164864|566027316|FG002|Overall Study|Protocol Violation|1|||
156801245|NCT02164864|566027314|FG000|Overall Study|Lost to Follow-up|4|||
156801246|NCT02164864|566027315|FG001|Overall Study|Lost to Follow-up|3|||
156801247|NCT02164864|566027316|FG002|Overall Study|Lost to Follow-up|2|||
156801248|NCT02164864|566027314|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
156801249|NCT02164864|566027315|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
156801250|NCT02164864|566027316|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
156801251|NCT02164864|566027314|FG000|Overall Study|Other than stated|3|||
156801252|NCT02164864|566027315|FG001|Overall Study|Other than stated|4|||
156801253|NCT02164864|566027316|FG002|Overall Study|Other than stated|14|||
156801254|NCT00652834|566027317|FG000|Overall Study|Withdrawal by Subject|3|||
156801255|NCT00652834|566027317|FG000|Overall Study|Lost to Follow-up|2|||
156801256|NCT00320606|566027318|FG000|Overall Study|Adverse Event|1|||
156801257|NCT00320606|566027318|FG000|Overall Study|Protocol Violation|1|||
156801258|NCT00320606|566027318|FG000|Overall Study|Withdrawal by Subject|1|||
156801259|NCT03984825|566027319|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
156801260|NCT03984825|566027319|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
156801261|NCT03984825|566027319|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
156801262|NCT00261833|566027320|FG000|Overall Study|Death|1|||
156801263|NCT00261833|566027321|FG001|Overall Study|Death|3|||
156801264|NCT00261833|566027320|FG000|Overall Study|Adverse Event|1|||
156801265|NCT00261833|566027321|FG001|Overall Study|Adverse Event|4|||
156801266|NCT00261833|566027320|FG000|Overall Study|Withdrawal by Subject|5|||
156801267|NCT00261833|566027321|FG001|Overall Study|Withdrawal by Subject|7|||
156801268|NCT00261833|566027320|FG000|Overall Study|Protocol Violation|0|||
156801269|NCT00261833|566027321|FG001|Overall Study|Protocol Violation|1|||
156801270|NCT00261833|566027320|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
156801271|NCT00261833|566027321|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
156801272|NCT00261833|566027320|FG000|Overall Study|Lung transplantation|1|||
156801273|NCT00261833|566027321|FG001|Overall Study|Lung transplantation|1|||
156801274|NCT00261833|566027320|FG000|Overall Study|Missing reason|1|||
156801275|NCT00261833|566027321|FG001|Overall Study|Missing reason|0|||
156801276|NCT00261833|566027320|FG000|Overall Study|Not interested in being participant|0|||
156801277|NCT00261833|566027321|FG001|Overall Study|Not interested in being participant|1|||
156801278|NCT00622726|566027322|FG000|March, 2008 to August, 2010|Death|5|||
156801279|NCT00622726|566027323|FG001|March, 2008 to August, 2010|Death|2|||
156801280|NCT00622726|566027322|FG000|August, 2010 to April, 2013|Death|1|||
156801281|NCT00622726|566027323|FG001|August, 2010 to April, 2013|Death|5|||
156801282|NCT00854360|566027326|FG000|Overall Study|Adverse Event|0|||
156801283|NCT00854360|566027327|FG001|Overall Study|Adverse Event|1|||
156801284|NCT00854360|566027328|FG002|Overall Study|Adverse Event|2|||
156801285|NCT00854360|566027329|FG003|Overall Study|Adverse Event|6|||
156801286|NCT00854360|566027326|FG000|Overall Study|Withdrawal by Subject|0|||
156801287|NCT00854360|566027327|FG001|Overall Study|Withdrawal by Subject|0|||
156801288|NCT00854360|566027328|FG002|Overall Study|Withdrawal by Subject|0|||
156801289|NCT00854360|566027329|FG003|Overall Study|Withdrawal by Subject|1|||
156801290|NCT00854360|566027326|FG000|Overall Study|Pregnancy|0|||
156801291|NCT00854360|566027327|FG001|Overall Study|Pregnancy|1|||
156801292|NCT00854360|566027328|FG002|Overall Study|Pregnancy|0|||
156801293|NCT00854360|566027329|FG003|Overall Study|Pregnancy|0|||
156801294|NCT00854360|566027326|FG000|Overall Study|Lack of Efficacy|2|||
156801295|NCT00854360|566027327|FG001|Overall Study|Lack of Efficacy|1|||
156801296|NCT00854360|566027328|FG002|Overall Study|Lack of Efficacy|0|||
156801297|NCT00854360|566027329|FG003|Overall Study|Lack of Efficacy|0|||
156801298|NCT00854360|566027326|FG000|Overall Study|Other|0|||
156801299|NCT00854360|566027327|FG001|Overall Study|Other|0|||
156801300|NCT00854360|566027328|FG002|Overall Study|Other|0|||
156801301|NCT00854360|566027329|FG003|Overall Study|Other|3|||
156537128|NCT00467779|565061103|FG008|Stage 1|Disease Progression|0|||
156801302|NCT00399529|566027330|FG000|Overall Study|Off Study Prior to Treatment|2|||
156801303|NCT01170663|566027331|FG000|Overall Study|Lost to Follow-up|3|||
156801304|NCT01170663|566027332|FG001|Overall Study|Lost to Follow-up|9|||
156801305|NCT01170663|566027331|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
156801306|NCT01170663|566027332|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
156801307|NCT03189719|566027333|FG000|Overall Study|Death|325|||
156801308|NCT03189719|566027334|FG001|Overall Study|Death|361|||
156537129|NCT00467779|565061104|FG009|Stage 1|Disease Progression|0|||
156801309|NCT03189719|566027333|FG000|Overall Study|Physician Decision|1|||
156801310|NCT03189719|566027334|FG001|Overall Study|Physician Decision|0|||
156337492|NCT02319837|564333650|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
156337493|NCT02319837|564333648|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
156337494|NCT02319837|564333649|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
156337495|NCT02319837|564333650|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
156337496|NCT02319837|564333648|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
156337497|NCT02319837|564333649|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
156337498|NCT02319837|564333650|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
156337499|NCT02319837|564333648|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
156337500|NCT02319837|564333649|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
156337501|NCT02319837|564333650|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
156337502|NCT02319837|564333648|FG000|Long-Term Follow-Up Phase|Death|33|||
156337503|NCT02319837|564333649|FG001|Long-Term Follow-Up Phase|Death|54|||
156337504|NCT02319837|564333650|FG002|Long-Term Follow-Up Phase|Death|42|||
156337505|NCT00753766|564333651|FG000|Overall Study|Physician Decision|1|||
156337506|NCT00753766|564333652|FG001|Overall Study|Physician Decision|0|||
156337507|NCT01206166|564333653|FG000|Overall Study|No evaluable data|2|||
156337508|NCT01206166|564333654|FG001|Overall Study|No evaluable data|3|||
156337509|NCT05306977|564333659|FG000|Overall Study|Withdrawal by Subject|1|||
156337510|NCT00415168|564333660|FG000|Overall Study|Death|26|||
156337511|NCT00415168|564333660|FG000|Overall Study|Lost to Follow-up|3|||
156337512|NCT00415168|564333660|FG000|Overall Study|Physician Decision|13|||
156337513|NCT00415168|564333660|FG000|Overall Study|Sponsor Decision|4|||
156337514|NCT00415168|564333660|FG000|Overall Study|Withdrawal by Subject|6|||
156337515|NCT00241358|564333661|FG000|Overall Study|Determined to be not ineligible|0|||
156337516|NCT00241358|564333662|FG001|Overall Study|Determined to be not ineligible|1|||
156801311|NCT03189719|566027333|FG000|Overall Study|Sponsor Decision|40|||
156801312|NCT03189719|566027334|FG001|Overall Study|Sponsor Decision|12|||
156801313|NCT03189719|566027333|FG000|Overall Study|Withdrawal by Subject|7|||
156801314|NCT03189719|566027334|FG001|Overall Study|Withdrawal by Subject|3|||
156801315|NCT03012880|566027335|FG000|Overall Study|Withdrawal by Subject|1|||
156801316|NCT03012880|566027336|FG001|Overall Study|Withdrawal by Subject|0|||
156801317|NCT03012880|566027335|FG000|Overall Study|Ineligible|1|||
156801318|NCT03012880|566027336|FG001|Overall Study|Ineligible|0|||
156801319|NCT01355627|566027337|FG000|Overall Study|Request By the Patient to Discontinue|5|||
156801320|NCT01355627|566027338|FG001|Overall Study|Request By the Patient to Discontinue|7|||
156801321|NCT01355627|566027337|FG000|Overall Study|Lost to Follow-up|8|||
156801322|NCT01355627|566027338|FG001|Overall Study|Lost to Follow-up|7|||
156801323|NCT01355627|566027337|FG000|Overall Study|Fatal Adverse Event|19|||
156801324|NCT01355627|566027338|FG001|Overall Study|Fatal Adverse Event|23|||
156801325|NCT01355627|566027337|FG000|Overall Study|Other|1|||
156801326|NCT01355627|566027338|FG001|Overall Study|Other|1|||
156801327|NCT02781558|566027339|FG000|Overall Study|Lost to Follow-up|2|||
156801328|NCT02781558|566027340|FG001|Overall Study|Lost to Follow-up|2|||
156801329|NCT02781558|566027339|FG000|Overall Study|Adverse Event|1|||
156801330|NCT02781558|566027340|FG001|Overall Study|Adverse Event|0|||
156801331|NCT04756531|566027345|FG000|Overall Study|Adverse Event|0|||
156801332|NCT04756531|566027346|FG001|Overall Study|Adverse Event|0|||
156801333|NCT04756531|566027347|FG002|Overall Study|Adverse Event|0|||
156801334|NCT04756531|566027348|FG003|Overall Study|Adverse Event|0|||
156801335|NCT04756531|566027349|FG004|Overall Study|Adverse Event|1|||
156801336|NCT04756531|566027350|FG005|Overall Study|Adverse Event|0|||
156801337|NCT04756531|566027351|FG006|Overall Study|Adverse Event|0|||
156801338|NCT04756531|566027352|FG007|Overall Study|Adverse Event|0|||
156801339|NCT04756531|566027353|FG008|Overall Study|Adverse Event|0|||
156801340|NCT04756531|566027354|FG009|Overall Study|Adverse Event|0|||
156801341|NCT04756531|566027355|FG010|Overall Study|Adverse Event|0|||
156801342|NCT04756531|566027356|FG011|Overall Study|Adverse Event|0|||
156801343|NCT04756531|566027357|FG012|Overall Study|Adverse Event|0|||
156801344|NCT04756531|566027358|FG013|Overall Study|Adverse Event|0|||
156801345|NCT04756531|566027359|FG014|Overall Study|Adverse Event|0|||
156801346|NCT04756531|566027360|FG015|Overall Study|Adverse Event|0|||
156801347|NCT04756531|566027361|FG016|Overall Study|Adverse Event|0|||
156801348|NCT04756531|566027362|FG017|Overall Study|Adverse Event|0|||
156801349|NCT04756531|566027345|FG000|Overall Study|Withdrawal by Subject|0|||
156801350|NCT04756531|566027346|FG001|Overall Study|Withdrawal by Subject|0|||
156801351|NCT04756531|566027347|FG002|Overall Study|Withdrawal by Subject|0|||
156801352|NCT04756531|566027348|FG003|Overall Study|Withdrawal by Subject|0|||
156801353|NCT04756531|566027349|FG004|Overall Study|Withdrawal by Subject|0|||
156801354|NCT04756531|566027350|FG005|Overall Study|Withdrawal by Subject|0|||
156801355|NCT04756531|566027351|FG006|Overall Study|Withdrawal by Subject|1|||
156801356|NCT04756531|566027352|FG007|Overall Study|Withdrawal by Subject|0|||
156801357|NCT04756531|566027353|FG008|Overall Study|Withdrawal by Subject|0|||
156801358|NCT04756531|566027354|FG009|Overall Study|Withdrawal by Subject|0|||
156801359|NCT04756531|566027355|FG010|Overall Study|Withdrawal by Subject|0|||
156801360|NCT04756531|566027356|FG011|Overall Study|Withdrawal by Subject|0|||
156801361|NCT04756531|566027357|FG012|Overall Study|Withdrawal by Subject|0|||
156801362|NCT04756531|566027358|FG013|Overall Study|Withdrawal by Subject|0|||
156801363|NCT04756531|566027359|FG014|Overall Study|Withdrawal by Subject|0|||
156801364|NCT04756531|566027360|FG015|Overall Study|Withdrawal by Subject|0|||
156801365|NCT04756531|566027361|FG016|Overall Study|Withdrawal by Subject|0|||
156801366|NCT04756531|566027362|FG017|Overall Study|Withdrawal by Subject|0|||
156801367|NCT02257528|566027363|FG000|Overall Study|Never received study treatment|1|||
156801368|NCT04237584|566027366|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
156801369|NCT04237584|566027367|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
156801370|NCT04237584|566027368|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
156801371|NCT04237584|566027369|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
156801372|NCT04237584|566027366|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
156801373|NCT04237584|566027367|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
156801374|NCT04237584|566027368|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
156801375|NCT04237584|566027369|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
156801376|NCT04237584|566027366|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
156801377|NCT04237584|566027367|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
156801378|NCT04237584|566027368|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
156801379|NCT04237584|566027369|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
156801380|NCT04237584|566027366|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
156801381|NCT04237584|566027367|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
156801382|NCT04237584|566027368|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
156801383|NCT04237584|566027369|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
156801384|NCT04237584|566027366|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
156801385|NCT04237584|566027367|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
156801386|NCT04237584|566027368|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
156801387|NCT04237584|566027369|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
156801388|NCT02465931|566029187|FG000|Overall Study|Lost to Follow-up|9|||
156801389|NCT02465931|566029188|FG001|Overall Study|Lost to Follow-up|11|||
156801390|NCT02465931|566029187|FG000|Overall Study|Protocol Violation|1|||
156801391|NCT02465931|566029188|FG001|Overall Study|Protocol Violation|0|||
156801392|NCT02465931|566029187|FG000|Overall Study|Withdrawal by Subject|1|||
156801393|NCT02465931|566029188|FG001|Overall Study|Withdrawal by Subject|0|||
156801394|NCT04778592|566029192|FG000|Overall Study|Adverse Event|1|||
156801395|NCT04778592|566029193|FG001|Overall Study|Adverse Event|2|||
156801396|NCT04778592|566029192|FG000|Overall Study|Withdrawal by Subject|1|||
156801397|NCT04778592|566029193|FG001|Overall Study|Withdrawal by Subject|2|||
156801398|NCT03423121|566029194|FG000|Overall Study|Lost to Follow-up|2|||
156801399|NCT03423121|566029195|FG001|Overall Study|Lost to Follow-up|6|||
156801400|NCT03423121|566029194|FG000|Overall Study|Adverse Event|1|||
156801401|NCT03423121|566029195|FG001|Overall Study|Adverse Event|0|||
156801402|NCT01354223|566029196|FG000|Overall Study|Withdrawal by Subject|3|||
156801403|NCT01354223|566029197|FG001|Overall Study|Withdrawal by Subject|1|||
156801404|NCT00524121|566029207|FG000|Overall Study|Disease progression|6|||
156801405|NCT00524121|566029207|FG000|Overall Study|Adverse Event|4|||
156801406|NCT00524121|566029207|FG000|Overall Study|Patient refused|2|||
156801407|NCT00524121|566029207|FG000|Overall Study|Other|1|||
156801408|NCT00524121|566029207|FG000|Overall Study|Death|1|||
156801409|NCT00524121|566029207|FG000|Overall Study|Not treated (became ineligible)|4|||
156801410|NCT00524121|566029207|FG000|Overall Study|Not treated (changed mind)|1|||
156801411|NCT04047446|566029208|FG000|Overall Study|Physician Decision|1|||
156801412|NCT04047446|566029209|FG001|Overall Study|Physician Decision|0|||
156801413|NCT01840943|566029210|FG000|Overall Study|Withdrawal by Subject|5|||
156801414|NCT01840943|566029211|FG001|Overall Study|Withdrawal by Subject|6|||
156801415|NCT01840943|566029210|FG000|Overall Study|Physician Decision|4|||
156801416|NCT01840943|566029211|FG001|Overall Study|Physician Decision|2|||
156801417|NCT01840943|566029210|FG000|Overall Study|Lost to Follow-up|4|||
156801418|NCT01840943|566029211|FG001|Overall Study|Lost to Follow-up|4|||
156801419|NCT00329420|566029212|FG000|Re-induction Phase|Lack of Efficacy|0|||
156801420|NCT00329420|566029213|FG001|Re-induction Phase|Lack of Efficacy|1|||
156801421|NCT00329420|566029214|FG002|Re-induction Phase|Lack of Efficacy|0|||
156337517|NCT00241358|564333663|FG002|Overall Study|Determined to be not ineligible|1|||
156337518|NCT00843856|564333664|FG000|Overall Study|Lost to Follow-up|1|||
156801422|NCT00329420|566029212|FG000|Re-induction Phase|Withdrawal of Consent|0|||
156537130|NCT00467779|565061105|FG010|Stage 1|Disease Progression|0|||
156801423|NCT00329420|566029213|FG001|Re-induction Phase|Withdrawal of Consent|0|||
156801424|NCT00329420|566029214|FG002|Re-induction Phase|Withdrawal of Consent|1|||
156801425|NCT00329420|566029212|FG000|Re-induction Phase|Did not respond to re-induction|6|||
156337519|NCT00843856|564333665|FG001|Overall Study|Lost to Follow-up|2|||
156801426|NCT00329420|566029213|FG001|Re-induction Phase|Did not respond to re-induction|5|||
156801427|NCT00329420|566029214|FG002|Re-induction Phase|Did not respond to re-induction|7|||
156801428|NCT00329420|566029212|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
156801429|NCT00329420|566029213|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
156801430|NCT00329420|566029214|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
156801431|NCT00329420|566029212|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
156801432|NCT00329420|566029213|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
156801433|NCT00329420|566029214|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
156801434|NCT00329420|566029212|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
156801435|NCT00329420|566029213|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
156801436|NCT00329420|566029214|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
156801437|NCT01446874|566029215|FG000|Overall Study|Not eligible|1|||
156801438|NCT01446874|566029216|FG001|Overall Study|Not eligible|0|||
156801439|NCT01446874|566029217|FG002|Overall Study|Not eligible|0|||
156801440|NCT01446874|566029215|FG000|Overall Study|No surgery/No qualifying surgery|1|||
156801441|NCT01446874|566029216|FG001|Overall Study|No surgery/No qualifying surgery|0|||
156801442|NCT01446874|566029217|FG002|Overall Study|No surgery/No qualifying surgery|12|||
156801443|NCT01446874|566029215|FG000|Overall Study|Non-compliance|0|||
156801444|NCT01446874|566029216|FG001|Overall Study|Non-compliance|4|||
156801445|NCT01446874|566029217|FG002|Overall Study|Non-compliance|0|||
156801446|NCT01446874|566029215|FG000|Overall Study|Antibiotics for pre-op infection|0|||
156801447|NCT01446874|566029216|FG001|Overall Study|Antibiotics for pre-op infection|0|||
156801448|NCT01446874|566029217|FG002|Overall Study|Antibiotics for pre-op infection|2|||
156801449|NCT01446874|566029215|FG000|Overall Study|Withdrawal by Subject|0|||
156801450|NCT01446874|566029216|FG001|Overall Study|Withdrawal by Subject|0|||
156801451|NCT01446874|566029217|FG002|Overall Study|Withdrawal by Subject|4|||
156801452|NCT02746809|566029218|FG000|Enrollment|Inclusion Exclusion not met|9|||
156801453|NCT02746809|566029218|FG000|Enrollment|Withdrawal by Subject|1|||
156801454|NCT02746809|566029218|FG000|Enrollment|Expected Enrollment Met|2|||
156801455|NCT02746809|566029218|FG000|Procedure|Death|1|||
156801456|NCT02746809|566029218|FG000|1-Month|Death|5|||
156801457|NCT02746809|566029218|FG000|6-Month|Death|2|||
156801458|NCT02746809|566029218|FG000|6-Month|Withdrawal by Subject|1|||
156801459|NCT02746809|566029218|FG000|12-Month|Death|3|||
156801460|NCT02746809|566029218|FG000|12-Month|Withdrawal by Subject|2|||
156801461|NCT02746809|566029218|FG000|24-Month|Death|1|||
156801462|NCT02746809|566029218|FG000|24-Month|Withdrawal by Subject|1|||
156801463|NCT02746809|566029218|FG000|36-Month|Death|8|||
156801464|NCT02746809|566029218|FG000|36-Month|Withdrawal by Subject|1|||
156801465|NCT02746809|566029218|FG000|48-Month|Death|7|||
156801466|NCT02746809|566029218|FG000|48-Month|Withdrawal by Subject|1|||
156801467|NCT02746809|566029218|FG000|60-Month|Death|1|||
156801468|NCT02746809|566029218|FG000|60-Month|Lost to Follow-up|2|||
156801469|NCT00742625|566029222|FG000|Remission Induction|Progression|6|||
156801470|NCT00742625|566029222|FG000|Remission Induction|Failed induction|8|||
156801471|NCT00742625|566029222|FG000|Remission Induction|Adverse Event|3|||
156801472|NCT00742625|566029222|FG000|Remission Induction|Death|10|||
156801473|NCT00742625|566029222|FG000|Remission Induction|Refusal|5|||
156801474|NCT00742625|566029222|FG000|Remission Induction|Non protocol treatment|17|||
156801475|NCT00742625|566029222|FG000|Remission Induction|Other, not specified|5|||
156801476|NCT00742625|566029222|FG000|Consolidation|Progression|5|||
156801477|NCT00742625|566029222|FG000|Consolidation|Adverse Event|1|||
156801478|NCT00742625|566029222|FG000|Consolidation|Death|1|||
156801479|NCT00742625|566029222|FG000|Consolidation|Refused|1|||
156801480|NCT00742625|566029222|FG000|Consolidation|Non protocol therapy|13|||
156801481|NCT01164007|566029223|FG000|Overall Study|Adverse Event|5|||
156801482|NCT01164007|566029223|FG000|Overall Study|Progression of Disease|30|||
156801483|NCT01164007|566029223|FG000|Overall Study|Protocol Violation|1|||
156801484|NCT01164007|566029223|FG000|Overall Study|Withdrawal by Subject|1|||
156801485|NCT01164007|566029223|FG000|Overall Study|Medical Decision|3|||
156801486|NCT00894387|566029224|FG000|Overall Study|Adverse Event|44|||
156801487|NCT00894387|566029225|FG001|Overall Study|Adverse Event|45|||
156801488|NCT00894387|566029224|FG000|Overall Study|Abnormal Laboratory values|2|||
156801489|NCT00894387|566029225|FG001|Overall Study|Abnormal Laboratory values|2|||
156801490|NCT00894387|566029224|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156801491|NCT00894387|566029225|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156801492|NCT00894387|566029224|FG000|Overall Study|Lost to Follow-up|3|||
156801493|NCT00894387|566029225|FG001|Overall Study|Lost to Follow-up|5|||
156801494|NCT00894387|566029224|FG000|Overall Study|Administrative problems|2|||
156801495|NCT00894387|566029225|FG001|Overall Study|Administrative problems|2|||
156801496|NCT00894387|566029224|FG000|Overall Study|Death|77|||
156801497|NCT00894387|566029225|FG001|Overall Study|Death|76|||
156801498|NCT00894387|566029224|FG000|Overall Study|Protocol Deviation|4|||
156801499|NCT00894387|566029225|FG001|Overall Study|Protocol Deviation|0|||
156801500|NCT00894387|566029224|FG000|Overall Study|Patient's request|25|||
156801501|NCT00894387|566029225|FG001|Overall Study|Patient's request|30|||
156801502|NCT00894387|566029224|FG000|Overall Study|Other (Missing)|5|||
156801503|NCT00894387|566029225|FG001|Overall Study|Other (Missing)|3|||
156801504|NCT00894387|566029224|FG000|Overall Study|Mis-randomized|13|||
156801505|NCT00894387|566029225|FG001|Overall Study|Mis-randomized|9|||
156801506|NCT00894387|566029224|FG000|Overall Study|GCP non-compliance|0|||
156801507|NCT00894387|566029225|FG001|Overall Study|GCP non-compliance|2|||
156801508|NCT01076010|566029226|FG000|Overall Study|Death|15|||
156801509|NCT01076010|566029227|FG001|Overall Study|Death|1|||
156801510|NCT01076010|566029228|FG002|Overall Study|Death|0|||
156801511|NCT01076010|566029226|FG000|Overall Study|Adverse Event|7|||
156801512|NCT01076010|566029227|FG001|Overall Study|Adverse Event|2|||
156801513|NCT01076010|566029228|FG002|Overall Study|Adverse Event|0|||
156801514|NCT01076010|566029226|FG000|Overall Study|Progressive disease|90|||
156801515|NCT01076010|566029227|FG001|Overall Study|Progressive disease|30|||
156801516|NCT01076010|566029228|FG002|Overall Study|Progressive disease|1|||
156801517|NCT01076010|566029226|FG000|Overall Study|Lack of Efficacy|4|||
156801518|NCT01076010|566029227|FG001|Overall Study|Lack of Efficacy|0|||
156801519|NCT01076010|566029228|FG002|Overall Study|Lack of Efficacy|0|||
156801520|NCT01076010|566029226|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
156801521|NCT01076010|566029227|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
156801522|NCT01076010|566029228|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
156801523|NCT01076010|566029226|FG000|Overall Study|Significant Surgical Procedure|0|||
156801524|NCT01076010|566029227|FG001|Overall Study|Significant Surgical Procedure|1|||
156801525|NCT01076010|566029228|FG002|Overall Study|Significant Surgical Procedure|0|||
156801526|NCT01076010|566029226|FG000|Overall Study|Protocol Violation|0|||
156801527|NCT01076010|566029227|FG001|Overall Study|Protocol Violation|1|||
156801528|NCT01076010|566029228|FG002|Overall Study|Protocol Violation|0|||
156801529|NCT01076010|566029226|FG000|Overall Study|Noncompliance|1|||
156801530|NCT01076010|566029227|FG001|Overall Study|Noncompliance|1|||
156801531|NCT01076010|566029228|FG002|Overall Study|Noncompliance|0|||
156801532|NCT01076010|566029226|FG000|Overall Study|Withdrawal by Subject|3|||
156801533|NCT01076010|566029227|FG001|Overall Study|Withdrawal by Subject|0|||
156801534|NCT01076010|566029228|FG002|Overall Study|Withdrawal by Subject|1|||
156801535|NCT01076010|566029226|FG000|Overall Study|Other|5|||
156801536|NCT01076010|566029227|FG001|Overall Study|Other|2|||
156801537|NCT01076010|566029228|FG002|Overall Study|Other|0|||
156801538|NCT01612676|566029229|FG000|Overall Study|Adverse Event|2|||
156801539|NCT01612676|566029230|FG001|Overall Study|Adverse Event|3|||
156801540|NCT01612676|566029231|FG002|Overall Study|Adverse Event|1|||
156801541|NCT01612676|566029232|FG003|Overall Study|Adverse Event|3|||
156801542|NCT01612676|566029229|FG000|Overall Study|Protocol Violation|0|||
156801543|NCT01612676|566029230|FG001|Overall Study|Protocol Violation|1|||
156801544|NCT01612676|566029231|FG002|Overall Study|Protocol Violation|0|||
156801545|NCT01612676|566029232|FG003|Overall Study|Protocol Violation|0|||
156801546|NCT01156844|566029235|FG000|Overall Study|Adverse Event|0|||
156801547|NCT01156844|566029236|FG001|Overall Study|Adverse Event|0|||
156801548|NCT01156844|566029237|FG002|Overall Study|Adverse Event|1|||
156801549|NCT01156844|566029238|FG003|Overall Study|Adverse Event|1|||
156801550|NCT01156844|566029235|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156801551|NCT01156844|566029236|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156801552|NCT01156844|566029237|FG002|Overall Study|Abnormal test procedure result(s)|2|||
156801553|NCT01156844|566029238|FG003|Overall Study|Abnormal test procedure result(s)|2|||
156801554|NCT01156844|566029235|FG000|Overall Study|Withdrawal by Subject|0|||
156801555|NCT01156844|566029236|FG001|Overall Study|Withdrawal by Subject|0|||
156801556|NCT01156844|566029237|FG002|Overall Study|Withdrawal by Subject|2|||
156801557|NCT01156844|566029238|FG003|Overall Study|Withdrawal by Subject|2|||
156801558|NCT01156844|566029235|FG000|Overall Study|Lost to Follow-up|0|||
156537131|NCT00467779|565061106|FG011|Stage 1|Disease Progression|0|||
156801559|NCT01156844|566029236|FG001|Overall Study|Lost to Follow-up|0|||
156801560|NCT01156844|566029237|FG002|Overall Study|Lost to Follow-up|1|||
156801561|NCT01156844|566029238|FG003|Overall Study|Lost to Follow-up|0|||
156801562|NCT01156844|566029235|FG000|Overall Study|Administrative problems|0|||
156801563|NCT01156844|566029236|FG001|Overall Study|Administrative problems|1|||
156801564|NCT01156844|566029237|FG002|Overall Study|Administrative problems|0|||
156801565|NCT01156844|566029238|FG003|Overall Study|Administrative problems|1|||
156801566|NCT01156844|566029235|FG000|Overall Study|Protocol deviation|2|||
156801567|NCT01156844|566029236|FG001|Overall Study|Protocol deviation|0|||
156801568|NCT01156844|566029237|FG002|Overall Study|Protocol deviation|0|||
156801569|NCT01156844|566029238|FG003|Overall Study|Protocol deviation|0|||
156801570|NCT01130337|566029242|FG000|Overall Study|Withdrawal by Subject|3|||
156801571|NCT01130337|566029242|FG000|Overall Study|Principal investigator decision|1|||
156801572|NCT01130337|566029242|FG000|Overall Study|Death|1|||
156801573|NCT01130337|566029242|FG000|Overall Study|Disease progression|1|||
156801574|NCT01130337|566029242|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
156801575|NCT01130337|566029242|FG000|Overall Study|Surgical resection (R2)|1|||
156801576|NCT03886493|566029243|FG000|Overall Study|Adverse Event|1|||
156801577|NCT04661033|566029244|FG000|Overall Study|Adverse Event|0|||
156801578|NCT04661033|566029245|FG001|Overall Study|Adverse Event|0|||
156801579|NCT04661033|566029246|FG002|Overall Study|Adverse Event|1|||
156801580|NCT04661033|566029247|FG003|Overall Study|Adverse Event|0|||
156801581|NCT04661033|566029244|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
156801582|NCT04661033|566029245|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
156801583|NCT04661033|566029246|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
156801584|NCT04661033|566029247|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
156801585|NCT04661033|566029244|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
156801586|NCT04661033|566029245|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
156801587|NCT04661033|566029246|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
156801588|NCT04661033|566029247|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
156801589|NCT04661033|566029244|FG000|Overall Study|Early discontinuation as per PI|1|||
156537132|NCT00467779|565061107|FG012|Stage 1|Disease Progression|0|||
156801590|NCT04661033|566029245|FG001|Overall Study|Early discontinuation as per PI|0|||
156801591|NCT04661033|566029246|FG002|Overall Study|Early discontinuation as per PI|0|||
156801592|NCT04661033|566029247|FG003|Overall Study|Early discontinuation as per PI|0|||
156801593|NCT05200845|566029250|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
156801594|NCT05200845|566029251|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
156801595|NCT05200845|566029252|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
156801596|NCT05200845|566029253|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
156801597|NCT05200845|566029250|FG000|Overall Study|Withdrawal by Subject|0|||
156801598|NCT05200845|566029251|FG001|Overall Study|Withdrawal by Subject|1|||
156801599|NCT05200845|566029252|FG002|Overall Study|Withdrawal by Subject|1|||
156801600|NCT05200845|566029253|FG003|Overall Study|Withdrawal by Subject|0|||
156801601|NCT00565409|566029258|FG000|Period 1 Open Label|Adverse Event|17|||
156801602|NCT00565409|566029259|FG001|Period 1 Open Label|Adverse Event|0|||
156801603|NCT00565409|566029260|FG002|Period 1 Open Label|Adverse Event|0|||
156801604|NCT00565409|566029261|FG003|Period 1 Open Label|Adverse Event|0|||
156801605|NCT00565409|566029258|FG000|Period 1 Open Label|Death|2|||
156801606|NCT00565409|566029259|FG001|Period 1 Open Label|Death|0|||
156801607|NCT00565409|566029260|FG002|Period 1 Open Label|Death|0|||
156801608|NCT00565409|566029261|FG003|Period 1 Open Label|Death|0|||
156801609|NCT00565409|566029258|FG000|Period 1 Open Label|Lost to Follow-up|1|||
156801610|NCT00565409|566029259|FG001|Period 1 Open Label|Lost to Follow-up|0|||
156801611|NCT00565409|566029260|FG002|Period 1 Open Label|Lost to Follow-up|0|||
156801612|NCT00565409|566029261|FG003|Period 1 Open Label|Lost to Follow-up|0|||
156801613|NCT00565409|566029258|FG000|Period 1 Open Label|Other|21|||
156801614|NCT00565409|566029259|FG001|Period 1 Open Label|Other|0|||
156801615|NCT00565409|566029260|FG002|Period 1 Open Label|Other|0|||
156801616|NCT00565409|566029261|FG003|Period 1 Open Label|Other|0|||
156801617|NCT00565409|566029258|FG000|Period 1 Open Label|Protocol Violation|14|||
156801618|NCT00565409|566029259|FG001|Period 1 Open Label|Protocol Violation|0|||
156801619|NCT00565409|566029260|FG002|Period 1 Open Label|Protocol Violation|0|||
156801620|NCT00565409|566029261|FG003|Period 1 Open Label|Protocol Violation|0|||
156801621|NCT00565409|566029258|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
156801622|NCT00565409|566029259|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
156801623|NCT00565409|566029260|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
156801624|NCT00565409|566029261|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
156801625|NCT00565409|566029258|FG000|Period 1 Open Label|no conclusion of participation record|1|||
156801626|NCT00565409|566029259|FG001|Period 1 Open Label|no conclusion of participation record|0|||
156801627|NCT00565409|566029260|FG002|Period 1 Open Label|no conclusion of participation record|0|||
156801628|NCT00565409|566029261|FG003|Period 1 Open Label|no conclusion of participation record|0|||
156801629|NCT00565409|566029258|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
156801630|NCT00565409|566029259|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
156801631|NCT00565409|566029260|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
156801632|NCT00565409|566029261|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
156801633|NCT00565409|566029258|FG000|Period 2 Double-Blind|Adverse Event|0|||
156801634|NCT00565409|566029259|FG001|Period 2 Double-Blind|Adverse Event|7|||
156801635|NCT00565409|566029260|FG002|Period 2 Double-Blind|Adverse Event|4|||
156801636|NCT00565409|566029261|FG003|Period 2 Double-Blind|Adverse Event|5|||
156801637|NCT00565409|566029258|FG000|Period 2 Double-Blind|Death|0|||
156801638|NCT00565409|566029259|FG001|Period 2 Double-Blind|Death|2|||
156537133|NCT00467779|565061108|FG013|Stage 1|Disease Progression|0|||
156459371|NCT03213665|564776804|FG000|Overall Study|Progressive Disease|13|||
156459372|NCT03034356|564776805|FG000|Baseline|Lost to Follow-up|2|||
156801639|NCT00565409|566029260|FG002|Period 2 Double-Blind|Death|0|||
156801640|NCT00565409|566029261|FG003|Period 2 Double-Blind|Death|0|||
156801641|NCT00565409|566029258|FG000|Period 2 Double-Blind|Protocol Violation|0|||
156801642|NCT00565409|566029259|FG001|Period 2 Double-Blind|Protocol Violation|4|||
156801643|NCT00565409|566029260|FG002|Period 2 Double-Blind|Protocol Violation|6|||
156801644|NCT00565409|566029261|FG003|Period 2 Double-Blind|Protocol Violation|2|||
156801645|NCT00565409|566029258|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
156801646|NCT00565409|566029259|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
156801647|NCT00565409|566029260|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
156801648|NCT00565409|566029261|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
156801649|NCT00565409|566029258|FG000|Period 2 Double-Blind|Other|0|||
156801650|NCT00565409|566029259|FG001|Period 2 Double-Blind|Other|4|||
156801651|NCT00565409|566029260|FG002|Period 2 Double-Blind|Other|5|||
156801652|NCT00565409|566029261|FG003|Period 2 Double-Blind|Other|9|||
156801653|NCT00565409|566029258|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
156801654|NCT00565409|566029259|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
156801655|NCT00565409|566029260|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
156801656|NCT00565409|566029261|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
156801657|NCT03440008|566029264|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
156801658|NCT03440008|566029265|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
156801659|NCT03440008|566029264|FG000|Overall Study|Withdrawal by Subject|1|||
156801660|NCT03440008|566029265|FG001|Overall Study|Withdrawal by Subject|0|||
156801661|NCT04064905|566029268|FG000|Overall Study|Lost to Follow-up|0|||
156801662|NCT04064905|566029269|FG001|Overall Study|Lost to Follow-up|3|||
156801663|NCT04064905|566029270|FG002|Overall Study|Lost to Follow-up|1|||
156801664|NCT04064905|566029271|FG003|Overall Study|Lost to Follow-up|4|||
156801665|NCT04064905|566029272|FG004|Overall Study|Lost to Follow-up|2|||
156801666|NCT03961308|566029278|FG000|Overall Study|Withdrawal by Subject|1|||
156801667|NCT03961308|566029279|FG001|Overall Study|Withdrawal by Subject|0|||
156801668|NCT03961308|566029278|FG000|Overall Study|Other|1|||
156801669|NCT03961308|566029279|FG001|Overall Study|Other|0|||
156801670|NCT03961308|566029278|FG000|Overall Study|Lost to Follow-up|0|||
156801671|NCT03961308|566029279|FG001|Overall Study|Lost to Follow-up|1|||
156801672|NCT03961308|566029278|FG000|Overall Study|Adverse Event|0|||
156801673|NCT03961308|566029279|FG001|Overall Study|Adverse Event|1|||
156801674|NCT05643495|566029284|FG000|Overall Study|Adverse Event|0|||
156801675|NCT05643495|566029285|FG001|Overall Study|Adverse Event|1|||
156801676|NCT05643495|566029284|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156801677|NCT05643495|566029285|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
156801678|NCT01729039|566029286|FG000|Overall Study|disqualified|2|||
156801679|NCT01729039|566029287|FG001|Overall Study|disqualified|5|||
156801680|NCT01729039|566029286|FG000|Overall Study|Withdrawal by Subject|8|||
156801681|NCT01729039|566029287|FG001|Overall Study|Withdrawal by Subject|7|||
156801682|NCT00404248|566029290|FG000|Overall Study|pts declining status|0|||
156801683|NCT00404248|566029291|FG001|Overall Study|pts declining status|1|||
156801684|NCT00404248|566029292|FG002|Overall Study|pts declining status|0|||
156801685|NCT00404248|566029293|FG003|Overall Study|pts declining status|0|||
156801686|NCT00404248|566029294|FG004|Overall Study|pts declining status|0|||
156801687|NCT00404248|566029295|FG005|Overall Study|pts declining status|0|||
156801688|NCT00404248|566029296|FG006|Overall Study|pts declining status|0|||
156801689|NCT00404248|566029297|FG007|Overall Study|pts declining status|0|||
156801690|NCT00404248|566029298|FG008|Overall Study|pts declining status|0|||
156801691|NCT00789555|566029299|FG000|Overall Study|Protocol Amendment|78|||
156801692|NCT00789555|566029300|FG001|Overall Study|Protocol Amendment|76|||
156801693|NCT00789555|566029301|FG002|Overall Study|Protocol Amendment|80|||
156801694|NCT00789555|566029299|FG000|Overall Study|Adverse Event|17|||
156801695|NCT00789555|566029300|FG001|Overall Study|Adverse Event|7|||
156801696|NCT00789555|566029301|FG002|Overall Study|Adverse Event|10|||
156801697|NCT00789555|566029299|FG000|Overall Study|Lost to Follow-up|9|||
156801698|NCT00789555|566029300|FG001|Overall Study|Lost to Follow-up|10|||
156801699|NCT00789555|566029301|FG002|Overall Study|Lost to Follow-up|18|||
156801700|NCT00789555|566029299|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
156801701|NCT00789555|566029300|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
156801702|NCT00789555|566029301|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
156801703|NCT00789555|566029299|FG000|Overall Study|Treatment failure|11|||
156801704|NCT00789555|566029300|FG001|Overall Study|Treatment failure|8|||
156801705|NCT00789555|566029301|FG002|Overall Study|Treatment failure|12|||
156801706|NCT00789555|566029299|FG000|Overall Study|Protocol Violation|6|||
156801707|NCT00789555|566029300|FG001|Overall Study|Protocol Violation|9|||
156801708|NCT00789555|566029301|FG002|Overall Study|Protocol Violation|13|||
156801709|NCT00698841|566029302|FG000|Overall Study|Withdrawal by Subject|2|||
156459373|NCT03034356|564776806|FG001|Baseline|Lost to Follow-up|4|||
156459374|NCT03034356|564776805|FG000|Baseline|Withdrawal by Subject|2|||
156459375|NCT03034356|564776806|FG001|Baseline|Withdrawal by Subject|0|||
156337520|NCT00590135|564333666|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
156337521|NCT02015754|564333673|FG000|Overall Study|Disease progression|5|||
156801710|NCT00698841|566029302|FG000|Overall Study|Adverse Event|3|||
156801711|NCT00698841|566029302|FG000|Overall Study|Disease progression|7|||
156801712|NCT00698841|566029302|FG000|Overall Study|Failure to meet eligibility criteria|2|||
156801713|NCT00698841|566029302|FG000|Overall Study|Study drug toxicity|2|||
156801714|NCT00698841|566029302|FG000|Overall Study|Other|2|||
156801715|NCT04646005|566029306|FG000|Overall Study|Adverse Event|1|||
156801716|NCT04646005|566029306|FG000|Overall Study|Progressive Disease|71|||
156801717|NCT04646005|566029306|FG000|Overall Study|Death|20|||
156801718|NCT04646005|566029306|FG000|Overall Study|Withdrawal by Subject|12|||
156801719|NCT04646005|566029306|FG000|Overall Study|Sponsor Request|9|||
156801720|NCT02661672|566029318|FG000|Overall Study|Lost to Follow-up|1|||
156801721|NCT02661672|566029318|FG000|Overall Study|Death|4|||
156801722|NCT02935192|566030693|FG000|Overall Study|Withdrawal by Subject|8|||
156801723|NCT02935192|566030694|FG001|Overall Study|Withdrawal by Subject|4|||
156801724|NCT00492557|566030696|FG000|Overall Study|Subject request|12|||
156801725|NCT00492557|566030697|FG001|Overall Study|Subject request|11|||
156801726|NCT00492557|566030696|FG000|Overall Study|Protocol Violation|7|||
156801727|NCT00492557|566030697|FG001|Overall Study|Protocol Violation|8|||
156801728|NCT00492557|566030696|FG000|Overall Study|Other|2|||
156801729|NCT00492557|566030697|FG001|Overall Study|Other|2|||
156801730|NCT00492557|566030696|FG000|Overall Study|Death|1|||
156801731|NCT00492557|566030697|FG001|Overall Study|Death|1|||
156801732|NCT00492557|566030696|FG000|Overall Study|Adverse Event|1|||
156801733|NCT00492557|566030697|FG001|Overall Study|Adverse Event|0|||
156801734|NCT00492557|566030696|FG000|Overall Study|Failed to return|1|||
156801735|NCT00492557|566030697|FG001|Overall Study|Failed to return|0|||
156801736|NCT00492557|566030696|FG000|Overall Study|Lost to Follow-up|0|||
156801737|NCT00492557|566030697|FG001|Overall Study|Lost to Follow-up|1|||
156801738|NCT01135992|566030699|FG000|Overall Study|Adverse Event|1|||
156801739|NCT01135992|566030699|FG000|Overall Study|Lack of Efficacy|1|||
156801740|NCT01135992|566030699|FG000|Overall Study|Protocol Violation|2|||
156801741|NCT01135992|566030699|FG000|Overall Study|Withdrawal criteria|10|||
156801742|NCT01135992|566030699|FG000|Overall Study|Unclassified|7|||
156801743|NCT01977898|566030700|FG000|Overall Study|Non functioning catheter|1|||
156801744|NCT01977898|566030701|FG001|Overall Study|Non functioning catheter|1|||
156801745|NCT03983421|566030706|FG000|Overall Study|Lost to Follow-up|1|||
156801746|NCT03386773|566030707|FG000|Overall Study|Lost to Follow-up|24|||
156801747|NCT03386773|566030708|FG001|Overall Study|Lost to Follow-up|33|||
156801748|NCT03386773|566030707|FG000|Overall Study|Withdrawal by Subject|3|||
156801749|NCT03386773|566030708|FG001|Overall Study|Withdrawal by Subject|2|||
156801750|NCT03639610|566030709|FG000|Overall Study|Adverse Event|7|||
156801751|NCT03639610|566030710|FG001|Overall Study|Adverse Event|1|||
156801752|NCT03639610|566030711|FG002|Overall Study|Adverse Event|0|||
156801753|NCT03639610|566030709|FG000|Overall Study|Physician Decision|3|||
156801754|NCT03639610|566030710|FG001|Overall Study|Physician Decision|1|||
156801755|NCT03639610|566030711|FG002|Overall Study|Physician Decision|0|||
156801756|NCT03639610|566030709|FG000|Overall Study|Disease progression|8|||
156801757|NCT03639610|566030710|FG001|Overall Study|Disease progression|5|||
156801758|NCT03639610|566030711|FG002|Overall Study|Disease progression|3|||
156801759|NCT03639610|566030709|FG000|Overall Study|Study terminated by sponsor|2|||
156801760|NCT03639610|566030710|FG001|Overall Study|Study terminated by sponsor|1|||
156801761|NCT03639610|566030711|FG002|Overall Study|Study terminated by sponsor|1|||
156801762|NCT03639610|566030709|FG000|Overall Study|Patient request to stop treatment|1|||
156801763|NCT03639610|566030710|FG001|Overall Study|Patient request to stop treatment|2|||
156801764|NCT03639610|566030711|FG002|Overall Study|Patient request to stop treatment|0|||
156801765|NCT02660229|566030712|FG000|Overall Study|Adverse Event|2|||
156801766|NCT02660229|566030713|FG001|Overall Study|Adverse Event|0|||
156801767|NCT02660229|566030712|FG000|Overall Study|Withdrawal by Subject|0|||
156801768|NCT02660229|566030713|FG001|Overall Study|Withdrawal by Subject|1|||
156801769|NCT01049373|566030717|FG000|Overall Study|Protocol Violation|9|||
156801770|NCT01049373|566030718|FG001|Overall Study|Protocol Violation|9|||
156801771|NCT01049373|566030717|FG000|Overall Study|Withdrawal by Subject|8|||
156801772|NCT01049373|566030718|FG001|Overall Study|Withdrawal by Subject|5|||
156801773|NCT01049373|566030717|FG000|Overall Study|Adverse Event|3|||
156801774|NCT01049373|566030718|FG001|Overall Study|Adverse Event|3|||
156801775|NCT01049373|566030717|FG000|Overall Study|Lost to Follow-up|9|||
156801776|NCT01049373|566030718|FG001|Overall Study|Lost to Follow-up|4|||
156801777|NCT01049373|566030717|FG000|Overall Study|no evaluable study values|9|||
156801778|NCT01049373|566030718|FG001|Overall Study|no evaluable study values|21|||
156801779|NCT01049373|566030717|FG000|Overall Study|Other|1|||
156801780|NCT01049373|566030718|FG001|Overall Study|Other|1|||
156801781|NCT01049373|566030717|FG000|Overall Study|Non-cooperation|0|||
156801782|NCT01049373|566030718|FG001|Overall Study|Non-cooperation|1|||
156801783|NCT03610048|566030719|FG000|Overall Study|Study terminated by sponsor|84|||
156801784|NCT03610048|566030719|FG000|Overall Study|Adverse Event|32|||
156801785|NCT03610048|566030719|FG000|Overall Study|Withdrawal by Subject|31|||
156801786|NCT03610048|566030719|FG000|Overall Study|Lost to Follow-up|8|||
156801787|NCT03610048|566030719|FG000|Overall Study|Other|4|||
156801788|NCT03610048|566030719|FG000|Overall Study|Physician Decision|1|||
156801789|NCT03610048|566030719|FG000|Overall Study|Pregnancy|1|||
156801790|NCT01155050|566030720|FG000|Overall Study|Lost to Follow-up|15|||
156801791|NCT01155050|566030721|FG001|Overall Study|Lost to Follow-up|20|||
156801792|NCT01155050|566030722|FG002|Overall Study|Lost to Follow-up|19|||
156801793|NCT01155050|566030723|FG003|Overall Study|Lost to Follow-up|22|||
156801794|NCT02136914|566030724|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
156801795|NCT02136914|566030725|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
156801796|NCT02136914|566030724|FG000|Overall Study|Withdrawal by Subject|3|||
156801797|NCT02136914|566030725|FG001|Overall Study|Withdrawal by Subject|10|||
156801798|NCT02136914|566030724|FG000|Overall Study|Subject Unwilling to Proceed|7|||
156801799|NCT02136914|566030725|FG001|Overall Study|Subject Unwilling to Proceed|2|||
156801800|NCT02136914|566030724|FG000|Overall Study|Lost to Follow-up|1|||
156801801|NCT02136914|566030725|FG001|Overall Study|Lost to Follow-up|1|||
156801802|NCT02136914|566030724|FG000|Overall Study|Did Not Receive Study Drug|2|||
156801803|NCT02136914|566030725|FG001|Overall Study|Did Not Receive Study Drug|0|||
156801804|NCT02136914|566030724|FG000|Overall Study|Lack of Efficacy|1|||
156801805|NCT02136914|566030725|FG001|Overall Study|Lack of Efficacy|0|||
156801806|NCT02136914|566030724|FG000|Overall Study|Death|0|||
156801807|NCT02136914|566030725|FG001|Overall Study|Death|1|||
156801808|NCT01496287|566030728|FG000|Overall Study|Lost to Follow-up|1|||
156801809|NCT01496287|566030728|FG000|Overall Study|Incomplete anesthesia|5|||
156801810|NCT00329030|566030729|FG000|Overall Study|Withdrawal by Subject|1|||
156801811|NCT00329030|566030730|FG001|Overall Study|Withdrawal by Subject|3|||
156801812|NCT00329030|566030729|FG000|Overall Study|Progressive Disease|6|||
156801813|NCT00329030|566030730|FG001|Overall Study|Progressive Disease|2|||
156801814|NCT00329030|566030729|FG000|Overall Study|Ineligible Pathology|1|||
156801815|NCT00329030|566030730|FG001|Overall Study|Ineligible Pathology|1|||
156801816|NCT00557193|566030731|FG000|Induction|Adverse Event|2|||
156801817|NCT00557193|566030732|FG001|Induction|Adverse Event|0|||
156801818|NCT00557193|566030733|FG002|Induction|Adverse Event|0|||
156801819|NCT00557193|566030734|FG003|Induction|Adverse Event|0|||
156801820|NCT00557193|566030735|FG004|Induction|Adverse Event|0|||
156801821|NCT00557193|566030736|FG005|Induction|Adverse Event|0|||
156801822|NCT00557193|566030731|FG000|Induction|Death|6|||
156801823|NCT00557193|566030732|FG001|Induction|Death|0|||
156801824|NCT00557193|566030733|FG002|Induction|Death|0|||
156801825|NCT00557193|566030734|FG003|Induction|Death|0|||
156801826|NCT00557193|566030735|FG004|Induction|Death|0|||
156801827|NCT00557193|566030736|FG005|Induction|Death|0|||
156801828|NCT00557193|566030731|FG000|Induction|Physician Decision|3|||
156801829|NCT00557193|566030732|FG001|Induction|Physician Decision|0|||
156801830|NCT00557193|566030733|FG002|Induction|Physician Decision|0|||
156801831|NCT00557193|566030734|FG003|Induction|Physician Decision|0|||
156801832|NCT00557193|566030735|FG004|Induction|Physician Decision|0|||
156801833|NCT00557193|566030736|FG005|Induction|Physician Decision|0|||
156801834|NCT00557193|566030731|FG000|Induction|Withdrawal by Subject|1|||
156801835|NCT00557193|566030732|FG001|Induction|Withdrawal by Subject|0|||
156801836|NCT00557193|566030733|FG002|Induction|Withdrawal by Subject|0|||
156801837|NCT00557193|566030734|FG003|Induction|Withdrawal by Subject|0|||
156801838|NCT00557193|566030735|FG004|Induction|Withdrawal by Subject|0|||
156801839|NCT00557193|566030736|FG005|Induction|Withdrawal by Subject|0|||
156801840|NCT00557193|566030731|FG000|Induction|Refusal of Further Protocol Therapy|2|||
156801841|NCT00557193|566030732|FG001|Induction|Refusal of Further Protocol Therapy|0|||
156801842|NCT00557193|566030733|FG002|Induction|Refusal of Further Protocol Therapy|0|||
156801843|NCT00557193|566030734|FG003|Induction|Refusal of Further Protocol Therapy|0|||
156801844|NCT00557193|566030735|FG004|Induction|Refusal of Further Protocol Therapy|0|||
156801845|NCT00557193|566030736|FG005|Induction|Refusal of Further Protocol Therapy|0|||
156801846|NCT00557193|566030731|FG000|Induction|Ineligible|8|||
156801847|NCT00557193|566030732|FG001|Induction|Ineligible|0|||
156801848|NCT00557193|566030733|FG002|Induction|Ineligible|0|||
156801849|NCT00557193|566030734|FG003|Induction|Ineligible|0|||
156801850|NCT00557193|566030735|FG004|Induction|Ineligible|0|||
156801851|NCT00557193|566030736|FG005|Induction|Ineligible|0|||
156801852|NCT00557193|566030731|FG000|Induction|Inevaluable for post Induction|2|||
156801853|NCT00557193|566030732|FG001|Induction|Inevaluable for post Induction|0|||
156801854|NCT00557193|566030733|FG002|Induction|Inevaluable for post Induction|0|||
156801855|NCT00557193|566030734|FG003|Induction|Inevaluable for post Induction|0|||
156801856|NCT00557193|566030735|FG004|Induction|Inevaluable for post Induction|0|||
156801857|NCT00557193|566030736|FG005|Induction|Inevaluable for post Induction|0|||
156801858|NCT00557193|566030731|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
156801859|NCT00557193|566030732|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801860|NCT00557193|566030733|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801861|NCT00557193|566030734|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801862|NCT00557193|566030735|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801863|NCT00557193|566030736|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801864|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
156801865|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
156801866|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
156801867|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
156801868|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
156801869|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
156801870|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
156801871|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
156801872|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
156801873|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
156801874|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
156801875|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
156801876|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
156801877|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
156801878|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
156801879|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
156801880|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
156801881|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
156801882|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
156801883|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
156801884|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
156801885|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
156801886|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
156801887|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
156801888|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
156801889|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
156801890|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
156801891|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
156801892|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
156801893|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
156801894|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801895|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801896|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
156801897|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801898|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801899|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801900|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801901|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801902|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
156801903|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801904|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801905|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801906|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
156801907|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
156801908|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
156801909|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
156801910|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
156801911|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
156801912|NCT03036852|566030737|FG000|Overall Study|Death|2|||
156801913|NCT03036852|566030737|FG000|Overall Study|Lack of Efficacy|2|||
156801914|NCT03036852|566030737|FG000|Overall Study|Adverse Event|1|||
156801915|NCT03036852|566030737|FG000|Overall Study|Lost to Follow-up|1|||
156801916|NCT02639390|566030749|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
156801917|NCT02639390|566030750|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
156801918|NCT01531998|566030754|FG000|Overall Study|Withdrawal by Subject|3|||
156801919|NCT02581891|566030755|FG000|Overall Study|Adverse Event|4|||
156801920|NCT02581891|566030756|FG001|Overall Study|Adverse Event|6|||
156801921|NCT02581891|566030755|FG000|Overall Study|Death|3|||
156801922|NCT02581891|566030756|FG001|Overall Study|Death|4|||
156801923|NCT02581891|566030755|FG000|Overall Study|Lost to Follow-up|1|||
156801924|NCT02581891|566030756|FG001|Overall Study|Lost to Follow-up|2|||
156801925|NCT02581891|566030755|FG000|Overall Study|Physician Decision|0|||
156801926|NCT02581891|566030756|FG001|Overall Study|Physician Decision|1|||
156801927|NCT02581891|566030755|FG000|Overall Study|Withdrawal by Subject|4|||
156801928|NCT02581891|566030756|FG001|Overall Study|Withdrawal by Subject|5|||
156801929|NCT02581891|566030755|FG000|Overall Study|Other Reasons|3|||
156801930|NCT02581891|566030756|FG001|Overall Study|Other Reasons|1|||
156801931|NCT02581891|566030755|FG000|Overall Study|Discontinued during followup|1|||
156801932|NCT02581891|566030756|FG001|Overall Study|Discontinued during followup|0|||
156801933|NCT04067011|566030758|FG000|Overall Study|Not Treated|8|||
156801934|NCT04067011|566030759|FG001|Overall Study|Not Treated|7|||
156801935|NCT04067011|566030760|FG002|Overall Study|Not Treated|5|||
156801936|NCT04067011|566030758|FG000|Overall Study|Adverse Event|2|||
156801937|NCT04067011|566030759|FG001|Overall Study|Adverse Event|1|||
156801938|NCT04067011|566030760|FG002|Overall Study|Adverse Event|0|||
156801939|NCT04067011|566030758|FG000|Overall Study|Withdrawal by Subject|6|||
156801940|NCT04067011|566030759|FG001|Overall Study|Withdrawal by Subject|2|||
156801941|NCT04067011|566030760|FG002|Overall Study|Withdrawal by Subject|1|||
156801942|NCT04067011|566030758|FG000|Overall Study|Lost to Follow-up|0|||
156801943|NCT04067011|566030759|FG001|Overall Study|Lost to Follow-up|0|||
156801944|NCT04067011|566030760|FG002|Overall Study|Lost to Follow-up|1|||
156801945|NCT04067011|566030758|FG000|Overall Study|Physician Decision|1|||
156801946|NCT04067011|566030759|FG001|Overall Study|Physician Decision|1|||
156801947|NCT04067011|566030760|FG002|Overall Study|Physician Decision|0|||
156801948|NCT04067011|566030758|FG000|Overall Study|Other Reasons|2|||
156801949|NCT04067011|566030759|FG001|Overall Study|Other Reasons|0|||
156801950|NCT04067011|566030760|FG002|Overall Study|Other Reasons|1|||
156801951|NCT04067011|566030758|FG000|Overall Study|Missing|0|||
156801952|NCT04067011|566030759|FG001|Overall Study|Missing|2|||
156801953|NCT04067011|566030760|FG002|Overall Study|Missing|0|||
156801954|NCT00760552|566030761|FG000|Overall Study|Death|2|||
156801955|NCT00760552|566030762|FG001|Overall Study|Death|0|||
156801956|NCT00760552|566030761|FG000|Overall Study|Lost to Follow-up|11|||
156801957|NCT00760552|566030762|FG001|Overall Study|Lost to Follow-up|10|||
156801958|NCT01038323|566030763|FG000|Overall Study|Withdrawal by Subject|3|||
156801959|NCT01038323|566030764|FG001|Overall Study|Withdrawal by Subject|2|||
156801960|NCT01038323|566030765|FG002|Overall Study|Withdrawal by Subject|4|||
156801961|NCT04211363|566030767|FG000|Overall Study|Adverse Event|5|||
156801962|NCT04211363|566030768|FG001|Overall Study|Adverse Event|2|||
156801963|NCT04211363|566030767|FG000|Overall Study|Physician Decision|0|||
156801964|NCT04211363|566030768|FG001|Overall Study|Physician Decision|1|||
156801965|NCT04211363|566030767|FG000|Overall Study|Protocol Violation|1|||
156801966|NCT04211363|566030768|FG001|Overall Study|Protocol Violation|0|||
156801967|NCT04211363|566030767|FG000|Overall Study|Pregnancy|1|||
156801968|NCT04211363|566030768|FG001|Overall Study|Pregnancy|0|||
156801969|NCT04211363|566030767|FG000|Overall Study|Lost to Follow-up|12|||
156801970|NCT04211363|566030768|FG001|Overall Study|Lost to Follow-up|4|||
156801971|NCT04211363|566030767|FG000|Overall Study|Withdrawal by Subject|11|||
156801972|NCT04211363|566030768|FG001|Overall Study|Withdrawal by Subject|11|||
156801973|NCT04211363|566030767|FG000|Overall Study|Other|1|||
156801974|NCT04211363|566030768|FG001|Overall Study|Other|2|||
156801975|NCT01736917|566030769|FG000|Overall Study|Adverse Event|1|||
156801976|NCT01736917|566030769|FG000|Overall Study|Protocol Violation|10|||
156801977|NCT01734902|566030770|FG000|Overall Study|Other than listed|0|||
156801978|NCT01734902|566030771|FG001|Overall Study|Other than listed|2|||
156801979|NCT00060944|566030772|FG000|Overall Study|Adverse Event|12|||
156801980|NCT00060944|566030773|FG001|Overall Study|Adverse Event|10|||
156801981|NCT00060944|566030772|FG000|Overall Study|Death|2|||
156801982|NCT00060944|566030773|FG001|Overall Study|Death|3|||
156801983|NCT00060944|566030772|FG000|Overall Study|Withdrawal by Subject|18|||
156801984|NCT00060944|566030773|FG001|Overall Study|Withdrawal by Subject|5|||
156801985|NCT00060944|566030772|FG000|Overall Study|Disease Progression|93|||
156801986|NCT00060944|566030773|FG001|Overall Study|Disease Progression|94|||
156801987|NCT00060944|566030772|FG000|Overall Study|Lost to Follow-up|1|||
156801988|NCT00060944|566030773|FG001|Overall Study|Lost to Follow-up|0|||
156801989|NCT00060944|566030772|FG000|Overall Study|Subject Ineligible To Continue|2|||
156801990|NCT00060944|566030773|FG001|Overall Study|Subject Ineligible To Continue|1|||
156801991|NCT00060944|566030772|FG000|Overall Study|Treatment Switch|0|||
156801992|NCT00060944|566030773|FG001|Overall Study|Treatment Switch|13|||
156801993|NCT00060944|566030772|FG000|Overall Study|Other|2|||
156801994|NCT00060944|566030773|FG001|Overall Study|Other|4|||
156801995|NCT00060944|566030772|FG000|Overall Study|randomized but not treated|6|||
156801996|NCT00060944|566030773|FG001|Overall Study|randomized but not treated|4|||
156801997|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
156801998|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
156801999|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
156802000|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Death|0|||
156802001|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Death|0|||
156802002|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Death|1|||
156802003|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
156802004|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
156802005|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
156802006|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
156802007|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
156802008|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
156802009|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
156802010|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
156802011|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
156337522|NCT02015754|564333673|FG000|Overall Study|Change in treatment modality|5|||
156337523|NCT02015754|564333673|FG000|Overall Study|Lost to Follow-up|1|||
156337524|NCT01681472|564333674|FG000|Overall Study|Adverse Event|0|||
156337525|NCT01681472|564333675|FG001|Overall Study|Adverse Event|1|||
156337526|NCT01681472|564333676|FG002|Overall Study|Adverse Event|0|||
156337527|NCT01681472|564333677|FG003|Overall Study|Adverse Event|0|||
156337528|NCT00672646|564333678|FG000|Overall Study|Lost to Follow-up|0|||
156337529|NCT00672646|564333679|FG001|Overall Study|Lost to Follow-up|1|||
156337530|NCT00672646|564333680|FG002|Overall Study|Lost to Follow-up|2|||
156802012|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Graft loss|0|||
156802013|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Graft loss|0|||
156802014|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Graft loss|7|||
156802015|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
156802016|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
156802017|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
156802018|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
156802019|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
156802020|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
156802021|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
156802022|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
156802023|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
156802024|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
156802025|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
156802026|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
156802027|NCT00956293|566030777|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
156802028|NCT00956293|566030778|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
156802029|NCT00956293|566030779|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
156802030|NCT00956293|566030777|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
156802031|NCT00956293|566030778|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
156802032|NCT00956293|566030779|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
156802033|NCT00956293|566030777|FG000|Main Period (Randomization)|Adverse Event|0|||
156537134|NCT00467779|565061109|FG014|Stage 1|Disease Progression|0|||
156802034|NCT00956293|566030778|FG001|Main Period (Randomization)|Adverse Event|15|||
156802035|NCT00956293|566030779|FG002|Main Period (Randomization)|Adverse Event|0|||
156802036|NCT00956293|566030777|FG000|Follow-up Period|Follow-up period was terminated.|20|||
156802037|NCT00956293|566030778|FG001|Follow-up Period|Follow-up period was terminated.|32|||
156802038|NCT00956293|566030779|FG002|Follow-up Period|Follow-up period was terminated.|0|||
156802039|NCT03383666|566030780|FG000|Overall Study|Withdrawal by Subject|2|||
156802040|NCT03383666|566030780|FG000|Overall Study|Lost to Follow-up|2|||
156802041|NCT02536664|566030781|FG000|Overall Study|Inadequate completion of documentation|2|||
156802042|NCT02536664|566030782|FG001|Overall Study|Inadequate completion of documentation|4|||
156802043|NCT02536664|566030781|FG000|Overall Study|Progression|13|||
156802044|NCT02536664|566030782|FG001|Overall Study|Progression|18|||
156802045|NCT02536664|566030781|FG000|Overall Study|Death due to lymphoma|2|||
156802046|NCT02536664|566030782|FG001|Overall Study|Death due to lymphoma|1|||
156337531|NCT00672646|564333678|FG000|Overall Study|Withdrawal by Subject|0|||
156337532|NCT00672646|564333679|FG001|Overall Study|Withdrawal by Subject|0|||
156802047|NCT02536664|566030781|FG000|Overall Study|Death due to other reason|3|||
156802048|NCT02536664|566030782|FG001|Overall Study|Death due to other reason|2|||
156459376|NCT03034356|564776805|FG000|Baseline|Physician Decision|0|||
156459377|NCT03034356|564776806|FG001|Baseline|Physician Decision|1|||
156802049|NCT02536664|566030781|FG000|Overall Study|Intolerability|8|||
156802050|NCT02536664|566030782|FG001|Overall Study|Intolerability|6|||
156802051|NCT02536664|566030781|FG000|Overall Study|Withdrawal by Subject|8|||
156802052|NCT02536664|566030782|FG001|Overall Study|Withdrawal by Subject|5|||
156802053|NCT02536664|566030781|FG000|Overall Study|Other|18|||
156802054|NCT02536664|566030782|FG001|Overall Study|Other|24|||
156802055|NCT02536664|566030781|FG000|Overall Study|Missing|53|||
156802056|NCT02536664|566030782|FG001|Overall Study|Missing|20|||
156802057|NCT00659425|566030784|FG000|Overall Study|Disease progression|1|||
156802058|NCT00659425|566030785|FG001|Overall Study|Disease progression|0|||
156802059|NCT00659425|566030786|FG002|Overall Study|Disease progression|0|||
156802060|NCT00659425|566030787|FG003|Overall Study|Disease progression|1|||
156802061|NCT00659425|566030788|FG004|Overall Study|Disease progression|0|||
156802062|NCT00659425|566030789|FG005|Overall Study|Disease progression|2|||
156802063|NCT00659425|566030790|FG006|Overall Study|Disease progression|4|||
156802064|NCT00659425|566030791|FG007|Overall Study|Disease progression|3|||
156802065|NCT00659425|566030792|FG008|Overall Study|Disease progression|5|||
156802066|NCT00659425|566030793|FG009|Overall Study|Disease progression|3|||
156802067|NCT00659425|566030784|FG000|Overall Study|Death|0|||
156802068|NCT00659425|566030785|FG001|Overall Study|Death|0|||
156802069|NCT00659425|566030786|FG002|Overall Study|Death|0|||
156802070|NCT00659425|566030787|FG003|Overall Study|Death|1|||
156802071|NCT00659425|566030788|FG004|Overall Study|Death|0|||
156802072|NCT00659425|566030789|FG005|Overall Study|Death|0|||
156802073|NCT00659425|566030790|FG006|Overall Study|Death|1|||
156802074|NCT00659425|566030791|FG007|Overall Study|Death|0|||
156802075|NCT00659425|566030792|FG008|Overall Study|Death|0|||
156802076|NCT00659425|566030793|FG009|Overall Study|Death|0|||
156802077|NCT00659425|566030784|FG000|Overall Study|Adverse Event|0|||
156802078|NCT00659425|566030785|FG001|Overall Study|Adverse Event|0|||
156802079|NCT00659425|566030786|FG002|Overall Study|Adverse Event|0|||
156802080|NCT00659425|566030787|FG003|Overall Study|Adverse Event|0|||
156802081|NCT00659425|566030788|FG004|Overall Study|Adverse Event|0|||
156802082|NCT00659425|566030789|FG005|Overall Study|Adverse Event|1|||
156802083|NCT00659425|566030790|FG006|Overall Study|Adverse Event|0|||
156802084|NCT00659425|566030791|FG007|Overall Study|Adverse Event|3|||
156802085|NCT00659425|566030792|FG008|Overall Study|Adverse Event|1|||
156802086|NCT00659425|566030793|FG009|Overall Study|Adverse Event|4|||
156802087|NCT00659425|566030784|FG000|Overall Study|Investigator Discretion|0|||
156802088|NCT00659425|566030785|FG001|Overall Study|Investigator Discretion|0|||
156802089|NCT00659425|566030786|FG002|Overall Study|Investigator Discretion|0|||
156802090|NCT00659425|566030787|FG003|Overall Study|Investigator Discretion|0|||
156802091|NCT00659425|566030788|FG004|Overall Study|Investigator Discretion|0|||
156802092|NCT00659425|566030789|FG005|Overall Study|Investigator Discretion|1|||
156802093|NCT00659425|566030790|FG006|Overall Study|Investigator Discretion|0|||
156802094|NCT00659425|566030791|FG007|Overall Study|Investigator Discretion|3|||
156802095|NCT00659425|566030792|FG008|Overall Study|Investigator Discretion|0|||
156802096|NCT00659425|566030793|FG009|Overall Study|Investigator Discretion|0|||
156802097|NCT00659425|566030784|FG000|Overall Study|Other|0|||
156802098|NCT00659425|566030785|FG001|Overall Study|Other|1|||
156802099|NCT00659425|566030786|FG002|Overall Study|Other|1|||
156802100|NCT00659425|566030787|FG003|Overall Study|Other|2|||
156802101|NCT00659425|566030788|FG004|Overall Study|Other|4|||
156802102|NCT00659425|566030789|FG005|Overall Study|Other|0|||
156802103|NCT00659425|566030790|FG006|Overall Study|Other|3|||
156802104|NCT00659425|566030791|FG007|Overall Study|Other|2|||
156802105|NCT00659425|566030792|FG008|Overall Study|Other|0|||
156802106|NCT00659425|566030793|FG009|Overall Study|Other|6|||
156802107|NCT03358030|566030794|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
156802108|NCT03358030|566030795|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
156802109|NCT03358030|566030796|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
156802110|NCT03358030|566030797|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
156802111|NCT03358030|566030794|FG000|Overall Study|Ineligibility|0|||
156802112|NCT03358030|566030795|FG001|Overall Study|Ineligibility|0|||
156802113|NCT03358030|566030796|FG002|Overall Study|Ineligibility|0|||
156802114|NCT03358030|566030797|FG003|Overall Study|Ineligibility|2|||
156802115|NCT03358030|566030794|FG000|Overall Study|Voluntary Withdrawal|1|||
156802116|NCT03358030|566030795|FG001|Overall Study|Voluntary Withdrawal|1|||
156802117|NCT03358030|566030796|FG002|Overall Study|Voluntary Withdrawal|3|||
156802118|NCT03358030|566030797|FG003|Overall Study|Voluntary Withdrawal|1|||
156802119|NCT03358030|566030794|FG000|Overall Study|Other|0|||
156802120|NCT03358030|566030795|FG001|Overall Study|Other|0|||
156802121|NCT03358030|566030796|FG002|Overall Study|Other|1|||
156802122|NCT03358030|566030797|FG003|Overall Study|Other|0|||
156802123|NCT03342560|566030798|FG000|Overall Study|Lost to Follow-up|2|||
156802124|NCT03770286|566030799|FG000|Overall Study|Lost to Follow-up|6|||
156802125|NCT03770286|566030800|FG001|Overall Study|Lost to Follow-up|4|||
156802126|NCT03770286|566030801|FG002|Overall Study|Lost to Follow-up|3|||
156802127|NCT03770286|566030799|FG000|Overall Study|Protocol Violation|1|||
156802128|NCT03770286|566030800|FG001|Overall Study|Protocol Violation|0|||
156802129|NCT03770286|566030801|FG002|Overall Study|Protocol Violation|2|||
156802130|NCT02505425|566030802|FG000|Overall Study|Lost to Follow-up|41|||
156802131|NCT02505425|566030803|FG001|Overall Study|Lost to Follow-up|61|||
156802132|NCT02505425|566030804|FG002|Overall Study|Lost to Follow-up|31|||
156802133|NCT02505425|566030805|FG003|Overall Study|Lost to Follow-up|19|||
156802134|NCT02505425|566030802|FG000|Overall Study|Withdrawal by Subject|39|||
156802135|NCT02505425|566030803|FG001|Overall Study|Withdrawal by Subject|9|||
156802136|NCT02505425|566030804|FG002|Overall Study|Withdrawal by Subject|19|||
156802137|NCT02505425|566030805|FG003|Overall Study|Withdrawal by Subject|7|||
156802138|NCT02505425|566030802|FG000|Overall Study|Death|8|||
156802139|NCT02505425|566030803|FG001|Overall Study|Death|12|||
156802140|NCT02505425|566030804|FG002|Overall Study|Death|0|||
156802141|NCT02505425|566030805|FG003|Overall Study|Death|0|||
156802142|NCT00545779|566030811|FG000|Overall Study|Violation of selection criteria at entry|8|||
156802143|NCT00545779|566030811|FG000|Overall Study|Other protocol violation|1|||
156802144|NCT00545779|566030811|FG000|Overall Study|Did not cooperate|7|||
156802145|NCT00545779|566030811|FG000|Overall Study|Withdrawal by Subject|20|||
156802146|NCT00545779|566030811|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
156802147|NCT00545779|566030811|FG000|Overall Study|Failure to return|3|||
156802148|NCT01405196|566030812|FG000|Overall Study|Study Terminated by Sponsor|0|||
156802149|NCT01405196|566030813|FG001|Overall Study|Study Terminated by Sponsor|0|||
156802150|NCT01405196|566030814|FG002|Overall Study|Study Terminated by Sponsor|9|||
156802151|NCT01405196|566030815|FG003|Overall Study|Study Terminated by Sponsor|0|||
156802152|NCT01405196|566030812|FG000|Overall Study|Other|2|||
156802153|NCT01405196|566030813|FG001|Overall Study|Other|2|||
156802154|NCT01405196|566030814|FG002|Overall Study|Other|5|||
156802155|NCT01405196|566030815|FG003|Overall Study|Other|0|||
156802156|NCT01405196|566030812|FG000|Overall Study|Withdrawal by Subject|4|||
156802157|NCT01405196|566030813|FG001|Overall Study|Withdrawal by Subject|6|||
156802158|NCT01405196|566030814|FG002|Overall Study|Withdrawal by Subject|3|||
156802159|NCT01405196|566030815|FG003|Overall Study|Withdrawal by Subject|6|||
156802160|NCT01405196|566030812|FG000|Overall Study|Adverse Event|2|||
156802161|NCT01405196|566030813|FG001|Overall Study|Adverse Event|2|||
156802162|NCT01405196|566030814|FG002|Overall Study|Adverse Event|0|||
156802163|NCT01405196|566030815|FG003|Overall Study|Adverse Event|2|||
156802164|NCT01405196|566030812|FG000|Overall Study|Death|1|||
156802165|NCT01405196|566030813|FG001|Overall Study|Death|0|||
156802166|NCT01405196|566030814|FG002|Overall Study|Death|3|||
156802167|NCT01405196|566030815|FG003|Overall Study|Death|0|||
156802168|NCT01405196|566030812|FG000|Overall Study|Lost to Follow-up|2|||
156802169|NCT01405196|566030813|FG001|Overall Study|Lost to Follow-up|2|||
156802170|NCT01405196|566030814|FG002|Overall Study|Lost to Follow-up|3|||
156802171|NCT01405196|566030815|FG003|Overall Study|Lost to Follow-up|1|||
156802172|NCT01542788|566030816|FG000|Overall Study|Randomized but Not Treated|2|||
156802173|NCT01542788|566030817|FG001|Overall Study|Randomized but Not Treated|0|||
156802174|NCT01542788|566030816|FG000|Overall Study|Lack of Efficacy|41|||
156802175|NCT01542788|566030817|FG001|Overall Study|Lack of Efficacy|71|||
156802176|NCT01542788|566030816|FG000|Overall Study|Lost to Follow-up|5|||
156802177|NCT01542788|566030817|FG001|Overall Study|Lost to Follow-up|0|||
156802178|NCT01542788|566030816|FG000|Overall Study|Death|3|||
156802179|NCT01542788|566030817|FG001|Overall Study|Death|0|||
156802180|NCT01542788|566030816|FG000|Overall Study|Protocol Violation|2|||
156802181|NCT01542788|566030817|FG001|Overall Study|Protocol Violation|0|||
156802182|NCT01542788|566030816|FG000|Overall Study|Physician Decision|1|||
156802183|NCT01542788|566030817|FG001|Overall Study|Physician Decision|0|||
156802184|NCT01542788|566030816|FG000|Overall Study|Withdrawal by Subject|1|||
156802185|NCT01542788|566030817|FG001|Overall Study|Withdrawal by Subject|0|||
156802186|NCT05788991|566030818|FG000|Overall Study|Not treated with study medication|1|||
156802187|NCT05788991|566030819|FG001|Overall Study|Not treated with study medication|3|||
156802188|NCT05788991|566030818|FG000|Overall Study|Withdrawal by Subject|1|||
156802189|NCT05788991|566030819|FG001|Overall Study|Withdrawal by Subject|0|||
156802190|NCT05788991|566030818|FG000|Overall Study|Lack of Efficacy|0|||
156802191|NCT05788991|566030819|FG001|Overall Study|Lack of Efficacy|1|||
156802192|NCT05788991|566030818|FG000|Overall Study|Protocol Violation|1|||
156802193|NCT05788991|566030819|FG001|Overall Study|Protocol Violation|2|||
156802194|NCT04464473|566030820|FG000|Overall Study|New piercing could not be removed for scanning|0|||
156802195|NCT04464473|566030821|FG001|Overall Study|New piercing could not be removed for scanning|0|||
156802196|NCT04464473|566030822|FG002|Overall Study|New piercing could not be removed for scanning|0|||
156802197|NCT04464473|566030823|FG003|Overall Study|New piercing could not be removed for scanning|1|||
156802198|NCT04464473|566030824|FG004|Overall Study|New piercing could not be removed for scanning|0|||
156802199|NCT04464473|566030825|FG005|Overall Study|New piercing could not be removed for scanning|0|||
156802200|NCT04464473|566030820|FG000|Overall Study|Adverse Event|0|||
156802201|NCT04464473|566030821|FG001|Overall Study|Adverse Event|0|||
156802202|NCT04464473|566030822|FG002|Overall Study|Adverse Event|0|||
156802203|NCT04464473|566030823|FG003|Overall Study|Adverse Event|1|||
156802204|NCT04464473|566030824|FG004|Overall Study|Adverse Event|0|||
156802205|NCT04464473|566030825|FG005|Overall Study|Adverse Event|0|||
156802206|NCT04464473|566030820|FG000|Overall Study|Lost to Follow-up|0|||
156802207|NCT04464473|566030821|FG001|Overall Study|Lost to Follow-up|0|||
156802208|NCT04464473|566030822|FG002|Overall Study|Lost to Follow-up|0|||
156802209|NCT04464473|566030823|FG003|Overall Study|Lost to Follow-up|1|||
156802210|NCT04464473|566030824|FG004|Overall Study|Lost to Follow-up|0|||
156802211|NCT04464473|566030825|FG005|Overall Study|Lost to Follow-up|0|||
156802212|NCT03802396|566030826|FG000|Overall Study|Withdrawal by Subject|2|||
156802213|NCT03802396|566030827|FG001|Overall Study|Withdrawal by Subject|0|||
156802214|NCT03802396|566030826|FG000|Overall Study|Surgery Cancelled|1|||
156802215|NCT03802396|566030827|FG001|Overall Study|Surgery Cancelled|0|||
156802216|NCT03549338|566032176|FG000|Overall Study|Progressive Disease|1|||
156802217|NCT03549338|566032177|FG001|Overall Study|Progressive Disease|0|||
156802218|NCT03549338|566032178|FG002|Overall Study|Progressive Disease|0|||
156802219|NCT03549338|566032176|FG000|Overall Study|Clinical Progression|0|||
156802220|NCT03549338|566032177|FG001|Overall Study|Clinical Progression|1|||
156802221|NCT03549338|566032178|FG002|Overall Study|Clinical Progression|0|||
156802222|NCT01492426|566032179|FG000|Treatment|Death|0|||
156802223|NCT01492426|566032180|FG001|Treatment|Death|1|||
156802224|NCT01492426|566032179|FG000|Treatment|Other|1|||
156802225|NCT01492426|566032180|FG001|Treatment|Other|0|||
156802226|NCT01492426|566032179|FG000|Treatment|Adverse Event|25|||
156802227|NCT01492426|566032180|FG001|Treatment|Adverse Event|25|||
156802228|NCT01492426|566032179|FG000|Treatment|Lack of Efficacy|38|||
156802229|NCT01492426|566032180|FG001|Treatment|Lack of Efficacy|5|||
156802230|NCT01492426|566032179|FG000|Treatment|Participant withdrew consent|1|||
156802231|NCT01492426|566032180|FG001|Treatment|Participant withdrew consent|2|||
156802232|NCT01492426|566032179|FG000|Treatment|Poor compliance/noncompliance|1|||
156802233|NCT01492426|566032180|FG001|Treatment|Poor compliance/noncompliance|0|||
156802234|NCT01492426|566032179|FG000|Treatment|Subject requested discontinue study drug|7|||
156802235|NCT01492426|566032180|FG001|Treatment|Subject requested discontinue study drug|3|||
156802236|NCT01492426|566032179|FG000|Treatment|Lost to Follow-up|9|||
156802237|NCT01492426|566032180|FG001|Treatment|Lost to Follow-up|4|||
156802238|NCT01492426|566032179|FG000|Treatment|Participant does not meet study criteria|1|||
156802239|NCT01492426|566032180|FG001|Treatment|Participant does not meet study criteria|0|||
156802240|NCT01492426|566032179|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
156802241|NCT01492426|566032180|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
156802242|NCT01492426|566032179|FG000|Follow-Up|Death|1|||
156802243|NCT01492426|566032180|FG001|Follow-Up|Death|0|||
156802244|NCT01492426|566032179|FG000|Follow-Up|Other|4|||
156802245|NCT01492426|566032180|FG001|Follow-Up|Other|2|||
156802246|NCT01492426|566032179|FG000|Follow-Up|Participant Withdrew Consent|6|||
156802247|NCT01492426|566032180|FG001|Follow-Up|Participant Withdrew Consent|1|||
156802248|NCT01492426|566032179|FG000|Follow-Up|Lost to Follow-up|12|||
156802249|NCT01492426|566032180|FG001|Follow-Up|Lost to Follow-up|6|||
156802250|NCT00269113|566032181|FG000|Overall Study|Adverse Event|14|||
156802251|NCT00269113|566032182|FG001|Overall Study|Adverse Event|7|||
156802252|NCT00269113|566032181|FG000|Overall Study|Lack of Efficacy|35|||
156802253|NCT00269113|566032182|FG001|Overall Study|Lack of Efficacy|18|||
156802254|NCT00269113|566032181|FG000|Overall Study|Early Improvement|2|||
156802255|NCT00269113|566032182|FG001|Overall Study|Early Improvement|0|||
156537135|NCT00467779|565061095|FG000|Stage 1|Unspecified Reason|1|||
156802256|NCT00269113|566032181|FG000|Overall Study|Withdrawal by Subject|0|||
156802257|NCT00269113|566032182|FG001|Overall Study|Withdrawal by Subject|2|||
156802258|NCT00269113|566032181|FG000|Overall Study|Death|6|||
156802259|NCT00269113|566032182|FG001|Overall Study|Death|2|||
156802260|NCT00269113|566032181|FG000|Overall Study|Lost to Follow-up|2|||
156802261|NCT00269113|566032182|FG001|Overall Study|Lost to Follow-up|1|||
156802262|NCT00269113|566032181|FG000|Overall Study|Protocol Violation|15|||
156802263|NCT00269113|566032182|FG001|Overall Study|Protocol Violation|5|||
156802264|NCT00269113|566032181|FG000|Overall Study|Other|0|||
156802265|NCT00269113|566032182|FG001|Overall Study|Other|2|||
156802266|NCT01770743|566032183|FG000|Overall Study|Adverse Event|1|||
156802267|NCT01770743|566032184|FG001|Overall Study|Adverse Event|0|||
156802268|NCT01770743|566032185|FG002|Overall Study|Adverse Event|0|||
156802269|NCT01770743|566032186|FG003|Overall Study|Adverse Event|0|||
156802270|NCT01770743|566032187|FG004|Overall Study|Adverse Event|0|||
156802271|NCT01770743|566032183|FG000|Overall Study|Withdrawal by Subject|0|||
156802272|NCT01770743|566032184|FG001|Overall Study|Withdrawal by Subject|0|||
156802273|NCT01770743|566032185|FG002|Overall Study|Withdrawal by Subject|1|||
156802274|NCT01770743|566032186|FG003|Overall Study|Withdrawal by Subject|1|||
156802275|NCT01770743|566032187|FG004|Overall Study|Withdrawal by Subject|1|||
156802276|NCT01770743|566032183|FG000|Overall Study|Lost to Follow-up|0|||
156802277|NCT01770743|566032184|FG001|Overall Study|Lost to Follow-up|2|||
156802278|NCT01770743|566032185|FG002|Overall Study|Lost to Follow-up|0|||
156802279|NCT01770743|566032186|FG003|Overall Study|Lost to Follow-up|0|||
156802280|NCT01770743|566032187|FG004|Overall Study|Lost to Follow-up|1|||
156802281|NCT01770743|566032183|FG000|Overall Study|Sponsor Terminated Subject|1|||
156802282|NCT01770743|566032184|FG001|Overall Study|Sponsor Terminated Subject|0|||
156802283|NCT01770743|566032185|FG002|Overall Study|Sponsor Terminated Subject|0|||
156802284|NCT01770743|566032186|FG003|Overall Study|Sponsor Terminated Subject|1|||
156802285|NCT01770743|566032187|FG004|Overall Study|Sponsor Terminated Subject|0|||
156802286|NCT01770743|566032183|FG000|Overall Study|Moving Out of State|0|||
156802287|NCT01770743|566032184|FG001|Overall Study|Moving Out of State|1|||
156802288|NCT01770743|566032185|FG002|Overall Study|Moving Out of State|0|||
156802289|NCT01770743|566032186|FG003|Overall Study|Moving Out of State|0|||
156802290|NCT01770743|566032187|FG004|Overall Study|Moving Out of State|0|||
156802291|NCT01585025|566032190|FG000|Overall Study|Withdrawal by Subject|0|||
156802292|NCT01585025|566032191|FG001|Overall Study|Withdrawal by Subject|3|||
156802293|NCT01585025|566032192|FG002|Overall Study|Withdrawal by Subject|4|||
156802294|NCT00503984|566032193|FG000|Overall Study|Protocol Violation|0|||
156802295|NCT00503984|566032194|FG001|Overall Study|Protocol Violation|1|||
156802296|NCT00503984|566032195|FG002|Overall Study|Protocol Violation|0|||
156802297|NCT00503984|566032196|FG003|Overall Study|Protocol Violation|0|||
156802298|NCT00503984|566032197|FG004|Overall Study|Protocol Violation|0|||
156802299|NCT00503984|566032198|FG005|Overall Study|Protocol Violation|0|||
156802300|NCT00503984|566032193|FG000|Overall Study|Adverse Event|0|||
156802301|NCT00503984|566032194|FG001|Overall Study|Adverse Event|1|||
156802302|NCT00503984|566032195|FG002|Overall Study|Adverse Event|0|||
156802303|NCT00503984|566032196|FG003|Overall Study|Adverse Event|0|||
156802304|NCT00503984|566032197|FG004|Overall Study|Adverse Event|0|||
156802305|NCT00503984|566032198|FG005|Overall Study|Adverse Event|0|||
156802306|NCT00503984|566032193|FG000|Overall Study|Death|0|||
156802307|NCT00503984|566032194|FG001|Overall Study|Death|0|||
156802308|NCT00503984|566032195|FG002|Overall Study|Death|0|||
156802309|NCT00503984|566032196|FG003|Overall Study|Death|0|||
156802310|NCT00503984|566032197|FG004|Overall Study|Death|1|||
156802311|NCT00503984|566032198|FG005|Overall Study|Death|0|||
156802312|NCT02122380|566032202|FG000|First Intervention (30 Days)|Adverse Event|1|||
156802313|NCT02122380|566032203|FG001|First Intervention (30 Days)|Adverse Event|0|||
156802314|NCT02122380|566032202|FG000|First Intervention (30 Days)|Physician Decision|0|||
156802315|NCT02122380|566032203|FG001|First Intervention (30 Days)|Physician Decision|1|||
156802316|NCT02122380|566032202|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
156802317|NCT02122380|566032203|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
156802318|NCT02122380|566032202|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
156802319|NCT02122380|566032203|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
156802320|NCT02122380|566032202|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
156802321|NCT02122380|566032203|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
156802322|NCT00952705|566032204|FG000|Overall Study|Lost to Follow-up|24|||
156802323|NCT00952705|566032205|FG001|Overall Study|Lost to Follow-up|8|||
156802324|NCT00952705|566032206|FG002|Overall Study|Lost to Follow-up|9|||
156802325|NCT00952705|566032204|FG000|Overall Study|Withdrawal by Subject|2|||
156802326|NCT00952705|566032205|FG001|Overall Study|Withdrawal by Subject|1|||
156802327|NCT00952705|566032206|FG002|Overall Study|Withdrawal by Subject|1|||
156802328|NCT00952705|566032204|FG000|Overall Study|Death|2|||
156802329|NCT00952705|566032205|FG001|Overall Study|Death|0|||
156802330|NCT00952705|566032206|FG002|Overall Study|Death|0|||
156802331|NCT00952705|566032204|FG000|Overall Study|Incarcerated post dose|5|||
156802332|NCT00952705|566032205|FG001|Overall Study|Incarcerated post dose|0|||
156802333|NCT00952705|566032206|FG002|Overall Study|Incarcerated post dose|0|||
156802334|NCT00952705|566032204|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
156802335|NCT00952705|566032205|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
156802336|NCT00952705|566032206|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
156802337|NCT00140140|566032207|FG000|Overall Study|Unacceptable toxicity|1|||
156802338|NCT00140140|566032208|FG001|Overall Study|Unacceptable toxicity|1|||
156802339|NCT00140140|566032209|FG002|Overall Study|Unacceptable toxicity|2|||
156802340|NCT00140140|566032207|FG000|Overall Study|Physician Decision|1|||
156802341|NCT00140140|566032208|FG001|Overall Study|Physician Decision|1|||
156802342|NCT00140140|566032209|FG002|Overall Study|Physician Decision|0|||
156802343|NCT00639457|566032210|FG000|Overall Study|Withdrawal by Subject|2|||
156802344|NCT00639457|566032211|FG001|Overall Study|Withdrawal by Subject|3|||
156802345|NCT01126190|566032212|FG000|Double-Blind Phase|Death|0|||
156802346|NCT01126190|566032213|FG001|Double-Blind Phase|Death|1|||
156802347|NCT01126190|566032214|FG002|Double-Blind Phase|Death|0|||
156802348|NCT01126190|566032212|FG000|Double-Blind Phase|Adverse Event|1|||
156802349|NCT01126190|566032213|FG001|Double-Blind Phase|Adverse Event|2|||
156802350|NCT01126190|566032214|FG002|Double-Blind Phase|Adverse Event|0|||
156802351|NCT01126190|566032212|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
156802352|NCT01126190|566032213|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
156802353|NCT01126190|566032214|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156802354|NCT01126190|566032212|FG000|Double-Blind Phase|Request of Investigator|1|||
156802355|NCT01126190|566032213|FG001|Double-Blind Phase|Request of Investigator|0|||
156802356|NCT01126190|566032214|FG002|Double-Blind Phase|Request of Investigator|0|||
156802357|NCT01126190|566032212|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
156802358|NCT01126190|566032213|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
156802359|NCT01126190|566032214|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
156802360|NCT01126190|566032212|FG000|Double-Blind Phase|Non-compliance|1|||
156802361|NCT01126190|566032213|FG001|Double-Blind Phase|Non-compliance|0|||
156802362|NCT01126190|566032214|FG002|Double-Blind Phase|Non-compliance|0|||
156802363|NCT01126190|566032212|FG000|Double-Blind Phase|Lost to Follow-up|1|||
156802364|NCT01126190|566032213|FG001|Double-Blind Phase|Lost to Follow-up|3|||
156802365|NCT01126190|566032214|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156802366|NCT01126190|566032212|FG000|Open-Label Phase|Death|0|||
156802367|NCT01126190|566032213|FG001|Open-Label Phase|Death|0|||
156802368|NCT01126190|566032214|FG002|Open-Label Phase|Death|1|||
156802369|NCT01126190|566032212|FG000|Open-Label Phase|Adverse Event|0|||
156802370|NCT01126190|566032213|FG001|Open-Label Phase|Adverse Event|0|||
156802371|NCT01126190|566032214|FG002|Open-Label Phase|Adverse Event|4|||
156802372|NCT01126190|566032212|FG000|Open-Label Phase|Withdrawal by Subject|0|||
156802373|NCT01126190|566032213|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156802374|NCT01126190|566032214|FG002|Open-Label Phase|Withdrawal by Subject|6|||
156802375|NCT00892008|566032217|FG000|Overall Study|Death|5|||
156802376|NCT00892008|566032217|FG000|Overall Study|Lack of Efficacy|3|||
156802377|NCT00892008|566032217|FG000|Overall Study|Lost to Follow-up|142|||
156802378|NCT00892008|566032217|FG000|Overall Study|Other|378|||
156802379|NCT00892008|566032217|FG000|Overall Study|Adverse Event|37|||
156802380|NCT01466491|566032218|FG000|Overall Study|Protocol Violation|0|||
156802381|NCT01466491|566032219|FG001|Overall Study|Protocol Violation|3|||
156802382|NCT01466491|566032220|FG002|Overall Study|Protocol Violation|2|||
156802383|NCT01466491|566032221|FG003|Overall Study|Protocol Violation|0|||
156802384|NCT01466491|566032218|FG000|Overall Study|Missing Data|0|||
156802385|NCT01466491|566032219|FG001|Overall Study|Missing Data|0|||
156802386|NCT01466491|566032220|FG002|Overall Study|Missing Data|1|||
156802387|NCT01466491|566032221|FG003|Overall Study|Missing Data|0|||
156802388|NCT02727322|566032222|FG000|Overall Study|Withdrawal by Subject|1|||
156802389|NCT02727322|566032223|FG001|Overall Study|Withdrawal by Subject|1|||
156802390|NCT02727322|566032222|FG000|Overall Study|Protocol Violation|1|||
156802391|NCT02727322|566032223|FG001|Overall Study|Protocol Violation|0|||
156802392|NCT03435380|566032224|FG000|Overall Study|Death|1|||
156802393|NCT03435380|566032225|FG001|Overall Study|Death|2|||
156802394|NCT03435380|566032226|FG002|Overall Study|Death|1|||
156802395|NCT03435380|566032224|FG000|Overall Study|Lost to Follow-up|12|||
156802396|NCT03435380|566032225|FG001|Overall Study|Lost to Follow-up|8|||
156802397|NCT03435380|566032226|FG002|Overall Study|Lost to Follow-up|6|||
156802398|NCT03435380|566032224|FG000|Overall Study|Physician Decision|1|||
156802399|NCT03435380|566032225|FG001|Overall Study|Physician Decision|0|||
156802400|NCT03435380|566032226|FG002|Overall Study|Physician Decision|0|||
156802401|NCT03435380|566032224|FG000|Overall Study|Withdrawal by Subject|0|||
156802402|NCT03435380|566032225|FG001|Overall Study|Withdrawal by Subject|1|||
156802403|NCT03435380|566032226|FG002|Overall Study|Withdrawal by Subject|1|||
156802404|NCT03435380|566032224|FG000|Overall Study|Ineligible|0|||
156802405|NCT03435380|566032225|FG001|Overall Study|Ineligible|1|||
156802406|NCT03435380|566032226|FG002|Overall Study|Ineligible|1|||
156802407|NCT02431325|566032227|FG000|Overall Study|Adverse Event|3|||
156802408|NCT02431325|566032228|FG001|Overall Study|Adverse Event|0|||
156802409|NCT02431325|566032227|FG000|Overall Study|Lost to Follow-up|0|||
156802410|NCT02431325|566032228|FG001|Overall Study|Lost to Follow-up|1|||
156802411|NCT02431325|566032227|FG000|Overall Study|Withdrawal by Subject|1|||
156459378|NCT03034356|564776805|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
156337533|NCT00672646|564333680|FG002|Overall Study|Withdrawal by Subject|1|||
156337534|NCT00289783|564333683|FG000|Primary Phase|Adverse Event|10|||
156459379|NCT03034356|564776806|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
156459380|NCT03034356|564776805|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
156802412|NCT02431325|566032228|FG001|Overall Study|Withdrawal by Subject|2|||
156802413|NCT02431325|566032227|FG000|Overall Study|Declined to take study medication|1|||
156802414|NCT02431325|566032228|FG001|Overall Study|Declined to take study medication|0|||
156802415|NCT02431325|566032227|FG000|Overall Study|Withdrew before starting study medication|1|||
156802416|NCT02431325|566032228|FG001|Overall Study|Withdrew before starting study medication|0|||
156802417|NCT02431325|566032227|FG000|Overall Study|Placebo shortage|2|||
156802418|NCT02431325|566032228|FG001|Overall Study|Placebo shortage|0|||
156802419|NCT01917318|566032229|FG000|First Treatment|Withdrawal by Subject|0|||
156802420|NCT01917318|566032230|FG001|First Treatment|Withdrawal by Subject|1|||
156802421|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Physician Decision|2|||
156802422|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Physician Decision|0|||
156802423|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Physician Decision|0|||
156802424|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Adverse Event|33|||
156802425|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Adverse Event|0|||
156802426|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Adverse Event|0|||
156802427|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
156802428|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
156802429|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
156802430|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
156802431|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
156802432|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
156802433|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
156802434|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
156802435|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
156802436|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
156802437|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
156802438|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
156802439|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
156802440|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
156802441|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
156802442|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
156802443|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
156802444|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
156802445|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
156802446|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
156802447|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
156802448|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
156802449|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
156802450|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
156802451|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
156802452|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
156802453|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
156802454|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
156802455|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
156802456|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
156802457|NCT01128569|566032234|FG000|Washout Period 1|Adverse Event|0|||
156802458|NCT01128569|566032235|FG001|Washout Period 1|Adverse Event|0|||
156802459|NCT01128569|566032236|FG002|Washout Period 1|Adverse Event|1|||
156802460|NCT01128569|566032237|FG003|Washout Period 1|Adverse Event|0|||
156802461|NCT01128569|566032238|FG004|Washout Period 1|Adverse Event|0|||
156802462|NCT01128569|566032239|FG005|Washout Period 1|Adverse Event|0|||
156802463|NCT01128569|566032234|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156802464|NCT01128569|566032235|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156802465|NCT01128569|566032236|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156802466|NCT01128569|566032237|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156802467|NCT01128569|566032238|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156802468|NCT01128569|566032239|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156802469|NCT03338400|566032240|FG000|Overall Study|Lost to Follow-up|1|||
156802470|NCT03338400|566032241|FG001|Overall Study|Lost to Follow-up|2|||
156802471|NCT00487981|566032242|FG000|Overall Study|Hypothyroidism diagnosis|1|||
156802472|NCT01865487|566032245|FG000|Overall Study|Lost to Follow-up|0|||
156802473|NCT01865487|566032246|FG001|Overall Study|Lost to Follow-up|0|||
156802474|NCT01865487|566032247|FG002|Overall Study|Lost to Follow-up|0|||
156802475|NCT01865487|566032248|FG003|Overall Study|Lost to Follow-up|1|||
156802476|NCT01865487|566032249|FG004|Overall Study|Lost to Follow-up|0|||
156802477|NCT01865487|566032250|FG005|Overall Study|Lost to Follow-up|0|||
156802478|NCT01865487|566032251|FG006|Overall Study|Lost to Follow-up|1|||
156802479|NCT01865487|566032252|FG007|Overall Study|Lost to Follow-up|0|||
156802480|NCT01865487|566032253|FG008|Overall Study|Lost to Follow-up|0|||
156802481|NCT01865487|566032254|FG009|Overall Study|Lost to Follow-up|0|||
156802482|NCT01865487|566032245|FG000|Overall Study|Withdrawal by Subject|0|||
156802483|NCT01865487|566032246|FG001|Overall Study|Withdrawal by Subject|0|||
156802484|NCT01865487|566032247|FG002|Overall Study|Withdrawal by Subject|0|||
156802485|NCT01865487|566032248|FG003|Overall Study|Withdrawal by Subject|0|||
156802486|NCT01865487|566032249|FG004|Overall Study|Withdrawal by Subject|1|||
156802487|NCT01865487|566032250|FG005|Overall Study|Withdrawal by Subject|0|||
156802488|NCT01865487|566032251|FG006|Overall Study|Withdrawal by Subject|0|||
156802489|NCT01865487|566032252|FG007|Overall Study|Withdrawal by Subject|0|||
156802490|NCT01865487|566032253|FG008|Overall Study|Withdrawal by Subject|0|||
156802491|NCT01865487|566032254|FG009|Overall Study|Withdrawal by Subject|0|||
156802492|NCT01627691|566032259|FG000|Overall Study|Death|11|||
156802493|NCT01627691|566032259|FG000|Overall Study|Lost to Follow-up|3|||
156802494|NCT01627691|566032259|FG000|Overall Study|Withdrawal by Subject|1|||
156802495|NCT01627691|566032259|FG000|Overall Study|Missed the visit|3|||
156802496|NCT01908140|566032260|FG000|Overall Study|Other or Progressive Disease|5|||
156802497|NCT01908140|566032261|FG001|Overall Study|Other or Progressive Disease|12|||
156802498|NCT01908140|566032260|FG000|Overall Study|Lack of Efficacy|7|||
156802499|NCT01908140|566032261|FG001|Overall Study|Lack of Efficacy|5|||
156802500|NCT01908140|566032260|FG000|Overall Study|Withdrawal by Subject|23|||
156802501|NCT01908140|566032261|FG001|Overall Study|Withdrawal by Subject|24|||
156802502|NCT01908140|566032260|FG000|Overall Study|Lost to Follow-up|1|||
156802503|NCT01908140|566032261|FG001|Overall Study|Lost to Follow-up|6|||
156802504|NCT01908140|566032260|FG000|Overall Study|Protocol Violation|8|||
156802505|NCT01908140|566032261|FG001|Overall Study|Protocol Violation|9|||
156802506|NCT01908140|566032260|FG000|Overall Study|Adverse Event|22|||
156802507|NCT01908140|566032261|FG001|Overall Study|Adverse Event|23|||
156802508|NCT01307449|566032262|FG000|Overall Study|Adverse Event|1|||
156802509|NCT01307449|566032263|FG001|Overall Study|Adverse Event|0|||
156802510|NCT01307449|566032264|FG002|Overall Study|Adverse Event|0|||
156802511|NCT01307449|566032265|FG003|Overall Study|Adverse Event|0|||
156802512|NCT03218917|566032266|FG000|Overall Study|Adverse Event|3|||
156802513|NCT03218917|566032267|FG001|Overall Study|Adverse Event|3|||
156802514|NCT03218917|566032268|FG002|Overall Study|Adverse Event|2|||
156802515|NCT03218917|566032266|FG000|Overall Study|Subject withdrew consent|2|||
156802516|NCT03218917|566032267|FG001|Overall Study|Subject withdrew consent|4|||
156802517|NCT03218917|566032268|FG002|Overall Study|Subject withdrew consent|10|||
156802518|NCT03218917|566032266|FG000|Overall Study|Physician Decision|0|||
156802519|NCT03218917|566032267|FG001|Overall Study|Physician Decision|1|||
156802520|NCT03218917|566032268|FG002|Overall Study|Physician Decision|1|||
156802521|NCT03218917|566032266|FG000|Overall Study|Lost to Follow-up|1|||
156802522|NCT03218917|566032267|FG001|Overall Study|Lost to Follow-up|0|||
156802523|NCT03218917|566032268|FG002|Overall Study|Lost to Follow-up|0|||
156802524|NCT03218917|566032266|FG000|Overall Study|Reason Missing|0|||
156802525|NCT03218917|566032267|FG001|Overall Study|Reason Missing|2|||
156802526|NCT03218917|566032268|FG002|Overall Study|Reason Missing|0|||
156802527|NCT03218917|566032266|FG000|Overall Study|Death|0|||
156802528|NCT03218917|566032267|FG001|Overall Study|Death|1|||
156802529|NCT03218917|566032268|FG002|Overall Study|Death|0|||
156802530|NCT03218917|566032266|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156802531|NCT03218917|566032267|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156802532|NCT03218917|566032268|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156802533|NCT02927795|566032271|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
156802534|NCT02927795|566032271|FG000|Overall Study|Not Treated|4|||
156802535|NCT05525910|566032273|FG000|Period 4|Per sponsor due to study timelines|0|||
156802536|NCT05525910|566032274|FG001|Period 4|Per sponsor due to study timelines|0|||
156802537|NCT05525910|566032275|FG002|Period 4|Per sponsor due to study timelines|1|||
156802538|NCT05525910|566032276|FG003|Period 4|Per sponsor due to study timelines|1|||
156802539|NCT05525910|566032277|FG004|Period 4|Per sponsor due to study timelines|1|||
156802540|NCT00181844|566032279|FG000|Signed Consent|Withdrawal by Subject|5|||
156802541|NCT00181844|566032279|FG000|Signed Consent|Did not meet entrance criteria|7|||
156802542|NCT00181844|566032279|FG000|Exposed to Study Medication|Adverse Event|10|||
156802543|NCT00181844|566032279|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
156802544|NCT00181844|566032279|FG000|Exposed to Study Medication|Non-compliance|2|||
156802545|NCT00181844|566032279|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
156802546|NCT00181844|566032279|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
156802547|NCT00107276|566032281|FG000|Overall Study|Progression|46|||
156802548|NCT00107276|566032281|FG000|Overall Study|Adverse Event|6|||
156802549|NCT00107276|566032281|FG000|Overall Study|M.D. decision|2|||
156802550|NCT00107276|566032281|FG000|Overall Study|Patient refusal|1|||
156802551|NCT00107276|566032281|FG000|Overall Study|Death|1|||
156802552|NCT00107276|566032281|FG000|Overall Study|Ineligible|16|||
156802553|NCT05209386|566032282|FG000|Overall Study|Withdrawal by Subject|8|||
156802554|NCT05209386|566032282|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
156802555|NCT03179761|566032283|FG000|Overall Study|Death|2|||
156802556|NCT03179761|566032284|FG001|Overall Study|Death|5|||
156802557|NCT03179761|566032283|FG000|Overall Study|Lost to Follow-up|2|||
156802558|NCT03179761|566032284|FG001|Overall Study|Lost to Follow-up|2|||
156802559|NCT03179761|566032283|FG000|Overall Study|Protocol Violation|1|||
156802560|NCT03179761|566032284|FG001|Overall Study|Protocol Violation|0|||
156802561|NCT03179761|566032283|FG000|Overall Study|Withdrawal by Subject|1|||
156802562|NCT03179761|566032284|FG001|Overall Study|Withdrawal by Subject|4|||
156802563|NCT03179761|566032283|FG000|Overall Study|Investigator Request|0|||
156802564|NCT03179761|566032284|FG001|Overall Study|Investigator Request|2|||
156802565|NCT02284191|566032285|FG000|Overall Study|Withdrawal by Subject|1|||
156802566|NCT02284191|566032286|FG001|Overall Study|Withdrawal by Subject|3|||
156802567|NCT02284191|566032285|FG000|Overall Study|Lost to Follow-up|1|||
156802568|NCT02284191|566032286|FG001|Overall Study|Lost to Follow-up|0|||
156802569|NCT02257684|566032289|FG000|Overall Study|Adverse Event|2|||
156802570|NCT02257684|566032289|FG000|Overall Study|Lack of Efficacy|1|||
156802571|NCT02257684|566032289|FG000|Overall Study|Sponsor's Decision|1|||
156802572|NCT02170064|566032293|FG000|Overall Study|Withdrawal by Subject|5|||
156802573|NCT02170064|566032294|FG001|Overall Study|Withdrawal by Subject|1|||
156802574|NCT02170064|566032295|FG002|Overall Study|Withdrawal by Subject|1|||
156802575|NCT02170064|566032293|FG000|Overall Study|Physician Decision|1|||
156802576|NCT02170064|566032294|FG001|Overall Study|Physician Decision|1|||
156802577|NCT02170064|566032295|FG002|Overall Study|Physician Decision|0|||
156802578|NCT02359903|566032296|FG000|Overall Study|Adverse Event|0|||
156802579|NCT02359903|566032297|FG001|Overall Study|Adverse Event|2|||
156802580|NCT03507127|566032305|FG000|Overall Study|Withdrawal by Subject|1|||
156802581|NCT03507127|566032306|FG001|Overall Study|Withdrawal by Subject|0|||
156802582|NCT03507127|566032305|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
156802583|NCT03507127|566032306|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
156802584|NCT01240863|566032307|FG000|Open-label Titration Period|Adverse Event|47|||
156802585|NCT01240863|566032308|FG001|Open-label Titration Period|Adverse Event|0|||
156802586|NCT01240863|566032309|FG002|Open-label Titration Period|Adverse Event|0|||
156802587|NCT01240863|566032307|FG000|Open-label Titration Period|Lack of Efficacy|19|||
156802588|NCT01240863|566032308|FG001|Open-label Titration Period|Lack of Efficacy|0|||
156802589|NCT01240863|566032309|FG002|Open-label Titration Period|Lack of Efficacy|0|||
156802590|NCT01240863|566032307|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
156802591|NCT01240863|566032308|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
156802592|NCT01240863|566032309|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
156802593|NCT01240863|566032307|FG000|Open-label Titration Period|Protocol Violation|7|||
156802594|NCT01240863|566032308|FG001|Open-label Titration Period|Protocol Violation|0|||
156802595|NCT01240863|566032309|FG002|Open-label Titration Period|Protocol Violation|0|||
156802596|NCT01240863|566032307|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
156802597|NCT01240863|566032308|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
156802598|NCT01240863|566032309|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
156802599|NCT01240863|566032307|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
156802600|NCT01240863|566032308|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
156802601|NCT01240863|566032309|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
156802602|NCT01240863|566032307|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
156802603|NCT01240863|566032308|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
156802604|NCT01240863|566032309|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
156802605|NCT01240863|566032307|FG000|Open-label Titration Period|Other|7|||
156802606|NCT01240863|566032308|FG001|Open-label Titration Period|Other|0|||
156802607|NCT01240863|566032309|FG002|Open-label Titration Period|Other|0|||
156802608|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
156802609|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
156802610|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
156802611|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
156802612|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
156802613|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
156802614|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156802615|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
156802616|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
156802617|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156802618|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
156802619|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
156802620|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
156802621|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
156802622|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
156802623|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
156802624|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
156802625|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
156802626|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
156802627|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
156802628|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
156802629|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
156802630|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
156802631|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
156802632|NCT00746811|566032312|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
156802633|NCT00746811|566032313|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
156802634|NCT02604511|566032314|FG000|Overall Study|Adverse Event|3|||
156802635|NCT02604511|566032314|FG000|Overall Study|Disease Progression|4|||
156802636|NCT02604511|566032314|FG000|Overall Study|Withdrawal by Subject|3|||
156802637|NCT02604511|566032314|FG000|Overall Study|Participant ineligible|1|||
156802638|NCT02604511|566032314|FG000|Overall Study|Intercurrent illness|1|||
156802639|NCT02561962|566032318|FG000|Overall Study|Withdrawal by Subject|1|||
156802640|NCT02561962|566032319|FG001|Overall Study|Withdrawal by Subject|0|||
156802641|NCT02561962|566032320|FG002|Overall Study|Withdrawal by Subject|0|||
156802642|NCT02561962|566032321|FG003|Overall Study|Withdrawal by Subject|0|||
156802643|NCT02561962|566032322|FG004|Overall Study|Withdrawal by Subject|1|||
156802644|NCT02561962|566032323|FG005|Overall Study|Withdrawal by Subject|1|||
156802645|NCT02561962|566032324|FG006|Overall Study|Withdrawal by Subject|2|||
156802646|NCT02561962|566032325|FG007|Overall Study|Withdrawal by Subject|1|||
156802647|NCT02561962|566032326|FG008|Overall Study|Withdrawal by Subject|0|||
156802648|NCT02561962|566032318|FG000|Overall Study|Decision by sponsor|0|||
156802649|NCT02561962|566032319|FG001|Overall Study|Decision by sponsor|0|||
156802650|NCT02561962|566032320|FG002|Overall Study|Decision by sponsor|0|||
156802651|NCT02561962|566032321|FG003|Overall Study|Decision by sponsor|0|||
156802652|NCT02561962|566032322|FG004|Overall Study|Decision by sponsor|1|||
156802653|NCT02561962|566032323|FG005|Overall Study|Decision by sponsor|1|||
156802654|NCT02561962|566032324|FG006|Overall Study|Decision by sponsor|0|||
156802655|NCT02561962|566032325|FG007|Overall Study|Decision by sponsor|3|||
156802656|NCT02561962|566032326|FG008|Overall Study|Decision by sponsor|0|||
156802657|NCT02561962|566032318|FG000|Overall Study|Lost to Follow-up|0|||
156802658|NCT02561962|566032319|FG001|Overall Study|Lost to Follow-up|0|||
156802659|NCT02561962|566032320|FG002|Overall Study|Lost to Follow-up|0|||
156802660|NCT02561962|566032321|FG003|Overall Study|Lost to Follow-up|0|||
156802661|NCT02561962|566032322|FG004|Overall Study|Lost to Follow-up|0|||
156802662|NCT02561962|566032323|FG005|Overall Study|Lost to Follow-up|1|||
156802663|NCT02561962|566032324|FG006|Overall Study|Lost to Follow-up|0|||
156802664|NCT02561962|566032325|FG007|Overall Study|Lost to Follow-up|0|||
156802665|NCT02561962|566032326|FG008|Overall Study|Lost to Follow-up|0|||
156802666|NCT03586973|566032327|FG000|Overall Study|Death|15|||
156802667|NCT03586973|566032328|FG001|Overall Study|Death|8|||
156802668|NCT03586973|566032327|FG000|Overall Study|Site Terminated by Sponsor|3|||
156802669|NCT03586973|566032328|FG001|Overall Study|Site Terminated by Sponsor|6|||
156802670|NCT03586973|566032327|FG000|Overall Study|Withdrawal by Subject|1|||
156802671|NCT03586973|566032328|FG001|Overall Study|Withdrawal by Subject|0|||
156802672|NCT03586973|566032327|FG000|Overall Study|Lost to Follow-up|1|||
156802673|NCT03586973|566032328|FG001|Overall Study|Lost to Follow-up|0|||
156802674|NCT01150357|566032334|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
156802675|NCT01150357|566032335|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
156802676|NCT01150357|566032336|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
156802677|NCT01150357|566032334|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
156802678|NCT01150357|566032335|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
156802679|NCT01150357|566032336|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
156802680|NCT01150357|566032334|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
156802681|NCT01150357|566032335|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
156802682|NCT01150357|566032336|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
156802683|NCT01150357|566032334|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
156802684|NCT01150357|566032335|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
156802685|NCT01150357|566032336|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
156802686|NCT01150357|566032334|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
156802687|NCT01150357|566032335|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
156802688|NCT01150357|566032336|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
156802689|NCT01150357|566032334|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
156802690|NCT01150357|566032335|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
156802691|NCT01150357|566032336|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
156802692|NCT01150357|566032334|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
156802693|NCT01150357|566032335|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
156802694|NCT01150357|566032336|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
156802695|NCT00652743|566033979|FG000|Months 12-18|Lost to Follow-up|1|||
156802696|NCT00652743|566033980|FG001|Months 12-18|Lost to Follow-up|2|||
156802697|NCT00652743|566033981|FG002|Months 12-18|Lost to Follow-up|7|||
156802698|NCT00652743|566033979|FG000|Months 24-30|Other|5|||
156802699|NCT00652743|566033980|FG001|Months 24-30|Other|1|||
156802700|NCT00652743|566033981|FG002|Months 24-30|Other|11|||
156802701|NCT00652743|566033979|FG000|Months 36-42|Serious Adverse Events|0|||
156802702|NCT00652743|566033980|FG001|Months 36-42|Serious Adverse Events|1|||
156802703|NCT00652743|566033981|FG002|Months 36-42|Serious Adverse Events|1|||
156802704|NCT00652743|566033979|FG000|Months 36-42|Withdrawal by Subject|1|||
156802705|NCT00652743|566033980|FG001|Months 36-42|Withdrawal by Subject|1|||
156802706|NCT00652743|566033981|FG002|Months 36-42|Withdrawal by Subject|0|||
156802707|NCT00652743|566033979|FG000|Months 36-42|Lost to Follow-up|0|||
156802708|NCT00652743|566033980|FG001|Months 36-42|Lost to Follow-up|1|||
156802709|NCT00652743|566033981|FG002|Months 36-42|Lost to Follow-up|0|||
156802710|NCT00652743|566033979|FG000|Months 36-42|Migrated/moved from study area|1|||
156802711|NCT00652743|566033980|FG001|Months 36-42|Migrated/moved from study area|0|||
156802712|NCT00652743|566033981|FG002|Months 36-42|Migrated/moved from study area|0|||
156802713|NCT00652743|566033979|FG000|Months 36-42|Other|4|||
156802714|NCT00652743|566033980|FG001|Months 36-42|Other|2|||
156802715|NCT00652743|566033981|FG002|Months 36-42|Other|8|||
156802716|NCT01114737|566033986|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
156802717|NCT01114737|566033987|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
156802718|NCT01114737|566033986|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
156802719|NCT01114737|566033987|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
156802720|NCT01114737|566033986|FG000|Randomized Treatment Period|Pregnancy|1|||
156802721|NCT01114737|566033987|FG001|Randomized Treatment Period|Pregnancy|0|||
156802722|NCT01114737|566033986|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
156802723|NCT01114737|566033987|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
156802724|NCT01114737|566033986|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
156802725|NCT01114737|566033987|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
156802726|NCT01114737|566033986|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
156802727|NCT01114737|566033987|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
156802728|NCT01123148|566033988|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
156802729|NCT01123148|566033988|FG000|Overall Study|Didn't meet milestone criteria|1|||
156802730|NCT02286895|566033989|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
156802731|NCT02286895|566033990|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
156802732|NCT02286895|566033989|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
156802733|NCT02286895|566033990|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
156802734|NCT02286895|566033989|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
156802735|NCT02286895|566033990|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
156802736|NCT00256126|566033991|FG000|Overall Study|Adverse Event|1|||
156802737|NCT00256126|566033992|FG001|Overall Study|Adverse Event|0|||
156802738|NCT00256126|566033991|FG000|Overall Study|Other|1|||
156802739|NCT00256126|566033992|FG001|Overall Study|Other|2|||
156802740|NCT00399035|566033993|FG000|Overall Study|Death|289|||
156802741|NCT00399035|566033994|FG001|Overall Study|Death|141|||
156802742|NCT00399035|566033995|FG002|Overall Study|Death|234|||
156802743|NCT00399035|566033993|FG000|Overall Study|Lost to Follow-up|2|||
156802744|NCT00399035|566033994|FG001|Overall Study|Lost to Follow-up|1|||
156802745|NCT00399035|566033995|FG002|Overall Study|Lost to Follow-up|5|||
156802746|NCT00399035|566033993|FG000|Overall Study|Withdrawal by Subject|19|||
156802747|NCT00399035|566033994|FG001|Overall Study|Withdrawal by Subject|15|||
156802748|NCT00399035|566033995|FG002|Overall Study|Withdrawal by Subject|12|||
156802749|NCT00399035|566033993|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
156802750|NCT00399035|566033994|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
156802751|NCT00399035|566033995|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
156802752|NCT00399035|566033993|FG000|Overall Study|Severe non-compliance with protocol|2|||
156802753|NCT00399035|566033994|FG001|Overall Study|Severe non-compliance with protocol|1|||
156802754|NCT00399035|566033995|FG002|Overall Study|Severe non-compliance with protocol|0|||
156802755|NCT02949011|566033998|FG000|Overall Study|Adverse Event|6|||
156802756|NCT02949011|566033999|FG001|Overall Study|Adverse Event|7|||
156802757|NCT02949011|566034000|FG002|Overall Study|Adverse Event|3|||
156802758|NCT02949011|566033998|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
156802759|NCT02949011|566033999|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
156802760|NCT02949011|566034000|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
156802761|NCT02949011|566033998|FG000|Overall Study|Protocol Deviation|5|||
156802762|NCT02949011|566033999|FG001|Overall Study|Protocol Deviation|3|||
156802763|NCT02949011|566034000|FG002|Overall Study|Protocol Deviation|3|||
156802764|NCT02949011|566033998|FG000|Overall Study|Lack of Efficacy|0|||
156802765|NCT02949011|566033999|FG001|Overall Study|Lack of Efficacy|2|||
156802766|NCT02949011|566034000|FG002|Overall Study|Lack of Efficacy|0|||
156802767|NCT02949011|566033998|FG000|Overall Study|Withdrawal by Subject|13|||
156802768|NCT02949011|566033999|FG001|Overall Study|Withdrawal by Subject|13|||
156802769|NCT02949011|566034000|FG002|Overall Study|Withdrawal by Subject|21|||
156802770|NCT02949011|566033998|FG000|Overall Study|Lost to Follow-up|7|||
156802771|NCT02949011|566033999|FG001|Overall Study|Lost to Follow-up|5|||
156802772|NCT02949011|566034000|FG002|Overall Study|Lost to Follow-up|5|||
156802773|NCT02949011|566033998|FG000|Overall Study|Death|0|||
156802774|NCT02949011|566033999|FG001|Overall Study|Death|0|||
156802775|NCT02949011|566034000|FG002|Overall Study|Death|1|||
156802776|NCT02949011|566033998|FG000|Overall Study|Miscellaneous|2|||
156802777|NCT02949011|566033999|FG001|Overall Study|Miscellaneous|4|||
156802778|NCT02949011|566034000|FG002|Overall Study|Miscellaneous|6|||
156802779|NCT04108273|566034001|FG000|Overall Study|COVID Pandemic|1|||
156802780|NCT04108273|566034002|FG001|Overall Study|COVID Pandemic|0|||
156802781|NCT01541371|566034003|FG000|Overall Study|Withdrawal by Subject|14|||
156802782|NCT01541371|566034003|FG000|Overall Study|Lost to Follow-up|21|||
156802783|NCT01541371|566034003|FG000|Overall Study|Adverse Event|15|||
156802784|NCT01541371|566034003|FG000|Overall Study|Lack of Efficacy|12|||
156802785|NCT01541371|566034003|FG000|Overall Study|Protocol Violation|6|||
156802786|NCT01541371|566034003|FG000|Overall Study|Study medication non-compliance|3|||
156802787|NCT01541371|566034003|FG000|Overall Study|Other|6|||
156802788|NCT02441218|566034004|FG000|Overall Study|Death|503|||
156802789|NCT02441218|566034005|FG001|Overall Study|Death|553|||
156802790|NCT02441218|566034004|FG000|Overall Study|Withdrawal by Subject|73|||
156802791|NCT02441218|566034005|FG001|Overall Study|Withdrawal by Subject|58|||
156802792|NCT02441218|566034004|FG000|Overall Study|Lost to Follow-up|2|||
156802793|NCT02441218|566034005|FG001|Overall Study|Lost to Follow-up|1|||
156802794|NCT00163189|566034008|FG000|Overall Study|Other|6|||
156802795|NCT00163189|566034008|FG000|Overall Study|Lost to Follow-up|1|||
156802796|NCT00163189|566034008|FG000|Overall Study|Protocol Violation|2|||
156802797|NCT00163189|566034008|FG000|Overall Study|Death|3|||
156802798|NCT00163189|566034008|FG000|Overall Study|Adverse Event|6|||
156802799|NCT00163189|566034008|FG000|Overall Study|Lack of Efficacy|7|||
156802800|NCT00163189|566034008|FG000|Overall Study|Study terminated by sponsor|11|||
156802801|NCT00163189|566034008|FG000|Overall Study|Withdrawal by Subject|11|||
156802802|NCT00163189|566034008|FG000|Overall Study|Did not meet continuation criterion|16|||
156802803|NCT04460183|566034009|FG000|Overall Study|Lost to Follow-up|3|||
156802804|NCT04460183|566034010|FG001|Overall Study|Lost to Follow-up|1|||
156802805|NCT04460183|566034009|FG000|Overall Study|Withdrawal by Subject|1|||
156802806|NCT04460183|566034010|FG001|Overall Study|Withdrawal by Subject|0|||
156802807|NCT01213082|566034011|FG000|Overall Study|Lost to Follow-up|6|||
156337535|NCT00289783|564333684|FG001|Primary Phase|Adverse Event|1|||
156337536|NCT00289783|564333683|FG000|Primary Phase|Protocol Violation|27|||
156802808|NCT01213082|566034012|FG001|Overall Study|Lost to Follow-up|7|||
156802809|NCT01213082|566034013|FG002|Overall Study|Lost to Follow-up|4|||
156802810|NCT01213082|566034011|FG000|Overall Study|Physician Decision|0|||
156802811|NCT01213082|566034012|FG001|Overall Study|Physician Decision|0|||
156802812|NCT01213082|566034013|FG002|Overall Study|Physician Decision|1|||
156802813|NCT00698828|566034024|FG000|Overall Study|Adverse Event|3|||
156802814|NCT00698828|566034025|FG001|Overall Study|Adverse Event|4|||
156802815|NCT00698828|566034026|FG002|Overall Study|Adverse Event|4|||
156802816|NCT00698828|566034024|FG000|Overall Study|Death|0|||
156802817|NCT00698828|566034025|FG001|Overall Study|Death|0|||
156802818|NCT00698828|566034026|FG002|Overall Study|Death|1|||
156802819|NCT00698828|566034024|FG000|Overall Study|Exacerbation of COPD|1|||
156802820|NCT00698828|566034025|FG001|Overall Study|Exacerbation of COPD|3|||
156802821|NCT00698828|566034026|FG002|Overall Study|Exacerbation of COPD|0|||
156802822|NCT00698828|566034024|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
156802823|NCT00698828|566034025|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
156802824|NCT00698828|566034026|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
156802825|NCT00698828|566034024|FG000|Overall Study|Investigator/Sponsor decision|1|||
156802826|NCT00698828|566034025|FG001|Overall Study|Investigator/Sponsor decision|0|||
156802827|NCT00698828|566034026|FG002|Overall Study|Investigator/Sponsor decision|2|||
156802828|NCT00698828|566034024|FG000|Overall Study|Lost to Follow-up|1|||
156802829|NCT00698828|566034025|FG001|Overall Study|Lost to Follow-up|1|||
156802830|NCT00698828|566034026|FG002|Overall Study|Lost to Follow-up|0|||
156802831|NCT00698828|566034024|FG000|Overall Study|Withdrew consent|0|||
156802832|NCT00698828|566034025|FG001|Overall Study|Withdrew consent|7|||
156802833|NCT00698828|566034026|FG002|Overall Study|Withdrew consent|4|||
156802834|NCT00698828|566034024|FG000|Overall Study|Withdrew consent (not treated)|2|||
156802835|NCT00698828|566034025|FG001|Overall Study|Withdrew consent (not treated)|0|||
156802836|NCT00698828|566034026|FG002|Overall Study|Withdrew consent (not treated)|0|||
156802837|NCT02013609|566034027|FG000|Overall Study|Withdrawal by Subject|9|||
156802838|NCT02013609|566034027|FG000|Overall Study|Lost to Follow-up|3|||
156802839|NCT02013609|566034027|FG000|Overall Study|Adverse Event|3|||
156802840|NCT02013609|566034027|FG000|Overall Study|Met Withdrawal Criteria|3|||
156802841|NCT01816295|566034028|FG000|Double Blind Phase|Adverse Event|11|||
156802842|NCT01816295|566034029|FG001|Double Blind Phase|Adverse Event|8|||
156802843|NCT01816295|566034028|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
156802844|NCT01816295|566034029|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
156802845|NCT01816295|566034028|FG000|Double Blind Phase|Lost to Follow-up|3|||
156802846|NCT01816295|566034029|FG001|Double Blind Phase|Lost to Follow-up|5|||
156802847|NCT01816295|566034028|FG000|Double Blind Phase|Physician Decision|2|||
156337537|NCT00289783|564333684|FG001|Primary Phase|Protocol Violation|6|||
156802848|NCT01816295|566034029|FG001|Double Blind Phase|Physician Decision|2|||
156802849|NCT01816295|566034028|FG000|Double Blind Phase|Protocol Violation|17|||
156802850|NCT01816295|566034029|FG001|Double Blind Phase|Protocol Violation|11|||
156802851|NCT01816295|566034028|FG000|Double Blind Phase|Sponsor Decision|8|||
156802852|NCT01816295|566034029|FG001|Double Blind Phase|Sponsor Decision|8|||
156802853|NCT01816295|566034028|FG000|Double Blind Phase|Withdrawal by Subject|22|||
156802854|NCT01816295|566034029|FG001|Double Blind Phase|Withdrawal by Subject|20|||
156337538|NCT00289783|564333683|FG000|Primary Phase|Withdrawal by Subject|93|||
156802855|NCT01816295|566034028|FG000|OLE Phase|Adverse Event|17|||
156802856|NCT01816295|566034029|FG001|OLE Phase|Adverse Event|15|||
156802857|NCT01816295|566034028|FG000|OLE Phase|Death|1|||
156802858|NCT01816295|566034029|FG001|OLE Phase|Death|0|||
156802859|NCT01816295|566034028|FG000|OLE Phase|Entry Criteria Not Met|3|||
156802860|NCT01816295|566034029|FG001|OLE Phase|Entry Criteria Not Met|5|||
156802861|NCT01816295|566034028|FG000|OLE Phase|Lost to Follow-up|5|||
156802862|NCT01816295|566034029|FG001|OLE Phase|Lost to Follow-up|5|||
156802863|NCT01816295|566034028|FG000|OLE Phase|Physician Decision|3|||
156802864|NCT01816295|566034029|FG001|OLE Phase|Physician Decision|1|||
156802865|NCT01816295|566034028|FG000|OLE Phase|Protocol Violation|4|||
156802866|NCT01816295|566034029|FG001|OLE Phase|Protocol Violation|4|||
156802867|NCT01816295|566034028|FG000|OLE Phase|Sponsor Decision|7|||
156802868|NCT01816295|566034029|FG001|OLE Phase|Sponsor Decision|9|||
156802869|NCT01816295|566034028|FG000|OLE Phase|Withdrawal by Subject|10|||
156802870|NCT01816295|566034029|FG001|OLE Phase|Withdrawal by Subject|10|||
156802871|NCT01816295|566034028|FG000|OLE Phase|Lack of Efficacy|3|||
156802872|NCT01816295|566034029|FG001|OLE Phase|Lack of Efficacy|7|||
156802873|NCT01119287|566034030|FG000|Overall Study|Patient Decision, not related to AE|0|||
156802874|NCT01119287|566034031|FG001|Overall Study|Patient Decision, not related to AE|0|||
156802875|NCT01119287|566034032|FG002|Overall Study|Patient Decision, not related to AE|2|||
156802876|NCT01119287|566034033|FG003|Overall Study|Patient Decision, not related to AE|2|||
156802877|NCT01119287|566034034|FG004|Overall Study|Patient Decision, not related to AE|1|||
156802878|NCT01119287|566034035|FG005|Overall Study|Patient Decision, not related to AE|0|||
156802879|NCT01534481|566034048|FG000|Overall Study|Lost to Follow-up|29|||
156802880|NCT01534481|566034049|FG001|Overall Study|Lost to Follow-up|24|||
156802881|NCT01534481|566034048|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
156802882|NCT01534481|566034049|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
156802883|NCT00945659|566034050|FG000|Overall Study|Lost to Follow-up|7|||
156802884|NCT00945659|566034051|FG001|Overall Study|Lost to Follow-up|20|||
156802885|NCT00945659|566034052|FG002|Overall Study|Lost to Follow-up|17|||
156802886|NCT03498716|566034067|FG000|Overall Study|Withdrawal by Subject|88|||
156802887|NCT03498716|566034068|FG001|Overall Study|Withdrawal by Subject|73|||
156802888|NCT03498716|566034067|FG000|Overall Study|Study Terminated By Sponsor|933|||
156802889|NCT03498716|566034068|FG001|Overall Study|Study Terminated By Sponsor|927|||
156802890|NCT03498716|566034067|FG000|Overall Study|Lost to Follow-up|15|||
156802891|NCT03498716|566034068|FG001|Overall Study|Lost to Follow-up|26|||
156802892|NCT03498716|566034067|FG000|Overall Study|Disease Relapse|0|||
156802893|NCT03498716|566034068|FG001|Overall Study|Disease Relapse|1|||
156802894|NCT03498716|566034067|FG000|Overall Study|Death|58|||
156802895|NCT03498716|566034068|FG001|Overall Study|Death|72|||
156802896|NCT03498716|566034067|FG000|Overall Study|Physician Decision|4|||
156802897|NCT03498716|566034068|FG001|Overall Study|Physician Decision|2|||
156802898|NCT01448616|566034069|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
156802899|NCT01448616|566034070|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
156537136|NCT00467779|565061096|FG001|Stage 1|Unspecified Reason|0|||
156537137|NCT00467779|565061097|FG002|Stage 1|Unspecified Reason|1|||
156537138|NCT00467779|565061098|FG003|Stage 1|Unspecified Reason|0|||
156537139|NCT00467779|565061099|FG004|Stage 1|Unspecified Reason|1|||
156537140|NCT00467779|565061100|FG005|Stage 1|Unspecified Reason|2|||
156537141|NCT00467779|565061101|FG006|Stage 1|Unspecified Reason|0|||
156537142|NCT00467779|565061102|FG007|Stage 1|Unspecified Reason|0|||
156537143|NCT00467779|565061103|FG008|Stage 1|Unspecified Reason|0|||
156537144|NCT00467779|565061104|FG009|Stage 1|Unspecified Reason|0|||
156537145|NCT00467779|565061105|FG010|Stage 1|Unspecified Reason|0|||
156537146|NCT00467779|565061106|FG011|Stage 1|Unspecified Reason|0|||
156537147|NCT00467779|565061107|FG012|Stage 1|Unspecified Reason|0|||
156537148|NCT00467779|565061108|FG013|Stage 1|Unspecified Reason|0|||
156537149|NCT00467779|565061109|FG014|Stage 1|Unspecified Reason|0|||
156537150|NCT00467779|565061095|FG000|Stage 1|Physician Decision|0|||
156537151|NCT00467779|565061096|FG001|Stage 1|Physician Decision|1|||
156537152|NCT00467779|565061097|FG002|Stage 1|Physician Decision|0|||
156537153|NCT00467779|565061098|FG003|Stage 1|Physician Decision|0|||
156537154|NCT00467779|565061099|FG004|Stage 1|Physician Decision|0|||
156802900|NCT01448616|566034071|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
156802901|NCT01448616|566034072|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
156802902|NCT01448616|566034069|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
156802903|NCT01448616|566034070|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
156802904|NCT01448616|566034071|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
156802905|NCT01448616|566034072|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
156802906|NCT01448616|566034069|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
156802907|NCT01448616|566034070|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
156802908|NCT01448616|566034071|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
156802909|NCT01448616|566034072|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
156802910|NCT01448616|566034069|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
156802911|NCT01448616|566034070|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
156802912|NCT01448616|566034071|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
156802913|NCT01448616|566034072|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
156802914|NCT01448616|566034069|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
156802915|NCT01448616|566034070|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
156802916|NCT01448616|566034071|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
156802917|NCT01448616|566034072|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
156802918|NCT01570387|566034073|FG000|Overall Study|Adverse Event|1|||
156802919|NCT01570387|566034074|FG001|Overall Study|Adverse Event|0|||
156802920|NCT01570387|566034075|FG002|Overall Study|Adverse Event|0|||
156802921|NCT01570387|566034076|FG003|Overall Study|Adverse Event|0|||
156802922|NCT01570387|566034073|FG000|Overall Study|Death|0|||
156802923|NCT01570387|566034074|FG001|Overall Study|Death|0|||
156802924|NCT01570387|566034075|FG002|Overall Study|Death|0|||
156802925|NCT01570387|566034076|FG003|Overall Study|Death|1|||
156802926|NCT01570387|566034073|FG000|Overall Study|Withdrawal by Subject|0|||
156802927|NCT01570387|566034074|FG001|Overall Study|Withdrawal by Subject|0|||
156802928|NCT01570387|566034075|FG002|Overall Study|Withdrawal by Subject|0|||
156802929|NCT01570387|566034076|FG003|Overall Study|Withdrawal by Subject|1|||
156802930|NCT03139448|566034077|FG000|Overall Study|Lack of Efficacy|6|||
156802931|NCT03139448|566034078|FG001|Overall Study|Lack of Efficacy|7|||
156802932|NCT03139448|566034077|FG000|Overall Study|Location of procedure changed|2|||
156802933|NCT03139448|566034078|FG001|Overall Study|Location of procedure changed|8|||
156802934|NCT03139448|566034077|FG000|Overall Study|Withdrawal by Subject|3|||
156802935|NCT03139448|566034078|FG001|Overall Study|Withdrawal by Subject|6|||
156802936|NCT03139448|566034077|FG000|Overall Study|Screen fail|1|||
156802937|NCT03139448|566034078|FG001|Overall Study|Screen fail|3|||
156802938|NCT03139448|566034077|FG000|Overall Study|Physician Decision|0|||
156802939|NCT03139448|566034078|FG001|Overall Study|Physician Decision|2|||
156802940|NCT01987557|566034079|FG000|Overall Study|Protocol Violation|1|||
156802941|NCT01987557|566034080|FG001|Overall Study|Protocol Violation|0|||
156802942|NCT01987557|566034081|FG002|Overall Study|Protocol Violation|1|||
156802943|NCT01987557|566034079|FG000|Overall Study|Withdrawal by Subject|2|||
156802944|NCT01987557|566034080|FG001|Overall Study|Withdrawal by Subject|1|||
156802945|NCT01987557|566034081|FG002|Overall Study|Withdrawal by Subject|2|||
156802946|NCT01987557|566034079|FG000|Overall Study|Adverse Event|0|||
156802947|NCT01987557|566034080|FG001|Overall Study|Adverse Event|2|||
156802948|NCT01987557|566034081|FG002|Overall Study|Adverse Event|0|||
156802949|NCT03323164|566034084|FG000|Overall Study|Poor quality imaging/scans|2|||
156802950|NCT03323164|566034085|FG001|Overall Study|Poor quality imaging/scans|2|||
156802951|NCT00461708|566034088|FG000|Overall Study|Adverse Event|17|||
156802952|NCT00461708|566034089|FG001|Overall Study|Adverse Event|7|||
156802953|NCT00461708|566034088|FG000|Overall Study|Lack of Efficacy|68|||
156802954|NCT00461708|566034089|FG001|Overall Study|Lack of Efficacy|20|||
156802955|NCT00461708|566034088|FG000|Overall Study|Physician Decision|10|||
156802956|NCT00461708|566034089|FG001|Overall Study|Physician Decision|4|||
156802957|NCT00461708|566034088|FG000|Overall Study|Withdrawal by Subject|8|||
156802958|NCT00461708|566034089|FG001|Overall Study|Withdrawal by Subject|2|||
156802959|NCT00461708|566034088|FG000|Overall Study|Other|4|||
156802960|NCT00461708|566034089|FG001|Overall Study|Other|4|||
156802961|NCT00461708|566034088|FG000|Overall Study|Death|8|||
156802962|NCT00461708|566034089|FG001|Overall Study|Death|1|||
156802963|NCT02394561|566034090|FG000|CORE Phase|Adverse Event|7|||
156802964|NCT02394561|566034091|FG001|CORE Phase|Adverse Event|9|||
156802965|NCT02394561|566034090|FG000|CORE Phase|Death|0|||
156802966|NCT02394561|566034091|FG001|CORE Phase|Death|1|||
156802967|NCT02394561|566034090|FG000|CORE Phase|Pregnancy|1|||
156802968|NCT02394561|566034091|FG001|CORE Phase|Pregnancy|0|||
156802969|NCT02394561|566034090|FG000|CORE Phase|Lost to Follow-up|1|||
156802970|NCT02394561|566034091|FG001|CORE Phase|Lost to Follow-up|0|||
156802971|NCT02394561|566034090|FG000|CORE Phase|Physician Decision|1|||
156802972|NCT02394561|566034091|FG001|CORE Phase|Physician Decision|1|||
156802973|NCT02394561|566034090|FG000|CORE Phase|Withdrawal by Subject|2|||
156802974|NCT02394561|566034091|FG001|CORE Phase|Withdrawal by Subject|2|||
156802975|NCT02394561|566034090|FG000|CORE Phase|Lack of Efficacy|1|||
156802976|NCT02394561|566034091|FG001|CORE Phase|Lack of Efficacy|6|||
156802977|NCT02394561|566034090|FG000|Extension Phase|Adverse Event|6|||
156459381|NCT03034356|564776806|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
156459382|NCT03034356|564776805|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
156802978|NCT02394561|566034091|FG001|Extension Phase|Adverse Event|1|||
156802979|NCT02394561|566034090|FG000|Extension Phase|Death|0|||
156802980|NCT02394561|566034091|FG001|Extension Phase|Death|1|||
156802981|NCT02394561|566034090|FG000|Extension Phase|Protocol Violation|1|||
156802982|NCT02394561|566034091|FG001|Extension Phase|Protocol Violation|0|||
156802983|NCT02394561|566034090|FG000|Extension Phase|Lost to Follow-up|1|||
156802984|NCT02394561|566034091|FG001|Extension Phase|Lost to Follow-up|0|||
156802985|NCT02394561|566034090|FG000|Extension Phase|Physician Decision|0|||
156802986|NCT02394561|566034091|FG001|Extension Phase|Physician Decision|2|||
156802987|NCT02394561|566034090|FG000|Extension Phase|Withdrawal by Subject|0|||
156802988|NCT02394561|566034091|FG001|Extension Phase|Withdrawal by Subject|5|||
156802989|NCT02394561|566034090|FG000|Extension Phase|Lack of Efficacy|3|||
156802990|NCT02394561|566034091|FG001|Extension Phase|Lack of Efficacy|3|||
156802991|NCT00501644|566034092|FG000|Overall Study|Adverse Event|4|||
156459383|NCT03034356|564776806|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
156802992|NCT00501644|566034092|FG000|Overall Study|Withdrawal by Subject|1|||
156802993|NCT01854528|566034097|FG000|Overall Study|Adverse Event|0|||
156802994|NCT01854528|566034098|FG001|Overall Study|Adverse Event|4|||
156802995|NCT01854528|566034097|FG000|Overall Study|Withdrawal by Subject|0|||
156802996|NCT01854528|566034098|FG001|Overall Study|Withdrawal by Subject|2|||
156802997|NCT01854528|566034097|FG000|Overall Study|Virologic Failure|0|||
156337539|NCT00289783|564333684|FG001|Primary Phase|Withdrawal by Subject|40|||
156802998|NCT01854528|566034098|FG001|Overall Study|Virologic Failure|9|||
156802999|NCT03710889|566034107|FG000|Overall Study|Adverse Event|2|||
156803000|NCT03710889|566034107|FG000|Overall Study|Protocol Deviation|1|||
156803001|NCT02850978|566034109|FG000|Overall Study|Uncollectable CRF|27|||
156803002|NCT02850978|566034109|FG000|Overall Study|No visit since the first visit|35|||
156803003|NCT02850978|566034109|FG000|Overall Study|Adverse Event|81|||
156803004|NCT02850978|566034109|FG000|Overall Study|Lack of Efficacy|40|||
156803005|NCT02850978|566034109|FG000|Overall Study|Improvement in condition|34|||
156803006|NCT02850978|566034109|FG000|Overall Study|Lost to Follow-up|121|||
156803007|NCT02850978|566034109|FG000|Overall Study|Reason not listed|88|||
156803008|NCT01538199|566034110|FG000|Overall Study|Lost to Follow-up|1|||
156803009|NCT01538199|566034111|FG001|Overall Study|Lost to Follow-up|2|||
156803010|NCT01538199|566034112|FG002|Overall Study|Lost to Follow-up|1|||
156803011|NCT01538199|566034113|FG003|Overall Study|Lost to Follow-up|0|||
156803012|NCT01538199|566034110|FG000|Overall Study|participant did not have time|1|||
156803013|NCT01538199|566034111|FG001|Overall Study|participant did not have time|0|||
156803014|NCT01538199|566034112|FG002|Overall Study|participant did not have time|0|||
156803015|NCT01538199|566034113|FG003|Overall Study|participant did not have time|2|||
156803016|NCT01538199|566034110|FG000|Overall Study|Lack of Efficacy|0|||
156803017|NCT01538199|566034111|FG001|Overall Study|Lack of Efficacy|1|||
156803018|NCT01538199|566034112|FG002|Overall Study|Lack of Efficacy|0|||
156803019|NCT01538199|566034113|FG003|Overall Study|Lack of Efficacy|0|||
156803020|NCT02081586|566034114|FG000|Overall Study|Lost to Follow-up|0|||
156803021|NCT02081586|566034115|FG001|Overall Study|Lost to Follow-up|1|||
156803022|NCT02081586|566034116|FG002|Overall Study|Lost to Follow-up|0|||
156803023|NCT02081586|566034117|FG003|Overall Study|Lost to Follow-up|1|||
156803024|NCT02081586|566034114|FG000|Overall Study|Head injury not related to study|0|||
156803025|NCT02081586|566034115|FG001|Overall Study|Head injury not related to study|0|||
156803026|NCT02081586|566034116|FG002|Overall Study|Head injury not related to study|1|||
156803027|NCT02081586|566034117|FG003|Overall Study|Head injury not related to study|0|||
156803028|NCT00636181|566034120|FG000|Overall Study|Withdrawal by Subject|8|||
156803029|NCT00636181|566034121|FG001|Overall Study|Withdrawal by Subject|6|||
156803030|NCT00636181|566034122|FG002|Overall Study|Withdrawal by Subject|10|||
156803031|NCT04549454|566034128|FG000|T1 to T2|Lost to Follow-up|22|||
156803032|NCT04549454|566034129|FG001|T1 to T2|Lost to Follow-up|26|||
156803033|NCT04549454|566034128|FG000|T1 to T3|Lost to Follow-up|31|||
156803034|NCT04549454|566034129|FG001|T1 to T3|Lost to Follow-up|36|||
156803035|NCT04712669|566034140|FG000|Double Blind Phase|Adverse Event|4|||
156803036|NCT04712669|566034141|FG001|Double Blind Phase|Adverse Event|4|||
156803037|NCT04712669|566034142|FG002|Double Blind Phase|Adverse Event|3|||
156803038|NCT04712669|566034143|FG003|Double Blind Phase|Adverse Event|0|||
156803039|NCT04712669|566034144|FG004|Double Blind Phase|Adverse Event|0|||
156803040|NCT04712669|566034145|FG005|Double Blind Phase|Adverse Event|0|||
156803041|NCT04712669|566034146|FG006|Double Blind Phase|Adverse Event|0|||
156803042|NCT04712669|566034147|FG007|Double Blind Phase|Adverse Event|0|||
156803043|NCT04712669|566034140|FG000|Double Blind Phase|Physician Decision|1|||
156803044|NCT04712669|566034141|FG001|Double Blind Phase|Physician Decision|0|||
156803045|NCT04712669|566034142|FG002|Double Blind Phase|Physician Decision|0|||
156803046|NCT04712669|566034143|FG003|Double Blind Phase|Physician Decision|0|||
156803047|NCT04712669|566034144|FG004|Double Blind Phase|Physician Decision|0|||
156803048|NCT04712669|566034145|FG005|Double Blind Phase|Physician Decision|0|||
156803049|NCT04712669|566034146|FG006|Double Blind Phase|Physician Decision|0|||
156803050|NCT04712669|566034147|FG007|Double Blind Phase|Physician Decision|0|||
156803051|NCT04712669|566034140|FG000|Double Blind Phase|Withdrawal by Subject|3|||
156803052|NCT04712669|566034141|FG001|Double Blind Phase|Withdrawal by Subject|6|||
156803053|NCT04712669|566034142|FG002|Double Blind Phase|Withdrawal by Subject|0|||
156803054|NCT04712669|566034143|FG003|Double Blind Phase|Withdrawal by Subject|0|||
156803055|NCT04712669|566034144|FG004|Double Blind Phase|Withdrawal by Subject|0|||
156803056|NCT04712669|566034145|FG005|Double Blind Phase|Withdrawal by Subject|0|||
156803057|NCT04712669|566034146|FG006|Double Blind Phase|Withdrawal by Subject|0|||
156803058|NCT04712669|566034147|FG007|Double Blind Phase|Withdrawal by Subject|0|||
156803059|NCT04712669|566034140|FG000|Double Blind Phase|Termination by Sponsor|0|||
156803060|NCT04712669|566034141|FG001|Double Blind Phase|Termination by Sponsor|0|||
156803061|NCT04712669|566034142|FG002|Double Blind Phase|Termination by Sponsor|1|||
156803062|NCT04712669|566034143|FG003|Double Blind Phase|Termination by Sponsor|0|||
156803063|NCT04712669|566034144|FG004|Double Blind Phase|Termination by Sponsor|0|||
156803064|NCT04712669|566034145|FG005|Double Blind Phase|Termination by Sponsor|0|||
156803065|NCT04712669|566034146|FG006|Double Blind Phase|Termination by Sponsor|0|||
156803066|NCT04712669|566034147|FG007|Double Blind Phase|Termination by Sponsor|0|||
156803067|NCT04712669|566034140|FG000|Open Label Phase|Adverse Event|0|||
156803068|NCT04712669|566034141|FG001|Open Label Phase|Adverse Event|0|||
156337540|NCT00289783|564333683|FG000|Primary Phase|Lost to Follow-up|60|||
156803069|NCT04712669|566034142|FG002|Open Label Phase|Adverse Event|0|||
156803070|NCT04712669|566034143|FG003|Open Label Phase|Adverse Event|1|||
156803071|NCT04712669|566034144|FG004|Open Label Phase|Adverse Event|1|||
156337541|NCT00289783|564333684|FG001|Primary Phase|Lost to Follow-up|14|||
156337542|NCT00289783|564333683|FG000|Primary Phase|Migration from the study area|26|||
156337543|NCT00289783|564333684|FG001|Primary Phase|Migration from the study area|10|||
156337544|NCT00289783|564333683|FG000|Primary Phase|Other|32|||
156337545|NCT00289783|564333684|FG001|Primary Phase|Other|12|||
156337546|NCT00289783|564333683|FG000|Fourth Dose Phase|Adverse Event|1|||
156337547|NCT00289783|564333684|FG001|Fourth Dose Phase|Adverse Event|0|||
156337548|NCT00289783|564333683|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
156337549|NCT00289783|564333684|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
156337550|NCT00289783|564333683|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
156337551|NCT00289783|564333684|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
156337552|NCT00289783|564333683|FG000|Fourth Dose Phase|Migration from the study area|1|||
156337553|NCT00289783|564333684|FG001|Fourth Dose Phase|Migration from the study area|1|||
156337554|NCT00289783|564333683|FG000|Fourth Dose Phase|Other|22|||
156337555|NCT00289783|564333684|FG001|Fourth Dose Phase|Other|10|||
156337556|NCT03128411|564333686|FG000|Treatment Phase|Adverse Event|21|||
156337557|NCT03128411|564333686|FG000|Treatment Phase|Physician Decision|1|||
156337558|NCT03128411|564333686|FG000|Treatment Phase|Other|2|||
156337559|NCT03128411|564333686|FG000|Long Term Follow-up Phase|Death|2|||
156337560|NCT03749447|564335046|FG000|Overall Study|Adverse Event|11|||
156337561|NCT03749447|564335047|FG001|Overall Study|Adverse Event|3|||
156337562|NCT03749447|564335046|FG000|Overall Study|Death|1|||
156337563|NCT03749447|564335047|FG001|Overall Study|Death|1|||
156337564|NCT03749447|564335046|FG000|Overall Study|Lost to Follow-up|2|||
156337565|NCT03749447|564335047|FG001|Overall Study|Lost to Follow-up|2|||
156337566|NCT03749447|564335046|FG000|Overall Study|Reason Not Specified|0|||
156337567|NCT03749447|564335047|FG001|Overall Study|Reason Not Specified|3|||
156337568|NCT03749447|564335046|FG000|Overall Study|Physician Decision|4|||
156337569|NCT03749447|564335047|FG001|Overall Study|Physician Decision|3|||
156337570|NCT03749447|564335046|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
156337571|NCT03749447|564335047|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
156337572|NCT03749447|564335046|FG000|Overall Study|Study Terminated By Sponsor|112|||
156337573|NCT03749447|564335047|FG001|Overall Study|Study Terminated By Sponsor|105|||
156337574|NCT03749447|564335046|FG000|Overall Study|Withdrawal by Subject|12|||
156337575|NCT03749447|564335047|FG001|Overall Study|Withdrawal by Subject|6|||
156337576|NCT03749447|564335046|FG000|Overall Study|Non-compliance With Study Drug|0|||
156337577|NCT03749447|564335047|FG001|Overall Study|Non-compliance With Study Drug|1|||
156337578|NCT01218113|564335048|FG000|Overall Study|Withdrawal by Subject|1|||
156337579|NCT01218113|564335049|FG001|Overall Study|Withdrawal by Subject|0|||
156337580|NCT01218113|564335050|FG002|Overall Study|Withdrawal by Subject|1|||
156337581|NCT01218113|564335048|FG000|Overall Study|Lost to Follow-up|4|||
156337582|NCT01218113|564335049|FG001|Overall Study|Lost to Follow-up|1|||
156337583|NCT01218113|564335050|FG002|Overall Study|Lost to Follow-up|4|||
156337584|NCT01218113|564335048|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
156337585|NCT01218113|564335049|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
156337586|NCT01218113|564335050|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
156337587|NCT00787891|564335055|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
156337588|NCT00787891|564335056|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
156337589|NCT00787891|564335055|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
156337590|NCT00787891|564335056|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
156337591|NCT00787891|564335055|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
156803072|NCT04712669|566034145|FG005|Open Label Phase|Adverse Event|3|||
156803073|NCT04712669|566034146|FG006|Open Label Phase|Adverse Event|1|||
156803074|NCT04712669|566034147|FG007|Open Label Phase|Adverse Event|2|||
156803075|NCT04712669|566034140|FG000|Open Label Phase|Death|0|||
156803076|NCT04712669|566034141|FG001|Open Label Phase|Death|0|||
156803077|NCT04712669|566034142|FG002|Open Label Phase|Death|0|||
156803078|NCT04712669|566034143|FG003|Open Label Phase|Death|1|||
156803079|NCT04712669|566034144|FG004|Open Label Phase|Death|0|||
156803080|NCT04712669|566034145|FG005|Open Label Phase|Death|0|||
156803081|NCT04712669|566034146|FG006|Open Label Phase|Death|0|||
156803082|NCT04712669|566034147|FG007|Open Label Phase|Death|0|||
156803083|NCT04712669|566034140|FG000|Open Label Phase|Lack of Efficacy|0|||
156337592|NCT00787891|564335056|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
156337593|NCT00787891|564335055|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
156337594|NCT00787891|564335056|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
156337595|NCT00787891|564335055|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
156337596|NCT00787891|564335056|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
156337597|NCT00787891|564335055|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
156337598|NCT00787891|564335056|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
156537155|NCT00467779|565061100|FG005|Stage 1|Physician Decision|0|||
156803084|NCT04712669|566034141|FG001|Open Label Phase|Lack of Efficacy|0|||
156803085|NCT04712669|566034142|FG002|Open Label Phase|Lack of Efficacy|0|||
156803086|NCT04712669|566034143|FG003|Open Label Phase|Lack of Efficacy|0|||
156803087|NCT04712669|566034144|FG004|Open Label Phase|Lack of Efficacy|1|||
156803088|NCT04712669|566034145|FG005|Open Label Phase|Lack of Efficacy|0|||
156803089|NCT04712669|566034146|FG006|Open Label Phase|Lack of Efficacy|0|||
156803090|NCT04712669|566034147|FG007|Open Label Phase|Lack of Efficacy|0|||
156803091|NCT04712669|566034140|FG000|Open Label Phase|Lost to Follow-up|0|||
156803092|NCT04712669|566034141|FG001|Open Label Phase|Lost to Follow-up|0|||
156803093|NCT04712669|566034142|FG002|Open Label Phase|Lost to Follow-up|0|||
156803094|NCT04712669|566034143|FG003|Open Label Phase|Lost to Follow-up|0|||
156803095|NCT04712669|566034144|FG004|Open Label Phase|Lost to Follow-up|0|||
156803096|NCT04712669|566034145|FG005|Open Label Phase|Lost to Follow-up|0|||
156803097|NCT04712669|566034146|FG006|Open Label Phase|Lost to Follow-up|1|||
156803098|NCT04712669|566034147|FG007|Open Label Phase|Lost to Follow-up|1|||
156803099|NCT04712669|566034140|FG000|Open Label Phase|Physician Decision|0|||
156803100|NCT04712669|566034141|FG001|Open Label Phase|Physician Decision|0|||
156803101|NCT04712669|566034142|FG002|Open Label Phase|Physician Decision|0|||
156803102|NCT04712669|566034143|FG003|Open Label Phase|Physician Decision|1|||
156803103|NCT04712669|566034144|FG004|Open Label Phase|Physician Decision|0|||
156803104|NCT04712669|566034145|FG005|Open Label Phase|Physician Decision|0|||
156803105|NCT04712669|566034146|FG006|Open Label Phase|Physician Decision|0|||
156803106|NCT04712669|566034147|FG007|Open Label Phase|Physician Decision|0|||
156803107|NCT04712669|566034140|FG000|Open Label Phase|Withdrawal by Subject|0|||
156803108|NCT04712669|566034141|FG001|Open Label Phase|Withdrawal by Subject|0|||
156803109|NCT04712669|566034142|FG002|Open Label Phase|Withdrawal by Subject|0|||
156803110|NCT04712669|566034143|FG003|Open Label Phase|Withdrawal by Subject|1|||
156803111|NCT04712669|566034144|FG004|Open Label Phase|Withdrawal by Subject|5|||
156803112|NCT04712669|566034145|FG005|Open Label Phase|Withdrawal by Subject|5|||
156803113|NCT04712669|566034146|FG006|Open Label Phase|Withdrawal by Subject|0|||
156803114|NCT04712669|566034147|FG007|Open Label Phase|Withdrawal by Subject|4|||
156803115|NCT04712669|566034140|FG000|Open Label Phase|Termination by Sponsor|0|||
156803116|NCT04712669|566034141|FG001|Open Label Phase|Termination by Sponsor|0|||
156803117|NCT04712669|566034142|FG002|Open Label Phase|Termination by Sponsor|0|||
156803118|NCT04712669|566034143|FG003|Open Label Phase|Termination by Sponsor|11|||
156803119|NCT04712669|566034144|FG004|Open Label Phase|Termination by Sponsor|9|||
156803120|NCT04712669|566034145|FG005|Open Label Phase|Termination by Sponsor|14|||
156803121|NCT04712669|566034146|FG006|Open Label Phase|Termination by Sponsor|0|||
156803122|NCT04712669|566034147|FG007|Open Label Phase|Termination by Sponsor|14|||
156803123|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
156803124|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
156803125|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
156803126|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
156803127|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
156803128|NCT02735421|566035918|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
156803129|NCT02735421|566035918|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
156803130|NCT01978145|566035920|FG000|Treatment Period 1|Adverse Event|1|||
156803131|NCT01978145|566035921|FG001|Treatment Period 1|Adverse Event|9|||
156803132|NCT01978145|566035920|FG000|Treatment Period 1|Physician Decision|1|||
156803133|NCT01978145|566035921|FG001|Treatment Period 1|Physician Decision|0|||
156803134|NCT01978145|566035920|FG000|Treatment Period 1|Withdrawal by Subject|5|||
156803135|NCT01978145|566035921|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156803136|NCT01978145|566035920|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
156803137|NCT01978145|566035921|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
156803138|NCT01978145|566035920|FG000|Washout Period 1|Adverse Event|0|||
156803139|NCT01978145|566035921|FG001|Washout Period 1|Adverse Event|1|||
156803140|NCT01978145|566035920|FG000|Washout Period 1|Withdrawal by Subject|1|||
156803141|NCT01978145|566035921|FG001|Washout Period 1|Withdrawal by Subject|1|||
156803142|NCT01978145|566035920|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
156803143|NCT01978145|566035921|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
156803144|NCT01978145|566035920|FG000|Treatment Period 2|Adverse Event|3|||
156803145|NCT01978145|566035921|FG001|Treatment Period 2|Adverse Event|3|||
156803146|NCT01978145|566035920|FG000|Treatment Period 2|Protocol Violation|0|||
156803147|NCT01978145|566035921|FG001|Treatment Period 2|Protocol Violation|1|||
156803148|NCT01978145|566035920|FG000|Treatment Period 2|Lost to Follow-up|1|||
156803149|NCT01978145|566035921|FG001|Treatment Period 2|Lost to Follow-up|1|||
156803150|NCT01978145|566035920|FG000|Treatment Period 2|Withdrawal by Subject|7|||
156803151|NCT01978145|566035921|FG001|Treatment Period 2|Withdrawal by Subject|4|||
156803152|NCT01978145|566035920|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
156803153|NCT01978145|566035921|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
156803154|NCT00322049|566035922|FG000|Overall Study|Moved out of area|0|||
156803155|NCT00322049|566035923|FG001|Overall Study|Moved out of area|0|||
156803156|NCT00322049|566035924|FG002|Overall Study|Moved out of area|0|||
156803157|NCT00322049|566035925|FG003|Overall Study|Moved out of area|1|||
156803158|NCT00322049|566035922|FG000|Overall Study|Infected with Dengue during study|0|||
156803159|NCT00322049|566035923|FG001|Overall Study|Infected with Dengue during study|1|||
156803160|NCT00322049|566035924|FG002|Overall Study|Infected with Dengue during study|0|||
156803161|NCT00322049|566035925|FG003|Overall Study|Infected with Dengue during study|0|||
156803162|NCT01250054|566035926|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
156803163|NCT01250054|566035927|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
156803164|NCT00755807|566035930|FG000|Acute Phase|Adverse Event|16|||
156803165|NCT00755807|566035931|FG001|Acute Phase|Adverse Event|5|||
156803166|NCT00755807|566035930|FG000|Acute Phase|Protocol Violation|1|||
156803167|NCT00755807|566035931|FG001|Acute Phase|Protocol Violation|3|||
156803168|NCT00755807|566035930|FG000|Acute Phase|Withdrawal by Subject|1|||
156803169|NCT00755807|566035931|FG001|Acute Phase|Withdrawal by Subject|2|||
156803170|NCT00755807|566035930|FG000|Acute Phase|Lack of Efficacy|0|||
156803171|NCT00755807|566035931|FG001|Acute Phase|Lack of Efficacy|1|||
156803172|NCT00755807|566035930|FG000|Acute Phase|Physician Decision|0|||
156803173|NCT00755807|566035931|FG001|Acute Phase|Physician Decision|1|||
156803174|NCT00755807|566035930|FG000|Open-label Extension Phase|Adverse Event|7|||
156803175|NCT00755807|566035931|FG001|Open-label Extension Phase|Adverse Event|7|||
156803176|NCT00755807|566035930|FG000|Open-label Extension Phase|Protocol Violation|5|||
156803177|NCT00755807|566035931|FG001|Open-label Extension Phase|Protocol Violation|2|||
156803178|NCT00755807|566035930|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
156803179|NCT00755807|566035931|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
156803180|NCT00755807|566035930|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
156803181|NCT00755807|566035931|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
156803182|NCT00755807|566035930|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
156459384|NCT03034356|564776805|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
156459385|NCT03034356|564776806|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
156459386|NCT02684227|564776807|FG000|Overall Study|Adverse Event|1|||
156459387|NCT02684227|564776808|FG001|Overall Study|Adverse Event|7|||
156803183|NCT00755807|566035931|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
156803184|NCT00755807|566035930|FG000|Open-label Extension Phase|Sponsor Decision|0|||
156803185|NCT00755807|566035931|FG001|Open-label Extension Phase|Sponsor Decision|1|||
156803186|NCT00939107|566035932|FG000|Overall Study|Lost to Follow-up|14|||
156803187|NCT00939107|566035933|FG001|Overall Study|Lost to Follow-up|12|||
156803188|NCT00427011|566035936|FG000|Overall Study|Adverse Event|10|||
156803189|NCT00427011|566035936|FG000|Overall Study|Withdrawal by Subject|1|||
156459388|NCT02684227|564776807|FG000|Overall Study|Death|0|||
156803190|NCT00427011|566035936|FG000|Overall Study|Lack of Efficacy|2|||
156803191|NCT00427011|566035936|FG000|Overall Study|Other|12|||
156803192|NCT01192126|566035937|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
156803193|NCT01192126|566035938|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
156803194|NCT01192126|566035937|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
156803195|NCT01192126|566035938|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
156803196|NCT01248793|566035939|FG000|Overall Study|Lost to Follow-up|0|||
156803197|NCT01248793|566035940|FG001|Overall Study|Lost to Follow-up|1|||
156803198|NCT01248793|566035939|FG000|Overall Study|Adverse Event|1|||
156803199|NCT01248793|566035940|FG001|Overall Study|Adverse Event|1|||
156803200|NCT01248793|566035939|FG000|Overall Study|Protocol Violation|0|||
156803201|NCT01248793|566035940|FG001|Overall Study|Protocol Violation|1|||
156803202|NCT01248793|566035939|FG000|Overall Study|Withdrawal by Subject|3|||
156803203|NCT01248793|566035940|FG001|Overall Study|Withdrawal by Subject|3|||
156803204|NCT00517699|566035941|FG000|Overall Study|Withdrawal by Subject|1|||
156803205|NCT00517699|566035941|FG000|Overall Study|Lack of Efficacy|1|||
156803206|NCT00517699|566035941|FG000|Overall Study|Administrative error|1|||
156803207|NCT00517699|566035941|FG000|Overall Study|Study terminated by Sponsor|2|||
156803208|NCT02580877|566035942|FG000|Overall Study|Withdrawal by Subject|1|||
156803209|NCT02580877|566035943|FG001|Overall Study|Withdrawal by Subject|3|||
156803210|NCT02580877|566035942|FG000|Overall Study|Adverse Event|0|||
156803211|NCT02580877|566035943|FG001|Overall Study|Adverse Event|1|||
156803212|NCT00355030|566035944|FG000|Study Period 1 Treatment|Adverse Event|1|||
156803213|NCT00355030|566035945|FG001|Study Period 1 Treatment|Adverse Event|1|||
156803214|NCT00355030|566035944|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
156803215|NCT00355030|566035945|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
156803216|NCT00355030|566035944|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
156803217|NCT00355030|566035945|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
156803218|NCT00355030|566035944|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
156803219|NCT00355030|566035945|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
156803220|NCT00355030|566035944|FG000|Study Period 1 Treatment|Physician Decision|0|||
156803221|NCT00355030|566035945|FG001|Study Period 1 Treatment|Physician Decision|1|||
156803222|NCT00355030|566035944|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
156803223|NCT00355030|566035945|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
156803224|NCT00355030|566035944|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
156803225|NCT00355030|566035945|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
156803226|NCT00355030|566035944|FG000|Study Period 1 Treatment|Other|2|||
156803227|NCT00355030|566035945|FG001|Study Period 1 Treatment|Other|6|||
156803228|NCT00355030|566035944|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
156803229|NCT00355030|566035945|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
156803230|NCT00355030|566035944|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
156803231|NCT00355030|566035945|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
156803232|NCT01693367|566035946|FG000|Overall Study|Withdrawal by Subject|1|||
156803233|NCT01693367|566035947|FG001|Overall Study|Withdrawal by Subject|1|||
156803234|NCT01693367|566035946|FG000|Overall Study|Physician Decision|0|||
156803235|NCT01693367|566035947|FG001|Overall Study|Physician Decision|1|||
156803236|NCT00325143|566035948|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
156803237|NCT00325143|566035948|FG000|Overall Study|Migrated/moved from study area|1|||
156803238|NCT00325143|566035948|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
156803239|NCT00325143|566035948|FG000|Overall Study|Withdrawal by Subject|8|||
156803240|NCT02154061|566035951|FG000|Overall Study|Pregnancy|1|||
156803241|NCT02154061|566035952|FG001|Overall Study|Pregnancy|0|||
156803242|NCT02154061|566035951|FG000|Overall Study|enrolled but not vaccinated|1|||
156803243|NCT02154061|566035952|FG001|Overall Study|enrolled but not vaccinated|0|||
156803244|NCT00506142|566035953|FG000|Overall Study|Adverse Event|8|||
156803245|NCT00506142|566035954|FG001|Overall Study|Adverse Event|7|||
156803246|NCT00506142|566035953|FG000|Overall Study|Lack of Efficacy|21|||
156803247|NCT00506142|566035954|FG001|Overall Study|Lack of Efficacy|7|||
156803248|NCT00506142|566035953|FG000|Overall Study|Withdrawal by Subject|4|||
156803249|NCT00506142|566035954|FG001|Overall Study|Withdrawal by Subject|5|||
156803250|NCT00506142|566035953|FG000|Overall Study|Physician Decision|1|||
156803251|NCT00506142|566035954|FG001|Overall Study|Physician Decision|0|||
156803252|NCT00506142|566035953|FG000|Overall Study|New health condition|1|||
156803253|NCT00506142|566035954|FG001|Overall Study|New health condition|0|||
156803254|NCT01936831|566035955|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803255|NCT01936831|566035956|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803256|NCT01936831|566035957|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803257|NCT01936831|566035958|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803258|NCT01936831|566035959|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803259|NCT01936831|566035960|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
156803260|NCT01936831|566035961|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803261|NCT01936831|566035962|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803262|NCT01936831|566035963|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803263|NCT02133573|566035969|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
156803264|NCT02133573|566035970|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
156803265|NCT02133573|566035969|FG000|Overall Study|Child Deaths|3|||
156803266|NCT02133573|566035970|FG001|Overall Study|Child Deaths|5|||
156803267|NCT02133573|566035969|FG000|Overall Study|Child Declined Follow Ups|2|||
156803268|NCT02133573|566035970|FG001|Overall Study|Child Declined Follow Ups|1|||
156803269|NCT02133573|566035969|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
156803270|NCT02133573|566035970|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
156803271|NCT00454116|566035971|FG000|Overall Study|Adverse Event|5|||
156803272|NCT00454116|566035972|FG001|Overall Study|Adverse Event|11|||
156803273|NCT00454116|566035973|FG002|Overall Study|Adverse Event|9|||
156803274|NCT00454116|566035971|FG000|Overall Study|Condition under investigation worsened|17|||
156803275|NCT00454116|566035972|FG001|Overall Study|Condition under investigation worsened|13|||
156803276|NCT00454116|566035973|FG002|Overall Study|Condition under investigation worsened|18|||
156803277|NCT00454116|566035971|FG000|Overall Study|Withdrawal by Subject|3|||
156803278|NCT00454116|566035972|FG001|Overall Study|Withdrawal by Subject|3|||
156803279|NCT00454116|566035973|FG002|Overall Study|Withdrawal by Subject|1|||
156803280|NCT00454116|566035971|FG000|Overall Study|Other|2|||
156803281|NCT00454116|566035972|FG001|Overall Study|Other|2|||
156803282|NCT00454116|566035973|FG002|Overall Study|Other|0|||
156803283|NCT03500211|566035978|FG000|Overall Study|Withdrawal by Subject|1|||
156803284|NCT03500211|566035979|FG001|Overall Study|Withdrawal by Subject|1|||
156803285|NCT01832727|566035985|FG000|Overall Study|Adverse Event|4|||
156803286|NCT01832727|566035986|FG001|Overall Study|Adverse Event|6|||
156803287|NCT01832727|566035987|FG002|Overall Study|Adverse Event|1|||
156803288|NCT01832727|566035988|FG003|Overall Study|Adverse Event|0|||
156803289|NCT01832727|566035989|FG004|Overall Study|Adverse Event|1|||
156803290|NCT01832727|566035990|FG005|Overall Study|Adverse Event|1|||
156803291|NCT01832727|566035991|FG006|Overall Study|Adverse Event|2|||
156803292|NCT01832727|566035992|FG007|Overall Study|Adverse Event|1|||
156803293|NCT01832727|566035993|FG008|Overall Study|Adverse Event|9|||
156803294|NCT01832727|566035985|FG000|Overall Study|Disease progression|3|||
156803295|NCT01832727|566035986|FG001|Overall Study|Disease progression|0|||
156803296|NCT01832727|566035987|FG002|Overall Study|Disease progression|2|||
156803297|NCT01832727|566035988|FG003|Overall Study|Disease progression|1|||
156803298|NCT01832727|566035989|FG004|Overall Study|Disease progression|3|||
156803299|NCT01832727|566035990|FG005|Overall Study|Disease progression|3|||
156803300|NCT01832727|566035991|FG006|Overall Study|Disease progression|6|||
156803301|NCT01832727|566035992|FG007|Overall Study|Disease progression|2|||
156803302|NCT01832727|566035993|FG008|Overall Study|Disease progression|7|||
156803303|NCT01832727|566035985|FG000|Overall Study|Lost to Follow-up|0|||
156803304|NCT01832727|566035986|FG001|Overall Study|Lost to Follow-up|0|||
156803305|NCT01832727|566035987|FG002|Overall Study|Lost to Follow-up|0|||
156803306|NCT01832727|566035988|FG003|Overall Study|Lost to Follow-up|1|||
156803307|NCT01832727|566035989|FG004|Overall Study|Lost to Follow-up|0|||
156803308|NCT01832727|566035990|FG005|Overall Study|Lost to Follow-up|0|||
156803309|NCT01832727|566035991|FG006|Overall Study|Lost to Follow-up|0|||
156803310|NCT01832727|566035992|FG007|Overall Study|Lost to Follow-up|0|||
156803311|NCT01832727|566035993|FG008|Overall Study|Lost to Follow-up|0|||
156803312|NCT01832727|566035985|FG000|Overall Study|Physician Decision|1|||
156803313|NCT01832727|566035986|FG001|Overall Study|Physician Decision|0|||
156803314|NCT01832727|566035987|FG002|Overall Study|Physician Decision|0|||
156803315|NCT01832727|566035988|FG003|Overall Study|Physician Decision|1|||
156803316|NCT01832727|566035989|FG004|Overall Study|Physician Decision|0|||
156803317|NCT01832727|566035990|FG005|Overall Study|Physician Decision|1|||
156803318|NCT01832727|566035991|FG006|Overall Study|Physician Decision|0|||
156803319|NCT01832727|566035992|FG007|Overall Study|Physician Decision|0|||
156803320|NCT01832727|566035993|FG008|Overall Study|Physician Decision|0|||
156803321|NCT01832727|566035985|FG000|Overall Study|Withdrawal by Subject|1|||
156803322|NCT01832727|566035986|FG001|Overall Study|Withdrawal by Subject|1|||
156803323|NCT01832727|566035987|FG002|Overall Study|Withdrawal by Subject|0|||
156459389|NCT02684227|564776808|FG001|Overall Study|Death|2|||
156459390|NCT02684227|564776807|FG000|Overall Study|Withdrawal by Subject|0|||
156459391|NCT02684227|564776808|FG001|Overall Study|Withdrawal by Subject|1|||
156459392|NCT02684227|564776807|FG000|Overall Study|Progressive Disease|0|||
156459393|NCT02684227|564776808|FG001|Overall Study|Progressive Disease|2|||
156459394|NCT05671653|564778378|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
156459395|NCT05671653|564778379|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
156459396|NCT05671653|564778380|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
156459397|NCT05671653|564778381|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
156459398|NCT05671653|564778382|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
156459399|NCT05671653|564778383|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
156337599|NCT00787891|564335055|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
156337600|NCT00787891|564335056|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
156337601|NCT00787891|564335055|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
156337602|NCT00787891|564335056|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
156337603|NCT00787891|564335055|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
156337604|NCT00787891|564335056|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
156337605|NCT00787891|564335055|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
156337606|NCT00787891|564335056|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
156337607|NCT00799383|564335057|FG000|Overall Study|Protocol Violation|1|||
156337608|NCT00799383|564335058|FG001|Overall Study|Protocol Violation|1|||
156337609|NCT00799383|564335057|FG000|Overall Study|Adverse Event|0|||
156337610|NCT00799383|564335058|FG001|Overall Study|Adverse Event|1|||
156337611|NCT00799383|564335057|FG000|Overall Study|Lost to Follow-up|1|||
156337612|NCT00799383|564335058|FG001|Overall Study|Lost to Follow-up|2|||
156337613|NCT00799383|564335057|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
156337614|NCT00799383|564335058|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
156337615|NCT00799383|564335057|FG000|Overall Study|Withdrawal by Subject|0|||
156337616|NCT00799383|564335058|FG001|Overall Study|Withdrawal by Subject|1|||
156337617|NCT00926328|564335062|FG000|Overall Study|Lost to Follow-up|12|||
156337618|NCT00926328|564335063|FG001|Overall Study|Lost to Follow-up|14|||
156337619|NCT00726986|564335064|FG000|Induction Phase|Adverse Event|4|||
156337620|NCT00726986|564335064|FG000|Induction Phase|Withdrawal by Subject|2|||
156337621|NCT00726986|564335064|FG000|Induction Phase|Death|2|||
156337622|NCT00726986|564335064|FG000|Induction Phase|Lack of Efficacy|5|||
156337623|NCT00726986|564335064|FG000|Induction Phase|Secondary Disease|2|||
156337624|NCT00726986|564335064|FG000|Maintenance Phase|Adverse Event|1|||
156337625|NCT00726986|564335064|FG000|Maintenance Phase|Lack of Efficacy|2|||
156803324|NCT01832727|566035988|FG003|Overall Study|Withdrawal by Subject|1|||
156803325|NCT01832727|566035989|FG004|Overall Study|Withdrawal by Subject|0|||
156803326|NCT01832727|566035990|FG005|Overall Study|Withdrawal by Subject|1|||
156803327|NCT01832727|566035991|FG006|Overall Study|Withdrawal by Subject|0|||
156803328|NCT01832727|566035992|FG007|Overall Study|Withdrawal by Subject|2|||
156803329|NCT01832727|566035993|FG008|Overall Study|Withdrawal by Subject|1|||
156803330|NCT01832727|566035985|FG000|Overall Study|Study terminated by sponsor|0|||
156803331|NCT01832727|566035986|FG001|Overall Study|Study terminated by sponsor|0|||
156803332|NCT01832727|566035987|FG002|Overall Study|Study terminated by sponsor|0|||
156803333|NCT01832727|566035988|FG003|Overall Study|Study terminated by sponsor|0|||
156803334|NCT01832727|566035989|FG004|Overall Study|Study terminated by sponsor|0|||
156803335|NCT01832727|566035990|FG005|Overall Study|Study terminated by sponsor|0|||
156803336|NCT01832727|566035991|FG006|Overall Study|Study terminated by sponsor|0|||
156803337|NCT01832727|566035992|FG007|Overall Study|Study terminated by sponsor|1|||
156803338|NCT01832727|566035993|FG008|Overall Study|Study terminated by sponsor|1|||
156803339|NCT02553629|566035994|FG000|Overall Study|Logistic reasons|3|||
156803340|NCT02553629|566035995|FG001|Overall Study|Logistic reasons|6|||
156803341|NCT03434834|566035996|FG000|Overall Study|unable to swallow OCT probe|16|||
156803342|NCT01823289|566035997|FG000|Overall Study|Lost to Follow-up|5|||
156803343|NCT01823289|566035997|FG000|Overall Study|Adverse Event|5|||
156803344|NCT01823289|566035997|FG000|Overall Study|Lack of Efficacy|1|||
156803345|NCT01823289|566035997|FG000|Overall Study|Physician Decision|9|||
156803346|NCT01823289|566035997|FG000|Overall Study|Administered contraindicated medicine|1|||
156803347|NCT01823289|566035997|FG000|Overall Study|Transaminase increased more than 3 times|1|||
156803348|NCT01823289|566035997|FG000|Overall Study|Drug affected efficacy and safety|1|||
156803349|NCT01823289|566035997|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
156803350|NCT01812057|566036005|FG000|Overall Study|Protocol Violation|1|||
156803351|NCT01812057|566036006|FG001|Overall Study|Protocol Violation|0|||
156803352|NCT01812057|566036005|FG000|Overall Study|Physician Decision|1|||
156803353|NCT01812057|566036006|FG001|Overall Study|Physician Decision|0|||
156803354|NCT01911260|566036008|FG000|Supplementation Period|transference or evasion of school|7|||
156803355|NCT01911260|566036009|FG001|Supplementation Period|transference or evasion of school|9|||
156803356|NCT01911260|566036010|FG002|Supplementation Period|transference or evasion of school|7|||
156803357|NCT01911260|566036011|FG003|Supplementation Period|transference or evasion of school|6|||
156803358|NCT01911260|566036008|FG000|Supplementation Period|Adverse Event|2|||
156803359|NCT01911260|566036009|FG001|Supplementation Period|Adverse Event|0|||
156803360|NCT01911260|566036010|FG002|Supplementation Period|Adverse Event|1|||
156803361|NCT01911260|566036011|FG003|Supplementation Period|Adverse Event|0|||
156803362|NCT01911260|566036008|FG000|Supplementation Period|refused to receive supplement|1|||
156803363|NCT01911260|566036009|FG001|Supplementation Period|refused to receive supplement|0|||
156803364|NCT01911260|566036010|FG002|Supplementation Period|refused to receive supplement|1|||
156337626|NCT03486223|564335070|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
156803365|NCT01911260|566036011|FG003|Supplementation Period|refused to receive supplement|0|||
156803366|NCT01911260|566036008|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
156803367|NCT01911260|566036009|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
156803368|NCT01911260|566036010|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
156537156|NCT00467779|565061101|FG006|Stage 1|Physician Decision|0|||
156803369|NCT01911260|566036011|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
156803370|NCT01911260|566036008|FG000|Follow-up Period|transference or evasion of school|13|||
156803371|NCT01911260|566036009|FG001|Follow-up Period|transference or evasion of school|20|||
156803372|NCT01911260|566036010|FG002|Follow-up Period|transference or evasion of school|15|||
156803373|NCT01911260|566036011|FG003|Follow-up Period|transference or evasion of school|12|||
156803374|NCT00654732|566036012|FG000|Overall Study|Adverse Event|4|||
156803375|NCT00654732|566036013|FG001|Overall Study|Adverse Event|6|||
156803376|NCT04436744|566036020|FG000|Overall Study|Adverse Event|1|||
156803377|NCT04436744|566036021|FG001|Overall Study|Adverse Event|1|||
156803378|NCT04436744|566036020|FG000|Overall Study|Death|1|||
156803379|NCT04436744|566036021|FG001|Overall Study|Death|0|||
156803380|NCT04436744|566036020|FG000|Overall Study|Lost to Follow-up|0|||
156803381|NCT04436744|566036021|FG001|Overall Study|Lost to Follow-up|2|||
156803382|NCT04436744|566036020|FG000|Overall Study|Physician Decision|0|||
156803383|NCT04436744|566036021|FG001|Overall Study|Physician Decision|1|||
156803384|NCT04436744|566036020|FG000|Overall Study|Progressive Disease|0|||
156803385|NCT04436744|566036021|FG001|Overall Study|Progressive Disease|4|||
156803386|NCT04436744|566036020|FG000|Overall Study|Protocol Deviation|1|||
156803387|NCT04436744|566036021|FG001|Overall Study|Protocol Deviation|1|||
156803388|NCT04436744|566036020|FG000|Overall Study|Withdrawal by Subject|1|||
156803389|NCT04436744|566036021|FG001|Overall Study|Withdrawal by Subject|2|||
156803390|NCT01133847|566036022|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
156803391|NCT01133847|566036023|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
156803392|NCT01133847|566036024|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
156803393|NCT01133847|566036022|FG000|Follow-Up Phase|Lost to Follow-up|1|||
156803394|NCT01133847|566036023|FG001|Follow-Up Phase|Lost to Follow-up|3|||
156803395|NCT01133847|566036024|FG002|Follow-Up Phase|Lost to Follow-up|7|||
156803396|NCT01880957|566036025|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
156803397|NCT01880957|566036026|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
156803398|NCT01880957|566036025|FG000|Overall Study|Lost to Follow-up|11|||
156803399|NCT01880957|566036026|FG001|Overall Study|Lost to Follow-up|0|||
156803400|NCT01880957|566036025|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
156803401|NCT01880957|566036026|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
156803402|NCT01378117|566036027|FG000|Overall Study|withdrawal|2|||
156803403|NCT01378117|566036028|FG001|Overall Study|withdrawal|1|||
156803404|NCT01378117|566036029|FG002|Overall Study|withdrawal|2|||
156803405|NCT01378117|566036027|FG000|Overall Study|discharged before med given|2|||
156803406|NCT01378117|566036028|FG001|Overall Study|discharged before med given|0|||
156803407|NCT01378117|566036029|FG002|Overall Study|discharged before med given|1|||
156803408|NCT01463033|566036030|FG000|Overall Study|Lost to Follow-up|4|||
156803409|NCT01463033|566036031|FG001|Overall Study|Lost to Follow-up|4|||
156803410|NCT01463033|566036030|FG000|Overall Study|Death|3|||
156803411|NCT01463033|566036031|FG001|Overall Study|Death|2|||
156803412|NCT00421148|566036034|FG000|Overall Study|Lost to Follow-up|0|||
156803413|NCT00421148|566036035|FG001|Overall Study|Lost to Follow-up|0|||
156803414|NCT00421148|566036036|FG002|Overall Study|Lost to Follow-up|0|||
156803415|NCT00421148|566036037|FG003|Overall Study|Lost to Follow-up|0|||
156803416|NCT00421148|566036038|FG004|Overall Study|Lost to Follow-up|0|||
156803417|NCT00421148|566036039|FG005|Overall Study|Lost to Follow-up|0|||
156803418|NCT00421148|566036040|FG006|Overall Study|Lost to Follow-up|0|||
156803419|NCT00421148|566036041|FG007|Overall Study|Lost to Follow-up|0|||
156803420|NCT00421148|566036042|FG008|Overall Study|Lost to Follow-up|0|||
156803421|NCT00421148|566036043|FG009|Overall Study|Lost to Follow-up|0|||
156803422|NCT00421148|566036044|FG010|Overall Study|Lost to Follow-up|0|||
156803423|NCT00421148|566036045|FG011|Overall Study|Lost to Follow-up|0|||
156803424|NCT00421148|566036046|FG012|Overall Study|Lost to Follow-up|0|||
156803425|NCT00421148|566036047|FG013|Overall Study|Lost to Follow-up|0|||
156803426|NCT00421148|566036048|FG014|Overall Study|Lost to Follow-up|0|||
156803427|NCT00421148|566036049|FG015|Overall Study|Lost to Follow-up|0|||
156803428|NCT00421148|566036050|FG016|Overall Study|Lost to Follow-up|0|||
156803429|NCT00421148|566036051|FG017|Overall Study|Lost to Follow-up|1|||
156803430|NCT00421148|566036052|FG018|Overall Study|Lost to Follow-up|0|||
156803431|NCT00421148|566036053|FG019|Overall Study|Lost to Follow-up|0|||
156803432|NCT00421148|566036034|FG000|Overall Study|Withdrawal by Subject|0|||
156803433|NCT00421148|566036035|FG001|Overall Study|Withdrawal by Subject|0|||
156803434|NCT00421148|566036036|FG002|Overall Study|Withdrawal by Subject|0|||
156803435|NCT00421148|566036037|FG003|Overall Study|Withdrawal by Subject|0|||
156803436|NCT00421148|566036038|FG004|Overall Study|Withdrawal by Subject|0|||
156803437|NCT00421148|566036039|FG005|Overall Study|Withdrawal by Subject|0|||
156803438|NCT00421148|566036040|FG006|Overall Study|Withdrawal by Subject|0|||
156803439|NCT00421148|566036041|FG007|Overall Study|Withdrawal by Subject|0|||
156803440|NCT00421148|566036042|FG008|Overall Study|Withdrawal by Subject|0|||
156803441|NCT00421148|566036043|FG009|Overall Study|Withdrawal by Subject|0|||
156803442|NCT00421148|566036044|FG010|Overall Study|Withdrawal by Subject|0|||
156803443|NCT00421148|566036045|FG011|Overall Study|Withdrawal by Subject|0|||
156803444|NCT00421148|566036046|FG012|Overall Study|Withdrawal by Subject|0|||
156803445|NCT00421148|566036047|FG013|Overall Study|Withdrawal by Subject|0|||
156803446|NCT00421148|566036048|FG014|Overall Study|Withdrawal by Subject|0|||
156803447|NCT00421148|566036049|FG015|Overall Study|Withdrawal by Subject|0|||
156803448|NCT00421148|566036050|FG016|Overall Study|Withdrawal by Subject|0|||
156803449|NCT00421148|566036051|FG017|Overall Study|Withdrawal by Subject|1|||
156803450|NCT00421148|566036052|FG018|Overall Study|Withdrawal by Subject|0|||
156803451|NCT00421148|566036053|FG019|Overall Study|Withdrawal by Subject|0|||
156803452|NCT00421148|566036034|FG000|Overall Study|Protocol Violation|0|||
156803453|NCT00421148|566036035|FG001|Overall Study|Protocol Violation|0|||
156803454|NCT00421148|566036036|FG002|Overall Study|Protocol Violation|0|||
156803455|NCT00421148|566036037|FG003|Overall Study|Protocol Violation|0|||
156803456|NCT00421148|566036038|FG004|Overall Study|Protocol Violation|0|||
156803457|NCT00421148|566036039|FG005|Overall Study|Protocol Violation|1|||
156803458|NCT00421148|566036040|FG006|Overall Study|Protocol Violation|0|||
156803459|NCT00421148|566036041|FG007|Overall Study|Protocol Violation|0|||
156803460|NCT00421148|566036042|FG008|Overall Study|Protocol Violation|0|||
156803461|NCT00421148|566036043|FG009|Overall Study|Protocol Violation|0|||
156803462|NCT00421148|566036044|FG010|Overall Study|Protocol Violation|0|||
156803463|NCT00421148|566036045|FG011|Overall Study|Protocol Violation|0|||
156803464|NCT00421148|566036046|FG012|Overall Study|Protocol Violation|0|||
156803465|NCT00421148|566036047|FG013|Overall Study|Protocol Violation|0|||
156803466|NCT00421148|566036048|FG014|Overall Study|Protocol Violation|0|||
156803467|NCT00421148|566036049|FG015|Overall Study|Protocol Violation|0|||
156803468|NCT00421148|566036050|FG016|Overall Study|Protocol Violation|0|||
156803469|NCT00421148|566036051|FG017|Overall Study|Protocol Violation|0|||
156803470|NCT00421148|566036052|FG018|Overall Study|Protocol Violation|1|||
156803471|NCT00421148|566036053|FG019|Overall Study|Protocol Violation|0|||
156803472|NCT04881760|566036054|FG000|Overall Study|Adverse Event|0|||
156803473|NCT04881760|566036055|FG001|Overall Study|Adverse Event|1|||
156803474|NCT04881760|566036056|FG002|Overall Study|Adverse Event|1|||
156803475|NCT04881760|566036057|FG003|Overall Study|Adverse Event|0|||
156803476|NCT04881760|566036058|FG004|Overall Study|Adverse Event|1|||
156803477|NCT04881760|566036059|FG005|Overall Study|Adverse Event|1|||
156803478|NCT04881760|566036060|FG006|Overall Study|Adverse Event|2|||
156803479|NCT04881760|566036054|FG000|Overall Study|Death|0|||
156803480|NCT04881760|566036055|FG001|Overall Study|Death|0|||
156803481|NCT04881760|566036056|FG002|Overall Study|Death|0|||
156803482|NCT04881760|566036057|FG003|Overall Study|Death|1|||
156803483|NCT04881760|566036058|FG004|Overall Study|Death|0|||
156803484|NCT04881760|566036059|FG005|Overall Study|Death|0|||
156803485|NCT04881760|566036060|FG006|Overall Study|Death|0|||
156803486|NCT04881760|566036054|FG000|Overall Study|Lost to Follow-up|5|||
156803487|NCT04881760|566036055|FG001|Overall Study|Lost to Follow-up|7|||
156803488|NCT04881760|566036056|FG002|Overall Study|Lost to Follow-up|5|||
156803489|NCT04881760|566036057|FG003|Overall Study|Lost to Follow-up|1|||
156803490|NCT04881760|566036058|FG004|Overall Study|Lost to Follow-up|2|||
156803491|NCT04881760|566036059|FG005|Overall Study|Lost to Follow-up|4|||
156803492|NCT04881760|566036060|FG006|Overall Study|Lost to Follow-up|4|||
156803493|NCT04881760|566036054|FG000|Overall Study|Withdrawal by Subject|13|||
156803494|NCT04881760|566036055|FG001|Overall Study|Withdrawal by Subject|1|||
156803495|NCT04881760|566036056|FG002|Overall Study|Withdrawal by Subject|1|||
156803496|NCT04881760|566036057|FG003|Overall Study|Withdrawal by Subject|4|||
156803497|NCT04881760|566036058|FG004|Overall Study|Withdrawal by Subject|2|||
156803498|NCT04881760|566036059|FG005|Overall Study|Withdrawal by Subject|1|||
156803499|NCT04881760|566036060|FG006|Overall Study|Withdrawal by Subject|2|||
156803500|NCT04881760|566036054|FG000|Overall Study|Randomized but Never Treated|0|||
156803501|NCT04881760|566036055|FG001|Overall Study|Randomized but Never Treated|0|||
156803502|NCT04881760|566036056|FG002|Overall Study|Randomized but Never Treated|0|||
156803503|NCT04881760|566036057|FG003|Overall Study|Randomized but Never Treated|1|||
156803504|NCT04881760|566036058|FG004|Overall Study|Randomized but Never Treated|0|||
156803505|NCT04881760|566036059|FG005|Overall Study|Randomized but Never Treated|0|||
156803506|NCT04881760|566036060|FG006|Overall Study|Randomized but Never Treated|0|||
156803507|NCT04881760|566036054|FG000|Overall Study|Inadvertent Enrollment|2|||
156803508|NCT04881760|566036055|FG001|Overall Study|Inadvertent Enrollment|0|||
156803509|NCT04881760|566036056|FG002|Overall Study|Inadvertent Enrollment|0|||
156803510|NCT04881760|566036057|FG003|Overall Study|Inadvertent Enrollment|0|||
156803511|NCT04881760|566036058|FG004|Overall Study|Inadvertent Enrollment|0|||
156803512|NCT04881760|566036059|FG005|Overall Study|Inadvertent Enrollment|0|||
156803513|NCT04881760|566036060|FG006|Overall Study|Inadvertent Enrollment|0|||
156803514|NCT04881760|566036054|FG000|Overall Study|Site Closure|0|||
156803515|NCT04881760|566036055|FG001|Overall Study|Site Closure|0|||
156803516|NCT04881760|566036056|FG002|Overall Study|Site Closure|0|||
156803517|NCT04881760|566036057|FG003|Overall Study|Site Closure|1|||
156803518|NCT04881760|566036058|FG004|Overall Study|Site Closure|0|||
156803519|NCT04881760|566036059|FG005|Overall Study|Site Closure|0|||
156803520|NCT04881760|566036060|FG006|Overall Study|Site Closure|0|||
156803521|NCT04540367|566036069|FG000|Overall Study|Withdrawal by Subject|0|||
156803522|NCT04540367|566036070|FG001|Overall Study|Withdrawal by Subject|0|||
156803523|NCT04540367|566036071|FG002|Overall Study|Withdrawal by Subject|0|||
156337627|NCT03486223|564335071|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
156337628|NCT01819831|564335072|FG000|Overall Study|Withdrawal by Subject|1|||
156337629|NCT01513343|564335073|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
156803524|NCT04540367|566036072|FG003|Overall Study|Withdrawal by Subject|2|||
156803525|NCT04540367|566036069|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
156803526|NCT04540367|566036070|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
156803527|NCT04540367|566036071|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
156803528|NCT04540367|566036072|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
156803529|NCT04540367|566036069|FG000|Overall Study|Adverse Event|0|||
156803530|NCT04540367|566036070|FG001|Overall Study|Adverse Event|0|||
156803531|NCT04540367|566036071|FG002|Overall Study|Adverse Event|1|||
156803532|NCT04540367|566036072|FG003|Overall Study|Adverse Event|1|||
156803533|NCT00165789|566036076|FG000|Overall Study|Adverse Event|0|||
156803534|NCT00165789|566036077|FG001|Overall Study|Adverse Event|3|||
156803535|NCT00165789|566036078|FG002|Overall Study|Adverse Event|0|||
156803536|NCT00165789|566036079|FG003|Overall Study|Adverse Event|12|||
156803537|NCT00165789|566036076|FG000|Overall Study|Withdrawal by Subject|0|||
156803538|NCT00165789|566036077|FG001|Overall Study|Withdrawal by Subject|1|||
156803539|NCT00165789|566036078|FG002|Overall Study|Withdrawal by Subject|1|||
156803540|NCT00165789|566036079|FG003|Overall Study|Withdrawal by Subject|2|||
156803541|NCT02031302|566036080|FG000|Overall Study|Death|115|||
156803542|NCT02031302|566036081|FG001|Overall Study|Death|0|||
156803543|NCT02031302|566036080|FG000|Overall Study|Not treated with study valve system|18|||
156803544|NCT02031302|566036081|FG001|Overall Study|Not treated with study valve system|0|||
156803545|NCT02031302|566036080|FG000|Overall Study|Missed Follow Up|27|||
156803546|NCT02031302|566036081|FG001|Overall Study|Missed Follow Up|0|||
156803547|NCT02031302|566036080|FG000|Overall Study|Lost to Follow-up|4|||
156803548|NCT02031302|566036081|FG001|Overall Study|Lost to Follow-up|0|||
156803549|NCT01816984|566036082|FG000|Overall Study|declining health status|1|||
156337630|NCT01513343|564335074|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
156459400|NCT05671653|564778384|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
156803550|NCT05899829|566036083|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
156803551|NCT05899829|566036084|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
156803552|NCT05899829|566036083|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
156803553|NCT05899829|566036084|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
156803554|NCT02121509|566036089|FG000|Washout Period (35 Days)|Adverse Event|1|||
156803555|NCT02121509|566036090|FG001|Washout Period (35 Days)|Adverse Event|1|||
156337631|NCT01513343|564335073|FG000|Post Data Collection|Dropped/withdrew from study|7|||
156803556|NCT02121509|566036091|FG002|Washout Period (35 Days)|Adverse Event|0|||
156803557|NCT02121509|566036092|FG003|Washout Period (35 Days)|Adverse Event|0|||
156803558|NCT02121509|566036089|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
156803559|NCT02121509|566036090|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
156803560|NCT02121509|566036091|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
156803561|NCT02121509|566036092|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
156803562|NCT02121509|566036089|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
156803563|NCT02121509|566036090|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
156803564|NCT02121509|566036091|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
156803565|NCT02121509|566036092|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
156803566|NCT00867035|566036095|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
156803567|NCT00867035|566036096|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
156803568|NCT00867035|566036095|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
156803569|NCT00867035|566036096|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
156803570|NCT05076045|566036097|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
156803571|NCT05076045|566036098|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
156803572|NCT04704193|566036105|FG000|Overall Study|Withdrawal by Subject|1|||
156803573|NCT00542178|566036106|FG000|Overall Study|did not complete year 4 follow-up|75|||
156803574|NCT00542178|566036107|FG001|Overall Study|did not complete year 4 follow-up|80|||
156803575|NCT00542178|566036108|FG002|Overall Study|did not complete year 4 follow-up|74|||
156803576|NCT00542178|566036109|FG003|Overall Study|did not complete year 4 follow-up|62|||
156803577|NCT00542178|566036110|FG004|Overall Study|did not complete year 4 follow-up|64|||
156803578|NCT00542178|566036111|FG005|Overall Study|did not complete year 4 follow-up|89|||
156803579|NCT00542178|566036112|FG006|Overall Study|did not complete year 4 follow-up|87|||
156803580|NCT00542178|566036113|FG007|Overall Study|did not complete year 4 follow-up|85|||
156803581|NCT05270863|566036114|FG000|Visit 2 First Intervention|Randomization error|0|||
156803582|NCT05270863|566036115|FG001|Visit 2 First Intervention|Randomization error|0|||
156803583|NCT05270863|566036116|FG002|Visit 2 First Intervention|Randomization error|0|||
156803584|NCT05270863|566036117|FG003|Visit 2 First Intervention|Randomization error|1|||
156803585|NCT05270863|566036118|FG004|Visit 2 First Intervention|Randomization error|0|||
156803586|NCT05270863|566036119|FG005|Visit 2 First Intervention|Randomization error|0|||
156803587|NCT05270863|566036114|FG000|First Washout|Withdrawal by Subject|0|||
156803588|NCT05270863|566036115|FG001|First Washout|Withdrawal by Subject|0|||
156803589|NCT05270863|566036116|FG002|First Washout|Withdrawal by Subject|0|||
156803590|NCT05270863|566036117|FG003|First Washout|Withdrawal by Subject|0|||
156803591|NCT05270863|566036118|FG004|First Washout|Withdrawal by Subject|1|||
156803592|NCT05270863|566036119|FG005|First Washout|Withdrawal by Subject|1|||
156803593|NCT05270863|566036114|FG000|First Washout|Lost to Follow-up|0|||
156803594|NCT05270863|566036115|FG001|First Washout|Lost to Follow-up|0|||
156803595|NCT05270863|566036116|FG002|First Washout|Lost to Follow-up|0|||
156803596|NCT05270863|566036117|FG003|First Washout|Lost to Follow-up|0|||
156803597|NCT05270863|566036118|FG004|First Washout|Lost to Follow-up|0|||
156803598|NCT05270863|566036119|FG005|First Washout|Lost to Follow-up|1|||
156803599|NCT05270863|566036114|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
156803600|NCT05270863|566036115|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
156803601|NCT05270863|566036116|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
156803602|NCT05270863|566036117|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
156803603|NCT05270863|566036118|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
156803604|NCT05270863|566036119|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
156803605|NCT05270863|566036114|FG000|Second Washout|Withdrawal by Subject|1|||
156803606|NCT05270863|566036115|FG001|Second Washout|Withdrawal by Subject|1|||
156803607|NCT05270863|566036116|FG002|Second Washout|Withdrawal by Subject|0|||
156803608|NCT05270863|566036117|FG003|Second Washout|Withdrawal by Subject|0|||
156803609|NCT05270863|566036118|FG004|Second Washout|Withdrawal by Subject|0|||
156803610|NCT05270863|566036119|FG005|Second Washout|Withdrawal by Subject|0|||
156803611|NCT05270863|566036114|FG000|Second Washout|Lost to Follow-up|0|||
156803612|NCT05270863|566036115|FG001|Second Washout|Lost to Follow-up|0|||
156803613|NCT05270863|566036116|FG002|Second Washout|Lost to Follow-up|0|||
156803614|NCT05270863|566036117|FG003|Second Washout|Lost to Follow-up|1|||
156803615|NCT05270863|566036118|FG004|Second Washout|Lost to Follow-up|0|||
156803616|NCT05270863|566036119|FG005|Second Washout|Lost to Follow-up|0|||
156803617|NCT03384875|566036120|FG000|Overall Study|Death|1|||
156803618|NCT03384875|566036121|FG001|Overall Study|Death|1|||
156803619|NCT03384875|566036122|FG002|Overall Study|Death|0|||
156803620|NCT03384875|566036120|FG000|Overall Study|Reason not provided|1|||
156803621|NCT03384875|566036121|FG001|Overall Study|Reason not provided|0|||
156803622|NCT03384875|566036122|FG002|Overall Study|Reason not provided|0|||
156803623|NCT02026011|566037516|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
156803624|NCT02026011|566037517|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
156803625|NCT02026011|566037516|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
156803626|NCT02026011|566037517|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
156803627|NCT02026011|566037516|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
156803628|NCT02026011|566037517|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
156803629|NCT02026011|566037516|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
156803630|NCT02026011|566037517|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
156803631|NCT05010070|566037518|FG000|Overall Study|Lost to Follow-up|1|||
156803632|NCT05010070|566037518|FG000|Overall Study|Withdrawal by Subject|1|||
156803633|NCT00529243|566037520|FG000|Overall Study|Adverse Event|1|||
156803634|NCT00529243|566037520|FG000|Overall Study|Death|1|||
156803635|NCT00529243|566037520|FG000|Overall Study|Relocated|1|||
156803636|NCT01783444|566037521|FG000|Treatment Phase|Adverse Event|9|||
156803637|NCT01783444|566037522|FG001|Treatment Phase|Adverse Event|20|||
156803638|NCT01783444|566037523|FG002|Treatment Phase|Adverse Event|19|||
156803639|NCT01783444|566037521|FG000|Treatment Phase|Disease Progression|76|||
156803640|NCT01783444|566037522|FG001|Treatment Phase|Disease Progression|66|||
156803641|NCT01783444|566037523|FG002|Treatment Phase|Disease Progression|64|||
156803642|NCT01783444|566037521|FG000|Treatment Phase|Death|2|||
156803643|NCT01783444|566037522|FG001|Treatment Phase|Death|2|||
156803644|NCT01783444|566037523|FG002|Treatment Phase|Death|2|||
156803645|NCT01783444|566037521|FG000|Treatment Phase|Protocol Violation|1|||
156803646|NCT01783444|566037522|FG001|Treatment Phase|Protocol Violation|1|||
156803647|NCT01783444|566037523|FG002|Treatment Phase|Protocol Violation|2|||
156803648|NCT01783444|566037521|FG000|Treatment Phase|Withdrawal by Subject|6|||
156803649|NCT01783444|566037522|FG001|Treatment Phase|Withdrawal by Subject|8|||
156803650|NCT01783444|566037523|FG002|Treatment Phase|Withdrawal by Subject|9|||
156803651|NCT01783444|566037521|FG000|Treatment Phase|Administrative problems|2|||
156803652|NCT01783444|566037522|FG001|Treatment Phase|Administrative problems|0|||
156803653|NCT01783444|566037523|FG002|Treatment Phase|Administrative problems|1|||
156803654|NCT01783444|566037521|FG000|Treatment Phase|Physician Decision|8|||
156803655|NCT01783444|566037522|FG001|Treatment Phase|Physician Decision|6|||
156803656|NCT01783444|566037523|FG002|Treatment Phase|Physician Decision|5|||
156803657|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
156803658|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
156803659|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
156803660|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
156803661|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
156803662|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
156803663|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
156803664|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
156803665|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
156803666|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
156803667|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
156803668|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
156803669|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
156803670|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
156803671|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
156803672|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
156803673|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
156803674|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
156803675|NCT02921789|566037524|FG000|Overall Study|Adverse Event|0|||
156803676|NCT02921789|566037525|FG001|Overall Study|Adverse Event|1|||
156803677|NCT02921789|566037524|FG000|Overall Study|Lost to Follow-up|1|||
156803678|NCT02921789|566037525|FG001|Overall Study|Lost to Follow-up|0|||
156803679|NCT02921789|566037524|FG000|Overall Study|Protocol Deviation|2|||
156803680|NCT02921789|566037525|FG001|Overall Study|Protocol Deviation|0|||
156803681|NCT02921789|566037524|FG000|Overall Study|Withdrawal by Subject|2|||
156803682|NCT02921789|566037525|FG001|Overall Study|Withdrawal by Subject|1|||
156803683|NCT02921789|566037524|FG000|Overall Study|Miscellaneous|3|||
156803684|NCT02921789|566037525|FG001|Overall Study|Miscellaneous|2|||
156803685|NCT03759600|566037526|FG000|Overall Study|Adverse Event|2|||
156803686|NCT03759600|566037526|FG000|Overall Study|Progressive Disease|15|||
156803687|NCT03759600|566037526|FG000|Overall Study|Site Terminated by Sponsor|3|||
156803688|NCT02332187|566037527|FG000|Overall Study|Withdrawal by Subject|2|||
156803689|NCT02332187|566037528|FG001|Overall Study|Withdrawal by Subject|2|||
156803690|NCT02332187|566037527|FG000|Overall Study|Adverse Event|0|||
156803691|NCT02332187|566037528|FG001|Overall Study|Adverse Event|1|||
156803692|NCT00339040|566037529|FG000|Stage I|Not able to attend clinic|1|||
156537157|NCT00467779|565061102|FG007|Stage 1|Physician Decision|0|||
156803693|NCT00339040|566037530|FG001|Stage I|Not able to attend clinic|0|||
156803694|NCT00339040|566037529|FG000|Stage I|Protocol Violation|1|||
156803695|NCT00339040|566037530|FG001|Stage I|Protocol Violation|1|||
156803696|NCT00339040|566037529|FG000|Stage II|Lost to Follow-up|3|||
156803697|NCT00339040|566037530|FG001|Stage II|Lost to Follow-up|0|||
156803698|NCT00339040|566037529|FG000|Stage II|Withdrawal by Subject|1|||
156803699|NCT00339040|566037530|FG001|Stage II|Withdrawal by Subject|2|||
156803700|NCT00339040|566037529|FG000|Stage II|Protocol Violation|3|||
156803701|NCT00339040|566037530|FG001|Stage II|Protocol Violation|0|||
156803702|NCT00339040|566037529|FG000|Stage II|Not able to attend clinic|1|||
156803703|NCT00339040|566037530|FG001|Stage II|Not able to attend clinic|0|||
156803704|NCT00339040|566037529|FG000|Stage II|Site closing|2|||
156803705|NCT00339040|566037530|FG001|Stage II|Site closing|0|||
156803706|NCT01462929|566037531|FG000|Overall Study|Adverse Event|3|||
156803707|NCT01462929|566037532|FG001|Overall Study|Adverse Event|3|||
156803708|NCT01462929|566037533|FG002|Overall Study|Adverse Event|4|||
156803709|NCT01462929|566037531|FG000|Overall Study|Withdrawal by Subject|2|||
156803710|NCT01462929|566037532|FG001|Overall Study|Withdrawal by Subject|1|||
156803711|NCT01462929|566037533|FG002|Overall Study|Withdrawal by Subject|0|||
156803712|NCT01462929|566037531|FG000|Overall Study|Lack of Efficacy|0|||
156803713|NCT01462929|566037532|FG001|Overall Study|Lack of Efficacy|0|||
156803714|NCT01462929|566037533|FG002|Overall Study|Lack of Efficacy|1|||
156803715|NCT02808897|566037536|FG000|Overall Study|Lost to Follow-up|9|||
156803716|NCT02808897|566037537|FG001|Overall Study|Lost to Follow-up|11|||
156803717|NCT01990742|566037543|FG000|Overall Study|Withdrawal by facility|407|||
156803718|NCT01990742|566037544|FG001|Overall Study|Withdrawal by facility|1083|||
156803719|NCT01990742|566037543|FG000|Overall Study|Facility closed|0|||
156803720|NCT01990742|566037544|FG001|Overall Study|Facility closed|270|||
156803721|NCT03848416|566037547|FG000|Overall Study|Withdrawal by Subject|1|||
156803722|NCT03848416|566037548|FG001|Overall Study|Withdrawal by Subject|0|||
156803723|NCT03848416|566037549|FG002|Overall Study|Withdrawal by Subject|0|||
156803724|NCT03848416|566037547|FG000|Overall Study|Death|0|||
156803725|NCT03848416|566037548|FG001|Overall Study|Death|0|||
156803726|NCT03848416|566037549|FG002|Overall Study|Death|1|||
156803727|NCT02808429|566037550|FG000|Overall Study|Lost to Follow-up|1|||
156803728|NCT02808429|566037551|FG001|Overall Study|Lost to Follow-up|0|||
156803729|NCT02808429|566037552|FG002|Overall Study|Lost to Follow-up|0|||
156803730|NCT02808429|566037550|FG000|Overall Study|Protocol Violation|0|||
156803731|NCT02808429|566037551|FG001|Overall Study|Protocol Violation|1|||
156803732|NCT02808429|566037552|FG002|Overall Study|Protocol Violation|0|||
156803733|NCT02808429|566037550|FG000|Overall Study|Premature study termination by sponsor|2|||
156803734|NCT02808429|566037551|FG001|Overall Study|Premature study termination by sponsor|0|||
156803735|NCT02808429|566037552|FG002|Overall Study|Premature study termination by sponsor|1|||
156803736|NCT02808429|566037550|FG000|Overall Study|Relocation|0|||
156803737|NCT02808429|566037551|FG001|Overall Study|Relocation|0|||
156803738|NCT02808429|566037552|FG002|Overall Study|Relocation|1|||
156803739|NCT00856609|566037556|FG000|Overall Study|Adverse Event|1|||
156803740|NCT00856609|566037557|FG001|Overall Study|Adverse Event|0|||
156803741|NCT01788943|566037558|FG000|Overall Study|Withdrawal by Subject|1|||
156803742|NCT01788943|566037559|FG001|Overall Study|Withdrawal by Subject|0|||
156803743|NCT00783432|566037560|FG000|Overall Study|Adverse Event|22|||
156537158|NCT00467779|565061103|FG008|Stage 1|Physician Decision|0|||
156803744|NCT00783432|566037561|FG001|Overall Study|Adverse Event|17|||
156803745|NCT00783432|566037560|FG000|Overall Study|Lack of Efficacy|20|||
156803746|NCT00783432|566037561|FG001|Overall Study|Lack of Efficacy|21|||
156803747|NCT00783432|566037560|FG000|Overall Study|Lost to Follow-up|11|||
156803748|NCT00783432|566037561|FG001|Overall Study|Lost to Follow-up|6|||
156803749|NCT00783432|566037560|FG000|Overall Study|Withdrawal by Subject|23|||
156803750|NCT00783432|566037561|FG001|Overall Study|Withdrawal by Subject|20|||
156803751|NCT00783432|566037560|FG000|Overall Study|subject moved|3|||
156803752|NCT00783432|566037561|FG001|Overall Study|subject moved|5|||
156803753|NCT00783432|566037560|FG000|Overall Study|Protocol Violation|6|||
156803754|NCT00783432|566037561|FG001|Overall Study|Protocol Violation|9|||
156803755|NCT00110214|566037562|FG000|Overall Study|Never started treatment|21|||
156803756|NCT00110214|566037563|FG001|Overall Study|Never started treatment|20|||
156803757|NCT00110214|566037562|FG000|Overall Study|Disease progression or death|260|||
156803758|NCT00110214|566037563|FG001|Overall Study|Disease progression or death|151|||
156803759|NCT00110214|566037562|FG000|Overall Study|Adverse Event|115|||
156803760|NCT00110214|566037563|FG001|Overall Study|Adverse Event|192|||
156803761|NCT00110214|566037562|FG000|Overall Study|Refused further treatment|52|||
156803762|NCT00110214|566037563|FG001|Overall Study|Refused further treatment|65|||
156803763|NCT00110214|566037562|FG000|Overall Study|Other (not specified)|61|||
156803764|NCT00110214|566037563|FG001|Overall Study|Other (not specified)|75|||
156803765|NCT01847092|566037564|FG000|Overall Study|Adverse Event|12|||
156803766|NCT01847092|566037565|FG001|Overall Study|Adverse Event|3|||
156803767|NCT01847092|566037564|FG000|Overall Study|Withdrawal by Subject|5|||
156803768|NCT01847092|566037565|FG001|Overall Study|Withdrawal by Subject|5|||
156537159|NCT00467779|565061104|FG009|Stage 1|Physician Decision|0|||
156337632|NCT01513343|564335074|FG001|Post Data Collection|Dropped/withdrew from study|1|||
156803769|NCT01847092|566037564|FG000|Overall Study|Protocol Specified|8|||
156803770|NCT01847092|566037565|FG001|Overall Study|Protocol Specified|0|||
156803771|NCT01847092|566037564|FG000|Overall Study|Physician Decision|1|||
156803772|NCT01847092|566037565|FG001|Overall Study|Physician Decision|1|||
156803773|NCT01847092|566037564|FG000|Overall Study|Protocol Violation|0|||
156803774|NCT01847092|566037565|FG001|Overall Study|Protocol Violation|2|||
156803775|NCT01567722|566037578|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
156803776|NCT01567722|566037579|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
156803777|NCT01567722|566037580|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
156803778|NCT01567722|566037578|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
156803779|NCT01567722|566037579|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
156803780|NCT01567722|566037580|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
156803781|NCT01567722|566037578|FG000|Overall Study|Protocol closure by the OCG|2|||
156803782|NCT01567722|566037579|FG001|Overall Study|Protocol closure by the OCG|0|||
156803783|NCT01567722|566037580|FG002|Overall Study|Protocol closure by the OCG|0|||
156803784|NCT01567722|566037578|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
156803785|NCT01567722|566037579|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
156803786|NCT01567722|566037580|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
156803787|NCT02259114|566037585|FG000|Overall Study|Progressive Disease|14|||
156803788|NCT02259114|566037586|FG001|Overall Study|Progressive Disease|2|||
156803789|NCT02259114|566037587|FG002|Overall Study|Progressive Disease|10|||
156803790|NCT02259114|566037588|FG003|Overall Study|Progressive Disease|2|||
156803791|NCT02259114|566037589|FG004|Overall Study|Progressive Disease|5|||
156803792|NCT02259114|566037585|FG000|Overall Study|Adverse Event|2|||
156803793|NCT02259114|566037586|FG001|Overall Study|Adverse Event|1|||
156803794|NCT02259114|566037587|FG002|Overall Study|Adverse Event|0|||
156803795|NCT02259114|566037588|FG003|Overall Study|Adverse Event|0|||
156803796|NCT02259114|566037589|FG004|Overall Study|Adverse Event|1|||
156803797|NCT02259114|566037585|FG000|Overall Study|Death|3|||
156803798|NCT02259114|566037586|FG001|Overall Study|Death|0|||
156803799|NCT02259114|566037587|FG002|Overall Study|Death|1|||
156803800|NCT02259114|566037588|FG003|Overall Study|Death|0|||
156803801|NCT02259114|566037589|FG004|Overall Study|Death|0|||
156803802|NCT02259114|566037585|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
156803803|NCT02259114|566037586|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
156803804|NCT02259114|566037587|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
156803805|NCT02259114|566037588|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
156803806|NCT02259114|566037589|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
156803807|NCT02259114|566037585|FG000|Overall Study|Withdrawal by Subject|0|||
156803808|NCT02259114|566037586|FG001|Overall Study|Withdrawal by Subject|0|||
156803809|NCT02259114|566037587|FG002|Overall Study|Withdrawal by Subject|1|||
156803810|NCT02259114|566037588|FG003|Overall Study|Withdrawal by Subject|1|||
156803811|NCT02259114|566037589|FG004|Overall Study|Withdrawal by Subject|0|||
156803812|NCT02259114|566037585|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
156803813|NCT02259114|566037586|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
156803814|NCT02259114|566037587|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
156803815|NCT02259114|566037588|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
156803816|NCT02259114|566037589|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
156803817|NCT02259114|566037585|FG000|Overall Study|Not Treated|1|||
156803818|NCT02259114|566037586|FG001|Overall Study|Not Treated|0|||
156803819|NCT02259114|566037587|FG002|Overall Study|Not Treated|0|||
156803820|NCT02259114|566037588|FG003|Overall Study|Not Treated|0|||
156803821|NCT02259114|566037589|FG004|Overall Study|Not Treated|0|||
156803822|NCT03937479|566037590|FG000|Overall Study|Adverse Event|2|||
156803823|NCT03937479|566037591|FG001|Overall Study|Adverse Event|3|||
156803824|NCT03937479|566037592|FG002|Overall Study|Adverse Event|0|||
156803825|NCT03937479|566037593|FG003|Overall Study|Adverse Event|0|||
156803826|NCT03937479|566037594|FG004|Overall Study|Adverse Event|1|||
156803827|NCT03937479|566037590|FG000|Overall Study|Withdrawal by Subject|3|||
156803828|NCT03937479|566037591|FG001|Overall Study|Withdrawal by Subject|5|||
156803829|NCT03937479|566037592|FG002|Overall Study|Withdrawal by Subject|2|||
156803830|NCT03937479|566037593|FG003|Overall Study|Withdrawal by Subject|2|||
156803831|NCT03937479|566037594|FG004|Overall Study|Withdrawal by Subject|1|||
156803832|NCT03937479|566037590|FG000|Overall Study|Protocol Violation|5|||
156803833|NCT03937479|566037591|FG001|Overall Study|Protocol Violation|6|||
156803834|NCT03937479|566037592|FG002|Overall Study|Protocol Violation|4|||
156803835|NCT03937479|566037593|FG003|Overall Study|Protocol Violation|3|||
156803836|NCT03937479|566037594|FG004|Overall Study|Protocol Violation|2|||
156803837|NCT03937479|566037590|FG000|Overall Study|Lost to Follow-up|0|||
156803838|NCT03937479|566037591|FG001|Overall Study|Lost to Follow-up|1|||
156803839|NCT03937479|566037592|FG002|Overall Study|Lost to Follow-up|0|||
156803840|NCT03937479|566037593|FG003|Overall Study|Lost to Follow-up|1|||
156803841|NCT03937479|566037594|FG004|Overall Study|Lost to Follow-up|0|||
156803842|NCT03937479|566037590|FG000|Overall Study|Physician Decision|0|||
156803843|NCT03937479|566037591|FG001|Overall Study|Physician Decision|0|||
156803844|NCT03937479|566037592|FG002|Overall Study|Physician Decision|1|||
156803845|NCT03937479|566037593|FG003|Overall Study|Physician Decision|0|||
156803846|NCT03937479|566037594|FG004|Overall Study|Physician Decision|1|||
156803847|NCT02712788|566037597|FG000|Overall Study|Physician Decision|1|||
156803848|NCT02712788|566037598|FG001|Overall Study|Physician Decision|0|||
156803849|NCT02712788|566037597|FG000|Overall Study|Protocol Violation|1|||
156803850|NCT02712788|566037598|FG001|Overall Study|Protocol Violation|0|||
156803851|NCT00940602|566037602|FG000|Overall Study|Administrative problems|1|||
156803852|NCT00940602|566037603|FG001|Overall Study|Administrative problems|1|||
156803853|NCT00940602|566037602|FG000|Overall Study|Patient/guardian decision|13|||
156803854|NCT00940602|566037603|FG001|Overall Study|Patient/guardian decision|28|||
156803855|NCT00940602|566037602|FG000|Overall Study|Physician Decision|8|||
156803856|NCT00940602|566037603|FG001|Overall Study|Physician Decision|5|||
156803857|NCT00940602|566037602|FG000|Overall Study|Pregnancy|1|||
156803858|NCT00940602|566037603|FG001|Overall Study|Pregnancy|0|||
156803859|NCT00940602|566037602|FG000|Overall Study|Protocol Deviation (untreated)|1|||
156803860|NCT00940602|566037603|FG001|Overall Study|Protocol Deviation (untreated)|0|||
156803861|NCT00940602|566037602|FG000|Overall Study|Disease progression|8|||
156803862|NCT00940602|566037603|FG001|Overall Study|Disease progression|2|||
156803863|NCT00940602|566037602|FG000|Overall Study|Death|38|||
156803864|NCT00940602|566037603|FG001|Overall Study|Death|19|||
156803865|NCT00940602|566037602|FG000|Overall Study|Lost to Follow-up|3|||
156803866|NCT00940602|566037603|FG001|Overall Study|Lost to Follow-up|1|||
156803867|NCT00940602|566037602|FG000|Overall Study|Patient withdrew consent|26|||
156803868|NCT00940602|566037603|FG001|Overall Study|Patient withdrew consent|13|||
156803869|NCT00940602|566037602|FG000|Overall Study|Adverse Event|7|||
156803870|NCT00940602|566037603|FG001|Overall Study|Adverse Event|2|||
156803871|NCT00940602|566037602|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
156803872|NCT00940602|566037603|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
156803873|NCT02961244|566037605|FG000|Overall Study|Protocol Violation|0|||
156803874|NCT02961244|566037606|FG001|Overall Study|Protocol Violation|1|||
156803875|NCT02961244|566037605|FG000|Overall Study|Withdrawal by Subject|1|||
156803876|NCT02961244|566037606|FG001|Overall Study|Withdrawal by Subject|2|||
156803877|NCT02961244|566037605|FG000|Overall Study|Surgery plan change after study approval|0|||
156803878|NCT02961244|566037606|FG001|Overall Study|Surgery plan change after study approval|2|||
156803879|NCT02961244|566037605|FG000|Overall Study|Lost to Follow-up|0|||
156803880|NCT02961244|566037606|FG001|Overall Study|Lost to Follow-up|2|||
156803881|NCT02961244|566037605|FG000|Overall Study|İnadequate data|0|||
156803882|NCT02961244|566037606|FG001|Overall Study|İnadequate data|2|||
156803883|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
156803884|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
156803885|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
156803886|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
156803887|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
156803888|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
156803889|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
156803890|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
156803891|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
156803892|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
156803893|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
156803894|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
156803895|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
156803896|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
156803897|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
156803898|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
156803899|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
156803900|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
156803901|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
156337633|NCT01513343|564335073|FG000|Post Data Collection|Lost to Follow-up|10|||
156337634|NCT01513343|564335074|FG001|Post Data Collection|Lost to Follow-up|23|||
156337635|NCT01513343|564335073|FG000|6-month Follow-up|Lost to Follow-up|28|||
156337636|NCT01513343|564335074|FG001|6-month Follow-up|Lost to Follow-up|17|||
156803902|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
156803903|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
156803904|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
156803905|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
156803906|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
156803907|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
156803908|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
156803909|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
156803910|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
156803911|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
156803912|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
156803913|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
156803914|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
156803915|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
156803916|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
156803917|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
156803918|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
156803919|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
156803920|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
156803921|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
156803922|NCT01696643|566037610|FG000|Overall Study|Adverse Event|15|||
156803923|NCT01696643|566037611|FG001|Overall Study|Adverse Event|7|||
156803924|NCT01696643|566037610|FG000|Overall Study|Death|1|||
156803925|NCT01696643|566037611|FG001|Overall Study|Death|2|||
156803926|NCT01696643|566037610|FG000|Overall Study|Lack of Efficacy|3|||
156803927|NCT01696643|566037611|FG001|Overall Study|Lack of Efficacy|0|||
156803928|NCT01696643|566037610|FG000|Overall Study|Lost to Follow-up|67|||
156803929|NCT01696643|566037611|FG001|Overall Study|Lost to Follow-up|67|||
156803930|NCT01696643|566037610|FG000|Overall Study|Physician Decision|3|||
156803931|NCT01696643|566037611|FG001|Overall Study|Physician Decision|2|||
156803932|NCT01696643|566037610|FG000|Overall Study|Pregnancy|0|||
156803933|NCT01696643|566037611|FG001|Overall Study|Pregnancy|1|||
156803934|NCT01696643|566037610|FG000|Overall Study|Protocol Violation|7|||
156803935|NCT01696643|566037611|FG001|Overall Study|Protocol Violation|7|||
156803936|NCT01696643|566037610|FG000|Overall Study|Study Terminated by Sponsor|286|||
156803937|NCT01696643|566037611|FG001|Overall Study|Study Terminated by Sponsor|294|||
156803938|NCT01696643|566037610|FG000|Overall Study|Withdrawal by Subject|142|||
156803939|NCT01696643|566037611|FG001|Overall Study|Withdrawal by Subject|149|||
156803940|NCT01696643|566037610|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
156803941|NCT01696643|566037611|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
156803942|NCT01696643|566037610|FG000|Overall Study|Site Error|2|||
156803943|NCT01696643|566037611|FG001|Overall Study|Site Error|1|||
156803944|NCT01696643|566037610|FG000|Overall Study|Participant Incarcerated|0|||
156803945|NCT01696643|566037611|FG001|Overall Study|Participant Incarcerated|1|||
156803946|NCT01696643|566037610|FG000|Overall Study|Medical Monitor Decision|0|||
156803947|NCT01696643|566037611|FG001|Overall Study|Medical Monitor Decision|2|||
156803948|NCT01696643|566037610|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
156803949|NCT01696643|566037611|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
156803950|NCT00518180|566037616|FG000|Overall Study|Withdrawal by Subject|29|||
156803951|NCT00518180|566037617|FG001|Overall Study|Withdrawal by Subject|30|||
156803952|NCT00518180|566037618|FG002|Overall Study|Withdrawal by Subject|42|||
156803953|NCT00518180|566037616|FG000|Overall Study|Lost to Follow-up|30|||
156803954|NCT00518180|566037617|FG001|Overall Study|Lost to Follow-up|28|||
156803955|NCT00518180|566037618|FG002|Overall Study|Lost to Follow-up|34|||
156803956|NCT00518180|566037616|FG000|Overall Study|Administrative reason|0|||
156803957|NCT00518180|566037617|FG001|Overall Study|Administrative reason|2|||
156803958|NCT00518180|566037618|FG002|Overall Study|Administrative reason|2|||
156803959|NCT00518180|566037616|FG000|Overall Study|Protocol Violation|5|||
156803960|NCT00518180|566037617|FG001|Overall Study|Protocol Violation|7|||
156803961|NCT00518180|566037618|FG002|Overall Study|Protocol Violation|4|||
156803962|NCT00518180|566037616|FG000|Overall Study|Unable to classify|0|||
156803963|NCT00518180|566037617|FG001|Overall Study|Unable to classify|2|||
156803964|NCT00518180|566037618|FG002|Overall Study|Unable to classify|0|||
156803965|NCT00518180|566037616|FG000|Overall Study|Adverse Event|1|||
156803966|NCT00518180|566037617|FG001|Overall Study|Adverse Event|0|||
156803967|NCT00518180|566037618|FG002|Overall Study|Adverse Event|0|||
156803968|NCT01368614|566037619|FG000|Screening Period|Screen Failure|58|||
156803969|NCT01368614|566037620|FG001|Screening Period|Screen Failure|0|||
156803970|NCT01368614|566037621|FG002|Screening Period|Screen Failure|0|||
156803971|NCT01368614|566037622|FG003|Screening Period|Screen Failure|0|||
156803972|NCT01368614|566037619|FG000|Study Period|Withdrawal by Subject|0|||
156803973|NCT01368614|566037620|FG001|Study Period|Withdrawal by Subject|1|||
156803974|NCT01368614|566037621|FG002|Study Period|Withdrawal by Subject|1|||
156803975|NCT01368614|566037622|FG003|Study Period|Withdrawal by Subject|3|||
156803976|NCT01368614|566037619|FG000|Study Period|Lost to Follow-up|0|||
156803977|NCT01368614|566037620|FG001|Study Period|Lost to Follow-up|0|||
156803978|NCT01368614|566037621|FG002|Study Period|Lost to Follow-up|1|||
156803979|NCT01368614|566037622|FG003|Study Period|Lost to Follow-up|0|||
156803980|NCT02951780|566037623|FG000|Period 1|Adverse Event|0|||
156803981|NCT02951780|566037624|FG001|Period 1|Adverse Event|0|||
156803982|NCT02951780|566037625|FG002|Period 1|Adverse Event|0|||
156803983|NCT02951780|566037626|FG003|Period 1|Adverse Event|1|||
156803984|NCT02951780|566037627|FG004|Period 1|Adverse Event|0|||
156803985|NCT02951780|566037628|FG005|Period 1|Adverse Event|0|||
156803986|NCT02951780|566037629|FG006|Period 1|Adverse Event|0|||
156803987|NCT02951780|566037630|FG007|Period 1|Adverse Event|0|||
156803988|NCT02951780|566037631|FG008|Period 1|Adverse Event|0|||
156803989|NCT02951780|566037623|FG000|Period 1|Scheduling Conflicts|0|||
156803990|NCT02951780|566037624|FG001|Period 1|Scheduling Conflicts|0|||
156803991|NCT02951780|566037625|FG002|Period 1|Scheduling Conflicts|0|||
156803992|NCT02951780|566037626|FG003|Period 1|Scheduling Conflicts|0|||
156803993|NCT02951780|566037627|FG004|Period 1|Scheduling Conflicts|0|||
156803994|NCT02951780|566037628|FG005|Period 1|Scheduling Conflicts|0|||
156803995|NCT02951780|566037629|FG006|Period 1|Scheduling Conflicts|0|||
156803996|NCT02951780|566037630|FG007|Period 1|Scheduling Conflicts|1|||
156803997|NCT02951780|566037631|FG008|Period 1|Scheduling Conflicts|0|||
156803998|NCT02951780|566037623|FG000|Period 2|Scheduling Conflicts|0|||
156803999|NCT02951780|566037624|FG001|Period 2|Scheduling Conflicts|0|||
156804000|NCT02951780|566037625|FG002|Period 2|Scheduling Conflicts|0|||
156804001|NCT02951780|566037626|FG003|Period 2|Scheduling Conflicts|0|||
156804002|NCT02951780|566037627|FG004|Period 2|Scheduling Conflicts|0|||
156804003|NCT02951780|566037628|FG005|Period 2|Scheduling Conflicts|0|||
156804004|NCT02951780|566037629|FG006|Period 2|Scheduling Conflicts|0|||
156804005|NCT02951780|566037630|FG007|Period 2|Scheduling Conflicts|1|||
156804006|NCT02951780|566037631|FG008|Period 2|Scheduling Conflicts|0|||
156804007|NCT00508482|566037632|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
156804008|NCT00508482|566037633|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
156804009|NCT00508482|566037634|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
156804010|NCT00508482|566037632|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
156804011|NCT00508482|566037633|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
156804012|NCT00508482|566037634|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
156804013|NCT00508482|566037632|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
156804014|NCT00508482|566037633|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
156804015|NCT00508482|566037634|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
156804016|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
156804017|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
156804018|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
156804019|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
156804020|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
156804021|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
156804022|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
156804023|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
156804024|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
156804025|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
156804026|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
156804027|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
156804028|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
156804029|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
156804030|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
156804031|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
156804032|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
156804033|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
156804034|NCT00546481|566037635|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
156804035|NCT00546481|566037636|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
156804036|NCT00546481|566037637|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
156804037|NCT00546481|566037635|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
156804038|NCT00546481|566037636|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
156804039|NCT00546481|566037637|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
156804040|NCT00546481|566037635|FG000|Maintenance Phase (CERA)|Other Reason|0|||
156804041|NCT00546481|566037636|FG001|Maintenance Phase (CERA)|Other Reason|0|||
156804042|NCT00546481|566037637|FG002|Maintenance Phase (CERA)|Other Reason|1|||
156804043|NCT00244621|566037638|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156804044|NCT00244621|566037639|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
156804045|NCT00244621|566037640|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
156804046|NCT00244621|566037638|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
156337637|NCT01513343|564335073|FG000|12-month Follow-up|Lost to Follow-up|10|||
156337638|NCT01513343|564335074|FG001|12-month Follow-up|Lost to Follow-up|3|||
156337639|NCT02034110|564335075|FG000|Overall Study|Physician Decision|0|||
156337640|NCT02034110|564335076|FG001|Overall Study|Physician Decision|0|||
156804047|NCT00244621|566037639|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
156804048|NCT00244621|566037640|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156804049|NCT00244621|566037638|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
156804050|NCT00244621|566037639|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
156804051|NCT00244621|566037640|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
156804052|NCT00244621|566037638|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
156804053|NCT00244621|566037639|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
156804054|NCT00244621|566037640|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
156804055|NCT00244621|566037638|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
156804056|NCT00244621|566037639|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
156804057|NCT00244621|566037640|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
156804058|NCT00244621|566037638|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
156804059|NCT00244621|566037639|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156804060|NCT00244621|566037640|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
156804061|NCT00244621|566037638|FG000|Open-label Treatment Period|Adverse Event|0|||
156804062|NCT00244621|566037639|FG001|Open-label Treatment Period|Adverse Event|0|||
156804063|NCT00244621|566037640|FG002|Open-label Treatment Period|Adverse Event|1|||
156804064|NCT00244621|566037638|FG000|Open-label Treatment Period|Moved abroad|0|||
156804065|NCT00244621|566037639|FG001|Open-label Treatment Period|Moved abroad|0|||
156804066|NCT00244621|566037640|FG002|Open-label Treatment Period|Moved abroad|1|||
156804067|NCT01193101|566037644|FG000|Overall Study|Adverse Event|0|||
156804068|NCT01193101|566037645|FG001|Overall Study|Adverse Event|1|||
156804069|NCT01193101|566037646|FG002|Overall Study|Adverse Event|1|||
156804070|NCT01193101|566037647|FG003|Overall Study|Adverse Event|3|||
156804071|NCT01193101|566037644|FG000|Overall Study|Lack of Efficacy|3|||
156804072|NCT01193101|566037645|FG001|Overall Study|Lack of Efficacy|1|||
156804073|NCT01193101|566037646|FG002|Overall Study|Lack of Efficacy|0|||
156804074|NCT01193101|566037647|FG003|Overall Study|Lack of Efficacy|8|||
156804075|NCT01193101|566037644|FG000|Overall Study|Withdrawal by Subject|2|||
156804076|NCT01193101|566037645|FG001|Overall Study|Withdrawal by Subject|4|||
156804077|NCT01193101|566037646|FG002|Overall Study|Withdrawal by Subject|1|||
156804078|NCT01193101|566037647|FG003|Overall Study|Withdrawal by Subject|1|||
156804079|NCT01193101|566037644|FG000|Overall Study|Administrative problems|0|||
156804080|NCT01193101|566037645|FG001|Overall Study|Administrative problems|0|||
156804081|NCT01193101|566037646|FG002|Overall Study|Administrative problems|1|||
156804082|NCT01193101|566037647|FG003|Overall Study|Administrative problems|0|||
156804083|NCT01193101|566037644|FG000|Overall Study|Abnormal test procedure results|0|||
156804084|NCT01193101|566037645|FG001|Overall Study|Abnormal test procedure results|1|||
156804085|NCT01193101|566037646|FG002|Overall Study|Abnormal test procedure results|0|||
156804086|NCT01193101|566037647|FG003|Overall Study|Abnormal test procedure results|0|||
156804087|NCT02347085|566037648|FG000|Overall Study|Adverse Event|2|||
156804088|NCT02347085|566037648|FG000|Overall Study|Lack of Efficacy|1|||
156804089|NCT02347085|566037648|FG000|Overall Study|Withdrawal by Subject|4|||
156804090|NCT02347085|566037648|FG000|Overall Study|Lost to Follow-up|1|||
156804091|NCT02347085|566037648|FG000|Overall Study|Protocol Criteria|2|||
156804092|NCT02271529|566037649|FG000|Overall Study|Withdrawal by Subject|1|||
156804093|NCT03508050|566037651|FG000|Overall Study|Pleural adhesions|1|||
156804094|NCT03508050|566037652|FG001|Overall Study|Pleural adhesions|0|||
156804095|NCT03508050|566037651|FG000|Overall Study|Mucus plug|1|||
156804096|NCT03508050|566037652|FG001|Overall Study|Mucus plug|0|||
156804097|NCT03508050|566037651|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
156804098|NCT03508050|566037652|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
156804099|NCT03508050|566037651|FG000|Overall Study|Sustained desaturation|0|||
156804100|NCT03508050|566037652|FG001|Overall Study|Sustained desaturation|1|||
156804101|NCT01957865|566037653|FG000|Overall Study|Found HIV negative|0|||
156804102|NCT01957865|566037654|FG001|Overall Study|Found HIV negative|0|||
156804103|NCT01957865|566037655|FG002|Overall Study|Found HIV negative|1|||
156804104|NCT01957865|566037653|FG000|Overall Study|Lost to Follow-up|0|||
156804105|NCT01957865|566037654|FG001|Overall Study|Lost to Follow-up|2|||
156804106|NCT01957865|566037655|FG002|Overall Study|Lost to Follow-up|2|||
156804107|NCT01082614|566037656|FG000|Overall Study|Adverse Event|1|||
156804108|NCT01082614|566037657|FG001|Overall Study|Adverse Event|4|||
156804109|NCT01082614|566037656|FG000|Overall Study|Equipment Malfunction|0|||
156804110|NCT01082614|566037657|FG001|Overall Study|Equipment Malfunction|1|||
156804111|NCT01082614|566037656|FG000|Overall Study|Physician Decision|2|||
156804112|NCT01082614|566037657|FG001|Overall Study|Physician Decision|0|||
156804113|NCT00811720|566037658|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
156804114|NCT00811720|566037659|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
156804115|NCT00811720|566037658|FG000|All Treated Patients|Adverse Event|20|||
156804116|NCT00811720|566037659|FG001|All Treated Patients|Adverse Event|62|||
156804117|NCT00811720|566037658|FG000|All Treated Patients|Lack of Efficacy|22|||
156804118|NCT00811720|566037659|FG001|All Treated Patients|Lack of Efficacy|18|||
156804119|NCT00811720|566037658|FG000|All Treated Patients|Non-compliance|0|||
156804120|NCT00811720|566037659|FG001|All Treated Patients|Non-compliance|14|||
156804121|NCT00811720|566037658|FG000|All Treated Patients|Protocol Violation|9|||
156804122|NCT00811720|566037659|FG001|All Treated Patients|Protocol Violation|16|||
156804123|NCT00811720|566037658|FG000|All Treated Patients|Withdrawal by Subject|28|||
156804124|NCT00811720|566037659|FG001|All Treated Patients|Withdrawal by Subject|34|||
156804125|NCT00811720|566037658|FG000|All Treated Patients|Lost to Follow-up|10|||
156804126|NCT00811720|566037659|FG001|All Treated Patients|Lost to Follow-up|16|||
156804127|NCT00811720|566037658|FG000|All Treated Patients|Other Reason|7|||
156804128|NCT00811720|566037659|FG001|All Treated Patients|Other Reason|4|||
156804129|NCT00950651|566037663|FG000|Overall Study|Adverse Event|17|||
156804130|NCT00950651|566037664|FG001|Overall Study|Adverse Event|20|||
156804131|NCT00950651|566037663|FG000|Overall Study|Death|1|||
156804132|NCT00950651|566037664|FG001|Overall Study|Death|0|||
156804133|NCT00950651|566037663|FG000|Overall Study|Lack of Efficacy|2|||
156804134|NCT00950651|566037664|FG001|Overall Study|Lack of Efficacy|2|||
156804135|NCT00950651|566037663|FG000|Overall Study|Protocol Violation|3|||
156804136|NCT00950651|566037664|FG001|Overall Study|Protocol Violation|4|||
156804137|NCT00950651|566037663|FG000|Overall Study|Withdrawal by Subject|8|||
156804138|NCT00950651|566037664|FG001|Overall Study|Withdrawal by Subject|9|||
156804139|NCT03783780|566037665|FG000|Overall Study|Withdrawn prior to completion|1|||
156804140|NCT03768427|566037666|FG000|Overall Study|Death|0|||
156804141|NCT03768427|566037667|FG001|Overall Study|Death|0|||
156804142|NCT03768427|566037668|FG002|Overall Study|Death|1|||
156804143|NCT03768427|566037669|FG003|Overall Study|Death|0|||
156804144|NCT03768427|566037666|FG000|Overall Study|Lost to Follow-up|2|||
156804145|NCT03768427|566037667|FG001|Overall Study|Lost to Follow-up|0|||
156804146|NCT03768427|566037668|FG002|Overall Study|Lost to Follow-up|0|||
156804147|NCT03768427|566037669|FG003|Overall Study|Lost to Follow-up|0|||
156804148|NCT03768427|566037666|FG000|Overall Study|Physician Decision|3|||
156804149|NCT03768427|566037667|FG001|Overall Study|Physician Decision|2|||
156804150|NCT03768427|566037668|FG002|Overall Study|Physician Decision|4|||
156804151|NCT03768427|566037669|FG003|Overall Study|Physician Decision|4|||
156804152|NCT03768427|566037666|FG000|Overall Study|Withdrawal by Subject|7|||
156804153|NCT03768427|566037667|FG001|Overall Study|Withdrawal by Subject|2|||
156804154|NCT03768427|566037668|FG002|Overall Study|Withdrawal by Subject|6|||
156804155|NCT03768427|566037669|FG003|Overall Study|Withdrawal by Subject|7|||
156804156|NCT00776789|566037674|FG000|Overall Study|Consent refusal|2|||
156804157|NCT00776789|566037675|FG001|Overall Study|Consent refusal|2|||
156804158|NCT00776789|566037674|FG000|Overall Study|Poor quality video|1|||
156804159|NCT00776789|566037675|FG001|Overall Study|Poor quality video|1|||
156804160|NCT02993263|566037676|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
156804161|NCT00829998|566037677|FG000|Washout|Adverse Event|0|||
156804162|NCT00829998|566037678|FG001|Washout|Adverse Event|1|||
156804163|NCT02896257|566039656|FG000|Providers|Without eligible patients|21|||
156804164|NCT02896257|566039657|FG001|Providers|Without eligible patients|28|||
156804165|NCT02896257|566039656|FG000|Patients|PFT entry criteria not met|43|||
156804166|NCT02896257|566039657|FG001|Patients|PFT entry criteria not met|50|||
156804167|NCT02896257|566039656|FG000|Patients|No capacity to review|8|||
156804168|NCT02896257|566039657|FG001|Patients|No capacity to review|11|||
156804169|NCT02896257|566039656|FG000|Patients|Appointment rescheduled/cancelled|5|||
156804170|NCT02896257|566039657|FG001|Patients|Appointment rescheduled/cancelled|7|||
156804171|NCT02896257|566039656|FG000|Patients|PCP not assigned a clinic|4|||
156804172|NCT02896257|566039657|FG001|Patients|PCP not assigned a clinic|0|||
156804173|NCT02896257|566039656|FG000|Patients|No history of COPD|0|||
156804174|NCT02896257|566039657|FG001|Patients|No history of COPD|1|||
156804175|NCT02896257|566039656|FG000|Patients|Deceased between review and index date|0|||
156804176|NCT02896257|566039657|FG001|Patients|Deceased between review and index date|1|||
156804177|NCT02896257|566039656|FG000|Patients|No ICS Rx upon review|1|||
156804178|NCT02896257|566039657|FG001|Patients|No ICS Rx upon review|1|||
156804179|NCT02896257|566039656|FG000|Patients|Protocol Violation|2|||
156804180|NCT02896257|566039657|FG001|Patients|Protocol Violation|1|||
156804181|NCT02896257|566039656|FG000|Patients|Hospice care|0|||
156804182|NCT02896257|566039657|FG001|Patients|Hospice care|1|||
156804183|NCT03257358|566039662|FG000|Overall Study|Adverse Event|25|||
156804184|NCT03257358|566039663|FG001|Overall Study|Adverse Event|12|||
156804185|NCT03257358|566039662|FG000|Overall Study|Lack of Efficacy|1|||
156804186|NCT03257358|566039663|FG001|Overall Study|Lack of Efficacy|1|||
156804187|NCT03257358|566039662|FG000|Overall Study|Lost to Follow-up|12|||
156804188|NCT03257358|566039663|FG001|Overall Study|Lost to Follow-up|4|||
156804189|NCT03257358|566039662|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
156804190|NCT03257358|566039663|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
156804191|NCT03257358|566039662|FG000|Overall Study|Physician Decision|2|||
156804192|NCT03257358|566039663|FG001|Overall Study|Physician Decision|2|||
156804193|NCT03257358|566039662|FG000|Overall Study|Protocol Violation|5|||
156537160|NCT00467779|565061105|FG010|Stage 1|Physician Decision|0|||
156537161|NCT00467779|565061106|FG011|Stage 1|Physician Decision|0|||
156804194|NCT03257358|566039663|FG001|Overall Study|Protocol Violation|3|||
156804195|NCT03257358|566039662|FG000|Overall Study|Technical problems|4|||
156804196|NCT03257358|566039663|FG001|Overall Study|Technical problems|1|||
156804197|NCT03257358|566039662|FG000|Overall Study|Withdrawal by Subject|8|||
156804198|NCT03257358|566039663|FG001|Overall Study|Withdrawal by Subject|3|||
156804199|NCT03257358|566039662|FG000|Overall Study|Withdrawal of informed consent|9|||
156804200|NCT03257358|566039663|FG001|Overall Study|Withdrawal of informed consent|5|||
156804201|NCT03257358|566039662|FG000|Overall Study|New therapy for study indication|1|||
156804202|NCT03257358|566039663|FG001|Overall Study|New therapy for study indication|0|||
156804203|NCT03257358|566039662|FG000|Overall Study|No longer requires treatment|0|||
156804204|NCT03257358|566039663|FG001|Overall Study|No longer requires treatment|1|||
156804205|NCT01669902|566039664|FG000|Overall Study|Adverse Event|11|||
156804206|NCT01669902|566039664|FG000|Overall Study|Lack of Efficacy|10|||
156804207|NCT01669902|566039664|FG000|Overall Study|Other|8|||
156804208|NCT02852967|566039665|FG000|Overall Study|Adverse Event|3|||
156804209|NCT02852967|566039666|FG001|Overall Study|Adverse Event|1|||
156804210|NCT02852967|566039667|FG002|Overall Study|Adverse Event|0|||
156804211|NCT02852967|566039668|FG003|Overall Study|Adverse Event|1|||
156804212|NCT02852967|566039669|FG004|Overall Study|Adverse Event|0|||
156804213|NCT02852967|566039665|FG000|Overall Study|Death|1|||
156804214|NCT02852967|566039666|FG001|Overall Study|Death|0|||
156804215|NCT02852967|566039667|FG002|Overall Study|Death|0|||
156804216|NCT02852967|566039668|FG003|Overall Study|Death|0|||
156804217|NCT02852967|566039669|FG004|Overall Study|Death|0|||
156804218|NCT02852967|566039665|FG000|Overall Study|Lost to Follow-up|1|||
156804219|NCT02852967|566039666|FG001|Overall Study|Lost to Follow-up|2|||
156804220|NCT02852967|566039667|FG002|Overall Study|Lost to Follow-up|3|||
156804221|NCT02852967|566039668|FG003|Overall Study|Lost to Follow-up|4|||
156804222|NCT02852967|566039669|FG004|Overall Study|Lost to Follow-up|4|||
156804223|NCT02852967|566039665|FG000|Overall Study|Withdrawal by Subject|6|||
156804224|NCT02852967|566039666|FG001|Overall Study|Withdrawal by Subject|12|||
156804225|NCT02852967|566039667|FG002|Overall Study|Withdrawal by Subject|7|||
156804226|NCT02852967|566039668|FG003|Overall Study|Withdrawal by Subject|10|||
156804227|NCT02852967|566039669|FG004|Overall Study|Withdrawal by Subject|10|||
156804228|NCT02852967|566039665|FG000|Overall Study|SAE|0|||
156804229|NCT02852967|566039666|FG001|Overall Study|SAE|0|||
156804230|NCT02852967|566039667|FG002|Overall Study|SAE|0|||
156804231|NCT02852967|566039668|FG003|Overall Study|SAE|3|||
156804232|NCT02852967|566039669|FG004|Overall Study|SAE|0|||
156804233|NCT02852967|566039665|FG000|Overall Study|Elevated Liver Enzymes|2|||
156804234|NCT02852967|566039666|FG001|Overall Study|Elevated Liver Enzymes|0|||
156804235|NCT02852967|566039667|FG002|Overall Study|Elevated Liver Enzymes|0|||
156804236|NCT02852967|566039668|FG003|Overall Study|Elevated Liver Enzymes|2|||
156804237|NCT02852967|566039669|FG004|Overall Study|Elevated Liver Enzymes|2|||
156804238|NCT02852967|566039665|FG000|Overall Study|Physician Decision|0|||
156804239|NCT02852967|566039666|FG001|Overall Study|Physician Decision|0|||
156804240|NCT02852967|566039667|FG002|Overall Study|Physician Decision|0|||
156804241|NCT02852967|566039668|FG003|Overall Study|Physician Decision|1|||
156804242|NCT02852967|566039669|FG004|Overall Study|Physician Decision|0|||
156804243|NCT02852967|566039665|FG000|Overall Study|Lack of Efficacy|0|||
156804244|NCT02852967|566039666|FG001|Overall Study|Lack of Efficacy|1|||
156804245|NCT02852967|566039667|FG002|Overall Study|Lack of Efficacy|0|||
156804246|NCT02852967|566039668|FG003|Overall Study|Lack of Efficacy|0|||
156804247|NCT02852967|566039669|FG004|Overall Study|Lack of Efficacy|0|||
156804248|NCT02852967|566039665|FG000|Overall Study|Non-compliance|0|||
156804249|NCT02852967|566039666|FG001|Overall Study|Non-compliance|0|||
156804250|NCT02852967|566039667|FG002|Overall Study|Non-compliance|1|||
156804251|NCT02852967|566039668|FG003|Overall Study|Non-compliance|1|||
156804252|NCT02852967|566039669|FG004|Overall Study|Non-compliance|0|||
156804253|NCT02852967|566039665|FG000|Overall Study|Dispensing Drug Violation|0|||
156804254|NCT02852967|566039666|FG001|Overall Study|Dispensing Drug Violation|0|||
156804255|NCT02852967|566039667|FG002|Overall Study|Dispensing Drug Violation|1|||
156804256|NCT02852967|566039668|FG003|Overall Study|Dispensing Drug Violation|0|||
156804257|NCT02852967|566039669|FG004|Overall Study|Dispensing Drug Violation|0|||
156804258|NCT02852967|566039665|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
156804259|NCT02852967|566039666|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
156804260|NCT02852967|566039667|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
156804261|NCT02852967|566039668|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
156804262|NCT02852967|566039669|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
156804263|NCT02903823|566039670|FG000|Overall Study|Physician Decision|5|||
156804264|NCT02903823|566039670|FG000|Overall Study|Could not advance catheter|1|||
156804265|NCT02903823|566039670|FG000|Overall Study|Catheter dislodgement|1|||
156804266|NCT00887159|566039677|FG000|Overall Study|Disease progression|6|||
156804267|NCT00887159|566039678|FG001|Overall Study|Disease progression|39|||
156804268|NCT00887159|566039679|FG002|Overall Study|Disease progression|33|||
156804269|NCT00887159|566039677|FG000|Overall Study|Adverse Event|3|||
156804270|NCT00887159|566039678|FG001|Overall Study|Adverse Event|4|||
156804271|NCT00887159|566039679|FG002|Overall Study|Adverse Event|17|||
156804272|NCT00887159|566039677|FG000|Overall Study|Death|2|||
156804273|NCT00887159|566039678|FG001|Overall Study|Death|2|||
156804274|NCT00887159|566039679|FG002|Overall Study|Death|0|||
156804275|NCT00887159|566039677|FG000|Overall Study|Withdrawal by Subject|4|||
156804276|NCT00887159|566039678|FG001|Overall Study|Withdrawal by Subject|4|||
156804277|NCT00887159|566039679|FG002|Overall Study|Withdrawal by Subject|2|||
156804278|NCT00887159|566039677|FG000|Overall Study|Alternative therapy|2|||
156804279|NCT00887159|566039678|FG001|Overall Study|Alternative therapy|0|||
156804280|NCT00887159|566039679|FG002|Overall Study|Alternative therapy|0|||
156804281|NCT00887159|566039677|FG000|Overall Study|Physician Decision|1|||
156804282|NCT00887159|566039678|FG001|Overall Study|Physician Decision|1|||
156804283|NCT00887159|566039679|FG002|Overall Study|Physician Decision|0|||
156804284|NCT00887159|566039677|FG000|Overall Study|Sympomatic deterioration|1|||
156804285|NCT00887159|566039678|FG001|Overall Study|Sympomatic deterioration|0|||
156804286|NCT00887159|566039679|FG002|Overall Study|Sympomatic deterioration|0|||
156804287|NCT00887159|566039677|FG000|Overall Study|Treatment delayed|1|||
156804288|NCT00887159|566039678|FG001|Overall Study|Treatment delayed|1|||
156804289|NCT00887159|566039679|FG002|Overall Study|Treatment delayed|0|||
156804290|NCT00887159|566039677|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
156804291|NCT00887159|566039678|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
156804292|NCT00887159|566039679|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
156804293|NCT00887159|566039677|FG000|Overall Study|Received more tx instead of observation|1|||
156804294|NCT00887159|566039678|FG001|Overall Study|Received more tx instead of observation|0|||
156804295|NCT00887159|566039679|FG002|Overall Study|Received more tx instead of observation|0|||
156804296|NCT00887159|566039677|FG000|Overall Study|Ineligible|5|||
156804297|NCT00887159|566039678|FG001|Overall Study|Ineligible|1|||
156804298|NCT00887159|566039679|FG002|Overall Study|Ineligible|0|||
156804299|NCT00887159|566039677|FG000|Overall Study|Never started assigned therapy|3|||
156804300|NCT00887159|566039678|FG001|Overall Study|Never started assigned therapy|3|||
156804301|NCT00887159|566039679|FG002|Overall Study|Never started assigned therapy|4|||
156804302|NCT00688467|566039680|FG000|Treatment Period 1|Adverse Event|2|||
156804303|NCT00688467|566039681|FG001|Treatment Period 1|Adverse Event|1|||
156804304|NCT00688467|566039680|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
156804305|NCT00688467|566039681|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
156804306|NCT00688467|566039680|FG000|Treatment Period 2|Protocol Violation|0|||
156804307|NCT00688467|566039681|FG001|Treatment Period 2|Protocol Violation|1|||
156804308|NCT00688467|566039680|FG000|Treatment Period 2|Adverse Event|0|||
156804309|NCT00688467|566039681|FG001|Treatment Period 2|Adverse Event|1|||
156804310|NCT00690794|566039682|FG000|Overall Study|Adverse Event|12|||
156804311|NCT00690794|566039683|FG001|Overall Study|Adverse Event|10|||
156804312|NCT00690794|566039682|FG000|Overall Study|Lost to Follow-up|1|||
156804313|NCT00690794|566039683|FG001|Overall Study|Lost to Follow-up|4|||
156804314|NCT00690794|566039682|FG000|Overall Study|Withdrawal by Subject|0|||
156804315|NCT00690794|566039683|FG001|Overall Study|Withdrawal by Subject|9|||
156804316|NCT00690794|566039682|FG000|Overall Study|Protocol Violation|6|||
156804317|NCT00690794|566039683|FG001|Overall Study|Protocol Violation|7|||
156804318|NCT00690794|566039682|FG000|Overall Study|Noncompliance|1|||
156804319|NCT00690794|566039683|FG001|Overall Study|Noncompliance|2|||
156804320|NCT00690794|566039682|FG000|Overall Study|Other not specified|1|||
156804321|NCT00690794|566039683|FG001|Overall Study|Other not specified|3|||
156804322|NCT00305448|566039684|FG000|Overall Study|Protocol Violation|0|||
156804323|NCT00305448|566039685|FG001|Overall Study|Protocol Violation|1|||
156804324|NCT00305448|566039686|FG002|Overall Study|Protocol Violation|0|||
156804325|NCT00305448|566039684|FG000|Overall Study|Withdrawal by Subject|2|||
156804326|NCT00305448|566039685|FG001|Overall Study|Withdrawal by Subject|0|||
156804327|NCT00305448|566039686|FG002|Overall Study|Withdrawal by Subject|1|||
156804328|NCT00305448|566039684|FG000|Overall Study|Adverse Event|1|||
156804329|NCT00305448|566039685|FG001|Overall Study|Adverse Event|0|||
156804330|NCT00305448|566039686|FG002|Overall Study|Adverse Event|1|||
156804331|NCT00305448|566039684|FG000|Overall Study|Disease Progression|27|||
156804332|NCT00305448|566039685|FG001|Overall Study|Disease Progression|31|||
156804333|NCT00305448|566039686|FG002|Overall Study|Disease Progression|28|||
156804334|NCT00305448|566039684|FG000|Overall Study|Subjective Disease Progression|1|||
156804335|NCT00305448|566039685|FG001|Overall Study|Subjective Disease Progression|2|||
156804336|NCT00305448|566039686|FG002|Overall Study|Subjective Disease Progression|2|||
156804337|NCT00305448|566039684|FG000|Overall Study|Tumor Marker Elevation|0|||
156804338|NCT00305448|566039685|FG001|Overall Study|Tumor Marker Elevation|0|||
156804339|NCT00305448|566039686|FG002|Overall Study|Tumor Marker Elevation|1|||
156804340|NCT00002766|566039687|FG000|Overall Study|Withdrawal by Subject|0|||
156804341|NCT00002766|566039688|FG001|Overall Study|Withdrawal by Subject|1|||
156337641|NCT02034110|564335077|FG002|Overall Study|Physician Decision|0|||
156337642|NCT02034110|564335078|FG003|Overall Study|Physician Decision|0|||
156337643|NCT02034110|564335079|FG004|Overall Study|Physician Decision|2|||
156337644|NCT02034110|564335080|FG005|Overall Study|Physician Decision|0|||
156337645|NCT02034110|564335081|FG006|Overall Study|Physician Decision|1|||
156337646|NCT02034110|564335082|FG007|Overall Study|Physician Decision|0|||
156337647|NCT02034110|564335075|FG000|Overall Study|Lost to Follow-up|1|||
156804342|NCT00002766|566039687|FG000|Overall Study|Patient Not Treated|1|||
156804343|NCT00002766|566039688|FG001|Overall Study|Patient Not Treated|2|||
156804344|NCT00002766|566039687|FG000|Overall Study|Adverse Event|1|||
156804345|NCT00002766|566039688|FG001|Overall Study|Adverse Event|1|||
156804346|NCT00002766|566039687|FG000|Overall Study|Protocol Violation|1|||
156804347|NCT00002766|566039688|FG001|Overall Study|Protocol Violation|0|||
156337648|NCT02034110|564335076|FG001|Overall Study|Lost to Follow-up|0|||
156337649|NCT02034110|564335077|FG002|Overall Study|Lost to Follow-up|0|||
156804348|NCT01343888|566039689|FG000|Overall Study|Adverse Event|12|||
156804349|NCT01343888|566039690|FG001|Overall Study|Adverse Event|22|||
156804350|NCT01343888|566039691|FG002|Overall Study|Adverse Event|5|||
156804351|NCT01343888|566039689|FG000|Overall Study|Lack of Efficacy|9|||
156804352|NCT01343888|566039690|FG001|Overall Study|Lack of Efficacy|9|||
156804353|NCT01343888|566039691|FG002|Overall Study|Lack of Efficacy|13|||
156804354|NCT01343888|566039689|FG000|Overall Study|Lost to Follow-up|0|||
156804355|NCT01343888|566039690|FG001|Overall Study|Lost to Follow-up|2|||
156804356|NCT01343888|566039691|FG002|Overall Study|Lost to Follow-up|1|||
156804357|NCT01343888|566039689|FG000|Overall Study|Protocol Violation|0|||
156804358|NCT01343888|566039690|FG001|Overall Study|Protocol Violation|2|||
156804359|NCT01343888|566039691|FG002|Overall Study|Protocol Violation|0|||
156804360|NCT01343888|566039689|FG000|Overall Study|Withdrawal by Subject|4|||
156804361|NCT01343888|566039690|FG001|Overall Study|Withdrawal by Subject|4|||
156804362|NCT01343888|566039691|FG002|Overall Study|Withdrawal by Subject|2|||
156804363|NCT01343888|566039689|FG000|Overall Study|other than stated above|0|||
156804364|NCT01343888|566039690|FG001|Overall Study|other than stated above|0|||
156804365|NCT01343888|566039691|FG002|Overall Study|other than stated above|1|||
156804366|NCT00387088|566039692|FG000|Overall Study|Adverse Event|143|||
156804367|NCT00387088|566039693|FG001|Overall Study|Adverse Event|156|||
156804368|NCT00387088|566039692|FG000|Overall Study|Protocol Violation|47|||
156804369|NCT00387088|566039693|FG001|Overall Study|Protocol Violation|35|||
156804370|NCT00387088|566039692|FG000|Overall Study|Withdrawal by Subject|20|||
156804371|NCT00387088|566039693|FG001|Overall Study|Withdrawal by Subject|35|||
156804372|NCT00387088|566039692|FG000|Overall Study|Lack of Efficacy|28|||
156804373|NCT00387088|566039693|FG001|Overall Study|Lack of Efficacy|67|||
156804374|NCT00387088|566039692|FG000|Overall Study|Lost to Follow-up|22|||
156804375|NCT00387088|566039693|FG001|Overall Study|Lost to Follow-up|28|||
156804376|NCT00387088|566039692|FG000|Overall Study|Other|58|||
156804377|NCT00387088|566039693|FG001|Overall Study|Other|52|||
156804378|NCT03443687|566039694|FG000|Overall Study|Lost to Follow-up|3|||
156804379|NCT03443687|566039695|FG001|Overall Study|Lost to Follow-up|5|||
156804380|NCT03443687|566039694|FG000|Overall Study|Withdrawal by Subject|1|||
156804381|NCT03443687|566039695|FG001|Overall Study|Withdrawal by Subject|0|||
156804382|NCT03443687|566039694|FG000|Overall Study|Discontinued intervention|1|||
156804383|NCT03443687|566039695|FG001|Overall Study|Discontinued intervention|1|||
156337650|NCT02034110|564335078|FG003|Overall Study|Lost to Follow-up|0|||
156459401|NCT05671653|564778385|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
156459402|NCT05671653|564778386|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
156459403|NCT05671653|564778387|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
156804384|NCT00800735|566039696|FG000|Overall Study|Administrative/Other|2|||
156804385|NCT00800735|566039696|FG000|Overall Study|Insufficient Therapeutic Response|2|||
156804386|NCT00800735|566039696|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
156804387|NCT00800735|566039696|FG000|Overall Study|Withdrew Consent|3|||
156804388|NCT02805790|566039697|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
156337651|NCT02034110|564335079|FG004|Overall Study|Lost to Follow-up|1|||
156804389|NCT02805790|566039698|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
156804390|NCT01436110|566039706|FG000|Overall Study|Lack of Efficacy|23|||
156804391|NCT01436110|566039707|FG001|Overall Study|Lack of Efficacy|14|||
156804392|NCT01436110|566039708|FG002|Overall Study|Lack of Efficacy|9|||
156804393|NCT01436110|566039706|FG000|Overall Study|Withdrawal by Subject|6|||
156804394|NCT01436110|566039707|FG001|Overall Study|Withdrawal by Subject|8|||
156804395|NCT01436110|566039708|FG002|Overall Study|Withdrawal by Subject|4|||
156804396|NCT01436110|566039706|FG000|Overall Study|Adverse Event|2|||
156804397|NCT01436110|566039707|FG001|Overall Study|Adverse Event|1|||
156804398|NCT01436110|566039708|FG002|Overall Study|Adverse Event|2|||
156804399|NCT01436110|566039706|FG000|Overall Study|Physician Decision|3|||
156804400|NCT01436110|566039707|FG001|Overall Study|Physician Decision|1|||
156804401|NCT01436110|566039708|FG002|Overall Study|Physician Decision|1|||
156804402|NCT01436110|566039706|FG000|Overall Study|Lost to Follow-up|1|||
156804403|NCT01436110|566039707|FG001|Overall Study|Lost to Follow-up|1|||
156804404|NCT01436110|566039708|FG002|Overall Study|Lost to Follow-up|3|||
156804405|NCT01436110|566039706|FG000|Overall Study|Protocol Violation|3|||
156804406|NCT01436110|566039707|FG001|Overall Study|Protocol Violation|1|||
156804407|NCT01436110|566039708|FG002|Overall Study|Protocol Violation|1|||
156804408|NCT01436110|566039706|FG000|Overall Study|Did Not Receive Trial Medication|1|||
156804409|NCT01436110|566039707|FG001|Overall Study|Did Not Receive Trial Medication|0|||
156804410|NCT01436110|566039708|FG002|Overall Study|Did Not Receive Trial Medication|3|||
156804411|NCT03273907|566039709|FG000|Overall Study|Death|1|||
156804412|NCT03273907|566039709|FG000|Overall Study|Lost to Follow-up|4|||
156804413|NCT03273907|566039709|FG000|Overall Study|Withdrawal by Subject|2|||
156804414|NCT03273907|566039709|FG000|Overall Study|COVID 19|2|||
156804415|NCT01088503|566039710|FG000|Overall Study|Withdrawal by Subject|118|||
156804416|NCT01088503|566039711|FG001|Overall Study|Withdrawal by Subject|327|||
156804417|NCT01088503|566039712|FG002|Overall Study|Withdrawal by Subject|10|||
156804418|NCT01088503|566039710|FG000|Overall Study|Death|64|||
156804419|NCT01088503|566039711|FG001|Overall Study|Death|358|||
156804420|NCT01088503|566039712|FG002|Overall Study|Death|7|||
156804421|NCT03604497|566039714|FG000|Overall Study|Protocol Violation|52|||
156804422|NCT00811954|566039715|FG000|Overall Study|Death|10|||
156804423|NCT00811954|566039716|FG001|Overall Study|Death|6|||
156804424|NCT00811954|566039717|FG002|Overall Study|Death|13|||
156804425|NCT00811954|566039715|FG000|Overall Study|Lost to Follow-up|29|||
156804426|NCT00811954|566039716|FG001|Overall Study|Lost to Follow-up|23|||
156804427|NCT00811954|566039717|FG002|Overall Study|Lost to Follow-up|34|||
156804428|NCT00811954|566039715|FG000|Overall Study|Not able to get to clinic|28|||
156804429|NCT00811954|566039716|FG001|Overall Study|Not able to get to clinic|35|||
156804430|NCT00811954|566039717|FG002|Overall Study|Not able to get to clinic|30|||
156804431|NCT00811954|566039715|FG000|Overall Study|Not willing to adhere to requirements|12|||
156804432|NCT00811954|566039716|FG001|Overall Study|Not willing to adhere to requirements|2|||
156804433|NCT00811954|566039717|FG002|Overall Study|Not willing to adhere to requirements|16|||
156804434|NCT00811954|566039715|FG000|Overall Study|Withdraw consent prior study completion|4|||
156804435|NCT00811954|566039716|FG001|Overall Study|Withdraw consent prior study completion|6|||
156804436|NCT00811954|566039717|FG002|Overall Study|Withdraw consent prior study completion|5|||
156804437|NCT00811954|566039715|FG000|Overall Study|Site Closure|4|||
156804438|NCT00811954|566039716|FG001|Overall Study|Site Closure|0|||
156804439|NCT00811954|566039717|FG002|Overall Study|Site Closure|1|||
156804440|NCT00811954|566039715|FG000|Overall Study|Severe Debilitation|2|||
156804441|NCT00811954|566039716|FG001|Overall Study|Severe Debilitation|0|||
156804442|NCT00811954|566039717|FG002|Overall Study|Severe Debilitation|1|||
156804443|NCT00811954|566039715|FG000|Overall Study|Complete Protocol: No follow-up|0|||
156804444|NCT00811954|566039716|FG001|Overall Study|Complete Protocol: No follow-up|0|||
156804445|NCT00811954|566039717|FG002|Overall Study|Complete Protocol: No follow-up|1|||
156804446|NCT01016067|566039718|FG000|Overall Study|Lost to Follow-up|1|||
156804447|NCT01016067|566039719|FG001|Overall Study|Lost to Follow-up|2|||
156804448|NCT01016067|566039718|FG000|Overall Study|Physician Decision|1|||
156804449|NCT01016067|566039719|FG001|Overall Study|Physician Decision|1|||
156804450|NCT01016067|566039718|FG000|Overall Study|Withdrew due to Relocation|0|||
156804451|NCT01016067|566039719|FG001|Overall Study|Withdrew due to Relocation|1|||
156804452|NCT00186628|566039720|FG000|Overall Study|Death|2|||
156804453|NCT00186628|566039720|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
156459404|NCT05671653|564778388|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
156804454|NCT01331681|566039721|FG000|Overall Study|Adverse Event|10|||
156804455|NCT01331681|566039722|FG001|Overall Study|Adverse Event|13|||
156804456|NCT01331681|566039723|FG002|Overall Study|Adverse Event|10|||
156804457|NCT01331681|566039721|FG000|Overall Study|Death|6|||
156804458|NCT01331681|566039722|FG001|Overall Study|Death|6|||
156459405|NCT05671653|564778389|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
156459406|NCT05671653|564778390|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
156804459|NCT01331681|566039723|FG002|Overall Study|Death|2|||
156804460|NCT01331681|566039721|FG000|Overall Study|Lack of Efficacy|0|||
156459407|NCT05671653|564778378|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156804461|NCT01331681|566039722|FG001|Overall Study|Lack of Efficacy|1|||
156804462|NCT01331681|566039723|FG002|Overall Study|Lack of Efficacy|0|||
156804463|NCT01331681|566039721|FG000|Overall Study|Withdrawal by Subject|12|||
156804464|NCT01331681|566039722|FG001|Overall Study|Withdrawal by Subject|8|||
156804465|NCT01331681|566039723|FG002|Overall Study|Withdrawal by Subject|15|||
156804466|NCT01331681|566039721|FG000|Overall Study|Protocol Violation|1|||
156804467|NCT01331681|566039722|FG001|Overall Study|Protocol Violation|1|||
156804468|NCT01331681|566039723|FG002|Overall Study|Protocol Violation|0|||
156804469|NCT01331681|566039721|FG000|Overall Study|Lost to Follow-up|2|||
156804470|NCT01331681|566039722|FG001|Overall Study|Lost to Follow-up|4|||
156804471|NCT01331681|566039723|FG002|Overall Study|Lost to Follow-up|1|||
156804472|NCT01331681|566039721|FG000|Overall Study|Physician Decision|2|||
156804473|NCT01331681|566039722|FG001|Overall Study|Physician Decision|0|||
156804474|NCT01331681|566039723|FG002|Overall Study|Physician Decision|4|||
156804475|NCT01331681|566039721|FG000|Overall Study|Therapeutic procedure required|1|||
156804476|NCT01331681|566039722|FG001|Overall Study|Therapeutic procedure required|0|||
156804477|NCT01331681|566039723|FG002|Overall Study|Therapeutic procedure required|0|||
156804478|NCT01331681|566039721|FG000|Overall Study|Sponsor decision|1|||
156804479|NCT01331681|566039722|FG001|Overall Study|Sponsor decision|1|||
156804480|NCT01331681|566039723|FG002|Overall Study|Sponsor decision|0|||
156804481|NCT01331681|566039721|FG000|Overall Study|Switching to other therapy|0|||
156804482|NCT01331681|566039722|FG001|Overall Study|Switching to other therapy|0|||
156804483|NCT01331681|566039723|FG002|Overall Study|Switching to other therapy|1|||
156804484|NCT01331681|566039721|FG000|Overall Study|Not Received Study Treatment|0|||
156804485|NCT01331681|566039722|FG001|Overall Study|Not Received Study Treatment|0|||
156804486|NCT01331681|566039723|FG002|Overall Study|Not Received Study Treatment|2|||
156804487|NCT00658541|566039726|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
156804488|NCT00658541|566039727|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156804489|NCT00658541|566039726|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156804490|NCT00658541|566039727|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156804491|NCT04828707|566039728|FG000|Overall Study|Lost to Follow-up|3|||
156804492|NCT04828707|566039729|FG001|Overall Study|Lost to Follow-up|2|||
156804493|NCT04828707|566039728|FG000|Overall Study|Withdrawal by Subject|2|||
156804494|NCT04828707|566039729|FG001|Overall Study|Withdrawal by Subject|1|||
156804495|NCT01188967|566039734|FG000|Overall Study|Withdrawal by Subject|1|||
156804496|NCT01188967|566039735|FG001|Overall Study|Withdrawal by Subject|1|||
156804497|NCT01188967|566039734|FG000|Overall Study|Physician Decision|1|||
156804498|NCT01188967|566039735|FG001|Overall Study|Physician Decision|1|||
156804499|NCT01188967|566039734|FG000|Overall Study|Lost to Follow-up|3|||
156804500|NCT01188967|566039735|FG001|Overall Study|Lost to Follow-up|2|||
156804501|NCT01876381|566039736|FG000|Overall Study|Lack of Efficacy|5|||
156804502|NCT01876381|566039736|FG000|Overall Study|Physician Decision|1|||
156804503|NCT01876381|566039736|FG000|Overall Study|Withdrawal by Subject|1|||
156804504|NCT00523978|566039737|FG000|Overall Study|Withdrawal by Subject|3|||
156804505|NCT00523978|566039738|FG001|Overall Study|Withdrawal by Subject|7|||
156804506|NCT00523978|566039737|FG000|Overall Study|Screen Failures|5|||
156804507|NCT00523978|566039738|FG001|Overall Study|Screen Failures|1|||
156804508|NCT00523978|566039737|FG000|Overall Study|Death|1|||
156804509|NCT00523978|566039738|FG001|Overall Study|Death|0|||
156804510|NCT00382174|566039739|FG000|Overall Study|Lost to Follow-up|1|||
156804511|NCT00382174|566039740|FG001|Overall Study|Lost to Follow-up|4|||
156804512|NCT00382174|566039741|FG002|Overall Study|Lost to Follow-up|5|||
156804513|NCT00382174|566039739|FG000|Overall Study|Adverse Event|1|||
156804514|NCT00382174|566039740|FG001|Overall Study|Adverse Event|4|||
156804515|NCT00382174|566039741|FG002|Overall Study|Adverse Event|5|||
156804516|NCT00382174|566039739|FG000|Overall Study|Withdrawal by Subject|1|||
156804517|NCT00382174|566039740|FG001|Overall Study|Withdrawal by Subject|4|||
156804518|NCT00382174|566039741|FG002|Overall Study|Withdrawal by Subject|5|||
156804519|NCT00382174|566039739|FG000|Overall Study|Non compliance|1|||
156804520|NCT00382174|566039740|FG001|Overall Study|Non compliance|0|||
156804521|NCT00382174|566039741|FG002|Overall Study|Non compliance|1|||
156804522|NCT00382174|566039739|FG000|Overall Study|Physician Decision|0|||
156804523|NCT00382174|566039740|FG001|Overall Study|Physician Decision|2|||
156804524|NCT00382174|566039741|FG002|Overall Study|Physician Decision|2|||
156804525|NCT00382174|566039739|FG000|Overall Study|Failed to meet criteria|0|||
156804526|NCT00382174|566039740|FG001|Overall Study|Failed to meet criteria|1|||
156537162|NCT00467779|565061107|FG012|Stage 1|Physician Decision|0|||
156804527|NCT00382174|566039741|FG002|Overall Study|Failed to meet criteria|1|||
156804528|NCT00382174|566039739|FG000|Overall Study|Wounds merged|0|||
156804529|NCT00382174|566039740|FG001|Overall Study|Wounds merged|2|||
156804530|NCT00382174|566039741|FG002|Overall Study|Wounds merged|2|||
156804531|NCT04577781|566039744|FG000|Overall Study|Adverse Event|2|||
156804532|NCT04577781|566039745|FG001|Overall Study|Adverse Event|2|||
156804533|NCT04577781|566039744|FG000|Overall Study|Physician Decision|1|||
156804534|NCT04577781|566039745|FG001|Overall Study|Physician Decision|0|||
156804535|NCT01464879|566039746|FG000|Overall Study|Physician Decision|1|||
156804536|NCT01464879|566039746|FG000|Overall Study|Non-compliance|1|||
156804537|NCT01657305|566039748|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
156804538|NCT01657305|566039748|FG000|Overall Study|Withdrawal by Subject|4|||
156804539|NCT01657305|566039748|FG000|Overall Study|Adverse Event|1|||
156804540|NCT01657305|566039748|FG000|Overall Study|Lost to Follow-up|1|||
156804541|NCT01657305|566039748|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
156804542|NCT00696878|566039751|FG000|Overall Study|Adverse Event|8|||
156804543|NCT00696878|566039751|FG000|Overall Study|Withdrawal by Subject|87|||
156804544|NCT00696878|566039751|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
156804545|NCT00696878|566039751|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
156804546|NCT00696878|566039751|FG000|Overall Study|Trial stopped|32|||
156804547|NCT00696878|566039751|FG000|Overall Study|Other reason (not specified)|55|||
156804548|NCT04103450|566039752|FG000|Overall Study|Adverse Event|4|||
156804549|NCT04103450|566039753|FG001|Overall Study|Adverse Event|2|||
156804550|NCT04103450|566039752|FG000|Overall Study|Lack of Efficacy|3|||
156804551|NCT04103450|566039753|FG001|Overall Study|Lack of Efficacy|0|||
156804552|NCT04103450|566039752|FG000|Overall Study|Withdrawal by Subject|5|||
156804553|NCT04103450|566039753|FG001|Overall Study|Withdrawal by Subject|3|||
156804554|NCT04103450|566039752|FG000|Overall Study|Lost to Follow-up|1|||
156804555|NCT04103450|566039753|FG001|Overall Study|Lost to Follow-up|2|||
156804556|NCT04103450|566039752|FG000|Overall Study|Physician Decision|1|||
156804557|NCT04103450|566039753|FG001|Overall Study|Physician Decision|2|||
156804558|NCT04103450|566039752|FG000|Overall Study|Protocol Violation|1|||
156804559|NCT04103450|566039753|FG001|Overall Study|Protocol Violation|0|||
156804560|NCT04103450|566039752|FG000|Overall Study|Other|1|||
156804561|NCT04103450|566039753|FG001|Overall Study|Other|1|||
156804562|NCT00967616|566039756|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
156804563|NCT00967616|566039757|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
156804564|NCT00967616|566039756|FG000|Overall Study|Death|0|||
156804565|NCT00967616|566039757|FG001|Overall Study|Death|3|||
156804566|NCT00967616|566039756|FG000|Overall Study|Withdrawal by Subject|8|||
156804567|NCT00967616|566039757|FG001|Overall Study|Withdrawal by Subject|4|||
156804568|NCT00967616|566039756|FG000|Overall Study|Progressive Disease|31|||
156804569|NCT00967616|566039757|FG001|Overall Study|Progressive Disease|18|||
156804570|NCT00967616|566039756|FG000|Overall Study|Other|8|||
156804571|NCT00967616|566039757|FG001|Overall Study|Other|8|||
156804572|NCT00967616|566039756|FG000|Overall Study|Protocol Violation|1|||
156804573|NCT00967616|566039757|FG001|Overall Study|Protocol Violation|0|||
156804574|NCT00575666|566039758|FG000|Overall Study|Withdrawal by Subject|3|||
156804575|NCT00575666|566039759|FG001|Overall Study|Withdrawal by Subject|2|||
156804576|NCT00575666|566039758|FG000|Overall Study|Physician Decision|1|||
156804577|NCT00575666|566039759|FG001|Overall Study|Physician Decision|1|||
156804578|NCT01374425|566039760|FG000|Overall Study|Radiographic Disease Progression|86|||
156804579|NCT01374425|566039761|FG001|Overall Study|Radiographic Disease Progression|81|||
156804580|NCT01374425|566039760|FG000|Overall Study|Clinical Disease Progression|9|||
156804581|NCT01374425|566039761|FG001|Overall Study|Clinical Disease Progression|6|||
156804582|NCT01374425|566039760|FG000|Overall Study|Adverse Event|29|||
156804583|NCT01374425|566039761|FG001|Overall Study|Adverse Event|18|||
156804584|NCT01374425|566039760|FG000|Overall Study|Death (Progression of Disease)|1|||
156804585|NCT01374425|566039761|FG001|Overall Study|Death (Progression of Disease)|0|||
156804586|NCT01374425|566039760|FG000|Overall Study|Death (Adverse Event)|2|||
156804587|NCT01374425|566039761|FG001|Overall Study|Death (Adverse Event)|4|||
156804588|NCT01374425|566039760|FG000|Overall Study|Withdrawal by Subject|6|||
156804589|NCT01374425|566039761|FG001|Overall Study|Withdrawal by Subject|7|||
156804590|NCT01374425|566039760|FG000|Overall Study|Refused Treatment|10|||
156804591|NCT01374425|566039761|FG001|Overall Study|Refused Treatment|24|||
156804592|NCT01374425|566039760|FG000|Overall Study|Protocol Violation|2|||
156804593|NCT01374425|566039761|FG001|Overall Study|Protocol Violation|3|||
156804594|NCT01374425|566039760|FG000|Overall Study|Sponsor Decision|0|||
156804595|NCT01374425|566039761|FG001|Overall Study|Sponsor Decision|1|||
156804596|NCT01374425|566039760|FG000|Overall Study|Lost to Follow-up|2|||
156804597|NCT01374425|566039761|FG001|Overall Study|Lost to Follow-up|1|||
156804598|NCT01374425|566039760|FG000|Overall Study|Other|41|||
156804599|NCT01374425|566039761|FG001|Overall Study|Other|43|||
156804600|NCT02289469|566039762|FG000|Overall Study|Unable to match a control|6|||
156804601|NCT02289469|566039763|FG001|Overall Study|Unable to match a control|0|||
156804602|NCT02750930|566039766|FG000|Overall Study|Study closed/terminated|8|||
156804603|NCT00553631|566039768|FG000|Overall Study|Withdrawal by Subject|0|||
156804604|NCT00553631|566039769|FG001|Overall Study|Withdrawal by Subject|1|||
156804605|NCT00553631|566039768|FG000|Overall Study|Lost to Follow-up|1|||
156804606|NCT00553631|566039769|FG001|Overall Study|Lost to Follow-up|0|||
156804607|NCT02761642|566039770|FG000|Overall Study|Did not Receive Study Treatment|3|||
156804608|NCT02761642|566039770|FG000|Overall Study|Adverse Event|13|||
156804609|NCT02761642|566039770|FG000|Overall Study|Withdrawal by Subject|2|||
156804610|NCT02761642|566039770|FG000|Overall Study|Non-compliant|7|||
156804611|NCT02761642|566039770|FG000|Overall Study|Death|3|||
156804612|NCT02761642|566039770|FG000|Overall Study|Lack of Efficacy|20|||
156804613|NCT02761642|566039770|FG000|Overall Study|Physician Decision|1|||
156804614|NCT02761642|566039770|FG000|Overall Study|Reason Unspecified|21|||
156804615|NCT04940130|566039775|FG000|Overall Study|Travel|1|||
156804616|NCT04940130|566039776|FG001|Overall Study|Travel|0|||
156804617|NCT04940130|566039777|FG002|Overall Study|Travel|2|||
156804618|NCT04940130|566039775|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
156804619|NCT04940130|566039776|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
156804620|NCT04940130|566039777|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
156804621|NCT04940130|566039775|FG000|Overall Study|Adverse Event|0|||
156804622|NCT04940130|566039776|FG001|Overall Study|Adverse Event|0|||
156804623|NCT04940130|566039777|FG002|Overall Study|Adverse Event|2|||
156804624|NCT04940130|566039775|FG000|Overall Study|Disease progression/treatment failure|0|||
156804625|NCT04940130|566039776|FG001|Overall Study|Disease progression/treatment failure|0|||
156804626|NCT04940130|566039777|FG002|Overall Study|Disease progression/treatment failure|1|||
156804627|NCT04940130|566039775|FG000|Overall Study|Participant refusal|0|||
156804628|NCT04940130|566039776|FG001|Overall Study|Participant refusal|0|||
156804629|NCT04940130|566039777|FG002|Overall Study|Participant refusal|1|||
156804630|NCT00114127|566039778|FG000|Overall Study|Adverse Event|2|||
156804631|NCT00114127|566039779|FG001|Overall Study|Adverse Event|1|||
156804632|NCT00114127|566039778|FG000|Overall Study|Lost to Follow-up|1|||
156804633|NCT00114127|566039779|FG001|Overall Study|Lost to Follow-up|0|||
156804634|NCT00114127|566039778|FG000|Overall Study|Withdrawal by Subject|1|||
156804635|NCT00114127|566039779|FG001|Overall Study|Withdrawal by Subject|3|||
156804636|NCT00570713|566039780|FG000|Overall Study|Adverse Event|16|||
156804637|NCT00570713|566039781|FG001|Overall Study|Adverse Event|9|||
156804638|NCT00570713|566039780|FG000|Overall Study|Death|7|||
156804639|NCT00570713|566039781|FG001|Overall Study|Death|7|||
156804640|NCT00570713|566039780|FG000|Overall Study|Lack of Efficacy|40|||
156804641|NCT00570713|566039781|FG001|Overall Study|Lack of Efficacy|49|||
156804642|NCT00570713|566039780|FG000|Overall Study|Physician Decision|2|||
156804643|NCT00570713|566039781|FG001|Overall Study|Physician Decision|2|||
156804644|NCT00570713|566039780|FG000|Overall Study|Withdrawal by Subject|3|||
156804645|NCT00570713|566039781|FG001|Overall Study|Withdrawal by Subject|3|||
156804646|NCT00570713|566039780|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
156804647|NCT00570713|566039781|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
156804648|NCT00469833|566039782|FG000|Overall Study|No IV access|2|||
156804649|NCT03289533|566039783|FG000|Overall Study|Death|12|||
156804650|NCT03289533|566039783|FG000|Overall Study|Terminated from study by sponsor|10|||
156804651|NCT00539240|566039784|FG000|Overall Study|Withdrawal by Subject|0|||
156804652|NCT00539240|566039785|FG001|Overall Study|Withdrawal by Subject|2|||
156804653|NCT00539240|566039786|FG002|Overall Study|Withdrawal by Subject|0|||
156804654|NCT00539240|566039784|FG000|Overall Study|Protocol Violation|1|||
156804655|NCT00539240|566039785|FG001|Overall Study|Protocol Violation|1|||
156804656|NCT00539240|566039786|FG002|Overall Study|Protocol Violation|4|||
156804657|NCT00539240|566039784|FG000|Overall Study|Lost to Follow-up|2|||
156804658|NCT00539240|566039785|FG001|Overall Study|Lost to Follow-up|3|||
156804659|NCT00539240|566039786|FG002|Overall Study|Lost to Follow-up|1|||
156804660|NCT00539240|566039784|FG000|Overall Study|Adverse Event|3|||
156804661|NCT00539240|566039785|FG001|Overall Study|Adverse Event|1|||
156804662|NCT00539240|566039786|FG002|Overall Study|Adverse Event|10|||
156804663|NCT00902330|566039791|FG000|Overall Study|Too overwhelmed by treatment|2|||
156804664|NCT00902330|566039792|FG001|Overall Study|Too overwhelmed by treatment|5|||
156804665|NCT00902330|566039791|FG000|Overall Study|Adverse Event|1|||
156804666|NCT00902330|566039792|FG001|Overall Study|Adverse Event|0|||
156804667|NCT00902330|566039791|FG000|Overall Study|No post baseline data|1|||
156804668|NCT00902330|566039792|FG001|Overall Study|No post baseline data|0|||
156804669|NCT01816048|566039793|FG000|Overall Study|Adverse Event|1|||
156804670|NCT01816048|566039793|FG000|Overall Study|Death|1|||
156804671|NCT01816048|566039793|FG000|Overall Study|Withdrawal by Subject|1|||
156804672|NCT01816048|566039793|FG000|Overall Study|Disease Progression|3|||
156804673|NCT01847443|566039794|FG000|Study Period 1|Withdrawal by Subject|0|||
156804674|NCT01847443|566039795|FG001|Study Period 1|Withdrawal by Subject|1|||
156804675|NCT01847443|566039796|FG002|Study Period 1|Withdrawal by Subject|0|||
156804676|NCT01847443|566039797|FG003|Study Period 1|Withdrawal by Subject|0|||
156804677|NCT01847443|566039794|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
156804678|NCT01847443|566039795|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
156804679|NCT01847443|566039796|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
156804680|NCT01847443|566039797|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
156804681|NCT01847443|566039794|FG000|Washout Period Before Study Period 2|Other reason|1|||
156804682|NCT01847443|566039795|FG001|Washout Period Before Study Period 2|Other reason|0|||
156804683|NCT01847443|566039796|FG002|Washout Period Before Study Period 2|Other reason|0|||
156804684|NCT01847443|566039797|FG003|Washout Period Before Study Period 2|Other reason|0|||
156804685|NCT01847443|566039794|FG000|Washout Period Before Study Period 3|Other reason|1|||
156804686|NCT01847443|566039795|FG001|Washout Period Before Study Period 3|Other reason|0|||
156804687|NCT01847443|566039796|FG002|Washout Period Before Study Period 3|Other reason|0|||
156804688|NCT01847443|566039797|FG003|Washout Period Before Study Period 3|Other reason|0|||
156804689|NCT01847443|566039794|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
156804690|NCT01847443|566039795|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
156804691|NCT01847443|566039796|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
156337652|NCT02034110|564335080|FG005|Overall Study|Lost to Follow-up|0|||
156804692|NCT01847443|566039797|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
156804693|NCT01847443|566039794|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
156804694|NCT01847443|566039795|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
156804695|NCT01847443|566039796|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
156804696|NCT01847443|566039797|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
156804697|NCT03571971|566039798|FG000|Overall Study|Lost to Follow-up|2|||
156804698|NCT03571971|566039799|FG001|Overall Study|Lost to Follow-up|2|||
156804699|NCT03571971|566039798|FG000|Overall Study|Protocol Violation|2|||
156804700|NCT03571971|566039799|FG001|Overall Study|Protocol Violation|3|||
156804701|NCT03571971|566039798|FG000|Overall Study|Withdrawal by Subject|2|||
156804702|NCT03571971|566039799|FG001|Overall Study|Withdrawal by Subject|0|||
156804703|NCT03571971|566039798|FG000|Overall Study|Incomplete primary outcome data|2|||
156804704|NCT03571971|566039799|FG001|Overall Study|Incomplete primary outcome data|0|||
156804705|NCT04067492|566039800|FG000|Overall Study|Lost to Follow-up|0|||
156804706|NCT04067492|566039801|FG001|Overall Study|Lost to Follow-up|0|||
156804707|NCT04067492|566039802|FG002|Overall Study|Lost to Follow-up|0|||
156804708|NCT04067492|566039803|FG003|Overall Study|Lost to Follow-up|0|||
156804709|NCT04067492|566039804|FG004|Overall Study|Lost to Follow-up|0|||
156804710|NCT04067492|566039805|FG005|Overall Study|Lost to Follow-up|1|||
156804711|NCT04067492|566039800|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804712|NCT04067492|566039801|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
156804713|NCT04067492|566039802|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804714|NCT04067492|566039803|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804715|NCT04067492|566039804|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804716|NCT04067492|566039805|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804717|NCT04067492|566039800|FG000|Overall Study|COVID-19 epidemiological situation|0|||
156804718|NCT04067492|566039801|FG001|Overall Study|COVID-19 epidemiological situation|0|||
156804719|NCT04067492|566039802|FG002|Overall Study|COVID-19 epidemiological situation|0|||
156804720|NCT04067492|566039803|FG003|Overall Study|COVID-19 epidemiological situation|1|||
156804721|NCT04067492|566039804|FG004|Overall Study|COVID-19 epidemiological situation|0|||
156804722|NCT04067492|566039805|FG005|Overall Study|COVID-19 epidemiological situation|0|||
156804723|NCT03950856|566039813|FG000|Overall Study|Death|1|||
156804724|NCT03950856|566039814|FG001|Overall Study|Death|2|||
156804725|NCT03950856|566039815|FG002|Overall Study|Death|0|||
156459408|NCT05671653|564778379|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156804726|NCT03950856|566039816|FG003|Overall Study|Death|0|||
156804727|NCT03950856|566039813|FG000|Overall Study|Lost to Follow-up|5|||
156804728|NCT03950856|566039814|FG001|Overall Study|Lost to Follow-up|6|||
156804729|NCT03950856|566039815|FG002|Overall Study|Lost to Follow-up|8|||
156804730|NCT03950856|566039816|FG003|Overall Study|Lost to Follow-up|2|||
156804731|NCT03950856|566039813|FG000|Overall Study|Protocol Violation|2|||
156459409|NCT05671653|564778380|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156804732|NCT03950856|566039814|FG001|Overall Study|Protocol Violation|0|||
156804733|NCT03950856|566039815|FG002|Overall Study|Protocol Violation|0|||
156804734|NCT03950856|566039816|FG003|Overall Study|Protocol Violation|1|||
156804735|NCT03950856|566039813|FG000|Overall Study|Withdrawal by Subject|4|||
156804736|NCT03950856|566039814|FG001|Overall Study|Withdrawal by Subject|1|||
156804737|NCT03950856|566039815|FG002|Overall Study|Withdrawal by Subject|3|||
156804738|NCT03950856|566039816|FG003|Overall Study|Withdrawal by Subject|1|||
156804739|NCT03950856|566039813|FG000|Overall Study|Unable to phone|7|||
156804740|NCT03950856|566039814|FG001|Overall Study|Unable to phone|6|||
156804741|NCT03950856|566039815|FG002|Overall Study|Unable to phone|7|||
156804742|NCT03950856|566039816|FG003|Overall Study|Unable to phone|2|||
156804743|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
156804744|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
156804745|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
156804746|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
156804747|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
156804748|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
156804749|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
156804750|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
156804751|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
156804752|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
156804753|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
156804754|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
156804755|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
156804756|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
156804757|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
156804758|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
156804759|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
156804760|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
156804761|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
156804762|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
156804763|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
156804764|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
156804765|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
156804766|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
156804767|NCT04021290|566039819|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
156804768|NCT04021290|566039820|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
156804769|NCT04021290|566039821|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
156804770|NCT04021290|566039819|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
156804771|NCT04021290|566039820|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
156804772|NCT04021290|566039821|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
156804773|NCT04021290|566039819|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
156804774|NCT04021290|566039820|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
156804775|NCT04021290|566039821|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
156804776|NCT04021290|566039819|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
156804777|NCT04021290|566039820|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
156804778|NCT04021290|566039821|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
156804779|NCT03391882|566039822|FG000|Study Overall|Adverse Event|3|||
156804780|NCT03391882|566039823|FG001|Study Overall|Adverse Event|6|||
156804781|NCT03391882|566039824|FG002|Study Overall|Adverse Event|1|||
156804782|NCT03391882|566039825|FG003|Study Overall|Adverse Event|1|||
156804783|NCT03391882|566039826|FG004|Study Overall|Adverse Event|3|||
156804784|NCT03391882|566039827|FG005|Study Overall|Adverse Event|1|||
156804785|NCT03391882|566039822|FG000|Study Overall|Lack of Efficacy|13|||
156804786|NCT03391882|566039823|FG001|Study Overall|Lack of Efficacy|9|||
156804787|NCT03391882|566039824|FG002|Study Overall|Lack of Efficacy|0|||
156804788|NCT03391882|566039825|FG003|Study Overall|Lack of Efficacy|0|||
156804789|NCT03391882|566039826|FG004|Study Overall|Lack of Efficacy|0|||
156804790|NCT03391882|566039827|FG005|Study Overall|Lack of Efficacy|0|||
156804791|NCT03391882|566039822|FG000|Study Overall|Withdrawal by Subject|3|||
156804792|NCT03391882|566039823|FG001|Study Overall|Withdrawal by Subject|3|||
156804793|NCT03391882|566039824|FG002|Study Overall|Withdrawal by Subject|2|||
156804794|NCT03391882|566039825|FG003|Study Overall|Withdrawal by Subject|2|||
156804795|NCT03391882|566039826|FG004|Study Overall|Withdrawal by Subject|1|||
156804796|NCT03391882|566039827|FG005|Study Overall|Withdrawal by Subject|3|||
156804797|NCT03391882|566039822|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156804798|NCT03391882|566039823|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
156804799|NCT03391882|566039824|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156804800|NCT03391882|566039825|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156804801|NCT03391882|566039826|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156804802|NCT03391882|566039827|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156459410|NCT05671653|564778381|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156459411|NCT05671653|564778382|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156804803|NCT03391882|566039822|FG000|Study Overall|Protocol Violation|1|||
156804804|NCT03391882|566039823|FG001|Study Overall|Protocol Violation|0|||
156804805|NCT03391882|566039824|FG002|Study Overall|Protocol Violation|0|||
156804806|NCT03391882|566039825|FG003|Study Overall|Protocol Violation|0|||
156804807|NCT03391882|566039826|FG004|Study Overall|Protocol Violation|0|||
156804808|NCT03391882|566039827|FG005|Study Overall|Protocol Violation|0|||
156804809|NCT03391882|566039822|FG000|Part A - Titration Phase|Adverse Event|3|||
156804810|NCT03391882|566039823|FG001|Part A - Titration Phase|Adverse Event|6|||
156804811|NCT03391882|566039824|FG002|Part A - Titration Phase|Adverse Event|0|||
156804812|NCT03391882|566039825|FG003|Part A - Titration Phase|Adverse Event|0|||
156804813|NCT03391882|566039826|FG004|Part A - Titration Phase|Adverse Event|0|||
156804814|NCT03391882|566039827|FG005|Part A - Titration Phase|Adverse Event|0|||
156804815|NCT03391882|566039822|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
156804816|NCT03391882|566039823|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
156804817|NCT03391882|566039824|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
156804818|NCT03391882|566039825|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
156804819|NCT03391882|566039826|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
156804820|NCT03391882|566039827|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
156804821|NCT03391882|566039822|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
156804822|NCT03391882|566039823|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
156804823|NCT03391882|566039824|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
156804824|NCT03391882|566039825|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
156804825|NCT03391882|566039826|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
156804826|NCT03391882|566039827|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
156804827|NCT03391882|566039822|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804828|NCT03391882|566039823|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
156804829|NCT03391882|566039824|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804830|NCT03391882|566039825|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804831|NCT03391882|566039826|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804832|NCT03391882|566039827|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804833|NCT03391882|566039822|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
156804834|NCT03391882|566039823|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
156804835|NCT03391882|566039824|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
156804836|NCT03391882|566039825|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
156804837|NCT03391882|566039826|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
156804838|NCT03391882|566039827|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
156804839|NCT03391882|566039822|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
156804840|NCT03391882|566039823|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
156804841|NCT03391882|566039824|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
156804842|NCT03391882|566039825|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
156804843|NCT03391882|566039826|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
156804844|NCT03391882|566039827|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
156804845|NCT03391882|566039822|FG000|Part B - Treatment Phase|Adverse Event|0|||
156804846|NCT03391882|566039823|FG001|Part B - Treatment Phase|Adverse Event|0|||
156804847|NCT03391882|566039824|FG002|Part B - Treatment Phase|Adverse Event|1|||
156804848|NCT03391882|566039825|FG003|Part B - Treatment Phase|Adverse Event|1|||
156804849|NCT03391882|566039826|FG004|Part B - Treatment Phase|Adverse Event|3|||
156804850|NCT03391882|566039827|FG005|Part B - Treatment Phase|Adverse Event|1|||
156804851|NCT03391882|566039822|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
156804852|NCT03391882|566039823|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
156804853|NCT03391882|566039824|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
156804854|NCT03391882|566039825|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
156804855|NCT03391882|566039826|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
156804856|NCT03391882|566039827|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
156804857|NCT03092479|566039828|FG000|Overall Study|Lost to Follow-up|3|||
156804858|NCT03092479|566039829|FG001|Overall Study|Lost to Follow-up|2|||
156804859|NCT03092479|566039828|FG000|Overall Study|Withdrawal by Subject|4|||
156804860|NCT03092479|566039829|FG001|Overall Study|Withdrawal by Subject|0|||
156804861|NCT04422431|566039832|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
156804862|NCT04422431|566039832|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
156804863|NCT04422431|566039832|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
156804864|NCT04422431|566039832|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
156804865|NCT04422431|566039832|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
156804866|NCT04422431|566039832|FG000|Extension Period (48 Weeks)|Other than specified|2|||
156804867|NCT03913130|566039833|FG000|Overall Study|Sponsor Decision|1|||
156804868|NCT01174563|566039836|FG000|Overall Study|Progressive Disease|45|||
156337653|NCT02034110|564335081|FG006|Overall Study|Lost to Follow-up|1|||
156804869|NCT01174563|566039836|FG000|Overall Study|Death|5|||
156804870|NCT01174563|566039836|FG000|Overall Study|Investigator's Discretion|5|||
156804871|NCT01174563|566039836|FG000|Overall Study|Participant Withdrew Consent|3|||
156804872|NCT01174563|566039836|FG000|Overall Study|Rash Adverse Event|1|||
156804873|NCT01174563|566039836|FG000|Overall Study|Sponsor's decision|1|||
156804874|NCT03402841|566039837|FG000|Overall Study|Withdrawal by Subject|3|||
156804875|NCT03402841|566039837|FG000|Overall Study|Lost to Follow-up|2|||
156537163|NCT00467779|565061108|FG013|Stage 1|Physician Decision|0|||
156804876|NCT03402841|566039837|FG000|Overall Study|Death|146|||
156804877|NCT01173679|566041753|FG000|Overall Study|Death|1|||
156804878|NCT03247829|566041758|FG000|Overall Study|Death|3|||
156804879|NCT03247829|566041759|FG001|Overall Study|Death|4|||
156804880|NCT03247829|566041758|FG000|Overall Study|Enter Hospice Care|1|||
156804881|NCT03247829|566041759|FG001|Overall Study|Enter Hospice Care|0|||
156804882|NCT03247829|566041758|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
156804883|NCT03247829|566041759|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
156804884|NCT03247829|566041758|FG000|Overall Study|LVAD Explant|1|||
156804885|NCT03247829|566041759|FG001|Overall Study|LVAD Explant|1|||
156804886|NCT03247829|566041758|FG000|Overall Study|Transplant|1|||
156804887|NCT03247829|566041759|FG001|Overall Study|Transplant|1|||
156804888|NCT00441272|566041760|FG000|Overall Study|Study terminated prior to enrollment|25|||
156804889|NCT00441272|566041761|FG001|Overall Study|Study terminated prior to enrollment|25|||
156804890|NCT00443703|566041762|FG000|Overall Study|Never Treated|3|||
156804891|NCT00443703|566041763|FG001|Overall Study|Never Treated|1|||
156804892|NCT00443703|566041762|FG000|Overall Study|Adverse Event|7|||
156804893|NCT00443703|566041763|FG001|Overall Study|Adverse Event|3|||
156804894|NCT00443703|566041762|FG000|Overall Study|Lack of Efficacy|3|||
156804895|NCT00443703|566041763|FG001|Overall Study|Lack of Efficacy|1|||
156804896|NCT00443703|566041762|FG000|Overall Study|Lost to Follow-up|0|||
156804897|NCT00443703|566041763|FG001|Overall Study|Lost to Follow-up|4|||
156804898|NCT00443703|566041762|FG000|Overall Study|Physician Decision|4|||
156804899|NCT00443703|566041763|FG001|Overall Study|Physician Decision|2|||
156804900|NCT00443703|566041762|FG000|Overall Study|Protocol Violation|1|||
156804901|NCT00443703|566041763|FG001|Overall Study|Protocol Violation|1|||
156804902|NCT00443703|566041762|FG000|Overall Study|Withdrawal by Subject|9|||
156804903|NCT00443703|566041763|FG001|Overall Study|Withdrawal by Subject|6|||
156804904|NCT00443703|566041762|FG000|Overall Study|Progressive Disease|1|||
156804905|NCT00443703|566041763|FG001|Overall Study|Progressive Disease|0|||
156804906|NCT01047007|566041764|FG000|Overall Study|Adverse Event|0|||
156804907|NCT01047007|566041765|FG001|Overall Study|Adverse Event|2|||
156804908|NCT01047007|566041766|FG002|Overall Study|Adverse Event|1|||
156804909|NCT01047007|566041767|FG003|Overall Study|Adverse Event|0|||
156804910|NCT01047007|566041764|FG000|Overall Study|Progressive Disease|2|||
156804911|NCT01047007|566041765|FG001|Overall Study|Progressive Disease|4|||
156804912|NCT01047007|566041766|FG002|Overall Study|Progressive Disease|1|||
156804913|NCT01047007|566041767|FG003|Overall Study|Progressive Disease|0|||
156804914|NCT03423602|566041771|FG000|Overall Study|Death|1|||
156804915|NCT03423602|566041771|FG000|Overall Study|Lost to Follow-up|6|||
156804916|NCT03423602|566041771|FG000|Overall Study|Protocol Violation|1|||
156804917|NCT03423602|566041771|FG000|Overall Study|Withdrawal by Subject|4|||
156804918|NCT01747915|566041775|FG000|Overall Study|Other|1|||
156537164|NCT00467779|565061109|FG014|Stage 1|Physician Decision|0|||
156537165|NCT00467779|565061095|FG000|Stage 1|Withdrawal by Subject|0|||
156804919|NCT01747915|566041776|FG001|Overall Study|Other|1|||
156804920|NCT01747915|566041777|FG002|Overall Study|Other|1|||
156804921|NCT01747915|566041775|FG000|Overall Study|Adverse Event|8|||
156804922|NCT01747915|566041776|FG001|Overall Study|Adverse Event|5|||
156804923|NCT01747915|566041777|FG002|Overall Study|Adverse Event|2|||
156804924|NCT01747915|566041775|FG000|Overall Study|Death|0|||
156804925|NCT01747915|566041776|FG001|Overall Study|Death|0|||
156804926|NCT01747915|566041777|FG002|Overall Study|Death|1|||
156804927|NCT01747915|566041775|FG000|Overall Study|Lack of Efficacy|0|||
156804928|NCT01747915|566041776|FG001|Overall Study|Lack of Efficacy|1|||
156804929|NCT01747915|566041777|FG002|Overall Study|Lack of Efficacy|0|||
156804930|NCT01747915|566041775|FG000|Overall Study|Lost to Follow-up|1|||
156804931|NCT01747915|566041776|FG001|Overall Study|Lost to Follow-up|0|||
156804932|NCT01747915|566041777|FG002|Overall Study|Lost to Follow-up|0|||
156804933|NCT01747915|566041775|FG000|Overall Study|Withdrawal by Subject|4|||
156804934|NCT01747915|566041776|FG001|Overall Study|Withdrawal by Subject|4|||
156804935|NCT01747915|566041777|FG002|Overall Study|Withdrawal by Subject|1|||
156804936|NCT01747915|566041775|FG000|Overall Study|Protocol Violation|1|||
156804937|NCT01747915|566041776|FG001|Overall Study|Protocol Violation|0|||
156804938|NCT01747915|566041777|FG002|Overall Study|Protocol Violation|0|||
156804939|NCT01747915|566041775|FG000|Overall Study|Pregnancy|0|||
156804940|NCT01747915|566041776|FG001|Overall Study|Pregnancy|0|||
156804941|NCT01747915|566041777|FG002|Overall Study|Pregnancy|1|||
156804942|NCT03341637|566041778|FG000|Overall Study|Lost to Follow-up|1|||
156804943|NCT03341637|566041779|FG001|Overall Study|Lost to Follow-up|0|||
156804944|NCT03341637|566041778|FG000|Overall Study|Withdrawal by Subject|3|||
156804945|NCT03341637|566041779|FG001|Overall Study|Withdrawal by Subject|3|||
156804946|NCT03341637|566041778|FG000|Overall Study|Reason not Specified|1|||
156804947|NCT03341637|566041779|FG001|Overall Study|Reason not Specified|1|||
156804948|NCT06164691|566041783|FG000|Overall Study|Withdrawal by Subject|2|||
156537166|NCT00467779|565061096|FG001|Stage 1|Withdrawal by Subject|0|||
156804949|NCT06164691|566041784|FG001|Overall Study|Withdrawal by Subject|0|||
156804950|NCT06164691|566041785|FG002|Overall Study|Withdrawal by Subject|0|||
156804951|NCT02391311|566041786|FG000|Overall Study|Lost to Follow-up|2|||
156804952|NCT02391311|566041787|FG001|Overall Study|Lost to Follow-up|1|||
156804953|NCT02391311|566041786|FG000|Overall Study|deemed ineligible after baseline|1|||
156804954|NCT02391311|566041787|FG001|Overall Study|deemed ineligible after baseline|1|||
156804955|NCT03046446|566041790|FG000|Overall Study|Lack of Efficacy|7|||
156804956|NCT03046446|566041790|FG000|Overall Study|Adverse Event|6|||
156804957|NCT03046446|566041790|FG000|Overall Study|Lost to Follow-up|3|||
156804958|NCT03046446|566041790|FG000|Overall Study|Withdrawal by Subject|14|||
156804959|NCT03046446|566041790|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
156804960|NCT03046446|566041790|FG000|Overall Study|Disease Progression (see caveats)|25|||
156804961|NCT03046446|566041790|FG000|Overall Study|Non OA related knee surgery|1|||
156804962|NCT03183063|566041791|FG000|Overall Study|Withdrawal by Subject|2|||
156804963|NCT03183063|566041792|FG001|Overall Study|Withdrawal by Subject|0|||
156804964|NCT03183063|566041793|FG002|Overall Study|Withdrawal by Subject|0|||
156804965|NCT03183063|566041791|FG000|Overall Study|Physician Decision|3|||
156804966|NCT03183063|566041792|FG001|Overall Study|Physician Decision|4|||
156804967|NCT03183063|566041793|FG002|Overall Study|Physician Decision|4|||
156804968|NCT00925002|566041796|FG000|Overall Study|Other|1|||
156804969|NCT00925002|566041797|FG001|Overall Study|Other|4|||
156804970|NCT00925002|566041798|FG002|Overall Study|Other|0|||
156804971|NCT00925002|566041796|FG000|Overall Study|Death|1|||
156804972|NCT00925002|566041797|FG001|Overall Study|Death|1|||
156804973|NCT00925002|566041798|FG002|Overall Study|Death|5|||
156804974|NCT00925002|566041796|FG000|Overall Study|Adverse Event|3|||
156804975|NCT00925002|566041797|FG001|Overall Study|Adverse Event|1|||
156804976|NCT00925002|566041798|FG002|Overall Study|Adverse Event|2|||
156804977|NCT00925002|566041796|FG000|Overall Study|Participant withdrew consent|1|||
156804978|NCT00925002|566041797|FG001|Overall Study|Participant withdrew consent|3|||
156804979|NCT00925002|566041798|FG002|Overall Study|Participant withdrew consent|3|||
156804980|NCT03012334|566041801|FG000|Period 1|Withdrawal by Subject|0|||
156804981|NCT03012334|566041802|FG001|Period 1|Withdrawal by Subject|0|||
156804982|NCT03012334|566041803|FG002|Period 1|Withdrawal by Subject|0|||
156804983|NCT03012334|566041804|FG003|Period 1|Withdrawal by Subject|0|||
156804984|NCT03012334|566041805|FG004|Period 1|Withdrawal by Subject|0|||
156804985|NCT03012334|566041806|FG005|Period 1|Withdrawal by Subject|0|||
156804986|NCT03012334|566041807|FG006|Period 1|Withdrawal by Subject|0|||
156804987|NCT03012334|566041808|FG007|Period 1|Withdrawal by Subject|0|||
156804988|NCT03012334|566041809|FG008|Period 1|Withdrawal by Subject|0|||
156804989|NCT03012334|566041810|FG009|Period 1|Withdrawal by Subject|1|||
156804990|NCT03012334|566041801|FG000|Period 2|Withdrawal by Subject|0|||
156804991|NCT03012334|566041802|FG001|Period 2|Withdrawal by Subject|1|||
156804992|NCT03012334|566041803|FG002|Period 2|Withdrawal by Subject|0|||
156804993|NCT03012334|566041804|FG003|Period 2|Withdrawal by Subject|0|||
156804994|NCT03012334|566041805|FG004|Period 2|Withdrawal by Subject|0|||
156804995|NCT03012334|566041806|FG005|Period 2|Withdrawal by Subject|0|||
156804996|NCT03012334|566041807|FG006|Period 2|Withdrawal by Subject|0|||
156804997|NCT03012334|566041808|FG007|Period 2|Withdrawal by Subject|0|||
156804998|NCT03012334|566041809|FG008|Period 2|Withdrawal by Subject|0|||
156804999|NCT03012334|566041810|FG009|Period 2|Withdrawal by Subject|0|||
156805000|NCT03012334|566041801|FG000|Period 2|Protocol Violation|0|||
156805001|NCT03012334|566041802|FG001|Period 2|Protocol Violation|0|||
156805002|NCT03012334|566041803|FG002|Period 2|Protocol Violation|1|||
156805003|NCT03012334|566041804|FG003|Period 2|Protocol Violation|0|||
156805004|NCT03012334|566041805|FG004|Period 2|Protocol Violation|0|||
156805005|NCT03012334|566041806|FG005|Period 2|Protocol Violation|0|||
156805006|NCT03012334|566041807|FG006|Period 2|Protocol Violation|0|||
156805007|NCT03012334|566041808|FG007|Period 2|Protocol Violation|1|||
156805008|NCT03012334|566041809|FG008|Period 2|Protocol Violation|0|||
156805009|NCT03012334|566041810|FG009|Period 2|Protocol Violation|0|||
156805010|NCT03012334|566041801|FG000|Period 4|Non-Compliance|0|||
156805011|NCT03012334|566041802|FG001|Period 4|Non-Compliance|0|||
156805012|NCT03012334|566041803|FG002|Period 4|Non-Compliance|0|||
156805013|NCT03012334|566041804|FG003|Period 4|Non-Compliance|0|||
156805014|NCT03012334|566041805|FG004|Period 4|Non-Compliance|0|||
156805015|NCT03012334|566041806|FG005|Period 4|Non-Compliance|0|||
156805016|NCT03012334|566041807|FG006|Period 4|Non-Compliance|1|||
156805017|NCT03012334|566041808|FG007|Period 4|Non-Compliance|0|||
156805018|NCT03012334|566041809|FG008|Period 4|Non-Compliance|0|||
156805019|NCT03012334|566041810|FG009|Period 4|Non-Compliance|0|||
156805020|NCT03012334|566041801|FG000|Period 4|Adverse Event|0|||
156805021|NCT03012334|566041802|FG001|Period 4|Adverse Event|0|||
156805022|NCT03012334|566041803|FG002|Period 4|Adverse Event|0|||
156805023|NCT03012334|566041804|FG003|Period 4|Adverse Event|0|||
156805024|NCT03012334|566041805|FG004|Period 4|Adverse Event|0|||
156805025|NCT03012334|566041806|FG005|Period 4|Adverse Event|0|||
156805026|NCT03012334|566041807|FG006|Period 4|Adverse Event|0|||
156805027|NCT03012334|566041808|FG007|Period 4|Adverse Event|0|||
156805028|NCT03012334|566041809|FG008|Period 4|Adverse Event|1|||
156805029|NCT03012334|566041810|FG009|Period 4|Adverse Event|0|||
156805030|NCT01823107|566041811|FG000|Overall Study|Withdrawal by Subject|1|||
156805031|NCT01073293|566041812|FG000|Overall Study|Lost to Follow-up|0|||
156805032|NCT01073293|566041813|FG001|Overall Study|Lost to Follow-up|1|||
156805033|NCT01073293|566041812|FG000|Overall Study|Withdrawal by Subject|5|||
156805034|NCT01073293|566041813|FG001|Overall Study|Withdrawal by Subject|10|||
156805035|NCT00328172|566041816|FG000|Overall Study|Adverse Event|3|||
156805036|NCT00328172|566041817|FG001|Overall Study|Adverse Event|2|||
156805037|NCT00328172|566041818|FG002|Overall Study|Adverse Event|1|||
156805038|NCT00328172|566041819|FG003|Overall Study|Adverse Event|2|||
156805039|NCT00328172|566041820|FG004|Overall Study|Adverse Event|1|||
156805040|NCT00328172|566041816|FG000|Overall Study|Protocol Violation|0|||
156805041|NCT00328172|566041817|FG001|Overall Study|Protocol Violation|1|||
156805042|NCT00328172|566041818|FG002|Overall Study|Protocol Violation|1|||
156805043|NCT00328172|566041819|FG003|Overall Study|Protocol Violation|0|||
156805044|NCT00328172|566041820|FG004|Overall Study|Protocol Violation|0|||
156805045|NCT00328172|566041816|FG000|Overall Study|Lost to Follow-up|1|||
156805046|NCT00328172|566041817|FG001|Overall Study|Lost to Follow-up|1|||
156805047|NCT00328172|566041818|FG002|Overall Study|Lost to Follow-up|2|||
156805048|NCT00328172|566041819|FG003|Overall Study|Lost to Follow-up|1|||
156805049|NCT00328172|566041820|FG004|Overall Study|Lost to Follow-up|1|||
156805050|NCT00328172|566041816|FG000|Overall Study|Withdrawal by Subject|1|||
156805051|NCT00328172|566041817|FG001|Overall Study|Withdrawal by Subject|1|||
156805052|NCT00328172|566041818|FG002|Overall Study|Withdrawal by Subject|1|||
156805053|NCT00328172|566041819|FG003|Overall Study|Withdrawal by Subject|6|||
156805054|NCT00328172|566041820|FG004|Overall Study|Withdrawal by Subject|0|||
156805055|NCT00328172|566041816|FG000|Overall Study|Lack of Efficacy|14|||
156805056|NCT00328172|566041817|FG001|Overall Study|Lack of Efficacy|9|||
156805057|NCT00328172|566041818|FG002|Overall Study|Lack of Efficacy|4|||
156805058|NCT00328172|566041819|FG003|Overall Study|Lack of Efficacy|4|||
156805059|NCT00328172|566041820|FG004|Overall Study|Lack of Efficacy|3|||
156805060|NCT00328172|566041816|FG000|Overall Study|Other reason (not specified)|3|||
156805061|NCT00328172|566041817|FG001|Overall Study|Other reason (not specified)|0|||
156805062|NCT00328172|566041818|FG002|Overall Study|Other reason (not specified)|1|||
156805063|NCT00328172|566041819|FG003|Overall Study|Other reason (not specified)|0|||
156805064|NCT00328172|566041820|FG004|Overall Study|Other reason (not specified)|0|||
156805065|NCT00077974|566041821|FG000|Overall Study|Adverse Event|22|||
156805066|NCT00077974|566041821|FG000|Overall Study|Protocol Violation|1|||
156805067|NCT00077974|566041821|FG000|Overall Study|Withdrawal by Subject|3|||
156805068|NCT00077974|566041821|FG000|Overall Study|Lack of Efficacy|76|||
156805069|NCT00077974|566041821|FG000|Overall Study|Decision of Sponsor|2|||
156805070|NCT00558636|566041827|FG000|Treatment|Adverse Event|9|||
156805071|NCT00558636|566041828|FG001|Treatment|Adverse Event|2|||
156805072|NCT00558636|566041827|FG000|Treatment|Withdrawal by Subject|2|||
156805073|NCT00558636|566041828|FG001|Treatment|Withdrawal by Subject|0|||
156805074|NCT00558636|566041827|FG000|Treatment|Premature termination of the study|35|||
156805075|NCT00558636|566041828|FG001|Treatment|Premature termination of the study|37|||
156805076|NCT00558636|566041827|FG000|Treatment|Disease progression|1|||
156805077|NCT00558636|566041828|FG001|Treatment|Disease progression|5|||
156805078|NCT00558636|566041827|FG000|Follow-up|Premature termination of the study|12|||
156805079|NCT00558636|566041828|FG001|Follow-up|Premature termination of the study|7|||
156805080|NCT02897115|566041831|FG000|Overall Study|Early termination of study by sponsor|11|||
156805081|NCT02897115|566041832|FG001|Overall Study|Early termination of study by sponsor|8|||
156805082|NCT02071771|566041833|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
156805083|NCT02071771|566041834|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
156805084|NCT02071771|566041833|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
156805085|NCT02071771|566041834|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
156805086|NCT02078752|566041835|FG000|Overall Study|Death|0|||
156805087|NCT02078752|566041836|FG001|Overall Study|Death|3|||
156805088|NCT02078752|566041837|FG002|Overall Study|Death|0|||
156805089|NCT02078752|566041838|FG003|Overall Study|Death|0|||
156805090|NCT02078752|566041839|FG004|Overall Study|Death|0|||
156805091|NCT02078752|566041840|FG005|Overall Study|Death|1|||
156805092|NCT02078752|566041841|FG006|Overall Study|Death|0|||
156805093|NCT02078752|566041842|FG007|Overall Study|Death|1|||
156805094|NCT02078752|566041843|FG008|Overall Study|Death|0|||
156805095|NCT02078752|566041844|FG009|Overall Study|Death|4|||
156805096|NCT02078752|566041835|FG000|Overall Study|Lost to Follow-up|1|||
156805097|NCT02078752|566041836|FG001|Overall Study|Lost to Follow-up|0|||
156805098|NCT02078752|566041837|FG002|Overall Study|Lost to Follow-up|0|||
156805099|NCT02078752|566041838|FG003|Overall Study|Lost to Follow-up|1|||
156805100|NCT02078752|566041839|FG004|Overall Study|Lost to Follow-up|0|||
156805101|NCT02078752|566041840|FG005|Overall Study|Lost to Follow-up|0|||
156805102|NCT02078752|566041841|FG006|Overall Study|Lost to Follow-up|0|||
156805103|NCT02078752|566041842|FG007|Overall Study|Lost to Follow-up|0|||
156805104|NCT02078752|566041843|FG008|Overall Study|Lost to Follow-up|0|||
156805105|NCT02078752|566041844|FG009|Overall Study|Lost to Follow-up|0|||
156805106|NCT02078752|566041835|FG000|Overall Study|Withdrawal by Subject|1|||
156805107|NCT02078752|566041836|FG001|Overall Study|Withdrawal by Subject|1|||
156805108|NCT02078752|566041837|FG002|Overall Study|Withdrawal by Subject|1|||
156805109|NCT02078752|566041838|FG003|Overall Study|Withdrawal by Subject|1|||
156805110|NCT02078752|566041839|FG004|Overall Study|Withdrawal by Subject|0|||
156805111|NCT02078752|566041840|FG005|Overall Study|Withdrawal by Subject|3|||
156805112|NCT02078752|566041841|FG006|Overall Study|Withdrawal by Subject|2|||
156337654|NCT02034110|564335082|FG007|Overall Study|Lost to Follow-up|0|||
156805113|NCT02078752|566041842|FG007|Overall Study|Withdrawal by Subject|1|||
156805114|NCT02078752|566041843|FG008|Overall Study|Withdrawal by Subject|0|||
156805115|NCT02078752|566041844|FG009|Overall Study|Withdrawal by Subject|1|||
156805116|NCT02078752|566041835|FG000|Overall Study|Other|0|||
156805117|NCT02078752|566041836|FG001|Overall Study|Other|3|||
156805118|NCT02078752|566041837|FG002|Overall Study|Other|0|||
156805119|NCT02078752|566041838|FG003|Overall Study|Other|0|||
156805120|NCT02078752|566041839|FG004|Overall Study|Other|1|||
156805121|NCT02078752|566041840|FG005|Overall Study|Other|0|||
156805122|NCT02078752|566041841|FG006|Overall Study|Other|0|||
156805123|NCT02078752|566041842|FG007|Overall Study|Other|1|||
156805124|NCT02078752|566041843|FG008|Overall Study|Other|0|||
156805125|NCT02078752|566041844|FG009|Overall Study|Other|0|||
156805126|NCT02078752|566041835|FG000|Overall Study|Study terminated by sponsor|0|||
156805127|NCT02078752|566041836|FG001|Overall Study|Study terminated by sponsor|0|||
156805128|NCT02078752|566041837|FG002|Overall Study|Study terminated by sponsor|0|||
156805129|NCT02078752|566041838|FG003|Overall Study|Study terminated by sponsor|0|||
156805130|NCT02078752|566041839|FG004|Overall Study|Study terminated by sponsor|0|||
156805131|NCT02078752|566041840|FG005|Overall Study|Study terminated by sponsor|0|||
156805132|NCT02078752|566041841|FG006|Overall Study|Study terminated by sponsor|0|||
156805133|NCT02078752|566041842|FG007|Overall Study|Study terminated by sponsor|0|||
156805134|NCT02078752|566041843|FG008|Overall Study|Study terminated by sponsor|0|||
156805135|NCT02078752|566041844|FG009|Overall Study|Study terminated by sponsor|5|||
156805136|NCT02776683|566041855|FG000|Pre-switch Period|Protocol Violation|1|||
156805137|NCT02776683|566041856|FG001|Pre-switch Period|Protocol Violation|0|||
156805138|NCT02776683|566041855|FG000|Pre-switch Period|Adverse Event|21|||
156805139|NCT02776683|566041856|FG001|Pre-switch Period|Adverse Event|0|||
156805140|NCT02776683|566041855|FG000|Pre-switch Period|Withdrawal by Subject|9|||
156805141|NCT02776683|566041856|FG001|Pre-switch Period|Withdrawal by Subject|0|||
156805142|NCT02776683|566041855|FG000|Pre-switch Period|Physician Decision|7|||
156805143|NCT02776683|566041856|FG001|Pre-switch Period|Physician Decision|0|||
156805144|NCT02776683|566041855|FG000|Pre-switch Period|Progressive disease|39|||
156805145|NCT02776683|566041856|FG001|Pre-switch Period|Progressive disease|0|||
156805146|NCT02776683|566041855|FG000|Pre-switch Period|Other than listed|3|||
156805147|NCT02776683|566041856|FG001|Pre-switch Period|Other than listed|0|||
156805148|NCT02776683|566041855|FG000|Post-switch Period|Adverse Event|0|||
156805149|NCT02776683|566041856|FG001|Post-switch Period|Adverse Event|3|||
156805150|NCT02776683|566041855|FG000|Post-switch Period|Withdrawal by Subject|0|||
156805151|NCT02776683|566041856|FG001|Post-switch Period|Withdrawal by Subject|2|||
156805152|NCT02776683|566041855|FG000|Post-switch Period|Physician Decision|0|||
156805153|NCT02776683|566041856|FG001|Post-switch Period|Physician Decision|3|||
156805154|NCT02776683|566041855|FG000|Post-switch Period|Progressive disease|0|||
156805155|NCT02776683|566041856|FG001|Post-switch Period|Progressive disease|20|||
156805156|NCT02776683|566041855|FG000|Post-switch Period|Other than listed|0|||
156805157|NCT02776683|566041856|FG001|Post-switch Period|Other than listed|15|||
156805158|NCT00616642|566041857|FG000|Overall Study|Withdrawal by Subject|0|||
156805159|NCT00616642|566041858|FG001|Overall Study|Withdrawal by Subject|1|||
156805160|NCT01664247|566041861|FG000|Overall Study|Adverse Event|5|||
156805161|NCT01664247|566041862|FG001|Overall Study|Adverse Event|3|||
156805162|NCT01664247|566041861|FG000|Overall Study|Protocol Violation|3|||
156805163|NCT01664247|566041862|FG001|Overall Study|Protocol Violation|5|||
156805164|NCT01664247|566041861|FG000|Overall Study|Withdrawal Criteria|1|||
156805165|NCT01664247|566041862|FG001|Overall Study|Withdrawal Criteria|4|||
156805166|NCT01664247|566041861|FG000|Overall Study|Unclassified|5|||
156805167|NCT01664247|566041862|FG001|Overall Study|Unclassified|29|||
156805168|NCT01000506|566041863|FG000|Overall Study|Adverse Event|6|||
156805169|NCT01000506|566041864|FG001|Overall Study|Adverse Event|5|||
156805170|NCT01000506|566041865|FG002|Overall Study|Adverse Event|8|||
156805171|NCT01000506|566041866|FG003|Overall Study|Adverse Event|9|||
156805172|NCT01000506|566041863|FG000|Overall Study|Lack of Efficacy|8|||
156805173|NCT01000506|566041864|FG001|Overall Study|Lack of Efficacy|6|||
156805174|NCT01000506|566041865|FG002|Overall Study|Lack of Efficacy|4|||
156805175|NCT01000506|566041866|FG003|Overall Study|Lack of Efficacy|4|||
156805176|NCT01000506|566041863|FG000|Overall Study|Protocol Violation|1|||
156805177|NCT01000506|566041864|FG001|Overall Study|Protocol Violation|1|||
156805178|NCT01000506|566041865|FG002|Overall Study|Protocol Violation|0|||
156805179|NCT01000506|566041866|FG003|Overall Study|Protocol Violation|0|||
156805180|NCT01000506|566041863|FG000|Overall Study|Lost to Follow-up|1|||
156805181|NCT01000506|566041864|FG001|Overall Study|Lost to Follow-up|1|||
156805182|NCT01000506|566041865|FG002|Overall Study|Lost to Follow-up|4|||
156805183|NCT01000506|566041866|FG003|Overall Study|Lost to Follow-up|0|||
156805184|NCT01000506|566041863|FG000|Overall Study|Physician Decision|1|||
156805185|NCT01000506|566041864|FG001|Overall Study|Physician Decision|3|||
156805186|NCT01000506|566041865|FG002|Overall Study|Physician Decision|3|||
156805187|NCT01000506|566041866|FG003|Overall Study|Physician Decision|3|||
156805188|NCT01000506|566041863|FG000|Overall Study|Withdrawal by Subject|11|||
156805189|NCT01000506|566041864|FG001|Overall Study|Withdrawal by Subject|8|||
156805190|NCT01000506|566041865|FG002|Overall Study|Withdrawal by Subject|2|||
156805191|NCT01000506|566041866|FG003|Overall Study|Withdrawal by Subject|7|||
156805192|NCT03188263|566041877|FG000|Overall Study|Withdrawal by Subject|3|||
156805193|NCT03188263|566041878|FG001|Overall Study|Withdrawal by Subject|0|||
156805194|NCT03188263|566041877|FG000|Overall Study|Physician Decision|1|||
156805195|NCT03188263|566041878|FG001|Overall Study|Physician Decision|0|||
156805196|NCT00699413|566041879|FG000|Overall Study|Withdrawal by Subject|0|||
156805197|NCT00699413|566041880|FG001|Overall Study|Withdrawal by Subject|2|||
156805198|NCT00699413|566041879|FG000|Overall Study|Study terminated by sponsor|4|||
156805199|NCT00699413|566041880|FG001|Overall Study|Study terminated by sponsor|2|||
156805200|NCT02779777|566041881|FG000|Overall Study|Disease Progression|1|||
156805201|NCT02779777|566041882|FG001|Overall Study|Disease Progression|0|||
156805202|NCT02779777|566041883|FG002|Overall Study|Disease Progression|0|||
156805203|NCT02779777|566041881|FG000|Overall Study|Adverse Event|3|||
156805204|NCT02779777|566041882|FG001|Overall Study|Adverse Event|1|||
156805205|NCT02779777|566041883|FG002|Overall Study|Adverse Event|0|||
156805206|NCT02779777|566041881|FG000|Overall Study|Physician Decision|9|||
156805207|NCT02779777|566041882|FG001|Overall Study|Physician Decision|0|||
156805208|NCT02779777|566041883|FG002|Overall Study|Physician Decision|1|||
156805209|NCT02779777|566041881|FG000|Overall Study|Withdrawal by Subject|1|||
156805210|NCT02779777|566041882|FG001|Overall Study|Withdrawal by Subject|0|||
156805211|NCT02779777|566041883|FG002|Overall Study|Withdrawal by Subject|0|||
156805212|NCT00251693|566041884|FG000|Overall Study|Adverse Event|17|||
156805213|NCT00251693|566041885|FG001|Overall Study|Adverse Event|9|||
156805214|NCT00251693|566041886|FG002|Overall Study|Adverse Event|9|||
156805215|NCT00251693|566041884|FG000|Overall Study|Protocol Violation|2|||
156805216|NCT00251693|566041885|FG001|Overall Study|Protocol Violation|0|||
156805217|NCT00251693|566041886|FG002|Overall Study|Protocol Violation|2|||
156805218|NCT00251693|566041884|FG000|Overall Study|Lost to Follow-up|12|||
156805219|NCT00251693|566041885|FG001|Overall Study|Lost to Follow-up|7|||
156805220|NCT00251693|566041886|FG002|Overall Study|Lost to Follow-up|8|||
156805221|NCT00251693|566041884|FG000|Overall Study|Withdrawal by Subject|11|||
156805222|NCT00251693|566041885|FG001|Overall Study|Withdrawal by Subject|17|||
156805223|NCT00251693|566041886|FG002|Overall Study|Withdrawal by Subject|14|||
156805224|NCT00251693|566041884|FG000|Overall Study|Lack of Efficacy|0|||
156805225|NCT00251693|566041885|FG001|Overall Study|Lack of Efficacy|1|||
156805226|NCT00251693|566041886|FG002|Overall Study|Lack of Efficacy|0|||
156805227|NCT00251693|566041884|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
156805228|NCT00251693|566041885|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
156805229|NCT00251693|566041886|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
156805230|NCT00251693|566041884|FG000|Overall Study|Noncompliant|0|||
156805231|NCT00251693|566041885|FG001|Overall Study|Noncompliant|0|||
156805232|NCT00251693|566041886|FG002|Overall Study|Noncompliant|2|||
156805233|NCT00251693|566041884|FG000|Overall Study|Possible Barrett's esophagus|3|||
156805234|NCT00251693|566041885|FG001|Overall Study|Possible Barrett's esophagus|5|||
156805235|NCT00251693|566041886|FG002|Overall Study|Possible Barrett's esophagus|2|||
156805236|NCT00251693|566041884|FG000|Overall Study|Subject request/subject unavailable|1|||
156805237|NCT00251693|566041885|FG001|Overall Study|Subject request/subject unavailable|2|||
156805238|NCT00251693|566041886|FG002|Overall Study|Subject request/subject unavailable|0|||
156805239|NCT00251693|566041884|FG000|Overall Study|Abnormal laboratory findings|0|||
156805240|NCT00251693|566041885|FG001|Overall Study|Abnormal laboratory findings|0|||
156805241|NCT00251693|566041886|FG002|Overall Study|Abnormal laboratory findings|1|||
156805242|NCT01030822|566041888|FG000|Overall Study|Moved/migrated from study area|6|||
156805243|NCT01030822|566041889|FG001|Overall Study|Moved/migrated from study area|7|||
156805244|NCT01030822|566041890|FG002|Overall Study|Moved/migrated from study area|3|||
156805245|NCT01030822|566041888|FG000|Overall Study|Withdrawal by Subject|16|||
156805246|NCT01030822|566041889|FG001|Overall Study|Withdrawal by Subject|13|||
156805247|NCT01030822|566041890|FG002|Overall Study|Withdrawal by Subject|16|||
156805248|NCT01030822|566041888|FG000|Overall Study|Lost to Follow-up|9|||
156805249|NCT01030822|566041889|FG001|Overall Study|Lost to Follow-up|4|||
156537167|NCT00467779|565061097|FG002|Stage 1|Withdrawal by Subject|0|||
156805250|NCT01030822|566041890|FG002|Overall Study|Lost to Follow-up|7|||
156805251|NCT01055613|566041892|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
156805252|NCT01055613|566041893|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156805253|NCT01055613|566041892|FG000|Overall Study|Unacceptable lens fit|1|||
156805254|NCT01055613|566041893|FG001|Overall Study|Unacceptable lens fit|0|||
156805255|NCT01055613|566041892|FG000|Overall Study|Discomfort|2|||
156805256|NCT01055613|566041893|FG001|Overall Study|Discomfort|1|||
156805257|NCT01055613|566041892|FG000|Overall Study|Lost to Follow-up|1|||
156805258|NCT01055613|566041893|FG001|Overall Study|Lost to Follow-up|1|||
156805259|NCT01055613|566041892|FG000|Overall Study|Protocol Violation|1|||
156805260|NCT01055613|566041893|FG001|Overall Study|Protocol Violation|1|||
156805261|NCT01055613|566041892|FG000|Overall Study|Subject Disinterest|1|||
156805262|NCT01055613|566041893|FG001|Overall Study|Subject Disinterest|1|||
156805263|NCT00363311|566041896|FG000|Overall Study|Adverse Event|6|||
156805264|NCT00363311|566041897|FG001|Overall Study|Adverse Event|4|||
156805265|NCT00363311|566041896|FG000|Overall Study|Lost to Follow-up|3|||
156805266|NCT00363311|566041897|FG001|Overall Study|Lost to Follow-up|0|||
156805267|NCT00363311|566041896|FG000|Overall Study|Protocol Violation|1|||
156805268|NCT00363311|566041897|FG001|Overall Study|Protocol Violation|2|||
156805269|NCT00363311|566041896|FG000|Overall Study|Withdrawal by Subject|12|||
156805270|NCT00363311|566041897|FG001|Overall Study|Withdrawal by Subject|6|||
156805271|NCT00363311|566041896|FG000|Overall Study|Physician Decision|1|||
156805272|NCT00363311|566041897|FG001|Overall Study|Physician Decision|1|||
156805273|NCT00363311|566041896|FG000|Overall Study|Sponsor Terminated Study|2|||
156805274|NCT00363311|566041897|FG001|Overall Study|Sponsor Terminated Study|2|||
156805275|NCT00363311|566041896|FG000|Overall Study|Disease Progression|46|||
156805276|NCT00363311|566041897|FG001|Overall Study|Disease Progression|26|||
156805277|NCT00363311|566041896|FG000|Overall Study|Non-Compliance|1|||
156805278|NCT00363311|566041897|FG001|Overall Study|Non-Compliance|1|||
156805279|NCT00363311|566041896|FG000|Overall Study|Participant Refused Biopsy|1|||
156805280|NCT00363311|566041897|FG001|Overall Study|Participant Refused Biopsy|0|||
156805281|NCT00363311|566041896|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
156805282|NCT00363311|566041897|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
156805283|NCT00363311|566041896|FG000|Overall Study|Participant Opted for Treatment|1|||
156805284|NCT00363311|566041897|FG001|Overall Study|Participant Opted for Treatment|0|||
156805285|NCT00363311|566041896|FG000|Overall Study|Participant Moved to Another Country|1|||
156805286|NCT00363311|566041897|FG001|Overall Study|Participant Moved to Another Country|0|||
156805287|NCT00363311|566041896|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
156805288|NCT00363311|566041897|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
156805289|NCT00363311|566041896|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
156805290|NCT00363311|566041897|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
156805291|NCT00363311|566041896|FG000|Overall Study|Participant Moved to Louisiana|0|||
156805292|NCT00363311|566041897|FG001|Overall Study|Participant Moved to Louisiana|1|||
156805293|NCT00401843|566041898|FG000|Overall Study|Achieved Complete Response|1|||
156805294|NCT00401843|566041899|FG001|Overall Study|Achieved Complete Response|5|||
156805295|NCT00401843|566041900|FG002|Overall Study|Achieved Complete Response|11|||
156805296|NCT00401843|566041898|FG000|Overall Study|Adverse Event|7|||
156805297|NCT00401843|566041899|FG001|Overall Study|Adverse Event|26|||
156805298|NCT00401843|566041900|FG002|Overall Study|Adverse Event|27|||
156805299|NCT00401843|566041898|FG000|Overall Study|Death|0|||
156805300|NCT00401843|566041899|FG001|Overall Study|Death|8|||
156805301|NCT00401843|566041900|FG002|Overall Study|Death|10|||
156805302|NCT00401843|566041898|FG000|Overall Study|Disease progression|10|||
156805303|NCT00401843|566041899|FG001|Overall Study|Disease progression|60|||
156805304|NCT00401843|566041900|FG002|Overall Study|Disease progression|49|||
156805305|NCT00401843|566041898|FG000|Overall Study|End of Study|1|||
156805306|NCT00401843|566041899|FG001|Overall Study|End of Study|1|||
156805307|NCT00401843|566041900|FG002|Overall Study|End of Study|2|||
156805308|NCT00401843|566041898|FG000|Overall Study|Lost to Follow-up|0|||
156805309|NCT00401843|566041899|FG001|Overall Study|Lost to Follow-up|0|||
156805310|NCT00401843|566041900|FG002|Overall Study|Lost to Follow-up|2|||
156805311|NCT00401843|566041898|FG000|Overall Study|Other Unspecified|0|||
156805312|NCT00401843|566041899|FG001|Overall Study|Other Unspecified|3|||
156805313|NCT00401843|566041900|FG002|Overall Study|Other Unspecified|5|||
156805314|NCT00401843|566041898|FG000|Overall Study|Physician Decision|0|||
156805315|NCT00401843|566041899|FG001|Overall Study|Physician Decision|16|||
156805316|NCT00401843|566041900|FG002|Overall Study|Physician Decision|10|||
156805317|NCT00401843|566041898|FG000|Overall Study|Protocol Violation|0|||
156805318|NCT00401843|566041899|FG001|Overall Study|Protocol Violation|0|||
156805319|NCT00401843|566041900|FG002|Overall Study|Protocol Violation|1|||
156805320|NCT00401843|566041898|FG000|Overall Study|Withdrawal by Subject|1|||
156805321|NCT00401843|566041899|FG001|Overall Study|Withdrawal by Subject|5|||
156805322|NCT00401843|566041900|FG002|Overall Study|Withdrawal by Subject|5|||
156805323|NCT00401843|566041898|FG000|Overall Study|Withdrawal of consent to study agent|1|||
156805324|NCT00401843|566041899|FG001|Overall Study|Withdrawal of consent to study agent|15|||
156805325|NCT00401843|566041900|FG002|Overall Study|Withdrawal of consent to study agent|17|||
156805326|NCT00401843|566041898|FG000|Overall Study|Randomized but not Treated|0|||
156805327|NCT00401843|566041899|FG001|Overall Study|Randomized but not Treated|2|||
156805328|NCT00401843|566041900|FG002|Overall Study|Randomized but not Treated|3|||
156805329|NCT00401843|566041898|FG000|Overall Study|Received incorrect treatment|0|||
156805330|NCT00401843|566041899|FG001|Overall Study|Received incorrect treatment|3|||
156805331|NCT00401843|566041900|FG002|Overall Study|Received incorrect treatment|0|||
156805332|NCT01182298|566041905|FG000|Overall Study|Lack of Efficacy|4|||
156805333|NCT01182298|566041905|FG000|Overall Study|Withdrawal by Subject|2|||
156805334|NCT01595529|566041906|FG000|Overall Study|Adverse Event|2|||
156805335|NCT01595529|566041907|FG001|Overall Study|Adverse Event|0|||
156805336|NCT01595529|566041906|FG000|Overall Study|Subject Non-Compliant|2|||
156805337|NCT01595529|566041907|FG001|Overall Study|Subject Non-Compliant|0|||
156805338|NCT01595529|566041906|FG000|Overall Study|Lost to Follow-up|8|||
156805339|NCT01595529|566041907|FG001|Overall Study|Lost to Follow-up|14|||
156805340|NCT01595529|566041906|FG000|Overall Study|Protocol Violation|1|||
156805341|NCT01595529|566041907|FG001|Overall Study|Protocol Violation|2|||
156805342|NCT01595529|566041906|FG000|Overall Study|Physician Decision|1|||
156805343|NCT01595529|566041907|FG001|Overall Study|Physician Decision|0|||
156805344|NCT01595529|566041906|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
156805345|NCT01595529|566041907|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
156805346|NCT01595529|566041906|FG000|Overall Study|Administrative Decision|1|||
156805347|NCT01595529|566041907|FG001|Overall Study|Administrative Decision|0|||
156805348|NCT01595529|566041906|FG000|Overall Study|Entry Failure/Screening Failure|6|||
156805349|NCT01595529|566041907|FG001|Overall Study|Entry Failure/Screening Failure|1|||
156805350|NCT01508910|566041908|FG000|Treatment|Death|2|||
156805351|NCT01508910|566041909|FG001|Treatment|Death|3|||
156805352|NCT01508910|566041910|FG002|Treatment|Death|2|||
156805353|NCT01508910|566041911|FG003|Treatment|Death|0|||
156805354|NCT01508910|566041908|FG000|Treatment|Lost to Follow-up|0|||
156805355|NCT01508910|566041909|FG001|Treatment|Lost to Follow-up|0|||
156805356|NCT01508910|566041910|FG002|Treatment|Lost to Follow-up|2|||
156805357|NCT01508910|566041911|FG003|Treatment|Lost to Follow-up|1|||
156805358|NCT01508910|566041908|FG000|Treatment|Withdrawal by Subject|0|||
156805359|NCT01508910|566041909|FG001|Treatment|Withdrawal by Subject|1|||
156805360|NCT01508910|566041910|FG002|Treatment|Withdrawal by Subject|6|||
156805361|NCT01508910|566041911|FG003|Treatment|Withdrawal by Subject|1|||
156805362|NCT01508910|566041908|FG000|Treatment|Sponsor Decision|0|||
156805363|NCT01508910|566041909|FG001|Treatment|Sponsor Decision|0|||
156805364|NCT01508910|566041910|FG002|Treatment|Sponsor Decision|0|||
156805365|NCT01508910|566041911|FG003|Treatment|Sponsor Decision|1|||
156805366|NCT04016714|566041912|FG000|Overall Study|Death|1|||
156805367|NCT04016714|566041913|FG001|Overall Study|Death|0|||
156805368|NCT04016714|566041912|FG000|Overall Study|Lost to Follow-up|3|||
156805369|NCT04016714|566041913|FG001|Overall Study|Lost to Follow-up|1|||
156805370|NCT04016714|566041912|FG000|Overall Study|Physician Decision|3|||
156805371|NCT04016714|566041913|FG001|Overall Study|Physician Decision|3|||
156805372|NCT04016714|566041912|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
156805373|NCT04016714|566041913|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
156805374|NCT01677988|566041914|FG000|Overall Study|Lack of Efficacy|2|||
156805375|NCT00730886|566041915|FG000|Overall Study|Lost to Follow-up|1|||
156805376|NCT00730886|566041916|FG001|Overall Study|Lost to Follow-up|0|||
156805377|NCT00730886|566041915|FG000|Overall Study|Physician Decision|1|||
156805378|NCT00730886|566041916|FG001|Overall Study|Physician Decision|0|||
156805379|NCT00444106|566041917|FG000|Overall Study|Lost to Follow-up|2|||
156805380|NCT00444106|566041918|FG001|Overall Study|Lost to Follow-up|1|||
156805381|NCT00444106|566041919|FG002|Overall Study|Lost to Follow-up|0|||
156805382|NCT00444106|566041917|FG000|Overall Study|Abnormal Test Procedure Results|0|||
156805383|NCT00444106|566041918|FG001|Overall Study|Abnormal Test Procedure Results|0|||
156805384|NCT00444106|566041919|FG002|Overall Study|Abnormal Test Procedure Results|1|||
156805385|NCT02317627|566041922|FG000|Overall Study|Withdrawal by Subject|0|||
156805386|NCT02317627|566041923|FG001|Overall Study|Withdrawal by Subject|1|||
156805387|NCT02317627|566041924|FG002|Overall Study|Withdrawal by Subject|1|||
156805388|NCT02317627|566041922|FG000|Overall Study|Lost to Follow-up|2|||
156805389|NCT02317627|566041923|FG001|Overall Study|Lost to Follow-up|0|||
156805390|NCT02317627|566041924|FG002|Overall Study|Lost to Follow-up|0|||
156805391|NCT02317627|566041922|FG000|Overall Study|Stopped by Investigator|0|||
156805392|NCT02317627|566041923|FG001|Overall Study|Stopped by Investigator|1|||
156805393|NCT02317627|566041924|FG002|Overall Study|Stopped by Investigator|0|||
156805394|NCT02317627|566041922|FG000|Overall Study|Adverse Event|0|||
156805395|NCT02317627|566041923|FG001|Overall Study|Adverse Event|2|||
156805396|NCT02317627|566041924|FG002|Overall Study|Adverse Event|3|||
156805397|NCT02317627|566041922|FG000|Overall Study|Non-compliance with study drug|0|||
156805398|NCT02317627|566041923|FG001|Overall Study|Non-compliance with study drug|1|||
156805399|NCT02317627|566041924|FG002|Overall Study|Non-compliance with study drug|0|||
156805400|NCT00279214|566041925|FG000|Overall Study|Physician Decision|3|||
156805401|NCT00279214|566041926|FG001|Overall Study|Physician Decision|2|||
156805402|NCT01280968|566041927|FG000|Overall Study|Lost to Follow-up|8|||
156805403|NCT01280968|566041928|FG001|Overall Study|Lost to Follow-up|2|||
156805404|NCT01280968|566041927|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
156805405|NCT01280968|566041928|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
156805406|NCT01280968|566041927|FG000|Overall Study|Commuting Problems|2|||
156805407|NCT01280968|566041928|FG001|Overall Study|Commuting Problems|0|||
156805408|NCT01280968|566041927|FG000|Overall Study|Anxiety|2|||
156805409|NCT01280968|566041928|FG001|Overall Study|Anxiety|0|||
156805410|NCT01280968|566041927|FG000|Overall Study|Adverse Event|1|||
156805411|NCT01280968|566041928|FG001|Overall Study|Adverse Event|0|||
156805412|NCT01280968|566041927|FG000|Overall Study|Scheduling Conflicts|1|||
156805413|NCT01280968|566041928|FG001|Overall Study|Scheduling Conflicts|1|||
156805414|NCT01280968|566041927|FG000|Overall Study|Pre-existing Neurological Condition|1|||
156805415|NCT01280968|566041928|FG001|Overall Study|Pre-existing Neurological Condition|0|||
156805416|NCT01280968|566041927|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
156805417|NCT01280968|566041928|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
156805418|NCT00038948|566041929|FG000|Overall Study|Adverse Event|131|||
156805419|NCT00038948|566041930|FG001|Overall Study|Adverse Event|43|||
156805420|NCT00038948|566041929|FG000|Overall Study|Lost to Follow-up|4|||
156805421|NCT00038948|566041930|FG001|Overall Study|Lost to Follow-up|4|||
156805422|NCT00038948|566041929|FG000|Overall Study|Nonmedical event|5|||
156805423|NCT00038948|566041930|FG001|Overall Study|Nonmedical event|7|||
156805424|NCT00038948|566041929|FG000|Overall Study|Withdrawal by Subject|23|||
156805425|NCT00038948|566041930|FG001|Overall Study|Withdrawal by Subject|10|||
156805426|NCT00038948|566041929|FG000|Overall Study|Protocol Violation|3|||
156805427|NCT00038948|566041930|FG001|Overall Study|Protocol Violation|7|||
156805428|NCT00038948|566041929|FG000|Overall Study|Lack of Efficacy|3|||
156805429|NCT00038948|566041930|FG001|Overall Study|Lack of Efficacy|6|||
156805430|NCT03984188|566041933|FG000|Overall Study|Death|2|||
156805431|NCT03984188|566041934|FG001|Overall Study|Death|4|||
156805432|NCT03984188|566041933|FG000|Overall Study|Physician Decision|0|||
156805433|NCT03984188|566041934|FG001|Overall Study|Physician Decision|2|||
156805434|NCT03984188|566041933|FG000|Overall Study|Lost to Follow-up|3|||
156805435|NCT03984188|566041934|FG001|Overall Study|Lost to Follow-up|2|||
156805436|NCT03984188|566041933|FG000|Overall Study|Withdrawal by Subject|6|||
156805437|NCT03984188|566041934|FG001|Overall Study|Withdrawal by Subject|0|||
156805438|NCT00272792|566043656|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
156805439|NCT00272792|566043657|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
156805440|NCT00272792|566043656|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
156805441|NCT00272792|566043657|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
156805442|NCT00272792|566043656|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
156805443|NCT00272792|566043657|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
156805444|NCT00272792|566043656|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
156805445|NCT00272792|566043657|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
156805446|NCT00937495|566043662|FG000|Overall Study|Protocol Violation|2|||
156805447|NCT02549989|566043663|FG000|Overall Study|Adverse Event|4|||
156805448|NCT02549989|566043663|FG000|Overall Study|Death|1|||
156805449|NCT02549989|566043663|FG000|Overall Study|Lack of Efficacy|19|||
156805450|NCT02549989|566043663|FG000|Overall Study|Withdrawal by Subject|3|||
156805451|NCT01856322|566043664|FG000|Overall Study|off study due to lack of accrual|0|||
156805452|NCT01856322|566043665|FG001|Overall Study|off study due to lack of accrual|0|||
156805453|NCT01856322|566043666|FG002|Overall Study|off study due to lack of accrual|3|||
156805454|NCT00288015|566043670|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
156805455|NCT00288015|566043670|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
156805456|NCT00288015|566043670|FG000|First Response Assessment|Withdrawal by Subject|1|||
156805457|NCT00288015|566043670|FG000|First Response Assessment|Death|1|||
156805458|NCT00288015|566043670|FG000|First Response Assessment|Physician Decision|2|||
156805459|NCT00288015|566043670|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
156805460|NCT00288015|566043670|FG000|Follow up for Survival x 2 Years|Death|13|||
156805461|NCT00288015|566043670|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
156805462|NCT00288015|566043670|FG000|Follow up for Survival x 2 Years|Other|9|||
156805463|NCT04592341|566043673|FG000|Overall Study|Physician Decision|5|||
156805464|NCT04592341|566043673|FG000|Overall Study|Study Terminated by Sponsor|5|||
156805465|NCT04592341|566043673|FG000|Overall Study|Withdrawal by Subject|53|||
156805466|NCT04592341|566043673|FG000|Overall Study|Lost to Follow-up|3|||
156805467|NCT04592341|566043673|FG000|Overall Study|Death|1|||
156805468|NCT04592341|566043673|FG000|Overall Study|Adverse Event|5|||
156805469|NCT04592341|566043673|FG000|Overall Study|other|4|||
156805470|NCT01944020|566043674|FG000|Overall Study|Withdrawal by Subject|5|||
156805471|NCT01944020|566043675|FG001|Overall Study|Withdrawal by Subject|0|||
156805472|NCT00692003|566043676|FG000|Overall Study|Sponsor Decision|5|||
156805473|NCT00692003|566043677|FG001|Overall Study|Sponsor Decision|1|||
156805474|NCT01535287|566043678|FG000|Overall Study|drug not prepared in time|5|||
156805475|NCT01535287|566043679|FG001|Overall Study|drug not prepared in time|6|||
156805476|NCT00305877|566043680|FG000|Overall Study|Lack of Efficacy|6|||
156805477|NCT00305877|566043681|FG001|Overall Study|Lack of Efficacy|9|||
156805478|NCT00305877|566043680|FG000|Overall Study|Adverse Event|9|||
156805479|NCT00305877|566043681|FG001|Overall Study|Adverse Event|14|||
156805480|NCT00305877|566043680|FG000|Overall Study|Death|0|||
156805481|NCT00305877|566043681|FG001|Overall Study|Death|1|||
156805482|NCT00305877|566043680|FG000|Overall Study|Withdrawal by Subject|4|||
156805483|NCT00305877|566043681|FG001|Overall Study|Withdrawal by Subject|2|||
156805484|NCT00305877|566043680|FG000|Overall Study|Physician Decision|1|||
156805485|NCT00305877|566043681|FG001|Overall Study|Physician Decision|1|||
156805486|NCT00305877|566043680|FG000|Overall Study|Never start treatment|2|||
156805487|NCT00305877|566043681|FG001|Overall Study|Never start treatment|5|||
156805488|NCT00305877|566043680|FG000|Overall Study|Ineligible|2|||
156805489|NCT00305877|566043681|FG001|Overall Study|Ineligible|1|||
156805490|NCT00305877|566043680|FG000|Overall Study|Transportation issue with daily RT|0|||
156805491|NCT00305877|566043681|FG001|Overall Study|Transportation issue with daily RT|1|||
156805492|NCT00457392|566043682|FG000|Overall Study|Objective Progression or Relapse|229|||
156805493|NCT00457392|566043683|FG001|Overall Study|Objective Progression or Relapse|296|||
156805494|NCT00457392|566043682|FG000|Overall Study|Death|106|||
156805495|NCT00457392|566043683|FG001|Overall Study|Death|106|||
156805496|NCT00457392|566043682|FG000|Overall Study|Adverse Event|84|||
156805497|NCT00457392|566043683|FG001|Overall Study|Adverse Event|41|||
156805498|NCT00457392|566043682|FG000|Overall Study|Global Deterioration of Health Status|22|||
156805499|NCT00457392|566043683|FG001|Overall Study|Global Deterioration of Health Status|8|||
156805500|NCT00457392|566043682|FG000|Overall Study|Withdrawal by Subject|14|||
156805501|NCT00457392|566043683|FG001|Overall Study|Withdrawal by Subject|8|||
156805502|NCT00457392|566043682|FG000|Overall Study|Lost to Follow-up|6|||
156805503|NCT00457392|566043683|FG001|Overall Study|Lost to Follow-up|7|||
156805504|NCT00457392|566043682|FG000|Overall Study|Protocol Violation|4|||
156805505|NCT00457392|566043683|FG001|Overall Study|Protocol Violation|3|||
156805506|NCT00457392|566043682|FG000|Overall Study|Other|7|||
156805507|NCT00457392|566043683|FG001|Overall Study|Other|4|||
156805508|NCT00457392|566043682|FG000|Overall Study|Study Terminated by Sponsor|1|||
156805509|NCT00457392|566043683|FG001|Overall Study|Study Terminated by Sponsor|4|||
156805510|NCT00457392|566043682|FG000|Overall Study|Randomized, Not Treated|7|||
156805511|NCT00457392|566043683|FG001|Overall Study|Randomized, Not Treated|3|||
156805512|NCT00980148|566043684|FG000|Overall Study|Discharged from facility|89|||
156805513|NCT00980148|566043685|FG001|Overall Study|Discharged from facility|96|||
156805514|NCT00980148|566043684|FG000|Overall Study|Received other antichlamydia treatment|20|||
156805515|NCT00980148|566043685|FG001|Overall Study|Received other antichlamydia treatment|14|||
156805516|NCT00980148|566043684|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
156805517|NCT00980148|566043685|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
156805518|NCT00980148|566043684|FG000|Overall Study|Various other reasons|8|||
156805519|NCT00980148|566043685|FG001|Overall Study|Various other reasons|9|||
156805520|NCT00812955|566043693|FG000|Overall Study|Adverse Event|7|||
156805521|NCT00812955|566043694|FG001|Overall Study|Adverse Event|6|||
156805522|NCT00812955|566043695|FG002|Overall Study|Adverse Event|3|||
156805523|NCT00812955|566043696|FG003|Overall Study|Adverse Event|4|||
156805524|NCT00812955|566043693|FG000|Overall Study|Lost to Follow-up|2|||
156805525|NCT00812955|566043694|FG001|Overall Study|Lost to Follow-up|1|||
156805526|NCT00812955|566043695|FG002|Overall Study|Lost to Follow-up|1|||
156805527|NCT00812955|566043696|FG003|Overall Study|Lost to Follow-up|2|||
156805528|NCT00812955|566043693|FG000|Overall Study|Withdrawal by Subject|1|||
156805529|NCT00812955|566043694|FG001|Overall Study|Withdrawal by Subject|0|||
156805530|NCT00812955|566043695|FG002|Overall Study|Withdrawal by Subject|1|||
156805531|NCT00812955|566043696|FG003|Overall Study|Withdrawal by Subject|2|||
156805532|NCT00812955|566043693|FG000|Overall Study|randomized in error|0|||
156805533|NCT00812955|566043694|FG001|Overall Study|randomized in error|0|||
156805534|NCT00812955|566043695|FG002|Overall Study|randomized in error|1|||
156805535|NCT00812955|566043696|FG003|Overall Study|randomized in error|0|||
156805536|NCT01309204|566043697|FG000|Overall Study|Adverse Event|48|||
156805537|NCT01309204|566043698|FG001|Overall Study|Adverse Event|58|||
156805538|NCT01309204|566043697|FG000|Overall Study|Lost to Follow-up|2|||
156805539|NCT01309204|566043698|FG001|Overall Study|Lost to Follow-up|2|||
156805540|NCT01309204|566043697|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
156805541|NCT01309204|566043698|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
156805542|NCT01309204|566043697|FG000|Overall Study|Inadequate control of IOP|4|||
156805543|NCT01309204|566043698|FG001|Overall Study|Inadequate control of IOP|4|||
156805544|NCT01309204|566043697|FG000|Overall Study|Other|4|||
156805545|NCT01309204|566043698|FG001|Overall Study|Other|1|||
156805546|NCT04512001|566043700|FG000|Week 0 to Week 24|Adverse Event|14|||
156805547|NCT04512001|566043701|FG001|Week 0 to Week 24|Adverse Event|10|||
156805548|NCT04512001|566043702|FG002|Week 0 to Week 24|Adverse Event|0|||
156805549|NCT04512001|566043703|FG003|Week 0 to Week 24|Adverse Event|0|||
156805550|NCT04512001|566043704|FG004|Week 0 to Week 24|Adverse Event|0|||
156805551|NCT04512001|566043700|FG000|Week 0 to Week 24|Death|0|||
156805552|NCT04512001|566043701|FG001|Week 0 to Week 24|Death|2|||
156805553|NCT04512001|566043702|FG002|Week 0 to Week 24|Death|0|||
156805554|NCT04512001|566043703|FG003|Week 0 to Week 24|Death|0|||
156805555|NCT04512001|566043704|FG004|Week 0 to Week 24|Death|0|||
156805556|NCT04512001|566043700|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
156805557|NCT04512001|566043701|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
156805558|NCT04512001|566043702|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
156805559|NCT04512001|566043703|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
156805560|NCT04512001|566043704|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
156805561|NCT04512001|566043700|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
156805562|NCT04512001|566043701|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
156805563|NCT04512001|566043702|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
156805564|NCT04512001|566043703|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
156805565|NCT04512001|566043704|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
156805566|NCT04512001|566043700|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
156805567|NCT04512001|566043701|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
156805568|NCT04512001|566043702|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
156805569|NCT04512001|566043703|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
156805570|NCT04512001|566043704|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
156805571|NCT04512001|566043700|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
156805572|NCT04512001|566043701|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
156805573|NCT04512001|566043702|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
156805574|NCT04512001|566043703|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
156805575|NCT04512001|566043704|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
156805576|NCT04512001|566043700|FG000|Week 24 to Week 63|Adverse Event|0|||
156805577|NCT04512001|566043701|FG001|Week 24 to Week 63|Adverse Event|0|||
156805578|NCT04512001|566043702|FG002|Week 24 to Week 63|Adverse Event|13|||
156805579|NCT04512001|566043703|FG003|Week 24 to Week 63|Adverse Event|8|||
156805580|NCT04512001|566043704|FG004|Week 24 to Week 63|Adverse Event|6|||
156805581|NCT04512001|566043700|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
156805582|NCT04512001|566043701|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
156805583|NCT04512001|566043702|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
156805584|NCT04512001|566043703|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
156805585|NCT04512001|566043704|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
156805586|NCT04512001|566043700|FG000|Week 24 to Week 63|Death|0|||
156805587|NCT04512001|566043701|FG001|Week 24 to Week 63|Death|0|||
156805588|NCT04512001|566043702|FG002|Week 24 to Week 63|Death|0|||
156805589|NCT04512001|566043703|FG003|Week 24 to Week 63|Death|1|||
156805590|NCT04512001|566043704|FG004|Week 24 to Week 63|Death|1|||
156805591|NCT04512001|566043700|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
156805592|NCT04512001|566043701|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
156805593|NCT04512001|566043702|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
156805594|NCT04512001|566043703|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
156805595|NCT04512001|566043704|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
156805596|NCT04512001|566043700|FG000|Week 24 to Week 63|Miscellaneous|0|||
156805597|NCT04512001|566043701|FG001|Week 24 to Week 63|Miscellaneous|0|||
156805598|NCT04512001|566043702|FG002|Week 24 to Week 63|Miscellaneous|3|||
156805599|NCT04512001|566043703|FG003|Week 24 to Week 63|Miscellaneous|2|||
156805600|NCT04512001|566043704|FG004|Week 24 to Week 63|Miscellaneous|1|||
156805601|NCT04232943|566043705|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
156805602|NCT04232943|566043706|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
156805603|NCT04232943|566043707|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
156805604|NCT04232943|566043705|FG000|Overall Study|Withdrawal by Subject|1|||
156805605|NCT04232943|566043706|FG001|Overall Study|Withdrawal by Subject|1|||
156805606|NCT04232943|566043707|FG002|Overall Study|Withdrawal by Subject|0|||
156805607|NCT02266147|566043708|FG000|PART 1: Dose Escalation|Physician Decision|0|||
156805608|NCT02266147|566043709|FG001|PART 1: Dose Escalation|Physician Decision|0|||
156805609|NCT02266147|566043710|FG002|PART 1: Dose Escalation|Physician Decision|1|||
156805610|NCT02266147|566043711|FG003|PART 1: Dose Escalation|Physician Decision|0|||
156805611|NCT02266147|566043708|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
156805612|NCT02266147|566043709|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
156805613|NCT02266147|566043710|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
156805614|NCT02266147|566043711|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
156805615|NCT02266147|566043708|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
156805616|NCT02266147|566043709|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
156805617|NCT02266147|566043710|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
156805618|NCT02266147|566043711|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
156805619|NCT02266147|566043708|FG000|PART 1: Dose Escalation|Other|1|||
156805620|NCT02266147|566043709|FG001|PART 1: Dose Escalation|Other|1|||
156805621|NCT02266147|566043710|FG002|PART 1: Dose Escalation|Other|0|||
156805622|NCT02266147|566043711|FG003|PART 1: Dose Escalation|Other|0|||
156805623|NCT02266147|566043708|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
156805624|NCT02266147|566043709|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
156805625|NCT02266147|566043710|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
156805626|NCT02266147|566043711|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
156805627|NCT02266147|566043708|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
156805628|NCT02266147|566043709|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
156805629|NCT02266147|566043710|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
156805630|NCT02266147|566043711|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
156805631|NCT00573391|566043712|FG000|Overall Study|study stopped|2|||
156805632|NCT00573391|566043713|FG001|Overall Study|study stopped|2|||
156805633|NCT00573391|566043712|FG000|Overall Study|Death|1|||
156805634|NCT00573391|566043713|FG001|Overall Study|Death|0|||
156805635|NCT03896477|566043716|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
156805636|NCT03896477|566043717|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
156805637|NCT03896477|566043718|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
156805638|NCT03896477|566043716|FG000|Overall Study|Parent Requested Withdrawal|8|||
156805639|NCT03896477|566043717|FG001|Overall Study|Parent Requested Withdrawal|12|||
156805640|NCT03896477|566043718|FG002|Overall Study|Parent Requested Withdrawal|9|||
156805641|NCT03896477|566043716|FG000|Overall Study|Adverse Event|0|||
156805642|NCT03896477|566043717|FG001|Overall Study|Adverse Event|0|||
156805643|NCT03896477|566043718|FG002|Overall Study|Adverse Event|1|||
156805644|NCT03896477|566043716|FG000|Overall Study|Death|1|||
156805645|NCT03896477|566043717|FG001|Overall Study|Death|0|||
156805646|NCT03896477|566043718|FG002|Overall Study|Death|0|||
156805647|NCT03896477|566043716|FG000|Overall Study|Other|5|||
156805648|NCT03896477|566043717|FG001|Overall Study|Other|6|||
156805649|NCT03896477|566043718|FG002|Overall Study|Other|7|||
156805650|NCT03896477|566043716|FG000|Overall Study|Lost to Follow-up|2|||
156805651|NCT03896477|566043717|FG001|Overall Study|Lost to Follow-up|1|||
156805652|NCT03896477|566043718|FG002|Overall Study|Lost to Follow-up|1|||
156805653|NCT01023217|566043720|FG000|Overall Study|Withdrawal by Subject|1|||
156805654|NCT01023217|566043721|FG001|Overall Study|Withdrawal by Subject|0|||
156805655|NCT01673646|566043722|FG000|Overall Study|Adverse Event|2|||
156805656|NCT01673646|566043723|FG001|Overall Study|Adverse Event|1|||
156805657|NCT01673646|566043724|FG002|Overall Study|Adverse Event|1|||
156805658|NCT01673646|566043722|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156805659|NCT01673646|566043723|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156805660|NCT01673646|566043724|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156805661|NCT01673646|566043722|FG000|Overall Study|Condition no longer requires study drug|0|||
156805662|NCT01673646|566043723|FG001|Overall Study|Condition no longer requires study drug|1|||
156805663|NCT01673646|566043724|FG002|Overall Study|Condition no longer requires study drug|0|||
156805664|NCT01673646|566043722|FG000|Overall Study|Withdrawal by Subject|0|||
156805665|NCT01673646|566043723|FG001|Overall Study|Withdrawal by Subject|2|||
156537168|NCT00467779|565061098|FG003|Stage 1|Withdrawal by Subject|0|||
156537169|NCT00467779|565061099|FG004|Stage 1|Withdrawal by Subject|0|||
156537170|NCT00467779|565061100|FG005|Stage 1|Withdrawal by Subject|0|||
156537171|NCT00467779|565061101|FG006|Stage 1|Withdrawal by Subject|1|||
156537172|NCT00467779|565061102|FG007|Stage 1|Withdrawal by Subject|1|||
156537173|NCT00467779|565061103|FG008|Stage 1|Withdrawal by Subject|0|||
156537174|NCT00467779|565061104|FG009|Stage 1|Withdrawal by Subject|0|||
156537175|NCT00467779|565061105|FG010|Stage 1|Withdrawal by Subject|0|||
156805666|NCT01673646|566043724|FG002|Overall Study|Withdrawal by Subject|2|||
156805667|NCT01673646|566043722|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
156805668|NCT01673646|566043723|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
156805669|NCT01673646|566043724|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
156805670|NCT03064074|566043725|FG000|Overall Study|Physician Decision|0|||
156805671|NCT03064074|566043726|FG001|Overall Study|Physician Decision|0|||
156537176|NCT00467779|565061106|FG011|Stage 1|Withdrawal by Subject|0|||
156537177|NCT00467779|565061107|FG012|Stage 1|Withdrawal by Subject|0|||
156537178|NCT00467779|565061108|FG013|Stage 1|Withdrawal by Subject|0|||
156805672|NCT03064074|566043727|FG002|Overall Study|Physician Decision|0|||
156805673|NCT03064074|566043728|FG003|Overall Study|Physician Decision|1|||
156805674|NCT01063348|566043730|FG000|Overall Study|Lost to Follow-up|3|||
156805675|NCT01063348|566043731|FG001|Overall Study|Lost to Follow-up|10|||
156805676|NCT01118780|566043732|FG000|Overall Study|Adverse Event|15|||
156805677|NCT01118780|566043733|FG001|Overall Study|Adverse Event|15|||
156805678|NCT01118780|566043732|FG000|Overall Study|Death|1|||
156805679|NCT01118780|566043733|FG001|Overall Study|Death|0|||
156805680|NCT01118780|566043732|FG000|Overall Study|Lack of Efficacy|2|||
156805681|NCT01118780|566043733|FG001|Overall Study|Lack of Efficacy|6|||
156805682|NCT01118780|566043732|FG000|Overall Study|Physician Decision|2|||
156805683|NCT01118780|566043733|FG001|Overall Study|Physician Decision|0|||
156805684|NCT01118780|566043732|FG000|Overall Study|Protocol Violation|3|||
156805685|NCT01118780|566043733|FG001|Overall Study|Protocol Violation|6|||
156805686|NCT01118780|566043732|FG000|Overall Study|Withdrawal by Subject|13|||
156805687|NCT01118780|566043733|FG001|Overall Study|Withdrawal by Subject|8|||
156805688|NCT05518461|566043734|FG000|Overall Study|Lost to Follow-up|25|||
156805689|NCT00269087|566043735|FG000|Overall Study|Adverse Event|20|||
156805690|NCT00269087|566043735|FG000|Overall Study|Withdrawal by Subject|1|||
156805691|NCT00269087|566043735|FG000|Overall Study|Exacerbation of COPD|13|||
156805692|NCT00332696|566043740|FG000|Overall Study|Death|24|||
156805693|NCT00332696|566043741|FG001|Overall Study|Death|14|||
156805694|NCT00332696|566043740|FG000|Overall Study|Insufficient therapeutic effect|4|||
156805695|NCT00332696|566043741|FG001|Overall Study|Insufficient therapeutic effect|11|||
156805696|NCT00332696|566043740|FG000|Overall Study|Adverse Event|1|||
156805697|NCT00332696|566043741|FG001|Overall Study|Adverse Event|2|||
156805698|NCT00332696|566043740|FG000|Overall Study|Condition does not justify treatment|0|||
156805699|NCT00332696|566043741|FG001|Overall Study|Condition does not justify treatment|2|||
156805700|NCT00332696|566043740|FG000|Overall Study|Lost to Follow-up|0|||
156805701|NCT00332696|566043741|FG001|Overall Study|Lost to Follow-up|1|||
156805702|NCT00332696|566043740|FG000|Overall Study|Withdrawal by Subject|1|||
156805703|NCT00332696|566043741|FG001|Overall Study|Withdrawal by Subject|0|||
156805704|NCT02216526|566043742|FG000|Overall Study|Adverse Event|1|||
156805705|NCT02216526|566043743|FG001|Overall Study|Adverse Event|1|||
156805706|NCT02216526|566043744|FG002|Overall Study|Adverse Event|0|||
156805707|NCT02216526|566043742|FG000|Overall Study|Death|0|||
156805708|NCT02216526|566043743|FG001|Overall Study|Death|1|||
156805709|NCT02216526|566043744|FG002|Overall Study|Death|3|||
156805710|NCT02216526|566043742|FG000|Overall Study|Protocol Violation|2|||
156805711|NCT02216526|566043743|FG001|Overall Study|Protocol Violation|0|||
156805712|NCT02216526|566043744|FG002|Overall Study|Protocol Violation|2|||
156805713|NCT02216526|566043742|FG000|Overall Study|Hospitalization|2|||
156805714|NCT02216526|566043743|FG001|Overall Study|Hospitalization|1|||
156805715|NCT02216526|566043744|FG002|Overall Study|Hospitalization|3|||
156805716|NCT03824392|566043747|FG000|Overall Study|Adverse Event|1|||
156805717|NCT03824392|566043748|FG001|Overall Study|Adverse Event|0|||
156805718|NCT03824392|566043749|FG002|Overall Study|Adverse Event|0|||
156805719|NCT03824392|566043750|FG003|Overall Study|Adverse Event|0|||
156805720|NCT03824392|566043747|FG000|Overall Study|Investigator Decision|0|||
156805721|NCT03824392|566043748|FG001|Overall Study|Investigator Decision|1|||
156805722|NCT03824392|566043749|FG002|Overall Study|Investigator Decision|0|||
156805723|NCT03824392|566043750|FG003|Overall Study|Investigator Decision|0|||
156805724|NCT03824392|566043747|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
156805725|NCT03824392|566043748|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
156805726|NCT03824392|566043749|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
156805727|NCT03824392|566043750|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
156805728|NCT02230189|566043751|FG000|Overall Study|Withdrawal by Subject|3|||
156805729|NCT02230189|566043752|FG001|Overall Study|Withdrawal by Subject|0|||
156805730|NCT02230189|566043753|FG002|Overall Study|Withdrawal by Subject|1|||
156805731|NCT02230189|566043751|FG000|Overall Study|Lost to Follow-up|1|||
156805732|NCT02230189|566043752|FG001|Overall Study|Lost to Follow-up|0|||
156805733|NCT02230189|566043753|FG002|Overall Study|Lost to Follow-up|0|||
156805734|NCT02230189|566043751|FG000|Overall Study|Physician Decision|1|||
156805735|NCT02230189|566043752|FG001|Overall Study|Physician Decision|0|||
156805736|NCT02230189|566043753|FG002|Overall Study|Physician Decision|0|||
156805737|NCT01847755|566043754|FG000|Overall Study|Adverse Event|2|||
156805738|NCT01847755|566043754|FG000|Overall Study|Withdrawal by Subject|2|||
156805739|NCT01847755|566043754|FG000|Overall Study|Physician Decision|1|||
156805740|NCT01904721|566043759|FG000|Overall Study|Other Reasons|0|||
156805741|NCT01904721|566043760|FG001|Overall Study|Other Reasons|0|||
156805742|NCT01904721|566043761|FG002|Overall Study|Other Reasons|1|||
156805743|NCT01904721|566043762|FG003|Overall Study|Other Reasons|1|||
156805744|NCT01904721|566043763|FG004|Overall Study|Other Reasons|2|||
156805745|NCT01904721|566043764|FG005|Overall Study|Other Reasons|2|||
156805746|NCT01904721|566043765|FG006|Overall Study|Other Reasons|2|||
156805747|NCT01904721|566043759|FG000|Overall Study|Personal Reasons|0|||
156337655|NCT02034110|564335075|FG000|Overall Study|Withdrawal by Subject|5|||
156337656|NCT02034110|564335076|FG001|Overall Study|Withdrawal by Subject|7|||
156337657|NCT02034110|564335077|FG002|Overall Study|Withdrawal by Subject|0|||
156337658|NCT02034110|564335078|FG003|Overall Study|Withdrawal by Subject|3|||
156337659|NCT02034110|564335079|FG004|Overall Study|Withdrawal by Subject|7|||
156337660|NCT02034110|564335080|FG005|Overall Study|Withdrawal by Subject|0|||
156337661|NCT02034110|564335081|FG006|Overall Study|Withdrawal by Subject|3|||
156337662|NCT02034110|564335082|FG007|Overall Study|Withdrawal by Subject|1|||
156337663|NCT02034110|564335075|FG000|Overall Study|Study closed by sponsor|6|||
156337664|NCT02034110|564335076|FG001|Overall Study|Study closed by sponsor|2|||
156337665|NCT02034110|564335077|FG002|Overall Study|Study closed by sponsor|0|||
156337666|NCT02034110|564335078|FG003|Overall Study|Study closed by sponsor|6|||
156337667|NCT02034110|564335079|FG004|Overall Study|Study closed by sponsor|7|||
156337668|NCT02034110|564335080|FG005|Overall Study|Study closed by sponsor|0|||
156337669|NCT02034110|564335081|FG006|Overall Study|Study closed by sponsor|42|||
156337670|NCT02034110|564335082|FG007|Overall Study|Study closed by sponsor|0|||
156337671|NCT02587234|564335083|FG000|Overall Study|Withdrawal by Subject|1|||
156337672|NCT02587234|564335084|FG001|Overall Study|Withdrawal by Subject|1|||
156337673|NCT02587234|564335083|FG000|Overall Study|Lost to Follow-up|0|||
156337674|NCT02587234|564335084|FG001|Overall Study|Lost to Follow-up|2|||
156337675|NCT04678661|564335085|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
156337676|NCT04678661|564335086|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
156337677|NCT04678661|564335085|FG000|Overall Study|Protocol Violation|2|||
156337678|NCT04678661|564335086|FG001|Overall Study|Protocol Violation|0|||
156337679|NCT04678661|564335085|FG000|Overall Study|Withdrawal by Subject|1|||
156337680|NCT04678661|564335086|FG001|Overall Study|Withdrawal by Subject|0|||
156337681|NCT04678661|564335085|FG000|Overall Study|Lost to Follow-up|2|||
156337682|NCT04678661|564335086|FG001|Overall Study|Lost to Follow-up|0|||
156337683|NCT04678661|564335085|FG000|Overall Study|Death|2|||
156337684|NCT04678661|564335086|FG001|Overall Study|Death|0|||
156337685|NCT01867424|564335087|FG000|Overall Study|Patient noncompliance|2|||
156337686|NCT01867424|564335088|FG001|Overall Study|Patient noncompliance|1|||
156337687|NCT00864721|564335089|FG000|Overall Study|Patient request|11|||
156337688|NCT00864721|564335089|FG000|Overall Study|Hospitalized|1|||
156337689|NCT00864721|564335089|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
156337690|NCT00864721|564335089|FG000|Overall Study|Adverse Event|21|||
156337691|NCT01921387|564335090|FG000|Overall Study|Adverse Event|1|||
156337692|NCT02527161|564335092|FG000|Overall Study|Failed MRI|52|||
156337693|NCT02527161|564335092|FG000|Overall Study|Withdrawal by Subject|19|||
156337694|NCT02527161|564335092|FG000|Overall Study|Delay in or unfit for surgery|16|||
156337695|NCT02527161|564335092|FG000|Overall Study|MRI contraindication|6|||
156805748|NCT01904721|566043760|FG001|Overall Study|Personal Reasons|0|||
156805749|NCT01904721|566043761|FG002|Overall Study|Personal Reasons|0|||
156805750|NCT01904721|566043762|FG003|Overall Study|Personal Reasons|0|||
156805751|NCT01904721|566043763|FG004|Overall Study|Personal Reasons|2|||
156805752|NCT01904721|566043764|FG005|Overall Study|Personal Reasons|3|||
156805753|NCT01904721|566043765|FG006|Overall Study|Personal Reasons|3|||
156805754|NCT01904721|566043759|FG000|Overall Study|Lost to Follow-up|0|||
156805755|NCT01904721|566043760|FG001|Overall Study|Lost to Follow-up|0|||
156805756|NCT01904721|566043761|FG002|Overall Study|Lost to Follow-up|0|||
156805757|NCT01904721|566043762|FG003|Overall Study|Lost to Follow-up|0|||
156805758|NCT01904721|566043763|FG004|Overall Study|Lost to Follow-up|1|||
156805759|NCT01904721|566043764|FG005|Overall Study|Lost to Follow-up|3|||
156805760|NCT01904721|566043765|FG006|Overall Study|Lost to Follow-up|1|||
156805761|NCT01904721|566043759|FG000|Overall Study|Lack of Efficacy|0|||
156805762|NCT01904721|566043760|FG001|Overall Study|Lack of Efficacy|0|||
156805763|NCT01904721|566043761|FG002|Overall Study|Lack of Efficacy|0|||
156805764|NCT01904721|566043762|FG003|Overall Study|Lack of Efficacy|0|||
156805765|NCT01904721|566043763|FG004|Overall Study|Lack of Efficacy|0|||
156805766|NCT01904721|566043764|FG005|Overall Study|Lack of Efficacy|0|||
156805767|NCT01904721|566043765|FG006|Overall Study|Lack of Efficacy|1|||
156805768|NCT01904721|566043759|FG000|Overall Study|Adverse Event|0|||
156805769|NCT01904721|566043760|FG001|Overall Study|Adverse Event|0|||
156805770|NCT01904721|566043761|FG002|Overall Study|Adverse Event|0|||
156805771|NCT01904721|566043762|FG003|Overall Study|Adverse Event|0|||
156805772|NCT01904721|566043763|FG004|Overall Study|Adverse Event|3|||
156805773|NCT01904721|566043764|FG005|Overall Study|Adverse Event|1|||
156805774|NCT01904721|566043765|FG006|Overall Study|Adverse Event|0|||
156805775|NCT00532844|566043769|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
156805776|NCT00532844|566043770|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
156805777|NCT00532844|566043769|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
156337696|NCT02527161|564335092|FG000|Overall Study|Consent violation|4|||
156337697|NCT02527161|564335092|FG000|Overall Study|Only Recruited to Part A|27|||
156337698|NCT02527161|564335092|FG000|Overall Study|Physician Decision|1|||
156337699|NCT02527161|564335092|FG000|Overall Study|Adverse Event|1|||
156805778|NCT00532844|566043770|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
156805779|NCT00532844|566043769|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
156805780|NCT00532844|566043770|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
156805781|NCT00532844|566043769|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
156805782|NCT00532844|566043770|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
156805783|NCT00532844|566043769|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
156805784|NCT00532844|566043770|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
156805785|NCT01077063|566043772|FG000|Overall Study|Adverse Event|3|||
156805786|NCT01077063|566043773|FG001|Overall Study|Adverse Event|0|||
156805787|NCT01077063|566043772|FG000|Overall Study|Death|1|||
156805788|NCT01077063|566043773|FG001|Overall Study|Death|1|||
156805789|NCT01077063|566043772|FG000|Overall Study|Withdrawal by Subject|0|||
156805790|NCT01077063|566043773|FG001|Overall Study|Withdrawal by Subject|2|||
156805791|NCT03894891|566043774|FG000|Overall Study|Withdrawal by Subject|1|||
156805792|NCT03894891|566043774|FG000|Overall Study|Completed protocol treatment per protocol|5|||
156805793|NCT04389866|566043778|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
156805794|NCT04389866|566043779|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
156805795|NCT01644643|566043783|FG000|Overall Study|Death|1|||
156805796|NCT01644643|566043784|FG001|Overall Study|Death|0|||
156805797|NCT01644643|566043785|FG002|Overall Study|Death|3|||
156805798|NCT01644643|566043786|FG003|Overall Study|Death|3|||
156805799|NCT01644643|566043783|FG000|Overall Study|Lost to Follow-up|0|||
156805800|NCT01644643|566043784|FG001|Overall Study|Lost to Follow-up|0|||
156805801|NCT01644643|566043785|FG002|Overall Study|Lost to Follow-up|0|||
156805802|NCT01644643|566043786|FG003|Overall Study|Lost to Follow-up|4|||
156805803|NCT01644643|566043783|FG000|Overall Study|Withdrawal by Subject|1|||
156805804|NCT01644643|566043784|FG001|Overall Study|Withdrawal by Subject|0|||
156805805|NCT01644643|566043785|FG002|Overall Study|Withdrawal by Subject|2|||
156805806|NCT01644643|566043786|FG003|Overall Study|Withdrawal by Subject|1|||
156805807|NCT01644643|566043783|FG000|Overall Study|Other Eligibility criteria|0|||
156805808|NCT01644643|566043784|FG001|Overall Study|Other Eligibility criteria|0|||
156805809|NCT01644643|566043785|FG002|Overall Study|Other Eligibility criteria|0|||
156805810|NCT01644643|566043786|FG003|Overall Study|Other Eligibility criteria|2|||
156805811|NCT01490918|566043791|FG000|Overall Study|Lost to Follow-up|2|||
156805812|NCT01490918|566043792|FG001|Overall Study|Lost to Follow-up|1|||
156805813|NCT01490918|566043793|FG002|Overall Study|Lost to Follow-up|0|||
156805814|NCT01490918|566043791|FG000|Overall Study|Withdrawal by Subject|7|||
156805815|NCT01490918|566043792|FG001|Overall Study|Withdrawal by Subject|8|||
156805816|NCT01490918|566043793|FG002|Overall Study|Withdrawal by Subject|3|||
156805817|NCT01490918|566043791|FG000|Overall Study|Adverse Event|0|||
156805818|NCT01490918|566043792|FG001|Overall Study|Adverse Event|0|||
156805819|NCT01490918|566043793|FG002|Overall Study|Adverse Event|1|||
156805820|NCT01490918|566043791|FG000|Overall Study|other cause|4|||
156805821|NCT01490918|566043792|FG001|Overall Study|other cause|5|||
156805822|NCT01490918|566043793|FG002|Overall Study|other cause|8|||
156805823|NCT00648037|566043794|FG000|Overall Study|Not Treated|1|||
156805824|NCT00648037|566043794|FG000|Overall Study|Withdrawal by Subject|1|||
156805825|NCT00648037|566043794|FG000|Overall Study|Adverse Event|11|||
156805826|NCT00648037|566043794|FG000|Overall Study|Relapse|2|||
156805827|NCT00648037|566043794|FG000|Overall Study|Other|1|||
156805828|NCT02967679|566043795|FG000|Overall Study|Adverse Event|1|||
156805829|NCT01284959|566043798|FG000|Overall Study|Withdrawal by Subject|1|||
156805830|NCT01284959|566043799|FG001|Overall Study|Withdrawal by Subject|0|||
156805831|NCT01284959|566043800|FG002|Overall Study|Withdrawal by Subject|0|||
156805832|NCT01284959|566043798|FG000|Overall Study|Adverse Event|0|||
156805833|NCT01284959|566043799|FG001|Overall Study|Adverse Event|0|||
156805834|NCT01284959|566043800|FG002|Overall Study|Adverse Event|1|||
156805835|NCT02765399|566043801|FG000|Overall Study|Nausea|1|||
156805836|NCT02765399|566043802|FG001|Overall Study|Nausea|0|||
156805837|NCT00120627|566043807|FG000|Overall Study|Withdrawal by Subject|5|||
156805838|NCT00120627|566043808|FG001|Overall Study|Withdrawal by Subject|5|||
156805839|NCT02629861|566043821|FG000|Overall Study|Adverse Event|7|||
156805840|NCT02629861|566043822|FG001|Overall Study|Adverse Event|5|||
156805841|NCT02629861|566043823|FG002|Overall Study|Adverse Event|4|||
156805842|NCT02629861|566043821|FG000|Overall Study|Withdrawal by Subject|5|||
156805843|NCT02629861|566043822|FG001|Overall Study|Withdrawal by Subject|8|||
156805844|NCT02629861|566043823|FG002|Overall Study|Withdrawal by Subject|13|||
156805845|NCT02629861|566043821|FG000|Overall Study|Protocol Violation|2|||
156805846|NCT02629861|566043822|FG001|Overall Study|Protocol Violation|3|||
156805847|NCT02629861|566043823|FG002|Overall Study|Protocol Violation|7|||
156805848|NCT02629861|566043821|FG000|Overall Study|Lost to Follow-up|12|||
156805849|NCT02629861|566043822|FG001|Overall Study|Lost to Follow-up|9|||
156805850|NCT02629861|566043823|FG002|Overall Study|Lost to Follow-up|4|||
156805851|NCT02629861|566043821|FG000|Overall Study|Other|1|||
156805852|NCT02629861|566043822|FG001|Overall Study|Other|1|||
156805853|NCT02629861|566043823|FG002|Overall Study|Other|0|||
156805854|NCT02629861|566043821|FG000|Overall Study|Pregnancy|2|||
156805855|NCT02629861|566043822|FG001|Overall Study|Pregnancy|1|||
156805856|NCT02629861|566043823|FG002|Overall Study|Pregnancy|0|||
156805857|NCT00271544|566043824|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
156805858|NCT00271544|566043824|FG000|Overall Study|Model 4196 lead not attempted|9|||
156805859|NCT00271544|566043824|FG000|Overall Study|Implant not attempted|4|||
156805860|NCT01822665|566043825|FG000|Overall Study|Adverse Event|3|||
156805861|NCT01822665|566043825|FG000|Overall Study|Other Reason|5|||
156805862|NCT00907621|566043826|FG000|Overall Study|Lost to Follow-up|6|||
156805863|NCT00907621|566043827|FG001|Overall Study|Lost to Follow-up|3|||
156805864|NCT00907621|566043826|FG000|Overall Study|intercurrent febrile illness|1|||
156805865|NCT00907621|566043827|FG001|Overall Study|intercurrent febrile illness|1|||
156805866|NCT04290624|566043828|FG000|Overall Study|Adverse Event|1|||
156805867|NCT04290624|566043829|FG001|Overall Study|Adverse Event|0|||
156805868|NCT00656370|566043830|FG000|Overall Study|Screen Failures|7|||
156805869|NCT00656370|566043830|FG000|Overall Study|Alternates|3|||
156805870|NCT00552071|566045432|FG000|Overall Study|Adverse Event|1|||
156805871|NCT00552071|566045433|FG001|Overall Study|Adverse Event|0|||
156805872|NCT00552071|566045432|FG000|Overall Study|Lack of Efficacy|1|||
156805873|NCT00552071|566045433|FG001|Overall Study|Lack of Efficacy|0|||
156805874|NCT00552071|566045432|FG000|Overall Study|Physician Decision|1|||
156805875|NCT00552071|566045433|FG001|Overall Study|Physician Decision|0|||
156805876|NCT00552071|566045432|FG000|Overall Study|Pregnancy|1|||
156805877|NCT00552071|566045433|FG001|Overall Study|Pregnancy|0|||
156805878|NCT00552071|566045432|FG000|Overall Study|Death|0|||
156805879|NCT00552071|566045433|FG001|Overall Study|Death|1|||
156805880|NCT00552071|566045432|FG000|Overall Study|Withdrawal by Subject|0|||
156337700|NCT02527161|564335092|FG000|Overall Study|Lost to Follow-up|6|||
156337701|NCT00762229|564335095|FG000|Overall Study|Lost to Follow-up|1|||
156337702|NCT00762229|564335096|FG001|Overall Study|Lost to Follow-up|1|||
156337703|NCT00762229|564335095|FG000|Overall Study|did not recveive intervention|0|||
156337704|NCT00762229|564335096|FG001|Overall Study|did not recveive intervention|1|||
156805881|NCT00552071|566045433|FG001|Overall Study|Withdrawal by Subject|1|||
156805882|NCT04723355|566045436|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
156805883|NCT04723355|566045436|FG000|Overall Study|Errors in the informed consent form|2|||
156805884|NCT03374358|566045437|FG000|Overall Study|Withdrawal by Subject|0|||
156805885|NCT03374358|566045438|FG001|Overall Study|Withdrawal by Subject|2|||
156805886|NCT01127633|566045439|FG000|Overall Study|Adverse Event|74|||
156805887|NCT01127633|566045440|FG001|Overall Study|Adverse Event|73|||
156805888|NCT01127633|566045439|FG000|Overall Study|Death|40|||
156337705|NCT02609828|564335097|FG000|Overall Study|Adverse Event|8|||
156337706|NCT02609828|564335098|FG001|Overall Study|Adverse Event|1|||
156337707|NCT02609828|564335099|FG002|Overall Study|Adverse Event|0|||
156337708|NCT02609828|564335100|FG003|Overall Study|Adverse Event|6|||
156337709|NCT02609828|564335097|FG000|Overall Study|Death|15|||
156337710|NCT02609828|564335098|FG001|Overall Study|Death|1|||
156337711|NCT02609828|564335099|FG002|Overall Study|Death|1|||
156337712|NCT02609828|564335100|FG003|Overall Study|Death|19|||
156337713|NCT02609828|564335097|FG000|Overall Study|Insufficient clinical response|2|||
156337714|NCT02609828|564335098|FG001|Overall Study|Insufficient clinical response|1|||
156337715|NCT02609828|564335099|FG002|Overall Study|Insufficient clinical response|0|||
156337716|NCT02609828|564335100|FG003|Overall Study|Insufficient clinical response|0|||
156337717|NCT02609828|564335097|FG000|Overall Study|Lost to Follow-up|0|||
156337718|NCT02609828|564335098|FG001|Overall Study|Lost to Follow-up|0|||
156337719|NCT02609828|564335099|FG002|Overall Study|Lost to Follow-up|0|||
156337720|NCT02609828|564335100|FG003|Overall Study|Lost to Follow-up|1|||
156337721|NCT02609828|564335097|FG000|Overall Study|Protocol Violation|2|||
156337722|NCT02609828|564335098|FG001|Overall Study|Protocol Violation|0|||
156337723|NCT02609828|564335099|FG002|Overall Study|Protocol Violation|0|||
156337724|NCT02609828|564335100|FG003|Overall Study|Protocol Violation|1|||
156805889|NCT01127633|566045440|FG001|Overall Study|Death|43|||
156805890|NCT01127633|566045439|FG000|Overall Study|Lost to Follow-up|4|||
156337725|NCT02609828|564335097|FG000|Overall Study|Withdrawal by Subject|12|||
156337726|NCT02609828|564335098|FG001|Overall Study|Withdrawal by Subject|1|||
156337727|NCT02609828|564335099|FG002|Overall Study|Withdrawal by Subject|0|||
156337728|NCT02609828|564335100|FG003|Overall Study|Withdrawal by Subject|10|||
156337729|NCT02609828|564335097|FG000|Overall Study|Other|3|||
156337730|NCT02609828|564335098|FG001|Overall Study|Other|0|||
156805891|NCT01127633|566045440|FG001|Overall Study|Lost to Follow-up|0|||
156805892|NCT01127633|566045439|FG000|Overall Study|Parent/Caregiver Decision|246|||
156805893|NCT01127633|566045440|FG001|Overall Study|Parent/Caregiver Decision|228|||
156805894|NCT01127633|566045439|FG000|Overall Study|Physician Decision|60|||
156805895|NCT01127633|566045440|FG001|Overall Study|Physician Decision|45|||
156805896|NCT01127633|566045439|FG000|Overall Study|Withdrawal by Subject|57|||
156805897|NCT01127633|566045440|FG001|Overall Study|Withdrawal by Subject|72|||
156805898|NCT01127633|566045439|FG000|Overall Study|Sponsor Decision|163|||
156805899|NCT01127633|566045440|FG001|Overall Study|Sponsor Decision|195|||
156805900|NCT01127633|566045439|FG000|Overall Study|Protocol Violation|8|||
156805901|NCT01127633|566045440|FG001|Overall Study|Protocol Violation|16|||
156805902|NCT01127633|566045439|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
156805903|NCT01127633|566045440|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
156805904|NCT01127633|566045439|FG000|Overall Study|Not treated|1|||
156805905|NCT01127633|566045440|FG001|Overall Study|Not treated|0|||
156805906|NCT00399568|566045442|FG000|Overall Study|Adverse Event|1|||
156805907|NCT00399568|566045443|FG001|Overall Study|Adverse Event|2|||
156805908|NCT00399568|566045442|FG000|Overall Study|Withdrawal by Subject|7|||
156805909|NCT00399568|566045443|FG001|Overall Study|Withdrawal by Subject|3|||
156805910|NCT00399568|566045442|FG000|Overall Study|Protocol non-compliance|2|||
156805911|NCT00399568|566045443|FG001|Overall Study|Protocol non-compliance|2|||
156805912|NCT00399568|566045442|FG000|Overall Study|Lost to Follow-up|2|||
156805913|NCT00399568|566045443|FG001|Overall Study|Lost to Follow-up|2|||
156805914|NCT00420381|566045449|FG000|Overall Study|Protocol Violation|1|||
156805915|NCT03432494|566045464|FG000|Overall Study|Death|1|||
156805916|NCT03432494|566045464|FG000|Overall Study|Noncompliance|1|||
156805917|NCT00775268|566045465|FG000|Baseline|Drug not synthesize dose|1|||
156805918|NCT00775268|566045466|FG001|Baseline|Drug not synthesize dose|0|||
156805919|NCT00775268|566045465|FG000|Baseline|Not treated-ineligible per CT|0|||
156337731|NCT02609828|564335099|FG002|Overall Study|Other|0|||
156337732|NCT02609828|564335100|FG003|Overall Study|Other|6|||
156337733|NCT02609828|564335097|FG000|Overall Study|Randomized but not treated|1|||
156337734|NCT02609828|564335098|FG001|Overall Study|Randomized but not treated|0|||
156337735|NCT02609828|564335099|FG002|Overall Study|Randomized but not treated|0|||
156337736|NCT02609828|564335100|FG003|Overall Study|Randomized but not treated|0|||
156805920|NCT00775268|566045466|FG001|Baseline|Not treated-ineligible per CT|1|||
156805921|NCT00775268|566045465|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
156337737|NCT01081678|564335102|FG000|Overall Study|Ineligibility Determined|0|||
156337738|NCT01081678|564335103|FG001|Overall Study|Ineligibility Determined|0|||
156337739|NCT01081678|564335104|FG002|Overall Study|Ineligibility Determined|1|||
156337740|NCT01081678|564335105|FG003|Overall Study|Ineligibility Determined|1|||
156337741|NCT01081678|564335102|FG000|Overall Study|Noncompliance|3|||
156337742|NCT01081678|564335103|FG001|Overall Study|Noncompliance|4|||
156337743|NCT01081678|564335104|FG002|Overall Study|Noncompliance|5|||
156337744|NCT01081678|564335105|FG003|Overall Study|Noncompliance|2|||
156337745|NCT01081678|564335102|FG000|Overall Study|Adverse Event|2|||
156337746|NCT01081678|564335103|FG001|Overall Study|Adverse Event|1|||
156337747|NCT01081678|564335104|FG002|Overall Study|Adverse Event|2|||
156337748|NCT01081678|564335105|FG003|Overall Study|Adverse Event|2|||
156337749|NCT01081678|564335102|FG000|Overall Study|Withdrawal by Subject|15|||
156337750|NCT01081678|564335103|FG001|Overall Study|Withdrawal by Subject|7|||
156337751|NCT01081678|564335104|FG002|Overall Study|Withdrawal by Subject|17|||
156337752|NCT01081678|564335105|FG003|Overall Study|Withdrawal by Subject|14|||
156337753|NCT01081678|564335102|FG000|Overall Study|Administrative Decision|1|||
156337754|NCT01081678|564335103|FG001|Overall Study|Administrative Decision|0|||
156337755|NCT01081678|564335104|FG002|Overall Study|Administrative Decision|0|||
156337756|NCT01081678|564335105|FG003|Overall Study|Administrative Decision|1|||
156805922|NCT00775268|566045466|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
156805923|NCT00775268|566045465|FG000|After Completion|Participant missed scan appointment|1|||
156805924|NCT00775268|566045466|FG001|After Completion|Participant missed scan appointment|0|||
156805925|NCT00592631|566045467|FG000|Overall Study|Lost to Follow-up|0|||
156805926|NCT00592631|566045468|FG001|Overall Study|Lost to Follow-up|2|||
156805927|NCT01244035|566045469|FG000|Part 1: Period 1|Adverse Event|0|||
156805928|NCT01244035|566045470|FG001|Part 1: Period 1|Adverse Event|0|||
156805929|NCT01244035|566045471|FG002|Part 1: Period 1|Adverse Event|0|||
156805930|NCT01244035|566045472|FG003|Part 1: Period 1|Adverse Event|0|||
156805931|NCT01244035|566045473|FG004|Part 1: Period 1|Adverse Event|0|||
156805932|NCT01244035|566045474|FG005|Part 1: Period 1|Adverse Event|1|||
156805933|NCT01244035|566045469|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
156805934|NCT01244035|566045470|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
156805935|NCT01244035|566045471|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
156805936|NCT01244035|566045472|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
156805937|NCT01244035|566045473|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
156805938|NCT01244035|566045474|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
156805939|NCT01244035|566045469|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
156805940|NCT01244035|566045470|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
156805941|NCT01244035|566045471|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
156805942|NCT01244035|566045472|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
156805943|NCT01244035|566045473|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
156805944|NCT01244035|566045474|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
156805945|NCT01244035|566045469|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805946|NCT01244035|566045470|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805947|NCT01244035|566045471|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
156805948|NCT01244035|566045472|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805949|NCT01244035|566045473|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805950|NCT01244035|566045474|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805951|NCT01244035|566045469|FG000|Part 1: Period 3|Adverse Event|0|||
156805952|NCT01244035|566045470|FG001|Part 1: Period 3|Adverse Event|0|||
156805953|NCT01244035|566045471|FG002|Part 1: Period 3|Adverse Event|0|||
156805954|NCT01244035|566045472|FG003|Part 1: Period 3|Adverse Event|0|||
156805955|NCT01244035|566045473|FG004|Part 1: Period 3|Adverse Event|0|||
156805956|NCT01244035|566045474|FG005|Part 1: Period 3|Adverse Event|1|||
156805957|NCT01244035|566045469|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
156805958|NCT01244035|566045470|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
156805959|NCT01244035|566045471|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
156805960|NCT01244035|566045472|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
156805961|NCT01244035|566045473|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
156805962|NCT01244035|566045474|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
156805963|NCT01244035|566045469|FG000|Part 1: Period 3|Protocol Deviation|0|||
156805964|NCT01244035|566045470|FG001|Part 1: Period 3|Protocol Deviation|1|||
156805965|NCT01244035|566045471|FG002|Part 1: Period 3|Protocol Deviation|0|||
156805966|NCT01244035|566045472|FG003|Part 1: Period 3|Protocol Deviation|0|||
156805967|NCT01244035|566045473|FG004|Part 1: Period 3|Protocol Deviation|0|||
156805968|NCT01244035|566045474|FG005|Part 1: Period 3|Protocol Deviation|0|||
156805969|NCT03389308|566045475|FG000|Overall Study|Withdrawal by Subject|5|||
156805970|NCT03389308|566045475|FG000|Overall Study|Lost to Follow-up|3|||
156805971|NCT03389308|566045475|FG000|Overall Study|Adverse Event|2|||
156805972|NCT03389308|566045475|FG000|Overall Study|Sponsor Request|2|||
156805973|NCT00570323|566045477|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
156805974|NCT00570323|566045478|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
156805975|NCT00570323|566045477|FG000|Started Treatment After Randomization|Protocol Violation|1|||
156805976|NCT00570323|566045478|FG001|Started Treatment After Randomization|Protocol Violation|0|||
156805977|NCT00570323|566045477|FG000|Started Treatment After Randomization|Physician Decision|1|||
156805978|NCT00570323|566045478|FG001|Started Treatment After Randomization|Physician Decision|0|||
156805979|NCT00570323|566045477|FG000|Complete Study After Start|Lost to Follow-up|0|||
156805980|NCT00570323|566045478|FG001|Complete Study After Start|Lost to Follow-up|1|||
156805981|NCT00570323|566045477|FG000|Complete Study After Start|Withdrawal by Subject|2|||
156805982|NCT00570323|566045478|FG001|Complete Study After Start|Withdrawal by Subject|0|||
156537179|NCT00467779|565061109|FG014|Stage 1|Withdrawal by Subject|0|||
156805983|NCT00570323|566045477|FG000|Complete Study After Start|Physician Decision|1|||
156805984|NCT00570323|566045478|FG001|Complete Study After Start|Physician Decision|0|||
156805985|NCT04263766|566045479|FG000|Overall Study|Withdrawal by Subject|6|||
156805986|NCT04263766|566045480|FG001|Overall Study|Withdrawal by Subject|4|||
156805987|NCT04263766|566045479|FG000|Overall Study|Lack of Efficacy|1|||
156805988|NCT04263766|566045480|FG001|Overall Study|Lack of Efficacy|3|||
156805989|NCT02639247|566045483|FG000|Overall Study|Lost to Follow-up|2|||
156805990|NCT02639247|566045484|FG001|Overall Study|Lost to Follow-up|1|||
156805991|NCT02639247|566045483|FG000|Overall Study|Death|2|||
156805992|NCT02639247|566045484|FG001|Overall Study|Death|0|||
156805993|NCT02639247|566045483|FG000|Overall Study|Withdrew Consent|0|||
156805994|NCT02639247|566045484|FG001|Overall Study|Withdrew Consent|1|||
156805995|NCT02639247|566045483|FG000|Overall Study|Protocol Violation|1|||
156805996|NCT02639247|566045484|FG001|Overall Study|Protocol Violation|0|||
156805997|NCT01891396|566045485|FG000|Overall Study|Withdrawal by Subject|4|||
156805998|NCT01891396|566045486|FG001|Overall Study|Withdrawal by Subject|4|||
156805999|NCT01891396|566045487|FG002|Overall Study|Withdrawal by Subject|3|||
156806000|NCT01891396|566045485|FG000|Overall Study|Lost to Follow-up|0|||
156806001|NCT01891396|566045486|FG001|Overall Study|Lost to Follow-up|1|||
156806002|NCT01891396|566045487|FG002|Overall Study|Lost to Follow-up|0|||
156806003|NCT00400517|566045492|FG000|Overall Study|Withdrawal by Subject|1|||
156806004|NCT00400517|566045492|FG000|Overall Study|Physician Decision|1|||
156806005|NCT01106157|566045493|FG000|Overall Study|Withdrawal by Subject|1|||
156806006|NCT01106157|566045494|FG001|Overall Study|Withdrawal by Subject|0|||
156806007|NCT01881009|566045498|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
156806008|NCT01881009|566045499|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
156806009|NCT02457247|566045501|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
156806010|NCT02457247|566045502|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
156806011|NCT02457247|566045503|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
156806012|NCT02457247|566045504|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
156806013|NCT02457247|566045501|FG000|Period 1|Significant Protocol Deviation|1|||
156806014|NCT02457247|566045502|FG001|Period 1|Significant Protocol Deviation|1|||
156806015|NCT02457247|566045503|FG002|Period 1|Significant Protocol Deviation|0|||
156806016|NCT02457247|566045504|FG003|Period 1|Significant Protocol Deviation|0|||
156806017|NCT02457247|566045501|FG000|Period 1|Voluntary Withdrawal|1|||
156806018|NCT02457247|566045502|FG001|Period 1|Voluntary Withdrawal|0|||
156806019|NCT02457247|566045503|FG002|Period 1|Voluntary Withdrawal|0|||
156806020|NCT02457247|566045504|FG003|Period 1|Voluntary Withdrawal|0|||
156806021|NCT02457247|566045501|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
156806022|NCT02457247|566045502|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
156806023|NCT02457247|566045503|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
156806024|NCT02457247|566045504|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
156806025|NCT02457247|566045501|FG000|Period 2|Significant Protocol Deviation|1|||
156806026|NCT02457247|566045502|FG001|Period 2|Significant Protocol Deviation|0|||
156806027|NCT02457247|566045503|FG002|Period 2|Significant Protocol Deviation|0|||
156806028|NCT02457247|566045504|FG003|Period 2|Significant Protocol Deviation|0|||
156806029|NCT02457247|566045501|FG000|Period 2|Lost to Follow-up|0|||
156806030|NCT02457247|566045502|FG001|Period 2|Lost to Follow-up|1|||
156806031|NCT02457247|566045503|FG002|Period 2|Lost to Follow-up|0|||
156806032|NCT02457247|566045504|FG003|Period 2|Lost to Follow-up|0|||
156806033|NCT02457247|566045501|FG000|Period 2|Voluntary Withdrawal|1|||
156806034|NCT02457247|566045502|FG001|Period 2|Voluntary Withdrawal|1|||
156806035|NCT02457247|566045503|FG002|Period 2|Voluntary Withdrawal|0|||
156806036|NCT02457247|566045504|FG003|Period 2|Voluntary Withdrawal|0|||
156537180|NCT00467779|565061095|FG000|Stage 1A|Adverse Event|0|||
156537181|NCT00467779|565061096|FG001|Stage 1A|Adverse Event|0|||
156806037|NCT02750514|566045507|FG000|Track 1|Disease progression|20|||
156806038|NCT02750514|566045508|FG001|Track 1|Disease progression|1|||
156806039|NCT02750514|566045509|FG002|Track 1|Disease progression|0|||
156806040|NCT02750514|566045510|FG003|Track 1|Disease progression|1|||
156806041|NCT02750514|566045511|FG004|Track 1|Disease progression|0|||
156806042|NCT02750514|566045507|FG000|Track 1|Adverse event unrelated to study drug|1|||
156806043|NCT02750514|566045508|FG001|Track 1|Adverse event unrelated to study drug|0|||
156806044|NCT02750514|566045509|FG002|Track 1|Adverse event unrelated to study drug|0|||
156806045|NCT02750514|566045510|FG003|Track 1|Adverse event unrelated to study drug|0|||
156806046|NCT02750514|566045511|FG004|Track 1|Adverse event unrelated to study drug|0|||
156806047|NCT02750514|566045507|FG000|Track 1|Study drug toxicity|4|||
156806048|NCT02750514|566045508|FG001|Track 1|Study drug toxicity|1|||
156806049|NCT02750514|566045509|FG002|Track 1|Study drug toxicity|0|||
156806050|NCT02750514|566045510|FG003|Track 1|Study drug toxicity|1|||
156337757|NCT01081678|564335102|FG000|Overall Study|Lost to Follow-up|4|||
156337758|NCT01081678|564335103|FG001|Overall Study|Lost to Follow-up|1|||
156337759|NCT01081678|564335104|FG002|Overall Study|Lost to Follow-up|4|||
156337760|NCT01081678|564335105|FG003|Overall Study|Lost to Follow-up|3|||
156337761|NCT01081678|564335102|FG000|Overall Study|Death|2|||
156337762|NCT01081678|564335103|FG001|Overall Study|Death|2|||
156337763|NCT01081678|564335104|FG002|Overall Study|Death|2|||
156337764|NCT01081678|564335105|FG003|Overall Study|Death|6|||
156337765|NCT01081678|564335102|FG000|Overall Study|Other|0|||
156337766|NCT01081678|564335103|FG001|Overall Study|Other|1|||
156337767|NCT01081678|564335104|FG002|Overall Study|Other|0|||
156337768|NCT01081678|564335105|FG003|Overall Study|Other|0|||
156337769|NCT03478657|564335106|FG000|Overall Study|Withdrawal by Subject|0|||
156337770|NCT03478657|564335107|FG001|Overall Study|Withdrawal by Subject|1|||
156806051|NCT02750514|566045511|FG004|Track 1|Study drug toxicity|0|||
156806052|NCT02750514|566045507|FG000|Track 1|Participant request to discontinue|1|||
156806053|NCT02750514|566045508|FG001|Track 1|Participant request to discontinue|0|||
156806054|NCT02750514|566045509|FG002|Track 1|Participant request to discontinue|0|||
156337771|NCT01350492|564335111|FG000|Intervention|Lost to Follow-up|2|||
156337772|NCT01350492|564335112|FG001|Intervention|Lost to Follow-up|5|||
156337773|NCT01350492|564335111|FG000|Intervention|Withdrawal by Subject|3|||
156806055|NCT02750514|566045510|FG003|Track 1|Participant request to discontinue|0|||
156806056|NCT02750514|566045511|FG004|Track 1|Participant request to discontinue|0|||
156806057|NCT02750514|566045507|FG000|Track 1|Other reasons|1|||
156806058|NCT02750514|566045508|FG001|Track 1|Other reasons|0|||
156806059|NCT02750514|566045509|FG002|Track 1|Other reasons|0|||
156806060|NCT02750514|566045510|FG003|Track 1|Other reasons|0|||
156806061|NCT02750514|566045511|FG004|Track 1|Other reasons|0|||
156806062|NCT02750514|566045507|FG000|Track 2|Disease progression|4|||
156337774|NCT01350492|564335112|FG001|Intervention|Withdrawal by Subject|1|||
156337775|NCT01350492|564335111|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
156337776|NCT01350492|564335112|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
156806063|NCT02750514|566045508|FG001|Track 2|Disease progression|5|||
156806064|NCT02750514|566045509|FG002|Track 2|Disease progression|2|||
156806065|NCT02750514|566045510|FG003|Track 2|Disease progression|5|||
156806066|NCT02750514|566045511|FG004|Track 2|Disease progression|0|||
156806067|NCT02750514|566045507|FG000|Track 2|Adverse event unrelated to study drug|1|||
156806068|NCT02750514|566045508|FG001|Track 2|Adverse event unrelated to study drug|0|||
156806069|NCT02750514|566045509|FG002|Track 2|Adverse event unrelated to study drug|0|||
156806070|NCT02750514|566045510|FG003|Track 2|Adverse event unrelated to study drug|0|||
156806071|NCT02750514|566045511|FG004|Track 2|Adverse event unrelated to study drug|0|||
156806072|NCT02750514|566045507|FG000|Track 2|Study drug toxicity|1|||
156806073|NCT02750514|566045508|FG001|Track 2|Study drug toxicity|2|||
156806074|NCT02750514|566045509|FG002|Track 2|Study drug toxicity|0|||
156806075|NCT02750514|566045510|FG003|Track 2|Study drug toxicity|2|||
156806076|NCT02750514|566045511|FG004|Track 2|Study drug toxicity|0|||
156806077|NCT02750514|566045507|FG000|Track 2|Participant withdrew consent|0|||
156806078|NCT02750514|566045508|FG001|Track 2|Participant withdrew consent|1|||
156806079|NCT02750514|566045509|FG002|Track 2|Participant withdrew consent|0|||
156806080|NCT02750514|566045510|FG003|Track 2|Participant withdrew consent|0|||
156806081|NCT02750514|566045511|FG004|Track 2|Participant withdrew consent|0|||
156806082|NCT02750514|566045507|FG000|Track 3|Disease progression|0|||
156806083|NCT02750514|566045508|FG001|Track 3|Disease progression|24|||
156806084|NCT02750514|566045509|FG002|Track 3|Disease progression|13|||
156806085|NCT02750514|566045510|FG003|Track 3|Disease progression|14|||
156806086|NCT02750514|566045511|FG004|Track 3|Disease progression|0|||
156806087|NCT02750514|566045507|FG000|Track 3|Adverse event unrelated to study drug|0|||
156806088|NCT02750514|566045508|FG001|Track 3|Adverse event unrelated to study drug|1|||
156806089|NCT02750514|566045509|FG002|Track 3|Adverse event unrelated to study drug|1|||
156806090|NCT02750514|566045510|FG003|Track 3|Adverse event unrelated to study drug|1|||
156806091|NCT02750514|566045511|FG004|Track 3|Adverse event unrelated to study drug|0|||
156806092|NCT02750514|566045507|FG000|Track 3|Study drug toxicity|0|||
156806093|NCT02750514|566045508|FG001|Track 3|Study drug toxicity|3|||
156806094|NCT02750514|566045509|FG002|Track 3|Study drug toxicity|0|||
156337777|NCT01350492|564335111|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
156337778|NCT01350492|564335112|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
156337779|NCT00702689|564335113|FG000|Overall Study|Withdrawal by Subject|4|||
156337780|NCT00702689|564335113|FG000|Overall Study|Recurrent malignancy|1|||
156806095|NCT02750514|566045510|FG003|Track 3|Study drug toxicity|1|||
156806096|NCT02750514|566045511|FG004|Track 3|Study drug toxicity|0|||
156806097|NCT02750514|566045507|FG000|Track 3|Participant request to discontinue|0|||
156806098|NCT02750514|566045508|FG001|Track 3|Participant request to discontinue|2|||
156806099|NCT02750514|566045509|FG002|Track 3|Participant request to discontinue|0|||
156806100|NCT02750514|566045510|FG003|Track 3|Participant request to discontinue|0|||
156806101|NCT02750514|566045511|FG004|Track 3|Participant request to discontinue|0|||
156337781|NCT00702689|564335113|FG000|Overall Study|Adverse Event|1|||
156806102|NCT02750514|566045507|FG000|Track 3|Participant withdrew consent|0|||
156806103|NCT02750514|566045508|FG001|Track 3|Participant withdrew consent|3|||
156806104|NCT02750514|566045509|FG002|Track 3|Participant withdrew consent|1|||
156806105|NCT02750514|566045510|FG003|Track 3|Participant withdrew consent|0|||
156806106|NCT02750514|566045511|FG004|Track 3|Participant withdrew consent|0|||
156806107|NCT02750514|566045507|FG000|Track 3|Other reasons|0|||
156806108|NCT02750514|566045508|FG001|Track 3|Other reasons|3|||
156806109|NCT02750514|566045509|FG002|Track 3|Other reasons|0|||
156806110|NCT02750514|566045510|FG003|Track 3|Other reasons|0|||
156806111|NCT02750514|566045511|FG004|Track 3|Other reasons|0|||
156806112|NCT02750514|566045507|FG000|Track 4|Study drug toxicity|0|||
156806113|NCT02750514|566045508|FG001|Track 4|Study drug toxicity|6|||
156806114|NCT02750514|566045509|FG002|Track 4|Study drug toxicity|0|||
156806115|NCT02750514|566045510|FG003|Track 4|Study drug toxicity|5|||
156806116|NCT02750514|566045511|FG004|Track 4|Study drug toxicity|0|||
156806117|NCT02750514|566045507|FG000|Track 4|Participant request to discontinue|0|||
156806118|NCT02750514|566045508|FG001|Track 4|Participant request to discontinue|1|||
156806119|NCT02750514|566045509|FG002|Track 4|Participant request to discontinue|0|||
156806120|NCT02750514|566045510|FG003|Track 4|Participant request to discontinue|1|||
156806121|NCT02750514|566045511|FG004|Track 4|Participant request to discontinue|0|||
156806122|NCT02750514|566045507|FG000|Track 4|Participant withdrew consent|0|||
156806123|NCT02750514|566045508|FG001|Track 4|Participant withdrew consent|1|||
156806124|NCT02750514|566045509|FG002|Track 4|Participant withdrew consent|0|||
156806125|NCT02750514|566045510|FG003|Track 4|Participant withdrew consent|0|||
156806126|NCT02750514|566045511|FG004|Track 4|Participant withdrew consent|0|||
156806127|NCT02750514|566045507|FG000|Track 4|Other reasons|0|||
156806128|NCT02750514|566045508|FG001|Track 4|Other reasons|5|||
156806129|NCT02750514|566045509|FG002|Track 4|Other reasons|0|||
156806130|NCT02750514|566045510|FG003|Track 4|Other reasons|3|||
156806131|NCT02750514|566045511|FG004|Track 4|Other reasons|0|||
156806132|NCT02750514|566045507|FG000|Track 4|Disease progression|0|||
156806133|NCT02750514|566045508|FG001|Track 4|Disease progression|33|||
156806134|NCT02750514|566045509|FG002|Track 4|Disease progression|0|||
156806135|NCT02750514|566045510|FG003|Track 4|Disease progression|32|||
156806136|NCT02750514|566045511|FG004|Track 4|Disease progression|0|||
156806137|NCT02750514|566045507|FG000|Track 4|Adverse event unrelated to study drug|0|||
156806138|NCT02750514|566045508|FG001|Track 4|Adverse event unrelated to study drug|5|||
156806139|NCT02750514|566045509|FG002|Track 4|Adverse event unrelated to study drug|0|||
156806140|NCT02750514|566045510|FG003|Track 4|Adverse event unrelated to study drug|0|||
156806141|NCT02750514|566045511|FG004|Track 4|Adverse event unrelated to study drug|0|||
156806142|NCT02750514|566045507|FG000|Track 4|Death|0|||
156806143|NCT02750514|566045508|FG001|Track 4|Death|0|||
156806144|NCT02750514|566045509|FG002|Track 4|Death|0|||
156806145|NCT02750514|566045510|FG003|Track 4|Death|1|||
156806146|NCT02750514|566045511|FG004|Track 4|Death|0|||
156806147|NCT02750514|566045507|FG000|Track 5|Disease progression|0|||
156806148|NCT02750514|566045508|FG001|Track 5|Disease progression|0|||
156806149|NCT02750514|566045509|FG002|Track 5|Disease progression|0|||
156806150|NCT02750514|566045510|FG003|Track 5|Disease progression|0|||
156806151|NCT02750514|566045511|FG004|Track 5|Disease progression|34|||
156806152|NCT02750514|566045507|FG000|Track 5|Adverse event unrelated to study drug|0|||
156806153|NCT02750514|566045508|FG001|Track 5|Adverse event unrelated to study drug|0|||
156806154|NCT02750514|566045509|FG002|Track 5|Adverse event unrelated to study drug|0|||
156806155|NCT02750514|566045510|FG003|Track 5|Adverse event unrelated to study drug|0|||
156806156|NCT02750514|566045511|FG004|Track 5|Adverse event unrelated to study drug|2|||
156806157|NCT02750514|566045507|FG000|Track 5|Study drug toxicity|0|||
156806158|NCT02750514|566045508|FG001|Track 5|Study drug toxicity|0|||
156806159|NCT02750514|566045509|FG002|Track 5|Study drug toxicity|0|||
156806160|NCT02750514|566045510|FG003|Track 5|Study drug toxicity|0|||
156806161|NCT02750514|566045511|FG004|Track 5|Study drug toxicity|2|||
156806162|NCT02750514|566045507|FG000|Track 5|Participant request to discontinue|0|||
156806163|NCT02750514|566045508|FG001|Track 5|Participant request to discontinue|0|||
156806164|NCT02750514|566045509|FG002|Track 5|Participant request to discontinue|0|||
156806165|NCT02750514|566045510|FG003|Track 5|Participant request to discontinue|0|||
156806166|NCT02750514|566045511|FG004|Track 5|Participant request to discontinue|3|||
156806167|NCT02750514|566045507|FG000|Track 5|Other reasons|0|||
156806168|NCT02750514|566045508|FG001|Track 5|Other reasons|0|||
156806169|NCT02750514|566045509|FG002|Track 5|Other reasons|0|||
156806170|NCT02750514|566045510|FG003|Track 5|Other reasons|0|||
156806171|NCT02750514|566045511|FG004|Track 5|Other reasons|2|||
156806172|NCT01882465|566045512|FG000|Period 1|Lens Discomfort|0|||
156806173|NCT01882465|566045513|FG001|Period 1|Lens Discomfort|0|||
156806174|NCT01882465|566045514|FG002|Period 1|Lens Discomfort|0|||
156806175|NCT01882465|566045515|FG003|Period 1|Lens Discomfort|1|||
156806176|NCT01882465|566045516|FG004|Period 1|Lens Discomfort|0|||
156806177|NCT01882465|566045517|FG005|Period 1|Lens Discomfort|0|||
156806178|NCT01882465|566045518|FG006|Period 1|Lens Discomfort|0|||
156806179|NCT01882465|566045512|FG000|Period 1|Withdrawal by Subject|0|||
156806180|NCT01882465|566045513|FG001|Period 1|Withdrawal by Subject|0|||
156806181|NCT01882465|566045514|FG002|Period 1|Withdrawal by Subject|0|||
156806182|NCT01882465|566045515|FG003|Period 1|Withdrawal by Subject|0|||
156806183|NCT01882465|566045516|FG004|Period 1|Withdrawal by Subject|0|||
156806184|NCT01882465|566045517|FG005|Period 1|Withdrawal by Subject|0|||
156806185|NCT01882465|566045518|FG006|Period 1|Withdrawal by Subject|1|||
156806186|NCT01882465|566045512|FG000|Period 2|Protocol Violation|0|||
156806187|NCT01882465|566045513|FG001|Period 2|Protocol Violation|0|||
156806188|NCT01882465|566045514|FG002|Period 2|Protocol Violation|0|||
156806189|NCT01882465|566045515|FG003|Period 2|Protocol Violation|0|||
156806190|NCT01882465|566045516|FG004|Period 2|Protocol Violation|1|||
156806191|NCT01882465|566045517|FG005|Period 2|Protocol Violation|0|||
156806192|NCT01882465|566045518|FG006|Period 2|Protocol Violation|0|||
156806193|NCT00800982|566045519|FG000|Overall Study|Lost to Follow-up|1|||
156806194|NCT00800982|566045520|FG001|Overall Study|Lost to Follow-up|2|||
156806195|NCT00800982|566045519|FG000|Overall Study|Withdrawal by Subject|0|||
156806196|NCT00800982|566045520|FG001|Overall Study|Withdrawal by Subject|1|||
156806197|NCT00800982|566045519|FG000|Overall Study|Patient moved out of state|1|||
156806198|NCT00800982|566045520|FG001|Overall Study|Patient moved out of state|0|||
156806199|NCT01824290|566045521|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
156806200|NCT01824290|566045522|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
156806201|NCT01824290|566045523|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
156806202|NCT01824290|566045524|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
156806203|NCT01824290|566045521|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
156806204|NCT01824290|566045522|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
156806205|NCT01824290|566045523|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
156806206|NCT01824290|566045524|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
156806207|NCT01824290|566045521|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
156806208|NCT01824290|566045522|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
156806209|NCT01824290|566045523|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
156806210|NCT01824290|566045524|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
156806211|NCT01824290|566045521|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
156806212|NCT01824290|566045522|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
156806213|NCT01824290|566045523|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
156806214|NCT01824290|566045524|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
156806215|NCT01824290|566045521|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
156806216|NCT01824290|566045522|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
156806217|NCT01824290|566045523|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
156806218|NCT01824290|566045524|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
156806219|NCT01824290|566045521|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
156806220|NCT01824290|566045522|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
156806221|NCT01824290|566045523|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
156806222|NCT01824290|566045524|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
156806223|NCT02756403|566045525|FG000|Overall Study|Unable to swallow medication|0|||
156806224|NCT02756403|566045526|FG001|Overall Study|Unable to swallow medication|1|||
156806225|NCT02756403|566045527|FG002|Overall Study|Unable to swallow medication|1|||
156806226|NCT02756403|566045528|FG003|Overall Study|Unable to swallow medication|1|||
156806227|NCT02756403|566045525|FG000|Overall Study|Did not complete Procedure|0|||
156806228|NCT02756403|566045526|FG001|Overall Study|Did not complete Procedure|1|||
156806229|NCT02756403|566045527|FG002|Overall Study|Did not complete Procedure|0|||
156806230|NCT02756403|566045528|FG003|Overall Study|Did not complete Procedure|0|||
156806231|NCT02756403|566045525|FG000|Overall Study|Changed Mind About Procedure|0|||
156806232|NCT02756403|566045526|FG001|Overall Study|Changed Mind About Procedure|0|||
156806233|NCT02756403|566045527|FG002|Overall Study|Changed Mind About Procedure|1|||
156806234|NCT02756403|566045528|FG003|Overall Study|Changed Mind About Procedure|0|||
156806235|NCT02756403|566045525|FG000|Overall Study|Protocol Violation|0|||
156806236|NCT02756403|566045526|FG001|Overall Study|Protocol Violation|1|||
156806237|NCT02756403|566045527|FG002|Overall Study|Protocol Violation|0|||
156806238|NCT02756403|566045528|FG003|Overall Study|Protocol Violation|1|||
156806239|NCT00527618|566045529|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
156806240|NCT00527618|566045530|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
156806241|NCT00527618|566045529|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
156806242|NCT00527618|566045530|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
156806243|NCT00527618|566045529|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
156806244|NCT00527618|566045530|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
156806245|NCT00527618|566045529|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
156806246|NCT00527618|566045530|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
156806247|NCT00527618|566045529|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
156806248|NCT00527618|566045530|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
156806249|NCT00527618|566045529|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
156806250|NCT00527618|566045530|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
156806251|NCT02240121|566045531|FG000|Overall Study|Protocol Violation|1|||
156806252|NCT02240121|566045532|FG001|Overall Study|Protocol Violation|2|||
156806253|NCT02240121|566045531|FG000|Overall Study|Physician Decision|0|||
156806254|NCT02240121|566045532|FG001|Overall Study|Physician Decision|1|||
156806255|NCT02240121|566045531|FG000|Overall Study|Change in protocol interpretation|1|||
156806256|NCT02240121|566045532|FG001|Overall Study|Change in protocol interpretation|0|||
156806257|NCT02240121|566045531|FG000|Overall Study|Lack of Efficacy|2|||
156806258|NCT02240121|566045532|FG001|Overall Study|Lack of Efficacy|3|||
156806259|NCT02240121|566045531|FG000|Overall Study|Site closed|1|||
156806260|NCT02240121|566045532|FG001|Overall Study|Site closed|1|||
156806261|NCT02240121|566045531|FG000|Overall Study|Pregnancy|1|||
156806262|NCT02240121|566045532|FG001|Overall Study|Pregnancy|0|||
156806263|NCT02240121|566045531|FG000|Overall Study|Adverse Event|2|||
156806264|NCT02240121|566045532|FG001|Overall Study|Adverse Event|4|||
156806265|NCT02240121|566045531|FG000|Overall Study|Withdrawal by Subject|6|||
156806266|NCT02240121|566045532|FG001|Overall Study|Withdrawal by Subject|2|||
156806267|NCT02240121|566045531|FG000|Overall Study|Lost to Follow-up|3|||
156337782|NCT02805972|564335118|FG000|Washout Period|Lost to Follow-up|3|||
156806268|NCT02240121|566045532|FG001|Overall Study|Lost to Follow-up|4|||
156806269|NCT02240121|566045531|FG000|Overall Study|Other than specified|1|||
156806270|NCT02240121|566045532|FG001|Overall Study|Other than specified|3|||
156337783|NCT02805972|564335119|FG001|Washout Period|Lost to Follow-up|0|||
156337784|NCT00939640|564335125|FG000|Overall Study|Physician Decision|1|||
156337785|NCT00239590|564335126|FG000|Randomized|Lost to Follow-up|0|||
156337786|NCT00239590|564335127|FG001|Randomized|Lost to Follow-up|1|||
156337787|NCT00239590|564335126|FG000|Randomized|Withdrawal by Subject|0|||
156337788|NCT00239590|564335127|FG001|Randomized|Withdrawal by Subject|1|||
156337789|NCT00239590|564335126|FG000|Completed Study Protocol|Adverse Event|1|||
156337790|NCT00239590|564335127|FG001|Completed Study Protocol|Adverse Event|1|||
156337791|NCT00239590|564335126|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
156337792|NCT00239590|564335127|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
156337793|NCT02121522|564335128|FG000|Overall Study|Adverse Event|1|||
156337794|NCT00892047|564335134|FG000|Overall Study|Adverse Event|2|||
156337795|NCT00892047|564335135|FG001|Overall Study|Adverse Event|2|||
156337796|NCT00892047|564335134|FG000|Overall Study|subject burden|2|||
156337797|NCT00892047|564335135|FG001|Overall Study|subject burden|3|||
156337798|NCT00892047|564335134|FG000|Overall Study|Lack of Efficacy|0|||
156337799|NCT00892047|564335135|FG001|Overall Study|Lack of Efficacy|2|||
156337800|NCT01443078|564335136|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
156337801|NCT01443078|564335136|FG000|Overall Study|Withdrawal by Subject|1|||
156337802|NCT01443078|564335136|FG000|Overall Study|Patient had brain mets|1|||
156337803|NCT02106975|564335145|FG000|Overall Study|Death|25|||
156337804|NCT02106975|564335146|FG001|Overall Study|Death|39|||
156337805|NCT00306189|564335149|FG000|Overall Study|Physician Decision|0|||
156337806|NCT00306189|564335150|FG001|Overall Study|Physician Decision|0|||
156337807|NCT00306189|564335151|FG002|Overall Study|Physician Decision|0|||
156337808|NCT00306189|564335152|FG003|Overall Study|Physician Decision|1|||
156337809|NCT00306189|564335149|FG000|Overall Study|Adverse Event|3|||
156337810|NCT00306189|564335150|FG001|Overall Study|Adverse Event|3|||
156337811|NCT00306189|564335151|FG002|Overall Study|Adverse Event|2|||
156337812|NCT00306189|564335152|FG003|Overall Study|Adverse Event|2|||
156337813|NCT00306189|564335149|FG000|Overall Study|Withdrawal by Subject|4|||
156337814|NCT00306189|564335150|FG001|Overall Study|Withdrawal by Subject|2|||
156337815|NCT00306189|564335151|FG002|Overall Study|Withdrawal by Subject|8|||
156337816|NCT00306189|564335152|FG003|Overall Study|Withdrawal by Subject|1|||
156337817|NCT00306189|564335149|FG000|Overall Study|Ineligibility determined|1|||
156337818|NCT00306189|564335150|FG001|Overall Study|Ineligibility determined|1|||
156337819|NCT00306189|564335151|FG002|Overall Study|Ineligibility determined|1|||
156337820|NCT00306189|564335152|FG003|Overall Study|Ineligibility determined|1|||
156337821|NCT00306189|564335149|FG000|Overall Study|Other|1|||
156337822|NCT00306189|564335150|FG001|Overall Study|Other|0|||
156337823|NCT00306189|564335151|FG002|Overall Study|Other|0|||
156337824|NCT00306189|564335152|FG003|Overall Study|Other|0|||
156337825|NCT00259610|564335153|FG000|Overall Study|Withdrawal by Subject|33|||
156337826|NCT00259610|564335154|FG001|Overall Study|Withdrawal by Subject|25|||
156806271|NCT00846846|566045533|FG000|Overall Study|Death|56|||
156806272|NCT00846846|566045533|FG000|Overall Study|Withdrawal by Subject|19|||
156337827|NCT00259610|564335155|FG002|Overall Study|Withdrawal by Subject|29|||
156337828|NCT00259610|564335156|FG003|Overall Study|Withdrawal by Subject|19|||
156537182|NCT00467779|565061097|FG002|Stage 1A|Adverse Event|0|||
156806273|NCT02103062|566045538|FG000|Overall Study|Adverse Event|1|||
156806274|NCT02103062|566045539|FG001|Overall Study|Adverse Event|2|||
156806275|NCT02103062|566045538|FG000|Overall Study|Progressive Disease|17|||
156806276|NCT02103062|566045539|FG001|Overall Study|Progressive Disease|20|||
156806277|NCT02103062|566045538|FG000|Overall Study|Death|0|||
156806278|NCT02103062|566045539|FG001|Overall Study|Death|1|||
156806279|NCT03386435|566045540|FG000|Overall Study|Protocol Violation|5|||
156806280|NCT03386435|566045541|FG001|Overall Study|Protocol Violation|7|||
156806281|NCT00959907|566045544|FG000|Overall Study|Protocol Violation|0|||
156806282|NCT00959907|566045545|FG001|Overall Study|Protocol Violation|1|||
156806283|NCT00959907|566045544|FG000|Overall Study|Adverse Event|1|||
156806284|NCT00959907|566045545|FG001|Overall Study|Adverse Event|0|||
156806285|NCT00959907|566045544|FG000|Overall Study|Withdrawal by Subject|2|||
156806286|NCT00959907|566045545|FG001|Overall Study|Withdrawal by Subject|0|||
156806287|NCT03958331|566045546|FG000|Overall Study|Withdrawal by Subject|3|||
156806288|NCT03958331|566045547|FG001|Overall Study|Withdrawal by Subject|1|||
156537183|NCT00467779|565061098|FG003|Stage 1A|Adverse Event|0|||
156806289|NCT03958331|566045548|FG002|Overall Study|Withdrawal by Subject|5|||
156337829|NCT00259610|564335153|FG000|Overall Study|Lost to Follow-up|19|||
156337830|NCT00259610|564335154|FG001|Overall Study|Lost to Follow-up|8|||
156337831|NCT00259610|564335155|FG002|Overall Study|Lost to Follow-up|18|||
156337832|NCT00259610|564335156|FG003|Overall Study|Lost to Follow-up|15|||
156806290|NCT03958331|566045546|FG000|Overall Study|Weaned from medicine|2|||
156806291|NCT03958331|566045547|FG001|Overall Study|Weaned from medicine|0|||
156806292|NCT03958331|566045548|FG002|Overall Study|Weaned from medicine|0|||
156806293|NCT03958331|566045546|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
156806294|NCT03958331|566045547|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
156337833|NCT00259610|564335153|FG000|Overall Study|Physician Decision|6|||
156337834|NCT00259610|564335154|FG001|Overall Study|Physician Decision|4|||
156337835|NCT00259610|564335155|FG002|Overall Study|Physician Decision|7|||
156337836|NCT00259610|564335156|FG003|Overall Study|Physician Decision|2|||
156337837|NCT00259610|564335153|FG000|Overall Study|Death|1|||
156337838|NCT00259610|564335154|FG001|Overall Study|Death|1|||
156337839|NCT00259610|564335155|FG002|Overall Study|Death|2|||
156337840|NCT00259610|564335156|FG003|Overall Study|Death|0|||
156337841|NCT00259610|564335153|FG000|Overall Study|non medical reason|6|||
156337842|NCT00259610|564335154|FG001|Overall Study|non medical reason|2|||
156337843|NCT00259610|564335155|FG002|Overall Study|non medical reason|10|||
156337844|NCT00259610|564335156|FG003|Overall Study|non medical reason|3|||
156337845|NCT00259610|564335153|FG000|Overall Study|Adverse Event|3|||
156337846|NCT00259610|564335154|FG001|Overall Study|Adverse Event|4|||
156337847|NCT00259610|564335155|FG002|Overall Study|Adverse Event|5|||
156337848|NCT00259610|564335156|FG003|Overall Study|Adverse Event|2|||
156337849|NCT00259610|564335153|FG000|Overall Study|Serious Adverse Event|8|||
156337850|NCT00259610|564335154|FG001|Overall Study|Serious Adverse Event|2|||
156337851|NCT00259610|564335155|FG002|Overall Study|Serious Adverse Event|2|||
156337852|NCT00259610|564335156|FG003|Overall Study|Serious Adverse Event|2|||
156337853|NCT02151110|564335160|FG000|Overall Study|Withdrawal by Subject|0|||
156337854|NCT02151110|564335161|FG001|Overall Study|Withdrawal by Subject|0|||
156337855|NCT02151110|564335162|FG002|Overall Study|Withdrawal by Subject|0|||
156337856|NCT02151110|564335163|FG003|Overall Study|Withdrawal by Subject|0|||
156337857|NCT02151110|564335164|FG004|Overall Study|Withdrawal by Subject|0|||
156337858|NCT02151110|564335165|FG005|Overall Study|Withdrawal by Subject|0|||
156337859|NCT02151110|564335166|FG006|Overall Study|Withdrawal by Subject|0|||
156337860|NCT02151110|564335167|FG007|Overall Study|Withdrawal by Subject|1|||
156337861|NCT02151110|564335160|FG000|Overall Study|Lost to Follow-up|0|||
156337862|NCT02151110|564335161|FG001|Overall Study|Lost to Follow-up|0|||
156337863|NCT02151110|564335162|FG002|Overall Study|Lost to Follow-up|0|||
156337864|NCT02151110|564335163|FG003|Overall Study|Lost to Follow-up|0|||
156337865|NCT02151110|564335164|FG004|Overall Study|Lost to Follow-up|0|||
156337866|NCT02151110|564335165|FG005|Overall Study|Lost to Follow-up|0|||
156337867|NCT02151110|564335166|FG006|Overall Study|Lost to Follow-up|0|||
156337868|NCT02151110|564335167|FG007|Overall Study|Lost to Follow-up|2|||
156337869|NCT06934993|564335172|FG000|Overall Study|Withdrawal by Subject|29|||
156337870|NCT06934993|564335172|FG000|Overall Study|elevated postoperative creatinine level|11|||
156337871|NCT06934993|564335172|FG000|Overall Study|Death|3|||
156337872|NCT05147428|564335173|FG000|Overall Study|Removed prior to mailing|289|||
156337873|NCT05147428|564335174|FG001|Overall Study|Removed prior to mailing|306|||
156337874|NCT05147428|564335175|FG002|Overall Study|Removed prior to mailing|270|||
156337875|NCT05147428|564335173|FG000|Overall Study|Died or disenrolled during blackout period|239|||
156337876|NCT05147428|564335174|FG001|Overall Study|Died or disenrolled during blackout period|278|||
156337877|NCT05147428|564335175|FG002|Overall Study|Died or disenrolled during blackout period|273|||
156337878|NCT03128047|564335176|FG000|Overall Study|Withdrawal by Subject|1|||
156337879|NCT00688753|564336481|FG000|Overall Study|Disease progression|55|||
156337880|NCT00688753|564336481|FG000|Overall Study|Missing|1|||
156337881|NCT00688753|564336481|FG000|Overall Study|Death|9|||
156337882|NCT00688753|564336481|FG000|Overall Study|Withdrawal by Subject|3|||
156337883|NCT00688753|564336481|FG000|Overall Study|Adverse Event|20|||
156337884|NCT00688753|564336481|FG000|Overall Study|Protocol Violation|1|||
156337885|NCT00688753|564336481|FG000|Overall Study|Lost to Follow-up|3|||
156337886|NCT05996718|564336483|FG000|Overall Study|Lost to Follow-up|3|||
156337887|NCT01713686|564336484|FG000|Overall Study|Lost to Follow-up|9|||
156459412|NCT05671653|564778383|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
156459413|NCT05671653|564778384|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156337888|NCT01713686|564336484|FG000|Overall Study|Withdrawal by Subject|6|||
156337889|NCT03187197|564336485|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
156337890|NCT03187197|564336486|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
156337891|NCT03187197|564336487|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
156337892|NCT03187197|564336485|FG000|Overall Study|Withdrawal by Subject|8|||
156337893|NCT03187197|564336486|FG001|Overall Study|Withdrawal by Subject|63|||
156337894|NCT03187197|564336487|FG002|Overall Study|Withdrawal by Subject|4|||
156337895|NCT03187197|564336485|FG000|Overall Study|Lost to Follow-up|1|||
156337896|NCT03187197|564336486|FG001|Overall Study|Lost to Follow-up|60|||
156337897|NCT03187197|564336487|FG002|Overall Study|Lost to Follow-up|7|||
156337898|NCT03187197|564336485|FG000|Overall Study|Adverse Event|6|||
156337899|NCT03187197|564336486|FG001|Overall Study|Adverse Event|29|||
156337900|NCT03187197|564336487|FG002|Overall Study|Adverse Event|0|||
156337901|NCT03187197|564336485|FG000|Overall Study|Death|0|||
156337902|NCT03187197|564336486|FG001|Overall Study|Death|11|||
156337903|NCT03187197|564336487|FG002|Overall Study|Death|0|||
156337904|NCT03187197|564336485|FG000|Overall Study|Administrative problem|1|||
156337905|NCT03187197|564336486|FG001|Overall Study|Administrative problem|1|||
156459414|NCT05671653|564778385|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156459415|NCT05671653|564778386|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156459416|NCT05671653|564778387|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156459417|NCT05671653|564778388|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156459418|NCT05671653|564778389|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156459419|NCT05671653|564778390|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156806295|NCT03958331|566045548|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
156806296|NCT01991483|566045549|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
156806297|NCT01991483|566045550|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
156806298|NCT01991483|566045551|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
156806299|NCT01991483|566045552|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
156806300|NCT01991483|566045549|FG000|Dose Level 600 mg|Physician Decision|0|||
156806301|NCT01991483|566045550|FG001|Dose Level 600 mg|Physician Decision|0|||
156806302|NCT01991483|566045551|FG002|Dose Level 600 mg|Physician Decision|1|||
156806303|NCT01991483|566045552|FG003|Dose Level 600 mg|Physician Decision|0|||
156806304|NCT01991483|566045549|FG000|Dose Level 1000 mg|Protocol Violation|0|||
156806305|NCT01991483|566045550|FG001|Dose Level 1000 mg|Protocol Violation|0|||
156806306|NCT01991483|566045551|FG002|Dose Level 1000 mg|Protocol Violation|0|||
156806307|NCT01991483|566045552|FG003|Dose Level 1000 mg|Protocol Violation|1|||
156806308|NCT02030821|566045555|FG000|Overall Study|Physician Decision|2|||
156806309|NCT02030821|566045556|FG001|Overall Study|Physician Decision|2|||
156806310|NCT02030821|566045557|FG002|Overall Study|Physician Decision|5|||
156806311|NCT02030821|566045558|FG003|Overall Study|Physician Decision|2|||
156806312|NCT00543985|566045572|FG000|Overall Study|Withdrawal by Subject|4|||
156806313|NCT01634152|566045573|FG000|Overall Study|Adverse Event|2|||
156806314|NCT01634152|566045574|FG001|Overall Study|Adverse Event|0|||
156806315|NCT01634152|566045575|FG002|Overall Study|Adverse Event|2|||
156806316|NCT01634152|566045573|FG000|Overall Study|Consent withdrawn not due to AE|1|||
156806317|NCT01634152|566045574|FG001|Overall Study|Consent withdrawn not due to AE|0|||
156806318|NCT01634152|566045575|FG002|Overall Study|Consent withdrawn not due to AE|1|||
156806319|NCT01634152|566045573|FG000|Overall Study|Not treated|0|||
156806320|NCT01634152|566045574|FG001|Overall Study|Not treated|1|||
156806321|NCT01634152|566045575|FG002|Overall Study|Not treated|0|||
156806322|NCT01634152|566045573|FG000|Overall Study|Other reason not defined above|1|||
156806323|NCT01634152|566045574|FG001|Overall Study|Other reason not defined above|0|||
156806324|NCT01634152|566045575|FG002|Overall Study|Other reason not defined above|1|||
156806325|NCT01900665|566045576|FG000|Placebo Controlled Period|Death|9|||
156806326|NCT01900665|566045577|FG001|Placebo Controlled Period|Death|16|||
156806327|NCT01900665|566045576|FG000|Placebo Controlled Period|Adverse Event|48|||
156806328|NCT01900665|566045577|FG001|Placebo Controlled Period|Adverse Event|39|||
156806329|NCT01900665|566045576|FG000|Placebo Controlled Period|Protocol Violation|1|||
156806330|NCT01900665|566045577|FG001|Placebo Controlled Period|Protocol Violation|7|||
156806331|NCT01900665|566045576|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
156806332|NCT01900665|566045577|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
156806333|NCT01900665|566045576|FG000|Placebo Controlled Period|Physician Decision|11|||
156806334|NCT01900665|566045577|FG001|Placebo Controlled Period|Physician Decision|7|||
156806335|NCT01900665|566045576|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
156806336|NCT01900665|566045577|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
156806337|NCT01900665|566045576|FG000|Placebo Controlled Period|Caregiver Decision|33|||
156806338|NCT01900665|566045577|FG001|Placebo Controlled Period|Caregiver Decision|41|||
156806339|NCT01900665|566045576|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
156806340|NCT01900665|566045577|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
156806341|NCT01900665|566045576|FG000|Open Label Period|Adverse Event|16|||
156806342|NCT01900665|566045577|FG001|Open Label Period|Adverse Event|20|||
156806343|NCT01900665|566045576|FG000|Open Label Period|Death|5|||
156806344|NCT01900665|566045577|FG001|Open Label Period|Death|6|||
156806345|NCT01900665|566045576|FG000|Open Label Period|Lost to Follow-up|1|||
156806346|NCT01900665|566045577|FG001|Open Label Period|Lost to Follow-up|1|||
156806347|NCT01900665|566045576|FG000|Open Label Period|Parent/Caregiver Decision|33|||
156806348|NCT01900665|566045577|FG001|Open Label Period|Parent/Caregiver Decision|34|||
156806349|NCT01900665|566045576|FG000|Open Label Period|Physician Decision|4|||
156806350|NCT01900665|566045577|FG001|Open Label Period|Physician Decision|4|||
156806351|NCT01900665|566045576|FG000|Open Label Period|Protocol Violation|0|||
156806352|NCT01900665|566045577|FG001|Open Label Period|Protocol Violation|1|||
156806353|NCT01900665|566045576|FG000|Open Label Period|Sponsor Decision|802|||
156806354|NCT01900665|566045577|FG001|Open Label Period|Sponsor Decision|765|||
156806355|NCT01900665|566045576|FG000|Open Label Period|Withdrawal by Subject|20|||
156806356|NCT01900665|566045577|FG001|Open Label Period|Withdrawal by Subject|28|||
156806357|NCT04749914|566045579|FG000|Period 1|Adverse Event|1|||
156806358|NCT04749914|566045580|FG001|Period 1|Adverse Event|0|||
156459420|NCT05671653|564778378|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459421|NCT05671653|564778379|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156537184|NCT00467779|565061099|FG004|Stage 1A|Adverse Event|0|||
156806359|NCT04749914|566045581|FG002|Period 1|Adverse Event|0|||
156806360|NCT04749914|566045582|FG003|Period 1|Adverse Event|0|||
156806361|NCT04749914|566045579|FG000|Period 1|Withdrawal by Subject|1|||
156806362|NCT04749914|566045580|FG001|Period 1|Withdrawal by Subject|0|||
156806363|NCT04749914|566045581|FG002|Period 1|Withdrawal by Subject|1|||
156806364|NCT04749914|566045582|FG003|Period 1|Withdrawal by Subject|0|||
156806365|NCT04046939|566045583|FG000|Primary Assessment Period|Adverse Event|1|||
156806366|NCT04046939|566045584|FG001|Primary Assessment Period|Adverse Event|0|||
156806367|NCT04046939|566045585|FG002|Primary Assessment Period|Adverse Event|0|||
156806368|NCT04046939|566045586|FG003|Primary Assessment Period|Adverse Event|0|||
156806369|NCT04046939|566045583|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
156806370|NCT04046939|566045584|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
156806371|NCT04046939|566045585|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
156806372|NCT04046939|566045586|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
156806373|NCT04046939|566045583|FG000|Primary Assessment Period|Physician Decision|0|||
156806374|NCT04046939|566045584|FG001|Primary Assessment Period|Physician Decision|0|||
156806375|NCT04046939|566045585|FG002|Primary Assessment Period|Physician Decision|1|||
156806376|NCT04046939|566045586|FG003|Primary Assessment Period|Physician Decision|0|||
156806377|NCT04046939|566045583|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
156806378|NCT04046939|566045584|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
156459422|NCT05671653|564778380|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156806379|NCT04046939|566045585|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
156806380|NCT04046939|566045586|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
156806381|NCT01897532|566045588|FG000|Discontinuation From Treatment|Not Treated|7|||
156806382|NCT01897532|566045589|FG001|Discontinuation From Treatment|Not Treated|5|||
156806383|NCT01897532|566045588|FG000|Discontinuation From Treatment|Other reason than specified|196|||
156806384|NCT01897532|566045589|FG001|Discontinuation From Treatment|Other reason than specified|176|||
156806385|NCT01897532|566045588|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
156806386|NCT01897532|566045589|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
156806387|NCT01897532|566045588|FG000|Discontinuation From Treatment|Non compliance|24|||
156806388|NCT01897532|566045589|FG001|Discontinuation From Treatment|Non compliance|15|||
156459423|NCT05671653|564778381|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459424|NCT05671653|564778382|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459425|NCT05671653|564778383|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
156806389|NCT01897532|566045588|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
156806390|NCT01897532|566045589|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
156806391|NCT01897532|566045588|FG000|Discontinuation From Trial|Not Treated|7|||
156806392|NCT01897532|566045589|FG001|Discontinuation From Trial|Not Treated|5|||
156806393|NCT01897532|566045588|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
156806394|NCT01897532|566045589|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
156806395|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
156806396|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
156806397|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
156806398|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
156806399|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
156806400|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
156806401|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
156806402|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
156806403|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
156806404|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
156806405|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
156806406|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
156806407|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
156806408|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
156806409|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
156806410|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
156806411|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
156806412|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
156806413|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
156806414|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
156806415|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
156806416|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
156806417|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
156806418|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
156806419|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
156806420|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
156806421|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
156806422|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
156806423|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
156806424|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
156806425|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
156806426|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
156806427|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
156806428|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
156806429|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
156806430|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
156806431|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
156806432|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
156806433|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
156806434|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
156806435|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
156806436|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
156806437|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
156806438|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
156806439|NCT01214837|566045600|FG000|Overall Study|Death|0|||
156806440|NCT01214837|566045601|FG001|Overall Study|Death|0|||
156537185|NCT00467779|565061100|FG005|Stage 1A|Adverse Event|0|||
156337906|NCT03187197|564336487|FG002|Overall Study|Administrative problem|0|||
156337907|NCT03187197|564336485|FG000|Overall Study|Reason not listed|2|||
156337908|NCT03187197|564336486|FG001|Overall Study|Reason not listed|54|||
156337909|NCT03187197|564336487|FG002|Overall Study|Reason not listed|1|||
156337910|NCT03187197|564336485|FG000|Overall Study|Missing|1|||
156337911|NCT03187197|564336486|FG001|Overall Study|Missing|32|||
156337912|NCT03187197|564336487|FG002|Overall Study|Missing|3|||
156337913|NCT03187197|564336485|FG000|Overall Study|Status missing|2|||
156337914|NCT03187197|564336486|FG001|Overall Study|Status missing|33|||
156337915|NCT03187197|564336487|FG002|Overall Study|Status missing|3|||
156459426|NCT05671653|564778384|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459427|NCT05671653|564778385|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459428|NCT05671653|564778386|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459429|NCT05671653|564778387|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459430|NCT05671653|564778388|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459431|NCT05671653|564778389|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459432|NCT05671653|564778390|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
156459433|NCT05671653|564778378|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459434|NCT05671653|564778379|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459435|NCT05671653|564778380|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459436|NCT05671653|564778381|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459437|NCT05671653|564778382|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459438|NCT05671653|564778383|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459439|NCT05671653|564778384|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459440|NCT05671653|564778385|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459441|NCT05671653|564778386|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
156459442|NCT05671653|564778387|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459443|NCT05671653|564778388|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459444|NCT05671653|564778389|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459445|NCT05671653|564778390|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
156459446|NCT05671653|564778378|FG000|Cohort 2 Period 2|Adverse Event|0|||
156459447|NCT05671653|564778379|FG001|Cohort 2 Period 2|Adverse Event|0|||
156806441|NCT01214837|566045602|FG002|Overall Study|Death|1|||
156806442|NCT01214837|566045600|FG000|Overall Study|Adverse Event|1|||
156806443|NCT01214837|566045601|FG001|Overall Study|Adverse Event|2|||
156806444|NCT01214837|566045602|FG002|Overall Study|Adverse Event|1|||
156806445|NCT01214837|566045600|FG000|Overall Study|Withdrawal by Subject|27|||
156806446|NCT01214837|566045601|FG001|Overall Study|Withdrawal by Subject|36|||
156806447|NCT01214837|566045602|FG002|Overall Study|Withdrawal by Subject|28|||
156806448|NCT01214837|566045600|FG000|Overall Study|Lost to Follow-up|20|||
156806449|NCT01214837|566045601|FG001|Overall Study|Lost to Follow-up|15|||
156806450|NCT01214837|566045602|FG002|Overall Study|Lost to Follow-up|21|||
156806451|NCT01214837|566045600|FG000|Overall Study|Inappropriate Enrolment|0|||
156806452|NCT01214837|566045601|FG001|Overall Study|Inappropriate Enrolment|1|||
156806453|NCT01214837|566045602|FG002|Overall Study|Inappropriate Enrolment|2|||
156806454|NCT01214837|566045600|FG000|Overall Study|Administrative Reason|2|||
156806455|NCT01214837|566045601|FG001|Overall Study|Administrative Reason|6|||
156806456|NCT01214837|566045602|FG002|Overall Study|Administrative Reason|4|||
156806457|NCT01214837|566045600|FG000|Overall Study|Protocol Violation|3|||
156806458|NCT01214837|566045601|FG001|Overall Study|Protocol Violation|1|||
156806459|NCT01214837|566045602|FG002|Overall Study|Protocol Violation|5|||
156806460|NCT01214837|566045600|FG000|Overall Study|Unable to Classify|1|||
156806461|NCT01214837|566045601|FG001|Overall Study|Unable to Classify|3|||
156806462|NCT01214837|566045602|FG002|Overall Study|Unable to Classify|0|||
156806463|NCT05414175|566045603|FG000|Overall Study|Withdrawal by Subject|1|||
156806464|NCT05414175|566045603|FG000|Overall Study|Other Reasons|1|||
156806465|NCT00027560|566045604|FG000|Overall Study|Withdrawal by Subject|1|||
156806466|NCT03559270|566045606|FG000|Overall Study|Adverse Event|6|||
156806467|NCT03559270|566045607|FG001|Overall Study|Adverse Event|5|||
156806468|NCT03559270|566045608|FG002|Overall Study|Adverse Event|3|||
156806469|NCT03559270|566045609|FG003|Overall Study|Adverse Event|0|||
156806470|NCT03559270|566045606|FG000|Overall Study|Lack of Efficacy|34|||
156806471|NCT03559270|566045607|FG001|Overall Study|Lack of Efficacy|52|||
156806472|NCT03559270|566045608|FG002|Overall Study|Lack of Efficacy|37|||
156806473|NCT03559270|566045609|FG003|Overall Study|Lack of Efficacy|2|||
156806474|NCT03559270|566045606|FG000|Overall Study|Death|0|||
156459448|NCT05671653|564778380|FG002|Cohort 2 Period 2|Adverse Event|0|||
156459449|NCT05671653|564778381|FG003|Cohort 2 Period 2|Adverse Event|0|||
156459450|NCT05671653|564778382|FG004|Cohort 2 Period 2|Adverse Event|0|||
156806475|NCT03559270|566045607|FG001|Overall Study|Death|2|||
156806476|NCT03559270|566045608|FG002|Overall Study|Death|0|||
156806477|NCT03559270|566045609|FG003|Overall Study|Death|0|||
156806478|NCT03559270|566045606|FG000|Overall Study|Lost to Follow-up|16|||
156337916|NCT03187197|564336485|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
156806479|NCT03559270|566045607|FG001|Overall Study|Lost to Follow-up|4|||
156806480|NCT03559270|566045608|FG002|Overall Study|Lost to Follow-up|12|||
156806481|NCT03559270|566045609|FG003|Overall Study|Lost to Follow-up|3|||
156806482|NCT03559270|566045606|FG000|Overall Study|Sponsor Decision|38|||
156806483|NCT03559270|566045607|FG001|Overall Study|Sponsor Decision|31|||
156806484|NCT03559270|566045608|FG002|Overall Study|Sponsor Decision|35|||
156806485|NCT03559270|566045609|FG003|Overall Study|Sponsor Decision|18|||
156806486|NCT03559270|566045606|FG000|Overall Study|Withdrawal by Subject|19|||
156806487|NCT03559270|566045607|FG001|Overall Study|Withdrawal by Subject|21|||
156806488|NCT03559270|566045608|FG002|Overall Study|Withdrawal by Subject|18|||
156806489|NCT03559270|566045609|FG003|Overall Study|Withdrawal by Subject|7|||
156806490|NCT03559270|566045606|FG000|Overall Study|Physician Decision|3|||
156806491|NCT03559270|566045607|FG001|Overall Study|Physician Decision|2|||
156806492|NCT03559270|566045608|FG002|Overall Study|Physician Decision|1|||
156806493|NCT03559270|566045609|FG003|Overall Study|Physician Decision|0|||
156806494|NCT03559270|566045606|FG000|Overall Study|Pregnancy|0|||
156806495|NCT03559270|566045607|FG001|Overall Study|Pregnancy|1|||
156806496|NCT03559270|566045608|FG002|Overall Study|Pregnancy|0|||
156806497|NCT03559270|566045609|FG003|Overall Study|Pregnancy|0|||
156806498|NCT03559270|566045606|FG000|Overall Study|Protocol Violation|1|||
156806499|NCT03559270|566045607|FG001|Overall Study|Protocol Violation|0|||
156806500|NCT03559270|566045608|FG002|Overall Study|Protocol Violation|2|||
156806501|NCT03559270|566045609|FG003|Overall Study|Protocol Violation|0|||
156806502|NCT00810277|566047434|FG000|Overall Study|Adverse Event|1|||
156806503|NCT00678288|566047441|FG000|Overall Study|Adverse Event|0|||
156806504|NCT00678288|566047442|FG001|Overall Study|Adverse Event|2|||
156806505|NCT00678288|566047441|FG000|Overall Study|Withdrawal by Subject|1|||
156806506|NCT00678288|566047442|FG001|Overall Study|Withdrawal by Subject|1|||
156806507|NCT00678288|566047441|FG000|Overall Study|Study terminated by the sponsor|2|||
156806508|NCT00678288|566047442|FG001|Overall Study|Study terminated by the sponsor|0|||
156806509|NCT00678288|566047441|FG000|Overall Study|Not compliant with study medication|0|||
156806510|NCT00678288|566047442|FG001|Overall Study|Not compliant with study medication|1|||
156806511|NCT00678288|566047441|FG000|Overall Study|Switch to commercial drug|0|||
156806512|NCT00678288|566047442|FG001|Overall Study|Switch to commercial drug|1|||
156806513|NCT00678288|566047441|FG000|Overall Study|Reason not reported|1|||
156806514|NCT00678288|566047442|FG001|Overall Study|Reason not reported|0|||
156806515|NCT00678288|566047441|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
156806516|NCT00678288|566047442|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
156806517|NCT04472650|566047453|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
156806518|NCT04472650|566047454|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
156806519|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
156806520|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806521|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806522|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806523|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806524|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806525|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806526|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806527|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806528|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806529|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
156806530|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
156806531|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806532|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806533|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156459451|NCT05671653|564778383|FG005|Cohort 2 Period 2|Adverse Event|0|||
156459452|NCT05671653|564778384|FG006|Cohort 2 Period 2|Adverse Event|0|||
156459453|NCT05671653|564778385|FG007|Cohort 2 Period 2|Adverse Event|0|||
156459454|NCT05671653|564778386|FG008|Cohort 2 Period 2|Adverse Event|0|||
156459455|NCT05671653|564778387|FG009|Cohort 2 Period 2|Adverse Event|0|||
156459456|NCT05671653|564778388|FG010|Cohort 2 Period 2|Adverse Event|1|||
156459457|NCT05671653|564778389|FG011|Cohort 2 Period 2|Adverse Event|0|||
156459458|NCT05671653|564778390|FG012|Cohort 2 Period 2|Adverse Event|0|||
156459459|NCT05671653|564778378|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
156459460|NCT05671653|564778379|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
156459461|NCT05671653|564778380|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
156459462|NCT05671653|564778381|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
156459463|NCT05671653|564778382|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
156459464|NCT05671653|564778383|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
156459465|NCT05671653|564778384|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
156459466|NCT05671653|564778385|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
156459467|NCT05671653|564778386|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
156459468|NCT05671653|564778387|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
156459469|NCT05671653|564778388|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
156459470|NCT05671653|564778389|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
156459471|NCT05671653|564778390|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
156459472|NCT05671653|564778378|FG000|Cohort 2 Period 2|Pregnancy|0|||
156459473|NCT05671653|564778379|FG001|Cohort 2 Period 2|Pregnancy|0|||
156459474|NCT05671653|564778380|FG002|Cohort 2 Period 2|Pregnancy|0|||
156459475|NCT05671653|564778381|FG003|Cohort 2 Period 2|Pregnancy|0|||
156459476|NCT05671653|564778382|FG004|Cohort 2 Period 2|Pregnancy|0|||
156459477|NCT05671653|564778383|FG005|Cohort 2 Period 2|Pregnancy|0|||
156459478|NCT05671653|564778384|FG006|Cohort 2 Period 2|Pregnancy|0|||
156459479|NCT05671653|564778385|FG007|Cohort 2 Period 2|Pregnancy|0|||
156459480|NCT05671653|564778386|FG008|Cohort 2 Period 2|Pregnancy|0|||
156459481|NCT05671653|564778387|FG009|Cohort 2 Period 2|Pregnancy|0|||
156459482|NCT05671653|564778388|FG010|Cohort 2 Period 2|Pregnancy|1|||
156459483|NCT05671653|564778389|FG011|Cohort 2 Period 2|Pregnancy|0|||
156459484|NCT05671653|564778390|FG012|Cohort 2 Period 2|Pregnancy|0|||
156459485|NCT05671653|564778378|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459486|NCT05671653|564778379|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459487|NCT05671653|564778380|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459488|NCT05671653|564778381|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459489|NCT05671653|564778382|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459490|NCT05671653|564778383|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459491|NCT05671653|564778384|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459492|NCT05671653|564778385|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459493|NCT05671653|564778386|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459494|NCT05671653|564778387|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459495|NCT05671653|564778388|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
156459496|NCT05671653|564778389|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459497|NCT05671653|564778390|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
156459498|NCT05671653|564778378|FG000|Cohort 2 Period 2|Other|0|||
156806534|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806535|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806536|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806537|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
156806538|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
156806539|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
156806540|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806541|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806542|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806543|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806544|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806545|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806546|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
156806547|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
156806548|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
156806549|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806550|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806551|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806552|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806553|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806554|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806555|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
156806556|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
156806557|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
156806558|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806559|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806560|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806561|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806562|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806563|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806564|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806565|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156459499|NCT05671653|564778379|FG001|Cohort 2 Period 2|Other|0|||
156459500|NCT05671653|564778380|FG002|Cohort 2 Period 2|Other|0|||
156459501|NCT05671653|564778381|FG003|Cohort 2 Period 2|Other|0|||
156459502|NCT05671653|564778382|FG004|Cohort 2 Period 2|Other|0|||
156459503|NCT05671653|564778383|FG005|Cohort 2 Period 2|Other|0|||
156459504|NCT05671653|564778384|FG006|Cohort 2 Period 2|Other|0|||
156459505|NCT05671653|564778385|FG007|Cohort 2 Period 2|Other|0|||
156459506|NCT05671653|564778386|FG008|Cohort 2 Period 2|Other|0|||
156459507|NCT05671653|564778387|FG009|Cohort 2 Period 2|Other|0|||
156459508|NCT05671653|564778388|FG010|Cohort 2 Period 2|Other|1|||
156459509|NCT05671653|564778389|FG011|Cohort 2 Period 2|Other|0|||
156459510|NCT05671653|564778390|FG012|Cohort 2 Period 2|Other|0|||
156459511|NCT05671653|564778378|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459512|NCT05671653|564778379|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459513|NCT05671653|564778380|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459514|NCT05671653|564778381|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459515|NCT05671653|564778382|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459516|NCT05671653|564778383|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459517|NCT05671653|564778384|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459518|NCT05671653|564778385|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459519|NCT05671653|564778386|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459520|NCT05671653|564778387|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459521|NCT05671653|564778388|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459522|NCT05671653|564778389|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
156459523|NCT05671653|564778390|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
156459524|NCT01197378|564778394|FG000|Overall Study|Adverse Event|3|||
156459525|NCT01197378|564778394|FG000|Overall Study|Withdrawal by Subject|1|||
156459526|NCT01197378|564778394|FG000|Overall Study|Physician Decision|1|||
156459527|NCT01197378|564778394|FG000|Overall Study|Other|2|||
156459528|NCT05274074|564778412|FG000|Overall Study|Lost to Follow-up|2|||
156459529|NCT05274074|564778413|FG001|Overall Study|Lost to Follow-up|3|||
156459530|NCT05274074|564778412|FG000|Overall Study|Withdrawal by Subject|1|||
156459531|NCT05274074|564778413|FG001|Overall Study|Withdrawal by Subject|2|||
156459532|NCT04117347|564778414|FG000|Overall Study|Adverse Event|0|||
156459533|NCT04117347|564778415|FG001|Overall Study|Adverse Event|0|||
156459534|NCT04117347|564778416|FG002|Overall Study|Adverse Event|1|||
156459535|NCT04117347|564778414|FG000|Overall Study|No time for study|0|||
156459536|NCT04117347|564778415|FG001|Overall Study|No time for study|2|||
156459537|NCT04117347|564778416|FG002|Overall Study|No time for study|0|||
156459538|NCT04117347|564778414|FG000|Overall Study|Family emergency|1|||
156459539|NCT04117347|564778415|FG001|Overall Study|Family emergency|0|||
156459540|NCT04117347|564778416|FG002|Overall Study|Family emergency|0|||
156459541|NCT03687086|564778417|FG000|Overall Study|Withdrawal by Subject|3|||
156459542|NCT03687086|564778418|FG001|Overall Study|Withdrawal by Subject|4|||
156459543|NCT03687086|564778417|FG000|Overall Study|Lost to Follow-up|1|||
156459544|NCT03687086|564778418|FG001|Overall Study|Lost to Follow-up|1|||
156459545|NCT03687086|564778417|FG000|Overall Study|Death|1|||
156459546|NCT03687086|564778418|FG001|Overall Study|Death|0|||
156459547|NCT03687086|564778417|FG000|Overall Study|Incomplete assessment|0|||
156459548|NCT03687086|564778418|FG001|Overall Study|Incomplete assessment|2|||
156459549|NCT05194956|564778419|FG000|Washout Period|Withdrawal by Subject|0|||
156459550|NCT05194956|564778420|FG001|Washout Period|Withdrawal by Subject|2|||
156459551|NCT02593773|564778421|FG000|Overall Study|Voluntary Withdrawal|3|||
156459552|NCT02593773|564778421|FG000|Overall Study|Study Terminated by Sponsor|31|||
156459553|NCT02593773|564778421|FG000|Overall Study|Death|1|||
156459554|NCT04294641|564778422|FG000|Overall Study|Screen failure|4|||
156459555|NCT01627574|564778423|FG000|Overall Study|Withdrawal by Subject|8|||
156459556|NCT01627574|564778424|FG001|Overall Study|Withdrawal by Subject|5|||
156459557|NCT01627574|564778423|FG000|Overall Study|Lost to Follow-up|13|||
156459558|NCT01627574|564778424|FG001|Overall Study|Lost to Follow-up|13|||
156459559|NCT04314778|564778436|FG000|Overall Study|Lost to Follow-up|5|||
156459560|NCT04314778|564778437|FG001|Overall Study|Lost to Follow-up|3|||
156459561|NCT05646355|564778438|FG000|Overall Study|Lost to Follow-up|1|||
156459562|NCT05646355|564778439|FG001|Overall Study|Lost to Follow-up|0|||
156459563|NCT05646355|564778438|FG000|Overall Study|translated materials not available for pilot|2|||
156459564|NCT05646355|564778439|FG001|Overall Study|translated materials not available for pilot|0|||
156459565|NCT05646355|564778438|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
156459566|NCT05646355|564778439|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
156459567|NCT04685135|564778440|FG000|Overall Study|Death|126|||
156459568|NCT04685135|564778441|FG001|Overall Study|Death|53|||
156459569|NCT04685135|564778440|FG000|Overall Study|Withdrawal by Subject|12|||
156459570|NCT04685135|564778441|FG001|Overall Study|Withdrawal by Subject|16|||
156459571|NCT05868382|564778444|FG000|Overall Study|Lost to Follow-up|5|||
156459572|NCT05868382|564778445|FG001|Overall Study|Lost to Follow-up|0|||
156459573|NCT05868382|564778446|FG002|Overall Study|Lost to Follow-up|6|||
156459574|NCT05868382|564778447|FG003|Overall Study|Lost to Follow-up|4|||
156459575|NCT05868382|564778448|FG004|Overall Study|Lost to Follow-up|2|||
156459576|NCT05868382|564778449|FG005|Overall Study|Lost to Follow-up|6|||
156459577|NCT05868382|564778444|FG000|Overall Study|Withdrawal by Subject|1|||
156537186|NCT00467779|565061101|FG006|Stage 1A|Adverse Event|0|||
156537187|NCT00467779|565061102|FG007|Stage 1A|Adverse Event|0|||
156537188|NCT00467779|565061103|FG008|Stage 1A|Adverse Event|0|||
156537189|NCT00467779|565061104|FG009|Stage 1A|Adverse Event|0|||
156537190|NCT00467779|565061105|FG010|Stage 1A|Adverse Event|0|||
156537191|NCT00467779|565061106|FG011|Stage 1A|Adverse Event|0|||
156537192|NCT00467779|565061107|FG012|Stage 1A|Adverse Event|1|||
156537193|NCT00467779|565061108|FG013|Stage 1A|Adverse Event|0|||
156537194|NCT00467779|565061109|FG014|Stage 1A|Adverse Event|0|||
156537195|NCT00467779|565061095|FG000|Stage 1A|Death|0|||
156537196|NCT00467779|565061096|FG001|Stage 1A|Death|0|||
156537197|NCT00467779|565061097|FG002|Stage 1A|Death|0|||
156537198|NCT00467779|565061098|FG003|Stage 1A|Death|0|||
156537199|NCT00467779|565061099|FG004|Stage 1A|Death|0|||
156537200|NCT00467779|565061100|FG005|Stage 1A|Death|0|||
156537201|NCT00467779|565061101|FG006|Stage 1A|Death|0|||
156537202|NCT00467779|565061102|FG007|Stage 1A|Death|0|||
156537203|NCT00467779|565061103|FG008|Stage 1A|Death|0|||
156537204|NCT00467779|565061104|FG009|Stage 1A|Death|0|||
156537205|NCT00467779|565061105|FG010|Stage 1A|Death|0|||
156537206|NCT00467779|565061106|FG011|Stage 1A|Death|1|||
156537207|NCT00467779|565061107|FG012|Stage 1A|Death|1|||
156537208|NCT00467779|565061108|FG013|Stage 1A|Death|0|||
156537209|NCT00467779|565061109|FG014|Stage 1A|Death|0|||
156537210|NCT00467779|565061095|FG000|Stage 1A|Disease Progression|0|||
156537211|NCT00467779|565061096|FG001|Stage 1A|Disease Progression|0|||
156537212|NCT00467779|565061097|FG002|Stage 1A|Disease Progression|0|||
156537213|NCT00467779|565061098|FG003|Stage 1A|Disease Progression|0|||
156537214|NCT00467779|565061099|FG004|Stage 1A|Disease Progression|0|||
156537215|NCT00467779|565061100|FG005|Stage 1A|Disease Progression|0|||
156806566|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156459578|NCT05868382|564778445|FG001|Overall Study|Withdrawal by Subject|0|||
156459579|NCT05868382|564778446|FG002|Overall Study|Withdrawal by Subject|0|||
156806567|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
156806568|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806569|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156337917|NCT03187197|564336486|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
156337918|NCT03187197|564336487|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
156459580|NCT05868382|564778447|FG003|Overall Study|Withdrawal by Subject|0|||
156537216|NCT00467779|565061101|FG006|Stage 1A|Disease Progression|0|||
156537217|NCT00467779|565061102|FG007|Stage 1A|Disease Progression|0|||
156537218|NCT00467779|565061103|FG008|Stage 1A|Disease Progression|0|||
156537219|NCT00467779|565061104|FG009|Stage 1A|Disease Progression|2|||
156537220|NCT00467779|565061105|FG010|Stage 1A|Disease Progression|2|||
156537221|NCT00467779|565061106|FG011|Stage 1A|Disease Progression|5|||
156537222|NCT00467779|565061107|FG012|Stage 1A|Disease Progression|2|||
156537223|NCT00467779|565061108|FG013|Stage 1A|Disease Progression|0|||
156537224|NCT00467779|565061109|FG014|Stage 1A|Disease Progression|0|||
156537225|NCT00467779|565061095|FG000|Stage 1A|Physician Decision|0|||
156537226|NCT00467779|565061096|FG001|Stage 1A|Physician Decision|0|||
156537227|NCT00467779|565061097|FG002|Stage 1A|Physician Decision|0|||
156537228|NCT00467779|565061098|FG003|Stage 1A|Physician Decision|0|||
156537229|NCT00467779|565061099|FG004|Stage 1A|Physician Decision|0|||
156537230|NCT00467779|565061100|FG005|Stage 1A|Physician Decision|0|||
156537231|NCT00467779|565061101|FG006|Stage 1A|Physician Decision|0|||
156537232|NCT00467779|565061102|FG007|Stage 1A|Physician Decision|0|||
156537233|NCT00467779|565061103|FG008|Stage 1A|Physician Decision|0|||
156537234|NCT00467779|565061104|FG009|Stage 1A|Physician Decision|1|||
156537235|NCT00467779|565061105|FG010|Stage 1A|Physician Decision|0|||
156537236|NCT00467779|565061106|FG011|Stage 1A|Physician Decision|0|||
156806570|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806571|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806572|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806573|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
156806574|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
156806575|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
156806576|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
156806577|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
156806578|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
156806579|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
156806580|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
156806581|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
156806582|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806583|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806584|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806585|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
156806586|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
156806587|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
156806588|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
156806589|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
156806590|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
156806591|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806592|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806593|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806594|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806595|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
156806596|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806597|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806598|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
156806599|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
156806600|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
156459581|NCT05868382|564778448|FG004|Overall Study|Withdrawal by Subject|1|||
156459582|NCT05868382|564778449|FG005|Overall Study|Withdrawal by Subject|0|||
156459583|NCT03513302|564778452|FG000|First Intervention (14 Days)|Screen failure|15|||
156459584|NCT03513302|564778453|FG001|First Intervention (14 Days)|Screen failure|16|||
156459585|NCT05256654|564778454|FG000|Overall Study|Adverse Event|0|||
156459586|NCT05256654|564778455|FG001|Overall Study|Adverse Event|0|||
156459587|NCT05256654|564778456|FG002|Overall Study|Adverse Event|1|||
156459588|NCT05256654|564778457|FG003|Overall Study|Adverse Event|0|||
156459589|NCT05256654|564778454|FG000|Overall Study|Lost to Follow-up|0|||
156459590|NCT05256654|564778455|FG001|Overall Study|Lost to Follow-up|0|||
156459591|NCT05256654|564778456|FG002|Overall Study|Lost to Follow-up|0|||
156459592|NCT05256654|564778457|FG003|Overall Study|Lost to Follow-up|1|||
156459593|NCT05256654|564778454|FG000|Overall Study|Withdrawal by Subject|1|||
156459594|NCT05256654|564778455|FG001|Overall Study|Withdrawal by Subject|2|||
156459595|NCT05256654|564778456|FG002|Overall Study|Withdrawal by Subject|1|||
156459596|NCT05256654|564778457|FG003|Overall Study|Withdrawal by Subject|3|||
156459597|NCT05256654|564778454|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
156459598|NCT05256654|564778455|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
156459599|NCT05256654|564778456|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
156459600|NCT05256654|564778457|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
156459601|NCT05256654|564778454|FG000|Overall Study|Other|0|||
156459602|NCT05256654|564778455|FG001|Overall Study|Other|0|||
156459603|NCT05256654|564778456|FG002|Overall Study|Other|0|||
156459604|NCT05256654|564778457|FG003|Overall Study|Other|1|||
156459605|NCT01309672|564778463|FG000|Overall Study|Lack of Efficacy|20|||
156459606|NCT01309672|564778463|FG000|Overall Study|Other|9|||
156459607|NCT01309672|564778463|FG000|Overall Study|Adverse Event|5|||
156459608|NCT01309672|564778463|FG000|Overall Study|Withdrawal by Subject|3|||
156459609|NCT01254864|564778464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
156459610|NCT01254864|564778465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
156459611|NCT01254864|564778466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
156459612|NCT01254864|564778464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
156459613|NCT01254864|564778465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
156459614|NCT01254864|564778466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
156537237|NCT00467779|565061107|FG012|Stage 1A|Physician Decision|0|||
156537238|NCT00467779|565061108|FG013|Stage 1A|Physician Decision|0|||
156459615|NCT01254864|564778464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
156459616|NCT01254864|564778465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
156459617|NCT01254864|564778466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
156459618|NCT01254864|564778464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
156459619|NCT01254864|564778465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
156459620|NCT01254864|564778466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
156459621|NCT01254864|564778464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
156806601|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
156806602|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
156806603|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
156806604|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
156806605|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
156806606|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
156806607|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
156806608|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
156806609|NCT01333722|566047466|FG000|Overall Study|Lack of Efficacy|0|||
156806610|NCT01333722|566047467|FG001|Overall Study|Lack of Efficacy|2|||
156806611|NCT01333722|566047466|FG000|Overall Study|Withdrawal by Subject|0|||
156806612|NCT01333722|566047467|FG001|Overall Study|Withdrawal by Subject|1|||
156806613|NCT02079909|566047468|FG000|Overall Study|Adverse Event|23|||
156806614|NCT02079909|566047469|FG001|Overall Study|Adverse Event|23|||
156806615|NCT02079909|566047470|FG002|Overall Study|Adverse Event|7|||
156806616|NCT02079909|566047468|FG000|Overall Study|Withdrawal by Subject|9|||
156806617|NCT02079909|566047469|FG001|Overall Study|Withdrawal by Subject|17|||
156806618|NCT02079909|566047470|FG002|Overall Study|Withdrawal by Subject|4|||
156806619|NCT02079909|566047468|FG000|Overall Study|Lost to Follow-up|2|||
156806620|NCT02079909|566047469|FG001|Overall Study|Lost to Follow-up|3|||
156806621|NCT02079909|566047470|FG002|Overall Study|Lost to Follow-up|1|||
156806622|NCT02079909|566047468|FG000|Overall Study|Death|2|||
156806623|NCT02079909|566047469|FG001|Overall Study|Death|2|||
156806624|NCT02079909|566047470|FG002|Overall Study|Death|0|||
156806625|NCT02079909|566047468|FG000|Overall Study|Lack of Efficacy|0|||
156806626|NCT02079909|566047469|FG001|Overall Study|Lack of Efficacy|0|||
156806627|NCT02079909|566047470|FG002|Overall Study|Lack of Efficacy|1|||
156806628|NCT02079909|566047468|FG000|Overall Study|Protocol Violation|0|||
156806629|NCT02079909|566047469|FG001|Overall Study|Protocol Violation|1|||
156806630|NCT02079909|566047470|FG002|Overall Study|Protocol Violation|1|||
156806631|NCT02079909|566047468|FG000|Overall Study|Physician Decision|0|||
156806632|NCT02079909|566047469|FG001|Overall Study|Physician Decision|1|||
156806633|NCT02079909|566047470|FG002|Overall Study|Physician Decision|1|||
156806634|NCT02079909|566047468|FG000|Overall Study|Relocation etc.|2|||
156806635|NCT02079909|566047469|FG001|Overall Study|Relocation etc.|2|||
156806636|NCT02079909|566047470|FG002|Overall Study|Relocation etc.|3|||
156806637|NCT00720356|566047475|FG000|Registration to Study|Determined to have methylated MGMT|67|||
156806638|NCT00720356|566047475|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
156806639|NCT00720356|566047475|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
156806640|NCT00720356|566047475|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
156806641|NCT00720356|566047475|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
156806642|NCT00720356|566047475|FG000|Follow up Until Death|Withdrawal by Subject|1|||
156806643|NCT00720356|566047475|FG000|Follow up Until Death|Alive at last data collection|4|||
156806644|NCT02237001|566047478|FG000|Overall Study|Lost to Follow-up|2|||
156806645|NCT02237001|566047478|FG000|Overall Study|Withdrawal by Subject|1|||
156806646|NCT02237001|566047478|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
156806647|NCT02237001|566047478|FG000|Overall Study|Re-operation|4|||
156337919|NCT02385045|564336488|FG000|Overall Study|Endoscopy could not be completed|4|||
156337920|NCT00115739|564336489|FG000|Overall Study|Lost to Follow-up|3|||
156459622|NCT01254864|564778465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
156459623|NCT01254864|564778466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
156459624|NCT01254864|564778464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
156459625|NCT01254864|564778465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
156459626|NCT01254864|564778466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
156459627|NCT01254864|564778464|FG000|Randomization Phase|Adverse Event|0|||
156459628|NCT01254864|564778465|FG001|Randomization Phase|Adverse Event|5|||
156459629|NCT01254864|564778466|FG002|Randomization Phase|Adverse Event|17|||
156459630|NCT01254864|564778464|FG000|Randomization Phase|Death|0|||
156459631|NCT01254864|564778465|FG001|Randomization Phase|Death|1|||
156459632|NCT01254864|564778466|FG002|Randomization Phase|Death|0|||
156459633|NCT01254864|564778464|FG000|Randomization Phase|Lost to Follow-up|0|||
156459634|NCT01254864|564778465|FG001|Randomization Phase|Lost to Follow-up|0|||
156459635|NCT01254864|564778466|FG002|Randomization Phase|Lost to Follow-up|1|||
156459636|NCT01254864|564778464|FG000|Randomization Phase|Physician Decision|0|||
156459637|NCT01254864|564778465|FG001|Randomization Phase|Physician Decision|20|||
156459638|NCT01254864|564778466|FG002|Randomization Phase|Physician Decision|25|||
156537239|NCT00467779|565061109|FG014|Stage 1A|Physician Decision|0|||
156537240|NCT00467779|565061095|FG000|Stage 1A|Withdrawal by Subject|0|||
156537241|NCT00467779|565061096|FG001|Stage 1A|Withdrawal by Subject|0|||
156459639|NCT01254864|564778464|FG000|Randomization Phase|Withdrawal by Subject|0|||
156459640|NCT01254864|564778465|FG001|Randomization Phase|Withdrawal by Subject|4|||
156459641|NCT01254864|564778466|FG002|Randomization Phase|Withdrawal by Subject|2|||
156459642|NCT01254864|564778464|FG000|Randomization Phase|Non-Compliance|0|||
156459643|NCT01254864|564778465|FG001|Randomization Phase|Non-Compliance|1|||
156459644|NCT01254864|564778466|FG002|Randomization Phase|Non-Compliance|0|||
156459645|NCT01254864|564778464|FG000|Randomization Phase|Comorbidities|0|||
156459646|NCT01254864|564778465|FG001|Randomization Phase|Comorbidities|2|||
156459647|NCT01254864|564778466|FG002|Randomization Phase|Comorbidities|1|||
156459648|NCT04141891|564778469|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
156459649|NCT04141891|564778470|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
156459650|NCT04141891|564778469|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
156459651|NCT04141891|564778470|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
156459652|NCT04141891|564778469|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
156459653|NCT04141891|564778470|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
156459654|NCT04141891|564778469|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
156459655|NCT04141891|564778470|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
156459656|NCT04141891|564778469|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
156459657|NCT04141891|564778470|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
156459658|NCT04141891|564778469|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
156459659|NCT04141891|564778470|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
156459660|NCT04141891|564778469|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
156459661|NCT04141891|564778470|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
156459662|NCT04141891|564778469|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
156459663|NCT04141891|564778470|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
156459664|NCT04141891|564778469|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
156459665|NCT04141891|564778470|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
156459666|NCT04141891|564778469|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
156459667|NCT04141891|564778470|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
156459668|NCT04141891|564778469|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
156459669|NCT04141891|564778470|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
156459670|NCT04141891|564778469|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
156459671|NCT04141891|564778470|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
156459672|NCT04141891|564778469|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
156459673|NCT04141891|564778470|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
156459674|NCT04141891|564778469|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
156459675|NCT04141891|564778470|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
156459676|NCT01828112|564778473|FG000|Treatment Phase|Adverse Event|7|||
156459677|NCT01828112|564778474|FG001|Treatment Phase|Adverse Event|8|||
156459678|NCT01828112|564778475|FG002|Treatment Phase|Adverse Event|0|||
156459679|NCT01828112|564778473|FG000|Treatment Phase|Death|9|||
156459680|NCT01828112|564778474|FG001|Treatment Phase|Death|5|||
156459681|NCT01828112|564778475|FG002|Treatment Phase|Death|0|||
156459682|NCT01828112|564778473|FG000|Treatment Phase|No longer required treatment|0|||
156459683|NCT01828112|564778474|FG001|Treatment Phase|No longer required treatment|1|||
156459684|NCT01828112|564778475|FG002|Treatment Phase|No longer required treatment|0|||
156459685|NCT01828112|564778473|FG000|Treatment Phase|Physician Decision|6|||
156459686|NCT01828112|564778474|FG001|Treatment Phase|Physician Decision|7|||
156459687|NCT01828112|564778475|FG002|Treatment Phase|Physician Decision|0|||
156459688|NCT01828112|564778473|FG000|Treatment Phase|Pregnancy|1|||
156459689|NCT01828112|564778474|FG001|Treatment Phase|Pregnancy|0|||
156537242|NCT00467779|565061097|FG002|Stage 1A|Withdrawal by Subject|0|||
156537243|NCT00467779|565061098|FG003|Stage 1A|Withdrawal by Subject|0|||
156537244|NCT00467779|565061099|FG004|Stage 1A|Withdrawal by Subject|0|||
156537245|NCT00467779|565061100|FG005|Stage 1A|Withdrawal by Subject|0|||
156537246|NCT00467779|565061101|FG006|Stage 1A|Withdrawal by Subject|0|||
156537247|NCT00467779|565061102|FG007|Stage 1A|Withdrawal by Subject|0|||
156537248|NCT00467779|565061103|FG008|Stage 1A|Withdrawal by Subject|0|||
156537249|NCT00467779|565061104|FG009|Stage 1A|Withdrawal by Subject|0|||
156537250|NCT00467779|565061105|FG010|Stage 1A|Withdrawal by Subject|1|||
156537251|NCT00467779|565061106|FG011|Stage 1A|Withdrawal by Subject|1|||
156537252|NCT00467779|565061107|FG012|Stage 1A|Withdrawal by Subject|1|||
156537253|NCT00467779|565061108|FG013|Stage 1A|Withdrawal by Subject|0|||
156537254|NCT00467779|565061109|FG014|Stage 1A|Withdrawal by Subject|0|||
156459690|NCT01828112|564778475|FG002|Treatment Phase|Pregnancy|0|||
156459691|NCT01828112|564778473|FG000|Treatment Phase|Progressive disease|79|||
156459692|NCT01828112|564778474|FG001|Treatment Phase|Progressive disease|87|||
156537255|NCT00467779|565061095|FG000|Stage 1A|Unspecified Reason|0|||
156537256|NCT00467779|565061096|FG001|Stage 1A|Unspecified Reason|0|||
156537257|NCT00467779|565061097|FG002|Stage 1A|Unspecified Reason|0|||
156459693|NCT01828112|564778475|FG002|Treatment Phase|Progressive disease|0|||
156459694|NCT01828112|564778473|FG000|Treatment Phase|Study terminated by sponsor|1|||
156459695|NCT01828112|564778474|FG001|Treatment Phase|Study terminated by sponsor|0|||
156459696|NCT01828112|564778475|FG002|Treatment Phase|Study terminated by sponsor|0|||
156459697|NCT01828112|564778473|FG000|Treatment Phase|Subject/guardian decision|12|||
156459698|NCT01828112|564778474|FG001|Treatment Phase|Subject/guardian decision|8|||
156459699|NCT01828112|564778475|FG002|Treatment Phase|Subject/guardian decision|0|||
156459700|NCT01828112|564778473|FG000|Extension Treatment Phase|Adverse Event|0|||
156459701|NCT01828112|564778474|FG001|Extension Treatment Phase|Adverse Event|0|||
156459702|NCT01828112|564778475|FG002|Extension Treatment Phase|Adverse Event|6|||
156459703|NCT01828112|564778473|FG000|Extension Treatment Phase|Death|0|||
156459704|NCT01828112|564778474|FG001|Extension Treatment Phase|Death|0|||
156459705|NCT01828112|564778475|FG002|Extension Treatment Phase|Death|17|||
156459706|NCT01828112|564778473|FG000|Extension Treatment Phase|Physician Decision|0|||
156459707|NCT01828112|564778474|FG001|Extension Treatment Phase|Physician Decision|0|||
156537258|NCT00467779|565061098|FG003|Stage 1A|Unspecified Reason|0|||
156537259|NCT00467779|565061099|FG004|Stage 1A|Unspecified Reason|0|||
156537260|NCT00467779|565061100|FG005|Stage 1A|Unspecified Reason|0|||
156537261|NCT00467779|565061101|FG006|Stage 1A|Unspecified Reason|0|||
156537262|NCT00467779|565061102|FG007|Stage 1A|Unspecified Reason|0|||
156537263|NCT00467779|565061103|FG008|Stage 1A|Unspecified Reason|0|||
156537264|NCT00467779|565061104|FG009|Stage 1A|Unspecified Reason|0|||
156537265|NCT00467779|565061105|FG010|Stage 1A|Unspecified Reason|0|||
156537266|NCT00467779|565061106|FG011|Stage 1A|Unspecified Reason|1|||
156537267|NCT00467779|565061107|FG012|Stage 1A|Unspecified Reason|1|||
156537268|NCT00467779|565061108|FG013|Stage 1A|Unspecified Reason|0|||
156537269|NCT00467779|565061109|FG014|Stage 1A|Unspecified Reason|0|||
156537270|NCT00467779|565061095|FG000|Stage 2|Adverse Event|0|||
156537271|NCT00467779|565061096|FG001|Stage 2|Adverse Event|0|||
156537272|NCT00467779|565061097|FG002|Stage 2|Adverse Event|0|||
156537273|NCT00467779|565061098|FG003|Stage 2|Adverse Event|0|||
156459708|NCT01828112|564778475|FG002|Extension Treatment Phase|Physician Decision|5|||
156459709|NCT01828112|564778473|FG000|Extension Treatment Phase|Progressive disease|0|||
156459710|NCT01828112|564778474|FG001|Extension Treatment Phase|Progressive disease|0|||
156459711|NCT01828112|564778475|FG002|Extension Treatment Phase|Progressive disease|46|||
156537274|NCT00467779|565061099|FG004|Stage 2|Adverse Event|0|||
156459712|NCT01828112|564778473|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
156459713|NCT01828112|564778474|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
156537275|NCT00467779|565061100|FG005|Stage 2|Adverse Event|0|||
156537276|NCT00467779|565061101|FG006|Stage 2|Adverse Event|0|||
156537277|NCT00467779|565061102|FG007|Stage 2|Adverse Event|0|||
156806648|NCT02237001|566047478|FG000|Overall Study|Incarceration|1|||
156806649|NCT01713582|566047479|FG000|Overall Study|Disease progression|3|||
156806650|NCT01713582|566047480|FG001|Overall Study|Disease progression|3|||
156806651|NCT01713582|566047481|FG002|Overall Study|Disease progression|3|||
156806652|NCT01713582|566047482|FG003|Overall Study|Disease progression|2|||
156806653|NCT01713582|566047483|FG004|Overall Study|Disease progression|3|||
156806654|NCT01713582|566047484|FG005|Overall Study|Disease progression|3|||
156806655|NCT01713582|566047485|FG006|Overall Study|Disease progression|3|||
156806656|NCT01713582|566047486|FG007|Overall Study|Disease progression|3|||
156806657|NCT01713582|566047487|FG008|Overall Study|Disease progression|3|||
156806658|NCT01713582|566047488|FG009|Overall Study|Disease progression|11|||
156806659|NCT01713582|566047489|FG010|Overall Study|Disease progression|10|||
156806660|NCT01713582|566047490|FG011|Overall Study|Disease progression|5|||
156806661|NCT01713582|566047491|FG012|Overall Study|Disease progression|3|||
156806662|NCT01713582|566047492|FG013|Overall Study|Disease progression|3|||
156806663|NCT01713582|566047493|FG014|Overall Study|Disease progression|6|||
156806664|NCT01713582|566047494|FG015|Overall Study|Disease progression|6|||
156806665|NCT01713582|566047495|FG016|Overall Study|Disease progression|5|||
156806666|NCT01713582|566047496|FG017|Overall Study|Disease progression|2|||
156806667|NCT01713582|566047497|FG018|Overall Study|Disease progression|3|||
156806668|NCT01713582|566047498|FG019|Overall Study|Disease progression|5|||
156806669|NCT01713582|566047499|FG020|Overall Study|Disease progression|15|||
156806670|NCT01713582|566047479|FG000|Overall Study|Death|0|||
156806671|NCT01713582|566047480|FG001|Overall Study|Death|0|||
156806672|NCT01713582|566047481|FG002|Overall Study|Death|0|||
156806673|NCT01713582|566047482|FG003|Overall Study|Death|1|||
156806674|NCT01713582|566047483|FG004|Overall Study|Death|1|||
156806675|NCT01713582|566047484|FG005|Overall Study|Death|3|||
156806676|NCT01713582|566047485|FG006|Overall Study|Death|3|||
156806677|NCT01713582|566047486|FG007|Overall Study|Death|2|||
156806678|NCT01713582|566047487|FG008|Overall Study|Death|3|||
156806679|NCT01713582|566047488|FG009|Overall Study|Death|4|||
156806680|NCT01713582|566047489|FG010|Overall Study|Death|3|||
156806681|NCT01713582|566047490|FG011|Overall Study|Death|0|||
156806682|NCT01713582|566047491|FG012|Overall Study|Death|0|||
156806683|NCT01713582|566047492|FG013|Overall Study|Death|0|||
156537278|NCT00467779|565061103|FG008|Stage 2|Adverse Event|1|||
156806684|NCT01713582|566047493|FG014|Overall Study|Death|0|||
156806685|NCT01713582|566047494|FG015|Overall Study|Death|0|||
156806686|NCT01713582|566047495|FG016|Overall Study|Death|0|||
156337921|NCT00259649|564336492|FG000|Overall Study|Lost to Follow-up|7|||
156337922|NCT00259649|564336492|FG000|Overall Study|irregular menses|3|||
156337923|NCT00745823|564336493|FG000|Overall Study|Adverse Event|5|||
156337924|NCT00745823|564336494|FG001|Overall Study|Adverse Event|3|||
156337925|NCT00745823|564336493|FG000|Overall Study|Lack of Efficacy|20|||
156337926|NCT00745823|564336494|FG001|Overall Study|Lack of Efficacy|6|||
156337927|NCT00745823|564336493|FG000|Overall Study|Lost to Follow-up|10|||
156337928|NCT00745823|564336494|FG001|Overall Study|Lost to Follow-up|11|||
156337929|NCT00745823|564336493|FG000|Overall Study|Physician Decision|10|||
156337930|NCT00745823|564336494|FG001|Overall Study|Physician Decision|5|||
156337931|NCT00745823|564336493|FG000|Overall Study|Pregnancy|0|||
156337932|NCT00745823|564336494|FG001|Overall Study|Pregnancy|4|||
156337933|NCT00745823|564336493|FG000|Overall Study|Withdrawal by Subject|14|||
156337934|NCT00745823|564336494|FG001|Overall Study|Withdrawal by Subject|8|||
156337935|NCT00745823|564336493|FG000|Overall Study|Study Terminated by Sponsor|326|||
156337936|NCT00745823|564336494|FG001|Overall Study|Study Terminated by Sponsor|349|||
156337937|NCT02955602|564336502|FG000|Overall Study|Adverse Event|0|||
156337938|NCT02955602|564336503|FG001|Overall Study|Adverse Event|3|||
156337939|NCT02955602|564336504|FG002|Overall Study|Adverse Event|0|||
156337940|NCT02955602|564336502|FG000|Overall Study|Withdrawal of informed consent|1|||
156337941|NCT02955602|564336503|FG001|Overall Study|Withdrawal of informed consent|3|||
156337942|NCT02955602|564336504|FG002|Overall Study|Withdrawal of informed consent|2|||
156337943|NCT02955602|564336502|FG000|Overall Study|Lost to Follow-up|0|||
156337944|NCT02955602|564336503|FG001|Overall Study|Lost to Follow-up|0|||
156337945|NCT02955602|564336504|FG002|Overall Study|Lost to Follow-up|1|||
156337946|NCT02955602|564336502|FG000|Overall Study|Other|0|||
156337947|NCT02955602|564336503|FG001|Overall Study|Other|1|||
156337948|NCT02955602|564336504|FG002|Overall Study|Other|3|||
156337949|NCT02980601|564336507|FG000|Overall Study|Lost to Follow-up|2|||
156337950|NCT02980601|564336508|FG001|Overall Study|Lost to Follow-up|2|||
156459714|NCT01828112|564778475|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
156459715|NCT01828112|564778473|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
156459716|NCT01828112|564778474|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
156459717|NCT01828112|564778475|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
156459718|NCT04308681|564778476|FG000|Pre-Treatment|Not reported|1|||
156459719|NCT04308681|564778477|FG001|Pre-Treatment|Not reported|1|||
156459720|NCT04308681|564778478|FG002|Pre-Treatment|Not reported|0|||
156459721|NCT04308681|564778479|FG003|Pre-Treatment|Not reported|0|||
156459722|NCT04308681|564778480|FG004|Pre-Treatment|Not reported|0|||
156459723|NCT04308681|564778481|FG005|Pre-Treatment|Not reported|2|||
156459724|NCT04308681|564778482|FG006|Pre-Treatment|Not reported|0|||
156459725|NCT04308681|564778483|FG007|Pre-Treatment|Not reported|0|||
156459726|NCT04308681|564778476|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
156459727|NCT04308681|564778477|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
156459728|NCT04308681|564778478|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
156459729|NCT04308681|564778479|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
156459730|NCT04308681|564778480|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
156459731|NCT04308681|564778481|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
156459732|NCT04308681|564778482|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
156459733|NCT04308681|564778483|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
156459734|NCT04308681|564778476|FG000|Treatment up to Week 26|Other reasons|2|||
156459735|NCT04308681|564778477|FG001|Treatment up to Week 26|Other reasons|0|||
156459736|NCT04308681|564778478|FG002|Treatment up to Week 26|Other reasons|0|||
156806687|NCT01713582|566047496|FG017|Overall Study|Death|0|||
156806688|NCT01713582|566047497|FG018|Overall Study|Death|0|||
156337951|NCT02980601|564336507|FG000|Overall Study|Death|0|||
156337952|NCT02980601|564336508|FG001|Overall Study|Death|1|||
156337953|NCT02980601|564336507|FG000|Overall Study|Graft loss|1|||
156337954|NCT02980601|564336508|FG001|Overall Study|Graft loss|0|||
156337955|NCT02980601|564336507|FG000|Overall Study|Failed to sign consent|2|||
156337956|NCT02980601|564336508|FG001|Overall Study|Failed to sign consent|0|||
156337957|NCT00592384|564336509|FG000|Overall Study|Withdrawal by Subject|5|||
156337958|NCT00592384|564336510|FG001|Overall Study|Withdrawal by Subject|6|||
156337959|NCT00590720|564336518|FG000|Overall Study|Lost to Follow-up|1|||
156337960|NCT00590720|564336519|FG001|Overall Study|Lost to Follow-up|0|||
156337961|NCT00590720|564336518|FG000|Overall Study|Withdrawal by Subject|0|||
156337962|NCT00590720|564336519|FG001|Overall Study|Withdrawal by Subject|1|||
156337963|NCT01847274|564336522|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
156337964|NCT01847274|564336523|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
156337965|NCT01847274|564336524|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
156337966|NCT01847274|564336525|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
156337967|NCT01847274|564336526|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156459737|NCT04308681|564778479|FG003|Treatment up to Week 26|Other reasons|0|||
156459738|NCT04308681|564778480|FG004|Treatment up to Week 26|Other reasons|1|||
156459739|NCT04308681|564778481|FG005|Treatment up to Week 26|Other reasons|1|||
156459740|NCT04308681|564778482|FG006|Treatment up to Week 26|Other reasons|0|||
156459741|NCT04308681|564778483|FG007|Treatment up to Week 26|Other reasons|0|||
156459742|NCT04308681|564778476|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
156459743|NCT04308681|564778477|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
156459744|NCT04308681|564778478|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
156459745|NCT04308681|564778479|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
156459746|NCT04308681|564778480|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
156459747|NCT04308681|564778481|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
156459748|NCT04308681|564778482|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
156806689|NCT01713582|566047498|FG019|Overall Study|Death|0|||
156806690|NCT01713582|566047499|FG020|Overall Study|Death|0|||
156806691|NCT01713582|566047479|FG000|Overall Study|Adverse event-related|0|||
156806692|NCT01713582|566047480|FG001|Overall Study|Adverse event-related|0|||
156806693|NCT01713582|566047481|FG002|Overall Study|Adverse event-related|0|||
156806694|NCT01713582|566047482|FG003|Overall Study|Adverse event-related|0|||
156806695|NCT01713582|566047483|FG004|Overall Study|Adverse event-related|0|||
156806696|NCT01713582|566047484|FG005|Overall Study|Adverse event-related|0|||
156806697|NCT01713582|566047485|FG006|Overall Study|Adverse event-related|0|||
156806698|NCT01713582|566047486|FG007|Overall Study|Adverse event-related|0|||
156806699|NCT01713582|566047487|FG008|Overall Study|Adverse event-related|0|||
156806700|NCT01713582|566047488|FG009|Overall Study|Adverse event-related|1|||
156806701|NCT01713582|566047489|FG010|Overall Study|Adverse event-related|1|||
156806702|NCT01713582|566047490|FG011|Overall Study|Adverse event-related|0|||
156806703|NCT01713582|566047491|FG012|Overall Study|Adverse event-related|0|||
156806704|NCT01713582|566047492|FG013|Overall Study|Adverse event-related|0|||
156806705|NCT01713582|566047493|FG014|Overall Study|Adverse event-related|0|||
156806706|NCT01713582|566047494|FG015|Overall Study|Adverse event-related|0|||
156806707|NCT01713582|566047495|FG016|Overall Study|Adverse event-related|0|||
156806708|NCT01713582|566047496|FG017|Overall Study|Adverse event-related|0|||
156806709|NCT01713582|566047497|FG018|Overall Study|Adverse event-related|1|||
156806710|NCT01713582|566047498|FG019|Overall Study|Adverse event-related|0|||
156806711|NCT01713582|566047499|FG020|Overall Study|Adverse event-related|0|||
156806712|NCT01713582|566047479|FG000|Overall Study|Adverse event-unrelated|0|||
156806713|NCT01713582|566047480|FG001|Overall Study|Adverse event-unrelated|0|||
156806714|NCT01713582|566047481|FG002|Overall Study|Adverse event-unrelated|0|||
156806715|NCT01713582|566047482|FG003|Overall Study|Adverse event-unrelated|0|||
156806716|NCT01713582|566047483|FG004|Overall Study|Adverse event-unrelated|0|||
156806717|NCT01713582|566047484|FG005|Overall Study|Adverse event-unrelated|1|||
156806718|NCT01713582|566047485|FG006|Overall Study|Adverse event-unrelated|1|||
156806719|NCT01713582|566047486|FG007|Overall Study|Adverse event-unrelated|1|||
156806720|NCT01713582|566047487|FG008|Overall Study|Adverse event-unrelated|0|||
156806721|NCT01713582|566047488|FG009|Overall Study|Adverse event-unrelated|0|||
156806722|NCT01713582|566047489|FG010|Overall Study|Adverse event-unrelated|0|||
156806723|NCT01713582|566047490|FG011|Overall Study|Adverse event-unrelated|0|||
156806724|NCT01713582|566047491|FG012|Overall Study|Adverse event-unrelated|0|||
156806725|NCT01713582|566047492|FG013|Overall Study|Adverse event-unrelated|1|||
156806726|NCT01713582|566047493|FG014|Overall Study|Adverse event-unrelated|1|||
156806727|NCT01713582|566047494|FG015|Overall Study|Adverse event-unrelated|0|||
156806728|NCT01713582|566047495|FG016|Overall Study|Adverse event-unrelated|0|||
156806729|NCT01713582|566047496|FG017|Overall Study|Adverse event-unrelated|0|||
156806730|NCT01713582|566047497|FG018|Overall Study|Adverse event-unrelated|0|||
156806731|NCT01713582|566047498|FG019|Overall Study|Adverse event-unrelated|0|||
156806732|NCT01713582|566047499|FG020|Overall Study|Adverse event-unrelated|0|||
156806733|NCT01713582|566047479|FG000|Overall Study|Withdrawal of consent|0|||
156806734|NCT01713582|566047480|FG001|Overall Study|Withdrawal of consent|0|||
156806735|NCT01713582|566047481|FG002|Overall Study|Withdrawal of consent|1|||
156459749|NCT04308681|564778483|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
156459750|NCT04308681|564778476|FG000|Treatment up to Week 26|Adverse Event|6|||
156459751|NCT04308681|564778477|FG001|Treatment up to Week 26|Adverse Event|5|||
156459752|NCT04308681|564778478|FG002|Treatment up to Week 26|Adverse Event|5|||
156459753|NCT04308681|564778479|FG003|Treatment up to Week 26|Adverse Event|0|||
156459754|NCT04308681|564778480|FG004|Treatment up to Week 26|Adverse Event|6|||
156459755|NCT04308681|564778481|FG005|Treatment up to Week 26|Adverse Event|1|||
156459756|NCT04308681|564778482|FG006|Treatment up to Week 26|Adverse Event|0|||
156459757|NCT04308681|564778483|FG007|Treatment up to Week 26|Adverse Event|0|||
156459758|NCT04308681|564778476|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
156459759|NCT04308681|564778477|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
156806736|NCT01713582|566047482|FG003|Overall Study|Withdrawal of consent|0|||
156806737|NCT01713582|566047483|FG004|Overall Study|Withdrawal of consent|0|||
156806738|NCT01713582|566047484|FG005|Overall Study|Withdrawal of consent|1|||
156806739|NCT01713582|566047485|FG006|Overall Study|Withdrawal of consent|0|||
156806740|NCT01713582|566047486|FG007|Overall Study|Withdrawal of consent|0|||
156806741|NCT01713582|566047487|FG008|Overall Study|Withdrawal of consent|0|||
156537279|NCT00467779|565061104|FG009|Stage 2|Adverse Event|0|||
156337968|NCT01847274|564336527|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156337969|NCT01847274|564336528|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156337970|NCT01847274|564336529|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156337971|NCT01847274|564336530|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156337972|NCT01847274|564336531|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156337973|NCT01847274|564336532|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156337974|NCT01847274|564336522|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
156337975|NCT01847274|564336523|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
156337976|NCT01847274|564336524|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
156337977|NCT01847274|564336525|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
156337978|NCT01847274|564336526|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156337979|NCT01847274|564336527|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156337980|NCT01847274|564336528|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156337981|NCT01847274|564336529|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156337982|NCT01847274|564336530|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156337983|NCT01847274|564336531|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156337984|NCT01847274|564336532|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156337985|NCT01847274|564336522|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
156337986|NCT01847274|564336523|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
156337987|NCT01847274|564336524|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
156337988|NCT01847274|564336525|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
156337989|NCT01847274|564336526|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156337990|NCT01847274|564336527|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156337991|NCT01847274|564336528|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156337992|NCT01847274|564336529|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156337993|NCT01847274|564336530|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156337994|NCT01847274|564336531|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156337995|NCT01847274|564336532|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156337996|NCT01847274|564336522|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156337997|NCT01847274|564336523|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156337998|NCT01847274|564336524|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156337999|NCT01847274|564336525|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
156338000|NCT01847274|564336526|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156338001|NCT01847274|564336527|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156338002|NCT01847274|564336528|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156338003|NCT01847274|564336529|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156338004|NCT01847274|564336530|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156338005|NCT01847274|564336531|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156338006|NCT01847274|564336532|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156338007|NCT01847274|564336522|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
156338008|NCT01847274|564336523|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
156338009|NCT01847274|564336524|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
156338010|NCT01847274|564336525|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
156338011|NCT01847274|564336526|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156338012|NCT01847274|564336527|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156459760|NCT04308681|564778478|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
156459761|NCT04308681|564778479|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
156459762|NCT04308681|564778480|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
156459763|NCT04308681|564778481|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
156459764|NCT04308681|564778482|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
156459765|NCT04308681|564778483|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
156459766|NCT04308681|564778476|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
156806742|NCT01713582|566047488|FG009|Overall Study|Withdrawal of consent|1|||
156806743|NCT01713582|566047489|FG010|Overall Study|Withdrawal of consent|0|||
156806744|NCT01713582|566047490|FG011|Overall Study|Withdrawal of consent|0|||
156806745|NCT01713582|566047491|FG012|Overall Study|Withdrawal of consent|0|||
156806746|NCT01713582|566047492|FG013|Overall Study|Withdrawal of consent|0|||
156806747|NCT01713582|566047493|FG014|Overall Study|Withdrawal of consent|0|||
156806748|NCT01713582|566047494|FG015|Overall Study|Withdrawal of consent|0|||
156806749|NCT01713582|566047495|FG016|Overall Study|Withdrawal of consent|0|||
156806750|NCT01713582|566047496|FG017|Overall Study|Withdrawal of consent|0|||
156806751|NCT01713582|566047497|FG018|Overall Study|Withdrawal of consent|1|||
156806752|NCT01713582|566047498|FG019|Overall Study|Withdrawal of consent|0|||
156806753|NCT01713582|566047499|FG020|Overall Study|Withdrawal of consent|0|||
156459767|NCT04308681|564778477|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
156459768|NCT04308681|564778478|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
156459769|NCT04308681|564778479|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
156459770|NCT04308681|564778480|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
156459771|NCT04308681|564778481|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
156459772|NCT04308681|564778482|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
156459773|NCT04308681|564778483|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
156459774|NCT04308681|564778476|FG000|OTE - 26 Weeks|Death|0|||
156459775|NCT04308681|564778477|FG001|OTE - 26 Weeks|Death|1|||
156459776|NCT04308681|564778478|FG002|OTE - 26 Weeks|Death|0|||
156459777|NCT04308681|564778479|FG003|OTE - 26 Weeks|Death|0|||
156459778|NCT04308681|564778480|FG004|OTE - 26 Weeks|Death|0|||
156459779|NCT04308681|564778481|FG005|OTE - 26 Weeks|Death|0|||
156459780|NCT04308681|564778482|FG006|OTE - 26 Weeks|Death|1|||
156459781|NCT04308681|564778483|FG007|OTE - 26 Weeks|Death|0|||
156459782|NCT04308681|564778476|FG000|OTE - 26 Weeks|Adverse Event|0|||
156459783|NCT04308681|564778477|FG001|OTE - 26 Weeks|Adverse Event|2|||
156459784|NCT04308681|564778478|FG002|OTE - 26 Weeks|Adverse Event|8|||
156459785|NCT04308681|564778479|FG003|OTE - 26 Weeks|Adverse Event|3|||
156459786|NCT04308681|564778480|FG004|OTE - 26 Weeks|Adverse Event|0|||
156459787|NCT04308681|564778481|FG005|OTE - 26 Weeks|Adverse Event|1|||
156459788|NCT04308681|564778482|FG006|OTE - 26 Weeks|Adverse Event|2|||
156459789|NCT04308681|564778483|FG007|OTE - 26 Weeks|Adverse Event|0|||
156459790|NCT04308681|564778476|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
156459791|NCT04308681|564778477|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
156459792|NCT04308681|564778478|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
156459793|NCT04308681|564778479|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
156459794|NCT04308681|564778480|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
156459795|NCT04308681|564778481|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
156459796|NCT04308681|564778482|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
156459797|NCT04308681|564778483|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
156459798|NCT04571619|564778490|FG000|Phase 1|Death|22|||
156459799|NCT04571619|564778491|FG001|Phase 1|Death|18|||
156459800|NCT04571619|564778490|FG000|Phase 1|Withdrawal by Subject|7|||
156459801|NCT04571619|564778491|FG001|Phase 1|Withdrawal by Subject|2|||
156459802|NCT04571619|564778490|FG000|Phase 2|Death|13|||
156459803|NCT04571619|564778491|FG001|Phase 2|Death|16|||
156459804|NCT04571619|564778490|FG000|Phase 2|Withdrawal by Subject|6|||
156459805|NCT04571619|564778491|FG001|Phase 2|Withdrawal by Subject|4|||
156459806|NCT05309291|564778496|FG000|Overall Study|Adverse Event|0|||
156459807|NCT05309291|564778497|FG001|Overall Study|Adverse Event|1|||
156459808|NCT05292391|564778500|FG000|Overall Study|Lost to Follow-up|0|||
156459809|NCT05292391|564778501|FG001|Overall Study|Lost to Follow-up|0|||
156459810|NCT05292391|564778502|FG002|Overall Study|Lost to Follow-up|0|||
156459811|NCT05292391|564778503|FG003|Overall Study|Lost to Follow-up|1|||
156459812|NCT05292391|564778504|FG004|Overall Study|Lost to Follow-up|0|||
156459813|NCT04857723|564778508|FG000|Overall Study|Withdrawal by Subject|2|||
156459814|NCT03221426|564778509|FG000|Overall Study|Ongoing in study|212|||
156459815|NCT03221426|564778510|FG001|Overall Study|Ongoing in study|193|||
156459816|NCT03221426|564778511|FG002|Overall Study|Ongoing in study|61|||
156459817|NCT03221426|564778512|FG003|Overall Study|Ongoing in study|55|||
156459818|NCT03221426|564778509|FG000|Overall Study|Withdrawal by Subject|12|||
156459819|NCT03221426|564778510|FG001|Overall Study|Withdrawal by Subject|4|||
156459820|NCT03221426|564778511|FG002|Overall Study|Withdrawal by Subject|2|||
156459821|NCT03221426|564778512|FG003|Overall Study|Withdrawal by Subject|3|||
156459822|NCT03221426|564778509|FG000|Overall Study|Lost to Follow-up|4|||
156459823|NCT03221426|564778510|FG001|Overall Study|Lost to Follow-up|1|||
156459824|NCT03221426|564778511|FG002|Overall Study|Lost to Follow-up|1|||
156459825|NCT03221426|564778512|FG003|Overall Study|Lost to Follow-up|0|||
156459826|NCT03221426|564778509|FG000|Overall Study|Death|174|||
156459827|NCT03221426|564778510|FG001|Overall Study|Death|204|||
156459828|NCT03221426|564778511|FG002|Overall Study|Death|36|||
156459829|NCT03221426|564778512|FG003|Overall Study|Death|45|||
156459830|NCT00696111|564780043|FG000|Overall Study|Withdrawal by Subject|17|||
156459831|NCT03676192|564780047|FG000|Induction Study Period|Adverse Event|21|||
156806754|NCT01713582|566047479|FG000|Overall Study|Lack of Efficacy|0|||
156806755|NCT01713582|566047480|FG001|Overall Study|Lack of Efficacy|0|||
156806756|NCT01713582|566047481|FG002|Overall Study|Lack of Efficacy|0|||
156806757|NCT01713582|566047482|FG003|Overall Study|Lack of Efficacy|0|||
156806758|NCT01713582|566047483|FG004|Overall Study|Lack of Efficacy|0|||
156806759|NCT01713582|566047484|FG005|Overall Study|Lack of Efficacy|0|||
156806760|NCT01713582|566047485|FG006|Overall Study|Lack of Efficacy|0|||
156806761|NCT01713582|566047486|FG007|Overall Study|Lack of Efficacy|0|||
156806762|NCT01713582|566047487|FG008|Overall Study|Lack of Efficacy|0|||
156459832|NCT03676192|564780048|FG001|Induction Study Period|Adverse Event|20|||
156459833|NCT03676192|564780047|FG000|Induction Study Period|Death|23|||
156459834|NCT03676192|564780048|FG001|Induction Study Period|Death|20|||
156459835|NCT03676192|564780047|FG000|Induction Study Period|Lost to Follow-up|3|||
156459836|NCT03676192|564780048|FG001|Induction Study Period|Lost to Follow-up|3|||
156806763|NCT01713582|566047488|FG009|Overall Study|Lack of Efficacy|1|||
156338013|NCT01847274|564336528|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156338014|NCT01847274|564336529|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156338015|NCT01847274|564336530|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156338016|NCT01847274|564336531|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156338017|NCT01847274|564336532|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156338018|NCT01847274|564336522|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
156459837|NCT03676192|564780047|FG000|Induction Study Period|Physician Decision|6|||
156459838|NCT03676192|564780048|FG001|Induction Study Period|Physician Decision|3|||
156459839|NCT03676192|564780047|FG000|Induction Study Period|Progressive Disease|32|||
156537280|NCT00467779|565061105|FG010|Stage 2|Adverse Event|0|||
156537281|NCT00467779|565061106|FG011|Stage 2|Adverse Event|0|||
156537282|NCT00467779|565061107|FG012|Stage 2|Adverse Event|0|||
156537283|NCT00467779|565061108|FG013|Stage 2|Adverse Event|0|||
156537284|NCT00467779|565061109|FG014|Stage 2|Adverse Event|0|||
156459840|NCT03676192|564780048|FG001|Induction Study Period|Progressive Disease|21|||
156459841|NCT03676192|564780047|FG000|Induction Study Period|Protocol Violation|1|||
156459842|NCT03676192|564780048|FG001|Induction Study Period|Protocol Violation|2|||
156459843|NCT03676192|564780047|FG000|Induction Study Period|Withdrawal by Subject|20|||
156459844|NCT03676192|564780048|FG001|Induction Study Period|Withdrawal by Subject|15|||
156459845|NCT03386578|564780050|FG000|PK Component|Lost to Follow-up|0|||
156459846|NCT03386578|564780051|FG001|PK Component|Lost to Follow-up|1|||
156459847|NCT03386578|564780052|FG002|PK Component|Lost to Follow-up|0|||
156459848|NCT03386578|564780053|FG003|PK Component|Lost to Follow-up|0|||
156459849|NCT03386578|564780054|FG004|PK Component|Lost to Follow-up|0|||
156459850|NCT03386578|564780055|FG005|PK Component|Lost to Follow-up|0|||
156459851|NCT03386578|564780056|FG006|PK Component|Lost to Follow-up|1|||
156459852|NCT03386578|564780057|FG007|PK Component|Lost to Follow-up|0|||
156459853|NCT03386578|564780058|FG008|PK Component|Lost to Follow-up|0|||
156459854|NCT03386578|564780059|FG009|PK Component|Lost to Follow-up|0|||
156459855|NCT03386578|564780050|FG000|PK Component|Stillbirth/Abortion|0|||
156459856|NCT03386578|564780051|FG001|PK Component|Stillbirth/Abortion|0|||
156459857|NCT03386578|564780052|FG002|PK Component|Stillbirth/Abortion|0|||
156459858|NCT03386578|564780053|FG003|PK Component|Stillbirth/Abortion|0|||
156459859|NCT03386578|564780054|FG004|PK Component|Stillbirth/Abortion|0|||
156459860|NCT03386578|564780055|FG005|PK Component|Stillbirth/Abortion|2|||
156459861|NCT03386578|564780056|FG006|PK Component|Stillbirth/Abortion|0|||
156459862|NCT03386578|564780057|FG007|PK Component|Stillbirth/Abortion|0|||
156459863|NCT03386578|564780058|FG008|PK Component|Stillbirth/Abortion|0|||
156459864|NCT03386578|564780059|FG009|PK Component|Stillbirth/Abortion|0|||
156459865|NCT03386578|564780050|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
156459866|NCT03386578|564780051|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
156459867|NCT03386578|564780052|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
156459868|NCT03386578|564780053|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
156537285|NCT00467779|565061095|FG000|Stage 2|Death|0|||
156537286|NCT00467779|565061096|FG001|Stage 2|Death|0|||
156537287|NCT00467779|565061097|FG002|Stage 2|Death|0|||
156537288|NCT00467779|565061098|FG003|Stage 2|Death|0|||
156537289|NCT00467779|565061099|FG004|Stage 2|Death|0|||
156537290|NCT00467779|565061100|FG005|Stage 2|Death|0|||
156537291|NCT00467779|565061101|FG006|Stage 2|Death|0|||
156537292|NCT00467779|565061102|FG007|Stage 2|Death|0|||
156537293|NCT00467779|565061103|FG008|Stage 2|Death|1|||
156537294|NCT00467779|565061104|FG009|Stage 2|Death|0|||
156537295|NCT00467779|565061105|FG010|Stage 2|Death|0|||
156537296|NCT00467779|565061106|FG011|Stage 2|Death|0|||
156537297|NCT00467779|565061107|FG012|Stage 2|Death|0|||
156537298|NCT00467779|565061108|FG013|Stage 2|Death|0|||
156537299|NCT00467779|565061109|FG014|Stage 2|Death|0|||
156537300|NCT00467779|565061095|FG000|Stage 2|Disease Progression|0|||
156459869|NCT03386578|564780054|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
156459870|NCT03386578|564780055|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
156459871|NCT03386578|564780056|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
156459872|NCT03386578|564780057|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
156459873|NCT03386578|564780058|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
156459874|NCT03386578|564780059|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
156459875|NCT03386578|564780050|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
156537301|NCT00467779|565061096|FG001|Stage 2|Disease Progression|0|||
156537302|NCT00467779|565061097|FG002|Stage 2|Disease Progression|0|||
156537303|NCT00467779|565061098|FG003|Stage 2|Disease Progression|0|||
156537304|NCT00467779|565061099|FG004|Stage 2|Disease Progression|0|||
156537305|NCT00467779|565061100|FG005|Stage 2|Disease Progression|0|||
156537306|NCT00467779|565061101|FG006|Stage 2|Disease Progression|0|||
156537307|NCT00467779|565061102|FG007|Stage 2|Disease Progression|0|||
156537308|NCT00467779|565061103|FG008|Stage 2|Disease Progression|16|||
156806764|NCT01713582|566047489|FG010|Overall Study|Lack of Efficacy|2|||
156459876|NCT03386578|564780051|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
156537309|NCT00467779|565061104|FG009|Stage 2|Disease Progression|0|||
156537310|NCT00467779|565061105|FG010|Stage 2|Disease Progression|0|||
156338019|NCT01847274|564336523|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
156338020|NCT01847274|564336524|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
156338021|NCT01847274|564336525|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
156338022|NCT01847274|564336526|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156459877|NCT03386578|564780052|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
156459878|NCT03386578|564780053|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
156459879|NCT03386578|564780054|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
156459880|NCT03386578|564780055|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
156459881|NCT03386578|564780056|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
156459882|NCT03386578|564780057|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
156459883|NCT03386578|564780058|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
156459884|NCT03386578|564780059|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
156459885|NCT03386578|564780050|FG000|PrEP Comparison Component Step 1|Death|0|||
156459886|NCT03386578|564780051|FG001|PrEP Comparison Component Step 1|Death|0|||
156459887|NCT03386578|564780052|FG002|PrEP Comparison Component Step 1|Death|1|||
156459888|NCT03386578|564780053|FG003|PrEP Comparison Component Step 1|Death|0|||
156459889|NCT03386578|564780054|FG004|PrEP Comparison Component Step 1|Death|0|||
156459890|NCT03386578|564780055|FG005|PrEP Comparison Component Step 1|Death|0|||
156459891|NCT03386578|564780056|FG006|PrEP Comparison Component Step 1|Death|0|||
156459892|NCT03386578|564780057|FG007|PrEP Comparison Component Step 1|Death|9|||
156459893|NCT03386578|564780058|FG008|PrEP Comparison Component Step 1|Death|5|||
156459894|NCT03386578|564780059|FG009|PrEP Comparison Component Step 1|Death|0|||
156459895|NCT03386578|564780050|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
156459896|NCT03386578|564780051|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
156459897|NCT03386578|564780052|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
156459898|NCT03386578|564780053|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
156459899|NCT03386578|564780054|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
156459900|NCT03386578|564780055|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
156459901|NCT03386578|564780056|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
156459902|NCT03386578|564780057|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
156459903|NCT03386578|564780058|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
156459904|NCT03386578|564780059|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
156459905|NCT03386578|564780050|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
156459906|NCT03386578|564780051|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
156459907|NCT03386578|564780052|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
156459908|NCT03386578|564780053|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
156459909|NCT03386578|564780054|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
156459910|NCT03386578|564780055|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
156459911|NCT03386578|564780056|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
156459912|NCT03386578|564780057|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
156459913|NCT03386578|564780058|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
156537311|NCT00467779|565061106|FG011|Stage 2|Disease Progression|0|||
156806765|NCT01713582|566047490|FG011|Overall Study|Lack of Efficacy|0|||
156806766|NCT01713582|566047491|FG012|Overall Study|Lack of Efficacy|0|||
156806767|NCT01713582|566047492|FG013|Overall Study|Lack of Efficacy|0|||
156459914|NCT03386578|564780059|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
156459915|NCT03386578|564780050|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
156459916|NCT03386578|564780051|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
156806768|NCT01713582|566047493|FG014|Overall Study|Lack of Efficacy|0|||
156806769|NCT01713582|566047494|FG015|Overall Study|Lack of Efficacy|0|||
156806770|NCT01713582|566047495|FG016|Overall Study|Lack of Efficacy|0|||
156806771|NCT01713582|566047496|FG017|Overall Study|Lack of Efficacy|0|||
156806772|NCT01713582|566047497|FG018|Overall Study|Lack of Efficacy|0|||
156806773|NCT01713582|566047498|FG019|Overall Study|Lack of Efficacy|0|||
156806774|NCT01713582|566047499|FG020|Overall Study|Lack of Efficacy|0|||
156806775|NCT01713582|566047479|FG000|Overall Study|Withdrawal by Subject|0|||
156806776|NCT01713582|566047480|FG001|Overall Study|Withdrawal by Subject|0|||
156806777|NCT01713582|566047481|FG002|Overall Study|Withdrawal by Subject|0|||
156806778|NCT01713582|566047482|FG003|Overall Study|Withdrawal by Subject|0|||
156806779|NCT01713582|566047483|FG004|Overall Study|Withdrawal by Subject|0|||
156806780|NCT01713582|566047484|FG005|Overall Study|Withdrawal by Subject|0|||
156806781|NCT01713582|566047485|FG006|Overall Study|Withdrawal by Subject|0|||
156806782|NCT01713582|566047486|FG007|Overall Study|Withdrawal by Subject|0|||
156806783|NCT01713582|566047487|FG008|Overall Study|Withdrawal by Subject|0|||
156806784|NCT01713582|566047488|FG009|Overall Study|Withdrawal by Subject|0|||
156806785|NCT01713582|566047489|FG010|Overall Study|Withdrawal by Subject|0|||
156806786|NCT01713582|566047490|FG011|Overall Study|Withdrawal by Subject|0|||
156806787|NCT01713582|566047491|FG012|Overall Study|Withdrawal by Subject|0|||
156806788|NCT01713582|566047492|FG013|Overall Study|Withdrawal by Subject|0|||
156806789|NCT01713582|566047493|FG014|Overall Study|Withdrawal by Subject|0|||
156806790|NCT01713582|566047494|FG015|Overall Study|Withdrawal by Subject|0|||
156806791|NCT01713582|566047495|FG016|Overall Study|Withdrawal by Subject|0|||
156806792|NCT01713582|566047496|FG017|Overall Study|Withdrawal by Subject|1|||
156806793|NCT01713582|566047497|FG018|Overall Study|Withdrawal by Subject|0|||
156806794|NCT01713582|566047498|FG019|Overall Study|Withdrawal by Subject|0|||
156806795|NCT01713582|566047499|FG020|Overall Study|Withdrawal by Subject|0|||
156806796|NCT01713582|566047479|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
156806797|NCT01713582|566047480|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
156806798|NCT01713582|566047481|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
156806799|NCT01713582|566047482|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
156806800|NCT01713582|566047483|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
156806801|NCT01713582|566047484|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
156806802|NCT01713582|566047485|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
156806803|NCT01713582|566047486|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
156806804|NCT01713582|566047487|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
156806805|NCT01713582|566047488|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
156806806|NCT01713582|566047489|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
156806807|NCT01713582|566047490|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
156806808|NCT01713582|566047491|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
156806809|NCT01713582|566047492|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
156806810|NCT01713582|566047493|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
156806811|NCT01713582|566047494|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
156806812|NCT01713582|566047495|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
156806813|NCT01713582|566047496|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
156806814|NCT01713582|566047497|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
156806815|NCT01713582|566047498|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
156806816|NCT01713582|566047499|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
156806817|NCT01713582|566047479|FG000|Overall Study|Disease progression and adverse event|0|||
156806818|NCT01713582|566047480|FG001|Overall Study|Disease progression and adverse event|0|||
156806819|NCT01713582|566047481|FG002|Overall Study|Disease progression and adverse event|0|||
156806820|NCT01713582|566047482|FG003|Overall Study|Disease progression and adverse event|0|||
156806821|NCT01713582|566047483|FG004|Overall Study|Disease progression and adverse event|0|||
156806822|NCT01713582|566047484|FG005|Overall Study|Disease progression and adverse event|0|||
156806823|NCT01713582|566047485|FG006|Overall Study|Disease progression and adverse event|0|||
156806824|NCT01713582|566047486|FG007|Overall Study|Disease progression and adverse event|0|||
156806825|NCT01713582|566047487|FG008|Overall Study|Disease progression and adverse event|0|||
156806826|NCT01713582|566047488|FG009|Overall Study|Disease progression and adverse event|0|||
156806827|NCT01713582|566047489|FG010|Overall Study|Disease progression and adverse event|0|||
156806828|NCT01713582|566047490|FG011|Overall Study|Disease progression and adverse event|0|||
156806829|NCT01713582|566047491|FG012|Overall Study|Disease progression and adverse event|0|||
156806830|NCT01713582|566047492|FG013|Overall Study|Disease progression and adverse event|0|||
156806831|NCT01713582|566047493|FG014|Overall Study|Disease progression and adverse event|0|||
156459917|NCT03386578|564780052|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
156459918|NCT03386578|564780053|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
156459919|NCT03386578|564780054|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
156459920|NCT03386578|564780055|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
156459921|NCT03386578|564780056|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
156459922|NCT03386578|564780057|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
156459923|NCT03386578|564780058|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
156459924|NCT03386578|564780059|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
156459925|NCT02694822|564780060|FG000|Phase 1|Death|2|||
156459926|NCT02694822|564780061|FG001|Phase 1|Death|1|||
156459927|NCT02694822|564780062|FG002|Phase 1|Death|6|||
156459928|NCT02694822|564780063|FG003|Phase 1|Death|6|||
156459929|NCT02694822|564780064|FG004|Phase 1|Death|3|||
156459930|NCT02694822|564780065|FG005|Phase 1|Death|0|||
156459931|NCT02694822|564780060|FG000|Phase 1|Withdrawal by Subject|2|||
156459932|NCT02694822|564780061|FG001|Phase 1|Withdrawal by Subject|2|||
156459933|NCT02694822|564780062|FG002|Phase 1|Withdrawal by Subject|4|||
156459934|NCT02694822|564780063|FG003|Phase 1|Withdrawal by Subject|8|||
156459935|NCT02694822|564780064|FG004|Phase 1|Withdrawal by Subject|1|||
156459936|NCT02694822|564780065|FG005|Phase 1|Withdrawal by Subject|0|||
156459937|NCT02694822|564780060|FG000|Phase 2|Death|0|||
156459938|NCT02694822|564780061|FG001|Phase 2|Death|0|||
156459939|NCT02694822|564780062|FG002|Phase 2|Death|0|||
156459940|NCT02694822|564780063|FG003|Phase 2|Death|0|||
156459941|NCT02694822|564780064|FG004|Phase 2|Death|0|||
156459942|NCT02694822|564780065|FG005|Phase 2|Death|26|||
156459943|NCT02694822|564780060|FG000|Phase 2|Withdrawal by Subject|0|||
156459944|NCT02694822|564780061|FG001|Phase 2|Withdrawal by Subject|0|||
156459945|NCT02694822|564780062|FG002|Phase 2|Withdrawal by Subject|0|||
156459946|NCT02694822|564780063|FG003|Phase 2|Withdrawal by Subject|0|||
156459947|NCT02694822|564780064|FG004|Phase 2|Withdrawal by Subject|0|||
156459948|NCT02694822|564780065|FG005|Phase 2|Withdrawal by Subject|13|||
156459949|NCT02694822|564780060|FG000|Phase 2|Administrative Study Closure|0|||
156459950|NCT02694822|564780061|FG001|Phase 2|Administrative Study Closure|0|||
156459951|NCT02694822|564780062|FG002|Phase 2|Administrative Study Closure|0|||
156459952|NCT02694822|564780063|FG003|Phase 2|Administrative Study Closure|0|||
156459953|NCT02694822|564780064|FG004|Phase 2|Administrative Study Closure|0|||
156459954|NCT02694822|564780065|FG005|Phase 2|Administrative Study Closure|2|||
156459955|NCT02694822|564780060|FG000|Phase 2|Lost to Follow-up|0|||
156459956|NCT02694822|564780061|FG001|Phase 2|Lost to Follow-up|0|||
156459957|NCT02694822|564780062|FG002|Phase 2|Lost to Follow-up|0|||
156459958|NCT02694822|564780063|FG003|Phase 2|Lost to Follow-up|0|||
156459959|NCT02694822|564780064|FG004|Phase 2|Lost to Follow-up|0|||
156459960|NCT02694822|564780065|FG005|Phase 2|Lost to Follow-up|1|||
156459961|NCT02694822|564780060|FG000|Phase 2|Participant Transferred to Another Site|0|||
156459962|NCT02694822|564780061|FG001|Phase 2|Participant Transferred to Another Site|0|||
156459963|NCT02694822|564780062|FG002|Phase 2|Participant Transferred to Another Site|0|||
156459964|NCT02694822|564780063|FG003|Phase 2|Participant Transferred to Another Site|0|||
156459965|NCT02694822|564780064|FG004|Phase 2|Participant Transferred to Another Site|0|||
156459966|NCT02694822|564780065|FG005|Phase 2|Participant Transferred to Another Site|1|||
156459967|NCT01868997|564780068|FG000|Overall Study|Adverse Event|2|||
156459968|NCT01868997|564780069|FG001|Overall Study|Adverse Event|5|||
156459969|NCT01868997|564780068|FG000|Overall Study|Lack of Efficacy|2|||
156459970|NCT01868997|564780069|FG001|Overall Study|Lack of Efficacy|0|||
156459971|NCT01868997|564780068|FG000|Overall Study|Other|3|||
156459972|NCT01868997|564780069|FG001|Overall Study|Other|1|||
156459973|NCT05370040|564780070|FG000|Overall Study|Lost to Follow-up|0|||
156806832|NCT01713582|566047494|FG015|Overall Study|Disease progression and adverse event|0|||
156806833|NCT01713582|566047495|FG016|Overall Study|Disease progression and adverse event|1|||
156806834|NCT01713582|566047496|FG017|Overall Study|Disease progression and adverse event|0|||
156459974|NCT05370040|564780071|FG001|Overall Study|Lost to Follow-up|0|||
156459975|NCT05370040|564780072|FG002|Overall Study|Lost to Follow-up|1|||
156459976|NCT05370040|564780073|FG003|Overall Study|Lost to Follow-up|0|||
156459977|NCT05370040|564780074|FG004|Overall Study|Lost to Follow-up|1|||
156459978|NCT05370040|564780075|FG005|Overall Study|Lost to Follow-up|0|||
156459979|NCT04971109|564780076|FG000|Overall Study|Adverse Event|4|||
156459980|NCT04971109|564780077|FG001|Overall Study|Adverse Event|3|||
156459981|NCT04971109|564780076|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
156459982|NCT04971109|564780077|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
156459983|NCT04971109|564780076|FG000|Overall Study|Lost to Follow-up|8|||
156459984|NCT04971109|564780077|FG001|Overall Study|Lost to Follow-up|2|||
156459985|NCT04971109|564780076|FG000|Overall Study|Physician Decision|5|||
156806835|NCT01713582|566047497|FG018|Overall Study|Disease progression and adverse event|0|||
156459986|NCT04971109|564780077|FG001|Overall Study|Physician Decision|0|||
156459987|NCT04971109|564780076|FG000|Overall Study|Protocol Violation|0|||
156459988|NCT04971109|564780077|FG001|Overall Study|Protocol Violation|1|||
156459989|NCT04971109|564780076|FG000|Overall Study|Withdrawal by Subject|18|||
156459990|NCT04971109|564780077|FG001|Overall Study|Withdrawal by Subject|3|||
156459991|NCT04971109|564780076|FG000|Overall Study|Subject was randomized in error|1|||
156459992|NCT04971109|564780077|FG001|Overall Study|Subject was randomized in error|0|||
156459993|NCT04778397|564780080|FG000|Overall Study|Death|59|||
156459994|NCT04778397|564780081|FG001|Overall Study|Death|54|||
156459995|NCT04778397|564780082|FG002|Overall Study|Death|11|||
156459996|NCT04778397|564780083|FG003|Overall Study|Death|9|||
156459997|NCT04778397|564780080|FG000|Overall Study|Study Terminated by Sponsor|34|||
156459998|NCT04778397|564780081|FG001|Overall Study|Study Terminated by Sponsor|42|||
156459999|NCT04778397|564780082|FG002|Overall Study|Study Terminated by Sponsor|15|||
156460000|NCT04778397|564780083|FG003|Overall Study|Study Terminated by Sponsor|12|||
156460001|NCT04778397|564780080|FG000|Overall Study|Withdrew Consent|5|||
156460002|NCT04778397|564780081|FG001|Overall Study|Withdrew Consent|4|||
156460003|NCT04778397|564780082|FG002|Overall Study|Withdrew Consent|1|||
156460004|NCT04778397|564780083|FG003|Overall Study|Withdrew Consent|1|||
156460005|NCT04778397|564780080|FG000|Overall Study|Reason Not Specified|1|||
156460006|NCT04778397|564780081|FG001|Overall Study|Reason Not Specified|3|||
156460007|NCT04778397|564780082|FG002|Overall Study|Reason Not Specified|0|||
156460008|NCT04778397|564780083|FG003|Overall Study|Reason Not Specified|2|||
156460009|NCT04778397|564780080|FG000|Overall Study|Lost to Follow-up|2|||
156460010|NCT04778397|564780081|FG001|Overall Study|Lost to Follow-up|1|||
156460011|NCT04778397|564780082|FG002|Overall Study|Lost to Follow-up|0|||
156460012|NCT04778397|564780083|FG003|Overall Study|Lost to Follow-up|1|||
156460013|NCT05906784|564780085|FG000|Overall Study|Lost to Follow-up|2|||
156460014|NCT05906784|564780086|FG001|Overall Study|Lost to Follow-up|1|||
156460015|NCT05906784|564780087|FG002|Overall Study|Lost to Follow-up|1|||
156460016|NCT05906784|564780088|FG003|Overall Study|Lost to Follow-up|1|||
156460017|NCT04730739|564780092|FG000|Overall Study|Death|1|||
156460018|NCT03308877|564780093|FG000|Overall Study|Lost to Follow-up|32|||
156460019|NCT03308877|564780094|FG001|Overall Study|Lost to Follow-up|28|||
156460020|NCT03249090|564780095|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
156460021|NCT03249090|564780096|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
156460022|NCT03249090|564780095|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
156460023|NCT03249090|564780096|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
156460024|NCT03249090|564780095|FG000|3 Month Time Point|Voluntary withdrawal|6|||
156460025|NCT03249090|564780096|FG001|3 Month Time Point|Voluntary withdrawal|3|||
156460026|NCT03249090|564780095|FG000|3 Month Time Point|Changed oncology practice|4|||
156460027|NCT03249090|564780096|FG001|3 Month Time Point|Changed oncology practice|2|||
156460028|NCT03249090|564780095|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
156460029|NCT03249090|564780096|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
156460030|NCT03249090|564780095|FG000|12 Month Time Point|Voluntary withdrawal|35|||
156460031|NCT03249090|564780096|FG001|12 Month Time Point|Voluntary withdrawal|4|||
156460032|NCT03249090|564780095|FG000|12 Month Time Point|Changed oncology practice|20|||
156460033|NCT03249090|564780096|FG001|12 Month Time Point|Changed oncology practice|9|||
156460034|NCT03523572|564780098|FG000|Dose Escalation|Progressive disease|1|||
156460035|NCT03523572|564780099|FG001|Dose Escalation|Progressive disease|0|||
156460036|NCT03523572|564780100|FG002|Dose Escalation|Progressive disease|0|||
156460037|NCT03523572|564780101|FG003|Dose Escalation|Progressive disease|0|||
156460038|NCT03523572|564780102|FG004|Dose Escalation|Progressive disease|0|||
156460039|NCT03523572|564780103|FG005|Dose Escalation|Progressive disease|0|||
156460040|NCT03523572|564780098|FG000|Dose Escalation|Clinical Progression|0|||
156460041|NCT03523572|564780099|FG001|Dose Escalation|Clinical Progression|1|||
156460042|NCT03523572|564780100|FG002|Dose Escalation|Clinical Progression|0|||
156460043|NCT03523572|564780101|FG003|Dose Escalation|Clinical Progression|0|||
156460044|NCT03523572|564780102|FG004|Dose Escalation|Clinical Progression|0|||
156460045|NCT03523572|564780103|FG005|Dose Escalation|Clinical Progression|0|||
156460046|NCT03523572|564780098|FG000|Dose Escalation|Adverse Event|2|||
156460047|NCT03523572|564780099|FG001|Dose Escalation|Adverse Event|0|||
156460048|NCT03523572|564780100|FG002|Dose Escalation|Adverse Event|0|||
156460049|NCT03523572|564780101|FG003|Dose Escalation|Adverse Event|0|||
156460050|NCT03523572|564780102|FG004|Dose Escalation|Adverse Event|0|||
156460051|NCT03523572|564780103|FG005|Dose Escalation|Adverse Event|0|||
156460052|NCT03523572|564780098|FG000|Dose Escalation|Physician Decision|1|||
156460053|NCT03523572|564780099|FG001|Dose Escalation|Physician Decision|1|||
156460054|NCT03523572|564780100|FG002|Dose Escalation|Physician Decision|0|||
156460055|NCT03523572|564780101|FG003|Dose Escalation|Physician Decision|0|||
156460056|NCT03523572|564780102|FG004|Dose Escalation|Physician Decision|0|||
156460057|NCT03523572|564780103|FG005|Dose Escalation|Physician Decision|0|||
156460058|NCT03523572|564780098|FG000|Dose Expansion|Progressive Disease|0|||
156460059|NCT03523572|564780099|FG001|Dose Expansion|Progressive Disease|0|||
156460060|NCT03523572|564780100|FG002|Dose Expansion|Progressive Disease|9|||
156460061|NCT03523572|564780101|FG003|Dose Expansion|Progressive Disease|11|||
156460062|NCT03523572|564780102|FG004|Dose Expansion|Progressive Disease|15|||
156460063|NCT03523572|564780103|FG005|Dose Expansion|Progressive Disease|2|||
156460064|NCT03523572|564780098|FG000|Dose Expansion|Clinical Progression|0|||
156460065|NCT03523572|564780099|FG001|Dose Expansion|Clinical Progression|0|||
156460066|NCT03523572|564780100|FG002|Dose Expansion|Clinical Progression|2|||
156460067|NCT03523572|564780101|FG003|Dose Expansion|Clinical Progression|2|||
156460068|NCT03523572|564780102|FG004|Dose Expansion|Clinical Progression|2|||
156460069|NCT03523572|564780103|FG005|Dose Expansion|Clinical Progression|0|||
156460070|NCT03523572|564780098|FG000|Dose Expansion|Adverse Event|0|||
156460071|NCT03523572|564780099|FG001|Dose Expansion|Adverse Event|0|||
156460072|NCT03523572|564780100|FG002|Dose Expansion|Adverse Event|10|||
156460073|NCT03523572|564780101|FG003|Dose Expansion|Adverse Event|1|||
156460074|NCT03523572|564780102|FG004|Dose Expansion|Adverse Event|5|||
156460075|NCT03523572|564780103|FG005|Dose Expansion|Adverse Event|2|||
156460076|NCT03523572|564780098|FG000|Dose Expansion|Withdrawal by Subject|0|||
156460077|NCT03523572|564780099|FG001|Dose Expansion|Withdrawal by Subject|0|||
156460078|NCT03523572|564780100|FG002|Dose Expansion|Withdrawal by Subject|1|||
156460079|NCT03523572|564780101|FG003|Dose Expansion|Withdrawal by Subject|1|||
156460080|NCT03523572|564780102|FG004|Dose Expansion|Withdrawal by Subject|0|||
156460081|NCT03523572|564780103|FG005|Dose Expansion|Withdrawal by Subject|0|||
156460082|NCT03523572|564780098|FG000|Dose Expansion|Physician Decision|0|||
156460083|NCT03523572|564780099|FG001|Dose Expansion|Physician Decision|0|||
156460084|NCT03523572|564780100|FG002|Dose Expansion|Physician Decision|1|||
156460085|NCT03523572|564780101|FG003|Dose Expansion|Physician Decision|0|||
156460086|NCT03523572|564780102|FG004|Dose Expansion|Physician Decision|1|||
156460087|NCT03523572|564780103|FG005|Dose Expansion|Physician Decision|0|||
156460088|NCT03523572|564780098|FG000|Dose Expansion|Miscellaneous|0|||
156460089|NCT03523572|564780099|FG001|Dose Expansion|Miscellaneous|0|||
156460090|NCT03523572|564780100|FG002|Dose Expansion|Miscellaneous|0|||
156460091|NCT03523572|564780101|FG003|Dose Expansion|Miscellaneous|0|||
156460092|NCT03523572|564780102|FG004|Dose Expansion|Miscellaneous|3|||
156460093|NCT03523572|564780103|FG005|Dose Expansion|Miscellaneous|0|||
156460094|NCT02315703|564780109|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
156460095|NCT02315703|564780110|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
156460096|NCT02315703|564780111|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
156460097|NCT02315703|564780112|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
156460098|NCT02315703|564780113|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
156460099|NCT02315703|564780114|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
156460100|NCT02315703|564780115|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
156460101|NCT02315703|564780116|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
156460102|NCT02315703|564780109|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
156460103|NCT02315703|564780110|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
156460104|NCT02315703|564780111|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
156460105|NCT02315703|564780112|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
156460106|NCT02315703|564780113|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
156460107|NCT02315703|564780114|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
156460108|NCT02315703|564780115|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
156460109|NCT02315703|564780116|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
156460110|NCT02315703|564780109|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
156460111|NCT02315703|564780110|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
156460112|NCT02315703|564780111|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
156460113|NCT02315703|564780112|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
156460114|NCT02315703|564780113|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
156460115|NCT02315703|564780114|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
156460116|NCT02315703|564780115|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
156460117|NCT02315703|564780116|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
156460118|NCT02315703|564780109|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
156460119|NCT02315703|564780110|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
156537312|NCT00467779|565061107|FG012|Stage 2|Disease Progression|0|||
156460120|NCT02315703|564780111|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
156460121|NCT02315703|564780112|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
156460122|NCT02315703|564780113|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
156537313|NCT00467779|565061108|FG013|Stage 2|Disease Progression|0|||
156537314|NCT00467779|565061109|FG014|Stage 2|Disease Progression|0|||
156460123|NCT02315703|564780114|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
156460124|NCT02315703|564780115|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
156460125|NCT02315703|564780116|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
156460126|NCT02315703|564780109|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
156460127|NCT02315703|564780110|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
156806836|NCT01713582|566047498|FG019|Overall Study|Disease progression and adverse event|0|||
156806837|NCT01713582|566047499|FG020|Overall Study|Disease progression and adverse event|0|||
156806838|NCT04776161|566047501|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
156806839|NCT04776161|566047502|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
156806840|NCT04776161|566047503|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
156806841|NCT04776161|566047501|FG000|Overall Study|Withdrawal by Subject|1|||
156460128|NCT02315703|564780111|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
156460129|NCT02315703|564780112|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
156460130|NCT02315703|564780113|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
156460131|NCT02315703|564780114|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
156460132|NCT02315703|564780115|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
156460133|NCT02315703|564780116|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
156460134|NCT02315703|564780109|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
156460135|NCT02315703|564780110|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
156460136|NCT02315703|564780111|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
156460137|NCT02315703|564780112|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
156460138|NCT02315703|564780113|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
156460139|NCT02315703|564780114|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
156460140|NCT02315703|564780115|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
156460141|NCT02315703|564780116|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
156460142|NCT02315703|564780109|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
156460143|NCT02315703|564780110|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
156460144|NCT02315703|564780111|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
156460145|NCT02315703|564780112|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
156460146|NCT02315703|564780113|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
156460147|NCT02315703|564780114|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
156460148|NCT02315703|564780115|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
156460149|NCT02315703|564780116|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
156460150|NCT02315703|564780109|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156460151|NCT02315703|564780110|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
156460152|NCT02315703|564780111|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156460153|NCT02315703|564780112|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156460154|NCT02315703|564780113|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156460155|NCT02315703|564780114|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156460156|NCT02315703|564780115|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156460157|NCT02315703|564780116|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156460158|NCT02315703|564780109|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
156460159|NCT02315703|564780110|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
156460160|NCT02315703|564780111|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
156460161|NCT02315703|564780112|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
156460162|NCT02315703|564780113|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
156460163|NCT02315703|564780114|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
156460164|NCT02315703|564780115|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
156460165|NCT02315703|564780116|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
156460166|NCT03625115|564780118|FG000|Overall Study|Withdrawal by Subject|4|||
156460167|NCT03625115|564780119|FG001|Overall Study|Withdrawal by Subject|7|||
156460168|NCT03625115|564780118|FG000|Overall Study|Lost to Follow-up|17|||
156460169|NCT03625115|564780119|FG001|Overall Study|Lost to Follow-up|24|||
156460170|NCT03672916|564780120|FG000|Overall Study|Death|6|||
156460171|NCT03672916|564780120|FG000|Overall Study|Lost to Follow-up|29|||
156460172|NCT03672916|564780120|FG000|Overall Study|Adverse Event|6|||
156460173|NCT03672916|564780120|FG000|Overall Study|Withdrawal by Subject|11|||
156460174|NCT04197336|564780121|FG000|Overall Study|Withdrawal by Subject|1|||
156460175|NCT03852550|564780131|FG000|Overall Study|Lost to Follow-up|4|||
156460176|NCT03852550|564780132|FG001|Overall Study|Lost to Follow-up|3|||
156460177|NCT03852550|564780131|FG000|Overall Study|Only parent outcomes completed|0|||
156460178|NCT03852550|564780132|FG001|Overall Study|Only parent outcomes completed|1|||
156460179|NCT03852550|564780131|FG000|Overall Study|Withdrawal by Subject|1|||
156460180|NCT03852550|564780132|FG001|Overall Study|Withdrawal by Subject|0|||
156806842|NCT04776161|566047502|FG001|Overall Study|Withdrawal by Subject|0|||
156460181|NCT05204654|564780133|FG000|Overall Study|Study terminated due to time restraint|2|||
156460182|NCT05204654|564780134|FG001|Overall Study|Study terminated due to time restraint|2|||
156460183|NCT01221948|564780135|FG000|Overall Study|Physician Decision|5|||
156460184|NCT01221948|564780135|FG000|Overall Study|Withdrawal by Subject|2|||
156460185|NCT01221948|564780135|FG000|Overall Study|not disclosed|2|||
156460186|NCT01221948|564780135|FG000|Overall Study|Death|1|||
156460187|NCT01221948|564780135|FG000|Overall Study|Protocol Violation|4|||
156806843|NCT04776161|566047503|FG002|Overall Study|Withdrawal by Subject|1|||
156460188|NCT03756662|564780136|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
156460189|NCT03626220|564780137|FG000|Overall Study|Withdrawal by Subject|2|||
156460190|NCT03626220|564780138|FG001|Overall Study|Withdrawal by Subject|0|||
156460191|NCT05565820|564780145|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
156460192|NCT05565820|564780146|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
156460193|NCT05565820|564780145|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
156460194|NCT05565820|564780146|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
156460195|NCT05828017|564780147|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
156460196|NCT05012163|564780151|FG000|Overall Study|Protocol Violation|0|||
156460197|NCT05012163|564780152|FG001|Overall Study|Protocol Violation|0|||
156460198|NCT05012163|564780153|FG002|Overall Study|Protocol Violation|1|||
156460199|NCT05012163|564780154|FG003|Overall Study|Protocol Violation|1|||
156460200|NCT04132518|564780155|FG000|Overall Study|Prematurely withdrawn from the study|0|||
156460201|NCT04132518|564780156|FG001|Overall Study|Prematurely withdrawn from the study|9|||
156460202|NCT04132518|564780157|FG002|Overall Study|Prematurely withdrawn from the study|1|||
156460203|NCT05425420|564780159|FG000|Overall Study|Physician Decision|1|||
156460204|NCT05425420|564780159|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
156460205|NCT03673501|564780160|FG000|Overall Study|Participants ongoing.|36|||
156460206|NCT03673501|564780161|FG001|Overall Study|Participants ongoing.|24|||
156460207|NCT04599634|564780162|FG000|Overall Study|Dose limiting toxicity|0|||
156460208|NCT04599634|564780163|FG001|Overall Study|Dose limiting toxicity|0|||
156460209|NCT04599634|564780164|FG002|Overall Study|Dose limiting toxicity|2|||
156806844|NCT04776161|566047501|FG000|Overall Study|Adverse Event|0|||
156806845|NCT04776161|566047502|FG001|Overall Study|Adverse Event|1|||
156806846|NCT04776161|566047503|FG002|Overall Study|Adverse Event|1|||
156806847|NCT00342628|566047504|FG000|Overall Study|Withdrawal by Subject|19|||
156806848|NCT00342628|566047505|FG001|Overall Study|Withdrawal by Subject|19|||
156806849|NCT00342628|566047506|FG002|Overall Study|Withdrawal by Subject|18|||
156806850|NCT00342628|566047504|FG000|Overall Study|Death|1|||
156806851|NCT00342628|566047505|FG001|Overall Study|Death|1|||
156806852|NCT00342628|566047506|FG002|Overall Study|Death|0|||
156806853|NCT00342628|566047504|FG000|Overall Study|moved residence|0|||
156806854|NCT00342628|566047505|FG001|Overall Study|moved residence|1|||
156806855|NCT00342628|566047506|FG002|Overall Study|moved residence|1|||
156806856|NCT04551898|566047507|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
156806857|NCT04551898|566047508|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
156806858|NCT04551898|566047509|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
156806859|NCT04551898|566047510|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
156806860|NCT04551898|566047507|FG000|Overall Study|Withdrawal by Subject|5|||
156806861|NCT04551898|566047508|FG001|Overall Study|Withdrawal by Subject|1|||
156806862|NCT04551898|566047509|FG002|Overall Study|Withdrawal by Subject|2|||
156806863|NCT04551898|566047510|FG003|Overall Study|Withdrawal by Subject|2|||
156806864|NCT04551898|566047507|FG000|Overall Study|Lost to Follow-up|2|||
156806865|NCT04551898|566047508|FG001|Overall Study|Lost to Follow-up|1|||
156806866|NCT04551898|566047509|FG002|Overall Study|Lost to Follow-up|2|||
156806867|NCT04551898|566047510|FG003|Overall Study|Lost to Follow-up|2|||
156806868|NCT04551898|566047507|FG000|Overall Study|Death|1|||
156806869|NCT04551898|566047508|FG001|Overall Study|Death|0|||
156806870|NCT04551898|566047509|FG002|Overall Study|Death|0|||
156806871|NCT04551898|566047510|FG003|Overall Study|Death|0|||
156806872|NCT04551898|566047507|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
156806873|NCT04551898|566047508|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
156806874|NCT04551898|566047509|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
156806875|NCT04551898|566047510|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
156806876|NCT03427814|566047511|FG000|Overall Study|Withdrawal by Subject|4|||
156806877|NCT03427814|566047512|FG001|Overall Study|Withdrawal by Subject|4|||
156806878|NCT03427814|566047511|FG000|Overall Study|Lost to Follow-up|0|||
156806879|NCT03427814|566047512|FG001|Overall Study|Lost to Follow-up|2|||
156806880|NCT03427814|566047511|FG000|Overall Study|Death|42|||
156806881|NCT03427814|566047512|FG001|Overall Study|Death|31|||
156338023|NCT01847274|564336527|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156338024|NCT01847274|564336528|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156338025|NCT01847274|564336529|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156460210|NCT04599634|564780165|FG003|Overall Study|Dose limiting toxicity|0|||
156806882|NCT03427814|566047511|FG000|Overall Study|Sponsor's Decision|1|||
156806883|NCT03427814|566047512|FG001|Overall Study|Sponsor's Decision|0|||
156806884|NCT03427814|566047511|FG000|Overall Study|Investigator's Decision|1|||
156460211|NCT03714815|564780166|FG000|Overall Study|Physician Decision|2|||
156806885|NCT03427814|566047512|FG001|Overall Study|Investigator's Decision|2|||
156537315|NCT00467779|565061095|FG000|Stage 2|Unspecified Reason|0|||
156460212|NCT03714815|564780166|FG000|Overall Study|Withdrawal by Subject|2|||
156460213|NCT03714815|564780166|FG000|Overall Study|Death|11|||
156806886|NCT03427814|566047511|FG000|Overall Study|Disease progression|1|||
156806887|NCT03427814|566047512|FG001|Overall Study|Disease progression|0|||
156806888|NCT03427814|566047511|FG000|Overall Study|Treatment Completed|0|||
156806889|NCT03427814|566047512|FG001|Overall Study|Treatment Completed|1|||
156460214|NCT03733925|564780167|FG000|Overall Study|Lost to Follow-up|1|||
156460215|NCT03733925|564780167|FG000|Overall Study|Withdrawal by Subject|2|||
156460216|NCT03733925|564780167|FG000|Overall Study|Adverse Event|2|||
156460217|NCT03733925|564780167|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156460218|NCT02631746|564780173|FG000|Overall Study|Lack of Efficacy|3|||
156460219|NCT02361216|564780174|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
156460220|NCT02361216|564780175|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
156460221|NCT02361216|564780174|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
156460222|NCT02361216|564780175|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
156460223|NCT02361216|564780174|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
156460224|NCT02361216|564780175|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
156460225|NCT02361216|564780174|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
156460226|NCT02361216|564780175|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
156460227|NCT02361216|564780174|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
156460228|NCT02361216|564780175|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
156460229|NCT02361216|564780174|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
156460230|NCT02361216|564780175|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
156460231|NCT00323856|564780176|FG000|Overall Study|Withdrawal by Subject|1|||
156460232|NCT00323856|564780176|FG000|Overall Study|Was uncooperative and noncompliant|1|||
156460233|NCT00323856|564780176|FG000|Overall Study|Reason not specified|1|||
156460234|NCT00323856|564780176|FG000|Overall Study|Missing|2|||
156460235|NCT04086121|564780181|FG000|Overall Study|Other than listed|8|||
156460236|NCT04086121|564780181|FG000|Overall Study|Withdrawal by Subject|3|||
156460237|NCT04086121|564780181|FG000|Overall Study|Lost to Follow-up|2|||
156460238|NCT04086121|564780181|FG000|Overall Study|Adverse Event|1|||
156460239|NCT04167553|564780182|FG000|Overall Study|Withdrawal by Subject|1|||
156460240|NCT04167553|564780183|FG001|Overall Study|Withdrawal by Subject|0|||
156460241|NCT04167553|564780184|FG002|Overall Study|Withdrawal by Subject|1|||
156460242|NCT04167553|564780185|FG003|Overall Study|Withdrawal by Subject|2|||
156460243|NCT04167553|564780186|FG004|Overall Study|Withdrawal by Subject|1|||
156460244|NCT04167553|564780187|FG005|Overall Study|Withdrawal by Subject|0|||
156460245|NCT04167553|564780188|FG006|Overall Study|Withdrawal by Subject|0|||
156806890|NCT03427814|566047511|FG000|Overall Study|Sponsor's Decision to End study|21|||
156806891|NCT03427814|566047512|FG001|Overall Study|Sponsor's Decision to End study|25|||
156806892|NCT03427814|566047511|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
156806893|NCT03427814|566047512|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
156806894|NCT03846427|566047513|FG000|Overall Study|Death|13|||
156806895|NCT03846427|566047513|FG000|Overall Study|Withdrawal by Subject|3|||
156806896|NCT03846427|566047513|FG000|Overall Study|Physician Decision|1|||
156806897|NCT01334554|566047514|FG000|Overall Study|Adverse Event|4|||
156806898|NCT01334554|566047515|FG001|Overall Study|Adverse Event|2|||
156806899|NCT02393859|566047517|FG000|Overall Study|Decision by Sponsor|2|||
156806900|NCT02393859|566047518|FG001|Overall Study|Decision by Sponsor|4|||
156806901|NCT02393859|566047517|FG000|Overall Study|Withdrawal by Subject|11|||
156806902|NCT02393859|566047518|FG001|Overall Study|Withdrawal by Subject|6|||
156806903|NCT02393859|566047517|FG000|Overall Study|Death|27|||
156806904|NCT02393859|566047518|FG001|Overall Study|Death|10|||
156806905|NCT02393859|566047517|FG000|Overall Study|Lost to Follow-up|1|||
156806906|NCT02393859|566047518|FG001|Overall Study|Lost to Follow-up|1|||
156806907|NCT00954447|566047519|FG000|Overall Study|Adverse Event|33|||
156806908|NCT00954447|566047520|FG001|Overall Study|Adverse Event|25|||
156806909|NCT00954447|566047519|FG000|Overall Study|Lack of Efficacy|17|||
156806910|NCT00954447|566047520|FG001|Overall Study|Lack of Efficacy|3|||
156806911|NCT00954447|566047519|FG000|Overall Study|Protocol Violation|5|||
156806912|NCT00954447|566047520|FG001|Overall Study|Protocol Violation|7|||
156806913|NCT00954447|566047519|FG000|Overall Study|Lost to Follow-up|8|||
156806914|NCT00954447|566047520|FG001|Overall Study|Lost to Follow-up|14|||
156806915|NCT00954447|566047519|FG000|Overall Study|Withdrawal by Subject|26|||
156806916|NCT00954447|566047520|FG001|Overall Study|Withdrawal by Subject|21|||
156806917|NCT00954447|566047519|FG000|Overall Study|Other|21|||
156806918|NCT00954447|566047520|FG001|Overall Study|Other|18|||
156806919|NCT01979614|566047521|FG000|Overall Study|Adverse Event|1|||
156460246|NCT04167553|564780182|FG000|Overall Study|Physician Decision|0|||
156460247|NCT04167553|564780183|FG001|Overall Study|Physician Decision|0|||
156460248|NCT04167553|564780184|FG002|Overall Study|Physician Decision|0|||
156460249|NCT04167553|564780185|FG003|Overall Study|Physician Decision|0|||
156460250|NCT04167553|564780186|FG004|Overall Study|Physician Decision|2|||
156460251|NCT04167553|564780187|FG005|Overall Study|Physician Decision|2|||
156460252|NCT04167553|564780188|FG006|Overall Study|Physician Decision|0|||
156806920|NCT01979614|566047522|FG001|Overall Study|Adverse Event|1|||
156338026|NCT01847274|564336530|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156338027|NCT01847274|564336531|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156338028|NCT01847274|564336532|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156338029|NCT01847274|564336522|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
156338030|NCT01847274|564336523|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
156338031|NCT01847274|564336524|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
156338032|NCT01847274|564336525|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
156338033|NCT01847274|564336526|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156338034|NCT01847274|564336527|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156338035|NCT01847274|564336528|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156338036|NCT01847274|564336529|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156338037|NCT01847274|564336530|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156338038|NCT01847274|564336531|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156338039|NCT01847274|564336532|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156338040|NCT01847274|564336522|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156338041|NCT01847274|564336523|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156338042|NCT01847274|564336524|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156338043|NCT01847274|564336525|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156338044|NCT01847274|564336526|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156338045|NCT01847274|564336527|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
156338046|NCT01847274|564336528|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156537316|NCT00467779|565061096|FG001|Stage 2|Unspecified Reason|0|||
156537317|NCT00467779|565061097|FG002|Stage 2|Unspecified Reason|0|||
156537318|NCT00467779|565061098|FG003|Stage 2|Unspecified Reason|0|||
156537319|NCT00467779|565061099|FG004|Stage 2|Unspecified Reason|0|||
156537320|NCT00467779|565061100|FG005|Stage 2|Unspecified Reason|0|||
156537321|NCT00467779|565061101|FG006|Stage 2|Unspecified Reason|0|||
156537322|NCT00467779|565061102|FG007|Stage 2|Unspecified Reason|0|||
156537323|NCT00467779|565061103|FG008|Stage 2|Unspecified Reason|3|||
156537324|NCT00467779|565061104|FG009|Stage 2|Unspecified Reason|0|||
156537325|NCT00467779|565061105|FG010|Stage 2|Unspecified Reason|0|||
156537326|NCT00467779|565061106|FG011|Stage 2|Unspecified Reason|0|||
156537327|NCT00467779|565061107|FG012|Stage 2|Unspecified Reason|0|||
156537328|NCT00467779|565061108|FG013|Stage 2|Unspecified Reason|0|||
156537329|NCT00467779|565061109|FG014|Stage 2|Unspecified Reason|0|||
156537330|NCT00467779|565061095|FG000|Stage 2A|Adverse Event|0|||
156537331|NCT00467779|565061096|FG001|Stage 2A|Adverse Event|0|||
156537332|NCT00467779|565061097|FG002|Stage 2A|Adverse Event|0|||
156537333|NCT00467779|565061098|FG003|Stage 2A|Adverse Event|0|||
156537334|NCT00467779|565061099|FG004|Stage 2A|Adverse Event|0|||
156537335|NCT00467779|565061100|FG005|Stage 2A|Adverse Event|0|||
156537336|NCT00467779|565061101|FG006|Stage 2A|Adverse Event|0|||
156537337|NCT00467779|565061102|FG007|Stage 2A|Adverse Event|0|||
156537338|NCT00467779|565061103|FG008|Stage 2A|Adverse Event|0|||
156537339|NCT00467779|565061104|FG009|Stage 2A|Adverse Event|0|||
156537340|NCT00467779|565061105|FG010|Stage 2A|Adverse Event|0|||
156537341|NCT00467779|565061106|FG011|Stage 2A|Adverse Event|0|||
156537342|NCT00467779|565061107|FG012|Stage 2A|Adverse Event|0|||
156537343|NCT00467779|565061108|FG013|Stage 2A|Adverse Event|2|||
156537344|NCT00467779|565061109|FG014|Stage 2A|Adverse Event|0|||
156537345|NCT00467779|565061095|FG000|Stage 2A|Death|0|||
156537346|NCT00467779|565061096|FG001|Stage 2A|Death|0|||
156806921|NCT00488514|566047523|FG000|Overall Study|Adverse Event|41|||
156806922|NCT00488514|566047523|FG000|Overall Study|Lost to Follow-up|44|||
156806923|NCT00488514|566047523|FG000|Overall Study|Protocol Violation|32|||
156806924|NCT00488514|566047523|FG000|Overall Study|Withdrawal by Subject|106|||
156806925|NCT00488514|566047523|FG000|Overall Study|Lack of Efficacy|28|||
156806926|NCT00488514|566047523|FG000|Overall Study|Did not meet criteria for treatment|30|||
156806927|NCT00488514|566047523|FG000|Overall Study|Postive drug screen|1|||
156806928|NCT00488514|566047523|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
156806929|NCT00488514|566047523|FG000|Overall Study|Investigator decision|1|||
156806930|NCT00488514|566047523|FG000|Overall Study|Participant had too few migraines|5|||
156806931|NCT00488514|566047523|FG000|Overall Study|Increase in number of migraines|2|||
156806932|NCT00488514|566047523|FG000|Overall Study|Increased use of concomitant medication|1|||
156806933|NCT00628446|566047526|FG000|Overall Study|Lost to Follow-up|3|||
156806934|NCT00628446|566047526|FG000|Overall Study|Withdrawal by Subject|1|||
156806935|NCT00628446|566047526|FG000|Overall Study|Protocol Violation|3|||
156806936|NCT00756275|566047527|FG000|Overall Study|Lost to Follow-up|25|||
156806937|NCT00756275|566047528|FG001|Overall Study|Lost to Follow-up|21|||
156806938|NCT00756275|566047527|FG000|Overall Study|Withdrawal by Subject|4|||
156806939|NCT00756275|566047528|FG001|Overall Study|Withdrawal by Subject|7|||
156806940|NCT04971967|566047531|FG000|Overall Study|Lost to Follow-up|6|||
156806941|NCT04971967|566047532|FG001|Overall Study|Lost to Follow-up|7|||
156806942|NCT00682929|566047539|FG000|Overall Study|Adverse Event|4|||
156806943|NCT00682929|566047540|FG001|Overall Study|Adverse Event|1|||
156806944|NCT00682929|566047541|FG002|Overall Study|Adverse Event|1|||
156537347|NCT00467779|565061097|FG002|Stage 2A|Death|0|||
156806945|NCT00682929|566047539|FG000|Overall Study|Withdrawal by Subject|1|||
156537348|NCT00467779|565061098|FG003|Stage 2A|Death|0|||
156537349|NCT00467779|565061099|FG004|Stage 2A|Death|0|||
156537350|NCT00467779|565061100|FG005|Stage 2A|Death|0|||
156537351|NCT00467779|565061101|FG006|Stage 2A|Death|0|||
156537352|NCT00467779|565061102|FG007|Stage 2A|Death|0|||
156537353|NCT00467779|565061103|FG008|Stage 2A|Death|0|||
156537354|NCT00467779|565061104|FG009|Stage 2A|Death|0|||
156537355|NCT00467779|565061105|FG010|Stage 2A|Death|0|||
156537356|NCT00467779|565061106|FG011|Stage 2A|Death|0|||
156537357|NCT00467779|565061107|FG012|Stage 2A|Death|0|||
156537358|NCT00467779|565061108|FG013|Stage 2A|Death|1|||
156537359|NCT00467779|565061109|FG014|Stage 2A|Death|0|||
156537360|NCT00467779|565061095|FG000|Stage 2A|Disease Progression|0|||
156537361|NCT00467779|565061096|FG001|Stage 2A|Disease Progression|0|||
156537362|NCT00467779|565061097|FG002|Stage 2A|Disease Progression|0|||
156537363|NCT00467779|565061098|FG003|Stage 2A|Disease Progression|0|||
156537364|NCT00467779|565061099|FG004|Stage 2A|Disease Progression|0|||
156537365|NCT00467779|565061100|FG005|Stage 2A|Disease Progression|0|||
156537366|NCT00467779|565061101|FG006|Stage 2A|Disease Progression|0|||
156537367|NCT00467779|565061102|FG007|Stage 2A|Disease Progression|0|||
156537368|NCT00467779|565061103|FG008|Stage 2A|Disease Progression|0|||
156537369|NCT00467779|565061104|FG009|Stage 2A|Disease Progression|0|||
156537370|NCT00467779|565061105|FG010|Stage 2A|Disease Progression|0|||
156537371|NCT00467779|565061106|FG011|Stage 2A|Disease Progression|0|||
156537372|NCT00467779|565061107|FG012|Stage 2A|Disease Progression|0|||
156537373|NCT00467779|565061108|FG013|Stage 2A|Disease Progression|10|||
156537374|NCT00467779|565061109|FG014|Stage 2A|Disease Progression|0|||
156537375|NCT00467779|565061095|FG000|Stage 2A|Unspecified Reason|0|||
156537376|NCT00467779|565061096|FG001|Stage 2A|Unspecified Reason|0|||
156537377|NCT00467779|565061097|FG002|Stage 2A|Unspecified Reason|0|||
156537378|NCT00467779|565061098|FG003|Stage 2A|Unspecified Reason|0|||
156537379|NCT00467779|565061099|FG004|Stage 2A|Unspecified Reason|0|||
156537380|NCT00467779|565061100|FG005|Stage 2A|Unspecified Reason|0|||
156537381|NCT00467779|565061101|FG006|Stage 2A|Unspecified Reason|0|||
156537382|NCT00467779|565061102|FG007|Stage 2A|Unspecified Reason|0|||
156537383|NCT00467779|565061103|FG008|Stage 2A|Unspecified Reason|0|||
156537384|NCT00467779|565061104|FG009|Stage 2A|Unspecified Reason|0|||
156537385|NCT00467779|565061105|FG010|Stage 2A|Unspecified Reason|0|||
156537386|NCT00467779|565061106|FG011|Stage 2A|Unspecified Reason|0|||
156537387|NCT00467779|565061107|FG012|Stage 2A|Unspecified Reason|0|||
156537388|NCT00467779|565061108|FG013|Stage 2A|Unspecified Reason|7|||
156537389|NCT00467779|565061109|FG014|Stage 2A|Unspecified Reason|0|||
156537390|NCT00467779|565061095|FG000|Stage 2A|Withdrawal by Subject|0|||
156537391|NCT00467779|565061096|FG001|Stage 2A|Withdrawal by Subject|0|||
156537392|NCT00467779|565061097|FG002|Stage 2A|Withdrawal by Subject|0|||
156537393|NCT00467779|565061098|FG003|Stage 2A|Withdrawal by Subject|0|||
156537394|NCT00467779|565061099|FG004|Stage 2A|Withdrawal by Subject|0|||
156537395|NCT00467779|565061100|FG005|Stage 2A|Withdrawal by Subject|0|||
156806946|NCT00682929|566047540|FG001|Overall Study|Withdrawal by Subject|2|||
156806947|NCT00682929|566047541|FG002|Overall Study|Withdrawal by Subject|1|||
156806948|NCT00682929|566047539|FG000|Overall Study|dosing compliance < 80%|0|||
156806949|NCT00682929|566047540|FG001|Overall Study|dosing compliance < 80%|2|||
156806950|NCT00682929|566047541|FG002|Overall Study|dosing compliance < 80%|0|||
156806951|NCT00682929|566047539|FG000|Overall Study|lag in DEA renewal|1|||
156806952|NCT00682929|566047540|FG001|Overall Study|lag in DEA renewal|0|||
156806953|NCT00682929|566047541|FG002|Overall Study|lag in DEA renewal|0|||
156806954|NCT00938912|566047542|FG000|Overall Study|Withdrawal by Subject|28|||
156806955|NCT00938912|566047542|FG000|Overall Study|Lost to Follow-up|4|||
156806956|NCT00938912|566047542|FG000|Overall Study|Lack of Efficacy|43|||
156806957|NCT00938912|566047542|FG000|Overall Study|Adverse event, non-fatal|24|||
156806958|NCT00938912|566047542|FG000|Overall Study|Adverse event, fatal|1|||
156806959|NCT00938912|566047542|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
156806960|NCT00938912|566047542|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
156806961|NCT00938912|566047542|FG000|Overall Study|Participant needed prohibit medication|1|||
156806962|NCT00938912|566047542|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
156537396|NCT00467779|565061101|FG006|Stage 2A|Withdrawal by Subject|0|||
156537397|NCT00467779|565061102|FG007|Stage 2A|Withdrawal by Subject|0|||
156537398|NCT00467779|565061103|FG008|Stage 2A|Withdrawal by Subject|0|||
156537399|NCT00467779|565061104|FG009|Stage 2A|Withdrawal by Subject|0|||
156537400|NCT00467779|565061105|FG010|Stage 2A|Withdrawal by Subject|0|||
156537401|NCT00467779|565061106|FG011|Stage 2A|Withdrawal by Subject|0|||
156537402|NCT00467779|565061107|FG012|Stage 2A|Withdrawal by Subject|0|||
156537403|NCT00467779|565061108|FG013|Stage 2A|Withdrawal by Subject|1|||
156537404|NCT00467779|565061109|FG014|Stage 2A|Withdrawal by Subject|0|||
156537405|NCT00467779|565061095|FG000|Stage 3|Adverse Event|0|||
156537406|NCT00467779|565061096|FG001|Stage 3|Adverse Event|0|||
156537407|NCT00467779|565061097|FG002|Stage 3|Adverse Event|0|||
156537408|NCT00467779|565061098|FG003|Stage 3|Adverse Event|0|||
156460253|NCT04167553|564780182|FG000|Overall Study|Lost to Follow-up|0|||
156806963|NCT00938912|566047542|FG000|Overall Study|Did not meet Eligibility criteria|1|||
156806964|NCT00938912|566047542|FG000|Overall Study|Participant relocated not related to AE|1|||
156806965|NCT00938912|566047542|FG000|Overall Study|Participant moved to another city|1|||
156806966|NCT00938912|566047542|FG000|Overall Study|Participant experienced break through seizures|1|||
156806967|NCT00938912|566047542|FG000|Overall Study|No longer wished to participate in the study|1|||
156460254|NCT04167553|564780183|FG001|Overall Study|Lost to Follow-up|0|||
156806968|NCT00938912|566047542|FG000|Overall Study|Protocol Deviation|2|||
156806969|NCT01772550|566047545|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
156806970|NCT01772550|566047546|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
156806971|NCT01772550|566047547|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
156806972|NCT01772550|566047545|FG000|Overall Study|Adverse Event|0|||
156806973|NCT01772550|566047546|FG001|Overall Study|Adverse Event|0|||
156806974|NCT01772550|566047547|FG002|Overall Study|Adverse Event|1|||
156806975|NCT00559104|566047548|FG000|Overall Study|Lack of Efficacy|9|||
156806976|NCT00559104|566047549|FG001|Overall Study|Lack of Efficacy|0|||
156806977|NCT01694433|566047554|FG000|Overall Study|Adverse Event|7|||
156806978|NCT01694433|566047555|FG001|Overall Study|Adverse Event|0|||
156806979|NCT01694433|566047554|FG000|Overall Study|Physician Decision|1|||
156806980|NCT01694433|566047555|FG001|Overall Study|Physician Decision|0|||
156806981|NCT01694433|566047554|FG000|Overall Study|Withdrawal by Subject|3|||
156806982|NCT01694433|566047555|FG001|Overall Study|Withdrawal by Subject|4|||
156806983|NCT00374595|566047556|FG000|Overall Study|Death|23|||
156806984|NCT00374595|566047556|FG000|Overall Study|Withdrawal by Subject|39|||
156806985|NCT00374595|566047556|FG000|Overall Study|Lost to Follow-up|3|||
156806986|NCT00374595|566047556|FG000|Overall Study|too much time commitment|1|||
156806987|NCT00374595|566047556|FG000|Overall Study|transfer care to other clinical site|1|||
156806988|NCT00374595|566047556|FG000|Overall Study|relocation|3|||
156806989|NCT03745768|566047558|FG000|Overall Study|discontinued study|2|||
156806990|NCT03745768|566047559|FG001|Overall Study|discontinued study|0|||
156460255|NCT04167553|564780184|FG002|Overall Study|Lost to Follow-up|2|||
156460256|NCT04167553|564780185|FG003|Overall Study|Lost to Follow-up|0|||
156460257|NCT04167553|564780186|FG004|Overall Study|Lost to Follow-up|0|||
156460258|NCT04167553|564780187|FG005|Overall Study|Lost to Follow-up|0|||
156460259|NCT04167553|564780188|FG006|Overall Study|Lost to Follow-up|0|||
156460260|NCT02828358|564780189|FG000|Overall Study|Physician Decision|7|||
156460261|NCT02828358|564780190|FG001|Overall Study|Physician Decision|1|||
156460262|NCT02828358|564780189|FG000|Overall Study|Treatment Failure|6|||
156460263|NCT02828358|564780190|FG001|Overall Study|Treatment Failure|0|||
156460264|NCT02828358|564780189|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
156460265|NCT02828358|564780190|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
156460266|NCT02828358|564780189|FG000|Overall Study|Refusal of further protocol therapy|2|||
156460267|NCT02828358|564780190|FG001|Overall Study|Refusal of further protocol therapy|0|||
156460268|NCT02828358|564780189|FG000|Overall Study|Relapse|25|||
156460269|NCT02828358|564780190|FG001|Overall Study|Relapse|0|||
156537409|NCT00467779|565061099|FG004|Stage 3|Adverse Event|0|||
156537410|NCT00467779|565061100|FG005|Stage 3|Adverse Event|0|||
156537411|NCT00467779|565061101|FG006|Stage 3|Adverse Event|0|||
156537412|NCT00467779|565061102|FG007|Stage 3|Adverse Event|0|||
156537413|NCT00467779|565061103|FG008|Stage 3|Adverse Event|0|||
156537414|NCT00467779|565061104|FG009|Stage 3|Adverse Event|0|||
156806991|NCT00443118|566047560|FG000|Overall Study|unknown primary outcome|3|||
156806992|NCT00443118|566047561|FG001|Overall Study|unknown primary outcome|1|||
156806993|NCT00443118|566047562|FG002|Overall Study|unknown primary outcome|0|||
156806994|NCT00443118|566047560|FG000|Overall Study|Withdrawal by Subject|1|||
156806995|NCT00443118|566047561|FG001|Overall Study|Withdrawal by Subject|0|||
156806996|NCT00443118|566047562|FG002|Overall Study|Withdrawal by Subject|0|||
156806997|NCT02298868|566047570|FG000|Overall Study|Adverse Event|1|||
156806998|NCT02298868|566047570|FG000|Overall Study|Death|1|||
156806999|NCT02298868|566047570|FG000|Overall Study|Patient underwent transplant|1|||
156807000|NCT01194245|566047571|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
156807001|NCT01194245|566047572|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
156807002|NCT01194245|566047573|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
156807003|NCT01194245|566047574|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
156807004|NCT01194245|566047575|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
156807005|NCT01194245|566047571|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
156807006|NCT01194245|566047572|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
156460270|NCT02828358|564780189|FG000|Overall Study|Still on therapy|5|||
156460271|NCT02828358|564780190|FG001|Overall Study|Still on therapy|0|||
156460272|NCT05285137|564780203|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
156460273|NCT05285137|564780204|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
156460274|NCT05285137|564780205|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
156537415|NCT00467779|565061105|FG010|Stage 3|Adverse Event|0|||
156537416|NCT00467779|565061106|FG011|Stage 3|Adverse Event|0|||
156460275|NCT05285137|564780206|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
156460276|NCT05285137|564780207|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
156460277|NCT05285137|564780208|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
156460278|NCT05285137|564780209|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
156460279|NCT05285137|564780210|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
156460280|NCT05285137|564780211|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
156460281|NCT05285137|564780203|FG000|Overall Study|Lost to Follow-up|0|||
156460282|NCT05285137|564780204|FG001|Overall Study|Lost to Follow-up|0|||
156460283|NCT05285137|564780205|FG002|Overall Study|Lost to Follow-up|1|||
156460284|NCT05285137|564780206|FG003|Overall Study|Lost to Follow-up|3|||
156460285|NCT05285137|564780207|FG004|Overall Study|Lost to Follow-up|0|||
156460286|NCT05285137|564780208|FG005|Overall Study|Lost to Follow-up|0|||
156460287|NCT05285137|564780209|FG006|Overall Study|Lost to Follow-up|1|||
156460288|NCT05285137|564780210|FG007|Overall Study|Lost to Follow-up|0|||
156460289|NCT05285137|564780211|FG008|Overall Study|Lost to Follow-up|0|||
156460290|NCT05285137|564780203|FG000|Overall Study|Physician Decision|0|||
156460291|NCT05285137|564780204|FG001|Overall Study|Physician Decision|1|||
156460292|NCT05285137|564780205|FG002|Overall Study|Physician Decision|0|||
156460293|NCT05285137|564780206|FG003|Overall Study|Physician Decision|0|||
156460294|NCT05285137|564780207|FG004|Overall Study|Physician Decision|0|||
156460295|NCT05285137|564780208|FG005|Overall Study|Physician Decision|0|||
156460296|NCT05285137|564780209|FG006|Overall Study|Physician Decision|0|||
156460297|NCT05285137|564780210|FG007|Overall Study|Physician Decision|0|||
156460298|NCT05285137|564780211|FG008|Overall Study|Physician Decision|0|||
156460299|NCT05285137|564780203|FG000|Overall Study|Pregnancy|0|||
156460300|NCT05285137|564780204|FG001|Overall Study|Pregnancy|0|||
156460301|NCT05285137|564780205|FG002|Overall Study|Pregnancy|0|||
156460302|NCT05285137|564780206|FG003|Overall Study|Pregnancy|0|||
156460303|NCT05285137|564780207|FG004|Overall Study|Pregnancy|0|||
156460304|NCT05285137|564780208|FG005|Overall Study|Pregnancy|0|||
156460305|NCT05285137|564780209|FG006|Overall Study|Pregnancy|1|||
156460306|NCT05285137|564780210|FG007|Overall Study|Pregnancy|0|||
156460307|NCT05285137|564780211|FG008|Overall Study|Pregnancy|0|||
156460308|NCT05285137|564780203|FG000|Overall Study|Withdrawal by Subject|0|||
156460309|NCT05285137|564780204|FG001|Overall Study|Withdrawal by Subject|1|||
156460310|NCT05285137|564780205|FG002|Overall Study|Withdrawal by Subject|2|||
156460311|NCT05285137|564780206|FG003|Overall Study|Withdrawal by Subject|1|||
156460312|NCT05285137|564780207|FG004|Overall Study|Withdrawal by Subject|0|||
156460313|NCT05285137|564780208|FG005|Overall Study|Withdrawal by Subject|0|||
156460314|NCT05285137|564780209|FG006|Overall Study|Withdrawal by Subject|0|||
156460315|NCT05285137|564780210|FG007|Overall Study|Withdrawal by Subject|0|||
156460316|NCT05285137|564780211|FG008|Overall Study|Withdrawal by Subject|1|||
156460317|NCT04479761|564780212|FG000|Overall Study|could not perform the balance tasks|1|||
156460318|NCT04479761|564780213|FG001|Overall Study|could not perform the balance tasks|0|||
156460319|NCT04479761|564780214|FG002|Overall Study|could not perform the balance tasks|0|||
156460320|NCT04479761|564780212|FG000|Overall Study|Adverse Event|1|||
156460321|NCT04479761|564780213|FG001|Overall Study|Adverse Event|0|||
156460322|NCT04479761|564780214|FG002|Overall Study|Adverse Event|0|||
156460323|NCT04479761|564780212|FG000|Overall Study|one control did not meet screening criteria|0|||
156460324|NCT04479761|564780213|FG001|Overall Study|one control did not meet screening criteria|0|||
156460325|NCT04479761|564780214|FG002|Overall Study|one control did not meet screening criteria|1|||
156460326|NCT04479761|564780212|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
156460327|NCT04479761|564780213|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
156460328|NCT04479761|564780214|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
156807007|NCT01194245|566047573|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
156807008|NCT01194245|566047574|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
156807009|NCT01194245|566047575|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
156807010|NCT01194245|566047571|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
156807011|NCT01194245|566047572|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
156807012|NCT01194245|566047573|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
156807013|NCT01194245|566047574|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
156807014|NCT01194245|566047575|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
156460329|NCT05209152|564780215|FG000|Overall Study|Sponsor decision|1|||
156460330|NCT05209152|564780216|FG001|Overall Study|Sponsor decision|2|||
156460331|NCT05209152|564780215|FG000|Overall Study|Death|3|||
156460332|NCT05209152|564780216|FG001|Overall Study|Death|1|||
156460333|NCT05809453|564781603|FG000|Overall Study|Withdrawal by Subject|1|||
156460334|NCT05809453|564781604|FG001|Overall Study|Withdrawal by Subject|0|||
156460335|NCT05809453|564781605|FG002|Overall Study|Withdrawal by Subject|0|||
156460336|NCT05809453|564781606|FG003|Overall Study|Withdrawal by Subject|0|||
156460337|NCT04183283|564781608|FG000|Period 1|Withdrawal by Subject|0|||
156460338|NCT04183283|564781609|FG001|Period 1|Withdrawal by Subject|1|||
156460339|NCT04183283|564781610|FG002|Period 1|Withdrawal by Subject|0|||
156460340|NCT04183283|564781611|FG003|Period 1|Withdrawal by Subject|0|||
156460341|NCT04183283|564781608|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
156460342|NCT04183283|564781609|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
156460343|NCT04183283|564781610|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
156460344|NCT04183283|564781611|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
156460345|NCT04850898|564781613|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
156460346|NCT04850898|564781614|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
156460347|NCT04909801|564781615|FG000|Overall Study|Lack of Efficacy|2|||
156460348|NCT04909801|564781616|FG001|Overall Study|Lack of Efficacy|1|||
156460349|NCT04909801|564781615|FG000|Overall Study|Adverse Event|1|||
156460350|NCT04909801|564781616|FG001|Overall Study|Adverse Event|2|||
156460351|NCT04909801|564781615|FG000|Overall Study|Participant request to discontinue study treatment|1|||
156460352|NCT04909801|564781616|FG001|Overall Study|Participant request to discontinue study treatment|2|||
156460353|NCT04909801|564781615|FG000|Overall Study|Withdrawal by Subject|2|||
156460354|NCT04909801|564781616|FG001|Overall Study|Withdrawal by Subject|1|||
156460355|NCT04909801|564781615|FG000|Overall Study|other reasons|1|||
156460356|NCT04909801|564781616|FG001|Overall Study|other reasons|1|||
156460357|NCT04550221|564781617|FG000|Overall Study|Lost to Follow-up|0|||
156460358|NCT04550221|564781618|FG001|Overall Study|Lost to Follow-up|4|||
156460359|NCT04550221|564781617|FG000|Overall Study|Withdrawn|3|||
156460360|NCT04550221|564781618|FG001|Overall Study|Withdrawn|0|||
156460361|NCT04550221|564781617|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
156460362|NCT04550221|564781618|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
156460363|NCT04447040|564781619|FG000|Overall Study|Lost to Follow-up|2|||
156460364|NCT04447040|564781620|FG001|Overall Study|Lost to Follow-up|1|||
156460365|NCT04447040|564781621|FG002|Overall Study|Lost to Follow-up|3|||
156460366|NCT04447040|564781622|FG003|Overall Study|Lost to Follow-up|3|||
156460367|NCT04447040|564781623|FG004|Overall Study|Lost to Follow-up|1|||
156460368|NCT04447040|564781624|FG005|Overall Study|Lost to Follow-up|3|||
156460369|NCT04447040|564781619|FG000|Overall Study|Withdrawal by Subject|0|||
156460370|NCT04447040|564781620|FG001|Overall Study|Withdrawal by Subject|1|||
156460371|NCT04447040|564781621|FG002|Overall Study|Withdrawal by Subject|1|||
156460372|NCT04447040|564781622|FG003|Overall Study|Withdrawal by Subject|1|||
156460373|NCT04447040|564781623|FG004|Overall Study|Withdrawal by Subject|0|||
156460374|NCT04447040|564781624|FG005|Overall Study|Withdrawal by Subject|0|||
156460375|NCT01208662|564781625|FG000|Induction and Consolidation|Disease Progression|23|||
156460376|NCT01208662|564781626|FG001|Induction and Consolidation|Disease Progression|13|||
156460377|NCT01208662|564781627|FG002|Induction and Consolidation|Disease Progression|0|||
156460378|NCT01208662|564781625|FG000|Induction and Consolidation|Adverse Event|16|||
156807015|NCT01194245|566047571|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
156807016|NCT01194245|566047572|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
156807017|NCT01194245|566047573|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
156807018|NCT01194245|566047574|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
156807019|NCT01194245|566047575|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
156807020|NCT01194245|566047571|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156807021|NCT01194245|566047572|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156807022|NCT01194245|566047573|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156807023|NCT01194245|566047574|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156807024|NCT01194245|566047575|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
156807025|NCT01194245|566047571|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156807026|NCT01194245|566047572|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156807027|NCT01194245|566047573|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
156807028|NCT01194245|566047574|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
156807029|NCT01194245|566047575|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
156807030|NCT03962855|566047576|FG000|Overall Study|Death|0|||
156807031|NCT03962855|566047577|FG001|Overall Study|Death|1|||
156807032|NCT03962855|566047576|FG000|Overall Study|Lost to Follow-up|0|||
156807033|NCT03962855|566047577|FG001|Overall Study|Lost to Follow-up|1|||
156807034|NCT03962855|566047576|FG000|Overall Study|Adverse Event|0|||
156807035|NCT03962855|566047577|FG001|Overall Study|Adverse Event|1|||
156807036|NCT03962855|566047576|FG000|Overall Study|Physician Decision|0|||
156807037|NCT03962855|566047577|FG001|Overall Study|Physician Decision|2|||
156460379|NCT01208662|564781626|FG001|Induction and Consolidation|Adverse Event|18|||
156460380|NCT01208662|564781627|FG002|Induction and Consolidation|Adverse Event|2|||
156460381|NCT01208662|564781625|FG000|Induction and Consolidation|MD or Participant Decision|16|||
156460382|NCT01208662|564781626|FG001|Induction and Consolidation|MD or Participant Decision|34|||
156460383|NCT01208662|564781627|FG002|Induction and Consolidation|MD or Participant Decision|4|||
156460384|NCT01208662|564781625|FG000|Induction and Consolidation|Death|1|||
156460385|NCT01208662|564781626|FG001|Induction and Consolidation|Death|3|||
156460386|NCT01208662|564781627|FG002|Induction and Consolidation|Death|1|||
156807038|NCT03326063|566047578|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
156807039|NCT03326063|566047579|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
156807040|NCT00881894|566047580|FG000|Overall Study|Consent withdrawn|0|||
156807041|NCT00881894|566047581|FG001|Overall Study|Consent withdrawn|1|||
156807042|NCT00881894|566047580|FG000|Overall Study|Other reasons for premature termination|1|||
156807043|NCT00881894|566047581|FG001|Overall Study|Other reasons for premature termination|2|||
156807044|NCT01253369|566047582|FG000|Overall Study|Adverse Event|4|||
156807045|NCT01253369|566047582|FG000|Overall Study|Withdrawal by Subject|2|||
156807046|NCT01253369|566047582|FG000|Overall Study|Death|1|||
156807047|NCT01253369|566047582|FG000|Overall Study|Progressive disease|23|||
156807048|NCT01253369|566047582|FG000|Overall Study|Not Evaluable|3|||
156807049|NCT01220401|566047587|FG000|Overall Study|Withdrawal by Subject|2|||
156807050|NCT01220401|566047587|FG000|Overall Study|Protocol Violation|1|||
156807051|NCT01853462|566047588|FG000|Overall Study|Withdrawal by Subject|1|||
156807052|NCT01853462|566047589|FG001|Overall Study|Withdrawal by Subject|1|||
156807053|NCT04068922|566047590|FG000|Overall Study|Lost to Follow-up|5|||
156807054|NCT04068922|566047590|FG000|Overall Study|Withdrawal by Subject|7|||
156807055|NCT04068922|566047590|FG000|Overall Study|Adverse Event|1|||
156807056|NCT03192137|566047593|FG000|Overall Study|Adverse Event|10|||
156807057|NCT03192137|566047594|FG001|Overall Study|Adverse Event|11|||
156807058|NCT03192137|566047593|FG000|Overall Study|Physician Decision|1|||
156807059|NCT03192137|566047594|FG001|Overall Study|Physician Decision|0|||
156807060|NCT03192137|566047593|FG000|Overall Study|Lack of Efficacy|20|||
156807061|NCT03192137|566047594|FG001|Overall Study|Lack of Efficacy|37|||
156807062|NCT03192137|566047593|FG000|Overall Study|Withdrawal by Subject|3|||
156807063|NCT03192137|566047594|FG001|Overall Study|Withdrawal by Subject|3|||
156807064|NCT03192137|566047593|FG000|Overall Study|Protocol Violation|4|||
156807065|NCT03192137|566047594|FG001|Overall Study|Protocol Violation|3|||
156807066|NCT03192137|566047593|FG000|Overall Study|Surgery Cancelled|4|||
156807067|NCT03192137|566047594|FG001|Overall Study|Surgery Cancelled|1|||
156807068|NCT03192137|566047593|FG000|Overall Study|Other - Various Administrative Reasons|8|||
156807069|NCT03192137|566047594|FG001|Overall Study|Other - Various Administrative Reasons|3|||
156807070|NCT01261975|566047599|FG000|Overall Study|Surgical complication|1|||
156807071|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
156807072|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807073|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807074|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807075|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807076|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807077|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
156807078|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
156807079|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
156807080|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
156807081|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
156807082|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
156807083|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
156807084|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156807085|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156460387|NCT01208662|564781625|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
156460388|NCT01208662|564781626|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
156460389|NCT01208662|564781627|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
156460390|NCT01208662|564781625|FG000|Maintenance|Disease Progression|156|||
156460391|NCT01208662|564781626|FG001|Maintenance|Disease Progression|102|||
156460392|NCT01208662|564781627|FG002|Maintenance|Disease Progression|0|||
156460393|NCT01208662|564781625|FG000|Maintenance|Adverse Event|12|||
156460394|NCT01208662|564781626|FG001|Maintenance|Adverse Event|28|||
156460395|NCT01208662|564781627|FG002|Maintenance|Adverse Event|0|||
156460396|NCT01208662|564781625|FG000|Maintenance|MD or Participant Decision|24|||
156537417|NCT00467779|565061107|FG012|Stage 3|Adverse Event|0|||
156807086|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156807087|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156807088|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156807089|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
156807090|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
156807091|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
156807092|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
156807093|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
156807094|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
156460397|NCT01208662|564781626|FG001|Maintenance|MD or Participant Decision|36|||
156537418|NCT00467779|565061108|FG013|Stage 3|Adverse Event|0|||
156807095|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
156807096|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
156807097|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
156807098|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
156807099|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
156807100|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
156807101|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807102|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
156807103|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807104|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807105|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807106|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807107|NCT00716274|566047600|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807108|NCT00716274|566047601|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807109|NCT00716274|566047602|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
156807110|NCT00716274|566047603|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807111|NCT00716274|566047604|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807112|NCT00716274|566047605|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807113|NCT00716274|566047600|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
156807114|NCT00716274|566047601|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
156807115|NCT00716274|566047602|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
156807116|NCT00716274|566047603|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
156807117|NCT00716274|566047604|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
156807118|NCT00716274|566047605|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
156807119|NCT00716274|566047600|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
156807120|NCT00716274|566047601|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
156807121|NCT00716274|566047602|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
156807122|NCT00716274|566047603|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
156807123|NCT00716274|566047604|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
156807124|NCT00716274|566047605|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
156807125|NCT00716274|566047600|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
156807126|NCT00716274|566047601|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
156807127|NCT00716274|566047602|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
156807128|NCT00716274|566047603|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
156807129|NCT00716274|566047604|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
156807130|NCT00716274|566047605|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
156807131|NCT01932788|566047606|FG000|Overall Study|Protocol Violation|18|||
156807132|NCT01932788|566047607|FG001|Overall Study|Protocol Violation|0|||
156807133|NCT01932788|566047606|FG000|Overall Study|Lost to Follow-up|18|||
156807134|NCT01932788|566047607|FG001|Overall Study|Lost to Follow-up|46|||
156807135|NCT01932788|566047606|FG000|Overall Study|Lack of Efficacy|2|||
156807136|NCT01932788|566047607|FG001|Overall Study|Lack of Efficacy|0|||
156807137|NCT01932788|566047606|FG000|Overall Study|Withdrawal by Subject|0|||
156807138|NCT01932788|566047607|FG001|Overall Study|Withdrawal by Subject|5|||
156807139|NCT04790279|566049532|FG000|Overall Study|Did not meet medication start criteria|27|||
156807140|NCT04790279|566049533|FG001|Overall Study|Did not meet medication start criteria|15|||
156807141|NCT04790279|566049532|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
156807142|NCT04790279|566049533|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
156807143|NCT04790279|566049532|FG000|Overall Study|Protocol Violation|8|||
156807144|NCT04790279|566049533|FG001|Overall Study|Protocol Violation|3|||
156807145|NCT04790279|566049532|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
156807146|NCT04790279|566049533|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
156807147|NCT00784368|566049536|FG000|Overall Study|Physician Decision|0|||
156807148|NCT00784368|566049537|FG001|Overall Study|Physician Decision|0|||
156807149|NCT00784368|566049538|FG002|Overall Study|Physician Decision|6|||
156807150|NCT00784368|566049536|FG000|Overall Study|Lack of Efficacy|2|||
156807151|NCT00784368|566049537|FG001|Overall Study|Lack of Efficacy|0|||
156807152|NCT00784368|566049538|FG002|Overall Study|Lack of Efficacy|1|||
156807153|NCT00784368|566049536|FG000|Overall Study|Adverse Event|6|||
156807154|NCT00784368|566049537|FG001|Overall Study|Adverse Event|9|||
156807155|NCT00784368|566049538|FG002|Overall Study|Adverse Event|2|||
156807156|NCT00784368|566049536|FG000|Overall Study|Diagnosis of fever|0|||
156807157|NCT00784368|566049537|FG001|Overall Study|Diagnosis of fever|0|||
156807158|NCT00784368|566049538|FG002|Overall Study|Diagnosis of fever|1|||
156807159|NCT00784368|566049536|FG000|Overall Study|Worsening of complications|0|||
156807160|NCT00784368|566049537|FG001|Overall Study|Worsening of complications|0|||
156807161|NCT00784368|566049538|FG002|Overall Study|Worsening of complications|1|||
156807162|NCT00784368|566049536|FG000|Overall Study|Worsening of symptoms|0|||
156338047|NCT01847274|564336529|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156807163|NCT00784368|566049537|FG001|Overall Study|Worsening of symptoms|1|||
156807164|NCT00784368|566049538|FG002|Overall Study|Worsening of symptoms|0|||
156807165|NCT00784368|566049536|FG000|Overall Study|Withdrawal of informed consent|0|||
156807166|NCT00784368|566049537|FG001|Overall Study|Withdrawal of informed consent|1|||
156807167|NCT00784368|566049538|FG002|Overall Study|Withdrawal of informed consent|0|||
156807168|NCT01475721|566049544|FG000|Overall Study|Death|3|||
156807169|NCT01475721|566049545|FG001|Overall Study|Death|6|||
156460398|NCT01208662|564781627|FG002|Maintenance|MD or Participant Decision|0|||
156460399|NCT01208662|564781625|FG000|Maintenance|Death|0|||
156460400|NCT01208662|564781626|FG001|Maintenance|Death|3|||
156460401|NCT01208662|564781627|FG002|Maintenance|Death|0|||
156460402|NCT01208662|564781625|FG000|Maintenance|Discontinued for other reasons|21|||
156460403|NCT01208662|564781626|FG001|Maintenance|Discontinued for other reasons|31|||
156460404|NCT01208662|564781627|FG002|Maintenance|Discontinued for other reasons|0|||
156807170|NCT01475721|566049544|FG000|Overall Study|Withdrawal by Subject|8|||
156807171|NCT01475721|566049545|FG001|Overall Study|Withdrawal by Subject|8|||
156807172|NCT00803738|566049547|FG000|Overall Study|Adverse Event|3|||
156807173|NCT00803738|566049548|FG001|Overall Study|Adverse Event|5|||
156807174|NCT00803738|566049547|FG000|Overall Study|Lost to Follow-up|4|||
156807175|NCT00803738|566049548|FG001|Overall Study|Lost to Follow-up|4|||
156807176|NCT00803738|566049547|FG000|Overall Study|Protocol Violation|18|||
156807177|NCT00803738|566049548|FG001|Overall Study|Protocol Violation|10|||
156807178|NCT00803738|566049547|FG000|Overall Study|Withdrawal by Subject|1|||
156807179|NCT00803738|566049548|FG001|Overall Study|Withdrawal by Subject|4|||
156807180|NCT00803738|566049547|FG000|Overall Study|Lack of Efficacy|10|||
156807181|NCT00803738|566049548|FG001|Overall Study|Lack of Efficacy|16|||
156807182|NCT00803738|566049547|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
156807183|NCT00803738|566049548|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
156807184|NCT00803738|566049547|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
156807185|NCT00803738|566049548|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
156807186|NCT01048242|566049549|FG000|Overall Study|See study flow chart|4|||
156807187|NCT01048242|566049550|FG001|Overall Study|See study flow chart|2|||
156807188|NCT02364037|566049551|FG000|Overall Study|Withdrawal by Subject|7|||
156807189|NCT02364037|566049552|FG001|Overall Study|Withdrawal by Subject|4|||
156807190|NCT02364037|566049551|FG000|Overall Study|Lost to Follow-up|37|||
156807191|NCT02364037|566049552|FG001|Overall Study|Lost to Follow-up|49|||
156807192|NCT01453036|566049553|FG000|Overall Study|Lost to Follow-up|26|||
156807193|NCT01453036|566049554|FG001|Overall Study|Lost to Follow-up|115|||
156807194|NCT01453036|566049555|FG002|Overall Study|Lost to Follow-up|31|||
156807195|NCT01815424|566049557|FG000|Week 0 to 16|Adverse Event|1|||
156807196|NCT01815424|566049558|FG001|Week 0 to 16|Adverse Event|3|||
156807197|NCT01815424|566049559|FG002|Week 0 to 16|Adverse Event|3|||
156807198|NCT01815424|566049560|FG003|Week 0 to 16|Adverse Event|0|||
156807199|NCT01815424|566049561|FG004|Week 0 to 16|Adverse Event|0|||
156807200|NCT01815424|566049557|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
156807201|NCT01815424|566049558|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
156807202|NCT01815424|566049559|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
156807203|NCT01815424|566049560|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
156807204|NCT01815424|566049561|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
156807205|NCT01815424|566049557|FG000|Week 0 to 16|Lost to Follow-up|0|||
156807206|NCT01815424|566049558|FG001|Week 0 to 16|Lost to Follow-up|1|||
156807207|NCT01815424|566049559|FG002|Week 0 to 16|Lost to Follow-up|0|||
156807208|NCT01815424|566049560|FG003|Week 0 to 16|Lost to Follow-up|0|||
156807209|NCT01815424|566049561|FG004|Week 0 to 16|Lost to Follow-up|0|||
156807210|NCT01815424|566049557|FG000|Week 0 to 16|Withdrawal by Subject|0|||
156807211|NCT01815424|566049558|FG001|Week 0 to 16|Withdrawal by Subject|0|||
156807212|NCT01815424|566049559|FG002|Week 0 to 16|Withdrawal by Subject|1|||
156460405|NCT01208662|564781625|FG000|Maintenance|Still on Treatment|78|||
156807213|NCT01815424|566049560|FG003|Week 0 to 16|Withdrawal by Subject|0|||
156807214|NCT01815424|566049561|FG004|Week 0 to 16|Withdrawal by Subject|0|||
156807215|NCT01815424|566049557|FG000|Week 0 to 16|Other|1|||
156807216|NCT01815424|566049558|FG001|Week 0 to 16|Other|0|||
156807217|NCT01815424|566049559|FG002|Week 0 to 16|Other|3|||
156807218|NCT01815424|566049560|FG003|Week 0 to 16|Other|0|||
156807219|NCT01815424|566049561|FG004|Week 0 to 16|Other|0|||
156807220|NCT01815424|566049557|FG000|Week 0 to 16|Protocol Violation|1|||
156807221|NCT01815424|566049558|FG001|Week 0 to 16|Protocol Violation|0|||
156807222|NCT01815424|566049559|FG002|Week 0 to 16|Protocol Violation|0|||
156807223|NCT01815424|566049560|FG003|Week 0 to 16|Protocol Violation|0|||
156807224|NCT01815424|566049561|FG004|Week 0 to 16|Protocol Violation|0|||
156807225|NCT01815424|566049557|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
156807226|NCT01815424|566049558|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
156807227|NCT01815424|566049559|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
156807228|NCT01815424|566049560|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
156807229|NCT01815424|566049561|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
156807230|NCT01815424|566049557|FG000|Week 16 to 52|Other|0|||
156807231|NCT01815424|566049558|FG001|Week 16 to 52|Other|1|||
156807232|NCT01815424|566049559|FG002|Week 16 to 52|Other|0|||
156807233|NCT01815424|566049560|FG003|Week 16 to 52|Other|0|||
156807234|NCT01815424|566049561|FG004|Week 16 to 52|Other|0|||
156807235|NCT01815424|566049557|FG000|Week 16 to 52|Adverse Event|0|||
156807236|NCT01815424|566049558|FG001|Week 16 to 52|Adverse Event|0|||
156807237|NCT01815424|566049559|FG002|Week 16 to 52|Adverse Event|0|||
156807238|NCT01815424|566049560|FG003|Week 16 to 52|Adverse Event|0|||
156807239|NCT01815424|566049561|FG004|Week 16 to 52|Adverse Event|1|||
156807240|NCT01815424|566049557|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
156807241|NCT01815424|566049558|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
156807242|NCT01815424|566049559|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
156807243|NCT01815424|566049560|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
156807244|NCT01815424|566049561|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
156807245|NCT01815424|566049557|FG000|Week 16 to 52|Lost to Follow-up|0|||
156807246|NCT01815424|566049558|FG001|Week 16 to 52|Lost to Follow-up|2|||
156807247|NCT01815424|566049559|FG002|Week 16 to 52|Lost to Follow-up|0|||
156807248|NCT01815424|566049560|FG003|Week 16 to 52|Lost to Follow-up|2|||
156807249|NCT01815424|566049561|FG004|Week 16 to 52|Lost to Follow-up|1|||
156807250|NCT01815424|566049557|FG000|Week 16 to 52|Withdrawal by Subject|1|||
156807251|NCT01815424|566049558|FG001|Week 16 to 52|Withdrawal by Subject|2|||
156807252|NCT01815424|566049559|FG002|Week 16 to 52|Withdrawal by Subject|0|||
156807253|NCT01815424|566049560|FG003|Week 16 to 52|Withdrawal by Subject|0|||
156807254|NCT01815424|566049561|FG004|Week 16 to 52|Withdrawal by Subject|0|||
156807255|NCT04072835|566049562|FG000|Overall Study|Overall trial ended|603|||
156807256|NCT04072835|566049562|FG000|Overall Study|Ablation|97|||
156807257|NCT04072835|566049562|FG000|Overall Study|Withdrawal of consent|66|||
156807258|NCT04072835|566049562|FG000|Overall Study|Physician Decision|50|||
156807259|NCT04072835|566049562|FG000|Overall Study|Lost to Follow-up|39|||
156807260|NCT04072835|566049562|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
156807261|NCT04072835|566049562|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
156807262|NCT04072835|566049562|FG000|Overall Study|Adverse Event|25|||
156807263|NCT04072835|566049562|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
156807264|NCT04072835|566049562|FG000|Overall Study|Death|11|||
156807265|NCT04072835|566049562|FG000|Overall Study|Participant felt the drug did not work|8|||
156807266|NCT04072835|566049562|FG000|Overall Study|Participant tolerability|5|||
156807267|NCT04072835|566049562|FG000|Overall Study|Missing|5|||
156807268|NCT04072835|566049562|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
156807269|NCT04072835|566049562|FG000|Overall Study|Pregnancy|3|||
156807270|NCT02477527|566049563|FG000|Overall Study|Lost to Follow-up|2|||
156807271|NCT02477527|566049563|FG000|Overall Study|Withdrawal by Subject|1|||
156807272|NCT02477527|566049563|FG000|Overall Study|Screen Failure|3|||
156807273|NCT01976299|566049564|FG000|Overall Study|Withdrawal by Subject|3|||
156807274|NCT01976299|566049565|FG001|Overall Study|Withdrawal by Subject|1|||
156807275|NCT01976299|566049564|FG000|Overall Study|Death|4|||
156807276|NCT01976299|566049565|FG001|Overall Study|Death|2|||
156807277|NCT01976299|566049564|FG000|Overall Study|Lost to Follow-up|7|||
156807278|NCT01976299|566049565|FG001|Overall Study|Lost to Follow-up|1|||
156807279|NCT01976299|566049564|FG000|Overall Study|See clarification above in comments|9|||
156807280|NCT01976299|566049565|FG001|Overall Study|See clarification above in comments|2|||
156807281|NCT03692403|566049566|FG000|Overall Study|Withdrawal by Subject|1|||
156807282|NCT03692403|566049567|FG001|Overall Study|Withdrawal by Subject|0|||
156807283|NCT03692403|566049568|FG002|Overall Study|Withdrawal by Subject|1|||
156807284|NCT03692403|566049569|FG003|Overall Study|Withdrawal by Subject|0|||
156460406|NCT01208662|564781626|FG001|Maintenance|Still on Treatment|89|||
156807285|NCT03692403|566049566|FG000|Overall Study|Adverse Event|0|||
156807286|NCT03692403|566049567|FG001|Overall Study|Adverse Event|0|||
156807287|NCT03692403|566049568|FG002|Overall Study|Adverse Event|0|||
156807288|NCT03692403|566049569|FG003|Overall Study|Adverse Event|1|||
156807289|NCT03692403|566049566|FG000|Overall Study|Pregnancy|0|||
156807290|NCT03692403|566049567|FG001|Overall Study|Pregnancy|1|||
156807291|NCT03692403|566049568|FG002|Overall Study|Pregnancy|0|||
156807292|NCT03692403|566049569|FG003|Overall Study|Pregnancy|0|||
156807293|NCT03692403|566049566|FG000|Overall Study|Other|0|||
156807294|NCT03692403|566049567|FG001|Overall Study|Other|0|||
156807295|NCT03692403|566049568|FG002|Overall Study|Other|1|||
156807296|NCT03692403|566049569|FG003|Overall Study|Other|0|||
156807297|NCT04567524|566049570|FG000|Overall Study|Adverse Event|1|||
156807298|NCT04567524|566049571|FG001|Overall Study|Adverse Event|1|||
156460407|NCT01208662|564781627|FG002|Maintenance|Still on Treatment|0|||
156460408|NCT05147116|564781628|FG000|Overall Study|Withdrawal by Subject|0|||
156460409|NCT05147116|564781629|FG001|Overall Study|Withdrawal by Subject|1|||
156460410|NCT04101357|564781630|FG000|Overall Study|Death|1|||
156460411|NCT04101357|564781631|FG001|Overall Study|Death|1|||
156460412|NCT04101357|564781632|FG002|Overall Study|Death|1|||
156807299|NCT04567524|566049572|FG002|Overall Study|Adverse Event|0|||
156807300|NCT04567524|566049573|FG003|Overall Study|Adverse Event|0|||
156807301|NCT04567524|566049570|FG000|Overall Study|Withdrawal by Subject|2|||
156807302|NCT04567524|566049571|FG001|Overall Study|Withdrawal by Subject|0|||
156807303|NCT04567524|566049572|FG002|Overall Study|Withdrawal by Subject|0|||
156807304|NCT04567524|566049573|FG003|Overall Study|Withdrawal by Subject|1|||
156807305|NCT00856323|566049575|FG000|Overall Study|Withdrawal by Subject|2|||
156807306|NCT02848092|566049576|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
156807307|NCT02848092|566049577|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
156807308|NCT02848092|566049576|FG000|1-month Post-training Follow-up|Adverse Event|2|||
156807309|NCT02848092|566049577|FG001|1-month Post-training Follow-up|Adverse Event|1|||
156807310|NCT02848092|566049576|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
156807311|NCT02848092|566049577|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
156807312|NCT02848092|566049576|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
156807313|NCT02848092|566049577|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
156807314|NCT02848092|566049576|FG000|1-month Post-training Follow-up|fatigue|0|||
156807315|NCT02848092|566049577|FG001|1-month Post-training Follow-up|fatigue|1|||
156807316|NCT02848092|566049576|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
156807317|NCT02848092|566049577|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
156807318|NCT02848092|566049576|FG000|6-month Post-training Follow-up|Adverse Event|1|||
156807319|NCT02848092|566049577|FG001|6-month Post-training Follow-up|Adverse Event|1|||
156807320|NCT02848092|566049576|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
156807321|NCT02848092|566049577|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
156807322|NCT02848092|566049576|FG000|6-month Post-training Follow-up|frustrated with task|1|||
156807323|NCT02848092|566049577|FG001|6-month Post-training Follow-up|frustrated with task|0|||
156807324|NCT02848092|566049576|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
156807325|NCT02848092|566049577|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
156807326|NCT02848092|566049576|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
156807327|NCT02848092|566049577|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
156807328|NCT01639469|566049582|FG000|Overall Study|Death|4|||
156807329|NCT01639469|566049583|FG001|Overall Study|Death|2|||
156460413|NCT04101357|564781633|FG003|Overall Study|Death|2|||
156460414|NCT04101357|564781634|FG004|Overall Study|Death|4|||
156460415|NCT04101357|564781635|FG005|Overall Study|Death|11|||
156460416|NCT04101357|564781636|FG006|Overall Study|Death|4|||
156460417|NCT04101357|564781637|FG007|Overall Study|Death|4|||
156460418|NCT04101357|564781638|FG008|Overall Study|Death|5|||
156807330|NCT01639469|566049582|FG000|Overall Study|Lost to Follow-up|1|||
156807331|NCT01639469|566049583|FG001|Overall Study|Lost to Follow-up|1|||
156807332|NCT01119443|566049584|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
156807333|NCT01119443|566049585|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
156807334|NCT02329743|566049588|FG000|Overall Study|Adverse Event|1|||
156807335|NCT02329743|566049589|FG001|Overall Study|Adverse Event|1|||
156807336|NCT02329743|566049590|FG002|Overall Study|Adverse Event|3|||
156460419|NCT04101357|564781639|FG009|Overall Study|Death|2|||
156537419|NCT00467779|565061109|FG014|Stage 3|Adverse Event|2|||
156807337|NCT02329743|566049588|FG000|Overall Study|Lost to Follow-up|1|||
156807338|NCT02329743|566049589|FG001|Overall Study|Lost to Follow-up|0|||
156807339|NCT02329743|566049590|FG002|Overall Study|Lost to Follow-up|1|||
156807340|NCT02329743|566049588|FG000|Overall Study|Withdrawal by Subject|4|||
156807341|NCT02329743|566049589|FG001|Overall Study|Withdrawal by Subject|4|||
156807342|NCT02329743|566049590|FG002|Overall Study|Withdrawal by Subject|1|||
156807343|NCT02329743|566049588|FG000|Overall Study|Other|0|||
156460420|NCT04101357|564781640|FG010|Overall Study|Death|3|||
156460421|NCT04101357|564781630|FG000|Overall Study|Trial closure|0|||
156460422|NCT04101357|564781631|FG001|Overall Study|Trial closure|0|||
156460423|NCT04101357|564781632|FG002|Overall Study|Trial closure|0|||
156537420|NCT00467779|565061095|FG000|Stage 3|Death|0|||
156338048|NCT01847274|564336530|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156338049|NCT01847274|564336531|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156338050|NCT01847274|564336532|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156338051|NCT01847274|564336522|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338052|NCT01847274|564336523|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338053|NCT01847274|564336524|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338054|NCT01847274|564336525|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338055|NCT01847274|564336526|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
156338056|NCT01847274|564336527|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338057|NCT01847274|564336528|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338058|NCT01847274|564336529|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338059|NCT01847274|564336530|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338060|NCT01847274|564336531|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338061|NCT01847274|564336532|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156338062|NCT01847274|564336522|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338063|NCT01847274|564336523|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338064|NCT01847274|564336524|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338065|NCT01847274|564336525|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338066|NCT01847274|564336526|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338067|NCT01847274|564336527|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338068|NCT01847274|564336528|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
156338069|NCT01847274|564336529|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338070|NCT01847274|564336530|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338071|NCT01847274|564336531|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338072|NCT01847274|564336532|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156338073|NCT01847274|564336522|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338074|NCT01847274|564336523|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338075|NCT01847274|564336524|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338076|NCT01847274|564336525|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338077|NCT01847274|564336526|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338078|NCT01847274|564336527|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338079|NCT01847274|564336528|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
156338080|NCT01847274|564336529|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338081|NCT01847274|564336530|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338082|NCT01847274|564336531|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338083|NCT01847274|564336532|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156338084|NCT01847274|564336522|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156338085|NCT01847274|564336523|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156338086|NCT01847274|564336524|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156338087|NCT01847274|564336525|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156537421|NCT00467779|565061096|FG001|Stage 3|Death|0|||
156537422|NCT00467779|565061097|FG002|Stage 3|Death|0|||
156537423|NCT00467779|565061098|FG003|Stage 3|Death|0|||
156537424|NCT00467779|565061099|FG004|Stage 3|Death|0|||
156807344|NCT02329743|566049589|FG001|Overall Study|Other|2|||
156807345|NCT02329743|566049590|FG002|Overall Study|Other|3|||
156807346|NCT01147393|566049597|FG000|Dose Level 1|Dose limiting Toxicity|2|||
156807347|NCT01147393|566049597|FG000|Dose Level -1|Dose Limited Toxicity|1|||
156807348|NCT01428219|566049604|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
156807349|NCT00825994|566049605|FG000|Overall Study|Withdrawal by Subject|2|||
156807350|NCT00825994|566049605|FG000|Overall Study|Lost to Follow-up|1|||
156807351|NCT00825994|566049605|FG000|Overall Study|Protocol Violation|1|||
156807352|NCT00825994|566049605|FG000|Overall Study|Placebo Responder at V2|1|||
156807353|NCT01833494|566049609|FG000|Overall Study|Adverse Event|24|||
156807354|NCT01833494|566049609|FG000|Overall Study|Physician Decision|6|||
156807355|NCT01833494|566049609|FG000|Overall Study|Withdrawal by Subject|6|||
156807356|NCT01833494|566049609|FG000|Overall Study|Decrease in serum phosphorus|4|||
156807357|NCT01833494|566049609|FG000|Overall Study|Decrease in serum calcium|4|||
156807358|NCT01833494|566049609|FG000|Overall Study|Increase in serum ferritin|1|||
156807359|NCT00600067|566049614|FG000|Overall Study|Adverse Event|0|||
156807360|NCT00600067|566049615|FG001|Overall Study|Adverse Event|1|||
156807361|NCT00600067|566049614|FG000|Overall Study|Lost to Follow-up|2|||
156807362|NCT00600067|566049615|FG001|Overall Study|Lost to Follow-up|3|||
156537425|NCT00467779|565061100|FG005|Stage 3|Death|0|||
156537426|NCT00467779|565061101|FG006|Stage 3|Death|0|||
156807363|NCT00600067|566049614|FG000|Overall Study|protocol non-compliance|0|||
156807364|NCT00600067|566049615|FG001|Overall Study|protocol non-compliance|3|||
156807365|NCT00600067|566049614|FG000|Overall Study|Lack of Efficacy|1|||
156807366|NCT00600067|566049615|FG001|Overall Study|Lack of Efficacy|0|||
156807367|NCT04571060|566049619|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
156807368|NCT04571060|566049620|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
156807369|NCT04571060|566049619|FG000|Overall Study|Never treated migraine|47|||
156807370|NCT04571060|566049620|FG001|Overall Study|Never treated migraine|36|||
156807371|NCT04571060|566049619|FG000|Overall Study|Protocol Violation|4|||
156807372|NCT04571060|566049620|FG001|Overall Study|Protocol Violation|2|||
156807373|NCT04571060|566049619|FG000|Overall Study|Withdrawal by Subject|6|||
156807374|NCT04571060|566049620|FG001|Overall Study|Withdrawal by Subject|2|||
156807375|NCT04571060|566049619|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
156807376|NCT04571060|566049620|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
156807377|NCT00625586|566049626|FG000|Overall Study|Adverse Event|1|||
156807378|NCT00625586|566049626|FG000|Overall Study|Progressive disease|1|||
156807379|NCT01171677|566049629|FG000|Overall Study|Withdrawal by Subject|0|||
156807380|NCT01171677|566049630|FG001|Overall Study|Withdrawal by Subject|3|||
156807381|NCT01171677|566049629|FG000|Overall Study|Adverse Event|1|||
156807382|NCT01171677|566049630|FG001|Overall Study|Adverse Event|0|||
156807383|NCT01171677|566049629|FG000|Overall Study|completed <70% IntenSati classes|5|||
156807384|NCT01171677|566049630|FG001|Overall Study|completed <70% IntenSati classes|0|||
156807385|NCT04819113|566049631|FG000|Overall Study|Withdrawal by parent/guardian|3|||
156807386|NCT04819113|566049631|FG000|Overall Study|Lost to Follow-up|1|||
156807387|NCT04819113|566049631|FG000|Overall Study|Withdrawn before vaccination|2|||
156807388|NCT00437268|566049632|FG000|Overall Study|Adverse Event|1|||
156807389|NCT00437268|566049633|FG001|Overall Study|Adverse Event|1|||
156807390|NCT00437268|566049632|FG000|Overall Study|Withdrawal by Subject|2|||
156807391|NCT00437268|566049633|FG001|Overall Study|Withdrawal by Subject|2|||
156807392|NCT00437268|566049632|FG000|Overall Study|Progressive disease|9|||
156807393|NCT00437268|566049633|FG001|Overall Study|Progressive disease|9|||
156807394|NCT00437268|566049632|FG000|Overall Study|Physician Decision|1|||
156807395|NCT00437268|566049633|FG001|Overall Study|Physician Decision|0|||
156807396|NCT00437268|566049632|FG000|Overall Study|Death|0|||
156807397|NCT00437268|566049633|FG001|Overall Study|Death|1|||
156807398|NCT00833027|566049638|FG000|Overall Study|Adverse Event|33|||
156807399|NCT00833027|566049638|FG000|Overall Study|Death|1|||
156807400|NCT00833027|566049638|FG000|Overall Study|Lack of Efficacy|12|||
156807401|NCT00833027|566049638|FG000|Overall Study|Lost to Follow-up|24|||
156807402|NCT00833027|566049638|FG000|Overall Study|Protocol Violation|115|||
156807403|NCT00833027|566049638|FG000|Overall Study|Withdrawal by Subject|16|||
156807404|NCT00833027|566049638|FG000|Overall Study|Missing|10|||
156807405|NCT00444925|566049639|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
156807406|NCT00444925|566049640|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
156807407|NCT00444925|566049641|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
156807408|NCT00444925|566049639|FG000|Double-blind Treatment Period|Death|2|||
156807409|NCT00444925|566049640|FG001|Double-blind Treatment Period|Death|0|||
156807410|NCT00444925|566049641|FG002|Double-blind Treatment Period|Death|0|||
156807411|NCT00444925|566049639|FG000|Double-blind Treatment Period|Adverse Event|6|||
156807412|NCT00444925|566049640|FG001|Double-blind Treatment Period|Adverse Event|28|||
156807413|NCT00444925|566049641|FG002|Double-blind Treatment Period|Adverse Event|44|||
156807414|NCT00444925|566049639|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
156807415|NCT00444925|566049640|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
156807416|NCT00444925|566049641|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
156807417|NCT00444925|566049639|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
156807418|NCT00444925|566049640|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
156807419|NCT00444925|566049641|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
156807420|NCT00444925|566049639|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
156807421|NCT00444925|566049640|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
156807422|NCT00444925|566049641|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
156807423|NCT00444925|566049639|FG000|Double-blind Treatment Period|Other|7|||
156807424|NCT00444925|566049640|FG001|Double-blind Treatment Period|Other|7|||
156807425|NCT00444925|566049641|FG002|Double-blind Treatment Period|Other|12|||
156807426|NCT01342094|566049645|FG000|Overall Study|Adverse Event|5|||
156807427|NCT01342094|566049646|FG001|Overall Study|Adverse Event|0|||
156807428|NCT01342094|566049645|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
156807429|NCT01342094|566049646|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
156807430|NCT01342094|566049645|FG000|Overall Study|Withdrawal by Subject|0|||
156807431|NCT01342094|566049646|FG001|Overall Study|Withdrawal by Subject|2|||
156807432|NCT02806414|566049649|FG000|Overall Study|Lost to Follow-up|2|||
156807433|NCT05653700|566049658|FG000|Overall Study|Non Responders|9|||
156807434|NCT05653700|566049659|FG001|Overall Study|Non Responders|0|||
156807435|NCT01085214|566049662|FG000|Overall Study|Alternate treatment required|1|||
156807436|NCT01985022|566049677|FG000|Overall Study|Lost to Follow-up|0|||
156807437|NCT01985022|566049678|FG001|Overall Study|Lost to Follow-up|1|||
156807438|NCT01985022|566049677|FG000|Overall Study|Protocol Violation|0|||
156807439|NCT01985022|566049678|FG001|Overall Study|Protocol Violation|1|||
156807440|NCT01985022|566049677|FG000|Overall Study|Withdrawal by Subject|4|||
156807441|NCT01985022|566049678|FG001|Overall Study|Withdrawal by Subject|1|||
156460424|NCT04101357|564781633|FG003|Overall Study|Trial closure|0|||
156460425|NCT04101357|564781634|FG004|Overall Study|Trial closure|0|||
156460426|NCT04101357|564781635|FG005|Overall Study|Trial closure|2|||
156460427|NCT04101357|564781636|FG006|Overall Study|Trial closure|2|||
156460428|NCT04101357|564781637|FG007|Overall Study|Trial closure|0|||
156460429|NCT04101357|564781638|FG008|Overall Study|Trial closure|0|||
156460430|NCT04101357|564781639|FG009|Overall Study|Trial closure|0|||
156460431|NCT04101357|564781640|FG010|Overall Study|Trial closure|1|||
156460432|NCT04101357|564781630|FG000|Overall Study|Lost to Follow-up|0|||
156460433|NCT04101357|564781631|FG001|Overall Study|Lost to Follow-up|0|||
156460434|NCT04101357|564781632|FG002|Overall Study|Lost to Follow-up|0|||
156460435|NCT04101357|564781633|FG003|Overall Study|Lost to Follow-up|1|||
156460436|NCT04101357|564781634|FG004|Overall Study|Lost to Follow-up|0|||
156460437|NCT04101357|564781635|FG005|Overall Study|Lost to Follow-up|0|||
156460438|NCT04101357|564781636|FG006|Overall Study|Lost to Follow-up|0|||
156460439|NCT04101357|564781637|FG007|Overall Study|Lost to Follow-up|1|||
156460440|NCT04101357|564781638|FG008|Overall Study|Lost to Follow-up|0|||
156460441|NCT04101357|564781639|FG009|Overall Study|Lost to Follow-up|0|||
156460442|NCT04101357|564781640|FG010|Overall Study|Lost to Follow-up|0|||
156460443|NCT04101357|564781630|FG000|Overall Study|Withdrawal by Subject|1|||
156460444|NCT04101357|564781631|FG001|Overall Study|Withdrawal by Subject|0|||
156460445|NCT04101357|564781632|FG002|Overall Study|Withdrawal by Subject|0|||
156460446|NCT04101357|564781633|FG003|Overall Study|Withdrawal by Subject|0|||
156460447|NCT04101357|564781634|FG004|Overall Study|Withdrawal by Subject|0|||
156460448|NCT04101357|564781635|FG005|Overall Study|Withdrawal by Subject|0|||
156460449|NCT04101357|564781636|FG006|Overall Study|Withdrawal by Subject|0|||
156460450|NCT04101357|564781637|FG007|Overall Study|Withdrawal by Subject|0|||
156460451|NCT04101357|564781638|FG008|Overall Study|Withdrawal by Subject|1|||
156460452|NCT04101357|564781639|FG009|Overall Study|Withdrawal by Subject|1|||
156460453|NCT04101357|564781640|FG010|Overall Study|Withdrawal by Subject|0|||
156460454|NCT04101357|564781630|FG000|Overall Study|Other|0|||
156460455|NCT04101357|564781631|FG001|Overall Study|Other|0|||
156460456|NCT04101357|564781632|FG002|Overall Study|Other|0|||
156460457|NCT04101357|564781633|FG003|Overall Study|Other|0|||
156460458|NCT04101357|564781634|FG004|Overall Study|Other|0|||
156460459|NCT04101357|564781635|FG005|Overall Study|Other|1|||
156460460|NCT04101357|564781636|FG006|Overall Study|Other|2|||
156460461|NCT04101357|564781637|FG007|Overall Study|Other|1|||
156460462|NCT04101357|564781638|FG008|Overall Study|Other|0|||
156460463|NCT04101357|564781639|FG009|Overall Study|Other|0|||
156460464|NCT04101357|564781640|FG010|Overall Study|Other|0|||
156460465|NCT04101357|564781630|FG000|Overall Study|Enrolled but not treated|0|||
156460466|NCT04101357|564781631|FG001|Overall Study|Enrolled but not treated|0|||
156460467|NCT04101357|564781632|FG002|Overall Study|Enrolled but not treated|0|||
156460468|NCT04101357|564781633|FG003|Overall Study|Enrolled but not treated|0|||
156460469|NCT04101357|564781634|FG004|Overall Study|Enrolled but not treated|0|||
156460470|NCT04101357|564781635|FG005|Overall Study|Enrolled but not treated|1|||
156807442|NCT01152437|566049679|FG000|Overall Study|Other Adverse Event|8|||
156807443|NCT01152437|566049680|FG001|Overall Study|Other Adverse Event|1|||
156807444|NCT01152437|566049681|FG002|Overall Study|Other Adverse Event|7|||
156807445|NCT01152437|566049679|FG000|Overall Study|Not treated|0|||
156807446|NCT01152437|566049680|FG001|Overall Study|Not treated|1|||
156807447|NCT01152437|566049681|FG002|Overall Study|Not treated|2|||
156807448|NCT01152437|566049679|FG000|Overall Study|Progressive disease|27|||
156807449|NCT01152437|566049680|FG001|Overall Study|Progressive disease|13|||
156807450|NCT01152437|566049681|FG002|Overall Study|Progressive disease|32|||
156807451|NCT01152437|566049679|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
156807452|NCT01152437|566049680|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
156807453|NCT01152437|566049681|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
156807454|NCT02015039|566049682|FG000|Overall Study|Not eligible|0|||
156807455|NCT02015039|566049683|FG001|Overall Study|Not eligible|1|||
156807456|NCT00403130|566049690|FG000|2 Years From Start of Treatment|Not Eligible|3|||
156807457|NCT00403130|566049690|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
156807458|NCT00403130|566049690|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
156807459|NCT00403130|566049690|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
156338088|NCT01847274|564336526|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156460471|NCT04101357|564781636|FG006|Overall Study|Enrolled but not treated|1|||
156807460|NCT00806260|566049691|FG000|Period 1 (1 Day)|Adverse Event|0|||
156807461|NCT00806260|566049692|FG001|Period 1 (1 Day)|Adverse Event|0|||
156807462|NCT00806260|566049693|FG002|Period 1 (1 Day)|Adverse Event|0|||
156460472|NCT04101357|564781637|FG007|Overall Study|Enrolled but not treated|0|||
156460473|NCT04101357|564781638|FG008|Overall Study|Enrolled but not treated|0|||
156460474|NCT04101357|564781639|FG009|Overall Study|Enrolled but not treated|0|||
156460475|NCT04101357|564781640|FG010|Overall Study|Enrolled but not treated|0|||
156460476|NCT03655028|564781641|FG000|12-weeks Follow up|Death|1|||
156460477|NCT03655028|564781642|FG001|12-weeks Follow up|Death|0|||
156460478|NCT03655028|564781641|FG000|12-weeks Follow up|Physician Decision|3|||
156460479|NCT03655028|564781642|FG001|12-weeks Follow up|Physician Decision|3|||
156460480|NCT03655028|564781641|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
156807463|NCT00806260|566049694|FG003|Period 1 (1 Day)|Adverse Event|0|||
156807464|NCT00806260|566049695|FG004|Period 1 (1 Day)|Adverse Event|3|||
156807465|NCT00806260|566049696|FG005|Period 1 (1 Day)|Adverse Event|0|||
156807466|NCT00806260|566049691|FG000|Period 2|Adverse Event|0|||
156807467|NCT00806260|566049692|FG001|Period 2|Adverse Event|0|||
156807468|NCT00806260|566049693|FG002|Period 2|Adverse Event|0|||
156807469|NCT00806260|566049694|FG003|Period 2|Adverse Event|1|||
156807470|NCT00806260|566049695|FG004|Period 2|Adverse Event|0|||
156807471|NCT00806260|566049696|FG005|Period 2|Adverse Event|0|||
156807472|NCT00806260|566049691|FG000|Period 2|Protocol Violation|1|||
156807473|NCT00806260|566049692|FG001|Period 2|Protocol Violation|0|||
156807474|NCT00806260|566049693|FG002|Period 2|Protocol Violation|1|||
156807475|NCT00806260|566049694|FG003|Period 2|Protocol Violation|0|||
156807476|NCT00806260|566049695|FG004|Period 2|Protocol Violation|0|||
156807477|NCT00806260|566049696|FG005|Period 2|Protocol Violation|0|||
156807478|NCT00806260|566049691|FG000|Period 2|Need to take concomitant medication|1|||
156807479|NCT00806260|566049692|FG001|Period 2|Need to take concomitant medication|0|||
156807480|NCT00806260|566049693|FG002|Period 2|Need to take concomitant medication|0|||
156807481|NCT00806260|566049694|FG003|Period 2|Need to take concomitant medication|0|||
156807482|NCT00806260|566049695|FG004|Period 2|Need to take concomitant medication|0|||
156807483|NCT00806260|566049696|FG005|Period 2|Need to take concomitant medication|0|||
156807484|NCT00806260|566049691|FG000|Period 2|sponsor request|0|||
156807485|NCT00806260|566049692|FG001|Period 2|sponsor request|0|||
156807486|NCT00806260|566049693|FG002|Period 2|sponsor request|1|||
156807487|NCT00806260|566049694|FG003|Period 2|sponsor request|1|||
156807488|NCT00806260|566049695|FG004|Period 2|sponsor request|0|||
156807489|NCT00806260|566049696|FG005|Period 2|sponsor request|0|||
156807490|NCT00806260|566049691|FG000|Period 3|Protocol Violation|0|||
156807491|NCT00806260|566049692|FG001|Period 3|Protocol Violation|1|||
156807492|NCT00806260|566049693|FG002|Period 3|Protocol Violation|1|||
156807493|NCT00806260|566049694|FG003|Period 3|Protocol Violation|0|||
156807494|NCT00806260|566049695|FG004|Period 3|Protocol Violation|0|||
156807495|NCT00806260|566049696|FG005|Period 3|Protocol Violation|0|||
156807496|NCT00806260|566049691|FG000|Period 3|Pregnancy|1|||
156807497|NCT00806260|566049692|FG001|Period 3|Pregnancy|0|||
156807498|NCT00806260|566049693|FG002|Period 3|Pregnancy|0|||
156807499|NCT00806260|566049694|FG003|Period 3|Pregnancy|0|||
156807500|NCT00806260|566049695|FG004|Period 3|Pregnancy|0|||
156807501|NCT00806260|566049696|FG005|Period 3|Pregnancy|0|||
156807502|NCT02670473|566049697|FG000|Overall Study|Withdrawal by Subject|1|||
156807503|NCT01404234|566049698|FG000|Overall Study|Withdrawal by Subject|2|||
156808889|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
156808890|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
156808891|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
156808892|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
156808893|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
156808894|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
156808895|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
156808896|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
156808897|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
156808898|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
156808899|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
156808900|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
156808901|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
156808902|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
156808903|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
156808904|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
156808905|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
156808906|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Other|4|||
156808907|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Other|0|||
156808908|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Other|0|||
156808909|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
156808910|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
156808911|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
156808912|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Death|0|||
156808913|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Death|0|||
156808914|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Death|2|||
156808915|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
156808916|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
156808917|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
156808918|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
156338089|NCT01847274|564336527|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156808919|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
156808920|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
156808921|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
156807504|NCT03145064|566051097|FG000|Overall Study|Death|24|||
156807505|NCT03145064|566051097|FG000|Overall Study|Lost to Follow-up|3|||
156807506|NCT03145064|566051097|FG000|Overall Study|Withdrawal by Subject|6|||
156807507|NCT03145064|566051097|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
156807508|NCT03145064|566051097|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
156807509|NCT00661830|566051098|FG000|Overall Study|Death|37|||
156807510|NCT00661830|566051099|FG001|Overall Study|Death|33|||
156807511|NCT00661830|566051098|FG000|Overall Study|Lost to Follow-up|1|||
156807512|NCT00661830|566051099|FG001|Overall Study|Lost to Follow-up|3|||
156807513|NCT00661830|566051098|FG000|Overall Study|Withdrawal by Subject|1|||
156807514|NCT00661830|566051099|FG001|Overall Study|Withdrawal by Subject|1|||
156807515|NCT00661830|566051098|FG000|Overall Study|Other reason|1|||
156807516|NCT00661830|566051099|FG001|Overall Study|Other reason|5|||
156807517|NCT00551031|566051103|FG000|Overall Study|Adverse Event|0|||
156807518|NCT00551031|566051104|FG001|Overall Study|Adverse Event|1|||
156807519|NCT00551031|566051105|FG002|Overall Study|Adverse Event|0|||
156807520|NCT00551031|566051106|FG003|Overall Study|Adverse Event|0|||
156807521|NCT00551031|566051107|FG004|Overall Study|Adverse Event|0|||
156807522|NCT00551031|566051103|FG000|Overall Study|Protocol Violation|1|||
156807523|NCT00551031|566051104|FG001|Overall Study|Protocol Violation|1|||
156807524|NCT00551031|566051105|FG002|Overall Study|Protocol Violation|0|||
156807525|NCT00551031|566051106|FG003|Overall Study|Protocol Violation|0|||
156807526|NCT00551031|566051107|FG004|Overall Study|Protocol Violation|0|||
156807527|NCT00551031|566051103|FG000|Overall Study|Lost to Follow-up|0|||
156807528|NCT00551031|566051104|FG001|Overall Study|Lost to Follow-up|1|||
156807529|NCT00551031|566051105|FG002|Overall Study|Lost to Follow-up|0|||
156807530|NCT00551031|566051106|FG003|Overall Study|Lost to Follow-up|1|||
156807531|NCT00551031|566051107|FG004|Overall Study|Lost to Follow-up|1|||
156807532|NCT00551031|566051103|FG000|Overall Study|Withdrawal by Subject|0|||
156807533|NCT00551031|566051104|FG001|Overall Study|Withdrawal by Subject|4|||
156807534|NCT00551031|566051105|FG002|Overall Study|Withdrawal by Subject|1|||
156807535|NCT00551031|566051106|FG003|Overall Study|Withdrawal by Subject|2|||
156807536|NCT00551031|566051107|FG004|Overall Study|Withdrawal by Subject|0|||
156807537|NCT00551031|566051103|FG000|Overall Study|Serious Adverse Event|0|||
156807538|NCT00551031|566051104|FG001|Overall Study|Serious Adverse Event|2|||
156807539|NCT00551031|566051105|FG002|Overall Study|Serious Adverse Event|1|||
156807540|NCT00551031|566051106|FG003|Overall Study|Serious Adverse Event|0|||
156807541|NCT00551031|566051107|FG004|Overall Study|Serious Adverse Event|0|||
156807542|NCT00551031|566051103|FG000|Overall Study|Did not receive vaccine|1|||
156807543|NCT00551031|566051104|FG001|Overall Study|Did not receive vaccine|2|||
156807544|NCT00551031|566051105|FG002|Overall Study|Did not receive vaccine|0|||
156807545|NCT00551031|566051106|FG003|Overall Study|Did not receive vaccine|0|||
156807546|NCT00551031|566051107|FG004|Overall Study|Did not receive vaccine|0|||
156807547|NCT01650831|566051111|FG000|Overall Study|Screen failure|1|||
156807548|NCT00456755|566051114|FG000|Overall Study|Lost to Follow-up|2|||
156807549|NCT00456755|566051115|FG001|Overall Study|Lost to Follow-up|1|||
156807550|NCT02964273|566051116|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
156807551|NCT02964273|566051117|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
156807552|NCT02964273|566051118|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
156807553|NCT02964273|566051119|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
156807554|NCT02964273|566051116|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
156807555|NCT02964273|566051117|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
156807556|NCT02964273|566051118|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
156807557|NCT02964273|566051119|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
156807558|NCT02964273|566051116|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
156807559|NCT02964273|566051117|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
156807560|NCT02964273|566051118|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
156807561|NCT02964273|566051119|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
156807562|NCT02964273|566051116|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
156807563|NCT02964273|566051117|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
156807564|NCT02964273|566051118|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
156807565|NCT02964273|566051119|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
156807566|NCT02964273|566051116|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
156807567|NCT02964273|566051117|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
156807568|NCT02964273|566051118|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
156807569|NCT02964273|566051119|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
156807570|NCT02964273|566051116|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
156807571|NCT02964273|566051117|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
156807572|NCT02964273|566051118|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
156807573|NCT02964273|566051119|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
156807574|NCT01336712|566051121|FG000|Overall Study|Death|2|||
156807575|NCT01336712|566051121|FG000|Overall Study|Lack of Efficacy|1|||
156460481|NCT03655028|564781642|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
156460482|NCT03655028|564781641|FG000|12-weeks Follow up|Lost to Follow-up|4|||
156460483|NCT03655028|564781642|FG001|12-weeks Follow up|Lost to Follow-up|4|||
156460484|NCT03655028|564781641|FG000|24-weeks|Lost to Follow-up|1|||
156460485|NCT03655028|564781642|FG001|24-weeks|Lost to Follow-up|1|||
156460486|NCT03655028|564781641|FG000|24-weeks|Death|0|||
156460487|NCT03655028|564781642|FG001|24-weeks|Death|1|||
156460488|NCT04625725|564781646|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
156460489|NCT04625725|564781647|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
156460490|NCT04625725|564781648|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
156460491|NCT04625725|564781649|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
156460492|NCT04625725|564781650|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
156460493|NCT04625725|564781651|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
156460494|NCT04625725|564781646|FG000|Provent Main Study|Withdrawal by Subject|242|||
156460495|NCT04625725|564781647|FG001|Provent Main Study|Withdrawal by Subject|144|||
156460496|NCT04625725|564781648|FG002|Provent Main Study|Withdrawal by Subject|0|||
156460497|NCT04625725|564781649|FG003|Provent Main Study|Withdrawal by Subject|0|||
156460498|NCT04625725|564781650|FG004|Provent Main Study|Withdrawal by Subject|0|||
156460499|NCT04625725|564781651|FG005|Provent Main Study|Withdrawal by Subject|0|||
156460500|NCT04625725|564781646|FG000|Provent Main Study|Physician Decision|5|||
156460501|NCT04625725|564781647|FG001|Provent Main Study|Physician Decision|0|||
156460502|NCT04625725|564781648|FG002|Provent Main Study|Physician Decision|0|||
156460503|NCT04625725|564781649|FG003|Provent Main Study|Physician Decision|0|||
156460504|NCT04625725|564781650|FG004|Provent Main Study|Physician Decision|0|||
156460505|NCT04625725|564781651|FG005|Provent Main Study|Physician Decision|0|||
156460506|NCT04625725|564781646|FG000|Provent Main Study|Protocol Violation|1|||
156460507|NCT04625725|564781647|FG001|Provent Main Study|Protocol Violation|0|||
156807576|NCT03073525|566051123|FG000|Overall Study|Withdrawal by Subject|0|||
156807577|NCT03073525|566051124|FG001|Overall Study|Withdrawal by Subject|0|||
156807578|NCT03073525|566051125|FG002|Overall Study|Withdrawal by Subject|3|||
156807579|NCT00856635|566051126|FG000|Overall Study|Lost to Follow-up|2|||
156807580|NCT00856635|566051127|FG001|Overall Study|Lost to Follow-up|5|||
156807581|NCT00856635|566051126|FG000|Overall Study|Pregnancy|1|||
156807582|NCT00856635|566051127|FG001|Overall Study|Pregnancy|0|||
156807583|NCT00856635|566051126|FG000|Overall Study|Withdrawal by Subject|3|||
156807584|NCT00856635|566051127|FG001|Overall Study|Withdrawal by Subject|1|||
156807585|NCT00856635|566051126|FG000|Overall Study|Serious Adverse Event|1|||
156807586|NCT00856635|566051127|FG001|Overall Study|Serious Adverse Event|0|||
156807587|NCT00856635|566051126|FG000|Overall Study|Other|1|||
156807588|NCT00856635|566051127|FG001|Overall Study|Other|0|||
156807589|NCT00856635|566051126|FG000|Overall Study|Discontinued at Randomization|2|||
156807590|NCT00856635|566051127|FG001|Overall Study|Discontinued at Randomization|2|||
156807591|NCT02383862|566051128|FG000|3 Month Follow up|Lost to Follow-up|23|||
156807592|NCT02383862|566051129|FG001|3 Month Follow up|Lost to Follow-up|21|||
156807593|NCT01665911|566051130|FG000|Overall Study|Protocol Violation|4|||
156807594|NCT01665911|566051130|FG000|Overall Study|Withdrawal by Subject|1|||
156807595|NCT01665911|566051130|FG000|Overall Study|Adverse Event|1|||
156807596|NCT00506779|566051131|FG000|Overall Study|Withdrawal by Subject|1|||
156807597|NCT00506779|566051132|FG001|Overall Study|Withdrawal by Subject|0|||
156807598|NCT00506779|566051133|FG002|Overall Study|Withdrawal by Subject|1|||
156807599|NCT00506779|566051134|FG003|Overall Study|Withdrawal by Subject|0|||
156807600|NCT00506779|566051131|FG000|Overall Study|Adverse Event|0|||
156807601|NCT00506779|566051132|FG001|Overall Study|Adverse Event|1|||
156807602|NCT00506779|566051133|FG002|Overall Study|Adverse Event|1|||
156807603|NCT00506779|566051134|FG003|Overall Study|Adverse Event|1|||
156807604|NCT03198767|566051135|FG000|Overall Study|Protocol Violation|0|||
156460508|NCT04625725|564781648|FG002|Provent Main Study|Protocol Violation|0|||
156807605|NCT03198767|566051136|FG001|Overall Study|Protocol Violation|0|||
156807606|NCT03198767|566051137|FG002|Overall Study|Protocol Violation|0|||
156807607|NCT03198767|566051138|FG003|Overall Study|Protocol Violation|6|||
156807608|NCT03198767|566051139|FG004|Overall Study|Protocol Violation|0|||
156807609|NCT03198767|566051140|FG005|Overall Study|Protocol Violation|0|||
156807610|NCT03198767|566051141|FG006|Overall Study|Protocol Violation|0|||
156807611|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
156807612|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
156807613|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
156807614|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
156460509|NCT04625725|564781649|FG003|Provent Main Study|Protocol Violation|0|||
156460510|NCT04625725|564781650|FG004|Provent Main Study|Protocol Violation|0|||
156460511|NCT04625725|564781651|FG005|Provent Main Study|Protocol Violation|0|||
156807615|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
156807616|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
156807617|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
156807618|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
156460512|NCT04625725|564781646|FG000|Provent Main Study|Lost to Follow-up|357|||
156807619|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
156807620|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
156807621|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
156807622|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
156807623|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807624|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
156460513|NCT04625725|564781647|FG001|Provent Main Study|Lost to Follow-up|200|||
156460514|NCT04625725|564781648|FG002|Provent Main Study|Lost to Follow-up|0|||
156460515|NCT04625725|564781649|FG003|Provent Main Study|Lost to Follow-up|0|||
156460516|NCT04625725|564781650|FG004|Provent Main Study|Lost to Follow-up|0|||
156460517|NCT04625725|564781651|FG005|Provent Main Study|Lost to Follow-up|0|||
156807625|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807626|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807627|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807628|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807629|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
156807630|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
156807631|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
156807632|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
156807633|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
156807634|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
156807635|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
156807636|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807637|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807638|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807639|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807640|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807641|NCT02820844|566051142|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
156807642|NCT02820844|566051143|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
156807643|NCT02820844|566051144|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
156807644|NCT02820844|566051145|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
156807645|NCT02820844|566051146|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
156807646|NCT02820844|566051147|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
156807647|NCT02820844|566051142|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807648|NCT02820844|566051143|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807649|NCT02820844|566051144|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
156807650|NCT02820844|566051145|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807651|NCT02820844|566051146|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807652|NCT02820844|566051147|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807653|NCT02820844|566051142|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807654|NCT02820844|566051143|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807655|NCT02820844|566051144|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
156807656|NCT02820844|566051145|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
156807657|NCT02820844|566051146|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807658|NCT02820844|566051147|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807659|NCT02820844|566051142|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807660|NCT02820844|566051143|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807661|NCT02820844|566051144|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807662|NCT02820844|566051145|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807663|NCT02820844|566051146|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
156807664|NCT02820844|566051147|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807665|NCT02820844|566051142|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807666|NCT02820844|566051143|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807667|NCT02820844|566051144|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807668|NCT02820844|566051145|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807669|NCT02820844|566051146|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807670|NCT02820844|566051147|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
156807671|NCT00739310|566051148|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
156807672|NCT00739310|566051148|FG000|Overall Study|Withdrawal by Subject|1|||
156807673|NCT00739310|566051148|FG000|Overall Study|Lost to Follow-up|2|||
156807674|NCT02954887|566051149|FG000|Overall Study|Withdrawal by Subject|3|||
156807675|NCT02954887|566051149|FG000|Overall Study|Lack of Efficacy|3|||
156460518|NCT04625725|564781646|FG000|Provent Main Study|Death|22|||
156807676|NCT02954887|566051149|FG000|Overall Study|Other|1|||
156807677|NCT01492088|566051150|FG000|Overall Study|Withdrawal by Patient|0|||
156807678|NCT01492088|566051151|FG001|Overall Study|Withdrawal by Patient|2|||
156807679|NCT01492088|566051152|FG002|Overall Study|Withdrawal by Patient|0|||
156807680|NCT01492088|566051150|FG000|Overall Study|Death|1|||
156807681|NCT01492088|566051151|FG001|Overall Study|Death|6|||
156807682|NCT01492088|566051152|FG002|Overall Study|Death|2|||
156807683|NCT01492088|566051150|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
156807684|NCT01492088|566051151|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
156807685|NCT01492088|566051152|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
156807686|NCT01492088|566051150|FG000|Overall Study|Alive at Last Follow-up|0|||
156807687|NCT01492088|566051151|FG001|Overall Study|Alive at Last Follow-up|6|||
156807688|NCT01492088|566051152|FG002|Overall Study|Alive at Last Follow-up|11|||
156807689|NCT02803203|566051153|FG000|Overall Study|Adverse Event|4|||
156807690|NCT02803203|566051153|FG000|Overall Study|Death|4|||
156807691|NCT02803203|566051153|FG000|Overall Study|Progressive disease|29|||
156807692|NCT02803203|566051153|FG000|Overall Study|Withdrawal by Subject|8|||
156807693|NCT02803203|566051153|FG000|Overall Study|Complete resection of target disease|2|||
156807694|NCT02803203|566051153|FG000|Overall Study|Switched to commercial Osi|1|||
156807695|NCT02803203|566051153|FG000|Overall Study|Participant moved away|1|||
156807696|NCT00590967|566051154|FG000|Overall Study|Withdrawal by Subject|1|||
156807697|NCT00590967|566051155|FG001|Overall Study|Withdrawal by Subject|1|||
156807698|NCT00590967|566051154|FG000|Overall Study|Ineligible|1|||
156807699|NCT00590967|566051155|FG001|Overall Study|Ineligible|0|||
156807700|NCT00590967|566051154|FG000|Overall Study|Poor performance status|0|||
156807701|NCT00590967|566051155|FG001|Overall Study|Poor performance status|1|||
156807702|NCT00590967|566051154|FG000|Overall Study|Non-compliant|0|||
156807703|NCT00590967|566051155|FG001|Overall Study|Non-compliant|2|||
156807704|NCT00590967|566051154|FG000|Overall Study|Did not sign consent form|0|||
156807705|NCT00590967|566051155|FG001|Overall Study|Did not sign consent form|1|||
156807706|NCT00590967|566051154|FG000|Overall Study|Did not receive chemo per protocol|1|||
156807707|NCT00590967|566051155|FG001|Overall Study|Did not receive chemo per protocol|0|||
156807708|NCT01881789|566051156|FG000|Overall Study|Withdrawal by Subject|0|||
156807709|NCT01881789|566051157|FG001|Overall Study|Withdrawal by Subject|2|||
156807710|NCT01881789|566051158|FG002|Overall Study|Withdrawal by Subject|1|||
156807711|NCT01881789|566051159|FG003|Overall Study|Withdrawal by Subject|0|||
156807712|NCT01881789|566051160|FG004|Overall Study|Withdrawal by Subject|1|||
156807713|NCT01881789|566051161|FG005|Overall Study|Withdrawal by Subject|1|||
156807714|NCT01881789|566051156|FG000|Overall Study|Study Terminated by Sponsor|0|||
156807715|NCT01881789|566051157|FG001|Overall Study|Study Terminated by Sponsor|0|||
156807716|NCT01881789|566051158|FG002|Overall Study|Study Terminated by Sponsor|0|||
156807717|NCT01881789|566051159|FG003|Overall Study|Study Terminated by Sponsor|0|||
156807718|NCT01881789|566051160|FG004|Overall Study|Study Terminated by Sponsor|0|||
156807719|NCT01881789|566051161|FG005|Overall Study|Study Terminated by Sponsor|1|||
156807720|NCT01881789|566051156|FG000|Overall Study|Other|3|||
156807721|NCT01881789|566051157|FG001|Overall Study|Other|5|||
156807722|NCT01881789|566051158|FG002|Overall Study|Other|2|||
156807723|NCT01881789|566051159|FG003|Overall Study|Other|3|||
156807724|NCT01881789|566051160|FG004|Overall Study|Other|1|||
156807725|NCT01881789|566051161|FG005|Overall Study|Other|1|||
156807726|NCT01887717|566051162|FG000|Overall Study|Withdrawal by Subject|1|||
156807727|NCT01887717|566051163|FG001|Overall Study|Withdrawal by Subject|7|||
156807728|NCT01887717|566051162|FG000|Overall Study|Physician Decision|0|||
156807729|NCT01887717|566051163|FG001|Overall Study|Physician Decision|2|||
156807730|NCT01887717|566051162|FG000|Overall Study|Administrative reasons|5|||
156807731|NCT01887717|566051163|FG001|Overall Study|Administrative reasons|2|||
156807732|NCT00920556|566051164|FG000|Overall Study|Adverse Event|16|||
156807733|NCT00920556|566051164|FG000|Overall Study|Physician Decision|7|||
156807734|NCT00920556|566051164|FG000|Overall Study|Withdrawal by Subject|1|||
156807735|NCT01299389|566051165|FG000|Double-blind|Adverse Event|45|||
156807736|NCT01299389|566051166|FG001|Double-blind|Adverse Event|27|||
156807737|NCT01299389|566051167|FG002|Double-blind|Adverse Event|0|||
156807738|NCT01299389|566051168|FG003|Double-blind|Adverse Event|0|||
156807739|NCT01299389|566051165|FG000|Double-blind|Lack of Efficacy|45|||
156807740|NCT01299389|566051166|FG001|Double-blind|Lack of Efficacy|21|||
156807741|NCT01299389|566051167|FG002|Double-blind|Lack of Efficacy|0|||
156807742|NCT01299389|566051168|FG003|Double-blind|Lack of Efficacy|0|||
156807743|NCT01299389|566051165|FG000|Double-blind|Lost to Follow-up|2|||
156807744|NCT01299389|566051166|FG001|Double-blind|Lost to Follow-up|1|||
156807745|NCT01299389|566051167|FG002|Double-blind|Lost to Follow-up|0|||
156807746|NCT01299389|566051168|FG003|Double-blind|Lost to Follow-up|0|||
156807747|NCT01299389|566051165|FG000|Double-blind|Withdrawal by Subject|16|||
156807748|NCT01299389|566051166|FG001|Double-blind|Withdrawal by Subject|13|||
156807749|NCT01299389|566051167|FG002|Double-blind|Withdrawal by Subject|0|||
156807750|NCT01299389|566051168|FG003|Double-blind|Withdrawal by Subject|0|||
156807751|NCT01299389|566051165|FG000|Double-blind|Other|1|||
156807752|NCT01299389|566051166|FG001|Double-blind|Other|1|||
156807753|NCT01299389|566051167|FG002|Double-blind|Other|0|||
156807754|NCT01299389|566051168|FG003|Double-blind|Other|0|||
156807755|NCT01299389|566051165|FG000|Double-blind|"fail to meet study population criteria"|0|||
156807756|NCT01299389|566051166|FG001|Double-blind|"fail to meet study population criteria"|1|||
156460519|NCT04625725|564781647|FG001|Provent Main Study|Death|10|||
156460520|NCT04625725|564781648|FG002|Provent Main Study|Death|0|||
156460521|NCT04625725|564781649|FG003|Provent Main Study|Death|0|||
156460522|NCT04625725|564781650|FG004|Provent Main Study|Death|0|||
156460523|NCT04625725|564781651|FG005|Provent Main Study|Death|0|||
156460524|NCT04625725|564781646|FG000|Provent Main Study|Adverse Event|2|||
156460525|NCT04625725|564781647|FG001|Provent Main Study|Adverse Event|1|||
156807757|NCT01299389|566051167|FG002|Double-blind|"fail to meet study population criteria"|0|||
156807758|NCT01299389|566051168|FG003|Double-blind|"fail to meet study population criteria"|0|||
156807759|NCT01299389|566051165|FG000|Post-observational|Other|0|||
156807760|NCT01299389|566051166|FG001|Post-observational|Other|0|||
156807761|NCT01299389|566051167|FG002|Post-observational|Other|12|||
156807762|NCT01299389|566051168|FG003|Post-observational|Other|6|||
156807763|NCT03637491|566051169|FG000|Overall Study|Death|9|||
156807764|NCT03637491|566051170|FG001|Overall Study|Death|9|||
156807765|NCT03637491|566051171|FG002|Overall Study|Death|5|||
156807766|NCT03637491|566051172|FG003|Overall Study|Death|3|||
156807767|NCT03637491|566051169|FG000|Overall Study|Lost to Follow-up|0|||
156807768|NCT03637491|566051170|FG001|Overall Study|Lost to Follow-up|1|||
156807769|NCT03637491|566051171|FG002|Overall Study|Lost to Follow-up|0|||
156807770|NCT03637491|566051172|FG003|Overall Study|Lost to Follow-up|1|||
156807771|NCT03637491|566051169|FG000|Overall Study|Study Terminated By Sponsor|0|||
156807772|NCT03637491|566051170|FG001|Overall Study|Study Terminated By Sponsor|2|||
156807773|NCT03637491|566051171|FG002|Overall Study|Study Terminated By Sponsor|1|||
156807774|NCT03637491|566051172|FG003|Overall Study|Study Terminated By Sponsor|0|||
156807775|NCT03637491|566051169|FG000|Overall Study|Withdrawal by Subject|1|||
156807776|NCT03637491|566051170|FG001|Overall Study|Withdrawal by Subject|0|||
156807777|NCT03637491|566051171|FG002|Overall Study|Withdrawal by Subject|1|||
156807778|NCT03637491|566051172|FG003|Overall Study|Withdrawal by Subject|2|||
156807779|NCT00889707|566051174|FG000|Overall Study|Adverse Event|1|||
156807780|NCT00889707|566051175|FG001|Overall Study|Adverse Event|0|||
156807781|NCT00889707|566051174|FG000|Overall Study|Withdrawal by Subject|4|||
156807782|NCT00889707|566051175|FG001|Overall Study|Withdrawal by Subject|3|||
156807783|NCT00889707|566051174|FG000|Overall Study|Lost to Follow-up|0|||
156807784|NCT00889707|566051175|FG001|Overall Study|Lost to Follow-up|2|||
156807785|NCT00889707|566051174|FG000|Overall Study|Lack of Efficacy|2|||
156807786|NCT00889707|566051175|FG001|Overall Study|Lack of Efficacy|5|||
156807787|NCT02185534|566051176|FG000|First Period|Withdrawal by Subject|0|||
156807788|NCT02185534|566051177|FG001|First Period|Withdrawal by Subject|0|||
156807789|NCT02185534|566051178|FG002|First Period|Withdrawal by Subject|0|||
156807790|NCT02185534|566051179|FG003|First Period|Withdrawal by Subject|1|||
156807791|NCT02185534|566051180|FG004|First Period|Withdrawal by Subject|0|||
156807792|NCT02185534|566051181|FG005|First Period|Withdrawal by Subject|0|||
156807793|NCT02185534|566051176|FG000|First Washout Period|Withdrawal by Subject|1|||
156807794|NCT02185534|566051177|FG001|First Washout Period|Withdrawal by Subject|0|||
156807795|NCT02185534|566051178|FG002|First Washout Period|Withdrawal by Subject|0|||
156807796|NCT02185534|566051179|FG003|First Washout Period|Withdrawal by Subject|0|||
156807797|NCT02185534|566051180|FG004|First Washout Period|Withdrawal by Subject|1|||
156807798|NCT02185534|566051181|FG005|First Washout Period|Withdrawal by Subject|0|||
156807799|NCT02185534|566051176|FG000|First Washout Period|Protocol Violation|0|||
156807800|NCT02185534|566051177|FG001|First Washout Period|Protocol Violation|0|||
156807801|NCT02185534|566051178|FG002|First Washout Period|Protocol Violation|0|||
156807802|NCT02185534|566051179|FG003|First Washout Period|Protocol Violation|0|||
156807803|NCT02185534|566051180|FG004|First Washout Period|Protocol Violation|0|||
156807804|NCT02185534|566051181|FG005|First Washout Period|Protocol Violation|1|||
156807805|NCT01151020|566051185|FG000|Overall Study|Death|25|||
156807806|NCT01151020|566051185|FG000|Overall Study|Conversion to open repair|1|||
156807807|NCT01151020|566051185|FG000|Overall Study|Lost to Follow-up|4|||
156807808|NCT01151020|566051185|FG000|Overall Study|Withdrawal by Subject|22|||
156807809|NCT01151020|566051185|FG000|Overall Study|Patients did not receive the device|2|||
156807810|NCT01635998|566051186|FG000|Overall Study|Death|1|||
156807811|NCT01635998|566051187|FG001|Overall Study|Death|1|||
156807812|NCT01635998|566051186|FG000|Overall Study|Lost to Follow-up|2|||
156807813|NCT01635998|566051187|FG001|Overall Study|Lost to Follow-up|1|||
156460526|NCT04625725|564781648|FG002|Provent Main Study|Adverse Event|0|||
156807814|NCT01635998|566051186|FG000|Overall Study|Withdrawal by Subject|1|||
156807815|NCT01635998|566051187|FG001|Overall Study|Withdrawal by Subject|5|||
156807816|NCT04419467|566051188|FG000|Overall Study|Not treated with IP|0|||
156807817|NCT04419467|566051189|FG001|Overall Study|Not treated with IP|0|||
156460527|NCT04625725|564781649|FG003|Provent Main Study|Adverse Event|0|||
156460528|NCT04625725|564781650|FG004|Provent Main Study|Adverse Event|0|||
156460529|NCT04625725|564781651|FG005|Provent Main Study|Adverse Event|0|||
156807818|NCT04419467|566051190|FG002|Overall Study|Not treated with IP|2|||
156807819|NCT04419467|566051188|FG000|Overall Study|Adverse Event|0|||
156807820|NCT04419467|566051189|FG001|Overall Study|Adverse Event|2|||
156807821|NCT04419467|566051190|FG002|Overall Study|Adverse Event|0|||
156807822|NCT04419467|566051188|FG000|Overall Study|Death|1|||
156807823|NCT04419467|566051189|FG001|Overall Study|Death|0|||
156807824|NCT04419467|566051190|FG002|Overall Study|Death|0|||
156807825|NCT04419467|566051188|FG000|Overall Study|Lost to Follow-up|0|||
156807826|NCT04419467|566051189|FG001|Overall Study|Lost to Follow-up|1|||
156807827|NCT04419467|566051190|FG002|Overall Study|Lost to Follow-up|2|||
156807828|NCT04419467|566051188|FG000|Overall Study|Withdrawal by Subject|0|||
156807829|NCT04419467|566051189|FG001|Overall Study|Withdrawal by Subject|0|||
156807830|NCT04419467|566051190|FG002|Overall Study|Withdrawal by Subject|4|||
156807831|NCT04419467|566051188|FG000|Overall Study|Pandemic related|0|||
156807832|NCT04419467|566051189|FG001|Overall Study|Pandemic related|0|||
156807833|NCT04419467|566051190|FG002|Overall Study|Pandemic related|1|||
156460530|NCT04625725|564781646|FG000|Provent Main Study|Participants dosed in sub-study|310|||
156460531|NCT04625725|564781647|FG001|Provent Main Study|Participants dosed in sub-study|193|||
156460532|NCT04625725|564781648|FG002|Provent Main Study|Participants dosed in sub-study|0|||
156460533|NCT04625725|564781649|FG003|Provent Main Study|Participants dosed in sub-study|0|||
156460534|NCT04625725|564781650|FG004|Provent Main Study|Participants dosed in sub-study|0|||
156460535|NCT04625725|564781651|FG005|Provent Main Study|Participants dosed in sub-study|0|||
156460536|NCT04625725|564781646|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
156460537|NCT04625725|564781647|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
156460538|NCT04625725|564781648|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
156460539|NCT04625725|564781649|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
156807834|NCT04419467|566051188|FG000|Overall Study|Reason not known|1|||
156807835|NCT04419467|566051189|FG001|Overall Study|Reason not known|0|||
156807836|NCT04419467|566051190|FG002|Overall Study|Reason not known|0|||
156807837|NCT00003631|566051195|FG000|Overall Study|Patient not treated|1|||
156807838|NCT00003631|566051196|FG001|Overall Study|Patient not treated|0|||
156807839|NCT00003631|566051197|FG002|Overall Study|Patient not treated|1|||
156807840|NCT00003631|566051195|FG000|Overall Study|Protocol Violation|1|||
156807841|NCT00003631|566051196|FG001|Overall Study|Protocol Violation|0|||
156807842|NCT00003631|566051197|FG002|Overall Study|Protocol Violation|0|||
156807843|NCT00003631|566051195|FG000|Overall Study|Adverse Event|1|||
156807844|NCT00003631|566051196|FG001|Overall Study|Adverse Event|1|||
156807845|NCT00003631|566051197|FG002|Overall Study|Adverse Event|5|||
156807846|NCT00003631|566051195|FG000|Overall Study|Death|0|||
156807847|NCT00003631|566051196|FG001|Overall Study|Death|0|||
156807848|NCT00003631|566051197|FG002|Overall Study|Death|1|||
156807849|NCT00003631|566051195|FG000|Overall Study|Evaluable for toxicity only|0|||
156807850|NCT00003631|566051196|FG001|Overall Study|Evaluable for toxicity only|0|||
156807851|NCT00003631|566051197|FG002|Overall Study|Evaluable for toxicity only|2|||
156807852|NCT03943290|566051207|FG000|Overall Study|Sponsor Terminated Study|6|||
156807853|NCT03943290|566051208|FG001|Overall Study|Sponsor Terminated Study|1|||
156807854|NCT03943290|566051209|FG002|Overall Study|Sponsor Terminated Study|11|||
156807855|NCT03943290|566051210|FG003|Overall Study|Sponsor Terminated Study|6|||
156807856|NCT03943290|566051211|FG004|Overall Study|Sponsor Terminated Study|7|||
156807857|NCT03943290|566051212|FG005|Overall Study|Sponsor Terminated Study|6|||
156807858|NCT03943290|566051213|FG006|Overall Study|Sponsor Terminated Study|6|||
156807859|NCT03943290|566051214|FG007|Overall Study|Sponsor Terminated Study|7|||
156807860|NCT03943290|566051215|FG008|Overall Study|Sponsor Terminated Study|8|||
156807861|NCT03943290|566051207|FG000|Overall Study|Lost to Follow-up|1|||
156807862|NCT03943290|566051208|FG001|Overall Study|Lost to Follow-up|0|||
156807863|NCT03943290|566051209|FG002|Overall Study|Lost to Follow-up|1|||
156807864|NCT03943290|566051210|FG003|Overall Study|Lost to Follow-up|0|||
156807865|NCT03943290|566051211|FG004|Overall Study|Lost to Follow-up|0|||
156807866|NCT03943290|566051212|FG005|Overall Study|Lost to Follow-up|0|||
156807867|NCT03943290|566051213|FG006|Overall Study|Lost to Follow-up|0|||
156807868|NCT03943290|566051214|FG007|Overall Study|Lost to Follow-up|1|||
156807869|NCT03943290|566051215|FG008|Overall Study|Lost to Follow-up|0|||
156807870|NCT03943290|566051207|FG000|Overall Study|Withdrawal by Subject|0|||
156807871|NCT03943290|566051208|FG001|Overall Study|Withdrawal by Subject|0|||
156807872|NCT03943290|566051209|FG002|Overall Study|Withdrawal by Subject|1|||
156807873|NCT03943290|566051210|FG003|Overall Study|Withdrawal by Subject|0|||
156807874|NCT03943290|566051211|FG004|Overall Study|Withdrawal by Subject|0|||
156807875|NCT03943290|566051212|FG005|Overall Study|Withdrawal by Subject|0|||
156460540|NCT04625725|564781650|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
156460541|NCT04625725|564781651|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
156460542|NCT04625725|564781646|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
156460543|NCT04625725|564781647|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
156807876|NCT03943290|566051213|FG006|Overall Study|Withdrawal by Subject|0|||
156807877|NCT03943290|566051214|FG007|Overall Study|Withdrawal by Subject|0|||
156807878|NCT03943290|566051215|FG008|Overall Study|Withdrawal by Subject|0|||
156807879|NCT02737501|566051216|FG000|Randomized Phase|Died|41|||
156807880|NCT02737501|566051217|FG001|Randomized Phase|Died|29|||
156807881|NCT02737501|566051218|FG002|Randomized Phase|Died|0|||
156807882|NCT02737501|566051216|FG000|Randomized Phase|Withdrawal by Subject|16|||
156807883|NCT02737501|566051217|FG001|Randomized Phase|Withdrawal by Subject|6|||
156807884|NCT02737501|566051218|FG002|Randomized Phase|Withdrawal by Subject|0|||
156807885|NCT02737501|566051216|FG000|Randomized Phase|Lost to Follow-up|0|||
156460544|NCT04625725|564781648|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
156460545|NCT04625725|564781649|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
156460546|NCT04625725|564781650|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
156460547|NCT04625725|564781651|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
156460548|NCT04625725|564781646|FG000|Provent Main Study|INCARCERATION|3|||
156460549|NCT04625725|564781647|FG001|Provent Main Study|INCARCERATION|0|||
156460550|NCT04625725|564781648|FG002|Provent Main Study|INCARCERATION|0|||
156460551|NCT04625725|564781649|FG003|Provent Main Study|INCARCERATION|0|||
156807886|NCT02737501|566051217|FG001|Randomized Phase|Lost to Follow-up|1|||
156807887|NCT02737501|566051218|FG002|Randomized Phase|Lost to Follow-up|0|||
156807888|NCT02737501|566051216|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
156807889|NCT02737501|566051217|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
156807890|NCT02737501|566051218|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
156807891|NCT02737501|566051216|FG000|Randomized Phase|Reason not Specified|1|||
156807892|NCT02737501|566051217|FG001|Randomized Phase|Reason not Specified|1|||
156807893|NCT02737501|566051218|FG002|Randomized Phase|Reason not Specified|0|||
156807894|NCT02737501|566051216|FG000|Randomized Phase|Never Treated|1|||
156807895|NCT02737501|566051217|FG001|Randomized Phase|Never Treated|1|||
156807896|NCT02737501|566051218|FG002|Randomized Phase|Never Treated|0|||
156807897|NCT02737501|566051216|FG000|Crossover Phase|Died|0|||
156807898|NCT02737501|566051217|FG001|Crossover Phase|Died|0|||
156807899|NCT02737501|566051218|FG002|Crossover Phase|Died|22|||
156807900|NCT02737501|566051216|FG000|Crossover Phase|Withdrew Consent|0|||
156807901|NCT02737501|566051217|FG001|Crossover Phase|Withdrew Consent|0|||
156807902|NCT02737501|566051218|FG002|Crossover Phase|Withdrew Consent|9|||
156807903|NCT02737501|566051216|FG000|Crossover Phase|Physician Decision|0|||
156807904|NCT02737501|566051217|FG001|Crossover Phase|Physician Decision|0|||
156807905|NCT02737501|566051218|FG002|Crossover Phase|Physician Decision|1|||
156807906|NCT02737501|566051216|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
156807907|NCT02737501|566051217|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
156807908|NCT02737501|566051218|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
156807909|NCT01913327|566051219|FG000|Overall Study|Withdrawal by Subject|0|||
156807910|NCT01913327|566051220|FG001|Overall Study|Withdrawal by Subject|1|||
156807911|NCT01074931|566051221|FG000|Overall Study|Economic reasons|1|||
156807912|NCT01074931|566051221|FG000|Overall Study|Death|5|||
156807913|NCT05223673|566051222|FG000|Overall Study|Protocol Violation|1|||
156807914|NCT05223673|566051222|FG000|Overall Study|Study termination|6|||
156807915|NCT01088906|566051223|FG000|Overall Study|Inclusion error|1|||
156807916|NCT01088906|566051223|FG000|Overall Study|Did not receive study treatment|3|||
156807917|NCT01088906|566051223|FG000|Overall Study|Missing data|1|||
156807918|NCT00457626|566051224|FG000|Overall Study|Adverse Event|3|||
156807919|NCT00457626|566051224|FG000|Overall Study|Administrative Problems|2|||
156460552|NCT04625725|564781650|FG004|Provent Main Study|INCARCERATION|0|||
156460553|NCT04625725|564781651|FG005|Provent Main Study|INCARCERATION|0|||
156460554|NCT04625725|564781646|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
156460555|NCT04625725|564781647|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
156460556|NCT04625725|564781648|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
156460557|NCT04625725|564781649|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
156807920|NCT00457626|566051224|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
156807921|NCT00532129|566052612|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
156460558|NCT04625725|564781650|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
156460559|NCT04625725|564781651|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
156807922|NCT00532129|566052612|FG000|Treatment Period|Physician Decision|15|||
156807923|NCT00532129|566052612|FG000|Treatment Period|Disease progression|3|||
156807924|NCT00532129|566052612|FG000|Treatment Period|Protocol Violation|1|||
156807925|NCT00532129|566052612|FG000|Treatment Period|Other|5|||
156807926|NCT00532129|566052612|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
156807927|NCT00532129|566052612|FG000|Follow-up Period|Disease progression|57|||
156807928|NCT00532129|566052612|FG000|Follow-up Period|Lost to Follow-up|1|||
156807929|NCT00532129|566052612|FG000|Follow-up Period|Other|6|||
156807930|NCT00841776|566052613|FG000|Overall Study|Lack of Efficacy|0|||
156807931|NCT00841776|566052614|FG001|Overall Study|Lack of Efficacy|1|||
156807932|NCT00841776|566052613|FG000|Overall Study|Lost to Follow-up|2|||
156807933|NCT00841776|566052614|FG001|Overall Study|Lost to Follow-up|1|||
156807934|NCT00841776|566052613|FG000|Overall Study|Withdrawal by Subject|0|||
156807935|NCT00841776|566052614|FG001|Overall Study|Withdrawal by Subject|1|||
156807936|NCT00355368|566052617|FG000|Overall Study|Protocol Violation|8|||
156807937|NCT00355368|566052618|FG001|Overall Study|Protocol Violation|7|||
156807938|NCT00355368|566052617|FG000|Overall Study|cardiac arrest prior to intubation|2|||
156807939|NCT00355368|566052618|FG001|Overall Study|cardiac arrest prior to intubation|2|||
156807940|NCT01349673|566052619|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
156807941|NCT01349673|566052619|FG000|Overall Study|No Longer Qualified For Study|1|||
156807942|NCT01349673|566052619|FG000|Overall Study|Site Closure|10|||
156807943|NCT01349673|566052619|FG000|Overall Study|Withdrawal by Subject|21|||
156807944|NCT01349673|566052619|FG000|Overall Study|Lost to Follow-up|6|||
156807945|NCT01349673|566052619|FG000|Overall Study|Adverse Event|17|||
156807946|NCT01349673|566052619|FG000|Overall Study|Study Terminated By Sponsor|50|||
156807947|NCT01349673|566052619|FG000|Overall Study|Lack of Efficacy|8|||
156807948|NCT00347932|566052622|FG000|Overall Study|Adverse Event|4|||
156807949|NCT00347932|566052623|FG001|Overall Study|Adverse Event|5|||
156807950|NCT00347932|566052622|FG000|Overall Study|Lack of Efficacy|3|||
156807951|NCT00347932|566052623|FG001|Overall Study|Lack of Efficacy|14|||
156807952|NCT00347932|566052622|FG000|Overall Study|Lost to Follow-up|10|||
156807953|NCT00347932|566052623|FG001|Overall Study|Lost to Follow-up|9|||
156807954|NCT00347932|566052622|FG000|Overall Study|Withdrawal by Subject|10|||
156807955|NCT00347932|566052623|FG001|Overall Study|Withdrawal by Subject|16|||
156807956|NCT00347932|566052622|FG000|Overall Study|Did not meet inclusion criteria|4|||
156807957|NCT00347932|566052623|FG001|Overall Study|Did not meet inclusion criteria|8|||
156807958|NCT03462758|566052624|FG000|Overall Study|Chose no or other method of contraception|20|||
156807959|NCT03462758|566052625|FG001|Overall Study|Chose no or other method of contraception|23|||
156807960|NCT03462758|566052624|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
156807961|NCT03462758|566052625|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
156807962|NCT03462758|566052624|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
156807963|NCT03462758|566052625|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
156807964|NCT03462758|566052624|FG000|Overall Study|Medical contraindication|2|||
156807965|NCT03462758|566052625|FG001|Overall Study|Medical contraindication|2|||
156807966|NCT03462758|566052624|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
156807967|NCT03462758|566052625|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
156807968|NCT00413660|566052626|FG000|Up To Week 12|Adverse Event|1|||
156807969|NCT00413660|566052627|FG001|Up To Week 12|Adverse Event|3|||
156807970|NCT00413660|566052628|FG002|Up To Week 12|Adverse Event|1|||
156807971|NCT00413660|566052629|FG003|Up To Week 12|Adverse Event|4|||
156807972|NCT00413660|566052630|FG004|Up To Week 12|Adverse Event|6|||
156807973|NCT00413660|566052631|FG005|Up To Week 12|Adverse Event|4|||
156807974|NCT00413660|566052632|FG006|Up To Week 12|Adverse Event|1|||
156807975|NCT00413660|566052633|FG007|Up To Week 12|Adverse Event|0|||
156807976|NCT00413660|566052634|FG008|Up To Week 12|Adverse Event|0|||
156807977|NCT00413660|566052635|FG009|Up To Week 12|Adverse Event|0|||
156807978|NCT00413660|566052636|FG010|Up To Week 12|Adverse Event|0|||
156807979|NCT00413660|566052626|FG000|Up To Week 12|Lack of Efficacy|2|||
156807980|NCT00413660|566052627|FG001|Up To Week 12|Lack of Efficacy|0|||
156807981|NCT00413660|566052628|FG002|Up To Week 12|Lack of Efficacy|0|||
156807982|NCT00413660|566052629|FG003|Up To Week 12|Lack of Efficacy|0|||
156807983|NCT00413660|566052630|FG004|Up To Week 12|Lack of Efficacy|0|||
156807984|NCT00413660|566052631|FG005|Up To Week 12|Lack of Efficacy|0|||
156807985|NCT00413660|566052632|FG006|Up To Week 12|Lack of Efficacy|5|||
156807986|NCT00413660|566052633|FG007|Up To Week 12|Lack of Efficacy|0|||
156807987|NCT00413660|566052634|FG008|Up To Week 12|Lack of Efficacy|0|||
156807988|NCT00413660|566052635|FG009|Up To Week 12|Lack of Efficacy|0|||
156807989|NCT00413660|566052636|FG010|Up To Week 12|Lack of Efficacy|0|||
156807990|NCT00413660|566052626|FG000|Up To Week 12|Lost to Follow-up|0|||
156807991|NCT00413660|566052627|FG001|Up To Week 12|Lost to Follow-up|1|||
156807992|NCT00413660|566052628|FG002|Up To Week 12|Lost to Follow-up|0|||
156807993|NCT00413660|566052629|FG003|Up To Week 12|Lost to Follow-up|0|||
156807994|NCT00413660|566052630|FG004|Up To Week 12|Lost to Follow-up|1|||
156807995|NCT00413660|566052631|FG005|Up To Week 12|Lost to Follow-up|0|||
156807996|NCT00413660|566052632|FG006|Up To Week 12|Lost to Follow-up|0|||
156807997|NCT00413660|566052633|FG007|Up To Week 12|Lost to Follow-up|0|||
156807998|NCT00413660|566052634|FG008|Up To Week 12|Lost to Follow-up|0|||
156807999|NCT00413660|566052635|FG009|Up To Week 12|Lost to Follow-up|0|||
156808000|NCT00413660|566052636|FG010|Up To Week 12|Lost to Follow-up|0|||
156808001|NCT00413660|566052626|FG000|Up To Week 12|Withdrawal by Subject|0|||
156808002|NCT00413660|566052627|FG001|Up To Week 12|Withdrawal by Subject|2|||
156808003|NCT00413660|566052628|FG002|Up To Week 12|Withdrawal by Subject|0|||
156808004|NCT00413660|566052629|FG003|Up To Week 12|Withdrawal by Subject|2|||
156808005|NCT00413660|566052630|FG004|Up To Week 12|Withdrawal by Subject|0|||
156808006|NCT00413660|566052631|FG005|Up To Week 12|Withdrawal by Subject|2|||
156808007|NCT00413660|566052632|FG006|Up To Week 12|Withdrawal by Subject|2|||
156808008|NCT00413660|566052633|FG007|Up To Week 12|Withdrawal by Subject|0|||
156808009|NCT00413660|566052634|FG008|Up To Week 12|Withdrawal by Subject|0|||
156808010|NCT00413660|566052635|FG009|Up To Week 12|Withdrawal by Subject|0|||
156808011|NCT00413660|566052636|FG010|Up To Week 12|Withdrawal by Subject|0|||
156808012|NCT00413660|566052626|FG000|Up To Week 12|Randomized, Not Treated|1|||
156808013|NCT00413660|566052627|FG001|Up To Week 12|Randomized, Not Treated|0|||
156808014|NCT00413660|566052628|FG002|Up To Week 12|Randomized, Not Treated|0|||
156808015|NCT00413660|566052629|FG003|Up To Week 12|Randomized, Not Treated|1|||
156808016|NCT00413660|566052630|FG004|Up To Week 12|Randomized, Not Treated|0|||
156808017|NCT00413660|566052631|FG005|Up To Week 12|Randomized, Not Treated|0|||
156808018|NCT00413660|566052632|FG006|Up To Week 12|Randomized, Not Treated|0|||
156808019|NCT00413660|566052633|FG007|Up To Week 12|Randomized, Not Treated|0|||
156808020|NCT00413660|566052634|FG008|Up To Week 12|Randomized, Not Treated|0|||
156808021|NCT00413660|566052635|FG009|Up To Week 12|Randomized, Not Treated|0|||
156808022|NCT00413660|566052636|FG010|Up To Week 12|Randomized, Not Treated|0|||
156808023|NCT00413660|566052626|FG000|Up To Week 12|Other|3|||
156808024|NCT00413660|566052627|FG001|Up To Week 12|Other|1|||
156338090|NCT01847274|564336528|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
156338091|NCT01847274|564336529|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156808025|NCT00413660|566052628|FG002|Up To Week 12|Other|6|||
156808026|NCT00413660|566052629|FG003|Up To Week 12|Other|1|||
156808027|NCT00413660|566052630|FG004|Up To Week 12|Other|2|||
156808028|NCT00413660|566052631|FG005|Up To Week 12|Other|4|||
156808029|NCT00413660|566052632|FG006|Up To Week 12|Other|3|||
156808030|NCT00413660|566052633|FG007|Up To Week 12|Other|0|||
156808031|NCT00413660|566052634|FG008|Up To Week 12|Other|0|||
156808032|NCT00413660|566052635|FG009|Up To Week 12|Other|0|||
156808033|NCT00413660|566052636|FG010|Up To Week 12|Other|0|||
156808034|NCT00413660|566052626|FG000|Post Week 12|Adverse Event|2|||
156808035|NCT00413660|566052627|FG001|Post Week 12|Adverse Event|0|||
156808036|NCT00413660|566052628|FG002|Post Week 12|Adverse Event|2|||
156808037|NCT00413660|566052629|FG003|Post Week 12|Adverse Event|1|||
156808038|NCT00413660|566052630|FG004|Post Week 12|Adverse Event|4|||
156808039|NCT00413660|566052631|FG005|Post Week 12|Adverse Event|2|||
156808040|NCT00413660|566052632|FG006|Post Week 12|Adverse Event|2|||
156808041|NCT00413660|566052633|FG007|Post Week 12|Adverse Event|0|||
156808042|NCT00413660|566052634|FG008|Post Week 12|Adverse Event|0|||
156808043|NCT00413660|566052635|FG009|Post Week 12|Adverse Event|0|||
156808044|NCT00413660|566052636|FG010|Post Week 12|Adverse Event|0|||
156808045|NCT00413660|566052626|FG000|Post Week 12|Lack of Efficacy|0|||
156808046|NCT00413660|566052627|FG001|Post Week 12|Lack of Efficacy|0|||
156808047|NCT00413660|566052628|FG002|Post Week 12|Lack of Efficacy|1|||
156808048|NCT00413660|566052629|FG003|Post Week 12|Lack of Efficacy|0|||
156808049|NCT00413660|566052630|FG004|Post Week 12|Lack of Efficacy|0|||
156808050|NCT00413660|566052631|FG005|Post Week 12|Lack of Efficacy|0|||
156808051|NCT00413660|566052632|FG006|Post Week 12|Lack of Efficacy|0|||
156808052|NCT00413660|566052633|FG007|Post Week 12|Lack of Efficacy|0|||
156808053|NCT00413660|566052634|FG008|Post Week 12|Lack of Efficacy|0|||
156808054|NCT00413660|566052635|FG009|Post Week 12|Lack of Efficacy|1|||
156808055|NCT00413660|566052636|FG010|Post Week 12|Lack of Efficacy|0|||
156808056|NCT00413660|566052626|FG000|Post Week 12|Lost to Follow-up|0|||
156808057|NCT00413660|566052627|FG001|Post Week 12|Lost to Follow-up|1|||
156808058|NCT00413660|566052628|FG002|Post Week 12|Lost to Follow-up|1|||
156808059|NCT00413660|566052629|FG003|Post Week 12|Lost to Follow-up|0|||
156808060|NCT00413660|566052630|FG004|Post Week 12|Lost to Follow-up|0|||
156808061|NCT00413660|566052631|FG005|Post Week 12|Lost to Follow-up|0|||
156808062|NCT00413660|566052632|FG006|Post Week 12|Lost to Follow-up|0|||
156808063|NCT00413660|566052633|FG007|Post Week 12|Lost to Follow-up|0|||
156808064|NCT00413660|566052634|FG008|Post Week 12|Lost to Follow-up|0|||
156808065|NCT00413660|566052635|FG009|Post Week 12|Lost to Follow-up|0|||
156808066|NCT00413660|566052636|FG010|Post Week 12|Lost to Follow-up|0|||
156808067|NCT00413660|566052626|FG000|Post Week 12|Withdrawal by Subject|0|||
156808068|NCT00413660|566052627|FG001|Post Week 12|Withdrawal by Subject|1|||
156808069|NCT00413660|566052628|FG002|Post Week 12|Withdrawal by Subject|1|||
156808070|NCT00413660|566052629|FG003|Post Week 12|Withdrawal by Subject|0|||
156808071|NCT00413660|566052630|FG004|Post Week 12|Withdrawal by Subject|1|||
156808072|NCT00413660|566052631|FG005|Post Week 12|Withdrawal by Subject|0|||
156808073|NCT00413660|566052632|FG006|Post Week 12|Withdrawal by Subject|0|||
156808074|NCT00413660|566052633|FG007|Post Week 12|Withdrawal by Subject|0|||
156808075|NCT00413660|566052634|FG008|Post Week 12|Withdrawal by Subject|0|||
156808076|NCT00413660|566052635|FG009|Post Week 12|Withdrawal by Subject|0|||
156808077|NCT00413660|566052636|FG010|Post Week 12|Withdrawal by Subject|1|||
156808078|NCT00413660|566052626|FG000|Post Week 12|Other|1|||
156808079|NCT00413660|566052627|FG001|Post Week 12|Other|2|||
156808080|NCT00413660|566052628|FG002|Post Week 12|Other|3|||
156808081|NCT00413660|566052629|FG003|Post Week 12|Other|0|||
156808082|NCT00413660|566052630|FG004|Post Week 12|Other|1|||
156808083|NCT00413660|566052631|FG005|Post Week 12|Other|1|||
156808084|NCT00413660|566052632|FG006|Post Week 12|Other|1|||
156808085|NCT00413660|566052633|FG007|Post Week 12|Other|0|||
156808086|NCT00413660|566052634|FG008|Post Week 12|Other|0|||
156808087|NCT00413660|566052635|FG009|Post Week 12|Other|0|||
156808088|NCT00413660|566052636|FG010|Post Week 12|Other|0|||
156808089|NCT01791517|566052637|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
156808090|NCT01791517|566052638|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
156808091|NCT01791517|566052639|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
156808092|NCT01791517|566052640|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
156808093|NCT01791517|566052641|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
156808094|NCT01791517|566052642|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
156808095|NCT01791517|566052643|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
156808096|NCT01791517|566052644|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
156808097|NCT01791517|566052645|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
156808098|NCT01791517|566052646|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
156808099|NCT01791517|566052647|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
156808100|NCT01791517|566052648|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
156537427|NCT00467779|565061102|FG007|Stage 3|Death|0|||
156537428|NCT00467779|565061103|FG008|Stage 3|Death|0|||
156537429|NCT00467779|565061104|FG009|Stage 3|Death|0|||
156537430|NCT00467779|565061105|FG010|Stage 3|Death|0|||
156537431|NCT00467779|565061106|FG011|Stage 3|Death|0|||
156537432|NCT00467779|565061107|FG012|Stage 3|Death|0|||
156537433|NCT00467779|565061108|FG013|Stage 3|Death|0|||
156537434|NCT00467779|565061109|FG014|Stage 3|Death|1|||
156537435|NCT00467779|565061095|FG000|Stage 3|Disease Progression|0|||
156537436|NCT00467779|565061096|FG001|Stage 3|Disease Progression|0|||
156537437|NCT00467779|565061097|FG002|Stage 3|Disease Progression|0|||
156537438|NCT00467779|565061098|FG003|Stage 3|Disease Progression|0|||
156537439|NCT00467779|565061099|FG004|Stage 3|Disease Progression|0|||
156537440|NCT00467779|565061100|FG005|Stage 3|Disease Progression|0|||
156537441|NCT00467779|565061101|FG006|Stage 3|Disease Progression|0|||
156537442|NCT00467779|565061102|FG007|Stage 3|Disease Progression|0|||
156537443|NCT00467779|565061103|FG008|Stage 3|Disease Progression|0|||
156537444|NCT00467779|565061104|FG009|Stage 3|Disease Progression|0|||
156537445|NCT00467779|565061105|FG010|Stage 3|Disease Progression|0|||
156537446|NCT00467779|565061106|FG011|Stage 3|Disease Progression|0|||
156537447|NCT00467779|565061107|FG012|Stage 3|Disease Progression|0|||
156537448|NCT00467779|565061108|FG013|Stage 3|Disease Progression|0|||
156537449|NCT00467779|565061109|FG014|Stage 3|Disease Progression|9|||
156537450|NCT00467779|565061095|FG000|Stage 3|Unspecified Reason|0|||
156537451|NCT00467779|565061096|FG001|Stage 3|Unspecified Reason|0|||
156537452|NCT00467779|565061097|FG002|Stage 3|Unspecified Reason|0|||
156537453|NCT00467779|565061098|FG003|Stage 3|Unspecified Reason|0|||
156537454|NCT00467779|565061099|FG004|Stage 3|Unspecified Reason|0|||
156537455|NCT00467779|565061100|FG005|Stage 3|Unspecified Reason|0|||
156537456|NCT00467779|565061101|FG006|Stage 3|Unspecified Reason|0|||
156537457|NCT00467779|565061102|FG007|Stage 3|Unspecified Reason|0|||
156537458|NCT00467779|565061103|FG008|Stage 3|Unspecified Reason|0|||
156537459|NCT00467779|565061104|FG009|Stage 3|Unspecified Reason|0|||
156537460|NCT00467779|565061105|FG010|Stage 3|Unspecified Reason|0|||
156537461|NCT00467779|565061106|FG011|Stage 3|Unspecified Reason|0|||
156537462|NCT00467779|565061107|FG012|Stage 3|Unspecified Reason|0|||
156537463|NCT00467779|565061108|FG013|Stage 3|Unspecified Reason|0|||
156537464|NCT00467779|565061109|FG014|Stage 3|Unspecified Reason|5|||
156537465|NCT01509079|565061110|FG000|Overall Study|Lack of Efficacy|0|||
156537466|NCT01509079|565061111|FG001|Overall Study|Lack of Efficacy|2|||
156537467|NCT01509079|565061110|FG000|Overall Study|started an excluded medication|0|||
156537468|NCT01509079|565061111|FG001|Overall Study|started an excluded medication|1|||
156537469|NCT04912245|565061112|FG000|Overall Study|Withdrawal by Subject|21|||
156537470|NCT04912245|565061113|FG001|Overall Study|Withdrawal by Subject|4|||
156537471|NCT04912245|565061112|FG000|Overall Study|Lost to Follow-up|5|||
156537472|NCT04912245|565061113|FG001|Overall Study|Lost to Follow-up|11|||
156537473|NCT01205230|565061114|FG000|Overall Study|Adverse Event|4|||
156537474|NCT01205230|565061115|FG001|Overall Study|Adverse Event|0|||
156537475|NCT01205230|565061114|FG000|Overall Study|Physician Decision|1|||
156537476|NCT01205230|565061115|FG001|Overall Study|Physician Decision|0|||
156537477|NCT00041080|565061116|FG000|Overall Study|Adverse Event|21|||
156537478|NCT00041080|565061117|FG001|Overall Study|Adverse Event|1|||
156537479|NCT00041080|565061116|FG000|Overall Study|Withdrawal by Subject|6|||
156537480|NCT00041080|565061117|FG001|Overall Study|Withdrawal by Subject|6|||
156537481|NCT00041080|565061116|FG000|Overall Study|Concommitant Illness/Other|1|||
156537482|NCT00041080|565061117|FG001|Overall Study|Concommitant Illness/Other|2|||
156537483|NCT00041080|565061116|FG000|Overall Study|Did not start therapy|1|||
156537484|NCT00041080|565061117|FG001|Overall Study|Did not start therapy|1|||
156537485|NCT00041080|565061116|FG000|Overall Study|Ineligible|1|||
156537486|NCT00041080|565061117|FG001|Overall Study|Ineligible|0|||
156537487|NCT03198520|565061118|FG000|Overall Study|Physician Decision|2|||
156537488|NCT03198520|565061118|FG000|Overall Study|Protocol Violation|2|||
156537489|NCT03198520|565061118|FG000|Overall Study|Withdrawal by Subject|1|||
156537490|NCT03198520|565061118|FG000|Overall Study|Study Ended|1|||
156537491|NCT01670539|565061119|FG000|Overall Study|Death|3|||
156537492|NCT01670539|565061120|FG001|Overall Study|Death|5|||
156537493|NCT01670539|565061119|FG000|Overall Study|Withdrawal by Subject|3|||
156537494|NCT01670539|565061120|FG001|Overall Study|Withdrawal by Subject|0|||
156537495|NCT04353596|565061121|FG000|Overall Study|Protocol Violation|4|||
156537496|NCT04353596|565061122|FG001|Overall Study|Protocol Violation|4|||
156537497|NCT04353596|565061121|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
156537498|NCT04353596|565061122|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
156338092|NCT01847274|564336530|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156537499|NCT02665052|565061123|FG000|Overall Study|Lost to Follow-up|1|||
156537500|NCT02665052|565061124|FG001|Overall Study|Lost to Follow-up|0|||
156537501|NCT02665052|565061125|FG002|Overall Study|Lost to Follow-up|0|||
156537502|NCT02665052|565061126|FG003|Overall Study|Lost to Follow-up|0|||
156537503|NCT02665052|565061123|FG000|Overall Study|Withdrawal by Subject|1|||
156537504|NCT02665052|565061124|FG001|Overall Study|Withdrawal by Subject|1|||
156537505|NCT02665052|565061125|FG002|Overall Study|Withdrawal by Subject|0|||
156537506|NCT02665052|565061126|FG003|Overall Study|Withdrawal by Subject|5|||
156808101|NCT01791517|566052637|FG000|Phase I: Period 1|Adverse Event|0|||
156808102|NCT01791517|566052638|FG001|Phase I: Period 1|Adverse Event|0|||
156808103|NCT01791517|566052639|FG002|Phase I: Period 1|Adverse Event|1|||
156808104|NCT01791517|566052640|FG003|Phase I: Period 1|Adverse Event|1|||
156808105|NCT01791517|566052641|FG004|Phase I: Period 1|Adverse Event|0|||
156808106|NCT01791517|566052642|FG005|Phase I: Period 1|Adverse Event|0|||
156808107|NCT01791517|566052643|FG006|Phase I: Period 1|Adverse Event|0|||
156808108|NCT01791517|566052644|FG007|Phase I: Period 1|Adverse Event|0|||
156808109|NCT01791517|566052645|FG008|Phase I: Period 1|Adverse Event|0|||
156808110|NCT01791517|566052646|FG009|Phase I: Period 1|Adverse Event|0|||
156808111|NCT01791517|566052647|FG010|Phase I: Period 1|Adverse Event|0|||
156808112|NCT01791517|566052648|FG011|Phase I: Period 1|Adverse Event|0|||
156808113|NCT01791517|566052637|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
156808114|NCT01791517|566052638|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808115|NCT01791517|566052639|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808116|NCT01791517|566052640|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808117|NCT01791517|566052641|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156338093|NCT01847274|564336531|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156338094|NCT01847274|564336532|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156537507|NCT02665052|565061123|FG000|Overall Study|Adverse Event|1|||
156808118|NCT01791517|566052642|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808119|NCT01791517|566052643|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808120|NCT01791517|566052644|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808121|NCT01791517|566052645|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808122|NCT01791517|566052646|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808123|NCT01791517|566052647|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808124|NCT01791517|566052648|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808125|NCT01791517|566052637|FG000|Phase I: Period 1|Protocol Violation|0|||
156808126|NCT01791517|566052638|FG001|Phase I: Period 1|Protocol Violation|1|||
156808127|NCT01791517|566052639|FG002|Phase I: Period 1|Protocol Violation|0|||
156808128|NCT01791517|566052640|FG003|Phase I: Period 1|Protocol Violation|0|||
156808129|NCT01791517|566052641|FG004|Phase I: Period 1|Protocol Violation|0|||
156808130|NCT01791517|566052642|FG005|Phase I: Period 1|Protocol Violation|0|||
156808131|NCT01791517|566052643|FG006|Phase I: Period 1|Protocol Violation|0|||
156808132|NCT01791517|566052644|FG007|Phase I: Period 1|Protocol Violation|0|||
156808133|NCT01791517|566052645|FG008|Phase I: Period 1|Protocol Violation|0|||
156808134|NCT01791517|566052646|FG009|Phase I: Period 1|Protocol Violation|0|||
156808135|NCT01791517|566052647|FG010|Phase I: Period 1|Protocol Violation|0|||
156808136|NCT01791517|566052648|FG011|Phase I: Period 1|Protocol Violation|0|||
156808137|NCT01791517|566052637|FG000|Phase I: Period 1|Lost to Follow-up|0|||
156808138|NCT01791517|566052638|FG001|Phase I: Period 1|Lost to Follow-up|0|||
156808139|NCT01791517|566052639|FG002|Phase I: Period 1|Lost to Follow-up|0|||
156808140|NCT01791517|566052640|FG003|Phase I: Period 1|Lost to Follow-up|1|||
156808141|NCT01791517|566052641|FG004|Phase I: Period 1|Lost to Follow-up|0|||
156808142|NCT01791517|566052642|FG005|Phase I: Period 1|Lost to Follow-up|0|||
156808143|NCT01791517|566052643|FG006|Phase I: Period 1|Lost to Follow-up|1|||
156808144|NCT01791517|566052644|FG007|Phase I: Period 1|Lost to Follow-up|0|||
156808145|NCT01791517|566052645|FG008|Phase I: Period 1|Lost to Follow-up|1|||
156808146|NCT01791517|566052646|FG009|Phase I: Period 1|Lost to Follow-up|1|||
156808147|NCT01791517|566052647|FG010|Phase I: Period 1|Lost to Follow-up|0|||
156808148|NCT01791517|566052648|FG011|Phase I: Period 1|Lost to Follow-up|0|||
156808149|NCT01791517|566052637|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808150|NCT01791517|566052638|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808151|NCT01791517|566052639|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808152|NCT01791517|566052640|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808153|NCT01791517|566052641|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808154|NCT01791517|566052642|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808155|NCT01791517|566052643|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808156|NCT01791517|566052644|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808157|NCT01791517|566052645|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808158|NCT01791517|566052646|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808159|NCT01791517|566052647|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808160|NCT01791517|566052648|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
156808161|NCT01791517|566052637|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
156808162|NCT01791517|566052638|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808163|NCT01791517|566052639|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808164|NCT01791517|566052640|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808165|NCT01791517|566052641|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808166|NCT01791517|566052642|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808167|NCT01791517|566052643|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808168|NCT01791517|566052644|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808169|NCT01791517|566052645|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808170|NCT01791517|566052646|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808171|NCT01791517|566052647|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808172|NCT01791517|566052648|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808173|NCT01791517|566052637|FG000|Phase I: Period 2|Protocol Violation|0|||
156808174|NCT01791517|566052638|FG001|Phase I: Period 2|Protocol Violation|0|||
156808175|NCT01791517|566052639|FG002|Phase I: Period 2|Protocol Violation|0|||
156808176|NCT01791517|566052640|FG003|Phase I: Period 2|Protocol Violation|1|||
156808177|NCT01791517|566052641|FG004|Phase I: Period 2|Protocol Violation|0|||
156808178|NCT01791517|566052642|FG005|Phase I: Period 2|Protocol Violation|0|||
156808179|NCT01791517|566052643|FG006|Phase I: Period 2|Protocol Violation|0|||
156808180|NCT01791517|566052644|FG007|Phase I: Period 2|Protocol Violation|0|||
156808181|NCT01791517|566052645|FG008|Phase I: Period 2|Protocol Violation|0|||
156808182|NCT01791517|566052646|FG009|Phase I: Period 2|Protocol Violation|0|||
156808183|NCT01791517|566052647|FG010|Phase I: Period 2|Protocol Violation|0|||
156808184|NCT01791517|566052648|FG011|Phase I: Period 2|Protocol Violation|0|||
156808185|NCT01791517|566052637|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
156808186|NCT01791517|566052638|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
156808187|NCT01791517|566052639|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
156808188|NCT01791517|566052640|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
156808189|NCT01791517|566052641|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
156808190|NCT01791517|566052642|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
156808191|NCT01791517|566052643|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
156808192|NCT01791517|566052644|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
156808193|NCT01791517|566052645|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
156808194|NCT01791517|566052646|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
156808195|NCT01791517|566052647|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
156808196|NCT01791517|566052648|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
156808197|NCT01791517|566052637|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808198|NCT01791517|566052638|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808199|NCT01791517|566052639|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808200|NCT01791517|566052640|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808201|NCT01791517|566052641|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808202|NCT01791517|566052642|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808203|NCT01791517|566052643|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808204|NCT01791517|566052644|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808205|NCT01791517|566052645|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808206|NCT01791517|566052646|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808207|NCT01791517|566052647|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
156808208|NCT01791517|566052648|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808209|NCT01791517|566052637|FG000|Phase I: Period 2|Lens Discomfort|0|||
156808210|NCT01791517|566052638|FG001|Phase I: Period 2|Lens Discomfort|0|||
156808211|NCT01791517|566052639|FG002|Phase I: Period 2|Lens Discomfort|0|||
156808212|NCT01791517|566052640|FG003|Phase I: Period 2|Lens Discomfort|0|||
156808213|NCT01791517|566052641|FG004|Phase I: Period 2|Lens Discomfort|0|||
156808214|NCT01791517|566052642|FG005|Phase I: Period 2|Lens Discomfort|1|||
156808215|NCT01791517|566052643|FG006|Phase I: Period 2|Lens Discomfort|0|||
156808216|NCT01791517|566052644|FG007|Phase I: Period 2|Lens Discomfort|0|||
156808217|NCT01791517|566052645|FG008|Phase I: Period 2|Lens Discomfort|0|||
156808218|NCT01791517|566052646|FG009|Phase I: Period 2|Lens Discomfort|0|||
156808219|NCT01791517|566052647|FG010|Phase I: Period 2|Lens Discomfort|0|||
156808220|NCT01791517|566052648|FG011|Phase I: Period 2|Lens Discomfort|0|||
156808221|NCT01791517|566052637|FG000|Phase I: Period 2|Lost to Follow-up|0|||
156808222|NCT01791517|566052638|FG001|Phase I: Period 2|Lost to Follow-up|3|||
156808223|NCT01791517|566052639|FG002|Phase I: Period 2|Lost to Follow-up|2|||
156808224|NCT01791517|566052640|FG003|Phase I: Period 2|Lost to Follow-up|0|||
156537508|NCT02665052|565061124|FG001|Overall Study|Adverse Event|1|||
156537509|NCT02665052|565061125|FG002|Overall Study|Adverse Event|0|||
156537510|NCT02665052|565061126|FG003|Overall Study|Adverse Event|0|||
156537511|NCT03023059|565061127|FG000|Overall Study|Withdrawal by Subject|5|||
156537512|NCT00536809|565061128|FG000|Phase II|Adverse Event|1|||
156537513|NCT00536809|565061128|FG000|Phase II|Referred for surgical resection|1|||
156537514|NCT01353508|565061137|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
156537515|NCT01353508|565061138|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
156537516|NCT01353508|565061139|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
156537517|NCT01353508|565061140|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
156537518|NCT01353508|565061137|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
156537519|NCT01353508|565061138|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
156537520|NCT01353508|565061139|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
156537521|NCT01353508|565061140|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
156537522|NCT00433914|565061147|FG000|Overall Study|Withdrawal by Subject|0|||
156537523|NCT00433914|565061148|FG001|Overall Study|Withdrawal by Subject|2|||
156537524|NCT00433914|565061147|FG000|Overall Study|Lost to Follow-up|0|||
156537525|NCT00433914|565061148|FG001|Overall Study|Lost to Follow-up|1|||
156537526|NCT02247960|565061150|FG000|Patient Consent and Randomization|Physician Decision|2|||
156537527|NCT02247960|565061151|FG001|Patient Consent and Randomization|Physician Decision|2|||
156537528|NCT02247960|565061150|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
156537529|NCT02247960|565061151|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
156537530|NCT02247960|565061150|FG000|Catheter Removed|Lost to Follow-up|7|||
156537531|NCT02247960|565061151|FG001|Catheter Removed|Lost to Follow-up|10|||
156808225|NCT01791517|566052641|FG004|Phase I: Period 2|Lost to Follow-up|0|||
156808226|NCT01791517|566052642|FG005|Phase I: Period 2|Lost to Follow-up|0|||
156808227|NCT01791517|566052643|FG006|Phase I: Period 2|Lost to Follow-up|0|||
156808228|NCT01791517|566052644|FG007|Phase I: Period 2|Lost to Follow-up|0|||
156808229|NCT01791517|566052645|FG008|Phase I: Period 2|Lost to Follow-up|0|||
156808230|NCT01791517|566052646|FG009|Phase I: Period 2|Lost to Follow-up|0|||
156808231|NCT01791517|566052647|FG010|Phase I: Period 2|Lost to Follow-up|0|||
156808232|NCT01791517|566052648|FG011|Phase I: Period 2|Lost to Follow-up|0|||
156808233|NCT01791517|566052637|FG000|Phase I: Period 3|Lens Discomfort|0|||
156808234|NCT01791517|566052638|FG001|Phase I: Period 3|Lens Discomfort|0|||
156808235|NCT01791517|566052639|FG002|Phase I: Period 3|Lens Discomfort|0|||
156808236|NCT01791517|566052640|FG003|Phase I: Period 3|Lens Discomfort|0|||
156808237|NCT01791517|566052641|FG004|Phase I: Period 3|Lens Discomfort|0|||
156808238|NCT01791517|566052642|FG005|Phase I: Period 3|Lens Discomfort|0|||
156808239|NCT01791517|566052643|FG006|Phase I: Period 3|Lens Discomfort|0|||
156808240|NCT01791517|566052644|FG007|Phase I: Period 3|Lens Discomfort|0|||
156808241|NCT01791517|566052645|FG008|Phase I: Period 3|Lens Discomfort|0|||
156808242|NCT01791517|566052646|FG009|Phase I: Period 3|Lens Discomfort|0|||
156338095|NCT01847274|564336522|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156808243|NCT01791517|566052647|FG010|Phase I: Period 3|Lens Discomfort|0|||
156808244|NCT01791517|566052648|FG011|Phase I: Period 3|Lens Discomfort|1|||
156808245|NCT01791517|566052637|FG000|Phase I: Period 3|Lost to Follow-up|0|||
156808246|NCT01791517|566052638|FG001|Phase I: Period 3|Lost to Follow-up|1|||
156808247|NCT01791517|566052639|FG002|Phase I: Period 3|Lost to Follow-up|0|||
156808248|NCT01791517|566052640|FG003|Phase I: Period 3|Lost to Follow-up|0|||
156808249|NCT01791517|566052641|FG004|Phase I: Period 3|Lost to Follow-up|1|||
156808250|NCT01791517|566052642|FG005|Phase I: Period 3|Lost to Follow-up|0|||
156808251|NCT01791517|566052643|FG006|Phase I: Period 3|Lost to Follow-up|0|||
156808252|NCT01791517|566052644|FG007|Phase I: Period 3|Lost to Follow-up|0|||
156808253|NCT01791517|566052645|FG008|Phase I: Period 3|Lost to Follow-up|0|||
156808254|NCT01791517|566052646|FG009|Phase I: Period 3|Lost to Follow-up|0|||
156808255|NCT01791517|566052647|FG010|Phase I: Period 3|Lost to Follow-up|0|||
156808256|NCT01791517|566052648|FG011|Phase I: Period 3|Lost to Follow-up|0|||
156808257|NCT01791517|566052637|FG000|Phase I: Period 3|Adverse Event|0|||
156808258|NCT01791517|566052638|FG001|Phase I: Period 3|Adverse Event|0|||
156808259|NCT01791517|566052639|FG002|Phase I: Period 3|Adverse Event|0|||
156338250|NCT05248867|564336592|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156537532|NCT01848353|565061152|FG000|Phase 1|Withdrawal by Subject|3|||
156537533|NCT01848353|565061153|FG001|Phase 1|Withdrawal by Subject|1|||
156808260|NCT01791517|566052640|FG003|Phase I: Period 3|Adverse Event|1|||
156808261|NCT01791517|566052641|FG004|Phase I: Period 3|Adverse Event|0|||
156808262|NCT01791517|566052642|FG005|Phase I: Period 3|Adverse Event|0|||
156808263|NCT01791517|566052643|FG006|Phase I: Period 3|Adverse Event|0|||
156537534|NCT01848353|565061154|FG002|Phase 1|Withdrawal by Subject|0|||
156537535|NCT01848353|565061155|FG003|Phase 1|Withdrawal by Subject|0|||
156808264|NCT01791517|566052644|FG007|Phase I: Period 3|Adverse Event|0|||
156808265|NCT01791517|566052645|FG008|Phase I: Period 3|Adverse Event|0|||
156808266|NCT01791517|566052646|FG009|Phase I: Period 3|Adverse Event|0|||
156808267|NCT01791517|566052647|FG010|Phase I: Period 3|Adverse Event|0|||
156808268|NCT01791517|566052648|FG011|Phase I: Period 3|Adverse Event|0|||
156808269|NCT01791517|566052637|FG000|Phase II|Lost to Follow-up|1|||
156338096|NCT01847274|564336523|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156537536|NCT01848353|565061152|FG000|Phase 2|Withdrawal by Subject|3|||
156537537|NCT01848353|565061153|FG001|Phase 2|Withdrawal by Subject|2|||
156537538|NCT01848353|565061154|FG002|Phase 2|Withdrawal by Subject|0|||
156537539|NCT01848353|565061155|FG003|Phase 2|Withdrawal by Subject|0|||
156808270|NCT01791517|566052638|FG001|Phase II|Lost to Follow-up|0|||
156808271|NCT01791517|566052639|FG002|Phase II|Lost to Follow-up|1|||
156808272|NCT01791517|566052640|FG003|Phase II|Lost to Follow-up|0|||
156808273|NCT01791517|566052641|FG004|Phase II|Lost to Follow-up|1|||
156808274|NCT01791517|566052642|FG005|Phase II|Lost to Follow-up|2|||
156808275|NCT01791517|566052643|FG006|Phase II|Lost to Follow-up|0|||
156808276|NCT01791517|566052644|FG007|Phase II|Lost to Follow-up|1|||
156808277|NCT01791517|566052645|FG008|Phase II|Lost to Follow-up|1|||
156808278|NCT01791517|566052646|FG009|Phase II|Lost to Follow-up|1|||
156808279|NCT01791517|566052647|FG010|Phase II|Lost to Follow-up|0|||
156808280|NCT01791517|566052648|FG011|Phase II|Lost to Follow-up|0|||
156808281|NCT01791517|566052637|FG000|Phase II|Withdrawal by Subject|1|||
156808282|NCT01791517|566052638|FG001|Phase II|Withdrawal by Subject|0|||
156808283|NCT01791517|566052639|FG002|Phase II|Withdrawal by Subject|0|||
156808284|NCT01791517|566052640|FG003|Phase II|Withdrawal by Subject|0|||
156808285|NCT01791517|566052641|FG004|Phase II|Withdrawal by Subject|0|||
156808286|NCT01791517|566052642|FG005|Phase II|Withdrawal by Subject|2|||
156808287|NCT01791517|566052643|FG006|Phase II|Withdrawal by Subject|0|||
156808288|NCT01791517|566052644|FG007|Phase II|Withdrawal by Subject|1|||
156808289|NCT01791517|566052645|FG008|Phase II|Withdrawal by Subject|0|||
156808290|NCT01791517|566052646|FG009|Phase II|Withdrawal by Subject|0|||
156808291|NCT01791517|566052647|FG010|Phase II|Withdrawal by Subject|1|||
156808292|NCT01791517|566052648|FG011|Phase II|Withdrawal by Subject|0|||
156808293|NCT01791517|566052637|FG000|Phase II|Lack of Efficacy|0|||
156537540|NCT01848353|565061152|FG000|Phase 3|Withdrawal by Subject|1|||
156808294|NCT01791517|566052638|FG001|Phase II|Lack of Efficacy|0|||
156808295|NCT01791517|566052639|FG002|Phase II|Lack of Efficacy|0|||
156808296|NCT01791517|566052640|FG003|Phase II|Lack of Efficacy|0|||
156808297|NCT01791517|566052641|FG004|Phase II|Lack of Efficacy|1|||
156808298|NCT01791517|566052642|FG005|Phase II|Lack of Efficacy|0|||
156808299|NCT01791517|566052643|FG006|Phase II|Lack of Efficacy|0|||
156537541|NCT01848353|565061153|FG001|Phase 3|Withdrawal by Subject|1|||
156808300|NCT01791517|566052644|FG007|Phase II|Lack of Efficacy|0|||
156808301|NCT01791517|566052645|FG008|Phase II|Lack of Efficacy|0|||
156808302|NCT01791517|566052646|FG009|Phase II|Lack of Efficacy|0|||
156808303|NCT01791517|566052647|FG010|Phase II|Lack of Efficacy|0|||
156808304|NCT01791517|566052648|FG011|Phase II|Lack of Efficacy|0|||
156808305|NCT01791517|566052637|FG000|Phase II|Adverse Event|0|||
156808306|NCT01791517|566052638|FG001|Phase II|Adverse Event|0|||
156808307|NCT01791517|566052639|FG002|Phase II|Adverse Event|0|||
156808308|NCT01791517|566052640|FG003|Phase II|Adverse Event|0|||
156808309|NCT01791517|566052641|FG004|Phase II|Adverse Event|0|||
156808310|NCT01791517|566052642|FG005|Phase II|Adverse Event|0|||
156808311|NCT01791517|566052643|FG006|Phase II|Adverse Event|2|||
156808312|NCT01791517|566052644|FG007|Phase II|Adverse Event|1|||
156808313|NCT01791517|566052645|FG008|Phase II|Adverse Event|0|||
156808314|NCT01791517|566052646|FG009|Phase II|Adverse Event|1|||
156808315|NCT01791517|566052647|FG010|Phase II|Adverse Event|0|||
156808316|NCT01791517|566052648|FG011|Phase II|Adverse Event|0|||
156808317|NCT01791517|566052637|FG000|Phase II|Lens Handling Difficulties|0|||
156808318|NCT01791517|566052638|FG001|Phase II|Lens Handling Difficulties|0|||
156808319|NCT01791517|566052639|FG002|Phase II|Lens Handling Difficulties|0|||
156808320|NCT01791517|566052640|FG003|Phase II|Lens Handling Difficulties|0|||
156808321|NCT01791517|566052641|FG004|Phase II|Lens Handling Difficulties|0|||
156808322|NCT01791517|566052642|FG005|Phase II|Lens Handling Difficulties|0|||
156808323|NCT01791517|566052643|FG006|Phase II|Lens Handling Difficulties|0|||
156808324|NCT01791517|566052644|FG007|Phase II|Lens Handling Difficulties|0|||
156808325|NCT01791517|566052645|FG008|Phase II|Lens Handling Difficulties|1|||
156808326|NCT01791517|566052646|FG009|Phase II|Lens Handling Difficulties|0|||
156808327|NCT01791517|566052647|FG010|Phase II|Lens Handling Difficulties|0|||
156808328|NCT01791517|566052648|FG011|Phase II|Lens Handling Difficulties|0|||
156808329|NCT01791517|566052637|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
156808330|NCT01791517|566052638|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
156808331|NCT01791517|566052639|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
156808332|NCT01791517|566052640|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
156808333|NCT01791517|566052641|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
156808334|NCT01791517|566052642|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
156808335|NCT01791517|566052643|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
156808336|NCT01791517|566052644|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
156808337|NCT01791517|566052645|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
156808338|NCT01791517|566052646|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
156808339|NCT01791517|566052647|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
156808340|NCT01791517|566052648|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
156808341|NCT01791517|566052637|FG000|Phase II|Pre-Existing Ocular Issue|0|||
156808342|NCT01791517|566052638|FG001|Phase II|Pre-Existing Ocular Issue|0|||
156808343|NCT01791517|566052639|FG002|Phase II|Pre-Existing Ocular Issue|0|||
156808344|NCT01791517|566052640|FG003|Phase II|Pre-Existing Ocular Issue|0|||
156808345|NCT01791517|566052641|FG004|Phase II|Pre-Existing Ocular Issue|0|||
156808346|NCT01791517|566052642|FG005|Phase II|Pre-Existing Ocular Issue|0|||
156808347|NCT01791517|566052643|FG006|Phase II|Pre-Existing Ocular Issue|0|||
156808348|NCT01791517|566052644|FG007|Phase II|Pre-Existing Ocular Issue|0|||
156808349|NCT01791517|566052645|FG008|Phase II|Pre-Existing Ocular Issue|0|||
156808350|NCT01791517|566052646|FG009|Phase II|Pre-Existing Ocular Issue|0|||
156808351|NCT01791517|566052647|FG010|Phase II|Pre-Existing Ocular Issue|0|||
156808352|NCT01791517|566052648|FG011|Phase II|Pre-Existing Ocular Issue|1|||
156808353|NCT03230318|566052650|FG000|Overall Study|Radiographic disease progression|72|||
156808354|NCT03230318|566052651|FG001|Overall Study|Radiographic disease progression|19|||
156808355|NCT03230318|566052650|FG000|Overall Study|Clinical progression|17|||
156808356|NCT03230318|566052651|FG001|Overall Study|Clinical progression|7|||
156808357|NCT03230318|566052650|FG000|Overall Study|Adverse Event|5|||
156808358|NCT03230318|566052651|FG001|Overall Study|Adverse Event|3|||
156808359|NCT03230318|566052650|FG000|Overall Study|Physician Decision|2|||
156808360|NCT03230318|566052651|FG001|Overall Study|Physician Decision|3|||
156808361|NCT03230318|566052650|FG000|Overall Study|Death|3|||
156808362|NCT03230318|566052651|FG001|Overall Study|Death|2|||
156808363|NCT03230318|566052650|FG000|Overall Study|Lost to Follow-up|1|||
156808364|NCT03230318|566052651|FG001|Overall Study|Lost to Follow-up|0|||
156808365|NCT03230318|566052650|FG000|Overall Study|Withdrawal by Subject|1|||
156808366|NCT03230318|566052651|FG001|Overall Study|Withdrawal by Subject|3|||
156808367|NCT03230318|566052650|FG000|Overall Study|Other|3|||
156808368|NCT03230318|566052651|FG001|Overall Study|Other|7|||
156808369|NCT02141672|566052652|FG000|Overall Study|Adverse Event|0|||
156808370|NCT02141672|566052653|FG001|Overall Study|Adverse Event|1|||
156808371|NCT02141672|566052654|FG002|Overall Study|Adverse Event|0|||
156808372|NCT02141672|566052652|FG000|Overall Study|Death|10|||
156808373|NCT02141672|566052653|FG001|Overall Study|Death|2|||
156808374|NCT02141672|566052654|FG002|Overall Study|Death|1|||
156808375|NCT02141672|566052652|FG000|Overall Study|Lack of Efficacy|0|||
156808376|NCT02141672|566052653|FG001|Overall Study|Lack of Efficacy|0|||
156808377|NCT02141672|566052654|FG002|Overall Study|Lack of Efficacy|2|||
156808378|NCT02141672|566052652|FG000|Overall Study|Lost to Follow-up|1|||
156808379|NCT02141672|566052653|FG001|Overall Study|Lost to Follow-up|1|||
156808380|NCT02141672|566052654|FG002|Overall Study|Lost to Follow-up|3|||
156808381|NCT02141672|566052652|FG000|Overall Study|Physician Decision|1|||
156808382|NCT02141672|566052653|FG001|Overall Study|Physician Decision|2|||
156808383|NCT02141672|566052654|FG002|Overall Study|Physician Decision|5|||
156808384|NCT02141672|566052652|FG000|Overall Study|Protocol Violation|0|||
156808385|NCT02141672|566052653|FG001|Overall Study|Protocol Violation|0|||
156808386|NCT02141672|566052654|FG002|Overall Study|Protocol Violation|1|||
156808387|NCT02141672|566052652|FG000|Overall Study|Withdrawal by Subject|3|||
156808388|NCT02141672|566052653|FG001|Overall Study|Withdrawal by Subject|2|||
156808389|NCT02141672|566052654|FG002|Overall Study|Withdrawal by Subject|5|||
156808390|NCT02141672|566052652|FG000|Overall Study|refused to follow-up|1|||
156808391|NCT02141672|566052653|FG001|Overall Study|refused to follow-up|0|||
156808392|NCT02141672|566052654|FG002|Overall Study|refused to follow-up|1|||
156808393|NCT00075764|566052655|FG000|Overall Study|Adverse Event|5|||
156808394|NCT00075764|566052656|FG001|Overall Study|Adverse Event|12|||
156808395|NCT00075764|566052655|FG000|Overall Study|Death|4|||
156808396|NCT00075764|566052656|FG001|Overall Study|Death|8|||
156808397|NCT00075764|566052655|FG000|Overall Study|Withdrawal by Subject|28|||
156808398|NCT00075764|566052656|FG001|Overall Study|Withdrawal by Subject|18|||
156808399|NCT00075764|566052655|FG000|Overall Study|Progression|269|||
156808400|NCT00075764|566052656|FG001|Overall Study|Progression|274|||
156808401|NCT00075764|566052655|FG000|Overall Study|Still on treatment|8|||
156808402|NCT00075764|566052656|FG001|Overall Study|Still on treatment|15|||
156338097|NCT01847274|564336524|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156338098|NCT01847274|564336525|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156808403|NCT00075764|566052655|FG000|Overall Study|Delinquent|4|||
156808404|NCT00075764|566052656|FG001|Overall Study|Delinquent|2|||
156808405|NCT00075764|566052655|FG000|Overall Study|Not protocol specified|27|||
156808406|NCT00075764|566052656|FG001|Overall Study|Not protocol specified|19|||
156808407|NCT00075764|566052655|FG000|Overall Study|Under review|0|||
156808408|NCT00075764|566052656|FG001|Overall Study|Under review|1|||
156808409|NCT02817594|566052660|FG000|Overall Study|Withdrawal by Subject|1|||
156808410|NCT02817594|566052660|FG000|Overall Study|Other|1|||
156808411|NCT02817594|566052660|FG000|Overall Study|Did Not Receive Treatment|1|||
156808412|NCT02010593|566052661|FG000|Overall Study|Lost to Follow-up|1|||
156808413|NCT02010593|566052662|FG001|Overall Study|Lost to Follow-up|0|||
156808414|NCT02010593|566052661|FG000|Overall Study|Physician Decision|1|||
156808415|NCT02010593|566052662|FG001|Overall Study|Physician Decision|0|||
156808416|NCT02010593|566052661|FG000|Overall Study|Unable to adhere to visit schedule|0|||
156808417|NCT02010593|566052662|FG001|Overall Study|Unable to adhere to visit schedule|2|||
156808418|NCT01773967|566052663|FG000|Overall Study|Lost to Follow-up|15|||
156808419|NCT01773967|566052664|FG001|Overall Study|Lost to Follow-up|13|||
156537542|NCT01848353|565061154|FG002|Phase 3|Withdrawal by Subject|0|||
156537543|NCT01848353|565061155|FG003|Phase 3|Withdrawal by Subject|0|||
156537544|NCT03123250|565061161|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
156537545|NCT00773136|565061188|FG000|Overall Study|Physician Decision|2|||
156537546|NCT02463071|565061193|FG000|Overall Study|Adverse Event|3|||
156537547|NCT02463071|565061194|FG001|Overall Study|Adverse Event|5|||
156537548|NCT02463071|565061195|FG002|Overall Study|Adverse Event|1|||
156537549|NCT02463071|565061193|FG000|Overall Study|Death|1|||
156537550|NCT02463071|565061194|FG001|Overall Study|Death|0|||
156537551|NCT02463071|565061195|FG002|Overall Study|Death|0|||
156537552|NCT02463071|565061193|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
156537553|NCT02463071|565061194|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156537554|NCT02463071|565061195|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
156537555|NCT02463071|565061193|FG000|Overall Study|Reason not specified|7|||
156537556|NCT02463071|565061194|FG001|Overall Study|Reason not specified|9|||
156537557|NCT02463071|565061195|FG002|Overall Study|Reason not specified|4|||
156537558|NCT02463071|565061193|FG000|Overall Study|Protocol Violation|0|||
156537559|NCT02463071|565061194|FG001|Overall Study|Protocol Violation|2|||
156537560|NCT02463071|565061195|FG002|Overall Study|Protocol Violation|0|||
156537561|NCT02463071|565061193|FG000|Overall Study|Lost to Follow-up|0|||
156537562|NCT02463071|565061194|FG001|Overall Study|Lost to Follow-up|0|||
156537563|NCT02463071|565061195|FG002|Overall Study|Lost to Follow-up|1|||
156537564|NCT00175877|565061211|FG000|Overall Study|Adverse Event|136|||
156537565|NCT00175877|565061211|FG000|Overall Study|Withdrawal by Subject|141|||
156537566|NCT00175877|565061211|FG000|Overall Study|Lost to Follow-up|9|||
156537567|NCT00175877|565061211|FG000|Overall Study|Lack of Efficacy|26|||
156537568|NCT00175877|565061211|FG000|Overall Study|Protocol Violation|15|||
156537569|NCT00175877|565061211|FG000|Overall Study|Other Reason|20|||
156537570|NCT00175877|565061211|FG000|Overall Study|AE & Other|1|||
156537571|NCT00175877|565061211|FG000|Overall Study|Withdrawal by subject & Other|1|||
156537572|NCT00805025|565061215|FG000|Overall Study|Screened but not enrolled/treated|42|||
156537573|NCT00805025|565061215|FG000|Overall Study|Adverse Event|4|||
156537574|NCT00805025|565061215|FG000|Overall Study|Withdrawal by Subject|2|||
156537575|NCT00805025|565061215|FG000|Overall Study|Physician Decision|1|||
156537576|NCT04029961|565061216|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
156537577|NCT04029961|565061217|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
156537578|NCT04029961|565061216|FG000|Overall Study|Change in Treatment Course|0|||
156537579|NCT04029961|565061217|FG001|Overall Study|Change in Treatment Course|1|||
156537580|NCT02737852|565062780|FG000|Overall Study|Withdrawal by Subject|2|||
156537581|NCT03688880|565062781|FG000|Overall Study|Withdrawal by Subject|0|||
156537582|NCT03688880|565062782|FG001|Overall Study|Withdrawal by Subject|2|||
156537583|NCT03688880|565062781|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
156537584|NCT03688880|565062782|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
156537585|NCT03688880|565062781|FG000|Overall Study|Lost to Follow-up|4|||
156537586|NCT03688880|565062782|FG001|Overall Study|Lost to Follow-up|7|||
156537587|NCT03688880|565062781|FG000|Overall Study|Adverse Event|0|||
156537588|NCT03688880|565062782|FG001|Overall Study|Adverse Event|2|||
156537589|NCT03688880|565062781|FG000|Overall Study|Device deficiencies|0|||
156537590|NCT03688880|565062782|FG001|Overall Study|Device deficiencies|2|||
156537591|NCT03688880|565062781|FG000|Overall Study|Other|10|||
156537592|NCT03688880|565062782|FG001|Overall Study|Other|16|||
156537593|NCT01704287|565062784|FG000|Initial Treatment Period|Death|139|||
156537594|NCT01704287|565062785|FG001|Initial Treatment Period|Death|129|||
156537595|NCT01704287|565062786|FG002|Initial Treatment Period|Death|71|||
156537596|NCT01704287|565062787|FG003|Initial Treatment Period|Death|0|||
156537597|NCT01704287|565062788|FG004|Initial Treatment Period|Death|0|||
156537598|NCT01704287|565062784|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
156537599|NCT01704287|565062785|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
156537600|NCT01704287|565062786|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
156808420|NCT02655887|566052669|FG000|Overall Study|Lost to Follow-up|3|||
156808421|NCT02655887|566052669|FG000|Overall Study|Death|4|||
156808422|NCT02655887|566052669|FG000|Overall Study|Withdrawal by Subject|3|||
156808423|NCT02655887|566052669|FG000|Overall Study|Missed 12-month follow-up visit|4|||
156537601|NCT01704287|565062787|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
156537602|NCT01704287|565062788|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
156537603|NCT01704287|565062784|FG000|Initial Treatment Period|Lost to Follow-up|5|||
156537604|NCT01704287|565062785|FG001|Initial Treatment Period|Lost to Follow-up|3|||
156537605|NCT01704287|565062786|FG002|Initial Treatment Period|Lost to Follow-up|0|||
156537606|NCT01704287|565062787|FG003|Initial Treatment Period|Lost to Follow-up|0|||
156537607|NCT01704287|565062788|FG004|Initial Treatment Period|Lost to Follow-up|0|||
156537608|NCT01704287|565062784|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
156537609|NCT01704287|565062785|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
156537610|NCT01704287|565062786|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
156537611|NCT01704287|565062787|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
156537612|NCT01704287|565062788|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
156537613|NCT01704287|565062784|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
156537614|NCT01704287|565062785|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
156537615|NCT01704287|565062786|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
156537616|NCT01704287|565062787|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
156537617|NCT01704287|565062788|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
156537618|NCT01704287|565062784|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
156537619|NCT01704287|565062785|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
156537620|NCT01704287|565062786|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
156537621|NCT01704287|565062787|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
156537622|NCT01704287|565062788|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
156537623|NCT01704287|565062784|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
156537624|NCT01704287|565062785|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
156537625|NCT01704287|565062786|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
156537626|NCT01704287|565062787|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
156808424|NCT02834819|566052670|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
156808425|NCT02834819|566052671|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
156808426|NCT02041299|566052673|FG000|Overall Study|Adverse Event|9|||
156808427|NCT02041299|566052674|FG001|Overall Study|Adverse Event|3|||
156808428|NCT02041299|566052673|FG000|Overall Study|Lost to Follow-up|4|||
156808429|NCT02041299|566052674|FG001|Overall Study|Lost to Follow-up|1|||
156808430|NCT02041299|566052673|FG000|Overall Study|Physician Decision|1|||
156808431|NCT02041299|566052674|FG001|Overall Study|Physician Decision|1|||
156808432|NCT02041299|566052673|FG000|Overall Study|Withdrawal by Subject|13|||
156808433|NCT02041299|566052674|FG001|Overall Study|Withdrawal by Subject|7|||
156808434|NCT02041299|566052673|FG000|Overall Study|Protocol Violation|11|||
156808435|NCT02041299|566052674|FG001|Overall Study|Protocol Violation|4|||
156808436|NCT02041299|566052673|FG000|Overall Study|Termination of the study|7|||
156808437|NCT02041299|566052674|FG001|Overall Study|Termination of the study|3|||
156808438|NCT02041299|566052673|FG000|Overall Study|Required bone marrow transplant|0|||
156808439|NCT02041299|566052674|FG001|Overall Study|Required bone marrow transplant|1|||
156808440|NCT02041299|566052673|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
156808441|NCT02041299|566052674|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
156808442|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
156808443|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156808444|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
156808445|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
156537627|NCT01704287|565062788|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
156537628|NCT04042740|565062789|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
156808446|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
156808447|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
156808448|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
156808449|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
156808450|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
156808451|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
156808452|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
156808453|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
156808454|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
156808455|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
156808456|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
156808457|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
156808458|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
156808459|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
156808460|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
156808461|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
156808462|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
156808463|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
156808464|NCT00087698|566052680|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
156808465|NCT00087698|566052680|FG000|Overall Study|Death from Other Causes|3|||
156808466|NCT00087698|566052680|FG000|Overall Study|Adverse Event|4|||
156808467|NCT00087698|566052680|FG000|Overall Study|Withdrawal by Subject|4|||
156808468|NCT00087698|566052680|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
156808469|NCT00087698|566052680|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
156808470|NCT00087698|566052680|FG000|Overall Study|Clinical Relapse|1|||
156808471|NCT00087698|566052680|FG000|Overall Study|Death from Study Disease|2|||
156808472|NCT00087698|566052680|FG000|Overall Study|Death from Study Drug Toxicity|2|||
156808473|NCT00087698|566052680|FG000|Overall Study|Protocol Violation|1|||
156808474|NCT04179305|566052681|FG000|Overall Study|Death|1|||
156808475|NCT04179305|566052682|FG001|Overall Study|Death|1|||
156808476|NCT04179305|566052683|FG002|Overall Study|Death|0|||
156808477|NCT04179305|566052684|FG003|Overall Study|Death|0|||
156808478|NCT04179305|566052681|FG000|Overall Study|Lost to Follow-up|1|||
156808479|NCT04179305|566052682|FG001|Overall Study|Lost to Follow-up|1|||
156808480|NCT04179305|566052683|FG002|Overall Study|Lost to Follow-up|0|||
156808481|NCT04179305|566052684|FG003|Overall Study|Lost to Follow-up|0|||
156808482|NCT04179305|566052681|FG000|Overall Study|Withdrawal by Subject|0|||
156808483|NCT04179305|566052682|FG001|Overall Study|Withdrawal by Subject|1|||
156808484|NCT04179305|566052683|FG002|Overall Study|Withdrawal by Subject|0|||
156808485|NCT04179305|566052684|FG003|Overall Study|Withdrawal by Subject|0|||
156808486|NCT04179305|566052681|FG000|Overall Study|Did not have scan|1|||
156808487|NCT04179305|566052682|FG001|Overall Study|Did not have scan|0|||
156808488|NCT04179305|566052683|FG002|Overall Study|Did not have scan|0|||
156808489|NCT04179305|566052684|FG003|Overall Study|Did not have scan|0|||
156808490|NCT04179305|566052681|FG000|Overall Study|In hospice care|3|||
156808491|NCT04179305|566052682|FG001|Overall Study|In hospice care|0|||
156808492|NCT04179305|566052683|FG002|Overall Study|In hospice care|0|||
156808493|NCT04179305|566052684|FG003|Overall Study|In hospice care|0|||
156808494|NCT01737762|566052687|FG000|Overall Study|Adverse Event|2|||
156808495|NCT01737762|566052688|FG001|Overall Study|Adverse Event|2|||
156808496|NCT01737762|566052687|FG000|Overall Study|Lost to Follow-up|1|||
156808497|NCT01737762|566052688|FG001|Overall Study|Lost to Follow-up|0|||
156808498|NCT01737762|566052687|FG000|Overall Study|Withdrawal by Subject|2|||
156808499|NCT01737762|566052688|FG001|Overall Study|Withdrawal by Subject|2|||
156808500|NCT01737762|566052687|FG000|Overall Study|Progressive disease|1|||
156808501|NCT01737762|566052688|FG001|Overall Study|Progressive disease|2|||
156808502|NCT01737762|566052687|FG000|Overall Study|Physician Decision|1|||
156808503|NCT01737762|566052688|FG001|Overall Study|Physician Decision|1|||
156808504|NCT01737762|566052687|FG000|Overall Study|Moved from area|2|||
156808505|NCT01737762|566052688|FG001|Overall Study|Moved from area|1|||
156808506|NCT01737762|566052687|FG000|Overall Study|Trial termination|11|||
156808507|NCT01737762|566052688|FG001|Overall Study|Trial termination|9|||
156808508|NCT01964378|566052689|FG000|Overall Study|Disc. due to death before first dosing|0|||
156808509|NCT01964378|566052690|FG001|Overall Study|Disc. due to death before first dosing|1|||
156808510|NCT01964378|566052689|FG000|Overall Study|Disc. due to AE before first dosing|1|||
156808511|NCT01964378|566052690|FG001|Overall Study|Disc. due to AE before first dosing|0|||
156338099|NCT01847274|564336526|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156808512|NCT01964378|566052689|FG000|Overall Study|Death|3|||
156537629|NCT04042740|565062789|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
156537630|NCT02615470|565062790|FG000|Overall Study|Lost to Follow-up|21|||
156537631|NCT02615470|565062791|FG001|Overall Study|Lost to Follow-up|32|||
156537632|NCT03713034|565062792|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
156537633|NCT03713034|565062793|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
156537634|NCT01717287|565062797|FG000|Overall Study|Lost to Follow-up|0|||
156537635|NCT01717287|565062798|FG001|Overall Study|Lost to Follow-up|2|||
156537636|NCT01717287|565062797|FG000|Overall Study|Protocol Violation|0|||
156537637|NCT01717287|565062798|FG001|Overall Study|Protocol Violation|1|||
156537638|NCT04024228|565062799|FG000|Overall Study|Adverse Event|1|||
156537639|NCT04024228|565062800|FG001|Overall Study|Adverse Event|0|||
156537640|NCT04024228|565062799|FG000|Overall Study|Protocol Deviation|0|||
156537641|NCT04024228|565062800|FG001|Overall Study|Protocol Deviation|2|||
156338100|NCT01847274|564336527|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156537642|NCT04024228|565062799|FG000|Overall Study|Withdrawal by Subject|3|||
156537643|NCT04024228|565062800|FG001|Overall Study|Withdrawal by Subject|4|||
156537644|NCT02982590|565062803|FG000|Overall Study|Lost to Follow-up|0|||
156537645|NCT02982590|565062804|FG001|Overall Study|Lost to Follow-up|1|||
156537646|NCT02982590|565062803|FG000|Overall Study|Death|4|||
156537647|NCT02982590|565062804|FG001|Overall Study|Death|0|||
156537648|NCT01858532|565062807|FG000|Overall Study|Adverse Event|58|||
156537649|NCT01858532|565062808|FG001|Overall Study|Adverse Event|50|||
156537650|NCT01858532|565062809|FG002|Overall Study|Adverse Event|23|||
156537651|NCT01858532|565062810|FG003|Overall Study|Adverse Event|28|||
156537652|NCT01858532|565062807|FG000|Overall Study|Withdrew consent|71|||
156537653|NCT01858532|565062808|FG001|Overall Study|Withdrew consent|93|||
156537654|NCT01858532|565062809|FG002|Overall Study|Withdrew consent|46|||
156537655|NCT01858532|565062810|FG003|Overall Study|Withdrew consent|27|||
156537656|NCT01858532|565062807|FG000|Overall Study|Lost to Follow-up|17|||
156537657|NCT01858532|565062808|FG001|Overall Study|Lost to Follow-up|26|||
156537658|NCT01858532|565062809|FG002|Overall Study|Lost to Follow-up|11|||
156537659|NCT01858532|565062810|FG003|Overall Study|Lost to Follow-up|14|||
156537660|NCT01858532|565062807|FG000|Overall Study|Deterioration of medical status|3|||
156537661|NCT01858532|565062808|FG001|Overall Study|Deterioration of medical status|4|||
156537662|NCT01858532|565062809|FG002|Overall Study|Deterioration of medical status|3|||
156537663|NCT01858532|565062810|FG003|Overall Study|Deterioration of medical status|7|||
156537664|NCT01858532|565062807|FG000|Overall Study|Investigator request|3|||
156537665|NCT01858532|565062808|FG001|Overall Study|Investigator request|4|||
156537666|NCT01858532|565062809|FG002|Overall Study|Investigator request|2|||
156537667|NCT01858532|565062810|FG003|Overall Study|Investigator request|6|||
156537668|NCT01858532|565062807|FG000|Overall Study|Other, not specified|29|||
156537669|NCT01858532|565062808|FG001|Overall Study|Other, not specified|15|||
156537670|NCT01858532|565062809|FG002|Overall Study|Other, not specified|13|||
156537671|NCT01858532|565062810|FG003|Overall Study|Other, not specified|11|||
156537672|NCT00514514|565062811|FG000|Pre-phase|Death|10|||
156537673|NCT00514514|565062812|FG001|Pre-phase|Death|0|||
156537674|NCT00514514|565062813|FG002|Pre-phase|Death|0|||
156537675|NCT00514514|565062811|FG000|Pre-phase|administrative problems|2|||
156537676|NCT00514514|565062812|FG001|Pre-phase|administrative problems|0|||
156537677|NCT00514514|565062813|FG002|Pre-phase|administrative problems|0|||
156537678|NCT00514514|565062811|FG000|Pre-phase|Protocol Violation|6|||
156537679|NCT00514514|565062812|FG001|Pre-phase|Protocol Violation|0|||
156537680|NCT00514514|565062813|FG002|Pre-phase|Protocol Violation|0|||
156537681|NCT00514514|565062811|FG000|Pre-phase|condition no longer requires study drug|7|||
156537682|NCT00514514|565062812|FG001|Pre-phase|condition no longer requires study drug|0|||
156537683|NCT00514514|565062813|FG002|Pre-phase|condition no longer requires study drug|0|||
156537684|NCT00514514|565062811|FG000|Pre-phase|abnormal test procedure results|15|||
156537685|NCT00514514|565062812|FG001|Pre-phase|abnormal test procedure results|0|||
156537686|NCT00514514|565062813|FG002|Pre-phase|abnormal test procedure results|0|||
156537687|NCT00514514|565062811|FG000|Pre-phase|Lost to Follow-up|2|||
156537688|NCT00514514|565062812|FG001|Pre-phase|Lost to Follow-up|0|||
156537689|NCT00514514|565062813|FG002|Pre-phase|Lost to Follow-up|0|||
156537690|NCT00514514|565062811|FG000|Pre-phase|abnormal lab values|23|||
156537691|NCT00514514|565062812|FG001|Pre-phase|abnormal lab values|0|||
156537692|NCT00514514|565062813|FG002|Pre-phase|abnormal lab values|0|||
156537693|NCT00514514|565062811|FG000|Pre-phase|Lack of Efficacy|35|||
156537694|NCT00514514|565062812|FG001|Pre-phase|Lack of Efficacy|0|||
156537695|NCT00514514|565062813|FG002|Pre-phase|Lack of Efficacy|0|||
156537696|NCT00514514|565062811|FG000|Pre-phase|Adverse Event|137|||
156537697|NCT00514514|565062812|FG001|Pre-phase|Adverse Event|0|||
156537698|NCT00514514|565062813|FG002|Pre-phase|Adverse Event|0|||
156537699|NCT00514514|565062811|FG000|Pre-phase|Withdrawal by Subject|66|||
156537700|NCT00514514|565062812|FG001|Pre-phase|Withdrawal by Subject|0|||
156537701|NCT00514514|565062813|FG002|Pre-phase|Withdrawal by Subject|0|||
156537702|NCT00514514|565062811|FG000|Randomized - 9 Month|Death|3|||
156537703|NCT00514514|565062812|FG001|Randomized - 9 Month|Death|2|||
156537704|NCT00514514|565062813|FG002|Randomized - 9 Month|Death|2|||
156537705|NCT00514514|565062811|FG000|Randomized - 9 Month|Administrative problems|1|||
156537706|NCT00514514|565062812|FG001|Randomized - 9 Month|Administrative problems|1|||
156537707|NCT00514514|565062813|FG002|Randomized - 9 Month|Administrative problems|2|||
156537708|NCT00514514|565062811|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
156537709|NCT00514514|565062812|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
156537710|NCT00514514|565062813|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
156537711|NCT00514514|565062811|FG000|Randomized - 9 Month|Protocol Violation|1|||
156537712|NCT00514514|565062812|FG001|Randomized - 9 Month|Protocol Violation|1|||
156537713|NCT00514514|565062813|FG002|Randomized - 9 Month|Protocol Violation|0|||
156537714|NCT00514514|565062811|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
156537715|NCT00514514|565062812|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
156537716|NCT00514514|565062813|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
156537717|NCT00514514|565062811|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
156537718|NCT00514514|565062812|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
156537719|NCT00514514|565062813|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
156537720|NCT00514514|565062811|FG000|Randomized - 9 Month|Adverse Event|25|||
156537721|NCT00514514|565062812|FG001|Randomized - 9 Month|Adverse Event|44|||
156537722|NCT00514514|565062813|FG002|Randomized - 9 Month|Adverse Event|27|||
156537723|NCT00514514|565062811|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
156537724|NCT00514514|565062812|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
156537725|NCT00514514|565062813|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
156537726|NCT00514514|565062811|FG000|Extension - 4 Years|Lost to Follow-up|12|||
156537727|NCT00514514|565062812|FG001|Extension - 4 Years|Lost to Follow-up|10|||
156537728|NCT00514514|565062813|FG002|Extension - 4 Years|Lost to Follow-up|9|||
156537729|NCT00514514|565062811|FG000|Extension - 4 Years|Administrative problems|3|||
156537730|NCT00514514|565062812|FG001|Extension - 4 Years|Administrative problems|1|||
156537731|NCT00514514|565062813|FG002|Extension - 4 Years|Administrative problems|1|||
156537732|NCT00514514|565062811|FG000|Extension - 4 Years|Death|8|||
156338101|NCT01847274|564336528|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156537733|NCT00514514|565062812|FG001|Extension - 4 Years|Death|3|||
156537734|NCT00514514|565062813|FG002|Extension - 4 Years|Death|6|||
156537735|NCT00514514|565062811|FG000|Extension - 4 Years|Adverse Event|9|||
156537736|NCT00514514|565062812|FG001|Extension - 4 Years|Adverse Event|6|||
156537737|NCT00514514|565062813|FG002|Extension - 4 Years|Adverse Event|3|||
156537738|NCT02234479|565062815|FG000|Overall Study|Withdrawal by Subject|1|||
156537739|NCT02234479|565062816|FG001|Overall Study|Withdrawal by Subject|3|||
156537740|NCT00677820|565062819|FG000|Overall Study|Lost to Follow-up|1|||
156537741|NCT00677820|565062820|FG001|Overall Study|Lost to Follow-up|0|||
156537742|NCT02357134|565062823|FG000|Overall Study|Lost to Follow-up|1|||
156537743|NCT02357134|565062824|FG001|Overall Study|Lost to Follow-up|0|||
156537744|NCT02357134|565062825|FG002|Overall Study|Lost to Follow-up|0|||
156537745|NCT02357134|565062826|FG003|Overall Study|Lost to Follow-up|0|||
156537746|NCT02716675|565062828|FG000|Overall Study|Death|2|||
156537747|NCT02716675|565062829|FG001|Overall Study|Death|3|||
156537748|NCT02716675|565062830|FG002|Overall Study|Death|0|||
156537749|NCT02716675|565062828|FG000|Overall Study|Physician Decision|2|||
156537750|NCT02716675|565062829|FG001|Overall Study|Physician Decision|1|||
156537751|NCT02716675|565062830|FG002|Overall Study|Physician Decision|1|||
156537752|NCT02716675|565062828|FG000|Overall Study|Lost to Follow-up|100|||
156537753|NCT02716675|565062829|FG001|Overall Study|Lost to Follow-up|87|||
156537754|NCT02716675|565062830|FG002|Overall Study|Lost to Follow-up|99|||
156537755|NCT02716675|565062828|FG000|Overall Study|Withdrawal by Subject|22|||
156537756|NCT02716675|565062829|FG001|Overall Study|Withdrawal by Subject|25|||
156537757|NCT02716675|565062830|FG002|Overall Study|Withdrawal by Subject|20|||
156537758|NCT02716675|565062828|FG000|Overall Study|Protocol Violation|0|||
156537759|NCT02716675|565062829|FG001|Overall Study|Protocol Violation|3|||
156537760|NCT02716675|565062830|FG002|Overall Study|Protocol Violation|1|||
156537761|NCT02716675|565062828|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
156537762|NCT02716675|565062829|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
156537763|NCT02716675|565062830|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
156537764|NCT02716675|565062828|FG000|Overall Study|Other|38|||
156338251|NCT05248867|564336593|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156537765|NCT02716675|565062829|FG001|Overall Study|Other|47|||
156537766|NCT02716675|565062830|FG002|Overall Study|Other|48|||
156537767|NCT00290290|565062835|FG000|Overall Study|Death|3|||
156537768|NCT00290290|565062836|FG001|Overall Study|Death|4|||
156537769|NCT00290290|565062835|FG000|Overall Study|Withdrawal by Subject|2|||
156537770|NCT00290290|565062836|FG001|Overall Study|Withdrawal by Subject|2|||
156537771|NCT00290290|565062835|FG000|Overall Study|Underwent clean surgical procedure|13|||
156537772|NCT00290290|565062836|FG001|Overall Study|Underwent clean surgical procedure|12|||
156537773|NCT03374995|565062837|FG000|Overall Study|Withdrawal by Subject|0|||
156537774|NCT03374995|565062838|FG001|Overall Study|Withdrawal by Subject|1|||
156338102|NCT01847274|564336529|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
156537775|NCT01211535|565062841|FG000|Overall Study|Adverse Event|0|||
156338103|NCT01847274|564336530|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
156537776|NCT01211535|565062842|FG001|Overall Study|Adverse Event|1|||
156537777|NCT03593850|565062844|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
156537778|NCT03593850|565062845|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
156537779|NCT00003895|565062846|FG000|Overall Study|Adverse Event|4|||
156537780|NCT00003895|565062847|FG001|Overall Study|Adverse Event|0|||
156537781|NCT00003895|565062846|FG000|Overall Study|Lack of Efficacy|1|||
156537782|NCT00003895|565062847|FG001|Overall Study|Lack of Efficacy|1|||
156537783|NCT00003895|565062846|FG000|Overall Study|Patient Vacation|2|||
156537784|NCT00003895|565062847|FG001|Overall Study|Patient Vacation|0|||
156537785|NCT00003895|565062846|FG000|Overall Study|Withdrawal by Subject|0|||
156537786|NCT00003895|565062847|FG001|Overall Study|Withdrawal by Subject|3|||
156537787|NCT01380730|565062848|FG000|Overall Study|Death|0|||
156537788|NCT01380730|565062849|FG001|Overall Study|Death|0|||
156537789|NCT01380730|565062850|FG002|Overall Study|Death|0|||
156537790|NCT01380730|565062851|FG003|Overall Study|Death|0|||
156537791|NCT01380730|565062852|FG004|Overall Study|Death|1|||
156537792|NCT01380730|565062853|FG005|Overall Study|Death|0|||
156537793|NCT01380730|565062854|FG006|Overall Study|Death|0|||
156537794|NCT01380730|565062855|FG007|Overall Study|Death|0|||
156537795|NCT02490475|565062856|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
156537796|NCT02490475|565062857|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
156537797|NCT02490475|565062858|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
156537798|NCT02490475|565062859|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
156537799|NCT02490475|565062856|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
156537800|NCT02490475|565062857|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
156537801|NCT02490475|565062858|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
156537802|NCT02490475|565062859|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
156537803|NCT02490475|565062856|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
156537804|NCT02490475|565062857|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
156537805|NCT02490475|565062858|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
156537806|NCT02490475|565062859|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
156537807|NCT02490475|565062856|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
156537808|NCT02490475|565062857|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
156537809|NCT02490475|565062858|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
156537810|NCT02490475|565062859|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
156537811|NCT02490475|565062856|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
156537812|NCT02490475|565062857|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
156537813|NCT02490475|565062858|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
156537814|NCT02490475|565062859|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
156537815|NCT02490475|565062856|FG000|Period 2: Extension Phase|Refused Treatment|0|||
156808513|NCT01964378|566052690|FG001|Overall Study|Death|2|||
156808514|NCT01964378|566052689|FG000|Overall Study|Adverse Event|12|||
156808515|NCT01964378|566052690|FG001|Overall Study|Adverse Event|5|||
156808516|NCT01964378|566052689|FG000|Overall Study|Lack of Efficacy|0|||
156808517|NCT01964378|566052690|FG001|Overall Study|Lack of Efficacy|1|||
156808518|NCT01964378|566052689|FG000|Overall Study|Protocol Violation|0|||
156808519|NCT01964378|566052690|FG001|Overall Study|Protocol Violation|1|||
156808520|NCT01964378|566052689|FG000|Overall Study|Lost to Follow-up|0|||
156808521|NCT01964378|566052690|FG001|Overall Study|Lost to Follow-up|1|||
156808522|NCT01964378|566052689|FG000|Overall Study|Withdrawal by Subject|7|||
156808523|NCT01964378|566052690|FG001|Overall Study|Withdrawal by Subject|5|||
156808524|NCT01964378|566052689|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
156808525|NCT01964378|566052690|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
156808526|NCT01964378|566052689|FG000|Overall Study|Other|1|||
156808527|NCT01964378|566052690|FG001|Overall Study|Other|2|||
156808528|NCT00326599|566052691|FG000|Overall Study|Withdrawal by Subject|1|||
156808529|NCT00326599|566052692|FG001|Overall Study|Withdrawal by Subject|0|||
156808530|NCT00326599|566052693|FG002|Overall Study|Withdrawal by Subject|5|||
156808531|NCT00326599|566052694|FG003|Overall Study|Withdrawal by Subject|2|||
156808532|NCT00326599|566052691|FG000|Overall Study|Adverse Event|1|||
156808533|NCT00326599|566052692|FG001|Overall Study|Adverse Event|0|||
156808534|NCT00326599|566052693|FG002|Overall Study|Adverse Event|32|||
156808535|NCT00326599|566052694|FG003|Overall Study|Adverse Event|3|||
156808536|NCT00326599|566052691|FG000|Overall Study|Disease Progression|3|||
156808537|NCT00326599|566052692|FG001|Overall Study|Disease Progression|1|||
156808538|NCT00326599|566052693|FG002|Overall Study|Disease Progression|13|||
156808539|NCT00326599|566052694|FG003|Overall Study|Disease Progression|11|||
156808540|NCT00326599|566052691|FG000|Overall Study|Alternate Treatment|1|||
156808541|NCT00326599|566052692|FG001|Overall Study|Alternate Treatment|0|||
156808542|NCT00326599|566052693|FG002|Overall Study|Alternate Treatment|0|||
156808543|NCT00326599|566052694|FG003|Overall Study|Alternate Treatment|0|||
156808544|NCT00326599|566052691|FG000|Overall Study|Death|0|||
156808545|NCT00326599|566052692|FG001|Overall Study|Death|0|||
156808546|NCT00326599|566052693|FG002|Overall Study|Death|1|||
156808547|NCT00326599|566052694|FG003|Overall Study|Death|2|||
156808548|NCT00326599|566052691|FG000|Overall Study|Other Unspecified Reason|0|||
156808549|NCT00326599|566052692|FG001|Overall Study|Other Unspecified Reason|0|||
156808550|NCT00326599|566052693|FG002|Overall Study|Other Unspecified Reason|2|||
156808551|NCT00326599|566052694|FG003|Overall Study|Other Unspecified Reason|1|||
156808552|NCT03542266|566052695|FG000|Treatment Phase|Withdrawal by Subject|1|||
156808553|NCT03542266|566052695|FG000|Treatment Phase|Adverse Event|1|||
156808554|NCT03542266|566052695|FG000|Treatment Phase|PD|1|||
156808555|NCT00657267|566052712|FG000|Overall Study|Progressive disease|45|||
156808556|NCT00657267|566052712|FG000|Overall Study|Adverse Event|9|||
156808557|NCT01070979|566052715|FG000|Overall Study|Adverse Event|2|||
156808558|NCT01070979|566052716|FG001|Overall Study|Adverse Event|3|||
156808559|NCT01070979|566052717|FG002|Overall Study|Adverse Event|3|||
156808560|NCT01070979|566052715|FG000|Overall Study|Lost to Follow-up|2|||
156808561|NCT01070979|566052716|FG001|Overall Study|Lost to Follow-up|1|||
156808562|NCT01070979|566052717|FG002|Overall Study|Lost to Follow-up|1|||
156808563|NCT01070979|566052715|FG000|Overall Study|Protocol Violation|0|||
156808564|NCT01070979|566052716|FG001|Overall Study|Protocol Violation|2|||
156808565|NCT01070979|566052717|FG002|Overall Study|Protocol Violation|6|||
156537840|NCT01236573|565062877|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
156537841|NCT01236573|565062878|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
156537842|NCT01236573|565062879|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
156537843|NCT01236573|565062880|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
156537844|NCT01236573|565062881|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
156537845|NCT01236573|565062882|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
156537846|NCT01236573|565062883|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
156537847|NCT01236573|565062884|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
156537848|NCT01236573|565062874|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537849|NCT01236573|565062875|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537850|NCT01236573|565062876|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537851|NCT01236573|565062877|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537852|NCT01236573|565062878|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537853|NCT01236573|565062879|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537854|NCT01236573|565062880|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537855|NCT01236573|565062881|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537856|NCT01236573|565062882|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
156537857|NCT01236573|565062883|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537858|NCT01236573|565062884|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
156537859|NCT01236573|565062874|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537860|NCT01236573|565062875|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537861|NCT01236573|565062876|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537862|NCT01236573|565062877|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537863|NCT01236573|565062878|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537864|NCT01236573|565062879|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537865|NCT01236573|565062880|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537866|NCT01236573|565062881|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537867|NCT01236573|565062882|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537868|NCT01236573|565062883|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
156537869|NCT01236573|565062884|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
156537870|NCT00823823|565062887|FG000|Overall Study|Lost to Follow-up|3|||
156537871|NCT00823823|565062888|FG001|Overall Study|Lost to Follow-up|1|||
156537872|NCT00823823|565062887|FG000|Overall Study|Protocol Violation|5|||
156537873|NCT00823823|565062888|FG001|Overall Study|Protocol Violation|5|||
156537874|NCT04754802|565062889|FG000|Overall Study|Lost to Follow-up|0|||
156537875|NCT04754802|565062890|FG001|Overall Study|Lost to Follow-up|2|||
156537876|NCT04754802|565062889|FG000|Overall Study|Withdrawal by Subject|2|||
156537877|NCT04754802|565062890|FG001|Overall Study|Withdrawal by Subject|0|||
156537878|NCT01490814|565062902|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
156537879|NCT01490814|565062903|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
156537880|NCT01490814|565062902|FG000|Overall Study|Physician Decision|1|||
156537881|NCT01490814|565062903|FG001|Overall Study|Physician Decision|0|||
156537882|NCT01490814|565062902|FG000|Overall Study|Withdrawal by Subject|0|||
156537883|NCT01490814|565062903|FG001|Overall Study|Withdrawal by Subject|5|||
156537884|NCT00496730|565062904|FG000|Overall Study|Lost to Follow-up|4|||
156537885|NCT00496730|565062905|FG001|Overall Study|Lost to Follow-up|3|||
156537886|NCT00496730|565062904|FG000|Overall Study|Withdrawal by Subject|2|||
156537887|NCT00496730|565062905|FG001|Overall Study|Withdrawal by Subject|2|||
156537888|NCT00369785|565062906|FG000|Overall Study|Physician Decision|3|||
156537889|NCT00369785|565062907|FG001|Overall Study|Physician Decision|2|||
156537890|NCT00369785|565062906|FG000|Overall Study|Death|1|||
156537891|NCT00369785|565062907|FG001|Overall Study|Death|2|||
156537892|NCT00369785|565062906|FG000|Overall Study|Withdrawal by Subject|7|||
156537893|NCT00369785|565062907|FG001|Overall Study|Withdrawal by Subject|6|||
156537894|NCT00369785|565062906|FG000|Overall Study|Toxicity|6|||
156537895|NCT00369785|565062907|FG001|Overall Study|Toxicity|4|||
156537896|NCT00369785|565062906|FG000|Overall Study|Never started|0|||
156537897|NCT00369785|565062907|FG001|Overall Study|Never started|2|||
156537898|NCT00369785|565062906|FG000|Overall Study|Progression|4|||
156537899|NCT00369785|565062907|FG001|Overall Study|Progression|4|||
156537900|NCT00369785|565062906|FG000|Overall Study|Multiple reasons|6|||
156537901|NCT00369785|565062907|FG001|Overall Study|Multiple reasons|5|||
156537902|NCT00800683|565062908|FG000|Overall Study|Adverse Event|11|||
156537903|NCT00800683|565062909|FG001|Overall Study|Adverse Event|8|||
156537904|NCT00800683|565062908|FG000|Overall Study|Lost to Follow-up|3|||
156537905|NCT00800683|565062909|FG001|Overall Study|Lost to Follow-up|1|||
156537906|NCT00800683|565062908|FG000|Overall Study|Withdrawal by Subject|1|||
156537907|NCT00800683|565062909|FG001|Overall Study|Withdrawal by Subject|7|||
156537908|NCT00800683|565062908|FG000|Overall Study|Lack of Efficacy|1|||
156537909|NCT00800683|565062909|FG001|Overall Study|Lack of Efficacy|1|||
156537910|NCT00800683|565062908|FG000|Overall Study|Other|1|||
156537911|NCT00800683|565062909|FG001|Overall Study|Other|2|||
156537912|NCT00935272|565062910|FG000|Overall Study|Lost to Follow-up|10|||
156537913|NCT00935272|565062911|FG001|Overall Study|Lost to Follow-up|3|||
156537914|NCT00935272|565062910|FG000|Overall Study|Withdrawal by Subject|8|||
156537915|NCT00935272|565062911|FG001|Overall Study|Withdrawal by Subject|2|||
156537916|NCT00935272|565062910|FG000|Overall Study|Physician Decision|1|||
156537917|NCT00935272|565062911|FG001|Overall Study|Physician Decision|0|||
156537918|NCT00935272|565062910|FG000|Overall Study|Protocol Violation|0|||
156537919|NCT00935272|565062911|FG001|Overall Study|Protocol Violation|1|||
156537920|NCT02361944|565062912|FG000|Overall Study|surgery cancellation|0|||
156537921|NCT02361944|565062913|FG001|Overall Study|surgery cancellation|1|||
156537922|NCT04305275|565062916|FG000|Overall Study|Adverse Event|4|||
156537923|NCT04305275|565062917|FG001|Overall Study|Adverse Event|0|||
156537924|NCT04305275|565062916|FG000|Overall Study|Lost to Follow-up|1|||
156537925|NCT04305275|565062917|FG001|Overall Study|Lost to Follow-up|1|||
156537926|NCT04305275|565062916|FG000|Overall Study|Withdrawal by Participant|8|||
156537927|NCT04305275|565062917|FG001|Overall Study|Withdrawal by Participant|1|||
156537928|NCT00199836|565062918|FG000|Overall Study|Progressive Disease|5|||
156537929|NCT00199836|565062918|FG000|Overall Study|Death|1|||
156537930|NCT03061175|565062921|FG000|Baseline|Participant was deemed ineligible|1|||
156537931|NCT03061175|565062922|FG001|Baseline|Participant was deemed ineligible|0|||
156537932|NCT03061175|565062921|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
156537933|NCT03061175|565062922|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
156537934|NCT03061175|565062921|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
156537935|NCT03061175|565062922|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
156537936|NCT03061175|565062921|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
156537937|NCT03061175|565062922|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
156537938|NCT00760669|565062923|FG000|Overall Study|Not assessed for overall improvement|18|||
156537939|NCT00760669|565062923|FG000|Overall Study|Participants missing efficacy assessment|6|||
156537940|NCT00760669|565062923|FG000|Overall Study|Participants with overlapping cases|1|||
156537941|NCT00760669|565062923|FG000|Overall Study|Took drug before entering in contract|5|||
156537942|NCT02003014|565062925|FG000|Overall Study|Case report forms uncollected|9|||
156537943|NCT02003014|565062925|FG000|Overall Study|Treatment started after contract period|1|||
156537944|NCT02003014|565062925|FG000|Overall Study|Patient did not visit the study site|5|||
156537945|NCT02003014|565062925|FG000|Overall Study|Investigator's transfer|4|||
156537946|NCT02456662|565062928|FG000|Overall Study|Lost to Follow-up|2|||
156537947|NCT02456662|565062929|FG001|Overall Study|Lost to Follow-up|1|||
156537948|NCT00504153|565062934|FG000|Overall Study|Withdrawal by Subject|1|||
156537949|NCT00504153|565062934|FG000|Overall Study|Adverse Event|4|||
156537950|NCT00504153|565062934|FG000|Overall Study|Death|1|||
156537951|NCT00074581|565062936|FG000|Overall Study|Death|15|||
156537952|NCT00074581|565062937|FG001|Overall Study|Death|16|||
156537953|NCT00074581|565062936|FG000|Overall Study|Withdrawal by Subject|50|||
156537954|NCT00074581|565062937|FG001|Overall Study|Withdrawal by Subject|49|||
156537955|NCT00074581|565062936|FG000|Overall Study|Unable to adhere to visit schedule|13|||
156537956|NCT00074581|565062937|FG001|Overall Study|Unable to adhere to visit schedule|14|||
156537957|NCT00074581|565062936|FG000|Overall Study|Relocated|14|||
156537958|NCT00074581|565062937|FG001|Overall Study|Relocated|9|||
156537959|NCT00074581|565062936|FG000|Overall Study|Were withdrawn by investigator|5|||
156537960|NCT00074581|565062937|FG001|Overall Study|Were withdrawn by investigator|2|||
156537961|NCT00074581|565062936|FG000|Overall Study|Lost to Follow-up|16|||
156537962|NCT00074581|565062937|FG001|Overall Study|Lost to Follow-up|11|||
156537963|NCT00074581|565062936|FG000|Overall Study|Ended relationship w. index participant|117|||
156537964|NCT00074581|565062937|FG001|Overall Study|Ended relationship w. index participant|106|||
156537965|NCT00074581|565062936|FG000|Overall Study|Other|14|||
156338256|NCT05248867|564336592|FG000|Open-label Period|Lost to Follow-up|0|||
156338257|NCT05248867|564336593|FG001|Open-label Period|Lost to Follow-up|0|||
156338258|NCT05248867|564336594|FG002|Open-label Period|Lost to Follow-up|0|||
156338259|NCT05248867|564336595|FG003|Open-label Period|Lost to Follow-up|0|||
156338260|NCT05248867|564336596|FG004|Open-label Period|Lost to Follow-up|5|||
156338261|NCT05248867|564336597|FG005|Open-label Period|Lost to Follow-up|2|||
156338262|NCT05248867|564336592|FG000|Open-label Period|COVID-19 Infection|0|||
156338263|NCT05248867|564336593|FG001|Open-label Period|COVID-19 Infection|0|||
156338264|NCT05248867|564336594|FG002|Open-label Period|COVID-19 Infection|0|||
156338265|NCT05248867|564336595|FG003|Open-label Period|COVID-19 Infection|0|||
156338266|NCT05248867|564336596|FG004|Open-label Period|COVID-19 Infection|1|||
156338267|NCT05248867|564336597|FG005|Open-label Period|COVID-19 Infection|0|||
156537966|NCT00074581|565062937|FG001|Overall Study|Other|19|||
156537967|NCT00617604|565062938|FG000|Overall Study|Death|2|||
156537968|NCT00617604|565062939|FG001|Overall Study|Death|1|||
156537969|NCT00617604|565062938|FG000|Overall Study|Lost to Follow-up|1|||
156537970|NCT00617604|565062939|FG001|Overall Study|Lost to Follow-up|0|||
156537971|NCT00617604|565062938|FG000|Overall Study|Miscellaneous Reasons|8|||
156338268|NCT05248867|564336592|FG000|Open-label Period|Other, not specified|0|||
156338269|NCT05248867|564336593|FG001|Open-label Period|Other, not specified|0|||
156338270|NCT05248867|564336594|FG002|Open-label Period|Other, not specified|0|||
156537972|NCT00617604|565062939|FG001|Overall Study|Miscellaneous Reasons|10|||
156537973|NCT00617604|565062938|FG000|Overall Study|Withdrawal by Subject|4|||
156537974|NCT00617604|565062939|FG001|Overall Study|Withdrawal by Subject|6|||
156537975|NCT00617604|565062938|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
156537976|NCT00617604|565062939|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
156537977|NCT01708291|565062940|FG000|Overall Study|fighting|2|||
156537978|NCT01708291|565062941|FG001|Overall Study|fighting|1|||
156537979|NCT02303704|565062942|FG000|Overall Study|Protocol Violation|5|||
156537980|NCT02303704|565062943|FG001|Overall Study|Protocol Violation|9|||
156537981|NCT04411628|565062945|FG000|Overall Study|Withdrawal by Subject|1|||
156537982|NCT04411628|565062946|FG001|Overall Study|Withdrawal by Subject|1|||
156537983|NCT04411628|565062947|FG002|Overall Study|Withdrawal by Subject|2|||
156537984|NCT04411628|565062948|FG003|Overall Study|Withdrawal by Subject|0|||
156537985|NCT04411628|565062945|FG000|Overall Study|Lost to Follow-up|0|||
156537986|NCT04411628|565062946|FG001|Overall Study|Lost to Follow-up|1|||
156537987|NCT04411628|565062947|FG002|Overall Study|Lost to Follow-up|0|||
156537988|NCT04411628|565062948|FG003|Overall Study|Lost to Follow-up|0|||
156537989|NCT02322125|565064530|FG000|Overall Study|Withdrawal by Subject|2|||
156537990|NCT00382720|565064531|FG000|Overall Study|Adverse Event|21|||
156537991|NCT00382720|565064532|FG001|Overall Study|Adverse Event|23|||
156537992|NCT00382720|565064533|FG002|Overall Study|Adverse Event|15|||
156537993|NCT00382720|565064531|FG000|Overall Study|Protocol Violation|2|||
156537994|NCT00382720|565064532|FG001|Overall Study|Protocol Violation|5|||
156537995|NCT00382720|565064533|FG002|Overall Study|Protocol Violation|1|||
156537996|NCT00382720|565064531|FG000|Overall Study|Death|0|||
156537997|NCT00382720|565064532|FG001|Overall Study|Death|1|||
156537998|NCT00382720|565064533|FG002|Overall Study|Death|2|||
156537999|NCT00382720|565064531|FG000|Overall Study|Progressive disease|37|||
156538000|NCT00382720|565064532|FG001|Overall Study|Progressive disease|28|||
156538001|NCT00382720|565064533|FG002|Overall Study|Progressive disease|38|||
156538002|NCT00382720|565064531|FG000|Overall Study|Withdrew consent|1|||
156538003|NCT00382720|565064532|FG001|Overall Study|Withdrew consent|1|||
156538004|NCT00382720|565064533|FG002|Overall Study|Withdrew consent|2|||
156538005|NCT00382720|565064531|FG000|Overall Study|Withdrawal by Subject|11|||
156538006|NCT00382720|565064532|FG001|Overall Study|Withdrawal by Subject|20|||
156538007|NCT00382720|565064533|FG002|Overall Study|Withdrawal by Subject|12|||
156538008|NCT00382720|565064531|FG000|Overall Study|Surgery|1|||
156538009|NCT00382720|565064532|FG001|Overall Study|Surgery|1|||
156538010|NCT00382720|565064533|FG002|Overall Study|Surgery|4|||
156538011|NCT00382720|565064531|FG000|Overall Study|Patient did not receive study medication|1|||
156538012|NCT00382720|565064532|FG001|Overall Study|Patient did not receive study medication|1|||
156538013|NCT00382720|565064533|FG002|Overall Study|Patient did not receive study medication|4|||
156538014|NCT00382720|565064531|FG000|Overall Study|Clinically progressive disease|0|||
156538015|NCT00382720|565064532|FG001|Overall Study|Clinically progressive disease|1|||
156538016|NCT00382720|565064533|FG002|Overall Study|Clinically progressive disease|0|||
156538017|NCT00382720|565064531|FG000|Overall Study|Good prognosis|0|||
156538018|NCT00382720|565064532|FG001|Overall Study|Good prognosis|1|||
156538019|NCT00382720|565064533|FG002|Overall Study|Good prognosis|0|||
156538020|NCT00382720|565064531|FG000|Overall Study|Investigator/Clinical decision|5|||
156538021|NCT00382720|565064532|FG001|Overall Study|Investigator/Clinical decision|6|||
156538022|NCT00382720|565064533|FG002|Overall Study|Investigator/Clinical decision|6|||
156538023|NCT00382720|565064531|FG000|Overall Study|Discontinued at end of study|0|||
156538024|NCT00382720|565064532|FG001|Overall Study|Discontinued at end of study|1|||
156538025|NCT00382720|565064533|FG002|Overall Study|Discontinued at end of study|2|||
156538026|NCT01183143|565064536|FG000|Overall Study|Protocol Violation|115|||
156538027|NCT01183143|565064536|FG000|Overall Study|Withdrawal by Subject|19|||
156538028|NCT01183143|565064536|FG000|Overall Study|Subject Questionnaires not returned|5|||
156538029|NCT01183143|565064536|FG000|Overall Study|Subjects enrolled, but not treated|11|||
156538030|NCT04096274|565064537|FG000|Phase I|Lost to Follow-up|5|||
156538031|NCT04096274|565064538|FG001|Phase I|Lost to Follow-up|5|||
156538032|NCT04096274|565064537|FG000|Phase II|Lost to Follow-up|11|||
156538033|NCT04096274|565064538|FG001|Phase II|Lost to Follow-up|11|||
156538034|NCT04490395|565064539|FG000|Overall Study|Lost to Follow-up|0|||
156538035|NCT04490395|565064540|FG001|Overall Study|Lost to Follow-up|1|||
156538036|NCT05092919|565064542|FG000|Overall Study|Lost to Follow-up|7|||
156538037|NCT05092919|565064542|FG000|Overall Study|Withdrawal by Subject|2|||
156538038|NCT01942148|565064546|FG000|Overall Study|Adverse Event|4|||
156538039|NCT01942148|565064546|FG000|Overall Study|Lack of Efficacy|2|||
156538040|NCT01942148|565064546|FG000|Overall Study|Physician Decision|11|||
156538041|NCT01942148|565064546|FG000|Overall Study|Protocol Violation|1|||
156538042|NCT01942148|565064546|FG000|Overall Study|Withdrawal by Subject|8|||
156538043|NCT01942148|565064546|FG000|Overall Study|Use of the prohibition medicine|1|||
156538044|NCT02248259|565064547|FG000|Treatment Period 1|Adverse Event|0|||
156538045|NCT02248259|565064548|FG001|Treatment Period 1|Adverse Event|0|||
156538046|NCT02248259|565064549|FG002|Treatment Period 1|Adverse Event|1|||
156538047|NCT02248259|565064550|FG003|Treatment Period 1|Adverse Event|0|||
156538048|NCT02807480|565064555|FG000|Overall Study|Withdrawal by Subject|14|||
156538049|NCT02807480|565064556|FG001|Overall Study|Withdrawal by Subject|10|||
156538050|NCT02369848|565064557|FG000|Overall Study|Death|1|||
156538051|NCT02369848|565064557|FG000|Overall Study|Withdrawal by Subject|2|||
156538052|NCT02369848|565064557|FG000|Overall Study|Lost to Follow-up|1|||
156538053|NCT02081534|565064564|FG000|Overall Study|Adverse Event|5|||
156538054|NCT02081534|565064565|FG001|Overall Study|Adverse Event|4|||
156538055|NCT02081534|565064566|FG002|Overall Study|Adverse Event|3|||
156538056|NCT02081534|565064567|FG003|Overall Study|Adverse Event|10|||
156538057|NCT02081534|565064568|FG004|Overall Study|Adverse Event|2|||
156538058|NCT02081534|565064569|FG005|Overall Study|Adverse Event|8|||
156538059|NCT02081534|565064570|FG006|Overall Study|Adverse Event|2|||
156538060|NCT02081534|565064564|FG000|Overall Study|Withdrawal by Subject|0|||
156538061|NCT02081534|565064565|FG001|Overall Study|Withdrawal by Subject|1|||
156538062|NCT02081534|565064566|FG002|Overall Study|Withdrawal by Subject|1|||
156538063|NCT02081534|565064567|FG003|Overall Study|Withdrawal by Subject|1|||
156538064|NCT02081534|565064568|FG004|Overall Study|Withdrawal by Subject|1|||
156538065|NCT02081534|565064569|FG005|Overall Study|Withdrawal by Subject|0|||
156538066|NCT02081534|565064570|FG006|Overall Study|Withdrawal by Subject|1|||
156538067|NCT02081534|565064564|FG000|Overall Study|Protocol Violation|0|||
156538068|NCT02081534|565064565|FG001|Overall Study|Protocol Violation|3|||
156538069|NCT02081534|565064566|FG002|Overall Study|Protocol Violation|0|||
156538070|NCT02081534|565064567|FG003|Overall Study|Protocol Violation|0|||
156538071|NCT02081534|565064568|FG004|Overall Study|Protocol Violation|0|||
156538072|NCT02081534|565064569|FG005|Overall Study|Protocol Violation|0|||
156538073|NCT02081534|565064570|FG006|Overall Study|Protocol Violation|1|||
156538074|NCT02081534|565064564|FG000|Overall Study|Lost to Follow-up|0|||
156538075|NCT02081534|565064565|FG001|Overall Study|Lost to Follow-up|0|||
156538076|NCT02081534|565064566|FG002|Overall Study|Lost to Follow-up|0|||
156538077|NCT02081534|565064567|FG003|Overall Study|Lost to Follow-up|2|||
156538078|NCT02081534|565064568|FG004|Overall Study|Lost to Follow-up|1|||
156538079|NCT02081534|565064569|FG005|Overall Study|Lost to Follow-up|1|||
156538080|NCT02081534|565064570|FG006|Overall Study|Lost to Follow-up|0|||
156538081|NCT00762892|565064571|FG000|Overall Study|Lost to Follow-up|2|||
156538082|NCT00762892|565064572|FG001|Overall Study|Lost to Follow-up|5|||
156538083|NCT00762892|565064571|FG000|Overall Study|Withdrawal by Subject|0|||
156538084|NCT00762892|565064572|FG001|Overall Study|Withdrawal by Subject|1|||
156538085|NCT00762892|565064571|FG000|Overall Study|Death|1|||
156538086|NCT00762892|565064572|FG001|Overall Study|Death|0|||
156538087|NCT00762892|565064571|FG000|Overall Study|Pregnancy|1|||
156538088|NCT00762892|565064572|FG001|Overall Study|Pregnancy|0|||
156538089|NCT00762892|565064571|FG000|Overall Study|Incarceration|1|||
156538090|NCT00762892|565064572|FG001|Overall Study|Incarceration|0|||
156538091|NCT01848288|565064575|FG000|Overall Study|Death|1|||
156538092|NCT01848288|565064575|FG000|Overall Study|Protocol Violation|1|||
156538093|NCT01848288|565064575|FG000|Overall Study|Withdrawal by Subject|1|||
156538094|NCT01007032|565064577|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
156538095|NCT01007032|565064578|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
156538096|NCT01007032|565064579|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
156538097|NCT01007032|565064580|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
156538098|NCT01007032|565064577|FG000|Overall Study|Withdrawal by Subject|0|||
156538099|NCT01007032|565064578|FG001|Overall Study|Withdrawal by Subject|0|||
156538100|NCT01007032|565064579|FG002|Overall Study|Withdrawal by Subject|0|||
156538101|NCT01007032|565064580|FG003|Overall Study|Withdrawal by Subject|1|||
156538102|NCT01841749|565064581|FG000|Overall Study|Protocol Violation|1|||
156538103|NCT01480284|565064589|FG000|Overall Study|Withdrawal by Subject|2|||
156538104|NCT01480284|565064590|FG001|Overall Study|Withdrawal by Subject|0|||
156538105|NCT01480284|565064589|FG000|Overall Study|Adverse Event|1|||
156538106|NCT01480284|565064590|FG001|Overall Study|Adverse Event|0|||
156538107|NCT01480284|565064589|FG000|Overall Study|Study closed/terminated|3|||
156538108|NCT01480284|565064590|FG001|Overall Study|Study closed/terminated|0|||
156538109|NCT01480284|565064589|FG000|Overall Study|Lost to Follow-up|1|||
156538110|NCT01480284|565064590|FG001|Overall Study|Lost to Follow-up|0|||
156538111|NCT01480284|565064589|FG000|Overall Study|Physician Decision|1|||
156538112|NCT01480284|565064590|FG001|Overall Study|Physician Decision|0|||
156538113|NCT00066742|565064591|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
156538114|NCT00066742|565064591|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
156538115|NCT00066742|565064591|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
156808922|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
156808923|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
156338271|NCT05248867|564336595|FG003|Open-label Period|Other, not specified|0|||
156338272|NCT05248867|564336596|FG004|Open-label Period|Other, not specified|4|||
156538116|NCT00066742|565064591|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
156538117|NCT00066742|565064591|FG000|Induction Chemoradiotherapy|Ineligible|3|||
156538118|NCT00066742|565064591|FG000|Consolidation Chemotherapy|not protocol specified|1|||
156538119|NCT00066742|565064591|FG000|Consolidation Chemotherapy|Ineligible|2|||
156538120|NCT04784897|565064596|FG000|Overall Study|Death|4|||
156538121|NCT04784897|565064597|FG001|Overall Study|Death|2|||
156538122|NCT04784897|565064598|FG002|Overall Study|Death|1|||
156538123|NCT04784897|565064596|FG000|Overall Study|Withdrawal by Subject|0|||
156538124|NCT04784897|565064597|FG001|Overall Study|Withdrawal by Subject|0|||
156538125|NCT04784897|565064598|FG002|Overall Study|Withdrawal by Subject|1|||
156808924|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Other|0|||
156808925|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Other|2|||
156808926|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Other|5|||
156808927|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
156808928|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
156808929|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
156808930|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
156808931|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
156808932|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
156808933|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
156808934|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
156808935|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
156808936|NCT02688192|566054509|FG000|Overall Study|Lost to Follow-up|11|||
156338273|NCT05248867|564336597|FG005|Open-label Period|Other, not specified|0|||
156460688|NCT04689256|564781689|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
156460689|NCT03556293|564781690|FG000|Overall Study|Ineligible for analysis|1904|||
156460690|NCT03556293|564781691|FG001|Overall Study|Ineligible for analysis|1471|||
156460691|NCT03556293|564781692|FG002|Overall Study|Ineligible for analysis|1091|||
156460692|NCT03556293|564781693|FG003|Overall Study|Ineligible for analysis|1269|||
156460693|NCT02224144|564781722|FG000|Overall Study|Lost to Follow-up|3|||
156460694|NCT02224144|564781723|FG001|Overall Study|Lost to Follow-up|1|||
156460695|NCT02224144|564781722|FG000|Overall Study|Death|2|||
156460696|NCT02224144|564781723|FG001|Overall Study|Death|0|||
156460697|NCT02224144|564781722|FG000|Overall Study|Withdrawal by Subject|0|||
156460698|NCT02224144|564781723|FG001|Overall Study|Withdrawal by Subject|1|||
156460699|NCT03505008|564781724|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
156460700|NCT03505008|564781725|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
156338274|NCT01064310|564336598|FG000|Period 1|Adverse Event|7|||
156338275|NCT01064310|564336599|FG001|Period 1|Adverse Event|10|||
156338276|NCT01064310|564336600|FG002|Period 1|Adverse Event|0|||
156338277|NCT01064310|564336598|FG000|Period 1|Physician Decision|1|||
156338278|NCT01064310|564336599|FG001|Period 1|Physician Decision|0|||
156338279|NCT01064310|564336600|FG002|Period 1|Physician Decision|0|||
156338280|NCT01064310|564336598|FG000|Period 1|Withdrawal by Subject|2|||
156338281|NCT01064310|564336599|FG001|Period 1|Withdrawal by Subject|2|||
156338282|NCT01064310|564336600|FG002|Period 1|Withdrawal by Subject|0|||
156338283|NCT01064310|564336598|FG000|Period 1|Lack of Efficacy|3|||
156338284|NCT01064310|564336599|FG001|Period 1|Lack of Efficacy|5|||
156338285|NCT01064310|564336600|FG002|Period 1|Lack of Efficacy|0|||
156338286|NCT01064310|564336598|FG000|Period 1|Entered Open-label Period|1|||
156338287|NCT01064310|564336599|FG001|Period 1|Entered Open-label Period|1|||
156460701|NCT03505008|564781726|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
156460702|NCT03505008|564781727|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
156460703|NCT03505008|564781724|FG000|Before Week 24 Randomization|Adverse Event|10|||
156460704|NCT03505008|564781725|FG001|Before Week 24 Randomization|Adverse Event|0|||
156808937|NCT02688192|566054510|FG001|Overall Study|Lost to Follow-up|5|||
156538126|NCT00701090|565064603|FG000|Overall Study|Adverse Event|11|||
156538127|NCT00701090|565064604|FG001|Overall Study|Adverse Event|2|||
156538128|NCT00701090|565064603|FG000|Overall Study|Death|0|||
156538129|NCT00701090|565064604|FG001|Overall Study|Death|1|||
156538130|NCT00701090|565064603|FG000|Overall Study|Lack of Efficacy|5|||
156538131|NCT00701090|565064604|FG001|Overall Study|Lack of Efficacy|4|||
156538132|NCT00701090|565064603|FG000|Overall Study|Lost to Follow-up|9|||
156538133|NCT00701090|565064604|FG001|Overall Study|Lost to Follow-up|9|||
156538134|NCT00701090|565064603|FG000|Overall Study|Physician Decision|3|||
156538135|NCT00701090|565064604|FG001|Overall Study|Physician Decision|4|||
156538136|NCT00701090|565064603|FG000|Overall Study|Protocol Violation|2|||
156538137|NCT00701090|565064604|FG001|Overall Study|Protocol Violation|3|||
156538138|NCT00701090|565064603|FG000|Overall Study|Withdrawal by Subject|11|||
156538139|NCT00701090|565064604|FG001|Overall Study|Withdrawal by Subject|16|||
156538140|NCT00701090|565064603|FG000|Overall Study|Other|7|||
156808938|NCT02688192|566054509|FG000|Overall Study|Physician Decision|1|||
156808939|NCT02688192|566054510|FG001|Overall Study|Physician Decision|0|||
156808940|NCT02959463|566054511|FG000|Overall Study|Adverse Event|1|||
156808941|NCT02959463|566054512|FG001|Overall Study|Adverse Event|1|||
156808942|NCT02959463|566054511|FG000|Overall Study|Death|1|||
156808943|NCT02959463|566054512|FG001|Overall Study|Death|0|||
156808944|NCT02959463|566054511|FG000|Overall Study|Withdrawal by Subject|1|||
156808945|NCT02959463|566054512|FG001|Overall Study|Withdrawal by Subject|0|||
156808946|NCT00041470|566054524|FG000|Overall Study|Loss of Funding|38|||
156808947|NCT01459666|566054525|FG000|Overall Study|PI left institution|5|||
156538141|NCT00701090|565064604|FG001|Overall Study|Other|12|||
156808948|NCT01459666|566054526|FG001|Overall Study|PI left institution|4|||
156808949|NCT01061385|566054528|FG000|Overall Study|Lost to Follow-up|1|||
156808950|NCT01061385|566054529|FG001|Overall Study|Lost to Follow-up|0|||
156808951|NCT01061385|566054528|FG000|Overall Study|subject decision not related to AE|0|||
156808952|NCT01061385|566054529|FG001|Overall Study|subject decision not related to AE|1|||
156808953|NCT00533429|566054530|FG000|Overall Study|Adverse Event|3|||
156808954|NCT00533429|566054531|FG001|Overall Study|Adverse Event|1|||
156808955|NCT00533429|566054530|FG000|Overall Study|Death|1|||
156808956|NCT00533429|566054531|FG001|Overall Study|Death|0|||
156808957|NCT00533429|566054530|FG000|Overall Study|Withdrawal by Subject|2|||
156808958|NCT00533429|566054531|FG001|Overall Study|Withdrawal by Subject|0|||
156808959|NCT00533429|566054530|FG000|Overall Study|Progressive Disease|12|||
156808960|NCT00533429|566054531|FG001|Overall Study|Progressive Disease|13|||
156808961|NCT00533429|566054530|FG000|Overall Study|Symptomatic deterioration|1|||
156808962|NCT00533429|566054531|FG001|Overall Study|Symptomatic deterioration|2|||
156808963|NCT02379052|566054538|FG000|Overall Study|Protocol Violation|0|||
156808964|NCT02379052|566054539|FG001|Overall Study|Protocol Violation|1|||
156808965|NCT02379052|566054538|FG000|Overall Study|Adverse Event|0|||
156808966|NCT02379052|566054539|FG001|Overall Study|Adverse Event|1|||
156808967|NCT02379052|566054538|FG000|Overall Study|Physician Decision|1|||
156808968|NCT02379052|566054539|FG001|Overall Study|Physician Decision|1|||
156808969|NCT02379052|566054538|FG000|Overall Study|Withdrawal by Subject|2|||
156808970|NCT02379052|566054539|FG001|Overall Study|Withdrawal by Subject|0|||
156808971|NCT02379052|566054538|FG000|Overall Study|Lost to Follow-up|2|||
156808972|NCT02379052|566054539|FG001|Overall Study|Lost to Follow-up|1|||
156808973|NCT02379052|566054538|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
156808974|NCT02379052|566054539|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
156808975|NCT02379052|566054538|FG000|Overall Study|Subject was Incarcerated|0|||
156808976|NCT02379052|566054539|FG001|Overall Study|Subject was Incarcerated|1|||
156808977|NCT00127855|566054540|FG000|Primary Vaccination Course|Adverse Event|0|||
156808978|NCT00127855|566054541|FG001|Primary Vaccination Course|Adverse Event|0|||
156808979|NCT00127855|566054542|FG002|Primary Vaccination Course|Adverse Event|1|||
156808980|NCT00127855|566054543|FG003|Primary Vaccination Course|Adverse Event|0|||
156808981|NCT00127855|566054544|FG004|Primary Vaccination Course|Adverse Event|0|||
156808982|NCT00127855|566054540|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
156808983|NCT00127855|566054541|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
156808984|NCT00127855|566054542|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
156338288|NCT01064310|564336600|FG002|Period 1|Entered Open-label Period|0|||
156338289|NCT01064310|564336598|FG000|Period 2|Adverse Event|2|||
156538142|NCT00873366|565064605|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
156538143|NCT00873366|565064605|FG000|Overall Study|Off tamoxifen due to side effects|2|||
156538144|NCT00873366|565064605|FG000|Overall Study|Refused to continue DM-BT testing|3|||
156538145|NCT01299376|565064611|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
156538146|NCT01299376|565064612|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
156808985|NCT00127855|566054543|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
156808986|NCT00127855|566054544|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
156808987|NCT00127855|566054540|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
156808988|NCT00127855|566054541|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
156808989|NCT00127855|566054542|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
156808990|NCT00127855|566054543|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
156808991|NCT00127855|566054544|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
156538147|NCT01299376|565064611|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
156538148|NCT01299376|565064612|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
156538149|NCT01299376|565064611|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
156538150|NCT01299376|565064612|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
156538151|NCT01299376|565064611|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
156538152|NCT01299376|565064612|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
156538153|NCT01299376|565064611|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
156538154|NCT01299376|565064612|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
156538155|NCT01299376|565064611|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
156538156|NCT01299376|565064612|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
156538157|NCT01299376|565064611|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
156538158|NCT01299376|565064612|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
156538159|NCT01299376|565064611|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
156538160|NCT01299376|565064612|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
156538161|NCT01299376|565064611|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
156538162|NCT01299376|565064612|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
156538163|NCT01299376|565064611|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
156538164|NCT01299376|565064612|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
156538165|NCT01299376|565064611|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
156538166|NCT01299376|565064612|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
156538167|NCT02170779|565064617|FG000|Overall Study|Withdrawal by Subject|1|||
156538168|NCT02170779|565064618|FG001|Overall Study|Withdrawal by Subject|0|||
156538169|NCT02170779|565064617|FG000|Overall Study|Lost to Follow-up|0|||
156538170|NCT02170779|565064618|FG001|Overall Study|Lost to Follow-up|1|||
156538171|NCT03492554|565064621|FG000|Overall Study|Protocol Violation|0|||
156538172|NCT03492554|565064622|FG001|Overall Study|Protocol Violation|14|||
156538173|NCT04340557|565064626|FG000|Overall Study|Transferred to ICU and/or death|1|||
156538174|NCT04340557|565064627|FG001|Overall Study|Transferred to ICU and/or death|2|||
156538175|NCT00529451|565064628|FG000|Overall Study|Subject withdrew consent|16|||
156538176|NCT00529451|565064629|FG001|Overall Study|Subject withdrew consent|21|||
156538177|NCT00529451|565064630|FG002|Overall Study|Subject withdrew consent|13|||
156538178|NCT00529451|565064631|FG003|Overall Study|Subject withdrew consent|12|||
156538179|NCT00529451|565064628|FG000|Overall Study|Adverse Event|9|||
156538180|NCT00529451|565064629|FG001|Overall Study|Adverse Event|16|||
156538181|NCT00529451|565064630|FG002|Overall Study|Adverse Event|14|||
156538182|NCT00529451|565064631|FG003|Overall Study|Adverse Event|8|||
156538183|NCT00529451|565064628|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
156538184|NCT00529451|565064629|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
156538185|NCT00529451|565064630|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
156538186|NCT00529451|565064631|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
156538187|NCT00529451|565064628|FG000|Overall Study|Lost to Follow-up|4|||
156538188|NCT00529451|565064629|FG001|Overall Study|Lost to Follow-up|7|||
156538189|NCT00529451|565064630|FG002|Overall Study|Lost to Follow-up|4|||
156538190|NCT00529451|565064631|FG003|Overall Study|Lost to Follow-up|4|||
156538191|NCT00529451|565064628|FG000|Overall Study|Protocol deviation|1|||
156538192|NCT00529451|565064629|FG001|Overall Study|Protocol deviation|1|||
156538193|NCT00529451|565064630|FG002|Overall Study|Protocol deviation|4|||
156538194|NCT00529451|565064631|FG003|Overall Study|Protocol deviation|1|||
156538195|NCT00529451|565064628|FG000|Overall Study|Administrative problems|1|||
156538196|NCT00529451|565064629|FG001|Overall Study|Administrative problems|1|||
156538197|NCT00529451|565064630|FG002|Overall Study|Administrative problems|0|||
156538198|NCT00529451|565064631|FG003|Overall Study|Administrative problems|2|||
156538199|NCT03700320|565064632|FG000|Overall Study|Adverse Event|5|||
156338290|NCT01064310|564336599|FG001|Period 2|Adverse Event|1|||
156338291|NCT01064310|564336600|FG002|Period 2|Adverse Event|0|||
156338292|NCT01064310|564336598|FG000|Period 2|Physician Decision|0|||
156338293|NCT01064310|564336599|FG001|Period 2|Physician Decision|1|||
156338294|NCT01064310|564336600|FG002|Period 2|Physician Decision|0|||
156338295|NCT01064310|564336598|FG000|Period 2|Entered Open-label Period|1|||
156338296|NCT01064310|564336599|FG001|Period 2|Entered Open-label Period|0|||
156338297|NCT01064310|564336600|FG002|Period 2|Entered Open-label Period|0|||
156338298|NCT01064310|564336598|FG000|Period 2|Lack of Efficacy|1|||
156338299|NCT01064310|564336599|FG001|Period 2|Lack of Efficacy|4|||
156338300|NCT01064310|564336600|FG002|Period 2|Lack of Efficacy|0|||
156338301|NCT01064310|564336598|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
156338302|NCT01064310|564336599|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
156538200|NCT03700320|565064633|FG001|Overall Study|Adverse Event|31|||
156538201|NCT03700320|565064632|FG000|Overall Study|Lack of Efficacy|2|||
156538202|NCT03700320|565064633|FG001|Overall Study|Lack of Efficacy|5|||
156538203|NCT03700320|565064632|FG000|Overall Study|Withdrawal by Subject|29|||
156538204|NCT03700320|565064633|FG001|Overall Study|Withdrawal by Subject|75|||
156338303|NCT01064310|564336600|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
156338304|NCT01064310|564336598|FG000|Open Label Pazopinib|Adverse Event|0|||
156338305|NCT01064310|564336599|FG001|Open Label Pazopinib|Adverse Event|0|||
156538205|NCT03700320|565064632|FG000|Overall Study|Lost to Follow-up|16|||
156538206|NCT03700320|565064633|FG001|Overall Study|Lost to Follow-up|23|||
156538207|NCT03700320|565064632|FG000|Overall Study|Pregnancy|2|||
156538208|NCT03700320|565064633|FG001|Overall Study|Pregnancy|4|||
156538209|NCT03700320|565064632|FG000|Overall Study|Protocol Deviation|7|||
156538210|NCT03700320|565064633|FG001|Overall Study|Protocol Deviation|31|||
156538211|NCT03700320|565064632|FG000|Overall Study|Non-compliance with Study Drug|1|||
156538212|NCT03700320|565064633|FG001|Overall Study|Non-compliance with Study Drug|3|||
156538213|NCT03700320|565064632|FG000|Overall Study|Reason not Specified|0|||
156538214|NCT03700320|565064633|FG001|Overall Study|Reason not Specified|1|||
156538215|NCT02243865|565064637|FG000|Overall Study|Protocol Violation|1|||
156538216|NCT02243865|565064638|FG001|Overall Study|Protocol Violation|3|||
156538217|NCT02243865|565064637|FG000|Overall Study|Lost to Follow-up|1|||
156538218|NCT02243865|565064638|FG001|Overall Study|Lost to Follow-up|1|||
156538219|NCT02243865|565064637|FG000|Overall Study|Withdrawal by Subject|1|||
156538220|NCT02243865|565064638|FG001|Overall Study|Withdrawal by Subject|0|||
156538221|NCT02243865|565064637|FG000|Overall Study|Adverse Event|1|||
156538222|NCT02243865|565064638|FG001|Overall Study|Adverse Event|1|||
156538223|NCT01235793|565064639|FG000|Overall Study|Death|6|||
156538224|NCT02054325|565064640|FG000|Overall Study|Lost to Follow-up|8|||
156538225|NCT02054325|565064641|FG001|Overall Study|Lost to Follow-up|5|||
156538226|NCT05093322|565064642|FG000|Overall Study|Death|6|||
156538227|NCT05093322|565064643|FG001|Overall Study|Death|2|||
156538228|NCT05093322|565064642|FG000|Overall Study|Other|4|||
156538229|NCT05093322|565064643|FG001|Overall Study|Other|1|||
156538230|NCT01034540|565064644|FG000|Overall Study|Adverse Event|0|||
156538231|NCT01034540|565064645|FG001|Overall Study|Adverse Event|1|||
156538232|NCT00932425|565064648|FG000|Overall Study|Lost to Follow-up|0|||
156538233|NCT00932425|565064649|FG001|Overall Study|Lost to Follow-up|1|||
156538234|NCT00932425|565064648|FG000|Overall Study|Withdrawal by Subject|0|||
156538235|NCT00932425|565064649|FG001|Overall Study|Withdrawal by Subject|1|||
156538236|NCT05293743|565064650|FG000|Overall Study|Withdrawal by Subject|1|||
156538237|NCT05293743|565064651|FG001|Overall Study|Withdrawal by Subject|0|||
156538238|NCT02844816|565064654|FG000|Overall Study|No protocol treatment received|5|||
156538239|NCT02844816|565064655|FG001|Overall Study|No protocol treatment received|1|||
156538240|NCT02844816|565064654|FG000|Overall Study|Ineligible|22|||
156538241|NCT02844816|565064655|FG001|Overall Study|Ineligible|15|||
156538242|NCT02844816|565064654|FG000|Overall Study|Participant refusal|5|||
156538243|NCT02844816|565064655|FG001|Overall Study|Participant refusal|5|||
156538244|NCT02844816|565064654|FG000|Overall Study|Adverse Event|5|||
156538245|NCT02844816|565064655|FG001|Overall Study|Adverse Event|4|||
156538246|NCT02844816|565064654|FG000|Overall Study|Death|0|||
156538247|NCT02844816|565064655|FG001|Overall Study|Death|1|||
156538248|NCT02844816|565064654|FG000|Overall Study|Disease progression/recurrence|50|||
156538249|NCT02844816|565064655|FG001|Overall Study|Disease progression/recurrence|24|||
156538250|NCT02844816|565064654|FG000|Overall Study|Physician Decision|1|||
156538251|NCT02844816|565064655|FG001|Overall Study|Physician Decision|1|||
156538252|NCT01200238|565064657|FG000|Overall Study|Adverse Event|2|||
156538253|NCT01200238|565064658|FG001|Overall Study|Adverse Event|1|||
156538254|NCT01200238|565064657|FG000|Overall Study|Progressive Disease|5|||
156538255|NCT01200238|565064658|FG001|Overall Study|Progressive Disease|8|||
156538256|NCT01200238|565064657|FG000|Overall Study|Withdrawal by Subject|0|||
156538257|NCT01200238|565064658|FG001|Overall Study|Withdrawal by Subject|1|||
156538258|NCT02717754|565064659|FG000|Overall Study|Incorrect Infusion Duration|0|||
156538259|NCT02717754|565064660|FG001|Overall Study|Incorrect Infusion Duration|0|||
156538260|NCT02717754|565064661|FG002|Overall Study|Incorrect Infusion Duration|0|||
156538261|NCT02717754|565064662|FG003|Overall Study|Incorrect Infusion Duration|10|||
156538262|NCT02717754|565064663|FG004|Overall Study|Incorrect Infusion Duration|20|||
156538263|NCT02717754|565064664|FG005|Overall Study|Incorrect Infusion Duration|20|||
156538264|NCT00482703|565064665|FG000|Overall Study|Poor compliance|1|||
156538265|NCT00482703|565064666|FG001|Overall Study|Poor compliance|0|||
156538266|NCT00667823|565064668|FG000|Overall Study|Lost to Follow-up|5|||
156538267|NCT00667823|565064668|FG000|Overall Study|Adverse Event|7|||
156538268|NCT00667823|565064668|FG000|Overall Study|Death|182|||
156538269|NCT00667823|565064668|FG000|Overall Study|Withdrawal by Subject|12|||
156538270|NCT00667823|565064668|FG000|Overall Study|Other|8|||
156538271|NCT00667823|565064668|FG000|Overall Study|Missing (completion page missing)|2|||
156538272|NCT01428661|565064671|FG000|Double-Masked Phase|Protocol Violation|9|||
156538273|NCT01428661|565064672|FG001|Double-Masked Phase|Protocol Violation|4|||
156538274|NCT01428661|565064673|FG002|Double-Masked Phase|Protocol Violation|0|||
156538275|NCT01428661|565064671|FG000|Double-Masked Phase|Adverse Event|13|||
156538276|NCT01428661|565064672|FG001|Double-Masked Phase|Adverse Event|4|||
156538277|NCT01428661|565064673|FG002|Double-Masked Phase|Adverse Event|0|||
156538278|NCT01428661|565064671|FG000|Double-Masked Phase|Lost to Follow-up|14|||
156538279|NCT01428661|565064672|FG001|Double-Masked Phase|Lost to Follow-up|14|||
156538280|NCT01428661|565064673|FG002|Double-Masked Phase|Lost to Follow-up|0|||
156538281|NCT01428661|565064671|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
156538282|NCT01428661|565064672|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
156538283|NCT01428661|565064673|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
156538284|NCT01428661|565064671|FG000|Double-Masked Phase|Lack of Efficacy|2|||
156538285|NCT01428661|565064672|FG001|Double-Masked Phase|Lack of Efficacy|1|||
156538286|NCT01428661|565064673|FG002|Double-Masked Phase|Lack of Efficacy|0|||
156538287|NCT01428661|565064671|FG000|Double-Masked Phase|*Various|1|||
156538288|NCT01428661|565064672|FG001|Double-Masked Phase|*Various|6|||
156538289|NCT01428661|565064673|FG002|Double-Masked Phase|*Various|0|||
156538290|NCT01428661|565064671|FG000|Open Label Extension|Protocol Violation|0|||
156538291|NCT01428661|565064672|FG001|Open Label Extension|Protocol Violation|0|||
156538292|NCT01428661|565064673|FG002|Open Label Extension|Protocol Violation|9|||
156538293|NCT01428661|565064671|FG000|Open Label Extension|Adverse Event|0|||
156538294|NCT01428661|565064672|FG001|Open Label Extension|Adverse Event|0|||
156538295|NCT01428661|565064673|FG002|Open Label Extension|Adverse Event|15|||
156538296|NCT01428661|565064671|FG000|Open Label Extension|Lost to Follow-up|0|||
156538297|NCT01428661|565064672|FG001|Open Label Extension|Lost to Follow-up|0|||
156538298|NCT01428661|565064673|FG002|Open Label Extension|Lost to Follow-up|38|||
156538299|NCT01428661|565064671|FG000|Open Label Extension|Withdrawal by Subject|0|||
156538300|NCT01428661|565064672|FG001|Open Label Extension|Withdrawal by Subject|0|||
156538301|NCT01428661|565064673|FG002|Open Label Extension|Withdrawal by Subject|49|||
156538302|NCT01428661|565064671|FG000|Open Label Extension|Lack of Efficacy|0|||
156538303|NCT01428661|565064672|FG001|Open Label Extension|Lack of Efficacy|0|||
156538304|NCT01428661|565064673|FG002|Open Label Extension|Lack of Efficacy|24|||
156538305|NCT01428661|565064671|FG000|Open Label Extension|**Various|0|||
156538306|NCT01428661|565064672|FG001|Open Label Extension|**Various|0|||
156538307|NCT01428661|565064673|FG002|Open Label Extension|**Various|185|||
156538308|NCT03828292|565064674|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
156538309|NCT03828292|565064675|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
156538310|NCT03828292|565064676|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
156538311|NCT03828292|565064677|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
156538312|NCT03828292|565064678|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
156538313|NCT03828292|565064679|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
156538314|NCT03828292|565064674|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
156538315|NCT03828292|565064675|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
156538316|NCT03828292|565064676|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
156538317|NCT03828292|565064677|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
156538318|NCT03828292|565064678|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
156538319|NCT03828292|565064679|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
156538320|NCT03828292|565064674|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
156538321|NCT03828292|565064675|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
156538322|NCT03828292|565064676|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
156538323|NCT03828292|565064677|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
156538324|NCT03828292|565064678|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
156538325|NCT03828292|565064679|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
156538326|NCT03828292|565064674|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
156538327|NCT03828292|565064675|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
156538328|NCT03828292|565064676|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
156538329|NCT03828292|565064677|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
156538330|NCT03828292|565064678|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
156538331|NCT03828292|565064679|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
156538332|NCT03828292|565064674|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
156538333|NCT03828292|565064675|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
156538334|NCT03828292|565064676|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
156538335|NCT03828292|565064677|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
156538336|NCT03828292|565064678|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
156538337|NCT03828292|565064679|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
156538338|NCT04376827|565064680|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
156538339|NCT04376827|565064681|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
156538340|NCT04376827|565064680|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
156538341|NCT04376827|565064681|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
156538342|NCT04376827|565064680|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
156538343|NCT04376827|565064681|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
156538344|NCT04376827|565064680|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
156338306|NCT01064310|564336600|FG002|Open Label Pazopinib|Adverse Event|12|||
156338307|NCT01064310|564336598|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
156338308|NCT01064310|564336599|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
156338309|NCT01064310|564336600|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
156338310|NCT01064310|564336598|FG000|Open Label Pazopinib|Physician Decision|0|||
156338311|NCT01064310|564336599|FG001|Open Label Pazopinib|Physician Decision|0|||
156338312|NCT01064310|564336600|FG002|Open Label Pazopinib|Physician Decision|20|||
156338313|NCT00001880|564336601|FG000|Overall Study|Death|14|||
156338314|NCT02639065|564336602|FG000|Study Treatment|Disease Progression|13|||
156338315|NCT02639065|564336602|FG000|Study Treatment|Adverse Event|9|||
156338316|NCT02639065|564336602|FG000|Study Treatment|Withdrawal by Subject|1|||
156338317|NCT02639065|564336602|FG000|Follow up|Subject refused to follow up|1|||
156338318|NCT02639065|564336602|FG000|Follow up|Symptomatic Deterioration|2|||
156338319|NCT02639065|564336602|FG000|Follow up|Death|2|||
156338320|NCT02639065|564336602|FG000|Follow up|Study Terminated|1|||
156338321|NCT02639065|564336602|FG000|Follow up|Disease Progression|3|||
156338322|NCT00873015|564336603|FG000|Overall Study|Withdrawal by Subject|0|||
156338323|NCT00873015|564336604|FG001|Overall Study|Withdrawal by Subject|1|||
156338324|NCT00873015|564336605|FG002|Overall Study|Withdrawal by Subject|0|||
156338325|NCT00873015|564336606|FG003|Overall Study|Withdrawal by Subject|0|||
156338326|NCT00345839|564336607|FG000|Overall Study|Withdrawal by Subject|91|||
156338327|NCT00345839|564336608|FG001|Overall Study|Withdrawal by Subject|98|||
156338328|NCT00345839|564336607|FG000|Overall Study|Lost to Follow-up|58|||
156338329|NCT00345839|564336608|FG001|Overall Study|Lost to Follow-up|61|||
156338330|NCT00660699|564336614|FG000|Overall Study|Withdrawal by Subject|2|||
156338331|NCT01235351|564338188|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
156338332|NCT01235351|564338189|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
156338333|NCT01575769|564338190|FG000|Overall Study|Adverse Event|1|||
156338334|NCT01575769|564338190|FG000|Overall Study|Study terminated by sponsor|40|||
156338335|NCT01709513|564338191|FG000|Overall Study|Randomized but not treated|0|||
156338336|NCT01709513|564338192|FG001|Overall Study|Randomized but not treated|1|||
156338337|NCT01709513|564338193|FG002|Overall Study|Randomized but not treated|0|||
156338338|NCT01709513|564338191|FG000|Overall Study|Adverse Event|16|||
156338339|NCT01709513|564338192|FG001|Overall Study|Adverse Event|31|||
156338340|NCT01709513|564338193|FG002|Overall Study|Adverse Event|23|||
156338341|NCT01709513|564338191|FG000|Overall Study|Poor compliance to protocol|2|||
156338342|NCT01709513|564338192|FG001|Overall Study|Poor compliance to protocol|0|||
156338343|NCT01709513|564338193|FG002|Overall Study|Poor compliance to protocol|0|||
156338344|NCT01709513|564338191|FG000|Overall Study|Other|3|||
156338345|NCT01709513|564338192|FG001|Overall Study|Other|11|||
156338346|NCT01709513|564338193|FG002|Overall Study|Other|7|||
156338347|NCT01034631|564338194|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
156338348|NCT01034631|564338195|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
156338349|NCT01034631|564338196|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
156460705|NCT03505008|564781726|FG002|Before Week 24 Randomization|Adverse Event|0|||
156460706|NCT03505008|564781727|FG003|Before Week 24 Randomization|Adverse Event|0|||
156460707|NCT03505008|564781724|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
156460708|NCT03505008|564781725|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
156460709|NCT03505008|564781726|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
156460710|NCT03505008|564781727|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
156460711|NCT03505008|564781724|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
156538345|NCT04376827|565064681|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
156808992|NCT00127855|566054540|FG000|Primary Vaccination Course|Other|0|||
156808993|NCT00127855|566054541|FG001|Primary Vaccination Course|Other|0|||
156808994|NCT00127855|566054542|FG002|Primary Vaccination Course|Other|0|||
156808995|NCT00127855|566054543|FG003|Primary Vaccination Course|Other|0|||
156808996|NCT00127855|566054544|FG004|Primary Vaccination Course|Other|1|||
156808997|NCT02343302|566054545|FG000|Overall Study|Physician Decision|1|||
156808998|NCT02343302|566054546|FG001|Overall Study|Physician Decision|1|||
156808999|NCT04245709|566054549|FG000|Overall Study|Adverse Event|13|||
156809000|NCT04245709|566054549|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
156809001|NCT02389465|566054556|FG000|Overall Study|Lost to Follow-up|1|||
156809002|NCT02389465|566054557|FG001|Overall Study|Lost to Follow-up|3|||
156809003|NCT02389465|566054558|FG002|Overall Study|Lost to Follow-up|3|||
156809004|NCT02389465|566054559|FG003|Overall Study|Lost to Follow-up|0|||
156809005|NCT02389465|566054556|FG000|Overall Study|Physician Decision|0|||
156809006|NCT02389465|566054557|FG001|Overall Study|Physician Decision|0|||
156809007|NCT02389465|566054558|FG002|Overall Study|Physician Decision|0|||
156338350|NCT01034631|564338194|FG000|Phase II|Not Evaluable per protocol|0|||
156338351|NCT01034631|564338195|FG001|Phase II|Not Evaluable per protocol|0|||
156338352|NCT01034631|564338196|FG002|Phase II|Not Evaluable per protocol|2|||
156338353|NCT01034631|564338194|FG000|Phase II|Determined Ineligible per protocol|0|||
156338354|NCT01034631|564338195|FG001|Phase II|Determined Ineligible per protocol|1|||
156338355|NCT01034631|564338196|FG002|Phase II|Determined Ineligible per protocol|0|||
156809008|NCT02389465|566054559|FG003|Overall Study|Physician Decision|1|||
156809009|NCT02389465|566054556|FG000|Overall Study|Withdrawal by Subject|0|||
156338356|NCT01193530|564338197|FG000|Overall Study|Withdrawal by Subject|2|||
156338357|NCT01193530|564338198|FG001|Overall Study|Withdrawal by Subject|2|||
156338358|NCT01193530|564338197|FG000|Overall Study|Began Contraindicated Therapy|1|||
156338359|NCT01193530|564338198|FG001|Overall Study|Began Contraindicated Therapy|0|||
156338360|NCT01193530|564338197|FG000|Overall Study|Lost Light Box|0|||
156338361|NCT01193530|564338198|FG001|Overall Study|Lost Light Box|1|||
156338362|NCT01193530|564338197|FG000|Overall Study|Returned home - out of state|0|||
156338363|NCT01193530|564338198|FG001|Overall Study|Returned home - out of state|1|||
156338364|NCT01193530|564338197|FG000|Overall Study|Non-Compliance|0|||
156338365|NCT01193530|564338198|FG001|Overall Study|Non-Compliance|1|||
156338366|NCT00599924|564338210|FG000|Overall Study|Lack of Efficacy|3|||
156338367|NCT00599924|564338211|FG001|Overall Study|Lack of Efficacy|5|||
156338368|NCT00599924|564338212|FG002|Overall Study|Lack of Efficacy|1|||
156338369|NCT00599924|564338213|FG003|Overall Study|Lack of Efficacy|2|||
156338370|NCT00599924|564338214|FG004|Overall Study|Lack of Efficacy|3|||
156338371|NCT00599924|564338215|FG005|Overall Study|Lack of Efficacy|2|||
156338372|NCT00599924|564338216|FG006|Overall Study|Lack of Efficacy|0|||
156338373|NCT00599924|564338210|FG000|Overall Study|Adverse Event|0|||
156338374|NCT00599924|564338211|FG001|Overall Study|Adverse Event|0|||
156338375|NCT00599924|564338212|FG002|Overall Study|Adverse Event|0|||
156338376|NCT00599924|564338213|FG003|Overall Study|Adverse Event|2|||
156460712|NCT03505008|564781725|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
156460713|NCT03505008|564781726|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
156460714|NCT03505008|564781727|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
156460715|NCT03505008|564781724|FG000|Before Week 24 Randomization|Physician Decision|2|||
156460716|NCT03505008|564781725|FG001|Before Week 24 Randomization|Physician Decision|0|||
156460717|NCT03505008|564781726|FG002|Before Week 24 Randomization|Physician Decision|0|||
156460718|NCT03505008|564781727|FG003|Before Week 24 Randomization|Physician Decision|0|||
156460719|NCT03505008|564781724|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
156460720|NCT03505008|564781725|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
156460721|NCT03505008|564781726|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
156460722|NCT03505008|564781727|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
156460723|NCT03505008|564781724|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
156460724|NCT03505008|564781725|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
156460725|NCT03505008|564781726|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
156460726|NCT03505008|564781727|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
156460727|NCT03505008|564781724|FG000|Before Week 24 Randomization|Complication|1|||
156460728|NCT03505008|564781725|FG001|Before Week 24 Randomization|Complication|0|||
156460729|NCT03505008|564781726|FG002|Before Week 24 Randomization|Complication|0|||
156460730|NCT03505008|564781727|FG003|Before Week 24 Randomization|Complication|0|||
156460731|NCT03505008|564781724|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
156460732|NCT03505008|564781725|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
156460733|NCT03505008|564781726|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
156460734|NCT03505008|564781727|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
156460735|NCT03505008|564781724|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
156460736|NCT03505008|564781725|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
156460737|NCT03505008|564781726|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
156460738|NCT03505008|564781727|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
156460739|NCT03505008|564781724|FG000|After Week 24 Randomization|Adverse Event|0|||
156460740|NCT03505008|564781725|FG001|After Week 24 Randomization|Adverse Event|1|||
156460741|NCT03505008|564781726|FG002|After Week 24 Randomization|Adverse Event|2|||
156460742|NCT03505008|564781727|FG003|After Week 24 Randomization|Adverse Event|2|||
156460743|NCT03505008|564781724|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
156460744|NCT03505008|564781725|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
156460745|NCT03505008|564781726|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
156460746|NCT03505008|564781727|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
156460747|NCT03505008|564781724|FG000|After Week 24 Randomization|Protocol Violation|0|||
156460748|NCT03505008|564781725|FG001|After Week 24 Randomization|Protocol Violation|0|||
156460749|NCT03505008|564781726|FG002|After Week 24 Randomization|Protocol Violation|1|||
156460750|NCT03505008|564781727|FG003|After Week 24 Randomization|Protocol Violation|0|||
156460751|NCT02962076|564781728|FG000|Overall Study|MHED tracer not available|5|||
156460752|NCT02962076|564781728|FG000|Overall Study|Protocol Violation|1|||
156460753|NCT02962076|564781728|FG000|Overall Study|Physician Decision|1|||
156460754|NCT02780700|564781729|FG000|Overall Study|Progressive disease|1|||
156460755|NCT04580914|564781733|FG000|Overall Study|Withdrawal by Subject|6|||
156460756|NCT04580914|564781733|FG000|Overall Study|Lost to Follow-up|2|||
156565211|NCT06001307|565157641|FG001|Overall Study|Lost to Follow-up|2|||
156338377|NCT00599924|564338214|FG004|Overall Study|Adverse Event|0|||
156338378|NCT00599924|564338215|FG005|Overall Study|Adverse Event|0|||
156338379|NCT00599924|564338216|FG006|Overall Study|Adverse Event|2|||
156338380|NCT00599924|564338210|FG000|Overall Study|Death|0|||
156460757|NCT02998528|564781735|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
156460758|NCT02998528|564781736|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
156460759|NCT02998528|564781737|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
156460760|NCT02998528|564781735|FG000|Randomization Period|Participant withdrew consent|0|||
156460761|NCT02998528|564781736|FG001|Randomization Period|Participant withdrew consent|3|||
156460762|NCT02998528|564781737|FG002|Randomization Period|Participant withdrew consent|0|||
156460763|NCT02998528|564781735|FG000|Randomization Period|Participant no longer meets study criteria|1|||
156460764|NCT02998528|564781736|FG001|Randomization Period|Participant no longer meets study criteria|3|||
156460765|NCT02998528|564781737|FG002|Randomization Period|Participant no longer meets study criteria|2|||
156460766|NCT02998528|564781735|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
156460767|NCT02998528|564781736|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
156460768|NCT02998528|564781737|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
156460769|NCT02998528|564781735|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
156460770|NCT02998528|564781736|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
156460771|NCT02998528|564781737|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
156460772|NCT02998528|564781735|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
156460773|NCT02998528|564781736|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
156460774|NCT02998528|564781737|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
156460775|NCT02998528|564781735|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
156460776|NCT02998528|564781736|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
156460777|NCT02998528|564781737|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
156460778|NCT02998528|564781735|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
156460779|NCT02998528|564781736|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
156460780|NCT02998528|564781737|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
156460781|NCT02998528|564781735|FG000|Neoadjuvant Treatment Period|Death|1|||
156460782|NCT02998528|564781736|FG001|Neoadjuvant Treatment Period|Death|0|||
156460783|NCT02998528|564781737|FG002|Neoadjuvant Treatment Period|Death|0|||
156460784|NCT02998528|564781735|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
156460785|NCT02998528|564781736|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
156460786|NCT02998528|564781737|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
156460787|NCT02998528|564781735|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
156460788|NCT02998528|564781736|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
156460789|NCT02998528|564781737|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
156460790|NCT02998528|564781735|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
156460791|NCT02998528|564781736|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
156460792|NCT02998528|564781737|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
156460793|NCT02998528|564781735|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
156460794|NCT02998528|564781736|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
156460795|NCT02998528|564781737|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
156460796|NCT02998528|564781735|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
156460797|NCT02998528|564781736|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
156460798|NCT02998528|564781737|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
156460799|NCT02998528|564781735|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
156460800|NCT02998528|564781736|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
156460801|NCT02998528|564781737|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
156460802|NCT05035654|564781740|FG000|Overall Study|Physician Decision|0|||
156460803|NCT05035654|564781741|FG001|Overall Study|Physician Decision|1|||
156460804|NCT05035654|564781742|FG002|Overall Study|Physician Decision|0|||
156460805|NCT05035654|564781740|FG000|Overall Study|Adverse Event|0|||
156460806|NCT05035654|564781741|FG001|Overall Study|Adverse Event|1|||
156460807|NCT05035654|564781742|FG002|Overall Study|Adverse Event|0|||
156460808|NCT05035654|564781740|FG000|Overall Study|Withdrawal by Subject|0|||
156460809|NCT05035654|564781741|FG001|Overall Study|Withdrawal by Subject|0|||
156460810|NCT05035654|564781742|FG002|Overall Study|Withdrawal by Subject|4|||
156460811|NCT05035654|564781740|FG000|Overall Study|Bilateral Dislodgement|1|||
156460812|NCT05035654|564781741|FG001|Overall Study|Bilateral Dislodgement|0|||
156460813|NCT05035654|564781742|FG002|Overall Study|Bilateral Dislodgement|0|||
156338381|NCT00599924|564338211|FG001|Overall Study|Death|0|||
156460814|NCT03993392|564781747|FG000|Overall Study|Withdrawal by Subject|3|||
156460815|NCT03993392|564781747|FG000|Overall Study|Lost to Follow-up|2|||
156565212|NCT03263806|565157643|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
156460816|NCT03993392|564781747|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
156460817|NCT03106740|564783556|FG000|Overall Study|Lost to Follow-up|2|||
156460818|NCT03106740|564783557|FG001|Overall Study|Lost to Follow-up|2|||
156460819|NCT03106740|564783556|FG000|Overall Study|Withdrawal by Subject|2|||
156460820|NCT03106740|564783557|FG001|Overall Study|Withdrawal by Subject|4|||
156460821|NCT03106740|564783556|FG000|Overall Study|Physician Decision|0|||
156460822|NCT03106740|564783557|FG001|Overall Study|Physician Decision|1|||
156460823|NCT03106740|564783556|FG000|Overall Study|Partial data|1|||
156460824|NCT03106740|564783557|FG001|Overall Study|Partial data|0|||
156460825|NCT06262477|564783558|FG000|Overall Study|Withdrawal by Subject|1|||
156460826|NCT06262477|564783559|FG001|Overall Study|Withdrawal by Subject|0|||
156460827|NCT06262477|564783558|FG000|Overall Study|Adverse Event|0|||
156460828|NCT06262477|564783559|FG001|Overall Study|Adverse Event|1|||
156460829|NCT06262477|564783558|FG000|Overall Study|Lost to Follow-up|0|||
156460830|NCT06262477|564783559|FG001|Overall Study|Lost to Follow-up|1|||
156460831|NCT03220035|564783563|FG000|Overall Study|Adverse Event|1|||
156460832|NCT03220035|564783563|FG000|Overall Study|Protocol Violation|1|||
156460833|NCT03220035|564783563|FG000|Overall Study|Progressive Disease|2|||
156460834|NCT05452460|564783564|FG000|Overall Study|Lost to Follow-up|3|||
156460835|NCT05452460|564783565|FG001|Overall Study|Lost to Follow-up|3|||
156460836|NCT05452460|564783564|FG000|Overall Study|Did not receive intervention|1|||
156460837|NCT05452460|564783565|FG001|Overall Study|Did not receive intervention|0|||
156460838|NCT04433208|564783566|FG000|Overall Study|Withdrawal by Subject|0|||
156460839|NCT04433208|564783567|FG001|Overall Study|Withdrawal by Subject|1|||
156460840|NCT04433208|564783568|FG002|Overall Study|Withdrawal by Subject|1|||
156460841|NCT04433208|564783569|FG003|Overall Study|Withdrawal by Subject|0|||
156460842|NCT04433208|564783570|FG004|Overall Study|Withdrawal by Subject|2|||
156460843|NCT04433208|564783571|FG005|Overall Study|Withdrawal by Subject|1|||
156460844|NCT04433208|564783566|FG000|Overall Study|Lost to Follow-up|0|||
156460845|NCT04433208|564783567|FG001|Overall Study|Lost to Follow-up|0|||
156460846|NCT04433208|564783568|FG002|Overall Study|Lost to Follow-up|0|||
156460847|NCT04433208|564783569|FG003|Overall Study|Lost to Follow-up|0|||
156460848|NCT04433208|564783570|FG004|Overall Study|Lost to Follow-up|0|||
156460849|NCT04433208|564783571|FG005|Overall Study|Lost to Follow-up|1|||
156460850|NCT02424617|564783574|FG000|Overall Study|Adverse Event|0|||
156460851|NCT02424617|564783575|FG001|Overall Study|Adverse Event|1|||
156460852|NCT02424617|564783576|FG002|Overall Study|Adverse Event|0|||
156460853|NCT02424617|564783577|FG003|Overall Study|Adverse Event|0|||
156460854|NCT02424617|564783574|FG000|Overall Study|Investigator Decision|0|||
156460855|NCT02424617|564783575|FG001|Overall Study|Investigator Decision|0|||
156460856|NCT02424617|564783576|FG002|Overall Study|Investigator Decision|0|||
156460857|NCT02424617|564783577|FG003|Overall Study|Investigator Decision|1|||
156460858|NCT02424617|564783574|FG000|Overall Study|Withdrawal by Subject|1|||
156460859|NCT02424617|564783575|FG001|Overall Study|Withdrawal by Subject|1|||
156460860|NCT02424617|564783576|FG002|Overall Study|Withdrawal by Subject|0|||
156460861|NCT02424617|564783577|FG003|Overall Study|Withdrawal by Subject|1|||
156460862|NCT02424617|564783574|FG000|Overall Study|Progressive Disease|7|||
156460863|NCT02424617|564783575|FG001|Overall Study|Progressive Disease|6|||
156460864|NCT02424617|564783576|FG002|Overall Study|Progressive Disease|11|||
156460865|NCT02424617|564783577|FG003|Overall Study|Progressive Disease|10|||
156460866|NCT02424617|564783574|FG000|Overall Study|Other|0|||
156460867|NCT02424617|564783575|FG001|Overall Study|Other|0|||
156460868|NCT02424617|564783576|FG002|Overall Study|Other|0|||
156460869|NCT02424617|564783577|FG003|Overall Study|Other|1|||
156460870|NCT04359654|564783579|FG000|Overall Study|Withdrawal by Subject|1|||
156460871|NCT04359654|564783580|FG001|Overall Study|Withdrawal by Subject|0|||
156460872|NCT04359654|564783579|FG000|Overall Study|Adverse Event|0|||
156460873|NCT04359654|564783580|FG001|Overall Study|Adverse Event|1|||
156460874|NCT04024020|564783581|FG000|Overall Study|Withdrawal by Subject|2|||
156460875|NCT04024020|564783582|FG001|Overall Study|Withdrawal by Subject|2|||
156460876|NCT05269966|564783585|FG000|Overall Study|Adverse Event|4|||
156460877|NCT05269966|564783585|FG000|Overall Study|Withdrawal by Subject|1|||
156460878|NCT05269966|564783585|FG000|Overall Study|Lost to Follow-up|4|||
156460879|NCT05269966|564783585|FG000|Overall Study|Physician Decision|1|||
156460880|NCT06262347|564783588|FG000|Overall Study|Lost to Follow-up|4|||
156460881|NCT06262347|564783589|FG001|Overall Study|Lost to Follow-up|3|||
156460882|NCT06262347|564783588|FG000|Overall Study|Withdrawal by Subject|0|||
156460883|NCT06262347|564783589|FG001|Overall Study|Withdrawal by Subject|1|||
156460884|NCT03476343|564783590|FG000|Overall Study|Clinical exam moved to another scanner|7|||
156460885|NCT03476343|564783590|FG000|Overall Study|Clinical order cancelled|4|||
156460886|NCT03476343|564783590|FG000|Overall Study|Neonate did not settle down for the scan|1|||
156460887|NCT05974501|564783591|FG000|Overall Study|Physician Decision|0|||
156460888|NCT05974501|564783592|FG001|Overall Study|Physician Decision|1|||
156460889|NCT04304144|564783593|FG000|DLT Observation Period|Physician Decision|0|||
156460890|NCT04304144|564783594|FG001|DLT Observation Period|Physician Decision|1|||
156460891|NCT04304144|564783595|FG002|DLT Observation Period|Physician Decision|0|||
156460892|NCT04304144|564783596|FG003|DLT Observation Period|Physician Decision|0|||
156809010|NCT02389465|566054557|FG001|Overall Study|Withdrawal by Subject|1|||
156809011|NCT02389465|566054558|FG002|Overall Study|Withdrawal by Subject|2|||
156809012|NCT02389465|566054559|FG003|Overall Study|Withdrawal by Subject|2|||
156809013|NCT04339413|566054562|FG000|Overall Study|Reason Not Specified|2|||
156809014|NCT04339413|566054563|FG001|Overall Study|Reason Not Specified|7|||
156809015|NCT04339413|566054562|FG000|Overall Study|Study Terminated by Sponsor|30|||
156809016|NCT04339413|566054563|FG001|Overall Study|Study Terminated by Sponsor|33|||
156809017|NCT04339413|566054562|FG000|Overall Study|Progressive Disease|9|||
156809018|NCT04339413|566054563|FG001|Overall Study|Progressive Disease|6|||
156809019|NCT04339413|566054562|FG000|Overall Study|Withdrawal by Subject|9|||
156809020|NCT04339413|566054563|FG001|Overall Study|Withdrawal by Subject|10|||
156809021|NCT04339413|566054562|FG000|Overall Study|Physician Decision|3|||
156809022|NCT04339413|566054563|FG001|Overall Study|Physician Decision|1|||
156809023|NCT04339413|566054562|FG000|Overall Study|Death|2|||
156809024|NCT04339413|566054563|FG001|Overall Study|Death|0|||
156809025|NCT04339413|566054562|FG000|Overall Study|Adverse Event|3|||
156809026|NCT04339413|566054563|FG001|Overall Study|Adverse Event|0|||
156809027|NCT02012218|566054564|FG000|Overall Study|Withdrawal by Subject|1|||
156809028|NCT02012218|566054565|FG001|Overall Study|Withdrawal by Subject|0|||
156809029|NCT02012218|566054566|FG002|Overall Study|Withdrawal by Subject|1|||
156809030|NCT02012218|566054567|FG003|Overall Study|Withdrawal by Subject|1|||
156809031|NCT02012218|566054568|FG004|Overall Study|Withdrawal by Subject|1|||
156809032|NCT02012218|566054564|FG000|Overall Study|Adverse Event|1|||
156809033|NCT02012218|566054565|FG001|Overall Study|Adverse Event|0|||
156809034|NCT02012218|566054566|FG002|Overall Study|Adverse Event|0|||
156809035|NCT02012218|566054567|FG003|Overall Study|Adverse Event|1|||
156809036|NCT02012218|566054568|FG004|Overall Study|Adverse Event|0|||
156809037|NCT02012218|566054564|FG000|Overall Study|Lost to Follow-up|0|||
156809038|NCT02012218|566054565|FG001|Overall Study|Lost to Follow-up|1|||
156809039|NCT02012218|566054566|FG002|Overall Study|Lost to Follow-up|1|||
156809040|NCT02012218|566054567|FG003|Overall Study|Lost to Follow-up|0|||
156809041|NCT02012218|566054568|FG004|Overall Study|Lost to Follow-up|0|||
156460893|NCT04304144|564783593|FG000|Continued Treatment Period|Adverse Event|0|||
156460894|NCT04304144|564783594|FG001|Continued Treatment Period|Adverse Event|1|||
156460895|NCT04304144|564783595|FG002|Continued Treatment Period|Adverse Event|0|||
156460896|NCT04304144|564783596|FG003|Continued Treatment Period|Adverse Event|0|||
156460897|NCT04304144|564783593|FG000|Continued Treatment Period|Death|0|||
156460898|NCT04304144|564783594|FG001|Continued Treatment Period|Death|0|||
156460899|NCT04304144|564783595|FG002|Continued Treatment Period|Death|1|||
156460900|NCT04304144|564783596|FG003|Continued Treatment Period|Death|2|||
156460901|NCT04304144|564783593|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
156460902|NCT04304144|564783594|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
156460903|NCT04304144|564783595|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
156460904|NCT04304144|564783596|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
156460905|NCT04304144|564783593|FG000|Continued Treatment Period|Other than specified|2|||
156460906|NCT04304144|564783594|FG001|Continued Treatment Period|Other than specified|0|||
156460907|NCT04304144|564783595|FG002|Continued Treatment Period|Other than specified|1|||
156460908|NCT04304144|564783596|FG003|Continued Treatment Period|Other than specified|1|||
156460909|NCT04585815|564783597|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
156460910|NCT04585815|564783598|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
156460911|NCT04585815|564783599|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
156460912|NCT04585815|564783600|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
156460913|NCT04585815|564783601|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
156460914|NCT04585815|564783602|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
156460915|NCT04585815|564783603|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
156460916|NCT04585815|564783597|FG000|Sub-study A- Treatment Phase|Death|0|||
156460917|NCT04585815|564783598|FG001|Sub-study A- Treatment Phase|Death|1|||
156460918|NCT04585815|564783599|FG002|Sub-study A- Treatment Phase|Death|0|||
156460919|NCT04585815|564783600|FG003|Sub-study A- Treatment Phase|Death|0|||
156460920|NCT04585815|564783601|FG004|Sub-study A- Treatment Phase|Death|0|||
156460921|NCT04585815|564783602|FG005|Sub-study A- Treatment Phase|Death|0|||
156460922|NCT04585815|564783603|FG006|Sub-study A- Treatment Phase|Death|0|||
156460923|NCT04585815|564783597|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
156460924|NCT04585815|564783598|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
156460925|NCT04585815|564783599|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
156460926|NCT04585815|564783600|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
156460927|NCT04585815|564783601|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
156460928|NCT04585815|564783602|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
156809042|NCT02012218|566054564|FG000|Overall Study|Protocol Specified|1|||
156460929|NCT04585815|564783603|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
156565213|NCT03263806|565157644|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
156809043|NCT02012218|566054565|FG001|Overall Study|Protocol Specified|0|||
156809044|NCT02012218|566054566|FG002|Overall Study|Protocol Specified|0|||
156809045|NCT02012218|566054567|FG003|Overall Study|Protocol Specified|0|||
156460930|NCT04585815|564783597|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
156460931|NCT04585815|564783598|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
156460932|NCT04585815|564783599|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
156809046|NCT02012218|566054568|FG004|Overall Study|Protocol Specified|0|||
156809047|NCT02012218|566054564|FG000|Overall Study|Protocol Deviation|1|||
156809048|NCT02012218|566054565|FG001|Overall Study|Protocol Deviation|0|||
156809049|NCT02012218|566054566|FG002|Overall Study|Protocol Deviation|0|||
156338382|NCT00599924|564338212|FG002|Overall Study|Death|0|||
156460933|NCT04585815|564783600|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
156460934|NCT04585815|564783601|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
156460935|NCT04585815|564783602|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
156460936|NCT04585815|564783603|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
156460937|NCT04585815|564783597|FG000|Sub-study A- Treatment Phase|Other|1|||
156460938|NCT04585815|564783598|FG001|Sub-study A- Treatment Phase|Other|0|||
156460939|NCT04585815|564783599|FG002|Sub-study A- Treatment Phase|Other|0|||
156460940|NCT04585815|564783600|FG003|Sub-study A- Treatment Phase|Other|0|||
156460941|NCT04585815|564783601|FG004|Sub-study A- Treatment Phase|Other|0|||
156460942|NCT04585815|564783602|FG005|Sub-study A- Treatment Phase|Other|0|||
156460943|NCT04585815|564783603|FG006|Sub-study A- Treatment Phase|Other|0|||
156460944|NCT04585815|564783597|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
156460945|NCT04585815|564783598|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
156460946|NCT04585815|564783599|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
156460947|NCT04585815|564783600|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
156460948|NCT04585815|564783601|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
156460949|NCT04585815|564783602|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
156460950|NCT04585815|564783603|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
156460951|NCT04585815|564783597|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
156460952|NCT04585815|564783598|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
156460953|NCT04585815|564783599|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
156460954|NCT04585815|564783600|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
156460955|NCT04585815|564783601|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
156460956|NCT04585815|564783602|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
156460957|NCT04585815|564783603|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
156460958|NCT04585815|564783597|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
156460959|NCT04585815|564783598|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
156460960|NCT04585815|564783599|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
156460961|NCT04585815|564783600|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
156460962|NCT04585815|564783601|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
156460963|NCT04585815|564783602|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
156460964|NCT04585815|564783603|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
156460965|NCT04585815|564783597|FG000|Sub-study B- Treatment Phase|Death|0|||
156460966|NCT04585815|564783598|FG001|Sub-study B- Treatment Phase|Death|0|||
156460967|NCT04585815|564783599|FG002|Sub-study B- Treatment Phase|Death|0|||
156460968|NCT04585815|564783600|FG003|Sub-study B- Treatment Phase|Death|1|||
156460969|NCT04585815|564783601|FG004|Sub-study B- Treatment Phase|Death|0|||
156460970|NCT04585815|564783602|FG005|Sub-study B- Treatment Phase|Death|0|||
156460971|NCT04585815|564783603|FG006|Sub-study B- Treatment Phase|Death|0|||
156460972|NCT04585815|564783597|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
156460973|NCT04585815|564783598|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
156460974|NCT04585815|564783599|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
156460975|NCT04585815|564783600|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
156460976|NCT04585815|564783601|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
156460977|NCT04585815|564783602|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
156460978|NCT04585815|564783603|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
156460979|NCT04585815|564783597|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
156460980|NCT04585815|564783598|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
156460981|NCT04585815|564783599|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
156809050|NCT02012218|566054567|FG003|Overall Study|Protocol Deviation|0|||
156338383|NCT00599924|564338213|FG003|Overall Study|Death|2|||
156338384|NCT00599924|564338214|FG004|Overall Study|Death|0|||
156338385|NCT00599924|564338215|FG005|Overall Study|Death|2|||
156338386|NCT00599924|564338216|FG006|Overall Study|Death|1|||
156338387|NCT00599924|564338210|FG000|Overall Study|Protocol Violation|0|||
156338388|NCT00599924|564338211|FG001|Overall Study|Protocol Violation|0|||
156338389|NCT00599924|564338212|FG002|Overall Study|Protocol Violation|0|||
156338390|NCT00599924|564338213|FG003|Overall Study|Protocol Violation|1|||
156338391|NCT00599924|564338214|FG004|Overall Study|Protocol Violation|0|||
156338392|NCT00599924|564338215|FG005|Overall Study|Protocol Violation|0|||
156338393|NCT00599924|564338216|FG006|Overall Study|Protocol Violation|0|||
156338394|NCT00599924|564338210|FG000|Overall Study|Withdrawal by Subject|0|||
156338395|NCT00599924|564338211|FG001|Overall Study|Withdrawal by Subject|0|||
156338396|NCT00599924|564338212|FG002|Overall Study|Withdrawal by Subject|1|||
156338397|NCT00599924|564338213|FG003|Overall Study|Withdrawal by Subject|0|||
156338398|NCT00599924|564338214|FG004|Overall Study|Withdrawal by Subject|1|||
156338399|NCT00599924|564338215|FG005|Overall Study|Withdrawal by Subject|0|||
156338400|NCT00599924|564338216|FG006|Overall Study|Withdrawal by Subject|0|||
156338401|NCT00599924|564338210|FG000|Overall Study|Other|0|||
156338402|NCT00599924|564338211|FG001|Overall Study|Other|0|||
156338403|NCT00599924|564338212|FG002|Overall Study|Other|0|||
156338404|NCT00599924|564338213|FG003|Overall Study|Other|1|||
156338405|NCT00599924|564338214|FG004|Overall Study|Other|2|||
156338406|NCT00599924|564338215|FG005|Overall Study|Other|0|||
156338407|NCT00599924|564338216|FG006|Overall Study|Other|2|||
156338408|NCT01806298|564338217|FG000|Overall Study|Adverse Event|3|||
156338409|NCT01806298|564338217|FG000|Overall Study|Protocol Non-compliance|1|||
156338410|NCT01806298|564338217|FG000|Overall Study|Withdrawal by Subject|1|||
156338411|NCT01806298|564338217|FG000|Overall Study|Other|5|||
156338412|NCT01877265|564338218|FG000|Treatment Period 1|Sponsor Decision|0|||
156338413|NCT01877265|564338219|FG001|Treatment Period 1|Sponsor Decision|0|||
156338414|NCT01877265|564338220|FG002|Treatment Period 1|Sponsor Decision|1|||
156338415|NCT01877265|564338221|FG003|Treatment Period 1|Sponsor Decision|0|||
156338416|NCT01877265|564338222|FG004|Treatment Period 1|Sponsor Decision|0|||
156338417|NCT01877265|564338223|FG005|Treatment Period 1|Sponsor Decision|0|||
156338418|NCT01877265|564338218|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156338419|NCT01877265|564338219|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156338420|NCT01877265|564338220|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156338421|NCT01877265|564338221|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156338422|NCT01877265|564338222|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156338423|NCT01877265|564338223|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
156338424|NCT01877265|564338218|FG000|Treatment Period 3|Lost to Follow-up|1|||
156338425|NCT01877265|564338219|FG001|Treatment Period 3|Lost to Follow-up|0|||
156338426|NCT01877265|564338220|FG002|Treatment Period 3|Lost to Follow-up|0|||
156338427|NCT01877265|564338221|FG003|Treatment Period 3|Lost to Follow-up|0|||
156338428|NCT01877265|564338222|FG004|Treatment Period 3|Lost to Follow-up|0|||
156338429|NCT01877265|564338223|FG005|Treatment Period 3|Lost to Follow-up|0|||
156338430|NCT03039283|564338228|FG000|Overall Study|Protocol Violation|2|||
156338431|NCT00867568|564338229|FG000|Overall Study|Lack of Efficacy|10|||
156338432|NCT00867568|564338229|FG000|Overall Study|Adverse Event|4|||
156338433|NCT00867568|564338229|FG000|Overall Study|Withdrawal by Subject|1|||
156338434|NCT01056653|564338230|FG000|Overall Study|Lost to Follow-up|0|||
156338435|NCT01056653|564338231|FG001|Overall Study|Lost to Follow-up|0|||
156338436|NCT01056653|564338232|FG002|Overall Study|Lost to Follow-up|2|||
156338437|NCT03639935|564338233|FG000|Overall Study|Death|3|||
156338438|NCT03639935|564338233|FG000|Overall Study|Adverse Event|1|||
156338439|NCT06333613|564338235|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
156338440|NCT02059395|564338238|FG000|Overall Study|Lost to Follow-up|2|||
156338441|NCT02059395|564338239|FG001|Overall Study|Lost to Follow-up|4|||
156338442|NCT05209360|564338240|FG000|Overall Study|Withdrawal by Subject|0|||
156338443|NCT05209360|564338241|FG001|Overall Study|Withdrawal by Subject|0|||
156338444|NCT05209360|564338242|FG002|Overall Study|Withdrawal by Subject|1|||
156338445|NCT05209360|564338243|FG003|Overall Study|Withdrawal by Subject|0|||
156338446|NCT05209360|564338244|FG004|Overall Study|Withdrawal by Subject|0|||
156338447|NCT05209360|564338245|FG005|Overall Study|Withdrawal by Subject|0|||
156338448|NCT00134082|564338246|FG000|Overall Study|Adverse Event|2|||
156338449|NCT00134082|564338246|FG000|Overall Study|Death|1|||
156338450|NCT00724932|564338249|FG000|Overall Study|Lost to Follow-up|1|||
156338451|NCT00724932|564338250|FG001|Overall Study|Lost to Follow-up|0|||
156338452|NCT00724932|564338249|FG000|Overall Study|Not treated|4|||
156338453|NCT00724932|564338250|FG001|Overall Study|Not treated|3|||
156338454|NCT02849678|564338251|FG000|Overall Study|Protocol Violation|3|||
156338455|NCT02849678|564338252|FG001|Overall Study|Protocol Violation|6|||
156338456|NCT00289991|564338253|FG000|Overall Study|Death|35|||
156338457|NCT00289991|564338254|FG001|Overall Study|Death|38|||
156338458|NCT00289991|564338253|FG000|Overall Study|Adverse Event|15|||
156338459|NCT00289991|564338254|FG001|Overall Study|Adverse Event|13|||
156338460|NCT00289991|564338253|FG000|Overall Study|Failure of prophylaxis|1|||
156338461|NCT00289991|564338254|FG001|Overall Study|Failure of prophylaxis|1|||
156338462|NCT00289991|564338253|FG000|Overall Study|Fungal breakthrough infection|0|||
156338463|NCT00289991|564338254|FG001|Overall Study|Fungal breakthrough infection|1|||
156338464|NCT00289991|564338253|FG000|Overall Study|Lost to Follow-up|0|||
156338465|NCT00289991|564338254|FG001|Overall Study|Lost to Follow-up|1|||
156338466|NCT00289991|564338253|FG000|Overall Study|Withdrawal by Subject|2|||
156338467|NCT00289991|564338254|FG001|Overall Study|Withdrawal by Subject|12|||
156338468|NCT00289991|564338253|FG000|Overall Study|Other|5|||
156338469|NCT00289991|564338254|FG001|Overall Study|Other|14|||
156338470|NCT02340975|564338255|FG000|Overall Study|Death|6|||
156460982|NCT04585815|564783600|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
156338471|NCT02340975|564338256|FG001|Overall Study|Death|23|||
156338472|NCT02340975|564338257|FG002|Overall Study|Death|21|||
156460983|NCT04585815|564783601|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
156460984|NCT04585815|564783602|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
156809051|NCT02012218|566054568|FG004|Overall Study|Protocol Deviation|0|||
156809052|NCT04417257|566054569|FG000|Pilot Phase 2|Adverse Event|2|||
156809053|NCT04417257|566054570|FG001|Pilot Phase 2|Adverse Event|0|||
156809054|NCT04417257|566054569|FG000|Pilot Phase 2|Death|14|||
156809055|NCT04417257|566054570|FG001|Pilot Phase 2|Death|11|||
156809056|NCT04417257|566054569|FG000|Pilot Phase 2|Lost to Follow-up|3|||
156809057|NCT04417257|566054570|FG001|Pilot Phase 2|Lost to Follow-up|5|||
156809058|NCT04417257|566054569|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
156809059|NCT04417257|566054570|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
156809060|NCT04417257|566054569|FG000|Pilot Phase 2|Hepatic impairment|1|||
156809061|NCT04417257|566054570|FG001|Pilot Phase 2|Hepatic impairment|0|||
156460985|NCT04585815|564783603|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
156460986|NCT04585815|564783597|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
156460987|NCT04585815|564783598|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
156460988|NCT04585815|564783599|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
156460989|NCT04585815|564783600|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
156460990|NCT04585815|564783601|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
156460991|NCT04585815|564783602|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
156460992|NCT04585815|564783603|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
156460993|NCT04585815|564783597|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
156460994|NCT04585815|564783598|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
156460995|NCT04585815|564783599|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
156460996|NCT04585815|564783600|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
156460997|NCT04585815|564783601|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
156460998|NCT04585815|564783602|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
156460999|NCT04585815|564783603|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
156461000|NCT04585815|564783597|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
156461001|NCT04585815|564783598|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
156461002|NCT04585815|564783599|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
156461003|NCT04585815|564783600|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
156461004|NCT04585815|564783601|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
156461005|NCT04585815|564783602|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
156461006|NCT04585815|564783603|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
156461007|NCT04585815|564783597|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
156461008|NCT04585815|564783598|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
156461009|NCT04585815|564783599|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
156461010|NCT04585815|564783600|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
156461011|NCT04585815|564783601|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
156461012|NCT04585815|564783602|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
156461013|NCT04585815|564783603|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
156461014|NCT04585815|564783597|FG000|Sub-study B- Follow-up Phase|Death|0|||
156461015|NCT04585815|564783598|FG001|Sub-study B- Follow-up Phase|Death|0|||
156461016|NCT04585815|564783599|FG002|Sub-study B- Follow-up Phase|Death|1|||
156461017|NCT04585815|564783600|FG003|Sub-study B- Follow-up Phase|Death|3|||
156461018|NCT04585815|564783601|FG004|Sub-study B- Follow-up Phase|Death|0|||
156461019|NCT04585815|564783602|FG005|Sub-study B- Follow-up Phase|Death|0|||
156461020|NCT04585815|564783603|FG006|Sub-study B- Follow-up Phase|Death|1|||
156461021|NCT02497950|564783606|FG000|Overall Study|Death|209|||
156461022|NCT02497950|564783606|FG000|Overall Study|Transplanted|85|||
156461023|NCT02497950|564783606|FG000|Overall Study|Explanted|8|||
156461024|NCT02497950|564783606|FG000|Overall Study|Device Permanently Deactivated|4|||
156461025|NCT02497950|564783606|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
156461026|NCT02497950|564783606|FG000|Overall Study|Lost to Follow-up|6|||
156461027|NCT02497950|564783606|FG000|Overall Study|Withdrawal by Subject|2|||
156461028|NCT02497950|564783606|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
156461029|NCT02497950|564783606|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
156461030|NCT04660539|564783607|FG000|Overall Study|Adverse Event|10|||
156461031|NCT04660539|564783607|FG000|Overall Study|Lack of Efficacy|4|||
156461032|NCT04660539|564783607|FG000|Overall Study|Lost to Follow-up|5|||
156461033|NCT04660539|564783607|FG000|Overall Study|Non-Compliance With Study Drug|3|||
156461034|NCT04660539|564783607|FG000|Overall Study|Reason not Specified|12|||
156461035|NCT04660539|564783607|FG000|Overall Study|Pregnancy|2|||
156461036|NCT04660539|564783607|FG000|Overall Study|Protocol Violation|2|||
156461037|NCT04660539|564783607|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
156461038|NCT04660539|564783607|FG000|Overall Study|Withdrawal by Subject|21|||
156461039|NCT04862234|564783610|FG000|Overall Study|Surgery cancellation|1|||
156809062|NCT04417257|566054569|FG000|Pilot Phase 2|Unblinding|1|||
156809063|NCT04417257|566054570|FG001|Pilot Phase 2|Unblinding|0|||
156809064|NCT04417257|566054569|FG000|Pilot Phase 2|All other|0|||
156809065|NCT04417257|566054570|FG001|Pilot Phase 2|All other|2|||
156809066|NCT04417257|566054569|FG000|Phase 3 Extension|Death|3|||
156809067|NCT04417257|566054570|FG001|Phase 3 Extension|Death|1|||
156338473|NCT02340975|564338258|FG003|Overall Study|Death|7|||
156338474|NCT02340975|564338259|FG004|Overall Study|Death|21|||
156338475|NCT02340975|564338260|FG005|Overall Study|Death|13|||
156338476|NCT02340975|564338255|FG000|Overall Study|Lost to Follow-up|0|||
156338477|NCT02340975|564338256|FG001|Overall Study|Lost to Follow-up|0|||
156338478|NCT02340975|564338257|FG002|Overall Study|Lost to Follow-up|0|||
156338479|NCT02340975|564338258|FG003|Overall Study|Lost to Follow-up|0|||
156338480|NCT02340975|564338259|FG004|Overall Study|Lost to Follow-up|2|||
156338481|NCT02340975|564338260|FG005|Overall Study|Lost to Follow-up|0|||
156338482|NCT02340975|564338255|FG000|Overall Study|Withdrawal by Subject|0|||
156338483|NCT02340975|564338256|FG001|Overall Study|Withdrawal by Subject|0|||
156338484|NCT02340975|564338257|FG002|Overall Study|Withdrawal by Subject|3|||
156338485|NCT02340975|564338258|FG003|Overall Study|Withdrawal by Subject|3|||
156338486|NCT02340975|564338259|FG004|Overall Study|Withdrawal by Subject|2|||
156338487|NCT02340975|564338260|FG005|Overall Study|Withdrawal by Subject|0|||
156338488|NCT02340975|564338255|FG000|Overall Study|Other|0|||
156338489|NCT02340975|564338256|FG001|Overall Study|Other|4|||
156338490|NCT02340975|564338257|FG002|Overall Study|Other|0|||
156338491|NCT02340975|564338258|FG003|Overall Study|Other|2|||
156338492|NCT02340975|564338259|FG004|Overall Study|Other|0|||
156338493|NCT02340975|564338260|FG005|Overall Study|Other|6|||
156338494|NCT01007812|564338261|FG000|Period 1, One Week|Lost to Follow-up|0|||
156338495|NCT01007812|564338262|FG001|Period 1, One Week|Lost to Follow-up|1|||
156338496|NCT01007812|564338261|FG000|Period 1, One Week|Discomfort|1|||
156338497|NCT01007812|564338262|FG001|Period 1, One Week|Discomfort|0|||
156338498|NCT01091974|564338263|FG000|Overall Study|Did not start intervention|3|||
156338499|NCT01091974|564338264|FG001|Overall Study|Did not start intervention|1|||
156338500|NCT01091974|564338265|FG002|Overall Study|Did not start intervention|3|||
156338501|NCT01091974|564338266|FG003|Overall Study|Did not start intervention|1|||
156338502|NCT01091974|564338263|FG000|Overall Study|resumed sleep medication|0|||
156338503|NCT01091974|564338264|FG001|Overall Study|resumed sleep medication|0|||
156338504|NCT01091974|564338265|FG002|Overall Study|resumed sleep medication|1|||
156338505|NCT01091974|564338266|FG003|Overall Study|resumed sleep medication|2|||
156338506|NCT01091974|564338263|FG000|Overall Study|Withdrawal by Subject|1|||
156338507|NCT01091974|564338264|FG001|Overall Study|Withdrawal by Subject|3|||
156338508|NCT01091974|564338265|FG002|Overall Study|Withdrawal by Subject|2|||
156338509|NCT01091974|564338266|FG003|Overall Study|Withdrawal by Subject|2|||
156338510|NCT01091974|564338263|FG000|Overall Study|side-effects|1|||
156338511|NCT01091974|564338264|FG001|Overall Study|side-effects|1|||
156338512|NCT01091974|564338265|FG002|Overall Study|side-effects|0|||
156338513|NCT01091974|564338266|FG003|Overall Study|side-effects|2|||
156338514|NCT04891978|564338267|FG000|Baseline|Protocol Violation|2|||
156338515|NCT04891978|564338268|FG001|Baseline|Protocol Violation|1|||
156338516|NCT04891978|564338269|FG002|Baseline|Protocol Violation|0|||
156338517|NCT04891978|564338267|FG000|Baseline|Missing AIRQ|1|||
156338518|NCT04891978|564338268|FG001|Baseline|Missing AIRQ|0|||
156338519|NCT04891978|564338269|FG002|Baseline|Missing AIRQ|0|||
156338520|NCT04891978|564338267|FG000|Baseline|Did not attend a baseline visit|0|||
156338521|NCT04891978|564338268|FG001|Baseline|Did not attend a baseline visit|0|||
156338522|NCT04891978|564338269|FG002|Baseline|Did not attend a baseline visit|9|||
156338523|NCT03948581|564338270|FG000|Overall Study|Lost to Follow-up|0|||
156338524|NCT03948581|564338271|FG001|Overall Study|Lost to Follow-up|1|||
156338525|NCT03068455|564338272|FG000|Pre-treatment Period|Disease progression|0|||
156338526|NCT03068455|564338273|FG001|Pre-treatment Period|Disease progression|1|||
156338527|NCT03068455|564338272|FG000|Pre-treatment Period|Participant withdrew consent|1|||
156338528|NCT03068455|564338273|FG001|Pre-treatment Period|Participant withdrew consent|1|||
156338529|NCT03068455|564338272|FG000|Pre-treatment Period|Poor/non-compliance|0|||
156338530|NCT03068455|564338273|FG001|Pre-treatment Period|Poor/non-compliance|1|||
156338531|NCT03068455|564338272|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
156461040|NCT04862234|564783611|FG001|Overall Study|Surgery cancellation|2|||
156338532|NCT03068455|564338273|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
156338533|NCT03068455|564338272|FG000|Pre-treatment Period|Not reported|2|||
156338534|NCT03068455|564338273|FG001|Pre-treatment Period|Not reported|1|||
156338535|NCT03068455|564338272|FG000|Treatment Period|Disease progression|166|||
156338536|NCT03068455|564338273|FG001|Treatment Period|Disease progression|208|||
156338537|NCT03068455|564338272|FG000|Treatment Period|Study drug toxicity|317|||
156338538|NCT03068455|564338273|FG001|Treatment Period|Study drug toxicity|104|||
156338539|NCT03068455|564338272|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
156338540|NCT03068455|564338273|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
156338541|NCT03068455|564338272|FG000|Treatment Period|Participant request to stop therapy|33|||
156338542|NCT03068455|564338273|FG001|Treatment Period|Participant request to stop therapy|20|||
156338543|NCT03068455|564338272|FG000|Treatment Period|Participant withdrew consent|5|||
156338544|NCT03068455|564338273|FG001|Treatment Period|Participant withdrew consent|10|||
156338545|NCT03068455|564338272|FG000|Treatment Period|Poor/non-compliance|3|||
156338546|NCT03068455|564338273|FG001|Treatment Period|Poor/non-compliance|0|||
156338547|NCT03068455|564338272|FG000|Treatment Period|Participant no longer meets study criteria|1|||
156461041|NCT04862234|564783610|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
156809068|NCT04417257|566054569|FG000|Phase 3 Extension|Lost to Follow-up|4|||
156809069|NCT04417257|566054570|FG001|Phase 3 Extension|Lost to Follow-up|2|||
156809070|NCT04417257|566054569|FG000|Phase 3 Extension|Patient withdrawal|2|||
156809071|NCT04417257|566054570|FG001|Phase 3 Extension|Patient withdrawal|2|||
156809072|NCT04417257|566054569|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
156809073|NCT04417257|566054570|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
156461042|NCT04862234|564783611|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
156461043|NCT04862234|564783610|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
156461044|NCT04862234|564783611|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
156461045|NCT03292484|564783612|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
156461046|NCT03292484|564783612|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
156461047|NCT03292484|564783612|FG000|Overall Study|Protocol Violation|2|||
156461048|NCT03292484|564783612|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
156461049|NCT03292484|564783612|FG000|Overall Study|Sponsor decision|349|||
156461050|NCT03292484|564783612|FG000|Overall Study|Lost to Follow-up|7|||
156461051|NCT03292484|564783612|FG000|Overall Study|Coronavirus Disease 2019|1|||
156461052|NCT03292484|564783612|FG000|Overall Study|Other|20|||
156461053|NCT05290493|564783615|FG000|Overall Study|Withdrawal by Subject|2|||
156461054|NCT05290493|564783616|FG001|Overall Study|Withdrawal by Subject|2|||
156461055|NCT05290493|564783615|FG000|Overall Study|Adverse Event|1|||
156461056|NCT05290493|564783616|FG001|Overall Study|Adverse Event|0|||
156461057|NCT05524402|564783617|FG000|Overall Study|Withdrawal by Subject|3|||
156461058|NCT05524402|564783618|FG001|Overall Study|Withdrawal by Subject|1|||
156461059|NCT05524402|564783617|FG000|Overall Study|Lost to Follow-up|2|||
156461060|NCT05524402|564783618|FG001|Overall Study|Lost to Follow-up|1|||
156461061|NCT05976334|564783619|FG000|Part B|Death|0|||
156461062|NCT05976334|564783620|FG001|Part B|Death|1|||
156461063|NCT05976334|564783619|FG000|Part B|Study Terminated by Sponsor|0|||
156461064|NCT05976334|564783620|FG001|Part B|Study Terminated by Sponsor|1|||
156461065|NCT05976334|564783619|FG000|Part B|Reason Not Specified|0|||
156461066|NCT05976334|564783620|FG001|Part B|Reason Not Specified|1|||
156461067|NCT03381586|564783621|FG000|Overall Study|Adverse Event|1|||
156461068|NCT03381586|564783622|FG001|Overall Study|Adverse Event|1|||
156461069|NCT03381586|564783621|FG000|Overall Study|Protocol Violation|1|||
156461070|NCT03381586|564783622|FG001|Overall Study|Protocol Violation|0|||
156461071|NCT03381586|564783621|FG000|Overall Study|Withdrawal by Subject|1|||
156461072|NCT03381586|564783622|FG001|Overall Study|Withdrawal by Subject|2|||
156461073|NCT05280574|564783623|FG000|Overall Study|Withdrawal by Subject|0|||
156461074|NCT05280574|564783624|FG001|Overall Study|Withdrawal by Subject|2|||
156461075|NCT05280574|564783625|FG002|Overall Study|Withdrawal by Subject|0|||
156461076|NCT05363163|564783626|FG000|Overall Study|Withdrawal by Subject|13|||
156461077|NCT05838027|564783630|FG000|Overall Study|Lost to Follow-up|5|||
156461078|NCT05838027|564783631|FG001|Overall Study|Lost to Follow-up|1|||
156461079|NCT05838027|564783630|FG000|Overall Study|Withdrawal by Subject|1|||
156461080|NCT05838027|564783631|FG001|Overall Study|Withdrawal by Subject|0|||
156461081|NCT05237284|564783632|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
156461082|NCT05237284|564783633|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
156461083|NCT05237284|564783634|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
156461084|NCT05237284|564783635|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
156461085|NCT05237284|564783632|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
156461086|NCT05237284|564783633|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
156461087|NCT05237284|564783634|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
156461088|NCT05237284|564783635|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
156461089|NCT05237284|564783632|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
156461090|NCT05237284|564783633|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
156461091|NCT05237284|564783634|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
156461092|NCT05237284|564783635|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
156461093|NCT05237284|564783632|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
156461094|NCT05237284|564783633|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
156461095|NCT05237284|564783634|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
156461096|NCT05237284|564783635|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
156461097|NCT05237284|564783632|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
156461098|NCT05237284|564783633|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
156461099|NCT05237284|564783634|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
156461100|NCT05237284|564783635|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
156461101|NCT05237284|564783632|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
156461102|NCT05237284|564783633|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
156461103|NCT05237284|564783634|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
156809074|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Death|2|||
156809075|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
156809076|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
156809077|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Physician Decision|1|||
156809078|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
156809079|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
156809080|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Adverse Event|2|||
156809081|NCT00786422|566054572|FG000|Follow-up Period|Death|1|||
156809082|NCT00786422|566054572|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
156809083|NCT03484429|566054573|FG000|Overall Study|Withdrawal by Subject|1|||
156809084|NCT03484429|566054574|FG001|Overall Study|Withdrawal by Subject|0|||
156809085|NCT03484429|566054573|FG000|Overall Study|Adverse Event|2|||
156809086|NCT03484429|566054574|FG001|Overall Study|Adverse Event|0|||
156809087|NCT04466384|566054575|FG000|First Phase|Protocol Violation|1|||
156809088|NCT04466384|566054576|FG001|First Phase|Protocol Violation|0|||
156809089|NCT04466384|566054575|FG000|First Phase|Missing data|1|||
156809090|NCT04466384|566054576|FG001|First Phase|Missing data|0|||
156809091|NCT04466384|566054575|FG000|Cross Over Phase|Physician Decision|1|||
156809092|NCT04466384|566054576|FG001|Cross Over Phase|Physician Decision|0|||
156809093|NCT04466384|566054575|FG000|Cross Over Phase|Withdrawal by Subject|0|||
156809094|NCT04466384|566054576|FG001|Cross Over Phase|Withdrawal by Subject|1|||
156338548|NCT03068455|564338273|FG001|Treatment Period|Participant no longer meets study criteria|3|||
156338549|NCT03068455|564338272|FG000|Treatment Period|Other reasons|12|||
156338550|NCT03068455|564338273|FG001|Treatment Period|Other reasons|4|||
156338551|NCT01876420|564338276|FG000|Overall Study|Missed 30 day visit|1|||
156338552|NCT01042678|564338277|FG000|Overall Study|Physician Decision|1|||
156338553|NCT01042678|564338278|FG001|Overall Study|Physician Decision|0|||
156338554|NCT01042678|564338279|FG002|Overall Study|Physician Decision|0|||
156338555|NCT01042678|564338280|FG003|Overall Study|Physician Decision|0|||
156338556|NCT01042678|564338281|FG004|Overall Study|Physician Decision|0|||
156338557|NCT01042678|564338282|FG005|Overall Study|Physician Decision|0|||
156338558|NCT00205881|564338289|FG000|Overall Study|Withdrawal by Subject|16|||
156338559|NCT03546062|564338293|FG000|Overall Study|Adverse Event|6|||
156338560|NCT03546062|564338294|FG001|Overall Study|Adverse Event|5|||
156338561|NCT03546062|564338295|FG002|Overall Study|Adverse Event|8|||
156338562|NCT00181155|564338296|FG000|Overall Study|Physician Decision|1|||
156338563|NCT00181155|564338297|FG001|Overall Study|Physician Decision|0|||
156338564|NCT00181155|564338296|FG000|Overall Study|Withdrawal by Subject|1|||
156338565|NCT00181155|564338297|FG001|Overall Study|Withdrawal by Subject|0|||
156338566|NCT02083965|564338298|FG000|Treatment Period|Other|1|||
156338567|NCT02083965|564338299|FG001|Treatment Period|Other|0|||
156338568|NCT00282984|564338301|FG000|Overall Study|Death|2|||
156338569|NCT00282984|564338302|FG001|Overall Study|Death|5|||
156338570|NCT00282984|564338301|FG000|Overall Study|Adverse Event|8|||
156338571|NCT00282984|564338302|FG001|Overall Study|Adverse Event|5|||
156338572|NCT00282984|564338301|FG000|Overall Study|Lack of Efficacy|0|||
156338573|NCT00282984|564338302|FG001|Overall Study|Lack of Efficacy|2|||
156338574|NCT00282984|564338301|FG000|Overall Study|Lost to Follow-up|14|||
156338575|NCT00282984|564338302|FG001|Overall Study|Lost to Follow-up|10|||
156338576|NCT00282984|564338301|FG000|Overall Study|Withdrawal by Participant|22|||
156338577|NCT00282984|564338302|FG001|Overall Study|Withdrawal by Participant|34|||
156338578|NCT00282984|564338301|FG000|Overall Study|Participant stopped study medication|2|||
156338579|NCT00282984|564338302|FG001|Overall Study|Participant stopped study medication|2|||
156338580|NCT00282984|564338301|FG000|Overall Study|Participant only allowed phone follow-up|0|||
156338581|NCT00282984|564338302|FG001|Overall Study|Participant only allowed phone follow-up|1|||
156338582|NCT00282984|564338301|FG000|Overall Study|Participant used antipsychosis meds|0|||
156338583|NCT00282984|564338302|FG001|Overall Study|Participant used antipsychosis meds|1|||
156809095|NCT00714948|566054579|FG000|Overall Study|Adverse Event|2|||
156809096|NCT02454530|566054584|FG000|Overall Study|Other|8|||
156809097|NCT02454530|566054585|FG001|Overall Study|Other|13|||
156338584|NCT00282984|564338301|FG000|Overall Study|lack of motivation|1|||
156338585|NCT00282984|564338302|FG001|Overall Study|lack of motivation|0|||
156809098|NCT02454530|566054584|FG000|Overall Study|Missing information|56|||
156809099|NCT02454530|566054585|FG001|Overall Study|Missing information|69|||
156338586|NCT00282984|564338301|FG000|Overall Study|in prison|0|||
156338587|NCT00282984|564338302|FG001|Overall Study|in prison|1|||
156338588|NCT00282984|564338301|FG000|Overall Study|Protocol Violation|2|||
156338589|NCT00282984|564338302|FG001|Overall Study|Protocol Violation|0|||
156809100|NCT02454530|566054584|FG000|Overall Study|Death|2|||
156809101|NCT02454530|566054585|FG001|Overall Study|Death|41|||
156809102|NCT02454530|566054584|FG000|Overall Study|Lost to Follow-up|4|||
156809103|NCT02454530|566054585|FG001|Overall Study|Lost to Follow-up|4|||
156809104|NCT00326001|566054586|FG000|Overall Study|Adverse Event|4|||
156809105|NCT00326001|566054587|FG001|Overall Study|Adverse Event|5|||
156809106|NCT00326001|566054586|FG000|Overall Study|Physician Decision|3|||
156809107|NCT00326001|566054587|FG001|Overall Study|Physician Decision|3|||
156809108|NCT01234480|566055685|FG000|Overall Study|Pregnancy|88|||
156809109|NCT01234480|566055685|FG000|Overall Study|>36/Normal History|50|||
156809110|NCT01234480|566055685|FG000|Overall Study|Age|3|||
156809111|NCT01234480|566055685|FG000|Overall Study|HPV Vaccine History|28|||
156809112|NCT01234480|566055685|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
156809113|NCT01234480|566055685|FG000|Overall Study|Hysterectomy|2|||
156809114|NCT01234480|566055685|FG000|Overall Study|Hysterectomy post enrollment|1|||
156338590|NCT00868608|564338303|FG000|Overall Study|Withdrawal by Subject|3|||
156338591|NCT00868608|564338304|FG001|Overall Study|Withdrawal by Subject|1|||
156338592|NCT00868608|564338305|FG002|Overall Study|Withdrawal by Subject|0|||
156338593|NCT00868608|564338303|FG000|Overall Study|Lost to Follow-up|3|||
156338594|NCT00868608|564338304|FG001|Overall Study|Lost to Follow-up|0|||
156338595|NCT00868608|564338305|FG002|Overall Study|Lost to Follow-up|1|||
156338596|NCT00868608|564338303|FG000|Overall Study|Death|16|||
156338597|NCT00868608|564338304|FG001|Overall Study|Death|2|||
156338598|NCT00868608|564338305|FG002|Overall Study|Death|4|||
156338599|NCT00868608|564338303|FG000|Overall Study|Other - Unspecified|1|||
156338600|NCT00868608|564338304|FG001|Overall Study|Other - Unspecified|0|||
156338601|NCT00868608|564338305|FG002|Overall Study|Other - Unspecified|0|||
156338602|NCT00911547|564338306|FG000|Overall Study|Adverse Event|8|||
156338603|NCT00911547|564338307|FG001|Overall Study|Adverse Event|27|||
156338604|NCT00911547|564338308|FG002|Overall Study|Adverse Event|11|||
156338605|NCT00911547|564338309|FG003|Overall Study|Adverse Event|6|||
156338606|NCT00911547|564338306|FG000|Overall Study|Lost to Follow-up|0|||
156338607|NCT00911547|564338307|FG001|Overall Study|Lost to Follow-up|0|||
156338608|NCT00911547|564338308|FG002|Overall Study|Lost to Follow-up|2|||
156338609|NCT00911547|564338309|FG003|Overall Study|Lost to Follow-up|1|||
156338610|NCT00911547|564338306|FG000|Overall Study|Protocol Violation|0|||
156338611|NCT00911547|564338307|FG001|Overall Study|Protocol Violation|5|||
156338612|NCT00911547|564338308|FG002|Overall Study|Protocol Violation|5|||
156338613|NCT00911547|564338309|FG003|Overall Study|Protocol Violation|1|||
156338614|NCT00911547|564338306|FG000|Overall Study|Withdrawal by Subject|3|||
156338615|NCT00911547|564338307|FG001|Overall Study|Withdrawal by Subject|10|||
156338616|NCT00911547|564338308|FG002|Overall Study|Withdrawal by Subject|4|||
156338617|NCT00911547|564338309|FG003|Overall Study|Withdrawal by Subject|8|||
156809115|NCT01234480|566055685|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
156338618|NCT00457301|564338310|FG000|Overall Study|Withdrawal by Subject|3|||
156338619|NCT00457301|564338311|FG001|Overall Study|Withdrawal by Subject|3|||
156809116|NCT01234480|566055685|FG000|Overall Study|Informed Consent Form Violation|30|||
156338620|NCT00457301|564338310|FG000|Overall Study|Censored out of the study|15|||
156338621|NCT00457301|564338311|FG001|Overall Study|Censored out of the study|14|||
156338622|NCT00457301|564338310|FG000|Overall Study|Death|5|||
156338623|NCT00457301|564338311|FG001|Overall Study|Death|7|||
156338624|NCT00191269|564338312|FG000|Overall Study|Protocol Violation|0|||
156338625|NCT00191269|564338313|FG001|Overall Study|Protocol Violation|2|||
156338626|NCT00191269|564338312|FG000|Overall Study|Adverse Event|1|||
156338627|NCT00191269|564338313|FG001|Overall Study|Adverse Event|4|||
156338628|NCT00191269|564338312|FG000|Overall Study|Progression of Disease|4|||
156809117|NCT01234480|566055685|FG000|Overall Study|Incorrect Visit|3|||
156809118|NCT01234480|566055685|FG000|Overall Study|No Florida Lab License|20|||
156809119|NCT01234480|566055685|FG000|Overall Study|Out of Window|42|||
156809120|NCT01234480|566055685|FG000|Overall Study|Sample Processing/Storage|92|||
156809121|NCT01234480|566055685|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
156809122|NCT01234480|566055685|FG000|Overall Study|Site/Subject non-compliance|44|||
156809123|NCT01234480|566055685|FG000|Overall Study|Missing Sample|9|||
156809124|NCT01897727|566055686|FG000|Overall Study|Exclusion: central sleep apnea|0|||
156809125|NCT01897727|566055687|FG001|Overall Study|Exclusion: central sleep apnea|1|||
156809126|NCT01465386|566055692|FG000|Overall Study|Lack of Efficacy|3|||
156809127|NCT01465386|566055692|FG000|Overall Study|Adverse Event|1|||
156809128|NCT02479880|566055693|FG000|Overall Study|Study Terminated by Sponsor|13|||
156809129|NCT02479880|566055694|FG001|Overall Study|Study Terminated by Sponsor|12|||
156809130|NCT02479880|566055693|FG000|Overall Study|Pregnancy|0|||
156809131|NCT02479880|566055694|FG001|Overall Study|Pregnancy|1|||
156809132|NCT01279044|566055695|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
156809133|NCT01279044|566055696|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
156809134|NCT01279044|566055697|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
156809135|NCT01279044|566055695|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
156461104|NCT05237284|564783635|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
156461105|NCT05237284|564783632|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
156461106|NCT05237284|564783633|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
156461107|NCT05237284|564783634|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
156461108|NCT05237284|564783635|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
156461109|NCT05237284|564783632|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
156461110|NCT05237284|564783633|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
156461111|NCT05237284|564783634|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
156461112|NCT05237284|564783635|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
156461113|NCT05237284|564783632|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
156461114|NCT05237284|564783633|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
156461115|NCT05237284|564783634|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
156461116|NCT05237284|564783635|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
156461117|NCT04999111|564783636|FG000|Overall Study|Lost to Follow-up|21|||
156461118|NCT04999111|564783637|FG001|Overall Study|Lost to Follow-up|16|||
156461119|NCT04999111|564783638|FG002|Overall Study|Lost to Follow-up|2|||
156461120|NCT04999111|564783639|FG003|Overall Study|Lost to Follow-up|26|||
156461121|NCT04999111|564783640|FG004|Overall Study|Lost to Follow-up|30|||
156461122|NCT04999111|564783641|FG005|Overall Study|Lost to Follow-up|6|||
156461123|NCT04999111|564783636|FG000|Overall Study|Physician Decision|1|||
156461124|NCT04999111|564783637|FG001|Overall Study|Physician Decision|3|||
156461125|NCT04999111|564783638|FG002|Overall Study|Physician Decision|0|||
156461126|NCT04999111|564783639|FG003|Overall Study|Physician Decision|1|||
156461127|NCT04999111|564783640|FG004|Overall Study|Physician Decision|2|||
156461128|NCT04999111|564783641|FG005|Overall Study|Physician Decision|0|||
156461129|NCT04999111|564783636|FG000|Overall Study|Withdrawal by Subject|23|||
156461130|NCT04999111|564783637|FG001|Overall Study|Withdrawal by Subject|29|||
156461131|NCT04999111|564783638|FG002|Overall Study|Withdrawal by Subject|15|||
156461132|NCT04999111|564783639|FG003|Overall Study|Withdrawal by Subject|30|||
156461133|NCT04999111|564783640|FG004|Overall Study|Withdrawal by Subject|35|||
156461134|NCT04999111|564783641|FG005|Overall Study|Withdrawal by Subject|10|||
156461135|NCT04999111|564783636|FG000|Overall Study|Other|6|||
156461136|NCT04999111|564783637|FG001|Overall Study|Other|6|||
156461137|NCT04999111|564783638|FG002|Overall Study|Other|3|||
156461138|NCT04999111|564783639|FG003|Overall Study|Other|8|||
156461139|NCT04999111|564783640|FG004|Overall Study|Other|8|||
156461140|NCT04999111|564783641|FG005|Overall Study|Other|5|||
156461141|NCT04999111|564783636|FG000|Overall Study|Non-compliance with study schedule|1|||
156461142|NCT04999111|564783637|FG001|Overall Study|Non-compliance with study schedule|0|||
156461143|NCT04999111|564783638|FG002|Overall Study|Non-compliance with study schedule|0|||
156461144|NCT04999111|564783639|FG003|Overall Study|Non-compliance with study schedule|1|||
156461145|NCT04999111|564783640|FG004|Overall Study|Non-compliance with study schedule|1|||
156461146|NCT04999111|564783641|FG005|Overall Study|Non-compliance with study schedule|1|||
156461147|NCT04999111|564783636|FG000|Overall Study|Randomized but not vaccinated|1|||
156461148|NCT04999111|564783637|FG001|Overall Study|Randomized but not vaccinated|2|||
156461149|NCT04999111|564783638|FG002|Overall Study|Randomized but not vaccinated|0|||
156461150|NCT04999111|564783639|FG003|Overall Study|Randomized but not vaccinated|3|||
156461151|NCT04999111|564783640|FG004|Overall Study|Randomized but not vaccinated|3|||
156461152|NCT04999111|564783641|FG005|Overall Study|Randomized but not vaccinated|0|||
156461153|NCT04999111|564783636|FG000|Overall Study|Adverse Event|1|||
156461154|NCT04999111|564783637|FG001|Overall Study|Adverse Event|1|||
156461155|NCT04999111|564783638|FG002|Overall Study|Adverse Event|0|||
156461156|NCT04999111|564783639|FG003|Overall Study|Adverse Event|0|||
156461157|NCT04999111|564783640|FG004|Overall Study|Adverse Event|0|||
156461158|NCT04999111|564783641|FG005|Overall Study|Adverse Event|0|||
156809136|NCT01279044|566055696|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
156809137|NCT01279044|566055697|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
156809138|NCT01279044|566055695|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
156809139|NCT01279044|566055696|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
156809140|NCT01279044|566055697|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
156809141|NCT02840253|566055700|FG000|Overall Study|Unsuccessful block|4|||
156809142|NCT00564733|566055703|FG000|Overall Study|Withdrawal by Subject|4|||
156809143|NCT00564733|566055703|FG000|Overall Study|Ineligible|5|||
156809144|NCT01456130|566055706|FG000|Overall Study|Adverse Event|4|||
156809145|NCT01456130|566055706|FG000|Overall Study|Voluntary Withdrawal|1|||
156809146|NCT01456130|566055706|FG000|Overall Study|Lack of Efficacy|4|||
156809147|NCT01456130|566055706|FG000|Overall Study|Other|1|||
156809148|NCT01135459|566055707|FG000|Overall Study|Adverse Event|8|||
156538346|NCT04376827|565064680|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
156538347|NCT04376827|565064681|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
156538348|NCT03697720|565066248|FG000|Overall Study|Lost to Follow-up|7|||
156538349|NCT03496012|565066249|FG000|Overall Study|Withdrawal by Subject|2|||
156538350|NCT03496012|565066250|FG001|Overall Study|Withdrawal by Subject|0|||
156538351|NCT03496012|565066251|FG002|Overall Study|Withdrawal by Subject|2|||
156538352|NCT03496012|565066249|FG000|Overall Study|Adverse Event|0|||
156538353|NCT03496012|565066250|FG001|Overall Study|Adverse Event|0|||
156538354|NCT03496012|565066251|FG002|Overall Study|Adverse Event|1|||
156538355|NCT03496012|565066249|FG000|Overall Study|Reason Not Specified|2|||
156538356|NCT03496012|565066250|FG001|Overall Study|Reason Not Specified|0|||
156538357|NCT03496012|565066251|FG002|Overall Study|Reason Not Specified|1|||
156538358|NCT01490450|565066254|FG000|Period 1|Lack of Efficacy|2|||
156538359|NCT01490450|565066255|FG001|Period 1|Lack of Efficacy|0|||
156538360|NCT01490450|565066256|FG002|Period 1|Lack of Efficacy|3|||
156538361|NCT01490450|565066257|FG003|Period 1|Lack of Efficacy|0|||
156538362|NCT01490450|565066254|FG000|Period 1|Adverse Event|0|||
156538363|NCT01490450|565066255|FG001|Period 1|Adverse Event|0|||
156538364|NCT01490450|565066256|FG002|Period 1|Adverse Event|0|||
156538365|NCT01490450|565066257|FG003|Period 1|Adverse Event|5|||
156538366|NCT01490450|565066254|FG000|Period 1|Request to discontinue treatment|1|||
156538367|NCT01490450|565066255|FG001|Period 1|Request to discontinue treatment|0|||
156538368|NCT01490450|565066256|FG002|Period 1|Request to discontinue treatment|0|||
156538369|NCT01490450|565066257|FG003|Period 1|Request to discontinue treatment|0|||
156538370|NCT01490450|565066254|FG000|Period 1|Withdrawal by Subject|0|||
156538371|NCT01490450|565066255|FG001|Period 1|Withdrawal by Subject|0|||
156538372|NCT01490450|565066256|FG002|Period 1|Withdrawal by Subject|0|||
156538373|NCT01490450|565066257|FG003|Period 1|Withdrawal by Subject|3|||
156538374|NCT01490450|565066254|FG000|Period 1|No longer met study criteria|0|||
156538375|NCT01490450|565066255|FG001|Period 1|No longer met study criteria|1|||
156538376|NCT01490450|565066256|FG002|Period 1|No longer met study criteria|1|||
156538377|NCT01490450|565066257|FG003|Period 1|No longer met study criteria|0|||
156538378|NCT01490450|565066254|FG000|Period 2|Lack of Efficacy|0|||
156538379|NCT01490450|565066255|FG001|Period 2|Lack of Efficacy|0|||
156538380|NCT01490450|565066256|FG002|Period 2|Lack of Efficacy|0|||
156538381|NCT01490450|565066257|FG003|Period 2|Lack of Efficacy|1|||
156538382|NCT01490450|565066254|FG000|Period 2|Adverse Event|1|||
156538383|NCT01490450|565066255|FG001|Period 2|Adverse Event|1|||
156538384|NCT01490450|565066256|FG002|Period 2|Adverse Event|0|||
156538385|NCT01490450|565066257|FG003|Period 2|Adverse Event|1|||
156538386|NCT01490450|565066254|FG000|Period 2|Withdrawal by Subject|1|||
156538387|NCT01490450|565066255|FG001|Period 2|Withdrawal by Subject|0|||
156538388|NCT01490450|565066256|FG002|Period 2|Withdrawal by Subject|0|||
156538389|NCT01490450|565066257|FG003|Period 2|Withdrawal by Subject|0|||
156538390|NCT01490450|565066254|FG000|Period 2|Lost to Follow-up|0|||
156538391|NCT01490450|565066255|FG001|Period 2|Lost to Follow-up|0|||
156538392|NCT01490450|565066256|FG002|Period 2|Lost to Follow-up|0|||
156538393|NCT01490450|565066257|FG003|Period 2|Lost to Follow-up|2|||
156538394|NCT00404820|565066258|FG000|Overall Study|Adverse Event|4|||
156538395|NCT00404820|565066259|FG001|Overall Study|Adverse Event|16|||
156538396|NCT00404820|565066258|FG000|Overall Study|Withdrawal by Subject|5|||
156538397|NCT00404820|565066259|FG001|Overall Study|Withdrawal by Subject|3|||
156538398|NCT00404820|565066258|FG000|Overall Study|Lost to Follow-up|7|||
156809149|NCT01135459|566055708|FG001|Overall Study|Adverse Event|10|||
156809150|NCT01135459|566055707|FG000|Overall Study|Lack of Efficacy|3|||
156809151|NCT01135459|566055708|FG001|Overall Study|Lack of Efficacy|1|||
156809152|NCT01135459|566055707|FG000|Overall Study|Withdrawal by Subject|2|||
156338629|NCT00191269|564338313|FG001|Overall Study|Progression of Disease|42|||
156538399|NCT00404820|565066259|FG001|Overall Study|Lost to Follow-up|3|||
156538400|NCT00404820|565066258|FG000|Overall Study|Administrative problems|2|||
156538401|NCT00404820|565066259|FG001|Overall Study|Administrative problems|0|||
156538402|NCT00404820|565066258|FG000|Overall Study|Death|1|||
156538403|NCT00404820|565066259|FG001|Overall Study|Death|0|||
156538404|NCT00404820|565066258|FG000|Overall Study|Other|0|||
156538405|NCT00404820|565066259|FG001|Overall Study|Other|2|||
156538406|NCT00938717|565066260|FG000|Overall Study|Adverse Event|10|||
156538407|NCT00938717|565066261|FG001|Overall Study|Adverse Event|41|||
156538408|NCT00938717|565066260|FG000|Overall Study|Protocol Violation|11|||
156461159|NCT04999111|564783636|FG000|Overall Study|Initiated prohibited medication|0|||
156461160|NCT04999111|564783637|FG001|Overall Study|Initiated prohibited medication|0|||
156461161|NCT04999111|564783638|FG002|Overall Study|Initiated prohibited medication|0|||
156461162|NCT04999111|564783639|FG003|Overall Study|Initiated prohibited medication|0|||
156461163|NCT04999111|564783640|FG004|Overall Study|Initiated prohibited medication|1|||
156461164|NCT04999111|564783641|FG005|Overall Study|Initiated prohibited medication|0|||
156461165|NCT04056611|564783648|FG000|Overall Study|Physician Decision|1|||
156461166|NCT03213873|564783649|FG000|Overall Study|Withdrawal by Subject|8|||
156461167|NCT03213873|564783650|FG001|Overall Study|Withdrawal by Subject|9|||
156461168|NCT03213873|564783649|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
156461169|NCT03213873|564783650|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
156461170|NCT03213873|564783649|FG000|Overall Study|Lost to Follow-up|0|||
156461171|NCT03213873|564783650|FG001|Overall Study|Lost to Follow-up|2|||
156461172|NCT04709419|564783651|FG000|Overall Study|Physician Decision|1|||
156461173|NCT04709419|564783652|FG001|Overall Study|Physician Decision|0|||
156461174|NCT05683340|564783653|FG000|Overall Study|Adverse Event|1|||
156461175|NCT05683340|564783654|FG001|Overall Study|Adverse Event|1|||
156461176|NCT05683340|564783653|FG000|Overall Study|Protocol Violation|1|||
156461177|NCT05683340|564783654|FG001|Overall Study|Protocol Violation|0|||
156461178|NCT05683340|564783653|FG000|Overall Study|Withdrawal by Subject|0|||
156461179|NCT05683340|564783654|FG001|Overall Study|Withdrawal by Subject|2|||
156461180|NCT02437136|564783655|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
156461181|NCT02437136|564783656|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
156461182|NCT02437136|564783657|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
156461183|NCT02437136|564783658|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
156461184|NCT02437136|564783659|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
156461185|NCT02437136|564783660|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
156461186|NCT02437136|564783661|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
156461187|NCT02437136|564783655|FG000|Expansion (Phase 2)|Death|0|||
156461188|NCT02437136|564783656|FG001|Expansion (Phase 2)|Death|0|||
156461189|NCT02437136|564783657|FG002|Expansion (Phase 2)|Death|0|||
156461190|NCT02437136|564783658|FG003|Expansion (Phase 2)|Death|6|||
156461191|NCT02437136|564783659|FG004|Expansion (Phase 2)|Death|37|||
156461192|NCT02437136|564783660|FG005|Expansion (Phase 2)|Death|29|||
156461193|NCT02437136|564783661|FG006|Expansion (Phase 2)|Death|24|||
156461194|NCT02437136|564783655|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
156461195|NCT02437136|564783656|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
156461196|NCT02437136|564783657|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
156461197|NCT02437136|564783658|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
156461198|NCT02437136|564783659|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
156461199|NCT02437136|564783660|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
156461200|NCT02437136|564783661|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
156461201|NCT02437136|564783655|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
156461202|NCT02437136|564783656|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
156461203|NCT02437136|564783657|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
156461204|NCT02437136|564783658|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
156461205|NCT02437136|564783659|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
156461206|NCT02437136|564783660|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
156461207|NCT02437136|564783661|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
156461208|NCT02056834|564783664|FG000|Overall Study|Lost to Follow-up|7|||
156461209|NCT03276676|564783669|FG000|Overall Study|Withdrawal by Subject|2|||
156461210|NCT03276676|564783670|FG001|Overall Study|Withdrawal by Subject|1|||
156461211|NCT03583333|564783679|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
156461212|NCT03583333|564783680|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
156461213|NCT03583333|564783679|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
156461214|NCT03583333|564783680|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
156461215|NCT03583333|564783679|FG000|Overall Study|Withdrawal by Subject|9|||
156461216|NCT03583333|564783680|FG001|Overall Study|Withdrawal by Subject|5|||
156461217|NCT03583333|564783679|FG000|Overall Study|Physician Decision|3|||
156461218|NCT03583333|564783680|FG001|Overall Study|Physician Decision|2|||
156461219|NCT03583333|564783679|FG000|Overall Study|Death|12|||
156538409|NCT00938717|565066261|FG001|Overall Study|Protocol Violation|8|||
156461220|NCT03583333|564783680|FG001|Overall Study|Death|7|||
156461221|NCT03926130|564783681|FG000|Overall Study|Adverse Event|9|||
156461222|NCT03926130|564783682|FG001|Overall Study|Adverse Event|11|||
156461223|NCT03926130|564783683|FG002|Overall Study|Adverse Event|2|||
156461224|NCT03926130|564783684|FG003|Overall Study|Adverse Event|0|||
156461225|NCT03926130|564783681|FG000|Overall Study|Death|2|||
156461226|NCT03926130|564783682|FG001|Overall Study|Death|0|||
156461227|NCT03926130|564783683|FG002|Overall Study|Death|1|||
156461228|NCT03926130|564783684|FG003|Overall Study|Death|0|||
156461229|NCT03926130|564783681|FG000|Overall Study|Lack of Efficacy|14|||
156538410|NCT00938717|565066260|FG000|Overall Study|Withdrawal by Subject|26|||
156538411|NCT00938717|565066261|FG001|Overall Study|Withdrawal by Subject|24|||
156538412|NCT00938717|565066260|FG000|Overall Study|Lost to Follow-up|13|||
156538413|NCT00938717|565066261|FG001|Overall Study|Lost to Follow-up|18|||
156538414|NCT00938717|565066260|FG000|Overall Study|Lack of Efficacy|33|||
156538415|NCT00938717|565066261|FG001|Overall Study|Lack of Efficacy|15|||
156538416|NCT00938717|565066260|FG000|Overall Study|Other reason|5|||
156538417|NCT00938717|565066261|FG001|Overall Study|Other reason|2|||
156538418|NCT00096785|565066263|FG000|Overall Study|Lost to Follow-up|1|||
156538419|NCT00096785|565066264|FG001|Overall Study|Lost to Follow-up|0|||
156538420|NCT00096785|565066263|FG000|Overall Study|Withdrawal by Subject|0|||
156538421|NCT00096785|565066264|FG001|Overall Study|Withdrawal by Subject|1|||
156538422|NCT00096785|565066263|FG000|Overall Study|Relocated|1|||
156809153|NCT01135459|566055708|FG001|Overall Study|Withdrawal by Subject|3|||
156809154|NCT01135459|566055707|FG000|Overall Study|Protocol Violation|5|||
156809155|NCT01135459|566055708|FG001|Overall Study|Protocol Violation|3|||
156809156|NCT01135459|566055707|FG000|Overall Study|Lost to Follow-up|2|||
156809157|NCT01135459|566055708|FG001|Overall Study|Lost to Follow-up|1|||
156809158|NCT01135459|566055707|FG000|Overall Study|Non-compliance to study procedures|0|||
156809159|NCT01135459|566055708|FG001|Overall Study|Non-compliance to study procedures|1|||
156809160|NCT01135459|566055707|FG000|Overall Study|Other than specified|1|||
156809161|NCT01135459|566055708|FG001|Overall Study|Other than specified|1|||
156809162|NCT02236572|566055710|FG000|Overall Study|Withdrawal by Subject|1|||
156809163|NCT02236572|566055710|FG000|Overall Study|Protocol Violation|1|||
156809164|NCT02236572|566055710|FG000|Overall Study|Lost to Follow-up|1|||
156809165|NCT03465722|566055713|FG000|Overall Study|Withdrawal by Subject|21|||
156809166|NCT03465722|566055714|FG001|Overall Study|Withdrawal by Subject|14|||
156809167|NCT03465722|566055713|FG000|Overall Study|Death|89|||
156809168|NCT03465722|566055714|FG001|Overall Study|Death|87|||
156809169|NCT03465722|566055713|FG000|Overall Study|Lost to Follow-up|5|||
156809170|NCT03465722|566055714|FG001|Overall Study|Lost to Follow-up|3|||
156809171|NCT03465722|566055713|FG000|Overall Study|Administrative/Other|33|||
156809172|NCT03465722|566055714|FG001|Overall Study|Administrative/Other|32|||
156809173|NCT03465722|566055713|FG000|Overall Study|Not treated|1|||
156809174|NCT03465722|566055714|FG001|Overall Study|Not treated|2|||
156809175|NCT03465722|566055713|FG000|Overall Study|Sponsor decision|91|||
156809176|NCT03465722|566055714|FG001|Overall Study|Sponsor decision|98|||
156809177|NCT02948582|566055715|FG000|Washout Period 1|Adverse Event|0|||
156809178|NCT02948582|566055716|FG001|Washout Period 1|Adverse Event|2|||
156809179|NCT02948582|566055717|FG002|Washout Period 1|Adverse Event|0|||
156809180|NCT02948582|566055718|FG003|Washout Period 1|Adverse Event|0|||
156809181|NCT02948582|566055719|FG004|Washout Period 1|Adverse Event|0|||
156809182|NCT02948582|566055720|FG005|Washout Period 1|Adverse Event|0|||
156809183|NCT02948582|566055715|FG000|Washout Period 1|Protocol Violation|0|||
156809184|NCT02948582|566055716|FG001|Washout Period 1|Protocol Violation|0|||
156809185|NCT02948582|566055717|FG002|Washout Period 1|Protocol Violation|0|||
156809186|NCT02948582|566055718|FG003|Washout Period 1|Protocol Violation|0|||
156809187|NCT02948582|566055719|FG004|Washout Period 1|Protocol Violation|0|||
156809188|NCT02948582|566055720|FG005|Washout Period 1|Protocol Violation|1|||
156809189|NCT02948582|566055715|FG000|Washout Period 2|Adverse Event|0|||
156461230|NCT03926130|564783682|FG001|Overall Study|Lack of Efficacy|11|||
156538423|NCT00096785|565066264|FG001|Overall Study|Relocated|0|||
156538424|NCT01838616|565066265|FG000|Titration Period|Adverse Event|18|||
156538425|NCT01838616|565066266|FG001|Titration Period|Adverse Event|48|||
156809190|NCT02948582|566055716|FG001|Washout Period 2|Adverse Event|1|||
156809191|NCT02948582|566055717|FG002|Washout Period 2|Adverse Event|0|||
156809192|NCT02948582|566055718|FG003|Washout Period 2|Adverse Event|0|||
156809193|NCT02948582|566055719|FG004|Washout Period 2|Adverse Event|0|||
156809194|NCT02948582|566055720|FG005|Washout Period 2|Adverse Event|0|||
156809195|NCT02948582|566055715|FG000|Washout Period 2|personal reasons|0|||
156809196|NCT02948582|566055716|FG001|Washout Period 2|personal reasons|0|||
156809197|NCT02948582|566055717|FG002|Washout Period 2|personal reasons|0|||
156809198|NCT02948582|566055718|FG003|Washout Period 2|personal reasons|1|||
156809199|NCT02948582|566055719|FG004|Washout Period 2|personal reasons|0|||
156809200|NCT02948582|566055720|FG005|Washout Period 2|personal reasons|0|||
156809201|NCT02948582|566055715|FG000|Washout Period 4|Adverse Event|1|||
156809202|NCT02948582|566055716|FG001|Washout Period 4|Adverse Event|0|||
156461231|NCT03926130|564783683|FG002|Overall Study|Lack of Efficacy|7|||
156461232|NCT03926130|564783684|FG003|Overall Study|Lack of Efficacy|1|||
156538426|NCT01838616|565066265|FG000|Titration Period|Lack of Efficacy|5|||
156809203|NCT02948582|566055717|FG002|Washout Period 4|Adverse Event|1|||
156809204|NCT02948582|566055718|FG003|Washout Period 4|Adverse Event|0|||
156809205|NCT02948582|566055719|FG004|Washout Period 4|Adverse Event|0|||
156809206|NCT02948582|566055720|FG005|Washout Period 4|Adverse Event|0|||
156809207|NCT00955474|566055728|FG000|Overall Study|Physician Decision|7|||
156809208|NCT00955474|566055729|FG001|Overall Study|Physician Decision|5|||
156809209|NCT04721158|566055731|FG000|Overall Study|Lost to Follow-up|4|||
156809210|NCT04721158|566055731|FG000|Overall Study|Device did not connect|1|||
156809211|NCT02382991|566055732|FG000|Overall Study|Adverse Event|1|||
156809212|NCT02382991|566055733|FG001|Overall Study|Adverse Event|2|||
156809213|NCT02382991|566055732|FG000|Overall Study|Lost to Follow-up|1|||
156809214|NCT02382991|566055733|FG001|Overall Study|Lost to Follow-up|0|||
156809215|NCT02382991|566055732|FG000|Overall Study|Withdrawal by Subject|0|||
156809216|NCT02382991|566055733|FG001|Overall Study|Withdrawal by Subject|1|||
156809217|NCT04162470|566055734|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
156809218|NCT03929913|566055737|FG000|Overall Study|Death|4|||
156809219|NCT03929913|566055737|FG000|Overall Study|Lost to Follow-up|1|||
156809220|NCT03929913|566055737|FG000|Overall Study|Failed Procedure|2|||
156809221|NCT03919929|566055740|FG000|Overall Study|Withdrawal by Subject|0|||
156809222|NCT03919929|566055741|FG001|Overall Study|Withdrawal by Subject|4|||
156809223|NCT03919929|566055740|FG000|Overall Study|Screen Failure|0|||
156809224|NCT03919929|566055741|FG001|Overall Study|Screen Failure|5|||
156809225|NCT04570384|566055744|FG000|Overall Study|Adverse Event|2|||
156461233|NCT03926130|564783681|FG000|Overall Study|Lost to Follow-up|0|||
156461234|NCT03926130|564783682|FG001|Overall Study|Lost to Follow-up|7|||
156461235|NCT03926130|564783683|FG002|Overall Study|Lost to Follow-up|1|||
156461236|NCT03926130|564783684|FG003|Overall Study|Lost to Follow-up|0|||
156461237|NCT03926130|564783681|FG000|Overall Study|As Reported by Investigator|2|||
156461238|NCT03926130|564783682|FG001|Overall Study|As Reported by Investigator|6|||
156461239|NCT03926130|564783683|FG002|Overall Study|As Reported by Investigator|6|||
156461240|NCT03926130|564783684|FG003|Overall Study|As Reported by Investigator|0|||
156461241|NCT03926130|564783681|FG000|Overall Study|Physician Decision|3|||
156461242|NCT03926130|564783682|FG001|Overall Study|Physician Decision|2|||
156461243|NCT03926130|564783683|FG002|Overall Study|Physician Decision|1|||
156461244|NCT03926130|564783684|FG003|Overall Study|Physician Decision|0|||
156461245|NCT03926130|564783681|FG000|Overall Study|Pregnancy|2|||
156461246|NCT03926130|564783682|FG001|Overall Study|Pregnancy|2|||
156461247|NCT03926130|564783683|FG002|Overall Study|Pregnancy|1|||
156461248|NCT03926130|564783684|FG003|Overall Study|Pregnancy|0|||
156461249|NCT03926130|564783681|FG000|Overall Study|Withdrawal by Subject|20|||
156461250|NCT03926130|564783682|FG001|Overall Study|Withdrawal by Subject|28|||
156461251|NCT03926130|564783683|FG002|Overall Study|Withdrawal by Subject|18|||
156461252|NCT03926130|564783684|FG003|Overall Study|Withdrawal by Subject|1|||
156461253|NCT03926130|564783681|FG000|Overall Study|Non-Compliance|1|||
156461254|NCT03926130|564783682|FG001|Overall Study|Non-Compliance|1|||
156461255|NCT03926130|564783683|FG002|Overall Study|Non-Compliance|0|||
156461256|NCT03926130|564783684|FG003|Overall Study|Non-Compliance|0|||
156461257|NCT03926130|564783681|FG000|Overall Study|Disposition Not Captured|0|||
156461258|NCT03926130|564783682|FG001|Overall Study|Disposition Not Captured|2|||
156461259|NCT03926130|564783683|FG002|Overall Study|Disposition Not Captured|1|||
156461260|NCT03926130|564783684|FG003|Overall Study|Disposition Not Captured|0|||
156461261|NCT03824366|564783700|FG000|Overall Study|Death|1|||
156461262|NCT03824366|564783700|FG000|Overall Study|Previously unidentified metal artifact|1|||
156461263|NCT03824366|564783700|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
156461264|NCT03824366|564783700|FG000|Overall Study|Withdrawal by Subject|1|||
156461265|NCT05069896|564783703|FG000|Overall Study|Adverse Event|0|||
156461266|NCT05069896|564783704|FG001|Overall Study|Adverse Event|1|||
156461267|NCT05069896|564783705|FG002|Overall Study|Adverse Event|1|||
156461268|NCT05069896|564783706|FG003|Overall Study|Adverse Event|0|||
156461269|NCT05069896|564783707|FG004|Overall Study|Adverse Event|0|||
156461270|NCT05069896|564783708|FG005|Overall Study|Adverse Event|0|||
156461271|NCT05069896|564783703|FG000|Overall Study|Lost to Follow-up|0|||
156461272|NCT05069896|564783704|FG001|Overall Study|Lost to Follow-up|0|||
156461273|NCT05069896|564783705|FG002|Overall Study|Lost to Follow-up|1|||
156538427|NCT01838616|565066266|FG001|Titration Period|Lack of Efficacy|12|||
156538428|NCT01838616|565066265|FG000|Titration Period|Withdrawal by Subject|5|||
156809226|NCT04570384|566055745|FG001|Overall Study|Adverse Event|1|||
156809227|NCT04570384|566055744|FG000|Overall Study|Death|2|||
156809228|NCT04570384|566055745|FG001|Overall Study|Death|5|||
156809229|NCT04570384|566055744|FG000|Overall Study|Lost to Follow-up|1|||
156461274|NCT05069896|564783706|FG003|Overall Study|Lost to Follow-up|0|||
156461275|NCT05069896|564783707|FG004|Overall Study|Lost to Follow-up|1|||
156461276|NCT05069896|564783708|FG005|Overall Study|Lost to Follow-up|2|||
156461277|NCT04068831|564783709|FG000|Overall Study|Disease Progression|10|||
156461278|NCT04068831|564783710|FG001|Overall Study|Disease Progression|8|||
156461279|NCT01199133|564783721|FG000|Year 1|Adverse Event|16|||
156461280|NCT01199133|564783722|FG001|Year 1|Adverse Event|4|||
156809230|NCT04570384|566055745|FG001|Overall Study|Lost to Follow-up|0|||
156809231|NCT04570384|566055744|FG000|Overall Study|Other|1|||
156809232|NCT04570384|566055745|FG001|Overall Study|Other|0|||
156809233|NCT04570384|566055744|FG000|Overall Study|Protocol Violation|0|||
156809234|NCT04570384|566055745|FG001|Overall Study|Protocol Violation|1|||
156809235|NCT04570384|566055744|FG000|Overall Study|Sponsor Decision|1|||
156809236|NCT04570384|566055745|FG001|Overall Study|Sponsor Decision|0|||
156809237|NCT04570384|566055744|FG000|Overall Study|Withdrawal by Subject|4|||
156809238|NCT04570384|566055745|FG001|Overall Study|Withdrawal by Subject|2|||
156809239|NCT02573948|566055746|FG000|Longitudinal Cohort|Death|9|||
156809240|NCT02573948|566055746|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
156809241|NCT02573948|566055746|FG000|Longitudinal Cohort|Incarcerated|25|||
156809242|NCT03654274|566055751|FG000|Overall Study|Adverse Event|19|||
156809243|NCT03654274|566055752|FG001|Overall Study|Adverse Event|23|||
156809244|NCT03654274|566055753|FG002|Overall Study|Adverse Event|24|||
156809245|NCT03654274|566055751|FG000|Overall Study|Protocol Deviation|0|||
156809246|NCT03654274|566055752|FG001|Overall Study|Protocol Deviation|2|||
156809247|NCT03654274|566055753|FG002|Overall Study|Protocol Deviation|0|||
156809248|NCT03654274|566055751|FG000|Overall Study|Lost to Follow-up|8|||
156809249|NCT03654274|566055752|FG001|Overall Study|Lost to Follow-up|6|||
156809250|NCT03654274|566055753|FG002|Overall Study|Lost to Follow-up|5|||
156809251|NCT03654274|566055751|FG000|Overall Study|Withdrawal by Subject|46|||
156809252|NCT03654274|566055752|FG001|Overall Study|Withdrawal by Subject|25|||
156809253|NCT03654274|566055753|FG002|Overall Study|Withdrawal by Subject|33|||
156809254|NCT03654274|566055751|FG000|Overall Study|Lack of Efficacy|4|||
156809255|NCT03654274|566055752|FG001|Overall Study|Lack of Efficacy|5|||
156809256|NCT03654274|566055753|FG002|Overall Study|Lack of Efficacy|7|||
156809257|NCT03654274|566055751|FG000|Overall Study|Pregnancy|2|||
156809258|NCT03654274|566055752|FG001|Overall Study|Pregnancy|2|||
156809259|NCT03654274|566055753|FG002|Overall Study|Pregnancy|1|||
156809260|NCT03654274|566055751|FG000|Overall Study|Other|27|||
156809261|NCT03654274|566055752|FG001|Overall Study|Other|29|||
156809262|NCT03654274|566055753|FG002|Overall Study|Other|32|||
156809263|NCT03654274|566055751|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
156809264|NCT03654274|566055752|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
156809265|NCT03654274|566055753|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
156809266|NCT01102491|566055754|FG000|Overall Study|Protocol Violation|11|||
156809267|NCT01102491|566055755|FG001|Overall Study|Protocol Violation|12|||
156809268|NCT01265992|566055756|FG000|Overall Study|Lost to Follow-up|1|||
156809269|NCT01265992|566055756|FG000|Overall Study|Withdrawal by Subject|1|||
156809270|NCT01265992|566055756|FG000|Overall Study|Adverse Event|1|||
156809271|NCT01265992|566055756|FG000|Overall Study|Administrative reasons|2|||
156809272|NCT01265992|566055756|FG000|Overall Study|Stopped treatment|3|||
156809273|NCT01265992|566055756|FG000|Overall Study|Did not receive treatment|1|||
156809274|NCT01837680|566055757|FG000|Overall Study|Lost to Follow-up|2|||
156809275|NCT01837680|566055758|FG001|Overall Study|Lost to Follow-up|2|||
156809276|NCT01837680|566055757|FG000|Overall Study|lack of insurance|0|||
156809277|NCT01837680|566055758|FG001|Overall Study|lack of insurance|2|||
156809278|NCT01837680|566055757|FG000|Overall Study|allergic reaction|6|||
156809279|NCT01837680|566055758|FG001|Overall Study|allergic reaction|0|||
156809280|NCT01837680|566055757|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
156809281|NCT01837680|566055758|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
156809282|NCT03265145|566055759|FG000|Overall Study|Protocol Violation|2|||
156809283|NCT03265145|566055760|FG001|Overall Study|Protocol Violation|0|||
156809284|NCT03265145|566055759|FG000|Overall Study|Adverse Event|1|||
156809285|NCT03265145|566055760|FG001|Overall Study|Adverse Event|0|||
156809286|NCT03265145|566055759|FG000|Overall Study|Withdrawal by Subject|23|||
156809287|NCT03265145|566055760|FG001|Overall Study|Withdrawal by Subject|19|||
156809288|NCT03265145|566055759|FG000|Overall Study|Death|12|||
156809289|NCT03265145|566055760|FG001|Overall Study|Death|12|||
156809290|NCT03265145|566055759|FG000|Overall Study|Lost to Follow-up|13|||
156809291|NCT03265145|566055760|FG001|Overall Study|Lost to Follow-up|9|||
156338630|NCT00191269|564338312|FG000|Overall Study|Lack of Efficacy|1|||
156809292|NCT03265145|566055759|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
156809293|NCT03265145|566055760|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
156809294|NCT03265145|566055759|FG000|Overall Study|Switched back to previous medication|1|||
156809295|NCT03265145|566055760|FG001|Overall Study|Switched back to previous medication|0|||
156809296|NCT03265145|566055759|FG000|Overall Study|Did not want to take medication|1|||
156809297|NCT03265145|566055760|FG001|Overall Study|Did not want to take medication|0|||
156809298|NCT03265145|566055759|FG000|Overall Study|Subject could not afford medication|0|||
156809299|NCT03265145|566055760|FG001|Overall Study|Subject could not afford medication|1|||
156809300|NCT03265145|566055759|FG000|Overall Study|Site closed|2|||
156461281|NCT01199133|564783721|FG000|Year 1|Withdrawal by Subject|8|||
156461282|NCT01199133|564783722|FG001|Year 1|Withdrawal by Subject|4|||
156461283|NCT01199133|564783721|FG000|Year 1|Any other reason not above-mentioned|6|||
156461284|NCT01199133|564783722|FG001|Year 1|Any other reason not above-mentioned|7|||
156461285|NCT01199133|564783721|FG000|Year 2|Adverse Event|1|||
156461286|NCT01199133|564783722|FG001|Year 2|Adverse Event|0|||
156461287|NCT01199133|564783721|FG000|Year 2|Withdrawal by Subject|1|||
156461288|NCT01199133|564783722|FG001|Year 2|Withdrawal by Subject|1|||
156461289|NCT01199133|564783721|FG000|Year 2|Any other reason not above-mentioned|1|||
156461290|NCT01199133|564783722|FG001|Year 2|Any other reason not above-mentioned|2|||
156461291|NCT02575950|564783723|FG000|Overall Study|Withdrawal by Subject|0|||
156461292|NCT02575950|564783724|FG001|Overall Study|Withdrawal by Subject|0|||
156461293|NCT02575950|564783725|FG002|Overall Study|Withdrawal by Subject|0|||
156461294|NCT02575950|564783726|FG003|Overall Study|Withdrawal by Subject|2|||
156461295|NCT02575950|564783723|FG000|Overall Study|Lost to Follow-up|0|||
156461296|NCT02575950|564783724|FG001|Overall Study|Lost to Follow-up|1|||
156461297|NCT02575950|564783725|FG002|Overall Study|Lost to Follow-up|0|||
156461298|NCT02575950|564783726|FG003|Overall Study|Lost to Follow-up|3|||
156461299|NCT04565990|564785122|FG000|Overall Study|Death|5|||
156461300|NCT04565990|564785122|FG000|Overall Study|Lost to Follow-up|1|||
156461301|NCT04565990|564785122|FG000|Overall Study|Withdrawal by Subject|1|||
156461302|NCT04797858|564785123|FG000|Overall Study|Withdrawal by Subject|0|||
156461303|NCT04797858|564785124|FG001|Overall Study|Withdrawal by Subject|1|||
156461304|NCT04797858|564785123|FG000|Overall Study|Excluded due to administrative error|7|||
156461305|NCT04797858|564785124|FG001|Overall Study|Excluded due to administrative error|8|||
156461306|NCT01960452|564785128|FG000|Overall Study|Withdrawal by Subject|2|||
156461307|NCT01960452|564785129|FG001|Overall Study|Withdrawal by Subject|1|||
156461308|NCT01960452|564785128|FG000|Overall Study|Sleep apnea in Night 1|1|||
156461309|NCT01960452|564785129|FG001|Overall Study|Sleep apnea in Night 1|0|||
156461310|NCT01960452|564785128|FG000|Overall Study|Poor Sleep in Night 1|0|||
156461311|NCT01960452|564785129|FG001|Overall Study|Poor Sleep in Night 1|2|||
156461312|NCT01960452|564785128|FG000|Overall Study|No Sex/Age Match Night 1|1|||
156461313|NCT01960452|564785129|FG001|Overall Study|No Sex/Age Match Night 1|0|||
156461314|NCT01960452|564785128|FG000|Overall Study|No Sex/Age Match Night 2|0|||
156461315|NCT01960452|564785129|FG001|Overall Study|No Sex/Age Match Night 2|2|||
156461316|NCT01960452|564785128|FG000|Overall Study|Technical Difficulties Night 2|2|||
156461317|NCT01960452|564785129|FG001|Overall Study|Technical Difficulties Night 2|0|||
156461318|NCT04766892|564785130|FG000|Overall Study|Withdrawal by Subject|1|||
156461319|NCT04766892|564785130|FG000|Overall Study|Lost to Follow-up|1|||
156461320|NCT04766892|564785130|FG000|Overall Study|Adverse Event|3|||
156461321|NCT04766892|564785130|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
156461322|NCT02668692|564785131|FG000|Overall Study|Adverse Event|1|||
156461323|NCT02668692|564785132|FG001|Overall Study|Adverse Event|0|||
156461324|NCT03981926|564785133|FG000|Overall Study|Lost to Follow-up|5|||
156461325|NCT03981926|564785134|FG001|Overall Study|Lost to Follow-up|9|||
156461326|NCT03711474|564785150|FG000|Overall Study|Physician Decision|2|||
156461327|NCT03711474|564785151|FG001|Overall Study|Physician Decision|0|||
156461328|NCT05618587|564785152|FG000|Overall Study|Lost to Follow-up|2|||
156461329|NCT05618587|564785153|FG001|Overall Study|Lost to Follow-up|0|||
156461330|NCT02446236|564785156|FG000|Overall Study|Screen Failure|1|||
156461331|NCT02446236|564785157|FG001|Overall Study|Screen Failure|0|||
156461332|NCT02446236|564785158|FG002|Overall Study|Screen Failure|1|||
156461333|NCT02446236|564785156|FG000|Overall Study|Actively Receiving Therapy|0|||
156461334|NCT02446236|564785157|FG001|Overall Study|Actively Receiving Therapy|0|||
156461335|NCT02446236|564785158|FG002|Overall Study|Actively Receiving Therapy|1|||
156461336|NCT04136912|564785163|FG000|Overall Study|Operational reasons|0|||
156461337|NCT04136912|564785164|FG001|Overall Study|Operational reasons|0|||
156461338|NCT04136912|564785165|FG002|Overall Study|Operational reasons|2|||
156809301|NCT03265145|566055760|FG001|Overall Study|Site closed|3|||
156809302|NCT03265145|566055759|FG000|Overall Study|Incorrectly randomized|16|||
156809303|NCT03265145|566055760|FG001|Overall Study|Incorrectly randomized|6|||
156809304|NCT03265145|566055759|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
156809305|NCT03265145|566055760|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
156809306|NCT03265145|566055759|FG000|Overall Study|Physician Decision|0|||
156809307|NCT03265145|566055760|FG001|Overall Study|Physician Decision|3|||
156338631|NCT00191269|564338313|FG001|Overall Study|Lack of Efficacy|5|||
156338632|NCT00191269|564338312|FG000|Overall Study|Withdrawal by Subject|0|||
156338633|NCT00191269|564338313|FG001|Overall Study|Withdrawal by Subject|1|||
156338634|NCT00191269|564338312|FG000|Overall Study|Pathologic Aggrevation|0|||
156338635|NCT00191269|564338313|FG001|Overall Study|Pathologic Aggrevation|1|||
156338636|NCT00191269|564338312|FG000|Overall Study|Physician Decision|0|||
156338637|NCT00191269|564338313|FG001|Overall Study|Physician Decision|3|||
156338638|NCT00674362|564338316|FG000|Double Blind|Adverse Event|6|||
156338639|NCT00674362|564338317|FG001|Double Blind|Adverse Event|6|||
156338640|NCT00674362|564338316|FG000|Double Blind|Lack of Efficacy|2|||
156338641|NCT00674362|564338317|FG001|Double Blind|Lack of Efficacy|6|||
156338642|NCT00674362|564338316|FG000|Double Blind|Loss of efficacy|0|||
156338643|NCT00674362|564338317|FG001|Double Blind|Loss of efficacy|1|||
156338644|NCT00674362|564338316|FG000|Double Blind|Withdrawal by Subject|4|||
156338645|NCT00674362|564338317|FG001|Double Blind|Withdrawal by Subject|3|||
156338646|NCT00674362|564338316|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
156338647|NCT00674362|564338317|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
156338648|NCT00674362|564338316|FG000|Double Blind|Other: Surgery|0|||
156338649|NCT00674362|564338317|FG001|Double Blind|Other: Surgery|1|||
156338650|NCT00674362|564338316|FG000|Open Label|Adverse Event|1|||
156338651|NCT00674362|564338317|FG001|Open Label|Adverse Event|0|||
156338652|NCT00674362|564338316|FG000|Open Label|Other: Subject moved to extension study|1|||
156338653|NCT00674362|564338317|FG001|Open Label|Other: Subject moved to extension study|0|||
156338654|NCT00939770|564338320|FG000|Overall Study|Adverse Event|1|||
156338655|NCT00939770|564338321|FG001|Overall Study|Adverse Event|1|||
156461339|NCT04003246|564785176|FG000|Overall Study|Death|9|||
156461340|NCT05715528|564785182|FG000|Overall Study|Randomized but never treated|11|||
156461341|NCT05715528|564785183|FG001|Overall Study|Randomized but never treated|13|||
156461342|NCT05715528|564785182|FG000|Overall Study|Withdrew consent|7|||
156461343|NCT05715528|564785183|FG001|Overall Study|Withdrew consent|15|||
156809308|NCT03265145|566055759|FG000|Overall Study|Subject transferred to another facility|0|||
156809309|NCT03265145|566055760|FG001|Overall Study|Subject transferred to another facility|1|||
156338656|NCT00939770|564338322|FG002|Overall Study|Adverse Event|0|||
156338657|NCT00939770|564338323|FG003|Overall Study|Adverse Event|0|||
156338658|NCT00939770|564338324|FG004|Overall Study|Adverse Event|6|||
156338659|NCT00939770|564338325|FG005|Overall Study|Adverse Event|2|||
156338660|NCT00939770|564338326|FG006|Overall Study|Adverse Event|1|||
156461344|NCT05715528|564785182|FG000|Overall Study|Lost to Follow-up|5|||
156461345|NCT05715528|564785183|FG001|Overall Study|Lost to Follow-up|13|||
156461346|NCT05715528|564785182|FG000|Overall Study|Investigator's discretion|3|||
156809310|NCT05005273|566055761|FG000|Overall Study|Study Terminated|1|||
156809311|NCT05005273|566055762|FG001|Overall Study|Study Terminated|0|||
156809312|NCT04409834|566055763|FG000|Overall Study|Death|55|||
156809313|NCT04409834|566055764|FG001|Overall Study|Death|62|||
156538429|NCT01838616|565066266|FG001|Titration Period|Withdrawal by Subject|5|||
156538430|NCT01838616|565066265|FG000|Titration Period|Technical problems|1|||
156538431|NCT01838616|565066266|FG001|Titration Period|Technical problems|0|||
156538432|NCT01838616|565066265|FG000|Titration Period|Other|1|||
156809314|NCT02137070|566055765|FG000|Overall Study|Adverse Event|12|||
156809315|NCT02137070|566055766|FG001|Overall Study|Adverse Event|3|||
156809316|NCT02137070|566055765|FG000|Overall Study|Death|2|||
156809317|NCT02137070|566055766|FG001|Overall Study|Death|0|||
156809318|NCT02137070|566055765|FG000|Overall Study|Lost to Follow-up|24|||
156809319|NCT02137070|566055766|FG001|Overall Study|Lost to Follow-up|9|||
156809320|NCT02137070|566055765|FG000|Overall Study|Physician Decision|0|||
156809321|NCT02137070|566055766|FG001|Overall Study|Physician Decision|1|||
156809322|NCT02137070|566055765|FG000|Overall Study|Protocol Violation|18|||
156809323|NCT02137070|566055766|FG001|Overall Study|Protocol Violation|4|||
156809324|NCT02137070|566055765|FG000|Overall Study|Withdrawal by Subject|18|||
156809325|NCT02137070|566055766|FG001|Overall Study|Withdrawal by Subject|1|||
156809326|NCT02151786|566055767|FG000|Overall Study|Unavailability of Case Report Form|26|||
156809327|NCT02151786|566055767|FG000|Overall Study|Outside the Contract Period|1|||
156809328|NCT02151786|566055767|FG000|Overall Study|Randomized, not Treated|1|||
156809329|NCT02151786|566055767|FG000|Overall Study|Unavailability of Information|8|||
156809330|NCT02112656|566055771|FG000|Overall Study|Death|78|||
156809331|NCT02112656|566055772|FG001|Overall Study|Death|82|||
156809332|NCT02112656|566055771|FG000|Overall Study|Withdrawal by Subject|9|||
156538433|NCT01838616|565066266|FG001|Titration Period|Other|0|||
156809333|NCT02112656|566055772|FG001|Overall Study|Withdrawal by Subject|11|||
156809334|NCT02112656|566055771|FG000|Overall Study|Lost to Follow-up|2|||
156809335|NCT02112656|566055772|FG001|Overall Study|Lost to Follow-up|4|||
156809336|NCT02112656|566055771|FG000|Overall Study|Noncompliance|1|||
156809337|NCT02112656|566055772|FG001|Overall Study|Noncompliance|2|||
156809338|NCT03761056|566055773|FG000|Overall Study|Death|8|||
156809339|NCT03761056|566055773|FG000|Overall Study|Enrolled but never treated|2|||
156809340|NCT03761056|566055773|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
156809341|NCT03761056|566055773|FG000|Overall Study|Investigator decision|1|||
156809342|NCT03941483|566055774|FG000|Overall Study|Miscellaneous|2|||
156809343|NCT03941483|566055775|FG001|Overall Study|Miscellaneous|3|||
156809344|NCT03941483|566055776|FG002|Overall Study|Miscellaneous|0|||
156809345|NCT03941483|566055774|FG000|Overall Study|Study Terminated by Sponsor|1|||
156809346|NCT03941483|566055775|FG001|Overall Study|Study Terminated by Sponsor|0|||
156809347|NCT03941483|566055776|FG002|Overall Study|Study Terminated by Sponsor|0|||
156809348|NCT03941483|566055774|FG000|Overall Study|Withdrawal by Subject|1|||
156809349|NCT03941483|566055775|FG001|Overall Study|Withdrawal by Subject|4|||
156809350|NCT03941483|566055776|FG002|Overall Study|Withdrawal by Subject|1|||
156809351|NCT03941483|566055774|FG000|Overall Study|Lost to Follow-up|2|||
156809352|NCT03941483|566055775|FG001|Overall Study|Lost to Follow-up|1|||
156809353|NCT03941483|566055776|FG002|Overall Study|Lost to Follow-up|8|||
156809354|NCT03941483|566055774|FG000|Overall Study|Death|3|||
156809355|NCT03941483|566055775|FG001|Overall Study|Death|2|||
156809356|NCT03941483|566055776|FG002|Overall Study|Death|6|||
156809357|NCT04749745|566055777|FG000|Overall Study|Withdrawal by Subject|1|||
156809358|NCT04749745|566055778|FG001|Overall Study|Withdrawal by Subject|0|||
156809359|NCT00617084|566056994|FG000|Overall Study|Withdrawal by Subject|5|||
156809360|NCT00617084|566056995|FG001|Overall Study|Withdrawal by Subject|7|||
156809361|NCT00617084|566056994|FG000|Overall Study|Missed 12 Months visit|16|||
156809362|NCT00617084|566056995|FG001|Overall Study|Missed 12 Months visit|19|||
156538434|NCT01838616|565066265|FG000|Titration Period|Protocol Violation|0|||
156538435|NCT01838616|565066266|FG001|Titration Period|Protocol Violation|1|||
156538436|NCT01838616|565066265|FG000|Continuation Period|Lack of Efficacy|3|||
156809363|NCT03370419|566056996|FG000|Overall Study|Lost to Follow-up|16|||
156809364|NCT01693250|566057001|FG000|Overall Study|Lost to Follow-up|2|||
156809365|NCT01693250|566057002|FG001|Overall Study|Lost to Follow-up|2|||
156809366|NCT01147965|566057003|FG000|Overall Study|Progressive Disease|3|||
156809367|NCT01147965|566057004|FG001|Overall Study|Progressive Disease|3|||
156809368|NCT01147965|566057005|FG002|Overall Study|Progressive Disease|5|||
156809369|NCT01147965|566057006|FG003|Overall Study|Progressive Disease|9|||
156538437|NCT01838616|565066266|FG001|Continuation Period|Lack of Efficacy|5|||
156809370|NCT01147965|566057007|FG004|Overall Study|Progressive Disease|5|||
156809371|NCT01147965|566057008|FG005|Overall Study|Progressive Disease|5|||
156538438|NCT01838616|565066265|FG000|Continuation Period|Adverse Event|8|||
156809372|NCT01147965|566057003|FG000|Overall Study|Death|0|||
156809373|NCT01147965|566057004|FG001|Overall Study|Death|0|||
156809374|NCT01147965|566057005|FG002|Overall Study|Death|1|||
156809375|NCT01147965|566057006|FG003|Overall Study|Death|1|||
156809376|NCT01147965|566057007|FG004|Overall Study|Death|0|||
156809377|NCT01147965|566057008|FG005|Overall Study|Death|2|||
156809378|NCT01147965|566057003|FG000|Overall Study|Withdrawal by Subject|0|||
156809379|NCT01147965|566057004|FG001|Overall Study|Withdrawal by Subject|0|||
156809380|NCT01147965|566057005|FG002|Overall Study|Withdrawal by Subject|1|||
156809381|NCT01147965|566057006|FG003|Overall Study|Withdrawal by Subject|1|||
156809382|NCT01147965|566057007|FG004|Overall Study|Withdrawal by Subject|0|||
156809383|NCT01147965|566057008|FG005|Overall Study|Withdrawal by Subject|0|||
156809384|NCT01147965|566057003|FG000|Overall Study|Administration Of Alternative Therapy|0|||
156809385|NCT01147965|566057004|FG001|Overall Study|Administration Of Alternative Therapy|0|||
156809386|NCT01147965|566057005|FG002|Overall Study|Administration Of Alternative Therapy|0|||
156809387|NCT01147965|566057006|FG003|Overall Study|Administration Of Alternative Therapy|0|||
156809388|NCT01147965|566057007|FG004|Overall Study|Administration Of Alternative Therapy|0|||
156809389|NCT01147965|566057008|FG005|Overall Study|Administration Of Alternative Therapy|1|||
156809390|NCT01147965|566057003|FG000|Overall Study|Other|0|||
156809391|NCT01147965|566057004|FG001|Overall Study|Other|0|||
156809392|NCT01147965|566057005|FG002|Overall Study|Other|0|||
156809393|NCT01147965|566057006|FG003|Overall Study|Other|3|||
156809394|NCT01147965|566057007|FG004|Overall Study|Other|1|||
156338661|NCT00939770|564338327|FG007|Overall Study|Adverse Event|1|||
156338662|NCT00939770|564338320|FG000|Overall Study|Lack of Efficacy|4|||
156338663|NCT00939770|564338321|FG001|Overall Study|Lack of Efficacy|6|||
156338664|NCT00939770|564338322|FG002|Overall Study|Lack of Efficacy|13|||
156338665|NCT00939770|564338323|FG003|Overall Study|Lack of Efficacy|9|||
156461347|NCT05715528|564785183|FG001|Overall Study|Investigator's discretion|1|||
156809395|NCT01147965|566057008|FG005|Overall Study|Other|0|||
156809396|NCT01273038|566057009|FG000|Second Intervention (14 Days)|Adverse Event|0|||
156809397|NCT01273038|566057010|FG001|Second Intervention (14 Days)|Adverse Event|1|||
156809398|NCT01273038|566057009|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
156809399|NCT01273038|566057010|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
156809400|NCT02197572|566057011|FG000|Overall Study|Progressive Disease|28|||
156809401|NCT02197572|566057011|FG000|Overall Study|Withdrawal by Subject|9|||
156809402|NCT02197572|566057011|FG000|Overall Study|Adverse Event|3|||
156809403|NCT02197572|566057011|FG000|Overall Study|Reason Not Specified|4|||
156809404|NCT01306643|566057012|FG000|Overall Study|Adverse Event|5|||
156809405|NCT01306643|566057012|FG000|Overall Study|Disease Progression|7|||
156809406|NCT01306643|566057012|FG000|Overall Study|Other: Change in Eligibility Status|1|||
156809407|NCT03783962|566057015|FG000|Overall Study|Lost to Follow-up|3|||
156809408|NCT03783962|566057016|FG001|Overall Study|Lost to Follow-up|6|||
156809409|NCT03783962|566057015|FG000|Overall Study|Protocol Violation|0|||
156809410|NCT03783962|566057016|FG001|Overall Study|Protocol Violation|1|||
156809411|NCT01724216|566057017|FG000|Overall Study|Scan was not completed|1|||
156809412|NCT04423939|566057018|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
156809413|NCT04423939|566057019|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
156809414|NCT04423939|566057018|FG000|Overall Study|Death|3|||
156809415|NCT04423939|566057019|FG001|Overall Study|Death|0|||
156809416|NCT04423939|566057018|FG000|Overall Study|Withdrawal by Subject|3|||
156809417|NCT04423939|566057019|FG001|Overall Study|Withdrawal by Subject|0|||
156809418|NCT04423939|566057018|FG000|Overall Study|Caregiver to patient who died|0|||
156809419|NCT04423939|566057019|FG001|Overall Study|Caregiver to patient who died|3|||
156809420|NCT04423939|566057018|FG000|Overall Study|Caregiver to patient who withdrew|0|||
156809421|NCT04423939|566057019|FG001|Overall Study|Caregiver to patient who withdrew|3|||
156809422|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
156809423|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
156809424|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
156809425|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
156809426|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
156809427|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
156809428|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
156809429|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
156809430|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
156809431|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
156809432|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
156809433|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
156809434|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
156809435|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
156809436|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
156809437|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
156809438|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
156809439|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
156809440|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
156809441|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
156461348|NCT05715528|564785182|FG000|Overall Study|Protocol Violation|2|||
156809442|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
156809443|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
156809444|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
156338666|NCT00939770|564338324|FG004|Overall Study|Lack of Efficacy|16|||
156809445|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
156809446|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
156809447|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
156809448|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
156809449|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
156809450|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
156338667|NCT00939770|564338325|FG005|Overall Study|Lack of Efficacy|8|||
156338668|NCT00939770|564338326|FG006|Overall Study|Lack of Efficacy|11|||
156338669|NCT00939770|564338327|FG007|Overall Study|Lack of Efficacy|1|||
156338670|NCT00939770|564338320|FG000|Overall Study|Lost to Follow-up|0|||
156338671|NCT00939770|564338321|FG001|Overall Study|Lost to Follow-up|0|||
156809451|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
156809452|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
156809453|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
156809454|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
156809455|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Other|6|||
156809456|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Other|0|||
156809457|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Other|0|||
156809458|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
156809459|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
156809460|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
156809461|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
156338672|NCT00939770|564338322|FG002|Overall Study|Lost to Follow-up|0|||
156338673|NCT00939770|564338323|FG003|Overall Study|Lost to Follow-up|0|||
156338674|NCT00939770|564338324|FG004|Overall Study|Lost to Follow-up|1|||
156338675|NCT00939770|564338325|FG005|Overall Study|Lost to Follow-up|0|||
156338676|NCT00939770|564338326|FG006|Overall Study|Lost to Follow-up|0|||
156338677|NCT00939770|564338327|FG007|Overall Study|Lost to Follow-up|0|||
156338678|NCT00939770|564338320|FG000|Overall Study|Physician Decision|0|||
156338679|NCT00939770|564338321|FG001|Overall Study|Physician Decision|0|||
156338680|NCT00939770|564338322|FG002|Overall Study|Physician Decision|2|||
156338681|NCT00939770|564338323|FG003|Overall Study|Physician Decision|0|||
156338682|NCT00939770|564338324|FG004|Overall Study|Physician Decision|7|||
156338683|NCT00939770|564338325|FG005|Overall Study|Physician Decision|1|||
156338684|NCT00939770|564338326|FG006|Overall Study|Physician Decision|0|||
156338685|NCT00939770|564338327|FG007|Overall Study|Physician Decision|6|||
156338686|NCT00939770|564338320|FG000|Overall Study|Protocol Violation|0|||
156338687|NCT00939770|564338321|FG001|Overall Study|Protocol Violation|0|||
156338688|NCT00939770|564338322|FG002|Overall Study|Protocol Violation|0|||
156338689|NCT00939770|564338323|FG003|Overall Study|Protocol Violation|0|||
156338690|NCT00939770|564338324|FG004|Overall Study|Protocol Violation|1|||
156338691|NCT00939770|564338325|FG005|Overall Study|Protocol Violation|0|||
156338692|NCT00939770|564338326|FG006|Overall Study|Protocol Violation|0|||
156338693|NCT00939770|564338327|FG007|Overall Study|Protocol Violation|0|||
156338694|NCT00939770|564338320|FG000|Overall Study|Withdrawal by Subject|0|||
156338695|NCT00939770|564338321|FG001|Overall Study|Withdrawal by Subject|1|||
156338696|NCT00939770|564338322|FG002|Overall Study|Withdrawal by Subject|5|||
156338697|NCT00939770|564338323|FG003|Overall Study|Withdrawal by Subject|2|||
156338698|NCT00939770|564338324|FG004|Overall Study|Withdrawal by Subject|6|||
156338699|NCT00939770|564338325|FG005|Overall Study|Withdrawal by Subject|0|||
156338700|NCT00939770|564338326|FG006|Overall Study|Withdrawal by Subject|2|||
156338701|NCT00939770|564338327|FG007|Overall Study|Withdrawal by Subject|2|||
156338702|NCT04066023|564338328|FG000|Overall Study|Adverse Event|0|||
156338703|NCT04066023|564338329|FG001|Overall Study|Adverse Event|0|||
156338704|NCT04066023|564338330|FG002|Overall Study|Adverse Event|1|||
156338705|NCT04066023|564338328|FG000|Overall Study|Sponsor decision|3|||
156338706|NCT04066023|564338329|FG001|Overall Study|Sponsor decision|6|||
156338707|NCT04066023|564338330|FG002|Overall Study|Sponsor decision|2|||
156338708|NCT04066023|564338328|FG000|Overall Study|Physician Decision|0|||
156338709|NCT04066023|564338329|FG001|Overall Study|Physician Decision|0|||
156338710|NCT04066023|564338330|FG002|Overall Study|Physician Decision|1|||
156338711|NCT04066023|564338328|FG000|Overall Study|Lost to Follow-up|0|||
156338712|NCT04066023|564338329|FG001|Overall Study|Lost to Follow-up|1|||
156338713|NCT04066023|564338330|FG002|Overall Study|Lost to Follow-up|1|||
156338714|NCT04066023|564338328|FG000|Overall Study|Noncompliance|0|||
156338715|NCT04066023|564338329|FG001|Overall Study|Noncompliance|1|||
156338716|NCT04066023|564338330|FG002|Overall Study|Noncompliance|1|||
156338717|NCT04665856|564338331|FG000|Overall Study|Site Terminated by Sponsor|1|||
156338718|NCT04665856|564338332|FG001|Overall Study|Site Terminated by Sponsor|0|||
156338719|NCT04665856|564338331|FG000|Overall Study|Withdrawal by Subject|2|||
156338720|NCT04665856|564338332|FG001|Overall Study|Withdrawal by Subject|0|||
156338721|NCT04665856|564338331|FG000|Overall Study|Lost to Follow-up|3|||
156338722|NCT04665856|564338332|FG001|Overall Study|Lost to Follow-up|2|||
156338723|NCT04665856|564338331|FG000|Overall Study|Death|39|||
156338724|NCT04665856|564338332|FG001|Overall Study|Death|44|||
156338725|NCT04665856|564338331|FG000|Overall Study|Ongoing in study|17|||
156809462|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
156809463|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
156809464|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
156809465|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
156809466|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
156809467|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
156338726|NCT04665856|564338332|FG001|Overall Study|Ongoing in study|15|||
156338727|NCT03386448|564338333|FG000|Overall Study|Adverse Event|0|||
156338728|NCT03386448|564338334|FG001|Overall Study|Adverse Event|2|||
156338729|NCT03338010|564338335|FG000|Overall Study|Withdrawal by Subject|14|||
156338730|NCT03338010|564338336|FG001|Overall Study|Withdrawal by Subject|8|||
156338731|NCT03338010|564338335|FG000|Overall Study|Lost to Follow-up|4|||
156338732|NCT03338010|564338336|FG001|Overall Study|Lost to Follow-up|2|||
156338733|NCT03338010|564338335|FG000|Overall Study|Adverse Event|3|||
156338734|NCT03338010|564338336|FG001|Overall Study|Adverse Event|2|||
156338735|NCT03338010|564338335|FG000|Overall Study|Physician Decision|2|||
156338736|NCT03338010|564338336|FG001|Overall Study|Physician Decision|2|||
156809468|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
156809469|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
156809470|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
156809471|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
156809472|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
156809473|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
156809474|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
156809475|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
156809476|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
156809477|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
156809478|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
156809479|NCT02413996|566057023|FG000|Overall Study|not comfortable with the intervention|9|||
156809480|NCT02413996|566057024|FG001|Overall Study|not comfortable with the intervention|2|||
156809481|NCT00709319|566057025|FG000|Overall Study|Death|4|||
156809482|NCT00709319|566057025|FG000|Overall Study|Withdrawal by Subject|2|||
156809483|NCT00579553|566057029|FG000|Overall Study|Lost to Follow-up|16|||
156809484|NCT00579553|566057030|FG001|Overall Study|Lost to Follow-up|13|||
156809485|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
156809486|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
156809487|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
156809488|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
156338737|NCT03338010|564338335|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156338738|NCT03338010|564338336|FG001|Overall Study|Non-Compliance with Study Drug|3|||
156338739|NCT03338010|564338335|FG000|Overall Study|Protocol Violation|0|||
156338740|NCT03338010|564338336|FG001|Overall Study|Protocol Violation|1|||
156338741|NCT01146665|564338337|FG000|Overall Study|Withdrawal by Subject|10|||
156338742|NCT01146665|564338338|FG001|Overall Study|Withdrawal by Subject|16|||
156338743|NCT02564796|564338343|FG000|Overall Study|Physician Decision|2|||
156338744|NCT02564796|564338344|FG001|Overall Study|Physician Decision|2|||
156338745|NCT00293033|564338345|FG000|Open-label Titration Period|Adverse Event|10|||
156338746|NCT00293033|564338345|FG000|Open-label Titration Period|Death|3|||
156338747|NCT00293033|564338345|FG000|Open-label Titration Period|Lack of Efficacy|5|||
156338748|NCT00293033|564338345|FG000|Open-label Titration Period|Protocol Violation|2|||
156338749|NCT00293033|564338345|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
156338750|NCT00293033|564338345|FG000|Open-label Titration Period|Noncompliance and other|27|||
156338751|NCT00293033|564338345|FG000|Double-blind Treatment Period|Adverse Event|3|||
156338752|NCT00293033|564338345|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
156809489|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
156809490|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
156809491|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
156809492|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
156809493|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
156809494|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
156809495|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
156809496|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
156809497|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
156338753|NCT00293033|564338345|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
156809498|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
156338754|NCT00293033|564338345|FG000|Double-blind Treatment Period|Noncompliance|4|||
156338755|NCT00743483|564338351|FG000|Baseline Period|Physician Decision|1|||
156338756|NCT00743483|564338351|FG000|Treatment Period|Adverse Event|1|||
156809499|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
156809500|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
156338757|NCT00873912|564338353|FG000|Overall Study|Withdrawal by Subject|1|||
156809501|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
156809502|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
156461349|NCT05715528|564785183|FG001|Overall Study|Protocol Violation|0|||
156461350|NCT05715528|564785182|FG000|Overall Study|Non-compliance with study drug|0|||
156461351|NCT05715528|564785183|FG001|Overall Study|Non-compliance with study drug|1|||
156461352|NCT02834390|564785184|FG000|Induction Phase|Progressive disease|0|||
156461353|NCT02834390|564785185|FG001|Induction Phase|Progressive disease|1|||
156461354|NCT02834390|564785184|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
156461355|NCT02834390|564785185|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
156461356|NCT02834390|564785184|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
156461357|NCT02834390|564785185|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
156461358|NCT02834390|564785184|FG000|Consolidation Phase|Physician Decision|1|||
156461359|NCT02834390|564785185|FG001|Consolidation Phase|Physician Decision|1|||
156461360|NCT03118518|564785186|FG000|Overall Study|Early Exit after treatment|2|||
156461361|NCT03118518|564785187|FG001|Overall Study|Early Exit after treatment|8|||
156461362|NCT03118518|564785186|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
156461363|NCT03118518|564785187|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
156461364|NCT05533190|564785197|FG000|Overall Study|Lost to Follow-up|19|||
156461365|NCT05533190|564785198|FG001|Overall Study|Lost to Follow-up|7|||
156461366|NCT05533190|564785197|FG000|Overall Study|Failed to download app|1|||
156461367|NCT05533190|564785198|FG001|Overall Study|Failed to download app|0|||
156461368|NCT05533190|564785197|FG000|Overall Study|Thought app was a scam|1|||
156461369|NCT05533190|564785198|FG001|Overall Study|Thought app was a scam|0|||
156461370|NCT05533190|564785197|FG000|Overall Study|Withdrawal by Subject|2|||
156461371|NCT05533190|564785198|FG001|Overall Study|Withdrawal by Subject|0|||
156461372|NCT05856435|564785199|FG000|Overall Study|Lost to Follow-up|6|||
156461373|NCT05660434|564785200|FG000|Overall Study|Never obtained study materials|2|||
156461374|NCT05660434|564785201|FG001|Overall Study|Never obtained study materials|1|||
156461375|NCT03213678|564785202|FG000|Overall Study|Death|1|||
156461376|NCT03213678|564785202|FG000|Overall Study|Physician Decision|1|||
156461377|NCT03213678|564785202|FG000|Overall Study|Progressive disease|16|||
156461378|NCT02413489|564785203|FG000|Overall Study|Death|11|||
156461379|NCT02413489|564785204|FG001|Overall Study|Death|3|||
156461380|NCT02413489|564785205|FG002|Overall Study|Death|4|||
156461381|NCT02413489|564785203|FG000|Overall Study|Withdrawal by Subject|2|||
156461382|NCT02413489|564785204|FG001|Overall Study|Withdrawal by Subject|0|||
156461383|NCT02413489|564785205|FG002|Overall Study|Withdrawal by Subject|0|||
156461384|NCT02413489|564785203|FG000|Overall Study|Study Terminated By Sponsor|2|||
156461385|NCT02413489|564785204|FG001|Overall Study|Study Terminated By Sponsor|13|||
156461386|NCT02413489|564785205|FG002|Overall Study|Study Terminated By Sponsor|1|||
156461387|NCT04456296|564785206|FG000|Overall Study|Withdrawal by Subject|14|||
156461388|NCT04456296|564785207|FG001|Overall Study|Withdrawal by Subject|21|||
156461389|NCT04456296|564785208|FG002|Overall Study|Withdrawal by Subject|21|||
156461390|NCT04456296|564785206|FG000|Overall Study|Adverse Event|2|||
156461391|NCT04456296|564785207|FG001|Overall Study|Adverse Event|2|||
156461392|NCT04456296|564785208|FG002|Overall Study|Adverse Event|2|||
156461393|NCT04456296|564785206|FG000|Overall Study|Death|1|||
156461394|NCT04456296|564785207|FG001|Overall Study|Death|0|||
156461395|NCT04456296|564785208|FG002|Overall Study|Death|0|||
156461396|NCT04456296|564785206|FG000|Overall Study|Lost to Follow-up|3|||
156461397|NCT04456296|564785207|FG001|Overall Study|Lost to Follow-up|5|||
156461398|NCT04456296|564785208|FG002|Overall Study|Lost to Follow-up|6|||
156461399|NCT04456296|564785206|FG000|Overall Study|Other than specified|0|||
156461400|NCT04456296|564785207|FG001|Overall Study|Other than specified|1|||
156461401|NCT04456296|564785208|FG002|Overall Study|Other than specified|4|||
156461402|NCT04456296|564785206|FG000|Overall Study|Randomized, not treated|2|||
156461403|NCT04456296|564785207|FG001|Overall Study|Randomized, not treated|1|||
156461404|NCT04456296|564785208|FG002|Overall Study|Randomized, not treated|0|||
156461405|NCT05736458|564785209|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
156461406|NCT05736458|564785210|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
156461407|NCT05736458|564785211|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
156809503|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
156461408|NCT05736458|564785209|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
156461409|NCT05736458|564785210|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
156461410|NCT05736458|564785211|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
156461411|NCT05736458|564785209|FG000|TMS/fMRI #1|Physician Decision|0|||
156461412|NCT05736458|564785210|FG001|TMS/fMRI #1|Physician Decision|0|||
156461413|NCT05736458|564785211|FG002|TMS/fMRI #1|Physician Decision|2|||
156461414|NCT05736458|564785209|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
156461415|NCT05736458|564785210|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
156461416|NCT05736458|564785211|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
156461417|NCT05100628|564785216|FG000|Overall Study|Progressive Disease|1|||
156461418|NCT05100628|564785217|FG001|Overall Study|Progressive Disease|0|||
156461419|NCT05100628|564785218|FG002|Overall Study|Progressive Disease|0|||
156461420|NCT05100628|564785219|FG003|Overall Study|Progressive Disease|0|||
156809504|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
156809505|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
156809506|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
156809507|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
156809508|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
156809509|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
156809510|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
156809511|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
156809512|NCT01672879|566057031|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
156809513|NCT01672879|566057032|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
156809514|NCT01672879|566057033|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
156809515|NCT01672879|566057031|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
156809516|NCT01672879|566057032|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
156809517|NCT01672879|566057033|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
156809518|NCT01672879|566057031|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
156809519|NCT01672879|566057032|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
156809520|NCT01672879|566057033|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
156809521|NCT01672879|566057031|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
156809522|NCT01672879|566057032|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
156809523|NCT01672879|566057033|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
156809524|NCT04860869|566057034|FG000|Overall Study|Withdrawal by Subject|1|||
156809525|NCT04860869|566057035|FG001|Overall Study|Withdrawal by Subject|0|||
156809526|NCT02651116|566057038|FG000|Overall Study|Adverse Event|0|||
156809527|NCT02651116|566057039|FG001|Overall Study|Adverse Event|1|||
156809528|NCT02651116|566057038|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
156809529|NCT02651116|566057039|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
156809530|NCT01775553|566057040|FG000|Overall Study|Adverse Event|1|||
156809531|NCT01775553|566057040|FG000|Overall Study|Disease Progression|12|||
156809532|NCT04834726|566057043|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
156809533|NCT04834726|566057044|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
156809534|NCT04834726|566057045|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
156809535|NCT04834726|566057046|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
156809536|NCT04834726|566057047|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
156809537|NCT04834726|566057048|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
156809538|NCT04834726|566057049|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
156809539|NCT04834726|566057050|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
156809540|NCT04834726|566057051|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
156809541|NCT03810014|566057055|FG000|Overall Study|Pregnancy|2|||
156809542|NCT03810014|566057056|FG001|Overall Study|Pregnancy|2|||
156809543|NCT03810014|566057057|FG002|Overall Study|Pregnancy|0|||
156809544|NCT03810014|566057058|FG003|Overall Study|Pregnancy|2|||
156809545|NCT03606486|566057059|FG000|Overall Study|Unable to collect sample|5|||
156809546|NCT00442416|566057065|FG000|Overall Study|Adverse Event|4|||
156809547|NCT00442416|566057066|FG001|Overall Study|Adverse Event|1|||
156809548|NCT00442416|566057065|FG000|Overall Study|Death|1|||
156809549|NCT00442416|566057066|FG001|Overall Study|Death|0|||
156809550|NCT00442416|566057065|FG000|Overall Study|Lack of Efficacy|2|||
156809551|NCT00442416|566057066|FG001|Overall Study|Lack of Efficacy|0|||
156809552|NCT00442416|566057065|FG000|Overall Study|Protocol Violation|2|||
156538439|NCT01838616|565066266|FG001|Continuation Period|Adverse Event|4|||
156538440|NCT01838616|565066265|FG000|Continuation Period|Protocol Violation|2|||
156809553|NCT00442416|566057066|FG001|Overall Study|Protocol Violation|3|||
156809554|NCT00442416|566057065|FG000|Overall Study|Withdrew consent|1|||
156809555|NCT00442416|566057066|FG001|Overall Study|Withdrew consent|2|||
156809556|NCT00442416|566057065|FG000|Overall Study|Administrative/Other|27|||
156461421|NCT05100628|564785216|FG000|Overall Study|Study Terminated by Sponsor|0|||
156461422|NCT05100628|564785217|FG001|Overall Study|Study Terminated by Sponsor|0|||
156461423|NCT05100628|564785218|FG002|Overall Study|Study Terminated by Sponsor|3|||
156461424|NCT05100628|564785219|FG003|Overall Study|Study Terminated by Sponsor|0|||
156461425|NCT05100628|564785216|FG000|Overall Study|unkown|0|||
156461426|NCT05100628|564785217|FG001|Overall Study|unkown|1|||
156461427|NCT05100628|564785218|FG002|Overall Study|unkown|0|||
156461428|NCT05100628|564785219|FG003|Overall Study|unkown|0|||
156461429|NCT05900154|564785224|FG000|Follow-Up Period|Lost to Follow-up|1|||
156461430|NCT05900154|564785225|FG001|Follow-Up Period|Lost to Follow-up|2|||
156461431|NCT05900154|564785226|FG002|Follow-Up Period|Lost to Follow-up|1|||
156461432|NCT05900154|564785227|FG003|Follow-Up Period|Lost to Follow-up|0|||
156461433|NCT05900154|564785228|FG004|Follow-Up Period|Lost to Follow-up|1|||
156461434|NCT05900154|564785229|FG005|Follow-Up Period|Lost to Follow-up|1|||
156461435|NCT01570361|564785230|FG000|Overall Study|Subject discontinued|1|||
156461436|NCT01570361|564785231|FG001|Overall Study|Subject discontinued|2|||
156809557|NCT00442416|566057066|FG001|Overall Study|Administrative/Other|33|||
156809558|NCT00503425|566057076|FG000|Overall Study|Participant files lost|6|||
156809559|NCT00503425|566057076|FG000|Overall Study|Adverse Event|5|||
156809560|NCT00503425|566057076|FG000|Overall Study|Lack of Efficacy|25|||
156809561|NCT00503425|566057076|FG000|Overall Study|Withdrawal by Subject|8|||
156809562|NCT00503425|566057076|FG000|Overall Study|Lost to Follow-up|3|||
156809563|NCT00503425|566057076|FG000|Overall Study|Death|3|||
156809564|NCT00503425|566057076|FG000|Overall Study|Missing Data/Unknown|4|||
156538441|NCT01838616|565066266|FG001|Continuation Period|Protocol Violation|0|||
156538442|NCT01838616|565066265|FG000|Continuation Period|Lost to Follow-up|1|||
156538443|NCT01838616|565066266|FG001|Continuation Period|Lost to Follow-up|0|||
156538444|NCT01838616|565066265|FG000|Continuation Period|Withdrawal by Subject|0|||
156538445|NCT01838616|565066266|FG001|Continuation Period|Withdrawal by Subject|4|||
156538446|NCT01838616|565066265|FG000|Continuation Period|Technical problems|0|||
156538447|NCT01838616|565066266|FG001|Continuation Period|Technical problems|1|||
156538448|NCT01838616|565066265|FG000|Pick-up Arm|Lack of Efficacy|4|||
156538449|NCT01838616|565066266|FG001|Pick-up Arm|Lack of Efficacy|0|||
156538450|NCT01838616|565066265|FG000|Pick-up Arm|Adverse Event|9|||
156538451|NCT01838616|565066266|FG001|Pick-up Arm|Adverse Event|0|||
156538452|NCT01838616|565066265|FG000|Pick-up Arm|Withdrawal by Subject|1|||
156538453|NCT01838616|565066266|FG001|Pick-up Arm|Withdrawal by Subject|0|||
156538454|NCT01838616|565066265|FG000|Pick-up Arm|Technical problems|1|||
156809565|NCT02148263|566057077|FG000|Overall Study|Withdrawal by Subject|3|||
156809566|NCT02148263|566057078|FG001|Overall Study|Withdrawal by Subject|2|||
156809567|NCT00003869|566057079|FG000|Overall Study|Adverse Event|14|||
156538455|NCT01838616|565066266|FG001|Pick-up Arm|Technical problems|0|||
156538456|NCT00257725|565066267|FG000|Overall Study|Adverse Event|3|||
156538457|NCT02573870|565066268|FG000|Overall Study|Adverse Event|0|||
156538458|NCT02573870|565066269|FG001|Overall Study|Adverse Event|2|||
156538459|NCT02573870|565066268|FG000|Overall Study|Lack of Efficacy|0|||
156538460|NCT02573870|565066269|FG001|Overall Study|Lack of Efficacy|1|||
156538461|NCT02573870|565066268|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
156538462|NCT02573870|565066269|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
156538463|NCT02573870|565066268|FG000|Overall Study|Lost to Follow-up|0|||
156538464|NCT02573870|565066269|FG001|Overall Study|Lost to Follow-up|1|||
156538465|NCT02573870|565066268|FG000|Overall Study|Other: Fail to Meet Visit|0|||
156538466|NCT02573870|565066269|FG001|Overall Study|Other: Fail to Meet Visit|2|||
156538467|NCT00709111|565066271|FG000|Overall Study|Withdrawal by Subject|1|||
156538468|NCT00709111|565066271|FG000|Overall Study|Unable to attend clinic visits|1|||
156538469|NCT00915772|565066272|FG000|Overall Study|Adverse Event|12|||
156809568|NCT00003869|566057080|FG001|Overall Study|Adverse Event|3|||
156809569|NCT00003869|566057079|FG000|Overall Study|Withdrawal by Subject|21|||
156809570|NCT00003869|566057080|FG001|Overall Study|Withdrawal by Subject|3|||
156809571|NCT00003869|566057079|FG000|Overall Study|Death|1|||
156809572|NCT00003869|566057080|FG001|Overall Study|Death|2|||
156809573|NCT00003869|566057079|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
156809574|NCT00003869|566057080|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
156809575|NCT03364231|566057081|FG000|Overall Study|Adverse Event|1|||
156809576|NCT03364231|566057082|FG001|Overall Study|Adverse Event|4|||
156809577|NCT03364231|566057081|FG000|Overall Study|Death|1|||
156809578|NCT03364231|566057082|FG001|Overall Study|Death|0|||
156809579|NCT03364231|566057081|FG000|Overall Study|Investigator Decision|2|||
156809580|NCT03364231|566057082|FG001|Overall Study|Investigator Decision|2|||
156809581|NCT03364231|566057081|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
156809582|NCT03364231|566057082|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
156809583|NCT03364231|566057081|FG000|Overall Study|Withdrawal of Subject Consent|1|||
156809584|NCT03364231|566057082|FG001|Overall Study|Withdrawal of Subject Consent|0|||
156809585|NCT03364231|566057081|FG000|Overall Study|Reason Not Specified|1|||
156809586|NCT03364231|566057082|FG001|Overall Study|Reason Not Specified|0|||
156809587|NCT03364231|566057081|FG000|Overall Study|Disease Progression|0|||
156809588|NCT03364231|566057082|FG001|Overall Study|Disease Progression|6|||
156809589|NCT02534883|566057089|FG000|Overall Study|Early Termination|8|||
156809590|NCT02534883|566057090|FG001|Overall Study|Early Termination|3|||
156538470|NCT00915772|565066273|FG001|Overall Study|Adverse Event|13|||
156538471|NCT00915772|565066274|FG002|Overall Study|Adverse Event|11|||
156538472|NCT00915772|565066272|FG000|Overall Study|Protocol Violation|4|||
156538473|NCT00915772|565066273|FG001|Overall Study|Protocol Violation|1|||
156538474|NCT00915772|565066274|FG002|Overall Study|Protocol Violation|2|||
156538475|NCT00915772|565066272|FG000|Overall Study|Lost to Follow-up|1|||
156809591|NCT00886769|566057091|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
156809592|NCT00886769|566057092|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
156809593|NCT03328832|566057093|FG000|Overall Study|Lost to Follow-up|0|||
156809594|NCT03328832|566057094|FG001|Overall Study|Lost to Follow-up|1|||
156809595|NCT00778336|566057095|FG000|Index Procedure-Discharge|Death|6|||
156809596|NCT00778336|566057096|FG001|Index Procedure-Discharge|Death|3|||
156538476|NCT00915772|565066273|FG001|Overall Study|Lost to Follow-up|2|||
156809597|NCT00778336|566057097|FG002|Index Procedure-Discharge|Death|2|||
156809598|NCT00778336|566057098|FG003|Index Procedure-Discharge|Death|0|||
156809599|NCT00778336|566057095|FG000|3 Month Follow Up|Lost to Follow-up|15|||
156809600|NCT00778336|566057096|FG001|3 Month Follow Up|Lost to Follow-up|20|||
156809601|NCT00778336|566057097|FG002|3 Month Follow Up|Lost to Follow-up|3|||
156809602|NCT00778336|566057098|FG003|3 Month Follow Up|Lost to Follow-up|0|||
156809603|NCT00778336|566057095|FG000|3 Month Follow Up|Death|8|||
156809604|NCT00778336|566057096|FG001|3 Month Follow Up|Death|3|||
156809605|NCT00778336|566057097|FG002|3 Month Follow Up|Death|2|||
156809606|NCT00778336|566057098|FG003|3 Month Follow Up|Death|0|||
156809607|NCT00414076|566057101|FG000|Overall Study|Progression|1|||
156809608|NCT00414076|566057102|FG001|Overall Study|Progression|2|||
156809609|NCT00414076|566057101|FG000|Overall Study|Withdrawal by Subject|1|||
156461437|NCT01570361|564785230|FG000|Overall Study|Sponsor closing the study|51|||
156461438|NCT01570361|564785231|FG001|Overall Study|Sponsor closing the study|50|||
156461439|NCT01570361|564785230|FG000|Overall Study|Subject excluded|5|||
156461440|NCT01570361|564785231|FG001|Overall Study|Subject excluded|3|||
156461441|NCT01570361|564785230|FG000|Overall Study|Subject withdrew consent|14|||
156461442|NCT01570361|564785231|FG001|Overall Study|Subject withdrew consent|9|||
156461443|NCT01570361|564785230|FG000|Overall Study|Adverse Event|2|||
156461444|NCT01570361|564785231|FG001|Overall Study|Adverse Event|1|||
156461445|NCT01570361|564785230|FG000|Overall Study|Lost to Follow-up|4|||
156461446|NCT01570361|564785231|FG001|Overall Study|Lost to Follow-up|4|||
156461447|NCT01570361|564785230|FG000|Overall Study|Death|5|||
156461448|NCT01570361|564785231|FG001|Overall Study|Death|4|||
156461449|NCT01570361|564785230|FG000|Overall Study|Other|0|||
156461450|NCT01570361|564785231|FG001|Overall Study|Other|2|||
156461451|NCT04129554|564785232|FG000|Overall Study|Withdrawal by Subject|4|||
156461452|NCT04129554|564785233|FG001|Overall Study|Withdrawal by Subject|3|||
156461453|NCT04129554|564785232|FG000|Overall Study|Other|0|||
156461454|NCT04129554|564785233|FG001|Overall Study|Other|2|||
156461455|NCT05158504|564785236|FG000|Overall Study|Lost to Follow-up|2|||
156461456|NCT05158504|564785237|FG001|Overall Study|Lost to Follow-up|3|||
156461457|NCT03606512|564785238|FG000|Overall Study|Lost to Follow-up|0|||
156461458|NCT03606512|564785239|FG001|Overall Study|Lost to Follow-up|1|||
156461459|NCT03606512|564785238|FG000|Overall Study|'moved from study area|0|||
156461460|NCT03606512|564785239|FG001|Overall Study|'moved from study area|1|||
156461461|NCT05513937|564785240|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
156461462|NCT05513937|564785241|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
156461463|NCT05513937|564785242|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
156461464|NCT05513937|564785243|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
156461465|NCT05513937|564785240|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
156461466|NCT05513937|564785241|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
156461467|NCT05513937|564785242|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
156461468|NCT05513937|564785243|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
156461469|NCT05513937|564785240|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
156461470|NCT05513937|564785241|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
156461471|NCT05513937|564785242|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
156461472|NCT05513937|564785243|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
156461473|NCT05513937|564785240|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
156461474|NCT05513937|564785241|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
156461475|NCT05513937|564785242|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
156461476|NCT05513937|564785243|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
156461477|NCT05513937|564785240|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
156461478|NCT05513937|564785241|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
156461479|NCT05513937|564785242|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
156461480|NCT05513937|564785243|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
156461481|NCT05513937|564785240|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
156461482|NCT05513937|564785241|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
156461483|NCT05513937|564785242|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
156809610|NCT00414076|566057102|FG001|Overall Study|Withdrawal by Subject|3|||
156809611|NCT00414076|566057101|FG000|Overall Study|Adverse Event|1|||
156809612|NCT00414076|566057102|FG001|Overall Study|Adverse Event|0|||
156809613|NCT00049257|566057103|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
156809614|NCT00049257|566057103|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
156809615|NCT00049257|566057103|FG000|Carboplatin, Paclitaxel|Death|2|||
156461484|NCT05513937|564785243|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
156461485|NCT02846545|564785244|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
156538477|NCT00915772|565066274|FG002|Overall Study|Lost to Follow-up|2|||
156809616|NCT00049257|566057103|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
156809617|NCT02708680|566057104|FG000|Overall Study|Withdrawal by Subject|4|||
156809618|NCT02708680|566057105|FG001|Overall Study|Withdrawal by Subject|12|||
156809619|NCT02708680|566057106|FG002|Overall Study|Withdrawal by Subject|12|||
156809620|NCT02708680|566057104|FG000|Overall Study|Death|4|||
156809621|NCT02708680|566057105|FG001|Overall Study|Death|19|||
156809622|NCT02708680|566057106|FG002|Overall Study|Death|21|||
156809623|NCT02708680|566057104|FG000|Overall Study|Lost to Follow-up|0|||
156809624|NCT02708680|566057105|FG001|Overall Study|Lost to Follow-up|3|||
156461486|NCT02846545|564785245|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
156461487|NCT02846545|564785244|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
156461488|NCT02846545|564785245|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
156461489|NCT02846545|564785244|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
156461490|NCT02846545|564785245|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
156461491|NCT02846545|564785244|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
156461492|NCT02846545|564785245|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
156461493|NCT02846545|564785244|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
156461494|NCT02846545|564785245|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
156461495|NCT05654662|564785248|FG000|Overall Study|Withdrawal by Subject|1|||
156461496|NCT05654662|564785249|FG001|Overall Study|Withdrawal by Subject|0|||
156461497|NCT05654662|564785248|FG000|Overall Study|A death in the family|1|||
156461498|NCT05654662|564785249|FG001|Overall Study|A death in the family|0|||
156461499|NCT04230681|564785250|FG000|Overall Study|Physician Decision|2|||
156461500|NCT04230681|564785251|FG001|Overall Study|Physician Decision|3|||
156461501|NCT04230681|564785250|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
156461502|NCT04230681|564785251|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
156461503|NCT04230681|564785250|FG000|Overall Study|IV inadvertently removed|0|||
156461504|NCT04230681|564785251|FG001|Overall Study|IV inadvertently removed|1|||
156809625|NCT02708680|566057106|FG002|Overall Study|Lost to Follow-up|3|||
156809626|NCT02708680|566057104|FG000|Overall Study|Study Terminated By Sponsor|0|||
156809627|NCT02708680|566057105|FG001|Overall Study|Study Terminated By Sponsor|5|||
156809628|NCT02708680|566057106|FG002|Overall Study|Study Terminated By Sponsor|4|||
156809629|NCT02708680|566057104|FG000|Overall Study|Other than Specified|0|||
156809630|NCT02708680|566057105|FG001|Overall Study|Other than Specified|0|||
156809631|NCT02708680|566057106|FG002|Overall Study|Other than Specified|1|||
156809632|NCT02708680|566057104|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
156809633|NCT02708680|566057105|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
156809634|NCT02708680|566057106|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
156809635|NCT01342926|566057107|FG000|Overall Study|Adverse Event|5|||
156809636|NCT01342926|566057108|FG001|Overall Study|Adverse Event|8|||
156809637|NCT01342926|566057109|FG002|Overall Study|Adverse Event|10|||
156809638|NCT01342926|566057110|FG003|Overall Study|Adverse Event|7|||
156809639|NCT01342926|566057107|FG000|Overall Study|Lost to Follow-up|0|||
156809640|NCT01342926|566057108|FG001|Overall Study|Lost to Follow-up|1|||
156809641|NCT01342926|566057109|FG002|Overall Study|Lost to Follow-up|1|||
156809642|NCT01342926|566057110|FG003|Overall Study|Lost to Follow-up|0|||
156809643|NCT01342926|566057107|FG000|Overall Study|Investigator Discretion|2|||
156809644|NCT01342926|566057108|FG001|Overall Study|Investigator Discretion|2|||
156809645|NCT01342926|566057109|FG002|Overall Study|Investigator Discretion|0|||
156809646|NCT01342926|566057110|FG003|Overall Study|Investigator Discretion|0|||
156809647|NCT01342926|566057107|FG000|Overall Study|Withdrawal by Subject|2|||
156809648|NCT01342926|566057108|FG001|Overall Study|Withdrawal by Subject|4|||
156809649|NCT01342926|566057109|FG002|Overall Study|Withdrawal by Subject|3|||
156809650|NCT01342926|566057110|FG003|Overall Study|Withdrawal by Subject|5|||
156809651|NCT03382912|566057111|FG000|Overall Study|Physician Decision|0|||
156809652|NCT03382912|566057112|FG001|Overall Study|Physician Decision|1|||
156809653|NCT03382912|566057111|FG000|Overall Study|Sponsor Decision|6|||
156809654|NCT03382912|566057112|FG001|Overall Study|Sponsor Decision|6|||
156809655|NCT03382912|566057111|FG000|Overall Study|Withdrawal by Subject|0|||
156809656|NCT03382912|566057112|FG001|Overall Study|Withdrawal by Subject|5|||
156809657|NCT00996658|566057115|FG000|Overall Study|Adverse Event|2|||
156809658|NCT00996658|566057116|FG001|Overall Study|Adverse Event|5|||
156461505|NCT01064440|564786707|FG000|Overall Study|Lost to Follow-up|1|||
156461506|NCT01064440|564786708|FG001|Overall Study|Lost to Follow-up|1|||
156461507|NCT01064440|564786709|FG002|Overall Study|Lost to Follow-up|1|||
156338758|NCT00873912|564338354|FG001|Overall Study|Withdrawal by Subject|0|||
156461508|NCT01064440|564786707|FG000|Overall Study|Non-compliance|0|||
156809659|NCT00996658|566057115|FG000|Overall Study|Protocol Violation|0|||
156809660|NCT00996658|566057116|FG001|Overall Study|Protocol Violation|1|||
156809661|NCT00996658|566057115|FG000|Overall Study|Lost to Follow-up|2|||
156809662|NCT00996658|566057116|FG001|Overall Study|Lost to Follow-up|5|||
156461509|NCT01064440|564786708|FG001|Overall Study|Non-compliance|1|||
156461510|NCT01064440|564786709|FG002|Overall Study|Non-compliance|0|||
156461511|NCT01064440|564786707|FG000|Overall Study|Death|1|||
156461512|NCT01064440|564786708|FG001|Overall Study|Death|0|||
156809663|NCT00996658|566057115|FG000|Overall Study|Non-compliance issues|3|||
156809664|NCT00996658|566057116|FG001|Overall Study|Non-compliance issues|3|||
156809665|NCT00996658|566057115|FG000|Overall Study|Other|9|||
156809666|NCT00996658|566057116|FG001|Overall Study|Other|7|||
156809667|NCT02685826|566057122|FG000|Overall Study|Adverse Event|2|||
156461513|NCT01064440|564786709|FG002|Overall Study|Death|1|||
156461514|NCT01064440|564786707|FG000|Overall Study|Withdrawal by Subject|0|||
156461515|NCT01064440|564786708|FG001|Overall Study|Withdrawal by Subject|1|||
156461516|NCT01064440|564786709|FG002|Overall Study|Withdrawal by Subject|1|||
156461517|NCT01064440|564786707|FG000|Overall Study|Other: amputation|1|||
156461518|NCT01064440|564786708|FG001|Overall Study|Other: amputation|0|||
156461519|NCT01064440|564786709|FG002|Overall Study|Other: amputation|0|||
156461520|NCT05507333|564786710|FG000|Overall Study|Protocol Violation|1|||
156461521|NCT01880515|564786711|FG000|Overall Study|Lost to Follow-up|3|||
156461522|NCT01880515|564786712|FG001|Overall Study|Lost to Follow-up|2|||
156461523|NCT01880515|564786711|FG000|Overall Study|Disease Progression|5|||
156461524|NCT01880515|564786712|FG001|Overall Study|Disease Progression|7|||
156461525|NCT05247034|564786713|FG000|Overall Study|Lost to Follow-up|3|||
156461526|NCT05247034|564786714|FG001|Overall Study|Lost to Follow-up|2|||
156461527|NCT05247034|564786713|FG000|Overall Study|Organizational problems when attending appointments|1|||
156461528|NCT05247034|564786714|FG001|Overall Study|Organizational problems when attending appointments|0|||
156461529|NCT03505710|564786717|FG000|Overall Study|Progressive Disease|24|||
156461530|NCT03505710|564786718|FG001|Overall Study|Progressive Disease|17|||
156461531|NCT03505710|564786719|FG002|Overall Study|Progressive Disease|43|||
156461532|NCT03505710|564786717|FG000|Overall Study|Clinical Progression|6|||
156461533|NCT03505710|564786718|FG001|Overall Study|Clinical Progression|8|||
156461534|NCT03505710|564786719|FG002|Overall Study|Clinical Progression|3|||
156461535|NCT03505710|564786717|FG000|Overall Study|Adverse Event|12|||
156461536|NCT03505710|564786718|FG001|Overall Study|Adverse Event|6|||
156461537|NCT03505710|564786719|FG002|Overall Study|Adverse Event|28|||
156461538|NCT03505710|564786717|FG000|Overall Study|Withdrawal by Subject|1|||
156461539|NCT03505710|564786718|FG001|Overall Study|Withdrawal by Subject|3|||
156461540|NCT03505710|564786719|FG002|Overall Study|Withdrawal by Subject|7|||
156461541|NCT03505710|564786717|FG000|Overall Study|Physician Decision|1|||
156461542|NCT03505710|564786718|FG001|Overall Study|Physician Decision|1|||
156461543|NCT03505710|564786719|FG002|Overall Study|Physician Decision|2|||
156461544|NCT03505710|564786717|FG000|Overall Study|Death|4|||
156461545|NCT03505710|564786718|FG001|Overall Study|Death|5|||
156461546|NCT03505710|564786719|FG002|Overall Study|Death|6|||
156461547|NCT03505710|564786717|FG000|Overall Study|Other Reasons|1|||
156461548|NCT03505710|564786718|FG001|Overall Study|Other Reasons|1|||
156461549|NCT03505710|564786719|FG002|Overall Study|Other Reasons|1|||
156461550|NCT03505710|564786717|FG000|Overall Study|Study Terminated by Sponsor|0|||
156461551|NCT03505710|564786718|FG001|Overall Study|Study Terminated by Sponsor|0|||
156461552|NCT03505710|564786719|FG002|Overall Study|Study Terminated by Sponsor|1|||
156461553|NCT04414722|564786722|FG000|Overall Study|Lost to Follow-up|3|||
156461554|NCT04414722|564786723|FG001|Overall Study|Lost to Follow-up|4|||
156461555|NCT04414722|564786724|FG002|Overall Study|Lost to Follow-up|3|||
156461556|NCT04414722|564786725|FG003|Overall Study|Lost to Follow-up|2|||
156461557|NCT04414722|564786726|FG004|Overall Study|Lost to Follow-up|3|||
156461558|NCT04414722|564786722|FG000|Overall Study|Withdrawal by Subject|6|||
156461559|NCT04414722|564786723|FG001|Overall Study|Withdrawal by Subject|3|||
156461560|NCT04414722|564786724|FG002|Overall Study|Withdrawal by Subject|1|||
156461561|NCT04414722|564786725|FG003|Overall Study|Withdrawal by Subject|5|||
156461562|NCT04414722|564786726|FG004|Overall Study|Withdrawal by Subject|1|||
156461563|NCT04414722|564786722|FG000|Overall Study|Physician Decision|0|||
156461564|NCT04414722|564786723|FG001|Overall Study|Physician Decision|1|||
156461565|NCT04414722|564786724|FG002|Overall Study|Physician Decision|2|||
156461566|NCT04414722|564786725|FG003|Overall Study|Physician Decision|0|||
156461567|NCT04414722|564786726|FG004|Overall Study|Physician Decision|0|||
156461568|NCT04414722|564786722|FG000|Overall Study|Non-participatory|0|||
156461569|NCT04414722|564786723|FG001|Overall Study|Non-participatory|1|||
156461570|NCT04414722|564786724|FG002|Overall Study|Non-participatory|1|||
156461571|NCT04414722|564786725|FG003|Overall Study|Non-participatory|0|||
156809668|NCT02685826|566057123|FG001|Overall Study|Adverse Event|0|||
156809669|NCT02685826|566057124|FG002|Overall Study|Adverse Event|1|||
156809670|NCT02685826|566057122|FG000|Overall Study|Progressive Disease|2|||
156809671|NCT02685826|566057123|FG001|Overall Study|Progressive Disease|1|||
156809672|NCT02685826|566057124|FG002|Overall Study|Progressive Disease|0|||
156809673|NCT02685826|566057122|FG000|Overall Study|Withdrawal by Subject|2|||
156461572|NCT04414722|564786726|FG004|Overall Study|Non-participatory|0|||
156461573|NCT05464069|564786727|FG000|Overall Study|Protocol Violation|3|||
156461574|NCT05464069|564786728|FG001|Overall Study|Protocol Violation|2|||
156461575|NCT03442309|564786729|FG000|Overall Study|Lost to Follow-up|1676|||
156461576|NCT03442309|564786730|FG001|Overall Study|Lost to Follow-up|1642|||
156461577|NCT04615273|564786734|FG000|Overall Study|Withdrawal by Subject|3|||
156461578|NCT04615273|564786735|FG001|Overall Study|Withdrawal by Subject|1|||
156461579|NCT04615273|564786736|FG002|Overall Study|Withdrawal by Subject|2|||
156461580|NCT04615273|564786734|FG000|Overall Study|Adverse Event|1|||
156461581|NCT04615273|564786735|FG001|Overall Study|Adverse Event|0|||
156461582|NCT04615273|564786736|FG002|Overall Study|Adverse Event|1|||
156461583|NCT04615273|564786734|FG000|Overall Study|Lost to Follow-up|0|||
156461584|NCT04615273|564786735|FG001|Overall Study|Lost to Follow-up|1|||
156461585|NCT04615273|564786736|FG002|Overall Study|Lost to Follow-up|0|||
156461586|NCT04615273|564786734|FG000|Overall Study|Physician Decision|0|||
156461587|NCT04615273|564786735|FG001|Overall Study|Physician Decision|0|||
156461588|NCT04615273|564786736|FG002|Overall Study|Physician Decision|1|||
156461589|NCT04615273|564786734|FG000|Overall Study|Other|0|||
156461590|NCT04615273|564786735|FG001|Overall Study|Other|1|||
156461591|NCT04615273|564786736|FG002|Overall Study|Other|0|||
156461592|NCT04615273|564786734|FG000|Overall Study|Randomized but not treated|1|||
156461593|NCT04615273|564786735|FG001|Overall Study|Randomized but not treated|3|||
156461594|NCT04615273|564786736|FG002|Overall Study|Randomized but not treated|1|||
156461595|NCT03677141|564786737|FG000|Overall Study|Death|2|||
156461596|NCT03677141|564786738|FG001|Overall Study|Death|1|||
156461597|NCT03677141|564786739|FG002|Overall Study|Death|6|||
156461598|NCT03677141|564786740|FG003|Overall Study|Death|9|||
156461599|NCT03677141|564786741|FG004|Overall Study|Death|5|||
156461600|NCT03677141|564786742|FG005|Overall Study|Death|3|||
156461601|NCT03677141|564786737|FG000|Overall Study|Lost to Follow-up|0|||
156461602|NCT03677141|564786738|FG001|Overall Study|Lost to Follow-up|0|||
156461603|NCT03677141|564786739|FG002|Overall Study|Lost to Follow-up|0|||
156461604|NCT03677141|564786740|FG003|Overall Study|Lost to Follow-up|2|||
156461605|NCT03677141|564786741|FG004|Overall Study|Lost to Follow-up|0|||
156461606|NCT03677141|564786742|FG005|Overall Study|Lost to Follow-up|0|||
156461607|NCT03677141|564786737|FG000|Overall Study|Screen failure or enrolled in error|0|||
156461608|NCT03677141|564786738|FG001|Overall Study|Screen failure or enrolled in error|0|||
156461609|NCT03677141|564786739|FG002|Overall Study|Screen failure or enrolled in error|0|||
156461610|NCT03677141|564786740|FG003|Overall Study|Screen failure or enrolled in error|0|||
156461611|NCT03677141|564786741|FG004|Overall Study|Screen failure or enrolled in error|2|||
156461612|NCT03677141|564786742|FG005|Overall Study|Screen failure or enrolled in error|0|||
156461613|NCT03677141|564786737|FG000|Overall Study|Physician Decision|0|||
156461614|NCT03677141|564786738|FG001|Overall Study|Physician Decision|0|||
156461615|NCT03677141|564786739|FG002|Overall Study|Physician Decision|0|||
156461616|NCT03677141|564786740|FG003|Overall Study|Physician Decision|0|||
156461617|NCT03677141|564786741|FG004|Overall Study|Physician Decision|1|||
156461618|NCT03677141|564786742|FG005|Overall Study|Physician Decision|0|||
156461619|NCT03677141|564786737|FG000|Overall Study|Withdrawal by Subject|0|||
156461620|NCT03677141|564786738|FG001|Overall Study|Withdrawal by Subject|0|||
156461621|NCT03677141|564786739|FG002|Overall Study|Withdrawal by Subject|1|||
156461622|NCT03677141|564786740|FG003|Overall Study|Withdrawal by Subject|1|||
156461623|NCT03677141|564786741|FG004|Overall Study|Withdrawal by Subject|1|||
156461624|NCT03677141|564786742|FG005|Overall Study|Withdrawal by Subject|0|||
156461625|NCT01314105|564786744|FG000|Overall Study|Progressive Disease|6|||
156461626|NCT01314105|564786745|FG001|Overall Study|Progressive Disease|10|||
156461627|NCT01314105|564786744|FG000|Overall Study|Refused to continue taking medication|0|||
156461628|NCT01314105|564786745|FG001|Overall Study|Refused to continue taking medication|1|||
156461629|NCT01314105|564786744|FG000|Overall Study|Other Adverse Event|1|||
156461630|NCT01314105|564786745|FG001|Overall Study|Other Adverse Event|1|||
156461631|NCT04526886|564786746|FG000|Overall Study|Physician Decision|4|||
156461632|NCT03640286|564786752|FG000|Overall Study|Adverse Event|6|||
156461633|NCT03640286|564786753|FG001|Overall Study|Adverse Event|6|||
156461634|NCT03640286|564786752|FG000|Overall Study|Lost to Follow-up|3|||
156461635|NCT03640286|564786753|FG001|Overall Study|Lost to Follow-up|6|||
156461636|NCT03640286|564786752|FG000|Overall Study|Pregnancy|1|||
156461637|NCT03640286|564786753|FG001|Overall Study|Pregnancy|0|||
156461638|NCT03640286|564786752|FG000|Overall Study|Withdrawal by Subject|10|||
156461639|NCT03640286|564786753|FG001|Overall Study|Withdrawal by Subject|10|||
156461640|NCT03640286|564786752|FG000|Overall Study|Non-compliance|4|||
156461641|NCT03640286|564786753|FG001|Overall Study|Non-compliance|10|||
156461642|NCT03640286|564786752|FG000|Overall Study|Medication change|1|||
156461643|NCT03640286|564786753|FG001|Overall Study|Medication change|0|||
156461644|NCT03640286|564786752|FG000|Overall Study|Other|1|||
156461645|NCT03640286|564786753|FG001|Overall Study|Other|2|||
156461646|NCT03640286|564786752|FG000|Overall Study|Joined another lifestyle program|0|||
156461647|NCT03640286|564786753|FG001|Overall Study|Joined another lifestyle program|1|||
156538478|NCT00915772|565066272|FG000|Overall Study|Lack of Efficacy|9|||
156538479|NCT00915772|565066273|FG001|Overall Study|Lack of Efficacy|15|||
156538480|NCT00915772|565066274|FG002|Overall Study|Lack of Efficacy|3|||
156538481|NCT00915772|565066272|FG000|Overall Study|Refused to continue trial medication|6|||
156461648|NCT03580356|564786756|FG000|Treatment Period|Withdrawal by Subject|13|||
156461649|NCT03580356|564786757|FG001|Treatment Period|Withdrawal by Subject|0|||
156461650|NCT03580356|564786758|FG002|Treatment Period|Withdrawal by Subject|13|||
156461651|NCT03580356|564786759|FG003|Treatment Period|Withdrawal by Subject|1|||
156461652|NCT03580356|564786760|FG004|Treatment Period|Withdrawal by Subject|17|||
156461653|NCT03580356|564786761|FG005|Treatment Period|Withdrawal by Subject|0|||
156461654|NCT03580356|564786762|FG006|Treatment Period|Withdrawal by Subject|5|||
156461655|NCT03580356|564786763|FG007|Treatment Period|Withdrawal by Subject|0|||
156461656|NCT03580356|564786756|FG000|Treatment Period|Adverse Event|10|||
156461657|NCT03580356|564786757|FG001|Treatment Period|Adverse Event|0|||
156461658|NCT03580356|564786758|FG002|Treatment Period|Adverse Event|13|||
156461659|NCT03580356|564786759|FG003|Treatment Period|Adverse Event|0|||
156538482|NCT00915772|565066273|FG001|Overall Study|Refused to continue trial medication|8|||
156538483|NCT00915772|565066274|FG002|Overall Study|Refused to continue trial medication|4|||
156538484|NCT00915772|565066272|FG000|Overall Study|Any other reason|4|||
156538485|NCT00915772|565066273|FG001|Overall Study|Any other reason|7|||
156538486|NCT00915772|565066274|FG002|Overall Study|Any other reason|7|||
156538487|NCT00549939|565066278|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
156538488|NCT00549939|565066279|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
156538489|NCT00549939|565066280|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
156538490|NCT00549939|565066278|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
156538491|NCT00549939|565066279|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
156538492|NCT00549939|565066280|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
156538493|NCT00549939|565066278|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
156538494|NCT00549939|565066279|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
156538495|NCT00549939|565066280|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
156538496|NCT00549939|565066278|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
156538497|NCT00549939|565066279|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
156538498|NCT00549939|565066280|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
156538499|NCT00549939|565066278|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
156538500|NCT00549939|565066279|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
156538501|NCT00549939|565066280|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
156538502|NCT00549939|565066278|FG000|40-week Open Label Treatment Period|Other|0|||
156538503|NCT00549939|565066279|FG001|40-week Open Label Treatment Period|Other|1|||
156538504|NCT00549939|565066280|FG002|40-week Open Label Treatment Period|Other|4|||
156538505|NCT01735279|565066281|FG000|Overall Study|Lost to Follow-up|11|||
156538506|NCT01735279|565066282|FG001|Overall Study|Lost to Follow-up|8|||
156538507|NCT00806195|565066283|FG000|Overall Study|Death|6|||
156538508|NCT00806195|565066284|FG001|Overall Study|Death|0|||
156538509|NCT00806195|565066285|FG002|Overall Study|Death|1|||
156538510|NCT00806195|565066286|FG003|Overall Study|Death|0|||
156538511|NCT00806195|565066283|FG000|Overall Study|Adverse Event|25|||
156538512|NCT00806195|565066284|FG001|Overall Study|Adverse Event|5|||
156538513|NCT00806195|565066285|FG002|Overall Study|Adverse Event|11|||
156538514|NCT00806195|565066286|FG003|Overall Study|Adverse Event|2|||
156538515|NCT00806195|565066283|FG000|Overall Study|Withdrawal by Subject|119|||
156538516|NCT00806195|565066284|FG001|Overall Study|Withdrawal by Subject|31|||
156538517|NCT00806195|565066285|FG002|Overall Study|Withdrawal by Subject|76|||
156538518|NCT00806195|565066286|FG003|Overall Study|Withdrawal by Subject|35|||
156538519|NCT00806195|565066283|FG000|Overall Study|Lost to Follow-up|217|||
156538520|NCT00806195|565066284|FG001|Overall Study|Lost to Follow-up|66|||
156538521|NCT00806195|565066285|FG002|Overall Study|Lost to Follow-up|90|||
156461660|NCT03580356|564786760|FG004|Treatment Period|Adverse Event|5|||
156461661|NCT03580356|564786761|FG005|Treatment Period|Adverse Event|0|||
156461662|NCT03580356|564786762|FG006|Treatment Period|Adverse Event|8|||
156461663|NCT03580356|564786763|FG007|Treatment Period|Adverse Event|0|||
156461664|NCT03580356|564786756|FG000|Treatment Period|Protocol Violation|5|||
156461665|NCT03580356|564786757|FG001|Treatment Period|Protocol Violation|0|||
156461666|NCT03580356|564786758|FG002|Treatment Period|Protocol Violation|6|||
156461667|NCT03580356|564786759|FG003|Treatment Period|Protocol Violation|1|||
156461668|NCT03580356|564786760|FG004|Treatment Period|Protocol Violation|9|||
156461669|NCT03580356|564786761|FG005|Treatment Period|Protocol Violation|1|||
156461670|NCT03580356|564786762|FG006|Treatment Period|Protocol Violation|1|||
156461671|NCT03580356|564786763|FG007|Treatment Period|Protocol Violation|0|||
156461672|NCT03580356|564786756|FG000|Treatment Period|Lack of Efficacy|6|||
156461673|NCT03580356|564786757|FG001|Treatment Period|Lack of Efficacy|0|||
156461674|NCT03580356|564786758|FG002|Treatment Period|Lack of Efficacy|2|||
156461675|NCT03580356|564786759|FG003|Treatment Period|Lack of Efficacy|0|||
156461676|NCT03580356|564786760|FG004|Treatment Period|Lack of Efficacy|3|||
156538522|NCT00806195|565066286|FG003|Overall Study|Lost to Follow-up|34|||
156538523|NCT00806195|565066283|FG000|Overall Study|Inappropriate Enrollment|0|||
156538524|NCT00806195|565066284|FG001|Overall Study|Inappropriate Enrollment|1|||
156538525|NCT00806195|565066285|FG002|Overall Study|Inappropriate Enrollment|0|||
156538526|NCT00806195|565066286|FG003|Overall Study|Inappropriate Enrollment|0|||
156538527|NCT00806195|565066283|FG000|Overall Study|Administrative Reason|113|||
156809674|NCT02685826|566057123|FG001|Overall Study|Withdrawal by Subject|0|||
156809675|NCT02685826|566057124|FG002|Overall Study|Withdrawal by Subject|0|||
156809676|NCT02685826|566057122|FG000|Overall Study|Full Clinical Hold by FDA|19|||
156538528|NCT00806195|565066284|FG001|Overall Study|Administrative Reason|35|||
156809677|NCT02685826|566057123|FG001|Overall Study|Full Clinical Hold by FDA|9|||
156809678|NCT02685826|566057124|FG002|Overall Study|Full Clinical Hold by FDA|20|||
156809679|NCT03154476|566057125|FG000|Overall Study|Lost to Follow-up|4|||
156538529|NCT00806195|565066285|FG002|Overall Study|Administrative Reason|66|||
156538530|NCT00806195|565066286|FG003|Overall Study|Administrative Reason|26|||
156461677|NCT03580356|564786761|FG005|Treatment Period|Lack of Efficacy|0|||
156461678|NCT03580356|564786762|FG006|Treatment Period|Lack of Efficacy|3|||
156461679|NCT03580356|564786763|FG007|Treatment Period|Lack of Efficacy|0|||
156538531|NCT00806195|565066283|FG000|Overall Study|Protocol Violation|34|||
156538532|NCT00806195|565066284|FG001|Overall Study|Protocol Violation|24|||
156538533|NCT00806195|565066285|FG002|Overall Study|Protocol Violation|26|||
156809680|NCT03154476|566057126|FG001|Overall Study|Lost to Follow-up|4|||
156809681|NCT01444430|566057128|FG000|Overall Study|Withdrawal by Subject|53|||
156809682|NCT01444430|566057129|FG001|Overall Study|Withdrawal by Subject|72|||
156809683|NCT01444430|566057128|FG000|Overall Study|Death|6|||
156809684|NCT01444430|566057129|FG001|Overall Study|Death|8|||
156809685|NCT01444430|566057128|FG000|Overall Study|Lost to Follow-up|2|||
156809686|NCT01444430|566057129|FG001|Overall Study|Lost to Follow-up|0|||
156809687|NCT01444430|566057128|FG000|Overall Study|CRF termination module not completed.|0|||
156809688|NCT01444430|566057129|FG001|Overall Study|CRF termination module not completed.|1|||
156809689|NCT02257242|566058689|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
156809690|NCT02257242|566058690|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809691|NCT02257242|566058691|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809692|NCT02257242|566058692|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809693|NCT02257242|566058693|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809694|NCT02257242|566058694|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809695|NCT02257242|566058695|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809696|NCT02257242|566058696|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809697|NCT02257242|566058697|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809698|NCT02522429|566058700|FG000|Overall Study|Lost to Follow-up|8|||
156809699|NCT02522429|566058700|FG000|Overall Study|Adverse Event|2|||
156809700|NCT02522429|566058700|FG000|Overall Study|Death|1|||
156809701|NCT02522429|566058700|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
156809702|NCT00600106|566058701|FG000|Overall Study|Withdrawal by Subject|1|||
156809703|NCT00600106|566058702|FG001|Overall Study|Withdrawal by Subject|1|||
156809704|NCT04667949|566058703|FG000|Overall Study|Adverse Event|0|||
156809705|NCT04667949|566058704|FG001|Overall Study|Adverse Event|2|||
156809706|NCT04667949|566058703|FG000|Overall Study|Lost to Follow-up|0|||
156809707|NCT04667949|566058704|FG001|Overall Study|Lost to Follow-up|1|||
156809708|NCT04667949|566058703|FG000|Overall Study|Physician Decision|0|||
156809709|NCT04667949|566058704|FG001|Overall Study|Physician Decision|2|||
156809710|NCT04667949|566058703|FG000|Overall Study|Subject decision|1|||
156809711|NCT04667949|566058704|FG001|Overall Study|Subject decision|7|||
156809712|NCT02763059|566058708|FG000|Overall Study|Lost to Follow-up|4|||
156809713|NCT02763059|566058709|FG001|Overall Study|Lost to Follow-up|1|||
156809714|NCT02763059|566058710|FG002|Overall Study|Lost to Follow-up|6|||
156809715|NCT02763059|566058708|FG000|Overall Study|Withdrawal by Subject|1|||
156809716|NCT02763059|566058709|FG001|Overall Study|Withdrawal by Subject|0|||
156809717|NCT02763059|566058710|FG002|Overall Study|Withdrawal by Subject|3|||
156809718|NCT02370368|566058711|FG000|Overall Study|Adverse Event|1|||
156809719|NCT02370368|566058712|FG001|Overall Study|Adverse Event|2|||
156809720|NCT02370368|566058711|FG000|Overall Study|Withdrawal by Subject|5|||
156809721|NCT02370368|566058712|FG001|Overall Study|Withdrawal by Subject|4|||
156809722|NCT04024436|566058713|FG000|Overall Study|Death|10|||
156809723|NCT04024436|566058714|FG001|Overall Study|Death|14|||
156809724|NCT04024436|566058715|FG002|Overall Study|Death|2|||
156809725|NCT04024436|566058716|FG003|Overall Study|Death|7|||
156809726|NCT04024436|566058713|FG000|Overall Study|Loss to follow up|1|||
156809727|NCT04024436|566058714|FG001|Overall Study|Loss to follow up|0|||
156809728|NCT04024436|566058715|FG002|Overall Study|Loss to follow up|0|||
156809729|NCT04024436|566058716|FG003|Overall Study|Loss to follow up|1|||
156809730|NCT04024436|566058713|FG000|Overall Study|Withdrawal of consent|2|||
156809731|NCT04024436|566058714|FG001|Overall Study|Withdrawal of consent|0|||
156809732|NCT04024436|566058715|FG002|Overall Study|Withdrawal of consent|0|||
156809733|NCT04024436|566058716|FG003|Overall Study|Withdrawal of consent|1|||
156809734|NCT04024436|566058713|FG000|Overall Study|Study termination by sponsor|4|||
156538534|NCT00806195|565066286|FG003|Overall Study|Protocol Violation|9|||
156809735|NCT04024436|566058714|FG001|Overall Study|Study termination by sponsor|6|||
156809736|NCT04024436|566058715|FG002|Overall Study|Study termination by sponsor|2|||
156809737|NCT04024436|566058716|FG003|Overall Study|Study termination by sponsor|11|||
156809738|NCT04024436|566058713|FG000|Overall Study|Reason Not Specified|0|||
156809739|NCT04024436|566058714|FG001|Overall Study|Reason Not Specified|1|||
156809740|NCT04024436|566058715|FG002|Overall Study|Reason Not Specified|0|||
156809741|NCT04024436|566058716|FG003|Overall Study|Reason Not Specified|2|||
156809742|NCT01169337|566058717|FG000|Overall Study|Lack of Efficacy|5|||
156809743|NCT01169337|566058718|FG001|Overall Study|Lack of Efficacy|7|||
156809744|NCT01169337|566058719|FG002|Overall Study|Lack of Efficacy|0|||
156809745|NCT01169337|566058717|FG000|Overall Study|Adverse Event|12|||
156809746|NCT01169337|566058718|FG001|Overall Study|Adverse Event|18|||
156461680|NCT03580356|564786756|FG000|Treatment Period|Pregnancy|1|||
156461681|NCT03580356|564786757|FG001|Treatment Period|Pregnancy|0|||
156461682|NCT03580356|564786758|FG002|Treatment Period|Pregnancy|7|||
156461683|NCT03580356|564786759|FG003|Treatment Period|Pregnancy|0|||
156461684|NCT03580356|564786760|FG004|Treatment Period|Pregnancy|2|||
156461685|NCT03580356|564786761|FG005|Treatment Period|Pregnancy|0|||
156461686|NCT03580356|564786762|FG006|Treatment Period|Pregnancy|1|||
156461687|NCT03580356|564786763|FG007|Treatment Period|Pregnancy|0|||
156461688|NCT03580356|564786756|FG000|Treatment Period|Physician Decision|2|||
156461689|NCT03580356|564786757|FG001|Treatment Period|Physician Decision|0|||
156461690|NCT03580356|564786758|FG002|Treatment Period|Physician Decision|1|||
156461691|NCT03580356|564786759|FG003|Treatment Period|Physician Decision|0|||
156461692|NCT03580356|564786760|FG004|Treatment Period|Physician Decision|4|||
156461693|NCT03580356|564786761|FG005|Treatment Period|Physician Decision|0|||
156461694|NCT03580356|564786762|FG006|Treatment Period|Physician Decision|2|||
156461695|NCT03580356|564786763|FG007|Treatment Period|Physician Decision|0|||
156461696|NCT03580356|564786756|FG000|Treatment Period|Lost to Follow-up|1|||
156461697|NCT03580356|564786757|FG001|Treatment Period|Lost to Follow-up|1|||
156461698|NCT03580356|564786758|FG002|Treatment Period|Lost to Follow-up|1|||
156461699|NCT03580356|564786759|FG003|Treatment Period|Lost to Follow-up|0|||
156461700|NCT03580356|564786760|FG004|Treatment Period|Lost to Follow-up|3|||
156461701|NCT03580356|564786761|FG005|Treatment Period|Lost to Follow-up|0|||
156461702|NCT03580356|564786762|FG006|Treatment Period|Lost to Follow-up|1|||
156461703|NCT03580356|564786763|FG007|Treatment Period|Lost to Follow-up|0|||
156461704|NCT03580356|564786756|FG000|Treatment Period|Death|0|||
156461705|NCT03580356|564786757|FG001|Treatment Period|Death|0|||
156461706|NCT03580356|564786758|FG002|Treatment Period|Death|1|||
156461707|NCT03580356|564786759|FG003|Treatment Period|Death|0|||
156461708|NCT03580356|564786760|FG004|Treatment Period|Death|0|||
156461709|NCT03580356|564786761|FG005|Treatment Period|Death|0|||
156461710|NCT03580356|564786762|FG006|Treatment Period|Death|0|||
156461711|NCT03580356|564786763|FG007|Treatment Period|Death|0|||
156461712|NCT03580356|564786756|FG000|Treatment Period|Technical problems|0|||
156461713|NCT03580356|564786757|FG001|Treatment Period|Technical problems|0|||
156461714|NCT03580356|564786758|FG002|Treatment Period|Technical problems|0|||
156461715|NCT03580356|564786759|FG003|Treatment Period|Technical problems|0|||
156461716|NCT03580356|564786760|FG004|Treatment Period|Technical problems|1|||
156461717|NCT03580356|564786761|FG005|Treatment Period|Technical problems|0|||
156461718|NCT03580356|564786762|FG006|Treatment Period|Technical problems|0|||
156461719|NCT03580356|564786763|FG007|Treatment Period|Technical problems|0|||
156461720|NCT03580356|564786756|FG000|Treatment Period|Misrandomized, no treatment|0|||
156461721|NCT03580356|564786757|FG001|Treatment Period|Misrandomized, no treatment|0|||
156461722|NCT03580356|564786758|FG002|Treatment Period|Misrandomized, no treatment|1|||
156461723|NCT03580356|564786759|FG003|Treatment Period|Misrandomized, no treatment|0|||
156461724|NCT03580356|564786760|FG004|Treatment Period|Misrandomized, no treatment|2|||
156461725|NCT03580356|564786761|FG005|Treatment Period|Misrandomized, no treatment|0|||
156461726|NCT03580356|564786762|FG006|Treatment Period|Misrandomized, no treatment|0|||
156461727|NCT03580356|564786763|FG007|Treatment Period|Misrandomized, no treatment|0|||
156461728|NCT03580356|564786756|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
156461729|NCT03580356|564786757|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
156461730|NCT03580356|564786758|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
156461731|NCT03580356|564786759|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
156461732|NCT03580356|564786760|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
156461733|NCT03580356|564786761|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
156461734|NCT03580356|564786762|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
156461735|NCT03580356|564786763|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
156461736|NCT03580356|564786756|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
156461737|NCT03580356|564786757|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
156461738|NCT03580356|564786758|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
156461739|NCT03580356|564786759|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
156461740|NCT03580356|564786760|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
156461741|NCT03580356|564786761|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
156461742|NCT03580356|564786762|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
156538535|NCT02319668|565066290|FG000|Overall Study|Other (Not specified)|0|||
156538536|NCT02319668|565066291|FG001|Overall Study|Other (Not specified)|2|||
156461743|NCT03580356|564786763|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
156461744|NCT03580356|564786756|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
156461745|NCT03580356|564786757|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
156461746|NCT03580356|564786758|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
156461747|NCT03580356|564786759|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
156461748|NCT03580356|564786760|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
156461749|NCT03580356|564786761|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
156461750|NCT03580356|564786762|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
156461751|NCT03580356|564786763|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
156809747|NCT01169337|566058719|FG002|Overall Study|Adverse Event|0|||
156809748|NCT01169337|566058717|FG000|Overall Study|Death|2|||
156809749|NCT01169337|566058718|FG001|Overall Study|Death|0|||
156809750|NCT01169337|566058719|FG002|Overall Study|Death|0|||
156809751|NCT01169337|566058717|FG000|Overall Study|Withdrawal by Subject|11|||
156809752|NCT01169337|566058718|FG001|Overall Study|Withdrawal by Subject|11|||
156809753|NCT01169337|566058719|FG002|Overall Study|Withdrawal by Subject|6|||
156809754|NCT01169337|566058717|FG000|Overall Study|Noncompliance|2|||
156809755|NCT01169337|566058718|FG001|Overall Study|Noncompliance|0|||
156809756|NCT01169337|566058719|FG002|Overall Study|Noncompliance|0|||
156809757|NCT01169337|566058717|FG000|Overall Study|Other complicating disease|1|||
156809758|NCT01169337|566058718|FG001|Overall Study|Other complicating disease|1|||
156809759|NCT01169337|566058719|FG002|Overall Study|Other complicating disease|0|||
156809760|NCT01169337|566058717|FG000|Overall Study|Physician Decision|1|||
156809761|NCT01169337|566058718|FG001|Overall Study|Physician Decision|5|||
156809762|NCT01169337|566058719|FG002|Overall Study|Physician Decision|0|||
156809763|NCT01169337|566058717|FG000|Overall Study|Alternative therapy|0|||
156809764|NCT01169337|566058718|FG001|Overall Study|Alternative therapy|2|||
156809765|NCT01169337|566058719|FG002|Overall Study|Alternative therapy|0|||
156809766|NCT01169337|566058717|FG000|Overall Study|Changed hospital|0|||
156809767|NCT01169337|566058718|FG001|Overall Study|Changed hospital|1|||
156809768|NCT01169337|566058719|FG002|Overall Study|Changed hospital|0|||
156809769|NCT01169337|566058717|FG000|Overall Study|Never started treatment|0|||
156809770|NCT01169337|566058718|FG001|Overall Study|Never started treatment|2|||
156809771|NCT01169337|566058719|FG002|Overall Study|Never started treatment|0|||
156809772|NCT01169337|566058717|FG000|Overall Study|Reason not reported|1|||
156809773|NCT01169337|566058718|FG001|Overall Study|Reason not reported|0|||
156809774|NCT01169337|566058719|FG002|Overall Study|Reason not reported|0|||
156809775|NCT01169337|566058717|FG000|Overall Study|Continuing lenalidomide|9|||
156809776|NCT01169337|566058718|FG001|Overall Study|Continuing lenalidomide|43|||
156809777|NCT01169337|566058719|FG002|Overall Study|Continuing lenalidomide|0|||
156809778|NCT01134614|566058720|FG000|Overall Study|Still on treatment as of March 2013|21|||
156809779|NCT01134614|566058721|FG001|Overall Study|Still on treatment as of March 2013|13|||
156809780|NCT01134614|566058720|FG000|Overall Study|Progressive disease|60|||
156809781|NCT01134614|566058721|FG001|Overall Study|Progressive disease|54|||
156809782|NCT01134614|566058720|FG000|Overall Study|Adverse Event|26|||
156809783|NCT01134614|566058721|FG001|Overall Study|Adverse Event|39|||
156809784|NCT01134614|566058720|FG000|Overall Study|Death|5|||
156809785|NCT01134614|566058721|FG001|Overall Study|Death|8|||
156809786|NCT01134614|566058720|FG000|Overall Study|Withdrawal by Subject|3|||
156809787|NCT01134614|566058721|FG001|Overall Study|Withdrawal by Subject|2|||
156809788|NCT01134614|566058720|FG000|Overall Study|Alternative therapy|2|||
156809789|NCT01134614|566058721|FG001|Overall Study|Alternative therapy|0|||
156809790|NCT01134614|566058720|FG000|Overall Study|Complicating disease|2|||
156809791|NCT01134614|566058721|FG001|Overall Study|Complicating disease|1|||
156809792|NCT01134614|566058720|FG000|Overall Study|Physician's decision|0|||
156809793|NCT01134614|566058721|FG001|Overall Study|Physician's decision|1|||
156809794|NCT01134614|566058720|FG000|Overall Study|Never started treatment|4|||
156809795|NCT01134614|566058721|FG001|Overall Study|Never started treatment|1|||
156809796|NCT01134614|566058720|FG000|Overall Study|Pt received tx not allowed on study|0|||
156809797|NCT01134614|566058721|FG001|Overall Study|Pt received tx not allowed on study|1|||
156809798|NCT01134614|566058720|FG000|Overall Study|Symptomatic deterioration|0|||
156809799|NCT01134614|566058721|FG001|Overall Study|Symptomatic deterioration|1|||
156809800|NCT01134614|566058720|FG000|Overall Study|Patient in hospice care|0|||
156809801|NCT01134614|566058721|FG001|Overall Study|Patient in hospice care|1|||
156809802|NCT00540592|566058722|FG000|Overall Study|Adverse Event|0|||
156809803|NCT00540592|566058723|FG001|Overall Study|Adverse Event|1|||
156809804|NCT00540592|566058724|FG002|Overall Study|Adverse Event|0|||
156809805|NCT00540592|566058725|FG003|Overall Study|Adverse Event|0|||
156809806|NCT00540592|566058726|FG004|Overall Study|Adverse Event|1|||
156809807|NCT00540592|566058727|FG005|Overall Study|Adverse Event|0|||
156809808|NCT00540592|566058728|FG006|Overall Study|Adverse Event|0|||
156809809|NCT00540592|566058729|FG007|Overall Study|Adverse Event|1|||
156809810|NCT00540592|566058730|FG008|Overall Study|Adverse Event|1|||
156809811|NCT00540592|566058731|FG009|Overall Study|Adverse Event|2|||
156809812|NCT00540592|566058722|FG000|Overall Study|Lost to Follow-up|2|||
156809813|NCT00540592|566058723|FG001|Overall Study|Lost to Follow-up|0|||
156809814|NCT00540592|566058724|FG002|Overall Study|Lost to Follow-up|0|||
156809815|NCT00540592|566058725|FG003|Overall Study|Lost to Follow-up|0|||
156809816|NCT00540592|566058726|FG004|Overall Study|Lost to Follow-up|0|||
156809817|NCT00540592|566058727|FG005|Overall Study|Lost to Follow-up|0|||
156809818|NCT00540592|566058728|FG006|Overall Study|Lost to Follow-up|0|||
156809819|NCT00540592|566058729|FG007|Overall Study|Lost to Follow-up|0|||
156809820|NCT00540592|566058730|FG008|Overall Study|Lost to Follow-up|0|||
156809821|NCT00540592|566058731|FG009|Overall Study|Lost to Follow-up|0|||
156809822|NCT00540592|566058722|FG000|Overall Study|Withdrawal by Subject|0|||
156809823|NCT00540592|566058723|FG001|Overall Study|Withdrawal by Subject|0|||
156809824|NCT00540592|566058724|FG002|Overall Study|Withdrawal by Subject|1|||
156809825|NCT00540592|566058725|FG003|Overall Study|Withdrawal by Subject|1|||
156461752|NCT03580356|564786756|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
156461753|NCT03580356|564786757|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
156461754|NCT03580356|564786758|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
156461755|NCT03580356|564786759|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
156461756|NCT03580356|564786760|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
156461757|NCT03580356|564786761|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
156461758|NCT03580356|564786762|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
156461759|NCT03580356|564786763|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
156461760|NCT03580356|564786756|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
156461761|NCT03580356|564786757|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
156461762|NCT03580356|564786758|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
156461763|NCT03580356|564786759|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
156461764|NCT03580356|564786760|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
156461765|NCT03580356|564786761|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
156461766|NCT03580356|564786762|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
156461767|NCT03580356|564786763|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
156461768|NCT03580356|564786756|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
156461769|NCT03580356|564786757|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
156461770|NCT03580356|564786758|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
156461771|NCT03580356|564786759|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
156461772|NCT03580356|564786760|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
156461773|NCT03580356|564786761|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
156461774|NCT03580356|564786762|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
156461775|NCT03580356|564786763|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
156461776|NCT03580356|564786756|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
156461777|NCT03580356|564786757|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
156461778|NCT03580356|564786758|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
156461779|NCT03580356|564786759|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
156809826|NCT00540592|566058726|FG004|Overall Study|Withdrawal by Subject|0|||
156809827|NCT00540592|566058727|FG005|Overall Study|Withdrawal by Subject|0|||
156809828|NCT00540592|566058728|FG006|Overall Study|Withdrawal by Subject|0|||
156809829|NCT00540592|566058729|FG007|Overall Study|Withdrawal by Subject|0|||
156461780|NCT03580356|564786760|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
156809830|NCT00540592|566058730|FG008|Overall Study|Withdrawal by Subject|0|||
156809831|NCT00540592|566058731|FG009|Overall Study|Withdrawal by Subject|0|||
156461781|NCT03580356|564786761|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
156461782|NCT03580356|564786762|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
156461783|NCT03580356|564786763|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
156461784|NCT03485729|564786774|FG000|Overall Study|Withdrawal by Subject|0|||
156461785|NCT03485729|564786775|FG001|Overall Study|Withdrawal by Subject|0|||
156461786|NCT03485729|564786776|FG002|Overall Study|Withdrawal by Subject|1|||
156461787|NCT03485729|564786774|FG000|Overall Study|Disease progression|8|||
156461788|NCT03485729|564786775|FG001|Overall Study|Disease progression|13|||
156461789|NCT03485729|564786776|FG002|Overall Study|Disease progression|1|||
156461790|NCT03485729|564786774|FG000|Overall Study|Hospice care|1|||
156461791|NCT03485729|564786775|FG001|Overall Study|Hospice care|0|||
156461792|NCT03485729|564786776|FG002|Overall Study|Hospice care|0|||
156461793|NCT03485729|564786774|FG000|Overall Study|Poor performance status|1|||
156461794|NCT03485729|564786775|FG001|Overall Study|Poor performance status|0|||
156461795|NCT03485729|564786776|FG002|Overall Study|Poor performance status|0|||
156461796|NCT03485729|564786774|FG000|Overall Study|Illness|0|||
156461797|NCT03485729|564786775|FG001|Overall Study|Illness|1|||
156461798|NCT03485729|564786776|FG002|Overall Study|Illness|0|||
156461799|NCT02839265|564786778|FG000|Overall Study|Screen Failure|2|||
156809832|NCT04908683|566058733|FG000|Overall Study|Failure to meet continuation criteria|34|||
156809833|NCT04908683|566058734|FG001|Overall Study|Failure to meet continuation criteria|22|||
156809834|NCT04908683|566058733|FG000|Overall Study|Initiated prohibited medication|3|||
156809835|NCT04908683|566058734|FG001|Overall Study|Initiated prohibited medication|0|||
156809836|NCT04908683|566058733|FG000|Overall Study|Randomized by mistake|1|||
156809837|NCT04908683|566058734|FG001|Overall Study|Randomized by mistake|0|||
156809838|NCT04908683|566058733|FG000|Overall Study|Lost to Follow-up|679|||
156809839|NCT04908683|566058734|FG001|Overall Study|Lost to Follow-up|341|||
156809840|NCT04908683|566058733|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
156809841|NCT04908683|566058734|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
156461800|NCT02839265|564786778|FG000|Overall Study|Death|1|||
156461801|NCT02839265|564786778|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
156461802|NCT05552508|564786779|FG000|Overall Study|Adverse Event|3|||
156461803|NCT04311632|564786781|FG000|Overall Study|Withdrawal by Subject|0|||
156461804|NCT04311632|564786782|FG001|Overall Study|Withdrawal by Subject|0|||
156461805|NCT04311632|564786783|FG002|Overall Study|Withdrawal by Subject|1|||
156461806|NCT04632225|564786784|FG000|Overall Study|Withdrawal by Subject|2|||
156461807|NCT04632225|564786785|FG001|Overall Study|Withdrawal by Subject|2|||
156338759|NCT00873912|564338353|FG000|Overall Study|Lost to Follow-up|2|||
156338760|NCT00873912|564338354|FG001|Overall Study|Lost to Follow-up|0|||
156338761|NCT03192462|564340036|FG000|Overall Study|Death|13|||
156338762|NCT03192462|564340037|FG001|Overall Study|Death|11|||
156338763|NCT03192462|564340038|FG002|Overall Study|Death|10|||
156338764|NCT03192462|564340036|FG000|Overall Study|Lost to Follow-up|0|||
156338765|NCT03192462|564340037|FG001|Overall Study|Lost to Follow-up|1|||
156338766|NCT03192462|564340038|FG002|Overall Study|Lost to Follow-up|0|||
156338767|NCT02200211|564340040|FG000|Overall Study|Lost to Follow-up|7|||
156338768|NCT02200211|564340041|FG001|Overall Study|Lost to Follow-up|7|||
156338769|NCT02200211|564340042|FG002|Overall Study|Lost to Follow-up|1|||
156338770|NCT02200211|564340043|FG003|Overall Study|Lost to Follow-up|2|||
156338771|NCT02200211|564340040|FG000|Overall Study|Withdrawal by Subject|1|||
156338772|NCT02200211|564340041|FG001|Overall Study|Withdrawal by Subject|0|||
156338773|NCT02200211|564340042|FG002|Overall Study|Withdrawal by Subject|0|||
156338774|NCT02200211|564340043|FG003|Overall Study|Withdrawal by Subject|0|||
156338775|NCT00381485|564340044|FG000|Open-Label Run-In Period|Adverse Event|9|||
156338776|NCT00381485|564340045|FG001|Open-Label Run-In Period|Adverse Event|0|||
156338777|NCT00381485|564340046|FG002|Open-Label Run-In Period|Adverse Event|0|||
156338778|NCT00381485|564340047|FG003|Open-Label Run-In Period|Adverse Event|0|||
156338779|NCT00381485|564340044|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
156338780|NCT00381485|564340045|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
156338781|NCT00381485|564340046|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
156338782|NCT00381485|564340047|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
156338783|NCT00381485|564340044|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
156338784|NCT00381485|564340045|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
156338785|NCT00381485|564340046|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
156338786|NCT00381485|564340047|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
156338787|NCT00381485|564340044|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
156338788|NCT00381485|564340045|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
156338789|NCT00381485|564340046|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
156338790|NCT00381485|564340047|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
156338791|NCT00381485|564340044|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
156809842|NCT04908683|566058733|FG000|Overall Study|Physician Decision|44|||
156809843|NCT04908683|566058734|FG001|Overall Study|Physician Decision|35|||
156809844|NCT04908683|566058733|FG000|Overall Study|Technical problems|12|||
156809845|NCT04908683|566058734|FG001|Overall Study|Technical problems|9|||
156809846|NCT04908683|566058733|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
156809847|NCT04908683|566058734|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
156809848|NCT04908683|566058733|FG000|Overall Study|Protocol Violation|2|||
156809849|NCT04908683|566058734|FG001|Overall Study|Protocol Violation|0|||
156809850|NCT04908683|566058733|FG000|Overall Study|Withdrawal by Subject|1188|||
156809851|NCT04908683|566058734|FG001|Overall Study|Withdrawal by Subject|570|||
156809852|NCT04908683|566058733|FG000|Overall Study|Site Closure by Sponsor|6|||
156809853|NCT04908683|566058734|FG001|Overall Study|Site Closure by Sponsor|3|||
156809854|NCT04908683|566058733|FG000|Overall Study|Adverse Event|21|||
156809855|NCT04908683|566058734|FG001|Overall Study|Adverse Event|11|||
156809856|NCT04908683|566058733|FG000|Overall Study|Death|101|||
156809857|NCT04908683|566058734|FG001|Overall Study|Death|61|||
156809858|NCT04908683|566058733|FG000|Overall Study|Sponsor's decision|14398|||
156809859|NCT04908683|566058734|FG001|Overall Study|Sponsor's decision|7205|||
156809860|NCT04908683|566058733|FG000|Overall Study|Other|92|||
156809861|NCT04908683|566058734|FG001|Overall Study|Other|50|||
156809862|NCT04908683|566058733|FG000|Overall Study|Randomized not vaccinated|108|||
156809863|NCT04908683|566058734|FG001|Overall Study|Randomized not vaccinated|52|||
156809864|NCT05507567|566058735|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
156809865|NCT05507567|566058736|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
156809866|NCT05507567|566058737|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
156809867|NCT05507567|566058735|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
156809868|NCT05507567|566058736|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
156809869|NCT05507567|566058737|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
156809870|NCT05507567|566058735|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
156809871|NCT05507567|566058736|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
156809872|NCT05507567|566058737|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
156809873|NCT05507567|566058735|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
156809874|NCT05507567|566058736|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
156809875|NCT05507567|566058737|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
156809876|NCT01722994|566058740|FG000|Overall Study|Missing data|25|||
156809877|NCT01722994|566058741|FG001|Overall Study|Missing data|17|||
156809878|NCT01206140|566058742|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
156338792|NCT00381485|564340045|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
156461808|NCT02323880|564786786|FG000|Overall Study|Adverse Event|2|||
156809879|NCT01206140|566058743|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
156809880|NCT01803880|566058744|FG000|Overall Study|Adverse Event|1|||
156809881|NCT01803880|566058745|FG001|Overall Study|Adverse Event|0|||
156461809|NCT02323880|564786787|FG001|Overall Study|Adverse Event|0|||
156461810|NCT02323880|564786788|FG002|Overall Study|Adverse Event|1|||
156461811|NCT02323880|564786789|FG003|Overall Study|Adverse Event|1|||
156461812|NCT02323880|564786790|FG004|Overall Study|Adverse Event|1|||
156461813|NCT02323880|564786791|FG005|Overall Study|Adverse Event|0|||
156461814|NCT02323880|564786792|FG006|Overall Study|Adverse Event|1|||
156461815|NCT02323880|564786793|FG007|Overall Study|Adverse Event|0|||
156461816|NCT02323880|564786786|FG000|Overall Study|Death|0|||
156461817|NCT02323880|564786787|FG001|Overall Study|Death|0|||
156461818|NCT02323880|564786788|FG002|Overall Study|Death|0|||
156461819|NCT02323880|564786789|FG003|Overall Study|Death|0|||
156461820|NCT02323880|564786790|FG004|Overall Study|Death|0|||
156461821|NCT02323880|564786791|FG005|Overall Study|Death|1|||
156461822|NCT02323880|564786792|FG006|Overall Study|Death|0|||
156461823|NCT02323880|564786793|FG007|Overall Study|Death|0|||
156461824|NCT02323880|564786786|FG000|Overall Study|Lack of Efficacy|4|||
156461825|NCT02323880|564786787|FG001|Overall Study|Lack of Efficacy|11|||
156461826|NCT02323880|564786788|FG002|Overall Study|Lack of Efficacy|5|||
156461827|NCT02323880|564786789|FG003|Overall Study|Lack of Efficacy|5|||
156461828|NCT02323880|564786790|FG004|Overall Study|Lack of Efficacy|4|||
156461829|NCT02323880|564786791|FG005|Overall Study|Lack of Efficacy|8|||
156461830|NCT02323880|564786792|FG006|Overall Study|Lack of Efficacy|4|||
156461831|NCT02323880|564786793|FG007|Overall Study|Lack of Efficacy|6|||
156461832|NCT02323880|564786786|FG000|Overall Study|Physician Decision|0|||
156461833|NCT02323880|564786787|FG001|Overall Study|Physician Decision|0|||
156461834|NCT02323880|564786788|FG002|Overall Study|Physician Decision|0|||
156461835|NCT02323880|564786789|FG003|Overall Study|Physician Decision|0|||
156461836|NCT02323880|564786790|FG004|Overall Study|Physician Decision|1|||
156461837|NCT02323880|564786791|FG005|Overall Study|Physician Decision|1|||
156461838|NCT02323880|564786792|FG006|Overall Study|Physician Decision|1|||
156461839|NCT02323880|564786793|FG007|Overall Study|Physician Decision|0|||
156461840|NCT02323880|564786786|FG000|Overall Study|Withdrawal by Subject|0|||
156461841|NCT02323880|564786787|FG001|Overall Study|Withdrawal by Subject|2|||
156461842|NCT02323880|564786788|FG002|Overall Study|Withdrawal by Subject|0|||
156461843|NCT02323880|564786789|FG003|Overall Study|Withdrawal by Subject|0|||
156461844|NCT02323880|564786790|FG004|Overall Study|Withdrawal by Subject|0|||
156809882|NCT01803880|566058746|FG002|Overall Study|Adverse Event|0|||
156809883|NCT01803880|566058744|FG000|Overall Study|Withdrawal by Subject|1|||
156809884|NCT01803880|566058745|FG001|Overall Study|Withdrawal by Subject|1|||
156809885|NCT01803880|566058746|FG002|Overall Study|Withdrawal by Subject|4|||
156809886|NCT01803880|566058744|FG000|Overall Study|Physician Decision|0|||
156809887|NCT01803880|566058745|FG001|Overall Study|Physician Decision|0|||
156809888|NCT01803880|566058746|FG002|Overall Study|Physician Decision|1|||
156809889|NCT01803880|566058744|FG000|Overall Study|Unable to return for follow-up visits|0|||
156809890|NCT01803880|566058745|FG001|Overall Study|Unable to return for follow-up visits|1|||
156809891|NCT01803880|566058746|FG002|Overall Study|Unable to return for follow-up visits|2|||
156809892|NCT01803880|566058744|FG000|Overall Study|Lost to Follow-up|1|||
156809893|NCT01803880|566058745|FG001|Overall Study|Lost to Follow-up|2|||
156809894|NCT01803880|566058746|FG002|Overall Study|Lost to Follow-up|3|||
156809895|NCT01803880|566058744|FG000|Overall Study|Protocol Violation|1|||
156809896|NCT01803880|566058745|FG001|Overall Study|Protocol Violation|0|||
156809897|NCT01803880|566058746|FG002|Overall Study|Protocol Violation|0|||
156809898|NCT01803880|566058744|FG000|Overall Study|Early study termination|0|||
156809899|NCT01803880|566058745|FG001|Overall Study|Early study termination|6|||
156809900|NCT01803880|566058746|FG002|Overall Study|Early study termination|5|||
156809901|NCT01803880|566058744|FG000|Overall Study|Incomplete data entry by sites|2|||
156809902|NCT01803880|566058745|FG001|Overall Study|Incomplete data entry by sites|0|||
156809903|NCT01803880|566058746|FG002|Overall Study|Incomplete data entry by sites|0|||
156809904|NCT01766037|566058748|FG000|Overall Study|Adverse Event|1|||
156809905|NCT01766037|566058749|FG001|Overall Study|Adverse Event|0|||
156809906|NCT01766037|566058748|FG000|Overall Study|Lack of Efficacy|1|||
156338793|NCT00381485|564340046|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
156461845|NCT02323880|564786791|FG005|Overall Study|Withdrawal by Subject|0|||
156809907|NCT01766037|566058749|FG001|Overall Study|Lack of Efficacy|0|||
156809908|NCT01766037|566058748|FG000|Overall Study|Lost to Follow-up|0|||
156809909|NCT01766037|566058749|FG001|Overall Study|Lost to Follow-up|10|||
156809910|NCT01766037|566058748|FG000|Overall Study|Physician Decision|0|||
156809911|NCT01766037|566058749|FG001|Overall Study|Physician Decision|1|||
156809912|NCT01766037|566058748|FG000|Overall Study|Withdrawal by Subject|18|||
156809913|NCT01766037|566058749|FG001|Overall Study|Withdrawal by Subject|16|||
156461846|NCT02323880|564786792|FG006|Overall Study|Withdrawal by Subject|0|||
156461847|NCT02323880|564786793|FG007|Overall Study|Withdrawal by Subject|0|||
156461848|NCT04934072|564786794|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
156461849|NCT04934072|564786795|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
156461850|NCT04934072|564786796|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
156461851|NCT04934072|564786797|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
156538537|NCT01161043|565066292|FG000|Overall Study|Withdrawal by Subject|3|||
156809914|NCT01766037|566058748|FG000|Overall Study|Moved from area|5|||
156809915|NCT01766037|566058749|FG001|Overall Study|Moved from area|0|||
156809916|NCT01766037|566058748|FG000|Overall Study|medical - unrelated|1|||
156809917|NCT01766037|566058749|FG001|Overall Study|medical - unrelated|2|||
156809918|NCT01766037|566058748|FG000|Overall Study|nausea / discomfort|3|||
156809919|NCT01766037|566058749|FG001|Overall Study|nausea / discomfort|0|||
156809920|NCT05226598|566058752|FG000|Overall Study|Death|186|||
156809921|NCT05226598|566058753|FG001|Overall Study|Death|191|||
156809922|NCT05226598|566058752|FG000|Overall Study|Withdrawal by Subject|6|||
156809923|NCT05226598|566058753|FG001|Overall Study|Withdrawal by Subject|6|||
156809924|NCT05226598|566058752|FG000|Overall Study|Ongoing|174|||
156809925|NCT05226598|566058753|FG001|Overall Study|Ongoing|176|||
156809926|NCT00090779|566058754|FG000|Step 1|Withdrawal by Subject|4|||
156809927|NCT00090779|566058755|FG001|Step 1|Withdrawal by Subject|2|||
156809928|NCT00090779|566058754|FG000|Step 1|Lost to Follow-up|3|||
156809929|NCT00090779|566058755|FG001|Step 1|Lost to Follow-up|2|||
156809930|NCT00090779|566058754|FG000|Step 1|Death|0|||
156809931|NCT00090779|566058755|FG001|Step 1|Death|2|||
156809932|NCT00090779|566058754|FG000|Step 1|Physician Decision|1|||
156809933|NCT00090779|566058755|FG001|Step 1|Physician Decision|0|||
156809934|NCT00090779|566058754|FG000|Step 1|Pregnancy|1|||
156809935|NCT00090779|566058755|FG001|Step 1|Pregnancy|0|||
156809936|NCT00090779|566058754|FG000|Step 1|Non-compliance to study requirements|0|||
156809937|NCT00090779|566058755|FG001|Step 1|Non-compliance to study requirements|1|||
156809938|NCT00090779|566058754|FG000|Step 1|Subject relocated|2|||
156809939|NCT00090779|566058755|FG001|Step 1|Subject relocated|8|||
156809940|NCT00090779|566058754|FG000|Step 2|Off study per study closure|6|||
156809941|NCT00090779|566058755|FG001|Step 2|Off study per study closure|16|||
156338794|NCT00381485|564340047|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
156338795|NCT00381485|564340044|FG000|Open-Label Run-In Period|Treatment failure|1|||
156338796|NCT00381485|564340045|FG001|Open-Label Run-In Period|Treatment failure|0|||
156338797|NCT00381485|564340046|FG002|Open-Label Run-In Period|Treatment failure|0|||
156338798|NCT00381485|564340047|FG003|Open-Label Run-In Period|Treatment failure|0|||
156338799|NCT00381485|564340044|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156338800|NCT00381485|564340045|FG001|Double-Blind Treatment Period|Adverse Event|2|||
156338801|NCT00381485|564340046|FG002|Double-Blind Treatment Period|Adverse Event|2|||
156338802|NCT00381485|564340047|FG003|Double-Blind Treatment Period|Adverse Event|5|||
156338803|NCT00381485|564340044|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156338804|NCT00381485|564340045|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
156338805|NCT00381485|564340046|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
156338806|NCT00381485|564340047|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
156338807|NCT00381485|564340044|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156338808|NCT00381485|564340045|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
156338809|NCT00381485|564340046|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
156338810|NCT00381485|564340047|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
156338811|NCT00381485|564340044|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
156338812|NCT00381485|564340045|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
156338813|NCT00381485|564340046|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
156338814|NCT00381485|564340047|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
156338815|NCT00381485|564340044|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
156338816|NCT00381485|564340045|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
156338817|NCT00381485|564340046|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
156338818|NCT00381485|564340047|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
156338819|NCT00381485|564340044|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
156338820|NCT00381485|564340045|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
156338821|NCT00381485|564340046|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
156338822|NCT00381485|564340047|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
156338823|NCT00381485|564340044|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
156338824|NCT00381485|564340045|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
156338825|NCT00381485|564340046|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
156338826|NCT00381485|564340047|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
156338827|NCT00381485|564340044|FG000|Double-Blind Treatment Period|Administrative|0|||
156338828|NCT00381485|564340045|FG001|Double-Blind Treatment Period|Administrative|1|||
156338829|NCT00381485|564340046|FG002|Double-Blind Treatment Period|Administrative|0|||
156338830|NCT00381485|564340047|FG003|Double-Blind Treatment Period|Administrative|1|||
156338831|NCT01433991|564340050|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
156809942|NCT00090779|566058754|FG000|Step 2|Subject relocated|0|||
156809943|NCT00090779|566058755|FG001|Step 2|Subject relocated|1|||
156809944|NCT00090779|566058754|FG000|Step 2|Non-compliance to study requirements|0|||
156809945|NCT00090779|566058755|FG001|Step 2|Non-compliance to study requirements|1|||
156809946|NCT00090779|566058754|FG000|Step 3|Initiation of ART and off extended study|3|||
156461852|NCT04934072|564786798|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
156461853|NCT04934072|564786794|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
156461854|NCT04934072|564786795|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
156461855|NCT04934072|564786796|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
156461856|NCT04934072|564786797|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
156461857|NCT04934072|564786798|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
156461858|NCT04934072|564786794|FG000|Day 0 to Week 52|Other|3|||
156461859|NCT04934072|564786795|FG001|Day 0 to Week 52|Other|1|||
156461860|NCT04934072|564786796|FG002|Day 0 to Week 52|Other|0|||
156461861|NCT04934072|564786797|FG003|Day 0 to Week 52|Other|0|||
156461862|NCT04934072|564786798|FG004|Day 0 to Week 52|Other|0|||
156461863|NCT04934072|564786794|FG000|Day 0 to Week 52|Adverse Event|1|||
156461864|NCT04934072|564786795|FG001|Day 0 to Week 52|Adverse Event|3|||
156461865|NCT04934072|564786796|FG002|Day 0 to Week 52|Adverse Event|0|||
156461866|NCT04934072|564786797|FG003|Day 0 to Week 52|Adverse Event|0|||
156461867|NCT04934072|564786798|FG004|Day 0 to Week 52|Adverse Event|0|||
156461868|NCT04934072|564786794|FG000|Week 52 to Week 78|Adverse Event|0|||
156461869|NCT04934072|564786795|FG001|Week 52 to Week 78|Adverse Event|0|||
156461870|NCT04934072|564786796|FG002|Week 52 to Week 78|Adverse Event|0|||
156461871|NCT04934072|564786797|FG003|Week 52 to Week 78|Adverse Event|1|||
156461872|NCT04934072|564786798|FG004|Week 52 to Week 78|Adverse Event|1|||
156461873|NCT04934072|564786794|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
156461874|NCT04934072|564786795|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
156461875|NCT04934072|564786796|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
156461876|NCT04934072|564786797|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
156461877|NCT04934072|564786798|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
156461878|NCT04934072|564786794|FG000|Week 52 to Week 78|Other|0|||
156461879|NCT04934072|564786795|FG001|Week 52 to Week 78|Other|0|||
156461880|NCT04934072|564786796|FG002|Week 52 to Week 78|Other|1|||
156461881|NCT04934072|564786797|FG003|Week 52 to Week 78|Other|0|||
156461882|NCT04934072|564786798|FG004|Week 52 to Week 78|Other|0|||
156461883|NCT00844415|564786804|FG000|Overall Study|Withdrawal by Subject|1|||
156461884|NCT03174275|564786807|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
156461885|NCT03174275|564786807|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
156461886|NCT03174275|564786807|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
156461887|NCT03174275|564786807|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
156461888|NCT03174275|564786807|FG000|Adjuvant Chemotherapy|Progression|1|||
156461889|NCT03174275|564786807|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
156461890|NCT03174275|564786807|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
156461891|NCT03174275|564786807|FG000|Adjuvant Durvalumab|Progression|1|||
156461892|NCT03174275|564786807|FG000|Adjuvant Durvalumab|Adverse Event|3|||
156461893|NCT03174275|564786807|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
156461894|NCT03174275|564786807|FG000|Adjuvant Radiotherapy|Progression|1|||
156809947|NCT00090779|566058755|FG001|Step 3|Initiation of ART and off extended study|2|||
156809948|NCT00090779|566058754|FG000|Step 3|Off extended study due to study closure|4|||
156809949|NCT00090779|566058755|FG001|Step 3|Off extended study due to study closure|3|||
156809950|NCT03951766|566058764|FG000|Treatment Phase|Lost to Follow-up|1|||
156809951|NCT03951766|566058764|FG000|Follow-up Phase|Lost to Follow-up|10|||
156809952|NCT04158375|566058767|FG000|Overall Study|Withdrawal by Subject|0|||
156809953|NCT04158375|566058768|FG001|Overall Study|Withdrawal by Subject|3|||
156809954|NCT04158375|566058769|FG002|Overall Study|Withdrawal by Subject|0|||
156809955|NCT04847843|566058770|FG000|Overall Study|Scheduling Conflicts|6|||
156809956|NCT04847843|566058771|FG001|Overall Study|Scheduling Conflicts|9|||
156809957|NCT04847843|566058770|FG000|Overall Study|Withdrawal by Subject|1|||
156809958|NCT04847843|566058771|FG001|Overall Study|Withdrawal by Subject|0|||
156809959|NCT04847843|566058770|FG000|Overall Study|Lost to Follow-up|1|||
156809960|NCT04847843|566058771|FG001|Overall Study|Lost to Follow-up|1|||
156809961|NCT04847843|566058770|FG000|Overall Study|Pregnancy|0|||
156809962|NCT04847843|566058771|FG001|Overall Study|Pregnancy|2|||
156809963|NCT04847843|566058770|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
156461895|NCT03174275|564786807|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
156461896|NCT03717935|564786808|FG000|Overall Study|Withdrawal by Subject|0|||
156461897|NCT03717935|564786809|FG001|Overall Study|Withdrawal by Subject|2|||
156461898|NCT03015532|564786814|FG000|Overall Study|Adverse Event|0|||
156809964|NCT04847843|566058771|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
156809965|NCT02734004|566058772|FG000|Overall Study|Death|36|||
156461899|NCT03015532|564786815|FG001|Overall Study|Adverse Event|0|||
156461900|NCT03015532|564786816|FG002|Overall Study|Adverse Event|0|||
156461901|NCT03015532|564786817|FG003|Overall Study|Adverse Event|0|||
156461902|NCT03015532|564786818|FG004|Overall Study|Adverse Event|0|||
156461903|NCT03015532|564786819|FG005|Overall Study|Adverse Event|2|||
156461904|NCT03015532|564786820|FG006|Overall Study|Adverse Event|1|||
156461905|NCT03015532|564786821|FG007|Overall Study|Adverse Event|0|||
156809966|NCT02734004|566058773|FG001|Overall Study|Death|24|||
156809967|NCT02734004|566058774|FG002|Overall Study|Death|26|||
156809968|NCT02734004|566058775|FG003|Overall Study|Death|35|||
156461906|NCT03015532|564786814|FG000|Overall Study|Withdrawal by Subject|0|||
156461907|NCT03015532|564786815|FG001|Overall Study|Withdrawal by Subject|0|||
156461908|NCT03015532|564786816|FG002|Overall Study|Withdrawal by Subject|0|||
156461909|NCT03015532|564786817|FG003|Overall Study|Withdrawal by Subject|0|||
156461910|NCT03015532|564786818|FG004|Overall Study|Withdrawal by Subject|0|||
156461911|NCT03015532|564786819|FG005|Overall Study|Withdrawal by Subject|0|||
156461912|NCT03015532|564786820|FG006|Overall Study|Withdrawal by Subject|1|||
156461913|NCT03015532|564786821|FG007|Overall Study|Withdrawal by Subject|0|||
156461914|NCT02990338|564786822|FG000|Overall Study|Randomized and not treated|4|||
156461915|NCT02990338|564786823|FG001|Overall Study|Randomized and not treated|2|||
156461916|NCT02990338|564786822|FG000|Overall Study|Adverse Event|23|||
156461917|NCT02990338|564786823|FG001|Overall Study|Adverse Event|22|||
156461918|NCT02990338|564786822|FG000|Overall Study|Progressive disease|118|||
156461919|NCT02990338|564786823|FG001|Overall Study|Progressive disease|107|||
156461920|NCT02990338|564786822|FG000|Overall Study|Poor compliance to protocol|0|||
156461921|NCT02990338|564786823|FG001|Overall Study|Poor compliance to protocol|1|||
156461922|NCT02990338|564786822|FG000|Overall Study|Withdrawal by Subject|6|||
156461923|NCT02990338|564786823|FG001|Overall Study|Withdrawal by Subject|8|||
156461924|NCT02990338|564786822|FG000|Overall Study|Physician's decision|2|||
156461925|NCT02990338|564786823|FG001|Overall Study|Physician's decision|6|||
156461926|NCT02990338|564786822|FG000|Overall Study|Treatment extension study|0|||
156461927|NCT02990338|564786823|FG001|Overall Study|Treatment extension study|6|||
156461928|NCT02990338|564786822|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
156461929|NCT02990338|564786823|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
156461930|NCT02990338|564786822|FG000|Overall Study|Continue with therapy available commercially|0|||
156461931|NCT02990338|564786823|FG001|Overall Study|Continue with therapy available commercially|1|||
156461932|NCT02641730|564786827|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
156461933|NCT02641730|564786828|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156461934|NCT02641730|564786829|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156461935|NCT02641730|564786830|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
156461936|NCT02641730|564786831|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
156461937|NCT02641730|564786827|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
156461938|NCT02641730|564786828|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
156461939|NCT02641730|564786829|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
156461940|NCT02641730|564786830|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
156461941|NCT02641730|564786831|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
156461942|NCT02641730|564786827|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
156461943|NCT02641730|564786828|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
156461944|NCT02641730|564786829|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
156461945|NCT02641730|564786830|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
156461946|NCT02641730|564786831|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
156461947|NCT02641730|564786827|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
156461948|NCT02641730|564786828|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
156461949|NCT02641730|564786829|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
156461950|NCT02641730|564786830|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
156461951|NCT02641730|564786831|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
156461952|NCT02641730|564786827|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
156461953|NCT02641730|564786828|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
156461954|NCT02641730|564786829|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
156461955|NCT02641730|564786830|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
156461956|NCT02641730|564786831|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
156538538|NCT02164929|565066293|FG000|Overall Study|Converted to open procedure|1|||
156809969|NCT02734004|566058776|FG004|Overall Study|Death|13|||
156809970|NCT02734004|566058777|FG005|Overall Study|Death|17|||
156809971|NCT02734004|566058778|FG006|Overall Study|Death|20|||
156809972|NCT02734004|566058772|FG000|Overall Study|Lost to Follow-up|1|||
156809973|NCT02734004|566058773|FG001|Overall Study|Lost to Follow-up|1|||
156809974|NCT02734004|566058774|FG002|Overall Study|Lost to Follow-up|0|||
156809975|NCT02734004|566058775|FG003|Overall Study|Lost to Follow-up|0|||
156809976|NCT02734004|566058776|FG004|Overall Study|Lost to Follow-up|1|||
156809977|NCT02734004|566058777|FG005|Overall Study|Lost to Follow-up|0|||
156538539|NCT02164929|565066294|FG001|Overall Study|Converted to open procedure|0|||
156461957|NCT02641730|564786827|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
156809978|NCT02734004|566058778|FG006|Overall Study|Lost to Follow-up|0|||
156809979|NCT02734004|566058772|FG000|Overall Study|Withdrawal by Subject|3|||
156461958|NCT02641730|564786828|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
156809980|NCT02734004|566058773|FG001|Overall Study|Withdrawal by Subject|1|||
156461959|NCT02641730|564786829|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
156461960|NCT02641730|564786830|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
156461961|NCT02641730|564786831|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
156809981|NCT02734004|566058774|FG002|Overall Study|Withdrawal by Subject|1|||
156809982|NCT02734004|566058775|FG003|Overall Study|Withdrawal by Subject|1|||
156809983|NCT02734004|566058776|FG004|Overall Study|Withdrawal by Subject|3|||
156809984|NCT02734004|566058777|FG005|Overall Study|Withdrawal by Subject|0|||
156809985|NCT02734004|566058778|FG006|Overall Study|Withdrawal by Subject|2|||
156809986|NCT02734004|566058772|FG000|Overall Study|Other|0|||
156809987|NCT02734004|566058773|FG001|Overall Study|Other|8|||
156809988|NCT02734004|566058774|FG002|Overall Study|Other|7|||
156809989|NCT02734004|566058775|FG003|Overall Study|Other|4|||
156809990|NCT02734004|566058776|FG004|Overall Study|Other|34|||
156809991|NCT02734004|566058777|FG005|Overall Study|Other|14|||
156809992|NCT02734004|566058778|FG006|Overall Study|Other|10|||
156809993|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
156809994|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
156809995|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
156809996|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
156809997|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
156809998|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
156809999|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
156810000|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
156461962|NCT05460871|564786832|FG000|Overall Study|Withdrawal by Subject|1|||
156810001|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
156810002|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
156810003|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
156810004|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
156810005|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
156810006|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
156810007|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
156810008|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
156810009|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
156810010|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
156810011|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
156810012|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
156810013|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
156810014|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
156810015|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
156810016|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
156810017|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Other|6|||
156810018|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Other|0|||
156810019|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Other|0|||
156461963|NCT05460871|564786833|FG001|Overall Study|Withdrawal by Subject|2|||
156461964|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
156461965|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
156538540|NCT02164929|565066295|FG002|Overall Study|Converted to open procedure|0|||
156538541|NCT02164929|565066296|FG003|Overall Study|Converted to open procedure|2|||
156538542|NCT02164929|565066293|FG000|Overall Study|Failed regional block|0|||
156538543|NCT02164929|565066294|FG001|Overall Study|Failed regional block|0|||
156538544|NCT02164929|565066295|FG002|Overall Study|Failed regional block|1|||
156538545|NCT02164929|565066296|FG003|Overall Study|Failed regional block|0|||
156538546|NCT00365456|565066297|FG000|Trial Period I (12 Months)|Adverse Event|84|||
156538547|NCT00365456|565066298|FG001|Trial Period I (12 Months)|Adverse Event|0|||
156538548|NCT00365456|565066297|FG000|Trial Period I (12 Months)|Non-compliance|3|||
156461966|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
156461967|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
156538549|NCT00365456|565066298|FG001|Trial Period I (12 Months)|Non-compliance|0|||
156538550|NCT00365456|565066297|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
156461968|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
156461969|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
156461970|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
156461971|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
156461972|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
156461973|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
156461974|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
156461975|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
156461976|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
156461977|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
156461978|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
156461979|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
156461980|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
156461981|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
156538551|NCT00365456|565066298|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
156538552|NCT00365456|565066297|FG000|Trial Period I (12 Months)|Other|11|||
156538553|NCT00365456|565066298|FG001|Trial Period I (12 Months)|Other|0|||
156538554|NCT00365456|565066297|FG000|Trial Period II (12 Months)|Adverse Event|0|||
156538555|NCT00365456|565066298|FG001|Trial Period II (12 Months)|Adverse Event|6|||
156538556|NCT00365456|565066297|FG000|Trial Period II (12 Months)|Non-compliance|0|||
156538557|NCT00365456|565066298|FG001|Trial Period II (12 Months)|Non-compliance|2|||
156538558|NCT00365456|565066297|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
156538559|NCT00365456|565066298|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
156538560|NCT00365456|565066297|FG000|Trial Period II (12 Months)|Other|0|||
156538561|NCT00365456|565066298|FG001|Trial Period II (12 Months)|Other|1|||
156538562|NCT00365456|565066297|FG000|Trial Period III (12 Months)|Adverse Event|13|||
156538563|NCT00365456|565066298|FG001|Trial Period III (12 Months)|Adverse Event|3|||
156538564|NCT00365456|565066297|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
156538565|NCT00365456|565066298|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
156538566|NCT00365456|565066297|FG000|Trial Period III (12 Months)|Other|1|||
156461982|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
156461983|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
156461984|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
156461985|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
156810020|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
156810021|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
156810022|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
156810023|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
156810024|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
156810025|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
156810026|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
156810027|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
156810028|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
156810029|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
156810030|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
156810031|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
156810032|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
156810033|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
156810034|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
156810035|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
156810036|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
156810037|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
156810038|NCT01282866|566058791|FG000|Overall Study|Adverse Event|1|||
156810039|NCT01541865|566058793|FG000|Overall Study|Lost to Follow-up|11|||
156810040|NCT01541865|566058793|FG000|Overall Study|Withdrawal by Subject|9|||
156810041|NCT01541865|566058793|FG000|Overall Study|Adverse Event|1|||
156810042|NCT01541865|566058793|FG000|Overall Study|Protocol Violation|1|||
156810043|NCT00049322|566058794|FG000|Overall Study|disease burden|0|||
156810044|NCT00049322|566058795|FG001|Overall Study|disease burden|3|||
156810045|NCT00049322|566058794|FG000|Overall Study|Adverse Event|1|||
156810046|NCT00049322|566058795|FG001|Overall Study|Adverse Event|0|||
156810047|NCT00049322|566058794|FG000|Overall Study|refused angio|0|||
156810048|NCT00049322|566058795|FG001|Overall Study|refused angio|3|||
156810049|NCT01162473|566058797|FG000|Overall Study|Adverse Event|2|||
156810050|NCT01162473|566058798|FG001|Overall Study|Adverse Event|1|||
156810051|NCT01162473|566058797|FG000|Overall Study|Withdrawal by Subject|0|||
156810052|NCT01162473|566058798|FG001|Overall Study|Withdrawal by Subject|4|||
156810053|NCT01144416|566058799|FG000|Intervention Period|Adverse Event|5|||
156810054|NCT01144416|566058800|FG001|Intervention Period|Adverse Event|6|||
156810055|NCT01144416|566058799|FG000|Intervention Period|Insufficient ovarian response|11|||
156810056|NCT01144416|566058800|FG001|Intervention Period|Insufficient ovarian response|17|||
156810057|NCT01144416|566058799|FG000|Intervention Period|Risk of OHSS|0|||
156810058|NCT01144416|566058800|FG001|Intervention Period|Risk of OHSS|1|||
156810059|NCT01144416|566058799|FG000|Intervention Period|Too high ovarian response|4|||
156810060|NCT01144416|566058800|FG001|Intervention Period|Too high ovarian response|2|||
156810061|NCT01144416|566058799|FG000|Intervention Period|No/too few/bad oocytes|7|||
156810062|NCT01144416|566058800|FG001|Intervention Period|No/too few/bad oocytes|5|||
156810063|NCT01144416|566058799|FG000|Intervention Period|No or abnormal fertilization|25|||
156810064|NCT01144416|566058800|FG001|Intervention Period|No or abnormal fertilization|10|||
156810065|NCT01144416|566058799|FG000|Intervention Period|No/too few/bad quality embryos|3|||
156810066|NCT01144416|566058800|FG001|Intervention Period|No/too few/bad quality embryos|3|||
156810067|NCT01144416|566058799|FG000|Intervention Period|Other|7|||
156810068|NCT01144416|566058800|FG001|Intervention Period|Other|5|||
156810069|NCT00124072|566058801|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
156810070|NCT00124072|566058802|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
156810071|NCT00124072|566058803|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
156810072|NCT00124072|566058804|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
156810073|NCT00124072|566058801|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
156810074|NCT00124072|566058802|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
156810075|NCT00124072|566058803|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
156810076|NCT00124072|566058804|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
156810077|NCT00124072|566058801|FG000|Overall Study|Death|499|||
156461986|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
156461987|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
156461988|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
156810078|NCT00124072|566058802|FG001|Overall Study|Death|484|||
156810079|NCT00124072|566058803|FG002|Overall Study|Death|471|||
156810080|NCT00124072|566058804|FG003|Overall Study|Death|480|||
156810081|NCT00132301|566058808|FG000|Overall Study|Death|7|||
156810082|NCT00132301|566058809|FG001|Overall Study|Death|6|||
156810083|NCT00132301|566058808|FG000|Overall Study|Withdrawal by Subject|5|||
156810084|NCT00132301|566058809|FG001|Overall Study|Withdrawal by Subject|2|||
156810085|NCT00132301|566058808|FG000|Overall Study|Physician Decision|1|||
156810086|NCT00132301|566058809|FG001|Overall Study|Physician Decision|1|||
156810087|NCT00132301|566058808|FG000|Overall Study|Lost to Follow-up|5|||
156461989|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
156810088|NCT00132301|566058809|FG001|Overall Study|Lost to Follow-up|3|||
156810089|NCT00132301|566058808|FG000|Overall Study|Other|1|||
156810090|NCT00132301|566058809|FG001|Overall Study|Other|1|||
156810091|NCT00132301|566058808|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
156810092|NCT00132301|566058809|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
156810093|NCT04872569|566058812|FG000|Overall Study|Withdrawal by Subject|2|||
156810094|NCT01890265|566058819|FG000|Overall Study|Other (Unspecified reason)|0|||
156810095|NCT01890265|566058820|FG001|Overall Study|Other (Unspecified reason)|1|||
156810096|NCT01890265|566058821|FG002|Overall Study|Other (Unspecified reason)|0|||
156810097|NCT01890265|566058822|FG003|Overall Study|Other (Unspecified reason)|0|||
156810098|NCT01890265|566058823|FG004|Overall Study|Other (Unspecified reason)|0|||
156810099|NCT01890265|566058824|FG005|Overall Study|Other (Unspecified reason)|0|||
156810100|NCT01890265|566058819|FG000|Overall Study|Progressive disease|6|||
156810101|NCT01890265|566058820|FG001|Overall Study|Progressive disease|6|||
156810102|NCT01890265|566058821|FG002|Overall Study|Progressive disease|0|||
156338832|NCT01433991|564340051|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
156338833|NCT01433991|564340052|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
156338834|NCT01433991|564340053|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
156810103|NCT01890265|566058822|FG003|Overall Study|Progressive disease|0|||
156810104|NCT01890265|566058823|FG004|Overall Study|Progressive disease|0|||
156810105|NCT01890265|566058824|FG005|Overall Study|Progressive disease|0|||
156810106|NCT01890265|566058819|FG000|Overall Study|Adverse Event|2|||
156810107|NCT01890265|566058820|FG001|Overall Study|Adverse Event|1|||
156810108|NCT01890265|566058821|FG002|Overall Study|Adverse Event|0|||
156810109|NCT01890265|566058822|FG003|Overall Study|Adverse Event|0|||
156810110|NCT01890265|566058823|FG004|Overall Study|Adverse Event|0|||
156810111|NCT01890265|566058824|FG005|Overall Study|Adverse Event|0|||
156810112|NCT01890265|566058819|FG000|Overall Study|Death|2|||
156810113|NCT01890265|566058820|FG001|Overall Study|Death|3|||
156810114|NCT01890265|566058821|FG002|Overall Study|Death|1|||
156810115|NCT01890265|566058822|FG003|Overall Study|Death|0|||
156810116|NCT01890265|566058823|FG004|Overall Study|Death|0|||
156810117|NCT01890265|566058824|FG005|Overall Study|Death|0|||
156810118|NCT01890265|566058819|FG000|Overall Study|Withdrawal by Subject|0|||
156810119|NCT01890265|566058820|FG001|Overall Study|Withdrawal by Subject|2|||
156810120|NCT01890265|566058821|FG002|Overall Study|Withdrawal by Subject|3|||
156810121|NCT01890265|566058822|FG003|Overall Study|Withdrawal by Subject|0|||
156810122|NCT01890265|566058823|FG004|Overall Study|Withdrawal by Subject|2|||
156810123|NCT01890265|566058824|FG005|Overall Study|Withdrawal by Subject|0|||
156810124|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
156810125|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
156810126|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
156810127|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
156810128|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
156338835|NCT01433991|564340050|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
156810129|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
156810130|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
156810131|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
156810132|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
156810133|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
156810134|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
156810135|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
156810136|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
156461990|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
156461991|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
156461992|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
156461993|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
156461994|NCT04614948|564786835|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
156461995|NCT04614948|564786836|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
156461996|NCT04614948|564786837|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
156810137|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
156810138|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
156810139|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
156810140|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
156810141|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
156810142|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
156810143|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
156810144|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
156810145|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
156810146|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
156810147|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
156810148|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
156810149|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
156810150|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
156810151|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
156810152|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
156810153|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
156810154|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
156810155|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
156810156|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
156810157|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
156810158|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
156810159|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
156810160|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
156810161|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
156810162|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
156810163|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
156810164|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
156810165|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
156810166|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
156810167|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
156810168|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
156810169|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
156810170|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
156810171|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
156810172|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
156810173|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
156810174|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
156810175|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
156810176|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
156810177|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
156810178|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
156810179|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
156810180|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
156810181|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
156810182|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
156810183|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
156810184|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
156810185|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
156461997|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
156461998|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
156461999|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
156462000|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
156462001|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
156810186|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
156810187|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
156810188|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
156810189|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
156810190|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
156810191|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
156810192|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
156810193|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
156810194|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
156462002|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
156462003|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
156462004|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
156462005|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
156462006|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
156462007|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
156462008|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
156462009|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
156462010|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
156462011|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
156462012|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
156462013|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
156462014|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
156462015|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
156462016|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
156462017|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
156462018|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
156462019|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
156462020|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
156462021|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
156462022|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
156462023|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
156462024|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
156462025|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
156462026|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
156462027|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
156462028|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
156462029|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
156462030|NCT04614948|564786835|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
156462031|NCT04614948|564786836|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
156462032|NCT04614948|564786837|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
156462033|NCT04271046|564786838|FG000|Overall Study|Death|0|||
156462034|NCT04271046|564786839|FG001|Overall Study|Death|2|||
156462035|NCT04271046|564786840|FG002|Overall Study|Death|0|||
156538567|NCT00365456|565066298|FG001|Trial Period III (12 Months)|Other|1|||
156538568|NCT01537198|565066300|FG000|Overall Study|RSV infection|2|||
156810195|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
156810196|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
156810197|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
156810198|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
156810199|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
156810200|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
156810201|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
156810202|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
156810203|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
156810204|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
156810205|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
156810206|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
156810207|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
156810208|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
156810209|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
156810210|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
156810211|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
156810212|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
156810213|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
156538569|NCT01537198|565066300|FG000|Overall Study|Adverse Event|4|||
156538570|NCT01537198|565066300|FG000|Overall Study|No Further Visits to the Clinic|37|||
156810214|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
156810215|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
156810216|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
156810217|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
156810218|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
156810219|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
156810220|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
156810221|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
156810222|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
156810223|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
156810224|NCT03517436|566058832|FG000|Overall Study|Death|3|||
156810225|NCT03517436|566058832|FG000|Overall Study|Withdrawal by Subject|4|||
156810226|NCT03517436|566058832|FG000|Overall Study|Did not receive study valve.|1|||
156810227|NCT04271540|566058833|FG000|Overall Study|Lost to Follow-up|1|||
156810228|NCT04271540|566058833|FG000|Overall Study|Screen Fail|5|||
156810229|NCT04587869|566058836|FG000|Overall Study|Death|1|||
156810230|NCT04587869|566058837|FG001|Overall Study|Death|0|||
156810231|NCT04587869|566058836|FG000|Overall Study|Lost to Follow-up|27|||
156810232|NCT04587869|566058837|FG001|Overall Study|Lost to Follow-up|34|||
156810233|NCT04587869|566058836|FG000|Overall Study|Grant Termination|13|||
156810234|NCT04587869|566058837|FG001|Overall Study|Grant Termination|25|||
156810235|NCT04587869|566058836|FG000|Overall Study|too busy|2|||
156462036|NCT04271046|564786841|FG003|Overall Study|Death|2|||
156462037|NCT04271046|564786838|FG000|Overall Study|Lost to Follow-up|12|||
156462038|NCT04271046|564786839|FG001|Overall Study|Lost to Follow-up|12|||
156462039|NCT04271046|564786840|FG002|Overall Study|Lost to Follow-up|11|||
156462040|NCT04271046|564786841|FG003|Overall Study|Lost to Follow-up|11|||
156462041|NCT04271046|564786838|FG000|Overall Study|Patient with Dementia Died|2|||
156462042|NCT04271046|564786839|FG001|Overall Study|Patient with Dementia Died|0|||
156462043|NCT04271046|564786840|FG002|Overall Study|Patient with Dementia Died|2|||
156462044|NCT04271046|564786841|FG003|Overall Study|Patient with Dementia Died|0|||
156462045|NCT04271046|564786838|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
156462046|NCT04271046|564786839|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
156462047|NCT04271046|564786840|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
156462048|NCT04271046|564786841|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
156462049|NCT03663205|564786842|FG000|Overall Study|Death|144|||
156462050|NCT03663205|564786843|FG001|Overall Study|Death|69|||
156462051|NCT03663205|564786842|FG000|Overall Study|Sponsor decision|53|||
156462052|NCT03663205|564786843|FG001|Overall Study|Sponsor decision|19|||
156462053|NCT03663205|564786842|FG000|Overall Study|Withdrawal by Subject|8|||
156462054|NCT03663205|564786843|FG001|Overall Study|Withdrawal by Subject|11|||
156462055|NCT03663205|564786842|FG000|Overall Study|Lost to Follow-up|7|||
156462056|NCT03663205|564786843|FG001|Overall Study|Lost to Follow-up|9|||
156462057|NCT03663205|564786842|FG000|Overall Study|Transferred to long term extension study|11|||
156462058|NCT03663205|564786843|FG001|Overall Study|Transferred to long term extension study|3|||
156462059|NCT05962814|564786844|FG000|Overall Study|failed eligibility|1|||
156462060|NCT03057054|564786847|FG000|Overall Study|Death|4|||
156462061|NCT03057054|564786848|FG001|Overall Study|Death|4|||
156462062|NCT03057054|564786847|FG000|Overall Study|Withdrawal by Subject|6|||
156462063|NCT03057054|564786848|FG001|Overall Study|Withdrawal by Subject|3|||
156462064|NCT03057054|564786847|FG000|Overall Study|Ineligible|1|||
156462065|NCT03057054|564786848|FG001|Overall Study|Ineligible|1|||
156462066|NCT03972150|564787969|FG000|Overall Study|Adverse Event|0|||
156462067|NCT03972150|564787970|FG001|Overall Study|Adverse Event|1|||
156462068|NCT03972150|564787971|FG002|Overall Study|Adverse Event|1|||
156462069|NCT03972150|564787972|FG003|Overall Study|Adverse Event|0|||
156462070|NCT03972150|564787973|FG004|Overall Study|Adverse Event|0|||
156462071|NCT03972150|564787969|FG000|Overall Study|Progressive disease|3|||
156462072|NCT03972150|564787970|FG001|Overall Study|Progressive disease|5|||
156462073|NCT03972150|564787971|FG002|Overall Study|Progressive disease|2|||
156810236|NCT04587869|566058837|FG001|Overall Study|too busy|0|||
156810237|NCT04587869|566058836|FG000|Overall Study|Withdrawal by Subject|2|||
156810238|NCT04587869|566058837|FG001|Overall Study|Withdrawal by Subject|2|||
156810239|NCT04587869|566058836|FG000|Overall Study|Other|1|||
156810240|NCT04587869|566058837|FG001|Overall Study|Other|0|||
156810241|NCT00943761|566058840|FG000|Overall Study|Lost to Follow-up|2|||
156810242|NCT00943761|566058841|FG001|Overall Study|Lost to Follow-up|0|||
156462074|NCT03972150|564787972|FG003|Overall Study|Progressive disease|2|||
156462075|NCT03972150|564787973|FG004|Overall Study|Progressive disease|3|||
156462076|NCT04820322|564787976|FG000|Overall Study|Adverse Event|1|||
156462077|NCT04820322|564787977|FG001|Overall Study|Adverse Event|0|||
156462078|NCT03156465|564787983|FG000|Overall Study|Withdrawal by Subject|2|||
156538571|NCT01537198|565066300|FG000|Overall Study|Other|111|||
156462079|NCT03181516|564787985|FG000|Overall Study|Withdrawal by Subject|14|||
156462080|NCT03181516|564787986|FG001|Overall Study|Withdrawal by Subject|7|||
156462081|NCT03181516|564787985|FG000|Overall Study|Lost to Follow-up|2|||
156810243|NCT00943761|566058840|FG000|Overall Study|Withdrawal by Subject|2|||
156810244|NCT00943761|566058841|FG001|Overall Study|Withdrawal by Subject|1|||
156810245|NCT02268383|566058842|FG000|Overall Study|Death|12|||
156810246|NCT02268383|566058842|FG000|Overall Study|Lost to Follow-up|2|||
156810247|NCT02268383|566058842|FG000|Overall Study|Withdrawal by Subject|9|||
156462082|NCT03181516|564787986|FG001|Overall Study|Lost to Follow-up|2|||
156462083|NCT04544007|564787987|FG000|Overall Study|Withdrawal by Subject|1|||
156462084|NCT04544007|564787987|FG000|Overall Study|Confirmed Progressive Disease|1|||
156462085|NCT04880733|564787988|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
156462086|NCT04880733|564787989|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
156462087|NCT04880733|564787990|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
156462088|NCT04880733|564787988|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
156462089|NCT04880733|564787989|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
156462090|NCT04880733|564787990|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
156462091|NCT04880733|564787988|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
156462092|NCT04880733|564787989|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
156462093|NCT04880733|564787990|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
156462094|NCT04880733|564787988|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
156462095|NCT04880733|564787989|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
156462096|NCT04880733|564787990|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
156462097|NCT04880733|564787988|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
156462098|NCT04880733|564787989|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
156462099|NCT04880733|564787990|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
156462100|NCT04451772|564788005|FG000|Overall Study|Adverse Event|1|||
156462101|NCT04451772|564788006|FG001|Overall Study|Adverse Event|0|||
156462102|NCT04451772|564788007|FG002|Overall Study|Adverse Event|1|||
156462103|NCT04451772|564788008|FG003|Overall Study|Adverse Event|1|||
156462104|NCT04451772|564788009|FG004|Overall Study|Adverse Event|0|||
156462105|NCT04451772|564788010|FG005|Overall Study|Adverse Event|3|||
156462106|NCT04451772|564788005|FG000|Overall Study|Withdrawal by Subject|2|||
156462107|NCT04451772|564788006|FG001|Overall Study|Withdrawal by Subject|7|||
156462108|NCT04451772|564788007|FG002|Overall Study|Withdrawal by Subject|2|||
156462109|NCT04451772|564788008|FG003|Overall Study|Withdrawal by Subject|1|||
156462110|NCT04451772|564788009|FG004|Overall Study|Withdrawal by Subject|1|||
156462111|NCT04451772|564788010|FG005|Overall Study|Withdrawal by Subject|0|||
156462112|NCT04451772|564788005|FG000|Overall Study|Other, not specified|1|||
156462113|NCT04451772|564788006|FG001|Overall Study|Other, not specified|2|||
156462114|NCT04451772|564788007|FG002|Overall Study|Other, not specified|1|||
156462115|NCT04451772|564788008|FG003|Overall Study|Other, not specified|0|||
156462116|NCT04451772|564788009|FG004|Overall Study|Other, not specified|0|||
156462117|NCT04451772|564788010|FG005|Overall Study|Other, not specified|1|||
156462118|NCT04451772|564788005|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
156462119|NCT04451772|564788006|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
156462120|NCT04451772|564788007|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
156462121|NCT04451772|564788008|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
156462122|NCT04451772|564788009|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
156462123|NCT04451772|564788010|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
156462124|NCT04605159|564788011|FG000|Overall Study|Adverse Event|6|||
156462125|NCT04605159|564788012|FG001|Overall Study|Adverse Event|3|||
156462126|NCT04605159|564788013|FG002|Overall Study|Adverse Event|21|||
156462127|NCT04605159|564788014|FG003|Overall Study|Adverse Event|4|||
156462128|NCT04605159|564788011|FG000|Overall Study|Lost to Follow-up|74|||
156462129|NCT04605159|564788012|FG001|Overall Study|Lost to Follow-up|45|||
156462130|NCT04605159|564788013|FG002|Overall Study|Lost to Follow-up|119|||
156462131|NCT04605159|564788014|FG003|Overall Study|Lost to Follow-up|80|||
156462132|NCT04605159|564788011|FG000|Overall Study|Protocol Violation|4|||
156462133|NCT04605159|564788012|FG001|Overall Study|Protocol Violation|5|||
156462134|NCT04605159|564788013|FG002|Overall Study|Protocol Violation|2|||
156462135|NCT04605159|564788014|FG003|Overall Study|Protocol Violation|0|||
156462136|NCT04605159|564788011|FG000|Overall Study|Withdrawal by Subject|66|||
156462137|NCT04605159|564788012|FG001|Overall Study|Withdrawal by Subject|37|||
156462138|NCT04605159|564788013|FG002|Overall Study|Withdrawal by Subject|68|||
156462139|NCT04605159|564788014|FG003|Overall Study|Withdrawal by Subject|50|||
156462140|NCT04605159|564788011|FG000|Overall Study|Migrated / moved from the study area|32|||
156462141|NCT04605159|564788012|FG001|Overall Study|Migrated / moved from the study area|22|||
156462142|NCT04605159|564788013|FG002|Overall Study|Migrated / moved from the study area|41|||
156462143|NCT04605159|564788014|FG003|Overall Study|Migrated / moved from the study area|21|||
156462144|NCT04605159|564788011|FG000|Overall Study|Other|1|||
156462145|NCT04605159|564788012|FG001|Overall Study|Other|2|||
156462146|NCT04605159|564788013|FG002|Overall Study|Other|7|||
156810248|NCT02268383|566058842|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
156462147|NCT04605159|564788014|FG003|Overall Study|Other|3|||
156810249|NCT02268383|566058842|FG000|Overall Study|Protocol deviation|3|||
156810250|NCT02268383|566058842|FG000|Overall Study|Sponsor decision|22|||
156810251|NCT02268383|566058842|FG000|Overall Study|Not reported|12|||
156810252|NCT01402869|566058845|FG000|Overall Study|Required Tooth Extraction|0|||
156810253|NCT01402869|566058846|FG001|Overall Study|Required Tooth Extraction|0|||
156810254|NCT01402869|566058847|FG002|Overall Study|Required Tooth Extraction|1|||
156810255|NCT01544348|566058848|FG000|Overall Study|Lost to Follow-up|1|||
156810256|NCT01544348|566058849|FG001|Overall Study|Lost to Follow-up|0|||
156810257|NCT01544348|566058850|FG002|Overall Study|Lost to Follow-up|0|||
156810258|NCT01544348|566058851|FG003|Overall Study|Lost to Follow-up|0|||
156810259|NCT01544348|566058852|FG004|Overall Study|Lost to Follow-up|0|||
156810260|NCT01544348|566058853|FG005|Overall Study|Lost to Follow-up|0|||
156810261|NCT01544348|566058854|FG006|Overall Study|Lost to Follow-up|1|||
156810262|NCT01544348|566058855|FG007|Overall Study|Lost to Follow-up|0|||
156810263|NCT01544348|566058848|FG000|Overall Study|Withdrawal by Subject|1|||
156810264|NCT01544348|566058849|FG001|Overall Study|Withdrawal by Subject|0|||
156810265|NCT01544348|566058850|FG002|Overall Study|Withdrawal by Subject|0|||
156810266|NCT01544348|566058851|FG003|Overall Study|Withdrawal by Subject|0|||
156810267|NCT01544348|566058852|FG004|Overall Study|Withdrawal by Subject|1|||
156810268|NCT01544348|566058853|FG005|Overall Study|Withdrawal by Subject|2|||
156810269|NCT01544348|566058854|FG006|Overall Study|Withdrawal by Subject|1|||
156810270|NCT01544348|566058855|FG007|Overall Study|Withdrawal by Subject|0|||
156810271|NCT01544348|566058848|FG000|Overall Study|Physician Decision|0|||
156810272|NCT01544348|566058849|FG001|Overall Study|Physician Decision|0|||
156810273|NCT01544348|566058850|FG002|Overall Study|Physician Decision|0|||
156810274|NCT01544348|566058851|FG003|Overall Study|Physician Decision|0|||
156810275|NCT01544348|566058852|FG004|Overall Study|Physician Decision|0|||
156810276|NCT01544348|566058853|FG005|Overall Study|Physician Decision|1|||
156810277|NCT01544348|566058854|FG006|Overall Study|Physician Decision|0|||
156810278|NCT01544348|566058855|FG007|Overall Study|Physician Decision|0|||
156810279|NCT00642707|566058856|FG000|Overall Study|Adverse Event|0|||
156810280|NCT00642707|566058857|FG001|Overall Study|Adverse Event|0|||
156810281|NCT00642707|566058858|FG002|Overall Study|Adverse Event|0|||
156810282|NCT00642707|566058859|FG003|Overall Study|Adverse Event|2|||
156810283|NCT00642707|566058856|FG000|Overall Study|Withdrawal by Subject|1|||
156810284|NCT00642707|566058857|FG001|Overall Study|Withdrawal by Subject|0|||
156810285|NCT00642707|566058858|FG002|Overall Study|Withdrawal by Subject|0|||
156810286|NCT00642707|566058859|FG003|Overall Study|Withdrawal by Subject|0|||
156810287|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
156810288|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
156810289|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
156810290|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810291|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810292|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810293|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810294|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810295|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810296|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810297|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810298|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810299|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810300|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810301|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810302|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810303|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
156810304|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
156810305|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810306|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810307|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810308|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810309|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810310|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810311|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810312|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810313|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810314|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810315|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810316|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810317|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810318|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810319|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810320|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810321|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810322|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
156462148|NCT04218851|564788018|FG000|Overall Study|Death|1|||
156810323|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810324|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810325|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810326|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810327|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810328|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810329|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810330|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810331|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810332|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810333|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810334|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810335|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810336|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810337|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
156810338|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810339|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810340|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810341|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810342|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810343|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810344|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810345|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810346|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810347|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810348|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810349|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810350|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810351|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810352|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810353|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810354|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
156810355|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810356|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810357|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810358|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810359|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810360|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810361|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810362|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810363|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810364|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810365|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810366|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810367|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810368|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810369|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810370|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
156810371|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810372|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810373|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810374|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810375|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156462149|NCT04218851|564788019|FG001|Overall Study|Death|3|||
156462150|NCT01820611|564788020|FG000|Overall Study|Death|8|||
156462151|NCT01820611|564788020|FG000|Overall Study|Adverse Event|1|||
156338836|NCT01433991|564340051|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
156810376|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810377|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810378|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810379|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810380|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810381|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810382|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810383|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810384|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810385|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810386|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810387|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810388|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810389|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
156810390|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
156810391|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
156810392|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
156810393|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810394|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810395|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810396|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810397|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810398|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810399|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810400|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810401|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810402|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810403|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810404|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
156810405|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810406|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810407|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810408|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
156810409|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810410|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810411|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810412|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810413|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810414|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810415|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810416|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810417|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810418|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810419|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810420|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810421|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
156810422|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
156810423|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
156810424|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
156810425|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810426|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810427|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810428|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810429|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810430|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810431|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810432|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810433|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810434|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156338837|NCT01433991|564340052|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
156338838|NCT01433991|564340053|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
156338839|NCT01433991|564340050|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
156338840|NCT01433991|564340051|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
156338841|NCT01433991|564340052|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
156338842|NCT01433991|564340053|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
156338843|NCT01433991|564340050|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
156338844|NCT01433991|564340051|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
156338845|NCT01433991|564340052|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
156338846|NCT01433991|564340053|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
156338847|NCT01433991|564340050|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
156338848|NCT01433991|564340051|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
156338849|NCT01433991|564340052|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
156338850|NCT01433991|564340053|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
156338851|NCT01433991|564340050|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
156810435|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
156538572|NCT00113074|565066307|FG000|Overall Study|Lost to Follow-up|10|||
156538573|NCT00113074|565066308|FG001|Overall Study|Lost to Follow-up|10|||
156538574|NCT00113074|565066309|FG002|Overall Study|Lost to Follow-up|14|||
156538575|NCT03680911|565066310|FG000|At Home Treatment|Study Termination|3|||
156538576|NCT03680911|565066311|FG001|At Home Treatment|Study Termination|0|||
156538577|NCT03680911|565066310|FG000|At Home Treatment|Lost to Follow-up|0|||
156538578|NCT03680911|565066311|FG001|At Home Treatment|Lost to Follow-up|1|||
156538579|NCT03680911|565066310|FG000|At Home Treatment|Withdrawal by Subject|0|||
156538580|NCT03680911|565066311|FG001|At Home Treatment|Withdrawal by Subject|2|||
156538581|NCT03680911|565066310|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
156538582|NCT03680911|565066311|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
156538583|NCT03962738|565066312|FG000|Overall Study|Protocol Deviation|3|||
156538584|NCT03962738|565066313|FG001|Overall Study|Protocol Deviation|0|||
156538585|NCT03962738|565066314|FG002|Overall Study|Protocol Deviation|1|||
156538586|NCT03962738|565066315|FG003|Overall Study|Protocol Deviation|1|||
156538587|NCT03962738|565066312|FG000|Overall Study|Withdrawal by Subject|4|||
156538588|NCT03962738|565066313|FG001|Overall Study|Withdrawal by Subject|0|||
156538589|NCT03962738|565066314|FG002|Overall Study|Withdrawal by Subject|0|||
156538590|NCT03962738|565066315|FG003|Overall Study|Withdrawal by Subject|0|||
156538591|NCT03962738|565066312|FG000|Overall Study|Lost to Follow-up|0|||
156538592|NCT03962738|565066313|FG001|Overall Study|Lost to Follow-up|0|||
156538593|NCT03962738|565066314|FG002|Overall Study|Lost to Follow-up|1|||
156538594|NCT03962738|565066315|FG003|Overall Study|Lost to Follow-up|0|||
156538595|NCT01478360|565066316|FG000|Overall Study|Lost to Follow-up|1|||
156810436|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810437|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810438|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810439|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810440|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810441|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810442|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810443|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810444|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810445|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810446|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810447|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810448|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810449|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810450|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810451|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810452|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810453|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
156810454|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810455|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810456|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810457|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810458|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810459|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810460|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810461|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810462|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810463|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810464|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810465|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810466|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810467|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810468|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810469|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810470|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
156810471|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
156810472|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
156810473|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810474|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156538596|NCT01478360|565066317|FG001|Overall Study|Lost to Follow-up|0|||
156538597|NCT01478360|565066316|FG000|Overall Study|Adverse Event|0|||
156538598|NCT01478360|565066317|FG001|Overall Study|Adverse Event|1|||
156810475|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810476|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810477|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810478|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810479|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810480|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810481|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810482|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810483|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810484|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810485|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810486|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
156810487|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810488|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810489|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810490|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810491|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810492|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810493|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810494|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810495|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810496|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810497|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810498|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810499|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810500|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810501|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810502|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810503|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
156810504|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810505|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810506|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810507|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810508|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810509|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810510|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810511|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810512|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810513|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810514|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810515|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810516|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810517|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810518|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810519|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810520|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
156810521|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810522|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810523|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810524|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810525|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810526|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810527|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810528|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810529|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810530|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810531|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810532|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810533|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810534|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810535|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810536|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
156810537|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810538|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810539|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810540|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810541|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810542|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810543|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810544|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810545|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810546|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810547|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810548|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810549|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810550|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810551|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810552|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810553|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
156810554|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810555|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810556|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810557|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810558|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810559|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810560|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810561|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810562|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810563|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156538599|NCT01478360|565066316|FG000|Overall Study|Administrative problems|1|||
156810564|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810565|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810566|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810567|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810568|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810569|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
156810570|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810571|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810572|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810573|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810574|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810575|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810576|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810577|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810578|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810579|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810580|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810581|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810582|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810583|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810584|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810585|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
156810586|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810587|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810588|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810589|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810590|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810591|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810592|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810593|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810594|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810595|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810596|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810597|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810598|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810599|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810600|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810601|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
156810602|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810603|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810604|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810605|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810606|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810607|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810608|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810609|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810610|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810611|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810612|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810613|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810614|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810615|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810616|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810617|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
156810618|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810619|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810620|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810621|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810622|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810623|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810624|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810625|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810626|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156538600|NCT01478360|565066317|FG001|Overall Study|Administrative problems|2|||
156538601|NCT01221727|565066318|FG000|Overall Study|Physician Decision|2|||
156538602|NCT01221727|565066319|FG001|Overall Study|Physician Decision|0|||
156538603|NCT01221727|565066318|FG000|Overall Study|Withdrawal by Subject|1|||
156538604|NCT01221727|565066319|FG001|Overall Study|Withdrawal by Subject|1|||
156538605|NCT02566577|565066320|FG000|Overall Study|Withdrawal by Subject|1|||
156538606|NCT02566577|565066321|FG001|Overall Study|Withdrawal by Subject|1|||
156538607|NCT02566577|565066320|FG000|Overall Study|Equipment failure|1|||
156538608|NCT02566577|565066321|FG001|Overall Study|Equipment failure|1|||
156538609|NCT02566577|565066320|FG000|Overall Study|Physical limitation|1|||
156538610|NCT02566577|565066321|FG001|Overall Study|Physical limitation|0|||
156538611|NCT01289821|565066322|FG000|Treatment Period|Withdrawal by Subject|1|||
156538612|NCT01289821|565066322|FG000|Treatment Period|Physician Decision|3|||
156538613|NCT01289821|565066322|FG000|Treatment Period|Adverse Event|4|||
156538614|NCT01289821|565066322|FG000|Treatment Period|Radiological Progression|43|||
156538615|NCT01289821|565066322|FG000|Treatment Period|Clinical Progression|2|||
156538616|NCT01289821|565066322|FG000|Treatment Period|Therapeutic procedure required|1|||
156538617|NCT01289821|565066322|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
156538618|NCT01289821|565066322|FG000|Safety Follow-up Period|Protocol Violation|3|||
156538619|NCT01289821|565066322|FG000|Safety Follow-up Period|Unspecified reason|1|||
156538620|NCT01289821|565066322|FG000|Survival Follow-up Period|Protocol Violation|1|||
156810627|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810628|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810629|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810630|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810631|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810632|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810633|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
156810634|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810635|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156462152|NCT01820611|564788020|FG000|Overall Study|Withdrawal by Subject|9|||
156462153|NCT03484819|564788021|FG000|Overall Study|Death|2|||
156462154|NCT03484819|564788021|FG000|Overall Study|Adverse Event|2|||
156462155|NCT03484819|564788021|FG000|Overall Study|Physician Decision|1|||
156462156|NCT03484819|564788021|FG000|Overall Study|Withdrawal by Subject|2|||
156462157|NCT03484819|564788021|FG000|Overall Study|Disease Progression|4|||
156462158|NCT03484819|564788021|FG000|Overall Study|Complicating Condition|1|||
156462159|NCT05970861|564788022|FG000|Overall Study|Physician Decision|4|||
156462160|NCT05970861|564788023|FG001|Overall Study|Physician Decision|4|||
156462161|NCT05970861|564788022|FG000|Overall Study|Lost to Follow-up|4|||
156462162|NCT05970861|564788023|FG001|Overall Study|Lost to Follow-up|3|||
156462163|NCT04186819|564788025|FG000|Overall Study|Adverse Event|1|||
156462164|NCT04186819|564788025|FG000|Overall Study|Lost to Follow-up|1|||
156462165|NCT04186819|564788025|FG000|Overall Study|Opted for EBRT|1|||
156462166|NCT04186819|564788025|FG000|Overall Study|Opted SBRT|1|||
156462167|NCT04186819|564788025|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
156462168|NCT04186819|564788025|FG000|Overall Study|Physician Decision|1|||
156462169|NCT04186819|564788025|FG000|Overall Study|RP Delayed|1|||
156462170|NCT04186819|564788025|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
156462171|NCT04186819|564788025|FG000|Overall Study|Subject declined for financial reasons|1|||
156462172|NCT04186819|564788025|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
156462173|NCT04186819|564788025|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
156462174|NCT04186819|564788025|FG000|Overall Study|The subject opted for other treatment option|2|||
156462175|NCT04186819|564788025|FG000|Overall Study|The subject opted for other treatment options|1|||
156462176|NCT04186819|564788025|FG000|Overall Study|Withdrawal by Subject|3|||
156462177|NCT04186819|564788025|FG000|Overall Study|Reason not specified|1|||
156462178|NCT05013385|564788029|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
156462179|NCT01447719|564788030|FG000|Overall Study|Image acquisition failure|2|||
156462180|NCT01447719|564788030|FG000|Overall Study|Invalid image or not imaged|3|||
156538621|NCT01289821|565066322|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
156810636|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810637|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810638|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810639|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810640|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810641|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810642|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810643|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810644|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810645|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810646|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810647|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810648|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810649|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
156810650|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810651|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810652|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810653|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810654|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810655|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810656|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810657|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810658|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810659|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810660|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810661|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810662|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810663|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810664|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810665|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
156810666|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810667|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810668|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810669|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810670|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810671|NCT02891226|566058860|FG000|Follow-up Period|Withdrawal by Subject|0|||
156810672|NCT02891226|566058861|FG001|Follow-up Period|Withdrawal by Subject|0|||
156338852|NCT01433991|564340051|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
156462181|NCT01447719|564788030|FG000|Overall Study|Subject still living at end of study|79|||
156462182|NCT01447719|564788030|FG000|Overall Study|Withdrawal by Subject|2|||
156462183|NCT01447719|564788030|FG000|Overall Study|Family withdrew autopsy consent|7|||
156462184|NCT03914469|564788031|FG000|Overall Study|Lost to Follow-up|1|||
156462185|NCT03914469|564788032|FG001|Overall Study|Lost to Follow-up|4|||
156462186|NCT03252288|564788033|FG000|Overall Study|Death|1|||
156462187|NCT03252288|564788034|FG001|Overall Study|Death|0|||
156462188|NCT03252288|564788035|FG002|Overall Study|Death|0|||
156462189|NCT03252288|564788033|FG000|Overall Study|Death|11|||
156462190|NCT03252288|564788034|FG001|Overall Study|Death|0|||
156462191|NCT03252288|564788035|FG002|Overall Study|Death|0|||
156462192|NCT03252288|564788033|FG000|Overall Study|Withdrawal by Subject|2|||
156462193|NCT03252288|564788034|FG001|Overall Study|Withdrawal by Subject|0|||
156462194|NCT03252288|564788035|FG002|Overall Study|Withdrawal by Subject|0|||
156810673|NCT02891226|566058862|FG002|Follow-up Period|Withdrawal by Subject|0|||
156810674|NCT02891226|566058863|FG003|Follow-up Period|Withdrawal by Subject|0|||
156810675|NCT02891226|566058864|FG004|Follow-up Period|Withdrawal by Subject|0|||
156810676|NCT02891226|566058865|FG005|Follow-up Period|Withdrawal by Subject|0|||
156810677|NCT02891226|566058866|FG006|Follow-up Period|Withdrawal by Subject|0|||
156810678|NCT02891226|566058867|FG007|Follow-up Period|Withdrawal by Subject|0|||
156810679|NCT02891226|566058868|FG008|Follow-up Period|Withdrawal by Subject|0|||
156810680|NCT02891226|566058869|FG009|Follow-up Period|Withdrawal by Subject|0|||
156810681|NCT02891226|566058870|FG010|Follow-up Period|Withdrawal by Subject|0|||
156810682|NCT02891226|566058871|FG011|Follow-up Period|Withdrawal by Subject|1|||
156810683|NCT02891226|566058872|FG012|Follow-up Period|Withdrawal by Subject|0|||
156810684|NCT02891226|566058873|FG013|Follow-up Period|Withdrawal by Subject|0|||
156810685|NCT02891226|566058874|FG014|Follow-up Period|Withdrawal by Subject|1|||
156462195|NCT03252288|564788033|FG000|Overall Study|Lost to Follow-up|79|||
156462196|NCT03252288|564788034|FG001|Overall Study|Lost to Follow-up|0|||
156462197|NCT03252288|564788035|FG002|Overall Study|Lost to Follow-up|0|||
156462198|NCT03252288|564788033|FG000|Overall Study|Loss of baseline data on tablets|6|||
156462199|NCT03252288|564788034|FG001|Overall Study|Loss of baseline data on tablets|0|||
156462200|NCT03252288|564788035|FG002|Overall Study|Loss of baseline data on tablets|0|||
156462201|NCT00677365|564788036|FG000|Overall Study|Adverse Event|2|||
156462202|NCT00677365|564788037|FG001|Overall Study|Adverse Event|1|||
156462203|NCT00677365|564788038|FG002|Overall Study|Adverse Event|1|||
156462204|NCT00677365|564788039|FG003|Overall Study|Adverse Event|2|||
156462205|NCT00677365|564788036|FG000|Overall Study|Withdrawal by Subject|0|||
156462206|NCT00677365|564788037|FG001|Overall Study|Withdrawal by Subject|0|||
156462207|NCT00677365|564788038|FG002|Overall Study|Withdrawal by Subject|1|||
156462208|NCT00677365|564788039|FG003|Overall Study|Withdrawal by Subject|0|||
156462209|NCT00677365|564788036|FG000|Overall Study|Other reason|0|||
156462210|NCT00677365|564788037|FG001|Overall Study|Other reason|0|||
156462211|NCT00677365|564788038|FG002|Overall Study|Other reason|0|||
156462212|NCT00677365|564788039|FG003|Overall Study|Other reason|1|||
156462213|NCT02944968|564788040|FG000|Overall Study|Subject excluded before study procedure|1|||
156462214|NCT02944968|564788040|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
156462215|NCT02905331|564788041|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
156462216|NCT02905331|564788042|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
156462217|NCT02905331|564788043|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
156462218|NCT02905331|564788041|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
156462219|NCT02905331|564788042|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
156462220|NCT02905331|564788043|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
156462221|NCT02905331|564788041|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
156462222|NCT02905331|564788042|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
156462223|NCT02905331|564788043|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
156462224|NCT02905331|564788041|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
156462225|NCT02905331|564788042|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
156462226|NCT02905331|564788043|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
156462227|NCT02905331|564788041|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
156462228|NCT02905331|564788042|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
156462229|NCT02905331|564788043|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
156462230|NCT04102111|564788051|FG000|Overall Study|Withdrawal by Subject|2|||
156462231|NCT04102111|564788052|FG001|Overall Study|Withdrawal by Subject|3|||
156462232|NCT04102111|564788051|FG000|Overall Study|Adverse Event|1|||
156462233|NCT04102111|564788052|FG001|Overall Study|Adverse Event|1|||
156462234|NCT04102111|564788051|FG000|Overall Study|Study terminated by sponsor|1|||
156462235|NCT04102111|564788052|FG001|Overall Study|Study terminated by sponsor|3|||
156462236|NCT03334695|564788053|FG000|Overall Study|Lost to Follow-up|3|||
156462237|NCT03334695|564788054|FG001|Overall Study|Lost to Follow-up|3|||
156462238|NCT03334695|564788053|FG000|Overall Study|Physician Decision|1|||
156462239|NCT03334695|564788054|FG001|Overall Study|Physician Decision|2|||
156462240|NCT03334695|564788053|FG000|Overall Study|Protocol Violation|0|||
156462241|NCT03334695|564788054|FG001|Overall Study|Protocol Violation|1|||
156462242|NCT02542631|564788055|FG000|Overall Study|Adverse Event|1|||
156462243|NCT02542631|564788056|FG001|Overall Study|Adverse Event|1|||
156462244|NCT02542631|564788055|FG000|Overall Study|Sponsor Termination|1|||
156462245|NCT02542631|564788056|FG001|Overall Study|Sponsor Termination|0|||
156462246|NCT02542631|564788055|FG000|Overall Study|Withdrawal by Subject|11|||
156462247|NCT02542631|564788056|FG001|Overall Study|Withdrawal by Subject|16|||
156462248|NCT02542631|564788055|FG000|Overall Study|Protocol Violation|1|||
156538622|NCT01289821|565066322|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
156538623|NCT02941926|565066323|FG000|Core Phase|Progressive disease|1109|||
156538624|NCT02941926|565066323|FG000|Core Phase|Adverse Event|504|||
156538625|NCT02941926|565066323|FG000|Core Phase|Subject/guardian decision|127|||
156810686|NCT02891226|566058875|FG015|Follow-up Period|Withdrawal by Subject|1|||
156810687|NCT01445847|566058876|FG000|Overall Study|Protocol Violation|13|||
156810688|NCT01445847|566058877|FG001|Overall Study|Protocol Violation|14|||
156810689|NCT01445847|566058876|FG000|Overall Study|Missed Data|1|||
156810690|NCT01445847|566058877|FG001|Overall Study|Missed Data|0|||
156810691|NCT00707993|566058878|FG000|Overall Study|Adverse Event|16|||
156810692|NCT00707993|566058879|FG001|Overall Study|Adverse Event|20|||
156810693|NCT00707993|566058878|FG000|Overall Study|Protocol Violation|4|||
156462249|NCT02542631|564788056|FG001|Overall Study|Protocol Violation|1|||
156462250|NCT02542631|564788055|FG000|Overall Study|Physician Decision|6|||
156462251|NCT02542631|564788056|FG001|Overall Study|Physician Decision|4|||
156462252|NCT02542631|564788055|FG000|Overall Study|Lost to Follow-up|6|||
156462253|NCT02542631|564788056|FG001|Overall Study|Lost to Follow-up|5|||
156462254|NCT02542631|564788055|FG000|Overall Study|Death|1|||
156462255|NCT02542631|564788056|FG001|Overall Study|Death|2|||
156462256|NCT02542631|564788055|FG000|Overall Study|Other|2|||
156462257|NCT02542631|564788056|FG001|Overall Study|Other|1|||
156462258|NCT02542631|564788055|FG000|Overall Study|Used Prohibited Medication|2|||
156462259|NCT02542631|564788056|FG001|Overall Study|Used Prohibited Medication|1|||
156810694|NCT00707993|566058879|FG001|Overall Study|Protocol Violation|7|||
156810695|NCT00707993|566058878|FG000|Overall Study|Lost to Follow-up|0|||
156810696|NCT00707993|566058879|FG001|Overall Study|Lost to Follow-up|4|||
156810697|NCT00707993|566058878|FG000|Overall Study|Withdrawal by Subject|12|||
156810698|NCT00707993|566058879|FG001|Overall Study|Withdrawal by Subject|16|||
156810699|NCT00707993|566058878|FG000|Overall Study|Hyperglycemic Rescue|55|||
156810700|NCT00707993|566058879|FG001|Overall Study|Hyperglycemic Rescue|47|||
156810701|NCT00707993|566058878|FG000|Overall Study|Other|2|||
156810702|NCT00707993|566058879|FG001|Overall Study|Other|0|||
156810703|NCT03960684|566058880|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
156810704|NCT03816176|566058881|FG000|Overall Study|Miscellaneous|5|||
156810705|NCT03816176|566058881|FG000|Overall Study|Lack of Efficacy|4|||
156810706|NCT03816176|566058881|FG000|Overall Study|Adverse Event|3|||
156810707|NCT01142388|566060401|FG000|Overall Study|Lack of Efficacy|21|||
156810708|NCT01142388|566060402|FG001|Overall Study|Lack of Efficacy|31|||
156810709|NCT01142388|566060401|FG000|Overall Study|Adverse Event|9|||
156810710|NCT01142388|566060402|FG001|Overall Study|Adverse Event|5|||
156810711|NCT01142388|566060401|FG000|Overall Study|Death|3|||
156810712|NCT01142388|566060402|FG001|Overall Study|Death|2|||
156810713|NCT01142388|566060401|FG000|Overall Study|Withdrawal by Subject|5|||
156810714|NCT01142388|566060402|FG001|Overall Study|Withdrawal by Subject|3|||
156810715|NCT01142388|566060401|FG000|Overall Study|Alternative therapy|1|||
156810716|NCT01142388|566060402|FG001|Overall Study|Alternative therapy|0|||
156810717|NCT01142388|566060401|FG000|Overall Study|Other complications|0|||
156810718|NCT01142388|566060402|FG001|Overall Study|Other complications|2|||
156810719|NCT01142388|566060401|FG000|Overall Study|Other|1|||
156810720|NCT01142388|566060402|FG001|Overall Study|Other|1|||
156810721|NCT01142388|566060401|FG000|Overall Study|Never started therapy|7|||
156810722|NCT01142388|566060402|FG001|Overall Study|Never started therapy|3|||
156810723|NCT03640325|566060408|FG000|Overall Study|Withdrawal by Subject|4|||
156810724|NCT03640325|566060409|FG001|Overall Study|Withdrawal by Subject|1|||
156810725|NCT03640325|566060410|FG002|Overall Study|Withdrawal by Subject|0|||
156810726|NCT03640325|566060408|FG000|Overall Study|Lost to Follow-up|4|||
156810727|NCT03640325|566060409|FG001|Overall Study|Lost to Follow-up|5|||
156810728|NCT03640325|566060410|FG002|Overall Study|Lost to Follow-up|21|||
156810729|NCT03640325|566060408|FG000|Overall Study|Death|5|||
156810730|NCT03640325|566060409|FG001|Overall Study|Death|5|||
156810731|NCT03640325|566060410|FG002|Overall Study|Death|0|||
156810732|NCT05265728|566060411|FG000|Overall Study|Adverse Event|1|||
156810733|NCT05265728|566060411|FG000|Overall Study|Study Terminated by Sponsor|5|||
156810734|NCT05265728|566060411|FG000|Overall Study|Withdrawal by Subject|2|||
156810735|NCT03493451|566060412|FG000|Overall Study|Death|11|||
156810736|NCT03493451|566060413|FG001|Overall Study|Death|26|||
156810737|NCT03493451|566060414|FG002|Overall Study|Death|3|||
156810738|NCT03493451|566060412|FG000|Overall Study|Lost to Follow-up|1|||
156810739|NCT03493451|566060413|FG001|Overall Study|Lost to Follow-up|4|||
156810740|NCT03493451|566060414|FG002|Overall Study|Lost to Follow-up|1|||
156810741|NCT03493451|566060412|FG000|Overall Study|Withdrawal by Subject|1|||
156810742|NCT03493451|566060413|FG001|Overall Study|Withdrawal by Subject|1|||
156810743|NCT03493451|566060414|FG002|Overall Study|Withdrawal by Subject|2|||
156810744|NCT03493451|566060412|FG000|Overall Study|Progressive Disease|1|||
156810745|NCT03493451|566060413|FG001|Overall Study|Progressive Disease|0|||
156810746|NCT03493451|566060414|FG002|Overall Study|Progressive Disease|0|||
156810747|NCT03493451|566060412|FG000|Overall Study|Transferred to long term extension study|8|||
156810748|NCT03493451|566060413|FG001|Overall Study|Transferred to long term extension study|13|||
156810749|NCT03493451|566060414|FG002|Overall Study|Transferred to long term extension study|5|||
156810750|NCT01566149|566060417|FG000|Overall Study|Adverse Event|0|||
156810751|NCT01566149|566060418|FG001|Overall Study|Adverse Event|1|||
156810752|NCT01566149|566060417|FG000|Overall Study|Non-compliance with study medication|2|||
156810753|NCT01566149|566060418|FG001|Overall Study|Non-compliance with study medication|0|||
156810754|NCT01566149|566060417|FG000|Overall Study|Protocol Violation|0|||
156810755|NCT01566149|566060418|FG001|Overall Study|Protocol Violation|1|||
156810756|NCT01566149|566060417|FG000|Overall Study|Withdrawal by Subject|1|||
156810757|NCT01566149|566060418|FG001|Overall Study|Withdrawal by Subject|0|||
156810758|NCT03687957|566060423|FG000|Overall Study|Withdrawal by Subject|0|||
156810759|NCT03687957|566060424|FG001|Overall Study|Withdrawal by Subject|0|||
156810760|NCT03687957|566060425|FG002|Overall Study|Withdrawal by Subject|0|||
156810761|NCT03687957|566060426|FG003|Overall Study|Withdrawal by Subject|2|||
156810762|NCT03687957|566060427|FG004|Overall Study|Withdrawal by Subject|0|||
156810763|NCT03687957|566060428|FG005|Overall Study|Withdrawal by Subject|0|||
156810764|NCT03687957|566060429|FG006|Overall Study|Withdrawal by Subject|3|||
156810765|NCT03687957|566060430|FG007|Overall Study|Withdrawal by Subject|1|||
156810766|NCT03687957|566060431|FG008|Overall Study|Withdrawal by Subject|1|||
156810767|NCT03687957|566060432|FG009|Overall Study|Withdrawal by Subject|0|||
156810768|NCT03687957|566060423|FG000|Overall Study|Disease progression|0|||
156810769|NCT03687957|566060424|FG001|Overall Study|Disease progression|1|||
156810770|NCT03687957|566060425|FG002|Overall Study|Disease progression|1|||
156462260|NCT02938923|564788057|FG000|Overall Study|Death|1|||
156810771|NCT03687957|566060426|FG003|Overall Study|Disease progression|2|||
156810772|NCT03687957|566060427|FG004|Overall Study|Disease progression|2|||
156810773|NCT03687957|566060428|FG005|Overall Study|Disease progression|0|||
156810774|NCT03687957|566060429|FG006|Overall Study|Disease progression|2|||
156810775|NCT03687957|566060430|FG007|Overall Study|Disease progression|1|||
156810776|NCT03687957|566060431|FG008|Overall Study|Disease progression|0|||
156810777|NCT03687957|566060432|FG009|Overall Study|Disease progression|0|||
156810778|NCT03687957|566060423|FG000|Overall Study|Physician Decision|0|||
156810779|NCT03687957|566060424|FG001|Overall Study|Physician Decision|0|||
156810780|NCT03687957|566060425|FG002|Overall Study|Physician Decision|0|||
156810781|NCT03687957|566060426|FG003|Overall Study|Physician Decision|2|||
156810782|NCT03687957|566060427|FG004|Overall Study|Physician Decision|1|||
156810783|NCT03687957|566060428|FG005|Overall Study|Physician Decision|0|||
156810784|NCT03687957|566060429|FG006|Overall Study|Physician Decision|1|||
156810785|NCT03687957|566060430|FG007|Overall Study|Physician Decision|0|||
156810786|NCT03687957|566060431|FG008|Overall Study|Physician Decision|0|||
156810787|NCT03687957|566060432|FG009|Overall Study|Physician Decision|0|||
156810788|NCT03687957|566060423|FG000|Overall Study|New malignancy|0|||
156810789|NCT03687957|566060424|FG001|Overall Study|New malignancy|0|||
156810790|NCT03687957|566060425|FG002|Overall Study|New malignancy|0|||
156810791|NCT03687957|566060426|FG003|Overall Study|New malignancy|0|||
156810792|NCT03687957|566060427|FG004|Overall Study|New malignancy|1|||
156810793|NCT03687957|566060428|FG005|Overall Study|New malignancy|0|||
156810794|NCT03687957|566060429|FG006|Overall Study|New malignancy|0|||
156810795|NCT03687957|566060430|FG007|Overall Study|New malignancy|0|||
156810796|NCT03687957|566060431|FG008|Overall Study|New malignancy|0|||
156810797|NCT03687957|566060432|FG009|Overall Study|New malignancy|0|||
156810798|NCT03687957|566060423|FG000|Overall Study|Adverse Event|0|||
156810799|NCT03687957|566060424|FG001|Overall Study|Adverse Event|0|||
156810800|NCT03687957|566060425|FG002|Overall Study|Adverse Event|0|||
156810801|NCT03687957|566060426|FG003|Overall Study|Adverse Event|0|||
156810802|NCT03687957|566060427|FG004|Overall Study|Adverse Event|0|||
156810803|NCT03687957|566060428|FG005|Overall Study|Adverse Event|2|||
156810804|NCT03687957|566060429|FG006|Overall Study|Adverse Event|0|||
156810805|NCT03687957|566060430|FG007|Overall Study|Adverse Event|3|||
156810806|NCT03687957|566060431|FG008|Overall Study|Adverse Event|0|||
156810807|NCT03687957|566060432|FG009|Overall Study|Adverse Event|0|||
156810808|NCT03687957|566060423|FG000|Overall Study|Patient went on hospice|0|||
156810809|NCT03687957|566060424|FG001|Overall Study|Patient went on hospice|0|||
156810810|NCT03687957|566060425|FG002|Overall Study|Patient went on hospice|0|||
156810811|NCT03687957|566060426|FG003|Overall Study|Patient went on hospice|0|||
156810812|NCT03687957|566060427|FG004|Overall Study|Patient went on hospice|0|||
156810813|NCT03687957|566060428|FG005|Overall Study|Patient went on hospice|0|||
156810814|NCT03687957|566060429|FG006|Overall Study|Patient went on hospice|1|||
156810815|NCT03687957|566060430|FG007|Overall Study|Patient went on hospice|0|||
156810816|NCT03687957|566060431|FG008|Overall Study|Patient went on hospice|0|||
156810817|NCT03687957|566060432|FG009|Overall Study|Patient went on hospice|0|||
156810818|NCT03687957|566060423|FG000|Overall Study|Death|0|||
156810819|NCT03687957|566060424|FG001|Overall Study|Death|0|||
156810820|NCT03687957|566060425|FG002|Overall Study|Death|0|||
156810821|NCT03687957|566060426|FG003|Overall Study|Death|0|||
156810822|NCT03687957|566060427|FG004|Overall Study|Death|0|||
156810823|NCT03687957|566060428|FG005|Overall Study|Death|0|||
156810824|NCT03687957|566060429|FG006|Overall Study|Death|0|||
156810825|NCT03687957|566060430|FG007|Overall Study|Death|1|||
156810826|NCT03687957|566060431|FG008|Overall Study|Death|0|||
156810827|NCT03687957|566060432|FG009|Overall Study|Death|0|||
156810828|NCT03276728|566060433|FG000|Overall Study|Lost to Follow-up|0|||
156810829|NCT03276728|566060434|FG001|Overall Study|Lost to Follow-up|0|||
156810830|NCT03276728|566060435|FG002|Overall Study|Lost to Follow-up|2|||
156810831|NCT03276728|566060436|FG003|Overall Study|Lost to Follow-up|2|||
156810832|NCT03276728|566060437|FG004|Overall Study|Lost to Follow-up|0|||
156810833|NCT03276728|566060438|FG005|Overall Study|Lost to Follow-up|0|||
156538626|NCT02941926|565066323|FG000|Core Phase|Physician Decision|112|||
156538627|NCT02941926|565066323|FG000|Core Phase|Death|46|||
156538628|NCT02941926|565066323|FG000|Core Phase|Protocol deviation|34|||
156538629|NCT02941926|565066323|FG000|Core Phase|Lost to Follow-up|8|||
156810834|NCT03276728|566060439|FG006|Overall Study|Lost to Follow-up|0|||
156810835|NCT03276728|566060440|FG007|Overall Study|Lost to Follow-up|0|||
156810836|NCT03276728|566060433|FG000|Overall Study|Withdrawal by Subject|0|||
156810837|NCT03276728|566060434|FG001|Overall Study|Withdrawal by Subject|0|||
156810838|NCT03276728|566060435|FG002|Overall Study|Withdrawal by Subject|0|||
156810839|NCT03276728|566060436|FG003|Overall Study|Withdrawal by Subject|3|||
156810840|NCT03276728|566060437|FG004|Overall Study|Withdrawal by Subject|0|||
156810841|NCT03276728|566060438|FG005|Overall Study|Withdrawal by Subject|0|||
156810842|NCT03276728|566060439|FG006|Overall Study|Withdrawal by Subject|0|||
156810843|NCT03276728|566060440|FG007|Overall Study|Withdrawal by Subject|0|||
156810844|NCT03276728|566060433|FG000|Overall Study|Decision by sponsor|0|||
156810845|NCT03276728|566060434|FG001|Overall Study|Decision by sponsor|0|||
156810846|NCT03276728|566060435|FG002|Overall Study|Decision by sponsor|0|||
156810847|NCT03276728|566060436|FG003|Overall Study|Decision by sponsor|0|||
156810848|NCT03276728|566060437|FG004|Overall Study|Decision by sponsor|1|||
156810849|NCT03276728|566060438|FG005|Overall Study|Decision by sponsor|0|||
156810850|NCT03276728|566060439|FG006|Overall Study|Decision by sponsor|2|||
156810851|NCT03276728|566060440|FG007|Overall Study|Decision by sponsor|1|||
156810852|NCT02213926|566060443|FG000|Overall Study|Death|59|||
156810853|NCT02213926|566060443|FG000|Overall Study|Withdrawal by Subject|10|||
156810854|NCT02213926|566060443|FG000|Overall Study|study terminated by sponsor|51|||
156810855|NCT02213926|566060443|FG000|Overall Study|Lost to Follow-up|3|||
156810856|NCT02213926|566060443|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
156810857|NCT01188551|566060444|FG000|Overall Study|Pharmacy issues|1|||
156810858|NCT01188551|566060445|FG001|Overall Study|Pharmacy issues|0|||
156810859|NCT01188551|566060446|FG002|Overall Study|Pharmacy issues|0|||
156810860|NCT01188551|566060447|FG003|Overall Study|Pharmacy issues|0|||
156810861|NCT03458325|566060455|FG000|Overall Study|Withdrawal by Subject|1|||
156810862|NCT02630693|566060460|FG000|Overall Study|No receive treatment|0|||
156810863|NCT02630693|566060461|FG001|Overall Study|No receive treatment|1|||
156810864|NCT00175916|566060462|FG000|Overall Study|Death|19|||
156810865|NCT00175916|566060462|FG000|Overall Study|Adverse Event|81|||
156810866|NCT00175916|566060462|FG000|Overall Study|Lack of Efficacy|354|||
156810867|NCT00175916|566060462|FG000|Overall Study|Lost to Follow-up|17|||
156810868|NCT00175916|566060462|FG000|Overall Study|Subject Choice|98|||
156810869|NCT00175916|566060462|FG000|Overall Study|Lack of compliance|8|||
156810870|NCT00175916|566060462|FG000|Overall Study|Patient cannot record seizures|1|||
156810871|NCT00175916|566060462|FG000|Overall Study|Sponsor decision|17|||
156810872|NCT00175916|566060462|FG000|Overall Study|Vigabatrin intake|1|||
156810873|NCT00175916|566060462|FG000|Overall Study|Suicidal behaviour|1|||
156810874|NCT00175916|566060462|FG000|Overall Study|Withdrawal by Subject|1|||
156810875|NCT00175916|566060462|FG000|Overall Study|Seizure - free|4|||
156810876|NCT00175916|566060462|FG000|Overall Study|Administrative reason|1|||
156810877|NCT00175916|566060462|FG000|Overall Study|Pregnancy|1|||
156810878|NCT00175916|566060462|FG000|Overall Study|Patient's request|2|||
156810879|NCT00175916|566060462|FG000|Overall Study|Treating physiciant's choice|1|||
156810880|NCT00175916|566060462|FG000|Overall Study|Moved overseas|1|||
156810881|NCT00175916|566060462|FG000|Overall Study|Loss of job and economic burden|1|||
156810882|NCT00175916|566060462|FG000|Overall Study|Site was closed|9|||
156810883|NCT00175916|566060462|FG000|Overall Study|Patient went to prison|1|||
156810884|NCT00310375|566060463|FG000|Primary Reporting Phase|Adverse Event|28|||
156810885|NCT00310375|566060464|FG001|Primary Reporting Phase|Adverse Event|22|||
156810886|NCT00310375|566060465|FG002|Primary Reporting Phase|Adverse Event|0|||
156810887|NCT00310375|566060463|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
156810888|NCT00310375|566060464|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
156810889|NCT00310375|566060465|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
156810890|NCT00310375|566060463|FG000|Primary Reporting Phase|Pregnancy|2|||
156810891|NCT00310375|566060464|FG001|Primary Reporting Phase|Pregnancy|2|||
156810892|NCT00310375|566060465|FG002|Primary Reporting Phase|Pregnancy|0|||
156810893|NCT00310375|566060463|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
156810894|NCT00310375|566060464|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
156810895|NCT00310375|566060465|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
156810896|NCT00310375|566060463|FG000|Primary Reporting Phase|Protocol Violation|8|||
156810897|NCT00310375|566060464|FG001|Primary Reporting Phase|Protocol Violation|5|||
156810898|NCT00310375|566060465|FG002|Primary Reporting Phase|Protocol Violation|0|||
156810899|NCT00310375|566060463|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
156810900|NCT00310375|566060464|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
156810901|NCT00310375|566060465|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
156810902|NCT00310375|566060463|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
156810903|NCT00310375|566060464|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
156810904|NCT00310375|566060465|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
156462261|NCT02938923|564788058|FG001|Overall Study|Death|0|||
156462262|NCT02938923|564788059|FG002|Overall Study|Death|0|||
156462263|NCT02938923|564788057|FG000|Overall Study|Physician Decision|0|||
156810905|NCT00310375|566060463|FG000|Primary Reporting Phase|Physician Decision|5|||
156810906|NCT00310375|566060464|FG001|Primary Reporting Phase|Physician Decision|3|||
156810907|NCT00310375|566060465|FG002|Primary Reporting Phase|Physician Decision|0|||
156810908|NCT00310375|566060463|FG000|Primary Reporting Phase|Request of the sponsor|2|||
156810909|NCT00310375|566060464|FG001|Primary Reporting Phase|Request of the sponsor|2|||
156810910|NCT00310375|566060465|FG002|Primary Reporting Phase|Request of the sponsor|0|||
156810911|NCT00310375|566060463|FG000|Primary Reporting Phase|Failed to return|1|||
156810912|NCT00310375|566060464|FG001|Primary Reporting Phase|Failed to return|3|||
156810913|NCT00310375|566060465|FG002|Primary Reporting Phase|Failed to return|0|||
156462264|NCT02938923|564788058|FG001|Overall Study|Physician Decision|2|||
156462265|NCT02938923|564788059|FG002|Overall Study|Physician Decision|0|||
156462266|NCT02938923|564788057|FG000|Overall Study|Withdrawal by Subject|0|||
156810914|NCT00310375|566060463|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
156810915|NCT00310375|566060464|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
156810916|NCT00310375|566060465|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
156810917|NCT00310375|566060463|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
156810918|NCT00310375|566060464|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
156810919|NCT00310375|566060465|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
156810920|NCT00310375|566060463|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
156810921|NCT00310375|566060464|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
156810922|NCT00310375|566060465|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
156810923|NCT00310375|566060463|FG000|Primary Reporting Phase|Site closure|3|||
156810924|NCT00310375|566060464|FG001|Primary Reporting Phase|Site closure|0|||
156810925|NCT00310375|566060465|FG002|Primary Reporting Phase|Site closure|0|||
156810926|NCT00310375|566060463|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
156810927|NCT00310375|566060464|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
156810928|NCT00310375|566060465|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
156810929|NCT00310375|566060463|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
156810930|NCT00310375|566060464|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
156810931|NCT00310375|566060465|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
156810932|NCT00310375|566060463|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
156810933|NCT00310375|566060464|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
156810934|NCT00310375|566060465|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
156810935|NCT00310375|566060463|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
156810936|NCT00310375|566060464|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
156810937|NCT00310375|566060465|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
156810938|NCT05338710|566060466|FG000|Overall Study|Withdrawal by Subject|3|||
156810939|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
156810940|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
156810941|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810942|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810943|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810944|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810945|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810946|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810947|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810948|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810949|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
156810950|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
156810951|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810952|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810953|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810954|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810955|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810956|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810957|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810958|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810959|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
156810960|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810961|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810962|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810963|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810964|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810965|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810966|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810967|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810968|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810969|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
156810970|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
156810971|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810972|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156462267|NCT02938923|564788058|FG001|Overall Study|Withdrawal by Subject|1|||
156462268|NCT02938923|564788059|FG002|Overall Study|Withdrawal by Subject|1|||
156462269|NCT00721149|564788060|FG000|Overall Study|Physician Decision|1|||
156810973|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810974|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810975|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810976|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810977|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810978|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810979|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810980|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
156810981|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810982|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810983|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810984|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810985|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810986|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810987|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810988|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810989|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
156810990|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
156810991|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810992|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810993|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810994|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810995|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810996|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810997|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810998|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810999|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
156811000|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
156811001|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811002|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811003|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811004|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811005|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811006|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811007|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811008|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811009|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
156811010|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
156811011|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811012|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811013|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811014|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811015|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811016|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811017|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811018|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811019|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811020|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811021|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
156811022|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
156811023|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811024|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811025|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811026|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811027|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811028|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811029|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811030|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811031|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
156811032|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
156811033|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811034|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811035|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156462270|NCT06010836|564788068|FG000|Overall Study|Lost to Follow-up|2|||
156811036|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156462271|NCT06010836|564788069|FG001|Overall Study|Lost to Follow-up|2|||
156462272|NCT06010836|564788068|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
156462273|NCT06010836|564788069|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
156811037|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811038|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811039|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811040|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811041|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
156811042|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
156811043|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811044|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811045|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811046|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811047|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811048|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811049|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811050|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811051|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
156811052|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
156811053|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811054|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811055|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811056|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811057|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811058|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811059|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811060|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811061|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
156811062|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811063|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811064|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811065|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811066|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811067|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811068|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811069|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811070|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811071|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811072|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
156811073|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811074|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811075|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811076|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811077|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811078|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811079|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Other|0|||
156811080|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Other|0|||
156811081|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Other|2|||
156811082|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Other|1|||
156811083|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Other|0|||
156811084|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Other|0|||
156811085|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Other|0|||
156811086|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Other|0|||
156811087|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Other|0|||
156811088|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Other|0|||
156811089|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156338853|NCT01433991|564340052|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
156338854|NCT01433991|564340053|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
156538630|NCT02941926|565066323|FG000|Core Phase|Technical problems|5|||
156538631|NCT02941926|565066323|FG000|Extension Phase|Physician Decision|155|||
156811090|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811091|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811092|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811093|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811094|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
156811095|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
156811096|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
156811097|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811098|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811099|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811100|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811101|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811102|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811103|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
156811104|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
156811105|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
156811106|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
156811107|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811108|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811109|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811110|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811111|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811112|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811113|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
156811114|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811115|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
156811116|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811117|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811118|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811119|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811120|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811121|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811122|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811123|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
156811124|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811125|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
156811126|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
156811127|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811128|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811129|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811130|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811131|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811132|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811133|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
156811134|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
156811135|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
156811136|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811137|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811138|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811139|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811140|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811141|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811142|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811143|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811144|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811145|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811146|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
156811147|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811148|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811149|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811150|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811151|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811152|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156538632|NCT02941926|565066323|FG000|Extension Phase|Progressive disease|115|||
156811153|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811154|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811155|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
156811156|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811157|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811158|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811159|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811160|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811161|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811162|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811163|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811164|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811165|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811166|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811167|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
156811168|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
156811169|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811170|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811171|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811172|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811173|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811174|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811175|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811176|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811177|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
156811178|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
156811179|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811180|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811181|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811182|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811183|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811184|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811185|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811186|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811187|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
156811188|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
156811189|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811190|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811191|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811192|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811193|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811194|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811195|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811196|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811197|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
156811198|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
156811199|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
156811200|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
156811201|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
156811202|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
156811203|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
156811204|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
156811205|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
156811206|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
156811207|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
156538633|NCT02941926|565066323|FG000|Extension Phase|Adverse Event|13|||
156811208|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
156811209|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811210|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811211|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156338855|NCT01433991|564340050|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
156811212|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811213|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811214|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811215|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811216|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811217|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
156811218|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
156811219|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811220|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811221|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811222|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811223|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811224|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811225|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811226|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156462274|NCT06010836|564788068|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
156462275|NCT06010836|564788069|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
156811227|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
156811228|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811229|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811230|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811231|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811232|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811233|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811234|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811235|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811236|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811237|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
156811238|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
156811239|NCT01081951|566060477|FG000|Overall Study|Death|54|||
156811240|NCT01081951|566060478|FG001|Overall Study|Death|47|||
156811241|NCT01081951|566060477|FG000|Overall Study|Withdrawal by Subject|2|||
156811242|NCT01081951|566060478|FG001|Overall Study|Withdrawal by Subject|6|||
156811243|NCT01081951|566060477|FG000|Overall Study|Allocated treatment but did not take it|0|||
156811244|NCT01081951|566060478|FG001|Overall Study|Allocated treatment but did not take it|1|||
156811245|NCT01081951|566060477|FG000|Overall Study|Lost to Follow-up|0|||
156811246|NCT01081951|566060478|FG001|Overall Study|Lost to Follow-up|1|||
156811247|NCT05384834|566060481|FG000|Overall Study|Lost to Follow-up|43|||
156811248|NCT05384834|566060481|FG000|Overall Study|Withdrawal by Subject|5|||
156811249|NCT01871545|566060482|FG000|Overall Study|Death|2|||
156811250|NCT01871545|566060483|FG001|Overall Study|Death|0|||
156811251|NCT01871545|566060482|FG000|Overall Study|Lack of Efficacy|11|||
156811252|NCT01871545|566060483|FG001|Overall Study|Lack of Efficacy|2|||
156811253|NCT01871545|566060482|FG000|Overall Study|Physician Decision|4|||
156811254|NCT01871545|566060483|FG001|Overall Study|Physician Decision|0|||
156811255|NCT01871545|566060482|FG000|Overall Study|Withdrawal by Subject|0|||
156811256|NCT01871545|566060483|FG001|Overall Study|Withdrawal by Subject|1|||
156811257|NCT05710640|566060484|FG000|Overall Study|Physician Decision|0|||
156811258|NCT05710640|566060485|FG001|Overall Study|Physician Decision|1|||
156811259|NCT05710640|566060484|FG000|Overall Study|Withdrawal by Subject|1|||
156811260|NCT05710640|566060485|FG001|Overall Study|Withdrawal by Subject|0|||
156811261|NCT05710640|566060484|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
156811262|NCT05710640|566060485|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
156811263|NCT04188509|566060486|FG000|Overall Study|Adverse Event|2|||
156811264|NCT04188509|566060486|FG000|Overall Study|Lost to Follow-up|1|||
156811265|NCT04188509|566060486|FG000|Overall Study|Withdrawal of Consent|1|||
156811266|NCT04188509|566060486|FG000|Overall Study|Discretion of Investigator|1|||
156811267|NCT04188509|566060486|FG000|Overall Study|Noncompliance|3|||
156811268|NCT04188509|566060486|FG000|Overall Study|Sponsor Decision|127|||
156811269|NCT04188509|566060486|FG000|Overall Study|Other|2|||
156811270|NCT00763256|566060487|FG000|Overall Study|Didn't return for appointments|7|||
156811271|NCT00763256|566060488|FG001|Overall Study|Didn't return for appointments|10|||
156811272|NCT01272037|566060491|FG000|Overall Study|Death|25|||
156811273|NCT01272037|566060492|FG001|Overall Study|Death|28|||
156811274|NCT01272037|566060491|FG000|Overall Study|Adverse Event|12|||
156338856|NCT01433991|564340051|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
156462276|NCT06010836|564788068|FG000|Overall Study|Did not receive intervention discussion|0|||
156462277|NCT06010836|564788069|FG001|Overall Study|Did not receive intervention discussion|4|||
156811275|NCT01272037|566060492|FG001|Overall Study|Adverse Event|7|||
156811276|NCT01272037|566060491|FG000|Overall Study|Withdrawal by Subject|175|||
156811277|NCT01272037|566060492|FG001|Overall Study|Withdrawal by Subject|93|||
156811278|NCT01272037|566060491|FG000|Overall Study|Disease progression|70|||
156811279|NCT01272037|566060492|FG001|Overall Study|Disease progression|111|||
156811280|NCT01272037|566060491|FG000|Overall Study|Other reason|42|||
156811281|NCT01272037|566060492|FG001|Overall Study|Other reason|41|||
156811282|NCT01272037|566060491|FG000|Overall Study|Delinquent data|24|||
156811283|NCT01272037|566060492|FG001|Overall Study|Delinquent data|19|||
156811284|NCT01272037|566060491|FG000|Overall Study|Reason under review|33|||
156811285|NCT01272037|566060492|FG001|Overall Study|Reason under review|29|||
156462278|NCT05890105|564788073|FG000|Overall Study|Adverse Event|1|||
156811286|NCT01272037|566060491|FG000|Overall Study|On treatment|626|||
156811287|NCT01272037|566060492|FG001|Overall Study|On treatment|632|||
156811288|NCT01393899|566060493|FG000|Overall Study|Study terminated by sponsor|1|||
156811289|NCT01393899|566060494|FG001|Overall Study|Study terminated by sponsor|0|||
156811290|NCT01393899|566060495|FG002|Overall Study|Study terminated by sponsor|1|||
156811291|NCT01393899|566060493|FG000|Overall Study|Other|1|||
156811292|NCT01393899|566060494|FG001|Overall Study|Other|0|||
156811293|NCT01393899|566060495|FG002|Overall Study|Other|0|||
156811294|NCT01393899|566060493|FG000|Overall Study|Withdrawal by Subject|2|||
156811295|NCT01393899|566060494|FG001|Overall Study|Withdrawal by Subject|2|||
156811296|NCT01393899|566060495|FG002|Overall Study|Withdrawal by Subject|1|||
156811297|NCT01393899|566060493|FG000|Overall Study|Lost to Follow-up|0|||
156811298|NCT01393899|566060494|FG001|Overall Study|Lost to Follow-up|0|||
156811299|NCT01393899|566060495|FG002|Overall Study|Lost to Follow-up|1|||
156811300|NCT01393899|566060493|FG000|Overall Study|Does not meet entrance criteria|1|||
156811301|NCT01393899|566060494|FG001|Overall Study|Does not meet entrance criteria|0|||
156811302|NCT01393899|566060495|FG002|Overall Study|Does not meet entrance criteria|1|||
156811303|NCT01393899|566060493|FG000|Overall Study|Lack of Efficacy|26|||
156811304|NCT01393899|566060494|FG001|Overall Study|Lack of Efficacy|21|||
156811305|NCT01393899|566060495|FG002|Overall Study|Lack of Efficacy|16|||
156811306|NCT01393899|566060493|FG000|Overall Study|Adverse Event|1|||
156811307|NCT01393899|566060494|FG001|Overall Study|Adverse Event|5|||
156811308|NCT01393899|566060495|FG002|Overall Study|Adverse Event|3|||
156811309|NCT02503085|566060498|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
156811310|NCT02503085|566060499|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
156811311|NCT02503085|566060500|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
156811312|NCT02503085|566060501|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
156811313|NCT02720523|566060505|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811314|NCT02720523|566060506|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811315|NCT02720523|566060507|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
156811316|NCT02720523|566060508|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
156811317|NCT02720523|566060509|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811318|NCT02720523|566060510|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811319|NCT02720523|566060511|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811320|NCT02720523|566060505|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
156811321|NCT02720523|566060506|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811322|NCT02720523|566060507|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811323|NCT02720523|566060508|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811324|NCT02720523|566060509|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811325|NCT02720523|566060510|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811326|NCT02720523|566060511|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811327|NCT02720523|566060505|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
156811328|NCT02720523|566060506|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811329|NCT02720523|566060507|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811330|NCT02720523|566060508|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811331|NCT02720523|566060509|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811332|NCT02720523|566060510|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811333|NCT02720523|566060511|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156462279|NCT05890105|564788074|FG001|Overall Study|Adverse Event|0|||
156462280|NCT05890105|564788075|FG002|Overall Study|Adverse Event|0|||
156462281|NCT05890105|564788073|FG000|Overall Study|Other|1|||
156462282|NCT05890105|564788074|FG001|Overall Study|Other|2|||
156462283|NCT05890105|564788075|FG002|Overall Study|Other|0|||
156462284|NCT04206787|564788076|FG000|Overall Study|Other than listed|2|||
156811334|NCT02720523|566060505|FG000|Period 1: Placebo-controlled Period|Other|0|||
156811335|NCT02720523|566060506|FG001|Period 1: Placebo-controlled Period|Other|0|||
156811336|NCT02720523|566060507|FG002|Period 1: Placebo-controlled Period|Other|1|||
156462285|NCT04206787|564788076|FG000|Overall Study|Investigator decision|1|||
156462286|NCT04206787|564788076|FG000|Overall Study|Death|25|||
156462287|NCT04206787|564788076|FG000|Overall Study|Lost to Follow-up|9|||
156462288|NCT04206787|564788076|FG000|Overall Study|Withdrawal of consent|9|||
156462289|NCT04505410|564788078|FG000|Overall Study|Adverse Event|2|||
156462290|NCT04505410|564788079|FG001|Overall Study|Adverse Event|0|||
156462291|NCT04505410|564788078|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
156462292|NCT04505410|564788079|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
156462293|NCT04505410|564788078|FG000|Overall Study|did not want to follow diet|1|||
156538634|NCT02941926|565066323|FG000|Extension Phase|Subject/Guardian decision|12|||
156811337|NCT02720523|566060508|FG003|Period 1: Placebo-controlled Period|Other|1|||
156811338|NCT02720523|566060509|FG004|Period 1: Placebo-controlled Period|Other|0|||
156462294|NCT04505410|564788079|FG001|Overall Study|did not want to follow diet|0|||
156462295|NCT04505410|564788078|FG000|Overall Study|flare up of ulcerative colitis|0|||
156462296|NCT04505410|564788079|FG001|Overall Study|flare up of ulcerative colitis|1|||
156811339|NCT02720523|566060510|FG005|Period 1: Placebo-controlled Period|Other|0|||
156811340|NCT02720523|566060511|FG006|Period 1: Placebo-controlled Period|Other|0|||
156811341|NCT02720523|566060505|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
156811342|NCT02720523|566060506|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
156811343|NCT02720523|566060507|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
156811344|NCT02720523|566060508|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
156811345|NCT02720523|566060509|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
156811346|NCT02720523|566060510|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
156811347|NCT02720523|566060511|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
156811348|NCT02720523|566060505|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
156811349|NCT02720523|566060506|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
156811350|NCT02720523|566060507|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
156811351|NCT02720523|566060508|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
156811352|NCT02720523|566060509|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
156811353|NCT02720523|566060510|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
156811354|NCT02720523|566060511|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
156811355|NCT02720523|566060505|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
156811356|NCT02720523|566060506|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
156811357|NCT02720523|566060507|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
156811358|NCT02720523|566060508|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
156811359|NCT02720523|566060509|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
156811360|NCT02720523|566060510|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
156811361|NCT02720523|566060511|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
156811362|NCT02720523|566060505|FG000|Period 2: Long-term Extension Period|Other|0|||
156811363|NCT02720523|566060506|FG001|Period 2: Long-term Extension Period|Other|0|||
156811364|NCT02720523|566060507|FG002|Period 2: Long-term Extension Period|Other|0|||
156811365|NCT02720523|566060508|FG003|Period 2: Long-term Extension Period|Other|0|||
156811366|NCT02720523|566060509|FG004|Period 2: Long-term Extension Period|Other|2|||
156811367|NCT02720523|566060510|FG005|Period 2: Long-term Extension Period|Other|0|||
156811368|NCT02720523|566060511|FG006|Period 2: Long-term Extension Period|Other|3|||
156811369|NCT03670355|566060512|FG000|Overall Study|Adverse Event|1|||
156811370|NCT03670355|566060513|FG001|Overall Study|Adverse Event|0|||
156811371|NCT03670355|566060512|FG000|Overall Study|Unable to comply with study procedures|0|||
156811372|NCT03670355|566060513|FG001|Overall Study|Unable to comply with study procedures|1|||
156811373|NCT03670355|566060512|FG000|Overall Study|Participant refused|0|||
156811374|NCT03670355|566060513|FG001|Overall Study|Participant refused|1|||
156811375|NCT03146663|566060514|FG000|Overall Study|Did not receive study treatment|1|||
156811376|NCT03146663|566060515|FG001|Overall Study|Did not receive study treatment|1|||
156811377|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
156811378|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
156811379|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
156811380|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
156811381|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
156811382|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
156811383|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Other|0|||
156811384|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Other|1|||
156811385|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Other|1|||
156811386|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Other|0|||
156811387|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Other|0|||
156811388|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Other|0|||
156811389|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
156811390|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
156811391|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
156811392|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
156811393|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
156811394|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
156811395|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811396|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811397|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
156462297|NCT04505410|564788078|FG000|Overall Study|Lost to Follow-up|0|||
156462298|NCT04505410|564788079|FG001|Overall Study|Lost to Follow-up|2|||
156462299|NCT04505410|564788078|FG000|Overall Study|Lost to Follow-up|1|||
156462300|NCT04505410|564788079|FG001|Overall Study|Lost to Follow-up|0|||
156462301|NCT04505410|564788078|FG000|Overall Study|initiated another diet on their own|0|||
156462302|NCT04505410|564788079|FG001|Overall Study|initiated another diet on their own|2|||
156462303|NCT03533257|564788088|FG000|Overall Study|Adverse Event|4|||
156462304|NCT03533257|564788089|FG001|Overall Study|Adverse Event|2|||
156462305|NCT03533257|564788088|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
156462306|NCT03533257|564788089|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
156538635|NCT02941926|565066323|FG000|Extension Phase|Death|6|||
156538636|NCT00097773|565066324|FG000|Overall Study|Lost to Follow-up|2|||
156811398|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811399|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811400|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811401|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
156811402|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811403|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811404|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811405|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811406|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811407|NCT05526521|566060527|FG000|Overall Study|Withdrawal by Subject|0|||
156811408|NCT05526521|566060528|FG001|Overall Study|Withdrawal by Subject|1|||
156811409|NCT05526521|566060529|FG002|Overall Study|Withdrawal by Subject|0|||
156811410|NCT05526521|566060530|FG003|Overall Study|Withdrawal by Subject|0|||
156811411|NCT00436436|566060536|FG000|Overall Study|Progression|4|||
156811412|NCT00436436|566060536|FG000|Overall Study|Adverse Event|2|||
156811413|NCT00436436|566060536|FG000|Overall Study|Death|6|||
156811414|NCT03008070|566060540|FG000|Overall Study|Adverse Event|3|||
156811415|NCT03008070|566060541|FG001|Overall Study|Adverse Event|3|||
156811416|NCT03008070|566060542|FG002|Overall Study|Adverse Event|3|||
156811417|NCT03008070|566060540|FG000|Overall Study|Lost to Follow-up|1|||
156811418|NCT03008070|566060541|FG001|Overall Study|Lost to Follow-up|1|||
156811419|NCT03008070|566060542|FG002|Overall Study|Lost to Follow-up|0|||
156811420|NCT03008070|566060540|FG000|Overall Study|Non compliance|0|||
156811421|NCT03008070|566060541|FG001|Overall Study|Non compliance|1|||
156811422|NCT03008070|566060542|FG002|Overall Study|Non compliance|1|||
156811423|NCT03008070|566060540|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
156811424|NCT03008070|566060541|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
156811425|NCT03008070|566060542|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
156811426|NCT03008070|566060540|FG000|Overall Study|Withdrawal by Subject|2|||
156811427|NCT03008070|566060541|FG001|Overall Study|Withdrawal by Subject|0|||
156811428|NCT03008070|566060542|FG002|Overall Study|Withdrawal by Subject|1|||
156811429|NCT03008070|566060540|FG000|Overall Study|Use of prohibited drug|0|||
156811430|NCT03008070|566060541|FG001|Overall Study|Use of prohibited drug|0|||
156811431|NCT03008070|566060542|FG002|Overall Study|Use of prohibited drug|2|||
156811432|NCT03533660|566060543|FG000|Overall Study|Withdrawal by Subject|2|||
156811433|NCT03533660|566060544|FG001|Overall Study|Withdrawal by Subject|2|||
156811434|NCT03533660|566060543|FG000|Overall Study|Death|2|||
156811435|NCT03533660|566060544|FG001|Overall Study|Death|4|||
156811436|NCT03533660|566060543|FG000|Overall Study|Adverse Event|0|||
156811437|NCT03533660|566060544|FG001|Overall Study|Adverse Event|2|||
156811438|NCT07214935|566060550|FG000|Overall Study|Adverse Event|1|||
156811439|NCT07214935|566060551|FG001|Overall Study|Adverse Event|1|||
156811440|NCT07214935|566060552|FG002|Overall Study|Adverse Event|1|||
156811441|NCT07214935|566060553|FG003|Overall Study|Adverse Event|0|||
156811442|NCT07214935|566060550|FG000|Overall Study|Lost to Follow-up|0|||
156811443|NCT07214935|566060551|FG001|Overall Study|Lost to Follow-up|1|||
156811444|NCT07214935|566060552|FG002|Overall Study|Lost to Follow-up|0|||
156811445|NCT07214935|566060553|FG003|Overall Study|Lost to Follow-up|0|||
156811446|NCT07214935|566060550|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
156811447|NCT07214935|566060551|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
156811448|NCT07214935|566060552|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
156811449|NCT07214935|566060553|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
156811450|NCT07214935|566060550|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
156811451|NCT07214935|566060551|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
156811452|NCT07214935|566060552|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
156811453|NCT07214935|566060553|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
156811454|NCT01133756|566062487|FG000|Overall Study|Adverse Event|1|||
156811455|NCT01133756|566062488|FG001|Overall Study|Adverse Event|2|||
156811456|NCT01133756|566062489|FG002|Overall Study|Adverse Event|1|||
156811457|NCT01133756|566062487|FG000|Overall Study|Investigator Decision|1|||
156811458|NCT01133756|566062488|FG001|Overall Study|Investigator Decision|0|||
156811459|NCT01133756|566062489|FG002|Overall Study|Investigator Decision|0|||
156811460|NCT01133756|566062487|FG000|Overall Study|Withdrawal by Subject|0|||
156811461|NCT01133756|566062488|FG001|Overall Study|Withdrawal by Subject|1|||
156811462|NCT01133756|566062489|FG002|Overall Study|Withdrawal by Subject|0|||
156811463|NCT01133756|566062487|FG000|Overall Study|Progression of Disease|0|||
156811464|NCT01133756|566062488|FG001|Overall Study|Progression of Disease|0|||
156462307|NCT04108130|564789320|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
156462308|NCT04108130|564789321|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
156462309|NCT04108130|564789320|FG000|Overall Study|Consent Withdrawn|9|||
156811465|NCT01133756|566062489|FG002|Overall Study|Progression of Disease|1|||
156811466|NCT01945216|566062495|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
156811467|NCT01945216|566062495|FG000|Overall Study|Protocol Violation|42|||
156811468|NCT01945216|566062495|FG000|Overall Study|CRF not assured by investigators|5|||
156811469|NCT03941873|566062502|FG000|Overall Study|Death|0|||
156811470|NCT03941873|566062503|FG001|Overall Study|Death|12|||
156811471|NCT03941873|566062504|FG002|Overall Study|Death|2|||
156811472|NCT03941873|566062505|FG003|Overall Study|Death|53|||
156811473|NCT03941873|566062502|FG000|Overall Study|Withdrawal by Subject|1|||
156811474|NCT03941873|566062503|FG001|Overall Study|Withdrawal by Subject|1|||
156811475|NCT03941873|566062504|FG002|Overall Study|Withdrawal by Subject|0|||
156811476|NCT03941873|566062505|FG003|Overall Study|Withdrawal by Subject|5|||
156811477|NCT03941873|566062502|FG000|Overall Study|Lost to Follow-up|1|||
156811478|NCT03941873|566062503|FG001|Overall Study|Lost to Follow-up|2|||
156811479|NCT03941873|566062504|FG002|Overall Study|Lost to Follow-up|0|||
156811480|NCT03941873|566062505|FG003|Overall Study|Lost to Follow-up|0|||
156811481|NCT03941873|566062502|FG000|Overall Study|Sponsor Decision|0|||
156811482|NCT03941873|566062503|FG001|Overall Study|Sponsor Decision|6|||
156811483|NCT03941873|566062504|FG002|Overall Study|Sponsor Decision|0|||
156811484|NCT03941873|566062505|FG003|Overall Study|Sponsor Decision|15|||
156811485|NCT02574078|566062509|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811486|NCT02574078|566062510|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811487|NCT02574078|566062511|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811488|NCT02574078|566062512|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811489|NCT02574078|566062513|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811490|NCT02574078|566062514|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156811491|NCT02574078|566062515|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
156811492|NCT02574078|566062516|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811493|NCT02574078|566062517|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156811494|NCT02574078|566062518|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811495|NCT02574078|566062519|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811496|NCT02574078|566062520|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811497|NCT02574078|566062521|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811498|NCT02574078|566062509|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
156811499|NCT02574078|566062510|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
156811500|NCT02574078|566062511|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
156811501|NCT02574078|566062512|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
156811502|NCT02574078|566062513|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
156811503|NCT02574078|566062514|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
156811504|NCT02574078|566062515|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
156811505|NCT02574078|566062516|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
156811506|NCT02574078|566062517|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
156811507|NCT02574078|566062518|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
156811508|NCT02574078|566062519|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
156811509|NCT02574078|566062520|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
156811510|NCT02574078|566062521|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
156811511|NCT02574078|566062509|FG000|Pre-Treatment Period|Other reasons|0|||
156811512|NCT02574078|566062510|FG001|Pre-Treatment Period|Other reasons|0|||
156811513|NCT02574078|566062511|FG002|Pre-Treatment Period|Other reasons|0|||
156811514|NCT02574078|566062512|FG003|Pre-Treatment Period|Other reasons|0|||
156811515|NCT02574078|566062513|FG004|Pre-Treatment Period|Other reasons|0|||
156811516|NCT02574078|566062514|FG005|Pre-Treatment Period|Other reasons|0|||
156811517|NCT02574078|566062515|FG006|Pre-Treatment Period|Other reasons|2|||
156811518|NCT02574078|566062516|FG007|Pre-Treatment Period|Other reasons|0|||
156811519|NCT02574078|566062517|FG008|Pre-Treatment Period|Other reasons|0|||
156811520|NCT02574078|566062518|FG009|Pre-Treatment Period|Other reasons|0|||
156811521|NCT02574078|566062519|FG010|Pre-Treatment Period|Other reasons|2|||
156811522|NCT02574078|566062520|FG011|Pre-Treatment Period|Other reasons|0|||
156811523|NCT02574078|566062521|FG012|Pre-Treatment Period|Other reasons|0|||
156811524|NCT02574078|566062509|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
156811525|NCT02574078|566062510|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
156811526|NCT02574078|566062511|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
156811527|NCT02574078|566062512|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
156811528|NCT02574078|566062513|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
156811529|NCT02574078|566062514|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
156462310|NCT04108130|564789321|FG001|Overall Study|Consent Withdrawn|6|||
156462311|NCT04108130|564789320|FG000|Overall Study|Surgery Cancelled|4|||
156462312|NCT04108130|564789321|FG001|Overall Study|Surgery Cancelled|4|||
156462313|NCT04108130|564789320|FG000|Overall Study|Found Ineligible for Study|4|||
156462314|NCT04108130|564789321|FG001|Overall Study|Found Ineligible for Study|3|||
156462315|NCT04108130|564789320|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
156462316|NCT04108130|564789321|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
156462317|NCT04108130|564789320|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
156462318|NCT04108130|564789321|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
156462319|NCT05311176|564789322|FG000|Overall Study|Death|6|||
156462320|NCT05311176|564789322|FG000|Overall Study|Sponsor discontinued the study|1|||
156462321|NCT06106022|564789327|FG000|Overall Study|Lost to Follow-up|1|||
156462322|NCT06106022|564789328|FG001|Overall Study|Lost to Follow-up|0|||
156462323|NCT06106022|564789327|FG000|Overall Study|Voluntary Withdrawal|0|||
156462324|NCT06106022|564789328|FG001|Overall Study|Voluntary Withdrawal|2|||
156462325|NCT05405985|564789329|FG000|Overall Study|Withdrawal by Subject|1|||
156462326|NCT05405985|564789330|FG001|Overall Study|Withdrawal by Subject|0|||
156462327|NCT05424380|564789333|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
156462328|NCT05424380|564789334|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
156462329|NCT05424380|564789335|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
156462330|NCT05424380|564789336|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
156462331|NCT05424380|564789337|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
156462332|NCT05424380|564789338|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
156462333|NCT05424380|564789333|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
156538637|NCT00097773|565066325|FG001|Overall Study|Lost to Follow-up|2|||
156538638|NCT00097773|565066326|FG002|Overall Study|Lost to Follow-up|0|||
156538639|NCT00097773|565066327|FG003|Overall Study|Lost to Follow-up|1|||
156538640|NCT00097773|565066324|FG000|Overall Study|Physician Decision|2|||
156811530|NCT02574078|566062515|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
156811531|NCT02574078|566062516|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
156811532|NCT02574078|566062517|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
156811533|NCT02574078|566062518|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
156811534|NCT02574078|566062519|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
156811535|NCT02574078|566062520|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
156811536|NCT02574078|566062521|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
156811537|NCT02574078|566062509|FG000|Treatment Period|Disease progression|6|||
156811538|NCT02574078|566062510|FG001|Treatment Period|Disease progression|4|||
156811539|NCT02574078|566062511|FG002|Treatment Period|Disease progression|7|||
156811540|NCT02574078|566062512|FG003|Treatment Period|Disease progression|18|||
156811541|NCT02574078|566062513|FG004|Treatment Period|Disease progression|16|||
156811542|NCT02574078|566062514|FG005|Treatment Period|Disease progression|26|||
156811543|NCT02574078|566062515|FG006|Treatment Period|Disease progression|5|||
156811544|NCT02574078|566062516|FG007|Treatment Period|Disease progression|9|||
156811545|NCT02574078|566062517|FG008|Treatment Period|Disease progression|8|||
156811546|NCT02574078|566062518|FG009|Treatment Period|Disease progression|5|||
156811547|NCT02574078|566062519|FG010|Treatment Period|Disease progression|20|||
156811548|NCT02574078|566062520|FG011|Treatment Period|Disease progression|29|||
156811549|NCT02574078|566062521|FG012|Treatment Period|Disease progression|2|||
156811550|NCT02574078|566062509|FG000|Treatment Period|Study drug toxicity|1|||
156811551|NCT02574078|566062510|FG001|Treatment Period|Study drug toxicity|1|||
156811552|NCT02574078|566062511|FG002|Treatment Period|Study drug toxicity|0|||
156811553|NCT02574078|566062512|FG003|Treatment Period|Study drug toxicity|5|||
156811554|NCT02574078|566062513|FG004|Treatment Period|Study drug toxicity|3|||
156811555|NCT02574078|566062514|FG005|Treatment Period|Study drug toxicity|1|||
156811556|NCT02574078|566062515|FG006|Treatment Period|Study drug toxicity|2|||
156811557|NCT02574078|566062516|FG007|Treatment Period|Study drug toxicity|0|||
156811558|NCT02574078|566062517|FG008|Treatment Period|Study drug toxicity|2|||
156811559|NCT02574078|566062518|FG009|Treatment Period|Study drug toxicity|1|||
156811560|NCT02574078|566062519|FG010|Treatment Period|Study drug toxicity|16|||
156811561|NCT02574078|566062520|FG011|Treatment Period|Study drug toxicity|2|||
156811562|NCT02574078|566062521|FG012|Treatment Period|Study drug toxicity|4|||
156811563|NCT02574078|566062509|FG000|Treatment Period|Death|2|||
156811564|NCT02574078|566062510|FG001|Treatment Period|Death|0|||
156811565|NCT02574078|566062511|FG002|Treatment Period|Death|0|||
156811566|NCT02574078|566062512|FG003|Treatment Period|Death|0|||
156811567|NCT02574078|566062513|FG004|Treatment Period|Death|1|||
156811568|NCT02574078|566062514|FG005|Treatment Period|Death|1|||
156811569|NCT02574078|566062515|FG006|Treatment Period|Death|1|||
156462334|NCT05424380|564789334|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
156462335|NCT05424380|564789335|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
156462336|NCT05424380|564789336|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
156462337|NCT05424380|564789337|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
156462338|NCT05424380|564789338|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
156811570|NCT02574078|566062516|FG007|Treatment Period|Death|1|||
156811571|NCT02574078|566062517|FG008|Treatment Period|Death|7|||
156811572|NCT02574078|566062518|FG009|Treatment Period|Death|1|||
156811573|NCT02574078|566062519|FG010|Treatment Period|Death|0|||
156811574|NCT02574078|566062520|FG011|Treatment Period|Death|2|||
156811575|NCT02574078|566062521|FG012|Treatment Period|Death|1|||
156462339|NCT05424380|564789333|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
156811576|NCT02574078|566062509|FG000|Treatment Period|Adverse event unrelated to drug|0|||
156811577|NCT02574078|566062510|FG001|Treatment Period|Adverse event unrelated to drug|0|||
156811578|NCT02574078|566062511|FG002|Treatment Period|Adverse event unrelated to drug|1|||
156811579|NCT02574078|566062512|FG003|Treatment Period|Adverse event unrelated to drug|0|||
156811580|NCT02574078|566062513|FG004|Treatment Period|Adverse event unrelated to drug|2|||
156811581|NCT02574078|566062514|FG005|Treatment Period|Adverse event unrelated to drug|3|||
156811582|NCT02574078|566062515|FG006|Treatment Period|Adverse event unrelated to drug|0|||
156811583|NCT02574078|566062516|FG007|Treatment Period|Adverse event unrelated to drug|0|||
156462340|NCT05424380|564789334|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
156462341|NCT05424380|564789335|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
156811584|NCT02574078|566062517|FG008|Treatment Period|Adverse event unrelated to drug|1|||
156811585|NCT02574078|566062518|FG009|Treatment Period|Adverse event unrelated to drug|2|||
156811586|NCT02574078|566062519|FG010|Treatment Period|Adverse event unrelated to drug|4|||
156811587|NCT02574078|566062520|FG011|Treatment Period|Adverse event unrelated to drug|1|||
156811588|NCT02574078|566062521|FG012|Treatment Period|Adverse event unrelated to drug|0|||
156811589|NCT02574078|566062509|FG000|Treatment Period|Administrative reason by Sponsor|0|||
156811590|NCT02574078|566062510|FG001|Treatment Period|Administrative reason by Sponsor|1|||
156811591|NCT02574078|566062511|FG002|Treatment Period|Administrative reason by Sponsor|0|||
156811592|NCT02574078|566062512|FG003|Treatment Period|Administrative reason by Sponsor|0|||
156811593|NCT02574078|566062513|FG004|Treatment Period|Administrative reason by Sponsor|0|||
156811594|NCT02574078|566062514|FG005|Treatment Period|Administrative reason by Sponsor|0|||
156811595|NCT02574078|566062515|FG006|Treatment Period|Administrative reason by Sponsor|1|||
156811596|NCT02574078|566062516|FG007|Treatment Period|Administrative reason by Sponsor|0|||
156811597|NCT02574078|566062517|FG008|Treatment Period|Administrative reason by Sponsor|0|||
156811598|NCT02574078|566062518|FG009|Treatment Period|Administrative reason by Sponsor|0|||
156811599|NCT02574078|566062519|FG010|Treatment Period|Administrative reason by Sponsor|0|||
156811600|NCT02574078|566062520|FG011|Treatment Period|Administrative reason by Sponsor|0|||
156811601|NCT02574078|566062521|FG012|Treatment Period|Administrative reason by Sponsor|3|||
156811602|NCT02574078|566062509|FG000|Treatment Period|Other reasons|1|||
156811603|NCT02574078|566062510|FG001|Treatment Period|Other reasons|0|||
156811604|NCT02574078|566062511|FG002|Treatment Period|Other reasons|1|||
156811605|NCT02574078|566062512|FG003|Treatment Period|Other reasons|3|||
156811606|NCT02574078|566062513|FG004|Treatment Period|Other reasons|3|||
156811607|NCT02574078|566062514|FG005|Treatment Period|Other reasons|1|||
156811608|NCT02574078|566062515|FG006|Treatment Period|Other reasons|2|||
156811609|NCT02574078|566062516|FG007|Treatment Period|Other reasons|1|||
156811610|NCT02574078|566062517|FG008|Treatment Period|Other reasons|3|||
156811611|NCT02574078|566062518|FG009|Treatment Period|Other reasons|1|||
156811612|NCT02574078|566062519|FG010|Treatment Period|Other reasons|1|||
156811613|NCT02574078|566062520|FG011|Treatment Period|Other reasons|3|||
156811614|NCT02574078|566062521|FG012|Treatment Period|Other reasons|1|||
156811615|NCT02574078|566062509|FG000|Treatment Period|Participant request to stop drug|0|||
156811616|NCT02574078|566062510|FG001|Treatment Period|Participant request to stop drug|0|||
156811617|NCT02574078|566062511|FG002|Treatment Period|Participant request to stop drug|0|||
156811618|NCT02574078|566062512|FG003|Treatment Period|Participant request to stop drug|2|||
156811619|NCT02574078|566062513|FG004|Treatment Period|Participant request to stop drug|4|||
156811620|NCT02574078|566062514|FG005|Treatment Period|Participant request to stop drug|0|||
156811621|NCT02574078|566062515|FG006|Treatment Period|Participant request to stop drug|1|||
156811622|NCT02574078|566062516|FG007|Treatment Period|Participant request to stop drug|0|||
156811623|NCT02574078|566062517|FG008|Treatment Period|Participant request to stop drug|3|||
156811624|NCT02574078|566062518|FG009|Treatment Period|Participant request to stop drug|2|||
156811625|NCT02574078|566062519|FG010|Treatment Period|Participant request to stop drug|2|||
156811626|NCT02574078|566062520|FG011|Treatment Period|Participant request to stop drug|4|||
156811627|NCT02574078|566062521|FG012|Treatment Period|Participant request to stop drug|1|||
156811628|NCT02574078|566062509|FG000|Treatment Period|Participant withdrew consent|0|||
156811629|NCT02574078|566062510|FG001|Treatment Period|Participant withdrew consent|0|||
156811630|NCT02574078|566062511|FG002|Treatment Period|Participant withdrew consent|0|||
156811631|NCT02574078|566062512|FG003|Treatment Period|Participant withdrew consent|0|||
156811632|NCT02574078|566062513|FG004|Treatment Period|Participant withdrew consent|1|||
156811633|NCT02574078|566062514|FG005|Treatment Period|Participant withdrew consent|1|||
156811634|NCT02574078|566062515|FG006|Treatment Period|Participant withdrew consent|0|||
156811635|NCT02574078|566062516|FG007|Treatment Period|Participant withdrew consent|1|||
156462342|NCT05424380|564789336|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
156462343|NCT05424380|564789337|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
156538641|NCT00097773|565066325|FG001|Overall Study|Physician Decision|2|||
156811636|NCT02574078|566062517|FG008|Treatment Period|Participant withdrew consent|0|||
156811637|NCT02574078|566062518|FG009|Treatment Period|Participant withdrew consent|2|||
156811638|NCT02574078|566062519|FG010|Treatment Period|Participant withdrew consent|1|||
156811639|NCT02574078|566062520|FG011|Treatment Period|Participant withdrew consent|4|||
156811640|NCT02574078|566062521|FG012|Treatment Period|Participant withdrew consent|1|||
156811641|NCT02574078|566062509|FG000|Treatment Period|Participant no longer meets criteria|0|||
156811642|NCT02574078|566062510|FG001|Treatment Period|Participant no longer meets criteria|0|||
156811643|NCT02574078|566062511|FG002|Treatment Period|Participant no longer meets criteria|0|||
156811644|NCT02574078|566062512|FG003|Treatment Period|Participant no longer meets criteria|0|||
156811645|NCT02574078|566062513|FG004|Treatment Period|Participant no longer meets criteria|1|||
156811646|NCT02574078|566062514|FG005|Treatment Period|Participant no longer meets criteria|0|||
156811647|NCT02574078|566062515|FG006|Treatment Period|Participant no longer meets criteria|0|||
156811648|NCT02574078|566062516|FG007|Treatment Period|Participant no longer meets criteria|0|||
156811649|NCT02574078|566062517|FG008|Treatment Period|Participant no longer meets criteria|0|||
156811650|NCT02574078|566062518|FG009|Treatment Period|Participant no longer meets criteria|1|||
156811651|NCT02574078|566062519|FG010|Treatment Period|Participant no longer meets criteria|1|||
156811652|NCT02574078|566062520|FG011|Treatment Period|Participant no longer meets criteria|1|||
156811653|NCT02574078|566062521|FG012|Treatment Period|Participant no longer meets criteria|0|||
156811654|NCT02574078|566062509|FG000|Treatment Period|Lost to Follow-up|0|||
156811655|NCT02574078|566062510|FG001|Treatment Period|Lost to Follow-up|0|||
156811656|NCT02574078|566062511|FG002|Treatment Period|Lost to Follow-up|0|||
156811657|NCT02574078|566062512|FG003|Treatment Period|Lost to Follow-up|0|||
156811658|NCT02574078|566062513|FG004|Treatment Period|Lost to Follow-up|0|||
156811659|NCT02574078|566062514|FG005|Treatment Period|Lost to Follow-up|0|||
156811660|NCT02574078|566062515|FG006|Treatment Period|Lost to Follow-up|0|||
156811661|NCT02574078|566062516|FG007|Treatment Period|Lost to Follow-up|0|||
156811662|NCT02574078|566062517|FG008|Treatment Period|Lost to Follow-up|0|||
156811663|NCT02574078|566062518|FG009|Treatment Period|Lost to Follow-up|1|||
156811664|NCT02574078|566062519|FG010|Treatment Period|Lost to Follow-up|0|||
156811665|NCT02574078|566062520|FG011|Treatment Period|Lost to Follow-up|1|||
156811666|NCT02574078|566062521|FG012|Treatment Period|Lost to Follow-up|0|||
156811667|NCT02574078|566062509|FG000|Treatment Period|Maximum clinical benefit|0|||
156811668|NCT02574078|566062510|FG001|Treatment Period|Maximum clinical benefit|0|||
156811669|NCT02574078|566062511|FG002|Treatment Period|Maximum clinical benefit|0|||
156811670|NCT02574078|566062512|FG003|Treatment Period|Maximum clinical benefit|0|||
156811671|NCT02574078|566062513|FG004|Treatment Period|Maximum clinical benefit|0|||
156811672|NCT02574078|566062514|FG005|Treatment Period|Maximum clinical benefit|0|||
156811673|NCT02574078|566062515|FG006|Treatment Period|Maximum clinical benefit|0|||
156811674|NCT02574078|566062516|FG007|Treatment Period|Maximum clinical benefit|0|||
156811675|NCT02574078|566062517|FG008|Treatment Period|Maximum clinical benefit|0|||
156811676|NCT02574078|566062518|FG009|Treatment Period|Maximum clinical benefit|1|||
156811677|NCT02574078|566062519|FG010|Treatment Period|Maximum clinical benefit|0|||
156811678|NCT02574078|566062520|FG011|Treatment Period|Maximum clinical benefit|0|||
156811679|NCT02574078|566062521|FG012|Treatment Period|Maximum clinical benefit|0|||
156811680|NCT00293813|566062528|FG000|Overall Study|Physician Decision|0|||
156811681|NCT00293813|566062529|FG001|Overall Study|Physician Decision|1|||
156811682|NCT00293813|566062530|FG002|Overall Study|Physician Decision|0|||
156811683|NCT00293813|566062528|FG000|Overall Study|Adverse Event|3|||
156811684|NCT00293813|566062529|FG001|Overall Study|Adverse Event|1|||
156811685|NCT00293813|566062530|FG002|Overall Study|Adverse Event|1|||
156811686|NCT00293813|566062528|FG000|Overall Study|Withdrawal by Subject|7|||
156811687|NCT00293813|566062529|FG001|Overall Study|Withdrawal by Subject|4|||
156811688|NCT00293813|566062530|FG002|Overall Study|Withdrawal by Subject|4|||
156811689|NCT00293813|566062528|FG000|Overall Study|Lost to Follow-up|3|||
156811690|NCT00293813|566062529|FG001|Overall Study|Lost to Follow-up|2|||
156811691|NCT00293813|566062530|FG002|Overall Study|Lost to Follow-up|3|||
156811692|NCT00293813|566062528|FG000|Overall Study|Noncompliance|0|||
156462344|NCT05424380|564789338|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
156462345|NCT05424380|564789333|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
156462346|NCT05424380|564789334|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
156462347|NCT05424380|564789335|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
156811693|NCT00293813|566062529|FG001|Overall Study|Noncompliance|1|||
156811694|NCT00293813|566062530|FG002|Overall Study|Noncompliance|0|||
156811695|NCT00460655|566062531|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
156811696|NCT00460655|566062532|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156811697|NCT00460655|566062533|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156811698|NCT00460655|566062534|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156811699|NCT00460655|566062531|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
156462348|NCT05424380|564789336|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
156462349|NCT05424380|564789337|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
156811700|NCT00460655|566062532|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156811701|NCT00460655|566062533|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156462350|NCT05424380|564789338|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
156462351|NCT05424380|564789333|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
156462352|NCT05424380|564789334|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
156462353|NCT05424380|564789335|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
156462354|NCT05424380|564789336|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
156462355|NCT05424380|564789337|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
156462356|NCT05424380|564789338|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
156462357|NCT05424380|564789333|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
156462358|NCT05424380|564789334|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
156462359|NCT05424380|564789335|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
156462360|NCT05424380|564789336|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
156462361|NCT05424380|564789337|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
156462362|NCT05424380|564789338|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
156462363|NCT05424380|564789333|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
156462364|NCT05424380|564789334|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
156462365|NCT05424380|564789335|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
156462366|NCT05424380|564789336|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
156462367|NCT05424380|564789337|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
156462368|NCT05424380|564789338|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
156462369|NCT05424380|564789333|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
156462370|NCT05424380|564789334|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
156462371|NCT05424380|564789335|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
156462372|NCT05424380|564789336|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
156462373|NCT05424380|564789337|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
156462374|NCT05424380|564789338|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
156462375|NCT05424380|564789333|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462376|NCT05424380|564789334|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462377|NCT05424380|564789335|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462378|NCT05424380|564789336|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
156462379|NCT05424380|564789337|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462380|NCT05424380|564789338|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462381|NCT05424380|564789333|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
156462382|NCT05424380|564789334|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
156462383|NCT05424380|564789335|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
156462384|NCT05424380|564789336|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
156462385|NCT05424380|564789337|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
156462386|NCT05424380|564789338|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
156462387|NCT05424380|564789333|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
156462388|NCT05424380|564789334|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
156462389|NCT05424380|564789335|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
156462390|NCT05424380|564789336|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
156462391|NCT05424380|564789337|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
156462392|NCT05424380|564789338|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
156462393|NCT05424380|564789333|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
156462394|NCT05424380|564789334|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
156462395|NCT05424380|564789335|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
156462396|NCT05424380|564789336|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
156462397|NCT05424380|564789337|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
156462398|NCT05424380|564789338|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
156462399|NCT05424380|564789333|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462400|NCT05424380|564789334|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462401|NCT05424380|564789335|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462402|NCT05424380|564789336|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462403|NCT05424380|564789337|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
156462404|NCT05424380|564789338|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
156462405|NCT05424380|564789333|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
156811702|NCT00460655|566062534|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156811703|NCT00460655|566062531|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
156811704|NCT00460655|566062532|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
156811705|NCT00460655|566062533|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
156811706|NCT00460655|566062534|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
156462406|NCT05424380|564789334|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
156462407|NCT05424380|564789335|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
156462408|NCT05424380|564789336|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
156462409|NCT05424380|564789337|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
156462410|NCT05424380|564789338|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
156811707|NCT00460655|566062531|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
156462411|NCT02473445|564789343|FG000|Overall Study|Withdrawal by Subject|2|||
156462412|NCT02473445|564789343|FG000|Overall Study|Sponsor Decision|20|||
156462413|NCT03988621|564789344|FG000|Overall Study|Lost to Follow-up|16|||
156462414|NCT03988621|564789345|FG001|Overall Study|Lost to Follow-up|17|||
156462415|NCT03988621|564789344|FG000|Overall Study|Withdrawal by Subject|14|||
156462416|NCT03988621|564789345|FG001|Overall Study|Withdrawal by Subject|7|||
156462417|NCT03988621|564789344|FG000|Overall Study|Patient Lost to Follow Up|15|||
156462418|NCT03988621|564789345|FG001|Overall Study|Patient Lost to Follow Up|15|||
156462419|NCT03988621|564789344|FG000|Overall Study|Patient death|1|||
156462420|NCT03988621|564789345|FG001|Overall Study|Patient death|5|||
156462421|NCT04247802|564789346|FG000|Overall Study|Withdrawal by Subject|1|||
156462422|NCT04247802|564789347|FG001|Overall Study|Withdrawal by Subject|3|||
156462423|NCT04247802|564789346|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
156462424|NCT04247802|564789347|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
156462425|NCT04778410|564789356|FG000|Safety Run-in Period|Death|5|||
156462426|NCT04778410|564789357|FG001|Safety Run-in Period|Death|6|||
156462427|NCT04778410|564789358|FG002|Safety Run-in Period|Death|0|||
156462428|NCT04778410|564789359|FG003|Safety Run-in Period|Death|0|||
156462429|NCT04778410|564789360|FG004|Safety Run-in Period|Death|0|||
156462430|NCT04778410|564789361|FG005|Safety Run-in Period|Death|0|||
156462431|NCT04778410|564789356|FG000|Phase 2 Period|Death|0|||
156462432|NCT04778410|564789357|FG001|Phase 2 Period|Death|0|||
156462433|NCT04778410|564789358|FG002|Phase 2 Period|Death|0|||
156462434|NCT04778410|564789359|FG003|Phase 2 Period|Death|5|||
156462435|NCT04778410|564789360|FG004|Phase 2 Period|Death|18|||
156462436|NCT04778410|564789361|FG005|Phase 2 Period|Death|0|||
156462437|NCT04778410|564789356|FG000|Phase 2 Period|Lost to Follow-up|0|||
156462438|NCT04778410|564789357|FG001|Phase 2 Period|Lost to Follow-up|0|||
156462439|NCT04778410|564789358|FG002|Phase 2 Period|Lost to Follow-up|0|||
156462440|NCT04778410|564789359|FG003|Phase 2 Period|Lost to Follow-up|1|||
156462441|NCT04778410|564789360|FG004|Phase 2 Period|Lost to Follow-up|1|||
156462442|NCT04778410|564789361|FG005|Phase 2 Period|Lost to Follow-up|0|||
156462443|NCT04778410|564789356|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
156462444|NCT04778410|564789357|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
156462445|NCT04778410|564789358|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
156462446|NCT04778410|564789359|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
156462447|NCT04778410|564789360|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
156462448|NCT04778410|564789361|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
156462449|NCT04778410|564789356|FG000|Phase 2 Period|Withdrew Consent|0|||
156462450|NCT04778410|564789357|FG001|Phase 2 Period|Withdrew Consent|0|||
156462451|NCT04778410|564789358|FG002|Phase 2 Period|Withdrew Consent|0|||
156462452|NCT04778410|564789359|FG003|Phase 2 Period|Withdrew Consent|0|||
156462453|NCT04778410|564789360|FG004|Phase 2 Period|Withdrew Consent|2|||
156462454|NCT04778410|564789361|FG005|Phase 2 Period|Withdrew Consent|0|||
156462455|NCT05422885|564789366|FG000|Overall Study|Lost to Follow-up|1|||
156462456|NCT05422885|564789366|FG000|Overall Study|Withdrawal by Subject|2|||
156462457|NCT03691298|564789369|FG000|Overall Study|Lost to Follow-up|8|||
156462458|NCT03691298|564789369|FG000|Overall Study|Sponsor terminated study|2|||
156462459|NCT04214834|564789376|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
156462460|NCT04214834|564789377|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
156462461|NCT04924400|564789378|FG000|Overall Study|Lost to Follow-up|3|||
156462462|NCT04924400|564789379|FG001|Overall Study|Lost to Follow-up|0|||
156462463|NCT04424316|564789380|FG000|Overall Study|Adverse Event|0|||
156462464|NCT04424316|564789381|FG001|Overall Study|Adverse Event|1|||
156462465|NCT04424316|564789382|FG002|Overall Study|Adverse Event|0|||
156462466|NCT04424316|564789383|FG003|Overall Study|Adverse Event|0|||
156462467|NCT04424316|564789380|FG000|Overall Study|Death|1|||
156462468|NCT04424316|564789381|FG001|Overall Study|Death|0|||
156462469|NCT04424316|564789382|FG002|Overall Study|Death|8|||
156462470|NCT04424316|564789383|FG003|Overall Study|Death|14|||
156462471|NCT04424316|564789380|FG000|Overall Study|Lost to Follow-up|93|||
156462472|NCT04424316|564789381|FG001|Overall Study|Lost to Follow-up|88|||
156462473|NCT04424316|564789382|FG002|Overall Study|Lost to Follow-up|224|||
156462474|NCT04424316|564789383|FG003|Overall Study|Lost to Follow-up|211|||
156462475|NCT04424316|564789380|FG000|Overall Study|No longer met eligibility criteria|1|||
156462476|NCT04424316|564789381|FG001|Overall Study|No longer met eligibility criteria|0|||
156462477|NCT04424316|564789382|FG002|Overall Study|No longer met eligibility criteria|0|||
156462478|NCT04424316|564789383|FG003|Overall Study|No longer met eligibility criteria|0|||
156811708|NCT00460655|566062532|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
156462479|NCT04424316|564789380|FG000|Overall Study|Other|15|||
156462480|NCT04424316|564789381|FG001|Overall Study|Other|11|||
156462481|NCT04424316|564789382|FG002|Overall Study|Other|34|||
156462482|NCT04424316|564789383|FG003|Overall Study|Other|45|||
156462483|NCT04424316|564789380|FG000|Overall Study|Physician Decision|1|||
156462484|NCT04424316|564789381|FG001|Overall Study|Physician Decision|0|||
156462485|NCT04424316|564789382|FG002|Overall Study|Physician Decision|1|||
156462486|NCT04424316|564789383|FG003|Overall Study|Physician Decision|1|||
156462487|NCT04424316|564789380|FG000|Overall Study|Protocol Violation|0|||
156462488|NCT04424316|564789381|FG001|Overall Study|Protocol Violation|1|||
156811709|NCT00460655|566062533|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
156811710|NCT00460655|566062534|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
156811711|NCT00460655|566062531|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156811712|NCT00460655|566062532|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156811713|NCT00460655|566062533|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
156811714|NCT00460655|566062534|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
156811715|NCT00460655|566062531|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
156811716|NCT00460655|566062532|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
156811717|NCT00460655|566062533|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
156811718|NCT00460655|566062534|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
156811719|NCT03650413|566062535|FG000|Overall Study|Adverse Event|1|||
156811720|NCT03650413|566062535|FG000|Overall Study|Lack of Efficacy|17|||
156811721|NCT03650413|566062535|FG000|Overall Study|Other|9|||
156811722|NCT03650413|566062535|FG000|Overall Study|Physician Decision|2|||
156811723|NCT03650413|566062535|FG000|Overall Study|Study Terminated By Sponsor|16|||
156811724|NCT03650413|566062535|FG000|Overall Study|Withdrawal by Subject|16|||
156811725|NCT02553928|566062536|FG000|Overall Study|Adverse Event|2|||
156811726|NCT02553928|566062537|FG001|Overall Study|Adverse Event|1|||
156811727|NCT02553928|566062536|FG000|Overall Study|Lost to Follow-up|0|||
156811728|NCT02553928|566062537|FG001|Overall Study|Lost to Follow-up|1|||
156811729|NCT02553928|566062536|FG000|Overall Study|Administrative reason(s)|0|||
156811730|NCT02553928|566062537|FG001|Overall Study|Administrative reason(s)|1|||
156811731|NCT00910910|566062538|FG000|Overall Study|Adverse Event|63|||
156811732|NCT00910910|566062539|FG001|Overall Study|Adverse Event|35|||
156811733|NCT00910910|566062538|FG000|Overall Study|PD without histologic change|27|||
156811734|NCT00910910|566062539|FG001|Overall Study|PD without histologic change|23|||
156811735|NCT00910910|566062538|FG000|Overall Study|PD with histologic change|0|||
156811736|NCT00910910|566062539|FG001|Overall Study|PD with histologic change|2|||
156811737|NCT00910910|566062538|FG000|Overall Study|Withdrawal by Subject|7|||
156811738|NCT00910910|566062539|FG001|Overall Study|Withdrawal by Subject|5|||
156811739|NCT00910910|566062538|FG000|Overall Study|Lost to Follow-up|2|||
156811740|NCT00910910|566062539|FG001|Overall Study|Lost to Follow-up|2|||
156811741|NCT00910910|566062538|FG000|Overall Study|Death|9|||
156811742|NCT00910910|566062539|FG001|Overall Study|Death|3|||
156811743|NCT00910910|566062538|FG000|Overall Study|Protocol Violation|2|||
156811744|NCT00910910|566062539|FG001|Overall Study|Protocol Violation|2|||
156811745|NCT00910910|566062538|FG000|Overall Study|Completed 13 cycles of treatment|0|||
156811746|NCT00910910|566062539|FG001|Overall Study|Completed 13 cycles of treatment|118|||
156811747|NCT00910910|566062538|FG000|Overall Study|Other|114|||
156811748|NCT00910910|566062539|FG001|Overall Study|Other|32|||
156811749|NCT00910910|566062538|FG000|Overall Study|Untreated before cycle 1|1|||
156811750|NCT00910910|566062539|FG001|Overall Study|Untreated before cycle 1|2|||
156811751|NCT01973231|566062540|FG000|Overall Study|Protocol Violation|1|||
156811752|NCT01973231|566062541|FG001|Overall Study|Protocol Violation|1|||
156811753|NCT01973231|566062540|FG000|Overall Study|Lost to Follow-up|1|||
156811754|NCT01973231|566062541|FG001|Overall Study|Lost to Follow-up|1|||
156811755|NCT01973231|566062540|FG000|Overall Study|unclassified|2|||
156811756|NCT01973231|566062541|FG001|Overall Study|unclassified|1|||
156811757|NCT01973231|566062540|FG000|Overall Study|Withdrawal by Subject|7|||
156811758|NCT01973231|566062541|FG001|Overall Study|Withdrawal by Subject|9|||
156811759|NCT01485796|566062542|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
156811760|NCT01485796|566062542|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
156811761|NCT01485796|566062542|FG000|Period 2: Epoch 2|Adverse Event|3|||
156811762|NCT01485796|566062542|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
156811763|NCT01485796|566062542|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
156811764|NCT01485796|566062542|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
156811765|NCT01485796|566062542|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
156811766|NCT01485796|566062542|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
156811767|NCT04830215|566062543|FG000|Overall Study|Adverse Event|6|||
156811768|NCT04830215|566062543|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
156811769|NCT04830215|566062543|FG000|Overall Study|Withdrawal by Subject|3|||
156811770|NCT04830215|566062543|FG000|Overall Study|Protocol Deviation|1|||
156811771|NCT00770562|566062549|FG000|Overall Study|Did not take treatment|1|||
156811772|NCT00770562|566062550|FG001|Overall Study|Did not take treatment|1|||
156811773|NCT01643408|566062551|FG000|Overall Study|Adverse Event|12|||
156811774|NCT01643408|566062551|FG000|Overall Study|Other|2|||
156811775|NCT00292045|566062555|FG000|Core Study (Through Week 13)|Adverse Event|1|||
156811776|NCT00292045|566062555|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
156811777|NCT00606411|566062556|FG000|Overall Study|Adverse Event|1|||
156811778|NCT00606411|566062557|FG001|Overall Study|Adverse Event|2|||
156811779|NCT00606411|566062556|FG000|Overall Study|Lack of Adherence|1|||
156811780|NCT00606411|566062557|FG001|Overall Study|Lack of Adherence|1|||
156811781|NCT00606411|566062556|FG000|Overall Study|Lack of Efficacy|1|||
156811782|NCT00606411|566062557|FG001|Overall Study|Lack of Efficacy|1|||
156811783|NCT00606411|566062556|FG000|Overall Study|Withdrawal by Subject|2|||
156462489|NCT04424316|564789382|FG002|Overall Study|Protocol Violation|0|||
156462490|NCT04424316|564789383|FG003|Overall Study|Protocol Violation|0|||
156462491|NCT04424316|564789380|FG000|Overall Study|Withdrawal by Subject|71|||
156462492|NCT04424316|564789381|FG001|Overall Study|Withdrawal by Subject|77|||
156462493|NCT04424316|564789382|FG002|Overall Study|Withdrawal by Subject|0|||
156462494|NCT04424316|564789383|FG003|Overall Study|Withdrawal by Subject|0|||
156462495|NCT04424316|564789380|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156462496|NCT04424316|564789381|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156462497|NCT04424316|564789382|FG002|Overall Study|Withdrawal by parent/guardian|74|||
156462498|NCT04424316|564789383|FG003|Overall Study|Withdrawal by parent/guardian|81|||
156462499|NCT04424316|564789380|FG000|Overall Study|Randomized but not vaccinated|13|||
156462500|NCT04424316|564789381|FG001|Overall Study|Randomized but not vaccinated|21|||
156462501|NCT04424316|564789382|FG002|Overall Study|Randomized but not vaccinated|0|||
156462502|NCT04424316|564789383|FG003|Overall Study|Randomized but not vaccinated|0|||
156462503|NCT04424316|564789380|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
156462504|NCT04424316|564789381|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
156462505|NCT04424316|564789382|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
156462506|NCT04424316|564789383|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
156462507|NCT04633538|564789384|FG000|Overall Study|Death|1|||
156462508|NCT04633538|564789384|FG000|Overall Study|Lost to Follow-up|3|||
156462509|NCT04633538|564789384|FG000|Overall Study|Withdrawal by Subject|1|||
156462510|NCT05070741|564789385|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
156462511|NCT03245840|564789386|FG000|Overall Study|Adverse Event|6|||
156462512|NCT03245840|564789387|FG001|Overall Study|Adverse Event|0|||
156462513|NCT03245840|564789386|FG000|Overall Study|Death|2|||
156462514|NCT03245840|564789387|FG001|Overall Study|Death|0|||
156462515|NCT03245840|564789386|FG000|Overall Study|Withdrawal by Subject|31|||
156462516|NCT03245840|564789387|FG001|Overall Study|Withdrawal by Subject|1|||
156462517|NCT03245840|564789386|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156462518|NCT03245840|564789387|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156462519|NCT03245840|564789386|FG000|Overall Study|Physician Decision|4|||
156462520|NCT03245840|564789387|FG001|Overall Study|Physician Decision|1|||
156462521|NCT03245840|564789386|FG000|Overall Study|Study Terminated by Sponsor|56|||
156462522|NCT03245840|564789387|FG001|Overall Study|Study Terminated by Sponsor|6|||
156462523|NCT03245840|564789386|FG000|Overall Study|Site Terminated by Sponsor|4|||
156462524|NCT03245840|564789387|FG001|Overall Study|Site Terminated by Sponsor|0|||
156462525|NCT03245840|564789386|FG000|Overall Study|Lost to Follow-up|12|||
156462526|NCT03245840|564789387|FG001|Overall Study|Lost to Follow-up|2|||
156462527|NCT03245840|564789386|FG000|Overall Study|Pregnancy|2|||
156462528|NCT03245840|564789387|FG001|Overall Study|Pregnancy|0|||
156462529|NCT03245840|564789386|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156462530|NCT03245840|564789387|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156462531|NCT03245840|564789386|FG000|Overall Study|Not treated|1|||
156462532|NCT03245840|564789387|FG001|Overall Study|Not treated|1|||
156462533|NCT03582033|564789390|FG000|Part A|Other|0|||
156462534|NCT03582033|564789391|FG001|Part A|Other|0|||
156462535|NCT03582033|564789392|FG002|Part A|Other|0|||
156462536|NCT03582033|564789393|FG003|Part A|Other|0|||
156462537|NCT03582033|564789394|FG004|Part A|Other|2|||
156462538|NCT03582033|564789395|FG005|Part A|Other|0|||
156462539|NCT03582033|564789396|FG006|Part A|Other|0|||
156462540|NCT03582033|564789397|FG007|Part A|Other|0|||
156462541|NCT03582033|564789398|FG008|Part A|Other|0|||
156462542|NCT03582033|564789399|FG009|Part A|Other|0|||
156462543|NCT03582033|564789390|FG000|Part A|Death|1|||
156462544|NCT03582033|564789391|FG001|Part A|Death|1|||
156462545|NCT03582033|564789392|FG002|Part A|Death|2|||
156462546|NCT03582033|564789393|FG003|Part A|Death|4|||
156462547|NCT03582033|564789394|FG004|Part A|Death|11|||
156462548|NCT03582033|564789395|FG005|Part A|Death|0|||
156462549|NCT03582033|564789396|FG006|Part A|Death|0|||
156462550|NCT03582033|564789397|FG007|Part A|Death|0|||
156462551|NCT03582033|564789398|FG008|Part A|Death|0|||
156462552|NCT03582033|564789399|FG009|Part A|Death|0|||
156462553|NCT03582033|564789390|FG000|Part A|Lost to Follow-up|0|||
156462554|NCT03582033|564789391|FG001|Part A|Lost to Follow-up|0|||
156462555|NCT03582033|564789392|FG002|Part A|Lost to Follow-up|0|||
156462556|NCT03582033|564789393|FG003|Part A|Lost to Follow-up|0|||
156811784|NCT00606411|566062557|FG001|Overall Study|Withdrawal by Subject|0|||
156811785|NCT00606411|566062556|FG000|Overall Study|Lost to Follow-up|1|||
156811786|NCT00606411|566062557|FG001|Overall Study|Lost to Follow-up|2|||
156338857|NCT01433991|564340052|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
156462557|NCT03582033|564789394|FG004|Part A|Lost to Follow-up|1|||
156462558|NCT03582033|564789395|FG005|Part A|Lost to Follow-up|0|||
156462559|NCT03582033|564789396|FG006|Part A|Lost to Follow-up|0|||
156462560|NCT03582033|564789397|FG007|Part A|Lost to Follow-up|0|||
156462561|NCT03582033|564789398|FG008|Part A|Lost to Follow-up|0|||
156462562|NCT03582033|564789399|FG009|Part A|Lost to Follow-up|0|||
156462563|NCT03582033|564789390|FG000|Part A|Study terminated by sponsor|0|||
156462564|NCT03582033|564789391|FG001|Part A|Study terminated by sponsor|0|||
156538642|NCT00097773|565066326|FG002|Overall Study|Physician Decision|3|||
156538643|NCT00097773|565066327|FG003|Overall Study|Physician Decision|1|||
156538644|NCT00097773|565066324|FG000|Overall Study|Withdrawal by Subject|3|||
156538645|NCT00097773|565066325|FG001|Overall Study|Withdrawal by Subject|3|||
156538646|NCT00097773|565066326|FG002|Overall Study|Withdrawal by Subject|3|||
156538647|NCT00097773|565066327|FG003|Overall Study|Withdrawal by Subject|1|||
156538648|NCT00097773|565066324|FG000|Overall Study|Adverse Event|0|||
156538649|NCT00097773|565066325|FG001|Overall Study|Adverse Event|1|||
156538650|NCT00097773|565066326|FG002|Overall Study|Adverse Event|0|||
156538651|NCT00097773|565066327|FG003|Overall Study|Adverse Event|0|||
156538652|NCT00097773|565066324|FG000|Overall Study|Other|1|||
156538653|NCT00097773|565066325|FG001|Overall Study|Other|0|||
156538654|NCT00097773|565066326|FG002|Overall Study|Other|2|||
156538655|NCT00097773|565066327|FG003|Overall Study|Other|0|||
156538656|NCT01009034|565066328|FG000|Overall Study|Lost to Follow-up|2|||
156538657|NCT01009034|565066328|FG000|Overall Study|Withdrawal by Subject|2|||
156538658|NCT00474708|565066329|FG000|Overall Study|Lack of Efficacy|11|||
156538659|NCT00474708|565066330|FG001|Overall Study|Lack of Efficacy|5|||
156538660|NCT00474708|565066329|FG000|Overall Study|Suicide ideation/behavior|0|||
156538661|NCT00474708|565066330|FG001|Overall Study|Suicide ideation/behavior|1|||
156538662|NCT00474708|565066329|FG000|Overall Study|Withdrawal by Subject|7|||
156538663|NCT00474708|565066330|FG001|Overall Study|Withdrawal by Subject|0|||
156538664|NCT00474708|565066329|FG000|Overall Study|Lack of compliance|12|||
156538665|NCT00474708|565066330|FG001|Overall Study|Lack of compliance|4|||
156538666|NCT00474708|565066329|FG000|Overall Study|Lost to Follow-up|18|||
156538667|NCT00474708|565066330|FG001|Overall Study|Lost to Follow-up|9|||
156538668|NCT00474708|565066329|FG000|Overall Study|Physician Decision|9|||
156538669|NCT00474708|565066330|FG001|Overall Study|Physician Decision|6|||
156538670|NCT01660451|565066338|FG000|Overall Study|Protocol Violation|0|||
156538671|NCT01660451|565066339|FG001|Overall Study|Protocol Violation|1|||
156538672|NCT01660451|565066340|FG002|Overall Study|Protocol Violation|1|||
156538673|NCT01660451|565066338|FG000|Overall Study|AE not associated with clinical disease progression|13|||
156538674|NCT01660451|565066339|FG001|Overall Study|AE not associated with clinical disease progression|10|||
156538675|NCT01660451|565066340|FG002|Overall Study|AE not associated with clinical disease progression|40|||
156538676|NCT01660451|565066338|FG000|Overall Study|AE associated with clinical disease progression|1|||
156538677|NCT01660451|565066339|FG001|Overall Study|AE associated with clinical disease progression|3|||
156538678|NCT01660451|565066340|FG002|Overall Study|AE associated with clinical disease progression|11|||
156538679|NCT01660451|565066338|FG000|Overall Study|Sponsor Decision|0|||
156538680|NCT01660451|565066339|FG001|Overall Study|Sponsor Decision|0|||
156538681|NCT01660451|565066340|FG002|Overall Study|Sponsor Decision|1|||
156538682|NCT01660451|565066338|FG000|Overall Study|Protocol Deviation|0|||
156538683|NCT01660451|565066339|FG001|Overall Study|Protocol Deviation|0|||
156538684|NCT01660451|565066340|FG002|Overall Study|Protocol Deviation|1|||
156538685|NCT01660451|565066338|FG000|Overall Study|Physician Decision|1|||
156538686|NCT01660451|565066339|FG001|Overall Study|Physician Decision|2|||
156538687|NCT01660451|565066340|FG002|Overall Study|Physician Decision|5|||
156538688|NCT01660451|565066338|FG000|Overall Study|Withdrawal by Subject|1|||
156538689|NCT01660451|565066339|FG001|Overall Study|Withdrawal by Subject|1|||
156538690|NCT01660451|565066340|FG002|Overall Study|Withdrawal by Subject|20|||
156538691|NCT01660451|565066338|FG000|Overall Study|Trial closure.|0|||
156462565|NCT03582033|564789392|FG002|Part A|Study terminated by sponsor|0|||
156462566|NCT03582033|564789393|FG003|Part A|Study terminated by sponsor|2|||
156462567|NCT03582033|564789394|FG004|Part A|Study terminated by sponsor|1|||
156462568|NCT03582033|564789395|FG005|Part A|Study terminated by sponsor|0|||
156462569|NCT03582033|564789396|FG006|Part A|Study terminated by sponsor|0|||
156462570|NCT03582033|564789397|FG007|Part A|Study terminated by sponsor|0|||
156462571|NCT03582033|564789398|FG008|Part A|Study terminated by sponsor|0|||
156462572|NCT03582033|564789399|FG009|Part A|Study terminated by sponsor|0|||
156338858|NCT01433991|564340053|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
156462573|NCT03582033|564789390|FG000|Part A|Withdrawal by Subject|1|||
156462574|NCT03582033|564789391|FG001|Part A|Withdrawal by Subject|1|||
156462575|NCT03582033|564789392|FG002|Part A|Withdrawal by Subject|0|||
156462576|NCT03582033|564789393|FG003|Part A|Withdrawal by Subject|1|||
156462577|NCT03582033|564789394|FG004|Part A|Withdrawal by Subject|7|||
156538692|NCT01660451|565066339|FG001|Overall Study|Trial closure.|0|||
156538693|NCT01660451|565066340|FG002|Overall Study|Trial closure.|1|||
156538694|NCT01660451|565066338|FG000|Overall Study|Switching to other therapy|0|||
156462578|NCT03582033|564789395|FG005|Part A|Withdrawal by Subject|0|||
156462579|NCT03582033|564789396|FG006|Part A|Withdrawal by Subject|0|||
156538695|NCT01660451|565066339|FG001|Overall Study|Switching to other therapy|1|||
156538696|NCT01660451|565066340|FG002|Overall Study|Switching to other therapy|1|||
156538697|NCT01660451|565066338|FG000|Overall Study|Progressive disease - clinical progression|4|||
156538698|NCT01660451|565066339|FG001|Overall Study|Progressive disease - clinical progression|10|||
156538699|NCT01660451|565066340|FG002|Overall Study|Progressive disease - clinical progression|9|||
156462580|NCT03582033|564789397|FG007|Part A|Withdrawal by Subject|0|||
156811787|NCT00606411|566062556|FG000|Overall Study|Move out of state|0|||
156462581|NCT03582033|564789398|FG008|Part A|Withdrawal by Subject|0|||
156462582|NCT03582033|564789399|FG009|Part A|Withdrawal by Subject|0|||
156462583|NCT03582033|564789390|FG000|Part B|Death|0|||
156462584|NCT03582033|564789391|FG001|Part B|Death|0|||
156462585|NCT03582033|564789392|FG002|Part B|Death|0|||
156462586|NCT03582033|564789393|FG003|Part B|Death|0|||
156462587|NCT03582033|564789394|FG004|Part B|Death|0|||
156462588|NCT03582033|564789395|FG005|Part B|Death|2|||
156462589|NCT03582033|564789396|FG006|Part B|Death|0|||
156462590|NCT03582033|564789397|FG007|Part B|Death|0|||
156462591|NCT03582033|564789398|FG008|Part B|Death|0|||
156462592|NCT03582033|564789399|FG009|Part B|Death|0|||
156462593|NCT03582033|564789390|FG000|Part B|Study terminated by sponsor|0|||
156462594|NCT03582033|564789391|FG001|Part B|Study terminated by sponsor|0|||
156462595|NCT03582033|564789392|FG002|Part B|Study terminated by sponsor|0|||
156462596|NCT03582033|564789393|FG003|Part B|Study terminated by sponsor|0|||
156462597|NCT03582033|564789394|FG004|Part B|Study terminated by sponsor|0|||
156462598|NCT03582033|564789395|FG005|Part B|Study terminated by sponsor|12|||
156462599|NCT03582033|564789396|FG006|Part B|Study terminated by sponsor|0|||
156462600|NCT03582033|564789397|FG007|Part B|Study terminated by sponsor|0|||
156462601|NCT03582033|564789398|FG008|Part B|Study terminated by sponsor|0|||
156462602|NCT03582033|564789399|FG009|Part B|Study terminated by sponsor|0|||
156462603|NCT03582033|564789390|FG000|Part B|Withdrawal by Subject|0|||
156462604|NCT03582033|564789391|FG001|Part B|Withdrawal by Subject|0|||
156462605|NCT03582033|564789392|FG002|Part B|Withdrawal by Subject|0|||
156462606|NCT03582033|564789393|FG003|Part B|Withdrawal by Subject|0|||
156462607|NCT03582033|564789394|FG004|Part B|Withdrawal by Subject|0|||
156462608|NCT03582033|564789395|FG005|Part B|Withdrawal by Subject|6|||
156462609|NCT03582033|564789396|FG006|Part B|Withdrawal by Subject|0|||
156462610|NCT03582033|564789397|FG007|Part B|Withdrawal by Subject|0|||
156462611|NCT03582033|564789398|FG008|Part B|Withdrawal by Subject|0|||
156462612|NCT03582033|564789399|FG009|Part B|Withdrawal by Subject|0|||
156462613|NCT03582033|564789390|FG000|Part C|Other|0|||
156462614|NCT03582033|564789391|FG001|Part C|Other|0|||
156462615|NCT03582033|564789392|FG002|Part C|Other|0|||
156462616|NCT03582033|564789393|FG003|Part C|Other|0|||
156462617|NCT03582033|564789394|FG004|Part C|Other|0|||
156462618|NCT03582033|564789395|FG005|Part C|Other|0|||
156462619|NCT03582033|564789396|FG006|Part C|Other|2|||
156462620|NCT03582033|564789397|FG007|Part C|Other|0|||
156462621|NCT03582033|564789398|FG008|Part C|Other|0|||
156462622|NCT03582033|564789399|FG009|Part C|Other|0|||
156462623|NCT03582033|564789390|FG000|Part C|Death|0|||
156462624|NCT03582033|564789391|FG001|Part C|Death|0|||
156462625|NCT03582033|564789392|FG002|Part C|Death|0|||
156462626|NCT03582033|564789393|FG003|Part C|Death|0|||
156462627|NCT03582033|564789394|FG004|Part C|Death|0|||
156462628|NCT03582033|564789395|FG005|Part C|Death|0|||
156462629|NCT03582033|564789396|FG006|Part C|Death|6|||
156462630|NCT03582033|564789397|FG007|Part C|Death|1|||
156462631|NCT03582033|564789398|FG008|Part C|Death|2|||
156462632|NCT03582033|564789399|FG009|Part C|Death|0|||
156462633|NCT03582033|564789390|FG000|Part C|Study terminated by sponsor|0|||
156462634|NCT03582033|564789391|FG001|Part C|Study terminated by sponsor|0|||
156462635|NCT03582033|564789392|FG002|Part C|Study terminated by sponsor|0|||
156462636|NCT03582033|564789393|FG003|Part C|Study terminated by sponsor|0|||
156462637|NCT03582033|564789394|FG004|Part C|Study terminated by sponsor|0|||
156462638|NCT03582033|564789395|FG005|Part C|Study terminated by sponsor|0|||
156462639|NCT03582033|564789396|FG006|Part C|Study terminated by sponsor|3|||
156462640|NCT03582033|564789397|FG007|Part C|Study terminated by sponsor|3|||
156462641|NCT03582033|564789398|FG008|Part C|Study terminated by sponsor|2|||
156462642|NCT03582033|564789399|FG009|Part C|Study terminated by sponsor|0|||
156462643|NCT03582033|564789390|FG000|Part C|Withdrawal by Subject|0|||
156462644|NCT03582033|564789391|FG001|Part C|Withdrawal by Subject|0|||
156462645|NCT03582033|564789392|FG002|Part C|Withdrawal by Subject|0|||
156462646|NCT03582033|564789393|FG003|Part C|Withdrawal by Subject|0|||
156462647|NCT03582033|564789394|FG004|Part C|Withdrawal by Subject|0|||
156462648|NCT03582033|564789395|FG005|Part C|Withdrawal by Subject|0|||
156462649|NCT03582033|564789396|FG006|Part C|Withdrawal by Subject|1|||
156462650|NCT03582033|564789397|FG007|Part C|Withdrawal by Subject|2|||
156462651|NCT03582033|564789398|FG008|Part C|Withdrawal by Subject|1|||
156462652|NCT03582033|564789399|FG009|Part C|Withdrawal by Subject|0|||
156462653|NCT03582033|564789390|FG000|Part D|Death|0|||
156462654|NCT03582033|564789391|FG001|Part D|Death|0|||
156462655|NCT03582033|564789392|FG002|Part D|Death|0|||
156462656|NCT03582033|564789393|FG003|Part D|Death|0|||
156462657|NCT03582033|564789394|FG004|Part D|Death|0|||
156462658|NCT03582033|564789395|FG005|Part D|Death|0|||
156462659|NCT03582033|564789396|FG006|Part D|Death|0|||
156462660|NCT03582033|564789397|FG007|Part D|Death|0|||
156462661|NCT03582033|564789398|FG008|Part D|Death|0|||
156462662|NCT03582033|564789399|FG009|Part D|Death|1|||
156462663|NCT03582033|564789390|FG000|Part D|Study terminated by sponsor|0|||
156462664|NCT03582033|564789391|FG001|Part D|Study terminated by sponsor|0|||
156462665|NCT03582033|564789392|FG002|Part D|Study terminated by sponsor|0|||
156462666|NCT03582033|564789393|FG003|Part D|Study terminated by sponsor|0|||
156462667|NCT03582033|564789394|FG004|Part D|Study terminated by sponsor|0|||
156462668|NCT03582033|564789395|FG005|Part D|Study terminated by sponsor|0|||
156462669|NCT03582033|564789396|FG006|Part D|Study terminated by sponsor|0|||
156462670|NCT03582033|564789397|FG007|Part D|Study terminated by sponsor|0|||
156462671|NCT03582033|564789398|FG008|Part D|Study terminated by sponsor|0|||
156462672|NCT03582033|564789399|FG009|Part D|Study terminated by sponsor|4|||
156462673|NCT05741294|564789400|FG000|Overall Study|Lost to Follow-up|3|||
156462674|NCT05741294|564789400|FG000|Overall Study|Protocol deviation|3|||
156462675|NCT05741294|564789400|FG000|Overall Study|Withdrawal by Subject|1|||
156462676|NCT04707768|564789411|FG000|Overall Study|Adverse Event|9|||
156462677|NCT04707768|564789412|FG001|Overall Study|Adverse Event|18|||
156462678|NCT04707768|564789413|FG002|Overall Study|Adverse Event|3|||
156462679|NCT04707768|564789411|FG000|Overall Study|Investigator's Discretion|8|||
156462680|NCT04707768|564789412|FG001|Overall Study|Investigator's Discretion|4|||
156462681|NCT04707768|564789413|FG002|Overall Study|Investigator's Discretion|3|||
156462682|NCT04707768|564789411|FG000|Overall Study|Withdrawal by Subject|6|||
156462683|NCT04707768|564789412|FG001|Overall Study|Withdrawal by Subject|8|||
156462684|NCT04707768|564789413|FG002|Overall Study|Withdrawal by Subject|2|||
156462685|NCT04707768|564789411|FG000|Overall Study|Lack of Efficacy|1|||
156462686|NCT04707768|564789412|FG001|Overall Study|Lack of Efficacy|3|||
156462687|NCT04707768|564789413|FG002|Overall Study|Lack of Efficacy|0|||
156462688|NCT04707768|564789411|FG000|Overall Study|Lost to Follow-up|0|||
156462689|NCT04707768|564789412|FG001|Overall Study|Lost to Follow-up|0|||
156462690|NCT04707768|564789413|FG002|Overall Study|Lost to Follow-up|3|||
156462691|NCT04707768|564789411|FG000|Overall Study|Death|13|||
156462692|NCT04707768|564789412|FG001|Overall Study|Death|11|||
156462693|NCT04707768|564789413|FG002|Overall Study|Death|13|||
156462694|NCT04707768|564789411|FG000|Overall Study|Protocol Violation|2|||
156462695|NCT04707768|564789412|FG001|Overall Study|Protocol Violation|1|||
156462696|NCT04707768|564789413|FG002|Overall Study|Protocol Violation|0|||
156462697|NCT04707768|564789411|FG000|Overall Study|Non Compliance with Study Drug|1|||
156462698|NCT04707768|564789412|FG001|Overall Study|Non Compliance with Study Drug|0|||
156462699|NCT04707768|564789413|FG002|Overall Study|Non Compliance with Study Drug|0|||
156462700|NCT04707768|564789411|FG000|Overall Study|Transplant|4|||
156462701|NCT04707768|564789412|FG001|Overall Study|Transplant|4|||
156462702|NCT04707768|564789413|FG002|Overall Study|Transplant|8|||
156462703|NCT04707768|564789411|FG000|Overall Study|Other|9|||
156462704|NCT04707768|564789412|FG001|Overall Study|Other|5|||
156462705|NCT04707768|564789413|FG002|Overall Study|Other|2|||
156462706|NCT02518048|564789414|FG000|Overall Study|Withdrawal by Subject|1|||
156462707|NCT05123027|564789419|FG000|Overall Study|Lost to Follow-up|17|||
156462708|NCT05123027|564789420|FG001|Overall Study|Lost to Follow-up|22|||
156462709|NCT05123027|564789419|FG000|Overall Study|Incarceration|3|||
156462710|NCT05123027|564789420|FG001|Overall Study|Incarceration|4|||
156462711|NCT05123027|564789419|FG000|Overall Study|Death|2|||
156462712|NCT05123027|564789420|FG001|Overall Study|Death|2|||
156462713|NCT05123027|564789419|FG000|Overall Study|Other|2|||
156462714|NCT05123027|564789420|FG001|Overall Study|Other|0|||
156462715|NCT03735979|564789421|FG000|Overall Study|Lost to Follow-up|1|||
156462716|NCT03735979|564789422|FG001|Overall Study|Lost to Follow-up|12|||
156462717|NCT03735979|564789423|FG002|Overall Study|Lost to Follow-up|14|||
156462718|NCT03735979|564789421|FG000|Overall Study|Withdrawal by Subject|1|||
156462719|NCT03735979|564789422|FG001|Overall Study|Withdrawal by Subject|5|||
156462720|NCT03735979|564789423|FG002|Overall Study|Withdrawal by Subject|2|||
156462721|NCT03735979|564789421|FG000|Overall Study|Not due to the above reasons|1|||
156462722|NCT03735979|564789422|FG001|Overall Study|Not due to the above reasons|0|||
156811788|NCT00606411|566062557|FG001|Overall Study|Move out of state|1|||
156811789|NCT04503551|566062558|FG000|Overall Study|Withdrawal by Subject|5|||
156811790|NCT04503551|566062559|FG001|Overall Study|Withdrawal by Subject|3|||
156811791|NCT04503551|566062558|FG000|Overall Study|Physician Decision|1|||
156811792|NCT04503551|566062559|FG001|Overall Study|Physician Decision|0|||
156811793|NCT04503551|566062558|FG000|Overall Study|Death|0|||
156811794|NCT04503551|566062559|FG001|Overall Study|Death|1|||
156811795|NCT04503551|566062558|FG000|Overall Study|Lost to Follow-up|1|||
156811796|NCT04503551|566062559|FG001|Overall Study|Lost to Follow-up|2|||
156811797|NCT04503551|566062558|FG000|Overall Study|Ongoing at Week 52|99|||
156811798|NCT04503551|566062559|FG001|Overall Study|Ongoing at Week 52|62|||
156338859|NCT00290888|564340056|FG000|Overall Study|Physician Decision|3|||
156462723|NCT03735979|564789423|FG002|Overall Study|Not due to the above reasons|0|||
156462724|NCT04330040|564789426|FG000|Overall Study|Other: Adverse event|5|||
156462725|NCT04330040|564789427|FG001|Overall Study|Other: Adverse event|0|||
156462726|NCT04330040|564789428|FG002|Overall Study|Other: Adverse event|0|||
156462727|NCT04330040|564789426|FG000|Overall Study|Disease progression|38|||
156811799|NCT03726658|566062560|FG000|Overall Study|Lost to Follow-up|0|||
156338860|NCT00290888|564340057|FG001|Overall Study|Physician Decision|1|||
156338861|NCT01473836|564340060|FG000|Overall Study|Adverse Event|4|||
156462728|NCT04330040|564789427|FG001|Overall Study|Disease progression|10|||
156462729|NCT04330040|564789428|FG002|Overall Study|Disease progression|0|||
156462730|NCT04330040|564789426|FG000|Overall Study|Physician Decision|5|||
156811800|NCT03726658|566062561|FG001|Overall Study|Lost to Follow-up|0|||
156538700|NCT01660451|565066338|FG000|Overall Study|Progressive disease - radiological progression|12|||
156538701|NCT01660451|565066339|FG001|Overall Study|Progressive disease - radiological progression|23|||
156538702|NCT01660451|565066340|FG002|Overall Study|Progressive disease - radiological progression|50|||
156538703|NCT01660451|565066338|FG000|Overall Study|Death|1|||
156538704|NCT01660451|565066339|FG001|Overall Study|Death|0|||
156538705|NCT01660451|565066340|FG002|Overall Study|Death|1|||
156538706|NCT01660451|565066338|FG000|Overall Study|Other|0|||
156538707|NCT01660451|565066339|FG001|Overall Study|Other|0|||
156538708|NCT01660451|565066340|FG002|Overall Study|Other|1|||
156538709|NCT00898443|565066341|FG000|Overall Study|Withdrawal by Subject|1|||
156538710|NCT00898443|565066342|FG001|Overall Study|Withdrawal by Subject|0|||
156538711|NCT01770912|565066345|FG000|Overall Study|Lost to Follow-up|2|||
156538712|NCT01770912|565066346|FG001|Overall Study|Lost to Follow-up|0|||
156538713|NCT03250832|565066348|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
156538714|NCT03250832|565066349|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
156538715|NCT03250832|565066350|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
156538716|NCT03250832|565066351|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
156538717|NCT03250832|565066352|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
156538718|NCT03250832|565066353|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
156538719|NCT03250832|565066354|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
156811801|NCT03726658|566062562|FG002|Overall Study|Lost to Follow-up|2|||
156811802|NCT03726658|566062563|FG003|Overall Study|Lost to Follow-up|0|||
156811803|NCT03726658|566062564|FG004|Overall Study|Lost to Follow-up|0|||
156338862|NCT01473836|564340060|FG000|Overall Study|Lack of Efficacy|1|||
156462731|NCT04330040|564789427|FG001|Overall Study|Physician Decision|3|||
156462732|NCT04330040|564789428|FG002|Overall Study|Physician Decision|0|||
156462733|NCT04330040|564789426|FG000|Overall Study|Lost to Follow-up|1|||
156462734|NCT04330040|564789427|FG001|Overall Study|Lost to Follow-up|1|||
156462735|NCT04330040|564789428|FG002|Overall Study|Lost to Follow-up|0|||
156462736|NCT04330040|564789426|FG000|Overall Study|Death|2|||
156462737|NCT04330040|564789427|FG001|Overall Study|Death|1|||
156462738|NCT04330040|564789428|FG002|Overall Study|Death|0|||
156462739|NCT04330040|564789426|FG000|Overall Study|Withdrawal by Subject|3|||
156462740|NCT04330040|564789427|FG001|Overall Study|Withdrawal by Subject|3|||
156462741|NCT04330040|564789428|FG002|Overall Study|Withdrawal by Subject|0|||
156462742|NCT04330040|564789426|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
156462743|NCT04330040|564789427|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
156462744|NCT04330040|564789428|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
156462745|NCT04330040|564789426|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
156462746|NCT04330040|564789427|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
156462747|NCT04330040|564789428|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
156462748|NCT04330040|564789426|FG000|Overall Study|Other: Disease progression|1|||
156462749|NCT04330040|564789427|FG001|Overall Study|Other: Disease progression|0|||
156462750|NCT04330040|564789428|FG002|Overall Study|Other: Disease progression|0|||
156462751|NCT04330040|564789426|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
156462752|NCT04330040|564789427|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
156462753|NCT04330040|564789428|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
156462754|NCT04330040|564789426|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
156462755|NCT04330040|564789427|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
156462756|NCT04330040|564789428|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
156462757|NCT04330040|564789426|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
156462758|NCT04330040|564789427|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
156462759|NCT04330040|564789428|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
156462760|NCT04761198|564789429|FG000|Overall Study|Progressive Disease|1|||
156462761|NCT04761198|564789430|FG001|Overall Study|Progressive Disease|0|||
156462762|NCT04761198|564789431|FG002|Overall Study|Progressive Disease|0|||
156462763|NCT04761198|564789432|FG003|Overall Study|Progressive Disease|1|||
156462764|NCT04761198|564789433|FG004|Overall Study|Progressive Disease|4|||
156462765|NCT04761198|564789434|FG005|Overall Study|Progressive Disease|1|||
156462766|NCT04761198|564789435|FG006|Overall Study|Progressive Disease|2|||
156462767|NCT04761198|564789429|FG000|Overall Study|Protocol Violation|0|||
156462768|NCT04761198|564789430|FG001|Overall Study|Protocol Violation|0|||
156462769|NCT04761198|564789431|FG002|Overall Study|Protocol Violation|0|||
156462770|NCT04761198|564789432|FG003|Overall Study|Protocol Violation|0|||
156462771|NCT04761198|564789433|FG004|Overall Study|Protocol Violation|1|||
156462772|NCT04761198|564789434|FG005|Overall Study|Protocol Violation|0|||
156462773|NCT04761198|564789435|FG006|Overall Study|Protocol Violation|0|||
156462774|NCT04761198|564789429|FG000|Overall Study|Death|2|||
156462775|NCT04761198|564789430|FG001|Overall Study|Death|1|||
156462776|NCT04761198|564789431|FG002|Overall Study|Death|2|||
156538720|NCT03250832|565066355|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
156811804|NCT03726658|566062565|FG005|Overall Study|Lost to Follow-up|1|||
156811805|NCT03726658|566062566|FG006|Overall Study|Lost to Follow-up|1|||
156462777|NCT04761198|564789432|FG003|Overall Study|Death|5|||
156462778|NCT04761198|564789433|FG004|Overall Study|Death|14|||
156462779|NCT04761198|564789434|FG005|Overall Study|Death|2|||
156462780|NCT04761198|564789435|FG006|Overall Study|Death|5|||
156462781|NCT04761198|564789429|FG000|Overall Study|Lost to Follow-up|0|||
156462782|NCT04761198|564789430|FG001|Overall Study|Lost to Follow-up|0|||
156462783|NCT04761198|564789431|FG002|Overall Study|Lost to Follow-up|0|||
156462784|NCT04761198|564789432|FG003|Overall Study|Lost to Follow-up|0|||
156811806|NCT03726658|566062560|FG000|Overall Study|Withdrawal by Subject|1|||
156811807|NCT03726658|566062561|FG001|Overall Study|Withdrawal by Subject|0|||
156811808|NCT03726658|566062562|FG002|Overall Study|Withdrawal by Subject|0|||
156811809|NCT03726658|566062563|FG003|Overall Study|Withdrawal by Subject|0|||
156811810|NCT03726658|566062564|FG004|Overall Study|Withdrawal by Subject|6|||
156811811|NCT03726658|566062565|FG005|Overall Study|Withdrawal by Subject|4|||
156811812|NCT03726658|566062566|FG006|Overall Study|Withdrawal by Subject|2|||
156811813|NCT03726658|566062560|FG000|Overall Study|Pregnancy|0|||
156811814|NCT03726658|566062561|FG001|Overall Study|Pregnancy|0|||
156811815|NCT03726658|566062562|FG002|Overall Study|Pregnancy|0|||
156811816|NCT03726658|566062563|FG003|Overall Study|Pregnancy|0|||
156811817|NCT03726658|566062564|FG004|Overall Study|Pregnancy|0|||
156811818|NCT03726658|566062565|FG005|Overall Study|Pregnancy|0|||
156811819|NCT03726658|566062566|FG006|Overall Study|Pregnancy|1|||
156811820|NCT03726658|566062560|FG000|Overall Study|Not Reported|0|||
156811821|NCT03726658|566062561|FG001|Overall Study|Not Reported|0|||
156811822|NCT03726658|566062562|FG002|Overall Study|Not Reported|0|||
156811823|NCT03726658|566062563|FG003|Overall Study|Not Reported|0|||
156811824|NCT03726658|566062564|FG004|Overall Study|Not Reported|0|||
156811825|NCT03726658|566062565|FG005|Overall Study|Not Reported|0|||
156811826|NCT03726658|566062566|FG006|Overall Study|Not Reported|1|||
156811827|NCT00412958|566062567|FG000|Overall Study|Withdrawal by Subject|3|||
156811828|NCT00412958|566062568|FG001|Overall Study|Withdrawal by Subject|0|||
156811829|NCT00412958|566062569|FG002|Overall Study|Withdrawal by Subject|0|||
156811830|NCT00412958|566062570|FG003|Overall Study|Withdrawal by Subject|1|||
156811831|NCT00412958|566062567|FG000|Overall Study|Adverse Event|0|||
156811832|NCT00412958|566062568|FG001|Overall Study|Adverse Event|1|||
156811833|NCT00412958|566062569|FG002|Overall Study|Adverse Event|0|||
156811834|NCT00412958|566062570|FG003|Overall Study|Adverse Event|0|||
156811835|NCT00412958|566062567|FG000|Overall Study|Lost to Follow-up|0|||
156811836|NCT00412958|566062568|FG001|Overall Study|Lost to Follow-up|1|||
156811837|NCT00412958|566062569|FG002|Overall Study|Lost to Follow-up|0|||
156811838|NCT00412958|566062570|FG003|Overall Study|Lost to Follow-up|0|||
156811839|NCT00412958|566062567|FG000|Overall Study|Death|0|||
156811840|NCT00412958|566062568|FG001|Overall Study|Death|1|||
156811841|NCT00412958|566062569|FG002|Overall Study|Death|0|||
156811842|NCT00412958|566062570|FG003|Overall Study|Death|0|||
156811843|NCT00412958|566062567|FG000|Overall Study|Transport issue|0|||
156811844|NCT00412958|566062568|FG001|Overall Study|Transport issue|1|||
156811845|NCT00412958|566062569|FG002|Overall Study|Transport issue|0|||
156811846|NCT00412958|566062570|FG003|Overall Study|Transport issue|0|||
156811847|NCT01318135|566062571|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
156811848|NCT01318135|566062572|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811849|NCT01318135|566062573|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811850|NCT01318135|566062574|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811851|NCT01318135|566062575|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811852|NCT01318135|566062576|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811853|NCT01318135|566062577|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811854|NCT01318135|566062578|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811855|NCT01318135|566062571|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
156811856|NCT01318135|566062572|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811857|NCT01318135|566062573|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811858|NCT01318135|566062574|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811859|NCT01318135|566062575|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811860|NCT01318135|566062576|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156462785|NCT04761198|564789433|FG004|Overall Study|Lost to Follow-up|1|||
156462786|NCT04761198|564789434|FG005|Overall Study|Lost to Follow-up|0|||
156462787|NCT04761198|564789435|FG006|Overall Study|Lost to Follow-up|0|||
156811861|NCT01318135|566062577|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811862|NCT01318135|566062578|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156462788|NCT04761198|564789429|FG000|Overall Study|Withdrawal by Subject|2|||
156811863|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
156811864|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
156811865|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
156811866|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
156462789|NCT04761198|564789430|FG001|Overall Study|Withdrawal by Subject|0|||
156462790|NCT04761198|564789431|FG002|Overall Study|Withdrawal by Subject|1|||
156538721|NCT03250832|565066356|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
156538722|NCT03250832|565066357|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
156538723|NCT03250832|565066358|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
156538724|NCT03250832|565066359|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
156338863|NCT01473836|564340060|FG000|Overall Study|Does not meet entrance criteria|1|||
156462791|NCT04761198|564789432|FG003|Overall Study|Withdrawal by Subject|0|||
156462792|NCT04761198|564789433|FG004|Overall Study|Withdrawal by Subject|2|||
156462793|NCT04761198|564789434|FG005|Overall Study|Withdrawal by Subject|0|||
156462794|NCT04761198|564789435|FG006|Overall Study|Withdrawal by Subject|1|||
156462795|NCT04761198|564789429|FG000|Overall Study|Study Terminated by Sponsor|6|||
156462796|NCT04761198|564789430|FG001|Overall Study|Study Terminated by Sponsor|0|||
156462797|NCT04761198|564789431|FG002|Overall Study|Study Terminated by Sponsor|5|||
156462798|NCT04761198|564789432|FG003|Overall Study|Study Terminated by Sponsor|3|||
156462799|NCT04761198|564789433|FG004|Overall Study|Study Terminated by Sponsor|10|||
156462800|NCT04761198|564789434|FG005|Overall Study|Study Terminated by Sponsor|1|||
156462801|NCT04761198|564789435|FG006|Overall Study|Study Terminated by Sponsor|2|||
156462802|NCT05525104|564789436|FG000|Overall Study|Failed caudal analgesia|1|||
156462803|NCT05525104|564789437|FG001|Overall Study|Failed caudal analgesia|3|||
156462804|NCT05525104|564789436|FG000|Overall Study|Premedication needed|0|||
156462805|NCT05525104|564789437|FG001|Overall Study|Premedication needed|1|||
156462806|NCT05525104|564789436|FG000|Overall Study|Protocol Violation|10|||
156462807|NCT05525104|564789437|FG001|Overall Study|Protocol Violation|0|||
156462808|NCT05525104|564789436|FG000|Overall Study|Cancelled operation|1|||
156462809|NCT05525104|564789437|FG001|Overall Study|Cancelled operation|0|||
156462810|NCT02039401|564789438|FG000|Overall Study|Adverse Event|0|||
156462811|NCT02039401|564789439|FG001|Overall Study|Adverse Event|1|||
156462812|NCT04427007|564791202|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
156462813|NCT04427007|564791203|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
156462814|NCT01130883|564791204|FG000|Overall Study|Patient Noncompliance|6|||
156462815|NCT01130883|564791204|FG000|Overall Study|Reason Unknown|1|||
156462816|NCT01130883|564791204|FG000|Overall Study|Adverse Event|3|||
156462817|NCT02585323|564791205|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
156462818|NCT02585323|564791206|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
156462819|NCT02585323|564791205|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
156462820|NCT02585323|564791206|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
156462821|NCT02585323|564791205|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
156462822|NCT02585323|564791206|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
156462823|NCT02585323|564791205|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
156462824|NCT02585323|564791206|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
156462825|NCT05524116|564791215|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
156462826|NCT05524116|564791216|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
156462827|NCT05524116|564791215|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
156462828|NCT05524116|564791216|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
156462829|NCT05524116|564791215|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
156462830|NCT05524116|564791216|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
156462831|NCT05524116|564791215|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
156462832|NCT05524116|564791216|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
156462833|NCT05524116|564791215|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
156462834|NCT05524116|564791216|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
156462835|NCT04389957|564791224|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
156462836|NCT04389957|564791225|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
156462837|NCT04389957|564791226|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
156462838|NCT04389957|564791227|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
156462839|NCT04389957|564791228|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
156462840|NCT04084574|564791233|FG000|Overall Study|Lost to Follow-up|1|||
156462841|NCT04084574|564791234|FG001|Overall Study|Lost to Follow-up|0|||
156462842|NCT04084574|564791233|FG000|Overall Study|Physician Decision|1|||
156462843|NCT04084574|564791234|FG001|Overall Study|Physician Decision|0|||
156462844|NCT04084574|564791233|FG000|Overall Study|Relocated out of state|1|||
156462845|NCT04084574|564791234|FG001|Overall Study|Relocated out of state|0|||
156462846|NCT01121588|564791235|FG000|Overall Study|Death|5|||
156462847|NCT01121588|564791236|FG001|Overall Study|Death|3|||
156462848|NCT01121588|564791237|FG002|Overall Study|Death|13|||
156462849|NCT01121588|564791235|FG000|Overall Study|Study Terminated by Sponsor|1|||
156462850|NCT01121588|564791236|FG001|Overall Study|Study Terminated by Sponsor|1|||
156462851|NCT01121588|564791237|FG002|Overall Study|Study Terminated by Sponsor|0|||
156462852|NCT01121588|564791235|FG000|Overall Study|Participant Refused Further Followup|2|||
156462853|NCT01121588|564791236|FG001|Overall Study|Participant Refused Further Followup|0|||
156538725|NCT03250832|565066348|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
156538726|NCT03250832|565066349|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
156538727|NCT03250832|565066350|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
156538728|NCT03250832|565066351|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
156538729|NCT03250832|565066352|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
156538730|NCT03250832|565066353|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
156538731|NCT03250832|565066354|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
156538732|NCT03250832|565066355|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
156538733|NCT03250832|565066356|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
156538734|NCT03250832|565066357|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
156538735|NCT03250832|565066358|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
156538736|NCT03250832|565066359|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
156538737|NCT03250832|565066348|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538738|NCT03250832|565066349|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538739|NCT03250832|565066350|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
156538740|NCT03250832|565066351|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538741|NCT03250832|565066352|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538742|NCT03250832|565066353|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538743|NCT03250832|565066354|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538744|NCT03250832|565066355|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538745|NCT03250832|565066356|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538746|NCT03250832|565066357|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538747|NCT03250832|565066358|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538748|NCT03250832|565066359|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
156538749|NCT03250832|565066348|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
156538750|NCT03250832|565066349|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
156538751|NCT03250832|565066350|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
156538752|NCT03250832|565066351|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
156462854|NCT01121588|564791237|FG002|Overall Study|Participant Refused Further Followup|2|||
156462855|NCT01121588|564791235|FG000|Overall Study|Lost to Follow-up|0|||
156462856|NCT01121588|564791236|FG001|Overall Study|Lost to Follow-up|1|||
156462857|NCT01121588|564791237|FG002|Overall Study|Lost to Follow-up|1|||
156462858|NCT01121588|564791235|FG000|Overall Study|Non-Specified Reasons|9|||
156462859|NCT01121588|564791236|FG001|Overall Study|Non-Specified Reasons|4|||
156462860|NCT01121588|564791237|FG002|Overall Study|Non-Specified Reasons|2|||
156462861|NCT00942877|564791238|FG000|Overall Study|Refused further treatment|1|||
156462862|NCT00942877|564791239|FG001|Overall Study|Refused further treatment|1|||
156462863|NCT00942877|564791238|FG000|Overall Study|Patient was not treated|1|||
156462864|NCT00942877|564791239|FG001|Overall Study|Patient was not treated|0|||
156462865|NCT00942877|564791238|FG000|Overall Study|Adverse Event|1|||
156462866|NCT00942877|564791239|FG001|Overall Study|Adverse Event|0|||
156462867|NCT00942877|564791238|FG000|Overall Study|Progressive disease|42|||
156462868|NCT00942877|564791239|FG001|Overall Study|Progressive disease|3|||
156462869|NCT01385202|564791242|FG000|Overall Study|Lost to Follow-up|6|||
156462870|NCT01385202|564791242|FG000|Overall Study|Not Eligible|11|||
156462871|NCT01385202|564791242|FG000|Overall Study|Withdrawn|1|||
156462872|NCT02095691|564791243|FG000|Overall Study|Physician Decision|1|||
156462873|NCT03681262|564791244|FG000|Overall Study|Continuing on study|3|||
156462874|NCT03681262|564791245|FG001|Overall Study|Continuing on study|3|||
156462875|NCT03681262|564791244|FG000|Overall Study|Lost to Follow-up|1|||
156462876|NCT03681262|564791245|FG001|Overall Study|Lost to Follow-up|0|||
156538753|NCT03250832|565066352|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
156338864|NCT03068130|564340063|FG000|Overall Study|Adverse Event|19|||
156462877|NCT04583280|564791246|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
156462878|NCT04583280|564791247|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
156462879|NCT00964392|564791248|FG000|Overall Study|Withdrawal by Subject|4|||
156462880|NCT00964392|564791249|FG001|Overall Study|Withdrawal by Subject|6|||
156462881|NCT00964392|564791248|FG000|Overall Study|Lost to Follow-up|4|||
156462882|NCT00964392|564791249|FG001|Overall Study|Lost to Follow-up|10|||
156462883|NCT00964392|564791248|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
156462884|NCT00964392|564791249|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
156462885|NCT00964392|564791248|FG000|Overall Study|Not completed|44|||
156462886|NCT00964392|564791249|FG001|Overall Study|Not completed|168|||
156462887|NCT03652272|564791254|FG000|3 Month|Withdrawal by Subject|1|||
156462888|NCT03652272|564791255|FG001|3 Month|Withdrawal by Subject|1|||
156462889|NCT03652272|564791254|FG000|3 Month|Lost to Follow-up|16|||
156462890|NCT03652272|564791255|FG001|3 Month|Lost to Follow-up|14|||
156462891|NCT02326974|564791256|FG000|Overall Study|Withdrawal by Subject|2|||
156462892|NCT02326974|564791256|FG000|Overall Study|failed heterogenity evaluation|5|||
156462893|NCT02577354|564791257|FG000|Overall Study|Lack of Efficacy|4|||
156462894|NCT02577354|564791258|FG001|Overall Study|Lack of Efficacy|4|||
156462895|NCT02577354|564791257|FG000|Overall Study|Lost to Follow-up|3|||
156462896|NCT02577354|564791258|FG001|Overall Study|Lost to Follow-up|1|||
156462897|NCT02577354|564791257|FG000|Overall Study|Missed Visit|4|||
156462898|NCT02577354|564791258|FG001|Overall Study|Missed Visit|3|||
156462899|NCT02577354|564791257|FG000|Overall Study|Adverse Event|4|||
156462900|NCT02577354|564791258|FG001|Overall Study|Adverse Event|5|||
156462901|NCT03812614|564791267|FG000|Intervention|Withdrawal by Subject|7|||
156462902|NCT03812614|564791268|FG001|Intervention|Withdrawal by Subject|2|||
156462903|NCT03812614|564791269|FG002|Intervention|Withdrawal by Subject|7|||
156462904|NCT03812614|564791270|FG003|Intervention|Withdrawal by Subject|2|||
156462905|NCT03812614|564791267|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
156462906|NCT03812614|564791268|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
156462907|NCT03812614|564791269|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
156462908|NCT03812614|564791270|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
156462909|NCT03812614|564791267|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
156462910|NCT03812614|564791268|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
156462911|NCT03812614|564791269|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
156462912|NCT03812614|564791270|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
156462913|NCT03812614|564791267|FG000|6-month Follow-up|Lost to Follow-up|0|||
156462914|NCT03812614|564791268|FG001|6-month Follow-up|Lost to Follow-up|0|||
156462915|NCT03812614|564791269|FG002|6-month Follow-up|Lost to Follow-up|12|||
156462916|NCT03812614|564791270|FG003|6-month Follow-up|Lost to Follow-up|8|||
156462917|NCT03812614|564791267|FG000|12-month Follow-up|Lost to Follow-up|18|||
156462918|NCT03812614|564791268|FG001|12-month Follow-up|Lost to Follow-up|17|||
156462919|NCT03812614|564791269|FG002|12-month Follow-up|Lost to Follow-up|5|||
156462920|NCT03812614|564791270|FG003|12-month Follow-up|Lost to Follow-up|2|||
156462921|NCT05652010|564791271|FG000|First Intervention|Withdrawal by Subject|0|||
156462922|NCT05652010|564791272|FG001|First Intervention|Withdrawal by Subject|1|||
156538754|NCT03250832|565066353|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
156811867|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
156811868|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
156811869|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
156811870|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
156811871|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
156811872|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
156811873|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811874|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811875|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
156811876|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811877|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811878|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811879|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156811880|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156811881|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156811882|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156811883|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156462923|NCT05652010|564791271|FG000|Second Intervention|Withdrawal by Subject|1|||
156462924|NCT05652010|564791272|FG001|Second Intervention|Withdrawal by Subject|0|||
156462925|NCT05451693|564791273|FG000|Overall Study|Withdrawal by Subject|1|||
156338865|NCT03068130|564340063|FG000|Overall Study|Death|14|||
156338866|NCT03068130|564340063|FG000|Overall Study|Lost to Follow-up|4|||
156338867|NCT03068130|564340063|FG000|Overall Study|Withdrawal by Subject|26|||
156462926|NCT05451693|564791274|FG001|Overall Study|Withdrawal by Subject|1|||
156462927|NCT04490109|564791281|FG000|Overall Study|Lost to Follow-up|3|||
156462928|NCT04490109|564791282|FG001|Overall Study|Lost to Follow-up|10|||
156462929|NCT04490109|564791283|FG002|Overall Study|Lost to Follow-up|4|||
156462930|NCT04490109|564791281|FG000|Overall Study|Withdrawal by Subject|8|||
156462931|NCT04490109|564791282|FG001|Overall Study|Withdrawal by Subject|6|||
156462932|NCT04490109|564791283|FG002|Overall Study|Withdrawal by Subject|9|||
156462933|NCT04490109|564791281|FG000|Overall Study|Physician Decision|0|||
156462934|NCT04490109|564791282|FG001|Overall Study|Physician Decision|2|||
156462935|NCT04490109|564791283|FG002|Overall Study|Physician Decision|3|||
156462936|NCT04490109|564791281|FG000|Overall Study|Adverse Event|2|||
156462937|NCT04490109|564791282|FG001|Overall Study|Adverse Event|1|||
156462938|NCT04490109|564791283|FG002|Overall Study|Adverse Event|0|||
156462939|NCT04490109|564791281|FG000|Overall Study|Significant Non-Compliance|2|||
156462940|NCT04490109|564791282|FG001|Overall Study|Significant Non-Compliance|4|||
156462941|NCT04490109|564791283|FG002|Overall Study|Significant Non-Compliance|4|||
156462942|NCT04490109|564791281|FG000|Overall Study|Significant Clinical Event|0|||
156462943|NCT04490109|564791282|FG001|Overall Study|Significant Clinical Event|1|||
156462944|NCT04490109|564791283|FG002|Overall Study|Significant Clinical Event|0|||
156462945|NCT04490109|564791281|FG000|Overall Study|Other Reason|4|||
156462946|NCT04490109|564791282|FG001|Overall Study|Other Reason|1|||
156462947|NCT04490109|564791283|FG002|Overall Study|Other Reason|1|||
156462948|NCT03372057|564791284|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
156462949|NCT03372057|564791285|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
156462950|NCT03372057|564791286|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
156462951|NCT03372057|564791284|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
156462952|NCT03372057|564791285|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
156462953|NCT03372057|564791286|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
156462954|NCT03372057|564791284|FG000|Dose Optimization Phase|Death|16|||
156462955|NCT03372057|564791285|FG001|Dose Optimization Phase|Death|11|||
156462956|NCT03372057|564791286|FG002|Dose Optimization Phase|Death|0|||
156462957|NCT03372057|564791284|FG000|Expansion Phase|Withdrawal by Subject|0|||
156462958|NCT03372057|564791285|FG001|Expansion Phase|Withdrawal by Subject|0|||
156462959|NCT03372057|564791286|FG002|Expansion Phase|Withdrawal by Subject|4|||
156462960|NCT03372057|564791284|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
156462961|NCT03372057|564791285|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
156462962|NCT03372057|564791286|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
156462963|NCT03372057|564791284|FG000|Expansion Phase|Death|0|||
156462964|NCT03372057|564791285|FG001|Expansion Phase|Death|0|||
156462965|NCT03372057|564791286|FG002|Expansion Phase|Death|78|||
156462966|NCT03372057|564791284|FG000|Expansion Phase|Progressive Disease|0|||
156462967|NCT03372057|564791285|FG001|Expansion Phase|Progressive Disease|0|||
156462968|NCT03372057|564791286|FG002|Expansion Phase|Progressive Disease|1|||
156462969|NCT03372057|564791284|FG000|Expansion Phase|Adverse Event|0|||
156462970|NCT03372057|564791285|FG001|Expansion Phase|Adverse Event|0|||
156462971|NCT03372057|564791286|FG002|Expansion Phase|Adverse Event|1|||
156462972|NCT05953740|564791287|FG000|Period 1|Physician Decision|0|||
156462973|NCT05953740|564791288|FG001|Period 1|Physician Decision|1|||
156462974|NCT05953740|564791289|FG002|Period 1|Physician Decision|0|||
156462975|NCT05953740|564791290|FG003|Period 1|Physician Decision|0|||
156462976|NCT05953740|564791291|FG004|Period 1|Physician Decision|0|||
156462977|NCT05953740|564791292|FG005|Period 1|Physician Decision|0|||
156462978|NCT05953740|564791293|FG006|Period 1|Physician Decision|0|||
156462979|NCT05953740|564791294|FG007|Period 1|Physician Decision|0|||
156462980|NCT05953740|564791287|FG000|Period 2|Withdrawal by Subject|0|||
156462981|NCT05953740|564791288|FG001|Period 2|Withdrawal by Subject|1|||
156462982|NCT05953740|564791289|FG002|Period 2|Withdrawal by Subject|1|||
156462983|NCT05953740|564791290|FG003|Period 2|Withdrawal by Subject|0|||
156462984|NCT05953740|564791291|FG004|Period 2|Withdrawal by Subject|0|||
156462985|NCT05953740|564791292|FG005|Period 2|Withdrawal by Subject|0|||
156462986|NCT05953740|564791293|FG006|Period 2|Withdrawal by Subject|0|||
156462987|NCT05953740|564791294|FG007|Period 2|Withdrawal by Subject|0|||
156462988|NCT03880955|564791295|FG000|Overall Study|Adverse Event|1|||
156338868|NCT03068130|564340063|FG000|Overall Study|Administrative Reasons|3|||
156338869|NCT03068130|564340063|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
156462989|NCT03880955|564791295|FG000|Overall Study|Death|1|||
156462990|NCT03880955|564791295|FG000|Overall Study|Lost to Follow-up|12|||
156462991|NCT03880955|564791295|FG000|Overall Study|Withdrawal by Subject|4|||
156462992|NCT03880955|564791295|FG000|Overall Study|Missing- Study Site Closed|27|||
156462993|NCT05112900|564791296|FG000|Overall Study|Withdrawal by Subject|960|||
156462994|NCT05112900|564791297|FG001|Overall Study|Withdrawal by Subject|921|||
156462995|NCT05112900|564791298|FG002|Overall Study|Withdrawal by Subject|968|||
156462996|NCT00319111|564791299|FG000|Overall Study|Adverse Event|20|||
156462997|NCT00319111|564791299|FG000|Overall Study|Withdrawal of consent|11|||
156462998|NCT00319111|564791299|FG000|Overall Study|Death|9|||
156462999|NCT00319111|564791299|FG000|Overall Study|Lack of clinical improvement|4|||
156463000|NCT00319111|564791299|FG000|Overall Study|Administrative|2|||
156463001|NCT00319111|564791299|FG000|Overall Study|Treatment failure|1|||
156463002|NCT02994927|564791302|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156463003|NCT02994927|564791303|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156463004|NCT02994927|564791302|FG000|Overall Study|Did not meet eligibility criteria|0|||
156463005|NCT02994927|564791303|FG001|Overall Study|Did not meet eligibility criteria|1|||
156463006|NCT02994927|564791302|FG000|Overall Study|Physician Decision|4|||
156463007|NCT02994927|564791303|FG001|Overall Study|Physician Decision|3|||
156463008|NCT02994927|564791302|FG000|Overall Study|Death|4|||
156463009|NCT02994927|564791303|FG001|Overall Study|Death|2|||
156463010|NCT02994927|564791302|FG000|Overall Study|Adverse Event|2|||
156463011|NCT02994927|564791303|FG001|Overall Study|Adverse Event|1|||
156463012|NCT02994927|564791302|FG000|Overall Study|Withdrawal by Subject|3|||
156463013|NCT02994927|564791303|FG001|Overall Study|Withdrawal by Subject|6|||
156463014|NCT02994927|564791302|FG000|Overall Study|Lost to Follow-up|2|||
156463015|NCT02994927|564791303|FG001|Overall Study|Lost to Follow-up|1|||
156463016|NCT02865538|564791305|FG000|Overall Study|Withdrawal by Subject|0|||
156463017|NCT02865538|564791306|FG001|Overall Study|Withdrawal by Subject|0|||
156463018|NCT02865538|564791307|FG002|Overall Study|Withdrawal by Subject|1|||
156463019|NCT02865538|564791308|FG003|Overall Study|Withdrawal by Subject|0|||
156463020|NCT02865538|564791309|FG004|Overall Study|Withdrawal by Subject|0|||
156463021|NCT02865538|564791305|FG000|Overall Study|Lost to Follow-up|1|||
156538755|NCT03250832|565066354|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
156811884|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156811885|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156811886|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156811887|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
156811888|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
156811889|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
156811890|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
156811891|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
156811892|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
156811893|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
156811894|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
156811895|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811896|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811897|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811898|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811899|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811900|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811901|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811902|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
156811903|NCT00703963|566062584|FG000|Overall Study|Withdrawal by Subject|7|||
156811904|NCT00703963|566062585|FG001|Overall Study|Withdrawal by Subject|13|||
156811905|NCT00703963|566062584|FG000|Overall Study|Physician Decision|0|||
156811906|NCT00703963|566062585|FG001|Overall Study|Physician Decision|1|||
156811907|NCT03994211|566062592|FG000|Core Phase|Adverse Event|0|||
156811908|NCT03994211|566062593|FG001|Core Phase|Adverse Event|1|||
156811909|NCT03994211|566062594|FG002|Core Phase|Adverse Event|0|||
156811910|NCT03994211|566062592|FG000|Extension Phase|Adverse Event|0|||
156811911|NCT03994211|566062593|FG001|Extension Phase|Adverse Event|0|||
156811912|NCT03994211|566062594|FG002|Extension Phase|Adverse Event|1|||
156811913|NCT03994211|566062592|FG000|Extension Phase|Physician Decision|0|||
156811914|NCT03994211|566062593|FG001|Extension Phase|Physician Decision|0|||
156811915|NCT03994211|566062594|FG002|Extension Phase|Physician Decision|1|||
156811916|NCT03994211|566062592|FG000|Extension Phase|Progressive Disease|0|||
156811917|NCT03994211|566062593|FG001|Extension Phase|Progressive Disease|0|||
156811918|NCT03994211|566062594|FG002|Extension Phase|Progressive Disease|20|||
156811919|NCT03994211|566062592|FG000|Extension Phase|Withdrawal by Subject|0|||
156811920|NCT03994211|566062593|FG001|Extension Phase|Withdrawal by Subject|0|||
156811921|NCT03994211|566062594|FG002|Extension Phase|Withdrawal by Subject|2|||
156463022|NCT02865538|564791306|FG001|Overall Study|Lost to Follow-up|0|||
156463023|NCT02865538|564791307|FG002|Overall Study|Lost to Follow-up|0|||
156463024|NCT02865538|564791308|FG003|Overall Study|Lost to Follow-up|0|||
156463025|NCT02865538|564791309|FG004|Overall Study|Lost to Follow-up|0|||
156463026|NCT04165213|564792814|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
156463027|NCT04165213|564792815|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
156463028|NCT04165213|564792814|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
156463029|NCT04165213|564792815|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
156463030|NCT04165213|564792814|FG000|Clinician Enrollment|Termination from site|0|||
156463031|NCT04165213|564792815|FG001|Clinician Enrollment|Termination from site|1|||
156463032|NCT04165213|564792814|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
156463033|NCT04165213|564792815|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
156463034|NCT04165213|564792814|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
156463035|NCT04165213|564792815|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
156463036|NCT04165213|564792814|FG000|Caregiver Enrollment|Physician Decision|1|||
156463037|NCT04165213|564792815|FG001|Caregiver Enrollment|Physician Decision|0|||
156463038|NCT04165213|564792814|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
156463039|NCT04165213|564792815|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
156463040|NCT04165213|564792814|FG000|Caregiver Enrollment|PLWD death|2|||
156463041|NCT04165213|564792815|FG001|Caregiver Enrollment|PLWD death|0|||
156463042|NCT04165213|564792814|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
156463043|NCT04165213|564792815|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
156463044|NCT04165213|564792814|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
156463045|NCT04165213|564792815|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
156463046|NCT04165213|564792814|FG000|PLWD Enrollment|Lost to Follow-up|1|||
156463047|NCT04165213|564792815|FG001|PLWD Enrollment|Lost to Follow-up|1|||
156463048|NCT04165213|564792814|FG000|PLWD Enrollment|Physician Decision|1|||
156463049|NCT04165213|564792815|FG001|PLWD Enrollment|Physician Decision|0|||
156463050|NCT04165213|564792814|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
156463051|NCT04165213|564792815|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
156463052|NCT04165213|564792814|FG000|PLWD Enrollment|Death|2|||
156463053|NCT04165213|564792815|FG001|PLWD Enrollment|Death|0|||
156463054|NCT04165213|564792814|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
156463055|NCT04165213|564792815|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
156463056|NCT04464564|564792816|FG000|Period A (Placebo lead-in)|Other|5|||
156463057|NCT04464564|564792817|FG001|Period A (Placebo lead-in)|Other|0|||
156463058|NCT04464564|564792818|FG002|Period A (Placebo lead-in)|Other|0|||
156463059|NCT04464564|564792819|FG003|Period A (Placebo lead-in)|Other|0|||
156463060|NCT04464564|564792816|FG000|Period B (Randomization Period)|Adverse Event|0|||
156463061|NCT04464564|564792817|FG001|Period B (Randomization Period)|Adverse Event|1|||
156463062|NCT04464564|564792818|FG002|Period B (Randomization Period)|Adverse Event|2|||
156463063|NCT04464564|564792819|FG003|Period B (Randomization Period)|Adverse Event|8|||
156463064|NCT04464564|564792816|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
156463065|NCT04464564|564792817|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
156463066|NCT04464564|564792818|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
156463067|NCT04464564|564792819|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
156463068|NCT04464564|564792816|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
156463069|NCT04464564|564792817|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
156463070|NCT04464564|564792818|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
156463071|NCT04464564|564792819|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
156463072|NCT04464564|564792816|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
156463073|NCT04464564|564792817|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
156463074|NCT04464564|564792818|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
156463075|NCT04464564|564792819|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
156463076|NCT04464564|564792816|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
156463077|NCT04464564|564792817|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
156463078|NCT04464564|564792818|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
156463079|NCT04464564|564792819|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
156463080|NCT04464564|564792816|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
156463081|NCT04464564|564792817|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
156463082|NCT04464564|564792818|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
156463083|NCT04464564|564792819|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
156463084|NCT04464564|564792816|FG000|Period B (Randomization Period)|Reason not Specified|0|||
156463085|NCT04464564|564792817|FG001|Period B (Randomization Period)|Reason not Specified|3|||
156463086|NCT04464564|564792818|FG002|Period B (Randomization Period)|Reason not Specified|3|||
156463087|NCT04464564|564792819|FG003|Period B (Randomization Period)|Reason not Specified|3|||
156463088|NCT04089865|564792828|FG000|Overall Study|Withdrawal by Subject|2|||
156463089|NCT04089865|564792829|FG001|Overall Study|Withdrawal by Subject|2|||
156463090|NCT04089865|564792830|FG002|Overall Study|Withdrawal by Subject|7|||
156463091|NCT04089865|564792831|FG003|Overall Study|Withdrawal by Subject|2|||
156463092|NCT04282980|564792836|FG000|Overall Study|Remained on treatment|6|||
156463093|NCT04282980|564792836|FG000|Overall Study|Survival follow-up|11|||
156463094|NCT04282980|564792836|FG000|Overall Study|Withdrawal of informed consent|1|||
156463095|NCT04282980|564792836|FG000|Overall Study|Lost to Follow-up|1|||
156463096|NCT01917084|564792838|FG000|Overall Study|Withdrawal by Subject|1|||
156463097|NCT03571386|564792839|FG000|Overall Study|scheduling conflict|4|||
156463098|NCT03571386|564792840|FG001|Overall Study|scheduling conflict|0|||
156463099|NCT03571386|564792839|FG000|Overall Study|Withdrawal by Subject|15|||
156463100|NCT03571386|564792840|FG001|Overall Study|Withdrawal by Subject|5|||
156463101|NCT02909686|564792848|FG000|Overall Study|Physician Decision|3|||
156463102|NCT02909686|564792848|FG000|Overall Study|Withdrawal by Subject|2|||
156463103|NCT03858517|564792849|FG000|Overall Study|Adverse Event|1|||
156463104|NCT03858517|564792849|FG000|Overall Study|Lost to Follow-up|1|||
156463105|NCT03858517|564792849|FG000|Overall Study|removed for being incarcerated|1|||
156811922|NCT02528942|566062595|FG000|Overall Study|Did not meet imaging criteria|9|||
156811923|NCT02528942|566062595|FG000|Overall Study|Lost to Follow-up|25|||
156463106|NCT03858517|564792849|FG000|Overall Study|Sponsor Closure|48|||
156463107|NCT00887198|564792851|FG000|Randomized Period|Ongoing|42|||
156463108|NCT00887198|564792852|FG001|Randomized Period|Ongoing|0|||
156463109|NCT00887198|564792853|FG002|Randomized Period|Ongoing|0|||
156463110|NCT00887198|564792851|FG000|Randomized Period|Adverse Event|50|||
156463111|NCT00887198|564792852|FG001|Randomized Period|Adverse Event|33|||
156463112|NCT00887198|564792853|FG002|Randomized Period|Adverse Event|0|||
156463113|NCT00887198|564792851|FG000|Randomized Period|Lost to Follow-up|1|||
156463114|NCT00887198|564792852|FG001|Randomized Period|Lost to Follow-up|0|||
156463115|NCT00887198|564792853|FG002|Randomized Period|Lost to Follow-up|0|||
156463116|NCT00887198|564792851|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
156463117|NCT00887198|564792852|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
156463118|NCT00887198|564792853|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
156463119|NCT00887198|564792851|FG000|Randomized Period|Withdrawal by Subject|41|||
156463120|NCT00887198|564792852|FG001|Randomized Period|Withdrawal by Subject|56|||
156463121|NCT00887198|564792853|FG002|Randomized Period|Withdrawal by Subject|0|||
156463122|NCT00887198|564792851|FG000|Randomized Period|Progressive disease|366|||
156463123|NCT00887198|564792852|FG001|Randomized Period|Progressive disease|370|||
156463124|NCT00887198|564792853|FG002|Randomized Period|Progressive disease|0|||
156463125|NCT00887198|564792851|FG000|Randomized Period|Other|42|||
156463126|NCT00887198|564792852|FG001|Randomized Period|Other|30|||
156463127|NCT00887198|564792853|FG002|Randomized Period|Other|0|||
156463128|NCT00887198|564792851|FG000|Randomized Period|Randomized, Not treated|4|||
156463129|NCT00887198|564792852|FG001|Randomized Period|Randomized, Not treated|2|||
156463130|NCT00887198|564792853|FG002|Randomized Period|Randomized, Not treated|0|||
156463131|NCT00887198|564792851|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
156463132|NCT00887198|564792852|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
156463133|NCT00887198|564792853|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
156463134|NCT00887198|564792851|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
156463135|NCT00887198|564792852|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
156463136|NCT00887198|564792853|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
156463137|NCT00887198|564792851|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
156463138|NCT00887198|564792852|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
156463139|NCT00887198|564792853|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
156463140|NCT00887198|564792851|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
156463141|NCT00887198|564792852|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
156463142|NCT00887198|564792853|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
156463143|NCT00887198|564792851|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
156463144|NCT00887198|564792852|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
156463145|NCT00887198|564792853|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
156463146|NCT00887198|564792851|FG000|Cross Over (Placebo to AA)|Other|0|||
156463147|NCT00887198|564792852|FG001|Cross Over (Placebo to AA)|Other|0|||
156463148|NCT00887198|564792853|FG002|Cross Over (Placebo to AA)|Other|19|||
156463149|NCT02782676|564792854|FG000|Overall Study|Lost to Follow-up|0|||
156463150|NCT02782676|564792855|FG001|Overall Study|Lost to Follow-up|1|||
156463151|NCT05007080|564792856|FG000|Overall Study|Lost to Follow-up|0|||
156463152|NCT05007080|564792857|FG001|Overall Study|Lost to Follow-up|1|||
156463153|NCT05007080|564792858|FG002|Overall Study|Lost to Follow-up|0|||
156463154|NCT05007080|564792859|FG003|Overall Study|Lost to Follow-up|1|||
156463155|NCT05007080|564792860|FG004|Overall Study|Lost to Follow-up|1|||
156463156|NCT05007080|564792861|FG005|Overall Study|Lost to Follow-up|1|||
156463157|NCT05007080|564792856|FG000|Overall Study|Death|0|||
156463158|NCT05007080|564792857|FG001|Overall Study|Death|1|||
156463159|NCT05007080|564792858|FG002|Overall Study|Death|0|||
156463160|NCT05007080|564792859|FG003|Overall Study|Death|0|||
156463161|NCT05007080|564792860|FG004|Overall Study|Death|0|||
156463162|NCT05007080|564792861|FG005|Overall Study|Death|0|||
156463163|NCT05007080|564792856|FG000|Overall Study|Withdrawal by Subject|1|||
156463164|NCT05007080|564792857|FG001|Overall Study|Withdrawal by Subject|2|||
156463165|NCT05007080|564792858|FG002|Overall Study|Withdrawal by Subject|0|||
156463166|NCT05007080|564792859|FG003|Overall Study|Withdrawal by Subject|2|||
156463167|NCT05007080|564792860|FG004|Overall Study|Withdrawal by Subject|1|||
156463168|NCT05007080|564792861|FG005|Overall Study|Withdrawal by Subject|1|||
156463169|NCT05007080|564792856|FG000|Overall Study|Other|1|||
156463170|NCT05007080|564792857|FG001|Overall Study|Other|0|||
156463171|NCT05007080|564792858|FG002|Overall Study|Other|1|||
156463172|NCT05007080|564792859|FG003|Overall Study|Other|1|||
156463173|NCT05007080|564792860|FG004|Overall Study|Other|0|||
156463174|NCT05007080|564792861|FG005|Overall Study|Other|2|||
156463175|NCT05007080|564792856|FG000|Overall Study|Randomized not vaccinated|0|||
156463176|NCT05007080|564792857|FG001|Overall Study|Randomized not vaccinated|0|||
156463177|NCT05007080|564792858|FG002|Overall Study|Randomized not vaccinated|0|||
156463178|NCT05007080|564792859|FG003|Overall Study|Randomized not vaccinated|0|||
156463179|NCT05007080|564792860|FG004|Overall Study|Randomized not vaccinated|0|||
156463180|NCT05007080|564792861|FG005|Overall Study|Randomized not vaccinated|1|||
156463181|NCT02874742|564792863|FG000|Overall Study|Death|0|||
156463182|NCT02874742|564792864|FG001|Overall Study|Death|1|||
156463183|NCT02874742|564792865|FG002|Overall Study|Death|0|||
156338870|NCT03068130|564340063|FG000|Overall Study|Study terminated by sponsor|194|||
156338871|NCT01001377|564340064|FG000|Overall Study|Ineligibility determined|2|||
156338872|NCT01001377|564340065|FG001|Overall Study|Ineligibility determined|0|||
156338873|NCT01001377|564340064|FG000|Overall Study|Withdrawal by Subject|19|||
156338874|NCT01001377|564340065|FG001|Overall Study|Withdrawal by Subject|20|||
156338875|NCT01001377|564340064|FG000|Overall Study|Lost to Follow-up|14|||
156338876|NCT01001377|564340065|FG001|Overall Study|Lost to Follow-up|17|||
156463184|NCT02874742|564792863|FG000|Overall Study|Lost to Follow-up|5|||
156463185|NCT02874742|564792864|FG001|Overall Study|Lost to Follow-up|4|||
156463186|NCT02874742|564792865|FG002|Overall Study|Lost to Follow-up|1|||
156463187|NCT02874742|564792863|FG000|Overall Study|Withdrawal by Subject|17|||
156463188|NCT02874742|564792864|FG001|Overall Study|Withdrawal by Subject|8|||
156463189|NCT02874742|564792865|FG002|Overall Study|Withdrawal by Subject|0|||
156463190|NCT02874742|564792863|FG000|Overall Study|Other|4|||
156463191|NCT02874742|564792864|FG001|Overall Study|Other|1|||
156463192|NCT02874742|564792865|FG002|Overall Study|Other|0|||
156463193|NCT02874742|564792863|FG000|Overall Study|Progressive Disease|1|||
156463194|NCT02874742|564792864|FG001|Overall Study|Progressive Disease|0|||
156463195|NCT02874742|564792865|FG002|Overall Study|Progressive Disease|0|||
156463196|NCT02874742|564792863|FG000|Overall Study|Screen Failure|0|||
156463197|NCT02874742|564792864|FG001|Overall Study|Screen Failure|2|||
156463198|NCT02874742|564792865|FG002|Overall Study|Screen Failure|0|||
156463199|NCT00631475|564792871|FG000|Overall Study|Death|18|||
156463200|NCT00631475|564792871|FG000|Overall Study|Adverse Event|14|||
156463201|NCT00631475|564792871|FG000|Overall Study|Withdrew consent|5|||
156463202|NCT00631475|564792871|FG000|Overall Study|Preparation for lung transplant|8|||
156463203|NCT00303459|564792872|FG000|Overall Study|Death|33|||
156463204|NCT00303459|564792873|FG001|Overall Study|Death|44|||
156463205|NCT00303459|564792872|FG000|Overall Study|Withdrawal of consent|32|||
156463206|NCT00303459|564792873|FG001|Overall Study|Withdrawal of consent|26|||
156463207|NCT00303459|564792872|FG000|Overall Study|Lost to Follow-up|5|||
156463208|NCT00303459|564792873|FG001|Overall Study|Lost to Follow-up|4|||
156463209|NCT00303459|564792872|FG000|Overall Study|Administrative reason|7|||
156463210|NCT00303459|564792873|FG001|Overall Study|Administrative reason|7|||
156463211|NCT00303459|564792872|FG000|Overall Study|Decision by the investigator|5|||
156463212|NCT00303459|564792873|FG001|Overall Study|Decision by the investigator|7|||
156463213|NCT00303459|564792872|FG000|Overall Study|Lung transplantation|1|||
156463214|NCT00303459|564792873|FG001|Overall Study|Lung transplantation|1|||
156463215|NCT02492711|564792876|FG000|Overall Study|Adverse Event|9|||
156463216|NCT02492711|564792877|FG001|Overall Study|Adverse Event|9|||
156463217|NCT02492711|564792878|FG002|Overall Study|Adverse Event|2|||
156463218|NCT02492711|564792876|FG000|Overall Study|Death|3|||
156463219|NCT02492711|564792877|FG001|Overall Study|Death|3|||
156463220|NCT02492711|564792878|FG002|Overall Study|Death|0|||
156463221|NCT02492711|564792876|FG000|Overall Study|Withdrawal by Subject|10|||
156463222|NCT02492711|564792877|FG001|Overall Study|Withdrawal by Subject|16|||
156463223|NCT02492711|564792878|FG002|Overall Study|Withdrawal by Subject|5|||
156463224|NCT02492711|564792876|FG000|Overall Study|Physician Decision|10|||
156463225|NCT02492711|564792877|FG001|Overall Study|Physician Decision|6|||
156463226|NCT02492711|564792878|FG002|Overall Study|Physician Decision|4|||
156463227|NCT02492711|564792876|FG000|Overall Study|Lost to Follow-up|0|||
156463228|NCT02492711|564792877|FG001|Overall Study|Lost to Follow-up|0|||
156463229|NCT02492711|564792878|FG002|Overall Study|Lost to Follow-up|1|||
156463230|NCT02492711|564792876|FG000|Overall Study|study treatment delay|2|||
156463231|NCT02492711|564792877|FG001|Overall Study|study treatment delay|1|||
156463232|NCT02492711|564792878|FG002|Overall Study|study treatment delay|0|||
156338877|NCT01001377|564340064|FG000|Overall Study|Death|391|||
156338878|NCT01001377|564340065|FG001|Overall Study|Death|384|||
156338879|NCT00964860|564340068|FG000|Overall Study|Withdrawal by Subject|0|||
156463233|NCT02492711|564792876|FG000|Overall Study|change in chemotherapy|0|||
156463234|NCT02492711|564792877|FG001|Overall Study|change in chemotherapy|1|||
156463235|NCT02492711|564792878|FG002|Overall Study|change in chemotherapy|0|||
156463236|NCT02492711|564792876|FG000|Overall Study|never treated|2|||
156463237|NCT02492711|564792877|FG001|Overall Study|never treated|4|||
156463238|NCT02492711|564792878|FG002|Overall Study|never treated|0|||
156463239|NCT02492711|564792876|FG000|Overall Study|Other|0|||
156463240|NCT02492711|564792877|FG001|Overall Study|Other|0|||
156463241|NCT02492711|564792878|FG002|Overall Study|Other|1|||
156463242|NCT05830799|564792883|FG000|Overall Study|Withdrawal by Subject|1|||
156811924|NCT00881530|566062596|FG000|Overall Study|Adverse Event|5|||
156811925|NCT00881530|566062597|FG001|Overall Study|Adverse Event|1|||
156811926|NCT00881530|566062598|FG002|Overall Study|Adverse Event|1|||
156811927|NCT00881530|566062599|FG003|Overall Study|Adverse Event|4|||
156811928|NCT00881530|566062600|FG004|Overall Study|Adverse Event|10|||
156811929|NCT00881530|566062601|FG005|Overall Study|Adverse Event|2|||
156811930|NCT00881530|566062596|FG000|Overall Study|Lack of Efficacy|1|||
156811931|NCT00881530|566062597|FG001|Overall Study|Lack of Efficacy|0|||
156811932|NCT00881530|566062598|FG002|Overall Study|Lack of Efficacy|0|||
156811933|NCT00881530|566062599|FG003|Overall Study|Lack of Efficacy|0|||
156811934|NCT00881530|566062600|FG004|Overall Study|Lack of Efficacy|1|||
156811935|NCT00881530|566062601|FG005|Overall Study|Lack of Efficacy|1|||
156811936|NCT00881530|566062596|FG000|Overall Study|Not compliant with the protocol|0|||
156811937|NCT00881530|566062597|FG001|Overall Study|Not compliant with the protocol|0|||
156811938|NCT00881530|566062598|FG002|Overall Study|Not compliant with the protocol|0|||
156811939|NCT00881530|566062599|FG003|Overall Study|Not compliant with the protocol|0|||
156811940|NCT00881530|566062600|FG004|Overall Study|Not compliant with the protocol|2|||
156811941|NCT00881530|566062601|FG005|Overall Study|Not compliant with the protocol|0|||
156811942|NCT00881530|566062596|FG000|Overall Study|Lost to Follow-up|0|||
156811943|NCT00881530|566062597|FG001|Overall Study|Lost to Follow-up|1|||
156811944|NCT00881530|566062598|FG002|Overall Study|Lost to Follow-up|1|||
156811945|NCT00881530|566062599|FG003|Overall Study|Lost to Follow-up|3|||
156538756|NCT03250832|565066355|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
156538757|NCT03250832|565066356|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
156538758|NCT03250832|565066357|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
156538759|NCT03250832|565066358|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
156538760|NCT03250832|565066359|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
156538761|NCT03250832|565066348|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538762|NCT03250832|565066349|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538763|NCT03250832|565066350|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538764|NCT03250832|565066351|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538765|NCT03250832|565066352|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538766|NCT03250832|565066353|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538767|NCT03250832|565066354|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538768|NCT03250832|565066355|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
156538769|NCT03250832|565066356|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538770|NCT03250832|565066357|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538771|NCT03250832|565066358|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156538772|NCT03250832|565066359|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
156338880|NCT00964860|564340069|FG001|Overall Study|Withdrawal by Subject|1|||
156463243|NCT04109066|564792895|FG000|Pre-treatment|Participant withdrew consent|2|||
156463244|NCT04109066|564792896|FG001|Pre-treatment|Participant withdrew consent|0|||
156463245|NCT04109066|564792895|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
156463246|NCT04109066|564792896|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
156463247|NCT04109066|564792895|FG000|Treatment|Lack of Efficacy|2|||
156463248|NCT04109066|564792896|FG001|Treatment|Lack of Efficacy|4|||
156463249|NCT04109066|564792895|FG000|Treatment|Adverse Event|23|||
156463250|NCT04109066|564792896|FG001|Treatment|Adverse Event|7|||
156463251|NCT04109066|564792895|FG000|Treatment|Participant request to discontinue Study treatment|15|||
156463252|NCT04109066|564792896|FG001|Treatment|Participant request to discontinue Study treatment|14|||
156463253|NCT04109066|564792895|FG000|Treatment|Withdrawal by Subject|8|||
156463254|NCT04109066|564792896|FG001|Treatment|Withdrawal by Subject|8|||
156463255|NCT04109066|564792895|FG000|Treatment|Death|3|||
156463256|NCT04109066|564792896|FG001|Treatment|Death|0|||
156463257|NCT04109066|564792895|FG000|Treatment|Participant no longer meets study criteria|2|||
156463258|NCT04109066|564792896|FG001|Treatment|Participant no longer meets study criteria|2|||
156463259|NCT04109066|564792895|FG000|Treatment|Administrative reasons by sponsor|2|||
156463260|NCT04109066|564792896|FG001|Treatment|Administrative reasons by sponsor|3|||
156463261|NCT04109066|564792895|FG000|Treatment|Other reasons|17|||
156463262|NCT04109066|564792896|FG001|Treatment|Other reasons|23|||
156463263|NCT04109066|564792895|FG000|Treatment|Disease Progression|4|||
156463264|NCT04109066|564792896|FG001|Treatment|Disease Progression|7|||
156463265|NCT04109066|564792895|FG000|Treatment|Study drug toxicity|12|||
156463266|NCT04109066|564792896|FG001|Treatment|Study drug toxicity|5|||
156463267|NCT04109066|564792895|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
156463268|NCT04109066|564792896|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
156463269|NCT04109066|564792895|FG000|Treatment|Disease Recurrence|0|||
156463270|NCT04109066|564792896|FG001|Treatment|Disease Recurrence|2|||
156463271|NCT04109066|564792895|FG000|Treatment|Not reported|4|||
156463272|NCT04109066|564792896|FG001|Treatment|Not reported|8|||
156463273|NCT05205161|564792897|FG000|Overall Study|Study terminated by sponsor|3|||
156463274|NCT05205161|564792898|FG001|Overall Study|Study terminated by sponsor|3|||
156463275|NCT05205161|564792899|FG002|Overall Study|Study terminated by sponsor|1|||
156463276|NCT04369911|564792901|FG000|Overall Study|Lost to Follow-up|3|||
156463277|NCT04369911|564792902|FG001|Overall Study|Lost to Follow-up|3|||
156463278|NCT04369911|564792901|FG000|Overall Study|Withdrawal by Subject|1|||
156463279|NCT04369911|564792902|FG001|Overall Study|Withdrawal by Subject|2|||
156463280|NCT04163991|564792905|FG000|Overall Study|Adverse Event|0|||
156463281|NCT04163991|564792906|FG001|Overall Study|Adverse Event|0|||
156463282|NCT04163991|564792907|FG002|Overall Study|Adverse Event|0|||
156463283|NCT04163991|564792908|FG003|Overall Study|Adverse Event|1|||
156463284|NCT04163991|564792909|FG004|Overall Study|Adverse Event|0|||
156463285|NCT04163991|564792905|FG000|Overall Study|Death|0|||
156463286|NCT04163991|564792906|FG001|Overall Study|Death|0|||
156538773|NCT03250832|565066348|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156338881|NCT03727230|564340070|FG000|Overall Study|Lost to Follow-up|12|||
156463287|NCT04163991|564792907|FG002|Overall Study|Death|1|||
156463288|NCT04163991|564792908|FG003|Overall Study|Death|0|||
156463289|NCT04163991|564792909|FG004|Overall Study|Death|0|||
156463290|NCT04163991|564792905|FG000|Overall Study|Lost to Follow-up|0|||
156463291|NCT04163991|564792906|FG001|Overall Study|Lost to Follow-up|1|||
156463292|NCT04163991|564792907|FG002|Overall Study|Lost to Follow-up|0|||
156463293|NCT04163991|564792908|FG003|Overall Study|Lost to Follow-up|0|||
156538774|NCT03250832|565066349|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538775|NCT03250832|565066350|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538776|NCT03250832|565066351|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538777|NCT03250832|565066352|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538778|NCT03250832|565066353|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538779|NCT03250832|565066354|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538780|NCT03250832|565066355|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
156538781|NCT03250832|565066356|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538782|NCT03250832|565066357|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538783|NCT03250832|565066358|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538784|NCT03250832|565066359|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
156538785|NCT03250832|565066348|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538786|NCT03250832|565066349|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538787|NCT03250832|565066350|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538788|NCT03250832|565066351|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538789|NCT03250832|565066352|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538790|NCT03250832|565066353|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538791|NCT03250832|565066354|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538792|NCT03250832|565066355|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
156538793|NCT03250832|565066356|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538794|NCT03250832|565066357|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538795|NCT03250832|565066358|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538796|NCT03250832|565066359|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
156538797|NCT03250832|565066348|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538798|NCT03250832|565066349|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538799|NCT03250832|565066350|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538800|NCT03250832|565066351|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538801|NCT03250832|565066352|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538802|NCT03250832|565066353|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538803|NCT03250832|565066354|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538804|NCT03250832|565066355|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
156538805|NCT03250832|565066356|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538806|NCT03250832|565066357|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538807|NCT03250832|565066358|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538808|NCT03250832|565066359|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
156538809|NCT03250832|565066348|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538810|NCT03250832|565066349|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538811|NCT03250832|565066350|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538812|NCT03250832|565066351|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538813|NCT03250832|565066352|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538814|NCT03250832|565066353|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538815|NCT03250832|565066354|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538816|NCT03250832|565066355|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538817|NCT03250832|565066356|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
156538818|NCT03250832|565066357|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
156538819|NCT03250832|565066358|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538820|NCT03250832|565066359|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
156538821|NCT03250832|565066348|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538822|NCT03250832|565066349|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538823|NCT03250832|565066350|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538824|NCT03250832|565066351|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156463294|NCT04163991|564792909|FG004|Overall Study|Lost to Follow-up|0|||
156463295|NCT04163991|564792905|FG000|Overall Study|Withdrawal by Subject|1|||
156463296|NCT04163991|564792906|FG001|Overall Study|Withdrawal by Subject|1|||
156463297|NCT04163991|564792907|FG002|Overall Study|Withdrawal by Subject|3|||
156463298|NCT04163991|564792908|FG003|Overall Study|Withdrawal by Subject|1|||
156463299|NCT04163991|564792909|FG004|Overall Study|Withdrawal by Subject|1|||
156463300|NCT04163991|564792905|FG000|Overall Study|Other, Not Specified|0|||
156463301|NCT04163991|564792906|FG001|Overall Study|Other, Not Specified|1|||
156463302|NCT04163991|564792907|FG002|Overall Study|Other, Not Specified|1|||
156463303|NCT04163991|564792908|FG003|Overall Study|Other, Not Specified|1|||
156463304|NCT04163991|564792909|FG004|Overall Study|Other, Not Specified|0|||
156463305|NCT02510235|564792911|FG000|Overall Study|Withdrawal by Subject|1|||
156463306|NCT02510235|564792912|FG001|Overall Study|Withdrawal by Subject|0|||
156463307|NCT00450216|564792913|FG000|Overall Study|Adverse Event|38|||
156463308|NCT00450216|564792914|FG001|Overall Study|Adverse Event|23|||
156463309|NCT00450216|564792913|FG000|Overall Study|Withdrawal by Subject|48|||
156463310|NCT00450216|564792914|FG001|Overall Study|Withdrawal by Subject|26|||
156463311|NCT00450216|564792913|FG000|Overall Study|Lost to Follow-up|16|||
156463312|NCT00450216|564792914|FG001|Overall Study|Lost to Follow-up|9|||
156463313|NCT00450216|564792913|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
156463314|NCT00450216|564792914|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
156463315|NCT00450216|564792913|FG000|Overall Study|misc|21|||
156463316|NCT00450216|564792914|FG001|Overall Study|misc|20|||
156463317|NCT03011034|564792922|FG000|Overall Study|Adverse Event|1|||
156463318|NCT03011034|564792923|FG001|Overall Study|Adverse Event|0|||
156463319|NCT01475786|564792928|FG000|Overall Study|Adverse Event|0|||
156463320|NCT01475786|564792929|FG001|Overall Study|Adverse Event|1|||
156463321|NCT01475786|564792930|FG002|Overall Study|Adverse Event|0|||
156463322|NCT01475786|564792928|FG000|Overall Study|Lost to Follow-up|1|||
156463323|NCT01475786|564792929|FG001|Overall Study|Lost to Follow-up|2|||
156463324|NCT01475786|564792930|FG002|Overall Study|Lost to Follow-up|1|||
156463325|NCT01475786|564792928|FG000|Overall Study|Withdrawal by Subject|0|||
156463326|NCT01475786|564792929|FG001|Overall Study|Withdrawal by Subject|1|||
156463327|NCT01475786|564792930|FG002|Overall Study|Withdrawal by Subject|1|||
156463328|NCT01475786|564792928|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
156463329|NCT01475786|564792929|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
156463330|NCT01475786|564792930|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
156463331|NCT02461134|564792932|FG000|Overall Study|Adverse Event|1|||
156463332|NCT03165955|564792933|FG000|Treatment|Withdrawal by Subject|3|||
156463333|NCT03165955|564792933|FG000|Treatment|Death|1|||
156463334|NCT03165955|564792933|FG000|Treatment|Adverse Event|1|||
156463335|NCT03165955|564792933|FG000|Treatment|Progressive disease|3|||
156463336|NCT00626795|564792934|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
156463337|NCT00626795|564792935|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
156463338|NCT00626795|564792936|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
156463339|NCT00626795|564792934|FG000|Blinded Treatment|Lack of Efficacy|2|||
156463340|NCT00626795|564792935|FG001|Blinded Treatment|Lack of Efficacy|0|||
156463341|NCT00626795|564792936|FG002|Blinded Treatment|Lack of Efficacy|0|||
156463342|NCT00626795|564792934|FG000|Blinded Treatment|Unacceptable adverse event|0|||
156463343|NCT00626795|564792935|FG001|Blinded Treatment|Unacceptable adverse event|0|||
156463344|NCT00626795|564792936|FG002|Blinded Treatment|Unacceptable adverse event|1|||
156463345|NCT00626795|564792934|FG000|Blinded Treatment|Protocol Violation|0|||
156463346|NCT00626795|564792935|FG001|Blinded Treatment|Protocol Violation|1|||
156463347|NCT00626795|564792936|FG002|Blinded Treatment|Protocol Violation|1|||
156463348|NCT00626795|564792934|FG000|Blinded Treatment|Withdrawal by Subject|1|||
156463349|NCT00626795|564792935|FG001|Blinded Treatment|Withdrawal by Subject|1|||
156463350|NCT00626795|564792936|FG002|Blinded Treatment|Withdrawal by Subject|0|||
156463351|NCT00626795|564792934|FG000|Blinded Treatment|Other reasons|2|||
156463352|NCT00626795|564792935|FG001|Blinded Treatment|Other reasons|0|||
156463353|NCT00626795|564792936|FG002|Blinded Treatment|Other reasons|2|||
156463354|NCT00626795|564792934|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
156463355|NCT00626795|564792935|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
156463356|NCT00626795|564792936|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
156463357|NCT03493542|564792937|FG000|Base Study|Withdrawal by Subject|0|||
156463358|NCT03493542|564792938|FG001|Base Study|Withdrawal by Subject|4|||
156463359|NCT03493542|564792939|FG002|Base Study|Withdrawal by Subject|0|||
156463360|NCT03493542|564792937|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
156463361|NCT03493542|564792938|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
156463362|NCT03493542|564792939|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
156463363|NCT03493542|564792937|FG000|Extension Study|Withdrawal by Subject|0|||
156463364|NCT03493542|564792938|FG001|Extension Study|Withdrawal by Subject|0|||
156463365|NCT03493542|564792939|FG002|Extension Study|Withdrawal by Subject|25|||
156463366|NCT04499521|564792940|FG000|Overall Study|Disease Progression|1|||
156463367|NCT04499521|564792941|FG001|Overall Study|Disease Progression|0|||
156463368|NCT04244175|564793705|FG000|Overall Study|Adverse Event|3|||
156463369|NCT04244175|564793706|FG001|Overall Study|Adverse Event|2|||
156463370|NCT04244175|564793707|FG002|Overall Study|Adverse Event|5|||
156463371|NCT04244175|564793705|FG000|Overall Study|Lack of Efficacy|1|||
156463372|NCT04244175|564793706|FG001|Overall Study|Lack of Efficacy|0|||
156463373|NCT04244175|564793707|FG002|Overall Study|Lack of Efficacy|1|||
156463374|NCT04244175|564793705|FG000|Overall Study|Lost to Follow-up|1|||
156463375|NCT04244175|564793706|FG001|Overall Study|Lost to Follow-up|0|||
156463376|NCT04244175|564793707|FG002|Overall Study|Lost to Follow-up|0|||
156463377|NCT04244175|564793705|FG000|Overall Study|Non-compliance with study drug|1|||
156463378|NCT04244175|564793706|FG001|Overall Study|Non-compliance with study drug|0|||
156463379|NCT04244175|564793707|FG002|Overall Study|Non-compliance with study drug|1|||
156463380|NCT04244175|564793705|FG000|Overall Study|Protocol deviation|0|||
156463381|NCT04244175|564793706|FG001|Overall Study|Protocol deviation|1|||
156463382|NCT04244175|564793707|FG002|Overall Study|Protocol deviation|0|||
156463383|NCT04244175|564793705|FG000|Overall Study|Withdrawal by Subject|1|||
156463384|NCT04244175|564793706|FG001|Overall Study|Withdrawal by Subject|3|||
156463385|NCT04244175|564793707|FG002|Overall Study|Withdrawal by Subject|1|||
156538825|NCT03250832|565066352|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538826|NCT03250832|565066353|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538827|NCT03250832|565066354|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538828|NCT03250832|565066355|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538829|NCT03250832|565066356|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
156538830|NCT03250832|565066357|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
156538831|NCT03250832|565066358|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538832|NCT03250832|565066359|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
156538833|NCT03250832|565066348|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538834|NCT03250832|565066349|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538835|NCT03250832|565066350|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538836|NCT03250832|565066351|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538837|NCT03250832|565066352|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538838|NCT03250832|565066353|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538839|NCT03250832|565066354|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538840|NCT03250832|565066355|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538841|NCT03250832|565066356|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
156538842|NCT03250832|565066357|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
156538843|NCT03250832|565066358|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538844|NCT03250832|565066359|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
156538845|NCT03250832|565066348|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538846|NCT03250832|565066349|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538847|NCT03250832|565066350|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538848|NCT03250832|565066351|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538849|NCT03250832|565066352|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538850|NCT03250832|565066353|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538851|NCT03250832|565066354|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538852|NCT03250832|565066355|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538853|NCT03250832|565066356|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156538854|NCT03250832|565066357|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156811946|NCT00881530|566062600|FG004|Overall Study|Lost to Follow-up|1|||
156811947|NCT00881530|566062601|FG005|Overall Study|Lost to Follow-up|0|||
156811948|NCT00881530|566062596|FG000|Overall Study|Refused to continue medication|7|||
156811949|NCT00881530|566062597|FG001|Overall Study|Refused to continue medication|2|||
156811950|NCT00881530|566062598|FG002|Overall Study|Refused to continue medication|1|||
156811951|NCT00881530|566062599|FG003|Overall Study|Refused to continue medication|2|||
156811952|NCT00881530|566062600|FG004|Overall Study|Refused to continue medication|0|||
156811953|NCT00881530|566062601|FG005|Overall Study|Refused to continue medication|0|||
156811954|NCT00881530|566062596|FG000|Overall Study|Other reason not defined above|1|||
156811955|NCT00881530|566062597|FG001|Overall Study|Other reason not defined above|1|||
156811956|NCT00881530|566062598|FG002|Overall Study|Other reason not defined above|2|||
156811957|NCT00881530|566062599|FG003|Overall Study|Other reason not defined above|0|||
156811958|NCT00881530|566062600|FG004|Overall Study|Other reason not defined above|0|||
156811959|NCT00881530|566062601|FG005|Overall Study|Other reason not defined above|2|||
156811960|NCT03900728|566062602|FG000|Overall Study|No text responses|0|||
156811961|NCT03900728|566062603|FG001|Overall Study|No text responses|0|||
156811962|NCT03900728|566062604|FG002|Overall Study|No text responses|4|||
156811963|NCT04585269|566062610|FG000|Intervention|Withdrawal by Subject|9|||
156811964|NCT04585269|566062611|FG001|Intervention|Withdrawal by Subject|0|||
156811965|NCT04585269|566062610|FG000|Intervention|Unable to schedule|15|||
156811966|NCT04585269|566062611|FG001|Intervention|Unable to schedule|0|||
156811967|NCT04585269|566062610|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
156811968|NCT04585269|566062611|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
156811969|NCT04585269|566062610|FG000|FU Time 2 (3 months)|Death|2|||
156811970|NCT04585269|566062611|FG001|FU Time 2 (3 months)|Death|2|||
156811971|NCT04585269|566062610|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
156811972|NCT04585269|566062611|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
156811973|NCT04585269|566062610|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
156811974|NCT04585269|566062611|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
156811975|NCT04585269|566062610|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
156811976|NCT04585269|566062611|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
156811977|NCT04585269|566062610|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
156811978|NCT04585269|566062611|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
156811979|NCT04585269|566062610|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
156811980|NCT04585269|566062611|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
156811981|NCT03307785|566062616|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
156338882|NCT00288054|564340071|FG000|Overall Study|Protocol Violation|2|||
156338883|NCT00288054|564340071|FG000|Overall Study|Lack of Efficacy|16|||
156463386|NCT04244175|564793705|FG000|Overall Study|Other, not specified|0|||
156463387|NCT04244175|564793706|FG001|Overall Study|Other, not specified|1|||
156463388|NCT04244175|564793707|FG002|Overall Study|Other, not specified|2|||
156463389|NCT03417284|564793708|FG000|Overall Study|Inadequate supply on study drug|1|||
156463390|NCT03417284|564793709|FG001|Overall Study|Inadequate supply on study drug|0|||
156463391|NCT03417284|564793710|FG002|Overall Study|Inadequate supply on study drug|0|||
156463392|NCT03417284|564793711|FG003|Overall Study|Inadequate supply on study drug|0|||
156463393|NCT03417284|564793708|FG000|Overall Study|Disease Progression|0|||
156463394|NCT03417284|564793709|FG001|Overall Study|Disease Progression|0|||
156463395|NCT03417284|564793710|FG002|Overall Study|Disease Progression|1|||
156463396|NCT03417284|564793711|FG003|Overall Study|Disease Progression|0|||
156463397|NCT03636490|564793712|FG000|Overall Study|Dropped out or incomplete data|141|||
156463398|NCT02278211|564793715|FG000|Overall Study|Unable to analyse PET scan|2|||
156463399|NCT06037668|564793718|FG000|Overall Study|Lost to Follow-up|1|||
156463400|NCT06037668|564793719|FG001|Overall Study|Lost to Follow-up|1|||
156463401|NCT06037668|564793718|FG000|Overall Study|Protocol Violation|1|||
156463402|NCT06037668|564793719|FG001|Overall Study|Protocol Violation|0|||
156463403|NCT06037668|564793718|FG000|Overall Study|Withdrawal by Subject|1|||
156463404|NCT06037668|564793719|FG001|Overall Study|Withdrawal by Subject|0|||
156463405|NCT06037668|564793718|FG000|Overall Study|Other Study Discontinuation Reason|1|||
156463406|NCT06037668|564793719|FG001|Overall Study|Other Study Discontinuation Reason|0|||
156463407|NCT04804540|564793720|FG000|Overall Study|Adverse Event|26|||
156463408|NCT04804540|564793721|FG001|Overall Study|Adverse Event|13|||
156463409|NCT05172232|564793722|FG000|Overall Study|Lost to Follow-up|3|||
156463410|NCT04881461|564793723|FG000|Overall Study|Adverse Event|2|||
156463411|NCT04881461|564793724|FG001|Overall Study|Adverse Event|4|||
156463412|NCT04881461|564793723|FG000|Overall Study|Withdrawal by Subject|19|||
156463413|NCT04881461|564793724|FG001|Overall Study|Withdrawal by Subject|19|||
156463414|NCT04881461|564793723|FG000|Overall Study|Lost to Follow-up|4|||
156463415|NCT04881461|564793724|FG001|Overall Study|Lost to Follow-up|4|||
156463416|NCT04881461|564793723|FG000|Overall Study|Lack of Efficacy|1|||
156463417|NCT04881461|564793724|FG001|Overall Study|Lack of Efficacy|0|||
156463418|NCT04881461|564793723|FG000|Overall Study|"Reason stated as other in CRF"|1|||
156463419|NCT04881461|564793724|FG001|Overall Study|"Reason stated as other in CRF"|2|||
156811982|NCT03307785|566062617|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811983|NCT03307785|566062618|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811984|NCT03307785|566062619|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811985|NCT03307785|566062620|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811986|NCT03307785|566062621|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811987|NCT03307785|566062622|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811988|NCT03307785|566062623|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811989|NCT03307785|566062624|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811990|NCT03307785|566062625|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811991|NCT03307785|566062626|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811992|NCT03307785|566062627|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811993|NCT03307785|566062628|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811994|NCT03307785|566062616|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
156811995|NCT03307785|566062617|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
156811996|NCT03307785|566062618|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156811997|NCT03307785|566062619|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156811998|NCT03307785|566062620|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156811999|NCT03307785|566062621|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812000|NCT03307785|566062622|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812001|NCT03307785|566062623|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812002|NCT03307785|566062624|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812003|NCT03307785|566062625|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812004|NCT03307785|566062626|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812005|NCT03307785|566062627|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812006|NCT03307785|566062628|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812007|NCT03307785|566062616|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
156812008|NCT03307785|566062617|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
156812009|NCT03307785|566062618|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812010|NCT03307785|566062619|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812011|NCT03307785|566062620|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812012|NCT03307785|566062621|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
156463420|NCT02997202|564793725|FG000|Overall Study|Miscellaneous|2|||
156338884|NCT00288054|564340071|FG000|Overall Study|Adverse Event|3|||
156338885|NCT00288054|564340071|FG000|Overall Study|Withdrawal by Subject|1|||
156338886|NCT00288054|564340071|FG000|Overall Study|Not protocol specified|2|||
156338887|NCT01849783|564340082|FG000|Overall Study|Adverse Event|5|||
156338888|NCT01849783|564340082|FG000|Overall Study|Death|2|||
156338889|NCT01849783|564340082|FG000|Overall Study|Physician Decision|1|||
156338890|NCT01849783|564340082|FG000|Overall Study|Withdrawal by Subject|1|||
156338891|NCT01849783|564340082|FG000|Overall Study|Unable to comply|2|||
156338892|NCT01849783|564340082|FG000|Overall Study|Disease progression|11|||
156338893|NCT03173313|564340083|FG000|Overall Study|Lost to Follow-up|2|||
156338894|NCT03173313|564340084|FG001|Overall Study|Lost to Follow-up|3|||
156538855|NCT03250832|565066358|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156812013|NCT03307785|566062622|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812014|NCT03307785|566062623|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812015|NCT03307785|566062624|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812016|NCT03307785|566062625|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812017|NCT03307785|566062626|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812018|NCT03307785|566062627|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812019|NCT03307785|566062628|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812020|NCT03307785|566062616|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
156338895|NCT03173313|564340083|FG000|Overall Study|Withdrawal by Subject|0|||
156338896|NCT03173313|564340084|FG001|Overall Study|Withdrawal by Subject|1|||
156338897|NCT03173313|564340083|FG000|Overall Study|Death|5|||
156338898|NCT03173313|564340084|FG001|Overall Study|Death|0|||
156338899|NCT03173313|564340083|FG000|Overall Study|Physician Decision|1|||
156338900|NCT03173313|564340084|FG001|Overall Study|Physician Decision|0|||
156338901|NCT03173313|564340083|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
156338902|NCT03173313|564340084|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
156338903|NCT03173313|564340083|FG000|Overall Study|Bone Fracture|1|||
156338904|NCT03173313|564340084|FG001|Overall Study|Bone Fracture|0|||
156338905|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
156338906|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
156338907|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
156338908|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
156338909|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
156338910|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
156338911|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
156338912|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
156338913|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
156338914|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
156338915|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
156338916|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
156338917|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
156338918|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
156338919|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
156338920|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
156338921|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
156338922|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
156338923|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
156338924|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
156338925|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
156338926|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
156338927|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
156338928|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
156338929|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
156338930|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
156338931|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
156338932|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
156338933|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
156338934|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
156338935|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
156338936|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
156338937|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
156463421|NCT02997202|564793726|FG001|Overall Study|Miscellaneous|2|||
156463422|NCT02997202|564793725|FG000|Overall Study|Withdrawal by Subject|8|||
156463423|NCT02997202|564793726|FG001|Overall Study|Withdrawal by Subject|12|||
156463424|NCT02997202|564793725|FG000|Overall Study|Lost to Follow-up|5|||
156463425|NCT02997202|564793726|FG001|Overall Study|Lost to Follow-up|3|||
156463426|NCT02997202|564793725|FG000|Overall Study|Death|41|||
156463427|NCT02997202|564793726|FG001|Overall Study|Death|45|||
156463428|NCT04629339|564793730|FG000|Overall Study|Death|1|||
156463429|NCT04629339|564793731|FG001|Overall Study|Death|0|||
156463430|NCT04629339|564793732|FG002|Overall Study|Death|2|||
156463431|NCT04629339|564793733|FG003|Overall Study|Death|2|||
156463432|NCT04629339|564793734|FG004|Overall Study|Death|0|||
156463433|NCT04629339|564793730|FG000|Overall Study|Disease Progression|0|||
156463434|NCT04629339|564793731|FG001|Overall Study|Disease Progression|0|||
156463435|NCT04629339|564793732|FG002|Overall Study|Disease Progression|1|||
156463436|NCT04629339|564793733|FG003|Overall Study|Disease Progression|1|||
156463437|NCT04629339|564793734|FG004|Overall Study|Disease Progression|0|||
156463438|NCT04629339|564793730|FG000|Overall Study|Lost to Follow-up|0|||
156463439|NCT04629339|564793731|FG001|Overall Study|Lost to Follow-up|0|||
156463440|NCT04629339|564793732|FG002|Overall Study|Lost to Follow-up|0|||
156463441|NCT04629339|564793733|FG003|Overall Study|Lost to Follow-up|1|||
156463442|NCT04629339|564793734|FG004|Overall Study|Lost to Follow-up|0|||
156463443|NCT04629339|564793730|FG000|Overall Study|Physician Decision|0|||
156463444|NCT04629339|564793731|FG001|Overall Study|Physician Decision|1|||
156463445|NCT04629339|564793732|FG002|Overall Study|Physician Decision|0|||
156463446|NCT04629339|564793733|FG003|Overall Study|Physician Decision|0|||
156463447|NCT04629339|564793734|FG004|Overall Study|Physician Decision|0|||
156463448|NCT04629339|564793730|FG000|Overall Study|Study Terminated by Sponsor|0|||
156463449|NCT04629339|564793731|FG001|Overall Study|Study Terminated by Sponsor|0|||
156463450|NCT04629339|564793732|FG002|Overall Study|Study Terminated by Sponsor|0|||
156463451|NCT04629339|564793733|FG003|Overall Study|Study Terminated by Sponsor|1|||
156463452|NCT04629339|564793734|FG004|Overall Study|Study Terminated by Sponsor|0|||
156463453|NCT04629339|564793730|FG000|Overall Study|Withdrawal by Subject|0|||
156463454|NCT04629339|564793731|FG001|Overall Study|Withdrawal by Subject|0|||
156463455|NCT04629339|564793732|FG002|Overall Study|Withdrawal by Subject|2|||
156463456|NCT04629339|564793733|FG003|Overall Study|Withdrawal by Subject|2|||
156463457|NCT04629339|564793734|FG004|Overall Study|Withdrawal by Subject|0|||
156463458|NCT04158739|564793735|FG000|Overall Study|Adverse Event|1|||
156463459|NCT04158739|564793736|FG001|Overall Study|Adverse Event|0|||
156463460|NCT04158739|564793735|FG000|Overall Study|Death|0|||
156463461|NCT04158739|564793736|FG001|Overall Study|Death|1|||
156463462|NCT04158739|564793735|FG000|Overall Study|Lack of Efficacy|3|||
156463463|NCT04158739|564793736|FG001|Overall Study|Lack of Efficacy|7|||
156463464|NCT04158739|564793735|FG000|Overall Study|Physician Decision|0|||
156463465|NCT04158739|564793736|FG001|Overall Study|Physician Decision|1|||
156463466|NCT04158739|564793735|FG000|Overall Study|Withdrawal by Subject|3|||
156463467|NCT04158739|564793736|FG001|Overall Study|Withdrawal by Subject|0|||
156463468|NCT04055012|564793743|FG000|Overall Study|Withdrawal by Subject|1|||
156463469|NCT04055012|564793744|FG001|Overall Study|Withdrawal by Subject|3|||
156463470|NCT04055012|564793745|FG002|Overall Study|Withdrawal by Subject|1|||
156463471|NCT04055012|564793746|FG003|Overall Study|Withdrawal by Subject|0|||
156463472|NCT04055012|564793743|FG000|Overall Study|Metformin Recall|1|||
156463473|NCT04055012|564793744|FG001|Overall Study|Metformin Recall|1|||
156463474|NCT04055012|564793745|FG002|Overall Study|Metformin Recall|1|||
156463475|NCT04055012|564793746|FG003|Overall Study|Metformin Recall|0|||
156463476|NCT04173247|564793747|FG000|Overall Study|Withdrawal by Subject|0|||
156463477|NCT04173247|564793748|FG001|Overall Study|Withdrawal by Subject|2|||
156463478|NCT04173247|564793747|FG000|Overall Study|Death|1|||
156463479|NCT04173247|564793748|FG001|Overall Study|Death|0|||
156463480|NCT04173247|564793747|FG000|Overall Study|Physician Decision|1|||
156463481|NCT04173247|564793748|FG001|Overall Study|Physician Decision|0|||
156463482|NCT03744676|564793749|FG000|Pre-Treatment Phase|Disease related complications|2|||
156463483|NCT03744676|564793749|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
156463484|NCT03744676|564793749|FG000|Pre-Treatment Phase|Death|7|||
156463485|NCT03744676|564793749|FG000|Pre-Treatment Phase|Other Reasons|7|||
156463486|NCT03744676|564793749|FG000|Treatment Phase|Participant withdrew consent|8|||
156463487|NCT03744676|564793749|FG000|Treatment Phase|Death|33|||
156463488|NCT03744676|564793749|FG000|Treatment Phase|other reasons|6|||
156463489|NCT05008055|564793752|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
156463490|NCT05008055|564793753|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
156463491|NCT05008055|564793754|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
156463492|NCT03418740|564793760|FG000|Overall Study|Lost to Follow-up|13|||
156463493|NCT03418740|564793760|FG000|Overall Study|Scheduling Issues|7|||
156463494|NCT03418740|564793760|FG000|Overall Study|Withdrawal by Subject|2|||
156463495|NCT03418740|564793760|FG000|Overall Study|Unable to Continue Consent|1|||
156463496|NCT04678856|564793769|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
156463497|NCT04678856|564793770|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
156463498|NCT04678856|564793769|FG000|Overall Study|Withdrawal by Subject|5|||
156463499|NCT04678856|564793770|FG001|Overall Study|Withdrawal by Subject|1|||
156463500|NCT01828021|564794190|FG000|Overall Study|Adverse Event|5|||
156463501|NCT01828021|564794190|FG000|Overall Study|Lack of Efficacy|17|||
156463502|NCT01828021|564794190|FG000|Overall Study|Withdrawal by Subject|2|||
156463503|NCT01828021|564794190|FG000|Overall Study|Ileal obstruction, unrelated|1|||
156463504|NCT02163694|564794200|FG000|Overall Study|Adverse event- related to progression|4|||
156463505|NCT02163694|564794201|FG001|Overall Study|Adverse event- related to progression|10|||
156463506|NCT02163694|564794200|FG000|Overall Study|Adverse event- not related to progression|7|||
156463507|NCT02163694|564794201|FG001|Overall Study|Adverse event- not related to progression|22|||
156463508|NCT02163694|564794200|FG000|Overall Study|Withdrew consent|13|||
156463509|NCT02163694|564794201|FG001|Overall Study|Withdrew consent|28|||
156463510|NCT02163694|564794200|FG000|Overall Study|Lost to Follow-up|2|||
156463511|NCT02163694|564794201|FG001|Overall Study|Lost to Follow-up|2|||
156463512|NCT02163694|564794200|FG000|Overall Study|Sponsor discontinued study|3|||
156463513|NCT02163694|564794201|FG001|Overall Study|Sponsor discontinued study|29|||
156463514|NCT02163694|564794200|FG000|Overall Study|Progressive disease per protocol|125|||
156463515|NCT02163694|564794201|FG001|Overall Study|Progressive disease per protocol|224|||
156463516|NCT02163694|564794200|FG000|Overall Study|Other, not specified|17|||
156463517|NCT02163694|564794201|FG001|Overall Study|Other, not specified|22|||
156463518|NCT02163694|564794200|FG000|Overall Study|Randomized but Not Treated|1|||
156463519|NCT02163694|564794201|FG001|Overall Study|Randomized but Not Treated|0|||
156463520|NCT02163694|564794200|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
156463521|NCT02163694|564794201|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
156463522|NCT04967599|564794208|FG000|Overall Study|Lost to Follow-up|35|||
156463523|NCT04967599|564794209|FG001|Overall Study|Lost to Follow-up|19|||
156463524|NCT04967599|564794210|FG002|Overall Study|Lost to Follow-up|23|||
156463525|NCT03817983|564794211|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
156463526|NCT03817983|564794212|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
156463527|NCT03817983|564794213|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
156463528|NCT05541484|564794214|FG000|Overall Study|Withdrawal by Subject|1|||
156463529|NCT05541484|564794215|FG001|Overall Study|Withdrawal by Subject|0|||
156463530|NCT01438853|564794216|FG000|Overall Study|Death|0|||
156463531|NCT01438853|564794217|FG001|Overall Study|Death|0|||
156463532|NCT01438853|564794218|FG002|Overall Study|Death|0|||
156463533|NCT01438853|564794219|FG003|Overall Study|Death|1|||
156463534|NCT01438853|564794216|FG000|Overall Study|Withdrawal by Subject|0|||
156463535|NCT01438853|564794217|FG001|Overall Study|Withdrawal by Subject|0|||
156463536|NCT01438853|564794218|FG002|Overall Study|Withdrawal by Subject|1|||
156463537|NCT01438853|564794219|FG003|Overall Study|Withdrawal by Subject|0|||
156463538|NCT02919917|564794220|FG000|Overall Study|Withdrawal by Subject|4|||
156463539|NCT02919917|564794221|FG001|Overall Study|Withdrawal by Subject|8|||
156463540|NCT04743973|564794225|FG000|Overall Study|Withdrawal by Subject|5|||
156463541|NCT04159519|564794226|FG000|Overall Study|Adverse Event|1|||
156463542|NCT04159519|564794227|FG001|Overall Study|Adverse Event|1|||
156463543|NCT04159519|564794226|FG000|Overall Study|Lack of Efficacy|1|||
156538856|NCT03250832|565066359|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
156463544|NCT04159519|564794227|FG001|Overall Study|Lack of Efficacy|0|||
156463545|NCT04159519|564794226|FG000|Overall Study|Discontinued from study|1|||
156463546|NCT04159519|564794227|FG001|Overall Study|Discontinued from study|0|||
156463547|NCT04159519|564794226|FG000|Overall Study|Protocol Violation|1|||
156463548|NCT04159519|564794227|FG001|Overall Study|Protocol Violation|1|||
156463549|NCT04159519|564794226|FG000|Overall Study|Withdrawal by Subject|4|||
156463550|NCT04159519|564794227|FG001|Overall Study|Withdrawal by Subject|4|||
156463551|NCT04780581|564794231|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
156463552|NCT04780581|564794232|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
156463553|NCT04780581|564794231|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
156463554|NCT04780581|564794232|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
156463555|NCT01756300|564794233|FG000|Overall Study|Death|1|||
156463556|NCT01756300|564794233|FG000|Overall Study|Withdrawal by Subject|1|||
156463557|NCT04595331|564794759|FG000|Overall Study|Withdrawal by Subject|0|||
156463558|NCT04595331|564794760|FG001|Overall Study|Withdrawal by Subject|1|||
156463559|NCT04595331|564794759|FG000|Overall Study|Lost to Follow-up|0|||
156463560|NCT04595331|564794760|FG001|Overall Study|Lost to Follow-up|5|||
156463561|NCT04595331|564794759|FG000|Overall Study|Medical reason|0|||
156463562|NCT04595331|564794760|FG001|Overall Study|Medical reason|1|||
156463563|NCT02246127|564794761|FG000|First Course Treatment|Adverse Event|9|||
156463564|NCT02246127|564794762|FG001|First Course Treatment|Adverse Event|7|||
156463565|NCT02246127|564794761|FG000|First Course Treatment|Withdrawal by Subject|6|||
156463566|NCT02246127|564794762|FG001|First Course Treatment|Withdrawal by Subject|7|||
156463567|NCT02246127|564794761|FG000|First Course Treatment|Physician Decision|9|||
156463568|NCT02246127|564794762|FG001|First Course Treatment|Physician Decision|9|||
156463569|NCT02246127|564794761|FG000|First Course Treatment|Death|3|||
156463570|NCT02246127|564794762|FG001|First Course Treatment|Death|3|||
156463571|NCT02246127|564794761|FG000|First Course Treatment|Not reported reasons|6|||
156463572|NCT02246127|564794762|FG001|First Course Treatment|Not reported reasons|7|||
156463573|NCT02246127|564794761|FG000|First Course Treatment|Not treated|3|||
156463574|NCT02246127|564794762|FG001|First Course Treatment|Not treated|3|||
156463575|NCT03635567|564794763|FG000|Overall Study|Lost to Follow-up|4|||
156463576|NCT03635567|564794764|FG001|Overall Study|Lost to Follow-up|1|||
156463577|NCT03635567|564794763|FG000|Overall Study|Withdrawal by Subject|11|||
156463578|NCT03635567|564794764|FG001|Overall Study|Withdrawal by Subject|16|||
156463579|NCT03635567|564794763|FG000|Overall Study|Sponsor Decision|99|||
156463580|NCT03635567|564794764|FG001|Overall Study|Sponsor Decision|57|||
156812021|NCT03307785|566062617|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
156812022|NCT03307785|566062618|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812023|NCT03307785|566062619|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812024|NCT03307785|566062620|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812025|NCT03307785|566062621|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812026|NCT03307785|566062622|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812027|NCT03307785|566062623|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812028|NCT03307785|566062624|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812029|NCT03307785|566062625|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812030|NCT03307785|566062626|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812031|NCT03307785|566062627|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812032|NCT03307785|566062628|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812033|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812034|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812035|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
156812036|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812037|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812038|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812039|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812040|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812041|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812042|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812043|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812044|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812045|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812046|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812047|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812048|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
156812049|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812050|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812051|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
156463581|NCT03635567|564794763|FG000|Overall Study|Death|194|||
156538857|NCT01536951|565066362|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
156538858|NCT01536951|565066363|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
156538859|NCT01536951|565066364|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
156538860|NCT01536951|565066365|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
156538861|NCT01536951|565066366|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
156538862|NCT01536951|565066367|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
156538863|NCT01536951|565066368|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
156538864|NCT01536951|565066369|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
156538865|NCT01536951|565066370|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
156538866|NCT01536951|565066362|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
156538867|NCT01536951|565066363|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
156538868|NCT01536951|565066364|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
156538869|NCT01536951|565066365|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
156538870|NCT01536951|565066366|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
156538871|NCT01536951|565066367|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
156538872|NCT01536951|565066368|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
156538873|NCT01536951|565066369|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
156538874|NCT01536951|565066370|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
156538875|NCT01843972|565066371|FG000|Overall Study|Withdrawal by Subject|0|||
156538876|NCT01843972|565066372|FG001|Overall Study|Withdrawal by Subject|0|||
156538877|NCT01843972|565066373|FG002|Overall Study|Withdrawal by Subject|0|||
156538878|NCT01843972|565066374|FG003|Overall Study|Withdrawal by Subject|0|||
156538879|NCT01843972|565066375|FG004|Overall Study|Withdrawal by Subject|1|||
156538880|NCT01843972|565066376|FG005|Overall Study|Withdrawal by Subject|0|||
156538881|NCT01843972|565066377|FG006|Overall Study|Withdrawal by Subject|0|||
156538882|NCT01843972|565066378|FG007|Overall Study|Withdrawal by Subject|0|||
156538883|NCT01843972|565066379|FG008|Overall Study|Withdrawal by Subject|0|||
156538884|NCT01843972|565066380|FG009|Overall Study|Withdrawal by Subject|0|||
156538885|NCT00545402|565066383|FG000|Overall Study|Discontinuation of treatment|17|||
156538886|NCT00545402|565066384|FG001|Overall Study|Discontinuation of treatment|9|||
156538887|NCT00545402|565066383|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
156538888|NCT00545402|565066384|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
156538889|NCT00545402|565066383|FG000|Overall Study|Death|5|||
156538890|NCT00545402|565066384|FG001|Overall Study|Death|7|||
156538891|NCT00545402|565066383|FG000|Overall Study|Graft loss|2|||
156538892|NCT00545402|565066384|FG001|Overall Study|Graft loss|4|||
156538893|NCT00545402|565066383|FG000|Overall Study|Withdrawal by Subject|0|||
156538894|NCT00545402|565066384|FG001|Overall Study|Withdrawal by Subject|1|||
156538895|NCT00545402|565066383|FG000|Overall Study|Protocol Violation|1|||
156538896|NCT00545402|565066384|FG001|Overall Study|Protocol Violation|0|||
156538897|NCT00545402|565066383|FG000|Overall Study|Reason not specified|1|||
156538898|NCT00545402|565066384|FG001|Overall Study|Reason not specified|1|||
156538899|NCT01721876|565066385|FG000|Overall Study|Not treated|1|||
156538900|NCT01721876|565066386|FG001|Overall Study|Not treated|4|||
156538901|NCT01721876|565066385|FG000|Overall Study|Disease progression / relapse|123|||
156538902|NCT01721876|565066386|FG001|Overall Study|Disease progression / relapse|156|||
156538903|NCT01721876|565066385|FG000|Overall Study|Death|6|||
156538904|NCT01721876|565066386|FG001|Overall Study|Death|13|||
156812052|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812053|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812054|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812055|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812056|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812057|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812058|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812059|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812060|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812061|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
156812062|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812063|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812064|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812065|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156538905|NCT01721876|565066385|FG000|Overall Study|Adverse Event|41|||
156538906|NCT01721876|565066386|FG001|Overall Study|Adverse Event|165|||
156538907|NCT01721876|565066385|FG000|Overall Study|Protocol Violation|2|||
156538908|NCT01721876|565066386|FG001|Overall Study|Protocol Violation|1|||
156538909|NCT01721876|565066385|FG000|Overall Study|Withdrawal by Subject|15|||
156538910|NCT01721876|565066386|FG001|Overall Study|Withdrawal by Subject|38|||
156538911|NCT01721876|565066385|FG000|Overall Study|Reason not listed|34|||
156538912|NCT01721876|565066386|FG001|Overall Study|Reason not listed|63|||
156538913|NCT01721876|565066385|FG000|Overall Study|Sponsor terminated trial|0|||
156538914|NCT01721876|565066386|FG001|Overall Study|Sponsor terminated trial|4|||
156538915|NCT01252810|565066387|FG000|Overall Study|Withdrawal by Subject|4|||
156538916|NCT01252810|565066388|FG001|Overall Study|Withdrawal by Subject|1|||
156538917|NCT01252810|565066387|FG000|Overall Study|Lost to Follow-up|0|||
156538918|NCT01252810|565066388|FG001|Overall Study|Lost to Follow-up|1|||
156538919|NCT01252810|565066387|FG000|Overall Study|Physician Decision|2|||
156538920|NCT01252810|565066388|FG001|Overall Study|Physician Decision|1|||
156538921|NCT01252810|565066387|FG000|Overall Study|Various reasons|8|||
156538922|NCT01252810|565066388|FG001|Overall Study|Various reasons|0|||
156538923|NCT03805750|565066389|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
156538924|NCT03805750|565066390|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
156538925|NCT01984164|565066391|FG000|Overall Study|Withdrawal by Subject|4|||
156538926|NCT01984164|565066392|FG001|Overall Study|Withdrawal by Subject|3|||
156538927|NCT01984164|565066391|FG000|Overall Study|Adverse Event|5|||
156538928|NCT01984164|565066392|FG001|Overall Study|Adverse Event|19|||
156538929|NCT01984164|565066391|FG000|Overall Study|Lost to Follow-up|1|||
156538930|NCT01984164|565066392|FG001|Overall Study|Lost to Follow-up|3|||
156538931|NCT02811549|565066393|FG000|Overall Study|Lost to Follow-up|1|||
156538932|NCT02811549|565066393|FG000|Overall Study|Withdrawal by Subject|3|||
156538933|NCT02811549|565066393|FG000|Overall Study|Subject screen failed|4|||
156538934|NCT02811549|565066393|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
156538935|NCT05082376|565066394|FG000|Overall Study|Lost to Follow-up|2|||
156538936|NCT00493220|565066395|FG000|Third Intervention|Withdrawal by Subject|1|||
156538937|NCT00493220|565066396|FG001|Third Intervention|Withdrawal by Subject|0|||
156538938|NCT00493220|565066397|FG002|Third Intervention|Withdrawal by Subject|0|||
156538939|NCT00493220|565066398|FG003|Third Intervention|Withdrawal by Subject|0|||
156538940|NCT00493220|565066399|FG004|Third Intervention|Withdrawal by Subject|0|||
156538941|NCT00493220|565066400|FG005|Third Intervention|Withdrawal by Subject|0|||
156538942|NCT00916279|565066401|FG000|Overall Study|Death|2|||
156538943|NCT00916279|565066401|FG000|Overall Study|Lost to Follow-up|2|||
156538944|NCT00310804|565066402|FG000|Overall Study|Lost to Follow-up|2|||
156538945|NCT00310804|565066403|FG001|Overall Study|Lost to Follow-up|0|||
156538946|NCT00310804|565066402|FG000|Overall Study|Withdrawal by Subject|3|||
156538947|NCT00310804|565066403|FG001|Overall Study|Withdrawal by Subject|0|||
156538948|NCT03184077|565066409|FG000|Overall Study|Lost to Follow-up|21|||
156538949|NCT03184077|565066410|FG001|Overall Study|Lost to Follow-up|21|||
156538950|NCT01889238|565066412|FG000|Overall Study|Death|1|||
156538951|NCT01889238|565066412|FG000|Overall Study|Withdrawal by Subject|1|||
156538952|NCT01889238|565066412|FG000|Overall Study|Adverse Event|6|||
156538953|NCT01889238|565066412|FG000|Overall Study|Disease Progression|104|||
156538954|NCT01889238|565066412|FG000|Overall Study|Other|6|||
156538955|NCT04136184|565066413|FG000|Overall Study|Lost to Follow-up|0|||
156538956|NCT04136184|565066414|FG001|Overall Study|Lost to Follow-up|3|||
156538957|NCT04136184|565066413|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
156538958|NCT04136184|565066414|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
156538959|NCT03318978|565066418|FG000|Overall Study|Withdrawal by Subject|1|||
156538960|NCT02592018|565066422|FG000|Overall Study|Adverse Event|1|||
156538961|NCT02592018|565066422|FG000|Overall Study|Lost to Follow-up|1|||
156538962|NCT06156215|565066425|FG000|Overall Study|Withdrawal by Subject|2|||
156463582|NCT03635567|564794764|FG001|Overall Study|Death|235|||
156463583|NCT00739908|564794765|FG000|Overall Study|Adverse Event|5|||
156463584|NCT00739908|564794766|FG001|Overall Study|Adverse Event|6|||
156463585|NCT00739908|564794765|FG000|Overall Study|Withdrawal by Subject|4|||
156463586|NCT00739908|564794766|FG001|Overall Study|Withdrawal by Subject|2|||
156463587|NCT00739908|564794765|FG000|Overall Study|Lost to Follow-up|14|||
156463588|NCT00739908|564794766|FG001|Overall Study|Lost to Follow-up|9|||
156463589|NCT00739908|564794765|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
156463590|NCT00739908|564794766|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
156463591|NCT00739908|564794765|FG000|Overall Study|Non-Compliance With Study Medication|0|||
156463592|NCT00739908|564794766|FG001|Overall Study|Non-Compliance With Study Medication|3|||
156463593|NCT00739908|564794765|FG000|Overall Study|Lack of Efficacy|0|||
156463594|NCT00739908|564794766|FG001|Overall Study|Lack of Efficacy|1|||
156538963|NCT06156215|565066426|FG001|Overall Study|Withdrawal by Subject|4|||
156538964|NCT06156215|565066427|FG002|Overall Study|Withdrawal by Subject|4|||
156538965|NCT06156215|565066428|FG003|Overall Study|Withdrawal by Subject|0|||
156338938|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
156338939|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
156538966|NCT06156215|565066429|FG004|Overall Study|Withdrawal by Subject|2|||
156538967|NCT06156215|565066430|FG005|Overall Study|Withdrawal by Subject|2|||
156538968|NCT06156215|565066425|FG000|Overall Study|Left ED without completing study|9|||
156538969|NCT06156215|565066426|FG001|Overall Study|Left ED without completing study|3|||
156538970|NCT06156215|565066427|FG002|Overall Study|Left ED without completing study|9|||
156538971|NCT06156215|565066428|FG003|Overall Study|Left ED without completing study|0|||
156463595|NCT00739908|564794765|FG000|Overall Study|Relocation|0|||
156463596|NCT00739908|564794766|FG001|Overall Study|Relocation|1|||
156463597|NCT05157841|564794767|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
156463598|NCT05157841|564794768|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
156463599|NCT05157841|564794769|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
156463600|NCT05157841|564794767|FG000|Part A (14 Days)|Adverse Event|1|||
156463601|NCT05157841|564794768|FG001|Part A (14 Days)|Adverse Event|0|||
156463602|NCT05157841|564794769|FG002|Part A (14 Days)|Adverse Event|0|||
156463603|NCT05157841|564794767|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
156463604|NCT05157841|564794768|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
156463605|NCT05157841|564794769|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
156463606|NCT03884101|564794770|FG000|Overall Study|Participant Ongoing in Study|202|||
156463607|NCT03884101|564794771|FG001|Overall Study|Participant Ongoing in Study|186|||
156463608|NCT03884101|564794770|FG000|Overall Study|Death|212|||
156463609|NCT03884101|564794771|FG001|Overall Study|Death|224|||
156463610|NCT03884101|564794770|FG000|Overall Study|Lost to Follow-up|0|||
156463611|NCT03884101|564794771|FG001|Overall Study|Lost to Follow-up|1|||
156463612|NCT03884101|564794770|FG000|Overall Study|Withdrawal by Subject|6|||
156463613|NCT03884101|564794771|FG001|Overall Study|Withdrawal by Subject|11|||
156463614|NCT04560179|564794772|FG000|Overall Study|Physician Decision|1|||
156463615|NCT04560179|564794773|FG001|Overall Study|Physician Decision|0|||
156463616|NCT04560179|564794774|FG002|Overall Study|Physician Decision|0|||
156463617|NCT04560179|564794775|FG003|Overall Study|Physician Decision|0|||
156463618|NCT04560179|564794776|FG004|Overall Study|Physician Decision|0|||
156463619|NCT04560179|564794772|FG000|Overall Study|Adverse Event|0|||
156463620|NCT04560179|564794773|FG001|Overall Study|Adverse Event|0|||
156463621|NCT04560179|564794774|FG002|Overall Study|Adverse Event|0|||
156463622|NCT04560179|564794775|FG003|Overall Study|Adverse Event|1|||
156463623|NCT04560179|564794776|FG004|Overall Study|Adverse Event|0|||
156463624|NCT04631016|564794777|FG000|Overall Study|Adverse Event|3|||
156463625|NCT04631016|564794778|FG001|Overall Study|Adverse Event|0|||
156463626|NCT04631016|564794777|FG000|Overall Study|Withdrawal by Subject|5|||
156463627|NCT04631016|564794778|FG001|Overall Study|Withdrawal by Subject|4|||
156463628|NCT04631016|564794777|FG000|Overall Study|Reason unspecified|1|||
156463629|NCT04631016|564794778|FG001|Overall Study|Reason unspecified|0|||
156463630|NCT04631016|564794777|FG000|Overall Study|Failure to meet randomization criteria|2|||
156812066|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812067|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812068|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812069|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812070|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812071|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812072|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812073|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812074|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
156812075|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812076|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812077|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812078|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812079|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812080|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812081|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812082|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812083|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812084|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812085|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812086|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812087|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
156812088|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812089|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812090|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812091|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812092|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812093|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812094|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812095|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156463631|NCT04631016|564794778|FG001|Overall Study|Failure to meet randomization criteria|1|||
156463632|NCT05454514|564794784|FG000|Overall Study|Withdrawal by Subject|4|||
156463633|NCT02624050|564794790|FG000|Overall Study|Physician Decision|4|||
156463634|NCT02624050|564794791|FG001|Overall Study|Physician Decision|0|||
156463635|NCT02624050|564794790|FG000|Overall Study|Protocol Violation|2|||
156812096|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812097|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812098|NCT03307785|566062616|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812099|NCT03307785|566062617|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812100|NCT03307785|566062618|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812101|NCT03307785|566062619|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
156812102|NCT03307785|566062620|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
156812103|NCT03307785|566062621|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812104|NCT03307785|566062622|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812105|NCT03307785|566062623|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812106|NCT03307785|566062624|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812107|NCT03307785|566062625|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812108|NCT03307785|566062626|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812109|NCT03307785|566062627|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812110|NCT03307785|566062628|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812111|NCT03307785|566062616|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812112|NCT03307785|566062617|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812113|NCT03307785|566062618|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812114|NCT03307785|566062619|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
156812115|NCT03307785|566062620|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
156812116|NCT03307785|566062621|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812117|NCT03307785|566062622|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812118|NCT03307785|566062623|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812119|NCT03307785|566062624|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812120|NCT03307785|566062625|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812121|NCT03307785|566062626|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812122|NCT03307785|566062627|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812123|NCT03307785|566062628|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812124|NCT03307785|566062616|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812125|NCT03307785|566062617|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812126|NCT03307785|566062618|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812127|NCT03307785|566062619|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
156812128|NCT03307785|566062620|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812129|NCT03307785|566062621|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812130|NCT03307785|566062622|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812131|NCT03307785|566062623|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812132|NCT03307785|566062624|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812133|NCT03307785|566062625|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812134|NCT03307785|566062626|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812135|NCT03307785|566062627|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812136|NCT03307785|566062628|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812137|NCT03307785|566062616|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812138|NCT03307785|566062617|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812139|NCT03307785|566062618|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812140|NCT03307785|566062619|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812141|NCT03307785|566062620|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
156812142|NCT03307785|566062621|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812143|NCT03307785|566062622|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156463636|NCT02624050|564794791|FG001|Overall Study|Protocol Violation|0|||
156463637|NCT04795245|564794792|FG000|Overall Study|Unkown reason|7|||
156463638|NCT04795245|564794792|FG000|Overall Study|Death|17|||
156463639|NCT04795245|564794792|FG000|Overall Study|Other than listed|19|||
156463640|NCT04795245|564794792|FG000|Overall Study|Adverse Event|143|||
156463641|NCT04795245|564794792|FG000|Overall Study|Progressive disease|512|||
156463642|NCT04795245|564794792|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
156463643|NCT03904576|564794793|FG000|Washout Period|Protocol Violation|1|||
156463644|NCT03904576|564794794|FG001|Washout Period|Protocol Violation|1|||
156463645|NCT03279978|564794795|FG000|Overall Study|Withdrawal by Subject|0|||
156812144|NCT03307785|566062623|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812145|NCT03307785|566062624|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156463646|NCT03279978|564794796|FG001|Overall Study|Withdrawal by Subject|1|||
156463647|NCT03279978|564794797|FG002|Overall Study|Withdrawal by Subject|0|||
156463648|NCT03279978|564794798|FG003|Overall Study|Withdrawal by Subject|0|||
156463649|NCT03279978|564794799|FG004|Overall Study|Withdrawal by Subject|0|||
156463650|NCT03279978|564794800|FG005|Overall Study|Withdrawal by Subject|0|||
156812146|NCT03307785|566062625|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812147|NCT03307785|566062626|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812148|NCT03307785|566062627|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812149|NCT03307785|566062628|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812150|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812151|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812152|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812153|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812154|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156463651|NCT03279978|564794801|FG006|Overall Study|Withdrawal by Subject|0|||
156338940|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
156812155|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
156812156|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812157|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812158|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812159|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812160|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812161|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812162|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812163|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812164|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812165|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812166|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812167|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812168|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
156812169|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812170|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812171|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812172|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812173|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812174|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812175|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812176|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812177|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812178|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812179|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812180|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812181|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
156812182|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812183|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812184|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812185|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812186|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812187|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812188|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812189|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812190|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812191|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812192|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812193|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812194|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
156812195|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812196|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812197|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812198|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812199|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812200|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812201|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812202|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812203|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812204|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812205|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812206|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812207|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
156812208|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812209|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812210|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812211|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812212|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812213|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812214|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812215|NCT03307785|566062616|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812216|NCT03307785|566062617|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812217|NCT03307785|566062618|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812218|NCT03307785|566062619|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812219|NCT03307785|566062620|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812220|NCT03307785|566062621|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812221|NCT03307785|566062622|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
156812222|NCT03307785|566062623|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812223|NCT03307785|566062624|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812224|NCT03307785|566062625|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812225|NCT03307785|566062626|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812226|NCT03307785|566062627|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812227|NCT03307785|566062628|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812228|NCT03307785|566062616|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812229|NCT03307785|566062617|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812230|NCT03307785|566062618|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812231|NCT03307785|566062619|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812232|NCT03307785|566062620|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812233|NCT03307785|566062621|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812234|NCT03307785|566062622|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
156812235|NCT03307785|566062623|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812236|NCT03307785|566062624|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812237|NCT03307785|566062625|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812238|NCT03307785|566062626|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812239|NCT03307785|566062627|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812240|NCT03307785|566062628|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812241|NCT03307785|566062616|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812242|NCT03307785|566062617|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812243|NCT03307785|566062618|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812244|NCT03307785|566062619|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812245|NCT03307785|566062620|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812246|NCT03307785|566062621|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812247|NCT03307785|566062622|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812248|NCT03307785|566062623|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
156812249|NCT03307785|566062624|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812250|NCT03307785|566062625|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812251|NCT03307785|566062626|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812252|NCT03307785|566062627|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812253|NCT03307785|566062628|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812254|NCT03307785|566062616|FG000|PACT Phase: Up to 19 Months|Death|0|||
156812255|NCT03307785|566062617|FG001|PACT Phase: Up to 19 Months|Death|0|||
156812256|NCT03307785|566062618|FG002|PACT Phase: Up to 19 Months|Death|0|||
156812257|NCT03307785|566062619|FG003|PACT Phase: Up to 19 Months|Death|0|||
156812258|NCT03307785|566062620|FG004|PACT Phase: Up to 19 Months|Death|0|||
156812259|NCT03307785|566062621|FG005|PACT Phase: Up to 19 Months|Death|0|||
156812260|NCT03307785|566062622|FG006|PACT Phase: Up to 19 Months|Death|0|||
156812261|NCT03307785|566062623|FG007|PACT Phase: Up to 19 Months|Death|0|||
156812262|NCT03307785|566062624|FG008|PACT Phase: Up to 19 Months|Death|0|||
156812263|NCT03307785|566062625|FG009|PACT Phase: Up to 19 Months|Death|0|||
156812264|NCT03307785|566062626|FG010|PACT Phase: Up to 19 Months|Death|0|||
156812265|NCT03307785|566062627|FG011|PACT Phase: Up to 19 Months|Death|0|||
156812266|NCT03307785|566062628|FG012|PACT Phase: Up to 19 Months|Death|1|||
156812267|NCT05588440|566062630|FG000|Overall Study|Sponsor Decision|2|||
156812268|NCT05588440|566062631|FG001|Overall Study|Sponsor Decision|0|||
156812269|NCT05588440|566062632|FG002|Overall Study|Sponsor Decision|1|||
156812270|NCT05588440|566062630|FG000|Overall Study|Death|1|||
156812271|NCT05588440|566062631|FG001|Overall Study|Death|1|||
156812272|NCT05588440|566062632|FG002|Overall Study|Death|1|||
156812273|NCT05588440|566062630|FG000|Overall Study|Screen Fail|0|||
156812274|NCT05588440|566062631|FG001|Overall Study|Screen Fail|1|||
156812275|NCT05588440|566062632|FG002|Overall Study|Screen Fail|1|||
156812276|NCT05588440|566062630|FG000|Overall Study|Withdrawal by Subject|0|||
156812277|NCT05588440|566062631|FG001|Overall Study|Withdrawal by Subject|0|||
156812278|NCT05588440|566062632|FG002|Overall Study|Withdrawal by Subject|1|||
156812279|NCT03381287|566062634|FG000|Overall Study|Withdrawal by Subject|0|||
156812280|NCT03381287|566062635|FG001|Overall Study|Withdrawal by Subject|1|||
156812281|NCT03381287|566062636|FG002|Overall Study|Withdrawal by Subject|0|||
156812282|NCT03381287|566062637|FG003|Overall Study|Withdrawal by Subject|0|||
156812283|NCT03381287|566062634|FG000|Overall Study|Adverse Event|0|||
156812284|NCT03381287|566062635|FG001|Overall Study|Adverse Event|0|||
156812285|NCT03381287|566062636|FG002|Overall Study|Adverse Event|0|||
156812286|NCT03381287|566062637|FG003|Overall Study|Adverse Event|1|||
156812287|NCT03381287|566062634|FG000|Overall Study|Physician Decision|0|||
156812288|NCT03381287|566062635|FG001|Overall Study|Physician Decision|0|||
156812289|NCT03381287|566062636|FG002|Overall Study|Physician Decision|0|||
156812290|NCT03381287|566062637|FG003|Overall Study|Physician Decision|1|||
156812291|NCT00325130|566062671|FG000|Overall Study|Lost to Follow-up|6|||
156812292|NCT00325130|566062672|FG001|Overall Study|Lost to Follow-up|14|||
156812293|NCT00325130|566062671|FG000|Overall Study|Withdrawal by Subject|12|||
156812294|NCT00325130|566062672|FG001|Overall Study|Withdrawal by Subject|14|||
156812295|NCT00325130|566062671|FG000|Overall Study|Protocol Deviation|0|||
156812296|NCT00325130|566062672|FG001|Overall Study|Protocol Deviation|1|||
156812297|NCT00325130|566062671|FG000|Overall Study|Moved|0|||
156812298|NCT00325130|566062672|FG001|Overall Study|Moved|1|||
156812299|NCT00325130|566062671|FG000|Overall Study|Patient Discontinued for Other|1|||
156812300|NCT00325130|566062672|FG001|Overall Study|Patient Discontinued for Other|0|||
156812301|NCT01671956|566062675|FG000|Overall Study|Disease progression|0|||
156812302|NCT01671956|566062676|FG001|Overall Study|Disease progression|1|||
156812303|NCT01671956|566062675|FG000|Overall Study|Withdrawal by Subject|1|||
156812304|NCT01671956|566062676|FG001|Overall Study|Withdrawal by Subject|1|||
156812305|NCT01671956|566062675|FG000|Overall Study|Adverse Event|1|||
156812306|NCT01671956|566062676|FG001|Overall Study|Adverse Event|0|||
156812307|NCT04266912|566062682|FG000|Overall Study|Withdrawal by Subject|1|||
156812308|NCT04266912|566062683|FG001|Overall Study|Withdrawal by Subject|0|||
156812309|NCT04266912|566062684|FG002|Overall Study|Withdrawal by Subject|0|||
156812310|NCT04266912|566062685|FG003|Overall Study|Withdrawal by Subject|0|||
156812311|NCT04266912|566062682|FG000|Overall Study|Progression|6|||
156812312|NCT04266912|566062683|FG001|Overall Study|Progression|6|||
156812313|NCT04266912|566062684|FG002|Overall Study|Progression|0|||
156812314|NCT04266912|566062685|FG003|Overall Study|Progression|10|||
156812315|NCT02842086|566062692|FG000|Overall Study|Randomized but Never Treated|6|||
156812316|NCT02842086|566062693|FG001|Overall Study|Randomized but Never Treated|6|||
156812317|NCT02842086|566062692|FG000|Overall Study|Still in Double-Blind Phase|7|||
156812318|NCT02842086|566062693|FG001|Overall Study|Still in Double-Blind Phase|3|||
156812319|NCT02842086|566062692|FG000|Overall Study|Adverse Event|18|||
156812320|NCT02842086|566062693|FG001|Overall Study|Adverse Event|20|||
156812321|NCT02842086|566062692|FG000|Overall Study|Death|3|||
156812322|NCT02842086|566062693|FG001|Overall Study|Death|3|||
156812323|NCT02842086|566062692|FG000|Overall Study|Investigator's Discretion|9|||
156812324|NCT02842086|566062693|FG001|Overall Study|Investigator's Discretion|13|||
156812325|NCT02842086|566062692|FG000|Overall Study|Non-Compliance with Study Drug|9|||
156812326|NCT02842086|566062693|FG001|Overall Study|Non-Compliance with Study Drug|8|||
156812327|NCT02842086|566062692|FG000|Overall Study|Protocol Violation|8|||
156812328|NCT02842086|566062693|FG001|Overall Study|Protocol Violation|4|||
156812329|NCT02842086|566062692|FG000|Overall Study|Withdrew Consent|205|||
156812330|NCT02842086|566062693|FG001|Overall Study|Withdrew Consent|194|||
156812331|NCT02842086|566062692|FG000|Overall Study|Lost to Follow-up|274|||
156812332|NCT02842086|566062693|FG001|Overall Study|Lost to Follow-up|236|||
156812333|NCT02842086|566062692|FG000|Overall Study|HIV-1 Infection|5|||
156812334|NCT02842086|566062693|FG001|Overall Study|HIV-1 Infection|6|||
156812335|NCT03581292|566062694|FG000|Overall Study|Physician Decision|9|||
156812336|NCT03581292|566062695|FG001|Overall Study|Physician Decision|5|||
156812337|NCT03581292|566062694|FG000|Overall Study|Withdrawal by Subject|3|||
156812338|NCT03581292|566062695|FG001|Overall Study|Withdrawal by Subject|0|||
156812339|NCT03581292|566062694|FG000|Overall Study|Withdrawal before Therapy Start|1|||
156812340|NCT03581292|566062695|FG001|Overall Study|Withdrawal before Therapy Start|0|||
156338941|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
156812341|NCT05823974|566064731|FG000|Overall Study|Lost to Follow-up|0|||
156812342|NCT05823974|566064732|FG001|Overall Study|Lost to Follow-up|3|||
156812343|NCT05823974|566064733|FG002|Overall Study|Lost to Follow-up|1|||
156812344|NCT05823974|566064734|FG003|Overall Study|Lost to Follow-up|0|||
156812345|NCT05823974|566064735|FG004|Overall Study|Lost to Follow-up|1|||
156812346|NCT05823974|566064736|FG005|Overall Study|Lost to Follow-up|0|||
156812347|NCT05823974|566064737|FG006|Overall Study|Lost to Follow-up|1|||
156812348|NCT05823974|566064738|FG007|Overall Study|Lost to Follow-up|0|||
156812349|NCT05823974|566064739|FG008|Overall Study|Lost to Follow-up|0|||
156812350|NCT05823974|566064740|FG009|Overall Study|Lost to Follow-up|1|||
156812351|NCT05823974|566064741|FG010|Overall Study|Lost to Follow-up|1|||
156812352|NCT05823974|566064742|FG011|Overall Study|Lost to Follow-up|0|||
156812353|NCT05823974|566064743|FG012|Overall Study|Lost to Follow-up|1|||
156812354|NCT05823974|566064744|FG013|Overall Study|Lost to Follow-up|2|||
156812355|NCT05823974|566064745|FG014|Overall Study|Lost to Follow-up|1|||
156812356|NCT05823974|566064746|FG015|Overall Study|Lost to Follow-up|1|||
156812357|NCT05823974|566064747|FG016|Overall Study|Lost to Follow-up|1|||
156812358|NCT05823974|566064748|FG017|Overall Study|Lost to Follow-up|0|||
156812359|NCT05823974|566064749|FG018|Overall Study|Lost to Follow-up|0|||
156812360|NCT05823974|566064750|FG019|Overall Study|Lost to Follow-up|2|||
156812361|NCT05823974|566064751|FG020|Overall Study|Lost to Follow-up|0|||
156812362|NCT05823974|566064731|FG000|Overall Study|Physician Decision|0|||
156463652|NCT03279978|564794802|FG007|Overall Study|Withdrawal by Subject|0|||
156812363|NCT05823974|566064732|FG001|Overall Study|Physician Decision|0|||
156812364|NCT05823974|566064733|FG002|Overall Study|Physician Decision|0|||
156812365|NCT05823974|566064734|FG003|Overall Study|Physician Decision|0|||
156812366|NCT05823974|566064735|FG004|Overall Study|Physician Decision|0|||
156812367|NCT05823974|566064736|FG005|Overall Study|Physician Decision|0|||
156812368|NCT05823974|566064737|FG006|Overall Study|Physician Decision|0|||
156812369|NCT05823974|566064738|FG007|Overall Study|Physician Decision|0|||
156812370|NCT05823974|566064739|FG008|Overall Study|Physician Decision|0|||
156812371|NCT05823974|566064740|FG009|Overall Study|Physician Decision|0|||
156812372|NCT05823974|566064741|FG010|Overall Study|Physician Decision|0|||
156812373|NCT05823974|566064742|FG011|Overall Study|Physician Decision|0|||
156812374|NCT05823974|566064743|FG012|Overall Study|Physician Decision|0|||
156812375|NCT05823974|566064744|FG013|Overall Study|Physician Decision|0|||
156812376|NCT05823974|566064745|FG014|Overall Study|Physician Decision|0|||
156812377|NCT05823974|566064746|FG015|Overall Study|Physician Decision|1|||
156812378|NCT05823974|566064747|FG016|Overall Study|Physician Decision|0|||
156812379|NCT05823974|566064748|FG017|Overall Study|Physician Decision|1|||
156812380|NCT05823974|566064749|FG018|Overall Study|Physician Decision|1|||
156812381|NCT05823974|566064750|FG019|Overall Study|Physician Decision|0|||
156812382|NCT05823974|566064751|FG020|Overall Study|Physician Decision|0|||
156812383|NCT05823974|566064731|FG000|Overall Study|Withdrawal by Subject|1|||
156812384|NCT05823974|566064732|FG001|Overall Study|Withdrawal by Subject|1|||
156812385|NCT05823974|566064733|FG002|Overall Study|Withdrawal by Subject|2|||
156812386|NCT05823974|566064734|FG003|Overall Study|Withdrawal by Subject|0|||
156812387|NCT05823974|566064735|FG004|Overall Study|Withdrawal by Subject|2|||
156812388|NCT05823974|566064736|FG005|Overall Study|Withdrawal by Subject|3|||
156812389|NCT05823974|566064737|FG006|Overall Study|Withdrawal by Subject|1|||
156812390|NCT05823974|566064738|FG007|Overall Study|Withdrawal by Subject|1|||
156812391|NCT05823974|566064739|FG008|Overall Study|Withdrawal by Subject|2|||
156812392|NCT05823974|566064740|FG009|Overall Study|Withdrawal by Subject|1|||
156812393|NCT05823974|566064741|FG010|Overall Study|Withdrawal by Subject|1|||
156812394|NCT05823974|566064742|FG011|Overall Study|Withdrawal by Subject|0|||
156812395|NCT05823974|566064743|FG012|Overall Study|Withdrawal by Subject|0|||
156812396|NCT05823974|566064744|FG013|Overall Study|Withdrawal by Subject|1|||
156463653|NCT03279978|564794803|FG008|Overall Study|Withdrawal by Subject|0|||
156463654|NCT03279978|564794804|FG009|Overall Study|Withdrawal by Subject|1|||
156812397|NCT05823974|566064745|FG014|Overall Study|Withdrawal by Subject|1|||
156812398|NCT05823974|566064746|FG015|Overall Study|Withdrawal by Subject|3|||
156812399|NCT05823974|566064747|FG016|Overall Study|Withdrawal by Subject|0|||
156463655|NCT03279978|564794795|FG000|Overall Study|Lost to Follow-up|1|||
156463656|NCT03279978|564794796|FG001|Overall Study|Lost to Follow-up|0|||
156812400|NCT05823974|566064748|FG017|Overall Study|Withdrawal by Subject|2|||
156463657|NCT03279978|564794797|FG002|Overall Study|Lost to Follow-up|1|||
156463658|NCT03279978|564794798|FG003|Overall Study|Lost to Follow-up|0|||
156463659|NCT03279978|564794799|FG004|Overall Study|Lost to Follow-up|0|||
156463660|NCT03279978|564794800|FG005|Overall Study|Lost to Follow-up|0|||
156463661|NCT03279978|564794801|FG006|Overall Study|Lost to Follow-up|0|||
156812401|NCT05823974|566064749|FG018|Overall Study|Withdrawal by Subject|2|||
156812402|NCT05823974|566064750|FG019|Overall Study|Withdrawal by Subject|0|||
156812403|NCT05823974|566064751|FG020|Overall Study|Withdrawal by Subject|1|||
156812404|NCT05823974|566064731|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812405|NCT05823974|566064732|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812406|NCT05823974|566064733|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156812407|NCT05823974|566064734|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812408|NCT05823974|566064735|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812409|NCT05823974|566064736|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812410|NCT05823974|566064737|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812411|NCT05823974|566064738|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812412|NCT05823974|566064739|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812413|NCT05823974|566064740|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812414|NCT05823974|566064741|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812415|NCT05823974|566064742|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812416|NCT05823974|566064743|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812417|NCT05823974|566064744|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812418|NCT05823974|566064745|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156812419|NCT05823974|566064746|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812420|NCT05823974|566064747|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812421|NCT05823974|566064748|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812422|NCT05823974|566064749|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812423|NCT05823974|566064750|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812424|NCT05823974|566064751|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812425|NCT05823974|566064731|FG000|Overall Study|Other|0|||
156812426|NCT05823974|566064732|FG001|Overall Study|Other|1|||
156812427|NCT05823974|566064733|FG002|Overall Study|Other|1|||
156812428|NCT05823974|566064734|FG003|Overall Study|Other|1|||
156812429|NCT05823974|566064735|FG004|Overall Study|Other|0|||
156812430|NCT05823974|566064736|FG005|Overall Study|Other|1|||
156812431|NCT05823974|566064737|FG006|Overall Study|Other|1|||
156812432|NCT05823974|566064738|FG007|Overall Study|Other|1|||
156812433|NCT05823974|566064739|FG008|Overall Study|Other|1|||
156812434|NCT05823974|566064740|FG009|Overall Study|Other|0|||
156812435|NCT05823974|566064741|FG010|Overall Study|Other|0|||
156812436|NCT05823974|566064742|FG011|Overall Study|Other|0|||
156812437|NCT05823974|566064743|FG012|Overall Study|Other|2|||
156812438|NCT05823974|566064744|FG013|Overall Study|Other|1|||
156812439|NCT05823974|566064745|FG014|Overall Study|Other|0|||
156812440|NCT05823974|566064746|FG015|Overall Study|Other|1|||
156812441|NCT05823974|566064747|FG016|Overall Study|Other|0|||
156812442|NCT05823974|566064748|FG017|Overall Study|Other|0|||
156812443|NCT05823974|566064749|FG018|Overall Study|Other|0|||
156812444|NCT05823974|566064750|FG019|Overall Study|Other|0|||
156812445|NCT05823974|566064751|FG020|Overall Study|Other|0|||
156812446|NCT02744612|566064752|FG000|Overall Study|Withdrawal by Subject|0|||
156812447|NCT02744612|566064753|FG001|Overall Study|Withdrawal by Subject|2|||
156812448|NCT00316706|566064754|FG000|Overall Study|Lost to Follow-up|38|||
156812449|NCT00316706|566064755|FG001|Overall Study|Lost to Follow-up|48|||
156812450|NCT00283803|566064757|FG000|Overall Study|Physician Decision|9|||
156812451|NCT00283803|566064757|FG000|Overall Study|Withdrawal by Subject|4|||
156812452|NCT01127607|566064758|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
156812453|NCT01127607|566064759|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
156812454|NCT01127607|566064758|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
156812455|NCT01127607|566064759|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
156812456|NCT02220855|566064760|FG000|Overall Study|Adverse Event|8|||
156812457|NCT02220855|566064760|FG000|Overall Study|Disease Progression|5|||
156463662|NCT03279978|564794802|FG007|Overall Study|Lost to Follow-up|0|||
156463663|NCT03279978|564794803|FG008|Overall Study|Lost to Follow-up|0|||
156463664|NCT03279978|564794804|FG009|Overall Study|Lost to Follow-up|0|||
156463665|NCT03279978|564794795|FG000|Overall Study|Other than stated above|0|||
156812458|NCT02220855|566064760|FG000|Overall Study|Withdrawal by Subject|1|||
156812459|NCT03419897|566064761|FG000|Overall Study|Death|180|||
156812460|NCT03419897|566064761|FG000|Overall Study|Lost to Follow-up|1|||
156812461|NCT03419897|566064761|FG000|Overall Study|Withdrawal by Subject|6|||
156812462|NCT03419897|566064761|FG000|Overall Study|Sponsor Decision|61|||
156812463|NCT03419897|566064761|FG000|Overall Study|Physician Decision|1|||
156812464|NCT05730725|566064764|FG000|Overall Study|Withdrawal by Subject|3|||
156812465|NCT05730725|566064765|FG001|Overall Study|Withdrawal by Subject|0|||
156463666|NCT03279978|564794796|FG001|Overall Study|Other than stated above|0|||
156812466|NCT05730725|566064766|FG002|Overall Study|Withdrawal by Subject|0|||
156812467|NCT05730725|566064767|FG003|Overall Study|Withdrawal by Subject|1|||
156812468|NCT05730725|566064764|FG000|Overall Study|Not Reported|1|||
156812469|NCT05730725|566064765|FG001|Overall Study|Not Reported|1|||
156812470|NCT05730725|566064766|FG002|Overall Study|Not Reported|1|||
156812471|NCT05730725|566064767|FG003|Overall Study|Not Reported|1|||
156812472|NCT02982772|566064771|FG000|Intervention|Lost to Follow-up|19|||
156812473|NCT02982772|566064772|FG001|Intervention|Lost to Follow-up|13|||
156812474|NCT02982772|566064771|FG000|1M Follow-Up|Lost to Follow-up|21|||
156812475|NCT02982772|566064772|FG001|1M Follow-Up|Lost to Follow-up|18|||
156812476|NCT02982772|566064771|FG000|3M Follow-Up|Lost to Follow-up|17|||
156812477|NCT02982772|566064772|FG001|3M Follow-Up|Lost to Follow-up|11|||
156812478|NCT02982772|566064771|FG000|6M Follow-Up|Lost to Follow-up|11|||
156812479|NCT02982772|566064772|FG001|6M Follow-Up|Lost to Follow-up|9|||
156812480|NCT02982772|566064771|FG000|12M Follow-Up|Lost to Follow-up|11|||
156812481|NCT02982772|566064772|FG001|12M Follow-Up|Lost to Follow-up|5|||
156812482|NCT02974140|566064773|FG000|Overall Study|Adverse Event|2|||
156812483|NCT02974140|566064773|FG000|Overall Study|Lost to Follow-up|1|||
156812484|NCT02974140|566064773|FG000|Overall Study|Study Terminated by Sponsor|36|||
156812485|NCT01905943|566064774|FG000|Overall Study|Withdrawal of consent|90|||
156812486|NCT01905943|566064774|FG000|Overall Study|Lost to Follow-up|16|||
156812487|NCT01905943|566064774|FG000|Overall Study|Investigator discretion|7|||
156812488|NCT01905943|566064774|FG000|Overall Study|Death|186|||
156812489|NCT01905943|566064774|FG000|Overall Study|Adverse Event|3|||
156812490|NCT01905943|566064774|FG000|Overall Study|Other|12|||
156812491|NCT01238991|566064777|FG000|Overall Study|Adverse Event|1|||
156812492|NCT01238991|566064778|FG001|Overall Study|Adverse Event|0|||
156812493|NCT01238991|566064779|FG002|Overall Study|Adverse Event|3|||
156812494|NCT01238991|566064780|FG003|Overall Study|Adverse Event|1|||
156812495|NCT01238991|566064781|FG004|Overall Study|Adverse Event|1|||
156812496|NCT01238991|566064782|FG005|Overall Study|Adverse Event|0|||
156812497|NCT01238991|566064783|FG006|Overall Study|Adverse Event|1|||
156812498|NCT01238991|566064784|FG007|Overall Study|Adverse Event|1|||
156812499|NCT01238991|566064785|FG008|Overall Study|Adverse Event|0|||
156812500|NCT01238991|566064786|FG009|Overall Study|Adverse Event|0|||
156812501|NCT01238991|566064777|FG000|Overall Study|Death|0|||
156812502|NCT01238991|566064778|FG001|Overall Study|Death|0|||
156812503|NCT01238991|566064779|FG002|Overall Study|Death|0|||
156812504|NCT01238991|566064780|FG003|Overall Study|Death|1|||
156812505|NCT01238991|566064781|FG004|Overall Study|Death|0|||
156812506|NCT01238991|566064782|FG005|Overall Study|Death|0|||
156812507|NCT01238991|566064783|FG006|Overall Study|Death|0|||
156812508|NCT01238991|566064784|FG007|Overall Study|Death|0|||
156812509|NCT01238991|566064785|FG008|Overall Study|Death|0|||
156812510|NCT01238991|566064786|FG009|Overall Study|Death|0|||
156812511|NCT01238991|566064777|FG000|Overall Study|Lack of Efficacy|0|||
156812512|NCT01238991|566064778|FG001|Overall Study|Lack of Efficacy|0|||
156812513|NCT01238991|566064779|FG002|Overall Study|Lack of Efficacy|1|||
156812514|NCT01238991|566064780|FG003|Overall Study|Lack of Efficacy|0|||
156812515|NCT01238991|566064781|FG004|Overall Study|Lack of Efficacy|0|||
156812516|NCT01238991|566064782|FG005|Overall Study|Lack of Efficacy|0|||
156812517|NCT01238991|566064783|FG006|Overall Study|Lack of Efficacy|0|||
156812518|NCT01238991|566064784|FG007|Overall Study|Lack of Efficacy|0|||
156812519|NCT01238991|566064785|FG008|Overall Study|Lack of Efficacy|1|||
156812520|NCT01238991|566064786|FG009|Overall Study|Lack of Efficacy|0|||
156812521|NCT01238991|566064777|FG000|Overall Study|Withdrawal by Subject|0|||
156812522|NCT01238991|566064778|FG001|Overall Study|Withdrawal by Subject|0|||
156812523|NCT01238991|566064779|FG002|Overall Study|Withdrawal by Subject|1|||
156812524|NCT01238991|566064780|FG003|Overall Study|Withdrawal by Subject|0|||
156812525|NCT01238991|566064781|FG004|Overall Study|Withdrawal by Subject|0|||
156812526|NCT01238991|566064782|FG005|Overall Study|Withdrawal by Subject|0|||
156812527|NCT01238991|566064783|FG006|Overall Study|Withdrawal by Subject|0|||
156812528|NCT01238991|566064784|FG007|Overall Study|Withdrawal by Subject|0|||
156812529|NCT01238991|566064785|FG008|Overall Study|Withdrawal by Subject|0|||
156812530|NCT01238991|566064786|FG009|Overall Study|Withdrawal by Subject|0|||
156338942|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
156812531|NCT01238991|566064777|FG000|Overall Study|Study Terminated by Sponsor|0|||
156812532|NCT01238991|566064778|FG001|Overall Study|Study Terminated by Sponsor|0|||
156812533|NCT01238991|566064779|FG002|Overall Study|Study Terminated by Sponsor|0|||
156812534|NCT01238991|566064780|FG003|Overall Study|Study Terminated by Sponsor|0|||
156812535|NCT01238991|566064781|FG004|Overall Study|Study Terminated by Sponsor|1|||
156812536|NCT01238991|566064782|FG005|Overall Study|Study Terminated by Sponsor|0|||
156812537|NCT01238991|566064783|FG006|Overall Study|Study Terminated by Sponsor|7|||
156812538|NCT01238991|566064784|FG007|Overall Study|Study Terminated by Sponsor|4|||
156812539|NCT01238991|566064785|FG008|Overall Study|Study Terminated by Sponsor|2|||
156812540|NCT01238991|566064786|FG009|Overall Study|Study Terminated by Sponsor|2|||
156812541|NCT01238991|566064777|FG000|Overall Study|Caregiver's request|0|||
156812542|NCT01238991|566064778|FG001|Overall Study|Caregiver's request|0|||
156812543|NCT01238991|566064779|FG002|Overall Study|Caregiver's request|0|||
156812544|NCT01238991|566064780|FG003|Overall Study|Caregiver's request|0|||
156812545|NCT01238991|566064781|FG004|Overall Study|Caregiver's request|0|||
156812546|NCT01238991|566064782|FG005|Overall Study|Caregiver's request|0|||
156812547|NCT01238991|566064783|FG006|Overall Study|Caregiver's request|0|||
156812548|NCT01238991|566064784|FG007|Overall Study|Caregiver's request|0|||
156812549|NCT01238991|566064785|FG008|Overall Study|Caregiver's request|1|||
156812550|NCT01238991|566064786|FG009|Overall Study|Caregiver's request|0|||
156812551|NCT01238991|566064777|FG000|Overall Study|Admission to a nursing home|1|||
156812552|NCT01238991|566064778|FG001|Overall Study|Admission to a nursing home|0|||
156812553|NCT01238991|566064779|FG002|Overall Study|Admission to a nursing home|1|||
156812554|NCT01238991|566064780|FG003|Overall Study|Admission to a nursing home|0|||
156812555|NCT01238991|566064781|FG004|Overall Study|Admission to a nursing home|0|||
156812556|NCT01238991|566064782|FG005|Overall Study|Admission to a nursing home|0|||
156812557|NCT01238991|566064783|FG006|Overall Study|Admission to a nursing home|0|||
156812558|NCT01238991|566064784|FG007|Overall Study|Admission to a nursing home|0|||
156812559|NCT01238991|566064785|FG008|Overall Study|Admission to a nursing home|0|||
156812560|NCT01238991|566064786|FG009|Overall Study|Admission to a nursing home|0|||
156812561|NCT02222688|566064789|FG000|Overall Study|Withdrawal by Subject|0|||
156812562|NCT02222688|566064790|FG001|Overall Study|Withdrawal by Subject|0|||
156812563|NCT02222688|566064791|FG002|Overall Study|Withdrawal by Subject|0|||
156812564|NCT02222688|566064792|FG003|Overall Study|Withdrawal by Subject|2|||
156812565|NCT02222688|566064793|FG004|Overall Study|Withdrawal by Subject|1|||
156812566|NCT02222688|566064794|FG005|Overall Study|Withdrawal by Subject|0|||
156812567|NCT02222688|566064795|FG006|Overall Study|Withdrawal by Subject|1|||
156812568|NCT02222688|566064789|FG000|Overall Study|Disease progression|1|||
156812569|NCT02222688|566064790|FG001|Overall Study|Disease progression|0|||
156812570|NCT02222688|566064791|FG002|Overall Study|Disease progression|0|||
156812571|NCT02222688|566064792|FG003|Overall Study|Disease progression|0|||
156338943|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
156812572|NCT02222688|566064793|FG004|Overall Study|Disease progression|0|||
156812573|NCT02222688|566064794|FG005|Overall Study|Disease progression|0|||
156812574|NCT02222688|566064795|FG006|Overall Study|Disease progression|0|||
156812575|NCT02297815|566064798|FG000|Overall Study|Lost to Follow-up|236|||
156463667|NCT03279978|564794797|FG002|Overall Study|Other than stated above|0|||
156463668|NCT03279978|564794798|FG003|Overall Study|Other than stated above|0|||
156463669|NCT03279978|564794799|FG004|Overall Study|Other than stated above|0|||
156463670|NCT03279978|564794800|FG005|Overall Study|Other than stated above|0|||
156463671|NCT03279978|564794801|FG006|Overall Study|Other than stated above|1|||
156463672|NCT03279978|564794802|FG007|Overall Study|Other than stated above|0|||
156463673|NCT03279978|564794803|FG008|Overall Study|Other than stated above|0|||
156463674|NCT03279978|564794804|FG009|Overall Study|Other than stated above|0|||
156463675|NCT01651000|564794805|FG000|Overall Study|Adverse Event|2|||
156463676|NCT01651000|564794806|FG001|Overall Study|Adverse Event|8|||
156463677|NCT01651000|564794805|FG000|Overall Study|Lost to Follow-up|3|||
156463678|NCT01651000|564794806|FG001|Overall Study|Lost to Follow-up|2|||
156463679|NCT01651000|564794805|FG000|Overall Study|Protocol Violation|0|||
156463680|NCT01651000|564794806|FG001|Overall Study|Protocol Violation|3|||
156463681|NCT01651000|564794805|FG000|Overall Study|Withdrawal by Subject|2|||
156463682|NCT01651000|564794806|FG001|Overall Study|Withdrawal by Subject|10|||
156463683|NCT01651000|564794805|FG000|Overall Study|Subject noncompliance|0|||
156463684|NCT01651000|564794806|FG001|Overall Study|Subject noncompliance|3|||
156463685|NCT01651000|564794805|FG000|Overall Study|Lack of Efficacy|1|||
156463686|NCT01651000|564794806|FG001|Overall Study|Lack of Efficacy|1|||
156463687|NCT01651000|564794805|FG000|Overall Study|Physician Decision|1|||
156463688|NCT01651000|564794806|FG001|Overall Study|Physician Decision|0|||
156463689|NCT01651000|564794805|FG000|Overall Study|Administrative reason|1|||
156812576|NCT02297815|566064799|FG001|Overall Study|Lost to Follow-up|140|||
156463690|NCT01651000|564794806|FG001|Overall Study|Administrative reason|0|||
156463691|NCT01651000|564794805|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
156463692|NCT01651000|564794806|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
156463693|NCT02765412|564794807|FG000|Overall Study|Death|482|||
156463694|NCT02765412|564794808|FG001|Overall Study|Death|855|||
156463695|NCT03990883|564794809|FG000|Blinded Treatment Phase|Adverse Event|1|||
156463696|NCT03990883|564794810|FG001|Blinded Treatment Phase|Adverse Event|1|||
156463697|NCT03990883|564794811|FG002|Blinded Treatment Phase|Adverse Event|0|||
156463698|NCT03990883|564794809|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
156463699|NCT03990883|564794810|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
156463700|NCT03990883|564794811|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
156463701|NCT03990883|564794809|FG000|Blinded Treatment Phase|Physician Decision|1|||
156463702|NCT03990883|564794810|FG001|Blinded Treatment Phase|Physician Decision|0|||
156463703|NCT03990883|564794811|FG002|Blinded Treatment Phase|Physician Decision|0|||
156463704|NCT03990883|564794809|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
156812577|NCT00294671|566064800|FG000|Overall Study|Lack of Efficacy|11|||
156812578|NCT00294671|566064801|FG001|Overall Study|Lack of Efficacy|23|||
156812579|NCT00294671|566064800|FG000|Overall Study|Liver transplant|7|||
156812580|NCT00294671|566064801|FG001|Overall Study|Liver transplant|9|||
156812581|NCT00294671|566064800|FG000|Overall Study|Drug related adverse event (AE)|4|||
156812582|NCT00294671|566064801|FG001|Overall Study|Drug related adverse event (AE)|2|||
156812583|NCT00294671|566064800|FG000|Overall Study|Non-drug related AE|3|||
156812584|NCT00294671|566064801|FG001|Overall Study|Non-drug related AE|2|||
156812585|NCT00294671|566064800|FG000|Overall Study|Lost to Follow-up|1|||
156812586|NCT00294671|566064801|FG001|Overall Study|Lost to Follow-up|3|||
156812587|NCT00294671|566064800|FG000|Overall Study|Non-compliance|1|||
156463705|NCT03990883|564794810|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
156463706|NCT03990883|564794811|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
156463707|NCT03990883|564794809|FG000|Blinded Treatment Phase|COVID-19|3|||
156463708|NCT03990883|564794810|FG001|Blinded Treatment Phase|COVID-19|2|||
156463709|NCT03990883|564794811|FG002|Blinded Treatment Phase|COVID-19|0|||
156463710|NCT03990883|564794809|FG000|Blinded Treatment Phase|Personal Reasons|6|||
156463711|NCT03990883|564794810|FG001|Blinded Treatment Phase|Personal Reasons|3|||
156463712|NCT03990883|564794811|FG002|Blinded Treatment Phase|Personal Reasons|0|||
156463713|NCT03990883|564794809|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
156463714|NCT03990883|564794810|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
156463715|NCT03990883|564794811|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
156463716|NCT03990883|564794809|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
156463717|NCT03990883|564794810|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
156463718|NCT03990883|564794811|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
156463719|NCT03990883|564794809|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
156463720|NCT03990883|564794810|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
156463721|NCT03990883|564794811|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
156463722|NCT03734029|564794812|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
156463723|NCT03734029|564794813|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
156463724|NCT03734029|564794812|FG000|Overall Study|Adverse Event|60|||
156463725|NCT03734029|564794813|FG001|Overall Study|Adverse Event|14|||
156463726|NCT03734029|564794812|FG000|Overall Study|Withdrawal by Subject|12|||
156812588|NCT00294671|566064801|FG001|Overall Study|Non-compliance|0|||
156812589|NCT00294671|566064800|FG000|Overall Study|Death|0|||
156812590|NCT00294671|566064801|FG001|Overall Study|Death|1|||
156338944|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
156463727|NCT03734029|564794813|FG001|Overall Study|Withdrawal by Subject|11|||
156463728|NCT03734029|564794812|FG000|Overall Study|Clinical progression by investigator|10|||
156463729|NCT03734029|564794813|FG001|Overall Study|Clinical progression by investigator|8|||
156463730|NCT03734029|564794812|FG000|Overall Study|Death|5|||
156463731|NCT03734029|564794813|FG001|Overall Study|Death|2|||
156463732|NCT03734029|564794812|FG000|Overall Study|Physician Decision|4|||
156463733|NCT03734029|564794813|FG001|Overall Study|Physician Decision|3|||
156463734|NCT03734029|564794812|FG000|Overall Study|Other|2|||
156463735|NCT03734029|564794813|FG001|Overall Study|Other|0|||
156463736|NCT03734029|564794812|FG000|Overall Study|Lost to Follow-up|0|||
156463737|NCT03734029|564794813|FG001|Overall Study|Lost to Follow-up|1|||
156463738|NCT03734029|564794812|FG000|Overall Study|Randomized, but not treated|2|||
156463739|NCT03734029|564794813|FG001|Overall Study|Randomized, but not treated|12|||
156463740|NCT05412004|564795837|FG000|Overall Study|Adverse Event|0|||
156463741|NCT05412004|564795838|FG001|Overall Study|Adverse Event|2|||
156463742|NCT05412004|564795839|FG002|Overall Study|Adverse Event|1|||
156463743|NCT05412004|564795840|FG003|Overall Study|Adverse Event|5|||
156463744|NCT05412004|564795837|FG000|Overall Study|Assigned Treatment by Mistake|5|||
156463745|NCT05412004|564795838|FG001|Overall Study|Assigned Treatment by Mistake|10|||
156463746|NCT05412004|564795839|FG002|Overall Study|Assigned Treatment by Mistake|2|||
156463747|NCT05412004|564795840|FG003|Overall Study|Assigned Treatment by Mistake|5|||
156463748|NCT05412004|564795837|FG000|Overall Study|Lost to Follow-up|3|||
156463749|NCT05412004|564795838|FG001|Overall Study|Lost to Follow-up|0|||
156463750|NCT05412004|564795839|FG002|Overall Study|Lost to Follow-up|0|||
156463751|NCT05412004|564795840|FG003|Overall Study|Lost to Follow-up|0|||
156463752|NCT05412004|564795837|FG000|Overall Study|Patient could not travel to site|0|||
156463753|NCT05412004|564795838|FG001|Overall Study|Patient could not travel to site|1|||
156463754|NCT05412004|564795839|FG002|Overall Study|Patient could not travel to site|0|||
156463755|NCT05412004|564795840|FG003|Overall Study|Patient could not travel to site|0|||
156463756|NCT05412004|564795837|FG000|Overall Study|Physician Decision|0|||
156463757|NCT05412004|564795838|FG001|Overall Study|Physician Decision|1|||
156463758|NCT05412004|564795839|FG002|Overall Study|Physician Decision|0|||
156463759|NCT05412004|564795840|FG003|Overall Study|Physician Decision|0|||
156463760|NCT05412004|564795837|FG000|Overall Study|Pregnancy|0|||
156463761|NCT05412004|564795838|FG001|Overall Study|Pregnancy|1|||
156463762|NCT05412004|564795839|FG002|Overall Study|Pregnancy|0|||
156463763|NCT05412004|564795840|FG003|Overall Study|Pregnancy|0|||
156463764|NCT05412004|564795837|FG000|Overall Study|Protocol Violation|1|||
156463765|NCT05412004|564795838|FG001|Overall Study|Protocol Violation|0|||
156463766|NCT05412004|564795839|FG002|Overall Study|Protocol Violation|0|||
156463767|NCT05412004|564795840|FG003|Overall Study|Protocol Violation|0|||
156463768|NCT05412004|564795837|FG000|Overall Study|Withdrawal by Subject|4|||
156463769|NCT05412004|564795838|FG001|Overall Study|Withdrawal by Subject|19|||
156463770|NCT05412004|564795839|FG002|Overall Study|Withdrawal by Subject|4|||
156463771|NCT05412004|564795840|FG003|Overall Study|Withdrawal by Subject|14|||
156463772|NCT05412004|564795837|FG000|Overall Study|Screen Failure|0|||
156463773|NCT05412004|564795838|FG001|Overall Study|Screen Failure|0|||
156463774|NCT05412004|564795839|FG002|Overall Study|Screen Failure|0|||
156463775|NCT05412004|564795840|FG003|Overall Study|Screen Failure|1|||
156463776|NCT05412004|564795837|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
156463777|NCT05412004|564795838|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
156463778|NCT05412004|564795839|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
156463779|NCT05412004|564795840|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
156463780|NCT03781089|564795841|FG000|Overall Study|Constipation|1|||
156463781|NCT03781089|564795842|FG001|Overall Study|Constipation|0|||
156463782|NCT03781089|564795841|FG000|Overall Study|Positive pregnancy test|0|||
156463783|NCT03781089|564795842|FG001|Overall Study|Positive pregnancy test|1|||
156463784|NCT04644029|564795843|FG000|Overall Study|Death|1|||
156463785|NCT04644029|564795844|FG001|Overall Study|Death|0|||
156463786|NCT04644029|564795843|FG000|Overall Study|Physician Decision|1|||
156463787|NCT04644029|564795844|FG001|Overall Study|Physician Decision|2|||
156463788|NCT04644029|564795843|FG000|Overall Study|Withdrawal by Subject|21|||
156463789|NCT04644029|564795844|FG001|Overall Study|Withdrawal by Subject|19|||
156463790|NCT04644029|564795843|FG000|Overall Study|Lost to Follow-up|31|||
156463791|NCT04644029|564795844|FG001|Overall Study|Lost to Follow-up|34|||
156463792|NCT04644029|564795843|FG000|Overall Study|Study Terminated by Sponsor|308|||
156463793|NCT04644029|564795844|FG001|Overall Study|Study Terminated by Sponsor|309|||
156463794|NCT04644029|564795843|FG000|Overall Study|Randomized in Error|2|||
156463795|NCT04644029|564795844|FG001|Overall Study|Randomized in Error|1|||
156463796|NCT04644029|564795843|FG000|Overall Study|Other|0|||
156463797|NCT04644029|564795844|FG001|Overall Study|Other|1|||
156463798|NCT05132400|564795845|FG000|Overall Study|Withdrawal by Subject|14|||
156463799|NCT05132400|564795846|FG001|Overall Study|Withdrawal by Subject|8|||
156538972|NCT06156215|565066429|FG004|Overall Study|Left ED without completing study|8|||
156538973|NCT06156215|565066430|FG005|Overall Study|Left ED without completing study|16|||
156538974|NCT06156215|565066425|FG000|Overall Study|Physician Decision|1|||
156538975|NCT06156215|565066426|FG001|Overall Study|Physician Decision|0|||
156538976|NCT06156215|565066427|FG002|Overall Study|Physician Decision|0|||
156538977|NCT06156215|565066428|FG003|Overall Study|Physician Decision|0|||
156538978|NCT06156215|565066429|FG004|Overall Study|Physician Decision|0|||
156538979|NCT06156215|565066430|FG005|Overall Study|Physician Decision|0|||
156538980|NCT06156215|565066425|FG000|Overall Study|Became or found ineligible|2|||
156538981|NCT06156215|565066426|FG001|Overall Study|Became or found ineligible|0|||
156538982|NCT06156215|565066427|FG002|Overall Study|Became or found ineligible|2|||
156538983|NCT06156215|565066428|FG003|Overall Study|Became or found ineligible|0|||
156538984|NCT06156215|565066429|FG004|Overall Study|Became or found ineligible|1|||
156538985|NCT06156215|565066430|FG005|Overall Study|Became or found ineligible|2|||
156538986|NCT04360551|565068133|FG000|Overall Study|Withdrawal by Subject|1|||
156538987|NCT04360551|565068134|FG001|Overall Study|Withdrawal by Subject|0|||
156538988|NCT01524198|565068143|FG000|Overall Study|Protocol Violation|8|||
156538989|NCT01524198|565068144|FG001|Overall Study|Protocol Violation|6|||
156538990|NCT01524198|565068143|FG000|Overall Study|Withdrawal by Subject|15|||
156538991|NCT01524198|565068144|FG001|Overall Study|Withdrawal by Subject|10|||
156538992|NCT02232802|565068145|FG000|Period 1|Sponsor request|1|||
156538993|NCT02232802|565068146|FG001|Period 1|Sponsor request|0|||
156538994|NCT02232802|565068145|FG000|Period 1|Adverse Event|1|||
156538995|NCT02232802|565068146|FG001|Period 1|Adverse Event|1|||
156538996|NCT00885703|565068151|FG000|Overall Study|Death|9|||
156538997|NCT00885703|565068152|FG001|Overall Study|Death|7|||
156538998|NCT00885703|565068153|FG002|Overall Study|Death|8|||
156538999|NCT00885703|565068154|FG003|Overall Study|Death|7|||
156539000|NCT00885703|565068155|FG004|Overall Study|Death|7|||
156539001|NCT00885703|565068156|FG005|Overall Study|Death|8|||
156539002|NCT00885703|565068157|FG006|Overall Study|Death|4|||
156539003|NCT00885703|565068151|FG000|Overall Study|Lost to Follow-up|0|||
156539004|NCT00885703|565068152|FG001|Overall Study|Lost to Follow-up|0|||
156539005|NCT00885703|565068153|FG002|Overall Study|Lost to Follow-up|1|||
156539006|NCT00885703|565068154|FG003|Overall Study|Lost to Follow-up|0|||
156539007|NCT00885703|565068155|FG004|Overall Study|Lost to Follow-up|0|||
156539008|NCT00885703|565068156|FG005|Overall Study|Lost to Follow-up|1|||
156539009|NCT00885703|565068157|FG006|Overall Study|Lost to Follow-up|0|||
156539010|NCT00885703|565068151|FG000|Overall Study|Withdrawal by Subject|0|||
156539011|NCT00885703|565068152|FG001|Overall Study|Withdrawal by Subject|0|||
156539012|NCT00885703|565068153|FG002|Overall Study|Withdrawal by Subject|0|||
156539013|NCT00885703|565068154|FG003|Overall Study|Withdrawal by Subject|1|||
156539014|NCT00885703|565068155|FG004|Overall Study|Withdrawal by Subject|3|||
156539015|NCT00885703|565068156|FG005|Overall Study|Withdrawal by Subject|1|||
156539016|NCT00885703|565068157|FG006|Overall Study|Withdrawal by Subject|1|||
156539017|NCT00885703|565068151|FG000|Overall Study|Ineligible (no CM)|1|||
156539018|NCT00885703|565068152|FG001|Overall Study|Ineligible (no CM)|3|||
156539019|NCT00885703|565068153|FG002|Overall Study|Ineligible (no CM)|2|||
156539020|NCT00885703|565068154|FG003|Overall Study|Ineligible (no CM)|1|||
156539021|NCT00885703|565068155|FG004|Overall Study|Ineligible (no CM)|2|||
156539022|NCT00885703|565068156|FG005|Overall Study|Ineligible (no CM)|3|||
156539023|NCT00885703|565068157|FG006|Overall Study|Ineligible (no CM)|1|||
156539024|NCT01462435|565068158|FG000|Overall Study|Lack of Efficacy|1|||
156539025|NCT01462435|565068159|FG001|Overall Study|Lack of Efficacy|0|||
156539026|NCT01462435|565068160|FG002|Overall Study|Lack of Efficacy|0|||
156539027|NCT01462435|565068161|FG003|Overall Study|Lack of Efficacy|3|||
156539028|NCT01462435|565068158|FG000|Overall Study|Physician Decision|0|||
156539029|NCT01462435|565068159|FG001|Overall Study|Physician Decision|0|||
156539030|NCT01462435|565068160|FG002|Overall Study|Physician Decision|1|||
156539031|NCT01462435|565068161|FG003|Overall Study|Physician Decision|0|||
156539032|NCT01462435|565068158|FG000|Overall Study|Withdrawal by Subject|0|||
156539033|NCT01462435|565068159|FG001|Overall Study|Withdrawal by Subject|0|||
156539034|NCT01462435|565068160|FG002|Overall Study|Withdrawal by Subject|0|||
156539035|NCT01462435|565068161|FG003|Overall Study|Withdrawal by Subject|1|||
156539036|NCT01462435|565068158|FG000|Overall Study|Lost to Follow-up|0|||
156539037|NCT01462435|565068159|FG001|Overall Study|Lost to Follow-up|0|||
156539038|NCT01462435|565068160|FG002|Overall Study|Lost to Follow-up|0|||
156539039|NCT01462435|565068161|FG003|Overall Study|Lost to Follow-up|1|||
156539040|NCT01543152|565068164|FG000|Overall Study|Withdrawal by Subject|0|||
156539041|NCT01543152|565068165|FG001|Overall Study|Withdrawal by Subject|2|||
156539042|NCT01543152|565068166|FG002|Overall Study|Withdrawal by Subject|0|||
156539043|NCT01543152|565068167|FG003|Overall Study|Withdrawal by Subject|0|||
156539044|NCT01543152|565068168|FG004|Overall Study|Withdrawal by Subject|0|||
156539045|NCT02053168|565068171|FG000|Overall Study|Withdrawal by Subject|1|||
156539046|NCT02053168|565068171|FG000|Overall Study|Physician Decision|1|||
156539047|NCT02053168|565068171|FG000|Overall Study|Lost to Follow-up|1|||
156539048|NCT02687542|565068173|FG000|Overall Study|Medication error without associated AEs|0|||
156539049|NCT02687542|565068174|FG001|Overall Study|Medication error without associated AEs|0|||
156539050|NCT02687542|565068175|FG002|Overall Study|Medication error without associated AEs|0|||
156463800|NCT05132400|564795845|FG000|Overall Study|Lost to Follow-up|132|||
156463801|NCT05132400|564795846|FG001|Overall Study|Lost to Follow-up|121|||
156463802|NCT03934931|564795847|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
156463803|NCT03934931|564795848|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
156463804|NCT03934931|564795849|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
156338945|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
156338946|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
156338947|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
156463805|NCT02076009|564795852|FG000|Overall Study|Death|172|||
156463806|NCT02076009|564795853|FG001|Overall Study|Death|153|||
156463807|NCT02076009|564795852|FG000|Overall Study|Withdrawal by Subject|16|||
156463808|NCT02076009|564795853|FG001|Overall Study|Withdrawal by Subject|12|||
156463809|NCT02076009|564795852|FG000|Overall Study|Lost to Follow-up|4|||
156463810|NCT02076009|564795853|FG001|Overall Study|Lost to Follow-up|2|||
156463811|NCT02076009|564795852|FG000|Overall Study|Progressive Disease|1|||
156463812|NCT02076009|564795853|FG001|Overall Study|Progressive Disease|0|||
156463813|NCT02076009|564795852|FG000|Overall Study|Physician Decision|0|||
156463814|NCT02076009|564795853|FG001|Overall Study|Physician Decision|1|||
156463815|NCT02076009|564795852|FG000|Overall Study|End of data collection|90|||
156463816|NCT02076009|564795853|FG001|Overall Study|End of data collection|118|||
156463817|NCT03786926|564795856|FG000|Overall Study|Adverse Event|0|||
156463818|NCT03786926|564795857|FG001|Overall Study|Adverse Event|0|||
156463819|NCT03786926|564795858|FG002|Overall Study|Adverse Event|0|||
156463820|NCT03786926|564795859|FG003|Overall Study|Adverse Event|0|||
156463821|NCT03786926|564795860|FG004|Overall Study|Adverse Event|0|||
156463822|NCT03786926|564795861|FG005|Overall Study|Adverse Event|0|||
156463823|NCT03786926|564795862|FG006|Overall Study|Adverse Event|0|||
156463824|NCT03786926|564795863|FG007|Overall Study|Adverse Event|1|||
156463825|NCT03786926|564795864|FG008|Overall Study|Adverse Event|1|||
156463826|NCT03786926|564795865|FG009|Overall Study|Adverse Event|0|||
156463827|NCT03786926|564795866|FG010|Overall Study|Adverse Event|1|||
156463828|NCT03786926|564795856|FG000|Overall Study|Progressive disease|3|||
156463829|NCT03786926|564795857|FG001|Overall Study|Progressive disease|0|||
156463830|NCT03786926|564795858|FG002|Overall Study|Progressive disease|3|||
156463831|NCT03786926|564795859|FG003|Overall Study|Progressive disease|1|||
156463832|NCT03786926|564795860|FG004|Overall Study|Progressive disease|2|||
156463833|NCT03786926|564795861|FG005|Overall Study|Progressive disease|2|||
156463834|NCT03786926|564795862|FG006|Overall Study|Progressive disease|1|||
156463835|NCT03786926|564795863|FG007|Overall Study|Progressive disease|6|||
156463836|NCT03786926|564795864|FG008|Overall Study|Progressive disease|1|||
156463837|NCT03786926|564795865|FG009|Overall Study|Progressive disease|1|||
156463838|NCT03786926|564795866|FG010|Overall Study|Progressive disease|1|||
156463839|NCT03786926|564795856|FG000|Overall Study|Death|0|||
156463840|NCT03786926|564795857|FG001|Overall Study|Death|1|||
156463841|NCT03786926|564795858|FG002|Overall Study|Death|1|||
156463842|NCT03786926|564795859|FG003|Overall Study|Death|0|||
156463843|NCT03786926|564795860|FG004|Overall Study|Death|0|||
156463844|NCT03786926|564795861|FG005|Overall Study|Death|0|||
156463845|NCT03786926|564795862|FG006|Overall Study|Death|0|||
156463846|NCT03786926|564795863|FG007|Overall Study|Death|0|||
156463847|NCT03786926|564795864|FG008|Overall Study|Death|0|||
156463848|NCT03786926|564795865|FG009|Overall Study|Death|1|||
156463849|NCT03786926|564795866|FG010|Overall Study|Death|2|||
156463850|NCT03786926|564795856|FG000|Overall Study|Physician Decision|0|||
156463851|NCT03786926|564795857|FG001|Overall Study|Physician Decision|1|||
156463852|NCT03786926|564795858|FG002|Overall Study|Physician Decision|0|||
156463853|NCT03786926|564795859|FG003|Overall Study|Physician Decision|1|||
156463854|NCT03786926|564795860|FG004|Overall Study|Physician Decision|2|||
156463855|NCT03786926|564795861|FG005|Overall Study|Physician Decision|0|||
156463856|NCT03786926|564795862|FG006|Overall Study|Physician Decision|0|||
156463857|NCT03786926|564795863|FG007|Overall Study|Physician Decision|2|||
156463858|NCT03786926|564795864|FG008|Overall Study|Physician Decision|1|||
156463859|NCT03786926|564795865|FG009|Overall Study|Physician Decision|1|||
156463860|NCT03786926|564795866|FG010|Overall Study|Physician Decision|0|||
156463861|NCT03786926|564795856|FG000|Overall Study|Withdrawal by Subject|0|||
156463862|NCT03786926|564795857|FG001|Overall Study|Withdrawal by Subject|1|||
156463863|NCT03786926|564795858|FG002|Overall Study|Withdrawal by Subject|1|||
156463864|NCT03786926|564795859|FG003|Overall Study|Withdrawal by Subject|0|||
156338948|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
156463865|NCT03786926|564795860|FG004|Overall Study|Withdrawal by Subject|0|||
156463866|NCT03786926|564795861|FG005|Overall Study|Withdrawal by Subject|0|||
156463867|NCT03786926|564795862|FG006|Overall Study|Withdrawal by Subject|1|||
156463868|NCT03786926|564795863|FG007|Overall Study|Withdrawal by Subject|0|||
156463869|NCT03786926|564795864|FG008|Overall Study|Withdrawal by Subject|1|||
156463870|NCT03786926|564795865|FG009|Overall Study|Withdrawal by Subject|0|||
156463871|NCT03786926|564795866|FG010|Overall Study|Withdrawal by Subject|1|||
156463872|NCT03786926|564795856|FG000|Overall Study|Study terminated by Sponsor|0|||
156463873|NCT03786926|564795857|FG001|Overall Study|Study terminated by Sponsor|0|||
156463874|NCT03786926|564795858|FG002|Overall Study|Study terminated by Sponsor|0|||
156463875|NCT03786926|564795859|FG003|Overall Study|Study terminated by Sponsor|0|||
156463876|NCT03786926|564795860|FG004|Overall Study|Study terminated by Sponsor|1|||
156463877|NCT03786926|564795861|FG005|Overall Study|Study terminated by Sponsor|0|||
156463878|NCT03786926|564795862|FG006|Overall Study|Study terminated by Sponsor|0|||
156463879|NCT03786926|564795863|FG007|Overall Study|Study terminated by Sponsor|4|||
156463880|NCT03786926|564795864|FG008|Overall Study|Study terminated by Sponsor|0|||
156539051|NCT02687542|565068176|FG003|Overall Study|Medication error without associated AEs|0|||
156539052|NCT02687542|565068177|FG004|Overall Study|Medication error without associated AEs|1|||
156539053|NCT02687542|565068173|FG000|Overall Study|Lost to Follow-up|0|||
156539054|NCT02687542|565068174|FG001|Overall Study|Lost to Follow-up|0|||
156539055|NCT02687542|565068175|FG002|Overall Study|Lost to Follow-up|0|||
156539056|NCT02687542|565068176|FG003|Overall Study|Lost to Follow-up|0|||
156539057|NCT02687542|565068177|FG004|Overall Study|Lost to Follow-up|1|||
156539058|NCT02687542|565068173|FG000|Overall Study|Protocol Violation|0|||
156539059|NCT02687542|565068174|FG001|Overall Study|Protocol Violation|1|||
156539060|NCT02687542|565068175|FG002|Overall Study|Protocol Violation|0|||
156539061|NCT02687542|565068176|FG003|Overall Study|Protocol Violation|0|||
156539062|NCT02687542|565068177|FG004|Overall Study|Protocol Violation|0|||
156539063|NCT02687542|565068173|FG000|Overall Study|Other|5|||
156539064|NCT02687542|565068174|FG001|Overall Study|Other|9|||
156539065|NCT02687542|565068175|FG002|Overall Study|Other|10|||
156539066|NCT02687542|565068176|FG003|Overall Study|Other|6|||
156539067|NCT02687542|565068177|FG004|Overall Study|Other|5|||
156539068|NCT02687542|565068173|FG000|Overall Study|Adverse Event|3|||
156539069|NCT02687542|565068174|FG001|Overall Study|Adverse Event|1|||
156539070|NCT02687542|565068175|FG002|Overall Study|Adverse Event|3|||
156539071|NCT02687542|565068176|FG003|Overall Study|Adverse Event|2|||
156539072|NCT02687542|565068177|FG004|Overall Study|Adverse Event|9|||
156539073|NCT02687542|565068173|FG000|Overall Study|Withdrawal by Subject|0|||
156539074|NCT02687542|565068174|FG001|Overall Study|Withdrawal by Subject|1|||
156539075|NCT02687542|565068175|FG002|Overall Study|Withdrawal by Subject|1|||
156539076|NCT02687542|565068176|FG003|Overall Study|Withdrawal by Subject|2|||
156539077|NCT02687542|565068177|FG004|Overall Study|Withdrawal by Subject|4|||
156539078|NCT00636675|565068178|FG000|Overall Study|Lost to Follow-up|121|||
156539079|NCT00636675|565068179|FG001|Overall Study|Lost to Follow-up|31|||
156539080|NCT00636675|565068178|FG000|Overall Study|Withdrawal by Subject|19|||
156539081|NCT00636675|565068179|FG001|Overall Study|Withdrawal by Subject|10|||
156539082|NCT03785925|565068180|FG000|Overall Study|Withdrawal by Subject|15|||
156539083|NCT03785925|565068180|FG000|Overall Study|Lost to Follow-up|1|||
156539084|NCT01227187|565068181|FG000|Overall Study|Physician Decision|0|||
156539085|NCT01227187|565068182|FG001|Overall Study|Physician Decision|0|||
156539086|NCT01227187|565068183|FG002|Overall Study|Physician Decision|0|||
156539087|NCT01227187|565068184|FG003|Overall Study|Physician Decision|1|||
156539088|NCT00957528|565068188|FG000|Overall Study|Protocol Violation|0|||
156539089|NCT00957528|565068189|FG001|Overall Study|Protocol Violation|1|||
156539090|NCT00957528|565068190|FG002|Overall Study|Protocol Violation|0|||
156539091|NCT00957528|565068188|FG000|Overall Study|Withdrawal by Subject|0|||
156539092|NCT00957528|565068189|FG001|Overall Study|Withdrawal by Subject|0|||
156539093|NCT00957528|565068190|FG002|Overall Study|Withdrawal by Subject|1|||
156539094|NCT01101438|565068192|FG000|Overall Study|Withdrawal by Subject|8|||
156539095|NCT01101438|565068193|FG001|Overall Study|Withdrawal by Subject|9|||
156539096|NCT03677596|565068209|FG000|Overall Study|Adverse Event|0|||
156539097|NCT03677596|565068210|FG001|Overall Study|Adverse Event|1|||
156539098|NCT03677596|565068209|FG000|Overall Study|Death|10|||
156539099|NCT03677596|565068210|FG001|Overall Study|Death|6|||
156539100|NCT03677596|565068209|FG000|Overall Study|Lost to Follow-up|0|||
156539101|NCT03677596|565068210|FG001|Overall Study|Lost to Follow-up|1|||
156539102|NCT03677596|565068209|FG000|Overall Study|Progressive Disease|8|||
156539103|NCT03677596|565068210|FG001|Overall Study|Progressive Disease|8|||
156539104|NCT03677596|565068209|FG000|Overall Study|Withdrawal by Subject|3|||
156539105|NCT03677596|565068210|FG001|Overall Study|Withdrawal by Subject|0|||
156539106|NCT03677596|565068209|FG000|Overall Study|Disease Relapse|2|||
156539107|NCT03677596|565068210|FG001|Overall Study|Disease Relapse|2|||
156539108|NCT03677596|565068209|FG000|Overall Study|Other|0|||
156539109|NCT03677596|565068210|FG001|Overall Study|Other|1|||
156539110|NCT00914927|565068215|FG000|Overall Study|Adverse Event|0|||
156539111|NCT00914927|565068216|FG001|Overall Study|Adverse Event|0|||
156463881|NCT03786926|564795865|FG009|Overall Study|Study terminated by Sponsor|0|||
156463882|NCT03786926|564795866|FG010|Overall Study|Study terminated by Sponsor|0|||
156463883|NCT03786926|564795856|FG000|Overall Study|Anti-neoplasm treatment|0|||
156463884|NCT03786926|564795857|FG001|Overall Study|Anti-neoplasm treatment|0|||
156463885|NCT03786926|564795858|FG002|Overall Study|Anti-neoplasm treatment|0|||
156463886|NCT03786926|564795859|FG003|Overall Study|Anti-neoplasm treatment|0|||
156463887|NCT03786926|564795860|FG004|Overall Study|Anti-neoplasm treatment|1|||
156463888|NCT03786926|564795861|FG005|Overall Study|Anti-neoplasm treatment|0|||
156539112|NCT00914927|565068217|FG002|Overall Study|Adverse Event|0|||
156539113|NCT00914927|565068218|FG003|Overall Study|Adverse Event|0|||
156539114|NCT00914927|565068219|FG004|Overall Study|Adverse Event|1|||
156539115|NCT00914927|565068220|FG005|Overall Study|Adverse Event|0|||
156463889|NCT03786926|564795862|FG006|Overall Study|Anti-neoplasm treatment|1|||
156463890|NCT03786926|564795863|FG007|Overall Study|Anti-neoplasm treatment|0|||
156463891|NCT03786926|564795864|FG008|Overall Study|Anti-neoplasm treatment|0|||
156463892|NCT03786926|564795865|FG009|Overall Study|Anti-neoplasm treatment|0|||
156463893|NCT03786926|564795866|FG010|Overall Study|Anti-neoplasm treatment|0|||
156463894|NCT03786926|564795856|FG000|Overall Study|Other|0|||
156463895|NCT03786926|564795857|FG001|Overall Study|Other|0|||
156463896|NCT03786926|564795858|FG002|Overall Study|Other|0|||
156463897|NCT03786926|564795859|FG003|Overall Study|Other|1|||
156463898|NCT03786926|564795860|FG004|Overall Study|Other|0|||
156463899|NCT03786926|564795861|FG005|Overall Study|Other|1|||
156463900|NCT03786926|564795862|FG006|Overall Study|Other|0|||
156463901|NCT03786926|564795863|FG007|Overall Study|Other|0|||
156463902|NCT03786926|564795864|FG008|Overall Study|Other|2|||
156463903|NCT03786926|564795865|FG009|Overall Study|Other|0|||
156463904|NCT03786926|564795866|FG010|Overall Study|Other|0|||
156463905|NCT05988398|564795872|FG000|Overall Study|Lack of time|21|||
156463906|NCT05988398|564795873|FG001|Overall Study|Lack of time|0|||
156463907|NCT05988398|564795872|FG000|Overall Study|Absent from school|0|||
156463908|NCT05988398|564795873|FG001|Overall Study|Absent from school|38|||
156463909|NCT05988398|564795872|FG000|Overall Study|Chose not to participate|0|||
156463910|NCT05988398|564795873|FG001|Overall Study|Chose not to participate|42|||
156463911|NCT05988398|564795872|FG000|Overall Study|Other commitments (e.g., sports)|0|||
156463912|NCT05988398|564795873|FG001|Overall Study|Other commitments (e.g., sports)|25|||
156463913|NCT00942734|564795875|FG000|Overall Study|Adverse Event|2|||
156463914|NCT00942734|564795875|FG000|Overall Study|Protocol Violation|3|||
156463915|NCT00942734|564795875|FG000|Overall Study|Disease Progression|2|||
156463916|NCT00942734|564795875|FG000|Overall Study|Physician Decision|1|||
156463917|NCT00319046|564795876|FG000|Overall Study|withdrawal of subject's consent|7|||
156463918|NCT00319046|564795876|FG000|Overall Study|administrative reason|1|||
156463919|NCT05147584|564795877|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
156463920|NCT03370913|564795883|FG000|Overall Study|Death|1|||
156463921|NCT03370913|564795883|FG000|Overall Study|Lost to Follow-up|1|||
156463922|NCT04496752|564795888|FG000|Second Assessment|Lost to Follow-up|3|||
156463923|NCT04496752|564795889|FG001|Second Assessment|Lost to Follow-up|3|||
156463924|NCT04496752|564795888|FG000|Second Assessment|Adverse Event|2|||
156463925|NCT04496752|564795889|FG001|Second Assessment|Adverse Event|0|||
156463926|NCT04078152|564795890|FG000|Overall Study|Other|83|||
156463927|NCT04078152|564795891|FG001|Overall Study|Other|22|||
156463928|NCT04078152|564795892|FG002|Overall Study|Other|25|||
156463929|NCT04078152|564795890|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
156463930|NCT04078152|564795891|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
156463931|NCT04078152|564795892|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
156463932|NCT04078152|564795890|FG000|Overall Study|Withdrawal by Subject|5|||
156463933|NCT04078152|564795891|FG001|Overall Study|Withdrawal by Subject|0|||
156463934|NCT04078152|564795892|FG002|Overall Study|Withdrawal by Subject|1|||
156463935|NCT04078152|564795890|FG000|Overall Study|Death|10|||
156463936|NCT04078152|564795891|FG001|Overall Study|Death|2|||
156463937|NCT04078152|564795892|FG002|Overall Study|Death|12|||
156463938|NCT04078152|564795890|FG000|Overall Study|Adverse Event|1|||
156463939|NCT04078152|564795891|FG001|Overall Study|Adverse Event|0|||
156463940|NCT04078152|564795892|FG002|Overall Study|Adverse Event|0|||
156463941|NCT04679389|564795893|FG000|Overall Study|Adverse Event|1|||
156463942|NCT04679389|564795894|FG001|Overall Study|Adverse Event|0|||
156463943|NCT04679389|564795893|FG000|Overall Study|Protocol Violation|2|||
156463944|NCT04679389|564795894|FG001|Overall Study|Protocol Violation|0|||
156463945|NCT04679389|564795893|FG000|Overall Study|Physician Decision|3|||
156463946|NCT04679389|564795894|FG001|Overall Study|Physician Decision|5|||
156463947|NCT04679389|564795893|FG000|Overall Study|Withdrawal by Subject|5|||
156463948|NCT04679389|564795894|FG001|Overall Study|Withdrawal by Subject|7|||
156463949|NCT03522298|564795906|FG000|Overall Study|Adverse Event|1|||
156463950|NCT03522298|564795907|FG001|Overall Study|Adverse Event|0|||
156463951|NCT03522298|564795908|FG002|Overall Study|Adverse Event|0|||
156463952|NCT03522298|564795909|FG003|Overall Study|Adverse Event|1|||
156463953|NCT03522298|564795906|FG000|Overall Study|Death|2|||
156463954|NCT03522298|564795907|FG001|Overall Study|Death|4|||
156463955|NCT03522298|564795908|FG002|Overall Study|Death|8|||
156463956|NCT03522298|564795909|FG003|Overall Study|Death|8|||
156463957|NCT03522298|564795906|FG000|Overall Study|Patient decision|0|||
156463958|NCT03522298|564795907|FG001|Overall Study|Patient decision|2|||
156463959|NCT03522298|564795908|FG002|Overall Study|Patient decision|2|||
156463960|NCT03522298|564795909|FG003|Overall Study|Patient decision|2|||
156463961|NCT05718687|564795912|FG000|Overall Study|Withdrawal by Subject|3|||
156463962|NCT01897441|564795915|FG000|Overall Study|Lost to Follow-up|0|||
156463963|NCT01897441|564795916|FG001|Overall Study|Lost to Follow-up|0|||
156463964|NCT01897441|564795917|FG002|Overall Study|Lost to Follow-up|1|||
156463965|NCT01897441|564795918|FG003|Overall Study|Lost to Follow-up|0|||
156463966|NCT01897441|564795919|FG004|Overall Study|Lost to Follow-up|0|||
156463967|NCT01897441|564795920|FG005|Overall Study|Lost to Follow-up|0|||
156463968|NCT01897441|564795915|FG000|Overall Study|Withdrawal by Subject|0|||
156338949|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
156463969|NCT01897441|564795916|FG001|Overall Study|Withdrawal by Subject|0|||
156463970|NCT01897441|564795917|FG002|Overall Study|Withdrawal by Subject|0|||
156463971|NCT01897441|564795918|FG003|Overall Study|Withdrawal by Subject|0|||
156463972|NCT01897441|564795919|FG004|Overall Study|Withdrawal by Subject|1|||
156463973|NCT01897441|564795920|FG005|Overall Study|Withdrawal by Subject|0|||
156463974|NCT01897441|564795915|FG000|Overall Study|Withdrawn by Provider|0|||
156463975|NCT01897441|564795916|FG001|Overall Study|Withdrawn by Provider|2|||
156463976|NCT01897441|564795917|FG002|Overall Study|Withdrawn by Provider|0|||
156463977|NCT01897441|564795918|FG003|Overall Study|Withdrawn by Provider|0|||
156463978|NCT01897441|564795919|FG004|Overall Study|Withdrawn by Provider|0|||
156463979|NCT01897441|564795920|FG005|Overall Study|Withdrawn by Provider|0|||
156463980|NCT03250676|564795925|FG000|Overall Study|Adverse Event|0|||
156463981|NCT03250676|564795926|FG001|Overall Study|Adverse Event|0|||
156463982|NCT03250676|564795927|FG002|Overall Study|Adverse Event|0|||
156463983|NCT03250676|564795928|FG003|Overall Study|Adverse Event|1|||
156463984|NCT03250676|564795929|FG004|Overall Study|Adverse Event|2|||
156463985|NCT03250676|564795930|FG005|Overall Study|Adverse Event|9|||
156463986|NCT03250676|564795925|FG000|Overall Study|Withdrawal by Subject|1|||
156463987|NCT03250676|564795926|FG001|Overall Study|Withdrawal by Subject|0|||
156463988|NCT03250676|564795927|FG002|Overall Study|Withdrawal by Subject|0|||
156463989|NCT03250676|564795928|FG003|Overall Study|Withdrawal by Subject|1|||
156463990|NCT03250676|564795929|FG004|Overall Study|Withdrawal by Subject|1|||
156463991|NCT03250676|564795930|FG005|Overall Study|Withdrawal by Subject|2|||
156463992|NCT03250676|564795925|FG000|Overall Study|Physician Decision|0|||
156463993|NCT03250676|564795926|FG001|Overall Study|Physician Decision|0|||
156463994|NCT03250676|564795927|FG002|Overall Study|Physician Decision|0|||
156463995|NCT03250676|564795928|FG003|Overall Study|Physician Decision|2|||
156463996|NCT03250676|564795929|FG004|Overall Study|Physician Decision|0|||
156463997|NCT03250676|564795930|FG005|Overall Study|Physician Decision|3|||
156463998|NCT03250676|564795925|FG000|Overall Study|Withdrawal of consent|0|||
156463999|NCT03250676|564795926|FG001|Overall Study|Withdrawal of consent|0|||
156464000|NCT03250676|564795927|FG002|Overall Study|Withdrawal of consent|2|||
156464001|NCT03250676|564795928|FG003|Overall Study|Withdrawal of consent|0|||
156464002|NCT03250676|564795929|FG004|Overall Study|Withdrawal of consent|0|||
156464003|NCT03250676|564795930|FG005|Overall Study|Withdrawal of consent|2|||
156464004|NCT03250676|564795925|FG000|Overall Study|Other|1|||
156464005|NCT03250676|564795926|FG001|Overall Study|Other|0|||
156464006|NCT03250676|564795927|FG002|Overall Study|Other|0|||
156464007|NCT03250676|564795928|FG003|Overall Study|Other|0|||
156464008|NCT03250676|564795929|FG004|Overall Study|Other|0|||
156464009|NCT03250676|564795930|FG005|Overall Study|Other|0|||
156464010|NCT03250676|564795925|FG000|Overall Study|Disease progression|4|||
156464011|NCT03250676|564795926|FG001|Overall Study|Disease progression|12|||
156464012|NCT03250676|564795927|FG002|Overall Study|Disease progression|9|||
156464013|NCT03250676|564795928|FG003|Overall Study|Disease progression|7|||
156464014|NCT03250676|564795929|FG004|Overall Study|Disease progression|4|||
156464015|NCT03250676|564795930|FG005|Overall Study|Disease progression|88|||
156464016|NCT05020353|564797052|FG000|Overall Study|Protocol Violation|7|||
156464017|NCT05020353|564797052|FG000|Overall Study|Withdrawal by Subject|33|||
156464018|NCT04633278|564797056|FG000|Overall Study|Adverse Event|1|||
156464019|NCT04633278|564797057|FG001|Overall Study|Adverse Event|0|||
156464020|NCT04633278|564797056|FG000|Overall Study|Withdrawal by Subject|1|||
156464021|NCT04633278|564797057|FG001|Overall Study|Withdrawal by Subject|0|||
156464022|NCT04633278|564797056|FG000|Overall Study|Death|11|||
156464023|NCT04633278|564797057|FG001|Overall Study|Death|7|||
156464024|NCT04633278|564797056|FG000|Overall Study|Sponsor Decision|3|||
156464025|NCT04633278|564797057|FG001|Overall Study|Sponsor Decision|0|||
156464026|NCT04633278|564797056|FG000|Overall Study|Not Listed|1|||
156464027|NCT04633278|564797057|FG001|Overall Study|Not Listed|0|||
156464028|NCT02611687|564797058|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
156464029|NCT02611687|564797059|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
156464030|NCT02075554|564797063|FG000|Overall Study|Lost to Follow-up|7|||
156464031|NCT02075554|564797063|FG000|Overall Study|Withdrawal by Subject|5|||
156464032|NCT02075554|564797063|FG000|Overall Study|Physician Decision|3|||
156464033|NCT04933474|564797069|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
156464034|NCT04933474|564797070|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
156464035|NCT04933474|564797069|FG000|Overall Study|Lost to Follow-up|19|||
156464036|NCT04933474|564797070|FG001|Overall Study|Lost to Follow-up|9|||
156464037|NCT04933474|564797069|FG000|Overall Study|Life Burden - unable to participate|6|||
156464038|NCT04933474|564797070|FG001|Overall Study|Life Burden - unable to participate|2|||
156464039|NCT04933474|564797069|FG000|Overall Study|Disease Burden - unable to participate|4|||
156464040|NCT04933474|564797070|FG001|Overall Study|Disease Burden - unable to participate|1|||
156464041|NCT04933474|564797069|FG000|Overall Study|Surgery/Hospitalization|1|||
156464042|NCT04933474|564797070|FG001|Overall Study|Surgery/Hospitalization|2|||
156464043|NCT04933474|564797069|FG000|Overall Study|Dissatisfied with Intervention|1|||
156464044|NCT04933474|564797070|FG001|Overall Study|Dissatisfied with Intervention|1|||
156539116|NCT00914927|565068221|FG006|Overall Study|Adverse Event|0|||
156539117|NCT00914927|565068215|FG000|Overall Study|Withdrawal by Subject|0|||
156539118|NCT00914927|565068216|FG001|Overall Study|Withdrawal by Subject|1|||
156539119|NCT00914927|565068217|FG002|Overall Study|Withdrawal by Subject|0|||
156539120|NCT00914927|565068218|FG003|Overall Study|Withdrawal by Subject|1|||
156539121|NCT00914927|565068219|FG004|Overall Study|Withdrawal by Subject|0|||
156539122|NCT00914927|565068220|FG005|Overall Study|Withdrawal by Subject|0|||
156539123|NCT00914927|565068221|FG006|Overall Study|Withdrawal by Subject|0|||
156539124|NCT00914927|565068215|FG000|Overall Study|Lost to Follow-up|0|||
156539125|NCT00914927|565068216|FG001|Overall Study|Lost to Follow-up|0|||
156539126|NCT00914927|565068217|FG002|Overall Study|Lost to Follow-up|0|||
156539127|NCT00914927|565068218|FG003|Overall Study|Lost to Follow-up|1|||
156539128|NCT00914927|565068219|FG004|Overall Study|Lost to Follow-up|0|||
156539129|NCT00914927|565068220|FG005|Overall Study|Lost to Follow-up|0|||
156539130|NCT00914927|565068221|FG006|Overall Study|Lost to Follow-up|0|||
156539131|NCT00914927|565068215|FG000|Overall Study|Administrative/Other|2|||
156539132|NCT00914927|565068216|FG001|Overall Study|Administrative/Other|1|||
156539133|NCT00914927|565068217|FG002|Overall Study|Administrative/Other|0|||
156539134|NCT00914927|565068218|FG003|Overall Study|Administrative/Other|0|||
156539135|NCT00914927|565068219|FG004|Overall Study|Administrative/Other|1|||
156539136|NCT00914927|565068220|FG005|Overall Study|Administrative/Other|0|||
156539137|NCT00914927|565068221|FG006|Overall Study|Administrative/Other|0|||
156539138|NCT01519934|565068222|FG000|Overall Study|Lost to Follow-up|3|||
156539139|NCT00922480|565068223|FG000|Main Study|Protocol Violation|3|||
156539140|NCT00922480|565068224|FG001|Main Study|Protocol Violation|6|||
156539141|NCT00922480|565068223|FG000|Main Study|Adverse Event|6|||
156539142|NCT00922480|565068224|FG001|Main Study|Adverse Event|7|||
156539143|NCT00922480|565068223|FG000|Main Study|Lack of Efficacy|3|||
156539144|NCT00922480|565068224|FG001|Main Study|Lack of Efficacy|0|||
156539145|NCT00922480|565068223|FG000|Main Study|Withdrawal by Subject|20|||
156539146|NCT00922480|565068224|FG001|Main Study|Withdrawal by Subject|15|||
156539147|NCT00922480|565068223|FG000|Main Study|Lost to Follow-up|5|||
156539148|NCT00922480|565068224|FG001|Main Study|Lost to Follow-up|0|||
156539149|NCT00922480|565068223|FG000|Main Study|Physician Decision|0|||
156539150|NCT00922480|565068224|FG001|Main Study|Physician Decision|1|||
156539151|NCT00922480|565068223|FG000|Extension Study|Protocol Violation|3|||
156539152|NCT00922480|565068224|FG001|Extension Study|Protocol Violation|0|||
156539153|NCT00922480|565068223|FG000|Extension Study|Adverse Event|1|||
156539154|NCT00922480|565068224|FG001|Extension Study|Adverse Event|1|||
156539155|NCT00922480|565068223|FG000|Extension Study|Withdrawal by Subject|1|||
156539156|NCT00922480|565068224|FG001|Extension Study|Withdrawal by Subject|1|||
156539157|NCT00922480|565068223|FG000|Extension Study|Others|0|||
156539158|NCT00922480|565068224|FG001|Extension Study|Others|1|||
156539159|NCT00971178|565068229|FG000|Overall Study|Lost to Follow-up|2|||
156539160|NCT00971178|565068230|FG001|Overall Study|Lost to Follow-up|2|||
156539161|NCT00971178|565068231|FG002|Overall Study|Lost to Follow-up|2|||
156539162|NCT00326209|565068236|FG000|Overall Study|Adverse Event|28|||
156539163|NCT00326209|565068236|FG000|Overall Study|Withdrawal by Subject|22|||
156539164|NCT00326209|565068236|FG000|Overall Study|Lack of Efficacy|31|||
156539165|NCT00326209|565068236|FG000|Overall Study|Lost to Follow-up|18|||
156539166|NCT00326209|565068236|FG000|Overall Study|Participant non-compliant|6|||
156539167|NCT00326209|565068236|FG000|Overall Study|Sponsor closed study|173|||
156539168|NCT00326209|565068236|FG000|Overall Study|Prohibited medication use|1|||
156539169|NCT00326209|565068236|FG000|Overall Study|Violation of entry criteria|1|||
156539170|NCT00326209|565068236|FG000|Overall Study|Withdrawn in error|1|||
156539171|NCT00326209|565068236|FG000|Overall Study|Pregnancy|1|||
156539172|NCT03716050|565068238|FG000|Overall Study|Lost to Follow-up|0|||
156539173|NCT03716050|565068239|FG001|Overall Study|Lost to Follow-up|0|||
156539174|NCT03716050|565068240|FG002|Overall Study|Lost to Follow-up|1|||
156539175|NCT03716050|565068241|FG003|Overall Study|Lost to Follow-up|0|||
156539176|NCT03716050|565068242|FG004|Overall Study|Lost to Follow-up|0|||
156539177|NCT03716050|565068243|FG005|Overall Study|Lost to Follow-up|0|||
156539178|NCT03716050|565068244|FG006|Overall Study|Lost to Follow-up|0|||
156539179|NCT03716050|565068245|FG007|Overall Study|Lost to Follow-up|0|||
156539180|NCT03716050|565068238|FG000|Overall Study|Physician Decision|0|||
156539181|NCT03716050|565068239|FG001|Overall Study|Physician Decision|0|||
156539182|NCT03716050|565068240|FG002|Overall Study|Physician Decision|0|||
156539183|NCT03716050|565068241|FG003|Overall Study|Physician Decision|1|||
156539184|NCT03716050|565068242|FG004|Overall Study|Physician Decision|0|||
156539185|NCT03716050|565068243|FG005|Overall Study|Physician Decision|0|||
156539186|NCT03716050|565068244|FG006|Overall Study|Physician Decision|0|||
156539187|NCT03716050|565068245|FG007|Overall Study|Physician Decision|0|||
156539188|NCT03716050|565068238|FG000|Overall Study|Protocol Violation|0|||
156539189|NCT03716050|565068239|FG001|Overall Study|Protocol Violation|0|||
156539190|NCT03716050|565068240|FG002|Overall Study|Protocol Violation|0|||
156539191|NCT03716050|565068241|FG003|Overall Study|Protocol Violation|1|||
156539192|NCT03716050|565068242|FG004|Overall Study|Protocol Violation|0|||
156539193|NCT03716050|565068243|FG005|Overall Study|Protocol Violation|0|||
156539194|NCT03716050|565068244|FG006|Overall Study|Protocol Violation|0|||
156539195|NCT03716050|565068245|FG007|Overall Study|Protocol Violation|2|||
156338950|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
156338951|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
156464045|NCT04933474|564797069|FG000|Overall Study|Withdrew interest in participation|1|||
156464046|NCT04933474|564797070|FG001|Overall Study|Withdrew interest in participation|0|||
156464047|NCT04933474|564797069|FG000|Overall Study|Had previously enrolled in the study|0|||
156464048|NCT04933474|564797070|FG001|Overall Study|Had previously enrolled in the study|1|||
156464049|NCT04757753|564797075|FG000|Overall Study|Lost to Follow-up|7|||
156464050|NCT04757753|564797076|FG001|Overall Study|Lost to Follow-up|7|||
156464051|NCT04757753|564797075|FG000|Overall Study|Withdrawal by Subject|0|||
156464052|NCT04757753|564797076|FG001|Overall Study|Withdrawal by Subject|3|||
156464053|NCT04757753|564797075|FG000|Overall Study|Endodontic treatment failure|1|||
156464054|NCT04757753|564797076|FG001|Overall Study|Endodontic treatment failure|2|||
156464055|NCT04757753|564797075|FG000|Overall Study|Tooth fracture/extraction|3|||
156464056|NCT04757753|564797076|FG001|Overall Study|Tooth fracture/extraction|0|||
156464057|NCT06655818|564797081|FG000|Overall Study|Withdrawal by Subject|1|||
156464058|NCT03816397|564797086|FG000|Overall Study|Censored at interim analysis date.|13|||
156464059|NCT03816397|564797087|FG001|Overall Study|Censored at interim analysis date.|6|||
156464060|NCT03816397|564797086|FG000|Overall Study|Withdrawal by Subject|1|||
156464061|NCT03816397|564797087|FG001|Overall Study|Withdrawal by Subject|1|||
156464062|NCT04908930|564797090|FG000|Overall Study|Lost to Follow-up|1|||
156464063|NCT04908930|564797091|FG001|Overall Study|Lost to Follow-up|1|||
156464064|NCT04908930|564797092|FG002|Overall Study|Lost to Follow-up|0|||
156464065|NCT04908930|564797093|FG003|Overall Study|Lost to Follow-up|0|||
156464066|NCT04908930|564797094|FG004|Overall Study|Lost to Follow-up|0|||
156464067|NCT04908930|564797090|FG000|Overall Study|hardware in mouth|1|||
156464068|NCT04908930|564797091|FG001|Overall Study|hardware in mouth|1|||
156464069|NCT04908930|564797092|FG002|Overall Study|hardware in mouth|0|||
156464070|NCT04908930|564797093|FG003|Overall Study|hardware in mouth|0|||
156464071|NCT04908930|564797094|FG004|Overall Study|hardware in mouth|0|||
156464072|NCT04908930|564797090|FG000|Overall Study|wrong team|1|||
156464073|NCT04908930|564797091|FG001|Overall Study|wrong team|0|||
156464074|NCT04908930|564797092|FG002|Overall Study|wrong team|0|||
156464075|NCT04908930|564797093|FG003|Overall Study|wrong team|0|||
156464076|NCT04908930|564797094|FG004|Overall Study|wrong team|0|||
156464077|NCT04908930|564797090|FG000|Overall Study|quit team|2|||
156464078|NCT04908930|564797091|FG001|Overall Study|quit team|4|||
156464079|NCT04908930|564797092|FG002|Overall Study|quit team|0|||
156464080|NCT04908930|564797093|FG003|Overall Study|quit team|0|||
156464081|NCT04908930|564797094|FG004|Overall Study|quit team|0|||
156464082|NCT04908930|564797090|FG000|Overall Study|Withdrawal by Subject|1|||
156464083|NCT04908930|564797091|FG001|Overall Study|Withdrawal by Subject|2|||
156464084|NCT04908930|564797092|FG002|Overall Study|Withdrawal by Subject|0|||
156464085|NCT04908930|564797093|FG003|Overall Study|Withdrawal by Subject|0|||
156464086|NCT04908930|564797094|FG004|Overall Study|Withdrawal by Subject|0|||
156464087|NCT04908930|564797090|FG000|Overall Study|parent not liking program|0|||
156464088|NCT04908930|564797091|FG001|Overall Study|parent not liking program|1|||
156464089|NCT04908930|564797092|FG002|Overall Study|parent not liking program|0|||
156464090|NCT04908930|564797093|FG003|Overall Study|parent not liking program|0|||
156464091|NCT04908930|564797094|FG004|Overall Study|parent not liking program|0|||
156464092|NCT03248479|564797095|FG000|Overall Study|Death|12|||
156464093|NCT03248479|564797096|FG001|Overall Study|Death|44|||
156464094|NCT03248479|564797097|FG002|Overall Study|Death|1|||
156464095|NCT03248479|564797098|FG003|Overall Study|Death|72|||
156464096|NCT03248479|564797099|FG004|Overall Study|Death|17|||
156464097|NCT03248479|564797100|FG005|Overall Study|Death|6|||
156338952|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
156338953|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
156539196|NCT01010633|565068248|FG000|Overall Study|Adverse Event|1|||
156539197|NCT01010633|565068249|FG001|Overall Study|Adverse Event|1|||
156539198|NCT01010633|565068248|FG000|Overall Study|Protocol Violation|1|||
156539199|NCT01010633|565068249|FG001|Overall Study|Protocol Violation|2|||
156539200|NCT01010633|565068248|FG000|Overall Study|Withdrawal by Subject|2|||
156539201|NCT01010633|565068249|FG001|Overall Study|Withdrawal by Subject|1|||
156539202|NCT01010633|565068248|FG000|Overall Study|Investigator decision|0|||
156539203|NCT01010633|565068249|FG001|Overall Study|Investigator decision|1|||
156539204|NCT00073528|565068250|FG000|Overall Study|Death|488|||
156539205|NCT00073528|565068251|FG001|Overall Study|Death|473|||
156539206|NCT00073528|565068250|FG000|Overall Study|Lost to Follow-up|52|||
156539207|NCT00073528|565068251|FG001|Overall Study|Lost to Follow-up|45|||
156539208|NCT00073528|565068250|FG000|Overall Study|Withdrawal by Subject|50|||
156539209|NCT00073528|565068251|FG001|Overall Study|Withdrawal by Subject|45|||
156539210|NCT00073528|565068250|FG000|Overall Study|Study terminated by Sponsor|10|||
156539211|NCT00073528|565068251|FG001|Overall Study|Study terminated by Sponsor|29|||
156539212|NCT00073528|565068250|FG000|Overall Study|Other|18|||
156539213|NCT00073528|565068251|FG001|Overall Study|Other|19|||
156539214|NCT00073528|565068250|FG000|Overall Study|Other|9|||
156539215|NCT00073528|565068251|FG001|Overall Study|Other|12|||
156539216|NCT00073528|565068250|FG000|Overall Study|Protocol Violation|3|||
156539217|NCT00073528|565068251|FG001|Overall Study|Protocol Violation|5|||
156539218|NCT03086057|565068252|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
156539219|NCT03086057|565068253|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
156539220|NCT03086057|565068254|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
156539221|NCT03086057|565068255|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
156539222|NCT03086057|565068252|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
156539223|NCT03086057|565068253|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
156539224|NCT03086057|565068254|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
156539225|NCT03086057|565068255|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
156539226|NCT03086057|565068252|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
156539227|NCT03086057|565068253|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
156539228|NCT03086057|565068254|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
156539229|NCT03086057|565068255|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
156539230|NCT03086057|565068252|FG000|Stage 1: PrEP Uptake|Death|1|||
156539231|NCT03086057|565068253|FG001|Stage 1: PrEP Uptake|Death|0|||
156539232|NCT03086057|565068254|FG002|Stage 1: PrEP Uptake|Death|0|||
156539233|NCT03086057|565068255|FG003|Stage 1: PrEP Uptake|Death|0|||
156539234|NCT03086057|565068252|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
156539235|NCT03086057|565068253|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
156539236|NCT03086057|565068254|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
156539237|NCT03086057|565068255|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
156539238|NCT03086057|565068252|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
156539239|NCT03086057|565068253|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
156539240|NCT03086057|565068254|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
156539241|NCT03086057|565068255|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
156539242|NCT03086057|565068252|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
156539243|NCT03086057|565068253|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
156539244|NCT03086057|565068254|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
156539245|NCT03086057|565068255|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
156539246|NCT01494350|565068260|FG000|Overall Study|Worsening of lesion|1|||
156539247|NCT01786603|565068261|FG000|Overall Study|Death|5|||
156539248|NCT01786603|565068262|FG001|Overall Study|Death|1|||
156539249|NCT01786603|565068261|FG000|Overall Study|Adverse Event|6|||
156539250|NCT01786603|565068262|FG001|Overall Study|Adverse Event|2|||
156539251|NCT01786603|565068261|FG000|Overall Study|Physician decision to withdraw|6|||
156539252|NCT01786603|565068262|FG001|Overall Study|Physician decision to withdraw|7|||
156539253|NCT01786603|565068261|FG000|Overall Study|Lost to Follow-up|1|||
156539254|NCT01786603|565068262|FG001|Overall Study|Lost to Follow-up|2|||
156539255|NCT03654976|565068272|FG000|Overall Study|Withdrawal by Subject|12|||
156539256|NCT03654976|565068273|FG001|Overall Study|Withdrawal by Subject|11|||
156539257|NCT03654976|565068272|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
156539258|NCT03654976|565068273|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
156539259|NCT03654976|565068272|FG000|Overall Study|Adverse Event|5|||
156539260|NCT03654976|565068273|FG001|Overall Study|Adverse Event|0|||
156539261|NCT03654976|565068272|FG000|Overall Study|Lost to Follow-up|2|||
156539262|NCT03654976|565068273|FG001|Overall Study|Lost to Follow-up|0|||
156539263|NCT03654976|565068272|FG000|Overall Study|Lack of Efficacy|0|||
156539264|NCT03654976|565068273|FG001|Overall Study|Lack of Efficacy|1|||
156539265|NCT03098836|565068274|FG000|Overall Study|Adverse Event|1|||
156539266|NCT03098836|565068275|FG001|Overall Study|Adverse Event|3|||
156539267|NCT03098836|565068274|FG000|Overall Study|Lack of Efficacy|30|||
156539268|NCT03098836|565068275|FG001|Overall Study|Lack of Efficacy|15|||
156539269|NCT03098836|565068274|FG000|Overall Study|Physician Decision|2|||
156539270|NCT03098836|565068275|FG001|Overall Study|Physician Decision|1|||
156464098|NCT03248479|564797101|FG006|Overall Study|Death|1|||
156464099|NCT03248479|564797102|FG007|Overall Study|Death|14|||
156464100|NCT03248479|564797103|FG008|Overall Study|Death|3|||
156464101|NCT03248479|564797104|FG009|Overall Study|Death|7|||
156464102|NCT03248479|564797105|FG010|Overall Study|Death|3|||
156464103|NCT03248479|564797106|FG011|Overall Study|Death|1|||
156464104|NCT03248479|564797107|FG012|Overall Study|Death|1|||
156464105|NCT03248479|564797095|FG000|Overall Study|Study terminated by sponsor|12|||
156464106|NCT03248479|564797096|FG001|Overall Study|Study terminated by sponsor|15|||
156464107|NCT03248479|564797097|FG002|Overall Study|Study terminated by sponsor|0|||
156464108|NCT03248479|564797098|FG003|Overall Study|Study terminated by sponsor|5|||
156464109|NCT03248479|564797099|FG004|Overall Study|Study terminated by sponsor|0|||
156464110|NCT03248479|564797100|FG005|Overall Study|Study terminated by sponsor|0|||
156464111|NCT03248479|564797101|FG006|Overall Study|Study terminated by sponsor|0|||
156464112|NCT03248479|564797102|FG007|Overall Study|Study terminated by sponsor|1|||
156464113|NCT03248479|564797103|FG008|Overall Study|Study terminated by sponsor|1|||
156464114|NCT03248479|564797104|FG009|Overall Study|Study terminated by sponsor|0|||
156464115|NCT03248479|564797105|FG010|Overall Study|Study terminated by sponsor|5|||
156464116|NCT03248479|564797106|FG011|Overall Study|Study terminated by sponsor|4|||
156464117|NCT03248479|564797107|FG012|Overall Study|Study terminated by sponsor|0|||
156464118|NCT03248479|564797095|FG000|Overall Study|Consent withdrawn|6|||
156464119|NCT03248479|564797096|FG001|Overall Study|Consent withdrawn|3|||
156464120|NCT03248479|564797097|FG002|Overall Study|Consent withdrawn|0|||
156464121|NCT03248479|564797098|FG003|Overall Study|Consent withdrawn|9|||
156464122|NCT03248479|564797099|FG004|Overall Study|Consent withdrawn|1|||
156464123|NCT03248479|564797100|FG005|Overall Study|Consent withdrawn|0|||
156464124|NCT03248479|564797101|FG006|Overall Study|Consent withdrawn|0|||
156464125|NCT03248479|564797102|FG007|Overall Study|Consent withdrawn|1|||
156464126|NCT03248479|564797103|FG008|Overall Study|Consent withdrawn|0|||
156464127|NCT03248479|564797104|FG009|Overall Study|Consent withdrawn|3|||
156464128|NCT03248479|564797105|FG010|Overall Study|Consent withdrawn|1|||
156464129|NCT03248479|564797106|FG011|Overall Study|Consent withdrawn|0|||
156464130|NCT03248479|564797107|FG012|Overall Study|Consent withdrawn|1|||
156464131|NCT03248479|564797095|FG000|Overall Study|Lost to Follow-up|2|||
156464132|NCT03248479|564797096|FG001|Overall Study|Lost to Follow-up|1|||
156464133|NCT03248479|564797097|FG002|Overall Study|Lost to Follow-up|0|||
156464134|NCT03248479|564797098|FG003|Overall Study|Lost to Follow-up|0|||
156464135|NCT03248479|564797099|FG004|Overall Study|Lost to Follow-up|0|||
156464136|NCT03248479|564797100|FG005|Overall Study|Lost to Follow-up|0|||
156464137|NCT03248479|564797101|FG006|Overall Study|Lost to Follow-up|0|||
156464138|NCT03248479|564797102|FG007|Overall Study|Lost to Follow-up|0|||
156464139|NCT03248479|564797103|FG008|Overall Study|Lost to Follow-up|0|||
156464140|NCT03248479|564797104|FG009|Overall Study|Lost to Follow-up|0|||
156464141|NCT03248479|564797105|FG010|Overall Study|Lost to Follow-up|0|||
156464142|NCT03248479|564797106|FG011|Overall Study|Lost to Follow-up|0|||
156464143|NCT03248479|564797107|FG012|Overall Study|Lost to Follow-up|1|||
156464144|NCT03248479|564797095|FG000|Overall Study|Not reported|0|||
156464145|NCT03248479|564797096|FG001|Overall Study|Not reported|0|||
156464146|NCT03248479|564797097|FG002|Overall Study|Not reported|0|||
156464147|NCT03248479|564797098|FG003|Overall Study|Not reported|1|||
156464148|NCT03248479|564797099|FG004|Overall Study|Not reported|1|||
156464149|NCT03248479|564797100|FG005|Overall Study|Not reported|0|||
156464150|NCT03248479|564797101|FG006|Overall Study|Not reported|0|||
156464151|NCT03248479|564797102|FG007|Overall Study|Not reported|1|||
156464152|NCT03248479|564797103|FG008|Overall Study|Not reported|1|||
156464153|NCT03248479|564797104|FG009|Overall Study|Not reported|0|||
156464154|NCT03248479|564797105|FG010|Overall Study|Not reported|0|||
156464155|NCT03248479|564797106|FG011|Overall Study|Not reported|0|||
156464156|NCT03248479|564797107|FG012|Overall Study|Not reported|0|||
156464157|NCT02777593|564797108|FG000|Overall Study|Still in study|1|||
156464158|NCT02777593|564797109|FG001|Overall Study|Still in study|32|||
156464159|NCT02777593|564797110|FG002|Overall Study|Still in study|3|||
156464160|NCT02777593|564797111|FG003|Overall Study|Still in study|6|||
156464161|NCT02777593|564797112|FG004|Overall Study|Still in study|5|||
156464162|NCT02777593|564797108|FG000|Overall Study|Death|21|||
156464163|NCT02777593|564797109|FG001|Overall Study|Death|28|||
156464164|NCT02777593|564797110|FG002|Overall Study|Death|0|||
156464165|NCT02777593|564797111|FG003|Overall Study|Death|5|||
156464166|NCT02777593|564797112|FG004|Overall Study|Death|0|||
156464167|NCT02777593|564797108|FG000|Overall Study|Withdrawal by Subject|8|||
156464168|NCT02777593|564797109|FG001|Overall Study|Withdrawal by Subject|4|||
156464169|NCT02777593|564797110|FG002|Overall Study|Withdrawal by Subject|1|||
156464170|NCT02777593|564797111|FG003|Overall Study|Withdrawal by Subject|1|||
156464171|NCT02777593|564797112|FG004|Overall Study|Withdrawal by Subject|0|||
156464172|NCT02777593|564797108|FG000|Overall Study|Lost to Follow-up|8|||
156464173|NCT02777593|564797109|FG001|Overall Study|Lost to Follow-up|16|||
156464174|NCT02777593|564797110|FG002|Overall Study|Lost to Follow-up|5|||
156464175|NCT02777593|564797111|FG003|Overall Study|Lost to Follow-up|0|||
156464176|NCT02777593|564797112|FG004|Overall Study|Lost to Follow-up|1|||
156464177|NCT02777593|564797108|FG000|Overall Study|Physician Decision|2|||
156464178|NCT02777593|564797109|FG001|Overall Study|Physician Decision|2|||
156464179|NCT02777593|564797110|FG002|Overall Study|Physician Decision|0|||
156464180|NCT02777593|564797111|FG003|Overall Study|Physician Decision|0|||
156464181|NCT02777593|564797112|FG004|Overall Study|Physician Decision|0|||
156464182|NCT02777593|564797108|FG000|Overall Study|Discontinued due to Other|1|||
156464183|NCT02777593|564797109|FG001|Overall Study|Discontinued due to Other|0|||
156464184|NCT02777593|564797110|FG002|Overall Study|Discontinued due to Other|0|||
156464185|NCT02777593|564797111|FG003|Overall Study|Discontinued due to Other|0|||
156464186|NCT02777593|564797112|FG004|Overall Study|Discontinued due to Other|0|||
156464187|NCT05785130|564797116|FG000|Overall Study|Withdrawal by Subject|1|||
156464188|NCT05785130|564797117|FG001|Overall Study|Withdrawal by Subject|0|||
156464189|NCT05785130|564797116|FG000|Overall Study|Lack of Efficacy|0|||
156464190|NCT05785130|564797117|FG001|Overall Study|Lack of Efficacy|1|||
156464191|NCT03547271|564797118|FG000|Overall Study|Adverse Event|1|||
156464192|NCT03547271|564797119|FG001|Overall Study|Adverse Event|1|||
156464193|NCT03547271|564797120|FG002|Overall Study|Adverse Event|0|||
156464194|NCT03547271|564797121|FG003|Overall Study|Adverse Event|0|||
156464195|NCT03547271|564797118|FG000|Overall Study|Protocol deviation|5|||
156464196|NCT03547271|564797119|FG001|Overall Study|Protocol deviation|7|||
156464197|NCT03547271|564797120|FG002|Overall Study|Protocol deviation|3|||
156464198|NCT03547271|564797121|FG003|Overall Study|Protocol deviation|0|||
156464199|NCT03547271|564797118|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
156464200|NCT03547271|564797119|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
156464201|NCT03547271|564797120|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156464202|NCT03547271|564797121|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
156464203|NCT03547271|564797118|FG000|Overall Study|Lost to Follow-up|3|||
156464204|NCT03547271|564797119|FG001|Overall Study|Lost to Follow-up|3|||
156464205|NCT03547271|564797120|FG002|Overall Study|Lost to Follow-up|1|||
156464206|NCT03547271|564797121|FG003|Overall Study|Lost to Follow-up|0|||
156464207|NCT06065735|564797122|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
156464208|NCT06065735|564797123|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
156464209|NCT06065735|564797124|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
156464210|NCT06065735|564797122|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
156464211|NCT06065735|564797123|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
156464212|NCT06065735|564797124|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
156464213|NCT06065735|564797122|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
156464214|NCT06065735|564797123|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
156464215|NCT06065735|564797124|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
156464216|NCT06065735|564797122|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
156464217|NCT06065735|564797123|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
156464218|NCT06065735|564797124|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
156464219|NCT06065735|564797122|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
156464220|NCT06065735|564797123|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
156464221|NCT06065735|564797124|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
156464222|NCT01499368|564797125|FG000|Overall Study|Did not meet I/E criteria|8|||
156464223|NCT01499368|564797126|FG001|Overall Study|Did not meet I/E criteria|4|||
156464224|NCT01499368|564797127|FG002|Overall Study|Did not meet I/E criteria|4|||
156464225|NCT01499368|564797125|FG000|Overall Study|Prohibited Concomitant medication|1|||
156464226|NCT01499368|564797126|FG001|Overall Study|Prohibited Concomitant medication|1|||
156464227|NCT01499368|564797127|FG002|Overall Study|Prohibited Concomitant medication|0|||
156464228|NCT01499368|564797125|FG000|Overall Study|Withdrawal by Subject|11|||
156464229|NCT01499368|564797126|FG001|Overall Study|Withdrawal by Subject|10|||
156464230|NCT01499368|564797127|FG002|Overall Study|Withdrawal by Subject|8|||
156464231|NCT01499368|564797125|FG000|Overall Study|Lost to Follow-up|3|||
156464232|NCT01499368|564797126|FG001|Overall Study|Lost to Follow-up|2|||
156464233|NCT01499368|564797127|FG002|Overall Study|Lost to Follow-up|5|||
156464234|NCT01499368|564797125|FG000|Overall Study|Adverse Event|4|||
156464235|NCT01499368|564797126|FG001|Overall Study|Adverse Event|0|||
156464236|NCT01499368|564797127|FG002|Overall Study|Adverse Event|2|||
156464237|NCT01499368|564797125|FG000|Overall Study|Physician Decision|0|||
156464238|NCT01499368|564797126|FG001|Overall Study|Physician Decision|1|||
156464239|NCT01499368|564797127|FG002|Overall Study|Physician Decision|0|||
156464240|NCT01499368|564797125|FG000|Overall Study|Deviation from visit window|0|||
156464241|NCT01499368|564797126|FG001|Overall Study|Deviation from visit window|0|||
156464242|NCT01499368|564797127|FG002|Overall Study|Deviation from visit window|1|||
156464243|NCT01499368|564797125|FG000|Overall Study|Error of Prescriptions|0|||
156464244|NCT01499368|564797126|FG001|Overall Study|Error of Prescriptions|0|||
156464245|NCT01499368|564797127|FG002|Overall Study|Error of Prescriptions|1|||
156464246|NCT03092674|564797128|FG000|Overall Study|Adverse Event or Side Effects|1|||
156464247|NCT03092674|564797129|FG001|Overall Study|Adverse Event or Side Effects|4|||
156464248|NCT03092674|564797130|FG002|Overall Study|Adverse Event or Side Effects|4|||
156464249|NCT03092674|564797128|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
156464250|NCT03092674|564797129|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
156464251|NCT03092674|564797130|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
156464252|NCT03092674|564797128|FG000|Overall Study|Progression/Relapse|5|||
156464253|NCT03092674|564797129|FG001|Overall Study|Progression/Relapse|4|||
156812591|NCT01061723|566064805|FG000|Overall Study|Adverse Event|0|||
156812592|NCT01061723|566064806|FG001|Overall Study|Adverse Event|2|||
156812593|NCT01061723|566064807|FG002|Overall Study|Adverse Event|5|||
156812594|NCT01061723|566064808|FG003|Overall Study|Adverse Event|5|||
156812595|NCT01061723|566064809|FG004|Overall Study|Adverse Event|2|||
156812596|NCT01061723|566064810|FG005|Overall Study|Adverse Event|6|||
156812597|NCT01061723|566064805|FG000|Overall Study|Lack of Efficacy|2|||
156812598|NCT01061723|566064806|FG001|Overall Study|Lack of Efficacy|3|||
156812599|NCT01061723|566064807|FG002|Overall Study|Lack of Efficacy|4|||
156812600|NCT01061723|566064808|FG003|Overall Study|Lack of Efficacy|2|||
156812601|NCT01061723|566064809|FG004|Overall Study|Lack of Efficacy|1|||
156812602|NCT01061723|566064810|FG005|Overall Study|Lack of Efficacy|1|||
156812603|NCT01061723|566064805|FG000|Overall Study|Randomized but not treated|0|||
156812604|NCT01061723|566064806|FG001|Overall Study|Randomized but not treated|0|||
156812605|NCT01061723|566064807|FG002|Overall Study|Randomized but not treated|0|||
156812606|NCT01061723|566064808|FG003|Overall Study|Randomized but not treated|0|||
156812607|NCT01061723|566064809|FG004|Overall Study|Randomized but not treated|0|||
156812608|NCT01061723|566064810|FG005|Overall Study|Randomized but not treated|1|||
156812609|NCT01061723|566064805|FG000|Overall Study|Other than specified above|2|||
156812610|NCT01061723|566064806|FG001|Overall Study|Other than specified above|1|||
156812611|NCT01061723|566064807|FG002|Overall Study|Other than specified above|1|||
156812612|NCT01061723|566064808|FG003|Overall Study|Other than specified above|1|||
156812613|NCT01061723|566064809|FG004|Overall Study|Other than specified above|0|||
156812614|NCT01061723|566064810|FG005|Overall Study|Other than specified above|1|||
156812615|NCT01734785|566064811|FG000|Open-Label Period|Adverse Event|0|||
156812616|NCT01734785|566064812|FG001|Open-Label Period|Adverse Event|0|||
156812617|NCT01734785|566064813|FG002|Open-Label Period|Adverse Event|0|||
156812618|NCT01734785|566064814|FG003|Open-Label Period|Adverse Event|9|||
156812619|NCT01734785|566064811|FG000|Open-Label Period|Lack of Efficacy|0|||
156812620|NCT01734785|566064812|FG001|Open-Label Period|Lack of Efficacy|0|||
156812621|NCT01734785|566064813|FG002|Open-Label Period|Lack of Efficacy|0|||
156812622|NCT01734785|566064814|FG003|Open-Label Period|Lack of Efficacy|1|||
156812623|NCT01734785|566064811|FG000|Open-Label Period|Protocol Violation|0|||
156812624|NCT01734785|566064812|FG001|Open-Label Period|Protocol Violation|0|||
156812625|NCT01734785|566064813|FG002|Open-Label Period|Protocol Violation|0|||
156812626|NCT01734785|566064814|FG003|Open-Label Period|Protocol Violation|13|||
156812627|NCT01734785|566064811|FG000|Open-Label Period|Lost to Follow-up|0|||
156812628|NCT01734785|566064812|FG001|Open-Label Period|Lost to Follow-up|0|||
156812629|NCT01734785|566064813|FG002|Open-Label Period|Lost to Follow-up|0|||
156812630|NCT01734785|566064814|FG003|Open-Label Period|Lost to Follow-up|14|||
156812631|NCT01734785|566064811|FG000|Open-Label Period|Withdrawal by Subject|0|||
156812632|NCT01734785|566064812|FG001|Open-Label Period|Withdrawal by Subject|0|||
156812633|NCT01734785|566064813|FG002|Open-Label Period|Withdrawal by Subject|0|||
156812634|NCT01734785|566064814|FG003|Open-Label Period|Withdrawal by Subject|12|||
156812635|NCT01734785|566064811|FG000|Open-Label Period|Other Reasons|0|||
156464254|NCT03092674|564797130|FG002|Overall Study|Progression/Relapse|8|||
156464255|NCT03092674|564797128|FG000|Overall Study|Death|4|||
156464256|NCT03092674|564797129|FG001|Overall Study|Death|8|||
156464257|NCT03092674|564797130|FG002|Overall Study|Death|2|||
156464258|NCT03092674|564797128|FG000|Overall Study|Other - Not Protocol Specified|11|||
156464259|NCT03092674|564797129|FG001|Overall Study|Other - Not Protocol Specified|8|||
156464260|NCT03092674|564797130|FG002|Overall Study|Other - Not Protocol Specified|8|||
156464261|NCT03982186|564797131|FG000|Overall Study|Lost to Follow-up|0|||
156464262|NCT03982186|564797132|FG001|Overall Study|Lost to Follow-up|1|||
156464263|NCT03982186|564797133|FG002|Overall Study|Lost to Follow-up|2|||
156464264|NCT03982186|564797134|FG003|Overall Study|Lost to Follow-up|1|||
156464265|NCT03982186|564797135|FG004|Overall Study|Lost to Follow-up|1|||
156464266|NCT03982186|564797136|FG005|Overall Study|Lost to Follow-up|0|||
156464267|NCT03982186|564797131|FG000|Overall Study|Physician Decision|0|||
156464268|NCT03982186|564797132|FG001|Overall Study|Physician Decision|1|||
156464269|NCT03982186|564797133|FG002|Overall Study|Physician Decision|0|||
156464270|NCT03982186|564797134|FG003|Overall Study|Physician Decision|0|||
156464271|NCT03982186|564797135|FG004|Overall Study|Physician Decision|0|||
156464272|NCT03982186|564797136|FG005|Overall Study|Physician Decision|0|||
156464273|NCT03982186|564797131|FG000|Overall Study|Withdrawal by Subject|3|||
156812636|NCT01734785|566064812|FG001|Open-Label Period|Other Reasons|0|||
156464274|NCT03982186|564797132|FG001|Overall Study|Withdrawal by Subject|4|||
156464275|NCT03982186|564797133|FG002|Overall Study|Withdrawal by Subject|1|||
156464276|NCT03982186|564797134|FG003|Overall Study|Withdrawal by Subject|7|||
156464277|NCT03982186|564797135|FG004|Overall Study|Withdrawal by Subject|2|||
156812637|NCT01734785|566064813|FG002|Open-Label Period|Other Reasons|0|||
156812638|NCT01734785|566064814|FG003|Open-Label Period|Other Reasons|224|||
156812639|NCT01734785|566064811|FG000|Double-Blind Period|Adverse Event|0|||
156812640|NCT01734785|566064812|FG001|Double-Blind Period|Adverse Event|3|||
156464278|NCT03982186|564797136|FG005|Overall Study|Withdrawal by Subject|0|||
156812641|NCT01734785|566064813|FG002|Double-Blind Period|Adverse Event|2|||
156812642|NCT01734785|566064814|FG003|Double-Blind Period|Adverse Event|0|||
156812643|NCT01734785|566064811|FG000|Double-Blind Period|Lack of Efficacy|0|||
156812644|NCT01734785|566064812|FG001|Double-Blind Period|Lack of Efficacy|1|||
156812645|NCT01734785|566064813|FG002|Double-Blind Period|Lack of Efficacy|0|||
156812646|NCT01734785|566064814|FG003|Double-Blind Period|Lack of Efficacy|0|||
156812647|NCT01734785|566064811|FG000|Double-Blind Period|Protocol Violation|0|||
156812648|NCT01734785|566064812|FG001|Double-Blind Period|Protocol Violation|1|||
156812649|NCT01734785|566064813|FG002|Double-Blind Period|Protocol Violation|1|||
156812650|NCT01734785|566064814|FG003|Double-Blind Period|Protocol Violation|0|||
156812651|NCT01734785|566064811|FG000|Double-Blind Period|Lost to Follow-up|2|||
156812652|NCT01734785|566064812|FG001|Double-Blind Period|Lost to Follow-up|4|||
156812653|NCT01734785|566064813|FG002|Double-Blind Period|Lost to Follow-up|2|||
156812654|NCT01734785|566064814|FG003|Double-Blind Period|Lost to Follow-up|0|||
156812655|NCT01734785|566064811|FG000|Double-Blind Period|Withdrawal by Subject|2|||
156464279|NCT03982186|564797131|FG000|Overall Study|Randomized and not treated|0|||
156464280|NCT03982186|564797132|FG001|Overall Study|Randomized and not treated|0|||
156464281|NCT03982186|564797133|FG002|Overall Study|Randomized and not treated|0|||
156464282|NCT03982186|564797134|FG003|Overall Study|Randomized and not treated|1|||
156812656|NCT01734785|566064812|FG001|Double-Blind Period|Withdrawal by Subject|0|||
156812657|NCT01734785|566064813|FG002|Double-Blind Period|Withdrawal by Subject|0|||
156812658|NCT01734785|566064814|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156812659|NCT01734785|566064811|FG000|Double-Blind Period|Not treated|1|||
156812660|NCT01734785|566064812|FG001|Double-Blind Period|Not treated|0|||
156812661|NCT01734785|566064813|FG002|Double-Blind Period|Not treated|0|||
156812662|NCT01734785|566064814|FG003|Double-Blind Period|Not treated|0|||
156812663|NCT02397915|566064815|FG000|Period 1|Protocol Violation|0|||
156812664|NCT02397915|566064816|FG001|Period 1|Protocol Violation|1|||
156812665|NCT02397915|566064817|FG002|Period 1|Protocol Violation|0|||
156812666|NCT02397915|566064818|FG003|Period 1|Protocol Violation|0|||
156812667|NCT02397915|566064815|FG000|Period 1|Physician Decision|1|||
156812668|NCT02397915|566064816|FG001|Period 1|Physician Decision|0|||
156812669|NCT02397915|566064817|FG002|Period 1|Physician Decision|0|||
156812670|NCT02397915|566064818|FG003|Period 1|Physician Decision|0|||
156812671|NCT00368745|566064819|FG000|Double-blind Treatment Period|Adverse Event|6|||
156812672|NCT00368745|566064820|FG001|Double-blind Treatment Period|Adverse Event|6|||
156812673|NCT00368745|566064819|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
156812674|NCT00368745|566064820|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
156812675|NCT00368745|566064819|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
156812676|NCT00368745|566064820|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
156812677|NCT00368745|566064819|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
156812678|NCT00368745|566064820|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
156812679|NCT00368745|566064819|FG000|Double-blind Treatment Period|Other|7|||
156812680|NCT00368745|566064820|FG001|Double-blind Treatment Period|Other|6|||
156812681|NCT03292874|566064821|FG000|Overall Study|Due to pandemic|5|||
156812682|NCT01961297|566064827|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
156812683|NCT01961297|566064828|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
156812684|NCT02482298|566064829|FG000|Overall Study|Withdrawal by Subject|2|||
156812685|NCT02482298|566064830|FG001|Overall Study|Withdrawal by Subject|1|||
156812686|NCT02482298|566064831|FG002|Overall Study|Withdrawal by Subject|2|||
156812687|NCT02482298|566064829|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
156812688|NCT02482298|566064830|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
156812689|NCT02482298|566064831|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
156812690|NCT02482298|566064829|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
156812691|NCT02482298|566064830|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
156812692|NCT02482298|566064831|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
156812693|NCT02482298|566064829|FG000|Overall Study|Lost to Follow-up|0|||
156812694|NCT02482298|566064830|FG001|Overall Study|Lost to Follow-up|1|||
156812695|NCT02482298|566064831|FG002|Overall Study|Lost to Follow-up|0|||
156812696|NCT03053440|566064836|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
156812697|NCT03053440|566064837|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
156812698|NCT03053440|566064836|FG000|Overall Study|Death|18|||
156812699|NCT03053440|566064837|FG001|Overall Study|Death|14|||
156812700|NCT03053440|566064836|FG000|Overall Study|Withdrawal by Subject|9|||
156812701|NCT03053440|566064837|FG001|Overall Study|Withdrawal by Subject|8|||
156812702|NCT03053440|566064836|FG000|Overall Study|Lost to Follow-up|1|||
156812703|NCT03053440|566064837|FG001|Overall Study|Lost to Follow-up|0|||
156812704|NCT03053440|566064836|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
156812705|NCT03053440|566064837|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
156812706|NCT03053440|566064836|FG000|Overall Study|Physician Decision|2|||
156464283|NCT03982186|564797135|FG004|Overall Study|Randomized and not treated|0|||
156812707|NCT03053440|566064837|FG001|Overall Study|Physician Decision|1|||
156812708|NCT03053440|566064836|FG000|Overall Study|Participant Randomized but died before dosing|1|||
156812709|NCT03053440|566064837|FG001|Overall Study|Participant Randomized but died before dosing|0|||
156812710|NCT01582009|566064838|FG000|Overall Study|Withdrawal by Subject|1|||
156812711|NCT01582009|566064838|FG000|Overall Study|Physician Decision|1|||
156812712|NCT01523743|566064841|FG000|Period 1|Adverse Event|1|||
156812713|NCT01523743|566064842|FG001|Period 1|Adverse Event|0|||
156464284|NCT03982186|564797136|FG005|Overall Study|Randomized and not treated|0|||
156464285|NCT02325154|564797137|FG000|Overall Study|Physician Decision|1|||
156464286|NCT03512301|564797838|FG000|Overall Study|Protocol Violation|2|||
156464287|NCT03512301|564797838|FG000|Overall Study|Did Not Qualify|3|||
156464288|NCT03512301|564797838|FG000|Overall Study|Age-ineligible|1|||
156464289|NCT03512301|564797838|FG000|Overall Study|Inadequate fluency with the English language|3|||
156464290|NCT02720068|564797842|FG000|Overall Study|Adverse Event|0|||
156812714|NCT01523743|566064841|FG000|Period 1|Withdrawal by Subject|6|||
156812715|NCT01523743|566064842|FG001|Period 1|Withdrawal by Subject|2|||
156812716|NCT01523743|566064841|FG000|Period 1|Lost to Follow-up|1|||
156812717|NCT01523743|566064842|FG001|Period 1|Lost to Follow-up|0|||
156812718|NCT01523743|566064841|FG000|Period 1|Lack of Efficacy|1|||
156812719|NCT01523743|566064842|FG001|Period 1|Lack of Efficacy|0|||
156812720|NCT01523743|566064841|FG000|Period 1|Felt unable to empty bladder|1|||
156812721|NCT01523743|566064842|FG001|Period 1|Felt unable to empty bladder|0|||
156812722|NCT01523743|566064841|FG000|Period 2|Withdrawal by Subject|0|||
156812723|NCT01523743|566064842|FG001|Period 2|Withdrawal by Subject|2|||
156812724|NCT01523743|566064841|FG000|Period 2|Adverse Event|1|||
156812725|NCT01523743|566064842|FG001|Period 2|Adverse Event|0|||
156812726|NCT02569476|566064843|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
156812727|NCT02569476|566064843|FG000|Overall Study|Death|33|||
156812728|NCT02569476|566064843|FG000|Overall Study|Withdrawal by Subject|9|||
156812729|NCT02569476|566064843|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
156812730|NCT02569476|566064843|FG000|Overall Study|Palliative care|1|||
156812731|NCT02569476|566064843|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
156812732|NCT02569476|566064843|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
156812733|NCT01071954|566064844|FG000|Overall Study|Noncompliance|4|||
156812734|NCT01071954|566064844|FG000|Overall Study|Adverse Event|1|||
156812735|NCT01071954|566064844|FG000|Overall Study|Withdrawal by Subject|11|||
156812736|NCT01071954|566064844|FG000|Overall Study|Requirement for Alternative Therapy|5|||
156812737|NCT01071954|566064844|FG000|Overall Study|Administrative Decision|5|||
156812738|NCT01071954|566064844|FG000|Overall Study|Protocol Specified Criteria|1|||
156812739|NCT01152788|566064845|FG000|Overall Study|Withdrawal by Subject|0|||
156812740|NCT01152788|566064846|FG001|Overall Study|Withdrawal by Subject|3|||
156812741|NCT01152788|566064845|FG000|Overall Study|No treatment|0|||
156812742|NCT01152788|566064846|FG001|Overall Study|No treatment|1|||
156812743|NCT01434654|566064848|FG000|Overall Study|Withdrawal by Subject|1|||
156812744|NCT01434654|566064849|FG001|Overall Study|Withdrawal by Subject|0|||
156812745|NCT01434654|566064848|FG000|Overall Study|Lost to Follow-up|1|||
156812746|NCT01434654|566064849|FG001|Overall Study|Lost to Follow-up|0|||
156812747|NCT03782064|566064852|FG000|Overall Study|Lack of Efficacy|2|||
156812748|NCT03782064|566064852|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
156812749|NCT00363142|566064853|FG000|Overall Study|Adverse Event|2|||
156812750|NCT00363142|566064854|FG001|Overall Study|Adverse Event|0|||
156812751|NCT00363142|566064853|FG000|Overall Study|Lack of Efficacy|0|||
156812752|NCT00363142|566064854|FG001|Overall Study|Lack of Efficacy|1|||
156812753|NCT00363142|566064853|FG000|Overall Study|Lost to Follow-up|1|||
156812754|NCT00363142|566064854|FG001|Overall Study|Lost to Follow-up|0|||
156812755|NCT00363142|566064853|FG000|Overall Study|Non-compliance|1|||
156812756|NCT00363142|566064854|FG001|Overall Study|Non-compliance|1|||
156812757|NCT00363142|566064853|FG000|Overall Study|Withdrawal by Subject|3|||
156812758|NCT00363142|566064854|FG001|Overall Study|Withdrawal by Subject|1|||
156812759|NCT02625220|566064856|FG000|Overall Study|Adverse Event|2|||
156812760|NCT02625220|566064856|FG000|Overall Study|Lost to Follow-up|2|||
156812761|NCT02625220|566064856|FG000|Overall Study|Protocol Violation|1|||
156812762|NCT02625220|566064856|FG000|Overall Study|Study discontinued at site|2|||
156338954|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
156464291|NCT02720068|564797843|FG001|Overall Study|Adverse Event|0|||
156464292|NCT02720068|564797844|FG002|Overall Study|Adverse Event|0|||
156464293|NCT02720068|564797845|FG003|Overall Study|Adverse Event|0|||
156464294|NCT02720068|564797846|FG004|Overall Study|Adverse Event|0|||
156464295|NCT02720068|564797847|FG005|Overall Study|Adverse Event|0|||
156464296|NCT02720068|564797848|FG006|Overall Study|Adverse Event|0|||
156464297|NCT02720068|564797849|FG007|Overall Study|Adverse Event|0|||
156464298|NCT02720068|564797850|FG008|Overall Study|Adverse Event|0|||
156812763|NCT01140867|566064857|FG000|Overall Study|Adverse Event|22|||
156812764|NCT01140867|566064857|FG000|Overall Study|Lack of Efficacy|3|||
156812765|NCT01140867|566064857|FG000|Overall Study|Lost to Follow-up|2|||
156812766|NCT01140867|566064857|FG000|Overall Study|Withdrawal by Subject|1|||
156812767|NCT01140867|566064857|FG000|Overall Study|Protocol Violation|1|||
156812768|NCT01140867|566064857|FG000|Overall Study|Uncooperative patient|2|||
156812769|NCT01140867|566064857|FG000|Overall Study|Medication Noncompliance|2|||
156812770|NCT01926444|566064858|FG000|Overall Study|Colonoscopy not performed|0|||
156812771|NCT01926444|566064859|FG001|Overall Study|Colonoscopy not performed|0|||
156812772|NCT01926444|566064860|FG002|Overall Study|Colonoscopy not performed|4|||
156812773|NCT01926444|566064861|FG003|Overall Study|Colonoscopy not performed|2|||
156812774|NCT00995436|566064865|FG000|Overall Study|Withdrawal by Subject|2|||
156812775|NCT00995436|566064866|FG001|Overall Study|Withdrawal by Subject|5|||
156812776|NCT00995436|566064867|FG002|Overall Study|Withdrawal by Subject|0|||
156812777|NCT03035864|566064870|FG000|Treatment Period|Adverse Event|1|||
156812778|NCT03035864|566064871|FG001|Treatment Period|Adverse Event|0|||
156812779|NCT03035864|566064870|FG000|Treatment Period|Other|3|||
156812780|NCT03035864|566064871|FG001|Treatment Period|Other|1|||
156812781|NCT03035864|566064870|FG000|Follow-up Period|Adverse Event|1|||
156812782|NCT03035864|566064871|FG001|Follow-up Period|Adverse Event|0|||
156812783|NCT03035864|566064870|FG000|Follow-up Period|Lost to Follow-up|6|||
156812784|NCT03035864|566064871|FG001|Follow-up Period|Lost to Follow-up|2|||
156812785|NCT03035864|566064870|FG000|Follow-up Period|Physician Decision|1|||
156812786|NCT03035864|566064871|FG001|Follow-up Period|Physician Decision|0|||
156812787|NCT03035864|566064870|FG000|Follow-up Period|Other|3|||
156812788|NCT03035864|566064871|FG001|Follow-up Period|Other|2|||
156812789|NCT01154452|566064875|FG000|Phase Ib|Not Treated|1|||
156812790|NCT01154452|566064876|FG001|Phase Ib|Not Treated|0|||
156812791|NCT01154452|566064877|FG002|Phase Ib|Not Treated|0|||
156812792|NCT01154452|566064878|FG003|Phase Ib|Not Treated|0|||
156812793|NCT01154452|566064875|FG000|Phase Ib|Adverse Event|2|||
156812794|NCT01154452|566064876|FG001|Phase Ib|Adverse Event|1|||
156812795|NCT01154452|566064877|FG002|Phase Ib|Adverse Event|0|||
156812796|NCT01154452|566064878|FG003|Phase Ib|Adverse Event|0|||
156812797|NCT01154452|566064875|FG000|Phase II|Withdrawal by Subject|0|||
156812798|NCT01154452|566064876|FG001|Phase II|Withdrawal by Subject|0|||
156812799|NCT01154452|566064877|FG002|Phase II|Withdrawal by Subject|1|||
156812800|NCT01154452|566064878|FG003|Phase II|Withdrawal by Subject|2|||
156812801|NCT01154452|566064875|FG000|Phase II|Adverse Event|0|||
156812802|NCT01154452|566064876|FG001|Phase II|Adverse Event|0|||
156812803|NCT01154452|566064877|FG002|Phase II|Adverse Event|4|||
156812804|NCT01154452|566064878|FG003|Phase II|Adverse Event|4|||
156812805|NCT00100802|566064883|FG000|Overall Study|Adverse Event|9|||
156812806|NCT00100802|566064883|FG000|Overall Study|Death|1|||
156464299|NCT02720068|564797851|FG009|Overall Study|Adverse Event|0|||
156464300|NCT02720068|564797852|FG010|Overall Study|Adverse Event|0|||
156464301|NCT02720068|564797853|FG011|Overall Study|Adverse Event|1|||
156464302|NCT02720068|564797854|FG012|Overall Study|Adverse Event|0|||
156464303|NCT02720068|564797855|FG013|Overall Study|Adverse Event|0|||
156464304|NCT02720068|564797856|FG014|Overall Study|Adverse Event|0|||
156464305|NCT02720068|564797857|FG015|Overall Study|Adverse Event|0|||
156464306|NCT02720068|564797858|FG016|Overall Study|Adverse Event|0|||
156812807|NCT00100802|566064883|FG000|Overall Study|Lack of Efficacy|47|||
156812808|NCT00100802|566064883|FG000|Overall Study|Physician Decision|5|||
156812809|NCT00100802|566064883|FG000|Overall Study|Protocol Violation|1|||
156812810|NCT00100802|566064883|FG000|Overall Study|Withdrawal by Subject|5|||
156812811|NCT00100802|566064883|FG000|Overall Study|Ineligible|12|||
156812812|NCT05935878|566066162|FG000|Overall Study|Death|1|||
156812813|NCT05935878|566066163|FG001|Overall Study|Death|2|||
156812814|NCT05935878|566066162|FG000|Overall Study|Withdrawal by Subject|5|||
156812815|NCT05935878|566066163|FG001|Overall Study|Withdrawal by Subject|5|||
156464307|NCT02720068|564797859|FG017|Overall Study|Adverse Event|0|||
156464308|NCT02720068|564797842|FG000|Overall Study|Death|1|||
156464309|NCT02720068|564797843|FG001|Overall Study|Death|3|||
156812816|NCT05935878|566066162|FG000|Overall Study|Revision of implant|1|||
156812817|NCT05935878|566066163|FG001|Overall Study|Revision of implant|1|||
156812818|NCT05935878|566066162|FG000|Overall Study|Mobile bearing dislocation|0|||
156812819|NCT05935878|566066163|FG001|Overall Study|Mobile bearing dislocation|1|||
156812820|NCT00662831|566066177|FG000|Overall Study|Death|4|||
156812821|NCT00662831|566066178|FG001|Overall Study|Death|1|||
156812822|NCT00662831|566066177|FG000|Overall Study|Lack of Efficacy|6|||
156812823|NCT00662831|566066178|FG001|Overall Study|Lack of Efficacy|6|||
156812824|NCT00662831|566066177|FG000|Overall Study|Lost to Follow-up|1|||
156812825|NCT00662831|566066178|FG001|Overall Study|Lost to Follow-up|0|||
156812826|NCT00662831|566066177|FG000|Overall Study|Withdrawal by Subject|2|||
156812827|NCT00662831|566066178|FG001|Overall Study|Withdrawal by Subject|1|||
156812828|NCT00662831|566066177|FG000|Overall Study|Other|62|||
156812829|NCT00662831|566066178|FG001|Overall Study|Other|31|||
156812830|NCT00662831|566066177|FG000|Overall Study|Protocol Violation|8|||
156812831|NCT00662831|566066178|FG001|Overall Study|Protocol Violation|4|||
156812832|NCT00662831|566066177|FG000|Overall Study|Adverse Event|23|||
156812833|NCT00662831|566066178|FG001|Overall Study|Adverse Event|16|||
156812834|NCT05002985|566066179|FG000|Overall Study|Withdrawal by Subject|1|||
156812835|NCT00735553|566066180|FG000|Overall Study|Study prematurely terminated|77|||
156812836|NCT05069597|566066181|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
156812837|NCT05069597|566066182|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
156812838|NCT02705105|566066183|FG000|Treatment|Objective Disease Progression|1|||
156812839|NCT02705105|566066184|FG001|Treatment|Objective Disease Progression|50|||
156812840|NCT02705105|566066183|FG000|Treatment|Withdrawal by Subject|3|||
156812841|NCT02705105|566066184|FG001|Treatment|Withdrawal by Subject|5|||
156812842|NCT02705105|566066183|FG000|Treatment|Adverse Event|0|||
156812843|NCT02705105|566066184|FG001|Treatment|Adverse Event|17|||
156812844|NCT02705105|566066183|FG000|Treatment|Clinical Disease Progression|0|||
156812845|NCT02705105|566066184|FG001|Treatment|Clinical Disease Progression|32|||
156812846|NCT02705105|566066183|FG000|Treatment|Physician Decision|0|||
156812847|NCT02705105|566066184|FG001|Treatment|Physician Decision|3|||
156812848|NCT02705105|566066183|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
156812849|NCT02705105|566066184|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
156812850|NCT02705105|566066183|FG000|Follow-Up|Death|3|||
156812851|NCT02705105|566066184|FG001|Follow-Up|Death|68|||
156812852|NCT02705105|566066183|FG000|Follow-Up|Withdrawal by Subject|1|||
156812853|NCT02705105|566066184|FG001|Follow-Up|Withdrawal by Subject|14|||
156812854|NCT02705105|566066183|FG000|Follow-Up|Study Terminated|0|||
156812855|NCT02705105|566066184|FG001|Follow-Up|Study Terminated|26|||
156812856|NCT02705105|566066183|FG000|Follow-Up|Discontinued per Amendment 3|0|||
156812857|NCT02705105|566066184|FG001|Follow-Up|Discontinued per Amendment 3|2|||
156812858|NCT02707965|566066186|FG000|Overall Study|Withdrawal by Subject|0|||
156812859|NCT02707965|566066187|FG001|Overall Study|Withdrawal by Subject|0|||
156812860|NCT02707965|566066188|FG002|Overall Study|Withdrawal by Subject|1|||
156812861|NCT02707965|566066189|FG003|Overall Study|Withdrawal by Subject|0|||
156812862|NCT02707965|566066190|FG004|Overall Study|Withdrawal by Subject|0|||
156812863|NCT02707965|566066191|FG005|Overall Study|Withdrawal by Subject|0|||
156812864|NCT02707965|566066192|FG006|Overall Study|Withdrawal by Subject|0|||
156812865|NCT02707965|566066193|FG007|Overall Study|Withdrawal by Subject|2|||
156812866|NCT02707965|566066194|FG008|Overall Study|Withdrawal by Subject|0|||
156812867|NCT02707965|566066195|FG009|Overall Study|Withdrawal by Subject|0|||
156812868|NCT02707965|566066196|FG010|Overall Study|Withdrawal by Subject|0|||
156812869|NCT02707965|566066197|FG011|Overall Study|Withdrawal by Subject|0|||
156812870|NCT02707965|566066198|FG012|Overall Study|Withdrawal by Subject|0|||
156812871|NCT02707965|566066199|FG013|Overall Study|Withdrawal by Subject|0|||
156812872|NCT02707965|566066200|FG014|Overall Study|Withdrawal by Subject|0|||
156812873|NCT02707965|566066201|FG015|Overall Study|Withdrawal by Subject|0|||
156812874|NCT02707965|566066186|FG000|Overall Study|PI decisions|0|||
156812875|NCT02707965|566066187|FG001|Overall Study|PI decisions|0|||
156812876|NCT02707965|566066188|FG002|Overall Study|PI decisions|0|||
156812877|NCT02707965|566066189|FG003|Overall Study|PI decisions|0|||
156464310|NCT02720068|564797844|FG002|Overall Study|Death|2|||
156812878|NCT02707965|566066190|FG004|Overall Study|PI decisions|0|||
156812879|NCT02707965|566066191|FG005|Overall Study|PI decisions|0|||
156812880|NCT02707965|566066192|FG006|Overall Study|PI decisions|0|||
156812881|NCT02707965|566066193|FG007|Overall Study|PI decisions|0|||
156812882|NCT02707965|566066194|FG008|Overall Study|PI decisions|0|||
156812883|NCT02707965|566066195|FG009|Overall Study|PI decisions|0|||
156812884|NCT02707965|566066196|FG010|Overall Study|PI decisions|0|||
156812885|NCT02707965|566066197|FG011|Overall Study|PI decisions|0|||
156812886|NCT02707965|566066198|FG012|Overall Study|PI decisions|0|||
156812887|NCT02707965|566066199|FG013|Overall Study|PI decisions|0|||
156812888|NCT02707965|566066200|FG014|Overall Study|PI decisions|2|||
156812889|NCT02707965|566066201|FG015|Overall Study|PI decisions|0|||
156812890|NCT02707965|566066186|FG000|Overall Study|Protocol deviation|1|||
156812891|NCT02707965|566066187|FG001|Overall Study|Protocol deviation|1|||
156812892|NCT02707965|566066188|FG002|Overall Study|Protocol deviation|0|||
156812893|NCT02707965|566066189|FG003|Overall Study|Protocol deviation|0|||
156338955|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
156812894|NCT02707965|566066190|FG004|Overall Study|Protocol deviation|0|||
156812895|NCT02707965|566066191|FG005|Overall Study|Protocol deviation|0|||
156812896|NCT02707965|566066192|FG006|Overall Study|Protocol deviation|0|||
156812897|NCT02707965|566066193|FG007|Overall Study|Protocol deviation|1|||
156812898|NCT02707965|566066194|FG008|Overall Study|Protocol deviation|0|||
156812899|NCT02707965|566066195|FG009|Overall Study|Protocol deviation|0|||
156812900|NCT02707965|566066196|FG010|Overall Study|Protocol deviation|0|||
156812901|NCT02707965|566066197|FG011|Overall Study|Protocol deviation|0|||
156812902|NCT02707965|566066198|FG012|Overall Study|Protocol deviation|0|||
156812903|NCT02707965|566066199|FG013|Overall Study|Protocol deviation|0|||
156464311|NCT02720068|564797845|FG003|Overall Study|Death|1|||
156812904|NCT02707965|566066200|FG014|Overall Study|Protocol deviation|0|||
156812905|NCT02707965|566066201|FG015|Overall Study|Protocol deviation|0|||
156812906|NCT00485758|566066204|FG000|Overall Study|Adverse Event|102|||
156812907|NCT00485758|566066205|FG001|Overall Study|Adverse Event|31|||
156812908|NCT00485758|566066204|FG000|Overall Study|Death|0|||
156812909|NCT00485758|566066205|FG001|Overall Study|Death|1|||
156812910|NCT00485758|566066204|FG000|Overall Study|Lost to Follow-up|5|||
156812911|NCT00485758|566066205|FG001|Overall Study|Lost to Follow-up|1|||
156812912|NCT00485758|566066204|FG000|Overall Study|Physician Decision|3|||
156812913|NCT00485758|566066205|FG001|Overall Study|Physician Decision|3|||
156812914|NCT00485758|566066204|FG000|Overall Study|Protocol Violation|11|||
156812915|NCT00485758|566066205|FG001|Overall Study|Protocol Violation|2|||
156812916|NCT00485758|566066204|FG000|Overall Study|Withdrawal by Subject|32|||
156812917|NCT00485758|566066205|FG001|Overall Study|Withdrawal by Subject|27|||
156812918|NCT00485758|566066204|FG000|Overall Study|Study Terminated by Sponsor|3|||
156812919|NCT00485758|566066205|FG001|Overall Study|Study Terminated by Sponsor|0|||
156812920|NCT04556591|566066206|FG000|Overall Study|Lost to Follow-up|1|||
156812921|NCT04556591|566066207|FG001|Overall Study|Lost to Follow-up|0|||
156812922|NCT04556591|566066206|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
156812923|NCT04556591|566066207|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
156812924|NCT03332173|566066208|FG000|Overall Study|Death|7|||
156812925|NCT03332173|566066208|FG000|Overall Study|Withdrawal by Subject|6|||
156812926|NCT03332173|566066208|FG000|Overall Study|Lost to Follow-up|2|||
156812927|NCT03332173|566066208|FG000|Overall Study|Transferred to long-term extension study|29|||
156812928|NCT00211172|566066209|FG000|Overall Study|Died or lost health plan eligibility|39|||
156812929|NCT00211172|566066210|FG001|Overall Study|Died or lost health plan eligibility|32|||
156812930|NCT04474197|566066211|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
156812931|NCT04474197|566066212|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
156812932|NCT04474197|566066213|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
156812933|NCT04474197|566066214|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
156812934|NCT00624468|566066216|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
156812935|NCT00624468|566066217|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
156812936|NCT00624468|566066218|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
156812937|NCT00624468|566066219|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
156812938|NCT00624468|566066216|FG000|Double-blind Period|Withdrew Prematurely|1|||
156812939|NCT00624468|566066217|FG001|Double-blind Period|Withdrew Prematurely|1|||
156812940|NCT00624468|566066218|FG002|Double-blind Period|Withdrew Prematurely|0|||
156812941|NCT00624468|566066219|FG003|Double-blind Period|Withdrew Prematurely|0|||
156812942|NCT00624468|566066216|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
156812943|NCT00624468|566066217|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
156812944|NCT00624468|566066218|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
156812945|NCT00624468|566066219|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
156812946|NCT00624468|566066216|FG000|Safety Follow-up (SFU) Period|Other|0|||
156812947|NCT00624468|566066217|FG001|Safety Follow-up (SFU) Period|Other|0|||
156812948|NCT00624468|566066218|FG002|Safety Follow-up (SFU) Period|Other|1|||
156812949|NCT00624468|566066219|FG003|Safety Follow-up (SFU) Period|Other|1|||
156812950|NCT03072043|566066228|FG000|Overall Study|Death|0|||
156812951|NCT03072043|566066229|FG001|Overall Study|Death|0|||
156812952|NCT03072043|566066230|FG002|Overall Study|Death|3|||
156812953|NCT03072043|566066228|FG000|Overall Study|Adverse Event|0|||
156812954|NCT03072043|566066229|FG001|Overall Study|Adverse Event|0|||
156812955|NCT03072043|566066230|FG002|Overall Study|Adverse Event|2|||
156812956|NCT03072043|566066228|FG000|Overall Study|Withdrawal by Subject|0|||
156812957|NCT03072043|566066229|FG001|Overall Study|Withdrawal by Subject|0|||
156812958|NCT03072043|566066230|FG002|Overall Study|Withdrawal by Subject|4|||
156812959|NCT01340664|566066231|FG000|Overall Study|Adverse Event|0|||
156812960|NCT01340664|566066232|FG001|Overall Study|Adverse Event|1|||
156812961|NCT01340664|566066233|FG002|Overall Study|Adverse Event|7|||
156812962|NCT01340664|566066231|FG000|Overall Study|Lost to Follow-up|2|||
156812963|NCT01340664|566066232|FG001|Overall Study|Lost to Follow-up|0|||
156812964|NCT01340664|566066233|FG002|Overall Study|Lost to Follow-up|2|||
156812965|NCT01340664|566066231|FG000|Overall Study|Withdrawal by Subject|2|||
156812966|NCT01340664|566066232|FG001|Overall Study|Withdrawal by Subject|4|||
156812967|NCT01340664|566066233|FG002|Overall Study|Withdrawal by Subject|0|||
156812968|NCT01340664|566066231|FG000|Overall Study|Glycemic withdrawal criteria|2|||
156812969|NCT01340664|566066232|FG001|Overall Study|Glycemic withdrawal criteria|0|||
156338956|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
156464312|NCT02720068|564797846|FG004|Overall Study|Death|2|||
156338957|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
156338958|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
156464313|NCT02720068|564797847|FG005|Overall Study|Death|1|||
156812970|NCT01340664|566066233|FG002|Overall Study|Glycemic withdrawal criteria|0|||
156812971|NCT01340664|566066231|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
156812972|NCT01340664|566066232|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
156464314|NCT02720068|564797848|FG006|Overall Study|Death|2|||
156464315|NCT02720068|564797849|FG007|Overall Study|Death|2|||
156464316|NCT02720068|564797850|FG008|Overall Study|Death|3|||
156812973|NCT01340664|566066233|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
156812974|NCT01340664|566066231|FG000|Overall Study|Other|1|||
156812975|NCT01340664|566066232|FG001|Overall Study|Other|2|||
156812976|NCT01340664|566066233|FG002|Overall Study|Other|2|||
156812977|NCT02923531|566066234|FG000|Overall Study|Adverse Event|4|||
156812978|NCT02923531|566066234|FG000|Overall Study|Clinical Deterioration|1|||
156812979|NCT02923531|566066234|FG000|Overall Study|Disease Progression|3|||
156812980|NCT02923531|566066234|FG000|Overall Study|Study Termination|1|||
156812981|NCT01823198|566066236|FG000|Overall Study|Physician Decision|0|||
156812982|NCT01823198|566066237|FG001|Overall Study|Physician Decision|1|||
156812983|NCT01823198|566066238|FG002|Overall Study|Physician Decision|0|||
156812984|NCT01823198|566066239|FG003|Overall Study|Physician Decision|0|||
156812985|NCT01823198|566066240|FG004|Overall Study|Physician Decision|0|||
156812986|NCT01823198|566066241|FG005|Overall Study|Physician Decision|3|||
156812987|NCT01823198|566066242|FG006|Overall Study|Physician Decision|3|||
156812988|NCT02517398|566066246|FG000|Overall Study|Death|2|||
156812989|NCT02517398|566066247|FG001|Overall Study|Death|3|||
156812990|NCT02517398|566066248|FG002|Overall Study|Death|4|||
156812991|NCT02517398|566066249|FG003|Overall Study|Death|2|||
156812992|NCT02517398|566066250|FG004|Overall Study|Death|3|||
156812993|NCT02517398|566066251|FG005|Overall Study|Death|8|||
156812994|NCT02517398|566066252|FG006|Overall Study|Death|3|||
156812995|NCT02517398|566066253|FG007|Overall Study|Death|2|||
156812996|NCT02517398|566066254|FG008|Overall Study|Death|6|||
156812997|NCT02517398|566066255|FG009|Overall Study|Death|24|||
156812998|NCT02517398|566066256|FG010|Overall Study|Death|53|||
156812999|NCT02517398|566066257|FG011|Overall Study|Death|25|||
156464317|NCT02720068|564797851|FG009|Overall Study|Death|1|||
156464318|NCT02720068|564797852|FG010|Overall Study|Death|20|||
156464319|NCT02720068|564797853|FG011|Overall Study|Death|166|||
156464320|NCT02720068|564797854|FG012|Overall Study|Death|34|||
156464321|NCT02720068|564797855|FG013|Overall Study|Death|30|||
156464322|NCT02720068|564797856|FG014|Overall Study|Death|45|||
156464323|NCT02720068|564797857|FG015|Overall Study|Death|16|||
156464324|NCT02720068|564797858|FG016|Overall Study|Death|20|||
156539271|NCT03098836|565068274|FG000|Overall Study|Withdrawal by Subject|3|||
156539272|NCT03098836|565068275|FG001|Overall Study|Withdrawal by Subject|2|||
156539273|NCT03986866|565068276|FG000|Overall Study|Withdrawal by Subject|0|||
156539274|NCT03986866|565068277|FG001|Overall Study|Withdrawal by Subject|3|||
156539275|NCT03986866|565068276|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
156539276|NCT03986866|565068277|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
156539277|NCT00545064|565068280|FG000|Overall Study|Lost to Follow-up|3|||
156539278|NCT00545064|565068280|FG000|Overall Study|Withdrawal by Subject|2|||
156539279|NCT00545064|565068280|FG000|Overall Study|did not complete course of treatment|1|||
156813000|NCT02517398|566066258|FG012|Overall Study|Death|73|||
156813001|NCT02517398|566066259|FG013|Overall Study|Death|29|||
156464325|NCT02720068|564797859|FG017|Overall Study|Death|28|||
156464326|NCT02720068|564797842|FG000|Overall Study|Lost to Follow-up|0|||
156464327|NCT02720068|564797843|FG001|Overall Study|Lost to Follow-up|0|||
156464328|NCT02720068|564797844|FG002|Overall Study|Lost to Follow-up|0|||
156464329|NCT02720068|564797845|FG003|Overall Study|Lost to Follow-up|0|||
156464330|NCT02720068|564797846|FG004|Overall Study|Lost to Follow-up|0|||
156464331|NCT02720068|564797847|FG005|Overall Study|Lost to Follow-up|0|||
156464332|NCT02720068|564797848|FG006|Overall Study|Lost to Follow-up|0|||
156539280|NCT00545064|565068280|FG000|Overall Study|cancel all appointments, no rebooking|1|||
156539281|NCT00545064|565068280|FG000|Overall Study|inclement weather|1|||
156539282|NCT04688775|565068281|FG000|Placebo-controlled Period|Randomized, not treated|1|||
156539283|NCT04688775|565068282|FG001|Placebo-controlled Period|Randomized, not treated|1|||
156539284|NCT04688775|565068283|FG002|Placebo-controlled Period|Randomized, not treated|0|||
156813002|NCT02517398|566066260|FG014|Overall Study|Death|26|||
156813003|NCT02517398|566066261|FG015|Overall Study|Death|23|||
156813004|NCT02517398|566066262|FG016|Overall Study|Death|26|||
156813005|NCT02517398|566066263|FG017|Overall Study|Death|25|||
156464333|NCT02720068|564797849|FG007|Overall Study|Lost to Follow-up|0|||
156813006|NCT02517398|566066264|FG018|Overall Study|Death|22|||
156813007|NCT02517398|566066265|FG019|Overall Study|Death|7|||
156813008|NCT02517398|566066266|FG020|Overall Study|Death|26|||
156813009|NCT02517398|566066267|FG021|Overall Study|Death|30|||
156813010|NCT02517398|566066268|FG022|Overall Study|Death|20|||
156813011|NCT02517398|566066246|FG000|Overall Study|Other|0|||
156813012|NCT02517398|566066247|FG001|Overall Study|Other|0|||
156813013|NCT02517398|566066248|FG002|Overall Study|Other|0|||
156464334|NCT02720068|564797850|FG008|Overall Study|Lost to Follow-up|0|||
156464335|NCT02720068|564797851|FG009|Overall Study|Lost to Follow-up|0|||
156464336|NCT02720068|564797852|FG010|Overall Study|Lost to Follow-up|0|||
156464337|NCT02720068|564797853|FG011|Overall Study|Lost to Follow-up|1|||
156464338|NCT02720068|564797854|FG012|Overall Study|Lost to Follow-up|0|||
156464339|NCT02720068|564797855|FG013|Overall Study|Lost to Follow-up|1|||
156813014|NCT02517398|566066249|FG003|Overall Study|Other|1|||
156813015|NCT02517398|566066250|FG004|Overall Study|Other|0|||
156813016|NCT02517398|566066251|FG005|Overall Study|Other|0|||
156813017|NCT02517398|566066252|FG006|Overall Study|Other|0|||
156813018|NCT02517398|566066253|FG007|Overall Study|Other|0|||
156813019|NCT02517398|566066254|FG008|Overall Study|Other|0|||
156813020|NCT02517398|566066255|FG009|Overall Study|Other|1|||
156813021|NCT02517398|566066256|FG010|Overall Study|Other|0|||
156813022|NCT02517398|566066257|FG011|Overall Study|Other|0|||
156813023|NCT02517398|566066258|FG012|Overall Study|Other|0|||
156813024|NCT02517398|566066259|FG013|Overall Study|Other|1|||
156813025|NCT02517398|566066260|FG014|Overall Study|Other|0|||
156813026|NCT02517398|566066261|FG015|Overall Study|Other|1|||
156813027|NCT02517398|566066262|FG016|Overall Study|Other|1|||
156813028|NCT02517398|566066263|FG017|Overall Study|Other|0|||
156813029|NCT02517398|566066264|FG018|Overall Study|Other|0|||
156813030|NCT02517398|566066265|FG019|Overall Study|Other|1|||
156813031|NCT02517398|566066266|FG020|Overall Study|Other|0|||
156813032|NCT02517398|566066267|FG021|Overall Study|Other|0|||
156813033|NCT02517398|566066268|FG022|Overall Study|Other|0|||
156813034|NCT02517398|566066246|FG000|Overall Study|Lost to Follow-up|0|||
156813035|NCT02517398|566066247|FG001|Overall Study|Lost to Follow-up|0|||
156813036|NCT02517398|566066248|FG002|Overall Study|Lost to Follow-up|0|||
156813037|NCT02517398|566066249|FG003|Overall Study|Lost to Follow-up|0|||
156813038|NCT02517398|566066250|FG004|Overall Study|Lost to Follow-up|0|||
156813039|NCT02517398|566066251|FG005|Overall Study|Lost to Follow-up|0|||
156813040|NCT02517398|566066252|FG006|Overall Study|Lost to Follow-up|0|||
156813041|NCT02517398|566066253|FG007|Overall Study|Lost to Follow-up|0|||
156813042|NCT02517398|566066254|FG008|Overall Study|Lost to Follow-up|0|||
156813043|NCT02517398|566066255|FG009|Overall Study|Lost to Follow-up|1|||
156813044|NCT02517398|566066256|FG010|Overall Study|Lost to Follow-up|0|||
156813045|NCT02517398|566066257|FG011|Overall Study|Lost to Follow-up|2|||
156813046|NCT02517398|566066258|FG012|Overall Study|Lost to Follow-up|2|||
156813047|NCT02517398|566066259|FG013|Overall Study|Lost to Follow-up|0|||
156813048|NCT02517398|566066260|FG014|Overall Study|Lost to Follow-up|1|||
156813049|NCT02517398|566066261|FG015|Overall Study|Lost to Follow-up|1|||
156813050|NCT02517398|566066262|FG016|Overall Study|Lost to Follow-up|0|||
156813051|NCT02517398|566066263|FG017|Overall Study|Lost to Follow-up|3|||
156813052|NCT02517398|566066264|FG018|Overall Study|Lost to Follow-up|1|||
156813053|NCT02517398|566066265|FG019|Overall Study|Lost to Follow-up|0|||
156539285|NCT04688775|565068284|FG003|Placebo-controlled Period|Randomized, not treated|0|||
156813054|NCT02517398|566066266|FG020|Overall Study|Lost to Follow-up|1|||
156813055|NCT02517398|566066267|FG021|Overall Study|Lost to Follow-up|0|||
156813056|NCT02517398|566066268|FG022|Overall Study|Lost to Follow-up|2|||
156813057|NCT02517398|566066246|FG000|Overall Study|Withdrew Consent|0|||
156813058|NCT02517398|566066247|FG001|Overall Study|Withdrew Consent|0|||
156813059|NCT02517398|566066248|FG002|Overall Study|Withdrew Consent|0|||
156813060|NCT02517398|566066249|FG003|Overall Study|Withdrew Consent|0|||
156813061|NCT02517398|566066250|FG004|Overall Study|Withdrew Consent|0|||
156813062|NCT02517398|566066251|FG005|Overall Study|Withdrew Consent|0|||
156813063|NCT02517398|566066252|FG006|Overall Study|Withdrew Consent|1|||
156813064|NCT02517398|566066253|FG007|Overall Study|Withdrew Consent|0|||
156813065|NCT02517398|566066254|FG008|Overall Study|Withdrew Consent|0|||
156813066|NCT02517398|566066255|FG009|Overall Study|Withdrew Consent|2|||
156813067|NCT02517398|566066256|FG010|Overall Study|Withdrew Consent|7|||
156813068|NCT02517398|566066257|FG011|Overall Study|Withdrew Consent|1|||
156813069|NCT02517398|566066258|FG012|Overall Study|Withdrew Consent|5|||
156813070|NCT02517398|566066259|FG013|Overall Study|Withdrew Consent|4|||
156813071|NCT02517398|566066260|FG014|Overall Study|Withdrew Consent|2|||
156813072|NCT02517398|566066261|FG015|Overall Study|Withdrew Consent|5|||
156813073|NCT02517398|566066262|FG016|Overall Study|Withdrew Consent|4|||
156813074|NCT02517398|566066263|FG017|Overall Study|Withdrew Consent|2|||
156813075|NCT02517398|566066264|FG018|Overall Study|Withdrew Consent|3|||
156813076|NCT02517398|566066265|FG019|Overall Study|Withdrew Consent|2|||
156813077|NCT02517398|566066266|FG020|Overall Study|Withdrew Consent|9|||
156813078|NCT02517398|566066267|FG021|Overall Study|Withdrew Consent|3|||
156813079|NCT02517398|566066268|FG022|Overall Study|Withdrew Consent|1|||
156813080|NCT00130039|566066275|FG000|Overall Study|Withdrawal by Subject|15|||
156813081|NCT00130039|566066276|FG001|Overall Study|Withdrawal by Subject|11|||
156813082|NCT00130039|566066275|FG000|Overall Study|Lost to Follow-up|3|||
156813083|NCT00130039|566066276|FG001|Overall Study|Lost to Follow-up|1|||
156813084|NCT00130039|566066275|FG000|Overall Study|Adverse Event|4|||
156813085|NCT00130039|566066276|FG001|Overall Study|Adverse Event|2|||
156813086|NCT00130039|566066275|FG000|Overall Study|Physician Decision|3|||
156813087|NCT00130039|566066276|FG001|Overall Study|Physician Decision|0|||
156813088|NCT00130039|566066275|FG000|Overall Study|clinical events without follow up MRI|5|||
156813089|NCT00130039|566066276|FG001|Overall Study|clinical events without follow up MRI|4|||
156813090|NCT03706430|566066277|FG000|Overall Study|No A-Line placed|5|||
156813091|NCT03706430|566066277|FG000|Overall Study|Subject had gel nail polish|1|||
156813092|NCT03706430|566066277|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
156813093|NCT03706430|566066277|FG000|Overall Study|Cancelled Case|6|||
156813094|NCT03706430|566066277|FG000|Overall Study|Physician Decision|2|||
156813095|NCT00145626|566066278|FG000|Overall Study|Did not have NK infusions|2|||
156813096|NCT00145626|566066278|FG000|Overall Study|Turned 2 years old before treatment|1|||
156813097|NCT00145626|566066278|FG000|Overall Study|Death|1|||
156813098|NCT00145626|566066278|FG000|Overall Study|Withdrawal by Subject|1|||
156813099|NCT02709720|566066279|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
156813100|NCT02709720|566066279|FG000|Overall Study|Protocol Violation|1|||
156813101|NCT02709720|566066279|FG000|Overall Study|Not take study medication|1|||
156813102|NCT01198574|566066283|FG000|Overall Study|Resigned from schools|4|||
156813103|NCT01198574|566066284|FG001|Overall Study|Resigned from schools|1|||
156813104|NCT01198574|566066285|FG002|Overall Study|Resigned from schools|1|||
156813105|NCT01198574|566066286|FG003|Overall Study|Resigned from schools|4|||
156813106|NCT00200967|566066288|FG000|First Treatment Period|Withdrawal by Subject|5|||
156813107|NCT00200967|566066289|FG001|First Treatment Period|Withdrawal by Subject|1|||
156813108|NCT00200967|566066288|FG000|First Treatment Period|Pregnancy|1|||
156813109|NCT00200967|566066289|FG001|First Treatment Period|Pregnancy|0|||
156813110|NCT00200967|566066288|FG000|Wash-out Period|Lost to Follow-up|0|||
156813111|NCT00200967|566066289|FG001|Wash-out Period|Lost to Follow-up|1|||
156813112|NCT00200967|566066288|FG000|Second Treatment Period|Withdrawal by Subject|1|||
156813113|NCT00200967|566066289|FG001|Second Treatment Period|Withdrawal by Subject|2|||
156813114|NCT00200967|566066288|FG000|Run-out Period|Lost to Follow-up|1|||
156813115|NCT00200967|566066289|FG001|Run-out Period|Lost to Follow-up|0|||
156813116|NCT00980460|566066290|FG000|Overall Study|Death|0|||
156813117|NCT00980460|566066291|FG001|Overall Study|Death|0|||
156813118|NCT00980460|566066292|FG002|Overall Study|Death|1|||
156813119|NCT00980460|566066293|FG003|Overall Study|Death|2|||
156813120|NCT00980460|566066294|FG004|Overall Study|Death|1|||
156464340|NCT02720068|564797856|FG014|Overall Study|Lost to Follow-up|2|||
156464341|NCT02720068|564797857|FG015|Overall Study|Lost to Follow-up|0|||
156464342|NCT02720068|564797858|FG016|Overall Study|Lost to Follow-up|0|||
156813121|NCT00980460|566066290|FG000|Overall Study|Lack of Efficacy|0|||
156813122|NCT00980460|566066291|FG001|Overall Study|Lack of Efficacy|0|||
156813123|NCT00980460|566066292|FG002|Overall Study|Lack of Efficacy|10|||
156338959|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
156338960|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
156338961|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
156338962|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
156338963|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
156338964|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
156338965|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
156338966|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
156464343|NCT02720068|564797859|FG017|Overall Study|Lost to Follow-up|1|||
156464344|NCT02720068|564797842|FG000|Overall Study|Physician Decision|0|||
156464345|NCT02720068|564797843|FG001|Overall Study|Physician Decision|0|||
156464346|NCT02720068|564797844|FG002|Overall Study|Physician Decision|0|||
156464347|NCT02720068|564797845|FG003|Overall Study|Physician Decision|1|||
156464348|NCT02720068|564797846|FG004|Overall Study|Physician Decision|0|||
156813124|NCT00980460|566066293|FG003|Overall Study|Lack of Efficacy|6|||
156813125|NCT00980460|566066294|FG004|Overall Study|Lack of Efficacy|8|||
156813126|NCT00980460|566066290|FG000|Overall Study|Lost to Follow-up|0|||
156813127|NCT00980460|566066291|FG001|Overall Study|Lost to Follow-up|0|||
156813128|NCT00980460|566066292|FG002|Overall Study|Lost to Follow-up|0|||
156813129|NCT00980460|566066293|FG003|Overall Study|Lost to Follow-up|1|||
156813130|NCT00980460|566066294|FG004|Overall Study|Lost to Follow-up|0|||
156813131|NCT00980460|566066290|FG000|Overall Study|Physician Decision|0|||
156813132|NCT00980460|566066291|FG001|Overall Study|Physician Decision|0|||
156813133|NCT00980460|566066292|FG002|Overall Study|Physician Decision|11|||
156813134|NCT00980460|566066293|FG003|Overall Study|Physician Decision|5|||
156813135|NCT00980460|566066294|FG004|Overall Study|Physician Decision|3|||
156813136|NCT00980460|566066290|FG000|Overall Study|Withdrawal by Subject|0|||
156813137|NCT00980460|566066291|FG001|Overall Study|Withdrawal by Subject|0|||
156813138|NCT00980460|566066292|FG002|Overall Study|Withdrawal by Subject|1|||
156813139|NCT00980460|566066293|FG003|Overall Study|Withdrawal by Subject|0|||
156813140|NCT00980460|566066294|FG004|Overall Study|Withdrawal by Subject|0|||
156813141|NCT00980460|566066290|FG000|Overall Study|Ineligible|0|||
156813142|NCT00980460|566066291|FG001|Overall Study|Ineligible|2|||
156813143|NCT00980460|566066292|FG002|Overall Study|Ineligible|3|||
156813144|NCT00980460|566066293|FG003|Overall Study|Ineligible|1|||
156813145|NCT00980460|566066294|FG004|Overall Study|Ineligible|4|||
156813146|NCT00980460|566066290|FG000|Overall Study|Refusal of further therapy|0|||
156813147|NCT00980460|566066291|FG001|Overall Study|Refusal of further therapy|2|||
156813148|NCT00980460|566066292|FG002|Overall Study|Refusal of further therapy|3|||
156813149|NCT00980460|566066293|FG003|Overall Study|Refusal of further therapy|2|||
156464349|NCT02720068|564797847|FG005|Overall Study|Physician Decision|0|||
156464350|NCT02720068|564797848|FG006|Overall Study|Physician Decision|0|||
156464351|NCT02720068|564797849|FG007|Overall Study|Physician Decision|0|||
156464352|NCT02720068|564797850|FG008|Overall Study|Physician Decision|0|||
156464353|NCT02720068|564797851|FG009|Overall Study|Physician Decision|0|||
156464354|NCT02720068|564797852|FG010|Overall Study|Physician Decision|0|||
156464355|NCT02720068|564797853|FG011|Overall Study|Physician Decision|1|||
156464356|NCT02720068|564797854|FG012|Overall Study|Physician Decision|0|||
156464357|NCT02720068|564797855|FG013|Overall Study|Physician Decision|0|||
156464358|NCT02720068|564797856|FG014|Overall Study|Physician Decision|0|||
156464359|NCT02720068|564797857|FG015|Overall Study|Physician Decision|0|||
156464360|NCT02720068|564797858|FG016|Overall Study|Physician Decision|0|||
156464361|NCT02720068|564797859|FG017|Overall Study|Physician Decision|1|||
156464362|NCT02720068|564797842|FG000|Overall Study|Progressive Disease|2|||
156464363|NCT02720068|564797843|FG001|Overall Study|Progressive Disease|3|||
156464364|NCT02720068|564797844|FG002|Overall Study|Progressive Disease|1|||
156464365|NCT02720068|564797845|FG003|Overall Study|Progressive Disease|1|||
156464366|NCT02720068|564797846|FG004|Overall Study|Progressive Disease|1|||
156464367|NCT02720068|564797847|FG005|Overall Study|Progressive Disease|2|||
156464368|NCT02720068|564797848|FG006|Overall Study|Progressive Disease|1|||
156464369|NCT02720068|564797849|FG007|Overall Study|Progressive Disease|1|||
156464370|NCT02720068|564797850|FG008|Overall Study|Progressive Disease|0|||
156464371|NCT02720068|564797851|FG009|Overall Study|Progressive Disease|1|||
156464372|NCT02720068|564797852|FG010|Overall Study|Progressive Disease|0|||
156464373|NCT02720068|564797853|FG011|Overall Study|Progressive Disease|4|||
156464374|NCT02720068|564797854|FG012|Overall Study|Progressive Disease|1|||
156464375|NCT02720068|564797855|FG013|Overall Study|Progressive Disease|0|||
156464376|NCT02720068|564797856|FG014|Overall Study|Progressive Disease|0|||
156464377|NCT02720068|564797857|FG015|Overall Study|Progressive Disease|0|||
156464378|NCT02720068|564797858|FG016|Overall Study|Progressive Disease|0|||
156464379|NCT02720068|564797859|FG017|Overall Study|Progressive Disease|0|||
156464380|NCT02720068|564797842|FG000|Overall Study|Sponsor Decision|0|||
156464381|NCT02720068|564797843|FG001|Overall Study|Sponsor Decision|0|||
156464382|NCT02720068|564797844|FG002|Overall Study|Sponsor Decision|0|||
156464383|NCT02720068|564797845|FG003|Overall Study|Sponsor Decision|0|||
156464384|NCT02720068|564797846|FG004|Overall Study|Sponsor Decision|0|||
156464385|NCT02720068|564797847|FG005|Overall Study|Sponsor Decision|0|||
156464386|NCT02720068|564797848|FG006|Overall Study|Sponsor Decision|0|||
156464387|NCT02720068|564797849|FG007|Overall Study|Sponsor Decision|0|||
156464388|NCT02720068|564797850|FG008|Overall Study|Sponsor Decision|0|||
156464389|NCT02720068|564797851|FG009|Overall Study|Sponsor Decision|0|||
156464390|NCT02720068|564797852|FG010|Overall Study|Sponsor Decision|0|||
156464391|NCT02720068|564797853|FG011|Overall Study|Sponsor Decision|6|||
156464392|NCT02720068|564797854|FG012|Overall Study|Sponsor Decision|3|||
156813150|NCT00980460|566066294|FG004|Overall Study|Refusal of further therapy|0|||
156813151|NCT00980460|566066290|FG000|Overall Study|No therapy within 42 days of resection|0|||
156813152|NCT00980460|566066291|FG001|Overall Study|No therapy within 42 days of resection|0|||
156813153|NCT00980460|566066292|FG002|Overall Study|No therapy within 42 days of resection|3|||
156813154|NCT00980460|566066293|FG003|Overall Study|No therapy within 42 days of resection|1|||
156813155|NCT00980460|566066294|FG004|Overall Study|No therapy within 42 days of resection|0|||
156813156|NCT00980460|566066290|FG000|Overall Study|No transplant by protocol timepoints|0|||
156813157|NCT00980460|566066291|FG001|Overall Study|No transplant by protocol timepoints|0|||
156813158|NCT00980460|566066292|FG002|Overall Study|No transplant by protocol timepoints|3|||
156813159|NCT00980460|566066293|FG003|Overall Study|No transplant by protocol timepoints|0|||
156813160|NCT00980460|566066294|FG004|Overall Study|No transplant by protocol timepoints|0|||
156813161|NCT00928187|566066295|FG000|Overall Study|Death|1|||
156813162|NCT00928187|566066296|FG001|Overall Study|Death|2|||
156813163|NCT00928187|566066297|FG002|Overall Study|Death|3|||
156813164|NCT00928187|566066295|FG000|Overall Study|Lost to Follow-up|1|||
156813165|NCT00928187|566066296|FG001|Overall Study|Lost to Follow-up|2|||
156464393|NCT02720068|564797855|FG013|Overall Study|Sponsor Decision|2|||
156464394|NCT02720068|564797856|FG014|Overall Study|Sponsor Decision|4|||
156464395|NCT02720068|564797857|FG015|Overall Study|Sponsor Decision|4|||
156464396|NCT02720068|564797858|FG016|Overall Study|Sponsor Decision|0|||
156464397|NCT02720068|564797859|FG017|Overall Study|Sponsor Decision|8|||
156464398|NCT02720068|564797842|FG000|Overall Study|Withdrawal by Subject|0|||
156464399|NCT02720068|564797843|FG001|Overall Study|Withdrawal by Subject|0|||
156464400|NCT02720068|564797844|FG002|Overall Study|Withdrawal by Subject|0|||
156464401|NCT02720068|564797845|FG003|Overall Study|Withdrawal by Subject|0|||
156464402|NCT02720068|564797846|FG004|Overall Study|Withdrawal by Subject|0|||
156464403|NCT02720068|564797847|FG005|Overall Study|Withdrawal by Subject|0|||
156464404|NCT02720068|564797848|FG006|Overall Study|Withdrawal by Subject|0|||
156464405|NCT02720068|564797849|FG007|Overall Study|Withdrawal by Subject|0|||
156464406|NCT02720068|564797850|FG008|Overall Study|Withdrawal by Subject|0|||
156464407|NCT02720068|564797851|FG009|Overall Study|Withdrawal by Subject|1|||
156464408|NCT02720068|564797852|FG010|Overall Study|Withdrawal by Subject|0|||
156464409|NCT02720068|564797853|FG011|Overall Study|Withdrawal by Subject|27|||
156813166|NCT00928187|566066297|FG002|Overall Study|Lost to Follow-up|1|||
156813167|NCT00928187|566066295|FG000|Overall Study|Withdrawal by Subject|0|||
156813168|NCT00928187|566066296|FG001|Overall Study|Withdrawal by Subject|1|||
156813169|NCT00928187|566066297|FG002|Overall Study|Withdrawal by Subject|1|||
156813170|NCT00928187|566066295|FG000|Overall Study|Protocol Violation|0|||
156813171|NCT00928187|566066296|FG001|Overall Study|Protocol Violation|1|||
156813172|NCT00928187|566066297|FG002|Overall Study|Protocol Violation|0|||
156813173|NCT05200572|566066298|FG000|Overall Study|Withdrawal by Subject|14|||
156813174|NCT02524145|566066299|FG000|Overall Study|Withdrawal by Subject|2|||
156813175|NCT02524145|566066300|FG001|Overall Study|Withdrawal by Subject|2|||
156813176|NCT02524145|566066301|FG002|Overall Study|Withdrawal by Subject|3|||
156813177|NCT00131352|566068179|FG000|Initial Treatment Period|Adverse Event|1|||
156813178|NCT00131352|566068180|FG001|Initial Treatment Period|Adverse Event|3|||
156813179|NCT00131352|566068179|FG000|Initial Treatment Period|Non-compliant|1|||
156813180|NCT00131352|566068180|FG001|Initial Treatment Period|Non-compliant|2|||
156813181|NCT00131352|566068179|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
156813182|NCT00131352|566068180|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
156813183|NCT00131352|566068179|FG000|Initial Treatment Period|Lack of Efficacy|6|||
156813184|NCT00131352|566068180|FG001|Initial Treatment Period|Lack of Efficacy|4|||
156813185|NCT00131352|566068179|FG000|Initial Treatment Period|Other|0|||
156813186|NCT00131352|566068180|FG001|Initial Treatment Period|Other|2|||
156813187|NCT00131352|566068179|FG000|Repeat Treatment Period|Adverse Event|1|||
156813188|NCT00131352|566068180|FG001|Repeat Treatment Period|Adverse Event|0|||
156813189|NCT00131352|566068179|FG000|Repeat Treatment Period|Other|1|||
156813190|NCT00131352|566068180|FG001|Repeat Treatment Period|Other|0|||
156813191|NCT00383331|566068181|FG000|Overall Study|Protocol Violation|0|||
156813192|NCT00383331|566068182|FG001|Overall Study|Protocol Violation|1|||
156813193|NCT00135330|566068183|FG000|Overall Study|Adverse Event|2|||
156813194|NCT00135330|566068184|FG001|Overall Study|Adverse Event|5|||
156813195|NCT00135330|566068185|FG002|Overall Study|Adverse Event|1|||
156813196|NCT00135330|566068183|FG000|Overall Study|Lost to Follow-up|0|||
156464410|NCT02720068|564797854|FG012|Overall Study|Withdrawal by Subject|2|||
156813197|NCT00135330|566068184|FG001|Overall Study|Lost to Follow-up|2|||
156813198|NCT00135330|566068185|FG002|Overall Study|Lost to Follow-up|3|||
156813199|NCT00135330|566068183|FG000|Overall Study|Physician Decision|1|||
156813200|NCT00135330|566068184|FG001|Overall Study|Physician Decision|1|||
156813201|NCT00135330|566068185|FG002|Overall Study|Physician Decision|0|||
156813202|NCT00135330|566068183|FG000|Overall Study|Protocol Violation|4|||
156338967|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
156338968|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
156338969|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
156338970|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
156813203|NCT00135330|566068184|FG001|Overall Study|Protocol Violation|3|||
156813204|NCT00135330|566068185|FG002|Overall Study|Protocol Violation|3|||
156813205|NCT00135330|566068183|FG000|Overall Study|Patient Decision|5|||
156813206|NCT00135330|566068184|FG001|Overall Study|Patient Decision|1|||
156813207|NCT00135330|566068185|FG002|Overall Study|Patient Decision|4|||
156813208|NCT00135330|566068183|FG000|Overall Study|Sponsor Decision|0|||
156813209|NCT00135330|566068184|FG001|Overall Study|Sponsor Decision|1|||
156813210|NCT00135330|566068185|FG002|Overall Study|Sponsor Decision|0|||
156813211|NCT02253433|566068194|FG000|Overall Study|Unable to Contact|9|||
156813212|NCT02253433|566068195|FG001|Overall Study|Unable to Contact|16|||
156813213|NCT02253433|566068194|FG000|Overall Study|Death|1|||
156813214|NCT02253433|566068195|FG001|Overall Study|Death|1|||
156813215|NCT02253433|566068194|FG000|Overall Study|No Longer Interested|3|||
156813216|NCT02253433|566068195|FG001|Overall Study|No Longer Interested|15|||
156464411|NCT02720068|564797855|FG013|Overall Study|Withdrawal by Subject|8|||
156464412|NCT02720068|564797856|FG014|Overall Study|Withdrawal by Subject|7|||
156813217|NCT02253433|566068194|FG000|Overall Study|Out of Study Area|2|||
156813218|NCT02253433|566068195|FG001|Overall Study|Out of Study Area|7|||
156813219|NCT02253433|566068194|FG000|Overall Study|Uncomfortable with home visitors|0|||
156813220|NCT02253433|566068195|FG001|Overall Study|Uncomfortable with home visitors|3|||
156813221|NCT02253433|566068194|FG000|Overall Study|Unstable Housing/Homeless|0|||
156813222|NCT02253433|566068195|FG001|Overall Study|Unstable Housing/Homeless|7|||
156813223|NCT02253433|566068194|FG000|Overall Study|Too Busy|0|||
156813224|NCT02253433|566068195|FG001|Overall Study|Too Busy|4|||
156813225|NCT02253433|566068194|FG000|Overall Study|Medical or Other Concerns|1|||
156813226|NCT02253433|566068195|FG001|Overall Study|Medical or Other Concerns|2|||
156813227|NCT02229825|566068198|FG000|Overall Study|Personal Reasons|0|||
156813228|NCT02229825|566068199|FG001|Overall Study|Personal Reasons|1|||
156813229|NCT02229825|566068198|FG000|Overall Study|Refused continuing medication|7|||
156813230|NCT02229825|566068199|FG001|Overall Study|Refused continuing medication|6|||
156813231|NCT02229825|566068198|FG000|Overall Study|Lost to Follow-up|1|||
156813232|NCT02229825|566068199|FG001|Overall Study|Lost to Follow-up|2|||
156813233|NCT02229825|566068198|FG000|Overall Study|Protocol Violation|1|||
156813234|NCT02229825|566068199|FG001|Overall Study|Protocol Violation|1|||
156813235|NCT02229825|566068198|FG000|Overall Study|Lack of Efficacy|4|||
156813236|NCT02229825|566068199|FG001|Overall Study|Lack of Efficacy|10|||
156813237|NCT02229825|566068198|FG000|Overall Study|Adverse Event|11|||
156464413|NCT02720068|564797857|FG015|Overall Study|Withdrawal by Subject|0|||
156464414|NCT02720068|564797858|FG016|Overall Study|Withdrawal by Subject|0|||
156464415|NCT02720068|564797859|FG017|Overall Study|Withdrawal by Subject|2|||
156813238|NCT02229825|566068199|FG001|Overall Study|Adverse Event|9|||
156813239|NCT02229825|566068198|FG000|Overall Study|Not treated|0|||
156813240|NCT02229825|566068199|FG001|Overall Study|Not treated|1|||
156813241|NCT01532921|566068202|FG000|Overall Study|Death|3|||
156813242|NCT01532921|566068202|FG000|Overall Study|Withdrawal by Subject|2|||
156813243|NCT01532921|566068202|FG000|Overall Study|Lost to Follow-up|3|||
156813244|NCT01532921|566068202|FG000|Overall Study|Physician Decision|7|||
156813245|NCT01532921|566068202|FG000|Overall Study|Device was explanted during procedure|1|||
156813246|NCT02526212|566068203|FG000|Overall Study|Incarceration|1|||
156813247|NCT02526212|566068204|FG001|Overall Study|Incarceration|0|||
156813248|NCT02526212|566068203|FG000|Overall Study|Lost to Follow-up|1|||
156813249|NCT02526212|566068204|FG001|Overall Study|Lost to Follow-up|0|||
156813250|NCT02526212|566068203|FG000|Overall Study|Death|0|||
156813251|NCT02526212|566068204|FG001|Overall Study|Death|1|||
156813252|NCT01390298|566068205|FG000|Overall Study|Death|1|||
156813253|NCT01390298|566068205|FG000|Overall Study|long term ICU admission|1|||
156813254|NCT01390298|566068205|FG000|Overall Study|Withdrawal by Subject|14|||
156813255|NCT01390298|566068205|FG000|Overall Study|Lost to Follow-up|7|||
156813256|NCT01390298|566068205|FG000|Overall Study|Surgery cancelled|1|||
156813257|NCT02443337|566068206|FG000|Overall Study|Adverse Event|0|||
156813258|NCT02443337|566068207|FG001|Overall Study|Adverse Event|1|||
156813259|NCT02443337|566068206|FG000|Overall Study|Clinical Progressive Disease|3|||
156813260|NCT02443337|566068207|FG001|Overall Study|Clinical Progressive Disease|0|||
156813261|NCT02443337|566068206|FG000|Overall Study|Withdrawal by Subject|2|||
156813262|NCT02443337|566068207|FG001|Overall Study|Withdrawal by Subject|1|||
156813263|NCT02096952|566068214|FG000|Overall Study|Adverse Event|1|||
156813264|NCT00040742|566068215|FG000|Overall Study|Death|0|||
156813265|NCT00040742|566068216|FG001|Overall Study|Death|0|||
156813266|NCT00040742|566068217|FG002|Overall Study|Death|1|||
156813267|NCT00040742|566068218|FG003|Overall Study|Death|0|||
156813268|NCT00040742|566068215|FG000|Overall Study|Adverse Event|15|||
156813269|NCT00040742|566068216|FG001|Overall Study|Adverse Event|16|||
156813270|NCT00040742|566068217|FG002|Overall Study|Adverse Event|21|||
156813271|NCT00040742|566068218|FG003|Overall Study|Adverse Event|9|||
156813272|NCT00040742|566068215|FG000|Overall Study|Withdrawal by Subject|7|||
156813273|NCT00040742|566068216|FG001|Overall Study|Withdrawal by Subject|15|||
156813274|NCT00040742|566068217|FG002|Overall Study|Withdrawal by Subject|10|||
156813275|NCT00040742|566068218|FG003|Overall Study|Withdrawal by Subject|13|||
156813276|NCT00040742|566068215|FG000|Overall Study|Chemotoxicity|4|||
156813277|NCT00040742|566068216|FG001|Overall Study|Chemotoxicity|3|||
156813278|NCT00040742|566068217|FG002|Overall Study|Chemotoxicity|5|||
156813279|NCT00040742|566068218|FG003|Overall Study|Chemotoxicity|2|||
156813280|NCT00040742|566068215|FG000|Overall Study|Incomplete Forms|6|||
156813281|NCT00040742|566068216|FG001|Overall Study|Incomplete Forms|10|||
156813282|NCT00040742|566068217|FG002|Overall Study|Incomplete Forms|4|||
156813283|NCT00040742|566068218|FG003|Overall Study|Incomplete Forms|5|||
156813284|NCT00040742|566068215|FG000|Overall Study|Other medical|7|||
156813285|NCT00040742|566068216|FG001|Overall Study|Other medical|5|||
156813286|NCT00040742|566068217|FG002|Overall Study|Other medical|5|||
156813287|NCT00040742|566068218|FG003|Overall Study|Other medical|5|||
156813288|NCT03520920|566068219|FG000|Overall Study|Death|13|||
156338971|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
156464416|NCT02720068|564797842|FG000|Overall Study|Protocol Violation|0|||
156464417|NCT02720068|564797843|FG001|Overall Study|Protocol Violation|0|||
156464418|NCT02720068|564797844|FG002|Overall Study|Protocol Violation|0|||
156464419|NCT02720068|564797845|FG003|Overall Study|Protocol Violation|0|||
156464420|NCT02720068|564797846|FG004|Overall Study|Protocol Violation|0|||
156464421|NCT02720068|564797847|FG005|Overall Study|Protocol Violation|0|||
156464422|NCT02720068|564797848|FG006|Overall Study|Protocol Violation|0|||
156464423|NCT02720068|564797849|FG007|Overall Study|Protocol Violation|0|||
156464424|NCT02720068|564797850|FG008|Overall Study|Protocol Violation|0|||
156464425|NCT02720068|564797851|FG009|Overall Study|Protocol Violation|0|||
156464426|NCT02720068|564797852|FG010|Overall Study|Protocol Violation|1|||
156464427|NCT02720068|564797853|FG011|Overall Study|Protocol Violation|0|||
156464428|NCT02720068|564797854|FG012|Overall Study|Protocol Violation|0|||
156464429|NCT02720068|564797855|FG013|Overall Study|Protocol Violation|0|||
156464430|NCT02720068|564797856|FG014|Overall Study|Protocol Violation|1|||
156813289|NCT03520920|566068220|FG001|Overall Study|Death|1|||
156813290|NCT03520920|566068221|FG002|Overall Study|Death|0|||
156813291|NCT03520920|566068219|FG000|Overall Study|Withdrawal by Subject|2|||
156813292|NCT03520920|566068220|FG001|Overall Study|Withdrawal by Subject|1|||
156813293|NCT03520920|566068221|FG002|Overall Study|Withdrawal by Subject|0|||
156813294|NCT03520920|566068219|FG000|Overall Study|Study Terminated by the Sponsor|5|||
156813295|NCT03520920|566068220|FG001|Overall Study|Study Terminated by the Sponsor|14|||
156813296|NCT03520920|566068221|FG002|Overall Study|Study Terminated by the Sponsor|5|||
156813297|NCT00372619|566068223|FG000|Overall Study|Ineligible|0|||
156813298|NCT00372619|566068224|FG001|Overall Study|Ineligible|0|||
156464431|NCT02720068|564797857|FG015|Overall Study|Protocol Violation|0|||
156464432|NCT02720068|564797858|FG016|Overall Study|Protocol Violation|1|||
156464433|NCT02720068|564797859|FG017|Overall Study|Protocol Violation|0|||
156464434|NCT01773993|564797863|FG000|Overall Study|No Visit After Treatment|35|||
156813299|NCT00372619|566068225|FG002|Overall Study|Ineligible|0|||
156813300|NCT00372619|566068226|FG003|Overall Study|Ineligible|0|||
156813301|NCT00372619|566068227|FG004|Overall Study|Ineligible|0|||
156813302|NCT00372619|566068228|FG005|Overall Study|Ineligible|2|||
156813303|NCT00372619|566068229|FG006|Overall Study|Ineligible|0|||
156813304|NCT00372619|566068223|FG000|Overall Study|Inevaluable|0|||
156813305|NCT00372619|566068224|FG001|Overall Study|Inevaluable|0|||
156813306|NCT00372619|566068225|FG002|Overall Study|Inevaluable|0|||
156813307|NCT00372619|566068226|FG003|Overall Study|Inevaluable|0|||
156813308|NCT00372619|566068227|FG004|Overall Study|Inevaluable|0|||
156813309|NCT00372619|566068228|FG005|Overall Study|Inevaluable|1|||
156464435|NCT04993677|564797867|FG000|Overall Study|Lost to Follow-up|1|||
156464436|NCT04993677|564797868|FG001|Overall Study|Lost to Follow-up|0|||
156464437|NCT04993677|564797869|FG002|Overall Study|Lost to Follow-up|0|||
156464438|NCT04993677|564797870|FG003|Overall Study|Lost to Follow-up|0|||
156464439|NCT04993677|564797867|FG000|Overall Study|Death|11|||
156813310|NCT00372619|566068229|FG006|Overall Study|Inevaluable|0|||
156813311|NCT00066222|566068230|FG000|Overall Study|No protocol treatment received|1|||
156813312|NCT00635349|566068231|FG000|Overall Study|Other|8|||
156813313|NCT00635349|566068232|FG001|Overall Study|Other|6|||
156813314|NCT00635349|566068231|FG000|Overall Study|Protocol Violation|18|||
156813315|NCT00635349|566068232|FG001|Overall Study|Protocol Violation|22|||
156813316|NCT00635349|566068231|FG000|Overall Study|Withdrawal by Subject|3|||
156813317|NCT00635349|566068232|FG001|Overall Study|Withdrawal by Subject|8|||
156813318|NCT00635349|566068231|FG000|Overall Study|Lost to Follow-up|4|||
156813319|NCT00635349|566068232|FG001|Overall Study|Lost to Follow-up|3|||
156813320|NCT00635349|566068231|FG000|Overall Study|Adverse Event|11|||
156813321|NCT00635349|566068232|FG001|Overall Study|Adverse Event|9|||
156813322|NCT02446769|566068235|FG000|Screening Period|Screen Failure|11|||
156813323|NCT02446769|566068236|FG001|Screening Period|Screen Failure|0|||
156813324|NCT02446769|566068237|FG002|Screening Period|Screen Failure|0|||
156813325|NCT02446769|566068235|FG000|Study Period|Randomized in Error|0|||
156813326|NCT02446769|566068236|FG001|Study Period|Randomized in Error|2|||
156813327|NCT02446769|566068237|FG002|Study Period|Randomized in Error|0|||
156813328|NCT04482439|566068238|FG000|Overall Study|Lost to Follow-up|1|||
156813329|NCT04482439|566068238|FG000|Overall Study|Unrelated illness|1|||
156813330|NCT00645840|566068239|FG000|Overall Study|Protocol Violation|3|||
156813331|NCT00402324|566068240|FG000|Overall Study|Lost to Follow-up|11|||
156813332|NCT00402324|566068241|FG001|Overall Study|Lost to Follow-up|11|||
156813333|NCT00402324|566068240|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
156813334|NCT00402324|566068241|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
156813335|NCT00402324|566068240|FG000|Overall Study|Protocol Violation|8|||
156813336|NCT00402324|566068241|FG001|Overall Study|Protocol Violation|7|||
156813337|NCT00402324|566068240|FG000|Overall Study|Withdrawal by Subject|5|||
156813338|NCT00402324|566068241|FG001|Overall Study|Withdrawal by Subject|2|||
156813339|NCT00402324|566068240|FG000|Overall Study|Physician Decision|2|||
156813340|NCT00402324|566068241|FG001|Overall Study|Physician Decision|4|||
156813341|NCT00402324|566068240|FG000|Overall Study|Sponsor Decision|4|||
156813342|NCT00402324|566068241|FG001|Overall Study|Sponsor Decision|5|||
156813343|NCT00402324|566068240|FG000|Overall Study|Lack of Efficacy|1|||
156813344|NCT00402324|566068241|FG001|Overall Study|Lack of Efficacy|4|||
156813345|NCT00402324|566068240|FG000|Overall Study|Adverse Event|6|||
156813346|NCT00402324|566068241|FG001|Overall Study|Adverse Event|4|||
156813347|NCT00402324|566068240|FG000|Overall Study|Death|1|||
156813348|NCT00402324|566068241|FG001|Overall Study|Death|0|||
156813349|NCT01277822|566068242|FG000|Overall Study|Adverse Event|2|||
156813350|NCT01277822|566068243|FG001|Overall Study|Adverse Event|1|||
156813351|NCT01277822|566068242|FG000|Overall Study|Withdrawal by Subject|6|||
156813352|NCT01277822|566068243|FG001|Overall Study|Withdrawal by Subject|7|||
156813353|NCT01277822|566068242|FG000|Overall Study|Physician Decision|1|||
156813354|NCT01277822|566068243|FG001|Overall Study|Physician Decision|1|||
156813355|NCT01277822|566068242|FG000|Overall Study|Protocol Violation|1|||
156813356|NCT01277822|566068243|FG001|Overall Study|Protocol Violation|0|||
156464440|NCT04993677|564797868|FG001|Overall Study|Death|8|||
156813357|NCT01277822|566068242|FG000|Overall Study|Lost to Follow-up|2|||
156813358|NCT01277822|566068243|FG001|Overall Study|Lost to Follow-up|1|||
156813359|NCT01277822|566068242|FG000|Overall Study|Contraindicated medication used|2|||
156813360|NCT01277822|566068243|FG001|Overall Study|Contraindicated medication used|1|||
156813361|NCT01277822|566068242|FG000|Overall Study|Participant moved|1|||
156813362|NCT01277822|566068243|FG001|Overall Study|Participant moved|0|||
156813363|NCT00997984|566068244|FG000|Overall Study|Adverse Event|1|||
156813364|NCT00997984|566068245|FG001|Overall Study|Adverse Event|8|||
156813365|NCT00997984|566068246|FG002|Overall Study|Adverse Event|8|||
156813366|NCT00997984|566068244|FG000|Overall Study|Protocol Violation|1|||
156813367|NCT00997984|566068245|FG001|Overall Study|Protocol Violation|3|||
156813368|NCT00997984|566068246|FG002|Overall Study|Protocol Violation|0|||
156813369|NCT00997984|566068244|FG000|Overall Study|Withdrawal by Subject|6|||
156813370|NCT00997984|566068245|FG001|Overall Study|Withdrawal by Subject|9|||
156813371|NCT00997984|566068246|FG002|Overall Study|Withdrawal by Subject|5|||
156813372|NCT00997984|566068244|FG000|Overall Study|Lost to Follow-up|8|||
156813373|NCT00997984|566068245|FG001|Overall Study|Lost to Follow-up|5|||
156813374|NCT00997984|566068246|FG002|Overall Study|Lost to Follow-up|4|||
156813375|NCT00997984|566068244|FG000|Overall Study|Lack of Efficacy|20|||
156813376|NCT00997984|566068245|FG001|Overall Study|Lack of Efficacy|6|||
156813377|NCT00997984|566068246|FG002|Overall Study|Lack of Efficacy|3|||
156813378|NCT00997984|566068244|FG000|Overall Study|Met exclusion criteria|1|||
156813379|NCT00997984|566068245|FG001|Overall Study|Met exclusion criteria|0|||
156813380|NCT00997984|566068246|FG002|Overall Study|Met exclusion criteria|0|||
156813381|NCT00997984|566068244|FG000|Overall Study|non-compliance|0|||
156813382|NCT00997984|566068245|FG001|Overall Study|non-compliance|2|||
156813383|NCT00997984|566068246|FG002|Overall Study|non-compliance|3|||
156813384|NCT00997984|566068244|FG000|Overall Study|Wrong medication dispensed|0|||
156813385|NCT00997984|566068245|FG001|Overall Study|Wrong medication dispensed|1|||
156813386|NCT00997984|566068246|FG002|Overall Study|Wrong medication dispensed|0|||
156813387|NCT00997984|566068244|FG000|Overall Study|Suicidal ideation|0|||
156813388|NCT00997984|566068245|FG001|Overall Study|Suicidal ideation|0|||
156813389|NCT00997984|566068246|FG002|Overall Study|Suicidal ideation|1|||
156813390|NCT00997984|566068244|FG000|Overall Study|Work schedule|0|||
156813391|NCT00997984|566068245|FG001|Overall Study|Work schedule|0|||
156813392|NCT00997984|566068246|FG002|Overall Study|Work schedule|2|||
156813393|NCT02997865|566068248|FG000|Overall Study|Death|2|||
156813394|NCT02997865|566068249|FG001|Overall Study|Death|1|||
156813395|NCT02997865|566068248|FG000|Overall Study|Lost to Follow-up|6|||
156813396|NCT02997865|566068249|FG001|Overall Study|Lost to Follow-up|3|||
156813397|NCT02997865|566068248|FG000|Overall Study|Withdrawal by Subject|5|||
156813398|NCT02997865|566068249|FG001|Overall Study|Withdrawal by Subject|0|||
156813399|NCT01119066|566068250|FG000|Overall Study|Withdrawal by Subject|4|||
156813400|NCT01119066|566068251|FG001|Overall Study|Withdrawal by Subject|6|||
156813401|NCT01119066|566068252|FG002|Overall Study|Withdrawal by Subject|0|||
156813402|NCT01119066|566068253|FG003|Overall Study|Withdrawal by Subject|0|||
156813403|NCT01119066|566068250|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
156813404|NCT01119066|566068251|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
156813405|NCT01119066|566068252|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
156813406|NCT01119066|566068253|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
156813407|NCT01119066|566068250|FG000|Overall Study|Relapse identified before transplant|1|||
156813408|NCT01119066|566068251|FG001|Overall Study|Relapse identified before transplant|0|||
156813409|NCT01119066|566068252|FG002|Overall Study|Relapse identified before transplant|0|||
156813410|NCT01119066|566068253|FG003|Overall Study|Relapse identified before transplant|0|||
156813411|NCT01119066|566068250|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
156813412|NCT01119066|566068251|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
156813413|NCT01119066|566068252|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
156813414|NCT01119066|566068253|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
156813415|NCT01119066|566068250|FG000|Overall Study|Relapse identified before transplant|0|||
156813416|NCT01119066|566068251|FG001|Overall Study|Relapse identified before transplant|4|||
156338972|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
156813417|NCT01119066|566068252|FG002|Overall Study|Relapse identified before transplant|0|||
156338973|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
156813418|NCT01119066|566068253|FG003|Overall Study|Relapse identified before transplant|0|||
156464441|NCT04993677|564797869|FG002|Overall Study|Death|3|||
156464442|NCT04993677|564797870|FG003|Overall Study|Death|1|||
156464443|NCT04993677|564797867|FG000|Overall Study|Subject withdrawal of consent|4|||
156464444|NCT04993677|564797868|FG001|Overall Study|Subject withdrawal of consent|3|||
156813419|NCT02243371|566068260|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
156813420|NCT02243371|566068261|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
156813421|NCT02243371|566068260|FG000|Overall Study|Death (unrelated)|2|||
156813422|NCT02243371|566068261|FG001|Overall Study|Death (unrelated)|4|||
156813423|NCT02243371|566068260|FG000|Overall Study|Adverse Event (unrelated)|0|||
156813424|NCT02243371|566068261|FG001|Overall Study|Adverse Event (unrelated)|1|||
156813425|NCT02243371|566068260|FG000|Overall Study|Lack of Clinical Benefit|0|||
156813426|NCT02243371|566068261|FG001|Overall Study|Lack of Clinical Benefit|1|||
156813427|NCT02243371|566068260|FG000|Overall Study|Withdrawal by Subject|0|||
156813428|NCT02243371|566068261|FG001|Overall Study|Withdrawal by Subject|2|||
156813429|NCT02441101|566068262|FG000|Overall Study|Withdrawal by Subject|1|||
156813430|NCT02441101|566068263|FG001|Overall Study|Withdrawal by Subject|0|||
156813431|NCT02441101|566068262|FG000|Overall Study|Lost to Follow-up|1|||
156813432|NCT02441101|566068263|FG001|Overall Study|Lost to Follow-up|0|||
156813433|NCT02441101|566068262|FG000|Overall Study|PI relocated and study terminated|1|||
156813434|NCT02441101|566068263|FG001|Overall Study|PI relocated and study terminated|0|||
156813435|NCT00271856|566068266|FG000|Overall Study|Withdrawal by Subject|1|||
156813436|NCT00271856|566068267|FG001|Overall Study|Withdrawal by Subject|7|||
156813437|NCT00271856|566068266|FG000|Overall Study|Lost to Follow-up|10|||
156813438|NCT00271856|566068267|FG001|Overall Study|Lost to Follow-up|11|||
156813439|NCT04599803|566068268|FG000|Overall Study|Withdrawal by Subject|5|||
156813440|NCT04599803|566068268|FG000|Overall Study|Lost to Follow-up|26|||
156813441|NCT02544750|566068269|FG000|Overall Study|Physician Decision|3|||
156813442|NCT02544750|566068270|FG001|Overall Study|Physician Decision|1|||
156813443|NCT02544750|566068269|FG000|Overall Study|Other reasons|69|||
156813444|NCT02544750|566068270|FG001|Overall Study|Other reasons|39|||
156813445|NCT02544750|566068269|FG000|Overall Study|Met withdrawal criteria|2|||
156813446|NCT02544750|566068270|FG001|Overall Study|Met withdrawal criteria|2|||
156813447|NCT02544750|566068269|FG000|Overall Study|Transition To Commercial Product|1|||
156813448|NCT02544750|566068270|FG001|Overall Study|Transition To Commercial Product|0|||
156813449|NCT02544750|566068269|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
156813450|NCT02544750|566068270|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
156813451|NCT02544750|566068269|FG000|Overall Study|Adverse Event|8|||
156813452|NCT02544750|566068270|FG001|Overall Study|Adverse Event|10|||
156813453|NCT02544750|566068269|FG000|Overall Study|Withdrawal by Subject|10|||
156813454|NCT02544750|566068270|FG001|Overall Study|Withdrawal by Subject|4|||
156813455|NCT02544750|566068269|FG000|Overall Study|Lost to Follow-up|1|||
156813456|NCT02544750|566068270|FG001|Overall Study|Lost to Follow-up|0|||
156813457|NCT02366923|566068271|FG000|Overall Study|Withdrawal by Subject|1|||
156813458|NCT02366923|566068271|FG000|Overall Study|Positive Slit Lamp Findings|2|||
156813459|NCT02366923|566068271|FG000|Overall Study|High Astigmatism|3|||
156813460|NCT04677543|566068272|FG000|Overall Study|Withdrawal by Subject|4|||
156813461|NCT04677543|566068273|FG001|Overall Study|Withdrawal by Subject|1|||
156813462|NCT04677543|566068272|FG000|Overall Study|Physician Decision|0|||
156813463|NCT04677543|566068273|FG001|Overall Study|Physician Decision|1|||
156813464|NCT04677543|566068272|FG000|Overall Study|Adverse Event|0|||
156813465|NCT04677543|566068273|FG001|Overall Study|Adverse Event|1|||
156813466|NCT02689206|566068274|FG000|Overall Study|Adverse Event|0|||
156813467|NCT02689206|566068275|FG001|Overall Study|Adverse Event|0|||
156813468|NCT02689206|566068276|FG002|Overall Study|Adverse Event|1|||
156813469|NCT02689206|566068277|FG003|Overall Study|Adverse Event|0|||
156813470|NCT02689206|566068278|FG004|Overall Study|Adverse Event|2|||
156464445|NCT04993677|564797869|FG002|Overall Study|Subject withdrawal of consent|0|||
156464446|NCT04993677|564797870|FG003|Overall Study|Subject withdrawal of consent|2|||
156464447|NCT04993677|564797867|FG000|Overall Study|Study termination by sponsor|3|||
156464448|NCT04993677|564797868|FG001|Overall Study|Study termination by sponsor|25|||
156464449|NCT04993677|564797869|FG002|Overall Study|Study termination by sponsor|3|||
156464450|NCT04993677|564797870|FG003|Overall Study|Study termination by sponsor|3|||
156464451|NCT04993677|564797867|FG000|Overall Study|Other|2|||
156464452|NCT04993677|564797868|FG001|Overall Study|Other|3|||
156464453|NCT04993677|564797869|FG002|Overall Study|Other|3|||
156464454|NCT04993677|564797870|FG003|Overall Study|Other|2|||
156464455|NCT04408755|564797883|FG000|Period A (Placebo lead-in)|Other|11|||
156464456|NCT04408755|564797884|FG001|Period A (Placebo lead-in)|Other|0|||
156464457|NCT04408755|564797885|FG002|Period A (Placebo lead-in)|Other|0|||
156813471|NCT02689206|566068274|FG000|Overall Study|Protocol Violation|1|||
156813472|NCT02689206|566068275|FG001|Overall Study|Protocol Violation|0|||
156813473|NCT02689206|566068276|FG002|Overall Study|Protocol Violation|0|||
156813474|NCT02689206|566068277|FG003|Overall Study|Protocol Violation|1|||
156813475|NCT02689206|566068278|FG004|Overall Study|Protocol Violation|2|||
156813476|NCT02689206|566068274|FG000|Overall Study|Other: Reached stopping criteria|0|||
156813477|NCT02689206|566068275|FG001|Overall Study|Other: Reached stopping criteria|1|||
156813478|NCT02689206|566068276|FG002|Overall Study|Other: Reached stopping criteria|2|||
156539286|NCT04688775|565068281|FG000|Placebo-controlled Period|Adverse Event|2|||
156539287|NCT04688775|565068282|FG001|Placebo-controlled Period|Adverse Event|0|||
156539288|NCT04688775|565068283|FG002|Placebo-controlled Period|Adverse Event|0|||
156464458|NCT04408755|564797886|FG003|Period A (Placebo lead-in)|Other|0|||
156464459|NCT04408755|564797883|FG000|Period B (Randomization Period)|Adverse Event|0|||
156464460|NCT04408755|564797884|FG001|Period B (Randomization Period)|Adverse Event|3|||
156464461|NCT04408755|564797885|FG002|Period B (Randomization Period)|Adverse Event|0|||
156539289|NCT04688775|565068284|FG003|Placebo-controlled Period|Adverse Event|0|||
156539290|NCT04688775|565068281|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
156539291|NCT04688775|565068282|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
156539292|NCT04688775|565068283|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
156539293|NCT04688775|565068284|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
156539294|NCT04688775|565068281|FG000|Placebo-controlled Period|Protocol Violation|0|||
156539295|NCT04688775|565068282|FG001|Placebo-controlled Period|Protocol Violation|1|||
156539296|NCT04688775|565068283|FG002|Placebo-controlled Period|Protocol Violation|0|||
156539297|NCT04688775|565068284|FG003|Placebo-controlled Period|Protocol Violation|0|||
156539298|NCT04688775|565068281|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
156539299|NCT04688775|565068282|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
156539300|NCT04688775|565068283|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
156539301|NCT04688775|565068284|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
156539302|NCT04688775|565068281|FG000|Placebo-controlled Period|Other reasons|0|||
156539303|NCT04688775|565068282|FG001|Placebo-controlled Period|Other reasons|1|||
156539304|NCT04688775|565068283|FG002|Placebo-controlled Period|Other reasons|0|||
156813479|NCT02689206|566068277|FG003|Overall Study|Other: Reached stopping criteria|3|||
156813480|NCT02689206|566068278|FG004|Overall Study|Other: Reached stopping criteria|4|||
156813481|NCT02689206|566068274|FG000|Overall Study|Physician Decision|1|||
156813482|NCT02689206|566068275|FG001|Overall Study|Physician Decision|0|||
156813483|NCT02689206|566068276|FG002|Overall Study|Physician Decision|0|||
156813484|NCT02689206|566068277|FG003|Overall Study|Physician Decision|0|||
156813485|NCT02689206|566068278|FG004|Overall Study|Physician Decision|0|||
156813486|NCT02689206|566068274|FG000|Overall Study|Withdrawal by Subject|1|||
156813487|NCT02689206|566068275|FG001|Overall Study|Withdrawal by Subject|0|||
156813488|NCT02689206|566068276|FG002|Overall Study|Withdrawal by Subject|1|||
156813489|NCT02689206|566068277|FG003|Overall Study|Withdrawal by Subject|0|||
156813490|NCT02689206|566068278|FG004|Overall Study|Withdrawal by Subject|0|||
156813491|NCT01437111|566068279|FG000|Overall Study|Adverse Event|2|||
156813492|NCT01437111|566068279|FG000|Overall Study|Withdrawal by Subject|4|||
156813493|NCT01437111|566068279|FG000|Overall Study|Not reported|5|||
156813494|NCT01437111|566068279|FG000|Overall Study|Physician Decision|1|||
156813495|NCT01437111|566068279|FG000|Overall Study|Lost to Follow-up|5|||
156813496|NCT01437111|566068279|FG000|Overall Study|Protocol Violation|1|||
156813497|NCT01232127|566068280|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
156813498|NCT01232127|566068281|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
156813499|NCT01232127|566068282|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
156813500|NCT02623205|566068285|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
156813501|NCT02623205|566068286|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
156813502|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
156813503|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
156813504|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
156813505|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
156813506|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
156813507|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
156813508|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
156813509|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
156813510|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
156813511|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
156813512|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
156813513|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
156813514|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
156464462|NCT04408755|564797886|FG003|Period B (Randomization Period)|Adverse Event|1|||
156464463|NCT04408755|564797883|FG000|Period B (Randomization Period)|Death|0|||
156464464|NCT04408755|564797884|FG001|Period B (Randomization Period)|Death|0|||
156464465|NCT04408755|564797885|FG002|Period B (Randomization Period)|Death|1|||
156813515|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
156813516|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
156813517|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
156813518|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
156464466|NCT04408755|564797886|FG003|Period B (Randomization Period)|Death|0|||
156464467|NCT04408755|564797883|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
156539305|NCT04688775|565068284|FG003|Placebo-controlled Period|Other reasons|0|||
156464468|NCT04408755|564797884|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
156813519|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
156813520|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
156813521|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
156813522|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
156813523|NCT03162796|566068287|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
156813524|NCT03162796|566068288|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
156813525|NCT03162796|566068289|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
156813526|NCT03162796|566068287|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
156813527|NCT03162796|566068288|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
156813528|NCT03162796|566068289|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
156813529|NCT03162796|566068287|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
156813530|NCT03162796|566068288|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
156813531|NCT03162796|566068289|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
156813532|NCT03162796|566068287|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
156813533|NCT03162796|566068288|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
156813534|NCT03162796|566068289|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
156813535|NCT02375373|566068294|FG000|Overall Study|Withdrawal by Subject|11|||
156813536|NCT02725476|566068295|FG000|Overall Study|Physician Decision|2|||
156813537|NCT02725476|566068296|FG001|Overall Study|Physician Decision|0|||
156813538|NCT02725476|566068295|FG000|Overall Study|Adverse Event|1|||
156813539|NCT02725476|566068296|FG001|Overall Study|Adverse Event|1|||
156813540|NCT00289289|566068298|FG000|Overall Study|Withdrawal by Subject|5|||
156813541|NCT00289289|566068299|FG001|Overall Study|Withdrawal by Subject|3|||
156813542|NCT00289289|566068300|FG002|Overall Study|Withdrawal by Subject|15|||
156813543|NCT00289289|566068298|FG000|Overall Study|Lost to Follow-up|1|||
156813544|NCT00289289|566068299|FG001|Overall Study|Lost to Follow-up|0|||
156813545|NCT00289289|566068300|FG002|Overall Study|Lost to Follow-up|1|||
156813546|NCT00289289|566068298|FG000|Overall Study|Death|4|||
156813547|NCT00289289|566068299|FG001|Overall Study|Death|2|||
156813548|NCT00289289|566068300|FG002|Overall Study|Death|5|||
156813549|NCT00289289|566068298|FG000|Overall Study|No implant attempted|0|||
156813550|NCT00289289|566068299|FG001|Overall Study|No implant attempted|0|||
156813551|NCT00289289|566068300|FG002|Overall Study|No implant attempted|1|||
156813552|NCT00289289|566068298|FG000|Overall Study|Physician Decision|1|||
156813553|NCT00289289|566068299|FG001|Overall Study|Physician Decision|0|||
156813554|NCT00289289|566068300|FG002|Overall Study|Physician Decision|6|||
156813555|NCT00289289|566068298|FG000|Overall Study|Non-study device implanted|2|||
156813556|NCT00289289|566068299|FG001|Overall Study|Non-study device implanted|1|||
156813557|NCT00289289|566068300|FG002|Overall Study|Non-study device implanted|3|||
156813558|NCT00289289|566068298|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
156813559|NCT00289289|566068299|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
156813560|NCT00289289|566068300|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
156813561|NCT00289289|566068298|FG000|Overall Study|Other Exit Reason|6|||
156813562|NCT00289289|566068299|FG001|Overall Study|Other Exit Reason|4|||
156813563|NCT00289289|566068300|FG002|Overall Study|Other Exit Reason|12|||
156813564|NCT01445613|566068301|FG000|30-day Follow-up|Withdrawal by Subject|6|||
156813565|NCT01445613|566068301|FG000|30-day Follow-up|Physician Decision|3|||
156813566|NCT01445613|566068301|FG000|30-day Follow-up|Missed visit|23|||
156813567|NCT01445613|566068301|FG000|30-day Follow-up|Death|3|||
156813568|NCT01445613|566068301|FG000|1-year Follow-up|Withdrawal by Subject|12|||
156813569|NCT01445613|566068301|FG000|1-year Follow-up|Missed visit|29|||
156813570|NCT01445613|566068301|FG000|1-year Follow-up|Lost to Follow-up|2|||
156813571|NCT01445613|566068301|FG000|1-year Follow-up|Death|30|||
156813572|NCT01445613|566068301|FG000|1-year Follow-up|Physician Decision|2|||
156813573|NCT01445613|566068301|FG000|1-year Follow-up|Received a non-study stent|2|||
156813574|NCT03711370|566068302|FG000|Overall Study|Lost to Follow-up|16|||
156813575|NCT03711370|566068303|FG001|Overall Study|Lost to Follow-up|10|||
156813576|NCT03711370|566068302|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
156813577|NCT03711370|566068303|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
156813578|NCT00407602|566068304|FG000|Overall Study|Death - unrelated to device|1|||
156813579|NCT00407602|566068304|FG000|Overall Study|Device explanted|5|||
156813580|NCT00407602|566068304|FG000|Overall Study|Withdrawal by Subject|1|||
156813581|NCT01169701|566068305|FG000|Overall Study|Lost to Follow-up|1|||
156813582|NCT01169701|566068306|FG001|Overall Study|Lost to Follow-up|1|||
156539306|NCT04688775|565068281|FG000|Delayed Start Period|Adverse Event|0|||
156813583|NCT01169701|566068305|FG000|Overall Study|Withdrawal by Subject|1|||
156813584|NCT01169701|566068306|FG001|Overall Study|Withdrawal by Subject|3|||
156813585|NCT01169701|566068305|FG000|Overall Study|Adverse Event|1|||
156813586|NCT01169701|566068306|FG001|Overall Study|Adverse Event|2|||
156813587|NCT01169701|566068305|FG000|Overall Study|Exclusion criteria|2|||
156813588|NCT01169701|566068306|FG001|Overall Study|Exclusion criteria|0|||
156813589|NCT01169701|566068305|FG000|Overall Study|Death|0|||
156813590|NCT01169701|566068306|FG001|Overall Study|Death|1|||
156813591|NCT01169701|566068305|FG000|Overall Study|Administrative problems|0|||
156539307|NCT04688775|565068282|FG001|Delayed Start Period|Adverse Event|0|||
156813592|NCT01169701|566068306|FG001|Overall Study|Administrative problems|1|||
156813593|NCT01169701|566068305|FG000|Overall Study|Serious adverse event|0|||
156813594|NCT01169701|566068306|FG001|Overall Study|Serious adverse event|1|||
156813595|NCT01169701|566068305|FG000|Overall Study|Sponsor decision|0|||
156813596|NCT01169701|566068306|FG001|Overall Study|Sponsor decision|1|||
156813597|NCT00553436|566068307|FG000|Overall Study|Conversion to another procedure|1|||
156813598|NCT04188834|566068308|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
156813599|NCT02455336|566068311|FG000|Overall Study|Withdrawal by Subject|0|||
156813600|NCT02455336|566068312|FG001|Overall Study|Withdrawal by Subject|2|||
156813601|NCT02455336|566068311|FG000|Overall Study|Adverse Event|3|||
156813602|NCT02455336|566068312|FG001|Overall Study|Adverse Event|0|||
156813603|NCT02455336|566068311|FG000|Overall Study|Non-responder to treatment|2|||
156813604|NCT02455336|566068312|FG001|Overall Study|Non-responder to treatment|0|||
156813605|NCT00391430|566068313|FG000|Overall Study|Withdrawal by Subject|3|||
156813606|NCT00391430|566068314|FG001|Overall Study|Withdrawal by Subject|0|||
156813607|NCT00391430|566068315|FG002|Overall Study|Withdrawal by Subject|12|||
156813608|NCT00577707|566068316|FG000|Overall Study|Withdrawal by Subject|3|||
156813609|NCT03299244|566068317|FG000|Overall Study|Withdrawal by Subject|34|||
156813610|NCT03299244|566068318|FG001|Overall Study|Withdrawal by Subject|29|||
156813611|NCT03299244|566068317|FG000|Overall Study|Decision by Sponsor|4|||
156813612|NCT03299244|566068318|FG001|Overall Study|Decision by Sponsor|5|||
156813613|NCT03299244|566068317|FG000|Overall Study|Death|9|||
156813614|NCT03299244|566068318|FG001|Overall Study|Death|4|||
156813615|NCT01392573|566068322|FG000|Overall Study|Adverse Event|1|||
156813616|NCT01392573|566068323|FG001|Overall Study|Adverse Event|3|||
156813617|NCT01392573|566068322|FG000|Overall Study|Lack of Efficacy|1|||
156813618|NCT01392573|566068323|FG001|Overall Study|Lack of Efficacy|2|||
156813619|NCT01392573|566068322|FG000|Overall Study|Protocol Violation|0|||
156813620|NCT01392573|566068323|FG001|Overall Study|Protocol Violation|2|||
156813621|NCT01392573|566068322|FG000|Overall Study|Withdrawal Criteria|13|||
156813622|NCT01392573|566068323|FG001|Overall Study|Withdrawal Criteria|15|||
156813623|NCT01392573|566068322|FG000|Overall Study|Site closure|8|||
156813624|NCT01392573|566068323|FG001|Overall Study|Site closure|7|||
156813625|NCT01392573|566068322|FG000|Overall Study|Unclassified|9|||
156813626|NCT01392573|566068323|FG001|Overall Study|Unclassified|6|||
156813627|NCT05696444|566068326|FG000|Treatment|Physician Decision|0|||
156813628|NCT05696444|566068327|FG001|Treatment|Physician Decision|1|||
156813629|NCT05696444|566068328|FG002|Treatment|Physician Decision|0|||
156813630|NCT05696444|566068326|FG000|30 Days|Death|1|||
156813631|NCT05696444|566068327|FG001|30 Days|Death|1|||
156813632|NCT05696444|566068328|FG002|30 Days|Death|0|||
156813633|NCT05696444|566068326|FG000|30 Days|Missed Visit|1|||
156813634|NCT05696444|566068327|FG001|30 Days|Missed Visit|1|||
156813635|NCT05696444|566068328|FG002|30 Days|Missed Visit|1|||
156813636|NCT03744910|566069895|FG000|Overall Study|Withdrew Consent|1|||
156813637|NCT03744910|566069896|FG001|Overall Study|Withdrew Consent|8|||
156813638|NCT03744910|566069895|FG000|Overall Study|Physician Decision|5|||
156813639|NCT03744910|566069896|FG001|Overall Study|Physician Decision|4|||
156813640|NCT03744910|566069895|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
156813641|NCT03744910|566069896|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
156813642|NCT03744910|566069895|FG000|Overall Study|Lost to Follow-up|0|||
156813643|NCT03744910|566069896|FG001|Overall Study|Lost to Follow-up|1|||
156813644|NCT03744910|566069895|FG000|Overall Study|Other-unspecified|4|||
156813645|NCT03744910|566069896|FG001|Overall Study|Other-unspecified|1|||
156813646|NCT03280303|566069897|FG000|Overall Study|Death|505|||
156813647|NCT03280303|566069897|FG000|Overall Study|Study terminated by sponsor|383|||
156813648|NCT03280303|566069897|FG000|Overall Study|Other|148|||
156813649|NCT03280303|566069897|FG000|Overall Study|No longer willing to participate in study|101|||
156813650|NCT03280303|566069897|FG000|Overall Study|Lost to follow up|39|||
156813651|NCT03280303|566069897|FG000|Overall Study|Adverse Event|20|||
156813652|NCT00948857|566069898|FG000|Overall Study|Lost to Follow-up|1|||
156813653|NCT00948857|566069899|FG001|Overall Study|Lost to Follow-up|0|||
156539308|NCT04688775|565068283|FG002|Delayed Start Period|Adverse Event|1|||
156813654|NCT03430843|566069900|FG000|Overall Study|Death|233|||
156813655|NCT03430843|566069901|FG001|Overall Study|Death|233|||
156813656|NCT03430843|566069900|FG000|Overall Study|Sponsor Decision|17|||
156813657|NCT03430843|566069901|FG001|Overall Study|Sponsor Decision|6|||
156813658|NCT03430843|566069900|FG000|Overall Study|Withdrawal by Subject|5|||
156813659|NCT03430843|566069901|FG001|Overall Study|Withdrawal by Subject|14|||
156813660|NCT03430843|566069900|FG000|Overall Study|Lost to Follow-up|1|||
156813661|NCT03430843|566069901|FG001|Overall Study|Lost to Follow-up|3|||
156813662|NCT05360966|566069906|FG000|Overall Study|Adverse Event|5|||
156813663|NCT05360966|566069907|FG001|Overall Study|Adverse Event|5|||
156813664|NCT05360966|566069906|FG000|Overall Study|Withdrawal of Consent|5|||
156813665|NCT05360966|566069907|FG001|Overall Study|Withdrawal of Consent|3|||
156813666|NCT05360966|566069906|FG000|Overall Study|Noncompliance|2|||
156813667|NCT05360966|566069907|FG001|Overall Study|Noncompliance|1|||
156813668|NCT05360966|566069906|FG000|Overall Study|Lost to Follow-up|2|||
156813669|NCT05360966|566069907|FG001|Overall Study|Lost to Follow-up|3|||
156464469|NCT04408755|564797885|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
156464470|NCT04408755|564797886|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
156813670|NCT05360966|566069906|FG000|Overall Study|Protocol Deviation|2|||
156813671|NCT05360966|566069907|FG001|Overall Study|Protocol Deviation|1|||
156813672|NCT05360966|566069906|FG000|Overall Study|As specified in the Clinical Study Report|1|||
156813673|NCT05360966|566069907|FG001|Overall Study|As specified in the Clinical Study Report|3|||
156813674|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
156813675|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813676|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813677|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813678|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813679|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813680|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813681|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813682|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813683|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813684|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813685|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813686|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813687|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
156813688|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813689|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813690|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813691|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813692|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813693|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813694|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813695|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813696|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813697|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813698|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813699|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813700|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
156813701|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813702|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813703|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813704|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156464471|NCT04408755|564797883|FG000|Period B (Randomization Period)|Physician Decision|0|||
156464472|NCT04408755|564797884|FG001|Period B (Randomization Period)|Physician Decision|0|||
156464473|NCT04408755|564797885|FG002|Period B (Randomization Period)|Physician Decision|1|||
156464474|NCT04408755|564797886|FG003|Period B (Randomization Period)|Physician Decision|0|||
156464475|NCT04408755|564797883|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
156464476|NCT04408755|564797884|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
156464477|NCT04408755|564797885|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
156813705|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813706|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813707|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813708|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813709|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813710|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813711|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813712|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813713|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
156813714|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813715|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813716|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813717|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
156813718|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813719|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813720|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813721|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813722|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813723|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813724|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813725|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813726|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813727|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813728|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813729|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813730|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
156813731|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813732|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813733|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813734|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813735|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813736|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813737|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813738|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813739|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813740|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813741|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813742|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813743|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
156813744|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813745|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813746|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813747|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813748|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813749|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813750|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813751|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813752|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813753|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813754|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813755|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813756|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
156813757|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813758|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156464478|NCT04408755|564797886|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
156813759|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813760|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
156813761|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813762|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813763|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813764|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813765|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813766|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813767|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813768|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813769|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813770|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813771|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813772|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813773|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
156813774|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813775|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813776|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813777|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813778|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813779|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813780|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813781|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813782|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813783|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813784|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813785|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813786|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
156813787|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813788|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813789|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813790|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813791|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813792|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813793|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813794|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813795|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813796|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813797|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813798|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813799|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
156813800|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813801|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813802|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813803|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813804|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813805|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813806|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813807|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813808|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813809|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813810|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813811|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813812|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813813|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813814|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813815|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813816|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813817|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813818|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813819|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813820|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813821|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813822|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813823|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813824|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813825|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813826|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813827|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813828|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813829|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
156813830|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813831|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813832|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813833|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813834|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813835|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813836|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813837|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813838|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813839|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813840|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813841|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813842|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
156813843|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813844|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813845|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813846|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813847|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813848|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813849|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813850|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813851|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813852|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813853|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813854|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813855|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813856|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813857|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813858|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813859|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813860|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813861|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813862|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813863|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813864|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813865|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813866|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813867|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813868|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813869|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813870|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813871|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813872|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
156813873|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813874|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813875|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813876|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813877|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813878|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813879|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813880|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813881|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813882|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813883|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813884|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813885|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813886|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813887|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813888|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813889|NCT05396014|566069908|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813890|NCT05396014|566069909|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813891|NCT05396014|566069910|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813892|NCT05396014|566069911|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813893|NCT05396014|566069912|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813894|NCT05396014|566069913|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813895|NCT05396014|566069914|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813896|NCT05396014|566069915|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813897|NCT05396014|566069916|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813898|NCT05396014|566069917|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813899|NCT05396014|566069918|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813900|NCT05396014|566069919|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813901|NCT05396014|566069920|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813902|NCT05396014|566069921|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
156813903|NCT05396014|566069922|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813904|NCT05396014|566069923|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813905|NCT05396014|566069924|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813906|NCT05396014|566069925|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813907|NCT05396014|566069926|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813908|NCT05396014|566069927|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813909|NCT05396014|566069928|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813910|NCT05396014|566069929|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813911|NCT05396014|566069930|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813912|NCT05396014|566069931|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813913|NCT05396014|566069932|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813914|NCT05396014|566069933|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813915|NCT05396014|566069934|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813916|NCT05396014|566069935|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813917|NCT05396014|566069936|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813918|NCT05396014|566069937|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813919|NCT05396014|566069938|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813920|NCT05396014|566069939|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813921|NCT05396014|566069940|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813922|NCT05396014|566069941|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813923|NCT05396014|566069942|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813924|NCT05396014|566069943|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813925|NCT05396014|566069944|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813926|NCT05396014|566069945|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813927|NCT05396014|566069946|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813928|NCT05396014|566069947|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813929|NCT05396014|566069948|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813930|NCT05396014|566069949|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813931|NCT05396014|566069950|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813932|NCT05396014|566069908|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
156813933|NCT05396014|566069909|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813934|NCT05396014|566069910|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813935|NCT05396014|566069911|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813936|NCT05396014|566069912|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813937|NCT05396014|566069913|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813938|NCT05396014|566069914|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813939|NCT05396014|566069915|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813940|NCT05396014|566069916|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813941|NCT05396014|566069917|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813942|NCT05396014|566069918|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813943|NCT05396014|566069919|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813944|NCT05396014|566069920|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813945|NCT05396014|566069921|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
156464479|NCT04408755|564797883|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
156813946|NCT05396014|566069922|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813947|NCT05396014|566069923|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813948|NCT05396014|566069924|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813949|NCT05396014|566069925|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813950|NCT05396014|566069926|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813951|NCT05396014|566069927|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813952|NCT05396014|566069928|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813953|NCT05396014|566069929|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813954|NCT05396014|566069930|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156464480|NCT04408755|564797884|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
156464481|NCT04408755|564797885|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
156464482|NCT04408755|564797886|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
156464483|NCT04408755|564797883|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
156464484|NCT04408755|564797884|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
156464485|NCT04408755|564797885|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
156464486|NCT04408755|564797886|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
156464487|NCT04408755|564797883|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
156464488|NCT04408755|564797884|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
156813955|NCT05396014|566069931|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813956|NCT05396014|566069932|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813957|NCT05396014|566069933|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813958|NCT05396014|566069934|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813959|NCT05396014|566069935|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813960|NCT05396014|566069936|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813961|NCT05396014|566069937|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813962|NCT05396014|566069938|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813963|NCT05396014|566069939|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813964|NCT05396014|566069940|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813965|NCT05396014|566069941|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813966|NCT05396014|566069942|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813967|NCT05396014|566069943|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813968|NCT05396014|566069944|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813969|NCT05396014|566069945|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813970|NCT05396014|566069946|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813971|NCT05396014|566069947|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
156813972|NCT05396014|566069948|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813973|NCT05396014|566069949|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813974|NCT05396014|566069950|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813975|NCT05396014|566069908|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
156813976|NCT05396014|566069909|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813977|NCT05396014|566069910|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813978|NCT05396014|566069911|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813979|NCT05396014|566069912|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813980|NCT05396014|566069913|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813981|NCT05396014|566069914|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813982|NCT05396014|566069915|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813983|NCT05396014|566069916|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813984|NCT05396014|566069917|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813985|NCT05396014|566069918|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813986|NCT05396014|566069919|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813987|NCT05396014|566069920|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813988|NCT05396014|566069921|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813989|NCT05396014|566069922|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813990|NCT05396014|566069923|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813991|NCT05396014|566069924|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813992|NCT05396014|566069925|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813993|NCT05396014|566069926|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813994|NCT05396014|566069927|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156464489|NCT04408755|564797885|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
156464490|NCT04408755|564797886|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
156464491|NCT04408755|564797883|FG000|Period B (Randomization Period)|Reason not Specified|0|||
156464492|NCT04408755|564797884|FG001|Period B (Randomization Period)|Reason not Specified|1|||
156464493|NCT04408755|564797885|FG002|Period B (Randomization Period)|Reason not Specified|0|||
156813995|NCT05396014|566069928|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813996|NCT05396014|566069929|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813997|NCT05396014|566069930|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813998|NCT05396014|566069931|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813999|NCT05396014|566069932|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814000|NCT05396014|566069933|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814001|NCT05396014|566069934|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
156814002|NCT05396014|566069935|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814003|NCT05396014|566069936|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814004|NCT05396014|566069937|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814005|NCT05396014|566069938|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814006|NCT05396014|566069939|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814007|NCT05396014|566069940|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814008|NCT05396014|566069941|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814009|NCT05396014|566069942|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814010|NCT05396014|566069943|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814011|NCT05396014|566069944|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814012|NCT05396014|566069945|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814013|NCT05396014|566069946|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814014|NCT05396014|566069947|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814015|NCT05396014|566069948|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814016|NCT05396014|566069949|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814017|NCT05396014|566069950|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814018|NCT05396014|566069908|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814019|NCT05396014|566069909|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814020|NCT05396014|566069910|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156464494|NCT04408755|564797886|FG003|Period B (Randomization Period)|Reason not Specified|2|||
156464495|NCT03733626|564797887|FG000|Overall Study|Physician Decision|4|||
156464496|NCT03733626|564797888|FG001|Overall Study|Physician Decision|4|||
156814021|NCT05396014|566069911|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814022|NCT05396014|566069912|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814023|NCT05396014|566069913|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814024|NCT05396014|566069914|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814025|NCT05396014|566069915|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814026|NCT05396014|566069916|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814027|NCT05396014|566069917|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814028|NCT05396014|566069918|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814029|NCT05396014|566069919|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814030|NCT05396014|566069920|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814031|NCT05396014|566069921|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
156814032|NCT05396014|566069922|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814033|NCT05396014|566069923|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814034|NCT05396014|566069924|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814035|NCT05396014|566069925|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814036|NCT05396014|566069926|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814037|NCT05396014|566069927|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814038|NCT05396014|566069928|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814039|NCT05396014|566069929|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814040|NCT05396014|566069930|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814041|NCT05396014|566069931|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814042|NCT05396014|566069932|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814043|NCT05396014|566069933|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814044|NCT05396014|566069934|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814045|NCT05396014|566069935|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814046|NCT05396014|566069936|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814047|NCT05396014|566069937|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814048|NCT05396014|566069938|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814049|NCT05396014|566069939|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156464497|NCT00412607|564797891|FG000|Overall Study|Withdrawal by Subject|9|||
156464498|NCT00412607|564797891|FG000|Overall Study|Lost to Follow-up|19|||
156464499|NCT00412607|564797891|FG000|Overall Study|Death|61|||
156464500|NCT00412607|564797891|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
156464501|NCT03662022|564797892|FG000|Year 1 2019|prevalent case|83|||
156464502|NCT03662022|564797893|FG001|Year 1 2019|prevalent case|116|||
156814050|NCT05396014|566069940|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814051|NCT05396014|566069941|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814052|NCT05396014|566069942|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814053|NCT05396014|566069943|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814054|NCT05396014|566069944|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814055|NCT05396014|566069945|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814056|NCT05396014|566069946|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814057|NCT05396014|566069947|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814058|NCT05396014|566069948|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814059|NCT05396014|566069949|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814060|NCT05396014|566069950|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814061|NCT05396014|566069908|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814062|NCT05396014|566069909|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814063|NCT05396014|566069910|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814064|NCT05396014|566069911|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
156814065|NCT05396014|566069912|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814066|NCT05396014|566069913|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814067|NCT05396014|566069914|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814068|NCT05396014|566069915|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814069|NCT05396014|566069916|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
156814070|NCT05396014|566069917|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814071|NCT05396014|566069918|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814072|NCT05396014|566069919|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814073|NCT05396014|566069920|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814074|NCT05396014|566069921|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814075|NCT05396014|566069922|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814076|NCT05396014|566069923|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814077|NCT05396014|566069924|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814078|NCT05396014|566069925|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814079|NCT05396014|566069926|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814080|NCT05396014|566069927|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814081|NCT05396014|566069928|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814082|NCT05396014|566069929|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814083|NCT05396014|566069930|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814084|NCT05396014|566069931|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814085|NCT05396014|566069932|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814086|NCT05396014|566069933|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
156814087|NCT05396014|566069934|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814088|NCT05396014|566069935|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814089|NCT05396014|566069936|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814090|NCT05396014|566069937|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814091|NCT05396014|566069938|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814092|NCT05396014|566069939|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814093|NCT05396014|566069940|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814094|NCT05396014|566069941|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814095|NCT05396014|566069942|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814096|NCT05396014|566069943|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814097|NCT05396014|566069944|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814098|NCT05396014|566069945|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814099|NCT05396014|566069946|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814100|NCT05396014|566069947|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814101|NCT05396014|566069948|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
156814102|NCT05396014|566069949|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
156814103|NCT05396014|566069950|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814104|NCT05396014|566069908|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814105|NCT05396014|566069909|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814106|NCT05396014|566069910|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814107|NCT05396014|566069911|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814108|NCT05396014|566069912|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814109|NCT05396014|566069913|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814110|NCT05396014|566069914|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814111|NCT05396014|566069915|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156464503|NCT03662022|564797894|FG002|Year 1 2019|prevalent case|158|||
156464504|NCT03662022|564797895|FG003|Year 1 2019|prevalent case|99|||
156814112|NCT05396014|566069916|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
156814113|NCT05396014|566069917|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156464505|NCT03662022|564797892|FG000|Year 2 2020|incident case|18|||
156464506|NCT03662022|564797893|FG001|Year 2 2020|incident case|18|||
156464507|NCT03662022|564797894|FG002|Year 2 2020|incident case|16|||
156464508|NCT03662022|564797895|FG003|Year 2 2020|incident case|26|||
156464509|NCT03662022|564797892|FG000|Year 2 2020|other case|18|||
156464510|NCT03662022|564797893|FG001|Year 2 2020|other case|16|||
156464511|NCT03662022|564797894|FG002|Year 2 2020|other case|16|||
156464512|NCT03662022|564797895|FG003|Year 2 2020|other case|24|||
156464513|NCT03662022|564797892|FG000|Year 2 2020|Lost to Follow-up|1633|||
156539309|NCT04688775|565068284|FG003|Delayed Start Period|Adverse Event|0|||
156539310|NCT04688775|565068281|FG000|Delayed Start Period|Lack of Efficacy|0|||
156539311|NCT04688775|565068282|FG001|Delayed Start Period|Lack of Efficacy|0|||
156539312|NCT04688775|565068283|FG002|Delayed Start Period|Lack of Efficacy|0|||
156539313|NCT04688775|565068284|FG003|Delayed Start Period|Lack of Efficacy|3|||
156539314|NCT04688775|565068281|FG000|Delayed Start Period|Withdrawal by Subject|0|||
156539315|NCT04688775|565068282|FG001|Delayed Start Period|Withdrawal by Subject|0|||
156539316|NCT04688775|565068283|FG002|Delayed Start Period|Withdrawal by Subject|2|||
156539317|NCT04688775|565068284|FG003|Delayed Start Period|Withdrawal by Subject|4|||
156539318|NCT04688775|565068281|FG000|Delayed Start Period|Lost to Follow-up|0|||
156539319|NCT04688775|565068282|FG001|Delayed Start Period|Lost to Follow-up|0|||
156539320|NCT04688775|565068283|FG002|Delayed Start Period|Lost to Follow-up|2|||
156539321|NCT04688775|565068284|FG003|Delayed Start Period|Lost to Follow-up|1|||
156814114|NCT05396014|566069918|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814115|NCT05396014|566069919|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814116|NCT05396014|566069920|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814117|NCT05396014|566069921|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814118|NCT05396014|566069922|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814119|NCT05396014|566069923|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814120|NCT05396014|566069924|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814121|NCT05396014|566069925|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814122|NCT05396014|566069926|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814123|NCT05396014|566069927|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814124|NCT05396014|566069928|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814125|NCT05396014|566069929|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814126|NCT05396014|566069930|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
156814127|NCT05396014|566069931|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814128|NCT05396014|566069932|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814129|NCT05396014|566069933|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814130|NCT05396014|566069934|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814131|NCT05396014|566069935|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814132|NCT05396014|566069936|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814133|NCT05396014|566069937|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814134|NCT05396014|566069938|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814135|NCT05396014|566069939|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814136|NCT05396014|566069940|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814137|NCT05396014|566069941|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814138|NCT05396014|566069942|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814139|NCT05396014|566069943|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
156814140|NCT05396014|566069944|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814141|NCT05396014|566069945|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814142|NCT05396014|566069946|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814143|NCT05396014|566069947|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814144|NCT05396014|566069948|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814145|NCT05396014|566069949|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
156814146|NCT05396014|566069950|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814147|NCT05396014|566069908|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814148|NCT05396014|566069909|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814149|NCT05396014|566069910|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814150|NCT05396014|566069911|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814151|NCT05396014|566069912|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814152|NCT05396014|566069913|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814153|NCT05396014|566069914|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814154|NCT05396014|566069915|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814155|NCT05396014|566069916|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156464514|NCT03662022|564797893|FG001|Year 2 2020|Lost to Follow-up|1183|||
156464515|NCT03662022|564797894|FG002|Year 2 2020|Lost to Follow-up|1381|||
156464516|NCT03662022|564797895|FG003|Year 2 2020|Lost to Follow-up|2858|||
156464517|NCT03662022|564797892|FG000|Year 3 2021|incident case|24|||
156539322|NCT04688775|565068281|FG000|Delayed Start Period|other reasons|0|||
156464518|NCT03662022|564797893|FG001|Year 3 2021|incident case|27|||
156464519|NCT03662022|564797894|FG002|Year 3 2021|incident case|24|||
156814156|NCT05396014|566069917|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814157|NCT05396014|566069918|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814158|NCT05396014|566069919|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814159|NCT05396014|566069920|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814160|NCT05396014|566069921|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
156814161|NCT05396014|566069922|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814162|NCT05396014|566069923|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814163|NCT05396014|566069924|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814164|NCT05396014|566069925|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814165|NCT05396014|566069926|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814166|NCT05396014|566069927|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814167|NCT05396014|566069928|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814168|NCT05396014|566069929|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814169|NCT05396014|566069930|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814170|NCT05396014|566069931|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814171|NCT05396014|566069932|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814172|NCT05396014|566069933|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814173|NCT05396014|566069934|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
156464520|NCT03662022|564797895|FG003|Year 3 2021|incident case|11|||
156464521|NCT03662022|564797892|FG000|Year 3 2021|other case|4|||
156464522|NCT03662022|564797893|FG001|Year 3 2021|other case|15|||
156464523|NCT03662022|564797894|FG002|Year 3 2021|other case|10|||
156464524|NCT03662022|564797895|FG003|Year 3 2021|other case|14|||
156464525|NCT03662022|564797892|FG000|Year 3 2021|Lost to Follow-up|179|||
156464526|NCT03662022|564797893|FG001|Year 3 2021|Lost to Follow-up|244|||
156814174|NCT05396014|566069935|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814175|NCT05396014|566069936|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156464527|NCT03662022|564797894|FG002|Year 3 2021|Lost to Follow-up|480|||
156464528|NCT03662022|564797895|FG003|Year 3 2021|Lost to Follow-up|477|||
156464529|NCT03662022|564797892|FG000|Year 4 2022|incident case|25|||
156464530|NCT03662022|564797893|FG001|Year 4 2022|incident case|41|||
156464531|NCT03662022|564797894|FG002|Year 4 2022|incident case|28|||
156464532|NCT03662022|564797895|FG003|Year 4 2022|incident case|7|||
156464533|NCT03662022|564797892|FG000|Year 4 2022|other case|8|||
156464534|NCT03662022|564797893|FG001|Year 4 2022|other case|19|||
156464535|NCT03662022|564797894|FG002|Year 4 2022|other case|13|||
156464536|NCT03662022|564797895|FG003|Year 4 2022|other case|7|||
156464537|NCT03662022|564797892|FG000|Year 4 2022|Lost to Follow-up|986|||
156464538|NCT03662022|564797893|FG001|Year 4 2022|Lost to Follow-up|1079|||
156464539|NCT03662022|564797894|FG002|Year 4 2022|Lost to Follow-up|1236|||
156464540|NCT03662022|564797895|FG003|Year 4 2022|Lost to Follow-up|1826|||
156464541|NCT04214418|564797896|FG000|Overall Study|Withdrawal by Subject|1|||
156464542|NCT04214418|564797897|FG001|Overall Study|Withdrawal by Subject|0|||
156464543|NCT04214418|564797898|FG002|Overall Study|Withdrawal by Subject|0|||
156464544|NCT04214418|564797899|FG003|Overall Study|Withdrawal by Subject|0|||
156464545|NCT04214418|564797900|FG004|Overall Study|Withdrawal by Subject|0|||
156464546|NCT04214418|564797901|FG005|Overall Study|Withdrawal by Subject|0|||
156464547|NCT04214418|564797896|FG000|Overall Study|Adverse Event|0|||
156464548|NCT04214418|564797897|FG001|Overall Study|Adverse Event|2|||
156464549|NCT04214418|564797898|FG002|Overall Study|Adverse Event|0|||
156464550|NCT04214418|564797899|FG003|Overall Study|Adverse Event|0|||
156464551|NCT04214418|564797900|FG004|Overall Study|Adverse Event|0|||
156464552|NCT04214418|564797901|FG005|Overall Study|Adverse Event|0|||
156464553|NCT04214418|564797896|FG000|Overall Study|Death|1|||
156464554|NCT04214418|564797897|FG001|Overall Study|Death|0|||
156464555|NCT04214418|564797898|FG002|Overall Study|Death|0|||
156464556|NCT04214418|564797899|FG003|Overall Study|Death|0|||
156464557|NCT04214418|564797900|FG004|Overall Study|Death|0|||
156464558|NCT04214418|564797901|FG005|Overall Study|Death|0|||
156464559|NCT03884439|564797911|FG000|Overall Study|No informed consent for publication of study results|38|||
156464560|NCT03884439|564797911|FG000|Overall Study|Contract violation/deficiency|7|||
156464561|NCT05215054|564797915|FG000|Overall Study|Lost to Follow-up|1|||
156464562|NCT05215054|564797916|FG001|Overall Study|Lost to Follow-up|1|||
156464563|NCT05215054|564797915|FG000|Overall Study|Protocol Violation|1|||
156464564|NCT05215054|564797916|FG001|Overall Study|Protocol Violation|1|||
156464565|NCT05215054|564797915|FG000|Overall Study|Withdrawal by Subject|4|||
156464566|NCT05215054|564797916|FG001|Overall Study|Withdrawal by Subject|4|||
156464567|NCT02933489|564797917|FG000|Overall Study|Ineligible|3|||
156464568|NCT02933489|564797918|FG001|Overall Study|Ineligible|3|||
156464569|NCT02933489|564797917|FG000|Overall Study|Withdrawal by Subject|27|||
156464570|NCT02933489|564797918|FG001|Overall Study|Withdrawal by Subject|18|||
156464571|NCT02933489|564797917|FG000|Overall Study|Unable to complete exams (other)|14|||
156464572|NCT02933489|564797918|FG001|Overall Study|Unable to complete exams (other)|7|||
156464573|NCT05485935|564797919|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
156464574|NCT05485935|564797920|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
156464575|NCT05485935|564797919|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
156464576|NCT05485935|564797920|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
156539323|NCT04688775|565068282|FG001|Delayed Start Period|other reasons|0|||
156539324|NCT04688775|565068283|FG002|Delayed Start Period|other reasons|1|||
156539325|NCT04688775|565068284|FG003|Delayed Start Period|other reasons|0|||
156539326|NCT00427349|565068287|FG000|Overall Study|Lack of Efficacy|23|||
156539327|NCT00427349|565068287|FG000|Overall Study|Adverse Event|14|||
156539328|NCT00427349|565068287|FG000|Overall Study|Death|1|||
156539329|NCT00427349|565068287|FG000|Overall Study|Withdrawal by Subject|3|||
156539330|NCT00427349|565068287|FG000|Overall Study|Alternative therapy|1|||
156539331|NCT00427349|565068287|FG000|Overall Study|Other|2|||
156539332|NCT00427349|565068287|FG000|Overall Study|Ineligible|1|||
156539333|NCT00427349|565068287|FG000|Overall Study|Never started therapy|1|||
156539334|NCT02064920|565068290|FG000|Overall Study|Adverse Event|0|||
156539335|NCT02064920|565068291|FG001|Overall Study|Adverse Event|4|||
156539336|NCT02064920|565068290|FG000|Overall Study|Physician Decision|0|||
156539337|NCT02064920|565068291|FG001|Overall Study|Physician Decision|1|||
156539338|NCT02064920|565068290|FG000|Overall Study|Technical Problems|0|||
156539339|NCT02064920|565068291|FG001|Overall Study|Technical Problems|1|||
156539340|NCT02064920|565068290|FG000|Overall Study|Withdrawal by Subject|1|||
156539341|NCT02064920|565068291|FG001|Overall Study|Withdrawal by Subject|3|||
156539342|NCT02109562|565068292|FG000|Overall Study|Insufficient clinical response|2|||
156539343|NCT02109562|565068293|FG001|Overall Study|Insufficient clinical response|0|||
156539344|NCT02109562|565068294|FG002|Overall Study|Insufficient clinical response|4|||
156539345|NCT02109562|565068292|FG000|Overall Study|Adverse Event|0|||
156539346|NCT02109562|565068293|FG001|Overall Study|Adverse Event|2|||
156539347|NCT02109562|565068294|FG002|Overall Study|Adverse Event|3|||
156539348|NCT02109562|565068292|FG000|Overall Study|Lost to Follow-up|1|||
156539349|NCT02109562|565068293|FG001|Overall Study|Lost to Follow-up|0|||
156539350|NCT02109562|565068294|FG002|Overall Study|Lost to Follow-up|1|||
156539351|NCT02109562|565068292|FG000|Overall Study|Protocol Violation|0|||
156539352|NCT02109562|565068293|FG001|Overall Study|Protocol Violation|3|||
156539353|NCT02109562|565068294|FG002|Overall Study|Protocol Violation|1|||
156539354|NCT02109562|565068292|FG000|Overall Study|Withdrawal by Subject|20|||
156539355|NCT02109562|565068293|FG001|Overall Study|Withdrawal by Subject|25|||
156539356|NCT02109562|565068294|FG002|Overall Study|Withdrawal by Subject|21|||
156539357|NCT02109562|565068292|FG000|Overall Study|Physician Decision|3|||
156539358|NCT02109562|565068293|FG001|Overall Study|Physician Decision|4|||
156539359|NCT02109562|565068294|FG002|Overall Study|Physician Decision|5|||
156539360|NCT00445224|565068300|FG000|Specific Exercises|Withdrawal by Subject|3|||
156539361|NCT00445224|565068301|FG001|Specific Exercises|Withdrawal by Subject|3|||
156539362|NCT00445224|565068300|FG000|Specific Exercises|Withdrawal by Subject|1|||
156539363|NCT00445224|565068301|FG001|Specific Exercises|Withdrawal by Subject|0|||
156539364|NCT01566773|565069690|FG000|Overall Study|Protocol specified criteria|4|||
156539365|NCT01566773|565069690|FG000|Overall Study|Protocol Violation|4|||
156539366|NCT01566773|565069690|FG000|Overall Study|Withdrawal by Subject|9|||
156539367|NCT01566773|565069690|FG000|Overall Study|Administrative reason|1|||
156539368|NCT01566773|565069690|FG000|Overall Study|Adverse Event|10|||
156539369|NCT01566773|565069690|FG000|Overall Study|Physician Decision|2|||
156539370|NCT02318667|565069691|FG000|Overall Study|Adverse Event|1|||
156539371|NCT02318667|565069691|FG000|Overall Study|Lack of Efficacy|6|||
156539372|NCT02318667|565069691|FG000|Overall Study|Protocol Violation|2|||
156539373|NCT02161575|565069702|FG000|Overall Study|Protocol Violation|8|||
156539374|NCT02161575|565069702|FG000|Overall Study|Lack of Efficacy|1|||
156539375|NCT02161575|565069702|FG000|Overall Study|Adverse Event|2|||
156539376|NCT00714285|565069703|FG000|Overall Study|Lost to Follow-up|0|||
156539377|NCT00714285|565069704|FG001|Overall Study|Lost to Follow-up|2|||
156539378|NCT00714285|565069705|FG002|Overall Study|Lost to Follow-up|0|||
156539379|NCT00714285|565069706|FG003|Overall Study|Lost to Follow-up|1|||
156539380|NCT00714285|565069703|FG000|Overall Study|Migrated/moved from study area|0|||
156539381|NCT00714285|565069704|FG001|Overall Study|Migrated/moved from study area|1|||
156539382|NCT00714285|565069705|FG002|Overall Study|Migrated/moved from study area|0|||
156539383|NCT00714285|565069706|FG003|Overall Study|Migrated/moved from study area|0|||
156539384|NCT01131676|565069711|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
156539385|NCT01131676|565069712|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
156539386|NCT01131676|565069713|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
156539387|NCT01131676|565069711|FG000|Discontinuation From Treatment|Not treated|4|||
156539388|NCT01131676|565069712|FG001|Discontinuation From Treatment|Not treated|2|||
156539389|NCT01131676|565069713|FG002|Discontinuation From Treatment|Not treated|2|||
156539390|NCT01131676|565069711|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
156539391|NCT01131676|565069712|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
156539392|NCT01131676|565069713|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
156539393|NCT01131676|565069711|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
156539394|NCT01131676|565069712|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
156539395|NCT01131676|565069713|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
156539396|NCT01131676|565069711|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
156539397|NCT01131676|565069712|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
156539398|NCT01131676|565069713|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
156814176|NCT05396014|566069937|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814177|NCT05396014|566069938|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814178|NCT05396014|566069939|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814179|NCT05396014|566069940|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814180|NCT05396014|566069941|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814181|NCT05396014|566069942|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
156464577|NCT05485935|564797919|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
156464578|NCT05485935|564797920|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
156464579|NCT05485935|564797919|FG000|Period 2 (T2 and V3)|loss of contact|0|||
156464580|NCT05485935|564797920|FG001|Period 2 (T2 and V3)|loss of contact|1|||
156464581|NCT04626427|564797921|FG000|Overall Study|Death|1|||
156464582|NCT04626427|564797921|FG000|Overall Study|Withdrawal by Subject|1|||
156464583|NCT04626427|564797921|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
156464584|NCT04626427|564797921|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
156464585|NCT01265537|564797922|FG000|Overall Study|Adverse Event|2|||
156464586|NCT01265537|564797923|FG001|Overall Study|Adverse Event|1|||
156464587|NCT01265537|564797922|FG000|Overall Study|Physician Decision|0|||
156464588|NCT01265537|564797923|FG001|Overall Study|Physician Decision|1|||
156464589|NCT04518943|564798686|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
156464590|NCT04518943|564798687|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
156464591|NCT04518943|564798688|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
156464592|NCT04518943|564798689|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
156464593|NCT04518943|564798690|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
156464594|NCT04518943|564798691|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
156464595|NCT04518943|564798692|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
156464596|NCT04518943|564798693|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
156464597|NCT04518943|564798694|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
156464598|NCT04518943|564798695|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
156464599|NCT04518943|564798696|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
156464600|NCT04518943|564798697|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
156464601|NCT04518943|564798698|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
156464602|NCT04518943|564798699|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
156464603|NCT04518943|564798700|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
156464604|NCT04518943|564798701|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
156464605|NCT03705793|564798705|FG000|Overall Study|Lost to Follow-up|3|||
156464606|NCT03705793|564798706|FG001|Overall Study|Lost to Follow-up|4|||
156464607|NCT03705793|564798705|FG000|Overall Study|Withdrawal by Subject|2|||
156814182|NCT05396014|566069943|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156464608|NCT03705793|564798706|FG001|Overall Study|Withdrawal by Subject|1|||
156814183|NCT05396014|566069944|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814184|NCT05396014|566069945|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156464609|NCT04174170|564798709|FG000|Placebo Run-in Period|Not Randomized|38|||
156464610|NCT04174170|564798710|FG001|Placebo Run-in Period|Not Randomized|0|||
156464611|NCT04174170|564798711|FG002|Placebo Run-in Period|Not Randomized|0|||
156464612|NCT04174170|564798712|FG003|Placebo Run-in Period|Not Randomized|0|||
156464613|NCT04174170|564798709|FG000|Double Blind Treatment Period|Adverse Event|0|||
156464614|NCT04174170|564798710|FG001|Double Blind Treatment Period|Adverse Event|9|||
156814185|NCT05396014|566069946|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814186|NCT05396014|566069947|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814187|NCT05396014|566069948|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814188|NCT05396014|566069949|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814189|NCT05396014|566069950|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
156814190|NCT05396014|566069908|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814191|NCT05396014|566069909|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814192|NCT05396014|566069910|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814193|NCT05396014|566069911|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814194|NCT05396014|566069912|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814195|NCT05396014|566069913|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814196|NCT05396014|566069914|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814197|NCT05396014|566069915|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814198|NCT05396014|566069916|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814199|NCT05396014|566069917|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814200|NCT05396014|566069918|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814201|NCT05396014|566069919|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814202|NCT05396014|566069920|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814203|NCT05396014|566069921|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814204|NCT05396014|566069922|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814205|NCT05396014|566069923|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814206|NCT05396014|566069924|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814207|NCT05396014|566069925|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814208|NCT05396014|566069926|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814209|NCT05396014|566069927|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814210|NCT05396014|566069928|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814211|NCT05396014|566069929|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814212|NCT05396014|566069930|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814213|NCT05396014|566069931|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814214|NCT05396014|566069932|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814215|NCT05396014|566069933|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814216|NCT05396014|566069934|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
156814217|NCT05396014|566069935|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814218|NCT05396014|566069936|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814219|NCT05396014|566069937|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814220|NCT05396014|566069938|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814221|NCT05396014|566069939|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814222|NCT05396014|566069940|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814223|NCT05396014|566069941|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814224|NCT05396014|566069942|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814225|NCT05396014|566069943|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814226|NCT05396014|566069944|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814227|NCT05396014|566069945|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814228|NCT05396014|566069946|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814229|NCT05396014|566069947|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814230|NCT05396014|566069948|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814231|NCT05396014|566069949|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814232|NCT05396014|566069950|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814233|NCT04439539|566069951|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
156814234|NCT04439539|566069952|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
156814235|NCT04439539|566069953|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
156814236|NCT04439539|566069951|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
156814237|NCT04439539|566069952|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
156814238|NCT04439539|566069953|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
156814239|NCT04439539|566069951|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
156814240|NCT04439539|566069952|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
156814241|NCT04439539|566069953|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
156814242|NCT05258890|566069955|FG000|Overall Study|Patient withdrawal|6|||
156464615|NCT04174170|564798711|FG002|Double Blind Treatment Period|Adverse Event|9|||
156814243|NCT05258890|566069956|FG001|Overall Study|Patient withdrawal|7|||
156814244|NCT05258890|566069955|FG000|Overall Study|Patient lost to follow-up|10|||
156814245|NCT05258890|566069956|FG001|Overall Study|Patient lost to follow-up|3|||
156814246|NCT05258890|566069955|FG000|Overall Study|Social network member withdrawal|1|||
156814247|NCT05258890|566069956|FG001|Overall Study|Social network member withdrawal|0|||
156814248|NCT05258890|566069955|FG000|Overall Study|Social network member lost to follow-up|5|||
156814249|NCT05258890|566069956|FG001|Overall Study|Social network member lost to follow-up|0|||
156814250|NCT05959447|566069963|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
156814251|NCT05959447|566069964|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
156814252|NCT05959447|566069963|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
156814253|NCT05959447|566069964|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
156814254|NCT05959447|566069963|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
156814255|NCT05959447|566069964|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
156814256|NCT05959447|566069963|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
156464616|NCT04174170|564798712|FG003|Double Blind Treatment Period|Adverse Event|8|||
156814257|NCT05959447|566069964|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
156814258|NCT03015363|566069973|FG000|Overall Study|Physician Decision|14|||
156814259|NCT03015363|566069973|FG000|Overall Study|Withdrawal by Subject|3|||
156814260|NCT03107052|566069974|FG000|Overall Study|Adverse Event|6|||
156814261|NCT03107052|566069975|FG001|Overall Study|Adverse Event|1|||
156814262|NCT03107052|566069976|FG002|Overall Study|Adverse Event|2|||
156814263|NCT03107052|566069974|FG000|Overall Study|Withdrawal by Subject|9|||
156814264|NCT03107052|566069975|FG001|Overall Study|Withdrawal by Subject|5|||
156814265|NCT03107052|566069976|FG002|Overall Study|Withdrawal by Subject|8|||
156814266|NCT03107052|566069974|FG000|Overall Study|Protocol Violation|6|||
156814267|NCT03107052|566069975|FG001|Overall Study|Protocol Violation|0|||
156814268|NCT03107052|566069976|FG002|Overall Study|Protocol Violation|3|||
156814269|NCT03107052|566069974|FG000|Overall Study|Lost to Follow-up|4|||
156814270|NCT03107052|566069975|FG001|Overall Study|Lost to Follow-up|0|||
156814271|NCT03107052|566069976|FG002|Overall Study|Lost to Follow-up|1|||
156814272|NCT03107052|566069974|FG000|Overall Study|Lack of Efficacy|23|||
156814273|NCT03107052|566069975|FG001|Overall Study|Lack of Efficacy|7|||
156814274|NCT03107052|566069976|FG002|Overall Study|Lack of Efficacy|4|||
156814275|NCT03107052|566069974|FG000|Overall Study|Other than specified|4|||
156814276|NCT03107052|566069975|FG001|Overall Study|Other than specified|2|||
156814277|NCT03107052|566069976|FG002|Overall Study|Other than specified|0|||
156464617|NCT04174170|564798709|FG000|Double Blind Treatment Period|Death|0|||
156464618|NCT04174170|564798710|FG001|Double Blind Treatment Period|Death|1|||
156464619|NCT04174170|564798711|FG002|Double Blind Treatment Period|Death|0|||
156464620|NCT04174170|564798712|FG003|Double Blind Treatment Period|Death|0|||
156464621|NCT04174170|564798709|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
156464622|NCT04174170|564798710|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
156464623|NCT04174170|564798711|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
156464624|NCT04174170|564798712|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
156464625|NCT04174170|564798709|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
156464626|NCT04174170|564798710|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
156464627|NCT04174170|564798711|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
156464628|NCT04174170|564798712|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
156464629|NCT04174170|564798709|FG000|Double Blind Treatment Period|Physician Decision|0|||
156464630|NCT04174170|564798710|FG001|Double Blind Treatment Period|Physician Decision|1|||
156464631|NCT04174170|564798711|FG002|Double Blind Treatment Period|Physician Decision|0|||
156464632|NCT04174170|564798712|FG003|Double Blind Treatment Period|Physician Decision|1|||
156464633|NCT04174170|564798709|FG000|Double Blind Treatment Period|Pregnancy|0|||
156464634|NCT04174170|564798710|FG001|Double Blind Treatment Period|Pregnancy|1|||
156464635|NCT04174170|564798711|FG002|Double Blind Treatment Period|Pregnancy|0|||
156464636|NCT04174170|564798712|FG003|Double Blind Treatment Period|Pregnancy|1|||
156464637|NCT04174170|564798709|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
156464638|NCT04174170|564798710|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
156539399|NCT01131676|565069711|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
156539400|NCT01131676|565069712|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
156539401|NCT01131676|565069713|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
156539402|NCT01131676|565069711|FG000|Discontinuation From Treatment|Other than those specified|162|||
156814278|NCT03107052|566069974|FG000|Overall Study|Study terminated due to futility|67|||
156814279|NCT03107052|566069975|FG001|Overall Study|Study terminated due to futility|31|||
156814280|NCT03107052|566069976|FG002|Overall Study|Study terminated due to futility|23|||
156814281|NCT00958360|566069977|FG000|Overall Study|Withdrawal by Subject|3|||
156814282|NCT00958360|566069978|FG001|Overall Study|Withdrawal by Subject|1|||
156814283|NCT00958360|566069977|FG000|Overall Study|Death|6|||
156814284|NCT00958360|566069978|FG001|Overall Study|Death|7|||
156814285|NCT00958360|566069977|FG000|Overall Study|Physician Decision|2|||
156814286|NCT00958360|566069978|FG001|Overall Study|Physician Decision|1|||
156814287|NCT00958360|566069977|FG000|Overall Study|Lost to Follow-up|0|||
156464639|NCT04174170|564798711|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
156814288|NCT00958360|566069978|FG001|Overall Study|Lost to Follow-up|1|||
156814289|NCT02263326|566069979|FG000|Overall Study|Lost to Follow-up|1|||
156464640|NCT04174170|564798712|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
156464641|NCT04174170|564798709|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
156464642|NCT04174170|564798710|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
156464643|NCT04174170|564798711|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
156464644|NCT04174170|564798712|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
156464645|NCT04174170|564798709|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
156814290|NCT02263326|566069980|FG001|Overall Study|Lost to Follow-up|1|||
156814291|NCT00500357|566069981|FG000|Overall Study|Death|1|||
156814292|NCT00078806|566069982|FG000|Part 1A|Adverse Event|2|||
156814293|NCT00078806|566069983|FG001|Part 1A|Adverse Event|0|||
156814294|NCT00078806|566069984|FG002|Part 1A|Adverse Event|0|||
156814295|NCT00078806|566069985|FG003|Part 1A|Adverse Event|0|||
156814296|NCT00078806|566069982|FG000|Part 1A|Lack of Efficacy|7|||
156814297|NCT00078806|566069983|FG001|Part 1A|Lack of Efficacy|0|||
156814298|NCT00078806|566069984|FG002|Part 1A|Lack of Efficacy|0|||
156814299|NCT00078806|566069985|FG003|Part 1A|Lack of Efficacy|0|||
156814300|NCT00078806|566069982|FG000|Part 1A|Other|1|||
156814301|NCT00078806|566069983|FG001|Part 1A|Other|0|||
156814302|NCT00078806|566069984|FG002|Part 1A|Other|0|||
156814303|NCT00078806|566069985|FG003|Part 1A|Other|0|||
156814304|NCT00078806|566069982|FG000|Part 1B|Adverse Event|1|||
156814305|NCT00078806|566069983|FG001|Part 1B|Adverse Event|0|||
156814306|NCT00078806|566069984|FG002|Part 1B|Adverse Event|0|||
156814307|NCT00078806|566069985|FG003|Part 1B|Adverse Event|0|||
156814308|NCT00078806|566069982|FG000|Part 1B|Lack of Efficacy|7|||
156814309|NCT00078806|566069983|FG001|Part 1B|Lack of Efficacy|0|||
156814310|NCT00078806|566069984|FG002|Part 1B|Lack of Efficacy|0|||
156814311|NCT00078806|566069985|FG003|Part 1B|Lack of Efficacy|0|||
156814312|NCT00078806|566069982|FG000|Part 2|Adverse Event|0|||
156814313|NCT00078806|566069983|FG001|Part 2|Adverse Event|1|||
156814314|NCT00078806|566069984|FG002|Part 2|Adverse Event|0|||
156814315|NCT00078806|566069985|FG003|Part 2|Adverse Event|0|||
156814316|NCT01893411|566069988|FG000|Overall Study|Protocol Violation|1|||
156814317|NCT01893411|566069989|FG001|Overall Study|Protocol Violation|0|||
156814318|NCT01893411|566069990|FG002|Overall Study|Protocol Violation|0|||
156814319|NCT01893411|566069988|FG000|Overall Study|Physician Decision|1|||
156814320|NCT01893411|566069989|FG001|Overall Study|Physician Decision|1|||
156814321|NCT01893411|566069990|FG002|Overall Study|Physician Decision|2|||
156814322|NCT01893411|566069988|FG000|Overall Study|Lack of Efficacy|2|||
156814323|NCT01893411|566069989|FG001|Overall Study|Lack of Efficacy|1|||
156814324|NCT01893411|566069990|FG002|Overall Study|Lack of Efficacy|0|||
156814325|NCT01893411|566069988|FG000|Overall Study|Other|3|||
156814326|NCT01893411|566069989|FG001|Overall Study|Other|1|||
156814327|NCT01893411|566069990|FG002|Overall Study|Other|3|||
156814328|NCT01893411|566069988|FG000|Overall Study|Adverse Event|1|||
156814329|NCT01893411|566069989|FG001|Overall Study|Adverse Event|0|||
156814330|NCT01893411|566069990|FG002|Overall Study|Adverse Event|0|||
156814331|NCT01893411|566069988|FG000|Overall Study|Withdrawal by Subject|7|||
156814332|NCT01893411|566069989|FG001|Overall Study|Withdrawal by Subject|4|||
156814333|NCT01893411|566069990|FG002|Overall Study|Withdrawal by Subject|3|||
156814334|NCT01893411|566069988|FG000|Overall Study|Lost to Follow-up|2|||
156814335|NCT01893411|566069989|FG001|Overall Study|Lost to Follow-up|0|||
156814336|NCT01893411|566069990|FG002|Overall Study|Lost to Follow-up|1|||
156814337|NCT00566982|566069991|FG000|Overall Study|Adverse Event|6|||
156814338|NCT00566982|566069992|FG001|Overall Study|Adverse Event|48|||
156814339|NCT00566982|566069991|FG000|Overall Study|Withdrawal by Subject|1|||
156814340|NCT00566982|566069992|FG001|Overall Study|Withdrawal by Subject|14|||
156814341|NCT00566982|566069991|FG000|Overall Study|Protocol Violation|1|||
156814342|NCT00566982|566069992|FG001|Overall Study|Protocol Violation|4|||
156814343|NCT00566982|566069991|FG000|Overall Study|Lost to Follow-up|0|||
156814344|NCT00566982|566069992|FG001|Overall Study|Lost to Follow-up|1|||
156814345|NCT00566982|566069991|FG000|Overall Study|Other-family problems & doctor's request|0|||
156814346|NCT00566982|566069992|FG001|Overall Study|Other-family problems & doctor's request|2|||
156814347|NCT00161616|566069993|FG000|Overall Study|Withdrawal by Subject|6|||
156814348|NCT00161616|566069994|FG001|Overall Study|Withdrawal by Subject|5|||
156814349|NCT00161616|566069993|FG000|Overall Study|Physician Decision|1|||
156814350|NCT00161616|566069994|FG001|Overall Study|Physician Decision|0|||
156464646|NCT04174170|564798710|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
156814351|NCT00161616|566069993|FG000|Overall Study|Death|1|||
156814352|NCT00161616|566069994|FG001|Overall Study|Death|1|||
156464647|NCT04174170|564798711|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
156814353|NCT00161616|566069993|FG000|Overall Study|Lost to Follow-up|17|||
156814354|NCT00161616|566069994|FG001|Overall Study|Lost to Follow-up|13|||
156814355|NCT00161616|566069993|FG000|Overall Study|Protocol deviation|1|||
156814356|NCT00161616|566069994|FG001|Overall Study|Protocol deviation|0|||
156814357|NCT02013778|566069995|FG000|Overall Study|Death|4|||
156814358|NCT02013778|566069995|FG000|Overall Study|Withdrawal by Subject|1|||
156814359|NCT02013778|566069995|FG000|Overall Study|Physician Decision|1|||
156814360|NCT02013778|566069995|FG000|Overall Study|Adverse Event|1|||
156814361|NCT02719691|566069996|FG000|Overall Study|Physician Decision|0|||
156814362|NCT02719691|566069997|FG001|Overall Study|Physician Decision|0|||
156814363|NCT02719691|566069998|FG002|Overall Study|Physician Decision|1|||
156814364|NCT02719691|566069999|FG003|Overall Study|Physician Decision|0|||
156814365|NCT02719691|566070000|FG004|Overall Study|Physician Decision|0|||
156814366|NCT02719691|566070001|FG005|Overall Study|Physician Decision|0|||
156464648|NCT04174170|564798712|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
156464649|NCT04664881|564798713|FG000|Overall Study|Withdrawal by Subject|1|||
156814367|NCT02719691|566070002|FG006|Overall Study|Physician Decision|0|||
156814368|NCT02719691|566069996|FG000|Overall Study|Withdrawal by Subject|0|||
156814369|NCT02719691|566069997|FG001|Overall Study|Withdrawal by Subject|0|||
156814370|NCT02719691|566069998|FG002|Overall Study|Withdrawal by Subject|0|||
156814371|NCT02719691|566069999|FG003|Overall Study|Withdrawal by Subject|0|||
156814372|NCT02719691|566070000|FG004|Overall Study|Withdrawal by Subject|0|||
156814373|NCT02719691|566070001|FG005|Overall Study|Withdrawal by Subject|1|||
156814374|NCT02719691|566070002|FG006|Overall Study|Withdrawal by Subject|0|||
156814375|NCT00861757|566070005|FG000|Overall Study|Adverse Event|1|||
156814376|NCT00861757|566070006|FG001|Overall Study|Adverse Event|5|||
156814377|NCT00861757|566070007|FG002|Overall Study|Adverse Event|7|||
156814378|NCT00861757|566070008|FG003|Overall Study|Adverse Event|2|||
156814379|NCT00861757|566070005|FG000|Overall Study|Entry Criteria Not Met|1|||
156814380|NCT00861757|566070006|FG001|Overall Study|Entry Criteria Not Met|2|||
156814381|NCT00861757|566070007|FG002|Overall Study|Entry Criteria Not Met|1|||
156814382|NCT00861757|566070008|FG003|Overall Study|Entry Criteria Not Met|1|||
156814383|NCT00861757|566070005|FG000|Overall Study|Lack of Efficacy|3|||
156814384|NCT00861757|566070006|FG001|Overall Study|Lack of Efficacy|1|||
156814385|NCT00861757|566070007|FG002|Overall Study|Lack of Efficacy|0|||
156814386|NCT00861757|566070008|FG003|Overall Study|Lack of Efficacy|1|||
156814387|NCT00861757|566070005|FG000|Overall Study|Lost to Follow-up|1|||
156814388|NCT00861757|566070006|FG001|Overall Study|Lost to Follow-up|0|||
156814389|NCT00861757|566070007|FG002|Overall Study|Lost to Follow-up|1|||
156814390|NCT00861757|566070008|FG003|Overall Study|Lost to Follow-up|1|||
156814391|NCT00861757|566070005|FG000|Overall Study|Physician Decision|0|||
156814392|NCT00861757|566070006|FG001|Overall Study|Physician Decision|0|||
156814393|NCT00861757|566070007|FG002|Overall Study|Physician Decision|0|||
156814394|NCT00861757|566070008|FG003|Overall Study|Physician Decision|1|||
156814395|NCT00861757|566070005|FG000|Overall Study|Protocol Violation|2|||
156814396|NCT00861757|566070006|FG001|Overall Study|Protocol Violation|2|||
156814397|NCT00861757|566070007|FG002|Overall Study|Protocol Violation|4|||
156814398|NCT00861757|566070008|FG003|Overall Study|Protocol Violation|1|||
156814399|NCT00861757|566070005|FG000|Overall Study|Withdrawal by Subject|1|||
156814400|NCT00861757|566070006|FG001|Overall Study|Withdrawal by Subject|5|||
156814401|NCT00861757|566070007|FG002|Overall Study|Withdrawal by Subject|5|||
156814402|NCT00861757|566070008|FG003|Overall Study|Withdrawal by Subject|2|||
156814403|NCT02141633|566070011|FG000|Overall Study|Physician Decision|1|||
156814404|NCT02141633|566070012|FG001|Overall Study|Physician Decision|0|||
156814405|NCT02403817|566070015|FG000|Overall Study|Withdrawal by Subject|5|||
156814406|NCT02403817|566070016|FG001|Overall Study|Withdrawal by Subject|0|||
156814407|NCT00391053|566070022|FG000|Overall Study|Serious Adverse Events|1|||
156814408|NCT00391053|566070023|FG001|Overall Study|Serious Adverse Events|0|||
156814409|NCT00391053|566070024|FG002|Overall Study|Serious Adverse Events|1|||
156814410|NCT00391053|566070025|FG003|Overall Study|Serious Adverse Events|4|||
156814411|NCT00391053|566070022|FG000|Overall Study|Protocol Violation|2|||
156464650|NCT04664881|564798714|FG001|Overall Study|Withdrawal by Subject|8|||
156464651|NCT04664881|564798713|FG000|Overall Study|Physician Decision|0|||
156464652|NCT04664881|564798714|FG001|Overall Study|Physician Decision|5|||
156814412|NCT00391053|566070023|FG001|Overall Study|Protocol Violation|0|||
156814413|NCT00391053|566070024|FG002|Overall Study|Protocol Violation|0|||
156814414|NCT00391053|566070025|FG003|Overall Study|Protocol Violation|0|||
156814415|NCT00391053|566070022|FG000|Overall Study|Lost to Follow-up|1|||
156814416|NCT00391053|566070023|FG001|Overall Study|Lost to Follow-up|0|||
156814417|NCT00391053|566070024|FG002|Overall Study|Lost to Follow-up|0|||
156814418|NCT00391053|566070025|FG003|Overall Study|Lost to Follow-up|5|||
156814419|NCT00391053|566070022|FG000|Overall Study|Withdrawal by Subject|5|||
156464653|NCT04664881|564798713|FG000|Overall Study|Lost to Follow-up|1|||
156814420|NCT00391053|566070023|FG001|Overall Study|Withdrawal by Subject|1|||
156814421|NCT00391053|566070024|FG002|Overall Study|Withdrawal by Subject|1|||
156814422|NCT00391053|566070025|FG003|Overall Study|Withdrawal by Subject|1|||
156814423|NCT00473889|566070027|FG000|Overall Study|Did not receive study medication|1|||
156814424|NCT00473889|566070028|FG001|Overall Study|Did not receive study medication|4|||
156814425|NCT00473889|566070027|FG000|Overall Study|Adverse Event|30|||
156814426|NCT00473889|566070028|FG001|Overall Study|Adverse Event|17|||
156814427|NCT00473889|566070027|FG000|Overall Study|Protocol Violation|4|||
156814428|NCT00473889|566070028|FG001|Overall Study|Protocol Violation|2|||
156814429|NCT00473889|566070027|FG000|Overall Study|Lack of Efficacy|28|||
156814430|NCT00473889|566070028|FG001|Overall Study|Lack of Efficacy|29|||
156814431|NCT00473889|566070027|FG000|Overall Study|Lost to Follow-up|2|||
156814432|NCT00473889|566070028|FG001|Overall Study|Lost to Follow-up|1|||
156814433|NCT00473889|566070027|FG000|Overall Study|Physician Decision|10|||
156814434|NCT00473889|566070028|FG001|Overall Study|Physician Decision|5|||
156814435|NCT00473889|566070027|FG000|Overall Study|Trial Terminated|3|||
156814436|NCT00473889|566070028|FG001|Overall Study|Trial Terminated|6|||
156814437|NCT00473889|566070027|FG000|Overall Study|Withdrawal by Subject|5|||
156814438|NCT00473889|566070028|FG001|Overall Study|Withdrawal by Subject|0|||
156814439|NCT02140970|566070029|FG000|Overall Study|Lost to Follow-up|1|||
156814440|NCT02140970|566070030|FG001|Overall Study|Lost to Follow-up|2|||
156814441|NCT02140970|566070029|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
156814442|NCT02140970|566070030|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
156814443|NCT02140970|566070029|FG000|Overall Study|Did not meet inclusion criteria|0|||
156814444|NCT02140970|566070030|FG001|Overall Study|Did not meet inclusion criteria|1|||
156814445|NCT01947283|566070034|FG000|Overall Study|Death|1|||
156814446|NCT01947283|566070035|FG001|Overall Study|Death|1|||
156814447|NCT01947283|566070036|FG002|Overall Study|Death|1|||
156814448|NCT01947283|566070037|FG003|Overall Study|Death|0|||
156814449|NCT01947283|566070038|FG004|Overall Study|Death|0|||
156814450|NCT01947283|566070039|FG005|Overall Study|Death|0|||
156814451|NCT01947283|566070040|FG006|Overall Study|Death|0|||
156814452|NCT01947283|566070034|FG000|Overall Study|Lost to Follow-up|4|||
156464654|NCT04664881|564798714|FG001|Overall Study|Lost to Follow-up|0|||
156464655|NCT04772534|564798723|FG000|Overall Study|Physician Decision|1|||
156464656|NCT04772534|564798724|FG001|Overall Study|Physician Decision|0|||
156464657|NCT04772534|564798725|FG002|Overall Study|Physician Decision|0|||
156464658|NCT04772534|564798723|FG000|Overall Study|Withdrawal by Subject|3|||
156464659|NCT04772534|564798724|FG001|Overall Study|Withdrawal by Subject|0|||
156464660|NCT04772534|564798725|FG002|Overall Study|Withdrawal by Subject|1|||
156464661|NCT04194450|564798726|FG000|Overall Study|not eligible|1|||
156464662|NCT04194450|564798727|FG001|Overall Study|not eligible|0|||
156464663|NCT05875701|564798734|FG000|Overall Study|Lost to Follow-up|2|||
156464664|NCT05875701|564798735|FG001|Overall Study|Lost to Follow-up|0|||
156464665|NCT05875701|564798734|FG000|Overall Study|Withdrawal by Subject|1|||
156464666|NCT05875701|564798735|FG001|Overall Study|Withdrawal by Subject|1|||
156464667|NCT00308997|564798743|FG000|Overall Study|Subject feigned clinical data|0|||
156464668|NCT00308997|564798744|FG001|Overall Study|Subject feigned clinical data|1|||
156464669|NCT00308997|564798743|FG000|Overall Study|Unable to tolerate intervention|1|||
156464670|NCT00308997|564798744|FG001|Overall Study|Unable to tolerate intervention|0|||
156464671|NCT04490356|564798746|FG000|Overall Study|Lost to Follow-up|1|||
156464672|NCT05836012|564798762|FG000|Overall Study|Lost to Follow-up|1|||
156464673|NCT05836012|564798763|FG001|Overall Study|Lost to Follow-up|0|||
156464674|NCT05836012|564798762|FG000|Overall Study|Withdrawal by Subject|1|||
156464675|NCT05836012|564798763|FG001|Overall Study|Withdrawal by Subject|3|||
156464676|NCT05836012|564798762|FG000|Overall Study|Reason not included in pre-specified categories|2|||
156464677|NCT05836012|564798763|FG001|Overall Study|Reason not included in pre-specified categories|1|||
156464678|NCT04093869|564798764|FG000|Overall Study|Death|0|||
156464679|NCT04093869|564798765|FG001|Overall Study|Death|1|||
156464680|NCT04093869|564798764|FG000|Overall Study|Withdrawal by Subject|1|||
156464681|NCT04093869|564798765|FG001|Overall Study|Withdrawal by Subject|0|||
156464682|NCT02806726|564798766|FG000|Overall Study|Lost to Follow-up|1|||
156464683|NCT05129501|564798767|FG000|Overall Study|Lost to Follow-up|54|||
156464684|NCT05129501|564798768|FG001|Overall Study|Lost to Follow-up|41|||
156464685|NCT03142009|564798771|FG000|Overall Study|Lost to Follow-up|45|||
156464686|NCT03142009|564798772|FG001|Overall Study|Lost to Follow-up|30|||
156464687|NCT01527188|564798773|FG000|Overall Study|Adverse Event|5|||
156464688|NCT01527188|564798774|FG001|Overall Study|Adverse Event|5|||
156464689|NCT01527188|564798775|FG002|Overall Study|Adverse Event|11|||
156464690|NCT01527188|564798776|FG003|Overall Study|Adverse Event|0|||
156464691|NCT01527188|564798773|FG000|Overall Study|Withdrawal by Subject|3|||
156464692|NCT01527188|564798774|FG001|Overall Study|Withdrawal by Subject|6|||
156464693|NCT01527188|564798775|FG002|Overall Study|Withdrawal by Subject|4|||
156464694|NCT01527188|564798776|FG003|Overall Study|Withdrawal by Subject|4|||
156464695|NCT01527188|564798773|FG000|Overall Study|Any other reason not above-mentioned|6|||
156464696|NCT01527188|564798774|FG001|Overall Study|Any other reason not above-mentioned|7|||
156464697|NCT01527188|564798775|FG002|Overall Study|Any other reason not above-mentioned|8|||
156464698|NCT01527188|564798776|FG003|Overall Study|Any other reason not above-mentioned|8|||
156814453|NCT01947283|566070035|FG001|Overall Study|Lost to Follow-up|6|||
156814454|NCT01947283|566070036|FG002|Overall Study|Lost to Follow-up|5|||
156814455|NCT01947283|566070037|FG003|Overall Study|Lost to Follow-up|5|||
156814456|NCT01947283|566070038|FG004|Overall Study|Lost to Follow-up|0|||
156814457|NCT01947283|566070039|FG005|Overall Study|Lost to Follow-up|2|||
156814458|NCT01947283|566070040|FG006|Overall Study|Lost to Follow-up|5|||
156814459|NCT01947283|566070034|FG000|Overall Study|Withdrawal by Subject|10|||
156814460|NCT01947283|566070035|FG001|Overall Study|Withdrawal by Subject|8|||
156814461|NCT01947283|566070036|FG002|Overall Study|Withdrawal by Subject|4|||
156464699|NCT00447980|564799392|FG000|Overall Study|Withdrawal by Subject|1|||
156464700|NCT00447980|564799393|FG001|Overall Study|Withdrawal by Subject|1|||
156814462|NCT01947283|566070037|FG003|Overall Study|Withdrawal by Subject|1|||
156814463|NCT01947283|566070038|FG004|Overall Study|Withdrawal by Subject|0|||
156814464|NCT01947283|566070039|FG005|Overall Study|Withdrawal by Subject|0|||
156814465|NCT01947283|566070040|FG006|Overall Study|Withdrawal by Subject|2|||
156814466|NCT01947283|566070034|FG000|Overall Study|No Clinical Recording|12|||
156814467|NCT01947283|566070035|FG001|Overall Study|No Clinical Recording|6|||
156814468|NCT01947283|566070036|FG002|Overall Study|No Clinical Recording|8|||
156814469|NCT01947283|566070037|FG003|Overall Study|No Clinical Recording|10|||
156814470|NCT01947283|566070038|FG004|Overall Study|No Clinical Recording|0|||
156814471|NCT01947283|566070039|FG005|Overall Study|No Clinical Recording|0|||
156814472|NCT01947283|566070040|FG006|Overall Study|No Clinical Recording|0|||
156814473|NCT01947283|566070034|FG000|Overall Study|Non-coding Clinical Recording language|0|||
156814474|NCT01947283|566070035|FG001|Overall Study|Non-coding Clinical Recording language|0|||
156814475|NCT01947283|566070036|FG002|Overall Study|Non-coding Clinical Recording language|0|||
156814476|NCT01947283|566070037|FG003|Overall Study|Non-coding Clinical Recording language|1|||
156814477|NCT01947283|566070038|FG004|Overall Study|Non-coding Clinical Recording language|0|||
156814478|NCT01947283|566070039|FG005|Overall Study|Non-coding Clinical Recording language|0|||
156814479|NCT01947283|566070040|FG006|Overall Study|Non-coding Clinical Recording language|0|||
156814480|NCT01947283|566070034|FG000|Overall Study|Missing Follow-up Assessment|2|||
156814481|NCT01947283|566070035|FG001|Overall Study|Missing Follow-up Assessment|2|||
156814482|NCT01947283|566070036|FG002|Overall Study|Missing Follow-up Assessment|3|||
156814483|NCT01947283|566070037|FG003|Overall Study|Missing Follow-up Assessment|0|||
156814484|NCT01947283|566070038|FG004|Overall Study|Missing Follow-up Assessment|0|||
156814485|NCT01947283|566070039|FG005|Overall Study|Missing Follow-up Assessment|2|||
156814486|NCT01947283|566070040|FG006|Overall Study|Missing Follow-up Assessment|0|||
156814487|NCT01947283|566070034|FG000|Overall Study|No patients were enrolled in study|0|||
156814488|NCT01947283|566070035|FG001|Overall Study|No patients were enrolled in study|0|||
156814489|NCT01947283|566070036|FG002|Overall Study|No patients were enrolled in study|0|||
156814490|NCT01947283|566070037|FG003|Overall Study|No patients were enrolled in study|0|||
156814491|NCT01947283|566070038|FG004|Overall Study|No patients were enrolled in study|0|||
156814492|NCT01947283|566070039|FG005|Overall Study|No patients were enrolled in study|3|||
156814493|NCT01947283|566070040|FG006|Overall Study|No patients were enrolled in study|1|||
156814494|NCT01498692|566070041|FG000|Overall Study|Death|4|||
156814495|NCT01498692|566070041|FG000|Overall Study|Withdrawal by Subject|1|||
156814496|NCT01498692|566070041|FG000|Overall Study|Missed 12-month visit|3|||
156814497|NCT04729972|566070042|FG000|Overall Study|Adverse Event|1|||
156814498|NCT00430989|566070043|FG000|Overall Study|Lost to Follow-up|2|||
156464701|NCT00447980|564799394|FG002|Overall Study|Withdrawal by Subject|4|||
156464702|NCT00447980|564799395|FG003|Overall Study|Withdrawal by Subject|4|||
156464703|NCT00447980|564799392|FG000|Overall Study|Lost to Follow-up|1|||
156464704|NCT00447980|564799393|FG001|Overall Study|Lost to Follow-up|1|||
156464705|NCT00447980|564799394|FG002|Overall Study|Lost to Follow-up|0|||
156464706|NCT00447980|564799395|FG003|Overall Study|Lost to Follow-up|0|||
156464707|NCT00447980|564799392|FG000|Overall Study|Did not proceed with surgery|3|||
156464708|NCT00447980|564799393|FG001|Overall Study|Did not proceed with surgery|3|||
156464709|NCT00447980|564799394|FG002|Overall Study|Did not proceed with surgery|2|||
156464710|NCT00447980|564799395|FG003|Overall Study|Did not proceed with surgery|2|||
156464711|NCT06408870|564799396|FG000|Washout period|Withdrawal by Subject|1|||
156464712|NCT06408870|564799397|FG001|Washout period|Withdrawal by Subject|0|||
156464713|NCT06408870|564799396|FG000|Washout period|Adverse Event|2|||
156464714|NCT06408870|564799397|FG001|Washout period|Adverse Event|0|||
156464715|NCT05162586|564799402|FG000|Overall Study|Other|0|||
156464716|NCT05162586|564799403|FG001|Overall Study|Other|0|||
156464717|NCT05162586|564799404|FG002|Overall Study|Other|0|||
156464718|NCT05162586|564799405|FG003|Overall Study|Other|0|||
156464719|NCT05162586|564799406|FG004|Overall Study|Other|1|||
156464720|NCT05162586|564799407|FG005|Overall Study|Other|0|||
156464721|NCT05162586|564799408|FG006|Overall Study|Other|2|||
156464722|NCT05162586|564799409|FG007|Overall Study|Other|2|||
156464723|NCT05162586|564799402|FG000|Overall Study|Lack of Efficacy|0|||
156464724|NCT05162586|564799403|FG001|Overall Study|Lack of Efficacy|0|||
156464725|NCT05162586|564799404|FG002|Overall Study|Lack of Efficacy|0|||
156464726|NCT05162586|564799405|FG003|Overall Study|Lack of Efficacy|0|||
156814499|NCT00430989|566070044|FG001|Overall Study|Lost to Follow-up|3|||
156814500|NCT00430989|566070043|FG000|Overall Study|Withdrawal by Subject|15|||
156814501|NCT00430989|566070044|FG001|Overall Study|Withdrawal by Subject|14|||
156814502|NCT00430989|566070043|FG000|Overall Study|Protocol Violation|30|||
156814503|NCT00430989|566070044|FG001|Overall Study|Protocol Violation|37|||
156814504|NCT00430989|566070043|FG000|Overall Study|Not eligible|13|||
156464727|NCT05162586|564799406|FG004|Overall Study|Lack of Efficacy|1|||
156464728|NCT05162586|564799407|FG005|Overall Study|Lack of Efficacy|0|||
156814505|NCT00430989|566070044|FG001|Overall Study|Not eligible|6|||
156814506|NCT03782259|566070045|FG000|Overall Study|Lost to Follow-up|1|||
156464729|NCT05162586|564799408|FG006|Overall Study|Lack of Efficacy|0|||
156464730|NCT05162586|564799409|FG007|Overall Study|Lack of Efficacy|1|||
156464731|NCT05162586|564799402|FG000|Overall Study|Lost to Follow-up|0|||
156814507|NCT03782259|566070046|FG001|Overall Study|Lost to Follow-up|1|||
156814508|NCT03782259|566070045|FG000|Overall Study|Moved out of state|0|||
156814509|NCT03782259|566070046|FG001|Overall Study|Moved out of state|2|||
156814510|NCT03782259|566070045|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
156814511|NCT03782259|566070046|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
156814512|NCT03782259|566070045|FG000|Overall Study|Subject discontinued intervention|1|||
156814513|NCT03782259|566070046|FG001|Overall Study|Subject discontinued intervention|0|||
156814514|NCT03050450|566070047|FG000|Overall Study|Physician Decision|1|||
156814515|NCT03050450|566070048|FG001|Overall Study|Physician Decision|0|||
156814516|NCT03050450|566070049|FG002|Overall Study|Physician Decision|0|||
156814517|NCT03050450|566070050|FG003|Overall Study|Physician Decision|0|||
156814518|NCT03050450|566070051|FG004|Overall Study|Physician Decision|0|||
156814519|NCT00590122|566070052|FG000|Overall Study|swallowed oral dissolving dose|1|||
156814520|NCT00590122|566070053|FG001|Overall Study|swallowed oral dissolving dose|0|||
156814521|NCT00603941|566070057|FG000|Overall Study|Disease progression|6|||
156814522|NCT00603941|566070058|FG001|Overall Study|Disease progression|7|||
156814523|NCT00603941|566070059|FG002|Overall Study|Disease progression|1|||
156814524|NCT00603941|566070057|FG000|Overall Study|Adverse Event|1|||
156814525|NCT00603941|566070058|FG001|Overall Study|Adverse Event|0|||
156814526|NCT00603941|566070059|FG002|Overall Study|Adverse Event|1|||
156814527|NCT00603941|566070057|FG000|Overall Study|Physician Decision|0|||
156814528|NCT00603941|566070058|FG001|Overall Study|Physician Decision|1|||
156338974|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
156338975|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Change of location|0|||
156814529|NCT00603941|566070059|FG002|Overall Study|Physician Decision|0|||
156814530|NCT00603941|566070057|FG000|Overall Study|Withdrawal by Subject|0|||
156814531|NCT00603941|566070058|FG001|Overall Study|Withdrawal by Subject|2|||
156814532|NCT00603941|566070059|FG002|Overall Study|Withdrawal by Subject|0|||
156814533|NCT03592771|566070060|FG000|Overall Study|Adverse Event|2|||
156814534|NCT03592771|566070061|FG001|Overall Study|Adverse Event|0|||
156814535|NCT03592771|566070062|FG002|Overall Study|Adverse Event|1|||
156464732|NCT05162586|564799403|FG001|Overall Study|Lost to Follow-up|0|||
156464733|NCT05162586|564799404|FG002|Overall Study|Lost to Follow-up|0|||
156464734|NCT05162586|564799405|FG003|Overall Study|Lost to Follow-up|0|||
156464735|NCT05162586|564799406|FG004|Overall Study|Lost to Follow-up|2|||
156464736|NCT05162586|564799407|FG005|Overall Study|Lost to Follow-up|0|||
156464737|NCT05162586|564799408|FG006|Overall Study|Lost to Follow-up|0|||
156464738|NCT05162586|564799409|FG007|Overall Study|Lost to Follow-up|2|||
156464739|NCT05162586|564799402|FG000|Overall Study|Non-Compliance|0|||
156464740|NCT05162586|564799403|FG001|Overall Study|Non-Compliance|1|||
156464741|NCT05162586|564799404|FG002|Overall Study|Non-Compliance|0|||
156464742|NCT05162586|564799405|FG003|Overall Study|Non-Compliance|0|||
156464743|NCT05162586|564799406|FG004|Overall Study|Non-Compliance|1|||
156464744|NCT05162586|564799407|FG005|Overall Study|Non-Compliance|0|||
156464745|NCT05162586|564799408|FG006|Overall Study|Non-Compliance|0|||
156464746|NCT05162586|564799409|FG007|Overall Study|Non-Compliance|1|||
156464747|NCT05162586|564799402|FG000|Overall Study|Withdrawal by Subject|2|||
156464748|NCT05162586|564799403|FG001|Overall Study|Withdrawal by Subject|0|||
156464749|NCT05162586|564799404|FG002|Overall Study|Withdrawal by Subject|0|||
156464750|NCT05162586|564799405|FG003|Overall Study|Withdrawal by Subject|0|||
156464751|NCT05162586|564799406|FG004|Overall Study|Withdrawal by Subject|7|||
156464752|NCT05162586|564799407|FG005|Overall Study|Withdrawal by Subject|6|||
156464753|NCT05162586|564799408|FG006|Overall Study|Withdrawal by Subject|2|||
156464754|NCT05162586|564799409|FG007|Overall Study|Withdrawal by Subject|2|||
156464755|NCT05162586|564799402|FG000|Overall Study|Adverse Event|2|||
156464756|NCT05162586|564799403|FG001|Overall Study|Adverse Event|0|||
156464757|NCT05162586|564799404|FG002|Overall Study|Adverse Event|1|||
156464758|NCT05162586|564799405|FG003|Overall Study|Adverse Event|2|||
156464759|NCT05162586|564799406|FG004|Overall Study|Adverse Event|4|||
156814536|NCT03592771|566070060|FG000|Overall Study|Death|0|||
156814537|NCT03592771|566070061|FG001|Overall Study|Death|1|||
156464760|NCT05162586|564799407|FG005|Overall Study|Adverse Event|1|||
156814538|NCT03592771|566070062|FG002|Overall Study|Death|1|||
156814539|NCT03592771|566070060|FG000|Overall Study|Lost to Follow-up|5|||
156814540|NCT03592771|566070061|FG001|Overall Study|Lost to Follow-up|11|||
156814541|NCT03592771|566070062|FG002|Overall Study|Lost to Follow-up|15|||
156814542|NCT03592771|566070060|FG000|Overall Study|Withdrawal by Subject|0|||
156814543|NCT03592771|566070061|FG001|Overall Study|Withdrawal by Subject|2|||
156338976|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Change of location|0|||
156464761|NCT05162586|564799408|FG006|Overall Study|Adverse Event|5|||
156464762|NCT05162586|564799409|FG007|Overall Study|Adverse Event|2|||
156464763|NCT02656706|564799411|FG000|Overall Study|Insurance Denial|1|||
156464764|NCT04675034|564799414|FG000|Overall Study|Lost to Follow-up|1|||
156464765|NCT04675034|564799415|FG001|Overall Study|Lost to Follow-up|1|||
156464766|NCT04675034|564799416|FG002|Overall Study|Lost to Follow-up|0|||
156814544|NCT03592771|566070062|FG002|Overall Study|Withdrawal by Subject|0|||
156814545|NCT01642901|566070063|FG000|12-month Follow-up|Withdrawal by Subject|1|||
156814546|NCT01642901|566070064|FG001|12-month Follow-up|Withdrawal by Subject|0|||
156539403|NCT01131676|565069712|FG001|Discontinuation From Treatment|Other than those specified|142|||
156539404|NCT01131676|565069713|FG002|Discontinuation From Treatment|Other than those specified|125|||
156539405|NCT01131676|565069711|FG000|Discontinuation From Treatment|Adverse Event|303|||
156539406|NCT01131676|565069712|FG001|Discontinuation From Treatment|Adverse Event|267|||
156539407|NCT01131676|565069713|FG002|Discontinuation From Treatment|Adverse Event|273|||
156539408|NCT01131676|565069711|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
156539409|NCT01131676|565069712|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
156539410|NCT01131676|565069713|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
156539411|NCT01131676|565069711|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
156539412|NCT01131676|565069712|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
156539413|NCT01131676|565069713|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
156539414|NCT01131676|565069711|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
156539415|NCT01131676|565069712|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
156539416|NCT01131676|565069713|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
156539417|NCT01131676|565069711|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
156539418|NCT01131676|565069712|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
156539419|NCT01131676|565069713|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
156539420|NCT01131676|565069711|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
156539421|NCT01131676|565069712|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
156539422|NCT01131676|565069713|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
156539423|NCT01131676|565069711|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
156539424|NCT01131676|565069712|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
156539425|NCT01131676|565069713|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
156539426|NCT04109222|565069714|FG000|Overall Study|Adverse Event|1|||
156539427|NCT04109222|565069715|FG001|Overall Study|Adverse Event|0|||
156539428|NCT04109222|565069716|FG002|Overall Study|Adverse Event|0|||
156539429|NCT02577406|565069717|FG000|Randomized Period|Death|1|||
156539430|NCT02577406|565069718|FG001|Randomized Period|Death|0|||
156539431|NCT02577406|565069717|FG000|Randomized Period|Other reasons|0|||
156539432|NCT02577406|565069718|FG001|Randomized Period|Other reasons|20|||
156539433|NCT02577406|565069717|FG000|Treatment Period|Death|38|||
156539434|NCT02577406|565069718|FG001|Treatment Period|Death|23|||
156539435|NCT02577406|565069717|FG000|Treatment Period|Adverse Event|17|||
156539436|NCT02577406|565069718|FG001|Treatment Period|Adverse Event|12|||
156539437|NCT02577406|565069717|FG000|Treatment Period|Progressive Disease|53|||
156539438|NCT02577406|565069718|FG001|Treatment Period|Progressive Disease|37|||
156539439|NCT02577406|565069717|FG000|Treatment Period|Withdrawal by Subject|10|||
156539440|NCT02577406|565069718|FG001|Treatment Period|Withdrawal by Subject|24|||
156814547|NCT00249808|566070067|FG000|Overall Study|Other|27|||
156814548|NCT00249808|566070067|FG000|Overall Study|Protocol Violation|3|||
156814549|NCT00249808|566070067|FG000|Overall Study|Lost to Follow-up|8|||
156814550|NCT00249808|566070067|FG000|Overall Study|Adverse Event|81|||
156814551|NCT00249808|566070067|FG000|Overall Study|Lack of Efficacy|52|||
156814552|NCT00249808|566070067|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
156814553|NCT00711594|566070068|FG000|Overall Study|Progressive disease|2|||
156814554|NCT00711594|566070069|FG001|Overall Study|Progressive disease|2|||
156814555|NCT00711594|566070070|FG002|Overall Study|Progressive disease|6|||
156814556|NCT00711594|566070071|FG003|Overall Study|Progressive disease|44|||
156814557|NCT00711594|566070068|FG000|Overall Study|Other Adverse Event|1|||
156814558|NCT00711594|566070069|FG001|Overall Study|Other Adverse Event|0|||
156814559|NCT00711594|566070070|FG002|Overall Study|Other Adverse Event|0|||
156814560|NCT00711594|566070071|FG003|Overall Study|Other Adverse Event|16|||
156814561|NCT00711594|566070068|FG000|Overall Study|Withdrawal by Subject|0|||
156814562|NCT00711594|566070069|FG001|Overall Study|Withdrawal by Subject|1|||
156814563|NCT00711594|566070070|FG002|Overall Study|Withdrawal by Subject|0|||
156814564|NCT00711594|566070071|FG003|Overall Study|Withdrawal by Subject|2|||
156814565|NCT00984165|566070078|FG000|Overall Study|Death on study|2|||
156814566|NCT00984165|566070079|FG001|Overall Study|Death on study|0|||
156814567|NCT00984165|566070080|FG002|Overall Study|Death on study|0|||
156814568|NCT00984165|566070081|FG003|Overall Study|Death on study|0|||
156814569|NCT00984165|566070078|FG000|Overall Study|Disease progression on study|5|||
156814570|NCT00984165|566070079|FG001|Overall Study|Disease progression on study|1|||
156539441|NCT02577406|565069717|FG000|Treatment Period|Lost to Follow-up|0|||
156539442|NCT02577406|565069718|FG001|Treatment Period|Lost to Follow-up|1|||
156814571|NCT00984165|566070080|FG002|Overall Study|Disease progression on study|0|||
156814572|NCT00984165|566070081|FG003|Overall Study|Disease progression on study|0|||
156814573|NCT00984165|566070078|FG000|Overall Study|Death of recipient|0|||
156814574|NCT00984165|566070079|FG001|Overall Study|Death of recipient|0|||
156814575|NCT00984165|566070080|FG002|Overall Study|Death of recipient|0|||
156814576|NCT00984165|566070081|FG003|Overall Study|Death of recipient|1|||
156539443|NCT02577406|565069717|FG000|Treatment Period|Transition to commercially available treatment|1|||
156539444|NCT02577406|565069718|FG001|Treatment Period|Transition to commercially available treatment|1|||
156539445|NCT02577406|565069717|FG000|Treatment Period|Physician Decision|1|||
156539446|NCT02577406|565069718|FG001|Treatment Period|Physician Decision|0|||
156539447|NCT02577406|565069717|FG000|Treatment Period|Disease Relapse|28|||
156539448|NCT02577406|565069718|FG001|Treatment Period|Disease Relapse|1|||
156539449|NCT02577406|565069717|FG000|Treatment Period|Protocol Violation|0|||
156539450|NCT02577406|565069718|FG001|Treatment Period|Protocol Violation|1|||
156539451|NCT02577406|565069717|FG000|Treatment Period|Other Reasons|3|||
156539452|NCT02577406|565069718|FG001|Treatment Period|Other Reasons|39|||
156539453|NCT02577406|565069717|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
156539454|NCT02577406|565069718|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
156539455|NCT02138617|565069719|FG000|Overall Study|Death|1|||
156539456|NCT02138617|565069720|FG001|Overall Study|Death|2|||
156539457|NCT02138617|565069721|FG002|Overall Study|Death|2|||
156539458|NCT02138617|565069719|FG000|Overall Study|Adverse Event|8|||
156539459|NCT02138617|565069720|FG001|Overall Study|Adverse Event|5|||
156539460|NCT02138617|565069721|FG002|Overall Study|Adverse Event|2|||
156539461|NCT02138617|565069719|FG000|Overall Study|Disease Progression|20|||
156539462|NCT02138617|565069720|FG001|Overall Study|Disease Progression|13|||
156539463|NCT02138617|565069721|FG002|Overall Study|Disease Progression|4|||
156539464|NCT02138617|565069719|FG000|Overall Study|Withdrawal by Subject|7|||
156539465|NCT02138617|565069720|FG001|Overall Study|Withdrawal by Subject|10|||
156539466|NCT02138617|565069721|FG002|Overall Study|Withdrawal by Subject|2|||
156539467|NCT02138617|565069719|FG000|Overall Study|other complicating disease|0|||
156539468|NCT02138617|565069720|FG001|Overall Study|other complicating disease|2|||
156539469|NCT02138617|565069721|FG002|Overall Study|other complicating disease|0|||
156539470|NCT02138617|565069719|FG000|Overall Study|Protocol Violation|1|||
156539471|NCT02138617|565069720|FG001|Overall Study|Protocol Violation|0|||
156539472|NCT02138617|565069721|FG002|Overall Study|Protocol Violation|0|||
156814577|NCT00984165|566070078|FG000|Overall Study|New protocol|0|||
156814578|NCT00984165|566070079|FG001|Overall Study|New protocol|0|||
156814579|NCT00984165|566070080|FG002|Overall Study|New protocol|0|||
156814580|NCT00984165|566070081|FG003|Overall Study|New protocol|1|||
156814581|NCT00984165|566070078|FG000|Overall Study|P+/donor pair removed from protocol|0|||
156814582|NCT00984165|566070079|FG001|Overall Study|P+/donor pair removed from protocol|0|||
156814583|NCT00984165|566070080|FG002|Overall Study|P+/donor pair removed from protocol|0|||
156814584|NCT00984165|566070081|FG003|Overall Study|P+/donor pair removed from protocol|1|||
156814585|NCT00984165|566070078|FG000|Overall Study|removed with a pair recipient|0|||
156814586|NCT00984165|566070079|FG001|Overall Study|removed with a pair recipient|0|||
156814587|NCT00984165|566070080|FG002|Overall Study|removed with a pair recipient|0|||
156814588|NCT00984165|566070081|FG003|Overall Study|removed with a pair recipient|1|||
156814589|NCT00700622|566070083|FG000|Overall Study|Adverse Event|4|||
156814590|NCT00700622|566070084|FG001|Overall Study|Adverse Event|0|||
156814591|NCT00700622|566070083|FG000|Overall Study|Lost to Follow-up|0|||
156814592|NCT00700622|566070084|FG001|Overall Study|Lost to Follow-up|1|||
156814593|NCT00700622|566070083|FG000|Overall Study|Physician Decision|2|||
156814594|NCT00700622|566070084|FG001|Overall Study|Physician Decision|1|||
156814595|NCT00700622|566070083|FG000|Overall Study|Protocol Violation|0|||
156814596|NCT00700622|566070084|FG001|Overall Study|Protocol Violation|1|||
156814597|NCT00700622|566070083|FG000|Overall Study|Withdrawal by Subject|4|||
156814598|NCT00700622|566070084|FG001|Overall Study|Withdrawal by Subject|1|||
156814599|NCT00700622|566070083|FG000|Overall Study|Other|3|||
156814600|NCT00700622|566070084|FG001|Overall Study|Other|1|||
156814601|NCT01309997|566070085|FG000|Overall Study|Adverse Event|1|||
156814602|NCT01309997|566070086|FG001|Overall Study|Adverse Event|0|||
156814603|NCT01309997|566070085|FG000|Overall Study|Death|1|||
156814604|NCT01309997|566070086|FG001|Overall Study|Death|3|||
156814605|NCT01309997|566070085|FG000|Overall Study|Lack of Efficacy|2|||
156814606|NCT01309997|566070086|FG001|Overall Study|Lack of Efficacy|2|||
156814607|NCT01309997|566070085|FG000|Overall Study|Withdrawal by Subject|1|||
156814608|NCT01309997|566070086|FG001|Overall Study|Withdrawal by Subject|1|||
156814609|NCT00282087|566070087|FG000|Overall Study|Death|1|||
156539473|NCT02138617|565069719|FG000|Overall Study|Physician Decision|7|||
156814610|NCT00405392|566070090|FG000|Overall Study|Adverse Event|15|||
156814611|NCT00405392|566070091|FG001|Overall Study|Adverse Event|14|||
156814612|NCT00405392|566070090|FG000|Overall Study|Did not meet Eligibility criteria|7|||
156539474|NCT02138617|565069720|FG001|Overall Study|Physician Decision|6|||
156539475|NCT02138617|565069721|FG002|Overall Study|Physician Decision|0|||
156539476|NCT02138617|565069719|FG000|Overall Study|financial reason|0|||
156539477|NCT02138617|565069720|FG001|Overall Study|financial reason|1|||
156539478|NCT02138617|565069721|FG002|Overall Study|financial reason|0|||
156539479|NCT02138617|565069719|FG000|Overall Study|other therapy|3|||
156814613|NCT00405392|566070091|FG001|Overall Study|Did not meet Eligibility criteria|2|||
156814614|NCT00405392|566070090|FG000|Overall Study|Withdrawal by Subject|4|||
156814615|NCT00405392|566070091|FG001|Overall Study|Withdrawal by Subject|3|||
156814616|NCT00405392|566070090|FG000|Overall Study|Lost to Follow-up|1|||
156814617|NCT00405392|566070091|FG001|Overall Study|Lost to Follow-up|2|||
156814618|NCT00405392|566070090|FG000|Overall Study|Data missing|2|||
156814619|NCT00405392|566070091|FG001|Overall Study|Data missing|0|||
156814620|NCT00405392|566070090|FG000|Overall Study|Non-compliance|0|||
156814621|NCT00405392|566070091|FG001|Overall Study|Non-compliance|1|||
156814622|NCT00405392|566070090|FG000|Overall Study|Other|1|||
156814623|NCT00405392|566070091|FG001|Overall Study|Other|5|||
156814624|NCT03012828|566070092|FG000|Overall Study|Lost to Follow-up|1|||
156814625|NCT03012828|566070093|FG001|Overall Study|Lost to Follow-up|0|||
156814626|NCT03012828|566070094|FG002|Overall Study|Lost to Follow-up|1|||
156814627|NCT03012828|566070095|FG003|Overall Study|Lost to Follow-up|0|||
156814628|NCT03012828|566070096|FG004|Overall Study|Lost to Follow-up|1|||
156814629|NCT03012828|566070097|FG005|Overall Study|Lost to Follow-up|0|||
156814630|NCT03012828|566070092|FG000|Overall Study|Withdrawal by Subject|0|||
156814631|NCT03012828|566070093|FG001|Overall Study|Withdrawal by Subject|0|||
156814632|NCT03012828|566070094|FG002|Overall Study|Withdrawal by Subject|1|||
156814633|NCT03012828|566070095|FG003|Overall Study|Withdrawal by Subject|0|||
156814634|NCT03012828|566070096|FG004|Overall Study|Withdrawal by Subject|0|||
156814635|NCT03012828|566070097|FG005|Overall Study|Withdrawal by Subject|1|||
156814636|NCT03012828|566070092|FG000|Overall Study|Non-compliance with protocol|0|||
156464767|NCT04675034|564799417|FG003|Overall Study|Lost to Follow-up|2|||
156464768|NCT04675034|564799418|FG004|Overall Study|Lost to Follow-up|0|||
156464769|NCT04675034|564799414|FG000|Overall Study|Protocol Violation|1|||
156464770|NCT04675034|564799415|FG001|Overall Study|Protocol Violation|0|||
156464771|NCT04675034|564799416|FG002|Overall Study|Protocol Violation|0|||
156814637|NCT03012828|566070093|FG001|Overall Study|Non-compliance with protocol|0|||
156814638|NCT03012828|566070094|FG002|Overall Study|Non-compliance with protocol|0|||
156814639|NCT03012828|566070095|FG003|Overall Study|Non-compliance with protocol|0|||
156814640|NCT03012828|566070096|FG004|Overall Study|Non-compliance with protocol|1|||
156814641|NCT03012828|566070097|FG005|Overall Study|Non-compliance with protocol|0|||
156814642|NCT03012828|566070092|FG000|Overall Study|Delay to last visit would delay DBL|0|||
156814643|NCT03012828|566070093|FG001|Overall Study|Delay to last visit would delay DBL|0|||
156814644|NCT03012828|566070094|FG002|Overall Study|Delay to last visit would delay DBL|0|||
156814645|NCT03012828|566070095|FG003|Overall Study|Delay to last visit would delay DBL|0|||
156814646|NCT03012828|566070096|FG004|Overall Study|Delay to last visit would delay DBL|0|||
156814647|NCT03012828|566070097|FG005|Overall Study|Delay to last visit would delay DBL|1|||
156814648|NCT02520388|566070101|FG000|Overall Study|Physician Decision|1|||
156814649|NCT02520388|566070102|FG001|Overall Study|Physician Decision|0|||
156464772|NCT04675034|564799417|FG003|Overall Study|Protocol Violation|1|||
156814650|NCT02520388|566070101|FG000|Overall Study|Subject or parent/guardian request|0|||
156814651|NCT02520388|566070102|FG001|Overall Study|Subject or parent/guardian request|6|||
156814652|NCT02520388|566070101|FG000|Overall Study|Adverse Event|1|||
156814653|NCT02520388|566070102|FG001|Overall Study|Adverse Event|4|||
156464773|NCT04675034|564799418|FG004|Overall Study|Protocol Violation|3|||
156464774|NCT04675034|564799414|FG000|Overall Study|Withdrawal by Subject|9|||
156464775|NCT04675034|564799415|FG001|Overall Study|Withdrawal by Subject|3|||
156814654|NCT02520388|566070101|FG000|Overall Study|Lost to Follow-up|3|||
156814655|NCT02520388|566070102|FG001|Overall Study|Lost to Follow-up|2|||
156814656|NCT02520388|566070101|FG000|Overall Study|Other (reason not defined)|4|||
156814657|NCT02520388|566070102|FG001|Overall Study|Other (reason not defined)|4|||
156464776|NCT04675034|564799416|FG002|Overall Study|Withdrawal by Subject|4|||
156464777|NCT04675034|564799417|FG003|Overall Study|Withdrawal by Subject|8|||
156464778|NCT04675034|564799418|FG004|Overall Study|Withdrawal by Subject|6|||
156464779|NCT03201939|564799419|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
156464780|NCT03201939|564799420|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
156464781|NCT04281498|564799429|FG000|Overall Study|Progression of disease|1|||
156464782|NCT04281498|564799429|FG000|Overall Study|Planned SCT|1|||
156464783|NCT04281498|564799429|FG000|Overall Study|Alternative Treatment|1|||
156464784|NCT03587805|564799430|FG000|Overall Study|Adverse Event|72|||
156464785|NCT03587805|564799430|FG000|Overall Study|Death|1|||
156464786|NCT03587805|564799430|FG000|Overall Study|Lost to Follow-up|78|||
156464787|NCT03587805|564799430|FG000|Overall Study|Withdrawal by Subject|105|||
156464788|NCT03587805|564799430|FG000|Overall Study|Lack of Efficacy|119|||
156464789|NCT03587805|564799430|FG000|Overall Study|Reason unknown|26|||
156464790|NCT03587805|564799430|FG000|Overall Study|COVID_19 pandemic|4|||
156464791|NCT03587805|564799430|FG000|Overall Study|Various reasons|121|||
156464792|NCT03587805|564799430|FG000|Overall Study|Withdrawal by parent/guardian|3|||
156464793|NCT01553149|564799431|FG000|Overall Study|Adverse Event|0|||
156464794|NCT01553149|564799432|FG001|Overall Study|Adverse Event|9|||
156464795|NCT01553149|564799431|FG000|Overall Study|Physician Decision|5|||
156464796|NCT01553149|564799432|FG001|Overall Study|Physician Decision|10|||
156464797|NCT01553149|564799431|FG000|Overall Study|Ineligible|0|||
156464798|NCT01553149|564799432|FG001|Overall Study|Ineligible|1|||
156464799|NCT03008382|564799433|FG000|Overall Study|Withdrawal by Subject|2|||
156814658|NCT02342288|566070103|FG000|Overall Study|no protocol anesthesiologist available|3|||
156814659|NCT02342288|566070104|FG001|Overall Study|no protocol anesthesiologist available|2|||
156814660|NCT02342288|566070103|FG000|Overall Study|anesthesia leak in system|1|||
156814661|NCT02342288|566070104|FG001|Overall Study|anesthesia leak in system|0|||
156814662|NCT02342288|566070103|FG000|Overall Study|Withdrawal by Subject|1|||
156814663|NCT02342288|566070104|FG001|Overall Study|Withdrawal by Subject|0|||
156814664|NCT02342288|566070103|FG000|Overall Study|coordinator contaminated with blood|0|||
156814665|NCT02342288|566070104|FG001|Overall Study|coordinator contaminated with blood|1|||
156814666|NCT02342288|566070103|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
156814667|NCT02342288|566070104|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
156814668|NCT02342288|566070103|FG000|Overall Study|coordinator not available|0|||
156814669|NCT02342288|566070104|FG001|Overall Study|coordinator not available|2|||
156814670|NCT03037476|566071302|FG000|Overall Study|Lost to Follow-up|63|||
156814671|NCT03037476|566071303|FG001|Overall Study|Lost to Follow-up|46|||
156814672|NCT04908384|566071306|FG000|Overall Study|Lost to Follow-up|4|||
156814673|NCT04908384|566071307|FG001|Overall Study|Lost to Follow-up|4|||
156814674|NCT04908384|566071308|FG002|Overall Study|Lost to Follow-up|0|||
156814675|NCT04908384|566071309|FG003|Overall Study|Lost to Follow-up|0|||
156814676|NCT00833469|566071310|FG000|Overall Study|Withdrawal by Subject|1|||
156814677|NCT00833469|566071310|FG000|Overall Study|Lost to Follow-up|1|||
156814678|NCT01208324|566071311|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
156814679|NCT01208324|566071312|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
156814680|NCT01208324|566071313|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
156814681|NCT01208324|566071314|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
156814682|NCT02943070|566071315|FG000|Overall Study|Physician Decision|1|||
156814683|NCT02943070|566071315|FG000|Overall Study|Adverse Event|2|||
156814684|NCT02943070|566071315|FG000|Overall Study|Death|2|||
156814685|NCT02943070|566071315|FG000|Overall Study|Withdrawal by Subject|3|||
156814686|NCT02943070|566071315|FG000|Overall Study|Lost to Follow-up|4|||
156814687|NCT02943070|566071315|FG000|Overall Study|Retreatment or TURP|13|||
156814688|NCT02943070|566071315|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
156814689|NCT01701362|566071316|FG000|Overall Study|Adverse events not related to study drug|1|||
156814690|NCT01701362|566071317|FG001|Overall Study|Adverse events not related to study drug|6|||
156814691|NCT01701362|566071316|FG000|Overall Study|Adverse events related to study drug|12|||
156814692|NCT01701362|566071317|FG001|Overall Study|Adverse events related to study drug|10|||
156814693|NCT01701362|566071316|FG000|Overall Study|Protocol Violation|5|||
156814694|NCT01701362|566071317|FG001|Overall Study|Protocol Violation|3|||
156814695|NCT01701362|566071316|FG000|Overall Study|No longer willing to participate|8|||
156814696|NCT01701362|566071317|FG001|Overall Study|No longer willing to participate|14|||
156814697|NCT01701362|566071316|FG000|Overall Study|Lost to Follow-up|6|||
156814698|NCT01701362|566071317|FG001|Overall Study|Lost to Follow-up|9|||
156814699|NCT01701362|566071316|FG000|Overall Study|Insufficient clinical response|6|||
156814700|NCT01701362|566071317|FG001|Overall Study|Insufficient clinical response|6|||
156814701|NCT01701362|566071316|FG000|Overall Study|Death|0|||
156814702|NCT01701362|566071317|FG001|Overall Study|Death|1|||
156814703|NCT01701362|566071316|FG000|Overall Study|Randomized but not treated|1|||
156814704|NCT01701362|566071317|FG001|Overall Study|Randomized but not treated|2|||
156814705|NCT01701362|566071316|FG000|Overall Study|Reasons other than those mentioned above|3|||
156814706|NCT01701362|566071317|FG001|Overall Study|Reasons other than those mentioned above|5|||
156464800|NCT03008382|564799434|FG001|Overall Study|Withdrawal by Subject|5|||
156464801|NCT03008382|564799435|FG002|Overall Study|Withdrawal by Subject|2|||
156464802|NCT03008382|564799436|FG003|Overall Study|Withdrawal by Subject|0|||
156464803|NCT03008382|564799433|FG000|Overall Study|Protocol Violation|1|||
156464804|NCT03008382|564799434|FG001|Overall Study|Protocol Violation|0|||
156464805|NCT03008382|564799435|FG002|Overall Study|Protocol Violation|0|||
156464806|NCT03008382|564799436|FG003|Overall Study|Protocol Violation|0|||
156464807|NCT03008382|564799433|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
156464808|NCT03008382|564799434|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
156464809|NCT03008382|564799435|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
156464810|NCT03008382|564799436|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
156464811|NCT03008382|564799433|FG000|Overall Study|Lost to Follow-up|0|||
156464812|NCT03008382|564799434|FG001|Overall Study|Lost to Follow-up|0|||
156464813|NCT03008382|564799435|FG002|Overall Study|Lost to Follow-up|1|||
156464814|NCT03008382|564799436|FG003|Overall Study|Lost to Follow-up|0|||
156464815|NCT03008382|564799433|FG000|Overall Study|Screenfail|0|||
156464816|NCT03008382|564799434|FG001|Overall Study|Screenfail|0|||
156464817|NCT03008382|564799435|FG002|Overall Study|Screenfail|2|||
156814707|NCT00570778|566071318|FG000|Overall Study|Protocol deviation|2|||
156814708|NCT00570778|566071319|FG001|Overall Study|Protocol deviation|1|||
156814709|NCT00570778|566071320|FG002|Overall Study|Protocol deviation|2|||
156814710|NCT00570778|566071321|FG003|Overall Study|Protocol deviation|2|||
156464818|NCT03008382|564799436|FG003|Overall Study|Screenfail|0|||
156464819|NCT05267639|564800110|FG000|Overall Study|Withdrawal by Subject|1|||
156814711|NCT00570778|566071318|FG000|Overall Study|Adverse Event|0|||
156814712|NCT00570778|566071319|FG001|Overall Study|Adverse Event|1|||
156464820|NCT05267639|564800111|FG001|Overall Study|Withdrawal by Subject|0|||
156464821|NCT04732871|564800112|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
156814713|NCT00570778|566071320|FG002|Overall Study|Adverse Event|4|||
156814714|NCT00570778|566071321|FG003|Overall Study|Adverse Event|1|||
156814715|NCT00570778|566071318|FG000|Overall Study|Subject withdrew consent|0|||
156814716|NCT00570778|566071319|FG001|Overall Study|Subject withdrew consent|1|||
156814717|NCT00570778|566071320|FG002|Overall Study|Subject withdrew consent|0|||
156814718|NCT00570778|566071321|FG003|Overall Study|Subject withdrew consent|1|||
156814719|NCT00570778|566071318|FG000|Overall Study|Abnormal test procedure|1|||
156814720|NCT00570778|566071319|FG001|Overall Study|Abnormal test procedure|0|||
156814721|NCT00570778|566071320|FG002|Overall Study|Abnormal test procedure|0|||
156814722|NCT00570778|566071321|FG003|Overall Study|Abnormal test procedure|0|||
156814723|NCT00570778|566071318|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156814724|NCT00570778|566071319|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156814725|NCT00570778|566071320|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156814726|NCT00570778|566071321|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156814727|NCT00570778|566071318|FG000|Overall Study|Lost to Follow-up|0|||
156814728|NCT00570778|566071319|FG001|Overall Study|Lost to Follow-up|0|||
156814729|NCT00570778|566071320|FG002|Overall Study|Lost to Follow-up|1|||
156814730|NCT00570778|566071321|FG003|Overall Study|Lost to Follow-up|0|||
156814731|NCT00570778|566071318|FG000|Overall Study|Subject no longer requires study drug|0|||
156814732|NCT00570778|566071319|FG001|Overall Study|Subject no longer requires study drug|1|||
156814733|NCT00570778|566071320|FG002|Overall Study|Subject no longer requires study drug|0|||
156814734|NCT00570778|566071321|FG003|Overall Study|Subject no longer requires study drug|0|||
156814735|NCT00443872|566071322|FG000|Overall Study|Protocol Violation|7|||
156814736|NCT00443872|566071322|FG000|Overall Study|Lost to Follow-up|2|||
156814737|NCT00443872|566071322|FG000|Overall Study|Adverse Event|8|||
156814738|NCT02789345|566071323|FG000|Overall Study|Adverse Event|0|||
156814739|NCT02789345|566071324|FG001|Overall Study|Adverse Event|0|||
156814740|NCT02789345|566071325|FG002|Overall Study|Adverse Event|1|||
156814741|NCT02789345|566071323|FG000|Overall Study|Death|0|||
156814742|NCT02789345|566071324|FG001|Overall Study|Death|0|||
156814743|NCT02789345|566071325|FG002|Overall Study|Death|1|||
156814744|NCT02789345|566071323|FG000|Overall Study|Physician Decision|2|||
156814745|NCT02789345|566071324|FG001|Overall Study|Physician Decision|0|||
156814746|NCT02789345|566071325|FG002|Overall Study|Physician Decision|1|||
156814747|NCT02789345|566071323|FG000|Overall Study|Progressive Disease|1|||
156814748|NCT02789345|566071324|FG001|Overall Study|Progressive Disease|3|||
156814749|NCT02789345|566071325|FG002|Overall Study|Progressive Disease|14|||
156814750|NCT00441142|566071343|FG000|Overall Study|Adverse Event|2|||
156814751|NCT00441142|566071344|FG001|Overall Study|Adverse Event|3|||
156814752|NCT00441142|566071345|FG002|Overall Study|Adverse Event|3|||
156814753|NCT00441142|566071346|FG003|Overall Study|Adverse Event|22|||
156814754|NCT00441142|566071343|FG000|Overall Study|Lack of Efficacy|3|||
156814755|NCT00441142|566071344|FG001|Overall Study|Lack of Efficacy|3|||
156814756|NCT00441142|566071345|FG002|Overall Study|Lack of Efficacy|17|||
156814757|NCT00441142|566071346|FG003|Overall Study|Lack of Efficacy|32|||
156814758|NCT00441142|566071343|FG000|Overall Study|Withdrawal by Subject|0|||
156814759|NCT00441142|566071344|FG001|Overall Study|Withdrawal by Subject|0|||
156464822|NCT04732871|564800113|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
156464823|NCT04732871|564800114|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
156814760|NCT00441142|566071345|FG002|Overall Study|Withdrawal by Subject|2|||
156814761|NCT00441142|566071346|FG003|Overall Study|Withdrawal by Subject|10|||
156814762|NCT00441142|566071343|FG000|Overall Study|Patient still receiving active study tx|1|||
156814763|NCT00441142|566071344|FG001|Overall Study|Patient still receiving active study tx|0|||
156814764|NCT00441142|566071345|FG002|Overall Study|Patient still receiving active study tx|0|||
156814765|NCT00441142|566071346|FG003|Overall Study|Patient still receiving active study tx|2|||
156814766|NCT00441142|566071343|FG000|Overall Study|Physician Decision|0|||
156814767|NCT00441142|566071344|FG001|Overall Study|Physician Decision|1|||
156814768|NCT00441142|566071345|FG002|Overall Study|Physician Decision|0|||
156814769|NCT00441142|566071346|FG003|Overall Study|Physician Decision|1|||
156814770|NCT00441142|566071343|FG000|Overall Study|Death|0|||
156814771|NCT00441142|566071344|FG001|Overall Study|Death|0|||
156814772|NCT00441142|566071345|FG002|Overall Study|Death|0|||
156814773|NCT00441142|566071346|FG003|Overall Study|Death|1|||
156814774|NCT00988052|566071349|FG000|Overall Study|Missing|1|||
156814775|NCT00988052|566071350|FG001|Overall Study|Missing|0|||
156814776|NCT00988052|566071349|FG000|Overall Study|Teva requested subject withdrawal|3|||
156814777|NCT00988052|566071350|FG001|Overall Study|Teva requested subject withdrawal|1|||
156814778|NCT00988052|566071349|FG000|Overall Study|Death|1|||
156814779|NCT00988052|566071350|FG001|Overall Study|Death|3|||
156814780|NCT00988052|566071349|FG000|Overall Study|Protocol Violation|6|||
156814781|NCT00988052|566071350|FG001|Overall Study|Protocol Violation|5|||
156814782|NCT00988052|566071349|FG000|Overall Study|Pregnancy|6|||
156814783|NCT00988052|566071350|FG001|Overall Study|Pregnancy|6|||
156814784|NCT00988052|566071349|FG000|Overall Study|Lack of Efficacy|8|||
156814785|NCT00988052|566071350|FG001|Overall Study|Lack of Efficacy|7|||
156814786|NCT00988052|566071349|FG000|Overall Study|Lost to Follow-up|6|||
156814787|NCT00988052|566071350|FG001|Overall Study|Lost to Follow-up|11|||
156814788|NCT00988052|566071349|FG000|Overall Study|Physician Decision|27|||
156814789|NCT00988052|566071350|FG001|Overall Study|Physician Decision|28|||
156814790|NCT00988052|566071349|FG000|Overall Study|Adverse Event|35|||
156814791|NCT00988052|566071350|FG001|Overall Study|Adverse Event|28|||
156814792|NCT00988052|566071349|FG000|Overall Study|Withdrawal by Subject|90|||
156814793|NCT00988052|566071350|FG001|Overall Study|Withdrawal by Subject|91|||
156814794|NCT00988052|566071349|FG000|Overall Study|Study terminated by sponsor|240|||
156814795|NCT00988052|566071350|FG001|Overall Study|Study terminated by sponsor|236|||
156814796|NCT00295646|566071351|FG000|Overall Study|Protocol Violation|18|||
156814797|NCT00295646|566071352|FG001|Overall Study|Protocol Violation|20|||
156814798|NCT00295646|566071353|FG002|Overall Study|Protocol Violation|20|||
156814799|NCT00295646|566071354|FG003|Overall Study|Protocol Violation|18|||
156814800|NCT00295646|566071351|FG000|Overall Study|Withdrawal by Subject|8|||
156814801|NCT00295646|566071352|FG001|Overall Study|Withdrawal by Subject|9|||
156814802|NCT00295646|566071353|FG002|Overall Study|Withdrawal by Subject|11|||
156814803|NCT00295646|566071354|FG003|Overall Study|Withdrawal by Subject|14|||
156814804|NCT00295646|566071351|FG000|Overall Study|Lost to Follow-up|0|||
156814805|NCT00295646|566071352|FG001|Overall Study|Lost to Follow-up|5|||
156814806|NCT00295646|566071353|FG002|Overall Study|Lost to Follow-up|1|||
156814807|NCT00295646|566071354|FG003|Overall Study|Lost to Follow-up|5|||
156814808|NCT00295646|566071351|FG000|Overall Study|Death|9|||
156814809|NCT00295646|566071352|FG001|Overall Study|Death|7|||
156814810|NCT00295646|566071353|FG002|Overall Study|Death|18|||
156814811|NCT00295646|566071354|FG003|Overall Study|Death|8|||
156814812|NCT01509846|566071356|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
156814813|NCT01509846|566071357|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
156814814|NCT01509846|566071358|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
156814815|NCT01509846|566071359|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
156814816|NCT01509846|566071360|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
156814817|NCT01509846|566071356|FG000|Received Vaccination 2|Illness|0|||
156814818|NCT01509846|566071357|FG001|Received Vaccination 2|Illness|0|||
156814819|NCT01509846|566071358|FG002|Received Vaccination 2|Illness|0|||
156814820|NCT01509846|566071359|FG003|Received Vaccination 2|Illness|0|||
156814821|NCT01509846|566071360|FG004|Received Vaccination 2|Illness|1|||
156814822|NCT01509846|566071356|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
156814823|NCT01509846|566071357|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
156814824|NCT01509846|566071358|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
156814825|NCT01509846|566071359|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
156814826|NCT01509846|566071360|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
156814827|NCT01509846|566071356|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
156814828|NCT01509846|566071357|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
156814829|NCT01509846|566071358|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
156814830|NCT01509846|566071359|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
156814831|NCT01509846|566071360|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
156814832|NCT01509846|566071356|FG000|Received Vaccination 3|Pregnancy|0|||
156814833|NCT01509846|566071357|FG001|Received Vaccination 3|Pregnancy|0|||
156814834|NCT01509846|566071358|FG002|Received Vaccination 3|Pregnancy|0|||
156814835|NCT01509846|566071359|FG003|Received Vaccination 3|Pregnancy|1|||
156814836|NCT01509846|566071360|FG004|Received Vaccination 3|Pregnancy|0|||
156814837|NCT01509846|566071356|FG000|Received Vaccination 3|Lost to Follow-up|0|||
156814838|NCT01509846|566071357|FG001|Received Vaccination 3|Lost to Follow-up|0|||
156814839|NCT01509846|566071358|FG002|Received Vaccination 3|Lost to Follow-up|1|||
156814840|NCT01509846|566071359|FG003|Received Vaccination 3|Lost to Follow-up|0|||
156814841|NCT01509846|566071360|FG004|Received Vaccination 3|Lost to Follow-up|0|||
156814842|NCT04396795|566071362|FG000|Month 1|Lost to Follow-up|2|||
156814843|NCT04396795|566071363|FG001|Month 1|Lost to Follow-up|3|||
156814844|NCT04396795|566071362|FG000|Month 3|Lost to Follow-up|1|||
156814845|NCT04396795|566071363|FG001|Month 3|Lost to Follow-up|3|||
156814846|NCT04396795|566071362|FG000|Month 6|Lost to Follow-up|3|||
156814847|NCT04396795|566071363|FG001|Month 6|Lost to Follow-up|3|||
156814848|NCT01637584|566071364|FG000|Overall Study|Withdrawal by Subject|1|||
156814849|NCT01637584|566071365|FG001|Overall Study|Withdrawal by Subject|3|||
156338977|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Change of location|0|||
156814850|NCT02484443|566071366|FG000|Overall Study|Lack of Efficacy|28|||
156814851|NCT02484443|566071366|FG000|Overall Study|Physician Decision|2|||
156814852|NCT02484443|566071366|FG000|Overall Study|Ineligible|2|||
156814853|NCT01970241|566071367|FG000|Overall Study|Withdrawal by Subject|2|||
156814854|NCT01970241|566071368|FG001|Overall Study|Withdrawal by Subject|0|||
156814855|NCT01970241|566071367|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
156814856|NCT01970241|566071368|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
156814857|NCT03472495|566071369|FG000|Overall Study|Treatment no longer indicated|1|||
156814858|NCT03472495|566071370|FG001|Overall Study|Treatment no longer indicated|2|||
156814859|NCT03472495|566071369|FG000|Overall Study|Physician Decision|0|||
156814860|NCT03472495|566071370|FG001|Overall Study|Physician Decision|2|||
156814861|NCT02595866|566071371|FG000|Overall Study|Adverse Event|2|||
156814862|NCT02595866|566071372|FG001|Overall Study|Adverse Event|5|||
156814863|NCT02595866|566071371|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
156814864|NCT02595866|566071372|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
156814865|NCT02595866|566071371|FG000|Overall Study|Death|0|||
156814866|NCT02595866|566071372|FG001|Overall Study|Death|1|||
156814867|NCT02595866|566071371|FG000|Overall Study|Incarceration|1|||
156814868|NCT02595866|566071372|FG001|Overall Study|Incarceration|0|||
156814869|NCT02595866|566071371|FG000|Overall Study|Lack of Efficacy|17|||
156814870|NCT02595866|566071372|FG001|Overall Study|Lack of Efficacy|7|||
156814871|NCT02595866|566071371|FG000|Overall Study|Physician Decision|4|||
156814872|NCT02595866|566071372|FG001|Overall Study|Physician Decision|3|||
156814873|NCT02595866|566071371|FG000|Overall Study|Switched to Alternative Treatment|1|||
156814874|NCT02595866|566071372|FG001|Overall Study|Switched to Alternative Treatment|0|||
156814875|NCT02595866|566071371|FG000|Overall Study|Study Terminated|0|||
156814876|NCT02595866|566071372|FG001|Overall Study|Study Terminated|4|||
156814877|NCT02595866|566071371|FG000|Overall Study|Withdrawal by Subject|6|||
156814878|NCT02595866|566071372|FG001|Overall Study|Withdrawal by Subject|1|||
156814879|NCT02131311|566071374|FG000|Overall Study|Adverse Event|2|||
156814880|NCT02131311|566071374|FG000|Overall Study|Protocol Violation|1|||
156814881|NCT02131311|566071374|FG000|Overall Study|Lost to Follow-up|1|||
156814882|NCT01479764|566071375|FG000|Randomized|Adverse Event|1|||
156814883|NCT01479764|566071376|FG001|Randomized|Adverse Event|1|||
156814884|NCT01479764|566071375|FG000|Randomized|Withdrawal by Subject|1|||
156814885|NCT01479764|566071376|FG001|Randomized|Withdrawal by Subject|0|||
156814886|NCT01479764|566071375|FG000|Treated|Lost to Follow-up|0|||
156814887|NCT01479764|566071376|FG001|Treated|Lost to Follow-up|2|||
156814888|NCT03082677|566071377|FG000|Overall Study|Not Treated|2|||
156814889|NCT00255723|566071382|FG000|Overall Study|Adverse Event|1|||
156814890|NCT00255723|566071383|FG001|Overall Study|Adverse Event|1|||
156814891|NCT00255723|566071382|FG000|Overall Study|Death|0|||
156814892|NCT00255723|566071383|FG001|Overall Study|Death|1|||
156814893|NCT00255723|566071382|FG000|Overall Study|Response Data Not Available|1|||
156814894|NCT00255723|566071383|FG001|Overall Study|Response Data Not Available|0|||
156814895|NCT00431444|566071384|FG000|Overall Study|Protocol Violation|1|||
156814896|NCT00431444|566071385|FG001|Overall Study|Protocol Violation|4|||
156814897|NCT00431444|566071384|FG000|Overall Study|Adverse Event|2|||
156814898|NCT00431444|566071385|FG001|Overall Study|Adverse Event|1|||
156814899|NCT00431444|566071384|FG000|Overall Study|Withdrawal by Subject|1|||
156814900|NCT00431444|566071385|FG001|Overall Study|Withdrawal by Subject|1|||
156814901|NCT00431444|566071384|FG000|Overall Study|Lost to Follow-up|1|||
156814902|NCT00431444|566071385|FG001|Overall Study|Lost to Follow-up|0|||
156814903|NCT00431444|566071384|FG000|Overall Study|Administrative Problems|0|||
156814904|NCT00431444|566071385|FG001|Overall Study|Administrative Problems|1|||
156814905|NCT03497039|566071389|FG000|Overall Study|Withdrawal by Subject|1|||
156814906|NCT03497039|566071390|FG001|Overall Study|Withdrawal by Subject|0|||
156814907|NCT03497039|566071389|FG000|Overall Study|Protocol Violation|0|||
156814908|NCT03497039|566071390|FG001|Overall Study|Protocol Violation|1|||
156814909|NCT03554018|566071392|FG000|Overall Study|Lost to Follow-up|3|||
156814910|NCT03554018|566071393|FG001|Overall Study|Lost to Follow-up|7|||
156814911|NCT02131662|566071394|FG000|Overall Study|Protocol Violation|1|||
156814912|NCT02131662|566071395|FG001|Overall Study|Protocol Violation|0|||
156814913|NCT02131662|566071396|FG002|Overall Study|Protocol Violation|0|||
156814914|NCT02131662|566071397|FG003|Overall Study|Protocol Violation|0|||
156814915|NCT02131662|566071398|FG004|Overall Study|Protocol Violation|0|||
156814916|NCT02131662|566071394|FG000|Overall Study|Other|2|||
156814917|NCT02131662|566071395|FG001|Overall Study|Other|4|||
156814918|NCT02131662|566071396|FG002|Overall Study|Other|3|||
156814919|NCT02131662|566071397|FG003|Overall Study|Other|3|||
156814920|NCT02131662|566071398|FG004|Overall Study|Other|4|||
156814921|NCT02131662|566071394|FG000|Overall Study|Adverse Event|0|||
156814922|NCT02131662|566071395|FG001|Overall Study|Adverse Event|1|||
156814923|NCT02131662|566071396|FG002|Overall Study|Adverse Event|1|||
156814924|NCT02131662|566071397|FG003|Overall Study|Adverse Event|1|||
156814925|NCT02131662|566071398|FG004|Overall Study|Adverse Event|3|||
156814926|NCT02131662|566071394|FG000|Overall Study|Pregnancy|0|||
156814927|NCT02131662|566071395|FG001|Overall Study|Pregnancy|1|||
156814928|NCT02131662|566071396|FG002|Overall Study|Pregnancy|0|||
156814929|NCT02131662|566071397|FG003|Overall Study|Pregnancy|1|||
156814930|NCT02131662|566071398|FG004|Overall Study|Pregnancy|0|||
156814931|NCT02131662|566071394|FG000|Overall Study|Wish for pregnancy|0|||
156814932|NCT02131662|566071395|FG001|Overall Study|Wish for pregnancy|0|||
156814933|NCT02131662|566071396|FG002|Overall Study|Wish for pregnancy|0|||
156814934|NCT02131662|566071397|FG003|Overall Study|Wish for pregnancy|0|||
156814935|NCT02131662|566071398|FG004|Overall Study|Wish for pregnancy|1|||
156814936|NCT02131662|566071394|FG000|Overall Study|Lack of Efficacy|1|||
156814937|NCT02131662|566071395|FG001|Overall Study|Lack of Efficacy|0|||
156814938|NCT02131662|566071396|FG002|Overall Study|Lack of Efficacy|0|||
156814939|NCT02131662|566071397|FG003|Overall Study|Lack of Efficacy|0|||
156814940|NCT02131662|566071398|FG004|Overall Study|Lack of Efficacy|1|||
156814941|NCT02131662|566071394|FG000|Overall Study|Withdrawal by Subject|1|||
156814942|NCT02131662|566071395|FG001|Overall Study|Withdrawal by Subject|5|||
156814943|NCT02131662|566071396|FG002|Overall Study|Withdrawal by Subject|1|||
156814944|NCT02131662|566071397|FG003|Overall Study|Withdrawal by Subject|5|||
156814945|NCT02131662|566071398|FG004|Overall Study|Withdrawal by Subject|6|||
156814946|NCT02131662|566071394|FG000|Overall Study|Lost to Follow-up|1|||
156814947|NCT02131662|566071395|FG001|Overall Study|Lost to Follow-up|3|||
156814948|NCT02131662|566071396|FG002|Overall Study|Lost to Follow-up|0|||
156814949|NCT02131662|566071397|FG003|Overall Study|Lost to Follow-up|9|||
156814950|NCT02131662|566071398|FG004|Overall Study|Lost to Follow-up|0|||
156814951|NCT02131662|566071394|FG000|Overall Study|Not treated|2|||
156814952|NCT02131662|566071395|FG001|Overall Study|Not treated|0|||
156814953|NCT02131662|566071396|FG002|Overall Study|Not treated|2|||
156814954|NCT02131662|566071397|FG003|Overall Study|Not treated|2|||
156814955|NCT02131662|566071398|FG004|Overall Study|Not treated|3|||
156814956|NCT01928433|566071400|FG000|Overall Study|Adverse Event|5|||
156814957|NCT01928433|566071401|FG001|Overall Study|Adverse Event|2|||
156814958|NCT01928433|566071402|FG002|Overall Study|Adverse Event|5|||
156814959|NCT01928433|566071400|FG000|Overall Study|Protocol Violation|0|||
156814960|NCT01928433|566071401|FG001|Overall Study|Protocol Violation|0|||
156814961|NCT01928433|566071402|FG002|Overall Study|Protocol Violation|2|||
156814962|NCT01928433|566071400|FG000|Overall Study|Lack of Efficacy|5|||
156814963|NCT01928433|566071401|FG001|Overall Study|Lack of Efficacy|4|||
156814964|NCT01928433|566071402|FG002|Overall Study|Lack of Efficacy|4|||
156814965|NCT01928433|566071400|FG000|Overall Study|Withdrawal by Subject|0|||
156814966|NCT01928433|566071401|FG001|Overall Study|Withdrawal by Subject|4|||
156814967|NCT01928433|566071402|FG002|Overall Study|Withdrawal by Subject|0|||
156814968|NCT01928433|566071400|FG000|Overall Study|Negative screening urine culture|7|||
156814969|NCT01928433|566071401|FG001|Overall Study|Negative screening urine culture|6|||
156814970|NCT01928433|566071402|FG002|Overall Study|Negative screening urine culture|10|||
156814971|NCT01928433|566071400|FG000|Overall Study|Lost to Follow-up|0|||
156814972|NCT01928433|566071401|FG001|Overall Study|Lost to Follow-up|2|||
156814973|NCT01928433|566071402|FG002|Overall Study|Lost to Follow-up|3|||
156814974|NCT01928433|566071400|FG000|Overall Study|Other reasons|3|||
156814975|NCT01928433|566071401|FG001|Overall Study|Other reasons|3|||
156814976|NCT01928433|566071402|FG002|Overall Study|Other reasons|4|||
156814977|NCT01740687|566071403|FG000|Overall Study|Lost to Follow-up|11|||
156814978|NCT01740687|566071403|FG000|Overall Study|Withdrawal by Subject|2|||
156814979|NCT01740687|566071403|FG000|Overall Study|other reason|22|||
156814980|NCT01740687|566071403|FG000|Overall Study|treatment not received|2|||
156814981|NCT01016132|566071406|FG000|Overall Study|Discomfort|1|||
156814982|NCT01451749|566071409|FG000|Overall Study|Protocol Violation|14|||
156814983|NCT01451749|566071410|FG001|Overall Study|Protocol Violation|7|||
156814984|NCT01451749|566071409|FG000|Overall Study|Lost to Follow-up|15|||
156814985|NCT01451749|566071410|FG001|Overall Study|Lost to Follow-up|5|||
156814986|NCT01451749|566071409|FG000|Overall Study|Meet the exclusion criteria,and|1|||
156814987|NCT01451749|566071410|FG001|Overall Study|Meet the exclusion criteria,and|1|||
156814988|NCT01451749|566071409|FG000|Overall Study|Adverse Event|2|||
156814989|NCT01451749|566071410|FG001|Overall Study|Adverse Event|0|||
156814990|NCT01451749|566071409|FG000|Overall Study|Withdrawal by Subject|0|||
156814991|NCT01451749|566071410|FG001|Overall Study|Withdrawal by Subject|1|||
156814992|NCT00972517|566071411|FG000|Overall Study|Adverse Event|0|||
156814993|NCT00972517|566071412|FG001|Overall Study|Adverse Event|0|||
156814994|NCT00972517|566071413|FG002|Overall Study|Adverse Event|0|||
156814995|NCT00972517|566071414|FG003|Overall Study|Adverse Event|1|||
156814996|NCT00972517|566071415|FG004|Overall Study|Adverse Event|0|||
156814997|NCT00972517|566071416|FG005|Overall Study|Adverse Event|0|||
156814998|NCT00972517|566071411|FG000|Overall Study|Withdrawal by Subject|0|||
156814999|NCT00972517|566071412|FG001|Overall Study|Withdrawal by Subject|1|||
156815000|NCT00972517|566071413|FG002|Overall Study|Withdrawal by Subject|0|||
156815001|NCT00972517|566071414|FG003|Overall Study|Withdrawal by Subject|2|||
156815002|NCT00972517|566071415|FG004|Overall Study|Withdrawal by Subject|1|||
156815003|NCT00972517|566071416|FG005|Overall Study|Withdrawal by Subject|0|||
156815004|NCT02311881|566071417|FG000|Overall Study|Did not meet the study criteria|2|||
156815005|NCT02311881|566071418|FG001|Overall Study|Did not meet the study criteria|2|||
156815006|NCT02311881|566071419|FG002|Overall Study|Did not meet the study criteria|0|||
156815007|NCT02311881|566071417|FG000|Overall Study|Adverse Event|7|||
156815008|NCT02311881|566071418|FG001|Overall Study|Adverse Event|15|||
156815009|NCT02311881|566071419|FG002|Overall Study|Adverse Event|8|||
156815010|NCT02311881|566071417|FG000|Overall Study|Lost to Follow-up|3|||
156815011|NCT02311881|566071418|FG001|Overall Study|Lost to Follow-up|3|||
156815012|NCT02311881|566071419|FG002|Overall Study|Lost to Follow-up|2|||
156815013|NCT02311881|566071417|FG000|Overall Study|Protocol Violation|1|||
156815014|NCT02311881|566071418|FG001|Overall Study|Protocol Violation|2|||
156815015|NCT02311881|566071419|FG002|Overall Study|Protocol Violation|3|||
156815016|NCT02311881|566071417|FG000|Overall Study|Withdrawal of consent|14|||
156815017|NCT02311881|566071418|FG001|Overall Study|Withdrawal of consent|16|||
156815018|NCT02311881|566071419|FG002|Overall Study|Withdrawal of consent|17|||
156464824|NCT04732871|564800112|FG000|Overall Study|Lost to Follow-up|7|||
156815019|NCT02311881|566071417|FG000|Overall Study|Other|0|||
156815020|NCT02311881|566071418|FG001|Overall Study|Other|0|||
156815021|NCT02311881|566071419|FG002|Overall Study|Other|1|||
156815022|NCT02311881|566071417|FG000|Overall Study|Lack of Efficacy|1|||
156815023|NCT02311881|566071418|FG001|Overall Study|Lack of Efficacy|2|||
156815024|NCT02311881|566071419|FG002|Overall Study|Lack of Efficacy|0|||
156815025|NCT02311881|566071417|FG000|Overall Study|Subject has border line pregnancy test|1|||
156815026|NCT02311881|566071418|FG001|Overall Study|Subject has border line pregnancy test|0|||
156815027|NCT02311881|566071419|FG002|Overall Study|Subject has border line pregnancy test|0|||
156815028|NCT02311881|566071417|FG000|Overall Study|Withdrawal by Subject|3|||
156815029|NCT02311881|566071418|FG001|Overall Study|Withdrawal by Subject|1|||
156815030|NCT02311881|566071419|FG002|Overall Study|Withdrawal by Subject|4|||
156815031|NCT02311881|566071417|FG000|Overall Study|Sponsor Decision|1|||
156815032|NCT02311881|566071418|FG001|Overall Study|Sponsor Decision|1|||
156815033|NCT02311881|566071419|FG002|Overall Study|Sponsor Decision|1|||
156815034|NCT02311881|566071417|FG000|Overall Study|Protocol Deviation|1|||
156815035|NCT02311881|566071418|FG001|Overall Study|Protocol Deviation|0|||
156815036|NCT02311881|566071419|FG002|Overall Study|Protocol Deviation|0|||
156815037|NCT02311881|566071417|FG000|Overall Study|Non-Compliance|1|||
156815038|NCT02311881|566071418|FG001|Overall Study|Non-Compliance|0|||
156815039|NCT02311881|566071419|FG002|Overall Study|Non-Compliance|2|||
156815040|NCT02311881|566071417|FG000|Overall Study|Physician Decision|0|||
156815041|NCT02311881|566071418|FG001|Overall Study|Physician Decision|0|||
156815042|NCT02311881|566071419|FG002|Overall Study|Physician Decision|1|||
156815043|NCT02311881|566071417|FG000|Overall Study|Medical Monitor Discretion|0|||
156815044|NCT02311881|566071418|FG001|Overall Study|Medical Monitor Discretion|0|||
156815045|NCT02311881|566071419|FG002|Overall Study|Medical Monitor Discretion|1|||
156815046|NCT02311881|566071417|FG000|Overall Study|Participant taking another medication|0|||
156815047|NCT02311881|566071418|FG001|Overall Study|Participant taking another medication|0|||
156815048|NCT02311881|566071419|FG002|Overall Study|Participant taking another medication|1|||
156815049|NCT02311881|566071417|FG000|Overall Study|Serious Adverse Event|0|||
156815050|NCT02311881|566071418|FG001|Overall Study|Serious Adverse Event|1|||
156815051|NCT02311881|566071419|FG002|Overall Study|Serious Adverse Event|0|||
156815052|NCT00556439|566071423|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
156815053|NCT00556439|566071424|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
156815054|NCT00556439|566071425|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
156815055|NCT00556439|566071426|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
156815056|NCT00556439|566071423|FG000|Study Entry to Week 12|Physician Decision|1|||
156815057|NCT00556439|566071424|FG001|Study Entry to Week 12|Physician Decision|0|||
156815058|NCT00556439|566071425|FG002|Study Entry to Week 12|Physician Decision|0|||
156815059|NCT00556439|566071426|FG003|Study Entry to Week 12|Physician Decision|0|||
156815060|NCT00556439|566071423|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
156815061|NCT00556439|566071424|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
156464825|NCT04732871|564800113|FG001|Overall Study|Lost to Follow-up|4|||
156464826|NCT04732871|564800114|FG002|Overall Study|Lost to Follow-up|3|||
156815062|NCT00556439|566071425|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
156815063|NCT00556439|566071426|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
156815064|NCT00556439|566071423|FG000|Study Entry to Week 12|Recurrent infection|1|||
156815065|NCT00556439|566071424|FG001|Study Entry to Week 12|Recurrent infection|0|||
156815066|NCT00556439|566071425|FG002|Study Entry to Week 12|Recurrent infection|0|||
156815067|NCT00556439|566071426|FG003|Study Entry to Week 12|Recurrent infection|0|||
156815068|NCT00556439|566071423|FG000|Study Entry to Week 12|Malignancy|0|||
156815069|NCT00556439|566071424|FG001|Study Entry to Week 12|Malignancy|0|||
156815070|NCT00556439|566071425|FG002|Study Entry to Week 12|Malignancy|1|||
156815071|NCT00556439|566071426|FG003|Study Entry to Week 12|Malignancy|0|||
156815072|NCT00556439|566071423|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
156815073|NCT00556439|566071424|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
156815074|NCT00556439|566071425|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
156815075|NCT00556439|566071426|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
156464827|NCT04732871|564800112|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
156464828|NCT04732871|564800113|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
156464829|NCT04732871|564800114|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
156464830|NCT04732871|564800112|FG000|Overall Study|Migrated / moved from the study area|5|||
156815076|NCT00556439|566071423|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
156815077|NCT00556439|566071424|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
156815078|NCT00556439|566071425|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
156464831|NCT04732871|564800113|FG001|Overall Study|Migrated / moved from the study area|0|||
156815079|NCT00556439|566071426|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
156815080|NCT00556439|566071423|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
156815081|NCT00556439|566071424|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
156815082|NCT00556439|566071425|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
156815083|NCT00556439|566071426|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
156815084|NCT00556439|566071423|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
156815085|NCT00556439|566071424|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
156815086|NCT00556439|566071425|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
156815087|NCT00556439|566071426|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
156815088|NCT02100423|566071428|FG000|Overall Study|Death|1|||
156815089|NCT02100423|566071428|FG000|Overall Study|Withdrawal by Subject|3|||
156815090|NCT02100423|566071428|FG000|Overall Study|Adverse Event|1|||
156815091|NCT02100423|566071428|FG000|Overall Study|Physician Decision|1|||
156815092|NCT02949024|566071429|FG000|Overall Study|Withdrawal by Subject|0|||
156815093|NCT02949024|566071430|FG001|Overall Study|Withdrawal by Subject|1|||
156815094|NCT00854724|566072877|FG000|First Intervention|Withdrawal by Subject|1|||
156815095|NCT00854724|566072878|FG001|First Intervention|Withdrawal by Subject|1|||
156815096|NCT00854724|566072877|FG000|Washout|Protocol Violation|1|||
156815097|NCT00854724|566072878|FG001|Washout|Protocol Violation|0|||
156815098|NCT00854724|566072877|FG000|Washout|Withdrawal by Subject|0|||
156815099|NCT00854724|566072878|FG001|Washout|Withdrawal by Subject|1|||
156815100|NCT00854724|566072877|FG000|Second Intervention|Protocol Violation|1|||
156815101|NCT00854724|566072878|FG001|Second Intervention|Protocol Violation|0|||
156815102|NCT00854724|566072877|FG000|Second Intervention|Physician Decision|0|||
156815103|NCT00854724|566072878|FG001|Second Intervention|Physician Decision|1|||
156815104|NCT00933608|566072880|FG000|Overall Study|Adverse Event|4|||
156815105|NCT00933608|566072881|FG001|Overall Study|Adverse Event|2|||
156815106|NCT00933608|566072880|FG000|Overall Study|Physician Decision|1|||
156815107|NCT00933608|566072881|FG001|Overall Study|Physician Decision|0|||
156815108|NCT00336284|566072884|FG000|Overall Study|Death|52|||
156815109|NCT00336284|566072885|FG001|Overall Study|Death|26|||
156815110|NCT00336284|566072884|FG000|Overall Study|Lost to Follow-up|82|||
156815111|NCT00336284|566072885|FG001|Overall Study|Lost to Follow-up|61|||
156815112|NCT00336284|566072884|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
156815113|NCT00336284|566072885|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
156815114|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
156815115|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
156815116|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
156815117|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
156815118|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
156815119|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
156815120|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
156815121|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
156815122|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
156815123|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
156815124|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
156815125|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
156815126|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
156815127|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
156815128|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
156815129|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
156815130|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
156815131|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
156815132|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
156815133|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
156815134|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
156815135|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
156464832|NCT04732871|564800114|FG002|Overall Study|Migrated / moved from the study area|0|||
156464833|NCT04732871|564800112|FG000|Overall Study|Other|1|||
156464834|NCT04732871|564800113|FG001|Overall Study|Other|0|||
156464835|NCT04732871|564800114|FG002|Overall Study|Other|1|||
156464836|NCT04732871|564800112|FG000|Overall Study|Ongoing|6|||
156464837|NCT04732871|564800113|FG001|Overall Study|Ongoing|0|||
156464838|NCT04732871|564800114|FG002|Overall Study|Ongoing|1|||
156464839|NCT04732871|564800112|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
156464840|NCT04732871|564800113|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
156464841|NCT04732871|564800114|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
156464842|NCT05180539|564800124|FG000|Overall Study|Lost to Follow-up|27|||
156464843|NCT05180539|564800125|FG001|Overall Study|Lost to Follow-up|30|||
156464844|NCT00968149|564800129|FG000|Overall Study|Adverse Event|5|||
156464845|NCT00968149|564800130|FG001|Overall Study|Adverse Event|1|||
156464846|NCT00968149|564800129|FG000|Overall Study|Lack of Efficacy|0|||
156815136|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
156815137|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
156464847|NCT00968149|564800130|FG001|Overall Study|Lack of Efficacy|4|||
156464848|NCT00968149|564800129|FG000|Overall Study|Lost to Follow-up|0|||
156464849|NCT00968149|564800130|FG001|Overall Study|Lost to Follow-up|1|||
156815138|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
156815139|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
156815140|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
156815141|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
156815142|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
156815143|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
156815144|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
156815145|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
156815146|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
156815147|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
156815148|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
156815149|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
156815150|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
156815151|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
156815152|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
156815153|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
156815154|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
156815155|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
156815156|NCT01521923|566072896|FG000|Overall Study|AE, serious fatal|1|||
156815157|NCT01521923|566072897|FG001|Overall Study|AE, serious fatal|0|||
156464850|NCT00968149|564800129|FG000|Overall Study|Protocol Violation|4|||
156464851|NCT00968149|564800130|FG001|Overall Study|Protocol Violation|0|||
156815158|NCT01521923|566072898|FG002|Overall Study|AE, serious fatal|0|||
156815159|NCT01521923|566072899|FG003|Overall Study|AE, serious fatal|0|||
156815160|NCT01521923|566072896|FG000|Overall Study|SAE, non-fatal|0|||
156815161|NCT01521923|566072897|FG001|Overall Study|SAE, non-fatal|2|||
156815162|NCT01521923|566072898|FG002|Overall Study|SAE, non-fatal|2|||
156815163|NCT01521923|566072899|FG003|Overall Study|SAE, non-fatal|0|||
156815164|NCT01521923|566072896|FG000|Overall Study|AE, non-serious, non-fatal|1|||
156815165|NCT01521923|566072897|FG001|Overall Study|AE, non-serious, non-fatal|3|||
156815166|NCT01521923|566072898|FG002|Overall Study|AE, non-serious, non-fatal|6|||
156815167|NCT01521923|566072899|FG003|Overall Study|AE, non-serious, non-fatal|2|||
156815168|NCT01521923|566072896|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
156815169|NCT01521923|566072897|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
156464852|NCT00968149|564800129|FG000|Overall Study|Withdrawal by Subject|2|||
156464853|NCT00968149|564800130|FG001|Overall Study|Withdrawal by Subject|0|||
156464854|NCT02467270|564800131|FG000|Overall Study|Participants Never Treated|0|||
156464855|NCT02467270|564800132|FG001|Overall Study|Participants Never Treated|1|||
156815170|NCT01521923|566072898|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
156815171|NCT01521923|566072899|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
156815172|NCT01521923|566072896|FG000|Overall Study|Lack of Efficacy|1|||
156815173|NCT01521923|566072897|FG001|Overall Study|Lack of Efficacy|1|||
156815174|NCT01521923|566072898|FG002|Overall Study|Lack of Efficacy|0|||
156815175|NCT01521923|566072899|FG003|Overall Study|Lack of Efficacy|0|||
156815176|NCT01521923|566072896|FG000|Overall Study|Protocol Violation|0|||
156815177|NCT01521923|566072897|FG001|Overall Study|Protocol Violation|0|||
156815178|NCT01521923|566072898|FG002|Overall Study|Protocol Violation|1|||
156815179|NCT01521923|566072899|FG003|Overall Study|Protocol Violation|0|||
156815180|NCT01521923|566072896|FG000|Overall Study|Lost to Follow-up|1|||
156815181|NCT01521923|566072897|FG001|Overall Study|Lost to Follow-up|0|||
156815182|NCT01521923|566072898|FG002|Overall Study|Lost to Follow-up|2|||
156815183|NCT01521923|566072899|FG003|Overall Study|Lost to Follow-up|1|||
156815184|NCT01521923|566072896|FG000|Overall Study|Withdrawal by Subject|1|||
156815185|NCT01521923|566072897|FG001|Overall Study|Withdrawal by Subject|1|||
156815186|NCT01521923|566072898|FG002|Overall Study|Withdrawal by Subject|1|||
156815187|NCT01521923|566072899|FG003|Overall Study|Withdrawal by Subject|2|||
156815188|NCT01521923|566072896|FG000|Overall Study|Other|2|||
156815189|NCT01521923|566072897|FG001|Overall Study|Other|1|||
156815190|NCT01521923|566072898|FG002|Overall Study|Other|3|||
156815191|NCT01521923|566072899|FG003|Overall Study|Other|6|||
156815192|NCT01521923|566072896|FG000|Overall Study|AE, captured in Period 1|0|||
156815193|NCT01521923|566072897|FG001|Overall Study|AE, captured in Period 1|1|||
156815194|NCT01521923|566072898|FG002|Overall Study|AE, captured in Period 1|0|||
156815195|NCT01521923|566072899|FG003|Overall Study|AE, captured in Period 1|1|||
156338978|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Change of location|1|||
156815196|NCT02836717|566072916|FG000|Test Phase|Lack of Efficacy|14|||
156815197|NCT02836717|566072917|FG001|Test Phase|Lack of Efficacy|8|||
156815198|NCT02836717|566072918|FG002|Test Phase|Lack of Efficacy|0|||
156815199|NCT02836717|566072916|FG000|Study Phase|Adverse Event|2|||
156815200|NCT02836717|566072917|FG001|Study Phase|Adverse Event|0|||
156815201|NCT02836717|566072918|FG002|Study Phase|Adverse Event|0|||
156338979|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Change of location|0|||
156815202|NCT02836717|566072916|FG000|Study Phase|Lack of Efficacy|8|||
156815203|NCT02836717|566072917|FG001|Study Phase|Lack of Efficacy|6|||
156464856|NCT02467270|564800133|FG002|Overall Study|Participants Never Treated|0|||
156464857|NCT02467270|564800131|FG000|Overall Study|Ongoing|50|||
156464858|NCT02467270|564800132|FG001|Overall Study|Ongoing|41|||
156464859|NCT02467270|564800133|FG002|Overall Study|Ongoing|43|||
156815204|NCT02836717|566072918|FG002|Study Phase|Lack of Efficacy|1|||
156815205|NCT02836717|566072916|FG000|Study Phase|Withdrawal by Subject|1|||
156815206|NCT02836717|566072917|FG001|Study Phase|Withdrawal by Subject|0|||
156815207|NCT02836717|566072918|FG002|Study Phase|Withdrawal by Subject|0|||
156815208|NCT02836717|566072916|FG000|Study Phase|Death|1|||
156815209|NCT02836717|566072917|FG001|Study Phase|Death|0|||
156815210|NCT02836717|566072918|FG002|Study Phase|Death|0|||
156815211|NCT02836717|566072916|FG000|Study Phase|abdominal surgeries|2|||
156815212|NCT02836717|566072917|FG001|Study Phase|abdominal surgeries|1|||
156815213|NCT02836717|566072918|FG002|Study Phase|abdominal surgeries|0|||
156815214|NCT03226249|566072919|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
156815215|NCT03226249|566072919|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
156815216|NCT03226249|566072919|FG000|Survival Follow-up|Patients still in follow-up.|30|||
156815217|NCT00588237|566072922|FG000|Overall Study|Evaluable for toxicity only|3|||
156815218|NCT00588237|566072922|FG000|Overall Study|Patien not treated|1|||
156815219|NCT01703091|566072928|FG000|Overall Study|Adverse Event|5|||
156815220|NCT01703091|566072929|FG001|Overall Study|Adverse Event|3|||
156815221|NCT01703091|566072928|FG000|Overall Study|Physician Decision|2|||
156815222|NCT01703091|566072929|FG001|Overall Study|Physician Decision|1|||
156815223|NCT01703091|566072928|FG000|Overall Study|Withdrawal by Subject|1|||
156815224|NCT01703091|566072929|FG001|Overall Study|Withdrawal by Subject|0|||
156815225|NCT01703091|566072928|FG000|Overall Study|Sponsor Decision|1|||
156815226|NCT01703091|566072929|FG001|Overall Study|Sponsor Decision|0|||
156815227|NCT00022763|566072940|FG000|Overall Study|Adverse Event|1|||
156815228|NCT00022763|566072941|FG001|Overall Study|Adverse Event|2|||
156815229|NCT00022763|566072940|FG000|Overall Study|Injection Site Reactions|0|||
156815230|NCT00022763|566072941|FG001|Overall Study|Injection Site Reactions|2|||
156815231|NCT00022763|566072940|FG000|Overall Study|Death|0|||
156815232|NCT00022763|566072941|FG001|Overall Study|Death|1|||
156815233|NCT00022763|566072940|FG000|Overall Study|Lost to Follow-up|0|||
156815234|NCT00022763|566072941|FG001|Overall Study|Lost to Follow-up|3|||
156815235|NCT00022763|566072940|FG000|Overall Study|Withdrawal by Subject|4|||
156815236|NCT00022763|566072941|FG001|Overall Study|Withdrawal by Subject|7|||
156815237|NCT00022763|566072940|FG000|Overall Study|Insufficient Therapy|1|||
156815238|NCT00022763|566072941|FG001|Overall Study|Insufficient Therapy|0|||
156815239|NCT00022763|566072940|FG000|Overall Study|Admin|3|||
156815240|NCT00022763|566072941|FG001|Overall Study|Admin|2|||
156815241|NCT01524224|566072944|FG000|Overall Study|Progressive Disease|1|||
156815242|NCT01524224|566072945|FG001|Overall Study|Progressive Disease|0|||
156815243|NCT01524224|566072946|FG002|Overall Study|Progressive Disease|2|||
156815244|NCT01524224|566072947|FG003|Overall Study|Progressive Disease|1|||
156815245|NCT01524224|566072948|FG004|Overall Study|Progressive Disease|2|||
156815246|NCT01524224|566072949|FG005|Overall Study|Progressive Disease|1|||
156815247|NCT01524224|566072950|FG006|Overall Study|Progressive Disease|1|||
156815248|NCT01524224|566072951|FG007|Overall Study|Progressive Disease|5|||
156815249|NCT01524224|566072944|FG000|Overall Study|Withdrawal by Subject|2|||
156815250|NCT01524224|566072945|FG001|Overall Study|Withdrawal by Subject|0|||
156815251|NCT01524224|566072946|FG002|Overall Study|Withdrawal by Subject|0|||
156815252|NCT01524224|566072947|FG003|Overall Study|Withdrawal by Subject|0|||
156815253|NCT01524224|566072948|FG004|Overall Study|Withdrawal by Subject|0|||
156815254|NCT01524224|566072949|FG005|Overall Study|Withdrawal by Subject|0|||
156815255|NCT01524224|566072950|FG006|Overall Study|Withdrawal by Subject|2|||
156815256|NCT01524224|566072951|FG007|Overall Study|Withdrawal by Subject|0|||
156815257|NCT01524224|566072944|FG000|Overall Study|Adverse Event|0|||
156815258|NCT01524224|566072945|FG001|Overall Study|Adverse Event|1|||
156464860|NCT02467270|564800131|FG000|Overall Study|Adverse Event|16|||
156464861|NCT02467270|564800132|FG001|Overall Study|Adverse Event|15|||
156464862|NCT02467270|564800133|FG002|Overall Study|Adverse Event|14|||
156815259|NCT01524224|566072946|FG002|Overall Study|Adverse Event|0|||
156815260|NCT01524224|566072947|FG003|Overall Study|Adverse Event|0|||
156815261|NCT01524224|566072948|FG004|Overall Study|Adverse Event|0|||
156815262|NCT01524224|566072949|FG005|Overall Study|Adverse Event|1|||
156815263|NCT01524224|566072950|FG006|Overall Study|Adverse Event|0|||
156815264|NCT01524224|566072951|FG007|Overall Study|Adverse Event|0|||
156815265|NCT01524224|566072944|FG000|Overall Study|Physician Decision|0|||
156815266|NCT01524224|566072945|FG001|Overall Study|Physician Decision|0|||
156815267|NCT01524224|566072946|FG002|Overall Study|Physician Decision|0|||
156815268|NCT01524224|566072947|FG003|Overall Study|Physician Decision|1|||
156815269|NCT01524224|566072948|FG004|Overall Study|Physician Decision|1|||
156815270|NCT01524224|566072949|FG005|Overall Study|Physician Decision|0|||
156815271|NCT01524224|566072950|FG006|Overall Study|Physician Decision|0|||
156815272|NCT01524224|566072951|FG007|Overall Study|Physician Decision|1|||
156815273|NCT01524224|566072944|FG000|Overall Study|Sponsor Decision|0|||
156815274|NCT01524224|566072945|FG001|Overall Study|Sponsor Decision|0|||
156815275|NCT01524224|566072946|FG002|Overall Study|Sponsor Decision|0|||
156464863|NCT02467270|564800131|FG000|Overall Study|Progressive Disease|7|||
156464864|NCT02467270|564800132|FG001|Overall Study|Progressive Disease|7|||
156815276|NCT01524224|566072947|FG003|Overall Study|Sponsor Decision|0|||
156815277|NCT01524224|566072948|FG004|Overall Study|Sponsor Decision|1|||
156815278|NCT01524224|566072949|FG005|Overall Study|Sponsor Decision|0|||
156815279|NCT01524224|566072950|FG006|Overall Study|Sponsor Decision|0|||
156815280|NCT01524224|566072951|FG007|Overall Study|Sponsor Decision|0|||
156815281|NCT04283656|566072952|FG000|Overall Study|Adverse Event|1|||
156815282|NCT04283656|566072953|FG001|Overall Study|Adverse Event|0|||
156815283|NCT04283656|566072952|FG000|Overall Study|Lost to Follow-up|0|||
156815284|NCT04283656|566072953|FG001|Overall Study|Lost to Follow-up|1|||
156815285|NCT00803361|566072954|FG000|Overall Study|Adverse Event|13|||
156815286|NCT00803361|566072955|FG001|Overall Study|Adverse Event|3|||
156815287|NCT00803361|566072954|FG000|Overall Study|Lack of Efficacy|4|||
156815288|NCT00803361|566072955|FG001|Overall Study|Lack of Efficacy|13|||
156815289|NCT00803361|566072954|FG000|Overall Study|Lost to Follow-up|1|||
156539480|NCT02138617|565069720|FG001|Overall Study|other therapy|4|||
156539481|NCT02138617|565069721|FG002|Overall Study|other therapy|0|||
156539482|NCT01111851|565069722|FG000|Overall Study|All planned PET scans were not obtained.|2|||
156539483|NCT01111851|565069723|FG001|Overall Study|All planned PET scans were not obtained.|0|||
156539484|NCT01816061|565069725|FG000|Overall Study|Lost to Follow-up|13|||
156539485|NCT01816061|565069726|FG001|Overall Study|Lost to Follow-up|24|||
156539486|NCT01970488|565069727|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
156539487|NCT01970488|565069728|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
156539488|NCT01970488|565069729|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
156539489|NCT01970488|565069730|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
156539490|NCT01970488|565069731|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
156539491|NCT01970488|565069727|FG000|Part 1: Through Week 16|Protocol Violation|1|||
156539492|NCT01970488|565069728|FG001|Part 1: Through Week 16|Protocol Violation|2|||
156539493|NCT01970488|565069729|FG002|Part 1: Through Week 16|Protocol Violation|0|||
156539494|NCT01970488|565069730|FG003|Part 1: Through Week 16|Protocol Violation|0|||
156539495|NCT01970488|565069731|FG004|Part 1: Through Week 16|Protocol Violation|0|||
156539496|NCT01970488|565069727|FG000|Part 1: Through Week 16|Adverse Event|6|||
156539497|NCT01970488|565069728|FG001|Part 1: Through Week 16|Adverse Event|5|||
156539498|NCT01970488|565069729|FG002|Part 1: Through Week 16|Adverse Event|0|||
156539499|NCT01970488|565069730|FG003|Part 1: Through Week 16|Adverse Event|0|||
156539500|NCT01970488|565069731|FG004|Part 1: Through Week 16|Adverse Event|0|||
156539501|NCT01970488|565069727|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
156539502|NCT01970488|565069728|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
156539503|NCT01970488|565069729|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
156539504|NCT01970488|565069730|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
156815290|NCT00803361|566072955|FG001|Overall Study|Lost to Follow-up|2|||
156815291|NCT00803361|566072954|FG000|Overall Study|Physician Decision|1|||
156815292|NCT00803361|566072955|FG001|Overall Study|Physician Decision|0|||
156815293|NCT00803361|566072954|FG000|Overall Study|Protocol Violation|2|||
156815294|NCT00803361|566072955|FG001|Overall Study|Protocol Violation|4|||
156815295|NCT00803361|566072954|FG000|Overall Study|Withdrawal by Subject|5|||
156815296|NCT00803361|566072955|FG001|Overall Study|Withdrawal by Subject|6|||
156815297|NCT04445519|566072956|FG000|Overall Study|Due to adaptive design|3|||
156815298|NCT04445519|566072957|FG001|Overall Study|Due to adaptive design|0|||
156815299|NCT04445519|566072958|FG002|Overall Study|Due to adaptive design|0|||
156815300|NCT04445519|566072956|FG000|Overall Study|Lost to Follow-up|0|||
156815301|NCT04445519|566072957|FG001|Overall Study|Lost to Follow-up|1|||
156464865|NCT02467270|564800133|FG002|Overall Study|Progressive Disease|4|||
156464866|NCT02467270|564800131|FG000|Overall Study|Death|2|||
156464867|NCT02467270|564800132|FG001|Overall Study|Death|0|||
156464868|NCT02467270|564800133|FG002|Overall Study|Death|2|||
156464869|NCT02467270|564800131|FG000|Overall Study|Lack of Efficacy|12|||
156464870|NCT02467270|564800132|FG001|Overall Study|Lack of Efficacy|18|||
156464871|NCT02467270|564800133|FG002|Overall Study|Lack of Efficacy|23|||
156464872|NCT02467270|564800131|FG000|Overall Study|Non-compliance With Study Drug|0|||
156464873|NCT02467270|564800132|FG001|Overall Study|Non-compliance With Study Drug|2|||
156464874|NCT02467270|564800133|FG002|Overall Study|Non-compliance With Study Drug|1|||
156464875|NCT02467270|564800131|FG000|Overall Study|Lost to Follow-up|2|||
156464876|NCT02467270|564800132|FG001|Overall Study|Lost to Follow-up|1|||
156539505|NCT01970488|565069731|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
156539506|NCT01970488|565069727|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
156815302|NCT04445519|566072958|FG002|Overall Study|Lost to Follow-up|4|||
156815303|NCT04445519|566072956|FG000|Overall Study|Sponsor or IRB Decision|0|||
156815304|NCT04445519|566072957|FG001|Overall Study|Sponsor or IRB Decision|1|||
156815305|NCT04445519|566072958|FG002|Overall Study|Sponsor or IRB Decision|2|||
156815306|NCT04445519|566072956|FG000|Overall Study|Withdrawal by Subject|0|||
156815307|NCT04445519|566072957|FG001|Overall Study|Withdrawal by Subject|3|||
156815308|NCT04445519|566072958|FG002|Overall Study|Withdrawal by Subject|3|||
156464877|NCT02467270|564800133|FG002|Overall Study|Lost to Follow-up|0|||
156464878|NCT02467270|564800131|FG000|Overall Study|Pregnancy|0|||
156815309|NCT04445519|566072956|FG000|Overall Study|Adverse Event|0|||
156815310|NCT04445519|566072957|FG001|Overall Study|Adverse Event|8|||
156815311|NCT04445519|566072958|FG002|Overall Study|Adverse Event|6|||
156815312|NCT04445519|566072956|FG000|Overall Study|Other Reason|0|||
156815313|NCT04445519|566072957|FG001|Overall Study|Other Reason|1|||
156815314|NCT04445519|566072958|FG002|Overall Study|Other Reason|1|||
156815315|NCT04445519|566072956|FG000|Overall Study|Protocol Violation|0|||
156815316|NCT04445519|566072957|FG001|Overall Study|Protocol Violation|0|||
156815317|NCT04445519|566072958|FG002|Overall Study|Protocol Violation|1|||
156815318|NCT02858440|566072963|FG000|Overall Study|Lost to Follow-up|3|||
156815319|NCT02858440|566072963|FG000|Overall Study|Protocol Violation|2|||
156815320|NCT02858440|566072963|FG000|Overall Study|Consent withdrawal|3|||
156815321|NCT02858440|566072963|FG000|Overall Study|Migrated/moved from study area|4|||
156815322|NCT04660552|566072964|FG000|Overall Study|Withdrawal by Subject|3|||
156815323|NCT04660552|566072965|FG001|Overall Study|Withdrawal by Subject|1|||
156815324|NCT00470262|566072966|FG000|Overall Study|Withdrawal by Subject|2|||
156815325|NCT00470262|566072967|FG001|Overall Study|Withdrawal by Subject|0|||
156815326|NCT01001767|566072970|FG000|Overall Study|no baseline study performed|1|||
156815327|NCT01001767|566072971|FG001|Overall Study|no baseline study performed|0|||
156815328|NCT01001767|566072970|FG000|Overall Study|Protocol Violation|1|||
156815329|NCT01001767|566072971|FG001|Overall Study|Protocol Violation|0|||
156815330|NCT01001767|566072970|FG000|Overall Study|Lost to Follow-up|1|||
156815331|NCT01001767|566072971|FG001|Overall Study|Lost to Follow-up|0|||
156815332|NCT01001767|566072970|FG000|Overall Study|Physician Decision|1|||
156815333|NCT01001767|566072971|FG001|Overall Study|Physician Decision|0|||
156815334|NCT01107392|566072972|FG000|Overall Study|Adverse Event|2|||
156815335|NCT01107392|566072973|FG001|Overall Study|Adverse Event|0|||
156815336|NCT01107392|566072972|FG000|Overall Study|Personal Reasons|2|||
156815337|NCT01107392|566072973|FG001|Overall Study|Personal Reasons|3|||
156815338|NCT01107392|566072972|FG000|Overall Study|Administrative decision|1|||
156815339|NCT01107392|566072973|FG001|Overall Study|Administrative decision|0|||
156815340|NCT02584452|566072974|FG000|Overall Study|Physician Decision|1|||
156815341|NCT02584452|566072975|FG001|Overall Study|Physician Decision|1|||
156815342|NCT02584452|566072974|FG000|Overall Study|Lost to Follow-up|1|||
156815343|NCT02584452|566072975|FG001|Overall Study|Lost to Follow-up|1|||
156815344|NCT00851552|566072976|FG000|Overall Study|Death|2|||
156815345|NCT00851552|566072976|FG000|Overall Study|Adverse Event|1|||
156815346|NCT00851552|566072976|FG000|Overall Study|Disease Progression|4|||
156815347|NCT00177294|566072977|FG000|Overall Study|Withdrawal by Subject|7|||
156815348|NCT00177294|566072978|FG001|Overall Study|Withdrawal by Subject|5|||
156815349|NCT02998671|566072979|FG000|Period 1|Study Terminated By Sponsor|2|||
156815350|NCT02998671|566072980|FG001|Period 1|Study Terminated By Sponsor|1|||
156815351|NCT02998671|566072981|FG002|Period 1|Study Terminated By Sponsor|0|||
156815352|NCT02998671|566072982|FG003|Period 1|Study Terminated By Sponsor|0|||
156815353|NCT02998671|566072983|FG004|Period 1|Study Terminated By Sponsor|1|||
156815354|NCT02998671|566072979|FG000|Period 1|Withdrawal by Subject|1|||
156815355|NCT02998671|566072980|FG001|Period 1|Withdrawal by Subject|2|||
156815356|NCT02998671|566072981|FG002|Period 1|Withdrawal by Subject|0|||
156815357|NCT02998671|566072982|FG003|Period 1|Withdrawal by Subject|0|||
156815358|NCT02998671|566072983|FG004|Period 1|Withdrawal by Subject|2|||
156815359|NCT02998671|566072979|FG000|Period 1|Pregnancy|1|||
156815360|NCT02998671|566072980|FG001|Period 1|Pregnancy|0|||
156815361|NCT02998671|566072981|FG002|Period 1|Pregnancy|0|||
156815362|NCT02998671|566072982|FG003|Period 1|Pregnancy|0|||
156815363|NCT02998671|566072983|FG004|Period 1|Pregnancy|0|||
156815364|NCT02998671|566072979|FG000|Period 1|Adverse Event|0|||
156815365|NCT02998671|566072980|FG001|Period 1|Adverse Event|0|||
156815366|NCT02998671|566072981|FG002|Period 1|Adverse Event|0|||
156815367|NCT02998671|566072982|FG003|Period 1|Adverse Event|0|||
156815368|NCT02998671|566072983|FG004|Period 1|Adverse Event|1|||
156464879|NCT02467270|564800132|FG001|Overall Study|Pregnancy|1|||
156815369|NCT02998671|566072979|FG000|Period 2|Adverse Event|0|||
156815370|NCT02998671|566072980|FG001|Period 2|Adverse Event|1|||
156815371|NCT02998671|566072981|FG002|Period 2|Adverse Event|0|||
156815372|NCT02998671|566072982|FG003|Period 2|Adverse Event|0|||
156815373|NCT02998671|566072983|FG004|Period 2|Adverse Event|0|||
156815374|NCT02998671|566072979|FG000|Period 2|Study Terminated By Sponsor|3|||
156815375|NCT02998671|566072980|FG001|Period 2|Study Terminated By Sponsor|5|||
156815376|NCT02998671|566072981|FG002|Period 2|Study Terminated By Sponsor|1|||
156815377|NCT02998671|566072982|FG003|Period 2|Study Terminated By Sponsor|3|||
156815378|NCT02998671|566072983|FG004|Period 2|Study Terminated By Sponsor|0|||
156815379|NCT02998671|566072979|FG000|Period 2|Withdrawal by Subject|0|||
156464880|NCT02467270|564800133|FG002|Overall Study|Pregnancy|0|||
156464881|NCT02467270|564800131|FG000|Overall Study|Physician Decision|0|||
156464882|NCT02467270|564800132|FG001|Overall Study|Physician Decision|4|||
156464883|NCT02467270|564800133|FG002|Overall Study|Physician Decision|1|||
156464884|NCT02467270|564800131|FG000|Overall Study|Withdrawal by Subject|4|||
156464885|NCT02467270|564800132|FG001|Overall Study|Withdrawal by Subject|3|||
156464886|NCT02467270|564800133|FG002|Overall Study|Withdrawal by Subject|5|||
156464887|NCT02467270|564800131|FG000|Overall Study|Reason not Specified|1|||
156815380|NCT02998671|566072980|FG001|Period 2|Withdrawal by Subject|1|||
156815381|NCT02998671|566072981|FG002|Period 2|Withdrawal by Subject|0|||
156815382|NCT02998671|566072982|FG003|Period 2|Withdrawal by Subject|0|||
156815383|NCT02998671|566072983|FG004|Period 2|Withdrawal by Subject|0|||
156815384|NCT02998671|566072979|FG000|Period 2|Lost to Follow-up|0|||
156815385|NCT02998671|566072980|FG001|Period 2|Lost to Follow-up|0|||
156815386|NCT02998671|566072981|FG002|Period 2|Lost to Follow-up|0|||
156815387|NCT02998671|566072982|FG003|Period 2|Lost to Follow-up|1|||
156815388|NCT02998671|566072983|FG004|Period 2|Lost to Follow-up|0|||
156815389|NCT01558596|566072984|FG000|Overall Study|Withdrawal by Subject|1|||
156815390|NCT01558596|566072985|FG001|Overall Study|Withdrawal by Subject|0|||
156815391|NCT01558596|566072984|FG000|Overall Study|surgery elsewhere or cancelled|1|||
156815392|NCT01558596|566072985|FG001|Overall Study|surgery elsewhere or cancelled|1|||
156815393|NCT01558596|566072984|FG000|Overall Study|Protocol Violation|1|||
156815394|NCT01558596|566072985|FG001|Overall Study|Protocol Violation|0|||
156815395|NCT02038946|566072987|FG000|Overall Study|Death|5|||
156815396|NCT02038946|566072987|FG000|Overall Study|Withdrawal by Subject|3|||
156815397|NCT02038946|566072987|FG000|Overall Study|Lost to Follow-up|2|||
156815398|NCT02038946|566072987|FG000|Overall Study|Other reasons|2|||
156815399|NCT02473471|566072990|FG000|Overall Study|poor oral hygiene|2|||
156815400|NCT02473471|566072990|FG000|Overall Study|Lost to Follow-up|1|||
156815401|NCT00191945|566072994|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
156815402|NCT00191945|566072995|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
156815403|NCT00191945|566072994|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
156815404|NCT00191945|566072995|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
156815405|NCT00191945|566072994|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
156815406|NCT00191945|566072995|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
156815407|NCT00191945|566072994|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
156815408|NCT00191945|566072995|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
156815409|NCT02063984|566072997|FG000|Overall Study|Lost to Follow-up|6|||
156815410|NCT02063984|566072998|FG001|Overall Study|Lost to Follow-up|5|||
156815411|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
156815412|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
156815413|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
156815414|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
156464888|NCT02467270|564800132|FG001|Overall Study|Reason not Specified|2|||
156464889|NCT02467270|564800133|FG002|Overall Study|Reason not Specified|1|||
156464890|NCT00495677|564800135|FG000|Stage 1 (25 Days)|Adverse Event|0|||
156464891|NCT00495677|564800136|FG001|Stage 1 (25 Days)|Adverse Event|0|||
156464892|NCT00495677|564800137|FG002|Stage 1 (25 Days)|Adverse Event|1|||
156464893|NCT00495677|564800138|FG003|Stage 1 (25 Days)|Adverse Event|0|||
156464894|NCT00495677|564800139|FG004|Stage 1 (25 Days)|Adverse Event|0|||
156464895|NCT00495677|564800140|FG005|Stage 1 (25 Days)|Adverse Event|0|||
156464896|NCT00495677|564800141|FG006|Stage 1 (25 Days)|Adverse Event|0|||
156464897|NCT02567435|564800144|FG000|Overall Study|Death|1|||
156464898|NCT02567435|564800145|FG001|Overall Study|Death|1|||
156464899|NCT02567435|564800146|FG002|Overall Study|Death|0|||
156464900|NCT02567435|564800147|FG003|Overall Study|Death|0|||
156464901|NCT02567435|564800144|FG000|Overall Study|Ineligible|1|||
156464902|NCT02567435|564800145|FG001|Overall Study|Ineligible|3|||
156464903|NCT02567435|564800146|FG002|Overall Study|Ineligible|0|||
156464904|NCT02567435|564800147|FG003|Overall Study|Ineligible|0|||
156464905|NCT02567435|564800144|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
156464906|NCT02567435|564800145|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
156464907|NCT02567435|564800146|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
156464908|NCT02567435|564800147|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
156464909|NCT02532621|564800148|FG000|Overall Study|Death|3|||
156464910|NCT02532621|564800148|FG000|Overall Study|Lost to Follow-up|3|||
156464911|NCT02532621|564800148|FG000|Overall Study|Withdrawal by Subject|6|||
156464912|NCT02532621|564800148|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
156464913|NCT02532621|564800148|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
156464914|NCT05771467|564800149|FG000|Overall Study|Lost to Follow-up|6|||
156464915|NCT05771467|564800150|FG001|Overall Study|Lost to Follow-up|3|||
156464916|NCT01220531|564800153|FG000|Overall Study|Death|7|||
156815415|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
156464917|NCT01220531|564800153|FG000|Overall Study|Lost to Follow-up|1|||
156464918|NCT05866926|564800157|FG000|Overall Study|Death|16|||
156815416|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
156815417|NCT01030952|566073004|FG000|Overall Study|Protocol Violation|0|||
156815418|NCT01030952|566073005|FG001|Overall Study|Protocol Violation|1|||
156815419|NCT01030952|566073004|FG000|Overall Study|Informed consent withdrawal|1|||
156815420|NCT01030952|566073005|FG001|Overall Study|Informed consent withdrawal|0|||
156815421|NCT01030952|566073004|FG000|Overall Study|Lost to Follow-up|0|||
156464919|NCT05866926|564800158|FG001|Overall Study|Death|9|||
156464920|NCT05866926|564800157|FG000|Overall Study|Lost to Follow-up|0|||
156464921|NCT05866926|564800158|FG001|Overall Study|Lost to Follow-up|1|||
156815422|NCT01030952|566073005|FG001|Overall Study|Lost to Follow-up|1|||
156815423|NCT01030952|566073004|FG000|Overall Study|Unexplained|1|||
156815424|NCT01030952|566073005|FG001|Overall Study|Unexplained|1|||
156815425|NCT03583359|566073006|FG000|Overall Study|Withdrawal by Subject|15|||
156815426|NCT03583359|566073007|FG001|Overall Study|Withdrawal by Subject|6|||
156815427|NCT03583359|566073006|FG000|Overall Study|Lost to Follow-up|12|||
156815428|NCT03583359|566073007|FG001|Overall Study|Lost to Follow-up|3|||
156815429|NCT03583359|566073006|FG000|Overall Study|Adverse Event|0|||
156815430|NCT03583359|566073007|FG001|Overall Study|Adverse Event|1|||
156815431|NCT03583359|566073006|FG000|Overall Study|Protocol Violation|0|||
156815432|NCT03583359|566073007|FG001|Overall Study|Protocol Violation|1|||
156815433|NCT03583359|566073006|FG000|Overall Study|Other|2|||
156815434|NCT03583359|566073007|FG001|Overall Study|Other|1|||
156815435|NCT00429182|566073014|FG000|Overall Study|Not evaluable, Disease Progression|2|||
156815436|NCT00429182|566073014|FG000|Overall Study|Not eligible|5|||
156815437|NCT02146131|566073018|FG000|Overall Study|Physician Decision|61|||
156815438|NCT02146131|566073019|FG001|Overall Study|Physician Decision|56|||
156815439|NCT02567799|566073020|FG000|Concurrent Chemoradiotherapy|Death|1|||
156815440|NCT02567799|566073021|FG001|Concurrent Chemoradiotherapy|Death|0|||
156815441|NCT02567799|566073022|FG002|Concurrent Chemoradiotherapy|Death|0|||
156815442|NCT02567799|566073020|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
156815443|NCT02567799|566073021|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
156815444|NCT02567799|566073022|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
156815445|NCT02567799|566073020|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
156815446|NCT02567799|566073021|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
156815447|NCT02567799|566073022|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
156815448|NCT02567799|566073020|FG000|Follow-up|Death|1|||
156815449|NCT02567799|566073021|FG001|Follow-up|Death|0|||
156815450|NCT02567799|566073022|FG002|Follow-up|Death|1|||
156815451|NCT02567799|566073020|FG000|Follow-up|Progressive Disease|1|||
156815452|NCT02567799|566073021|FG001|Follow-up|Progressive Disease|1|||
156815453|NCT02567799|566073022|FG002|Follow-up|Progressive Disease|3|||
156815454|NCT01042158|566073025|FG000|Overall Study|Physician Decision|1|||
156815455|NCT01014767|566075276|FG000|Overall Study|PI left institution, data unavailable|12|||
156815456|NCT01014767|566075277|FG001|Overall Study|PI left institution, data unavailable|1|||
156815457|NCT01014767|566075278|FG002|Overall Study|PI left institution, data unavailable|4|||
156815458|NCT01014767|566075279|FG003|Overall Study|PI left institution, data unavailable|1|||
156815459|NCT01709110|566075280|FG000|Overall Study|Adverse Event|56|||
156815460|NCT01709110|566075281|FG001|Overall Study|Adverse Event|48|||
156815461|NCT01709110|566075280|FG000|Overall Study|Death|14|||
156815462|NCT01709110|566075281|FG001|Overall Study|Death|6|||
156815463|NCT01709110|566075280|FG000|Overall Study|Lost to Follow-up|7|||
156815464|NCT01709110|566075281|FG001|Overall Study|Lost to Follow-up|5|||
156815465|NCT01709110|566075280|FG000|Overall Study|Protocol Violation|4|||
156815466|NCT01709110|566075281|FG001|Overall Study|Protocol Violation|6|||
156815467|NCT01709110|566075280|FG000|Overall Study|Withdrawal by Subject|96|||
156464922|NCT05866926|564800157|FG000|Overall Study|Adverse Event|1|||
156464923|NCT05866926|564800158|FG001|Overall Study|Adverse Event|0|||
156464924|NCT05866926|564800157|FG000|Overall Study|Withdrawal by Subject|5|||
156464925|NCT05866926|564800158|FG001|Overall Study|Withdrawal by Subject|1|||
156464926|NCT05866926|564800157|FG000|Overall Study|Disease progression|1|||
156464927|NCT05866926|564800158|FG001|Overall Study|Disease progression|0|||
156464928|NCT05866926|564800157|FG000|Overall Study|other causes|2|||
156464929|NCT05866926|564800158|FG001|Overall Study|other causes|1|||
156464930|NCT00709956|564800159|FG000|Overall Study|Withdrawal by Subject|1|||
156464931|NCT00709956|564800160|FG001|Overall Study|Withdrawal by Subject|1|||
156464932|NCT00709956|564800159|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
156464933|NCT00709956|564800160|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
156464934|NCT01105091|564800161|FG000|Overall Study|Death|2|||
156464935|NCT01105091|564800162|FG001|Overall Study|Death|0|||
156464936|NCT02206828|564800165|FG000|Overall Study|Lost to Follow-up|7|||
156464937|NCT04039113|564800170|FG000|Overall Study|Withdrawal by Subject|8|||
156464938|NCT04039113|564800171|FG001|Overall Study|Withdrawal by Subject|11|||
156464939|NCT04039113|564800170|FG000|Overall Study|Lost to Follow-up|1|||
156464940|NCT04039113|564800171|FG001|Overall Study|Lost to Follow-up|1|||
156464941|NCT04039113|564800170|FG000|Overall Study|Adverse Event|2|||
156464942|NCT04039113|564800171|FG001|Overall Study|Adverse Event|2|||
156464943|NCT04039113|564800170|FG000|Overall Study|Death|2|||
156464944|NCT04039113|564800171|FG001|Overall Study|Death|4|||
156815468|NCT01709110|566075281|FG001|Overall Study|Withdrawal by Subject|89|||
156464945|NCT04039113|564800170|FG000|Overall Study|Site Closure|6|||
156464946|NCT04039113|564800171|FG001|Overall Study|Site Closure|0|||
156464947|NCT04039113|564800170|FG000|Overall Study|Failure to meet randomisation criteria|4|||
156815469|NCT01709110|566075280|FG000|Overall Study|Physician Decision|4|||
156815470|NCT01709110|566075281|FG001|Overall Study|Physician Decision|10|||
156815471|NCT01709110|566075280|FG000|Overall Study|Sponsor Decision|2|||
156815472|NCT01709110|566075281|FG001|Overall Study|Sponsor Decision|2|||
156815473|NCT01709110|566075280|FG000|Overall Study|Lack of Efficacy|1|||
156815474|NCT01709110|566075281|FG001|Overall Study|Lack of Efficacy|1|||
156815475|NCT01709110|566075280|FG000|Overall Study|Caregiver Decision|1|||
156815476|NCT01709110|566075281|FG001|Overall Study|Caregiver Decision|1|||
156815477|NCT04123093|566075285|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
156815478|NCT04123093|566075286|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
156815479|NCT04123093|566075285|FG000|Phase 2|Physician Decision|0|||
156815480|NCT04123093|566075286|FG001|Phase 2|Physician Decision|1|||
156815481|NCT04123093|566075285|FG000|Phase 2|Withdrawal by Subject|0|||
156815482|NCT04123093|566075286|FG001|Phase 2|Withdrawal by Subject|1|||
156815483|NCT01164891|566075291|FG000|Overall Study|Disease Progression|5|||
156815484|NCT01164891|566075291|FG000|Overall Study|Adverse Event|1|||
156815485|NCT00338286|566075292|FG000|Overall Study|Withdrawal by Subject|50|||
156815486|NCT00338286|566075293|FG001|Overall Study|Withdrawal by Subject|54|||
156815487|NCT00338286|566075292|FG000|Overall Study|Lost to Follow-up|80|||
156815488|NCT00338286|566075293|FG001|Overall Study|Lost to Follow-up|66|||
156815489|NCT00338286|566075292|FG000|Overall Study|Other|103|||
156815490|NCT00338286|566075293|FG001|Overall Study|Other|93|||
156815491|NCT01265563|566075294|FG000|Overall Study|Withdrawal by Subject|0|||
156815492|NCT01265563|566075295|FG001|Overall Study|Withdrawal by Subject|1|||
156815493|NCT01265563|566075296|FG002|Overall Study|Withdrawal by Subject|1|||
156815494|NCT01265563|566075297|FG003|Overall Study|Withdrawal by Subject|0|||
156815495|NCT01265563|566075298|FG004|Overall Study|Withdrawal by Subject|2|||
156815496|NCT04908865|566075299|FG000|Overall Study|Adverse Event|2|||
156815497|NCT04908865|566075299|FG000|Overall Study|Lack of Efficacy|5|||
156815498|NCT04908865|566075299|FG000|Overall Study|Lost to Follow-up|1|||
156815499|NCT02550288|566075300|FG000|Overall Study|Adverse Event|0|||
156815500|NCT02550288|566075301|FG001|Overall Study|Adverse Event|1|||
156815501|NCT02550288|566075302|FG002|Overall Study|Adverse Event|0|||
156815502|NCT02550288|566075303|FG003|Overall Study|Adverse Event|0|||
156815503|NCT02550288|566075304|FG004|Overall Study|Adverse Event|0|||
156815504|NCT02550288|566075300|FG000|Overall Study|Physician Decision|0|||
156815505|NCT02550288|566075301|FG001|Overall Study|Physician Decision|0|||
156815506|NCT02550288|566075302|FG002|Overall Study|Physician Decision|0|||
156815507|NCT02550288|566075303|FG003|Overall Study|Physician Decision|1|||
156815508|NCT02550288|566075304|FG004|Overall Study|Physician Decision|0|||
156815509|NCT02550288|566075300|FG000|Overall Study|Protocol Violation|2|||
156815510|NCT02550288|566075301|FG001|Overall Study|Protocol Violation|2|||
156815511|NCT02550288|566075302|FG002|Overall Study|Protocol Violation|1|||
156815512|NCT02550288|566075303|FG003|Overall Study|Protocol Violation|0|||
156815513|NCT02550288|566075304|FG004|Overall Study|Protocol Violation|3|||
156815514|NCT02550288|566075300|FG000|Overall Study|Participant moved|0|||
156815515|NCT02550288|566075301|FG001|Overall Study|Participant moved|0|||
156815516|NCT02550288|566075302|FG002|Overall Study|Participant moved|0|||
156815517|NCT02550288|566075303|FG003|Overall Study|Participant moved|1|||
156815518|NCT02550288|566075304|FG004|Overall Study|Participant moved|0|||
156815519|NCT02550288|566075300|FG000|Overall Study|Withdrawal by Subject|0|||
156815520|NCT02550288|566075301|FG001|Overall Study|Withdrawal by Subject|0|||
156815521|NCT02550288|566075302|FG002|Overall Study|Withdrawal by Subject|0|||
156815522|NCT02550288|566075303|FG003|Overall Study|Withdrawal by Subject|1|||
156815523|NCT02550288|566075304|FG004|Overall Study|Withdrawal by Subject|0|||
156815524|NCT05312697|566075305|FG000|Overall Study|Sponsor Terminated Trial|2|||
156815525|NCT05420961|566075306|FG000|Overall Study|Withdrawal by Subject|2|||
156815526|NCT05420961|566075307|FG001|Overall Study|Withdrawal by Subject|1|||
156815527|NCT05420961|566075308|FG002|Overall Study|Withdrawal by Subject|1|||
156815528|NCT05420961|566075309|FG003|Overall Study|Withdrawal by Subject|0|||
156815529|NCT05420961|566075310|FG004|Overall Study|Withdrawal by Subject|0|||
156815530|NCT05420961|566075306|FG000|Overall Study|Lost to Follow-up|0|||
156815531|NCT05420961|566075307|FG001|Overall Study|Lost to Follow-up|0|||
156815532|NCT05420961|566075308|FG002|Overall Study|Lost to Follow-up|1|||
156815533|NCT05420961|566075309|FG003|Overall Study|Lost to Follow-up|0|||
156815534|NCT05420961|566075310|FG004|Overall Study|Lost to Follow-up|0|||
156815535|NCT05420961|566075306|FG000|Overall Study|Randomized by mistake without study treatment|0|||
156815536|NCT05420961|566075307|FG001|Overall Study|Randomized by mistake without study treatment|0|||
156815537|NCT05420961|566075308|FG002|Overall Study|Randomized by mistake without study treatment|1|||
156815538|NCT05420961|566075309|FG003|Overall Study|Randomized by mistake without study treatment|0|||
156815539|NCT05420961|566075310|FG004|Overall Study|Randomized by mistake without study treatment|1|||
156464948|NCT04039113|564800171|FG001|Overall Study|Failure to meet randomisation criteria|0|||
156464949|NCT00353496|564800172|FG000|Overall Study|Adverse Event|1|||
156464950|NCT00353496|564800173|FG001|Overall Study|Adverse Event|0|||
156464951|NCT00353496|564800172|FG000|Overall Study|Protocol Violation|2|||
156464952|NCT00353496|564800173|FG001|Overall Study|Protocol Violation|2|||
156464953|NCT00353496|564800172|FG000|Overall Study|Withdrawal by Subject|3|||
156464954|NCT00353496|564800173|FG001|Overall Study|Withdrawal by Subject|4|||
156464955|NCT00353496|564800172|FG000|Overall Study|Physician Decision|6|||
156464956|NCT00353496|564800173|FG001|Overall Study|Physician Decision|9|||
156464957|NCT00353496|564800172|FG000|Overall Study|Not otherwise specified|4|||
156464958|NCT00353496|564800173|FG001|Overall Study|Not otherwise specified|2|||
156815540|NCT00783835|566075311|FG000|Overall Study|Adverse Event|3|||
156815541|NCT00783835|566075311|FG000|Overall Study|Medical Criteria|1|||
156815542|NCT00783835|566075311|FG000|Overall Study|Withdrawal by Subject|2|||
156815543|NCT00783835|566075311|FG000|Overall Study|Lost to Follow-up|1|||
156815544|NCT00783835|566075311|FG000|Overall Study|Participant not Adherent|3|||
156815545|NCT01945996|566075312|FG000|Overall Study|Lost to Follow-up|3|||
156815546|NCT01945996|566075313|FG001|Overall Study|Lost to Follow-up|5|||
156815547|NCT03248167|566075314|FG000|Overall Study|Withdrawal by Subject|2|||
156815548|NCT03248167|566075315|FG001|Overall Study|Withdrawal by Subject|2|||
156815549|NCT03248167|566075314|FG000|Overall Study|Physician Decision|0|||
156815550|NCT03248167|566075315|FG001|Overall Study|Physician Decision|1|||
156815551|NCT03248167|566075314|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
156815552|NCT03248167|566075315|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
156815553|NCT03248167|566075314|FG000|Overall Study|Lost to Follow-up|1|||
156815554|NCT03248167|566075315|FG001|Overall Study|Lost to Follow-up|0|||
156815555|NCT02122146|566075316|FG000|Part 1: Dose Escalation|Death|0|||
156815556|NCT02122146|566075317|FG001|Part 1: Dose Escalation|Death|1|||
156815557|NCT02122146|566075318|FG002|Part 1: Dose Escalation|Death|1|||
156815558|NCT02122146|566075319|FG003|Part 1: Dose Escalation|Death|0|||
156815559|NCT02122146|566075320|FG004|Part 1: Dose Escalation|Death|0|||
156815560|NCT02122146|566075321|FG005|Part 1: Dose Escalation|Death|0|||
156815561|NCT02122146|566075322|FG006|Part 1: Dose Escalation|Death|0|||
156815562|NCT02122146|566075323|FG007|Part 1: Dose Escalation|Death|0|||
156815563|NCT02122146|566075316|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815564|NCT02122146|566075317|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815565|NCT02122146|566075318|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
156815566|NCT02122146|566075319|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815567|NCT02122146|566075320|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
156815568|NCT02122146|566075321|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815569|NCT02122146|566075322|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815570|NCT02122146|566075323|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815571|NCT02122146|566075316|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815572|NCT02122146|566075317|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815573|NCT02122146|566075318|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815574|NCT02122146|566075319|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
156815575|NCT02122146|566075320|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815576|NCT02122146|566075321|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815577|NCT02122146|566075322|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815578|NCT02122146|566075323|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815579|NCT02122146|566075316|FG000|Part 1: Dose Escalation|Other|1|||
156815580|NCT02122146|566075317|FG001|Part 1: Dose Escalation|Other|0|||
156815581|NCT02122146|566075318|FG002|Part 1: Dose Escalation|Other|0|||
156815582|NCT02122146|566075319|FG003|Part 1: Dose Escalation|Other|0|||
156815583|NCT02122146|566075320|FG004|Part 1: Dose Escalation|Other|0|||
156815584|NCT02122146|566075321|FG005|Part 1: Dose Escalation|Other|1|||
156815585|NCT02122146|566075322|FG006|Part 1: Dose Escalation|Other|1|||
156815586|NCT02122146|566075323|FG007|Part 1: Dose Escalation|Other|2|||
156815587|NCT00992056|566075328|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
156815588|NCT00992056|566075329|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
156815589|NCT00992056|566075328|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
156815590|NCT00992056|566075329|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
156815591|NCT02467192|566075337|FG000|Overall Study|Death|1|||
156815592|NCT02467192|566075337|FG000|Overall Study|revealed to have pneumonia before|2|||
156815593|NCT01814046|566075339|FG000|Drug Administration|Death due to complications of RSV|1|||
156815594|NCT01814046|566075340|FG001|Drug Administration|Death due to complications of RSV|0|||
156815595|NCT01814046|566075341|FG002|Drug Administration|Death due to complications of RSV|0|||
156815596|NCT00564902|566075342|FG000|Overall Study|Withdrawal by Subject|0|||
156815597|NCT00564902|566075343|FG001|Overall Study|Withdrawal by Subject|3|||
156815598|NCT00564902|566075344|FG002|Overall Study|Withdrawal by Subject|4|||
156815599|NCT00564902|566075342|FG000|Overall Study|Death|1|||
156815600|NCT00564902|566075343|FG001|Overall Study|Death|1|||
156815601|NCT00564902|566075344|FG002|Overall Study|Death|0|||
156815602|NCT00958347|566075345|FG000|Overall Study|Death|43|||
156815603|NCT00958347|566075345|FG000|Overall Study|Withdrawal by Subject|23|||
156815604|NCT00958347|566075345|FG000|Overall Study|Lost to Follow-up|15|||
156815605|NCT00958347|566075345|FG000|Overall Study|revision/removal|10|||
156815606|NCT00958347|566075345|FG000|Overall Study|study termination|135|||
156539507|NCT01970488|565069728|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
156815607|NCT04552288|566075348|FG000|Overall Study|Death|3|||
156815608|NCT04552288|566075348|FG000|Overall Study|Lost to Follow-up|6|||
156815609|NCT04552288|566075348|FG000|Overall Study|Physician Decision|3|||
156815610|NCT04552288|566075348|FG000|Overall Study|Protocol Violation|9|||
156815611|NCT04552288|566075348|FG000|Overall Study|Withdrawal by Subject|6|||
156815612|NCT04552288|566075348|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
156815613|NCT01603043|566075349|FG000|Overall Study|Study Futility|7|||
156815614|NCT01603043|566075350|FG001|Overall Study|Study Futility|3|||
156815615|NCT03089047|566075351|FG000|Overall Study|Lost to Follow-up|1|||
156815616|NCT03089047|566075352|FG001|Overall Study|Lost to Follow-up|0|||
156815617|NCT03599518|566075367|FG000|Overall Study|Clinical progression|0|||
156815618|NCT03599518|566075368|FG001|Overall Study|Clinical progression|0|||
156815619|NCT03599518|566075369|FG002|Overall Study|Clinical progression|0|||
156815620|NCT03599518|566075370|FG003|Overall Study|Clinical progression|0|||
156815621|NCT03599518|566075371|FG004|Overall Study|Clinical progression|1|||
156815622|NCT03599518|566075367|FG000|Overall Study|Adverse Event|0|||
156815623|NCT03599518|566075368|FG001|Overall Study|Adverse Event|0|||
156815624|NCT03599518|566075369|FG002|Overall Study|Adverse Event|0|||
156815625|NCT03599518|566075370|FG003|Overall Study|Adverse Event|0|||
156815626|NCT03599518|566075371|FG004|Overall Study|Adverse Event|1|||
156815627|NCT03599518|566075367|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
156815628|NCT03599518|566075368|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
156815629|NCT03599518|566075369|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
156539508|NCT01970488|565069729|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
156815630|NCT03599518|566075370|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
156815631|NCT03599518|566075371|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
156815632|NCT03599518|566075367|FG000|Overall Study|Participant withdrawal from study treatment|0|||
156815633|NCT03599518|566075368|FG001|Overall Study|Participant withdrawal from study treatment|0|||
156815634|NCT03599518|566075369|FG002|Overall Study|Participant withdrawal from study treatment|1|||
156539509|NCT01970488|565069730|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
156539510|NCT01970488|565069731|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
156539511|NCT01970488|565069727|FG000|Part 2: Post Week 16|Physician Decision|0|||
156539512|NCT01970488|565069728|FG001|Part 2: Post Week 16|Physician Decision|0|||
156539513|NCT01970488|565069729|FG002|Part 2: Post Week 16|Physician Decision|0|||
156539514|NCT01970488|565069730|FG003|Part 2: Post Week 16|Physician Decision|0|||
156539515|NCT01970488|565069731|FG004|Part 2: Post Week 16|Physician Decision|1|||
156539516|NCT01970488|565069727|FG000|Part 2: Post Week 16|Non-compliance|0|||
156539517|NCT01970488|565069728|FG001|Part 2: Post Week 16|Non-compliance|0|||
156815635|NCT03599518|566075370|FG003|Overall Study|Participant withdrawal from study treatment|0|||
156815636|NCT03599518|566075371|FG004|Overall Study|Participant withdrawal from study treatment|0|||
156815637|NCT00375505|566075372|FG000|Overall Study|Adverse Event|1|||
156815638|NCT00375505|566075373|FG001|Overall Study|Adverse Event|2|||
156815639|NCT01831466|566075377|FG000|Overall Study|Protocol Violation|1|||
156815640|NCT01831466|566075378|FG001|Overall Study|Protocol Violation|1|||
156815641|NCT01831466|566075379|FG002|Overall Study|Protocol Violation|2|||
156815642|NCT01831466|566075380|FG003|Overall Study|Protocol Violation|0|||
156815643|NCT01831466|566075381|FG004|Overall Study|Protocol Violation|0|||
156815644|NCT01831466|566075382|FG005|Overall Study|Protocol Violation|1|||
156539518|NCT01970488|565069729|FG002|Part 2: Post Week 16|Non-compliance|1|||
156539519|NCT01970488|565069730|FG003|Part 2: Post Week 16|Non-compliance|0|||
156539520|NCT01970488|565069731|FG004|Part 2: Post Week 16|Non-compliance|0|||
156539521|NCT01970488|565069727|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
156539522|NCT01970488|565069728|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
156539523|NCT01970488|565069729|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
156539524|NCT01970488|565069730|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
156539525|NCT01970488|565069731|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
156539526|NCT01970488|565069727|FG000|Part 2: Post Week 16|Adverse Event|0|||
156539527|NCT01970488|565069728|FG001|Part 2: Post Week 16|Adverse Event|0|||
156539528|NCT01970488|565069729|FG002|Part 2: Post Week 16|Adverse Event|5|||
156539529|NCT01970488|565069730|FG003|Part 2: Post Week 16|Adverse Event|1|||
156539530|NCT01970488|565069731|FG004|Part 2: Post Week 16|Adverse Event|1|||
156539531|NCT01970488|565069727|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
156539532|NCT01970488|565069728|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
156815645|NCT01831466|566075383|FG006|Overall Study|Protocol Violation|0|||
156815646|NCT01831466|566075384|FG007|Overall Study|Protocol Violation|0|||
156815647|NCT01831466|566075385|FG008|Overall Study|Protocol Violation|0|||
156815648|NCT01831466|566075386|FG009|Overall Study|Protocol Violation|0|||
156815649|NCT01831466|566075387|FG010|Overall Study|Protocol Violation|0|||
156815650|NCT01831466|566075388|FG011|Overall Study|Protocol Violation|0|||
156815651|NCT01831466|566075377|FG000|Overall Study|Other|2|||
156815652|NCT01831466|566075378|FG001|Overall Study|Other|3|||
156815653|NCT01831466|566075379|FG002|Overall Study|Other|2|||
156815654|NCT01831466|566075380|FG003|Overall Study|Other|2|||
156815655|NCT01831466|566075381|FG004|Overall Study|Other|2|||
156815656|NCT01831466|566075382|FG005|Overall Study|Other|1|||
156815657|NCT01831466|566075383|FG006|Overall Study|Other|0|||
156815658|NCT01831466|566075384|FG007|Overall Study|Other|0|||
156539533|NCT01970488|565069729|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
156815659|NCT01831466|566075385|FG008|Overall Study|Other|0|||
156815660|NCT01831466|566075386|FG009|Overall Study|Other|0|||
156815661|NCT01831466|566075387|FG010|Overall Study|Other|0|||
156539534|NCT01970488|565069730|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
156815662|NCT01831466|566075388|FG011|Overall Study|Other|0|||
156815663|NCT01831466|566075377|FG000|Overall Study|Non-compliance with study treatment|2|||
156815664|NCT01831466|566075378|FG001|Overall Study|Non-compliance with study treatment|1|||
156815665|NCT01831466|566075379|FG002|Overall Study|Non-compliance with study treatment|1|||
156815666|NCT01831466|566075380|FG003|Overall Study|Non-compliance with study treatment|0|||
156815667|NCT01831466|566075381|FG004|Overall Study|Non-compliance with study treatment|0|||
156815668|NCT01831466|566075382|FG005|Overall Study|Non-compliance with study treatment|1|||
156815669|NCT01831466|566075383|FG006|Overall Study|Non-compliance with study treatment|0|||
156815670|NCT01831466|566075384|FG007|Overall Study|Non-compliance with study treatment|0|||
156815671|NCT01831466|566075385|FG008|Overall Study|Non-compliance with study treatment|0|||
156815672|NCT01831466|566075386|FG009|Overall Study|Non-compliance with study treatment|0|||
156815673|NCT01831466|566075387|FG010|Overall Study|Non-compliance with study treatment|0|||
156464959|NCT00945724|564800174|FG000|Overall Study|Withdrawal by Subject|2|||
156464960|NCT00945724|564800174|FG000|Overall Study|Physician Decision|1|||
156464961|NCT00945724|564800174|FG000|Overall Study|Adverse Event|5|||
156464962|NCT00945724|564800174|FG000|Overall Study|Second malignancy|1|||
156539535|NCT01970488|565069731|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
156815674|NCT01831466|566075388|FG011|Overall Study|Non-compliance with study treatment|0|||
156539536|NCT01970488|565069727|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
156539537|NCT01970488|565069728|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
156539538|NCT01970488|565069729|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
156539539|NCT01970488|565069730|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
156539540|NCT01970488|565069731|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
156539541|NCT01961349|565069732|FG000|Overall Study|Withdrawal by Subject|1|||
156539542|NCT01961349|565069733|FG001|Overall Study|Withdrawal by Subject|4|||
156539543|NCT01961349|565069734|FG002|Overall Study|Withdrawal by Subject|0|||
156539544|NCT01961349|565069732|FG000|Overall Study|Adverse Event|0|||
156539545|NCT01961349|565069733|FG001|Overall Study|Adverse Event|0|||
156539546|NCT01961349|565069734|FG002|Overall Study|Adverse Event|1|||
156539547|NCT01961349|565069732|FG000|Overall Study|registration error, personal reason etc|2|||
156539548|NCT01961349|565069733|FG001|Overall Study|registration error, personal reason etc|2|||
156539549|NCT01961349|565069734|FG002|Overall Study|registration error, personal reason etc|1|||
156539550|NCT05525689|565069736|FG000|Overall Study|Lost to Follow-up|1|||
156539551|NCT05525689|565069737|FG001|Overall Study|Lost to Follow-up|0|||
156539552|NCT01671111|565069742|FG000|Overall Study|Adverse Event|2|||
156539553|NCT01671111|565069742|FG000|Overall Study|Lack of Efficacy|1|||
156539554|NCT01671111|565069742|FG000|Overall Study|Withdrawal by Subject|2|||
156539555|NCT01671111|565069742|FG000|Overall Study|Physician Decision|1|||
156539556|NCT01671111|565069742|FG000|Overall Study|Other|24|||
156539557|NCT01231659|565069743|FG000|Overall Study|Adverse Event|9|||
156539558|NCT01231659|565069743|FG000|Overall Study|Disease Progression|48|||
156539559|NCT01231659|565069743|FG000|Overall Study|Death|2|||
156539560|NCT01231659|565069743|FG000|Overall Study|Patient refused to complete study visit|1|||
156539561|NCT01231659|565069743|FG000|Overall Study|Other protocol defined criteria|12|||
156539562|NCT01075412|565069748|FG000|Overall Study|Withdrawal by Subject|0|||
156539563|NCT01075412|565069749|FG001|Overall Study|Withdrawal by Subject|1|||
156539564|NCT00509067|565069750|FG000|Overall Study|Lost to Follow-up|1|||
156539565|NCT00509067|565069751|FG001|Overall Study|Lost to Follow-up|1|||
156539566|NCT00509067|565069750|FG000|Overall Study|Adverse Event|3|||
156539567|NCT00509067|565069751|FG001|Overall Study|Adverse Event|1|||
156539568|NCT00509067|565069750|FG000|Overall Study|Protocol Violation|0|||
156539569|NCT00509067|565069751|FG001|Overall Study|Protocol Violation|3|||
156539570|NCT00702325|565069765|FG000|Overall Study|Adverse Event|1|||
156539571|NCT00702325|565069766|FG001|Overall Study|Adverse Event|0|||
156539572|NCT00702325|565069765|FG000|Overall Study|Withdrawal by Subject|7|||
156539573|NCT00702325|565069766|FG001|Overall Study|Withdrawal by Subject|7|||
156539574|NCT00702325|565069765|FG000|Overall Study|Lost to Follow-up|3|||
156539575|NCT00702325|565069766|FG001|Overall Study|Lost to Follow-up|4|||
156539576|NCT00702325|565069765|FG000|Overall Study|Incorrect enrollment|5|||
156539577|NCT00702325|565069766|FG001|Overall Study|Incorrect enrollment|7|||
156539578|NCT00702325|565069765|FG000|Overall Study|Developed study discontinuation criteria|18|||
156539579|NCT00702325|565069766|FG001|Overall Study|Developed study discontinuation criteria|28|||
156539580|NCT00702325|565069765|FG000|Overall Study|Severe noncompliance to protocol|3|||
156539581|NCT00702325|565069766|FG001|Overall Study|Severe noncompliance to protocol|3|||
156539582|NCT00702325|565069765|FG000|Overall Study|Termination due to lab results|1|||
156539583|NCT00702325|565069766|FG001|Overall Study|Termination due to lab results|0|||
156815675|NCT01831466|566075377|FG000|Overall Study|Death|0|||
156815676|NCT01831466|566075378|FG001|Overall Study|Death|1|||
156815677|NCT01831466|566075379|FG002|Overall Study|Death|0|||
156815678|NCT01831466|566075380|FG003|Overall Study|Death|0|||
156539584|NCT00702325|565069765|FG000|Overall Study|Didn't follow study medication dosage|0|||
156539585|NCT00702325|565069766|FG001|Overall Study|Didn't follow study medication dosage|2|||
156539586|NCT00702325|565069765|FG000|Overall Study|Withdrew consent|0|||
156539587|NCT00702325|565069766|FG001|Overall Study|Withdrew consent|1|||
156539588|NCT00702325|565069765|FG000|Overall Study|Incorrectly Discontinued|0|||
156539589|NCT00702325|565069766|FG001|Overall Study|Incorrectly Discontinued|1|||
156539590|NCT04556136|565069770|FG000|Overall Study|Lost to Follow-up|6|||
156539591|NCT04556136|565069771|FG001|Overall Study|Lost to Follow-up|6|||
156815679|NCT01831466|566075381|FG004|Overall Study|Death|0|||
156815680|NCT01831466|566075382|FG005|Overall Study|Death|0|||
156815681|NCT01831466|566075383|FG006|Overall Study|Death|0|||
156815682|NCT01831466|566075384|FG007|Overall Study|Death|0|||
156815683|NCT01831466|566075385|FG008|Overall Study|Death|0|||
156815684|NCT01831466|566075386|FG009|Overall Study|Death|0|||
156815685|NCT01831466|566075387|FG010|Overall Study|Death|0|||
156815686|NCT01831466|566075388|FG011|Overall Study|Death|0|||
156815687|NCT01831466|566075377|FG000|Overall Study|Withdrawal by Subject|6|||
156815688|NCT01831466|566075378|FG001|Overall Study|Withdrawal by Subject|3|||
156815689|NCT01831466|566075379|FG002|Overall Study|Withdrawal by Subject|3|||
156815690|NCT01831466|566075380|FG003|Overall Study|Withdrawal by Subject|3|||
156815691|NCT01831466|566075381|FG004|Overall Study|Withdrawal by Subject|3|||
156815692|NCT01831466|566075382|FG005|Overall Study|Withdrawal by Subject|5|||
156815693|NCT01831466|566075383|FG006|Overall Study|Withdrawal by Subject|0|||
156815694|NCT01831466|566075384|FG007|Overall Study|Withdrawal by Subject|0|||
156815695|NCT01831466|566075385|FG008|Overall Study|Withdrawal by Subject|0|||
156815696|NCT01831466|566075386|FG009|Overall Study|Withdrawal by Subject|1|||
156815697|NCT01831466|566075387|FG010|Overall Study|Withdrawal by Subject|0|||
156815698|NCT01831466|566075388|FG011|Overall Study|Withdrawal by Subject|1|||
156539592|NCT04556136|565069770|FG000|Overall Study|Physician Decision|2|||
156539593|NCT04556136|565069771|FG001|Overall Study|Physician Decision|1|||
156539594|NCT04556136|565069770|FG000|Overall Study|Withdrawal by Subject|2|||
156539595|NCT04556136|565069771|FG001|Overall Study|Withdrawal by Subject|1|||
156539596|NCT01022502|565069774|FG000|Overall Study|Adverse Event|1|||
156539597|NCT01022502|565069774|FG000|Overall Study|employment related reasons|1|||
156539598|NCT01022502|565069774|FG000|Overall Study|Withdrawal by Subject|1|||
156539599|NCT03199040|565069782|FG000|Overall Study|Lack of Efficacy|2|||
156539600|NCT03199040|565069783|FG001|Overall Study|Lack of Efficacy|0|||
156539601|NCT03199040|565069782|FG000|Overall Study|Withdrawal by Subject|2|||
156539602|NCT03199040|565069783|FG001|Overall Study|Withdrawal by Subject|0|||
156815699|NCT01831466|566075377|FG000|Overall Study|Lost to Follow-up|0|||
156815700|NCT01831466|566075378|FG001|Overall Study|Lost to Follow-up|1|||
156815701|NCT01831466|566075379|FG002|Overall Study|Lost to Follow-up|4|||
156815702|NCT01831466|566075380|FG003|Overall Study|Lost to Follow-up|2|||
156815703|NCT01831466|566075381|FG004|Overall Study|Lost to Follow-up|0|||
156815704|NCT01831466|566075382|FG005|Overall Study|Lost to Follow-up|3|||
156815705|NCT01831466|566075383|FG006|Overall Study|Lost to Follow-up|0|||
156815706|NCT01831466|566075384|FG007|Overall Study|Lost to Follow-up|0|||
156815707|NCT01831466|566075385|FG008|Overall Study|Lost to Follow-up|0|||
156815708|NCT01831466|566075386|FG009|Overall Study|Lost to Follow-up|1|||
156815709|NCT01831466|566075387|FG010|Overall Study|Lost to Follow-up|0|||
156464963|NCT02502266|564800789|FG000|Overall Study|Adverse Event|0|||
156464964|NCT02502266|564800790|FG001|Overall Study|Adverse Event|0|||
156464965|NCT02502266|564800791|FG002|Overall Study|Adverse Event|0|||
156464966|NCT02502266|564800792|FG003|Overall Study|Adverse Event|0|||
156464967|NCT02502266|564800793|FG004|Overall Study|Adverse Event|1|||
156464968|NCT02502266|564800794|FG005|Overall Study|Adverse Event|1|||
156464969|NCT02502266|564800795|FG006|Overall Study|Adverse Event|1|||
156464970|NCT02502266|564800789|FG000|Overall Study|Withdrawal by Subject|30|||
156464971|NCT02502266|564800790|FG001|Overall Study|Withdrawal by Subject|15|||
156464972|NCT02502266|564800791|FG002|Overall Study|Withdrawal by Subject|16|||
156464973|NCT02502266|564800792|FG003|Overall Study|Withdrawal by Subject|0|||
156464974|NCT02502266|564800793|FG004|Overall Study|Withdrawal by Subject|0|||
156464975|NCT02502266|564800794|FG005|Overall Study|Withdrawal by Subject|0|||
156464976|NCT02502266|564800795|FG006|Overall Study|Withdrawal by Subject|0|||
156464977|NCT02502266|564800789|FG000|Overall Study|Still on Treatment|0|||
156464978|NCT02502266|564800790|FG001|Overall Study|Still on Treatment|0|||
156464979|NCT02502266|564800791|FG002|Overall Study|Still on Treatment|1|||
156464980|NCT02502266|564800792|FG003|Overall Study|Still on Treatment|0|||
156815710|NCT01831466|566075388|FG011|Overall Study|Lost to Follow-up|1|||
156815711|NCT01831466|566075377|FG000|Overall Study|Lack of Efficacy|5|||
156815712|NCT01831466|566075378|FG001|Overall Study|Lack of Efficacy|8|||
156815713|NCT01831466|566075379|FG002|Overall Study|Lack of Efficacy|7|||
156815714|NCT01831466|566075380|FG003|Overall Study|Lack of Efficacy|6|||
156464981|NCT02502266|564800793|FG004|Overall Study|Still on Treatment|0|||
156464982|NCT02502266|564800794|FG005|Overall Study|Still on Treatment|0|||
156464983|NCT02502266|564800795|FG006|Overall Study|Still on Treatment|0|||
156464984|NCT02502266|564800789|FG000|Overall Study|Other Reasons|19|||
156539603|NCT03199040|565069782|FG000|Overall Study|Adverse Event|0|||
156539604|NCT03199040|565069783|FG001|Overall Study|Adverse Event|1|||
156464985|NCT02502266|564800790|FG001|Overall Study|Other Reasons|6|||
156815715|NCT01831466|566075381|FG004|Overall Study|Lack of Efficacy|9|||
156815716|NCT01831466|566075382|FG005|Overall Study|Lack of Efficacy|8|||
156464986|NCT02502266|564800791|FG002|Overall Study|Other Reasons|14|||
156539605|NCT03199040|565069782|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
156815717|NCT01831466|566075383|FG006|Overall Study|Lack of Efficacy|1|||
156539606|NCT03199040|565069783|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
156539607|NCT01226459|565069784|FG000|Overall Study|Adverse Event|2|||
156539608|NCT01226459|565069785|FG001|Overall Study|Adverse Event|8|||
156539609|NCT01226459|565069784|FG000|Overall Study|Protocol Violation|4|||
156539610|NCT01226459|565069785|FG001|Overall Study|Protocol Violation|3|||
156539611|NCT01226459|565069784|FG000|Overall Study|Withdrawal by Subject|10|||
156539612|NCT01226459|565069785|FG001|Overall Study|Withdrawal by Subject|13|||
156539613|NCT01226459|565069784|FG000|Overall Study|Lost to Follow-up|4|||
156539614|NCT01226459|565069785|FG001|Overall Study|Lost to Follow-up|8|||
156539615|NCT01226459|565069784|FG000|Overall Study|Pregnancy|1|||
156539616|NCT01226459|565069785|FG001|Overall Study|Pregnancy|0|||
156539617|NCT01092143|565069786|FG000|Overall Study|Adverse Event|10|||
156539618|NCT01092143|565069787|FG001|Overall Study|Adverse Event|5|||
156539619|NCT01092143|565069788|FG002|Overall Study|Adverse Event|1|||
156539620|NCT01092143|565069789|FG003|Overall Study|Adverse Event|4|||
156539621|NCT01092143|565069790|FG004|Overall Study|Adverse Event|3|||
156539622|NCT01092143|565069786|FG000|Overall Study|Lost to Follow-up|1|||
156539623|NCT01092143|565069787|FG001|Overall Study|Lost to Follow-up|0|||
156539624|NCT01092143|565069788|FG002|Overall Study|Lost to Follow-up|1|||
156539625|NCT01092143|565069789|FG003|Overall Study|Lost to Follow-up|0|||
156539626|NCT01092143|565069790|FG004|Overall Study|Lost to Follow-up|0|||
156539627|NCT01092143|565069786|FG000|Overall Study|Consent withdrawn|2|||
156539628|NCT01092143|565069787|FG001|Overall Study|Consent withdrawn|1|||
156539629|NCT01092143|565069788|FG002|Overall Study|Consent withdrawn|0|||
156539630|NCT01092143|565069789|FG003|Overall Study|Consent withdrawn|1|||
156539631|NCT01092143|565069790|FG004|Overall Study|Consent withdrawn|3|||
156539632|NCT01092143|565069786|FG000|Overall Study|Not treated|0|||
156539633|NCT01092143|565069787|FG001|Overall Study|Not treated|0|||
156539634|NCT01092143|565069788|FG002|Overall Study|Not treated|1|||
156539635|NCT01092143|565069789|FG003|Overall Study|Not treated|0|||
156539636|NCT01092143|565069790|FG004|Overall Study|Not treated|0|||
156539637|NCT01092143|565069786|FG000|Overall Study|did not reversibility criteria|0|||
156539638|NCT01092143|565069787|FG001|Overall Study|did not reversibility criteria|0|||
156539639|NCT01092143|565069788|FG002|Overall Study|did not reversibility criteria|1|||
156539640|NCT01092143|565069789|FG003|Overall Study|did not reversibility criteria|0|||
156539641|NCT01092143|565069790|FG004|Overall Study|did not reversibility criteria|0|||
156539642|NCT01092143|565069786|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
156539643|NCT01092143|565069787|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
156539644|NCT01092143|565069788|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
156539645|NCT01092143|565069789|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
156539646|NCT01092143|565069790|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
156539647|NCT01092143|565069786|FG000|Overall Study|Ineligible patient|1|||
156539648|NCT01092143|565069787|FG001|Overall Study|Ineligible patient|0|||
156539649|NCT01092143|565069788|FG002|Overall Study|Ineligible patient|0|||
156539650|NCT01092143|565069789|FG003|Overall Study|Ineligible patient|0|||
156539651|NCT01092143|565069790|FG004|Overall Study|Ineligible patient|0|||
156539652|NCT01092143|565069786|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
156539653|NCT01092143|565069787|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
156539654|NCT01092143|565069788|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
156539655|NCT01092143|565069789|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
156539656|NCT01092143|565069790|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
156539657|NCT01092143|565069786|FG000|Overall Study|Patient travel|0|||
156539658|NCT01092143|565069787|FG001|Overall Study|Patient travel|0|||
156539659|NCT01092143|565069788|FG002|Overall Study|Patient travel|0|||
156539660|NCT01092143|565069789|FG003|Overall Study|Patient travel|0|||
156539661|NCT01092143|565069790|FG004|Overall Study|Patient travel|1|||
156539662|NCT01092143|565069786|FG000|Overall Study|Non compliance with study medication|0|||
156539663|NCT01092143|565069787|FG001|Overall Study|Non compliance with study medication|0|||
156539664|NCT01092143|565069788|FG002|Overall Study|Non compliance with study medication|0|||
156539665|NCT01092143|565069789|FG003|Overall Study|Non compliance with study medication|0|||
156539666|NCT01092143|565069790|FG004|Overall Study|Non compliance with study medication|1|||
156539667|NCT01092143|565069786|FG000|Overall Study|Randomized by mistake|0|||
156539668|NCT01092143|565069787|FG001|Overall Study|Randomized by mistake|0|||
156539669|NCT01092143|565069788|FG002|Overall Study|Randomized by mistake|0|||
156539670|NCT01092143|565069789|FG003|Overall Study|Randomized by mistake|1|||
156539671|NCT01092143|565069790|FG004|Overall Study|Randomized by mistake|0|||
156539672|NCT01092143|565069786|FG000|Overall Study|Pregnancy|0|||
156539673|NCT01092143|565069787|FG001|Overall Study|Pregnancy|0|||
156539674|NCT01092143|565069788|FG002|Overall Study|Pregnancy|0|||
156539675|NCT01092143|565069789|FG003|Overall Study|Pregnancy|1|||
156539676|NCT01092143|565069790|FG004|Overall Study|Pregnancy|0|||
156539677|NCT00117598|565069791|FG000|Prior to Treatment Cross Over|Death|40|||
156539678|NCT00117598|565069792|FG001|Prior to Treatment Cross Over|Death|41|||
156815718|NCT01831466|566075384|FG007|Overall Study|Lack of Efficacy|1|||
156815719|NCT01831466|566075385|FG008|Overall Study|Lack of Efficacy|2|||
156815720|NCT01831466|566075386|FG009|Overall Study|Lack of Efficacy|2|||
156815721|NCT01831466|566075387|FG010|Overall Study|Lack of Efficacy|2|||
156815722|NCT01831466|566075388|FG011|Overall Study|Lack of Efficacy|0|||
156815723|NCT01831466|566075377|FG000|Overall Study|Adverse Event|0|||
156815724|NCT01831466|566075378|FG001|Overall Study|Adverse Event|0|||
156815725|NCT01831466|566075379|FG002|Overall Study|Adverse Event|4|||
156815726|NCT01831466|566075380|FG003|Overall Study|Adverse Event|6|||
156815727|NCT01831466|566075381|FG004|Overall Study|Adverse Event|3|||
156815728|NCT01831466|566075382|FG005|Overall Study|Adverse Event|7|||
156815729|NCT01831466|566075383|FG006|Overall Study|Adverse Event|0|||
156815730|NCT01831466|566075384|FG007|Overall Study|Adverse Event|1|||
156815731|NCT01831466|566075385|FG008|Overall Study|Adverse Event|1|||
156815732|NCT01831466|566075386|FG009|Overall Study|Adverse Event|1|||
156815733|NCT01831466|566075387|FG010|Overall Study|Adverse Event|0|||
156815734|NCT01831466|566075388|FG011|Overall Study|Adverse Event|2|||
156815735|NCT00005947|566075389|FG000|Overall Study|Death|54|||
156815736|NCT00005947|566075390|FG001|Overall Study|Death|40|||
156815737|NCT00005947|566075389|FG000|Overall Study|Patient Refused to Continue|2|||
156815738|NCT00005947|566075390|FG001|Overall Study|Patient Refused to Continue|1|||
156815739|NCT00005947|566075389|FG000|Overall Study|Site Closure|1|||
156815740|NCT00005947|566075390|FG001|Overall Study|Site Closure|0|||
156815741|NCT03335150|566075392|FG000|Overall Study|Withdrawal by Subject|10|||
156815742|NCT03335150|566075393|FG001|Overall Study|Withdrawal by Subject|4|||
156815743|NCT03335150|566075392|FG000|Overall Study|Adverse Event|0|||
156815744|NCT03335150|566075393|FG001|Overall Study|Adverse Event|1|||
156815745|NCT00861692|566075398|FG000|Overall Study|Death|6|||
156464987|NCT02502266|564800792|FG003|Overall Study|Other Reasons|0|||
156464988|NCT02502266|564800793|FG004|Overall Study|Other Reasons|1|||
156464989|NCT02502266|564800794|FG005|Overall Study|Other Reasons|1|||
156464990|NCT02502266|564800795|FG006|Overall Study|Other Reasons|0|||
156464991|NCT02502266|564800789|FG000|Overall Study|Arm 4 Discontinued|0|||
156464992|NCT02502266|564800790|FG001|Overall Study|Arm 4 Discontinued|0|||
156464993|NCT02502266|564800791|FG002|Overall Study|Arm 4 Discontinued|0|||
156464994|NCT02502266|564800792|FG003|Overall Study|Arm 4 Discontinued|52|||
156464995|NCT02502266|564800793|FG004|Overall Study|Arm 4 Discontinued|0|||
156464996|NCT02502266|564800794|FG005|Overall Study|Arm 4 Discontinued|0|||
156464997|NCT02502266|564800795|FG006|Overall Study|Arm 4 Discontinued|0|||
156464998|NCT02502266|564800789|FG000|Overall Study|Never treated|0|||
156464999|NCT02502266|564800790|FG001|Overall Study|Never treated|0|||
156465000|NCT02502266|564800791|FG002|Overall Study|Never treated|0|||
156465001|NCT02502266|564800792|FG003|Overall Study|Never treated|0|||
156465002|NCT02502266|564800793|FG004|Overall Study|Never treated|0|||
156465003|NCT02502266|564800794|FG005|Overall Study|Never treated|1|||
156465004|NCT02502266|564800795|FG006|Overall Study|Never treated|0|||
156465005|NCT02719574|564800796|FG000|Phase 1 (Dose Escalation)|Other|0|||
156465006|NCT02719574|564800797|FG001|Phase 1 (Dose Escalation)|Other|2|||
156539679|NCT00117598|565069793|FG002|Prior to Treatment Cross Over|Death|37|||
156539680|NCT00117598|565069794|FG003|Prior to Treatment Cross Over|Death|0|||
156539681|NCT00117598|565069795|FG004|Prior to Treatment Cross Over|Death|0|||
156815746|NCT02218697|566075401|FG000|Overall Study|Adverse Event|0|||
156815747|NCT02218697|566075402|FG001|Overall Study|Adverse Event|2|||
156815748|NCT02218697|566075401|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
156815749|NCT02218697|566075402|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
156815750|NCT02218697|566075401|FG000|Overall Study|Withdrawal by Subject|2|||
156465007|NCT02719574|564800798|FG002|Phase 1 (Dose Escalation)|Other|1|||
156465008|NCT02719574|564800799|FG003|Phase 1 (Dose Escalation)|Other|2|||
156539682|NCT00117598|565069791|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
156465009|NCT02719574|564800800|FG004|Phase 1 (Dose Escalation)|Other|2|||
156465010|NCT02719574|564800801|FG005|Phase 1 (Dose Escalation)|Other|0|||
156465011|NCT02719574|564800802|FG006|Phase 1 (Dose Escalation)|Other|0|||
156815751|NCT02218697|566075402|FG001|Overall Study|Withdrawal by Subject|3|||
156815752|NCT02142803|566075407|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
156815753|NCT02142803|566075408|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
156465012|NCT02719574|564800803|FG007|Phase 1 (Dose Escalation)|Other|0|||
156465013|NCT02719574|564800804|FG008|Phase 1 (Dose Escalation)|Other|0|||
156465014|NCT02719574|564800805|FG009|Phase 1 (Dose Escalation)|Other|0|||
156465015|NCT02719574|564800806|FG010|Phase 1 (Dose Escalation)|Other|0|||
156465016|NCT02719574|564800807|FG011|Phase 1 (Dose Escalation)|Other|0|||
156465017|NCT02719574|564800808|FG012|Phase 1 (Dose Escalation)|Other|0|||
156465018|NCT02719574|564800809|FG013|Phase 1 (Dose Escalation)|Other|0|||
156465019|NCT02719574|564800810|FG014|Phase 1 (Dose Escalation)|Other|0|||
156815754|NCT02142803|566075409|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
156815755|NCT02142803|566075410|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
156815756|NCT05111002|566075413|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
156815757|NCT05111002|566075414|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
156815758|NCT05111002|566075413|FG000|Secondary Outcome|Lost to Follow-up|1|||
156465020|NCT02719574|564800811|FG015|Phase 1 (Dose Escalation)|Other|0|||
156465021|NCT02719574|564800812|FG016|Phase 1 (Dose Escalation)|Other|0|||
156465022|NCT02719574|564800796|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
156465023|NCT02719574|564800797|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
156465024|NCT02719574|564800798|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
156465025|NCT02719574|564800799|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
156465026|NCT02719574|564800800|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
156465027|NCT02719574|564800801|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
156465028|NCT02719574|564800802|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465029|NCT02719574|564800803|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465030|NCT02719574|564800804|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465031|NCT02719574|564800805|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465032|NCT02719574|564800806|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465033|NCT02719574|564800807|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465034|NCT02719574|564800808|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465035|NCT02719574|564800809|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465036|NCT02719574|564800810|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465037|NCT02719574|564800811|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465038|NCT02719574|564800812|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
156465039|NCT02719574|564800796|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465040|NCT02719574|564800797|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
156465041|NCT02719574|564800798|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
156465042|NCT02719574|564800799|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465043|NCT02719574|564800800|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
156465044|NCT02719574|564800801|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
156465045|NCT02719574|564800802|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465046|NCT02719574|564800803|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465047|NCT02719574|564800804|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465048|NCT02719574|564800805|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465049|NCT02719574|564800806|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465050|NCT02719574|564800807|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465051|NCT02719574|564800808|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465052|NCT02719574|564800809|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465053|NCT02719574|564800810|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465054|NCT02719574|564800811|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465055|NCT02719574|564800812|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156465056|NCT02719574|564800796|FG000|Phase 1 (Dose Escalation)|Death|2|||
156465057|NCT02719574|564800797|FG001|Phase 1 (Dose Escalation)|Death|1|||
156465058|NCT02719574|564800798|FG002|Phase 1 (Dose Escalation)|Death|1|||
156465059|NCT02719574|564800799|FG003|Phase 1 (Dose Escalation)|Death|0|||
156465060|NCT02719574|564800800|FG004|Phase 1 (Dose Escalation)|Death|0|||
156815759|NCT05111002|566075414|FG001|Secondary Outcome|Lost to Follow-up|0|||
156815760|NCT04380753|566075415|FG000|Overall Study|Participants continuing study|4|||
156815761|NCT04380753|566075415|FG000|Overall Study|Death|2|||
156815762|NCT00809926|566075416|FG000|Overall Study|Adverse Event|18|||
156815763|NCT00809926|566075417|FG001|Overall Study|Adverse Event|10|||
156815764|NCT00809926|566075416|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156815765|NCT00809926|566075417|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156815766|NCT00809926|566075416|FG000|Overall Study|Patient withdrew consent|8|||
156815767|NCT00809926|566075417|FG001|Overall Study|Patient withdrew consent|6|||
156815768|NCT00809926|566075416|FG000|Overall Study|Lost to Follow-up|2|||
156465061|NCT02719574|564800801|FG005|Phase 1 (Dose Escalation)|Death|0|||
156465062|NCT02719574|564800802|FG006|Phase 1 (Dose Escalation)|Death|0|||
156465063|NCT02719574|564800803|FG007|Phase 1 (Dose Escalation)|Death|0|||
156465064|NCT02719574|564800804|FG008|Phase 1 (Dose Escalation)|Death|0|||
156815769|NCT00809926|566075417|FG001|Overall Study|Lost to Follow-up|1|||
156815770|NCT00809926|566075416|FG000|Overall Study|Administrative Problems|0|||
156815771|NCT00809926|566075417|FG001|Overall Study|Administrative Problems|1|||
156465065|NCT02719574|564800805|FG009|Phase 1 (Dose Escalation)|Death|0|||
156465066|NCT02719574|564800806|FG010|Phase 1 (Dose Escalation)|Death|0|||
156465067|NCT02719574|564800807|FG011|Phase 1 (Dose Escalation)|Death|0|||
156465068|NCT02719574|564800808|FG012|Phase 1 (Dose Escalation)|Death|0|||
156815772|NCT00809926|566075416|FG000|Overall Study|Protocol deviation|0|||
156815773|NCT00809926|566075417|FG001|Overall Study|Protocol deviation|2|||
156815774|NCT04776720|566075435|FG000|Overall Study|COVID Related|4|||
156815775|NCT04776720|566075436|FG001|Overall Study|COVID Related|2|||
156815776|NCT04776720|566075435|FG000|Overall Study|Adverse Event|2|||
156815777|NCT04776720|566075436|FG001|Overall Study|Adverse Event|0|||
156815778|NCT04776720|566075435|FG000|Overall Study|Serious Adverse Event|0|||
156815779|NCT04776720|566075436|FG001|Overall Study|Serious Adverse Event|1|||
156815780|NCT04776720|566075435|FG000|Overall Study|Too Busy|3|||
156815781|NCT04776720|566075436|FG001|Overall Study|Too Busy|1|||
156815782|NCT04776720|566075435|FG000|Overall Study|Lost to Follow-up|1|||
156815783|NCT04776720|566075436|FG001|Overall Study|Lost to Follow-up|2|||
156815784|NCT04776720|566075435|FG000|Overall Study|Family|2|||
156815785|NCT04776720|566075436|FG001|Overall Study|Family|2|||
156815786|NCT04776720|566075435|FG000|Overall Study|No remote technology access|0|||
156815787|NCT04776720|566075436|FG001|Overall Study|No remote technology access|1|||
156815788|NCT04776720|566075435|FG000|Overall Study|Withdrawal by Subject|1|||
156815789|NCT04776720|566075436|FG001|Overall Study|Withdrawal by Subject|0|||
156815790|NCT04776720|566075435|FG000|Overall Study|Cannot tolerate intervention|1|||
156815791|NCT04776720|566075436|FG001|Overall Study|Cannot tolerate intervention|0|||
156815792|NCT04776720|566075435|FG000|Overall Study|Incomplete outcome data|6|||
156815793|NCT04776720|566075436|FG001|Overall Study|Incomplete outcome data|1|||
156815794|NCT05356910|566075439|FG000|Overall Study|Lost to Follow-up|10|||
156815795|NCT05356910|566075440|FG001|Overall Study|Lost to Follow-up|19|||
156815796|NCT05356910|566075441|FG002|Overall Study|Lost to Follow-up|0|||
156815797|NCT05356910|566075442|FG003|Overall Study|Lost to Follow-up|0|||
156815798|NCT05356910|566075439|FG000|Overall Study|Withdrawal by Subject|4|||
156815799|NCT05356910|566075440|FG001|Overall Study|Withdrawal by Subject|2|||
156815800|NCT05356910|566075441|FG002|Overall Study|Withdrawal by Subject|0|||
156815801|NCT05356910|566075442|FG003|Overall Study|Withdrawal by Subject|0|||
156815802|NCT02712996|566075446|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
156815803|NCT02712996|566075447|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
156815804|NCT03306433|566075451|FG000|Overall Study|Lost to Follow-up|3|||
156815805|NCT03306433|566075451|FG000|Overall Study|Patient did not have teeth extracted|1|||
156815806|NCT03306433|566075451|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
156815807|NCT00819156|566075452|FG000|Overall Study|Adverse Event|1|||
156815808|NCT00819156|566075453|FG001|Overall Study|Adverse Event|4|||
156815809|NCT00819156|566075454|FG002|Overall Study|Adverse Event|2|||
156815810|NCT00819156|566075455|FG003|Overall Study|Adverse Event|1|||
156815811|NCT00819156|566075456|FG004|Overall Study|Adverse Event|2|||
156815812|NCT00819156|566075457|FG005|Overall Study|Adverse Event|3|||
156815813|NCT00819156|566075452|FG000|Overall Study|Withdrawal by Subject|0|||
156815814|NCT00819156|566075453|FG001|Overall Study|Withdrawal by Subject|3|||
156815815|NCT00819156|566075454|FG002|Overall Study|Withdrawal by Subject|2|||
156815816|NCT00819156|566075455|FG003|Overall Study|Withdrawal by Subject|0|||
156815817|NCT00819156|566075456|FG004|Overall Study|Withdrawal by Subject|1|||
156815818|NCT00819156|566075457|FG005|Overall Study|Withdrawal by Subject|0|||
156815819|NCT00819156|566075452|FG000|Overall Study|Protocol Violation|1|||
156815820|NCT00819156|566075453|FG001|Overall Study|Protocol Violation|0|||
156815821|NCT00819156|566075454|FG002|Overall Study|Protocol Violation|1|||
156815822|NCT00819156|566075455|FG003|Overall Study|Protocol Violation|0|||
156815823|NCT00819156|566075456|FG004|Overall Study|Protocol Violation|0|||
156815824|NCT00819156|566075457|FG005|Overall Study|Protocol Violation|1|||
156815825|NCT00819156|566075452|FG000|Overall Study|Lost to Follow-up|0|||
156815826|NCT00819156|566075453|FG001|Overall Study|Lost to Follow-up|1|||
156815827|NCT00819156|566075454|FG002|Overall Study|Lost to Follow-up|0|||
156815828|NCT00819156|566075455|FG003|Overall Study|Lost to Follow-up|0|||
156815829|NCT00819156|566075456|FG004|Overall Study|Lost to Follow-up|0|||
156815830|NCT00819156|566075457|FG005|Overall Study|Lost to Follow-up|2|||
156815831|NCT00819156|566075452|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
156815832|NCT00819156|566075453|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
156815833|NCT00819156|566075454|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
156815834|NCT00819156|566075455|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
156815835|NCT00819156|566075456|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
156815836|NCT00819156|566075457|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
156815837|NCT00819156|566075452|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
156815838|NCT00819156|566075453|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
156815839|NCT00819156|566075454|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
156815840|NCT00819156|566075455|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
156815841|NCT00819156|566075456|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
156815842|NCT00819156|566075457|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
156815843|NCT00819156|566075452|FG000|Overall Study|Prostate-specific antigen progression|0|||
156815844|NCT00819156|566075453|FG001|Overall Study|Prostate-specific antigen progression|0|||
156815845|NCT00819156|566075454|FG002|Overall Study|Prostate-specific antigen progression|0|||
156815846|NCT00819156|566075455|FG003|Overall Study|Prostate-specific antigen progression|0|||
156465069|NCT02719574|564800809|FG013|Phase 1 (Dose Escalation)|Death|0|||
156465070|NCT02719574|564800810|FG014|Phase 1 (Dose Escalation)|Death|0|||
156465071|NCT02719574|564800811|FG015|Phase 1 (Dose Escalation)|Death|0|||
156465072|NCT02719574|564800812|FG016|Phase 1 (Dose Escalation)|Death|0|||
156465073|NCT02719574|564800796|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
156815847|NCT00819156|566075456|FG004|Overall Study|Prostate-specific antigen progression|1|||
156815848|NCT00819156|566075457|FG005|Overall Study|Prostate-specific antigen progression|0|||
156815849|NCT00790582|566075458|FG000|Overall Study|Death|14|||
156815850|NCT00790582|566075459|FG001|Overall Study|Death|32|||
156815851|NCT00790582|566075458|FG000|Overall Study|Physician Decision|7|||
156815852|NCT00790582|566075459|FG001|Overall Study|Physician Decision|1|||
156815853|NCT00790582|566075458|FG000|Overall Study|Lost to Follow-up|3|||
156815854|NCT00790582|566075459|FG001|Overall Study|Lost to Follow-up|3|||
156815855|NCT00790582|566075458|FG000|Overall Study|Withdrawal by Subject|7|||
156815856|NCT00790582|566075459|FG001|Overall Study|Withdrawal by Subject|51|||
156815857|NCT00803595|566075460|FG000|Overall Study|Adverse Event|3|||
156815858|NCT00803595|566075461|FG001|Overall Study|Adverse Event|4|||
156815859|NCT00803595|566075462|FG002|Overall Study|Adverse Event|1|||
156815860|NCT00803595|566075460|FG000|Overall Study|Protocol Violation|7|||
156815861|NCT00803595|566075461|FG001|Overall Study|Protocol Violation|2|||
156815862|NCT00803595|566075462|FG002|Overall Study|Protocol Violation|12|||
156815863|NCT00803595|566075460|FG000|Overall Study|Withdrawal by Subject|5|||
156815864|NCT00803595|566075461|FG001|Overall Study|Withdrawal by Subject|2|||
156815865|NCT00803595|566075462|FG002|Overall Study|Withdrawal by Subject|3|||
156465074|NCT02719574|564800797|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
156465075|NCT02719574|564800798|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465076|NCT02719574|564800799|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465077|NCT02719574|564800800|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
156465078|NCT02719574|564800801|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
156465079|NCT02719574|564800802|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
156815866|NCT00703846|566075464|FG000|Overall Study|Adverse Event|8|||
156815867|NCT00703846|566075464|FG000|Overall Study|Lost to Follow-up|55|||
156815868|NCT00703846|566075464|FG000|Overall Study|Lack of Efficacy|15|||
156815869|NCT00703846|566075464|FG000|Overall Study|Noncompliance with Study Treatment|2|||
156815870|NCT00703846|566075464|FG000|Overall Study|Withdrawal by Subject|40|||
156815871|NCT00703846|566075464|FG000|Overall Study|Death|1|||
156815872|NCT00703846|566075464|FG000|Overall Study|Other|14|||
156815873|NCT00703846|566075464|FG000|Overall Study|Did Not Receive Study Drug|2|||
156465080|NCT02719574|564800803|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465081|NCT02719574|564800804|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465082|NCT02719574|564800805|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465083|NCT02719574|564800806|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465084|NCT02719574|564800807|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465085|NCT02719574|564800808|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465086|NCT02719574|564800809|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465087|NCT02719574|564800810|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465088|NCT02719574|564800811|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465089|NCT02719574|564800812|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
156465090|NCT02719574|564800796|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465091|NCT02719574|564800797|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465092|NCT02719574|564800798|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465093|NCT02719574|564800799|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465094|NCT02719574|564800800|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
156465095|NCT02719574|564800801|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
156465096|NCT02719574|564800802|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465097|NCT02719574|564800803|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465098|NCT02719574|564800804|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465099|NCT02719574|564800805|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465100|NCT02719574|564800806|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465101|NCT02719574|564800807|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465102|NCT02719574|564800808|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465103|NCT02719574|564800809|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465104|NCT02719574|564800810|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465105|NCT02719574|564800811|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465106|NCT02719574|564800812|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
156465107|NCT02719574|564800796|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465108|NCT02719574|564800797|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156815874|NCT02195700|566075465|FG000|Overall Study|Protocol Violation|0|||
156539683|NCT00117598|565069792|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
156815875|NCT02195700|566075466|FG001|Overall Study|Protocol Violation|2|||
156815876|NCT02195700|566075465|FG000|Overall Study|Noncompliance|1|||
156815877|NCT02195700|566075466|FG001|Overall Study|Noncompliance|0|||
156815878|NCT02195700|566075465|FG000|Overall Study|Adverse Event|1|||
156465109|NCT02719574|564800798|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
156465110|NCT02719574|564800799|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465111|NCT02719574|564800800|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465112|NCT02719574|564800801|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465113|NCT02719574|564800802|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465114|NCT02719574|564800803|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465115|NCT02719574|564800804|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156815879|NCT02195700|566075466|FG001|Overall Study|Adverse Event|2|||
156815880|NCT02195700|566075465|FG000|Overall Study|Withdrawal by Subject|3|||
156815881|NCT02195700|566075466|FG001|Overall Study|Withdrawal by Subject|2|||
156815882|NCT02195700|566075465|FG000|Overall Study|Lost to Follow-up|1|||
156815883|NCT02195700|566075466|FG001|Overall Study|Lost to Follow-up|1|||
156815884|NCT04601532|566075467|FG000|Overall Study|Lost to Follow-up|1|||
156815885|NCT04601532|566075468|FG001|Overall Study|Lost to Follow-up|2|||
156815886|NCT04601532|566075467|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
156815887|NCT04601532|566075468|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
156815888|NCT01352221|566075469|FG000|Double-blind Phase|Adverse Event|6|||
156815889|NCT01352221|566075470|FG001|Double-blind Phase|Adverse Event|4|||
156815890|NCT01352221|566075471|FG002|Double-blind Phase|Adverse Event|0|||
156815891|NCT01352221|566075472|FG003|Double-blind Phase|Adverse Event|0|||
156815892|NCT01352221|566075469|FG000|Double-blind Phase|Withdrawal by Subject|3|||
156815893|NCT01352221|566075470|FG001|Double-blind Phase|Withdrawal by Subject|5|||
156815894|NCT01352221|566075471|FG002|Double-blind Phase|Withdrawal by Subject|0|||
156815895|NCT01352221|566075472|FG003|Double-blind Phase|Withdrawal by Subject|0|||
156815896|NCT01352221|566075469|FG000|Double-blind Phase|Lost to Follow-up|0|||
156815897|NCT01352221|566075470|FG001|Double-blind Phase|Lost to Follow-up|1|||
156815898|NCT01352221|566075471|FG002|Double-blind Phase|Lost to Follow-up|0|||
156815899|NCT01352221|566075472|FG003|Double-blind Phase|Lost to Follow-up|0|||
156815900|NCT01352221|566075469|FG000|Double-blind Phase|Protocol Violation|0|||
156815901|NCT01352221|566075470|FG001|Double-blind Phase|Protocol Violation|1|||
156815902|NCT01352221|566075471|FG002|Double-blind Phase|Protocol Violation|0|||
156815903|NCT01352221|566075472|FG003|Double-blind Phase|Protocol Violation|0|||
156815904|NCT01352221|566075469|FG000|Open-label Phase|Physician Decision|0|||
156815905|NCT01352221|566075470|FG001|Open-label Phase|Physician Decision|0|||
156815906|NCT01352221|566075471|FG002|Open-label Phase|Physician Decision|2|||
156815907|NCT01352221|566075472|FG003|Open-label Phase|Physician Decision|1|||
156815908|NCT01352221|566075469|FG000|Open-label Phase|Pregnancy|0|||
156815909|NCT01352221|566075470|FG001|Open-label Phase|Pregnancy|0|||
156815910|NCT01352221|566075471|FG002|Open-label Phase|Pregnancy|1|||
156815911|NCT01352221|566075472|FG003|Open-label Phase|Pregnancy|0|||
156815912|NCT01352221|566075469|FG000|Open-label Phase|Adverse Event|0|||
156815913|NCT01352221|566075470|FG001|Open-label Phase|Adverse Event|0|||
156815914|NCT01352221|566075471|FG002|Open-label Phase|Adverse Event|8|||
156815915|NCT01352221|566075472|FG003|Open-label Phase|Adverse Event|4|||
156815916|NCT01352221|566075469|FG000|Open-label Phase|Withdrawal by Subject|0|||
156815917|NCT01352221|566075470|FG001|Open-label Phase|Withdrawal by Subject|0|||
156815918|NCT01352221|566075471|FG002|Open-label Phase|Withdrawal by Subject|1|||
156815919|NCT01352221|566075472|FG003|Open-label Phase|Withdrawal by Subject|6|||
156815920|NCT01352221|566075469|FG000|Open-label Phase|Worsening of IBD|0|||
156815921|NCT01352221|566075470|FG001|Open-label Phase|Worsening of IBD|0|||
156815922|NCT01352221|566075471|FG002|Open-label Phase|Worsening of IBD|1|||
156465116|NCT02719574|564800805|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465117|NCT02719574|564800806|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465118|NCT02719574|564800807|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465119|NCT02719574|564800808|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465120|NCT02719574|564800809|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156815923|NCT01352221|566075472|FG003|Open-label Phase|Worsening of IBD|0|||
156815924|NCT02566785|566075473|FG000|Overall Study|Lost to Follow-up|0|||
156815925|NCT02566785|566075474|FG001|Overall Study|Lost to Follow-up|2|||
156465121|NCT02719574|564800810|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465122|NCT02719574|564800811|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465123|NCT02719574|564800812|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156465124|NCT02719574|564800796|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465125|NCT02719574|564800797|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465126|NCT02719574|564800798|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465127|NCT02719574|564800799|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156815926|NCT02566785|566075473|FG000|Overall Study|Worsening condition|1|||
156815927|NCT02566785|566075474|FG001|Overall Study|Worsening condition|1|||
156815928|NCT01597908|566075475|FG000|Randomized Phase|Death|217|||
156815929|NCT01597908|566075476|FG001|Randomized Phase|Death|238|||
156815930|NCT01597908|566075477|FG002|Randomized Phase|Death|0|||
156465128|NCT02719574|564800800|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465129|NCT02719574|564800801|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156815931|NCT01597908|566075475|FG000|Randomized Phase|Sponsor Decision|93|||
156815932|NCT01597908|566075476|FG001|Randomized Phase|Sponsor Decision|39|||
156815933|NCT01597908|566075477|FG002|Randomized Phase|Sponsor Decision|0|||
156815934|NCT01597908|566075475|FG000|Randomized Phase|Lost to Follow-up|9|||
156815935|NCT01597908|566075476|FG001|Randomized Phase|Lost to Follow-up|16|||
156815936|NCT01597908|566075477|FG002|Randomized Phase|Lost to Follow-up|0|||
156815937|NCT01597908|566075475|FG000|Randomized Phase|Physician Decision|6|||
156815938|NCT01597908|566075476|FG001|Randomized Phase|Physician Decision|3|||
156815939|NCT01597908|566075477|FG002|Randomized Phase|Physician Decision|0|||
156815940|NCT01597908|566075475|FG000|Randomized Phase|Withdrawal by Subject|26|||
156815941|NCT01597908|566075476|FG001|Randomized Phase|Withdrawal by Subject|22|||
156815942|NCT01597908|566075477|FG002|Randomized Phase|Withdrawal by Subject|0|||
156815943|NCT01597908|566075475|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
156815944|NCT01597908|566075476|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
156815945|NCT01597908|566075477|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
156815946|NCT01597908|566075475|FG000|Crossover Phase|Death|0|||
156815947|NCT01597908|566075476|FG001|Crossover Phase|Death|0|||
156815948|NCT01597908|566075477|FG002|Crossover Phase|Death|11|||
156815949|NCT01597908|566075475|FG000|Crossover Phase|Withdrawal by Subject|0|||
156815950|NCT01597908|566075476|FG001|Crossover Phase|Withdrawal by Subject|0|||
156815951|NCT01597908|566075477|FG002|Crossover Phase|Withdrawal by Subject|3|||
156815952|NCT01597908|566075475|FG000|Crossover Phase|Sponsor Decision|0|||
156815953|NCT01597908|566075476|FG001|Crossover Phase|Sponsor Decision|0|||
156815954|NCT01597908|566075477|FG002|Crossover Phase|Sponsor Decision|20|||
156815955|NCT00837161|566075480|FG000|Overall Study|refused hysterectomy|2|||
156815956|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Adverse Event|21|||
156815957|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Adverse Event|34|||
156815958|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Adverse Event|14|||
156815959|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Adverse Event|17|||
156465130|NCT02719574|564800802|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
156465131|NCT02719574|564800803|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
156465132|NCT02719574|564800804|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
156465133|NCT02719574|564800805|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465134|NCT02719574|564800806|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465135|NCT02719574|564800807|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465136|NCT02719574|564800808|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465137|NCT02719574|564800809|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465138|NCT02719574|564800810|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465139|NCT02719574|564800811|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465140|NCT02719574|564800812|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
156465141|NCT02719574|564800796|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465142|NCT02719574|564800797|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465143|NCT02719574|564800798|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465144|NCT02719574|564800799|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465145|NCT02719574|564800800|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465146|NCT02719574|564800801|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465147|NCT02719574|564800802|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
156465148|NCT02719574|564800803|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
156465149|NCT02719574|564800804|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465150|NCT02719574|564800805|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465151|NCT02719574|564800806|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465152|NCT02719574|564800807|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465153|NCT02719574|564800808|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465154|NCT02719574|564800809|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465155|NCT02719574|564800810|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465156|NCT02719574|564800811|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465157|NCT02719574|564800812|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
156465158|NCT02719574|564800796|FG000|Phase 1 (Dose Expansion)|Death|0|||
156465159|NCT02719574|564800797|FG001|Phase 1 (Dose Expansion)|Death|0|||
156465160|NCT02719574|564800798|FG002|Phase 1 (Dose Expansion)|Death|0|||
156465161|NCT02719574|564800799|FG003|Phase 1 (Dose Expansion)|Death|0|||
156465162|NCT02719574|564800800|FG004|Phase 1 (Dose Expansion)|Death|0|||
156465163|NCT02719574|564800801|FG005|Phase 1 (Dose Expansion)|Death|0|||
156465164|NCT02719574|564800802|FG006|Phase 1 (Dose Expansion)|Death|1|||
156465165|NCT02719574|564800803|FG007|Phase 1 (Dose Expansion)|Death|6|||
156815960|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Adverse Event|0|||
156815961|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
156465166|NCT02719574|564800804|FG008|Phase 1 (Dose Expansion)|Death|0|||
156465167|NCT02719574|564800805|FG009|Phase 1 (Dose Expansion)|Death|0|||
156539684|NCT00117598|565069793|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
156465168|NCT02719574|564800806|FG010|Phase 1 (Dose Expansion)|Death|0|||
156815962|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
156465169|NCT02719574|564800807|FG011|Phase 1 (Dose Expansion)|Death|0|||
156465170|NCT02719574|564800808|FG012|Phase 1 (Dose Expansion)|Death|0|||
156465171|NCT02719574|564800809|FG013|Phase 1 (Dose Expansion)|Death|0|||
156465172|NCT02719574|564800810|FG014|Phase 1 (Dose Expansion)|Death|0|||
156465173|NCT02719574|564800811|FG015|Phase 1 (Dose Expansion)|Death|0|||
156815963|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
156815964|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
156815965|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
156815966|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
156815967|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
156815968|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
156815969|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
156815970|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
156815971|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Physician Decision|2|||
156815972|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Physician Decision|4|||
156815973|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Physician Decision|4|||
156815974|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Physician Decision|4|||
156815975|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Physician Decision|0|||
156815976|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
156815977|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
156815978|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
156815979|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
156815980|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
156815981|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
156815982|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
156815983|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
156815984|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
156815985|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
156815986|NCT01027650|566075488|FG000|Overall Study|Personal Reasons|0|||
156815987|NCT01027650|566075489|FG001|Overall Study|Personal Reasons|0|||
156815988|NCT01027650|566075490|FG002|Overall Study|Personal Reasons|0|||
156465174|NCT02719574|564800812|FG016|Phase 1 (Dose Expansion)|Death|0|||
156815989|NCT01027650|566075491|FG003|Overall Study|Personal Reasons|0|||
156815990|NCT01027650|566075492|FG004|Overall Study|Personal Reasons|2|||
156815991|NCT01027650|566075493|FG005|Overall Study|Personal Reasons|1|||
156815992|NCT01027650|566075494|FG006|Overall Study|Personal Reasons|0|||
156815993|NCT01027650|566075495|FG007|Overall Study|Personal Reasons|0|||
156815994|NCT01027650|566075488|FG000|Overall Study|Lost to Follow-up|0|||
156815995|NCT01027650|566075489|FG001|Overall Study|Lost to Follow-up|0|||
156815996|NCT01027650|566075490|FG002|Overall Study|Lost to Follow-up|0|||
156815997|NCT01027650|566075491|FG003|Overall Study|Lost to Follow-up|0|||
156815998|NCT01027650|566075492|FG004|Overall Study|Lost to Follow-up|0|||
156815999|NCT01027650|566075493|FG005|Overall Study|Lost to Follow-up|0|||
156816000|NCT01027650|566075494|FG006|Overall Study|Lost to Follow-up|1|||
156816001|NCT01027650|566075495|FG007|Overall Study|Lost to Follow-up|0|||
156816002|NCT01027650|566075488|FG000|Overall Study|Lack of Efficacy|0|||
156816003|NCT01027650|566075489|FG001|Overall Study|Lack of Efficacy|0|||
156816004|NCT01027650|566075490|FG002|Overall Study|Lack of Efficacy|0|||
156465175|NCT02719574|564800796|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465176|NCT02719574|564800797|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465177|NCT02719574|564800798|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465178|NCT02719574|564800799|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465179|NCT02719574|564800800|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465180|NCT02719574|564800801|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465181|NCT02719574|564800802|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
156465182|NCT02719574|564800803|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
156465183|NCT02719574|564800804|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465184|NCT02719574|564800805|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465185|NCT02719574|564800806|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465186|NCT02719574|564800807|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465187|NCT02719574|564800808|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465188|NCT02719574|564800809|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465189|NCT02719574|564800810|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465190|NCT02719574|564800811|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465191|NCT02719574|564800812|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
156465192|NCT02719574|564800796|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465193|NCT02719574|564800797|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465194|NCT02719574|564800798|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
156816005|NCT01027650|566075491|FG003|Overall Study|Lack of Efficacy|0|||
156816006|NCT01027650|566075492|FG004|Overall Study|Lack of Efficacy|0|||
156816007|NCT01027650|566075493|FG005|Overall Study|Lack of Efficacy|1|||
156465195|NCT02719574|564800799|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465196|NCT02719574|564800800|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465197|NCT02719574|564800801|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465198|NCT02719574|564800802|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
156816008|NCT01027650|566075494|FG006|Overall Study|Lack of Efficacy|0|||
156816009|NCT01027650|566075495|FG007|Overall Study|Lack of Efficacy|0|||
156816010|NCT02175277|566075496|FG000|Overall Study|Protocol-specified Criteria|1|||
156816011|NCT01082081|566075497|FG000|Overall Study|Lost to Follow-up|0|||
156816012|NCT01082081|566075498|FG001|Overall Study|Lost to Follow-up|0|||
156539685|NCT00117598|565069794|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
156539686|NCT00117598|565069795|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
156539687|NCT00117598|565069791|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
156539688|NCT00117598|565069792|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
156539689|NCT00117598|565069793|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
156539690|NCT00117598|565069794|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
156539691|NCT00117598|565069795|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
156539692|NCT00117598|565069791|FG000|Prior to Treatment Cross Over|Other|15|||
156539693|NCT00117598|565069792|FG001|Prior to Treatment Cross Over|Other|9|||
156539694|NCT00117598|565069793|FG002|Prior to Treatment Cross Over|Other|9|||
156539695|NCT00117598|565069794|FG003|Prior to Treatment Cross Over|Other|0|||
156539696|NCT00117598|565069795|FG004|Prior to Treatment Cross Over|Other|0|||
156539697|NCT00117598|565069791|FG000|After Treament Cross Over|Death|0|||
156539698|NCT00117598|565069792|FG001|After Treament Cross Over|Death|0|||
156539699|NCT00117598|565069793|FG002|After Treament Cross Over|Death|0|||
156539700|NCT00117598|565069794|FG003|After Treament Cross Over|Death|1|||
156539701|NCT00117598|565069795|FG004|After Treament Cross Over|Death|2|||
156539702|NCT00117598|565069791|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
156539703|NCT00117598|565069792|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
156539704|NCT00117598|565069793|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
156539705|NCT00117598|565069794|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
156539706|NCT00117598|565069795|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
156539707|NCT00117598|565069791|FG000|After Treament Cross Over|Other|0|||
156539708|NCT00117598|565069792|FG001|After Treament Cross Over|Other|0|||
156539709|NCT00117598|565069793|FG002|After Treament Cross Over|Other|0|||
156539710|NCT00117598|565069794|FG003|After Treament Cross Over|Other|1|||
156539711|NCT00117598|565069795|FG004|After Treament Cross Over|Other|2|||
156539712|NCT01854645|565069802|FG000|Overall Study|Protocol-Specified Criteria|13|||
156539713|NCT01854645|565069803|FG001|Overall Study|Protocol-Specified Criteria|10|||
156539714|NCT01854645|565069804|FG002|Overall Study|Protocol-Specified Criteria|8|||
156539715|NCT01854645|565069805|FG003|Overall Study|Protocol-Specified Criteria|5|||
156539716|NCT01854645|565069806|FG004|Overall Study|Protocol-Specified Criteria|7|||
156539717|NCT01854645|565069802|FG000|Overall Study|Administrative Reasons / Missing|0|||
156539718|NCT01854645|565069803|FG001|Overall Study|Administrative Reasons / Missing|0|||
156539719|NCT01854645|565069804|FG002|Overall Study|Administrative Reasons / Missing|0|||
156539720|NCT01854645|565069805|FG003|Overall Study|Administrative Reasons / Missing|1|||
156539721|NCT01854645|565069806|FG004|Overall Study|Administrative Reasons / Missing|1|||
156539722|NCT01854645|565069802|FG000|Overall Study|Protocol Violation|3|||
156539723|NCT01854645|565069803|FG001|Overall Study|Protocol Violation|0|||
156539724|NCT01854645|565069804|FG002|Overall Study|Protocol Violation|5|||
156539725|NCT01854645|565069805|FG003|Overall Study|Protocol Violation|4|||
156539726|NCT01854645|565069806|FG004|Overall Study|Protocol Violation|1|||
156539727|NCT01854645|565069802|FG000|Overall Study|Lost to Follow-up|10|||
156539728|NCT01854645|565069803|FG001|Overall Study|Lost to Follow-up|7|||
156539729|NCT01854645|565069804|FG002|Overall Study|Lost to Follow-up|8|||
156539730|NCT01854645|565069805|FG003|Overall Study|Lost to Follow-up|5|||
156539731|NCT01854645|565069806|FG004|Overall Study|Lost to Follow-up|0|||
156539732|NCT01854645|565069802|FG000|Overall Study|Physician Decision|1|||
156539733|NCT01854645|565069803|FG001|Overall Study|Physician Decision|5|||
156539734|NCT01854645|565069804|FG002|Overall Study|Physician Decision|3|||
156465199|NCT02719574|564800803|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
156465200|NCT02719574|564800804|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465201|NCT02719574|564800805|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465202|NCT02719574|564800806|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465203|NCT02719574|564800807|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465204|NCT02719574|564800808|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465205|NCT02719574|564800809|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465206|NCT02719574|564800810|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465207|NCT02719574|564800811|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465208|NCT02719574|564800812|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
156465209|NCT02719574|564800796|FG000|Phase 1 (Dose Expansion)|Other|0|||
156465210|NCT02719574|564800797|FG001|Phase 1 (Dose Expansion)|Other|0|||
156539735|NCT01854645|565069805|FG003|Overall Study|Physician Decision|3|||
156539736|NCT01854645|565069806|FG004|Overall Study|Physician Decision|7|||
156539737|NCT01854645|565069802|FG000|Overall Study|Withdrawal by Subject|31|||
156539738|NCT01854645|565069803|FG001|Overall Study|Withdrawal by Subject|41|||
156539739|NCT01854645|565069804|FG002|Overall Study|Withdrawal by Subject|30|||
156465211|NCT02719574|564800798|FG002|Phase 1 (Dose Expansion)|Other|0|||
156465212|NCT02719574|564800799|FG003|Phase 1 (Dose Expansion)|Other|0|||
156539740|NCT01854645|565069805|FG003|Overall Study|Withdrawal by Subject|21|||
156539741|NCT01854645|565069806|FG004|Overall Study|Withdrawal by Subject|24|||
156539742|NCT01854645|565069802|FG000|Overall Study|Lack of Efficacy|7|||
156539743|NCT01854645|565069803|FG001|Overall Study|Lack of Efficacy|12|||
156539744|NCT01854645|565069804|FG002|Overall Study|Lack of Efficacy|9|||
156539745|NCT01854645|565069805|FG003|Overall Study|Lack of Efficacy|3|||
156539746|NCT01854645|565069806|FG004|Overall Study|Lack of Efficacy|9|||
156539747|NCT01854645|565069802|FG000|Overall Study|Adverse Event|33|||
156539748|NCT01854645|565069803|FG001|Overall Study|Adverse Event|31|||
156539749|NCT01854645|565069804|FG002|Overall Study|Adverse Event|19|||
156539750|NCT01854645|565069805|FG003|Overall Study|Adverse Event|20|||
156539751|NCT01854645|565069806|FG004|Overall Study|Adverse Event|11|||
156539752|NCT01817751|565069810|FG000|Overall Study|Physician Decision|1|||
156539753|NCT00382018|565069811|FG000|Overall Study|Progression|0|||
156539754|NCT00382018|565069812|FG001|Overall Study|Progression|136|||
156539755|NCT00382018|565069813|FG002|Overall Study|Progression|51|||
156539756|NCT00382018|565069814|FG003|Overall Study|Progression|43|||
156539757|NCT00382018|565069811|FG000|Overall Study|Death|0|||
156539758|NCT00382018|565069812|FG001|Overall Study|Death|9|||
156539759|NCT00382018|565069813|FG002|Overall Study|Death|7|||
156539760|NCT00382018|565069814|FG003|Overall Study|Death|11|||
156539761|NCT00382018|565069811|FG000|Overall Study|Withdrawal by Subject|0|||
156539762|NCT00382018|565069812|FG001|Overall Study|Withdrawal by Subject|4|||
156539763|NCT00382018|565069813|FG002|Overall Study|Withdrawal by Subject|3|||
156539764|NCT00382018|565069814|FG003|Overall Study|Withdrawal by Subject|4|||
156539765|NCT00382018|565069811|FG000|Overall Study|Other, not protocol specified|0|||
156539766|NCT00382018|565069812|FG001|Overall Study|Other, not protocol specified|16|||
156539767|NCT00382018|565069813|FG002|Overall Study|Other, not protocol specified|3|||
156539768|NCT00382018|565069814|FG003|Overall Study|Other, not protocol specified|1|||
156539769|NCT00574145|565071376|FG000|Overall Study|Withdrawal by Subject|2|||
156539770|NCT00574145|565071377|FG001|Overall Study|Withdrawal by Subject|1|||
156539771|NCT03227471|565071378|FG000|Overall Study|Withdrawal by Subject|0|||
156539772|NCT03227471|565071379|FG001|Overall Study|Withdrawal by Subject|0|||
156539773|NCT03227471|565071380|FG002|Overall Study|Withdrawal by Subject|0|||
156539774|NCT03227471|565071381|FG003|Overall Study|Withdrawal by Subject|0|||
156539775|NCT03227471|565071382|FG004|Overall Study|Withdrawal by Subject|1|||
156539776|NCT03227471|565071383|FG005|Overall Study|Withdrawal by Subject|0|||
156539777|NCT03227471|565071384|FG006|Overall Study|Withdrawal by Subject|0|||
156539778|NCT03227471|565071385|FG007|Overall Study|Withdrawal by Subject|0|||
156539779|NCT03227471|565071386|FG008|Overall Study|Withdrawal by Subject|0|||
156539780|NCT03227471|565071387|FG009|Overall Study|Withdrawal by Subject|0|||
156539781|NCT03227471|565071388|FG010|Overall Study|Withdrawal by Subject|0|||
156539782|NCT03227471|565071389|FG011|Overall Study|Withdrawal by Subject|0|||
156539783|NCT03227471|565071390|FG012|Overall Study|Withdrawal by Subject|1|||
156539784|NCT03227471|565071391|FG013|Overall Study|Withdrawal by Subject|0|||
156539785|NCT03227471|565071392|FG014|Overall Study|Withdrawal by Subject|0|||
156539786|NCT03227471|565071378|FG000|Overall Study|Randomized, Never Dosed|0|||
156539787|NCT03227471|565071379|FG001|Overall Study|Randomized, Never Dosed|0|||
156539788|NCT03227471|565071380|FG002|Overall Study|Randomized, Never Dosed|0|||
156539789|NCT03227471|565071381|FG003|Overall Study|Randomized, Never Dosed|0|||
156539790|NCT03227471|565071382|FG004|Overall Study|Randomized, Never Dosed|0|||
156539791|NCT03227471|565071383|FG005|Overall Study|Randomized, Never Dosed|0|||
156539792|NCT03227471|565071384|FG006|Overall Study|Randomized, Never Dosed|0|||
156539793|NCT03227471|565071385|FG007|Overall Study|Randomized, Never Dosed|0|||
156539794|NCT03227471|565071386|FG008|Overall Study|Randomized, Never Dosed|0|||
156539795|NCT03227471|565071387|FG009|Overall Study|Randomized, Never Dosed|0|||
156539796|NCT03227471|565071388|FG010|Overall Study|Randomized, Never Dosed|0|||
156539797|NCT03227471|565071389|FG011|Overall Study|Randomized, Never Dosed|0|||
156539798|NCT03227471|565071390|FG012|Overall Study|Randomized, Never Dosed|0|||
156539799|NCT03227471|565071391|FG013|Overall Study|Randomized, Never Dosed|0|||
156539800|NCT03227471|565071392|FG014|Overall Study|Randomized, Never Dosed|1|||
156539801|NCT00176605|565071402|FG000|Overall Study|Withdrawal by Subject|2|||
156539802|NCT00833053|565071403|FG000|Overall Study|Adverse Event|4|||
156539803|NCT00833053|565071404|FG001|Overall Study|Adverse Event|0|||
156539804|NCT00833053|565071403|FG000|Overall Study|Treatment Failure|3|||
156539805|NCT00833053|565071404|FG001|Overall Study|Treatment Failure|1|||
156539806|NCT00833053|565071403|FG000|Overall Study|Withdrawal by Subject|0|||
156539807|NCT00833053|565071404|FG001|Overall Study|Withdrawal by Subject|1|||
156539808|NCT00833053|565071403|FG000|Overall Study|Protocol Violation|2|||
156539809|NCT00833053|565071404|FG001|Overall Study|Protocol Violation|1|||
156539810|NCT02187471|565071405|FG000|Overall Study|Protocol Violation|4|||
156539811|NCT02187471|565071406|FG001|Overall Study|Protocol Violation|5|||
156539812|NCT02187471|565071407|FG002|Overall Study|Protocol Violation|4|||
156539813|NCT02187471|565071408|FG003|Overall Study|Protocol Violation|4|||
156539814|NCT02187471|565071405|FG000|Overall Study|Missing|0|||
156539815|NCT02187471|565071406|FG001|Overall Study|Missing|0|||
156539816|NCT02187471|565071407|FG002|Overall Study|Missing|0|||
156539817|NCT02187471|565071408|FG003|Overall Study|Missing|1|||
156539818|NCT02187471|565071405|FG000|Overall Study|Lack of Efficacy|18|||
156539819|NCT02187471|565071406|FG001|Overall Study|Lack of Efficacy|9|||
156539820|NCT02187471|565071407|FG002|Overall Study|Lack of Efficacy|13|||
156539821|NCT02187471|565071408|FG003|Overall Study|Lack of Efficacy|11|||
156539822|NCT02187471|565071405|FG000|Overall Study|Adverse Event|24|||
156539823|NCT02187471|565071406|FG001|Overall Study|Adverse Event|34|||
156465213|NCT02719574|564800800|FG004|Phase 1 (Dose Expansion)|Other|0|||
156816013|NCT01082081|566075499|FG002|Overall Study|Lost to Follow-up|1|||
156816014|NCT01082081|566075497|FG000|Overall Study|Withdrawal by Subject|0|||
156816015|NCT01082081|566075498|FG001|Overall Study|Withdrawal by Subject|0|||
156816016|NCT01082081|566075499|FG002|Overall Study|Withdrawal by Subject|1|||
156816017|NCT01082081|566075497|FG000|Overall Study|Other Reason|0|||
156816018|NCT01082081|566075498|FG001|Overall Study|Other Reason|1|||
156816019|NCT01082081|566075499|FG002|Overall Study|Other Reason|0|||
156816020|NCT00670930|566075500|FG000|Overall Study|Adminstrative Problem|0|||
156816021|NCT00670930|566075501|FG001|Overall Study|Adminstrative Problem|1|||
156816022|NCT00670930|566075500|FG000|Overall Study|Lost to Follow-up|1|||
156816023|NCT00670930|566075501|FG001|Overall Study|Lost to Follow-up|0|||
156465214|NCT02719574|564800801|FG005|Phase 1 (Dose Expansion)|Other|0|||
156465215|NCT02719574|564800802|FG006|Phase 1 (Dose Expansion)|Other|1|||
156465216|NCT02719574|564800803|FG007|Phase 1 (Dose Expansion)|Other|7|||
156465217|NCT02719574|564800804|FG008|Phase 1 (Dose Expansion)|Other|0|||
156465218|NCT02719574|564800805|FG009|Phase 1 (Dose Expansion)|Other|0|||
156465219|NCT02719574|564800806|FG010|Phase 1 (Dose Expansion)|Other|0|||
156465220|NCT02719574|564800807|FG011|Phase 1 (Dose Expansion)|Other|0|||
156465221|NCT02719574|564800808|FG012|Phase 1 (Dose Expansion)|Other|0|||
156465222|NCT02719574|564800809|FG013|Phase 1 (Dose Expansion)|Other|0|||
156465223|NCT02719574|564800810|FG014|Phase 1 (Dose Expansion)|Other|0|||
156465224|NCT02719574|564800811|FG015|Phase 1 (Dose Expansion)|Other|0|||
156465225|NCT02719574|564800812|FG016|Phase 1 (Dose Expansion)|Other|0|||
156465226|NCT02719574|564800796|FG000|Phase 2|Protocol Defined Disease Progression|0|||
156465227|NCT02719574|564800797|FG001|Phase 2|Protocol Defined Disease Progression|0|||
156465228|NCT02719574|564800798|FG002|Phase 2|Protocol Defined Disease Progression|0|||
156465229|NCT02719574|564800799|FG003|Phase 2|Protocol Defined Disease Progression|0|||
156465230|NCT02719574|564800800|FG004|Phase 2|Protocol Defined Disease Progression|0|||
156465231|NCT02719574|564800801|FG005|Phase 2|Protocol Defined Disease Progression|0|||
156465232|NCT02719574|564800802|FG006|Phase 2|Protocol Defined Disease Progression|0|||
156465233|NCT02719574|564800803|FG007|Phase 2|Protocol Defined Disease Progression|0|||
156465234|NCT02719574|564800804|FG008|Phase 2|Protocol Defined Disease Progression|0|||
156465235|NCT02719574|564800805|FG009|Phase 2|Protocol Defined Disease Progression|65|||
156465236|NCT02719574|564800806|FG010|Phase 2|Protocol Defined Disease Progression|8|||
156465237|NCT02719574|564800807|FG011|Phase 2|Protocol Defined Disease Progression|2|||
156465238|NCT02719574|564800808|FG012|Phase 2|Protocol Defined Disease Progression|4|||
156465239|NCT02719574|564800809|FG013|Phase 2|Protocol Defined Disease Progression|9|||
156465240|NCT02719574|564800810|FG014|Phase 2|Protocol Defined Disease Progression|11|||
156465241|NCT02719574|564800811|FG015|Phase 2|Protocol Defined Disease Progression|3|||
156465242|NCT02719574|564800812|FG016|Phase 2|Protocol Defined Disease Progression|4|||
156465243|NCT02719574|564800796|FG000|Phase 2|Adverse Event|0|||
156465244|NCT02719574|564800797|FG001|Phase 2|Adverse Event|0|||
156465245|NCT02719574|564800798|FG002|Phase 2|Adverse Event|0|||
156465246|NCT02719574|564800799|FG003|Phase 2|Adverse Event|0|||
156816024|NCT02712983|566077424|FG000|Treatment Phase|Adverse Event|3|||
156816025|NCT02712983|566077425|FG001|Treatment Phase|Adverse Event|1|||
156816026|NCT02712983|566077426|FG002|Treatment Phase|Adverse Event|1|||
156816027|NCT02712983|566077427|FG003|Treatment Phase|Adverse Event|4|||
156816028|NCT02712983|566077428|FG004|Treatment Phase|Adverse Event|3|||
156816029|NCT02712983|566077429|FG005|Treatment Phase|Adverse Event|0|||
156816030|NCT02712983|566077430|FG006|Treatment Phase|Adverse Event|6|||
156816031|NCT02712983|566077431|FG007|Treatment Phase|Adverse Event|6|||
156816032|NCT02712983|566077432|FG008|Treatment Phase|Adverse Event|1|||
156816033|NCT02712983|566077424|FG000|Treatment Phase|Protocol Deviation|0|||
156816034|NCT02712983|566077425|FG001|Treatment Phase|Protocol Deviation|0|||
156816035|NCT02712983|566077426|FG002|Treatment Phase|Protocol Deviation|0|||
156816036|NCT02712983|566077427|FG003|Treatment Phase|Protocol Deviation|2|||
156465247|NCT02719574|564800800|FG004|Phase 2|Adverse Event|0|||
156465248|NCT02719574|564800801|FG005|Phase 2|Adverse Event|0|||
156465249|NCT02719574|564800802|FG006|Phase 2|Adverse Event|0|||
156465250|NCT02719574|564800803|FG007|Phase 2|Adverse Event|0|||
156465251|NCT02719574|564800804|FG008|Phase 2|Adverse Event|0|||
156465252|NCT02719574|564800805|FG009|Phase 2|Adverse Event|27|||
156465253|NCT02719574|564800806|FG010|Phase 2|Adverse Event|0|||
156465254|NCT02719574|564800807|FG011|Phase 2|Adverse Event|1|||
156465255|NCT02719574|564800808|FG012|Phase 2|Adverse Event|1|||
156465256|NCT02719574|564800809|FG013|Phase 2|Adverse Event|1|||
156465257|NCT02719574|564800810|FG014|Phase 2|Adverse Event|2|||
156465258|NCT02719574|564800811|FG015|Phase 2|Adverse Event|2|||
156465259|NCT02719574|564800812|FG016|Phase 2|Adverse Event|3|||
156465260|NCT02719574|564800796|FG000|Phase 2|Other|0|||
156816037|NCT02712983|566077428|FG004|Treatment Phase|Protocol Deviation|0|||
156465261|NCT02719574|564800797|FG001|Phase 2|Other|0|||
156465262|NCT02719574|564800798|FG002|Phase 2|Other|0|||
156465263|NCT02719574|564800799|FG003|Phase 2|Other|0|||
156465264|NCT02719574|564800800|FG004|Phase 2|Other|0|||
156465265|NCT02719574|564800801|FG005|Phase 2|Other|0|||
156465266|NCT02719574|564800802|FG006|Phase 2|Other|0|||
156465267|NCT02719574|564800803|FG007|Phase 2|Other|0|||
156465268|NCT02719574|564800804|FG008|Phase 2|Other|0|||
156465269|NCT02719574|564800805|FG009|Phase 2|Other|20|||
156465270|NCT02719574|564800806|FG010|Phase 2|Other|7|||
156465271|NCT02719574|564800807|FG011|Phase 2|Other|0|||
156465272|NCT02719574|564800808|FG012|Phase 2|Other|5|||
156465273|NCT02719574|564800809|FG013|Phase 2|Other|7|||
156465274|NCT02719574|564800810|FG014|Phase 2|Other|0|||
156465275|NCT02719574|564800811|FG015|Phase 2|Other|1|||
156465276|NCT02719574|564800812|FG016|Phase 2|Other|4|||
156465277|NCT02719574|564800796|FG000|Phase 2|Transplant|0|||
156465278|NCT02719574|564800797|FG001|Phase 2|Transplant|0|||
156465279|NCT02719574|564800798|FG002|Phase 2|Transplant|0|||
156465280|NCT02719574|564800799|FG003|Phase 2|Transplant|0|||
156465281|NCT02719574|564800800|FG004|Phase 2|Transplant|0|||
156465282|NCT02719574|564800801|FG005|Phase 2|Transplant|0|||
156539824|NCT02187471|565071407|FG002|Overall Study|Adverse Event|44|||
156539825|NCT02187471|565071408|FG003|Overall Study|Adverse Event|36|||
156539826|NCT02187471|565071405|FG000|Overall Study|Withdrawal by Subject|23|||
156539827|NCT02187471|565071406|FG001|Overall Study|Withdrawal by Subject|29|||
156539828|NCT02187471|565071407|FG002|Overall Study|Withdrawal by Subject|22|||
156539829|NCT02187471|565071408|FG003|Overall Study|Withdrawal by Subject|24|||
156539830|NCT02187471|565071405|FG000|Overall Study|Other|7|||
156539831|NCT02187471|565071406|FG001|Overall Study|Other|5|||
156539832|NCT02187471|565071407|FG002|Overall Study|Other|3|||
156539833|NCT02187471|565071408|FG003|Overall Study|Other|4|||
156539834|NCT01033734|565071409|FG000|Overall Study|Withdrawal by Subject|1|||
156539835|NCT02289742|565071411|FG000|First Wear Period|Adverse event prior to treatment|0|||
156539836|NCT02289742|565071412|FG001|First Wear Period|Adverse event prior to treatment|1|||
156539837|NCT02289742|565071413|FG002|First Wear Period|Adverse event prior to treatment|0|||
156539838|NCT02289742|565071414|FG003|First Wear Period|Adverse event prior to treatment|0|||
156539839|NCT02289742|565071411|FG000|First Wear Period|Adverse Event|0|||
156539840|NCT02289742|565071412|FG001|First Wear Period|Adverse Event|0|||
156539841|NCT02289742|565071413|FG002|First Wear Period|Adverse Event|1|||
156539842|NCT02289742|565071414|FG003|First Wear Period|Adverse Event|0|||
156539843|NCT02289742|565071411|FG000|First Wear Period|Other prior to treatment|0|||
156539844|NCT02289742|565071412|FG001|First Wear Period|Other prior to treatment|0|||
156539845|NCT02289742|565071413|FG002|First Wear Period|Other prior to treatment|0|||
156539846|NCT02289742|565071414|FG003|First Wear Period|Other prior to treatment|1|||
156539847|NCT02289742|565071411|FG000|Third Wear Period|Adverse Event|0|||
156539848|NCT02289742|565071412|FG001|Third Wear Period|Adverse Event|1|||
156539849|NCT02289742|565071413|FG002|Third Wear Period|Adverse Event|0|||
156539850|NCT02289742|565071414|FG003|Third Wear Period|Adverse Event|0|||
156539851|NCT02289742|565071411|FG000|Third Wear Period|Reason not given|0|||
156539852|NCT02289742|565071412|FG001|Third Wear Period|Reason not given|0|||
156539853|NCT02289742|565071413|FG002|Third Wear Period|Reason not given|0|||
156539854|NCT02289742|565071414|FG003|Third Wear Period|Reason not given|1|||
156539855|NCT02865018|565071416|FG000|Overall Study|Withdrawal by Subject|1|||
156539856|NCT01365039|565071417|FG000|Overall Study|Study related symptoms and complaints|1|||
156539857|NCT01365039|565071418|FG001|Overall Study|Study related symptoms and complaints|0|||
156539858|NCT00294060|565071421|FG000|Overall Study|Death|225|||
156539859|NCT00294060|565071421|FG000|Overall Study|Other|59|||
156539860|NCT00294060|565071421|FG000|Overall Study|Lost to Follow-up|55|||
156539861|NCT00294060|565071421|FG000|Overall Study|Withdrawal by Subject|11|||
156539862|NCT00294060|565071421|FG000|Overall Study|Physician Decision|797|||
156539863|NCT00294060|565071421|FG000|Overall Study|Medical condition|3|||
156539864|NCT00294060|565071421|FG000|Overall Study|Device explanted/not replaced|23|||
156539865|NCT00139776|565071422|FG000|Period I|Did not enter Period II|575|||
156539866|NCT00139776|565071423|FG001|Period I|Did not enter Period II|0|||
156539867|NCT00139776|565071424|FG002|Period I|Did not enter Period II|0|||
156539868|NCT00139776|565071425|FG003|Period I|Did not enter Period II|0|||
156539869|NCT00139776|565071422|FG000|Period II|Not Randomized into Period III|0|||
156539870|NCT00139776|565071423|FG001|Period II|Not Randomized into Period III|322|||
156539871|NCT00139776|565071424|FG002|Period II|Not Randomized into Period III|0|||
156465283|NCT02719574|564800802|FG006|Phase 2|Transplant|0|||
156465284|NCT02719574|564800803|FG007|Phase 2|Transplant|0|||
156539872|NCT00139776|565071425|FG003|Period II|Not Randomized into Period III|0|||
156539873|NCT00139776|565071422|FG000|Period III|Adverse Event|0|||
156465285|NCT02719574|564800804|FG008|Phase 2|Transplant|0|||
156465286|NCT02719574|564800805|FG009|Phase 2|Transplant|15|||
156465287|NCT02719574|564800806|FG010|Phase 2|Transplant|2|||
156465288|NCT02719574|564800807|FG011|Phase 2|Transplant|0|||
156539874|NCT00139776|565071423|FG001|Period III|Adverse Event|0|||
156539875|NCT00139776|565071424|FG002|Period III|Adverse Event|22|||
156539876|NCT00139776|565071425|FG003|Period III|Adverse Event|23|||
156539877|NCT00139776|565071422|FG000|Period III|Other|0|||
156539878|NCT00139776|565071423|FG001|Period III|Other|0|||
156465289|NCT02719574|564800808|FG012|Phase 2|Transplant|6|||
156465290|NCT02719574|564800809|FG013|Phase 2|Transplant|1|||
156465291|NCT02719574|564800810|FG014|Phase 2|Transplant|1|||
156465292|NCT02719574|564800811|FG015|Phase 2|Transplant|0|||
156539879|NCT00139776|565071424|FG002|Period III|Other|23|||
156539880|NCT00139776|565071425|FG003|Period III|Other|34|||
156539881|NCT00139776|565071422|FG000|Period III|Lack of Efficacy|0|||
156539882|NCT00139776|565071423|FG001|Period III|Lack of Efficacy|0|||
156539883|NCT00139776|565071424|FG002|Period III|Lack of Efficacy|10|||
156539884|NCT00139776|565071425|FG003|Period III|Lack of Efficacy|24|||
156539885|NCT00139776|565071422|FG000|Period III|Lost to Follow-up|0|||
156539886|NCT00139776|565071423|FG001|Period III|Lost to Follow-up|0|||
156539887|NCT00139776|565071424|FG002|Period III|Lost to Follow-up|5|||
156539888|NCT00139776|565071425|FG003|Period III|Lost to Follow-up|4|||
156539889|NCT00139776|565071422|FG000|Period III|Withdrawal by Subject|0|||
156539890|NCT00139776|565071423|FG001|Period III|Withdrawal by Subject|0|||
156539891|NCT00139776|565071424|FG002|Period III|Withdrawal by Subject|16|||
156539892|NCT00139776|565071425|FG003|Period III|Withdrawal by Subject|21|||
156539893|NCT01360554|565071426|FG000|Overall Study|Death|359|||
156539894|NCT01360554|565071427|FG001|Overall Study|Death|371|||
156539895|NCT01360554|565071426|FG000|Overall Study|Lost to Follow-up|4|||
156539896|NCT01360554|565071427|FG001|Overall Study|Lost to Follow-up|4|||
156539897|NCT01360554|565071426|FG000|Overall Study|Withdrawal by Subject|23|||
156539898|NCT01360554|565071427|FG001|Overall Study|Withdrawal by Subject|24|||
156539899|NCT01360554|565071426|FG000|Overall Study|Study terminated by sponsor|49|||
156539900|NCT01360554|565071427|FG001|Overall Study|Study terminated by sponsor|37|||
156539901|NCT01360554|565071426|FG000|Overall Study|Other, not specified|1|||
156539902|NCT01360554|565071427|FG001|Overall Study|Other, not specified|0|||
156539903|NCT01360554|565071426|FG000|Overall Study|Randomized but not treated.|3|||
156539904|NCT01360554|565071427|FG001|Overall Study|Randomized but not treated.|3|||
156539905|NCT00187096|565071428|FG000|Overall Study|unacceptable toxicity|0|||
156539906|NCT00187096|565071429|FG001|Overall Study|unacceptable toxicity|0|||
156539907|NCT00187096|565071430|FG002|Overall Study|unacceptable toxicity|1|||
156539908|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
156539909|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
156539910|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
156816038|NCT02712983|566077429|FG005|Treatment Phase|Protocol Deviation|0|||
156816039|NCT02712983|566077430|FG006|Treatment Phase|Protocol Deviation|1|||
156816040|NCT02712983|566077431|FG007|Treatment Phase|Protocol Deviation|0|||
156816041|NCT02712983|566077432|FG008|Treatment Phase|Protocol Deviation|0|||
156465293|NCT02719574|564800812|FG016|Phase 2|Transplant|0|||
156465294|NCT02719574|564800796|FG000|Phase 2|Death|0|||
156465295|NCT02719574|564800797|FG001|Phase 2|Death|0|||
156465296|NCT02719574|564800798|FG002|Phase 2|Death|0|||
156465297|NCT02719574|564800799|FG003|Phase 2|Death|0|||
156465298|NCT02719574|564800800|FG004|Phase 2|Death|0|||
156465299|NCT02719574|564800801|FG005|Phase 2|Death|0|||
156465300|NCT02719574|564800802|FG006|Phase 2|Death|0|||
156465301|NCT02719574|564800803|FG007|Phase 2|Death|0|||
156465302|NCT02719574|564800804|FG008|Phase 2|Death|0|||
156465303|NCT02719574|564800805|FG009|Phase 2|Death|14|||
156465304|NCT02719574|564800806|FG010|Phase 2|Death|0|||
156465305|NCT02719574|564800807|FG011|Phase 2|Death|0|||
156465306|NCT02719574|564800808|FG012|Phase 2|Death|1|||
156465307|NCT02719574|564800809|FG013|Phase 2|Death|1|||
156465308|NCT02719574|564800810|FG014|Phase 2|Death|2|||
156465309|NCT02719574|564800811|FG015|Phase 2|Death|0|||
156465310|NCT02719574|564800812|FG016|Phase 2|Death|0|||
156465311|NCT02719574|564800796|FG000|Phase 2|Investigator Decision|0|||
156465312|NCT02719574|564800797|FG001|Phase 2|Investigator Decision|0|||
156465313|NCT02719574|564800798|FG002|Phase 2|Investigator Decision|0|||
156465314|NCT02719574|564800799|FG003|Phase 2|Investigator Decision|0|||
156465315|NCT02719574|564800800|FG004|Phase 2|Investigator Decision|0|||
156465316|NCT02719574|564800801|FG005|Phase 2|Investigator Decision|0|||
156465317|NCT02719574|564800802|FG006|Phase 2|Investigator Decision|0|||
156465318|NCT02719574|564800803|FG007|Phase 2|Investigator Decision|0|||
156465319|NCT02719574|564800804|FG008|Phase 2|Investigator Decision|0|||
156465320|NCT02719574|564800805|FG009|Phase 2|Investigator Decision|6|||
156465321|NCT02719574|564800806|FG010|Phase 2|Investigator Decision|1|||
156465322|NCT02719574|564800807|FG011|Phase 2|Investigator Decision|2|||
156465323|NCT02719574|564800808|FG012|Phase 2|Investigator Decision|3|||
156465324|NCT02719574|564800809|FG013|Phase 2|Investigator Decision|1|||
156465325|NCT02719574|564800810|FG014|Phase 2|Investigator Decision|3|||
156539911|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
156539912|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
156539913|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
156539914|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
156539915|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
156539916|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
156539917|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
156539918|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
156539919|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
156539920|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
156465326|NCT02719574|564800811|FG015|Phase 2|Investigator Decision|2|||
156465327|NCT02719574|564800812|FG016|Phase 2|Investigator Decision|0|||
156465328|NCT02719574|564800796|FG000|Phase 2|Withdrawal by Subject|0|||
156465329|NCT02719574|564800797|FG001|Phase 2|Withdrawal by Subject|0|||
156465330|NCT02719574|564800798|FG002|Phase 2|Withdrawal by Subject|0|||
156465331|NCT02719574|564800799|FG003|Phase 2|Withdrawal by Subject|0|||
156465332|NCT02719574|564800800|FG004|Phase 2|Withdrawal by Subject|0|||
156465333|NCT02719574|564800801|FG005|Phase 2|Withdrawal by Subject|0|||
156465334|NCT02719574|564800802|FG006|Phase 2|Withdrawal by Subject|0|||
156465335|NCT02719574|564800803|FG007|Phase 2|Withdrawal by Subject|0|||
156465336|NCT02719574|564800804|FG008|Phase 2|Withdrawal by Subject|0|||
156465337|NCT02719574|564800805|FG009|Phase 2|Withdrawal by Subject|5|||
156465338|NCT02719574|564800806|FG010|Phase 2|Withdrawal by Subject|0|||
156465339|NCT02719574|564800807|FG011|Phase 2|Withdrawal by Subject|0|||
156465340|NCT02719574|564800808|FG012|Phase 2|Withdrawal by Subject|0|||
156465341|NCT02719574|564800809|FG013|Phase 2|Withdrawal by Subject|1|||
156465342|NCT02719574|564800810|FG014|Phase 2|Withdrawal by Subject|1|||
156465343|NCT02719574|564800811|FG015|Phase 2|Withdrawal by Subject|2|||
156465344|NCT02719574|564800812|FG016|Phase 2|Withdrawal by Subject|0|||
156465345|NCT02719574|564800796|FG000|Phase 2|Protocol Violation|0|||
156465346|NCT02719574|564800797|FG001|Phase 2|Protocol Violation|0|||
156465347|NCT02719574|564800798|FG002|Phase 2|Protocol Violation|0|||
156465348|NCT02719574|564800799|FG003|Phase 2|Protocol Violation|0|||
156465349|NCT02719574|564800800|FG004|Phase 2|Protocol Violation|0|||
156465350|NCT02719574|564800801|FG005|Phase 2|Protocol Violation|0|||
156465351|NCT02719574|564800802|FG006|Phase 2|Protocol Violation|0|||
156465352|NCT02719574|564800803|FG007|Phase 2|Protocol Violation|0|||
156465353|NCT02719574|564800804|FG008|Phase 2|Protocol Violation|0|||
156465354|NCT02719574|564800805|FG009|Phase 2|Protocol Violation|1|||
156465355|NCT02719574|564800806|FG010|Phase 2|Protocol Violation|0|||
156465356|NCT02719574|564800807|FG011|Phase 2|Protocol Violation|0|||
156465357|NCT02719574|564800808|FG012|Phase 2|Protocol Violation|0|||
156465358|NCT02719574|564800809|FG013|Phase 2|Protocol Violation|0|||
156465359|NCT02719574|564800810|FG014|Phase 2|Protocol Violation|0|||
156465360|NCT02719574|564800811|FG015|Phase 2|Protocol Violation|0|||
156465361|NCT02719574|564800812|FG016|Phase 2|Protocol Violation|0|||
156465362|NCT00113360|564800814|FG000|Overall Study|Adverse Event|3|||
156465363|NCT00113360|564800814|FG000|Overall Study|Subject required surgery|1|||
156465364|NCT00113360|564800814|FG000|Overall Study|Did not meet eligibility criteria|3|||
156465365|NCT01976936|564800827|FG000|Overall Study|Did not receive at least 9 doses|9|||
156465366|NCT01976936|564800828|FG001|Overall Study|Did not receive at least 9 doses|4|||
156465367|NCT02231749|564800832|FG000|Overall Study|Disease progression|229|||
156465368|NCT02231749|564800833|FG001|Overall Study|Disease progression|297|||
156465369|NCT02231749|564800832|FG000|Overall Study|Study Drug Toxicity|134|||
156465370|NCT02231749|564800833|FG001|Overall Study|Study Drug Toxicity|63|||
156465371|NCT02231749|564800832|FG000|Overall Study|Death|1|||
156465372|NCT02231749|564800833|FG001|Overall Study|Death|1|||
156465373|NCT02231749|564800832|FG000|Overall Study|AE unrelated to Study drug|32|||
156465374|NCT02231749|564800833|FG001|Overall Study|AE unrelated to Study drug|31|||
156465375|NCT02231749|564800832|FG000|Overall Study|Participant's request to discontinue|10|||
156465376|NCT02231749|564800833|FG001|Overall Study|Participant's request to discontinue|21|||
156465377|NCT02231749|564800832|FG000|Overall Study|Participant withdrew Consent|8|||
156465378|NCT02231749|564800833|FG001|Overall Study|Participant withdrew Consent|15|||
156465379|NCT02231749|564800832|FG000|Overall Study|Lost to Follow-up|1|||
156465380|NCT02231749|564800833|FG001|Overall Study|Lost to Follow-up|2|||
156465381|NCT02231749|564800832|FG000|Overall Study|Maximum Clinical Benefit|5|||
156465382|NCT02231749|564800833|FG001|Overall Study|Maximum Clinical Benefit|8|||
156465383|NCT02231749|564800832|FG000|Overall Study|Poor/Non-Compliance|0|||
156465384|NCT02231749|564800833|FG001|Overall Study|Poor/Non-Compliance|3|||
156465385|NCT02231749|564800832|FG000|Overall Study|Pregnancy|1|||
156465386|NCT02231749|564800833|FG001|Overall Study|Pregnancy|0|||
156465387|NCT02231749|564800832|FG000|Overall Study|other|0|||
156465388|NCT02231749|564800833|FG001|Overall Study|other|8|||
156465389|NCT02231749|564800832|FG000|Overall Study|No longer meets Study Criteria|1|||
156465390|NCT02231749|564800833|FG001|Overall Study|No longer meets Study Criteria|0|||
156465391|NCT02989662|564800840|FG000|Overall Study|Lost to Follow-up|0|||
156465392|NCT02989662|564800841|FG001|Overall Study|Lost to Follow-up|0|||
156465393|NCT02989662|564800842|FG002|Overall Study|Lost to Follow-up|0|||
156465394|NCT02989662|564800843|FG003|Overall Study|Lost to Follow-up|2|||
156465395|NCT02989662|564800840|FG000|Overall Study|Physician Decision|3|||
156465396|NCT02989662|564800841|FG001|Overall Study|Physician Decision|0|||
156465397|NCT02989662|564800842|FG002|Overall Study|Physician Decision|0|||
156465398|NCT02989662|564800843|FG003|Overall Study|Physician Decision|0|||
156465399|NCT02989662|564800840|FG000|Overall Study|Withdrawal by Subject|1|||
156465400|NCT02989662|564800841|FG001|Overall Study|Withdrawal by Subject|0|||
156465401|NCT02989662|564800842|FG002|Overall Study|Withdrawal by Subject|0|||
156465402|NCT02989662|564800843|FG003|Overall Study|Withdrawal by Subject|0|||
156465403|NCT00328783|564800844|FG000|Overall Study|Could not tolerate ABC|21|||
156465404|NCT00328783|564800844|FG000|Overall Study|No heart in RT field|4|||
156465405|NCT00328783|564800844|FG000|Overall Study|Withdrawal by Subject|1|||
156465406|NCT00357682|564800845|FG000|Overall Study|Did not receive allocated Treatment|10|||
156465407|NCT00357682|564800846|FG001|Overall Study|Did not receive allocated Treatment|9|||
156465408|NCT00357682|564800847|FG002|Overall Study|Did not receive allocated Treatment|9|||
156816042|NCT02712983|566077424|FG000|Treatment Phase|Technical Problems|0|||
156816043|NCT02712983|566077425|FG001|Treatment Phase|Technical Problems|0|||
156816044|NCT02712983|566077426|FG002|Treatment Phase|Technical Problems|0|||
156816045|NCT02712983|566077427|FG003|Treatment Phase|Technical Problems|0|||
156816046|NCT02712983|566077428|FG004|Treatment Phase|Technical Problems|0|||
156816047|NCT02712983|566077429|FG005|Treatment Phase|Technical Problems|0|||
156816048|NCT02712983|566077430|FG006|Treatment Phase|Technical Problems|1|||
156816049|NCT02712983|566077431|FG007|Treatment Phase|Technical Problems|0|||
156816050|NCT02712983|566077432|FG008|Treatment Phase|Technical Problems|0|||
156816051|NCT02712983|566077424|FG000|Treatment Phase|Physician Decision|0|||
156816052|NCT02712983|566077425|FG001|Treatment Phase|Physician Decision|0|||
156816053|NCT02712983|566077426|FG002|Treatment Phase|Physician Decision|0|||
156816054|NCT02712983|566077427|FG003|Treatment Phase|Physician Decision|0|||
156816055|NCT02712983|566077428|FG004|Treatment Phase|Physician Decision|0|||
156816056|NCT02712983|566077429|FG005|Treatment Phase|Physician Decision|0|||
156816057|NCT02712983|566077430|FG006|Treatment Phase|Physician Decision|0|||
156816058|NCT02712983|566077431|FG007|Treatment Phase|Physician Decision|1|||
156816059|NCT02712983|566077432|FG008|Treatment Phase|Physician Decision|1|||
156816060|NCT02712983|566077424|FG000|Treatment Phase|Subject Decision|2|||
156816061|NCT02712983|566077425|FG001|Treatment Phase|Subject Decision|0|||
156816062|NCT02712983|566077426|FG002|Treatment Phase|Subject Decision|0|||
156816063|NCT02712983|566077427|FG003|Treatment Phase|Subject Decision|2|||
156816064|NCT02712983|566077428|FG004|Treatment Phase|Subject Decision|1|||
156816065|NCT02712983|566077429|FG005|Treatment Phase|Subject Decision|0|||
156816066|NCT02712983|566077430|FG006|Treatment Phase|Subject Decision|1|||
156816067|NCT02712983|566077431|FG007|Treatment Phase|Subject Decision|2|||
156816068|NCT02712983|566077432|FG008|Treatment Phase|Subject Decision|0|||
156816069|NCT02712983|566077424|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816070|NCT02712983|566077425|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
156816071|NCT02712983|566077426|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816072|NCT02712983|566077427|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816073|NCT02712983|566077428|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816074|NCT02712983|566077429|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816075|NCT02712983|566077430|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
156816076|NCT02712983|566077431|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
156816077|NCT02712983|566077432|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816078|NCT02712983|566077424|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816079|NCT02712983|566077425|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816080|NCT02712983|566077426|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816081|NCT02712983|566077427|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
156816082|NCT02712983|566077428|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816083|NCT02712983|566077429|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816084|NCT02712983|566077430|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816085|NCT02712983|566077431|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816086|NCT02712983|566077432|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816087|NCT02712983|566077424|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816088|NCT02712983|566077425|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816089|NCT02712983|566077426|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816090|NCT02712983|566077427|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816091|NCT02712983|566077428|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
156816092|NCT02712983|566077429|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
156816093|NCT02712983|566077430|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
156816094|NCT02712983|566077431|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
156816095|NCT02712983|566077432|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816096|NCT00064259|566077433|FG000|Overall Study|Adverse Event|1|||
156816097|NCT00064259|566077434|FG001|Overall Study|Adverse Event|0|||
156816098|NCT00064259|566077435|FG002|Overall Study|Adverse Event|0|||
156816099|NCT00064259|566077436|FG003|Overall Study|Adverse Event|1|||
156816100|NCT01132651|566077439|FG000|Overall Study|Lost to Follow-up|1|||
156816101|NCT01132651|566077440|FG001|Overall Study|Lost to Follow-up|1|||
156816102|NCT03062280|566077451|FG000|Overall Study|Adverse Event|1|||
156816103|NCT03062280|566077451|FG000|Overall Study|Death|1|||
156816104|NCT03062280|566077451|FG000|Overall Study|Fertility Treatment|2|||
156816105|NCT03062280|566077451|FG000|Overall Study|Physician Decision|2|||
156816106|NCT03062280|566077451|FG000|Overall Study|Pregnancy|5|||
156816107|NCT03062280|566077451|FG000|Overall Study|Withdrawal by Subject|11|||
156816108|NCT03462641|566077452|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
156816109|NCT03462641|566077453|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
156816110|NCT03462641|566077452|FG000|Visit 2|Withdrawal by Subject|0|||
156816111|NCT03462641|566077453|FG001|Visit 2|Withdrawal by Subject|1|||
156816112|NCT01804049|566077454|FG000|Overall Study|Adverse Event|2|||
156816113|NCT01804049|566077455|FG001|Overall Study|Adverse Event|10|||
156816114|NCT01804049|566077454|FG000|Overall Study|Lost to Follow-up|2|||
156816115|NCT01804049|566077455|FG001|Overall Study|Lost to Follow-up|1|||
156816116|NCT01804049|566077454|FG000|Overall Study|Decreased interest/personal|4|||
156816117|NCT01804049|566077455|FG001|Overall Study|Decreased interest/personal|5|||
156816118|NCT01804049|566077454|FG000|Overall Study|Other health concerns|2|||
156816119|NCT01804049|566077455|FG001|Overall Study|Other health concerns|7|||
156816120|NCT01804049|566077454|FG000|Overall Study|Moved out of area|0|||
156816121|NCT01804049|566077455|FG001|Overall Study|Moved out of area|7|||
156816122|NCT01804049|566077454|FG000|Overall Study|other MD recommended|1|||
156816123|NCT01804049|566077455|FG001|Overall Study|other MD recommended|1|||
156816124|NCT01804049|566077454|FG000|Overall Study|Enrollment in dual studies|0|||
156816125|NCT01804049|566077455|FG001|Overall Study|Enrollment in dual studies|1|||
156816126|NCT00070109|566077456|FG000|Overall Study|Death|1|||
156816127|NCT00070109|566077457|FG001|Overall Study|Death|1|||
156816128|NCT00070109|566077458|FG002|Overall Study|Death|0|||
156816129|NCT00070109|566077459|FG003|Overall Study|Death|0|||
156816130|NCT00070109|566077460|FG004|Overall Study|Death|1|||
156816131|NCT00070109|566077456|FG000|Overall Study|Lack of Efficacy|6|||
156816132|NCT00070109|566077457|FG001|Overall Study|Lack of Efficacy|4|||
156816133|NCT00070109|566077458|FG002|Overall Study|Lack of Efficacy|5|||
156816134|NCT00070109|566077459|FG003|Overall Study|Lack of Efficacy|15|||
156816135|NCT00070109|566077460|FG004|Overall Study|Lack of Efficacy|5|||
156816136|NCT00070109|566077456|FG000|Overall Study|Physician Decision|1|||
156816137|NCT00070109|566077457|FG001|Overall Study|Physician Decision|0|||
156816138|NCT00070109|566077458|FG002|Overall Study|Physician Decision|0|||
156816139|NCT00070109|566077459|FG003|Overall Study|Physician Decision|0|||
156816140|NCT00070109|566077460|FG004|Overall Study|Physician Decision|0|||
156465409|NCT00357682|564800848|FG003|Overall Study|Did not receive allocated Treatment|10|||
156465410|NCT00357682|564800845|FG000|Overall Study|Withdrew consent|6|||
156465411|NCT00357682|564800846|FG001|Overall Study|Withdrew consent|6|||
156465412|NCT00357682|564800847|FG002|Overall Study|Withdrew consent|5|||
156465413|NCT00357682|564800848|FG003|Overall Study|Withdrew consent|5|||
156465414|NCT00357682|564800845|FG000|Overall Study|Lost to Follow-up|39|||
156465415|NCT00357682|564800846|FG001|Overall Study|Lost to Follow-up|33|||
156465416|NCT00357682|564800847|FG002|Overall Study|Lost to Follow-up|26|||
156465417|NCT00357682|564800848|FG003|Overall Study|Lost to Follow-up|35|||
156465418|NCT00357682|564800845|FG000|Overall Study|Adverse Event|24|||
156465419|NCT00357682|564800846|FG001|Overall Study|Adverse Event|32|||
156465420|NCT00357682|564800847|FG002|Overall Study|Adverse Event|22|||
156465421|NCT00357682|564800848|FG003|Overall Study|Adverse Event|27|||
156465422|NCT00357682|564800845|FG000|Overall Study|Physician Decision|32|||
156465423|NCT00357682|564800846|FG001|Overall Study|Physician Decision|20|||
156816141|NCT00070109|566077456|FG000|Overall Study|Withdrawal by Subject|0|||
156816142|NCT00070109|566077457|FG001|Overall Study|Withdrawal by Subject|1|||
156816143|NCT00070109|566077458|FG002|Overall Study|Withdrawal by Subject|1|||
156465424|NCT00357682|564800847|FG002|Overall Study|Physician Decision|24|||
156465425|NCT00357682|564800848|FG003|Overall Study|Physician Decision|30|||
156465426|NCT00357682|564800845|FG000|Overall Study|Patient decision|73|||
156465427|NCT00357682|564800846|FG001|Overall Study|Patient decision|80|||
156465428|NCT00357682|564800847|FG002|Overall Study|Patient decision|51|||
156816144|NCT00070109|566077459|FG003|Overall Study|Withdrawal by Subject|0|||
156816145|NCT00070109|566077460|FG004|Overall Study|Withdrawal by Subject|0|||
156816146|NCT00070109|566077456|FG000|Overall Study|Adverse Event|0|||
156816147|NCT00070109|566077457|FG001|Overall Study|Adverse Event|0|||
156816148|NCT00070109|566077458|FG002|Overall Study|Adverse Event|2|||
156816149|NCT00070109|566077459|FG003|Overall Study|Adverse Event|4|||
156816150|NCT00070109|566077460|FG004|Overall Study|Adverse Event|2|||
156816151|NCT00070109|566077456|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
156816152|NCT00070109|566077457|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
156816153|NCT00070109|566077458|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
156816154|NCT00070109|566077459|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
156816155|NCT00070109|566077460|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
156816156|NCT01147250|566077463|FG000|Overall Study|Lost to Follow-up|14|||
156465429|NCT00357682|564800848|FG003|Overall Study|Patient decision|59|||
156816157|NCT01147250|566077464|FG001|Overall Study|Lost to Follow-up|11|||
156816158|NCT01147250|566077463|FG000|Overall Study|Withdrawal by Subject|83|||
156816159|NCT01147250|566077464|FG001|Overall Study|Withdrawal by Subject|88|||
156816160|NCT01147250|566077463|FG000|Overall Study|Site termination by sponsor|13|||
156816161|NCT01147250|566077464|FG001|Overall Study|Site termination by sponsor|5|||
156816162|NCT01147250|566077463|FG000|Overall Study|Other than specified|0|||
156816163|NCT01147250|566077464|FG001|Overall Study|Other than specified|1|||
156816164|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156465430|NCT00357682|564800845|FG000|Overall Study|Other reason|157|||
156465431|NCT00357682|564800846|FG001|Overall Study|Other reason|130|||
156465432|NCT00357682|564800847|FG002|Overall Study|Other reason|114|||
156465433|NCT00357682|564800848|FG003|Overall Study|Other reason|99|||
156465434|NCT05424718|564800855|FG000|Overall Study|Lost to Follow-up|5|||
156465435|NCT05424718|564800856|FG001|Overall Study|Lost to Follow-up|4|||
156465436|NCT04046549|564800857|FG000|Overall Study|Adverse Event|1|||
156816165|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
156816166|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156816167|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156816168|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156816169|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156816170|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
156816171|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
156816172|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156816173|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156816174|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156816175|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156816176|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
156816177|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
156816178|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156816179|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156816180|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156816181|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156816182|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
156816183|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
156816184|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
156816185|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
156816186|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
156816187|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
156465437|NCT04046549|564800857|FG000|Overall Study|Physician Decision|1|||
156465438|NCT04046549|564800857|FG000|Overall Study|Withdrawal by Subject|3|||
156465439|NCT04046549|564800857|FG000|Overall Study|Other, Not Specified|5|||
156465440|NCT06059443|564800858|FG000|Overall Study|Withdrawal by Subject|2|||
156465441|NCT06059443|564800859|FG001|Overall Study|Withdrawal by Subject|0|||
156816188|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816189|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
156816190|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816191|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816192|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816193|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816194|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
156816195|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
156816196|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
156816197|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
156465442|NCT06059443|564800858|FG000|Overall Study|Lost to Follow-up|2|||
156539921|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
156539922|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
156816198|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
156816199|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
156816200|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156465443|NCT06059443|564800859|FG001|Overall Study|Lost to Follow-up|2|||
156539923|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
156465444|NCT04479787|564800864|FG000|Through 6 Months|Withdrawal by Subject|16|||
156465445|NCT04479787|564800865|FG001|Through 6 Months|Withdrawal by Subject|14|||
156539924|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
156465446|NCT04479787|564800864|FG000|Through 6 Months|Unsuccessful Trial|17|||
156465447|NCT04479787|564800865|FG001|Through 6 Months|Unsuccessful Trial|0|||
156465448|NCT04479787|564800864|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
156465449|NCT04479787|564800865|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
156465450|NCT04479787|564800864|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
156465451|NCT04479787|564800865|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
156465452|NCT04479787|564800864|FG000|Through 6 Months|Lost to Follow-up|3|||
156465453|NCT04479787|564800865|FG001|Through 6 Months|Lost to Follow-up|2|||
156465454|NCT04479787|564800864|FG000|Through 6 Months|Death|3|||
156539925|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
156539926|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
156539927|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
156465455|NCT04479787|564800865|FG001|Through 6 Months|Death|0|||
156465456|NCT04479787|564800864|FG000|Through 6 Months|Inclusion/Exclusion|2|||
156465457|NCT04479787|564800865|FG001|Through 6 Months|Inclusion/Exclusion|1|||
156539928|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
156539929|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
156539930|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
156816201|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
156539931|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
156539932|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
156539933|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
156539934|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
156539935|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
156539936|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
156539937|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
156539938|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
156539939|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
156539940|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
156539941|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
156539942|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
156816202|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156816203|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156816204|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156816205|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156816206|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816207|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
156539943|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
156539944|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
156539945|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
156539946|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
156539947|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
156539948|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
156539949|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
156539950|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
156539951|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
156539952|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
156816208|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816209|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816210|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816211|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816212|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156816213|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156816214|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
156816215|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
156816216|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
156816217|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
156816218|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156816219|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156816220|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
156816221|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
156816222|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
156816223|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
156816224|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
156816225|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
156816226|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
156816227|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
156816228|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
156816229|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
156816230|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156816231|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156816232|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156816233|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
156816234|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
156816235|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
156539953|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
156539954|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
156539955|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
156539956|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
156539957|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
156816236|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
156816237|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
156816238|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
156816239|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
156816240|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
156816241|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
156816242|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
156816243|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
156816244|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
156816245|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
156816246|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
156816247|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
156816248|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
156816249|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
156816250|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
156816251|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
156816252|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
156816253|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
156816254|NCT00716482|566077475|FG000|Overall Study|Lost to Follow-up|6|||
156816255|NCT00716482|566077475|FG000|Overall Study|Inadequate acquisition or analysis|50|||
156816256|NCT00716482|566077475|FG000|Overall Study|no pathology obtained|10|||
156816257|NCT00716482|566077475|FG000|Overall Study|technical/machine error|28|||
156816258|NCT00716482|566077475|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
156816259|NCT03248531|566077476|FG000|Overall Study|Adverse Event|0|||
156816260|NCT03248531|566077477|FG001|Overall Study|Adverse Event|0|||
156816261|NCT03248531|566077478|FG002|Overall Study|Adverse Event|1|||
156816262|NCT03248531|566077476|FG000|Overall Study|Lost to Follow-up|1|||
156816263|NCT03248531|566077477|FG001|Overall Study|Lost to Follow-up|0|||
156816264|NCT03248531|566077478|FG002|Overall Study|Lost to Follow-up|5|||
156816265|NCT03248531|566077476|FG000|Overall Study|Withdrawal by Subject|3|||
156816266|NCT03248531|566077477|FG001|Overall Study|Withdrawal by Subject|3|||
156816267|NCT03248531|566077478|FG002|Overall Study|Withdrawal by Subject|2|||
156816268|NCT03248531|566077476|FG000|Overall Study|Sponsor Request|0|||
156816269|NCT03248531|566077477|FG001|Overall Study|Sponsor Request|2|||
156816270|NCT03248531|566077478|FG002|Overall Study|Sponsor Request|0|||
156816271|NCT04075513|566077481|FG000|Overall Study|Withdrawal by Subject|2|||
156816272|NCT04075513|566077482|FG001|Overall Study|Withdrawal by Subject|2|||
156816273|NCT04075513|566077481|FG000|Overall Study|Lack of Efficacy|1|||
156816274|NCT04075513|566077482|FG001|Overall Study|Lack of Efficacy|0|||
156816275|NCT04075513|566077481|FG000|Overall Study|Lost to Follow-up|4|||
156816276|NCT04075513|566077482|FG001|Overall Study|Lost to Follow-up|2|||
156816277|NCT04075513|566077481|FG000|Overall Study|Switch to insulin pump|1|||
156816278|NCT04075513|566077482|FG001|Overall Study|Switch to insulin pump|0|||
156816279|NCT03249909|566077483|FG000|Overall Study|Withdrawal by Subject|3|||
156816280|NCT03249909|566077484|FG001|Overall Study|Withdrawal by Subject|0|||
156816281|NCT03249909|566077485|FG002|Overall Study|Withdrawal by Subject|0|||
156816282|NCT03249909|566077483|FG000|Overall Study|Adverse Event|3|||
156816283|NCT03249909|566077484|FG001|Overall Study|Adverse Event|0|||
156816284|NCT03249909|566077485|FG002|Overall Study|Adverse Event|0|||
156816285|NCT03249909|566077483|FG000|Overall Study|Lost to Follow-up|0|||
156816286|NCT03249909|566077484|FG001|Overall Study|Lost to Follow-up|1|||
156816287|NCT03249909|566077485|FG002|Overall Study|Lost to Follow-up|0|||
156816288|NCT00842153|566077488|FG000|Overall Study|Adverse Event|0|||
156816289|NCT00842153|566077489|FG001|Overall Study|Adverse Event|1|||
156816290|NCT00842153|566077488|FG000|Overall Study|Lost to Follow-up|1|||
156816291|NCT00842153|566077489|FG001|Overall Study|Lost to Follow-up|2|||
156816292|NCT03517371|566077490|FG000|Overall Study|Adverse Event|8|||
156816293|NCT03517371|566077491|FG001|Overall Study|Adverse Event|9|||
156816294|NCT03517371|566077490|FG000|Overall Study|Lost to Follow-up|1|||
156816295|NCT03517371|566077491|FG001|Overall Study|Lost to Follow-up|2|||
156816296|NCT03517371|566077490|FG000|Overall Study|Withdrawal by Subject|4|||
156816297|NCT03517371|566077491|FG001|Overall Study|Withdrawal by Subject|4|||
156816298|NCT03517371|566077490|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
156816299|NCT03517371|566077491|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
156816300|NCT03517371|566077490|FG000|Overall Study|COVID restrictions|2|||
156816301|NCT03517371|566077491|FG001|Overall Study|COVID restrictions|0|||
156816302|NCT03517371|566077490|FG000|Overall Study|Receiving DBS Surgery|0|||
156816303|NCT03517371|566077491|FG001|Overall Study|Receiving DBS Surgery|1|||
156816304|NCT05411822|566077492|FG000|Overall Study|Withdrawal by Subject|2|||
156816305|NCT05411822|566077493|FG001|Overall Study|Withdrawal by Subject|1|||
156816306|NCT02201329|566077495|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
156816307|NCT02201329|566077495|FG000|Overall Study|Withdrawal by Subject|2|||
156816308|NCT01534351|566077496|FG000|Overall Study|Study Terminated Early|1|||
156816309|NCT01534351|566077497|FG001|Overall Study|Study Terminated Early|0|||
156338980|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
156338981|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
156338982|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
156338983|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
156338984|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
156338985|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
156338986|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
156338987|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
156338988|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
156338989|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
156338990|NCT00730405|564340090|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
156338991|NCT00730405|564340091|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
156338992|NCT00730405|564340092|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
156816310|NCT01534351|566077498|FG002|Overall Study|Study Terminated Early|0|||
156465458|NCT04479787|564800864|FG000|Through 6 Months|Subject Became Pregnant|1|||
156465459|NCT04479787|564800865|FG001|Through 6 Months|Subject Became Pregnant|1|||
156465460|NCT04479787|564800864|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
156465461|NCT04479787|564800865|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
156816311|NCT02702609|566077499|FG000|Overall Study|Lost to Follow-up|8|||
156816312|NCT02702609|566077500|FG001|Overall Study|Lost to Follow-up|4|||
156816313|NCT02702609|566077499|FG000|Overall Study|Physician Decision|1|||
156816314|NCT02702609|566077500|FG001|Overall Study|Physician Decision|0|||
156816315|NCT02674464|566077501|FG000|Overall Study|Death|10|||
156816316|NCT02674464|566077502|FG001|Overall Study|Death|21|||
156816317|NCT02674464|566077501|FG000|Overall Study|Withdrawal by Subject|24|||
156816318|NCT02674464|566077502|FG001|Overall Study|Withdrawal by Subject|44|||
156816319|NCT02674464|566077501|FG000|Overall Study|Lost to Follow-up|97|||
156816320|NCT02674464|566077502|FG001|Overall Study|Lost to Follow-up|92|||
156816321|NCT02674464|566077501|FG000|Overall Study|Outside survey window|6|||
156816322|NCT02674464|566077502|FG001|Overall Study|Outside survey window|3|||
156816323|NCT04153981|566077503|FG000|Overall Study|Death|1|||
156816324|NCT04153981|566077503|FG000|Overall Study|Withdrawal by Subject|24|||
156816325|NCT04153981|566077503|FG000|Overall Study|Lost to Follow-up|1|||
156816326|NCT04153981|566077503|FG000|Overall Study|Physician Decision|1|||
156816327|NCT04153981|566077503|FG000|Overall Study|Due to Unavailable Glucometer|1|||
156816328|NCT04153981|566077503|FG000|Overall Study|Covid 19|52|||
156816329|NCT04153981|566077503|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
156816330|NCT04153981|566077503|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
156816331|NCT01262638|566077504|FG000|Overall Study|Adverse Event|3|||
156816332|NCT01262638|566077505|FG001|Overall Study|Adverse Event|4|||
156816333|NCT01262638|566077506|FG002|Overall Study|Adverse Event|3|||
156816334|NCT01262638|566077507|FG003|Overall Study|Adverse Event|4|||
156816335|NCT01262638|566077504|FG000|Overall Study|Protocol Violation|1|||
156816336|NCT01262638|566077505|FG001|Overall Study|Protocol Violation|0|||
156816337|NCT01262638|566077506|FG002|Overall Study|Protocol Violation|0|||
156816338|NCT01262638|566077507|FG003|Overall Study|Protocol Violation|1|||
156816339|NCT01262638|566077504|FG000|Overall Study|Withdrawal by Subject|2|||
156816340|NCT01262638|566077505|FG001|Overall Study|Withdrawal by Subject|1|||
156816341|NCT01262638|566077506|FG002|Overall Study|Withdrawal by Subject|0|||
156816342|NCT01262638|566077507|FG003|Overall Study|Withdrawal by Subject|1|||
156816343|NCT01262638|566077504|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
156816344|NCT01262638|566077505|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
156816345|NCT01262638|566077506|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
156816346|NCT01262638|566077507|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
156816347|NCT01262638|566077504|FG000|Overall Study|Lost to Follow-up|1|||
156816348|NCT01262638|566077505|FG001|Overall Study|Lost to Follow-up|1|||
156816349|NCT01262638|566077506|FG002|Overall Study|Lost to Follow-up|1|||
156816350|NCT01262638|566077507|FG003|Overall Study|Lost to Follow-up|1|||
156816351|NCT01262638|566077504|FG000|Overall Study|Participant Went Out of Town|0|||
156816352|NCT01262638|566077505|FG001|Overall Study|Participant Went Out of Town|0|||
156816353|NCT01262638|566077506|FG002|Overall Study|Participant Went Out of Town|1|||
156816354|NCT01262638|566077507|FG003|Overall Study|Participant Went Out of Town|0|||
156816355|NCT01369199|566077510|FG000|Overall Study|Withdrawal by Subject|1|||
156816356|NCT01369199|566077510|FG000|Overall Study|Lost to Follow-up|2|||
156816357|NCT01071252|566077511|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
156338993|NCT00730405|564340093|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
156465462|NCT04479787|564800864|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
156465463|NCT04479787|564800865|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
156816358|NCT01071252|566077512|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
156816359|NCT01071252|566077513|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
156816360|NCT01071252|566077514|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
156816361|NCT01071252|566077515|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
156465464|NCT04479787|564800864|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
156465465|NCT04479787|564800865|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
156465466|NCT04479787|564800864|FG000|After 6 Months|Withdrawal by Subject|3|||
156816362|NCT01071252|566077511|FG000|Overall Study|Withdrawal by Subject|8|||
156816363|NCT01071252|566077512|FG001|Overall Study|Withdrawal by Subject|2|||
156816364|NCT01071252|566077513|FG002|Overall Study|Withdrawal by Subject|1|||
156816365|NCT01071252|566077514|FG003|Overall Study|Withdrawal by Subject|2|||
156816366|NCT01071252|566077515|FG004|Overall Study|Withdrawal by Subject|3|||
156816367|NCT01071252|566077511|FG000|Overall Study|administrative problems|1|||
156816368|NCT01071252|566077512|FG001|Overall Study|administrative problems|1|||
156816369|NCT01071252|566077513|FG002|Overall Study|administrative problems|0|||
156816370|NCT01071252|566077514|FG003|Overall Study|administrative problems|2|||
156816371|NCT01071252|566077515|FG004|Overall Study|administrative problems|1|||
156816372|NCT01071252|566077511|FG000|Overall Study|Lost to Follow-up|1|||
156816373|NCT01071252|566077512|FG001|Overall Study|Lost to Follow-up|0|||
156816374|NCT01071252|566077513|FG002|Overall Study|Lost to Follow-up|1|||
156816375|NCT01071252|566077514|FG003|Overall Study|Lost to Follow-up|2|||
156816376|NCT01071252|566077515|FG004|Overall Study|Lost to Follow-up|0|||
156816377|NCT01071252|566077511|FG000|Overall Study|Adverse Event|1|||
156816378|NCT01071252|566077512|FG001|Overall Study|Adverse Event|1|||
156816379|NCT01071252|566077513|FG002|Overall Study|Adverse Event|0|||
156816380|NCT01071252|566077514|FG003|Overall Study|Adverse Event|1|||
156816381|NCT01071252|566077515|FG004|Overall Study|Adverse Event|0|||
156816382|NCT01071252|566077511|FG000|Overall Study|Death|0|||
156816383|NCT01071252|566077512|FG001|Overall Study|Death|0|||
156816384|NCT01071252|566077513|FG002|Overall Study|Death|0|||
156816385|NCT01071252|566077514|FG003|Overall Study|Death|0|||
156816386|NCT01071252|566077515|FG004|Overall Study|Death|1|||
156816387|NCT01066104|566077516|FG000|Overall Study|Adverse Event|1|||
156816388|NCT01066104|566077517|FG001|Overall Study|Adverse Event|1|||
156816389|NCT01066104|566077516|FG000|Overall Study|Protocol Violation|1|||
156816390|NCT01066104|566077517|FG001|Overall Study|Protocol Violation|0|||
156816391|NCT02125838|566077518|FG000|Overall Study|Lost to Follow-up|4|||
156816392|NCT02125838|566077519|FG001|Overall Study|Lost to Follow-up|4|||
156816393|NCT00787839|566077520|FG000|Overall Study|Failure to have the OGTT was most common|404|||
156816394|NCT03902392|566077521|FG000|Overall Study|Lost to Follow-up|7|||
156816395|NCT03902392|566077522|FG001|Overall Study|Lost to Follow-up|7|||
156816396|NCT00244725|566077527|FG000|Overall Study|Lost to Follow-up|3|||
156816397|NCT00244725|566077528|FG001|Overall Study|Lost to Follow-up|4|||
156816398|NCT00244725|566077529|FG002|Overall Study|Lost to Follow-up|9|||
156816399|NCT00244725|566077530|FG003|Overall Study|Lost to Follow-up|2|||
156816400|NCT00244725|566077527|FG000|Overall Study|Withdrawal by Subject|9|||
156816401|NCT00244725|566077528|FG001|Overall Study|Withdrawal by Subject|7|||
156816402|NCT00244725|566077529|FG002|Overall Study|Withdrawal by Subject|7|||
156816403|NCT00244725|566077530|FG003|Overall Study|Withdrawal by Subject|8|||
156816404|NCT00244725|566077527|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
156816405|NCT00244725|566077528|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
156816406|NCT00244725|566077529|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
156816407|NCT00244725|566077530|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
156816408|NCT00244725|566077527|FG000|Overall Study|Physician Decision|3|||
156816409|NCT00244725|566077528|FG001|Overall Study|Physician Decision|0|||
156816410|NCT00244725|566077529|FG002|Overall Study|Physician Decision|1|||
156816411|NCT00244725|566077530|FG003|Overall Study|Physician Decision|2|||
156816412|NCT00244725|566077527|FG000|Overall Study|Adverse Events|3|||
156816413|NCT00244725|566077528|FG001|Overall Study|Adverse Events|1|||
156816414|NCT00244725|566077529|FG002|Overall Study|Adverse Events|4|||
156816415|NCT00244725|566077530|FG003|Overall Study|Adverse Events|4|||
156816416|NCT00244725|566077527|FG000|Overall Study|Withdrwal by participant|1|||
156816417|NCT00244725|566077528|FG001|Overall Study|Withdrwal by participant|0|||
156816418|NCT00244725|566077529|FG002|Overall Study|Withdrwal by participant|0|||
156816419|NCT00244725|566077530|FG003|Overall Study|Withdrwal by participant|1|||
156816420|NCT00244725|566077527|FG000|Overall Study|Liver function test abnormality|2|||
156816421|NCT00244725|566077528|FG001|Overall Study|Liver function test abnormality|0|||
156816422|NCT00244725|566077529|FG002|Overall Study|Liver function test abnormality|0|||
156816423|NCT00244725|566077530|FG003|Overall Study|Liver function test abnormality|1|||
156816424|NCT00244725|566077527|FG000|Overall Study|Sponsor withdrew the participant|1|||
156816425|NCT00244725|566077528|FG001|Overall Study|Sponsor withdrew the participant|0|||
156816426|NCT00244725|566077529|FG002|Overall Study|Sponsor withdrew the participant|0|||
156816427|NCT00244725|566077530|FG003|Overall Study|Sponsor withdrew the participant|1|||
156816428|NCT00244725|566077527|FG000|Overall Study|Mediciation Error|0|||
156465467|NCT04479787|564800865|FG001|After 6 Months|Withdrawal by Subject|13|||
156816429|NCT00244725|566077528|FG001|Overall Study|Mediciation Error|1|||
156816430|NCT00244725|566077529|FG002|Overall Study|Mediciation Error|0|||
156816431|NCT00244725|566077530|FG003|Overall Study|Mediciation Error|0|||
156816432|NCT00244725|566077527|FG000|Overall Study|Rehab Refused to allow participantion|0|||
156816433|NCT00244725|566077528|FG001|Overall Study|Rehab Refused to allow participantion|1|||
156816434|NCT00244725|566077529|FG002|Overall Study|Rehab Refused to allow participantion|0|||
156816435|NCT00244725|566077530|FG003|Overall Study|Rehab Refused to allow participantion|0|||
156816436|NCT00244725|566077527|FG000|Overall Study|Headache|0|||
156816437|NCT00244725|566077528|FG001|Overall Study|Headache|1|||
156816438|NCT00244725|566077529|FG002|Overall Study|Headache|0|||
156816439|NCT00244725|566077530|FG003|Overall Study|Headache|0|||
156816440|NCT00244725|566077527|FG000|Overall Study|Received prohibited medication|0|||
156816441|NCT00244725|566077528|FG001|Overall Study|Received prohibited medication|1|||
156816442|NCT00244725|566077529|FG002|Overall Study|Received prohibited medication|0|||
156816443|NCT00244725|566077530|FG003|Overall Study|Received prohibited medication|1|||
156816444|NCT00244725|566077527|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
156816445|NCT00244725|566077528|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
156816446|NCT00244725|566077529|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
156816447|NCT00244725|566077530|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
156816448|NCT00244725|566077527|FG000|Overall Study|Administrative reason|0|||
156816449|NCT00244725|566077528|FG001|Overall Study|Administrative reason|0|||
156816450|NCT00244725|566077529|FG002|Overall Study|Administrative reason|1|||
156338994|NCT00730405|564340094|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
156816451|NCT00244725|566077530|FG003|Overall Study|Administrative reason|0|||
156816452|NCT00244725|566077527|FG000|Overall Study|Vomit|0|||
156816453|NCT00244725|566077528|FG001|Overall Study|Vomit|0|||
156816454|NCT00244725|566077529|FG002|Overall Study|Vomit|1|||
156816455|NCT00244725|566077530|FG003|Overall Study|Vomit|0|||
156816456|NCT00244725|566077527|FG000|Overall Study|Failed to follow-up|0|||
156816457|NCT00244725|566077528|FG001|Overall Study|Failed to follow-up|0|||
156816458|NCT00244725|566077529|FG002|Overall Study|Failed to follow-up|1|||
156816459|NCT00244725|566077530|FG003|Overall Study|Failed to follow-up|1|||
156816460|NCT00335738|566077531|FG000|Overall Study|Physician Decision|6|||
156816461|NCT00335738|566077532|FG001|Overall Study|Physician Decision|0|||
156816462|NCT00335738|566077531|FG000|Overall Study|Withdrawal by Subject|2|||
156816463|NCT00335738|566077532|FG001|Overall Study|Withdrawal by Subject|0|||
156816464|NCT00335738|566077531|FG000|Overall Study|Ineligible|3|||
156816465|NCT00335738|566077532|FG001|Overall Study|Ineligible|4|||
156816466|NCT01667133|566077533|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
156816467|NCT01667133|566077534|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
156816468|NCT01667133|566077535|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
156816469|NCT01667133|566077536|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
156816470|NCT01667133|566077537|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
156816471|NCT01667133|566077538|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
156816472|NCT01667133|566077539|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
156816473|NCT01667133|566077540|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
156816474|NCT01667133|566077541|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
156338995|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
156816475|NCT01667133|566077542|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
156816476|NCT01667133|566077543|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
156816477|NCT01667133|566077544|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
156816478|NCT01667133|566077533|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816479|NCT01667133|566077534|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816480|NCT01667133|566077535|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
156816481|NCT01667133|566077536|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816482|NCT01667133|566077537|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816483|NCT01667133|566077538|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156338996|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
156338997|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
156338998|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
156338999|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
156465468|NCT04479787|564800864|FG000|After 6 Months|Unsuccessful Trial|0|||
156465469|NCT04479787|564800865|FG001|After 6 Months|Unsuccessful Trial|7|||
156465470|NCT04479787|564800864|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
156465471|NCT04479787|564800865|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
156465472|NCT04479787|564800864|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
156465473|NCT04479787|564800865|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
156465474|NCT04479787|564800864|FG000|After 6 Months|Death|2|||
156465475|NCT04479787|564800865|FG001|After 6 Months|Death|0|||
156816484|NCT01667133|566077539|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816485|NCT01667133|566077540|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816486|NCT01667133|566077541|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816487|NCT01667133|566077542|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816488|NCT01667133|566077543|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816489|NCT01667133|566077544|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816490|NCT01667133|566077533|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
156816491|NCT01667133|566077534|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
156816492|NCT01667133|566077535|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
156816493|NCT01667133|566077536|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
156465476|NCT04479787|564800864|FG000|After 6 Months|Lost to Follow-up|1|||
156816494|NCT01667133|566077537|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
156816495|NCT01667133|566077538|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
156816496|NCT01667133|566077539|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
156816497|NCT01667133|566077540|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
156816498|NCT01667133|566077541|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
156816499|NCT01667133|566077542|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
156816500|NCT01667133|566077543|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
156816501|NCT01667133|566077544|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
156816502|NCT01667133|566077533|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816503|NCT01667133|566077534|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816504|NCT01667133|566077535|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816505|NCT01667133|566077536|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
156816506|NCT01667133|566077537|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816507|NCT01667133|566077538|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816508|NCT01667133|566077539|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816509|NCT01667133|566077540|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816510|NCT01667133|566077541|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816511|NCT01667133|566077542|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816512|NCT01667133|566077543|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816513|NCT01667133|566077544|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816514|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
156816515|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
156816516|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
156816517|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
156816518|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
156816519|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
156816520|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
156816521|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
156816522|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
156816523|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
156816524|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
156816525|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
156816526|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816527|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816528|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816529|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816530|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156465477|NCT04479787|564800865|FG001|After 6 Months|Lost to Follow-up|1|||
156465478|NCT04479787|564800864|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
156465479|NCT04479787|564800865|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
156816531|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816532|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816533|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816534|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816535|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
156816536|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816537|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816538|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
156816539|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
156816540|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
156816541|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
156816542|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
156816543|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
156816544|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
156816545|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
156816546|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
156816547|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
156816548|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
156816549|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
156816550|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156339000|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
156339001|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
156339002|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
156465480|NCT04479787|564800864|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
156816551|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816552|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816553|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816554|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816555|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156339003|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
156339004|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
156816556|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816557|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816558|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816559|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
156816560|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816561|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156539958|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
156539959|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
156539960|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
156539961|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
156816562|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Death|0|||
156816563|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Death|0|||
156539962|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
156539963|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
156539964|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
156539965|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
156539966|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
156539967|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
156539968|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
156539969|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
156539970|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
156539971|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
156539972|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
156539973|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
156539974|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
156539975|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
156539976|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
156539977|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
156539978|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
156539979|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
156816564|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Death|0|||
156816565|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Death|0|||
156816566|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Death|0|||
156816567|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Death|0|||
156816568|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Death|0|||
156816569|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Death|0|||
156816570|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Death|0|||
156816571|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Death|1|||
156816572|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Death|0|||
156816573|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Death|0|||
156816574|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Other|0|||
156816575|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Other|0|||
156816576|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Other|0|||
156816577|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Other|0|||
156816578|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Other|0|||
156816579|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Other|0|||
156816580|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Other|0|||
156816581|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Other|0|||
156816582|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Other|0|||
156816583|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Other|0|||
156816584|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Other|0|||
156816585|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Other|1|||
156816586|NCT01916824|566077547|FG000|Overall Study|Lost to Follow-up|3|||
156816587|NCT01916824|566077548|FG001|Overall Study|Lost to Follow-up|6|||
156816588|NCT01916824|566077547|FG000|Overall Study|Physician Decision|2|||
156816589|NCT01916824|566077548|FG001|Overall Study|Physician Decision|0|||
156816590|NCT01916824|566077547|FG000|Overall Study|Withdrawal by Subject|2|||
156816591|NCT01916824|566077548|FG001|Overall Study|Withdrawal by Subject|3|||
156816592|NCT00771927|566077551|FG000|Overall Study|Adverse Event|100|||
156816593|NCT00771927|566077552|FG001|Overall Study|Adverse Event|105|||
156816594|NCT00771927|566077551|FG000|Overall Study|Lack of Efficacy|70|||
156816595|NCT00771927|566077552|FG001|Overall Study|Lack of Efficacy|42|||
156816596|NCT00771927|566077551|FG000|Overall Study|Lost to Follow-up|46|||
156816597|NCT00771927|566077552|FG001|Overall Study|Lost to Follow-up|46|||
156816598|NCT00771927|566077551|FG000|Overall Study|Withdrawal by Subject|16|||
156816599|NCT00771927|566077552|FG001|Overall Study|Withdrawal by Subject|17|||
156816600|NCT00771927|566077551|FG000|Overall Study|Other reason|23|||
156816601|NCT00771927|566077552|FG001|Overall Study|Other reason|27|||
156816602|NCT03835481|566077553|FG000|Double-blind Period|Other not stated below|0|||
156816603|NCT03835481|566077554|FG001|Double-blind Period|Other not stated below|0|||
156816604|NCT03835481|566077555|FG002|Double-blind Period|Other not stated below|0|||
156465481|NCT04479787|564800865|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
156465482|NCT04479787|564800864|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
156465483|NCT04479787|564800865|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
156465484|NCT04479787|564800864|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
156465485|NCT04479787|564800865|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
156465486|NCT03983382|564801554|FG000|Overall Study|Death|1|||
156465487|NCT03983382|564801554|FG000|Overall Study|Lost to Follow-up|3|||
156465488|NCT03983382|564801554|FG000|Overall Study|Physician Decision|2|||
156465489|NCT03983382|564801554|FG000|Overall Study|Withdrawal by Subject|10|||
156465490|NCT03983382|564801554|FG000|Overall Study|Change in cancer treatment|2|||
156465491|NCT02166463|564801561|FG000|Overall Study|Lost to Follow-up|0|||
156539980|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
156816605|NCT03835481|566077556|FG003|Double-blind Period|Other not stated below|1|||
156816606|NCT03835481|566077557|FG004|Double-blind Period|Other not stated below|1|||
156816607|NCT03835481|566077553|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
156816608|NCT03835481|566077554|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
156539981|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
156539982|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
156539983|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
156539984|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
156539985|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
156539986|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
156539987|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
156539988|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
156539989|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
156539990|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
156539991|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
156539992|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
156539993|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
156539994|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
156539995|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
156539996|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
156539997|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
156539998|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
156539999|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
156540000|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
156540001|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
156540002|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
156540003|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
156540004|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
156540005|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
156540006|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
156540007|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
156540008|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
156816609|NCT03835481|566077555|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
156816610|NCT03835481|566077556|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
156816611|NCT03835481|566077557|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
156816612|NCT03835481|566077553|FG000|Double-blind Period|Withdrawal by Subject|0|||
156816613|NCT03835481|566077554|FG001|Double-blind Period|Withdrawal by Subject|0|||
156816614|NCT03835481|566077555|FG002|Double-blind Period|Withdrawal by Subject|1|||
156816615|NCT03835481|566077556|FG003|Double-blind Period|Withdrawal by Subject|0|||
156816616|NCT03835481|566077557|FG004|Double-blind Period|Withdrawal by Subject|5|||
156816617|NCT03835481|566077553|FG000|Double-blind Period|Lost to Follow-up|0|||
156816618|NCT03835481|566077554|FG001|Double-blind Period|Lost to Follow-up|0|||
156816619|NCT03835481|566077555|FG002|Double-blind Period|Lost to Follow-up|0|||
156816620|NCT03835481|566077556|FG003|Double-blind Period|Lost to Follow-up|1|||
156540009|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
156540010|NCT00111800|565071437|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
156540011|NCT00111800|565071438|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
156540012|NCT00111800|565071439|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
156816621|NCT03835481|566077557|FG004|Double-blind Period|Lost to Follow-up|0|||
156465492|NCT02166463|564801562|FG001|Overall Study|Lost to Follow-up|1|||
156465493|NCT02166463|564801561|FG000|Overall Study|Physician Decision|10|||
156465494|NCT02166463|564801562|FG001|Overall Study|Physician Decision|10|||
156465495|NCT02166463|564801561|FG000|Overall Study|Ineligible|11|||
156540013|NCT00111800|565071440|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
156540014|NCT00111800|565071441|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
156540015|NCT00111800|565071442|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
156540016|NCT00111800|565071437|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
156540017|NCT00111800|565071438|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
156540018|NCT00111800|565071439|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
156540019|NCT00111800|565071440|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
156540020|NCT00111800|565071441|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
156540021|NCT00111800|565071442|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
156540022|NCT00111800|565071437|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
156540023|NCT00111800|565071438|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
156540024|NCT00111800|565071439|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
156540025|NCT00111800|565071440|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
156540026|NCT00111800|565071441|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
156540027|NCT00111800|565071442|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
156540028|NCT00111800|565071437|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
156540029|NCT00111800|565071438|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
156540030|NCT00111800|565071439|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
156540031|NCT00111800|565071440|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
156540032|NCT00111800|565071441|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
156540033|NCT00111800|565071442|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
156540034|NCT00111800|565071437|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
156540035|NCT00111800|565071438|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
156540036|NCT00111800|565071439|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
156540037|NCT00111800|565071440|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
156540038|NCT00111800|565071441|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
156540039|NCT00111800|565071442|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
156540040|NCT00111800|565071437|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
156540041|NCT00111800|565071438|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
156540042|NCT00111800|565071439|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
156540043|NCT00111800|565071440|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
156540044|NCT00111800|565071441|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
156540045|NCT00111800|565071442|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
156540046|NCT00111800|565071437|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
156540047|NCT00111800|565071438|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
156540048|NCT00111800|565071439|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
156540049|NCT00111800|565071440|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
156816622|NCT03835481|566077553|FG000|Double-blind Period|Protocol Violation|0|||
156816623|NCT03835481|566077554|FG001|Double-blind Period|Protocol Violation|2|||
156816624|NCT03835481|566077555|FG002|Double-blind Period|Protocol Violation|0|||
156816625|NCT03835481|566077556|FG003|Double-blind Period|Protocol Violation|1|||
156816626|NCT03835481|566077557|FG004|Double-blind Period|Protocol Violation|0|||
156816627|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
156816628|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
156816629|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
156816630|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
156816631|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
156816632|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
156816633|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
156816634|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
156816635|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
156540050|NCT00111800|565071441|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
156540051|NCT00111800|565071442|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
156540052|NCT00111800|565071437|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
156540053|NCT00111800|565071438|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
156540054|NCT00111800|565071439|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
156540055|NCT00111800|565071440|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
156540056|NCT00111800|565071441|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
156540057|NCT00111800|565071442|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
156540058|NCT00111800|565071437|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
156540059|NCT00111800|565071438|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
156540060|NCT00111800|565071439|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
156540061|NCT00111800|565071440|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
156540062|NCT00111800|565071441|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
156540063|NCT00111800|565071442|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
156540064|NCT02752035|565071443|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
156540065|NCT02752035|565071444|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
156540066|NCT02752035|565071445|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
156540067|NCT02752035|565071446|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
156540068|NCT02752035|565071443|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
156540069|NCT02752035|565071444|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
156540070|NCT02752035|565071445|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
156540071|NCT02752035|565071446|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
156540072|NCT02752035|565071443|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
156540073|NCT02752035|565071444|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
156540074|NCT02752035|565071445|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
156540075|NCT02752035|565071446|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
156540076|NCT02752035|565071443|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
156540077|NCT02752035|565071444|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
156540078|NCT02752035|565071445|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
156816636|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
156816637|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
156816638|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
156816639|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
156816640|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
156816641|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
156816642|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
156816643|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
156816644|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
156816645|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
156816646|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
156816647|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
156816648|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
156816649|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
156816650|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
156816651|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
156816652|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
156816653|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
156816654|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
156816655|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
156816656|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
156816657|NCT00976716|566077564|FG000|Overall Study|Adverse Event|1|||
156816658|NCT04222699|566077565|FG000|Overall Study|Lost to Follow-up|2|||
156816659|NCT00281099|566077566|FG000|Overall Study|Death|46|||
156816660|NCT00281099|566077567|FG001|Overall Study|Death|57|||
156816661|NCT00281099|566077566|FG000|Overall Study|Lost to Follow-up|10|||
156816662|NCT00281099|566077567|FG001|Overall Study|Lost to Follow-up|19|||
156816663|NCT00281099|566077566|FG000|Overall Study|Withdrawal by Subject|65|||
156816664|NCT00281099|566077567|FG001|Overall Study|Withdrawal by Subject|70|||
156816665|NCT00281099|566077566|FG000|Overall Study|Physician Decision|79|||
156816666|NCT00281099|566077567|FG001|Overall Study|Physician Decision|72|||
156816667|NCT00281099|566077566|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
156816668|NCT00281099|566077567|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
156816669|NCT02931838|566077568|FG000|Overall Study|Reason not provided by investigator|1|||
156816670|NCT02931838|566077569|FG001|Overall Study|Reason not provided by investigator|0|||
156816671|NCT02931838|566077570|FG002|Overall Study|Reason not provided by investigator|1|||
156816672|NCT02931838|566077571|FG003|Overall Study|Reason not provided by investigator|0|||
156816673|NCT02931838|566077572|FG004|Overall Study|Reason not provided by investigator|0|||
156816674|NCT02931838|566077573|FG005|Overall Study|Reason not provided by investigator|0|||
156816675|NCT02931838|566077568|FG000|Overall Study|Poor/non-compliance|0|||
156816676|NCT02931838|566077569|FG001|Overall Study|Poor/non-compliance|0|||
156816677|NCT02931838|566077570|FG002|Overall Study|Poor/non-compliance|1|||
156816678|NCT02931838|566077571|FG003|Overall Study|Poor/non-compliance|0|||
156816679|NCT02931838|566077572|FG004|Overall Study|Poor/non-compliance|0|||
156816680|NCT02931838|566077573|FG005|Overall Study|Poor/non-compliance|0|||
156816681|NCT02931838|566077568|FG000|Overall Study|Lack of Efficacy|5|||
156816682|NCT02931838|566077569|FG001|Overall Study|Lack of Efficacy|4|||
156816683|NCT02931838|566077570|FG002|Overall Study|Lack of Efficacy|0|||
156816684|NCT02931838|566077571|FG003|Overall Study|Lack of Efficacy|0|||
156816685|NCT02931838|566077572|FG004|Overall Study|Lack of Efficacy|0|||
156816686|NCT02931838|566077573|FG005|Overall Study|Lack of Efficacy|1|||
156816687|NCT02931838|566077568|FG000|Overall Study|Lost to Follow-up|1|||
156816688|NCT02931838|566077569|FG001|Overall Study|Lost to Follow-up|0|||
156816689|NCT02931838|566077570|FG002|Overall Study|Lost to Follow-up|1|||
156816690|NCT02931838|566077571|FG003|Overall Study|Lost to Follow-up|1|||
156816691|NCT02931838|566077572|FG004|Overall Study|Lost to Follow-up|2|||
156816692|NCT02931838|566077573|FG005|Overall Study|Lost to Follow-up|0|||
156816693|NCT02931838|566077568|FG000|Overall Study|Subject request to discontinue treatment|4|||
156816694|NCT02931838|566077569|FG001|Overall Study|Subject request to discontinue treatment|3|||
156465496|NCT02166463|564801562|FG001|Overall Study|Ineligible|2|||
156816695|NCT02931838|566077570|FG002|Overall Study|Subject request to discontinue treatment|3|||
156816696|NCT02931838|566077571|FG003|Overall Study|Subject request to discontinue treatment|0|||
156816697|NCT02931838|566077572|FG004|Overall Study|Subject request to discontinue treatment|1|||
156816698|NCT02931838|566077573|FG005|Overall Study|Subject request to discontinue treatment|0|||
156816699|NCT02931838|566077568|FG000|Overall Study|Withdrawal by Subject|1|||
156816700|NCT02931838|566077569|FG001|Overall Study|Withdrawal by Subject|2|||
156465497|NCT02166463|564801561|FG000|Overall Study|Progressive Disease|9|||
156465498|NCT02166463|564801562|FG001|Overall Study|Progressive Disease|6|||
156465499|NCT02166463|564801561|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
156465500|NCT02166463|564801562|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
156465501|NCT02166463|564801561|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
156816701|NCT02931838|566077570|FG002|Overall Study|Withdrawal by Subject|0|||
156816702|NCT02931838|566077571|FG003|Overall Study|Withdrawal by Subject|1|||
156816703|NCT02931838|566077572|FG004|Overall Study|Withdrawal by Subject|0|||
156816704|NCT02931838|566077573|FG005|Overall Study|Withdrawal by Subject|0|||
156816705|NCT02931838|566077568|FG000|Overall Study|Adverse Event|2|||
156816706|NCT02931838|566077569|FG001|Overall Study|Adverse Event|1|||
156816707|NCT02931838|566077570|FG002|Overall Study|Adverse Event|2|||
156816708|NCT02931838|566077571|FG003|Overall Study|Adverse Event|1|||
156816709|NCT02931838|566077572|FG004|Overall Study|Adverse Event|3|||
156816710|NCT02931838|566077573|FG005|Overall Study|Adverse Event|1|||
156816711|NCT00104728|566077574|FG000|Overall Study|screen failures|19|||
156816712|NCT01963767|566077575|FG000|Overall Study|Withdrawal by Subject|4|||
156816713|NCT01963767|566077576|FG001|Overall Study|Withdrawal by Subject|2|||
156816714|NCT01963767|566077575|FG000|Overall Study|Adverse Event|2|||
156816715|NCT01963767|566077576|FG001|Overall Study|Adverse Event|0|||
156816716|NCT02709577|566077577|FG000|Overall Study|non-accommodating anatomy|0|||
156816717|NCT02709577|566077578|FG001|Overall Study|non-accommodating anatomy|1|||
156816718|NCT02709577|566077579|FG002|Overall Study|non-accommodating anatomy|0|||
156816719|NCT02709577|566077580|FG003|Overall Study|non-accommodating anatomy|0|||
156816720|NCT02709577|566077577|FG000|Overall Study|procedural complication|0|||
156816721|NCT02709577|566077578|FG001|Overall Study|procedural complication|1|||
156816722|NCT02709577|566077579|FG002|Overall Study|procedural complication|0|||
156816723|NCT02709577|566077580|FG003|Overall Study|procedural complication|0|||
156816724|NCT02709577|566077577|FG000|Overall Study|Withdrawal by Subject|2|||
156816725|NCT02709577|566077578|FG001|Overall Study|Withdrawal by Subject|3|||
156816726|NCT02709577|566077579|FG002|Overall Study|Withdrawal by Subject|2|||
156816727|NCT02709577|566077580|FG003|Overall Study|Withdrawal by Subject|0|||
156816728|NCT03823287|566077581|FG000|Overall Study|Withdrawal by Subject|25|||
156816729|NCT03823287|566077582|FG001|Overall Study|Withdrawal by Subject|17|||
156816730|NCT03823287|566077581|FG000|Overall Study|Death|13|||
156816731|NCT03823287|566077582|FG001|Overall Study|Death|7|||
156816732|NCT03823287|566077581|FG000|Overall Study|Lost to Follow-up|7|||
156816733|NCT03823287|566077582|FG001|Overall Study|Lost to Follow-up|8|||
156816734|NCT03823287|566077581|FG000|Overall Study|Adverse Event|6|||
156816735|NCT03823287|566077582|FG001|Overall Study|Adverse Event|8|||
156816736|NCT03823287|566077581|FG000|Overall Study|Physician Decision|5|||
156816737|NCT03823287|566077582|FG001|Overall Study|Physician Decision|2|||
156816738|NCT03823287|566077581|FG000|Overall Study|Lack of Efficacy|2|||
156816739|NCT03823287|566077582|FG001|Overall Study|Lack of Efficacy|0|||
156816740|NCT03823287|566077581|FG000|Overall Study|Other|2|||
156816741|NCT03823287|566077582|FG001|Overall Study|Other|4|||
156816742|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Adverse Event|7|||
156339005|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
156339006|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
156339007|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
156339008|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
156339009|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
156339010|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Death|0|||
156339011|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Death|1|||
156816743|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Adverse Event|0|||
156816744|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Adverse Event|0|||
156816745|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
156816746|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
156816747|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
156816748|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
156816749|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
156816750|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
156816751|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
156816752|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
156816753|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
156816754|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
156816755|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
156816756|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
156816757|NCT01059864|566077583|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156816758|NCT01059864|566077584|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
156816759|NCT01059864|566077585|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
156339012|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Death|0|||
156816760|NCT01575808|566077586|FG000|Overall Study|Death|2|||
156816761|NCT01575808|566077587|FG001|Overall Study|Death|0|||
156816762|NCT01575808|566077586|FG000|Overall Study|Withdrawal by Subject|1|||
156816763|NCT01575808|566077587|FG001|Overall Study|Withdrawal by Subject|0|||
156816764|NCT03159468|566077588|FG000|Overall Study|Withdrawal by Subject|0|||
156816765|NCT03159468|566077589|FG001|Overall Study|Withdrawal by Subject|0|||
156816766|NCT03159468|566077590|FG002|Overall Study|Withdrawal by Subject|3|||
156816767|NCT03159468|566077591|FG003|Overall Study|Withdrawal by Subject|0|||
156816768|NCT03159468|566077592|FG004|Overall Study|Withdrawal by Subject|0|||
156816769|NCT03159468|566077593|FG005|Overall Study|Withdrawal by Subject|0|||
156816770|NCT00875485|566079408|FG000|Challenge Dose Epoch|Pregnancy|1|||
156816771|NCT00875485|566079409|FG001|Challenge Dose Epoch|Pregnancy|0|||
156816772|NCT02908685|566079410|FG000|Part 1 OLE|Withdrawal by Subject|0|||
156816773|NCT02908685|566079411|FG001|Part 1 OLE|Withdrawal by Subject|0|||
156816774|NCT02908685|566079412|FG002|Part 1 OLE|Withdrawal by Subject|0|||
156816775|NCT02908685|566079413|FG003|Part 1 OLE|Withdrawal by Subject|0|||
156816776|NCT02908685|566079414|FG004|Part 1 OLE|Withdrawal by Subject|0|||
156816777|NCT02908685|566079415|FG005|Part 1 OLE|Withdrawal by Subject|0|||
156816778|NCT02908685|566079416|FG006|Part 1 OLE|Withdrawal by Subject|0|||
156816779|NCT02908685|566079417|FG007|Part 1 OLE|Withdrawal by Subject|0|||
156816780|NCT02908685|566079418|FG008|Part 1 OLE|Withdrawal by Subject|0|||
156816781|NCT02908685|566079419|FG009|Part 1 OLE|Withdrawal by Subject|0|||
156816782|NCT02908685|566079420|FG010|Part 1 OLE|Withdrawal by Subject|2|||
156816783|NCT02908685|566079421|FG011|Part 1 OLE|Withdrawal by Subject|1|||
156816784|NCT02908685|566079422|FG012|Part 1 OLE|Withdrawal by Subject|0|||
156816785|NCT02908685|566079423|FG013|Part 1 OLE|Withdrawal by Subject|0|||
156816786|NCT02908685|566079410|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816787|NCT02908685|566079411|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816788|NCT02908685|566079412|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816789|NCT02908685|566079413|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816790|NCT02908685|566079414|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816791|NCT02908685|566079415|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816792|NCT02908685|566079416|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816793|NCT02908685|566079417|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816794|NCT02908685|566079418|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816795|NCT02908685|566079419|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816796|NCT02908685|566079420|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816797|NCT02908685|566079421|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816798|NCT02908685|566079422|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
156816799|NCT02908685|566079423|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
156816800|NCT02908685|566079410|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816801|NCT02908685|566079411|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816802|NCT02908685|566079412|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816803|NCT02908685|566079413|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816804|NCT02908685|566079414|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816805|NCT02908685|566079415|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816806|NCT02908685|566079416|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816807|NCT02908685|566079417|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816808|NCT02908685|566079418|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816809|NCT02908685|566079419|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816810|NCT02908685|566079420|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816811|NCT02908685|566079421|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816812|NCT02908685|566079422|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
156816813|NCT02908685|566079423|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816814|NCT02908685|566079410|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816815|NCT02908685|566079411|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816816|NCT02908685|566079412|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816817|NCT02908685|566079413|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156339013|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Death|1|||
156339014|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Death|0|||
156465502|NCT02166463|564801562|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
156465503|NCT02166463|564801561|FG000|Overall Study|Refusal of further protocol therapy|5|||
156465504|NCT02166463|564801562|FG001|Overall Study|Refusal of further protocol therapy|6|||
156816818|NCT02908685|566079414|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816819|NCT02908685|566079415|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816820|NCT02908685|566079416|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816821|NCT02908685|566079417|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816822|NCT02908685|566079418|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816823|NCT02908685|566079419|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816824|NCT02908685|566079420|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816825|NCT02908685|566079421|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816826|NCT02908685|566079422|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
156816827|NCT02908685|566079423|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816828|NCT02908685|566079410|FG000|Part 2 OLE: > Month 24|Death|0|||
156816829|NCT02908685|566079411|FG001|Part 2 OLE: > Month 24|Death|0|||
156816830|NCT02908685|566079412|FG002|Part 2 OLE: > Month 24|Death|0|||
156816831|NCT02908685|566079413|FG003|Part 2 OLE: > Month 24|Death|0|||
156816832|NCT02908685|566079414|FG004|Part 2 OLE: > Month 24|Death|0|||
156816833|NCT02908685|566079415|FG005|Part 2 OLE: > Month 24|Death|0|||
156816834|NCT02908685|566079416|FG006|Part 2 OLE: > Month 24|Death|0|||
156816835|NCT02908685|566079417|FG007|Part 2 OLE: > Month 24|Death|0|||
156816836|NCT02908685|566079418|FG008|Part 2 OLE: > Month 24|Death|0|||
156816837|NCT02908685|566079419|FG009|Part 2 OLE: > Month 24|Death|0|||
156816838|NCT02908685|566079420|FG010|Part 2 OLE: > Month 24|Death|0|||
156816839|NCT02908685|566079421|FG011|Part 2 OLE: > Month 24|Death|0|||
156816840|NCT02908685|566079422|FG012|Part 2 OLE: > Month 24|Death|1|||
156816841|NCT02908685|566079423|FG013|Part 2 OLE: > Month 24|Death|0|||
156816842|NCT02908685|566079410|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
156816843|NCT02908685|566079411|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
156816844|NCT02908685|566079412|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
156816845|NCT02908685|566079413|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
156816846|NCT02908685|566079414|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
156816847|NCT02908685|566079415|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
156816848|NCT02908685|566079416|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
156816849|NCT02908685|566079417|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
156816850|NCT02908685|566079418|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
156816851|NCT02908685|566079419|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
156816852|NCT02908685|566079420|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
156816853|NCT02908685|566079421|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
156816854|NCT02908685|566079422|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
156816855|NCT02908685|566079423|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
156816856|NCT02908685|566079410|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816857|NCT02908685|566079411|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816858|NCT02908685|566079412|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816859|NCT02908685|566079413|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816860|NCT02908685|566079414|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816861|NCT02908685|566079415|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816862|NCT02908685|566079416|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816863|NCT02908685|566079417|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816864|NCT02908685|566079418|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816865|NCT02908685|566079419|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816866|NCT02908685|566079420|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816867|NCT02908685|566079421|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816868|NCT02908685|566079422|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
156816869|NCT02908685|566079423|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
156816870|NCT02954406|566079424|FG000|Overall Study|Adverse Event|0|||
156816871|NCT02954406|566079425|FG001|Overall Study|Adverse Event|1|||
156816872|NCT02954406|566079426|FG002|Overall Study|Adverse Event|0|||
156816873|NCT02954406|566079427|FG003|Overall Study|Adverse Event|0|||
156816874|NCT02954406|566079428|FG004|Overall Study|Adverse Event|1|||
156816875|NCT02954406|566079429|FG005|Overall Study|Adverse Event|0|||
156816876|NCT02954406|566079430|FG006|Overall Study|Adverse Event|0|||
156816877|NCT02954406|566079431|FG007|Overall Study|Adverse Event|0|||
156816878|NCT02954406|566079432|FG008|Overall Study|Adverse Event|1|||
156816879|NCT02954406|566079433|FG009|Overall Study|Adverse Event|1|||
156816880|NCT02954406|566079434|FG010|Overall Study|Adverse Event|0|||
156816881|NCT02954406|566079424|FG000|Overall Study|Progressive Disease|3|||
156816882|NCT02954406|566079425|FG001|Overall Study|Progressive Disease|4|||
156816883|NCT02954406|566079426|FG002|Overall Study|Progressive Disease|3|||
156816884|NCT02954406|566079427|FG003|Overall Study|Progressive Disease|4|||
156816885|NCT02954406|566079428|FG004|Overall Study|Progressive Disease|3|||
156816886|NCT02954406|566079429|FG005|Overall Study|Progressive Disease|3|||
156816887|NCT02954406|566079430|FG006|Overall Study|Progressive Disease|2|||
156816888|NCT02954406|566079431|FG007|Overall Study|Progressive Disease|2|||
156816889|NCT02954406|566079432|FG008|Overall Study|Progressive Disease|1|||
156816890|NCT02954406|566079433|FG009|Overall Study|Progressive Disease|1|||
156816891|NCT02954406|566079434|FG010|Overall Study|Progressive Disease|0|||
156816892|NCT02954406|566079424|FG000|Overall Study|Symptomatic Deterioration|0|||
156816893|NCT02954406|566079425|FG001|Overall Study|Symptomatic Deterioration|1|||
156816894|NCT02954406|566079426|FG002|Overall Study|Symptomatic Deterioration|0|||
156816895|NCT02954406|566079427|FG003|Overall Study|Symptomatic Deterioration|0|||
156816896|NCT02954406|566079428|FG004|Overall Study|Symptomatic Deterioration|0|||
156816897|NCT02954406|566079429|FG005|Overall Study|Symptomatic Deterioration|0|||
156816898|NCT02954406|566079430|FG006|Overall Study|Symptomatic Deterioration|0|||
156816899|NCT02954406|566079431|FG007|Overall Study|Symptomatic Deterioration|0|||
156816900|NCT02954406|566079432|FG008|Overall Study|Symptomatic Deterioration|0|||
156816901|NCT02954406|566079433|FG009|Overall Study|Symptomatic Deterioration|0|||
156816902|NCT02954406|566079434|FG010|Overall Study|Symptomatic Deterioration|0|||
156816903|NCT02954406|566079424|FG000|Overall Study|Death|0|||
156816904|NCT02954406|566079425|FG001|Overall Study|Death|0|||
156816905|NCT02954406|566079426|FG002|Overall Study|Death|0|||
156816906|NCT02954406|566079427|FG003|Overall Study|Death|0|||
156816907|NCT02954406|566079428|FG004|Overall Study|Death|1|||
156816908|NCT02954406|566079429|FG005|Overall Study|Death|0|||
156816909|NCT02954406|566079430|FG006|Overall Study|Death|0|||
156816910|NCT02954406|566079431|FG007|Overall Study|Death|0|||
156816911|NCT02954406|566079432|FG008|Overall Study|Death|1|||
156816912|NCT02954406|566079433|FG009|Overall Study|Death|1|||
156816913|NCT02954406|566079434|FG010|Overall Study|Death|0|||
156816914|NCT02954406|566079424|FG000|Overall Study|Reason Not Specified|0|||
156816915|NCT02954406|566079425|FG001|Overall Study|Reason Not Specified|0|||
156816916|NCT02954406|566079426|FG002|Overall Study|Reason Not Specified|3|||
156816917|NCT02954406|566079427|FG003|Overall Study|Reason Not Specified|2|||
156816918|NCT02954406|566079428|FG004|Overall Study|Reason Not Specified|2|||
156816919|NCT02954406|566079429|FG005|Overall Study|Reason Not Specified|0|||
156816920|NCT02954406|566079430|FG006|Overall Study|Reason Not Specified|1|||
156816921|NCT02954406|566079431|FG007|Overall Study|Reason Not Specified|0|||
156816922|NCT02954406|566079432|FG008|Overall Study|Reason Not Specified|1|||
156816923|NCT02954406|566079433|FG009|Overall Study|Reason Not Specified|0|||
156816924|NCT02954406|566079434|FG010|Overall Study|Reason Not Specified|0|||
156816925|NCT00782171|566079435|FG000|Overall Study|Lost to Follow-up|2|||
156816926|NCT00782171|566079436|FG001|Overall Study|Lost to Follow-up|2|||
156816927|NCT00782171|566079435|FG000|Overall Study|Withdrawal by Subject|2|||
156816928|NCT00782171|566079436|FG001|Overall Study|Withdrawal by Subject|1|||
156816929|NCT00782171|566079435|FG000|Overall Study|complications|3|||
156816930|NCT00782171|566079436|FG001|Overall Study|complications|1|||
156816931|NCT00782171|566079435|FG000|Overall Study|others|7|||
156816932|NCT00782171|566079436|FG001|Overall Study|others|9|||
156816933|NCT00782171|566079435|FG000|Overall Study|not eligible|8|||
156816934|NCT00782171|566079436|FG001|Overall Study|not eligible|6|||
156816935|NCT01691014|566079437|FG000|Overall Study|Premature Termination|1|||
156816936|NCT01691014|566079438|FG001|Overall Study|Premature Termination|6|||
156816937|NCT01691014|566079439|FG002|Overall Study|Premature Termination|0|||
156816938|NCT01691014|566079440|FG003|Overall Study|Premature Termination|3|||
156816939|NCT01691014|566079437|FG000|Overall Study|Other|0|||
156816940|NCT01691014|566079438|FG001|Overall Study|Other|0|||
156816941|NCT01691014|566079439|FG002|Overall Study|Other|2|||
156816942|NCT01691014|566079440|FG003|Overall Study|Other|0|||
156816943|NCT01691014|566079437|FG000|Overall Study|Withdrawal by Subject|0|||
156816944|NCT01691014|566079438|FG001|Overall Study|Withdrawal by Subject|1|||
156816945|NCT01691014|566079439|FG002|Overall Study|Withdrawal by Subject|1|||
156816946|NCT01691014|566079440|FG003|Overall Study|Withdrawal by Subject|1|||
156816947|NCT01691014|566079437|FG000|Overall Study|Adverse Event|0|||
156816948|NCT01691014|566079438|FG001|Overall Study|Adverse Event|5|||
156816949|NCT01691014|566079439|FG002|Overall Study|Adverse Event|1|||
156816950|NCT01691014|566079440|FG003|Overall Study|Adverse Event|1|||
156816951|NCT01691014|566079437|FG000|Overall Study|Lack of Efficacy|2|||
156816952|NCT01691014|566079438|FG001|Overall Study|Lack of Efficacy|3|||
156816953|NCT01691014|566079439|FG002|Overall Study|Lack of Efficacy|7|||
156816954|NCT01691014|566079440|FG003|Overall Study|Lack of Efficacy|0|||
156816955|NCT05897242|566079443|FG000|Overall Study|Lost to Follow-up|6|||
156465505|NCT00982644|564801563|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
156465506|NCT00982644|564801564|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
156465507|NCT00982644|564801563|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
156465508|NCT00982644|564801564|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
156816956|NCT05897242|566079444|FG001|Overall Study|Lost to Follow-up|1|||
156816957|NCT05897242|566079443|FG000|Overall Study|Incomplete|1|||
156816958|NCT05897242|566079444|FG001|Overall Study|Incomplete|0|||
156816959|NCT05897242|566079443|FG000|Overall Study|Withdrawal by Subject|1|||
156816960|NCT05897242|566079444|FG001|Overall Study|Withdrawal by Subject|0|||
156816961|NCT03522246|566079445|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
156816962|NCT03522246|566079446|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
156816963|NCT03522246|566079447|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
156816964|NCT03522246|566079448|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
156816965|NCT03522246|566079449|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
156816966|NCT00814580|566079450|FG000|Overall Study|Adverse Event|6|||
156816967|NCT00814580|566079451|FG001|Overall Study|Adverse Event|15|||
156816968|NCT00814580|566079450|FG000|Overall Study|Lack of Efficacy|18|||
156816969|NCT00814580|566079451|FG001|Overall Study|Lack of Efficacy|25|||
156816970|NCT00814580|566079450|FG000|Overall Study|Protocol Violation|2|||
156816971|NCT00814580|566079451|FG001|Overall Study|Protocol Violation|0|||
156816972|NCT00814580|566079450|FG000|Overall Study|Withdrawal by Subject|2|||
156816973|NCT00814580|566079451|FG001|Overall Study|Withdrawal by Subject|2|||
156816974|NCT00814580|566079450|FG000|Overall Study|Other|1|||
156816975|NCT00814580|566079451|FG001|Overall Study|Other|3|||
156816976|NCT00814580|566079450|FG000|Overall Study|Did Not Take Drug|2|||
156816977|NCT00814580|566079451|FG001|Overall Study|Did Not Take Drug|2|||
156816978|NCT02482428|566079452|FG000|Overall Study|Lost to Follow-up|4|||
156816979|NCT02482428|566079453|FG001|Overall Study|Lost to Follow-up|9|||
156816980|NCT02482428|566079454|FG002|Overall Study|Lost to Follow-up|1|||
156816981|NCT02482428|566079455|FG003|Overall Study|Lost to Follow-up|2|||
156816982|NCT02482428|566079456|FG004|Overall Study|Lost to Follow-up|4|||
156816983|NCT02482428|566079452|FG000|Overall Study|Physician Decision|0|||
156816984|NCT02482428|566079453|FG001|Overall Study|Physician Decision|0|||
156816985|NCT02482428|566079454|FG002|Overall Study|Physician Decision|0|||
156816986|NCT02482428|566079455|FG003|Overall Study|Physician Decision|0|||
156816987|NCT02482428|566079456|FG004|Overall Study|Physician Decision|1|||
156816988|NCT02482428|566079452|FG000|Overall Study|protocol deviation|1|||
156816989|NCT02482428|566079453|FG001|Overall Study|protocol deviation|1|||
156816990|NCT02482428|566079454|FG002|Overall Study|protocol deviation|0|||
156816991|NCT02482428|566079455|FG003|Overall Study|protocol deviation|0|||
156816992|NCT02482428|566079456|FG004|Overall Study|protocol deviation|0|||
156816993|NCT02482428|566079452|FG000|Overall Study|subject/guardian decision|4|||
156816994|NCT02482428|566079453|FG001|Overall Study|subject/guardian decision|2|||
156816995|NCT02482428|566079454|FG002|Overall Study|subject/guardian decision|0|||
156816996|NCT02482428|566079455|FG003|Overall Study|subject/guardian decision|0|||
156816997|NCT02482428|566079456|FG004|Overall Study|subject/guardian decision|2|||
156816998|NCT00809835|566079459|FG000|Overall Study|Lost to Follow-up|7|||
156816999|NCT00809835|566079460|FG001|Overall Study|Lost to Follow-up|6|||
156817000|NCT00809835|566079461|FG002|Overall Study|Lost to Follow-up|10|||
156817001|NCT00809835|566079462|FG003|Overall Study|Lost to Follow-up|2|||
156817002|NCT00809835|566079459|FG000|Overall Study|Withdrawal by Subject|1|||
156817003|NCT00809835|566079460|FG001|Overall Study|Withdrawal by Subject|1|||
156817004|NCT00809835|566079461|FG002|Overall Study|Withdrawal by Subject|1|||
156817005|NCT00809835|566079462|FG003|Overall Study|Withdrawal by Subject|0|||
156817006|NCT02547038|566079463|FG000|Overall Study|Lost to Follow-up|3|||
156817007|NCT02547038|566079464|FG001|Overall Study|Lost to Follow-up|2|||
156817008|NCT00516893|566079465|FG000|Overall Study|Lost to Follow-up|4|||
156817009|NCT00516893|566079465|FG000|Overall Study|Adverse Event|3|||
156817010|NCT00516893|566079465|FG000|Overall Study|Withdrawal by Subject|2|||
156817011|NCT00516893|566079465|FG000|Overall Study|Noncompliance|2|||
156817012|NCT00516893|566079465|FG000|Overall Study|Death|1|||
156817013|NCT00516893|566079465|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
156817014|NCT00516893|566079465|FG000|Overall Study|Relocated|1|||
156817015|NCT00516893|566079465|FG000|Overall Study|Pregnancy|1|||
156817016|NCT00516893|566079465|FG000|Overall Study|Received Medication From Another Study|1|||
156817017|NCT01340625|566079468|FG000|First Intervention|Adverse Event|1|||
156817018|NCT01340625|566079469|FG001|First Intervention|Adverse Event|0|||
156817019|NCT01340625|566079468|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
156817020|NCT01340625|566079469|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
156817021|NCT05160415|566079470|FG000|Overall Study|Withdrawal by Subject|3|||
156817022|NCT01519791|566079471|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
156817023|NCT01519791|566079472|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
156817024|NCT01519791|566079471|FG000|Overall Study|Protocol Violation|6|||
156817025|NCT01519791|566079472|FG001|Overall Study|Protocol Violation|19|||
156817026|NCT01519791|566079471|FG000|Overall Study|Other Reason|87|||
156817027|NCT01519791|566079472|FG001|Overall Study|Other Reason|222|||
156817028|NCT01519791|566079471|FG000|Overall Study|subjects randomized in error|2|||
156817029|NCT01519791|566079472|FG001|Overall Study|subjects randomized in error|0|||
156817030|NCT01519791|566079471|FG000|Overall Study|Lack of Efficacy|16|||
156817031|NCT01519791|566079472|FG001|Overall Study|Lack of Efficacy|20|||
156817032|NCT01519791|566079471|FG000|Overall Study|SAE, non-fatal|6|||
156817033|NCT01519791|566079472|FG001|Overall Study|SAE, non-fatal|22|||
156817034|NCT01519791|566079471|FG000|Overall Study|AE, serious fatal|0|||
156817035|NCT01519791|566079472|FG001|Overall Study|AE, serious fatal|1|||
156817036|NCT01519791|566079471|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
156817037|NCT01519791|566079472|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
156817038|NCT01519791|566079471|FG000|Overall Study|AE, non-serious non-fatal|12|||
156817039|NCT01519791|566079472|FG001|Overall Study|AE, non-serious non-fatal|31|||
156817040|NCT01519791|566079471|FG000|Overall Study|Withdrawal by Subject|15|||
156817041|NCT01519791|566079472|FG001|Overall Study|Withdrawal by Subject|37|||
156817042|NCT01519791|566079471|FG000|Overall Study|Lost to Follow-up|6|||
156817043|NCT01519791|566079472|FG001|Overall Study|Lost to Follow-up|14|||
156817044|NCT00623233|566079473|FG000|Overall Study|Adverse Event|10|||
156817045|NCT00623233|566079473|FG000|Overall Study|Physician Decision|10|||
156817046|NCT00623233|566079473|FG000|Overall Study|Lost to Follow-up|1|||
156339015|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Change of location|1|||
156339016|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Change of location|1|||
156339017|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Change of location|0|||
156339018|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Change of location|1|||
156817047|NCT00623233|566079473|FG000|Overall Study|Withdrawal by Subject|3|||
156817048|NCT00559845|566079474|FG000|Overall Study|Withdrew Consent|1|||
156817049|NCT00559845|566079474|FG000|Overall Study|Disease Progression|1|||
156817050|NCT00559845|566079474|FG000|Overall Study|Adverse Event|3|||
156817051|NCT00559845|566079474|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
156817052|NCT00559845|566079474|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
156817053|NCT00459875|566079475|FG000|Overall Study|Ineligible participant|1|||
156817054|NCT00459875|566079475|FG000|Overall Study|Adverse Event|2|||
156817055|NCT00576628|566079478|FG000|Overall Study|Adverse Event|11|||
156817056|NCT00576628|566079478|FG000|Overall Study|Death|2|||
156817057|NCT00576628|566079478|FG000|Overall Study|Failure to return|1|||
156817058|NCT00576628|566079478|FG000|Overall Study|Refused Treatment|8|||
156817059|NCT00576628|566079478|FG000|Overall Study|Pregnancy|1|||
156817060|NCT00576628|566079478|FG000|Overall Study|RBC transfusion|1|||
156817061|NCT00576628|566079478|FG000|Overall Study|Progression of Kidney Disease|1|||
156817062|NCT00576628|566079478|FG000|Overall Study|Progression of Renal Failure|1|||
156817063|NCT00576628|566079478|FG000|Overall Study|The patient move into other town|1|||
156817064|NCT00576628|566079478|FG000|Overall Study|Transplantation|1|||
156817065|NCT00576628|566079478|FG000|Overall Study|Dialysis|15|||
156817066|NCT03206970|566079479|FG000|Overall Study|Death|21|||
156817067|NCT03206970|566079479|FG000|Overall Study|Withdrawal by Subject|13|||
156817068|NCT03206970|566079479|FG000|Overall Study|Lost to Follow-up|3|||
156817069|NCT03206970|566079479|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
156817070|NCT02516982|566079486|FG000|Overall Study|Called in to antenatal appointment|32|||
156817071|NCT02516982|566079487|FG001|Overall Study|Called in to antenatal appointment|35|||
156817072|NCT02516982|566079488|FG002|Overall Study|Called in to antenatal appointment|0|||
156817073|NCT02516982|566079489|FG003|Overall Study|Called in to antenatal appointment|0|||
156817074|NCT02516982|566079486|FG000|Overall Study|Withdrawal by Subject|0|||
156817075|NCT02516982|566079487|FG001|Overall Study|Withdrawal by Subject|0|||
156817076|NCT02516982|566079488|FG002|Overall Study|Withdrawal by Subject|1|||
156817077|NCT02516982|566079489|FG003|Overall Study|Withdrawal by Subject|2|||
156817078|NCT02516982|566079486|FG000|Overall Study|Protocol Violation|0|||
156817079|NCT02516982|566079487|FG001|Overall Study|Protocol Violation|0|||
156817080|NCT02516982|566079488|FG002|Overall Study|Protocol Violation|1|||
156817081|NCT02516982|566079489|FG003|Overall Study|Protocol Violation|1|||
156817082|NCT02516982|566079486|FG000|Overall Study|Did not install the app|0|||
156817083|NCT02516982|566079487|FG001|Overall Study|Did not install the app|0|||
156817084|NCT02516982|566079488|FG002|Overall Study|Did not install the app|46|||
156817085|NCT02516982|566079489|FG003|Overall Study|Did not install the app|47|||
156817086|NCT03654040|566079490|FG000|Overall Study|Death|1|||
156817087|NCT03654040|566079491|FG001|Overall Study|Death|0|||
156817088|NCT03654040|566079490|FG000|Overall Study|Withdrawal by Subject|1|||
156817089|NCT03654040|566079491|FG001|Overall Study|Withdrawal by Subject|0|||
156817090|NCT03654040|566079490|FG000|Overall Study|Study terminated by sponsor|8|||
156817091|NCT03654040|566079491|FG001|Overall Study|Study terminated by sponsor|2|||
156817092|NCT03654040|566079490|FG000|Overall Study|Failure to initiate study therapy|2|||
156817093|NCT03654040|566079491|FG001|Overall Study|Failure to initiate study therapy|0|||
156817094|NCT03654040|566079490|FG000|Overall Study|Transplanted at another center|2|||
156817095|NCT03654040|566079491|FG001|Overall Study|Transplanted at another center|0|||
156817096|NCT03654040|566079490|FG000|Overall Study|Failure to meet eligibility criteria|14|||
156817097|NCT03654040|566079491|FG001|Overall Study|Failure to meet eligibility criteria|2|||
156817098|NCT03654040|566079490|FG000|Overall Study|No longer transplant candidate|1|||
156817099|NCT03654040|566079491|FG001|Overall Study|No longer transplant candidate|0|||
156339019|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Change of location|0|||
156339020|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
156540079|NCT02752035|565071446|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
156540080|NCT02752035|565071443|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
156817100|NCT03654040|566079490|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
156817101|NCT03654040|566079491|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
156817102|NCT03654040|566079490|FG000|Overall Study|Recipient ineligible|0|||
156817103|NCT03654040|566079491|FG001|Overall Study|Recipient ineligible|2|||
156817104|NCT03654040|566079490|FG000|Overall Study|Received deceased liver|0|||
156817105|NCT03654040|566079491|FG001|Overall Study|Received deceased liver|1|||
156817106|NCT01951586|566079496|FG000|Overall Study|Death|61|||
156817107|NCT01951586|566079497|FG001|Overall Study|Death|120|||
156817108|NCT01951586|566079496|FG000|Overall Study|Withdrawal by Subject|8|||
156817109|NCT01951586|566079497|FG001|Overall Study|Withdrawal by Subject|17|||
156817110|NCT01951586|566079496|FG000|Overall Study|Lost to Follow-up|0|||
156817111|NCT01951586|566079497|FG001|Overall Study|Lost to Follow-up|1|||
156817112|NCT01951586|566079496|FG000|Overall Study|Sponsor Decision|9|||
156540081|NCT02752035|565071444|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
156817113|NCT01951586|566079497|FG001|Overall Study|Sponsor Decision|10|||
156817114|NCT03645421|566079500|FG000|Overall Study|Adverse Event|0|||
156817115|NCT03645421|566079501|FG001|Overall Study|Adverse Event|0|||
156817116|NCT03645421|566079502|FG002|Overall Study|Adverse Event|4|||
156817117|NCT03645421|566079503|FG003|Overall Study|Adverse Event|1|||
156817118|NCT03645421|566079500|FG000|Overall Study|Withdrawal by patient|0|||
156817119|NCT03645421|566079501|FG001|Overall Study|Withdrawal by patient|0|||
156817120|NCT03645421|566079502|FG002|Overall Study|Withdrawal by patient|0|||
156817121|NCT03645421|566079503|FG003|Overall Study|Withdrawal by patient|3|||
156817122|NCT03645421|566079500|FG000|Overall Study|Study specific withdrawal criteria|0|||
156817123|NCT03645421|566079501|FG001|Overall Study|Study specific withdrawal criteria|0|||
156817124|NCT03645421|566079502|FG002|Overall Study|Study specific withdrawal criteria|1|||
156817125|NCT03645421|566079503|FG003|Overall Study|Study specific withdrawal criteria|0|||
156817126|NCT02120781|566079504|FG000|Overall Study|Physician Decision|2|||
156817127|NCT02120781|566079505|FG001|Overall Study|Physician Decision|0|||
156817128|NCT02120781|566079504|FG000|Overall Study|Completion not documented|2|||
156817129|NCT02120781|566079505|FG001|Overall Study|Completion not documented|1|||
156817130|NCT03379259|566079506|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
156817131|NCT03379259|566079507|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
156817132|NCT03379259|566079508|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
156817133|NCT03379259|566079509|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
156817134|NCT03379259|566079510|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
156817135|NCT03379259|566079511|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
156817136|NCT03379259|566079506|FG000|Overall Study|Death|0|||
156817137|NCT03379259|566079507|FG001|Overall Study|Death|1|||
156817138|NCT03379259|566079508|FG002|Overall Study|Death|2|||
156817139|NCT03379259|566079509|FG003|Overall Study|Death|1|||
156817140|NCT03379259|566079510|FG004|Overall Study|Death|4|||
156817141|NCT03379259|566079511|FG005|Overall Study|Death|2|||
156817142|NCT03379259|566079506|FG000|Overall Study|Withdrawal by Subject|0|||
156817143|NCT03379259|566079507|FG001|Overall Study|Withdrawal by Subject|0|||
156817144|NCT03379259|566079508|FG002|Overall Study|Withdrawal by Subject|1|||
156817145|NCT03379259|566079509|FG003|Overall Study|Withdrawal by Subject|0|||
156817146|NCT03379259|566079510|FG004|Overall Study|Withdrawal by Subject|2|||
156817147|NCT03379259|566079511|FG005|Overall Study|Withdrawal by Subject|0|||
156817148|NCT03379259|566079506|FG000|Overall Study|Study terminated by sponsor|0|||
156817149|NCT03379259|566079507|FG001|Overall Study|Study terminated by sponsor|0|||
156817150|NCT03379259|566079508|FG002|Overall Study|Study terminated by sponsor|0|||
156817151|NCT03379259|566079509|FG003|Overall Study|Study terminated by sponsor|1|||
156817152|NCT03379259|566079510|FG004|Overall Study|Study terminated by sponsor|1|||
156817153|NCT03379259|566079511|FG005|Overall Study|Study terminated by sponsor|4|||
156817154|NCT03379259|566079506|FG000|Overall Study|Disease progression|0|||
156817155|NCT03379259|566079507|FG001|Overall Study|Disease progression|0|||
156817156|NCT03379259|566079508|FG002|Overall Study|Disease progression|0|||
156817157|NCT03379259|566079509|FG003|Overall Study|Disease progression|1|||
156817158|NCT03379259|566079510|FG004|Overall Study|Disease progression|0|||
156817159|NCT03379259|566079511|FG005|Overall Study|Disease progression|1|||
156817160|NCT03379259|566079506|FG000|Overall Study|Lost to Follow-up|0|||
156817161|NCT03379259|566079507|FG001|Overall Study|Lost to Follow-up|0|||
156817162|NCT03379259|566079508|FG002|Overall Study|Lost to Follow-up|0|||
156817163|NCT03379259|566079509|FG003|Overall Study|Lost to Follow-up|0|||
156817164|NCT03379259|566079510|FG004|Overall Study|Lost to Follow-up|1|||
156817165|NCT03379259|566079511|FG005|Overall Study|Lost to Follow-up|0|||
156817166|NCT03379259|566079506|FG000|Overall Study|Deteriorating condition|0|||
156339021|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
156339022|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
156339023|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
156339024|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
156339025|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
156339026|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
156540082|NCT02752035|565071445|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
156540083|NCT02752035|565071446|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
156817167|NCT03379259|566079507|FG001|Overall Study|Deteriorating condition|0|||
156817168|NCT03379259|566079508|FG002|Overall Study|Deteriorating condition|0|||
156817169|NCT03379259|566079509|FG003|Overall Study|Deteriorating condition|0|||
156817170|NCT03379259|566079510|FG004|Overall Study|Deteriorating condition|1|||
156817171|NCT03379259|566079511|FG005|Overall Study|Deteriorating condition|0|||
156817172|NCT03195660|566079512|FG000|Overall Study|The study was terminated|2|||
156817173|NCT00375427|566079513|FG000|Overall Study|Adverse Event|21|||
156817174|NCT00375427|566079514|FG001|Overall Study|Adverse Event|27|||
156817175|NCT00375427|566079513|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156817176|NCT00375427|566079514|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156817177|NCT00375427|566079513|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156817178|NCT00375427|566079514|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156817179|NCT00375427|566079513|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156817180|NCT00375427|566079514|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156817181|NCT00375427|566079513|FG000|Overall Study|Patient no longer requires study drug|3|||
156817182|NCT00375427|566079514|FG001|Overall Study|Patient no longer requires study drug|7|||
156817183|NCT00375427|566079513|FG000|Overall Study|Protocol Violation|10|||
156817184|NCT00375427|566079514|FG001|Overall Study|Protocol Violation|8|||
156817185|NCT00375427|566079513|FG000|Overall Study|Withdrawal by Subject|9|||
156817186|NCT00375427|566079514|FG001|Overall Study|Withdrawal by Subject|13|||
156817187|NCT00375427|566079513|FG000|Overall Study|Lost to Follow-up|1|||
156817188|NCT00375427|566079514|FG001|Overall Study|Lost to Follow-up|1|||
156817189|NCT00375427|566079513|FG000|Overall Study|Administrative reasons|0|||
156817190|NCT00375427|566079514|FG001|Overall Study|Administrative reasons|1|||
156817191|NCT00375427|566079513|FG000|Overall Study|Death|11|||
156817192|NCT00375427|566079514|FG001|Overall Study|Death|10|||
156817193|NCT03286543|566079520|FG000|Consented|Screen failure before randomization|2|||
156817194|NCT03286543|566079521|FG001|Consented|Screen failure before randomization|0|||
156817195|NCT03286543|566079522|FG002|Consented|Screen failure before randomization|0|||
156817196|NCT03286543|566079520|FG000|Consented|Screen failure before enrollment|4|||
156817197|NCT03286543|566079521|FG001|Consented|Screen failure before enrollment|0|||
156817198|NCT03286543|566079522|FG002|Consented|Screen failure before enrollment|0|||
156817199|NCT03286543|566079520|FG000|Consented|TKA cancelled after enrollment|1|||
156817200|NCT03286543|566079521|FG001|Consented|TKA cancelled after enrollment|0|||
156817201|NCT03286543|566079522|FG002|Consented|TKA cancelled after enrollment|0|||
156817202|NCT03286543|566079520|FG000|Consented|Withdrawn from study|12|||
156817203|NCT03286543|566079521|FG001|Consented|Withdrawn from study|0|||
156817204|NCT03286543|566079522|FG002|Consented|Withdrawn from study|0|||
156817205|NCT03286543|566079520|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
156817206|NCT03286543|566079521|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
156817207|NCT03286543|566079522|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
156817208|NCT03286543|566079520|FG000|Study Enrollment|Withdrawn from study|0|||
156817209|NCT03286543|566079521|FG001|Study Enrollment|Withdrawn from study|6|||
156817210|NCT03286543|566079522|FG002|Study Enrollment|Withdrawn from study|6|||
156817211|NCT05332392|566079523|FG000|Overall Study|Did not meet inclusion criteria|25|||
156817212|NCT05332392|566079523|FG000|Overall Study|Principal Investigator's decision|17|||
156817213|NCT05332392|566079523|FG000|Overall Study|Adverse Event|1|||
156817214|NCT05332392|566079523|FG000|Overall Study|Subject's decision|1|||
156817215|NCT01268046|566079524|FG000|Overall Study|Withdrawal by Subject|1|||
156817216|NCT01268046|566079525|FG001|Overall Study|Withdrawal by Subject|0|||
156817217|NCT01268046|566079526|FG002|Overall Study|Withdrawal by Subject|0|||
156817218|NCT01268046|566079527|FG003|Overall Study|Withdrawal by Subject|1|||
156817219|NCT01268046|566079524|FG000|Overall Study|Lost to Follow-up|0|||
156817220|NCT01268046|566079525|FG001|Overall Study|Lost to Follow-up|0|||
156817221|NCT01268046|566079526|FG002|Overall Study|Lost to Follow-up|1|||
156817222|NCT01268046|566079527|FG003|Overall Study|Lost to Follow-up|0|||
156817223|NCT03850093|566079528|FG000|Overall Study|Withdrawal by Subject|1|||
156817224|NCT03850093|566079529|FG001|Overall Study|Withdrawal by Subject|0|||
156817225|NCT03850093|566079530|FG002|Overall Study|Withdrawal by Subject|2|||
156817226|NCT03636893|566079532|FG000|Overall Study|Death|0|||
156817227|NCT03636893|566079533|FG001|Overall Study|Death|1|||
156817228|NCT03636893|566079532|FG000|Overall Study|Protocol Violation|0|||
156817229|NCT03636893|566079533|FG001|Overall Study|Protocol Violation|3|||
156817230|NCT03636893|566079532|FG000|Overall Study|Withdrawal by Subject|1|||
156817231|NCT03636893|566079533|FG001|Overall Study|Withdrawal by Subject|2|||
156817232|NCT03636893|566079532|FG000|Overall Study|Refusal to surgery|4|||
156817233|NCT03636893|566079533|FG001|Overall Study|Refusal to surgery|3|||
156817234|NCT03636893|566079532|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
156817235|NCT03636893|566079533|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
156817236|NCT03636893|566079532|FG000|Overall Study|Adverse Event|1|||
156817237|NCT03636893|566079533|FG001|Overall Study|Adverse Event|1|||
156817238|NCT02314156|566079534|FG000|Overall Study|Adverse Event|1|||
156817239|NCT02314156|566079535|FG001|Overall Study|Adverse Event|0|||
156817240|NCT02314156|566079534|FG000|Overall Study|Withdrawal by Subject|1|||
156817241|NCT02314156|566079535|FG001|Overall Study|Withdrawal by Subject|0|||
156817242|NCT00224120|566079536|FG000|Overall Study|Adverse Event|10|||
156817243|NCT00224120|566079537|FG001|Overall Study|Adverse Event|4|||
156817244|NCT00224120|566079536|FG000|Overall Study|Protocol Violation|1|||
156817245|NCT00224120|566079537|FG001|Overall Study|Protocol Violation|0|||
156817246|NCT00224120|566079536|FG000|Overall Study|Withdrawal by Subject|5|||
156817247|NCT00224120|566079537|FG001|Overall Study|Withdrawal by Subject|10|||
156817248|NCT00224120|566079536|FG000|Overall Study|Lack of Efficacy|0|||
156817249|NCT00224120|566079537|FG001|Overall Study|Lack of Efficacy|2|||
156817250|NCT00224120|566079536|FG000|Overall Study|Lost to Follow-up|2|||
156817251|NCT00224120|566079537|FG001|Overall Study|Lost to Follow-up|3|||
156817252|NCT00224120|566079536|FG000|Overall Study|Other|4|||
156817253|NCT00224120|566079537|FG001|Overall Study|Other|5|||
156817254|NCT00104416|566079540|FG000|Double-Blind Phase|Adverse Event|2|||
156817255|NCT00104416|566079541|FG001|Double-Blind Phase|Adverse Event|1|||
156817256|NCT00104416|566079542|FG002|Double-Blind Phase|Adverse Event|0|||
156817257|NCT00104416|566079543|FG003|Double-Blind Phase|Adverse Event|0|||
156817258|NCT00104416|566079544|FG004|Double-Blind Phase|Adverse Event|0|||
156817259|NCT00104416|566079540|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156817260|NCT00104416|566079541|FG001|Double-Blind Phase|Lost to Follow-up|1|||
156817261|NCT00104416|566079542|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156817262|NCT00104416|566079543|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156817263|NCT00104416|566079544|FG004|Double-Blind Phase|Lost to Follow-up|0|||
156817264|NCT00104416|566079540|FG000|Double-Blind Phase|Protocol Violation|0|||
156817265|NCT00104416|566079541|FG001|Double-Blind Phase|Protocol Violation|1|||
156817266|NCT00104416|566079542|FG002|Double-Blind Phase|Protocol Violation|0|||
156817267|NCT00104416|566079543|FG003|Double-Blind Phase|Protocol Violation|0|||
156817268|NCT00104416|566079544|FG004|Double-Blind Phase|Protocol Violation|0|||
156817269|NCT00104416|566079540|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
156817270|NCT00104416|566079541|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
156817271|NCT00104416|566079542|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156817272|NCT00104416|566079543|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156817273|NCT00104416|566079544|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156817274|NCT00104416|566079540|FG000|Double-Blind Phase|Pregnancy|1|||
156817275|NCT00104416|566079541|FG001|Double-Blind Phase|Pregnancy|0|||
156817276|NCT00104416|566079542|FG002|Double-Blind Phase|Pregnancy|0|||
156817277|NCT00104416|566079543|FG003|Double-Blind Phase|Pregnancy|0|||
156817278|NCT00104416|566079544|FG004|Double-Blind Phase|Pregnancy|0|||
156817279|NCT00104416|566079540|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
156817280|NCT00104416|566079541|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
156817281|NCT00104416|566079542|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
156817282|NCT00104416|566079543|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
156817283|NCT00104416|566079544|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
156817284|NCT00104416|566079540|FG000|Continuation Phase|Adverse Event|0|||
156817285|NCT00104416|566079541|FG001|Continuation Phase|Adverse Event|0|||
156817286|NCT00104416|566079542|FG002|Continuation Phase|Adverse Event|2|||
156817287|NCT00104416|566079543|FG003|Continuation Phase|Adverse Event|0|||
156817288|NCT00104416|566079544|FG004|Continuation Phase|Adverse Event|2|||
156817289|NCT00104416|566079540|FG000|Continuation Phase|Lost to Follow-up|0|||
156817290|NCT00104416|566079541|FG001|Continuation Phase|Lost to Follow-up|0|||
156817291|NCT00104416|566079542|FG002|Continuation Phase|Lost to Follow-up|1|||
156817292|NCT00104416|566079543|FG003|Continuation Phase|Lost to Follow-up|0|||
156817293|NCT00104416|566079544|FG004|Continuation Phase|Lost to Follow-up|1|||
156817294|NCT00104416|566079540|FG000|Continuation Phase|Withdrawal by Subject|0|||
156817295|NCT00104416|566079541|FG001|Continuation Phase|Withdrawal by Subject|0|||
156817296|NCT00104416|566079542|FG002|Continuation Phase|Withdrawal by Subject|2|||
156817297|NCT00104416|566079543|FG003|Continuation Phase|Withdrawal by Subject|1|||
156817298|NCT00104416|566079544|FG004|Continuation Phase|Withdrawal by Subject|1|||
156817299|NCT00104416|566079540|FG000|Continuation Phase|Pregnancy|0|||
156817300|NCT00104416|566079541|FG001|Continuation Phase|Pregnancy|0|||
156817301|NCT00104416|566079542|FG002|Continuation Phase|Pregnancy|1|||
156817302|NCT00104416|566079543|FG003|Continuation Phase|Pregnancy|1|||
156817303|NCT00104416|566079544|FG004|Continuation Phase|Pregnancy|0|||
156817304|NCT00104416|566079540|FG000|Continuation Phase|Non-compliance|0|||
156817305|NCT00104416|566079541|FG001|Continuation Phase|Non-compliance|0|||
156817306|NCT00104416|566079542|FG002|Continuation Phase|Non-compliance|0|||
156817307|NCT00104416|566079543|FG003|Continuation Phase|Non-compliance|0|||
156817308|NCT00104416|566079544|FG004|Continuation Phase|Non-compliance|1|||
156817309|NCT00438360|566079545|FG000|Overall Study|Adverse Event|6|||
156817310|NCT00438360|566079546|FG001|Overall Study|Adverse Event|1|||
156817311|NCT00438360|566079545|FG000|Overall Study|Lack of Efficacy|42|||
156817312|NCT00438360|566079546|FG001|Overall Study|Lack of Efficacy|27|||
156817313|NCT00438360|566079545|FG000|Overall Study|Other|24|||
156817314|NCT00438360|566079546|FG001|Overall Study|Other|15|||
156817315|NCT00758069|566079549|FG000|Overall Study|Lack of Efficacy|0|||
156817316|NCT00758069|566079550|FG001|Overall Study|Lack of Efficacy|0|||
156817317|NCT00758069|566079551|FG002|Overall Study|Lack of Efficacy|1|||
156817318|NCT00758069|566079549|FG000|Overall Study|Incorrect Study Drug|1|||
156817319|NCT00758069|566079550|FG001|Overall Study|Incorrect Study Drug|0|||
156817320|NCT00758069|566079551|FG002|Overall Study|Incorrect Study Drug|0|||
156817321|NCT04560816|566079552|FG000|Overall Study|Withdrawal by Subject|1|||
156817322|NCT04560816|566079553|FG001|Overall Study|Withdrawal by Subject|1|||
156817323|NCT04560816|566079554|FG002|Overall Study|Withdrawal by Subject|1|||
156817324|NCT04560816|566079555|FG003|Overall Study|Withdrawal by Subject|0|||
156817325|NCT04560816|566079556|FG004|Overall Study|Withdrawal by Subject|3|||
156817326|NCT04560816|566079557|FG005|Overall Study|Withdrawal by Subject|0|||
156817327|NCT04560816|566079552|FG000|Overall Study|Lost to Follow-up|1|||
156817328|NCT04560816|566079553|FG001|Overall Study|Lost to Follow-up|0|||
156817329|NCT04560816|566079554|FG002|Overall Study|Lost to Follow-up|0|||
156817330|NCT04560816|566079555|FG003|Overall Study|Lost to Follow-up|0|||
156817331|NCT04560816|566079556|FG004|Overall Study|Lost to Follow-up|0|||
156817332|NCT04560816|566079557|FG005|Overall Study|Lost to Follow-up|0|||
156817333|NCT04560816|566079552|FG000|Overall Study|Protocol Violation|1|||
156817334|NCT04560816|566079553|FG001|Overall Study|Protocol Violation|0|||
156817335|NCT04560816|566079554|FG002|Overall Study|Protocol Violation|0|||
156817336|NCT04560816|566079555|FG003|Overall Study|Protocol Violation|0|||
156817337|NCT04560816|566079556|FG004|Overall Study|Protocol Violation|0|||
156817338|NCT04560816|566079557|FG005|Overall Study|Protocol Violation|0|||
156817339|NCT02277691|566079558|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
156817340|NCT02277691|566079558|FG000|Overall Study|Voluntary Withdrawal|7|||
156817341|NCT02277691|566079558|FG000|Overall Study|Lack of Efficacy|5|||
156817342|NCT02277691|566079558|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
156817343|NCT02846389|566079561|FG000|Overall Study|Withdrawal by Subject|1|||
156817344|NCT02846389|566079562|FG001|Overall Study|Withdrawal by Subject|1|||
156817345|NCT03818607|566079565|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
156817346|NCT03818607|566079566|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
156817347|NCT03818607|566079565|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
156817348|NCT03818607|566079566|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
156817349|NCT03818607|566079565|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
156817350|NCT03818607|566079566|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
156817351|NCT05286658|566079568|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
156817352|NCT05286658|566079568|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
156817353|NCT01345929|566079569|FG000|Overall Study|Withdrawal by Subject|9|||
156817354|NCT01345929|566079570|FG001|Overall Study|Withdrawal by Subject|8|||
156817355|NCT01345929|566079569|FG000|Overall Study|Lost to Follow-up|9|||
156817356|NCT01345929|566079570|FG001|Overall Study|Lost to Follow-up|9|||
156817357|NCT01345929|566079569|FG000|Overall Study|Adverse Event|0|||
156817358|NCT01345929|566079570|FG001|Overall Study|Adverse Event|1|||
156817359|NCT01345929|566079569|FG000|Overall Study|Didn't meet eligibility criteria|2|||
156817360|NCT01345929|566079570|FG001|Overall Study|Didn't meet eligibility criteria|0|||
156817361|NCT01345929|566079569|FG000|Overall Study|40,000 CFU/ML|1|||
156817362|NCT01345929|566079570|FG001|Overall Study|40,000 CFU/ML|0|||
156817363|NCT01345929|566079569|FG000|Overall Study|Patient withdrawal|0|||
156817364|NCT01345929|566079570|FG001|Overall Study|Patient withdrawal|1|||
156817365|NCT02819297|566079571|FG000|Overall Study|Withdrawal by Subject|25|||
156817366|NCT02819297|566079572|FG001|Overall Study|Withdrawal by Subject|13|||
156817367|NCT02819297|566079571|FG000|Overall Study|Lost to Follow-up|12|||
156817368|NCT02819297|566079572|FG001|Overall Study|Lost to Follow-up|14|||
156339027|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
156339028|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
156339029|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
156817369|NCT02819297|566079571|FG000|Overall Study|Adverse Event|12|||
156817370|NCT02819297|566079572|FG001|Overall Study|Adverse Event|10|||
156817371|NCT02819297|566079571|FG000|Overall Study|Physician Decision|5|||
156817372|NCT02819297|566079572|FG001|Overall Study|Physician Decision|5|||
156817373|NCT02819297|566079571|FG000|Overall Study|Lack of Efficacy|5|||
156817374|NCT02819297|566079572|FG001|Overall Study|Lack of Efficacy|8|||
156817375|NCT02819297|566079571|FG000|Overall Study|Protocol Violation|1|||
156817376|NCT02819297|566079572|FG001|Overall Study|Protocol Violation|2|||
156817377|NCT01670279|566079573|FG000|Overall Study|Adverse Event|0|||
156817378|NCT01670279|566079574|FG001|Overall Study|Adverse Event|1|||
156817379|NCT01670279|566079575|FG002|Overall Study|Adverse Event|0|||
156817380|NCT01670279|566079576|FG003|Overall Study|Adverse Event|0|||
156339030|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
156339031|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
156817381|NCT01670279|566079573|FG000|Overall Study|Physician Decision|0|||
156339032|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
156339033|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
156339034|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
156817382|NCT01670279|566079574|FG001|Overall Study|Physician Decision|1|||
156817383|NCT01670279|566079575|FG002|Overall Study|Physician Decision|0|||
156817384|NCT01670279|566079576|FG003|Overall Study|Physician Decision|0|||
156817385|NCT01670279|566079573|FG000|Overall Study|Participant met withdrawal criteria|0|||
156817386|NCT01670279|566079574|FG001|Overall Study|Participant met withdrawal criteria|0|||
156817387|NCT01670279|566079575|FG002|Overall Study|Participant met withdrawal criteria|0|||
156817388|NCT01670279|566079576|FG003|Overall Study|Participant met withdrawal criteria|1|||
156817389|NCT01901614|566079579|FG000|Overall Study|Adverse Event|0|||
156817390|NCT01901614|566079580|FG001|Overall Study|Adverse Event|1|||
156817391|NCT01901614|566079579|FG000|Overall Study|Lost to Follow-up|1|||
156817392|NCT01901614|566079580|FG001|Overall Study|Lost to Follow-up|0|||
156817393|NCT01901614|566079579|FG000|Overall Study|Screen Fail|1|||
156817394|NCT01901614|566079580|FG001|Overall Study|Screen Fail|0|||
156817395|NCT03629223|566079581|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817396|NCT03629223|566079582|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817397|NCT03629223|566079583|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817398|NCT03629223|566079584|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
156817399|NCT03629223|566079585|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817400|NCT03629223|566079586|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817401|NCT03629223|566079581|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817402|NCT03629223|566079582|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817403|NCT03629223|566079583|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817404|NCT03629223|566079584|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
156817405|NCT03629223|566079585|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817406|NCT03629223|566079586|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817407|NCT03629223|566079581|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817408|NCT03629223|566079582|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
156817409|NCT03629223|566079583|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817410|NCT03629223|566079584|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817411|NCT03629223|566079585|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817412|NCT03629223|566079586|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817413|NCT03629223|566079581|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817414|NCT03629223|566079582|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
156817415|NCT03629223|566079583|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817416|NCT03629223|566079584|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817417|NCT03629223|566079585|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817418|NCT03629223|566079586|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817419|NCT03629223|566079581|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
156817420|NCT03629223|566079582|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817421|NCT03629223|566079583|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817422|NCT03629223|566079584|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817423|NCT03629223|566079585|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817424|NCT03629223|566079586|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817425|NCT01104545|566079587|FG000|Overall Study|Adverse Event|0|||
156817426|NCT01104545|566079588|FG001|Overall Study|Adverse Event|1|||
156817427|NCT01104545|566079589|FG002|Overall Study|Adverse Event|2|||
156817428|NCT04532294|566079590|FG000|Overall Study|Withdrawal by Subject|0|||
156817429|NCT04532294|566079591|FG001|Overall Study|Withdrawal by Subject|0|||
156817430|NCT04532294|566079592|FG002|Overall Study|Withdrawal by Subject|1|||
156817431|NCT04532294|566079590|FG000|Overall Study|Participants Not Dosed|0|||
156817432|NCT04532294|566079591|FG001|Overall Study|Participants Not Dosed|0|||
156817433|NCT04532294|566079592|FG002|Overall Study|Participants Not Dosed|2|||
156817434|NCT02798315|566079593|FG000|Overall Study|Failure to return|1|||
156817435|NCT00912782|566079595|FG000|Overall Study|Death|2|||
156817436|NCT00912782|566079596|FG001|Overall Study|Death|1|||
156817437|NCT00912782|566079595|FG000|Overall Study|Lost to Follow-up|0|||
156817438|NCT00912782|566079596|FG001|Overall Study|Lost to Follow-up|1|||
156817439|NCT00912782|566079595|FG000|Overall Study|Did not receive vascular access type|1|||
156817440|NCT00912782|566079596|FG001|Overall Study|Did not receive vascular access type|2|||
156817441|NCT00912782|566079595|FG000|Overall Study|Relocated before study completion|0|||
156817442|NCT00912782|566079596|FG001|Overall Study|Relocated before study completion|1|||
156817443|NCT01986231|566081241|FG000|Overall Study|Adverse Event|1|||
156817444|NCT05791565|566081242|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
156817445|NCT05791565|566081243|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
156817446|NCT02300558|566081244|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
156817447|NCT02300558|566081244|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
156817448|NCT02300558|566081244|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
156817449|NCT02300558|566081244|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
156817450|NCT02318368|566081245|FG000|Overall Study|Withdrawal by Subject|2|||
156817451|NCT02318368|566081246|FG001|Overall Study|Withdrawal by Subject|0|||
156817452|NCT02318368|566081245|FG000|Overall Study|Study terminated by the sponsor|5|||
156817453|NCT02318368|566081246|FG001|Overall Study|Study terminated by the sponsor|2|||
156817454|NCT02318368|566081245|FG000|Overall Study|Death|0|||
156817455|NCT02318368|566081246|FG001|Overall Study|Death|1|||
156817456|NCT01555073|566081247|FG000|Overall Study|Lost to Follow-up|1|||
156817457|NCT01555073|566081248|FG001|Overall Study|Lost to Follow-up|2|||
156817458|NCT01555073|566081249|FG002|Overall Study|Lost to Follow-up|0|||
156817459|NCT01555073|566081250|FG003|Overall Study|Lost to Follow-up|5|||
156817460|NCT02027311|566081251|FG000|Overall Study|Protocol Violation|3|||
156817461|NCT02027311|566081252|FG001|Overall Study|Protocol Violation|2|||
156817462|NCT03928418|566081253|FG000|Overall Study|Lost to Follow-up|5|||
156339035|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
156817463|NCT03928418|566081254|FG001|Overall Study|Lost to Follow-up|3|||
156817464|NCT03928418|566081255|FG002|Overall Study|Lost to Follow-up|5|||
156540084|NCT02752035|565071443|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
156540085|NCT02752035|565071444|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
156817465|NCT03928418|566081253|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
156817466|NCT03928418|566081254|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
156817467|NCT03928418|566081255|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
156817468|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
156817469|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
156817470|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
156817471|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
156817472|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Death|58|||
156817473|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Death|65|||
156817474|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Adverse Event|28|||
156817475|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Adverse Event|40|||
156817476|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Disease Progression|22|||
156817477|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Disease Progression|35|||
156817478|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Other|25|||
156817479|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Other|33|||
156817480|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
156817481|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
156817482|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Noncompliance|8|||
156817483|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Noncompliance|8|||
156817484|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
156817485|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
156817486|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
156817487|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
156817488|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
156817489|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
156817490|NCT00286091|566081267|FG000|Open-label Treatment Phase|Physician Decision|24|||
156817491|NCT00286091|566081268|FG001|Open-label Treatment Phase|Physician Decision|21|||
156817492|NCT00286091|566081267|FG000|Open-label Treatment Phase|Adverse Event|5|||
156817493|NCT00286091|566081268|FG001|Open-label Treatment Phase|Adverse Event|16|||
156817494|NCT00286091|566081267|FG000|Open-label Treatment Phase|Other|11|||
156817495|NCT00286091|566081268|FG001|Open-label Treatment Phase|Other|11|||
156817496|NCT00286091|566081267|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
156817497|NCT00286091|566081268|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
156817498|NCT00286091|566081267|FG000|Open-label Treatment Phase|Death|10|||
156817499|NCT00286091|566081268|FG001|Open-label Treatment Phase|Death|7|||
156817500|NCT00286091|566081267|FG000|Open-label Treatment Phase|Disease Progression|9|||
156817501|NCT00286091|566081268|FG001|Open-label Treatment Phase|Disease Progression|3|||
156817502|NCT00286091|566081267|FG000|Open-label Treatment Phase|Noncompliance|3|||
156817503|NCT00286091|566081268|FG001|Open-label Treatment Phase|Noncompliance|1|||
156817504|NCT00286091|566081267|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
156817505|NCT00286091|566081268|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
156817506|NCT00286091|566081267|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
156817507|NCT00286091|566081268|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
156817508|NCT00286091|566081267|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
156817509|NCT00286091|566081268|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
156817510|NCT03799952|566081269|FG000|Overall Study|Program was too easy, discontinued|1|||
156817511|NCT03799952|566081270|FG001|Overall Study|Program was too easy, discontinued|0|||
156817512|NCT03799952|566081269|FG000|Overall Study|Lost to Follow-up|0|||
156817513|NCT03799952|566081270|FG001|Overall Study|Lost to Follow-up|2|||
156817514|NCT02936869|566081271|FG000|Overall Study|Lost to Follow-up|1|||
156817515|NCT02936869|566081272|FG001|Overall Study|Lost to Follow-up|3|||
156817516|NCT02936869|566081271|FG000|Overall Study|Death|0|||
156817517|NCT02936869|566081272|FG001|Overall Study|Death|1|||
156817518|NCT02936869|566081271|FG000|Overall Study|Legal Case|0|||
156817519|NCT02936869|566081272|FG001|Overall Study|Legal Case|1|||
156817520|NCT02936869|566081271|FG000|Overall Study|Protocol Violation|1|||
156817521|NCT02936869|566081272|FG001|Overall Study|Protocol Violation|0|||
156817522|NCT04004221|566081279|FG000|Overall Study|Death|89|||
156817523|NCT04004221|566081279|FG000|Overall Study|Withdrawal by Subject|5|||
156540086|NCT02752035|565071445|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
156817524|NCT04004221|566081279|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
156817525|NCT04004221|566081279|FG000|Overall Study|Sponsor Decision|9|||
156817526|NCT04004221|566081279|FG000|Overall Study|Participant refused to enter LTE|1|||
156817527|NCT03423238|566081280|FG000|Overall Study|Lost to Follow-up|1|||
156817528|NCT03423238|566081281|FG001|Overall Study|Lost to Follow-up|0|||
156817529|NCT03423238|566081280|FG000|Overall Study|Withdrawal by Subject|1|||
156540087|NCT02752035|565071446|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
156817530|NCT03423238|566081281|FG001|Overall Study|Withdrawal by Subject|0|||
156540088|NCT02752035|565071443|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
156817531|NCT02036580|566081285|FG000|Overall Study|Withdrawal by Subject|0|||
156817532|NCT02036580|566081286|FG001|Overall Study|Withdrawal by Subject|1|||
156817533|NCT02036580|566081287|FG002|Overall Study|Withdrawal by Subject|0|||
156817534|NCT02036580|566081285|FG000|Overall Study|Adverse Event|1|||
156817535|NCT02036580|566081286|FG001|Overall Study|Adverse Event|0|||
156817536|NCT02036580|566081287|FG002|Overall Study|Adverse Event|0|||
156817537|NCT00506454|566081288|FG000|Overall Study|Withdrawal by Subject|1|||
156817538|NCT00506454|566081289|FG001|Overall Study|Withdrawal by Subject|1|||
156817539|NCT00260832|566081290|FG000|Overall Study|Adverse Event|26|||
156817540|NCT00260832|566081291|FG001|Overall Study|Adverse Event|19|||
156817541|NCT00260832|566081290|FG000|Overall Study|Progression|116|||
156817542|NCT00260832|566081291|FG001|Overall Study|Progression|96|||
156817543|NCT00260832|566081290|FG000|Overall Study|Withdrawal by Subject|15|||
156817544|NCT00260832|566081291|FG001|Overall Study|Withdrawal by Subject|17|||
156817545|NCT00260832|566081290|FG000|Overall Study|Physician Decision|15|||
156817546|NCT00260832|566081291|FG001|Overall Study|Physician Decision|9|||
156817547|NCT00260832|566081290|FG000|Overall Study|Death|43|||
156817548|NCT00260832|566081291|FG001|Overall Study|Death|62|||
156817549|NCT00260832|566081290|FG000|Overall Study|Other|10|||
156817550|NCT00260832|566081291|FG001|Overall Study|Other|7|||
156817551|NCT00260832|566081290|FG000|Overall Study|Protocol Violation|3|||
156817552|NCT00260832|566081291|FG001|Overall Study|Protocol Violation|1|||
156817553|NCT00902850|566081292|FG000|Overall Study|Physician Decision|2|||
156817554|NCT00902850|566081293|FG001|Overall Study|Physician Decision|2|||
156817555|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
156817556|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
156817557|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
156817558|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156817559|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156817560|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156817561|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156817562|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
156817563|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817564|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817565|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817566|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817567|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817568|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817569|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
156817570|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
156817571|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
156817572|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156817573|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156817574|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156817575|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156817576|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
156817577|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
156817578|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817579|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817580|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817581|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817582|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817583|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
156817584|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817585|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817586|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817587|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817588|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817589|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817590|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817591|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
156817592|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817593|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817594|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817595|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817596|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817597|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
156540089|NCT02752035|565071444|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
156540090|NCT02752035|565071445|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
156817598|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
156817599|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
156817600|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156817601|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156817602|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156817603|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156817604|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
156817605|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
156817606|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817607|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817608|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817609|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817610|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817611|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817612|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817613|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817614|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817615|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817616|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
156817617|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
156817618|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156817619|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156817620|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156817621|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
156817622|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156817623|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
156817624|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
156817625|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156817626|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156817627|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156817628|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
156817629|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
156817630|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
156817631|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
156817632|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817633|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817634|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817635|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817636|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
156817637|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
156817638|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817639|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817640|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817641|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817642|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817643|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817644|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
156817645|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817646|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156817647|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156817648|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156817649|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
156817650|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
156817651|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
156817652|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
156817653|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156817654|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156817655|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156339036|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
156339037|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
156339038|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
156339039|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
156465509|NCT00982644|564801563|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
156817656|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156817657|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156817658|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
156817659|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
156817660|NCT02993822|566081308|FG000|Overall Study|Lack of Efficacy|1|||
156817661|NCT02993822|566081309|FG001|Overall Study|Lack of Efficacy|1|||
156817662|NCT02993822|566081310|FG002|Overall Study|Lack of Efficacy|0|||
156817663|NCT02993822|566081311|FG003|Overall Study|Lack of Efficacy|0|||
156817664|NCT02993822|566081308|FG000|Overall Study|Protocol Violation|1|||
156817665|NCT02993822|566081309|FG001|Overall Study|Protocol Violation|0|||
156540091|NCT02752035|565071446|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
156540092|NCT02752035|565071443|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
156540093|NCT02752035|565071444|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
156540094|NCT02752035|565071445|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
156540095|NCT02752035|565071446|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
156540096|NCT02752035|565071443|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
156540097|NCT02752035|565071444|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
156540098|NCT02752035|565071445|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
156540099|NCT02752035|565071446|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
156540100|NCT02752035|565071443|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
156540101|NCT02752035|565071444|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
156540102|NCT02752035|565071445|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
156540103|NCT02752035|565071446|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
156540104|NCT02752035|565071443|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
156540105|NCT02752035|565071444|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
156540106|NCT02752035|565071445|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
156465510|NCT00982644|564801564|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
156540107|NCT02752035|565071446|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
156540108|NCT02752035|565071443|FG000|Randomization: Approximately 3 Years|Death|0|||
156540109|NCT02752035|565071444|FG001|Randomization: Approximately 3 Years|Death|25|||
156465511|NCT00982644|564801563|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
156540110|NCT02752035|565071445|FG002|Randomization: Approximately 3 Years|Death|13|||
156540111|NCT02752035|565071446|FG003|Randomization: Approximately 3 Years|Death|4|||
156540112|NCT02752035|565071443|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
156540113|NCT02752035|565071444|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
156540114|NCT02752035|565071445|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
156540115|NCT02752035|565071446|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
156540116|NCT02752035|565071443|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
156540117|NCT02752035|565071444|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
156540118|NCT02752035|565071445|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
156540119|NCT02752035|565071446|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
156540120|NCT02752035|565071443|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
156540121|NCT02752035|565071444|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
156540122|NCT02752035|565071445|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
156540123|NCT02752035|565071446|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
156540124|NCT02752035|565071443|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
156540125|NCT02752035|565071444|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
156540126|NCT02752035|565071445|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
156540127|NCT02752035|565071446|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
156540128|NCT02752035|565071443|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
156540129|NCT02752035|565071444|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
156540130|NCT02752035|565071445|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
156540131|NCT02752035|565071446|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
156540132|NCT03668600|565071447|FG000|Overall Study|Study Terminated by the Sponsor|157|||
156540133|NCT03668600|565071447|FG000|Overall Study|Protocol Violation|1|||
156540134|NCT03668600|565071447|FG000|Overall Study|Pregnancy|1|||
156540135|NCT03668600|565071447|FG000|Overall Study|Lost to Follow-up|7|||
156465512|NCT00982644|564801564|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
156465513|NCT00982644|564801563|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
156540136|NCT03668600|565071447|FG000|Overall Study|Withdrawal by Subject|56|||
156540137|NCT03668600|565071447|FG000|Overall Study|Lack of Efficacy|7|||
156540138|NCT03668600|565071447|FG000|Overall Study|Adverse Event|1|||
156540139|NCT00424749|565071449|FG000|Overall Study|Withdrawal by Subject|1|||
156540140|NCT02343159|565071450|FG000|Overall Study|Early Study Termination|16|||
156465514|NCT00982644|564801564|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
156540141|NCT02343159|565071451|FG001|Overall Study|Early Study Termination|19|||
156540142|NCT02343159|565071452|FG002|Overall Study|Early Study Termination|23|||
156465515|NCT00982644|564801563|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
156465516|NCT00982644|564801564|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
156540143|NCT02343159|565071450|FG000|Overall Study|Physician Decision|2|||
156540144|NCT02343159|565071451|FG001|Overall Study|Physician Decision|0|||
156540145|NCT02343159|565071452|FG002|Overall Study|Physician Decision|1|||
156465517|NCT00982644|564801563|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
156540146|NCT02343159|565071450|FG000|Overall Study|Withdrawal by Subject|3|||
156540147|NCT02343159|565071451|FG001|Overall Study|Withdrawal by Subject|0|||
156540148|NCT02343159|565071452|FG002|Overall Study|Withdrawal by Subject|2|||
156540149|NCT02343159|565071450|FG000|Overall Study|Lost to Follow-up|0|||
156540150|NCT02343159|565071451|FG001|Overall Study|Lost to Follow-up|2|||
156540151|NCT02343159|565071452|FG002|Overall Study|Lost to Follow-up|2|||
156540152|NCT02343159|565071450|FG000|Overall Study|Adverse Event|4|||
156540153|NCT02343159|565071451|FG001|Overall Study|Adverse Event|4|||
156540154|NCT02343159|565071452|FG002|Overall Study|Adverse Event|2|||
156540155|NCT02343159|565071450|FG000|Overall Study|Sponsor Decision|0|||
156540156|NCT02343159|565071451|FG001|Overall Study|Sponsor Decision|1|||
156540157|NCT02343159|565071452|FG002|Overall Study|Sponsor Decision|0|||
156540158|NCT02343159|565071450|FG000|Overall Study|Enrollment Error|1|||
156540159|NCT02343159|565071451|FG001|Overall Study|Enrollment Error|0|||
156540160|NCT02343159|565071452|FG002|Overall Study|Enrollment Error|0|||
156540161|NCT00555477|565071457|FG000|Overall Study|Adverse Event|0|||
156540162|NCT00555477|565071458|FG001|Overall Study|Adverse Event|9|||
156540163|NCT00555477|565071457|FG000|Overall Study|Withdrawal by Subject|1|||
156540164|NCT00555477|565071458|FG001|Overall Study|Withdrawal by Subject|2|||
156540165|NCT00555477|565071457|FG000|Overall Study|Physician Decision|1|||
156540166|NCT00555477|565071458|FG001|Overall Study|Physician Decision|2|||
156540167|NCT00397033|565071459|FG000|Overall Study|Adverse Event|7|||
156540168|NCT00397033|565071460|FG001|Overall Study|Adverse Event|10|||
156540169|NCT00397033|565071461|FG002|Overall Study|Adverse Event|4|||
156540170|NCT00397033|565071459|FG000|Overall Study|Lack of Efficacy|22|||
156540171|NCT00397033|565071460|FG001|Overall Study|Lack of Efficacy|12|||
156540172|NCT00397033|565071461|FG002|Overall Study|Lack of Efficacy|9|||
156540173|NCT00397033|565071459|FG000|Overall Study|Lost to Follow-up|3|||
156540174|NCT00397033|565071460|FG001|Overall Study|Lost to Follow-up|3|||
156540175|NCT00397033|565071461|FG002|Overall Study|Lost to Follow-up|3|||
156540176|NCT00397033|565071459|FG000|Overall Study|Withdrawal by Subject|12|||
156540177|NCT00397033|565071460|FG001|Overall Study|Withdrawal by Subject|7|||
156540178|NCT00397033|565071461|FG002|Overall Study|Withdrawal by Subject|5|||
156540179|NCT00397033|565071459|FG000|Overall Study|Other|0|||
156540180|NCT00397033|565071460|FG001|Overall Study|Other|5|||
156540181|NCT00397033|565071461|FG002|Overall Study|Other|2|||
156540182|NCT03519867|565071462|FG000|Overall Study|Adverse Event|1|||
156540183|NCT03519867|565071463|FG001|Overall Study|Adverse Event|1|||
156540184|NCT03519867|565071464|FG002|Overall Study|Adverse Event|0|||
156540185|NCT03519867|565071465|FG003|Overall Study|Adverse Event|0|||
156540186|NCT03519867|565071466|FG004|Overall Study|Adverse Event|0|||
156540187|NCT03519867|565071467|FG005|Overall Study|Adverse Event|0|||
156540188|NCT03519867|565071468|FG006|Overall Study|Adverse Event|0|||
156540189|NCT03519867|565071469|FG007|Overall Study|Adverse Event|0|||
156540190|NCT03519867|565071470|FG008|Overall Study|Adverse Event|0|||
156540191|NCT03519867|565071471|FG009|Overall Study|Adverse Event|0|||
156540192|NCT03519867|565071462|FG000|Overall Study|Protocol Violation|0|||
156540193|NCT03519867|565071463|FG001|Overall Study|Protocol Violation|0|||
156540194|NCT03519867|565071464|FG002|Overall Study|Protocol Violation|0|||
156540195|NCT03519867|565071465|FG003|Overall Study|Protocol Violation|0|||
156540196|NCT03519867|565071466|FG004|Overall Study|Protocol Violation|0|||
156540197|NCT03519867|565071467|FG005|Overall Study|Protocol Violation|1|||
156540198|NCT03519867|565071468|FG006|Overall Study|Protocol Violation|0|||
156540199|NCT03519867|565071469|FG007|Overall Study|Protocol Violation|0|||
156540200|NCT03519867|565071470|FG008|Overall Study|Protocol Violation|0|||
156540201|NCT03519867|565071471|FG009|Overall Study|Protocol Violation|0|||
156540202|NCT03519867|565071462|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540203|NCT03519867|565071463|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540204|NCT03519867|565071464|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540205|NCT03519867|565071465|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540206|NCT03519867|565071466|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540207|NCT03519867|565071467|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540208|NCT03519867|565071468|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
156465518|NCT00982644|564801564|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
156540209|NCT03519867|565071469|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540210|NCT03519867|565071470|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540211|NCT03519867|565071471|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
156540212|NCT03519867|565071462|FG000|Overall Study|Admin. of other reversal agent|1|||
156540213|NCT03519867|565071463|FG001|Overall Study|Admin. of other reversal agent|1|||
156540214|NCT03519867|565071464|FG002|Overall Study|Admin. of other reversal agent|0|||
156540215|NCT03519867|565071465|FG003|Overall Study|Admin. of other reversal agent|0|||
156540216|NCT03519867|565071466|FG004|Overall Study|Admin. of other reversal agent|0|||
156540217|NCT03519867|565071467|FG005|Overall Study|Admin. of other reversal agent|1|||
156339040|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
156339041|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
156339042|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
156465519|NCT00982644|564801563|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
156540218|NCT03519867|565071468|FG006|Overall Study|Admin. of other reversal agent|0|||
156540219|NCT03519867|565071469|FG007|Overall Study|Admin. of other reversal agent|0|||
156540220|NCT03519867|565071470|FG008|Overall Study|Admin. of other reversal agent|0|||
156540221|NCT03519867|565071471|FG009|Overall Study|Admin. of other reversal agent|0|||
156540222|NCT03519867|565071462|FG000|Overall Study|Reason not provided|1|||
156540223|NCT03519867|565071463|FG001|Overall Study|Reason not provided|1|||
156540224|NCT03519867|565071464|FG002|Overall Study|Reason not provided|1|||
156540225|NCT03519867|565071465|FG003|Overall Study|Reason not provided|1|||
156540226|NCT03519867|565071466|FG004|Overall Study|Reason not provided|0|||
156540227|NCT03519867|565071467|FG005|Overall Study|Reason not provided|1|||
156540228|NCT03519867|565071468|FG006|Overall Study|Reason not provided|0|||
156540229|NCT03519867|565071469|FG007|Overall Study|Reason not provided|1|||
156540230|NCT03519867|565071470|FG008|Overall Study|Reason not provided|1|||
156540231|NCT03519867|565071471|FG009|Overall Study|Reason not provided|0|||
156540232|NCT01846624|565071472|FG000|Overall Study|Died during induction, no midostaurin|1|||
156540233|NCT01721057|565071473|FG000|Treatment Period|Withdrawal by Subject|11|||
156540234|NCT01721057|565071474|FG001|Treatment Period|Withdrawal by Subject|5|||
156540235|NCT01721057|565071475|FG002|Treatment Period|Withdrawal by Subject|8|||
156540236|NCT01721057|565071476|FG003|Treatment Period|Withdrawal by Subject|0|||
156540237|NCT01721057|565071477|FG004|Treatment Period|Withdrawal by Subject|0|||
156540238|NCT01721057|565071478|FG005|Treatment Period|Withdrawal by Subject|0|||
156540239|NCT01721057|565071479|FG006|Treatment Period|Withdrawal by Subject|0|||
156540240|NCT01721057|565071473|FG000|Treatment Period|Adverse Event|7|||
156540241|NCT01721057|565071474|FG001|Treatment Period|Adverse Event|10|||
156540242|NCT01721057|565071475|FG002|Treatment Period|Adverse Event|12|||
156540243|NCT01721057|565071476|FG003|Treatment Period|Adverse Event|0|||
156540244|NCT01721057|565071477|FG004|Treatment Period|Adverse Event|0|||
156540245|NCT01721057|565071478|FG005|Treatment Period|Adverse Event|0|||
156540246|NCT01721057|565071479|FG006|Treatment Period|Adverse Event|0|||
156540247|NCT01721057|565071473|FG000|Treatment Period|Lack of Efficacy|7|||
156540248|NCT01721057|565071474|FG001|Treatment Period|Lack of Efficacy|3|||
156540249|NCT01721057|565071475|FG002|Treatment Period|Lack of Efficacy|0|||
156540250|NCT01721057|565071476|FG003|Treatment Period|Lack of Efficacy|0|||
156540251|NCT01721057|565071477|FG004|Treatment Period|Lack of Efficacy|0|||
156540252|NCT01721057|565071478|FG005|Treatment Period|Lack of Efficacy|0|||
156540253|NCT01721057|565071479|FG006|Treatment Period|Lack of Efficacy|0|||
156540254|NCT01721057|565071473|FG000|Treatment Period|Lost to Follow-up|1|||
156540255|NCT01721057|565071474|FG001|Treatment Period|Lost to Follow-up|0|||
156540256|NCT01721057|565071475|FG002|Treatment Period|Lost to Follow-up|0|||
156540257|NCT01721057|565071476|FG003|Treatment Period|Lost to Follow-up|0|||
156540258|NCT01721057|565071477|FG004|Treatment Period|Lost to Follow-up|0|||
156540259|NCT01721057|565071478|FG005|Treatment Period|Lost to Follow-up|0|||
156540260|NCT01721057|565071479|FG006|Treatment Period|Lost to Follow-up|0|||
156540261|NCT01721057|565071473|FG000|Treatment Period|Physician Decision|0|||
156540262|NCT01721057|565071474|FG001|Treatment Period|Physician Decision|1|||
156540263|NCT01721057|565071475|FG002|Treatment Period|Physician Decision|3|||
156540264|NCT01721057|565071476|FG003|Treatment Period|Physician Decision|0|||
156540265|NCT01721057|565071477|FG004|Treatment Period|Physician Decision|0|||
156540266|NCT01721057|565071478|FG005|Treatment Period|Physician Decision|0|||
156540267|NCT01721057|565071479|FG006|Treatment Period|Physician Decision|0|||
156540268|NCT01721057|565071473|FG000|Treatment Period|Death|2|||
156540269|NCT01721057|565071474|FG001|Treatment Period|Death|0|||
156540270|NCT01721057|565071475|FG002|Treatment Period|Death|0|||
156540271|NCT01721057|565071476|FG003|Treatment Period|Death|0|||
156540272|NCT01721057|565071477|FG004|Treatment Period|Death|0|||
156540273|NCT01721057|565071478|FG005|Treatment Period|Death|0|||
156540274|NCT01721057|565071479|FG006|Treatment Period|Death|0|||
156540275|NCT01721057|565071473|FG000|Rescue Period|Adverse Event|0|||
156540276|NCT01721057|565071474|FG001|Rescue Period|Adverse Event|0|||
156540277|NCT01721057|565071475|FG002|Rescue Period|Adverse Event|0|||
156540278|NCT01721057|565071476|FG003|Rescue Period|Adverse Event|1|||
156540279|NCT01721057|565071477|FG004|Rescue Period|Adverse Event|0|||
156540280|NCT01721057|565071478|FG005|Rescue Period|Adverse Event|0|||
156540281|NCT01721057|565071479|FG006|Rescue Period|Adverse Event|0|||
156540282|NCT01721057|565071473|FG000|Rescue Period|Lack of Efficacy|0|||
156540283|NCT01721057|565071474|FG001|Rescue Period|Lack of Efficacy|0|||
156540284|NCT01721057|565071475|FG002|Rescue Period|Lack of Efficacy|0|||
156540285|NCT01721057|565071476|FG003|Rescue Period|Lack of Efficacy|2|||
156540286|NCT01721057|565071477|FG004|Rescue Period|Lack of Efficacy|0|||
156540287|NCT01721057|565071478|FG005|Rescue Period|Lack of Efficacy|0|||
156540288|NCT01721057|565071479|FG006|Rescue Period|Lack of Efficacy|0|||
156540289|NCT01202279|565071480|FG000|Overall Study|Adverse Event|8|||
156540290|NCT01202279|565071481|FG001|Overall Study|Adverse Event|6|||
156540291|NCT01202279|565071480|FG000|Overall Study|Withdrawal by Subject|13|||
156540292|NCT01202279|565071481|FG001|Overall Study|Withdrawal by Subject|10|||
156540293|NCT01202279|565071480|FG000|Overall Study|Physician Decision|0|||
156540294|NCT01202279|565071481|FG001|Overall Study|Physician Decision|1|||
156540295|NCT01202279|565071480|FG000|Overall Study|Lost to Follow-up|10|||
156540296|NCT01202279|565071481|FG001|Overall Study|Lost to Follow-up|7|||
156540297|NCT01202279|565071480|FG000|Overall Study|Protocol Violation|1|||
156540298|NCT01202279|565071481|FG001|Overall Study|Protocol Violation|1|||
156540299|NCT01202279|565071480|FG000|Overall Study|study compliance|5|||
156540300|NCT01202279|565071481|FG001|Overall Study|study compliance|2|||
156540301|NCT03574753|565071482|FG000|Overall Study|Adverse Event|3|||
156540302|NCT03574753|565071482|FG000|Overall Study|Progression/relapse|19|||
156540303|NCT03574753|565071482|FG000|Overall Study|Death|1|||
156540304|NCT01177683|565071483|FG000|Study Treatment|Disease Progressions during treatment|2|||
156540305|NCT01177683|565071484|FG001|Study Treatment|Disease Progressions during treatment|0|||
156540306|NCT01177683|565071485|FG002|Study Treatment|Disease Progressions during treatment|3|||
156540307|NCT01177683|565071483|FG000|Study Treatment|Adverse Event|0|||
156540308|NCT01177683|565071484|FG001|Study Treatment|Adverse Event|1|||
156540309|NCT01177683|565071485|FG002|Study Treatment|Adverse Event|12|||
156540310|NCT01177683|565071483|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
156540311|NCT01177683|565071484|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
156540312|NCT01177683|565071485|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
156540313|NCT01177683|565071483|FG000|Study Treatment|Alternative therapy|0|||
156540314|NCT01177683|565071484|FG001|Study Treatment|Alternative therapy|0|||
156540315|NCT01177683|565071485|FG002|Study Treatment|Alternative therapy|4|||
156540316|NCT01177683|565071483|FG000|Study Treatment|Physician Decision|1|||
156540317|NCT01177683|565071484|FG001|Study Treatment|Physician Decision|0|||
156540318|NCT01177683|565071485|FG002|Study Treatment|Physician Decision|1|||
156540319|NCT01177683|565071483|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
156540320|NCT01177683|565071484|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
156540321|NCT01177683|565071485|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
156540322|NCT01177683|565071483|FG000|Study Treatment|Symptomatic Deterioration|0|||
156540323|NCT01177683|565071484|FG001|Study Treatment|Symptomatic Deterioration|0|||
156540324|NCT01177683|565071485|FG002|Study Treatment|Symptomatic Deterioration|1|||
156540325|NCT01177683|565071483|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
156540326|NCT01177683|565071484|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
156540327|NCT01177683|565071485|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
156540328|NCT01177683|565071483|FG000|Follow up|Patient lost to follow up|0|||
156540329|NCT01177683|565071484|FG001|Follow up|Patient lost to follow up|0|||
156540330|NCT01177683|565071485|FG002|Follow up|Patient lost to follow up|2|||
156540331|NCT01177683|565071483|FG000|Follow up|Death|2|||
156540332|NCT01177683|565071484|FG001|Follow up|Death|1|||
156540333|NCT01177683|565071485|FG002|Follow up|Death|7|||
156540334|NCT01177683|565071483|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
156540335|NCT01177683|565071484|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
156540336|NCT01177683|565071485|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
156540337|NCT02546765|565071488|FG000|Overall Study|Withdrawal by Subject|0|||
156540338|NCT02546765|565071489|FG001|Overall Study|Withdrawal by Subject|1|||
156540339|NCT02546765|565071490|FG002|Overall Study|Withdrawal by Subject|0|||
156540340|NCT02546765|565071491|FG003|Overall Study|Withdrawal by Subject|0|||
156540341|NCT01977820|565071492|FG000|Overall Study|Sponsor terminated the study|1|||
156540342|NCT01977820|565071493|FG001|Overall Study|Sponsor terminated the study|1|||
156540343|NCT00698997|565071494|FG000|Overall Study|Lost to Follow-up|3|||
156540344|NCT00698997|565071495|FG001|Overall Study|Lost to Follow-up|0|||
156540345|NCT00698997|565071494|FG000|Overall Study|Withdrawal by Subject|7|||
156540346|NCT00698997|565071495|FG001|Overall Study|Withdrawal by Subject|27|||
156540347|NCT00475722|565071496|FG000|Overall Study|Withdrawal by Subject|12|||
156540348|NCT00475722|565071497|FG001|Overall Study|Withdrawal by Subject|12|||
156540349|NCT00475722|565071496|FG000|Overall Study|Protocol Violation|3|||
156540350|NCT00475722|565071497|FG001|Overall Study|Protocol Violation|0|||
156540351|NCT02568475|565071498|FG000|Overall Study|Lost to Follow-up|40|||
156540352|NCT02568475|565071499|FG001|Overall Study|Lost to Follow-up|39|||
156540353|NCT02568475|565071498|FG000|Overall Study|Withdrawal by Subject|2|||
156540354|NCT02568475|565071499|FG001|Overall Study|Withdrawal by Subject|0|||
156540355|NCT02568475|565071498|FG000|Overall Study|Discharged home|4|||
156540356|NCT02568475|565071499|FG001|Overall Study|Discharged home|4|||
156540357|NCT02568475|565071498|FG000|Overall Study|Short-term: Discharge location unknown|4|||
156540358|NCT02568475|565071499|FG001|Overall Study|Short-term: Discharge location unknown|0|||
156540359|NCT02568475|565071498|FG000|Overall Study|Transferred to another facility|1|||
156540360|NCT02568475|565071499|FG001|Overall Study|Transferred to another facility|0|||
156540361|NCT02625233|565071500|FG000|Overall Study|Adverse Event|2|||
156540362|NCT02625233|565071501|FG001|Overall Study|Adverse Event|0|||
156540363|NCT04425720|565071502|FG000|Overall Study|Withdrawal by Subject|0|||
156540364|NCT04425720|565071503|FG001|Overall Study|Withdrawal by Subject|20|||
156465520|NCT00982644|564801564|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
156540365|NCT00290186|565071504|FG000|Overall Study|Adverse Event|1|||
156540366|NCT00290186|565071505|FG001|Overall Study|Adverse Event|1|||
156540367|NCT00290186|565071504|FG000|Overall Study|Lost to Follow-up|3|||
156540368|NCT00290186|565071505|FG001|Overall Study|Lost to Follow-up|2|||
156540369|NCT00290186|565071504|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
156540370|NCT00290186|565071505|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
156540371|NCT00290186|565071504|FG000|Overall Study|Withdrawal by Subject|0|||
156540372|NCT00290186|565071505|FG001|Overall Study|Withdrawal by Subject|1|||
156540373|NCT00262522|565071508|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
156540374|NCT00262522|565071509|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
156540375|NCT00262522|565071510|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
156540376|NCT00262522|565071511|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
156540377|NCT00262522|565071508|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
156540378|NCT00262522|565071509|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
156540379|NCT00262522|565071510|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
156540380|NCT00262522|565071511|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
156540381|NCT00262522|565071508|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
156540382|NCT00262522|565071509|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
156540383|NCT00262522|565071510|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
156540384|NCT00262522|565071511|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
156540385|NCT00262522|565071508|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
156540386|NCT00262522|565071509|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
156540387|NCT00262522|565071510|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
156540388|NCT00262522|565071511|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
156540389|NCT00262522|565071508|FG000|Study Start Through 8 Weeks|Death|1|||
156540390|NCT00262522|565071509|FG001|Study Start Through 8 Weeks|Death|0|||
156540391|NCT00262522|565071510|FG002|Study Start Through 8 Weeks|Death|0|||
156540392|NCT00262522|565071511|FG003|Study Start Through 8 Weeks|Death|0|||
156540393|NCT00262522|565071508|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
156540394|NCT00262522|565071509|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
156540395|NCT00262522|565071510|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
156540396|NCT00262522|565071511|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
156540397|NCT00262522|565071508|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
156540398|NCT00262522|565071509|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
156540399|NCT00262522|565071510|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
156540400|NCT00262522|565071511|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
156540401|NCT00262522|565071508|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
156540402|NCT00262522|565071509|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
156540403|NCT00262522|565071510|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
156540404|NCT00262522|565071511|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
156540405|NCT00262522|565071508|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
156540406|NCT00262522|565071509|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
156540407|NCT00262522|565071510|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
156540408|NCT00262522|565071511|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
156540409|NCT00262522|565071508|FG000|Study Start Through 48 Weeks|Death|2|||
156540410|NCT00262522|565071509|FG001|Study Start Through 48 Weeks|Death|0|||
156540411|NCT00262522|565071510|FG002|Study Start Through 48 Weeks|Death|1|||
156540412|NCT00262522|565071511|FG003|Study Start Through 48 Weeks|Death|0|||
156540413|NCT00262522|565071508|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
156540414|NCT00262522|565071509|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
156540415|NCT00262522|565071510|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
156540416|NCT00262522|565071511|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
156540417|NCT00262522|565071508|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
156540418|NCT00262522|565071509|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
156540419|NCT00262522|565071510|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
156540420|NCT00262522|565071511|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
156540421|NCT00262522|565071508|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
156540422|NCT00262522|565071509|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
156540423|NCT00262522|565071510|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
156540424|NCT00262522|565071511|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
156465521|NCT00982644|564801563|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
156540425|NCT00262522|565071508|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
156540426|NCT00262522|565071509|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
156540427|NCT00262522|565071510|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
156540428|NCT00262522|565071511|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
156540429|NCT00262522|565071508|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
156540430|NCT00262522|565071509|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
156540431|NCT00262522|565071510|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
156540432|NCT00262522|565071511|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
156540433|NCT00262522|565071508|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
156540434|NCT00262522|565071509|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
156540435|NCT00262522|565071510|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
156540436|NCT00262522|565071511|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
156540437|NCT00262522|565071508|FG000|Study Start Through 96 Weeks|Death|2|||
156540438|NCT00262522|565071509|FG001|Study Start Through 96 Weeks|Death|0|||
156540439|NCT00262522|565071510|FG002|Study Start Through 96 Weeks|Death|2|||
156540440|NCT00262522|565071511|FG003|Study Start Through 96 Weeks|Death|0|||
156540441|NCT00262522|565071508|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
156540442|NCT00262522|565071509|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
156540443|NCT00262522|565071510|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
156540444|NCT00262522|565071511|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
156540445|NCT00262522|565071508|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
156540446|NCT00262522|565071509|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
156540447|NCT00262522|565071510|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
156540448|NCT00262522|565071511|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
156540449|NCT05314517|565071523|FG000|Double-blind Period|Adverse Event|4|||
156540450|NCT05314517|565071524|FG001|Double-blind Period|Adverse Event|0|||
156540451|NCT05314517|565071525|FG002|Double-blind Period|Adverse Event|0|||
156465522|NCT00982644|564801564|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
156465523|NCT00982644|564801563|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
156465524|NCT00982644|564801564|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
156465525|NCT03767335|564801565|FG000|Overall Study|Physician Decision|1|||
156465526|NCT03767335|564801566|FG001|Overall Study|Physician Decision|1|||
156465527|NCT03767335|564801567|FG002|Overall Study|Physician Decision|0|||
156540452|NCT05314517|565071526|FG003|Double-blind Period|Adverse Event|0|||
156540453|NCT05314517|565071523|FG000|Double-blind Period|Noncompliance|0|||
156540454|NCT05314517|565071524|FG001|Double-blind Period|Noncompliance|1|||
156540455|NCT05314517|565071525|FG002|Double-blind Period|Noncompliance|0|||
156540456|NCT05314517|565071526|FG003|Double-blind Period|Noncompliance|0|||
156540457|NCT05314517|565071523|FG000|Double-blind Period|Randomized, not treated|1|||
156540458|NCT05314517|565071524|FG001|Double-blind Period|Randomized, not treated|0|||
156540459|NCT05314517|565071525|FG002|Double-blind Period|Randomized, not treated|0|||
156540460|NCT05314517|565071526|FG003|Double-blind Period|Randomized, not treated|0|||
156540461|NCT05314517|565071523|FG000|Open-label Extension|Adverse Event|0|||
156540462|NCT05314517|565071524|FG001|Open-label Extension|Adverse Event|0|||
156540463|NCT05314517|565071525|FG002|Open-label Extension|Adverse Event|1|||
156540464|NCT05314517|565071526|FG003|Open-label Extension|Adverse Event|2|||
156540465|NCT05314517|565071523|FG000|Open-label Extension|Investigator decision|0|||
156540466|NCT05314517|565071524|FG001|Open-label Extension|Investigator decision|0|||
156540467|NCT05314517|565071525|FG002|Open-label Extension|Investigator decision|1|||
156540468|NCT05314517|565071526|FG003|Open-label Extension|Investigator decision|0|||
156540469|NCT05314517|565071523|FG000|Open-label Extension|Lost to Follow-up|0|||
156540470|NCT05314517|565071524|FG001|Open-label Extension|Lost to Follow-up|0|||
156540471|NCT05314517|565071525|FG002|Open-label Extension|Lost to Follow-up|0|||
156540472|NCT05314517|565071526|FG003|Open-label Extension|Lost to Follow-up|1|||
156540473|NCT05314517|565071523|FG000|Open-label Extension|Withdrawal by Subject|0|||
156540474|NCT05314517|565071524|FG001|Open-label Extension|Withdrawal by Subject|0|||
156540475|NCT05314517|565071525|FG002|Open-label Extension|Withdrawal by Subject|1|||
156540476|NCT05314517|565071526|FG003|Open-label Extension|Withdrawal by Subject|2|||
156540477|NCT05314517|565071523|FG000|Open-label Extension|Use of prohibited medication|0|||
156540478|NCT05314517|565071524|FG001|Open-label Extension|Use of prohibited medication|0|||
156540479|NCT05314517|565071525|FG002|Open-label Extension|Use of prohibited medication|1|||
156540480|NCT05314517|565071526|FG003|Open-label Extension|Use of prohibited medication|0|||
156540481|NCT05314517|565071523|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
156540482|NCT05314517|565071524|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
156540483|NCT05314517|565071525|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
156540484|NCT05314517|565071526|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
156540485|NCT02710136|565071529|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
156540486|NCT02710136|565071530|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
156540487|NCT02269787|565071531|FG000|Overall Study|Lost to Follow-up|20|||
156540488|NCT02269787|565071532|FG001|Overall Study|Lost to Follow-up|6|||
156540489|NCT02269787|565071531|FG000|Overall Study|Death|2|||
156540490|NCT02269787|565071532|FG001|Overall Study|Death|3|||
156465528|NCT03767335|564801565|FG000|Overall Study|Withdrawal by Subject|0|||
156540491|NCT02269787|565071531|FG000|Overall Study|Incapacitated|0|||
156540492|NCT02269787|565071532|FG001|Overall Study|Incapacitated|1|||
156540493|NCT00798135|565071533|FG000|Overall Study|Disease progression, relapse|11|||
156540494|NCT00798135|565071533|FG000|Overall Study|Disease progression, refractory|1|||
156540495|NCT00798135|565071533|FG000|Overall Study|Physician Decision|1|||
156540496|NCT02228720|565071534|FG000|Open Label - Day 30|Lost to Follow-up|1|||
156465529|NCT03767335|564801566|FG001|Overall Study|Withdrawal by Subject|0|||
156540497|NCT00282295|565071537|FG000|Overall Study|Adverse Event|0|||
156540498|NCT00282295|565071538|FG001|Overall Study|Adverse Event|1|||
156540499|NCT00282295|565071539|FG002|Overall Study|Adverse Event|0|||
156540500|NCT00282295|565071537|FG000|Overall Study|Serious Adverse Events|0|||
156540501|NCT00282295|565071538|FG001|Overall Study|Serious Adverse Events|0|||
156540502|NCT00282295|565071539|FG002|Overall Study|Serious Adverse Events|1|||
156540503|NCT00282295|565071537|FG000|Overall Study|Protocol Violation|0|||
156540504|NCT00282295|565071538|FG001|Overall Study|Protocol Violation|2|||
156540505|NCT00282295|565071539|FG002|Overall Study|Protocol Violation|1|||
156540506|NCT00282295|565071537|FG000|Overall Study|Withdrawal by Subject|2|||
156540507|NCT00282295|565071538|FG001|Overall Study|Withdrawal by Subject|6|||
156540508|NCT00282295|565071539|FG002|Overall Study|Withdrawal by Subject|4|||
156540509|NCT00282295|565071537|FG000|Overall Study|Lost to Follow-up|1|||
156540510|NCT00282295|565071538|FG001|Overall Study|Lost to Follow-up|7|||
156540511|NCT00282295|565071539|FG002|Overall Study|Lost to Follow-up|2|||
156540512|NCT00282295|565071537|FG000|Overall Study|Other|0|||
156540513|NCT00282295|565071538|FG001|Overall Study|Other|1|||
156540514|NCT00282295|565071539|FG002|Overall Study|Other|0|||
156540515|NCT01401842|565071540|FG000|Overall Study|Withdrawal by Subject|3|||
156540516|NCT01401842|565071541|FG001|Overall Study|Withdrawal by Subject|2|||
156540517|NCT01401842|565071540|FG000|Overall Study|academic reason|4|||
156540518|NCT01401842|565071541|FG001|Overall Study|academic reason|1|||
156540519|NCT01401842|565071540|FG000|Overall Study|changed companies|20|||
156540520|NCT01401842|565071541|FG001|Overall Study|changed companies|34|||
156540521|NCT01401842|565071540|FG000|Overall Study|discharged from US Army|3|||
156540522|NCT01401842|565071541|FG001|Overall Study|discharged from US Army|4|||
156540523|NCT01401842|565071540|FG000|Overall Study|invalid follow-up strength data|1|||
156540524|NCT01401842|565071541|FG001|Overall Study|invalid follow-up strength data|4|||
156540525|NCT01401842|565071540|FG000|Overall Study|on profile|9|||
156540526|NCT01401842|565071541|FG001|Overall Study|on profile|5|||
156540527|NCT01401842|565071540|FG000|Overall Study|other/unknown|28|||
156540528|NCT01401842|565071541|FG001|Overall Study|other/unknown|17|||
156540529|NCT03337542|565071542|FG000|Overall Study|Withdrew Consent|17|||
156540530|NCT03337542|565071542|FG000|Overall Study|Allergic Adverse Event|1|||
156540531|NCT03337542|565071542|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
156540532|NCT03337542|565071542|FG000|Overall Study|Lost to Follow-up|1|||
156540533|NCT03337542|565071542|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
156540534|NCT00430482|565071547|FG000|Completed Treatment|Insufficient Treatment|7|||
156540535|NCT00430482|565071548|FG001|Completed Treatment|Insufficient Treatment|11|||
156540536|NCT00583024|565071549|FG000|Overall Study|Lost to Follow-up|4|||
156540537|NCT04198623|565073211|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
156540538|NCT05050318|565073219|FG000|Overall Study|Protocol Deviation|1|||
156540539|NCT05050318|565073220|FG001|Overall Study|Protocol Deviation|0|||
156540540|NCT05050318|565073221|FG002|Overall Study|Protocol Deviation|0|||
156540541|NCT04259411|565073222|FG000|Overall Study|Death|1|||
156540542|NCT04259411|565073222|FG000|Overall Study|Missed visit|2|||
156540543|NCT00736255|565073223|FG000|Overall Study|Adverse Event|1|||
156540544|NCT00736255|565073224|FG001|Overall Study|Adverse Event|0|||
156540545|NCT00736255|565073223|FG000|Overall Study|Physician Decision|1|||
156540546|NCT00736255|565073224|FG001|Overall Study|Physician Decision|0|||
156540547|NCT00736255|565073223|FG000|Overall Study|Non-compliance|1|||
156540548|NCT00736255|565073224|FG001|Overall Study|Non-compliance|1|||
156540549|NCT00766038|565073227|FG000|Overall Study|Lost to Follow-up|15|||
156540550|NCT00766038|565073228|FG001|Overall Study|Lost to Follow-up|14|||
156540551|NCT00449670|565073229|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
156540552|NCT00449670|565073230|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
156540553|NCT00449670|565073229|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
156540554|NCT00449670|565073230|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
156540555|NCT00449670|565073229|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
156540556|NCT00449670|565073230|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
156540557|NCT00449670|565073229|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
156540558|NCT00449670|565073230|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
156540559|NCT00449670|565073229|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
156540560|NCT00449670|565073230|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
156540561|NCT00449670|565073229|FG000|Booster Phase (Study no.109873)|Other|0|||
156540562|NCT00449670|565073230|FG001|Booster Phase (Study no.109873)|Other|2|||
156540563|NCT04183790|565073234|FG000|Overall Study|Participants did not rollover to Part B|12|||
156540564|NCT04183790|565073235|FG001|Overall Study|Participants did not rollover to Part B|0|||
156540565|NCT04183790|565073234|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
156540566|NCT04183790|565073235|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
156540567|NCT04183790|565073234|FG000|Overall Study|Commercial drug is available for participant|6|||
156540568|NCT04183790|565073235|FG001|Overall Study|Commercial drug is available for participant|0|||
156339043|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
156540569|NCT04183790|565073234|FG000|Overall Study|Adverse Event|1|||
156540570|NCT04183790|565073235|FG001|Overall Study|Adverse Event|0|||
156540571|NCT04183790|565073234|FG000|Overall Study|Not enrolled in 107 study|0|||
156540572|NCT04183790|565073235|FG001|Overall Study|Not enrolled in 107 study|2|||
156465530|NCT03767335|564801567|FG002|Overall Study|Withdrawal by Subject|6|||
156465531|NCT03767335|564801565|FG000|Overall Study|Participant excluded from efficacy population|0|||
156465532|NCT03767335|564801566|FG001|Overall Study|Participant excluded from efficacy population|0|||
156465533|NCT03767335|564801567|FG002|Overall Study|Participant excluded from efficacy population|1|||
156540573|NCT01251653|565073236|FG000|Overall Study|Progressive Disease|1|||
156540574|NCT01251653|565073237|FG001|Overall Study|Progressive Disease|7|||
156540575|NCT01251653|565073238|FG002|Overall Study|Progressive Disease|16|||
156540576|NCT01251653|565073239|FG003|Overall Study|Progressive Disease|4|||
156540577|NCT01251653|565073240|FG004|Overall Study|Progressive Disease|0|||
156540578|NCT01251653|565073241|FG005|Overall Study|Progressive Disease|17|||
156540579|NCT01251653|565073242|FG006|Overall Study|Progressive Disease|14|||
156540580|NCT01251653|565073243|FG007|Overall Study|Progressive Disease|7|||
156540581|NCT01251653|565073244|FG008|Overall Study|Progressive Disease|5|||
156540582|NCT01251653|565073236|FG000|Overall Study|Dose-limiting toxicity|0|||
156540583|NCT01251653|565073237|FG001|Overall Study|Dose-limiting toxicity|1|||
156540584|NCT01251653|565073238|FG002|Overall Study|Dose-limiting toxicity|1|||
156540585|NCT01251653|565073239|FG003|Overall Study|Dose-limiting toxicity|1|||
156540586|NCT01251653|565073240|FG004|Overall Study|Dose-limiting toxicity|0|||
156540587|NCT01251653|565073241|FG005|Overall Study|Dose-limiting toxicity|0|||
156540588|NCT01251653|565073242|FG006|Overall Study|Dose-limiting toxicity|2|||
156540589|NCT01251653|565073243|FG007|Overall Study|Dose-limiting toxicity|0|||
156540590|NCT01251653|565073244|FG008|Overall Study|Dose-limiting toxicity|0|||
156540591|NCT01251653|565073236|FG000|Overall Study|Adverse Event|1|||
156540592|NCT01251653|565073237|FG001|Overall Study|Adverse Event|0|||
156540593|NCT01251653|565073238|FG002|Overall Study|Adverse Event|2|||
156540594|NCT01251653|565073239|FG003|Overall Study|Adverse Event|1|||
156540595|NCT01251653|565073240|FG004|Overall Study|Adverse Event|1|||
156540596|NCT01251653|565073241|FG005|Overall Study|Adverse Event|0|||
156540597|NCT01251653|565073242|FG006|Overall Study|Adverse Event|2|||
156540598|NCT01251653|565073243|FG007|Overall Study|Adverse Event|2|||
156540599|NCT01251653|565073244|FG008|Overall Study|Adverse Event|1|||
156540600|NCT01251653|565073236|FG000|Overall Study|Withdrawal by Subject|1|||
156540601|NCT01251653|565073237|FG001|Overall Study|Withdrawal by Subject|0|||
156540602|NCT01251653|565073238|FG002|Overall Study|Withdrawal by Subject|1|||
156540603|NCT01251653|565073239|FG003|Overall Study|Withdrawal by Subject|0|||
156540604|NCT01251653|565073240|FG004|Overall Study|Withdrawal by Subject|1|||
156540605|NCT01251653|565073241|FG005|Overall Study|Withdrawal by Subject|1|||
156540606|NCT01251653|565073242|FG006|Overall Study|Withdrawal by Subject|0|||
156540607|NCT01251653|565073243|FG007|Overall Study|Withdrawal by Subject|1|||
156540608|NCT01251653|565073244|FG008|Overall Study|Withdrawal by Subject|0|||
156540609|NCT01251653|565073236|FG000|Overall Study|Other reason not mentioned above|0|||
156540610|NCT01251653|565073237|FG001|Overall Study|Other reason not mentioned above|0|||
156540611|NCT01251653|565073238|FG002|Overall Study|Other reason not mentioned above|0|||
156540612|NCT01251653|565073239|FG003|Overall Study|Other reason not mentioned above|0|||
156540613|NCT01251653|565073240|FG004|Overall Study|Other reason not mentioned above|0|||
156540614|NCT01251653|565073241|FG005|Overall Study|Other reason not mentioned above|0|||
156540615|NCT01251653|565073242|FG006|Overall Study|Other reason not mentioned above|0|||
156540616|NCT01251653|565073243|FG007|Overall Study|Other reason not mentioned above|2|||
156540617|NCT01251653|565073244|FG008|Overall Study|Other reason not mentioned above|0|||
156540618|NCT00847145|565073245|FG000|Overall Study|AE or Death|0|||
156540619|NCT00847145|565073246|FG001|Overall Study|AE or Death|1|||
156540620|NCT00847145|565073247|FG002|Overall Study|AE or Death|1|||
156540621|NCT00847145|565073248|FG003|Overall Study|AE or Death|0|||
156540622|NCT00847145|565073249|FG004|Overall Study|AE or Death|0|||
156540623|NCT00847145|565073250|FG005|Overall Study|AE or Death|0|||
156540624|NCT00847145|565073251|FG006|Overall Study|AE or Death|0|||
156540625|NCT00847145|565073252|FG007|Overall Study|AE or Death|0|||
156540626|NCT00847145|565073245|FG000|Overall Study|Withdrawal by Subject|3|||
156540627|NCT00847145|565073246|FG001|Overall Study|Withdrawal by Subject|4|||
156540628|NCT00847145|565073247|FG002|Overall Study|Withdrawal by Subject|6|||
156540629|NCT00847145|565073248|FG003|Overall Study|Withdrawal by Subject|1|||
156465534|NCT03767335|564801565|FG000|Overall Study|Death|0|||
156540630|NCT00847145|565073249|FG004|Overall Study|Withdrawal by Subject|0|||
156540631|NCT00847145|565073250|FG005|Overall Study|Withdrawal by Subject|0|||
156465535|NCT03767335|564801566|FG001|Overall Study|Death|0|||
156465536|NCT03767335|564801567|FG002|Overall Study|Death|2|||
156540632|NCT00847145|565073251|FG006|Overall Study|Withdrawal by Subject|1|||
156540633|NCT00847145|565073252|FG007|Overall Study|Withdrawal by Subject|1|||
156540634|NCT00847145|565073245|FG000|Overall Study|Lost to Follow-up|3|||
156540635|NCT00847145|565073246|FG001|Overall Study|Lost to Follow-up|1|||
156540636|NCT00847145|565073247|FG002|Overall Study|Lost to Follow-up|1|||
156540637|NCT00847145|565073248|FG003|Overall Study|Lost to Follow-up|0|||
156540638|NCT00847145|565073249|FG004|Overall Study|Lost to Follow-up|4|||
156540639|NCT00847145|565073250|FG005|Overall Study|Lost to Follow-up|4|||
156540640|NCT00847145|565073251|FG006|Overall Study|Lost to Follow-up|8|||
156540641|NCT00847145|565073252|FG007|Overall Study|Lost to Follow-up|2|||
156540642|NCT00847145|565073245|FG000|Overall Study|Inappropriate enrollment|0|||
156540643|NCT00847145|565073246|FG001|Overall Study|Inappropriate enrollment|0|||
156540644|NCT00847145|565073247|FG002|Overall Study|Inappropriate enrollment|0|||
156540645|NCT00847145|565073248|FG003|Overall Study|Inappropriate enrollment|0|||
156540646|NCT00847145|565073249|FG004|Overall Study|Inappropriate enrollment|1|||
156540647|NCT00847145|565073250|FG005|Overall Study|Inappropriate enrollment|0|||
156540648|NCT00847145|565073251|FG006|Overall Study|Inappropriate enrollment|0|||
156540649|NCT00847145|565073252|FG007|Overall Study|Inappropriate enrollment|0|||
156540650|NCT00847145|565073245|FG000|Overall Study|Protocol Violation|0|||
156540651|NCT00847145|565073246|FG001|Overall Study|Protocol Violation|0|||
156540652|NCT00847145|565073247|FG002|Overall Study|Protocol Violation|3|||
156540653|NCT00847145|565073248|FG003|Overall Study|Protocol Violation|0|||
156540654|NCT00847145|565073249|FG004|Overall Study|Protocol Violation|1|||
156540655|NCT00847145|565073250|FG005|Overall Study|Protocol Violation|0|||
156540656|NCT00847145|565073251|FG006|Overall Study|Protocol Violation|0|||
156540657|NCT00847145|565073252|FG007|Overall Study|Protocol Violation|1|||
156540658|NCT02833974|565073253|FG000|Overall Study|Lost to Follow-up|1|||
156540659|NCT02833974|565073254|FG001|Overall Study|Lost to Follow-up|0|||
156540660|NCT02833974|565073253|FG000|Overall Study|Adverse Event|0|||
156540661|NCT02833974|565073254|FG001|Overall Study|Adverse Event|3|||
156540662|NCT01502709|565073256|FG000|Overall Study|Lost to Follow-up|4|||
156540663|NCT01502709|565073257|FG001|Overall Study|Lost to Follow-up|0|||
156540664|NCT00346073|565073259|FG000|Overall Study|Serious Adverse Event|2|||
156540665|NCT00346073|565073260|FG001|Overall Study|Serious Adverse Event|0|||
156540666|NCT00346073|565073259|FG000|Overall Study|Lost to Follow-up|39|||
156540667|NCT00346073|565073260|FG001|Overall Study|Lost to Follow-up|24|||
156540668|NCT00980200|565073262|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
156540669|NCT00980200|565073263|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
156540670|NCT00980200|565073264|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
156540671|NCT00980200|565073265|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
156540672|NCT00980200|565073266|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
156540673|NCT00980200|565073262|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
156540674|NCT00980200|565073263|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
156540675|NCT00980200|565073264|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
156540676|NCT00980200|565073265|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
156540677|NCT00980200|565073266|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
156540678|NCT01617460|565073267|FG000|Overall Study|Adverse Event|10|||
156540679|NCT01617460|565073267|FG000|Overall Study|Physician Decision|16|||
156540680|NCT01617460|565073267|FG000|Overall Study|Protocol Violation|5|||
156540681|NCT01617460|565073267|FG000|Overall Study|Withdrawal by Subject|9|||
156540682|NCT00457015|565073269|FG000|Overall Study|Left study site against medical advice|0|||
156540683|NCT00457015|565073270|FG001|Overall Study|Left study site against medical advice|1|||
156540684|NCT03670953|565073271|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
156540685|NCT03670953|565073272|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
156540686|NCT03670953|565073273|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
156540687|NCT03670953|565073274|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
156540688|NCT03670953|565073271|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
156540689|NCT03670953|565073272|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
156540690|NCT03670953|565073273|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
156540691|NCT03670953|565073274|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
156540692|NCT03670953|565073271|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
156540693|NCT03670953|565073272|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
156540694|NCT03670953|565073273|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
156540695|NCT03670953|565073274|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
156540696|NCT03670953|565073271|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
156540697|NCT03670953|565073272|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
156540698|NCT03670953|565073273|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
156540699|NCT03670953|565073274|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
156540700|NCT03670953|565073271|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
156540701|NCT03670953|565073272|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
156540702|NCT03670953|565073273|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
156540703|NCT03670953|565073274|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
156540704|NCT03670953|565073271|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
156465537|NCT03767335|564801565|FG000|Overall Study|Progressive Disease|2|||
156540705|NCT03670953|565073272|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
156540706|NCT03670953|565073273|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
156540707|NCT03670953|565073274|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
156540708|NCT03670953|565073271|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
156540709|NCT03670953|565073272|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
156540710|NCT03670953|565073273|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
156465538|NCT03767335|564801566|FG001|Overall Study|Progressive Disease|2|||
156465539|NCT03767335|564801567|FG002|Overall Study|Progressive Disease|2|||
156465540|NCT03767335|564801565|FG000|Overall Study|Disease progression needing additional medication|0|||
156540711|NCT03670953|565073274|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
156540712|NCT03670953|565073271|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
156540713|NCT03670953|565073272|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
156540714|NCT03670953|565073273|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
156540715|NCT03670953|565073274|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
156540716|NCT03670953|565073271|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
156540717|NCT03670953|565073272|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
156540718|NCT03670953|565073273|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
156540719|NCT03670953|565073274|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
156540720|NCT03670953|565073271|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
156540721|NCT03670953|565073272|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
156540722|NCT03670953|565073273|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
156540723|NCT03670953|565073274|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
156540724|NCT03670953|565073271|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
156540725|NCT03670953|565073272|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
156540726|NCT03670953|565073273|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
156540727|NCT03670953|565073274|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
156540728|NCT03670953|565073271|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
156540729|NCT03670953|565073272|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
156540730|NCT03670953|565073273|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
156540731|NCT03670953|565073274|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
156540732|NCT03670953|565073271|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
156540733|NCT03670953|565073272|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
156540734|NCT03670953|565073273|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
156540735|NCT03670953|565073274|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
156540736|NCT03670953|565073271|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
156540737|NCT03670953|565073272|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
156540738|NCT03670953|565073273|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
156540739|NCT03670953|565073274|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
156540740|NCT03670953|565073271|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
156540741|NCT03670953|565073272|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
156540742|NCT03670953|565073273|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
156540743|NCT03670953|565073274|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
156540744|NCT03670953|565073271|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
156540745|NCT03670953|565073272|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
156540746|NCT03670953|565073273|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
156540747|NCT03670953|565073274|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
156540748|NCT03670953|565073271|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
156540749|NCT03670953|565073272|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
156540750|NCT03670953|565073273|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
156540751|NCT03670953|565073274|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
156540752|NCT03670953|565073271|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
156540753|NCT03670953|565073272|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
156540754|NCT03670953|565073273|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
156540755|NCT03670953|565073274|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
156540756|NCT04179734|565073275|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
156540757|NCT04179734|565073276|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
156540758|NCT04179734|565073275|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
156540759|NCT04179734|565073276|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
156540760|NCT00937937|565073278|FG000|Overall Study|Adverse Event|6|||
156540761|NCT00937937|565073278|FG000|Overall Study|Withdrawal by Subject|2|||
156540762|NCT00937937|565073278|FG000|Overall Study|Progression/relapse|61|||
156540763|NCT00937937|565073278|FG000|Overall Study|Death|1|||
156540764|NCT00937937|565073278|FG000|Overall Study|Other|2|||
156540765|NCT03197493|565073280|FG000|Overall Study|Withdrawal by Subject|5|||
156540766|NCT00054704|565073281|FG000|Overall Study|Lack of Efficacy|2|||
156540767|NCT00054704|565073282|FG001|Overall Study|Lack of Efficacy|3|||
156540768|NCT00054704|565073281|FG000|Overall Study|Adverse Event|3|||
156540769|NCT00054704|565073282|FG001|Overall Study|Adverse Event|1|||
156540770|NCT00054704|565073281|FG000|Overall Study|Lost to Follow-up|0|||
156540771|NCT00054704|565073282|FG001|Overall Study|Lost to Follow-up|1|||
156540772|NCT00362414|565073285|FG000|Overall Study|Death|2|||
156540773|NCT00362414|565073285|FG000|Overall Study|Adverse Event|1|||
156540774|NCT02603120|565073286|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
156817666|NCT02993822|566081310|FG002|Overall Study|Protocol Violation|0|||
156465541|NCT03767335|564801566|FG001|Overall Study|Disease progression needing additional medication|0|||
156465542|NCT03767335|564801567|FG002|Overall Study|Disease progression needing additional medication|17|||
156465543|NCT03767335|564801565|FG000|Overall Study|Sponsor decision|0|||
156465544|NCT03767335|564801566|FG001|Overall Study|Sponsor decision|0|||
156540775|NCT02603120|565073287|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
156540776|NCT02603120|565073286|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
156540777|NCT02603120|565073287|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
156540778|NCT02603120|565073286|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
156540779|NCT02603120|565073287|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
156540780|NCT02603120|565073286|FG000|Double-Blind Treatment Phase|Death|2|||
156540781|NCT02603120|565073287|FG001|Double-Blind Treatment Phase|Death|0|||
156540782|NCT02603120|565073286|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
156540783|NCT02603120|565073287|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
156540784|NCT02603120|565073286|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
156540785|NCT02603120|565073287|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
156540786|NCT02603120|565073286|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
156540787|NCT02603120|565073287|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
156540788|NCT02603120|565073286|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
156540789|NCT02603120|565073287|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
156540790|NCT02603120|565073286|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
156540791|NCT02603120|565073287|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
156540792|NCT02603120|565073286|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
156540793|NCT02603120|565073287|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
156540794|NCT02603120|565073286|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
156540795|NCT02603120|565073287|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
156540796|NCT02603120|565073286|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
156540797|NCT02603120|565073287|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
156540798|NCT02603120|565073286|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
156540799|NCT02603120|565073287|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
156540800|NCT02603120|565073286|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
156540801|NCT02603120|565073287|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
156540802|NCT01469182|565073290|FG000|Overall Study|Adverse Event|21|||
156540803|NCT01469182|565073291|FG001|Overall Study|Adverse Event|3|||
156540804|NCT01469182|565073290|FG000|Overall Study|Lost to Follow-up|3|||
156540805|NCT01469182|565073291|FG001|Overall Study|Lost to Follow-up|0|||
156540806|NCT01469182|565073290|FG000|Overall Study|Withdrawal by Subject|4|||
156540807|NCT01469182|565073291|FG001|Overall Study|Withdrawal by Subject|1|||
156540808|NCT01469182|565073290|FG000|Overall Study|Protocol Violation|4|||
156540809|NCT01469182|565073291|FG001|Overall Study|Protocol Violation|2|||
156540810|NCT01469182|565073290|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
156540811|NCT01469182|565073291|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
156540812|NCT01785160|565073293|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
156540813|NCT01785160|565073293|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
156540814|NCT01263483|565073294|FG000|Overall Study|Adverse Event|4|||
156540815|NCT01263483|565073295|FG001|Overall Study|Adverse Event|0|||
156540816|NCT01263483|565073296|FG002|Overall Study|Adverse Event|3|||
156540817|NCT01263483|565073294|FG000|Overall Study|Withdrawal by Subject|1|||
156540818|NCT01263483|565073295|FG001|Overall Study|Withdrawal by Subject|0|||
156540819|NCT01263483|565073296|FG002|Overall Study|Withdrawal by Subject|0|||
156540820|NCT01263483|565073294|FG000|Overall Study|Lack of Efficacy|2|||
156540821|NCT01263483|565073295|FG001|Overall Study|Lack of Efficacy|0|||
156540822|NCT01263483|565073296|FG002|Overall Study|Lack of Efficacy|0|||
156540823|NCT01263483|565073294|FG000|Overall Study|Protocol Violation|0|||
156540824|NCT01263483|565073295|FG001|Overall Study|Protocol Violation|1|||
156540825|NCT01263483|565073296|FG002|Overall Study|Protocol Violation|1|||
156540826|NCT01263483|565073294|FG000|Overall Study|Participant Unavailability|0|||
156540827|NCT01263483|565073295|FG001|Overall Study|Participant Unavailability|1|||
156540828|NCT01263483|565073296|FG002|Overall Study|Participant Unavailability|1|||
156540829|NCT05500274|565073302|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
156540830|NCT05500274|565073303|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
156540831|NCT05500274|565073302|FG000|Overall Study|Lost to Follow-up|76|||
156540832|NCT05500274|565073303|FG001|Overall Study|Lost to Follow-up|51|||
156540833|NCT05807464|565073306|FG000|Overall Study|Adverse Event|1|||
156540834|NCT01555151|565073307|FG000|Overall Study|Withdrawal by Subject|6|||
156540835|NCT01555151|565073308|FG001|Overall Study|Withdrawal by Subject|2|||
156540836|NCT01555151|565073309|FG002|Overall Study|Withdrawal by Subject|0|||
156540837|NCT01555151|565073310|FG003|Overall Study|Withdrawal by Subject|2|||
156540838|NCT01555151|565073307|FG000|Overall Study|Administrative|3|||
156540839|NCT01555151|565073308|FG001|Overall Study|Administrative|1|||
156540840|NCT01555151|565073309|FG002|Overall Study|Administrative|2|||
156540841|NCT01555151|565073310|FG003|Overall Study|Administrative|0|||
156540842|NCT01555151|565073307|FG000|Overall Study|Protocol Violation|3|||
156540843|NCT01555151|565073308|FG001|Overall Study|Protocol Violation|3|||
156540844|NCT01555151|565073309|FG002|Overall Study|Protocol Violation|3|||
156540845|NCT01555151|565073310|FG003|Overall Study|Protocol Violation|5|||
156540846|NCT01555151|565073307|FG000|Overall Study|Adverse Event|1|||
156540847|NCT01555151|565073308|FG001|Overall Study|Adverse Event|2|||
156540848|NCT01555151|565073309|FG002|Overall Study|Adverse Event|1|||
156540849|NCT01555151|565073310|FG003|Overall Study|Adverse Event|2|||
156540850|NCT01555151|565073307|FG000|Overall Study|Lost to Follow-up|0|||
156540851|NCT01555151|565073308|FG001|Overall Study|Lost to Follow-up|0|||
156540852|NCT01555151|565073309|FG002|Overall Study|Lost to Follow-up|0|||
156540853|NCT01555151|565073310|FG003|Overall Study|Lost to Follow-up|1|||
156540854|NCT03596866|565073311|FG000|Overall Study|Site terminated by Sponsor|64|||
156540855|NCT03596866|565073312|FG001|Overall Study|Site terminated by Sponsor|65|||
156540856|NCT03596866|565073311|FG000|Overall Study|Death|37|||
156540857|NCT03596866|565073312|FG001|Overall Study|Death|24|||
156540858|NCT03596866|565073311|FG000|Overall Study|Withdrawal by Subject|4|||
156540859|NCT03596866|565073312|FG001|Overall Study|Withdrawal by Subject|6|||
156540860|NCT03596866|565073311|FG000|Overall Study|Missing|0|||
156540861|NCT03596866|565073312|FG001|Overall Study|Missing|6|||
156540862|NCT03596866|565073311|FG000|Overall Study|Lost to Follow-up|2|||
156540863|NCT03596866|565073312|FG001|Overall Study|Lost to Follow-up|3|||
156540864|NCT03596866|565073311|FG000|Overall Study|Protocol Violation|1|||
156540865|NCT03596866|565073312|FG001|Overall Study|Protocol Violation|0|||
156540866|NCT03596866|565073311|FG000|Overall Study|Reason Not Specified|14|||
156540867|NCT03596866|565073312|FG001|Overall Study|Reason Not Specified|13|||
156540868|NCT02114268|565073314|FG000|Overall Study|Lost to Follow-up|4|||
156540869|NCT02114268|565073315|FG001|Overall Study|Lost to Follow-up|1|||
156540870|NCT02114268|565073316|FG002|Overall Study|Lost to Follow-up|1|||
156540871|NCT02114268|565073317|FG003|Overall Study|Lost to Follow-up|0|||
156540872|NCT02114268|565073318|FG004|Overall Study|Lost to Follow-up|0|||
156540873|NCT02114268|565073319|FG005|Overall Study|Lost to Follow-up|2|||
156540874|NCT02114268|565073314|FG000|Overall Study|Withdrawal by Subject|1|||
156540875|NCT02114268|565073315|FG001|Overall Study|Withdrawal by Subject|0|||
156540876|NCT02114268|565073316|FG002|Overall Study|Withdrawal by Subject|0|||
156540877|NCT02114268|565073317|FG003|Overall Study|Withdrawal by Subject|0|||
156540878|NCT02114268|565073318|FG004|Overall Study|Withdrawal by Subject|0|||
156540879|NCT02114268|565073319|FG005|Overall Study|Withdrawal by Subject|1|||
156540880|NCT02114268|565073314|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
156339044|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
156339045|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
156339046|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
156339047|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
156540881|NCT02114268|565073315|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
156540882|NCT02114268|565073316|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
156339048|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
156339049|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
156339050|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
156339051|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
156339052|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
156339053|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
156339054|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
156339055|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
156339056|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
156339057|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
156339058|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
156339059|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
156339060|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
156339061|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
156540883|NCT02114268|565073317|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
156540884|NCT02114268|565073318|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
156540885|NCT02114268|565073319|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
156540886|NCT01431274|565073324|FG000|Overall Study|Adverse Event|51|||
156540887|NCT01431274|565073325|FG001|Overall Study|Adverse Event|37|||
156540888|NCT01431274|565073326|FG002|Overall Study|Adverse Event|43|||
156540889|NCT01431274|565073327|FG003|Overall Study|Adverse Event|30|||
156339062|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
156465545|NCT03767335|564801567|FG002|Overall Study|Sponsor decision|2|||
156540890|NCT01431274|565073328|FG004|Overall Study|Adverse Event|37|||
156540891|NCT01431274|565073324|FG000|Overall Study|Consent withdrawn not due to AE|29|||
156540892|NCT01431274|565073325|FG001|Overall Study|Consent withdrawn not due to AE|20|||
156540893|NCT01431274|565073326|FG002|Overall Study|Consent withdrawn not due to AE|17|||
156540894|NCT01431274|565073327|FG003|Overall Study|Consent withdrawn not due to AE|20|||
156540895|NCT01431274|565073328|FG004|Overall Study|Consent withdrawn not due to AE|11|||
156540896|NCT01431274|565073324|FG000|Overall Study|Non compliant with protocol|5|||
156540897|NCT01431274|565073325|FG001|Overall Study|Non compliant with protocol|8|||
156540898|NCT01431274|565073326|FG002|Overall Study|Non compliant with protocol|4|||
156540899|NCT01431274|565073327|FG003|Overall Study|Non compliant with protocol|4|||
156339063|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
156465546|NCT03767335|564801565|FG000|Overall Study|Other Medical Reasons|0|||
156540900|NCT01431274|565073328|FG004|Overall Study|Non compliant with protocol|4|||
156540901|NCT01431274|565073324|FG000|Overall Study|Lost to Follow-up|6|||
156540902|NCT01431274|565073325|FG001|Overall Study|Lost to Follow-up|7|||
156540903|NCT01431274|565073326|FG002|Overall Study|Lost to Follow-up|1|||
156540904|NCT01431274|565073327|FG003|Overall Study|Lost to Follow-up|4|||
156540905|NCT01431274|565073328|FG004|Overall Study|Lost to Follow-up|0|||
156540906|NCT01431274|565073324|FG000|Overall Study|Other reason not stated above|6|||
156540907|NCT01431274|565073325|FG001|Overall Study|Other reason not stated above|5|||
156465547|NCT03767335|564801566|FG001|Overall Study|Other Medical Reasons|0|||
156465548|NCT03767335|564801567|FG002|Overall Study|Other Medical Reasons|3|||
156465549|NCT03705390|564801568|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
156465550|NCT03705390|564801568|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
156465551|NCT03660930|564801569|FG000|Overall Study|Adverse Event|0|||
156540908|NCT01431274|565073326|FG002|Overall Study|Other reason not stated above|7|||
156540909|NCT01431274|565073327|FG003|Overall Study|Other reason not stated above|2|||
156540910|NCT01431274|565073328|FG004|Overall Study|Other reason not stated above|4|||
156540911|NCT00003702|565073329|FG000|Overall Study|Ineligible cell types|2|||
156540912|NCT00003702|565073330|FG001|Overall Study|Ineligible cell types|2|||
156540913|NCT00003702|565073329|FG000|Overall Study|Did not meet criteria for persistence|8|||
156540914|NCT00003702|565073330|FG001|Overall Study|Did not meet criteria for persistence|5|||
156540915|NCT00003702|565073329|FG000|Overall Study|WHO score > 6|2|||
156540916|NCT00003702|565073330|FG001|Overall Study|WHO score > 6|1|||
156540917|NCT00003702|565073329|FG000|Overall Study|Inadequate documentation of disease|1|||
156540918|NCT00003702|565073330|FG001|Overall Study|Inadequate documentation of disease|3|||
156540919|NCT02790138|565073331|FG000|Overall Study|Adverse Event|5|||
156540920|NCT02790138|565073332|FG001|Overall Study|Adverse Event|2|||
156540921|NCT02790138|565073331|FG000|Overall Study|Significant Protocol Deviation|0|||
156540922|NCT02790138|565073332|FG001|Overall Study|Significant Protocol Deviation|1|||
156540923|NCT02790138|565073331|FG000|Overall Study|Lost to Follow-up|1|||
156540924|NCT02790138|565073332|FG001|Overall Study|Lost to Follow-up|0|||
156540925|NCT02790138|565073331|FG000|Overall Study|Voluntary Withdrawal|8|||
156540926|NCT02790138|565073332|FG001|Overall Study|Voluntary Withdrawal|9|||
156540927|NCT02790138|565073331|FG000|Overall Study|Lack of Efficacy|6|||
156540928|NCT02790138|565073332|FG001|Overall Study|Lack of Efficacy|7|||
156540929|NCT02790138|565073331|FG000|Overall Study|Reason not Specified|1|||
156540930|NCT02790138|565073332|FG001|Overall Study|Reason not Specified|0|||
156540931|NCT04037748|565073333|FG000|Treatment Period 1|Withdrawal by Subject|3|||
156540932|NCT04037748|565073334|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156540933|NCT04037748|565073333|FG000|Treatment Period 1|Adverse Event|1|||
156540934|NCT04037748|565073334|FG001|Treatment Period 1|Adverse Event|1|||
156540935|NCT04037748|565073333|FG000|Treatment Period 1|Protocol Violation|4|||
156540936|NCT04037748|565073334|FG001|Treatment Period 1|Protocol Violation|5|||
156540937|NCT04037748|565073333|FG000|Treatment Period 2|Adverse Event|0|||
156540938|NCT04037748|565073334|FG001|Treatment Period 2|Adverse Event|1|||
156540939|NCT04037748|565073333|FG000|Treatment Period 2|Protocol Violation|2|||
156540940|NCT04037748|565073334|FG001|Treatment Period 2|Protocol Violation|0|||
156540941|NCT04702737|565073335|FG000|Overall Study|Decision by Sponsor|1|||
156540942|NCT04702737|565073335|FG000|Overall Study|Withdrawal of Consent from Study|3|||
156540943|NCT04702737|565073335|FG000|Overall Study|Lost to Follow-up|1|||
156540944|NCT04702737|565073335|FG000|Overall Study|Death|35|||
156540945|NCT02047253|565073336|FG000|Overall Study|Lost to Follow-up|8|||
156540946|NCT03472924|565073338|FG000|Overall Study|Adverse Event|1|||
156540947|NCT03472924|565073339|FG001|Overall Study|Adverse Event|0|||
156540948|NCT00807742|565073346|FG000|Overall Study|Death|9|||
156540949|NCT00807742|565073347|FG001|Overall Study|Death|2|||
156540950|NCT00807742|565073346|FG000|Overall Study|Withdrawal by Subject|2|||
156540951|NCT00807742|565073347|FG001|Overall Study|Withdrawal by Subject|1|||
156540952|NCT00807742|565073346|FG000|Overall Study|Lost to Follow-up|35|||
156540953|NCT00807742|565073347|FG001|Overall Study|Lost to Follow-up|51|||
156339064|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
156339065|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
156465552|NCT03660930|564801570|FG001|Overall Study|Adverse Event|0|||
156339066|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
156465553|NCT03660930|564801571|FG002|Overall Study|Adverse Event|0|||
156465554|NCT03660930|564801572|FG003|Overall Study|Adverse Event|2|||
156540954|NCT04814823|565073349|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
156540955|NCT05318937|565073350|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156465555|NCT03660930|564801573|FG004|Overall Study|Adverse Event|0|||
156540956|NCT05318937|565073351|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156540957|NCT05318937|565073350|FG000|Overall Study|Lost to Follow-up|0|||
156540958|NCT05318937|565073351|FG001|Overall Study|Lost to Follow-up|1|||
156540959|NCT05318937|565073350|FG000|Overall Study|Withdrawal by Subject|0|||
156540960|NCT05318937|565073351|FG001|Overall Study|Withdrawal by Subject|2|||
156540961|NCT05318937|565073350|FG000|Overall Study|Protocol Violation|0|||
156540962|NCT05318937|565073351|FG001|Overall Study|Protocol Violation|1|||
156540963|NCT01877915|565073352|FG000|Overall Study|Lost to Follow-up|10|||
156540964|NCT01877915|565073353|FG001|Overall Study|Lost to Follow-up|9|||
156540965|NCT01877915|565073352|FG000|Overall Study|Withdrawal by Subject|42|||
156540966|NCT01877915|565073353|FG001|Overall Study|Withdrawal by Subject|55|||
156540967|NCT01877915|565073352|FG000|Overall Study|Other|2|||
156540968|NCT01877915|565073353|FG001|Overall Study|Other|4|||
156540969|NCT05678257|565073358|FG000|Overall Study|Withdrawal by Subject|2|||
156540970|NCT05678257|565073359|FG001|Overall Study|Withdrawal by Subject|0|||
156540971|NCT05678257|565073360|FG002|Overall Study|Withdrawal by Subject|5|||
156540972|NCT05678257|565073358|FG000|Overall Study|Physician Decision|1|||
156540973|NCT05678257|565073359|FG001|Overall Study|Physician Decision|0|||
156540974|NCT05678257|565073360|FG002|Overall Study|Physician Decision|1|||
156540975|NCT05678257|565073358|FG000|Overall Study|Adverse Event|1|||
156540976|NCT05678257|565073359|FG001|Overall Study|Adverse Event|3|||
156540977|NCT05678257|565073360|FG002|Overall Study|Adverse Event|1|||
156540978|NCT05678257|565073358|FG000|Overall Study|Progressive disease|11|||
156540979|NCT05678257|565073359|FG001|Overall Study|Progressive disease|18|||
156540980|NCT05678257|565073360|FG002|Overall Study|Progressive disease|7|||
156540981|NCT05678257|565073358|FG000|Overall Study|No longer clinically benefitting|2|||
156540982|NCT05678257|565073359|FG001|Overall Study|No longer clinically benefitting|1|||
156540983|NCT05678257|565073360|FG002|Overall Study|No longer clinically benefitting|0|||
156540984|NCT05678257|565073358|FG000|Overall Study|Sponsor decision|5|||
156540985|NCT05678257|565073359|FG001|Overall Study|Sponsor decision|9|||
156540986|NCT05678257|565073360|FG002|Overall Study|Sponsor decision|8|||
156540987|NCT05678257|565073358|FG000|Overall Study|Protocol Violation|0|||
156540988|NCT05678257|565073359|FG001|Overall Study|Protocol Violation|0|||
156540989|NCT05678257|565073360|FG002|Overall Study|Protocol Violation|1|||
156540990|NCT05678257|565073358|FG000|Overall Study|Patient non-compliance|0|||
156540991|NCT05678257|565073359|FG001|Overall Study|Patient non-compliance|0|||
156540992|NCT05678257|565073360|FG002|Overall Study|Patient non-compliance|3|||
156540993|NCT03520959|565073361|FG000|Overall Study|Study terminated by Sponsor|0|||
156540994|NCT03520959|565073362|FG001|Overall Study|Study terminated by Sponsor|1|||
156540995|NCT01045798|565073363|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
156540996|NCT01045798|565073364|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
156540997|NCT01045798|565073363|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
156540998|NCT01045798|565073364|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
156540999|NCT01045798|565073363|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
156541000|NCT01045798|565073364|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
156541001|NCT01045798|565073363|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
156541002|NCT01045798|565073364|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
156541003|NCT01449461|565073365|FG000|Overall Study|Adverse Event|0|||
156541004|NCT01449461|565073366|FG001|Overall Study|Adverse Event|3|||
156541005|NCT01449461|565073367|FG002|Overall Study|Adverse Event|2|||
156541006|NCT01449461|565073368|FG003|Overall Study|Adverse Event|3|||
156541007|NCT01449461|565073369|FG004|Overall Study|Adverse Event|4|||
156541008|NCT01449461|565073370|FG005|Overall Study|Adverse Event|4|||
156541009|NCT01449461|565073365|FG000|Overall Study|Death|0|||
156541010|NCT01449461|565073366|FG001|Overall Study|Death|2|||
156541011|NCT01449461|565073367|FG002|Overall Study|Death|0|||
156541012|NCT01449461|565073368|FG003|Overall Study|Death|0|||
156541013|NCT01449461|565073369|FG004|Overall Study|Death|7|||
156541014|NCT01449461|565073370|FG005|Overall Study|Death|1|||
156541015|NCT01449461|565073365|FG000|Overall Study|Physician Decision|0|||
156541016|NCT01449461|565073366|FG001|Overall Study|Physician Decision|1|||
156541017|NCT01449461|565073367|FG002|Overall Study|Physician Decision|0|||
156541018|NCT01449461|565073368|FG003|Overall Study|Physician Decision|4|||
156541019|NCT01449461|565073369|FG004|Overall Study|Physician Decision|1|||
156541020|NCT01449461|565073370|FG005|Overall Study|Physician Decision|0|||
156541021|NCT01449461|565073365|FG000|Overall Study|Documented Progressive Disease|4|||
156541022|NCT01449461|565073366|FG001|Overall Study|Documented Progressive Disease|7|||
156541023|NCT01449461|565073367|FG002|Overall Study|Documented Progressive Disease|14|||
156541024|NCT01449461|565073368|FG003|Overall Study|Documented Progressive Disease|15|||
156541025|NCT01449461|565073369|FG004|Overall Study|Documented Progressive Disease|24|||
156541026|NCT01449461|565073370|FG005|Overall Study|Documented Progressive Disease|5|||
156541027|NCT01449461|565073365|FG000|Overall Study|Clinical Progressive Disease|2|||
156541028|NCT01449461|565073366|FG001|Overall Study|Clinical Progressive Disease|2|||
156541029|NCT01449461|565073367|FG002|Overall Study|Clinical Progressive Disease|0|||
156541030|NCT01449461|565073368|FG003|Overall Study|Clinical Progressive Disease|3|||
156541031|NCT01449461|565073369|FG004|Overall Study|Clinical Progressive Disease|4|||
156541032|NCT01449461|565073370|FG005|Overall Study|Clinical Progressive Disease|2|||
156541033|NCT01449461|565073365|FG000|Overall Study|Protocol Violation|0|||
156541034|NCT01449461|565073366|FG001|Overall Study|Protocol Violation|0|||
156541035|NCT01449461|565073367|FG002|Overall Study|Protocol Violation|0|||
156541036|NCT01449461|565073368|FG003|Overall Study|Protocol Violation|1|||
156541037|NCT01449461|565073369|FG004|Overall Study|Protocol Violation|0|||
156541038|NCT01449461|565073370|FG005|Overall Study|Protocol Violation|0|||
156541039|NCT01449461|565073365|FG000|Overall Study|Site Terminated by Sponsor|0|||
156541040|NCT01449461|565073366|FG001|Overall Study|Site Terminated by Sponsor|1|||
156541041|NCT01449461|565073367|FG002|Overall Study|Site Terminated by Sponsor|2|||
156541042|NCT01449461|565073368|FG003|Overall Study|Site Terminated by Sponsor|3|||
156541043|NCT01449461|565073369|FG004|Overall Study|Site Terminated by Sponsor|4|||
156541044|NCT01449461|565073370|FG005|Overall Study|Site Terminated by Sponsor|1|||
156541045|NCT01449461|565073365|FG000|Overall Study|Withdrawal by Subject|0|||
156541046|NCT01449461|565073366|FG001|Overall Study|Withdrawal by Subject|1|||
156541047|NCT01449461|565073367|FG002|Overall Study|Withdrawal by Subject|0|||
156541048|NCT01449461|565073368|FG003|Overall Study|Withdrawal by Subject|0|||
156541049|NCT01449461|565073369|FG004|Overall Study|Withdrawal by Subject|2|||
156541050|NCT01449461|565073370|FG005|Overall Study|Withdrawal by Subject|1|||
156541051|NCT01449461|565073365|FG000|Overall Study|Reason not Specified|0|||
156541052|NCT01449461|565073366|FG001|Overall Study|Reason not Specified|1|||
156541053|NCT01449461|565073367|FG002|Overall Study|Reason not Specified|0|||
156541054|NCT01449461|565073368|FG003|Overall Study|Reason not Specified|3|||
156541055|NCT01449461|565073369|FG004|Overall Study|Reason not Specified|2|||
156541056|NCT01449461|565073370|FG005|Overall Study|Reason not Specified|1|||
156541057|NCT02236520|565074467|FG000|Overall Study|Physician Decision|0|||
156541058|NCT02236520|565074468|FG001|Overall Study|Physician Decision|5|||
156541059|NCT02236520|565074469|FG002|Overall Study|Physician Decision|0|||
156541060|NCT02236520|565074470|FG003|Overall Study|Physician Decision|0|||
156541061|NCT02236520|565074467|FG000|Overall Study|Withdrawal by Subject|1|||
156541062|NCT02236520|565074468|FG001|Overall Study|Withdrawal by Subject|0|||
156541063|NCT02236520|565074469|FG002|Overall Study|Withdrawal by Subject|0|||
156541064|NCT02236520|565074470|FG003|Overall Study|Withdrawal by Subject|1|||
156541065|NCT02236520|565074467|FG000|Overall Study|Pregnancy|1|||
156541066|NCT02236520|565074468|FG001|Overall Study|Pregnancy|0|||
156541067|NCT02236520|565074469|FG002|Overall Study|Pregnancy|0|||
156541068|NCT02236520|565074470|FG003|Overall Study|Pregnancy|0|||
156541069|NCT00916357|565074471|FG000|Period 1|Withdrawal by Subject|1|||
156541070|NCT00916357|565074472|FG001|Period 1|Withdrawal by Subject|0|||
156541071|NCT00916357|565074473|FG002|Period 1|Withdrawal by Subject|0|||
156541072|NCT00916357|565074474|FG003|Period 1|Withdrawal by Subject|0|||
156541073|NCT00916357|565074475|FG004|Period 1|Withdrawal by Subject|0|||
156541074|NCT00916357|565074476|FG005|Period 1|Withdrawal by Subject|0|||
156541075|NCT00916357|565074471|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
156541076|NCT00916357|565074472|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
156541077|NCT00916357|565074473|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
156541078|NCT00916357|565074474|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
156541079|NCT00916357|565074475|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
156817667|NCT02993822|566081311|FG003|Overall Study|Protocol Violation|0|||
156817668|NCT02993822|566081308|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
156817669|NCT02993822|566081309|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
156817670|NCT02993822|566081310|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
156817671|NCT02993822|566081311|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
156817672|NCT02993822|566081308|FG000|Overall Study|Adverse Event|3|||
156817673|NCT02993822|566081309|FG001|Overall Study|Adverse Event|1|||
156817674|NCT02993822|566081310|FG002|Overall Study|Adverse Event|7|||
156817675|NCT02993822|566081311|FG003|Overall Study|Adverse Event|0|||
156817676|NCT02993822|566081308|FG000|Overall Study|Withdrawal by Subject|4|||
156817677|NCT02993822|566081309|FG001|Overall Study|Withdrawal by Subject|2|||
156817678|NCT02993822|566081310|FG002|Overall Study|Withdrawal by Subject|2|||
156817679|NCT02993822|566081311|FG003|Overall Study|Withdrawal by Subject|3|||
156817680|NCT02993822|566081308|FG000|Overall Study|Lost to Follow-up|1|||
156817681|NCT02993822|566081309|FG001|Overall Study|Lost to Follow-up|0|||
156817682|NCT02993822|566081310|FG002|Overall Study|Lost to Follow-up|1|||
156817683|NCT02993822|566081311|FG003|Overall Study|Lost to Follow-up|0|||
156817684|NCT01221753|566081315|FG000|Overall Study|Adverse Event|1|||
156817685|NCT01939977|566081316|FG000|Overall Study|Adverse Event|4|||
156817686|NCT01939977|566081317|FG001|Overall Study|Adverse Event|3|||
156817687|NCT01939977|566081316|FG000|Overall Study|Lack of Efficacy|3|||
156817688|NCT01939977|566081317|FG001|Overall Study|Lack of Efficacy|0|||
156817689|NCT01939977|566081316|FG000|Overall Study|Physician Decision|1|||
156817690|NCT01939977|566081317|FG001|Overall Study|Physician Decision|1|||
156541080|NCT00916357|565074476|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
156541081|NCT03807349|565074479|FG000|Overall Study|Early Study Termination|9|||
156541082|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
156541083|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
156541084|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
156541085|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
156541086|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
156541087|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
156541088|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
156541089|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
156817691|NCT01939977|566081316|FG000|Overall Study|Withdrawal by Subject|0|||
156817692|NCT01939977|566081317|FG001|Overall Study|Withdrawal by Subject|2|||
156817693|NCT01939977|566081316|FG000|Overall Study|Did not meet inclusion criteria|1|||
156817694|NCT01939977|566081317|FG001|Overall Study|Did not meet inclusion criteria|0|||
156817695|NCT01939977|566081316|FG000|Overall Study|Did not receive study medication|0|||
156817696|NCT01939977|566081317|FG001|Overall Study|Did not receive study medication|1|||
156817697|NCT03213938|566081320|FG000|Overall Study|Lost to Follow-up|4|||
156817698|NCT03213938|566081321|FG001|Overall Study|Lost to Follow-up|3|||
156817699|NCT03213938|566081320|FG000|Overall Study|Lack of Efficacy|1|||
156817700|NCT03213938|566081321|FG001|Overall Study|Lack of Efficacy|0|||
156817701|NCT03213938|566081320|FG000|Overall Study|Decline to participate|5|||
156817702|NCT03213938|566081321|FG001|Overall Study|Decline to participate|4|||
156817703|NCT03213938|566081320|FG000|Overall Study|Without reason|4|||
156817704|NCT03213938|566081321|FG001|Overall Study|Without reason|5|||
156817705|NCT01917929|566081322|FG000|Overall Study|Death|8|||
156817706|NCT01917929|566081322|FG000|Overall Study|Lost to Follow-up|19|||
156817707|NCT01917929|566081322|FG000|Overall Study|Withdrawal by Subject|33|||
156817708|NCT01917929|566081322|FG000|Overall Study|Adverse Event|6|||
156817709|NCT01917929|566081322|FG000|Overall Study|Investigative Site Terminated|35|||
156817710|NCT01917929|566081322|FG000|Overall Study|Censored because study device not implanted|6|||
156817711|NCT01917929|566081322|FG000|Overall Study|Censored because surgery not performed|3|||
156817712|NCT01917929|566081322|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
156817713|NCT01917929|566081322|FG000|Overall Study|Sponsor terminated study|175|||
156817714|NCT01854775|566081323|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
156817715|NCT01854775|566081324|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
156817716|NCT01854775|566081325|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
156817717|NCT01854775|566081323|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
156817718|NCT01854775|566081324|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
156817719|NCT01854775|566081325|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
156817720|NCT01854775|566081323|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
156817721|NCT01854775|566081324|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
156817722|NCT01854775|566081325|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
156817723|NCT01854775|566081323|FG000|Extension Phase|Pregnancy|3|||
156817724|NCT01854775|566081324|FG001|Extension Phase|Pregnancy|0|||
156817725|NCT01854775|566081325|FG002|Extension Phase|Pregnancy|0|||
156817726|NCT01854775|566081323|FG000|Extension Phase|Investigator's Discretion|1|||
156817727|NCT01854775|566081324|FG001|Extension Phase|Investigator's Discretion|0|||
156817728|NCT01854775|566081325|FG002|Extension Phase|Investigator's Discretion|0|||
156817729|NCT01854775|566081323|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
156817730|NCT01854775|566081324|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
156817731|NCT01854775|566081325|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
156817732|NCT01854775|566081323|FG000|Extension Phase|Lost to Follow-up|2|||
156817733|NCT01854775|566081324|FG001|Extension Phase|Lost to Follow-up|0|||
156817734|NCT01854775|566081325|FG002|Extension Phase|Lost to Follow-up|0|||
156817735|NCT01854775|566081323|FG000|Extension Phase|Still on Study|32|||
156817736|NCT01854775|566081324|FG001|Extension Phase|Still on Study|47|||
156817737|NCT01854775|566081325|FG002|Extension Phase|Still on Study|18|||
156817738|NCT00984594|566081332|FG000|Overall Study|Lost to Follow-up|1|||
156817739|NCT00984594|566081333|FG001|Overall Study|Lost to Follow-up|0|||
156817740|NCT00984594|566081332|FG000|Overall Study|Withdrawal by Subject|0|||
156817741|NCT00984594|566081333|FG001|Overall Study|Withdrawal by Subject|1|||
156817742|NCT00851890|566081334|FG000|Overall Study|Lost to Follow-up|0|||
156817743|NCT00851890|566081335|FG001|Overall Study|Lost to Follow-up|1|||
156817744|NCT00851890|566081336|FG002|Overall Study|Lost to Follow-up|0|||
156817745|NCT00851890|566081337|FG003|Overall Study|Lost to Follow-up|1|||
156817746|NCT03135431|566081338|FG000|Overall Study|Study Surgeon not available|2|||
156817747|NCT03135431|566081339|FG001|Overall Study|Study Surgeon not available|0|||
156817748|NCT01063062|566081340|FG000|Overall Study|Patient withdrew consent|0|||
156817749|NCT01063062|566081341|FG001|Overall Study|Patient withdrew consent|1|||
156817750|NCT01063062|566081340|FG000|Overall Study|Adverse Event|2|||
156817751|NCT01063062|566081341|FG001|Overall Study|Adverse Event|4|||
156817752|NCT01063062|566081340|FG000|Overall Study|Protocol Violation|5|||
156817753|NCT01063062|566081341|FG001|Overall Study|Protocol Violation|4|||
156817754|NCT01063062|566081340|FG000|Overall Study|Investigator's request|1|||
156817755|NCT01063062|566081341|FG001|Overall Study|Investigator's request|0|||
156817756|NCT01063062|566081340|FG000|Overall Study|Lost to Follow-up|0|||
156817757|NCT01063062|566081341|FG001|Overall Study|Lost to Follow-up|2|||
156817758|NCT01063062|566081340|FG000|Overall Study|Miscellaneous reason|0|||
156817759|NCT01063062|566081341|FG001|Overall Study|Miscellaneous reason|1|||
156817760|NCT02015481|566081342|FG000|Overall Study|Death|1|||
156817761|NCT02597452|566081344|FG000|Overall Study|testing incomplete|30|||
156465556|NCT03660930|564801574|FG005|Overall Study|Adverse Event|1|||
156465557|NCT03660930|564801575|FG006|Overall Study|Adverse Event|0|||
156817762|NCT03122145|566081347|FG000|Overall Study|Concurrent respiratory disease|3|||
156817763|NCT03122145|566081348|FG001|Overall Study|Concurrent respiratory disease|0|||
156817764|NCT02016716|566081353|FG000|Overall Study|Withdrawal by Subject|5|||
156465558|NCT03660930|564801576|FG007|Overall Study|Adverse Event|0|||
156465559|NCT03660930|564801569|FG000|Overall Study|Withdrawal by Subject|0|||
156465560|NCT03660930|564801570|FG001|Overall Study|Withdrawal by Subject|0|||
156465561|NCT03660930|564801571|FG002|Overall Study|Withdrawal by Subject|0|||
156817765|NCT02016716|566081354|FG001|Overall Study|Withdrawal by Subject|5|||
156817766|NCT02016716|566081355|FG002|Overall Study|Withdrawal by Subject|5|||
156817767|NCT02016716|566081353|FG000|Overall Study|Protocol-specified Criteria|0|||
156817768|NCT02016716|566081354|FG001|Overall Study|Protocol-specified Criteria|1|||
156817769|NCT02016716|566081355|FG002|Overall Study|Protocol-specified Criteria|0|||
156817770|NCT02016716|566081353|FG000|Overall Study|Lost to Follow-up|1|||
156817771|NCT02016716|566081354|FG001|Overall Study|Lost to Follow-up|2|||
156817772|NCT02016716|566081355|FG002|Overall Study|Lost to Follow-up|1|||
156817773|NCT00079391|566081356|FG000|Overall Study|Withdrawal by Subject|1|||
156817774|NCT01659996|566081357|FG000|Overall Study|Protocol Violation|3|||
156817775|NCT01659996|566081358|FG001|Overall Study|Protocol Violation|3|||
156817776|NCT01659996|566081359|FG002|Overall Study|Protocol Violation|3|||
156817777|NCT01659996|566081357|FG000|Overall Study|Lost to Follow-up|1|||
156817778|NCT01659996|566081358|FG001|Overall Study|Lost to Follow-up|3|||
156817779|NCT01659996|566081359|FG002|Overall Study|Lost to Follow-up|2|||
156817780|NCT01659996|566081357|FG000|Overall Study|Adverse Event|0|||
156817781|NCT01659996|566081358|FG001|Overall Study|Adverse Event|0|||
156817782|NCT01659996|566081359|FG002|Overall Study|Adverse Event|1|||
156817783|NCT01659996|566081357|FG000|Overall Study|Withdrawal by Subject|4|||
156817784|NCT01659996|566081358|FG001|Overall Study|Withdrawal by Subject|1|||
156817785|NCT01659996|566081359|FG002|Overall Study|Withdrawal by Subject|5|||
156817786|NCT03206918|566081360|FG000|Overall Study|Death|11|||
156817787|NCT03206918|566081360|FG000|Overall Study|Withdrawal by Subject|5|||
156817788|NCT03206918|566081360|FG000|Overall Study|Study terminated by sponsor|12|||
156817789|NCT03206918|566081360|FG000|Overall Study|Lost to Follow-up|3|||
156817790|NCT03206918|566081360|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
156817791|NCT02701764|566081361|FG000|Overall Study|Lost to Follow-up|0|||
156541090|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
156541091|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
156541092|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
156541093|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
156541094|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
156541095|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
156541096|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
156817792|NCT02701764|566081362|FG001|Overall Study|Lost to Follow-up|1|||
156817793|NCT03108521|566081367|FG000|Overall Study|Lost to Follow-up|3|||
156817794|NCT03108521|566081368|FG001|Overall Study|Lost to Follow-up|0|||
156817795|NCT03108521|566081367|FG000|Overall Study|Lack of Efficacy|2|||
156817796|NCT03108521|566081368|FG001|Overall Study|Lack of Efficacy|0|||
156817797|NCT03108521|566081367|FG000|Overall Study|Physician Decision|4|||
156817798|NCT03108521|566081368|FG001|Overall Study|Physician Decision|0|||
156817799|NCT03108521|566081367|FG000|Overall Study|Adverse Event|3|||
156817800|NCT03108521|566081368|FG001|Overall Study|Adverse Event|0|||
156817801|NCT06899737|566081374|FG000|Overall Study|Lost to Follow-up|19|||
156817802|NCT06899737|566081375|FG001|Overall Study|Lost to Follow-up|7|||
156817803|NCT03281629|566081377|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
156817804|NCT03281629|566081378|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
156817805|NCT03281629|566081377|FG000|Overall Study|Death|0|||
156817806|NCT03281629|566081378|FG001|Overall Study|Death|1|||
156817807|NCT03281629|566081377|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
156817808|NCT03281629|566081378|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
156817809|NCT01170273|566081383|FG000|Overall Study|Lost to Follow-up|6|||
156817810|NCT01170273|566081384|FG001|Overall Study|Lost to Follow-up|8|||
156817811|NCT01170273|566081383|FG000|Overall Study|Protocol Violation|1|||
156817812|NCT01170273|566081384|FG001|Overall Study|Protocol Violation|0|||
156465562|NCT03660930|564801572|FG003|Overall Study|Withdrawal by Subject|0|||
156465563|NCT03660930|564801573|FG004|Overall Study|Withdrawal by Subject|0|||
156465564|NCT03660930|564801574|FG005|Overall Study|Withdrawal by Subject|1|||
156541097|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
156541098|NCT00094770|565074481|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
156465565|NCT03660930|564801575|FG006|Overall Study|Withdrawal by Subject|0|||
156817813|NCT01170273|566081383|FG000|Overall Study|Death|1|||
156817814|NCT01170273|566081384|FG001|Overall Study|Death|0|||
156817815|NCT01170273|566081383|FG000|Overall Study|Adverse Event|0|||
156817816|NCT01170273|566081384|FG001|Overall Study|Adverse Event|1|||
156817817|NCT00334737|566081385|FG000|Hospital Phase|Death|1|||
156817818|NCT00334737|566081386|FG001|Hospital Phase|Death|2|||
156817819|NCT00334737|566081387|FG002|Hospital Phase|Death|3|||
156817820|NCT00334737|566081385|FG000|Hospital Phase|Withdrawal by Subject|0|||
156465566|NCT03660930|564801576|FG007|Overall Study|Withdrawal by Subject|0|||
156541099|NCT00094770|565074482|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
156817821|NCT00334737|566081386|FG001|Hospital Phase|Withdrawal by Subject|0|||
156817822|NCT00334737|566081387|FG002|Hospital Phase|Withdrawal by Subject|1|||
156817823|NCT00334737|566081385|FG000|Hospital Phase|Did not receive study drug|1|||
156817824|NCT00334737|566081386|FG001|Hospital Phase|Did not receive study drug|0|||
156817825|NCT00334737|566081387|FG002|Hospital Phase|Did not receive study drug|0|||
156817826|NCT00334737|566081385|FG000|Follow up Phase|Lost to Follow-up|5|||
156817827|NCT00334737|566081386|FG001|Follow up Phase|Lost to Follow-up|3|||
156817828|NCT00334737|566081387|FG002|Follow up Phase|Lost to Follow-up|6|||
156817829|NCT02316353|566081388|FG000|Overall Study|Pregnancy|1|||
156817830|NCT02316353|566081389|FG001|Overall Study|Pregnancy|3|||
156817831|NCT02316353|566081388|FG000|Overall Study|Adverse Event|1|||
156817832|NCT02316353|566081389|FG001|Overall Study|Adverse Event|3|||
156817833|NCT02316353|566081388|FG000|Overall Study|Withdrawal by Subject|6|||
156817834|NCT02316353|566081389|FG001|Overall Study|Withdrawal by Subject|2|||
156817835|NCT00375674|566081390|FG000|Overall Study|Other|26|||
156817836|NCT00375674|566081391|FG001|Overall Study|Other|18|||
156817837|NCT00375674|566081390|FG000|Overall Study|Death|67|||
156817838|NCT00375674|566081391|FG001|Overall Study|Death|76|||
156817839|NCT00375674|566081390|FG000|Overall Study|Participants refused further follow-up|31|||
156817840|NCT00375674|566081391|FG001|Overall Study|Participants refused further follow-up|30|||
156817841|NCT00375674|566081390|FG000|Overall Study|Lost to Follow-up|17|||
156817842|NCT00375674|566081391|FG001|Overall Study|Lost to Follow-up|15|||
156817843|NCT00375674|566081390|FG000|Overall Study|Enrolled but not treated|3|||
156817844|NCT00375674|566081391|FG001|Overall Study|Enrolled but not treated|2|||
156817845|NCT01271010|566083190|FG000|Overall Study|Reason not specified|11|||
156817846|NCT01271010|566083190|FG000|Overall Study|Start of new CLL therapy|1|||
156817847|NCT01271010|566083190|FG000|Overall Study|Protocol Violation|1|||
156817848|NCT01271010|566083190|FG000|Overall Study|Death|2|||
156817849|NCT01271010|566083190|FG000|Overall Study|Progression and relapse of disease|1|||
156817850|NCT01271010|566083190|FG000|Overall Study|Withdrawal by Subject|18|||
156817851|NCT01271010|566083190|FG000|Overall Study|Disease progression|27|||
156817852|NCT01631747|566083191|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
156817853|NCT01631747|566083192|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
156817854|NCT01631747|566083191|FG000|Live Birth|Pregnancy Termination|1|||
156817855|NCT01631747|566083192|FG001|Live Birth|Pregnancy Termination|0|||
156817856|NCT01631747|566083191|FG000|Live Birth|MIscarriage|2|||
156817857|NCT01631747|566083192|FG001|Live Birth|MIscarriage|0|||
156817858|NCT01631747|566083191|FG000|Live Birth|Stillbirth|1|||
156817859|NCT01631747|566083192|FG001|Live Birth|Stillbirth|1|||
156817860|NCT01631747|566083191|FG000|One Year Infant Outcomes|Patient Refused|13|||
156817861|NCT01631747|566083192|FG001|One Year Infant Outcomes|Patient Refused|9|||
156817862|NCT01456195|566083193|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156817863|NCT01456195|566083194|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
156817864|NCT01456195|566083195|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
156817865|NCT01456195|566083193|FG000|Overall Study|Lost to Follow-up|3|||
156817866|NCT01456195|566083194|FG001|Overall Study|Lost to Follow-up|1|||
156817867|NCT01456195|566083195|FG002|Overall Study|Lost to Follow-up|3|||
156817868|NCT01456195|566083193|FG000|Overall Study|Voluntary Withdrawal|5|||
156817869|NCT01456195|566083194|FG001|Overall Study|Voluntary Withdrawal|3|||
156817870|NCT01456195|566083195|FG002|Overall Study|Voluntary Withdrawal|7|||
156817871|NCT01456195|566083193|FG000|Overall Study|Lack of Efficacy|0|||
156817872|NCT01456195|566083194|FG001|Overall Study|Lack of Efficacy|1|||
156817873|NCT01456195|566083195|FG002|Overall Study|Lack of Efficacy|0|||
156817874|NCT01456195|566083193|FG000|Overall Study|Other Reasons|2|||
156817875|NCT01456195|566083194|FG001|Overall Study|Other Reasons|1|||
156817876|NCT01456195|566083195|FG002|Overall Study|Other Reasons|3|||
156817877|NCT02109432|566083196|FG000|Overall Study|Withdrawal by Subject|1|||
156817878|NCT03372551|566083203|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
156817879|NCT03372551|566083204|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
156817880|NCT04683029|566083213|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
156817881|NCT04683029|566083214|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
156817882|NCT04683029|566083215|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
156817883|NCT04683029|566083216|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
156817884|NCT04683029|566083213|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
156817885|NCT04683029|566083214|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
156817886|NCT04683029|566083215|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
156817887|NCT04683029|566083216|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
156817888|NCT04683029|566083213|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
156817889|NCT04683029|566083214|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
156465567|NCT02726386|564801581|FG000|Overall Study|Adverse Event|17|||
156465568|NCT02726386|564801582|FG001|Overall Study|Adverse Event|20|||
156465569|NCT02726386|564801581|FG000|Overall Study|Withdrawal by Subject|14|||
156465570|NCT02726386|564801582|FG001|Overall Study|Withdrawal by Subject|28|||
156465571|NCT02726386|564801581|FG000|Overall Study|Other reasons|7|||
156465572|NCT02726386|564801582|FG001|Overall Study|Other reasons|8|||
156465573|NCT02112916|564801587|FG000|Overall Study|Adverse Event|6|||
156465574|NCT02112916|564801588|FG001|Overall Study|Adverse Event|9|||
156465575|NCT02112916|564801589|FG002|Overall Study|Adverse Event|3|||
156465576|NCT02112916|564801590|FG003|Overall Study|Adverse Event|2|||
156465577|NCT02112916|564801587|FG000|Overall Study|Death|9|||
156465578|NCT02112916|564801588|FG001|Overall Study|Death|9|||
156465579|NCT02112916|564801589|FG002|Overall Study|Death|3|||
156817890|NCT04683029|566083215|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
156817891|NCT04683029|566083216|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
156817892|NCT04299308|566083217|FG000|Overall Study|Withdrawal by Subject|1|||
156817893|NCT04299308|566083218|FG001|Overall Study|Withdrawal by Subject|0|||
156817894|NCT04299308|566083217|FG000|Overall Study|issue with PET image (1)|1|||
156817895|NCT04299308|566083218|FG001|Overall Study|issue with PET image (1)|0|||
156817896|NCT02920528|566083221|FG000|Overall Study|Incomplete Data|1|||
156817897|NCT02920528|566083222|FG001|Overall Study|Incomplete Data|1|||
156817898|NCT02920528|566083223|FG002|Overall Study|Incomplete Data|1|||
156817899|NCT02920528|566083221|FG000|Overall Study|Adverse Event|0|||
156817900|NCT02920528|566083222|FG001|Overall Study|Adverse Event|0|||
156817901|NCT02920528|566083223|FG002|Overall Study|Adverse Event|3|||
156817902|NCT02920528|566083221|FG000|Overall Study|Did not meet inclusion criteria|2|||
156817903|NCT02920528|566083222|FG001|Overall Study|Did not meet inclusion criteria|0|||
156817904|NCT02920528|566083223|FG002|Overall Study|Did not meet inclusion criteria|1|||
156817905|NCT00066703|566083224|FG000|Overall Study|Adverse Event|80|||
156817906|NCT00066703|566083225|FG001|Overall Study|Adverse Event|111|||
156817907|NCT00066703|566083224|FG000|Overall Study|Death|3|||
156817908|NCT00066703|566083225|FG001|Overall Study|Death|0|||
156817909|NCT00066703|566083224|FG000|Overall Study|Lack of Efficacy|114|||
156817910|NCT00066703|566083225|FG001|Overall Study|Lack of Efficacy|69|||
156817911|NCT00066703|566083224|FG000|Overall Study|Lost to Follow-up|31|||
156817912|NCT00066703|566083225|FG001|Overall Study|Lost to Follow-up|28|||
156817913|NCT00066703|566083224|FG000|Overall Study|Withdrawal by Subject|38|||
156817914|NCT00066703|566083225|FG001|Overall Study|Withdrawal by Subject|63|||
156817915|NCT00066703|566083224|FG000|Overall Study|Treatment ongoing|346|||
156817916|NCT00066703|566083225|FG001|Overall Study|Treatment ongoing|311|||
156817917|NCT05924165|566083228|FG000|Overall Study|Physician Decision|2|||
156817918|NCT05924165|566083229|FG001|Overall Study|Physician Decision|3|||
156817919|NCT01681186|566083230|FG000|Washout Period From Second Intervention|Adverse Event|0|||
156817920|NCT01681186|566083231|FG001|Washout Period From Second Intervention|Adverse Event|0|||
156817921|NCT01681186|566083232|FG002|Washout Period From Second Intervention|Adverse Event|0|||
156817922|NCT01681186|566083233|FG003|Washout Period From Second Intervention|Adverse Event|0|||
156817923|NCT01681186|566083234|FG004|Washout Period From Second Intervention|Adverse Event|0|||
156817924|NCT01681186|566083235|FG005|Washout Period From Second Intervention|Adverse Event|0|||
156817925|NCT01681186|566083236|FG006|Washout Period From Second Intervention|Adverse Event|1|||
156465580|NCT02112916|564801590|FG003|Overall Study|Death|4|||
156465581|NCT02112916|564801587|FG000|Overall Study|Lost to Follow-up|1|||
156817926|NCT01681186|566083237|FG007|Washout Period From Second Intervention|Adverse Event|0|||
156817927|NCT01681186|566083230|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
156817928|NCT01681186|566083231|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
156817929|NCT01681186|566083232|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
156817930|NCT01681186|566083233|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
156465582|NCT02112916|564801588|FG001|Overall Study|Lost to Follow-up|0|||
156465583|NCT02112916|564801589|FG002|Overall Study|Lost to Follow-up|0|||
156465584|NCT02112916|564801590|FG003|Overall Study|Lost to Follow-up|0|||
156465585|NCT02112916|564801587|FG000|Overall Study|Physician Decision|94|||
156465586|NCT02112916|564801588|FG001|Overall Study|Physician Decision|72|||
156817931|NCT01681186|566083234|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
156817932|NCT01681186|566083235|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
156817933|NCT01681186|566083236|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
156817934|NCT01681186|566083237|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
156817935|NCT01681186|566083230|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817936|NCT01681186|566083231|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817937|NCT01681186|566083232|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817938|NCT01681186|566083233|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817939|NCT01681186|566083234|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817940|NCT01681186|566083235|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817941|NCT01681186|566083236|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
156465587|NCT02112916|564801589|FG002|Overall Study|Physician Decision|24|||
156817942|NCT01681186|566083237|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817943|NCT01681186|566083230|FG000|Fourth Intervention|Protocol Violation|0|||
156817944|NCT01681186|566083231|FG001|Fourth Intervention|Protocol Violation|0|||
156817945|NCT01681186|566083232|FG002|Fourth Intervention|Protocol Violation|0|||
156817946|NCT01681186|566083233|FG003|Fourth Intervention|Protocol Violation|0|||
156817947|NCT01681186|566083234|FG004|Fourth Intervention|Protocol Violation|0|||
156817948|NCT01681186|566083235|FG005|Fourth Intervention|Protocol Violation|0|||
156817949|NCT01681186|566083236|FG006|Fourth Intervention|Protocol Violation|0|||
156817950|NCT01681186|566083237|FG007|Fourth Intervention|Protocol Violation|1|||
156817951|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Adverse Event|1|||
156817952|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Adverse Event|0|||
156817953|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
156817954|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
156817955|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
156817956|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
156817957|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
156817958|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
156817959|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Other|1|||
156817960|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Other|4|||
156817961|NCT00301262|566083244|FG000|Open Label Phase (OL)|Adverse Event|1|||
156817962|NCT00301262|566083245|FG001|Open Label Phase (OL)|Adverse Event|0|||
156817963|NCT00301262|566083244|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
156817964|NCT00301262|566083245|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
156817965|NCT00301262|566083244|FG000|Open Label Phase (OL)|Other|2|||
156817966|NCT00301262|566083245|FG001|Open Label Phase (OL)|Other|0|||
156817967|NCT03530995|566083249|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
156817968|NCT03530995|566083250|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
156817969|NCT03530995|566083249|FG000|Part 1 Period 3|Protocol Violation|1|||
156817970|NCT03530995|566083250|FG001|Part 1 Period 3|Protocol Violation|0|||
156817971|NCT03530995|566083249|FG000|Part 1 Period 4|Physician Decision|1|||
156817972|NCT03530995|566083250|FG001|Part 1 Period 4|Physician Decision|0|||
156817973|NCT03530995|566083249|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
156817974|NCT03530995|566083250|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
156817975|NCT04308239|566083256|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
156817976|NCT04308239|566083257|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
156817977|NCT04308239|566083256|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
156817978|NCT04308239|566083257|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
156817979|NCT04308239|566083256|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
156817980|NCT04308239|566083257|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
156817981|NCT04308239|566083256|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
156817982|NCT04308239|566083257|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
156817983|NCT01443364|566083258|FG000|Overall Study|Lack of Efficacy|14|||
156817984|NCT01443364|566083258|FG000|Overall Study|Lost to Follow-up|3|||
156817985|NCT01443364|566083258|FG000|Overall Study|Withdrawal by Subject|5|||
156817986|NCT01443364|566083258|FG000|Overall Study|Other Reason|4|||
156817987|NCT01443364|566083258|FG000|Overall Study|SAE, non-fatal|6|||
156817988|NCT01443364|566083258|FG000|Overall Study|AE, non-serious non-fatal|8|||
156817989|NCT01443364|566083258|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156817990|NCT04848220|566083263|FG000|Overall Study|Unable to proceed to study procedure|0|||
156817991|NCT04848220|566083264|FG001|Overall Study|Unable to proceed to study procedure|1|||
156817992|NCT04848220|566083265|FG002|Overall Study|Unable to proceed to study procedure|0|||
156817993|NCT04848220|566083263|FG000|Overall Study|Fractional flow not significant|0|||
156817994|NCT04848220|566083264|FG001|Overall Study|Fractional flow not significant|1|||
156817995|NCT04848220|566083265|FG002|Overall Study|Fractional flow not significant|0|||
156817996|NCT02150057|566083271|FG000|Overall Study|Lost to Follow-up|6|||
156465588|NCT02112916|564801590|FG003|Overall Study|Physician Decision|15|||
156817997|NCT02150057|566083272|FG001|Overall Study|Lost to Follow-up|4|||
156817998|NCT01558115|566083273|FG000|Overall Study|Withdrawal by Subject|3|||
156817999|NCT01558115|566083273|FG000|Overall Study|Study closed due to poor enrollment|4|||
156465589|NCT02112916|564801587|FG000|Overall Study|Withdrawal by Subject|5|||
156465590|NCT02112916|564801588|FG001|Overall Study|Withdrawal by Subject|3|||
156465591|NCT02112916|564801589|FG002|Overall Study|Withdrawal by Subject|1|||
156465592|NCT02112916|564801590|FG003|Overall Study|Withdrawal by Subject|1|||
156465593|NCT02112916|564801587|FG000|Overall Study|Ineligible|4|||
156465594|NCT02112916|564801588|FG001|Overall Study|Ineligible|8|||
156465595|NCT02112916|564801589|FG002|Overall Study|Ineligible|3|||
156465596|NCT02112916|564801590|FG003|Overall Study|Ineligible|8|||
156465597|NCT02112916|564801587|FG000|Overall Study|Inevaluable|6|||
156465598|NCT02112916|564801588|FG001|Overall Study|Inevaluable|4|||
156465599|NCT02112916|564801589|FG002|Overall Study|Inevaluable|5|||
156465600|NCT02112916|564801590|FG003|Overall Study|Inevaluable|5|||
156465601|NCT02112916|564801587|FG000|Overall Study|Refusal of further protocol therapy|19|||
156465602|NCT02112916|564801588|FG001|Overall Study|Refusal of further protocol therapy|16|||
156465603|NCT02112916|564801589|FG002|Overall Study|Refusal of further protocol therapy|1|||
156465604|NCT02112916|564801590|FG003|Overall Study|Refusal of further protocol therapy|7|||
156465605|NCT02112916|564801587|FG000|Overall Study|Development of SMN|1|||
156465606|NCT02112916|564801588|FG001|Overall Study|Development of SMN|0|||
156465607|NCT02112916|564801589|FG002|Overall Study|Development of SMN|0|||
156818000|NCT01696994|566083274|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
156818001|NCT01696994|566083275|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
156818002|NCT01696994|566083274|FG000|Overall Study|Died Before Randomization|1|||
156818003|NCT01696994|566083275|FG001|Overall Study|Died Before Randomization|2|||
156818004|NCT01696994|566083274|FG000|Overall Study|Died Before ASU (Control)|73|||
156818005|NCT01696994|566083275|FG001|Overall Study|Died Before ASU (Control)|0|||
156818006|NCT01696994|566083274|FG000|Overall Study|No Ovaries at Baseline|4807|||
156818007|NCT01696994|566083275|FG001|Overall Study|No Ovaries at Baseline|4851|||
156818008|NCT01696994|566083274|FG000|Overall Study|Refused ASU (Control)|311|||
156818009|NCT01696994|566083275|FG001|Overall Study|Refused ASU (Control)|0|||
156818010|NCT01696994|566083274|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
156818011|NCT01696994|566083275|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
156818012|NCT02388165|566083276|FG000|Overall Study|Study terminated by sponsor|5|||
156818013|NCT02388165|566083277|FG001|Overall Study|Study terminated by sponsor|5|||
156818014|NCT02388165|566083276|FG000|Overall Study|Other|11|||
156818015|NCT02388165|566083277|FG001|Overall Study|Other|13|||
156818016|NCT02388165|566083276|FG000|Overall Study|No longer meet eligibility criteria|40|||
156818017|NCT02388165|566083277|FG001|Overall Study|No longer meet eligibility criteria|43|||
156818018|NCT02388165|566083276|FG000|Overall Study|Withdrawal of consent|31|||
156818019|NCT02388165|566083277|FG001|Overall Study|Withdrawal of consent|32|||
156818020|NCT02388165|566083276|FG000|Overall Study|Lost to Follow-up|19|||
156818021|NCT02388165|566083277|FG001|Overall Study|Lost to Follow-up|20|||
156818022|NCT02388165|566083276|FG000|Overall Study|Death|13|||
156818023|NCT02388165|566083277|FG001|Overall Study|Death|10|||
156818024|NCT02388165|566083276|FG000|Overall Study|Adverse Event|3|||
156818025|NCT02388165|566083277|FG001|Overall Study|Adverse Event|5|||
156818026|NCT02388165|566083276|FG000|Overall Study|Did not meet entrance criteria|5|||
156818027|NCT02388165|566083277|FG001|Overall Study|Did not meet entrance criteria|2|||
156818028|NCT01406938|566083278|FG000|Induction Period|Subject/guardian decision|6|||
156818029|NCT01406938|566083279|FG001|Induction Period|Subject/guardian decision|8|||
156818030|NCT01406938|566083280|FG002|Induction Period|Subject/guardian decision|0|||
156818031|NCT01406938|566083281|FG003|Induction Period|Subject/guardian decision|0|||
156818032|NCT01406938|566083282|FG004|Induction Period|Subject/guardian decision|0|||
156818033|NCT01406938|566083283|FG005|Induction Period|Subject/guardian decision|0|||
156818034|NCT01406938|566083278|FG000|Induction Period|Protocol deviation|1|||
156818035|NCT01406938|566083279|FG001|Induction Period|Protocol deviation|0|||
156818036|NCT01406938|566083280|FG002|Induction Period|Protocol deviation|0|||
156818037|NCT01406938|566083281|FG003|Induction Period|Protocol deviation|0|||
156818038|NCT01406938|566083282|FG004|Induction Period|Protocol deviation|0|||
156818039|NCT01406938|566083283|FG005|Induction Period|Protocol deviation|0|||
156818040|NCT01406938|566083278|FG000|Induction Period|Adverse Event|8|||
156818041|NCT01406938|566083279|FG001|Induction Period|Adverse Event|9|||
156818042|NCT01406938|566083280|FG002|Induction Period|Adverse Event|0|||
156818043|NCT01406938|566083281|FG003|Induction Period|Adverse Event|0|||
156818044|NCT01406938|566083282|FG004|Induction Period|Adverse Event|0|||
156818045|NCT01406938|566083283|FG005|Induction Period|Adverse Event|0|||
156818046|NCT01406938|566083278|FG000|Induction Period|Lack of Efficacy|1|||
156818047|NCT01406938|566083279|FG001|Induction Period|Lack of Efficacy|0|||
156818048|NCT01406938|566083280|FG002|Induction Period|Lack of Efficacy|0|||
156818049|NCT01406938|566083281|FG003|Induction Period|Lack of Efficacy|0|||
156465608|NCT02112916|564801590|FG003|Overall Study|Development of SMN|1|||
156465609|NCT02112916|564801587|FG000|Overall Study|Relapse/Progression|10|||
156465610|NCT02112916|564801588|FG001|Overall Study|Relapse/Progression|18|||
156465611|NCT02112916|564801589|FG002|Overall Study|Relapse/Progression|15|||
156465612|NCT02112916|564801590|FG003|Overall Study|Relapse/Progression|2|||
156818050|NCT01406938|566083282|FG004|Induction Period|Lack of Efficacy|0|||
156818051|NCT01406938|566083283|FG005|Induction Period|Lack of Efficacy|0|||
156818052|NCT01406938|566083278|FG000|Induction Period|Lost to Follow-up|2|||
156818053|NCT01406938|566083279|FG001|Induction Period|Lost to Follow-up|3|||
156818054|NCT01406938|566083280|FG002|Induction Period|Lost to Follow-up|0|||
156818055|NCT01406938|566083281|FG003|Induction Period|Lost to Follow-up|0|||
156818056|NCT01406938|566083282|FG004|Induction Period|Lost to Follow-up|0|||
156818057|NCT01406938|566083283|FG005|Induction Period|Lost to Follow-up|0|||
156818058|NCT01406938|566083278|FG000|Maintenance Period|Adverse Event|0|||
156818059|NCT01406938|566083279|FG001|Maintenance Period|Adverse Event|0|||
156818060|NCT01406938|566083280|FG002|Maintenance Period|Adverse Event|2|||
156818061|NCT01406938|566083281|FG003|Maintenance Period|Adverse Event|8|||
156818062|NCT01406938|566083282|FG004|Maintenance Period|Adverse Event|4|||
156818063|NCT01406938|566083283|FG005|Maintenance Period|Adverse Event|2|||
156818064|NCT01406938|566083278|FG000|Maintenance Period|Death|0|||
156818065|NCT01406938|566083279|FG001|Maintenance Period|Death|0|||
156818066|NCT01406938|566083280|FG002|Maintenance Period|Death|0|||
156818067|NCT01406938|566083281|FG003|Maintenance Period|Death|0|||
156818068|NCT01406938|566083282|FG004|Maintenance Period|Death|1|||
156818069|NCT01406938|566083283|FG005|Maintenance Period|Death|0|||
156818070|NCT01406938|566083278|FG000|Maintenance Period|Subject/guardian decision|0|||
156818071|NCT01406938|566083279|FG001|Maintenance Period|Subject/guardian decision|0|||
156818072|NCT01406938|566083280|FG002|Maintenance Period|Subject/guardian decision|11|||
156818073|NCT01406938|566083281|FG003|Maintenance Period|Subject/guardian decision|7|||
156818074|NCT01406938|566083282|FG004|Maintenance Period|Subject/guardian decision|10|||
156818075|NCT01406938|566083283|FG005|Maintenance Period|Subject/guardian decision|7|||
156818076|NCT01406938|566083278|FG000|Maintenance Period|Protocol Violation|0|||
156818077|NCT01406938|566083279|FG001|Maintenance Period|Protocol Violation|0|||
156818078|NCT01406938|566083280|FG002|Maintenance Period|Protocol Violation|2|||
156818079|NCT01406938|566083281|FG003|Maintenance Period|Protocol Violation|2|||
156818080|NCT01406938|566083282|FG004|Maintenance Period|Protocol Violation|2|||
156818081|NCT01406938|566083283|FG005|Maintenance Period|Protocol Violation|2|||
156818082|NCT01406938|566083278|FG000|Maintenance Period|Pregnancy|0|||
156818083|NCT01406938|566083279|FG001|Maintenance Period|Pregnancy|0|||
156818084|NCT01406938|566083280|FG002|Maintenance Period|Pregnancy|0|||
156818085|NCT01406938|566083281|FG003|Maintenance Period|Pregnancy|0|||
156818086|NCT01406938|566083282|FG004|Maintenance Period|Pregnancy|1|||
156818087|NCT01406938|566083283|FG005|Maintenance Period|Pregnancy|0|||
156818088|NCT01406938|566083278|FG000|Maintenance Period|Lost to Follow-up|0|||
156818089|NCT01406938|566083279|FG001|Maintenance Period|Lost to Follow-up|0|||
156818090|NCT01406938|566083280|FG002|Maintenance Period|Lost to Follow-up|0|||
156818091|NCT01406938|566083281|FG003|Maintenance Period|Lost to Follow-up|0|||
156818092|NCT01406938|566083282|FG004|Maintenance Period|Lost to Follow-up|4|||
156818093|NCT01406938|566083283|FG005|Maintenance Period|Lost to Follow-up|0|||
156818094|NCT01406938|566083278|FG000|Maintenance Period|Lack of Efficacy|0|||
156818095|NCT01406938|566083279|FG001|Maintenance Period|Lack of Efficacy|0|||
156818096|NCT01406938|566083280|FG002|Maintenance Period|Lack of Efficacy|2|||
156818097|NCT01406938|566083281|FG003|Maintenance Period|Lack of Efficacy|1|||
156465613|NCT02112916|564801587|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
156465614|NCT02112916|564801588|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
156465615|NCT02112916|564801589|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
156465616|NCT02112916|564801590|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
156465617|NCT02112916|564801587|FG000|Overall Study|Still on Therapy|44|||
156465618|NCT02112916|564801588|FG001|Overall Study|Still on Therapy|47|||
156465619|NCT02112916|564801589|FG002|Overall Study|Still on Therapy|3|||
156465620|NCT02112916|564801590|FG003|Overall Study|Still on Therapy|2|||
156465621|NCT02112916|564801587|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
156465622|NCT02112916|564801588|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
156818098|NCT01406938|566083282|FG004|Maintenance Period|Lack of Efficacy|3|||
156818099|NCT01406938|566083283|FG005|Maintenance Period|Lack of Efficacy|5|||
156818100|NCT01406938|566083278|FG000|Follow up|Lack of Efficacy|3|||
156818101|NCT01406938|566083279|FG001|Follow up|Lack of Efficacy|2|||
156818102|NCT01406938|566083280|FG002|Follow up|Lack of Efficacy|1|||
156818103|NCT01406938|566083281|FG003|Follow up|Lack of Efficacy|0|||
156465623|NCT02112916|564801589|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
156465624|NCT02112916|564801590|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
156818104|NCT01406938|566083282|FG004|Follow up|Lack of Efficacy|0|||
156818105|NCT01406938|566083283|FG005|Follow up|Lack of Efficacy|0|||
156818106|NCT01406938|566083278|FG000|Follow up|Patient/guardian decision|4|||
156818107|NCT01406938|566083279|FG001|Follow up|Patient/guardian decision|2|||
156818108|NCT01406938|566083280|FG002|Follow up|Patient/guardian decision|4|||
156818109|NCT01406938|566083281|FG003|Follow up|Patient/guardian decision|2|||
156818110|NCT01406938|566083282|FG004|Follow up|Patient/guardian decision|4|||
156818111|NCT01406938|566083283|FG005|Follow up|Patient/guardian decision|1|||
156818112|NCT01406938|566083278|FG000|Follow up|Protocol Violation|0|||
156818113|NCT01406938|566083279|FG001|Follow up|Protocol Violation|0|||
156818114|NCT01406938|566083280|FG002|Follow up|Protocol Violation|1|||
156818115|NCT01406938|566083281|FG003|Follow up|Protocol Violation|0|||
156818116|NCT01406938|566083282|FG004|Follow up|Protocol Violation|0|||
156818117|NCT01406938|566083283|FG005|Follow up|Protocol Violation|0|||
156818118|NCT01406938|566083278|FG000|Follow up|Physician Decision|0|||
156818119|NCT01406938|566083279|FG001|Follow up|Physician Decision|0|||
156818120|NCT01406938|566083280|FG002|Follow up|Physician Decision|2|||
156818121|NCT01406938|566083281|FG003|Follow up|Physician Decision|0|||
156818122|NCT01406938|566083282|FG004|Follow up|Physician Decision|3|||
156818123|NCT01406938|566083283|FG005|Follow up|Physician Decision|1|||
156818124|NCT01406938|566083278|FG000|Follow up|Lost to Follow-up|1|||
156818125|NCT01406938|566083279|FG001|Follow up|Lost to Follow-up|1|||
156818126|NCT01406938|566083280|FG002|Follow up|Lost to Follow-up|0|||
156818127|NCT01406938|566083281|FG003|Follow up|Lost to Follow-up|1|||
156818128|NCT01406938|566083282|FG004|Follow up|Lost to Follow-up|2|||
156818129|NCT01406938|566083283|FG005|Follow up|Lost to Follow-up|1|||
156818130|NCT02249091|566083284|FG000|Overall Study|Lack of Efficacy|8|||
156818131|NCT02249091|566083285|FG001|Overall Study|Lack of Efficacy|3|||
156818132|NCT02249091|566083284|FG000|Overall Study|Physician Decision|4|||
156818133|NCT02249091|566083285|FG001|Overall Study|Physician Decision|1|||
156818134|NCT02249091|566083284|FG000|Overall Study|Withdrawal by Subject|2|||
156818135|NCT02249091|566083285|FG001|Overall Study|Withdrawal by Subject|2|||
156818136|NCT02249091|566083284|FG000|Overall Study|Death|3|||
156818137|NCT02249091|566083285|FG001|Overall Study|Death|4|||
156818138|NCT02249091|566083284|FG000|Overall Study|Adverse Event|1|||
156541100|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
156818139|NCT02249091|566083285|FG001|Overall Study|Adverse Event|0|||
156818140|NCT02249091|566083284|FG000|Overall Study|Stable disease with following SCT|0|||
156818141|NCT02249091|566083285|FG001|Overall Study|Stable disease with following SCT|1|||
156818142|NCT02249091|566083284|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
156818143|NCT02249091|566083285|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
156818144|NCT02249091|566083284|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
156818145|NCT02249091|566083285|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
156818146|NCT02249091|566083284|FG000|Overall Study|Refractory AML|1|||
156818147|NCT02249091|566083285|FG001|Overall Study|Refractory AML|1|||
156818148|NCT02684617|566083286|FG000|Overall Study|Adverse Event|1|||
156818149|NCT02684617|566083287|FG001|Overall Study|Adverse Event|0|||
156818150|NCT02684617|566083288|FG002|Overall Study|Adverse Event|1|||
156818151|NCT02684617|566083286|FG000|Overall Study|Death|8|||
156818152|NCT02684617|566083287|FG001|Overall Study|Death|16|||
156818153|NCT02684617|566083288|FG002|Overall Study|Death|28|||
156818154|NCT02684617|566083286|FG000|Overall Study|Withdrawal by Subject|2|||
156818155|NCT02684617|566083287|FG001|Overall Study|Withdrawal by Subject|0|||
156818156|NCT02684617|566083288|FG002|Overall Study|Withdrawal by Subject|4|||
156818157|NCT02684617|566083286|FG000|Overall Study|Screen Failure|1|||
156818158|NCT02684617|566083287|FG001|Overall Study|Screen Failure|0|||
156818159|NCT02684617|566083288|FG002|Overall Study|Screen Failure|2|||
156818160|NCT02684617|566083286|FG000|Overall Study|Study Terminated by Sponsor|6|||
156818161|NCT02684617|566083287|FG001|Overall Study|Study Terminated by Sponsor|1|||
156818162|NCT02684617|566083288|FG002|Overall Study|Study Terminated by Sponsor|5|||
156818163|NCT02141399|566083289|FG000|Overall Study|Adverse Event|158|||
156818164|NCT02141399|566083289|FG000|Overall Study|Lack of Efficacy|62|||
156541101|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
156541102|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
156541103|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
156818165|NCT02141399|566083289|FG000|Overall Study|Lost to Follow-up|151|||
156818166|NCT02141399|566083289|FG000|Overall Study|Non-compliance with study drug|18|||
156818167|NCT02141399|566083289|FG000|Overall Study|Other|45|||
156818168|NCT02141399|566083289|FG000|Overall Study|Physician Decision|17|||
156818169|NCT02141399|566083289|FG000|Overall Study|Pregnancy|3|||
156818170|NCT02141399|566083289|FG000|Overall Study|Protocol Violation|38|||
156818171|NCT02141399|566083289|FG000|Overall Study|Withdrawal by Subject|238|||
156818172|NCT02141399|566083289|FG000|Overall Study|Failure to meet eligibility criteria|14|||
156818173|NCT05730335|566083290|FG000|Overall Study|Lost to Follow-up|8|||
156818174|NCT05730335|566083290|FG000|Overall Study|Withdrawal by Subject|6|||
156818175|NCT00765037|566083291|FG000|Overall Study|Lost to Follow-up|5|||
156818176|NCT00765037|566083291|FG000|Overall Study|Adverse Event|1|||
156818177|NCT00615719|566083292|FG000|Overall Study|Physician Decision|5|||
156818178|NCT01471028|566083293|FG000|VTI-208|Adverse Event|39|||
156541104|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
156818179|NCT01471028|566083294|FG001|VTI-208|Adverse Event|41|||
156818180|NCT01471028|566083293|FG000|VTI-208|Withdrawal by Subject|0|||
156818181|NCT01471028|566083294|FG001|VTI-208|Withdrawal by Subject|2|||
156818182|NCT01471028|566083293|FG000|VTI-208|Lost to Follow-up|1|||
156818183|NCT01471028|566083294|FG001|VTI-208|Lost to Follow-up|1|||
156818184|NCT01471028|566083293|FG000|VTI-208E|Death|7|||
156818185|NCT01471028|566083294|FG001|VTI-208E|Death|10|||
156818186|NCT01471028|566083293|FG000|VTI-208E|Withdrawal by Subject|1|||
156818187|NCT01471028|566083294|FG001|VTI-208E|Withdrawal by Subject|0|||
156818188|NCT01471028|566083293|FG000|VTI-208E|Lost to Follow-up|0|||
156541105|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
156541106|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
156541107|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
156541108|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
156541109|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
156541110|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
156541111|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
156541112|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
156541113|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
156541114|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
156541115|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
156818189|NCT01471028|566083294|FG001|VTI-208E|Lost to Follow-up|2|||
156818190|NCT00935493|566083295|FG000|Overall Study|Lost to Follow-up|1|||
156818191|NCT00935493|566083296|FG001|Overall Study|Lost to Follow-up|1|||
156818192|NCT00935493|566083297|FG002|Overall Study|Lost to Follow-up|1|||
156818193|NCT00935493|566083295|FG000|Overall Study|Treatment Discontinued|0|||
156818194|NCT00935493|566083296|FG001|Overall Study|Treatment Discontinued|1|||
156818195|NCT00935493|566083297|FG002|Overall Study|Treatment Discontinued|0|||
156818196|NCT02091362|566083307|FG000|Period 1|Protocol Violation|1|||
156818197|NCT02091362|566083308|FG001|Period 1|Protocol Violation|0|||
156818198|NCT02091362|566083307|FG000|Period 1|Withdrawal by Subject|2|||
156818199|NCT02091362|566083308|FG001|Period 1|Withdrawal by Subject|3|||
156818200|NCT02091362|566083307|FG000|Period 1|Lost to Follow-up|0|||
156818201|NCT02091362|566083308|FG001|Period 1|Lost to Follow-up|1|||
156818202|NCT02091362|566083307|FG000|Period 1|Adverse Event|2|||
156818203|NCT02091362|566083308|FG001|Period 1|Adverse Event|0|||
156818204|NCT02091362|566083307|FG000|Wash-out|Lost to Follow-up|1|||
156818205|NCT02091362|566083308|FG001|Wash-out|Lost to Follow-up|1|||
156818206|NCT02091362|566083307|FG000|Wash-out|Withdrawal by Subject|0|||
156818207|NCT02091362|566083308|FG001|Wash-out|Withdrawal by Subject|2|||
156818208|NCT02091362|566083307|FG000|Period 2|Adverse Event|1|||
156818209|NCT02091362|566083308|FG001|Period 2|Adverse Event|0|||
156818210|NCT02091362|566083307|FG000|Period 2|Lost to Follow-up|0|||
156818211|NCT02091362|566083308|FG001|Period 2|Lost to Follow-up|1|||
156818212|NCT02091362|566083307|FG000|Period 2|Withdrawal by Subject|1|||
156818213|NCT02091362|566083308|FG001|Period 2|Withdrawal by Subject|1|||
156818214|NCT00690430|566083309|FG000|Core Phase|Abnormal Laboratory value|0|||
156818215|NCT00690430|566083310|FG001|Core Phase|Abnormal Laboratory value|1|||
156818216|NCT00690430|566083311|FG002|Core Phase|Abnormal Laboratory value|0|||
156818217|NCT00690430|566083309|FG000|Core Phase|Adverse Event|5|||
156818218|NCT00690430|566083310|FG001|Core Phase|Adverse Event|1|||
156465625|NCT02112916|564801587|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
156465626|NCT02112916|564801588|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
156465627|NCT02112916|564801589|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
156465628|NCT02112916|564801590|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
156465629|NCT03333915|564801592|FG000|Overall Study|Lost to Follow-up|0|||
156465630|NCT03333915|564801593|FG001|Overall Study|Lost to Follow-up|0|||
156465631|NCT03333915|564801594|FG002|Overall Study|Lost to Follow-up|1|||
156465632|NCT03333915|564801595|FG003|Overall Study|Lost to Follow-up|0|||
156465633|NCT03333915|564801596|FG004|Overall Study|Lost to Follow-up|0|||
156465634|NCT03333915|564801592|FG000|Overall Study|Disease Progression|0|||
156818219|NCT00690430|566083311|FG002|Core Phase|Adverse Event|0|||
156818220|NCT00690430|566083309|FG000|Core Phase|Death|0|||
156818221|NCT00690430|566083310|FG001|Core Phase|Death|2|||
156541116|NCT00094770|565074481|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
156818222|NCT00690430|566083311|FG002|Core Phase|Death|0|||
156465635|NCT03333915|564801593|FG001|Overall Study|Disease Progression|1|||
156465636|NCT03333915|564801594|FG002|Overall Study|Disease Progression|0|||
156465637|NCT03333915|564801595|FG003|Overall Study|Disease Progression|0|||
156465638|NCT03333915|564801596|FG004|Overall Study|Disease Progression|0|||
156465639|NCT03333915|564801592|FG000|Overall Study|Death|0|||
156541117|NCT00094770|565074482|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
156818223|NCT00690430|566083309|FG000|Core Phase|Protocol Violation|1|||
156818224|NCT00690430|566083310|FG001|Core Phase|Protocol Violation|0|||
156818225|NCT00690430|566083311|FG002|Core Phase|Protocol Violation|0|||
156818226|NCT00690430|566083309|FG000|Core Phase|Withdrawal by Subject|3|||
156818227|NCT00690430|566083310|FG001|Core Phase|Withdrawal by Subject|3|||
156818228|NCT00690430|566083311|FG002|Core Phase|Withdrawal by Subject|0|||
156818229|NCT00690430|566083309|FG000|Core Phase|Subject no longer requires study drug|1|||
156818230|NCT00690430|566083310|FG001|Core Phase|Subject no longer requires study drug|0|||
156818231|NCT00690430|566083311|FG002|Core Phase|Subject no longer requires study drug|0|||
156818232|NCT00690430|566083309|FG000|Core Phase|Lack of Efficacy|8|||
156818233|NCT00690430|566083310|FG001|Core Phase|Lack of Efficacy|10|||
156339067|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
156465640|NCT03333915|564801593|FG001|Overall Study|Death|0|||
156465641|NCT03333915|564801594|FG002|Overall Study|Death|0|||
156465642|NCT03333915|564801595|FG003|Overall Study|Death|37|||
156465643|NCT03333915|564801596|FG004|Overall Study|Death|18|||
156465644|NCT03333915|564801592|FG000|Overall Study|Sponsor's Decision|0|||
156818234|NCT00690430|566083311|FG002|Core Phase|Lack of Efficacy|0|||
156818235|NCT00690430|566083309|FG000|Core Phase|Administrative Problems|0|||
156818236|NCT00690430|566083310|FG001|Core Phase|Administrative Problems|1|||
156818237|NCT00690430|566083311|FG002|Core Phase|Administrative Problems|0|||
156818238|NCT00690430|566083309|FG000|Core Phase|Early Termination|0|||
156818239|NCT00690430|566083310|FG001|Core Phase|Early Termination|5|||
156818240|NCT00690430|566083311|FG002|Core Phase|Early Termination|0|||
156818241|NCT00690430|566083309|FG000|Extension Phase|Lack of Efficacy|3|||
156818242|NCT00690430|566083310|FG001|Extension Phase|Lack of Efficacy|1|||
156818243|NCT00690430|566083311|FG002|Extension Phase|Lack of Efficacy|4|||
156818244|NCT00690430|566083309|FG000|Extension Phase|Abnormal Lab Values|1|||
156818245|NCT00690430|566083310|FG001|Extension Phase|Abnormal Lab Values|0|||
156818246|NCT00690430|566083311|FG002|Extension Phase|Abnormal Lab Values|0|||
156818247|NCT00690430|566083309|FG000|Extension Phase|Abnormal test procedure results|1|||
156818248|NCT00690430|566083310|FG001|Extension Phase|Abnormal test procedure results|0|||
156818249|NCT00690430|566083311|FG002|Extension Phase|Abnormal test procedure results|0|||
156818250|NCT00690430|566083309|FG000|Extension Phase|Administrative Problems|0|||
156818251|NCT00690430|566083310|FG001|Extension Phase|Administrative Problems|1|||
156818252|NCT00690430|566083311|FG002|Extension Phase|Administrative Problems|1|||
156818253|NCT00690430|566083309|FG000|Extension Phase|Adverse Event|2|||
156818254|NCT00690430|566083310|FG001|Extension Phase|Adverse Event|1|||
156818255|NCT00690430|566083311|FG002|Extension Phase|Adverse Event|2|||
156818256|NCT00690430|566083309|FG000|Extension Phase|Death|1|||
156818257|NCT00690430|566083310|FG001|Extension Phase|Death|1|||
156818258|NCT00690430|566083311|FG002|Extension Phase|Death|1|||
156818259|NCT00690430|566083309|FG000|Extension Phase|Withdrawal by Subject|0|||
156818260|NCT00690430|566083310|FG001|Extension Phase|Withdrawal by Subject|0|||
156818261|NCT00690430|566083311|FG002|Extension Phase|Withdrawal by Subject|2|||
156818262|NCT00690430|566083309|FG000|Extension Phase|Early Termination|10|||
156818263|NCT00690430|566083310|FG001|Extension Phase|Early Termination|1|||
156818264|NCT00690430|566083311|FG002|Extension Phase|Early Termination|3|||
156818265|NCT02565147|566083312|FG000|Overall Study|Withdrawal by Subject|5|||
156818266|NCT02565147|566083313|FG001|Overall Study|Withdrawal by Subject|1|||
156818267|NCT02565147|566083312|FG000|Overall Study|Lost to Follow-up|0|||
156818268|NCT02565147|566083313|FG001|Overall Study|Lost to Follow-up|1|||
156818269|NCT02565147|566083312|FG000|Overall Study|Death|1|||
156818270|NCT02565147|566083313|FG001|Overall Study|Death|1|||
156818271|NCT03098433|566083317|FG000|Overall Study|Withdrawal by Subject|10|||
156818272|NCT04470050|566083318|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156818273|NCT04470050|566083319|FG001|Double-blind Treatment Phase|Adverse Event|0|||
156818274|NCT04470050|566083320|FG002|Double-blind Treatment Phase|Adverse Event|0|||
156818275|NCT04470050|566083321|FG003|Double-blind Treatment Phase|Adverse Event|1|||
156818276|NCT04470050|566083322|FG004|Double-blind Treatment Phase|Adverse Event|0|||
156818277|NCT04470050|566083323|FG005|Double-blind Treatment Phase|Adverse Event|0|||
156818278|NCT04470050|566083324|FG006|Double-blind Treatment Phase|Adverse Event|0|||
156818279|NCT04470050|566083318|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818280|NCT04470050|566083319|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818281|NCT04470050|566083320|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818282|NCT04470050|566083321|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818283|NCT04470050|566083322|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
156818284|NCT04470050|566083323|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818285|NCT04470050|566083324|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818286|NCT04470050|566083318|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
156818287|NCT04470050|566083319|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
156818288|NCT04470050|566083320|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
156818289|NCT04470050|566083321|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
156818290|NCT04470050|566083322|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
156465645|NCT03333915|564801593|FG001|Overall Study|Sponsor's Decision|0|||
156818291|NCT04470050|566083323|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
156818292|NCT04470050|566083324|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
156818293|NCT03640507|566083325|FG000|Overall Study|Withdrawal by Subject|0|||
156818294|NCT03640507|566083326|FG001|Overall Study|Withdrawal by Subject|0|||
156818295|NCT03640507|566083327|FG002|Overall Study|Withdrawal by Subject|1|||
156339068|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
156339069|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
156465646|NCT03333915|564801594|FG002|Overall Study|Sponsor's Decision|0|||
156465647|NCT03333915|564801595|FG003|Overall Study|Sponsor's Decision|48|||
156818296|NCT01270880|566083328|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
156339070|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Missing|0|||
156339071|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Missing|0|||
156339072|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Missing|2|||
156465648|NCT03333915|564801596|FG004|Overall Study|Sponsor's Decision|4|||
156465649|NCT03333915|564801592|FG000|Overall Study|Withdrawal by Subject|0|||
156465650|NCT03333915|564801593|FG001|Overall Study|Withdrawal by Subject|0|||
156818297|NCT00395486|566083333|FG000|Overall Study|Adverse Event|1|||
156818298|NCT00395486|566083334|FG001|Overall Study|Adverse Event|2|||
156818299|NCT00395486|566083333|FG000|Overall Study|Withdrawal by Subject|5|||
156818300|NCT00395486|566083334|FG001|Overall Study|Withdrawal by Subject|2|||
156818301|NCT00395486|566083333|FG000|Overall Study|Lost to Follow-up|0|||
156818302|NCT00395486|566083334|FG001|Overall Study|Lost to Follow-up|1|||
156818303|NCT02443116|566083337|FG000|Part 1|Adverse Event|2|||
156818304|NCT02443116|566083338|FG001|Part 1|Adverse Event|3|||
156818305|NCT02443116|566083339|FG002|Part 1|Adverse Event|0|||
156818306|NCT02443116|566083340|FG003|Part 1|Adverse Event|0|||
156818307|NCT02443116|566083341|FG004|Part 1|Adverse Event|0|||
156818308|NCT02443116|566083342|FG005|Part 1|Adverse Event|0|||
156818309|NCT02443116|566083343|FG006|Part 1|Adverse Event|0|||
156818310|NCT02443116|566083344|FG007|Part 1|Adverse Event|0|||
156818311|NCT02443116|566083345|FG008|Part 1|Adverse Event|0|||
156818312|NCT02443116|566083337|FG000|Part 1|Withdrew informed consent|0|||
156818313|NCT02443116|566083338|FG001|Part 1|Withdrew informed consent|1|||
156818314|NCT02443116|566083339|FG002|Part 1|Withdrew informed consent|0|||
156818315|NCT02443116|566083340|FG003|Part 1|Withdrew informed consent|0|||
156818316|NCT02443116|566083341|FG004|Part 1|Withdrew informed consent|0|||
156818317|NCT02443116|566083342|FG005|Part 1|Withdrew informed consent|0|||
156818318|NCT02443116|566083343|FG006|Part 1|Withdrew informed consent|0|||
156818319|NCT02443116|566083344|FG007|Part 1|Withdrew informed consent|0|||
156818320|NCT02443116|566083345|FG008|Part 1|Withdrew informed consent|0|||
156818321|NCT02443116|566083337|FG000|Part 1|Lost to Follow-up|0|||
156818322|NCT02443116|566083338|FG001|Part 1|Lost to Follow-up|0|||
156818323|NCT02443116|566083339|FG002|Part 1|Lost to Follow-up|2|||
156818324|NCT02443116|566083340|FG003|Part 1|Lost to Follow-up|0|||
156818325|NCT02443116|566083341|FG004|Part 1|Lost to Follow-up|0|||
156818326|NCT02443116|566083342|FG005|Part 1|Lost to Follow-up|0|||
156818327|NCT02443116|566083343|FG006|Part 1|Lost to Follow-up|0|||
156818328|NCT02443116|566083344|FG007|Part 1|Lost to Follow-up|0|||
156818329|NCT02443116|566083345|FG008|Part 1|Lost to Follow-up|0|||
156818330|NCT02443116|566083337|FG000|Part 1|Participant moved out of state|0|||
156818331|NCT02443116|566083338|FG001|Part 1|Participant moved out of state|0|||
156818332|NCT02443116|566083339|FG002|Part 1|Participant moved out of state|1|||
156818333|NCT02443116|566083340|FG003|Part 1|Participant moved out of state|0|||
156818334|NCT02443116|566083341|FG004|Part 1|Participant moved out of state|0|||
156818335|NCT02443116|566083342|FG005|Part 1|Participant moved out of state|0|||
156818336|NCT02443116|566083343|FG006|Part 1|Participant moved out of state|0|||
156339073|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Missing|0|||
156339074|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Missing|0|||
156339075|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
156818337|NCT02443116|566083344|FG007|Part 1|Participant moved out of state|0|||
156818338|NCT02443116|566083345|FG008|Part 1|Participant moved out of state|0|||
156818339|NCT02443116|566083337|FG000|Part 1|Participant enrolled in another clinical trial|0|||
156818340|NCT02443116|566083338|FG001|Part 1|Participant enrolled in another clinical trial|0|||
156818341|NCT02443116|566083339|FG002|Part 1|Participant enrolled in another clinical trial|1|||
156818342|NCT02443116|566083340|FG003|Part 1|Participant enrolled in another clinical trial|0|||
156818343|NCT02443116|566083341|FG004|Part 1|Participant enrolled in another clinical trial|0|||
156818344|NCT02443116|566083342|FG005|Part 1|Participant enrolled in another clinical trial|0|||
156339076|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
156465651|NCT03333915|564801594|FG002|Overall Study|Withdrawal by Subject|0|||
156818345|NCT02443116|566083343|FG006|Part 1|Participant enrolled in another clinical trial|0|||
156818346|NCT02443116|566083344|FG007|Part 1|Participant enrolled in another clinical trial|0|||
156818347|NCT02443116|566083345|FG008|Part 1|Participant enrolled in another clinical trial|0|||
156818348|NCT02443116|566083337|FG000|Part 2|Adverse Event|0|||
156818349|NCT02443116|566083338|FG001|Part 2|Adverse Event|0|||
156818350|NCT02443116|566083339|FG002|Part 2|Adverse Event|0|||
156818351|NCT02443116|566083340|FG003|Part 2|Adverse Event|0|||
156818352|NCT02443116|566083341|FG004|Part 2|Adverse Event|1|||
156818353|NCT02443116|566083342|FG005|Part 2|Adverse Event|1|||
156818354|NCT02443116|566083343|FG006|Part 2|Adverse Event|2|||
156818355|NCT02443116|566083344|FG007|Part 2|Adverse Event|0|||
156818356|NCT02443116|566083345|FG008|Part 2|Adverse Event|0|||
156818357|NCT02443116|566083337|FG000|Part 2|Withdrew informed consent|0|||
156818358|NCT02443116|566083338|FG001|Part 2|Withdrew informed consent|0|||
156818359|NCT02443116|566083339|FG002|Part 2|Withdrew informed consent|0|||
156818360|NCT02443116|566083340|FG003|Part 2|Withdrew informed consent|0|||
156818361|NCT02443116|566083341|FG004|Part 2|Withdrew informed consent|0|||
156818362|NCT02443116|566083342|FG005|Part 2|Withdrew informed consent|1|||
156818363|NCT02443116|566083343|FG006|Part 2|Withdrew informed consent|1|||
156818364|NCT02443116|566083344|FG007|Part 2|Withdrew informed consent|0|||
156818365|NCT02443116|566083345|FG008|Part 2|Withdrew informed consent|0|||
156818366|NCT02443116|566083337|FG000|Part 2|Inability to comply with protocol|0|||
156818367|NCT02443116|566083338|FG001|Part 2|Inability to comply with protocol|0|||
156818368|NCT02443116|566083339|FG002|Part 2|Inability to comply with protocol|0|||
156818369|NCT02443116|566083340|FG003|Part 2|Inability to comply with protocol|1|||
156818370|NCT02443116|566083341|FG004|Part 2|Inability to comply with protocol|0|||
156818371|NCT02443116|566083342|FG005|Part 2|Inability to comply with protocol|0|||
156818372|NCT02443116|566083343|FG006|Part 2|Inability to comply with protocol|0|||
156818373|NCT02443116|566083344|FG007|Part 2|Inability to comply with protocol|0|||
156818374|NCT02443116|566083345|FG008|Part 2|Inability to comply with protocol|0|||
156818375|NCT02443116|566083337|FG000|Part 2|Lost to Follow-up|0|||
156818376|NCT02443116|566083338|FG001|Part 2|Lost to Follow-up|0|||
156818377|NCT02443116|566083339|FG002|Part 2|Lost to Follow-up|0|||
156818378|NCT02443116|566083340|FG003|Part 2|Lost to Follow-up|1|||
156818379|NCT02443116|566083341|FG004|Part 2|Lost to Follow-up|0|||
156818380|NCT02443116|566083342|FG005|Part 2|Lost to Follow-up|0|||
156818381|NCT02443116|566083343|FG006|Part 2|Lost to Follow-up|0|||
156818382|NCT02443116|566083344|FG007|Part 2|Lost to Follow-up|0|||
156818383|NCT02443116|566083345|FG008|Part 2|Lost to Follow-up|0|||
156818384|NCT02443116|566083337|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818385|NCT02443116|566083338|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818386|NCT02443116|566083339|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818387|NCT02443116|566083340|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818388|NCT02443116|566083341|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818389|NCT02443116|566083342|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
156818390|NCT02443116|566083343|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818391|NCT02443116|566083344|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818392|NCT02443116|566083345|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818393|NCT02443116|566083337|FG000|Part 3|Adverse Event|0|||
156818394|NCT02443116|566083338|FG001|Part 3|Adverse Event|0|||
156818395|NCT02443116|566083339|FG002|Part 3|Adverse Event|0|||
156818396|NCT02443116|566083340|FG003|Part 3|Adverse Event|0|||
156818397|NCT02443116|566083341|FG004|Part 3|Adverse Event|0|||
156818398|NCT02443116|566083342|FG005|Part 3|Adverse Event|0|||
156818399|NCT02443116|566083343|FG006|Part 3|Adverse Event|0|||
156818400|NCT02443116|566083344|FG007|Part 3|Adverse Event|0|||
156818401|NCT02443116|566083345|FG008|Part 3|Adverse Event|1|||
156818402|NCT02443116|566083337|FG000|Part 3|Withdrew informed consent|0|||
156818403|NCT02443116|566083338|FG001|Part 3|Withdrew informed consent|0|||
156818404|NCT02443116|566083339|FG002|Part 3|Withdrew informed consent|0|||
156818405|NCT02443116|566083340|FG003|Part 3|Withdrew informed consent|0|||
156818406|NCT02443116|566083341|FG004|Part 3|Withdrew informed consent|0|||
156818407|NCT02443116|566083342|FG005|Part 3|Withdrew informed consent|0|||
156818408|NCT02443116|566083343|FG006|Part 3|Withdrew informed consent|0|||
156818409|NCT02443116|566083344|FG007|Part 3|Withdrew informed consent|3|||
156818410|NCT02443116|566083345|FG008|Part 3|Withdrew informed consent|2|||
156818411|NCT02443116|566083337|FG000|Part 3|Lost to Follow-up|0|||
156818412|NCT02443116|566083338|FG001|Part 3|Lost to Follow-up|0|||
156818413|NCT02443116|566083339|FG002|Part 3|Lost to Follow-up|0|||
156818414|NCT02443116|566083340|FG003|Part 3|Lost to Follow-up|0|||
156818415|NCT02443116|566083341|FG004|Part 3|Lost to Follow-up|0|||
156818416|NCT02443116|566083342|FG005|Part 3|Lost to Follow-up|0|||
156818417|NCT02443116|566083343|FG006|Part 3|Lost to Follow-up|0|||
156818418|NCT02443116|566083344|FG007|Part 3|Lost to Follow-up|1|||
156818419|NCT02443116|566083345|FG008|Part 3|Lost to Follow-up|2|||
156818420|NCT04295759|566083346|FG000|Overall Study|Lack of Efficacy|9|||
156818421|NCT04295759|566083346|FG000|Overall Study|Death|1|||
156818422|NCT04295759|566083346|FG000|Overall Study|Withdrawal by Subject|2|||
156818423|NCT04295759|566083346|FG000|Overall Study|Deemed ineligible|1|||
156818424|NCT01696981|566083347|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
156818425|NCT01696981|566083348|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
156818426|NCT01696981|566083347|FG000|Overall Study|Died Before Randomization|3|||
156818427|NCT01696981|566083348|FG001|Overall Study|Died Before Randomization|8|||
156818428|NCT01696981|566083347|FG000|Overall Study|Died Before ASU (Control)|278|||
156818429|NCT01696981|566083348|FG001|Overall Study|Died Before ASU (Control)|0|||
156818430|NCT01696981|566083347|FG000|Overall Study|Refused ASU (Control)|920|||
156818431|NCT01696981|566083348|FG001|Overall Study|Refused ASU (Control)|0|||
156339077|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
156818432|NCT01696981|566083347|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
156818433|NCT01696981|566083348|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
156818434|NCT00465972|566083351|FG000|Overall Study|Withdrawal by Subject|2|||
156818435|NCT00465972|566083352|FG001|Overall Study|Withdrawal by Subject|1|||
156818436|NCT02097719|566083353|FG000|Overall Study|Subject Withdrew Consent|1|||
156818437|NCT02097719|566083354|FG001|Overall Study|Subject Withdrew Consent|0|||
156818438|NCT02097719|566083353|FG000|Overall Study|Lost to Follow-up|0|||
156818439|NCT02097719|566083354|FG001|Overall Study|Lost to Follow-up|1|||
156818440|NCT02097719|566083353|FG000|Overall Study|Adverse Event|2|||
156818441|NCT02097719|566083354|FG001|Overall Study|Adverse Event|0|||
156818442|NCT03292640|566083355|FG000|Overall Study|Withdrawal by Subject|17|||
156818443|NCT03292640|566083356|FG001|Overall Study|Withdrawal by Subject|16|||
156818444|NCT03292640|566083355|FG000|Overall Study|Adverse Event|20|||
156818445|NCT03292640|566083356|FG001|Overall Study|Adverse Event|2|||
156818446|NCT03292640|566083355|FG000|Overall Study|Lost to Follow-up|24|||
156818447|NCT03292640|566083356|FG001|Overall Study|Lost to Follow-up|24|||
156818448|NCT01108731|566083358|FG000|Overall Study|Withdrawal by Subject|1|||
156818449|NCT01108731|566083359|FG001|Overall Study|Withdrawal by Subject|1|||
156818450|NCT01108731|566083358|FG000|Overall Study|Adverse Event|3|||
156818451|NCT01108731|566083359|FG001|Overall Study|Adverse Event|3|||
156818452|NCT03479541|566083363|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
156818453|NCT03479541|566083364|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
156818454|NCT03479541|566083365|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
156818455|NCT03479541|566083366|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
156818456|NCT03479541|566083363|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
156818457|NCT03479541|566083364|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
156818458|NCT03479541|566083365|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
156818459|NCT03479541|566083366|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
156818460|NCT03479541|566083363|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
156818461|NCT03479541|566083364|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
156818462|NCT03479541|566083365|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
156818463|NCT03479541|566083366|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
156818464|NCT03479541|566083363|FG000|Home Monitoring|Lost to Follow-up|0|||
156818465|NCT03479541|566083364|FG001|Home Monitoring|Lost to Follow-up|0|||
156818466|NCT03479541|566083365|FG002|Home Monitoring|Lost to Follow-up|8|||
156818467|NCT03479541|566083366|FG003|Home Monitoring|Lost to Follow-up|12|||
156818468|NCT03479541|566083363|FG000|Home Monitoring|Withdrawal by Subject|0|||
156818469|NCT03479541|566083364|FG001|Home Monitoring|Withdrawal by Subject|0|||
156818470|NCT03479541|566083365|FG002|Home Monitoring|Withdrawal by Subject|17|||
156818471|NCT03479541|566083366|FG003|Home Monitoring|Withdrawal by Subject|30|||
156818472|NCT03479541|566083363|FG000|Home Monitoring|Early Termination - PI Decision|0|||
156818473|NCT03479541|566083364|FG001|Home Monitoring|Early Termination - PI Decision|0|||
156818474|NCT03479541|566083365|FG002|Home Monitoring|Early Termination - PI Decision|4|||
156818475|NCT03479541|566083366|FG003|Home Monitoring|Early Termination - PI Decision|6|||
156818476|NCT03110029|566083367|FG000|Overall Study|Withdrawal by Subject|1|||
156818477|NCT03110029|566083368|FG001|Overall Study|Withdrawal by Subject|1|||
156818478|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
156818479|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
156818480|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
156818481|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
156818482|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
156818483|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
156818484|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
156818485|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
156818486|NCT01673854|566083370|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
156818487|NCT01673854|566083370|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
156818488|NCT01673854|566083370|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
156818489|NCT01673854|566083370|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
156818490|NCT00489424|566085320|FG000|Overall Study|Adverse Event|3|||
156818491|NCT00489424|566085321|FG001|Overall Study|Adverse Event|3|||
156818492|NCT00489424|566085322|FG002|Overall Study|Adverse Event|4|||
156339078|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
156339079|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
156818493|NCT00489424|566085320|FG000|Overall Study|Lack of Efficacy|1|||
156818494|NCT00489424|566085321|FG001|Overall Study|Lack of Efficacy|0|||
156818495|NCT00489424|566085322|FG002|Overall Study|Lack of Efficacy|0|||
156818496|NCT00489424|566085320|FG000|Overall Study|Administrative problems|0|||
156818497|NCT00489424|566085321|FG001|Overall Study|Administrative problems|2|||
156818498|NCT00489424|566085322|FG002|Overall Study|Administrative problems|1|||
156818499|NCT01436656|566085323|FG000|Dose Escalation|Death|1|||
156818500|NCT01436656|566085324|FG001|Dose Escalation|Death|3|||
156818501|NCT01436656|566085325|FG002|Dose Escalation|Death|1|||
156818502|NCT01436656|566085326|FG003|Dose Escalation|Death|0|||
156818503|NCT01436656|566085327|FG004|Dose Escalation|Death|2|||
156818504|NCT01436656|566085328|FG005|Dose Escalation|Death|1|||
156818505|NCT01436656|566085329|FG006|Dose Escalation|Death|1|||
156818506|NCT01436656|566085330|FG007|Dose Escalation|Death|1|||
156818507|NCT01436656|566085331|FG008|Dose Escalation|Death|1|||
156818508|NCT01436656|566085332|FG009|Dose Escalation|Death|0|||
156818509|NCT01436656|566085333|FG010|Dose Escalation|Death|0|||
156818510|NCT01436656|566085334|FG011|Dose Escalation|Death|0|||
156818511|NCT01436656|566085335|FG012|Dose Escalation|Death|0|||
156818512|NCT01436656|566085336|FG013|Dose Escalation|Death|0|||
156818513|NCT01436656|566085337|FG014|Dose Escalation|Death|0|||
156818514|NCT01436656|566085338|FG015|Dose Escalation|Death|0|||
156818515|NCT01436656|566085339|FG016|Dose Escalation|Death|0|||
156818516|NCT01436656|566085340|FG017|Dose Escalation|Death|0|||
156818517|NCT01436656|566085323|FG000|Dose Escalation|Protocol Violation|0|||
156818518|NCT01436656|566085324|FG001|Dose Escalation|Protocol Violation|0|||
156818519|NCT01436656|566085325|FG002|Dose Escalation|Protocol Violation|0|||
156818520|NCT01436656|566085326|FG003|Dose Escalation|Protocol Violation|0|||
156818521|NCT01436656|566085327|FG004|Dose Escalation|Protocol Violation|0|||
156818522|NCT01436656|566085328|FG005|Dose Escalation|Protocol Violation|1|||
156818523|NCT01436656|566085329|FG006|Dose Escalation|Protocol Violation|0|||
156818524|NCT01436656|566085330|FG007|Dose Escalation|Protocol Violation|0|||
156818525|NCT01436656|566085331|FG008|Dose Escalation|Protocol Violation|0|||
156818526|NCT01436656|566085332|FG009|Dose Escalation|Protocol Violation|0|||
156818527|NCT01436656|566085333|FG010|Dose Escalation|Protocol Violation|0|||
156818528|NCT01436656|566085334|FG011|Dose Escalation|Protocol Violation|0|||
156818529|NCT01436656|566085335|FG012|Dose Escalation|Protocol Violation|0|||
156818530|NCT01436656|566085336|FG013|Dose Escalation|Protocol Violation|0|||
156818531|NCT01436656|566085337|FG014|Dose Escalation|Protocol Violation|0|||
156818532|NCT01436656|566085338|FG015|Dose Escalation|Protocol Violation|0|||
156818533|NCT01436656|566085339|FG016|Dose Escalation|Protocol Violation|0|||
156818534|NCT01436656|566085340|FG017|Dose Escalation|Protocol Violation|0|||
156818535|NCT01436656|566085323|FG000|Dose Escalation|Withdrawal by Subject|0|||
156818536|NCT01436656|566085324|FG001|Dose Escalation|Withdrawal by Subject|0|||
156818537|NCT01436656|566085325|FG002|Dose Escalation|Withdrawal by Subject|0|||
156818538|NCT01436656|566085326|FG003|Dose Escalation|Withdrawal by Subject|0|||
156818539|NCT01436656|566085327|FG004|Dose Escalation|Withdrawal by Subject|1|||
156818540|NCT01436656|566085328|FG005|Dose Escalation|Withdrawal by Subject|0|||
156818541|NCT01436656|566085329|FG006|Dose Escalation|Withdrawal by Subject|0|||
156818542|NCT01436656|566085330|FG007|Dose Escalation|Withdrawal by Subject|2|||
156818543|NCT01436656|566085331|FG008|Dose Escalation|Withdrawal by Subject|0|||
156818544|NCT01436656|566085332|FG009|Dose Escalation|Withdrawal by Subject|1|||
156818545|NCT01436656|566085333|FG010|Dose Escalation|Withdrawal by Subject|1|||
156818546|NCT01436656|566085334|FG011|Dose Escalation|Withdrawal by Subject|0|||
156818547|NCT01436656|566085335|FG012|Dose Escalation|Withdrawal by Subject|0|||
156818548|NCT01436656|566085336|FG013|Dose Escalation|Withdrawal by Subject|0|||
156818549|NCT01436656|566085337|FG014|Dose Escalation|Withdrawal by Subject|0|||
156818550|NCT01436656|566085338|FG015|Dose Escalation|Withdrawal by Subject|0|||
156818551|NCT01436656|566085339|FG016|Dose Escalation|Withdrawal by Subject|0|||
156818552|NCT01436656|566085340|FG017|Dose Escalation|Withdrawal by Subject|0|||
156818553|NCT01436656|566085323|FG000|Dose Escalation|Administrative problems|0|||
156818554|NCT01436656|566085324|FG001|Dose Escalation|Administrative problems|1|||
156818555|NCT01436656|566085325|FG002|Dose Escalation|Administrative problems|0|||
156818556|NCT01436656|566085326|FG003|Dose Escalation|Administrative problems|0|||
156818557|NCT01436656|566085327|FG004|Dose Escalation|Administrative problems|0|||
156818558|NCT01436656|566085328|FG005|Dose Escalation|Administrative problems|0|||
156818559|NCT01436656|566085329|FG006|Dose Escalation|Administrative problems|0|||
156818560|NCT01436656|566085330|FG007|Dose Escalation|Administrative problems|0|||
156818561|NCT01436656|566085331|FG008|Dose Escalation|Administrative problems|0|||
156465652|NCT03333915|564801595|FG003|Overall Study|Withdrawal by Subject|5|||
156465653|NCT03333915|564801596|FG004|Overall Study|Withdrawal by Subject|1|||
156465654|NCT04174560|564801614|FG000|Overall Study|Lost to Follow-up|1|||
156465655|NCT04174560|564801615|FG001|Overall Study|Lost to Follow-up|0|||
156818562|NCT01436656|566085332|FG009|Dose Escalation|Administrative problems|0|||
156818563|NCT01436656|566085333|FG010|Dose Escalation|Administrative problems|0|||
156818564|NCT01436656|566085334|FG011|Dose Escalation|Administrative problems|0|||
156818565|NCT01436656|566085335|FG012|Dose Escalation|Administrative problems|0|||
156818566|NCT01436656|566085336|FG013|Dose Escalation|Administrative problems|0|||
156465656|NCT04174560|564801616|FG002|Overall Study|Lost to Follow-up|0|||
156818567|NCT01436656|566085337|FG014|Dose Escalation|Administrative problems|0|||
156818568|NCT01436656|566085338|FG015|Dose Escalation|Administrative problems|0|||
156818569|NCT01436656|566085339|FG016|Dose Escalation|Administrative problems|0|||
156818570|NCT01436656|566085340|FG017|Dose Escalation|Administrative problems|0|||
156818571|NCT01436656|566085323|FG000|Dose Escalation|Lost to Follow-up|1|||
156818572|NCT01436656|566085324|FG001|Dose Escalation|Lost to Follow-up|0|||
156818573|NCT01436656|566085325|FG002|Dose Escalation|Lost to Follow-up|0|||
156818574|NCT01436656|566085326|FG003|Dose Escalation|Lost to Follow-up|0|||
156465657|NCT04174560|564801617|FG003|Overall Study|Lost to Follow-up|0|||
156818575|NCT01436656|566085327|FG004|Dose Escalation|Lost to Follow-up|1|||
156818576|NCT01436656|566085328|FG005|Dose Escalation|Lost to Follow-up|0|||
156818577|NCT01436656|566085329|FG006|Dose Escalation|Lost to Follow-up|0|||
156818578|NCT01436656|566085330|FG007|Dose Escalation|Lost to Follow-up|0|||
156818579|NCT01436656|566085331|FG008|Dose Escalation|Lost to Follow-up|0|||
156818580|NCT01436656|566085332|FG009|Dose Escalation|Lost to Follow-up|0|||
156818581|NCT01436656|566085333|FG010|Dose Escalation|Lost to Follow-up|0|||
156818582|NCT01436656|566085334|FG011|Dose Escalation|Lost to Follow-up|0|||
156818583|NCT01436656|566085335|FG012|Dose Escalation|Lost to Follow-up|0|||
156818584|NCT01436656|566085336|FG013|Dose Escalation|Lost to Follow-up|0|||
156818585|NCT01436656|566085337|FG014|Dose Escalation|Lost to Follow-up|0|||
156818586|NCT01436656|566085338|FG015|Dose Escalation|Lost to Follow-up|0|||
156818587|NCT01436656|566085339|FG016|Dose Escalation|Lost to Follow-up|0|||
156818588|NCT01436656|566085340|FG017|Dose Escalation|Lost to Follow-up|0|||
156818589|NCT01436656|566085323|FG000|Dose Escalation|New anti-cancer therapy|1|||
156818590|NCT01436656|566085324|FG001|Dose Escalation|New anti-cancer therapy|0|||
156818591|NCT01436656|566085325|FG002|Dose Escalation|New anti-cancer therapy|0|||
156818592|NCT01436656|566085326|FG003|Dose Escalation|New anti-cancer therapy|0|||
156818593|NCT01436656|566085327|FG004|Dose Escalation|New anti-cancer therapy|0|||
156818594|NCT01436656|566085328|FG005|Dose Escalation|New anti-cancer therapy|0|||
156818595|NCT01436656|566085329|FG006|Dose Escalation|New anti-cancer therapy|0|||
156818596|NCT01436656|566085330|FG007|Dose Escalation|New anti-cancer therapy|0|||
156818597|NCT01436656|566085331|FG008|Dose Escalation|New anti-cancer therapy|1|||
156818598|NCT01436656|566085332|FG009|Dose Escalation|New anti-cancer therapy|1|||
156818599|NCT01436656|566085333|FG010|Dose Escalation|New anti-cancer therapy|0|||
156818600|NCT01436656|566085334|FG011|Dose Escalation|New anti-cancer therapy|0|||
156818601|NCT01436656|566085335|FG012|Dose Escalation|New anti-cancer therapy|0|||
156818602|NCT01436656|566085336|FG013|Dose Escalation|New anti-cancer therapy|0|||
156818603|NCT01436656|566085337|FG014|Dose Escalation|New anti-cancer therapy|0|||
156818604|NCT01436656|566085338|FG015|Dose Escalation|New anti-cancer therapy|0|||
156818605|NCT01436656|566085339|FG016|Dose Escalation|New anti-cancer therapy|0|||
156818606|NCT01436656|566085340|FG017|Dose Escalation|New anti-cancer therapy|0|||
156818607|NCT01436656|566085323|FG000|Dose Expansion|Adverse Event|0|||
156818608|NCT01436656|566085324|FG001|Dose Expansion|Adverse Event|0|||
156818609|NCT01436656|566085325|FG002|Dose Expansion|Adverse Event|0|||
156818610|NCT01436656|566085326|FG003|Dose Expansion|Adverse Event|0|||
156818611|NCT01436656|566085327|FG004|Dose Expansion|Adverse Event|0|||
156818612|NCT01436656|566085328|FG005|Dose Expansion|Adverse Event|0|||
156818613|NCT01436656|566085329|FG006|Dose Expansion|Adverse Event|0|||
156818614|NCT01436656|566085330|FG007|Dose Expansion|Adverse Event|0|||
156818615|NCT01436656|566085331|FG008|Dose Expansion|Adverse Event|0|||
156818616|NCT01436656|566085332|FG009|Dose Expansion|Adverse Event|0|||
156818617|NCT01436656|566085333|FG010|Dose Expansion|Adverse Event|0|||
156818618|NCT01436656|566085334|FG011|Dose Expansion|Adverse Event|1|||
156818619|NCT01436656|566085335|FG012|Dose Expansion|Adverse Event|0|||
156818620|NCT01436656|566085336|FG013|Dose Expansion|Adverse Event|0|||
156818621|NCT01436656|566085337|FG014|Dose Expansion|Adverse Event|0|||
156818622|NCT01436656|566085338|FG015|Dose Expansion|Adverse Event|0|||
156818623|NCT01436656|566085339|FG016|Dose Expansion|Adverse Event|0|||
156818624|NCT01436656|566085340|FG017|Dose Expansion|Adverse Event|0|||
156818625|NCT01436656|566085323|FG000|Dose Expansion|Withdrawal by Subject|0|||
156818626|NCT01436656|566085324|FG001|Dose Expansion|Withdrawal by Subject|0|||
156818627|NCT01436656|566085325|FG002|Dose Expansion|Withdrawal by Subject|0|||
156818628|NCT01436656|566085326|FG003|Dose Expansion|Withdrawal by Subject|0|||
156818629|NCT01436656|566085327|FG004|Dose Expansion|Withdrawal by Subject|0|||
156818630|NCT01436656|566085328|FG005|Dose Expansion|Withdrawal by Subject|0|||
156465658|NCT04174560|564801614|FG000|Overall Study|Withdrawal by Subject|0|||
156465659|NCT04174560|564801615|FG001|Overall Study|Withdrawal by Subject|0|||
156465660|NCT04174560|564801616|FG002|Overall Study|Withdrawal by Subject|2|||
156818631|NCT01436656|566085329|FG006|Dose Expansion|Withdrawal by Subject|0|||
156818632|NCT01436656|566085330|FG007|Dose Expansion|Withdrawal by Subject|0|||
156818633|NCT01436656|566085331|FG008|Dose Expansion|Withdrawal by Subject|0|||
156818634|NCT01436656|566085332|FG009|Dose Expansion|Withdrawal by Subject|0|||
156465661|NCT04174560|564801617|FG003|Overall Study|Withdrawal by Subject|0|||
156818635|NCT01436656|566085333|FG010|Dose Expansion|Withdrawal by Subject|0|||
156818636|NCT01436656|566085334|FG011|Dose Expansion|Withdrawal by Subject|1|||
156818637|NCT01436656|566085335|FG012|Dose Expansion|Withdrawal by Subject|3|||
156818638|NCT01436656|566085336|FG013|Dose Expansion|Withdrawal by Subject|1|||
156818639|NCT01436656|566085337|FG014|Dose Expansion|Withdrawal by Subject|2|||
156818640|NCT01436656|566085338|FG015|Dose Expansion|Withdrawal by Subject|0|||
156818641|NCT01436656|566085339|FG016|Dose Expansion|Withdrawal by Subject|1|||
156339080|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
156818642|NCT01436656|566085340|FG017|Dose Expansion|Withdrawal by Subject|1|||
156818643|NCT01436656|566085323|FG000|Dose Expansion|Death|0|||
156339081|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
156465662|NCT04940624|564801620|FG000|Overall Study|Adverse Event|4|||
156339082|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
156339083|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
156339084|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
156339085|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
156339086|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
156339087|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
156339088|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
156339089|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
156339090|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
156339091|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
156339092|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
156339093|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
156339094|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
156339095|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
156339096|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
156339097|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
156339098|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
156339099|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
156339100|NCT00730405|564340090|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
156339101|NCT00730405|564340091|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
156339102|NCT00730405|564340092|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
156339103|NCT00730405|564340093|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
156339104|NCT00730405|564340094|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
156339105|NCT01496807|564340095|FG000|Overall Study|Progressive Disease|21|||
156339106|NCT01496807|564340095|FG000|Overall Study|Participant preference/toxicity|8|||
156339107|NCT01496807|564340095|FG000|Overall Study|Change in diagnosis|1|||
156818644|NCT01436656|566085324|FG001|Dose Expansion|Death|0|||
156818645|NCT01436656|566085325|FG002|Dose Expansion|Death|0|||
156818646|NCT01436656|566085326|FG003|Dose Expansion|Death|0|||
156818647|NCT01436656|566085327|FG004|Dose Expansion|Death|0|||
156818648|NCT01436656|566085328|FG005|Dose Expansion|Death|0|||
156818649|NCT01436656|566085329|FG006|Dose Expansion|Death|0|||
156818650|NCT01436656|566085330|FG007|Dose Expansion|Death|0|||
156818651|NCT01436656|566085331|FG008|Dose Expansion|Death|0|||
156818652|NCT01436656|566085332|FG009|Dose Expansion|Death|0|||
156818653|NCT01436656|566085333|FG010|Dose Expansion|Death|0|||
156818654|NCT01436656|566085334|FG011|Dose Expansion|Death|0|||
156818655|NCT01436656|566085335|FG012|Dose Expansion|Death|1|||
156818656|NCT01436656|566085336|FG013|Dose Expansion|Death|0|||
156818657|NCT01436656|566085337|FG014|Dose Expansion|Death|3|||
156818658|NCT01436656|566085338|FG015|Dose Expansion|Death|0|||
156818659|NCT01436656|566085339|FG016|Dose Expansion|Death|3|||
156818660|NCT01436656|566085340|FG017|Dose Expansion|Death|3|||
156818661|NCT01436656|566085323|FG000|Dose Expansion|Lost to Follow-up|0|||
156818662|NCT01436656|566085324|FG001|Dose Expansion|Lost to Follow-up|0|||
156818663|NCT01436656|566085325|FG002|Dose Expansion|Lost to Follow-up|0|||
156818664|NCT01436656|566085326|FG003|Dose Expansion|Lost to Follow-up|0|||
156818665|NCT01436656|566085327|FG004|Dose Expansion|Lost to Follow-up|0|||
156818666|NCT01436656|566085328|FG005|Dose Expansion|Lost to Follow-up|0|||
156818667|NCT01436656|566085329|FG006|Dose Expansion|Lost to Follow-up|0|||
156818668|NCT01436656|566085330|FG007|Dose Expansion|Lost to Follow-up|0|||
156339108|NCT03095612|564340099|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156339109|NCT03095612|564340100|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
156339110|NCT03095612|564340101|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156339111|NCT03095612|564340102|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156339112|NCT03095612|564340103|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156339113|NCT03095612|564340104|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156339114|NCT03095612|564340105|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156339115|NCT04447794|564340106|FG000|Overall Study|Lost to Follow-up|2|||
156339116|NCT04447794|564340107|FG001|Overall Study|Lost to Follow-up|3|||
156339117|NCT04447794|564340108|FG002|Overall Study|Lost to Follow-up|8|||
156818669|NCT01436656|566085331|FG008|Dose Expansion|Lost to Follow-up|0|||
156818670|NCT01436656|566085332|FG009|Dose Expansion|Lost to Follow-up|0|||
156818671|NCT01436656|566085333|FG010|Dose Expansion|Lost to Follow-up|0|||
156818672|NCT01436656|566085334|FG011|Dose Expansion|Lost to Follow-up|0|||
156818673|NCT01436656|566085335|FG012|Dose Expansion|Lost to Follow-up|0|||
156818674|NCT01436656|566085336|FG013|Dose Expansion|Lost to Follow-up|0|||
156818675|NCT01436656|566085337|FG014|Dose Expansion|Lost to Follow-up|0|||
156818676|NCT01436656|566085338|FG015|Dose Expansion|Lost to Follow-up|0|||
156818677|NCT01436656|566085339|FG016|Dose Expansion|Lost to Follow-up|0|||
156818678|NCT01436656|566085340|FG017|Dose Expansion|Lost to Follow-up|3|||
156818679|NCT01436656|566085323|FG000|Dose Expansion|Disease progression|0|||
156465663|NCT04940624|564801621|FG001|Overall Study|Adverse Event|11|||
156465664|NCT04940624|564801620|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156465665|NCT04940624|564801621|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156465666|NCT04940624|564801620|FG000|Overall Study|Physician Decision|1|||
156465667|NCT04940624|564801621|FG001|Overall Study|Physician Decision|0|||
156465668|NCT04940624|564801620|FG000|Overall Study|Lost to Follow-up|1|||
156818680|NCT01436656|566085324|FG001|Dose Expansion|Disease progression|0|||
156818681|NCT01436656|566085325|FG002|Dose Expansion|Disease progression|0|||
156818682|NCT01436656|566085326|FG003|Dose Expansion|Disease progression|0|||
156818683|NCT01436656|566085327|FG004|Dose Expansion|Disease progression|0|||
156818684|NCT01436656|566085328|FG005|Dose Expansion|Disease progression|0|||
156818685|NCT01436656|566085329|FG006|Dose Expansion|Disease progression|0|||
156818686|NCT01436656|566085330|FG007|Dose Expansion|Disease progression|0|||
156818687|NCT01436656|566085331|FG008|Dose Expansion|Disease progression|0|||
156818688|NCT01436656|566085332|FG009|Dose Expansion|Disease progression|0|||
156818689|NCT01436656|566085333|FG010|Dose Expansion|Disease progression|0|||
156818690|NCT01436656|566085334|FG011|Dose Expansion|Disease progression|3|||
156818691|NCT01436656|566085335|FG012|Dose Expansion|Disease progression|1|||
156818692|NCT01436656|566085336|FG013|Dose Expansion|Disease progression|0|||
156818693|NCT01436656|566085337|FG014|Dose Expansion|Disease progression|1|||
156818694|NCT01436656|566085338|FG015|Dose Expansion|Disease progression|0|||
156818695|NCT01436656|566085339|FG016|Dose Expansion|Disease progression|0|||
156818696|NCT01436656|566085340|FG017|Dose Expansion|Disease progression|1|||
156818697|NCT01436656|566085323|FG000|Dose Expansion|New cancer therapy|0|||
156818698|NCT01436656|566085324|FG001|Dose Expansion|New cancer therapy|0|||
156818699|NCT01436656|566085325|FG002|Dose Expansion|New cancer therapy|0|||
156818700|NCT01436656|566085326|FG003|Dose Expansion|New cancer therapy|0|||
156818701|NCT01436656|566085327|FG004|Dose Expansion|New cancer therapy|0|||
156818702|NCT01436656|566085328|FG005|Dose Expansion|New cancer therapy|0|||
156818703|NCT01436656|566085329|FG006|Dose Expansion|New cancer therapy|0|||
156818704|NCT01436656|566085330|FG007|Dose Expansion|New cancer therapy|0|||
156818705|NCT01436656|566085331|FG008|Dose Expansion|New cancer therapy|0|||
156818706|NCT01436656|566085332|FG009|Dose Expansion|New cancer therapy|0|||
156818707|NCT01436656|566085333|FG010|Dose Expansion|New cancer therapy|0|||
156818708|NCT01436656|566085334|FG011|Dose Expansion|New cancer therapy|1|||
156818709|NCT01436656|566085335|FG012|Dose Expansion|New cancer therapy|1|||
156818710|NCT01436656|566085336|FG013|Dose Expansion|New cancer therapy|0|||
156818711|NCT01436656|566085337|FG014|Dose Expansion|New cancer therapy|2|||
156818712|NCT01436656|566085338|FG015|Dose Expansion|New cancer therapy|0|||
156818713|NCT01436656|566085339|FG016|Dose Expansion|New cancer therapy|0|||
156818714|NCT01436656|566085340|FG017|Dose Expansion|New cancer therapy|0|||
156818715|NCT00705250|566085343|FG000|Overall Study|Withdrawal by Subject|1|||
156818716|NCT00705250|566085343|FG000|Overall Study|Patient died in car accident|1|||
156818717|NCT00880269|566085344|FG000|Overall Study|Protocol Violation|1|||
156818718|NCT00880269|566085345|FG001|Overall Study|Protocol Violation|0|||
156818719|NCT00880269|566085344|FG000|Overall Study|Disease Progression|13|||
156818720|NCT00880269|566085345|FG001|Overall Study|Disease Progression|11|||
156818721|NCT00880269|566085344|FG000|Overall Study|New Cancer Therapy|1|||
156818722|NCT00880269|566085345|FG001|Overall Study|New Cancer Therapy|0|||
156818723|NCT00880269|566085344|FG000|Overall Study|Death|4|||
156818724|NCT00880269|566085345|FG001|Overall Study|Death|2|||
156818725|NCT00880269|566085344|FG000|Overall Study|Lost to Follow-up|0|||
156818726|NCT00880269|566085345|FG001|Overall Study|Lost to Follow-up|1|||
156818727|NCT00880269|566085344|FG000|Overall Study|Withdrawal by Subject|3|||
156818728|NCT00880269|566085345|FG001|Overall Study|Withdrawal by Subject|4|||
156818729|NCT00880269|566085344|FG000|Overall Study|Adverse Event|10|||
156818730|NCT00880269|566085345|FG001|Overall Study|Adverse Event|9|||
156818731|NCT00962741|566085350|FG000|Overall Study|Failed to return|3|||
156465669|NCT04940624|564801621|FG001|Overall Study|Lost to Follow-up|0|||
156818732|NCT00962741|566085350|FG000|Overall Study|Lost to Follow-up|2|||
156818733|NCT00962741|566085350|FG000|Overall Study|Withdrawal by Subject|1|||
156818734|NCT00962741|566085350|FG000|Overall Study|Lack of Efficacy|1|||
156818735|NCT00962741|566085350|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
156818736|NCT00316225|566085351|FG000|Overall Study|Adverse Event|2|||
156818737|NCT00316225|566085351|FG000|Overall Study|Physician Decision|3|||
156818738|NCT00316225|566085351|FG000|Overall Study|Progressive Disease|15|||
156818739|NCT00316225|566085351|FG000|Overall Study|Withdrawal by Subject|3|||
156818740|NCT00316225|566085351|FG000|Overall Study|Death|2|||
156818741|NCT01814878|566085353|FG000|Overall Study|Adverse Event|16|||
156818742|NCT01814878|566085354|FG001|Overall Study|Adverse Event|5|||
156465670|NCT04940624|564801620|FG000|Overall Study|Reason Not Specified|1|||
156465671|NCT04940624|564801621|FG001|Overall Study|Reason Not Specified|0|||
156818743|NCT01814878|566085353|FG000|Overall Study|Withdrawal by Subject|20|||
156818744|NCT01814878|566085354|FG001|Overall Study|Withdrawal by Subject|16|||
156465672|NCT02890355|564801624|FG000|Overall Study|Adverse Event|5|||
156465673|NCT02890355|564801625|FG001|Overall Study|Adverse Event|5|||
156818745|NCT01814878|566085353|FG000|Overall Study|Protocol Violation|5|||
156818746|NCT01814878|566085354|FG001|Overall Study|Protocol Violation|5|||
156818747|NCT01814878|566085353|FG000|Overall Study|Physician Decision|3|||
156818748|NCT01814878|566085354|FG001|Overall Study|Physician Decision|1|||
156818749|NCT01814878|566085353|FG000|Overall Study|Screening failure (drop-out)|0|||
156465674|NCT02890355|564801624|FG000|Overall Study|Refusal unrelated to adverse event|5|||
156465675|NCT02890355|564801625|FG001|Overall Study|Refusal unrelated to adverse event|10|||
156465676|NCT02890355|564801624|FG000|Overall Study|Progression/relapse|46|||
156465677|NCT02890355|564801625|FG001|Overall Study|Progression/relapse|39|||
156465678|NCT02890355|564801624|FG000|Overall Study|Not protocol specified|3|||
156465679|NCT02890355|564801625|FG001|Overall Study|Not protocol specified|4|||
156465680|NCT02180867|564801627|FG000|Overall Study|Adverse Event|3|||
156818750|NCT01814878|566085354|FG001|Overall Study|Screening failure (drop-out)|3|||
156818751|NCT01814878|566085353|FG000|Overall Study|Other|2|||
156818752|NCT01814878|566085354|FG001|Overall Study|Other|0|||
156818753|NCT01545934|566085355|FG000|Overall Study|Withdrawal by Subject|4|||
156818754|NCT01545934|566085356|FG001|Overall Study|Withdrawal by Subject|3|||
156818755|NCT01545934|566085355|FG000|Overall Study|Lost to Follow-up|1|||
156818756|NCT01545934|566085356|FG001|Overall Study|Lost to Follow-up|0|||
156818757|NCT03654404|566085357|FG000|Overall Study|Death|1|||
156818758|NCT03654404|566085357|FG000|Overall Study|Lost to Follow-up|2|||
156818759|NCT03654404|566085357|FG000|Overall Study|Withdrawal by Subject|5|||
156818760|NCT02003638|566085364|FG000|Overall Study|Withdrawal by Subject|1|||
156818761|NCT02003638|566085365|FG001|Overall Study|Withdrawal by Subject|0|||
156818762|NCT00654745|566085368|FG000|Overall Study|Adverse Event|12|||
156818763|NCT00654745|566085368|FG000|Overall Study|Lost to Follow-up|7|||
156818764|NCT00654745|566085368|FG000|Overall Study|Protocol Violation|11|||
156818765|NCT00654745|566085368|FG000|Overall Study|Withdrawal by Subject|10|||
156818766|NCT00654745|566085368|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
156818767|NCT04551963|566085369|FG000|Overall Study|Physician Decision|1|||
156818768|NCT04551963|566085370|FG001|Overall Study|Physician Decision|1|||
156818769|NCT04551963|566085369|FG000|Overall Study|Death|1|||
156818770|NCT04551963|566085370|FG001|Overall Study|Death|0|||
156818771|NCT02974855|566085371|FG000|Overall Study|Adverse Event|0|||
156818772|NCT02974855|566085372|FG001|Overall Study|Adverse Event|1|||
156818773|NCT02974855|566085373|FG002|Overall Study|Adverse Event|0|||
156818774|NCT02974855|566085374|FG003|Overall Study|Adverse Event|1|||
156818775|NCT01474772|566085375|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
156818776|NCT01474772|566085376|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
156818777|NCT01474772|566085375|FG000|Period 1|AE not Related to Study Drug|1|||
156339118|NCT04447794|564340106|FG000|Overall Study|Withdrawal by Subject|1|||
156818778|NCT01474772|566085376|FG001|Period 1|AE not Related to Study Drug|0|||
156818779|NCT01474772|566085375|FG000|Period 1|Withdrawal by Subject|3|||
156818780|NCT01474772|566085376|FG001|Period 1|Withdrawal by Subject|1|||
156818781|NCT01474772|566085375|FG000|Period 1|Lost to Follow-up|1|||
156818782|NCT01474772|566085376|FG001|Period 1|Lost to Follow-up|0|||
156818783|NCT01474772|566085375|FG000|Period 1|Reason not Specified|1|||
156818784|NCT01474772|566085376|FG001|Period 1|Reason not Specified|1|||
156818785|NCT01474772|566085375|FG000|Washout|AE not Related to Study Drug|2|||
156818786|NCT01474772|566085376|FG001|Washout|AE not Related to Study Drug|0|||
156818787|NCT01474772|566085375|FG000|Washout|Withdrawal by Subject|1|||
156818788|NCT01474772|566085376|FG001|Washout|Withdrawal by Subject|0|||
156818789|NCT01474772|566085375|FG000|Washout|Lost to Follow-up|0|||
156818790|NCT01474772|566085376|FG001|Washout|Lost to Follow-up|1|||
156818791|NCT01474772|566085375|FG000|Washout|Reason not Specified|0|||
156818792|NCT01474772|566085376|FG001|Washout|Reason not Specified|1|||
156818793|NCT01474772|566085375|FG000|Period 2|Death|0|||
156818794|NCT01474772|566085376|FG001|Period 2|Death|1|||
156818795|NCT01474772|566085375|FG000|Period 2|AE Related to Study Drug|0|||
156818796|NCT01474772|566085376|FG001|Period 2|AE Related to Study Drug|1|||
156818797|NCT01474772|566085375|FG000|Period 2|AE not Related to Study Drug|4|||
156818798|NCT01474772|566085376|FG001|Period 2|AE not Related to Study Drug|1|||
156818799|NCT01474772|566085375|FG000|Period 2|Lack of Efficacy|1|||
156818800|NCT01474772|566085376|FG001|Period 2|Lack of Efficacy|0|||
156818801|NCT01474772|566085375|FG000|Period 2|Withdrawal by Subject|3|||
156818802|NCT01474772|566085376|FG001|Period 2|Withdrawal by Subject|4|||
156818803|NCT01474772|566085375|FG000|Period 2|Lost to Follow-up|1|||
156818804|NCT01474772|566085376|FG001|Period 2|Lost to Follow-up|1|||
156818805|NCT01474772|566085375|FG000|Period 2|Reason not Specified|0|||
156465681|NCT02180867|564801628|FG001|Overall Study|Adverse Event|4|||
156465682|NCT02180867|564801629|FG002|Overall Study|Adverse Event|1|||
156465683|NCT02180867|564801630|FG003|Overall Study|Adverse Event|5|||
156465684|NCT02180867|564801631|FG004|Overall Study|Adverse Event|0|||
156818806|NCT01474772|566085376|FG001|Period 2|Reason not Specified|2|||
156818807|NCT01474772|566085375|FG000|Follow-up|AE not Related to Study Drug|0|||
156818808|NCT01474772|566085376|FG001|Follow-up|AE not Related to Study Drug|1|||
156818809|NCT00748618|566085377|FG000|Overall Study|Adverse Event|1|||
156818810|NCT00748618|566085378|FG001|Overall Study|Adverse Event|0|||
156818811|NCT00466947|566085379|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
156818812|NCT00466947|566085380|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
156818813|NCT00466947|566085379|FG000|Study End Analysis Period|Adverse Event|35|||
156818814|NCT00466947|566085380|FG001|Study End Analysis Period|Adverse Event|43|||
156818815|NCT00466947|566085379|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
156818816|NCT00466947|566085380|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
156818817|NCT00466947|566085379|FG000|Study End Analysis Period|Physician Decision|29|||
156818818|NCT00466947|566085380|FG001|Study End Analysis Period|Physician Decision|29|||
156818819|NCT00466947|566085379|FG000|Study End Analysis Period|Protocol Violation|9|||
156818820|NCT00466947|566085380|FG001|Study End Analysis Period|Protocol Violation|17|||
156818821|NCT00466947|566085379|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
156818822|NCT00466947|566085380|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
156818823|NCT00466947|566085379|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
156818824|NCT00466947|566085380|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
156818825|NCT00466947|566085379|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
156818826|NCT00466947|566085380|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
156818827|NCT00466947|566085379|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
156818828|NCT00466947|566085380|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
156818829|NCT00878254|566085381|FG000|Overall Study|Physician Decision|1|||
156818830|NCT00878254|566085381|FG000|Overall Study|Death|1|||
156818831|NCT00878254|566085381|FG000|Overall Study|Withdrawal by Subject|1|||
156818832|NCT01977729|566085385|FG000|Overall Study|Study terminated|1|||
156818833|NCT00759876|566085388|FG000|Overall Study|Sponsor terminated study early|36|||
156818834|NCT01450696|566085390|FG000|Overall Study|Never Treated|1|||
156818835|NCT01450696|566085391|FG001|Overall Study|Never Treated|1|||
156818836|NCT01450696|566085390|FG000|Overall Study|Death|77|||
156818837|NCT01450696|566085391|FG001|Overall Study|Death|84|||
156818838|NCT01450696|566085390|FG000|Overall Study|Lost to Follow-up|3|||
156818839|NCT01450696|566085391|FG001|Overall Study|Lost to Follow-up|3|||
156818840|NCT01450696|566085390|FG000|Overall Study|Non-Compliance|1|||
156818841|NCT01450696|566085391|FG001|Overall Study|Non-Compliance|0|||
156818842|NCT01450696|566085390|FG000|Overall Study|Withdrawal by Subject|13|||
156818843|NCT01450696|566085391|FG001|Overall Study|Withdrawal by Subject|2|||
156818844|NCT01450696|566085390|FG000|Overall Study|Study Terminated by Sponsor|53|||
156818845|NCT01450696|566085391|FG001|Overall Study|Study Terminated by Sponsor|58|||
156818846|NCT02321319|566085393|FG000|Overall Study|Product discontinued|5|||
156818847|NCT02570152|566085396|FG000|Overall Study|Protocol Violation|2|||
156818848|NCT02570152|566085396|FG000|Overall Study|Migrated/moved from study area|13|||
156818849|NCT00853242|566085397|FG000|Overall Study|Adverse Event|0|||
156818850|NCT00853242|566085398|FG001|Overall Study|Adverse Event|1|||
156818851|NCT00853242|566085399|FG002|Overall Study|Adverse Event|1|||
156818852|NCT00853242|566085400|FG003|Overall Study|Adverse Event|0|||
156818853|NCT00853242|566085401|FG004|Overall Study|Adverse Event|3|||
156818854|NCT00853242|566085402|FG005|Overall Study|Adverse Event|1|||
156818855|NCT00853242|566085403|FG006|Overall Study|Adverse Event|1|||
156818856|NCT00853242|566085397|FG000|Overall Study|Noncompliant|0|||
156818857|NCT00853242|566085398|FG001|Overall Study|Noncompliant|0|||
156818858|NCT00853242|566085399|FG002|Overall Study|Noncompliant|0|||
156818859|NCT00853242|566085400|FG003|Overall Study|Noncompliant|0|||
156818860|NCT00853242|566085401|FG004|Overall Study|Noncompliant|1|||
156818861|NCT00853242|566085402|FG005|Overall Study|Noncompliant|0|||
156818862|NCT00853242|566085403|FG006|Overall Study|Noncompliant|0|||
156818863|NCT00853242|566085397|FG000|Overall Study|Withdrawal by Subject|1|||
156818864|NCT00853242|566085398|FG001|Overall Study|Withdrawal by Subject|2|||
156818865|NCT00853242|566085399|FG002|Overall Study|Withdrawal by Subject|0|||
156818866|NCT00853242|566085400|FG003|Overall Study|Withdrawal by Subject|4|||
156818867|NCT00853242|566085401|FG004|Overall Study|Withdrawal by Subject|0|||
156818868|NCT00853242|566085402|FG005|Overall Study|Withdrawal by Subject|0|||
156818869|NCT00853242|566085403|FG006|Overall Study|Withdrawal by Subject|2|||
156818870|NCT00853242|566085397|FG000|Overall Study|Other|2|||
156818871|NCT00853242|566085398|FG001|Overall Study|Other|0|||
156818872|NCT00853242|566085399|FG002|Overall Study|Other|2|||
156818873|NCT00853242|566085400|FG003|Overall Study|Other|0|||
156818874|NCT00853242|566085401|FG004|Overall Study|Other|0|||
156339119|NCT04447794|564340107|FG001|Overall Study|Withdrawal by Subject|1|||
156339120|NCT04447794|564340108|FG002|Overall Study|Withdrawal by Subject|0|||
156818875|NCT00853242|566085402|FG005|Overall Study|Other|1|||
156818876|NCT00853242|566085403|FG006|Overall Study|Other|2|||
156818877|NCT03497975|566085404|FG000|Overall Study|Withdrew Consent|34|||
156818878|NCT03497975|566085405|FG001|Overall Study|Withdrew Consent|35|||
156818879|NCT03497975|566085404|FG000|Overall Study|Lost to Follow-up|7|||
156818880|NCT03497975|566085405|FG001|Overall Study|Lost to Follow-up|7|||
156818881|NCT03497975|566085404|FG000|Overall Study|Physician Decision|4|||
156818882|NCT03497975|566085405|FG001|Overall Study|Physician Decision|5|||
156818883|NCT03497975|566085404|FG000|Overall Study|Discontinued|42|||
156818884|NCT03497975|566085405|FG001|Overall Study|Discontinued|39|||
156818885|NCT03497975|566085404|FG000|Overall Study|Reason Not Specified|15|||
156818886|NCT03497975|566085405|FG001|Overall Study|Reason Not Specified|14|||
156818887|NCT00606034|566085412|FG000|Overall Study|incarceration|1|||
156818888|NCT02516098|566085414|FG000|Period 1|Protocol Violation|1|||
156818889|NCT02516098|566085415|FG001|Period 1|Protocol Violation|0|||
156818890|NCT02516098|566085414|FG000|Washout After Period 1|Adverse Event|0|||
156818891|NCT02516098|566085415|FG001|Washout After Period 1|Adverse Event|1|||
156818892|NCT02516098|566085414|FG000|Period 2|Withdrawal by Subject|0|||
156818893|NCT02516098|566085415|FG001|Period 2|Withdrawal by Subject|1|||
156818894|NCT01355679|566085417|FG000|Overall Study|benign tumor types found at biopsy|2|||
156818895|NCT00964002|566085419|FG000|Overall Study|Protocol Violation|8|||
156818896|NCT02466425|566085422|FG000|Overall Study|Adverse Event|3|||
156818897|NCT02466425|566085423|FG001|Overall Study|Adverse Event|11|||
156818898|NCT02466425|566085422|FG000|Overall Study|Lack of Efficacy|4|||
156818899|NCT02466425|566085423|FG001|Overall Study|Lack of Efficacy|1|||
156818900|NCT02466425|566085422|FG000|Overall Study|Lost to Follow-up|3|||
156818901|NCT02466425|566085423|FG001|Overall Study|Lost to Follow-up|0|||
156818902|NCT02466425|566085422|FG000|Overall Study|Protocol Violation|1|||
156818903|NCT02466425|566085423|FG001|Overall Study|Protocol Violation|0|||
156818904|NCT02466425|566085422|FG000|Overall Study|Withdrawal by Subject|0|||
156818905|NCT02466425|566085423|FG001|Overall Study|Withdrawal by Subject|1|||
156818906|NCT02466425|566085422|FG000|Overall Study|Other|1|||
156818907|NCT02466425|566085423|FG001|Overall Study|Other|3|||
156818908|NCT02466425|566085422|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156818909|NCT02466425|566085423|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156818910|NCT00582712|566085426|FG000|Overall Study|Adverse Event|1|||
156818911|NCT00582712|566085426|FG000|Overall Study|Lack of Efficacy|1|||
156818912|NCT00582712|566085426|FG000|Overall Study|Withdrawal by Subject|1|||
156818913|NCT00582712|566085426|FG000|Overall Study|Complicating disease requiring treatment|1|||
156818914|NCT05141175|566085433|FG000|Overall Study|Withdrawal by Subject|1|||
156818915|NCT01813058|566085440|FG000|Overall Study|Withdrawal by Subject|5|||
156818916|NCT01813058|566085441|FG001|Overall Study|Withdrawal by Subject|4|||
156818917|NCT03585764|566085442|FG000|Overall Study|Death|3|||
156818918|NCT03585764|566085443|FG001|Overall Study|Death|2|||
156818919|NCT03585764|566085444|FG002|Overall Study|Death|3|||
156818920|NCT03585764|566085445|FG003|Overall Study|Death|0|||
156818921|NCT03585764|566085442|FG000|Overall Study|Lost to Follow-up|0|||
156818922|NCT03585764|566085443|FG001|Overall Study|Lost to Follow-up|1|||
156818923|NCT03585764|566085444|FG002|Overall Study|Lost to Follow-up|0|||
156818924|NCT03585764|566085445|FG003|Overall Study|Lost to Follow-up|0|||
156818925|NCT03585764|566085442|FG000|Overall Study|Physician Decision|0|||
156818926|NCT03585764|566085443|FG001|Overall Study|Physician Decision|0|||
156818927|NCT03585764|566085444|FG002|Overall Study|Physician Decision|2|||
156818928|NCT03585764|566085445|FG003|Overall Study|Physician Decision|0|||
156818929|NCT01581021|566085447|FG000|Overall Study|Lost to Follow-up|4|||
156818930|NCT01581021|566085448|FG001|Overall Study|Lost to Follow-up|6|||
156818931|NCT01581021|566085447|FG000|Overall Study|More than 2 hooks in thoracic|3|||
156818932|NCT01581021|566085448|FG001|Overall Study|More than 2 hooks in thoracic|0|||
156818933|NCT01581021|566085447|FG000|Overall Study|Neuromuscular|2|||
156818934|NCT01581021|566085448|FG001|Overall Study|Neuromuscular|1|||
156818935|NCT01581021|566085447|FG000|Overall Study|Not Randomized|1|||
156818936|NCT01581021|566085448|FG001|Overall Study|Not Randomized|2|||
156818937|NCT01581021|566085447|FG000|Overall Study|Lenke 6 Classification|0|||
156818938|NCT01581021|566085448|FG001|Overall Study|Lenke 6 Classification|1|||
156818939|NCT01581021|566085447|FG000|Overall Study|Lack of Efficacy|0|||
156818940|NCT01581021|566085448|FG001|Overall Study|Lack of Efficacy|1|||
156818941|NCT03604172|566085449|FG000|Overall Study|Lost to Follow-up|1|||
156818942|NCT03604172|566085450|FG001|Overall Study|Lost to Follow-up|2|||
156818943|NCT02676895|566085451|FG000|Overall Study|Administrative reason|1|||
156818944|NCT02676895|566085452|FG001|Overall Study|Administrative reason|0|||
156818945|NCT02676895|566085453|FG002|Overall Study|Administrative reason|0|||
156818946|NCT02676895|566085451|FG000|Overall Study|Protocol Violation|1|||
156818947|NCT02676895|566085452|FG001|Overall Study|Protocol Violation|0|||
156339121|NCT00963937|564340111|FG000|Overall Study|Protocol Violation|1|||
156818948|NCT02676895|566085453|FG002|Overall Study|Protocol Violation|0|||
156818949|NCT02676895|566085451|FG000|Overall Study|Adverse Event|0|||
156818950|NCT02676895|566085452|FG001|Overall Study|Adverse Event|3|||
156818951|NCT02676895|566085453|FG002|Overall Study|Adverse Event|1|||
156818952|NCT02676895|566085451|FG000|Overall Study|Lost to Follow-up|0|||
156818953|NCT02676895|566085452|FG001|Overall Study|Lost to Follow-up|0|||
156818954|NCT02676895|566085453|FG002|Overall Study|Lost to Follow-up|1|||
156818955|NCT02676895|566085451|FG000|Overall Study|Withdrawal by Subject|0|||
156818956|NCT02676895|566085452|FG001|Overall Study|Withdrawal by Subject|0|||
156818957|NCT02676895|566085453|FG002|Overall Study|Withdrawal by Subject|1|||
156818958|NCT00054327|566085454|FG000|Overall Study|Engraftment failure|1|||
156818959|NCT00054327|566085455|FG001|Overall Study|Engraftment failure|0|||
156818960|NCT00054327|566085456|FG002|Overall Study|Engraftment failure|0|||
156818961|NCT00054327|566085457|FG003|Overall Study|Engraftment failure|0|||
156818962|NCT00054327|566085458|FG004|Overall Study|Engraftment failure|0|||
156818963|NCT00054327|566085459|FG005|Overall Study|Engraftment failure|0|||
156818964|NCT03028129|566085465|FG000|Overall Study|Adverse Event|13|||
156818965|NCT03028129|566085466|FG001|Overall Study|Adverse Event|2|||
156818966|NCT03028129|566085465|FG000|Overall Study|Lost to Follow-up|50|||
156818967|NCT03028129|566085466|FG001|Overall Study|Lost to Follow-up|38|||
156818968|NCT03028129|566085465|FG000|Overall Study|Physician Decision|0|||
156818969|NCT03028129|566085466|FG001|Overall Study|Physician Decision|1|||
156818970|NCT03028129|566085465|FG000|Overall Study|Protocol Violation|1|||
156818971|NCT03028129|566085466|FG001|Overall Study|Protocol Violation|1|||
156818972|NCT03028129|566085465|FG000|Overall Study|Withdrawal by Subject|62|||
156818973|NCT03028129|566085466|FG001|Overall Study|Withdrawal by Subject|45|||
156818974|NCT00923351|566085467|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
156818975|NCT00923351|566085468|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
156818976|NCT00923351|566085469|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
156818977|NCT00182078|566085470|FG000|Overall Study|Withdrawal by Subject|1|||
156818978|NCT00182078|566085471|FG001|Overall Study|Withdrawal by Subject|0|||
156818979|NCT01076205|566085472|FG000|Overall Study|Adverse Drug Reaction|299|||
156818980|NCT01076205|566085472|FG000|Overall Study|Lack of Effectiveness|1423|||
156818981|NCT01076205|566085472|FG000|Overall Study|Other Reason|1075|||
156818982|NCT01076205|566085472|FG000|Overall Study|Unknown Reason|71|||
156818983|NCT01076205|566085472|FG000|Overall Study|Lost to Follow-up|3151|||
156818984|NCT00361231|566085473|FG000|Overall Study|Physician Decision|3|||
156818985|NCT00361231|566085473|FG000|Overall Study|Symptomatic deterioration|5|||
156818986|NCT00361231|566085473|FG000|Overall Study|Radiographic disease progression|16|||
156818987|NCT00361231|566085473|FG000|Overall Study|Withdrawal by Subject|4|||
156818988|NCT00361231|566085473|FG000|Overall Study|Adverse Event|6|||
156818989|NCT01208961|566085474|FG000|High-Fat Period III|Protocol Violation|1|||
156818990|NCT01208961|566085475|FG001|High-Fat Period III|Protocol Violation|0|||
156818991|NCT03403361|566085476|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
156818992|NCT03596047|566087480|FG000|Overall Study|Withdrawal by Subject|7|||
156818993|NCT03596047|566087481|FG001|Overall Study|Withdrawal by Subject|4|||
156818994|NCT03596047|566087480|FG000|Overall Study|Lost to Follow-up|0|||
156818995|NCT03596047|566087481|FG001|Overall Study|Lost to Follow-up|2|||
156818996|NCT01696968|566087482|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
156818997|NCT01696968|566087483|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
156818998|NCT01696968|566087482|FG000|Overall Study|Died Before Randomization|3|||
156818999|NCT01696968|566087483|FG001|Overall Study|Died Before Randomization|8|||
156819000|NCT01696968|566087482|FG000|Overall Study|Died Before ASU (Control)|278|||
156819001|NCT01696968|566087483|FG001|Overall Study|Died Before ASU (Control)|0|||
156819002|NCT01696968|566087482|FG000|Overall Study|Refused ASU (Control)|920|||
156819003|NCT01696968|566087483|FG001|Overall Study|Refused ASU (Control)|0|||
156819004|NCT01696968|566087482|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
156819005|NCT01696968|566087483|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
156819006|NCT03727646|566087484|FG000|Overall Study|Adverse Event|1|||
156819007|NCT03727646|566087485|FG001|Overall Study|Adverse Event|0|||
156819008|NCT04753658|566087486|FG000|Overall Study|Progressive disease|7|||
156819009|NCT04753658|566087486|FG000|Overall Study|Other|7|||
156819010|NCT04753658|566087486|FG000|Overall Study|Adverse Event|1|||
156819011|NCT02582814|566087493|FG000|Overall Study|Study-specific withdrawal criteria|1|||
156819012|NCT02582814|566087494|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156819013|NCT02582814|566087493|FG000|Overall Study|Withdrawal by Subject|4|||
156339122|NCT00963937|564340112|FG001|Overall Study|Protocol Violation|1|||
156339123|NCT00963937|564340113|FG002|Overall Study|Protocol Violation|0|||
156339124|NCT00963937|564340111|FG000|Overall Study|Physician Decision|18|||
156339125|NCT00963937|564340112|FG001|Overall Study|Physician Decision|10|||
156819014|NCT02582814|566087494|FG001|Overall Study|Withdrawal by Subject|3|||
156819015|NCT02582814|566087493|FG000|Overall Study|Adverse Event|4|||
156819016|NCT02582814|566087494|FG001|Overall Study|Adverse Event|4|||
156339126|NCT00963937|564340113|FG002|Overall Study|Physician Decision|4|||
156339127|NCT04203498|564340116|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
156339128|NCT04203498|564340117|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
156339129|NCT04203498|564340116|FG000|Overall Study|Withdrawal of patient consent|7|||
156339130|NCT04203498|564340117|FG001|Overall Study|Withdrawal of patient consent|2|||
156339131|NCT04203498|564340116|FG000|Overall Study|Adverse Event|4|||
156339132|NCT04203498|564340117|FG001|Overall Study|Adverse Event|1|||
156339133|NCT04203498|564340116|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
156541118|NCT05611671|565074483|FG000|Overall Study|Adverse Event|1|||
156541119|NCT05611671|565074484|FG001|Overall Study|Adverse Event|1|||
156541120|NCT05611671|565074485|FG002|Overall Study|Adverse Event|0|||
156541121|NCT05611671|565074486|FG003|Overall Study|Adverse Event|1|||
156541122|NCT05611671|565074483|FG000|Overall Study|Lack of Efficacy|1|||
156541123|NCT05611671|565074484|FG001|Overall Study|Lack of Efficacy|0|||
156819017|NCT00306293|566087495|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
156819018|NCT00306293|566087496|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
156819019|NCT00306293|566087495|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
156819020|NCT00306293|566087496|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
156819021|NCT00306293|566087495|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
156819022|NCT00306293|566087496|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
156465685|NCT02180867|564801632|FG005|Overall Study|Adverse Event|0|||
156465686|NCT02180867|564801633|FG006|Overall Study|Adverse Event|0|||
156465687|NCT02180867|564801627|FG000|Overall Study|Death|0|||
156465688|NCT02180867|564801628|FG001|Overall Study|Death|0|||
156465689|NCT02180867|564801629|FG002|Overall Study|Death|0|||
156465690|NCT02180867|564801630|FG003|Overall Study|Death|0|||
156465691|NCT02180867|564801631|FG004|Overall Study|Death|1|||
156465692|NCT02180867|564801632|FG005|Overall Study|Death|0|||
156541124|NCT05611671|565074485|FG002|Overall Study|Lack of Efficacy|1|||
156541125|NCT05611671|565074486|FG003|Overall Study|Lack of Efficacy|2|||
156541126|NCT05611671|565074483|FG000|Overall Study|Lost to Follow-up|0|||
156541127|NCT05611671|565074484|FG001|Overall Study|Lost to Follow-up|0|||
156541128|NCT05611671|565074485|FG002|Overall Study|Lost to Follow-up|0|||
156819023|NCT00306293|566087495|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
156819024|NCT00306293|566087496|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
156819025|NCT00306293|566087495|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
156819026|NCT00306293|566087496|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
156819027|NCT00306293|566087495|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
156819028|NCT00306293|566087496|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
156819029|NCT00306293|566087495|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
156819030|NCT00306293|566087496|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
156819031|NCT00306293|566087495|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
156819032|NCT00306293|566087496|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
156819033|NCT00176488|566087497|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
156819034|NCT02650804|566087498|FG000|Overall Study|Adverse Event|3|||
156819035|NCT02650804|566087499|FG001|Overall Study|Adverse Event|2|||
156819036|NCT02650804|566087498|FG000|Overall Study|Death|1|||
156819037|NCT02650804|566087499|FG001|Overall Study|Death|2|||
156819038|NCT02650804|566087498|FG000|Overall Study|Progressive Disease|7|||
156819039|NCT02650804|566087499|FG001|Overall Study|Progressive Disease|10|||
156819040|NCT02650804|566087498|FG000|Overall Study|Physician Decision|0|||
156819041|NCT02650804|566087499|FG001|Overall Study|Physician Decision|2|||
156819042|NCT02650804|566087498|FG000|Overall Study|Withdrawal by Subject|1|||
156819043|NCT02650804|566087499|FG001|Overall Study|Withdrawal by Subject|4|||
156819044|NCT02650804|566087498|FG000|Overall Study|Symptomatic deterioration|5|||
156819045|NCT02650804|566087499|FG001|Overall Study|Symptomatic deterioration|7|||
156819046|NCT02650804|566087498|FG000|Overall Study|Protocol Violation|0|||
156819047|NCT02650804|566087499|FG001|Overall Study|Protocol Violation|1|||
156819048|NCT02557100|566087511|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
156819049|NCT02557100|566087512|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
156819050|NCT02557100|566087513|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
156819051|NCT02557100|566087511|FG000|Single Blind Treatment Period|Death|0|||
156819052|NCT02557100|566087512|FG001|Single Blind Treatment Period|Death|1|||
156819053|NCT02557100|566087513|FG002|Single Blind Treatment Period|Death|0|||
156819054|NCT02557100|566087511|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
156819055|NCT02557100|566087512|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
156819056|NCT02557100|566087513|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
156819057|NCT02557100|566087511|FG000|Single Blind Treatment Period|Adverse Event|0|||
156819058|NCT02557100|566087512|FG001|Single Blind Treatment Period|Adverse Event|1|||
156819059|NCT02557100|566087513|FG002|Single Blind Treatment Period|Adverse Event|0|||
156819060|NCT02557100|566087511|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
156819061|NCT02557100|566087512|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
156819062|NCT02557100|566087513|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
156819063|NCT02557100|566087511|FG000|Cumulative Abatacept Period|Other Reasons|0|||
156819064|NCT02557100|566087512|FG001|Cumulative Abatacept Period|Other Reasons|0|||
156819065|NCT02557100|566087513|FG002|Cumulative Abatacept Period|Other Reasons|1|||
156819066|NCT02557100|566087511|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
156819067|NCT02557100|566087512|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
156819068|NCT02557100|566087513|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
156465693|NCT02180867|564801633|FG006|Overall Study|Death|0|||
156541129|NCT05611671|565074486|FG003|Overall Study|Lost to Follow-up|1|||
156541130|NCT05611671|565074483|FG000|Overall Study|Protocol Violation|0|||
156819069|NCT02557100|566087511|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
156819070|NCT02557100|566087512|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
156819071|NCT02557100|566087513|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
156819072|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
156819073|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
156339134|NCT04203498|564340117|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
156819074|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
156465694|NCT02180867|564801627|FG000|Overall Study|Lack of Efficacy|0|||
156465695|NCT02180867|564801628|FG001|Overall Study|Lack of Efficacy|2|||
156465696|NCT02180867|564801629|FG002|Overall Study|Lack of Efficacy|0|||
156465697|NCT02180867|564801630|FG003|Overall Study|Lack of Efficacy|1|||
156465698|NCT02180867|564801631|FG004|Overall Study|Lack of Efficacy|6|||
156819075|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
156465699|NCT02180867|564801632|FG005|Overall Study|Lack of Efficacy|0|||
156465700|NCT02180867|564801633|FG006|Overall Study|Lack of Efficacy|1|||
156465701|NCT02180867|564801627|FG000|Overall Study|Physician Decision|1|||
156465702|NCT02180867|564801628|FG001|Overall Study|Physician Decision|3|||
156465703|NCT02180867|564801629|FG002|Overall Study|Physician Decision|1|||
156465704|NCT02180867|564801630|FG003|Overall Study|Physician Decision|10|||
156465705|NCT02180867|564801631|FG004|Overall Study|Physician Decision|9|||
156465706|NCT02180867|564801632|FG005|Overall Study|Physician Decision|3|||
156465707|NCT02180867|564801633|FG006|Overall Study|Physician Decision|4|||
156465708|NCT02180867|564801627|FG000|Overall Study|Withdrawal by Subject|0|||
156465709|NCT02180867|564801628|FG001|Overall Study|Withdrawal by Subject|0|||
156465710|NCT02180867|564801629|FG002|Overall Study|Withdrawal by Subject|0|||
156465711|NCT02180867|564801630|FG003|Overall Study|Withdrawal by Subject|1|||
156465712|NCT02180867|564801631|FG004|Overall Study|Withdrawal by Subject|1|||
156819076|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
156819077|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
156819078|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
156819079|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
156819080|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
156819081|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
156819082|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
156819083|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
156819084|NCT04644276|566087518|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
156819085|NCT04644276|566087519|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
156819086|NCT04644276|566087520|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
156819087|NCT01576146|566087521|FG000|Extension Period 1|Adverse Event|2|||
156819088|NCT01576146|566087521|FG000|Extension Period 1|Death|2|||
156819089|NCT01576146|566087521|FG000|Extension Period 1|Physician Decision|2|||
156819090|NCT01576146|566087521|FG000|Extension Period 1|Withdrawal by Subject|1|||
156819091|NCT01576146|566087521|FG000|Extension Period 1|Lost to Follow-up|1|||
156819092|NCT01576146|566087521|FG000|Extension Period 1|Parathyroidectomy|1|||
156819093|NCT01576146|566087521|FG000|Extension Period 1|Renal Transplant|1|||
156819094|NCT01576146|566087521|FG000|Extension Period 2|Sponsor Decision|13|||
156819095|NCT01576146|566087521|FG000|Extension Period 2|Death|1|||
156819096|NCT01576146|566087521|FG000|Extension Period 2|Adverse Event|1|||
156819097|NCT01576146|566087521|FG000|Extension Period 2|Renal Transplant|1|||
156819098|NCT01576146|566087521|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
156819099|NCT01811485|566087523|FG000|Overall Study|Adverse Event|1|||
156819100|NCT01811485|566087524|FG001|Overall Study|Adverse Event|3|||
156819101|NCT01811485|566087525|FG002|Overall Study|Adverse Event|2|||
156819102|NCT01811485|566087523|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156819103|NCT01811485|566087524|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156819104|NCT01811485|566087525|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
156819105|NCT01811485|566087523|FG000|Overall Study|Administrative problems|1|||
156819106|NCT01811485|566087524|FG001|Overall Study|Administrative problems|0|||
156819107|NCT01811485|566087525|FG002|Overall Study|Administrative problems|0|||
156819108|NCT01811485|566087523|FG000|Overall Study|Protocol Deviation|0|||
156819109|NCT01811485|566087524|FG001|Overall Study|Protocol Deviation|1|||
156819110|NCT01811485|566087525|FG002|Overall Study|Protocol Deviation|0|||
156819111|NCT03299881|566087526|FG000|Overall Study|Study Termination|17|||
156819112|NCT03299881|566087527|FG001|Overall Study|Study Termination|13|||
156819113|NCT00633074|566087528|FG000|Overall Study|Adverse Event|1|||
156819114|NCT00633074|566087529|FG001|Overall Study|Adverse Event|0|||
156819115|NCT01995526|566087530|FG000|Overall Study|Physician Decision|1|||
156819116|NCT03367403|566087534|FG000|Overall Study|Adverse Event|20|||
156819117|NCT03367403|566087535|FG001|Overall Study|Adverse Event|6|||
156819118|NCT03367403|566087536|FG002|Overall Study|Adverse Event|2|||
156819119|NCT03367403|566087534|FG000|Overall Study|Withdrawal by Subject|12|||
156819120|NCT03367403|566087535|FG001|Overall Study|Withdrawal by Subject|13|||
156819121|NCT03367403|566087536|FG002|Overall Study|Withdrawal by Subject|1|||
156465713|NCT02180867|564801632|FG005|Overall Study|Withdrawal by Subject|0|||
156465714|NCT02180867|564801633|FG006|Overall Study|Withdrawal by Subject|0|||
156465715|NCT02180867|564801627|FG000|Overall Study|Ineligible|1|||
156465716|NCT02180867|564801628|FG001|Overall Study|Ineligible|2|||
156465717|NCT02180867|564801629|FG002|Overall Study|Ineligible|0|||
156819122|NCT03367403|566087534|FG000|Overall Study|Death|1|||
156819123|NCT03367403|566087535|FG001|Overall Study|Death|2|||
156339135|NCT04203498|564340116|FG000|Overall Study|Did not receive IMP|2|||
156465718|NCT02180867|564801630|FG003|Overall Study|Ineligible|3|||
156465719|NCT02180867|564801631|FG004|Overall Study|Ineligible|5|||
156465720|NCT02180867|564801632|FG005|Overall Study|Ineligible|0|||
156819124|NCT03367403|566087536|FG002|Overall Study|Death|0|||
156819125|NCT03367403|566087534|FG000|Overall Study|Physician Decision|0|||
156819126|NCT03367403|566087535|FG001|Overall Study|Physician Decision|1|||
156819127|NCT03367403|566087536|FG002|Overall Study|Physician Decision|0|||
156819128|NCT03367403|566087534|FG000|Overall Study|Protocol Violation|1|||
156819129|NCT03367403|566087535|FG001|Overall Study|Protocol Violation|1|||
156819130|NCT03367403|566087536|FG002|Overall Study|Protocol Violation|0|||
156819131|NCT03367403|566087534|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
156819132|NCT03367403|566087535|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
156819133|NCT03367403|566087536|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
156819134|NCT03367403|566087534|FG000|Overall Study|COVID-19|3|||
156819135|NCT03367403|566087535|FG001|Overall Study|COVID-19|6|||
156819136|NCT03367403|566087536|FG002|Overall Study|COVID-19|0|||
156819137|NCT03367403|566087534|FG000|Overall Study|Abuse of Alcohol Intake|0|||
156819138|NCT03367403|566087535|FG001|Overall Study|Abuse of Alcohol Intake|1|||
156819139|NCT03367403|566087536|FG002|Overall Study|Abuse of Alcohol Intake|0|||
156819140|NCT03367403|566087534|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
156819141|NCT03367403|566087535|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
156819142|NCT03367403|566087536|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
156819143|NCT00194077|566087537|FG000|Overall Study|Lack of Efficacy|22|||
156819144|NCT00194077|566087538|FG001|Overall Study|Lack of Efficacy|29|||
156819145|NCT00194077|566087537|FG000|Overall Study|Study nonadherence|1|||
156819146|NCT00194077|566087538|FG001|Overall Study|Study nonadherence|0|||
156819147|NCT00194077|566087537|FG000|Overall Study|Withdrawal by Subject|1|||
156819148|NCT00194077|566087538|FG001|Overall Study|Withdrawal by Subject|1|||
156819149|NCT03470194|566087539|FG000|Overall Study|Lost to Follow-up|11|||
156819150|NCT03470194|566087540|FG001|Overall Study|Lost to Follow-up|17|||
156819151|NCT01822899|566087541|FG000|Overall Study|Adverse Event|6|||
156819152|NCT01822899|566087542|FG001|Overall Study|Adverse Event|5|||
156819153|NCT01822899|566087541|FG000|Overall Study|Lack of Efficacy|6|||
156819154|NCT01822899|566087542|FG001|Overall Study|Lack of Efficacy|3|||
156819155|NCT01822899|566087541|FG000|Overall Study|Protocol Violation|6|||
156819156|NCT01822899|566087542|FG001|Overall Study|Protocol Violation|3|||
156819157|NCT01822899|566087541|FG000|Overall Study|Lost to Follow-up|1|||
156819158|NCT01822899|566087542|FG001|Overall Study|Lost to Follow-up|0|||
156819159|NCT01822899|566087541|FG000|Overall Study|Withdrawal by Subject|5|||
156819160|NCT01822899|566087542|FG001|Overall Study|Withdrawal by Subject|7|||
156819161|NCT01734395|566087546|FG000|Overall Study|Other|65|||
156819162|NCT01734395|566087546|FG000|Overall Study|Lost to Follow-up|287|||
156819163|NCT01734395|566087546|FG000|Overall Study|Lack of Efficacy|5|||
156819164|NCT01734395|566087546|FG000|Overall Study|Adverse Event|40|||
156819165|NCT01734395|566087546|FG000|Overall Study|Withdrawal by Subject|10|||
156819166|NCT01734395|566087546|FG000|Overall Study|Missing the reasons for not completed|3|||
156819167|NCT01092780|566087547|FG000|Washout Period 1|Adverse Event|0|||
156819168|NCT01092780|566087548|FG001|Washout Period 1|Adverse Event|1|||
156819169|NCT01092780|566087549|FG002|Washout Period 1|Adverse Event|0|||
156465721|NCT02180867|564801633|FG006|Overall Study|Ineligible|0|||
156819170|NCT01092780|566087550|FG003|Washout Period 1|Adverse Event|0|||
156819171|NCT01092780|566087547|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
156819172|NCT01092780|566087548|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
156819173|NCT01092780|566087549|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
156819174|NCT01092780|566087550|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
156465722|NCT02180867|564801627|FG000|Overall Study|Repeat Eligibility Studies|0|||
156465723|NCT02180867|564801628|FG001|Overall Study|Repeat Eligibility Studies|0|||
156465724|NCT02180867|564801629|FG002|Overall Study|Repeat Eligibility Studies|0|||
156465725|NCT02180867|564801630|FG003|Overall Study|Repeat Eligibility Studies|0|||
156465726|NCT02180867|564801631|FG004|Overall Study|Repeat Eligibility Studies|1|||
156465727|NCT02180867|564801632|FG005|Overall Study|Repeat Eligibility Studies|0|||
156465728|NCT02180867|564801633|FG006|Overall Study|Repeat Eligibility Studies|0|||
156465729|NCT02180867|564801627|FG000|Overall Study|Refusal of further protocol therapy|1|||
156465730|NCT02180867|564801628|FG001|Overall Study|Refusal of further protocol therapy|0|||
156465731|NCT02180867|564801629|FG002|Overall Study|Refusal of further protocol therapy|2|||
156465732|NCT02180867|564801630|FG003|Overall Study|Refusal of further protocol therapy|6|||
156465733|NCT02180867|564801631|FG004|Overall Study|Refusal of further protocol therapy|4|||
156465734|NCT02180867|564801632|FG005|Overall Study|Refusal of further protocol therapy|0|||
156465735|NCT02180867|564801633|FG006|Overall Study|Refusal of further protocol therapy|0|||
156465736|NCT00994643|564801995|FG000|Overall Study|Withdrawal by Subject|1|||
156465737|NCT00557492|564801996|FG000|Overall Study|Change in health insurance|1|||
156819175|NCT01092780|566087547|FG000|Washout Period 2|Adverse Event|0|||
156819176|NCT01092780|566087548|FG001|Washout Period 2|Adverse Event|1|||
156819177|NCT01092780|566087549|FG002|Washout Period 2|Adverse Event|1|||
156819178|NCT01092780|566087550|FG003|Washout Period 2|Adverse Event|0|||
156819179|NCT04026009|566087551|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156819180|NCT04026009|566087552|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156819181|NCT04026009|566087553|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
156819182|NCT04026009|566087554|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156819183|NCT04026009|566087555|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
156819184|NCT04026009|566087551|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
156465738|NCT03653364|564801997|FG000|Overall Study|Withdrawal by Subject|1|||
156465739|NCT03653364|564801997|FG000|Overall Study|Enrolled in Error|1|||
156465740|NCT03653364|564801997|FG000|Overall Study|Death|1|||
156819185|NCT04026009|566087552|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
156819186|NCT04026009|566087553|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
156819187|NCT04026009|566087554|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
156819188|NCT04026009|566087555|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
156819189|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
156819190|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
156819191|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
156819192|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
156819193|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
156819194|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
156819195|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
156819196|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
156819197|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
156819198|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
156819199|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
156819200|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
156819201|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
156819202|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
156819203|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
156819204|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
156819205|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
156819206|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819207|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819208|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819209|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819210|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819211|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819212|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819213|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819214|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819215|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819216|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819217|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819218|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819219|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
156819220|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
156819221|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
156819222|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
156819223|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
156819224|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
156819225|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
156819226|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
156819227|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
156819228|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
156819229|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
156819230|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
156819231|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
156819232|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
156819233|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
156819234|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
156819235|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
156819236|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
156819237|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
156819238|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
156819239|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
156465741|NCT02306161|564802000|FG000|Overall Study|Death|1|||
156465742|NCT02306161|564802001|FG001|Overall Study|Death|3|||
156465743|NCT02306161|564802000|FG000|Overall Study|Lack of Efficacy|20|||
156465744|NCT02306161|564802001|FG001|Overall Study|Lack of Efficacy|43|||
156465745|NCT02306161|564802000|FG000|Overall Study|Physician Decision|30|||
156465746|NCT02306161|564802001|FG001|Overall Study|Physician Decision|18|||
156819240|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
156819241|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
156819242|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
156819243|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
156819244|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
156819245|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
156819246|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
156819247|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
156465747|NCT02306161|564802000|FG000|Overall Study|Withdrawal by Subject|4|||
156465748|NCT02306161|564802001|FG001|Overall Study|Withdrawal by Subject|0|||
156465749|NCT02306161|564802000|FG000|Overall Study|Ineligible|9|||
156465750|NCT02306161|564802001|FG001|Overall Study|Ineligible|5|||
156465751|NCT03047213|564802006|FG000|Overall Study|Withdrawal by Subject|2|||
156465752|NCT03047213|564802007|FG001|Overall Study|Withdrawal by Subject|0|||
156465753|NCT03047213|564802006|FG000|Overall Study|Adverse Event|2|||
156465754|NCT03047213|564802007|FG001|Overall Study|Adverse Event|0|||
156465755|NCT02446600|564802009|FG000|Overall Study|Never treated|20|||
156465756|NCT02446600|564802010|FG001|Overall Study|Never treated|2|||
156465757|NCT02446600|564802011|FG002|Overall Study|Never treated|6|||
156465758|NCT02446600|564802012|FG003|Overall Study|Never treated|0|||
156465759|NCT02446600|564802009|FG000|Overall Study|Withdrawal by Subject|19|||
156465760|NCT02446600|564802010|FG001|Overall Study|Withdrawal by Subject|5|||
156465761|NCT02446600|564802011|FG002|Overall Study|Withdrawal by Subject|17|||
156465762|NCT02446600|564802012|FG003|Overall Study|Withdrawal by Subject|0|||
156465763|NCT02446600|564802009|FG000|Overall Study|Ineligible|1|||
156465764|NCT02446600|564802010|FG001|Overall Study|Ineligible|4|||
156465765|NCT02446600|564802011|FG002|Overall Study|Ineligible|4|||
156465766|NCT02446600|564802012|FG003|Overall Study|Ineligible|1|||
156465767|NCT02446600|564802009|FG000|Overall Study|Duplicate Enrollment|0|||
156465768|NCT02446600|564802010|FG001|Overall Study|Duplicate Enrollment|1|||
156465769|NCT02446600|564802011|FG002|Overall Study|Duplicate Enrollment|0|||
156465770|NCT02446600|564802012|FG003|Overall Study|Duplicate Enrollment|0|||
156465771|NCT03725332|564802013|FG000|Overall Study|Adverse Event|5|||
156465772|NCT03725332|564802014|FG001|Overall Study|Adverse Event|10|||
156819248|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
156819249|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
156819250|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
156819251|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
156819252|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
156819253|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819254|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819255|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819256|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819257|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819258|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819259|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819260|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819261|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819262|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819263|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819264|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
156819265|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
156819266|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
156819267|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
156819268|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819269|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819270|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819271|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819272|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819273|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819274|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819275|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819276|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819277|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819278|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819279|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819280|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819281|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
156465773|NCT03725332|564802013|FG000|Overall Study|Death|1|||
156465774|NCT03725332|564802014|FG001|Overall Study|Death|3|||
156819282|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
156819283|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819284|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819285|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819286|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
156465775|NCT03725332|564802013|FG000|Overall Study|Lost to Follow-up|43|||
156465776|NCT03725332|564802014|FG001|Overall Study|Lost to Follow-up|122|||
156465777|NCT03725332|564802013|FG000|Overall Study|Withdrawal by Subject|0|||
156465778|NCT03725332|564802014|FG001|Overall Study|Withdrawal by Subject|1|||
156465779|NCT03725332|564802013|FG000|Overall Study|Duplicate enrollment|0|||
156465780|NCT03725332|564802014|FG001|Overall Study|Duplicate enrollment|1|||
156819287|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819288|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819289|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819290|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819291|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819292|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819293|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819294|NCT03831191|566087557|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
156819295|NCT03831191|566087558|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
156819296|NCT03831191|566087559|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
156819297|NCT03831191|566087560|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
156819298|NCT03831191|566087561|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
156819299|NCT03831191|566087562|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
156819300|NCT03831191|566087563|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
156819301|NCT03831191|566087564|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
156819302|NCT03831191|566087565|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
156819303|NCT03831191|566087566|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
156819304|NCT03831191|566087567|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
156819305|NCT03831191|566087568|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
156819306|NCT03831191|566087569|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
156819307|NCT03831191|566087570|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
156819308|NCT03831191|566087571|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
156819309|NCT03831191|566087557|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819310|NCT03831191|566087558|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819311|NCT03831191|566087559|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819312|NCT03831191|566087560|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819313|NCT03831191|566087561|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156465781|NCT03725332|564802013|FG000|Overall Study|Did not consent|0|||
156465782|NCT03725332|564802014|FG001|Overall Study|Did not consent|1|||
156465783|NCT03242915|564802017|FG000|Overall Study|Adverse Event|5|||
156465784|NCT03242915|564802018|FG001|Overall Study|Adverse Event|1|||
156465785|NCT03242915|564802017|FG000|Overall Study|Withdrawal by Subject|0|||
156465786|NCT03242915|564802018|FG001|Overall Study|Withdrawal by Subject|2|||
156465787|NCT03242915|564802017|FG000|Overall Study|Physician Decision|4|||
156465788|NCT03242915|564802018|FG001|Overall Study|Physician Decision|1|||
156465789|NCT02754596|564802019|FG000|Overall Study|Withdrawal by Subject|3|||
156465790|NCT02754596|564802020|FG001|Overall Study|Withdrawal by Subject|4|||
156465791|NCT02754596|564802021|FG002|Overall Study|Withdrawal by Subject|0|||
156465792|NCT02754596|564802019|FG000|Overall Study|Physician Decision|1|||
156465793|NCT02754596|564802020|FG001|Overall Study|Physician Decision|1|||
156465794|NCT02754596|564802021|FG002|Overall Study|Physician Decision|1|||
156465795|NCT02754596|564802019|FG000|Overall Study|Lost to Follow-up|1|||
156465796|NCT02754596|564802020|FG001|Overall Study|Lost to Follow-up|1|||
156465797|NCT02754596|564802021|FG002|Overall Study|Lost to Follow-up|2|||
156465798|NCT02754596|564802019|FG000|Overall Study|Death|0|||
156465799|NCT02754596|564802020|FG001|Overall Study|Death|2|||
156465800|NCT02754596|564802021|FG002|Overall Study|Death|0|||
156465801|NCT02754596|564802019|FG000|Overall Study|Adverse Event|1|||
156465802|NCT02754596|564802020|FG001|Overall Study|Adverse Event|0|||
156465803|NCT02754596|564802021|FG002|Overall Study|Adverse Event|1|||
156465804|NCT02754596|564802019|FG000|Overall Study|Other|1|||
156819314|NCT03831191|566087562|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819315|NCT03831191|566087563|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819316|NCT03831191|566087564|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819317|NCT03831191|566087565|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819318|NCT03831191|566087566|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819319|NCT03831191|566087567|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819320|NCT03831191|566087568|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819321|NCT03831191|566087569|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819322|NCT03831191|566087570|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819323|NCT03831191|566087571|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
156819324|NCT03831191|566087557|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819325|NCT03831191|566087558|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819326|NCT03831191|566087559|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156465805|NCT02754596|564802020|FG001|Overall Study|Other|0|||
156465806|NCT02754596|564802021|FG002|Overall Study|Other|0|||
156465807|NCT03872466|564802022|FG000|Overall Study|Withdrawal by Subject|1|||
156465808|NCT03872466|564802023|FG001|Overall Study|Withdrawal by Subject|0|||
156465809|NCT03872466|564802022|FG000|Overall Study|Physician Decision|2|||
156465810|NCT03872466|564802023|FG001|Overall Study|Physician Decision|0|||
156465811|NCT01778686|564802024|FG000|Overall Study|Adverse Event|0|||
156465812|NCT01778686|564802025|FG001|Overall Study|Adverse Event|0|||
156819327|NCT03831191|566087560|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819328|NCT03831191|566087561|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819329|NCT03831191|566087562|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819330|NCT03831191|566087563|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819331|NCT03831191|566087564|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819332|NCT03831191|566087565|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819333|NCT03831191|566087566|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819334|NCT03831191|566087567|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819335|NCT03831191|566087568|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819336|NCT03831191|566087569|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819337|NCT03831191|566087570|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819338|NCT03831191|566087571|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
156819339|NCT00695955|566087572|FG000|Cohort 1|Adverse Event|26|||
156819340|NCT00695955|566087572|FG000|Cohort 1|Protocol Violation|2|||
156819341|NCT00695955|566087572|FG000|Cohort 1|Lost to Follow-up|30|||
156819342|NCT00695955|566087572|FG000|Cohort 1|Withdrawal by Subject|25|||
156819343|NCT00695955|566087572|FG000|Cohort 1|Lack of Efficacy|3|||
156819344|NCT00695955|566087572|FG000|Cohort 1|Other|16|||
156819345|NCT00695955|566087572|FG000|Cohort 2|Adverse Event|24|||
156819346|NCT00695955|566087572|FG000|Cohort 2|Protocol Violation|5|||
156819347|NCT00695955|566087572|FG000|Cohort 2|Lost to Follow-up|38|||
156819348|NCT00695955|566087572|FG000|Cohort 2|Withdrawal by Subject|28|||
156819349|NCT00695955|566087572|FG000|Cohort 2|Lack of Efficacy|4|||
156819350|NCT00695955|566087572|FG000|Cohort 2|Other|5|||
156819351|NCT02957747|566087575|FG000|Overall Study|Withdrawal by Subject|0|||
156819352|NCT02957747|566087576|FG001|Overall Study|Withdrawal by Subject|3|||
156819353|NCT02957747|566087575|FG000|Overall Study|Lost to Follow-up|10|||
156819354|NCT02957747|566087576|FG001|Overall Study|Lost to Follow-up|5|||
156819355|NCT01177553|566087577|FG000|Overall Study|babies not yet 6 months of age|1|||
156819356|NCT01177553|566087578|FG001|Overall Study|babies not yet 6 months of age|0|||
156819357|NCT00610857|566087580|FG000|Overall Study|Not evaluable for response|2|||
156819358|NCT00888329|566087581|FG000|Overall Study|Physician Decision|6|||
156819359|NCT00888329|566087582|FG001|Overall Study|Physician Decision|9|||
156819360|NCT00002540|566087583|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
156819361|NCT00002540|566087584|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
156819362|NCT00002540|566087583|FG000|Overall Study|Died Before Randomization|2|||
156819363|NCT00002540|566087584|FG001|Overall Study|Died Before Randomization|6|||
156819364|NCT00002540|566087583|FG000|Overall Study|Died Before ASU (Control)|202|||
156819365|NCT00002540|566087584|FG001|Overall Study|Died Before ASU (Control)|0|||
156819366|NCT00002540|566087583|FG000|Overall Study|Refused ASU (Control)|597|||
156819367|NCT00002540|566087584|FG001|Overall Study|Refused ASU (Control)|0|||
156819368|NCT00002540|566087583|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
156819369|NCT00002540|566087584|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
156819370|NCT04826094|566087585|FG000|Overall Study|Lost to Follow-up|2|||
156819371|NCT04826094|566087586|FG001|Overall Study|Lost to Follow-up|1|||
156819372|NCT04826094|566087587|FG002|Overall Study|Lost to Follow-up|0|||
156819373|NCT04826094|566087588|FG003|Overall Study|Lost to Follow-up|0|||
156819374|NCT04826094|566087589|FG004|Overall Study|Lost to Follow-up|1|||
156819375|NCT04826094|566087590|FG005|Overall Study|Lost to Follow-up|3|||
156819376|NCT04826094|566087591|FG006|Overall Study|Lost to Follow-up|1|||
156819377|NCT04826094|566087592|FG007|Overall Study|Lost to Follow-up|1|||
156819378|NCT04826094|566087585|FG000|Overall Study|Participant withdrew consent|1|||
156819379|NCT04826094|566087586|FG001|Overall Study|Participant withdrew consent|0|||
156819380|NCT04826094|566087587|FG002|Overall Study|Participant withdrew consent|0|||
156819381|NCT04826094|566087588|FG003|Overall Study|Participant withdrew consent|1|||
156819382|NCT04826094|566087589|FG004|Overall Study|Participant withdrew consent|1|||
156819383|NCT04826094|566087590|FG005|Overall Study|Participant withdrew consent|1|||
156819384|NCT04826094|566087591|FG006|Overall Study|Participant withdrew consent|0|||
156819385|NCT04826094|566087592|FG007|Overall Study|Participant withdrew consent|1|||
156819386|NCT04826094|566087585|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
156819387|NCT04826094|566087586|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
156819388|NCT04826094|566087587|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
156819389|NCT04826094|566087588|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
156819390|NCT04826094|566087589|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
156819391|NCT04826094|566087590|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
156819392|NCT04826094|566087591|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
156819393|NCT04826094|566087592|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
156819394|NCT04826094|566087585|FG000|Overall Study|Withdrawn by Investigator|0|||
156819395|NCT04826094|566087586|FG001|Overall Study|Withdrawn by Investigator|0|||
156819396|NCT04826094|566087587|FG002|Overall Study|Withdrawn by Investigator|0|||
156819397|NCT04826094|566087588|FG003|Overall Study|Withdrawn by Investigator|0|||
156819398|NCT04826094|566087589|FG004|Overall Study|Withdrawn by Investigator|0|||
156819399|NCT04826094|566087590|FG005|Overall Study|Withdrawn by Investigator|1|||
156819400|NCT04826094|566087591|FG006|Overall Study|Withdrawn by Investigator|0|||
156819401|NCT04826094|566087592|FG007|Overall Study|Withdrawn by Investigator|1|||
156819402|NCT04826094|566087585|FG000|Overall Study|Other: Moved from area|1|||
156819403|NCT04826094|566087586|FG001|Overall Study|Other: Moved from area|1|||
156819404|NCT04826094|566087587|FG002|Overall Study|Other: Moved from area|1|||
156819405|NCT04826094|566087588|FG003|Overall Study|Other: Moved from area|0|||
156819406|NCT04826094|566087589|FG004|Overall Study|Other: Moved from area|0|||
156819407|NCT04826094|566087590|FG005|Overall Study|Other: Moved from area|0|||
156819408|NCT04826094|566087591|FG006|Overall Study|Other: Moved from area|0|||
156819409|NCT04826094|566087592|FG007|Overall Study|Other: Moved from area|0|||
156819410|NCT04826094|566087585|FG000|Overall Study|Other: Declined|0|||
156819411|NCT04826094|566087586|FG001|Overall Study|Other: Declined|0|||
156819412|NCT04826094|566087587|FG002|Overall Study|Other: Declined|0|||
156819413|NCT04826094|566087588|FG003|Overall Study|Other: Declined|0|||
156819414|NCT04826094|566087589|FG004|Overall Study|Other: Declined|1|||
156819415|NCT04826094|566087590|FG005|Overall Study|Other: Declined|0|||
156819416|NCT04826094|566087591|FG006|Overall Study|Other: Declined|0|||
156819417|NCT04826094|566087592|FG007|Overall Study|Other: Declined|0|||
156819418|NCT04826094|566087585|FG000|Overall Study|Other: Vaccine not administered|0|||
156819419|NCT04826094|566087586|FG001|Overall Study|Other: Vaccine not administered|0|||
156819420|NCT04826094|566087587|FG002|Overall Study|Other: Vaccine not administered|1|||
156819421|NCT04826094|566087588|FG003|Overall Study|Other: Vaccine not administered|0|||
156819422|NCT04826094|566087589|FG004|Overall Study|Other: Vaccine not administered|0|||
156819423|NCT04826094|566087590|FG005|Overall Study|Other: Vaccine not administered|1|||
156819424|NCT04826094|566087591|FG006|Overall Study|Other: Vaccine not administered|1|||
156819425|NCT04826094|566087592|FG007|Overall Study|Other: Vaccine not administered|3|||
156819426|NCT02151903|566087594|FG000|Overall Study|Withdrawal by Subject|1|||
156819427|NCT02151903|566087595|FG001|Overall Study|Withdrawal by Subject|0|||
156819428|NCT02151903|566087594|FG000|Overall Study|Progressive disease|2|||
156819429|NCT02151903|566087595|FG001|Overall Study|Progressive disease|1|||
156819430|NCT00778375|566087601|FG000|Overall Study|Ineligible|3|||
156819431|NCT01421303|566087602|FG000|Overall Study|Lost to Follow-up|13|||
156819432|NCT01421303|566087602|FG000|Overall Study|Non compliance with study procedure|1|||
156819433|NCT01421303|566087602|FG000|Overall Study|Other|7|||
156819434|NCT01421303|566087602|FG000|Overall Study|Withdrawal by Subject|1|||
156819435|NCT06003777|566087603|FG000|Period 1|Adverse Event|0|||
156819436|NCT06003777|566087604|FG001|Period 1|Adverse Event|0|||
156819437|NCT06003777|566087605|FG002|Period 1|Adverse Event|1|||
156819438|NCT06003777|566087606|FG003|Period 1|Adverse Event|0|||
156819439|NCT06003777|566087607|FG004|Period 1|Adverse Event|0|||
156819440|NCT06003777|566087608|FG005|Period 1|Adverse Event|0|||
156819441|NCT06003777|566087609|FG006|Period 1|Adverse Event|0|||
156819442|NCT06003777|566087610|FG007|Period 1|Adverse Event|0|||
156819443|NCT06003777|566087611|FG008|Period 1|Adverse Event|0|||
156819444|NCT06003777|566087612|FG009|Period 1|Adverse Event|0|||
156819445|NCT06003777|566087613|FG010|Period 1|Adverse Event|0|||
156819446|NCT06003777|566087614|FG011|Period 1|Adverse Event|0|||
156819447|NCT06003777|566087603|FG000|Period 1|Withdrawal by Subject|0|||
156819448|NCT06003777|566087604|FG001|Period 1|Withdrawal by Subject|0|||
156819449|NCT06003777|566087605|FG002|Period 1|Withdrawal by Subject|0|||
156819450|NCT06003777|566087606|FG003|Period 1|Withdrawal by Subject|0|||
156819451|NCT06003777|566087607|FG004|Period 1|Withdrawal by Subject|1|||
156819452|NCT06003777|566087608|FG005|Period 1|Withdrawal by Subject|0|||
156819453|NCT06003777|566087609|FG006|Period 1|Withdrawal by Subject|0|||
156339136|NCT04203498|564340117|FG001|Overall Study|Did not receive IMP|0|||
156541131|NCT05611671|565074484|FG001|Overall Study|Protocol Violation|1|||
156819454|NCT06003777|566087610|FG007|Period 1|Withdrawal by Subject|0|||
156819455|NCT06003777|566087611|FG008|Period 1|Withdrawal by Subject|0|||
156819456|NCT06003777|566087612|FG009|Period 1|Withdrawal by Subject|0|||
156819457|NCT06003777|566087613|FG010|Period 1|Withdrawal by Subject|0|||
156819458|NCT06003777|566087614|FG011|Period 1|Withdrawal by Subject|0|||
156819459|NCT06003777|566087603|FG000|Period 2|Withdrawal by Subject|0|||
156339137|NCT00334958|564340122|FG000|Overall Study|Medication Noncompliance|0|||
156819460|NCT06003777|566087604|FG001|Period 2|Withdrawal by Subject|0|||
156819461|NCT06003777|566087605|FG002|Period 2|Withdrawal by Subject|0|||
156819462|NCT06003777|566087606|FG003|Period 2|Withdrawal by Subject|0|||
156819463|NCT06003777|566087607|FG004|Period 2|Withdrawal by Subject|0|||
156819464|NCT06003777|566087608|FG005|Period 2|Withdrawal by Subject|0|||
156819465|NCT06003777|566087609|FG006|Period 2|Withdrawal by Subject|0|||
156819466|NCT06003777|566087610|FG007|Period 2|Withdrawal by Subject|0|||
156819467|NCT06003777|566087611|FG008|Period 2|Withdrawal by Subject|1|||
156819468|NCT06003777|566087612|FG009|Period 2|Withdrawal by Subject|0|||
156819469|NCT06003777|566087613|FG010|Period 2|Withdrawal by Subject|0|||
156819470|NCT06003777|566087614|FG011|Period 2|Withdrawal by Subject|0|||
156819471|NCT06003777|566087603|FG000|Period 3|Adverse Event|0|||
156819472|NCT06003777|566087604|FG001|Period 3|Adverse Event|0|||
156819473|NCT06003777|566087605|FG002|Period 3|Adverse Event|0|||
156819474|NCT06003777|566087606|FG003|Period 3|Adverse Event|0|||
156819475|NCT06003777|566087607|FG004|Period 3|Adverse Event|0|||
156819476|NCT06003777|566087608|FG005|Period 3|Adverse Event|0|||
156819477|NCT06003777|566087609|FG006|Period 3|Adverse Event|1|||
156819478|NCT06003777|566087610|FG007|Period 3|Adverse Event|0|||
156819479|NCT06003777|566087611|FG008|Period 3|Adverse Event|0|||
156819480|NCT06003777|566087612|FG009|Period 3|Adverse Event|0|||
156819481|NCT06003777|566087613|FG010|Period 3|Adverse Event|0|||
156819482|NCT06003777|566087614|FG011|Period 3|Adverse Event|0|||
156465813|NCT01778686|564802026|FG002|Overall Study|Adverse Event|1|||
156465814|NCT04012567|564802027|FG000|Overall Study|Lost to Follow-up|0|||
156465815|NCT04012567|564802028|FG001|Overall Study|Lost to Follow-up|1|||
156465816|NCT04012567|564802027|FG000|Overall Study|Withdrawal by Subject|1|||
156465817|NCT04012567|564802028|FG001|Overall Study|Withdrawal by Subject|0|||
156465818|NCT03782116|564802031|FG000|Completed Intervetion|Lost to Follow-up|11|||
156465819|NCT03782116|564802032|FG001|Completed Intervetion|Lost to Follow-up|7|||
156465820|NCT03782116|564802031|FG000|Completed Intervetion|Withdrawal by Subject|6|||
156465821|NCT03782116|564802032|FG001|Completed Intervetion|Withdrawal by Subject|5|||
156465822|NCT03782116|564802031|FG000|Included in Analysis|Protocol Violation|5|||
156465823|NCT03782116|564802032|FG001|Included in Analysis|Protocol Violation|5|||
156465824|NCT05714059|564802035|FG000|Overall Study|Withdrawal by Subject|2|||
156465825|NCT05714059|564802036|FG001|Overall Study|Withdrawal by Subject|2|||
156465826|NCT05714059|564802035|FG000|Overall Study|Adverse Event|0|||
156465827|NCT05714059|564802036|FG001|Overall Study|Adverse Event|1|||
156465828|NCT05714059|564802035|FG000|Overall Study|Lost to Follow-up|0|||
156465829|NCT05714059|564802036|FG001|Overall Study|Lost to Follow-up|1|||
156819483|NCT06003777|566087603|FG000|Period 4|No longer met eligibility criteria|0|||
156819484|NCT06003777|566087604|FG001|Period 4|No longer met eligibility criteria|0|||
156819485|NCT06003777|566087605|FG002|Period 4|No longer met eligibility criteria|1|||
156819486|NCT06003777|566087606|FG003|Period 4|No longer met eligibility criteria|0|||
156819487|NCT06003777|566087607|FG004|Period 4|No longer met eligibility criteria|0|||
156819488|NCT06003777|566087608|FG005|Period 4|No longer met eligibility criteria|0|||
156819489|NCT06003777|566087609|FG006|Period 4|No longer met eligibility criteria|0|||
156819490|NCT06003777|566087610|FG007|Period 4|No longer met eligibility criteria|0|||
156819491|NCT06003777|566087611|FG008|Period 4|No longer met eligibility criteria|0|||
156819492|NCT06003777|566087612|FG009|Period 4|No longer met eligibility criteria|0|||
156819493|NCT06003777|566087613|FG010|Period 4|No longer met eligibility criteria|0|||
156819494|NCT06003777|566087614|FG011|Period 4|No longer met eligibility criteria|0|||
156819495|NCT06003777|566087603|FG000|Period 4|Withdrawal by Subject|0|||
156819496|NCT06003777|566087604|FG001|Period 4|Withdrawal by Subject|1|||
156819497|NCT06003777|566087605|FG002|Period 4|Withdrawal by Subject|0|||
156465830|NCT05714059|564802035|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
156465831|NCT05714059|564802036|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
156465832|NCT05714059|564802035|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
156819498|NCT06003777|566087606|FG003|Period 4|Withdrawal by Subject|0|||
156819499|NCT06003777|566087607|FG004|Period 4|Withdrawal by Subject|0|||
156819500|NCT06003777|566087608|FG005|Period 4|Withdrawal by Subject|0|||
156819501|NCT06003777|566087609|FG006|Period 4|Withdrawal by Subject|0|||
156819502|NCT06003777|566087610|FG007|Period 4|Withdrawal by Subject|0|||
156819503|NCT06003777|566087611|FG008|Period 4|Withdrawal by Subject|0|||
156819504|NCT06003777|566087612|FG009|Period 4|Withdrawal by Subject|0|||
156819505|NCT06003777|566087613|FG010|Period 4|Withdrawal by Subject|0|||
156819506|NCT06003777|566087614|FG011|Period 4|Withdrawal by Subject|0|||
156819507|NCT05319600|566087615|FG000|Overall Study|Withdrawal by Subject|1|||
156819508|NCT05319600|566087616|FG001|Overall Study|Withdrawal by Subject|0|||
156819509|NCT05319600|566087615|FG000|Overall Study|Lost to Follow-up|0|||
156819510|NCT05319600|566087616|FG001|Overall Study|Lost to Follow-up|4|||
156819511|NCT01732510|566087617|FG000|Overall Study|Adverse Event|0|||
156819512|NCT01732510|566087618|FG001|Overall Study|Adverse Event|1|||
156819513|NCT01732510|566087619|FG002|Overall Study|Adverse Event|1|||
156819514|NCT01732510|566087620|FG003|Overall Study|Adverse Event|0|||
156819515|NCT01732510|566087621|FG004|Overall Study|Adverse Event|0|||
156819516|NCT01732510|566087622|FG005|Overall Study|Adverse Event|0|||
156819517|NCT01732510|566087623|FG006|Overall Study|Adverse Event|1|||
156819518|NCT01732510|566087617|FG000|Overall Study|Protocol Violation|0|||
156819519|NCT01732510|566087618|FG001|Overall Study|Protocol Violation|0|||
156819520|NCT01732510|566087619|FG002|Overall Study|Protocol Violation|0|||
156819521|NCT01732510|566087620|FG003|Overall Study|Protocol Violation|1|||
156819522|NCT01732510|566087621|FG004|Overall Study|Protocol Violation|0|||
156819523|NCT01732510|566087622|FG005|Overall Study|Protocol Violation|0|||
156819524|NCT01732510|566087623|FG006|Overall Study|Protocol Violation|0|||
156819525|NCT01732510|566087617|FG000|Overall Study|Withdrawal by Subject|1|||
156819526|NCT01732510|566087618|FG001|Overall Study|Withdrawal by Subject|3|||
156819527|NCT01732510|566087619|FG002|Overall Study|Withdrawal by Subject|2|||
156819528|NCT01732510|566087620|FG003|Overall Study|Withdrawal by Subject|1|||
156819529|NCT01732510|566087621|FG004|Overall Study|Withdrawal by Subject|5|||
156819530|NCT01732510|566087622|FG005|Overall Study|Withdrawal by Subject|0|||
156819531|NCT01732510|566087623|FG006|Overall Study|Withdrawal by Subject|1|||
156819532|NCT01732510|566087617|FG000|Overall Study|Lost to Follow-up|0|||
156819533|NCT01732510|566087618|FG001|Overall Study|Lost to Follow-up|0|||
156819534|NCT01732510|566087619|FG002|Overall Study|Lost to Follow-up|1|||
156819535|NCT01732510|566087620|FG003|Overall Study|Lost to Follow-up|1|||
156819536|NCT01732510|566087621|FG004|Overall Study|Lost to Follow-up|0|||
156819537|NCT01732510|566087622|FG005|Overall Study|Lost to Follow-up|1|||
156819538|NCT01732510|566087623|FG006|Overall Study|Lost to Follow-up|0|||
156819539|NCT01732510|566087617|FG000|Overall Study|Physician Decision|0|||
156819540|NCT01732510|566087618|FG001|Overall Study|Physician Decision|1|||
156819541|NCT01732510|566087619|FG002|Overall Study|Physician Decision|0|||
156819542|NCT01732510|566087620|FG003|Overall Study|Physician Decision|0|||
156819543|NCT01732510|566087621|FG004|Overall Study|Physician Decision|0|||
156819544|NCT01732510|566087622|FG005|Overall Study|Physician Decision|0|||
156819545|NCT01732510|566087623|FG006|Overall Study|Physician Decision|0|||
156819546|NCT01732510|566087617|FG000|Overall Study|Pregnancy|0|||
156819547|NCT01732510|566087618|FG001|Overall Study|Pregnancy|0|||
156819548|NCT01732510|566087619|FG002|Overall Study|Pregnancy|0|||
156819549|NCT01732510|566087620|FG003|Overall Study|Pregnancy|1|||
156819550|NCT01732510|566087621|FG004|Overall Study|Pregnancy|0|||
156819551|NCT01732510|566087622|FG005|Overall Study|Pregnancy|0|||
156819552|NCT01732510|566087623|FG006|Overall Study|Pregnancy|0|||
156819553|NCT01732510|566087617|FG000|Overall Study|Study Terminated By Sponsor|0|||
156819554|NCT01732510|566087618|FG001|Overall Study|Study Terminated By Sponsor|0|||
156819555|NCT01732510|566087619|FG002|Overall Study|Study Terminated By Sponsor|0|||
156819556|NCT01732510|566087620|FG003|Overall Study|Study Terminated By Sponsor|1|||
156819557|NCT01732510|566087621|FG004|Overall Study|Study Terminated By Sponsor|0|||
156819558|NCT01732510|566087622|FG005|Overall Study|Study Terminated By Sponsor|12|||
156819559|NCT01732510|566087623|FG006|Overall Study|Study Terminated By Sponsor|6|||
156819560|NCT01262560|566087624|FG000|Overall Study|Protocol Violation|0|||
156819561|NCT01262560|566087625|FG001|Overall Study|Protocol Violation|1|||
156819562|NCT01262560|566087626|FG002|Overall Study|Protocol Violation|2|||
156819563|NCT00350870|566087631|FG000|Overall Study|Withdrawal by Subject|21|||
156819564|NCT00350870|566087632|FG001|Overall Study|Withdrawal by Subject|17|||
156819565|NCT00350870|566087633|FG002|Overall Study|Withdrawal by Subject|15|||
156819566|NCT00350870|566087634|FG003|Overall Study|Withdrawal by Subject|14|||
156819567|NCT00350870|566087631|FG000|Overall Study|Physician Decision|1|||
156819568|NCT00350870|566087632|FG001|Overall Study|Physician Decision|0|||
156819569|NCT00350870|566087633|FG002|Overall Study|Physician Decision|1|||
156819570|NCT00350870|566087634|FG003|Overall Study|Physician Decision|1|||
156819571|NCT01932372|566087635|FG000|Overall Study|Not meeting eligibility criteria|33|||
156465833|NCT05714059|564802036|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
156819572|NCT01932372|566087636|FG001|Overall Study|Not meeting eligibility criteria|179|||
156819573|NCT03594747|566087641|FG000|Overall Study|Death|78|||
156819574|NCT03594747|566087642|FG001|Overall Study|Death|86|||
156819575|NCT03594747|566087643|FG002|Overall Study|Death|87|||
156819576|NCT03594747|566087641|FG000|Overall Study|Withdrawal by Subject|5|||
156819577|NCT03594747|566087642|FG001|Overall Study|Withdrawal by Subject|2|||
156819578|NCT03594747|566087643|FG002|Overall Study|Withdrawal by Subject|11|||
156819579|NCT03594747|566087641|FG000|Overall Study|Lost to Follow-up|4|||
156819580|NCT03594747|566087642|FG001|Overall Study|Lost to Follow-up|1|||
156819581|NCT03594747|566087643|FG002|Overall Study|Lost to Follow-up|1|||
156819582|NCT03594747|566087641|FG000|Overall Study|Physician Decision|0|||
156819583|NCT03594747|566087642|FG001|Overall Study|Physician Decision|1|||
156819584|NCT03594747|566087643|FG002|Overall Study|Physician Decision|0|||
156819585|NCT03594747|566087641|FG000|Overall Study|Sponsor decision|23|||
156819586|NCT03594747|566087642|FG001|Overall Study|Sponsor decision|17|||
156819587|NCT03594747|566087643|FG002|Overall Study|Sponsor decision|16|||
156819588|NCT03594747|566087641|FG000|Overall Study|Did not meet inclusion criteria|0|||
156819589|NCT03594747|566087642|FG001|Overall Study|Did not meet inclusion criteria|0|||
156819590|NCT03594747|566087643|FG002|Overall Study|Did not meet inclusion criteria|1|||
156819591|NCT03594747|566087641|FG000|Overall Study|Transfer to long term extension study|10|||
156819592|NCT03594747|566087642|FG001|Overall Study|Transfer to long term extension study|12|||
156819593|NCT03594747|566087643|FG002|Overall Study|Transfer to long term extension study|5|||
156819594|NCT04382586|566087644|FG000|Overall Study|Death|3|||
156819595|NCT04382586|566087645|FG001|Overall Study|Death|4|||
156819596|NCT04382586|566087644|FG000|Overall Study|Lost to Follow-up|11|||
156819597|NCT04382586|566087645|FG001|Overall Study|Lost to Follow-up|8|||
156819598|NCT04382586|566087644|FG000|Overall Study|Withdrawal by Subject|3|||
156819599|NCT04382586|566087645|FG001|Overall Study|Withdrawal by Subject|1|||
156819600|NCT04382586|566087644|FG000|Overall Study|Physician Decision|0|||
156819601|NCT04382586|566087645|FG001|Overall Study|Physician Decision|3|||
156819602|NCT02265536|566087653|FG000|Overall Study|Adverse Event|1|||
156819603|NCT02265536|566087654|FG001|Overall Study|Adverse Event|0|||
156819604|NCT02265536|566087655|FG002|Overall Study|Adverse Event|0|||
156819605|NCT02265536|566087656|FG003|Overall Study|Adverse Event|0|||
156819606|NCT02265536|566087657|FG004|Overall Study|Adverse Event|1|||
156819607|NCT02265536|566087658|FG005|Overall Study|Adverse Event|0|||
156819608|NCT02265536|566087653|FG000|Overall Study|Physician Decision|0|||
156819609|NCT02265536|566087654|FG001|Overall Study|Physician Decision|0|||
156819610|NCT02265536|566087655|FG002|Overall Study|Physician Decision|0|||
156819611|NCT02265536|566087656|FG003|Overall Study|Physician Decision|0|||
156819612|NCT02265536|566087657|FG004|Overall Study|Physician Decision|2|||
156819613|NCT02265536|566087658|FG005|Overall Study|Physician Decision|0|||
156819614|NCT02265536|566087653|FG000|Overall Study|Withdrawal by Subject|0|||
156819615|NCT02265536|566087654|FG001|Overall Study|Withdrawal by Subject|3|||
156819616|NCT02265536|566087655|FG002|Overall Study|Withdrawal by Subject|0|||
156819617|NCT02265536|566087656|FG003|Overall Study|Withdrawal by Subject|0|||
156819618|NCT02265536|566087657|FG004|Overall Study|Withdrawal by Subject|0|||
156819619|NCT02265536|566087658|FG005|Overall Study|Withdrawal by Subject|0|||
156819620|NCT00349349|566087659|FG000|Overall Study|Adverse Event|5|||
156819621|NCT00349349|566087660|FG001|Overall Study|Adverse Event|6|||
156819622|NCT00349349|566087661|FG002|Overall Study|Adverse Event|2|||
156819623|NCT00349349|566087659|FG000|Overall Study|Withdrawal by Subject|5|||
156819624|NCT00349349|566087660|FG001|Overall Study|Withdrawal by Subject|2|||
156819625|NCT00349349|566087661|FG002|Overall Study|Withdrawal by Subject|1|||
156819626|NCT00349349|566087659|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
156819627|NCT00349349|566087660|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
156819628|NCT00349349|566087661|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
156819629|NCT00349349|566087659|FG000|Overall Study|Death|13|||
156819630|NCT00349349|566087660|FG001|Overall Study|Death|10|||
156819631|NCT00349349|566087661|FG002|Overall Study|Death|1|||
156819632|NCT00349349|566087659|FG000|Overall Study|Other Treatment Selected|2|||
156819633|NCT00349349|566087660|FG001|Overall Study|Other Treatment Selected|0|||
156819634|NCT00349349|566087661|FG002|Overall Study|Other Treatment Selected|0|||
156819635|NCT00349349|566087659|FG000|Overall Study|Participant Reduced General Condition|0|||
156819636|NCT00349349|566087660|FG001|Overall Study|Participant Reduced General Condition|1|||
156819637|NCT00349349|566087661|FG002|Overall Study|Participant Reduced General Condition|0|||
156819638|NCT00349349|566087659|FG000|Overall Study|Physician Decision|1|||
156819639|NCT00349349|566087660|FG001|Overall Study|Physician Decision|2|||
156819640|NCT00349349|566087661|FG002|Overall Study|Physician Decision|1|||
156819641|NCT00349349|566087659|FG000|Overall Study|No Response|0|||
156819642|NCT00349349|566087660|FG001|Overall Study|No Response|3|||
156819643|NCT00349349|566087661|FG002|Overall Study|No Response|0|||
156819644|NCT00349349|566087659|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
156819645|NCT00349349|566087660|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
156819646|NCT00349349|566087661|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
156819647|NCT02095873|566087662|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
156819648|NCT02095873|566087663|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
156819649|NCT02095873|566087662|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
156465834|NCT04899674|564802037|FG000|Test|Adverse Event|1|||
156819650|NCT02095873|566087663|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
156819651|NCT02095873|566087662|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
156819652|NCT02095873|566087663|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
156819653|NCT03763656|566087668|FG000|Overall Study|Physician Decision|1|||
156819654|NCT03763656|566087668|FG000|Overall Study|Protocol Violation|1|||
156819655|NCT03763656|566087668|FG000|Overall Study|Withdrawal by Subject|7|||
156819656|NCT00107900|566087672|FG000|Overall Study|Adverse Event|3|||
156819657|NCT00107900|566087673|FG001|Overall Study|Adverse Event|2|||
156819658|NCT00107900|566087674|FG002|Overall Study|Adverse Event|10|||
156819659|NCT00107900|566087675|FG003|Overall Study|Adverse Event|3|||
156819660|NCT00107900|566087676|FG004|Overall Study|Adverse Event|5|||
156819661|NCT00107900|566087677|FG005|Overall Study|Adverse Event|3|||
156819662|NCT00107900|566087672|FG000|Overall Study|Death|0|||
156819663|NCT00107900|566087673|FG001|Overall Study|Death|0|||
156819664|NCT00107900|566087674|FG002|Overall Study|Death|0|||
156819665|NCT00107900|566087675|FG003|Overall Study|Death|0|||
156819666|NCT00107900|566087676|FG004|Overall Study|Death|1|||
156819667|NCT00107900|566087677|FG005|Overall Study|Death|0|||
156819668|NCT00107900|566087672|FG000|Overall Study|Lost to Follow-up|4|||
156819669|NCT00107900|566087673|FG001|Overall Study|Lost to Follow-up|1|||
156819670|NCT00107900|566087674|FG002|Overall Study|Lost to Follow-up|3|||
156819671|NCT00107900|566087675|FG003|Overall Study|Lost to Follow-up|2|||
156819672|NCT00107900|566087676|FG004|Overall Study|Lost to Follow-up|5|||
156819673|NCT00107900|566087677|FG005|Overall Study|Lost to Follow-up|5|||
156819674|NCT00107900|566087672|FG000|Overall Study|Protocol Violation|1|||
156819675|NCT00107900|566087673|FG001|Overall Study|Protocol Violation|0|||
156819676|NCT00107900|566087674|FG002|Overall Study|Protocol Violation|5|||
156819677|NCT00107900|566087675|FG003|Overall Study|Protocol Violation|5|||
156819678|NCT00107900|566087676|FG004|Overall Study|Protocol Violation|7|||
156819679|NCT00107900|566087677|FG005|Overall Study|Protocol Violation|0|||
156819680|NCT00107900|566087672|FG000|Overall Study|Withdrawal by Subject|1|||
156819681|NCT00107900|566087673|FG001|Overall Study|Withdrawal by Subject|0|||
156819682|NCT00107900|566087674|FG002|Overall Study|Withdrawal by Subject|5|||
156819683|NCT00107900|566087675|FG003|Overall Study|Withdrawal by Subject|0|||
156819684|NCT00107900|566087676|FG004|Overall Study|Withdrawal by Subject|1|||
156819685|NCT00107900|566087677|FG005|Overall Study|Withdrawal by Subject|1|||
156819686|NCT00107900|566087672|FG000|Overall Study|Administrative Reasons|1|||
156819687|NCT00107900|566087673|FG001|Overall Study|Administrative Reasons|0|||
156819688|NCT00107900|566087674|FG002|Overall Study|Administrative Reasons|2|||
156819689|NCT00107900|566087675|FG003|Overall Study|Administrative Reasons|2|||
156819690|NCT00107900|566087676|FG004|Overall Study|Administrative Reasons|2|||
156819691|NCT00107900|566087677|FG005|Overall Study|Administrative Reasons|0|||
156819692|NCT00197145|566089739|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
156819693|NCT00197145|566089740|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
156819694|NCT00197145|566089739|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
156819695|NCT00197145|566089740|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
156819696|NCT00197145|566089739|FG000|Period 1: Randomized Treatment Phase|Other|2|||
156819697|NCT00197145|566089740|FG001|Period 1: Randomized Treatment Phase|Other|2|||
156819698|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
156819699|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
156819700|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
156819701|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
156819702|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
156819703|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
156819704|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
156819705|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
156819706|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Other|1|||
156819707|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Other|0|||
156819708|NCT02242435|566089741|FG000|Overall Study|Lost to Follow-up|3|||
156819709|NCT02242435|566089742|FG001|Overall Study|Lost to Follow-up|4|||
156819710|NCT02242435|566089741|FG000|Overall Study|Adverse Event|3|||
156819711|NCT02242435|566089742|FG001|Overall Study|Adverse Event|2|||
156819712|NCT02242435|566089741|FG000|Overall Study|Withdrawal by Subject|13|||
156819713|NCT02242435|566089742|FG001|Overall Study|Withdrawal by Subject|8|||
156819714|NCT02242435|566089741|FG000|Overall Study|Death|0|||
156819715|NCT02242435|566089742|FG001|Overall Study|Death|1|||
156819716|NCT02242435|566089741|FG000|Overall Study|Protocol Violation|1|||
156819717|NCT02242435|566089742|FG001|Overall Study|Protocol Violation|0|||
156819718|NCT02242435|566089741|FG000|Overall Study|Physician Decision|0|||
156819719|NCT02242435|566089742|FG001|Overall Study|Physician Decision|1|||
156819720|NCT01089413|566089744|FG000|Overall Study|Lost to Follow-up|1|||
156819721|NCT01089413|566089744|FG000|Overall Study|Progressive Disease|93|||
156819722|NCT01089413|566089744|FG000|Overall Study|Participant Withdrew Consent|1|||
156819723|NCT01089413|566089744|FG000|Overall Study|Unacceptable Toxicity|12|||
156819724|NCT01089413|566089744|FG000|Overall Study|Death|10|||
156819725|NCT01089413|566089744|FG000|Overall Study|Metastasectomy|13|||
156819726|NCT01089413|566089744|FG000|Overall Study|Other|71|||
156819727|NCT02513485|566089745|FG000|Overall Study|Adverse Event|1|||
156819728|NCT02513485|566089746|FG001|Overall Study|Adverse Event|0|||
156819729|NCT00394251|566089754|FG000|Overall Study|Adverse Event|7|||
156819730|NCT00394251|566089755|FG001|Overall Study|Adverse Event|5|||
156819731|NCT00394251|566089754|FG000|Overall Study|Unacceptable Toxicity|20|||
156819732|NCT00394251|566089755|FG001|Overall Study|Unacceptable Toxicity|18|||
156819733|NCT00394251|566089754|FG000|Overall Study|Physician Decision|1|||
156819734|NCT00394251|566089755|FG001|Overall Study|Physician Decision|1|||
156819735|NCT00394251|566089754|FG000|Overall Study|Protocol Violation|0|||
156819736|NCT00394251|566089755|FG001|Overall Study|Protocol Violation|1|||
156819737|NCT00394251|566089754|FG000|Overall Study|Withdrawal by Subject|7|||
156819738|NCT00394251|566089755|FG001|Overall Study|Withdrawal by Subject|11|||
156819739|NCT00394251|566089754|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
156819740|NCT00394251|566089755|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
156819741|NCT01667224|566089758|FG000|Overall Study|Withdrawal by Subject|3|||
156819742|NCT01667224|566089759|FG001|Overall Study|Withdrawal by Subject|1|||
156819743|NCT01667224|566089758|FG000|Overall Study|Protocol Violation|1|||
156819744|NCT01667224|566089759|FG001|Overall Study|Protocol Violation|1|||
156819745|NCT03350035|566089760|FG000|Overall Study|Lack of Efficacy|2|||
156819746|NCT03350035|566089761|FG001|Overall Study|Lack of Efficacy|0|||
156819747|NCT03350035|566089762|FG002|Overall Study|Lack of Efficacy|0|||
156819748|NCT03350035|566089760|FG000|Overall Study|Subject discharged to hospice|0|||
156819749|NCT03350035|566089761|FG001|Overall Study|Subject discharged to hospice|0|||
156819750|NCT03350035|566089762|FG002|Overall Study|Subject discharged to hospice|1|||
156819751|NCT01610557|566089763|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
156819752|NCT01610557|566089764|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
156819753|NCT01610557|566089765|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
156819754|NCT01610557|566089766|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
156819755|NCT01610557|566089767|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
156819756|NCT01610557|566089763|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
156819757|NCT01610557|566089764|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
156819758|NCT01610557|566089765|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
156819759|NCT01610557|566089766|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
156819760|NCT01610557|566089767|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
156819761|NCT01200407|566089768|FG000|Overall Study|Lost to Follow-up|56|||
156819762|NCT01200407|566089768|FG000|Overall Study|Adverse Event|3|||
156819763|NCT01200407|566089768|FG000|Overall Study|Withdrawal by Subject|4|||
156819764|NCT01200407|566089768|FG000|Overall Study|Other|19|||
156819765|NCT00365105|566089769|FG000|Overall Study|Protocol Violation|5|||
156819766|NCT00365105|566089770|FG001|Overall Study|Protocol Violation|8|||
156819767|NCT06004895|566089771|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
156819768|NCT06004895|566089771|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
156819769|NCT02752633|566089772|FG000|Overall Study|Withdrawal by Subject|1|||
156819770|NCT01843673|566089773|FG000|Overall Study|Lack of Efficacy|2|||
156819771|NCT01843673|566089773|FG000|Overall Study|Withdrawal by Subject|4|||
156819772|NCT00425698|566089774|FG000|Overall Study|Adverse Event|3|||
156819773|NCT00425698|566089775|FG001|Overall Study|Adverse Event|1|||
156819774|NCT00425698|566089774|FG000|Overall Study|Withdrawal by Subject|0|||
156819775|NCT00425698|566089775|FG001|Overall Study|Withdrawal by Subject|1|||
156819776|NCT03275246|566089776|FG000|Overall Study|Protocol Violation|5|||
156819777|NCT03275246|566089776|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
156819778|NCT00433966|566089779|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
156819779|NCT00433966|566089780|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
156819780|NCT00433966|566089781|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
156819781|NCT00433966|566089782|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
156819782|NCT00433966|566089779|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
156819783|NCT00433966|566089780|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
156819784|NCT00433966|566089781|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
156819785|NCT00433966|566089782|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
156819786|NCT00433966|566089779|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
156819787|NCT00433966|566089780|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
156819788|NCT00433966|566089781|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
156819789|NCT00433966|566089782|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
156819790|NCT00433966|566089779|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
156819791|NCT00433966|566089780|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
156819792|NCT00433966|566089781|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
156819793|NCT00433966|566089782|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
156819794|NCT00433966|566089779|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
156819795|NCT00433966|566089780|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
156819796|NCT00433966|566089781|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
156819797|NCT00433966|566089782|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
156819798|NCT05059301|566089783|FG000|Overall Study|Adverse Event|0|||
156819799|NCT05059301|566089784|FG001|Overall Study|Adverse Event|2|||
156819800|NCT05059301|566089785|FG002|Overall Study|Adverse Event|2|||
156339138|NCT00334958|564340123|FG001|Overall Study|Medication Noncompliance|3|||
156339139|NCT00334958|564340122|FG000|Overall Study|Protocol Violation|2|||
156819801|NCT05059301|566089783|FG000|Overall Study|Lost to Follow-up|2|||
156819802|NCT05059301|566089784|FG001|Overall Study|Lost to Follow-up|3|||
156819803|NCT05059301|566089785|FG002|Overall Study|Lost to Follow-up|3|||
156819804|NCT04952597|566089787|FG000|Overall Study|Death|12|||
156819805|NCT04952597|566089788|FG001|Overall Study|Death|13|||
156819806|NCT04952597|566089789|FG002|Overall Study|Death|14|||
156819807|NCT04952597|566089787|FG000|Overall Study|Withdrawal by Subject|1|||
156819808|NCT04952597|566089788|FG001|Overall Study|Withdrawal by Subject|0|||
156819809|NCT04952597|566089789|FG002|Overall Study|Withdrawal by Subject|3|||
156819810|NCT04952597|566089787|FG000|Overall Study|Lost to Follow-up|0|||
156819811|NCT04952597|566089788|FG001|Overall Study|Lost to Follow-up|1|||
156819812|NCT04952597|566089789|FG002|Overall Study|Lost to Follow-up|1|||
156819813|NCT01296711|566089790|FG000|Overall Study|Adverse Event|3|||
156819814|NCT01296711|566089791|FG001|Overall Study|Adverse Event|1|||
156819815|NCT01296711|566089792|FG002|Overall Study|Adverse Event|4|||
156819816|NCT01296711|566089793|FG003|Overall Study|Adverse Event|3|||
156819817|NCT01296711|566089794|FG004|Overall Study|Adverse Event|1|||
156819818|NCT01296711|566089795|FG005|Overall Study|Adverse Event|6|||
156819819|NCT01296711|566089796|FG006|Overall Study|Adverse Event|11|||
156819820|NCT01296711|566089797|FG007|Overall Study|Adverse Event|3|||
156819821|NCT01296711|566089790|FG000|Overall Study|Lack of Efficacy|1|||
156819822|NCT01296711|566089791|FG001|Overall Study|Lack of Efficacy|4|||
156819823|NCT01296711|566089792|FG002|Overall Study|Lack of Efficacy|1|||
156819824|NCT01296711|566089793|FG003|Overall Study|Lack of Efficacy|1|||
156819825|NCT01296711|566089794|FG004|Overall Study|Lack of Efficacy|1|||
156819826|NCT01296711|566089795|FG005|Overall Study|Lack of Efficacy|0|||
156819827|NCT01296711|566089796|FG006|Overall Study|Lack of Efficacy|2|||
156819828|NCT01296711|566089797|FG007|Overall Study|Lack of Efficacy|3|||
156819829|NCT01296711|566089790|FG000|Overall Study|Lost to Follow-up|0|||
156819830|NCT01296711|566089791|FG001|Overall Study|Lost to Follow-up|0|||
156819831|NCT01296711|566089792|FG002|Overall Study|Lost to Follow-up|1|||
156819832|NCT01296711|566089793|FG003|Overall Study|Lost to Follow-up|1|||
156819833|NCT01296711|566089794|FG004|Overall Study|Lost to Follow-up|2|||
156819834|NCT01296711|566089795|FG005|Overall Study|Lost to Follow-up|0|||
156819835|NCT01296711|566089796|FG006|Overall Study|Lost to Follow-up|4|||
156819836|NCT01296711|566089797|FG007|Overall Study|Lost to Follow-up|2|||
156819837|NCT01296711|566089790|FG000|Overall Study|Protocol Violation|0|||
156819838|NCT01296711|566089791|FG001|Overall Study|Protocol Violation|0|||
156819839|NCT01296711|566089792|FG002|Overall Study|Protocol Violation|0|||
156819840|NCT01296711|566089793|FG003|Overall Study|Protocol Violation|1|||
156819841|NCT01296711|566089794|FG004|Overall Study|Protocol Violation|1|||
156819842|NCT01296711|566089795|FG005|Overall Study|Protocol Violation|0|||
156819843|NCT01296711|566089796|FG006|Overall Study|Protocol Violation|0|||
156819844|NCT01296711|566089797|FG007|Overall Study|Protocol Violation|0|||
156819845|NCT01296711|566089790|FG000|Overall Study|Withdrawal by Subject|4|||
156819846|NCT01296711|566089791|FG001|Overall Study|Withdrawal by Subject|2|||
156819847|NCT01296711|566089792|FG002|Overall Study|Withdrawal by Subject|2|||
156819848|NCT01296711|566089793|FG003|Overall Study|Withdrawal by Subject|1|||
156819849|NCT01296711|566089794|FG004|Overall Study|Withdrawal by Subject|1|||
156819850|NCT01296711|566089795|FG005|Overall Study|Withdrawal by Subject|1|||
156819851|NCT01296711|566089796|FG006|Overall Study|Withdrawal by Subject|2|||
156819852|NCT01296711|566089797|FG007|Overall Study|Withdrawal by Subject|1|||
156819853|NCT01296711|566089790|FG000|Overall Study|Study termination|8|||
156819854|NCT01296711|566089791|FG001|Overall Study|Study termination|1|||
156819855|NCT01296711|566089792|FG002|Overall Study|Study termination|5|||
156465835|NCT04129450|564802038|FG000|Overall Study|Lost to Follow-up|20|||
156819856|NCT01296711|566089793|FG003|Overall Study|Study termination|4|||
156465836|NCT04129450|564802039|FG001|Overall Study|Lost to Follow-up|10|||
156819857|NCT01296711|566089794|FG004|Overall Study|Study termination|4|||
156819858|NCT01296711|566089795|FG005|Overall Study|Study termination|4|||
156819859|NCT01296711|566089796|FG006|Overall Study|Study termination|8|||
156819860|NCT01296711|566089797|FG007|Overall Study|Study termination|10|||
156819861|NCT01296711|566089790|FG000|Overall Study|Continued elevated liver enzymes|0|||
156819862|NCT01296711|566089791|FG001|Overall Study|Continued elevated liver enzymes|0|||
156819863|NCT01296711|566089792|FG002|Overall Study|Continued elevated liver enzymes|0|||
156819864|NCT01296711|566089793|FG003|Overall Study|Continued elevated liver enzymes|1|||
156819865|NCT01296711|566089794|FG004|Overall Study|Continued elevated liver enzymes|0|||
156819866|NCT01296711|566089795|FG005|Overall Study|Continued elevated liver enzymes|0|||
156819867|NCT01296711|566089796|FG006|Overall Study|Continued elevated liver enzymes|0|||
156819868|NCT01296711|566089797|FG007|Overall Study|Continued elevated liver enzymes|0|||
156819869|NCT01296711|566089790|FG000|Overall Study|Methotrexate discontinued|0|||
156819870|NCT01296711|566089791|FG001|Overall Study|Methotrexate discontinued|0|||
156465837|NCT04129450|564802038|FG000|Overall Study|Withdrawal by Subject|9|||
156819871|NCT01296711|566089792|FG002|Overall Study|Methotrexate discontinued|0|||
156819872|NCT01296711|566089793|FG003|Overall Study|Methotrexate discontinued|1|||
156541132|NCT05611671|565074485|FG002|Overall Study|Protocol Violation|0|||
156819873|NCT01296711|566089794|FG004|Overall Study|Methotrexate discontinued|0|||
156819874|NCT01296711|566089795|FG005|Overall Study|Methotrexate discontinued|0|||
156819875|NCT01296711|566089796|FG006|Overall Study|Methotrexate discontinued|0|||
156819876|NCT01296711|566089797|FG007|Overall Study|Methotrexate discontinued|0|||
156819877|NCT01296711|566089790|FG000|Overall Study|Investigator discretion|0|||
156819878|NCT01296711|566089791|FG001|Overall Study|Investigator discretion|0|||
156819879|NCT01296711|566089792|FG002|Overall Study|Investigator discretion|0|||
156819880|NCT01296711|566089793|FG003|Overall Study|Investigator discretion|0|||
156819881|NCT01296711|566089794|FG004|Overall Study|Investigator discretion|0|||
156819882|NCT01296711|566089795|FG005|Overall Study|Investigator discretion|0|||
156819883|NCT01296711|566089796|FG006|Overall Study|Investigator discretion|1|||
156819884|NCT01296711|566089797|FG007|Overall Study|Investigator discretion|0|||
156819885|NCT01296711|566089790|FG000|Overall Study|Other|0|||
156819886|NCT01296711|566089791|FG001|Overall Study|Other|0|||
156819887|NCT01296711|566089792|FG002|Overall Study|Other|0|||
156819888|NCT01296711|566089793|FG003|Overall Study|Other|0|||
156819889|NCT01296711|566089794|FG004|Overall Study|Other|0|||
156819890|NCT01296711|566089795|FG005|Overall Study|Other|0|||
156819891|NCT01296711|566089796|FG006|Overall Study|Other|1|||
156819892|NCT01296711|566089797|FG007|Overall Study|Other|0|||
156819893|NCT01296711|566089790|FG000|Overall Study|Required restricted steroid injections|0|||
156819894|NCT01296711|566089791|FG001|Overall Study|Required restricted steroid injections|0|||
156819895|NCT01296711|566089792|FG002|Overall Study|Required restricted steroid injections|0|||
156819896|NCT01296711|566089793|FG003|Overall Study|Required restricted steroid injections|0|||
156819897|NCT01296711|566089794|FG004|Overall Study|Required restricted steroid injections|0|||
156819898|NCT01296711|566089795|FG005|Overall Study|Required restricted steroid injections|0|||
156819899|NCT01296711|566089796|FG006|Overall Study|Required restricted steroid injections|1|||
156819900|NCT01296711|566089797|FG007|Overall Study|Required restricted steroid injections|0|||
156819901|NCT01296711|566089790|FG000|Overall Study|Ongoing missed appointments|0|||
156819902|NCT01296711|566089791|FG001|Overall Study|Ongoing missed appointments|0|||
156819903|NCT01296711|566089792|FG002|Overall Study|Ongoing missed appointments|0|||
156819904|NCT01296711|566089793|FG003|Overall Study|Ongoing missed appointments|0|||
156819905|NCT01296711|566089794|FG004|Overall Study|Ongoing missed appointments|0|||
156819906|NCT01296711|566089795|FG005|Overall Study|Ongoing missed appointments|0|||
156819907|NCT01296711|566089796|FG006|Overall Study|Ongoing missed appointments|1|||
156819908|NCT01296711|566089797|FG007|Overall Study|Ongoing missed appointments|0|||
156819909|NCT01296711|566089790|FG000|Overall Study|Failure to comply with visits|0|||
156819910|NCT01296711|566089791|FG001|Overall Study|Failure to comply with visits|0|||
156819911|NCT01296711|566089792|FG002|Overall Study|Failure to comply with visits|0|||
156819912|NCT01296711|566089793|FG003|Overall Study|Failure to comply with visits|0|||
156819913|NCT01296711|566089794|FG004|Overall Study|Failure to comply with visits|0|||
156819914|NCT01296711|566089795|FG005|Overall Study|Failure to comply with visits|0|||
156819915|NCT01296711|566089796|FG006|Overall Study|Failure to comply with visits|0|||
156819916|NCT01296711|566089797|FG007|Overall Study|Failure to comply with visits|1|||
156819917|NCT01296711|566089790|FG000|Overall Study|Patient decision due to transport|0|||
156819918|NCT01296711|566089791|FG001|Overall Study|Patient decision due to transport|0|||
156819919|NCT01296711|566089792|FG002|Overall Study|Patient decision due to transport|0|||
156819920|NCT01296711|566089793|FG003|Overall Study|Patient decision due to transport|0|||
156819921|NCT01296711|566089794|FG004|Overall Study|Patient decision due to transport|0|||
156819922|NCT01296711|566089795|FG005|Overall Study|Patient decision due to transport|0|||
156819923|NCT01296711|566089796|FG006|Overall Study|Patient decision due to transport|0|||
156819924|NCT01296711|566089797|FG007|Overall Study|Patient decision due to transport|1|||
156819925|NCT00923975|566089803|FG000|Overall Study|Did not meet inclusion criteria|1|||
156819926|NCT01328535|566089804|FG000|Overall Study|Ineligible|1|||
156819927|NCT01005316|566089807|FG000|Overall Study|Adverse Event|0|||
156819928|NCT01005316|566089808|FG001|Overall Study|Adverse Event|0|||
156819929|NCT01005316|566089809|FG002|Overall Study|Adverse Event|0|||
156819930|NCT01005316|566089810|FG003|Overall Study|Adverse Event|1|||
156819931|NCT01005316|566089807|FG000|Overall Study|Death|20|||
156819932|NCT01005316|566089808|FG001|Overall Study|Death|5|||
156819933|NCT01005316|566089809|FG002|Overall Study|Death|1|||
156819934|NCT01005316|566089810|FG003|Overall Study|Death|15|||
156819935|NCT01005316|566089807|FG000|Overall Study|Study Termination|5|||
156819936|NCT01005316|566089808|FG001|Overall Study|Study Termination|63|||
156819937|NCT01005316|566089809|FG002|Overall Study|Study Termination|9|||
156819938|NCT01005316|566089810|FG003|Overall Study|Study Termination|85|||
156819939|NCT01005316|566089807|FG000|Overall Study|Lost to Follow-up|1|||
156819940|NCT01005316|566089808|FG001|Overall Study|Lost to Follow-up|3|||
156819941|NCT01005316|566089809|FG002|Overall Study|Lost to Follow-up|0|||
156819942|NCT01005316|566089810|FG003|Overall Study|Lost to Follow-up|2|||
156819943|NCT01005316|566089807|FG000|Overall Study|Physician Decision|6|||
156819944|NCT01005316|566089808|FG001|Overall Study|Physician Decision|0|||
156819945|NCT01005316|566089809|FG002|Overall Study|Physician Decision|0|||
156819946|NCT01005316|566089810|FG003|Overall Study|Physician Decision|0|||
156819947|NCT01005316|566089807|FG000|Overall Study|Sponsor Decision|6|||
156819948|NCT01005316|566089808|FG001|Overall Study|Sponsor Decision|3|||
156819949|NCT01005316|566089809|FG002|Overall Study|Sponsor Decision|0|||
156819950|NCT01005316|566089810|FG003|Overall Study|Sponsor Decision|0|||
156819951|NCT01005316|566089807|FG000|Overall Study|Withdrawal by Subject|1|||
156819952|NCT01005316|566089808|FG001|Overall Study|Withdrawal by Subject|1|||
156819953|NCT01005316|566089809|FG002|Overall Study|Withdrawal by Subject|0|||
156819954|NCT01005316|566089810|FG003|Overall Study|Withdrawal by Subject|2|||
156819955|NCT01005316|566089807|FG000|Overall Study|Consented to Another Study|2|||
156819956|NCT01005316|566089808|FG001|Overall Study|Consented to Another Study|0|||
156819957|NCT01005316|566089809|FG002|Overall Study|Consented to Another Study|0|||
156819958|NCT01005316|566089810|FG003|Overall Study|Consented to Another Study|0|||
156819959|NCT01005316|566089807|FG000|Overall Study|Delisted|8|||
156819960|NCT01005316|566089808|FG001|Overall Study|Delisted|0|||
156819961|NCT01005316|566089809|FG002|Overall Study|Delisted|0|||
156819962|NCT01005316|566089810|FG003|Overall Study|Delisted|0|||
156819963|NCT01005316|566089807|FG000|Overall Study|Transferred Care|1|||
156819964|NCT01005316|566089808|FG001|Overall Study|Transferred Care|0|||
156819965|NCT01005316|566089809|FG002|Overall Study|Transferred Care|1|||
156819966|NCT01005316|566089810|FG003|Overall Study|Transferred Care|3|||
156819967|NCT01005316|566089807|FG000|Overall Study|Retransplanted|0|||
156819968|NCT01005316|566089808|FG001|Overall Study|Retransplanted|1|||
156819969|NCT01005316|566089809|FG002|Overall Study|Retransplanted|0|||
156819970|NCT01005316|566089810|FG003|Overall Study|Retransplanted|0|||
156819971|NCT00632827|566089811|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
156819972|NCT00632827|566089811|FG000|Overall Study|Death|2|||
156819973|NCT00632827|566089811|FG000|Overall Study|Adverse Event|5|||
156819974|NCT00632827|566089811|FG000|Overall Study|Lost to Follow-up|1|||
156819975|NCT01035463|566089812|FG000|Overall Study|Adverse Event|0|||
156819976|NCT01035463|566089813|FG001|Overall Study|Adverse Event|0|||
156819977|NCT01035463|566089814|FG002|Overall Study|Adverse Event|4|||
156819978|NCT01035463|566089815|FG003|Overall Study|Adverse Event|1|||
156819979|NCT01035463|566089816|FG004|Overall Study|Adverse Event|5|||
156819980|NCT01035463|566089817|FG005|Overall Study|Adverse Event|7|||
156819981|NCT01035463|566089812|FG000|Overall Study|Withdrawal by Subject|0|||
156819982|NCT01035463|566089813|FG001|Overall Study|Withdrawal by Subject|2|||
156819983|NCT01035463|566089814|FG002|Overall Study|Withdrawal by Subject|1|||
156819984|NCT01035463|566089815|FG003|Overall Study|Withdrawal by Subject|0|||
156819985|NCT01035463|566089816|FG004|Overall Study|Withdrawal by Subject|1|||
156819986|NCT01035463|566089817|FG005|Overall Study|Withdrawal by Subject|4|||
156819987|NCT01035463|566089812|FG000|Overall Study|Disease progression|0|||
156819988|NCT01035463|566089813|FG001|Overall Study|Disease progression|0|||
156819989|NCT01035463|566089814|FG002|Overall Study|Disease progression|0|||
156819990|NCT01035463|566089815|FG003|Overall Study|Disease progression|0|||
156819991|NCT01035463|566089816|FG004|Overall Study|Disease progression|0|||
156819992|NCT01035463|566089817|FG005|Overall Study|Disease progression|3|||
156819993|NCT01035463|566089812|FG000|Overall Study|Other Malignancy|0|||
156819994|NCT01035463|566089813|FG001|Overall Study|Other Malignancy|0|||
156819995|NCT01035463|566089814|FG002|Overall Study|Other Malignancy|0|||
156819996|NCT01035463|566089815|FG003|Overall Study|Other Malignancy|0|||
156819997|NCT01035463|566089816|FG004|Overall Study|Other Malignancy|0|||
156819998|NCT01035463|566089817|FG005|Overall Study|Other Malignancy|2|||
156819999|NCT01035463|566089812|FG000|Overall Study|Other|0|||
156820000|NCT01035463|566089813|FG001|Overall Study|Other|0|||
156820001|NCT01035463|566089814|FG002|Overall Study|Other|0|||
156820002|NCT01035463|566089815|FG003|Overall Study|Other|1|||
156820003|NCT01035463|566089816|FG004|Overall Study|Other|0|||
156820004|NCT01035463|566089817|FG005|Overall Study|Other|2|||
156820005|NCT01257230|566089820|FG000|Overall Study|Not Treated|0|||
156820006|NCT01257230|566089821|FG001|Overall Study|Not Treated|0|||
156820007|NCT01257230|566089822|FG002|Overall Study|Not Treated|1|||
156820008|NCT01257230|566089820|FG000|Overall Study|Adverse Event|2|||
156820009|NCT01257230|566089821|FG001|Overall Study|Adverse Event|0|||
156820010|NCT01257230|566089822|FG002|Overall Study|Adverse Event|0|||
156820011|NCT01257230|566089820|FG000|Overall Study|Lack of Efficacy|0|||
156820012|NCT01257230|566089821|FG001|Overall Study|Lack of Efficacy|1|||
156820013|NCT01257230|566089822|FG002|Overall Study|Lack of Efficacy|0|||
156820014|NCT01257230|566089820|FG000|Overall Study|Protocol Violation|3|||
156820015|NCT01257230|566089821|FG001|Overall Study|Protocol Violation|0|||
156820016|NCT01257230|566089822|FG002|Overall Study|Protocol Violation|1|||
156820017|NCT01257230|566089820|FG000|Overall Study|Withdrawal by Subject|0|||
156820018|NCT01257230|566089821|FG001|Overall Study|Withdrawal by Subject|4|||
156820019|NCT01257230|566089822|FG002|Overall Study|Withdrawal by Subject|1|||
156820020|NCT01257230|566089820|FG000|Overall Study|Other reason not defined above|1|||
156820021|NCT01257230|566089821|FG001|Overall Study|Other reason not defined above|5|||
156820022|NCT01257230|566089822|FG002|Overall Study|Other reason not defined above|3|||
156820023|NCT01205061|566089830|FG000|Overall Study|Adverse Event|4|||
156820024|NCT01205061|566089830|FG000|Overall Study|Withdrawal by Subject|11|||
156820025|NCT01205061|566089830|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
156820026|NCT01205061|566089830|FG000|Overall Study|Lost to Follow-up|9|||
156820027|NCT01205061|566089830|FG000|Overall Study|Other|1|||
156820028|NCT01988662|566089835|FG000|Overall Study|Subject/guardian decision|1|||
156820029|NCT01988662|566089836|FG001|Overall Study|Subject/guardian decision|1|||
156820030|NCT01988662|566089835|FG000|Overall Study|Adverse Event|3|||
156820031|NCT01988662|566089836|FG001|Overall Study|Adverse Event|1|||
156820032|NCT03748706|566089837|FG000|Overall Study|Lost to Follow-up|1|||
156820033|NCT03655054|566089845|FG000|Overall Study|Lost to Follow-up|1|||
156820034|NCT01626118|566089846|FG000|Overall Study|Lack of Efficacy|1|||
156820035|NCT01626118|566089847|FG001|Overall Study|Lack of Efficacy|0|||
156820036|NCT01626118|566089848|FG002|Overall Study|Lack of Efficacy|1|||
156820037|NCT01626118|566089849|FG003|Overall Study|Lack of Efficacy|3|||
156820038|NCT01626118|566089846|FG000|Overall Study|Lost to Follow-up|1|||
156820039|NCT01626118|566089847|FG001|Overall Study|Lost to Follow-up|0|||
156820040|NCT01626118|566089848|FG002|Overall Study|Lost to Follow-up|0|||
156820041|NCT01626118|566089849|FG003|Overall Study|Lost to Follow-up|0|||
156820042|NCT01626118|566089846|FG000|Overall Study|Adverse Event|0|||
156820043|NCT01626118|566089847|FG001|Overall Study|Adverse Event|1|||
156820044|NCT01626118|566089848|FG002|Overall Study|Adverse Event|1|||
156820045|NCT01626118|566089849|FG003|Overall Study|Adverse Event|0|||
156820046|NCT01626118|566089846|FG000|Overall Study|Investigator Decision|0|||
156820047|NCT01626118|566089847|FG001|Overall Study|Investigator Decision|1|||
156820048|NCT01626118|566089848|FG002|Overall Study|Investigator Decision|0|||
156820049|NCT01626118|566089849|FG003|Overall Study|Investigator Decision|0|||
156820050|NCT03931382|566089850|FG000|Overall Study|Equipment malfunction|2|||
156820051|NCT03931382|566089851|FG001|Overall Study|Equipment malfunction|0|||
156820052|NCT03931382|566089852|FG002|Overall Study|Equipment malfunction|2|||
156820053|NCT03931382|566089850|FG000|Overall Study|Withdrawal by Subject|0|||
156820054|NCT03931382|566089851|FG001|Overall Study|Withdrawal by Subject|1|||
156820055|NCT03931382|566089852|FG002|Overall Study|Withdrawal by Subject|0|||
156820056|NCT01864148|566089853|FG000|Overall Study|Other|2|||
156820057|NCT01864148|566089854|FG001|Overall Study|Other|1|||
156820058|NCT01864148|566089855|FG002|Overall Study|Other|1|||
156820059|NCT01864148|566089856|FG003|Overall Study|Other|3|||
156820060|NCT01864148|566089857|FG004|Overall Study|Other|1|||
156820061|NCT01864148|566089853|FG000|Overall Study|Death|0|||
156820062|NCT01864148|566089854|FG001|Overall Study|Death|0|||
156820063|NCT01864148|566089855|FG002|Overall Study|Death|0|||
156820064|NCT01864148|566089856|FG003|Overall Study|Death|1|||
156820065|NCT01864148|566089857|FG004|Overall Study|Death|0|||
156820066|NCT01864148|566089853|FG000|Overall Study|Investigator Decision|5|||
156820067|NCT01864148|566089854|FG001|Overall Study|Investigator Decision|0|||
156820068|NCT01864148|566089855|FG002|Overall Study|Investigator Decision|0|||
156820069|NCT01864148|566089856|FG003|Overall Study|Investigator Decision|4|||
156820070|NCT01864148|566089857|FG004|Overall Study|Investigator Decision|6|||
156820071|NCT01864148|566089853|FG000|Overall Study|Withdrawal by Subject|9|||
156820072|NCT01864148|566089854|FG001|Overall Study|Withdrawal by Subject|2|||
156820073|NCT01864148|566089855|FG002|Overall Study|Withdrawal by Subject|6|||
156820074|NCT01864148|566089856|FG003|Overall Study|Withdrawal by Subject|8|||
156820075|NCT01864148|566089857|FG004|Overall Study|Withdrawal by Subject|8|||
156820076|NCT01864148|566089853|FG000|Overall Study|Lost to Follow-up|0|||
156820077|NCT01864148|566089854|FG001|Overall Study|Lost to Follow-up|0|||
156820078|NCT01864148|566089855|FG002|Overall Study|Lost to Follow-up|0|||
156820079|NCT01864148|566089856|FG003|Overall Study|Lost to Follow-up|2|||
156820080|NCT01864148|566089857|FG004|Overall Study|Lost to Follow-up|1|||
156820081|NCT01864148|566089853|FG000|Overall Study|Adverse Event|4|||
156820082|NCT01864148|566089854|FG001|Overall Study|Adverse Event|2|||
156820083|NCT01864148|566089855|FG002|Overall Study|Adverse Event|4|||
156820084|NCT01864148|566089856|FG003|Overall Study|Adverse Event|7|||
156820085|NCT01864148|566089857|FG004|Overall Study|Adverse Event|7|||
156820086|NCT01864148|566089853|FG000|Overall Study|Not Dosed|0|||
156465838|NCT04129450|564802039|FG001|Overall Study|Withdrawal by Subject|5|||
156820087|NCT01864148|566089854|FG001|Overall Study|Not Dosed|0|||
156820088|NCT01864148|566089855|FG002|Overall Study|Not Dosed|0|||
156820089|NCT01864148|566089856|FG003|Overall Study|Not Dosed|1|||
156820090|NCT01864148|566089857|FG004|Overall Study|Not Dosed|0|||
156820091|NCT01500252|566089858|FG000|Overall Study|Death|4|||
156820092|NCT01500252|566089859|FG001|Overall Study|Death|2|||
156820093|NCT01500252|566089858|FG000|Overall Study|Lost to Follow-up|5|||
156820094|NCT01500252|566089859|FG001|Overall Study|Lost to Follow-up|4|||
156820095|NCT03490292|566089860|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
156820096|NCT03490292|566089861|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
156820097|NCT03490292|566089860|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
156820098|NCT03490292|566089861|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
156820099|NCT03490292|566089860|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
156820100|NCT03490292|566089861|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
156820101|NCT03490292|566089860|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
156820102|NCT03490292|566089861|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
156820103|NCT03490292|566089860|FG000|1 Year Follow Up Post Last Dose|Death|1|||
156820104|NCT03490292|566089861|FG001|1 Year Follow Up Post Last Dose|Death|1|||
156820105|NCT01106651|566089862|FG000|Overall Study|Adverse Event|17|||
156820106|NCT01106651|566089863|FG001|Overall Study|Adverse Event|9|||
156820107|NCT01106651|566089864|FG002|Overall Study|Adverse Event|23|||
156820108|NCT01106651|566089862|FG000|Overall Study|Lost to Follow-up|8|||
156820109|NCT01106651|566089863|FG001|Overall Study|Lost to Follow-up|2|||
156820110|NCT01106651|566089864|FG002|Overall Study|Lost to Follow-up|6|||
156820111|NCT01106651|566089862|FG000|Overall Study|Physician Decision|4|||
156820112|NCT01106651|566089863|FG001|Overall Study|Physician Decision|3|||
156820113|NCT01106651|566089864|FG002|Overall Study|Physician Decision|1|||
156820114|NCT01106651|566089862|FG000|Overall Study|Protocol Violation|1|||
156820115|NCT01106651|566089863|FG001|Overall Study|Protocol Violation|2|||
156820116|NCT01106651|566089864|FG002|Overall Study|Protocol Violation|1|||
156820117|NCT01106651|566089862|FG000|Overall Study|Withdrawal by Subject|14|||
156820118|NCT01106651|566089863|FG001|Overall Study|Withdrawal by Subject|7|||
156820119|NCT01106651|566089864|FG002|Overall Study|Withdrawal by Subject|4|||
156820120|NCT01106651|566089862|FG000|Overall Study|Noncompliance with study drug|1|||
156820121|NCT01106651|566089863|FG001|Overall Study|Noncompliance with study drug|0|||
156820122|NCT01106651|566089864|FG002|Overall Study|Noncompliance with study drug|2|||
156820123|NCT01106651|566089862|FG000|Overall Study|Other|34|||
156820124|NCT01106651|566089863|FG001|Overall Study|Other|31|||
156820125|NCT01106651|566089864|FG002|Overall Study|Other|21|||
156820126|NCT01106651|566089862|FG000|Overall Study|Death|0|||
156820127|NCT01106651|566089863|FG001|Overall Study|Death|3|||
156820128|NCT01106651|566089864|FG002|Overall Study|Death|0|||
156820129|NCT00904670|566089865|FG000|Open Label Phase|Withdrawal by Subject|2|||
156820130|NCT00904670|566089866|FG001|Open Label Phase|Withdrawal by Subject|0|||
156820131|NCT00904670|566089865|FG000|Open Label Phase|Adverse Event|2|||
156820132|NCT00904670|566089866|FG001|Open Label Phase|Adverse Event|0|||
156820133|NCT00904670|566089865|FG000|Open Label Phase|Lack of Efficacy|1|||
156820134|NCT00904670|566089866|FG001|Open Label Phase|Lack of Efficacy|0|||
156820135|NCT00904670|566089865|FG000|Open Label Phase|Lost to Follow-up|1|||
156820136|NCT00904670|566089866|FG001|Open Label Phase|Lost to Follow-up|0|||
156820137|NCT02120300|566089871|FG000|Overall Study|Enrolled but Never Treated|2|||
156820138|NCT02120300|566089872|FG001|Overall Study|Enrolled but Never Treated|0|||
156820139|NCT02120300|566089873|FG002|Overall Study|Enrolled but Never Treated|0|||
156820140|NCT02120300|566089874|FG003|Overall Study|Enrolled but Never Treated|0|||
156820141|NCT02120300|566089871|FG000|Overall Study|Lack of Efficacy|0|||
156820142|NCT02120300|566089872|FG001|Overall Study|Lack of Efficacy|0|||
156820143|NCT02120300|566089873|FG002|Overall Study|Lack of Efficacy|0|||
156820144|NCT02120300|566089874|FG003|Overall Study|Lack of Efficacy|1|||
156820145|NCT02120300|566089871|FG000|Overall Study|Lost to Follow-up|1|||
156820146|NCT02120300|566089872|FG001|Overall Study|Lost to Follow-up|0|||
156820147|NCT02120300|566089873|FG002|Overall Study|Lost to Follow-up|0|||
156820148|NCT02120300|566089874|FG003|Overall Study|Lost to Follow-up|0|||
156820149|NCT01721486|566089883|FG000|Overall Study|Protocol Violation|1|||
156820150|NCT01721486|566089884|FG001|Overall Study|Protocol Violation|0|||
156820151|NCT01721486|566089883|FG000|Overall Study|Physician Decision|0|||
156820152|NCT01721486|566089884|FG001|Overall Study|Physician Decision|1|||
156820153|NCT00889603|566089885|FG000|Overall Study|Adverse Event|7|||
156820154|NCT00889603|566089885|FG000|Overall Study|Death|3|||
156820155|NCT00889603|566089885|FG000|Overall Study|Lost to Follow-up|19|||
156820156|NCT00889603|566089885|FG000|Overall Study|No longer willing to participant in stud|4|||
156820157|NCT00889603|566089885|FG000|Overall Study|Other|4|||
156820158|NCT03525600|566089888|FG000|Overall Study|Adverse Event|9|||
156820159|NCT03525600|566089889|FG001|Overall Study|Adverse Event|6|||
156820160|NCT03525600|566089890|FG002|Overall Study|Adverse Event|5|||
156339140|NCT00334958|564340123|FG001|Overall Study|Protocol Violation|2|||
156820161|NCT03525600|566089891|FG003|Overall Study|Adverse Event|3|||
156820162|NCT03525600|566089888|FG000|Overall Study|Lost to Follow-up|2|||
156820163|NCT03525600|566089889|FG001|Overall Study|Lost to Follow-up|4|||
156820164|NCT03525600|566089890|FG002|Overall Study|Lost to Follow-up|4|||
156820165|NCT03525600|566089891|FG003|Overall Study|Lost to Follow-up|0|||
156820166|NCT03525600|566089888|FG000|Overall Study|Physician Decision|1|||
156820167|NCT03525600|566089889|FG001|Overall Study|Physician Decision|0|||
156820168|NCT03525600|566089890|FG002|Overall Study|Physician Decision|2|||
156820169|NCT03525600|566089891|FG003|Overall Study|Physician Decision|0|||
156820170|NCT03525600|566089888|FG000|Overall Study|Consent withdrawal|36|||
156820171|NCT03525600|566089889|FG001|Overall Study|Consent withdrawal|20|||
156820172|NCT03525600|566089890|FG002|Overall Study|Consent withdrawal|6|||
156820173|NCT03525600|566089891|FG003|Overall Study|Consent withdrawal|13|||
156820174|NCT03525600|566089888|FG000|Overall Study|Death|7|||
156820175|NCT03525600|566089889|FG001|Overall Study|Death|6|||
156820176|NCT03525600|566089890|FG002|Overall Study|Death|4|||
156820177|NCT03525600|566089891|FG003|Overall Study|Death|3|||
156820178|NCT03525600|566089888|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
156820179|NCT03525600|566089889|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
156820180|NCT03525600|566089890|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
156820181|NCT03525600|566089891|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
156820182|NCT03525600|566089888|FG000|Overall Study|Other|0|||
156820183|NCT03525600|566089889|FG001|Overall Study|Other|1|||
156820184|NCT03525600|566089890|FG002|Overall Study|Other|0|||
156820185|NCT03525600|566089891|FG003|Overall Study|Other|0|||
156820186|NCT00613327|566089892|FG000|Overall Study|Adverse Event|38|||
156820187|NCT00613327|566089892|FG000|Overall Study|Lost to Follow-up|8|||
156820188|NCT00613327|566089892|FG000|Overall Study|Withdrawal by Subject|6|||
156820189|NCT00613327|566089892|FG000|Overall Study|Protocol Violation|2|||
156820190|NCT00613327|566089892|FG000|Overall Study|Other|47|||
156820191|NCT01814397|566089893|FG000|Overall Study|Adverse Event|7|||
156820192|NCT01814397|566089893|FG000|Overall Study|Withdrawal by Subject|7|||
156820193|NCT00313144|566089894|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
156820194|NCT00313144|566089894|FG000|Overall Study|Death|7|||
156820195|NCT00313144|566089894|FG000|Overall Study|Lost to Follow-up|5|||
156820196|NCT00313144|566089894|FG000|Overall Study|Withdrawal by Subject|4|||
156820197|NCT00313144|566089894|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
156820198|NCT00313144|566089894|FG000|Overall Study|Physician Decision|4|||
156820199|NCT00313144|566089894|FG000|Overall Study|Adverse event - transient|5|||
156820200|NCT00313144|566089894|FG000|Overall Study|Liver transplant|1|||
156820201|NCT00313144|566089894|FG000|Overall Study|Insurance (homecare provider) change|1|||
156820202|NCT00313144|566089894|FG000|Overall Study|Change to different product|1|||
156820203|NCT00313144|566089894|FG000|Overall Study|Due to termination of the study|66|||
156820204|NCT04154293|566089897|FG000|Overall Study|Withdrawal by Subject|2|||
156820205|NCT04154293|566089898|FG001|Overall Study|Withdrawal by Subject|3|||
156820206|NCT04154293|566089899|FG002|Overall Study|Withdrawal by Subject|1|||
156820207|NCT04154293|566089897|FG000|Overall Study|Physician Decision|0|||
156820208|NCT04154293|566089898|FG001|Overall Study|Physician Decision|0|||
156820209|NCT04154293|566089899|FG002|Overall Study|Physician Decision|1|||
156820210|NCT04731298|566089900|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
156820211|NCT04731298|566089901|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
156820212|NCT02487654|566089910|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
156820213|NCT02487654|566089911|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
156820214|NCT02487654|566089910|FG000|Overall Study|Withdrawal by Subject|3|||
156820215|NCT02487654|566089911|FG001|Overall Study|Withdrawal by Subject|7|||
156820216|NCT04238481|566089912|FG000|Overall Study|Miscellaneous|0|||
156820217|NCT04238481|566089913|FG001|Overall Study|Miscellaneous|1|||
156820218|NCT04238481|566089914|FG002|Overall Study|Miscellaneous|0|||
156820219|NCT04238481|566089915|FG003|Overall Study|Miscellaneous|0|||
156820220|NCT02152371|566089916|FG000|Overall Study|Adverse Event|6|||
156820221|NCT02152371|566089917|FG001|Overall Study|Adverse Event|2|||
156820222|NCT02152371|566089916|FG000|Overall Study|Withdrawal by Subject|3|||
156820223|NCT02152371|566089917|FG001|Overall Study|Withdrawal by Subject|7|||
156820224|NCT02152371|566089916|FG000|Overall Study|Protocol Violation|2|||
156820225|NCT02152371|566089917|FG001|Overall Study|Protocol Violation|3|||
156820226|NCT02152371|566089916|FG000|Overall Study|Lost to Follow-up|1|||
156820227|NCT02152371|566089917|FG001|Overall Study|Lost to Follow-up|0|||
156820228|NCT02152371|566089916|FG000|Overall Study|Lack of Efficacy|0|||
156820229|NCT02152371|566089917|FG001|Overall Study|Lack of Efficacy|1|||
156820230|NCT02152371|566089916|FG000|Overall Study|Physician Decision|0|||
156820231|NCT02152371|566089917|FG001|Overall Study|Physician Decision|2|||
156820232|NCT02152371|566089916|FG000|Overall Study|Reason Not Given|0|||
156820233|NCT02152371|566089917|FG001|Overall Study|Reason Not Given|1|||
156820234|NCT00349921|566089918|FG000|First Spinal Injection|Physician Decision|1|||
156820235|NCT00349921|566089919|FG001|First Spinal Injection|Physician Decision|0|||
156820236|NCT00349921|566089920|FG002|First Spinal Injection|Physician Decision|0|||
156820237|NCT00349921|566089921|FG003|First Spinal Injection|Physician Decision|0|||
156820238|NCT00349921|566089918|FG000|First Spinal Injection|Adverse Event|0|||
156820239|NCT00349921|566089919|FG001|First Spinal Injection|Adverse Event|0|||
156820240|NCT00349921|566089920|FG002|First Spinal Injection|Adverse Event|1|||
156820241|NCT00349921|566089921|FG003|First Spinal Injection|Adverse Event|0|||
156820242|NCT05285644|566089922|FG000|Overall Study|Adverse Event|3|||
156541133|NCT05611671|565074486|FG003|Overall Study|Protocol Violation|0|||
156820243|NCT05285644|566089923|FG001|Overall Study|Adverse Event|3|||
156820244|NCT05285644|566089922|FG000|Overall Study|Withdrawal of Consent|2|||
156820245|NCT05285644|566089923|FG001|Overall Study|Withdrawal of Consent|5|||
156820246|NCT05285644|566089922|FG000|Overall Study|Noncompliance|0|||
156820247|NCT05285644|566089923|FG001|Overall Study|Noncompliance|4|||
156820248|NCT05285644|566089922|FG000|Overall Study|Lost to Follow-up|4|||
156820249|NCT05285644|566089923|FG001|Overall Study|Lost to Follow-up|6|||
156820250|NCT05285644|566089922|FG000|Overall Study|Disallowed Concurrent Medication|1|||
156820251|NCT05285644|566089923|FG001|Overall Study|Disallowed Concurrent Medication|1|||
156820252|NCT05285644|566089922|FG000|Overall Study|Investigator Decision|2|||
156820253|NCT05285644|566089923|FG001|Overall Study|Investigator Decision|0|||
156820254|NCT05285644|566089922|FG000|Overall Study|Protocol Deviation|1|||
156820255|NCT05285644|566089923|FG001|Overall Study|Protocol Deviation|0|||
156820256|NCT05285644|566089922|FG000|Overall Study|As specified in the Clinical Study Report|7|||
156820257|NCT05285644|566089923|FG001|Overall Study|As specified in the Clinical Study Report|3|||
156820258|NCT02470585|566089929|FG000|Overall Study|Death|224|||
156820259|NCT02470585|566089930|FG001|Overall Study|Death|227|||
156820260|NCT02470585|566089931|FG002|Overall Study|Death|199|||
156820261|NCT02470585|566089929|FG000|Overall Study|Withdrew consent|21|||
156820262|NCT02470585|566089930|FG001|Overall Study|Withdrew consent|22|||
156820263|NCT02470585|566089931|FG002|Overall Study|Withdrew consent|31|||
156820264|NCT02470585|566089929|FG000|Overall Study|Lost to Follow-up|8|||
156820265|NCT02470585|566089930|FG001|Overall Study|Lost to Follow-up|15|||
156820266|NCT02470585|566089931|FG002|Overall Study|Lost to Follow-up|13|||
156820267|NCT02470585|566089929|FG000|Overall Study|Sponsor discontinued study|117|||
156820268|NCT02470585|566089930|FG001|Overall Study|Sponsor discontinued study|110|||
156820269|NCT02470585|566089931|FG002|Overall Study|Sponsor discontinued study|122|||
156820270|NCT02470585|566089929|FG000|Overall Study|Other, not specified|5|||
156820271|NCT02470585|566089930|FG001|Overall Study|Other, not specified|7|||
156820272|NCT02470585|566089931|FG002|Overall Study|Other, not specified|14|||
156820273|NCT02470585|566089929|FG000|Overall Study|Missing due to site non-compliance|0|||
156820274|NCT02470585|566089930|FG001|Overall Study|Missing due to site non-compliance|2|||
156820275|NCT02470585|566089931|FG002|Overall Study|Missing due to site non-compliance|3|||
156820276|NCT03028415|566089932|FG000|Overall Study|Lost to Follow-up|6|||
156820277|NCT03028415|566089933|FG001|Overall Study|Lost to Follow-up|3|||
156820278|NCT03028415|566089932|FG000|Overall Study|Withdrawal by Subject|1|||
156820279|NCT03028415|566089933|FG001|Overall Study|Withdrawal by Subject|0|||
156820280|NCT03028415|566089932|FG000|Overall Study|Discontinued due to COVID-19|1|||
156820281|NCT03028415|566089933|FG001|Overall Study|Discontinued due to COVID-19|0|||
156820282|NCT02907216|566089934|FG000|Overall Study|No benefit to be obtained by continuing|0|||
156820283|NCT02907216|566089935|FG001|Overall Study|No benefit to be obtained by continuing|1|||
156820284|NCT02907216|566089934|FG000|Overall Study|Withdrawal by Subject|1|||
156820285|NCT02907216|566089935|FG001|Overall Study|Withdrawal by Subject|0|||
156820286|NCT02640625|566092477|FG000|Overall Study|Adverse Event|1|||
156820287|NCT02370537|566092478|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
156820288|NCT02370537|566092479|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
156820289|NCT02370537|566092480|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
156820290|NCT02370537|566092478|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
156820291|NCT02370537|566092479|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
156820292|NCT02370537|566092480|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
156820293|NCT02370537|566092478|FG000|Part B|Not randomised to receive treatment|1|||
156820294|NCT02370537|566092479|FG001|Part B|Not randomised to receive treatment|2|||
156820295|NCT02370537|566092480|FG002|Part B|Not randomised to receive treatment|259|||
156820296|NCT02370537|566092478|FG000|Part B|Withdrawal by Subject|0|||
156820297|NCT02370537|566092479|FG001|Part B|Withdrawal by Subject|1|||
156820298|NCT02370537|566092480|FG002|Part B|Withdrawal by Subject|0|||
156820299|NCT03100539|566092485|FG000|Overall Study|Lost to Follow-up|60|||
156820300|NCT03100539|566092486|FG001|Overall Study|Lost to Follow-up|54|||
156820301|NCT03100539|566092487|FG002|Overall Study|Lost to Follow-up|17|||
156820302|NCT03100539|566092485|FG000|Overall Study|Uncollected|8|||
156820303|NCT03100539|566092486|FG001|Overall Study|Uncollected|8|||
156820304|NCT03100539|566092487|FG002|Overall Study|Uncollected|0|||
156820305|NCT03100539|566092485|FG000|Overall Study|Ally Health|0|||
156820306|NCT03100539|566092486|FG001|Overall Study|Ally Health|0|||
156820307|NCT03100539|566092487|FG002|Overall Study|Ally Health|3|||
156820308|NCT03100539|566092485|FG000|Overall Study|Disinterest|0|||
156820309|NCT03100539|566092486|FG001|Overall Study|Disinterest|0|||
156820310|NCT03100539|566092487|FG002|Overall Study|Disinterest|22|||
156820311|NCT03100539|566092485|FG000|Overall Study|Veteran Health|0|||
156820312|NCT03100539|566092486|FG001|Overall Study|Veteran Health|0|||
156820313|NCT03100539|566092487|FG002|Overall Study|Veteran Health|8|||
156820314|NCT03100539|566092485|FG000|Overall Study|Moved|0|||
156820315|NCT03100539|566092486|FG001|Overall Study|Moved|0|||
156820316|NCT03100539|566092487|FG002|Overall Study|Moved|1|||
156820317|NCT03100539|566092485|FG000|Overall Study|Scheduling Conflicts|0|||
156820318|NCT03100539|566092486|FG001|Overall Study|Scheduling Conflicts|0|||
156820319|NCT03100539|566092487|FG002|Overall Study|Scheduling Conflicts|12|||
156820320|NCT05659719|566092491|FG000|Overall Study|At sponsor's request|0|||
156820321|NCT05659719|566092492|FG001|Overall Study|At sponsor's request|0|||
156820322|NCT05659719|566092493|FG002|Overall Study|At sponsor's request|0|||
156820323|NCT05659719|566092494|FG003|Overall Study|At sponsor's request|95|||
156820324|NCT05659719|566092491|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
156820325|NCT05659719|566092492|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
156820326|NCT05659719|566092493|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
156820327|NCT05659719|566092494|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
156820328|NCT05659719|566092491|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
156820329|NCT05659719|566092492|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
156820330|NCT05659719|566092493|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
156820331|NCT05659719|566092494|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
156820332|NCT05659719|566092491|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
156820333|NCT05659719|566092492|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
156820334|NCT05659719|566092493|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
156820335|NCT05659719|566092494|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
156820336|NCT05659719|566092491|FG000|Overall Study|Lost to Follow-up|0|||
156820337|NCT05659719|566092492|FG001|Overall Study|Lost to Follow-up|0|||
156820338|NCT05659719|566092493|FG002|Overall Study|Lost to Follow-up|0|||
156820339|NCT05659719|566092494|FG003|Overall Study|Lost to Follow-up|2|||
156820340|NCT05659719|566092491|FG000|Overall Study|Moved to another observational study|0|||
156820341|NCT05659719|566092492|FG001|Overall Study|Moved to another observational study|0|||
156820342|NCT05659719|566092493|FG002|Overall Study|Moved to another observational study|0|||
156820343|NCT05659719|566092494|FG003|Overall Study|Moved to another observational study|1|||
156820344|NCT05659719|566092491|FG000|Overall Study|The child was enrolled in an interventional study|0|||
156820345|NCT05659719|566092492|FG001|Overall Study|The child was enrolled in an interventional study|0|||
156820346|NCT05659719|566092493|FG002|Overall Study|The child was enrolled in an interventional study|0|||
156820347|NCT05659719|566092494|FG003|Overall Study|The child was enrolled in an interventional study|55|||
156820348|NCT05659719|566092491|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
156820349|NCT05659719|566092492|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
156820350|NCT05659719|566092493|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
156820351|NCT05659719|566092494|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
156820352|NCT05659719|566092491|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
156820353|NCT05659719|566092492|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
156820354|NCT05659719|566092493|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
156820355|NCT05659719|566092494|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
156820356|NCT02290691|566092495|FG000|Overall Study|Noncompliance|0|||
156820357|NCT02290691|566092496|FG001|Overall Study|Noncompliance|1|||
156820358|NCT02290691|566092495|FG000|Overall Study|Withdrawal by Subject|1|||
156820359|NCT02290691|566092496|FG001|Overall Study|Withdrawal by Subject|1|||
156820360|NCT02290691|566092495|FG000|Overall Study|Lost to Follow-up|7|||
156820361|NCT02290691|566092496|FG001|Overall Study|Lost to Follow-up|7|||
156820362|NCT00185380|566092500|FG000|Overall Study|Adverse Event|41|||
156820363|NCT00185380|566092501|FG001|Overall Study|Adverse Event|43|||
156820364|NCT00185380|566092502|FG002|Overall Study|Adverse Event|48|||
156820365|NCT00185380|566092500|FG000|Overall Study|Lost to Follow-up|0|||
156820366|NCT00185380|566092501|FG001|Overall Study|Lost to Follow-up|4|||
156820367|NCT00185380|566092502|FG002|Overall Study|Lost to Follow-up|3|||
156820368|NCT00185380|566092500|FG000|Overall Study|Pregnancy|1|||
156820369|NCT00185380|566092501|FG001|Overall Study|Pregnancy|4|||
156820370|NCT00185380|566092502|FG002|Overall Study|Pregnancy|0|||
156820371|NCT00185380|566092500|FG000|Overall Study|Protocol Violation|2|||
156820372|NCT00185380|566092501|FG001|Overall Study|Protocol Violation|2|||
156820373|NCT00185380|566092502|FG002|Overall Study|Protocol Violation|1|||
156820374|NCT00185380|566092500|FG000|Overall Study|Withdrawal by Subject|1|||
156820375|NCT00185380|566092501|FG001|Overall Study|Withdrawal by Subject|2|||
156820376|NCT00185380|566092502|FG002|Overall Study|Withdrawal by Subject|0|||
156820377|NCT00185380|566092500|FG000|Overall Study|Failed insertion|1|||
156820378|NCT00185380|566092501|FG001|Overall Study|Failed insertion|1|||
156820379|NCT00185380|566092502|FG002|Overall Study|Failed insertion|2|||
156820380|NCT00185380|566092500|FG000|Overall Study|Planned pregnancy|9|||
156820381|NCT00185380|566092501|FG001|Overall Study|Planned pregnancy|12|||
156820382|NCT00185380|566092502|FG002|Overall Study|Planned pregnancy|12|||
156820383|NCT00185380|566092500|FG000|Overall Study|No need for contraception|3|||
156820384|NCT00185380|566092501|FG001|Overall Study|No need for contraception|3|||
156541134|NCT05611671|565074483|FG000|Overall Study|Withdrawal by Subject|2|||
156541135|NCT05611671|565074484|FG001|Overall Study|Withdrawal by Subject|1|||
156820385|NCT00185380|566092502|FG002|Overall Study|No need for contraception|3|||
156820386|NCT00185380|566092500|FG000|Overall Study|Could not attend visits|2|||
156820387|NCT00185380|566092501|FG001|Overall Study|Could not attend visits|0|||
156820388|NCT00185380|566092502|FG002|Overall Study|Could not attend visits|4|||
156820389|NCT00185380|566092500|FG000|Overall Study|personal reason|6|||
156820390|NCT00185380|566092501|FG001|Overall Study|personal reason|1|||
156820391|NCT00185380|566092502|FG002|Overall Study|personal reason|1|||
156820392|NCT00978380|566092503|FG000|Overall Study|Protocol Violation|2|||
156820393|NCT00978380|566092503|FG000|Overall Study|Withdrawal criteria|9|||
156820394|NCT00978380|566092503|FG000|Overall Study|Unclassified|8|||
156820395|NCT02199314|566092504|FG000|Overall Study|Withdrawal by Subject|6|||
156820396|NCT02199314|566092504|FG000|Overall Study|Physician Decision|10|||
156820397|NCT01110330|566092509|FG000|Overall Study|Adverse Event|0|||
156820398|NCT01110330|566092510|FG001|Overall Study|Adverse Event|4|||
156820399|NCT01110330|566092511|FG002|Overall Study|Adverse Event|3|||
156820400|NCT01110330|566092509|FG000|Overall Study|Lack of Efficacy|3|||
156820401|NCT01110330|566092510|FG001|Overall Study|Lack of Efficacy|1|||
156820402|NCT01110330|566092511|FG002|Overall Study|Lack of Efficacy|1|||
156820403|NCT01110330|566092509|FG000|Overall Study|Lost to Follow-up|9|||
156820404|NCT01110330|566092510|FG001|Overall Study|Lost to Follow-up|10|||
156820405|NCT01110330|566092511|FG002|Overall Study|Lost to Follow-up|15|||
156820406|NCT01110330|566092509|FG000|Overall Study|Physician Decision|0|||
156820407|NCT01110330|566092510|FG001|Overall Study|Physician Decision|1|||
156820408|NCT01110330|566092511|FG002|Overall Study|Physician Decision|0|||
156820409|NCT01110330|566092509|FG000|Overall Study|Protocol Violation|2|||
156820410|NCT01110330|566092510|FG001|Overall Study|Protocol Violation|0|||
156820411|NCT01110330|566092511|FG002|Overall Study|Protocol Violation|4|||
156820412|NCT01110330|566092509|FG000|Overall Study|Withdrawal by Subject|0|||
156820413|NCT01110330|566092510|FG001|Overall Study|Withdrawal by Subject|6|||
156820414|NCT01110330|566092511|FG002|Overall Study|Withdrawal by Subject|2|||
156820415|NCT01110330|566092509|FG000|Overall Study|Other|1|||
156820416|NCT01110330|566092510|FG001|Overall Study|Other|1|||
156820417|NCT01110330|566092511|FG002|Overall Study|Other|1|||
156820418|NCT03215758|566092523|FG000|Overall Study|Technical Problems|1|||
156820419|NCT03215758|566092524|FG001|Overall Study|Technical Problems|0|||
156820420|NCT03215758|566092523|FG000|Overall Study|Protocol deviation|0|||
156820421|NCT03215758|566092524|FG001|Overall Study|Protocol deviation|1|||
156820422|NCT03215758|566092523|FG000|Overall Study|Physician Decision|0|||
156820423|NCT03215758|566092524|FG001|Overall Study|Physician Decision|1|||
156820424|NCT03215758|566092523|FG000|Overall Study|Death|0|||
156820425|NCT03215758|566092524|FG001|Overall Study|Death|1|||
156820426|NCT03215758|566092523|FG000|Overall Study|Adverse Event|1|||
156820427|NCT03215758|566092524|FG001|Overall Study|Adverse Event|2|||
156820428|NCT03215758|566092523|FG000|Overall Study|Subject/Guardian Decision|3|||
156820429|NCT03215758|566092524|FG001|Overall Study|Subject/Guardian Decision|3|||
156820430|NCT04115748|566092525|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
156820431|NCT04115748|566092526|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
156820432|NCT04115748|566092527|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
156820433|NCT04115748|566092528|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
156820434|NCT04115748|566092529|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820435|NCT04115748|566092530|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820436|NCT04115748|566092531|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820437|NCT04115748|566092532|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820438|NCT04115748|566092533|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820439|NCT04115748|566092534|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820440|NCT04115748|566092525|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820441|NCT04115748|566092526|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820442|NCT04115748|566092527|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820443|NCT04115748|566092528|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
156820444|NCT04115748|566092529|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820445|NCT04115748|566092530|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820446|NCT04115748|566092531|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820447|NCT04115748|566092532|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820448|NCT04115748|566092533|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820449|NCT04115748|566092534|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820450|NCT04115748|566092525|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
156820451|NCT04115748|566092526|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
156820452|NCT04115748|566092527|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
156820453|NCT04115748|566092528|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
156820454|NCT04115748|566092529|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
156820455|NCT04115748|566092530|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
156820456|NCT04115748|566092531|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
156820457|NCT04115748|566092532|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
156820458|NCT04115748|566092533|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
156820459|NCT04115748|566092534|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
156820460|NCT04115748|566092525|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820461|NCT04115748|566092526|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820462|NCT04115748|566092527|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820463|NCT04115748|566092528|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820464|NCT04115748|566092529|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820465|NCT04115748|566092530|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820466|NCT04115748|566092531|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820467|NCT04115748|566092532|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820468|NCT04115748|566092533|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
156820469|NCT04115748|566092534|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820470|NCT00713349|566092535|FG000|Overall Study|Protocol Violation|1|||
156820471|NCT01289353|566092536|FG000|Overall Study|Lost to Follow-up|2|||
156820472|NCT01549886|566092537|FG000|Overall Study|Sponsor's decision|2|||
156820473|NCT01549886|566092538|FG001|Overall Study|Sponsor's decision|3|||
156820474|NCT01126268|566092543|FG000|Overall Study|Adverse Event|1|||
156820475|NCT03425006|566092544|FG000|Overall Study|Withdrawal by Subject|1|||
156820476|NCT03425006|566092544|FG000|Overall Study|Physician Decision|1|||
156820477|NCT03425006|566092544|FG000|Overall Study|Death|1|||
156820478|NCT03070171|566092552|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
156820479|NCT03070171|566092553|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
156820480|NCT03070171|566092552|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
156820481|NCT03070171|566092553|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
156820482|NCT03768089|566092554|FG000|Part A|Lost to Follow-up|0|||
156820483|NCT03768089|566092555|FG001|Part A|Lost to Follow-up|0|||
156820484|NCT03768089|566092556|FG002|Part A|Lost to Follow-up|0|||
156820485|NCT03768089|566092557|FG003|Part A|Lost to Follow-up|0|||
156820486|NCT03768089|566092558|FG004|Part A|Lost to Follow-up|1|||
156820487|NCT03768089|566092559|FG005|Part A|Lost to Follow-up|0|||
156820488|NCT03768089|566092560|FG006|Part A|Lost to Follow-up|0|||
156820489|NCT03768089|566092561|FG007|Part A|Lost to Follow-up|0|||
156820490|NCT03768089|566092562|FG008|Part A|Lost to Follow-up|0|||
156820491|NCT03768089|566092563|FG009|Part A|Lost to Follow-up|0|||
156820492|NCT03768089|566092564|FG010|Part A|Lost to Follow-up|0|||
156820493|NCT03768089|566092565|FG011|Part A|Lost to Follow-up|0|||
156820494|NCT03768089|566092566|FG012|Part A|Lost to Follow-up|0|||
156820495|NCT03768089|566092567|FG013|Part A|Lost to Follow-up|0|||
156820496|NCT03768089|566092568|FG014|Part A|Lost to Follow-up|0|||
156820497|NCT03768089|566092569|FG015|Part A|Lost to Follow-up|0|||
156820498|NCT03768089|566092570|FG016|Part A|Lost to Follow-up|0|||
156820499|NCT03768089|566092571|FG017|Part A|Lost to Follow-up|0|||
156820500|NCT03768089|566092554|FG000|Part C|Randomized, Never Dosed|0|||
156820501|NCT03768089|566092555|FG001|Part C|Randomized, Never Dosed|0|||
156820502|NCT03768089|566092556|FG002|Part C|Randomized, Never Dosed|0|||
156820503|NCT03768089|566092557|FG003|Part C|Randomized, Never Dosed|0|||
156820504|NCT03768089|566092558|FG004|Part C|Randomized, Never Dosed|0|||
156820505|NCT03768089|566092559|FG005|Part C|Randomized, Never Dosed|0|||
156820506|NCT03768089|566092560|FG006|Part C|Randomized, Never Dosed|0|||
156820507|NCT03768089|566092561|FG007|Part C|Randomized, Never Dosed|0|||
156820508|NCT03768089|566092562|FG008|Part C|Randomized, Never Dosed|0|||
156820509|NCT03768089|566092563|FG009|Part C|Randomized, Never Dosed|0|||
156820510|NCT03768089|566092564|FG010|Part C|Randomized, Never Dosed|0|||
156820511|NCT03768089|566092565|FG011|Part C|Randomized, Never Dosed|0|||
156820512|NCT03768089|566092566|FG012|Part C|Randomized, Never Dosed|0|||
156820513|NCT03768089|566092567|FG013|Part C|Randomized, Never Dosed|0|||
156820514|NCT03768089|566092568|FG014|Part C|Randomized, Never Dosed|1|||
156820515|NCT03768089|566092569|FG015|Part C|Randomized, Never Dosed|0|||
156820516|NCT03768089|566092570|FG016|Part C|Randomized, Never Dosed|0|||
156820517|NCT03768089|566092571|FG017|Part C|Randomized, Never Dosed|0|||
156820518|NCT00344318|566092572|FG000|Overall Study|Adverse Event|0|||
156820519|NCT00344318|566092573|FG001|Overall Study|Adverse Event|3|||
156820520|NCT00344318|566092574|FG002|Overall Study|Adverse Event|0|||
156820521|NCT00344318|566092575|FG003|Overall Study|Adverse Event|1|||
156820522|NCT00344318|566092572|FG000|Overall Study|Withdrawal by Subject|2|||
156820523|NCT00344318|566092573|FG001|Overall Study|Withdrawal by Subject|2|||
156820524|NCT00344318|566092574|FG002|Overall Study|Withdrawal by Subject|0|||
156820525|NCT00344318|566092575|FG003|Overall Study|Withdrawal by Subject|2|||
156820526|NCT00344318|566092572|FG000|Overall Study|Lost to Follow-up|2|||
156820527|NCT00344318|566092573|FG001|Overall Study|Lost to Follow-up|0|||
156820528|NCT00344318|566092574|FG002|Overall Study|Lost to Follow-up|1|||
156820529|NCT00344318|566092575|FG003|Overall Study|Lost to Follow-up|0|||
156820530|NCT00700882|566092578|FG000|Overall Study|Never received treatment|6|||
156820531|NCT00700882|566092578|FG000|Overall Study|Ineligible|2|||
156820532|NCT00700882|566092578|FG000|Overall Study|No KIT mutation|51|||
156820533|NCT01606176|566092579|FG000|Overall Study|Adverse Event|2|||
156820534|NCT01606176|566092580|FG001|Overall Study|Adverse Event|3|||
156820535|NCT01606176|566092579|FG000|Overall Study|Disease progression|1|||
156820536|NCT01606176|566092580|FG001|Overall Study|Disease progression|0|||
156820537|NCT01606176|566092579|FG000|Overall Study|Withdrawal by Subject|1|||
156820538|NCT01606176|566092580|FG001|Overall Study|Withdrawal by Subject|0|||
156820539|NCT00673231|566092581|FG000|Overall Study|Withdrawal by Subject|14|||
156820540|NCT00673231|566092582|FG001|Overall Study|Withdrawal by Subject|10|||
156820541|NCT00673231|566092583|FG002|Overall Study|Withdrawal by Subject|8|||
156820542|NCT00673231|566092584|FG003|Overall Study|Withdrawal by Subject|6|||
156820543|NCT00673231|566092581|FG000|Overall Study|Adverse Event|6|||
156820544|NCT00673231|566092582|FG001|Overall Study|Adverse Event|5|||
156820545|NCT00673231|566092583|FG002|Overall Study|Adverse Event|9|||
156820546|NCT00673231|566092584|FG003|Overall Study|Adverse Event|6|||
156820547|NCT00673231|566092581|FG000|Overall Study|Lost to Follow-up|1|||
156820548|NCT00673231|566092582|FG001|Overall Study|Lost to Follow-up|2|||
156820549|NCT00673231|566092583|FG002|Overall Study|Lost to Follow-up|1|||
156820550|NCT00673231|566092584|FG003|Overall Study|Lost to Follow-up|2|||
156820551|NCT00673231|566092581|FG000|Overall Study|Death|0|||
156820552|NCT00673231|566092582|FG001|Overall Study|Death|0|||
156820553|NCT00673231|566092583|FG002|Overall Study|Death|1|||
156820554|NCT00673231|566092584|FG003|Overall Study|Death|0|||
156820555|NCT00673231|566092581|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
156820556|NCT00673231|566092582|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
156820557|NCT00673231|566092583|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
156820558|NCT00673231|566092584|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
156820559|NCT02952313|566092585|FG000|Primary Endpoint|Lost to Follow-up|4|||
156820560|NCT02952313|566092585|FG000|Primary Endpoint|Withdrawal by Subject|1|||
156820561|NCT02952313|566092585|FG000|Primary Endpoint|Lack of Efficacy|1|||
156820562|NCT02952313|566092585|FG000|Primary Endpoint|Missed visit|1|||
156820563|NCT02952313|566092585|FG000|Long-term Follow-up|Lost to Follow-up|12|||
156820564|NCT02952313|566092585|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
156820565|NCT02952313|566092585|FG000|Long-term Follow-up|Lack of Efficacy|6|||
156820566|NCT02952313|566092585|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
156820567|NCT02952313|566092585|FG000|Long-term Follow-up|Physician Decision|1|||
156820568|NCT02952313|566092585|FG000|Long-term Follow-up|Death|1|||
156820569|NCT00792740|566092588|FG000|Overall Study|Disease Worsening|3|||
156820570|NCT00792740|566092589|FG001|Overall Study|Disease Worsening|2|||
156820571|NCT00792740|566092588|FG000|Overall Study|Personal Reason|1|||
156820572|NCT00792740|566092589|FG001|Overall Study|Personal Reason|0|||
156820573|NCT00792740|566092588|FG000|Overall Study|Adverse Event|1|||
156820574|NCT00792740|566092589|FG001|Overall Study|Adverse Event|3|||
156820575|NCT00792740|566092588|FG000|Overall Study|Patient's withdrawal of consent|0|||
156820576|NCT00792740|566092589|FG001|Overall Study|Patient's withdrawal of consent|1|||
156820577|NCT00792740|566092588|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
156820578|NCT00792740|566092589|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
156820579|NCT00792740|566092588|FG000|Overall Study|Other reasons|0|||
156820580|NCT00792740|566092589|FG001|Overall Study|Other reasons|1|||
156820581|NCT02485639|566092592|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
156820582|NCT02485639|566092592|FG000|Overall Study|Early termination|4|||
156820583|NCT02485639|566092592|FG000|Overall Study|Withdrawal by Subject|4|||
156820584|NCT02791516|566092593|FG000|Overall Study|Withdrawal by Subject|1|||
156820585|NCT02791516|566092594|FG001|Overall Study|Withdrawal by Subject|1|||
156820586|NCT02524275|566092595|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
156820587|NCT01439971|566092596|FG000|Overall Study|Required number in cohort dosed|0|||
156820588|NCT01439971|566092597|FG001|Overall Study|Required number in cohort dosed|1|||
156820589|NCT01439971|566092598|FG002|Overall Study|Required number in cohort dosed|2|||
156820590|NCT01439971|566092599|FG003|Overall Study|Required number in cohort dosed|0|||
156820591|NCT01439971|566092600|FG004|Overall Study|Required number in cohort dosed|1|||
156820592|NCT02628600|566092601|FG000|Overall Study|Death|2|||
156820593|NCT02628600|566092602|FG001|Overall Study|Death|1|||
156820594|NCT02628600|566092601|FG000|Overall Study|Adverse Event|3|||
156820595|NCT02628600|566092602|FG001|Overall Study|Adverse Event|20|||
156820596|NCT02628600|566092601|FG000|Overall Study|Protocol Violation|0|||
156820597|NCT02628600|566092602|FG001|Overall Study|Protocol Violation|1|||
156820598|NCT02628600|566092601|FG000|Overall Study|Lack of Efficacy|2|||
156820599|NCT02628600|566092602|FG001|Overall Study|Lack of Efficacy|0|||
156820600|NCT02628600|566092601|FG000|Overall Study|Withdrawal by Subject|13|||
156820601|NCT02628600|566092602|FG001|Overall Study|Withdrawal by Subject|8|||
156820602|NCT02628600|566092601|FG000|Overall Study|Lost to Follow-up|1|||
156820603|NCT02628600|566092602|FG001|Overall Study|Lost to Follow-up|0|||
156820604|NCT02628600|566092601|FG000|Overall Study|Physician Decision|2|||
156820605|NCT02628600|566092602|FG001|Overall Study|Physician Decision|2|||
156820606|NCT02628600|566092601|FG000|Overall Study|Other not specified|1|||
156820607|NCT02628600|566092602|FG001|Overall Study|Other not specified|0|||
156820608|NCT00583752|566092604|FG000|Overall Study|Lost to Follow-up|5|||
156820609|NCT00583752|566092605|FG001|Overall Study|Lost to Follow-up|5|||
156820610|NCT04091581|566092609|FG000|Overall Study|Lost to Follow-up|0|||
156820611|NCT04091581|566092610|FG001|Overall Study|Lost to Follow-up|1|||
156820612|NCT03724981|566094841|FG000|First Device|Protocol Violation|1|||
156820613|NCT03724981|566094842|FG001|First Device|Protocol Violation|1|||
156820614|NCT00511433|566094844|FG000|Overall Study|Adverse Event|5|||
156820615|NCT00511433|566094845|FG001|Overall Study|Adverse Event|0|||
156820616|NCT00511433|566094844|FG000|Overall Study|Other Reason|1|||
156820617|NCT00511433|566094845|FG001|Overall Study|Other Reason|1|||
156820618|NCT00790868|566094846|FG000|Overall Study|Withdrawal by Subject|4|||
156820619|NCT00790868|566094847|FG001|Overall Study|Withdrawal by Subject|5|||
156820620|NCT00790868|566094846|FG000|Overall Study|Lost to Follow-up|2|||
156820621|NCT00790868|566094847|FG001|Overall Study|Lost to Follow-up|12|||
156820622|NCT01380535|566094848|FG000|Overall Study|Adverse Event|3|||
156820623|NCT01380535|566094849|FG001|Overall Study|Adverse Event|3|||
156820624|NCT01380535|566094848|FG000|Overall Study|Death|3|||
156820625|NCT01380535|566094849|FG001|Overall Study|Death|0|||
156820626|NCT01380535|566094848|FG000|Overall Study|Study site closed|0|||
156820627|NCT01380535|566094849|FG001|Overall Study|Study site closed|5|||
156820628|NCT01380535|566094848|FG000|Overall Study|Withdrawal by Subject|1|||
156820629|NCT01380535|566094849|FG001|Overall Study|Withdrawal by Subject|2|||
156820630|NCT01380535|566094848|FG000|Overall Study|Protocol Violation|0|||
156820631|NCT01380535|566094849|FG001|Overall Study|Protocol Violation|2|||
156820632|NCT01380535|566094848|FG000|Overall Study|Lack of Efficacy|0|||
156820633|NCT01380535|566094849|FG001|Overall Study|Lack of Efficacy|3|||
156820634|NCT01579565|566094850|FG000|Randomized|Adverse Event|1|||
156820635|NCT01579565|566094851|FG001|Randomized|Adverse Event|3|||
156820636|NCT01579565|566094850|FG000|Randomized|Withdrawal by Subject|3|||
156820637|NCT01579565|566094851|FG001|Randomized|Withdrawal by Subject|0|||
156820638|NCT01579565|566094850|FG000|Randomized|inadequate preoperative pupil dilation|0|||
156820639|NCT01579565|566094851|FG001|Randomized|inadequate preoperative pupil dilation|1|||
156820640|NCT01579565|566094850|FG000|Randomized|prohibited preoperative eating|1|||
156820641|NCT01579565|566094851|FG001|Randomized|prohibited preoperative eating|0|||
156820642|NCT01579565|566094850|FG000|Randomized|prohibited preoperative medication|0|||
156820643|NCT01579565|566094851|FG001|Randomized|prohibited preoperative medication|1|||
156820644|NCT01579565|566094850|FG000|Treated|Physician Decision|0|||
156820645|NCT01579565|566094851|FG001|Treated|Physician Decision|1|||
156820646|NCT01579565|566094850|FG000|Treated|Lost to Follow-up|2|||
156820647|NCT01579565|566094851|FG001|Treated|Lost to Follow-up|1|||
156820648|NCT01579565|566094850|FG000|Treated|declined to return for final visit|0|||
156820649|NCT01579565|566094851|FG001|Treated|declined to return for final visit|1|||
156820650|NCT02013206|566094852|FG000|Overall Study|Progressive disease (PD)|14|||
156820651|NCT02013206|566094853|FG001|Overall Study|Progressive disease (PD)|17|||
156820652|NCT02013206|566094852|FG000|Overall Study|Symptomatic deterioration|3|||
156820653|NCT02013206|566094853|FG001|Overall Study|Symptomatic deterioration|1|||
156820654|NCT02013206|566094852|FG000|Overall Study|Adverse Event|1|||
156820655|NCT02013206|566094853|FG001|Overall Study|Adverse Event|0|||
156820656|NCT02013206|566094852|FG000|Overall Study|Patient refusal|2|||
156820657|NCT02013206|566094853|FG001|Overall Study|Patient refusal|0|||
156820658|NCT02013206|566094852|FG000|Overall Study|Patient non-compliance|1|||
156820659|NCT02013206|566094853|FG001|Overall Study|Patient non-compliance|0|||
156820660|NCT02013206|566094852|FG000|Overall Study|Death|1|||
156820661|NCT02013206|566094853|FG001|Overall Study|Death|2|||
156820662|NCT02013206|566094852|FG000|Overall Study|Other reasons off treatment|5|||
156820663|NCT02013206|566094853|FG001|Overall Study|Other reasons off treatment|2|||
156820664|NCT02867813|566094854|FG000|Overall Study|Withdrawal by Subject|57|||
156820665|NCT02867813|566094855|FG001|Overall Study|Withdrawal by Subject|56|||
156820666|NCT02867813|566094854|FG000|Overall Study|Decision by Sponsor|7|||
156820667|NCT02867813|566094855|FG001|Overall Study|Decision by Sponsor|7|||
156820668|NCT02867813|566094854|FG000|Overall Study|Lost to Follow-up|91|||
156820669|NCT02867813|566094855|FG001|Overall Study|Lost to Follow-up|78|||
156820670|NCT02867813|566094854|FG000|Overall Study|Missing|2|||
156820671|NCT02867813|566094855|FG001|Overall Study|Missing|1|||
156820672|NCT02867813|566094854|FG000|Overall Study|Death|294|||
156820673|NCT02867813|566094855|FG001|Overall Study|Death|268|||
156820674|NCT02791191|566094861|FG000|Overall Study|Adverse Event|2|||
156339141|NCT00334958|564340122|FG000|Overall Study|Request of the investigator or sponsor|0|||
156339142|NCT00334958|564340123|FG001|Overall Study|Request of the investigator or sponsor|1|||
156820675|NCT02791191|566094862|FG001|Overall Study|Adverse Event|4|||
156820676|NCT02791191|566094863|FG002|Overall Study|Adverse Event|5|||
156820677|NCT02791191|566094861|FG000|Overall Study|Lack of Efficacy|0|||
156820678|NCT02791191|566094862|FG001|Overall Study|Lack of Efficacy|1|||
156820679|NCT02791191|566094863|FG002|Overall Study|Lack of Efficacy|0|||
156820680|NCT02791191|566094861|FG000|Overall Study|Study Drug Non-Compliance|0|||
156820681|NCT02791191|566094862|FG001|Overall Study|Study Drug Non-Compliance|2|||
156820682|NCT02791191|566094863|FG002|Overall Study|Study Drug Non-Compliance|0|||
156820683|NCT02791191|566094861|FG000|Overall Study|Site Closed by Sponsor|1|||
156820684|NCT02791191|566094862|FG001|Overall Study|Site Closed by Sponsor|1|||
156820685|NCT02791191|566094863|FG002|Overall Study|Site Closed by Sponsor|3|||
156820686|NCT02791191|566094861|FG000|Overall Study|Progressive Disease|1|||
156820687|NCT02791191|566094862|FG001|Overall Study|Progressive Disease|0|||
156820688|NCT02791191|566094863|FG002|Overall Study|Progressive Disease|0|||
156820689|NCT02791191|566094861|FG000|Overall Study|Study Terminated by Sponsor|29|||
156465839|NCT04129450|564802038|FG000|Overall Study|Work Family Obligations|2|||
156820690|NCT02791191|566094862|FG001|Overall Study|Study Terminated by Sponsor|101|||
156820691|NCT02791191|566094863|FG002|Overall Study|Study Terminated by Sponsor|109|||
156820692|NCT02791191|566094861|FG000|Overall Study|Withdrawal by Subject|3|||
156820693|NCT02791191|566094862|FG001|Overall Study|Withdrawal by Subject|1|||
156820694|NCT02791191|566094863|FG002|Overall Study|Withdrawal by Subject|3|||
156820695|NCT02791191|566094861|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
156820696|NCT02791191|566094862|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
156820697|NCT02791191|566094863|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
156820698|NCT01448824|566094864|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820699|NCT01448824|566094865|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820700|NCT01448824|566094866|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820701|NCT01448824|566094867|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820702|NCT01448824|566094868|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820703|NCT01448824|566094869|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820704|NCT01448824|566094870|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
156820705|NCT01448824|566094871|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820706|NCT01448824|566094864|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820707|NCT01448824|566094865|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820708|NCT01448824|566094866|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820709|NCT01448824|566094867|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
156820710|NCT01448824|566094868|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
156820711|NCT01448824|566094869|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
156820712|NCT01448824|566094870|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820713|NCT01448824|566094871|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820714|NCT01448824|566094864|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820715|NCT01448824|566094865|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820716|NCT01448824|566094866|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820717|NCT01448824|566094867|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820718|NCT01448824|566094868|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820719|NCT01448824|566094869|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
156820720|NCT01448824|566094870|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820721|NCT01448824|566094871|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820722|NCT01448824|566094864|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
156820723|NCT01448824|566094865|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
156820724|NCT01448824|566094866|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
156820725|NCT01448824|566094867|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
156820726|NCT01448824|566094868|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
156820727|NCT01448824|566094869|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
156820728|NCT01448824|566094870|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
156820729|NCT01448824|566094871|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
156820730|NCT01448824|566094864|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820731|NCT01448824|566094865|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820732|NCT01448824|566094866|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820733|NCT01448824|566094867|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820734|NCT01448824|566094868|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820735|NCT01448824|566094869|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820736|NCT01448824|566094870|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820737|NCT01448824|566094871|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
156820738|NCT01448824|566094864|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820739|NCT01448824|566094865|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820740|NCT01448824|566094866|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820741|NCT01448824|566094867|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820742|NCT01448824|566094868|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820743|NCT01448824|566094869|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820744|NCT01448824|566094870|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820745|NCT01448824|566094871|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
156820746|NCT01448824|566094864|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820747|NCT01448824|566094865|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820748|NCT01448824|566094866|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820749|NCT01448824|566094867|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820750|NCT01448824|566094868|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820751|NCT01448824|566094869|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820752|NCT01448824|566094870|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156339143|NCT00334958|564340122|FG000|Overall Study|Withdrawal by Subject|7|||
156820753|NCT01448824|566094871|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
156465840|NCT04129450|564802039|FG001|Overall Study|Work Family Obligations|0|||
156820754|NCT01448824|566094864|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820755|NCT01448824|566094865|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820756|NCT01448824|566094866|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820757|NCT01448824|566094867|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820758|NCT01448824|566094868|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820759|NCT01448824|566094869|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820760|NCT01448824|566094870|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820761|NCT01448824|566094871|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
156820762|NCT01952665|566094872|FG000|Overall Study|Physician Decision|3|||
156820763|NCT01952665|566094873|FG001|Overall Study|Physician Decision|2|||
156820764|NCT01952665|566094872|FG000|Overall Study|Lost to Follow-up|1|||
156820765|NCT01952665|566094873|FG001|Overall Study|Lost to Follow-up|2|||
156820766|NCT01952665|566094872|FG000|Overall Study|Adverse Event|2|||
156820767|NCT01952665|566094873|FG001|Overall Study|Adverse Event|1|||
156820768|NCT01952665|566094872|FG000|Overall Study|Protocol Violation|0|||
156820769|NCT01952665|566094873|FG001|Overall Study|Protocol Violation|1|||
156820770|NCT01537081|566094877|FG000|Overall Study|Adverse Event|5|||
156820771|NCT01537081|566094878|FG001|Overall Study|Adverse Event|2|||
156820772|NCT01537081|566094879|FG002|Overall Study|Adverse Event|2|||
156820773|NCT01537081|566094877|FG000|Overall Study|Lack of Efficacy|2|||
156820774|NCT01537081|566094878|FG001|Overall Study|Lack of Efficacy|1|||
156820775|NCT01537081|566094879|FG002|Overall Study|Lack of Efficacy|0|||
156820776|NCT01537081|566094877|FG000|Overall Study|Lost to Follow-up|17|||
156820777|NCT01537081|566094878|FG001|Overall Study|Lost to Follow-up|15|||
156820778|NCT01537081|566094879|FG002|Overall Study|Lost to Follow-up|9|||
156820779|NCT01537081|566094877|FG000|Overall Study|Protocol Violation|3|||
156820780|NCT01537081|566094878|FG001|Overall Study|Protocol Violation|2|||
156820781|NCT01537081|566094879|FG002|Overall Study|Protocol Violation|2|||
156820782|NCT01537081|566094877|FG000|Overall Study|Withdrawal by Subject|6|||
156820783|NCT01537081|566094878|FG001|Overall Study|Withdrawal by Subject|11|||
156820784|NCT01537081|566094879|FG002|Overall Study|Withdrawal by Subject|3|||
156820785|NCT01537081|566094877|FG000|Overall Study|Physician Decision|5|||
156820786|NCT01537081|566094878|FG001|Overall Study|Physician Decision|6|||
156820787|NCT01537081|566094879|FG002|Overall Study|Physician Decision|0|||
156820788|NCT01537081|566094877|FG000|Overall Study|Sponsor decision|0|||
156820789|NCT01537081|566094878|FG001|Overall Study|Sponsor decision|1|||
156820790|NCT01537081|566094879|FG002|Overall Study|Sponsor decision|0|||
156820791|NCT01537081|566094877|FG000|Overall Study|Assigned but never dosed|1|||
156820792|NCT01537081|566094878|FG001|Overall Study|Assigned but never dosed|0|||
156820793|NCT01537081|566094879|FG002|Overall Study|Assigned but never dosed|0|||
156820794|NCT01463111|566094882|FG000|Overall Study|Withdrawal by Subject|2|||
156820795|NCT01463111|566094882|FG000|Overall Study|Lost to Follow-up|5|||
156820796|NCT01463111|566094882|FG000|Overall Study|Physician Decision|2|||
156820797|NCT02578680|566094885|FG000|Overall Study|Death|329|||
156820798|NCT02578680|566094886|FG001|Overall Study|Death|181|||
156820799|NCT02578680|566094885|FG000|Overall Study|Lost to Follow-up|3|||
156820800|NCT02578680|566094886|FG001|Overall Study|Lost to Follow-up|1|||
156820801|NCT02578680|566094885|FG000|Overall Study|Physician Decision|0|||
156820802|NCT02578680|566094886|FG001|Overall Study|Physician Decision|1|||
156820803|NCT02578680|566094885|FG000|Overall Study|Protocol Violation|1|||
156820804|NCT02578680|566094886|FG001|Overall Study|Protocol Violation|1|||
156820805|NCT02578680|566094885|FG000|Overall Study|Sponsor Decision|64|||
156820806|NCT02578680|566094886|FG001|Overall Study|Sponsor Decision|13|||
156820807|NCT02578680|566094885|FG000|Overall Study|Withdrawal by Subject|13|||
156820808|NCT02578680|566094886|FG001|Overall Study|Withdrawal by Subject|9|||
156820809|NCT00882583|566094887|FG000|Overall Study|Physician Decision|1|||
156820810|NCT00882583|566094888|FG001|Overall Study|Physician Decision|0|||
156820811|NCT00882583|566094887|FG000|Overall Study|Adverse Event|0|||
156820812|NCT00882583|566094888|FG001|Overall Study|Adverse Event|1|||
156820813|NCT02596958|566094897|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
156820814|NCT02596958|566094897|FG000|Overall Study|Cancer Progression|441|||
156820815|NCT02596958|566094897|FG000|Overall Study|Death From Cancer|112|||
156820816|NCT02596958|566094897|FG000|Overall Study|Death From Other Cause|33|||
156820817|NCT02596958|566094897|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
156820818|NCT02596958|566094897|FG000|Overall Study|Administrative Reasons/Other|231|||
156820819|NCT02596958|566094897|FG000|Overall Study|Lost to Follow-up|33|||
156820820|NCT02596958|566094897|FG000|Overall Study|Missing|32|||
156820821|NCT02596958|566094897|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
156820822|NCT01559259|566094898|FG000|Overall Study|Withdrawal by Subject|0|||
156820823|NCT01559259|566094899|FG001|Overall Study|Withdrawal by Subject|0|||
156820824|NCT01559259|566094900|FG002|Overall Study|Withdrawal by Subject|0|||
156820825|NCT01559259|566094901|FG003|Overall Study|Withdrawal by Subject|1|||
156820826|NCT01559259|566094902|FG004|Overall Study|Withdrawal by Subject|0|||
156820827|NCT01559259|566094898|FG000|Overall Study|Adverse Event|0|||
156820828|NCT01559259|566094899|FG001|Overall Study|Adverse Event|1|||
156820829|NCT01559259|566094900|FG002|Overall Study|Adverse Event|1|||
156820830|NCT01559259|566094901|FG003|Overall Study|Adverse Event|0|||
156820831|NCT01559259|566094902|FG004|Overall Study|Adverse Event|0|||
156820832|NCT01995669|566094903|FG000|Overall Study|Progression|2|||
156820833|NCT01995669|566094904|FG001|Overall Study|Progression|1|||
156820834|NCT01995669|566094905|FG002|Overall Study|Progression|1|||
156820835|NCT01995669|566094906|FG003|Overall Study|Progression|13|||
156820836|NCT01995669|566094903|FG000|Overall Study|Adverse Event|0|||
156820837|NCT01995669|566094904|FG001|Overall Study|Adverse Event|0|||
156820838|NCT01995669|566094905|FG002|Overall Study|Adverse Event|0|||
156820839|NCT01995669|566094906|FG003|Overall Study|Adverse Event|3|||
156820840|NCT01995669|566094903|FG000|Overall Study|Death|0|||
156820841|NCT01995669|566094904|FG001|Overall Study|Death|0|||
156820842|NCT01995669|566094905|FG002|Overall Study|Death|0|||
156820843|NCT01995669|566094906|FG003|Overall Study|Death|6|||
156820844|NCT01995669|566094903|FG000|Overall Study|Withdrawal by Subject|0|||
156820845|NCT01995669|566094904|FG001|Overall Study|Withdrawal by Subject|0|||
156820846|NCT01995669|566094905|FG002|Overall Study|Withdrawal by Subject|0|||
156820847|NCT01995669|566094906|FG003|Overall Study|Withdrawal by Subject|6|||
156820848|NCT01995669|566094903|FG000|Overall Study|Insurance Expired|0|||
156820849|NCT01995669|566094904|FG001|Overall Study|Insurance Expired|0|||
156820850|NCT01995669|566094905|FG002|Overall Study|Insurance Expired|0|||
156820851|NCT01995669|566094906|FG003|Overall Study|Insurance Expired|1|||
156820852|NCT05425732|566094907|FG000|Overall Study|Death|4|||
156820853|NCT05425732|566094908|FG001|Overall Study|Death|2|||
156820854|NCT05425732|566094909|FG002|Overall Study|Death|0|||
156820855|NCT05425732|566094910|FG003|Overall Study|Death|0|||
156820856|NCT05425732|566094907|FG000|Overall Study|Lost to Follow-up|10|||
156820857|NCT05425732|566094908|FG001|Overall Study|Lost to Follow-up|15|||
156820858|NCT05425732|566094909|FG002|Overall Study|Lost to Follow-up|5|||
156820859|NCT05425732|566094910|FG003|Overall Study|Lost to Follow-up|3|||
156820860|NCT05425732|566094907|FG000|Overall Study|Physician Decision|0|||
156820861|NCT05425732|566094908|FG001|Overall Study|Physician Decision|2|||
156820862|NCT05425732|566094909|FG002|Overall Study|Physician Decision|0|||
156820863|NCT05425732|566094910|FG003|Overall Study|Physician Decision|0|||
156820864|NCT05425732|566094907|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156820865|NCT05425732|566094908|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
156820866|NCT05425732|566094909|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156820867|NCT05425732|566094910|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156820868|NCT05425732|566094907|FG000|Overall Study|Withdrawal by Subject|4|||
156820869|NCT05425732|566094908|FG001|Overall Study|Withdrawal by Subject|8|||
156820870|NCT05425732|566094909|FG002|Overall Study|Withdrawal by Subject|1|||
156820871|NCT05425732|566094910|FG003|Overall Study|Withdrawal by Subject|1|||
156820872|NCT05425732|566094907|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
156820873|NCT05425732|566094908|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
156820874|NCT05425732|566094909|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
156820875|NCT05425732|566094910|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
156820876|NCT00218634|566094912|FG000|Overall Study|Lost to Follow-up|8|||
156820877|NCT00218634|566094913|FG001|Overall Study|Lost to Follow-up|15|||
156820878|NCT00734604|566094914|FG000|Overall Study|Adverse Event|0|||
156820879|NCT00734604|566094915|FG001|Overall Study|Adverse Event|2|||
156820880|NCT00734604|566094916|FG002|Overall Study|Adverse Event|0|||
156820881|NCT00734604|566094917|FG003|Overall Study|Adverse Event|2|||
156820882|NCT00734604|566094918|FG004|Overall Study|Adverse Event|1|||
156820883|NCT00734604|566094919|FG005|Overall Study|Adverse Event|1|||
156820884|NCT00734604|566094914|FG000|Overall Study|Serious Adverse Event|1|||
156820885|NCT00734604|566094915|FG001|Overall Study|Serious Adverse Event|0|||
156820886|NCT00734604|566094916|FG002|Overall Study|Serious Adverse Event|1|||
156820887|NCT00734604|566094917|FG003|Overall Study|Serious Adverse Event|2|||
156820888|NCT00734604|566094918|FG004|Overall Study|Serious Adverse Event|0|||
156820889|NCT00734604|566094919|FG005|Overall Study|Serious Adverse Event|1|||
156820890|NCT00734604|566094914|FG000|Overall Study|Lost to Follow-up|1|||
156820891|NCT00734604|566094915|FG001|Overall Study|Lost to Follow-up|2|||
156820892|NCT00734604|566094916|FG002|Overall Study|Lost to Follow-up|2|||
156820893|NCT00734604|566094917|FG003|Overall Study|Lost to Follow-up|4|||
156820894|NCT00734604|566094918|FG004|Overall Study|Lost to Follow-up|2|||
156465841|NCT04129450|564802038|FG000|Overall Study|Other|3|||
156820895|NCT00734604|566094919|FG005|Overall Study|Lost to Follow-up|3|||
156820896|NCT00734604|566094914|FG000|Overall Study|Physician Decision|0|||
156820897|NCT00734604|566094915|FG001|Overall Study|Physician Decision|1|||
156820898|NCT00734604|566094916|FG002|Overall Study|Physician Decision|1|||
156820899|NCT00734604|566094917|FG003|Overall Study|Physician Decision|0|||
156820900|NCT00734604|566094918|FG004|Overall Study|Physician Decision|0|||
156820901|NCT00734604|566094919|FG005|Overall Study|Physician Decision|0|||
156820902|NCT00734604|566094914|FG000|Overall Study|Protocol Violation|0|||
156820903|NCT00734604|566094915|FG001|Overall Study|Protocol Violation|2|||
156820904|NCT00734604|566094916|FG002|Overall Study|Protocol Violation|0|||
156820905|NCT00734604|566094917|FG003|Overall Study|Protocol Violation|0|||
156820906|NCT00734604|566094918|FG004|Overall Study|Protocol Violation|1|||
156820907|NCT00734604|566094919|FG005|Overall Study|Protocol Violation|0|||
156820908|NCT00734604|566094914|FG000|Overall Study|Sponsor Decision|1|||
156820909|NCT00734604|566094915|FG001|Overall Study|Sponsor Decision|2|||
156820910|NCT00734604|566094916|FG002|Overall Study|Sponsor Decision|1|||
156820911|NCT00734604|566094917|FG003|Overall Study|Sponsor Decision|0|||
156820912|NCT00734604|566094918|FG004|Overall Study|Sponsor Decision|2|||
156820913|NCT00734604|566094919|FG005|Overall Study|Sponsor Decision|0|||
156820914|NCT00734604|566094914|FG000|Overall Study|Withdrawal by Subject|0|||
156820915|NCT00734604|566094915|FG001|Overall Study|Withdrawal by Subject|2|||
156820916|NCT00734604|566094916|FG002|Overall Study|Withdrawal by Subject|0|||
156820917|NCT00734604|566094917|FG003|Overall Study|Withdrawal by Subject|1|||
156820918|NCT00734604|566094918|FG004|Overall Study|Withdrawal by Subject|2|||
156820919|NCT00734604|566094919|FG005|Overall Study|Withdrawal by Subject|1|||
156820920|NCT00734604|566094914|FG000|Overall Study|Lack of Efficacy|0|||
156820921|NCT00734604|566094915|FG001|Overall Study|Lack of Efficacy|1|||
156820922|NCT00734604|566094916|FG002|Overall Study|Lack of Efficacy|1|||
156820923|NCT00734604|566094917|FG003|Overall Study|Lack of Efficacy|0|||
156820924|NCT00734604|566094918|FG004|Overall Study|Lack of Efficacy|0|||
156820925|NCT00734604|566094919|FG005|Overall Study|Lack of Efficacy|0|||
156820926|NCT00327015|566094922|FG000|Overall Study|Lack of Efficacy|18|||
156820927|NCT00327015|566094923|FG001|Overall Study|Lack of Efficacy|18|||
156820928|NCT00327015|566094924|FG002|Overall Study|Lack of Efficacy|35|||
156820929|NCT00327015|566094925|FG003|Overall Study|Lack of Efficacy|29|||
156820930|NCT00327015|566094922|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
156820931|NCT00327015|566094923|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
156820932|NCT00327015|566094924|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
156820933|NCT00327015|566094925|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
156820934|NCT00327015|566094922|FG000|Overall Study|Lost to Follow-up|22|||
156820935|NCT00327015|566094923|FG001|Overall Study|Lost to Follow-up|23|||
156820936|NCT00327015|566094924|FG002|Overall Study|Lost to Follow-up|29|||
156820937|NCT00327015|566094925|FG003|Overall Study|Lost to Follow-up|22|||
156820938|NCT00327015|566094922|FG000|Overall Study|Adverse Event|14|||
156820939|NCT00327015|566094923|FG001|Overall Study|Adverse Event|10|||
156820940|NCT00327015|566094924|FG002|Overall Study|Adverse Event|14|||
156820941|NCT00327015|566094925|FG003|Overall Study|Adverse Event|14|||
156820942|NCT00327015|566094922|FG000|Overall Study|Subject no longer meets study criteria|4|||
156820943|NCT00327015|566094923|FG001|Overall Study|Subject no longer meets study criteria|2|||
156820944|NCT00327015|566094924|FG002|Overall Study|Subject no longer meets study criteria|8|||
156820945|NCT00327015|566094925|FG003|Overall Study|Subject no longer meets study criteria|7|||
156820946|NCT00327015|566094922|FG000|Overall Study|Poor/Noncompliance|11|||
156820947|NCT00327015|566094923|FG001|Overall Study|Poor/Noncompliance|8|||
156820948|NCT00327015|566094924|FG002|Overall Study|Poor/Noncompliance|4|||
156820949|NCT00327015|566094925|FG003|Overall Study|Poor/Noncompliance|5|||
156820950|NCT00327015|566094922|FG000|Overall Study|Physician Decision|0|||
156820951|NCT00327015|566094923|FG001|Overall Study|Physician Decision|1|||
156820952|NCT00327015|566094924|FG002|Overall Study|Physician Decision|3|||
156820953|NCT00327015|566094925|FG003|Overall Study|Physician Decision|2|||
156820954|NCT00327015|566094922|FG000|Overall Study|Death|1|||
156820955|NCT00327015|566094923|FG001|Overall Study|Death|2|||
156820956|NCT00327015|566094924|FG002|Overall Study|Death|2|||
156820957|NCT00327015|566094925|FG003|Overall Study|Death|3|||
156820958|NCT00327015|566094922|FG000|Overall Study|Pregnancy|0|||
156820959|NCT00327015|566094923|FG001|Overall Study|Pregnancy|2|||
156820960|NCT00327015|566094924|FG002|Overall Study|Pregnancy|1|||
156820961|NCT00327015|566094925|FG003|Overall Study|Pregnancy|1|||
156820962|NCT00327015|566094922|FG000|Overall Study|Administrative Reason by Sponsor|1|||
156820963|NCT00327015|566094923|FG001|Overall Study|Administrative Reason by Sponsor|2|||
156820964|NCT00327015|566094924|FG002|Overall Study|Administrative Reason by Sponsor|2|||
156820965|NCT00327015|566094925|FG003|Overall Study|Administrative Reason by Sponsor|1|||
156820966|NCT03764631|566094930|FG000|Overall Study|Personal Reasons|3|||
156820967|NCT03764631|566094931|FG001|Overall Study|Personal Reasons|2|||
156820968|NCT03764631|566094930|FG000|Overall Study|Switching Therapy|3|||
156820969|NCT03764631|566094931|FG001|Overall Study|Switching Therapy|3|||
156820970|NCT03764631|566094930|FG000|Overall Study|Adverse Event|0|||
156820971|NCT03764631|566094931|FG001|Overall Study|Adverse Event|1|||
156820972|NCT03764631|566094930|FG000|Overall Study|Lost to Follow-up|33|||
156820973|NCT03764631|566094931|FG001|Overall Study|Lost to Follow-up|41|||
156820974|NCT03764631|566094930|FG000|Overall Study|No data as study site was closed|2|||
156820975|NCT03764631|566094931|FG001|Overall Study|No data as study site was closed|6|||
156820976|NCT04569136|566094932|FG000|Overall Study|Lost to Follow-up|2|||
156820977|NCT04569136|566094933|FG001|Overall Study|Lost to Follow-up|0|||
156820978|NCT04569136|566094934|FG002|Overall Study|Lost to Follow-up|1|||
156820979|NCT00129701|566094940|FG000|Overall Study|Withdrawal by Subject|33|||
156820980|NCT03576066|566094941|FG000|Overall Study|Noncompliance with study drug|0|||
156820981|NCT03576066|566094942|FG001|Overall Study|Noncompliance with study drug|1|||
156820982|NCT01466660|566094943|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
156820983|NCT01466660|566094944|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
156820984|NCT01466660|566094943|FG000|Overall Study|Worsening of underlying cancer disease|5|||
156820985|NCT01466660|566094944|FG001|Overall Study|Worsening of underlying cancer disease|2|||
156820986|NCT01466660|566094943|FG000|Overall Study|Other adverse event|19|||
156820987|NCT01466660|566094944|FG001|Overall Study|Other adverse event|18|||
156820988|NCT01466660|566094943|FG000|Overall Study|Protocol Violation|2|||
156820989|NCT01466660|566094944|FG001|Overall Study|Protocol Violation|1|||
156820990|NCT01466660|566094943|FG000|Overall Study|Refused continuation of trial medication|4|||
156820991|NCT01466660|566094944|FG001|Overall Study|Refused continuation of trial medication|3|||
156820992|NCT01466660|566094943|FG000|Overall Study|Other reason not defined above|10|||
156820993|NCT01466660|566094944|FG001|Overall Study|Other reason not defined above|8|||
156820994|NCT00712725|566094950|FG000|Overall Study|Adverse Event|1|||
156820995|NCT00712725|566094951|FG001|Overall Study|Adverse Event|0|||
156820996|NCT00712725|566094952|FG002|Overall Study|Adverse Event|0|||
156820997|NCT00712725|566094953|FG003|Overall Study|Adverse Event|1|||
156820998|NCT00712725|566094954|FG004|Overall Study|Adverse Event|0|||
156820999|NCT00712725|566094955|FG005|Overall Study|Adverse Event|0|||
156821000|NCT00712725|566094956|FG006|Overall Study|Adverse Event|0|||
156821001|NCT00712725|566094957|FG007|Overall Study|Adverse Event|0|||
156821002|NCT00712725|566094950|FG000|Overall Study|Lost to Follow-up|3|||
156821003|NCT00712725|566094951|FG001|Overall Study|Lost to Follow-up|2|||
156821004|NCT00712725|566094952|FG002|Overall Study|Lost to Follow-up|1|||
156821005|NCT00712725|566094953|FG003|Overall Study|Lost to Follow-up|1|||
156821006|NCT00712725|566094954|FG004|Overall Study|Lost to Follow-up|2|||
156339144|NCT00334958|564340123|FG001|Overall Study|Withdrawal by Subject|4|||
156339145|NCT00334958|564340122|FG000|Overall Study|Adverse Event|27|||
156339146|NCT00334958|564340123|FG001|Overall Study|Adverse Event|12|||
156339147|NCT00334958|564340122|FG000|Overall Study|Other|1|||
156339148|NCT00334958|564340123|FG001|Overall Study|Other|2|||
156339149|NCT00781274|564340124|FG000|Overall Study|Withdrawal by Subject|2|||
156339150|NCT02572401|564340125|FG000|Overall Study|Lost to Follow-up|5|||
156339151|NCT02572401|564340126|FG001|Overall Study|Lost to Follow-up|8|||
156339152|NCT02572401|564340127|FG002|Overall Study|Lost to Follow-up|9|||
156339153|NCT02572401|564340128|FG003|Overall Study|Lost to Follow-up|9|||
156339154|NCT02572401|564340125|FG000|Overall Study|Death|0|||
156339155|NCT02572401|564340126|FG001|Overall Study|Death|0|||
156339156|NCT02572401|564340127|FG002|Overall Study|Death|0|||
156339157|NCT02572401|564340128|FG003|Overall Study|Death|1|||
156339158|NCT01548287|564340129|FG000|Screening|No reason provided|0|||
156339159|NCT01548287|564340130|FG001|Screening|No reason provided|0|||
156339160|NCT01548287|564340131|FG002|Screening|No reason provided|0|||
156339161|NCT01548287|564340132|FG003|Screening|No reason provided|0|||
156339162|NCT01548287|564340133|FG004|Screening|No reason provided|9|||
156339163|NCT01548287|564340129|FG000|Screening|Did not meet eligibility criteria|0|||
156339164|NCT01548287|564340130|FG001|Screening|Did not meet eligibility criteria|0|||
156339165|NCT01548287|564340131|FG002|Screening|Did not meet eligibility criteria|0|||
156339166|NCT01548287|564340132|FG003|Screening|Did not meet eligibility criteria|0|||
156339167|NCT01548287|564340133|FG004|Screening|Did not meet eligibility criteria|74|||
156339168|NCT01548287|564340129|FG000|Randomized Period|Did not meet inclusion criteria|0|||
156339169|NCT01548287|564340130|FG001|Randomized Period|Did not meet inclusion criteria|0|||
156339170|NCT01548287|564340131|FG002|Randomized Period|Did not meet inclusion criteria|2|||
156821007|NCT00712725|566094955|FG005|Overall Study|Lost to Follow-up|2|||
156821008|NCT00712725|566094956|FG006|Overall Study|Lost to Follow-up|3|||
156821009|NCT00712725|566094957|FG007|Overall Study|Lost to Follow-up|1|||
156821010|NCT00712725|566094950|FG000|Overall Study|Physician Decision|2|||
156821011|NCT00712725|566094951|FG001|Overall Study|Physician Decision|0|||
156821012|NCT00712725|566094952|FG002|Overall Study|Physician Decision|0|||
156821013|NCT00712725|566094953|FG003|Overall Study|Physician Decision|0|||
156821014|NCT00712725|566094954|FG004|Overall Study|Physician Decision|1|||
156821015|NCT00712725|566094955|FG005|Overall Study|Physician Decision|0|||
156821016|NCT00712725|566094956|FG006|Overall Study|Physician Decision|2|||
156821017|NCT00712725|566094957|FG007|Overall Study|Physician Decision|0|||
156339171|NCT01548287|564340132|FG003|Randomized Period|Did not meet inclusion criteria|0|||
156339172|NCT01548287|564340133|FG004|Randomized Period|Did not meet inclusion criteria|0|||
156339173|NCT01548287|564340129|FG000|Randomized Period|Adverse Event|0|||
156339174|NCT01548287|564340130|FG001|Randomized Period|Adverse Event|2|||
156339175|NCT01548287|564340131|FG002|Randomized Period|Adverse Event|5|||
156339176|NCT01548287|564340132|FG003|Randomized Period|Adverse Event|0|||
156339177|NCT01548287|564340133|FG004|Randomized Period|Adverse Event|0|||
156339178|NCT02762578|564340140|FG000|Overall Study|Adverse Event|1|||
156465842|NCT04129450|564802039|FG001|Overall Study|Other|0|||
156465843|NCT05039021|564802730|FG000|Overall Study|Death|1|||
156821018|NCT00712725|566094950|FG000|Overall Study|Pregnancy|0|||
156821019|NCT00712725|566094951|FG001|Overall Study|Pregnancy|1|||
156821020|NCT00712725|566094952|FG002|Overall Study|Pregnancy|0|||
156821021|NCT00712725|566094953|FG003|Overall Study|Pregnancy|0|||
156339179|NCT02762578|564340141|FG001|Overall Study|Adverse Event|6|||
156339180|NCT02762578|564340140|FG000|Overall Study|Protocol Violation|4|||
156339181|NCT02762578|564340141|FG001|Overall Study|Protocol Violation|2|||
156339182|NCT02762578|564340140|FG000|Overall Study|Withdrawal by Subject|4|||
156339183|NCT02762578|564340141|FG001|Overall Study|Withdrawal by Subject|2|||
156821022|NCT00712725|566094954|FG004|Overall Study|Pregnancy|1|||
156821023|NCT00712725|566094955|FG005|Overall Study|Pregnancy|0|||
156821024|NCT00712725|566094956|FG006|Overall Study|Pregnancy|2|||
156821025|NCT00712725|566094957|FG007|Overall Study|Pregnancy|0|||
156821026|NCT00712725|566094950|FG000|Overall Study|Protocol Violation|2|||
156821027|NCT00712725|566094951|FG001|Overall Study|Protocol Violation|0|||
156821028|NCT00712725|566094952|FG002|Overall Study|Protocol Violation|1|||
156821029|NCT00712725|566094953|FG003|Overall Study|Protocol Violation|3|||
156821030|NCT00712725|566094954|FG004|Overall Study|Protocol Violation|2|||
156821031|NCT00712725|566094955|FG005|Overall Study|Protocol Violation|0|||
156821032|NCT00712725|566094956|FG006|Overall Study|Protocol Violation|1|||
156821033|NCT00712725|566094957|FG007|Overall Study|Protocol Violation|1|||
156821034|NCT00712725|566094950|FG000|Overall Study|Withdrawal by Subject|2|||
156821035|NCT00712725|566094951|FG001|Overall Study|Withdrawal by Subject|1|||
156821036|NCT00712725|566094952|FG002|Overall Study|Withdrawal by Subject|1|||
156821037|NCT00712725|566094953|FG003|Overall Study|Withdrawal by Subject|2|||
156821038|NCT00712725|566094954|FG004|Overall Study|Withdrawal by Subject|1|||
156821039|NCT00712725|566094955|FG005|Overall Study|Withdrawal by Subject|1|||
156821040|NCT00712725|566094956|FG006|Overall Study|Withdrawal by Subject|1|||
156821041|NCT00712725|566094957|FG007|Overall Study|Withdrawal by Subject|2|||
156821042|NCT00712725|566094950|FG000|Overall Study|Lack of Qualifying Event|16|||
156821043|NCT00712725|566094951|FG001|Overall Study|Lack of Qualifying Event|2|||
156821044|NCT00712725|566094952|FG002|Overall Study|Lack of Qualifying Event|6|||
156821045|NCT00712725|566094953|FG003|Overall Study|Lack of Qualifying Event|8|||
156821046|NCT00712725|566094954|FG004|Overall Study|Lack of Qualifying Event|11|||
156821047|NCT00712725|566094955|FG005|Overall Study|Lack of Qualifying Event|13|||
156821048|NCT00712725|566094956|FG006|Overall Study|Lack of Qualifying Event|11|||
156821049|NCT00712725|566094957|FG007|Overall Study|Lack of Qualifying Event|6|||
156821050|NCT00712725|566094950|FG000|Overall Study|Protocol Specified Criteria|3|||
156821051|NCT00712725|566094951|FG001|Overall Study|Protocol Specified Criteria|0|||
156821052|NCT00712725|566094952|FG002|Overall Study|Protocol Specified Criteria|1|||
156821053|NCT00712725|566094953|FG003|Overall Study|Protocol Specified Criteria|2|||
156821054|NCT00712725|566094954|FG004|Overall Study|Protocol Specified Criteria|1|||
156821055|NCT00712725|566094955|FG005|Overall Study|Protocol Specified Criteria|0|||
156821056|NCT00712725|566094956|FG006|Overall Study|Protocol Specified Criteria|2|||
156821057|NCT00712725|566094957|FG007|Overall Study|Protocol Specified Criteria|1|||
156821058|NCT01901289|566094958|FG000|Overall Study|Death|32|||
156821059|NCT01901289|566094958|FG000|Overall Study|Lost to Follow-up|16|||
156821060|NCT01901289|566094958|FG000|Overall Study|Withdrawal by Subject|35|||
156821061|NCT01901289|566094958|FG000|Overall Study|Other type of endpoint met|2|||
156821062|NCT01832493|566094966|FG000|Overall Study|Physician Decision|2|||
156821063|NCT01832493|566094966|FG000|Overall Study|Protocol Violation|4|||
156821064|NCT01832493|566094966|FG000|Overall Study|Unable to place LV lead|2|||
156821065|NCT00290771|566094975|FG000|Overall Study|Disease progression|95|||
156821066|NCT00290771|566094976|FG001|Overall Study|Disease progression|73|||
156821067|NCT00290771|566094975|FG000|Overall Study|Death|11|||
156821068|NCT00290771|566094976|FG001|Overall Study|Death|10|||
156821069|NCT00290771|566094975|FG000|Overall Study|Adverse Event|12|||
156821070|NCT00290771|566094976|FG001|Overall Study|Adverse Event|6|||
156821071|NCT00290771|566094975|FG000|Overall Study|Withdrawal by Subject|5|||
156821072|NCT00290771|566094976|FG001|Overall Study|Withdrawal by Subject|6|||
156821073|NCT00290771|566094975|FG000|Overall Study|Administrative problems|2|||
156821074|NCT00290771|566094976|FG001|Overall Study|Administrative problems|1|||
156821075|NCT00290771|566094975|FG000|Overall Study|Protocol Violation|2|||
156821076|NCT00290771|566094976|FG001|Overall Study|Protocol Violation|0|||
156821077|NCT00290771|566094975|FG000|Overall Study|Lost to Follow-up|0|||
156821078|NCT00290771|566094976|FG001|Overall Study|Lost to Follow-up|1|||
156821079|NCT03703817|566094978|FG000|Overall Study|Not meeting eligibility criteria|7|||
156821080|NCT03703817|566094979|FG001|Overall Study|Not meeting eligibility criteria|4|||
156821081|NCT05129449|566094980|FG000|Overall Study|Protocol Violation|1|||
156821082|NCT02247011|566094981|FG000|Overall Study|Poor quality of radiological results|125|||
156821083|NCT01818258|566094983|FG000|Overall Study|Death|3|||
156821084|NCT01818258|566094984|FG001|Overall Study|Death|0|||
156821085|NCT01818258|566094983|FG000|Overall Study|Withdrawal by Subject|0|||
156821086|NCT01818258|566094984|FG001|Overall Study|Withdrawal by Subject|1|||
156821087|NCT01818258|566094983|FG000|Overall Study|Lost to Follow-up|0|||
156339184|NCT02762578|564340140|FG000|Overall Study|Unclassified|6|||
156821088|NCT01818258|566094984|FG001|Overall Study|Lost to Follow-up|1|||
156821089|NCT01818258|566094983|FG000|Overall Study|Unable to Travel to Clinic|0|||
156821090|NCT01818258|566094984|FG001|Overall Study|Unable to Travel to Clinic|1|||
156821091|NCT02839720|566094987|FG000|Overall Study|Adverse Event|2|||
156821092|NCT02839720|566094987|FG000|Overall Study|Non-compliance|2|||
156821093|NCT02839720|566094987|FG000|Overall Study|Intercurrent Illness|1|||
156821094|NCT02839720|566094987|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
156821095|NCT05145322|566094988|FG000|Overall Study|Lost to Follow-up|4|||
156821096|NCT05145322|566094989|FG001|Overall Study|Lost to Follow-up|5|||
156821097|NCT06359028|566094990|FG000|Overall Study|Adverse Event|1|||
156821098|NCT06359028|566094991|FG001|Overall Study|Adverse Event|0|||
156821099|NCT06359028|566094990|FG000|Overall Study|Withdrawal by Subject|1|||
156821100|NCT06359028|566094991|FG001|Overall Study|Withdrawal by Subject|0|||
156821101|NCT02241733|566094994|FG000|Overall Study|Lost to Follow-up|9|||
156821102|NCT02241733|566094995|FG001|Overall Study|Lost to Follow-up|4|||
156821103|NCT02241733|566094994|FG000|Overall Study|Physician Decision|6|||
156821104|NCT02241733|566094995|FG001|Overall Study|Physician Decision|2|||
156821105|NCT02241733|566094994|FG000|Overall Study|Withdrawal by Subject|0|||
156821106|NCT02241733|566094995|FG001|Overall Study|Withdrawal by Subject|2|||
156821107|NCT02241733|566094994|FG000|Overall Study|Death|0|||
156821108|NCT02241733|566094995|FG001|Overall Study|Death|2|||
156821109|NCT04283994|566094996|FG000|Overall Study|Death|11|||
156821110|NCT04283994|566094997|FG001|Overall Study|Death|20|||
156821111|NCT04283994|566094998|FG002|Overall Study|Death|11|||
156465844|NCT05039021|564802730|FG000|Overall Study|Lost to Follow-up|3|||
156465845|NCT02566889|564802731|FG000|Overall Study|Withdrawal by Subject|3|||
156465846|NCT02566889|564802732|FG001|Overall Study|Withdrawal by Subject|1|||
156465847|NCT02566889|564802731|FG000|Overall Study|Adverse Event|4|||
156465848|NCT02566889|564802732|FG001|Overall Study|Adverse Event|2|||
156821112|NCT04283994|566094999|FG003|Overall Study|Death|0|||
156821113|NCT04283994|566095000|FG004|Overall Study|Death|0|||
156821114|NCT04283994|566095001|FG005|Overall Study|Death|0|||
156821115|NCT04283994|566095002|FG006|Overall Study|Death|0|||
156821116|NCT04283994|566094996|FG000|Overall Study|Withdrawal by Subject|16|||
156821117|NCT04283994|566094997|FG001|Overall Study|Withdrawal by Subject|4|||
156821118|NCT04283994|566094998|FG002|Overall Study|Withdrawal by Subject|6|||
156821119|NCT04283994|566094999|FG003|Overall Study|Withdrawal by Subject|1|||
156821120|NCT04283994|566095000|FG004|Overall Study|Withdrawal by Subject|0|||
156821121|NCT04283994|566095001|FG005|Overall Study|Withdrawal by Subject|1|||
156821122|NCT04283994|566095002|FG006|Overall Study|Withdrawal by Subject|0|||
156821123|NCT01700959|566095003|FG000|Overall Study|Adverse Event|0|||
156821124|NCT01700959|566095004|FG001|Overall Study|Adverse Event|1|||
156821125|NCT01700959|566095005|FG002|Overall Study|Adverse Event|1|||
156821126|NCT01700959|566095006|FG003|Overall Study|Adverse Event|2|||
156821127|NCT01700959|566095007|FG004|Overall Study|Adverse Event|0|||
156821128|NCT01700959|566095008|FG005|Overall Study|Adverse Event|2|||
156821129|NCT01700959|566095003|FG000|Overall Study|Withdrawal by Subject|15|||
156821130|NCT01700959|566095004|FG001|Overall Study|Withdrawal by Subject|9|||
156821131|NCT01700959|566095005|FG002|Overall Study|Withdrawal by Subject|12|||
156821132|NCT01700959|566095006|FG003|Overall Study|Withdrawal by Subject|11|||
156821133|NCT01700959|566095007|FG004|Overall Study|Withdrawal by Subject|8|||
156821134|NCT01700959|566095008|FG005|Overall Study|Withdrawal by Subject|12|||
156821135|NCT01700959|566095003|FG000|Overall Study|Ineligible|2|||
156821136|NCT01700959|566095004|FG001|Overall Study|Ineligible|1|||
156821137|NCT01700959|566095005|FG002|Overall Study|Ineligible|2|||
156821138|NCT01700959|566095006|FG003|Overall Study|Ineligible|0|||
156821139|NCT01700959|566095007|FG004|Overall Study|Ineligible|0|||
156821140|NCT01700959|566095008|FG005|Overall Study|Ineligible|1|||
156821141|NCT01700959|566095003|FG000|Overall Study|Noncompliant|9|||
156821142|NCT01700959|566095004|FG001|Overall Study|Noncompliant|9|||
156821143|NCT01700959|566095005|FG002|Overall Study|Noncompliant|17|||
156821144|NCT01700959|566095006|FG003|Overall Study|Noncompliant|18|||
156821145|NCT01700959|566095007|FG004|Overall Study|Noncompliant|15|||
156821146|NCT01700959|566095008|FG005|Overall Study|Noncompliant|9|||
156821147|NCT01700959|566095003|FG000|Overall Study|Side effects|1|||
156821148|NCT01700959|566095004|FG001|Overall Study|Side effects|4|||
156821149|NCT01700959|566095005|FG002|Overall Study|Side effects|8|||
156821150|NCT01700959|566095006|FG003|Overall Study|Side effects|4|||
156821151|NCT01700959|566095007|FG004|Overall Study|Side effects|4|||
156821152|NCT01700959|566095008|FG005|Overall Study|Side effects|1|||
156821153|NCT00830375|566095009|FG000|Overall Study|Lost to Follow-up|1|||
156821154|NCT02589665|566097143|FG000|Induction Period|Did not receive drug|0|||
156821155|NCT02589665|566097144|FG001|Induction Period|Did not receive drug|0|||
156465849|NCT02566889|564802731|FG000|Overall Study|Other|6|||
156465850|NCT02566889|564802732|FG001|Overall Study|Other|2|||
156821156|NCT02589665|566097145|FG002|Induction Period|Did not receive drug|0|||
156821157|NCT02589665|566097146|FG003|Induction Period|Did not receive drug|1|||
156821158|NCT02589665|566097147|FG004|Induction Period|Did not receive drug|0|||
156465851|NCT04974047|564802734|FG000|Overall Study|Sponsor Ended Study|20|||
156465852|NCT04974047|564802735|FG001|Overall Study|Sponsor Ended Study|22|||
156465853|NCT04974047|564802734|FG000|Overall Study|Death|8|||
156821159|NCT02589665|566097148|FG005|Induction Period|Did not receive drug|0|||
156821160|NCT02589665|566097149|FG006|Induction Period|Did not receive drug|0|||
156821161|NCT02589665|566097150|FG007|Induction Period|Did not receive drug|0|||
156821162|NCT02589665|566097151|FG008|Induction Period|Did not receive drug|0|||
156821163|NCT02589665|566097152|FG009|Induction Period|Did not receive drug|0|||
156821164|NCT02589665|566097143|FG000|Induction Period|Adverse Event|3|||
156821165|NCT02589665|566097144|FG001|Induction Period|Adverse Event|0|||
156821166|NCT02589665|566097145|FG002|Induction Period|Adverse Event|2|||
156821167|NCT02589665|566097146|FG003|Induction Period|Adverse Event|2|||
156821168|NCT02589665|566097147|FG004|Induction Period|Adverse Event|0|||
156821169|NCT02589665|566097148|FG005|Induction Period|Adverse Event|0|||
156821170|NCT02589665|566097149|FG006|Induction Period|Adverse Event|0|||
156821171|NCT02589665|566097150|FG007|Induction Period|Adverse Event|0|||
156821172|NCT02589665|566097151|FG008|Induction Period|Adverse Event|0|||
156821173|NCT02589665|566097152|FG009|Induction Period|Adverse Event|0|||
156821174|NCT02589665|566097143|FG000|Induction Period|Withdrawal by Subject|0|||
156821175|NCT02589665|566097144|FG001|Induction Period|Withdrawal by Subject|1|||
156821176|NCT02589665|566097145|FG002|Induction Period|Withdrawal by Subject|0|||
156821177|NCT02589665|566097146|FG003|Induction Period|Withdrawal by Subject|1|||
156821178|NCT02589665|566097147|FG004|Induction Period|Withdrawal by Subject|0|||
156821179|NCT02589665|566097148|FG005|Induction Period|Withdrawal by Subject|0|||
156821180|NCT02589665|566097149|FG006|Induction Period|Withdrawal by Subject|0|||
156821181|NCT02589665|566097150|FG007|Induction Period|Withdrawal by Subject|0|||
156821182|NCT02589665|566097151|FG008|Induction Period|Withdrawal by Subject|0|||
156821183|NCT02589665|566097152|FG009|Induction Period|Withdrawal by Subject|0|||
156821184|NCT02589665|566097143|FG000|Induction Period|Protocol Violation|0|||
156821185|NCT02589665|566097144|FG001|Induction Period|Protocol Violation|1|||
156821186|NCT02589665|566097145|FG002|Induction Period|Protocol Violation|0|||
156821187|NCT02589665|566097146|FG003|Induction Period|Protocol Violation|0|||
156821188|NCT02589665|566097147|FG004|Induction Period|Protocol Violation|0|||
156821189|NCT02589665|566097148|FG005|Induction Period|Protocol Violation|0|||
156821190|NCT02589665|566097149|FG006|Induction Period|Protocol Violation|0|||
156821191|NCT02589665|566097150|FG007|Induction Period|Protocol Violation|0|||
156465854|NCT04974047|564802735|FG001|Overall Study|Death|17|||
156465855|NCT04974047|564802734|FG000|Overall Study|Lost to Follow-up|2|||
156465856|NCT04974047|564802735|FG001|Overall Study|Lost to Follow-up|0|||
156821192|NCT02589665|566097151|FG008|Induction Period|Protocol Violation|0|||
156821193|NCT02589665|566097152|FG009|Induction Period|Protocol Violation|0|||
156821194|NCT02589665|566097143|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821195|NCT02589665|566097144|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821196|NCT02589665|566097145|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821197|NCT02589665|566097146|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821198|NCT02589665|566097147|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
156821199|NCT02589665|566097148|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
156821200|NCT02589665|566097149|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
156821201|NCT02589665|566097150|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821202|NCT02589665|566097151|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821203|NCT02589665|566097152|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821204|NCT02589665|566097143|FG000|Maintenance Period|Withdrawal by Subject|0|||
156821205|NCT02589665|566097144|FG001|Maintenance Period|Withdrawal by Subject|0|||
156821206|NCT02589665|566097145|FG002|Maintenance Period|Withdrawal by Subject|0|||
156821207|NCT02589665|566097146|FG003|Maintenance Period|Withdrawal by Subject|0|||
156821208|NCT02589665|566097147|FG004|Maintenance Period|Withdrawal by Subject|4|||
156821209|NCT02589665|566097148|FG005|Maintenance Period|Withdrawal by Subject|2|||
156821210|NCT02589665|566097149|FG006|Maintenance Period|Withdrawal by Subject|4|||
156821211|NCT02589665|566097150|FG007|Maintenance Period|Withdrawal by Subject|0|||
156821212|NCT02589665|566097151|FG008|Maintenance Period|Withdrawal by Subject|0|||
156821213|NCT02589665|566097152|FG009|Maintenance Period|Withdrawal by Subject|0|||
156821214|NCT02589665|566097143|FG000|Maintenance Period|Lack of Efficacy|0|||
156821215|NCT02589665|566097144|FG001|Maintenance Period|Lack of Efficacy|0|||
156821216|NCT02589665|566097145|FG002|Maintenance Period|Lack of Efficacy|0|||
156821217|NCT02589665|566097146|FG003|Maintenance Period|Lack of Efficacy|0|||
156821218|NCT02589665|566097147|FG004|Maintenance Period|Lack of Efficacy|2|||
156821219|NCT02589665|566097148|FG005|Maintenance Period|Lack of Efficacy|1|||
156821220|NCT02589665|566097149|FG006|Maintenance Period|Lack of Efficacy|0|||
156821221|NCT02589665|566097150|FG007|Maintenance Period|Lack of Efficacy|0|||
156821222|NCT02589665|566097151|FG008|Maintenance Period|Lack of Efficacy|0|||
156821223|NCT02589665|566097152|FG009|Maintenance Period|Lack of Efficacy|0|||
156465857|NCT04974047|564802734|FG000|Overall Study|Withdrawal by Subject|0|||
156465858|NCT04974047|564802735|FG001|Overall Study|Withdrawal by Subject|1|||
156821224|NCT02589665|566097143|FG000|Maintenance Period|Adverse Event|0|||
156821225|NCT02589665|566097144|FG001|Maintenance Period|Adverse Event|0|||
156821226|NCT02589665|566097145|FG002|Maintenance Period|Adverse Event|0|||
156821227|NCT02589665|566097146|FG003|Maintenance Period|Adverse Event|0|||
156821228|NCT02589665|566097147|FG004|Maintenance Period|Adverse Event|0|||
156821229|NCT02589665|566097148|FG005|Maintenance Period|Adverse Event|0|||
156821230|NCT02589665|566097149|FG006|Maintenance Period|Adverse Event|2|||
156821231|NCT02589665|566097150|FG007|Maintenance Period|Adverse Event|0|||
156821232|NCT02589665|566097151|FG008|Maintenance Period|Adverse Event|0|||
156821233|NCT02589665|566097152|FG009|Maintenance Period|Adverse Event|0|||
156465859|NCT00655499|564802736|FG000|Overall Study|not eligible|4|||
156465860|NCT03391466|564802737|FG000|Overall Study|Death|84|||
156465861|NCT03391466|564802738|FG001|Overall Study|Death|91|||
156821234|NCT02589665|566097143|FG000|Maintenance Period|Lost to Follow-up|0|||
156821235|NCT02589665|566097144|FG001|Maintenance Period|Lost to Follow-up|0|||
156821236|NCT02589665|566097145|FG002|Maintenance Period|Lost to Follow-up|0|||
156821237|NCT02589665|566097146|FG003|Maintenance Period|Lost to Follow-up|0|||
156821238|NCT02589665|566097147|FG004|Maintenance Period|Lost to Follow-up|0|||
156821239|NCT02589665|566097148|FG005|Maintenance Period|Lost to Follow-up|1|||
156821240|NCT02589665|566097149|FG006|Maintenance Period|Lost to Follow-up|0|||
156821241|NCT02589665|566097150|FG007|Maintenance Period|Lost to Follow-up|0|||
156821242|NCT02589665|566097151|FG008|Maintenance Period|Lost to Follow-up|0|||
156821243|NCT02589665|566097152|FG009|Maintenance Period|Lost to Follow-up|0|||
156821244|NCT02589665|566097143|FG000|Maintenance Period|Physician Decision|0|||
156821245|NCT02589665|566097144|FG001|Maintenance Period|Physician Decision|0|||
156821246|NCT02589665|566097145|FG002|Maintenance Period|Physician Decision|0|||
156821247|NCT02589665|566097146|FG003|Maintenance Period|Physician Decision|0|||
156821248|NCT02589665|566097147|FG004|Maintenance Period|Physician Decision|0|||
156821249|NCT02589665|566097148|FG005|Maintenance Period|Physician Decision|1|||
156821250|NCT02589665|566097149|FG006|Maintenance Period|Physician Decision|0|||
156821251|NCT02589665|566097150|FG007|Maintenance Period|Physician Decision|0|||
156821252|NCT02589665|566097151|FG008|Maintenance Period|Physician Decision|0|||
156821253|NCT02589665|566097152|FG009|Maintenance Period|Physician Decision|0|||
156821254|NCT02589665|566097143|FG000|Maintenance Period|Reason Not Collected|0|||
156821255|NCT02589665|566097144|FG001|Maintenance Period|Reason Not Collected|0|||
156821256|NCT02589665|566097145|FG002|Maintenance Period|Reason Not Collected|0|||
156821257|NCT02589665|566097146|FG003|Maintenance Period|Reason Not Collected|0|||
156821258|NCT02589665|566097147|FG004|Maintenance Period|Reason Not Collected|0|||
156821259|NCT02589665|566097148|FG005|Maintenance Period|Reason Not Collected|1|||
156821260|NCT02589665|566097149|FG006|Maintenance Period|Reason Not Collected|1|||
156821261|NCT02589665|566097150|FG007|Maintenance Period|Reason Not Collected|0|||
156821262|NCT02589665|566097151|FG008|Maintenance Period|Reason Not Collected|0|||
156821263|NCT02589665|566097152|FG009|Maintenance Period|Reason Not Collected|0|||
156821264|NCT02589665|566097143|FG000|Induction Extension Period|Adverse Event|0|||
156821265|NCT02589665|566097144|FG001|Induction Extension Period|Adverse Event|0|||
156821266|NCT02589665|566097145|FG002|Induction Extension Period|Adverse Event|0|||
156821267|NCT02589665|566097146|FG003|Induction Extension Period|Adverse Event|0|||
156821268|NCT02589665|566097147|FG004|Induction Extension Period|Adverse Event|0|||
156821269|NCT02589665|566097148|FG005|Induction Extension Period|Adverse Event|0|||
156821270|NCT02589665|566097149|FG006|Induction Extension Period|Adverse Event|0|||
156821271|NCT02589665|566097150|FG007|Induction Extension Period|Adverse Event|0|||
156821272|NCT02589665|566097151|FG008|Induction Extension Period|Adverse Event|4|||
156821273|NCT02589665|566097152|FG009|Induction Extension Period|Adverse Event|0|||
156821274|NCT02589665|566097143|FG000|Induction Extension Period|Lack of Efficacy|0|||
156821275|NCT02589665|566097144|FG001|Induction Extension Period|Lack of Efficacy|0|||
156821276|NCT02589665|566097145|FG002|Induction Extension Period|Lack of Efficacy|0|||
156821277|NCT02589665|566097146|FG003|Induction Extension Period|Lack of Efficacy|0|||
156821278|NCT02589665|566097147|FG004|Induction Extension Period|Lack of Efficacy|0|||
156821279|NCT02589665|566097148|FG005|Induction Extension Period|Lack of Efficacy|0|||
156821280|NCT02589665|566097149|FG006|Induction Extension Period|Lack of Efficacy|0|||
156821281|NCT02589665|566097150|FG007|Induction Extension Period|Lack of Efficacy|0|||
156821282|NCT02589665|566097151|FG008|Induction Extension Period|Lack of Efficacy|3|||
156821283|NCT02589665|566097152|FG009|Induction Extension Period|Lack of Efficacy|0|||
156821284|NCT02589665|566097143|FG000|Induction Extension Period|Withdrawal by Subject|0|||
156821285|NCT02589665|566097144|FG001|Induction Extension Period|Withdrawal by Subject|0|||
156821286|NCT02589665|566097145|FG002|Induction Extension Period|Withdrawal by Subject|0|||
156821287|NCT02589665|566097146|FG003|Induction Extension Period|Withdrawal by Subject|0|||
156821288|NCT02589665|566097147|FG004|Induction Extension Period|Withdrawal by Subject|0|||
156821289|NCT02589665|566097148|FG005|Induction Extension Period|Withdrawal by Subject|0|||
156821290|NCT02589665|566097149|FG006|Induction Extension Period|Withdrawal by Subject|0|||
156821291|NCT02589665|566097150|FG007|Induction Extension Period|Withdrawal by Subject|2|||
156821292|NCT02589665|566097151|FG008|Induction Extension Period|Withdrawal by Subject|3|||
156821293|NCT02589665|566097152|FG009|Induction Extension Period|Withdrawal by Subject|0|||
156821294|NCT02589665|566097143|FG000|Induction Extension Period|Physician Decision|0|||
156821295|NCT02589665|566097144|FG001|Induction Extension Period|Physician Decision|0|||
156821296|NCT02589665|566097145|FG002|Induction Extension Period|Physician Decision|0|||
156821297|NCT02589665|566097146|FG003|Induction Extension Period|Physician Decision|0|||
156821298|NCT02589665|566097147|FG004|Induction Extension Period|Physician Decision|0|||
156821299|NCT02589665|566097148|FG005|Induction Extension Period|Physician Decision|0|||
156821300|NCT02589665|566097149|FG006|Induction Extension Period|Physician Decision|0|||
156821301|NCT02589665|566097150|FG007|Induction Extension Period|Physician Decision|0|||
156821302|NCT02589665|566097151|FG008|Induction Extension Period|Physician Decision|1|||
156821303|NCT02589665|566097152|FG009|Induction Extension Period|Physician Decision|0|||
156821304|NCT02589665|566097143|FG000|Induction Extension Period|Reason Not Collected|0|||
156821305|NCT02589665|566097144|FG001|Induction Extension Period|Reason Not Collected|0|||
156821306|NCT02589665|566097145|FG002|Induction Extension Period|Reason Not Collected|0|||
156821307|NCT02589665|566097146|FG003|Induction Extension Period|Reason Not Collected|0|||
156821308|NCT02589665|566097147|FG004|Induction Extension Period|Reason Not Collected|0|||
156821309|NCT02589665|566097148|FG005|Induction Extension Period|Reason Not Collected|0|||
156821310|NCT02589665|566097149|FG006|Induction Extension Period|Reason Not Collected|0|||
156821311|NCT02589665|566097150|FG007|Induction Extension Period|Reason Not Collected|0|||
156821312|NCT02589665|566097151|FG008|Induction Extension Period|Reason Not Collected|1|||
156821313|NCT02589665|566097152|FG009|Induction Extension Period|Reason Not Collected|0|||
156821314|NCT02589665|566097143|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821315|NCT02589665|566097144|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821316|NCT02589665|566097145|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821317|NCT02589665|566097146|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821318|NCT02589665|566097147|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821319|NCT02589665|566097148|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821320|NCT02589665|566097149|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821321|NCT02589665|566097150|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821322|NCT02589665|566097151|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821323|NCT02589665|566097152|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
156821324|NCT02589665|566097143|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
156821325|NCT02589665|566097144|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
156821326|NCT02589665|566097145|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
156821327|NCT02589665|566097146|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
156821328|NCT02589665|566097147|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
156821329|NCT02589665|566097148|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
156821330|NCT02589665|566097149|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
156821331|NCT02589665|566097150|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
156821332|NCT02589665|566097151|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
156821333|NCT02589665|566097152|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
156821334|NCT02589665|566097143|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
156821335|NCT02589665|566097144|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
156821336|NCT02589665|566097145|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
156821337|NCT02589665|566097146|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
156821338|NCT02589665|566097147|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
156821339|NCT02589665|566097148|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
156821340|NCT02589665|566097149|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
156821341|NCT02589665|566097150|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
156821342|NCT02589665|566097151|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
156821343|NCT02589665|566097152|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
156821344|NCT02589665|566097143|FG000|Maintenance Extension Period|Adverse Event|0|||
156821345|NCT02589665|566097144|FG001|Maintenance Extension Period|Adverse Event|0|||
156821346|NCT02589665|566097145|FG002|Maintenance Extension Period|Adverse Event|0|||
156821347|NCT02589665|566097146|FG003|Maintenance Extension Period|Adverse Event|0|||
156821348|NCT02589665|566097147|FG004|Maintenance Extension Period|Adverse Event|0|||
156821349|NCT02589665|566097148|FG005|Maintenance Extension Period|Adverse Event|0|||
156821350|NCT02589665|566097149|FG006|Maintenance Extension Period|Adverse Event|0|||
156821351|NCT02589665|566097150|FG007|Maintenance Extension Period|Adverse Event|0|||
156821352|NCT02589665|566097151|FG008|Maintenance Extension Period|Adverse Event|0|||
156821353|NCT02589665|566097152|FG009|Maintenance Extension Period|Adverse Event|2|||
156821354|NCT02589665|566097143|FG000|Maintenance Extension Period|Non-responder|0|||
156821355|NCT02589665|566097144|FG001|Maintenance Extension Period|Non-responder|0|||
156821356|NCT02589665|566097145|FG002|Maintenance Extension Period|Non-responder|0|||
156821357|NCT02589665|566097146|FG003|Maintenance Extension Period|Non-responder|0|||
156821358|NCT02589665|566097147|FG004|Maintenance Extension Period|Non-responder|0|||
156821359|NCT02589665|566097148|FG005|Maintenance Extension Period|Non-responder|0|||
156821360|NCT02589665|566097149|FG006|Maintenance Extension Period|Non-responder|0|||
156821361|NCT02589665|566097150|FG007|Maintenance Extension Period|Non-responder|0|||
156821362|NCT02589665|566097151|FG008|Maintenance Extension Period|Non-responder|0|||
156821363|NCT02589665|566097152|FG009|Maintenance Extension Period|Non-responder|1|||
156821364|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Adverse Event|76|||
156821365|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Adverse Event|0|||
156821366|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Adverse Event|0|||
156821367|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Death|3|||
156821368|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Death|0|||
156821369|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Death|0|||
156821370|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
156821371|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
156821372|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
156821373|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Physician Decision|9|||
156541136|NCT05611671|565074485|FG002|Overall Study|Withdrawal by Subject|2|||
156821374|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Physician Decision|0|||
156821375|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Physician Decision|0|||
156821376|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
156821377|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
156821378|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
156821379|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Disease progression|45|||
156821380|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Disease progression|0|||
156821381|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Disease progression|0|||
156821382|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
156821383|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
156821384|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
156821385|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
156821386|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
156821387|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
156821388|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
156821389|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
156821390|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
156821391|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
156821392|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
156821393|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
156821394|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
156821395|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
156821396|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
156821397|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
156821398|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
156821399|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
156821400|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
156821401|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
156821402|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
156821403|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
156821404|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
156821405|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
156821406|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
156821407|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
156821408|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
156821409|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Promotor request|1|||
156821410|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Promotor request|0|||
156821411|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Promotor request|0|||
156821412|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
156821413|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
156821414|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
156821415|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
156821416|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
156821417|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
156821418|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Death|3|||
156821419|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Death|0|||
156821420|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Death|0|||
156821421|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
156821422|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
156821423|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
156821424|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
156821425|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
156821426|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
156821427|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Diseases progression|91|||
156821428|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Diseases progression|0|||
156821429|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Diseases progression|0|||
156821430|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Adverse Event|70|||
156821431|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Adverse Event|0|||
156821432|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Adverse Event|0|||
156821433|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Physician Decision|9|||
156821434|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Physician Decision|0|||
156541137|NCT05611671|565074486|FG003|Overall Study|Withdrawal by Subject|1|||
156821435|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Physician Decision|0|||
156821436|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
156821437|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
156821438|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
156821439|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
156821440|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
156821441|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
156821442|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
156821443|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
156821444|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
156821445|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Not compliant|1|||
156821446|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Not compliant|0|||
156821447|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Not compliant|0|||
156821448|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
156821449|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
156821450|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
156821451|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Adverse Event|0|||
156821452|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Adverse Event|2|||
156821453|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Adverse Event|0|||
156821454|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Death|0|||
156821455|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Death|10|||
156821456|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Death|8|||
156821457|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Physician Decision|0|||
156821458|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Physician Decision|0|||
156821459|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Physician Decision|4|||
156821460|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
156821461|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
156821462|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
156821463|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Moved to another town|0|||
156821464|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Moved to another town|1|||
156821465|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Moved to another town|0|||
156821466|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Disease progression|0|||
156821467|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Disease progression|0|||
156821468|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Disease progression|3|||
156821469|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
156821470|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
156821471|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
156821472|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
156821473|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
156821474|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
156821475|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
156821476|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
156821477|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
156821478|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
156821479|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
156821480|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
156821481|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
156821482|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
156821483|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
156821484|NCT01159171|566097158|FG000|Overall Study|Adverse Event|11|||
156821485|NCT01159171|566097158|FG000|Overall Study|Progression of Disease|28|||
156821486|NCT01159171|566097158|FG000|Overall Study|Protocol Violation|1|||
156821487|NCT01159171|566097158|FG000|Overall Study|Need for Surgery|5|||
156821488|NCT01159171|566097158|FG000|Overall Study|Medical Decision|4|||
156821489|NCT01159171|566097158|FG000|Overall Study|Death|1|||
156821490|NCT01892436|566097159|FG000|Overall Study|Withdrawal by Subject|8|||
156821491|NCT01892436|566097160|FG001|Overall Study|Withdrawal by Subject|15|||
156821492|NCT01892436|566097161|FG002|Overall Study|Withdrawal by Subject|4|||
156821493|NCT01892436|566097162|FG003|Overall Study|Withdrawal by Subject|4|||
156821494|NCT01892436|566097159|FG000|Overall Study|Death|1|||
156821495|NCT01892436|566097160|FG001|Overall Study|Death|1|||
156821496|NCT01892436|566097161|FG002|Overall Study|Death|0|||
156821497|NCT01892436|566097162|FG003|Overall Study|Death|0|||
156821498|NCT01892436|566097159|FG000|Overall Study|Physician Decision|2|||
156541138|NCT01911442|565074487|FG000|Overall Study|Adverse Event|2|||
156821499|NCT01892436|566097160|FG001|Overall Study|Physician Decision|1|||
156821500|NCT01892436|566097161|FG002|Overall Study|Physician Decision|0|||
156821501|NCT01892436|566097162|FG003|Overall Study|Physician Decision|1|||
156821502|NCT01892436|566097159|FG000|Overall Study|Pregnancy|0|||
156821503|NCT01892436|566097160|FG001|Overall Study|Pregnancy|2|||
156821504|NCT01892436|566097161|FG002|Overall Study|Pregnancy|1|||
156821505|NCT01892436|566097162|FG003|Overall Study|Pregnancy|0|||
156821506|NCT01892436|566097159|FG000|Overall Study|Technical problems|2|||
156821507|NCT01892436|566097160|FG001|Overall Study|Technical problems|1|||
156821508|NCT01892436|566097161|FG002|Overall Study|Technical problems|1|||
156821509|NCT01892436|566097162|FG003|Overall Study|Technical problems|1|||
156821510|NCT01892436|566097159|FG000|Overall Study|Lack of Efficacy|1|||
156821511|NCT01892436|566097160|FG001|Overall Study|Lack of Efficacy|2|||
156821512|NCT01892436|566097161|FG002|Overall Study|Lack of Efficacy|2|||
156821513|NCT01892436|566097162|FG003|Overall Study|Lack of Efficacy|2|||
156821514|NCT01892436|566097159|FG000|Overall Study|Lost to Follow-up|1|||
156821515|NCT01892436|566097160|FG001|Overall Study|Lost to Follow-up|1|||
156821516|NCT01892436|566097161|FG002|Overall Study|Lost to Follow-up|1|||
156821517|NCT01892436|566097162|FG003|Overall Study|Lost to Follow-up|3|||
156821518|NCT01892436|566097159|FG000|Overall Study|non-compliance with treatment|1|||
156821519|NCT01892436|566097160|FG001|Overall Study|non-compliance with treatment|0|||
156821520|NCT01892436|566097161|FG002|Overall Study|non-compliance with treatment|0|||
156821521|NCT01892436|566097162|FG003|Overall Study|non-compliance with treatment|0|||
156821522|NCT01892436|566097159|FG000|Overall Study|Adverse Event|7|||
156821523|NCT01892436|566097160|FG001|Overall Study|Adverse Event|6|||
156821524|NCT01892436|566097161|FG002|Overall Study|Adverse Event|2|||
156821525|NCT01892436|566097162|FG003|Overall Study|Adverse Event|3|||
156821526|NCT02923830|566097166|FG000|Overall Study|Physician Decision|13|||
156821527|NCT02923830|566097167|FG001|Overall Study|Physician Decision|15|||
156821528|NCT00837265|566097168|FG000|Pilot Phase|Withdrawal by Subject|0|||
156821529|NCT00837265|566097169|FG001|Pilot Phase|Withdrawal by Subject|2|||
156821530|NCT00837265|566097170|FG002|Pilot Phase|Withdrawal by Subject|3|||
156821531|NCT00837265|566097171|FG003|Pilot Phase|Withdrawal by Subject|2|||
156821532|NCT00837265|566097172|FG004|Pilot Phase|Withdrawal by Subject|0|||
156821533|NCT00837265|566097173|FG005|Pilot Phase|Withdrawal by Subject|0|||
156821534|NCT00837265|566097174|FG006|Pilot Phase|Withdrawal by Subject|0|||
156821535|NCT00837265|566097168|FG000|Pilot Phase|Decision of the investigator|2|||
156821536|NCT00837265|566097169|FG001|Pilot Phase|Decision of the investigator|1|||
156821537|NCT00837265|566097170|FG002|Pilot Phase|Decision of the investigator|0|||
156821538|NCT00837265|566097171|FG003|Pilot Phase|Decision of the investigator|0|||
156821539|NCT00837265|566097172|FG004|Pilot Phase|Decision of the investigator|0|||
156821540|NCT00837265|566097173|FG005|Pilot Phase|Decision of the investigator|0|||
156821541|NCT00837265|566097174|FG006|Pilot Phase|Decision of the investigator|0|||
156821542|NCT00837265|566097168|FG000|Pilot Phase|Adverse Event|1|||
156821543|NCT00837265|566097169|FG001|Pilot Phase|Adverse Event|0|||
156821544|NCT00837265|566097170|FG002|Pilot Phase|Adverse Event|0|||
156821545|NCT00837265|566097171|FG003|Pilot Phase|Adverse Event|0|||
156821546|NCT00837265|566097172|FG004|Pilot Phase|Adverse Event|0|||
156821547|NCT00837265|566097173|FG005|Pilot Phase|Adverse Event|0|||
156821548|NCT00837265|566097174|FG006|Pilot Phase|Adverse Event|0|||
156821549|NCT00837265|566097168|FG000|Pilot Phase|Disease progression|0|||
156821550|NCT00837265|566097169|FG001|Pilot Phase|Disease progression|0|||
156821551|NCT00837265|566097170|FG002|Pilot Phase|Disease progression|0|||
156821552|NCT00837265|566097171|FG003|Pilot Phase|Disease progression|1|||
156821553|NCT00837265|566097172|FG004|Pilot Phase|Disease progression|0|||
156821554|NCT00837265|566097173|FG005|Pilot Phase|Disease progression|0|||
156821555|NCT00837265|566097174|FG006|Pilot Phase|Disease progression|0|||
156821556|NCT00837265|566097168|FG000|Pilot Phase|Participant left the city|0|||
156821557|NCT00837265|566097169|FG001|Pilot Phase|Participant left the city|0|||
156821558|NCT00837265|566097170|FG002|Pilot Phase|Participant left the city|0|||
156821559|NCT00837265|566097171|FG003|Pilot Phase|Participant left the city|1|||
156821560|NCT00837265|566097172|FG004|Pilot Phase|Participant left the city|0|||
156821561|NCT00837265|566097173|FG005|Pilot Phase|Participant left the city|0|||
156821562|NCT00837265|566097174|FG006|Pilot Phase|Participant left the city|0|||
156821563|NCT00837265|566097168|FG000|Main Phase|Withdrawal by Subject|0|||
156821564|NCT00837265|566097169|FG001|Main Phase|Withdrawal by Subject|0|||
156821565|NCT00837265|566097170|FG002|Main Phase|Withdrawal by Subject|0|||
156821566|NCT00837265|566097171|FG003|Main Phase|Withdrawal by Subject|0|||
156821567|NCT00837265|566097172|FG004|Main Phase|Withdrawal by Subject|4|||
156821568|NCT00837265|566097173|FG005|Main Phase|Withdrawal by Subject|2|||
156339185|NCT02762578|564340141|FG001|Overall Study|Unclassified|0|||
156821569|NCT00837265|566097174|FG006|Main Phase|Withdrawal by Subject|1|||
156821570|NCT00837265|566097168|FG000|Main Phase|Decision of the investigator|0|||
156821571|NCT00837265|566097169|FG001|Main Phase|Decision of the investigator|0|||
156821572|NCT00837265|566097170|FG002|Main Phase|Decision of the investigator|0|||
156821573|NCT00837265|566097171|FG003|Main Phase|Decision of the investigator|0|||
156821574|NCT00837265|566097172|FG004|Main Phase|Decision of the investigator|0|||
156821575|NCT00837265|566097173|FG005|Main Phase|Decision of the investigator|2|||
156339186|NCT01090492|564340142|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
156821576|NCT00837265|566097174|FG006|Main Phase|Decision of the investigator|1|||
156821577|NCT00837265|566097168|FG000|Main Phase|Adverse Event|0|||
156821578|NCT00837265|566097169|FG001|Main Phase|Adverse Event|0|||
156339187|NCT01090492|564340143|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
156821579|NCT00837265|566097170|FG002|Main Phase|Adverse Event|0|||
156821580|NCT00837265|566097171|FG003|Main Phase|Adverse Event|0|||
156821581|NCT00837265|566097172|FG004|Main Phase|Adverse Event|0|||
156821582|NCT00837265|566097173|FG005|Main Phase|Adverse Event|1|||
156821583|NCT00837265|566097174|FG006|Main Phase|Adverse Event|0|||
156821584|NCT00837265|566097168|FG000|Main Phase|Death|0|||
156821585|NCT00837265|566097169|FG001|Main Phase|Death|0|||
156821586|NCT00837265|566097170|FG002|Main Phase|Death|0|||
156821587|NCT00837265|566097171|FG003|Main Phase|Death|0|||
156821588|NCT00837265|566097172|FG004|Main Phase|Death|2|||
156821589|NCT00837265|566097173|FG005|Main Phase|Death|0|||
156821590|NCT00837265|566097174|FG006|Main Phase|Death|1|||
156821591|NCT00837265|566097168|FG000|Main Phase|Lost to Follow-up|0|||
156821592|NCT00837265|566097169|FG001|Main Phase|Lost to Follow-up|0|||
156821593|NCT00837265|566097170|FG002|Main Phase|Lost to Follow-up|0|||
156821594|NCT00837265|566097171|FG003|Main Phase|Lost to Follow-up|0|||
156821595|NCT00837265|566097172|FG004|Main Phase|Lost to Follow-up|1|||
156821596|NCT00837265|566097173|FG005|Main Phase|Lost to Follow-up|0|||
156821597|NCT00837265|566097174|FG006|Main Phase|Lost to Follow-up|0|||
156821598|NCT00837265|566097168|FG000|Main Phase|Principal investigator resignation|0|||
156821599|NCT00837265|566097169|FG001|Main Phase|Principal investigator resignation|0|||
156821600|NCT00837265|566097170|FG002|Main Phase|Principal investigator resignation|0|||
156821601|NCT00837265|566097171|FG003|Main Phase|Principal investigator resignation|0|||
156821602|NCT00837265|566097172|FG004|Main Phase|Principal investigator resignation|2|||
156821603|NCT00837265|566097173|FG005|Main Phase|Principal investigator resignation|0|||
156821604|NCT00837265|566097174|FG006|Main Phase|Principal investigator resignation|0|||
156821605|NCT00837265|566097168|FG000|Main Phase|Participant's personal reason|0|||
156821606|NCT00837265|566097169|FG001|Main Phase|Participant's personal reason|0|||
156821607|NCT00837265|566097170|FG002|Main Phase|Participant's personal reason|0|||
156821608|NCT00837265|566097171|FG003|Main Phase|Participant's personal reason|0|||
156821609|NCT00837265|566097172|FG004|Main Phase|Participant's personal reason|1|||
156821610|NCT00837265|566097173|FG005|Main Phase|Participant's personal reason|0|||
156821611|NCT00837265|566097174|FG006|Main Phase|Participant's personal reason|0|||
156821612|NCT01751906|566097182|FG000|Overall Study|Lost to Follow-up|151|||
156821613|NCT01751906|566097183|FG001|Overall Study|Lost to Follow-up|68|||
156821614|NCT01751906|566097182|FG000|Overall Study|Withdrawal by Subject|22|||
156821615|NCT01751906|566097183|FG001|Overall Study|Withdrawal by Subject|18|||
156821616|NCT01751906|566097182|FG000|Overall Study|Physician Decision|5|||
156821617|NCT01751906|566097183|FG001|Overall Study|Physician Decision|2|||
156821618|NCT01751906|566097182|FG000|Overall Study|Death|84|||
156821619|NCT01751906|566097183|FG001|Overall Study|Death|43|||
156821620|NCT01751906|566097182|FG000|Overall Study|Denied on premises for follow-up by law|1|||
156821621|NCT01751906|566097183|FG001|Overall Study|Denied on premises for follow-up by law|0|||
156821622|NCT00733291|566097184|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
156821623|NCT00733291|566097185|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
156821624|NCT00733291|566097186|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
156821625|NCT00733291|566097187|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
156821626|NCT02759107|566097188|FG000|Overall Study|Adverse Event|0|||
156821627|NCT02759107|566097189|FG001|Overall Study|Adverse Event|0|||
156821628|NCT02759107|566097190|FG002|Overall Study|Adverse Event|0|||
156339188|NCT01090492|564340144|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
156541139|NCT01911442|565074488|FG001|Overall Study|Adverse Event|2|||
156541140|NCT01911442|565074489|FG002|Overall Study|Adverse Event|4|||
156541141|NCT01911442|565074487|FG000|Overall Study|Lack of Efficacy|1|||
156541142|NCT01911442|565074488|FG001|Overall Study|Lack of Efficacy|1|||
156541143|NCT01911442|565074489|FG002|Overall Study|Lack of Efficacy|1|||
156541144|NCT01911442|565074487|FG000|Overall Study|Lost to Follow-up|2|||
156541145|NCT01911442|565074488|FG001|Overall Study|Lost to Follow-up|0|||
156541146|NCT01911442|565074489|FG002|Overall Study|Lost to Follow-up|1|||
156541147|NCT01911442|565074487|FG000|Overall Study|Withdrawal by Subject|1|||
156541148|NCT01911442|565074488|FG001|Overall Study|Withdrawal by Subject|0|||
156541149|NCT01911442|565074489|FG002|Overall Study|Withdrawal by Subject|6|||
156541150|NCT01911442|565074487|FG000|Overall Study|Mother's Work Schedule|0|||
156541151|NCT01911442|565074488|FG001|Overall Study|Mother's Work Schedule|1|||
156541152|NCT01911442|565074489|FG002|Overall Study|Mother's Work Schedule|0|||
156821629|NCT02759107|566097191|FG003|Overall Study|Adverse Event|0|||
156821630|NCT02759107|566097192|FG004|Overall Study|Adverse Event|0|||
156821631|NCT02759107|566097193|FG005|Overall Study|Adverse Event|0|||
156821632|NCT02759107|566097194|FG006|Overall Study|Adverse Event|0|||
156821633|NCT02759107|566097195|FG007|Overall Study|Adverse Event|0|||
156821634|NCT02759107|566097196|FG008|Overall Study|Adverse Event|0|||
156339189|NCT01090492|564340145|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
156821635|NCT02759107|566097197|FG009|Overall Study|Adverse Event|0|||
156821636|NCT02759107|566097198|FG010|Overall Study|Adverse Event|0|||
156821637|NCT02759107|566097199|FG011|Overall Study|Adverse Event|0|||
156821638|NCT02759107|566097200|FG012|Overall Study|Adverse Event|2|||
156821639|NCT02759107|566097201|FG013|Overall Study|Adverse Event|0|||
156339190|NCT01090492|564340146|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
156541153|NCT00253643|565074490|FG000|Overall Study|Withdrawal by Subject|0|||
156541154|NCT00253643|565074491|FG001|Overall Study|Withdrawal by Subject|0|||
156541155|NCT00253643|565074492|FG002|Overall Study|Withdrawal by Subject|1|||
156541156|NCT00253643|565074493|FG003|Overall Study|Withdrawal by Subject|1|||
156821640|NCT02759107|566097202|FG014|Overall Study|Adverse Event|0|||
156821641|NCT02759107|566097203|FG015|Overall Study|Adverse Event|1|||
156821642|NCT02759107|566097204|FG016|Overall Study|Adverse Event|0|||
156821643|NCT02759107|566097205|FG017|Overall Study|Adverse Event|2|||
156821644|NCT02759107|566097188|FG000|Overall Study|Scheduling Conflict|0|||
156821645|NCT02759107|566097189|FG001|Overall Study|Scheduling Conflict|0|||
156821646|NCT02759107|566097190|FG002|Overall Study|Scheduling Conflict|0|||
156821647|NCT02759107|566097191|FG003|Overall Study|Scheduling Conflict|0|||
156821648|NCT02759107|566097192|FG004|Overall Study|Scheduling Conflict|0|||
156821649|NCT02759107|566097193|FG005|Overall Study|Scheduling Conflict|0|||
156821650|NCT02759107|566097194|FG006|Overall Study|Scheduling Conflict|0|||
156821651|NCT02759107|566097195|FG007|Overall Study|Scheduling Conflict|0|||
156821652|NCT02759107|566097196|FG008|Overall Study|Scheduling Conflict|0|||
156821653|NCT02759107|566097197|FG009|Overall Study|Scheduling Conflict|1|||
156821654|NCT02759107|566097198|FG010|Overall Study|Scheduling Conflict|0|||
156821655|NCT02759107|566097199|FG011|Overall Study|Scheduling Conflict|0|||
156821656|NCT02759107|566097200|FG012|Overall Study|Scheduling Conflict|0|||
156821657|NCT02759107|566097201|FG013|Overall Study|Scheduling Conflict|0|||
156821658|NCT02759107|566097202|FG014|Overall Study|Scheduling Conflict|0|||
156821659|NCT02759107|566097203|FG015|Overall Study|Scheduling Conflict|0|||
156821660|NCT02759107|566097204|FG016|Overall Study|Scheduling Conflict|0|||
156821661|NCT02759107|566097205|FG017|Overall Study|Scheduling Conflict|0|||
156821662|NCT00420004|566097213|FG000|Overall Study|Adverse Event|4|||
156821663|NCT00420004|566097214|FG001|Overall Study|Adverse Event|1|||
156821664|NCT00420004|566097215|FG002|Overall Study|Adverse Event|1|||
156821665|NCT00420004|566097213|FG000|Overall Study|Lack of Efficacy|5|||
156821666|NCT00420004|566097214|FG001|Overall Study|Lack of Efficacy|4|||
156821667|NCT00420004|566097215|FG002|Overall Study|Lack of Efficacy|1|||
156821668|NCT00420004|566097213|FG000|Overall Study|Lost to Follow-up|31|||
156821669|NCT00420004|566097214|FG001|Overall Study|Lost to Follow-up|12|||
156821670|NCT00420004|566097215|FG002|Overall Study|Lost to Follow-up|10|||
156821671|NCT00420004|566097213|FG000|Overall Study|Entry Criteria Not Met|0|||
156821672|NCT00420004|566097214|FG001|Overall Study|Entry Criteria Not Met|1|||
156821673|NCT00420004|566097215|FG002|Overall Study|Entry Criteria Not Met|0|||
156821674|NCT00420004|566097213|FG000|Overall Study|Physician Decision|14|||
156821675|NCT00420004|566097214|FG001|Overall Study|Physician Decision|4|||
156821676|NCT00420004|566097215|FG002|Overall Study|Physician Decision|2|||
156821677|NCT00420004|566097213|FG000|Overall Study|Protocol Violation|5|||
156821678|NCT00420004|566097214|FG001|Overall Study|Protocol Violation|4|||
156821679|NCT00420004|566097215|FG002|Overall Study|Protocol Violation|3|||
156821680|NCT00420004|566097213|FG000|Overall Study|Withdrawal by Subject|67|||
156821681|NCT00420004|566097214|FG001|Overall Study|Withdrawal by Subject|42|||
156821682|NCT00420004|566097215|FG002|Overall Study|Withdrawal by Subject|14|||
156821683|NCT00420004|566097213|FG000|Overall Study|Sponsor Decision|3|||
156821684|NCT00420004|566097214|FG001|Overall Study|Sponsor Decision|3|||
156821685|NCT00420004|566097215|FG002|Overall Study|Sponsor Decision|1|||
156821686|NCT00470093|566097217|FG000|Overall Study|Adverse Event|2|||
156821687|NCT00664560|566097218|FG000|Overall Study|Adverse Event|19|||
156821688|NCT00664560|566097219|FG001|Overall Study|Adverse Event|16|||
156821689|NCT00664560|566097220|FG002|Overall Study|Adverse Event|7|||
156821690|NCT00664560|566097218|FG000|Overall Study|Withdrawal by Subject|9|||
156821691|NCT00664560|566097219|FG001|Overall Study|Withdrawal by Subject|13|||
156821692|NCT00664560|566097220|FG002|Overall Study|Withdrawal by Subject|7|||
156821693|NCT00664560|566097218|FG000|Overall Study|Lost to Follow-up|0|||
156821694|NCT00664560|566097219|FG001|Overall Study|Lost to Follow-up|2|||
156821695|NCT00664560|566097220|FG002|Overall Study|Lost to Follow-up|0|||
156821696|NCT00664560|566097218|FG000|Overall Study|Other|11|||
156821697|NCT00664560|566097219|FG001|Overall Study|Other|4|||
156821698|NCT00664560|566097220|FG002|Overall Study|Other|5|||
156339191|NCT01090492|564340147|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
156339192|NCT01090492|564340148|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
156339193|NCT01090492|564340149|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
156339194|NCT01090492|564340142|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156821699|NCT00473668|566097223|FG000|Overall Study|Withdrawal by Subject|0|||
156821700|NCT00473668|566097224|FG001|Overall Study|Withdrawal by Subject|2|||
156821701|NCT00473668|566097225|FG002|Overall Study|Withdrawal by Subject|0|||
156821702|NCT00473668|566097223|FG000|Overall Study|Migrated/moved from study area|3|||
156821703|NCT00473668|566097224|FG001|Overall Study|Migrated/moved from study area|2|||
156339195|NCT01090492|564340143|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
156821704|NCT00473668|566097225|FG002|Overall Study|Migrated/moved from study area|0|||
156821705|NCT00473668|566097223|FG000|Overall Study|Lost to Follow-up|0|||
156821706|NCT00473668|566097224|FG001|Overall Study|Lost to Follow-up|4|||
156821707|NCT00473668|566097225|FG002|Overall Study|Lost to Follow-up|6|||
156821708|NCT00473668|566097223|FG000|Overall Study|Other|2|||
156821709|NCT00473668|566097224|FG001|Overall Study|Other|3|||
156821710|NCT00473668|566097225|FG002|Overall Study|Other|4|||
156821711|NCT02039219|566097226|FG000|Treatment|Withdrawal by Subject|1|||
156821712|NCT02039219|566097227|FG001|Treatment|Withdrawal by Subject|0|||
156821713|NCT02039219|566097226|FG000|Treatment|Adverse Event|0|||
156821714|NCT02039219|566097227|FG001|Treatment|Adverse Event|1|||
156821715|NCT02039219|566097226|FG000|Treatment|Physician Decision|1|||
156821716|NCT02039219|566097227|FG001|Treatment|Physician Decision|0|||
156821717|NCT02039219|566097226|FG000|Treatment|Lost to Follow-up|0|||
156821718|NCT02039219|566097227|FG001|Treatment|Lost to Follow-up|1|||
156821719|NCT02039219|566097226|FG000|Treatment|Protocol Violation|1|||
156821720|NCT02039219|566097227|FG001|Treatment|Protocol Violation|0|||
156821721|NCT02039219|566097226|FG000|Treatment|Death|1|||
156821722|NCT02039219|566097227|FG001|Treatment|Death|0|||
156821723|NCT02039219|566097226|FG000|Follow up|Adverse Event|0|||
156821724|NCT02039219|566097227|FG001|Follow up|Adverse Event|1|||
156821725|NCT02226562|566097228|FG000|Overall Study|Lost to Follow-up|0|||
156821726|NCT02226562|566097229|FG001|Overall Study|Lost to Follow-up|1|||
156821727|NCT00006164|566097235|FG000|Overall Study|Withdrew or lost to follow-up|70|||
156821728|NCT00006164|566097236|FG001|Overall Study|Withdrew or lost to follow-up|81|||
156821729|NCT02750345|566097237|FG000|Intervention 1|Adverse Event|0|||
156821730|NCT02750345|566097238|FG001|Intervention 1|Adverse Event|0|||
156821731|NCT02750345|566097239|FG002|Intervention 1|Adverse Event|0|||
156821732|NCT02750345|566097240|FG003|Intervention 1|Adverse Event|0|||
156821733|NCT02750345|566097241|FG004|Intervention 1|Adverse Event|1|||
156821734|NCT02750345|566097242|FG005|Intervention 1|Adverse Event|0|||
156821735|NCT00223808|566097243|FG000|Overall Study|<5 hrs therapy before discharge|3|||
156821736|NCT00223808|566097244|FG001|Overall Study|<5 hrs therapy before discharge|5|||
156821737|NCT00223808|566097245|FG002|Overall Study|<5 hrs therapy before discharge|5|||
156821738|NCT00191724|566097248|FG000|Overall Study|Adverse Event|0|||
156821739|NCT00191724|566097249|FG001|Overall Study|Adverse Event|0|||
156821740|NCT00191724|566097250|FG002|Overall Study|Adverse Event|1|||
156821741|NCT00191724|566097251|FG003|Overall Study|Adverse Event|0|||
156821742|NCT00191724|566097252|FG004|Overall Study|Adverse Event|0|||
156821743|NCT00191724|566097248|FG000|Overall Study|Lost to Follow-up|1|||
156821744|NCT00191724|566097249|FG001|Overall Study|Lost to Follow-up|1|||
156821745|NCT00191724|566097250|FG002|Overall Study|Lost to Follow-up|0|||
156821746|NCT00191724|566097251|FG003|Overall Study|Lost to Follow-up|2|||
156821747|NCT00191724|566097252|FG004|Overall Study|Lost to Follow-up|3|||
156821748|NCT00191724|566097248|FG000|Overall Study|Withdrawal by Subject|0|||
156821749|NCT00191724|566097249|FG001|Overall Study|Withdrawal by Subject|0|||
156821750|NCT00191724|566097250|FG002|Overall Study|Withdrawal by Subject|0|||
156821751|NCT00191724|566097251|FG003|Overall Study|Withdrawal by Subject|1|||
156821752|NCT00191724|566097252|FG004|Overall Study|Withdrawal by Subject|0|||
156821753|NCT00608023|566097253|FG000|Overall Study|Withdrawal by Subject|8|||
156821754|NCT00608023|566097254|FG001|Overall Study|Withdrawal by Subject|10|||
156821755|NCT00608023|566097255|FG002|Overall Study|Withdrawal by Subject|7|||
156821756|NCT00608023|566097253|FG000|Overall Study|Adverse Event|1|||
156821757|NCT00608023|566097254|FG001|Overall Study|Adverse Event|4|||
156821758|NCT00608023|566097255|FG002|Overall Study|Adverse Event|5|||
156821759|NCT00608023|566097253|FG000|Overall Study|Lost to Follow-up|2|||
156821760|NCT00608023|566097254|FG001|Overall Study|Lost to Follow-up|2|||
156821761|NCT00608023|566097255|FG002|Overall Study|Lost to Follow-up|1|||
156821762|NCT00608023|566097253|FG000|Overall Study|Protocol Violation|1|||
156821763|NCT00608023|566097254|FG001|Overall Study|Protocol Violation|3|||
156821764|NCT00608023|566097255|FG002|Overall Study|Protocol Violation|1|||
156821765|NCT00608023|566097253|FG000|Overall Study|Unknown reason|0|||
156821766|NCT00608023|566097254|FG001|Overall Study|Unknown reason|3|||
156821767|NCT00608023|566097255|FG002|Overall Study|Unknown reason|0|||
156821768|NCT01231321|566097258|FG000|Overall Study|Adverse Event|3|||
156821769|NCT01231321|566097258|FG000|Overall Study|Lack of Efficacy|2|||
156821770|NCT00489736|566097259|FG000|Overall Study|Lack of Efficacy|53|||
156821771|NCT00489736|566097260|FG001|Overall Study|Lack of Efficacy|14|||
156821772|NCT00489736|566097259|FG000|Overall Study|Adverse Event|32|||
156821773|NCT00489736|566097260|FG001|Overall Study|Adverse Event|45|||
156821774|NCT00489736|566097259|FG000|Overall Study|Poor compliance|6|||
156821775|NCT00489736|566097260|FG001|Overall Study|Poor compliance|2|||
156821776|NCT00489736|566097259|FG000|Overall Study|Not coded/ Not pre-specified|5|||
156821777|NCT00489736|566097260|FG001|Overall Study|Not coded/ Not pre-specified|8|||
156821778|NCT04021524|566097261|FG000|Overall Study|Change in surgical intervention|0|||
156821779|NCT04021524|566097262|FG001|Overall Study|Change in surgical intervention|1|||
156821780|NCT06422364|566097263|FG000|Overall Study|Withdrawn due to study closure|0|||
156821781|NCT06422364|566097264|FG001|Overall Study|Withdrawn due to study closure|2|||
156339196|NCT01090492|564340144|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156339197|NCT01090492|564340145|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156821782|NCT05260073|566097266|FG000|Overall Study|Physician Decision|1|||
156821783|NCT05260073|566097266|FG000|Overall Study|Withdrawal by Subject|6|||
156821784|NCT05260073|566097266|FG000|Overall Study|Lost to Follow-up|14|||
156821785|NCT03458910|566097267|FG000|Overall Study|Withdrawal by Subject|7|||
156821786|NCT03458910|566097268|FG001|Overall Study|Withdrawal by Subject|8|||
156821787|NCT03458910|566097269|FG002|Overall Study|Withdrawal by Subject|6|||
156821788|NCT03458910|566097270|FG003|Overall Study|Withdrawal by Subject|4|||
156821789|NCT03458910|566097267|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
156821790|NCT03458910|566097268|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
156821791|NCT03458910|566097269|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
156821792|NCT03458910|566097270|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
156821793|NCT05275010|566097271|FG000|Overall Study|Reason Not Specified|4|||
156821794|NCT05275010|566097272|FG001|Overall Study|Reason Not Specified|1|||
156821795|NCT05275010|566097271|FG000|Overall Study|Withdrawal by Subject|1|||
156821796|NCT05275010|566097272|FG001|Overall Study|Withdrawal by Subject|0|||
156821797|NCT05275010|566097271|FG000|Overall Study|Lost to Follow-up|0|||
156821798|NCT05275010|566097272|FG001|Overall Study|Lost to Follow-up|1|||
156821799|NCT00244933|566097291|FG000|Overall Study|Not response evaluable|2|||
156821800|NCT00656058|566097297|FG000|Overall Study|Withdrawal by Subject|2|||
156821801|NCT00656058|566097297|FG000|Overall Study|Withdrawal by Subject|4|||
156821802|NCT00616018|566097300|FG000|Overall Study|Protocol Violation|3|||
156821803|NCT03718884|566097301|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
156821804|NCT03718884|566097302|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
156821805|NCT03718884|566097301|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
156821806|NCT03718884|566097302|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
156821807|NCT02099344|566097303|FG000|Overall Study|Physician Decision|1|||
156821808|NCT02099344|566097304|FG001|Overall Study|Physician Decision|0|||
156821809|NCT00404755|566097305|FG000|Phase I (Bupropion)|Adverse Event|3|||
156821810|NCT00404755|566097305|FG000|Phase I (Bupropion)|Other|1|||
156821811|NCT00404755|566097305|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
156821812|NCT04700540|566097306|FG000|Overall Study|Withdrawal by Subject|12|||
156821813|NCT04700540|566097307|FG001|Overall Study|Withdrawal by Subject|8|||
156821814|NCT04700540|566097306|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
156821815|NCT04700540|566097307|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
156821816|NCT03194568|566097308|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
156821817|NCT05248997|566097311|FG000|Overall Study|Lost to Follow-up|1|||
156821818|NCT05248997|566097312|FG001|Overall Study|Lost to Follow-up|1|||
156821819|NCT05248997|566097311|FG000|Overall Study|Randomized but not treated|32|||
156821820|NCT05248997|566097312|FG001|Overall Study|Randomized but not treated|25|||
156821821|NCT03515551|566097313|FG000|Overall Study|Death|4|||
156821822|NCT03515551|566097314|FG001|Overall Study|Death|1|||
156821823|NCT03515551|566097315|FG002|Overall Study|Death|2|||
156821824|NCT03515551|566097316|FG003|Overall Study|Death|2|||
156821825|NCT03515551|566097317|FG004|Overall Study|Death|2|||
156821826|NCT03515551|566097318|FG005|Overall Study|Death|4|||
156821827|NCT03515551|566097319|FG006|Overall Study|Death|1|||
156821828|NCT03515551|566097313|FG000|Overall Study|Lost to Follow-up|0|||
156821829|NCT03515551|566097314|FG001|Overall Study|Lost to Follow-up|0|||
156821830|NCT03515551|566097315|FG002|Overall Study|Lost to Follow-up|1|||
156821831|NCT03515551|566097316|FG003|Overall Study|Lost to Follow-up|0|||
156821832|NCT03515551|566097317|FG004|Overall Study|Lost to Follow-up|0|||
156821833|NCT03515551|566097318|FG005|Overall Study|Lost to Follow-up|0|||
156821834|NCT03515551|566097319|FG006|Overall Study|Lost to Follow-up|0|||
156821835|NCT03515551|566097313|FG000|Overall Study|Withdrawal by Subject|0|||
156821836|NCT03515551|566097314|FG001|Overall Study|Withdrawal by Subject|1|||
156821837|NCT03515551|566097315|FG002|Overall Study|Withdrawal by Subject|0|||
156821838|NCT03515551|566097316|FG003|Overall Study|Withdrawal by Subject|0|||
156821839|NCT03515551|566097317|FG004|Overall Study|Withdrawal by Subject|0|||
156821840|NCT03515551|566097318|FG005|Overall Study|Withdrawal by Subject|0|||
156821841|NCT03515551|566097319|FG006|Overall Study|Withdrawal by Subject|1|||
156821842|NCT03515551|566097313|FG000|Overall Study|Study ended by sponsor|0|||
156821843|NCT03515551|566097314|FG001|Overall Study|Study ended by sponsor|0|||
156821844|NCT03515551|566097315|FG002|Overall Study|Study ended by sponsor|2|||
156821845|NCT03515551|566097316|FG003|Overall Study|Study ended by sponsor|1|||
156821846|NCT03515551|566097317|FG004|Overall Study|Study ended by sponsor|3|||
156821847|NCT03515551|566097318|FG005|Overall Study|Study ended by sponsor|0|||
156821848|NCT03515551|566097319|FG006|Overall Study|Study ended by sponsor|3|||
156821849|NCT03515551|566097313|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156821850|NCT03515551|566097314|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
156821851|NCT03515551|566097315|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156821852|NCT03515551|566097316|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156821853|NCT03515551|566097317|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156465862|NCT03391466|564802737|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
156465863|NCT03391466|564802738|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
156465864|NCT03391466|564802737|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
156465865|NCT03391466|564802738|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
156465866|NCT03391466|564802737|FG000|Overall Study|Lost to Follow-up|9|||
156821854|NCT03515551|566097318|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156821855|NCT03515551|566097319|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156465867|NCT03391466|564802738|FG001|Overall Study|Lost to Follow-up|5|||
156821856|NCT00920387|566097320|FG000|Stage 1|Adverse Event|1|||
156821857|NCT00920387|566097321|FG001|Stage 1|Adverse Event|0|||
156821858|NCT00920387|566097322|FG002|Stage 1|Adverse Event|0|||
156821859|NCT04470908|566097323|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
156821860|NCT02602275|566097334|FG000|Day 1|Physician Decision|0|||
156821861|NCT02602275|566097335|FG001|Day 1|Physician Decision|1|||
156821862|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
156821863|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
156821864|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
156821865|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
156821866|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
156821867|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
156821868|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
156821869|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
156821870|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
156821871|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
156821872|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
156821873|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
156821874|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
156821875|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
156821876|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
156821877|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
156821878|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
156821879|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
156821880|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
156821881|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
156821882|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
156821883|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
156821884|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
156821885|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
156821886|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
156821887|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
156821888|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
156821889|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
156821890|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
156821891|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
156821892|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
156821893|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
156821894|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
156821895|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
156821896|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
156821897|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
156821898|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
156821899|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
156821900|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
156821901|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
156821902|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
156821903|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
156821904|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
156821905|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
156821906|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Death|1|||
156821907|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Death|1|||
156821908|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Death|3|||
156821909|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Death|2|||
156821910|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
156821911|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
156821912|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
156821913|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
156821914|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
156821915|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
156465868|NCT03391466|564802737|FG000|Overall Study|Reason Not Specified|2|||
156465869|NCT03391466|564802738|FG001|Overall Study|Reason Not Specified|2|||
156465870|NCT03391466|564802737|FG000|Overall Study|Investigator Decision|0|||
156821916|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
156821917|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
156821918|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
156465871|NCT03391466|564802738|FG001|Overall Study|Investigator Decision|1|||
156465872|NCT03140670|564802739|FG000|Overall Study|Withdrawal by Subject|2|||
156465873|NCT03140670|564802739|FG000|Overall Study|Lost to Follow-up|1|||
156465874|NCT03140670|564802739|FG000|Overall Study|Physician Decision|1|||
156465875|NCT00220805|564802740|FG000|Overall Study|Adverse Event|1|||
156465876|NCT00220805|564802741|FG001|Overall Study|Adverse Event|3|||
156465877|NCT00220805|564802740|FG000|Overall Study|Withdrawal by Subject|3|||
156465878|NCT00220805|564802741|FG001|Overall Study|Withdrawal by Subject|0|||
156465879|NCT00220805|564802740|FG000|Overall Study|Lack of Efficacy|1|||
156821919|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
156821920|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
156821921|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
156821922|NCT04113018|566097344|FG000|Overall Study|Death|2|||
156821923|NCT04113018|566097344|FG000|Overall Study|Lost to Follow-up|1|||
156821924|NCT04113018|566097344|FG000|Overall Study|Still On Study (on study treatment)|24|||
156821925|NCT04113018|566097344|FG000|Overall Study|Still On Study (in follow up)|12|||
156821926|NCT03802630|566097345|FG000|Overall Study|Study terminated by sponsor|130|||
156821927|NCT03802630|566097346|FG001|Overall Study|Study terminated by sponsor|134|||
156821928|NCT03802630|566097345|FG000|Overall Study|Subject decision|16|||
156821929|NCT03802630|566097346|FG001|Overall Study|Subject decision|9|||
156821930|NCT03802630|566097345|FG000|Overall Study|Adverse Event|3|||
156821931|NCT03802630|566097346|FG001|Overall Study|Adverse Event|1|||
156821932|NCT03802630|566097345|FG000|Overall Study|Lost to Follow-up|2|||
156821933|NCT03802630|566097346|FG001|Overall Study|Lost to Follow-up|2|||
156821934|NCT03802630|566097345|FG000|Overall Study|Physician Decision|2|||
156821935|NCT03802630|566097346|FG001|Overall Study|Physician Decision|0|||
156821936|NCT03802630|566097345|FG000|Overall Study|Death|0|||
156821937|NCT03802630|566097346|FG001|Overall Study|Death|2|||
156821938|NCT00157196|566097347|FG000|Overall Study|Ongoing at data cut-off|9|||
156821939|NCT05005013|566097348|FG000|Overall Study|Withdrawal by Subject|5|||
156821940|NCT05005013|566097349|FG001|Overall Study|Withdrawal by Subject|1|||
156821941|NCT05005013|566097348|FG000|Overall Study|Lost to Follow-up|3|||
156821942|NCT05005013|566097349|FG001|Overall Study|Lost to Follow-up|1|||
156821943|NCT05005013|566097348|FG000|Overall Study|Ineligibility|1|||
156821944|NCT05005013|566097349|FG001|Overall Study|Ineligibility|1|||
156821945|NCT06099223|566097350|FG000|Overall Study|Preoperative surveys missed|0|||
156821946|NCT06099223|566097351|FG001|Overall Study|Preoperative surveys missed|1|||
156821947|NCT01252186|566097352|FG000|Overall Study|Adverse Event|9|||
156821948|NCT01252186|566097353|FG001|Overall Study|Adverse Event|6|||
156821949|NCT01252186|566097354|FG002|Overall Study|Adverse Event|8|||
156821950|NCT01252186|566097352|FG000|Overall Study|Withdrawal by Subject|2|||
156821951|NCT01252186|566097353|FG001|Overall Study|Withdrawal by Subject|5|||
156821952|NCT01252186|566097354|FG002|Overall Study|Withdrawal by Subject|2|||
156821953|NCT01252186|566097352|FG000|Overall Study|Physician Decision|0|||
156821954|NCT01252186|566097353|FG001|Overall Study|Physician Decision|0|||
156821955|NCT01252186|566097354|FG002|Overall Study|Physician Decision|1|||
156821956|NCT01252186|566097352|FG000|Overall Study|Non-compliance|0|||
156821957|NCT01252186|566097353|FG001|Overall Study|Non-compliance|3|||
156821958|NCT01252186|566097354|FG002|Overall Study|Non-compliance|4|||
156821959|NCT01252186|566097352|FG000|Overall Study|Protocol Violation|0|||
156821960|NCT01252186|566097353|FG001|Overall Study|Protocol Violation|0|||
156821961|NCT01252186|566097354|FG002|Overall Study|Protocol Violation|1|||
156821962|NCT01252186|566097352|FG000|Overall Study|Pregnancy|2|||
156821963|NCT01252186|566097353|FG001|Overall Study|Pregnancy|2|||
156821964|NCT01252186|566097354|FG002|Overall Study|Pregnancy|0|||
156821965|NCT01252186|566097352|FG000|Overall Study|Sponsor Request|2|||
156821966|NCT01252186|566097353|FG001|Overall Study|Sponsor Request|1|||
156821967|NCT01252186|566097354|FG002|Overall Study|Sponsor Request|0|||
156821968|NCT01252186|566097352|FG000|Overall Study|Lost to Follow-up|10|||
156821969|NCT01252186|566097353|FG001|Overall Study|Lost to Follow-up|10|||
156339198|NCT01090492|564340146|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156465880|NCT00220805|564802741|FG001|Overall Study|Lack of Efficacy|0|||
156465881|NCT00220805|564802740|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
156465882|NCT00220805|564802741|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
156821970|NCT01252186|566097354|FG002|Overall Study|Lost to Follow-up|11|||
156821971|NCT01252186|566097352|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
156821972|NCT01252186|566097353|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
156821973|NCT01252186|566097354|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
156465883|NCT02325466|564802742|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
156465884|NCT02325466|564802743|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
156465885|NCT02325466|564802744|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
156465886|NCT02325466|564802742|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
156821974|NCT01221623|566097360|FG000|Overall Study|Withdrawal by Subject|19|||
156821975|NCT01221623|566097361|FG001|Overall Study|Withdrawal by Subject|8|||
156465887|NCT02325466|564802743|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
156541157|NCT00253643|565074490|FG000|Overall Study|Non-Compliance|0|||
156821976|NCT01221623|566097360|FG000|Overall Study|Lost to Follow-up|7|||
156821977|NCT01221623|566097361|FG001|Overall Study|Lost to Follow-up|1|||
156821978|NCT01221623|566097360|FG000|Overall Study|Adverse Event|6|||
156821979|NCT01221623|566097361|FG001|Overall Study|Adverse Event|3|||
156821980|NCT01221623|566097360|FG000|Overall Study|Death|1|||
156821981|NCT01221623|566097361|FG001|Overall Study|Death|0|||
156821982|NCT01221623|566097360|FG000|Overall Study|Other|5|||
156821983|NCT01221623|566097361|FG001|Overall Study|Other|2|||
156821984|NCT00661726|566097362|FG000|Overall Study|Adverse Event|1|||
156821985|NCT02147197|566097363|FG000|Overall Study|Adverse Event|1|||
156821986|NCT02147197|566097364|FG001|Overall Study|Adverse Event|0|||
156821987|NCT02147197|566097365|FG002|Overall Study|Adverse Event|0|||
156821988|NCT02147197|566097363|FG000|Overall Study|Withdrawal of Consent|4|||
156821989|NCT02147197|566097364|FG001|Overall Study|Withdrawal of Consent|3|||
156821990|NCT02147197|566097365|FG002|Overall Study|Withdrawal of Consent|2|||
156821991|NCT02147197|566097363|FG000|Overall Study|Lost to Follow-up|2|||
156821992|NCT02147197|566097364|FG001|Overall Study|Lost to Follow-up|3|||
156821993|NCT02147197|566097365|FG002|Overall Study|Lost to Follow-up|1|||
156821994|NCT02147197|566097363|FG000|Overall Study|Protocol Violation|1|||
156821995|NCT02147197|566097364|FG001|Overall Study|Protocol Violation|0|||
156821996|NCT02147197|566097365|FG002|Overall Study|Protocol Violation|3|||
156821997|NCT02147197|566097363|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156821998|NCT02147197|566097364|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156821999|NCT02147197|566097365|FG002|Overall Study|Other Miscellaneous Reasons|3|||
156822000|NCT03315793|566097366|FG000|Overall Study|Adverse Event|4|||
156822001|NCT03315793|566097367|FG001|Overall Study|Adverse Event|2|||
156822002|NCT03315793|566097366|FG000|Overall Study|Protocol Deviation|1|||
156822003|NCT03315793|566097367|FG001|Overall Study|Protocol Deviation|0|||
156822004|NCT03315793|566097366|FG000|Overall Study|Difficult for regular visit|0|||
156822005|NCT03315793|566097367|FG001|Overall Study|Difficult for regular visit|1|||
156822006|NCT01331837|566097368|FG000|Overall Study|Death|30|||
156822007|NCT01331837|566097369|FG001|Overall Study|Death|34|||
156822008|NCT01331837|566097368|FG000|Overall Study|Lost to Follow-up|3|||
156822009|NCT01331837|566097369|FG001|Overall Study|Lost to Follow-up|1|||
156822010|NCT01331837|566097368|FG000|Overall Study|Info not recorded|10|||
156822011|NCT01331837|566097369|FG001|Overall Study|Info not recorded|16|||
156822012|NCT01331837|566097368|FG000|Overall Study|Withdrawal by Subject|13|||
156822013|NCT01331837|566097369|FG001|Overall Study|Withdrawal by Subject|16|||
156822014|NCT01740089|566098780|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
156822015|NCT01740089|566098781|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
156822016|NCT01740089|566098782|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
156822017|NCT01740089|566098780|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
156822018|NCT01740089|566098781|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
156822019|NCT01740089|566098782|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
156822020|NCT01740089|566098780|FG000|After 12 Weeks|Lack of Efficacy|3|||
156822021|NCT01740089|566098781|FG001|After 12 Weeks|Lack of Efficacy|1|||
156822022|NCT01740089|566098782|FG002|After 12 Weeks|Lack of Efficacy|4|||
156465888|NCT02325466|564802744|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
156465889|NCT02325466|564802742|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
156465890|NCT02325466|564802743|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
156822023|NCT01740089|566098780|FG000|After 12 Weeks|Adverse Event|2|||
156822024|NCT01740089|566098781|FG001|After 12 Weeks|Adverse Event|0|||
156822025|NCT01740089|566098782|FG002|After 12 Weeks|Adverse Event|5|||
156822026|NCT01740089|566098780|FG000|After 12 Weeks|Protocol Violation|1|||
156822027|NCT01740089|566098781|FG001|After 12 Weeks|Protocol Violation|1|||
156822028|NCT01740089|566098782|FG002|After 12 Weeks|Protocol Violation|1|||
156339199|NCT01090492|564340147|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156465891|NCT02325466|564802744|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
156339200|NCT01090492|564340148|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156822029|NCT01740089|566098780|FG000|After 12 Weeks|Withdrawal by Subject|1|||
156465892|NCT02325466|564802742|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
156822030|NCT01740089|566098781|FG001|After 12 Weeks|Withdrawal by Subject|1|||
156822031|NCT01740089|566098782|FG002|After 12 Weeks|Withdrawal by Subject|1|||
156822032|NCT02526524|566098789|FG000|Overall Study|Withdrawal by Subject|3|||
156822033|NCT02526524|566098790|FG001|Overall Study|Withdrawal by Subject|3|||
156822034|NCT02526524|566098791|FG002|Overall Study|Withdrawal by Subject|6|||
156822035|NCT02526524|566098792|FG003|Overall Study|Withdrawal by Subject|1|||
156822036|NCT02526524|566098793|FG004|Overall Study|Withdrawal by Subject|9|||
156822037|NCT02526524|566098794|FG005|Overall Study|Withdrawal by Subject|5|||
156822038|NCT02526524|566098789|FG000|Overall Study|Adverse Event|3|||
156822039|NCT02526524|566098790|FG001|Overall Study|Adverse Event|2|||
156822040|NCT02526524|566098791|FG002|Overall Study|Adverse Event|4|||
156822041|NCT02526524|566098792|FG003|Overall Study|Adverse Event|2|||
156822042|NCT02526524|566098793|FG004|Overall Study|Adverse Event|6|||
156822043|NCT02526524|566098794|FG005|Overall Study|Adverse Event|8|||
156822044|NCT02526524|566098789|FG000|Overall Study|Lost to Follow-up|2|||
156822045|NCT02526524|566098790|FG001|Overall Study|Lost to Follow-up|3|||
156822046|NCT02526524|566098791|FG002|Overall Study|Lost to Follow-up|8|||
156822047|NCT02526524|566098792|FG003|Overall Study|Lost to Follow-up|1|||
156822048|NCT02526524|566098793|FG004|Overall Study|Lost to Follow-up|2|||
156822049|NCT02526524|566098794|FG005|Overall Study|Lost to Follow-up|5|||
156822050|NCT02526524|566098789|FG000|Overall Study|Protocol Violation|3|||
156822051|NCT02526524|566098790|FG001|Overall Study|Protocol Violation|1|||
156822052|NCT02526524|566098791|FG002|Overall Study|Protocol Violation|5|||
156822053|NCT02526524|566098792|FG003|Overall Study|Protocol Violation|3|||
156822054|NCT02526524|566098793|FG004|Overall Study|Protocol Violation|4|||
156822055|NCT02526524|566098794|FG005|Overall Study|Protocol Violation|3|||
156822056|NCT02526524|566098789|FG000|Overall Study|Loss of Glucose Control|0|||
156822057|NCT02526524|566098790|FG001|Overall Study|Loss of Glucose Control|0|||
156822058|NCT02526524|566098791|FG002|Overall Study|Loss of Glucose Control|3|||
156822059|NCT02526524|566098792|FG003|Overall Study|Loss of Glucose Control|0|||
156822060|NCT02526524|566098793|FG004|Overall Study|Loss of Glucose Control|2|||
156822061|NCT02526524|566098794|FG005|Overall Study|Loss of Glucose Control|0|||
156822062|NCT02526524|566098789|FG000|Overall Study|Physician Decision|0|||
156822063|NCT02526524|566098790|FG001|Overall Study|Physician Decision|0|||
156822064|NCT02526524|566098791|FG002|Overall Study|Physician Decision|0|||
156822065|NCT02526524|566098792|FG003|Overall Study|Physician Decision|0|||
156822066|NCT02526524|566098793|FG004|Overall Study|Physician Decision|1|||
156822067|NCT02526524|566098794|FG005|Overall Study|Physician Decision|0|||
156822068|NCT02526524|566098789|FG000|Overall Study|Sponsor Decision|1|||
156822069|NCT02526524|566098790|FG001|Overall Study|Sponsor Decision|0|||
156822070|NCT02526524|566098791|FG002|Overall Study|Sponsor Decision|0|||
156822071|NCT02526524|566098792|FG003|Overall Study|Sponsor Decision|0|||
156822072|NCT02526524|566098793|FG004|Overall Study|Sponsor Decision|0|||
156822073|NCT02526524|566098794|FG005|Overall Study|Sponsor Decision|0|||
156822074|NCT00591149|566098798|FG000|Overall Study|Adverse Event|4|||
156822075|NCT00591149|566098798|FG000|Overall Study|Withdrawal by Subject|1|||
156822076|NCT00539513|566098799|FG000|Overall Study|Withdrawal by Subject|2|||
156822077|NCT00539513|566098800|FG001|Overall Study|Withdrawal by Subject|1|||
156822078|NCT00539513|566098799|FG000|Overall Study|Lost to Follow-up|0|||
156822079|NCT00539513|566098800|FG001|Overall Study|Lost to Follow-up|1|||
156822080|NCT03002818|566098801|FG000|Overall Study|Decision of the investigator|1|||
156822081|NCT01328041|566098802|FG000|Overall Study|Adverse Event|7|||
156822082|NCT01328041|566098802|FG000|Overall Study|Lack of Efficacy|27|||
156822083|NCT01328041|566098802|FG000|Overall Study|Protocol Violation|7|||
156822084|NCT01328041|566098802|FG000|Overall Study|Lost to Follow-up|7|||
156822085|NCT01328041|566098802|FG000|Overall Study|Physician Decision|2|||
156822086|NCT01328041|566098802|FG000|Overall Study|Withdrawal by Subject|7|||
156822087|NCT00711113|566098806|FG000|Overall Study|Lost to Follow-up|9|||
156822088|NCT00711113|566098806|FG000|Overall Study|Implant lost|2|||
156822089|NCT02456636|566098807|FG000|Overall Study|Death|0|||
156822090|NCT02456636|566098808|FG001|Overall Study|Death|3|||
156465893|NCT02325466|564802743|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
156465894|NCT02325466|564802744|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
156465895|NCT02325466|564802742|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
156465896|NCT02325466|564802743|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
156822091|NCT02456636|566098809|FG002|Overall Study|Death|0|||
156822092|NCT02456636|566098807|FG000|Overall Study|Pregnancy|1|||
156822093|NCT02456636|566098808|FG001|Overall Study|Pregnancy|3|||
156822094|NCT02456636|566098809|FG002|Overall Study|Pregnancy|5|||
156822095|NCT02456636|566098807|FG000|Overall Study|Physician Decision|4|||
156822096|NCT02456636|566098808|FG001|Overall Study|Physician Decision|5|||
156822097|NCT02456636|566098809|FG002|Overall Study|Physician Decision|4|||
156822098|NCT02456636|566098807|FG000|Overall Study|Withdrawal by Subject|13|||
156822099|NCT02456636|566098808|FG001|Overall Study|Withdrawal by Subject|14|||
156465897|NCT02325466|564802744|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
156465898|NCT02325466|564802742|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
156822100|NCT02456636|566098809|FG002|Overall Study|Withdrawal by Subject|16|||
156822101|NCT02456636|566098807|FG000|Overall Study|Lost to Follow-up|50|||
156822102|NCT02456636|566098808|FG001|Overall Study|Lost to Follow-up|44|||
156822103|NCT02456636|566098809|FG002|Overall Study|Lost to Follow-up|50|||
156822104|NCT01606787|566098811|FG000|Overall Study|Withdrawal by Subject|4|||
156465899|NCT02325466|564802743|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
156822105|NCT01606787|566098812|FG001|Overall Study|Withdrawal by Subject|5|||
156822106|NCT01606787|566098811|FG000|Overall Study|Surgery canceled|0|||
156339201|NCT01090492|564340149|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
156822107|NCT01606787|566098812|FG001|Overall Study|Surgery canceled|2|||
156822108|NCT04484649|566098816|FG000|Overall Study|Lost to Follow-up|2|||
156822109|NCT04484649|566098817|FG001|Overall Study|Lost to Follow-up|1|||
156822110|NCT04484649|566098816|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
156822111|NCT04484649|566098817|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
156822112|NCT01463696|566098818|FG000|Overall Study|Adverse Event|0|||
156822113|NCT01463696|566098819|FG001|Overall Study|Adverse Event|1|||
156822114|NCT01463696|566098820|FG002|Overall Study|Adverse Event|0|||
156822115|NCT01463696|566098821|FG003|Overall Study|Adverse Event|2|||
156822116|NCT01463696|566098822|FG004|Overall Study|Adverse Event|0|||
156822117|NCT01463696|566098823|FG005|Overall Study|Adverse Event|1|||
156822118|NCT01463696|566098824|FG006|Overall Study|Adverse Event|3|||
156822119|NCT01463696|566098825|FG007|Overall Study|Adverse Event|2|||
156822120|NCT01463696|566098818|FG000|Overall Study|Lost to Follow-up|0|||
156822121|NCT01463696|566098819|FG001|Overall Study|Lost to Follow-up|0|||
156822122|NCT01463696|566098820|FG002|Overall Study|Lost to Follow-up|1|||
156822123|NCT01463696|566098821|FG003|Overall Study|Lost to Follow-up|0|||
156822124|NCT01463696|566098822|FG004|Overall Study|Lost to Follow-up|0|||
156822125|NCT01463696|566098823|FG005|Overall Study|Lost to Follow-up|0|||
156822126|NCT01463696|566098824|FG006|Overall Study|Lost to Follow-up|0|||
156822127|NCT01463696|566098825|FG007|Overall Study|Lost to Follow-up|0|||
156822128|NCT01463696|566098818|FG000|Overall Study|Progressive Disease|0|||
156822129|NCT01463696|566098819|FG001|Overall Study|Progressive Disease|1|||
156822130|NCT01463696|566098820|FG002|Overall Study|Progressive Disease|0|||
156822131|NCT01463696|566098821|FG003|Overall Study|Progressive Disease|1|||
156822132|NCT01463696|566098822|FG004|Overall Study|Progressive Disease|0|||
156822133|NCT01463696|566098823|FG005|Overall Study|Progressive Disease|1|||
156822134|NCT01463696|566098824|FG006|Overall Study|Progressive Disease|4|||
156822135|NCT01463696|566098825|FG007|Overall Study|Progressive Disease|2|||
156822136|NCT01463696|566098818|FG000|Overall Study|Withdrawal by Subject|0|||
156822137|NCT01463696|566098819|FG001|Overall Study|Withdrawal by Subject|0|||
156822138|NCT01463696|566098820|FG002|Overall Study|Withdrawal by Subject|0|||
156822139|NCT01463696|566098821|FG003|Overall Study|Withdrawal by Subject|1|||
156822140|NCT01463696|566098822|FG004|Overall Study|Withdrawal by Subject|1|||
156822141|NCT01463696|566098823|FG005|Overall Study|Withdrawal by Subject|1|||
156822142|NCT01463696|566098824|FG006|Overall Study|Withdrawal by Subject|2|||
156822143|NCT01463696|566098825|FG007|Overall Study|Withdrawal by Subject|0|||
156822144|NCT01463696|566098818|FG000|Overall Study|Not Treated|0|||
156822145|NCT01463696|566098819|FG001|Overall Study|Not Treated|0|||
156822146|NCT01463696|566098820|FG002|Overall Study|Not Treated|0|||
156822147|NCT01463696|566098821|FG003|Overall Study|Not Treated|0|||
156822148|NCT01463696|566098822|FG004|Overall Study|Not Treated|0|||
156822149|NCT01463696|566098823|FG005|Overall Study|Not Treated|0|||
156822150|NCT01463696|566098824|FG006|Overall Study|Not Treated|1|||
156822151|NCT01463696|566098825|FG007|Overall Study|Not Treated|0|||
156822152|NCT00967694|566098828|FG000|Overall Study|Withdrawal by Subject|6|||
156822153|NCT00152477|566098834|FG000|Chemotherapy Period|Adverse Event|9|||
156822154|NCT00152477|566098835|FG001|Chemotherapy Period|Adverse Event|4|||
156822155|NCT00152477|566098836|FG002|Chemotherapy Period|Adverse Event|5|||
156822156|NCT00152477|566098834|FG000|Chemotherapy Period|Death|1|||
156822157|NCT00152477|566098835|FG001|Chemotherapy Period|Death|3|||
156822158|NCT00152477|566098836|FG002|Chemotherapy Period|Death|3|||
156822159|NCT00152477|566098834|FG000|Chemotherapy Period|Lack of Efficacy|4|||
156822160|NCT00152477|566098835|FG001|Chemotherapy Period|Lack of Efficacy|5|||
156822161|NCT00152477|566098836|FG002|Chemotherapy Period|Lack of Efficacy|6|||
156339202|NCT01090492|564340142|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156541158|NCT00253643|565074491|FG001|Overall Study|Non-Compliance|0|||
156822162|NCT00152477|566098834|FG000|Chemotherapy Period|Lost to Follow-up|1|||
156822163|NCT00152477|566098835|FG001|Chemotherapy Period|Lost to Follow-up|0|||
156822164|NCT00152477|566098836|FG002|Chemotherapy Period|Lost to Follow-up|1|||
156822165|NCT00152477|566098834|FG000|Chemotherapy Period|Protocol Violation|1|||
156822166|NCT00152477|566098835|FG001|Chemotherapy Period|Protocol Violation|1|||
156822167|NCT00152477|566098836|FG002|Chemotherapy Period|Protocol Violation|0|||
156822168|NCT00152477|566098834|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
156822169|NCT00152477|566098835|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
156822170|NCT00152477|566098836|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
156822171|NCT00152477|566098834|FG000|Chemotherapy Period|Progression of Disease|6|||
156822172|NCT00152477|566098835|FG001|Chemotherapy Period|Progression of Disease|8|||
156822173|NCT00152477|566098836|FG002|Chemotherapy Period|Progression of Disease|4|||
156822174|NCT00152477|566098834|FG000|Chemotherapy Period|Investigator decision|0|||
156822175|NCT00152477|566098835|FG001|Chemotherapy Period|Investigator decision|0|||
156822176|NCT00152477|566098836|FG002|Chemotherapy Period|Investigator decision|1|||
156822177|NCT00152477|566098834|FG000|Chemotherapy Period|Patient condition worsened|1|||
156822178|NCT00152477|566098835|FG001|Chemotherapy Period|Patient condition worsened|0|||
156822179|NCT00152477|566098836|FG002|Chemotherapy Period|Patient condition worsened|0|||
156822180|NCT00152477|566098834|FG000|Monotherapy Period|Adverse Event|1|||
156822181|NCT00152477|566098835|FG001|Monotherapy Period|Adverse Event|0|||
156822182|NCT00152477|566098836|FG002|Monotherapy Period|Adverse Event|5|||
156822183|NCT00152477|566098834|FG000|Monotherapy Period|Death|2|||
156822184|NCT00152477|566098835|FG001|Monotherapy Period|Death|0|||
156822185|NCT00152477|566098836|FG002|Monotherapy Period|Death|1|||
156822186|NCT00152477|566098834|FG000|Monotherapy Period|Lack of Efficacy|7|||
156822187|NCT00152477|566098835|FG001|Monotherapy Period|Lack of Efficacy|16|||
156822188|NCT00152477|566098836|FG002|Monotherapy Period|Lack of Efficacy|10|||
156822189|NCT00152477|566098834|FG000|Monotherapy Period|Protocol Violation|0|||
156822190|NCT00152477|566098835|FG001|Monotherapy Period|Protocol Violation|1|||
156822191|NCT00152477|566098836|FG002|Monotherapy Period|Protocol Violation|0|||
156822192|NCT00152477|566098834|FG000|Monotherapy Period|Withdrawal by Subject|0|||
156822193|NCT00152477|566098835|FG001|Monotherapy Period|Withdrawal by Subject|0|||
156822194|NCT00152477|566098836|FG002|Monotherapy Period|Withdrawal by Subject|4|||
156822195|NCT00152477|566098834|FG000|Monotherapy Period|Progression of Disease|5|||
156822196|NCT00152477|566098835|FG001|Monotherapy Period|Progression of Disease|11|||
156822197|NCT00152477|566098836|FG002|Monotherapy Period|Progression of Disease|12|||
156822198|NCT00152477|566098834|FG000|Monotherapy Period|Patient decision|0|||
156822199|NCT00152477|566098835|FG001|Monotherapy Period|Patient decision|1|||
156822200|NCT00152477|566098836|FG002|Monotherapy Period|Patient decision|1|||
156822201|NCT00152477|566098834|FG000|Monotherapy Period|Study personel decision|0|||
156822202|NCT00152477|566098835|FG001|Monotherapy Period|Study personel decision|0|||
156822203|NCT00152477|566098836|FG002|Monotherapy Period|Study personel decision|1|||
156822204|NCT02301546|566098837|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
156822205|NCT02301546|566098838|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
156822206|NCT02301546|566098837|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
156822207|NCT02301546|566098838|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
156822208|NCT02301546|566098837|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
156822209|NCT02301546|566098838|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
156822210|NCT02301546|566098837|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
156822211|NCT02301546|566098838|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
156822212|NCT02301546|566098837|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
156822213|NCT02301546|566098838|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
156822214|NCT02301546|566098837|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
156822215|NCT02301546|566098838|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
156822216|NCT02301546|566098837|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
156822217|NCT02301546|566098838|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
156822218|NCT03905265|566098840|FG000|Overall Study|Withdrawal by Subject|1|||
156822219|NCT03905265|566098841|FG001|Overall Study|Withdrawal by Subject|1|||
156822220|NCT03905265|566098842|FG002|Overall Study|Withdrawal by Subject|0|||
156822221|NCT03905265|566098843|FG003|Overall Study|Withdrawal by Subject|0|||
156822222|NCT01801436|566098846|FG000|Overall Study|Withdrawal by Subject|3|||
156822223|NCT01801436|566098846|FG000|Overall Study|Adverse Event|2|||
156822224|NCT01801436|566098846|FG000|Overall Study|Progressive disease|4|||
156822225|NCT02447250|566098849|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
156465900|NCT02325466|564802744|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
156822226|NCT02447250|566098849|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
156822227|NCT02447250|566098849|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
156822228|NCT03632993|566098850|FG000|Overall Study|Withdrawal by Subject|1|||
156822229|NCT03632993|566098851|FG001|Overall Study|Withdrawal by Subject|0|||
156822230|NCT03632993|566098852|FG002|Overall Study|Withdrawal by Subject|0|||
156822231|NCT03632993|566098853|FG003|Overall Study|Withdrawal by Subject|0|||
156822232|NCT03632993|566098854|FG004|Overall Study|Withdrawal by Subject|0|||
156822233|NCT03632993|566098855|FG005|Overall Study|Withdrawal by Subject|0|||
156822234|NCT03632993|566098856|FG006|Overall Study|Withdrawal by Subject|0|||
156822235|NCT03632993|566098857|FG007|Overall Study|Withdrawal by Subject|0|||
156822236|NCT03632993|566098858|FG008|Overall Study|Withdrawal by Subject|0|||
156822237|NCT03632993|566098859|FG009|Overall Study|Withdrawal by Subject|1|||
156465901|NCT02325466|564802742|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
156822238|NCT03632993|566098850|FG000|Overall Study|Protocol Non-compliance|0|||
156822239|NCT03632993|566098851|FG001|Overall Study|Protocol Non-compliance|1|||
156465902|NCT02325466|564802743|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
156822240|NCT03632993|566098852|FG002|Overall Study|Protocol Non-compliance|0|||
156822241|NCT03632993|566098853|FG003|Overall Study|Protocol Non-compliance|0|||
156822242|NCT03632993|566098854|FG004|Overall Study|Protocol Non-compliance|0|||
156822243|NCT03632993|566098855|FG005|Overall Study|Protocol Non-compliance|0|||
156822244|NCT03632993|566098856|FG006|Overall Study|Protocol Non-compliance|0|||
156822245|NCT03632993|566098857|FG007|Overall Study|Protocol Non-compliance|0|||
156822246|NCT03632993|566098858|FG008|Overall Study|Protocol Non-compliance|0|||
156822247|NCT03632993|566098859|FG009|Overall Study|Protocol Non-compliance|0|||
156822248|NCT03632993|566098850|FG000|Overall Study|Lost to Follow-up|0|||
156822249|NCT03632993|566098851|FG001|Overall Study|Lost to Follow-up|0|||
156822250|NCT03632993|566098852|FG002|Overall Study|Lost to Follow-up|0|||
156822251|NCT03632993|566098853|FG003|Overall Study|Lost to Follow-up|0|||
156822252|NCT03632993|566098854|FG004|Overall Study|Lost to Follow-up|0|||
156822253|NCT03632993|566098855|FG005|Overall Study|Lost to Follow-up|1|||
156822254|NCT03632993|566098856|FG006|Overall Study|Lost to Follow-up|0|||
156822255|NCT03632993|566098857|FG007|Overall Study|Lost to Follow-up|1|||
156822256|NCT03632993|566098858|FG008|Overall Study|Lost to Follow-up|0|||
156822257|NCT03632993|566098859|FG009|Overall Study|Lost to Follow-up|0|||
156822258|NCT03632993|566098850|FG000|Overall Study|Adverse Event|0|||
156822259|NCT03632993|566098851|FG001|Overall Study|Adverse Event|0|||
156822260|NCT03632993|566098852|FG002|Overall Study|Adverse Event|0|||
156822261|NCT03632993|566098853|FG003|Overall Study|Adverse Event|0|||
156822262|NCT03632993|566098854|FG004|Overall Study|Adverse Event|0|||
156822263|NCT03632993|566098855|FG005|Overall Study|Adverse Event|1|||
156822264|NCT03632993|566098856|FG006|Overall Study|Adverse Event|0|||
156822265|NCT03632993|566098857|FG007|Overall Study|Adverse Event|1|||
156822266|NCT03632993|566098858|FG008|Overall Study|Adverse Event|0|||
156822267|NCT03632993|566098859|FG009|Overall Study|Adverse Event|0|||
156822268|NCT02743949|566098860|FG000|Overall Study|Adverse Event|0|||
156822269|NCT02743949|566098861|FG001|Overall Study|Adverse Event|0|||
156822270|NCT02743949|566098862|FG002|Overall Study|Adverse Event|2|||
156822271|NCT02743949|566098860|FG000|Overall Study|Significant Protocol Deviation|2|||
156822272|NCT02743949|566098861|FG001|Overall Study|Significant Protocol Deviation|0|||
156822273|NCT02743949|566098862|FG002|Overall Study|Significant Protocol Deviation|1|||
156822274|NCT02743949|566098860|FG000|Overall Study|Voluntary Withdrawal|2|||
156822275|NCT02743949|566098861|FG001|Overall Study|Voluntary Withdrawal|1|||
156822276|NCT02743949|566098862|FG002|Overall Study|Voluntary Withdrawal|0|||
156822277|NCT01921218|566098863|FG000|Overall Study|Death|2|||
156822278|NCT01921218|566098864|FG001|Overall Study|Death|1|||
156822279|NCT01921218|566098863|FG000|Overall Study|Withdrawal by Subject|0|||
156822280|NCT01921218|566098864|FG001|Overall Study|Withdrawal by Subject|2|||
156822281|NCT01921218|566098863|FG000|Overall Study|Kidney transplant|1|||
156822282|NCT01921218|566098864|FG001|Overall Study|Kidney transplant|1|||
156822283|NCT03389555|566098865|FG000|Overall Study|Protocol Violation|1|||
156822284|NCT03389555|566098866|FG001|Overall Study|Protocol Violation|3|||
156822285|NCT03389555|566098865|FG000|Overall Study|Death|1|||
156822286|NCT03389555|566098866|FG001|Overall Study|Death|0|||
156822287|NCT01885208|566098867|FG000|Overall Study|Unclassified|32|||
156822288|NCT01885208|566098868|FG001|Overall Study|Unclassified|38|||
156822289|NCT00960011|566098869|FG000|Overall Study|Death|5|||
156822290|NCT00960011|566098870|FG001|Overall Study|Death|0|||
156822291|NCT00960011|566098869|FG000|Overall Study|Lost to Follow-up|6|||
156822292|NCT00960011|566098870|FG001|Overall Study|Lost to Follow-up|2|||
156822293|NCT04417218|566098871|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
156822294|NCT04417218|566098872|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
156822295|NCT00873041|566098873|FG000|Core Study|Adverse Event|2|||
156822296|NCT00873041|566098874|FG001|Core Study|Adverse Event|3|||
156822297|NCT00873041|566098875|FG002|Core Study|Adverse Event|1|||
156822298|NCT00873041|566098873|FG000|Core Study|Withdrawal by Subject|1|||
156822299|NCT00873041|566098874|FG001|Core Study|Withdrawal by Subject|2|||
156822300|NCT00873041|566098875|FG002|Core Study|Withdrawal by Subject|2|||
156822301|NCT00873041|566098873|FG000|Core Study|Lost to Follow-up|3|||
156822302|NCT00873041|566098874|FG001|Core Study|Lost to Follow-up|1|||
156822303|NCT00873041|566098875|FG002|Core Study|Lost to Follow-up|0|||
156822304|NCT00873041|566098873|FG000|Core Study|Abnormal laboratory value|0|||
156822305|NCT00873041|566098874|FG001|Core Study|Abnormal laboratory value|0|||
156822306|NCT00873041|566098875|FG002|Core Study|Abnormal laboratory value|1|||
156822307|NCT00873041|566098873|FG000|Core Study|Protocol deviation|1|||
156822308|NCT00873041|566098874|FG001|Core Study|Protocol deviation|0|||
156822309|NCT00873041|566098875|FG002|Core Study|Protocol deviation|1|||
156822310|NCT00873041|566098873|FG000|Extension Study|Adverse Event|1|||
156822311|NCT00873041|566098874|FG001|Extension Study|Adverse Event|0|||
156822312|NCT00873041|566098875|FG002|Extension Study|Adverse Event|1|||
156822313|NCT00873041|566098873|FG000|Extension Study|Administrative reasons|0|||
156822314|NCT00873041|566098874|FG001|Extension Study|Administrative reasons|0|||
156822315|NCT00873041|566098875|FG002|Extension Study|Administrative reasons|1|||
156822316|NCT02449889|566098878|FG000|Overall Study|Adverse Event|1|||
156822317|NCT02449889|566098879|FG001|Overall Study|Adverse Event|2|||
156822318|NCT02449889|566098880|FG002|Overall Study|Adverse Event|0|||
156822319|NCT02449889|566098878|FG000|Overall Study|Protocol Violation|0|||
156822320|NCT02449889|566098879|FG001|Overall Study|Protocol Violation|4|||
156822321|NCT02449889|566098880|FG002|Overall Study|Protocol Violation|1|||
156822322|NCT00313313|566098881|FG000|Overall Study|Lack of Efficacy|14|||
156822323|NCT00313313|566098882|FG001|Overall Study|Lack of Efficacy|9|||
156822324|NCT00313313|566098883|FG002|Overall Study|Lack of Efficacy|20|||
156822325|NCT00313313|566098881|FG000|Overall Study|Withdrawal of consent by subject|18|||
156822326|NCT00313313|566098882|FG001|Overall Study|Withdrawal of consent by subject|17|||
156822327|NCT00313313|566098883|FG002|Overall Study|Withdrawal of consent by subject|31|||
156822328|NCT00313313|566098881|FG000|Overall Study|Lost to Follow-up|10|||
156822329|NCT00313313|566098882|FG001|Overall Study|Lost to Follow-up|7|||
156822330|NCT00313313|566098883|FG002|Overall Study|Lost to Follow-up|9|||
156822331|NCT00313313|566098881|FG000|Overall Study|Adverse Event|15|||
156822332|NCT00313313|566098882|FG001|Overall Study|Adverse Event|16|||
156822333|NCT00313313|566098883|FG002|Overall Study|Adverse Event|12|||
156822334|NCT00313313|566098881|FG000|Overall Study|Physician Decision|2|||
156822335|NCT00313313|566098882|FG001|Overall Study|Physician Decision|6|||
156822336|NCT00313313|566098883|FG002|Overall Study|Physician Decision|4|||
156822337|NCT00313313|566098881|FG000|Overall Study|Poor/Noncompliance|3|||
156822338|NCT00313313|566098882|FG001|Overall Study|Poor/Noncompliance|6|||
156822339|NCT00313313|566098883|FG002|Overall Study|Poor/Noncompliance|2|||
156822340|NCT00313313|566098881|FG000|Overall Study|Pregnancy|1|||
156822341|NCT00313313|566098882|FG001|Overall Study|Pregnancy|2|||
156822342|NCT00313313|566098883|FG002|Overall Study|Pregnancy|0|||
156822343|NCT00313313|566098881|FG000|Overall Study|Death|0|||
156822344|NCT00313313|566098882|FG001|Overall Study|Death|0|||
156822345|NCT00313313|566098883|FG002|Overall Study|Death|2|||
156822346|NCT00313313|566098881|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
156822347|NCT00313313|566098882|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
156822348|NCT00313313|566098883|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
156822349|NCT00758264|566098884|FG000|Active Phase|Withdrawal by Subject|0|||
156822350|NCT00758264|566098885|FG001|Active Phase|Withdrawal by Subject|0|||
156822351|NCT00758264|566098886|FG002|Active Phase|Withdrawal by Subject|1|||
156822352|NCT00758264|566098884|FG000|Active Phase|Lost to Follow-up|1|||
156822353|NCT00758264|566098885|FG001|Active Phase|Lost to Follow-up|0|||
156822354|NCT00758264|566098886|FG002|Active Phase|Lost to Follow-up|0|||
156822355|NCT00758264|566098884|FG000|Active Phase|Other|0|||
156822356|NCT00758264|566098885|FG001|Active Phase|Other|0|||
156822357|NCT00758264|566098886|FG002|Active Phase|Other|4|||
156822358|NCT04154605|566098892|FG000|Overall Study|Procedure Canceled|1|||
156822359|NCT04154605|566098893|FG001|Overall Study|Procedure Canceled|1|||
156822360|NCT04154605|566098892|FG000|Overall Study|Missed follow up|1|||
156822361|NCT04154605|566098893|FG001|Overall Study|Missed follow up|1|||
156822362|NCT04154605|566098892|FG000|Overall Study|Withdrawal by Subject|1|||
156822363|NCT04154605|566098893|FG001|Overall Study|Withdrawal by Subject|0|||
156822364|NCT00675441|566098894|FG000|Overall Study|Withdrawal by Subject|2|||
156822365|NCT00675441|566098894|FG000|Overall Study|Death|1|||
156822366|NCT01923363|566098895|FG000|Overall Study|Protocol Violation|1|||
156822367|NCT02901054|566098900|FG000|Overall Study|Physician Decision|1|||
156822368|NCT02901054|566098900|FG000|Overall Study|Withdrawal by Subject|3|||
156822369|NCT05593913|566098904|FG000|Overall Study|Insufficient image quality|39|||
156822370|NCT01453205|566098905|FG000|Overall Study|Lost to Follow-up|3|||
156822371|NCT01453205|566098906|FG001|Overall Study|Lost to Follow-up|0|||
156822372|NCT01453205|566098907|FG002|Overall Study|Lost to Follow-up|1|||
156822373|NCT01453205|566098905|FG000|Overall Study|Withdrawal by Subject|8|||
156822374|NCT01453205|566098906|FG001|Overall Study|Withdrawal by Subject|3|||
156822375|NCT01453205|566098907|FG002|Overall Study|Withdrawal by Subject|0|||
156822376|NCT01453205|566098905|FG000|Overall Study|Death|24|||
156822377|NCT01453205|566098906|FG001|Overall Study|Death|22|||
156822378|NCT01453205|566098907|FG002|Overall Study|Death|18|||
156822379|NCT01453205|566098905|FG000|Overall Study|Other|45|||
156822380|NCT01453205|566098906|FG001|Overall Study|Other|27|||
156822381|NCT01453205|566098907|FG002|Overall Study|Other|35|||
156822382|NCT01666119|566098908|FG000|Overall Study|Adverse Event|6|||
156822383|NCT01666119|566098908|FG000|Overall Study|Withdrawal by Subject|16|||
156822384|NCT01666119|566098908|FG000|Overall Study|Lost to Follow-up|7|||
156822385|NCT01666119|566098908|FG000|Overall Study|non compliance with study medication, pa|18|||
156822386|NCT01666119|566098908|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
156822387|NCT03255967|566098913|FG000|Overall Study|Adverse Event|26|||
156822388|NCT03255967|566098914|FG001|Overall Study|Adverse Event|30|||
156822389|NCT03255967|566098913|FG000|Overall Study|Withdrawal by Subject|6|||
156822390|NCT03255967|566098914|FG001|Overall Study|Withdrawal by Subject|6|||
156822391|NCT03255967|566098913|FG000|Overall Study|Schedule conflict|6|||
156822392|NCT03255967|566098914|FG001|Overall Study|Schedule conflict|4|||
156822393|NCT03255967|566098913|FG000|Overall Study|POA did not sign consent form|2|||
156822394|NCT03255967|566098914|FG001|Overall Study|POA did not sign consent form|0|||
156822395|NCT02438384|566098917|FG000|Overall Study|Lost to Follow-up|8|||
156822396|NCT02438384|566098918|FG001|Overall Study|Lost to Follow-up|6|||
156822397|NCT02438384|566098919|FG002|Overall Study|Lost to Follow-up|4|||
156822398|NCT01795495|566098921|FG000|Overall Study|Protocol Violation|1|||
156822399|NCT01795495|566098922|FG001|Overall Study|Protocol Violation|0|||
156822400|NCT01795495|566098923|FG002|Overall Study|Protocol Violation|1|||
156822401|NCT01795495|566098921|FG000|Overall Study|Physician Decision|0|||
156822402|NCT01795495|566098922|FG001|Overall Study|Physician Decision|0|||
156822403|NCT01795495|566098923|FG002|Overall Study|Physician Decision|1|||
156822404|NCT04027049|566098924|FG000|Overall Study|Withdrawn by family|1|||
156822405|NCT04027049|566098925|FG001|Overall Study|Withdrawn by family|0|||
156822406|NCT04027049|566098924|FG000|Overall Study|Participant safety|1|||
156822407|NCT04027049|566098925|FG001|Overall Study|Participant safety|0|||
156822408|NCT02650128|566098926|FG000|Overall Study|Death|2|||
156822409|NCT01681069|566100131|FG000|Overall Study|Withdrawal by Subject|4|||
156822410|NCT01681069|566100132|FG001|Overall Study|Withdrawal by Subject|5|||
156822411|NCT01681069|566100131|FG000|Overall Study|Protocol Violation|1|||
156822412|NCT01681069|566100132|FG001|Overall Study|Protocol Violation|1|||
156822413|NCT01681069|566100131|FG000|Overall Study|Adverse Event|0|||
156822414|NCT01681069|566100132|FG001|Overall Study|Adverse Event|1|||
156822415|NCT03883165|566100134|FG000|Overall Study|Withdrawal by Subject|4|||
156822416|NCT03883165|566100135|FG001|Overall Study|Withdrawal by Subject|3|||
156822417|NCT00245050|566100136|FG000|Overall Study|Adverse Event|3|||
156822418|NCT00245050|566100137|FG001|Overall Study|Adverse Event|2|||
156822419|NCT00730041|566100138|FG000|Overall Study|Lost to Follow-up|0|||
156822420|NCT00730041|566100139|FG001|Overall Study|Lost to Follow-up|2|||
156822421|NCT05526781|566100142|FG000|Overall Study|Lost to Follow-up|1|||
156822422|NCT04085458|566100143|FG000|Overall Study|Other|1|||
156822423|NCT04085458|566100143|FG000|Overall Study|Withdrawal by Subject|2|||
156822424|NCT04085458|566100143|FG000|Overall Study|Adverse Event|2|||
156822425|NCT00920218|566100144|FG000|Overall Study|Serious Adverse Event|2|||
156822426|NCT00920218|566100145|FG001|Overall Study|Serious Adverse Event|0|||
156822427|NCT00920218|566100146|FG002|Overall Study|Serious Adverse Event|2|||
156822428|NCT00920218|566100147|FG003|Overall Study|Serious Adverse Event|1|||
156822429|NCT00920218|566100144|FG000|Overall Study|Withdrawal by Subject|0|||
156822430|NCT00920218|566100145|FG001|Overall Study|Withdrawal by Subject|3|||
156822431|NCT00920218|566100146|FG002|Overall Study|Withdrawal by Subject|2|||
156822432|NCT00920218|566100147|FG003|Overall Study|Withdrawal by Subject|0|||
156822433|NCT00920218|566100144|FG000|Overall Study|Migrated/moved from study area|0|||
156822434|NCT00920218|566100145|FG001|Overall Study|Migrated/moved from study area|0|||
156822435|NCT00920218|566100146|FG002|Overall Study|Migrated/moved from study area|1|||
156822436|NCT00920218|566100147|FG003|Overall Study|Migrated/moved from study area|0|||
156822437|NCT00920218|566100144|FG000|Overall Study|Lost to Follow-up|0|||
156822438|NCT00920218|566100145|FG001|Overall Study|Lost to Follow-up|1|||
156822439|NCT00920218|566100146|FG002|Overall Study|Lost to Follow-up|0|||
156822440|NCT00920218|566100147|FG003|Overall Study|Lost to Follow-up|3|||
156822441|NCT00920218|566100144|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
156822442|NCT00920218|566100145|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
156822443|NCT00920218|566100146|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
156822444|NCT00920218|566100147|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
156822445|NCT00920218|566100144|FG000|Overall Study|Other|0|||
156822446|NCT00920218|566100145|FG001|Overall Study|Other|0|||
156822447|NCT00920218|566100146|FG002|Overall Study|Other|1|||
156822448|NCT00920218|566100147|FG003|Overall Study|Other|0|||
156822449|NCT01973387|566100151|FG000|Overall Study|Adverse Event|14|||
156822450|NCT01973387|566100152|FG001|Overall Study|Adverse Event|4|||
156822451|NCT01973387|566100151|FG000|Overall Study|Withdrawal by Subject|7|||
156822452|NCT01973387|566100152|FG001|Overall Study|Withdrawal by Subject|4|||
156822453|NCT01973387|566100151|FG000|Overall Study|Study terminated by sponsor|63|||
156822454|NCT01973387|566100152|FG001|Overall Study|Study terminated by sponsor|0|||
156822455|NCT01973387|566100151|FG000|Overall Study|Progressive disease or relapse|16|||
156822456|NCT01973387|566100152|FG001|Overall Study|Progressive disease or relapse|5|||
156822457|NCT01973387|566100151|FG000|Overall Study|Death|4|||
156822458|NCT01973387|566100152|FG001|Overall Study|Death|3|||
156822459|NCT01973387|566100151|FG000|Overall Study|Randomized, not treated|2|||
156822460|NCT01973387|566100152|FG001|Overall Study|Randomized, not treated|2|||
156822461|NCT00368836|566100154|FG000|Phase II|Screen Failure|1|||
156822462|NCT00368836|566100154|FG000|Phase II|Withdrawal by Subject|1|||
156822463|NCT00368836|566100154|FG000|Phase II|unable to collect blood and/or breath|17|||
156465903|NCT02325466|564802744|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
156465904|NCT02325466|564802742|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
156822464|NCT00368836|566100154|FG000|Phase II|Protocol Violation|2|||
156822465|NCT01082874|566100155|FG000|Overall Study|Lost to Follow-up|10|||
156822466|NCT01082874|566100156|FG001|Overall Study|Lost to Follow-up|10|||
156822467|NCT01082874|566100157|FG002|Overall Study|Lost to Follow-up|6|||
156822468|NCT01082874|566100158|FG003|Overall Study|Lost to Follow-up|10|||
156822469|NCT01082874|566100155|FG000|Overall Study|Withdrawal by Subject|1|||
156822470|NCT01082874|566100156|FG001|Overall Study|Withdrawal by Subject|2|||
156822471|NCT01082874|566100157|FG002|Overall Study|Withdrawal by Subject|5|||
156822472|NCT01082874|566100158|FG003|Overall Study|Withdrawal by Subject|3|||
156822473|NCT01345591|566100163|FG000|Overall Study|Lost to Follow-up|1|||
156822474|NCT00090142|566100164|FG000|Treatment Period I|Lost to Follow-up|1|||
156822475|NCT00090142|566100165|FG001|Treatment Period I|Lost to Follow-up|2|||
156822476|NCT00090142|566100164|FG000|Treatment Period I|Protocol Violation|2|||
156822477|NCT00090142|566100165|FG001|Treatment Period I|Protocol Violation|0|||
156822478|NCT00090142|566100164|FG000|Treatment Period I|Withdrawal by Subject|2|||
156822479|NCT00090142|566100165|FG001|Treatment Period I|Withdrawal by Subject|0|||
156822480|NCT00090142|566100164|FG000|Treatment Period I|Other|0|||
156822481|NCT00090142|566100165|FG001|Treatment Period I|Other|1|||
156822482|NCT00090142|566100164|FG000|Treatment Period II|Other|1|||
156822483|NCT00090142|566100165|FG001|Treatment Period II|Other|0|||
156822484|NCT02442310|566100166|FG000|Overall Study|Adverse Event|2|||
156822485|NCT02442310|566100166|FG000|Overall Study|Withdrawal by Subject|1|||
156822486|NCT01126437|566100167|FG000|Overall Study|Not treated|11|||
156822487|NCT01126437|566100168|FG001|Overall Study|Not treated|18|||
156822488|NCT01126437|566100169|FG002|Overall Study|Not treated|19|||
156822489|NCT01126437|566100167|FG000|Overall Study|Sites with data irregularities/fraud|6|||
156822490|NCT01126437|566100168|FG001|Overall Study|Sites with data irregularities/fraud|6|||
156822491|NCT01126437|566100169|FG002|Overall Study|Sites with data irregularities/fraud|7|||
156822492|NCT01126437|566100167|FG000|Overall Study|Adverse Event|602|||
156822493|NCT01126437|566100168|FG001|Overall Study|Adverse Event|606|||
156822494|NCT01126437|566100169|FG002|Overall Study|Adverse Event|635|||
156822495|NCT01126437|566100167|FG000|Overall Study|Lack of Efficacy|65|||
156822496|NCT01126437|566100168|FG001|Overall Study|Lack of Efficacy|60|||
156465905|NCT02325466|564802743|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
156465906|NCT02325466|564802744|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
156465907|NCT02325466|564802742|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
156465908|NCT02325466|564802743|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
156822497|NCT01126437|566100169|FG002|Overall Study|Lack of Efficacy|59|||
156822498|NCT01126437|566100167|FG000|Overall Study|Protocol Violation|64|||
156822499|NCT01126437|566100168|FG001|Overall Study|Protocol Violation|66|||
156822500|NCT01126437|566100169|FG002|Overall Study|Protocol Violation|41|||
156822501|NCT01126437|566100167|FG000|Overall Study|Lost to Follow-up|52|||
156822502|NCT01126437|566100168|FG001|Overall Study|Lost to Follow-up|63|||
156822503|NCT01126437|566100169|FG002|Overall Study|Lost to Follow-up|55|||
156822504|NCT01126437|566100167|FG000|Overall Study|Withdrawal by Subject|331|||
156822505|NCT01126437|566100168|FG001|Overall Study|Withdrawal by Subject|335|||
156822506|NCT01126437|566100169|FG002|Overall Study|Withdrawal by Subject|319|||
156822507|NCT01126437|566100167|FG000|Overall Study|Other reason not specified|210|||
156822508|NCT01126437|566100168|FG001|Overall Study|Other reason not specified|176|||
156822509|NCT01126437|566100169|FG002|Overall Study|Other reason not specified|178|||
156822510|NCT00006046|566100181|FG000|Overall Study|Adverse Event|3|||
156822511|NCT00006046|566100182|FG001|Overall Study|Adverse Event|0|||
156822512|NCT00006046|566100183|FG002|Overall Study|Adverse Event|0|||
156822513|NCT00006046|566100184|FG003|Overall Study|Adverse Event|0|||
156822514|NCT00006046|566100185|FG004|Overall Study|Adverse Event|0|||
156822515|NCT00006046|566100181|FG000|Overall Study|Disease Progression|2|||
156822516|NCT00006046|566100182|FG001|Overall Study|Disease Progression|0|||
156822517|NCT00006046|566100183|FG002|Overall Study|Disease Progression|0|||
156822518|NCT00006046|566100184|FG003|Overall Study|Disease Progression|0|||
156822519|NCT00006046|566100185|FG004|Overall Study|Disease Progression|0|||
156822520|NCT03272828|566100186|FG000|Overall Study|Lost to Follow-up|7|||
156822521|NCT03272828|566100187|FG001|Overall Study|Lost to Follow-up|7|||
156822522|NCT03272828|566100186|FG000|Overall Study|Withdrawal by Subject|2|||
156822523|NCT03272828|566100187|FG001|Overall Study|Withdrawal by Subject|0|||
156822524|NCT03272828|566100186|FG000|Overall Study|Deceased|1|||
156822525|NCT03272828|566100187|FG001|Overall Study|Deceased|1|||
156822526|NCT03272828|566100186|FG000|Overall Study|Failed implant|1|||
156822527|NCT03272828|566100187|FG001|Overall Study|Failed implant|2|||
156822528|NCT03176472|566100188|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
156822529|NCT03176472|566100189|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
156822530|NCT03176472|566100188|FG000|Double Blind Treatment Period|Adverse Event|0|||
156465909|NCT02325466|564802744|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
156822531|NCT03176472|566100189|FG001|Double Blind Treatment Period|Adverse Event|5|||
156822532|NCT03176472|566100188|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
156822533|NCT03176472|566100189|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
156822534|NCT03176472|566100188|FG000|Double Blind Treatment Period|Physician Decision|0|||
156822535|NCT03176472|566100189|FG001|Double Blind Treatment Period|Physician Decision|1|||
156822536|NCT03176472|566100188|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156822537|NCT03176472|566100189|FG001|Double Blind Treatment Period|Protocol Violation|0|||
156822538|NCT03176472|566100188|FG000|Double Blind Treatment Period|Not Provided|1|||
156822539|NCT03176472|566100189|FG001|Double Blind Treatment Period|Not Provided|0|||
156822540|NCT03176472|566100188|FG000|Open Label Extension|Withdrawal by Subject|3|||
156822541|NCT03176472|566100189|FG001|Open Label Extension|Withdrawal by Subject|4|||
156822542|NCT03176472|566100188|FG000|Open Label Extension|Adverse Event|2|||
156822543|NCT03176472|566100189|FG001|Open Label Extension|Adverse Event|4|||
156822544|NCT03176472|566100188|FG000|Open Label Extension|Lost to Follow-up|1|||
156822545|NCT03176472|566100189|FG001|Open Label Extension|Lost to Follow-up|2|||
156822546|NCT03176472|566100188|FG000|Open Label Extension|Protocol Violation|0|||
156822547|NCT03176472|566100189|FG001|Open Label Extension|Protocol Violation|1|||
156822548|NCT03176472|566100188|FG000|Open Label Extension|Not Provided|2|||
156822549|NCT03176472|566100189|FG001|Open Label Extension|Not Provided|1|||
156822550|NCT00596154|566100190|FG000|Overall Study|Not Evaluable|2|||
156822551|NCT01846663|566100195|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
156822552|NCT01846663|566100196|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
156822553|NCT01846663|566100195|FG000|Overall Study|Withdrawal by Subject|1|||
156822554|NCT01846663|566100196|FG001|Overall Study|Withdrawal by Subject|0|||
156822555|NCT01846663|566100195|FG000|Overall Study|Adverse Event|1|||
156822556|NCT01846663|566100196|FG001|Overall Study|Adverse Event|2|||
156822557|NCT03888235|566100207|FG000|Overall Study|Lost to Follow-up|1|||
156822558|NCT03888235|566100208|FG001|Overall Study|Lost to Follow-up|1|||
156822559|NCT03888235|566100209|FG002|Overall Study|Lost to Follow-up|0|||
156822560|NCT01054560|566100216|FG000|Overall Study|Death|10|||
156822561|NCT01054560|566100217|FG001|Overall Study|Death|21|||
156822562|NCT01054560|566100216|FG000|Overall Study|Lost to Follow-up|2|||
156822563|NCT01054560|566100217|FG001|Overall Study|Lost to Follow-up|5|||
156822564|NCT01054560|566100216|FG000|Overall Study|Withdrawal by Subject|0|||
156822565|NCT01054560|566100217|FG001|Overall Study|Withdrawal by Subject|2|||
156822566|NCT01054560|566100216|FG000|Overall Study|Physician Decision|1|||
156822567|NCT01054560|566100217|FG001|Overall Study|Physician Decision|0|||
156822568|NCT02135029|566100224|FG000|Overall Study|Adverse Event|2|||
156822569|NCT02135029|566100225|FG001|Overall Study|Adverse Event|2|||
156822570|NCT02135029|566100226|FG002|Overall Study|Adverse Event|2|||
156822571|NCT02135029|566100224|FG000|Overall Study|Lost to Follow-up|0|||
156822572|NCT02135029|566100225|FG001|Overall Study|Lost to Follow-up|1|||
156822573|NCT02135029|566100226|FG002|Overall Study|Lost to Follow-up|0|||
156822574|NCT02135029|566100224|FG000|Overall Study|Withdrawal by Subject|2|||
156822575|NCT02135029|566100225|FG001|Overall Study|Withdrawal by Subject|0|||
156822576|NCT02135029|566100226|FG002|Overall Study|Withdrawal by Subject|1|||
156822577|NCT02135029|566100224|FG000|Overall Study|Other|0|||
156822578|NCT02135029|566100225|FG001|Overall Study|Other|1|||
156822579|NCT02135029|566100226|FG002|Overall Study|Other|0|||
156822580|NCT02135029|566100224|FG000|Overall Study|Death|0|||
156822581|NCT02135029|566100225|FG001|Overall Study|Death|1|||
156822582|NCT02135029|566100226|FG002|Overall Study|Death|0|||
156822583|NCT03466099|566100229|FG000|Overall Study|Adverse Event|1|||
156822584|NCT03466099|566100230|FG001|Overall Study|Adverse Event|1|||
156822585|NCT03466099|566100231|FG002|Overall Study|Adverse Event|1|||
156822586|NCT03466099|566100229|FG000|Overall Study|Withdrawal by Subject|2|||
156822587|NCT03466099|566100230|FG001|Overall Study|Withdrawal by Subject|3|||
156822588|NCT03466099|566100231|FG002|Overall Study|Withdrawal by Subject|1|||
156822589|NCT03466099|566100229|FG000|Overall Study|Use of rescue medication|8|||
156822590|NCT03466099|566100230|FG001|Overall Study|Use of rescue medication|9|||
156822591|NCT03466099|566100231|FG002|Overall Study|Use of rescue medication|13|||
156822592|NCT03466099|566100229|FG000|Overall Study|Rescued without meeting criteria|4|||
156822593|NCT03466099|566100230|FG001|Overall Study|Rescued without meeting criteria|1|||
156822594|NCT03466099|566100231|FG002|Overall Study|Rescued without meeting criteria|1|||
156822595|NCT03466099|566100229|FG000|Overall Study|Subject compliance|2|||
156822596|NCT03466099|566100230|FG001|Overall Study|Subject compliance|0|||
156822597|NCT03466099|566100231|FG002|Overall Study|Subject compliance|0|||
156822598|NCT03466099|566100229|FG000|Overall Study|Worsening disease|0|||
156822599|NCT03466099|566100230|FG001|Overall Study|Worsening disease|0|||
156822600|NCT03466099|566100231|FG002|Overall Study|Worsening disease|1|||
156822601|NCT02210689|566100234|FG000|Overall Study|Withdrawal by Subject|7|||
156822602|NCT02210689|566100235|FG001|Overall Study|Withdrawal by Subject|4|||
156822603|NCT02210689|566100236|FG002|Overall Study|Withdrawal by Subject|2|||
156822604|NCT02210689|566100234|FG000|Overall Study|Adverse Event|0|||
156822605|NCT02210689|566100235|FG001|Overall Study|Adverse Event|1|||
156822606|NCT02210689|566100236|FG002|Overall Study|Adverse Event|0|||
156822607|NCT02210689|566100234|FG000|Overall Study|Protocol Violation|1|||
156822608|NCT02210689|566100235|FG001|Overall Study|Protocol Violation|0|||
156822609|NCT02210689|566100236|FG002|Overall Study|Protocol Violation|0|||
156822610|NCT02210689|566100234|FG000|Overall Study|Lost to Follow-up|11|||
156822611|NCT02210689|566100235|FG001|Overall Study|Lost to Follow-up|9|||
156822612|NCT02210689|566100236|FG002|Overall Study|Lost to Follow-up|5|||
156822613|NCT02210689|566100234|FG000|Overall Study|Pregnancy|0|||
156822614|NCT02210689|566100235|FG001|Overall Study|Pregnancy|1|||
156822615|NCT02210689|566100236|FG002|Overall Study|Pregnancy|0|||
156822616|NCT02210689|566100234|FG000|Overall Study|Lack of Efficacy|0|||
156822617|NCT02210689|566100235|FG001|Overall Study|Lack of Efficacy|1|||
156822618|NCT02210689|566100236|FG002|Overall Study|Lack of Efficacy|5|||
156822619|NCT02210689|566100234|FG000|Overall Study|Prohibited medication|2|||
156822620|NCT02210689|566100235|FG001|Overall Study|Prohibited medication|8|||
156822621|NCT02210689|566100236|FG002|Overall Study|Prohibited medication|1|||
156822622|NCT02210689|566100234|FG000|Overall Study|Negative Nugent score at baseline|6|||
156822623|NCT02210689|566100235|FG001|Overall Study|Negative Nugent score at baseline|2|||
156822624|NCT02210689|566100236|FG002|Overall Study|Negative Nugent score at baseline|2|||
156822625|NCT02210689|566100234|FG000|Overall Study|Other|25|||
156822626|NCT02210689|566100235|FG001|Overall Study|Other|21|||
156822627|NCT02210689|566100236|FG002|Overall Study|Other|8|||
156822628|NCT00075946|566100237|FG000|Overall Study|Path ineligible: undetermined histology|0|||
156822629|NCT00075946|566100238|FG001|Overall Study|Path ineligible: undetermined histology|0|||
156822630|NCT00075946|566100239|FG002|Overall Study|Path ineligible: undetermined histology|0|||
156465910|NCT03699163|564802745|FG000|Overall Study|Physician Decision|12|||
156465911|NCT03699163|564802746|FG001|Overall Study|Physician Decision|0|||
156465912|NCT03699163|564802745|FG000|Overall Study|failed QC measures|205|||
156465913|NCT03699163|564802746|FG001|Overall Study|failed QC measures|206|||
156465914|NCT01596972|564802747|FG000|Overall Study|Physician Decision|1|||
156822631|NCT00075946|566100240|FG003|Overall Study|Path ineligible: undetermined histology|0|||
156822632|NCT00075946|566100241|FG004|Overall Study|Path ineligible: undetermined histology|6|||
156541159|NCT00253643|565074492|FG002|Overall Study|Non-Compliance|0|||
156541160|NCT00253643|565074493|FG003|Overall Study|Non-Compliance|2|||
156541161|NCT01368536|565074497|FG000|Overall Study|Adverse Event|5|||
156822633|NCT00075946|566100237|FG000|Overall Study|Did not achieve response after induction|0|||
156822634|NCT00075946|566100238|FG001|Overall Study|Did not achieve response after induction|0|||
156822635|NCT00075946|566100239|FG002|Overall Study|Did not achieve response after induction|0|||
156822636|NCT00075946|566100240|FG003|Overall Study|Did not achieve response after induction|0|||
156822637|NCT00075946|566100241|FG004|Overall Study|Did not achieve response after induction|182|||
156822638|NCT00075946|566100237|FG000|Overall Study|Incorrectly randomized (no response)|5|||
156822639|NCT00075946|566100238|FG001|Overall Study|Incorrectly randomized (no response)|5|||
156822640|NCT00075946|566100239|FG002|Overall Study|Incorrectly randomized (no response)|5|||
156822641|NCT00075946|566100240|FG003|Overall Study|Incorrectly randomized (no response)|1|||
156822642|NCT00075946|566100241|FG004|Overall Study|Incorrectly randomized (no response)|0|||
156822643|NCT00075946|566100237|FG000|Overall Study|Adverse Event|2|||
156822644|NCT00075946|566100238|FG001|Overall Study|Adverse Event|10|||
156822645|NCT00075946|566100239|FG002|Overall Study|Adverse Event|0|||
156822646|NCT00075946|566100240|FG003|Overall Study|Adverse Event|2|||
156822647|NCT00075946|566100241|FG004|Overall Study|Adverse Event|0|||
156822648|NCT00075946|566100237|FG000|Overall Study|Death|0|||
156822649|NCT00075946|566100238|FG001|Overall Study|Death|1|||
156822650|NCT00075946|566100239|FG002|Overall Study|Death|0|||
156822651|NCT00075946|566100240|FG003|Overall Study|Death|0|||
156822652|NCT00075946|566100241|FG004|Overall Study|Death|0|||
156822653|NCT00075946|566100237|FG000|Overall Study|Withdrawal by Subject|23|||
156822654|NCT00075946|566100238|FG001|Overall Study|Withdrawal by Subject|58|||
156822655|NCT00075946|566100239|FG002|Overall Study|Withdrawal by Subject|4|||
156822656|NCT00075946|566100240|FG003|Overall Study|Withdrawal by Subject|9|||
156822657|NCT00075946|566100241|FG004|Overall Study|Withdrawal by Subject|0|||
156822658|NCT00075946|566100237|FG000|Overall Study|Alternative therapy|16|||
156822659|NCT00075946|566100238|FG001|Overall Study|Alternative therapy|2|||
156822660|NCT00075946|566100239|FG002|Overall Study|Alternative therapy|5|||
156822661|NCT00075946|566100240|FG003|Overall Study|Alternative therapy|0|||
156822662|NCT00075946|566100241|FG004|Overall Study|Alternative therapy|0|||
156822663|NCT00075946|566100237|FG000|Overall Study|Other complicating disease|7|||
156822664|NCT00075946|566100238|FG001|Overall Study|Other complicating disease|13|||
156822665|NCT00075946|566100239|FG002|Overall Study|Other complicating disease|1|||
156822666|NCT00075946|566100240|FG003|Overall Study|Other complicating disease|4|||
156822667|NCT00075946|566100241|FG004|Overall Study|Other complicating disease|0|||
156822668|NCT00075946|566100237|FG000|Overall Study|No response to retreatment|23|||
156822669|NCT00075946|566100238|FG001|Overall Study|No response to retreatment|0|||
156822670|NCT00075946|566100239|FG002|Overall Study|No response to retreatment|2|||
156822671|NCT00075946|566100240|FG003|Overall Study|No response to retreatment|0|||
156822672|NCT00075946|566100241|FG004|Overall Study|No response to retreatment|0|||
156822673|NCT00075946|566100237|FG000|Overall Study|Time to progression less than 6 months|15|||
156822674|NCT00075946|566100238|FG001|Overall Study|Time to progression less than 6 months|30|||
156822675|NCT00075946|566100239|FG002|Overall Study|Time to progression less than 6 months|8|||
156822676|NCT00075946|566100240|FG003|Overall Study|Time to progression less than 6 months|3|||
156822677|NCT00075946|566100241|FG004|Overall Study|Time to progression less than 6 months|0|||
156822678|NCT00075946|566100237|FG000|Overall Study|Other|57|||
156822679|NCT00075946|566100238|FG001|Overall Study|Other|32|||
156822680|NCT00075946|566100239|FG002|Overall Study|Other|3|||
156822681|NCT00075946|566100240|FG003|Overall Study|Other|11|||
156822682|NCT00075946|566100241|FG004|Overall Study|Other|0|||
156822683|NCT00866047|566100242|FG000|Treatment Period|Progressive disease|13|||
156822684|NCT00866047|566100242|FG000|Treatment Period|Adverse Event|16|||
156822685|NCT00866047|566100242|FG000|Treatment Period|Physician Decision|14|||
156822686|NCT00866047|566100242|FG000|Treatment Period|Withdrawal by Subject|5|||
156822687|NCT00866047|566100242|FG000|Follow-up Period|Lost to Follow-up|5|||
156822688|NCT05427539|566100243|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
156822689|NCT05427539|566100244|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
156822690|NCT05427539|566100243|FG000|Period 1|Withdrawal by Subject|1|||
156822691|NCT05427539|566100244|FG001|Period 1|Withdrawal by Subject|0|||
156541162|NCT01368536|565074498|FG001|Overall Study|Adverse Event|6|||
156541163|NCT01368536|565074499|FG002|Overall Study|Adverse Event|8|||
156822692|NCT00223977|566100245|FG000|Overall Study|Adverse Event|7|||
156822693|NCT00223977|566100246|FG001|Overall Study|Adverse Event|10|||
156822694|NCT00223977|566100247|FG002|Overall Study|Adverse Event|0|||
156822695|NCT00223977|566100245|FG000|Overall Study|Protocol Violation|0|||
156822696|NCT00223977|566100246|FG001|Overall Study|Protocol Violation|0|||
156822697|NCT00223977|566100247|FG002|Overall Study|Protocol Violation|1|||
156822698|NCT00223977|566100245|FG000|Overall Study|Withdrawal by Subject|1|||
156822699|NCT00223977|566100246|FG001|Overall Study|Withdrawal by Subject|1|||
156822700|NCT00223977|566100247|FG002|Overall Study|Withdrawal by Subject|2|||
156822701|NCT00223977|566100245|FG000|Overall Study|Other|1|||
156822702|NCT00223977|566100246|FG001|Overall Study|Other|0|||
156822703|NCT00223977|566100247|FG002|Overall Study|Other|0|||
156822704|NCT00778258|566100251|FG000|Overall Study|Adverse Event|1|||
156822705|NCT00778258|566100252|FG001|Overall Study|Adverse Event|0|||
156822706|NCT00778258|566100253|FG002|Overall Study|Adverse Event|0|||
156822707|NCT00778258|566100254|FG003|Overall Study|Adverse Event|0|||
156822708|NCT00778258|566100255|FG004|Overall Study|Adverse Event|0|||
156822709|NCT00778258|566100256|FG005|Overall Study|Adverse Event|1|||
156822710|NCT00778258|566100257|FG006|Overall Study|Adverse Event|0|||
156822711|NCT00778258|566100258|FG007|Overall Study|Adverse Event|0|||
156822712|NCT00778258|566100259|FG008|Overall Study|Adverse Event|0|||
156822713|NCT00778258|566100251|FG000|Overall Study|Lost to Follow-up|0|||
156822714|NCT00778258|566100252|FG001|Overall Study|Lost to Follow-up|0|||
156822715|NCT00778258|566100253|FG002|Overall Study|Lost to Follow-up|2|||
156822716|NCT00778258|566100254|FG003|Overall Study|Lost to Follow-up|0|||
156822717|NCT00778258|566100255|FG004|Overall Study|Lost to Follow-up|0|||
156822718|NCT00778258|566100256|FG005|Overall Study|Lost to Follow-up|3|||
156822719|NCT00778258|566100257|FG006|Overall Study|Lost to Follow-up|2|||
156822720|NCT00778258|566100258|FG007|Overall Study|Lost to Follow-up|2|||
156822721|NCT00778258|566100259|FG008|Overall Study|Lost to Follow-up|0|||
156822722|NCT00778258|566100251|FG000|Overall Study|Withdrawal by Subject|6|||
156822723|NCT00778258|566100252|FG001|Overall Study|Withdrawal by Subject|2|||
156822724|NCT00778258|566100253|FG002|Overall Study|Withdrawal by Subject|8|||
156822725|NCT00778258|566100254|FG003|Overall Study|Withdrawal by Subject|2|||
156465915|NCT01596972|564802748|FG001|Overall Study|Physician Decision|9|||
156822726|NCT00778258|566100255|FG004|Overall Study|Withdrawal by Subject|0|||
156822727|NCT00778258|566100256|FG005|Overall Study|Withdrawal by Subject|6|||
156822728|NCT00778258|566100257|FG006|Overall Study|Withdrawal by Subject|12|||
156822729|NCT00778258|566100258|FG007|Overall Study|Withdrawal by Subject|12|||
156822730|NCT00778258|566100259|FG008|Overall Study|Withdrawal by Subject|4|||
156822731|NCT00778258|566100251|FG000|Overall Study|New Contraindication|0|||
156822732|NCT00778258|566100252|FG001|Overall Study|New Contraindication|0|||
156822733|NCT00778258|566100253|FG002|Overall Study|New Contraindication|0|||
156822734|NCT00778258|566100254|FG003|Overall Study|New Contraindication|0|||
156822735|NCT00778258|566100255|FG004|Overall Study|New Contraindication|0|||
156822736|NCT00778258|566100256|FG005|Overall Study|New Contraindication|0|||
156822737|NCT00778258|566100257|FG006|Overall Study|New Contraindication|0|||
156822738|NCT00778258|566100258|FG007|Overall Study|New Contraindication|1|||
156822739|NCT00778258|566100259|FG008|Overall Study|New Contraindication|0|||
156822740|NCT00778258|566100251|FG000|Overall Study|Non-compliance|0|||
156822741|NCT00778258|566100252|FG001|Overall Study|Non-compliance|0|||
156822742|NCT00778258|566100253|FG002|Overall Study|Non-compliance|0|||
156822743|NCT00778258|566100254|FG003|Overall Study|Non-compliance|1|||
156822744|NCT00778258|566100255|FG004|Overall Study|Non-compliance|0|||
156822745|NCT00778258|566100256|FG005|Overall Study|Non-compliance|0|||
156822746|NCT00778258|566100257|FG006|Overall Study|Non-compliance|0|||
156822747|NCT00778258|566100258|FG007|Overall Study|Non-compliance|0|||
156822748|NCT00778258|566100259|FG008|Overall Study|Non-compliance|0|||
156822749|NCT00778258|566100251|FG000|Overall Study|Other|0|||
156822750|NCT00778258|566100252|FG001|Overall Study|Other|0|||
156822751|NCT00778258|566100253|FG002|Overall Study|Other|0|||
156822752|NCT00778258|566100254|FG003|Overall Study|Other|0|||
156822753|NCT00778258|566100255|FG004|Overall Study|Other|0|||
156822754|NCT00778258|566100256|FG005|Overall Study|Other|0|||
156822755|NCT00778258|566100257|FG006|Overall Study|Other|1|||
156822756|NCT00778258|566100258|FG007|Overall Study|Other|0|||
156465916|NCT01596972|564802747|FG000|Overall Study|Lost to Follow-up|0|||
156465917|NCT01596972|564802748|FG001|Overall Study|Lost to Follow-up|4|||
156465918|NCT01596972|564802747|FG000|Overall Study|Withdrawal by Subject|0|||
156465919|NCT01596972|564802748|FG001|Overall Study|Withdrawal by Subject|1|||
156465920|NCT01964300|564802750|FG000|Overall Study|Ineligible after enrollment|0|||
156465921|NCT01964300|564802751|FG001|Overall Study|Ineligible after enrollment|1|||
156822757|NCT00778258|566100259|FG008|Overall Study|Other|0|||
156822758|NCT00780143|566100260|FG000|Overall Study|Progressive disease|1|||
156822759|NCT00780143|566100260|FG000|Overall Study|Toxicity|1|||
156822760|NCT00780143|566100260|FG000|Overall Study|Adverse Event|1|||
156822761|NCT02644096|566100263|FG000|Overall Study|Withdrawal by Subject|28|||
156822762|NCT02644096|566100264|FG001|Overall Study|Withdrawal by Subject|25|||
156822763|NCT02461290|566100265|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
156822764|NCT02461290|566100265|FG000|Overall Study|Lost to Follow-up|3|||
156822765|NCT00322452|566100266|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156822766|NCT00322452|566100267|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156822767|NCT00322452|566100266|FG000|Overall Study|Lost to Follow-up|5|||
156822768|NCT00322452|566100267|FG001|Overall Study|Lost to Follow-up|2|||
156822769|NCT00322452|566100266|FG000|Overall Study|Withdrawal by Subject|19|||
156822770|NCT00322452|566100267|FG001|Overall Study|Withdrawal by Subject|46|||
156822771|NCT00322452|566100266|FG000|Overall Study|Death|223|||
156822772|NCT00322452|566100267|FG001|Overall Study|Death|227|||
156465922|NCT01964300|564802750|FG000|Overall Study|Adverse Event|1|||
156822773|NCT00526656|566100268|FG000|Overall Study|Death|1|||
156822774|NCT00526656|566100268|FG000|Overall Study|Refused surgery|1|||
156822775|NCT03285958|566102603|FG000|Overall Study|Lost to Follow-up|1|||
156822776|NCT03285958|566102604|FG001|Overall Study|Lost to Follow-up|1|||
156822777|NCT03285958|566102603|FG000|Overall Study|Withdrawal by Subject|1|||
156822778|NCT03285958|566102604|FG001|Overall Study|Withdrawal by Subject|0|||
156465923|NCT01964300|564802751|FG001|Overall Study|Adverse Event|1|||
156465924|NCT01964300|564802750|FG000|Overall Study|Lack of Efficacy|3|||
156465925|NCT01964300|564802751|FG001|Overall Study|Lack of Efficacy|5|||
156465926|NCT01964300|564802750|FG000|Overall Study|Withdrawal by Subject|0|||
156465927|NCT01964300|564802751|FG001|Overall Study|Withdrawal by Subject|1|||
156465928|NCT01964300|564802750|FG000|Overall Study|To receive alternative therapy|1|||
156465929|NCT01964300|564802751|FG001|Overall Study|To receive alternative therapy|2|||
156465930|NCT01964300|564802750|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
156465931|NCT01964300|564802751|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
156465932|NCT01964300|564802750|FG000|Overall Study|Weight criteria not met|0|||
156465933|NCT01964300|564802751|FG001|Overall Study|Weight criteria not met|1|||
156465934|NCT04129164|564802753|FG000|Overall Study|Non-compliance with procedures|0|||
156465935|NCT04129164|564802754|FG001|Overall Study|Non-compliance with procedures|0|||
156465936|NCT04129164|564802755|FG002|Overall Study|Non-compliance with procedures|2|||
156465937|NCT04129164|564802756|FG003|Overall Study|Non-compliance with procedures|0|||
156465938|NCT04129164|564802753|FG000|Overall Study|Adverse Event|0|||
156465939|NCT04129164|564802754|FG001|Overall Study|Adverse Event|0|||
156465940|NCT04129164|564802755|FG002|Overall Study|Adverse Event|2|||
156465941|NCT04129164|564802756|FG003|Overall Study|Adverse Event|0|||
156465942|NCT04129164|564802753|FG000|Overall Study|Pregnancy|0|||
156465943|NCT04129164|564802754|FG001|Overall Study|Pregnancy|0|||
156465944|NCT04129164|564802755|FG002|Overall Study|Pregnancy|0|||
156465945|NCT04129164|564802756|FG003|Overall Study|Pregnancy|1|||
156465946|NCT04129164|564802753|FG000|Overall Study|Withdrawal by Subject|3|||
156465947|NCT04129164|564802754|FG001|Overall Study|Withdrawal by Subject|2|||
156465948|NCT04129164|564802755|FG002|Overall Study|Withdrawal by Subject|4|||
156465949|NCT04129164|564802756|FG003|Overall Study|Withdrawal by Subject|6|||
156465950|NCT04129164|564802753|FG000|Overall Study|Death|0|||
156465951|NCT04129164|564802754|FG001|Overall Study|Death|1|||
156465952|NCT04129164|564802755|FG002|Overall Study|Death|0|||
156465953|NCT04129164|564802756|FG003|Overall Study|Death|0|||
156465954|NCT04129164|564802753|FG000|Overall Study|Lost to Follow-up|0|||
156465955|NCT04129164|564802754|FG001|Overall Study|Lost to Follow-up|1|||
156465956|NCT04129164|564802755|FG002|Overall Study|Lost to Follow-up|0|||
156465957|NCT04129164|564802756|FG003|Overall Study|Lost to Follow-up|0|||
156465958|NCT01260896|564802763|FG000|First Intervention|Withdrawn Due to Emesis|2|||
156465959|NCT01260896|564802764|FG001|First Intervention|Withdrawn Due to Emesis|0|||
156465960|NCT00003222|564802774|FG000|Overall Study|Physician Decision|0|||
156465961|NCT00003222|564802775|FG001|Overall Study|Physician Decision|1|||
156465962|NCT05030584|564802776|FG000|Overall Study|Adverse Event|17|||
156465963|NCT05030584|564802777|FG001|Overall Study|Adverse Event|2|||
156822779|NCT03285958|566102603|FG000|Overall Study|Not able to attend required orientation|3|||
156822780|NCT03285958|566102604|FG001|Overall Study|Not able to attend required orientation|0|||
156339203|NCT01090492|564340143|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156339204|NCT01090492|564340144|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
156339205|NCT01090492|564340145|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156465964|NCT05030584|564802776|FG000|Overall Study|Lack of Efficacy|0|||
156465965|NCT05030584|564802777|FG001|Overall Study|Lack of Efficacy|6|||
156465966|NCT05030584|564802776|FG000|Overall Study|Lost to Follow-up|5|||
156541164|NCT01368536|565074497|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156465967|NCT05030584|564802777|FG001|Overall Study|Lost to Follow-up|2|||
156465968|NCT05030584|564802776|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156822781|NCT03116828|566102605|FG000|Overall Study|Adverse Event|1|||
156822782|NCT03116828|566102606|FG001|Overall Study|Adverse Event|10|||
156822783|NCT03116828|566102605|FG000|Overall Study|Withdrawal by Subject|4|||
156465969|NCT05030584|564802777|FG001|Overall Study|Non-Compliance with Study Drug|3|||
156465970|NCT05030584|564802776|FG000|Overall Study|Other reason|4|||
156465971|NCT05030584|564802777|FG001|Overall Study|Other reason|3|||
156465972|NCT05030584|564802776|FG000|Overall Study|Physician Decision|1|||
156465973|NCT05030584|564802777|FG001|Overall Study|Physician Decision|4|||
156465974|NCT05030584|564802776|FG000|Overall Study|Protocol Violation|0|||
156465975|NCT05030584|564802777|FG001|Overall Study|Protocol Violation|2|||
156465976|NCT05030584|564802776|FG000|Overall Study|Randomized by Mistake|0|||
156465977|NCT05030584|564802777|FG001|Overall Study|Randomized by Mistake|2|||
156822784|NCT03116828|566102606|FG001|Overall Study|Withdrawal by Subject|8|||
156822785|NCT03116828|566102605|FG000|Overall Study|OTHER|3|||
156822786|NCT03116828|566102606|FG001|Overall Study|OTHER|3|||
156822787|NCT00983515|566102609|FG000|Ritonavir Alone|liver panel out of range|6|||
156822788|NCT00983515|566102609|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
156822789|NCT05243745|566102610|FG000|Overall Study|Withdrawal by Subject|0|||
156822790|NCT05243745|566102611|FG001|Overall Study|Withdrawal by Subject|0|||
156822791|NCT05243745|566102612|FG002|Overall Study|Withdrawal by Subject|0|||
156822792|NCT05243745|566102613|FG003|Overall Study|Withdrawal by Subject|1|||
156822793|NCT05243745|566102610|FG000|Overall Study|Unable to Attend Visit 6|0|||
156822794|NCT05243745|566102611|FG001|Overall Study|Unable to Attend Visit 6|0|||
156822795|NCT05243745|566102612|FG002|Overall Study|Unable to Attend Visit 6|1|||
156822796|NCT05243745|566102613|FG003|Overall Study|Unable to Attend Visit 6|0|||
156822797|NCT02998203|566102614|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
156822798|NCT02998203|566102615|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
156822799|NCT02998203|566102614|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
156822800|NCT02998203|566102615|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
156822801|NCT04187144|566102628|FG000|Overall Study|Lost to Follow-up|12|||
156822802|NCT04187144|566102629|FG001|Overall Study|Lost to Follow-up|11|||
156822803|NCT04187144|566102628|FG000|Overall Study|Withdrawal by Subject|20|||
156822804|NCT04187144|566102629|FG001|Overall Study|Withdrawal by Subject|18|||
156822805|NCT04187144|566102628|FG000|Overall Study|Adverse Event|19|||
156822806|NCT04187144|566102629|FG001|Overall Study|Adverse Event|4|||
156822807|NCT04187144|566102628|FG000|Overall Study|Physician Decision|5|||
156822808|NCT04187144|566102629|FG001|Overall Study|Physician Decision|3|||
156822809|NCT04187144|566102628|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
156822810|NCT04187144|566102629|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
156822811|NCT04187144|566102628|FG000|Overall Study|Protocol Deviation|1|||
156822812|NCT04187144|566102629|FG001|Overall Study|Protocol Deviation|4|||
156822813|NCT03842969|566102630|FG000|Overall Study|Participant declined follow-up visit|0|||
156465978|NCT05030584|564802776|FG000|Overall Study|Withdrawal by Subject|21|||
156465979|NCT05030584|564802777|FG001|Overall Study|Withdrawal by Subject|28|||
156465980|NCT05030584|564802776|FG000|Overall Study|Technical Problems|0|||
156465981|NCT05030584|564802777|FG001|Overall Study|Technical Problems|1|||
156465982|NCT05030584|564802776|FG000|Overall Study|Completed post-treatment/FU visits|41|||
156465983|NCT05030584|564802777|FG001|Overall Study|Completed post-treatment/FU visits|31|||
156465984|NCT01313559|564802784|FG000|Overall Study|Withdrawal by Subject|1|||
156465985|NCT01313559|564802785|FG001|Overall Study|Withdrawal by Subject|2|||
156465986|NCT01313559|564802784|FG000|Overall Study|Disease progression|1|||
156465987|NCT01313559|564802785|FG001|Overall Study|Disease progression|0|||
156822814|NCT03842969|566102631|FG001|Overall Study|Participant declined follow-up visit|1|||
156822815|NCT03842969|566102632|FG002|Overall Study|Participant declined follow-up visit|0|||
156822816|NCT03842969|566102630|FG000|Overall Study|Sponsor's decision|12|||
156822817|NCT03842969|566102631|FG001|Overall Study|Sponsor's decision|99|||
156822818|NCT03842969|566102632|FG002|Overall Study|Sponsor's decision|61|||
156822819|NCT03842969|566102630|FG000|Overall Study|Pregnancy|0|||
156822820|NCT03842969|566102631|FG001|Overall Study|Pregnancy|0|||
156822821|NCT03842969|566102632|FG002|Overall Study|Pregnancy|1|||
156822822|NCT03842969|566102630|FG000|Overall Study|Death|1|||
156822823|NCT03842969|566102631|FG001|Overall Study|Death|0|||
156822824|NCT03842969|566102632|FG002|Overall Study|Death|1|||
156822825|NCT03842969|566102630|FG000|Overall Study|Withdrawal by Subject|3|||
156822826|NCT03842969|566102631|FG001|Overall Study|Withdrawal by Subject|30|||
156822827|NCT03842969|566102632|FG002|Overall Study|Withdrawal by Subject|18|||
156822828|NCT03842969|566102630|FG000|Overall Study|Protocol Violation|1|||
156822829|NCT03842969|566102631|FG001|Overall Study|Protocol Violation|1|||
156822830|NCT03842969|566102632|FG002|Overall Study|Protocol Violation|0|||
156822831|NCT03842969|566102630|FG000|Overall Study|Physician Decision|0|||
156822832|NCT03842969|566102631|FG001|Overall Study|Physician Decision|3|||
156822833|NCT03842969|566102632|FG002|Overall Study|Physician Decision|0|||
156822834|NCT03842969|566102630|FG000|Overall Study|Lost to Follow-up|0|||
156822835|NCT03842969|566102631|FG001|Overall Study|Lost to Follow-up|2|||
156822836|NCT03842969|566102632|FG002|Overall Study|Lost to Follow-up|0|||
156822837|NCT03842969|566102630|FG000|Overall Study|Adverse Event|0|||
156822838|NCT03842969|566102631|FG001|Overall Study|Adverse Event|2|||
156822839|NCT03842969|566102632|FG002|Overall Study|Adverse Event|0|||
156822840|NCT01044745|566102633|FG000|Overall Study|Ineiligible|2|||
156822841|NCT05312632|566102636|FG000|Overall Study|Adverse Event|12|||
156822842|NCT05312632|566102636|FG000|Overall Study|Withdrawal by Subject|10|||
156822843|NCT05312632|566102636|FG000|Overall Study|Lack of Efficacy|4|||
156822844|NCT05312632|566102636|FG000|Overall Study|Non-compliance with study procedures|9|||
156822845|NCT05312632|566102636|FG000|Overall Study|Other|4|||
156822846|NCT02379221|566102637|FG000|Overall Study|Lost to Follow-up|1|||
156822847|NCT02019108|566102638|FG000|Overall Study|Lost to Follow-up|5|||
156822848|NCT02019108|566102639|FG001|Overall Study|Lost to Follow-up|7|||
156822849|NCT00519376|566102646|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822850|NCT00519376|566102647|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822851|NCT00519376|566102648|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822852|NCT00519376|566102649|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822853|NCT00519376|566102650|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822854|NCT00519376|566102651|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822855|NCT00519376|566102652|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822856|NCT00519376|566102653|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822857|NCT00519376|566102654|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822858|NCT00519376|566102655|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822859|NCT00519376|566102656|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156465988|NCT01313559|564802784|FG000|Overall Study|Rising PSA|2|||
156465989|NCT01313559|564802785|FG001|Overall Study|Rising PSA|0|||
156465990|NCT06393127|564802786|FG000|Washout period|Withdrawal by Subject|1|||
156465991|NCT06393127|564802787|FG001|Washout period|Withdrawal by Subject|0|||
156465992|NCT06393127|564802786|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
156465993|NCT06393127|564802787|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
156465994|NCT02466971|564802790|FG000|Overall Study|eligible and never treated|14|||
156465995|NCT02466971|564802791|FG001|Overall Study|eligible and never treated|20|||
156465996|NCT02466971|564802790|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
156822860|NCT00519376|566102657|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822861|NCT00519376|566102658|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
156822862|NCT00519376|566102659|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822863|NCT00519376|566102660|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822864|NCT00519376|566102661|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822865|NCT00519376|566102646|FG000|Treatment Period 4|Lost to Follow-up|0|||
156822866|NCT00519376|566102647|FG001|Treatment Period 4|Lost to Follow-up|0|||
156822867|NCT00519376|566102648|FG002|Treatment Period 4|Lost to Follow-up|1|||
156822868|NCT00519376|566102649|FG003|Treatment Period 4|Lost to Follow-up|0|||
156822869|NCT00519376|566102650|FG004|Treatment Period 4|Lost to Follow-up|0|||
156822870|NCT00519376|566102651|FG005|Treatment Period 4|Lost to Follow-up|0|||
156822871|NCT00519376|566102652|FG006|Treatment Period 4|Lost to Follow-up|0|||
156822872|NCT00519376|566102653|FG007|Treatment Period 4|Lost to Follow-up|0|||
156822873|NCT00519376|566102654|FG008|Treatment Period 4|Lost to Follow-up|0|||
156822874|NCT00519376|566102655|FG009|Treatment Period 4|Lost to Follow-up|0|||
156822875|NCT00519376|566102656|FG010|Treatment Period 4|Lost to Follow-up|0|||
156822876|NCT00519376|566102657|FG011|Treatment Period 4|Lost to Follow-up|0|||
156822877|NCT00519376|566102658|FG012|Treatment Period 4|Lost to Follow-up|0|||
156822878|NCT00519376|566102659|FG013|Treatment Period 4|Lost to Follow-up|0|||
156822879|NCT00519376|566102660|FG014|Treatment Period 4|Lost to Follow-up|0|||
156822880|NCT00519376|566102661|FG015|Treatment Period 4|Lost to Follow-up|0|||
156822881|NCT02688088|566102662|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
156822882|NCT02688088|566102663|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
156822883|NCT02688088|566102664|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
156822884|NCT02688088|566102665|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
156822885|NCT02688088|566102666|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
156822886|NCT02688088|566102662|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
156822887|NCT02688088|566102663|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
156822888|NCT02688088|566102664|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
156822889|NCT02688088|566102665|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
156822890|NCT02688088|566102666|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
156822891|NCT02688088|566102662|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
156822892|NCT02688088|566102663|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
156822893|NCT02688088|566102664|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
156822894|NCT02688088|566102665|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
156822895|NCT02688088|566102666|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
156822896|NCT02688088|566102662|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
156822897|NCT02688088|566102663|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
156822898|NCT02688088|566102664|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
156822899|NCT02688088|566102665|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
156822900|NCT02688088|566102666|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
156822901|NCT02688088|566102662|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
156822902|NCT02688088|566102663|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
156822903|NCT02688088|566102664|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
156822904|NCT02688088|566102665|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
156822905|NCT02688088|566102666|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
156822906|NCT02688088|566102662|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
156822907|NCT02688088|566102663|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
156822908|NCT02688088|566102664|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
156822909|NCT02688088|566102665|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
156822910|NCT02688088|566102666|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
156822911|NCT02688088|566102662|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
156822912|NCT02688088|566102663|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
156822913|NCT02688088|566102664|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
156822914|NCT02688088|566102665|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
156822915|NCT02688088|566102666|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
156822916|NCT02688088|566102662|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
156822917|NCT02688088|566102663|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
156822918|NCT02688088|566102664|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
156822919|NCT02688088|566102665|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
156822920|NCT02688088|566102666|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
156822921|NCT02688088|566102662|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
156822922|NCT02688088|566102663|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
156822923|NCT02688088|566102664|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
156822924|NCT02688088|566102665|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
156822925|NCT02688088|566102666|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
156822926|NCT03812185|566102674|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
156822927|NCT01694121|566102686|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
156822928|NCT01694121|566102687|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
156822929|NCT02928029|566102688|FG000|Overall Study|Withdrawal by Subject|0|||
156822930|NCT02928029|566102689|FG001|Overall Study|Withdrawal by Subject|1|||
156822931|NCT02928029|566102688|FG000|Overall Study|Radiological progression|1|||
156822932|NCT02928029|566102689|FG001|Overall Study|Radiological progression|0|||
156822933|NCT02928029|566102688|FG000|Overall Study|Clinical progression|1|||
156822934|NCT02928029|566102689|FG001|Overall Study|Clinical progression|2|||
156822935|NCT02928029|566102688|FG000|Overall Study|AE not related to clinical progression|1|||
156822936|NCT02928029|566102689|FG001|Overall Study|AE not related to clinical progression|1|||
156822937|NCT04376684|566102699|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
156822938|NCT04376684|566102700|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
156822939|NCT04376684|566102701|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
156822940|NCT04376684|566102702|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
156822941|NCT04376684|566102699|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
156822942|NCT04376684|566102700|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
156822943|NCT04376684|566102701|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
156822944|NCT04376684|566102702|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
156822945|NCT04376684|566102699|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
156822946|NCT04376684|566102700|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
156822947|NCT04376684|566102701|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
156822948|NCT04376684|566102702|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
156822949|NCT04376684|566102699|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
156822950|NCT04376684|566102700|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
156822951|NCT04376684|566102701|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
156822952|NCT04376684|566102702|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
156822953|NCT04376684|566102699|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
156822954|NCT04376684|566102700|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
156822955|NCT04376684|566102701|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
156822956|NCT04376684|566102702|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
156822957|NCT04376684|566102699|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
156822958|NCT04376684|566102700|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
156822959|NCT04376684|566102701|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
156822960|NCT04376684|566102702|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
156822961|NCT04376684|566102699|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
156822962|NCT04376684|566102700|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
156822963|NCT04376684|566102701|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
156822964|NCT04376684|566102702|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
156822965|NCT02979093|566102717|FG000|First Scan Session|Scanning data problems|1|||
156822966|NCT02979093|566102718|FG001|First Scan Session|Scanning data problems|2|||
156822967|NCT02979093|566102719|FG002|First Scan Session|Scanning data problems|2|||
156822968|NCT02979093|566102720|FG003|First Scan Session|Scanning data problems|0|||
156822969|NCT02979093|566102717|FG000|Second Scan Session|Scanning data problems|3|||
156822970|NCT02979093|566102718|FG001|Second Scan Session|Scanning data problems|0|||
156822971|NCT02979093|566102719|FG002|Second Scan Session|Scanning data problems|1|||
156822972|NCT02979093|566102720|FG003|Second Scan Session|Scanning data problems|3|||
156822973|NCT06107803|566102721|FG000|Overall Study|Adverse Event|1|||
156822974|NCT06107803|566102721|FG000|Overall Study|Withdrawal by Subject|2|||
156822975|NCT06107803|566102721|FG000|Overall Study|Protocol Violation|1|||
156822976|NCT03099174|566102722|FG000|Overall Study|Withdrawal by Subject|0|||
156822977|NCT03099174|566102723|FG001|Overall Study|Withdrawal by Subject|0|||
156822978|NCT03099174|566102724|FG002|Overall Study|Withdrawal by Subject|1|||
156822979|NCT03099174|566102725|FG003|Overall Study|Withdrawal by Subject|0|||
156822980|NCT03099174|566102726|FG004|Overall Study|Withdrawal by Subject|2|||
156822981|NCT03099174|566102727|FG005|Overall Study|Withdrawal by Subject|2|||
156822982|NCT03099174|566102728|FG006|Overall Study|Withdrawal by Subject|1|||
156822983|NCT03099174|566102729|FG007|Overall Study|Withdrawal by Subject|4|||
156822984|NCT03099174|566102722|FG000|Overall Study|Adverse Event|0|||
156822985|NCT03099174|566102723|FG001|Overall Study|Adverse Event|1|||
156822986|NCT03099174|566102724|FG002|Overall Study|Adverse Event|1|||
156822987|NCT03099174|566102725|FG003|Overall Study|Adverse Event|2|||
156822988|NCT03099174|566102726|FG004|Overall Study|Adverse Event|5|||
156822989|NCT03099174|566102727|FG005|Overall Study|Adverse Event|3|||
156822990|NCT03099174|566102728|FG006|Overall Study|Adverse Event|6|||
156822991|NCT03099174|566102729|FG007|Overall Study|Adverse Event|4|||
156822992|NCT03099174|566102722|FG000|Overall Study|Other than listed|6|||
156822993|NCT03099174|566102723|FG001|Overall Study|Other than listed|6|||
156822994|NCT03099174|566102724|FG002|Overall Study|Other than listed|5|||
156822995|NCT03099174|566102725|FG003|Overall Study|Other than listed|6|||
156822996|NCT03099174|566102726|FG004|Overall Study|Other than listed|19|||
156822997|NCT03099174|566102727|FG005|Overall Study|Other than listed|10|||
156822998|NCT03099174|566102728|FG006|Overall Study|Other than listed|26|||
156822999|NCT03099174|566102729|FG007|Overall Study|Other than listed|23|||
156823000|NCT04730635|566102730|FG000|Overall Study|Lost to Follow-up|1|||
156823001|NCT04730635|566102731|FG001|Overall Study|Lost to Follow-up|0|||
156823002|NCT04730635|566102730|FG000|Overall Study|Withdrawal by Subject|0|||
156823003|NCT04730635|566102731|FG001|Overall Study|Withdrawal by Subject|1|||
156823004|NCT03070223|566102732|FG000|Overall Study|Lost to Follow-up|34|||
156465997|NCT02466971|564802791|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
156823005|NCT03070223|566102733|FG001|Overall Study|Lost to Follow-up|27|||
156823006|NCT03070223|566102732|FG000|Overall Study|Withdrawal by Subject|12|||
156823007|NCT03070223|566102733|FG001|Overall Study|Withdrawal by Subject|22|||
156823008|NCT03070223|566102732|FG000|Overall Study|Protocol Violation|0|||
156823009|NCT03070223|566102733|FG001|Overall Study|Protocol Violation|1|||
156541165|NCT01368536|565074498|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156823010|NCT04934800|566102734|FG000|Overall Study|Other|1|||
156823011|NCT04934800|566102734|FG000|Overall Study|Withdrawal by Subject|5|||
156823012|NCT04934800|566102734|FG000|Overall Study|Lack of Efficacy|1|||
156823013|NCT04934800|566102734|FG000|Overall Study|Adverse Event|9|||
156823014|NCT04934800|566102734|FG000|Overall Study|Lost to Follow-up|5|||
156823015|NCT04934800|566102734|FG000|Overall Study|Enrolled but not treated|1|||
156823016|NCT00516906|566102735|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
156823017|NCT00516906|566102736|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
156823018|NCT05596734|566102737|FG000|Substudy A|Withdrawal by Subject|1|||
156823019|NCT05596734|566102738|FG001|Substudy A|Withdrawal by Subject|0|||
156823020|NCT05596734|566102739|FG002|Substudy A|Withdrawal by Subject|0|||
156823021|NCT05596734|566102740|FG003|Substudy A|Withdrawal by Subject|0|||
156823022|NCT05596734|566102741|FG004|Substudy A|Withdrawal by Subject|0|||
156823023|NCT05596734|566102742|FG005|Substudy A|Withdrawal by Subject|0|||
156823024|NCT05596734|566102743|FG006|Substudy A|Withdrawal by Subject|1|||
156823025|NCT05596734|566102744|FG007|Substudy A|Withdrawal by Subject|0|||
156823026|NCT05596734|566102745|FG008|Substudy A|Withdrawal by Subject|0|||
156823027|NCT05596734|566102746|FG009|Substudy A|Withdrawal by Subject|0|||
156823028|NCT05596734|566102747|FG010|Substudy A|Withdrawal by Subject|0|||
156823029|NCT05596734|566102748|FG011|Substudy A|Withdrawal by Subject|0|||
156823030|NCT05596734|566102749|FG012|Substudy A|Withdrawal by Subject|0|||
156823031|NCT05596734|566102750|FG013|Substudy A|Withdrawal by Subject|0|||
156823032|NCT05596734|566102751|FG014|Substudy A|Withdrawal by Subject|0|||
156823033|NCT05596734|566102752|FG015|Substudy A|Withdrawal by Subject|0|||
156823034|NCT05596734|566102753|FG016|Substudy A|Withdrawal by Subject|0|||
156823035|NCT05596734|566102754|FG017|Substudy A|Withdrawal by Subject|0|||
156823036|NCT05596734|566102755|FG018|Substudy A|Withdrawal by Subject|0|||
156823037|NCT05596734|566102756|FG019|Substudy A|Withdrawal by Subject|0|||
156823038|NCT05596734|566102757|FG020|Substudy A|Withdrawal by Subject|0|||
156823039|NCT05596734|566102758|FG021|Substudy A|Withdrawal by Subject|0|||
156823040|NCT05596734|566102759|FG022|Substudy A|Withdrawal by Subject|0|||
156823041|NCT05596734|566102760|FG023|Substudy A|Withdrawal by Subject|0|||
156823042|NCT05596734|566102737|FG000|Substudy A|Lost to Follow-up|1|||
156823043|NCT05596734|566102738|FG001|Substudy A|Lost to Follow-up|0|||
156823044|NCT05596734|566102739|FG002|Substudy A|Lost to Follow-up|1|||
156823045|NCT05596734|566102740|FG003|Substudy A|Lost to Follow-up|0|||
156823046|NCT05596734|566102741|FG004|Substudy A|Lost to Follow-up|0|||
156823047|NCT05596734|566102742|FG005|Substudy A|Lost to Follow-up|0|||
156823048|NCT05596734|566102743|FG006|Substudy A|Lost to Follow-up|0|||
156823049|NCT05596734|566102744|FG007|Substudy A|Lost to Follow-up|0|||
156823050|NCT05596734|566102745|FG008|Substudy A|Lost to Follow-up|0|||
156823051|NCT05596734|566102746|FG009|Substudy A|Lost to Follow-up|0|||
156823052|NCT05596734|566102747|FG010|Substudy A|Lost to Follow-up|0|||
156823053|NCT05596734|566102748|FG011|Substudy A|Lost to Follow-up|0|||
156823054|NCT05596734|566102749|FG012|Substudy A|Lost to Follow-up|0|||
156823055|NCT05596734|566102750|FG013|Substudy A|Lost to Follow-up|0|||
156823056|NCT05596734|566102751|FG014|Substudy A|Lost to Follow-up|0|||
156823057|NCT05596734|566102752|FG015|Substudy A|Lost to Follow-up|0|||
156823058|NCT05596734|566102753|FG016|Substudy A|Lost to Follow-up|0|||
156823059|NCT05596734|566102754|FG017|Substudy A|Lost to Follow-up|0|||
156823060|NCT05596734|566102755|FG018|Substudy A|Lost to Follow-up|0|||
156823061|NCT05596734|566102756|FG019|Substudy A|Lost to Follow-up|0|||
156823062|NCT05596734|566102757|FG020|Substudy A|Lost to Follow-up|0|||
156823063|NCT05596734|566102758|FG021|Substudy A|Lost to Follow-up|0|||
156541166|NCT01368536|565074499|FG002|Overall Study|Abnormal laboratory value(s)|2|||
156823064|NCT05596734|566102759|FG022|Substudy A|Lost to Follow-up|0|||
156541167|NCT01368536|565074497|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156823065|NCT05596734|566102760|FG023|Substudy A|Lost to Follow-up|0|||
156823066|NCT05596734|566102737|FG000|Substudy B|Withdrawal by Subject|0|||
156823067|NCT05596734|566102738|FG001|Substudy B|Withdrawal by Subject|0|||
156339206|NCT01090492|564340146|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156823068|NCT05596734|566102739|FG002|Substudy B|Withdrawal by Subject|0|||
156823069|NCT05596734|566102740|FG003|Substudy B|Withdrawal by Subject|0|||
156823070|NCT05596734|566102741|FG004|Substudy B|Withdrawal by Subject|0|||
156823071|NCT05596734|566102742|FG005|Substudy B|Withdrawal by Subject|0|||
156823072|NCT05596734|566102743|FG006|Substudy B|Withdrawal by Subject|0|||
156823073|NCT05596734|566102744|FG007|Substudy B|Withdrawal by Subject|0|||
156823074|NCT05596734|566102745|FG008|Substudy B|Withdrawal by Subject|0|||
156823075|NCT05596734|566102746|FG009|Substudy B|Withdrawal by Subject|0|||
156823076|NCT05596734|566102747|FG010|Substudy B|Withdrawal by Subject|0|||
156823077|NCT05596734|566102748|FG011|Substudy B|Withdrawal by Subject|0|||
156823078|NCT05596734|566102749|FG012|Substudy B|Withdrawal by Subject|1|||
156823079|NCT05596734|566102750|FG013|Substudy B|Withdrawal by Subject|0|||
156823080|NCT05596734|566102751|FG014|Substudy B|Withdrawal by Subject|1|||
156823081|NCT05596734|566102752|FG015|Substudy B|Withdrawal by Subject|2|||
156823082|NCT05596734|566102753|FG016|Substudy B|Withdrawal by Subject|2|||
156823083|NCT05596734|566102754|FG017|Substudy B|Withdrawal by Subject|1|||
156823084|NCT05596734|566102755|FG018|Substudy B|Withdrawal by Subject|2|||
156823085|NCT05596734|566102756|FG019|Substudy B|Withdrawal by Subject|0|||
156823086|NCT05596734|566102757|FG020|Substudy B|Withdrawal by Subject|0|||
156823087|NCT05596734|566102758|FG021|Substudy B|Withdrawal by Subject|0|||
156823088|NCT05596734|566102759|FG022|Substudy B|Withdrawal by Subject|0|||
156823089|NCT05596734|566102760|FG023|Substudy B|Withdrawal by Subject|1|||
156823090|NCT05596734|566102737|FG000|Substudy B|Physician Decision|0|||
156823091|NCT05596734|566102738|FG001|Substudy B|Physician Decision|0|||
156823092|NCT05596734|566102739|FG002|Substudy B|Physician Decision|0|||
156823093|NCT05596734|566102740|FG003|Substudy B|Physician Decision|0|||
156823094|NCT05596734|566102741|FG004|Substudy B|Physician Decision|0|||
156823095|NCT05596734|566102742|FG005|Substudy B|Physician Decision|0|||
156823096|NCT05596734|566102743|FG006|Substudy B|Physician Decision|0|||
156823097|NCT05596734|566102744|FG007|Substudy B|Physician Decision|0|||
156823098|NCT05596734|566102745|FG008|Substudy B|Physician Decision|0|||
156823099|NCT05596734|566102746|FG009|Substudy B|Physician Decision|0|||
156823100|NCT05596734|566102747|FG010|Substudy B|Physician Decision|0|||
156823101|NCT05596734|566102748|FG011|Substudy B|Physician Decision|0|||
156823102|NCT05596734|566102749|FG012|Substudy B|Physician Decision|0|||
156823103|NCT05596734|566102750|FG013|Substudy B|Physician Decision|0|||
156823104|NCT05596734|566102751|FG014|Substudy B|Physician Decision|0|||
156823105|NCT05596734|566102752|FG015|Substudy B|Physician Decision|1|||
156823106|NCT05596734|566102753|FG016|Substudy B|Physician Decision|0|||
156823107|NCT05596734|566102754|FG017|Substudy B|Physician Decision|0|||
156823108|NCT05596734|566102755|FG018|Substudy B|Physician Decision|0|||
156823109|NCT05596734|566102756|FG019|Substudy B|Physician Decision|0|||
156823110|NCT05596734|566102757|FG020|Substudy B|Physician Decision|0|||
156823111|NCT05596734|566102758|FG021|Substudy B|Physician Decision|0|||
156823112|NCT05596734|566102759|FG022|Substudy B|Physician Decision|0|||
156823113|NCT05596734|566102760|FG023|Substudy B|Physician Decision|0|||
156823114|NCT05596734|566102737|FG000|Substudy B|Lost to Follow-up|0|||
156823115|NCT05596734|566102738|FG001|Substudy B|Lost to Follow-up|0|||
156823116|NCT05596734|566102739|FG002|Substudy B|Lost to Follow-up|0|||
156823117|NCT05596734|566102740|FG003|Substudy B|Lost to Follow-up|0|||
156823118|NCT05596734|566102741|FG004|Substudy B|Lost to Follow-up|0|||
156823119|NCT05596734|566102742|FG005|Substudy B|Lost to Follow-up|0|||
156823120|NCT05596734|566102743|FG006|Substudy B|Lost to Follow-up|0|||
156823121|NCT05596734|566102744|FG007|Substudy B|Lost to Follow-up|0|||
156823122|NCT05596734|566102745|FG008|Substudy B|Lost to Follow-up|0|||
156823123|NCT05596734|566102746|FG009|Substudy B|Lost to Follow-up|0|||
156541168|NCT01368536|565074498|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156541169|NCT01368536|565074499|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156541170|NCT01368536|565074497|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
156823124|NCT05596734|566102747|FG010|Substudy B|Lost to Follow-up|0|||
156823125|NCT05596734|566102748|FG011|Substudy B|Lost to Follow-up|0|||
156823126|NCT05596734|566102749|FG012|Substudy B|Lost to Follow-up|1|||
156823127|NCT05596734|566102750|FG013|Substudy B|Lost to Follow-up|0|||
156823128|NCT05596734|566102751|FG014|Substudy B|Lost to Follow-up|1|||
156823129|NCT05596734|566102752|FG015|Substudy B|Lost to Follow-up|1|||
156823130|NCT05596734|566102753|FG016|Substudy B|Lost to Follow-up|0|||
156823131|NCT05596734|566102754|FG017|Substudy B|Lost to Follow-up|0|||
156823132|NCT05596734|566102755|FG018|Substudy B|Lost to Follow-up|0|||
156823133|NCT05596734|566102756|FG019|Substudy B|Lost to Follow-up|0|||
156823134|NCT05596734|566102757|FG020|Substudy B|Lost to Follow-up|0|||
156823135|NCT05596734|566102758|FG021|Substudy B|Lost to Follow-up|0|||
156823136|NCT05596734|566102759|FG022|Substudy B|Lost to Follow-up|0|||
156823137|NCT05596734|566102760|FG023|Substudy B|Lost to Follow-up|0|||
156823138|NCT01974206|566102761|FG000|Overall Study|Did Not Take Study Drug|0|||
156823139|NCT01974206|566102762|FG001|Overall Study|Did Not Take Study Drug|1|||
156823140|NCT01974206|566102761|FG000|Overall Study|Physician Decision|1|||
156823141|NCT01974206|566102762|FG001|Overall Study|Physician Decision|0|||
156823142|NCT01974206|566102761|FG000|Overall Study|Withdrawal by Subject|3|||
156823143|NCT01974206|566102762|FG001|Overall Study|Withdrawal by Subject|0|||
156823144|NCT01974206|566102761|FG000|Overall Study|Lost to Follow-up|1|||
156823145|NCT01974206|566102762|FG001|Overall Study|Lost to Follow-up|0|||
156823146|NCT01974206|566102761|FG000|Overall Study|Death|1|||
156823147|NCT01974206|566102762|FG001|Overall Study|Death|0|||
156823148|NCT02059499|566102766|FG000|Upto Week 20|Lost to Follow-up|2|||
156823149|NCT02059499|566102767|FG001|Upto Week 20|Lost to Follow-up|6|||
156823150|NCT02059499|566102768|FG002|Upto Week 20|Lost to Follow-up|0|||
156823151|NCT02059499|566102766|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
156823152|NCT02059499|566102767|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
156823153|NCT02059499|566102768|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
156823154|NCT02059499|566102766|FG000|Upto Week 20|Withdrawal by Subject|1|||
156823155|NCT02059499|566102767|FG001|Upto Week 20|Withdrawal by Subject|1|||
156823156|NCT02059499|566102768|FG002|Upto Week 20|Withdrawal by Subject|0|||
156823157|NCT02059499|566102766|FG000|Upto Week 20|No treatment per protocol criteria|0|||
156823158|NCT02059499|566102767|FG001|Upto Week 20|No treatment per protocol criteria|0|||
156823159|NCT02059499|566102768|FG002|Upto Week 20|No treatment per protocol criteria|5|||
156823160|NCT02059499|566102766|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
156823161|NCT02059499|566102767|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
156823162|NCT02059499|566102768|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
156823163|NCT02059499|566102766|FG000|Post-week 20|Lost to Follow-up|0|||
156823164|NCT02059499|566102767|FG001|Post-week 20|Lost to Follow-up|2|||
156823165|NCT02059499|566102768|FG002|Post-week 20|Lost to Follow-up|0|||
156823166|NCT02059499|566102766|FG000|Post-week 20|Withdrawal by Subject|0|||
156823167|NCT02059499|566102767|FG001|Post-week 20|Withdrawal by Subject|1|||
156823168|NCT02059499|566102768|FG002|Post-week 20|Withdrawal by Subject|0|||
156823169|NCT02059499|566102766|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
156823170|NCT02059499|566102767|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
156823171|NCT02059499|566102768|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
156823172|NCT04210245|566102769|FG000|Overall Study|Adverse Event|0|||
156823173|NCT04210245|566102770|FG001|Overall Study|Adverse Event|3|||
156823174|NCT04210245|566102771|FG002|Overall Study|Adverse Event|6|||
156823175|NCT04210245|566102772|FG003|Overall Study|Adverse Event|0|||
156823176|NCT04210245|566102769|FG000|Overall Study|Withdrawal by Subject|0|||
156823177|NCT04210245|566102770|FG001|Overall Study|Withdrawal by Subject|1|||
156823178|NCT04210245|566102771|FG002|Overall Study|Withdrawal by Subject|4|||
156823179|NCT04210245|566102772|FG003|Overall Study|Withdrawal by Subject|4|||
156823180|NCT04210245|566102769|FG000|Overall Study|Lost to Follow-up|0|||
156823181|NCT04210245|566102770|FG001|Overall Study|Lost to Follow-up|1|||
156823182|NCT04210245|566102771|FG002|Overall Study|Lost to Follow-up|1|||
156823183|NCT04210245|566102772|FG003|Overall Study|Lost to Follow-up|1|||
156823184|NCT04210245|566102769|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
156823185|NCT04210245|566102770|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
156823186|NCT04210245|566102771|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
156823187|NCT04210245|566102772|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
156823188|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
156823189|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823190|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823191|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823192|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823193|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823194|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
156823195|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
156823196|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156823197|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156823198|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156823199|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156823200|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
156823201|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
156823202|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
156823203|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
156823204|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
156823205|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
156823206|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
156823207|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
156823208|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156823209|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156823210|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156823211|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156823212|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
156823213|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
156823214|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
156823215|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
156823216|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
156823217|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
156823218|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
156823219|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823220|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823221|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823222|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823223|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823224|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
156823225|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
156823226|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
156823227|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
156823228|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
156823229|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
156823230|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156823231|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156823232|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
156823233|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
156823234|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
156823235|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
156823236|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156823237|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156823238|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
156823239|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
156823240|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
156823241|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
156823242|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
156823243|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
156823244|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
156823245|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
156823246|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
156823247|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
156823248|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156823249|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156823250|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
156823251|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156823252|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
156823253|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156823254|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156823255|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156823256|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
156823257|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
156823258|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156823259|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
156823260|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
156823261|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
156823262|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
156823263|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
156339207|NCT01090492|564340147|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156823264|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
156823265|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
156823266|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
156823267|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
156823268|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
156823269|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
156823270|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
156823271|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
156823272|NCT02684058|566102783|FG000|Treatment Period|Progressive disease|4|||
156823273|NCT02684058|566102784|FG001|Treatment Period|Progressive disease|10|||
156823274|NCT02684058|566102785|FG002|Treatment Period|Progressive disease|19|||
156823275|NCT02684058|566102783|FG000|Treatment Period|Adverse Event|3|||
156823276|NCT02684058|566102784|FG001|Treatment Period|Adverse Event|8|||
156823277|NCT02684058|566102785|FG002|Treatment Period|Adverse Event|1|||
156823278|NCT02684058|566102783|FG000|Treatment Period|Physician Decision|5|||
156823279|NCT02684058|566102784|FG001|Treatment Period|Physician Decision|1|||
156823280|NCT02684058|566102785|FG002|Treatment Period|Physician Decision|2|||
156823281|NCT02684058|566102783|FG000|Treatment Period|New therapy for study indication|1|||
156823282|NCT02684058|566102784|FG001|Treatment Period|New therapy for study indication|0|||
156823283|NCT02684058|566102785|FG002|Treatment Period|New therapy for study indication|0|||
156823284|NCT02684058|566102783|FG000|Treatment Period|Protocol deviation|0|||
156823285|NCT02684058|566102784|FG001|Treatment Period|Protocol deviation|1|||
156823286|NCT02684058|566102785|FG002|Treatment Period|Protocol deviation|0|||
156823287|NCT02684058|566102783|FG000|Treatment Period|Subject/guardian decision|4|||
156823288|NCT02684058|566102784|FG001|Treatment Period|Subject/guardian decision|3|||
156823289|NCT02684058|566102785|FG002|Treatment Period|Subject/guardian decision|0|||
156823290|NCT02684058|566102783|FG000|Treatment Period|Death|0|||
156823291|NCT02684058|566102784|FG001|Treatment Period|Death|0|||
156823292|NCT02684058|566102785|FG002|Treatment Period|Death|2|||
156823293|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156823294|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156823295|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156823296|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
156823297|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
156823298|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
156823299|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156823300|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156823301|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
156823302|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|Death|0|||
156823303|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|Death|0|||
156823304|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|Death|3|||
156823305|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
156823306|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
156823307|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
156823308|NCT02684058|566102783|FG000|Post-treatment Survival Follow-up|Death|0|||
156823309|NCT02684058|566102784|FG001|Post-treatment Survival Follow-up|Death|0|||
156823310|NCT02684058|566102785|FG002|Post-treatment Survival Follow-up|Death|7|||
156823311|NCT02684058|566102783|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
156823312|NCT02684058|566102784|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
156823313|NCT02684058|566102785|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
156823314|NCT02684058|566102783|FG000|Crossover Treatment Period|Progressive disease|0|||
156823315|NCT02684058|566102784|FG001|Crossover Treatment Period|Progressive disease|1|||
156823316|NCT02684058|566102785|FG002|Crossover Treatment Period|Progressive disease|0|||
156823317|NCT03219034|566102786|FG000|Overall Study|Lost to Follow-up|9|||
156823318|NCT03219034|566102787|FG001|Overall Study|Lost to Follow-up|13|||
156823319|NCT03219034|566102786|FG000|Overall Study|Additional dental work needed|1|||
156823320|NCT03219034|566102787|FG001|Overall Study|Additional dental work needed|0|||
156823321|NCT03219034|566102786|FG000|Overall Study|UPPP Surgery|1|||
156823322|NCT03219034|566102787|FG001|Overall Study|UPPP Surgery|0|||
156823323|NCT03219034|566102786|FG000|Overall Study|Dental sensitivity|0|||
156823324|NCT03219034|566102787|FG001|Overall Study|Dental sensitivity|1|||
156823325|NCT03219034|566102786|FG000|Overall Study|Death in family|0|||
156823326|NCT03219034|566102787|FG001|Overall Study|Death in family|1|||
156823327|NCT01802580|566102788|FG000|Overall Study|Physician Decision|1|||
156823328|NCT01802580|566102789|FG001|Overall Study|Physician Decision|0|||
156541171|NCT01368536|565074498|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156823329|NCT01802580|566102788|FG000|Overall Study|Protocol Violation|2|||
156823330|NCT01802580|566102789|FG001|Overall Study|Protocol Violation|0|||
156823331|NCT01802580|566102788|FG000|Overall Study|Withdrawal by Subject|5|||
156823332|NCT01802580|566102789|FG001|Overall Study|Withdrawal by Subject|6|||
156823333|NCT01802580|566102788|FG000|Overall Study|Other|1|||
156823334|NCT01802580|566102789|FG001|Overall Study|Other|3|||
156823335|NCT01802580|566102788|FG000|Overall Study|Lack of Efficacy|0|||
156823336|NCT01802580|566102789|FG001|Overall Study|Lack of Efficacy|2|||
156823337|NCT01327053|566102792|FG000|Overall Study|Adverse Event|23|||
156823338|NCT01327053|566102793|FG001|Overall Study|Adverse Event|57|||
156823339|NCT01327053|566102792|FG000|Overall Study|Patient/guardian decision|11|||
156823340|NCT01327053|566102793|FG001|Overall Study|Patient/guardian decision|35|||
156823341|NCT01327053|566102792|FG000|Overall Study|Physician Decision|10|||
156823342|NCT01327053|566102793|FG001|Overall Study|Physician Decision|14|||
156823343|NCT01327053|566102792|FG000|Overall Study|Death|1|||
156823344|NCT01327053|566102793|FG001|Overall Study|Death|5|||
156823345|NCT01327053|566102792|FG000|Overall Study|Lost to Follow-up|2|||
156823346|NCT01327053|566102793|FG001|Overall Study|Lost to Follow-up|4|||
156823347|NCT01327053|566102792|FG000|Overall Study|Non-compliance with study treatment|0|||
156823348|NCT01327053|566102793|FG001|Overall Study|Non-compliance with study treatment|5|||
156823349|NCT01327053|566102792|FG000|Overall Study|Study terminated by Sponsor|1|||
156823350|NCT01327053|566102793|FG001|Overall Study|Study terminated by Sponsor|3|||
156823351|NCT01327053|566102792|FG000|Overall Study|Progressive disease|31|||
156823352|NCT01327053|566102793|FG001|Overall Study|Progressive disease|26|||
156823353|NCT01327053|566102792|FG000|Overall Study|Protocol Violation|0|||
156823354|NCT01327053|566102793|FG001|Overall Study|Protocol Violation|1|||
156823355|NCT01327053|566102792|FG000|Overall Study|Untreated|0|||
156823356|NCT01327053|566102793|FG001|Overall Study|Untreated|1|||
156823357|NCT00721578|566102799|FG000|Overall Study|Death|1|||
156823358|NCT00721578|566102800|FG001|Overall Study|Death|1|||
156823359|NCT00721578|566102799|FG000|Overall Study|Withdrawal by Subject|1|||
156823360|NCT00721578|566102800|FG001|Overall Study|Withdrawal by Subject|1|||
156823361|NCT04621240|566102801|FG000|Overall Study|Withdrawal by Subject|36|||
156823362|NCT00211757|566102804|FG000|Overall Study|Withdrawal by Subject|1|||
156823363|NCT00211757|566102805|FG001|Overall Study|Withdrawal by Subject|1|||
156465998|NCT02466971|564802790|FG000|Overall Study|ineligible and treated|1|||
156465999|NCT02466971|564802791|FG001|Overall Study|ineligible and treated|0|||
156823364|NCT00211757|566102804|FG000|Overall Study|Lack of Efficacy|0|||
156823365|NCT00211757|566102805|FG001|Overall Study|Lack of Efficacy|1|||
156823366|NCT01457014|566102808|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
156823367|NCT01457014|566102809|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
156823368|NCT01457014|566102810|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
156823369|NCT01457014|566102811|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
156823370|NCT01457014|566102808|FG000|First Night|Withdrawal by Subject|3|||
156823371|NCT01457014|566102809|FG001|First Night|Withdrawal by Subject|0|||
156823372|NCT01457014|566102810|FG002|First Night|Withdrawal by Subject|0|||
156466000|NCT02466971|564802790|FG000|Overall Study|ineligible and never treated|0|||
156466001|NCT02466971|564802791|FG001|Overall Study|ineligible and never treated|1|||
156466002|NCT02101853|564802792|FG000|Block 1 Induction|Adverse Event|11|||
156466003|NCT02101853|564802793|FG001|Block 1 Induction|Adverse Event|0|||
156466004|NCT02101853|564802794|FG002|Block 1 Induction|Adverse Event|0|||
156466005|NCT02101853|564802795|FG003|Block 1 Induction|Adverse Event|0|||
156466006|NCT02101853|564802796|FG004|Block 1 Induction|Adverse Event|0|||
156823373|NCT01457014|566102811|FG003|First Night|Withdrawal by Subject|0|||
156823374|NCT03319953|566102812|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
156823375|NCT03319953|566102813|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
156823376|NCT03319953|566102814|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
156823377|NCT03319953|566102815|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
156823378|NCT03319953|566102812|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
156823379|NCT03319953|566102813|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
156823380|NCT03319953|566102814|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
156823381|NCT03319953|566102815|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
156823382|NCT02264665|566104627|FG000|Overall Study|Other|0|||
156823383|NCT02264665|566104628|FG001|Overall Study|Other|0|||
156823384|NCT02264665|566104629|FG002|Overall Study|Other|3|||
156823385|NCT02264665|566104630|FG003|Overall Study|Other|0|||
156823386|NCT02264665|566104631|FG004|Overall Study|Other|0|||
156823387|NCT02264665|566104632|FG005|Overall Study|Other|0|||
156823388|NCT02264665|566104633|FG006|Overall Study|Other|0|||
156823389|NCT02264665|566104627|FG000|Overall Study|Death|9|||
156823390|NCT02264665|566104628|FG001|Overall Study|Death|8|||
156823391|NCT02264665|566104629|FG002|Overall Study|Death|13|||
156823392|NCT02264665|566104630|FG003|Overall Study|Death|5|||
156823393|NCT02264665|566104631|FG004|Overall Study|Death|0|||
156823394|NCT02264665|566104632|FG005|Overall Study|Death|0|||
156823395|NCT02264665|566104633|FG006|Overall Study|Death|1|||
156823396|NCT02264665|566104627|FG000|Overall Study|Lost to Follow-up|1|||
156823397|NCT02264665|566104628|FG001|Overall Study|Lost to Follow-up|0|||
156823398|NCT02264665|566104629|FG002|Overall Study|Lost to Follow-up|2|||
156823399|NCT02264665|566104630|FG003|Overall Study|Lost to Follow-up|1|||
156823400|NCT02264665|566104631|FG004|Overall Study|Lost to Follow-up|0|||
156823401|NCT02264665|566104632|FG005|Overall Study|Lost to Follow-up|0|||
156823402|NCT02264665|566104633|FG006|Overall Study|Lost to Follow-up|0|||
156823403|NCT02264665|566104627|FG000|Overall Study|Participant decision|0|||
156823404|NCT02264665|566104628|FG001|Overall Study|Participant decision|0|||
156823405|NCT02264665|566104629|FG002|Overall Study|Participant decision|0|||
156823406|NCT02264665|566104630|FG003|Overall Study|Participant decision|1|||
156823407|NCT02264665|566104631|FG004|Overall Study|Participant decision|0|||
156823408|NCT02264665|566104632|FG005|Overall Study|Participant decision|0|||
156823409|NCT02264665|566104633|FG006|Overall Study|Participant decision|0|||
156823410|NCT02264665|566104627|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
156823411|NCT02264665|566104628|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
156823412|NCT02264665|566104629|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
156823413|NCT02264665|566104630|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
156823414|NCT02264665|566104631|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
156823415|NCT02264665|566104632|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
156823416|NCT02264665|566104633|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
156823417|NCT02264665|566104627|FG000|Overall Study|Data Missing|0|||
156823418|NCT02264665|566104628|FG001|Overall Study|Data Missing|0|||
156823419|NCT02264665|566104629|FG002|Overall Study|Data Missing|1|||
156823420|NCT02264665|566104630|FG003|Overall Study|Data Missing|0|||
156823421|NCT02264665|566104631|FG004|Overall Study|Data Missing|0|||
156823422|NCT02264665|566104632|FG005|Overall Study|Data Missing|0|||
156823423|NCT02264665|566104633|FG006|Overall Study|Data Missing|0|||
156823424|NCT00789581|566104634|FG000|AC Therapy|Adverse Event|2|||
156466007|NCT02101853|564802797|FG005|Block 1 Induction|Adverse Event|0|||
156466008|NCT02101853|564802792|FG000|Block 1 Induction|Death|20|||
156466009|NCT02101853|564802793|FG001|Block 1 Induction|Death|0|||
156466010|NCT02101853|564802794|FG002|Block 1 Induction|Death|0|||
156466011|NCT02101853|564802795|FG003|Block 1 Induction|Death|0|||
156466012|NCT02101853|564802796|FG004|Block 1 Induction|Death|0|||
156466013|NCT02101853|564802797|FG005|Block 1 Induction|Death|0|||
156466014|NCT02101853|564802792|FG000|Block 1 Induction|Lack of Efficacy|6|||
156466015|NCT02101853|564802793|FG001|Block 1 Induction|Lack of Efficacy|0|||
156466016|NCT02101853|564802794|FG002|Block 1 Induction|Lack of Efficacy|0|||
156466017|NCT02101853|564802795|FG003|Block 1 Induction|Lack of Efficacy|0|||
156466018|NCT02101853|564802796|FG004|Block 1 Induction|Lack of Efficacy|0|||
156466019|NCT02101853|564802797|FG005|Block 1 Induction|Lack of Efficacy|0|||
156466020|NCT02101853|564802792|FG000|Block 1 Induction|Physician Decision|61|||
156541172|NCT01368536|565074499|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156541173|NCT01368536|565074497|FG000|Overall Study|No longer required study medication|0|||
156823425|NCT00789581|566104635|FG001|AC Therapy|Adverse Event|3|||
156823426|NCT00789581|566104634|FG000|AC Therapy|Withdrawal by Subject|4|||
156823427|NCT00789581|566104635|FG001|AC Therapy|Withdrawal by Subject|7|||
156466021|NCT02101853|564802793|FG001|Block 1 Induction|Physician Decision|0|||
156466022|NCT02101853|564802794|FG002|Block 1 Induction|Physician Decision|0|||
156466023|NCT02101853|564802795|FG003|Block 1 Induction|Physician Decision|0|||
156466024|NCT02101853|564802796|FG004|Block 1 Induction|Physician Decision|0|||
156823428|NCT00789581|566104634|FG000|AC Therapy|Disease recurrence|3|||
156823429|NCT00789581|566104635|FG001|AC Therapy|Disease recurrence|1|||
156823430|NCT00789581|566104634|FG000|AC Therapy|Intercurrent Illness|1|||
156823431|NCT00789581|566104635|FG001|AC Therapy|Intercurrent Illness|0|||
156823432|NCT00789581|566104634|FG000|AC Therapy|Never Treated|1|||
156823433|NCT00789581|566104635|FG001|AC Therapy|Never Treated|4|||
156823434|NCT00789581|566104634|FG000|AC Therapy|Other|0|||
156823435|NCT00789581|566104635|FG001|AC Therapy|Other|2|||
156823436|NCT00789581|566104634|FG000|Adjuvant Therapy|Never treated|2|||
156823437|NCT00789581|566104635|FG001|Adjuvant Therapy|Never treated|2|||
156823438|NCT00789581|566104634|FG000|Adjuvant Therapy|Adverse Event|20|||
156823439|NCT00789581|566104635|FG001|Adjuvant Therapy|Adverse Event|44|||
156823440|NCT00789581|566104634|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
156823441|NCT00789581|566104635|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
156823442|NCT00789581|566104634|FG000|Adjuvant Therapy|Disease recurrence|2|||
156823443|NCT00789581|566104635|FG001|Adjuvant Therapy|Disease recurrence|1|||
156823444|NCT00789581|566104634|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
156823445|NCT00789581|566104635|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
156823446|NCT00789581|566104634|FG000|Adjuvant Therapy|Protocol Violation|1|||
156823447|NCT00789581|566104635|FG001|Adjuvant Therapy|Protocol Violation|1|||
156823448|NCT00789581|566104634|FG000|Adjuvant Therapy|Other|0|||
156823449|NCT00789581|566104635|FG001|Adjuvant Therapy|Other|1|||
156823450|NCT03392883|566104636|FG000|Overall Study|Lost to Follow-up|122|||
156823451|NCT03392883|566104637|FG001|Overall Study|Lost to Follow-up|13|||
156823452|NCT03392883|566104638|FG002|Overall Study|Lost to Follow-up|9|||
156823453|NCT03392883|566104636|FG000|Overall Study|Death|4|||
156823454|NCT03392883|566104637|FG001|Overall Study|Death|0|||
156823455|NCT03392883|566104638|FG002|Overall Study|Death|0|||
156823456|NCT03392883|566104636|FG000|Overall Study|Lack of Efficacy|29|||
156823457|NCT03392883|566104637|FG001|Overall Study|Lack of Efficacy|0|||
156823458|NCT03392883|566104638|FG002|Overall Study|Lack of Efficacy|0|||
156823459|NCT03392883|566104636|FG000|Overall Study|Withdrawal by Subject|180|||
156823460|NCT03392883|566104637|FG001|Overall Study|Withdrawal by Subject|0|||
156823461|NCT03392883|566104638|FG002|Overall Study|Withdrawal by Subject|0|||
156823462|NCT03392883|566104636|FG000|Overall Study|Adverse Event|1|||
156823463|NCT03392883|566104637|FG001|Overall Study|Adverse Event|0|||
156823464|NCT03392883|566104638|FG002|Overall Study|Adverse Event|0|||
156823465|NCT00908115|566104643|FG000|Overall Study|Other|14|||
156823466|NCT01498575|566104646|FG000|Overall Sample|Withdrawal by Subject|60|||
156823467|NCT01498575|566104647|FG001|Overall Sample|Withdrawal by Subject|14|||
156823468|NCT01498575|566104646|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
156823469|NCT01498575|566104647|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
156823470|NCT01498575|566104646|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
156466025|NCT02101853|564802797|FG005|Block 1 Induction|Physician Decision|0|||
156466026|NCT02101853|564802792|FG000|Block 1 Induction|Protocol Violation|2|||
156466027|NCT02101853|564802793|FG001|Block 1 Induction|Protocol Violation|0|||
156466028|NCT02101853|564802794|FG002|Block 1 Induction|Protocol Violation|0|||
156466029|NCT02101853|564802795|FG003|Block 1 Induction|Protocol Violation|0|||
156466030|NCT02101853|564802796|FG004|Block 1 Induction|Protocol Violation|0|||
156466031|NCT02101853|564802797|FG005|Block 1 Induction|Protocol Violation|0|||
156466032|NCT02101853|564802792|FG000|Block 1 Induction|Withdrawal by Subject|65|||
156466033|NCT02101853|564802793|FG001|Block 1 Induction|Withdrawal by Subject|0|||
156466034|NCT02101853|564802794|FG002|Block 1 Induction|Withdrawal by Subject|0|||
156466035|NCT02101853|564802795|FG003|Block 1 Induction|Withdrawal by Subject|0|||
156466036|NCT02101853|564802796|FG004|Block 1 Induction|Withdrawal by Subject|0|||
156466037|NCT02101853|564802797|FG005|Block 1 Induction|Withdrawal by Subject|0|||
156466038|NCT02101853|564802792|FG000|Block 1 Induction|Ineligible|8|||
156466039|NCT02101853|564802793|FG001|Block 1 Induction|Ineligible|0|||
156466040|NCT02101853|564802794|FG002|Block 1 Induction|Ineligible|0|||
156466041|NCT02101853|564802795|FG003|Block 1 Induction|Ineligible|0|||
156466042|NCT02101853|564802796|FG004|Block 1 Induction|Ineligible|0|||
156466043|NCT02101853|564802797|FG005|Block 1 Induction|Ineligible|0|||
156466044|NCT02101853|564802792|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
156466045|NCT02101853|564802793|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
156823471|NCT01498575|566104647|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
156823472|NCT00847665|566104649|FG000|Overall Study|Withdrawal by Subject|1|||
156466046|NCT02101853|564802794|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
156466047|NCT02101853|564802795|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
156466048|NCT02101853|564802796|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
156466049|NCT02101853|564802797|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
156466050|NCT02101853|564802792|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
156466051|NCT02101853|564802793|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156823473|NCT00847665|566104650|FG001|Overall Study|Withdrawal by Subject|0|||
156823474|NCT00585546|566104657|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
156823475|NCT00585546|566104657|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
156823476|NCT02851797|566104658|FG000|Overall Study|Withdrawal by Subject|4|||
156823477|NCT02851797|566104659|FG001|Overall Study|Withdrawal by Subject|2|||
156823478|NCT02851797|566104658|FG000|Overall Study|Adverse Event|3|||
156823479|NCT02851797|566104659|FG001|Overall Study|Adverse Event|0|||
156823480|NCT03077438|566104660|FG000|Overall Study|Protocol Violation|3|||
156823481|NCT03077438|566104661|FG001|Overall Study|Protocol Violation|5|||
156823482|NCT03077438|566104660|FG000|Overall Study|Withdrawal by Subject|3|||
156823483|NCT03077438|566104661|FG001|Overall Study|Withdrawal by Subject|6|||
156823484|NCT03077438|566104660|FG000|Overall Study|Lost to Follow-up|6|||
156823485|NCT03077438|566104661|FG001|Overall Study|Lost to Follow-up|3|||
156823486|NCT00813865|566104662|FG000|Overall Study|Failure to Respond|3|||
156823487|NCT00813865|566104662|FG000|Overall Study|Lost to Follow-up|3|||
156823488|NCT00813865|566104662|FG000|Overall Study|Withdrawal by Subject|1|||
156823489|NCT04295681|566104672|FG000|Overall Study|Eligibility error|1|||
156823490|NCT04295681|566104673|FG001|Overall Study|Eligibility error|3|||
156823491|NCT00939029|566104674|FG000|Overall Study|Withdrawal by Subject|3|||
156823492|NCT00939029|566104675|FG001|Overall Study|Withdrawal by Subject|7|||
156823493|NCT00939029|566104674|FG000|Overall Study|Lost to Follow-up|3|||
156823494|NCT00939029|566104675|FG001|Overall Study|Lost to Follow-up|4|||
156823495|NCT00939029|566104674|FG000|Overall Study|Adverse Event|0|||
156823496|NCT00939029|566104675|FG001|Overall Study|Adverse Event|1|||
156823497|NCT04686084|566104677|FG000|Overall Study|Lost to Follow-up|1|||
156823498|NCT01535599|566104678|FG000|Overall Study|Adverse Event|6|||
156823499|NCT01535599|566104679|FG001|Overall Study|Adverse Event|15|||
156823500|NCT01535599|566104678|FG000|Overall Study|Lost to Follow-up|3|||
156823501|NCT01535599|566104679|FG001|Overall Study|Lost to Follow-up|4|||
156823502|NCT01535599|566104678|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
156823503|NCT01535599|566104679|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
156823504|NCT01535599|566104678|FG000|Overall Study|Treatment Failure|33|||
156823505|NCT01535599|566104679|FG001|Overall Study|Treatment Failure|66|||
156823506|NCT01535599|566104678|FG000|Overall Study|BL Culture + for Group A Strep|0|||
156823507|NCT01535599|566104679|FG001|Overall Study|BL Culture + for Group A Strep|1|||
156823508|NCT01535599|566104678|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
156823509|NCT01535599|566104679|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
156823510|NCT01535599|566104678|FG000|Overall Study|Randomized in Error|2|||
156823511|NCT01535599|566104679|FG001|Overall Study|Randomized in Error|4|||
156823512|NCT01535599|566104678|FG000|Overall Study|Did not use product|1|||
156823513|NCT01535599|566104679|FG001|Overall Study|Did not use product|0|||
156823514|NCT01535599|566104678|FG000|Overall Study|Other|1|||
156823515|NCT01535599|566104679|FG001|Overall Study|Other|0|||
156823516|NCT01535599|566104678|FG000|Overall Study|Stopped medication|0|||
156823517|NCT01535599|566104679|FG001|Overall Study|Stopped medication|1|||
156823518|NCT01535599|566104678|FG000|Overall Study|Noncompliance|0|||
156823519|NCT01535599|566104679|FG001|Overall Study|Noncompliance|1|||
156823520|NCT03172325|566104683|FG000|Overall Study|Adverse Event|2|||
156823521|NCT03172325|566104684|FG001|Overall Study|Adverse Event|3|||
156823522|NCT03172325|566104683|FG000|Overall Study|Positive PPD|1|||
156823523|NCT03172325|566104684|FG001|Overall Study|Positive PPD|0|||
156823524|NCT03172325|566104683|FG000|Overall Study|Poor Compliance|1|||
156823525|NCT03172325|566104684|FG001|Overall Study|Poor Compliance|1|||
156823526|NCT03622112|566104700|FG000|Overall Study|Withdrawal by Subject|6|||
156823527|NCT03622112|566104701|FG001|Overall Study|Withdrawal by Subject|2|||
156823528|NCT03622112|566104702|FG002|Overall Study|Withdrawal by Subject|4|||
156823529|NCT03622112|566104703|FG003|Overall Study|Withdrawal by Subject|2|||
156823530|NCT03622112|566104704|FG004|Overall Study|Withdrawal by Subject|1|||
156823531|NCT03622112|566104705|FG005|Overall Study|Withdrawal by Subject|2|||
156823532|NCT03622112|566104706|FG006|Overall Study|Withdrawal by Subject|2|||
156823533|NCT03622112|566104700|FG000|Overall Study|Death|0|||
156823534|NCT03622112|566104701|FG001|Overall Study|Death|0|||
156339208|NCT01090492|564340148|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156466052|NCT02101853|564802794|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156466053|NCT02101853|564802795|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156466054|NCT02101853|564802796|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156466055|NCT02101853|564802797|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156466056|NCT02101853|564802792|FG000|Post Induction Randomization|Adverse Event|0|||
156466057|NCT02101853|564802793|FG001|Post Induction Randomization|Adverse Event|3|||
156823535|NCT03622112|566104702|FG002|Overall Study|Death|0|||
156466058|NCT02101853|564802794|FG002|Post Induction Randomization|Adverse Event|8|||
156823536|NCT03622112|566104703|FG003|Overall Study|Death|1|||
156823537|NCT03622112|566104704|FG004|Overall Study|Death|0|||
156823538|NCT03622112|566104705|FG005|Overall Study|Death|0|||
156823539|NCT03622112|566104706|FG006|Overall Study|Death|0|||
156823540|NCT03622112|566104700|FG000|Overall Study|Lost to Follow-up|1|||
156823541|NCT03622112|566104701|FG001|Overall Study|Lost to Follow-up|1|||
156823542|NCT03622112|566104702|FG002|Overall Study|Lost to Follow-up|0|||
156823543|NCT03622112|566104703|FG003|Overall Study|Lost to Follow-up|0|||
156823544|NCT03622112|566104704|FG004|Overall Study|Lost to Follow-up|0|||
156823545|NCT03622112|566104705|FG005|Overall Study|Lost to Follow-up|0|||
156823546|NCT03622112|566104706|FG006|Overall Study|Lost to Follow-up|0|||
156823547|NCT03622112|566104700|FG000|Overall Study|Study-specific withdrawal criteria|10|||
156823548|NCT03622112|566104701|FG001|Overall Study|Study-specific withdrawal criteria|8|||
156823549|NCT03622112|566104702|FG002|Overall Study|Study-specific withdrawal criteria|7|||
156823550|NCT03622112|566104703|FG003|Overall Study|Study-specific withdrawal criteria|6|||
156823551|NCT03622112|566104704|FG004|Overall Study|Study-specific withdrawal criteria|4|||
156823552|NCT03622112|566104705|FG005|Overall Study|Study-specific withdrawal criteria|18|||
156823553|NCT03622112|566104706|FG006|Overall Study|Study-specific withdrawal criteria|4|||
156823554|NCT03622112|566104700|FG000|Overall Study|Protocol Violation|2|||
156823555|NCT03622112|566104701|FG001|Overall Study|Protocol Violation|0|||
156823556|NCT03622112|566104702|FG002|Overall Study|Protocol Violation|1|||
156823557|NCT03622112|566104703|FG003|Overall Study|Protocol Violation|1|||
156823558|NCT03622112|566104704|FG004|Overall Study|Protocol Violation|0|||
156823559|NCT03622112|566104705|FG005|Overall Study|Protocol Violation|0|||
156823560|NCT03622112|566104706|FG006|Overall Study|Protocol Violation|0|||
156823561|NCT03622112|566104700|FG000|Overall Study|Adverse Event|6|||
156823562|NCT03622112|566104701|FG001|Overall Study|Adverse Event|8|||
156823563|NCT03622112|566104702|FG002|Overall Study|Adverse Event|4|||
156823564|NCT03622112|566104703|FG003|Overall Study|Adverse Event|11|||
156823565|NCT03622112|566104704|FG004|Overall Study|Adverse Event|4|||
156823566|NCT03622112|566104705|FG005|Overall Study|Adverse Event|20|||
156823567|NCT03622112|566104706|FG006|Overall Study|Adverse Event|2|||
156823568|NCT03622112|566104700|FG000|Overall Study|Reason not specified|0|||
156823569|NCT03622112|566104701|FG001|Overall Study|Reason not specified|1|||
156823570|NCT03622112|566104702|FG002|Overall Study|Reason not specified|0|||
156823571|NCT03622112|566104703|FG003|Overall Study|Reason not specified|1|||
156823572|NCT03622112|566104704|FG004|Overall Study|Reason not specified|1|||
156823573|NCT03622112|566104705|FG005|Overall Study|Reason not specified|2|||
156823574|NCT03622112|566104706|FG006|Overall Study|Reason not specified|1|||
156823575|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
156823576|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
156823577|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
156823578|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
156339209|NCT01090492|564340149|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156466059|NCT02101853|564802795|FG003|Post Induction Randomization|Adverse Event|4|||
156466060|NCT02101853|564802796|FG004|Post Induction Randomization|Adverse Event|4|||
156466061|NCT02101853|564802797|FG005|Post Induction Randomization|Adverse Event|0|||
156823579|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
156823580|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
156823581|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
156823582|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
156823583|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
156823584|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
156823585|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Other|1|||
156823586|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Other|1|||
156823587|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
156823588|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
156823589|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
156823590|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
156823591|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
156823592|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
156823593|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
156823594|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
156823595|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
156823596|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
156823597|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
156823598|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
156823599|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Other|1|||
156823600|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Other|2|||
156823601|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
156823602|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
156823603|NCT03305419|566104712|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823604|NCT03305419|566104713|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
156823605|NCT03305419|566104714|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156466062|NCT02101853|564802792|FG000|Post Induction Randomization|Death|0|||
156466063|NCT02101853|564802793|FG001|Post Induction Randomization|Death|9|||
156466064|NCT02101853|564802794|FG002|Post Induction Randomization|Death|2|||
156823606|NCT03305419|566104715|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823607|NCT03305419|566104716|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823608|NCT03305419|566104717|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823609|NCT03305419|566104718|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156466065|NCT02101853|564802795|FG003|Post Induction Randomization|Death|2|||
156466066|NCT02101853|564802796|FG004|Post Induction Randomization|Death|0|||
156823610|NCT03305419|566104719|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823611|NCT03305419|566104712|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
156823612|NCT03305419|566104713|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823613|NCT03305419|566104714|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823614|NCT03305419|566104715|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823615|NCT03305419|566104716|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823616|NCT03305419|566104717|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823617|NCT03305419|566104718|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823618|NCT03305419|566104719|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823619|NCT03305419|566104712|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
156823620|NCT03305419|566104713|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823621|NCT03305419|566104714|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823622|NCT03305419|566104715|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823623|NCT03305419|566104716|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823624|NCT03305419|566104717|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823625|NCT03305419|566104718|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823626|NCT03305419|566104719|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823627|NCT03305419|566104712|FG000|Part B (14 Days)|Adverse Event|0|||
156823628|NCT03305419|566104713|FG001|Part B (14 Days)|Adverse Event|0|||
156823629|NCT03305419|566104714|FG002|Part B (14 Days)|Adverse Event|0|||
156823630|NCT03305419|566104715|FG003|Part B (14 Days)|Adverse Event|0|||
156823631|NCT03305419|566104716|FG004|Part B (14 Days)|Adverse Event|1|||
156823632|NCT03305419|566104717|FG005|Part B (14 Days)|Adverse Event|2|||
156823633|NCT03305419|566104718|FG006|Part B (14 Days)|Adverse Event|4|||
156823634|NCT03305419|566104719|FG007|Part B (14 Days)|Adverse Event|0|||
156823635|NCT03305419|566104712|FG000|Part B (14 Days)|Physician Decision|0|||
156823636|NCT03305419|566104713|FG001|Part B (14 Days)|Physician Decision|0|||
156823637|NCT03305419|566104714|FG002|Part B (14 Days)|Physician Decision|0|||
156823638|NCT03305419|566104715|FG003|Part B (14 Days)|Physician Decision|0|||
156823639|NCT03305419|566104716|FG004|Part B (14 Days)|Physician Decision|2|||
156823640|NCT03305419|566104717|FG005|Part B (14 Days)|Physician Decision|8|||
156823641|NCT03305419|566104718|FG006|Part B (14 Days)|Physician Decision|1|||
156823642|NCT03305419|566104719|FG007|Part B (14 Days)|Physician Decision|0|||
156823643|NCT01155466|566104720|FG000|Overall Study|Adverse Event|13|||
156823644|NCT01155466|566104721|FG001|Overall Study|Adverse Event|15|||
156823645|NCT01155466|566104722|FG002|Overall Study|Adverse Event|6|||
156823646|NCT01155466|566104723|FG003|Overall Study|Adverse Event|17|||
156823647|NCT01155466|566104724|FG004|Overall Study|Adverse Event|18|||
156823648|NCT01155466|566104720|FG000|Overall Study|Lost to Follow-up|0|||
156823649|NCT01155466|566104721|FG001|Overall Study|Lost to Follow-up|0|||
156823650|NCT01155466|566104722|FG002|Overall Study|Lost to Follow-up|0|||
156823651|NCT01155466|566104723|FG003|Overall Study|Lost to Follow-up|0|||
156823652|NCT01155466|566104724|FG004|Overall Study|Lost to Follow-up|2|||
156823653|NCT01155466|566104720|FG000|Overall Study|Withdrawal by Subject|7|||
156466067|NCT02101853|564802797|FG005|Post Induction Randomization|Death|0|||
156466068|NCT02101853|564802792|FG000|Post Induction Randomization|Lack of Efficacy|0|||
156466069|NCT02101853|564802793|FG001|Post Induction Randomization|Lack of Efficacy|14|||
156466070|NCT02101853|564802794|FG002|Post Induction Randomization|Lack of Efficacy|23|||
156466071|NCT02101853|564802795|FG003|Post Induction Randomization|Lack of Efficacy|18|||
156466072|NCT02101853|564802796|FG004|Post Induction Randomization|Lack of Efficacy|21|||
156466073|NCT02101853|564802797|FG005|Post Induction Randomization|Lack of Efficacy|0|||
156466074|NCT02101853|564802792|FG000|Post Induction Randomization|Physician Decision|0|||
156466075|NCT02101853|564802793|FG001|Post Induction Randomization|Physician Decision|43|||
156466076|NCT02101853|564802794|FG002|Post Induction Randomization|Physician Decision|23|||
156466077|NCT02101853|564802795|FG003|Post Induction Randomization|Physician Decision|14|||
156466078|NCT02101853|564802796|FG004|Post Induction Randomization|Physician Decision|14|||
156466079|NCT02101853|564802797|FG005|Post Induction Randomization|Physician Decision|0|||
156466080|NCT02101853|564802792|FG000|Post Induction Randomization|Protocol Violation|0|||
156466081|NCT02101853|564802793|FG001|Post Induction Randomization|Protocol Violation|3|||
156466082|NCT02101853|564802794|FG002|Post Induction Randomization|Protocol Violation|0|||
156466083|NCT02101853|564802795|FG003|Post Induction Randomization|Protocol Violation|0|||
156466084|NCT02101853|564802796|FG004|Post Induction Randomization|Protocol Violation|0|||
156466085|NCT02101853|564802797|FG005|Post Induction Randomization|Protocol Violation|0|||
156823654|NCT01155466|566104721|FG001|Overall Study|Withdrawal by Subject|5|||
156823655|NCT01155466|566104722|FG002|Overall Study|Withdrawal by Subject|9|||
156823656|NCT01155466|566104723|FG003|Overall Study|Withdrawal by Subject|4|||
156823657|NCT01155466|566104724|FG004|Overall Study|Withdrawal by Subject|4|||
156823658|NCT01155466|566104720|FG000|Overall Study|Protocol Violation|0|||
156823659|NCT01155466|566104721|FG001|Overall Study|Protocol Violation|0|||
156823660|NCT01155466|566104722|FG002|Overall Study|Protocol Violation|2|||
156466086|NCT02101853|564802792|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
156466087|NCT02101853|564802793|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
156823661|NCT01155466|566104723|FG003|Overall Study|Protocol Violation|0|||
156823662|NCT01155466|566104724|FG004|Overall Study|Protocol Violation|1|||
156823663|NCT01155466|566104720|FG000|Overall Study|Administrative|0|||
156823664|NCT01155466|566104721|FG001|Overall Study|Administrative|3|||
156823665|NCT01155466|566104722|FG002|Overall Study|Administrative|0|||
156823666|NCT01155466|566104723|FG003|Overall Study|Administrative|0|||
156823667|NCT01155466|566104724|FG004|Overall Study|Administrative|0|||
156823668|NCT01155466|566104720|FG000|Overall Study|Randomized not treated|2|||
156823669|NCT01155466|566104721|FG001|Overall Study|Randomized not treated|2|||
156823670|NCT01155466|566104722|FG002|Overall Study|Randomized not treated|3|||
156823671|NCT01155466|566104723|FG003|Overall Study|Randomized not treated|0|||
156823672|NCT01155466|566104724|FG004|Overall Study|Randomized not treated|2|||
156823673|NCT01229254|566104731|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
156823674|NCT01229254|566104732|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
156823675|NCT01229254|566104733|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
156823676|NCT01229254|566104731|FG000|Overall Study|Adverse Event|4|||
156823677|NCT01229254|566104732|FG001|Overall Study|Adverse Event|5|||
156823678|NCT01229254|566104733|FG002|Overall Study|Adverse Event|3|||
156823679|NCT01229254|566104731|FG000|Overall Study|Lost to Follow-up|3|||
156823680|NCT01229254|566104732|FG001|Overall Study|Lost to Follow-up|0|||
156823681|NCT01229254|566104733|FG002|Overall Study|Lost to Follow-up|1|||
156823682|NCT01229254|566104731|FG000|Overall Study|Physician Decision|0|||
156823683|NCT01229254|566104732|FG001|Overall Study|Physician Decision|3|||
156823684|NCT01229254|566104733|FG002|Overall Study|Physician Decision|0|||
156823685|NCT01229254|566104731|FG000|Overall Study|Protocol Violation|4|||
156823686|NCT01229254|566104732|FG001|Overall Study|Protocol Violation|6|||
156823687|NCT01229254|566104733|FG002|Overall Study|Protocol Violation|5|||
156823688|NCT01229254|566104731|FG000|Overall Study|Withdrawal by Subject|1|||
156823689|NCT01229254|566104732|FG001|Overall Study|Withdrawal by Subject|0|||
156823690|NCT01229254|566104733|FG002|Overall Study|Withdrawal by Subject|1|||
156823691|NCT01229254|566104731|FG000|Overall Study|Non-compliance with Study Drug|0|||
156466088|NCT02101853|564802794|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
156466089|NCT02101853|564802795|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
156466090|NCT02101853|564802796|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
156823692|NCT01229254|566104732|FG001|Overall Study|Non-compliance with Study Drug|1|||
156823693|NCT01229254|566104733|FG002|Overall Study|Non-compliance with Study Drug|1|||
156823694|NCT02231892|566104734|FG000|Overall Study|Lost to Follow-up|1|||
156823695|NCT02231892|566104735|FG001|Overall Study|Lost to Follow-up|0|||
156823696|NCT02231892|566104736|FG002|Overall Study|Lost to Follow-up|3|||
156823697|NCT02231892|566104734|FG000|Overall Study|Withdrawal by Subject|4|||
156823698|NCT02231892|566104735|FG001|Overall Study|Withdrawal by Subject|3|||
156466091|NCT02101853|564802797|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
156466092|NCT02101853|564802792|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156823699|NCT02231892|566104736|FG002|Overall Study|Withdrawal by Subject|15|||
156823700|NCT02231892|566104734|FG000|Overall Study|Physician Decision|0|||
156823701|NCT02231892|566104735|FG001|Overall Study|Physician Decision|2|||
156823702|NCT02231892|566104736|FG002|Overall Study|Physician Decision|4|||
156823703|NCT02231892|566104734|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
156823704|NCT02231892|566104735|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
156823705|NCT02231892|566104736|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
156823706|NCT02231892|566104734|FG000|Overall Study|Participant motor threshold was >83%|0|||
156823707|NCT02231892|566104735|FG001|Overall Study|Participant motor threshold was >83%|0|||
156823708|NCT02231892|566104736|FG002|Overall Study|Participant motor threshold was >83%|9|||
156823709|NCT02231892|566104734|FG000|Overall Study|Could not find motor threshold|2|||
156823710|NCT02231892|566104735|FG001|Overall Study|Could not find motor threshold|0|||
156823711|NCT02231892|566104736|FG002|Overall Study|Could not find motor threshold|1|||
156823712|NCT02231892|566104734|FG000|Overall Study|Could not find reliable motor hotspot|0|||
156823713|NCT02231892|566104735|FG001|Overall Study|Could not find reliable motor hotspot|0|||
156823714|NCT02231892|566104736|FG002|Overall Study|Could not find reliable motor hotspot|1|||
156823715|NCT03832322|566104737|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
156823716|NCT03832322|566104738|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
156823717|NCT00744978|566104749|FG000|Period 1|Lost to Follow-up|1|||
156823718|NCT00744978|566104750|FG001|Period 1|Lost to Follow-up|0|||
156823719|NCT00744978|566104749|FG000|Period 1|Withdrawal by Subject|0|||
156823720|NCT00744978|566104750|FG001|Period 1|Withdrawal by Subject|2|||
156823721|NCT00744978|566104749|FG000|Period 1|Other|0|||
156823722|NCT00744978|566104750|FG001|Period 1|Other|2|||
156823723|NCT00744978|566104749|FG000|Period 1|Adverse Event|4|||
156823724|NCT00744978|566104750|FG001|Period 1|Adverse Event|0|||
156823725|NCT00744978|566104749|FG000|Period 1|Randomized but not Treated|1|||
156823726|NCT00744978|566104750|FG001|Period 1|Randomized but not Treated|1|||
156823727|NCT00744978|566104749|FG000|Period 2|Adverse Event|0|||
156823728|NCT00744978|566104750|FG001|Period 2|Adverse Event|1|||
156823729|NCT03773133|566104751|FG000|Overall Study|Screen Failure|8|||
156823730|NCT00515294|566104752|FG000|Overall Study|Lost to Follow-up|3|||
156823731|NCT00515294|566104753|FG001|Overall Study|Lost to Follow-up|2|||
156823732|NCT00515294|566104754|FG002|Overall Study|Lost to Follow-up|3|||
156823733|NCT00515294|566104755|FG003|Overall Study|Lost to Follow-up|1|||
156823734|NCT00515294|566104752|FG000|Overall Study|Driver simulator problems|1|||
156823735|NCT00515294|566104753|FG001|Overall Study|Driver simulator problems|1|||
156823736|NCT00515294|566104754|FG002|Overall Study|Driver simulator problems|1|||
156823737|NCT00515294|566104755|FG003|Overall Study|Driver simulator problems|3|||
156823738|NCT00515294|566104752|FG000|Overall Study|Caffeine amount inaccurate|5|||
156823739|NCT00515294|566104753|FG001|Overall Study|Caffeine amount inaccurate|0|||
156823740|NCT00515294|566104754|FG002|Overall Study|Caffeine amount inaccurate|7|||
156823741|NCT00515294|566104755|FG003|Overall Study|Caffeine amount inaccurate|0|||
156823742|NCT02778555|566104758|FG000|Overall Study|Withdrawal by Subject|55|||
156823743|NCT02778555|566104759|FG001|Overall Study|Withdrawal by Subject|32|||
156823744|NCT02778555|566104760|FG002|Overall Study|Withdrawal by Subject|107|||
156823745|NCT00107315|566104761|FG000|Overall Study|Disease Progression|9|||
156823746|NCT00107315|566104761|FG000|Overall Study|Adverse Event|4|||
156823747|NCT00107315|566104761|FG000|Overall Study|Withdrawal by Subject|2|||
156823748|NCT03276026|566104773|FG000|Overall Study|Protocol Violation|1|||
156823749|NCT03276026|566104774|FG001|Overall Study|Protocol Violation|0|||
156823750|NCT03650803|566104776|FG000|Overall Study|Lost to Follow-up|6|||
156823751|NCT01534260|566104777|FG000|Overall Study|Adverse Event|1|||
156823752|NCT01534260|566104778|FG001|Overall Study|Adverse Event|8|||
156823753|NCT01534260|566104777|FG000|Overall Study|Death|2|||
156823754|NCT01534260|566104778|FG001|Overall Study|Death|0|||
156823755|NCT01534260|566104777|FG000|Overall Study|Lack of Efficacy|1|||
156823756|NCT01534260|566104778|FG001|Overall Study|Lack of Efficacy|1|||
156823757|NCT01534260|566104777|FG000|Overall Study|Withdrawal by Subject|1|||
156823758|NCT01534260|566104778|FG001|Overall Study|Withdrawal by Subject|3|||
156823759|NCT01534260|566104777|FG000|Overall Study|Disease Progression|8|||
156823760|NCT01534260|566104778|FG001|Overall Study|Disease Progression|6|||
156823761|NCT01534260|566104777|FG000|Overall Study|Physician Decision|3|||
156823762|NCT01534260|566104778|FG001|Overall Study|Physician Decision|1|||
156823763|NCT01534260|566104777|FG000|Overall Study|No treatment, per protocol|0|||
156823764|NCT01534260|566104778|FG001|Overall Study|No treatment, per protocol|1|||
156823765|NCT02359045|566104779|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
156823766|NCT02359045|566104780|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156823767|NCT02359045|566104779|FG000|Overall Study|Lost to Follow-up|1|||
156823768|NCT02359045|566104780|FG001|Overall Study|Lost to Follow-up|1|||
156823769|NCT02359045|566104779|FG000|Overall Study|Adverse Event|0|||
156823770|NCT02359045|566104780|FG001|Overall Study|Adverse Event|1|||
156823771|NCT00367744|566104786|FG000|Overall Study|Lost to Follow-up|4|||
156823772|NCT00367744|566104787|FG001|Overall Study|Lost to Follow-up|5|||
156823773|NCT00503581|566104790|FG000|Overall Study|Study closed|3|||
156823774|NCT00503581|566104791|FG001|Overall Study|Study closed|4|||
156823775|NCT00503581|566104792|FG002|Overall Study|Study closed|2|||
156823776|NCT01301066|566104794|FG000|Overall Study|Lost to Follow-up|5|||
156823777|NCT01301066|566104795|FG001|Overall Study|Lost to Follow-up|11|||
156823778|NCT01301066|566104794|FG000|Overall Study|Protocol Violation|8|||
156823779|NCT01301066|566104795|FG001|Overall Study|Protocol Violation|7|||
156823780|NCT01301066|566104794|FG000|Overall Study|Withdrawal by Subject|4|||
156823781|NCT01301066|566104795|FG001|Overall Study|Withdrawal by Subject|9|||
156823782|NCT01301066|566104794|FG000|Overall Study|Adverse Event|6|||
156823783|NCT01301066|566104795|FG001|Overall Study|Adverse Event|6|||
156823784|NCT01301066|566104794|FG000|Overall Study|Sponsor Decision|2|||
156823785|NCT01301066|566104795|FG001|Overall Study|Sponsor Decision|1|||
156823786|NCT01301066|566104794|FG000|Overall Study|Physician Decision|0|||
156823787|NCT01301066|566104795|FG001|Overall Study|Physician Decision|1|||
156823788|NCT01301066|566104794|FG000|Overall Study|Other|2|||
156823789|NCT01301066|566104795|FG001|Overall Study|Other|0|||
156823790|NCT02118766|566104800|FG000|Overall Study|Adverse Event|7|||
156823791|NCT02118766|566104801|FG001|Overall Study|Adverse Event|2|||
156823792|NCT02118766|566104800|FG000|Overall Study|Withdrawal by Subject|3|||
156823793|NCT02118766|566104801|FG001|Overall Study|Withdrawal by Subject|6|||
156823794|NCT02118766|566104800|FG000|Overall Study|Lost to Follow-up|5|||
156823795|NCT02118766|566104801|FG001|Overall Study|Lost to Follow-up|4|||
156823796|NCT02118766|566104800|FG000|Overall Study|Withdrawal by parent/guardian|12|||
156823797|NCT02118766|566104801|FG001|Overall Study|Withdrawal by parent/guardian|18|||
156823798|NCT02118766|566104800|FG000|Overall Study|Other|3|||
156823799|NCT02118766|566104801|FG001|Overall Study|Other|1|||
156823800|NCT02248649|566104804|FG000|Overall Study|Death|7|||
156823801|NCT02248649|566104805|FG001|Overall Study|Death|11|||
156823802|NCT02248649|566104804|FG000|Overall Study|Lost to Follow-up|14|||
156823803|NCT02248649|566104805|FG001|Overall Study|Lost to Follow-up|10|||
156823804|NCT02438683|566104806|FG000|Overall Study|Adverse Event|1|||
156823805|NCT02438683|566104807|FG001|Overall Study|Adverse Event|0|||
156823806|NCT02438683|566104808|FG002|Overall Study|Adverse Event|0|||
156466093|NCT02101853|564802793|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156466094|NCT02101853|564802794|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156466095|NCT02101853|564802795|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
156823807|NCT02438683|566104809|FG003|Overall Study|Adverse Event|0|||
156823808|NCT02438683|566104810|FG004|Overall Study|Adverse Event|0|||
156823809|NCT02438683|566104811|FG005|Overall Study|Adverse Event|0|||
156823810|NCT02226198|566107180|FG000|Lead-in Phase|Protocol Violation|1|||
156823811|NCT02226198|566107181|FG001|Lead-in Phase|Protocol Violation|0|||
156823812|NCT02226198|566107182|FG002|Lead-in Phase|Protocol Violation|0|||
156823813|NCT02226198|566107180|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
156823814|NCT02226198|566107181|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
156823815|NCT02226198|566107182|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
156466096|NCT02101853|564802796|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156823816|NCT01440517|566107186|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
156823817|NCT01288612|566107187|FG000|Overall Study|Unable to contact|11|||
156823818|NCT01288612|566107188|FG001|Overall Study|Unable to contact|16|||
156823819|NCT01288612|566107189|FG002|Overall Study|Unable to contact|20|||
156823820|NCT01288612|566107187|FG000|Overall Study|Declined|78|||
156823821|NCT01288612|566107188|FG001|Overall Study|Declined|63|||
156823822|NCT01288612|566107189|FG002|Overall Study|Declined|62|||
156823823|NCT01288612|566107187|FG000|Overall Study|Unable to intubate|0|||
156823824|NCT01288612|566107188|FG001|Overall Study|Unable to intubate|3|||
156823825|NCT01288612|566107189|FG002|Overall Study|Unable to intubate|0|||
156823826|NCT00871923|566107190|FG000|Overall Study|Death|1|||
156823827|NCT00871923|566107190|FG000|Overall Study|Withdrawal by Subject|1|||
156823828|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
156823829|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
156823830|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
156823831|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
156823832|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
156823833|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
156823834|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
156823835|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
156823836|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
156823837|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
156823838|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
156823839|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
156823840|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
156823841|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
156823842|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
156823843|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
156823844|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
156823845|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
156823846|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
156823847|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
156823848|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
156823849|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
156823850|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
156823851|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
156823852|NCT05599451|566107197|FG000|Overall Study|Not randomized|11|||
156823853|NCT05599451|566107198|FG001|Overall Study|Not randomized|0|||
156823854|NCT05599451|566107199|FG002|Overall Study|Not randomized|0|||
156823855|NCT05599451|566107200|FG003|Overall Study|Not randomized|0|||
156823856|NCT05599451|566107201|FG004|Overall Study|Not randomized|0|||
156823857|NCT05599451|566107197|FG000|Overall Study|Physician Decision|0|||
156823858|NCT05599451|566107198|FG001|Overall Study|Physician Decision|0|||
156823859|NCT05599451|566107199|FG002|Overall Study|Physician Decision|0|||
156823860|NCT05599451|566107200|FG003|Overall Study|Physician Decision|1|||
156823861|NCT05599451|566107201|FG004|Overall Study|Physician Decision|0|||
156823862|NCT02723006|566107202|FG000|Overall Study|Withdrawal by Subject|0|||
156823863|NCT02723006|566107203|FG001|Overall Study|Withdrawal by Subject|1|||
156823864|NCT02723006|566107204|FG002|Overall Study|Withdrawal by Subject|1|||
156823865|NCT02723006|566107202|FG000|Overall Study|Study Terminated by Sponsor|1|||
156823866|NCT02723006|566107203|FG001|Overall Study|Study Terminated by Sponsor|6|||
156823867|NCT02723006|566107204|FG002|Overall Study|Study Terminated by Sponsor|6|||
156823868|NCT00303446|566107205|FG000|Overall Study|Withdrawal by Subject|2|||
156823869|NCT00303446|566107206|FG001|Overall Study|Withdrawal by Subject|2|||
156823870|NCT00303446|566107205|FG000|Overall Study|Death|0|||
156823871|NCT00303446|566107206|FG001|Overall Study|Death|1|||
156823872|NCT00303446|566107205|FG000|Overall Study|Physician Decision|0|||
156823873|NCT00303446|566107206|FG001|Overall Study|Physician Decision|1|||
156823874|NCT01468207|566107207|FG000|Treatment Period 1|Adverse Event|1|||
156823875|NCT01468207|566107208|FG001|Treatment Period 1|Adverse Event|0|||
156823876|NCT01468207|566107209|FG002|Treatment Period 1|Adverse Event|0|||
156823877|NCT01468207|566107210|FG003|Treatment Period 1|Adverse Event|0|||
156823878|NCT01468207|566107211|FG004|Treatment Period 1|Adverse Event|0|||
156823879|NCT01468207|566107212|FG005|Treatment Period 1|Adverse Event|0|||
156466097|NCT02101853|564802797|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
156466098|NCT02101853|564802792|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
156466099|NCT02101853|564802793|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
156466100|NCT02101853|564802794|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
156466101|NCT02101853|564802795|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
156823880|NCT01468207|566107207|FG000|Treatment Period 1|Protocol Violation|1|||
156823881|NCT01468207|566107208|FG001|Treatment Period 1|Protocol Violation|1|||
156823882|NCT01468207|566107209|FG002|Treatment Period 1|Protocol Violation|0|||
156823883|NCT01468207|566107210|FG003|Treatment Period 1|Protocol Violation|0|||
156823884|NCT01468207|566107211|FG004|Treatment Period 1|Protocol Violation|0|||
156823885|NCT01468207|566107212|FG005|Treatment Period 1|Protocol Violation|0|||
156823886|NCT01468207|566107207|FG000|Treatment Period 1|Withdrawal by Subject|5|||
156823887|NCT01468207|566107208|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156339210|NCT01090492|564340142|FG000|First Intervention Period (4 Weeks)|Other|0|||
156823888|NCT01468207|566107209|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156823889|NCT01468207|566107210|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156823890|NCT01468207|566107211|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156823891|NCT01468207|566107212|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156823892|NCT01468207|566107207|FG000|Treatment Period 1|Lost to Follow-up|2|||
156823893|NCT01468207|566107208|FG001|Treatment Period 1|Lost to Follow-up|1|||
156823894|NCT01468207|566107209|FG002|Treatment Period 1|Lost to Follow-up|0|||
156823895|NCT01468207|566107210|FG003|Treatment Period 1|Lost to Follow-up|0|||
156823896|NCT01468207|566107211|FG004|Treatment Period 1|Lost to Follow-up|0|||
156823897|NCT01468207|566107212|FG005|Treatment Period 1|Lost to Follow-up|0|||
156823898|NCT01468207|566107207|FG000|Treatment Period 1|Other|0|||
156823899|NCT01468207|566107208|FG001|Treatment Period 1|Other|2|||
156823900|NCT01468207|566107209|FG002|Treatment Period 1|Other|0|||
156823901|NCT01468207|566107210|FG003|Treatment Period 1|Other|0|||
156823902|NCT01468207|566107211|FG004|Treatment Period 1|Other|0|||
156823903|NCT01468207|566107212|FG005|Treatment Period 1|Other|0|||
156823904|NCT01468207|566107207|FG000|Treatment Period 2|Adverse Event|0|||
156823905|NCT01468207|566107208|FG001|Treatment Period 2|Adverse Event|0|||
156823906|NCT01468207|566107209|FG002|Treatment Period 2|Adverse Event|6|||
156823907|NCT01468207|566107210|FG003|Treatment Period 2|Adverse Event|1|||
156823908|NCT01468207|566107211|FG004|Treatment Period 2|Adverse Event|2|||
156823909|NCT01468207|566107212|FG005|Treatment Period 2|Adverse Event|1|||
156823910|NCT01468207|566107207|FG000|Treatment Period 2|Lack of Efficacy|0|||
156823911|NCT01468207|566107208|FG001|Treatment Period 2|Lack of Efficacy|0|||
156823912|NCT01468207|566107209|FG002|Treatment Period 2|Lack of Efficacy|1|||
156823913|NCT01468207|566107210|FG003|Treatment Period 2|Lack of Efficacy|1|||
156823914|NCT01468207|566107211|FG004|Treatment Period 2|Lack of Efficacy|0|||
156823915|NCT01468207|566107212|FG005|Treatment Period 2|Lack of Efficacy|2|||
156823916|NCT01468207|566107207|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156823917|NCT01468207|566107208|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156823918|NCT01468207|566107209|FG002|Treatment Period 2|Withdrawal by Subject|5|||
156823919|NCT01468207|566107210|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156823920|NCT01468207|566107211|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156823921|NCT01468207|566107212|FG005|Treatment Period 2|Withdrawal by Subject|2|||
156823922|NCT01468207|566107207|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
156823923|NCT01468207|566107208|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
156823924|NCT01468207|566107209|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
156823925|NCT01468207|566107210|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
156823926|NCT01468207|566107211|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
156823927|NCT01468207|566107212|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
156823928|NCT01468207|566107207|FG000|Treatment Period 2|Lost to Follow-up|0|||
156823929|NCT01468207|566107208|FG001|Treatment Period 2|Lost to Follow-up|0|||
156823930|NCT01468207|566107209|FG002|Treatment Period 2|Lost to Follow-up|5|||
156823931|NCT01468207|566107210|FG003|Treatment Period 2|Lost to Follow-up|1|||
156823932|NCT01468207|566107211|FG004|Treatment Period 2|Lost to Follow-up|0|||
156823933|NCT01468207|566107212|FG005|Treatment Period 2|Lost to Follow-up|0|||
156823934|NCT01468207|566107207|FG000|Treatment Period 2|Other|0|||
156823935|NCT01468207|566107208|FG001|Treatment Period 2|Other|0|||
156823936|NCT01468207|566107209|FG002|Treatment Period 2|Other|5|||
156823937|NCT01468207|566107210|FG003|Treatment Period 2|Other|1|||
156823938|NCT01468207|566107211|FG004|Treatment Period 2|Other|1|||
156823939|NCT01468207|566107212|FG005|Treatment Period 2|Other|2|||
156823940|NCT00413894|566107213|FG000|Overall Study|Withdrawal by Subject|10|||
156823941|NCT00413894|566107213|FG000|Overall Study|Administrative Reasons|1|||
156823942|NCT00413894|566107213|FG000|Overall Study|Hb <10 grams/deciliter|12|||
156823943|NCT00413894|566107213|FG000|Overall Study|Adverse Event|28|||
156823944|NCT00413894|566107213|FG000|Overall Study|Protocol Violation|11|||
156823945|NCT00413894|566107213|FG000|Overall Study|Other|18|||
156823946|NCT04225676|566107214|FG000|Overall Study|Physician Decision|1|||
156823947|NCT04225676|566107214|FG000|Overall Study|Lack of Efficacy|1|||
156823948|NCT04225676|566107214|FG000|Overall Study|Study terminated by sponsor|3|||
156823949|NCT05289271|566107217|FG000|Overall Study|Mistakenly allocated, untreated|1|||
156823950|NCT05289271|566107218|FG001|Overall Study|Mistakenly allocated, untreated|0|||
156823951|NCT03356977|566107219|FG000|Overall Study|Lost to Follow-up|3|||
156823952|NCT03356977|566107219|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156823953|NCT01728077|566107225|FG000|Overall Study|Lack of Efficacy|3|||
156823954|NCT01728077|566107226|FG001|Overall Study|Lack of Efficacy|1|||
156823955|NCT01728077|566107225|FG000|Overall Study|Lost to Follow-up|1|||
156823956|NCT01728077|566107226|FG001|Overall Study|Lost to Follow-up|0|||
156823957|NCT01728077|566107225|FG000|Overall Study|Subject choice|2|||
156823958|NCT01728077|566107226|FG001|Overall Study|Subject choice|3|||
156823959|NCT01728077|566107225|FG000|Overall Study|Death|0|||
156823960|NCT01728077|566107226|FG001|Overall Study|Death|1|||
156823961|NCT01728077|566107225|FG000|Overall Study|Patient moving|1|||
156823962|NCT01728077|566107226|FG001|Overall Study|Patient moving|0|||
156823963|NCT01728077|566107225|FG000|Overall Study|Non compliance|1|||
156823964|NCT01728077|566107226|FG001|Overall Study|Non compliance|0|||
156823965|NCT00378599|566107229|FG000|Overall Study|Adverse Event|38|||
156823966|NCT00378599|566107229|FG000|Overall Study|Protocol Violation|2|||
156823967|NCT00378599|566107229|FG000|Overall Study|Treatment failure|7|||
156823968|NCT00378599|566107229|FG000|Overall Study|Withdrawal by Subject|5|||
156823969|NCT03224507|566107231|FG000|Overall Study|Death|3|||
156823970|NCT03224507|566107232|FG001|Overall Study|Death|0|||
156823971|NCT03224507|566107231|FG000|Overall Study|Lack of Efficacy|6|||
156823972|NCT03224507|566107232|FG001|Overall Study|Lack of Efficacy|0|||
156823973|NCT03224507|566107231|FG000|Overall Study|Withdrawal by Subject|6|||
156823974|NCT03224507|566107232|FG001|Overall Study|Withdrawal by Subject|0|||
156823975|NCT01032291|566107233|FG000|Safety Lead-in|Adverse Event|1|||
156823976|NCT01032291|566107234|FG001|Safety Lead-in|Adverse Event|0|||
156823977|NCT01032291|566107235|FG002|Safety Lead-in|Adverse Event|0|||
156823978|NCT01032291|566107233|FG000|Safety Lead-in|Death|1|||
156823979|NCT01032291|566107234|FG001|Safety Lead-in|Death|0|||
156823980|NCT01032291|566107235|FG002|Safety Lead-in|Death|0|||
156823981|NCT01032291|566107233|FG000|Proof of Concept|Adverse Event|0|||
156823982|NCT01032291|566107234|FG001|Proof of Concept|Adverse Event|5|||
156823983|NCT01032291|566107235|FG002|Proof of Concept|Adverse Event|1|||
156823984|NCT01032291|566107233|FG000|Proof of Concept|Death|0|||
156823985|NCT01032291|566107234|FG001|Proof of Concept|Death|1|||
156823986|NCT01032291|566107235|FG002|Proof of Concept|Death|2|||
156823987|NCT01032291|566107233|FG000|Proof of Concept|Lack of Efficacy|0|||
156823988|NCT01032291|566107234|FG001|Proof of Concept|Lack of Efficacy|1|||
156823989|NCT01032291|566107235|FG002|Proof of Concept|Lack of Efficacy|0|||
156823990|NCT01032291|566107233|FG000|Proof of Concept|Never Received Study Drug|0|||
156823991|NCT01032291|566107234|FG001|Proof of Concept|Never Received Study Drug|1|||
156823992|NCT01032291|566107235|FG002|Proof of Concept|Never Received Study Drug|0|||
156823993|NCT00642369|566107236|FG000|Overall Study|Adverse Event|2|||
156823994|NCT00642369|566107237|FG001|Overall Study|Adverse Event|3|||
156823995|NCT00642369|566107236|FG000|Overall Study|Withdrawal by Subject|1|||
156823996|NCT00642369|566107237|FG001|Overall Study|Withdrawal by Subject|0|||
156823997|NCT00642369|566107236|FG000|Overall Study|misdiagnosis|0|||
156823998|NCT00642369|566107237|FG001|Overall Study|misdiagnosis|1|||
156823999|NCT00642369|566107236|FG000|Overall Study|Lack of Efficacy|2|||
156824000|NCT00642369|566107237|FG001|Overall Study|Lack of Efficacy|2|||
156824001|NCT04035564|566107238|FG000|Overall Study|Protocol Violation|1|||
156824002|NCT04035564|566107239|FG001|Overall Study|Protocol Violation|2|||
156824003|NCT04035564|566107238|FG000|Overall Study|No laboratory available|2|||
156824004|NCT04035564|566107239|FG001|Overall Study|No laboratory available|2|||
156824005|NCT04035564|566107238|FG000|Overall Study|Guardian declined consent|1|||
156824006|NCT04035564|566107239|FG001|Overall Study|Guardian declined consent|2|||
156824007|NCT00624585|566107244|FG000|Overall Study|Death|3|||
156824008|NCT00624585|566107244|FG000|Overall Study|Disease Progression|6|||
156824009|NCT00624585|566107244|FG000|Overall Study|Adverse Event|3|||
156824010|NCT04154345|566107248|FG000|Overall Study|Covid-19 pandemic|4|||
156824011|NCT00676520|566107250|FG000|Overall Study|Withdrawal by Subject|163|||
156824012|NCT00676520|566107250|FG000|Overall Study|Lost to Follow-up|162|||
156824013|NCT00676520|566107250|FG000|Overall Study|Death|159|||
156824014|NCT00676520|566107250|FG000|Overall Study|Physician Decision|20|||
156824015|NCT00676520|566107250|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
156824016|NCT00676520|566107250|FG000|Overall Study|Other Reason|18|||
156824017|NCT01425359|566107251|FG000|Overall Study|Randomized but Not Treated|2|||
156824018|NCT01425359|566107252|FG001|Overall Study|Randomized but Not Treated|3|||
156824019|NCT01425359|566107251|FG000|Overall Study|Adverse Event|9|||
156824020|NCT01425359|566107252|FG001|Overall Study|Adverse Event|8|||
156824021|NCT01425359|566107251|FG000|Overall Study|Revascularization|0|||
156824022|NCT01425359|566107252|FG001|Overall Study|Revascularization|1|||
156824023|NCT01425359|566107251|FG000|Overall Study|Death|0|||
156824024|NCT01425359|566107252|FG001|Overall Study|Death|1|||
156824025|NCT01425359|566107251|FG000|Overall Study|Unsatisfactory Response|1|||
156824026|NCT01425359|566107252|FG001|Overall Study|Unsatisfactory Response|0|||
156466102|NCT02101853|564802796|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
156466103|NCT02101853|564802797|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
156466104|NCT02101853|564802792|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
156466105|NCT02101853|564802793|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
156824027|NCT01425359|566107251|FG000|Overall Study|Protocol Violation|1|||
156824028|NCT01425359|566107252|FG001|Overall Study|Protocol Violation|2|||
156824029|NCT01425359|566107251|FG000|Overall Study|Subject Withdrew Consent|1|||
156824030|NCT01425359|566107252|FG001|Overall Study|Subject Withdrew Consent|2|||
156824031|NCT01425359|566107251|FG000|Overall Study|Investigator's Discretion|2|||
156824032|NCT01425359|566107252|FG001|Overall Study|Investigator's Discretion|0|||
156824033|NCT01425359|566107251|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
156824034|NCT01425359|566107252|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
156824035|NCT04043234|566107257|FG000|Overall Study|Lost to Follow-up|1|||
156824036|NCT04043234|566107257|FG000|Overall Study|Withdrawal by Subject|1|||
156824037|NCT01165320|566107258|FG000|Overall Study|Clinical adverse experience|2|||
156824038|NCT01165320|566107259|FG001|Overall Study|Clinical adverse experience|1|||
156339211|NCT01090492|564340143|FG001|First Intervention Period (4 Weeks)|Other|0|||
156339212|NCT01090492|564340144|FG002|First Intervention Period (4 Weeks)|Other|1|||
156339213|NCT01090492|564340145|FG003|First Intervention Period (4 Weeks)|Other|1|||
156339214|NCT01090492|564340146|FG004|First Intervention Period (4 Weeks)|Other|2|||
156339215|NCT01090492|564340147|FG005|First Intervention Period (4 Weeks)|Other|0|||
156339216|NCT01090492|564340148|FG006|First Intervention Period (4 Weeks)|Other|0|||
156339217|NCT01090492|564340149|FG007|First Intervention Period (4 Weeks)|Other|0|||
156339218|NCT01090492|564340142|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
156339219|NCT01090492|564340143|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
156339220|NCT01090492|564340144|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
156339221|NCT01090492|564340145|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
156339222|NCT01090492|564340146|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
156339223|NCT01090492|564340147|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
156339224|NCT01090492|564340148|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
156339225|NCT01090492|564340149|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
156339226|NCT01090492|564340142|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
156339227|NCT01090492|564340143|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
156339228|NCT01090492|564340144|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
156339229|NCT01090492|564340145|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
156339230|NCT01090492|564340146|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
156466106|NCT02101853|564802794|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
156466107|NCT02101853|564802795|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
156466108|NCT02101853|564802796|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
156339231|NCT01090492|564340147|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
156339232|NCT01090492|564340148|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
156339233|NCT01090492|564340149|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
156339234|NCT01090492|564340142|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
156339235|NCT01090492|564340143|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
156339236|NCT01090492|564340144|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
156339237|NCT01090492|564340145|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
156339238|NCT01090492|564340146|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
156466109|NCT02101853|564802797|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
156824039|NCT01165320|566107260|FG002|Overall Study|Clinical adverse experience|0|||
156824040|NCT01165320|566107258|FG000|Overall Study|Laboratory adverse experience|1|||
156824041|NCT01165320|566107259|FG001|Overall Study|Laboratory adverse experience|0|||
156824042|NCT01165320|566107260|FG002|Overall Study|Laboratory adverse experience|0|||
156824043|NCT01165320|566107258|FG000|Overall Study|Lack of Efficacy|0|||
156824044|NCT01165320|566107259|FG001|Overall Study|Lack of Efficacy|2|||
156824045|NCT01165320|566107260|FG002|Overall Study|Lack of Efficacy|0|||
156824046|NCT01165320|566107258|FG000|Overall Study|Reason unknown|0|||
156824047|NCT01165320|566107259|FG001|Overall Study|Reason unknown|1|||
156824048|NCT01165320|566107260|FG002|Overall Study|Reason unknown|0|||
156824049|NCT02186652|566107265|FG000|Overall Study|Lost to Follow-up|2|||
156824050|NCT02186652|566107266|FG001|Overall Study|Lost to Follow-up|0|||
156824051|NCT03770728|566107271|FG000|Overall Study|Adverse Event|1|||
156824052|NCT03770728|566107272|FG001|Overall Study|Adverse Event|0|||
156824053|NCT03770728|566107273|FG002|Overall Study|Adverse Event|1|||
156824054|NCT03770728|566107274|FG003|Overall Study|Adverse Event|0|||
156824055|NCT03770728|566107271|FG000|Overall Study|Poor compliance to protocol|0|||
156824056|NCT03770728|566107272|FG001|Overall Study|Poor compliance to protocol|0|||
156824057|NCT03770728|566107273|FG002|Overall Study|Poor compliance to protocol|1|||
156824058|NCT03770728|566107274|FG003|Overall Study|Poor compliance to protocol|0|||
156824059|NCT03770728|566107271|FG000|Overall Study|Withdrawal by Subject|13|||
156824060|NCT03770728|566107272|FG001|Overall Study|Withdrawal by Subject|8|||
156824061|NCT03770728|566107273|FG002|Overall Study|Withdrawal by Subject|9|||
156466110|NCT02101853|564802792|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
156824062|NCT03770728|566107274|FG003|Overall Study|Withdrawal by Subject|13|||
156824063|NCT03770728|566107271|FG000|Overall Study|Other than specified|24|||
156339239|NCT01090492|564340147|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
156339240|NCT01090492|564340148|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
156339241|NCT01090492|564340149|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
156339242|NCT01090492|564340142|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156824064|NCT03770728|566107272|FG001|Overall Study|Other than specified|23|||
156339243|NCT01090492|564340143|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
156824065|NCT03770728|566107273|FG002|Overall Study|Other than specified|21|||
156824066|NCT03770728|566107274|FG003|Overall Study|Other than specified|22|||
156824067|NCT00503776|566107275|FG000|Overall Study|Withdrawal by Subject|1|||
156339244|NCT01090492|564340144|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156339245|NCT01090492|564340145|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156824068|NCT00503776|566107276|FG001|Overall Study|Withdrawal by Subject|0|||
156824069|NCT00503776|566107277|FG002|Overall Study|Withdrawal by Subject|1|||
156466111|NCT02101853|564802793|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
156466112|NCT02101853|564802794|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
156824070|NCT00503776|566107278|FG003|Overall Study|Withdrawal by Subject|1|||
156824071|NCT00503776|566107275|FG000|Overall Study|Physician Decision|0|||
156824072|NCT00503776|566107276|FG001|Overall Study|Physician Decision|0|||
156824073|NCT00503776|566107277|FG002|Overall Study|Physician Decision|1|||
156824074|NCT00503776|566107278|FG003|Overall Study|Physician Decision|1|||
156824075|NCT02379988|566107279|FG000|Overall Study|Not eligible|1|||
156824076|NCT02509039|566107282|FG000|Overall Study|Adverse Event|0|||
156824077|NCT02509039|566107283|FG001|Overall Study|Adverse Event|1|||
156824078|NCT02509039|566107284|FG002|Overall Study|Adverse Event|1|||
156824079|NCT02509039|566107285|FG003|Overall Study|Adverse Event|1|||
156824080|NCT02509039|566107282|FG000|Overall Study|Withdrawal by Subject|0|||
156824081|NCT02509039|566107283|FG001|Overall Study|Withdrawal by Subject|0|||
156824082|NCT02509039|566107284|FG002|Overall Study|Withdrawal by Subject|1|||
156824083|NCT02509039|566107285|FG003|Overall Study|Withdrawal by Subject|0|||
156824084|NCT02509039|566107282|FG000|Overall Study|Progressive disease|2|||
156824085|NCT02509039|566107283|FG001|Overall Study|Progressive disease|2|||
156824086|NCT02509039|566107284|FG002|Overall Study|Progressive disease|1|||
156824087|NCT02509039|566107285|FG003|Overall Study|Progressive disease|5|||
156824088|NCT02509039|566107282|FG000|Overall Study|Study terminated by Sponsor|1|||
156824089|NCT02509039|566107283|FG001|Overall Study|Study terminated by Sponsor|0|||
156824090|NCT02509039|566107284|FG002|Overall Study|Study terminated by Sponsor|0|||
156824091|NCT02509039|566107285|FG003|Overall Study|Study terminated by Sponsor|0|||
156824092|NCT03943550|566107288|FG000|Overall Study|Adverse Event|0|||
156824093|NCT03943550|566107289|FG001|Overall Study|Adverse Event|0|||
156824094|NCT03943550|566107290|FG002|Overall Study|Adverse Event|1|||
156824095|NCT03943550|566107288|FG000|Overall Study|Lost to Follow-up|0|||
156824096|NCT03943550|566107289|FG001|Overall Study|Lost to Follow-up|0|||
156824097|NCT03943550|566107290|FG002|Overall Study|Lost to Follow-up|1|||
156824098|NCT03943550|566107288|FG000|Overall Study|Progressive Disease|0|||
156824099|NCT03943550|566107289|FG001|Overall Study|Progressive Disease|0|||
156824100|NCT03943550|566107290|FG002|Overall Study|Progressive Disease|2|||
156824101|NCT03943550|566107288|FG000|Overall Study|Participant Moved Out of the Country|0|||
156824102|NCT03943550|566107289|FG001|Overall Study|Participant Moved Out of the Country|1|||
156824103|NCT03943550|566107290|FG002|Overall Study|Participant Moved Out of the Country|0|||
156824104|NCT03359785|566107291|FG000|Overall Study|Protocol Violation|0|||
156824105|NCT03359785|566107292|FG001|Overall Study|Protocol Violation|1|||
156824106|NCT03359785|566107293|FG002|Overall Study|Protocol Violation|0|||
156824107|NCT03359785|566107294|FG003|Overall Study|Protocol Violation|0|||
156824108|NCT03359785|566107291|FG000|Overall Study|Early study termination due to study pause|0|||
156824109|NCT03359785|566107292|FG001|Overall Study|Early study termination due to study pause|0|||
156824110|NCT03359785|566107293|FG002|Overall Study|Early study termination due to study pause|2|||
156824111|NCT03359785|566107294|FG003|Overall Study|Early study termination due to study pause|0|||
156824112|NCT03359785|566107291|FG000|Overall Study|Withdrawal by Subject|2|||
156824113|NCT03359785|566107292|FG001|Overall Study|Withdrawal by Subject|2|||
156824114|NCT03359785|566107293|FG002|Overall Study|Withdrawal by Subject|0|||
156824115|NCT03359785|566107294|FG003|Overall Study|Withdrawal by Subject|0|||
156824116|NCT04659174|566107296|FG000|Overall Study|Sponsor decision to discontinue study|0|||
156824117|NCT04659174|566107297|FG001|Overall Study|Sponsor decision to discontinue study|2|||
156824118|NCT04659174|566107296|FG000|Overall Study|Lost to Follow-up|9|||
156824119|NCT04659174|566107297|FG001|Overall Study|Lost to Follow-up|11|||
156824120|NCT04659174|566107296|FG000|Overall Study|Adverse Event|8|||
156824121|NCT04659174|566107297|FG001|Overall Study|Adverse Event|5|||
156824122|NCT04659174|566107296|FG000|Overall Study|Withdrawal by Subject|17|||
156824123|NCT04659174|566107297|FG001|Overall Study|Withdrawal by Subject|33|||
156824124|NCT04659174|566107296|FG000|Overall Study|Progressive disease|0|||
156824125|NCT04659174|566107297|FG001|Overall Study|Progressive disease|2|||
156824126|NCT04659174|566107296|FG000|Overall Study|Other reasons|0|||
156824127|NCT04659174|566107297|FG001|Overall Study|Other reasons|2|||
156339246|NCT01090492|564340146|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156541174|NCT01368536|565074498|FG001|Overall Study|No longer required study medication|0|||
156824128|NCT04659174|566107296|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
156824129|NCT04659174|566107297|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
156824130|NCT04659174|566107296|FG000|Overall Study|Alcohol or illegal drug use|0|||
156824131|NCT04659174|566107297|FG001|Overall Study|Alcohol or illegal drug use|3|||
156824132|NCT04659174|566107296|FG000|Overall Study|Violation of entry criteria|1|||
156824133|NCT04659174|566107297|FG001|Overall Study|Violation of entry criteria|0|||
156824134|NCT04659174|566107296|FG000|Overall Study|Death|0|||
156824135|NCT04659174|566107297|FG001|Overall Study|Death|1|||
156824136|NCT01202188|566107303|FG000|Overall Study|Protocol deviation|14|||
156824137|NCT01202188|566107304|FG001|Overall Study|Protocol deviation|8|||
156824138|NCT01202188|566107305|FG002|Overall Study|Protocol deviation|12|||
156824139|NCT01202188|566107306|FG003|Overall Study|Protocol deviation|10|||
156824140|NCT01202188|566107307|FG004|Overall Study|Protocol deviation|11|||
156824141|NCT01202188|566107303|FG000|Overall Study|Subject withdrew consent|12|||
156824142|NCT01202188|566107304|FG001|Overall Study|Subject withdrew consent|13|||
156824143|NCT01202188|566107305|FG002|Overall Study|Subject withdrew consent|22|||
156824144|NCT01202188|566107306|FG003|Overall Study|Subject withdrew consent|11|||
156824145|NCT01202188|566107307|FG004|Overall Study|Subject withdrew consent|13|||
156824146|NCT01202188|566107303|FG000|Overall Study|Adverse Event|5|||
156824147|NCT01202188|566107304|FG001|Overall Study|Adverse Event|23|||
156824148|NCT01202188|566107305|FG002|Overall Study|Adverse Event|13|||
156541175|NCT01368536|565074499|FG002|Overall Study|No longer required study medication|1|||
156541176|NCT01368536|565074497|FG000|Overall Study|Withdrawal by Subject|2|||
156541177|NCT01368536|565074498|FG001|Overall Study|Withdrawal by Subject|5|||
156541178|NCT01368536|565074499|FG002|Overall Study|Withdrawal by Subject|4|||
156541179|NCT01368536|565074497|FG000|Overall Study|Lost to Follow-up|3|||
156541180|NCT01368536|565074498|FG001|Overall Study|Lost to Follow-up|3|||
156541181|NCT01368536|565074499|FG002|Overall Study|Lost to Follow-up|5|||
156541182|NCT01368536|565074497|FG000|Overall Study|Administrative problems|34|||
156541183|NCT01368536|565074498|FG001|Overall Study|Administrative problems|39|||
156541184|NCT01368536|565074499|FG002|Overall Study|Administrative problems|35|||
156541185|NCT01368536|565074497|FG000|Overall Study|Protocol deviation|0|||
156824149|NCT01202188|566107306|FG003|Overall Study|Adverse Event|10|||
156824150|NCT01202188|566107307|FG004|Overall Study|Adverse Event|10|||
156824151|NCT01202188|566107303|FG000|Overall Study|Administrative problems|3|||
156824152|NCT01202188|566107304|FG001|Overall Study|Administrative problems|2|||
156824153|NCT01202188|566107305|FG002|Overall Study|Administrative problems|1|||
156824154|NCT01202188|566107306|FG003|Overall Study|Administrative problems|1|||
156824155|NCT01202188|566107307|FG004|Overall Study|Administrative problems|2|||
156824156|NCT01202188|566107303|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156824157|NCT01202188|566107304|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
156824158|NCT01202188|566107305|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156824159|NCT01202188|566107306|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
156824160|NCT01202188|566107307|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
156824161|NCT01202188|566107303|FG000|Overall Study|Lost to Follow-up|1|||
156824162|NCT01202188|566107304|FG001|Overall Study|Lost to Follow-up|1|||
156824163|NCT01202188|566107305|FG002|Overall Study|Lost to Follow-up|0|||
156824164|NCT01202188|566107306|FG003|Overall Study|Lost to Follow-up|4|||
156824165|NCT01202188|566107307|FG004|Overall Study|Lost to Follow-up|1|||
156824166|NCT01202188|566107303|FG000|Overall Study|Death|1|||
156824167|NCT01202188|566107304|FG001|Overall Study|Death|1|||
156824168|NCT01202188|566107305|FG002|Overall Study|Death|1|||
156824169|NCT01202188|566107306|FG003|Overall Study|Death|1|||
156824170|NCT01202188|566107307|FG004|Overall Study|Death|0|||
156824171|NCT01202188|566107303|FG000|Overall Study|Abnormal test procedure result (s)|0|||
156824172|NCT01202188|566107304|FG001|Overall Study|Abnormal test procedure result (s)|0|||
156824173|NCT01202188|566107305|FG002|Overall Study|Abnormal test procedure result (s)|2|||
156824174|NCT01202188|566107306|FG003|Overall Study|Abnormal test procedure result (s)|0|||
156824175|NCT01202188|566107307|FG004|Overall Study|Abnormal test procedure result (s)|0|||
156824176|NCT05032690|566107308|FG000|Period 1|Adverse Event|0|||
156824177|NCT05032690|566107309|FG001|Period 1|Adverse Event|1|||
156824178|NCT05032690|566107310|FG002|Period 1|Adverse Event|0|||
156824179|NCT05032690|566107311|FG003|Period 1|Adverse Event|0|||
156824180|NCT05032690|566107308|FG000|Period 1|Withdrawal by Subject|1|||
156824181|NCT05032690|566107309|FG001|Period 1|Withdrawal by Subject|0|||
156824182|NCT05032690|566107310|FG002|Period 1|Withdrawal by Subject|0|||
156824183|NCT05032690|566107311|FG003|Period 1|Withdrawal by Subject|0|||
156824184|NCT05032690|566107308|FG000|Period 1|No longer meets eligibility criteria|0|||
156824185|NCT05032690|566107309|FG001|Period 1|No longer meets eligibility criteria|1|||
156541186|NCT01368536|565074498|FG001|Overall Study|Protocol deviation|3|||
156541187|NCT01368536|565074499|FG002|Overall Study|Protocol deviation|1|||
156541188|NCT01486927|565074502|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
156824186|NCT05032690|566107310|FG002|Period 1|No longer meets eligibility criteria|0|||
156824187|NCT05032690|566107311|FG003|Period 1|No longer meets eligibility criteria|0|||
156824188|NCT05032690|566107308|FG000|Period 2|Adverse Event|1|||
156824189|NCT05032690|566107309|FG001|Period 2|Adverse Event|0|||
156824190|NCT05032690|566107310|FG002|Period 2|Adverse Event|0|||
156824191|NCT05032690|566107311|FG003|Period 2|Adverse Event|0|||
156824192|NCT05032690|566107308|FG000|Period 2|Withdrawal by Subject|0|||
156824193|NCT05032690|566107309|FG001|Period 2|Withdrawal by Subject|1|||
156824194|NCT05032690|566107310|FG002|Period 2|Withdrawal by Subject|0|||
156541189|NCT01486927|565074502|FG000|Overall Study|Physician Decision|1|||
156541190|NCT01486927|565074502|FG000|Overall Study|50 Exposure days not reached|2|||
156541191|NCT01486927|565074502|FG000|Overall Study|Withdrawal by Subject|8|||
156824195|NCT05032690|566107311|FG003|Period 2|Withdrawal by Subject|0|||
156824196|NCT05032690|566107308|FG000|Period 2|No longer meets eligibility criteria|0|||
156824197|NCT05032690|566107309|FG001|Period 2|No longer meets eligibility criteria|1|||
156824198|NCT05032690|566107310|FG002|Period 2|No longer meets eligibility criteria|0|||
156824199|NCT05032690|566107311|FG003|Period 2|No longer meets eligibility criteria|0|||
156824200|NCT05032690|566107308|FG000|Period 3|Adverse Event|0|||
156824201|NCT05032690|566107309|FG001|Period 3|Adverse Event|1|||
156824202|NCT05032690|566107310|FG002|Period 3|Adverse Event|0|||
156824203|NCT05032690|566107311|FG003|Period 3|Adverse Event|0|||
156824204|NCT00487942|566107312|FG000|Overall Study|Adverse Event|1|||
156824205|NCT00487942|566107313|FG001|Overall Study|Adverse Event|1|||
156824206|NCT00487942|566107314|FG002|Overall Study|Adverse Event|1|||
156824207|NCT00487942|566107315|FG003|Overall Study|Adverse Event|1|||
156824208|NCT00487942|566107312|FG000|Overall Study|Lost to Follow-up|1|||
156824209|NCT00487942|566107313|FG001|Overall Study|Lost to Follow-up|0|||
156824210|NCT00487942|566107314|FG002|Overall Study|Lost to Follow-up|0|||
156824211|NCT00487942|566107315|FG003|Overall Study|Lost to Follow-up|1|||
156824212|NCT00487942|566107312|FG000|Overall Study|Protocol Violation|1|||
156824213|NCT00487942|566107313|FG001|Overall Study|Protocol Violation|1|||
156824214|NCT00487942|566107314|FG002|Overall Study|Protocol Violation|0|||
156824215|NCT00487942|566107315|FG003|Overall Study|Protocol Violation|0|||
156824216|NCT00487942|566107312|FG000|Overall Study|Withdrawal by Subject|0|||
156824217|NCT00487942|566107313|FG001|Overall Study|Withdrawal by Subject|1|||
156824218|NCT00487942|566107314|FG002|Overall Study|Withdrawal by Subject|2|||
156824219|NCT00487942|566107315|FG003|Overall Study|Withdrawal by Subject|0|||
156824220|NCT05151445|566107316|FG000|Overall Study|Withdrawal by Subject|3|||
156824221|NCT02298179|566107320|FG000|Overall Study|Lost to Follow-up|0|||
156824222|NCT02298179|566107321|FG001|Overall Study|Lost to Follow-up|0|||
156824223|NCT02298179|566107322|FG002|Overall Study|Lost to Follow-up|1|||
156824224|NCT02298179|566107323|FG003|Overall Study|Lost to Follow-up|0|||
156824225|NCT02298179|566107324|FG004|Overall Study|Lost to Follow-up|0|||
156824226|NCT02298179|566107325|FG005|Overall Study|Lost to Follow-up|0|||
156824227|NCT02298179|566107326|FG006|Overall Study|Lost to Follow-up|0|||
156824228|NCT02298179|566107327|FG007|Overall Study|Lost to Follow-up|1|||
156824229|NCT02298179|566107328|FG008|Overall Study|Lost to Follow-up|0|||
156824230|NCT02298179|566107329|FG009|Overall Study|Lost to Follow-up|0|||
156824231|NCT02298179|566107330|FG010|Overall Study|Lost to Follow-up|0|||
156824232|NCT02298179|566107331|FG011|Overall Study|Lost to Follow-up|0|||
156824233|NCT00082368|566107334|FG000|Overall Study|Not treated-pt had poor IV access|1|||
156824234|NCT03559517|566107335|FG000|Overall Study|Withdrawal by Subject|1|||
156824235|NCT03559517|566107336|FG001|Overall Study|Withdrawal by Subject|0|||
156824236|NCT03559517|566107337|FG002|Overall Study|Withdrawal by Subject|0|||
156824237|NCT01846299|566107338|FG000|Overall Study|Physician Decision|4|||
156824238|NCT01846299|566107339|FG001|Overall Study|Physician Decision|2|||
156824239|NCT01846299|566107338|FG000|Overall Study|Protocol deviation|1|||
156824240|NCT01846299|566107339|FG001|Overall Study|Protocol deviation|0|||
156824241|NCT01846299|566107338|FG000|Overall Study|Death|1|||
156824242|NCT01846299|566107339|FG001|Overall Study|Death|2|||
156824243|NCT01846299|566107338|FG000|Overall Study|Lost to Follow-up|3|||
156824244|NCT01846299|566107339|FG001|Overall Study|Lost to Follow-up|0|||
156824245|NCT01846299|566107338|FG000|Overall Study|Withdrawal by Subject|1|||
156824246|NCT01846299|566107339|FG001|Overall Study|Withdrawal by Subject|6|||
156824247|NCT01846299|566107338|FG000|Overall Study|Adverse Event|2|||
156824248|NCT01846299|566107339|FG001|Overall Study|Adverse Event|0|||
156824249|NCT01330628|566107340|FG000|Overall Study|Death|2|||
156824250|NCT01330628|566107341|FG001|Overall Study|Death|3|||
156824251|NCT01330628|566107340|FG000|Overall Study|Lost to Follow-up|5|||
156824252|NCT01330628|566107341|FG001|Overall Study|Lost to Follow-up|6|||
156824253|NCT01330628|566107340|FG000|Overall Study|Adverse Event|44|||
156824254|NCT01330628|566107341|FG001|Overall Study|Adverse Event|25|||
156824255|NCT01330628|566107340|FG000|Overall Study|Withdrawn|18|||
156824256|NCT01330628|566107341|FG001|Overall Study|Withdrawn|6|||
156824257|NCT01330628|566107340|FG000|Overall Study|Didn't receive study treatment|1|||
156824258|NCT01330628|566107341|FG001|Overall Study|Didn't receive study treatment|0|||
156824259|NCT02825420|566107349|FG000|Overall Study|Death|30|||
156824260|NCT02825420|566107350|FG001|Overall Study|Death|12|||
156824261|NCT02825420|566107349|FG000|Overall Study|Progressive disease|6|||
156824262|NCT02825420|566107350|FG001|Overall Study|Progressive disease|1|||
156466113|NCT02101853|564802795|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
156824263|NCT02825420|566107349|FG000|Overall Study|Lost to Follow-up|2|||
156824264|NCT02825420|566107350|FG001|Overall Study|Lost to Follow-up|2|||
156824265|NCT02825420|566107349|FG000|Overall Study|Withdrawal by Subject|1|||
156824266|NCT02825420|566107350|FG001|Overall Study|Withdrawal by Subject|1|||
156824267|NCT02825420|566107349|FG000|Overall Study|Protocol amendment not signed|1|||
156824268|NCT02825420|566107350|FG001|Overall Study|Protocol amendment not signed|1|||
156824269|NCT02825420|566107349|FG000|Overall Study|Physician Decision|1|||
156824270|NCT02825420|566107350|FG001|Overall Study|Physician Decision|0|||
156466114|NCT02101853|564802796|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
156824271|NCT02825420|566107349|FG000|Overall Study|Did not receive PLD|2|||
156824272|NCT02825420|566107350|FG001|Overall Study|Did not receive PLD|0|||
156824273|NCT00496483|566109126|FG000|Overall Study|Not dosed|9|||
156824274|NCT00496483|566109126|FG000|Overall Study|Adverse Event|2|||
156824275|NCT00496483|566109126|FG000|Overall Study|Lack of Efficacy|1|||
156824276|NCT04258995|566109128|FG000|Overall Study|Lost to Follow-up|1|||
156824277|NCT04258995|566109129|FG001|Overall Study|Lost to Follow-up|1|||
156824278|NCT01962987|566109132|FG000|Overall Study|Adverse Event|4|||
156824279|NCT01962987|566109133|FG001|Overall Study|Adverse Event|4|||
156824280|NCT01962987|566109134|FG002|Overall Study|Adverse Event|0|||
156824281|NCT01962987|566109132|FG000|Overall Study|Lost to Follow-up|0|||
156824282|NCT01962987|566109133|FG001|Overall Study|Lost to Follow-up|0|||
156824283|NCT01962987|566109134|FG002|Overall Study|Lost to Follow-up|1|||
156824284|NCT01962987|566109132|FG000|Overall Study|Non compliance with dosing requirements|4|||
156824285|NCT01962987|566109133|FG001|Overall Study|Non compliance with dosing requirements|2|||
156824286|NCT01962987|566109134|FG002|Overall Study|Non compliance with dosing requirements|0|||
156824287|NCT01962987|566109132|FG000|Overall Study|Miscellaneous|1|||
156824288|NCT01962987|566109133|FG001|Overall Study|Miscellaneous|9|||
156824289|NCT01962987|566109134|FG002|Overall Study|Miscellaneous|2|||
156824290|NCT01962987|566109132|FG000|Overall Study|Restricted medication|5|||
156824291|NCT01962987|566109133|FG001|Overall Study|Restricted medication|1|||
156824292|NCT01962987|566109134|FG002|Overall Study|Restricted medication|1|||
156824293|NCT01962987|566109132|FG000|Overall Study|Serious Adverse Event|1|||
156824294|NCT01962987|566109133|FG001|Overall Study|Serious Adverse Event|0|||
156824295|NCT01962987|566109134|FG002|Overall Study|Serious Adverse Event|0|||
156824296|NCT01962987|566109132|FG000|Overall Study|Withdrawal by Subject|11|||
156824297|NCT01962987|566109133|FG001|Overall Study|Withdrawal by Subject|10|||
156824298|NCT01962987|566109134|FG002|Overall Study|Withdrawal by Subject|6|||
156824299|NCT01962987|566109132|FG000|Overall Study|Randomized in Error|4|||
156824300|NCT01962987|566109133|FG001|Overall Study|Randomized in Error|2|||
156824301|NCT01962987|566109134|FG002|Overall Study|Randomized in Error|2|||
156824302|NCT01967823|566109135|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
156824303|NCT00316693|566109136|FG000|Overall Study|Adverse Event|6|||
156824304|NCT00316693|566109137|FG001|Overall Study|Adverse Event|1|||
156824305|NCT00316693|566109136|FG000|Overall Study|Protocol Violation|1|||
156824306|NCT00316693|566109137|FG001|Overall Study|Protocol Violation|0|||
156824307|NCT00316693|566109136|FG000|Overall Study|Withdrawal by Subject|6|||
156824308|NCT00316693|566109137|FG001|Overall Study|Withdrawal by Subject|6|||
156824309|NCT00316693|566109136|FG000|Overall Study|Lost to Follow-up|26|||
156824310|NCT00316693|566109137|FG001|Overall Study|Lost to Follow-up|34|||
156824311|NCT00316693|566109136|FG000|Overall Study|Other|38|||
156824312|NCT00316693|566109137|FG001|Overall Study|Other|44|||
156824313|NCT03245736|566109144|FG000|Overall Study|Adverse Event|1|||
156824314|NCT03245736|566109144|FG000|Overall Study|Progressive Disease|4|||
156824315|NCT01942161|566109145|FG000|Overall Study|Adverse Event|1|||
156824316|NCT01942161|566109146|FG001|Overall Study|Adverse Event|2|||
156824317|NCT01942161|566109147|FG002|Overall Study|Adverse Event|5|||
156824318|NCT01942161|566109145|FG000|Overall Study|Physician Decision|3|||
156824319|NCT01942161|566109146|FG001|Overall Study|Physician Decision|1|||
156824320|NCT01942161|566109147|FG002|Overall Study|Physician Decision|0|||
156824321|NCT01942161|566109145|FG000|Overall Study|Protocol Violation|1|||
156824322|NCT01942161|566109146|FG001|Overall Study|Protocol Violation|0|||
156824323|NCT01942161|566109147|FG002|Overall Study|Protocol Violation|0|||
156824324|NCT01942161|566109145|FG000|Overall Study|Withdrawal by Subject|3|||
156824325|NCT01942161|566109146|FG001|Overall Study|Withdrawal by Subject|3|||
156824326|NCT01942161|566109147|FG002|Overall Study|Withdrawal by Subject|1|||
156824327|NCT01257568|566109151|FG000|Overall Study|Lost to Follow-up|2|||
156824328|NCT01257568|566109151|FG000|Overall Study|Withdrawal by Subject|6|||
156824329|NCT01257568|566109151|FG000|Overall Study|Terminated|1|||
156824330|NCT01257568|566109151|FG000|Overall Study|Component Revision|24|||
156824331|NCT00132691|566109153|FG000|Overall Study|Lost to Follow-up|5|||
156824332|NCT00132691|566109154|FG001|Overall Study|Lost to Follow-up|8|||
156824333|NCT00132691|566109153|FG000|Overall Study|Missed 2-year visit|4|||
156824334|NCT00132691|566109154|FG001|Overall Study|Missed 2-year visit|4|||
156824335|NCT00132691|566109153|FG000|Overall Study|Death|2|||
156824336|NCT00132691|566109154|FG001|Overall Study|Death|0|||
156824337|NCT01739933|566109161|FG000|Overall Study|Death|89|||
156824338|NCT01739933|566109162|FG001|Overall Study|Death|86|||
156824339|NCT01739933|566109161|FG000|Overall Study|Withdrawal by Subject|10|||
156339247|NCT01090492|564340147|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156339248|NCT01090492|564340148|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156339249|NCT01090492|564340149|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156339250|NCT01090492|564340142|FG000|Second Intervention Period (4 Weeks)|Other|0|||
156824340|NCT01739933|566109162|FG001|Overall Study|Withdrawal by Subject|8|||
156824341|NCT01739933|566109161|FG000|Overall Study|Lost to Follow-up|3|||
156824342|NCT01739933|566109162|FG001|Overall Study|Lost to Follow-up|10|||
156824343|NCT01739933|566109161|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
156824344|NCT01739933|566109162|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
156824345|NCT00416715|566109163|FG000|Overall Study|Not evaluable for joint aches|7|||
156824346|NCT00416715|566109163|FG000|Overall Study|Vitamin D levels not evaluable|8|||
156824347|NCT01007435|566109175|FG000|Overall Study|Adverse Event|16|||
156824348|NCT01007435|566109176|FG001|Overall Study|Adverse Event|25|||
156824349|NCT01007435|566109177|FG002|Overall Study|Adverse Event|47|||
156824350|NCT01007435|566109178|FG003|Overall Study|Adverse Event|31|||
156824351|NCT01007435|566109175|FG000|Overall Study|Death|2|||
156541192|NCT01486927|565074502|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
156824352|NCT01007435|566109176|FG001|Overall Study|Death|4|||
156824353|NCT01007435|566109177|FG002|Overall Study|Death|2|||
156824354|NCT01007435|566109178|FG003|Overall Study|Death|1|||
156824355|NCT01007435|566109175|FG000|Overall Study|Insufficient Therapeutic Response|21|||
156824356|NCT01007435|566109176|FG001|Overall Study|Insufficient Therapeutic Response|7|||
156824357|NCT01007435|566109177|FG002|Overall Study|Insufficient Therapeutic Response|2|||
156824358|NCT01007435|566109178|FG003|Overall Study|Insufficient Therapeutic Response|9|||
156824359|NCT01007435|566109175|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
156824360|NCT01007435|566109176|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
156824361|NCT01007435|566109177|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
156824362|NCT01007435|566109178|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
156824363|NCT01007435|566109175|FG000|Overall Study|Other Protocol Violation|2|||
156824364|NCT01007435|566109176|FG001|Overall Study|Other Protocol Violation|0|||
156824365|NCT01007435|566109177|FG002|Overall Study|Other Protocol Violation|1|||
156824366|NCT01007435|566109178|FG003|Overall Study|Other Protocol Violation|0|||
156824367|NCT01007435|566109175|FG000|Overall Study|Refused Treatment|13|||
156824368|NCT01007435|566109176|FG001|Overall Study|Refused Treatment|13|||
156824369|NCT01007435|566109177|FG002|Overall Study|Refused Treatment|5|||
156824370|NCT01007435|566109178|FG003|Overall Study|Refused Treatment|8|||
156824371|NCT01007435|566109175|FG000|Overall Study|Failure to Return|5|||
156824372|NCT01007435|566109176|FG001|Overall Study|Failure to Return|4|||
156824373|NCT01007435|566109177|FG002|Overall Study|Failure to Return|3|||
156824374|NCT01007435|566109178|FG003|Overall Study|Failure to Return|6|||
156824375|NCT01007435|566109175|FG000|Overall Study|Reason not Specified|1|||
156824376|NCT01007435|566109176|FG001|Overall Study|Reason not Specified|1|||
156824377|NCT01007435|566109177|FG002|Overall Study|Reason not Specified|2|||
156824378|NCT01007435|566109178|FG003|Overall Study|Reason not Specified|1|||
156824379|NCT02576535|566109179|FG000|Overall Study|Withdrawal by Subject|2|||
156824380|NCT00347438|566109180|FG000|Overall Study|Withdrawal by Subject|1|||
156824381|NCT00347438|566109180|FG000|Overall Study|Physician Decision|1|||
156824382|NCT02545517|566109181|FG000|Overall Study|Death|2|||
156824383|NCT02545517|566109182|FG001|Overall Study|Death|2|||
156824384|NCT02545517|566109183|FG002|Overall Study|Death|1|||
156824385|NCT02545517|566109181|FG000|Overall Study|Lost to Follow-up|14|||
156824386|NCT02545517|566109182|FG001|Overall Study|Lost to Follow-up|13|||
156824387|NCT02545517|566109183|FG002|Overall Study|Lost to Follow-up|17|||
156824388|NCT02545517|566109181|FG000|Overall Study|Protocol Violation|0|||
156824389|NCT02545517|566109182|FG001|Overall Study|Protocol Violation|1|||
156824390|NCT02545517|566109183|FG002|Overall Study|Protocol Violation|1|||
156824391|NCT02545517|566109181|FG000|Overall Study|Withdrawal by Subject|5|||
156824392|NCT02545517|566109182|FG001|Overall Study|Withdrawal by Subject|8|||
156824393|NCT02545517|566109183|FG002|Overall Study|Withdrawal by Subject|9|||
156824394|NCT02545517|566109181|FG000|Overall Study|Administrative reason|5|||
156824395|NCT02545517|566109182|FG001|Overall Study|Administrative reason|6|||
156824396|NCT02545517|566109183|FG002|Overall Study|Administrative reason|10|||
156824397|NCT02545517|566109181|FG000|Overall Study|Other|2|||
156824398|NCT02545517|566109182|FG001|Overall Study|Other|4|||
156824399|NCT02545517|566109183|FG002|Overall Study|Other|3|||
156824400|NCT01529515|566109184|FG000|TRANSITION PHASE|Adverse Event|16|||
156824401|NCT01529515|566109185|FG001|TRANSITION PHASE|Adverse Event|0|||
156824402|NCT01529515|566109186|FG002|TRANSITION PHASE|Adverse Event|0|||
156824403|NCT01529515|566109187|FG003|TRANSITION PHASE|Adverse Event|0|||
156824404|NCT01529515|566109184|FG000|TRANSITION PHASE|Death|1|||
156824405|NCT01529515|566109185|FG001|TRANSITION PHASE|Death|0|||
156824406|NCT01529515|566109186|FG002|TRANSITION PHASE|Death|0|||
156824407|NCT01529515|566109187|FG003|TRANSITION PHASE|Death|0|||
156824408|NCT01529515|566109184|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
156824409|NCT01529515|566109185|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
156824410|NCT01529515|566109186|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
156824411|NCT01529515|566109187|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
156824412|NCT01529515|566109184|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
156541193|NCT02159729|565074503|FG000|Overall Study|Adverse Event|0|||
156541194|NCT02159729|565074504|FG001|Overall Study|Adverse Event|1|||
156541195|NCT02159729|565074503|FG000|Overall Study|Subject's Request|13|||
156541196|NCT02159729|565074504|FG001|Overall Study|Subject's Request|10|||
156824413|NCT01529515|566109185|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
156824414|NCT01529515|566109186|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
156824415|NCT01529515|566109187|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
156824416|NCT01529515|566109184|FG000|TRANSITION PHASE|Protocol Violation|4|||
156824417|NCT01529515|566109185|FG001|TRANSITION PHASE|Protocol Violation|0|||
156824418|NCT01529515|566109186|FG002|TRANSITION PHASE|Protocol Violation|0|||
156824419|NCT01529515|566109187|FG003|TRANSITION PHASE|Protocol Violation|0|||
156824420|NCT01529515|566109184|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
156824421|NCT01529515|566109185|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
156541197|NCT02159729|565074503|FG000|Overall Study|Lost to Follow-up|24|||
156824422|NCT01529515|566109186|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
156824423|NCT01529515|566109187|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
156824424|NCT01529515|566109184|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
156824425|NCT01529515|566109185|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
156824426|NCT01529515|566109186|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
156824427|NCT01529515|566109187|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
156824428|NCT01529515|566109184|FG000|TRANSITION PHASE|Other|9|||
156824429|NCT01529515|566109185|FG001|TRANSITION PHASE|Other|0|||
156824430|NCT01529515|566109186|FG002|TRANSITION PHASE|Other|0|||
156824431|NCT01529515|566109187|FG003|TRANSITION PHASE|Other|0|||
156824432|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Adverse Event|0|||
156824433|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Adverse Event|10|||
156824434|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Adverse Event|0|||
156824435|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Adverse Event|0|||
156824436|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
156824437|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
156824438|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
156824439|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
156824440|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
156824441|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
156824442|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
156824443|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
156824444|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
156824445|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
156824446|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
156824447|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
156824448|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
156824449|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
156824450|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
156824451|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
156824452|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
156824453|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
156824454|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
156824455|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
156824456|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Other|0|||
156824457|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Other|10|||
156824458|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Other|0|||
156824459|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Other|0|||
156824460|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
156824461|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
156824462|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
156824463|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
156824464|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
156824465|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
156824466|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
156824467|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
156824468|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
156824469|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
156824470|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
156824471|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
156824472|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
156824473|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
156824474|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
156824475|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
156824476|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
156824477|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
156824478|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
156824479|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
156824480|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Other|0|||
156824481|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Other|0|||
156824482|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Other|9|||
156824483|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Other|2|||
156824484|NCT03334851|566109189|FG000|Overall Study|Other|0|||
156824485|NCT03334851|566109190|FG001|Overall Study|Other|0|||
156824486|NCT03334851|566109191|FG002|Overall Study|Other|0|||
156824487|NCT03334851|566109192|FG003|Overall Study|Other|0|||
156824488|NCT03334851|566109193|FG004|Overall Study|Other|0|||
156824489|NCT03334851|566109194|FG005|Overall Study|Other|0|||
156824490|NCT03334851|566109195|FG006|Overall Study|Other|0|||
156824491|NCT03334851|566109196|FG007|Overall Study|Other|1|||
156824492|NCT03334851|566109197|FG008|Overall Study|Other|0|||
156824493|NCT03334851|566109198|FG009|Overall Study|Other|0|||
156824494|NCT03334851|566109199|FG010|Overall Study|Other|0|||
156824495|NCT03334851|566109200|FG011|Overall Study|Other|0|||
156824496|NCT03334851|566109201|FG012|Overall Study|Other|0|||
156824497|NCT03334851|566109189|FG000|Overall Study|Adverse Event|0|||
156824498|NCT03334851|566109190|FG001|Overall Study|Adverse Event|0|||
156824499|NCT03334851|566109191|FG002|Overall Study|Adverse Event|0|||
156824500|NCT03334851|566109192|FG003|Overall Study|Adverse Event|0|||
156824501|NCT03334851|566109193|FG004|Overall Study|Adverse Event|0|||
156824502|NCT03334851|566109194|FG005|Overall Study|Adverse Event|0|||
156824503|NCT03334851|566109195|FG006|Overall Study|Adverse Event|0|||
156824504|NCT03334851|566109196|FG007|Overall Study|Adverse Event|1|||
156824505|NCT03334851|566109197|FG008|Overall Study|Adverse Event|0|||
156824506|NCT03334851|566109198|FG009|Overall Study|Adverse Event|0|||
156824507|NCT03334851|566109199|FG010|Overall Study|Adverse Event|0|||
156824508|NCT03334851|566109200|FG011|Overall Study|Adverse Event|0|||
156824509|NCT03334851|566109201|FG012|Overall Study|Adverse Event|0|||
156824510|NCT03334851|566109189|FG000|Overall Study|Withdrawal by Subject|0|||
156824511|NCT03334851|566109190|FG001|Overall Study|Withdrawal by Subject|0|||
156824512|NCT03334851|566109191|FG002|Overall Study|Withdrawal by Subject|0|||
156824513|NCT03334851|566109192|FG003|Overall Study|Withdrawal by Subject|0|||
156824514|NCT03334851|566109193|FG004|Overall Study|Withdrawal by Subject|0|||
156824515|NCT03334851|566109194|FG005|Overall Study|Withdrawal by Subject|0|||
156824516|NCT03334851|566109195|FG006|Overall Study|Withdrawal by Subject|0|||
156824517|NCT03334851|566109196|FG007|Overall Study|Withdrawal by Subject|0|||
156824518|NCT03334851|566109197|FG008|Overall Study|Withdrawal by Subject|0|||
156824519|NCT03334851|566109198|FG009|Overall Study|Withdrawal by Subject|0|||
156824520|NCT03334851|566109199|FG010|Overall Study|Withdrawal by Subject|1|||
156824521|NCT03334851|566109200|FG011|Overall Study|Withdrawal by Subject|0|||
156824522|NCT03334851|566109201|FG012|Overall Study|Withdrawal by Subject|1|||
156824523|NCT03334851|566109189|FG000|Overall Study|Lost to Follow-up|0|||
156824524|NCT03334851|566109190|FG001|Overall Study|Lost to Follow-up|0|||
156824525|NCT03334851|566109191|FG002|Overall Study|Lost to Follow-up|0|||
156824526|NCT03334851|566109192|FG003|Overall Study|Lost to Follow-up|0|||
156824527|NCT03334851|566109193|FG004|Overall Study|Lost to Follow-up|0|||
156824528|NCT03334851|566109194|FG005|Overall Study|Lost to Follow-up|0|||
156824529|NCT03334851|566109195|FG006|Overall Study|Lost to Follow-up|0|||
156824530|NCT03334851|566109196|FG007|Overall Study|Lost to Follow-up|0|||
156824531|NCT03334851|566109197|FG008|Overall Study|Lost to Follow-up|0|||
156824532|NCT03334851|566109198|FG009|Overall Study|Lost to Follow-up|0|||
156824533|NCT03334851|566109199|FG010|Overall Study|Lost to Follow-up|2|||
156824534|NCT03334851|566109200|FG011|Overall Study|Lost to Follow-up|1|||
156824535|NCT03334851|566109201|FG012|Overall Study|Lost to Follow-up|0|||
156824536|NCT03327220|566109202|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
156824537|NCT03327220|566109203|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
156824538|NCT03327220|566109202|FG000|Overall Study|Investigator Decision|2|||
156824539|NCT03327220|566109203|FG001|Overall Study|Investigator Decision|0|||
156824540|NCT03327220|566109202|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
156824541|NCT03327220|566109203|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
156824542|NCT03327220|566109202|FG000|Overall Study|Fungal infection|1|||
156824543|NCT03327220|566109203|FG001|Overall Study|Fungal infection|0|||
156824544|NCT03327220|566109202|FG000|Overall Study|Discharged to Rehabilitation|0|||
156824545|NCT03327220|566109203|FG001|Overall Study|Discharged to Rehabilitation|1|||
156824546|NCT03327220|566109202|FG000|Overall Study|Missing|1|||
156824547|NCT03327220|566109203|FG001|Overall Study|Missing|0|||
156824548|NCT00523705|566109204|FG000|Overall Study|No time for study.|0|||
156824549|NCT00523705|566109205|FG001|Overall Study|No time for study.|1|||
156824550|NCT00693017|566109206|FG000|Overall Study|Sponsor Decision|2|||
156824551|NCT00693017|566109207|FG001|Overall Study|Sponsor Decision|1|||
156824552|NCT00693017|566109206|FG000|Overall Study|Death|0|||
156824553|NCT00693017|566109207|FG001|Overall Study|Death|1|||
156824554|NCT01691885|566109209|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
156824555|NCT01691885|566109210|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
156824556|NCT01691885|566109209|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
156824557|NCT01691885|566109210|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
156824558|NCT00688324|566109212|FG000|Overall Study|Withdrawal by Subject|2|||
156824559|NCT00688324|566109212|FG000|Overall Study|Physician Decision|5|||
156824560|NCT00688324|566109212|FG000|Overall Study|Lost to Follow-up|1|||
156824561|NCT00385944|566109216|FG000|1st Maintenance Dose Period|Physician Decision|1|||
156824562|NCT00385944|566109217|FG001|1st Maintenance Dose Period|Physician Decision|0|||
156824563|NCT00385944|566109218|FG002|1st Maintenance Dose Period|Physician Decision|0|||
156824564|NCT00385944|566109216|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
156824565|NCT00385944|566109217|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
156824566|NCT00385944|566109218|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
156824567|NCT00385944|566109216|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
156824568|NCT00385944|566109217|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
156466115|NCT02101853|564802797|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
156466116|NCT02101853|564802792|FG000|Blinatumomab Salvage Therapy|Death|0|||
156466117|NCT02101853|564802793|FG001|Blinatumomab Salvage Therapy|Death|0|||
156466118|NCT02101853|564802794|FG002|Blinatumomab Salvage Therapy|Death|0|||
156824569|NCT00385944|566109218|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
156824570|NCT00385944|566109216|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
156824571|NCT00385944|566109217|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
156824572|NCT00385944|566109218|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
156824573|NCT00590824|566109219|FG000|Overall Study|Disease could not be resected|0|||
156824574|NCT00590824|566109220|FG001|Overall Study|Disease could not be resected|2|||
156824575|NCT00590824|566109221|FG002|Overall Study|Disease could not be resected|1|||
156824576|NCT00590824|566109222|FG003|Overall Study|Disease could not be resected|0|||
156824577|NCT00590824|566109219|FG000|Overall Study|Adverse Event|0|||
156824578|NCT00590824|566109220|FG001|Overall Study|Adverse Event|0|||
156824579|NCT00590824|566109221|FG002|Overall Study|Adverse Event|0|||
156824580|NCT00590824|566109222|FG003|Overall Study|Adverse Event|1|||
156824581|NCT01778049|566109224|FG000|Open Label Treatment Period|Adverse Event|5|||
156824582|NCT01778049|566109225|FG001|Open Label Treatment Period|Adverse Event|15|||
156824583|NCT01778049|566109226|FG002|Open Label Treatment Period|Adverse Event|0|||
156824584|NCT01778049|566109227|FG003|Open Label Treatment Period|Adverse Event|0|||
156824585|NCT01778049|566109228|FG004|Open Label Treatment Period|Adverse Event|0|||
156824586|NCT01778049|566109229|FG005|Open Label Treatment Period|Adverse Event|0|||
156824587|NCT01778049|566109224|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
156824588|NCT01778049|566109225|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
156824589|NCT01778049|566109226|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
156824590|NCT01778049|566109227|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
156824591|NCT01778049|566109228|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
156824592|NCT01778049|566109229|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
156824593|NCT01778049|566109224|FG000|Open Label Treatment Period|Protocol Violation|5|||
156824594|NCT01778049|566109225|FG001|Open Label Treatment Period|Protocol Violation|5|||
156824595|NCT01778049|566109226|FG002|Open Label Treatment Period|Protocol Violation|0|||
156824596|NCT01778049|566109227|FG003|Open Label Treatment Period|Protocol Violation|0|||
156824597|NCT01778049|566109228|FG004|Open Label Treatment Period|Protocol Violation|0|||
156824598|NCT01778049|566109229|FG005|Open Label Treatment Period|Protocol Violation|0|||
156824599|NCT01778049|566109224|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
156824600|NCT01778049|566109225|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
156824601|NCT01778049|566109226|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
156824602|NCT01778049|566109227|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
156824603|NCT01778049|566109228|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
156824604|NCT01778049|566109229|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
156824605|NCT01778049|566109224|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
156824606|NCT01778049|566109225|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
156824607|NCT01778049|566109226|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
156824608|NCT01778049|566109227|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
156824609|NCT01778049|566109228|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
156824610|NCT01778049|566109229|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
156824611|NCT01778049|566109224|FG000|Open Label Treatment Period|Not treated|2|||
156824612|NCT01778049|566109225|FG001|Open Label Treatment Period|Not treated|1|||
156824613|NCT01778049|566109226|FG002|Open Label Treatment Period|Not treated|0|||
156824614|NCT01778049|566109227|FG003|Open Label Treatment Period|Not treated|0|||
156824615|NCT01778049|566109228|FG004|Open Label Treatment Period|Not treated|0|||
156824616|NCT01778049|566109229|FG005|Open Label Treatment Period|Not treated|0|||
156824617|NCT01778049|566109224|FG000|Open Label Treatment Period|Other reason not defined above|77|||
156824618|NCT01778049|566109225|FG001|Open Label Treatment Period|Other reason not defined above|94|||
156824619|NCT01778049|566109226|FG002|Open Label Treatment Period|Other reason not defined above|0|||
156824620|NCT01778049|566109227|FG003|Open Label Treatment Period|Other reason not defined above|0|||
156824621|NCT01778049|566109228|FG004|Open Label Treatment Period|Other reason not defined above|0|||
156824622|NCT01778049|566109229|FG005|Open Label Treatment Period|Other reason not defined above|0|||
156824623|NCT01778049|566109224|FG000|Double Blind Treatment Period|Adverse Event|0|||
156824624|NCT01778049|566109225|FG001|Double Blind Treatment Period|Adverse Event|0|||
156824625|NCT01778049|566109226|FG002|Double Blind Treatment Period|Adverse Event|4|||
156824626|NCT01778049|566109227|FG003|Double Blind Treatment Period|Adverse Event|5|||
156824627|NCT01778049|566109228|FG004|Double Blind Treatment Period|Adverse Event|3|||
156824628|NCT01778049|566109229|FG005|Double Blind Treatment Period|Adverse Event|2|||
156824629|NCT01778049|566109224|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
156824630|NCT01778049|566109225|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
156466119|NCT02101853|564802795|FG003|Blinatumomab Salvage Therapy|Death|0|||
156466120|NCT02101853|564802796|FG004|Blinatumomab Salvage Therapy|Death|0|||
156466121|NCT02101853|564802797|FG005|Blinatumomab Salvage Therapy|Death|2|||
156466122|NCT02101853|564802792|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
156824631|NCT01778049|566109226|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
156824632|NCT01778049|566109227|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
156824633|NCT01778049|566109228|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
156824634|NCT01778049|566109229|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
156824635|NCT01778049|566109224|FG000|Double Blind Treatment Period|Protocol Violation|0|||
156824636|NCT01778049|566109225|FG001|Double Blind Treatment Period|Protocol Violation|0|||
156466123|NCT02101853|564802793|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
156339251|NCT01090492|564340143|FG001|Second Intervention Period (4 Weeks)|Other|1|||
156824637|NCT01778049|566109226|FG002|Double Blind Treatment Period|Protocol Violation|2|||
156824638|NCT01778049|566109227|FG003|Double Blind Treatment Period|Protocol Violation|0|||
156824639|NCT01778049|566109228|FG004|Double Blind Treatment Period|Protocol Violation|0|||
156824640|NCT01778049|566109229|FG005|Double Blind Treatment Period|Protocol Violation|0|||
156824641|NCT01778049|566109224|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
156824642|NCT01778049|566109225|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
156824643|NCT01778049|566109226|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
156824644|NCT01778049|566109227|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
156824645|NCT01778049|566109228|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
156824646|NCT01778049|566109229|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
156824647|NCT01778049|566109224|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
156824648|NCT01778049|566109225|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
156824649|NCT01778049|566109226|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
156824650|NCT01778049|566109227|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
156824651|NCT01778049|566109228|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
156824652|NCT01778049|566109229|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
156824653|NCT01778049|566109224|FG000|Double Blind Treatment Period|Not treated|0|||
156824654|NCT01778049|566109225|FG001|Double Blind Treatment Period|Not treated|0|||
156824655|NCT01778049|566109226|FG002|Double Blind Treatment Period|Not treated|0|||
156824656|NCT01778049|566109227|FG003|Double Blind Treatment Period|Not treated|2|||
156824657|NCT01778049|566109228|FG004|Double Blind Treatment Period|Not treated|2|||
156824658|NCT01778049|566109229|FG005|Double Blind Treatment Period|Not treated|0|||
156824659|NCT01778049|566109224|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
156824660|NCT01778049|566109225|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
156824661|NCT01778049|566109226|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
156824662|NCT01778049|566109227|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
156824663|NCT01778049|566109228|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
156824664|NCT01778049|566109229|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
156824665|NCT01895543|566109232|FG000|Overall Study|Withdrawal by Subject|43|||
156824666|NCT01895543|566109232|FG000|Overall Study|Lost to Follow-up|25|||
156824667|NCT01895543|566109232|FG000|Overall Study|Adverse Event|28|||
156824668|NCT01895543|566109232|FG000|Overall Study|Subject's substantial non-compliance|6|||
156824669|NCT01895543|566109232|FG000|Overall Study|Protocol Violation|1|||
156824670|NCT01895543|566109232|FG000|Overall Study|Physician Decision|2|||
156824671|NCT01895543|566109232|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
156824672|NCT04262882|566109233|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
156824673|NCT04262882|566109234|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
156824674|NCT04262882|566109233|FG000|Overall Study|Lost to Follow-up|1|||
156824675|NCT04262882|566109234|FG001|Overall Study|Lost to Follow-up|0|||
156824676|NCT00443053|566109236|FG000|Overall Study|Adverse Event|2|||
156824677|NCT00443053|566109237|FG001|Overall Study|Adverse Event|1|||
156824678|NCT00443053|566109236|FG000|Overall Study|Withdrawal by Subject|9|||
156824679|NCT00443053|566109237|FG001|Overall Study|Withdrawal by Subject|18|||
156541198|NCT02159729|565074504|FG001|Overall Study|Lost to Follow-up|9|||
156824680|NCT00443053|566109236|FG000|Overall Study|Lost to Follow-up|4|||
156824681|NCT00443053|566109237|FG001|Overall Study|Lost to Follow-up|5|||
156824682|NCT00443053|566109236|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
156824683|NCT00443053|566109237|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
156824684|NCT00443053|566109236|FG000|Overall Study|Noncompliance|2|||
156824685|NCT00443053|566109237|FG001|Overall Study|Noncompliance|1|||
156824686|NCT00443053|566109236|FG000|Overall Study|Other|3|||
156824687|NCT00443053|566109237|FG001|Overall Study|Other|4|||
156824688|NCT00443053|566109236|FG000|Overall Study|Physician Decision|0|||
156824689|NCT00443053|566109237|FG001|Overall Study|Physician Decision|4|||
156824690|NCT00541866|566109238|FG000|Overall Study|Adverse Event|3|||
156824691|NCT00541866|566109239|FG001|Overall Study|Adverse Event|0|||
156824692|NCT00541866|566109240|FG002|Overall Study|Adverse Event|0|||
156824693|NCT00541866|566109241|FG003|Overall Study|Adverse Event|0|||
156824694|NCT00541866|566109242|FG004|Overall Study|Adverse Event|0|||
156824695|NCT00541866|566109238|FG000|Overall Study|Death|1|||
156824696|NCT00541866|566109239|FG001|Overall Study|Death|0|||
156824697|NCT00541866|566109240|FG002|Overall Study|Death|0|||
156824698|NCT00541866|566109241|FG003|Overall Study|Death|0|||
156824699|NCT00541866|566109242|FG004|Overall Study|Death|0|||
156824700|NCT00541866|566109238|FG000|Overall Study|Lack of Efficacy|19|||
156824701|NCT00541866|566109239|FG001|Overall Study|Lack of Efficacy|15|||
156824702|NCT00541866|566109240|FG002|Overall Study|Lack of Efficacy|10|||
156824703|NCT00541866|566109241|FG003|Overall Study|Lack of Efficacy|12|||
156824704|NCT00541866|566109242|FG004|Overall Study|Lack of Efficacy|14|||
156824705|NCT00541866|566109238|FG000|Overall Study|Not Reported or Other|11|||
156824706|NCT00541866|566109239|FG001|Overall Study|Not Reported or Other|3|||
156824707|NCT00541866|566109240|FG002|Overall Study|Not Reported or Other|3|||
156824708|NCT00541866|566109241|FG003|Overall Study|Not Reported or Other|3|||
156824709|NCT00541866|566109242|FG004|Overall Study|Not Reported or Other|1|||
156824710|NCT00541866|566109238|FG000|Overall Study|Physician Decision|0|||
156824711|NCT00541866|566109239|FG001|Overall Study|Physician Decision|0|||
156824712|NCT00541866|566109240|FG002|Overall Study|Physician Decision|2|||
156824713|NCT00541866|566109241|FG003|Overall Study|Physician Decision|1|||
156824714|NCT00541866|566109242|FG004|Overall Study|Physician Decision|0|||
156824715|NCT00522418|566109243|FG000|Overall Study|Local IRB Consent Violation|5|||
156824716|NCT00522418|566109244|FG001|Overall Study|Local IRB Consent Violation|5|||
156824717|NCT00522418|566109243|FG000|Overall Study|Early Study Termination|46|||
156824718|NCT00522418|566109244|FG001|Overall Study|Early Study Termination|47|||
156824719|NCT00522418|566109243|FG000|Overall Study|Noncompliance|2|||
156824720|NCT00522418|566109244|FG001|Overall Study|Noncompliance|2|||
156824721|NCT00522418|566109243|FG000|Overall Study|Reason Not Specified|3|||
156824722|NCT00522418|566109244|FG001|Overall Study|Reason Not Specified|1|||
156824723|NCT00522418|566109243|FG000|Overall Study|Consent Withdraw|1|||
156824724|NCT00522418|566109244|FG001|Overall Study|Consent Withdraw|2|||
156824725|NCT00522418|566109243|FG000|Overall Study|Lack of Efficacy|0|||
156824726|NCT00522418|566109244|FG001|Overall Study|Lack of Efficacy|1|||
156824727|NCT00578877|566109245|FG000|Overall Study|Lost to Follow-up|8|||
156824728|NCT00578877|566109246|FG001|Overall Study|Lost to Follow-up|10|||
156824729|NCT00578877|566109245|FG000|Overall Study|early discontinue|61|||
156824730|NCT00578877|566109246|FG001|Overall Study|early discontinue|101|||
156824731|NCT00578877|566109245|FG000|Overall Study|did not provide follow-up data|12|||
156824732|NCT00578877|566109246|FG001|Overall Study|did not provide follow-up data|17|||
156824733|NCT02256384|566109252|FG000|Overall Study|Withdrawal by Subject|12|||
156824734|NCT02256384|566109252|FG000|Overall Study|Equipment not capturing data|2|||
156824735|NCT02136680|566109253|FG000|Overall Study|No Longer Interested|1|||
156824736|NCT02136680|566109254|FG001|Overall Study|No Longer Interested|1|||
156824737|NCT02136680|566109253|FG000|Overall Study|No longer receiving care at clinic|3|||
156824738|NCT02136680|566109254|FG001|Overall Study|No longer receiving care at clinic|5|||
156466124|NCT02101853|564802794|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
156466125|NCT02101853|564802795|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
156466126|NCT02101853|564802796|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
156466127|NCT02101853|564802797|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
156466128|NCT02101853|564802792|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
156824739|NCT02136680|566109253|FG000|Overall Study|Moved away|5|||
156824740|NCT02136680|566109254|FG001|Overall Study|Moved away|4|||
156824741|NCT02136680|566109253|FG000|Overall Study|Unable to schedule|17|||
156824742|NCT02136680|566109254|FG001|Overall Study|Unable to schedule|16|||
156824743|NCT02136680|566109253|FG000|Overall Study|Study ended before interview due|6|||
156824744|NCT02136680|566109254|FG001|Overall Study|Study ended before interview due|3|||
156824745|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
156824746|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
156824747|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
156466129|NCT02101853|564802793|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
156466130|NCT02101853|564802794|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
156466131|NCT02101853|564802795|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
156824748|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
156824749|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
156824750|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
156824751|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
156824752|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
156824753|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
156824754|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
156824755|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
156824756|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
156824757|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
156824758|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
156824759|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
156824760|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
156824761|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
156824762|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
156824763|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
156824764|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
156824765|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
156824766|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
156824767|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
156824768|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
156824769|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
156824770|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
156824771|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
156824772|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
156824773|NCT01638013|566109257|FG000|Overall Study|Adverse Event|36|||
156824774|NCT01638013|566109258|FG001|Overall Study|Adverse Event|29|||
156824775|NCT01638013|566109259|FG002|Overall Study|Adverse Event|48|||
156824776|NCT01638013|566109257|FG000|Overall Study|Lack of Efficacy|39|||
156824777|NCT01638013|566109258|FG001|Overall Study|Lack of Efficacy|11|||
156824778|NCT01638013|566109259|FG002|Overall Study|Lack of Efficacy|14|||
156824779|NCT01638013|566109257|FG000|Overall Study|Protocol Violation|10|||
156824780|NCT01638013|566109258|FG001|Overall Study|Protocol Violation|7|||
156824781|NCT01638013|566109259|FG002|Overall Study|Protocol Violation|11|||
156824782|NCT01638013|566109257|FG000|Overall Study|Met discontinuation criteria|4|||
156824783|NCT01638013|566109258|FG001|Overall Study|Met discontinuation criteria|0|||
156824784|NCT01638013|566109259|FG002|Overall Study|Met discontinuation criteria|7|||
156824785|NCT01638013|566109257|FG000|Overall Study|Subject Lost to Follow up|1|||
156824786|NCT01638013|566109258|FG001|Overall Study|Subject Lost to Follow up|0|||
156824787|NCT01638013|566109259|FG002|Overall Study|Subject Lost to Follow up|1|||
156824788|NCT01638013|566109257|FG000|Overall Study|Miscellaneous|25|||
156824789|NCT01638013|566109258|FG001|Overall Study|Miscellaneous|19|||
156824790|NCT01638013|566109259|FG002|Overall Study|Miscellaneous|23|||
156824791|NCT01638013|566109257|FG000|Overall Study|Withdrawal of Consent|16|||
156824792|NCT01638013|566109258|FG001|Overall Study|Withdrawal of Consent|12|||
156824793|NCT01638013|566109259|FG002|Overall Study|Withdrawal of Consent|16|||
156824794|NCT01638013|566109257|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
156824795|NCT01638013|566109258|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
156824796|NCT01638013|566109259|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
156824797|NCT01145352|566111012|FG000|Overall Study|Found to have been registered twice|6|||
156824798|NCT01145352|566111012|FG000|Overall Study|Treated before marketing approval|4|||
156824799|NCT01145352|566111012|FG000|Overall Study|Syringe formulation was used|1|||
156824800|NCT03095027|566111013|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
156824801|NCT03095027|566111014|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
156824802|NCT02982018|566111015|FG000|Overall Study|Incorrect Lens Dispensed|1|||
156824803|NCT02982018|566111016|FG001|Overall Study|Incorrect Lens Dispensed|0|||
156824804|NCT02982018|566111015|FG000|Overall Study|Protocol Violation|1|||
156824805|NCT02982018|566111016|FG001|Overall Study|Protocol Violation|1|||
156824806|NCT02982018|566111015|FG000|Overall Study|Adverse Event|1|||
156824807|NCT02982018|566111016|FG001|Overall Study|Adverse Event|1|||
156824808|NCT02982018|566111015|FG000|Overall Study|Lens Discomfort|2|||
156824809|NCT02982018|566111016|FG001|Overall Study|Lens Discomfort|0|||
156824810|NCT02982018|566111015|FG000|Overall Study|Withdrawal by Subject|0|||
156824811|NCT02982018|566111016|FG001|Overall Study|Withdrawal by Subject|1|||
156824812|NCT02251717|566111018|FG000|Overall Study|Adverse Event|0|||
156824813|NCT02251717|566111019|FG001|Overall Study|Adverse Event|1|||
156824814|NCT02251717|566111018|FG000|Overall Study|Withdrew Consent|1|||
156824815|NCT02251717|566111019|FG001|Overall Study|Withdrew Consent|0|||
156824816|NCT04098367|566111020|FG000|Overall Study|Adverse Event|0|||
156824817|NCT04098367|566111021|FG001|Overall Study|Adverse Event|0|||
156824818|NCT04098367|566111022|FG002|Overall Study|Adverse Event|1|||
156824819|NCT04098367|566111020|FG000|Overall Study|Lost to Follow-up|1|||
156824820|NCT04098367|566111021|FG001|Overall Study|Lost to Follow-up|5|||
156824821|NCT04098367|566111022|FG002|Overall Study|Lost to Follow-up|2|||
156824822|NCT04098367|566111020|FG000|Overall Study|Withdrawal by Subject|0|||
156824823|NCT04098367|566111021|FG001|Overall Study|Withdrawal by Subject|0|||
156824824|NCT04098367|566111022|FG002|Overall Study|Withdrawal by Subject|1|||
156824825|NCT04098367|566111020|FG000|Overall Study|Sick . Could not attend visit|1|||
156824826|NCT04098367|566111021|FG001|Overall Study|Sick . Could not attend visit|0|||
156824827|NCT04098367|566111022|FG002|Overall Study|Sick . Could not attend visit|0|||
156824828|NCT00322023|566111023|FG000|Overall Study|various|0|||
156824829|NCT00322023|566111024|FG001|Overall Study|various|2|||
156824830|NCT00322023|566111025|FG002|Overall Study|various|6|||
156824831|NCT03920293|566111026|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
156824832|NCT03920293|566111027|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
156824833|NCT03920293|566111026|FG000|Randomized-Controlled Period|Physician Decision|1|||
156824834|NCT03920293|566111027|FG001|Randomized-Controlled Period|Physician Decision|2|||
156824835|NCT03920293|566111026|FG000|Randomized-Controlled Period|Adverse Event|0|||
156824836|NCT03920293|566111027|FG001|Randomized-Controlled Period|Adverse Event|2|||
156824837|NCT03920293|566111026|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
156824838|NCT03920293|566111027|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
156824839|NCT03920293|566111026|FG000|Randomized-Controlled Period|Death|2|||
156824840|NCT03920293|566111027|FG001|Randomized-Controlled Period|Death|0|||
156824841|NCT03920293|566111026|FG000|Randomized-Controlled Period|Protocol Violation|1|||
156824842|NCT03920293|566111027|FG001|Randomized-Controlled Period|Protocol Violation|0|||
156824843|NCT03920293|566111026|FG000|Randomized-Controlled Period|Noncompliance|1|||
156824844|NCT03920293|566111027|FG001|Randomized-Controlled Period|Noncompliance|0|||
156824845|NCT03920293|566111026|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
156824846|NCT03920293|566111027|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
156824847|NCT03920293|566111026|FG000|Open- Label Extension Period|Death|3|||
156824848|NCT03920293|566111027|FG001|Open- Label Extension Period|Death|3|||
156824849|NCT03920293|566111026|FG000|Open- Label Extension Period|Physician Decision|5|||
156824850|NCT03920293|566111027|FG001|Open- Label Extension Period|Physician Decision|3|||
156824851|NCT03920293|566111026|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
156824852|NCT03920293|566111027|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
156824853|NCT01972308|566111028|FG000|Overall Study|Withdrawal by Subject|0|||
156824854|NCT01972308|566111029|FG001|Overall Study|Withdrawal by Subject|1|||
156824855|NCT01972308|566111028|FG000|Overall Study|Lost to Follow-up|4|||
156824856|NCT01972308|566111029|FG001|Overall Study|Lost to Follow-up|6|||
156824857|NCT01972308|566111028|FG000|Overall Study|Death|4|||
156824858|NCT01972308|566111029|FG001|Overall Study|Death|1|||
156824859|NCT01562314|566111030|FG000|Overall Study|Adverse Event|10|||
156824860|NCT01562314|566111031|FG001|Overall Study|Adverse Event|5|||
156824861|NCT01562314|566111030|FG000|Overall Study|Met Withdrawal Criteria|3|||
156824862|NCT01562314|566111031|FG001|Overall Study|Met Withdrawal Criteria|2|||
156824863|NCT01562314|566111030|FG000|Overall Study|Withdrawal by Subject|0|||
156824864|NCT01562314|566111031|FG001|Overall Study|Withdrawal by Subject|1|||
156824865|NCT01190475|566111034|FG000|Overall Study|Withdrawal by Subject|0|||
156824866|NCT01190475|566111035|FG001|Overall Study|Withdrawal by Subject|0|||
156824867|NCT01190475|566111036|FG002|Overall Study|Withdrawal by Subject|1|||
156824868|NCT00543803|566111037|FG000|Overall Study|Adverse Event|14|||
156466132|NCT02101853|564802796|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
156466133|NCT02101853|564802797|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
156466134|NCT02101853|564802792|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
156466135|NCT02101853|564802793|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
156466136|NCT02101853|564802794|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
156824869|NCT00543803|566111037|FG000|Overall Study|Lack of Efficacy|22|||
156824870|NCT00543803|566111037|FG000|Overall Study|Lost to Follow-up|20|||
156824871|NCT00543803|566111037|FG000|Overall Study|Other|86|||
156824872|NCT00996281|566111038|FG000|Overall Study|Adverse Event|75|||
156824873|NCT00996281|566111039|FG001|Overall Study|Adverse Event|37|||
156824874|NCT00996281|566111038|FG000|Overall Study|Major Protocol Deviation|6|||
156466137|NCT02101853|564802795|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
156466138|NCT02101853|564802796|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
156466139|NCT02101853|564802797|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
156824875|NCT00996281|566111039|FG001|Overall Study|Major Protocol Deviation|7|||
156824876|NCT00996281|566111038|FG000|Overall Study|Lost to Follow-up|14|||
156824877|NCT00996281|566111039|FG001|Overall Study|Lost to Follow-up|16|||
156824878|NCT00996281|566111038|FG000|Overall Study|Withdrawal by Subject|31|||
156824879|NCT00996281|566111039|FG001|Overall Study|Withdrawal by Subject|20|||
156824880|NCT00996281|566111038|FG000|Overall Study|Lack of Efficacy|0|||
156824881|NCT00996281|566111039|FG001|Overall Study|Lack of Efficacy|2|||
156824882|NCT00996281|566111038|FG000|Overall Study|Other|5|||
156824883|NCT00996281|566111039|FG001|Overall Study|Other|7|||
156824884|NCT03505788|566111042|FG000|Overall Study|Lost to Follow-up|2|||
156824885|NCT03505788|566111043|FG001|Overall Study|Lost to Follow-up|1|||
156824886|NCT03505788|566111042|FG000|Overall Study|Withdrawal by Subject|1|||
156824887|NCT03505788|566111043|FG001|Overall Study|Withdrawal by Subject|3|||
156824888|NCT03505788|566111042|FG000|Overall Study|Physician Decision|0|||
156824889|NCT03505788|566111043|FG001|Overall Study|Physician Decision|1|||
156824890|NCT03575065|566111044|FG000|Overall Study|Death|31|||
156824891|NCT03575065|566111045|FG001|Overall Study|Death|12|||
156824892|NCT03575065|566111044|FG000|Overall Study|Sponsor's Decision|28|||
156824893|NCT03575065|566111045|FG001|Overall Study|Sponsor's Decision|13|||
156824894|NCT03575065|566111044|FG000|Overall Study|Withdrawal by Subject|2|||
156824895|NCT03575065|566111045|FG001|Overall Study|Withdrawal by Subject|1|||
156824896|NCT03575065|566111044|FG000|Overall Study|Lost to Follow-up|1|||
156824897|NCT03575065|566111045|FG001|Overall Study|Lost to Follow-up|0|||
156824898|NCT02323126|566111050|FG000|Overall Study|Patient / guardian decision|0|||
156824899|NCT02323126|566111051|FG001|Overall Study|Patient / guardian decision|1|||
156824900|NCT02323126|566111052|FG002|Overall Study|Patient / guardian decision|2|||
156824901|NCT02323126|566111050|FG000|Overall Study|Progressive disease|14|||
156824902|NCT02323126|566111051|FG001|Overall Study|Progressive disease|8|||
156824903|NCT02323126|566111052|FG002|Overall Study|Progressive disease|14|||
156824904|NCT02323126|566111050|FG000|Overall Study|Physician Decision|0|||
156824905|NCT02323126|566111051|FG001|Overall Study|Physician Decision|1|||
156824906|NCT02323126|566111052|FG002|Overall Study|Physician Decision|3|||
156824907|NCT02323126|566111050|FG000|Overall Study|Death|1|||
156824908|NCT02323126|566111051|FG001|Overall Study|Death|1|||
156824909|NCT02323126|566111052|FG002|Overall Study|Death|4|||
156824910|NCT02323126|566111050|FG000|Overall Study|Adverse Event|3|||
156824911|NCT02323126|566111051|FG001|Overall Study|Adverse Event|5|||
156824912|NCT02323126|566111052|FG002|Overall Study|Adverse Event|7|||
156824913|NCT00396136|566111053|FG000|Overall Study|Death|43|||
156824914|NCT00396136|566111053|FG000|Overall Study|Withdrawal by Subject|59|||
156824915|NCT00396136|566111053|FG000|Overall Study|Lost to Follow-up|15|||
156824916|NCT00396136|566111053|FG000|Overall Study|Study device explanted|8|||
156824917|NCT01779856|566111054|FG000|Overall Study|Withdrawal by Subject|15|||
156824918|NCT01779856|566111054|FG000|Overall Study|Death|3|||
156824919|NCT01779856|566111054|FG000|Overall Study|Physician Decision|1|||
156824920|NCT01779856|566111054|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
156824921|NCT01779856|566111054|FG000|Overall Study|Delays in scheduling implant|1|||
156824922|NCT01779856|566111054|FG000|Overall Study|Subject ineligible for Implant|2|||
156824923|NCT03960580|566111058|FG000|Overall Study|Adverse Event|2|||
156824924|NCT03960580|566111059|FG001|Overall Study|Adverse Event|1|||
156824925|NCT03960580|566111060|FG002|Overall Study|Adverse Event|1|||
156824926|NCT03960580|566111058|FG000|Overall Study|Lost to Follow-up|1|||
156824927|NCT03960580|566111059|FG001|Overall Study|Lost to Follow-up|0|||
156824928|NCT03960580|566111060|FG002|Overall Study|Lost to Follow-up|0|||
156824929|NCT03960580|566111058|FG000|Overall Study|Lack of Efficacy|2|||
156824930|NCT03960580|566111059|FG001|Overall Study|Lack of Efficacy|1|||
156824931|NCT03960580|566111060|FG002|Overall Study|Lack of Efficacy|0|||
156824932|NCT03960580|566111058|FG000|Overall Study|Protocol Violation|0|||
156824933|NCT03960580|566111059|FG001|Overall Study|Protocol Violation|0|||
156824934|NCT03960580|566111060|FG002|Overall Study|Protocol Violation|1|||
156824935|NCT03960580|566111058|FG000|Overall Study|Withdrawal by Subject|1|||
156824936|NCT03960580|566111059|FG001|Overall Study|Withdrawal by Subject|1|||
156824937|NCT03960580|566111060|FG002|Overall Study|Withdrawal by Subject|1|||
156824938|NCT03960580|566111058|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
156824939|NCT03960580|566111059|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
156824940|NCT03960580|566111060|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
156824941|NCT01703208|566111063|FG000|Overall Study|Death|61|||
156824942|NCT01703208|566111064|FG001|Overall Study|Death|48|||
156824943|NCT01703208|566111063|FG000|Overall Study|Lack of Efficacy|1|||
156824944|NCT01703208|566111064|FG001|Overall Study|Lack of Efficacy|2|||
156824945|NCT01703208|566111063|FG000|Overall Study|Lost to Follow-up|68|||
156824946|NCT01703208|566111064|FG001|Overall Study|Lost to Follow-up|62|||
156824947|NCT01703208|566111063|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156824948|NCT01703208|566111064|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156824949|NCT01703208|566111063|FG000|Overall Study|Excluded Medication|1|||
156824950|NCT01703208|566111064|FG001|Overall Study|Excluded Medication|2|||
156824951|NCT01703208|566111063|FG000|Overall Study|Site Discontinued Study Participation|23|||
156824952|NCT01703208|566111064|FG001|Overall Study|Site Discontinued Study Participation|27|||
156824953|NCT01703208|566111063|FG000|Overall Study|Physician Decision|11|||
156824954|NCT01703208|566111064|FG001|Overall Study|Physician Decision|13|||
156824955|NCT01703208|566111063|FG000|Overall Study|Progressive disease|2|||
156824956|NCT01703208|566111064|FG001|Overall Study|Progressive disease|2|||
156824957|NCT01703208|566111063|FG000|Overall Study|Protocol Violation|1|||
156824958|NCT01703208|566111064|FG001|Overall Study|Protocol Violation|1|||
156824959|NCT01703208|566111063|FG000|Overall Study|Study Terminated by Sponsor|1710|||
156824960|NCT01703208|566111064|FG001|Overall Study|Study Terminated by Sponsor|1716|||
156824961|NCT01703208|566111063|FG000|Overall Study|Withdrawal by Subject|205|||
156824962|NCT01703208|566111064|FG001|Overall Study|Withdrawal by Subject|209|||
156824963|NCT01703208|566111063|FG000|Overall Study|Adverse Event|14|||
156824964|NCT01703208|566111064|FG001|Overall Study|Adverse Event|19|||
156824965|NCT01703208|566111063|FG000|Overall Study|Technical Problems|0|||
156824966|NCT01703208|566111064|FG001|Overall Study|Technical Problems|1|||
156824967|NCT01703208|566111063|FG000|Overall Study|Protocol Deviation|2|||
156824968|NCT01703208|566111064|FG001|Overall Study|Protocol Deviation|0|||
156824969|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
156824970|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
156824971|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
156824972|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
156824973|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
156824974|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
156824975|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
156824976|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
156824977|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
156824978|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
156824979|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
156824980|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
156824981|NCT01639339|566111065|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
156824982|NCT01639339|566111066|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
156824983|NCT01639339|566111065|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
156824984|NCT01639339|566111066|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
156824985|NCT01639339|566111065|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
156824986|NCT01639339|566111066|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
156824987|NCT01639339|566111065|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
156824988|NCT01639339|566111066|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
156824989|NCT00252694|566111067|FG000|Overall Study|Withdrawal by Subject|83|||
156824990|NCT00252694|566111068|FG001|Overall Study|Withdrawal by Subject|91|||
156824991|NCT00252694|566111067|FG000|Overall Study|Death|36|||
156824992|NCT00252694|566111068|FG001|Overall Study|Death|34|||
156824993|NCT00252694|566111067|FG000|Overall Study|Mostly Lost to Follow Up|8|||
156824994|NCT00252694|566111068|FG001|Overall Study|Mostly Lost to Follow Up|13|||
156824995|NCT00252694|566111067|FG000|Overall Study|Patient Moving|17|||
156824996|NCT00252694|566111068|FG001|Overall Study|Patient Moving|16|||
156824997|NCT02649218|566111069|FG000|Overall Study|Adverse Event|8|||
156824998|NCT02649218|566111069|FG000|Overall Study|Lack of Efficacy|8|||
156824999|NCT02649218|566111069|FG000|Overall Study|Pregnancy|3|||
156825000|NCT02649218|566111069|FG000|Overall Study|Protocol Violation|3|||
156825001|NCT02649218|566111069|FG000|Overall Study|Physician Decision|1|||
156825002|NCT02649218|566111069|FG000|Overall Study|Withdrawal by Subject|2|||
156825003|NCT04003207|566111075|FG000|Overall Study|Protocol Violation|1|||
156825004|NCT03894969|566111077|FG000|Overall Study|Adverse Event|0|||
156825005|NCT03894969|566111078|FG001|Overall Study|Adverse Event|2|||
156825006|NCT03894969|566111079|FG002|Overall Study|Adverse Event|0|||
156825007|NCT03894969|566111080|FG003|Overall Study|Adverse Event|1|||
156825008|NCT03894969|566111081|FG004|Overall Study|Adverse Event|2|||
156825009|NCT03894969|566111077|FG000|Overall Study|Lost to Follow-up|3|||
156825010|NCT03894969|566111078|FG001|Overall Study|Lost to Follow-up|1|||
156825011|NCT03894969|566111079|FG002|Overall Study|Lost to Follow-up|1|||
156825012|NCT03894969|566111080|FG003|Overall Study|Lost to Follow-up|0|||
156825013|NCT03894969|566111081|FG004|Overall Study|Lost to Follow-up|0|||
156825014|NCT03894969|566111077|FG000|Overall Study|Withdrawal by Subject|2|||
156339252|NCT01090492|564340144|FG002|Second Intervention Period (4 Weeks)|Other|1|||
156339253|NCT01090492|564340145|FG003|Second Intervention Period (4 Weeks)|Other|0|||
156825015|NCT03894969|566111078|FG001|Overall Study|Withdrawal by Subject|1|||
156825016|NCT03894969|566111079|FG002|Overall Study|Withdrawal by Subject|3|||
156825017|NCT03894969|566111080|FG003|Overall Study|Withdrawal by Subject|4|||
156825018|NCT03894969|566111081|FG004|Overall Study|Withdrawal by Subject|8|||
156825019|NCT03894969|566111077|FG000|Overall Study|Other|0|||
156339254|NCT01090492|564340146|FG004|Second Intervention Period (4 Weeks)|Other|0|||
156825020|NCT03894969|566111078|FG001|Overall Study|Other|0|||
156825021|NCT03894969|566111079|FG002|Overall Study|Other|0|||
156825022|NCT03894969|566111080|FG003|Overall Study|Other|0|||
156825023|NCT03894969|566111081|FG004|Overall Study|Other|3|||
156825024|NCT03894969|566111077|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
156825025|NCT03894969|566111078|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
156825026|NCT03894969|566111079|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
156825027|NCT03894969|566111080|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
156825028|NCT03894969|566111081|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
156825029|NCT03894969|566111077|FG000|Overall Study|Solicited Adverse Event|0|||
156825030|NCT03894969|566111078|FG001|Overall Study|Solicited Adverse Event|1|||
156825031|NCT03894969|566111079|FG002|Overall Study|Solicited Adverse Event|0|||
156825032|NCT03894969|566111080|FG003|Overall Study|Solicited Adverse Event|0|||
156825033|NCT03894969|566111081|FG004|Overall Study|Solicited Adverse Event|0|||
156825034|NCT00468676|566111082|FG000|Overall Study|Lost to Follow-up|14|||
156825035|NCT00468676|566111083|FG001|Overall Study|Lost to Follow-up|11|||
156825036|NCT00468676|566111082|FG000|Overall Study|Death|2|||
156825037|NCT00468676|566111083|FG001|Overall Study|Death|1|||
156825038|NCT02378298|566111086|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
156825039|NCT02378298|566111087|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
156825040|NCT02378298|566111088|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
156825041|NCT02378298|566111086|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
156825042|NCT02378298|566111087|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
156825043|NCT02378298|566111088|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
156825044|NCT02378298|566111086|FG000|Surveillance (19-68 Weeks)|Death|1|||
156825045|NCT02378298|566111087|FG001|Surveillance (19-68 Weeks)|Death|0|||
156825046|NCT02378298|566111088|FG002|Surveillance (19-68 Weeks)|Death|0|||
156825047|NCT04173260|566111089|FG000|Overall Study|Early termination|4|||
156825048|NCT02308163|566111092|FG000|Overall Study|Not fulfill eligible criteria|1|||
156825049|NCT02308163|566111093|FG001|Overall Study|Not fulfill eligible criteria|2|||
156825050|NCT02308163|566111094|FG002|Overall Study|Not fulfill eligible criteria|0|||
156825051|NCT02308163|566111095|FG003|Overall Study|Not fulfill eligible criteria|1|||
156825052|NCT02308163|566111096|FG004|Overall Study|Not fulfill eligible criteria|1|||
156825053|NCT02308163|566111092|FG000|Overall Study|Adverse Event|9|||
156825054|NCT02308163|566111093|FG001|Overall Study|Adverse Event|5|||
156825055|NCT02308163|566111094|FG002|Overall Study|Adverse Event|2|||
156825056|NCT02308163|566111095|FG003|Overall Study|Adverse Event|2|||
156825057|NCT02308163|566111096|FG004|Overall Study|Adverse Event|11|||
156825058|NCT02308163|566111092|FG000|Overall Study|Lack of Efficacy|11|||
156825059|NCT02308163|566111093|FG001|Overall Study|Lack of Efficacy|3|||
156825060|NCT02308163|566111094|FG002|Overall Study|Lack of Efficacy|8|||
156825061|NCT02308163|566111095|FG003|Overall Study|Lack of Efficacy|4|||
156825062|NCT02308163|566111096|FG004|Overall Study|Lack of Efficacy|6|||
156825063|NCT02308163|566111092|FG000|Overall Study|Withdrawal of consent|2|||
156825064|NCT02308163|566111093|FG001|Overall Study|Withdrawal of consent|3|||
156825065|NCT02308163|566111094|FG002|Overall Study|Withdrawal of consent|0|||
156825066|NCT02308163|566111095|FG003|Overall Study|Withdrawal of consent|2|||
156825067|NCT02308163|566111096|FG004|Overall Study|Withdrawal of consent|6|||
156825068|NCT02308163|566111092|FG000|Overall Study|Protocol Violation|3|||
156825069|NCT02308163|566111093|FG001|Overall Study|Protocol Violation|3|||
156825070|NCT02308163|566111094|FG002|Overall Study|Protocol Violation|3|||
156825071|NCT02308163|566111095|FG003|Overall Study|Protocol Violation|2|||
156825072|NCT02308163|566111096|FG004|Overall Study|Protocol Violation|5|||
156825073|NCT02308163|566111092|FG000|Overall Study|Lab data met discontinuation criteria|3|||
156825074|NCT02308163|566111093|FG001|Overall Study|Lab data met discontinuation criteria|0|||
156825075|NCT02308163|566111094|FG002|Overall Study|Lab data met discontinuation criteria|0|||
156825076|NCT02308163|566111095|FG003|Overall Study|Lab data met discontinuation criteria|2|||
156825077|NCT02308163|566111096|FG004|Overall Study|Lab data met discontinuation criteria|0|||
156825078|NCT02308163|566111092|FG000|Overall Study|Miscellaneous|2|||
156825079|NCT02308163|566111093|FG001|Overall Study|Miscellaneous|2|||
156825080|NCT02308163|566111094|FG002|Overall Study|Miscellaneous|1|||
156825081|NCT02308163|566111095|FG003|Overall Study|Miscellaneous|0|||
156825082|NCT02308163|566111096|FG004|Overall Study|Miscellaneous|5|||
156825083|NCT03761394|566111107|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
156825084|NCT03761394|566111108|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
156825085|NCT03761394|566111109|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
156825086|NCT03761394|566111110|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
156825087|NCT03761394|566111107|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
156825088|NCT03761394|566111108|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
156825089|NCT03761394|566111109|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
156825090|NCT03761394|566111110|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
156825091|NCT03761394|566111107|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
156825092|NCT03761394|566111108|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
156825093|NCT03761394|566111109|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
156825094|NCT03761394|566111110|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
156825095|NCT03761394|566111107|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
156825096|NCT03761394|566111108|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
156825097|NCT03761394|566111109|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
156825098|NCT03761394|566111110|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
156825099|NCT01939002|566111116|FG000|Overall Study|Adverse Event|13|||
156825100|NCT01939002|566111117|FG001|Overall Study|Adverse Event|13|||
156825101|NCT01939002|566111116|FG000|Overall Study|Withdrawal by Subject|5|||
156825102|NCT01939002|566111117|FG001|Overall Study|Withdrawal by Subject|3|||
156339255|NCT01090492|564340147|FG005|Second Intervention Period (4 Weeks)|Other|0|||
156825103|NCT01939002|566111116|FG000|Overall Study|Other|1|||
156825104|NCT01939002|566111117|FG001|Overall Study|Other|2|||
156825105|NCT02910401|566111120|FG000|Overall Study|Study closure Study closure|0|||
156825106|NCT02910401|566111121|FG001|Overall Study|Study closure Study closure|0|||
156825107|NCT02910401|566111122|FG002|Overall Study|Study closure Study closure|2|||
156825108|NCT02910401|566111120|FG000|Overall Study|Physician Decision|1|||
156825109|NCT02910401|566111121|FG001|Overall Study|Physician Decision|0|||
156825110|NCT02910401|566111122|FG002|Overall Study|Physician Decision|0|||
156825111|NCT00098748|566111124|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
156825112|NCT00098748|566111125|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
156825113|NCT00098748|566111126|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
156825114|NCT00098748|566111124|FG000|Received Study Treatment|Death|2|||
156825115|NCT00098748|566111125|FG001|Received Study Treatment|Death|1|||
156825116|NCT00098748|566111126|FG002|Received Study Treatment|Death|2|||
156825117|NCT00098748|566111124|FG000|Received Study Treatment|Adverse Event|1|||
156825118|NCT00098748|566111125|FG001|Received Study Treatment|Adverse Event|2|||
156825119|NCT00098748|566111126|FG002|Received Study Treatment|Adverse Event|5|||
156825120|NCT00098748|566111124|FG000|Received Study Treatment|Lack of Efficacy|40|||
156825121|NCT00098748|566111125|FG001|Received Study Treatment|Lack of Efficacy|27|||
156825122|NCT00098748|566111126|FG002|Received Study Treatment|Lack of Efficacy|27|||
156825123|NCT00098748|566111124|FG000|Received Study Treatment|Other|2|||
156825124|NCT00098748|566111125|FG001|Received Study Treatment|Other|2|||
156825125|NCT00098748|566111126|FG002|Received Study Treatment|Other|6|||
156825126|NCT00098748|566111124|FG000|Received Study Treatment|Subject defaulted|3|||
156825127|NCT00098748|566111125|FG001|Received Study Treatment|Subject defaulted|4|||
156825128|NCT00098748|566111126|FG002|Received Study Treatment|Subject defaulted|4|||
156825129|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
156825130|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
156825131|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
156825132|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
156825133|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
156825134|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
156825135|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
156825136|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
156825137|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
156825138|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
156825139|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
156825140|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
156825141|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
156825142|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
156825143|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
156825144|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
156825145|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
156825146|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Death|0|||
156825147|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Death|0|||
156825148|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
156825149|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
156825150|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
156825151|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
156825152|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
156825153|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
156825154|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
156825155|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
156825156|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
156825157|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
156825158|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
156825159|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
156825160|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
156541199|NCT02159729|565074503|FG000|Overall Study|Non compliance|2|||
156825161|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
156825162|NCT00433160|566111129|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
156825163|NCT00433160|566111130|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
156825164|NCT00433160|566111129|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
156825165|NCT00433160|566111130|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
156825166|NCT00433160|566111129|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
156825167|NCT00433160|566111130|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
156825168|NCT00433160|566111129|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
156825169|NCT00433160|566111130|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
156825170|NCT00433160|566111129|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
156825171|NCT00433160|566111130|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
156825172|NCT00433160|566111129|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
156825173|NCT00433160|566111130|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
156825174|NCT00433160|566111129|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
156825175|NCT00433160|566111130|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
156825176|NCT01774253|566111131|FG000|Overall Study|Lack of Efficacy|4|||
156825177|NCT01774253|566111131|FG000|Overall Study|Physician Decision|2|||
156825178|NCT01774253|566111131|FG000|Overall Study|Withdrawal by Subject|2|||
156825179|NCT01774253|566111131|FG000|Overall Study|Death|1|||
156825180|NCT02240368|566111132|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
156825181|NCT02240368|566111133|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
156825182|NCT02240368|566111134|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
156825183|NCT02240368|566111132|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
156825184|NCT02240368|566111133|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
156825185|NCT02240368|566111134|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
156825186|NCT00871117|566111143|FG000|Overall Study|Lost to Follow-up|5|||
156825187|NCT00871117|566111144|FG001|Overall Study|Lost to Follow-up|6|||
156825188|NCT00871117|566111143|FG000|Overall Study|Other|0|||
156825189|NCT00871117|566111144|FG001|Overall Study|Other|4|||
156825190|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
156825191|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
156825192|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
156825193|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
156825194|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
156825195|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
156825196|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
156825197|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
156825198|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
156825199|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
156825200|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
156825201|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
156825202|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
156825203|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
156825204|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
156825205|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
156825206|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
156825207|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
156466140|NCT05707351|564802801|FG000|Overall Study|Withdrawal by Subject|2|||
156466141|NCT05707351|564802801|FG000|Overall Study|Reason Not Specified|1|||
156466142|NCT04908514|564802810|FG000|Overall Study|Lost to Follow-up|2|||
156466143|NCT04908514|564802810|FG000|Overall Study|Withdrawal by Subject|1|||
156825208|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
156825209|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
156825210|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
156825211|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
156825212|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
156825213|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
156825214|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
156825215|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
156825216|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
156825217|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
156339256|NCT01090492|564340148|FG006|Second Intervention Period (4 Weeks)|Other|0|||
156825218|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
156825219|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
156825220|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
156466144|NCT05934292|564802812|FG000|Overall Study|Lost to Follow-up|0|||
156466145|NCT05934292|564802813|FG001|Overall Study|Lost to Follow-up|0|||
156466146|NCT05934292|564802814|FG002|Overall Study|Lost to Follow-up|1|||
156825221|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
156825222|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
156825223|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
156825224|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
156825225|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
156825226|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
156825227|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
156825228|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
156825229|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
156825230|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
156825231|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
156825232|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
156825233|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
156825234|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
156825235|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
156825236|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
156825237|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
156825238|NCT02080481|566111149|FG000|Overall Study|Never received a block.|1|||
156825239|NCT02080481|566111150|FG001|Overall Study|Never received a block.|0|||
156825240|NCT00642174|566113186|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
156825241|NCT00642174|566113187|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
156825242|NCT00896363|566113188|FG000|Overall Study|Adverse Event|3|||
156825243|NCT00896363|566113189|FG001|Overall Study|Adverse Event|4|||
156825244|NCT00896363|566113190|FG002|Overall Study|Adverse Event|2|||
156825245|NCT00896363|566113188|FG000|Overall Study|Lack of Efficacy|0|||
156825246|NCT00896363|566113189|FG001|Overall Study|Lack of Efficacy|2|||
156825247|NCT00896363|566113190|FG002|Overall Study|Lack of Efficacy|1|||
156825248|NCT00896363|566113188|FG000|Overall Study|Withdrawal by Subject|3|||
156825249|NCT00896363|566113189|FG001|Overall Study|Withdrawal by Subject|5|||
156825250|NCT00896363|566113190|FG002|Overall Study|Withdrawal by Subject|5|||
156825251|NCT01730339|566113191|FG000|Overall Study|Withdrawal by Subject|3|||
156825252|NCT01730339|566113192|FG001|Overall Study|Withdrawal by Subject|2|||
156825253|NCT01730339|566113191|FG000|Overall Study|Lost to Follow-up|1|||
156825254|NCT01730339|566113192|FG001|Overall Study|Lost to Follow-up|1|||
156825255|NCT01730339|566113191|FG000|Overall Study|Un-specified|1|||
156825256|NCT01730339|566113192|FG001|Overall Study|Un-specified|0|||
156825257|NCT00521599|566113194|FG000|Overall Study|Adverse Event|5|||
156825258|NCT00521599|566113195|FG001|Overall Study|Adverse Event|7|||
156825259|NCT00521599|566113196|FG002|Overall Study|Adverse Event|6|||
156825260|NCT00521599|566113194|FG000|Overall Study|Treatment Failure|8|||
156825261|NCT00521599|566113195|FG001|Overall Study|Treatment Failure|9|||
156825262|NCT00521599|566113196|FG002|Overall Study|Treatment Failure|22|||
156825263|NCT00521599|566113194|FG000|Overall Study|Lost to Follow-up|2|||
156825264|NCT00521599|566113195|FG001|Overall Study|Lost to Follow-up|1|||
156825265|NCT00521599|566113196|FG002|Overall Study|Lost to Follow-up|2|||
156825266|NCT00521599|566113194|FG000|Overall Study|Withdrawal by Subject|3|||
156825267|NCT00521599|566113195|FG001|Overall Study|Withdrawal by Subject|5|||
156825268|NCT00521599|566113196|FG002|Overall Study|Withdrawal by Subject|1|||
156825269|NCT00521599|566113194|FG000|Overall Study|Withdrawal by subject treatment related|3|||
156825270|NCT00521599|566113195|FG001|Overall Study|Withdrawal by subject treatment related|1|||
156825271|NCT00521599|566113196|FG002|Overall Study|Withdrawal by subject treatment related|2|||
156825272|NCT00521599|566113194|FG000|Overall Study|Protocol Violation|2|||
156825273|NCT00521599|566113195|FG001|Overall Study|Protocol Violation|4|||
156825274|NCT00521599|566113196|FG002|Overall Study|Protocol Violation|2|||
156825275|NCT00521599|566113194|FG000|Overall Study|Did not meet protocol eligibility|2|||
156825276|NCT00521599|566113195|FG001|Overall Study|Did not meet protocol eligibility|2|||
156825277|NCT00521599|566113196|FG002|Overall Study|Did not meet protocol eligibility|1|||
156825278|NCT00791479|566113197|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825279|NCT00791479|566113198|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825280|NCT00791479|566113199|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825281|NCT00791479|566113200|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825282|NCT00791479|566113201|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
156825283|NCT00791479|566113202|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825284|NCT00791479|566113197|FG000|Overall Study|Adverse Event|0|||
156825285|NCT00791479|566113198|FG001|Overall Study|Adverse Event|1|||
156825286|NCT00791479|566113199|FG002|Overall Study|Adverse Event|0|||
156825287|NCT00791479|566113200|FG003|Overall Study|Adverse Event|2|||
156825288|NCT00791479|566113201|FG004|Overall Study|Adverse Event|0|||
156825289|NCT00791479|566113202|FG005|Overall Study|Adverse Event|1|||
156825290|NCT00791479|566113197|FG000|Overall Study|Lost to Follow-up|0|||
156825291|NCT00791479|566113198|FG001|Overall Study|Lost to Follow-up|1|||
156825292|NCT00791479|566113199|FG002|Overall Study|Lost to Follow-up|0|||
156825293|NCT00791479|566113200|FG003|Overall Study|Lost to Follow-up|0|||
156825294|NCT00791479|566113201|FG004|Overall Study|Lost to Follow-up|0|||
156825295|NCT00791479|566113202|FG005|Overall Study|Lost to Follow-up|1|||
156825296|NCT00791479|566113197|FG000|Overall Study|Protocol Violation|2|||
156825297|NCT00791479|566113198|FG001|Overall Study|Protocol Violation|1|||
156825298|NCT00791479|566113199|FG002|Overall Study|Protocol Violation|0|||
156825299|NCT00791479|566113200|FG003|Overall Study|Protocol Violation|1|||
156825300|NCT00791479|566113201|FG004|Overall Study|Protocol Violation|0|||
156825301|NCT00791479|566113202|FG005|Overall Study|Protocol Violation|0|||
156825302|NCT00791479|566113197|FG000|Overall Study|Withdrawal by Subject|0|||
156825303|NCT00791479|566113198|FG001|Overall Study|Withdrawal by Subject|0|||
156825304|NCT00791479|566113199|FG002|Overall Study|Withdrawal by Subject|0|||
156825305|NCT00791479|566113200|FG003|Overall Study|Withdrawal by Subject|1|||
156825306|NCT00791479|566113201|FG004|Overall Study|Withdrawal by Subject|0|||
156825307|NCT00791479|566113202|FG005|Overall Study|Withdrawal by Subject|1|||
156825308|NCT00496197|566113203|FG000|Overall Study|Discontinued study due to death|43|||
156825309|NCT00496197|566113203|FG000|Overall Study|Adverse Event|13|||
156825310|NCT00496197|566113203|FG000|Overall Study|Does not meet entrance criteria|5|||
156825311|NCT00496197|566113203|FG000|Overall Study|Insufficient clinical response|3|||
156825312|NCT00496197|566113203|FG000|Overall Study|Insufficient bacteriological response|10|||
156825313|NCT00496197|566113203|FG000|Overall Study|Lost to Follow-up|11|||
156825314|NCT00496197|566113203|FG000|Overall Study|Withdrawal by Subject|11|||
156825315|NCT00496197|566113203|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
156825316|NCT00496197|566113203|FG000|Overall Study|Other|14|||
156825317|NCT00496197|566113203|FG000|Overall Study|Protocol Violation|8|||
156825318|NCT00149994|566113204|FG000|Overall Study|Administrative problems:|1|||
156825319|NCT00149994|566113205|FG001|Overall Study|Administrative problems:|0|||
156825320|NCT00149994|566113204|FG000|Overall Study|Protocol Violation|0|||
156825321|NCT00149994|566113205|FG001|Overall Study|Protocol Violation|1|||
156825322|NCT01610713|566113206|FG000|Overall Study|Adverse Event|3|||
156825323|NCT01610713|566113207|FG001|Overall Study|Adverse Event|0|||
156825324|NCT01610713|566113206|FG000|Overall Study|Lack of Efficacy|1|||
156825325|NCT01610713|566113207|FG001|Overall Study|Lack of Efficacy|0|||
156825326|NCT01610713|566113206|FG000|Overall Study|low mood and poor motivation|1|||
156825327|NCT01610713|566113207|FG001|Overall Study|low mood and poor motivation|0|||
156825328|NCT01610713|566113206|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
156825329|NCT01610713|566113207|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
156825330|NCT01610713|566113206|FG000|Overall Study|Lost to Follow-up|0|||
156825331|NCT01610713|566113207|FG001|Overall Study|Lost to Follow-up|1|||
156825332|NCT01774097|566113213|FG000|Overall Study|Withdrawal by Subject|1|||
156825333|NCT01774097|566113214|FG001|Overall Study|Withdrawal by Subject|1|||
156825334|NCT01774097|566113213|FG000|Overall Study|Adverse Event|1|||
156825335|NCT01774097|566113214|FG001|Overall Study|Adverse Event|1|||
156825336|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
156825337|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
156825338|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
156825339|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
156825340|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
156825341|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
156825342|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
156825343|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825344|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825345|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825346|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
156825347|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
156825348|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825349|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825350|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825351|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825352|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825353|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825354|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
156825355|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825356|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
156825357|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825358|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156466147|NCT05934292|564802815|FG003|Overall Study|Lost to Follow-up|0|||
156466148|NCT01639131|564803814|FG000|Overall Study|Disease Progression|6|||
156825359|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
156825360|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
156825361|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825362|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825363|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825364|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825365|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825366|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156466149|NCT01637402|564803815|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
156466150|NCT01637402|564803816|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
156466151|NCT01637402|564803815|FG000|Standard Dose Regimen|Adverse Event|1|||
156825367|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825368|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825369|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825370|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825371|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825372|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825373|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825374|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
156825375|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825376|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825377|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825378|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156466152|NCT01637402|564803816|FG001|Standard Dose Regimen|Adverse Event|0|||
156466153|NCT01637402|564803815|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
156825379|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825380|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825381|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825382|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825383|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825384|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825385|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825386|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825387|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825388|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825389|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825390|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825391|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825392|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
156825393|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825394|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825395|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825396|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825397|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825398|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825399|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825400|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825401|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825402|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825403|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825404|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825405|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825406|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825407|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825408|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825409|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825410|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825411|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825412|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825413|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825414|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825415|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825416|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825417|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825418|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
156863432|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
156863433|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
156466154|NCT01637402|564803816|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
156466155|NCT01637402|564803815|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
156466156|NCT01637402|564803816|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
156466157|NCT01637402|564803815|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
156466158|NCT01637402|564803816|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
156825419|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825420|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825421|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825422|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825423|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825424|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825425|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825426|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825427|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825428|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825429|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
156825430|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825431|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
156825432|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825433|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825434|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825435|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825436|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825437|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156339257|NCT01090492|564340149|FG007|Second Intervention Period (4 Weeks)|Other|0|||
156339258|NCT01090492|564340142|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
156339259|NCT01090492|564340143|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
156339260|NCT01090492|564340144|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
156339261|NCT01090492|564340145|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
156339262|NCT01090492|564340146|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
156339263|NCT01090492|564340147|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
156339264|NCT01090492|564340148|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
156339265|NCT01090492|564340149|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
156339266|NCT01090492|564340142|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156339267|NCT01090492|564340143|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156339268|NCT01090492|564340144|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156339269|NCT01090492|564340145|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156339270|NCT01090492|564340146|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156339271|NCT01090492|564340147|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156339272|NCT01090492|564340148|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
156339273|NCT01090492|564340149|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156339274|NCT01768286|564340150|FG000|Overall Study|Randomized But Not Treated|0|||
156339275|NCT01768286|564340151|FG001|Overall Study|Randomized But Not Treated|0|||
156339276|NCT01768286|564340152|FG002|Overall Study|Randomized But Not Treated|1|||
156339277|NCT01768286|564340153|FG003|Overall Study|Randomized But Not Treated|0|||
156339278|NCT01768286|564340150|FG000|Overall Study|Lack of Efficacy|7|||
156339279|NCT01768286|564340151|FG001|Overall Study|Lack of Efficacy|4|||
156339280|NCT01768286|564340152|FG002|Overall Study|Lack of Efficacy|0|||
156339281|NCT01768286|564340153|FG003|Overall Study|Lack of Efficacy|1|||
156339282|NCT01768286|564340150|FG000|Overall Study|Withdrew Consent|0|||
156339283|NCT01768286|564340151|FG001|Overall Study|Withdrew Consent|0|||
156339284|NCT01768286|564340152|FG002|Overall Study|Withdrew Consent|1|||
156339285|NCT01768286|564340153|FG003|Overall Study|Withdrew Consent|0|||
156339286|NCT03583697|564340157|FG000|Overall Study|Withdrawal by Subject|0|||
156339287|NCT03583697|564340158|FG001|Overall Study|Withdrawal by Subject|0|||
156339288|NCT03583697|564340159|FG002|Overall Study|Withdrawal by Subject|1|||
156339289|NCT03583697|564340157|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
156339290|NCT03583697|564340158|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
156339291|NCT03583697|564340159|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
156339292|NCT00365508|564340160|FG000|Overall Study|Lost to Follow-up|139|||
156339293|NCT00365508|564340161|FG001|Overall Study|Lost to Follow-up|154|||
156339294|NCT03724032|564340164|FG000|Overall Study|Physician Decision|1|||
156339295|NCT03724032|564340165|FG001|Overall Study|Physician Decision|0|||
156339296|NCT03724032|564340166|FG002|Overall Study|Physician Decision|0|||
156339297|NCT03724032|564340164|FG000|Overall Study|Protocol Violation|2|||
156339298|NCT03724032|564340165|FG001|Overall Study|Protocol Violation|2|||
156339299|NCT03724032|564340166|FG002|Overall Study|Protocol Violation|1|||
156339300|NCT02538029|564340168|FG000|Overall Study|unable to complete cognitive assessments|1|||
156339301|NCT02538029|564340169|FG001|Overall Study|unable to complete cognitive assessments|0|||
156339302|NCT02538029|564340170|FG002|Overall Study|unable to complete cognitive assessments|1|||
156339303|NCT00404235|564340173|FG000|Overall Study|Withdrawal by Subject|1|||
156541200|NCT02159729|565074504|FG001|Overall Study|Non compliance|0|||
156825438|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825439|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825440|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825441|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825442|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825443|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825444|NCT01920568|566113233|FG000|Overall Study|Adverse Event|27|||
156825445|NCT01920568|566113234|FG001|Overall Study|Adverse Event|8|||
156825446|NCT01920568|566113233|FG000|Overall Study|Protocol Violation|5|||
156825447|NCT01920568|566113234|FG001|Overall Study|Protocol Violation|3|||
156825448|NCT01920568|566113233|FG000|Overall Study|Lost to Follow-up|2|||
156825449|NCT01920568|566113234|FG001|Overall Study|Lost to Follow-up|2|||
156825450|NCT01920568|566113233|FG000|Overall Study|Physician Decision|13|||
156825451|NCT01920568|566113234|FG001|Overall Study|Physician Decision|4|||
156825452|NCT01920568|566113233|FG000|Overall Study|Withdrawal by Subject|79|||
156825453|NCT01920568|566113234|FG001|Overall Study|Withdrawal by Subject|55|||
156825454|NCT01920568|566113233|FG000|Overall Study|Death due to disease progression|25|||
156825455|NCT01920568|566113234|FG001|Overall Study|Death due to disease progression|12|||
156825456|NCT04049266|566113237|FG000|Overall Study|Adverse Event|16|||
156825457|NCT04049266|566113238|FG001|Overall Study|Adverse Event|9|||
156825458|NCT04049266|566113237|FG000|Overall Study|Non-compliance with study drug|0|||
156825459|NCT04049266|566113238|FG001|Overall Study|Non-compliance with study drug|3|||
156825460|NCT04049266|566113237|FG000|Overall Study|Withdrawal by Subject|6|||
156825461|NCT04049266|566113238|FG001|Overall Study|Withdrawal by Subject|10|||
156825462|NCT04049266|566113237|FG000|Overall Study|Lost to Follow-up|2|||
156825463|NCT04049266|566113238|FG001|Overall Study|Lost to Follow-up|2|||
156825464|NCT04049266|566113237|FG000|Overall Study|Progressive disease|11|||
156825465|NCT04049266|566113238|FG001|Overall Study|Progressive disease|2|||
156825466|NCT04049266|566113237|FG000|Overall Study|Physician Decision|1|||
156825467|NCT04049266|566113238|FG001|Overall Study|Physician Decision|0|||
156825468|NCT04049266|566113237|FG000|Overall Study|Patient moved out of state|1|||
156825469|NCT04049266|566113238|FG001|Overall Study|Patient moved out of state|0|||
156825470|NCT03664674|566113242|FG000|Overall Study|Adverse Event|1|||
156825471|NCT03664674|566113243|FG001|Overall Study|Adverse Event|1|||
156825472|NCT03664674|566113242|FG000|Overall Study|Physician Decision|0|||
156825473|NCT03664674|566113243|FG001|Overall Study|Physician Decision|1|||
156825474|NCT03664674|566113242|FG000|Overall Study|Withdrawal by Subject|2|||
156825475|NCT03664674|566113243|FG001|Overall Study|Withdrawal by Subject|0|||
156825476|NCT01342965|566113245|FG000|Overall Study|Death|58|||
156825477|NCT01342965|566113246|FG001|Overall Study|Death|57|||
156825478|NCT01342965|566113245|FG000|Overall Study|Lost to Follow-up|5|||
156825479|NCT01342965|566113246|FG001|Overall Study|Lost to Follow-up|3|||
156825480|NCT01342965|566113245|FG000|Overall Study|Other Reasons- Unspecified|44|||
156825481|NCT01342965|566113246|FG001|Overall Study|Other Reasons- Unspecified|38|||
156825482|NCT01342965|566113245|FG000|Overall Study|Withdrawal by Subject|2|||
156825483|NCT01342965|566113246|FG001|Overall Study|Withdrawal by Subject|9|||
156825484|NCT00856206|566113249|FG000|Overall Study|Protocol Violation|6|||
156825485|NCT00856206|566113250|FG001|Overall Study|Protocol Violation|18|||
156825486|NCT00856206|566113249|FG000|Overall Study|Adverse Event|10|||
156825487|NCT00856206|566113250|FG001|Overall Study|Adverse Event|46|||
156825488|NCT00856206|566113249|FG000|Overall Study|Lack of Efficacy|1|||
156825489|NCT00856206|566113250|FG001|Overall Study|Lack of Efficacy|2|||
156825490|NCT00856206|566113249|FG000|Overall Study|Withdrawal by Subject|15|||
156825491|NCT00856206|566113250|FG001|Overall Study|Withdrawal by Subject|36|||
156825492|NCT00856206|566113249|FG000|Overall Study|Lost to Follow-up|13|||
156825493|NCT00856206|566113250|FG001|Overall Study|Lost to Follow-up|39|||
156825494|NCT00856206|566113249|FG000|Overall Study|Death|2|||
156825495|NCT00856206|566113250|FG001|Overall Study|Death|2|||
156825496|NCT00856206|566113249|FG000|Overall Study|Decision by the Sponsor|4|||
156825497|NCT00856206|566113250|FG001|Overall Study|Decision by the Sponsor|8|||
156541201|NCT02159729|565074503|FG000|Overall Study|Other Unspecified|3|||
156825498|NCT00856206|566113249|FG000|Overall Study|Other than specified above|3|||
156825499|NCT00856206|566113250|FG001|Overall Study|Other than specified above|10|||
156825500|NCT01170598|566113254|FG000|Overall Study|Withdrawal by Subject|1|||
156825501|NCT01170598|566113254|FG000|Overall Study|Death|3|||
156825502|NCT01170598|566113254|FG000|Overall Study|Lost to Follow-up|1|||
156825503|NCT01170598|566113254|FG000|Overall Study|Refused|1|||
156825504|NCT04584346|566113257|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
156541202|NCT02159729|565074504|FG001|Overall Study|Other Unspecified|1|||
156541203|NCT02636582|565074505|FG000|Overall Study|Surgical Pathology|1|||
156825505|NCT04584346|566113258|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
156825506|NCT01271712|566113259|FG000|Double Blind Treatment|Death|2|||
156825507|NCT01271712|566113260|FG001|Double Blind Treatment|Death|0|||
156825508|NCT01271712|566113259|FG000|Double Blind Treatment|Lack of Efficacy|1|||
156825509|NCT01271712|566113260|FG001|Double Blind Treatment|Lack of Efficacy|0|||
156541204|NCT02636582|565074506|FG001|Overall Study|Surgical Pathology|0|||
156825510|NCT01271712|566113259|FG000|Double Blind Treatment|Adverse Event|9|||
156825511|NCT01271712|566113260|FG001|Double Blind Treatment|Adverse Event|4|||
156825512|NCT01271712|566113259|FG000|Double Blind Treatment|Progressive disease|23|||
156825513|NCT01271712|566113260|FG001|Double Blind Treatment|Progressive disease|3|||
156825514|NCT01271712|566113259|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
156825515|NCT01271712|566113260|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
156825516|NCT01271712|566113259|FG000|Double Blind Treatment|Non compliance with study drug|2|||
156825517|NCT01271712|566113260|FG001|Double Blind Treatment|Non compliance with study drug|0|||
156825518|NCT01271712|566113259|FG000|Double Blind Treatment|receive no study drug|1|||
156825519|NCT01271712|566113260|FG001|Double Blind Treatment|receive no study drug|0|||
156825520|NCT01271712|566113259|FG000|Open Label Treatment|Death|6|||
156825521|NCT01271712|566113260|FG001|Open Label Treatment|Death|5|||
156825522|NCT01271712|566113259|FG000|Open Label Treatment|Withdrawal by Subject|6|||
156825523|NCT01271712|566113260|FG001|Open Label Treatment|Withdrawal by Subject|11|||
156825524|NCT01271712|566113259|FG000|Open Label Treatment|Physician Decision|2|||
156825525|NCT01271712|566113260|FG001|Open Label Treatment|Physician Decision|0|||
156825526|NCT01271712|566113259|FG000|Open Label Treatment|Adverse Event|14|||
156825527|NCT01271712|566113260|FG001|Open Label Treatment|Adverse Event|8|||
156825528|NCT01271712|566113259|FG000|Open Label Treatment|Progressive disease|59|||
156825529|NCT01271712|566113260|FG001|Open Label Treatment|Progressive disease|32|||
156825530|NCT01271712|566113259|FG000|Open Label Treatment|transferred to rollover study|1|||
156825531|NCT01271712|566113260|FG001|Open Label Treatment|transferred to rollover study|0|||
156825532|NCT01271712|566113259|FG000|Open Label Treatment|Non-compliance with study drug|1|||
156825533|NCT01271712|566113260|FG001|Open Label Treatment|Non-compliance with study drug|0|||
156825534|NCT01271712|566113259|FG000|Open Label Treatment|Protocol Violation|0|||
156825535|NCT01271712|566113260|FG001|Open Label Treatment|Protocol Violation|1|||
156825536|NCT01271712|566113259|FG000|Open Label Treatment|Switching to other therapy|2|||
156825537|NCT01271712|566113260|FG001|Open Label Treatment|Switching to other therapy|1|||
156825538|NCT01271712|566113259|FG000|Safety Follow-up|Death|11|||
156825539|NCT01271712|566113260|FG001|Safety Follow-up|Death|7|||
156825540|NCT01271712|566113259|FG000|Safety Follow-up|Withdrawal by Subject|4|||
156825541|NCT01271712|566113260|FG001|Safety Follow-up|Withdrawal by Subject|2|||
156825542|NCT01271712|566113259|FG000|Safety Follow-up|Protocol Violation|1|||
156825543|NCT01271712|566113260|FG001|Safety Follow-up|Protocol Violation|1|||
156825544|NCT01271712|566113259|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
156825545|NCT01271712|566113260|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
156825546|NCT01271712|566113259|FG000|Safety Follow-up|No follow-up|1|||
156825547|NCT01271712|566113260|FG001|Safety Follow-up|No follow-up|1|||
156825548|NCT01271712|566113259|FG000|Safety Follow-up|Progressive disease|1|||
156825549|NCT01271712|566113260|FG001|Safety Follow-up|Progressive disease|0|||
156825550|NCT01271712|566113259|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
156825551|NCT01271712|566113260|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
156825552|NCT00096226|566113263|FG000|Overall Study|Ineligible|2|||
156825553|NCT00096226|566113263|FG000|Overall Study|Protocol treatment not started|1|||
156825554|NCT02780856|566113264|FG000|Overall Study|Lost to Follow-up|1|||
156825555|NCT03941964|566113271|FG000|Overall Study|Adverse Event|1|||
156825556|NCT03941964|566113272|FG001|Overall Study|Adverse Event|8|||
156825557|NCT03941964|566113271|FG000|Overall Study|Progressive disease|7|||
156825558|NCT03941964|566113272|FG001|Overall Study|Progressive disease|3|||
156825559|NCT03941964|566113271|FG000|Overall Study|Lack of Efficacy|0|||
156825560|NCT03941964|566113272|FG001|Overall Study|Lack of Efficacy|1|||
156825561|NCT03941964|566113271|FG000|Overall Study|Death|3|||
156825562|NCT03941964|566113272|FG001|Overall Study|Death|1|||
156825563|NCT03941964|566113271|FG000|Overall Study|Withdrew consent|1|||
156339304|NCT00404235|564340174|FG001|Overall Study|Withdrawal by Subject|2|||
156339305|NCT00679432|564340175|FG000|Overall Study|Adverse Event|5|||
156466159|NCT01637402|564803815|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
156466160|NCT01637402|564803816|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
156466161|NCT02285270|564803817|FG000|Overall Study|Lost to Follow-up|1|||
156466162|NCT02285270|564803817|FG000|Overall Study|Physician Decision|3|||
156466163|NCT02285270|564803817|FG000|Overall Study|Determined to be ineligible|1|||
156466164|NCT02111096|564803818|FG000|Overall Study|Adverse Event|4|||
156466165|NCT02111096|564803819|FG001|Overall Study|Adverse Event|1|||
156466166|NCT02111096|564803820|FG002|Overall Study|Adverse Event|2|||
156466167|NCT02111096|564803818|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156339306|NCT00679432|564340176|FG001|Overall Study|Adverse Event|6|||
156339307|NCT00679432|564340177|FG002|Overall Study|Adverse Event|10|||
156466168|NCT02111096|564803819|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156825564|NCT03941964|566113272|FG001|Overall Study|Withdrew consent|3|||
156825565|NCT03941964|566113271|FG000|Overall Study|Physician Decision|9|||
156825566|NCT03941964|566113272|FG001|Overall Study|Physician Decision|2|||
156825567|NCT03941964|566113271|FG000|Overall Study|Other, not specified|2|||
156825568|NCT03941964|566113272|FG001|Overall Study|Other, not specified|1|||
156825569|NCT03006458|566113273|FG000|First Intervention|Unsatisfied Vision|0|||
156825570|NCT03006458|566113274|FG001|First Intervention|Unsatisfied Vision|3|||
156825571|NCT00118846|566113276|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
156825572|NCT00118846|566113277|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
156825573|NCT00118846|566113276|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
156825574|NCT00118846|566113277|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
156825575|NCT00118846|566113276|FG000|Overall Study|Physician Decision|1|||
156825576|NCT00118846|566113277|FG001|Overall Study|Physician Decision|0|||
156825577|NCT00118846|566113276|FG000|Overall Study|Medical condition|2|||
156825578|NCT00118846|566113277|FG001|Overall Study|Medical condition|2|||
156825579|NCT00118846|566113276|FG000|Overall Study|Lost to Follow-up|0|||
156825580|NCT00118846|566113277|FG001|Overall Study|Lost to Follow-up|2|||
156825581|NCT00118846|566113276|FG000|Overall Study|Personal reason|4|||
156825582|NCT00118846|566113277|FG001|Overall Study|Personal reason|5|||
156825583|NCT01468233|566113278|FG000|Treatment Period 1|Adverse Event|5|||
156825584|NCT01468233|566113279|FG001|Treatment Period 1|Adverse Event|3|||
156825585|NCT01468233|566113280|FG002|Treatment Period 1|Adverse Event|0|||
156825586|NCT01468233|566113281|FG003|Treatment Period 1|Adverse Event|0|||
156825587|NCT01468233|566113282|FG004|Treatment Period 1|Adverse Event|0|||
156825588|NCT01468233|566113283|FG005|Treatment Period 1|Adverse Event|0|||
156825589|NCT01468233|566113278|FG000|Treatment Period 1|Withdrawal by Subject|3|||
156825590|NCT01468233|566113279|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156825591|NCT01468233|566113280|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156825592|NCT01468233|566113281|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156825593|NCT01468233|566113282|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156825594|NCT01468233|566113283|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156825595|NCT01468233|566113278|FG000|Treatment Period 1|Lost to Follow-up|3|||
156825596|NCT01468233|566113279|FG001|Treatment Period 1|Lost to Follow-up|0|||
156825597|NCT01468233|566113280|FG002|Treatment Period 1|Lost to Follow-up|0|||
156825598|NCT01468233|566113281|FG003|Treatment Period 1|Lost to Follow-up|0|||
156825599|NCT01468233|566113282|FG004|Treatment Period 1|Lost to Follow-up|0|||
156825600|NCT01468233|566113283|FG005|Treatment Period 1|Lost to Follow-up|0|||
156825601|NCT01468233|566113278|FG000|Treatment Period 1|Other|1|||
156825602|NCT01468233|566113279|FG001|Treatment Period 1|Other|1|||
156825603|NCT01468233|566113280|FG002|Treatment Period 1|Other|0|||
156825604|NCT01468233|566113281|FG003|Treatment Period 1|Other|0|||
156825605|NCT01468233|566113282|FG004|Treatment Period 1|Other|0|||
156825606|NCT01468233|566113283|FG005|Treatment Period 1|Other|0|||
156825607|NCT01468233|566113278|FG000|Treatment Period 2|Adverse Event|0|||
156825608|NCT01468233|566113279|FG001|Treatment Period 2|Adverse Event|0|||
156825609|NCT01468233|566113280|FG002|Treatment Period 2|Adverse Event|3|||
156825610|NCT01468233|566113281|FG003|Treatment Period 2|Adverse Event|0|||
156825611|NCT01468233|566113282|FG004|Treatment Period 2|Adverse Event|2|||
156825612|NCT01468233|566113283|FG005|Treatment Period 2|Adverse Event|1|||
156825613|NCT01468233|566113278|FG000|Treatment Period 2|Lack of Efficacy|0|||
156825614|NCT01468233|566113279|FG001|Treatment Period 2|Lack of Efficacy|0|||
156825615|NCT01468233|566113280|FG002|Treatment Period 2|Lack of Efficacy|9|||
156825616|NCT01468233|566113281|FG003|Treatment Period 2|Lack of Efficacy|2|||
156825617|NCT01468233|566113282|FG004|Treatment Period 2|Lack of Efficacy|0|||
156825618|NCT01468233|566113283|FG005|Treatment Period 2|Lack of Efficacy|1|||
156825619|NCT01468233|566113278|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156825620|NCT01468233|566113279|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156825621|NCT01468233|566113280|FG002|Treatment Period 2|Withdrawal by Subject|9|||
156825622|NCT01468233|566113281|FG003|Treatment Period 2|Withdrawal by Subject|1|||
156825623|NCT01468233|566113282|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156825624|NCT01468233|566113283|FG005|Treatment Period 2|Withdrawal by Subject|1|||
156825625|NCT01468233|566113278|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
156825626|NCT01468233|566113279|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
156339308|NCT00679432|564340178|FG003|Overall Study|Adverse Event|7|||
156466169|NCT02111096|564803820|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156466170|NCT02111096|564803818|FG000|Overall Study|Lost to Follow Up|1|||
156466171|NCT02111096|564803819|FG001|Overall Study|Lost to Follow Up|1|||
156466172|NCT02111096|564803820|FG002|Overall Study|Lost to Follow Up|1|||
156466173|NCT02111096|564803818|FG000|Overall Study|Physician Decision|0|||
156825627|NCT01468233|566113280|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
156825628|NCT01468233|566113281|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
156825629|NCT01468233|566113282|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
156339309|NCT00679432|564340175|FG000|Overall Study|Protocol Violation|1|||
156466174|NCT02111096|564803819|FG001|Overall Study|Physician Decision|1|||
156466175|NCT02111096|564803820|FG002|Overall Study|Physician Decision|0|||
156466176|NCT02111096|564803818|FG000|Overall Study|Protocol Violation|1|||
156825630|NCT01468233|566113283|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
156825631|NCT01468233|566113278|FG000|Treatment Period 2|Lost to Follow-up|0|||
156825632|NCT01468233|566113279|FG001|Treatment Period 2|Lost to Follow-up|0|||
156825633|NCT01468233|566113280|FG002|Treatment Period 2|Lost to Follow-up|3|||
156825634|NCT01468233|566113281|FG003|Treatment Period 2|Lost to Follow-up|0|||
156825635|NCT01468233|566113282|FG004|Treatment Period 2|Lost to Follow-up|2|||
156825636|NCT01468233|566113283|FG005|Treatment Period 2|Lost to Follow-up|0|||
156825637|NCT01468233|566113278|FG000|Treatment Period 2|Other|0|||
156825638|NCT01468233|566113279|FG001|Treatment Period 2|Other|0|||
156825639|NCT01468233|566113280|FG002|Treatment Period 2|Other|3|||
156825640|NCT01468233|566113281|FG003|Treatment Period 2|Other|0|||
156825641|NCT01468233|566113282|FG004|Treatment Period 2|Other|1|||
156825642|NCT01468233|566113283|FG005|Treatment Period 2|Other|0|||
156825643|NCT01574157|566113284|FG000|Overall Study|Withdrawal by Subject|4|||
156825644|NCT01574157|566113285|FG001|Overall Study|Withdrawal by Subject|5|||
156825645|NCT01574157|566113284|FG000|Overall Study|Lost to Follow-up|0|||
156825646|NCT01574157|566113285|FG001|Overall Study|Lost to Follow-up|3|||
156825647|NCT02437409|566113295|FG000|Overall Study|Withdrawal by Subject|3|||
156825648|NCT02437409|566113295|FG000|Overall Study|Screening failure|12|||
156825649|NCT01944098|566113296|FG000|Overall Study|Physician Decision|1|||
156825650|NCT01944098|566113297|FG001|Overall Study|Physician Decision|0|||
156825651|NCT04669262|566113307|FG000|Overall Study|Withdrawal by Subject|0|||
156825652|NCT04669262|566113308|FG001|Overall Study|Withdrawal by Subject|0|||
156825653|NCT04669262|566113309|FG002|Overall Study|Withdrawal by Subject|0|||
156825654|NCT04669262|566113310|FG003|Overall Study|Withdrawal by Subject|1|||
156825655|NCT04669262|566113307|FG000|Overall Study|Randomized but Not Treated|0|||
156825656|NCT04669262|566113308|FG001|Overall Study|Randomized but Not Treated|1|||
156825657|NCT04669262|566113309|FG002|Overall Study|Randomized but Not Treated|0|||
156825658|NCT04669262|566113310|FG003|Overall Study|Randomized but Not Treated|0|||
156825659|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
156825660|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
156825661|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
156825662|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
156825663|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
156825664|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
156825665|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
156825666|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
156825667|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
156825668|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
156825669|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
156825670|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
156825671|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
156825672|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
156825673|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
156825674|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
156825675|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
156825676|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
156825677|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
156825678|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
156825679|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
156825680|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
156825681|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
156825682|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
156825683|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
156825684|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
156825685|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
156825686|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
156825687|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
156825688|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
156825689|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
156825690|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
156825691|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
156825692|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
156825693|NCT00737568|566113317|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
156825694|NCT00737568|566113318|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
156825695|NCT00737568|566113317|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
156825696|NCT00737568|566113318|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
156825697|NCT00737568|566113317|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
156825698|NCT00737568|566113318|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
156825699|NCT01133626|566113319|FG000|Overall Study|Adverse Event|0|||
156825700|NCT01133626|566113320|FG001|Overall Study|Adverse Event|1|||
156825701|NCT01133626|566113321|FG002|Overall Study|Adverse Event|0|||
156825702|NCT01133626|566113319|FG000|Overall Study|Withdrawal by Subject|1|||
156825703|NCT01133626|566113320|FG001|Overall Study|Withdrawal by Subject|2|||
156825704|NCT01133626|566113321|FG002|Overall Study|Withdrawal by Subject|2|||
156466177|NCT02111096|564803819|FG001|Overall Study|Protocol Violation|0|||
156466178|NCT02111096|564803820|FG002|Overall Study|Protocol Violation|1|||
156466179|NCT02111096|564803818|FG000|Overall Study|Terminated by Sponsor|53|||
156466180|NCT02111096|564803819|FG001|Overall Study|Terminated by Sponsor|35|||
156825705|NCT01133626|566113319|FG000|Overall Study|Other|0|||
156825706|NCT01133626|566113320|FG001|Overall Study|Other|2|||
156825707|NCT01133626|566113321|FG002|Overall Study|Other|0|||
156825708|NCT00855933|566113322|FG000|Overall Study|Withdrawal by Subject|0|||
156825709|NCT00855933|566113323|FG001|Overall Study|Withdrawal by Subject|1|||
156825710|NCT00951080|566113324|FG000|Overall Study|Adverse Event|3|||
156825711|NCT00951080|566113325|FG001|Overall Study|Adverse Event|3|||
156825712|NCT00951080|566113324|FG000|Overall Study|Lost to Follow-up|0|||
156825713|NCT00951080|566113325|FG001|Overall Study|Lost to Follow-up|1|||
156825714|NCT00951080|566113324|FG000|Overall Study|Physician Decision|4|||
156825715|NCT00951080|566113325|FG001|Overall Study|Physician Decision|1|||
156825716|NCT00951080|566113324|FG000|Overall Study|Other|19|||
156825717|NCT00951080|566113325|FG001|Overall Study|Other|22|||
156825718|NCT05463744|566113326|FG000|Treatment Period|Withdrawal by Subject|19|||
156825719|NCT05463744|566113327|FG001|Treatment Period|Withdrawal by Subject|16|||
156825720|NCT05463744|566113326|FG000|Treatment Period|Adverse Event|4|||
156825721|NCT05463744|566113327|FG001|Treatment Period|Adverse Event|4|||
156825722|NCT05463744|566113326|FG000|Treatment Period|Pregnancy|0|||
156825723|NCT05463744|566113327|FG001|Treatment Period|Pregnancy|3|||
156825724|NCT05463744|566113326|FG000|Treatment Period|Lost to Follow-up|1|||
156825725|NCT05463744|566113327|FG001|Treatment Period|Lost to Follow-up|3|||
156825726|NCT05463744|566113326|FG000|Treatment Period|Inadvertent enrollment|2|||
156825727|NCT05463744|566113327|FG001|Treatment Period|Inadvertent enrollment|1|||
156825728|NCT05463744|566113326|FG000|Treatment Period|Death|0|||
156825729|NCT05463744|566113327|FG001|Treatment Period|Death|1|||
156825730|NCT05463744|566113326|FG000|Treatment Period|Non-compliance with Study Drug|1|||
156825731|NCT05463744|566113327|FG001|Treatment Period|Non-compliance with Study Drug|0|||
156825732|NCT05463744|566113326|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
156466181|NCT02111096|564803820|FG002|Overall Study|Terminated by Sponsor|54|||
156825733|NCT05463744|566113327|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
156825734|NCT05463744|566113326|FG000|Treatment Period|Physician Decision|0|||
156825735|NCT05463744|566113327|FG001|Treatment Period|Physician Decision|1|||
156825736|NCT05463744|566113326|FG000|Follow-Up Period|Withdrawal by Subject|3|||
156825737|NCT05463744|566113327|FG001|Follow-Up Period|Withdrawal by Subject|1|||
156825738|NCT05463744|566113326|FG000|Follow-Up Period|Lost to Follow-up|1|||
156466182|NCT02111096|564803818|FG000|Overall Study|Withdrawal by Subject|4|||
156825739|NCT05463744|566113327|FG001|Follow-Up Period|Lost to Follow-up|1|||
156339310|NCT00679432|564340176|FG001|Overall Study|Protocol Violation|1|||
156825740|NCT01960998|566113328|FG000|Overall Study|Lost to Follow-up|3|||
156825741|NCT01960998|566113329|FG001|Overall Study|Lost to Follow-up|7|||
156825742|NCT01960998|566113328|FG000|Overall Study|Death|0|||
156825743|NCT01960998|566113329|FG001|Overall Study|Death|1|||
156825744|NCT01960998|566113328|FG000|Overall Study|Withdrawal by Subject|8|||
156825745|NCT01960998|566113329|FG001|Overall Study|Withdrawal by Subject|2|||
156825746|NCT01960998|566113328|FG000|Overall Study|lost computer access|0|||
156825747|NCT01960998|566113329|FG001|Overall Study|lost computer access|1|||
156825748|NCT02439450|566113337|FG000|Overall Study|Adverse Event|4|||
156825749|NCT02439450|566113338|FG001|Overall Study|Adverse Event|1|||
156825750|NCT02439450|566113339|FG002|Overall Study|Adverse Event|0|||
156825751|NCT02439450|566113340|FG003|Overall Study|Adverse Event|0|||
156825752|NCT02439450|566113337|FG000|Overall Study|Withdrawal by Subject|1|||
156825753|NCT02439450|566113338|FG001|Overall Study|Withdrawal by Subject|2|||
156825754|NCT02439450|566113339|FG002|Overall Study|Withdrawal by Subject|0|||
156825755|NCT02439450|566113340|FG003|Overall Study|Withdrawal by Subject|0|||
156825756|NCT02439450|566113337|FG000|Overall Study|Death|3|||
156825757|NCT02439450|566113338|FG001|Overall Study|Death|0|||
156825758|NCT02439450|566113339|FG002|Overall Study|Death|0|||
156825759|NCT02439450|566113340|FG003|Overall Study|Death|1|||
156825760|NCT02439450|566113337|FG000|Overall Study|Progressive Disease|18|||
156825761|NCT02439450|566113338|FG001|Overall Study|Progressive Disease|41|||
156825762|NCT02439450|566113339|FG002|Overall Study|Progressive Disease|2|||
156825763|NCT02439450|566113340|FG003|Overall Study|Progressive Disease|3|||
156825764|NCT04508751|566113345|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
156825765|NCT04508751|566113346|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
156825766|NCT04508751|566113347|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
156825767|NCT03551665|566113350|FG000|Overall Study|Lost to Follow-up|11|||
156825768|NCT03551665|566113351|FG001|Overall Study|Lost to Follow-up|2|||
156825769|NCT00445939|566114316|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
156825770|NCT00445939|566114317|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
156825771|NCT00445939|566114318|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
156825772|NCT00445939|566114319|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
156825773|NCT00445939|566114316|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
156825774|NCT00445939|566114317|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
156825775|NCT00445939|566114318|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
156825776|NCT00445939|566114319|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
156825777|NCT00919867|566114320|FG000|First Intervention|Withdrawal by Subject|0|||
156825778|NCT00919867|566114321|FG001|First Intervention|Withdrawal by Subject|0|||
156825779|NCT00919867|566114322|FG002|First Intervention|Withdrawal by Subject|1|||
156825780|NCT00919867|566114323|FG003|First Intervention|Withdrawal by Subject|0|||
156825781|NCT00919867|566114324|FG004|First Intervention|Withdrawal by Subject|0|||
156825782|NCT00919867|566114325|FG005|First Intervention|Withdrawal by Subject|0|||
156825783|NCT00919867|566114320|FG000|First Intervention|Physician Decision|0|||
156825784|NCT00919867|566114321|FG001|First Intervention|Physician Decision|0|||
156825785|NCT00919867|566114322|FG002|First Intervention|Physician Decision|0|||
156825786|NCT00919867|566114323|FG003|First Intervention|Physician Decision|0|||
156825787|NCT00919867|566114324|FG004|First Intervention|Physician Decision|0|||
156825788|NCT00919867|566114325|FG005|First Intervention|Physician Decision|1|||
156825789|NCT03555981|566114334|FG000|Overall Study|Lost to Follow-up|0|||
156825790|NCT03555981|566114335|FG001|Overall Study|Lost to Follow-up|2|||
156825791|NCT00354107|566114338|FG000|Overall Study|Adverse Event|2|||
156825792|NCT00354107|566114338|FG000|Overall Study|Physician Decision|2|||
156825793|NCT00354107|566114338|FG000|Overall Study|Withdrawal by Subject|1|||
156825794|NCT03361189|566114344|FG000|Overall Study|Received heart transplant|1|||
156825795|NCT03361189|566114345|FG001|Overall Study|Received heart transplant|0|||
156825796|NCT03361189|566114344|FG000|Overall Study|Pacemake replacement|0|||
156825797|NCT03361189|566114345|FG001|Overall Study|Pacemake replacement|1|||
156825798|NCT03344549|566114346|FG000|Overall Study|Withdrawal by Subject|3|||
156825799|NCT03344549|566114347|FG001|Overall Study|Withdrawal by Subject|2|||
156825800|NCT03344549|566114346|FG000|Overall Study|Dialysis|2|||
156825801|NCT03344549|566114347|FG001|Overall Study|Dialysis|0|||
156825802|NCT03344549|566114346|FG000|Overall Study|Cancer|1|||
156825803|NCT03344549|566114347|FG001|Overall Study|Cancer|0|||
156825804|NCT03344549|566114346|FG000|Overall Study|Lack of electronic device|1|||
156825805|NCT03344549|566114347|FG001|Overall Study|Lack of electronic device|0|||
156825806|NCT03344549|566114346|FG000|Overall Study|Transportation difficulty|0|||
156825807|NCT03344549|566114347|FG001|Overall Study|Transportation difficulty|13|||
156825808|NCT03333252|566114348|FG000|Overall Study|Adverse Event|10|||
156825809|NCT03333252|566114349|FG001|Overall Study|Adverse Event|6|||
156825810|NCT03333252|566114350|FG002|Overall Study|Adverse Event|5|||
156825811|NCT03333252|566114351|FG003|Overall Study|Adverse Event|2|||
156825812|NCT03333252|566114348|FG000|Overall Study|Death|1|||
156825813|NCT03333252|566114349|FG001|Overall Study|Death|3|||
156825814|NCT03333252|566114350|FG002|Overall Study|Death|0|||
156825815|NCT03333252|566114351|FG003|Overall Study|Death|0|||
156825816|NCT03333252|566114348|FG000|Overall Study|Lack of Efficacy|8|||
156825817|NCT03333252|566114349|FG001|Overall Study|Lack of Efficacy|4|||
156825818|NCT03333252|566114350|FG002|Overall Study|Lack of Efficacy|0|||
156825819|NCT03333252|566114351|FG003|Overall Study|Lack of Efficacy|7|||
156825820|NCT03333252|566114348|FG000|Overall Study|Lost to Follow-up|0|||
156825821|NCT03333252|566114349|FG001|Overall Study|Lost to Follow-up|5|||
156825822|NCT03333252|566114350|FG002|Overall Study|Lost to Follow-up|9|||
156825823|NCT03333252|566114351|FG003|Overall Study|Lost to Follow-up|3|||
156825824|NCT03333252|566114348|FG000|Overall Study|Withdrawal by Subject|14|||
156825825|NCT03333252|566114349|FG001|Overall Study|Withdrawal by Subject|24|||
156825826|NCT03333252|566114350|FG002|Overall Study|Withdrawal by Subject|11|||
156825827|NCT03333252|566114351|FG003|Overall Study|Withdrawal by Subject|17|||
156825828|NCT01685801|566114357|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
156825829|NCT01685801|566114358|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
156825830|NCT01685801|566114359|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
156825831|NCT01685801|566114360|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
156825832|NCT01685801|566114357|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
156825833|NCT01685801|566114358|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
156825834|NCT01685801|566114359|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
156825835|NCT01685801|566114360|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
156825836|NCT00113399|566114361|FG000|Overall Study|Death|1|||
156825837|NCT00113399|566114362|FG001|Overall Study|Death|1|||
156825838|NCT00113399|566114361|FG000|Overall Study|Withdrawal by Subject|1|||
156825839|NCT00113399|566114362|FG001|Overall Study|Withdrawal by Subject|2|||
156825840|NCT00113399|566114361|FG000|Overall Study|Complete Response|0|||
156825841|NCT00113399|566114362|FG001|Overall Study|Complete Response|1|||
156825842|NCT00113399|566114361|FG000|Overall Study|Other|0|||
156825843|NCT00113399|566114362|FG001|Overall Study|Other|1|||
156825844|NCT00666588|566114363|FG000|Overall Study|ineligible|2|||
156825845|NCT00666588|566114364|FG001|Overall Study|ineligible|0|||
156825846|NCT00666588|566114365|FG002|Overall Study|ineligible|0|||
156825847|NCT00666588|566114366|FG003|Overall Study|ineligible|2|||
156825848|NCT00666588|566114363|FG000|Overall Study|inevaluable|2|||
156825849|NCT00666588|566114364|FG001|Overall Study|inevaluable|0|||
156825850|NCT00666588|566114365|FG002|Overall Study|inevaluable|0|||
156825851|NCT00666588|566114366|FG003|Overall Study|inevaluable|0|||
156825852|NCT02781792|566114370|FG000|Overall Study|Adverse Event|1|||
156825853|NCT02781792|566114371|FG001|Overall Study|Adverse Event|2|||
156825854|NCT02781792|566114370|FG000|Overall Study|Withdrawal by Subject|3|||
156825855|NCT02781792|566114371|FG001|Overall Study|Withdrawal by Subject|1|||
156825856|NCT02781792|566114370|FG000|Overall Study|Lack of Efficacy|1|||
156825857|NCT02781792|566114371|FG001|Overall Study|Lack of Efficacy|1|||
156825858|NCT02781792|566114370|FG000|Overall Study|Hospice|0|||
156825859|NCT02781792|566114371|FG001|Overall Study|Hospice|1|||
156825860|NCT04600076|566114372|FG000|Overall Study|Lost to Follow-up|3|||
156825861|NCT00457821|566114373|FG000|Part 2|Withdrawal by Subject|0|||
156825862|NCT00457821|566114374|FG001|Part 2|Withdrawal by Subject|0|||
156825863|NCT00457821|566114375|FG002|Part 2|Withdrawal by Subject|0|||
156825864|NCT00457821|566114376|FG003|Part 2|Withdrawal by Subject|0|||
156825865|NCT00457821|566114377|FG004|Part 2|Withdrawal by Subject|0|||
156825866|NCT00457821|566114378|FG005|Part 2|Withdrawal by Subject|0|||
156825867|NCT00457821|566114379|FG006|Part 2|Withdrawal by Subject|0|||
156825868|NCT00457821|566114380|FG007|Part 2|Withdrawal by Subject|1|||
156825869|NCT00790647|566114383|FG000|Overall Study|Adverse Event|1|||
156825870|NCT00027378|566114384|FG000|Overall Study|Physician Decision|0|||
156825871|NCT00027378|566114385|FG001|Overall Study|Physician Decision|3|||
156825872|NCT02851407|566114390|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156825873|NCT02851407|566114391|FG001|Overall Study|Withdrawal by parent/guardian|7|||
156825874|NCT02851407|566114390|FG000|Overall Study|Protocol deviation|0|||
156825875|NCT02851407|566114391|FG001|Overall Study|Protocol deviation|1|||
156825876|NCT02851407|566114390|FG000|Overall Study|Transferred to another hospital to continue|1|||
156825877|NCT02851407|566114391|FG001|Overall Study|Transferred to another hospital to continue|0|||
156825878|NCT02851407|566114390|FG000|Overall Study|Other Death|30|||
156825879|NCT02851407|566114391|FG001|Overall Study|Other Death|20|||
156825880|NCT02851407|566114390|FG000|Overall Study|Adverse event, serious fatal|6|||
156825881|NCT02851407|566114391|FG001|Overall Study|Adverse event, serious fatal|8|||
156825882|NCT02851407|566114390|FG000|Overall Study|Consent withdrawn by participant|5|||
156825883|NCT02851407|566114391|FG001|Overall Study|Consent withdrawn by participant|3|||
156825884|NCT02851407|566114390|FG000|Overall Study|Screen failure|2|||
156825885|NCT02851407|566114391|FG001|Overall Study|Screen failure|1|||
156825886|NCT02851407|566114390|FG000|Overall Study|Disease relapse|9|||
156825887|NCT02851407|566114391|FG001|Overall Study|Disease relapse|6|||
156825888|NCT02851407|566114390|FG000|Overall Study|Physician Decision|7|||
156825889|NCT02851407|566114391|FG001|Overall Study|Physician Decision|6|||
156825890|NCT02851407|566114390|FG000|Overall Study|Transferred to hospital closer to home|0|||
156825891|NCT02851407|566114391|FG001|Overall Study|Transferred to hospital closer to home|1|||
156825892|NCT02851407|566114390|FG000|Overall Study|Enrolled in an investigational study|0|||
156825893|NCT02851407|566114391|FG001|Overall Study|Enrolled in an investigational study|1|||
156825894|NCT02851407|566114390|FG000|Overall Study|Early recovery|1|||
156825895|NCT02851407|566114391|FG001|Overall Study|Early recovery|0|||
156825896|NCT02851407|566114390|FG000|Overall Study|Adverse event, non-fatal|7|||
156825897|NCT02851407|566114391|FG001|Overall Study|Adverse event, non-fatal|5|||
156825898|NCT02851407|566114390|FG000|Overall Study|Lost to Follow-up|0|||
156825899|NCT02851407|566114391|FG001|Overall Study|Lost to Follow-up|2|||
156825900|NCT01713283|566114395|FG000|Overall Study|Lack of Efficacy|10|||
156825901|NCT01713283|566114396|FG001|Overall Study|Lack of Efficacy|2|||
156825902|NCT01713283|566114395|FG000|Overall Study|Lost to Follow-up|1|||
156825903|NCT01713283|566114396|FG001|Overall Study|Lost to Follow-up|1|||
156825904|NCT02585830|566114397|FG000|Overall Study|Withdrawal by Subject|3|||
156825905|NCT00835640|566114398|FG000|Second Intervention|Protocol Violation|1|||
156825906|NCT00835640|566114399|FG001|Second Intervention|Protocol Violation|0|||
156825907|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
156825908|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
156825909|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Death|1|||
156825910|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Death|0|||
156825911|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
156825912|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
156825913|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
156825914|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
156825915|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
156825916|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
156825917|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
156825918|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
156825919|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
156825920|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
156825921|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
156825922|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
156825923|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
156825924|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
156825925|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
156825926|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
156825927|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
156825928|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
156825929|NCT00068250|566114402|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
156825930|NCT00068250|566114403|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
156825931|NCT00068250|566114404|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
156825932|NCT00068250|566114405|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
156825933|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Death|5|||
156825934|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Death|0|||
156825935|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Death|0|||
156825936|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
156825937|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
156825938|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
156825939|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
156825940|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
156825941|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
156825942|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
156825943|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
156825944|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
156825945|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
156825946|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
156825947|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
156825948|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
156825949|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
156825950|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
156825951|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
156825952|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
156825953|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
156825954|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
156825955|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
156825956|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
156825957|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
156825958|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
156825959|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
156825960|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
156825961|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
156825962|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
156825963|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
156825964|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
156825965|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
156825966|NCT00235391|566114409|FG000|Overall Study|Adverse Event|4|||
156825967|NCT00235391|566114410|FG001|Overall Study|Adverse Event|5|||
156825968|NCT00235391|566114411|FG002|Overall Study|Adverse Event|10|||
156825969|NCT00235391|566114412|FG003|Overall Study|Adverse Event|72|||
156825970|NCT00235391|566114413|FG004|Overall Study|Adverse Event|5|||
156825971|NCT00235391|566114414|FG005|Overall Study|Adverse Event|2|||
156825972|NCT00235391|566114409|FG000|Overall Study|Abnormal laboratory value(s)|3|||
156825973|NCT00235391|566114410|FG001|Overall Study|Abnormal laboratory value(s)|5|||
156825974|NCT00235391|566114411|FG002|Overall Study|Abnormal laboratory value(s)|4|||
156825975|NCT00235391|566114412|FG003|Overall Study|Abnormal laboratory value(s)|27|||
156825976|NCT00235391|566114413|FG004|Overall Study|Abnormal laboratory value(s)|1|||
156825977|NCT00235391|566114414|FG005|Overall Study|Abnormal laboratory value(s)|2|||
156825978|NCT00235391|566114409|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156825979|NCT00235391|566114410|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156825980|NCT00235391|566114411|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156825981|NCT00235391|566114412|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
156825982|NCT00235391|566114413|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
156825983|NCT00235391|566114414|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
156825984|NCT00235391|566114409|FG000|Overall Study|Condition no longer requires treatment|3|||
156825985|NCT00235391|566114410|FG001|Overall Study|Condition no longer requires treatment|0|||
156825986|NCT00235391|566114411|FG002|Overall Study|Condition no longer requires treatment|0|||
156825987|NCT00235391|566114412|FG003|Overall Study|Condition no longer requires treatment|11|||
156825988|NCT00235391|566114413|FG004|Overall Study|Condition no longer requires treatment|1|||
156825989|NCT00235391|566114414|FG005|Overall Study|Condition no longer requires treatment|0|||
156825990|NCT00235391|566114409|FG000|Overall Study|Protocol deviation|0|||
156825991|NCT00235391|566114410|FG001|Overall Study|Protocol deviation|0|||
156825992|NCT00235391|566114411|FG002|Overall Study|Protocol deviation|1|||
156825993|NCT00235391|566114412|FG003|Overall Study|Protocol deviation|11|||
156825994|NCT00235391|566114413|FG004|Overall Study|Protocol deviation|0|||
156825995|NCT00235391|566114414|FG005|Overall Study|Protocol deviation|0|||
156825996|NCT00235391|566114409|FG000|Overall Study|Withdrawal by Subject|2|||
156825997|NCT00235391|566114410|FG001|Overall Study|Withdrawal by Subject|3|||
156825998|NCT00235391|566114411|FG002|Overall Study|Withdrawal by Subject|3|||
156541205|NCT00573430|565074507|FG000|Overall Study|Incorrect enrollment of randomization|0|||
156825999|NCT00235391|566114412|FG003|Overall Study|Withdrawal by Subject|61|||
156826000|NCT00235391|566114413|FG004|Overall Study|Withdrawal by Subject|5|||
156826001|NCT00235391|566114414|FG005|Overall Study|Withdrawal by Subject|0|||
156826002|NCT00235391|566114409|FG000|Overall Study|Lost to Follow-up|0|||
156826003|NCT00235391|566114410|FG001|Overall Study|Lost to Follow-up|3|||
156826004|NCT00235391|566114411|FG002|Overall Study|Lost to Follow-up|3|||
156826005|NCT00235391|566114412|FG003|Overall Study|Lost to Follow-up|16|||
156826006|NCT00235391|566114413|FG004|Overall Study|Lost to Follow-up|0|||
156826007|NCT00235391|566114414|FG005|Overall Study|Lost to Follow-up|0|||
156826008|NCT00235391|566114409|FG000|Overall Study|Administrative problems|0|||
156826009|NCT00235391|566114410|FG001|Overall Study|Administrative problems|0|||
156826010|NCT00235391|566114411|FG002|Overall Study|Administrative problems|0|||
156826011|NCT00235391|566114412|FG003|Overall Study|Administrative problems|1|||
156826012|NCT00235391|566114413|FG004|Overall Study|Administrative problems|0|||
156826013|NCT00235391|566114414|FG005|Overall Study|Administrative problems|0|||
156826014|NCT00235391|566114409|FG000|Overall Study|Death|0|||
156826015|NCT00235391|566114410|FG001|Overall Study|Death|0|||
156826016|NCT00235391|566114411|FG002|Overall Study|Death|1|||
156826017|NCT00235391|566114412|FG003|Overall Study|Death|4|||
156826018|NCT00235391|566114413|FG004|Overall Study|Death|0|||
156826019|NCT00235391|566114414|FG005|Overall Study|Death|0|||
156826020|NCT01824823|566114415|FG000|Overall Study|Lack of Efficacy|1|||
156826021|NCT01824823|566114416|FG001|Overall Study|Lack of Efficacy|1|||
156826022|NCT01824823|566114415|FG000|Overall Study|Off-treatment reason not submitted|1|||
156826023|NCT01824823|566114416|FG001|Overall Study|Off-treatment reason not submitted|0|||
156826024|NCT03349645|566114417|FG000|Overall Study|Sponsor Terminated Study|75|||
156826025|NCT03349645|566114417|FG000|Overall Study|Withdrawal by Subject|4|||
156826026|NCT03349645|566114417|FG000|Overall Study|Protocol Violation|1|||
156826027|NCT03349645|566114417|FG000|Overall Study|Other|2|||
156826028|NCT01080768|566114427|FG000|Overall Study|Protocol Deviation|2|||
156826029|NCT01080768|566114428|FG001|Overall Study|Protocol Deviation|1|||
156826030|NCT03510468|566114429|FG000|Overall Study|Lost to Follow-up|1|||
156826031|NCT03510468|566114429|FG000|Overall Study|Adverse Event|5|||
156826032|NCT03510468|566114429|FG000|Overall Study|Physician Decision|1|||
156826033|NCT03510468|566114429|FG000|Overall Study|non-compliant with treatment|2|||
156826034|NCT03510468|566114429|FG000|Overall Study|Missed visit|1|||
156826035|NCT03730961|566114431|FG000|Overall Study|Adverse Event|0|||
156826036|NCT03730961|566114432|FG001|Overall Study|Adverse Event|1|||
156826037|NCT00840060|566116082|FG000|Overall Study|Withdrawal by Subject|1|||
156826038|NCT00840060|566116083|FG001|Overall Study|Withdrawal by Subject|0|||
156826039|NCT00840060|566116082|FG000|Overall Study|Change in emotional/behavioral status|0|||
156826040|NCT00840060|566116083|FG001|Overall Study|Change in emotional/behavioral status|1|||
156826041|NCT00428220|566116084|FG000|Overall Study|Participant died|8|||
156826042|NCT00428220|566116084|FG000|Overall Study|Global deterioration of health status|7|||
156826043|NCT00428220|566116084|FG000|Overall Study|Lost to Follow-up|4|||
156826044|NCT00428220|566116084|FG000|Overall Study|Objective progression or relapse|123|||
156826045|NCT00428220|566116084|FG000|Overall Study|Participant refused continued treatment|7|||
156826046|NCT00428220|566116084|FG000|Overall Study|Adverse Event|51|||
156826047|NCT00428220|566116084|FG000|Overall Study|Other|23|||
156826048|NCT00509093|566116085|FG000|Overall Study|Adverse Event|10|||
156826049|NCT00509093|566116085|FG000|Overall Study|Disease Progression|9|||
156826050|NCT00509093|566116085|FG000|Overall Study|Transformed into MDS|1|||
156826051|NCT00509093|566116085|FG000|Overall Study|Withdrawal by Subject|3|||
156826052|NCT00509093|566116085|FG000|Overall Study|Physician Decision|1|||
156826053|NCT01103063|566116086|FG000|Overall Study|Adverse Event|3|||
156826054|NCT01103063|566116087|FG001|Overall Study|Adverse Event|1|||
156826055|NCT01103063|566116086|FG000|Overall Study|Lost to Follow-up|68|||
156826056|NCT01103063|566116087|FG001|Overall Study|Lost to Follow-up|51|||
156826057|NCT01103063|566116086|FG000|Overall Study|Withdrawal by Subject|60|||
156826058|NCT01103063|566116087|FG001|Overall Study|Withdrawal by Subject|15|||
156826059|NCT01103063|566116086|FG000|Overall Study|Other|16|||
156826060|NCT01103063|566116087|FG001|Overall Study|Other|11|||
156826061|NCT01103063|566116086|FG000|Overall Study|Protocol Violation|1|||
156826062|NCT01103063|566116087|FG001|Overall Study|Protocol Violation|0|||
156826063|NCT01103063|566116086|FG000|Overall Study|Study terminated by Sponsor|326|||
156826064|NCT01103063|566116087|FG001|Overall Study|Study terminated by Sponsor|342|||
156826065|NCT01103063|566116086|FG000|Overall Study|Death|3|||
156826066|NCT01103063|566116087|FG001|Overall Study|Death|1|||
156826067|NCT04143217|566116094|FG000|Overall Study|Withdrawal by Subject|42|||
156826068|NCT04143217|566116094|FG000|Overall Study|Adverse Event|29|||
156826069|NCT04143217|566116094|FG000|Overall Study|Lost to Follow-up|29|||
156826070|NCT04143217|566116094|FG000|Overall Study|Lack of Efficacy|15|||
156826071|NCT04143217|566116094|FG000|Overall Study|Physician Decision|1|||
156826072|NCT04143217|566116094|FG000|Overall Study|Non-Compliance With Study Drug|6|||
156826073|NCT04143217|566116094|FG000|Overall Study|Other, Multiple Categories|11|||
156826074|NCT02210832|566116097|FG000|Overall Study|Pregnancy termination .|3|||
156826075|NCT02210832|566116098|FG001|Overall Study|Pregnancy termination .|4|||
156826076|NCT02210832|566116099|FG002|Overall Study|Pregnancy termination .|1|||
156826077|NCT02210832|566116097|FG000|Overall Study|Lost to Follow-up|26|||
156826078|NCT02210832|566116098|FG001|Overall Study|Lost to Follow-up|32|||
156826079|NCT02210832|566116099|FG002|Overall Study|Lost to Follow-up|17|||
156826080|NCT00798317|566116107|FG000|Overall Study|Physician Decision|0|||
156466183|NCT02111096|564803819|FG001|Overall Study|Withdrawal by Subject|2|||
156466184|NCT02111096|564803820|FG002|Overall Study|Withdrawal by Subject|8|||
156466185|NCT00439270|564803823|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
156466186|NCT00439270|564803824|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
156466187|NCT00439270|564803825|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
156826081|NCT00798317|566116108|FG001|Overall Study|Physician Decision|1|||
156826082|NCT00798317|566116107|FG000|Overall Study|Withdrawal by Subject|5|||
156826083|NCT00798317|566116108|FG001|Overall Study|Withdrawal by Subject|4|||
156826084|NCT00798317|566116107|FG000|Overall Study|Lost to Follow-up|2|||
156826085|NCT00798317|566116108|FG001|Overall Study|Lost to Follow-up|2|||
156826086|NCT00798317|566116107|FG000|Overall Study|Adverse Event|2|||
156826087|NCT00798317|566116108|FG001|Overall Study|Adverse Event|0|||
156826088|NCT00798317|566116107|FG000|Overall Study|Death|1|||
156826089|NCT00798317|566116108|FG001|Overall Study|Death|0|||
156826090|NCT03405935|566116111|FG000|Overall Study|Adverse Event|3|||
156826091|NCT03405935|566116111|FG000|Overall Study|Death|2|||
156826092|NCT03405935|566116111|FG000|Overall Study|Withdrawal by Subject|1|||
156826093|NCT03405935|566116111|FG000|Overall Study|Lost to Follow-up|2|||
156826094|NCT04979897|566116112|FG000|Overall Study|Death|1|||
156826095|NCT04979897|566116113|FG001|Overall Study|Death|8|||
156826096|NCT04979897|566116112|FG000|Overall Study|Lost to Follow-up|111|||
156826097|NCT04979897|566116113|FG001|Overall Study|Lost to Follow-up|56|||
156826098|NCT04979897|566116112|FG000|Overall Study|Withdrawal by Subject|7|||
156826099|NCT04979897|566116113|FG001|Overall Study|Withdrawal by Subject|2|||
156826100|NCT03136497|566116120|FG000|Overall Study|Screen Failure|1|||
156826101|NCT03136497|566116121|FG001|Overall Study|Screen Failure|0|||
156826102|NCT03136497|566116122|FG002|Overall Study|Screen Failure|0|||
156826103|NCT00934947|566116123|FG000|Overall Study|Adverse Event|0|||
156826104|NCT00934947|566116124|FG001|Overall Study|Adverse Event|2|||
156826105|NCT00557310|566116125|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
156826106|NCT00557310|566116125|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
156826107|NCT00557310|566116125|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
156826108|NCT00557310|566116125|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
156826109|NCT00557310|566116125|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
156826110|NCT00557310|566116125|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
156826111|NCT00683917|566116135|FG000|Overall Study|Study prematurely terminated|10|||
156826112|NCT02174523|566116136|FG000|Overall Study|Withdrawal by Subject|1|||
156826113|NCT02174523|566116137|FG001|Overall Study|Withdrawal by Subject|0|||
156826114|NCT00794365|566116138|FG000|Overall Study|Lost to Follow-up|38|||
156826115|NCT00794365|566116138|FG000|Overall Study|Other|17|||
156826116|NCT00794365|566116138|FG000|Overall Study|Poor Compliance|11|||
156826117|NCT00794365|566116138|FG000|Overall Study|Adverse Event|10|||
156826118|NCT00794365|566116138|FG000|Overall Study|Lack of Efficacy|3|||
156826119|NCT03538444|566116152|FG000|Overall Study|opioid withdrawal|1|||
156826120|NCT03538444|566116153|FG001|Overall Study|opioid withdrawal|0|||
156826121|NCT03022097|566116154|FG000|Overall Study|Adverse Event|3|||
156826122|NCT03022097|566116155|FG001|Overall Study|Adverse Event|4|||
156826123|NCT03022097|566116156|FG002|Overall Study|Adverse Event|1|||
156826124|NCT03022097|566116157|FG003|Overall Study|Adverse Event|3|||
156826125|NCT03022097|566116154|FG000|Overall Study|Progressive Disease|2|||
156826126|NCT03022097|566116155|FG001|Overall Study|Progressive Disease|0|||
156826127|NCT03022097|566116156|FG002|Overall Study|Progressive Disease|5|||
156826128|NCT03022097|566116157|FG003|Overall Study|Progressive Disease|2|||
156826129|NCT03022097|566116154|FG000|Overall Study|Lack of Efficacy|0|||
156826130|NCT03022097|566116155|FG001|Overall Study|Lack of Efficacy|0|||
156339311|NCT00679432|564340177|FG002|Overall Study|Protocol Violation|2|||
156826131|NCT03022097|566116156|FG002|Overall Study|Lack of Efficacy|3|||
156826132|NCT03022097|566116157|FG003|Overall Study|Lack of Efficacy|3|||
156339312|NCT00679432|564340178|FG003|Overall Study|Protocol Violation|1|||
156339313|NCT00679432|564340175|FG000|Overall Study|Withdrawal by Subject|8|||
156826133|NCT03022097|566116154|FG000|Overall Study|Protocol Violation|1|||
156826134|NCT03022097|566116155|FG001|Overall Study|Protocol Violation|0|||
156826135|NCT03022097|566116156|FG002|Overall Study|Protocol Violation|1|||
156826136|NCT03022097|566116157|FG003|Overall Study|Protocol Violation|0|||
156826137|NCT03022097|566116154|FG000|Overall Study|Withdrawal by Subject|11|||
156826138|NCT03022097|566116155|FG001|Overall Study|Withdrawal by Subject|13|||
156826139|NCT03022097|566116156|FG002|Overall Study|Withdrawal by Subject|15|||
156826140|NCT03022097|566116157|FG003|Overall Study|Withdrawal by Subject|21|||
156826141|NCT03022097|566116154|FG000|Overall Study|Lost to Follow-up|0|||
156826142|NCT03022097|566116155|FG001|Overall Study|Lost to Follow-up|0|||
156826143|NCT03022097|566116156|FG002|Overall Study|Lost to Follow-up|1|||
156826144|NCT03022097|566116157|FG003|Overall Study|Lost to Follow-up|1|||
156826145|NCT03022097|566116154|FG000|Overall Study|Other|4|||
156826146|NCT03022097|566116155|FG001|Overall Study|Other|1|||
156339314|NCT00679432|564340176|FG001|Overall Study|Withdrawal by Subject|11|||
156339315|NCT00679432|564340177|FG002|Overall Study|Withdrawal by Subject|10|||
156826147|NCT03022097|566116156|FG002|Overall Study|Other|6|||
156826148|NCT03022097|566116157|FG003|Overall Study|Other|4|||
156826149|NCT03022097|566116154|FG000|Overall Study|Due to COVID-19 pandemic|0|||
156826150|NCT03022097|566116155|FG001|Overall Study|Due to COVID-19 pandemic|1|||
156826151|NCT03022097|566116156|FG002|Overall Study|Due to COVID-19 pandemic|0|||
156826152|NCT03022097|566116157|FG003|Overall Study|Due to COVID-19 pandemic|0|||
156826153|NCT01451931|566116158|FG000|Overall Study|Lost to Follow-up|17|||
156826154|NCT01451931|566116159|FG001|Overall Study|Lost to Follow-up|36|||
156826155|NCT01451931|566116160|FG002|Overall Study|Lost to Follow-up|21|||
156826156|NCT01451931|566116158|FG000|Overall Study|Withdrawal by Subject|16|||
156826157|NCT01451931|566116159|FG001|Overall Study|Withdrawal by Subject|22|||
156826158|NCT01451931|566116160|FG002|Overall Study|Withdrawal by Subject|22|||
156826159|NCT04422561|566116167|FG000|Overall Study|Lost to Follow-up|25|||
156826160|NCT04422561|566116168|FG001|Overall Study|Lost to Follow-up|11|||
156826161|NCT03640052|566116169|FG000|Overall Study|Lost to Follow-up|0|||
156339316|NCT00679432|564340178|FG003|Overall Study|Withdrawal by Subject|9|||
156339317|NCT00679432|564340175|FG000|Overall Study|Lost to Follow-up|1|||
156339318|NCT00679432|564340176|FG001|Overall Study|Lost to Follow-up|5|||
156339319|NCT00679432|564340177|FG002|Overall Study|Lost to Follow-up|4|||
156826162|NCT03640052|566116170|FG001|Overall Study|Lost to Follow-up|1|||
156826163|NCT03640052|566116171|FG002|Overall Study|Lost to Follow-up|0|||
156826164|NCT03640052|566116172|FG003|Overall Study|Lost to Follow-up|0|||
156826165|NCT03640052|566116173|FG004|Overall Study|Lost to Follow-up|0|||
156826166|NCT04239222|566116174|FG000|Baseline|Withdrawal by Subject|0|||
156826167|NCT04239222|566116175|FG001|Baseline|Withdrawal by Subject|0|||
156826168|NCT04239222|566116176|FG002|Baseline|Withdrawal by Subject|1|||
156826169|NCT04239222|566116177|FG003|Baseline|Withdrawal by Subject|1|||
156826170|NCT04239222|566116174|FG000|First Foot Assignment|Withdrawal by Subject|0|||
156339320|NCT00679432|564340178|FG003|Overall Study|Lost to Follow-up|2|||
156339321|NCT00679432|564340175|FG000|Overall Study|Physician Decision|3|||
156339322|NCT00679432|564340176|FG001|Overall Study|Physician Decision|2|||
156339323|NCT00679432|564340177|FG002|Overall Study|Physician Decision|2|||
156339324|NCT00679432|564340178|FG003|Overall Study|Physician Decision|2|||
156339325|NCT00679432|564340175|FG000|Overall Study|Sponsor decision|1|||
156339326|NCT00679432|564340176|FG001|Overall Study|Sponsor decision|0|||
156339327|NCT00679432|564340177|FG002|Overall Study|Sponsor decision|0|||
156339328|NCT00679432|564340178|FG003|Overall Study|Sponsor decision|0|||
156339329|NCT00679432|564340175|FG000|Overall Study|Lack of Efficacy|13|||
156339330|NCT00679432|564340176|FG001|Overall Study|Lack of Efficacy|9|||
156339331|NCT00679432|564340177|FG002|Overall Study|Lack of Efficacy|14|||
156339332|NCT00679432|564340178|FG003|Overall Study|Lack of Efficacy|8|||
156339333|NCT00679432|564340175|FG000|Overall Study|Infectious colitis, normal histology|5|||
156339334|NCT00679432|564340176|FG001|Overall Study|Infectious colitis, normal histology|4|||
156339335|NCT00679432|564340177|FG002|Overall Study|Infectious colitis, normal histology|8|||
156339336|NCT00679432|564340178|FG003|Overall Study|Infectious colitis, normal histology|3|||
156339337|NCT00679432|564340175|FG000|Overall Study|Randomization error, return to prior Rx|0|||
156339338|NCT00679432|564340176|FG001|Overall Study|Randomization error, return to prior Rx|0|||
156339339|NCT00679432|564340177|FG002|Overall Study|Randomization error, return to prior Rx|3|||
156339340|NCT00679432|564340178|FG003|Overall Study|Randomization error, return to prior Rx|0|||
156339341|NCT00824720|564340179|FG000|Overall Study|failed plug insertion|3|||
156339342|NCT00824720|564340180|FG001|Overall Study|failed plug insertion|1|||
156339343|NCT00824720|564340181|FG002|Overall Study|failed plug insertion|0|||
156339344|NCT00824720|564340179|FG000|Overall Study|Protocol Violation|0|||
156339345|NCT00824720|564340180|FG001|Overall Study|Protocol Violation|0|||
156339346|NCT00824720|564340181|FG002|Overall Study|Protocol Violation|1|||
156826171|NCT04239222|566116175|FG001|First Foot Assignment|Withdrawal by Subject|0|||
156826172|NCT04239222|566116176|FG002|First Foot Assignment|Withdrawal by Subject|1|||
156826173|NCT04239222|566116177|FG003|First Foot Assignment|Withdrawal by Subject|0|||
156826174|NCT04239222|566116174|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
156826175|NCT04239222|566116175|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
156826176|NCT04239222|566116176|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
156826177|NCT04239222|566116177|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
156826178|NCT02685748|566116183|FG000|Overall Study|Withdrawal by Subject|3|||
156826179|NCT02685748|566116184|FG001|Overall Study|Withdrawal by Subject|2|||
156826180|NCT05479097|566116185|FG000|Overall Study|Withdrawal by Subject|2|||
156339347|NCT00481078|564340182|FG000|Overall Study|Progression of disease|11|||
156826181|NCT00230282|566116186|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
156339348|NCT00481078|564340183|FG001|Overall Study|Progression of disease|11|||
156339349|NCT00481078|564340182|FG000|Overall Study|Adverse Event|15|||
156339350|NCT00481078|564340183|FG001|Overall Study|Adverse Event|3|||
156339351|NCT00481078|564340182|FG000|Overall Study|Death|5|||
156339352|NCT00481078|564340183|FG001|Overall Study|Death|3|||
156339353|NCT00481078|564340182|FG000|Overall Study|Intercurrent illness|1|||
156339354|NCT00481078|564340183|FG001|Overall Study|Intercurrent illness|0|||
156339355|NCT00481078|564340182|FG000|Overall Study|Withdrawal by Subject|7|||
156339356|NCT00481078|564340183|FG001|Overall Study|Withdrawal by Subject|1|||
156466188|NCT00439270|564803826|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
156466189|NCT00439270|564803827|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
156826182|NCT00230282|566116186|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
156826183|NCT00230282|566116186|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
156826184|NCT00230282|566116186|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
156826185|NCT01369680|566116188|FG000|Overall Study|Lost to Follow-up|0|||
156339357|NCT00481078|564340182|FG000|Overall Study|Information not available|1|||
156339358|NCT00481078|564340183|FG001|Overall Study|Information not available|0|||
156826186|NCT01369680|566116189|FG001|Overall Study|Lost to Follow-up|0|||
156826187|NCT01369680|566116190|FG002|Overall Study|Lost to Follow-up|1|||
156826188|NCT01369680|566116191|FG003|Overall Study|Lost to Follow-up|2|||
156826189|NCT01904149|566116193|FG000|Overall Study|Adverse Event|3|||
156826190|NCT01904149|566116194|FG001|Overall Study|Adverse Event|4|||
156826191|NCT01904149|566116195|FG002|Overall Study|Adverse Event|0|||
156826192|NCT01904149|566116196|FG003|Overall Study|Adverse Event|1|||
156826193|NCT01904149|566116197|FG004|Overall Study|Adverse Event|1|||
156826194|NCT01904149|566116198|FG005|Overall Study|Adverse Event|2|||
156826195|NCT01904149|566116193|FG000|Overall Study|Lack of Efficacy|0|||
156826196|NCT01904149|566116194|FG001|Overall Study|Lack of Efficacy|3|||
156826197|NCT01904149|566116195|FG002|Overall Study|Lack of Efficacy|1|||
156826198|NCT01904149|566116196|FG003|Overall Study|Lack of Efficacy|3|||
156826199|NCT01904149|566116197|FG004|Overall Study|Lack of Efficacy|3|||
156826200|NCT01904149|566116198|FG005|Overall Study|Lack of Efficacy|1|||
156826201|NCT01904149|566116193|FG000|Overall Study|Withdrawal by Subject|1|||
156826202|NCT01904149|566116194|FG001|Overall Study|Withdrawal by Subject|3|||
156826203|NCT01904149|566116195|FG002|Overall Study|Withdrawal by Subject|1|||
156826204|NCT01904149|566116196|FG003|Overall Study|Withdrawal by Subject|0|||
156826205|NCT01904149|566116197|FG004|Overall Study|Withdrawal by Subject|1|||
156826206|NCT01904149|566116198|FG005|Overall Study|Withdrawal by Subject|0|||
156826207|NCT01904149|566116193|FG000|Overall Study|Protocol Violation|0|||
156826208|NCT01904149|566116194|FG001|Overall Study|Protocol Violation|1|||
156826209|NCT01904149|566116195|FG002|Overall Study|Protocol Violation|0|||
156826210|NCT01904149|566116196|FG003|Overall Study|Protocol Violation|0|||
156826211|NCT01904149|566116197|FG004|Overall Study|Protocol Violation|0|||
156826212|NCT01904149|566116198|FG005|Overall Study|Protocol Violation|0|||
156826213|NCT01904149|566116193|FG000|Overall Study|non compliance with study drug|1|||
156826214|NCT01904149|566116194|FG001|Overall Study|non compliance with study drug|0|||
156826215|NCT01904149|566116195|FG002|Overall Study|non compliance with study drug|0|||
156826216|NCT01904149|566116196|FG003|Overall Study|non compliance with study drug|0|||
156826217|NCT01904149|566116197|FG004|Overall Study|non compliance with study drug|0|||
156826218|NCT01904149|566116198|FG005|Overall Study|non compliance with study drug|0|||
156826219|NCT02927925|566116201|FG000|Overall Study|Death|16|||
156826220|NCT02927925|566116201|FG000|Overall Study|Physician Decision|1|||
156826221|NCT02927925|566116201|FG000|Overall Study|Withdrawal by Subject|11|||
156826222|NCT02927925|566116201|FG000|Overall Study|Other|3|||
156826223|NCT02927925|566116201|FG000|Overall Study|Disease progression at clinical cutoff|1|||
156826224|NCT00580034|566116203|FG000|Overall Study|Toxicity|10|||
156826225|NCT00580034|566116204|FG001|Overall Study|Toxicity|0|||
156826226|NCT00772369|566116206|FG000|Overall Study|Did not return record release form|1|||
156826227|NCT03372460|566116207|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
156826228|NCT03372460|566116208|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
156826229|NCT02499900|566116209|FG000|Core Study Period|Other|1|||
156826230|NCT02499900|566116210|FG001|Core Study Period|Other|4|||
156826231|NCT02499900|566116209|FG000|Core Study Period|Lost to Follow-up|1|||
156826232|NCT02499900|566116210|FG001|Core Study Period|Lost to Follow-up|2|||
156826233|NCT02499900|566116209|FG000|Core Study Period|Per sponsor request|0|||
156826234|NCT02499900|566116210|FG001|Core Study Period|Per sponsor request|1|||
156826235|NCT02499900|566116209|FG000|Core Study Period|Pregnancy|1|||
156826236|NCT02499900|566116210|FG001|Core Study Period|Pregnancy|0|||
156826237|NCT02499900|566116209|FG000|Core Study Period|Protocol Violation|3|||
156826238|NCT02499900|566116210|FG001|Core Study Period|Protocol Violation|0|||
156826239|NCT02499900|566116209|FG000|Core Study Period|Withdrawal by Subject|11|||
156826240|NCT02499900|566116210|FG001|Core Study Period|Withdrawal by Subject|10|||
156826241|NCT02499900|566116209|FG000|Core Study Period|Adverse Event|18|||
156826242|NCT02499900|566116210|FG001|Core Study Period|Adverse Event|14|||
156826243|NCT02499900|566116209|FG000|Core Study Period|Death|0|||
156826244|NCT02499900|566116210|FG001|Core Study Period|Death|1|||
156826245|NCT02499900|566116209|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
156826246|NCT02499900|566116210|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
156826247|NCT02499900|566116209|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
156826248|NCT02499900|566116210|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
156826249|NCT02499900|566116209|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
156826250|NCT02499900|566116210|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
156826251|NCT02499900|566116209|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
156826252|NCT02499900|566116210|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
156826253|NCT02499900|566116209|FG000|Extension Study Period|Adverse Event|2|||
156826254|NCT02499900|566116210|FG001|Extension Study Period|Adverse Event|4|||
156826255|NCT02499900|566116209|FG000|Extension Study Period|Withdrawal by Subject|5|||
156826256|NCT02499900|566116210|FG001|Extension Study Period|Withdrawal by Subject|2|||
156826257|NCT02499900|566116209|FG000|Extension Study Period|Physician Decision|2|||
156826258|NCT02499900|566116210|FG001|Extension Study Period|Physician Decision|5|||
156826259|NCT02499900|566116209|FG000|Extension Study Period|Pregnancy|1|||
156826260|NCT02499900|566116210|FG001|Extension Study Period|Pregnancy|2|||
156826261|NCT02499900|566116209|FG000|Extension Study Period|Lost to Follow-up|2|||
156826262|NCT02499900|566116210|FG001|Extension Study Period|Lost to Follow-up|5|||
156826263|NCT02499900|566116209|FG000|Extension Study Period|Other|0|||
156826264|NCT02499900|566116210|FG001|Extension Study Period|Other|2|||
156826265|NCT00916058|566116211|FG000|Phase 1|Screen Failure|0|||
156826266|NCT00916058|566116212|FG001|Phase 1|Screen Failure|0|||
156826267|NCT00916058|566116213|FG002|Phase 1|Screen Failure|0|||
156826268|NCT00916058|566116214|FG003|Phase 1|Screen Failure|0|||
156826269|NCT00916058|566116215|FG004|Phase 1|Screen Failure|0|||
156826270|NCT00916058|566116216|FG005|Phase 1|Screen Failure|1|||
156826271|NCT00916058|566116217|FG006|Phase 1|Screen Failure|0|||
156826272|NCT00916058|566116211|FG000|Phase 2|Screen Failure|0|||
156826273|NCT00916058|566116212|FG001|Phase 2|Screen Failure|0|||
156826274|NCT00916058|566116213|FG002|Phase 2|Screen Failure|0|||
156826275|NCT00916058|566116214|FG003|Phase 2|Screen Failure|0|||
156826276|NCT00916058|566116215|FG004|Phase 2|Screen Failure|0|||
156826277|NCT00916058|566116216|FG005|Phase 2|Screen Failure|0|||
156826278|NCT00916058|566116217|FG006|Phase 2|Screen Failure|3|||
156826279|NCT02752958|566116218|FG000|Overall Study|Adverse Event|3|||
156826280|NCT02752958|566116218|FG000|Overall Study|Lost to Follow-up|1|||
156826281|NCT02752958|566116218|FG000|Overall Study|Protocol Violation|1|||
156826282|NCT02752958|566116218|FG000|Overall Study|Withdrawal by Subject|2|||
156826283|NCT02752958|566116218|FG000|Overall Study|Other (Reason not specified)|2|||
156826284|NCT02836873|566116221|FG000|Overall Study|Protocol Violation|0|||
156826285|NCT02836873|566116222|FG001|Overall Study|Protocol Violation|1|||
156826286|NCT02836873|566116221|FG000|Overall Study|Adverse Event|1|||
156826287|NCT02836873|566116222|FG001|Overall Study|Adverse Event|4|||
156826288|NCT02836873|566116221|FG000|Overall Study|Withdrawal by Subject|2|||
156826289|NCT02836873|566116222|FG001|Overall Study|Withdrawal by Subject|2|||
156826290|NCT02836873|566116221|FG000|Overall Study|Lost to Follow-up|1|||
156826291|NCT02836873|566116222|FG001|Overall Study|Lost to Follow-up|3|||
156826292|NCT02836873|566116221|FG000|Overall Study|Physician Decision|0|||
156826293|NCT02836873|566116222|FG001|Overall Study|Physician Decision|1|||
156826294|NCT02836873|566116221|FG000|Overall Study|Other|1|||
156826295|NCT02836873|566116222|FG001|Overall Study|Other|0|||
156826296|NCT00853125|566116229|FG000|Overall Study|Study participant's donor was CMV +|1|||
156826297|NCT01646645|566116232|FG000|Overall Study|No Treated|1|||
156826298|NCT01646645|566116232|FG000|Overall Study|Inevaluable Donor|29|||
156826299|NCT00884039|566116233|FG000|Overall Study|Withdrawal by Subject|0|||
156826300|NCT00884039|566116234|FG001|Overall Study|Withdrawal by Subject|1|||
156826301|NCT00884039|566116233|FG000|Overall Study|Lack of Efficacy|2|||
156826302|NCT00884039|566116234|FG001|Overall Study|Lack of Efficacy|0|||
156826303|NCT00717522|566116235|FG000|Overall Study|Disease Progression|5|||
156826304|NCT00717522|566116235|FG000|Overall Study|Adverse Event|1|||
156826305|NCT00717522|566116235|FG000|Overall Study|Death|1|||
156826306|NCT01799239|566116236|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
156826307|NCT01799239|566116237|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
156826308|NCT01799239|566116236|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
156826309|NCT01799239|566116237|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
156826310|NCT01799239|566116236|FG000|Period 1 (7 Days)|Protocol Violation|0|||
156826311|NCT01799239|566116237|FG001|Period 1 (7 Days)|Protocol Violation|1|||
156826312|NCT01799239|566116236|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
156826313|NCT01799239|566116237|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
156826314|NCT01799239|566116236|FG000|Period 2 (7 Days)|Protocol Violation|1|||
156826315|NCT01799239|566116237|FG001|Period 2 (7 Days)|Protocol Violation|0|||
156826316|NCT01300819|566116241|FG000|Overall Study|Adverse Event|9|||
156826317|NCT01300819|566116242|FG001|Overall Study|Adverse Event|27|||
156826318|NCT01300819|566116241|FG000|Overall Study|Lack of Efficacy|2|||
156826319|NCT01300819|566116242|FG001|Overall Study|Lack of Efficacy|1|||
156826320|NCT01300819|566116241|FG000|Overall Study|Withdrawal by Subject|10|||
156826321|NCT01300819|566116242|FG001|Overall Study|Withdrawal by Subject|12|||
156826322|NCT01300819|566116241|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
156826323|NCT01300819|566116242|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
156826324|NCT01300819|566116241|FG000|Overall Study|Refusal to down titrate study drug|0|||
156826325|NCT01300819|566116242|FG001|Overall Study|Refusal to down titrate study drug|1|||
156826326|NCT01300819|566116241|FG000|Overall Study|Administrative reason|0|||
156826327|NCT01300819|566116242|FG001|Overall Study|Administrative reason|1|||
156826328|NCT01300819|566116241|FG000|Overall Study|Safety follow up not done by mistake|0|||
156826329|NCT01300819|566116242|FG001|Overall Study|Safety follow up not done by mistake|1|||
156826330|NCT01300819|566116241|FG000|Overall Study|Follow up call was not done|1|||
156826331|NCT01300819|566116242|FG001|Overall Study|Follow up call was not done|0|||
156826332|NCT01444027|566116243|FG000|Overall Study|Withdrawal by Subject|4|||
156826333|NCT01444027|566116244|FG001|Overall Study|Withdrawal by Subject|10|||
156826334|NCT01444027|566116245|FG002|Overall Study|Withdrawal by Subject|24|||
156826335|NCT01444027|566116243|FG000|Overall Study|Lost to Follow-up|26|||
156826336|NCT01444027|566116244|FG001|Overall Study|Lost to Follow-up|20|||
156826337|NCT01444027|566116245|FG002|Overall Study|Lost to Follow-up|14|||
156826338|NCT03966885|566117904|FG000|Overall Study|Death|1|||
156826339|NCT03966885|566117905|FG001|Overall Study|Death|0|||
156826340|NCT03966885|566117904|FG000|Overall Study|Lost to Follow-up|1|||
156826341|NCT03966885|566117905|FG001|Overall Study|Lost to Follow-up|2|||
156826342|NCT03966885|566117904|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
156826343|NCT03966885|566117905|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
156826344|NCT03966885|566117904|FG000|Overall Study|Moved from study area.|0|||
156826345|NCT03966885|566117905|FG001|Overall Study|Moved from study area.|2|||
156826346|NCT01514240|566117906|FG000|Overall Study|Adverse Event|4|||
156826347|NCT01514240|566117907|FG001|Overall Study|Adverse Event|4|||
156826348|NCT01514240|566117906|FG000|Overall Study|Subject Decision|2|||
156826349|NCT01514240|566117907|FG001|Overall Study|Subject Decision|7|||
156826350|NCT05013424|566117908|FG000|Overall Study|Lost to Follow-up|1|||
156826351|NCT05013424|566117909|FG001|Overall Study|Lost to Follow-up|1|||
156826352|NCT05013424|566117910|FG002|Overall Study|Lost to Follow-up|1|||
156826353|NCT05013424|566117908|FG000|Overall Study|Withdrawal by Subject|0|||
156826354|NCT05013424|566117909|FG001|Overall Study|Withdrawal by Subject|1|||
156826355|NCT05013424|566117910|FG002|Overall Study|Withdrawal by Subject|0|||
156826356|NCT04411420|566117911|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
156826357|NCT04411420|566117912|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
156826358|NCT04411420|566117911|FG000|Survey Subset|Lost to Follow-up|134|||
156826359|NCT04411420|566117912|FG001|Survey Subset|Lost to Follow-up|120|||
156826360|NCT00549900|566117913|FG000|Overall Study|Adverse Event|1|||
156826361|NCT03899064|566117917|FG000|Overall Study|Lost to Follow-up|1|||
156826362|NCT03899064|566117917|FG000|Overall Study|Protocol Violation|2|||
156826363|NCT03899064|566117917|FG000|Overall Study|Withdrawal by Subject|2|||
156826364|NCT03899064|566117917|FG000|Overall Study|Other|2|||
156826365|NCT03283098|566117918|FG000|Overall Study|Withdrawal by Subject|0|||
156826366|NCT03283098|566117919|FG001|Overall Study|Withdrawal by Subject|1|||
156826367|NCT01278407|566117922|FG000|Confirmatory Phase|Adverse Event|5|||
156826368|NCT01278407|566117923|FG001|Confirmatory Phase|Adverse Event|10|||
156826369|NCT01278407|566117924|FG002|Confirmatory Phase|Adverse Event|1|||
156826370|NCT01278407|566117925|FG003|Confirmatory Phase|Adverse Event|0|||
156826371|NCT01278407|566117926|FG004|Confirmatory Phase|Adverse Event|0|||
156826372|NCT01278407|566117922|FG000|Confirmatory Phase|Participant's Choice|3|||
156826373|NCT01278407|566117923|FG001|Confirmatory Phase|Participant's Choice|5|||
156826374|NCT01278407|566117924|FG002|Confirmatory Phase|Participant's Choice|3|||
156826375|NCT01278407|566117925|FG003|Confirmatory Phase|Participant's Choice|0|||
156826376|NCT01278407|566117926|FG004|Confirmatory Phase|Participant's Choice|0|||
156826377|NCT01278407|566117922|FG000|Confirmatory Phase|Other|1|||
156826378|NCT01278407|566117923|FG001|Confirmatory Phase|Other|1|||
156826379|NCT01278407|566117924|FG002|Confirmatory Phase|Other|2|||
156826380|NCT01278407|566117925|FG003|Confirmatory Phase|Other|0|||
156826381|NCT01278407|566117926|FG004|Confirmatory Phase|Other|0|||
156826382|NCT01278407|566117922|FG000|Extension Phase|Adverse Event|0|||
156826383|NCT01278407|566117923|FG001|Extension Phase|Adverse Event|0|||
156826384|NCT01278407|566117924|FG002|Extension Phase|Adverse Event|0|||
156826385|NCT01278407|566117925|FG003|Extension Phase|Adverse Event|7|||
156826386|NCT01278407|566117926|FG004|Extension Phase|Adverse Event|16|||
156826387|NCT01278407|566117922|FG000|Extension Phase|Participant's Choice|0|||
156826388|NCT01278407|566117923|FG001|Extension Phase|Participant's Choice|0|||
156826389|NCT01278407|566117924|FG002|Extension Phase|Participant's Choice|0|||
156826390|NCT01278407|566117925|FG003|Extension Phase|Participant's Choice|4|||
156826391|NCT01278407|566117926|FG004|Extension Phase|Participant's Choice|11|||
156826392|NCT01278407|566117922|FG000|Extension Phase|Other|0|||
156826393|NCT01278407|566117923|FG001|Extension Phase|Other|0|||
156826394|NCT01278407|566117924|FG002|Extension Phase|Other|0|||
156826395|NCT01278407|566117925|FG003|Extension Phase|Other|1|||
156826396|NCT01278407|566117926|FG004|Extension Phase|Other|3|||
156826397|NCT02534935|566117927|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
156826398|NCT02534935|566117928|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
156826399|NCT02534935|566117929|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
156826400|NCT02534935|566117927|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
156826401|NCT02534935|566117928|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
156826402|NCT02534935|566117929|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
156826403|NCT02534935|566117927|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
156826404|NCT02534935|566117928|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
156826405|NCT02534935|566117929|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
156826406|NCT02534935|566117927|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
156826407|NCT02534935|566117928|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
156826408|NCT02534935|566117929|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
156826409|NCT02534935|566117927|FG000|Stage 1: 24 Months|Adverse Event|0|||
156826410|NCT02534935|566117928|FG001|Stage 1: 24 Months|Adverse Event|2|||
156826411|NCT02534935|566117929|FG002|Stage 1: 24 Months|Adverse Event|0|||
156826412|NCT02534935|566117927|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
156826413|NCT02534935|566117928|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
156826414|NCT02534935|566117929|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
156826415|NCT02534935|566117927|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
156826416|NCT02534935|566117928|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
156826417|NCT02534935|566117929|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
156826418|NCT01069861|566117930|FG000|Overall Study|Death|1|||
156826419|NCT01069861|566117930|FG000|Overall Study|Adverse Event|1|||
156826420|NCT01069861|566117930|FG000|Overall Study|Did not meet entrance criteria|1|||
156826421|NCT01596335|566117931|FG000|Overall Study|exacerbation of primary disease|5|||
156826422|NCT01596335|566117932|FG001|Overall Study|exacerbation of primary disease|9|||
156826423|NCT01460719|566117933|FG000|Overall Study|Adverse Event|1|||
156826424|NCT01460719|566117933|FG000|Overall Study|Withdrawal by Subject|1|||
156826425|NCT03350256|566117934|FG000|Overall Study|Inclusion/exclusion violation|4|||
156826426|NCT03350256|566117934|FG000|Overall Study|Recommended for other therapies|2|||
156826427|NCT03350256|566117934|FG000|Overall Study|Protocol Violation|3|||
156826428|NCT03350256|566117934|FG000|Overall Study|Non compliance|2|||
156826429|NCT03350256|566117934|FG000|Overall Study|Denial by insurance|1|||
156826430|NCT03350256|566117934|FG000|Overall Study|Adverse Event|2|||
156826431|NCT03350256|566117934|FG000|Overall Study|Trial failure|12|||
156826432|NCT03350256|566117934|FG000|Overall Study|Did not proceed to permanent implant|3|||
156826433|NCT03350256|566117934|FG000|Overall Study|Withdrawal by Subject|3|||
156826434|NCT03350256|566117934|FG000|Overall Study|Subject moving out of state|1|||
156826435|NCT03350256|566117934|FG000|Overall Study|Lost to Follow-up|1|||
156826436|NCT03350256|566117934|FG000|Overall Study|Lack of Efficacy|2|||
156826437|NCT02680041|566117935|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
156826438|NCT02680041|566117935|FG000|Overall Study|Lost to Follow-up|2|||
156826439|NCT04431713|566117938|FG000|Overall Study|Withdrawal by Subject|2|||
156826440|NCT04431713|566117939|FG001|Overall Study|Withdrawal by Subject|0|||
156826441|NCT04431713|566117938|FG000|Overall Study|Death|2|||
156826442|NCT04431713|566117939|FG001|Overall Study|Death|2|||
156826443|NCT01344538|566117940|FG000|Overall Study|Adverse Event|1|||
156826444|NCT01344538|566117941|FG001|Overall Study|Adverse Event|1|||
156826445|NCT01344538|566117940|FG000|Overall Study|Lost to Follow-up|1|||
156826446|NCT01344538|566117941|FG001|Overall Study|Lost to Follow-up|0|||
156826447|NCT01655381|566117944|FG000|Overall Study|Investigator Decision|1|||
156826448|NCT01655381|566117944|FG000|Overall Study|Moved to Another City|1|||
156826449|NCT01655381|566117944|FG000|Overall Study|Insufficient Treatment Response|1|||
156826450|NCT02324205|566117945|FG000|Overall Study|Withdrawal by Subject|37|||
156826451|NCT04195438|566117949|FG000|Overall Study|Withdrawal by Subject|1|||
156826452|NCT00613925|566117954|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
156826453|NCT00613925|566117955|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
156826454|NCT00543296|566117956|FG000|Overall Study|Physician Decision|7|||
156826455|NCT02891681|566117961|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
156826456|NCT02891681|566117962|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
156826457|NCT02891681|566117963|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
156826458|NCT02891681|566117961|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
156826459|NCT02891681|566117962|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
156826460|NCT02891681|566117963|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
156826461|NCT02891681|566117961|FG000|Overall Study|Taken off study after first imaging appointment|1|||
156826462|NCT02891681|566117962|FG001|Overall Study|Taken off study after first imaging appointment|0|||
156826463|NCT02891681|566117963|FG002|Overall Study|Taken off study after first imaging appointment|0|||
156826464|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
156826465|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
156826466|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
156826467|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
156826468|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
156826469|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
156826470|NCT01224821|566117964|FG000|Long-Term Follow-Up|Death|2|||
156466190|NCT00439270|564803823|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
156466191|NCT00439270|564803824|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
156466192|NCT00439270|564803825|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
156466193|NCT00439270|564803826|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
156466194|NCT00439270|564803827|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
156466195|NCT00439270|564803823|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
156466196|NCT00439270|564803824|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
156466197|NCT00439270|564803825|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
156826471|NCT01224821|566117964|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
156826472|NCT00623545|566117965|FG000|Overall Study|Adverse Event|6|||
156826473|NCT00623545|566117965|FG000|Overall Study|Withdrawal by Subject|4|||
156826474|NCT04126564|566117966|FG000|Overall Study|Withdrawal by Subject|0|||
156826475|NCT04126564|566117967|FG001|Overall Study|Withdrawal by Subject|2|||
156826476|NCT04126564|566117966|FG000|Overall Study|Lost to Follow-up|0|||
156826477|NCT04126564|566117967|FG001|Overall Study|Lost to Follow-up|1|||
156826478|NCT00937404|566117968|FG000|Overall Study|Protocol Violation|1|||
156826479|NCT00937404|566117968|FG000|Overall Study|Withdrawal by Subject|1|||
156826480|NCT03541187|566117976|FG000|Overall Study|Lost to Follow-up|2|||
156826481|NCT03541187|566117977|FG001|Overall Study|Lost to Follow-up|6|||
156826482|NCT03541187|566117976|FG000|Overall Study|Pregnancy|0|||
156826483|NCT03541187|566117977|FG001|Overall Study|Pregnancy|1|||
156826484|NCT03541187|566117976|FG000|Overall Study|Withdrawal by Subject|6|||
156826485|NCT03541187|566117977|FG001|Overall Study|Withdrawal by Subject|2|||
156826486|NCT03541187|566117976|FG000|Overall Study|Moved out of town|1|||
156826487|NCT03541187|566117977|FG001|Overall Study|Moved out of town|0|||
156826488|NCT03541187|566117976|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
156826489|NCT03541187|566117977|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
156826490|NCT03541187|566117976|FG000|Overall Study|Did not meet randomization criteria|1|||
156826491|NCT03541187|566117977|FG001|Overall Study|Did not meet randomization criteria|1|||
156826492|NCT03541187|566117976|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
156826493|NCT03541187|566117977|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
156826494|NCT03541187|566117976|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
156826495|NCT03541187|566117977|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
156826496|NCT00812006|566117981|FG000|Overall Study|Lost to Follow-up|0|||
156826497|NCT00812006|566117982|FG001|Overall Study|Lost to Follow-up|0|||
156826498|NCT00812006|566117983|FG002|Overall Study|Lost to Follow-up|2|||
156826499|NCT00812006|566117981|FG000|Overall Study|Physician Decision|0|||
156826500|NCT00812006|566117982|FG001|Overall Study|Physician Decision|0|||
156826501|NCT00812006|566117983|FG002|Overall Study|Physician Decision|1|||
156826502|NCT00812006|566117981|FG000|Overall Study|Withdrawal by Subject|2|||
156826503|NCT00812006|566117982|FG001|Overall Study|Withdrawal by Subject|1|||
156826504|NCT00812006|566117983|FG002|Overall Study|Withdrawal by Subject|1|||
156826505|NCT00812006|566117981|FG000|Overall Study|Lack of Qualifying Event|4|||
156826506|NCT00812006|566117982|FG001|Overall Study|Lack of Qualifying Event|2|||
156826507|NCT00812006|566117983|FG002|Overall Study|Lack of Qualifying Event|2|||
156826508|NCT01571284|566117985|FG000|Overall Study|Participant's decision|84|||
156826509|NCT01571284|566117985|FG000|Overall Study|Lost to Follow-up|3|||
156826510|NCT01571284|566117985|FG000|Overall Study|Enrolled but not treated|2|||
156826511|NCT01571284|566117985|FG000|Overall Study|Other than specified above|80|||
156826512|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Death|1|||
156826513|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Death|1|||
156826514|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Death|0|||
156826515|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Death|0|||
156826516|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Death|1|||
156826517|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Death|0|||
156826518|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Death|0|||
156826519|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Death|0|||
156826520|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Death|0|||
156826521|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Death|0|||
156826522|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
156826523|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
156826524|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
156826525|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826526|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
156826527|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826528|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826529|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826530|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826531|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826532|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826533|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826534|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826535|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826536|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
156466198|NCT00439270|564803826|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
156466199|NCT00439270|564803827|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
156466200|NCT00439270|564803823|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
156466201|NCT00439270|564803824|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
156826537|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826538|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826539|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826540|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826541|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826542|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
156826543|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826544|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826545|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826546|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826547|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826548|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826549|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826550|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826551|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826552|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
156826553|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826554|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826555|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
156826556|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
156826557|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826558|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826559|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826560|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826561|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826562|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
156826563|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826564|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826565|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
156826566|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826567|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826568|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826569|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826570|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826571|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826572|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
156826573|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
156826574|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
156826575|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
156826576|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
156826577|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826578|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826579|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826580|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826581|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826582|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
156826583|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
156826584|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
156826585|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826586|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
156826587|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826588|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826589|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826590|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826591|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826592|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
156826593|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826594|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826595|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
156826596|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
156826597|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826598|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826599|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826600|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826601|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826602|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826603|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826604|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826605|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826606|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826607|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826608|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826609|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826610|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826611|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826612|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826613|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826614|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
156826615|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826616|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
156826617|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826618|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826619|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826620|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826621|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826622|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
156826623|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
156826624|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
156826625|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
156826626|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
156826627|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826628|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826629|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826630|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826631|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826632|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826633|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826634|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826635|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
156826636|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
156826637|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826638|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826639|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826640|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826641|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826642|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826643|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156466202|NCT00439270|564803825|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
156466203|NCT00439270|564803826|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
156826644|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826645|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826646|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826647|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826648|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826649|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826650|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826651|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826652|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
156826653|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826654|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826655|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826656|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
156826657|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826658|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826659|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826660|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826661|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826662|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826663|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826664|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826665|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826666|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
156826667|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826668|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826669|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826670|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826671|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826672|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826673|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
156826674|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826675|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826676|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
156826677|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826678|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826679|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826680|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826681|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826682|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
156826683|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826684|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826685|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826686|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
156826687|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826688|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826689|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826690|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826691|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826692|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
156826693|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826694|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
156826695|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826696|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
156826697|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826698|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826699|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826700|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826701|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826702|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Other|5|||
156826703|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Other|1|||
156826704|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Other|0|||
156826705|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Other|3|||
156826706|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Other|0|||
156826707|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Other|0|||
156826708|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Other|0|||
156826709|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Other|0|||
156826710|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Other|0|||
156826711|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Other|0|||
156826712|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826713|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826714|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826715|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826716|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
156826717|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826718|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826719|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826720|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826721|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826722|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Death|0|||
156826723|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Death|0|||
156826724|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Death|0|||
156826725|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Death|0|||
156826726|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Death|0|||
156826727|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Death|1|||
156826728|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Death|0|||
156826729|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Death|1|||
156826730|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Death|1|||
156826731|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Death|1|||
156826732|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826733|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826734|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826735|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826736|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826737|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
156826738|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826739|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826740|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826741|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826742|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826743|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826744|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826745|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826746|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826747|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826748|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826749|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826750|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
156826751|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826752|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826753|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826754|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826755|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826756|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826757|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
156826758|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
156826759|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
156826760|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
156826761|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
156826762|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826763|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826764|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826765|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826766|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826767|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
156826768|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826769|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
156826770|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
156826771|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
156826772|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826773|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826774|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826775|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826776|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826777|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826778|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826779|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826780|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826781|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826782|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826783|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826784|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826785|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826786|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826787|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
156826788|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826789|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
156826790|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
156826791|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
156826792|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826793|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826794|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826795|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826796|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826797|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826798|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826799|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826800|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
156826801|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
156826802|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826803|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826804|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826805|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826806|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826807|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826808|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826809|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826810|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826811|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826812|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826813|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826814|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826815|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826816|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826817|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826818|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826819|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
156826820|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826821|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826822|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826823|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826824|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826825|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826826|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826827|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826828|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826829|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
156826830|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
156826831|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826832|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826833|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826834|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826835|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826836|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826837|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
156826838|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826839|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826840|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
156826841|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826842|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826843|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826844|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826845|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826846|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826847|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826848|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826849|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826850|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826851|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
156826852|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826853|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826854|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826855|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826856|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826857|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826858|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826859|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826860|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
156826861|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
156826862|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826863|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826864|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826865|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826866|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826867|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826868|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826869|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
156826870|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
156826871|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826872|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Other|0|||
156826873|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Other|0|||
156826874|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Other|0|||
156826875|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Other|0|||
156826876|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Other|0|||
156466204|NCT00439270|564803827|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
156466205|NCT00439270|564803823|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
156466206|NCT00439270|564803824|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
156826877|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Other|0|||
156826878|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Other|0|||
156826879|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Other|1|||
156826880|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Other|0|||
156826881|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Other|0|||
156826882|NCT03242772|566117996|FG000|Overall Study|Lost to Follow-up|2|||
156826883|NCT03242772|566117997|FG001|Overall Study|Lost to Follow-up|0|||
156826884|NCT03242772|566117996|FG000|Overall Study|Physician Decision|0|||
156826885|NCT03242772|566117997|FG001|Overall Study|Physician Decision|1|||
156826886|NCT03242772|566117996|FG000|Overall Study|Withdrawal by Subject|1|||
156826887|NCT03242772|566117997|FG001|Overall Study|Withdrawal by Subject|0|||
156826888|NCT03385265|566118000|FG000|Overall Study|Withdrawal by Subject|5|||
156826889|NCT03385265|566118001|FG001|Overall Study|Withdrawal by Subject|2|||
156826890|NCT03385265|566118002|FG002|Overall Study|Withdrawal by Subject|5|||
156826891|NCT03385265|566118003|FG003|Overall Study|Withdrawal by Subject|2|||
156826892|NCT01170065|566118024|FG000|Overall Study|Adverse Event|17|||
156826893|NCT01170065|566118025|FG001|Overall Study|Adverse Event|50|||
156826894|NCT01170065|566118026|FG002|Overall Study|Adverse Event|10|||
156826895|NCT01170065|566118024|FG000|Overall Study|Lost to Follow-up|1|||
156826896|NCT01170065|566118025|FG001|Overall Study|Lost to Follow-up|4|||
156826897|NCT01170065|566118026|FG002|Overall Study|Lost to Follow-up|1|||
156826898|NCT01170065|566118024|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
156826899|NCT01170065|566118025|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
156826900|NCT01170065|566118026|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
156826901|NCT01170065|566118024|FG000|Overall Study|Reason other than specified|3|||
156826902|NCT01170065|566118025|FG001|Overall Study|Reason other than specified|8|||
156826903|NCT01170065|566118026|FG002|Overall Study|Reason other than specified|3|||
156826904|NCT01170065|566118024|FG000|Overall Study|Ongoing after planned observation time|5|||
156826905|NCT01170065|566118025|FG001|Overall Study|Ongoing after planned observation time|26|||
156826906|NCT01170065|566118026|FG002|Overall Study|Ongoing after planned observation time|10|||
156826907|NCT02434354|566118027|FG000|Overall Study|screen fail|3|||
156826908|NCT01071200|566118028|FG000|Overall Study|Lack of ovarian response|1|||
156826909|NCT01071200|566118029|FG001|Overall Study|Lack of ovarian response|1|||
156826910|NCT01071200|566118028|FG000|Overall Study|No fertilization|4|||
156826911|NCT01071200|566118029|FG001|Overall Study|No fertilization|0|||
156826912|NCT01071200|566118028|FG000|Overall Study|No oocytes retrieved|1|||
156826913|NCT01071200|566118029|FG001|Overall Study|No oocytes retrieved|1|||
156826914|NCT01071200|566118028|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
156826915|NCT01071200|566118029|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
156826916|NCT01071200|566118028|FG000|Overall Study|No viable embryos|0|||
156826917|NCT01071200|566118029|FG001|Overall Study|No viable embryos|1|||
156826918|NCT01920893|566118032|FG000|Overall Study|Adverse Event|5|||
156826919|NCT01920893|566118033|FG001|Overall Study|Adverse Event|2|||
156826920|NCT01920893|566118032|FG000|Overall Study|Lack of Efficacy|2|||
156826921|NCT01920893|566118033|FG001|Overall Study|Lack of Efficacy|0|||
156826922|NCT03440918|566118042|FG000|Overall Study|Protocol Violation|0|||
156826923|NCT03440918|566118043|FG001|Overall Study|Protocol Violation|16|||
156826924|NCT01767493|566118055|FG000|Overall Study|screen failures|3|||
156826925|NCT00724854|566118058|FG000|Overall Study|Lack of Efficacy|187|||
156826926|NCT00724854|566118059|FG001|Overall Study|Lack of Efficacy|13|||
156826927|NCT00724854|566118058|FG000|Overall Study|Lost to Follow-up|87|||
156466207|NCT00439270|564803825|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
156826928|NCT00724854|566118059|FG001|Overall Study|Lost to Follow-up|10|||
156826929|NCT00724854|566118058|FG000|Overall Study|Adverse Event|62|||
156826930|NCT00724854|566118059|FG001|Overall Study|Adverse Event|4|||
156826931|NCT00724854|566118058|FG000|Overall Study|Other|42|||
156826932|NCT00724854|566118059|FG001|Overall Study|Other|3|||
156826933|NCT00724854|566118058|FG000|Overall Study|Death|11|||
156826934|NCT00724854|566118059|FG001|Overall Study|Death|0|||
156826935|NCT00724854|566118058|FG000|Overall Study|Change of treatment|7|||
156826936|NCT00724854|566118059|FG001|Overall Study|Change of treatment|0|||
156826937|NCT00724854|566118058|FG000|Overall Study|Withdrawal by Subject|5|||
156826938|NCT00724854|566118059|FG001|Overall Study|Withdrawal by Subject|0|||
156826939|NCT00724854|566118058|FG000|Overall Study|Adverse event + lack of efficacy|2|||
156826940|NCT00724854|566118059|FG001|Overall Study|Adverse event + lack of efficacy|1|||
156826941|NCT01095653|566118060|FG000|Overall Study|Lack of Efficacy|3|||
156826942|NCT01095653|566118061|FG001|Overall Study|Lack of Efficacy|0|||
156826943|NCT01095653|566118062|FG002|Overall Study|Lack of Efficacy|0|||
156826944|NCT01095653|566118060|FG000|Overall Study|Adverse Event|1|||
156826945|NCT01095653|566118061|FG001|Overall Study|Adverse Event|4|||
156826946|NCT01095653|566118062|FG002|Overall Study|Adverse Event|4|||
156826947|NCT01095653|566118060|FG000|Overall Study|Lost to Follow-up|1|||
156826948|NCT01095653|566118061|FG001|Overall Study|Lost to Follow-up|0|||
156826949|NCT01095653|566118062|FG002|Overall Study|Lost to Follow-up|4|||
156826950|NCT01095653|566118060|FG000|Overall Study|Withdrawal by Subject|4|||
156826951|NCT01095653|566118061|FG001|Overall Study|Withdrawal by Subject|5|||
156826952|NCT01095653|566118062|FG002|Overall Study|Withdrawal by Subject|3|||
156826953|NCT01095653|566118060|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
156826954|NCT01095653|566118061|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
156826955|NCT01095653|566118062|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
156826956|NCT01819129|566118063|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
156826957|NCT01819129|566118064|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
156826958|NCT01819129|566118063|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
156826959|NCT01819129|566118064|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
156826960|NCT01819129|566118063|FG000|Overall Study|Other, Subject moved out of the country|0|||
156826961|NCT01819129|566118064|FG001|Overall Study|Other, Subject moved out of the country|1|||
156826962|NCT01819129|566118063|FG000|Overall Study|Withdrawal by Subject|15|||
156826963|NCT01819129|566118064|FG001|Overall Study|Withdrawal by Subject|15|||
156826964|NCT01819129|566118063|FG000|Overall Study|Lost to Follow-up|5|||
156826965|NCT01819129|566118064|FG001|Overall Study|Lost to Follow-up|2|||
156826966|NCT01819129|566118063|FG000|Overall Study|Lack of Efficacy|0|||
156826967|NCT01819129|566118064|FG001|Overall Study|Lack of Efficacy|1|||
156826968|NCT01819129|566118063|FG000|Overall Study|Adverse Event|1|||
156826969|NCT01819129|566118064|FG001|Overall Study|Adverse Event|4|||
156826970|NCT01819129|566118063|FG000|Overall Study|Death|1|||
156826971|NCT01819129|566118064|FG001|Overall Study|Death|1|||
156826972|NCT01819129|566118063|FG000|Overall Study|Withdrawal Criteria|20|||
156826973|NCT01819129|566118064|FG001|Overall Study|Withdrawal Criteria|15|||
156826974|NCT00054691|566118065|FG000|Overall Study|Unmeasurable Disease|2|||
156826975|NCT00054691|566118065|FG000|Overall Study|Noncompliant|1|||
156826976|NCT02914548|566118070|FG000|Overall Study|Adverse Event|15|||
156826977|NCT02914548|566118071|FG001|Overall Study|Adverse Event|7|||
156826978|NCT02914548|566118072|FG002|Overall Study|Adverse Event|15|||
156826979|NCT02914548|566118070|FG000|Overall Study|Physician Decision|2|||
156826980|NCT02914548|566118071|FG001|Overall Study|Physician Decision|2|||
156826981|NCT02914548|566118072|FG002|Overall Study|Physician Decision|0|||
156826982|NCT02914548|566118070|FG000|Overall Study|Protocol Violation|1|||
156826983|NCT02914548|566118071|FG001|Overall Study|Protocol Violation|0|||
156826984|NCT02914548|566118072|FG002|Overall Study|Protocol Violation|0|||
156826985|NCT02914548|566118070|FG000|Overall Study|Withdrawal by Subject|3|||
156826986|NCT02914548|566118071|FG001|Overall Study|Withdrawal by Subject|4|||
156826987|NCT02914548|566118072|FG002|Overall Study|Withdrawal by Subject|4|||
156826988|NCT02914548|566118070|FG000|Overall Study|>40% of body surface area|0|||
156826989|NCT02914548|566118071|FG001|Overall Study|>40% of body surface area|1|||
156826990|NCT02914548|566118072|FG002|Overall Study|>40% of body surface area|1|||
156826991|NCT03746600|566118073|FG000|Overall Study|Withdrawal by Subject|3|||
156826992|NCT03746600|566118074|FG001|Overall Study|Withdrawal by Subject|3|||
156826993|NCT03746600|566118073|FG000|Overall Study|dismissed from study|1|||
156826994|NCT03746600|566118074|FG001|Overall Study|dismissed from study|0|||
156826995|NCT03746600|566118073|FG000|Overall Study|Lost to Follow-up|1|||
156826996|NCT03746600|566118074|FG001|Overall Study|Lost to Follow-up|0|||
156826997|NCT01371643|566118080|FG000|Overall Study|Withdrawal by Subject|3|||
156826998|NCT01371643|566118081|FG001|Overall Study|Withdrawal by Subject|0|||
156826999|NCT02374814|566118082|FG000|Overall Study|Lost to Follow-up|1|||
156827000|NCT02374814|566118083|FG001|Overall Study|Lost to Follow-up|1|||
156827001|NCT02374814|566118084|FG002|Overall Study|Lost to Follow-up|0|||
156827002|NCT02374814|566118085|FG003|Overall Study|Lost to Follow-up|1|||
156827003|NCT02374814|566118086|FG004|Overall Study|Lost to Follow-up|0|||
156827004|NCT02374814|566118087|FG005|Overall Study|Lost to Follow-up|0|||
156827005|NCT02374814|566118082|FG000|Overall Study|Withdrawal by Subject|0|||
156827006|NCT02374814|566118083|FG001|Overall Study|Withdrawal by Subject|0|||
156827007|NCT02374814|566118084|FG002|Overall Study|Withdrawal by Subject|1|||
156827008|NCT02374814|566118085|FG003|Overall Study|Withdrawal by Subject|1|||
156827009|NCT02374814|566118086|FG004|Overall Study|Withdrawal by Subject|0|||
156827010|NCT02374814|566118087|FG005|Overall Study|Withdrawal by Subject|0|||
156827011|NCT04209114|566118088|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
156827012|NCT04209114|566118089|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
156827013|NCT04209114|566118090|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
156827014|NCT04209114|566118088|FG000|Pre-Treatment Phase|Other reasons|0|||
156827015|NCT04209114|566118089|FG001|Pre-Treatment Phase|Other reasons|0|||
156827016|NCT04209114|566118090|FG002|Pre-Treatment Phase|Other reasons|1|||
156827017|NCT04209114|566118088|FG000|Pre-Treatment Phase|Death|0|||
156827018|NCT04209114|566118089|FG001|Pre-Treatment Phase|Death|0|||
156827019|NCT04209114|566118090|FG002|Pre-Treatment Phase|Death|1|||
156827020|NCT04209114|566118088|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
156827021|NCT04209114|566118089|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
156827022|NCT04209114|566118090|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
156827023|NCT04209114|566118088|FG000|Treatment Phase|Other reasons|5|||
156827024|NCT04209114|566118089|FG001|Treatment Phase|Other reasons|3|||
156827025|NCT04209114|566118090|FG002|Treatment Phase|Other reasons|0|||
156827026|NCT04209114|566118088|FG000|Treatment Phase|Lost to Follow-up|1|||
156827027|NCT04209114|566118089|FG001|Treatment Phase|Lost to Follow-up|0|||
156827028|NCT04209114|566118090|FG002|Treatment Phase|Lost to Follow-up|0|||
156827029|NCT04209114|566118088|FG000|Treatment Phase|Participant withdrew consent|1|||
156827030|NCT04209114|566118089|FG001|Treatment Phase|Participant withdrew consent|0|||
156827031|NCT04209114|566118090|FG002|Treatment Phase|Participant withdrew consent|0|||
156827032|NCT04209114|566118088|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
156827033|NCT04209114|566118089|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
156827034|NCT04209114|566118090|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
156827035|NCT04209114|566118088|FG000|Treatment Phase|Death|4|||
156827036|NCT04209114|566118089|FG001|Treatment Phase|Death|1|||
156827037|NCT04209114|566118090|FG002|Treatment Phase|Death|0|||
156827038|NCT04209114|566118088|FG000|Treatment Phase|Study drug toxicity|4|||
156827039|NCT04209114|566118089|FG001|Treatment Phase|Study drug toxicity|6|||
156827040|NCT04209114|566118090|FG002|Treatment Phase|Study drug toxicity|0|||
156827041|NCT04209114|566118088|FG000|Treatment Phase|Disease progression|6|||
156827042|NCT04209114|566118089|FG001|Treatment Phase|Disease progression|9|||
156827043|NCT04209114|566118090|FG002|Treatment Phase|Disease progression|0|||
156827044|NCT03187834|566120998|FG000|Overall Study|Lost to Follow-up|0|||
156827045|NCT03187834|566120999|FG001|Overall Study|Lost to Follow-up|1|||
156827046|NCT03187834|566121000|FG002|Overall Study|Lost to Follow-up|2|||
156827047|NCT03187834|566121001|FG003|Overall Study|Lost to Follow-up|2|||
156827048|NCT03187834|566120998|FG000|Overall Study|Had invalid anthropometric measurements|5|||
156827049|NCT03187834|566120999|FG001|Overall Study|Had invalid anthropometric measurements|3|||
156827050|NCT03187834|566121000|FG002|Overall Study|Had invalid anthropometric measurements|4|||
156827051|NCT03187834|566121001|FG003|Overall Study|Had invalid anthropometric measurements|2|||
156827052|NCT00471887|566121007|FG000|Overall Study|Adverse Event|9|||
156827053|NCT01930890|566121008|FG000|Overall Study|Study Termination|14|||
156827054|NCT01930890|566121009|FG001|Overall Study|Study Termination|28|||
156827055|NCT01930890|566121010|FG002|Overall Study|Study Termination|13|||
156827056|NCT01930890|566121011|FG003|Overall Study|Study Termination|25|||
156827057|NCT01930890|566121008|FG000|Overall Study|Death|0|||
156827058|NCT01930890|566121009|FG001|Overall Study|Death|0|||
156827059|NCT01930890|566121010|FG002|Overall Study|Death|0|||
156827060|NCT01930890|566121011|FG003|Overall Study|Death|1|||
156827061|NCT01930890|566121008|FG000|Overall Study|Investigator Decision|0|||
156827062|NCT01930890|566121009|FG001|Overall Study|Investigator Decision|1|||
156827063|NCT01930890|566121010|FG002|Overall Study|Investigator Decision|0|||
156827064|NCT01930890|566121011|FG003|Overall Study|Investigator Decision|0|||
156827065|NCT01930890|566121008|FG000|Overall Study|Consent Withdrawn|0|||
156827066|NCT01930890|566121009|FG001|Overall Study|Consent Withdrawn|3|||
156827067|NCT01930890|566121010|FG002|Overall Study|Consent Withdrawn|0|||
156827068|NCT01930890|566121011|FG003|Overall Study|Consent Withdrawn|1|||
156827069|NCT01930890|566121008|FG000|Overall Study|Adverse Event|0|||
156827070|NCT01930890|566121009|FG001|Overall Study|Adverse Event|1|||
156827071|NCT01930890|566121010|FG002|Overall Study|Adverse Event|0|||
156827072|NCT01930890|566121011|FG003|Overall Study|Adverse Event|0|||
156827073|NCT03710876|566121012|FG000|Overall Study|Death|0|||
156827074|NCT03710876|566121013|FG001|Overall Study|Death|2|||
156827075|NCT03710876|566121012|FG000|Overall Study|Withdrawal by Subject|0|||
156827076|NCT03710876|566121013|FG001|Overall Study|Withdrawal by Subject|2|||
156827077|NCT01176565|566121021|FG000|Overall Study|Lost to Follow-up|12|||
156827078|NCT01176565|566121022|FG001|Overall Study|Lost to Follow-up|16|||
156827079|NCT01176565|566121021|FG000|Overall Study|Withdrawal by Subject|7|||
156827080|NCT01176565|566121022|FG001|Overall Study|Withdrawal by Subject|1|||
156827081|NCT01176565|566121021|FG000|Overall Study|Not Analyzed (any other reason)|1|||
156827082|NCT01176565|566121022|FG001|Overall Study|Not Analyzed (any other reason)|2|||
156827083|NCT03602885|566121024|FG000|Overall Study|Lost to Follow-up|3|||
156827084|NCT03602885|566121025|FG001|Overall Study|Lost to Follow-up|0|||
156827085|NCT02754141|566121026|FG000|Overall Study|Disease progression|11|||
156827086|NCT02754141|566121027|FG001|Overall Study|Disease progression|7|||
156827087|NCT02754141|566121028|FG002|Overall Study|Disease progression|8|||
156827088|NCT02754141|566121029|FG003|Overall Study|Disease progression|5|||
156827089|NCT02754141|566121030|FG004|Overall Study|Disease progression|7|||
156827090|NCT02754141|566121031|FG005|Overall Study|Disease progression|7|||
156827091|NCT02754141|566121032|FG006|Overall Study|Disease progression|7|||
156827092|NCT02754141|566121033|FG007|Overall Study|Disease progression|6|||
156827093|NCT02754141|566121034|FG008|Overall Study|Disease progression|11|||
156827094|NCT02754141|566121035|FG009|Overall Study|Disease progression|16|||
156827095|NCT02754141|566121036|FG010|Overall Study|Disease progression|18|||
156827096|NCT02754141|566121037|FG011|Overall Study|Disease progression|13|||
156827097|NCT02754141|566121038|FG012|Overall Study|Disease progression|10|||
156827098|NCT02754141|566121039|FG013|Overall Study|Disease progression|12|||
156827099|NCT02754141|566121040|FG014|Overall Study|Disease progression|12|||
156827100|NCT02754141|566121041|FG015|Overall Study|Disease progression|14|||
156827101|NCT02754141|566121042|FG016|Overall Study|Disease progression|0|||
156827102|NCT02754141|566121043|FG017|Overall Study|Disease progression|1|||
156827103|NCT02754141|566121026|FG000|Overall Study|Study drug toxicity|1|||
156827104|NCT02754141|566121027|FG001|Overall Study|Study drug toxicity|1|||
156827105|NCT02754141|566121028|FG002|Overall Study|Study drug toxicity|0|||
156827106|NCT02754141|566121029|FG003|Overall Study|Study drug toxicity|0|||
156827107|NCT02754141|566121030|FG004|Overall Study|Study drug toxicity|0|||
156827108|NCT02754141|566121031|FG005|Overall Study|Study drug toxicity|0|||
156827109|NCT02754141|566121032|FG006|Overall Study|Study drug toxicity|0|||
156827110|NCT02754141|566121033|FG007|Overall Study|Study drug toxicity|0|||
156827111|NCT02754141|566121034|FG008|Overall Study|Study drug toxicity|0|||
156827112|NCT02754141|566121035|FG009|Overall Study|Study drug toxicity|0|||
156827113|NCT02754141|566121036|FG010|Overall Study|Study drug toxicity|2|||
156827114|NCT02754141|566121037|FG011|Overall Study|Study drug toxicity|1|||
156827115|NCT02754141|566121038|FG012|Overall Study|Study drug toxicity|1|||
156827116|NCT02754141|566121039|FG013|Overall Study|Study drug toxicity|0|||
156827117|NCT02754141|566121040|FG014|Overall Study|Study drug toxicity|0|||
156827118|NCT02754141|566121041|FG015|Overall Study|Study drug toxicity|0|||
156827119|NCT02754141|566121042|FG016|Overall Study|Study drug toxicity|0|||
156827120|NCT02754141|566121043|FG017|Overall Study|Study drug toxicity|0|||
156827121|NCT02754141|566121026|FG000|Overall Study|AE unrelated to study drug|1|||
156827122|NCT02754141|566121027|FG001|Overall Study|AE unrelated to study drug|1|||
156827123|NCT02754141|566121028|FG002|Overall Study|AE unrelated to study drug|0|||
156827124|NCT02754141|566121029|FG003|Overall Study|AE unrelated to study drug|1|||
156827125|NCT02754141|566121030|FG004|Overall Study|AE unrelated to study drug|3|||
156827126|NCT02754141|566121031|FG005|Overall Study|AE unrelated to study drug|2|||
156827127|NCT02754141|566121032|FG006|Overall Study|AE unrelated to study drug|1|||
156827128|NCT02754141|566121033|FG007|Overall Study|AE unrelated to study drug|0|||
156827129|NCT02754141|566121034|FG008|Overall Study|AE unrelated to study drug|0|||
156827130|NCT02754141|566121035|FG009|Overall Study|AE unrelated to study drug|0|||
156827131|NCT02754141|566121036|FG010|Overall Study|AE unrelated to study drug|0|||
156827132|NCT02754141|566121037|FG011|Overall Study|AE unrelated to study drug|0|||
156827133|NCT02754141|566121038|FG012|Overall Study|AE unrelated to study drug|0|||
156827134|NCT02754141|566121039|FG013|Overall Study|AE unrelated to study drug|0|||
156827135|NCT02754141|566121040|FG014|Overall Study|AE unrelated to study drug|0|||
156827136|NCT02754141|566121041|FG015|Overall Study|AE unrelated to study drug|0|||
156827137|NCT02754141|566121042|FG016|Overall Study|AE unrelated to study drug|0|||
156827138|NCT02754141|566121043|FG017|Overall Study|AE unrelated to study drug|0|||
156827139|NCT02754141|566121026|FG000|Overall Study|Request to discontinue|0|||
156827140|NCT02754141|566121027|FG001|Overall Study|Request to discontinue|0|||
156827141|NCT02754141|566121028|FG002|Overall Study|Request to discontinue|0|||
156827142|NCT02754141|566121029|FG003|Overall Study|Request to discontinue|0|||
156827143|NCT02754141|566121030|FG004|Overall Study|Request to discontinue|0|||
156827144|NCT02754141|566121031|FG005|Overall Study|Request to discontinue|0|||
156827145|NCT02754141|566121032|FG006|Overall Study|Request to discontinue|0|||
156827146|NCT02754141|566121033|FG007|Overall Study|Request to discontinue|0|||
156827147|NCT02754141|566121034|FG008|Overall Study|Request to discontinue|1|||
156827148|NCT02754141|566121035|FG009|Overall Study|Request to discontinue|0|||
156827149|NCT02754141|566121036|FG010|Overall Study|Request to discontinue|0|||
156827150|NCT02754141|566121037|FG011|Overall Study|Request to discontinue|0|||
156466208|NCT00439270|564803826|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
156466209|NCT00439270|564803827|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
156827151|NCT02754141|566121038|FG012|Overall Study|Request to discontinue|0|||
156827152|NCT02754141|566121039|FG013|Overall Study|Request to discontinue|1|||
156827153|NCT02754141|566121040|FG014|Overall Study|Request to discontinue|1|||
156827154|NCT02754141|566121041|FG015|Overall Study|Request to discontinue|0|||
156827155|NCT02754141|566121042|FG016|Overall Study|Request to discontinue|0|||
156466210|NCT00439270|564803823|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
156466211|NCT00439270|564803824|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
156827156|NCT02754141|566121043|FG017|Overall Study|Request to discontinue|0|||
156827157|NCT02754141|566121026|FG000|Overall Study|Withdrew consent|0|||
156827158|NCT02754141|566121027|FG001|Overall Study|Withdrew consent|0|||
156827159|NCT02754141|566121028|FG002|Overall Study|Withdrew consent|0|||
156827160|NCT02754141|566121029|FG003|Overall Study|Withdrew consent|0|||
156827161|NCT02754141|566121030|FG004|Overall Study|Withdrew consent|0|||
156827162|NCT02754141|566121031|FG005|Overall Study|Withdrew consent|0|||
156827163|NCT02754141|566121032|FG006|Overall Study|Withdrew consent|0|||
156466212|NCT00439270|564803825|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
156827164|NCT02754141|566121033|FG007|Overall Study|Withdrew consent|0|||
156827165|NCT02754141|566121034|FG008|Overall Study|Withdrew consent|0|||
156827166|NCT02754141|566121035|FG009|Overall Study|Withdrew consent|1|||
156827167|NCT02754141|566121036|FG010|Overall Study|Withdrew consent|0|||
156827168|NCT02754141|566121037|FG011|Overall Study|Withdrew consent|0|||
156827169|NCT02754141|566121038|FG012|Overall Study|Withdrew consent|0|||
156827170|NCT02754141|566121039|FG013|Overall Study|Withdrew consent|0|||
156827171|NCT02754141|566121040|FG014|Overall Study|Withdrew consent|0|||
156827172|NCT02754141|566121041|FG015|Overall Study|Withdrew consent|0|||
156827173|NCT02754141|566121042|FG016|Overall Study|Withdrew consent|0|||
156827174|NCT02754141|566121043|FG017|Overall Study|Withdrew consent|0|||
156827175|NCT02754141|566121026|FG000|Overall Study|Maximum clinical benefit|0|||
156827176|NCT02754141|566121027|FG001|Overall Study|Maximum clinical benefit|0|||
156827177|NCT02754141|566121028|FG002|Overall Study|Maximum clinical benefit|0|||
156827178|NCT02754141|566121029|FG003|Overall Study|Maximum clinical benefit|1|||
156827179|NCT02754141|566121030|FG004|Overall Study|Maximum clinical benefit|0|||
156827180|NCT02754141|566121031|FG005|Overall Study|Maximum clinical benefit|0|||
156827181|NCT02754141|566121032|FG006|Overall Study|Maximum clinical benefit|0|||
156827182|NCT02754141|566121033|FG007|Overall Study|Maximum clinical benefit|0|||
156827183|NCT02754141|566121034|FG008|Overall Study|Maximum clinical benefit|0|||
156827184|NCT02754141|566121035|FG009|Overall Study|Maximum clinical benefit|0|||
156827185|NCT02754141|566121036|FG010|Overall Study|Maximum clinical benefit|0|||
156827186|NCT02754141|566121037|FG011|Overall Study|Maximum clinical benefit|0|||
156827187|NCT02754141|566121038|FG012|Overall Study|Maximum clinical benefit|0|||
156827188|NCT02754141|566121039|FG013|Overall Study|Maximum clinical benefit|0|||
156827189|NCT02754141|566121040|FG014|Overall Study|Maximum clinical benefit|0|||
156827190|NCT02754141|566121041|FG015|Overall Study|Maximum clinical benefit|0|||
156827191|NCT02754141|566121042|FG016|Overall Study|Maximum clinical benefit|0|||
156827192|NCT02754141|566121043|FG017|Overall Study|Maximum clinical benefit|0|||
156827193|NCT02754141|566121026|FG000|Overall Study|No longer meets study criteria|0|||
156827194|NCT02754141|566121027|FG001|Overall Study|No longer meets study criteria|0|||
156827195|NCT02754141|566121028|FG002|Overall Study|No longer meets study criteria|0|||
156827196|NCT02754141|566121029|FG003|Overall Study|No longer meets study criteria|1|||
156827197|NCT02754141|566121030|FG004|Overall Study|No longer meets study criteria|0|||
156827198|NCT02754141|566121031|FG005|Overall Study|No longer meets study criteria|0|||
156827199|NCT02754141|566121032|FG006|Overall Study|No longer meets study criteria|0|||
156827200|NCT02754141|566121033|FG007|Overall Study|No longer meets study criteria|0|||
156827201|NCT02754141|566121034|FG008|Overall Study|No longer meets study criteria|0|||
156827202|NCT02754141|566121035|FG009|Overall Study|No longer meets study criteria|0|||
156827203|NCT02754141|566121036|FG010|Overall Study|No longer meets study criteria|0|||
156827204|NCT02754141|566121037|FG011|Overall Study|No longer meets study criteria|0|||
156827205|NCT02754141|566121038|FG012|Overall Study|No longer meets study criteria|0|||
156827206|NCT02754141|566121039|FG013|Overall Study|No longer meets study criteria|0|||
156827207|NCT02754141|566121040|FG014|Overall Study|No longer meets study criteria|0|||
156827208|NCT02754141|566121041|FG015|Overall Study|No longer meets study criteria|0|||
156827209|NCT02754141|566121042|FG016|Overall Study|No longer meets study criteria|0|||
156827210|NCT02754141|566121043|FG017|Overall Study|No longer meets study criteria|0|||
156827211|NCT02754141|566121026|FG000|Overall Study|Other reasons|0|||
156827212|NCT02754141|566121027|FG001|Overall Study|Other reasons|0|||
156827213|NCT02754141|566121028|FG002|Overall Study|Other reasons|0|||
156827214|NCT02754141|566121029|FG003|Overall Study|Other reasons|0|||
156827215|NCT02754141|566121030|FG004|Overall Study|Other reasons|0|||
156827216|NCT02754141|566121031|FG005|Overall Study|Other reasons|0|||
156827217|NCT02754141|566121032|FG006|Overall Study|Other reasons|0|||
156827218|NCT02754141|566121033|FG007|Overall Study|Other reasons|1|||
156827219|NCT02754141|566121034|FG008|Overall Study|Other reasons|0|||
156827220|NCT02754141|566121035|FG009|Overall Study|Other reasons|0|||
156827221|NCT02754141|566121036|FG010|Overall Study|Other reasons|0|||
156827222|NCT02754141|566121037|FG011|Overall Study|Other reasons|0|||
156827223|NCT02754141|566121038|FG012|Overall Study|Other reasons|2|||
156827224|NCT02754141|566121039|FG013|Overall Study|Other reasons|0|||
156827225|NCT02754141|566121040|FG014|Overall Study|Other reasons|0|||
156827226|NCT02754141|566121041|FG015|Overall Study|Other reasons|0|||
156827227|NCT02754141|566121042|FG016|Overall Study|Other reasons|0|||
156827228|NCT02754141|566121043|FG017|Overall Study|Other reasons|0|||
156827229|NCT02754141|566121026|FG000|Overall Study|Completed treatment as per protocol|0|||
156827230|NCT02754141|566121027|FG001|Overall Study|Completed treatment as per protocol|1|||
156827231|NCT02754141|566121028|FG002|Overall Study|Completed treatment as per protocol|0|||
156827232|NCT02754141|566121029|FG003|Overall Study|Completed treatment as per protocol|0|||
156827233|NCT02754141|566121030|FG004|Overall Study|Completed treatment as per protocol|0|||
156827234|NCT02754141|566121031|FG005|Overall Study|Completed treatment as per protocol|0|||
156827235|NCT02754141|566121032|FG006|Overall Study|Completed treatment as per protocol|0|||
156827236|NCT02754141|566121033|FG007|Overall Study|Completed treatment as per protocol|0|||
156827237|NCT02754141|566121034|FG008|Overall Study|Completed treatment as per protocol|0|||
156827238|NCT02754141|566121035|FG009|Overall Study|Completed treatment as per protocol|0|||
156827239|NCT02754141|566121036|FG010|Overall Study|Completed treatment as per protocol|0|||
156827240|NCT02754141|566121037|FG011|Overall Study|Completed treatment as per protocol|0|||
156827241|NCT02754141|566121038|FG012|Overall Study|Completed treatment as per protocol|1|||
156827242|NCT02754141|566121039|FG013|Overall Study|Completed treatment as per protocol|0|||
156827243|NCT02754141|566121040|FG014|Overall Study|Completed treatment as per protocol|0|||
156827244|NCT02754141|566121041|FG015|Overall Study|Completed treatment as per protocol|0|||
156827245|NCT02754141|566121042|FG016|Overall Study|Completed treatment as per protocol|0|||
156827246|NCT02754141|566121043|FG017|Overall Study|Completed treatment as per protocol|0|||
156827247|NCT02754141|566121026|FG000|Overall Study|Not completing monotherapy|0|||
156827248|NCT02754141|566121027|FG001|Overall Study|Not completing monotherapy|0|||
156827249|NCT02754141|566121028|FG002|Overall Study|Not completing monotherapy|0|||
156827250|NCT02754141|566121029|FG003|Overall Study|Not completing monotherapy|0|||
156827251|NCT02754141|566121030|FG004|Overall Study|Not completing monotherapy|0|||
156827252|NCT02754141|566121031|FG005|Overall Study|Not completing monotherapy|0|||
156827253|NCT02754141|566121032|FG006|Overall Study|Not completing monotherapy|0|||
156339359|NCT00481078|564340182|FG000|Overall Study|Received other treatment|2|||
156339360|NCT00481078|564340183|FG001|Overall Study|Received other treatment|1|||
156339361|NCT00481078|564340182|FG000|Overall Study|Brain metastasis|0|||
156339362|NCT00481078|564340183|FG001|Overall Study|Brain metastasis|1|||
156339363|NCT01558271|564340184|FG000|Overall Study|Adverse Event|6|||
156339364|NCT01558271|564340185|FG001|Overall Study|Adverse Event|3|||
156339365|NCT01558271|564340186|FG002|Overall Study|Adverse Event|4|||
156339366|NCT01558271|564340184|FG000|Overall Study|Lost to Follow-up|1|||
156339367|NCT01558271|564340185|FG001|Overall Study|Lost to Follow-up|0|||
156339368|NCT01558271|564340186|FG002|Overall Study|Lost to Follow-up|0|||
156339369|NCT01558271|564340184|FG000|Overall Study|Protocol Violation|1|||
156339370|NCT01558271|564340185|FG001|Overall Study|Protocol Violation|0|||
156541206|NCT00573430|565074508|FG001|Overall Study|Incorrect enrollment of randomization|4|||
156541207|NCT00573430|565074509|FG002|Overall Study|Incorrect enrollment of randomization|3|||
156827254|NCT02754141|566121033|FG007|Overall Study|Not completing monotherapy|0|||
156827255|NCT02754141|566121034|FG008|Overall Study|Not completing monotherapy|0|||
156827256|NCT02754141|566121035|FG009|Overall Study|Not completing monotherapy|0|||
156827257|NCT02754141|566121036|FG010|Overall Study|Not completing monotherapy|0|||
156827258|NCT02754141|566121037|FG011|Overall Study|Not completing monotherapy|0|||
156827259|NCT02754141|566121038|FG012|Overall Study|Not completing monotherapy|0|||
156827260|NCT02754141|566121039|FG013|Overall Study|Not completing monotherapy|1|||
156827261|NCT02754141|566121040|FG014|Overall Study|Not completing monotherapy|0|||
156827262|NCT02754141|566121041|FG015|Overall Study|Not completing monotherapy|0|||
156827263|NCT02754141|566121042|FG016|Overall Study|Not completing monotherapy|0|||
156827264|NCT02754141|566121043|FG017|Overall Study|Not completing monotherapy|0|||
156827265|NCT01187446|566121047|FG000|Overall Study|Patient started non-protocol therapy|0|||
156827266|NCT01187446|566121048|FG001|Overall Study|Patient started non-protocol therapy|1|||
156827267|NCT00823212|566121049|FG000|Overall Study|Death|8|||
156827268|NCT00823212|566121050|FG001|Overall Study|Death|10|||
156827269|NCT00823212|566121049|FG000|Overall Study|Withdrawal by Subject|6|||
156827270|NCT00823212|566121050|FG001|Overall Study|Withdrawal by Subject|1|||
156827271|NCT00823212|566121049|FG000|Overall Study|Incarcerated|0|||
156827272|NCT00823212|566121050|FG001|Overall Study|Incarcerated|1|||
156827273|NCT00823212|566121049|FG000|Overall Study|Missed 12-month visit|21|||
156827274|NCT00823212|566121050|FG001|Overall Study|Missed 12-month visit|21|||
156827275|NCT02285114|566121052|FG000|Main Phase|Investigator's Discretion|0|||
156827276|NCT02285114|566121053|FG001|Main Phase|Investigator's Discretion|2|||
156827277|NCT02285114|566121054|FG002|Main Phase|Investigator's Discretion|0|||
156827278|NCT02285114|566121055|FG003|Main Phase|Investigator's Discretion|0|||
156827279|NCT02285114|566121056|FG004|Main Phase|Investigator's Discretion|0|||
156827280|NCT02285114|566121057|FG005|Main Phase|Investigator's Discretion|0|||
156827281|NCT02285114|566121052|FG000|Main Phase|Enrolled but Never Treated|1|||
156827282|NCT02285114|566121053|FG001|Main Phase|Enrolled but Never Treated|0|||
156827283|NCT02285114|566121054|FG002|Main Phase|Enrolled but Never Treated|0|||
156827284|NCT02285114|566121055|FG003|Main Phase|Enrolled but Never Treated|0|||
156827285|NCT02285114|566121056|FG004|Main Phase|Enrolled but Never Treated|0|||
156339371|NCT01558271|564340186|FG002|Overall Study|Protocol Violation|0|||
156541208|NCT00573430|565074507|FG000|Overall Study|Adverse Event|0|||
156339372|NCT01558271|564340184|FG000|Overall Study|Withdrawal by Subject|10|||
156827286|NCT02285114|566121057|FG005|Main Phase|Enrolled but Never Treated|0|||
156827287|NCT02285114|566121052|FG000|Main Phase|Withdrew Consent|0|||
156339373|NCT01558271|564340185|FG001|Overall Study|Withdrawal by Subject|6|||
156339374|NCT01558271|564340186|FG002|Overall Study|Withdrawal by Subject|12|||
156827288|NCT02285114|566121053|FG001|Main Phase|Withdrew Consent|0|||
156827289|NCT02285114|566121054|FG002|Main Phase|Withdrew Consent|1|||
156827290|NCT02285114|566121055|FG003|Main Phase|Withdrew Consent|0|||
156827291|NCT02285114|566121056|FG004|Main Phase|Withdrew Consent|0|||
156827292|NCT02285114|566121057|FG005|Main Phase|Withdrew Consent|0|||
156827293|NCT02285114|566121052|FG000|Extension Phase|Investigator's Discretion|0|||
156827294|NCT02285114|566121053|FG001|Extension Phase|Investigator's Discretion|0|||
156827295|NCT02285114|566121054|FG002|Extension Phase|Investigator's Discretion|0|||
156827296|NCT02285114|566121055|FG003|Extension Phase|Investigator's Discretion|14|||
156827297|NCT02285114|566121056|FG004|Extension Phase|Investigator's Discretion|1|||
156827298|NCT02285114|566121057|FG005|Extension Phase|Investigator's Discretion|0|||
156827299|NCT02285114|566121052|FG000|Extension Phase|Lost to Follow-up|0|||
156827300|NCT02285114|566121053|FG001|Extension Phase|Lost to Follow-up|0|||
156827301|NCT02285114|566121054|FG002|Extension Phase|Lost to Follow-up|0|||
156827302|NCT02285114|566121055|FG003|Extension Phase|Lost to Follow-up|1|||
156827303|NCT02285114|566121056|FG004|Extension Phase|Lost to Follow-up|1|||
156827304|NCT02285114|566121057|FG005|Extension Phase|Lost to Follow-up|0|||
156827305|NCT02285114|566121052|FG000|Extension Phase|Non-compliance with Study Drug|0|||
156827306|NCT02285114|566121053|FG001|Extension Phase|Non-compliance with Study Drug|0|||
156827307|NCT02285114|566121054|FG002|Extension Phase|Non-compliance with Study Drug|0|||
156827308|NCT02285114|566121055|FG003|Extension Phase|Non-compliance with Study Drug|2|||
156827309|NCT02285114|566121056|FG004|Extension Phase|Non-compliance with Study Drug|0|||
156827310|NCT02285114|566121057|FG005|Extension Phase|Non-compliance with Study Drug|0|||
156827311|NCT02285114|566121052|FG000|Extension Phase|Pregnancy|0|||
156827312|NCT02285114|566121053|FG001|Extension Phase|Pregnancy|0|||
156827313|NCT02285114|566121054|FG002|Extension Phase|Pregnancy|0|||
156827314|NCT02285114|566121055|FG003|Extension Phase|Pregnancy|1|||
156827315|NCT02285114|566121056|FG004|Extension Phase|Pregnancy|0|||
156827316|NCT02285114|566121057|FG005|Extension Phase|Pregnancy|0|||
156827317|NCT00320255|566121058|FG000|Overall Study|Lack of Efficacy|1|||
156827318|NCT00320255|566121059|FG001|Overall Study|Lack of Efficacy|0|||
156827319|NCT00320255|566121060|FG002|Overall Study|Lack of Efficacy|0|||
156827320|NCT00320255|566121061|FG003|Overall Study|Lack of Efficacy|0|||
156827321|NCT00320255|566121062|FG004|Overall Study|Lack of Efficacy|0|||
156827322|NCT00320255|566121063|FG005|Overall Study|Lack of Efficacy|0|||
156827323|NCT00320255|566121058|FG000|Overall Study|Adverse Event|5|||
156827324|NCT00320255|566121059|FG001|Overall Study|Adverse Event|2|||
156827325|NCT00320255|566121060|FG002|Overall Study|Adverse Event|3|||
156827326|NCT00320255|566121061|FG003|Overall Study|Adverse Event|2|||
156827327|NCT00320255|566121062|FG004|Overall Study|Adverse Event|0|||
156827328|NCT00320255|566121063|FG005|Overall Study|Adverse Event|0|||
156827329|NCT00320255|566121058|FG000|Overall Study|Withdrawal by Subject|1|||
156827330|NCT00320255|566121059|FG001|Overall Study|Withdrawal by Subject|2|||
156827331|NCT00320255|566121060|FG002|Overall Study|Withdrawal by Subject|2|||
156827332|NCT00320255|566121061|FG003|Overall Study|Withdrawal by Subject|4|||
156827333|NCT00320255|566121062|FG004|Overall Study|Withdrawal by Subject|0|||
156827334|NCT00320255|566121063|FG005|Overall Study|Withdrawal by Subject|0|||
156827335|NCT00320255|566121058|FG000|Overall Study|Poor compliance/noncompliance|1|||
156827336|NCT00320255|566121059|FG001|Overall Study|Poor compliance/noncompliance|1|||
156827337|NCT00320255|566121060|FG002|Overall Study|Poor compliance/noncompliance|0|||
156827338|NCT00320255|566121061|FG003|Overall Study|Poor compliance/noncompliance|1|||
156827339|NCT00320255|566121062|FG004|Overall Study|Poor compliance/noncompliance|0|||
156827340|NCT00320255|566121063|FG005|Overall Study|Poor compliance/noncompliance|0|||
156827341|NCT00320255|566121058|FG000|Overall Study|No longer meets study criteria|0|||
156827342|NCT00320255|566121059|FG001|Overall Study|No longer meets study criteria|0|||
156827343|NCT00320255|566121060|FG002|Overall Study|No longer meets study criteria|0|||
156827344|NCT00320255|566121061|FG003|Overall Study|No longer meets study criteria|1|||
156827345|NCT00320255|566121062|FG004|Overall Study|No longer meets study criteria|0|||
156827346|NCT00320255|566121063|FG005|Overall Study|No longer meets study criteria|0|||
156827347|NCT00320255|566121058|FG000|Overall Study|Other|3|||
156827348|NCT00320255|566121059|FG001|Overall Study|Other|2|||
156827349|NCT00320255|566121060|FG002|Overall Study|Other|1|||
156827350|NCT00320255|566121061|FG003|Overall Study|Other|0|||
156827351|NCT00320255|566121062|FG004|Overall Study|Other|0|||
156827352|NCT00320255|566121063|FG005|Overall Study|Other|0|||
156827353|NCT01156389|566121064|FG000|Overall Study|Elevated liver enzymes|4|||
156827354|NCT01156389|566121065|FG001|Overall Study|Elevated liver enzymes|0|||
156827355|NCT01156389|566121064|FG000|Overall Study|Vomiting|0|||
156827356|NCT01156389|566121065|FG001|Overall Study|Vomiting|1|||
156827357|NCT02351349|566121066|FG000|Overall Study|Withdrawal by Subject|2|||
156827358|NCT02351349|566121067|FG001|Overall Study|Withdrawal by Subject|3|||
156827359|NCT00350623|566121068|FG000|Overall Study|Lost to Follow-up|8|||
156827360|NCT00350623|566121069|FG001|Overall Study|Lost to Follow-up|3|||
156827361|NCT00350623|566121070|FG002|Overall Study|Lost to Follow-up|4|||
156827362|NCT00350623|566121068|FG000|Overall Study|Withdrawal by Subject|0|||
156827363|NCT00350623|566121069|FG001|Overall Study|Withdrawal by Subject|1|||
156827364|NCT00350623|566121070|FG002|Overall Study|Withdrawal by Subject|1|||
156827365|NCT00350623|566121068|FG000|Overall Study|patient traveling outside the country|0|||
156827366|NCT00350623|566121069|FG001|Overall Study|patient traveling outside the country|0|||
156827367|NCT00350623|566121070|FG002|Overall Study|patient traveling outside the country|1|||
156827368|NCT00090233|566121078|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
156827369|NCT00090233|566121079|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
156827370|NCT00090233|566121078|FG000|Overall Study|Adverse Event|214|||
156827371|NCT00090233|566121079|FG001|Overall Study|Adverse Event|198|||
156827372|NCT00090233|566121078|FG000|Overall Study|Lost to Follow-up|68|||
156827373|NCT00090233|566121079|FG001|Overall Study|Lost to Follow-up|95|||
156827374|NCT00090233|566121078|FG000|Overall Study|Protocol Violation|960|||
156827375|NCT00090233|566121079|FG001|Overall Study|Protocol Violation|1022|||
156827376|NCT00090233|566121078|FG000|Overall Study|Withdrawal by Subject|182|||
156827377|NCT00090233|566121079|FG001|Overall Study|Withdrawal by Subject|211|||
156827378|NCT00090233|566121078|FG000|Overall Study|Moved|203|||
156827379|NCT00090233|566121079|FG001|Overall Study|Moved|189|||
156827380|NCT00090233|566121078|FG000|Overall Study|Other|1211|||
156827381|NCT00090233|566121079|FG001|Overall Study|Other|1160|||
156827382|NCT00090233|566121078|FG000|Overall Study|Data not available at data cut-off point|1552|||
156827383|NCT00090233|566121079|FG001|Overall Study|Data not available at data cut-off point|1563|||
156827384|NCT04863248|566121080|FG000|Overall Study|Sponsor Terminated|4|||
156827385|NCT04863248|566121081|FG001|Overall Study|Sponsor Terminated|1|||
156827386|NCT04863248|566121080|FG000|Overall Study|Death|0|||
156827387|NCT04863248|566121081|FG001|Overall Study|Death|1|||
156827388|NCT04863248|566121080|FG000|Overall Study|Withdrawal by Subject|0|||
156827389|NCT04863248|566121081|FG001|Overall Study|Withdrawal by Subject|1|||
156827390|NCT02536300|566121082|FG000|Overall Study|Investigator's Discretion|17|||
156827391|NCT02536300|566121083|FG001|Overall Study|Investigator's Discretion|11|||
156827392|NCT02536300|566121084|FG002|Overall Study|Investigator's Discretion|2|||
156827393|NCT02536300|566121082|FG000|Overall Study|Progressive Disease|11|||
156827394|NCT02536300|566121083|FG001|Overall Study|Progressive Disease|7|||
156827395|NCT02536300|566121084|FG002|Overall Study|Progressive Disease|6|||
156827396|NCT02536300|566121082|FG000|Overall Study|Study Terminated by Sponsor|6|||
156827397|NCT02536300|566121083|FG001|Overall Study|Study Terminated by Sponsor|4|||
156827398|NCT02536300|566121084|FG002|Overall Study|Study Terminated by Sponsor|7|||
156827399|NCT02536300|566121082|FG000|Overall Study|Death|7|||
156827400|NCT02536300|566121083|FG001|Overall Study|Death|0|||
156827401|NCT02536300|566121084|FG002|Overall Study|Death|5|||
156827402|NCT02536300|566121082|FG000|Overall Study|Withdrew Consent|4|||
156827403|NCT02536300|566121083|FG001|Overall Study|Withdrew Consent|2|||
156827404|NCT02536300|566121084|FG002|Overall Study|Withdrew Consent|0|||
156827405|NCT02536300|566121082|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
156827406|NCT02536300|566121083|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
156827407|NCT02536300|566121084|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
156339375|NCT01558271|564340184|FG000|Overall Study|Physician Decision|0|||
156339376|NCT01558271|564340185|FG001|Overall Study|Physician Decision|2|||
156827408|NCT02536300|566121082|FG000|Overall Study|Enrolled but Never Treated|0|||
156827409|NCT02536300|566121083|FG001|Overall Study|Enrolled but Never Treated|0|||
156827410|NCT02536300|566121084|FG002|Overall Study|Enrolled but Never Treated|1|||
156827411|NCT02536300|566121082|FG000|Overall Study|Non-compliance With Study Drug|1|||
156827412|NCT02536300|566121083|FG001|Overall Study|Non-compliance With Study Drug|0|||
156827413|NCT02536300|566121084|FG002|Overall Study|Non-compliance With Study Drug|0|||
156827414|NCT02536300|566121082|FG000|Overall Study|Protocol Violation|0|||
156827415|NCT02536300|566121083|FG001|Overall Study|Protocol Violation|1|||
156827416|NCT02536300|566121084|FG002|Overall Study|Protocol Violation|0|||
156827417|NCT01779869|566121085|FG000|Overall Study|Physician Decision|2|||
156827418|NCT01691105|566121095|FG000|1 Month Follow-up|Lost to Follow-up|41|||
156827419|NCT01691105|566121096|FG001|1 Month Follow-up|Lost to Follow-up|38|||
156827420|NCT01691105|566121095|FG000|1 Month Follow-up|Death|2|||
156827421|NCT01691105|566121096|FG001|1 Month Follow-up|Death|3|||
156827422|NCT01691105|566121095|FG000|6 Month Follow-up|Lost to Follow-up|39|||
156827423|NCT01691105|566121096|FG001|6 Month Follow-up|Lost to Follow-up|58|||
156827424|NCT01691105|566121095|FG000|6 Month Follow-up|Death|13|||
156339377|NCT01558271|564340186|FG002|Overall Study|Physician Decision|1|||
156827425|NCT01691105|566121096|FG001|6 Month Follow-up|Death|13|||
156827426|NCT01691105|566121095|FG000|12 Month Follow-up|Lost to Follow-up|50|||
156827427|NCT01691105|566121096|FG001|12 Month Follow-up|Lost to Follow-up|71|||
156827428|NCT01691105|566121095|FG000|12 Month Follow-up|Death|22|||
156339378|NCT01785069|564340188|FG000|Overall Study|Implanted with nonstudy device|1|||
156339379|NCT01785069|564340189|FG001|Overall Study|Implanted with nonstudy device|2|||
156466213|NCT00439270|564803826|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
156827429|NCT01691105|566121096|FG001|12 Month Follow-up|Death|30|||
156827430|NCT01691105|566121095|FG000|12 Month Biochemical Verification|Death|22|||
156827431|NCT01691105|566121096|FG001|12 Month Biochemical Verification|Death|30|||
156827432|NCT01691105|566121095|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
156827433|NCT01691105|566121096|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
156827434|NCT01691105|566121095|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
156827435|NCT01691105|566121096|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
156827436|NCT00957944|566121097|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
156827437|NCT00957944|566121098|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
156827438|NCT01482169|566121100|FG000|Overall Study|Physician Decision|2|||
156827439|NCT00445848|566121103|FG000|Overall Study|Adverse Event|14|||
156827440|NCT00445848|566121103|FG000|Overall Study|Withdrawal by Subject|4|||
156827441|NCT00445848|566121103|FG000|Overall Study|Progression|62|||
156827442|NCT00445848|566121103|FG000|Overall Study|Other-Not protocol specified|5|||
156827443|NCT02701777|566121104|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
156827444|NCT02701777|566121105|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
156827445|NCT02701777|566121106|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
156827446|NCT02701777|566121107|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
156827447|NCT02701777|566121104|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
156827448|NCT02701777|566121105|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
156827449|NCT02701777|566121106|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
156827450|NCT02701777|566121107|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
156827451|NCT01560637|566121110|FG000|Overall Study|Adverse Event|63|||
156827452|NCT01560637|566121110|FG000|Overall Study|Death|69|||
156827453|NCT01560637|566121110|FG000|Overall Study|Lost to Follow-up|8|||
156827454|NCT01560637|566121110|FG000|Overall Study|Protocol Violation|8|||
156827455|NCT01560637|566121110|FG000|Overall Study|Withdrawal by Subject|24|||
156827456|NCT01560637|566121110|FG000|Overall Study|Progressive Disease|20|||
156827457|NCT01560637|566121110|FG000|Overall Study|Other Reason Not Specified|6|||
156827458|NCT01089023|566121111|FG000|Overall Study|Lost to Follow-up|3|||
156827459|NCT01089023|566121111|FG000|Overall Study|Adverse Event|1|||
156827460|NCT01089023|566121111|FG000|Overall Study|Withdrawal by Subject|1|||
156827461|NCT01089023|566121111|FG000|Overall Study|Protocol Violation|1|||
156827462|NCT01089023|566121111|FG000|Overall Study|Lack of Efficacy|1|||
156827463|NCT03220581|566121112|FG000|Overall Study|Withdrawal by Subject|0|||
156827464|NCT03220581|566121113|FG001|Overall Study|Withdrawal by Subject|1|||
156827465|NCT03220581|566121112|FG000|Overall Study|Lost to Follow-up|3|||
156827466|NCT03220581|566121113|FG001|Overall Study|Lost to Follow-up|6|||
156827467|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
156827468|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
156827469|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
156827470|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
156827471|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
156827472|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
156827473|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
156827474|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
156827475|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
156827476|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
156827477|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
156827478|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
156827479|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Adverse Event|1|||
156827480|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Adverse Event|0|||
156827481|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Adverse Event|2|||
156827482|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Adverse Event|0|||
156827483|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
156827484|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
156827485|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
156827486|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
156827487|NCT01185964|566121115|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
156827488|NCT01185964|566121116|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
156827489|NCT01185964|566121117|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
156827490|NCT01185964|566121118|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
156827491|NCT01185964|566121115|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
156827492|NCT01185964|566121116|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
156827493|NCT01185964|566121117|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
156827494|NCT01185964|566121118|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
156827495|NCT01185964|566121115|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
156827496|NCT01185964|566121116|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
156827497|NCT01185964|566121117|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
156827498|NCT01185964|566121118|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
156466214|NCT00439270|564803827|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
156466215|NCT00439270|564803823|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
156541209|NCT00573430|565074508|FG001|Overall Study|Adverse Event|0|||
156827499|NCT04465877|566121119|FG000|Overall Study|Noncompliant with study requirements|0|||
156827500|NCT04465877|566121120|FG001|Overall Study|Noncompliant with study requirements|0|||
156827501|NCT04465877|566121121|FG002|Overall Study|Noncompliant with study requirements|1|||
156827502|NCT04465877|566121122|FG003|Overall Study|Noncompliant with study requirements|0|||
156827503|NCT02323204|566121123|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
156827504|NCT02323204|566121124|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
156827505|NCT02323204|566121125|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
156827506|NCT02323204|566121126|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
156827507|NCT02323204|566121123|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
156827508|NCT02323204|566121124|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
156827509|NCT02323204|566121125|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
156827510|NCT02323204|566121126|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
156827511|NCT02323204|566121123|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
156827512|NCT02323204|566121124|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
156827513|NCT02323204|566121125|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
156827514|NCT02323204|566121126|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
156827515|NCT02323204|566121123|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
156827516|NCT02323204|566121124|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
156827517|NCT02323204|566121125|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
156827518|NCT02323204|566121126|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
156827519|NCT02323204|566121123|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
156827520|NCT02323204|566121124|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
156827521|NCT02323204|566121125|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
156827522|NCT02323204|566121126|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
156827523|NCT02323204|566121123|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
156827524|NCT02323204|566121124|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
156827525|NCT02323204|566121125|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
156827526|NCT02323204|566121126|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
156827527|NCT02323204|566121123|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
156827528|NCT02323204|566121124|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
156827529|NCT02323204|566121125|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
156827530|NCT02323204|566121126|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
156827531|NCT02323204|566121123|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
156827532|NCT02323204|566121124|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
156827533|NCT02323204|566121125|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
156827534|NCT02323204|566121126|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
156827535|NCT02323204|566121123|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
156827536|NCT02323204|566121124|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
156827537|NCT02323204|566121125|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
156827538|NCT02323204|566121126|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
156827539|NCT03576755|566121127|FG000|Overall Study|Withdrawal by Subject|1|||
156827540|NCT03576755|566121128|FG001|Overall Study|Withdrawal by Subject|0|||
156827541|NCT03576755|566121129|FG002|Overall Study|Withdrawal by Subject|0|||
156827542|NCT03576755|566121130|FG003|Overall Study|Withdrawal by Subject|0|||
156827543|NCT04962230|566121131|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
156827544|NCT04962230|566121131|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
156827545|NCT01396265|566121132|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
156827546|NCT03444766|566121133|FG000|Overall Study|Other Reasons|2|||
156827547|NCT03444766|566121133|FG000|Overall Study|Participant Withdrew Consent|5|||
156827548|NCT03444766|566121133|FG000|Overall Study|Lost to Follow-up|2|||
156827549|NCT03444766|566121133|FG000|Overall Study|Death|2|||
156827550|NCT03444766|566121133|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
156827551|NCT03444766|566121133|FG000|Overall Study|Disease Progression|49|||
156827552|NCT04346108|566121134|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
156827553|NCT04346108|566121135|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
156827554|NCT04346108|566121136|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
156827555|NCT04346108|566121134|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
156827556|NCT04346108|566121135|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
156827557|NCT04346108|566121136|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
156827558|NCT01598753|566121137|FG000|Overall Study|Adverse Event|1|||
156827559|NCT01598753|566121138|FG001|Overall Study|Adverse Event|9|||
156827560|NCT01598753|566121139|FG002|Overall Study|Adverse Event|1|||
156827561|NCT01598753|566121140|FG003|Overall Study|Adverse Event|7|||
156827562|NCT01598753|566121137|FG000|Overall Study|Lost to Follow-up|4|||
156827563|NCT01598753|566121138|FG001|Overall Study|Lost to Follow-up|3|||
156827564|NCT01598753|566121139|FG002|Overall Study|Lost to Follow-up|7|||
156827565|NCT01598753|566121140|FG003|Overall Study|Lost to Follow-up|5|||
156827566|NCT01598753|566121137|FG000|Overall Study|Physician Decision|0|||
156827567|NCT01598753|566121138|FG001|Overall Study|Physician Decision|1|||
156827568|NCT01598753|566121139|FG002|Overall Study|Physician Decision|0|||
156827569|NCT01598753|566121140|FG003|Overall Study|Physician Decision|2|||
156827570|NCT01598753|566121137|FG000|Overall Study|Withdrawal by Subject|7|||
156827571|NCT01598753|566121138|FG001|Overall Study|Withdrawal by Subject|2|||
156827572|NCT01598753|566121139|FG002|Overall Study|Withdrawal by Subject|0|||
156827573|NCT01598753|566121140|FG003|Overall Study|Withdrawal by Subject|1|||
156827574|NCT02275117|566121141|FG000|Overall Study|Adverse Event|0|||
156827575|NCT02275117|566121142|FG001|Overall Study|Adverse Event|0|||
156827576|NCT02275117|566121143|FG002|Overall Study|Adverse Event|0|||
156827577|NCT02275117|566121144|FG003|Overall Study|Adverse Event|0|||
156827578|NCT02275117|566121145|FG004|Overall Study|Adverse Event|1|||
156827579|NCT02275117|566121141|FG000|Overall Study|Lack of Efficacy|6|||
156827580|NCT02275117|566121142|FG001|Overall Study|Lack of Efficacy|7|||
156827581|NCT02275117|566121143|FG002|Overall Study|Lack of Efficacy|5|||
156827582|NCT02275117|566121144|FG003|Overall Study|Lack of Efficacy|2|||
156827583|NCT02275117|566121145|FG004|Overall Study|Lack of Efficacy|10|||
156827584|NCT02275117|566121141|FG000|Overall Study|Lost to Follow-up|11|||
156827585|NCT02275117|566121142|FG001|Overall Study|Lost to Follow-up|16|||
156827586|NCT02275117|566121143|FG002|Overall Study|Lost to Follow-up|15|||
156827587|NCT02275117|566121144|FG003|Overall Study|Lost to Follow-up|16|||
156827588|NCT02275117|566121145|FG004|Overall Study|Lost to Follow-up|8|||
156827589|NCT02275117|566121141|FG000|Overall Study|Physician Decision|0|||
156827590|NCT02275117|566121142|FG001|Overall Study|Physician Decision|1|||
156827591|NCT02275117|566121143|FG002|Overall Study|Physician Decision|1|||
156827592|NCT02275117|566121144|FG003|Overall Study|Physician Decision|0|||
156827593|NCT02275117|566121145|FG004|Overall Study|Physician Decision|1|||
156827594|NCT02275117|566121141|FG000|Overall Study|Protocol Violation|1|||
156827595|NCT02275117|566121142|FG001|Overall Study|Protocol Violation|0|||
156827596|NCT02275117|566121143|FG002|Overall Study|Protocol Violation|1|||
156827597|NCT02275117|566121144|FG003|Overall Study|Protocol Violation|1|||
156827598|NCT02275117|566121145|FG004|Overall Study|Protocol Violation|0|||
156827599|NCT02275117|566121141|FG000|Overall Study|Withdrawal by Subject|6|||
156827600|NCT02275117|566121142|FG001|Overall Study|Withdrawal by Subject|4|||
156827601|NCT02275117|566121143|FG002|Overall Study|Withdrawal by Subject|7|||
156827602|NCT02275117|566121144|FG003|Overall Study|Withdrawal by Subject|3|||
156827603|NCT02275117|566121145|FG004|Overall Study|Withdrawal by Subject|3|||
156827604|NCT02275117|566121141|FG000|Overall Study|Terminated by Sponsor|4|||
156827605|NCT02275117|566121142|FG001|Overall Study|Terminated by Sponsor|4|||
156827606|NCT02275117|566121143|FG002|Overall Study|Terminated by Sponsor|4|||
156827607|NCT02275117|566121144|FG003|Overall Study|Terminated by Sponsor|6|||
156827608|NCT02275117|566121145|FG004|Overall Study|Terminated by Sponsor|4|||
156827609|NCT02275117|566121141|FG000|Overall Study|Worsening of Study Indication|0|||
156827610|NCT02275117|566121142|FG001|Overall Study|Worsening of Study Indication|1|||
156827611|NCT02275117|566121143|FG002|Overall Study|Worsening of Study Indication|2|||
156827612|NCT02275117|566121144|FG003|Overall Study|Worsening of Study Indication|0|||
156827613|NCT02275117|566121145|FG004|Overall Study|Worsening of Study Indication|0|||
156827614|NCT02275117|566121141|FG000|Overall Study|Study Burden|5|||
156827615|NCT02275117|566121142|FG001|Overall Study|Study Burden|4|||
156827616|NCT02275117|566121143|FG002|Overall Study|Study Burden|7|||
156827617|NCT02275117|566121144|FG003|Overall Study|Study Burden|5|||
156827618|NCT02275117|566121145|FG004|Overall Study|Study Burden|7|||
156827619|NCT02275117|566121141|FG000|Overall Study|Other|1|||
156827620|NCT02275117|566121142|FG001|Overall Study|Other|0|||
156827621|NCT02275117|566121143|FG002|Overall Study|Other|0|||
156827622|NCT02275117|566121144|FG003|Overall Study|Other|0|||
156827623|NCT02275117|566121145|FG004|Overall Study|Other|2|||
156827624|NCT01081301|566121148|FG000|Overall Study|Bereaved|3|||
156827625|NCT01081301|566121148|FG000|Overall Study|Too busy|5|||
156827626|NCT01081301|566121148|FG000|Overall Study|Patient too ill|2|||
156827627|NCT01081301|566121148|FG000|Overall Study|Lost to Follow-up|4|||
156827628|NCT02014480|566121149|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827629|NCT02014480|566121150|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827630|NCT02014480|566121151|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
156827631|NCT02014480|566121152|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827632|NCT02014480|566121153|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827633|NCT02014480|566121154|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827634|NCT02014480|566121149|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156827635|NCT02014480|566121150|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156827636|NCT02014480|566121151|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156827637|NCT02014480|566121152|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
156827638|NCT02014480|566121153|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156827639|NCT02014480|566121154|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156827640|NCT02014480|566121149|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827641|NCT02014480|566121150|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827642|NCT02014480|566121151|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
156827643|NCT02014480|566121152|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827644|NCT02014480|566121153|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827645|NCT02014480|566121154|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827646|NCT02014480|566121149|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156827647|NCT02014480|566121150|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156827648|NCT02014480|566121151|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
156827649|NCT02014480|566121152|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156827650|NCT02014480|566121153|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156827651|NCT02014480|566121154|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156827652|NCT02014480|566121149|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827653|NCT02014480|566121150|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
156827654|NCT02014480|566121151|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827655|NCT02014480|566121152|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827656|NCT02014480|566121153|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827657|NCT02014480|566121154|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827658|NCT02014480|566121149|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
156827659|NCT02014480|566121150|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
156827660|NCT02014480|566121151|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
156827661|NCT02014480|566121152|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
156827662|NCT02014480|566121153|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
156827663|NCT02014480|566121154|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
156827664|NCT02014480|566121149|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827665|NCT02014480|566121150|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827666|NCT02014480|566121151|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827667|NCT02014480|566121152|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827668|NCT02014480|566121153|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827669|NCT02014480|566121154|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
156827670|NCT01338610|566121155|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
156827671|NCT01338610|566121156|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
156827672|NCT01338610|566121157|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
156827673|NCT01338610|566121155|FG000|Overall Study|Protocol Violation|1|||
156827674|NCT01338610|566121156|FG001|Overall Study|Protocol Violation|0|||
156827675|NCT01338610|566121157|FG002|Overall Study|Protocol Violation|1|||
156827676|NCT01338610|566121155|FG000|Overall Study|Adverse Event|3|||
156827677|NCT01338610|566121156|FG001|Overall Study|Adverse Event|0|||
156827678|NCT01338610|566121157|FG002|Overall Study|Adverse Event|0|||
156827679|NCT01865812|566121158|FG000|Primary Treatment Phase|Adverse Event|2|||
156827680|NCT01865812|566121159|FG001|Primary Treatment Phase|Adverse Event|0|||
156827681|NCT01865812|566121158|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
156827682|NCT01865812|566121159|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
156827683|NCT01865812|566121158|FG000|Long-term Safety Extension Phase|Pruritus|0|||
156827684|NCT01865812|566121159|FG001|Long-term Safety Extension Phase|Pruritus|3|||
156827685|NCT01865812|566121158|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
156827686|NCT01865812|566121159|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
156827687|NCT01865812|566121158|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
156827688|NCT01865812|566121159|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
156827689|NCT02046226|566121160|FG000|Overall Study|Lost to Follow-up|7|||
156827690|NCT00171925|566121164|FG000|Overall Study|Adverse Event|10|||
156827691|NCT00171925|566121165|FG001|Overall Study|Adverse Event|6|||
156827692|NCT00171925|566121164|FG000|Overall Study|Protocol Violation|1|||
156827693|NCT00171925|566121165|FG001|Overall Study|Protocol Violation|1|||
156827694|NCT00171925|566121164|FG000|Overall Study|Withdrawal by Subject|6|||
156827695|NCT00171925|566121165|FG001|Overall Study|Withdrawal by Subject|9|||
156827696|NCT00171925|566121164|FG000|Overall Study|Lost to Follow-up|2|||
156827697|NCT00171925|566121165|FG001|Overall Study|Lost to Follow-up|2|||
156827698|NCT00171925|566121164|FG000|Overall Study|Administrative problems|10|||
156827699|NCT00171925|566121165|FG001|Overall Study|Administrative problems|11|||
156827700|NCT00171925|566121164|FG000|Overall Study|Death|1|||
156827701|NCT00171925|566121165|FG001|Overall Study|Death|2|||
156827702|NCT02692040|566121166|FG000|Overall Study|Protocol Violation|0|||
156827703|NCT02692040|566121167|FG001|Overall Study|Protocol Violation|0|||
156827704|NCT02692040|566121168|FG002|Overall Study|Protocol Violation|0|||
156827705|NCT02692040|566121169|FG003|Overall Study|Protocol Violation|0|||
156827706|NCT02692040|566121170|FG004|Overall Study|Protocol Violation|0|||
156827707|NCT02692040|566121171|FG005|Overall Study|Protocol Violation|0|||
156827708|NCT02692040|566121172|FG006|Overall Study|Protocol Violation|0|||
156827709|NCT02692040|566121173|FG007|Overall Study|Protocol Violation|0|||
156827710|NCT02692040|566121174|FG008|Overall Study|Protocol Violation|0|||
156827711|NCT02692040|566121175|FG009|Overall Study|Protocol Violation|0|||
156827712|NCT02692040|566121176|FG010|Overall Study|Protocol Violation|0|||
156827713|NCT02692040|566121177|FG011|Overall Study|Protocol Violation|0|||
156827714|NCT02692040|566121178|FG012|Overall Study|Protocol Violation|1|||
156827715|NCT02692040|566121179|FG013|Overall Study|Protocol Violation|0|||
156827716|NCT02692040|566121180|FG014|Overall Study|Protocol Violation|0|||
156827717|NCT02692040|566121181|FG015|Overall Study|Protocol Violation|0|||
156827718|NCT02692040|566121182|FG016|Overall Study|Protocol Violation|0|||
156827719|NCT02692040|566121166|FG000|Overall Study|Adverse Event|0|||
156827720|NCT02692040|566121167|FG001|Overall Study|Adverse Event|0|||
156827721|NCT02692040|566121168|FG002|Overall Study|Adverse Event|0|||
156827722|NCT02692040|566121169|FG003|Overall Study|Adverse Event|0|||
156827723|NCT02692040|566121170|FG004|Overall Study|Adverse Event|0|||
156827724|NCT02692040|566121171|FG005|Overall Study|Adverse Event|0|||
156827725|NCT02692040|566121172|FG006|Overall Study|Adverse Event|0|||
156827726|NCT02692040|566121173|FG007|Overall Study|Adverse Event|0|||
156827727|NCT02692040|566121174|FG008|Overall Study|Adverse Event|0|||
156827728|NCT02692040|566121175|FG009|Overall Study|Adverse Event|0|||
156827729|NCT02692040|566121176|FG010|Overall Study|Adverse Event|0|||
156827730|NCT02692040|566121177|FG011|Overall Study|Adverse Event|0|||
156827731|NCT02692040|566121178|FG012|Overall Study|Adverse Event|0|||
156827732|NCT02692040|566121179|FG013|Overall Study|Adverse Event|3|||
156827733|NCT02692040|566121180|FG014|Overall Study|Adverse Event|1|||
156827734|NCT02692040|566121181|FG015|Overall Study|Adverse Event|1|||
156827735|NCT02692040|566121182|FG016|Overall Study|Adverse Event|0|||
156827736|NCT03023826|566121188|FG000|Period 1|Withdrawal by Subject|0|||
156827737|NCT03023826|566121189|FG001|Period 1|Withdrawal by Subject|0|||
156827738|NCT03023826|566121190|FG002|Period 1|Withdrawal by Subject|0|||
156827739|NCT03023826|566121191|FG003|Period 1|Withdrawal by Subject|0|||
156827740|NCT03023826|566121192|FG004|Period 1|Withdrawal by Subject|1|||
156827741|NCT03023826|566121193|FG005|Period 1|Withdrawal by Subject|0|||
156827742|NCT02142283|566121197|FG000|Overall Study|Death|20|||
156827743|NCT02142283|566121198|FG001|Overall Study|Death|18|||
156827744|NCT02142283|566121197|FG000|Overall Study|Withdrawal by Subject|1|||
156827745|NCT02142283|566121198|FG001|Overall Study|Withdrawal by Subject|3|||
156466216|NCT00439270|564803824|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
156827746|NCT00747344|566121199|FG000|Controlled Period|Adverse Event|3|||
156827747|NCT00747344|566121200|FG001|Controlled Period|Adverse Event|0|||
156827748|NCT00747344|566121201|FG002|Controlled Period|Adverse Event|0|||
156827749|NCT00747344|566121202|FG003|Controlled Period|Adverse Event|0|||
156827750|NCT00747344|566121199|FG000|Controlled Period|Lack of Efficacy|2|||
156827751|NCT00747344|566121200|FG001|Controlled Period|Lack of Efficacy|1|||
156827752|NCT00747344|566121201|FG002|Controlled Period|Lack of Efficacy|0|||
156466217|NCT00439270|564803825|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
156827753|NCT00747344|566121202|FG003|Controlled Period|Lack of Efficacy|0|||
156827754|NCT00747344|566121199|FG000|Controlled Period|Other|0|||
156827755|NCT00747344|566121200|FG001|Controlled Period|Other|3|||
156827756|NCT00747344|566121201|FG002|Controlled Period|Other|0|||
156827757|NCT00747344|566121202|FG003|Controlled Period|Other|0|||
156827758|NCT00747344|566121199|FG000|After Controlled Period|Adverse Event|0|||
156827759|NCT00747344|566121200|FG001|After Controlled Period|Adverse Event|0|||
156827760|NCT00747344|566121201|FG002|After Controlled Period|Adverse Event|0|||
156827761|NCT00747344|566121202|FG003|After Controlled Period|Adverse Event|1|||
156827762|NCT01484834|566121203|FG000|Overall Study|Lost to Follow-up|5|||
156827763|NCT01484834|566121204|FG001|Overall Study|Lost to Follow-up|8|||
156827764|NCT01484834|566121205|FG002|Overall Study|Lost to Follow-up|1|||
156827765|NCT01484834|566121206|FG003|Overall Study|Lost to Follow-up|4|||
156827766|NCT02460783|566121207|FG000|Overall Study|Withdrawal by Subject|1|||
156827767|NCT02460783|566121208|FG001|Overall Study|Withdrawal by Subject|3|||
156827768|NCT02460783|566121207|FG000|Overall Study|Lost to Follow-up|1|||
156827769|NCT02460783|566121208|FG001|Overall Study|Lost to Follow-up|1|||
156827770|NCT02182440|566121213|FG000|Overall Study|Adverse Event|0|||
156827771|NCT02182440|566121214|FG001|Overall Study|Adverse Event|1|||
156827772|NCT02182440|566121215|FG002|Overall Study|Adverse Event|0|||
156827773|NCT02182440|566121216|FG003|Overall Study|Adverse Event|0|||
156827774|NCT02182440|566121213|FG000|Overall Study|Death|31|||
156827775|NCT02182440|566121214|FG001|Overall Study|Death|8|||
156827776|NCT02182440|566121215|FG002|Overall Study|Death|5|||
156827777|NCT02182440|566121216|FG003|Overall Study|Death|16|||
156827778|NCT02182440|566121213|FG000|Overall Study|Protocol Violation|0|||
156827779|NCT02182440|566121214|FG001|Overall Study|Protocol Violation|1|||
156827780|NCT02182440|566121215|FG002|Overall Study|Protocol Violation|0|||
156827781|NCT02182440|566121216|FG003|Overall Study|Protocol Violation|0|||
156827782|NCT02182440|566121213|FG000|Overall Study|Physician Decision|1|||
156827783|NCT02182440|566121214|FG001|Overall Study|Physician Decision|0|||
156827784|NCT02182440|566121215|FG002|Overall Study|Physician Decision|0|||
156827785|NCT02182440|566121216|FG003|Overall Study|Physician Decision|0|||
156827786|NCT02182440|566121213|FG000|Overall Study|Withdrawal by Subject|1|||
156827787|NCT02182440|566121214|FG001|Overall Study|Withdrawal by Subject|1|||
156827788|NCT02182440|566121215|FG002|Overall Study|Withdrawal by Subject|3|||
156827789|NCT02182440|566121216|FG003|Overall Study|Withdrawal by Subject|4|||
156827790|NCT02182440|566121213|FG000|Overall Study|different, e.g adm other hospital|12|||
156827791|NCT02182440|566121214|FG001|Overall Study|different, e.g adm other hospital|3|||
156827792|NCT02182440|566121215|FG002|Overall Study|different, e.g adm other hospital|3|||
156827793|NCT02182440|566121216|FG003|Overall Study|different, e.g adm other hospital|10|||
156827794|NCT00072293|566121219|FG000|Overall Study|Lost to Follow-up|1|||
156827795|NCT00072293|566121220|FG001|Overall Study|Lost to Follow-up|1|||
156827796|NCT00072293|566121219|FG000|Overall Study|Withdrawal by Subject|0|||
156827797|NCT00072293|566121220|FG001|Overall Study|Withdrawal by Subject|1|||
156827798|NCT03754582|566121221|FG000|Treatment Phase|Adverse Event|0|||
156827799|NCT03754582|566121222|FG001|Treatment Phase|Adverse Event|1|||
156827800|NCT03754582|566121223|FG002|Treatment Phase|Adverse Event|0|||
156827801|NCT03754582|566121221|FG000|Follow-up Phase|Other|0|||
156827802|NCT03754582|566121222|FG001|Follow-up Phase|Other|0|||
156827803|NCT03754582|566121223|FG002|Follow-up Phase|Other|1|||
156827804|NCT01561755|566121224|FG000|Overall Study|Lost to Follow-up|0|||
156827805|NCT01561755|566121225|FG001|Overall Study|Lost to Follow-up|1|||
156827806|NCT02826421|566121228|FG000|Overall Study|Adverse Event|1|||
156827807|NCT02826421|566121229|FG001|Overall Study|Adverse Event|0|||
156827808|NCT02826421|566121230|FG002|Overall Study|Adverse Event|0|||
156827809|NCT02826421|566121231|FG003|Overall Study|Adverse Event|1|||
156827810|NCT02826421|566121228|FG000|Overall Study|Withdrawal by Subject|1|||
156827811|NCT02826421|566121229|FG001|Overall Study|Withdrawal by Subject|3|||
156827812|NCT02826421|566121230|FG002|Overall Study|Withdrawal by Subject|1|||
156827813|NCT02826421|566121231|FG003|Overall Study|Withdrawal by Subject|1|||
156827814|NCT02826421|566121228|FG000|Overall Study|Reason not given|1|||
156827815|NCT02826421|566121229|FG001|Overall Study|Reason not given|0|||
156827816|NCT02826421|566121230|FG002|Overall Study|Reason not given|1|||
156827817|NCT02826421|566121231|FG003|Overall Study|Reason not given|0|||
156827818|NCT02210221|566121234|FG000|Overall Study|Lack of Efficacy|7|||
156827819|NCT02210221|566121234|FG000|Overall Study|Withdrawal by Subject|43|||
156827820|NCT00405964|566121237|FG000|Overall Study|Treatment Failure|17|||
156827821|NCT00405964|566121238|FG001|Overall Study|Treatment Failure|45|||
156827822|NCT00405964|566121237|FG000|Overall Study|Adverse Event|7|||
156827823|NCT00405964|566121238|FG001|Overall Study|Adverse Event|16|||
156827824|NCT00405964|566121237|FG000|Overall Study|Lost to Follow-up|5|||
156827825|NCT00405964|566121238|FG001|Overall Study|Lost to Follow-up|5|||
156827826|NCT00405964|566121237|FG000|Overall Study|Withdrawal by Subject|19|||
156827827|NCT00405964|566121238|FG001|Overall Study|Withdrawal by Subject|23|||
156827828|NCT00405964|566121237|FG000|Overall Study|Protocol Violation|11|||
156827829|NCT00405964|566121238|FG001|Overall Study|Protocol Violation|6|||
156827830|NCT02981407|566121239|FG000|Overall Study|Withdrawal by Subject|2|||
156827831|NCT02981407|566121240|FG001|Overall Study|Withdrawal by Subject|0|||
156466218|NCT00439270|564803826|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
156466219|NCT00439270|564803827|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
156466220|NCT00439270|564803823|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
156541210|NCT00573430|565074509|FG002|Overall Study|Adverse Event|2|||
156827832|NCT02818036|566121246|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
156827833|NCT02818036|566121247|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
156827834|NCT02818036|566121246|FG000|Overall Study|Withdrawal by Subject|1|||
156827835|NCT02818036|566121247|FG001|Overall Study|Withdrawal by Subject|0|||
156827836|NCT01319721|566121250|FG000|Overall Study|Lost to Follow-up|1|||
156827837|NCT01319721|566121251|FG001|Overall Study|Lost to Follow-up|6|||
156827838|NCT03515941|566121254|FG000|Overall Study|Adverse Event|1|||
156827839|NCT03515941|566121255|FG001|Overall Study|Adverse Event|0|||
156827840|NCT00468845|566121256|FG000|Overall Study|Adverse Event|9|||
156827841|NCT00468845|566121257|FG001|Overall Study|Adverse Event|14|||
156827842|NCT00468845|566121258|FG002|Overall Study|Adverse Event|11|||
156827843|NCT00468845|566121256|FG000|Overall Study|Lost to Follow-up|2|||
156827844|NCT00468845|566121257|FG001|Overall Study|Lost to Follow-up|1|||
156827845|NCT00468845|566121258|FG002|Overall Study|Lost to Follow-up|2|||
156827846|NCT00468845|566121256|FG000|Overall Study|Other|4|||
156827847|NCT00468845|566121257|FG001|Overall Study|Other|9|||
156827848|NCT00468845|566121258|FG002|Overall Study|Other|5|||
156827849|NCT00468845|566121256|FG000|Overall Study|No longer willing to participate|5|||
156827850|NCT00468845|566121257|FG001|Overall Study|No longer willing to participate|6|||
156827851|NCT00468845|566121258|FG002|Overall Study|No longer willing to participate|10|||
156827852|NCT00468845|566121256|FG000|Overall Study|Randomized, not treated|1|||
156827853|NCT00468845|566121257|FG001|Overall Study|Randomized, not treated|4|||
156827854|NCT00468845|566121258|FG002|Overall Study|Randomized, not treated|2|||
156827855|NCT04030247|566122904|FG000|Overall Study|Withdrawal by Subject|4|||
156827856|NCT04030247|566122904|FG000|Overall Study|Lost to Follow-up|13|||
156827857|NCT05320393|566122905|FG000|Overall Study|Withdrawal by Subject|1|||
156827858|NCT05320393|566122906|FG001|Overall Study|Withdrawal by Subject|0|||
156827859|NCT05320393|566122907|FG002|Overall Study|Withdrawal by Subject|2|||
156827860|NCT05320393|566122905|FG000|Overall Study|Lost to Follow-up|1|||
156827861|NCT05320393|566122906|FG001|Overall Study|Lost to Follow-up|2|||
156827862|NCT05320393|566122907|FG002|Overall Study|Lost to Follow-up|1|||
156827863|NCT05320393|566122905|FG000|Overall Study|Moved; too much driving|0|||
156827864|NCT05320393|566122906|FG001|Overall Study|Moved; too much driving|0|||
156827865|NCT05320393|566122907|FG002|Overall Study|Moved; too much driving|2|||
156827866|NCT05320393|566122905|FG000|Overall Study|Did not receive treatment|0|||
156827867|NCT05320393|566122906|FG001|Overall Study|Did not receive treatment|0|||
156827868|NCT05320393|566122907|FG002|Overall Study|Did not receive treatment|1|||
156827869|NCT03559699|566122908|FG000|Overall Study|Withdrawal by Subject|6|||
156827870|NCT03559699|566122908|FG000|Overall Study|Lost to Follow-up|1|||
156827871|NCT00031460|566122909|FG000|Overall Study|Lost to Follow-up|0|||
156827872|NCT00031460|566122910|FG001|Overall Study|Lost to Follow-up|1|||
156827873|NCT00031460|566122909|FG000|Overall Study|Withdrawal by Subject|1|||
156827874|NCT00031460|566122910|FG001|Overall Study|Withdrawal by Subject|1|||
156827875|NCT00031460|566122909|FG000|Overall Study|Non-Compliant|1|||
156827876|NCT00031460|566122910|FG001|Overall Study|Non-Compliant|1|||
156827877|NCT00031460|566122909|FG000|Overall Study|Death|0|||
156827878|NCT00031460|566122910|FG001|Overall Study|Death|1|||
156827879|NCT00031460|566122909|FG000|Overall Study|Reactivation of Disease|5|||
156827880|NCT00031460|566122910|FG001|Overall Study|Reactivation of Disease|9|||
156827881|NCT00031460|566122909|FG000|Overall Study|Disruption of blinded drug supply|2|||
156827882|NCT00031460|566122910|FG001|Overall Study|Disruption of blinded drug supply|0|||
156827883|NCT00031460|566122909|FG000|Overall Study|Confirmed unevaluable|0|||
156827884|NCT00031460|566122910|FG001|Overall Study|Confirmed unevaluable|1|||
156827885|NCT02838901|566122916|FG000|Overall Study|Withdrawal by Subject|1|||
156827886|NCT02838901|566122917|FG001|Overall Study|Withdrawal by Subject|1|||
156827887|NCT02838901|566122916|FG000|Overall Study|Lost to Follow-up|1|||
156827888|NCT02838901|566122917|FG001|Overall Study|Lost to Follow-up|1|||
156827889|NCT01007123|566122918|FG000|Overall Study|Adverse Event|3|||
156827890|NCT01007123|566122919|FG001|Overall Study|Adverse Event|4|||
156827891|NCT01007123|566122920|FG002|Overall Study|Adverse Event|7|||
156827892|NCT01007123|566122921|FG003|Overall Study|Adverse Event|1|||
156827893|NCT01007123|566122918|FG000|Overall Study|Lack of Efficacy|1|||
156827894|NCT01007123|566122919|FG001|Overall Study|Lack of Efficacy|0|||
156827895|NCT01007123|566122920|FG002|Overall Study|Lack of Efficacy|1|||
156827896|NCT01007123|566122921|FG003|Overall Study|Lack of Efficacy|4|||
156827897|NCT01007123|566122918|FG000|Overall Study|Protocol Violation|1|||
156827898|NCT01007123|566122919|FG001|Overall Study|Protocol Violation|1|||
156827899|NCT01007123|566122920|FG002|Overall Study|Protocol Violation|2|||
156827900|NCT01007123|566122921|FG003|Overall Study|Protocol Violation|1|||
156827901|NCT01007123|566122918|FG000|Overall Study|Withdrawal by Subject|1|||
156827902|NCT01007123|566122919|FG001|Overall Study|Withdrawal by Subject|0|||
156827903|NCT01007123|566122920|FG002|Overall Study|Withdrawal by Subject|1|||
156827904|NCT01007123|566122921|FG003|Overall Study|Withdrawal by Subject|0|||
156827905|NCT01007123|566122918|FG000|Overall Study|Lost to Follow-up|0|||
156827906|NCT01007123|566122919|FG001|Overall Study|Lost to Follow-up|1|||
156827907|NCT01007123|566122920|FG002|Overall Study|Lost to Follow-up|0|||
156827908|NCT01007123|566122921|FG003|Overall Study|Lost to Follow-up|0|||
156827909|NCT01777542|566122924|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
156827910|NCT01777542|566122925|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
156339380|NCT01785069|564340190|FG002|Overall Study|Implanted with nonstudy device|1|||
156827911|NCT05605691|566122928|FG000|Overall Study|Lost to Follow-up|1|||
156827912|NCT02279719|566122929|FG000|Overall Study|Patients randomized but never treated|0|||
156827913|NCT02279719|566122930|FG001|Overall Study|Patients randomized but never treated|0|||
156827914|NCT02279719|566122931|FG002|Overall Study|Patients randomized but never treated|0|||
156827915|NCT02279719|566122932|FG003|Overall Study|Patients randomized but never treated|0|||
156827916|NCT02279719|566122933|FG004|Overall Study|Patients randomized but never treated|3|||
156827917|NCT02279719|566122934|FG005|Overall Study|Patients randomized but never treated|0|||
156827918|NCT02279719|566122935|FG006|Overall Study|Patients randomized but never treated|3|||
156827919|NCT04706273|566122936|FG000|Overall Study|Withdrawal by Subject|27|||
156827920|NCT04706273|566122936|FG000|Overall Study|Physician Decision|1|||
156827921|NCT04706273|566122936|FG000|Overall Study|Lost to Follow-up|42|||
156827922|NCT04706273|566122936|FG000|Overall Study|Death|85|||
156827923|NCT04706273|566122936|FG000|Overall Study|Amputation that removes study device|2|||
156827924|NCT04706273|566122936|FG000|Overall Study|Surgical bypass|3|||
156827925|NCT04706273|566122936|FG000|Overall Study|Changing hospital|23|||
156827926|NCT04706273|566122936|FG000|Overall Study|Unable to attend hospital|2|||
156827927|NCT00869050|566122939|FG000|Overall Study|Screen Failure|3|||
156827928|NCT03199053|566122942|FG000|ST Period|Withdrawal by Subject|2|||
156827929|NCT03199053|566122943|FG001|ST Period|Withdrawal by Subject|4|||
156827930|NCT03199053|566122944|FG002|ST Period|Withdrawal by Subject|6|||
156827931|NCT03199053|566122942|FG000|ST Period|Withdrawal by parent/guardian|1|||
156827932|NCT03199053|566122943|FG001|ST Period|Withdrawal by parent/guardian|1|||
156827933|NCT03199053|566122944|FG002|ST Period|Withdrawal by parent/guardian|1|||
156827934|NCT03199053|566122942|FG000|ST Period|Lost to Follow-up|2|||
156827935|NCT03199053|566122943|FG001|ST Period|Lost to Follow-up|0|||
156827936|NCT03199053|566122944|FG002|ST Period|Lost to Follow-up|1|||
156827937|NCT03199053|566122942|FG000|LT Period|Withdrawal by Subject|1|||
156827938|NCT03199053|566122943|FG001|LT Period|Withdrawal by Subject|3|||
156827939|NCT03199053|566122944|FG002|LT Period|Withdrawal by Subject|3|||
156827940|NCT03199053|566122942|FG000|LT Period|Withdrawal by parent/guardian|0|||
156827941|NCT03199053|566122943|FG001|LT Period|Withdrawal by parent/guardian|0|||
156827942|NCT03199053|566122944|FG002|LT Period|Withdrawal by parent/guardian|1|||
156827943|NCT03199053|566122942|FG000|LT Period|Lost to Follow-up|0|||
156827944|NCT03199053|566122943|FG001|LT Period|Lost to Follow-up|1|||
156827945|NCT03199053|566122944|FG002|LT Period|Lost to Follow-up|1|||
156827946|NCT03199053|566122942|FG000|LT Period|Miscellaneous|0|||
156827947|NCT03199053|566122943|FG001|LT Period|Miscellaneous|0|||
156827948|NCT03199053|566122944|FG002|LT Period|Miscellaneous|2|||
156827949|NCT03199053|566122942|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
156827950|NCT03199053|566122943|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
156827951|NCT03199053|566122944|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
156827952|NCT03199053|566122942|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
156827953|NCT03199053|566122943|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
156827954|NCT03199053|566122944|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
156827955|NCT03199053|566122942|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
156827956|NCT03199053|566122943|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
156827957|NCT03199053|566122944|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
156827958|NCT03199053|566122942|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
156827959|NCT03199053|566122943|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
156827960|NCT03199053|566122944|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
156827961|NCT00759356|566122945|FG000|Overall Study|Adverse Event|0|||
156827962|NCT00759356|566122946|FG001|Overall Study|Adverse Event|1|||
156827963|NCT00759356|566122945|FG000|Overall Study|Withdrawal by Subject|0|||
156827964|NCT00759356|566122946|FG001|Overall Study|Withdrawal by Subject|2|||
156827965|NCT00759356|566122945|FG000|Overall Study|Subject was unable to return|1|||
156827966|NCT00759356|566122946|FG001|Overall Study|Subject was unable to return|0|||
156827967|NCT03298984|566122951|FG000|Overall Study|Physician Decision|1|||
156827968|NCT03298984|566122952|FG001|Overall Study|Physician Decision|0|||
156827969|NCT03298984|566122953|FG002|Overall Study|Physician Decision|0|||
156827970|NCT03298984|566122954|FG003|Overall Study|Physician Decision|6|||
156827971|NCT03298984|566122951|FG000|Overall Study|Lack of Efficacy|0|||
156827972|NCT03298984|566122952|FG001|Overall Study|Lack of Efficacy|1|||
156827973|NCT03298984|566122953|FG002|Overall Study|Lack of Efficacy|1|||
156827974|NCT03298984|566122954|FG003|Overall Study|Lack of Efficacy|4|||
156827975|NCT03298984|566122951|FG000|Overall Study|Relapsed disease (following remission)|0|||
156827976|NCT03298984|566122952|FG001|Overall Study|Relapsed disease (following remission)|0|||
156827977|NCT03298984|566122953|FG002|Overall Study|Relapsed disease (following remission)|1|||
156827978|NCT03298984|566122954|FG003|Overall Study|Relapsed disease (following remission)|1|||
156827979|NCT03298984|566122951|FG000|Overall Study|Adverse Event|0|||
156827980|NCT03298984|566122952|FG001|Overall Study|Adverse Event|0|||
156827981|NCT03298984|566122953|FG002|Overall Study|Adverse Event|0|||
156827982|NCT03298984|566122954|FG003|Overall Study|Adverse Event|1|||
156827983|NCT03298984|566122951|FG000|Overall Study|Death|0|||
156827984|NCT03298984|566122952|FG001|Overall Study|Death|0|||
156827985|NCT03298984|566122953|FG002|Overall Study|Death|0|||
156827986|NCT03298984|566122954|FG003|Overall Study|Death|2|||
156827987|NCT03298984|566122951|FG000|Overall Study|Insurance Company Decision|0|||
156827988|NCT03298984|566122952|FG001|Overall Study|Insurance Company Decision|0|||
156827989|NCT03298984|566122953|FG002|Overall Study|Insurance Company Decision|0|||
156827990|NCT03298984|566122954|FG003|Overall Study|Insurance Company Decision|1|||
156827991|NCT02509052|566122962|FG000|Overall Study|Non compliance|0|||
156827992|NCT02509052|566122963|FG001|Overall Study|Non compliance|0|||
156827993|NCT02509052|566122964|FG002|Overall Study|Non compliance|1|||
156827994|NCT00585221|566122965|FG000|Overall Study|Protocol Violation|8|||
156827995|NCT01323270|566122966|FG000|Overall Study|Withdrawal by Subject|19|||
156827996|NCT01323270|566122967|FG001|Overall Study|Withdrawal by Subject|10|||
156827997|NCT01323270|566122966|FG000|Overall Study|Protocol Violation|9|||
156827998|NCT01323270|566122967|FG001|Overall Study|Protocol Violation|7|||
156827999|NCT01323270|566122966|FG000|Overall Study|Lost to Follow-up|4|||
156828000|NCT01323270|566122967|FG001|Overall Study|Lost to Follow-up|6|||
156828001|NCT01323270|566122966|FG000|Overall Study|Adverse Event|8|||
156828002|NCT01323270|566122967|FG001|Overall Study|Adverse Event|0|||
156828003|NCT01323270|566122966|FG000|Overall Study|Other|0|||
156828004|NCT01323270|566122967|FG001|Overall Study|Other|3|||
156828005|NCT01323270|566122966|FG000|Overall Study|Physician Decision|0|||
156828006|NCT01323270|566122967|FG001|Overall Study|Physician Decision|2|||
156828007|NCT01323270|566122966|FG000|Overall Study|Not eligible|1|||
156828008|NCT01323270|566122967|FG001|Overall Study|Not eligible|1|||
156828009|NCT01323270|566122966|FG000|Overall Study|Death|1|||
156828010|NCT01323270|566122967|FG001|Overall Study|Death|0|||
156828011|NCT01323270|566122966|FG000|Overall Study|Randomized, but not vaccinated|1|||
156828012|NCT01323270|566122967|FG001|Overall Study|Randomized, but not vaccinated|0|||
156828013|NCT00075725|566122974|FG000|Overall Study|Adverse Event|6|||
156828014|NCT00075725|566122975|FG001|Overall Study|Adverse Event|6|||
156828015|NCT00075725|566122976|FG002|Overall Study|Adverse Event|20|||
156828016|NCT00075725|566122977|FG003|Overall Study|Adverse Event|8|||
156828017|NCT00075725|566122978|FG004|Overall Study|Adverse Event|4|||
156828018|NCT00075725|566122979|FG005|Overall Study|Adverse Event|38|||
156828019|NCT00075725|566122980|FG006|Overall Study|Adverse Event|3|||
156828020|NCT00075725|566122981|FG007|Overall Study|Adverse Event|51|||
156828021|NCT00075725|566122982|FG008|Overall Study|Adverse Event|15|||
156828022|NCT00075725|566122983|FG009|Overall Study|Adverse Event|4|||
156828023|NCT00075725|566122984|FG010|Overall Study|Adverse Event|2|||
156828024|NCT00075725|566122985|FG011|Overall Study|Adverse Event|2|||
156828025|NCT00075725|566122974|FG000|Overall Study|Death|3|||
156828026|NCT00075725|566122975|FG001|Overall Study|Death|5|||
156828027|NCT00075725|566122976|FG002|Overall Study|Death|10|||
156828028|NCT00075725|566122977|FG003|Overall Study|Death|2|||
156828029|NCT00075725|566122978|FG004|Overall Study|Death|3|||
156828030|NCT00075725|566122979|FG005|Overall Study|Death|25|||
156828031|NCT00075725|566122980|FG006|Overall Study|Death|4|||
156828032|NCT00075725|566122981|FG007|Overall Study|Death|22|||
156828033|NCT00075725|566122982|FG008|Overall Study|Death|14|||
156828034|NCT00075725|566122983|FG009|Overall Study|Death|4|||
156828035|NCT00075725|566122984|FG010|Overall Study|Death|3|||
156828036|NCT00075725|566122985|FG011|Overall Study|Death|0|||
156828037|NCT00075725|566122974|FG000|Overall Study|Lost to Follow-up|1|||
156828038|NCT00075725|566122975|FG001|Overall Study|Lost to Follow-up|1|||
156828039|NCT00075725|566122976|FG002|Overall Study|Lost to Follow-up|4|||
156339381|NCT01785069|564340191|FG003|Overall Study|Implanted with nonstudy device|0|||
156828040|NCT00075725|566122977|FG003|Overall Study|Lost to Follow-up|1|||
156828041|NCT00075725|566122978|FG004|Overall Study|Lost to Follow-up|0|||
156828042|NCT00075725|566122979|FG005|Overall Study|Lost to Follow-up|13|||
156828043|NCT00075725|566122980|FG006|Overall Study|Lost to Follow-up|2|||
156828044|NCT00075725|566122981|FG007|Overall Study|Lost to Follow-up|4|||
156828045|NCT00075725|566122982|FG008|Overall Study|Lost to Follow-up|1|||
156828046|NCT00075725|566122983|FG009|Overall Study|Lost to Follow-up|0|||
156828047|NCT00075725|566122984|FG010|Overall Study|Lost to Follow-up|0|||
156828048|NCT00075725|566122985|FG011|Overall Study|Lost to Follow-up|0|||
156828049|NCT00075725|566122974|FG000|Overall Study|Physician Decision|2|||
156828050|NCT00075725|566122975|FG001|Overall Study|Physician Decision|6|||
156828051|NCT00075725|566122976|FG002|Overall Study|Physician Decision|5|||
156828052|NCT00075725|566122977|FG003|Overall Study|Physician Decision|8|||
156828053|NCT00075725|566122978|FG004|Overall Study|Physician Decision|4|||
156828054|NCT00075725|566122979|FG005|Overall Study|Physician Decision|19|||
156828055|NCT00075725|566122980|FG006|Overall Study|Physician Decision|3|||
156828056|NCT00075725|566122981|FG007|Overall Study|Physician Decision|17|||
156828057|NCT00075725|566122982|FG008|Overall Study|Physician Decision|5|||
156828058|NCT00075725|566122983|FG009|Overall Study|Physician Decision|0|||
156828059|NCT00075725|566122984|FG010|Overall Study|Physician Decision|1|||
156828060|NCT00075725|566122985|FG011|Overall Study|Physician Decision|0|||
156339382|NCT01785069|564340188|FG000|Overall Study|Death|0|||
156828061|NCT00075725|566122974|FG000|Overall Study|Pregnancy|0|||
156828062|NCT00075725|566122975|FG001|Overall Study|Pregnancy|0|||
156828063|NCT00075725|566122976|FG002|Overall Study|Pregnancy|0|||
156828064|NCT00075725|566122977|FG003|Overall Study|Pregnancy|0|||
156828065|NCT00075725|566122978|FG004|Overall Study|Pregnancy|0|||
156828066|NCT00075725|566122979|FG005|Overall Study|Pregnancy|1|||
156828067|NCT00075725|566122980|FG006|Overall Study|Pregnancy|0|||
156828068|NCT00075725|566122981|FG007|Overall Study|Pregnancy|1|||
156828069|NCT00075725|566122982|FG008|Overall Study|Pregnancy|0|||
156828070|NCT00075725|566122983|FG009|Overall Study|Pregnancy|0|||
156828071|NCT00075725|566122984|FG010|Overall Study|Pregnancy|0|||
156828072|NCT00075725|566122985|FG011|Overall Study|Pregnancy|0|||
156828073|NCT00075725|566122974|FG000|Overall Study|Protocol Violation|1|||
156828074|NCT00075725|566122975|FG001|Overall Study|Protocol Violation|1|||
156828075|NCT00075725|566122976|FG002|Overall Study|Protocol Violation|0|||
156828076|NCT00075725|566122977|FG003|Overall Study|Protocol Violation|3|||
156828077|NCT00075725|566122978|FG004|Overall Study|Protocol Violation|3|||
156828078|NCT00075725|566122979|FG005|Overall Study|Protocol Violation|2|||
156828079|NCT00075725|566122980|FG006|Overall Study|Protocol Violation|1|||
156828080|NCT00075725|566122981|FG007|Overall Study|Protocol Violation|2|||
156828081|NCT00075725|566122982|FG008|Overall Study|Protocol Violation|3|||
156828082|NCT00075725|566122983|FG009|Overall Study|Protocol Violation|0|||
156828083|NCT00075725|566122984|FG010|Overall Study|Protocol Violation|0|||
156828084|NCT00075725|566122985|FG011|Overall Study|Protocol Violation|1|||
156828085|NCT00075725|566122974|FG000|Overall Study|Withdrawal by Subject|12|||
156828086|NCT00075725|566122975|FG001|Overall Study|Withdrawal by Subject|3|||
156828087|NCT00075725|566122976|FG002|Overall Study|Withdrawal by Subject|6|||
156828088|NCT00075725|566122977|FG003|Overall Study|Withdrawal by Subject|10|||
156828089|NCT00075725|566122978|FG004|Overall Study|Withdrawal by Subject|6|||
156828090|NCT00075725|566122979|FG005|Overall Study|Withdrawal by Subject|27|||
156828091|NCT00075725|566122980|FG006|Overall Study|Withdrawal by Subject|7|||
156828092|NCT00075725|566122981|FG007|Overall Study|Withdrawal by Subject|31|||
156828093|NCT00075725|566122982|FG008|Overall Study|Withdrawal by Subject|10|||
156828094|NCT00075725|566122983|FG009|Overall Study|Withdrawal by Subject|2|||
156828095|NCT00075725|566122984|FG010|Overall Study|Withdrawal by Subject|0|||
156828096|NCT00075725|566122985|FG011|Overall Study|Withdrawal by Subject|0|||
156828097|NCT00075725|566122974|FG000|Overall Study|Disease Progression, all other reasons|17|||
156828098|NCT00075725|566122975|FG001|Overall Study|Disease Progression, all other reasons|5|||
156828099|NCT00075725|566122976|FG002|Overall Study|Disease Progression, all other reasons|33|||
156828100|NCT00075725|566122977|FG003|Overall Study|Disease Progression, all other reasons|6|||
156828101|NCT00075725|566122978|FG004|Overall Study|Disease Progression, all other reasons|21|||
156828102|NCT00075725|566122979|FG005|Overall Study|Disease Progression, all other reasons|59|||
156828103|NCT00075725|566122980|FG006|Overall Study|Disease Progression, all other reasons|20|||
156828104|NCT00075725|566122981|FG007|Overall Study|Disease Progression, all other reasons|46|||
156828105|NCT00075725|566122982|FG008|Overall Study|Disease Progression, all other reasons|21|||
156828106|NCT00075725|566122983|FG009|Overall Study|Disease Progression, all other reasons|4|||
156828107|NCT00075725|566122984|FG010|Overall Study|Disease Progression, all other reasons|0|||
156828108|NCT00075725|566122985|FG011|Overall Study|Disease Progression, all other reasons|5|||
156828109|NCT00075725|566122974|FG000|Overall Study|Patient off treatment|0|||
156828110|NCT00075725|566122975|FG001|Overall Study|Patient off treatment|0|||
156828111|NCT00075725|566122976|FG002|Overall Study|Patient off treatment|1|||
156828112|NCT00075725|566122977|FG003|Overall Study|Patient off treatment|2|||
156828113|NCT00075725|566122978|FG004|Overall Study|Patient off treatment|1|||
156828114|NCT00075725|566122979|FG005|Overall Study|Patient off treatment|0|||
156828115|NCT00075725|566122980|FG006|Overall Study|Patient off treatment|0|||
156828116|NCT00075725|566122981|FG007|Overall Study|Patient off treatment|2|||
156828117|NCT00075725|566122982|FG008|Overall Study|Patient off treatment|1|||
156828118|NCT00075725|566122983|FG009|Overall Study|Patient off treatment|0|||
156828119|NCT00075725|566122984|FG010|Overall Study|Patient off treatment|0|||
156828120|NCT00075725|566122985|FG011|Overall Study|Patient off treatment|0|||
156828121|NCT00075725|566122974|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
156828122|NCT00075725|566122975|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
156828123|NCT00075725|566122976|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
156828124|NCT00075725|566122977|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
156541211|NCT00573430|565074507|FG000|Overall Study|Withdrawal by Subject|1|||
156541212|NCT00573430|565074508|FG001|Overall Study|Withdrawal by Subject|0|||
156541213|NCT00573430|565074509|FG002|Overall Study|Withdrawal by Subject|1|||
156541214|NCT00573430|565074507|FG000|Overall Study|Protocol Violation|0|||
156828125|NCT00075725|566122978|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
156828126|NCT00075725|566122979|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
156828127|NCT00075725|566122980|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
156828128|NCT00075725|566122981|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
156828129|NCT00075725|566122982|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
156828130|NCT00075725|566122983|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
156828131|NCT00075725|566122984|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
156828132|NCT00075725|566122985|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
156828133|NCT00075725|566122974|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
156541215|NCT00573430|565074508|FG001|Overall Study|Protocol Violation|1|||
156541216|NCT00573430|565074509|FG002|Overall Study|Protocol Violation|1|||
156828134|NCT00075725|566122975|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
156828135|NCT00075725|566122976|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
156828136|NCT00075725|566122977|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
156828137|NCT00075725|566122978|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
156828138|NCT00075725|566122979|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
156828139|NCT00075725|566122980|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
156828140|NCT00075725|566122981|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
156828141|NCT00075725|566122982|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
156828142|NCT00075725|566122983|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
156828143|NCT00075725|566122984|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
156828144|NCT00075725|566122985|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
156828145|NCT00075725|566122974|FG000|Overall Study|Pt non compliant with therapy|2|||
156828146|NCT00075725|566122975|FG001|Overall Study|Pt non compliant with therapy|1|||
156828147|NCT00075725|566122976|FG002|Overall Study|Pt non compliant with therapy|1|||
156828148|NCT00075725|566122977|FG003|Overall Study|Pt non compliant with therapy|0|||
156828149|NCT00075725|566122978|FG004|Overall Study|Pt non compliant with therapy|2|||
156828150|NCT00075725|566122979|FG005|Overall Study|Pt non compliant with therapy|14|||
156828151|NCT00075725|566122980|FG006|Overall Study|Pt non compliant with therapy|2|||
156828152|NCT00075725|566122981|FG007|Overall Study|Pt non compliant with therapy|5|||
156828153|NCT00075725|566122982|FG008|Overall Study|Pt non compliant with therapy|3|||
156828154|NCT00075725|566122983|FG009|Overall Study|Pt non compliant with therapy|0|||
156828155|NCT00075725|566122984|FG010|Overall Study|Pt non compliant with therapy|0|||
156828156|NCT00075725|566122985|FG011|Overall Study|Pt non compliant with therapy|0|||
156828157|NCT00075725|566122974|FG000|Overall Study|Pt age out of range for treatment|0|||
156828158|NCT00075725|566122975|FG001|Overall Study|Pt age out of range for treatment|1|||
156828159|NCT00075725|566122976|FG002|Overall Study|Pt age out of range for treatment|0|||
156828160|NCT00075725|566122977|FG003|Overall Study|Pt age out of range for treatment|0|||
156828161|NCT00075725|566122978|FG004|Overall Study|Pt age out of range for treatment|0|||
156828162|NCT00075725|566122979|FG005|Overall Study|Pt age out of range for treatment|1|||
156828163|NCT00075725|566122980|FG006|Overall Study|Pt age out of range for treatment|0|||
156828164|NCT00075725|566122981|FG007|Overall Study|Pt age out of range for treatment|1|||
156828165|NCT00075725|566122982|FG008|Overall Study|Pt age out of range for treatment|0|||
156828166|NCT00075725|566122983|FG009|Overall Study|Pt age out of range for treatment|0|||
156828167|NCT00075725|566122984|FG010|Overall Study|Pt age out of range for treatment|0|||
156828168|NCT00075725|566122985|FG011|Overall Study|Pt age out of range for treatment|0|||
156828169|NCT00075725|566122974|FG000|Overall Study|Insurance issues|0|||
156828170|NCT00075725|566122975|FG001|Overall Study|Insurance issues|1|||
156828171|NCT00075725|566122976|FG002|Overall Study|Insurance issues|0|||
156828172|NCT00075725|566122977|FG003|Overall Study|Insurance issues|1|||
156828173|NCT00075725|566122978|FG004|Overall Study|Insurance issues|1|||
156828174|NCT00075725|566122979|FG005|Overall Study|Insurance issues|1|||
156828175|NCT00075725|566122980|FG006|Overall Study|Insurance issues|0|||
156828176|NCT00075725|566122981|FG007|Overall Study|Insurance issues|1|||
156828177|NCT00075725|566122982|FG008|Overall Study|Insurance issues|0|||
156828178|NCT00075725|566122983|FG009|Overall Study|Insurance issues|0|||
156828179|NCT00075725|566122984|FG010|Overall Study|Insurance issues|0|||
156828180|NCT00075725|566122985|FG011|Overall Study|Insurance issues|0|||
156828181|NCT00075725|566122974|FG000|Overall Study|MRD positive after extended ind|0|||
156828182|NCT00075725|566122975|FG001|Overall Study|MRD positive after extended ind|1|||
156828183|NCT00075725|566122976|FG002|Overall Study|MRD positive after extended ind|1|||
156828184|NCT00075725|566122977|FG003|Overall Study|MRD positive after extended ind|0|||
156828185|NCT00075725|566122978|FG004|Overall Study|MRD positive after extended ind|1|||
156828186|NCT00075725|566122979|FG005|Overall Study|MRD positive after extended ind|2|||
156828187|NCT00075725|566122980|FG006|Overall Study|MRD positive after extended ind|0|||
156828188|NCT00075725|566122981|FG007|Overall Study|MRD positive after extended ind|1|||
156828189|NCT00075725|566122982|FG008|Overall Study|MRD positive after extended ind|0|||
156828190|NCT00075725|566122983|FG009|Overall Study|MRD positive after extended ind|0|||
156828191|NCT00075725|566122984|FG010|Overall Study|MRD positive after extended ind|0|||
156828192|NCT00075725|566122985|FG011|Overall Study|MRD positive after extended ind|0|||
156828193|NCT00075725|566122974|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
156828194|NCT00075725|566122975|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
156828195|NCT00075725|566122976|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
156828196|NCT00075725|566122977|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
156828197|NCT00075725|566122978|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
156339383|NCT01785069|564340189|FG001|Overall Study|Death|0|||
156466221|NCT00439270|564803824|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
156828198|NCT00075725|566122979|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
156828199|NCT00075725|566122980|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
156828200|NCT00075725|566122981|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
156828201|NCT00075725|566122982|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
156828202|NCT00075725|566122983|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
156828203|NCT00075725|566122984|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
156828204|NCT00075725|566122985|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
156828205|NCT00075725|566122974|FG000|Overall Study|Inevaluable|1|||
156828206|NCT00075725|566122975|FG001|Overall Study|Inevaluable|1|||
156828207|NCT00075725|566122976|FG002|Overall Study|Inevaluable|4|||
156828208|NCT00075725|566122977|FG003|Overall Study|Inevaluable|2|||
156828209|NCT00075725|566122978|FG004|Overall Study|Inevaluable|2|||
156828210|NCT00075725|566122979|FG005|Overall Study|Inevaluable|9|||
156828211|NCT00075725|566122980|FG006|Overall Study|Inevaluable|1|||
156828212|NCT00075725|566122981|FG007|Overall Study|Inevaluable|11|||
156828213|NCT00075725|566122982|FG008|Overall Study|Inevaluable|2|||
156828214|NCT00075725|566122983|FG009|Overall Study|Inevaluable|0|||
156828215|NCT00075725|566122984|FG010|Overall Study|Inevaluable|1|||
156828216|NCT00075725|566122985|FG011|Overall Study|Inevaluable|0|||
156828217|NCT00075725|566122974|FG000|Overall Study|Other|4|||
156828218|NCT00075725|566122975|FG001|Overall Study|Other|2|||
156828219|NCT00075725|566122976|FG002|Overall Study|Other|1|||
156828220|NCT00075725|566122977|FG003|Overall Study|Other|1|||
156828221|NCT00075725|566122978|FG004|Overall Study|Other|1|||
156828222|NCT00075725|566122979|FG005|Overall Study|Other|4|||
156828223|NCT00075725|566122980|FG006|Overall Study|Other|2|||
156828224|NCT00075725|566122981|FG007|Overall Study|Other|9|||
156828225|NCT00075725|566122982|FG008|Overall Study|Other|2|||
156828226|NCT00075725|566122983|FG009|Overall Study|Other|1|||
156828227|NCT00075725|566122984|FG010|Overall Study|Other|0|||
156828228|NCT00075725|566122985|FG011|Overall Study|Other|3|||
156828229|NCT00075725|566122974|FG000|Overall Study|Pt trying to find a BM donor|0|||
156828230|NCT00075725|566122975|FG001|Overall Study|Pt trying to find a BM donor|1|||
156828231|NCT00075725|566122976|FG002|Overall Study|Pt trying to find a BM donor|0|||
156828232|NCT00075725|566122977|FG003|Overall Study|Pt trying to find a BM donor|0|||
156828233|NCT00075725|566122978|FG004|Overall Study|Pt trying to find a BM donor|0|||
156828234|NCT00075725|566122979|FG005|Overall Study|Pt trying to find a BM donor|0|||
156828235|NCT00075725|566122980|FG006|Overall Study|Pt trying to find a BM donor|0|||
156828236|NCT00075725|566122981|FG007|Overall Study|Pt trying to find a BM donor|0|||
156828237|NCT00075725|566122982|FG008|Overall Study|Pt trying to find a BM donor|0|||
156828238|NCT00075725|566122983|FG009|Overall Study|Pt trying to find a BM donor|0|||
156828239|NCT00075725|566122984|FG010|Overall Study|Pt trying to find a BM donor|0|||
156828240|NCT00075725|566122985|FG011|Overall Study|Pt trying to find a BM donor|0|||
156828241|NCT00075725|566122974|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
156828242|NCT00075725|566122975|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
156828243|NCT00075725|566122976|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
156828244|NCT00075725|566122977|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
156828245|NCT00075725|566122978|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
156828246|NCT00075725|566122979|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
156828247|NCT00075725|566122980|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
156828248|NCT00075725|566122981|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
156828249|NCT00075725|566122982|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
156828250|NCT00075725|566122983|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
156828251|NCT00075725|566122984|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
156828252|NCT00075725|566122985|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
156828253|NCT00075725|566122974|FG000|Overall Study|Unsuccessful institutional transfer|0|||
156828254|NCT00075725|566122975|FG001|Overall Study|Unsuccessful institutional transfer|0|||
156828255|NCT00075725|566122976|FG002|Overall Study|Unsuccessful institutional transfer|2|||
156828256|NCT00075725|566122977|FG003|Overall Study|Unsuccessful institutional transfer|0|||
156828257|NCT00075725|566122978|FG004|Overall Study|Unsuccessful institutional transfer|0|||
156828258|NCT00075725|566122979|FG005|Overall Study|Unsuccessful institutional transfer|0|||
156828259|NCT00075725|566122980|FG006|Overall Study|Unsuccessful institutional transfer|0|||
156828260|NCT00075725|566122981|FG007|Overall Study|Unsuccessful institutional transfer|0|||
156828261|NCT00075725|566122982|FG008|Overall Study|Unsuccessful institutional transfer|0|||
156339384|NCT01785069|564340190|FG002|Overall Study|Death|2|||
156828262|NCT00075725|566122983|FG009|Overall Study|Unsuccessful institutional transfer|1|||
156828263|NCT00075725|566122984|FG010|Overall Study|Unsuccessful institutional transfer|0|||
156828264|NCT00075725|566122985|FG011|Overall Study|Unsuccessful institutional transfer|0|||
156828265|NCT00075725|566122974|FG000|Overall Study|specimen(s) not submitted|0|||
156828266|NCT00075725|566122975|FG001|Overall Study|specimen(s) not submitted|0|||
156828267|NCT00075725|566122976|FG002|Overall Study|specimen(s) not submitted|2|||
156828268|NCT00075725|566122977|FG003|Overall Study|specimen(s) not submitted|0|||
156828269|NCT00075725|566122978|FG004|Overall Study|specimen(s) not submitted|0|||
156828270|NCT00075725|566122979|FG005|Overall Study|specimen(s) not submitted|0|||
156828271|NCT00075725|566122980|FG006|Overall Study|specimen(s) not submitted|0|||
156828272|NCT00075725|566122981|FG007|Overall Study|specimen(s) not submitted|0|||
156828273|NCT00075725|566122982|FG008|Overall Study|specimen(s) not submitted|0|||
156828274|NCT00075725|566122983|FG009|Overall Study|specimen(s) not submitted|0|||
156828275|NCT00075725|566122984|FG010|Overall Study|specimen(s) not submitted|0|||
156339385|NCT01785069|564340191|FG003|Overall Study|Death|0|||
156828276|NCT00075725|566122985|FG011|Overall Study|specimen(s) not submitted|0|||
156828277|NCT00075725|566122974|FG000|Overall Study|Pt went to transplant|0|||
156828278|NCT00075725|566122975|FG001|Overall Study|Pt went to transplant|0|||
156828279|NCT00075725|566122976|FG002|Overall Study|Pt went to transplant|0|||
156828280|NCT00075725|566122977|FG003|Overall Study|Pt went to transplant|1|||
156828281|NCT00075725|566122978|FG004|Overall Study|Pt went to transplant|0|||
156828282|NCT00075725|566122979|FG005|Overall Study|Pt went to transplant|1|||
156828283|NCT00075725|566122980|FG006|Overall Study|Pt went to transplant|0|||
156828284|NCT00075725|566122981|FG007|Overall Study|Pt went to transplant|0|||
156828285|NCT00075725|566122982|FG008|Overall Study|Pt went to transplant|0|||
156828286|NCT00075725|566122983|FG009|Overall Study|Pt went to transplant|0|||
156828287|NCT00075725|566122984|FG010|Overall Study|Pt went to transplant|0|||
156828288|NCT00075725|566122985|FG011|Overall Study|Pt went to transplant|0|||
156828289|NCT00075725|566122974|FG000|Overall Study|Pt received additional steroids|0|||
156828290|NCT00075725|566122975|FG001|Overall Study|Pt received additional steroids|0|||
156828291|NCT00075725|566122976|FG002|Overall Study|Pt received additional steroids|0|||
156828292|NCT00075725|566122977|FG003|Overall Study|Pt received additional steroids|1|||
156828293|NCT00075725|566122978|FG004|Overall Study|Pt received additional steroids|0|||
156828294|NCT00075725|566122979|FG005|Overall Study|Pt received additional steroids|0|||
156828295|NCT00075725|566122980|FG006|Overall Study|Pt received additional steroids|0|||
156828296|NCT00075725|566122981|FG007|Overall Study|Pt received additional steroids|0|||
156828297|NCT00075725|566122982|FG008|Overall Study|Pt received additional steroids|0|||
156828298|NCT00075725|566122983|FG009|Overall Study|Pt received additional steroids|0|||
156828299|NCT00075725|566122984|FG010|Overall Study|Pt received additional steroids|0|||
156828300|NCT00075725|566122985|FG011|Overall Study|Pt received additional steroids|0|||
156828301|NCT00075725|566122974|FG000|Overall Study|Pt relocated|0|||
156828302|NCT00075725|566122975|FG001|Overall Study|Pt relocated|0|||
156828303|NCT00075725|566122976|FG002|Overall Study|Pt relocated|0|||
156828304|NCT00075725|566122977|FG003|Overall Study|Pt relocated|2|||
156828305|NCT00075725|566122978|FG004|Overall Study|Pt relocated|0|||
156828306|NCT00075725|566122979|FG005|Overall Study|Pt relocated|1|||
156828307|NCT00075725|566122980|FG006|Overall Study|Pt relocated|1|||
156828308|NCT00075725|566122981|FG007|Overall Study|Pt relocated|2|||
156828309|NCT00075725|566122982|FG008|Overall Study|Pt relocated|1|||
156828310|NCT00075725|566122983|FG009|Overall Study|Pt relocated|0|||
156828311|NCT00075725|566122984|FG010|Overall Study|Pt relocated|0|||
156828312|NCT00075725|566122985|FG011|Overall Study|Pt relocated|0|||
156828313|NCT00075725|566122974|FG000|Overall Study|Institution Terminated|0|||
156828314|NCT00075725|566122975|FG001|Overall Study|Institution Terminated|0|||
156828315|NCT00075725|566122976|FG002|Overall Study|Institution Terminated|0|||
156828316|NCT00075725|566122977|FG003|Overall Study|Institution Terminated|0|||
156828317|NCT00075725|566122978|FG004|Overall Study|Institution Terminated|1|||
156828318|NCT00075725|566122979|FG005|Overall Study|Institution Terminated|0|||
156828319|NCT00075725|566122980|FG006|Overall Study|Institution Terminated|0|||
156828320|NCT00075725|566122981|FG007|Overall Study|Institution Terminated|3|||
156828321|NCT00075725|566122982|FG008|Overall Study|Institution Terminated|0|||
156828322|NCT00075725|566122983|FG009|Overall Study|Institution Terminated|0|||
156828323|NCT00075725|566122984|FG010|Overall Study|Institution Terminated|0|||
156828324|NCT00075725|566122985|FG011|Overall Study|Institution Terminated|0|||
156828325|NCT00075725|566122974|FG000|Overall Study|Study Closure|1|||
156828326|NCT00075725|566122975|FG001|Overall Study|Study Closure|0|||
156828327|NCT00075725|566122976|FG002|Overall Study|Study Closure|0|||
156828328|NCT00075725|566122977|FG003|Overall Study|Study Closure|0|||
156828329|NCT00075725|566122978|FG004|Overall Study|Study Closure|1|||
156828330|NCT00075725|566122979|FG005|Overall Study|Study Closure|3|||
156828331|NCT00075725|566122980|FG006|Overall Study|Study Closure|0|||
156828332|NCT00075725|566122981|FG007|Overall Study|Study Closure|1|||
156828333|NCT00075725|566122982|FG008|Overall Study|Study Closure|0|||
156828334|NCT00075725|566122983|FG009|Overall Study|Study Closure|0|||
156828335|NCT00075725|566122984|FG010|Overall Study|Study Closure|0|||
156828336|NCT00075725|566122985|FG011|Overall Study|Study Closure|0|||
156828337|NCT00075725|566122974|FG000|Overall Study|Other complications|0|||
156828338|NCT00075725|566122975|FG001|Overall Study|Other complications|0|||
156828339|NCT00075725|566122976|FG002|Overall Study|Other complications|0|||
156828340|NCT00075725|566122977|FG003|Overall Study|Other complications|0|||
156828341|NCT00075725|566122978|FG004|Overall Study|Other complications|0|||
156828342|NCT00075725|566122979|FG005|Overall Study|Other complications|1|||
156828343|NCT00075725|566122980|FG006|Overall Study|Other complications|0|||
156828344|NCT00075725|566122981|FG007|Overall Study|Other complications|0|||
156828345|NCT00075725|566122982|FG008|Overall Study|Other complications|0|||
156828346|NCT00075725|566122983|FG009|Overall Study|Other complications|0|||
156828347|NCT00075725|566122984|FG010|Overall Study|Other complications|0|||
156828348|NCT00075725|566122985|FG011|Overall Study|Other complications|0|||
156828349|NCT00075725|566122974|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
156828350|NCT00075725|566122975|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
156828351|NCT00075725|566122976|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
156828352|NCT00075725|566122977|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
156466222|NCT00439270|564803825|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
156828353|NCT00075725|566122978|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
156828354|NCT00075725|566122979|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
156828355|NCT00075725|566122980|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
156828356|NCT00075725|566122981|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
156828357|NCT00075725|566122982|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
156828358|NCT00075725|566122983|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
156828359|NCT00075725|566122984|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
156828360|NCT00075725|566122985|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
156828361|NCT00075725|566122974|FG000|Overall Study|Pt incarcerated|0|||
156828362|NCT00075725|566122975|FG001|Overall Study|Pt incarcerated|0|||
156828363|NCT00075725|566122976|FG002|Overall Study|Pt incarcerated|0|||
156828364|NCT00075725|566122977|FG003|Overall Study|Pt incarcerated|0|||
156828365|NCT00075725|566122978|FG004|Overall Study|Pt incarcerated|0|||
156828366|NCT00075725|566122979|FG005|Overall Study|Pt incarcerated|0|||
156828367|NCT00075725|566122980|FG006|Overall Study|Pt incarcerated|0|||
156828368|NCT00075725|566122981|FG007|Overall Study|Pt incarcerated|1|||
156828369|NCT00075725|566122982|FG008|Overall Study|Pt incarcerated|0|||
156828370|NCT00075725|566122983|FG009|Overall Study|Pt incarcerated|0|||
156828371|NCT00075725|566122984|FG010|Overall Study|Pt incarcerated|0|||
156828372|NCT00075725|566122985|FG011|Overall Study|Pt incarcerated|0|||
156828373|NCT04677660|566122986|FG000|Overall Study|Lost to Follow-up|0|||
156828374|NCT04677660|566122987|FG001|Overall Study|Lost to Follow-up|2|||
156828375|NCT04677660|566122986|FG000|Overall Study|Withdrawal by Subject|0|||
156828376|NCT04677660|566122987|FG001|Overall Study|Withdrawal by Subject|1|||
156828377|NCT04677660|566122986|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
156828378|NCT04677660|566122987|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
156828379|NCT02446418|566122991|FG000|Overall Study|Adverse Event|4|||
156828380|NCT02446418|566122992|FG001|Overall Study|Adverse Event|8|||
156828381|NCT02446418|566122991|FG000|Overall Study|Physician Decision|5|||
156828382|NCT02446418|566122992|FG001|Overall Study|Physician Decision|1|||
156828383|NCT02446418|566122991|FG000|Overall Study|Withdrawal by Subject|3|||
156828384|NCT02446418|566122992|FG001|Overall Study|Withdrawal by Subject|3|||
156828385|NCT02446418|566122991|FG000|Overall Study|Lost to Follow-up|2|||
156828386|NCT02446418|566122992|FG001|Overall Study|Lost to Follow-up|2|||
156828387|NCT02446418|566122991|FG000|Overall Study|Protocol Violation|1|||
156828388|NCT02446418|566122992|FG001|Overall Study|Protocol Violation|2|||
156828389|NCT02446418|566122991|FG000|Overall Study|Lack of Efficacy|2|||
156828390|NCT02446418|566122992|FG001|Overall Study|Lack of Efficacy|0|||
156828391|NCT02446418|566122991|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
156466223|NCT00439270|564803826|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
156466224|NCT00439270|564803827|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
156466225|NCT00439270|564803823|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
156466226|NCT00439270|564803824|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
156466227|NCT00439270|564803825|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
156466228|NCT00439270|564803826|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
156541217|NCT00573430|565074507|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156541218|NCT00573430|565074508|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156828392|NCT02446418|566122992|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
156828393|NCT03421743|566122995|FG000|Overall Study|Lack of Efficacy|1|||
156828394|NCT03421743|566122996|FG001|Overall Study|Lack of Efficacy|0|||
156828395|NCT03421743|566122995|FG000|Overall Study|Adverse Event|2|||
156828396|NCT03421743|566122996|FG001|Overall Study|Adverse Event|1|||
156828397|NCT03421743|566122995|FG000|Overall Study|Withdrawal by Subject|0|||
156828398|NCT03421743|566122996|FG001|Overall Study|Withdrawal by Subject|1|||
156828399|NCT00435162|566122997|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
156828400|NCT00435162|566122998|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
156828401|NCT00435162|566122999|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
156828402|NCT00435162|566123000|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
156828403|NCT00435162|566123001|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
156828404|NCT00435162|566123002|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
156828405|NCT00694096|566123003|FG000|Overall Study|Withdrawal by Subject|5|||
156828406|NCT00977938|566123008|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
156828407|NCT00977938|566123009|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
156828408|NCT00977938|566123010|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
156828409|NCT00977938|566123011|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
156828410|NCT00977938|566123008|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
156828411|NCT00977938|566123009|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
156828412|NCT00977938|566123010|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
156828413|NCT00977938|566123011|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
156828414|NCT00977938|566123008|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
156828415|NCT00977938|566123009|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
156828416|NCT00977938|566123010|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
156828417|NCT00977938|566123011|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
156828418|NCT00977938|566123008|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
156828419|NCT00977938|566123009|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
156828420|NCT00977938|566123010|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
156828421|NCT00977938|566123011|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
156828422|NCT00977938|566123008|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
156828423|NCT00977938|566123009|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
156828424|NCT00977938|566123010|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
156828425|NCT00977938|566123011|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
156828426|NCT00977938|566123008|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
156828427|NCT00977938|566123009|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
156828428|NCT00977938|566123010|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
156828429|NCT00977938|566123011|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
156828430|NCT01605227|566123020|FG000|Overall Study|Did not receive study treatment|2|||
156828431|NCT01605227|566123021|FG001|Overall Study|Did not receive study treatment|3|||
156828432|NCT01605227|566123020|FG000|Overall Study|Adverse Event|228|||
156828433|NCT01605227|566123021|FG001|Overall Study|Adverse Event|42|||
156828434|NCT01605227|566123020|FG000|Overall Study|Progressive Disease|132|||
156828435|NCT01605227|566123021|FG001|Overall Study|Progressive Disease|128|||
156828436|NCT01605227|566123020|FG000|Overall Study|Clinical Deterioration|227|||
156828437|NCT01605227|566123021|FG001|Overall Study|Clinical Deterioration|133|||
156828438|NCT01605227|566123020|FG000|Overall Study|Lost to Follow-up|1|||
156828439|NCT01605227|566123021|FG001|Overall Study|Lost to Follow-up|0|||
156828440|NCT01605227|566123020|FG000|Overall Study|Protocol Violation|1|||
156828441|NCT01605227|566123021|FG001|Overall Study|Protocol Violation|0|||
156828442|NCT01605227|566123020|FG000|Overall Study|Physician Decision|9|||
156828443|NCT01605227|566123021|FG001|Overall Study|Physician Decision|7|||
156828444|NCT01605227|566123020|FG000|Overall Study|Withdrawal by Subject|18|||
156828445|NCT01605227|566123021|FG001|Overall Study|Withdrawal by Subject|14|||
156828446|NCT01605227|566123020|FG000|Overall Study|Sponsor Decision|2|||
156828447|NCT01605227|566123021|FG001|Overall Study|Sponsor Decision|0|||
156828448|NCT01605227|566123020|FG000|Overall Study|Started New Therapy|1|||
156828449|NCT01605227|566123021|FG001|Overall Study|Started New Therapy|0|||
156828450|NCT01605227|566123020|FG000|Overall Study|Subject Decision|0|||
156828451|NCT01605227|566123021|FG001|Overall Study|Subject Decision|1|||
156828452|NCT01605227|566123020|FG000|Overall Study|Dose Held >6 weeks|0|||
156828453|NCT01605227|566123021|FG001|Overall Study|Dose Held >6 weeks|1|||
156828454|NCT01166958|566123022|FG000|Overall Study|Withdrawal by Subject|1|||
156828455|NCT01166958|566123023|FG001|Overall Study|Withdrawal by Subject|0|||
156828456|NCT02680574|566123024|FG000|Overall Study|Death|137|||
156828457|NCT02680574|566123025|FG001|Overall Study|Death|137|||
156828458|NCT02680574|566123024|FG000|Overall Study|Withdrawal by Subject|17|||
156828459|NCT02680574|566123025|FG001|Overall Study|Withdrawal by Subject|9|||
156828460|NCT02680574|566123024|FG000|Overall Study|Lost to Follow-up|4|||
156828461|NCT02680574|566123025|FG001|Overall Study|Lost to Follow-up|6|||
156828462|NCT01286987|566123026|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
156828463|NCT01286987|566123027|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
156828464|NCT01286987|566123028|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
156828465|NCT01286987|566123029|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
156828466|NCT01286987|566123030|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
156828467|NCT01286987|566123031|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
156828468|NCT01286987|566123032|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
156828469|NCT01286987|566123033|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
156828470|NCT01286987|566123034|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
156828471|NCT01286987|566123035|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
156828472|NCT01286987|566123036|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
156828473|NCT01286987|566123037|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
156828474|NCT01286987|566123038|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
156828475|NCT01286987|566123039|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
156828476|NCT01286987|566123040|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
156828477|NCT01286987|566123026|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
156828478|NCT01286987|566123027|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
156828479|NCT01286987|566123028|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
156828480|NCT01286987|566123029|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
156828481|NCT01286987|566123030|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
156828482|NCT01286987|566123031|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
156828483|NCT01286987|566123032|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
156828484|NCT01286987|566123033|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
156828485|NCT01286987|566123034|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
156828486|NCT01286987|566123035|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
156828487|NCT01286987|566123036|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
156828488|NCT01286987|566123037|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
156828489|NCT01286987|566123038|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
156828490|NCT01286987|566123039|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
156828491|NCT01286987|566123040|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
156828492|NCT01286987|566123026|FG000|Part 1: Dose Escalation|Physician Decision|0|||
156828493|NCT01286987|566123027|FG001|Part 1: Dose Escalation|Physician Decision|0|||
156828494|NCT01286987|566123028|FG002|Part 1: Dose Escalation|Physician Decision|0|||
156828495|NCT01286987|566123029|FG003|Part 1: Dose Escalation|Physician Decision|0|||
156828496|NCT01286987|566123030|FG004|Part 1: Dose Escalation|Physician Decision|1|||
156828497|NCT01286987|566123031|FG005|Part 1: Dose Escalation|Physician Decision|0|||
156828498|NCT01286987|566123032|FG006|Part 1: Dose Escalation|Physician Decision|0|||
156541219|NCT00573430|565074509|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
156541220|NCT04451161|565074510|FG000|Overall Study|Lost to Follow-up|28|||
156541221|NCT04451161|565074511|FG001|Overall Study|Lost to Follow-up|37|||
156541222|NCT04451161|565074512|FG002|Overall Study|Lost to Follow-up|22|||
156828499|NCT01286987|566123033|FG007|Part 1: Dose Escalation|Physician Decision|0|||
156828500|NCT01286987|566123034|FG008|Part 1: Dose Escalation|Physician Decision|0|||
156828501|NCT01286987|566123035|FG009|Part 1: Dose Escalation|Physician Decision|0|||
156828502|NCT01286987|566123036|FG010|Part 1: Dose Escalation|Physician Decision|0|||
156828503|NCT01286987|566123037|FG011|Part 1: Dose Escalation|Physician Decision|0|||
156828504|NCT01286987|566123038|FG012|Part 1: Dose Escalation|Physician Decision|0|||
156828505|NCT01286987|566123039|FG013|Part 1: Dose Escalation|Physician Decision|0|||
156828506|NCT01286987|566123040|FG014|Part 1: Dose Escalation|Physician Decision|0|||
156828507|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Death|0|||
156828508|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Death|0|||
156828509|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Death|0|||
156828510|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Death|0|||
156828511|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Death|0|||
156828512|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Death|0|||
156828513|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Death|0|||
156339386|NCT01785069|564340188|FG000|Overall Study|Subject choice|2|||
156339387|NCT01785069|564340189|FG001|Overall Study|Subject choice|2|||
156339388|NCT01785069|564340190|FG002|Overall Study|Subject choice|0|||
156339389|NCT01785069|564340191|FG003|Overall Study|Subject choice|1|||
156339390|NCT01785069|564340188|FG000|Overall Study|Lost to Follow-up|1|||
156339391|NCT01785069|564340189|FG001|Overall Study|Lost to Follow-up|2|||
156339392|NCT01785069|564340190|FG002|Overall Study|Lost to Follow-up|4|||
156339393|NCT01785069|564340191|FG003|Overall Study|Lost to Follow-up|1|||
156828514|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Death|0|||
156339394|NCT01785069|564340188|FG000|Overall Study|Reason not Specified|1|||
156339395|NCT01785069|564340189|FG001|Overall Study|Reason not Specified|2|||
156339396|NCT01785069|564340190|FG002|Overall Study|Reason not Specified|1|||
156339397|NCT01785069|564340191|FG003|Overall Study|Reason not Specified|4|||
156828515|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Death|0|||
156828516|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Death|0|||
156541223|NCT04451161|565074513|FG003|Overall Study|Lost to Follow-up|13|||
156541224|NCT04451161|565074514|FG004|Overall Study|Lost to Follow-up|11|||
156541225|NCT04451161|565074515|FG005|Overall Study|Lost to Follow-up|14|||
156541226|NCT04451161|565074510|FG000|Overall Study|Withdrawal by Subject|3|||
156541227|NCT04451161|565074511|FG001|Overall Study|Withdrawal by Subject|0|||
156541228|NCT04451161|565074512|FG002|Overall Study|Withdrawal by Subject|0|||
156541229|NCT04451161|565074513|FG003|Overall Study|Withdrawal by Subject|0|||
156541230|NCT04451161|565074514|FG004|Overall Study|Withdrawal by Subject|2|||
156541231|NCT04451161|565074515|FG005|Overall Study|Withdrawal by Subject|4|||
156828517|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Death|0|||
156828518|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Death|0|||
156339398|NCT01785069|564340188|FG000|Overall Study|Not evaluable|7|||
156541232|NCT00454857|565074519|FG000|Overall Study|Withdrawal by Subject|15|||
156541233|NCT00454857|565074519|FG000|Overall Study|Lost to Follow-up|16|||
156339399|NCT01785069|564340189|FG001|Overall Study|Not evaluable|4|||
156339400|NCT01785069|564340190|FG002|Overall Study|Not evaluable|5|||
156339401|NCT01785069|564340191|FG003|Overall Study|Not evaluable|8|||
156339402|NCT01088997|564340194|FG000|Overall Study|Physician Decision|1|||
156339403|NCT01088997|564340195|FG001|Overall Study|Physician Decision|1|||
156339404|NCT01088997|564340194|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
156339405|NCT01088997|564340195|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
156339406|NCT01088997|564340194|FG000|Overall Study|Excluded prior to receiving drug|1|||
156339407|NCT01088997|564340195|FG001|Overall Study|Excluded prior to receiving drug|1|||
156339408|NCT05570500|564340200|FG000|Overall Study|Lost to Follow-up|7|||
156339409|NCT05570500|564340201|FG001|Overall Study|Lost to Follow-up|5|||
156828519|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Death|1|||
156828520|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Death|1|||
156828521|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Death|0|||
156828522|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Physician Decision|0|||
156828523|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Physician Decision|0|||
156828524|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Physician Decision|0|||
156828525|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Physician Decision|0|||
156828526|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Physician Decision|0|||
156828527|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Physician Decision|0|||
156828528|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Physician Decision|0|||
156828529|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Physician Decision|0|||
156828530|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Physician Decision|0|||
156828531|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Physician Decision|0|||
156828532|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Physician Decision|1|||
156828533|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Physician Decision|1|||
156828534|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Physician Decision|0|||
156828535|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Physician Decision|1|||
156828536|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Physician Decision|0|||
156828537|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Other|0|||
156828538|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Other|0|||
156828539|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Other|0|||
156828540|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Other|0|||
156828541|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Other|0|||
156828542|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Other|0|||
156828543|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Other|0|||
156828544|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Other|0|||
156828545|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Other|0|||
156828546|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Other|0|||
156828547|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Other|0|||
156828548|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Other|0|||
156828549|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Other|0|||
156828550|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Other|1|||
156828551|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Other|0|||
156828552|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
156828553|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
156828554|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
156828555|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
156828556|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
156828557|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
156828558|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
156828559|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
156828560|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
156828561|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
156828562|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
156828563|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
156828564|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
156828565|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
156828566|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
156828567|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
156828568|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
156828569|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
156828570|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
156828571|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
156828572|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
156339410|NCT01095731|564340202|FG000|Overall Study|Protocol Violation|1|||
156339411|NCT01095731|564340203|FG001|Overall Study|Protocol Violation|1|||
156339412|NCT01095731|564340202|FG000|Overall Study|Withdrawal by Subject|0|||
156339413|NCT01095731|564340203|FG001|Overall Study|Withdrawal by Subject|1|||
156828573|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
156828574|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
156828575|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
156828576|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
156828577|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
156828578|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
156828579|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
156828580|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
156828581|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
156828582|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828583|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828584|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828585|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828586|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828587|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828588|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828589|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828590|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828591|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828592|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
156828593|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828594|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828595|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828596|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828597|NCT00624819|566123041|FG000|Follow-up Period: Year 4|Parents decision|0|||
156828598|NCT00624819|566123042|FG001|Follow-up Period: Year 4|Parents decision|0|||
156828599|NCT00624819|566123043|FG002|Follow-up Period: Year 4|Parents decision|1|||
156828600|NCT00624819|566123044|FG003|Follow-up Period: Year 4|Parents decision|0|||
156828601|NCT00624819|566123041|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
156828602|NCT00624819|566123042|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
156828603|NCT00624819|566123043|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
156828604|NCT00624819|566123044|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
156828605|NCT02847858|566123045|FG000|Overall Study|Lost to Follow-up|401|||
156828606|NCT02847858|566123046|FG001|Overall Study|Lost to Follow-up|269|||
156828607|NCT00681564|566123047|FG000|Overall Study|Lost to Follow-up|6|||
156828608|NCT00681564|566123048|FG001|Overall Study|Lost to Follow-up|6|||
156828609|NCT00681564|566123047|FG000|Overall Study|Withdrawal by Subject|0|||
156828610|NCT00681564|566123048|FG001|Overall Study|Withdrawal by Subject|1|||
156828611|NCT00681564|566123047|FG000|Overall Study|Death|0|||
156828612|NCT00681564|566123048|FG001|Overall Study|Death|1|||
156828613|NCT03093974|566123051|FG000|Overall Study|Withdrawal by Subject|32|||
156828614|NCT03093974|566123052|FG001|Overall Study|Withdrawal by Subject|27|||
156828615|NCT03093974|566123051|FG000|Overall Study|Adverse Event|17|||
156828616|NCT03093974|566123052|FG001|Overall Study|Adverse Event|24|||
156828617|NCT03093974|566123051|FG000|Overall Study|Death|0|||
156828618|NCT03093974|566123052|FG001|Overall Study|Death|1|||
156828619|NCT03093974|566123051|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156828620|NCT03093974|566123052|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156828621|NCT03093974|566123051|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
156828622|NCT03093974|566123052|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
156828623|NCT03093974|566123051|FG000|Overall Study|Lost to Follow-up|0|||
156828624|NCT03093974|566123052|FG001|Overall Study|Lost to Follow-up|1|||
156828625|NCT03093974|566123051|FG000|Overall Study|Other|1|||
156828626|NCT03093974|566123052|FG001|Overall Study|Other|2|||
156828627|NCT02387164|566123053|FG000|Overall Study|Lost to Follow-up|2|||
156828628|NCT02387164|566123054|FG001|Overall Study|Lost to Follow-up|0|||
156828629|NCT02387164|566123053|FG000|Overall Study|Diagnosed|1|||
156828630|NCT02387164|566123054|FG001|Overall Study|Diagnosed|2|||
156339414|NCT02302807|564340206|FG000|Overall Study|Withdrawal by Subject|28|||
156828631|NCT01253265|566123058|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
156828632|NCT01253265|566123059|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
156828633|NCT01253265|566123060|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
156828634|NCT01253265|566123061|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
156828635|NCT01253265|566123062|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
156828636|NCT01253265|566123058|FG000|Overall Study|Withdrawal by Subject|0|||
156828637|NCT01253265|566123059|FG001|Overall Study|Withdrawal by Subject|0|||
156828638|NCT01253265|566123060|FG002|Overall Study|Withdrawal by Subject|0|||
156828639|NCT01253265|566123061|FG003|Overall Study|Withdrawal by Subject|0|||
156339415|NCT02302807|564340207|FG001|Overall Study|Withdrawal by Subject|11|||
156541234|NCT00454857|565074519|FG000|Overall Study|Noncompliance|6|||
156828640|NCT01253265|566123062|FG004|Overall Study|Withdrawal by Subject|1|||
156828641|NCT00541099|566123064|FG000|Overall Study|Ineligible|3|||
156828642|NCT01416441|566123067|FG000|Overall Study|Lost to Follow-up|5|||
156828643|NCT01416441|566123067|FG000|Overall Study|Adverse Event|6|||
156828644|NCT01416441|566123067|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
156828645|NCT01416441|566123067|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
156828646|NCT01416441|566123067|FG000|Overall Study|Investigator Withdrew Subject|2|||
156828647|NCT01416441|566123067|FG000|Overall Study|Subject Withdrew Consent|12|||
156828648|NCT01416441|566123067|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
156828649|NCT00526110|566123068|FG000|Overall Study|Adverse Event|2|||
156828650|NCT00526110|566123069|FG001|Overall Study|Adverse Event|9|||
156828651|NCT00526110|566123068|FG000|Overall Study|Disease Progression|0|||
156828652|NCT00526110|566123069|FG001|Overall Study|Disease Progression|19|||
156828653|NCT00526110|566123068|FG000|Overall Study|Maximal Response|0|||
156828654|NCT00526110|566123069|FG001|Overall Study|Maximal Response|6|||
156828655|NCT00526110|566123068|FG000|Overall Study|Withdrawal by Subject|0|||
156828656|NCT00526110|566123069|FG001|Overall Study|Withdrawal by Subject|2|||
156828657|NCT00526110|566123068|FG000|Overall Study|Poor Tolerance|0|||
156828658|NCT00526110|566123069|FG001|Overall Study|Poor Tolerance|5|||
156828659|NCT01309269|566124993|FG000|Overall Study|Adverse Event|56|||
156828660|NCT01309269|566124993|FG000|Overall Study|Withdrawal by Subject|25|||
156828661|NCT01309269|566124993|FG000|Overall Study|Lack of Acceptance|15|||
156828662|NCT01309269|566124993|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
156828663|NCT01309269|566124993|FG000|Overall Study|Kidney Transplant|25|||
156828664|NCT01309269|566124993|FG000|Overall Study|Administrative Problems|141|||
156828665|NCT01309269|566124993|FG000|Overall Study|Other|256|||
156828666|NCT01309269|566124993|FG000|Overall Study|Other|1|||
156828667|NCT01309269|566124993|FG000|Overall Study|Study Completion Data Not Recorded|95|||
156828668|NCT01309269|566124993|FG000|Overall Study|Enrolled but not Treated|107|||
156828669|NCT03383783|566124996|FG000|Overall Study|Withdrawal by Subject|2|||
156828670|NCT02119156|566125002|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
156828671|NCT02119156|566125003|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
156828672|NCT02119156|566125004|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
156828673|NCT02119156|566125002|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
156828674|NCT02119156|566125003|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
156828675|NCT02119156|566125004|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
156828676|NCT02119156|566125002|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
156828677|NCT02119156|566125003|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
156828678|NCT02119156|566125004|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
156828679|NCT02119156|566125002|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
156828680|NCT02119156|566125003|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
156828681|NCT02119156|566125004|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
156828682|NCT02119156|566125002|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
156828683|NCT02119156|566125003|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
156828684|NCT02119156|566125004|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
156828685|NCT01030874|566125006|FG000|Overall Study|Withdrawal by Subject|1|||
156828686|NCT01030874|566125007|FG001|Overall Study|Withdrawal by Subject|0|||
156828687|NCT01030874|566125006|FG000|Overall Study|Discharged in first 2 weeks|17|||
156828688|NCT01030874|566125007|FG001|Overall Study|Discharged in first 2 weeks|16|||
156828689|NCT03263923|566125012|FG000|Overall Study|Withdrawal by Subject|10|||
156828690|NCT03263923|566125013|FG001|Overall Study|Withdrawal by Subject|8|||
156828691|NCT03263923|566125012|FG000|Overall Study|Lost to Follow-up|15|||
156828692|NCT03263923|566125013|FG001|Overall Study|Lost to Follow-up|13|||
156828693|NCT02229214|566125018|FG000|Overall Study|Adverse Event|2|||
156828694|NCT02229214|566125019|FG001|Overall Study|Adverse Event|0|||
156828695|NCT02229214|566125018|FG000|Overall Study|Withdrawal by Subject|4|||
156828696|NCT02229214|566125019|FG001|Overall Study|Withdrawal by Subject|0|||
156828697|NCT00246025|566125020|FG000|Overall Study|Adverse Event|7|||
156828698|NCT00246025|566125021|FG001|Overall Study|Adverse Event|9|||
156828699|NCT00246025|566125022|FG002|Overall Study|Adverse Event|9|||
156828700|NCT00246025|566125023|FG003|Overall Study|Adverse Event|10|||
156828701|NCT00246025|566125020|FG000|Overall Study|Withdrawal by Subject|3|||
156828702|NCT00246025|566125021|FG001|Overall Study|Withdrawal by Subject|0|||
156828703|NCT00246025|566125022|FG002|Overall Study|Withdrawal by Subject|1|||
156828704|NCT00246025|566125023|FG003|Overall Study|Withdrawal by Subject|2|||
156828705|NCT00246025|566125020|FG000|Overall Study|unsuitable medical history was found|0|||
156828706|NCT00246025|566125021|FG001|Overall Study|unsuitable medical history was found|0|||
156828707|NCT00246025|566125022|FG002|Overall Study|unsuitable medical history was found|0|||
156828708|NCT00246025|566125023|FG003|Overall Study|unsuitable medical history was found|1|||
156828709|NCT03054350|566125026|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
156828710|NCT03054350|566125027|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
156828711|NCT03054350|566125028|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
156828712|NCT03054350|566125029|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
156828713|NCT03054350|566125030|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
156828714|NCT03054350|566125031|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
156828715|NCT03054350|566125026|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828716|NCT03054350|566125027|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828717|NCT03054350|566125028|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
156828718|NCT03054350|566125029|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828719|NCT03054350|566125030|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828720|NCT03054350|566125031|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828721|NCT03054350|566125026|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
156828722|NCT03054350|566125027|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
156828723|NCT03054350|566125028|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
156828724|NCT03054350|566125029|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
156828725|NCT03054350|566125030|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
156828726|NCT03054350|566125031|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
156828727|NCT03054350|566125026|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828728|NCT03054350|566125027|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828729|NCT03054350|566125028|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
156828730|NCT03054350|566125029|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828731|NCT03054350|566125030|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828732|NCT03054350|566125031|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828733|NCT00931723|566125032|FG000|Overall Study|Withdrawal by Subject|11|||
156828734|NCT00931723|566125033|FG001|Overall Study|Withdrawal by Subject|13|||
156828735|NCT00931723|566125032|FG000|Overall Study|Adverse Event|6|||
156828736|NCT00931723|566125033|FG001|Overall Study|Adverse Event|13|||
156828737|NCT00931723|566125032|FG000|Overall Study|Lithium found in blood|0|||
156828738|NCT00931723|566125033|FG001|Overall Study|Lithium found in blood|1|||
156828739|NCT00931723|566125032|FG000|Overall Study|Condition under investigation worsened|1|||
156828740|NCT00931723|566125033|FG001|Overall Study|Condition under investigation worsened|2|||
156828741|NCT00931723|566125032|FG000|Overall Study|Lost to Follow-up|1|||
156828742|NCT00931723|566125033|FG001|Overall Study|Lost to Follow-up|2|||
156828743|NCT00931723|566125032|FG000|Overall Study|Study-specific discontinuation criteria|1|||
156828744|NCT00931723|566125033|FG001|Overall Study|Study-specific discontinuation criteria|1|||
156828745|NCT00931723|566125032|FG000|Overall Study|Severe non-compliance to protocol|2|||
156828746|NCT00931723|566125033|FG001|Overall Study|Severe non-compliance to protocol|0|||
156828747|NCT00931723|566125032|FG000|Overall Study|Safety reasons|0|||
156828748|NCT00931723|566125033|FG001|Overall Study|Safety reasons|1|||
156828749|NCT00931723|566125032|FG000|Overall Study|Took prohibited concomitant medication|0|||
156828750|NCT00931723|566125033|FG001|Overall Study|Took prohibited concomitant medication|1|||
156828751|NCT00931723|566125032|FG000|Overall Study|Lack or insufficient theraputic response|2|||
156828752|NCT00931723|566125033|FG001|Overall Study|Lack or insufficient theraputic response|5|||
156828753|NCT00931723|566125032|FG000|Overall Study|Sponsor decision|1|||
156828754|NCT00931723|566125033|FG001|Overall Study|Sponsor decision|0|||
156828755|NCT00931723|566125032|FG000|Overall Study|Late hospital discharge|1|||
156828756|NCT00931723|566125033|FG001|Overall Study|Late hospital discharge|0|||
156828757|NCT01643850|566125034|FG000|Overall Study|Withdrawal by Subject|0|||
156828758|NCT01643850|566125035|FG001|Overall Study|Withdrawal by Subject|0|||
156828759|NCT01643850|566125036|FG002|Overall Study|Withdrawal by Subject|0|||
156828760|NCT01643850|566125037|FG003|Overall Study|Withdrawal by Subject|0|||
156828761|NCT01643850|566125038|FG004|Overall Study|Withdrawal by Subject|1|||
156828762|NCT01643850|566125039|FG005|Overall Study|Withdrawal by Subject|0|||
156828763|NCT01643850|566125040|FG006|Overall Study|Withdrawal by Subject|0|||
156828764|NCT01643850|566125041|FG007|Overall Study|Withdrawal by Subject|0|||
156828765|NCT01643850|566125042|FG008|Overall Study|Withdrawal by Subject|0|||
156828766|NCT01643850|566125034|FG000|Overall Study|Lost to Follow-up|0|||
156828767|NCT01643850|566125035|FG001|Overall Study|Lost to Follow-up|0|||
156828768|NCT01643850|566125036|FG002|Overall Study|Lost to Follow-up|0|||
156828769|NCT01643850|566125037|FG003|Overall Study|Lost to Follow-up|0|||
156828770|NCT01643850|566125038|FG004|Overall Study|Lost to Follow-up|0|||
156828771|NCT01643850|566125039|FG005|Overall Study|Lost to Follow-up|0|||
156828772|NCT01643850|566125040|FG006|Overall Study|Lost to Follow-up|1|||
156828773|NCT01643850|566125041|FG007|Overall Study|Lost to Follow-up|0|||
156828774|NCT01643850|566125042|FG008|Overall Study|Lost to Follow-up|1|||
156828775|NCT01643850|566125034|FG000|Overall Study|Adverse Event|0|||
156828776|NCT01643850|566125035|FG001|Overall Study|Adverse Event|0|||
156828777|NCT01643850|566125036|FG002|Overall Study|Adverse Event|0|||
156828778|NCT01643850|566125037|FG003|Overall Study|Adverse Event|0|||
156828779|NCT01643850|566125038|FG004|Overall Study|Adverse Event|1|||
156828780|NCT01643850|566125039|FG005|Overall Study|Adverse Event|0|||
156828781|NCT01643850|566125040|FG006|Overall Study|Adverse Event|0|||
156828782|NCT01643850|566125041|FG007|Overall Study|Adverse Event|0|||
156828783|NCT01643850|566125042|FG008|Overall Study|Adverse Event|0|||
156828784|NCT01643850|566125034|FG000|Overall Study|Administrative Problems|0|||
156828785|NCT01643850|566125035|FG001|Overall Study|Administrative Problems|0|||
156828786|NCT01643850|566125036|FG002|Overall Study|Administrative Problems|1|||
156828787|NCT01643850|566125037|FG003|Overall Study|Administrative Problems|0|||
156828788|NCT01643850|566125038|FG004|Overall Study|Administrative Problems|1|||
156828789|NCT01643850|566125039|FG005|Overall Study|Administrative Problems|0|||
156828790|NCT01643850|566125040|FG006|Overall Study|Administrative Problems|0|||
156828791|NCT01643850|566125041|FG007|Overall Study|Administrative Problems|0|||
156828792|NCT01643850|566125042|FG008|Overall Study|Administrative Problems|0|||
156828793|NCT03305081|566125049|FG000|Overall Study|Lost to Follow-up|10|||
156828794|NCT03305081|566125050|FG001|Overall Study|Lost to Follow-up|15|||
156828795|NCT05426031|566125055|FG000|Overall Study|Circulatory Arrest|3|||
156828796|NCT05426031|566125056|FG001|Overall Study|Circulatory Arrest|2|||
156828797|NCT04065074|566125057|FG000|Overall Study|Adverse Event|1|||
156828798|NCT04065074|566125057|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
156828799|NCT00241631|566125058|FG000|Run in (2 Weeks)|Physician Decision|3|||
156828800|NCT00241631|566125059|FG001|Run in (2 Weeks)|Physician Decision|3|||
156828801|NCT00241631|566125058|FG000|Phase 1 (4 Weeks)|sore throat|1|||
156828802|NCT00241631|566125059|FG001|Phase 1 (4 Weeks)|sore throat|0|||
156828803|NCT00241631|566125058|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
156828804|NCT00241631|566125059|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
156828805|NCT00241631|566125058|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
156828806|NCT00241631|566125059|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
156828807|NCT00241631|566125058|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
156828808|NCT00241631|566125059|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
156828809|NCT01218100|566125060|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
156828810|NCT01218100|566125061|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
156828811|NCT01218100|566125062|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
156828812|NCT01218100|566125063|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
156828813|NCT01218100|566125060|FG000|Overall Study|Adverse Event|4|||
156828814|NCT01218100|566125061|FG001|Overall Study|Adverse Event|6|||
156828815|NCT01218100|566125062|FG002|Overall Study|Adverse Event|6|||
156828816|NCT01218100|566125063|FG003|Overall Study|Adverse Event|7|||
156828817|NCT01218100|566125060|FG000|Overall Study|Lack of Efficacy|9|||
156828818|NCT01218100|566125061|FG001|Overall Study|Lack of Efficacy|6|||
156828819|NCT01218100|566125062|FG002|Overall Study|Lack of Efficacy|5|||
156828820|NCT01218100|566125063|FG003|Overall Study|Lack of Efficacy|12|||
156828821|NCT01218100|566125060|FG000|Overall Study|Protocol Violation|0|||
156828822|NCT01218100|566125061|FG001|Overall Study|Protocol Violation|0|||
156828823|NCT01218100|566125062|FG002|Overall Study|Protocol Violation|1|||
156828824|NCT01218100|566125063|FG003|Overall Study|Protocol Violation|1|||
156828825|NCT01218100|566125060|FG000|Overall Study|Withdrawal by Subject|5|||
156828826|NCT01218100|566125061|FG001|Overall Study|Withdrawal by Subject|2|||
156828827|NCT01218100|566125062|FG002|Overall Study|Withdrawal by Subject|6|||
156339416|NCT02302807|564340206|FG000|Overall Study|Lost to Follow-up|4|||
156339417|NCT02302807|564340207|FG001|Overall Study|Lost to Follow-up|6|||
156828828|NCT01218100|566125063|FG003|Overall Study|Withdrawal by Subject|7|||
156828829|NCT01218100|566125060|FG000|Overall Study|Lost to Follow-up|3|||
156828830|NCT01218100|566125061|FG001|Overall Study|Lost to Follow-up|8|||
156828831|NCT01218100|566125062|FG002|Overall Study|Lost to Follow-up|2|||
156828832|NCT01218100|566125063|FG003|Overall Study|Lost to Follow-up|1|||
156828833|NCT01218100|566125060|FG000|Overall Study|Other Reason|2|||
156828834|NCT01218100|566125061|FG001|Overall Study|Other Reason|2|||
156828835|NCT01218100|566125062|FG002|Overall Study|Other Reason|6|||
156828836|NCT01218100|566125063|FG003|Overall Study|Other Reason|4|||
156828837|NCT02437305|566125064|FG000|Overall Study|Lost to Follow-up|18|||
156828838|NCT02437305|566125065|FG001|Overall Study|Lost to Follow-up|12|||
156828839|NCT03883113|566125067|FG000|Overall Study|Physician Decision|4|||
156339418|NCT02302807|564340206|FG000|Overall Study|Death|397|||
156828840|NCT03883113|566125068|FG001|Overall Study|Physician Decision|2|||
156828841|NCT03883113|566125067|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
156828842|NCT03883113|566125068|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
156828843|NCT03883113|566125067|FG000|Overall Study|Pregnancy|1|||
156828844|NCT03883113|566125068|FG001|Overall Study|Pregnancy|0|||
156339419|NCT02302807|564340207|FG001|Overall Study|Death|385|||
156339420|NCT02302807|564340206|FG000|Overall Study|Study Terminated By Sponsor|35|||
156828845|NCT03883113|566125067|FG000|Overall Study|Adverse Event|0|||
156828846|NCT03883113|566125068|FG001|Overall Study|Adverse Event|1|||
156339421|NCT02302807|564340207|FG001|Overall Study|Study Terminated By Sponsor|64|||
156339422|NCT02302807|564340206|FG000|Overall Study|Physician Decision|0|||
156339423|NCT02302807|564340207|FG001|Overall Study|Physician Decision|1|||
156339424|NCT04840615|564342115|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
156339425|NCT04840615|564342116|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
156339426|NCT04840615|564342117|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
156339427|NCT00126191|564342120|FG000|Overall Study|Physician Decision|0|||
156339428|NCT00126191|564342121|FG001|Overall Study|Physician Decision|1|||
156339429|NCT00126191|564342120|FG000|Overall Study|Death|0|||
156339430|NCT00126191|564342121|FG001|Overall Study|Death|1|||
156339431|NCT00307294|564342122|FG000|Overall Study|Withdrawal by Subject|1|||
156339432|NCT00674700|564342131|FG000|Year 1|Adverse Event|17|||
156339433|NCT00674700|564342132|FG001|Year 1|Adverse Event|20|||
156828847|NCT03883113|566125067|FG000|Overall Study|Withdrawal by Subject|1|||
156828848|NCT03883113|566125068|FG001|Overall Study|Withdrawal by Subject|2|||
156828849|NCT03883113|566125067|FG000|Overall Study|Lost to Follow-up|1|||
156828850|NCT03883113|566125068|FG001|Overall Study|Lost to Follow-up|0|||
156828851|NCT02141490|566125073|FG000|Overall Study|Screening failures|4|||
156828852|NCT02141490|566125074|FG001|Overall Study|Screening failures|0|||
156828853|NCT02141490|566125075|FG002|Overall Study|Screening failures|0|||
156828854|NCT01009346|566125076|FG000|Overall Study|Adverse Event|4|||
156828855|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
156828856|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
156828857|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
156828858|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
156828859|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
156828860|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
156828861|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
156828862|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
156828863|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
156339434|NCT00674700|564342133|FG002|Year 1|Adverse Event|5|||
156828864|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
156828865|NCT03906656|566125077|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
156828866|NCT03906656|566125078|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
156828867|NCT03906656|566125077|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
156828868|NCT03906656|566125078|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
156828869|NCT03906656|566125077|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
156828870|NCT03906656|566125078|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
156828871|NCT03906656|566125077|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
156828872|NCT03906656|566125078|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
156828873|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
156828874|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
156828875|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
156828876|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
156828877|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
156828878|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
156828879|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
156828880|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
156828881|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
156828882|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
156828883|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
156828884|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
156828885|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
156828886|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
156828887|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
156828888|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
156828889|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Death|2|||
156828890|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Death|0|||
156828891|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
156828892|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
156828893|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
156828894|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
156828895|NCT00033540|566125079|FG000|Overall Study|Adverse Event|14|||
156828896|NCT00033540|566125079|FG000|Overall Study|Death|1|||
156828897|NCT00033540|566125079|FG000|Overall Study|Progression|26|||
156828898|NCT00033540|566125079|FG000|Overall Study|Withdrawal by Subject|6|||
156339435|NCT00674700|564342131|FG000|Year 1|Withdrawal by Subject|7|||
156339436|NCT00674700|564342132|FG001|Year 1|Withdrawal by Subject|7|||
156339437|NCT00674700|564342133|FG002|Year 1|Withdrawal by Subject|6|||
156466229|NCT00439270|564803827|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
156828899|NCT00033540|566125079|FG000|Overall Study|Other|5|||
156828900|NCT00033540|566125079|FG000|Overall Study|Ineligible|3|||
156339438|NCT00674700|564342131|FG000|Year 1|Any other reason not above-mentioned|7|||
156339439|NCT00674700|564342132|FG001|Year 1|Any other reason not above-mentioned|7|||
156339440|NCT00674700|564342133|FG002|Year 1|Any other reason not above-mentioned|6|||
156339441|NCT00674700|564342131|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
156339442|NCT00674700|564342132|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
156339443|NCT00674700|564342133|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
156339444|NCT00674700|564342131|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
156339445|NCT00674700|564342132|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
156339446|NCT00674700|564342133|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
156339447|NCT00674700|564342131|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
156339448|NCT00674700|564342132|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
156339449|NCT00674700|564342133|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
156339450|NCT02954237|564342134|FG000|Overall Study|Withdrawal by Subject|25|||
156339451|NCT02954237|564342134|FG000|Overall Study|Missed visit|16|||
156339452|NCT02954237|564342134|FG000|Overall Study|Death|2|||
156339453|NCT00395304|564342135|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156339454|NCT00395304|564342136|FG001|Treatment Period 1|Withdrawal by Subject|3|||
156339455|NCT00395304|564342137|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156339456|NCT00395304|564342138|FG003|Treatment Period 1|Withdrawal by Subject|2|||
156339457|NCT00395304|564342139|FG004|Treatment Period 1|Withdrawal by Subject|1|||
156339458|NCT00395304|564342140|FG005|Treatment Period 1|Withdrawal by Subject|1|||
156339459|NCT00395304|564342135|FG000|Treatment Period 1|Lost to Follow-up|1|||
156339460|NCT00395304|564342136|FG001|Treatment Period 1|Lost to Follow-up|0|||
156339461|NCT00395304|564342137|FG002|Treatment Period 1|Lost to Follow-up|0|||
156339462|NCT00395304|564342138|FG003|Treatment Period 1|Lost to Follow-up|1|||
156339463|NCT00395304|564342139|FG004|Treatment Period 1|Lost to Follow-up|0|||
156339464|NCT00395304|564342140|FG005|Treatment Period 1|Lost to Follow-up|1|||
156339465|NCT00395304|564342135|FG000|Treatment Period 1|Physician Decision|0|||
156339466|NCT00395304|564342136|FG001|Treatment Period 1|Physician Decision|1|||
156339467|NCT00395304|564342137|FG002|Treatment Period 1|Physician Decision|0|||
156339468|NCT00395304|564342138|FG003|Treatment Period 1|Physician Decision|0|||
156339469|NCT00395304|564342139|FG004|Treatment Period 1|Physician Decision|0|||
156339470|NCT00395304|564342140|FG005|Treatment Period 1|Physician Decision|0|||
156339471|NCT00395304|564342135|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156339472|NCT00395304|564342136|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156339473|NCT00395304|564342137|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156339474|NCT00395304|564342138|FG003|Treatment Period 2|Withdrawal by Subject|1|||
156339475|NCT00395304|564342139|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156339476|NCT00395304|564342140|FG005|Treatment Period 2|Withdrawal by Subject|2|||
156339477|NCT00395304|564342135|FG000|Treatment Period 2|Lost to Follow-up|0|||
156339478|NCT00395304|564342136|FG001|Treatment Period 2|Lost to Follow-up|3|||
156339479|NCT00395304|564342137|FG002|Treatment Period 2|Lost to Follow-up|0|||
156339480|NCT00395304|564342138|FG003|Treatment Period 2|Lost to Follow-up|0|||
156339481|NCT00395304|564342139|FG004|Treatment Period 2|Lost to Follow-up|0|||
156339482|NCT00395304|564342140|FG005|Treatment Period 2|Lost to Follow-up|0|||
156339483|NCT00395304|564342135|FG000|Treatment Period 2|Physician Decision|0|||
156339484|NCT00395304|564342136|FG001|Treatment Period 2|Physician Decision|0|||
156339485|NCT00395304|564342137|FG002|Treatment Period 2|Physician Decision|1|||
156339486|NCT00395304|564342138|FG003|Treatment Period 2|Physician Decision|0|||
156339487|NCT00395304|564342139|FG004|Treatment Period 2|Physician Decision|0|||
156339488|NCT00395304|564342140|FG005|Treatment Period 2|Physician Decision|0|||
156339489|NCT00395304|564342135|FG000|Treatment Period 2|Other|0|||
156339490|NCT00395304|564342136|FG001|Treatment Period 2|Other|1|||
156339491|NCT00395304|564342137|FG002|Treatment Period 2|Other|0|||
156339492|NCT00395304|564342138|FG003|Treatment Period 2|Other|0|||
156339493|NCT00395304|564342139|FG004|Treatment Period 2|Other|0|||
156339494|NCT00395304|564342140|FG005|Treatment Period 2|Other|0|||
156339495|NCT00395304|564342135|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156339496|NCT00395304|564342136|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156339497|NCT00395304|564342137|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156466230|NCT00439270|564803823|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
156466231|NCT00439270|564803824|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
156466232|NCT00439270|564803825|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
156466233|NCT00439270|564803826|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
156541235|NCT00454857|565074519|FG000|Overall Study|Death|5|||
156339498|NCT00395304|564342138|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156339499|NCT00395304|564342139|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156339500|NCT00395304|564342140|FG005|Treatment Period 3|Withdrawal by Subject|1|||
156339501|NCT00395304|564342135|FG000|Treatment Period 3|Lost to Follow-up|1|||
156339502|NCT00395304|564342136|FG001|Treatment Period 3|Lost to Follow-up|1|||
156339503|NCT00395304|564342137|FG002|Treatment Period 3|Lost to Follow-up|0|||
156339504|NCT00395304|564342138|FG003|Treatment Period 3|Lost to Follow-up|0|||
156339505|NCT00395304|564342139|FG004|Treatment Period 3|Lost to Follow-up|0|||
156339506|NCT00395304|564342140|FG005|Treatment Period 3|Lost to Follow-up|0|||
156828901|NCT00033540|566125079|FG000|Overall Study|Never received treatment|2|||
156828902|NCT01036529|566125080|FG000|Overall Study|Adverse Event|0|||
156828903|NCT01036529|566125081|FG001|Overall Study|Adverse Event|1|||
156828904|NCT01036529|566125080|FG000|Overall Study|Lost to Follow-up|0|||
156828905|NCT01036529|566125081|FG001|Overall Study|Lost to Follow-up|1|||
156828906|NCT01036529|566125080|FG000|Overall Study|Physician Decision|1|||
156828907|NCT01036529|566125081|FG001|Overall Study|Physician Decision|0|||
156828908|NCT01036529|566125080|FG000|Overall Study|Withdrawal by Subject|1|||
156828909|NCT01036529|566125081|FG001|Overall Study|Withdrawal by Subject|1|||
156828910|NCT01036529|566125080|FG000|Overall Study|Sponsor study termination|11|||
156828911|NCT01036529|566125081|FG001|Overall Study|Sponsor study termination|12|||
156828912|NCT00066469|566125093|FG000|Overall Study|Death|3|||
156828913|NCT00066469|566125093|FG000|Overall Study|Lack of Efficacy|9|||
156828914|NCT00066469|566125093|FG000|Overall Study|Lost to Follow-up|1|||
156828915|NCT00066469|566125093|FG000|Overall Study|Physician Decision|1|||
156828916|NCT00066469|566125093|FG000|Overall Study|Withdrawal by Subject|1|||
156828917|NCT00066469|566125093|FG000|Overall Study|ineligible|1|||
156828918|NCT03271047|566125094|FG000|Phase 1b: Dose Finding Period|Death|8|||
156828919|NCT03271047|566125095|FG001|Phase 1b: Dose Finding Period|Death|8|||
156828920|NCT03271047|566125096|FG002|Phase 1b: Dose Finding Period|Death|0|||
156828921|NCT03271047|566125097|FG003|Phase 1b: Dose Finding Period|Death|0|||
156828922|NCT03271047|566125094|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
156828923|NCT03271047|566125095|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
156828924|NCT03271047|566125096|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
156828925|NCT03271047|566125097|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
156828926|NCT03271047|566125094|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
156828927|NCT03271047|566125095|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
156828928|NCT03271047|566125096|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
156828929|NCT03271047|566125097|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
156828930|NCT03271047|566125094|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
156828931|NCT03271047|566125095|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
156828932|NCT03271047|566125096|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
156828933|NCT03271047|566125097|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
156828934|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Other|0|||
156828935|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Other|0|||
156828936|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Other|0|||
156828937|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Other|1|||
156828938|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Death|0|||
156828939|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Death|0|||
156828940|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Death|20|||
156828941|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Death|21|||
156828942|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
156828943|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
156828944|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
156828945|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
156828946|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
156828947|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
156828948|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
156828949|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
156828950|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
156828951|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
156828952|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
156828953|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
156828954|NCT00711802|566125098|FG000|Overall Study|Not treated (no further detail)|2|||
156828955|NCT00711802|566125099|FG001|Overall Study|Not treated (no further detail)|1|||
156828956|NCT00711802|566125100|FG002|Overall Study|Not treated (no further detail)|2|||
156339507|NCT00395304|564342135|FG000|Treatment Period 3|Physician Decision|0|||
156828957|NCT00711802|566125101|FG003|Overall Study|Not treated (no further detail)|0|||
156828958|NCT00711802|566125102|FG004|Overall Study|Not treated (no further detail)|2|||
156828959|NCT00711802|566125103|FG005|Overall Study|Not treated (no further detail)|0|||
156828960|NCT00711802|566125104|FG006|Overall Study|Not treated (no further detail)|0|||
156828961|NCT00711802|566125105|FG007|Overall Study|Not treated (no further detail)|0|||
156828962|NCT00711802|566125098|FG000|Overall Study|Adverse Event|0|||
156828963|NCT00711802|566125099|FG001|Overall Study|Adverse Event|0|||
156828964|NCT00711802|566125100|FG002|Overall Study|Adverse Event|0|||
156828965|NCT00711802|566125101|FG003|Overall Study|Adverse Event|0|||
156828966|NCT00711802|566125102|FG004|Overall Study|Adverse Event|1|||
156339508|NCT00395304|564342136|FG001|Treatment Period 3|Physician Decision|1|||
156828967|NCT00711802|566125103|FG005|Overall Study|Adverse Event|1|||
156828968|NCT00711802|566125104|FG006|Overall Study|Adverse Event|0|||
156339509|NCT00395304|564342137|FG002|Treatment Period 3|Physician Decision|0|||
156541236|NCT00454857|565074519|FG000|Overall Study|Other|11|||
156541237|NCT00454857|565074519|FG000|Overall Study|Reason unknown|1|||
156828969|NCT00711802|566125105|FG007|Overall Study|Adverse Event|0|||
156828970|NCT00711802|566125098|FG000|Overall Study|Microbiological failure|0|||
156828971|NCT00711802|566125099|FG001|Overall Study|Microbiological failure|1|||
156828972|NCT00711802|566125100|FG002|Overall Study|Microbiological failure|0|||
156828973|NCT00711802|566125101|FG003|Overall Study|Microbiological failure|0|||
156828974|NCT00711802|566125102|FG004|Overall Study|Microbiological failure|0|||
156828975|NCT00711802|566125103|FG005|Overall Study|Microbiological failure|1|||
156828976|NCT00711802|566125104|FG006|Overall Study|Microbiological failure|0|||
156828977|NCT00711802|566125105|FG007|Overall Study|Microbiological failure|0|||
156828978|NCT00711802|566125098|FG000|Overall Study|Protocol Violation|0|||
156828979|NCT00711802|566125099|FG001|Overall Study|Protocol Violation|0|||
156828980|NCT00711802|566125100|FG002|Overall Study|Protocol Violation|0|||
156828981|NCT00711802|566125101|FG003|Overall Study|Protocol Violation|1|||
156828982|NCT00711802|566125102|FG004|Overall Study|Protocol Violation|0|||
156828983|NCT00711802|566125103|FG005|Overall Study|Protocol Violation|0|||
156828984|NCT00711802|566125104|FG006|Overall Study|Protocol Violation|0|||
156828985|NCT00711802|566125105|FG007|Overall Study|Protocol Violation|0|||
156828986|NCT00711802|566125098|FG000|Overall Study|Physician Decision|0|||
156828987|NCT00711802|566125099|FG001|Overall Study|Physician Decision|2|||
156828988|NCT00711802|566125100|FG002|Overall Study|Physician Decision|0|||
156828989|NCT00711802|566125101|FG003|Overall Study|Physician Decision|0|||
156828990|NCT00711802|566125102|FG004|Overall Study|Physician Decision|0|||
156828991|NCT00711802|566125103|FG005|Overall Study|Physician Decision|0|||
156828992|NCT00711802|566125104|FG006|Overall Study|Physician Decision|0|||
156828993|NCT00711802|566125105|FG007|Overall Study|Physician Decision|0|||
156828994|NCT00711802|566125098|FG000|Overall Study|Withdrawal by Subject|0|||
156828995|NCT00711802|566125099|FG001|Overall Study|Withdrawal by Subject|1|||
156828996|NCT00711802|566125100|FG002|Overall Study|Withdrawal by Subject|0|||
156828997|NCT00711802|566125101|FG003|Overall Study|Withdrawal by Subject|1|||
156828998|NCT00711802|566125102|FG004|Overall Study|Withdrawal by Subject|0|||
156828999|NCT00711802|566125103|FG005|Overall Study|Withdrawal by Subject|0|||
156829000|NCT00711802|566125104|FG006|Overall Study|Withdrawal by Subject|0|||
156829001|NCT00711802|566125105|FG007|Overall Study|Withdrawal by Subject|0|||
156829002|NCT00711802|566125098|FG000|Overall Study|Lost to Follow-up|0|||
156829003|NCT00711802|566125099|FG001|Overall Study|Lost to Follow-up|0|||
156829004|NCT00711802|566125100|FG002|Overall Study|Lost to Follow-up|3|||
156829005|NCT00711802|566125101|FG003|Overall Study|Lost to Follow-up|1|||
156829006|NCT00711802|566125102|FG004|Overall Study|Lost to Follow-up|10|||
156541238|NCT00829179|565074520|FG000|Overall Study|Withdrawal by Subject|1|||
156541239|NCT00596947|565074521|FG000|Overall Study|study halted due to low enrollment|5|||
156541240|NCT00596947|565074522|FG001|Overall Study|study halted due to low enrollment|3|||
156541241|NCT00596947|565074521|FG000|Overall Study|Lost to Follow-up|1|||
156541242|NCT00596947|565074522|FG001|Overall Study|Lost to Follow-up|0|||
156541243|NCT03000179|565074523|FG000|Overall Study|Lost to Follow-up|2|||
156541244|NCT00827606|565074525|FG000|Overall Study|Protocol Violation|4|||
156541245|NCT00827606|565074526|FG001|Overall Study|Protocol Violation|3|||
156541246|NCT00827606|565074525|FG000|Overall Study|Lost to Follow-up|3|||
156541247|NCT00827606|565074526|FG001|Overall Study|Lost to Follow-up|1|||
156541248|NCT00827606|565074525|FG000|Overall Study|Withdrawal by Subject|7|||
156541249|NCT00827606|565074526|FG001|Overall Study|Withdrawal by Subject|6|||
156541250|NCT00827606|565074525|FG000|Overall Study|Pregnancy|0|||
156541251|NCT00827606|565074526|FG001|Overall Study|Pregnancy|1|||
156541252|NCT00827606|565074525|FG000|Overall Study|Other|5|||
156541253|NCT00827606|565074526|FG001|Overall Study|Other|13|||
156541254|NCT00827606|565074525|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
156541255|NCT00827606|565074526|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
156829007|NCT00711802|566125103|FG005|Overall Study|Lost to Follow-up|6|||
156541256|NCT00827606|565074525|FG000|Overall Study|Adverse Event|4|||
156541257|NCT00827606|565074526|FG001|Overall Study|Adverse Event|2|||
156541258|NCT00243386|565074531|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
156541259|NCT00243386|565074532|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
156541260|NCT00243386|565074533|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
156541261|NCT00243386|565074531|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
156829008|NCT00711802|566125104|FG006|Overall Study|Lost to Follow-up|4|||
156829009|NCT00711802|566125105|FG007|Overall Study|Lost to Follow-up|2|||
156829010|NCT00711802|566125098|FG000|Overall Study|Reason not reported|0|||
156829011|NCT00711802|566125099|FG001|Overall Study|Reason not reported|1|||
156829012|NCT00711802|566125100|FG002|Overall Study|Reason not reported|1|||
156829013|NCT00711802|566125101|FG003|Overall Study|Reason not reported|0|||
156829014|NCT00711802|566125102|FG004|Overall Study|Reason not reported|1|||
156829015|NCT00711802|566125103|FG005|Overall Study|Reason not reported|0|||
156829016|NCT00711802|566125104|FG006|Overall Study|Reason not reported|1|||
156829017|NCT00711802|566125105|FG007|Overall Study|Reason not reported|0|||
156829018|NCT03283150|566125107|FG000|Overall Study|Withdrawal by Subject|6|||
156829019|NCT03283150|566125108|FG001|Overall Study|Withdrawal by Subject|0|||
156829020|NCT03283150|566125109|FG002|Overall Study|Withdrawal by Subject|0|||
156829021|NCT05291936|566125110|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156829022|NCT05291936|566125111|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
156829023|NCT05291936|566125110|FG000|Period 1|Withdrew Consent during study|1|||
156829024|NCT05291936|566125111|FG001|Period 1|Withdrew Consent during study|0|||
156829025|NCT05291936|566125110|FG000|Period 2|Adverse Event|0|||
156829026|NCT05291936|566125111|FG001|Period 2|Adverse Event|1|||
156829027|NCT05291936|566125110|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
156829028|NCT05291936|566125111|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156829029|NCT02410824|566125112|FG000|First Intervention (One Week)|Headache|0|||
156829030|NCT02410824|566125113|FG001|First Intervention (One Week)|Headache|1|||
156829031|NCT02084238|566125114|FG000|Overall Study|Lost to Follow-up|2|||
156829032|NCT00392808|566125115|FG000|Overall Study|Lost to Follow-up|3|||
156829033|NCT00392808|566125116|FG001|Overall Study|Lost to Follow-up|2|||
156829034|NCT00392808|566125117|FG002|Overall Study|Lost to Follow-up|1|||
156829035|NCT00392808|566125118|FG003|Overall Study|Lost to Follow-up|2|||
156829036|NCT00392808|566125115|FG000|Overall Study|Unable to withdraw blood|3|||
156829037|NCT00392808|566125116|FG001|Overall Study|Unable to withdraw blood|1|||
156829038|NCT00392808|566125117|FG002|Overall Study|Unable to withdraw blood|1|||
156829039|NCT00392808|566125118|FG003|Overall Study|Unable to withdraw blood|2|||
156829040|NCT00391391|566125119|FG000|Overall Study|Adverse Event|0|||
156829041|NCT00391391|566125120|FG001|Overall Study|Adverse Event|0|||
156829042|NCT00391391|566125121|FG002|Overall Study|Adverse Event|0|||
156829043|NCT00391391|566125122|FG003|Overall Study|Adverse Event|1|||
156829044|NCT00391391|566125119|FG000|Overall Study|Lost to Follow-up|1|||
156829045|NCT00391391|566125120|FG001|Overall Study|Lost to Follow-up|3|||
156829046|NCT00391391|566125121|FG002|Overall Study|Lost to Follow-up|7|||
156829047|NCT00391391|566125122|FG003|Overall Study|Lost to Follow-up|4|||
156829048|NCT00391391|566125119|FG000|Overall Study|Protocol Violation|2|||
156829049|NCT00391391|566125120|FG001|Overall Study|Protocol Violation|3|||
156829050|NCT00391391|566125121|FG002|Overall Study|Protocol Violation|6|||
156829051|NCT00391391|566125122|FG003|Overall Study|Protocol Violation|7|||
156829052|NCT00391391|566125119|FG000|Overall Study|Withdrawal by Subject|6|||
156829053|NCT00391391|566125120|FG001|Overall Study|Withdrawal by Subject|4|||
156829054|NCT00391391|566125121|FG002|Overall Study|Withdrawal by Subject|10|||
156829055|NCT00391391|566125122|FG003|Overall Study|Withdrawal by Subject|7|||
156829056|NCT02436408|566125123|FG000|Overall Study|Death|1|||
156829057|NCT02649855|566125124|FG000|Overall Study|Refused further treatment|2|||
156829058|NCT02649855|566125125|FG001|Overall Study|Refused further treatment|1|||
156829059|NCT02649855|566125126|FG002|Overall Study|Refused further treatment|1|||
156829060|NCT02649855|566125124|FG000|Overall Study|Withdrew consent|0|||
156829061|NCT02649855|566125125|FG001|Overall Study|Withdrew consent|1|||
156829062|NCT02649855|566125126|FG002|Overall Study|Withdrew consent|0|||
156829063|NCT02649855|566125124|FG000|Overall Study|Switched to alternative treatment|0|||
156829064|NCT02649855|566125125|FG001|Overall Study|Switched to alternative treatment|1|||
156829065|NCT02649855|566125126|FG002|Overall Study|Switched to alternative treatment|1|||
156829066|NCT02649855|566125124|FG000|Overall Study|Principal investigator discretion|0|||
156829067|NCT02649855|566125125|FG001|Overall Study|Principal investigator discretion|1|||
156829068|NCT02649855|566125126|FG002|Overall Study|Principal investigator discretion|1|||
156829069|NCT02649855|566125124|FG000|Overall Study|No treatment, per protocol|1|||
156466234|NCT00439270|564803827|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
156466235|NCT01268306|564803828|FG000|Overall Study|Lost to Follow-up|1|||
156466236|NCT04334317|564803829|FG000|Overall Study|Adverse Event|1|||
156466237|NCT04334317|564803830|FG001|Overall Study|Adverse Event|2|||
156466238|NCT04334317|564803831|FG002|Overall Study|Adverse Event|0|||
156466239|NCT04334317|564803832|FG003|Overall Study|Adverse Event|0|||
156466240|NCT04334317|564803829|FG000|Overall Study|Protocol Deviation|0|||
156466241|NCT04334317|564803830|FG001|Overall Study|Protocol Deviation|1|||
156466242|NCT04334317|564803831|FG002|Overall Study|Protocol Deviation|0|||
156466243|NCT04334317|564803832|FG003|Overall Study|Protocol Deviation|0|||
156466244|NCT04334317|564803829|FG000|Overall Study|Withdrawal by Subject|2|||
156466245|NCT04334317|564803830|FG001|Overall Study|Withdrawal by Subject|2|||
156829070|NCT02649855|566125125|FG001|Overall Study|No treatment, per protocol|0|||
156829071|NCT02649855|566125126|FG002|Overall Study|No treatment, per protocol|0|||
156829072|NCT02649855|566125124|FG000|Overall Study|Initiate new treatment|1|||
156829073|NCT02649855|566125125|FG001|Overall Study|Initiate new treatment|0|||
156829074|NCT02649855|566125126|FG002|Overall Study|Initiate new treatment|0|||
156829075|NCT01038713|566125127|FG000|Overall Study|Patient to hospice|1|||
156829076|NCT01038713|566125128|FG001|Overall Study|Patient to hospice|1|||
156829077|NCT01038713|566125129|FG002|Overall Study|Patient to hospice|1|||
156829078|NCT01038713|566125127|FG000|Overall Study|Lost to Follow-up|3|||
156829079|NCT01038713|566125128|FG001|Overall Study|Lost to Follow-up|0|||
156829080|NCT01038713|566125129|FG002|Overall Study|Lost to Follow-up|0|||
156829081|NCT01038713|566125127|FG000|Overall Study|Neuroendocrine Tumor|0|||
156829082|NCT01038713|566125128|FG001|Overall Study|Neuroendocrine Tumor|1|||
156829083|NCT01038713|566125129|FG002|Overall Study|Neuroendocrine Tumor|0|||
156829084|NCT01038713|566125127|FG000|Overall Study|died from PEP|0|||
156829085|NCT01038713|566125128|FG001|Overall Study|died from PEP|1|||
156829086|NCT01038713|566125129|FG002|Overall Study|died from PEP|0|||
156829087|NCT01038713|566125127|FG000|Overall Study|Autoimmune Pancreatitis|1|||
156829088|NCT01038713|566125128|FG001|Overall Study|Autoimmune Pancreatitis|0|||
156829089|NCT01038713|566125129|FG002|Overall Study|Autoimmune Pancreatitis|0|||
156829090|NCT03777917|566125130|FG000|Overall Study|Withdrawal by Subject|1|||
156829091|NCT03777917|566125131|FG001|Overall Study|Withdrawal by Subject|0|||
156466246|NCT04334317|564803831|FG002|Overall Study|Withdrawal by Subject|0|||
156829092|NCT03777917|566125130|FG000|Overall Study|Physician Decision|1|||
156829093|NCT03777917|566125131|FG001|Overall Study|Physician Decision|0|||
156829094|NCT03777917|566125130|FG000|Overall Study|Lost to Follow-up|6|||
156829095|NCT03777917|566125131|FG001|Overall Study|Lost to Follow-up|2|||
156829096|NCT03777917|566125130|FG000|Overall Study|Other|1|||
156829097|NCT03777917|566125131|FG001|Overall Study|Other|0|||
156466247|NCT04334317|564803832|FG003|Overall Study|Withdrawal by Subject|0|||
156466248|NCT04121546|564803837|FG000|Overall Study|Lost to Follow-up|1|||
156466249|NCT04121546|564803838|FG001|Overall Study|Lost to Follow-up|3|||
156829098|NCT01154283|566125132|FG000|0-6 Weeks|Withdrawal by Subject|7|||
156829099|NCT01154283|566125133|FG001|0-6 Weeks|Withdrawal by Subject|2|||
156466250|NCT03286114|564803842|FG000|Overall Study|Adverse Event|6|||
156829100|NCT01154283|566125132|FG000|0-6 Weeks|Death|0|||
156829101|NCT01154283|566125133|FG001|0-6 Weeks|Death|1|||
156466251|NCT03286114|564803842|FG000|Overall Study|Death|3|||
156829102|NCT01154283|566125132|FG000|7-12 Weeks|Death|1|||
156829103|NCT01154283|566125133|FG001|7-12 Weeks|Death|0|||
156466252|NCT00943917|564803851|FG000|Stage I|Adverse Event|1|||
156466253|NCT00943917|564803852|FG001|Stage I|Adverse Event|2|||
156829104|NCT01154283|566125132|FG000|7-12 Weeks|Withdrawal by Subject|0|||
156829105|NCT01154283|566125133|FG001|7-12 Weeks|Withdrawal by Subject|1|||
156829106|NCT00320372|566125134|FG000|Overall Study|Physician Decision|4|||
156829107|NCT00320372|566125135|FG001|Overall Study|Physician Decision|7|||
156829108|NCT00320372|566125134|FG000|Overall Study|Death|7|||
156829109|NCT00320372|566125135|FG001|Overall Study|Death|8|||
156829110|NCT00320372|566125134|FG000|Overall Study|Withdrawal by Subject|55|||
156829111|NCT00320372|566125135|FG001|Overall Study|Withdrawal by Subject|37|||
156829112|NCT00320372|566125134|FG000|Overall Study|Non-Compliance|40|||
156829113|NCT00320372|566125135|FG001|Overall Study|Non-Compliance|39|||
156829114|NCT00320372|566125134|FG000|Overall Study|Did not Meet (I/E)|3|||
156829115|NCT00320372|566125135|FG001|Overall Study|Did not Meet (I/E)|1|||
156829116|NCT00320372|566125134|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
156829117|NCT00320372|566125135|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
156829118|NCT04063787|566125136|FG000|Overall Study|Inadequate Doppler data|4|||
156829119|NCT04063787|566125136|FG000|Overall Study|Lost to Follow-up|2|||
156466254|NCT00943917|564803853|FG002|Stage I|Adverse Event|2|||
156829120|NCT04063787|566125136|FG000|Overall Study|Death|3|||
156829121|NCT01853072|566125137|FG000|Overall Study|Adverse event prior to treatment|0|||
156829122|NCT01853072|566125138|FG001|Overall Study|Adverse event prior to treatment|1|||
156829123|NCT01853072|566125137|FG000|Overall Study|Adverse Event|0|||
156829124|NCT01853072|566125138|FG001|Overall Study|Adverse Event|3|||
156829125|NCT01853072|566125137|FG000|Overall Study|Death|1|||
156829126|NCT01853072|566125138|FG001|Overall Study|Death|4|||
156829127|NCT01853072|566125137|FG000|Overall Study|Lost to Follow-up|0|||
156339510|NCT00395304|564342138|FG003|Treatment Period 3|Physician Decision|0|||
156339511|NCT00395304|564342139|FG004|Treatment Period 3|Physician Decision|0|||
156339512|NCT00395304|564342140|FG005|Treatment Period 3|Physician Decision|0|||
156339513|NCT00395304|564342135|FG000|Treatment Period 3|Other|0|||
156339514|NCT00395304|564342136|FG001|Treatment Period 3|Other|0|||
156339515|NCT00395304|564342137|FG002|Treatment Period 3|Other|0|||
156339516|NCT00395304|564342138|FG003|Treatment Period 3|Other|1|||
156339517|NCT00395304|564342139|FG004|Treatment Period 3|Other|0|||
156339518|NCT00395304|564342140|FG005|Treatment Period 3|Other|0|||
156339519|NCT00621985|564342149|FG000|Dexamethasone Admission|Adverse Event|1|||
156339520|NCT00980057|564342155|FG000|Overall Study|Death|13|||
156339521|NCT00980057|564342156|FG001|Overall Study|Death|3|||
156339522|NCT00980057|564342155|FG000|Overall Study|Adverse Event|0|||
156339523|NCT00980057|564342156|FG001|Overall Study|Adverse Event|1|||
156339524|NCT00980057|564342155|FG000|Overall Study|Physician Decision|4|||
156339525|NCT00980057|564342156|FG001|Overall Study|Physician Decision|0|||
156339526|NCT00980057|564342155|FG000|Overall Study|Lost to Follow-up|1|||
156339527|NCT00980057|564342156|FG001|Overall Study|Lost to Follow-up|0|||
156339528|NCT00980057|564342155|FG000|Overall Study|Withdrawal by Subject|1|||
156339529|NCT00980057|564342156|FG001|Overall Study|Withdrawal by Subject|1|||
156339530|NCT03766581|564342157|FG000|Randomization|Other reasons|2|||
156339531|NCT03766581|564342158|FG001|Randomization|Other reasons|1|||
156339532|NCT03766581|564342159|FG002|Randomization|Other reasons|0|||
156339533|NCT03766581|564342160|FG003|Randomization|Other reasons|1|||
156339534|NCT03766581|564342161|FG004|Randomization|Other reasons|0|||
156339535|NCT03766581|564342162|FG005|Randomization|Other reasons|0|||
156339536|NCT03766581|564342163|FG006|Randomization|Other reasons|0|||
156339537|NCT03766581|564342164|FG007|Randomization|Other reasons|0|||
156339538|NCT03766581|564342157|FG000|Randomization|Participant no longer meets study criteria|5|||
156339539|NCT03766581|564342158|FG001|Randomization|Participant no longer meets study criteria|3|||
156339540|NCT03766581|564342159|FG002|Randomization|Participant no longer meets study criteria|4|||
156339541|NCT03766581|564342160|FG003|Randomization|Participant no longer meets study criteria|0|||
156339542|NCT03766581|564342161|FG004|Randomization|Participant no longer meets study criteria|2|||
156339543|NCT03766581|564342162|FG005|Randomization|Participant no longer meets study criteria|3|||
156339544|NCT03766581|564342163|FG006|Randomization|Participant no longer meets study criteria|0|||
156339545|NCT03766581|564342164|FG007|Randomization|Participant no longer meets study criteria|1|||
156339546|NCT03766581|564342157|FG000|Randomization|Participant request to discontinue study treatment|1|||
156339547|NCT03766581|564342158|FG001|Randomization|Participant request to discontinue study treatment|0|||
156339548|NCT03766581|564342159|FG002|Randomization|Participant request to discontinue study treatment|0|||
156339549|NCT03766581|564342160|FG003|Randomization|Participant request to discontinue study treatment|0|||
156339550|NCT03766581|564342161|FG004|Randomization|Participant request to discontinue study treatment|1|||
156339551|NCT03766581|564342162|FG005|Randomization|Participant request to discontinue study treatment|2|||
156339552|NCT03766581|564342163|FG006|Randomization|Participant request to discontinue study treatment|0|||
156339553|NCT03766581|564342164|FG007|Randomization|Participant request to discontinue study treatment|0|||
156339554|NCT03766581|564342157|FG000|Randomization|Participant withdrew consent|1|||
156339555|NCT03766581|564342158|FG001|Randomization|Participant withdrew consent|0|||
156339556|NCT03766581|564342159|FG002|Randomization|Participant withdrew consent|1|||
156339557|NCT03766581|564342160|FG003|Randomization|Participant withdrew consent|2|||
156339558|NCT03766581|564342161|FG004|Randomization|Participant withdrew consent|1|||
156339559|NCT03766581|564342162|FG005|Randomization|Participant withdrew consent|1|||
156339560|NCT03766581|564342163|FG006|Randomization|Participant withdrew consent|0|||
156339561|NCT03766581|564342164|FG007|Randomization|Participant withdrew consent|0|||
156339562|NCT03766581|564342157|FG000|Treatment|Adverse Event|82|||
156339563|NCT03766581|564342158|FG001|Treatment|Adverse Event|44|||
156339564|NCT03766581|564342159|FG002|Treatment|Adverse Event|47|||
156339565|NCT03766581|564342160|FG003|Treatment|Adverse Event|46|||
156339566|NCT03766581|564342161|FG004|Treatment|Adverse Event|50|||
156339567|NCT03766581|564342162|FG005|Treatment|Adverse Event|77|||
156339568|NCT03766581|564342163|FG006|Treatment|Adverse Event|5|||
156466255|NCT00943917|564803854|FG003|Stage I|Adverse Event|0|||
156829128|NCT01853072|566125138|FG001|Overall Study|Lost to Follow-up|3|||
156829129|NCT01853072|566125137|FG000|Overall Study|Non-compliance with study drug|0|||
156829130|NCT01853072|566125138|FG001|Overall Study|Non-compliance with study drug|1|||
156829131|NCT01853072|566125137|FG000|Overall Study|Physician Decision|1|||
156339569|NCT03766581|564342164|FG007|Treatment|Adverse Event|2|||
156339570|NCT03766581|564342157|FG000|Treatment|Participant request to discontinue treatment|34|||
156339571|NCT03766581|564342158|FG001|Treatment|Participant request to discontinue treatment|6|||
156339572|NCT03766581|564342159|FG002|Treatment|Participant request to discontinue treatment|10|||
156339573|NCT03766581|564342160|FG003|Treatment|Participant request to discontinue treatment|10|||
156339574|NCT03766581|564342161|FG004|Treatment|Participant request to discontinue treatment|14|||
156339575|NCT03766581|564342162|FG005|Treatment|Participant request to discontinue treatment|15|||
156339576|NCT03766581|564342163|FG006|Treatment|Participant request to discontinue treatment|0|||
156339577|NCT03766581|564342164|FG007|Treatment|Participant request to discontinue treatment|1|||
156466256|NCT00943917|564803855|FG004|Stage I|Adverse Event|0|||
156829132|NCT01853072|566125138|FG001|Overall Study|Physician Decision|1|||
156829133|NCT01853072|566125137|FG000|Overall Study|Withdrawal by Subject|1|||
156829134|NCT01853072|566125138|FG001|Overall Study|Withdrawal by Subject|2|||
156829135|NCT01853072|566125137|FG000|Overall Study|Reason not specified|9|||
156829136|NCT01853072|566125138|FG001|Overall Study|Reason not specified|6|||
156829137|NCT00930969|566125139|FG000|Overall Study|Death|5|||
156829138|NCT00930969|566125139|FG000|Overall Study|Lost to Follow-up|1|||
156829139|NCT00930969|566125139|FG000|Overall Study|Physician Decision|13|||
156829140|NCT00930969|566125139|FG000|Overall Study|Withdrawal by Subject|19|||
156829141|NCT01287221|566125140|FG000|Overall Study|Lack of Perceived Benefit|1|||
156829142|NCT01287221|566125141|FG001|Overall Study|Lack of Perceived Benefit|1|||
156829143|NCT01287221|566125140|FG000|Overall Study|Adverse Event|3|||
156829144|NCT01287221|566125141|FG001|Overall Study|Adverse Event|3|||
156829145|NCT01287221|566125140|FG000|Overall Study|Withdrawal by Subject|0|||
156829146|NCT01287221|566125141|FG001|Overall Study|Withdrawal by Subject|1|||
156829147|NCT00657150|566125142|FG000|Overall Study|Adverse Event|19|||
156829148|NCT00657150|566125143|FG001|Overall Study|Adverse Event|10|||
156829149|NCT00657150|566125142|FG000|Overall Study|Non-compliant with protocol|5|||
156829150|NCT00657150|566125143|FG001|Overall Study|Non-compliant with protocol|9|||
156829151|NCT00657150|566125142|FG000|Overall Study|Lost to Follow-up|2|||
156829152|NCT00657150|566125143|FG001|Overall Study|Lost to Follow-up|0|||
156829153|NCT00657150|566125142|FG000|Overall Study|Withdrawal by Subject|51|||
156829154|NCT00657150|566125143|FG001|Overall Study|Withdrawal by Subject|36|||
156829155|NCT00657150|566125142|FG000|Overall Study|Other|38|||
156829156|NCT00657150|566125143|FG001|Overall Study|Other|38|||
156829157|NCT00657150|566125142|FG000|Treatment|Adverse Event|60|||
156829158|NCT00657150|566125143|FG001|Treatment|Adverse Event|53|||
156829159|NCT00657150|566125142|FG000|Treatment|Non-compliant with protocol|10|||
156829160|NCT00657150|566125143|FG001|Treatment|Non-compliant with protocol|9|||
156829161|NCT00657150|566125142|FG000|Treatment|Lost to Follow-up|1|||
156829162|NCT00657150|566125143|FG001|Treatment|Lost to Follow-up|0|||
156829163|NCT00657150|566125142|FG000|Treatment|Withdrawal by Subject|23|||
156829164|NCT00657150|566125143|FG001|Treatment|Withdrawal by Subject|20|||
156829165|NCT00657150|566125142|FG000|Treatment|Other|13|||
156829166|NCT00657150|566125143|FG001|Treatment|Other|15|||
156829167|NCT02653495|566125158|FG000|Overall Study|Lost to Follow-up|2|||
156829168|NCT02653495|566125159|FG001|Overall Study|Lost to Follow-up|0|||
156829169|NCT02653495|566125158|FG000|Overall Study|Screening Failure|10|||
156829170|NCT02653495|566125159|FG001|Overall Study|Screening Failure|0|||
156829171|NCT00461305|566125160|FG000|Treatment|Adverse Event|26|||
156829172|NCT00461305|566125161|FG001|Treatment|Adverse Event|3|||
156829173|NCT00461305|566125160|FG000|Treatment|Lost to Follow-up|4|||
156829174|NCT00461305|566125161|FG001|Treatment|Lost to Follow-up|2|||
156829175|NCT00461305|566125160|FG000|Treatment|Protocol Violation|13|||
156829176|NCT00461305|566125161|FG001|Treatment|Protocol Violation|2|||
156829177|NCT00461305|566125160|FG000|Treatment|Withdrawal by Subject|48|||
156829178|NCT00461305|566125161|FG001|Treatment|Withdrawal by Subject|2|||
156829179|NCT00461305|566125160|FG000|Treatment|Never dispensed|5|||
156829180|NCT00461305|566125161|FG001|Treatment|Never dispensed|0|||
156829181|NCT00461305|566125160|FG000|Treatment|Study drug not taken|1|||
156829182|NCT00461305|566125161|FG001|Treatment|Study drug not taken|0|||
156829183|NCT00461305|566125160|FG000|Treatment|Partially missing diary|2|||
156829184|NCT00461305|566125161|FG001|Treatment|Partially missing diary|0|||
156829185|NCT00461305|566125160|FG000|Treatment|Other (missing drug etc)|2|||
156829186|NCT00461305|566125161|FG001|Treatment|Other (missing drug etc)|0|||
156829187|NCT00461305|566125160|FG000|Continued Treatment|Adverse Event|26|||
156829188|NCT00461305|566125161|FG001|Continued Treatment|Adverse Event|0|||
156829189|NCT00461305|566125160|FG000|Continued Treatment|Lost to Follow-up|4|||
156829190|NCT00461305|566125161|FG001|Continued Treatment|Lost to Follow-up|0|||
156829191|NCT00461305|566125160|FG000|Continued Treatment|Protocol Violation|13|||
156829192|NCT00461305|566125161|FG001|Continued Treatment|Protocol Violation|0|||
156829193|NCT00461305|566125160|FG000|Continued Treatment|Withdrawal by Subject|48|||
156829194|NCT00461305|566125161|FG001|Continued Treatment|Withdrawal by Subject|0|||
156829195|NCT00461305|566125160|FG000|Continued Treatment|Partially missing diary|2|||
156829196|NCT00461305|566125161|FG001|Continued Treatment|Partially missing diary|0|||
156829197|NCT00461305|566125160|FG000|Continued Treatment|Other (missing drug etc)|2|||
156829198|NCT00461305|566125161|FG001|Continued Treatment|Other (missing drug etc)|0|||
156829199|NCT01896271|566125163|FG000|Overall Study|Physician Decision|10|||
156829200|NCT01294462|566125164|FG000|Overall Study|Lost to Follow-up|1|||
156829201|NCT01294462|566125165|FG001|Overall Study|Lost to Follow-up|0|||
156829202|NCT01294462|566125164|FG000|Overall Study|Withdrawal by Subject|65|||
156829203|NCT01294462|566125165|FG001|Overall Study|Withdrawal by Subject|63|||
156829204|NCT02743780|566125166|FG000|Part 3 (7 Days)|Adverse Event|0|||
156829205|NCT02743780|566125167|FG001|Part 3 (7 Days)|Adverse Event|0|||
156829206|NCT02743780|566125168|FG002|Part 3 (7 Days)|Adverse Event|1|||
156829207|NCT02743780|566125169|FG003|Part 3 (7 Days)|Adverse Event|0|||
156829208|NCT02743780|566125170|FG004|Part 3 (7 Days)|Adverse Event|0|||
156829209|NCT01460407|566125176|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
156829210|NCT01460407|566125177|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
156829211|NCT01400243|566125178|FG000|Overall Study|Protocol Violation|8|||
156829212|NCT01400243|566125179|FG001|Overall Study|Protocol Violation|11|||
156829213|NCT00953680|566125180|FG000|Period 1|Withdrawal by Subject|0|||
156829214|NCT00953680|566125181|FG001|Period 1|Withdrawal by Subject|1|||
156829215|NCT01703117|566127072|FG000|Overall Study|Adverse Event|4|||
156829216|NCT01703117|566127073|FG001|Overall Study|Adverse Event|3|||
156829217|NCT01703117|566127072|FG000|Overall Study|Withdrawal by Subject|0|||
156829218|NCT01703117|566127073|FG001|Overall Study|Withdrawal by Subject|1|||
156829219|NCT00440310|566127075|FG000|Overall Study|Lost to Follow-up|4|||
156829220|NCT00440310|566127076|FG001|Overall Study|Lost to Follow-up|5|||
156829221|NCT00440310|566127075|FG000|Overall Study|Protocol Violation|0|||
156829222|NCT00440310|566127076|FG001|Overall Study|Protocol Violation|1|||
156829223|NCT00440310|566127075|FG000|Overall Study|Withdrawal by Subject|15|||
156829224|NCT00440310|566127076|FG001|Overall Study|Withdrawal by Subject|14|||
156829225|NCT00440310|566127075|FG000|Overall Study|No Reply at EOS|7|||
156829226|NCT00440310|566127076|FG001|Overall Study|No Reply at EOS|7|||
156829227|NCT00440310|566127075|FG000|Overall Study|Other|1|||
156829228|NCT00440310|566127076|FG001|Overall Study|Other|0|||
156829229|NCT00440310|566127075|FG000|Overall Study|Status Unknown|1|||
156829230|NCT00440310|566127076|FG001|Overall Study|Status Unknown|3|||
156829231|NCT02469415|566127077|FG000|Overall Study|Withdrawal by Subject|1|||
156829232|NCT02469415|566127077|FG000|Overall Study|Investigational agent placed on hold|2|||
156829233|NCT00330928|566127085|FG000|Overall Study|Lost to Follow-up|6|||
156829234|NCT00330928|566127085|FG000|Overall Study|Physician Decision|9|||
156829235|NCT00330928|566127085|FG000|Overall Study|Death|1|||
156829236|NCT00330928|566127085|FG000|Overall Study|IVUS could not be performed.|1|||
156829237|NCT03028480|566127088|FG000|Overall Study|No revisit after the first prescription date|2|||
156829238|NCT03028480|566127088|FG000|Overall Study|Did not use the drug|1|||
156829239|NCT03028480|566127088|FG000|Overall Study|Violation of the enrollment deadline|10|||
156829240|NCT03028480|566127088|FG000|Overall Study|Case report forms were not collected|21|||
156829241|NCT02403635|566127091|FG000|Overall Study|Not eligible|9|||
156829242|NCT03554772|566127094|FG000|Overall Study|Lost to Follow-up|0|||
156829243|NCT03554772|566127095|FG001|Overall Study|Lost to Follow-up|0|||
156829244|NCT03554772|566127096|FG002|Overall Study|Lost to Follow-up|0|||
156829245|NCT03554772|566127097|FG003|Overall Study|Lost to Follow-up|2|||
156829246|NCT03362931|566127099|FG000|Overall Study|Adverse Event|1|||
156829247|NCT03362931|566127099|FG000|Overall Study|Death|2|||
156466257|NCT00943917|564803856|FG005|Stage I|Adverse Event|0|||
156829248|NCT01998893|566127100|FG000|Overall Study|Adverse Event|2|||
156829249|NCT01998893|566127100|FG000|Overall Study|Death|1|||
156829250|NCT01998893|566127100|FG000|Overall Study|Lost to Follow-up|8|||
156829251|NCT01998893|566127100|FG000|Overall Study|Physician Decision|2|||
156829252|NCT01998893|566127100|FG000|Overall Study|Protocol Violation|2|||
156829253|NCT01998893|566127100|FG000|Overall Study|Withdrawal by Subject|1|||
156829254|NCT01998893|566127100|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
156829255|NCT03276052|566127101|FG000|Overall Study|Withdrawal by Subject|5|||
156829256|NCT03276052|566127101|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
156339578|NCT03766581|564342157|FG000|Treatment|Participant withdrew consent|11|||
156339579|NCT03766581|564342158|FG001|Treatment|Participant withdrew consent|4|||
156466258|NCT00943917|564803857|FG006|Stage I|Adverse Event|0|||
156829257|NCT05136898|566127106|FG000|Overall Study|Adverse Event|2|||
156829258|NCT01133405|566127107|FG000|Period 1|Withdrawal by Subject|0|||
156829259|NCT01133405|566127108|FG001|Period 1|Withdrawal by Subject|1|||
156829260|NCT01133405|566127109|FG002|Period 1|Withdrawal by Subject|0|||
156829261|NCT01133405|566127110|FG003|Period 1|Withdrawal by Subject|1|||
156829262|NCT01133405|566127111|FG004|Period 1|Withdrawal by Subject|0|||
156829263|NCT01133405|566127112|FG005|Period 1|Withdrawal by Subject|1|||
156829264|NCT01133405|566127113|FG006|Period 1|Withdrawal by Subject|0|||
156829265|NCT01133405|566127114|FG007|Period 1|Withdrawal by Subject|0|||
156829266|NCT01133405|566127115|FG008|Period 1|Withdrawal by Subject|0|||
156829267|NCT01133405|566127116|FG009|Period 1|Withdrawal by Subject|0|||
156829268|NCT01133405|566127107|FG000|Period 1|Physician Decision|0|||
156829269|NCT01133405|566127108|FG001|Period 1|Physician Decision|0|||
156829270|NCT01133405|566127109|FG002|Period 1|Physician Decision|0|||
156829271|NCT01133405|566127110|FG003|Period 1|Physician Decision|1|||
156829272|NCT01133405|566127111|FG004|Period 1|Physician Decision|0|||
156829273|NCT01133405|566127112|FG005|Period 1|Physician Decision|0|||
156829274|NCT01133405|566127113|FG006|Period 1|Physician Decision|0|||
156829275|NCT01133405|566127114|FG007|Period 1|Physician Decision|0|||
156829276|NCT01133405|566127115|FG008|Period 1|Physician Decision|0|||
156829277|NCT01133405|566127116|FG009|Period 1|Physician Decision|0|||
156829278|NCT01133405|566127107|FG000|Period 1|Discontinued after randomization|1|||
156829279|NCT01133405|566127108|FG001|Period 1|Discontinued after randomization|0|||
156829280|NCT01133405|566127109|FG002|Period 1|Discontinued after randomization|0|||
156829281|NCT01133405|566127110|FG003|Period 1|Discontinued after randomization|0|||
156829282|NCT01133405|566127111|FG004|Period 1|Discontinued after randomization|0|||
156829283|NCT01133405|566127112|FG005|Period 1|Discontinued after randomization|0|||
156829284|NCT01133405|566127113|FG006|Period 1|Discontinued after randomization|1|||
156829285|NCT01133405|566127114|FG007|Period 1|Discontinued after randomization|0|||
156829286|NCT01133405|566127115|FG008|Period 1|Discontinued after randomization|0|||
156829287|NCT01133405|566127116|FG009|Period 1|Discontinued after randomization|0|||
156829288|NCT01133405|566127107|FG000|Period 1|Received drug only in period 2|0|||
156829289|NCT01133405|566127108|FG001|Period 1|Received drug only in period 2|1|||
156829290|NCT01133405|566127109|FG002|Period 1|Received drug only in period 2|0|||
156829291|NCT01133405|566127110|FG003|Period 1|Received drug only in period 2|2|||
156829292|NCT01133405|566127111|FG004|Period 1|Received drug only in period 2|0|||
156829293|NCT01133405|566127112|FG005|Period 1|Received drug only in period 2|1|||
156829294|NCT01133405|566127113|FG006|Period 1|Received drug only in period 2|0|||
156829295|NCT01133405|566127114|FG007|Period 1|Received drug only in period 2|0|||
156829296|NCT01133405|566127115|FG008|Period 1|Received drug only in period 2|0|||
156829297|NCT01133405|566127116|FG009|Period 1|Received drug only in period 2|0|||
156829298|NCT01133405|566127107|FG000|Period 1|Received drug only in period 3|0|||
156829299|NCT01133405|566127108|FG001|Period 1|Received drug only in period 3|1|||
156829300|NCT01133405|566127109|FG002|Period 1|Received drug only in period 3|1|||
156829301|NCT01133405|566127110|FG003|Period 1|Received drug only in period 3|0|||
156829302|NCT01133405|566127111|FG004|Period 1|Received drug only in period 3|0|||
156829303|NCT01133405|566127112|FG005|Period 1|Received drug only in period 3|0|||
156829304|NCT01133405|566127113|FG006|Period 1|Received drug only in period 3|0|||
156829305|NCT01133405|566127114|FG007|Period 1|Received drug only in period 3|0|||
156829306|NCT01133405|566127115|FG008|Period 1|Received drug only in period 3|0|||
156829307|NCT01133405|566127116|FG009|Period 1|Received drug only in period 3|0|||
156829308|NCT01133405|566127107|FG000|Period 2|Adverse Event|0|||
156829309|NCT01133405|566127108|FG001|Period 2|Adverse Event|0|||
156829310|NCT01133405|566127109|FG002|Period 2|Adverse Event|1|||
156829311|NCT01133405|566127110|FG003|Period 2|Adverse Event|0|||
156829312|NCT01133405|566127111|FG004|Period 2|Adverse Event|0|||
156829313|NCT01133405|566127112|FG005|Period 2|Adverse Event|0|||
156829314|NCT01133405|566127113|FG006|Period 2|Adverse Event|0|||
156829315|NCT01133405|566127114|FG007|Period 2|Adverse Event|0|||
156829316|NCT01133405|566127115|FG008|Period 2|Adverse Event|0|||
156829317|NCT01133405|566127116|FG009|Period 2|Adverse Event|0|||
156829318|NCT01133405|566127107|FG000|Period 2|Withdrawal by Subject|0|||
156829319|NCT01133405|566127108|FG001|Period 2|Withdrawal by Subject|0|||
156829320|NCT01133405|566127109|FG002|Period 2|Withdrawal by Subject|0|||
156829321|NCT01133405|566127110|FG003|Period 2|Withdrawal by Subject|1|||
156829322|NCT01133405|566127111|FG004|Period 2|Withdrawal by Subject|0|||
156829323|NCT01133405|566127112|FG005|Period 2|Withdrawal by Subject|1|||
156829324|NCT01133405|566127113|FG006|Period 2|Withdrawal by Subject|0|||
156829325|NCT01133405|566127114|FG007|Period 2|Withdrawal by Subject|0|||
156829326|NCT01133405|566127115|FG008|Period 2|Withdrawal by Subject|0|||
156829327|NCT01133405|566127116|FG009|Period 2|Withdrawal by Subject|0|||
156829328|NCT01133405|566127107|FG000|Period 2|Entry Criteria Not Met|0|||
156829329|NCT01133405|566127108|FG001|Period 2|Entry Criteria Not Met|1|||
156829330|NCT01133405|566127109|FG002|Period 2|Entry Criteria Not Met|0|||
156829331|NCT01133405|566127110|FG003|Period 2|Entry Criteria Not Met|0|||
156829332|NCT01133405|566127111|FG004|Period 2|Entry Criteria Not Met|0|||
156829333|NCT01133405|566127112|FG005|Period 2|Entry Criteria Not Met|0|||
156829334|NCT01133405|566127113|FG006|Period 2|Entry Criteria Not Met|0|||
156829335|NCT01133405|566127114|FG007|Period 2|Entry Criteria Not Met|0|||
156829336|NCT01133405|566127115|FG008|Period 2|Entry Criteria Not Met|0|||
156829337|NCT01133405|566127116|FG009|Period 2|Entry Criteria Not Met|0|||
156829338|NCT01133405|566127107|FG000|Period 2|Physician Decision|0|||
156829339|NCT01133405|566127108|FG001|Period 2|Physician Decision|0|||
156829340|NCT01133405|566127109|FG002|Period 2|Physician Decision|0|||
156829341|NCT01133405|566127110|FG003|Period 2|Physician Decision|0|||
156829342|NCT01133405|566127111|FG004|Period 2|Physician Decision|0|||
156829343|NCT01133405|566127112|FG005|Period 2|Physician Decision|1|||
156829344|NCT01133405|566127113|FG006|Period 2|Physician Decision|0|||
156829345|NCT01133405|566127114|FG007|Period 2|Physician Decision|0|||
156829346|NCT01133405|566127115|FG008|Period 2|Physician Decision|0|||
156829347|NCT01133405|566127116|FG009|Period 2|Physician Decision|0|||
156829348|NCT03300024|566127119|FG000|Overall Study|Physician Decision|4|||
156829349|NCT03300024|566127120|FG001|Overall Study|Physician Decision|6|||
156829350|NCT01238835|566127121|FG000|Overall Study|Death|124|||
156829351|NCT01238835|566127121|FG000|Overall Study|Withdrawal by Subject|9|||
156829352|NCT01238835|566127121|FG000|Overall Study|Lost to Follow-up|1|||
156829353|NCT01238835|566127121|FG000|Overall Study|Site early discontinuation|2|||
156829354|NCT00554619|566127122|FG000|Overall Study|Adverse Event|1|||
156829355|NCT00554619|566127122|FG000|Overall Study|Physician Decision|1|||
156829356|NCT00554619|566127122|FG000|Overall Study|Liver Function Test Abnormality|1|||
156829357|NCT00907803|566127126|FG000|Overall Study|Withdrawal of consent - long commute|1|||
156829358|NCT00907803|566127127|FG001|Overall Study|Withdrawal of consent - long commute|0|||
156829359|NCT00907803|566127128|FG002|Overall Study|Withdrawal of consent - long commute|0|||
156829360|NCT00907803|566127126|FG000|Overall Study|Adverse Event|2|||
156829361|NCT00907803|566127127|FG001|Overall Study|Adverse Event|0|||
156829362|NCT00907803|566127128|FG002|Overall Study|Adverse Event|0|||
156829363|NCT00907803|566127126|FG000|Overall Study|Withdrawal by Subject|0|||
156829364|NCT00907803|566127127|FG001|Overall Study|Withdrawal by Subject|1|||
156829365|NCT00907803|566127128|FG002|Overall Study|Withdrawal by Subject|0|||
156829366|NCT00907803|566127126|FG000|Overall Study|Lost to Follow-up|0|||
156829367|NCT00907803|566127127|FG001|Overall Study|Lost to Follow-up|1|||
156829368|NCT00907803|566127128|FG002|Overall Study|Lost to Follow-up|0|||
156829369|NCT00907803|566127126|FG000|Overall Study|Protocol Violation|0|||
156829370|NCT00907803|566127127|FG001|Overall Study|Protocol Violation|1|||
156829371|NCT00907803|566127128|FG002|Overall Study|Protocol Violation|0|||
156829372|NCT01118520|566127133|FG000|Overall Study|AAA repair|9|||
156829373|NCT01118520|566127134|FG001|Overall Study|AAA repair|7|||
156829374|NCT01118520|566127135|FG002|Overall Study|AAA repair|9|||
156829375|NCT01118520|566127133|FG000|Overall Study|Adverse Event|3|||
156829376|NCT01118520|566127134|FG001|Overall Study|Adverse Event|3|||
156829377|NCT01118520|566127135|FG002|Overall Study|Adverse Event|3|||
156829378|NCT01118520|566127133|FG000|Overall Study|Withdrawal by Subject|8|||
156829379|NCT01118520|566127134|FG001|Overall Study|Withdrawal by Subject|13|||
156829380|NCT01118520|566127135|FG002|Overall Study|Withdrawal by Subject|8|||
156829381|NCT03958656|566127136|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
156829382|NCT03958656|566127137|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
156829383|NCT03958656|566127138|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
156829384|NCT03958656|566127139|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
156829385|NCT03958656|566127136|FG000|Overall Study|No longer meets eligibility criteria|0|||
156829386|NCT03958656|566127137|FG001|Overall Study|No longer meets eligibility criteria|0|||
156829387|NCT03958656|566127138|FG002|Overall Study|No longer meets eligibility criteria|1|||
156829388|NCT03958656|566127139|FG003|Overall Study|No longer meets eligibility criteria|0|||
156829389|NCT03958656|566127136|FG000|Overall Study|Started anti-cancer treatment|0|||
156829390|NCT03958656|566127137|FG001|Overall Study|Started anti-cancer treatment|0|||
156829391|NCT03958656|566127138|FG002|Overall Study|Started anti-cancer treatment|1|||
156829392|NCT03958656|566127139|FG003|Overall Study|Started anti-cancer treatment|0|||
156829393|NCT03158012|566127140|FG000|Overall Study|Withdrawal by Subject|0|||
156829394|NCT03158012|566127141|FG001|Overall Study|Withdrawal by Subject|1|||
156829395|NCT01852825|566127142|FG000|Overall Study|Withdrawal by Subject|2|||
156829396|NCT01852825|566127143|FG001|Overall Study|Withdrawal by Subject|0|||
156829397|NCT01852825|566127144|FG002|Overall Study|Withdrawal by Subject|0|||
156829398|NCT02214225|566127151|FG000|Overall Study|Lost to Follow-up|46|||
156829399|NCT02214225|566127152|FG001|Overall Study|Lost to Follow-up|18|||
156829400|NCT02214225|566127153|FG002|Overall Study|Lost to Follow-up|18|||
156829401|NCT02214225|566127151|FG000|Overall Study|Withdrawal by Subject|2|||
156829402|NCT02214225|566127152|FG001|Overall Study|Withdrawal by Subject|0|||
156829403|NCT02214225|566127153|FG002|Overall Study|Withdrawal by Subject|2|||
156829404|NCT02214225|566127151|FG000|Overall Study|Death|5|||
156829405|NCT02214225|566127152|FG001|Overall Study|Death|0|||
156829406|NCT02214225|566127153|FG002|Overall Study|Death|1|||
156829407|NCT02214225|566127151|FG000|Overall Study|randomized in error, not vaccinated|2|||
156829408|NCT02214225|566127152|FG001|Overall Study|randomized in error, not vaccinated|1|||
156829409|NCT02214225|566127153|FG002|Overall Study|randomized in error, not vaccinated|1|||
156829410|NCT03987932|566127154|FG000|Overall Study|Lost to Follow-up|2|||
156829411|NCT03987932|566127155|FG001|Overall Study|Lost to Follow-up|1|||
156829412|NCT03987932|566127156|FG002|Overall Study|Lost to Follow-up|1|||
156829413|NCT03987932|566127154|FG000|Overall Study|Non-study related elective surgery|0|||
156829414|NCT03987932|566127155|FG001|Overall Study|Non-study related elective surgery|0|||
156829415|NCT03987932|566127156|FG002|Overall Study|Non-study related elective surgery|1|||
156829416|NCT01669421|566127159|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
156829417|NCT01669421|566127159|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
156829418|NCT02961790|566127161|FG000|Overall Study|Canceled|4|||
156829419|NCT02961790|566127162|FG001|Overall Study|Canceled|5|||
156829420|NCT02961790|566127163|FG002|Overall Study|Canceled|1|||
156829421|NCT02961790|566127164|FG003|Overall Study|Canceled|4|||
156829422|NCT02961790|566127161|FG000|Overall Study|without baseline data|4|||
156829423|NCT02961790|566127162|FG001|Overall Study|without baseline data|0|||
156829424|NCT02961790|566127163|FG002|Overall Study|without baseline data|1|||
156829425|NCT02961790|566127164|FG003|Overall Study|without baseline data|0|||
156829426|NCT02961790|566127161|FG000|Overall Study|without post baseline data|7|||
156829427|NCT02961790|566127162|FG001|Overall Study|without post baseline data|6|||
156829428|NCT02961790|566127163|FG002|Overall Study|without post baseline data|4|||
156829429|NCT02961790|566127164|FG003|Overall Study|without post baseline data|1|||
156829430|NCT02078102|566127167|FG000|Overall Study|Adverse Event|1|||
156829431|NCT02078102|566127168|FG001|Overall Study|Adverse Event|0|||
156829432|NCT02078102|566127167|FG000|Overall Study|Withdrawal by Subject|1|||
156829433|NCT02078102|566127168|FG001|Overall Study|Withdrawal by Subject|0|||
156829434|NCT02078102|566127167|FG000|Overall Study|Physician Decision|0|||
156829435|NCT02078102|566127168|FG001|Overall Study|Physician Decision|1|||
156829436|NCT02185014|566127171|FG000|Overall Study|Adverse Event|18|||
156829437|NCT02185014|566127171|FG000|Overall Study|Withdrew Consent|8|||
156829438|NCT02185014|566127171|FG000|Overall Study|Lost to Follow-up|4|||
156829439|NCT02185014|566127171|FG000|Overall Study|Lack of Efficacy|14|||
156829440|NCT02185014|566127171|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
156829441|NCT02185014|566127171|FG000|Overall Study|Subject Noncompliance|1|||
156829442|NCT02185014|566127171|FG000|Overall Study|Other|4|||
156829443|NCT01813721|566127175|FG000|Overall Study|Ineligibility determined|63|||
156829444|NCT01813721|566127175|FG000|Overall Study|Withdrawal by Subject|1|||
156829445|NCT02370641|566127176|FG000|Overall Study|dropped study|4|||
156829446|NCT02370641|566127177|FG001|Overall Study|dropped study|2|||
156829447|NCT02133664|566127180|FG000|Overall Study|Lost to Follow-up|2|||
156829448|NCT02133664|566127181|FG001|Overall Study|Lost to Follow-up|1|||
156829449|NCT02133664|566127180|FG000|Overall Study|Adverse Event|3|||
156829450|NCT02133664|566127181|FG001|Overall Study|Adverse Event|6|||
156829451|NCT02120365|566127184|FG000|Overall Study|Withdrawal by Subject|0|||
156829452|NCT02120365|566127185|FG001|Overall Study|Withdrawal by Subject|0|||
156829453|NCT02120365|566127186|FG002|Overall Study|Withdrawal by Subject|2|||
156829454|NCT02120365|566127187|FG003|Overall Study|Withdrawal by Subject|4|||
156829455|NCT02120365|566127188|FG004|Overall Study|Withdrawal by Subject|0|||
156829456|NCT02120365|566127189|FG005|Overall Study|Withdrawal by Subject|2|||
156829457|NCT00343915|566127191|FG000|Primary Study|Withdrawal by Subject|1|||
156829458|NCT00343915|566127192|FG001|Primary Study|Withdrawal by Subject|0|||
156829459|NCT00343915|566127191|FG000|Primary Study|Lost to Follow-up|2|||
156829460|NCT00343915|566127192|FG001|Primary Study|Lost to Follow-up|3|||
156829461|NCT00343915|566127191|FG000|Primary Study|Other|1|||
156829462|NCT00343915|566127192|FG001|Primary Study|Other|0|||
156829463|NCT01719003|566127193|FG000|Overall Study|Non compliant with protocol|1|||
156829464|NCT01719003|566127194|FG001|Overall Study|Non compliant with protocol|1|||
156829465|NCT01719003|566127195|FG002|Overall Study|Non compliant with protocol|0|||
156829466|NCT01719003|566127196|FG003|Overall Study|Non compliant with protocol|1|||
156829467|NCT01719003|566127197|FG004|Overall Study|Non compliant with protocol|2|||
156829468|NCT01719003|566127198|FG005|Overall Study|Non compliant with protocol|1|||
156829469|NCT01719003|566127199|FG006|Overall Study|Non compliant with protocol|2|||
156829470|NCT01719003|566127200|FG007|Overall Study|Non compliant with protocol|3|||
156829471|NCT01719003|566127201|FG008|Overall Study|Non compliant with protocol|0|||
156829472|NCT01719003|566127193|FG000|Overall Study|Adverse Event|6|||
156829473|NCT01719003|566127194|FG001|Overall Study|Adverse Event|5|||
156829474|NCT01719003|566127195|FG002|Overall Study|Adverse Event|4|||
156829475|NCT01719003|566127196|FG003|Overall Study|Adverse Event|3|||
156829476|NCT01719003|566127197|FG004|Overall Study|Adverse Event|4|||
156829477|NCT01719003|566127198|FG005|Overall Study|Adverse Event|3|||
156829478|NCT01719003|566127199|FG006|Overall Study|Adverse Event|6|||
156829479|NCT01719003|566127200|FG007|Overall Study|Adverse Event|5|||
156829480|NCT01719003|566127201|FG008|Overall Study|Adverse Event|0|||
156829481|NCT01719003|566127193|FG000|Overall Study|Lost to Follow-up|0|||
156829482|NCT01719003|566127194|FG001|Overall Study|Lost to Follow-up|6|||
156829483|NCT01719003|566127195|FG002|Overall Study|Lost to Follow-up|7|||
156829484|NCT01719003|566127196|FG003|Overall Study|Lost to Follow-up|2|||
156466259|NCT00943917|564803858|FG007|Stage I|Adverse Event|0|||
156829485|NCT01719003|566127197|FG004|Overall Study|Lost to Follow-up|3|||
156829486|NCT01719003|566127198|FG005|Overall Study|Lost to Follow-up|4|||
156829487|NCT01719003|566127199|FG006|Overall Study|Lost to Follow-up|3|||
156829488|NCT01719003|566127200|FG007|Overall Study|Lost to Follow-up|2|||
156829489|NCT01719003|566127201|FG008|Overall Study|Lost to Follow-up|2|||
156829490|NCT01719003|566127193|FG000|Overall Study|Refusal to continue, not due to AE|2|||
156829491|NCT01719003|566127194|FG001|Overall Study|Refusal to continue, not due to AE|5|||
156829492|NCT01719003|566127195|FG002|Overall Study|Refusal to continue, not due to AE|4|||
156829493|NCT01719003|566127196|FG003|Overall Study|Refusal to continue, not due to AE|4|||
156829494|NCT01719003|566127197|FG004|Overall Study|Refusal to continue, not due to AE|4|||
156829495|NCT01719003|566127198|FG005|Overall Study|Refusal to continue, not due to AE|3|||
156829496|NCT01719003|566127199|FG006|Overall Study|Refusal to continue, not due to AE|8|||
156829497|NCT01719003|566127200|FG007|Overall Study|Refusal to continue, not due to AE|7|||
156829498|NCT01719003|566127201|FG008|Overall Study|Refusal to continue, not due to AE|1|||
156829499|NCT01719003|566127193|FG000|Overall Study|Reason other than those specified|0|||
156829500|NCT01719003|566127194|FG001|Overall Study|Reason other than those specified|0|||
156829501|NCT01719003|566127195|FG002|Overall Study|Reason other than those specified|2|||
156829502|NCT01719003|566127196|FG003|Overall Study|Reason other than those specified|3|||
156829503|NCT01719003|566127197|FG004|Overall Study|Reason other than those specified|4|||
156829504|NCT01719003|566127198|FG005|Overall Study|Reason other than those specified|1|||
156829505|NCT01719003|566127199|FG006|Overall Study|Reason other than those specified|0|||
156829506|NCT01719003|566127200|FG007|Overall Study|Reason other than those specified|3|||
156829507|NCT01719003|566127201|FG008|Overall Study|Reason other than those specified|1|||
156829508|NCT01719003|566127193|FG000|Overall Study|Lack of Efficacy|0|||
156829509|NCT01719003|566127194|FG001|Overall Study|Lack of Efficacy|0|||
156829510|NCT01719003|566127195|FG002|Overall Study|Lack of Efficacy|0|||
156829511|NCT01719003|566127196|FG003|Overall Study|Lack of Efficacy|0|||
156829512|NCT01719003|566127197|FG004|Overall Study|Lack of Efficacy|0|||
156829513|NCT01719003|566127198|FG005|Overall Study|Lack of Efficacy|0|||
156829514|NCT01719003|566127199|FG006|Overall Study|Lack of Efficacy|1|||
156829515|NCT01719003|566127200|FG007|Overall Study|Lack of Efficacy|0|||
156829516|NCT01719003|566127201|FG008|Overall Study|Lack of Efficacy|0|||
156829517|NCT00882908|566127203|FG000|Overall Study|Adverse Event|0|||
156829518|NCT00882908|566127204|FG001|Overall Study|Adverse Event|0|||
156829519|NCT00882908|566127205|FG002|Overall Study|Adverse Event|1|||
156829520|NCT00882908|566127206|FG003|Overall Study|Adverse Event|0|||
156829521|NCT00882908|566127207|FG004|Overall Study|Adverse Event|1|||
156829522|NCT00882908|566127203|FG000|Overall Study|Lost to Follow-up|3|||
156829523|NCT00882908|566127204|FG001|Overall Study|Lost to Follow-up|5|||
156829524|NCT00882908|566127205|FG002|Overall Study|Lost to Follow-up|3|||
156829525|NCT00882908|566127206|FG003|Overall Study|Lost to Follow-up|1|||
156829526|NCT00882908|566127207|FG004|Overall Study|Lost to Follow-up|2|||
156829527|NCT00882908|566127203|FG000|Overall Study|Protocol Violation|0|||
156829528|NCT00882908|566127204|FG001|Overall Study|Protocol Violation|1|||
156829529|NCT00882908|566127205|FG002|Overall Study|Protocol Violation|0|||
156829530|NCT00882908|566127206|FG003|Overall Study|Protocol Violation|0|||
156829531|NCT00882908|566127207|FG004|Overall Study|Protocol Violation|0|||
156829532|NCT00882908|566127203|FG000|Overall Study|Withdrawal by Subject|0|||
156829533|NCT00882908|566127204|FG001|Overall Study|Withdrawal by Subject|0|||
156829534|NCT00882908|566127205|FG002|Overall Study|Withdrawal by Subject|3|||
156829535|NCT00882908|566127206|FG003|Overall Study|Withdrawal by Subject|5|||
156829536|NCT00882908|566127207|FG004|Overall Study|Withdrawal by Subject|2|||
156829537|NCT00882908|566127203|FG000|Overall Study|Subject reached a virologic endpoint|0|||
156829538|NCT00882908|566127204|FG001|Overall Study|Subject reached a virologic endpoint|0|||
156829539|NCT00882908|566127205|FG002|Overall Study|Subject reached a virologic endpoint|0|||
156829540|NCT00882908|566127206|FG003|Overall Study|Subject reached a virologic endpoint|0|||
156829541|NCT00882908|566127207|FG004|Overall Study|Subject reached a virologic endpoint|1|||
156829542|NCT00882908|566127203|FG000|Overall Study|Study terminated in error|0|||
156829543|NCT00882908|566127204|FG001|Overall Study|Study terminated in error|0|||
156829544|NCT00882908|566127205|FG002|Overall Study|Study terminated in error|0|||
156829545|NCT00882908|566127206|FG003|Overall Study|Study terminated in error|1|||
156829546|NCT00882908|566127207|FG004|Overall Study|Study terminated in error|0|||
156829547|NCT00581828|566127208|FG000|Overall Study|Protocol Violation|1|||
156829548|NCT02370095|566127209|FG000|Overall Study|Withdrawal by Subject|0|||
156829549|NCT02370095|566127210|FG001|Overall Study|Withdrawal by Subject|1|||
156829550|NCT00700102|566127211|FG000|Overall Study|Died|394|||
156829551|NCT00700102|566127212|FG001|Overall Study|Died|385|||
156829552|NCT00700102|566127211|FG000|Overall Study|Lost to Follow-up|8|||
156829553|NCT00700102|566127212|FG001|Overall Study|Lost to Follow-up|10|||
156829554|NCT02525939|566127213|FG000|Overall Study|Lost to Follow-up|27|||
156829555|NCT02525939|566127214|FG001|Overall Study|Lost to Follow-up|24|||
156829556|NCT02525939|566127213|FG000|Overall Study|Physician Decision|0|||
156829557|NCT02525939|566127214|FG001|Overall Study|Physician Decision|1|||
156829558|NCT02525939|566127213|FG000|Overall Study|Withdrawal by Subject|24|||
156829559|NCT02525939|566127214|FG001|Overall Study|Withdrawal by Subject|39|||
156829560|NCT02525939|566127213|FG000|Overall Study|Death|180|||
156829561|NCT02525939|566127214|FG001|Overall Study|Death|179|||
156829562|NCT01667562|566127215|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
156829563|NCT01667562|566127216|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
156829564|NCT01667562|566127215|FG000|Erlotinib Phase|Lost to Follow-up|0|||
156829565|NCT01667562|566127216|FG001|Erlotinib Phase|Lost to Follow-up|1|||
156829566|NCT01667562|566127215|FG000|Erlotinib Phase|Adverse Event|0|||
156829567|NCT01667562|566127216|FG001|Erlotinib Phase|Adverse Event|1|||
156829568|NCT01667562|566127215|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
156829569|NCT01667562|566127216|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
156829570|NCT01028716|566127217|FG000|Overall Study|Physician Decision|1|||
156829571|NCT02130986|566127218|FG000|Overall Study|Withdrawal by Subject|4|||
156829572|NCT02130986|566127219|FG001|Overall Study|Withdrawal by Subject|4|||
156829573|NCT02130986|566127218|FG000|Overall Study|Lost to Follow-up|151|||
156829574|NCT02130986|566127219|FG001|Overall Study|Lost to Follow-up|160|||
156829575|NCT01129882|566127220|FG000|Overall Study|Adverse Event|39|||
156829576|NCT01129882|566127220|FG000|Overall Study|Death|6|||
156829577|NCT01129882|566127220|FG000|Overall Study|Lack of Efficacy|5|||
156829578|NCT01129882|566127220|FG000|Overall Study|Lost to Follow-up|13|||
156829579|NCT01129882|566127220|FG000|Overall Study|Physician Decision|27|||
156829580|NCT01129882|566127220|FG000|Overall Study|Protocol Deviation|3|||
156829581|NCT01129882|566127220|FG000|Overall Study|Withdrawal Criteria Met|19|||
156829582|NCT01129882|566127220|FG000|Overall Study|Trial Termination by Sponsor|6|||
156829583|NCT01129882|566127220|FG000|Overall Study|Withdrawal by Subject|160|||
156829584|NCT02305849|566127221|FG000|Overall Study|Adverse Event|10|||
156829585|NCT02305849|566127222|FG001|Overall Study|Adverse Event|12|||
156829586|NCT02305849|566127223|FG002|Overall Study|Adverse Event|7|||
156829587|NCT02305849|566127224|FG003|Overall Study|Adverse Event|3|||
156829588|NCT02305849|566127221|FG000|Overall Study|Lack of Efficacy|10|||
156829589|NCT02305849|566127222|FG001|Overall Study|Lack of Efficacy|6|||
156829590|NCT02305849|566127223|FG002|Overall Study|Lack of Efficacy|3|||
156829591|NCT02305849|566127224|FG003|Overall Study|Lack of Efficacy|9|||
156829592|NCT02305849|566127221|FG000|Overall Study|Withdrawal by Subject|2|||
156829593|NCT02305849|566127222|FG001|Overall Study|Withdrawal by Subject|2|||
156829594|NCT02305849|566127223|FG002|Overall Study|Withdrawal by Subject|1|||
156829595|NCT02305849|566127224|FG003|Overall Study|Withdrawal by Subject|4|||
156829596|NCT02305849|566127221|FG000|Overall Study|Lost to Follow-up|0|||
156829597|NCT02305849|566127222|FG001|Overall Study|Lost to Follow-up|2|||
156829598|NCT02305849|566127223|FG002|Overall Study|Lost to Follow-up|0|||
156829599|NCT02305849|566127224|FG003|Overall Study|Lost to Follow-up|0|||
156829600|NCT02305849|566127221|FG000|Overall Study|Protocol Violation|3|||
156829601|NCT02305849|566127222|FG001|Overall Study|Protocol Violation|2|||
156829602|NCT02305849|566127223|FG002|Overall Study|Protocol Violation|1|||
156829603|NCT02305849|566127224|FG003|Overall Study|Protocol Violation|1|||
156829604|NCT02305849|566127221|FG000|Overall Study|Lab data met discontinuation criteria|0|||
156829605|NCT02305849|566127222|FG001|Overall Study|Lab data met discontinuation criteria|1|||
156829606|NCT02305849|566127223|FG002|Overall Study|Lab data met discontinuation criteria|2|||
156829607|NCT02305849|566127224|FG003|Overall Study|Lab data met discontinuation criteria|1|||
156829608|NCT02305849|566127221|FG000|Overall Study|Miscellaneous|1|||
156829609|NCT02305849|566127222|FG001|Overall Study|Miscellaneous|2|||
156829610|NCT02305849|566127223|FG002|Overall Study|Miscellaneous|4|||
156829611|NCT02305849|566127224|FG003|Overall Study|Miscellaneous|1|||
156829612|NCT02305849|566127221|FG000|Overall Study|Not fulfill eligibility criteria|1|||
156829613|NCT02305849|566127222|FG001|Overall Study|Not fulfill eligibility criteria|1|||
156339580|NCT03766581|564342159|FG002|Treatment|Participant withdrew consent|5|||
156339581|NCT03766581|564342160|FG003|Treatment|Participant withdrew consent|5|||
156829614|NCT02305849|566127223|FG002|Overall Study|Not fulfill eligibility criteria|0|||
156829615|NCT02305849|566127224|FG003|Overall Study|Not fulfill eligibility criteria|0|||
156829616|NCT00355342|566127225|FG000|Overall Study|Adverse Event|13|||
156829617|NCT00355342|566127226|FG001|Overall Study|Adverse Event|15|||
156829618|NCT00355342|566127225|FG000|Overall Study|Lost to Follow-up|4|||
156829619|NCT00355342|566127226|FG001|Overall Study|Lost to Follow-up|2|||
156339582|NCT03766581|564342161|FG004|Treatment|Participant withdrew consent|4|||
156829620|NCT00355342|566127225|FG000|Overall Study|Withdrawal by Subject|14|||
156829621|NCT00355342|566127226|FG001|Overall Study|Withdrawal by Subject|11|||
156829622|NCT00355342|566127225|FG000|Overall Study|Sponsor terminated study|2|||
156829623|NCT00355342|566127226|FG001|Overall Study|Sponsor terminated study|2|||
156829624|NCT00355342|566127225|FG000|Overall Study|Overcompliant-PI discretion|1|||
156829625|NCT00355342|566127226|FG001|Overall Study|Overcompliant-PI discretion|0|||
156829626|NCT00355342|566127225|FG000|Overall Study|Use of prohibited medication|1|||
156829627|NCT00355342|566127226|FG001|Overall Study|Use of prohibited medication|0|||
156829628|NCT00355342|566127225|FG000|Overall Study|COPD exacerbation|1|||
156829629|NCT00355342|566127226|FG001|Overall Study|COPD exacerbation|1|||
156829630|NCT00355342|566127225|FG000|Overall Study|Dispensed wrong study drug kit|1|||
156829631|NCT00355342|566127226|FG001|Overall Study|Dispensed wrong study drug kit|0|||
156829632|NCT00355342|566127225|FG000|Overall Study|Non-compliance with Dexa scans|1|||
156829633|NCT00355342|566127226|FG001|Overall Study|Non-compliance with Dexa scans|0|||
156829634|NCT00355342|566127225|FG000|Overall Study|Withdrawal by participant and physician|1|||
156829635|NCT00355342|566127226|FG001|Overall Study|Withdrawal by participant and physician|0|||
156829636|NCT00355342|566127225|FG000|Overall Study|Participant relocated|0|||
156829637|NCT00355342|566127226|FG001|Overall Study|Participant relocated|1|||
156829638|NCT00355342|566127225|FG000|Overall Study|Participant discontinued study drug|0|||
156829639|NCT00355342|566127226|FG001|Overall Study|Participant discontinued study drug|1|||
156829640|NCT00355342|566127225|FG000|Overall Study|Study management|0|||
156829641|NCT00355342|566127226|FG001|Overall Study|Study management|1|||
156829642|NCT00355342|566127225|FG000|Overall Study|Protocol Violation|0|||
156829643|NCT00355342|566127226|FG001|Overall Study|Protocol Violation|1|||
156829644|NCT00355342|566127225|FG000|Overall Study|Use of protocol excluded medication|0|||
156829645|NCT00355342|566127226|FG001|Overall Study|Use of protocol excluded medication|1|||
156829646|NCT00536874|566127227|FG000|Overall Study|Adverse Event|1|||
156829647|NCT00536874|566127227|FG000|Overall Study|Death|2|||
156829648|NCT00536874|566127227|FG000|Overall Study|Withdrawal by Subject|1|||
156829649|NCT00762996|566127228|FG000|Period One|Protocol Violation|0|||
156829650|NCT00762996|566127229|FG001|Period One|Protocol Violation|0|||
156829651|NCT00762996|566127230|FG002|Period One|Protocol Violation|1|||
156829652|NCT00762996|566127231|FG003|Period One|Protocol Violation|0|||
156829653|NCT00762996|566127228|FG000|Period One|ineligible|0|||
156829654|NCT00762996|566127229|FG001|Period One|ineligible|0|||
156829655|NCT00762996|566127230|FG002|Period One|ineligible|1|||
156829656|NCT00762996|566127231|FG003|Period One|ineligible|1|||
156829657|NCT00762996|566127228|FG000|Period One|Adverse Event|0|||
156829658|NCT00762996|566127229|FG001|Period One|Adverse Event|0|||
156829659|NCT00762996|566127230|FG002|Period One|Adverse Event|1|||
156829660|NCT00762996|566127231|FG003|Period One|Adverse Event|0|||
156829661|NCT00762996|566127228|FG000|Period One|Withdrawal by Subject|0|||
156829662|NCT00762996|566127229|FG001|Period One|Withdrawal by Subject|0|||
156829663|NCT00762996|566127230|FG002|Period One|Withdrawal by Subject|1|||
156829664|NCT00762996|566127231|FG003|Period One|Withdrawal by Subject|0|||
156829665|NCT00434759|566127237|FG000|Overall Study|Lack of Efficacy|5|||
156829666|NCT00434759|566127238|FG001|Overall Study|Lack of Efficacy|4|||
156829667|NCT00434759|566127237|FG000|Overall Study|Withdrawal by Subject|17|||
156829668|NCT00434759|566127238|FG001|Overall Study|Withdrawal by Subject|1|||
156829669|NCT00434759|566127237|FG000|Overall Study|family affairs|2|||
156829670|NCT00434759|566127238|FG001|Overall Study|family affairs|0|||
156829671|NCT02966795|566127241|FG000|Overall Study|Patient Left the Country|0|||
156829672|NCT02966795|566127242|FG001|Overall Study|Patient Left the Country|1|||
156829673|NCT02279498|566127247|FG000|Overall Study|Adverse Event|3|||
156829674|NCT02279498|566127248|FG001|Overall Study|Adverse Event|0|||
156829675|NCT02279498|566127247|FG000|Overall Study|Lack of Efficacy|4|||
156829676|NCT02279498|566127248|FG001|Overall Study|Lack of Efficacy|0|||
156829677|NCT02279498|566127247|FG000|Overall Study|Lost to Follow-up|0|||
156829678|NCT02279498|566127248|FG001|Overall Study|Lost to Follow-up|1|||
156829679|NCT02279498|566127247|FG000|Overall Study|Withdrawal by Subject|9|||
156829680|NCT02279498|566127248|FG001|Overall Study|Withdrawal by Subject|2|||
156829681|NCT02279498|566127247|FG000|Overall Study|Undefined|2|||
156829682|NCT02279498|566127248|FG001|Overall Study|Undefined|1|||
156829683|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
156829684|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
156829685|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
156829686|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
156829687|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
156829688|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
156829689|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
156829690|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
156829691|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
156829692|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
156829693|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
156829694|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
156829695|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
156829696|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
156829697|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
156829698|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
156829699|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
156829700|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
156829701|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
156829702|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
156829703|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
156829704|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
156829705|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
156829706|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
156829707|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
156829708|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
156466260|NCT00943917|564803859|FG008|Stage I|Adverse Event|0|||
156829709|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
156829710|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
156829711|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
156829712|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
156829713|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
156829714|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
156829715|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
156829716|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
156829717|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
156829718|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
156829719|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
156829720|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
156829721|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
156829722|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
156829723|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
156829724|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
156829725|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
156829726|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
156829727|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
156829728|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
156829729|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
156829730|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
156829731|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
156829732|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
156829733|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
156829734|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
156829735|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
156829736|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
156829737|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
156829738|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
156829739|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
156829740|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
156829741|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
156829742|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
156829743|NCT00624780|566127249|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
156829744|NCT00624780|566127250|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
156829745|NCT00624780|566127251|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
156829746|NCT00624780|566127252|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
156829747|NCT00624780|566127253|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
156829748|NCT00624780|566127254|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
156829749|NCT00624780|566127249|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
156829750|NCT00624780|566127250|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829751|NCT00624780|566127251|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829752|NCT00624780|566127252|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829753|NCT00624780|566127253|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829754|NCT00624780|566127254|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829755|NCT00624780|566127249|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829756|NCT00624780|566127250|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829757|NCT00624780|566127251|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
156829758|NCT00624780|566127252|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829759|NCT00624780|566127253|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829760|NCT00624780|566127254|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829761|NCT00624780|566127249|FG000|Follow-up (Week 26)|Death|0|||
156829762|NCT00624780|566127250|FG001|Follow-up (Week 26)|Death|0|||
156829763|NCT00624780|566127251|FG002|Follow-up (Week 26)|Death|1|||
156829764|NCT00624780|566127252|FG003|Follow-up (Week 26)|Death|0|||
156829765|NCT00624780|566127253|FG004|Follow-up (Week 26)|Death|0|||
156829766|NCT00624780|566127254|FG005|Follow-up (Week 26)|Death|0|||
156829767|NCT00624780|566127249|FG000|Follow-up (Week 26)|Adverse Event|0|||
156829768|NCT00624780|566127250|FG001|Follow-up (Week 26)|Adverse Event|0|||
156829769|NCT00624780|566127251|FG002|Follow-up (Week 26)|Adverse Event|0|||
156829770|NCT00624780|566127252|FG003|Follow-up (Week 26)|Adverse Event|0|||
156829771|NCT00624780|566127253|FG004|Follow-up (Week 26)|Adverse Event|1|||
156829772|NCT00624780|566127254|FG005|Follow-up (Week 26)|Adverse Event|0|||
156829773|NCT00624780|566127249|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
156466261|NCT00943917|564803860|FG009|Stage I|Adverse Event|0|||
156829774|NCT00624780|566127250|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
156829775|NCT00624780|566127251|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
156466262|NCT00943917|564803861|FG010|Stage I|Adverse Event|0|||
156466263|NCT00943917|564803862|FG011|Stage I|Adverse Event|0|||
156466264|NCT00943917|564803863|FG012|Stage I|Adverse Event|0|||
156339583|NCT03766581|564342162|FG005|Treatment|Participant withdrew consent|4|||
156339584|NCT03766581|564342163|FG006|Treatment|Participant withdrew consent|0|||
156829776|NCT00624780|566127252|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
156829777|NCT00624780|566127253|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
156829778|NCT00624780|566127254|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
156829779|NCT00624780|566127249|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
156829780|NCT00624780|566127250|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829781|NCT00624780|566127251|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829782|NCT00624780|566127252|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829783|NCT00624780|566127253|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829784|NCT00624780|566127254|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829785|NCT00624780|566127249|FG000|Follow-up (Week 26)|Other|1|||
156829786|NCT00624780|566127250|FG001|Follow-up (Week 26)|Other|1|||
156829787|NCT00624780|566127251|FG002|Follow-up (Week 26)|Other|0|||
156829788|NCT00624780|566127252|FG003|Follow-up (Week 26)|Other|0|||
156829789|NCT00624780|566127253|FG004|Follow-up (Week 26)|Other|0|||
156829790|NCT00624780|566127254|FG005|Follow-up (Week 26)|Other|0|||
156829791|NCT04068519|566127255|FG000|Dose Verification|Death|15|||
156829792|NCT04068519|566127255|FG000|Dose Verification|Withdrawal by Subject|1|||
156829793|NCT04068519|566127255|FG000|Pharmacokinetic Sub-study|Death|35|||
156829794|NCT04068519|566127255|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
156829795|NCT04068519|566127255|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
156829796|NCT04068519|566127255|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
156829797|NCT04068519|566127255|FG000|Indication Expansion|Death|152|||
156829798|NCT04068519|566127255|FG000|Indication Expansion|Withdrawal by Subject|10|||
156829799|NCT04068519|566127255|FG000|Indication Expansion|Lost to Follow-up|7|||
156829800|NCT03762616|566127256|FG000|Overall Study|Protocol Violation|2|||
156829801|NCT02032407|566129627|FG000|Overall Study|Lost to Follow-up|2|||
156829802|NCT02032407|566129627|FG000|Overall Study|Pregnancy|1|||
156829803|NCT02032407|566129627|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156829804|NCT03131596|566129628|FG000|Overall Study|Protocol Violation|3|||
156829805|NCT03131596|566129629|FG001|Overall Study|Protocol Violation|3|||
156829806|NCT03131596|566129628|FG000|Overall Study|Lost to Follow-up|3|||
156829807|NCT03131596|566129629|FG001|Overall Study|Lost to Follow-up|0|||
156829808|NCT02091284|566129632|FG000|Overall Study|Withdrawal by Subject|2|||
156829809|NCT02091284|566129633|FG001|Overall Study|Withdrawal by Subject|1|||
156829810|NCT02091284|566129632|FG000|Overall Study|unreliable data|1|||
156829811|NCT02091284|566129633|FG001|Overall Study|unreliable data|0|||
156829812|NCT04524455|566129640|FG000|Overall Study|Death|3|||
156829813|NCT04524455|566129641|FG001|Overall Study|Death|3|||
156829814|NCT04524455|566129640|FG000|Overall Study|Decision by Sponsor|0|||
156829815|NCT04524455|566129641|FG001|Overall Study|Decision by Sponsor|2|||
156829816|NCT04524455|566129640|FG000|Overall Study|Withdrawal of Consent From Study|1|||
156829817|NCT04524455|566129641|FG001|Overall Study|Withdrawal of Consent From Study|0|||
156829818|NCT04524455|566129640|FG000|Overall Study|Lost to Follow-up|0|||
156829819|NCT04524455|566129641|FG001|Overall Study|Lost to Follow-up|1|||
156829820|NCT01688739|566129642|FG000|Overall Study|Administrative Decision|1|||
156829821|NCT01688739|566129643|FG001|Overall Study|Administrative Decision|0|||
156829822|NCT01688739|566129644|FG002|Overall Study|Administrative Decision|0|||
156829823|NCT01688739|566129645|FG003|Overall Study|Administrative Decision|0|||
156829824|NCT01688739|566129646|FG004|Overall Study|Administrative Decision|0|||
156829825|NCT01688739|566129647|FG005|Overall Study|Administrative Decision|0|||
156339585|NCT03766581|564342164|FG007|Treatment|Participant withdrew consent|0|||
156339586|NCT03766581|564342157|FG000|Treatment|Death|1|||
156339587|NCT03766581|564342158|FG001|Treatment|Death|0|||
156339588|NCT03766581|564342159|FG002|Treatment|Death|0|||
156339589|NCT03766581|564342160|FG003|Treatment|Death|0|||
156339590|NCT03766581|564342161|FG004|Treatment|Death|0|||
156339591|NCT03766581|564342162|FG005|Treatment|Death|0|||
156541262|NCT00243386|565074532|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
156541263|NCT00243386|565074533|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
156829826|NCT01688739|566129648|FG006|Overall Study|Administrative Decision|0|||
156829827|NCT01688739|566129649|FG007|Overall Study|Administrative Decision|0|||
156829828|NCT01688739|566129650|FG008|Overall Study|Administrative Decision|0|||
156829829|NCT01688739|566129651|FG009|Overall Study|Administrative Decision|0|||
156829830|NCT00490776|566129652|FG000|Overall Study|Withdrawal by Subject|1|||
156829831|NCT00490776|566129652|FG000|Overall Study|Administrative Problems|1|||
156829832|NCT00490776|566129652|FG000|Overall Study|Death|1|||
156829833|NCT00490776|566129652|FG000|Overall Study|New Cancer Therapy|1|||
156829834|NCT00490776|566129652|FG000|Overall Study|Disease Progression|5|||
156829835|NCT01340937|566129653|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
156829836|NCT01340937|566129654|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
156339592|NCT03766581|564342163|FG006|Treatment|Death|0|||
156339593|NCT03766581|564342164|FG007|Treatment|Death|0|||
156339594|NCT03766581|564342157|FG000|Treatment|Lost to Follow-up|1|||
156339595|NCT03766581|564342158|FG001|Treatment|Lost to Follow-up|0|||
156829837|NCT01340937|566129655|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
156339596|NCT03766581|564342159|FG002|Treatment|Lost to Follow-up|0|||
156829838|NCT01340937|566129656|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
156829839|NCT01340937|566129653|FG000|Period 1: Infant Series|Adverse Event|0|||
156829840|NCT01340937|566129654|FG001|Period 1: Infant Series|Adverse Event|1|||
156829841|NCT01340937|566129655|FG002|Period 1: Infant Series|Adverse Event|4|||
156829842|NCT01340937|566129656|FG003|Period 1: Infant Series|Adverse Event|0|||
156829843|NCT01340937|566129653|FG000|Period 1: Infant Series|Death|2|||
156829844|NCT01340937|566129654|FG001|Period 1: Infant Series|Death|0|||
156829845|NCT01340937|566129655|FG002|Period 1: Infant Series|Death|2|||
156829846|NCT01340937|566129656|FG003|Period 1: Infant Series|Death|0|||
156829847|NCT01340937|566129653|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
156829848|NCT01340937|566129654|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
156829849|NCT01340937|566129655|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
156829850|NCT01340937|566129656|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
156829851|NCT01340937|566129653|FG000|Period 1: Infant Series|Physician Decision|2|||
156829852|NCT01340937|566129654|FG001|Period 1: Infant Series|Physician Decision|3|||
156829853|NCT01340937|566129655|FG002|Period 1: Infant Series|Physician Decision|1|||
156829854|NCT01340937|566129656|FG003|Period 1: Infant Series|Physician Decision|0|||
156829855|NCT01340937|566129653|FG000|Period 1: Infant Series|Protocol Violation|1|||
156829856|NCT01340937|566129654|FG001|Period 1: Infant Series|Protocol Violation|4|||
156829857|NCT01340937|566129655|FG002|Period 1: Infant Series|Protocol Violation|4|||
156829858|NCT01340937|566129656|FG003|Period 1: Infant Series|Protocol Violation|3|||
156829859|NCT01340937|566129653|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
156829860|NCT01340937|566129654|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
156829861|NCT01340937|566129655|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
156829862|NCT01340937|566129656|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
156829863|NCT01340937|566129653|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
156829864|NCT01340937|566129654|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
156829865|NCT01340937|566129655|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
156829866|NCT01340937|566129656|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
156829867|NCT01340937|566129653|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
156829868|NCT01340937|566129654|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
156829869|NCT01340937|566129655|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
156829870|NCT01340937|566129656|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
156829871|NCT01340937|566129653|FG000|Period 2: Interim Period|Adverse Event|1|||
156829872|NCT01340937|566129654|FG001|Period 2: Interim Period|Adverse Event|0|||
156829873|NCT01340937|566129655|FG002|Period 2: Interim Period|Adverse Event|1|||
156829874|NCT01340937|566129656|FG003|Period 2: Interim Period|Adverse Event|0|||
156829875|NCT01340937|566129653|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
156829876|NCT01340937|566129654|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
156829877|NCT01340937|566129655|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
156829878|NCT01340937|566129656|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
156829879|NCT01340937|566129653|FG000|Period 2: Interim Period|Physician Decision|0|||
156829880|NCT01340937|566129654|FG001|Period 2: Interim Period|Physician Decision|1|||
156829881|NCT01340937|566129655|FG002|Period 2: Interim Period|Physician Decision|1|||
156829882|NCT01340937|566129656|FG003|Period 2: Interim Period|Physician Decision|0|||
156829883|NCT01340937|566129653|FG000|Period 2: Interim Period|Protocol Violation|5|||
156829884|NCT01340937|566129654|FG001|Period 2: Interim Period|Protocol Violation|3|||
156829885|NCT01340937|566129655|FG002|Period 2: Interim Period|Protocol Violation|6|||
156829886|NCT01340937|566129656|FG003|Period 2: Interim Period|Protocol Violation|3|||
156829887|NCT01340937|566129653|FG000|Period 2: Interim Period|Technical problems|4|||
156829888|NCT01340937|566129654|FG001|Period 2: Interim Period|Technical problems|4|||
156829889|NCT01340937|566129655|FG002|Period 2: Interim Period|Technical problems|6|||
156829890|NCT01340937|566129656|FG003|Period 2: Interim Period|Technical problems|3|||
156829891|NCT01340937|566129653|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
156829892|NCT01340937|566129654|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
156829893|NCT01340937|566129655|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
156829894|NCT01340937|566129656|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
156829895|NCT01340937|566129653|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
156829896|NCT01340937|566129654|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
156829897|NCT01340937|566129655|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
156829898|NCT01340937|566129656|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
156829899|NCT01340937|566129653|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
156829900|NCT01340937|566129654|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
156829901|NCT01340937|566129655|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
156829902|NCT01340937|566129656|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
156829903|NCT01340937|566129653|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
156829904|NCT01340937|566129654|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
156829905|NCT01340937|566129655|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
156829906|NCT01340937|566129656|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
156829907|NCT02317809|566129657|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
156829908|NCT02317809|566129658|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
156829909|NCT02317809|566129657|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
156829910|NCT02317809|566129658|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
156829911|NCT02233738|566129659|FG000|Overall Study|Lost to Follow-up|5|||
156829912|NCT02233738|566129660|FG001|Overall Study|Lost to Follow-up|12|||
156829913|NCT02233738|566129659|FG000|Overall Study|Death|0|||
156829914|NCT02233738|566129660|FG001|Overall Study|Death|1|||
156829915|NCT02233738|566129659|FG000|Overall Study|Withdrawal by Subject|0|||
156829916|NCT02233738|566129660|FG001|Overall Study|Withdrawal by Subject|1|||
156829917|NCT02233738|566129659|FG000|Overall Study|Did not return after Baseline|3|||
156829918|NCT02233738|566129660|FG001|Overall Study|Did not return after Baseline|2|||
156829919|NCT00096174|566129661|FG000|Overall Study|Lack of Efficacy|9|||
156829920|NCT00096174|566129661|FG000|Overall Study|Adverse Event|15|||
156829921|NCT00096174|566129661|FG000|Overall Study|Death|6|||
156829922|NCT00096174|566129661|FG000|Overall Study|Withdrawal by Subject|15|||
156829923|NCT00096174|566129661|FG000|Overall Study|Not started protocol therapy|3|||
156829924|NCT00096174|566129661|FG000|Overall Study|Ineligible|6|||
156829925|NCT00096174|566129661|FG000|Overall Study|other reason|8|||
156829926|NCT00294645|566129664|FG000|Overall Study|Death|10|||
156829927|NCT00294645|566129665|FG001|Overall Study|Death|18|||
156829928|NCT00294645|566129664|FG000|Overall Study|Lost to Follow-up|1|||
156829929|NCT00294645|566129665|FG001|Overall Study|Lost to Follow-up|10|||
156829930|NCT00294645|566129664|FG000|Overall Study|Withdrawal by Subject|18|||
156829931|NCT00294645|566129665|FG001|Overall Study|Withdrawal by Subject|34|||
156829932|NCT00294645|566129664|FG000|Overall Study|Physician Decision|15|||
156829933|NCT00294645|566129665|FG001|Overall Study|Physician Decision|20|||
156829934|NCT00294645|566129664|FG000|Overall Study|Other|4|||
156829935|NCT00294645|566129665|FG001|Overall Study|Other|10|||
156829936|NCT02098369|566129668|FG000|Overall Study|Withdrawal by Subject|1|||
156829937|NCT02098369|566129669|FG001|Overall Study|Withdrawal by Subject|5|||
156829938|NCT02098369|566129670|FG002|Overall Study|Withdrawal by Subject|0|||
156829939|NCT02098369|566129668|FG000|Overall Study|Lost to Follow-up|5|||
156829940|NCT02098369|566129669|FG001|Overall Study|Lost to Follow-up|1|||
156829941|NCT02098369|566129670|FG002|Overall Study|Lost to Follow-up|3|||
156829942|NCT02098369|566129668|FG000|Overall Study|Death|1|||
156829943|NCT02098369|566129669|FG001|Overall Study|Death|1|||
156829944|NCT02098369|566129670|FG002|Overall Study|Death|1|||
156829945|NCT02098369|566129668|FG000|Overall Study|Other|0|||
156829946|NCT02098369|566129669|FG001|Overall Study|Other|2|||
156829947|NCT02098369|566129670|FG002|Overall Study|Other|1|||
156829948|NCT03784846|566129671|FG000|Pre-COVID Study|Lost to Follow-up|3|||
156829949|NCT03784846|566129672|FG001|Pre-COVID Study|Lost to Follow-up|3|||
156829950|NCT03784846|566129673|FG002|Pre-COVID Study|Lost to Follow-up|2|||
156829951|NCT03784846|566129671|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
156829952|NCT03784846|566129672|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
156829953|NCT03784846|566129673|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
156829954|NCT03784846|566129671|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
156829955|NCT03784846|566129672|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
156829956|NCT03784846|566129673|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
156829957|NCT03784846|566129671|FG000|Post-COVID Study|Lost to Follow-up|3|||
156829958|NCT03784846|566129672|FG001|Post-COVID Study|Lost to Follow-up|5|||
156829959|NCT03784846|566129673|FG002|Post-COVID Study|Lost to Follow-up|1|||
156829960|NCT03784846|566129671|FG000|Post-COVID Study|Withdrawal by Subject|1|||
156829961|NCT03784846|566129672|FG001|Post-COVID Study|Withdrawal by Subject|2|||
156829962|NCT03784846|566129673|FG002|Post-COVID Study|Withdrawal by Subject|0|||
156829963|NCT00867087|566129674|FG000|Overall Study|Other|1|||
156829964|NCT00867087|566129674|FG000|Overall Study|Withdrawal by Subject|4|||
156829965|NCT00867087|566129674|FG000|Overall Study|Death|37|||
156829966|NCT00570037|566129675|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
156829967|NCT00570037|566129676|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
156829968|NCT00089986|566129677|FG000|Overall Study|Adverse Event|6|||
156829969|NCT00089986|566129678|FG001|Overall Study|Adverse Event|9|||
156829970|NCT00089986|566129679|FG002|Overall Study|Adverse Event|6|||
156829971|NCT00089986|566129677|FG000|Overall Study|Lost to Follow-up|3|||
156829972|NCT00089986|566129678|FG001|Overall Study|Lost to Follow-up|1|||
156829973|NCT00089986|566129679|FG002|Overall Study|Lost to Follow-up|1|||
156339597|NCT03766581|564342160|FG003|Treatment|Lost to Follow-up|1|||
156829974|NCT00089986|566129677|FG000|Overall Study|Protocol Violation|0|||
156829975|NCT00089986|566129678|FG001|Overall Study|Protocol Violation|1|||
156829976|NCT00089986|566129679|FG002|Overall Study|Protocol Violation|0|||
156829977|NCT00089986|566129677|FG000|Overall Study|Patient transferred to another hospital|2|||
156829978|NCT00089986|566129678|FG001|Overall Study|Patient transferred to another hospital|1|||
156829979|NCT00089986|566129679|FG002|Overall Study|Patient transferred to another hospital|0|||
156829980|NCT00089986|566129677|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
156829981|NCT00089986|566129678|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
156829982|NCT00089986|566129679|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
156829983|NCT00089986|566129677|FG000|Overall Study|Hemohlobin stopping rule|0|||
156541264|NCT00243386|565074531|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
156829984|NCT00089986|566129678|FG001|Overall Study|Hemohlobin stopping rule|1|||
156829985|NCT00089986|566129679|FG002|Overall Study|Hemohlobin stopping rule|0|||
156829986|NCT00089986|566129677|FG000|Overall Study|Investigator decision to withdrew|0|||
156829987|NCT00089986|566129678|FG001|Overall Study|Investigator decision to withdrew|1|||
156829988|NCT00089986|566129679|FG002|Overall Study|Investigator decision to withdrew|0|||
156829989|NCT00089986|566129677|FG000|Overall Study|Enrollment in another study|0|||
156829990|NCT00089986|566129678|FG001|Overall Study|Enrollment in another study|1|||
156829991|NCT00089986|566129679|FG002|Overall Study|Enrollment in another study|0|||
156829992|NCT00089986|566129677|FG000|Overall Study|Family decision|0|||
156829993|NCT00089986|566129678|FG001|Overall Study|Family decision|1|||
156829994|NCT00089986|566129679|FG002|Overall Study|Family decision|0|||
156829995|NCT00089986|566129677|FG000|Overall Study|Do not resuscitate (DNR)|0|||
156829996|NCT00089986|566129678|FG001|Overall Study|Do not resuscitate (DNR)|0|||
156829997|NCT00089986|566129679|FG002|Overall Study|Do not resuscitate (DNR)|1|||
156829998|NCT00089986|566129677|FG000|Overall Study|Withdrawal by Subject|3|||
156829999|NCT00089986|566129678|FG001|Overall Study|Withdrawal by Subject|6|||
156830000|NCT00089986|566129679|FG002|Overall Study|Withdrawal by Subject|2|||
156830001|NCT03946124|566129680|FG000|Overall Study|Withdrawal by Subject|19|||
156830002|NCT02334683|566129682|FG000|First 12 Week Period|Lost to Follow-up|1|||
156830003|NCT02334683|566129683|FG001|First 12 Week Period|Lost to Follow-up|0|||
156830004|NCT02334683|566129682|FG000|Second 12 Week Period|Adverse Event|0|||
156830005|NCT02334683|566129683|FG001|Second 12 Week Period|Adverse Event|1|||
156830006|NCT01062841|566129684|FG000|Overall Study|Indwelling Device Removed|41|||
156830007|NCT01062841|566129685|FG001|Overall Study|Indwelling Device Removed|48|||
156830008|NCT01062841|566129684|FG000|Overall Study|Death|3|||
156830009|NCT01062841|566129685|FG001|Overall Study|Death|5|||
156830010|NCT01062841|566129684|FG000|Overall Study|Withdrawal by Subject|2|||
156830011|NCT01062841|566129685|FG001|Overall Study|Withdrawal by Subject|0|||
156830012|NCT01062841|566129684|FG000|Overall Study|Withdrawal by Study|3|||
156830013|NCT01062841|566129685|FG001|Overall Study|Withdrawal by Study|0|||
156830014|NCT02046174|566129686|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
156830015|NCT02046174|566129687|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
156830016|NCT00413920|566129691|FG000|Overall Study|Adverse Event|9|||
156830017|NCT00413920|566129692|FG001|Overall Study|Adverse Event|11|||
156830018|NCT00413920|566129691|FG000|Overall Study|Lack of Efficacy|11|||
156830019|NCT00413920|566129692|FG001|Overall Study|Lack of Efficacy|9|||
156830020|NCT00413920|566129691|FG000|Overall Study|Death|3|||
156830021|NCT00413920|566129692|FG001|Overall Study|Death|5|||
156830022|NCT00413920|566129691|FG000|Overall Study|Graft Loss|5|||
156830023|NCT00413920|566129692|FG001|Overall Study|Graft Loss|3|||
156830024|NCT03831880|566129693|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
156830025|NCT03831880|566129694|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
156830026|NCT03831880|566129693|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
156830027|NCT03831880|566129694|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
156830028|NCT01891344|566129695|FG000|Overall Study|Ongoing|6|||
156830029|NCT01891344|566129696|FG001|Overall Study|Ongoing|2|||
156830030|NCT01891344|566129697|FG002|Overall Study|Ongoing|0|||
156830031|NCT01891344|566129698|FG003|Overall Study|Ongoing|1|||
156830032|NCT01891344|566129699|FG004|Overall Study|Ongoing|4|||
156830033|NCT01891344|566129700|FG005|Overall Study|Ongoing|1|||
156830034|NCT01891344|566129701|FG006|Overall Study|Ongoing|0|||
156830035|NCT01891344|566129702|FG007|Overall Study|Ongoing|0|||
156830036|NCT02969590|566129706|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
156830037|NCT02969590|566129707|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
156541265|NCT00243386|565074532|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
156541266|NCT00243386|565074533|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
156541267|NCT00243386|565074531|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
156830038|NCT02969590|566129708|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
156830039|NCT01414205|566129709|FG000|Overall Study|Death|5|||
156830040|NCT01414205|566129710|FG001|Overall Study|Death|1|||
156830041|NCT01414205|566129709|FG000|Overall Study|Lost to Follow-up|1|||
156830042|NCT01414205|566129710|FG001|Overall Study|Lost to Follow-up|4|||
156830043|NCT01414205|566129709|FG000|Overall Study|Physician Decision|0|||
156830044|NCT01414205|566129710|FG001|Overall Study|Physician Decision|1|||
156830045|NCT01414205|566129709|FG000|Overall Study|Randomized but not Treated|1|||
156830046|NCT01414205|566129710|FG001|Overall Study|Randomized but not Treated|1|||
156830047|NCT01166373|566129711|FG000|Overall Study|Lost to Follow-up|3|||
156830048|NCT01166373|566129712|FG001|Overall Study|Lost to Follow-up|2|||
156830049|NCT01166373|566129713|FG002|Overall Study|Lost to Follow-up|2|||
156830050|NCT01166373|566129714|FG003|Overall Study|Lost to Follow-up|2|||
156830051|NCT01166373|566129711|FG000|Overall Study|Withdrawal by Subject|1|||
156830052|NCT01166373|566129712|FG001|Overall Study|Withdrawal by Subject|2|||
156830053|NCT01166373|566129713|FG002|Overall Study|Withdrawal by Subject|2|||
156830054|NCT01166373|566129714|FG003|Overall Study|Withdrawal by Subject|3|||
156830055|NCT01166373|566129711|FG000|Overall Study|Physician Decision|1|||
156830056|NCT01166373|566129712|FG001|Overall Study|Physician Decision|0|||
156339598|NCT03766581|564342161|FG004|Treatment|Lost to Follow-up|0|||
156339599|NCT03766581|564342162|FG005|Treatment|Lost to Follow-up|0|||
156339600|NCT03766581|564342163|FG006|Treatment|Lost to Follow-up|0|||
156339601|NCT03766581|564342164|FG007|Treatment|Lost to Follow-up|0|||
156339602|NCT03766581|564342157|FG000|Treatment|Poor/Non compliance|2|||
156339603|NCT03766581|564342158|FG001|Treatment|Poor/Non compliance|2|||
156339604|NCT03766581|564342159|FG002|Treatment|Poor/Non compliance|1|||
156339605|NCT03766581|564342160|FG003|Treatment|Poor/Non compliance|1|||
156339606|NCT03766581|564342161|FG004|Treatment|Poor/Non compliance|1|||
156339607|NCT03766581|564342162|FG005|Treatment|Poor/Non compliance|1|||
156339608|NCT03766581|564342163|FG006|Treatment|Poor/Non compliance|0|||
156339609|NCT03766581|564342164|FG007|Treatment|Poor/Non compliance|0|||
156339610|NCT03766581|564342157|FG000|Treatment|Participant no longer meets study criteria|9|||
156339611|NCT03766581|564342158|FG001|Treatment|Participant no longer meets study criteria|1|||
156339612|NCT03766581|564342159|FG002|Treatment|Participant no longer meets study criteria|5|||
156339613|NCT03766581|564342160|FG003|Treatment|Participant no longer meets study criteria|4|||
156339614|NCT03766581|564342161|FG004|Treatment|Participant no longer meets study criteria|4|||
156339615|NCT03766581|564342162|FG005|Treatment|Participant no longer meets study criteria|4|||
156339616|NCT03766581|564342163|FG006|Treatment|Participant no longer meets study criteria|2|||
156339617|NCT03766581|564342164|FG007|Treatment|Participant no longer meets study criteria|0|||
156339618|NCT03766581|564342157|FG000|Treatment|Other reasons|13|||
156339619|NCT03766581|564342158|FG001|Treatment|Other reasons|8|||
156339620|NCT03766581|564342159|FG002|Treatment|Other reasons|3|||
156339621|NCT03766581|564342160|FG003|Treatment|Other reasons|7|||
156339622|NCT03766581|564342161|FG004|Treatment|Other reasons|3|||
156339623|NCT03766581|564342162|FG005|Treatment|Other reasons|3|||
156339624|NCT03766581|564342163|FG006|Treatment|Other reasons|0|||
156339625|NCT03766581|564342164|FG007|Treatment|Other reasons|0|||
156339626|NCT02732119|564342165|FG000|Phase I|Adverse Event|1|||
156339627|NCT02732119|564342166|FG001|Phase I|Adverse Event|3|||
156339628|NCT02732119|564342167|FG002|Phase I|Adverse Event|1|||
156339629|NCT02732119|564342168|FG003|Phase I|Adverse Event|0|||
156339630|NCT02732119|564342169|FG004|Phase I|Adverse Event|0|||
156339631|NCT02732119|564342165|FG000|Phase I|Progressive disease|7|||
156339632|NCT02732119|564342166|FG001|Phase I|Progressive disease|3|||
156339633|NCT02732119|564342167|FG002|Phase I|Progressive disease|2|||
156339634|NCT02732119|564342168|FG003|Phase I|Progressive disease|0|||
156339635|NCT02732119|564342169|FG004|Phase I|Progressive disease|0|||
156339636|NCT02732119|564342165|FG000|Phase I|Protocol deviation|0|||
156339637|NCT02732119|564342166|FG001|Phase I|Protocol deviation|1|||
156339638|NCT02732119|564342167|FG002|Phase I|Protocol deviation|0|||
156339639|NCT02732119|564342168|FG003|Phase I|Protocol deviation|0|||
156339640|NCT02732119|564342169|FG004|Phase I|Protocol deviation|0|||
156339641|NCT02732119|564342165|FG000|Phase I|Physician Decision|0|||
156339642|NCT02732119|564342166|FG001|Phase I|Physician Decision|3|||
156339643|NCT02732119|564342167|FG002|Phase I|Physician Decision|4|||
156339644|NCT02732119|564342168|FG003|Phase I|Physician Decision|0|||
156339645|NCT02732119|564342169|FG004|Phase I|Physician Decision|0|||
156339646|NCT02732119|564342165|FG000|Phase II|Adverse Event|0|||
156339647|NCT02732119|564342166|FG001|Phase II|Adverse Event|0|||
156339648|NCT02732119|564342167|FG002|Phase II|Adverse Event|0|||
156339649|NCT02732119|564342168|FG003|Phase II|Adverse Event|3|||
156339650|NCT02732119|564342169|FG004|Phase II|Adverse Event|3|||
156339651|NCT02732119|564342165|FG000|Phase II|Death|0|||
156339652|NCT02732119|564342166|FG001|Phase II|Death|0|||
156339653|NCT02732119|564342167|FG002|Phase II|Death|0|||
156339654|NCT02732119|564342168|FG003|Phase II|Death|1|||
156339655|NCT02732119|564342169|FG004|Phase II|Death|0|||
156339656|NCT02732119|564342165|FG000|Phase II|Progressive dissease|0|||
156339657|NCT02732119|564342166|FG001|Phase II|Progressive dissease|0|||
156339658|NCT02732119|564342167|FG002|Phase II|Progressive dissease|0|||
156339659|NCT02732119|564342168|FG003|Phase II|Progressive dissease|30|||
156339660|NCT02732119|564342169|FG004|Phase II|Progressive dissease|23|||
156339661|NCT02732119|564342165|FG000|Phase II|Study terminated by sponsor|0|||
156339662|NCT02732119|564342166|FG001|Phase II|Study terminated by sponsor|0|||
156339663|NCT02732119|564342167|FG002|Phase II|Study terminated by sponsor|0|||
156339664|NCT02732119|564342168|FG003|Phase II|Study terminated by sponsor|2|||
156830057|NCT01166373|566129713|FG002|Overall Study|Physician Decision|0|||
156339665|NCT02732119|564342169|FG004|Phase II|Study terminated by sponsor|2|||
156339666|NCT02732119|564342165|FG000|Phase II|Other|0|||
156339667|NCT02732119|564342166|FG001|Phase II|Other|0|||
156339668|NCT02732119|564342167|FG002|Phase II|Other|0|||
156339669|NCT02732119|564342168|FG003|Phase II|Other|2|||
156339670|NCT02732119|564342169|FG004|Phase II|Other|0|||
156339671|NCT02732119|564342165|FG000|Phase II|Physician Decision|0|||
156339672|NCT02732119|564342166|FG001|Phase II|Physician Decision|0|||
156339673|NCT02732119|564342167|FG002|Phase II|Physician Decision|0|||
156339674|NCT02732119|564342168|FG003|Phase II|Physician Decision|8|||
156339675|NCT02732119|564342169|FG004|Phase II|Physician Decision|5|||
156339676|NCT05275400|564342170|FG000|Treatment Period|Adverse Event|7|||
156339677|NCT05275400|564342171|FG001|Treatment Period|Adverse Event|1|||
156339678|NCT05275400|564342170|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
156339679|NCT05275400|564342171|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
156339680|NCT05275400|564342170|FG000|Treatment Period|Death|5|||
156339681|NCT05275400|564342171|FG001|Treatment Period|Death|2|||
156339682|NCT05275400|564342170|FG000|Treatment Period|Protocol Violation|1|||
156339683|NCT05275400|564342171|FG001|Treatment Period|Protocol Violation|0|||
156339684|NCT05275400|564342170|FG000|Treatment Period|Physician Decision|5|||
156339685|NCT05275400|564342171|FG001|Treatment Period|Physician Decision|4|||
156339686|NCT05275400|564342170|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
156339687|NCT05275400|564342171|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
156339688|NCT05275400|564342170|FG000|Treatment Period|Withdrawal by Subject|30|||
156339689|NCT05275400|564342171|FG001|Treatment Period|Withdrawal by Subject|12|||
156339690|NCT05275400|564342170|FG000|Treatment Period|Lost to Follow-up|1|||
156339691|NCT05275400|564342171|FG001|Treatment Period|Lost to Follow-up|5|||
156339692|NCT05275400|564342170|FG000|Treatment Period|Lack of Efficacy|1|||
156339693|NCT05275400|564342171|FG001|Treatment Period|Lack of Efficacy|0|||
156339694|NCT05275400|564342170|FG000|Treatment Period|Sponsor Decision|1|||
156339695|NCT05275400|564342171|FG001|Treatment Period|Sponsor Decision|0|||
156339696|NCT05275400|564342170|FG000|Follow-Up Period|Death|2|||
156339697|NCT05275400|564342171|FG001|Follow-Up Period|Death|0|||
156339698|NCT05275400|564342170|FG000|Follow-Up Period|Protocol Violation|1|||
156339699|NCT05275400|564342171|FG001|Follow-Up Period|Protocol Violation|0|||
156339700|NCT05275400|564342170|FG000|Follow-Up Period|Withdrawal by Subject|3|||
156830058|NCT01166373|566129714|FG003|Overall Study|Physician Decision|0|||
156830059|NCT02498067|566129715|FG000|Overall Study|Lost to Follow-up|22|||
156830060|NCT02498067|566129715|FG000|Overall Study|Did not meet inclusion criteria|11|||
156830061|NCT01874275|566129716|FG000|Overall Study|Lost to Follow-up|1|||
156830062|NCT01874275|566129717|FG001|Overall Study|Lost to Follow-up|0|||
156830063|NCT02813668|566129723|FG000|Overall Study|Death|4|||
156830064|NCT02813668|566129723|FG000|Overall Study|Lost to Follow-up|509|||
156830065|NCT02813668|566129723|FG000|Overall Study|Withdrawal by Subject|148|||
156830066|NCT02813668|566129723|FG000|Overall Study|No longer at worksite|85|||
156830067|NCT02813668|566129723|FG000|Overall Study|Medical reasons not related to the study|4|||
156830068|NCT02594098|566129728|FG000|Overall Study|Lack of Efficacy|17|||
156830069|NCT02594098|566129729|FG001|Overall Study|Lack of Efficacy|6|||
156830070|NCT02594098|566129728|FG000|Overall Study|Withdrawal by Subject|1|||
156830071|NCT02594098|566129729|FG001|Overall Study|Withdrawal by Subject|3|||
156830072|NCT02594098|566129728|FG000|Overall Study|Terminated participation|6|||
156830073|NCT02594098|566129729|FG001|Overall Study|Terminated participation|2|||
156830074|NCT02594098|566129728|FG000|Overall Study|Seek alternative treatment|2|||
156830075|NCT02594098|566129729|FG001|Overall Study|Seek alternative treatment|1|||
156830076|NCT02594098|566129728|FG000|Overall Study|Other|0|||
156830077|NCT02594098|566129729|FG001|Overall Study|Other|1|||
156830078|NCT00495521|566129730|FG000|Overall Study|Physician Decision|0|||
156830079|NCT00495521|566129731|FG001|Overall Study|Physician Decision|1|||
156830080|NCT02782325|566129732|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
156830081|NCT02782325|566129733|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
156830082|NCT02782325|566129734|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
156830083|NCT02782325|566129732|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
156830084|NCT02782325|566129733|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
156830085|NCT02782325|566129734|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
156830086|NCT00042432|566129735|FG000|Overall Study|Adverse Event|4|||
156830087|NCT00042432|566129736|FG001|Overall Study|Adverse Event|1|||
156339701|NCT05275400|564342171|FG001|Follow-Up Period|Withdrawal by Subject|0|||
156339702|NCT02585960|564342172|FG000|PK/Safety Assessment Period|Physician Decision|0|||
156339703|NCT02585960|564342173|FG001|PK/Safety Assessment Period|Physician Decision|1|||
156339704|NCT02585960|564342174|FG002|PK/Safety Assessment Period|Physician Decision|0|||
156339705|NCT02585960|564342172|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
156339706|NCT02585960|564342173|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
156830088|NCT00042432|566129735|FG000|Overall Study|Withdrawal by Subject|1|||
156830089|NCT00042432|566129736|FG001|Overall Study|Withdrawal by Subject|3|||
156830090|NCT00042432|566129735|FG000|Overall Study|Death|0|||
156830091|NCT00042432|566129736|FG001|Overall Study|Death|2|||
156830092|NCT00042432|566129735|FG000|Overall Study|Ineligibility determined|1|||
156830093|NCT00042432|566129736|FG001|Overall Study|Ineligibility determined|0|||
156830094|NCT00042432|566129735|FG000|Overall Study|Initiation of maintenance dialysis|1|||
156830095|NCT00042432|566129736|FG001|Overall Study|Initiation of maintenance dialysis|1|||
156830096|NCT00042432|566129735|FG000|Overall Study|Other|2|||
156830097|NCT00042432|566129736|FG001|Overall Study|Other|0|||
156830098|NCT01527383|566129737|FG000|Overall Study|Adverse Event|5|||
156339707|NCT02585960|564342174|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
156339708|NCT02585960|564342172|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
156339709|NCT02585960|564342173|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
156830099|NCT01527383|566129738|FG001|Overall Study|Adverse Event|0|||
156830100|NCT01527383|566129737|FG000|Overall Study|Lost to Follow-up|3|||
156830101|NCT01527383|566129738|FG001|Overall Study|Lost to Follow-up|0|||
156830102|NCT01527383|566129737|FG000|Overall Study|Physician Decision|2|||
156830103|NCT01527383|566129738|FG001|Overall Study|Physician Decision|0|||
156830104|NCT01527383|566129737|FG000|Overall Study|Pregnancy|1|||
156830105|NCT01527383|566129738|FG001|Overall Study|Pregnancy|0|||
156830106|NCT01527383|566129737|FG000|Overall Study|Protocol Violation|1|||
156830107|NCT01527383|566129738|FG001|Overall Study|Protocol Violation|0|||
156830108|NCT01527383|566129737|FG000|Overall Study|Screen failure|1|||
156830109|NCT01527383|566129738|FG001|Overall Study|Screen failure|0|||
156830110|NCT01527383|566129737|FG000|Overall Study|Participant moved|0|||
156830111|NCT01527383|566129738|FG001|Overall Study|Participant moved|1|||
156830112|NCT01527383|566129737|FG000|Overall Study|Withdrawal by Subject|2|||
156830113|NCT01527383|566129738|FG001|Overall Study|Withdrawal by Subject|3|||
156830114|NCT00432744|566129739|FG000|Months 0-6|Withdrawal by Subject|4|||
156830115|NCT00432744|566129740|FG001|Months 0-6|Withdrawal by Subject|4|||
156830116|NCT00432744|566129739|FG000|Months 0-6|Too disabled to score|1|||
156830117|NCT00432744|566129740|FG001|Months 0-6|Too disabled to score|0|||
156830118|NCT00432744|566129739|FG000|Months 7 - 12|Withdrawal by Subject|1|||
156830119|NCT00432744|566129740|FG001|Months 7 - 12|Withdrawal by Subject|0|||
156830120|NCT00432744|566129739|FG000|Months 7 - 12|Too disabled to score|0|||
156830121|NCT00432744|566129740|FG001|Months 7 - 12|Too disabled to score|1|||
156830122|NCT02761694|566129745|FG000|Overall Study|Lack of Efficacy|0|||
156830123|NCT02761694|566129746|FG001|Overall Study|Lack of Efficacy|0|||
156830124|NCT02761694|566129747|FG002|Overall Study|Lack of Efficacy|0|||
156830125|NCT02761694|566129748|FG003|Overall Study|Lack of Efficacy|0|||
156830126|NCT02761694|566129749|FG004|Overall Study|Lack of Efficacy|0|||
156830127|NCT02761694|566129750|FG005|Overall Study|Lack of Efficacy|0|||
156830128|NCT02761694|566129751|FG006|Overall Study|Lack of Efficacy|6|||
156830129|NCT02761694|566129752|FG007|Overall Study|Lack of Efficacy|0|||
156830130|NCT02761694|566129753|FG008|Overall Study|Lack of Efficacy|0|||
156830131|NCT02761694|566129754|FG009|Overall Study|Lack of Efficacy|1|||
156830132|NCT02761694|566129755|FG010|Overall Study|Lack of Efficacy|1|||
156830133|NCT02761694|566129756|FG011|Overall Study|Lack of Efficacy|4|||
156830134|NCT02761694|566129745|FG000|Overall Study|Death|0|||
156830135|NCT02761694|566129746|FG001|Overall Study|Death|0|||
156830136|NCT02761694|566129747|FG002|Overall Study|Death|0|||
156830137|NCT02761694|566129748|FG003|Overall Study|Death|0|||
156830138|NCT02761694|566129749|FG004|Overall Study|Death|0|||
156830139|NCT02761694|566129750|FG005|Overall Study|Death|0|||
156830140|NCT02761694|566129751|FG006|Overall Study|Death|2|||
156830141|NCT02761694|566129752|FG007|Overall Study|Death|0|||
156830142|NCT02761694|566129753|FG008|Overall Study|Death|2|||
156830143|NCT02761694|566129754|FG009|Overall Study|Death|2|||
156830144|NCT02761694|566129755|FG010|Overall Study|Death|1|||
156830145|NCT02761694|566129756|FG011|Overall Study|Death|0|||
156830146|NCT02761694|566129745|FG000|Overall Study|Physician Decision|0|||
156830147|NCT02761694|566129746|FG001|Overall Study|Physician Decision|0|||
156830148|NCT02761694|566129747|FG002|Overall Study|Physician Decision|0|||
156830149|NCT02761694|566129748|FG003|Overall Study|Physician Decision|0|||
156830150|NCT02761694|566129749|FG004|Overall Study|Physician Decision|0|||
156830151|NCT02761694|566129750|FG005|Overall Study|Physician Decision|0|||
156541268|NCT00243386|565074532|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
156830152|NCT02761694|566129751|FG006|Overall Study|Physician Decision|1|||
156830153|NCT02761694|566129752|FG007|Overall Study|Physician Decision|0|||
156830154|NCT02761694|566129753|FG008|Overall Study|Physician Decision|0|||
156830155|NCT02761694|566129754|FG009|Overall Study|Physician Decision|0|||
156830156|NCT02761694|566129755|FG010|Overall Study|Physician Decision|0|||
156830157|NCT02761694|566129756|FG011|Overall Study|Physician Decision|0|||
156830158|NCT02761694|566129745|FG000|Overall Study|Withdrawal by Subject|0|||
156830159|NCT02761694|566129746|FG001|Overall Study|Withdrawal by Subject|0|||
156830160|NCT02761694|566129747|FG002|Overall Study|Withdrawal by Subject|0|||
156830161|NCT02761694|566129748|FG003|Overall Study|Withdrawal by Subject|1|||
156830162|NCT02761694|566129749|FG004|Overall Study|Withdrawal by Subject|0|||
156830163|NCT02761694|566129750|FG005|Overall Study|Withdrawal by Subject|0|||
156830164|NCT02761694|566129751|FG006|Overall Study|Withdrawal by Subject|4|||
156830165|NCT02761694|566129752|FG007|Overall Study|Withdrawal by Subject|0|||
156830166|NCT02761694|566129753|FG008|Overall Study|Withdrawal by Subject|2|||
156830167|NCT02761694|566129754|FG009|Overall Study|Withdrawal by Subject|1|||
156830168|NCT02761694|566129755|FG010|Overall Study|Withdrawal by Subject|0|||
156830169|NCT02761694|566129756|FG011|Overall Study|Withdrawal by Subject|0|||
156830170|NCT02761694|566129745|FG000|Overall Study|Lost to Follow-up|0|||
156830171|NCT02761694|566129746|FG001|Overall Study|Lost to Follow-up|0|||
156830172|NCT02761694|566129747|FG002|Overall Study|Lost to Follow-up|0|||
156466265|NCT00943917|564803864|FG013|Stage I|Adverse Event|0|||
156466266|NCT00943917|564803865|FG014|Stage I|Adverse Event|0|||
156466267|NCT00943917|564803851|FG000|Stage I|Lost to Follow-up|0|||
156466268|NCT00943917|564803852|FG001|Stage I|Lost to Follow-up|0|||
156466269|NCT00943917|564803853|FG002|Stage I|Lost to Follow-up|1|||
156466270|NCT00943917|564803854|FG003|Stage I|Lost to Follow-up|0|||
156466271|NCT00943917|564803855|FG004|Stage I|Lost to Follow-up|0|||
156466272|NCT00943917|564803856|FG005|Stage I|Lost to Follow-up|0|||
156466273|NCT00943917|564803857|FG006|Stage I|Lost to Follow-up|0|||
156466274|NCT00943917|564803858|FG007|Stage I|Lost to Follow-up|0|||
156466275|NCT00943917|564803859|FG008|Stage I|Lost to Follow-up|0|||
156466276|NCT00943917|564803860|FG009|Stage I|Lost to Follow-up|0|||
156466277|NCT00943917|564803861|FG010|Stage I|Lost to Follow-up|0|||
156466278|NCT00943917|564803862|FG011|Stage I|Lost to Follow-up|0|||
156466279|NCT00943917|564803863|FG012|Stage I|Lost to Follow-up|0|||
156466280|NCT00943917|564803864|FG013|Stage I|Lost to Follow-up|0|||
156466281|NCT00943917|564803865|FG014|Stage I|Lost to Follow-up|0|||
156466282|NCT00943917|564803851|FG000|Stage I|hyperglycemia|0|||
156466283|NCT00943917|564803852|FG001|Stage I|hyperglycemia|0|||
156466284|NCT00943917|564803853|FG002|Stage I|hyperglycemia|1|||
156466285|NCT00943917|564803854|FG003|Stage I|hyperglycemia|0|||
156466286|NCT00943917|564803855|FG004|Stage I|hyperglycemia|0|||
156466287|NCT00943917|564803856|FG005|Stage I|hyperglycemia|0|||
156830173|NCT02761694|566129748|FG003|Overall Study|Lost to Follow-up|0|||
156830174|NCT02761694|566129749|FG004|Overall Study|Lost to Follow-up|0|||
156830175|NCT02761694|566129750|FG005|Overall Study|Lost to Follow-up|0|||
156830176|NCT02761694|566129751|FG006|Overall Study|Lost to Follow-up|1|||
156830177|NCT02761694|566129752|FG007|Overall Study|Lost to Follow-up|0|||
156830178|NCT02761694|566129753|FG008|Overall Study|Lost to Follow-up|0|||
156830179|NCT02761694|566129754|FG009|Overall Study|Lost to Follow-up|0|||
156830180|NCT02761694|566129755|FG010|Overall Study|Lost to Follow-up|0|||
156830181|NCT02761694|566129756|FG011|Overall Study|Lost to Follow-up|1|||
156830182|NCT02761694|566129745|FG000|Overall Study|Adverse Event|0|||
156830183|NCT02761694|566129746|FG001|Overall Study|Adverse Event|0|||
156830184|NCT02761694|566129747|FG002|Overall Study|Adverse Event|0|||
156830185|NCT02761694|566129748|FG003|Overall Study|Adverse Event|0|||
156830186|NCT02761694|566129749|FG004|Overall Study|Adverse Event|0|||
156830187|NCT02761694|566129750|FG005|Overall Study|Adverse Event|0|||
156830188|NCT02761694|566129751|FG006|Overall Study|Adverse Event|1|||
156830189|NCT02761694|566129752|FG007|Overall Study|Adverse Event|0|||
156830190|NCT02761694|566129753|FG008|Overall Study|Adverse Event|1|||
156830191|NCT02761694|566129754|FG009|Overall Study|Adverse Event|0|||
156830192|NCT02761694|566129755|FG010|Overall Study|Adverse Event|0|||
156830193|NCT02761694|566129756|FG011|Overall Study|Adverse Event|1|||
156466288|NCT00943917|564803857|FG006|Stage I|hyperglycemia|0|||
156466289|NCT00943917|564803858|FG007|Stage I|hyperglycemia|0|||
156466290|NCT00943917|564803859|FG008|Stage I|hyperglycemia|0|||
156466291|NCT00943917|564803860|FG009|Stage I|hyperglycemia|0|||
156466292|NCT00943917|564803861|FG010|Stage I|hyperglycemia|0|||
156466293|NCT00943917|564803862|FG011|Stage I|hyperglycemia|0|||
156466294|NCT00943917|564803863|FG012|Stage I|hyperglycemia|0|||
156466295|NCT00943917|564803864|FG013|Stage I|hyperglycemia|0|||
156466296|NCT00943917|564803865|FG014|Stage I|hyperglycemia|0|||
156466297|NCT00943917|564803851|FG000|Stage I|A1C elevation|1|||
156466298|NCT00943917|564803852|FG001|Stage I|A1C elevation|0|||
156466299|NCT00943917|564803853|FG002|Stage I|A1C elevation|0|||
156541269|NCT00243386|565074533|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
156830194|NCT02761694|566129745|FG000|Overall Study|Other|4|||
156830195|NCT02761694|566129746|FG001|Overall Study|Other|4|||
156830196|NCT02761694|566129747|FG002|Overall Study|Other|1|||
156830197|NCT02761694|566129748|FG003|Overall Study|Other|2|||
156830198|NCT02761694|566129749|FG004|Overall Study|Other|3|||
156466300|NCT00943917|564803854|FG003|Stage I|A1C elevation|0|||
156466301|NCT00943917|564803855|FG004|Stage I|A1C elevation|0|||
156466302|NCT00943917|564803856|FG005|Stage I|A1C elevation|0|||
156466303|NCT00943917|564803857|FG006|Stage I|A1C elevation|0|||
156466304|NCT00943917|564803858|FG007|Stage I|A1C elevation|0|||
156466305|NCT00943917|564803859|FG008|Stage I|A1C elevation|0|||
156466306|NCT00943917|564803860|FG009|Stage I|A1C elevation|0|||
156466307|NCT00943917|564803861|FG010|Stage I|A1C elevation|0|||
156466308|NCT00943917|564803862|FG011|Stage I|A1C elevation|0|||
156466309|NCT00943917|564803863|FG012|Stage I|A1C elevation|0|||
156466310|NCT00943917|564803864|FG013|Stage I|A1C elevation|0|||
156466311|NCT00943917|564803865|FG014|Stage I|A1C elevation|0|||
156830199|NCT02761694|566129750|FG005|Overall Study|Other|3|||
156830200|NCT02761694|566129751|FG006|Overall Study|Other|18|||
156830201|NCT02761694|566129752|FG007|Overall Study|Other|8|||
156830202|NCT02761694|566129753|FG008|Overall Study|Other|0|||
156830203|NCT02761694|566129754|FG009|Overall Study|Other|1|||
156830204|NCT02761694|566129755|FG010|Overall Study|Other|1|||
156830205|NCT02761694|566129756|FG011|Overall Study|Other|0|||
156830206|NCT00787930|566129764|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
156830207|NCT02395055|566129765|FG000|Overall Study|Withdrawal by Subject|7|||
156830208|NCT02395055|566129766|FG001|Overall Study|Withdrawal by Subject|3|||
156830209|NCT02513823|566129767|FG000|Overall Study|Lost to Follow-up|4|||
156830210|NCT02513823|566129767|FG000|Overall Study|Physician Decision|1|||
156830211|NCT00394901|566129768|FG000|Baseline Phase|Protocol Violation|0|||
156830212|NCT00394901|566129769|FG001|Baseline Phase|Protocol Violation|0|||
156830213|NCT00394901|566129770|FG002|Baseline Phase|Protocol Violation|1|||
156830214|NCT00394901|566129771|FG003|Baseline Phase|Protocol Violation|0|||
156830215|NCT00394901|566129768|FG000|Double-blind Phase|Adverse Event|5|||
156830216|NCT00394901|566129769|FG001|Double-blind Phase|Adverse Event|7|||
156830217|NCT00394901|566129770|FG002|Double-blind Phase|Adverse Event|16|||
156830218|NCT00394901|566129771|FG003|Double-blind Phase|Adverse Event|20|||
156830219|NCT00394901|566129768|FG000|Double-blind Phase|Lack of Efficacy|6|||
156830220|NCT00394901|566129769|FG001|Double-blind Phase|Lack of Efficacy|4|||
156830221|NCT00394901|566129770|FG002|Double-blind Phase|Lack of Efficacy|1|||
156830222|NCT00394901|566129771|FG003|Double-blind Phase|Lack of Efficacy|3|||
156830223|NCT00394901|566129768|FG000|Double-blind Phase|Withdrawal by Subject|2|||
156830224|NCT00394901|566129769|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156830225|NCT00394901|566129770|FG002|Double-blind Phase|Withdrawal by Subject|0|||
156830226|NCT00394901|566129771|FG003|Double-blind Phase|Withdrawal by Subject|0|||
156830227|NCT00394901|566129768|FG000|Double-blind Phase|Lost to Follow-up|0|||
156830228|NCT00394901|566129769|FG001|Double-blind Phase|Lost to Follow-up|0|||
156830229|NCT00394901|566129770|FG002|Double-blind Phase|Lost to Follow-up|0|||
156830230|NCT00394901|566129771|FG003|Double-blind Phase|Lost to Follow-up|1|||
156830231|NCT00394901|566129768|FG000|Double-blind Phase|Protocol Violation|0|||
156830232|NCT00394901|566129769|FG001|Double-blind Phase|Protocol Violation|0|||
156830233|NCT00394901|566129770|FG002|Double-blind Phase|Protocol Violation|0|||
156830234|NCT00394901|566129771|FG003|Double-blind Phase|Protocol Violation|1|||
156830235|NCT00394901|566129768|FG000|Double-blind Phase|Death|1|||
156830236|NCT00394901|566129769|FG001|Double-blind Phase|Death|0|||
156830237|NCT00394901|566129770|FG002|Double-blind Phase|Death|0|||
156830238|NCT00394901|566129771|FG003|Double-blind Phase|Death|0|||
156830239|NCT00394901|566129768|FG000|Double-blind Phase|Subject's Personal Reason|1|||
156830240|NCT00394901|566129769|FG001|Double-blind Phase|Subject's Personal Reason|0|||
156830241|NCT00394901|566129770|FG002|Double-blind Phase|Subject's Personal Reason|0|||
156830242|NCT00394901|566129771|FG003|Double-blind Phase|Subject's Personal Reason|1|||
156830243|NCT00394901|566129768|FG000|Double-blind Phase|Lack of Compliance|0|||
156830244|NCT00394901|566129769|FG001|Double-blind Phase|Lack of Compliance|3|||
156830245|NCT00394901|566129770|FG002|Double-blind Phase|Lack of Compliance|0|||
156830246|NCT00394901|566129771|FG003|Double-blind Phase|Lack of Compliance|0|||
156830247|NCT00394901|566129768|FG000|Double-blind Phase|Entry into another study was found|0|||
156830248|NCT00394901|566129769|FG001|Double-blind Phase|Entry into another study was found|0|||
156830249|NCT00394901|566129770|FG002|Double-blind Phase|Entry into another study was found|1|||
156830250|NCT00394901|566129771|FG003|Double-blind Phase|Entry into another study was found|0|||
156830251|NCT00394901|566129768|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
156830252|NCT00394901|566129769|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
156830253|NCT00394901|566129770|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
156830254|NCT00394901|566129771|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
156830255|NCT03002623|566129774|FG000|Overall Study|Lost to Follow-up|1|||
156830256|NCT03002623|566129775|FG001|Overall Study|Lost to Follow-up|0|||
156466312|NCT00943917|564803851|FG000|Stage I|Withdrawal by Subject|2|||
156466313|NCT00943917|564803852|FG001|Stage I|Withdrawal by Subject|1|||
156466314|NCT00943917|564803853|FG002|Stage I|Withdrawal by Subject|2|||
156466315|NCT00943917|564803854|FG003|Stage I|Withdrawal by Subject|0|||
156466316|NCT00943917|564803855|FG004|Stage I|Withdrawal by Subject|0|||
156830257|NCT03002623|566129774|FG000|Overall Study|Physician Decision|1|||
156830258|NCT03002623|566129775|FG001|Overall Study|Physician Decision|1|||
156830259|NCT04342689|566129779|FG000|Overall Study|Withdrawal by Subject|32|||
156830260|NCT04342689|566129780|FG001|Overall Study|Withdrawal by Subject|33|||
156830261|NCT04342689|566129779|FG000|Overall Study|Lost to Follow-up|10|||
156830262|NCT04342689|566129780|FG001|Overall Study|Lost to Follow-up|12|||
156830263|NCT00844805|566129781|FG000|Treatment Phase|Adverse Event|5|||
156830264|NCT00844805|566129782|FG001|Treatment Phase|Adverse Event|1|||
156830265|NCT00844805|566129783|FG002|Treatment Phase|Adverse Event|0|||
156830266|NCT00844805|566129784|FG003|Treatment Phase|Adverse Event|0|||
156830267|NCT00844805|566129781|FG000|Treatment Phase|Withdrawal by Subject|3|||
156466317|NCT00943917|564803856|FG005|Stage I|Withdrawal by Subject|0|||
156466318|NCT00943917|564803857|FG006|Stage I|Withdrawal by Subject|0|||
156830268|NCT00844805|566129782|FG001|Treatment Phase|Withdrawal by Subject|4|||
156830269|NCT00844805|566129783|FG002|Treatment Phase|Withdrawal by Subject|0|||
156830270|NCT00844805|566129784|FG003|Treatment Phase|Withdrawal by Subject|0|||
156830271|NCT00844805|566129781|FG000|Treatment Phase|Noncompliance With Protocol|1|||
156830272|NCT00844805|566129782|FG001|Treatment Phase|Noncompliance With Protocol|0|||
156830273|NCT00844805|566129783|FG002|Treatment Phase|Noncompliance With Protocol|0|||
156830274|NCT00844805|566129784|FG003|Treatment Phase|Noncompliance With Protocol|0|||
156830275|NCT00844805|566129781|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
156830276|NCT00844805|566129782|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
156830277|NCT00844805|566129783|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
156830278|NCT00844805|566129784|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
156830279|NCT00844805|566129781|FG000|Follow-Up Phase|Adverse Event|0|||
156830280|NCT00844805|566129782|FG001|Follow-Up Phase|Adverse Event|0|||
156830281|NCT00844805|566129783|FG002|Follow-Up Phase|Adverse Event|1|||
156830282|NCT00844805|566129784|FG003|Follow-Up Phase|Adverse Event|0|||
156830283|NCT00844805|566129781|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
156830284|NCT00844805|566129782|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
156830285|NCT00844805|566129783|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
156830286|NCT00844805|566129784|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
156830287|NCT00844805|566129781|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
156830288|NCT00844805|566129782|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
156830289|NCT00844805|566129783|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
156830290|NCT00844805|566129784|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
156830291|NCT00844805|566129781|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
156830292|NCT00844805|566129782|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
156830293|NCT00844805|566129783|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
156830294|NCT00844805|566129784|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
156830295|NCT00844805|566129781|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
156830296|NCT00844805|566129782|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
156830297|NCT00844805|566129783|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
156830298|NCT00844805|566129784|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
156830299|NCT00475865|566129785|FG000|Overall Study|Adverse Event|0|||
156830300|NCT00475865|566129786|FG001|Overall Study|Adverse Event|3|||
156830301|NCT00475865|566129787|FG002|Overall Study|Adverse Event|4|||
156830302|NCT00475865|566129785|FG000|Overall Study|Lack of Efficacy|1|||
156830303|NCT00475865|566129786|FG001|Overall Study|Lack of Efficacy|0|||
156830304|NCT00475865|566129787|FG002|Overall Study|Lack of Efficacy|0|||
156830305|NCT00475865|566129785|FG000|Overall Study|Progressive disease|0|||
156830306|NCT00475865|566129786|FG001|Overall Study|Progressive disease|1|||
156830307|NCT00475865|566129787|FG002|Overall Study|Progressive disease|2|||
156830308|NCT00475865|566129785|FG000|Overall Study|Participant did not wish to continue|1|||
156830309|NCT00475865|566129786|FG001|Overall Study|Participant did not wish to continue|0|||
156830310|NCT00475865|566129787|FG002|Overall Study|Participant did not wish to continue|0|||
156830311|NCT00475865|566129785|FG000|Overall Study|Other than above|0|||
156830312|NCT00475865|566129786|FG001|Overall Study|Other than above|1|||
156830313|NCT00475865|566129787|FG002|Overall Study|Other than above|0|||
156830314|NCT04316741|566129788|FG000|Baseline Enrollment|Lost to Follow-up|1|||
156830315|NCT04316741|566129789|FG001|Baseline Enrollment|Lost to Follow-up|1|||
156830316|NCT04316741|566129788|FG000|Immediate Post-Test|Lost to Follow-up|5|||
156830317|NCT04316741|566129789|FG001|Immediate Post-Test|Lost to Follow-up|1|||
156830318|NCT04316741|566129788|FG000|1-month Post-test|Lost to Follow-up|7|||
156830319|NCT04316741|566129789|FG001|1-month Post-test|Lost to Follow-up|2|||
156830320|NCT04316741|566129788|FG000|3-month Follow-up|Lost to Follow-up|10|||
156830321|NCT04316741|566129789|FG001|3-month Follow-up|Lost to Follow-up|2|||
156830322|NCT02278614|566129793|FG000|Overall Study|Withdrawal by Subject|3|||
156830323|NCT02278614|566129794|FG001|Overall Study|Withdrawal by Subject|5|||
156830324|NCT02278614|566129793|FG000|Overall Study|Adverse Event|1|||
156466319|NCT00943917|564803858|FG007|Stage I|Withdrawal by Subject|0|||
156466320|NCT00943917|564803859|FG008|Stage I|Withdrawal by Subject|0|||
156466321|NCT00943917|564803860|FG009|Stage I|Withdrawal by Subject|0|||
156466322|NCT00943917|564803861|FG010|Stage I|Withdrawal by Subject|0|||
156466323|NCT00943917|564803862|FG011|Stage I|Withdrawal by Subject|0|||
156466324|NCT00943917|564803863|FG012|Stage I|Withdrawal by Subject|0|||
156830325|NCT02278614|566129794|FG001|Overall Study|Adverse Event|0|||
156830326|NCT02278614|566129793|FG000|Overall Study|left eye was not eligible|1|||
156466325|NCT00943917|564803864|FG013|Stage I|Withdrawal by Subject|0|||
156466326|NCT00943917|564803865|FG014|Stage I|Withdrawal by Subject|0|||
156466327|NCT00943917|564803851|FG000|Stage II|Adverse Event|0|||
156830327|NCT02278614|566129794|FG001|Overall Study|left eye was not eligible|0|||
156830328|NCT00737711|566129795|FG000|Overall Study|Adverse Event|2|||
156830329|NCT00737711|566129795|FG000|Overall Study|Death|8|||
156830330|NCT00737711|566129795|FG000|Overall Study|Failure to return|4|||
156830331|NCT00737711|566129795|FG000|Overall Study|Protocol Violation|1|||
156830332|NCT00737711|566129795|FG000|Overall Study|Withdrawal by Subject|5|||
156830333|NCT00737711|566129795|FG000|Overall Study|Blood transfusion|6|||
156466328|NCT00943917|564803852|FG001|Stage II|Adverse Event|0|||
156466329|NCT00943917|564803853|FG002|Stage II|Adverse Event|0|||
156830334|NCT00737711|566129795|FG000|Overall Study|Other|5|||
156830335|NCT03081858|566132210|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
156830336|NCT03081858|566132211|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
156830337|NCT03081858|566132212|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
156830338|NCT03081858|566132213|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
156830339|NCT03959982|566132216|FG000|Overall Study|Withdrawal by Subject|1|||
156830340|NCT03959982|566132217|FG001|Overall Study|Withdrawal by Subject|0|||
156830341|NCT03959982|566132216|FG000|Overall Study|Physician Decision|2|||
156830342|NCT03959982|566132217|FG001|Overall Study|Physician Decision|0|||
156830343|NCT03959982|566132216|FG000|Overall Study|Lost to Follow-up|1|||
156830344|NCT03959982|566132217|FG001|Overall Study|Lost to Follow-up|0|||
156830345|NCT00758589|566132218|FG000|Overall Study|Adverse Event|3|||
156830346|NCT00758589|566132219|FG001|Overall Study|Adverse Event|2|||
156830347|NCT00758589|566132220|FG002|Overall Study|Adverse Event|5|||
156830348|NCT00758589|566132221|FG003|Overall Study|Adverse Event|4|||
156830349|NCT00758589|566132218|FG000|Overall Study|Withdrawal by Subject|0|||
156830350|NCT00758589|566132219|FG001|Overall Study|Withdrawal by Subject|1|||
156830351|NCT00758589|566132220|FG002|Overall Study|Withdrawal by Subject|1|||
156830352|NCT00758589|566132221|FG003|Overall Study|Withdrawal by Subject|1|||
156830353|NCT00758589|566132218|FG000|Overall Study|Palm stopped to work|0|||
156830354|NCT00758589|566132219|FG001|Overall Study|Palm stopped to work|0|||
156830355|NCT00758589|566132220|FG002|Overall Study|Palm stopped to work|0|||
156830356|NCT00758589|566132221|FG003|Overall Study|Palm stopped to work|1|||
156830357|NCT02191605|566132222|FG000|Overall Study|Lost to Follow-up|9|||
156830358|NCT02191605|566132223|FG001|Overall Study|Lost to Follow-up|4|||
156830359|NCT02191605|566132224|FG002|Overall Study|Lost to Follow-up|7|||
156830360|NCT02191605|566132225|FG003|Overall Study|Lost to Follow-up|3|||
156830361|NCT02191605|566132226|FG004|Overall Study|Lost to Follow-up|4|||
156830362|NCT03647267|566132231|FG000|Overall Study|Lost to Follow-up|1|||
156830363|NCT03647267|566132232|FG001|Overall Study|Lost to Follow-up|0|||
156830364|NCT05079477|566132233|FG000|Overall Study|Lost to Follow-up|2|||
156830365|NCT05079477|566132234|FG001|Overall Study|Lost to Follow-up|0|||
156830366|NCT05079477|566132233|FG000|Overall Study|Withdrawal by Subject|1|||
156830367|NCT05079477|566132234|FG001|Overall Study|Withdrawal by Subject|0|||
156830368|NCT05079477|566132233|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
156830369|NCT05079477|566132234|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
156830370|NCT05079477|566132233|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
156830371|NCT05079477|566132234|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
156830372|NCT00734071|566132237|FG000|Overall Study|Adverse Event|4|||
156830373|NCT00734071|566132238|FG001|Overall Study|Adverse Event|3|||
156830374|NCT00734071|566132237|FG000|Overall Study|Lack of Efficacy|3|||
156830375|NCT00734071|566132238|FG001|Overall Study|Lack of Efficacy|1|||
156830376|NCT00734071|566132237|FG000|Overall Study|Noncompliance|2|||
156830377|NCT00734071|566132238|FG001|Overall Study|Noncompliance|2|||
156830378|NCT00734071|566132237|FG000|Overall Study|Protocol Deviations|3|||
156830379|NCT00734071|566132238|FG001|Overall Study|Protocol Deviations|4|||
156830380|NCT00734071|566132237|FG000|Overall Study|Voluntary Withdrawal|9|||
156830381|NCT00734071|566132238|FG001|Overall Study|Voluntary Withdrawal|7|||
156830382|NCT00734071|566132237|FG000|Overall Study|Lost to Follow-up|16|||
156830383|NCT00734071|566132238|FG001|Overall Study|Lost to Follow-up|8|||
156830384|NCT00734071|566132237|FG000|Overall Study|Other|1|||
156830385|NCT00734071|566132238|FG001|Overall Study|Other|2|||
156830386|NCT03654885|566132239|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
156830387|NCT03654885|566132240|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
156830388|NCT03654885|566132239|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
156830389|NCT03654885|566132240|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
156830390|NCT03654885|566132239|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
156830391|NCT03654885|566132240|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
156830392|NCT03654885|566132239|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
156830393|NCT03654885|566132240|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
156830394|NCT03654885|566132239|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
156830395|NCT03654885|566132240|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
156830396|NCT03654885|566132239|FG000|Overall Study|Adverse Event in Study Eye|3|||
156830397|NCT03654885|566132240|FG001|Overall Study|Adverse Event in Study Eye|0|||
156830398|NCT03654885|566132239|FG000|Overall Study|Consent Withdrawn|1|||
156830399|NCT03654885|566132240|FG001|Overall Study|Consent Withdrawn|0|||
156830400|NCT03654885|566132239|FG000|Overall Study|Death|3|||
156830401|NCT03654885|566132240|FG001|Overall Study|Death|1|||
156830402|NCT03654885|566132239|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
156830403|NCT03654885|566132240|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
156830404|NCT03654885|566132239|FG000|Overall Study|Lost to Follow-up|3|||
156830405|NCT03654885|566132240|FG001|Overall Study|Lost to Follow-up|3|||
156830406|NCT05275582|566132241|FG000|Overall Study|Lost to Follow-up|1|||
156830407|NCT05275582|566132242|FG001|Overall Study|Lost to Follow-up|0|||
156830408|NCT05275582|566132241|FG000|Overall Study|Withdrawal by Subject|0|||
156830409|NCT05275582|566132242|FG001|Overall Study|Withdrawal by Subject|2|||
156830410|NCT05275582|566132241|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
156830411|NCT05275582|566132242|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
156830412|NCT05275582|566132241|FG000|Overall Study|Death|1|||
156830413|NCT05275582|566132242|FG001|Overall Study|Death|0|||
156830414|NCT05275582|566132241|FG000|Overall Study|Protocol Violation|1|||
156830415|NCT05275582|566132242|FG001|Overall Study|Protocol Violation|0|||
156830416|NCT00240110|566132246|FG000|Overall Study|Lost to Follow-up|6|||
156830417|NCT00240110|566132247|FG001|Overall Study|Lost to Follow-up|7|||
156830418|NCT00583791|566132248|FG000|Overall Study|Other|67|||
156830419|NCT00583791|566132248|FG000|Overall Study|Death|6|||
156830420|NCT00203021|566132251|FG000|Overall Study|Death|4|||
156830421|NCT00203021|566132252|FG001|Overall Study|Death|1|||
156830422|NCT00203021|566132251|FG000|Overall Study|Adverse Event|10|||
156830423|NCT00203021|566132252|FG001|Overall Study|Adverse Event|5|||
156830424|NCT00203021|566132251|FG000|Overall Study|Withdrawal by Subject|45|||
156830425|NCT00203021|566132252|FG001|Overall Study|Withdrawal by Subject|48|||
156830426|NCT00203021|566132251|FG000|Overall Study|Lost to Follow-up|9|||
156830427|NCT00203021|566132252|FG001|Overall Study|Lost to Follow-up|7|||
156830428|NCT00203021|566132251|FG000|Overall Study|Other than specified|11|||
156830429|NCT00203021|566132252|FG001|Overall Study|Other than specified|16|||
156830430|NCT02080260|566132254|FG000|Overall Study|Death|18|||
156830431|NCT02080260|566132254|FG000|Overall Study|Withdrawal by Subject|1|||
156830432|NCT05438602|566132259|FG000|Treatment (15 Days)|Adverse Event|2|||
156830433|NCT05438602|566132260|FG001|Treatment (15 Days)|Adverse Event|1|||
156830434|NCT05438602|566132261|FG002|Treatment (15 Days)|Adverse Event|3|||
156830435|NCT05438602|566132259|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
156830436|NCT05438602|566132260|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
156830437|NCT05438602|566132261|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
156830438|NCT05438602|566132259|FG000|Treatment (15 Days)|Other|0|||
156830439|NCT05438602|566132260|FG001|Treatment (15 Days)|Other|0|||
156830440|NCT05438602|566132261|FG002|Treatment (15 Days)|Other|1|||
156830441|NCT05438602|566132259|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
156830442|NCT05438602|566132260|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
156830443|NCT05438602|566132261|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
156830444|NCT05438602|566132259|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
156541270|NCT00243386|565074531|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
156830445|NCT05438602|566132260|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
156830446|NCT05438602|566132261|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
156830447|NCT05438602|566132259|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
156830448|NCT05438602|566132260|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
156830449|NCT05438602|566132261|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
156830450|NCT05438602|566132259|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
156830451|NCT05438602|566132260|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
156830452|NCT05438602|566132261|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
156830453|NCT05438602|566132259|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
156830454|NCT05438602|566132260|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
156830455|NCT05438602|566132261|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
156830456|NCT05438602|566132259|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
156830457|NCT05438602|566132260|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
156830458|NCT05438602|566132261|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
156830459|NCT05438602|566132259|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
156830460|NCT05438602|566132260|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
156830461|NCT05438602|566132261|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
156830462|NCT03204890|566132262|FG000|Overall Study|Withdrawal by Subject|1|||
156830463|NCT02853435|566132263|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830464|NCT02853435|566132264|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830465|NCT02853435|566132265|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830466|NCT02853435|566132266|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830467|NCT02853435|566132267|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
156830468|NCT02853435|566132268|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830469|NCT03747120|566132271|FG000|Overall Study|treatment related toxicity|3|||
156830470|NCT03747120|566132272|FG001|Overall Study|treatment related toxicity|0|||
156830471|NCT03747120|566132273|FG002|Overall Study|treatment related toxicity|0|||
156830472|NCT03747120|566132271|FG000|Overall Study|Withdrawal by Subject|0|||
156830473|NCT03747120|566132272|FG001|Overall Study|Withdrawal by Subject|1|||
156830474|NCT03747120|566132273|FG002|Overall Study|Withdrawal by Subject|2|||
156830475|NCT01657760|566132287|FG000|Overall Study|Withdrawal by Subject|0|||
156830476|NCT01657760|566132288|FG001|Overall Study|Withdrawal by Subject|0|||
156830477|NCT01657760|566132289|FG002|Overall Study|Withdrawal by Subject|0|||
156830478|NCT01657760|566132290|FG003|Overall Study|Withdrawal by Subject|1|||
156830479|NCT01657760|566132287|FG000|Overall Study|Physician Decision|1|||
156830480|NCT01657760|566132288|FG001|Overall Study|Physician Decision|1|||
156830481|NCT01657760|566132289|FG002|Overall Study|Physician Decision|1|||
156830482|NCT01657760|566132290|FG003|Overall Study|Physician Decision|2|||
156830483|NCT02435680|566132304|FG000|Overall Study|Physician Decision|3|||
156830484|NCT02435680|566132305|FG001|Overall Study|Physician Decision|0|||
156830485|NCT02435680|566132306|FG002|Overall Study|Physician Decision|0|||
156830486|NCT02435680|566132304|FG000|Overall Study|subject / guardian decision|0|||
156830487|NCT02435680|566132305|FG001|Overall Study|subject / guardian decision|3|||
156830488|NCT02435680|566132306|FG002|Overall Study|subject / guardian decision|2|||
156830489|NCT02435680|566132304|FG000|Overall Study|Adverse Event|8|||
156830490|NCT02435680|566132305|FG001|Overall Study|Adverse Event|3|||
156830491|NCT02435680|566132306|FG002|Overall Study|Adverse Event|2|||
156830492|NCT02435680|566132304|FG000|Overall Study|progressive disease|10|||
156830493|NCT02435680|566132305|FG001|Overall Study|progressive disease|7|||
156830494|NCT02435680|566132306|FG002|Overall Study|progressive disease|11|||
156830495|NCT02435680|566132304|FG000|Overall Study|not treated|0|||
156830496|NCT02435680|566132305|FG001|Overall Study|not treated|0|||
156830497|NCT02435680|566132306|FG002|Overall Study|not treated|1|||
156830498|NCT00953524|566132307|FG000|Overall Study|Adverse Event|2|||
156830499|NCT00953524|566132308|FG001|Overall Study|Adverse Event|0|||
156830500|NCT00953524|566132309|FG002|Overall Study|Adverse Event|1|||
156830501|NCT00953524|566132310|FG003|Overall Study|Adverse Event|2|||
156830502|NCT00953524|566132307|FG000|Overall Study|Protocol Violation|18|||
156830503|NCT00953524|566132308|FG001|Overall Study|Protocol Violation|10|||
156830504|NCT00953524|566132309|FG002|Overall Study|Protocol Violation|11|||
156830505|NCT00953524|566132310|FG003|Overall Study|Protocol Violation|6|||
156830506|NCT00953524|566132307|FG000|Overall Study|Lost to Follow-up|0|||
156830507|NCT00953524|566132308|FG001|Overall Study|Lost to Follow-up|1|||
156830508|NCT00953524|566132309|FG002|Overall Study|Lost to Follow-up|1|||
156830509|NCT00953524|566132310|FG003|Overall Study|Lost to Follow-up|0|||
156830510|NCT00953524|566132307|FG000|Overall Study|Withdrawal by Subject|2|||
156830511|NCT00953524|566132308|FG001|Overall Study|Withdrawal by Subject|4|||
156830512|NCT00953524|566132309|FG002|Overall Study|Withdrawal by Subject|1|||
156830513|NCT00953524|566132310|FG003|Overall Study|Withdrawal by Subject|0|||
156830514|NCT01994863|566132312|FG000|Period 1|Adverse Event|4|||
156830515|NCT01994863|566132313|FG001|Period 1|Adverse Event|0|||
156830516|NCT01994863|566132312|FG000|Period 1|Withdrawal by Subject|1|||
156830517|NCT01994863|566132313|FG001|Period 1|Withdrawal by Subject|0|||
156830518|NCT01994863|566132312|FG000|Period 1|Trial stopped by sponsor|1|||
156830519|NCT01994863|566132313|FG001|Period 1|Trial stopped by sponsor|3|||
156830520|NCT01994863|566132312|FG000|Period 1|Lack of Efficacy|1|||
156830521|NCT01994863|566132313|FG001|Period 1|Lack of Efficacy|0|||
156830522|NCT01994863|566132312|FG000|Period 2|Adverse Event|0|||
156830523|NCT01994863|566132313|FG001|Period 2|Adverse Event|1|||
156830524|NCT01994863|566132312|FG000|Period 2|Lack of Efficacy|0|||
156830525|NCT01994863|566132313|FG001|Period 2|Lack of Efficacy|2|||
156830526|NCT01994863|566132312|FG000|Period 2|Withdrawal by Subject|1|||
156830527|NCT01994863|566132313|FG001|Period 2|Withdrawal by Subject|1|||
156830528|NCT04612842|566132314|FG000|Overall Study|Lost to Follow-up|20|||
156830529|NCT04612842|566132315|FG001|Overall Study|Lost to Follow-up|11|||
156466330|NCT00943917|564803854|FG003|Stage II|Adverse Event|0|||
156830530|NCT04612842|566132314|FG000|Overall Study|Withdrawal by Subject|26|||
156830531|NCT04612842|566132315|FG001|Overall Study|Withdrawal by Subject|15|||
156830532|NCT04612842|566132314|FG000|Overall Study|Death|2|||
156830533|NCT04612842|566132315|FG001|Overall Study|Death|2|||
156830534|NCT02419131|566132316|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
156830535|NCT02419131|566132317|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
156830536|NCT02419131|566132318|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
156830537|NCT02419131|566132316|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
156830538|NCT02419131|566132317|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
156830539|NCT02419131|566132318|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
156830540|NCT03060512|566132319|FG000|Overall Study|Adverse Event|4|||
156830541|NCT03060512|566132320|FG001|Overall Study|Adverse Event|6|||
156830542|NCT03060512|566132319|FG000|Overall Study|Lost to Follow-up|1|||
156830543|NCT03060512|566132320|FG001|Overall Study|Lost to Follow-up|1|||
156830544|NCT03060512|566132319|FG000|Overall Study|Withdrawal by Subject|1|||
156830545|NCT03060512|566132320|FG001|Overall Study|Withdrawal by Subject|0|||
156830546|NCT03060512|566132319|FG000|Overall Study|Non-compliance with study medication|1|||
156830547|NCT03060512|566132320|FG001|Overall Study|Non-compliance with study medication|2|||
156830548|NCT01765426|566132321|FG000|Overall Study|Lost to Follow-up|0|||
156830549|NCT01765426|566132322|FG001|Overall Study|Lost to Follow-up|1|||
156830550|NCT01765426|566132323|FG002|Overall Study|Lost to Follow-up|0|||
156830551|NCT01765426|566132324|FG003|Overall Study|Lost to Follow-up|0|||
156830552|NCT03351114|566132325|FG000|Overall Study|Withdrawal by Subject|1|||
156830553|NCT01665430|566132329|FG000|Overall Study|Adverse Event|1|||
156830554|NCT01665430|566132329|FG000|Overall Study|Withdrawal by Subject|6|||
156830555|NCT01665430|566132329|FG000|Overall Study|Other Unspecified|2|||
156466331|NCT00943917|564803855|FG004|Stage II|Adverse Event|0|||
156466332|NCT00943917|564803856|FG005|Stage II|Adverse Event|1|||
156466333|NCT00943917|564803857|FG006|Stage II|Adverse Event|3|||
156830556|NCT02310230|566132330|FG000|Overall Study|Physician Decision|1|||
156466334|NCT00943917|564803858|FG007|Stage II|Adverse Event|0|||
156466335|NCT00943917|564803859|FG008|Stage II|Adverse Event|1|||
156466336|NCT00943917|564803860|FG009|Stage II|Adverse Event|0|||
156466337|NCT00943917|564803861|FG010|Stage II|Adverse Event|0|||
156830557|NCT02310230|566132331|FG001|Overall Study|Physician Decision|3|||
156830558|NCT02310230|566132330|FG000|Overall Study|monitor baseline taken after induction|2|||
156830559|NCT02310230|566132331|FG001|Overall Study|monitor baseline taken after induction|7|||
156830560|NCT02310230|566132330|FG000|Overall Study|Poor signal quality|5|||
156830561|NCT02310230|566132331|FG001|Overall Study|Poor signal quality|8|||
156830562|NCT02310230|566132330|FG000|Overall Study|Case cancelled|1|||
156830563|NCT02310230|566132331|FG001|Overall Study|Case cancelled|0|||
156830564|NCT00989235|566132332|FG000|Overall Study|Death|0|||
156830565|NCT00989235|566132333|FG001|Overall Study|Death|1|||
156830566|NCT00989235|566132332|FG000|Overall Study|Adverse Event|0|||
156830567|NCT00989235|566132333|FG001|Overall Study|Adverse Event|1|||
156830568|NCT00989235|566132332|FG000|Overall Study|Lack of Efficacy|1|||
156830569|NCT00989235|566132333|FG001|Overall Study|Lack of Efficacy|0|||
156830570|NCT00989235|566132332|FG000|Overall Study|Withdrawal of Consent|1|||
156830571|NCT00989235|566132333|FG001|Overall Study|Withdrawal of Consent|1|||
156830572|NCT00989235|566132332|FG000|Overall Study|Desire to Become Pregnant|1|||
156830573|NCT00989235|566132333|FG001|Overall Study|Desire to Become Pregnant|0|||
156830574|NCT00989235|566132332|FG000|Overall Study|Randomized by Mistake|0|||
156830575|NCT00989235|566132333|FG001|Overall Study|Randomized by Mistake|2|||
156830576|NCT00989235|566132332|FG000|Overall Study|Lost to Follow-up|0|||
156830577|NCT00989235|566132333|FG001|Overall Study|Lost to Follow-up|1|||
156830578|NCT03249935|566132334|FG000|Overall Study|Discharged from facility early|36|||
156830579|NCT03249935|566132334|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
156830580|NCT03249935|566132334|FG000|Overall Study|Protocol Violation|5|||
156830581|NCT04662073|566132335|FG000|Overall Study|Withdrawal by Subject|1|||
156830582|NCT04662073|566132336|FG001|Overall Study|Withdrawal by Subject|0|||
156830583|NCT01135914|566132337|FG000|Overall Study|Withdrawal by Subject|1|||
156830584|NCT01135914|566132338|FG001|Overall Study|Withdrawal by Subject|3|||
156830585|NCT01135914|566132339|FG002|Overall Study|Withdrawal by Subject|6|||
156830586|NCT01135914|566132337|FG000|Overall Study|Lost to Follow-up|1|||
156830587|NCT01135914|566132338|FG001|Overall Study|Lost to Follow-up|0|||
156830588|NCT01135914|566132339|FG002|Overall Study|Lost to Follow-up|1|||
156830589|NCT01135914|566132337|FG000|Overall Study|Protocol Violation|0|||
156830590|NCT01135914|566132338|FG001|Overall Study|Protocol Violation|0|||
156830591|NCT01135914|566132339|FG002|Overall Study|Protocol Violation|3|||
156830592|NCT01135914|566132337|FG000|Overall Study|Lack of Efficacy|2|||
156830593|NCT01135914|566132338|FG001|Overall Study|Lack of Efficacy|1|||
156830594|NCT01135914|566132339|FG002|Overall Study|Lack of Efficacy|10|||
156830595|NCT01135914|566132337|FG000|Overall Study|Adverse Event|0|||
156830596|NCT01135914|566132338|FG001|Overall Study|Adverse Event|1|||
156830597|NCT01135914|566132339|FG002|Overall Study|Adverse Event|2|||
156830598|NCT00598078|566132340|FG000|Period 2 (Day 2)|Adverse Event|1|||
156830599|NCT00598078|566132341|FG001|Period 2 (Day 2)|Adverse Event|0|||
156830600|NCT00900146|566132342|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
156830601|NCT00900146|566132343|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
156830602|NCT00900146|566132344|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
156830603|NCT00900146|566132345|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
156830604|NCT00900146|566132346|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
156830605|NCT00900146|566132342|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
156830606|NCT00900146|566132343|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
156830607|NCT00900146|566132344|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
156830608|NCT00900146|566132345|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
156830609|NCT00900146|566132346|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
156830610|NCT00900146|566132342|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
156830611|NCT00900146|566132343|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
156830612|NCT00900146|566132344|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
156830613|NCT00900146|566132345|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
156830614|NCT00900146|566132346|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
156830615|NCT00900146|566132342|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
156830616|NCT00900146|566132343|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
156830617|NCT00900146|566132344|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
156830618|NCT00900146|566132345|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
156466338|NCT00943917|564803862|FG011|Stage II|Adverse Event|0|||
156830619|NCT00900146|566132346|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
156830620|NCT00900146|566132342|FG000|Intermediate: Period III|Lost to Follow-up|2|||
156830621|NCT00900146|566132343|FG001|Intermediate: Period III|Lost to Follow-up|0|||
156830622|NCT00900146|566132344|FG002|Intermediate: Period III|Lost to Follow-up|0|||
156830623|NCT00900146|566132345|FG003|Intermediate: Period III|Lost to Follow-up|0|||
156830624|NCT00900146|566132346|FG004|Intermediate: Period III|Lost to Follow-up|1|||
156830625|NCT00900146|566132342|FG000|Intermediate: Period III|Administrative problems|85|||
156830626|NCT00900146|566132343|FG001|Intermediate: Period III|Administrative problems|92|||
156830627|NCT00900146|566132344|FG002|Intermediate: Period III|Administrative problems|84|||
156830628|NCT00900146|566132345|FG003|Intermediate: Period III|Administrative problems|90|||
156830629|NCT00900146|566132346|FG004|Intermediate: Period III|Administrative problems|163|||
156830630|NCT01635764|566132347|FG000|Overall Study|Adverse Event|46|||
156466339|NCT00943917|564803863|FG012|Stage II|Adverse Event|0|||
156466340|NCT00943917|564803864|FG013|Stage II|Adverse Event|0|||
156339710|NCT02585960|564342174|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
156339711|NCT02585960|564342172|FG000|PK/Safety Assessment Period|Other|4|||
156339712|NCT02585960|564342173|FG001|PK/Safety Assessment Period|Other|4|||
156339713|NCT02585960|564342174|FG002|PK/Safety Assessment Period|Other|0|||
156339714|NCT02585960|564342172|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
156339715|NCT02585960|564342173|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
156339716|NCT02585960|564342174|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
156339717|NCT02585960|564342172|FG000|PK/Safety Assessment Period|Screen Failure|0|||
156339718|NCT02585960|564342173|FG001|PK/Safety Assessment Period|Screen Failure|0|||
156830631|NCT01635764|566132347|FG000|Overall Study|Lack of Efficacy|76|||
156830632|NCT01635764|566132347|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
156830633|NCT01635764|566132347|FG000|Overall Study|Protocol Deviation|1|||
156830634|NCT01635764|566132347|FG000|Overall Study|Withdrew Consent|67|||
156830635|NCT01635764|566132347|FG000|Overall Study|Lost to Follow-up|53|||
156830636|NCT01635764|566132347|FG000|Overall Study|Other|28|||
156830637|NCT05590000|566132348|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
156830638|NCT00693472|566132349|FG000|Part 1|Adverse Event|1|||
156830639|NCT00693472|566132350|FG001|Part 1|Adverse Event|1|||
156830640|NCT00693472|566132351|FG002|Part 1|Adverse Event|0|||
156830641|NCT00693472|566132352|FG003|Part 1|Adverse Event|0|||
156830642|NCT00693472|566132349|FG000|Part 1|Lost to Follow-up|0|||
156830643|NCT00693472|566132350|FG001|Part 1|Lost to Follow-up|1|||
156830644|NCT00693472|566132351|FG002|Part 1|Lost to Follow-up|0|||
156830645|NCT00693472|566132352|FG003|Part 1|Lost to Follow-up|0|||
156830646|NCT00693472|566132349|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
156830647|NCT00693472|566132350|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
156830648|NCT00693472|566132351|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
156830649|NCT00693472|566132352|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
156830650|NCT00693472|566132349|FG000|Part 2|Adverse Event|0|||
156830651|NCT00693472|566132350|FG001|Part 2|Adverse Event|0|||
156830652|NCT00693472|566132351|FG002|Part 2|Adverse Event|1|||
156830653|NCT00693472|566132352|FG003|Part 2|Adverse Event|0|||
156830654|NCT00693472|566132349|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
156830655|NCT00693472|566132350|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
156830656|NCT00693472|566132351|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
156830657|NCT00693472|566132352|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
156830658|NCT02075632|566132356|FG000|Overall Study|Adverse Event|1|||
156830659|NCT02075632|566132357|FG001|Overall Study|Adverse Event|1|||
156830660|NCT02075632|566132356|FG000|Overall Study|Lost to Follow-up|0|||
156830661|NCT02075632|566132357|FG001|Overall Study|Lost to Follow-up|3|||
156830662|NCT02075632|566132356|FG000|Overall Study|Withdrawal by Subject|0|||
156830663|NCT02075632|566132357|FG001|Overall Study|Withdrawal by Subject|1|||
156830664|NCT00740714|566132360|FG000|Overall Study|Withdrawal by Subject|17|||
156830665|NCT00740714|566132361|FG001|Overall Study|Withdrawal by Subject|19|||
156830666|NCT00740714|566132362|FG002|Overall Study|Withdrawal by Subject|29|||
156830667|NCT04070326|566132365|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
156830668|NCT04070326|566132366|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
156830669|NCT01367704|566132370|FG000|Overall Study|Lost to Follow-up|47|||
156830670|NCT01367704|566132371|FG001|Overall Study|Lost to Follow-up|161|||
156830671|NCT02193087|566132373|FG000|Overall Study|Adverse Event|2|||
156830672|NCT02193087|566132374|FG001|Overall Study|Adverse Event|0|||
156339719|NCT02585960|564342174|FG002|PK/Safety Assessment Period|Screen Failure|1|||
156339720|NCT02585960|564342172|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
156339721|NCT02585960|564342173|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
156339722|NCT02585960|564342174|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
156830673|NCT02193087|566132375|FG002|Overall Study|Adverse Event|0|||
156830674|NCT02193087|566132376|FG003|Overall Study|Adverse Event|11|||
156830675|NCT02193087|566132373|FG000|Overall Study|Lost to Follow-up|14|||
156830676|NCT02193087|566132374|FG001|Overall Study|Lost to Follow-up|6|||
156830677|NCT02193087|566132375|FG002|Overall Study|Lost to Follow-up|4|||
156830678|NCT02193087|566132376|FG003|Overall Study|Lost to Follow-up|37|||
156830679|NCT02193087|566132373|FG000|Overall Study|Protocol Violation|2|||
156830680|NCT02193087|566132374|FG001|Overall Study|Protocol Violation|0|||
156830681|NCT02193087|566132375|FG002|Overall Study|Protocol Violation|1|||
156830682|NCT02193087|566132376|FG003|Overall Study|Protocol Violation|2|||
156830683|NCT02193087|566132373|FG000|Overall Study|Withdrawal by Subject|10|||
156830684|NCT02193087|566132374|FG001|Overall Study|Withdrawal by Subject|3|||
156830685|NCT02193087|566132375|FG002|Overall Study|Withdrawal by Subject|1|||
156830686|NCT02193087|566132376|FG003|Overall Study|Withdrawal by Subject|19|||
156830687|NCT02193087|566132373|FG000|Overall Study|Other Reason Not Specified|7|||
156830688|NCT02193087|566132374|FG001|Overall Study|Other Reason Not Specified|2|||
156339723|NCT02585960|564342172|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
156830689|NCT02193087|566132375|FG002|Overall Study|Other Reason Not Specified|1|||
156339724|NCT02585960|564342173|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
156830690|NCT02193087|566132376|FG003|Overall Study|Other Reason Not Specified|9|||
156830691|NCT02193087|566132373|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
156830692|NCT02193087|566132374|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
156830693|NCT02193087|566132375|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
156830694|NCT02193087|566132376|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
156830695|NCT04096820|566132377|FG000|Overall Study|Did not return for intervention|2|||
156830696|NCT04096820|566132377|FG000|Overall Study|Death|1|||
156830697|NCT02726880|566132378|FG000|Overall Study|Withdrawal by Subject|2|||
156830698|NCT02726880|566132379|FG001|Overall Study|Withdrawal by Subject|0|||
156830699|NCT02726880|566132378|FG000|Overall Study|Lost to Follow-up|1|||
156830700|NCT02726880|566132379|FG001|Overall Study|Lost to Follow-up|3|||
156830701|NCT01510145|566132380|FG000|Overall Study|Adverse Event|6|||
156830702|NCT01510145|566132380|FG000|Overall Study|Lost to Follow-up|5|||
156830703|NCT01510145|566132380|FG000|Overall Study|Withdrawal by Subject|6|||
156830704|NCT01510145|566132380|FG000|Overall Study|Relative reported subject withdrew|1|||
156830705|NCT00787202|566132381|FG000|Overall Study|Adverse Event|3|||
156830706|NCT00787202|566132382|FG001|Overall Study|Adverse Event|2|||
156830707|NCT00787202|566132383|FG002|Overall Study|Adverse Event|0|||
156830708|NCT00787202|566132384|FG003|Overall Study|Adverse Event|0|||
156830709|NCT00787202|566132385|FG004|Overall Study|Adverse Event|2|||
156830710|NCT00787202|566132381|FG000|Overall Study|Lack of Efficacy|5|||
156830711|NCT00787202|566132382|FG001|Overall Study|Lack of Efficacy|6|||
156830712|NCT00787202|566132383|FG002|Overall Study|Lack of Efficacy|5|||
156830713|NCT00787202|566132384|FG003|Overall Study|Lack of Efficacy|2|||
156830714|NCT00787202|566132385|FG004|Overall Study|Lack of Efficacy|1|||
156830715|NCT00787202|566132381|FG000|Overall Study|Lost to Follow-up|1|||
156830716|NCT00787202|566132382|FG001|Overall Study|Lost to Follow-up|0|||
156830717|NCT00787202|566132383|FG002|Overall Study|Lost to Follow-up|0|||
156830718|NCT00787202|566132384|FG003|Overall Study|Lost to Follow-up|0|||
156830719|NCT00787202|566132385|FG004|Overall Study|Lost to Follow-up|0|||
156830720|NCT00787202|566132381|FG000|Overall Study|Withdrawal by Subject|2|||
156830721|NCT00787202|566132382|FG001|Overall Study|Withdrawal by Subject|2|||
156830722|NCT00787202|566132383|FG002|Overall Study|Withdrawal by Subject|2|||
156830723|NCT00787202|566132384|FG003|Overall Study|Withdrawal by Subject|0|||
156830724|NCT00787202|566132385|FG004|Overall Study|Withdrawal by Subject|0|||
156830725|NCT00787202|566132381|FG000|Overall Study|Protocol Violation|2|||
156830726|NCT00787202|566132382|FG001|Overall Study|Protocol Violation|1|||
156830727|NCT00787202|566132383|FG002|Overall Study|Protocol Violation|0|||
156830728|NCT00787202|566132384|FG003|Overall Study|Protocol Violation|0|||
156830729|NCT00787202|566132385|FG004|Overall Study|Protocol Violation|1|||
156830730|NCT00787202|566132381|FG000|Overall Study|Randomized, not treated|1|||
156830731|NCT00787202|566132382|FG001|Overall Study|Randomized, not treated|0|||
156830732|NCT00787202|566132383|FG002|Overall Study|Randomized, not treated|0|||
156830733|NCT00787202|566132384|FG003|Overall Study|Randomized, not treated|0|||
156830734|NCT00787202|566132385|FG004|Overall Study|Randomized, not treated|0|||
156830735|NCT02153346|566132386|FG000|Overall Study|Lost to Follow-up|11|||
156830736|NCT00969761|566132387|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
156830737|NCT00969761|566132388|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830738|NCT00969761|566132389|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830739|NCT00969761|566132390|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
156830740|NCT00969761|566132391|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830741|NCT00969761|566132392|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830742|NCT00969761|566132393|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830743|NCT00969761|566132394|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830744|NCT00969761|566132395|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
156339725|NCT02585960|564342174|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
156339726|NCT01651039|564342176|FG000|Overall Study|Non-evaluables|5|||
156339727|NCT01651039|564342176|FG000|Overall Study|Physician Decision|2|||
156339728|NCT01651039|564342176|FG000|Overall Study|Withdrawal by Subject|1|||
156830745|NCT00969761|566132396|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
156830746|NCT00969761|566132397|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830747|NCT00969761|566132398|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830748|NCT00969761|566132387|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830749|NCT00969761|566132388|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830750|NCT00969761|566132389|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
156830751|NCT00969761|566132390|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830752|NCT00969761|566132391|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830753|NCT00969761|566132392|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830754|NCT00969761|566132393|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830755|NCT00969761|566132394|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830756|NCT00969761|566132395|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830757|NCT00969761|566132396|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156339729|NCT01651039|564342176|FG000|Overall Study|Progressive Disease|22|||
156830758|NCT00969761|566132397|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830759|NCT00969761|566132398|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830760|NCT00969761|566132387|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830761|NCT00969761|566132388|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830762|NCT00969761|566132389|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
156830763|NCT00969761|566132390|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830764|NCT00969761|566132391|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830765|NCT00969761|566132392|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830766|NCT00969761|566132393|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830767|NCT00969761|566132394|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830768|NCT00969761|566132395|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156339730|NCT00444912|564342179|FG000|Overall Study|Death|1|||
156339731|NCT00444912|564342180|FG001|Overall Study|Death|2|||
156339732|NCT00444912|564342179|FG000|Overall Study|Lost to Follow-up|1|||
156339733|NCT00444912|564342180|FG001|Overall Study|Lost to Follow-up|0|||
156339734|NCT00444912|564342179|FG000|Overall Study|Participant Failed Mobilization|1|||
156339735|NCT00444912|564342180|FG001|Overall Study|Participant Failed Mobilization|0|||
156339736|NCT01606007|564342181|FG000|Overall Study|Reason 'Other' in the protocol|0|||
156830769|NCT00969761|566132396|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830770|NCT00969761|566132397|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830771|NCT00969761|566132398|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830772|NCT00969761|566132387|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830773|NCT00969761|566132388|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830774|NCT00969761|566132389|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830775|NCT00969761|566132390|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830776|NCT00969761|566132391|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830777|NCT00969761|566132392|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830778|NCT00969761|566132393|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156339737|NCT01606007|564342182|FG001|Overall Study|Reason 'Other' in the protocol|1|||
156339738|NCT01606007|564342183|FG002|Overall Study|Reason 'Other' in the protocol|1|||
156339739|NCT01606007|564342181|FG000|Overall Study|Pregnancy|0|||
156339740|NCT01606007|564342182|FG001|Overall Study|Pregnancy|1|||
156339741|NCT01606007|564342183|FG002|Overall Study|Pregnancy|1|||
156339742|NCT01606007|564342181|FG000|Overall Study|Withdrawal by Subject|8|||
156339743|NCT01606007|564342182|FG001|Overall Study|Withdrawal by Subject|6|||
156339744|NCT01606007|564342183|FG002|Overall Study|Withdrawal by Subject|1|||
156339745|NCT01606007|564342181|FG000|Overall Study|Adverse Event|0|||
156339746|NCT01606007|564342182|FG001|Overall Study|Adverse Event|1|||
156339747|NCT01606007|564342183|FG002|Overall Study|Adverse Event|1|||
156339748|NCT01606007|564342181|FG000|Overall Study|discontinue study treatment|0|||
156339749|NCT01606007|564342182|FG001|Overall Study|discontinue study treatment|2|||
156339750|NCT01606007|564342183|FG002|Overall Study|discontinue study treatment|1|||
156339751|NCT01606007|564342181|FG000|Overall Study|Lost to Follow-up|6|||
156339752|NCT01606007|564342182|FG001|Overall Study|Lost to Follow-up|8|||
156339753|NCT01606007|564342183|FG002|Overall Study|Lost to Follow-up|5|||
156339754|NCT01606007|564342181|FG000|Overall Study|Poor/Non-compliance|1|||
156339755|NCT01606007|564342182|FG001|Overall Study|Poor/Non-compliance|0|||
156339756|NCT01606007|564342183|FG002|Overall Study|Poor/Non-compliance|0|||
156339757|NCT03758066|564342184|FG000|Overall Study|Lost to Follow-up|14|||
156339758|NCT00851747|564342187|FG000|Overall Study|Physician Decision|6|||
156339759|NCT00851747|564342188|FG001|Overall Study|Physician Decision|6|||
156339760|NCT00851747|564342189|FG002|Overall Study|Physician Decision|6|||
156339761|NCT03570697|564342196|FG000|Overall Study|Lost to Follow-up|0|||
156339762|NCT03570697|564342197|FG001|Overall Study|Lost to Follow-up|1|||
156339763|NCT03570697|564342196|FG000|Overall Study|Death|2|||
156339764|NCT03570697|564342197|FG001|Overall Study|Death|0|||
156339765|NCT03570697|564342196|FG000|Overall Study|Withdrawal by Subject|4|||
156339766|NCT03570697|564342197|FG001|Overall Study|Withdrawal by Subject|2|||
156541271|NCT00243386|565074532|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
156541272|NCT00243386|565074533|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
156830779|NCT00969761|566132394|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830780|NCT00969761|566132395|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
156830781|NCT00969761|566132396|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156339767|NCT03988088|564342198|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
156339768|NCT03988088|564342199|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
156541273|NCT00243386|565074531|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
156339769|NCT03988088|564342200|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
156339770|NCT03988088|564342201|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
156339771|NCT03988088|564342198|FG000|Open-Label Addendum|Lost to Follow-up|0|||
156339772|NCT03988088|564342199|FG001|Open-Label Addendum|Lost to Follow-up|0|||
156830782|NCT00969761|566132397|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830783|NCT00969761|566132398|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830784|NCT00969761|566132387|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
156830785|NCT00969761|566132388|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830786|NCT00969761|566132389|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
156830787|NCT00969761|566132390|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830788|NCT00969761|566132391|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
156830789|NCT00969761|566132392|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830790|NCT00969761|566132393|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830791|NCT00969761|566132394|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
156830792|NCT00969761|566132395|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
156830793|NCT00969761|566132396|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
156830794|NCT00969761|566132397|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830795|NCT00969761|566132398|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830796|NCT00969761|566132387|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830797|NCT00969761|566132388|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830798|NCT00969761|566132389|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830799|NCT00969761|566132390|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
156830800|NCT00969761|566132391|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
156830801|NCT00969761|566132392|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830802|NCT00969761|566132393|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830803|NCT00969761|566132394|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830804|NCT00969761|566132395|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
156830805|NCT00969761|566132396|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830806|NCT00969761|566132397|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830807|NCT00969761|566132398|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830808|NCT00664326|566133844|FG000|Overall Study|Adverse Event|14|||
156830809|NCT00664326|566133844|FG000|Overall Study|Noncompliance with study medication|3|||
156830810|NCT00664326|566133844|FG000|Overall Study|Withdrawal by Subject|1|||
156830811|NCT00664326|566133844|FG000|Overall Study|Physician Decision|1|||
156830812|NCT00664326|566133844|FG000|Overall Study|Other Reasons|3|||
156830813|NCT00664326|566133844|FG000|Overall Study|Death|2|||
156830814|NCT00664326|566133844|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
156830815|NCT00262847|566133845|FG000|Overall Study|Disease Progression|309|||
156830816|NCT00262847|566133846|FG001|Overall Study|Disease Progression|274|||
156830817|NCT00262847|566133847|FG002|Overall Study|Disease Progression|195|||
156830818|NCT00262847|566133845|FG000|Overall Study|Patient Refusal|41|||
156830819|NCT00262847|566133846|FG001|Overall Study|Patient Refusal|52|||
156830820|NCT00262847|566133847|FG002|Overall Study|Patient Refusal|47|||
156830821|NCT00262847|566133845|FG000|Overall Study|Adverse Event|74|||
156830822|NCT00262847|566133846|FG001|Overall Study|Adverse Event|88|||
156830823|NCT00262847|566133847|FG002|Overall Study|Adverse Event|108|||
156830824|NCT00262847|566133845|FG000|Overall Study|Death|8|||
156830825|NCT00262847|566133846|FG001|Overall Study|Death|8|||
156830826|NCT00262847|566133847|FG002|Overall Study|Death|11|||
156830827|NCT00262847|566133845|FG000|Overall Study|Concomitant disease|3|||
156830828|NCT00262847|566133846|FG001|Overall Study|Concomitant disease|2|||
156830829|NCT00262847|566133847|FG002|Overall Study|Concomitant disease|4|||
156830830|NCT00262847|566133845|FG000|Overall Study|Other Reasons|79|||
156830831|NCT00262847|566133846|FG001|Overall Study|Other Reasons|88|||
156830832|NCT00262847|566133847|FG002|Overall Study|Other Reasons|27|||
156830833|NCT00262847|566133845|FG000|Overall Study|Did not receive study treatment|4|||
156830834|NCT00262847|566133846|FG001|Overall Study|Did not receive study treatment|1|||
156830835|NCT00262847|566133847|FG002|Overall Study|Did not receive study treatment|4|||
156830836|NCT00387647|566133848|FG000|Overall Study|Death|18|||
156830837|NCT02943915|566133849|FG000|Overall Study|Withdrawal by Subject|2|||
156830838|NCT02943915|566133850|FG001|Overall Study|Withdrawal by Subject|1|||
156830839|NCT02943915|566133851|FG002|Overall Study|Withdrawal by Subject|0|||
156830840|NCT02943915|566133852|FG003|Overall Study|Withdrawal by Subject|0|||
156830841|NCT02943915|566133849|FG000|Overall Study|Lost to Follow-up|3|||
156830842|NCT02943915|566133850|FG001|Overall Study|Lost to Follow-up|1|||
156830843|NCT02943915|566133851|FG002|Overall Study|Lost to Follow-up|0|||
156830844|NCT02943915|566133852|FG003|Overall Study|Lost to Follow-up|0|||
156830845|NCT02943915|566133849|FG000|Overall Study|excluded|0|||
156830846|NCT02943915|566133850|FG001|Overall Study|excluded|1|||
156830847|NCT02943915|566133851|FG002|Overall Study|excluded|0|||
156830848|NCT02943915|566133852|FG003|Overall Study|excluded|0|||
156830849|NCT03769311|566133853|FG000|Overall Study|Withdrawal by Subject|1|||
156830850|NCT03627065|566133854|FG000|Overall Study|Study Terminated by sponsor|1|||
156830851|NCT03627065|566133854|FG000|Overall Study|Withdrawal by Subject|2|||
156830852|NCT01266317|566133855|FG000|Overall Study|Withdrawal by Subject|2|||
156830853|NCT00098722|566133858|FG000|Double Blind Phase|Adverse Event|7|||
156830854|NCT00098722|566133859|FG001|Double Blind Phase|Adverse Event|7|||
156830855|NCT00098722|566133860|FG002|Double Blind Phase|Adverse Event|3|||
156339773|NCT03988088|564342200|FG002|Open-Label Addendum|Lost to Follow-up|1|||
156339774|NCT03988088|564342201|FG003|Open-Label Addendum|Lost to Follow-up|0|||
156339775|NCT02935842|564342202|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
156339776|NCT02935842|564342203|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
156339777|NCT02935842|564342204|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
156339778|NCT02935842|564342205|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
156339779|NCT02935842|564342202|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
156339780|NCT02935842|564342203|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
156339781|NCT02935842|564342204|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
156339782|NCT02935842|564342205|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
156339783|NCT02935842|564342202|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
156339784|NCT02935842|564342203|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
156339785|NCT02935842|564342204|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
156339786|NCT02935842|564342205|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
156339787|NCT02935842|564342202|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
156339788|NCT02935842|564342203|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
156339789|NCT02935842|564342204|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
156339790|NCT02935842|564342205|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
156339791|NCT02935842|564342202|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
156339792|NCT02935842|564342203|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
156339793|NCT02935842|564342204|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
156339794|NCT02935842|564342205|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
156339795|NCT03344796|564342206|FG000|Overall Study|Lost to Follow-up|0|||
156339796|NCT03344796|564342207|FG001|Overall Study|Lost to Follow-up|0|||
156339797|NCT03344796|564342208|FG002|Overall Study|Lost to Follow-up|0|||
156339798|NCT03344796|564342209|FG003|Overall Study|Lost to Follow-up|0|||
156339799|NCT03344796|564342210|FG004|Overall Study|Lost to Follow-up|0|||
156339800|NCT03344796|564342211|FG005|Overall Study|Lost to Follow-up|2|||
156339801|NCT00923156|564342223|FG000|Overall Study|Adverse Event|0|||
156339802|NCT00923156|564342224|FG001|Overall Study|Adverse Event|2|||
156339803|NCT00923156|564342225|FG002|Overall Study|Adverse Event|1|||
156339804|NCT00923156|564342223|FG000|Overall Study|Abnormal laboratory values|0|||
156339805|NCT00923156|564342224|FG001|Overall Study|Abnormal laboratory values|0|||
156339806|NCT00923156|564342225|FG002|Overall Study|Abnormal laboratory values|1|||
156339807|NCT00923156|564342223|FG000|Overall Study|Withdrawal by Subject|0|||
156466341|NCT00943917|564803865|FG014|Stage II|Adverse Event|0|||
156466342|NCT00943917|564803851|FG000|Stage II|Withdrawal by Subject|0|||
156466343|NCT00943917|564803852|FG001|Stage II|Withdrawal by Subject|0|||
156466344|NCT00943917|564803853|FG002|Stage II|Withdrawal by Subject|0|||
156466345|NCT00943917|564803854|FG003|Stage II|Withdrawal by Subject|0|||
156466346|NCT00943917|564803855|FG004|Stage II|Withdrawal by Subject|0|||
156466347|NCT00943917|564803856|FG005|Stage II|Withdrawal by Subject|1|||
156466348|NCT00943917|564803857|FG006|Stage II|Withdrawal by Subject|0|||
156830856|NCT00098722|566133861|FG003|Double Blind Phase|Adverse Event|0|||
156830857|NCT00098722|566133862|FG004|Double Blind Phase|Adverse Event|0|||
156830858|NCT00098722|566133863|FG005|Double Blind Phase|Adverse Event|0|||
156830859|NCT00098722|566133864|FG006|Double Blind Phase|Adverse Event|0|||
156830860|NCT00098722|566133858|FG000|Double Blind Phase|Death|2|||
156830861|NCT00098722|566133859|FG001|Double Blind Phase|Death|5|||
156830862|NCT00098722|566133860|FG002|Double Blind Phase|Death|0|||
156830863|NCT00098722|566133861|FG003|Double Blind Phase|Death|0|||
156830864|NCT00098722|566133862|FG004|Double Blind Phase|Death|0|||
156830865|NCT00098722|566133863|FG005|Double Blind Phase|Death|0|||
156830866|NCT00098722|566133864|FG006|Double Blind Phase|Death|0|||
156830867|NCT00098722|566133858|FG000|Double Blind Phase|Lack of Efficacy|21|||
156830868|NCT00098722|566133859|FG001|Double Blind Phase|Lack of Efficacy|23|||
156830869|NCT00098722|566133860|FG002|Double Blind Phase|Lack of Efficacy|15|||
156830870|NCT00098722|566133861|FG003|Double Blind Phase|Lack of Efficacy|0|||
156830871|NCT00098722|566133862|FG004|Double Blind Phase|Lack of Efficacy|0|||
156830872|NCT00098722|566133863|FG005|Double Blind Phase|Lack of Efficacy|0|||
156466349|NCT00943917|564803858|FG007|Stage II|Withdrawal by Subject|0|||
156466350|NCT00943917|564803859|FG008|Stage II|Withdrawal by Subject|0|||
156466351|NCT00943917|564803860|FG009|Stage II|Withdrawal by Subject|0|||
156830873|NCT00098722|566133864|FG006|Double Blind Phase|Lack of Efficacy|0|||
156830874|NCT00098722|566133858|FG000|Double Blind Phase|Participant defaulted|16|||
156830875|NCT00098722|566133859|FG001|Double Blind Phase|Participant defaulted|11|||
156339808|NCT00923156|564342224|FG001|Overall Study|Withdrawal by Subject|1|||
156339809|NCT00923156|564342225|FG002|Overall Study|Withdrawal by Subject|0|||
156466352|NCT00943917|564803861|FG010|Stage II|Withdrawal by Subject|0|||
156466353|NCT00943917|564803862|FG011|Stage II|Withdrawal by Subject|0|||
156466354|NCT00943917|564803863|FG012|Stage II|Withdrawal by Subject|0|||
156466355|NCT00943917|564803864|FG013|Stage II|Withdrawal by Subject|0|||
156830876|NCT00098722|566133860|FG002|Double Blind Phase|Participant defaulted|9|||
156830877|NCT00098722|566133861|FG003|Double Blind Phase|Participant defaulted|0|||
156830878|NCT00098722|566133862|FG004|Double Blind Phase|Participant defaulted|0|||
156541274|NCT00243386|565074532|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
156830879|NCT00098722|566133863|FG005|Double Blind Phase|Participant defaulted|0|||
156830880|NCT00098722|566133864|FG006|Double Blind Phase|Participant defaulted|0|||
156830881|NCT00098722|566133858|FG000|Double Blind Phase|Pregnancy|1|||
156830882|NCT00098722|566133859|FG001|Double Blind Phase|Pregnancy|0|||
156830883|NCT00098722|566133860|FG002|Double Blind Phase|Pregnancy|0|||
156830884|NCT00098722|566133861|FG003|Double Blind Phase|Pregnancy|0|||
156830885|NCT00098722|566133862|FG004|Double Blind Phase|Pregnancy|0|||
156830886|NCT00098722|566133863|FG005|Double Blind Phase|Pregnancy|0|||
156830887|NCT00098722|566133864|FG006|Double Blind Phase|Pregnancy|0|||
156830888|NCT00098722|566133858|FG000|Double Blind Phase|Randomized, not treated|4|||
156830889|NCT00098722|566133859|FG001|Double Blind Phase|Randomized, not treated|3|||
156830890|NCT00098722|566133860|FG002|Double Blind Phase|Randomized, not treated|3|||
156830891|NCT00098722|566133861|FG003|Double Blind Phase|Randomized, not treated|0|||
156830892|NCT00098722|566133862|FG004|Double Blind Phase|Randomized, not treated|0|||
156830893|NCT00098722|566133863|FG005|Double Blind Phase|Randomized, not treated|0|||
156830894|NCT00098722|566133864|FG006|Double Blind Phase|Randomized, not treated|0|||
156830895|NCT00098722|566133858|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
156830896|NCT00098722|566133859|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
156830897|NCT00098722|566133860|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
156830898|NCT00098722|566133861|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
156830899|NCT00098722|566133862|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
156830900|NCT00098722|566133863|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
156830901|NCT00098722|566133864|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
156830902|NCT00098722|566133858|FG000|Double Blind Phase|Other|7|||
156830903|NCT00098722|566133859|FG001|Double Blind Phase|Other|8|||
156830904|NCT00098722|566133860|FG002|Double Blind Phase|Other|7|||
156830905|NCT00098722|566133861|FG003|Double Blind Phase|Other|0|||
156830906|NCT00098722|566133862|FG004|Double Blind Phase|Other|0|||
156830907|NCT00098722|566133863|FG005|Double Blind Phase|Other|0|||
156830908|NCT00098722|566133864|FG006|Double Blind Phase|Other|0|||
156830909|NCT00098722|566133858|FG000|Open Label Phase|Adverse Event|0|||
156830910|NCT00098722|566133859|FG001|Open Label Phase|Adverse Event|0|||
156830911|NCT00098722|566133860|FG002|Open Label Phase|Adverse Event|0|||
156830912|NCT00098722|566133861|FG003|Open Label Phase|Adverse Event|5|||
156830913|NCT00098722|566133862|FG004|Open Label Phase|Adverse Event|0|||
156830914|NCT00098722|566133863|FG005|Open Label Phase|Adverse Event|0|||
156830915|NCT00098722|566133864|FG006|Open Label Phase|Adverse Event|0|||
156830916|NCT00098722|566133858|FG000|Open Label Phase|Death|0|||
156830917|NCT00098722|566133859|FG001|Open Label Phase|Death|0|||
156830918|NCT00098722|566133860|FG002|Open Label Phase|Death|0|||
156830919|NCT00098722|566133861|FG003|Open Label Phase|Death|2|||
156830920|NCT00098722|566133862|FG004|Open Label Phase|Death|0|||
156830921|NCT00098722|566133863|FG005|Open Label Phase|Death|0|||
156830922|NCT00098722|566133864|FG006|Open Label Phase|Death|0|||
156830923|NCT00098722|566133858|FG000|Open Label Phase|Lack of Efficacy|0|||
156830924|NCT00098722|566133859|FG001|Open Label Phase|Lack of Efficacy|0|||
156830925|NCT00098722|566133860|FG002|Open Label Phase|Lack of Efficacy|0|||
156830926|NCT00098722|566133861|FG003|Open Label Phase|Lack of Efficacy|8|||
156830927|NCT00098722|566133862|FG004|Open Label Phase|Lack of Efficacy|0|||
156830928|NCT00098722|566133863|FG005|Open Label Phase|Lack of Efficacy|0|||
156830929|NCT00098722|566133864|FG006|Open Label Phase|Lack of Efficacy|0|||
156541275|NCT00243386|565074533|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
156830930|NCT00098722|566133858|FG000|Open Label Phase|Pregnancy|0|||
156541276|NCT00243386|565074531|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
156541277|NCT00243386|565074532|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
156541278|NCT00243386|565074533|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
156830931|NCT00098722|566133859|FG001|Open Label Phase|Pregnancy|0|||
156830932|NCT00098722|566133860|FG002|Open Label Phase|Pregnancy|0|||
156830933|NCT00098722|566133861|FG003|Open Label Phase|Pregnancy|1|||
156830934|NCT00098722|566133862|FG004|Open Label Phase|Pregnancy|0|||
156830935|NCT00098722|566133863|FG005|Open Label Phase|Pregnancy|0|||
156830936|NCT00098722|566133864|FG006|Open Label Phase|Pregnancy|0|||
156830937|NCT00098722|566133858|FG000|Open Label Phase|Participant defaulted|0|||
156830938|NCT00098722|566133859|FG001|Open Label Phase|Participant defaulted|0|||
156830939|NCT00098722|566133860|FG002|Open Label Phase|Participant defaulted|0|||
156830940|NCT00098722|566133861|FG003|Open Label Phase|Participant defaulted|18|||
156830941|NCT00098722|566133862|FG004|Open Label Phase|Participant defaulted|0|||
156830942|NCT00098722|566133863|FG005|Open Label Phase|Participant defaulted|0|||
156830943|NCT00098722|566133864|FG006|Open Label Phase|Participant defaulted|0|||
156830944|NCT00098722|566133858|FG000|Open Label Phase|Ongoing at cut-off date|0|||
156830945|NCT00098722|566133859|FG001|Open Label Phase|Ongoing at cut-off date|0|||
156830946|NCT00098722|566133860|FG002|Open Label Phase|Ongoing at cut-off date|0|||
156830947|NCT00098722|566133861|FG003|Open Label Phase|Ongoing at cut-off date|220|||
156830948|NCT00098722|566133862|FG004|Open Label Phase|Ongoing at cut-off date|50|||
156830949|NCT00098722|566133863|FG005|Open Label Phase|Ongoing at cut-off date|0|||
156830950|NCT00098722|566133864|FG006|Open Label Phase|Ongoing at cut-off date|0|||
156830951|NCT00098722|566133858|FG000|Open Label Phase|Other|0|||
156830952|NCT00098722|566133859|FG001|Open Label Phase|Other|0|||
156830953|NCT00098722|566133860|FG002|Open Label Phase|Other|0|||
156830954|NCT00098722|566133861|FG003|Open Label Phase|Other|18|||
156339810|NCT00923156|564342223|FG000|Overall Study|Death|0|||
156339811|NCT00923156|564342224|FG001|Overall Study|Death|1|||
156339812|NCT00923156|564342225|FG002|Overall Study|Death|0|||
156830955|NCT00098722|566133862|FG004|Open Label Phase|Other|0|||
156830956|NCT00098722|566133863|FG005|Open Label Phase|Other|0|||
156830957|NCT00098722|566133864|FG006|Open Label Phase|Other|0|||
156830958|NCT00098722|566133858|FG000|Observation Phase|Death|0|||
156830959|NCT00098722|566133859|FG001|Observation Phase|Death|0|||
156830960|NCT00098722|566133860|FG002|Observation Phase|Death|0|||
156830961|NCT00098722|566133861|FG003|Observation Phase|Death|0|||
156830962|NCT00098722|566133862|FG004|Observation Phase|Death|0|||
156830963|NCT00098722|566133863|FG005|Observation Phase|Death|5|||
156830964|NCT00098722|566133864|FG006|Observation Phase|Death|3|||
156830965|NCT00098722|566133858|FG000|Observation Phase|Lack of Efficacy|0|||
156830966|NCT00098722|566133859|FG001|Observation Phase|Lack of Efficacy|0|||
156830967|NCT00098722|566133860|FG002|Observation Phase|Lack of Efficacy|0|||
156830968|NCT00098722|566133861|FG003|Observation Phase|Lack of Efficacy|0|||
156830969|NCT00098722|566133862|FG004|Observation Phase|Lack of Efficacy|0|||
156830970|NCT00098722|566133863|FG005|Observation Phase|Lack of Efficacy|2|||
156830971|NCT00098722|566133864|FG006|Observation Phase|Lack of Efficacy|0|||
156830972|NCT00098722|566133858|FG000|Observation Phase|Participant defaulted|0|||
156830973|NCT00098722|566133859|FG001|Observation Phase|Participant defaulted|0|||
156830974|NCT00098722|566133860|FG002|Observation Phase|Participant defaulted|0|||
156830975|NCT00098722|566133861|FG003|Observation Phase|Participant defaulted|0|||
156830976|NCT00098722|566133862|FG004|Observation Phase|Participant defaulted|0|||
156830977|NCT00098722|566133863|FG005|Observation Phase|Participant defaulted|17|||
156830978|NCT00098722|566133864|FG006|Observation Phase|Participant defaulted|4|||
156830979|NCT00098722|566133858|FG000|Observation Phase|Other|0|||
156830980|NCT00098722|566133859|FG001|Observation Phase|Other|0|||
156830981|NCT00098722|566133860|FG002|Observation Phase|Other|0|||
156830982|NCT00098722|566133861|FG003|Observation Phase|Other|0|||
156830983|NCT00098722|566133862|FG004|Observation Phase|Other|0|||
156830984|NCT00098722|566133863|FG005|Observation Phase|Other|21|||
156830985|NCT00098722|566133864|FG006|Observation Phase|Other|10|||
156830986|NCT01610596|566133867|FG000|Overall Study|Lost to Follow-up|0|||
156830987|NCT01610596|566133868|FG001|Overall Study|Lost to Follow-up|1|||
156830988|NCT00799591|566133871|FG000|Overall Study|De-escalation of doses|20|||
156830989|NCT00799591|566133871|FG000|Overall Study|Death|14|||
156830990|NCT00799591|566133871|FG000|Overall Study|Technical failure|12|||
156830991|NCT00799591|566133871|FG000|Overall Study|Resistant germ|11|||
156830992|NCT00799591|566133871|FG000|Overall Study|New infection|4|||
156830993|NCT00799591|566133871|FG000|Overall Study|Resistance germ and technical failure|2|||
156830994|NCT00799591|566133871|FG000|Overall Study|Persistance of fever undetermined origin|1|||
156830995|NCT00799591|566133871|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
156830996|NCT00799591|566133871|FG000|Overall Study|Infectious origin not probable|1|||
156830997|NCT04599166|566133872|FG000|Overall Study|Technological failure connecting to study app|80|||
156830998|NCT01974752|566133873|FG000|Overall Study|Death|33|||
156830999|NCT01974752|566133874|FG001|Overall Study|Death|11|||
156831000|NCT01974752|566133873|FG000|Overall Study|Lost to Follow-up|2|||
156831001|NCT01974752|566133874|FG001|Overall Study|Lost to Follow-up|0|||
156831002|NCT01974752|566133873|FG000|Overall Study|Withdrawal by Subject|2|||
156831003|NCT01974752|566133874|FG001|Overall Study|Withdrawal by Subject|3|||
156831004|NCT01974752|566133873|FG000|Overall Study|Other Eligibility Criteria|0|||
156831005|NCT01974752|566133874|FG001|Overall Study|Other Eligibility Criteria|1|||
156831006|NCT02088073|566133879|FG000|Acute Phase|Withdrawal by Subject|5|||
156831007|NCT02088073|566133880|FG001|Acute Phase|Withdrawal by Subject|0|||
156831008|NCT02088073|566133881|FG002|Acute Phase|Withdrawal by Subject|0|||
156831009|NCT02088073|566133882|FG003|Acute Phase|Withdrawal by Subject|0|||
156831010|NCT02088073|566133883|FG004|Acute Phase|Withdrawal by Subject|0|||
156831011|NCT02088073|566133879|FG000|Acute Phase|Hyperkalemia|2|||
156831012|NCT02088073|566133880|FG001|Acute Phase|Hyperkalemia|0|||
156831013|NCT02088073|566133881|FG002|Acute Phase|Hyperkalemia|0|||
156831014|NCT02088073|566133882|FG003|Acute Phase|Hyperkalemia|0|||
156831015|NCT02088073|566133883|FG004|Acute Phase|Hyperkalemia|0|||
156831016|NCT02088073|566133879|FG000|Maintanance Phase|Withdrawal by Subject|0|||
156831017|NCT02088073|566133880|FG001|Maintanance Phase|Withdrawal by Subject|2|||
156831018|NCT02088073|566133881|FG002|Maintanance Phase|Withdrawal by Subject|0|||
156831019|NCT02088073|566133882|FG003|Maintanance Phase|Withdrawal by Subject|0|||
156831020|NCT02088073|566133883|FG004|Maintanance Phase|Withdrawal by Subject|0|||
156831021|NCT02088073|566133879|FG000|Maintanance Phase|Adverse Event|0|||
156831022|NCT02088073|566133880|FG001|Maintanance Phase|Adverse Event|0|||
156831023|NCT02088073|566133881|FG002|Maintanance Phase|Adverse Event|3|||
156831024|NCT02088073|566133882|FG003|Maintanance Phase|Adverse Event|0|||
156831025|NCT02088073|566133883|FG004|Maintanance Phase|Adverse Event|1|||
156831026|NCT02088073|566133879|FG000|Maintanance Phase|Physician Decision|0|||
156831027|NCT02088073|566133880|FG001|Maintanance Phase|Physician Decision|0|||
156466356|NCT00943917|564803865|FG014|Stage II|Withdrawal by Subject|0|||
156466357|NCT00943917|564803851|FG000|Stage II|Pregnancy|0|||
156466358|NCT00943917|564803852|FG001|Stage II|Pregnancy|0|||
156466359|NCT00943917|564803853|FG002|Stage II|Pregnancy|0|||
156466360|NCT00943917|564803854|FG003|Stage II|Pregnancy|0|||
156466361|NCT00943917|564803855|FG004|Stage II|Pregnancy|0|||
156831028|NCT02088073|566133881|FG002|Maintanance Phase|Physician Decision|0|||
156831029|NCT02088073|566133882|FG003|Maintanance Phase|Physician Decision|0|||
156831030|NCT02088073|566133883|FG004|Maintanance Phase|Physician Decision|1|||
156831031|NCT02088073|566133879|FG000|Maintanance Phase|Sponsor's decision|0|||
156831032|NCT02088073|566133880|FG001|Maintanance Phase|Sponsor's decision|2|||
156831033|NCT02088073|566133881|FG002|Maintanance Phase|Sponsor's decision|0|||
156831034|NCT02088073|566133882|FG003|Maintanance Phase|Sponsor's decision|2|||
156831035|NCT02088073|566133883|FG004|Maintanance Phase|Sponsor's decision|1|||
156831036|NCT02088073|566133879|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
156831037|NCT02088073|566133880|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
156831038|NCT02088073|566133881|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
156831039|NCT02088073|566133882|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
156831040|NCT02088073|566133883|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
156831041|NCT02088073|566133879|FG000|Maintanance Phase|Miscellaneous|0|||
156831042|NCT02088073|566133880|FG001|Maintanance Phase|Miscellaneous|2|||
156831043|NCT02088073|566133881|FG002|Maintanance Phase|Miscellaneous|1|||
156831044|NCT02088073|566133882|FG003|Maintanance Phase|Miscellaneous|2|||
156831045|NCT02088073|566133883|FG004|Maintanance Phase|Miscellaneous|1|||
156831046|NCT02088073|566133879|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
156831047|NCT02088073|566133880|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
156831048|NCT02088073|566133881|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
156831049|NCT02088073|566133882|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
156831050|NCT02088073|566133883|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
156831051|NCT02088073|566133879|FG000|Maintanance Phase|Subject compliance|0|||
156831052|NCT02088073|566133880|FG001|Maintanance Phase|Subject compliance|1|||
156831053|NCT02088073|566133881|FG002|Maintanance Phase|Subject compliance|0|||
156831054|NCT02088073|566133882|FG003|Maintanance Phase|Subject compliance|0|||
156831055|NCT02088073|566133883|FG004|Maintanance Phase|Subject compliance|0|||
156831056|NCT02118597|566133889|FG000|Overall Study|Sponsor terminated the study|14|||
156831057|NCT02118597|566133889|FG000|Overall Study|Serious Adverse Event|1|||
156831058|NCT02118597|566133889|FG000|Overall Study|Investigator's decision|1|||
156831059|NCT02788201|566133890|FG000|Overall Study|Death|1|||
156831060|NCT02788201|566133891|FG001|Overall Study|Death|1|||
156831061|NCT02788201|566133892|FG002|Overall Study|Death|1|||
156831062|NCT02788201|566133893|FG003|Overall Study|Death|1|||
156831063|NCT02788201|566133894|FG004|Overall Study|Death|0|||
156466362|NCT00943917|564803856|FG005|Stage II|Pregnancy|1|||
156466363|NCT00943917|564803857|FG006|Stage II|Pregnancy|0|||
156831064|NCT02788201|566133895|FG005|Overall Study|Death|1|||
156831065|NCT02788201|566133890|FG000|Overall Study|Ineligible|0|||
156831066|NCT02788201|566133891|FG001|Overall Study|Ineligible|0|||
156831067|NCT02788201|566133892|FG002|Overall Study|Ineligible|0|||
156831068|NCT02788201|566133893|FG003|Overall Study|Ineligible|0|||
156831069|NCT02788201|566133894|FG004|Overall Study|Ineligible|0|||
156831070|NCT02788201|566133895|FG005|Overall Study|Ineligible|1|||
156831071|NCT02788201|566133890|FG000|Overall Study|Withdrawal by Subject|0|||
156831072|NCT02788201|566133891|FG001|Overall Study|Withdrawal by Subject|0|||
156831073|NCT02788201|566133892|FG002|Overall Study|Withdrawal by Subject|0|||
156466364|NCT00943917|564803858|FG007|Stage II|Pregnancy|0|||
156466365|NCT00943917|564803859|FG008|Stage II|Pregnancy|0|||
156831074|NCT02788201|566133893|FG003|Overall Study|Withdrawal by Subject|0|||
156831075|NCT02788201|566133894|FG004|Overall Study|Withdrawal by Subject|0|||
156831076|NCT02788201|566133895|FG005|Overall Study|Withdrawal by Subject|1|||
156831077|NCT00186537|566133896|FG000|Overall Study|Withdrawal by Subject|4|||
156831078|NCT00186537|566133897|FG001|Overall Study|Withdrawal by Subject|0|||
156831079|NCT00186537|566133898|FG002|Overall Study|Withdrawal by Subject|3|||
156831080|NCT00186537|566133896|FG000|Overall Study|ALT > 1.5 x ULN|3|||
156831081|NCT00186537|566133897|FG001|Overall Study|ALT > 1.5 x ULN|0|||
156831082|NCT00186537|566133898|FG002|Overall Study|ALT > 1.5 x ULN|0|||
156831083|NCT02590562|566133905|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
156831084|NCT01457950|566133906|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
156831085|NCT01457950|566133907|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
156831086|NCT01457950|566133908|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
156831087|NCT01457950|566133909|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
156831088|NCT01457950|566133906|FG000|Double-Blind Phase|Protocol Violation|2|||
156831089|NCT01457950|566133907|FG001|Double-Blind Phase|Protocol Violation|1|||
156831090|NCT01457950|566133908|FG002|Double-Blind Phase|Protocol Violation|0|||
156831091|NCT01457950|566133909|FG003|Double-Blind Phase|Protocol Violation|0|||
156831092|NCT01457950|566133906|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
156831093|NCT01457950|566133907|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
156831094|NCT01457950|566133908|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156831095|NCT01457950|566133909|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156339813|NCT00923156|564342223|FG000|Overall Study|Lack of Efficacy|0|||
156339814|NCT00923156|564342224|FG001|Overall Study|Lack of Efficacy|0|||
156831096|NCT01457950|566133906|FG000|Open-Label Phase|Adverse Event|0|||
156831097|NCT01457950|566133907|FG001|Open-Label Phase|Adverse Event|0|||
156831098|NCT01457950|566133908|FG002|Open-Label Phase|Adverse Event|0|||
156831099|NCT01457950|566133909|FG003|Open-Label Phase|Adverse Event|1|||
156831100|NCT01457950|566133906|FG000|Open-Label Phase|Protocol Violation|0|||
156831101|NCT01457950|566133907|FG001|Open-Label Phase|Protocol Violation|0|||
156831102|NCT01457950|566133908|FG002|Open-Label Phase|Protocol Violation|0|||
156831103|NCT01457950|566133909|FG003|Open-Label Phase|Protocol Violation|1|||
156831104|NCT01457950|566133906|FG000|Open-Label Phase|Withdrawal by Subject|0|||
156831105|NCT01457950|566133907|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156831106|NCT01457950|566133908|FG002|Open-Label Phase|Withdrawal by Subject|2|||
156831107|NCT01457950|566133909|FG003|Open-Label Phase|Withdrawal by Subject|0|||
156831108|NCT03684304|566133910|FG000|Overall Study|Lost to Follow-up|19|||
156831109|NCT03684304|566133911|FG001|Overall Study|Lost to Follow-up|17|||
156831110|NCT01510184|566133912|FG000|Overall Study|Sponsor discretion|28|||
156831111|NCT01510184|566133913|FG001|Overall Study|Sponsor discretion|28|||
156831112|NCT01510184|566133912|FG000|Overall Study|Death|1|||
156831113|NCT01510184|566133913|FG001|Overall Study|Death|2|||
156831114|NCT01510184|566133912|FG000|Overall Study|Withdrawal by Subject|1|||
156831115|NCT01510184|566133913|FG001|Overall Study|Withdrawal by Subject|4|||
156831116|NCT01510184|566133912|FG000|Overall Study|Other|0|||
156831117|NCT01510184|566133913|FG001|Overall Study|Other|1|||
156831118|NCT01143051|566133914|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
156831119|NCT01143051|566133915|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
156831120|NCT01143051|566133916|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
156831121|NCT01143051|566133917|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
156831122|NCT01143051|566133918|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
156831123|NCT01143051|566133919|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
156831124|NCT01143051|566133914|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
156831125|NCT01143051|566133915|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
156831126|NCT01143051|566133916|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
156831127|NCT01143051|566133917|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
156831128|NCT01143051|566133918|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
156339815|NCT00923156|564342225|FG002|Overall Study|Lack of Efficacy|1|||
156339816|NCT03137537|564342226|FG000|Overall Study|Adverse Event|0|||
156339817|NCT03137537|564342227|FG001|Overall Study|Adverse Event|1|||
156339818|NCT01552694|564342228|FG000|Overall Study|Lost to Follow-up|0|||
156339819|NCT01552694|564342229|FG001|Overall Study|Lost to Follow-up|1|||
156831129|NCT01143051|566133919|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
156831130|NCT02677844|566133921|FG000|Period 3|Withdrawal by Subject|0|||
156831131|NCT02677844|566133922|FG001|Period 3|Withdrawal by Subject|0|||
156831132|NCT02677844|566133923|FG002|Period 3|Withdrawal by Subject|0|||
156831133|NCT02677844|566133924|FG003|Period 3|Withdrawal by Subject|1|||
156831134|NCT02677844|566133925|FG004|Period 3|Withdrawal by Subject|0|||
156339820|NCT01552694|564342228|FG000|Overall Study|Protocol Violation|0|||
156339821|NCT01552694|564342229|FG001|Overall Study|Protocol Violation|1|||
156339822|NCT00191139|564342230|FG000|Overall Study|Adverse Event|2|||
156831135|NCT02677844|566133926|FG005|Period 3|Withdrawal by Subject|0|||
156339823|NCT00191139|564342231|FG001|Overall Study|Adverse Event|6|||
156831136|NCT02677844|566133927|FG006|Period 3|Withdrawal by Subject|0|||
156831137|NCT00765882|566133928|FG000|Overall Study|Adverse Event|10|||
156831138|NCT00765882|566133929|FG001|Overall Study|Adverse Event|21|||
156831139|NCT00765882|566133930|FG002|Overall Study|Adverse Event|20|||
156831140|NCT00765882|566133928|FG000|Overall Study|Lack of Efficacy|4|||
156831141|NCT00765882|566133929|FG001|Overall Study|Lack of Efficacy|0|||
156831142|NCT00765882|566133930|FG002|Overall Study|Lack of Efficacy|1|||
156831143|NCT00765882|566133928|FG000|Overall Study|Protocol Violation|4|||
156831144|NCT00765882|566133929|FG001|Overall Study|Protocol Violation|3|||
156831145|NCT00765882|566133930|FG002|Overall Study|Protocol Violation|1|||
156831146|NCT00765882|566133928|FG000|Overall Study|Withdrawal by Subject|2|||
156831147|NCT00765882|566133929|FG001|Overall Study|Withdrawal by Subject|6|||
156831148|NCT00765882|566133930|FG002|Overall Study|Withdrawal by Subject|6|||
156831149|NCT00765882|566133928|FG000|Overall Study|Lost to Follow-up|1|||
156831150|NCT00765882|566133929|FG001|Overall Study|Lost to Follow-up|9|||
156831151|NCT00765882|566133930|FG002|Overall Study|Lost to Follow-up|6|||
156831152|NCT00765882|566133928|FG000|Overall Study|Other Reason|3|||
156831153|NCT00765882|566133929|FG001|Overall Study|Other Reason|1|||
156831154|NCT00765882|566133930|FG002|Overall Study|Other Reason|2|||
156831155|NCT02231762|566133933|FG000|Combination Phase|Adverse Event|10|||
156831156|NCT02231762|566133934|FG001|Combination Phase|Adverse Event|0|||
156831157|NCT02231762|566133935|FG002|Combination Phase|Adverse Event|0|||
156831158|NCT02231762|566133936|FG003|Combination Phase|Adverse Event|0|||
156831159|NCT02231762|566133933|FG000|Combination Phase|Withdrawal by Subject|2|||
156831160|NCT02231762|566133934|FG001|Combination Phase|Withdrawal by Subject|0|||
156831161|NCT02231762|566133935|FG002|Combination Phase|Withdrawal by Subject|0|||
156831162|NCT02231762|566133936|FG003|Combination Phase|Withdrawal by Subject|0|||
156831163|NCT02231762|566133933|FG000|Combination Phase|Disease Progression|6|||
156831164|NCT02231762|566133934|FG001|Combination Phase|Disease Progression|0|||
156831165|NCT02231762|566133935|FG002|Combination Phase|Disease Progression|0|||
156831166|NCT02231762|566133936|FG003|Combination Phase|Disease Progression|0|||
156831167|NCT02231762|566133933|FG000|Combination Phase|Did not meet inclusion criteria|1|||
156831168|NCT02231762|566133934|FG001|Combination Phase|Did not meet inclusion criteria|0|||
156831169|NCT02231762|566133935|FG002|Combination Phase|Did not meet inclusion criteria|0|||
156831170|NCT02231762|566133936|FG003|Combination Phase|Did not meet inclusion criteria|0|||
156831171|NCT02231762|566133933|FG000|Combination Phase|Protocol Violation|1|||
156831172|NCT02231762|566133934|FG001|Combination Phase|Protocol Violation|0|||
156831173|NCT02231762|566133935|FG002|Combination Phase|Protocol Violation|0|||
156831174|NCT02231762|566133936|FG003|Combination Phase|Protocol Violation|0|||
156831175|NCT02231762|566133933|FG000|Maintenance Phase|Disease progression|0|||
156831176|NCT02231762|566133934|FG001|Maintenance Phase|Disease progression|3|||
156831177|NCT02231762|566133935|FG002|Maintenance Phase|Disease progression|4|||
156831178|NCT02231762|566133936|FG003|Maintenance Phase|Disease progression|3|||
156831179|NCT02231762|566133933|FG000|Maintenance Phase|Adverse Event|0|||
156831180|NCT02231762|566133934|FG001|Maintenance Phase|Adverse Event|0|||
156831181|NCT02231762|566133935|FG002|Maintenance Phase|Adverse Event|1|||
156831182|NCT02231762|566133936|FG003|Maintenance Phase|Adverse Event|2|||
156831183|NCT03593681|566133941|FG000|Overall Study|Inadequate sample collected|12|||
156831184|NCT03593681|566133941|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
156831185|NCT03593681|566133941|FG000|Overall Study|Protocol Violation|3|||
156831186|NCT03593681|566133941|FG000|Overall Study|Withdrawal by Subject|3|||
156831187|NCT03593681|566133941|FG000|Overall Study|Procedure not attempted|3|||
156831188|NCT03593681|566133941|FG000|Overall Study|Adverse Event|2|||
156831189|NCT03593681|566133941|FG000|Overall Study|Physician Decision|1|||
156831190|NCT00545532|566133944|FG000|Overall Study|Withdrawal by Subject|1|||
156831191|NCT00545532|566133945|FG001|Overall Study|Withdrawal by Subject|3|||
156831192|NCT00545532|566133944|FG000|Overall Study|Lost to Follow-up|5|||
156831193|NCT00545532|566133945|FG001|Overall Study|Lost to Follow-up|6|||
156831194|NCT00545532|566133944|FG000|Overall Study|Death|0|||
156831195|NCT00545532|566133945|FG001|Overall Study|Death|1|||
156831196|NCT01149486|566133946|FG000|First Intervention|Adverse Event|0|||
156831197|NCT01149486|566133947|FG001|First Intervention|Adverse Event|1|||
156831198|NCT03630302|566133948|FG000|Surgery|hardware issue prevented LFP recordings|1|||
156831199|NCT03630302|566133948|FG000|3 Month Visit|Adverse Event|2|||
156831200|NCT03630302|566133948|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
156831201|NCT01866423|566133952|FG000|Overall Study|Lack of Efficacy|3|||
156831202|NCT01866423|566133952|FG000|Overall Study|Sponsor Decision|1|||
156541279|NCT00243386|565074531|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
156831203|NCT01479595|566133955|FG000|Overall Study|Protocol deviation|0|||
156831204|NCT01479595|566133956|FG001|Overall Study|Protocol deviation|1|||
156831205|NCT01479595|566133955|FG000|Overall Study|Adverse Event|2|||
156831206|NCT01479595|566133956|FG001|Overall Study|Adverse Event|1|||
156831207|NCT03366103|566133957|FG000|Overall Study|Disease Progression|3|||
156831208|NCT03366103|566133958|FG001|Overall Study|Disease Progression|1|||
156831209|NCT03366103|566133959|FG002|Overall Study|Disease Progression|0|||
156831210|NCT03366103|566133957|FG000|Overall Study|Adverse Event|0|||
156831211|NCT03366103|566133958|FG001|Overall Study|Adverse Event|1|||
156831212|NCT03366103|566133959|FG002|Overall Study|Adverse Event|0|||
156541280|NCT00243386|565074532|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
156541281|NCT00243386|565074533|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
156541282|NCT04995055|565074534|FG000|Period 1|COVID-19 Related|1|||
156541283|NCT04995055|565074535|FG001|Period 1|COVID-19 Related|0|||
156541284|NCT04995055|565074534|FG000|Period 1|Withdrawal by Subject|0|||
156541285|NCT04995055|565074535|FG001|Period 1|Withdrawal by Subject|1|||
156831213|NCT01344629|566133964|FG000|Crossover Period 2|Withdrawal by Subject|0|||
156831214|NCT01344629|566133965|FG001|Crossover Period 2|Withdrawal by Subject|1|||
156831215|NCT01174004|566133974|FG000|Overall Study|Adverse Event|2|||
156831216|NCT01174004|566133975|FG001|Overall Study|Adverse Event|10|||
156831217|NCT01174004|566133974|FG000|Overall Study|Withdrawal by Subject|2|||
156831218|NCT01174004|566133975|FG001|Overall Study|Withdrawal by Subject|3|||
156831219|NCT01174004|566133974|FG000|Overall Study|At Discretion of Sponsor|2|||
156831220|NCT01174004|566133975|FG001|Overall Study|At Discretion of Sponsor|2|||
156831221|NCT01174004|566133974|FG000|Overall Study|Protocol Violation|0|||
156831222|NCT01174004|566133975|FG001|Overall Study|Protocol Violation|1|||
156831223|NCT01174004|566133974|FG000|Overall Study|Physician Decision|1|||
156831224|NCT01174004|566133975|FG001|Overall Study|Physician Decision|0|||
156831225|NCT00933244|566133976|FG000|Overall Study|Withdrawal by Subject|5|||
156831226|NCT00933244|566133977|FG001|Overall Study|Withdrawal by Subject|1|||
156831227|NCT00933244|566133978|FG002|Overall Study|Withdrawal by Subject|3|||
156831228|NCT00746733|566133984|FG000|Second Intervention|Adverse Event|1|||
156831229|NCT00746733|566133985|FG001|Second Intervention|Adverse Event|0|||
156831230|NCT00746733|566133984|FG000|Third Intervention|Withdrawal by Subject|1|||
156831231|NCT00746733|566133985|FG001|Third Intervention|Withdrawal by Subject|1|||
156831232|NCT00849875|566133986|FG000|Overall Study|Death|28|||
156831233|NCT00849875|566133986|FG000|Overall Study|Ongoing (unknown completion status)|11|||
156831234|NCT00849875|566133986|FG000|Overall Study|Others|6|||
156831235|NCT00849875|566133986|FG000|Overall Study|Lost to Follow-up|2|||
156831236|NCT00528996|566135758|FG000|Overall Study|Other reasons than listing|6|||
156831237|NCT00528996|566135759|FG001|Overall Study|Other reasons than listing|7|||
156831238|NCT00528996|566135760|FG002|Overall Study|Other reasons than listing|14|||
156831239|NCT00528996|566135761|FG003|Overall Study|Other reasons than listing|11|||
156831240|NCT00528996|566135762|FG004|Overall Study|Other reasons than listing|5|||
156831241|NCT00528996|566135758|FG000|Overall Study|Refused continue medication|16|||
156831242|NCT00528996|566135759|FG001|Overall Study|Refused continue medication|0|||
156831243|NCT00528996|566135760|FG002|Overall Study|Refused continue medication|3|||
156831244|NCT00528996|566135761|FG003|Overall Study|Refused continue medication|3|||
156831245|NCT00528996|566135762|FG004|Overall Study|Refused continue medication|6|||
156831246|NCT00528996|566135758|FG000|Overall Study|Lost to Follow-up|2|||
156831247|NCT00528996|566135759|FG001|Overall Study|Lost to Follow-up|0|||
156831248|NCT00528996|566135760|FG002|Overall Study|Lost to Follow-up|4|||
156831249|NCT00528996|566135761|FG003|Overall Study|Lost to Follow-up|1|||
156831250|NCT00528996|566135762|FG004|Overall Study|Lost to Follow-up|3|||
156831251|NCT00528996|566135758|FG000|Overall Study|Protocol Violation|1|||
156831252|NCT00528996|566135759|FG001|Overall Study|Protocol Violation|2|||
156831253|NCT00528996|566135760|FG002|Overall Study|Protocol Violation|3|||
156831254|NCT00528996|566135761|FG003|Overall Study|Protocol Violation|3|||
156831255|NCT00528996|566135762|FG004|Overall Study|Protocol Violation|2|||
156831256|NCT00528996|566135758|FG000|Overall Study|Lack of Efficacy|7|||
156831257|NCT00528996|566135759|FG001|Overall Study|Lack of Efficacy|2|||
156831258|NCT00528996|566135760|FG002|Overall Study|Lack of Efficacy|1|||
156831259|NCT00528996|566135761|FG003|Overall Study|Lack of Efficacy|3|||
156831260|NCT00528996|566135762|FG004|Overall Study|Lack of Efficacy|3|||
156831261|NCT00528996|566135758|FG000|Overall Study|Adverse Event|32|||
156831262|NCT00528996|566135759|FG001|Overall Study|Adverse Event|13|||
156831263|NCT00528996|566135760|FG002|Overall Study|Adverse Event|18|||
156831264|NCT00528996|566135761|FG003|Overall Study|Adverse Event|29|||
156831265|NCT00528996|566135762|FG004|Overall Study|Adverse Event|18|||
156831266|NCT00996801|566135763|FG000|Overall Study|Adverse Event|6|||
156831267|NCT00996801|566135764|FG001|Overall Study|Adverse Event|4|||
156831268|NCT00996801|566135765|FG002|Overall Study|Adverse Event|12|||
156831269|NCT00996801|566135766|FG003|Overall Study|Adverse Event|17|||
156831270|NCT00996801|566135767|FG004|Overall Study|Adverse Event|31|||
156831271|NCT00996801|566135768|FG005|Overall Study|Adverse Event|3|||
156831272|NCT00996801|566135763|FG000|Overall Study|Lack of Efficacy|3|||
156541286|NCT04995055|565074534|FG000|Period 1|Subject discontinued due to timing|4|||
156541287|NCT04995055|565074535|FG001|Period 1|Subject discontinued due to timing|4|||
156541288|NCT01358760|565074537|FG000|Overall Study|Adverse Event|3|||
156541289|NCT01358760|565074538|FG001|Overall Study|Adverse Event|4|||
156541290|NCT01358760|565074539|FG002|Overall Study|Adverse Event|3|||
156831273|NCT00996801|566135764|FG001|Overall Study|Lack of Efficacy|0|||
156831274|NCT00996801|566135765|FG002|Overall Study|Lack of Efficacy|1|||
156831275|NCT00996801|566135766|FG003|Overall Study|Lack of Efficacy|3|||
156831276|NCT00996801|566135767|FG004|Overall Study|Lack of Efficacy|0|||
156831277|NCT00996801|566135768|FG005|Overall Study|Lack of Efficacy|1|||
156831278|NCT00996801|566135763|FG000|Overall Study|Lost to Follow-up|0|||
156831279|NCT00996801|566135764|FG001|Overall Study|Lost to Follow-up|0|||
156831280|NCT00996801|566135765|FG002|Overall Study|Lost to Follow-up|0|||
156831281|NCT00996801|566135766|FG003|Overall Study|Lost to Follow-up|3|||
156831282|NCT00996801|566135767|FG004|Overall Study|Lost to Follow-up|3|||
156831283|NCT00996801|566135768|FG005|Overall Study|Lost to Follow-up|2|||
156831284|NCT00996801|566135763|FG000|Overall Study|Physician Decision|0|||
156831285|NCT00996801|566135764|FG001|Overall Study|Physician Decision|0|||
156831286|NCT00996801|566135765|FG002|Overall Study|Physician Decision|0|||
156831287|NCT00996801|566135766|FG003|Overall Study|Physician Decision|1|||
156831288|NCT00996801|566135767|FG004|Overall Study|Physician Decision|0|||
156831289|NCT00996801|566135768|FG005|Overall Study|Physician Decision|0|||
156831290|NCT00996801|566135763|FG000|Overall Study|Progressive Disease|0|||
156831291|NCT00996801|566135764|FG001|Overall Study|Progressive Disease|1|||
156831292|NCT00996801|566135765|FG002|Overall Study|Progressive Disease|0|||
156831293|NCT00996801|566135766|FG003|Overall Study|Progressive Disease|0|||
156831294|NCT00996801|566135767|FG004|Overall Study|Progressive Disease|0|||
156831295|NCT00996801|566135768|FG005|Overall Study|Progressive Disease|0|||
156831296|NCT00996801|566135763|FG000|Overall Study|Protocol Violation|3|||
156831297|NCT00996801|566135764|FG001|Overall Study|Protocol Violation|4|||
156831298|NCT00996801|566135765|FG002|Overall Study|Protocol Violation|1|||
156831299|NCT00996801|566135766|FG003|Overall Study|Protocol Violation|2|||
156831300|NCT00996801|566135767|FG004|Overall Study|Protocol Violation|3|||
156831301|NCT00996801|566135768|FG005|Overall Study|Protocol Violation|4|||
156831302|NCT00996801|566135763|FG000|Overall Study|Study Terminated by Sponsor|0|||
156831303|NCT00996801|566135764|FG001|Overall Study|Study Terminated by Sponsor|1|||
156831304|NCT00996801|566135765|FG002|Overall Study|Study Terminated by Sponsor|0|||
156831305|NCT00996801|566135766|FG003|Overall Study|Study Terminated by Sponsor|0|||
156831306|NCT00996801|566135767|FG004|Overall Study|Study Terminated by Sponsor|46|||
156831307|NCT00996801|566135768|FG005|Overall Study|Study Terminated by Sponsor|0|||
156831308|NCT00996801|566135763|FG000|Overall Study|Withdrawal by Subject|8|||
156831309|NCT00996801|566135764|FG001|Overall Study|Withdrawal by Subject|6|||
156831310|NCT00996801|566135765|FG002|Overall Study|Withdrawal by Subject|9|||
156831311|NCT00996801|566135766|FG003|Overall Study|Withdrawal by Subject|5|||
156831312|NCT00996801|566135767|FG004|Overall Study|Withdrawal by Subject|5|||
156831313|NCT00996801|566135768|FG005|Overall Study|Withdrawal by Subject|9|||
156831314|NCT00289198|566135769|FG000|Overall Study|Adverse Event|0|||
156831315|NCT00289198|566135770|FG001|Overall Study|Adverse Event|2|||
156831316|NCT00289198|566135769|FG000|Overall Study|Protocol Violation|2|||
156831317|NCT00289198|566135770|FG001|Overall Study|Protocol Violation|1|||
156831318|NCT00289198|566135769|FG000|Overall Study|Withdrawal by Subject|4|||
156831319|NCT00289198|566135770|FG001|Overall Study|Withdrawal by Subject|1|||
156831320|NCT00289198|566135769|FG000|Overall Study|Lack of Efficacy|2|||
156831321|NCT00289198|566135770|FG001|Overall Study|Lack of Efficacy|0|||
156831322|NCT00289198|566135769|FG000|Overall Study|Other: Low compliance|0|||
156831323|NCT00289198|566135770|FG001|Overall Study|Other: Low compliance|1|||
156831324|NCT00289198|566135769|FG000|Overall Study|Other: Physician's decision|0|||
156831325|NCT00289198|566135770|FG001|Overall Study|Other: Physician's decision|1|||
156831326|NCT00289198|566135769|FG000|Overall Study|Other: Unable to attend on schedule|2|||
156831327|NCT00289198|566135770|FG001|Overall Study|Other: Unable to attend on schedule|1|||
156831328|NCT00289198|566135769|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
156831329|NCT00289198|566135770|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
156831330|NCT00289198|566135769|FG000|Overall Study|Other: Impossible to come on visit|0|||
156831331|NCT00289198|566135770|FG001|Overall Study|Other: Impossible to come on visit|1|||
156831332|NCT03369431|566135778|FG000|Overall Study|Lost to Follow-up|1|||
156831333|NCT03369431|566135779|FG001|Overall Study|Lost to Follow-up|3|||
156831334|NCT03369431|566135778|FG000|Overall Study|Withdrawal by Subject|2|||
156831335|NCT03369431|566135779|FG001|Overall Study|Withdrawal by Subject|3|||
156831336|NCT03369431|566135778|FG000|Overall Study|Protocol Violation|1|||
156831337|NCT03369431|566135779|FG001|Overall Study|Protocol Violation|1|||
156831338|NCT01062061|566135780|FG000|Overall Study|Enrolled more than once|2|||
156831339|NCT01062061|566135780|FG000|Overall Study|Investigated before study start|13|||
156831340|NCT01062061|566135780|FG000|Overall Study|Outside chief indications|10|||
156831341|NCT01062061|566135780|FG000|Overall Study|Failed to meet inclusion criteria|2|||
156831342|NCT00004445|566135781|FG000|Overall Study|Physician Decision|2|||
156831343|NCT00004445|566135781|FG000|Overall Study|Withdrawal by Subject|1|||
156831344|NCT00076336|566135782|FG000|Overall Study|Death|13|||
156831345|NCT00076336|566135783|FG001|Overall Study|Death|17|||
156831346|NCT00076336|566135782|FG000|Overall Study|Adverse Event|4|||
156831347|NCT00076336|566135783|FG001|Overall Study|Adverse Event|4|||
156831348|NCT00076336|566135782|FG000|Overall Study|Lost to Follow-up|4|||
156831349|NCT00076336|566135783|FG001|Overall Study|Lost to Follow-up|4|||
156831350|NCT00076336|566135782|FG000|Overall Study|Non-Compliance|2|||
156831351|NCT00076336|566135783|FG001|Overall Study|Non-Compliance|0|||
156831352|NCT00076336|566135782|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
156831353|NCT00076336|566135783|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
156831354|NCT00076336|566135782|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
156831355|NCT00076336|566135783|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
156831356|NCT00076336|566135782|FG000|Overall Study|Liver Transplantation|3|||
156831357|NCT00076336|566135783|FG001|Overall Study|Liver Transplantation|3|||
156831358|NCT00076336|566135782|FG000|Overall Study|Virologic Breakthrough|14|||
156831359|NCT00076336|566135783|FG001|Overall Study|Virologic Breakthrough|16|||
156831360|NCT00076336|566135782|FG000|Overall Study|Treatment failure|4|||
156831361|NCT00076336|566135783|FG001|Overall Study|Treatment failure|5|||
156831362|NCT00524589|566135784|FG000|Overall Study|Withdrawal by Subject|2|||
156831363|NCT00524589|566135784|FG000|Overall Study|Disease Progression|16|||
156831364|NCT02753127|566135788|FG000|Overall Study|Lost to Follow-up|13|||
156831365|NCT02753127|566135789|FG001|Overall Study|Lost to Follow-up|11|||
156831366|NCT02753127|566135788|FG000|Overall Study|Withdrawal by Subject|37|||
156831367|NCT02753127|566135789|FG001|Overall Study|Withdrawal by Subject|47|||
156831368|NCT02753127|566135788|FG000|Overall Study|Other|3|||
156831369|NCT02753127|566135789|FG001|Overall Study|Other|8|||
156831370|NCT02753127|566135788|FG000|Overall Study|Hospice|0|||
156831371|NCT02753127|566135789|FG001|Overall Study|Hospice|2|||
156831372|NCT00046930|566135792|FG000|Overall Study|Ineligible|12|||
156831373|NCT00046930|566135793|FG001|Overall Study|Ineligible|4|||
156831374|NCT00940485|566135799|FG000|Overall Study|HBeAb positive at Baseline|3|||
156831375|NCT00940485|566135800|FG001|Overall Study|HBeAb positive at Baseline|2|||
156831376|NCT00940485|566135799|FG000|Overall Study|Lost to Follow-up|2|||
156831377|NCT00940485|566135800|FG001|Overall Study|Lost to Follow-up|3|||
156831378|NCT00940485|566135799|FG000|Overall Study|Adverse Event|8|||
156831379|NCT00940485|566135800|FG001|Overall Study|Adverse Event|0|||
156831380|NCT00940485|566135799|FG000|Overall Study|Withdrawal by Subject|1|||
156831381|NCT00940485|566135800|FG001|Overall Study|Withdrawal by Subject|1|||
156831382|NCT00940485|566135799|FG000|Overall Study|Others|1|||
156831383|NCT00940485|566135800|FG001|Overall Study|Others|1|||
156831384|NCT01113580|566135801|FG000|Overall Study|Protocol Violation|1|||
156831385|NCT01113580|566135802|FG001|Overall Study|Protocol Violation|0|||
156831386|NCT02936284|566135803|FG000|Overall Study|Withdrawal by Subject|3|||
156831387|NCT02936284|566135804|FG001|Overall Study|Withdrawal by Subject|1|||
156831388|NCT02936284|566135803|FG000|Overall Study|Lost to Follow-up|7|||
156831389|NCT02936284|566135804|FG001|Overall Study|Lost to Follow-up|8|||
156831390|NCT01519674|566135809|FG000|Overall Study|Adverse Event|3|||
156831391|NCT01519674|566135810|FG001|Overall Study|Adverse Event|3|||
156831392|NCT01519674|566135811|FG002|Overall Study|Adverse Event|0|||
156831393|NCT01519674|566135809|FG000|Overall Study|Lack of Efficacy|1|||
156831394|NCT01519674|566135810|FG001|Overall Study|Lack of Efficacy|1|||
156831395|NCT01519674|566135811|FG002|Overall Study|Lack of Efficacy|1|||
156831396|NCT01519674|566135809|FG000|Overall Study|Protocol Violation|0|||
156831397|NCT01519674|566135810|FG001|Overall Study|Protocol Violation|3|||
156831398|NCT01519674|566135811|FG002|Overall Study|Protocol Violation|1|||
156831399|NCT01519674|566135809|FG000|Overall Study|Withdrawal Criteria|7|||
156831400|NCT01519674|566135810|FG001|Overall Study|Withdrawal Criteria|2|||
156831401|NCT01519674|566135811|FG002|Overall Study|Withdrawal Criteria|7|||
156831402|NCT01519674|566135809|FG000|Overall Study|Unsclassified|10|||
156831403|NCT01519674|566135810|FG001|Overall Study|Unsclassified|4|||
156831404|NCT01519674|566135811|FG002|Overall Study|Unsclassified|3|||
156831405|NCT01146288|566135814|FG000|First Intervention(1 Day)|Adverse Event|0|||
156831406|NCT01146288|566135815|FG001|First Intervention(1 Day)|Adverse Event|1|||
156831407|NCT03458702|566135816|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
156831408|NCT03458702|566135817|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
156831409|NCT03458702|566135816|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
156831410|NCT03458702|566135817|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
156831411|NCT01697462|566135818|FG000|Overall Study|Disease Progression|1|||
156831412|NCT01697462|566135818|FG000|Overall Study|Adverse Event|6|||
156831413|NCT01697462|566135818|FG000|Overall Study|Lost to Follow-up|21|||
156831414|NCT01697462|566135818|FG000|Overall Study|Withdrawal by Subject|12|||
156831415|NCT01697462|566135818|FG000|Overall Study|Investigator Decision|21|||
156831416|NCT01697462|566135818|FG000|Overall Study|Death|1|||
156831417|NCT01697462|566135818|FG000|Overall Study|Other|10|||
156831418|NCT01697462|566135818|FG000|Overall Study|Missing|5|||
156831419|NCT03532932|566135819|FG000|Overall Study|Protocol Deviation|33|||
156831420|NCT03532932|566135820|FG001|Overall Study|Protocol Deviation|31|||
156831421|NCT03532932|566135819|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
156831422|NCT03532932|566135820|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
156831423|NCT03532932|566135819|FG000|Overall Study|Withdrawal by Subject|2|||
156831424|NCT03532932|566135820|FG001|Overall Study|Withdrawal by Subject|0|||
156831425|NCT03532932|566135819|FG000|Overall Study|Lost to Follow-up|15|||
156831426|NCT03532932|566135820|FG001|Overall Study|Lost to Follow-up|9|||
156831427|NCT03532932|566135819|FG000|Overall Study|Adverse Event|4|||
156831428|NCT03532932|566135820|FG001|Overall Study|Adverse Event|3|||
156831429|NCT03532932|566135819|FG000|Overall Study|Death|0|||
156831430|NCT03532932|566135820|FG001|Overall Study|Death|2|||
156831431|NCT03532932|566135819|FG000|Overall Study|Other|11|||
156831432|NCT03532932|566135820|FG001|Overall Study|Other|16|||
156831433|NCT02255565|566135822|FG000|Overall Study|Withdrawal by Subject|0|||
156831434|NCT02255565|566135823|FG001|Overall Study|Withdrawal by Subject|1|||
156831435|NCT02255565|566135824|FG002|Overall Study|Withdrawal by Subject|0|||
156831436|NCT02699450|566135825|FG000|Overall Study|Death|2|||
156831437|NCT02699450|566135826|FG001|Overall Study|Death|1|||
156831438|NCT02699450|566135827|FG002|Overall Study|Death|2|||
156831439|NCT02699450|566135825|FG000|Overall Study|Met Criteria for Study Exit|0|||
156831440|NCT02699450|566135826|FG001|Overall Study|Met Criteria for Study Exit|0|||
156831441|NCT02699450|566135827|FG002|Overall Study|Met Criteria for Study Exit|1|||
156831442|NCT02699450|566135825|FG000|Overall Study|Protocol Violation|4|||
156831443|NCT02699450|566135826|FG001|Overall Study|Protocol Violation|3|||
156831444|NCT02699450|566135827|FG002|Overall Study|Protocol Violation|5|||
156831445|NCT02699450|566135825|FG000|Overall Study|Lost to Follow-up|3|||
156831446|NCT02699450|566135826|FG001|Overall Study|Lost to Follow-up|0|||
156831447|NCT02699450|566135827|FG002|Overall Study|Lost to Follow-up|5|||
156831448|NCT02699450|566135825|FG000|Overall Study|Physician Decision|2|||
156831449|NCT02699450|566135826|FG001|Overall Study|Physician Decision|0|||
156831450|NCT02699450|566135827|FG002|Overall Study|Physician Decision|0|||
156831451|NCT02699450|566135825|FG000|Overall Study|Withdrawal by Subject|3|||
156831452|NCT02699450|566135826|FG001|Overall Study|Withdrawal by Subject|1|||
156831453|NCT02699450|566135827|FG002|Overall Study|Withdrawal by Subject|2|||
156831454|NCT02699450|566135825|FG000|Overall Study|Adverse Event|1|||
156831455|NCT02699450|566135826|FG001|Overall Study|Adverse Event|0|||
156831456|NCT02699450|566135827|FG002|Overall Study|Adverse Event|0|||
156831457|NCT00810901|566135828|FG000|Overall Study|Lost to Follow-up|88|||
156831458|NCT00810901|566135829|FG001|Overall Study|Lost to Follow-up|58|||
156831459|NCT00931801|566135830|FG000|Overall Study|Adverse Event|0|||
156831460|NCT00931801|566135831|FG001|Overall Study|Adverse Event|0|||
156831461|NCT00931801|566135832|FG002|Overall Study|Adverse Event|1|||
156831462|NCT00931801|566135830|FG000|Overall Study|Lost to Follow-up|0|||
156831463|NCT00931801|566135831|FG001|Overall Study|Lost to Follow-up|1|||
156831464|NCT00931801|566135832|FG002|Overall Study|Lost to Follow-up|0|||
156831465|NCT00931801|566135830|FG000|Overall Study|Withdrawal by Subject|1|||
156831466|NCT00931801|566135831|FG001|Overall Study|Withdrawal by Subject|0|||
156831467|NCT00931801|566135832|FG002|Overall Study|Withdrawal by Subject|0|||
156831468|NCT00931801|566135830|FG000|Overall Study|Confirmed Virologic Failure|0|||
156831469|NCT00931801|566135831|FG001|Overall Study|Confirmed Virologic Failure|0|||
156831470|NCT00931801|566135832|FG002|Overall Study|Confirmed Virologic Failure|3|||
156831471|NCT01133275|566135833|FG000|Overall Study|Withdrawal by Subject|1|||
156831472|NCT01133275|566135833|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
156831473|NCT02689076|566135834|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
156831474|NCT02689076|566135835|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
156831475|NCT02689076|566135836|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
156831476|NCT02689076|566135834|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
156831477|NCT02689076|566135835|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
156831478|NCT02689076|566135836|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
156831479|NCT02689076|566135834|FG000|Overall Study|Did not have an HIE match|2|||
156831480|NCT02689076|566135835|FG001|Overall Study|Did not have an HIE match|0|||
156831481|NCT02689076|566135836|FG002|Overall Study|Did not have an HIE match|0|||
156831482|NCT02689076|566135834|FG000|Overall Study|Death during non-VA encounter|2|||
156831483|NCT02689076|566135835|FG001|Overall Study|Death during non-VA encounter|5|||
156831484|NCT02689076|566135836|FG002|Overall Study|Death during non-VA encounter|0|||
156831485|NCT02689076|566135834|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
156831486|NCT02689076|566135835|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
156831487|NCT02689076|566135836|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
156831488|NCT02689076|566135834|FG000|Overall Study|Participant no longer active in VA system|1|||
156831489|NCT02689076|566135835|FG001|Overall Study|Participant no longer active in VA system|0|||
156831490|NCT02689076|566135836|FG002|Overall Study|Participant no longer active in VA system|0|||
156831491|NCT02689076|566135834|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
156831492|NCT02689076|566135835|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
156831493|NCT02689076|566135836|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
156831494|NCT02266875|566135837|FG000|Overall Study|Withdrawal by Subject|9|||
156831495|NCT02266875|566135838|FG001|Overall Study|Withdrawal by Subject|0|||
156831496|NCT02266875|566135837|FG000|Overall Study|Lost to Follow-up|2|||
156831497|NCT02266875|566135838|FG001|Overall Study|Lost to Follow-up|0|||
156831498|NCT01143896|566135839|FG000|Overall Study|Did not complete Baseline Interview|5|||
156831499|NCT01143896|566135840|FG001|Overall Study|Did not complete Baseline Interview|4|||
156831500|NCT01143896|566135839|FG000|Overall Study|Lost to Follow-up|18|||
156831501|NCT01143896|566135840|FG001|Overall Study|Lost to Follow-up|13|||
156831502|NCT01143896|566135839|FG000|Overall Study|Withdrawal by Subject|13|||
156831503|NCT01143896|566135840|FG001|Overall Study|Withdrawal by Subject|5|||
156831504|NCT01143896|566135839|FG000|Overall Study|Death|6|||
156831505|NCT01143896|566135840|FG001|Overall Study|Death|3|||
156831506|NCT01318070|566135841|FG000|Overall Study|Adverse Event|1|||
156831507|NCT01318070|566135842|FG001|Overall Study|Adverse Event|1|||
156831508|NCT01318070|566135843|FG002|Overall Study|Adverse Event|5|||
156466366|NCT00943917|564803860|FG009|Stage II|Pregnancy|0|||
156466367|NCT00943917|564803861|FG010|Stage II|Pregnancy|0|||
156831509|NCT01318070|566135841|FG000|Overall Study|Withdrawal by Subject|0|||
156831510|NCT01318070|566135842|FG001|Overall Study|Withdrawal by Subject|1|||
156831511|NCT01318070|566135843|FG002|Overall Study|Withdrawal by Subject|1|||
156466368|NCT00943917|564803862|FG011|Stage II|Pregnancy|0|||
156466369|NCT00943917|564803863|FG012|Stage II|Pregnancy|0|||
156466370|NCT00943917|564803864|FG013|Stage II|Pregnancy|0|||
156466371|NCT00943917|564803865|FG014|Stage II|Pregnancy|0|||
156466372|NCT00943917|564803851|FG000|Stage II Continuation|Adverse Event|0|||
156466373|NCT00943917|564803852|FG001|Stage II Continuation|Adverse Event|0|||
156466374|NCT00943917|564803853|FG002|Stage II Continuation|Adverse Event|0|||
156466375|NCT00943917|564803854|FG003|Stage II Continuation|Adverse Event|0|||
156466376|NCT00943917|564803855|FG004|Stage II Continuation|Adverse Event|0|||
156466377|NCT00943917|564803856|FG005|Stage II Continuation|Adverse Event|0|||
156466378|NCT00943917|564803857|FG006|Stage II Continuation|Adverse Event|0|||
156466379|NCT00943917|564803858|FG007|Stage II Continuation|Adverse Event|0|||
156466380|NCT00943917|564803859|FG008|Stage II Continuation|Adverse Event|0|||
156466381|NCT00943917|564803860|FG009|Stage II Continuation|Adverse Event|0|||
156466382|NCT00943917|564803861|FG010|Stage II Continuation|Adverse Event|0|||
156466383|NCT00943917|564803862|FG011|Stage II Continuation|Adverse Event|1|||
156466384|NCT00943917|564803863|FG012|Stage II Continuation|Adverse Event|2|||
156466385|NCT00943917|564803864|FG013|Stage II Continuation|Adverse Event|1|||
156466386|NCT00943917|564803865|FG014|Stage II Continuation|Adverse Event|1|||
156466387|NCT00943917|564803851|FG000|Stage II Continuation|Withdrawal by Subject|0|||
156466388|NCT00943917|564803852|FG001|Stage II Continuation|Withdrawal by Subject|0|||
156466389|NCT00943917|564803853|FG002|Stage II Continuation|Withdrawal by Subject|0|||
156466390|NCT00943917|564803854|FG003|Stage II Continuation|Withdrawal by Subject|0|||
156466391|NCT00943917|564803855|FG004|Stage II Continuation|Withdrawal by Subject|0|||
156466392|NCT00943917|564803856|FG005|Stage II Continuation|Withdrawal by Subject|0|||
156466393|NCT00943917|564803857|FG006|Stage II Continuation|Withdrawal by Subject|0|||
156466394|NCT00943917|564803858|FG007|Stage II Continuation|Withdrawal by Subject|0|||
156466395|NCT00943917|564803859|FG008|Stage II Continuation|Withdrawal by Subject|0|||
156466396|NCT00943917|564803860|FG009|Stage II Continuation|Withdrawal by Subject|0|||
156466397|NCT00943917|564803861|FG010|Stage II Continuation|Withdrawal by Subject|0|||
156831512|NCT01318070|566135841|FG000|Overall Study|Lack of Efficacy|0|||
156831513|NCT01318070|566135842|FG001|Overall Study|Lack of Efficacy|0|||
156831514|NCT01318070|566135843|FG002|Overall Study|Lack of Efficacy|1|||
156831515|NCT01318070|566135841|FG000|Overall Study|Principal Investigator Discretion|1|||
156831516|NCT01318070|566135842|FG001|Overall Study|Principal Investigator Discretion|0|||
156831517|NCT01318070|566135843|FG002|Overall Study|Principal Investigator Discretion|0|||
156831518|NCT01816906|566135848|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
156831519|NCT01816906|566135849|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
156831520|NCT01816906|566135848|FG000|Six Months|Lost to Follow-up|14|||
156831521|NCT01816906|566135849|FG001|Six Months|Lost to Follow-up|16|||
156339824|NCT00191139|564342230|FG000|Overall Study|Death|2|||
156339825|NCT00191139|564342231|FG001|Overall Study|Death|0|||
156339826|NCT00191139|564342230|FG000|Overall Study|Withdrawal by Subject|0|||
156339827|NCT00191139|564342231|FG001|Overall Study|Withdrawal by Subject|3|||
156339828|NCT00191139|564342230|FG000|Overall Study|Disease Progression|0|||
156831522|NCT01816906|566135848|FG000|12 Months|Adverse Event|2|||
156831523|NCT01816906|566135849|FG001|12 Months|Adverse Event|2|||
156831524|NCT01816906|566135848|FG000|12 Months|Death|0|||
156831525|NCT01816906|566135849|FG001|12 Months|Death|2|||
156831526|NCT01816906|566135848|FG000|12 Months|Lost to Follow-up|2|||
156831527|NCT01816906|566135849|FG001|12 Months|Lost to Follow-up|1|||
156831528|NCT04375397|566135850|FG000|Overall Study|Death|1|||
156831529|NCT04375397|566135851|FG001|Overall Study|Death|1|||
156831530|NCT04375397|566135850|FG000|Overall Study|Withdrew consent|2|||
156831531|NCT04375397|566135851|FG001|Overall Study|Withdrew consent|0|||
156831532|NCT04375397|566135850|FG000|Overall Study|Lost to Follow-up|6|||
156831533|NCT04375397|566135851|FG001|Overall Study|Lost to Follow-up|4|||
156831534|NCT04375397|566135850|FG000|Overall Study|Other, not specified|0|||
156339829|NCT00191139|564342231|FG001|Overall Study|Disease Progression|1|||
156466398|NCT00943917|564803862|FG011|Stage II Continuation|Withdrawal by Subject|0|||
156466399|NCT00943917|564803863|FG012|Stage II Continuation|Withdrawal by Subject|0|||
156339830|NCT00191139|564342230|FG000|Overall Study|Other|1|||
156466400|NCT00943917|564803864|FG013|Stage II Continuation|Withdrawal by Subject|1|||
156466401|NCT00943917|564803865|FG014|Stage II Continuation|Withdrawal by Subject|3|||
156339831|NCT00191139|564342231|FG001|Overall Study|Other|2|||
156466402|NCT00943917|564803851|FG000|Stage II Continuation|Protocol Violation|0|||
156831535|NCT04375397|566135851|FG001|Overall Study|Other, not specified|1|||
156466403|NCT00943917|564803852|FG001|Stage II Continuation|Protocol Violation|0|||
156466404|NCT00943917|564803853|FG002|Stage II Continuation|Protocol Violation|0|||
156466405|NCT00943917|564803854|FG003|Stage II Continuation|Protocol Violation|0|||
156466406|NCT00943917|564803855|FG004|Stage II Continuation|Protocol Violation|0|||
156831536|NCT00086502|566135852|FG000|Overall Study|Adverse Event|11|||
156466407|NCT00943917|564803856|FG005|Stage II Continuation|Protocol Violation|0|||
156466408|NCT00943917|564803857|FG006|Stage II Continuation|Protocol Violation|0|||
156466409|NCT00943917|564803858|FG007|Stage II Continuation|Protocol Violation|0|||
156466410|NCT00943917|564803859|FG008|Stage II Continuation|Protocol Violation|0|||
156466411|NCT00943917|564803860|FG009|Stage II Continuation|Protocol Violation|1|||
156466412|NCT00943917|564803861|FG010|Stage II Continuation|Protocol Violation|0|||
156466413|NCT00943917|564803862|FG011|Stage II Continuation|Protocol Violation|1|||
156466414|NCT00943917|564803863|FG012|Stage II Continuation|Protocol Violation|0|||
156466415|NCT00943917|564803864|FG013|Stage II Continuation|Protocol Violation|0|||
156466416|NCT00943917|564803865|FG014|Stage II Continuation|Protocol Violation|0|||
156466417|NCT00943917|564803851|FG000|Stage II Continuation|hypoglycemia|0|||
156466418|NCT00943917|564803852|FG001|Stage II Continuation|hypoglycemia|0|||
156466419|NCT00943917|564803853|FG002|Stage II Continuation|hypoglycemia|0|||
156831537|NCT00086502|566135853|FG001|Overall Study|Adverse Event|2|||
156831538|NCT00086502|566135852|FG000|Overall Study|Lack of Efficacy|0|||
156831539|NCT00086502|566135853|FG001|Overall Study|Lack of Efficacy|2|||
156831540|NCT00086502|566135852|FG000|Overall Study|Lost to Follow-up|3|||
156831541|NCT00086502|566135853|FG001|Overall Study|Lost to Follow-up|1|||
156831542|NCT00086502|566135852|FG000|Overall Study|Physician Decision|1|||
156831543|NCT00086502|566135853|FG001|Overall Study|Physician Decision|1|||
156831544|NCT00086502|566135852|FG000|Overall Study|Pregnancy|0|||
156831545|NCT00086502|566135853|FG001|Overall Study|Pregnancy|1|||
156831546|NCT00086502|566135852|FG000|Overall Study|Protocol Violation|3|||
156831547|NCT00086502|566135853|FG001|Overall Study|Protocol Violation|3|||
156831548|NCT00086502|566135852|FG000|Overall Study|Withdrawal by Subject|5|||
156831549|NCT00086502|566135853|FG001|Overall Study|Withdrawal by Subject|6|||
156831550|NCT00086502|566135852|FG000|Overall Study|Patient Moved|1|||
156831551|NCT00086502|566135853|FG001|Overall Study|Patient Moved|1|||
156831552|NCT00086502|566135852|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
156831553|NCT00086502|566135853|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
156831554|NCT00086502|566135852|FG000|Overall Study|Patient Accidentally Unblinded|1|||
156831555|NCT00086502|566135853|FG001|Overall Study|Patient Accidentally Unblinded|0|||
156831556|NCT03618628|566135858|FG000|Overall Study|Death|1|||
156831557|NCT03618628|566135858|FG000|Overall Study|Lost to Follow-up|1|||
156831558|NCT00612508|566135859|FG000|Overall Study|Withdrawal by Subject|3|||
156831559|NCT00612508|566135860|FG001|Overall Study|Withdrawal by Subject|4|||
156831560|NCT01442064|566135861|FG000|Overall Study|Adverse Event|2|||
156831561|NCT01442064|566135862|FG001|Overall Study|Adverse Event|2|||
156831562|NCT01442064|566135863|FG002|Overall Study|Adverse Event|2|||
156831563|NCT01442064|566135864|FG003|Overall Study|Adverse Event|1|||
156831564|NCT01442064|566135865|FG004|Overall Study|Adverse Event|2|||
156831565|NCT01442064|566135866|FG005|Overall Study|Adverse Event|0|||
156831566|NCT01442064|566135861|FG000|Overall Study|Death|0|||
156831567|NCT01442064|566135862|FG001|Overall Study|Death|1|||
156831568|NCT01442064|566135863|FG002|Overall Study|Death|3|||
156831569|NCT01442064|566135864|FG003|Overall Study|Death|3|||
156831570|NCT01442064|566135865|FG004|Overall Study|Death|1|||
156466420|NCT00943917|564803854|FG003|Stage II Continuation|hypoglycemia|0|||
156466421|NCT00943917|564803855|FG004|Stage II Continuation|hypoglycemia|0|||
156466422|NCT00943917|564803856|FG005|Stage II Continuation|hypoglycemia|0|||
156466423|NCT00943917|564803857|FG006|Stage II Continuation|hypoglycemia|0|||
156466424|NCT00943917|564803858|FG007|Stage II Continuation|hypoglycemia|0|||
156466425|NCT00943917|564803859|FG008|Stage II Continuation|hypoglycemia|0|||
156831571|NCT01442064|566135866|FG005|Overall Study|Death|3|||
156831572|NCT01442064|566135861|FG000|Overall Study|Lost to Follow-up|5|||
156831573|NCT01442064|566135862|FG001|Overall Study|Lost to Follow-up|5|||
156831574|NCT01442064|566135863|FG002|Overall Study|Lost to Follow-up|1|||
156831575|NCT01442064|566135864|FG003|Overall Study|Lost to Follow-up|1|||
156831576|NCT01442064|566135865|FG004|Overall Study|Lost to Follow-up|3|||
156831577|NCT01442064|566135866|FG005|Overall Study|Lost to Follow-up|3|||
156831578|NCT01442064|566135861|FG000|Overall Study|Physician Decision|1|||
156831579|NCT01442064|566135862|FG001|Overall Study|Physician Decision|1|||
156831580|NCT01442064|566135863|FG002|Overall Study|Physician Decision|2|||
156831581|NCT01442064|566135864|FG003|Overall Study|Physician Decision|3|||
156831582|NCT01442064|566135865|FG004|Overall Study|Physician Decision|3|||
156831583|NCT01442064|566135866|FG005|Overall Study|Physician Decision|1|||
156831584|NCT01442064|566135861|FG000|Overall Study|Withdrawal by Subject|6|||
156831585|NCT01442064|566135862|FG001|Overall Study|Withdrawal by Subject|3|||
156831586|NCT01442064|566135863|FG002|Overall Study|Withdrawal by Subject|2|||
156831587|NCT01442064|566135864|FG003|Overall Study|Withdrawal by Subject|2|||
156831588|NCT01442064|566135865|FG004|Overall Study|Withdrawal by Subject|2|||
156831589|NCT01442064|566135866|FG005|Overall Study|Withdrawal by Subject|1|||
156831590|NCT01442064|566135861|FG000|Overall Study|Sponsor decision|82|||
156831591|NCT01442064|566135862|FG001|Overall Study|Sponsor decision|88|||
156831592|NCT01442064|566135863|FG002|Overall Study|Sponsor decision|92|||
156831593|NCT01442064|566135864|FG003|Overall Study|Sponsor decision|88|||
156831594|NCT01442064|566135865|FG004|Overall Study|Sponsor decision|95|||
156831595|NCT01442064|566135866|FG005|Overall Study|Sponsor decision|87|||
156831596|NCT01442064|566135861|FG000|Overall Study|Subject non-compliance|0|||
156831597|NCT01442064|566135862|FG001|Overall Study|Subject non-compliance|0|||
156831598|NCT01442064|566135863|FG002|Overall Study|Subject non-compliance|0|||
156831599|NCT01442064|566135864|FG003|Overall Study|Subject non-compliance|0|||
156831600|NCT01442064|566135865|FG004|Overall Study|Subject non-compliance|0|||
156831601|NCT01442064|566135866|FG005|Overall Study|Subject non-compliance|2|||
156831602|NCT01442064|566135861|FG000|Overall Study|Condition mandated other intervention|1|||
156831603|NCT01442064|566135862|FG001|Overall Study|Condition mandated other intervention|1|||
156831604|NCT01442064|566135863|FG002|Overall Study|Condition mandated other intervention|2|||
156831605|NCT01442064|566135864|FG003|Overall Study|Condition mandated other intervention|0|||
156831606|NCT01442064|566135865|FG004|Overall Study|Condition mandated other intervention|0|||
156831607|NCT01442064|566135866|FG005|Overall Study|Condition mandated other intervention|2|||
156831608|NCT04941807|566135867|FG000|Overall Study|Lost to Follow-up|1|||
156831609|NCT04941807|566135868|FG001|Overall Study|Lost to Follow-up|1|||
156831610|NCT03553498|566135869|FG000|Overall Study|Missing primary outcome|1|||
156831611|NCT03553498|566135870|FG001|Overall Study|Missing primary outcome|2|||
156831612|NCT02741570|566135871|FG000|Pre-Treatment Period|Other reasons|0|||
156831613|NCT02741570|566135872|FG001|Pre-Treatment Period|Other reasons|3|||
156831614|NCT02741570|566135871|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
156831615|NCT02741570|566135872|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
156831616|NCT02741570|566135871|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
156831617|NCT02741570|566135872|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
156831618|NCT02741570|566135871|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
156831619|NCT02741570|566135872|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
156831620|NCT02741570|566135871|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
156831621|NCT02741570|566135872|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
156831622|NCT02741570|566135871|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
156831623|NCT02741570|566135872|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
156831624|NCT02741570|566135871|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
156831625|NCT02741570|566135872|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156831626|NCT02741570|566135871|FG000|Pre-Treatment Period|Death|0|||
156831627|NCT02741570|566135872|FG001|Pre-Treatment Period|Death|1|||
156831628|NCT02741570|566135871|FG000|Pre-Treatment Period|Disease progression|0|||
156831629|NCT02741570|566135872|FG001|Pre-Treatment Period|Disease progression|1|||
156831630|NCT02741570|566135871|FG000|Treatment Period|Other reasons|47|||
156831631|NCT02741570|566135872|FG001|Treatment Period|Other reasons|12|||
156831632|NCT02741570|566135871|FG000|Treatment Period|Poor/non-compliance|0|||
156831633|NCT02741570|566135872|FG001|Treatment Period|Poor/non-compliance|2|||
156831634|NCT02741570|566135871|FG000|Treatment Period|Maximum clinical benefit|4|||
156831635|NCT02741570|566135872|FG001|Treatment Period|Maximum clinical benefit|6|||
156831636|NCT02741570|566135871|FG000|Treatment Period|Lost to Follow-up|1|||
156831637|NCT02741570|566135872|FG001|Treatment Period|Lost to Follow-up|3|||
156831638|NCT02741570|566135871|FG000|Treatment Period|Participant withdrew consent|9|||
156831639|NCT02741570|566135872|FG001|Treatment Period|Participant withdrew consent|13|||
156831640|NCT02741570|566135871|FG000|Treatment Period|Participant request to discontinue treatment|8|||
156831641|NCT02741570|566135872|FG001|Treatment Period|Participant request to discontinue treatment|23|||
156831642|NCT02741570|566135871|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
156831643|NCT02741570|566135872|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
156831644|NCT02741570|566135871|FG000|Treatment Period|Death|9|||
156831645|NCT02741570|566135872|FG001|Treatment Period|Death|7|||
156831646|NCT02741570|566135871|FG000|Treatment Period|Study drug toxicity|55|||
156831647|NCT02741570|566135872|FG001|Treatment Period|Study drug toxicity|47|||
156831648|NCT02741570|566135871|FG000|Treatment Period|Disease progression|294|||
156831649|NCT02741570|566135872|FG001|Treatment Period|Disease progression|301|||
156466426|NCT00943917|564803860|FG009|Stage II Continuation|hypoglycemia|0|||
156466427|NCT00943917|564803861|FG010|Stage II Continuation|hypoglycemia|0|||
156466428|NCT00943917|564803862|FG011|Stage II Continuation|hypoglycemia|0|||
156466429|NCT00943917|564803863|FG012|Stage II Continuation|hypoglycemia|1|||
156466430|NCT00943917|564803864|FG013|Stage II Continuation|hypoglycemia|0|||
156466431|NCT00943917|564803865|FG014|Stage II Continuation|hypoglycemia|0|||
156466432|NCT00943917|564803851|FG000|Stage II Continuation|A1C elevation|0|||
156466433|NCT00943917|564803852|FG001|Stage II Continuation|A1C elevation|0|||
156466434|NCT00943917|564803853|FG002|Stage II Continuation|A1C elevation|0|||
156466435|NCT00943917|564803854|FG003|Stage II Continuation|A1C elevation|0|||
156466436|NCT00943917|564803855|FG004|Stage II Continuation|A1C elevation|0|||
156466437|NCT00943917|564803856|FG005|Stage II Continuation|A1C elevation|0|||
156466438|NCT00943917|564803857|FG006|Stage II Continuation|A1C elevation|0|||
156541291|NCT01358760|565074537|FG000|Overall Study|Lost to Follow-up|1|||
156831650|NCT02741570|566135871|FG000|Treatment Period|Administrative reason by sponsor|0|||
156831651|NCT02741570|566135872|FG001|Treatment Period|Administrative reason by sponsor|1|||
156831652|NCT01360398|566135873|FG000|Overall Study|Withdrawal by Subject|14|||
156831653|NCT01360398|566135873|FG000|Overall Study|Other|7|||
156831654|NCT01360398|566135873|FG000|Overall Study|Migrated/moved from study area|1|||
156339832|NCT00816595|564342235|FG000|Overall Study|Withdrawal by Subject|2|||
156339833|NCT00816595|564342236|FG001|Overall Study|Withdrawal by Subject|0|||
156339834|NCT00453063|564342237|FG000|Overall Study|Adverse Event|1|||
156339835|NCT00453063|564342238|FG001|Overall Study|Adverse Event|2|||
156339836|NCT00453063|564342237|FG000|Overall Study|Withdrawal by Subject|1|||
156339837|NCT00453063|564342238|FG001|Overall Study|Withdrawal by Subject|1|||
156339838|NCT00453063|564342237|FG000|Overall Study|Protocol Violation|1|||
156339839|NCT00453063|564342238|FG001|Overall Study|Protocol Violation|0|||
156831655|NCT00846040|566135874|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
156831656|NCT00846040|566135875|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
156831657|NCT00846040|566135876|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
156831658|NCT00846040|566135874|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
156831659|NCT00846040|566135875|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
156831660|NCT00846040|566135876|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
156831661|NCT03158272|566135880|FG000|Overall Study|Disease progression|3|||
156831662|NCT03158272|566135881|FG001|Overall Study|Disease progression|3|||
156831663|NCT03158272|566135882|FG002|Overall Study|Disease progression|4|||
156831664|NCT03158272|566135883|FG003|Overall Study|Disease progression|6|||
156831665|NCT03158272|566135880|FG000|Overall Study|Death|0|||
156831666|NCT03158272|566135881|FG001|Overall Study|Death|0|||
156831667|NCT03158272|566135882|FG002|Overall Study|Death|1|||
156831668|NCT03158272|566135883|FG003|Overall Study|Death|0|||
156831669|NCT03158272|566135880|FG000|Overall Study|Other reasons|0|||
156831670|NCT03158272|566135881|FG001|Overall Study|Other reasons|0|||
156831671|NCT03158272|566135882|FG002|Overall Study|Other reasons|1|||
156831672|NCT03158272|566135883|FG003|Overall Study|Other reasons|0|||
156831673|NCT03158272|566135880|FG000|Overall Study|Adverse event unrelated to the drug|0|||
156831674|NCT03158272|566135881|FG001|Overall Study|Adverse event unrelated to the drug|1|||
156831675|NCT03158272|566135882|FG002|Overall Study|Adverse event unrelated to the drug|0|||
156831676|NCT03158272|566135883|FG003|Overall Study|Adverse event unrelated to the drug|0|||
156831677|NCT01822535|566135884|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
156831678|NCT01822535|566135885|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
156831679|NCT01822535|566135884|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
156831680|NCT01822535|566135885|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
156831681|NCT01822535|566135884|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
156831682|NCT01822535|566135885|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
156831683|NCT01048866|566135890|FG000|Overall Study|Adverse Event|1|||
156831684|NCT01048866|566135891|FG001|Overall Study|Adverse Event|0|||
156831685|NCT01048866|566135890|FG000|Overall Study|Protocol Violation|1|||
156831686|NCT01048866|566135891|FG001|Overall Study|Protocol Violation|0|||
156831687|NCT01048866|566135890|FG000|Overall Study|Physician Decision|1|||
156831688|NCT01048866|566135891|FG001|Overall Study|Physician Decision|0|||
156831689|NCT01048866|566135890|FG000|Overall Study|Withdrawal by Subject|0|||
156831690|NCT01048866|566135891|FG001|Overall Study|Withdrawal by Subject|2|||
156831691|NCT01048866|566135890|FG000|Overall Study|Lost to Follow-up|0|||
156831692|NCT01048866|566135891|FG001|Overall Study|Lost to Follow-up|2|||
156831693|NCT01048866|566135890|FG000|Overall Study|Other|1|||
156831694|NCT01048866|566135891|FG001|Overall Study|Other|1|||
156831695|NCT03582813|566135892|FG000|Overall Study|Lost to Follow-up|18|||
156831696|NCT03582813|566135893|FG001|Overall Study|Lost to Follow-up|21|||
156831697|NCT03582813|566135892|FG000|Overall Study|Withdrawal by Subject|1|||
156831698|NCT03582813|566135893|FG001|Overall Study|Withdrawal by Subject|0|||
156831699|NCT01591863|566135898|FG000|Overall Study|Adverse Event|3|||
156831700|NCT01591863|566135898|FG000|Overall Study|Withdrawal by Subject|1|||
156831701|NCT01591863|566135898|FG000|Overall Study|recurrence|9|||
156831702|NCT01591863|566135898|FG000|Overall Study|Lack of Efficacy|1|||
156831703|NCT00160654|566135899|FG000|Overall Study|Adverse Event|14|||
156831704|NCT00160654|566135899|FG000|Overall Study|Lack of Efficacy|4|||
156831705|NCT00160654|566135899|FG000|Overall Study|Lost to Follow-up|2|||
156831706|NCT00160654|566135899|FG000|Overall Study|Intake of expired drug|7|||
156831707|NCT00160654|566135899|FG000|Overall Study|Psychological trauma|1|||
156831708|NCT00160654|566135899|FG000|Overall Study|Sponsor decision|1|||
156339840|NCT00114530|564342239|FG000|Overall Study|Death|3|||
156339841|NCT00114530|564342240|FG001|Overall Study|Death|11|||
156339842|NCT00114530|564342239|FG000|Overall Study|Lost to Follow-up|1|||
156466439|NCT00943917|564803858|FG007|Stage II Continuation|A1C elevation|0|||
156466440|NCT00943917|564803859|FG008|Stage II Continuation|A1C elevation|0|||
156831709|NCT00160654|566135899|FG000|Overall Study|Patient met exclusion criteria|1|||
156831710|NCT00160654|566135899|FG000|Overall Study|Patient decision|1|||
156831711|NCT00160654|566135899|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
156831712|NCT00160654|566135899|FG000|Overall Study|Met exclusion criteria|1|||
156831713|NCT02366767|566135902|FG000|Overall Study|left for home after 1 day at camp|1|||
156831714|NCT02366767|566135903|FG001|Overall Study|left for home after 1 day at camp|0|||
156831715|NCT02242981|566135904|FG000|Overall Study|Withdrawal by Subject|1|||
156339843|NCT00114530|564342240|FG001|Overall Study|Lost to Follow-up|1|||
156339844|NCT00114530|564342239|FG000|Overall Study|Physician Decision|1|||
156541292|NCT01358760|565074538|FG001|Overall Study|Lost to Follow-up|1|||
156831716|NCT03474081|566135909|FG000|Overall Study|Adverse Event|6|||
156831717|NCT03474081|566135910|FG001|Overall Study|Adverse Event|3|||
156831718|NCT03474081|566135909|FG000|Overall Study|Lost to Follow-up|2|||
156831719|NCT03474081|566135910|FG001|Overall Study|Lost to Follow-up|1|||
156831720|NCT03474081|566135909|FG000|Overall Study|Physician Decision|3|||
156831721|NCT03474081|566135910|FG001|Overall Study|Physician Decision|2|||
156831722|NCT03474081|566135909|FG000|Overall Study|Withdrawal by Subject|5|||
156831723|NCT03474081|566135910|FG001|Overall Study|Withdrawal by Subject|7|||
156831724|NCT03474081|566135909|FG000|Overall Study|Investigator site closed|1|||
156831725|NCT03474081|566135910|FG001|Overall Study|Investigator site closed|0|||
156831726|NCT02558400|566135913|FG000|Overall Study|Adverse Event|47|||
156831727|NCT02558400|566135914|FG001|Overall Study|Adverse Event|53|||
156831728|NCT02558400|566135915|FG002|Overall Study|Adverse Event|4|||
156831729|NCT02558400|566135913|FG000|Overall Study|Withdrawal by Subject|13|||
156831730|NCT02558400|566135914|FG001|Overall Study|Withdrawal by Subject|9|||
156831731|NCT02558400|566135915|FG002|Overall Study|Withdrawal by Subject|8|||
156831732|NCT02558400|566135913|FG000|Overall Study|Non-Compliant|0|||
156831733|NCT02558400|566135914|FG001|Overall Study|Non-Compliant|1|||
156831734|NCT02558400|566135915|FG002|Overall Study|Non-Compliant|3|||
156831735|NCT02558400|566135913|FG000|Overall Study|Lost to Follow-up|5|||
156831736|NCT02558400|566135914|FG001|Overall Study|Lost to Follow-up|5|||
156831737|NCT02558400|566135915|FG002|Overall Study|Lost to Follow-up|4|||
156831738|NCT02558400|566135913|FG000|Overall Study|Lack of Efficacy|0|||
156831739|NCT02558400|566135914|FG001|Overall Study|Lack of Efficacy|13|||
156831740|NCT02558400|566135915|FG002|Overall Study|Lack of Efficacy|1|||
156831741|NCT02558400|566135913|FG000|Overall Study|Disallowed Concurrent Medication|6|||
156831742|NCT02558400|566135914|FG001|Overall Study|Disallowed Concurrent Medication|7|||
156831743|NCT02558400|566135915|FG002|Overall Study|Disallowed Concurrent Medication|5|||
156831744|NCT02558400|566135913|FG000|Overall Study|Physician Decision|2|||
156831745|NCT02558400|566135914|FG001|Overall Study|Physician Decision|2|||
156831746|NCT02558400|566135915|FG002|Overall Study|Physician Decision|0|||
156831747|NCT02558400|566135913|FG000|Overall Study|Protocol Violation|6|||
156831748|NCT02558400|566135914|FG001|Overall Study|Protocol Violation|3|||
156831749|NCT02558400|566135915|FG002|Overall Study|Protocol Violation|8|||
156831750|NCT02558400|566135913|FG000|Overall Study|Death|0|||
156831751|NCT02558400|566135914|FG001|Overall Study|Death|1|||
156831752|NCT02558400|566135915|FG002|Overall Study|Death|0|||
156831753|NCT02558400|566135913|FG000|Overall Study|Ineligible for the study|0|||
156831754|NCT02558400|566135914|FG001|Overall Study|Ineligible for the study|2|||
156831755|NCT02558400|566135915|FG002|Overall Study|Ineligible for the study|0|||
156831756|NCT02230683|566135919|FG000|Overall Study|Adverse Event|1|||
156831757|NCT00456599|566135921|FG000|Overall Study|Non-compliance|1|||
156831758|NCT00456599|566135921|FG000|Overall Study|Withdrawal by Subject|2|||
156831759|NCT02198235|566135922|FG000|Overall Study|Lost to Follow-up|3|||
156831760|NCT02198235|566135923|FG001|Overall Study|Lost to Follow-up|2|||
156831761|NCT02198235|566135924|FG002|Overall Study|Lost to Follow-up|2|||
156831762|NCT00260065|566135925|FG000|Overall Study|Progressive Disease|22|||
156831763|NCT00260065|566135925|FG000|Overall Study|Adverse Event|17|||
156831764|NCT00260065|566135925|FG000|Overall Study|Death|13|||
156831765|NCT00260065|566135925|FG000|Overall Study|Withdrawal by Subject|13|||
156831766|NCT00260065|566135925|FG000|Overall Study|Physician Decision|19|||
156831767|NCT00260065|566135925|FG000|Overall Study|Not otherwise specified|8|||
156831768|NCT00260065|566135925|FG000|Overall Study|Medication Noncompliance|1|||
156831769|NCT04573881|566135927|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
156831770|NCT01304329|566137505|FG000|Third Intervention (3 Days)|Adverse Event|0|||
156831771|NCT01304329|566137506|FG001|Third Intervention (3 Days)|Adverse Event|1|||
156831772|NCT01304329|566137507|FG002|Third Intervention (3 Days)|Adverse Event|0|||
156831773|NCT01304329|566137508|FG003|Third Intervention (3 Days)|Adverse Event|0|||
156831774|NCT01304329|566137509|FG004|Third Intervention (3 Days)|Adverse Event|0|||
156831775|NCT01304329|566137510|FG005|Third Intervention (3 Days)|Adverse Event|0|||
156831776|NCT05545644|566137512|FG000|Overall Study|Lost to Follow-up|4|||
156831777|NCT05545644|566137513|FG001|Overall Study|Lost to Follow-up|3|||
156831778|NCT00610441|566137514|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
156831779|NCT00610441|566137515|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
156831780|NCT00610441|566137516|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
156831781|NCT00610441|566137517|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
156541293|NCT01358760|565074539|FG002|Overall Study|Lost to Follow-up|3|||
156831782|NCT00610441|566137514|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
156831783|NCT00610441|566137515|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
156831784|NCT00610441|566137516|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
156831785|NCT00610441|566137517|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
156831786|NCT00610441|566137514|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
156831787|NCT00610441|566137515|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
156831788|NCT00610441|566137516|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
156831789|NCT00610441|566137517|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
156831790|NCT00610441|566137514|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
156831791|NCT00610441|566137515|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
156466441|NCT00943917|564803860|FG009|Stage II Continuation|A1C elevation|0|||
156831792|NCT00610441|566137516|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
156831793|NCT00610441|566137517|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
156831794|NCT00610441|566137514|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
156831795|NCT00610441|566137515|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
156831796|NCT00610441|566137516|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
156831797|NCT00610441|566137517|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
156831798|NCT00610441|566137514|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
156831799|NCT00610441|566137515|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
156831800|NCT00610441|566137516|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
156831801|NCT00610441|566137517|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
156466442|NCT00943917|564803861|FG010|Stage II Continuation|A1C elevation|0|||
156466443|NCT00943917|564803862|FG011|Stage II Continuation|A1C elevation|0|||
156466444|NCT00943917|564803863|FG012|Stage II Continuation|A1C elevation|0|||
156466445|NCT00943917|564803864|FG013|Stage II Continuation|A1C elevation|1|||
156831802|NCT00610441|566137514|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
156466446|NCT00943917|564803865|FG014|Stage II Continuation|A1C elevation|0|||
156466447|NCT01171976|564803866|FG000|Overall Study|Protocol Violation|0|||
156466448|NCT01171976|564803867|FG001|Overall Study|Protocol Violation|0|||
156466449|NCT01171976|564803868|FG002|Overall Study|Protocol Violation|1|||
156466450|NCT01171976|564803866|FG000|Overall Study|Death|2|||
156466451|NCT01171976|564803867|FG001|Overall Study|Death|4|||
156466452|NCT01171976|564803868|FG002|Overall Study|Death|1|||
156466453|NCT01171976|564803866|FG000|Overall Study|Lost to Follow-up|4|||
156466454|NCT01171976|564803867|FG001|Overall Study|Lost to Follow-up|0|||
156466455|NCT01171976|564803868|FG002|Overall Study|Lost to Follow-up|2|||
156466456|NCT01171976|564803866|FG000|Overall Study|Withdrawal by Subject|1|||
156466457|NCT01171976|564803867|FG001|Overall Study|Withdrawal by Subject|5|||
156466458|NCT01171976|564803868|FG002|Overall Study|Withdrawal by Subject|6|||
156466459|NCT01171976|564803866|FG000|Overall Study|Abnormal test result|1|||
156466460|NCT01171976|564803867|FG001|Overall Study|Abnormal test result|0|||
156466461|NCT01171976|564803868|FG002|Overall Study|Abnormal test result|0|||
156466462|NCT01171976|564803866|FG000|Overall Study|Adverse Event|6|||
156466463|NCT01171976|564803867|FG001|Overall Study|Adverse Event|2|||
156466464|NCT01171976|564803868|FG002|Overall Study|Adverse Event|5|||
156466465|NCT03248492|564803869|FG000|Overall Study|Progressive Disease|24|||
156466466|NCT03248492|564803870|FG001|Overall Study|Progressive Disease|23|||
156466467|NCT03248492|564803871|FG002|Overall Study|Progressive Disease|11|||
156466468|NCT03248492|564803872|FG003|Overall Study|Progressive Disease|66|||
156466469|NCT03248492|564803873|FG004|Overall Study|Progressive Disease|1|||
156466470|NCT03248492|564803869|FG000|Overall Study|Adverse Event|14|||
156466471|NCT03248492|564803870|FG001|Overall Study|Adverse Event|13|||
156466472|NCT03248492|564803871|FG002|Overall Study|Adverse Event|9|||
156466473|NCT03248492|564803872|FG003|Overall Study|Adverse Event|22|||
156466474|NCT03248492|564803873|FG004|Overall Study|Adverse Event|2|||
156466475|NCT03248492|564803869|FG000|Overall Study|Withdrawal by Subject|5|||
156466476|NCT03248492|564803870|FG001|Overall Study|Withdrawal by Subject|4|||
156466477|NCT03248492|564803871|FG002|Overall Study|Withdrawal by Subject|0|||
156466478|NCT03248492|564803872|FG003|Overall Study|Withdrawal by Subject|8|||
156831803|NCT00610441|566137515|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
156831804|NCT00610441|566137516|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
156831805|NCT00610441|566137517|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
156831806|NCT00610441|566137514|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
156831807|NCT00610441|566137515|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
156831808|NCT00610441|566137516|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
156831809|NCT00610441|566137517|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
156831810|NCT00610441|566137514|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
156831811|NCT00610441|566137515|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
156831812|NCT00610441|566137516|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
156831813|NCT00610441|566137517|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
156831814|NCT01945775|566137527|FG000|Overall Study|Death|214|||
156831815|NCT01945775|566137528|FG001|Overall Study|Death|98|||
156831816|NCT01945775|566137527|FG000|Overall Study|Lost to Follow-up|12|||
156466479|NCT03248492|564803873|FG004|Overall Study|Withdrawal by Subject|1|||
156466480|NCT03248492|564803869|FG000|Overall Study|Physician Decision|1|||
156466481|NCT03248492|564803870|FG001|Overall Study|Physician Decision|1|||
156466482|NCT03248492|564803871|FG002|Overall Study|Physician Decision|1|||
156466483|NCT03248492|564803872|FG003|Overall Study|Physician Decision|7|||
156466484|NCT03248492|564803873|FG004|Overall Study|Physician Decision|0|||
156466485|NCT03248492|564803869|FG000|Overall Study|Death|1|||
156466486|NCT03248492|564803870|FG001|Overall Study|Death|1|||
156466487|NCT03248492|564803871|FG002|Overall Study|Death|0|||
156541294|NCT01358760|565074537|FG000|Overall Study|Withdrawal by Subject|5|||
156831817|NCT01945775|566137528|FG001|Overall Study|Lost to Follow-up|7|||
156466488|NCT03248492|564803872|FG003|Overall Study|Death|6|||
156466489|NCT03248492|564803873|FG004|Overall Study|Death|0|||
156466490|NCT03248492|564803869|FG000|Overall Study|Study Terminated by Sponsor|3|||
156831818|NCT01945775|566137527|FG000|Overall Study|Withdrawal by Subject|11|||
156831819|NCT01945775|566137528|FG001|Overall Study|Withdrawal by Subject|21|||
156831820|NCT01945775|566137527|FG000|Overall Study|Other|50|||
156831821|NCT01945775|566137528|FG001|Overall Study|Other|18|||
156831822|NCT02876328|566137529|FG000|Overall Study|Death|2|||
156831823|NCT02876328|566137530|FG001|Overall Study|Death|1|||
156831824|NCT02876328|566137531|FG002|Overall Study|Death|3|||
156831825|NCT02876328|566137532|FG003|Overall Study|Death|0|||
156831826|NCT02876328|566137533|FG004|Overall Study|Death|0|||
156831827|NCT02876328|566137534|FG005|Overall Study|Death|0|||
156831828|NCT02876328|566137535|FG006|Overall Study|Death|1|||
156831829|NCT02876328|566137536|FG007|Overall Study|Death|3|||
156831830|NCT02876328|566137537|FG008|Overall Study|Death|0|||
156831831|NCT02876328|566137538|FG009|Overall Study|Death|1|||
156831832|NCT02876328|566137539|FG010|Overall Study|Death|1|||
156831833|NCT02876328|566137540|FG011|Overall Study|Death|0|||
156831834|NCT02876328|566137541|FG012|Overall Study|Death|0|||
156831835|NCT02876328|566137542|FG013|Overall Study|Death|0|||
156831836|NCT02876328|566137543|FG014|Overall Study|Death|0|||
156831837|NCT02876328|566137544|FG015|Overall Study|Death|0|||
156831838|NCT02876328|566137545|FG016|Overall Study|Death|1|||
156831839|NCT02876328|566137546|FG017|Overall Study|Death|1|||
156831840|NCT02876328|566137547|FG018|Overall Study|Death|0|||
156831841|NCT02876328|566137548|FG019|Overall Study|Death|0|||
156831842|NCT02876328|566137549|FG020|Overall Study|Death|0|||
156831843|NCT02876328|566137550|FG021|Overall Study|Death|1|||
156831844|NCT02876328|566137551|FG022|Overall Study|Death|0|||
156831845|NCT02876328|566137552|FG023|Overall Study|Death|0|||
156831846|NCT02876328|566137529|FG000|Overall Study|Withdrawal by Subject|0|||
156831847|NCT02876328|566137530|FG001|Overall Study|Withdrawal by Subject|2|||
156831848|NCT02876328|566137531|FG002|Overall Study|Withdrawal by Subject|3|||
156831849|NCT02876328|566137532|FG003|Overall Study|Withdrawal by Subject|3|||
156831850|NCT02876328|566137533|FG004|Overall Study|Withdrawal by Subject|0|||
156831851|NCT02876328|566137534|FG005|Overall Study|Withdrawal by Subject|1|||
156831852|NCT02876328|566137535|FG006|Overall Study|Withdrawal by Subject|0|||
156831853|NCT02876328|566137536|FG007|Overall Study|Withdrawal by Subject|1|||
156831854|NCT02876328|566137537|FG008|Overall Study|Withdrawal by Subject|1|||
156831855|NCT02876328|566137538|FG009|Overall Study|Withdrawal by Subject|2|||
156831856|NCT02876328|566137539|FG010|Overall Study|Withdrawal by Subject|0|||
156831857|NCT02876328|566137540|FG011|Overall Study|Withdrawal by Subject|0|||
156831858|NCT02876328|566137541|FG012|Overall Study|Withdrawal by Subject|0|||
156831859|NCT02876328|566137542|FG013|Overall Study|Withdrawal by Subject|0|||
156831860|NCT02876328|566137543|FG014|Overall Study|Withdrawal by Subject|0|||
156831861|NCT02876328|566137544|FG015|Overall Study|Withdrawal by Subject|0|||
156831862|NCT02876328|566137545|FG016|Overall Study|Withdrawal by Subject|1|||
156831863|NCT02876328|566137546|FG017|Overall Study|Withdrawal by Subject|3|||
156831864|NCT02876328|566137547|FG018|Overall Study|Withdrawal by Subject|0|||
156831865|NCT02876328|566137548|FG019|Overall Study|Withdrawal by Subject|0|||
156831866|NCT02876328|566137549|FG020|Overall Study|Withdrawal by Subject|1|||
156831867|NCT02876328|566137550|FG021|Overall Study|Withdrawal by Subject|0|||
156831868|NCT02876328|566137551|FG022|Overall Study|Withdrawal by Subject|0|||
156831869|NCT02876328|566137552|FG023|Overall Study|Withdrawal by Subject|0|||
156831870|NCT02876328|566137529|FG000|Overall Study|Missed 12 Month Visit|15|||
156831871|NCT02876328|566137530|FG001|Overall Study|Missed 12 Month Visit|10|||
156831872|NCT02876328|566137531|FG002|Overall Study|Missed 12 Month Visit|11|||
156831873|NCT02876328|566137532|FG003|Overall Study|Missed 12 Month Visit|6|||
156831874|NCT02876328|566137533|FG004|Overall Study|Missed 12 Month Visit|10|||
156831875|NCT02876328|566137534|FG005|Overall Study|Missed 12 Month Visit|14|||
156831876|NCT02876328|566137535|FG006|Overall Study|Missed 12 Month Visit|3|||
156831877|NCT02876328|566137536|FG007|Overall Study|Missed 12 Month Visit|8|||
156831878|NCT02876328|566137537|FG008|Overall Study|Missed 12 Month Visit|9|||
156831879|NCT02876328|566137538|FG009|Overall Study|Missed 12 Month Visit|5|||
156831880|NCT02876328|566137539|FG010|Overall Study|Missed 12 Month Visit|4|||
156831881|NCT02876328|566137540|FG011|Overall Study|Missed 12 Month Visit|1|||
156831882|NCT02876328|566137541|FG012|Overall Study|Missed 12 Month Visit|5|||
156831883|NCT02876328|566137542|FG013|Overall Study|Missed 12 Month Visit|4|||
156831884|NCT02876328|566137543|FG014|Overall Study|Missed 12 Month Visit|4|||
156831885|NCT02876328|566137544|FG015|Overall Study|Missed 12 Month Visit|4|||
156466491|NCT03248492|564803870|FG001|Overall Study|Study Terminated by Sponsor|1|||
156831886|NCT02876328|566137545|FG016|Overall Study|Missed 12 Month Visit|3|||
156831887|NCT02876328|566137546|FG017|Overall Study|Missed 12 Month Visit|6|||
156831888|NCT02876328|566137547|FG018|Overall Study|Missed 12 Month Visit|2|||
156831889|NCT02876328|566137548|FG019|Overall Study|Missed 12 Month Visit|2|||
156831890|NCT02876328|566137549|FG020|Overall Study|Missed 12 Month Visit|11|||
156831891|NCT02876328|566137550|FG021|Overall Study|Missed 12 Month Visit|7|||
156831892|NCT02876328|566137551|FG022|Overall Study|Missed 12 Month Visit|1|||
156831893|NCT02876328|566137552|FG023|Overall Study|Missed 12 Month Visit|0|||
156831894|NCT01287195|566137553|FG000|Overall Study|Withdrawal by Subject|2|||
156831895|NCT00334282|566137561|FG000|Overall Study|Lost to Follow-up|11|||
156831896|NCT00334282|566137562|FG001|Overall Study|Lost to Follow-up|5|||
156831897|NCT00334282|566137561|FG000|Overall Study|Withdrawal by Subject|17|||
156831898|NCT00334282|566137562|FG001|Overall Study|Withdrawal by Subject|3|||
156831899|NCT00334282|566137561|FG000|Overall Study|Death|194|||
156831900|NCT00334282|566137562|FG001|Overall Study|Death|100|||
156831901|NCT01420627|566137563|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
156831902|NCT00837876|566137564|FG000|Overall Study|Death|2|||
156831903|NCT00837876|566137564|FG000|Overall Study|Adverse Event|7|||
156831904|NCT00837876|566137564|FG000|Overall Study|Physician Decision|1|||
156831905|NCT00837876|566137564|FG000|Overall Study|Withdrawal by Subject|3|||
156831906|NCT00837876|566137564|FG000|Overall Study|disease progression|24|||
156831907|NCT00276094|566137567|FG000|Overall Study|Adverse Event|15|||
156831908|NCT00276094|566137568|FG001|Overall Study|Adverse Event|13|||
156831909|NCT00276094|566137569|FG002|Overall Study|Adverse Event|11|||
156831910|NCT00276094|566137567|FG000|Overall Study|Withdrawal by Subject|14|||
156831911|NCT00276094|566137568|FG001|Overall Study|Withdrawal by Subject|14|||
156831912|NCT00276094|566137569|FG002|Overall Study|Withdrawal by Subject|12|||
156831913|NCT00276094|566137567|FG000|Overall Study|Protocol Violation|16|||
156831914|NCT00276094|566137568|FG001|Overall Study|Protocol Violation|7|||
156831915|NCT00276094|566137569|FG002|Overall Study|Protocol Violation|10|||
156831916|NCT00276094|566137567|FG000|Overall Study|Lost to Follow-up|8|||
156831917|NCT00276094|566137568|FG001|Overall Study|Lost to Follow-up|6|||
156831918|NCT00276094|566137569|FG002|Overall Study|Lost to Follow-up|4|||
156831919|NCT00276094|566137567|FG000|Overall Study|Other-Subject moved out of country|1|||
156831920|NCT00276094|566137568|FG001|Overall Study|Other-Subject moved out of country|0|||
156831921|NCT00276094|566137569|FG002|Overall Study|Other-Subject moved out of country|0|||
156831922|NCT00276094|566137567|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
156831923|NCT00276094|566137568|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
156831924|NCT00276094|566137569|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
156831925|NCT00276094|566137567|FG000|Overall Study|Other-Lack of efficacy|1|||
156831926|NCT00276094|566137568|FG001|Overall Study|Other-Lack of efficacy|0|||
156831927|NCT00276094|566137569|FG002|Overall Study|Other-Lack of efficacy|0|||
156831928|NCT00276094|566137567|FG000|Overall Study|Other-Refused follow-up visit|1|||
156831929|NCT00276094|566137568|FG001|Overall Study|Other-Refused follow-up visit|0|||
156831930|NCT00276094|566137569|FG002|Overall Study|Other-Refused follow-up visit|0|||
156831931|NCT00276094|566137567|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
156831932|NCT00276094|566137568|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
156831933|NCT00276094|566137569|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
156831934|NCT00276094|566137567|FG000|Overall Study|Other-Relocation|0|||
156831935|NCT00276094|566137568|FG001|Overall Study|Other-Relocation|1|||
156831936|NCT00276094|566137569|FG002|Overall Study|Other-Relocation|0|||
156831937|NCT00276094|566137567|FG000|Overall Study|Other-Study medication lost|0|||
156831938|NCT00276094|566137568|FG001|Overall Study|Other-Study medication lost|0|||
156831939|NCT00276094|566137569|FG002|Overall Study|Other-Study medication lost|1|||
156831940|NCT02759315|566137576|FG000|Overall Study|Adverse Event|0|||
156831941|NCT02759315|566137577|FG001|Overall Study|Adverse Event|0|||
156831942|NCT02759315|566137578|FG002|Overall Study|Adverse Event|0|||
156831943|NCT02759315|566137579|FG003|Overall Study|Adverse Event|1|||
156831944|NCT02759315|566137580|FG004|Overall Study|Adverse Event|0|||
156831945|NCT02759315|566137576|FG000|Overall Study|Death|0|||
156831946|NCT02759315|566137577|FG001|Overall Study|Death|0|||
156831947|NCT02759315|566137578|FG002|Overall Study|Death|1|||
156831948|NCT02759315|566137579|FG003|Overall Study|Death|0|||
156831949|NCT02759315|566137580|FG004|Overall Study|Death|0|||
156831950|NCT02759315|566137576|FG000|Overall Study|Lost to Follow-up|2|||
156831951|NCT02759315|566137577|FG001|Overall Study|Lost to Follow-up|0|||
156831952|NCT02759315|566137578|FG002|Overall Study|Lost to Follow-up|4|||
156831953|NCT02759315|566137579|FG003|Overall Study|Lost to Follow-up|0|||
156831954|NCT02759315|566137580|FG004|Overall Study|Lost to Follow-up|0|||
156831955|NCT02759315|566137576|FG000|Overall Study|Protocol Violation|0|||
156831956|NCT02759315|566137577|FG001|Overall Study|Protocol Violation|1|||
156831957|NCT02759315|566137578|FG002|Overall Study|Protocol Violation|0|||
156831958|NCT02759315|566137579|FG003|Overall Study|Protocol Violation|0|||
156831959|NCT02759315|566137580|FG004|Overall Study|Protocol Violation|0|||
156831960|NCT02759315|566137576|FG000|Overall Study|Study terminated prior to completion|2|||
156831961|NCT02759315|566137577|FG001|Overall Study|Study terminated prior to completion|0|||
156831962|NCT02759315|566137578|FG002|Overall Study|Study terminated prior to completion|5|||
156831963|NCT02759315|566137579|FG003|Overall Study|Study terminated prior to completion|0|||
156831964|NCT02759315|566137580|FG004|Overall Study|Study terminated prior to completion|1|||
156831965|NCT01996592|566137581|FG000|Overall Study|no response to text/no diary entry|32|||
156831966|NCT01996592|566137581|FG000|Overall Study|change in surgical date|4|||
156466492|NCT03248492|564803871|FG002|Overall Study|Study Terminated by Sponsor|0|||
156466493|NCT03248492|564803872|FG003|Overall Study|Study Terminated by Sponsor|7|||
156466494|NCT03248492|564803873|FG004|Overall Study|Study Terminated by Sponsor|0|||
156466495|NCT03248492|564803869|FG000|Overall Study|Other|2|||
156831967|NCT01996592|566137581|FG000|Overall Study|Withdrawal by Subject|5|||
156831968|NCT01996592|566137581|FG000|Overall Study|change in mode of delivery|4|||
156466496|NCT03248492|564803870|FG001|Overall Study|Other|5|||
156831969|NCT01406015|566137582|FG000|Overall Study|Withdrawal by Subject|3|||
156831970|NCT01406015|566137583|FG001|Overall Study|Withdrawal by Subject|3|||
156831971|NCT00787137|566137584|FG000|Overall Study|Study Termination|0|||
156831972|NCT00787137|566137585|FG001|Overall Study|Study Termination|0|||
156831973|NCT00787137|566137586|FG002|Overall Study|Study Termination|1|||
156831974|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
156831975|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
156831976|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
156831977|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
156831978|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
156831979|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
156831980|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156831981|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156831982|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
156831983|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
156831984|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
156831985|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
156831986|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
156831987|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
156831988|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
156831989|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
156831990|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
156831991|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
156831992|NCT00554099|566137590|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
156831993|NCT00554099|566137591|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
156831994|NCT00554099|566137592|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
156831995|NCT00554099|566137590|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
156831996|NCT00554099|566137591|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
156831997|NCT00554099|566137592|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
156831998|NCT00554099|566137590|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
156831999|NCT00554099|566137591|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
156832000|NCT00554099|566137592|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
156832001|NCT03464422|566137593|FG000|Overall Study|Lost to Follow-up|2|||
156832002|NCT03464422|566137593|FG000|Overall Study|Withdrawal by Subject|2|||
156832003|NCT01628367|566137597|FG000|Overall Study|Adverse Event|1|||
156832004|NCT01628367|566137598|FG001|Overall Study|Adverse Event|0|||
156832005|NCT04957758|566137601|FG000|Overall Study|Adverse Event|1|||
156832006|NCT04957758|566137602|FG001|Overall Study|Adverse Event|0|||
156832007|NCT04957758|566137601|FG000|Overall Study|Lost to Follow-up|0|||
156832008|NCT04957758|566137602|FG001|Overall Study|Lost to Follow-up|2|||
156832009|NCT04957758|566137601|FG000|Overall Study|Withdrawal by Subject|4|||
156832010|NCT04957758|566137602|FG001|Overall Study|Withdrawal by Subject|2|||
156832011|NCT04957758|566137601|FG000|Overall Study|Protocol Violation|0|||
156832012|NCT04957758|566137602|FG001|Overall Study|Protocol Violation|1|||
156832013|NCT03353922|566137603|FG000|Overall Study|Withdrawal by Subject|1|||
156832014|NCT03353922|566137604|FG001|Overall Study|Withdrawal by Subject|0|||
156832015|NCT03353922|566137605|FG002|Overall Study|Withdrawal by Subject|1|||
156832016|NCT03353922|566137606|FG003|Overall Study|Withdrawal by Subject|1|||
156832017|NCT03353922|566137607|FG004|Overall Study|Withdrawal by Subject|0|||
156832018|NCT03353922|566137608|FG005|Overall Study|Withdrawal by Subject|0|||
156832019|NCT03353922|566137603|FG000|Overall Study|Adverse Event|0|||
156832020|NCT03353922|566137604|FG001|Overall Study|Adverse Event|1|||
156832021|NCT03353922|566137605|FG002|Overall Study|Adverse Event|0|||
156832022|NCT03353922|566137606|FG003|Overall Study|Adverse Event|0|||
156832023|NCT03353922|566137607|FG004|Overall Study|Adverse Event|0|||
156832024|NCT03353922|566137608|FG005|Overall Study|Adverse Event|0|||
156832025|NCT03688555|566137609|FG000|Treatment Period|Adverse Event|0|||
156466497|NCT03248492|564803871|FG002|Overall Study|Other|0|||
156832026|NCT03688555|566137610|FG001|Treatment Period|Adverse Event|0|||
156832027|NCT03688555|566137611|FG002|Treatment Period|Adverse Event|1|||
156832028|NCT00886119|566137614|FG000|Period 1|Did not meet inclusion criteria|1|||
156832029|NCT00886119|566137615|FG001|Period 1|Did not meet inclusion criteria|0|||
156832030|NCT00357656|566137616|FG000|Overall Study|Other, No surgery performed|0|||
156832031|NCT00357656|566137617|FG001|Overall Study|Other, No surgery performed|3|||
156832032|NCT02256267|566137618|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
156832033|NCT02256267|566137618|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
156832034|NCT01685983|566137619|FG000|Overall Study|Adverse Event|7|||
156466498|NCT03248492|564803872|FG003|Overall Study|Other|14|||
156466499|NCT03248492|564803873|FG004|Overall Study|Other|0|||
156466500|NCT04495621|564803876|FG000|Overall Study|Withdrawal by Subject|0|||
156832035|NCT01685983|566137619|FG000|Overall Study|Death|1|||
156832036|NCT01685983|566137619|FG000|Overall Study|Withdrawal by Subject|19|||
156832037|NCT01685983|566137619|FG000|Overall Study|Protocol Violation|2|||
156832038|NCT01685983|566137619|FG000|Overall Study|Physician Decision|13|||
156832039|NCT01685983|566137619|FG000|Overall Study|Other|7|||
156832040|NCT01685983|566137619|FG000|Overall Study|Progressive Disease|32|||
156832041|NCT01685983|566137619|FG000|Overall Study|Noncompliance with Study Drug|1|||
156832042|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
156832043|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
156832044|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
156832045|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
156832046|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
156832047|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
156832048|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
156832049|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
156832050|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
156832051|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
156832052|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Other|4|||
156832053|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Other|0|||
156832054|NCT01352741|566137626|FG000|Double-blind Comparative Period|Protocol Violation|2|||
156832055|NCT01352741|566137627|FG001|Double-blind Comparative Period|Protocol Violation|0|||
156832056|NCT01352741|566137626|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
156832057|NCT01352741|566137627|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
156832058|NCT01352741|566137626|FG000|Double-blind Comparative Period|Adverse Event|16|||
156832059|NCT01352741|566137627|FG001|Double-blind Comparative Period|Adverse Event|17|||
156832060|NCT01352741|566137626|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
156832061|NCT01352741|566137627|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
156832062|NCT01352741|566137626|FG000|Double-blind Comparative Period|Death|0|||
156832063|NCT01352741|566137627|FG001|Double-blind Comparative Period|Death|1|||
156832064|NCT01352741|566137626|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
156339845|NCT00114530|564342240|FG001|Overall Study|Physician Decision|1|||
156339846|NCT00114530|564342239|FG000|Overall Study|Withdrawal by Subject|2|||
156339847|NCT00114530|564342240|FG001|Overall Study|Withdrawal by Subject|6|||
156339848|NCT00114530|564342239|FG000|Overall Study|Breast Cancer|1|||
156339849|NCT00114530|564342240|FG001|Overall Study|Breast Cancer|0|||
156339850|NCT00114530|564342239|FG000|Overall Study|Subject decision after endpoint failure|0|||
156339851|NCT00114530|564342240|FG001|Overall Study|Subject decision after endpoint failure|1|||
156339852|NCT00114530|564342239|FG000|Overall Study|Ineligible|1|||
156339853|NCT00114530|564342240|FG001|Overall Study|Ineligible|0|||
156339854|NCT01817530|564342241|FG000|Overall Study|Exclusionary Medication Received|0|||
156339855|NCT01817530|564342242|FG001|Overall Study|Exclusionary Medication Received|0|||
156339856|NCT01817530|564342243|FG002|Overall Study|Exclusionary Medication Received|0|||
156339857|NCT01817530|564342244|FG003|Overall Study|Exclusionary Medication Received|0|||
156339858|NCT01817530|564342245|FG004|Overall Study|Exclusionary Medication Received|1|||
156339859|NCT01817530|564342246|FG005|Overall Study|Exclusionary Medication Received|0|||
156339860|NCT01817530|564342247|FG006|Overall Study|Exclusionary Medication Received|0|||
156339861|NCT01817530|564342248|FG007|Overall Study|Exclusionary Medication Received|0|||
156339862|NCT01817530|564342241|FG000|Overall Study|Adverse Event|6|||
156339863|NCT01817530|564342242|FG001|Overall Study|Adverse Event|3|||
156339864|NCT01817530|564342243|FG002|Overall Study|Adverse Event|2|||
156339865|NCT01817530|564342244|FG003|Overall Study|Adverse Event|5|||
156466501|NCT04495621|564803877|FG001|Overall Study|Withdrawal by Subject|3|||
156466502|NCT04495621|564803876|FG000|Overall Study|Death|7|||
156832065|NCT01352741|566137627|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
156832066|NCT01352741|566137626|FG000|Double-blind Comparative Period|Other|1|||
156832067|NCT01352741|566137627|FG001|Double-blind Comparative Period|Other|2|||
156832068|NCT01352741|566137626|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
156832069|NCT01352741|566137627|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
156832070|NCT01352741|566137626|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
156832071|NCT01352741|566137627|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
156339866|NCT01817530|564342245|FG004|Overall Study|Adverse Event|0|||
156339867|NCT01817530|564342246|FG005|Overall Study|Adverse Event|10|||
156339868|NCT01817530|564342247|FG006|Overall Study|Adverse Event|5|||
156339869|NCT01817530|564342248|FG007|Overall Study|Adverse Event|8|||
156339870|NCT01817530|564342241|FG000|Overall Study|Subject Noncompliant|3|||
156339871|NCT01817530|564342242|FG001|Overall Study|Subject Noncompliant|1|||
156339872|NCT01817530|564342243|FG002|Overall Study|Subject Noncompliant|0|||
156466503|NCT04495621|564803877|FG001|Overall Study|Death|11|||
156466504|NCT04495621|564803876|FG000|Overall Study|Investigator Decision|0|||
156339873|NCT01817530|564342244|FG003|Overall Study|Subject Noncompliant|4|||
156339874|NCT01817530|564342245|FG004|Overall Study|Subject Noncompliant|0|||
156339875|NCT01817530|564342246|FG005|Overall Study|Subject Noncompliant|1|||
156339876|NCT01817530|564342247|FG006|Overall Study|Subject Noncompliant|1|||
156339877|NCT01817530|564342248|FG007|Overall Study|Subject Noncompliant|1|||
156339878|NCT01817530|564342241|FG000|Overall Study|Lack of Efficacy|1|||
156466505|NCT04495621|564803877|FG001|Overall Study|Investigator Decision|7|||
156466506|NCT04495621|564803876|FG000|Overall Study|Lost to Follow-up|0|||
156466507|NCT04495621|564803877|FG001|Overall Study|Lost to Follow-up|1|||
156466508|NCT04018495|564803880|FG000|Overall Study|Physician Decision|1|||
156466509|NCT03774472|564803889|FG000|Overall Study|Physician Decision|1|||
156466510|NCT03774472|564803890|FG001|Overall Study|Physician Decision|0|||
156466511|NCT03774472|564803891|FG002|Overall Study|Physician Decision|0|||
156466512|NCT03774472|564803889|FG000|Overall Study|Progression prior to 4 weeks|0|||
156466513|NCT03774472|564803890|FG001|Overall Study|Progression prior to 4 weeks|1|||
156466514|NCT03774472|564803891|FG002|Overall Study|Progression prior to 4 weeks|0|||
156466515|NCT03774472|564803889|FG000|Overall Study|Withdrawal by Subject|0|||
156466516|NCT03774472|564803890|FG001|Overall Study|Withdrawal by Subject|1|||
156466517|NCT03774472|564803891|FG002|Overall Study|Withdrawal by Subject|0|||
156466518|NCT05155306|564803896|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
156832072|NCT01352741|566137626|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
156832073|NCT01352741|566137627|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
156832074|NCT01352741|566137626|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
156832075|NCT01352741|566137627|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
156832076|NCT00259298|566137628|FG000|Overall Study|Withdrawal by Subject|1|||
156832077|NCT00259298|566137628|FG000|Overall Study|Physician Decision|2|||
156832078|NCT00645528|566137631|FG000|Overall Study|Did not show up for Visit 2|7|||
156832079|NCT03077698|566137633|FG000|Progestin Monotherapy|Stable Disease|8|||
156832080|NCT03077698|566137634|FG001|Progestin Monotherapy|Stable Disease|0|||
156832081|NCT03077698|566137633|FG000|Progestin Monotherapy|Adverse Event|1|||
156832082|NCT03077698|566137634|FG001|Progestin Monotherapy|Adverse Event|0|||
156832083|NCT03077698|566137633|FG000|Progestin Monotherapy|Death|1|||
156832084|NCT03077698|566137634|FG001|Progestin Monotherapy|Death|0|||
156832085|NCT03077698|566137633|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
156832086|NCT03077698|566137634|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
156832087|NCT03077698|566137633|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
156832088|NCT03077698|566137634|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
156832089|NCT03077698|566137633|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
156832090|NCT03077698|566137634|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
156832091|NCT03077698|566137633|FG000|Safety Follow Up|Withdrawal by Subject|2|||
156832092|NCT03077698|566137634|FG001|Safety Follow Up|Withdrawal by Subject|1|||
156832093|NCT03077698|566137633|FG000|Safety Follow Up|Transfer of care to hospice|1|||
156832094|NCT03077698|566137634|FG001|Safety Follow Up|Transfer of care to hospice|0|||
156832095|NCT01886690|566137635|FG000|Overall Study|Protocol Violation|0|||
156832096|NCT01886690|566137636|FG001|Overall Study|Protocol Violation|1|||
156832097|NCT01886690|566137635|FG000|Overall Study|Personal Reasons|0|||
156832098|NCT01886690|566137636|FG001|Overall Study|Personal Reasons|1|||
156832099|NCT01011933|566137637|FG000|Overall Study|Wrong cell type|1|||
156832100|NCT01011933|566137637|FG000|Overall Study|Improper pre-protocol Rx|1|||
156832101|NCT01011933|566137637|FG000|Overall Study|Inadequate pathology|1|||
156832102|NCT01011933|566137637|FG000|Overall Study|Never treated|1|||
156832103|NCT03461406|566137638|FG000|Overall Study|Death|1|||
156832104|NCT03461406|566137639|FG001|Overall Study|Death|2|||
156832105|NCT03461406|566137638|FG000|Overall Study|Consent Withdrawn by Participant|0|||
156832106|NCT03461406|566137639|FG001|Overall Study|Consent Withdrawn by Participant|1|||
156339879|NCT01817530|564342242|FG001|Overall Study|Lack of Efficacy|0|||
156466519|NCT05155306|564803897|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
156466520|NCT05155306|564803898|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
156466521|NCT05155306|564803899|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
156466522|NCT05155306|564803896|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
156466523|NCT05155306|564803897|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
156466524|NCT05155306|564803898|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
156466525|NCT05155306|564803899|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
156466526|NCT03150862|564803900|FG000|Overall Study|Death|2|||
156466527|NCT03150862|564803901|FG001|Overall Study|Death|7|||
156832107|NCT03461406|566137638|FG000|Overall Study|Screen Failure|3|||
156832108|NCT03461406|566137639|FG001|Overall Study|Screen Failure|1|||
156832109|NCT03461406|566137638|FG000|Overall Study|Reason not Specified|1|||
156832110|NCT03461406|566137639|FG001|Overall Study|Reason not Specified|3|||
156832111|NCT03461406|566137638|FG000|Overall Study|Lost to Follow-up|3|||
156832112|NCT03461406|566137639|FG001|Overall Study|Lost to Follow-up|0|||
156832113|NCT01439074|566137640|FG000|Overall Study|Lost to Follow-up|3|||
156832114|NCT01439074|566137641|FG001|Overall Study|Lost to Follow-up|4|||
156832115|NCT01439074|566137640|FG000|Overall Study|Subject shedding|1|||
156466528|NCT03150862|564803902|FG002|Overall Study|Death|8|||
156466529|NCT03150862|564803903|FG003|Overall Study|Death|27|||
156466530|NCT03150862|564803904|FG004|Overall Study|Death|4|||
156466531|NCT03150862|564803905|FG005|Overall Study|Death|8|||
156466532|NCT03150862|564803906|FG006|Overall Study|Death|6|||
156832116|NCT01439074|566137641|FG001|Overall Study|Subject shedding|0|||
156832117|NCT01439074|566137640|FG000|Overall Study|Withdrawal by Subject|1|||
156832118|NCT01439074|566137641|FG001|Overall Study|Withdrawal by Subject|5|||
156832119|NCT01439074|566137640|FG000|Overall Study|Other|4|||
156832120|NCT01439074|566137641|FG001|Overall Study|Other|4|||
156832121|NCT01140568|566137642|FG000|Overall Study|disease progression|31|||
156339880|NCT01817530|564342243|FG002|Overall Study|Lack of Efficacy|0|||
156339881|NCT01817530|564342244|FG003|Overall Study|Lack of Efficacy|0|||
156339882|NCT01817530|564342245|FG004|Overall Study|Lack of Efficacy|0|||
156339883|NCT01817530|564342246|FG005|Overall Study|Lack of Efficacy|1|||
156339884|NCT01817530|564342247|FG006|Overall Study|Lack of Efficacy|0|||
156339885|NCT01817530|564342248|FG007|Overall Study|Lack of Efficacy|1|||
156339886|NCT01817530|564342241|FG000|Overall Study|Pregnancy|0|||
156339887|NCT01817530|564342242|FG001|Overall Study|Pregnancy|0|||
156339888|NCT01817530|564342243|FG002|Overall Study|Pregnancy|0|||
156832122|NCT01140568|566137642|FG000|Overall Study|Withdrawal by Subject|1|||
156832123|NCT01140568|566137642|FG000|Overall Study|Screen Fail|4|||
156832124|NCT01969500|566137643|FG000|Overall Study|Death|0|||
156832125|NCT01969500|566137644|FG001|Overall Study|Death|1|||
156832126|NCT01969500|566137643|FG000|Overall Study|extended hospitalization|1|||
156832127|NCT01969500|566137644|FG001|Overall Study|extended hospitalization|1|||
156832128|NCT00815191|566137645|FG000|Overall Study|Protocol Violation|1|||
156832129|NCT00815191|566137646|FG001|Overall Study|Protocol Violation|1|||
156832130|NCT02463032|566137650|FG000|Overall Study|Lack of Efficacy|61|||
156832131|NCT02463032|566137651|FG001|Overall Study|Lack of Efficacy|50|||
156832132|NCT02463032|566137650|FG000|Overall Study|Death|8|||
156832133|NCT02463032|566137651|FG001|Overall Study|Death|8|||
156832134|NCT02463032|566137650|FG000|Overall Study|Adverse Event|2|||
156339889|NCT01817530|564342244|FG003|Overall Study|Pregnancy|0|||
156466533|NCT03150862|564803907|FG007|Overall Study|Death|21|||
156466534|NCT03150862|564803900|FG000|Overall Study|Withdrawal by Subject|1|||
156832135|NCT02463032|566137651|FG001|Overall Study|Adverse Event|6|||
156832136|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
156832137|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
156339890|NCT01817530|564342245|FG004|Overall Study|Pregnancy|0|||
156832138|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
156832139|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
156832140|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
156832141|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
156832142|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
156832143|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
156832144|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
156832145|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
156832146|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
156832147|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
156832148|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
156832149|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
156832150|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
156832151|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
156832152|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
156832153|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
156832154|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
156832155|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
156832156|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
156832157|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
156832158|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
156832159|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
156832160|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
156832161|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
156832162|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
156832163|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
156832164|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
156832165|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
156832166|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
156832167|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
156832168|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
156832169|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
156832170|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
156832171|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
156832172|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
156832173|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
156832174|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
156832175|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
156832176|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
156832177|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
156832178|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
156832179|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
156832180|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
156832181|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
156832182|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
156832183|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
156541295|NCT01358760|565074538|FG001|Overall Study|Withdrawal by Subject|3|||
156541296|NCT01358760|565074539|FG002|Overall Study|Withdrawal by Subject|2|||
156541297|NCT01358760|565074537|FG000|Overall Study|Physician Decision|1|||
156541298|NCT01358760|565074538|FG001|Overall Study|Physician Decision|0|||
156541299|NCT01358760|565074539|FG002|Overall Study|Physician Decision|1|||
156541300|NCT01358760|565074537|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
156541301|NCT01358760|565074538|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
156541302|NCT01358760|565074539|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
156541303|NCT04695392|565074540|FG000|Overall Study|Withdrawn by parent/guardian|0|||
156541304|NCT04695392|565074541|FG001|Overall Study|Withdrawn by parent/guardian|1|||
156541305|NCT04695392|565074540|FG000|Overall Study|Withdrawn by physician|0|||
156541306|NCT04695392|565074541|FG001|Overall Study|Withdrawn by physician|1|||
156541307|NCT01506960|565074542|FG000|Overall Study|Did not meet angiographic criteria|47|||
156541308|NCT01987960|565074544|FG000|Period 1|Adverse Event|24|||
156541309|NCT01987960|565074545|FG001|Period 1|Adverse Event|0|||
156541310|NCT01987960|565074546|FG002|Period 1|Adverse Event|0|||
156832184|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
156832185|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
156832186|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
156832187|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
156832188|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
156832189|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
156832190|NCT02008357|566137653|FG000|Open-label Extension Period|Adverse Event|8|||
156832191|NCT02008357|566137654|FG001|Open-label Extension Period|Adverse Event|7|||
156832192|NCT02008357|566137653|FG000|Open-label Extension Period|Death|7|||
156832193|NCT02008357|566137654|FG001|Open-label Extension Period|Death|4|||
156832194|NCT02008357|566137653|FG000|Open-label Extension Period|Lack of Efficacy|9|||
156832195|NCT02008357|566137654|FG001|Open-label Extension Period|Lack of Efficacy|5|||
156832196|NCT02008357|566137653|FG000|Open-label Extension Period|Lost to Follow-up|2|||
156832197|NCT02008357|566137654|FG001|Open-label Extension Period|Lost to Follow-up|2|||
156832198|NCT02008357|566137653|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
156832199|NCT02008357|566137654|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
156832200|NCT02008357|566137653|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
156832201|NCT02008357|566137654|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
156832202|NCT02008357|566137653|FG000|Open-label Extension Period|Safety Risk|2|||
156832203|NCT02008357|566137654|FG001|Open-label Extension Period|Safety Risk|1|||
156832204|NCT02008357|566137653|FG000|Open-label Extension Period|Non-Compliance|0|||
156832205|NCT02008357|566137654|FG001|Open-label Extension Period|Non-Compliance|1|||
156832206|NCT02008357|566137653|FG000|Open-label Extension Period|Investigator Recommendation|0|||
156832207|NCT02008357|566137654|FG001|Open-label Extension Period|Investigator Recommendation|1|||
156832208|NCT02008357|566137653|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
156832209|NCT02008357|566137654|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
156832210|NCT02008357|566137653|FG000|Open-label Extension Period|Coordinating Center Request|2|||
156832211|NCT02008357|566137654|FG001|Open-label Extension Period|Coordinating Center Request|4|||
156832212|NCT02008357|566137653|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
156832213|NCT02008357|566137654|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
156832214|NCT02008357|566137653|FG000|Open-label Extension Period|Study Ended|20|||
156832215|NCT02008357|566137654|FG001|Open-label Extension Period|Study Ended|25|||
156832216|NCT02008357|566137653|FG000|Open-label Extension Period|Personal Reasons|0|||
156832217|NCT02008357|566137654|FG001|Open-label Extension Period|Personal Reasons|1|||
156832218|NCT02008357|566137653|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
156832219|NCT02008357|566137654|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
156832220|NCT02008357|566137653|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
156832221|NCT02008357|566137654|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
156832222|NCT02008357|566137653|FG000|Open-label Extension Period|Other|2|||
156832223|NCT02008357|566137654|FG001|Open-label Extension Period|Other|0|||
156832224|NCT02312219|566137656|FG000|Overall Study|Withdrawal by Subject|1|||
156832225|NCT02312219|566137657|FG001|Overall Study|Withdrawal by Subject|2|||
156832226|NCT02312219|566137656|FG000|Overall Study|could not schedule imaging in time|0|||
156832227|NCT02312219|566137657|FG001|Overall Study|could not schedule imaging in time|2|||
156832228|NCT02312219|566137656|FG000|Overall Study|Other|0|||
156832229|NCT02312219|566137657|FG001|Overall Study|Other|1|||
156832230|NCT02312219|566137656|FG000|Overall Study|Not randomized. Ineligible|0|||
156832231|NCT02312219|566137657|FG001|Overall Study|Not randomized. Ineligible|1|||
156832232|NCT01269385|566137658|FG000|Overall Study|Adverse Event|1|||
156832233|NCT01269385|566137659|FG001|Overall Study|Adverse Event|1|||
156832234|NCT01269385|566137660|FG002|Overall Study|Adverse Event|0|||
156832235|NCT01269385|566137661|FG003|Overall Study|Adverse Event|0|||
156832236|NCT01100567|566137663|FG000|Overall Study|Withdrawal by Subject|5|||
156832237|NCT01100567|566137664|FG001|Overall Study|Withdrawal by Subject|8|||
156832238|NCT01100567|566137663|FG000|Overall Study|Early Hospital Discharge|6|||
156832239|NCT01100567|566137664|FG001|Overall Study|Early Hospital Discharge|4|||
156832240|NCT01100567|566137663|FG000|Overall Study|Lost to Follow-up|1|||
156541311|NCT01987960|565074547|FG003|Period 1|Adverse Event|0|||
156832241|NCT01100567|566137664|FG001|Overall Study|Lost to Follow-up|2|||
156832242|NCT01100567|566137663|FG000|Overall Study|Physician Decision|0|||
156832243|NCT01100567|566137664|FG001|Overall Study|Physician Decision|1|||
156832244|NCT01100567|566137663|FG000|Overall Study|Deemed ineligible after consent|0|||
156832245|NCT01100567|566137664|FG001|Overall Study|Deemed ineligible after consent|1|||
156832246|NCT01498185|566137665|FG000|Overall Study|Adverse Event|0|||
156832247|NCT01498185|566137666|FG001|Overall Study|Adverse Event|0|||
156832248|NCT01498185|566137667|FG002|Overall Study|Adverse Event|0|||
156832249|NCT01498185|566137668|FG003|Overall Study|Adverse Event|1|||
156832250|NCT01498185|566137669|FG004|Overall Study|Adverse Event|0|||
156832251|NCT01498185|566137665|FG000|Overall Study|Withdrawal by Subject|1|||
156832252|NCT01498185|566137666|FG001|Overall Study|Withdrawal by Subject|1|||
156832253|NCT01498185|566137667|FG002|Overall Study|Withdrawal by Subject|0|||
156832254|NCT01498185|566137668|FG003|Overall Study|Withdrawal by Subject|2|||
156832255|NCT01498185|566137669|FG004|Overall Study|Withdrawal by Subject|1|||
156832256|NCT01498185|566137665|FG000|Overall Study|No longer met criteria, etc|0|||
156832257|NCT01498185|566137666|FG001|Overall Study|No longer met criteria, etc|0|||
156832258|NCT01498185|566137667|FG002|Overall Study|No longer met criteria, etc|0|||
156832259|NCT01498185|566137668|FG003|Overall Study|No longer met criteria, etc|0|||
156832260|NCT01498185|566137669|FG004|Overall Study|No longer met criteria, etc|2|||
156832261|NCT00946322|566137670|FG000|Pre-treatment|participant failure to follow up|1|||
156832262|NCT00946322|566137670|FG000|Post-treatment|participant failure to follow up|2|||
156832263|NCT01453946|566137671|FG000|Overall Study|Did not receive drug for the taper phase|1|||
156832264|NCT01453946|566137671|FG000|Overall Study|Protocol Violation|2|||
156832265|NCT01453946|566137671|FG000|Overall Study|Lack of Efficacy|3|||
156832266|NCT01453946|566137671|FG000|Overall Study|Adverse Event|3|||
156832267|NCT01710527|566137672|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
156832268|NCT01710527|566137673|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
156466535|NCT03150862|564803901|FG001|Overall Study|Withdrawal by Subject|1|||
156832269|NCT01688921|566137675|FG000|Overall Study|Lost to Follow-up|7|||
156832270|NCT01688921|566137676|FG001|Overall Study|Lost to Follow-up|13|||
156832271|NCT01688921|566137675|FG000|Overall Study|Physician Decision|6|||
156339891|NCT01817530|564342246|FG005|Overall Study|Pregnancy|1|||
156832272|NCT01688921|566137676|FG001|Overall Study|Physician Decision|1|||
156339892|NCT01817530|564342247|FG006|Overall Study|Pregnancy|0|||
156832273|NCT01688921|566137675|FG000|Overall Study|Protocol Violation|0|||
156832274|NCT01688921|566137676|FG001|Overall Study|Protocol Violation|1|||
156832275|NCT01688921|566137675|FG000|Overall Study|informed consent|3|||
156832276|NCT01688921|566137676|FG001|Overall Study|informed consent|0|||
156832277|NCT03697993|566137679|FG000|Overall Study|Became Ineligible after Enrollment|1|||
156832278|NCT03697993|566137680|FG001|Overall Study|Became Ineligible after Enrollment|3|||
156832279|NCT03697993|566137679|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
156832280|NCT03697993|566137680|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
156832281|NCT03697993|566137679|FG000|Overall Study|Lost to Follow-up|3|||
156832282|NCT03697993|566137680|FG001|Overall Study|Lost to Follow-up|0|||
156832283|NCT03697993|566137679|FG000|Overall Study|Physician Decision|4|||
156832284|NCT03697993|566137680|FG001|Overall Study|Physician Decision|0|||
156832285|NCT03697993|566137679|FG000|Overall Study|Initial Urine Culture Negative|0|||
156832286|NCT03697993|566137680|FG001|Overall Study|Initial Urine Culture Negative|1|||
156832287|NCT04384107|566137681|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
156832288|NCT04384107|566137682|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
156832289|NCT04384107|566137681|FG000|Overall Study|Lost to Follow-up|1|||
156832290|NCT04384107|566137682|FG001|Overall Study|Lost to Follow-up|0|||
156832291|NCT02739321|566137683|FG000|Overall Study|Lack of Efficacy|1|||
156832292|NCT02739321|566137684|FG001|Overall Study|Lack of Efficacy|1|||
156832293|NCT02739321|566137683|FG000|Overall Study|Lost to Follow-up|1|||
156832294|NCT02739321|566137684|FG001|Overall Study|Lost to Follow-up|1|||
156832295|NCT02739321|566137683|FG000|Overall Study|Withdrawal by Subject|1|||
156832296|NCT02739321|566137684|FG001|Overall Study|Withdrawal by Subject|2|||
156832297|NCT01999218|566137688|FG000|Overall Study|Hyperglycemia|18|||
156832298|NCT01999218|566137689|FG001|Overall Study|Hyperglycemia|17|||
156832299|NCT01999218|566137690|FG002|Overall Study|Hyperglycemia|17|||
156832300|NCT01999218|566137688|FG000|Overall Study|Lack of Efficacy|1|||
156832301|NCT01999218|566137689|FG001|Overall Study|Lack of Efficacy|0|||
156832302|NCT01999218|566137690|FG002|Overall Study|Lack of Efficacy|1|||
156832303|NCT01999218|566137688|FG000|Overall Study|Lost to Follow-up|22|||
156832304|NCT01999218|566137689|FG001|Overall Study|Lost to Follow-up|17|||
156832305|NCT01999218|566137690|FG002|Overall Study|Lost to Follow-up|18|||
156832306|NCT01999218|566137688|FG000|Overall Study|Non-Compliance With Study Drug|6|||
156832307|NCT01999218|566137689|FG001|Overall Study|Non-Compliance With Study Drug|4|||
156832308|NCT01999218|566137690|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156832309|NCT01999218|566137688|FG000|Overall Study|Physician Decision|1|||
156832310|NCT01999218|566137689|FG001|Overall Study|Physician Decision|4|||
156832311|NCT01999218|566137690|FG002|Overall Study|Physician Decision|6|||
156832312|NCT01999218|566137688|FG000|Overall Study|Protocol Violation|4|||
156832313|NCT01999218|566137689|FG001|Overall Study|Protocol Violation|5|||
156832314|NCT01999218|566137690|FG002|Overall Study|Protocol Violation|4|||
156832315|NCT01999218|566137688|FG000|Overall Study|Screen failure|0|||
156832316|NCT01999218|566137689|FG001|Overall Study|Screen failure|1|||
156832317|NCT01999218|566137690|FG002|Overall Study|Screen failure|0|||
156832318|NCT01999218|566137688|FG000|Overall Study|Study Terminated By Sponsor|7|||
156832319|NCT01999218|566137689|FG001|Overall Study|Study Terminated By Sponsor|5|||
156832320|NCT01999218|566137690|FG002|Overall Study|Study Terminated By Sponsor|12|||
156832321|NCT01999218|566137688|FG000|Overall Study|Participant moves|2|||
156832322|NCT01999218|566137689|FG001|Overall Study|Participant moves|5|||
156832323|NCT01999218|566137690|FG002|Overall Study|Participant moves|3|||
156832324|NCT01999218|566137688|FG000|Overall Study|Withdrawal by Subject|28|||
156832325|NCT01999218|566137689|FG001|Overall Study|Withdrawal by Subject|29|||
156832326|NCT01999218|566137690|FG002|Overall Study|Withdrawal by Subject|34|||
156832327|NCT01999218|566137688|FG000|Overall Study|Creatinine/eGFR|0|||
156832328|NCT01999218|566137689|FG001|Overall Study|Creatinine/eGFR|0|||
156832329|NCT01999218|566137690|FG002|Overall Study|Creatinine/eGFR|1|||
156832330|NCT01999218|566137688|FG000|Overall Study|Death|7|||
156832331|NCT01999218|566137689|FG001|Overall Study|Death|1|||
156832332|NCT01999218|566137690|FG002|Overall Study|Death|2|||
156832333|NCT01999218|566137688|FG000|Overall Study|Excluded Medication|1|||
156832334|NCT01999218|566137689|FG001|Overall Study|Excluded Medication|1|||
156832335|NCT01999218|566137690|FG002|Overall Study|Excluded Medication|2|||
156832336|NCT01999218|566137688|FG000|Overall Study|Adverse Event|9|||
156832337|NCT01999218|566137689|FG001|Overall Study|Adverse Event|7|||
156832338|NCT01999218|566137690|FG002|Overall Study|Adverse Event|7|||
156832339|NCT01999218|566137688|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
156832340|NCT01999218|566137689|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
156832341|NCT01999218|566137690|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
156832342|NCT00546260|566137693|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
156832343|NCT00546260|566137694|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
156832344|NCT03780959|566137695|FG000|Part 1|Adverse Event|1|||
156832345|NCT03780959|566137696|FG001|Part 1|Adverse Event|0|||
156832346|NCT03780959|566137697|FG002|Part 1|Adverse Event|0|||
156832347|NCT03780959|566137695|FG000|Part 1|Withdrawal by Subject|1|||
156832348|NCT03780959|566137696|FG001|Part 1|Withdrawal by Subject|0|||
156832349|NCT03780959|566137697|FG002|Part 1|Withdrawal by Subject|0|||
156832350|NCT03780959|566137695|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
156466536|NCT03150862|564803902|FG002|Overall Study|Withdrawal by Subject|0|||
156466537|NCT03150862|564803903|FG003|Overall Study|Withdrawal by Subject|3|||
156466538|NCT03150862|564803904|FG004|Overall Study|Withdrawal by Subject|1|||
156466539|NCT03150862|564803905|FG005|Overall Study|Withdrawal by Subject|1|||
156466540|NCT03150862|564803906|FG006|Overall Study|Withdrawal by Subject|1|||
156466541|NCT03150862|564803907|FG007|Overall Study|Withdrawal by Subject|3|||
156466542|NCT03150862|564803900|FG000|Overall Study|Lost to Follow-up|0|||
156466543|NCT03150862|564803901|FG001|Overall Study|Lost to Follow-up|0|||
156466544|NCT03150862|564803902|FG002|Overall Study|Lost to Follow-up|1|||
156466545|NCT03150862|564803903|FG003|Overall Study|Lost to Follow-up|0|||
156466546|NCT03150862|564803904|FG004|Overall Study|Lost to Follow-up|0|||
156466547|NCT03150862|564803905|FG005|Overall Study|Lost to Follow-up|0|||
156466548|NCT03150862|564803906|FG006|Overall Study|Lost to Follow-up|0|||
156466549|NCT03150862|564803907|FG007|Overall Study|Lost to Follow-up|2|||
156466550|NCT03150862|564803900|FG000|Overall Study|Sponsor's decision|0|||
156466551|NCT03150862|564803901|FG001|Overall Study|Sponsor's decision|0|||
156466552|NCT03150862|564803902|FG002|Overall Study|Sponsor's decision|0|||
156466553|NCT03150862|564803903|FG003|Overall Study|Sponsor's decision|10|||
156466554|NCT03150862|564803904|FG004|Overall Study|Sponsor's decision|3|||
156466555|NCT03150862|564803905|FG005|Overall Study|Sponsor's decision|0|||
156466556|NCT03150862|564803906|FG006|Overall Study|Sponsor's decision|1|||
156466557|NCT03150862|564803907|FG007|Overall Study|Sponsor's decision|1|||
156466558|NCT03150862|564803900|FG000|Overall Study|Change in Methylation status|0|||
156466559|NCT03150862|564803901|FG001|Overall Study|Change in Methylation status|0|||
156466560|NCT03150862|564803902|FG002|Overall Study|Change in Methylation status|0|||
156466561|NCT03150862|564803903|FG003|Overall Study|Change in Methylation status|0|||
156832351|NCT03780959|566137696|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
156832352|NCT03780959|566137697|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
156832353|NCT03780959|566137695|FG000|Part 1|Response Status|2|||
156832354|NCT03780959|566137696|FG001|Part 1|Response Status|0|||
156832355|NCT03780959|566137697|FG002|Part 1|Response Status|0|||
156466562|NCT03150862|564803904|FG004|Overall Study|Change in Methylation status|1|||
156466563|NCT03150862|564803905|FG005|Overall Study|Change in Methylation status|0|||
156466564|NCT03150862|564803906|FG006|Overall Study|Change in Methylation status|0|||
156466565|NCT03150862|564803907|FG007|Overall Study|Change in Methylation status|0|||
156466566|NCT03150862|564803900|FG000|Overall Study|Roll over in to Long Term Extension|0|||
156466567|NCT03150862|564803901|FG001|Overall Study|Roll over in to Long Term Extension|0|||
156466568|NCT03150862|564803902|FG002|Overall Study|Roll over in to Long Term Extension|0|||
156466569|NCT03150862|564803903|FG003|Overall Study|Roll over in to Long Term Extension|0|||
156466570|NCT03150862|564803904|FG004|Overall Study|Roll over in to Long Term Extension|0|||
156466571|NCT03150862|564803905|FG005|Overall Study|Roll over in to Long Term Extension|0|||
156466572|NCT03150862|564803906|FG006|Overall Study|Roll over in to Long Term Extension|0|||
156466573|NCT03150862|564803907|FG007|Overall Study|Roll over in to Long Term Extension|1|||
156466574|NCT03150862|564803900|FG000|Overall Study|Progressive Disease|0|||
156466575|NCT03150862|564803901|FG001|Overall Study|Progressive Disease|0|||
156466576|NCT03150862|564803902|FG002|Overall Study|Progressive Disease|0|||
156466577|NCT03150862|564803903|FG003|Overall Study|Progressive Disease|0|||
156466578|NCT03150862|564803904|FG004|Overall Study|Progressive Disease|0|||
156832356|NCT03780959|566137695|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
156466579|NCT03150862|564803905|FG005|Overall Study|Progressive Disease|0|||
156466580|NCT03150862|564803906|FG006|Overall Study|Progressive Disease|0|||
156466581|NCT03150862|564803907|FG007|Overall Study|Progressive Disease|2|||
156466582|NCT04158141|564803908|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
156541312|NCT01987960|565074544|FG000|Period 1|Lack of Efficacy|4|||
156541313|NCT01987960|565074545|FG001|Period 1|Lack of Efficacy|0|||
156541314|NCT01987960|565074546|FG002|Period 1|Lack of Efficacy|0|||
156541315|NCT01987960|565074547|FG003|Period 1|Lack of Efficacy|0|||
156832357|NCT03780959|566137696|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
156832358|NCT03780959|566137697|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
156832359|NCT03780959|566137695|FG000|Part 2|Response Status|0|||
156832360|NCT03780959|566137696|FG001|Part 2|Response Status|18|||
156832361|NCT03780959|566137697|FG002|Part 2|Response Status|6|||
156832362|NCT03172130|566139834|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
156832363|NCT03172130|566139835|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
156466583|NCT04158141|564803909|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
156466584|NCT04158141|564803910|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
156466585|NCT04158141|564803908|FG000|Step 1: Registration|Adverse Event|1|||
156466586|NCT04158141|564803909|FG001|Step 1: Registration|Adverse Event|0|||
156466587|NCT04158141|564803910|FG002|Step 1: Registration|Adverse Event|0|||
156466588|NCT04158141|564803908|FG000|Step 1: Registration|Withdrawal by Subject|1|||
156541316|NCT01987960|565074544|FG000|Period 1|Non-compliance with IMP|6|||
156541317|NCT01987960|565074545|FG001|Period 1|Non-compliance with IMP|0|||
156466589|NCT04158141|564803909|FG001|Step 1: Registration|Withdrawal by Subject|0|||
156541318|NCT01987960|565074546|FG002|Period 1|Non-compliance with IMP|0|||
156541319|NCT01987960|565074547|FG003|Period 1|Non-compliance with IMP|0|||
156832364|NCT02559414|566139838|FG000|Overall Study|Lost to Follow-up|0|||
156832365|NCT02559414|566139839|FG001|Overall Study|Lost to Follow-up|1|||
156832366|NCT02559414|566139840|FG002|Overall Study|Lost to Follow-up|0|||
156832367|NCT02559414|566139838|FG000|Overall Study|Withdrawal by Subject|1|||
156832368|NCT02559414|566139839|FG001|Overall Study|Withdrawal by Subject|0|||
156832369|NCT02559414|566139840|FG002|Overall Study|Withdrawal by Subject|1|||
156832370|NCT02559414|566139838|FG000|Overall Study|Other|0|||
156832371|NCT02559414|566139839|FG001|Overall Study|Other|1|||
156832372|NCT02559414|566139840|FG002|Overall Study|Other|1|||
156832373|NCT02046070|566139843|FG000|Overall Study|Progressive Disease|18|||
156832374|NCT02046070|566139844|FG001|Overall Study|Progressive Disease|11|||
156832375|NCT02046070|566139845|FG002|Overall Study|Progressive Disease|40|||
156832376|NCT02046070|566139843|FG000|Overall Study|Adverse Event|8|||
156832377|NCT02046070|566139844|FG001|Overall Study|Adverse Event|10|||
156832378|NCT02046070|566139845|FG002|Overall Study|Adverse Event|17|||
156832379|NCT02046070|566139843|FG000|Overall Study|Withdrawal by Subject|1|||
156832380|NCT02046070|566139844|FG001|Overall Study|Withdrawal by Subject|2|||
156832381|NCT02046070|566139845|FG002|Overall Study|Withdrawal by Subject|6|||
156832382|NCT02046070|566139843|FG000|Overall Study|Study Terminated by Sponsor|1|||
156832383|NCT02046070|566139844|FG001|Overall Study|Study Terminated by Sponsor|1|||
156832384|NCT02046070|566139845|FG002|Overall Study|Study Terminated by Sponsor|1|||
156832385|NCT02046070|566139843|FG000|Overall Study|Reason not Specified|4|||
156832386|NCT02046070|566139844|FG001|Overall Study|Reason not Specified|4|||
156832387|NCT02046070|566139845|FG002|Overall Study|Reason not Specified|6|||
156832388|NCT04619004|566139846|FG000|Overall Study|Death|114|||
156832389|NCT04619004|566139847|FG001|Overall Study|Death|28|||
156832390|NCT04619004|566139846|FG000|Overall Study|Lost to Follow-up|1|||
156832391|NCT04619004|566139847|FG001|Overall Study|Lost to Follow-up|1|||
156832392|NCT04619004|566139846|FG000|Overall Study|Withdrawal by Subject|24|||
156832393|NCT04619004|566139847|FG001|Overall Study|Withdrawal by Subject|7|||
156832394|NCT04619004|566139846|FG000|Overall Study|Other - Not specified|0|||
156832395|NCT04619004|566139847|FG001|Overall Study|Other - Not specified|1|||
156832396|NCT03007745|566139849|FG000|Overall Study|Sleep test negative for OSA|53|||
156832397|NCT03007745|566139850|FG001|Overall Study|Sleep test negative for OSA|49|||
156832398|NCT03007745|566139849|FG000|Overall Study|Physician Decision|6|||
156832399|NCT03007745|566139850|FG001|Overall Study|Physician Decision|9|||
156832400|NCT03007745|566139849|FG000|Overall Study|Withdrawal by Subject|38|||
156832401|NCT03007745|566139850|FG001|Overall Study|Withdrawal by Subject|16|||
156832402|NCT03007745|566139849|FG000|Overall Study|Lost to Follow-up|19|||
156832403|NCT03007745|566139850|FG001|Overall Study|Lost to Follow-up|25|||
156832404|NCT03007745|566139849|FG000|Overall Study|Unable to login to website|17|||
156832405|NCT03007745|566139850|FG001|Overall Study|Unable to login to website|4|||
156832406|NCT04912895|566139851|FG000|Overall Study|Unable to provide specimen|2|||
156832407|NCT04912895|566139852|FG001|Overall Study|Unable to provide specimen|0|||
156832408|NCT04912895|566139853|FG002|Overall Study|Unable to provide specimen|0|||
156832409|NCT01145053|566139858|FG000|Overall Study|Adverse Event|22|||
156832410|NCT01145053|566139858|FG000|Overall Study|Lost to Follow-up|28|||
156832411|NCT01145053|566139858|FG000|Overall Study|Withdrawal by Subject|25|||
156832412|NCT01145053|566139858|FG000|Overall Study|Other|18|||
156832413|NCT00293709|566139859|FG000|Overall Study|Other|47|||
156832414|NCT02785458|566139860|FG000|1 Month|Withdrawal by Subject|2|||
156832415|NCT02785458|566139861|FG001|1 Month|Withdrawal by Subject|1|||
156832416|NCT02785458|566139860|FG000|1 Month|Lost to Follow-up|38|||
156832417|NCT02785458|566139861|FG001|1 Month|Lost to Follow-up|31|||
156832418|NCT02785458|566139860|FG000|1 Month|Deemed Ineligible|1|||
156832419|NCT02785458|566139861|FG001|1 Month|Deemed Ineligible|0|||
156832420|NCT02785458|566139860|FG000|1 Month|Completed Evaluation by Baseline|42|||
156832421|NCT02785458|566139861|FG001|1 Month|Completed Evaluation by Baseline|39|||
156832422|NCT02785458|566139860|FG000|1 Month|Partial Interview|0|||
156832423|NCT02785458|566139861|FG001|1 Month|Partial Interview|4|||
156832424|NCT02785458|566139860|FG000|3 Months|Withdrawal by Subject|3|||
156832425|NCT02785458|566139861|FG001|3 Months|Withdrawal by Subject|1|||
156832426|NCT02785458|566139860|FG000|3 Months|Lost to Follow-up|25|||
156832427|NCT02785458|566139861|FG001|3 Months|Lost to Follow-up|21|||
156832428|NCT02785458|566139860|FG000|3 Months|Completed Evaluation at 1 Month|100|||
156832429|NCT02785458|566139861|FG001|3 Months|Completed Evaluation at 1 Month|89|||
156832430|NCT01146652|566139862|FG000|Overall Study|Adverse Event|506|||
156832431|NCT01146652|566139863|FG001|Overall Study|Adverse Event|15|||
156832432|NCT01146652|566139862|FG000|Overall Study|Lack of Efficacy|91|||
156832433|NCT01146652|566139863|FG001|Overall Study|Lack of Efficacy|7|||
156466590|NCT04158141|564803910|FG002|Step 1: Registration|Withdrawal by Subject|0|||
156466591|NCT04158141|564803908|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
156466592|NCT04158141|564803909|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
156466593|NCT04158141|564803910|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
156832434|NCT01146652|566139862|FG000|Overall Study|Poor compliance to protocol|38|||
156832435|NCT01146652|566139863|FG001|Overall Study|Poor compliance to protocol|1|||
156832436|NCT01146652|566139862|FG000|Overall Study|Other unspecified reasons|314|||
156832437|NCT01146652|566139863|FG001|Overall Study|Other unspecified reasons|22|||
156832438|NCT01146652|566139862|FG000|Overall Study|Enrolled but not treated|2|||
156832439|NCT01146652|566139863|FG001|Overall Study|Enrolled but not treated|0|||
156832440|NCT00520013|566139864|FG000|Overall Study|Withdrawal by Subject|0|||
156832441|NCT00520013|566139865|FG001|Overall Study|Withdrawal by Subject|0|||
156466594|NCT04121741|564803914|FG000|Overall Study|Protocol Violation|1|||
156466595|NCT04121741|564803915|FG001|Overall Study|Protocol Violation|0|||
156466596|NCT04121741|564803916|FG002|Overall Study|Protocol Violation|0|||
156832442|NCT00520013|566139866|FG002|Overall Study|Withdrawal by Subject|1|||
156832443|NCT00520013|566139864|FG000|Overall Study|Adverse Event|2|||
156832444|NCT00520013|566139865|FG001|Overall Study|Adverse Event|10|||
156832445|NCT00520013|566139866|FG002|Overall Study|Adverse Event|7|||
156832446|NCT00520013|566139864|FG000|Overall Study|Progressive Disease|7|||
156832447|NCT00520013|566139865|FG001|Overall Study|Progressive Disease|3|||
156832448|NCT00520013|566139866|FG002|Overall Study|Progressive Disease|0|||
156832449|NCT00520013|566139864|FG000|Overall Study|Clinical Progression|3|||
156832450|NCT00520013|566139865|FG001|Overall Study|Clinical Progression|1|||
156832451|NCT00520013|566139866|FG002|Overall Study|Clinical Progression|0|||
156832452|NCT00520013|566139864|FG000|Overall Study|Death|0|||
156832453|NCT00520013|566139865|FG001|Overall Study|Death|1|||
156832454|NCT00520013|566139866|FG002|Overall Study|Death|0|||
156832455|NCT00520013|566139864|FG000|Overall Study|Physician Decision|0|||
156832456|NCT00520013|566139865|FG001|Overall Study|Physician Decision|0|||
156832457|NCT00520013|566139866|FG002|Overall Study|Physician Decision|3|||
156832458|NCT02981524|566139867|FG000|Overall Study|Progressive Disease|14|||
156832459|NCT02981524|566139867|FG000|Overall Study|Death (unrelated)|1|||
156832460|NCT02981524|566139867|FG000|Overall Study|Treatment Related Toxicity|1|||
156832461|NCT02981524|566139867|FG000|Overall Study|Withdrawal by Subject|1|||
156832462|NCT00159913|566139871|FG000|Overall Study|Adverse Event|1|||
156832463|NCT00159913|566139872|FG001|Overall Study|Adverse Event|0|||
156832464|NCT00159913|566139873|FG002|Overall Study|Adverse Event|1|||
156832465|NCT00159913|566139874|FG003|Overall Study|Adverse Event|0|||
156832466|NCT00159913|566139871|FG000|Overall Study|Withdrawal by Subject|0|||
156832467|NCT00159913|566139872|FG001|Overall Study|Withdrawal by Subject|0|||
156832468|NCT00159913|566139873|FG002|Overall Study|Withdrawal by Subject|0|||
156832469|NCT00159913|566139874|FG003|Overall Study|Withdrawal by Subject|1|||
156832470|NCT00159913|566139871|FG000|Overall Study|Lost to Follow-up|0|||
156832471|NCT00159913|566139872|FG001|Overall Study|Lost to Follow-up|0|||
156832472|NCT00159913|566139873|FG002|Overall Study|Lost to Follow-up|0|||
156832473|NCT00159913|566139874|FG003|Overall Study|Lost to Follow-up|1|||
156832474|NCT00159913|566139871|FG000|Overall Study|Protocol Violation|1|||
156832475|NCT00159913|566139872|FG001|Overall Study|Protocol Violation|0|||
156832476|NCT00159913|566139873|FG002|Overall Study|Protocol Violation|1|||
156832477|NCT00159913|566139874|FG003|Overall Study|Protocol Violation|0|||
156832478|NCT03294135|566139875|FG000|Overall Study|Serious Adverse Event|1|||
156832479|NCT03294135|566139876|FG001|Overall Study|Serious Adverse Event|0|||
156832480|NCT03294135|566139877|FG002|Overall Study|Serious Adverse Event|0|||
156832481|NCT03294135|566139875|FG000|Overall Study|Lost to Follow-up|1|||
156832482|NCT03294135|566139876|FG001|Overall Study|Lost to Follow-up|0|||
156832483|NCT03294135|566139877|FG002|Overall Study|Lost to Follow-up|1|||
156832484|NCT03294135|566139875|FG000|Overall Study|Withdrawal by Subject|0|||
156832485|NCT03294135|566139876|FG001|Overall Study|Withdrawal by Subject|0|||
156832486|NCT03294135|566139877|FG002|Overall Study|Withdrawal by Subject|1|||
156832487|NCT03294135|566139875|FG000|Overall Study|Other|2|||
156832488|NCT03294135|566139876|FG001|Overall Study|Other|0|||
156832489|NCT03294135|566139877|FG002|Overall Study|Other|0|||
156832490|NCT02763254|566139878|FG000|Overall Study|Adverse Event|1|||
156832491|NCT00824005|566139879|FG000|Overall Study|Death|0|||
156832492|NCT00824005|566139880|FG001|Overall Study|Death|1|||
156832493|NCT00824005|566139879|FG000|Overall Study|Lost to Follow-up|0|||
156832494|NCT00824005|566139880|FG001|Overall Study|Lost to Follow-up|1|||
156832495|NCT00431951|566139881|FG000|Overall Study|Inability to follow study procedures|1|||
156832496|NCT00431951|566139882|FG001|Overall Study|Inability to follow study procedures|0|||
156832497|NCT00431951|566139883|FG002|Overall Study|Inability to follow study procedures|1|||
156832498|NCT00431951|566139884|FG003|Overall Study|Inability to follow study procedures|2|||
156832499|NCT00431951|566139881|FG000|Overall Study|Lost to Follow-up|0|||
156466597|NCT04121741|564803917|FG003|Overall Study|Protocol Violation|0|||
156466598|NCT04121741|564803918|FG004|Overall Study|Protocol Violation|0|||
156832500|NCT00431951|566139882|FG001|Overall Study|Lost to Follow-up|1|||
156832501|NCT00431951|566139883|FG002|Overall Study|Lost to Follow-up|0|||
156832502|NCT00431951|566139884|FG003|Overall Study|Lost to Follow-up|0|||
156832503|NCT00431951|566139881|FG000|Overall Study|Withdrawal by Subject|0|||
156832504|NCT00431951|566139882|FG001|Overall Study|Withdrawal by Subject|1|||
156832505|NCT00431951|566139883|FG002|Overall Study|Withdrawal by Subject|0|||
156832506|NCT00431951|566139884|FG003|Overall Study|Withdrawal by Subject|0|||
156832507|NCT00431951|566139881|FG000|Overall Study|Adverse Event|0|||
156832508|NCT00431951|566139882|FG001|Overall Study|Adverse Event|0|||
156832509|NCT00431951|566139883|FG002|Overall Study|Adverse Event|1|||
156466599|NCT04121741|564803919|FG005|Overall Study|Protocol Violation|0|||
156541320|NCT01987960|565074544|FG000|Period 1|Protocol Violation|12|||
156832510|NCT00431951|566139884|FG003|Overall Study|Adverse Event|0|||
156832511|NCT00168103|566139885|FG000|Overall Study|Withdrawal by Subject|1|||
156832512|NCT00168103|566139886|FG001|Overall Study|Withdrawal by Subject|2|||
156832513|NCT00168103|566139887|FG002|Overall Study|Withdrawal by Subject|1|||
156832514|NCT00168103|566139888|FG003|Overall Study|Withdrawal by Subject|0|||
156832515|NCT00168103|566139885|FG000|Overall Study|Lost to Follow-up|1|||
156832516|NCT00168103|566139886|FG001|Overall Study|Lost to Follow-up|3|||
156832517|NCT00168103|566139887|FG002|Overall Study|Lost to Follow-up|0|||
156832518|NCT00168103|566139888|FG003|Overall Study|Lost to Follow-up|0|||
156832519|NCT02956850|566139890|FG000|Overall Study|Withdrawal by Subject|0|||
156832520|NCT02956850|566139891|FG001|Overall Study|Withdrawal by Subject|0|||
156832521|NCT02956850|566139892|FG002|Overall Study|Withdrawal by Subject|0|||
156832522|NCT02956850|566139893|FG003|Overall Study|Withdrawal by Subject|0|||
156832523|NCT02956850|566139894|FG004|Overall Study|Withdrawal by Subject|0|||
156832524|NCT02956850|566139895|FG005|Overall Study|Withdrawal by Subject|0|||
156832525|NCT02956850|566139896|FG006|Overall Study|Withdrawal by Subject|0|||
156832526|NCT02956850|566139897|FG007|Overall Study|Withdrawal by Subject|0|||
156832527|NCT02956850|566139898|FG008|Overall Study|Withdrawal by Subject|0|||
156832528|NCT02956850|566139899|FG009|Overall Study|Withdrawal by Subject|0|||
156832529|NCT02956850|566139900|FG010|Overall Study|Withdrawal by Subject|0|||
156832530|NCT02956850|566139901|FG011|Overall Study|Withdrawal by Subject|0|||
156832531|NCT02956850|566139902|FG012|Overall Study|Withdrawal by Subject|0|||
156832532|NCT02956850|566139903|FG013|Overall Study|Withdrawal by Subject|0|||
156832533|NCT02956850|566139904|FG014|Overall Study|Withdrawal by Subject|0|||
156832534|NCT02956850|566139905|FG015|Overall Study|Withdrawal by Subject|0|||
156832535|NCT02956850|566139906|FG016|Overall Study|Withdrawal by Subject|0|||
156832536|NCT02956850|566139907|FG017|Overall Study|Withdrawal by Subject|1|||
156832537|NCT01920152|566139908|FG000|Overall Study|Withdrawal by Subject|1|||
156832538|NCT01920152|566139909|FG001|Overall Study|Withdrawal by Subject|2|||
156832539|NCT03412604|566139910|FG000|Overall Study|Withdrawal by Subject|1|||
156832540|NCT00993499|566139911|FG000|Run-in Period (8 Days)|Adverse Event|0|||
156832541|NCT00993499|566139912|FG001|Run-in Period (8 Days)|Adverse Event|1|||
156832542|NCT00993499|566139913|FG002|Run-in Period (8 Days)|Adverse Event|0|||
156832543|NCT00993499|566139914|FG003|Run-in Period (8 Days)|Adverse Event|0|||
156832544|NCT00993499|566139915|FG004|Run-in Period (8 Days)|Adverse Event|0|||
156339893|NCT01817530|564342248|FG007|Overall Study|Pregnancy|0|||
156339894|NCT01817530|564342241|FG000|Overall Study|Other|0|||
156832545|NCT00993499|566139916|FG005|Run-in Period (8 Days)|Adverse Event|0|||
156832546|NCT00993499|566139911|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
156832547|NCT00993499|566139912|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832548|NCT00993499|566139913|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832549|NCT00993499|566139914|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832550|NCT00993499|566139915|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832551|NCT00993499|566139916|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832552|NCT00993499|566139911|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
156832553|NCT00993499|566139912|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
156832554|NCT00993499|566139913|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
156832555|NCT00993499|566139914|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
156832556|NCT00993499|566139915|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
156832557|NCT00993499|566139916|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
156832558|NCT00993499|566139911|FG000|Run-in Period (8 Days)|Progressive disease|0|||
156832559|NCT00993499|566139912|FG001|Run-in Period (8 Days)|Progressive disease|1|||
156832560|NCT00993499|566139913|FG002|Run-in Period (8 Days)|Progressive disease|1|||
156832561|NCT00993499|566139914|FG003|Run-in Period (8 Days)|Progressive disease|0|||
156832562|NCT00993499|566139915|FG004|Run-in Period (8 Days)|Progressive disease|0|||
156832563|NCT00993499|566139916|FG005|Run-in Period (8 Days)|Progressive disease|0|||
156832564|NCT00993499|566139911|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
156832565|NCT00993499|566139912|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
156832566|NCT00993499|566139913|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
156832567|NCT00993499|566139914|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
156832568|NCT00993499|566139915|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
156832569|NCT00993499|566139916|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
156832570|NCT00993499|566139911|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
156832571|NCT00993499|566139912|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
156832572|NCT00993499|566139913|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
156832573|NCT00993499|566139914|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
156832574|NCT00993499|566139915|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
156832575|NCT00993499|566139916|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
156832576|NCT00993499|566139911|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
156832577|NCT00993499|566139912|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
156832578|NCT00993499|566139913|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
156466600|NCT01084863|564803921|FG000|Main Study Treatment Period|Disease progression|11|||
156339895|NCT01817530|564342242|FG001|Overall Study|Other|1|||
156832579|NCT00993499|566139914|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
156832580|NCT00993499|566139915|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
156832581|NCT00993499|566139916|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
156832582|NCT00993499|566139911|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832583|NCT00993499|566139912|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832584|NCT00993499|566139913|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
156832585|NCT00993499|566139914|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832586|NCT00993499|566139915|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832587|NCT00993499|566139916|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832588|NCT00993499|566139911|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832589|NCT00993499|566139912|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
156832590|NCT00993499|566139913|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832591|NCT00993499|566139914|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832592|NCT00993499|566139915|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832593|NCT00993499|566139916|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832594|NCT00993499|566139911|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
156832595|NCT00993499|566139912|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
156832596|NCT00993499|566139913|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
156832597|NCT00993499|566139914|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
156832598|NCT00993499|566139915|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
156832599|NCT00993499|566139916|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
156832600|NCT00993499|566139911|FG000|Discontinued After Starting Course 3|DLT|1|||
156832601|NCT00993499|566139912|FG001|Discontinued After Starting Course 3|DLT|0|||
156832602|NCT00993499|566139913|FG002|Discontinued After Starting Course 3|DLT|2|||
156832603|NCT00993499|566139914|FG003|Discontinued After Starting Course 3|DLT|1|||
156832604|NCT00993499|566139915|FG004|Discontinued After Starting Course 3|DLT|0|||
156832605|NCT00993499|566139916|FG005|Discontinued After Starting Course 3|DLT|0|||
156832606|NCT00993499|566139911|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
156832607|NCT00993499|566139912|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
156832608|NCT00993499|566139913|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
156832609|NCT00993499|566139914|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
156832610|NCT00993499|566139915|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
156832611|NCT00993499|566139916|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
156832612|NCT02068118|566139917|FG000|18-month Comparative Study Period|Death|90|||
156832613|NCT02068118|566139918|FG001|18-month Comparative Study Period|Death|97|||
156832614|NCT02068118|566139917|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
156832615|NCT02068118|566139918|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
156832616|NCT02068118|566139917|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
156832617|NCT02068118|566139918|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
156832618|NCT02068118|566139917|FG000|18-month Comparative Study Period|Heart transplant|9|||
156339896|NCT01817530|564342243|FG002|Overall Study|Other|0|||
156832619|NCT02068118|566139918|FG001|18-month Comparative Study Period|Heart transplant|15|||
156832620|NCT02068118|566139917|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
156832621|NCT02068118|566139918|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
156832622|NCT02068118|566139917|FG000|18-month Comparative Study Period|Hemiplegia|0|||
156832623|NCT02068118|566139918|FG001|18-month Comparative Study Period|Hemiplegia|1|||
156832624|NCT02068118|566139917|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
156832625|NCT02068118|566139918|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
156832626|NCT02068118|566139917|FG000|18-month Comparative Study Period|Move|0|||
156832627|NCT02068118|566139918|FG001|18-month Comparative Study Period|Move|1|||
156832628|NCT02068118|566139917|FG000|18-month Comparative Study Period|Hearing loss|0|||
156832629|NCT02068118|566139918|FG001|18-month Comparative Study Period|Hearing loss|1|||
156832630|NCT02068118|566139917|FG000|Extension Period|Death|0|||
156832631|NCT02068118|566139918|FG001|Extension Period|Death|2|||
156832632|NCT02068118|566139917|FG000|Extension Period|Withdrawal by Subject|1|||
156832633|NCT02068118|566139918|FG001|Extension Period|Withdrawal by Subject|0|||
156832634|NCT02068118|566139917|FG000|Extension Period|Heart transplant|1|||
156832635|NCT02068118|566139918|FG001|Extension Period|Heart transplant|0|||
156832636|NCT02068118|566139917|FG000|Extension Period|Wrong device use|0|||
156832637|NCT02068118|566139918|FG001|Extension Period|Wrong device use|1|||
156832638|NCT00453973|566139919|FG000|Overall Study|Adverse Event|4|||
156832639|NCT00453973|566139920|FG001|Overall Study|Adverse Event|9|||
156832640|NCT00453973|566139919|FG000|Overall Study|Withdrawal by Subject|7|||
156832641|NCT00453973|566139920|FG001|Overall Study|Withdrawal by Subject|6|||
156832642|NCT00453973|566139919|FG000|Overall Study|PI Decision|0|||
156832643|NCT00453973|566139920|FG001|Overall Study|PI Decision|2|||
156832644|NCT00453973|566139919|FG000|Overall Study|Relocation|1|||
156832645|NCT00453973|566139920|FG001|Overall Study|Relocation|0|||
156339897|NCT01817530|564342244|FG003|Overall Study|Other|0|||
156832646|NCT00453973|566139919|FG000|Overall Study|Renal transplant|1|||
156832647|NCT00453973|566139920|FG001|Overall Study|Renal transplant|1|||
156832648|NCT00453973|566139919|FG000|Overall Study|Site closed by sponsor|3|||
156832649|NCT00453973|566139920|FG001|Overall Study|Site closed by sponsor|0|||
156832650|NCT00453973|566139919|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
156832651|NCT00453973|566139920|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
156832652|NCT00707746|566139921|FG000|Treatment Period|Adverse Event|2|||
156832653|NCT00707746|566139922|FG001|Treatment Period|Adverse Event|4|||
156832654|NCT00707746|566139921|FG000|Treatment Period|Ineligibility|0|||
156832655|NCT00707746|566139922|FG001|Treatment Period|Ineligibility|1|||
156832656|NCT01219933|566139930|FG000|Overall Study|Adverse Event|8|||
156832657|NCT01219933|566139930|FG000|Overall Study|No LDA reached|5|||
156832658|NCT01219933|566139930|FG000|Overall Study|No LDA maintained|7|||
156832659|NCT01219933|566139930|FG000|Overall Study|Lost to Follow-up|3|||
156832660|NCT01219933|566139930|FG000|Overall Study|GC free|1|||
156832661|NCT01219933|566139930|FG000|Overall Study|Withdrawal by Subject|5|||
156832662|NCT01219933|566139930|FG000|Overall Study|Protocol Violation|8|||
156832663|NCT01219933|566139930|FG000|Overall Study|Lack of Efficacy|1|||
156832664|NCT01902888|566139931|FG000|Overall Study|Study Terminated|3|||
156832665|NCT02226549|566139932|FG000|Overall Study|Randomized but Never Treated|1|||
156832666|NCT02226549|566139933|FG001|Overall Study|Randomized but Never Treated|0|||
156832667|NCT02226549|566139932|FG000|Overall Study|Lost to Follow-up|0|||
156832668|NCT02226549|566139933|FG001|Overall Study|Lost to Follow-up|1|||
156832669|NCT02713529|566139934|FG000|Overall Study|Withdrawal by Subject|3|||
156832670|NCT02713529|566139935|FG001|Overall Study|Withdrawal by Subject|1|||
156832671|NCT02713529|566139936|FG002|Overall Study|Withdrawal by Subject|4|||
156832672|NCT02713529|566139937|FG003|Overall Study|Withdrawal by Subject|2|||
156832673|NCT02713529|566139938|FG004|Overall Study|Withdrawal by Subject|0|||
156832674|NCT02713529|566139939|FG005|Overall Study|Withdrawal by Subject|1|||
156832675|NCT02713529|566139940|FG006|Overall Study|Withdrawal by Subject|1|||
156832676|NCT02713529|566139934|FG000|Overall Study|Lost to Follow-up|1|||
156832677|NCT02713529|566139935|FG001|Overall Study|Lost to Follow-up|0|||
156832678|NCT02713529|566139936|FG002|Overall Study|Lost to Follow-up|1|||
156832679|NCT02713529|566139937|FG003|Overall Study|Lost to Follow-up|0|||
156832680|NCT02713529|566139938|FG004|Overall Study|Lost to Follow-up|0|||
156832681|NCT02713529|566139939|FG005|Overall Study|Lost to Follow-up|0|||
156832682|NCT02713529|566139940|FG006|Overall Study|Lost to Follow-up|0|||
156832683|NCT02713529|566139934|FG000|Overall Study|Death|3|||
156832684|NCT02713529|566139935|FG001|Overall Study|Death|3|||
156832685|NCT02713529|566139936|FG002|Overall Study|Death|26|||
156832686|NCT02713529|566139937|FG003|Overall Study|Death|27|||
156832687|NCT02713529|566139938|FG004|Overall Study|Death|3|||
156832688|NCT02713529|566139939|FG005|Overall Study|Death|13|||
156832689|NCT02713529|566139940|FG006|Overall Study|Death|3|||
156832690|NCT03352453|566139943|FG000|Overall Study|Miscellaneous Reasons|1|||
156832691|NCT03352453|566139944|FG001|Overall Study|Miscellaneous Reasons|2|||
156832692|NCT03352453|566139943|FG000|Overall Study|Lack of Efficacy|1|||
156832693|NCT03352453|566139944|FG001|Overall Study|Lack of Efficacy|0|||
156832694|NCT03352453|566139943|FG000|Overall Study|Withdrawal by Subject|8|||
156832695|NCT03352453|566139944|FG001|Overall Study|Withdrawal by Subject|14|||
156832696|NCT03352453|566139943|FG000|Overall Study|Study Terminated by Sponsor|2|||
156832697|NCT03352453|566139944|FG001|Overall Study|Study Terminated by Sponsor|1|||
156832698|NCT03352453|566139943|FG000|Overall Study|Protocol Deviation|1|||
156832699|NCT03352453|566139944|FG001|Overall Study|Protocol Deviation|0|||
156832700|NCT03352453|566139943|FG000|Overall Study|Lost to Follow-up|7|||
156832701|NCT03352453|566139944|FG001|Overall Study|Lost to Follow-up|6|||
156832702|NCT03352453|566139943|FG000|Overall Study|Adverse Event|2|||
156832703|NCT03352453|566139944|FG001|Overall Study|Adverse Event|9|||
156832704|NCT02827500|566139945|FG000|Overall Study|Death|7|||
156832705|NCT02827500|566139946|FG001|Overall Study|Death|3|||
156832706|NCT02827500|566139945|FG000|Overall Study|Lost to Follow-up|1|||
156832707|NCT02827500|566139946|FG001|Overall Study|Lost to Follow-up|1|||
156832708|NCT02827500|566139945|FG000|Overall Study|Withdrawal by Subject|3|||
156832709|NCT02827500|566139946|FG001|Overall Study|Withdrawal by Subject|1|||
156832710|NCT02827500|566139945|FG000|Overall Study|Missing primary endpoint data|3|||
156832711|NCT02827500|566139946|FG001|Overall Study|Missing primary endpoint data|1|||
156832712|NCT02827500|566139945|FG000|Overall Study|Other|5|||
156832713|NCT02827500|566139946|FG001|Overall Study|Other|1|||
156832714|NCT01241760|566139949|FG000|Overall Study|Adverse Event|1|||
156832715|NCT01241760|566139950|FG001|Overall Study|Adverse Event|0|||
156832716|NCT01241760|566139949|FG000|Overall Study|Lost to Follow-up|18|||
156832717|NCT01241760|566139950|FG001|Overall Study|Lost to Follow-up|22|||
156832718|NCT01241760|566139949|FG000|Overall Study|Withdrawal by Subject|13|||
156832719|NCT01241760|566139950|FG001|Overall Study|Withdrawal by Subject|13|||
156832720|NCT01241760|566139949|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
156832721|NCT01241760|566139950|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
156832722|NCT01241760|566139949|FG000|Overall Study|Other|1|||
156832723|NCT01241760|566139950|FG001|Overall Study|Other|1|||
156832724|NCT00514020|566139951|FG000|Overall Study|Adverse Event|6|||
156832725|NCT00514020|566139951|FG000|Overall Study|Withdrawal by Subject|3|||
156832726|NCT00514020|566139951|FG000|Overall Study|Physician Decision|1|||
156832727|NCT00514020|566139951|FG000|Overall Study|disease progression|9|||
156832728|NCT00514020|566139951|FG000|Overall Study|other complicating disease|2|||
156832729|NCT00514020|566139951|FG000|Overall Study|patient went to radiation treatment|1|||
156832730|NCT00514020|566139951|FG000|Overall Study|"patients moved to the no tx group"|6|||
156832731|NCT01636713|566139956|FG000|Overall Study|Adverse Event|16|||
156832732|NCT01636713|566139957|FG001|Overall Study|Adverse Event|16|||
156832733|NCT01636713|566139958|FG002|Overall Study|Adverse Event|7|||
156832734|NCT01636713|566139956|FG000|Overall Study|Lack of Efficacy|6|||
156832735|NCT01636713|566139957|FG001|Overall Study|Lack of Efficacy|6|||
156832736|NCT01636713|566139958|FG002|Overall Study|Lack of Efficacy|2|||
156832737|NCT01636713|566139956|FG000|Overall Study|Protocol Violation|3|||
156832738|NCT01636713|566139957|FG001|Overall Study|Protocol Violation|0|||
156832739|NCT01636713|566139958|FG002|Overall Study|Protocol Violation|1|||
156832740|NCT01636713|566139956|FG000|Overall Study|Lost to Follow-up|0|||
156832741|NCT01636713|566139957|FG001|Overall Study|Lost to Follow-up|0|||
156832742|NCT01636713|566139958|FG002|Overall Study|Lost to Follow-up|1|||
156832743|NCT01636713|566139956|FG000|Overall Study|Withdrawal by Subject|5|||
156832744|NCT01636713|566139957|FG001|Overall Study|Withdrawal by Subject|4|||
156832745|NCT01636713|566139958|FG002|Overall Study|Withdrawal by Subject|8|||
156832746|NCT01636713|566139956|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
156832747|NCT01636713|566139957|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
156832748|NCT01636713|566139958|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
156832749|NCT00276614|566139966|FG000|Overall Study|Progression of disease under study|3|||
156832750|NCT02525094|566139970|FG000|Overall Study|Lost to Follow-up|2|||
156832751|NCT02525094|566139971|FG001|Overall Study|Lost to Follow-up|1|||
156832752|NCT02525094|566139970|FG000|Overall Study|Withdrawal by Subject|5|||
156832753|NCT02525094|566139971|FG001|Overall Study|Withdrawal by Subject|6|||
156832754|NCT02525094|566139970|FG000|Overall Study|Not Treated|1|||
156832755|NCT02525094|566139971|FG001|Overall Study|Not Treated|1|||
156832756|NCT01490294|566139972|FG000|Overall Study|Prematurely discontinuation|4|||
156832757|NCT01490294|566139973|FG001|Overall Study|Prematurely discontinuation|0|||
156832758|NCT01490294|566139974|FG002|Overall Study|Prematurely discontinuation|1|||
156832759|NCT01490294|566139975|FG003|Overall Study|Prematurely discontinuation|1|||
156832760|NCT01490294|566139972|FG000|Overall Study|Adverse Event|1|||
156832761|NCT01490294|566139973|FG001|Overall Study|Adverse Event|0|||
156832762|NCT01490294|566139974|FG002|Overall Study|Adverse Event|0|||
156832763|NCT01490294|566139975|FG003|Overall Study|Adverse Event|0|||
156832764|NCT01751776|566139978|FG000|Overall Study|Adverse Event|0|||
156832765|NCT01751776|566139979|FG001|Overall Study|Adverse Event|0|||
156832766|NCT01751776|566139980|FG002|Overall Study|Adverse Event|0|||
156832767|NCT01751776|566139981|FG003|Overall Study|Adverse Event|0|||
156832768|NCT01751776|566139982|FG004|Overall Study|Adverse Event|0|||
156832769|NCT01751776|566139983|FG005|Overall Study|Adverse Event|0|||
156832770|NCT01751776|566139984|FG006|Overall Study|Adverse Event|4|||
156832771|NCT01751776|566139985|FG007|Overall Study|Adverse Event|2|||
156832772|NCT01751776|566139978|FG000|Overall Study|Consent withdrawn|0|||
156832773|NCT01751776|566139979|FG001|Overall Study|Consent withdrawn|0|||
156832774|NCT01751776|566139980|FG002|Overall Study|Consent withdrawn|0|||
156832775|NCT01751776|566139981|FG003|Overall Study|Consent withdrawn|0|||
156832776|NCT01751776|566139982|FG004|Overall Study|Consent withdrawn|0|||
156832777|NCT01751776|566139983|FG005|Overall Study|Consent withdrawn|0|||
156832778|NCT01751776|566139984|FG006|Overall Study|Consent withdrawn|0|||
156832779|NCT01751776|566139985|FG007|Overall Study|Consent withdrawn|1|||
156832780|NCT01751776|566139978|FG000|Overall Study|Other reason not specified above|0|||
156832781|NCT01751776|566139979|FG001|Overall Study|Other reason not specified above|0|||
156832782|NCT01751776|566139980|FG002|Overall Study|Other reason not specified above|0|||
156832783|NCT01751776|566139981|FG003|Overall Study|Other reason not specified above|0|||
156832784|NCT01751776|566139982|FG004|Overall Study|Other reason not specified above|0|||
156832785|NCT01751776|566139983|FG005|Overall Study|Other reason not specified above|0|||
156832786|NCT01751776|566139984|FG006|Overall Study|Other reason not specified above|0|||
156832787|NCT01751776|566139985|FG007|Overall Study|Other reason not specified above|1|||
156832788|NCT00831701|566139988|FG000|Overall Study|Withdrawal by Subject|2|||
156832789|NCT00831701|566139989|FG001|Overall Study|Withdrawal by Subject|0|||
156832790|NCT00831701|566139988|FG000|Overall Study|Stone expulsion before first medication|2|||
156832791|NCT00831701|566139989|FG001|Overall Study|Stone expulsion before first medication|2|||
156466601|NCT01084863|564803922|FG001|Main Study Treatment Period|Disease progression|7|||
156832792|NCT00831701|566139988|FG000|Overall Study|Lost to Follow-up|1|||
156832793|NCT00831701|566139989|FG001|Overall Study|Lost to Follow-up|3|||
156832794|NCT02117349|566139990|FG000|Overall Study|Withdrawal by Subject|1|||
156832795|NCT02117349|566139991|FG001|Overall Study|Withdrawal by Subject|0|||
156832796|NCT02117349|566139990|FG000|Overall Study|Lost to Follow-up|1|||
156832797|NCT02117349|566139991|FG001|Overall Study|Lost to Follow-up|1|||
156832798|NCT02117349|566139990|FG000|Overall Study|Death|1|||
156466602|NCT01084863|564803921|FG000|Main Study Treatment Period|Adverse Event|5|||
156832799|NCT02117349|566139991|FG001|Overall Study|Death|0|||
156832800|NCT02535416|566139992|FG000|Overall Study|Family bereavement overseas|1|||
156832801|NCT02535416|566139993|FG001|Overall Study|Family bereavement overseas|0|||
156832802|NCT02535416|566139994|FG002|Overall Study|Family bereavement overseas|0|||
156832803|NCT02535416|566139995|FG003|Overall Study|Family bereavement overseas|0|||
156832804|NCT02535416|566139996|FG004|Overall Study|Family bereavement overseas|0|||
156832805|NCT02535416|566139997|FG005|Overall Study|Family bereavement overseas|0|||
156832806|NCT02535416|566139998|FG006|Overall Study|Family bereavement overseas|0|||
156832807|NCT02535416|566139999|FG007|Overall Study|Family bereavement overseas|0|||
156832808|NCT02535416|566140000|FG008|Overall Study|Family bereavement overseas|0|||
156832809|NCT01977690|566140003|FG000|Overall Study|Withdrawal by Subject|0|||
156832810|NCT01977690|566140004|FG001|Overall Study|Withdrawal by Subject|4|||
156832811|NCT01711866|566140009|FG000|Overall Study|Noncompliant|3|||
156832812|NCT01711866|566140009|FG000|Overall Study|Withdrawal by Subject|3|||
156832813|NCT01711866|566140009|FG000|Overall Study|Adverse Event|2|||
156832814|NCT00459537|566140010|FG000|Overall Study|Adverse Event|1|||
156832815|NCT00459537|566140011|FG001|Overall Study|Adverse Event|6|||
156832816|NCT00459537|566140010|FG000|Overall Study|Lack of Efficacy|10|||
156832817|NCT00459537|566140011|FG001|Overall Study|Lack of Efficacy|11|||
156832818|NCT00459537|566140010|FG000|Overall Study|Withdrawal by Subject|20|||
156832819|NCT00459537|566140011|FG001|Overall Study|Withdrawal by Subject|26|||
156832820|NCT00459537|566140010|FG000|Overall Study|Lost to Follow-up|27|||
156832821|NCT00459537|566140011|FG001|Overall Study|Lost to Follow-up|30|||
156832822|NCT00459537|566140010|FG000|Overall Study|Administrative problems|3|||
156832823|NCT00459537|566140011|FG001|Overall Study|Administrative problems|0|||
156832824|NCT00459537|566140010|FG000|Overall Study|Protocol Violation|4|||
156832825|NCT00459537|566140011|FG001|Overall Study|Protocol Violation|3|||
156832826|NCT00459537|566140010|FG000|Overall Study|Missing|1|||
156832827|NCT00459537|566140011|FG001|Overall Study|Missing|0|||
156832828|NCT01831817|566140012|FG000|Overall Study|Lost to Follow-up|1|||
156832829|NCT01831817|566140013|FG001|Overall Study|Lost to Follow-up|0|||
156832830|NCT01831817|566140014|FG002|Overall Study|Lost to Follow-up|0|||
156832831|NCT01831817|566140015|FG003|Overall Study|Lost to Follow-up|0|||
156832832|NCT01831817|566140012|FG000|Overall Study|Withdrawl of Consent|3|||
156832833|NCT01831817|566140013|FG001|Overall Study|Withdrawl of Consent|0|||
156832834|NCT01831817|566140014|FG002|Overall Study|Withdrawl of Consent|0|||
156832835|NCT01831817|566140015|FG003|Overall Study|Withdrawl of Consent|0|||
156832836|NCT03159104|566140016|FG000|Overall Study|Violation of inclusion criteria|1|||
156832837|NCT03159104|566140017|FG001|Overall Study|Violation of inclusion criteria|2|||
156832838|NCT00958217|566140018|FG000|Overall Study|Death|2|||
156832839|NCT00958217|566140019|FG001|Overall Study|Death|1|||
156832840|NCT00958217|566140018|FG000|Overall Study|Withdrawal by Subject|4|||
156832841|NCT00958217|566140019|FG001|Overall Study|Withdrawal by Subject|3|||
156832842|NCT00958217|566140018|FG000|Overall Study|Lost to Follow-up|17|||
156832843|NCT00958217|566140019|FG001|Overall Study|Lost to Follow-up|19|||
156832844|NCT00958217|566140018|FG000|Overall Study|Moved out of area|1|||
156832845|NCT00958217|566140019|FG001|Overall Study|Moved out of area|1|||
156832846|NCT00958217|566140018|FG000|Overall Study|Inpatient hospitalization|0|||
156832847|NCT00958217|566140019|FG001|Overall Study|Inpatient hospitalization|1|||
156832848|NCT02440789|566140022|FG000|Overall Study|Withdrawal by Subject|3|||
156832849|NCT02440789|566140022|FG000|Overall Study|Not willing to adhere to reqs|1|||
156832850|NCT01825941|566141430|FG000|Overall Study|Lost to Follow-up|4|||
156832851|NCT01825941|566141431|FG001|Overall Study|Lost to Follow-up|1|||
156832852|NCT02831933|566141432|FG000|Overall Study|Physician Decision|11|||
156832853|NCT05065190|566141433|FG000|Overall Study|Other than listed|2|||
156832854|NCT05065190|566141434|FG001|Overall Study|Other than listed|12|||
156832855|NCT05065190|566141433|FG000|Overall Study|Lack of Efficacy|4|||
156339898|NCT01817530|564342245|FG004|Overall Study|Other|1|||
156541321|NCT01987960|565074545|FG001|Period 1|Protocol Violation|0|||
156832856|NCT05065190|566141434|FG001|Overall Study|Lack of Efficacy|0|||
156832857|NCT05065190|566141433|FG000|Overall Study|Adverse Event|1|||
156832858|NCT05065190|566141434|FG001|Overall Study|Adverse Event|10|||
156832859|NCT03938324|566141442|FG000|Overall Study|Lost to Follow-up|42|||
156832860|NCT03938324|566141443|FG001|Overall Study|Lost to Follow-up|21|||
156832861|NCT03938324|566141442|FG000|Overall Study|Withdrawal by Subject|6|||
156832862|NCT03938324|566141443|FG001|Overall Study|Withdrawal by Subject|1|||
156832863|NCT02769962|566141444|FG000|Overall Study|Physician Decision|0|||
156832864|NCT02769962|566141445|FG001|Overall Study|Physician Decision|0|||
156832865|NCT02769962|566141446|FG002|Overall Study|Physician Decision|0|||
156832866|NCT02769962|566141447|FG003|Overall Study|Physician Decision|0|||
156832867|NCT02769962|566141448|FG004|Overall Study|Physician Decision|0|||
156541322|NCT01987960|565074546|FG002|Period 1|Protocol Violation|0|||
156832868|NCT02769962|566141449|FG005|Overall Study|Physician Decision|1|||
156832869|NCT02769962|566141450|FG006|Overall Study|Physician Decision|0|||
156832870|NCT02769962|566141451|FG007|Overall Study|Physician Decision|1|||
156541323|NCT01987960|565074547|FG003|Period 1|Protocol Violation|0|||
156541324|NCT01987960|565074544|FG000|Period 1|Withdrawal by Subject|21|||
156541325|NCT01987960|565074545|FG001|Period 1|Withdrawal by Subject|0|||
156541326|NCT01987960|565074546|FG002|Period 1|Withdrawal by Subject|0|||
156541327|NCT01987960|565074547|FG003|Period 1|Withdrawal by Subject|0|||
156541328|NCT01987960|565074544|FG000|Period 1|Lost to Follow-up|40|||
156541329|NCT01987960|565074545|FG001|Period 1|Lost to Follow-up|0|||
156541330|NCT01987960|565074546|FG002|Period 1|Lost to Follow-up|0|||
156541331|NCT01987960|565074547|FG003|Period 1|Lost to Follow-up|0|||
156541332|NCT01987960|565074544|FG000|Period 1|administrative or other reason|75|||
156541333|NCT01987960|565074545|FG001|Period 1|administrative or other reason|0|||
156541334|NCT01987960|565074546|FG002|Period 1|administrative or other reason|0|||
156541335|NCT01987960|565074547|FG003|Period 1|administrative or other reason|0|||
156832871|NCT02769962|566141444|FG000|Overall Study|Refused further treatment|0|||
156832872|NCT02769962|566141445|FG001|Overall Study|Refused further treatment|0|||
156832873|NCT02769962|566141446|FG002|Overall Study|Refused further treatment|0|||
156832874|NCT02769962|566141447|FG003|Overall Study|Refused further treatment|0|||
156832875|NCT02769962|566141448|FG004|Overall Study|Refused further treatment|0|||
156832876|NCT02769962|566141449|FG005|Overall Study|Refused further treatment|1|||
156832877|NCT02769962|566141450|FG006|Overall Study|Refused further treatment|1|||
156832878|NCT02769962|566141451|FG007|Overall Study|Refused further treatment|0|||
156832879|NCT05565937|566141452|FG000|Overall Study|Adverse Event|0|||
156832880|NCT05565937|566141453|FG001|Overall Study|Adverse Event|1|||
156832881|NCT05565937|566141452|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
156832882|NCT05565937|566141453|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
156832883|NCT05565937|566141452|FG000|Overall Study|Lost to Follow-up|2|||
156832884|NCT05565937|566141453|FG001|Overall Study|Lost to Follow-up|0|||
156832885|NCT05565937|566141452|FG000|Overall Study|Pregnancy|0|||
156832886|NCT05565937|566141453|FG001|Overall Study|Pregnancy|2|||
156832887|NCT05565937|566141452|FG000|Overall Study|Anisometropia|0|||
156832888|NCT05565937|566141453|FG001|Overall Study|Anisometropia|1|||
156339899|NCT01817530|564342246|FG005|Overall Study|Other|0|||
156339900|NCT01817530|564342247|FG006|Overall Study|Other|5|||
156339901|NCT01817530|564342248|FG007|Overall Study|Other|0|||
156339902|NCT01817530|564342241|FG000|Overall Study|Surgery or Invasive Intervention|1|||
156339903|NCT01817530|564342242|FG001|Overall Study|Surgery or Invasive Intervention|0|||
156339904|NCT01817530|564342243|FG002|Overall Study|Surgery or Invasive Intervention|0|||
156466603|NCT01084863|564803922|FG001|Main Study Treatment Period|Adverse Event|3|||
156466604|NCT01084863|564803921|FG000|Main Study Treatment Period|Other Reason|0|||
156466605|NCT01084863|564803922|FG001|Main Study Treatment Period|Other Reason|1|||
156466606|NCT01084863|564803921|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
156466607|NCT01084863|564803922|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
156466608|NCT01084863|564803921|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
156466609|NCT01084863|564803922|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
156466610|NCT01084863|564803921|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
156466611|NCT01084863|564803922|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
156466612|NCT01084863|564803921|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
156541336|NCT01987960|565074544|FG000|Period 1|Withdrawal of consent before treatment|4|||
156541337|NCT01987960|565074545|FG001|Period 1|Withdrawal of consent before treatment|0|||
156541338|NCT01987960|565074546|FG002|Period 1|Withdrawal of consent before treatment|0|||
156541339|NCT01987960|565074547|FG003|Period 1|Withdrawal of consent before treatment|0|||
156541340|NCT01987960|565074544|FG000|Period 2|Adverse Event|0|||
156541341|NCT01987960|565074545|FG001|Period 2|Adverse Event|0|||
156541342|NCT01987960|565074546|FG002|Period 2|Adverse Event|1|||
156541343|NCT01987960|565074547|FG003|Period 2|Adverse Event|0|||
156541344|NCT01987960|565074544|FG000|Period 2|Withdrawal by Subject|0|||
156541345|NCT01987960|565074545|FG001|Period 2|Withdrawal by Subject|0|||
156832889|NCT04544683|566141454|FG000|Overall Study|Lost to Follow-up|2|||
156832890|NCT04544683|566141454|FG000|Overall Study|Underwent cervical spine surgery|6|||
156832891|NCT00151372|566141455|FG000|Overall Study|Death|12|||
156832892|NCT00151372|566141456|FG001|Overall Study|Death|11|||
156832893|NCT00151372|566141455|FG000|Overall Study|Lost to Follow-up|5|||
156466613|NCT01084863|564803922|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
156466614|NCT01084863|564803921|FG000|Treatment Period Beyond Cycle 8|Other|0|||
156466615|NCT01084863|564803922|FG001|Treatment Period Beyond Cycle 8|Other|1|||
156466616|NCT01084863|564803921|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
156466617|NCT01084863|564803922|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
156466618|NCT04505722|564803923|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
156466619|NCT04505722|564803924|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
156466620|NCT04505722|564803925|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
156466621|NCT04505722|564803923|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
156466622|NCT04505722|564803924|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
156466623|NCT04505722|564803925|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
156466624|NCT04505722|564803923|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
156466625|NCT04505722|564803924|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
156466626|NCT04505722|564803925|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
156466627|NCT04505722|564803923|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
156466628|NCT04505722|564803924|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
156466629|NCT04505722|564803925|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
156466630|NCT04505722|564803923|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
156466631|NCT04505722|564803924|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
156466632|NCT04505722|564803925|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
156466633|NCT04505722|564803923|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
156832894|NCT00151372|566141456|FG001|Overall Study|Lost to Follow-up|5|||
156832895|NCT00151372|566141455|FG000|Overall Study|Too sick medically to continue|5|||
156832896|NCT00151372|566141456|FG001|Overall Study|Too sick medically to continue|6|||
156832897|NCT00151372|566141455|FG000|Overall Study|Withdrawal by Subject|7|||
156832898|NCT00151372|566141456|FG001|Overall Study|Withdrawal by Subject|7|||
156832899|NCT01266590|566141457|FG000|Overall Study|Adverse Event|3|||
156832900|NCT01266590|566141457|FG000|Overall Study|Lost to Follow-up|1|||
156832901|NCT01266590|566141457|FG000|Overall Study|Withdrawal by Subject|1|||
156466634|NCT04505722|564803924|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
156466635|NCT04505722|564803925|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
156466636|NCT04505722|564803923|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
156466637|NCT04505722|564803924|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
156466638|NCT04505722|564803925|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
156466639|NCT04505722|564803923|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
156466640|NCT04505722|564803924|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
156466641|NCT04505722|564803925|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
156466642|NCT04505722|564803923|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
156466643|NCT04505722|564803924|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
156466644|NCT04505722|564803925|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
156466645|NCT04505722|564803923|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
156466646|NCT04505722|564803924|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
156466647|NCT04505722|564803925|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
156466648|NCT04505722|564803923|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
156466649|NCT04505722|564803924|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
156832902|NCT01266590|566141457|FG000|Overall Study|Physician Decision|1|||
156832903|NCT04732949|566141460|FG000|Overall Study|Withdrawal by Subject|23|||
156832904|NCT04732949|566141461|FG001|Overall Study|Withdrawal by Subject|27|||
156466650|NCT04505722|564803925|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
156466651|NCT04505722|564803923|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
156466652|NCT04505722|564803924|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
156466653|NCT04505722|564803925|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
156832905|NCT04732949|566141460|FG000|Overall Study|Protocol Violation|0|||
156832906|NCT04732949|566141461|FG001|Overall Study|Protocol Violation|1|||
156832907|NCT04732949|566141460|FG000|Overall Study|Non-compliance|0|||
156832908|NCT04732949|566141461|FG001|Overall Study|Non-compliance|2|||
156832909|NCT04732949|566141460|FG000|Overall Study|Physician Decision|2|||
156832910|NCT04732949|566141461|FG001|Overall Study|Physician Decision|1|||
156832911|NCT04732949|566141460|FG000|Overall Study|Serious adverse event (Fatal)|16|||
156832912|NCT04732949|566141461|FG001|Overall Study|Serious adverse event (Fatal)|18|||
156832913|NCT04732949|566141460|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
156832914|NCT04732949|566141461|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
156832915|NCT04732949|566141460|FG000|Overall Study|Non-serious adverse event|1|||
156832916|NCT04732949|566141461|FG001|Overall Study|Non-serious adverse event|3|||
156832917|NCT04732949|566141460|FG000|Overall Study|Lost to Follow-up|26|||
156832918|NCT04732949|566141461|FG001|Overall Study|Lost to Follow-up|27|||
156832919|NCT04732949|566141460|FG000|Overall Study|Other|6|||
156832920|NCT04732949|566141461|FG001|Overall Study|Other|3|||
156832921|NCT05160766|566141462|FG000|Overall Study|Adverse Event|0|||
156832922|NCT05160766|566141463|FG001|Overall Study|Adverse Event|1|||
156832923|NCT05160766|566141464|FG002|Overall Study|Adverse Event|0|||
156832924|NCT05160766|566141465|FG003|Overall Study|Adverse Event|0|||
156832925|NCT05160766|566141462|FG000|Overall Study|COVID-19 infection|0|||
156832926|NCT05160766|566141463|FG001|Overall Study|COVID-19 infection|1|||
156832927|NCT05160766|566141464|FG002|Overall Study|COVID-19 infection|0|||
156832928|NCT05160766|566141465|FG003|Overall Study|COVID-19 infection|0|||
156832929|NCT05160766|566141462|FG000|Overall Study|travel time|1|||
156832930|NCT05160766|566141463|FG001|Overall Study|travel time|0|||
156832931|NCT05160766|566141464|FG002|Overall Study|travel time|0|||
156832932|NCT05160766|566141465|FG003|Overall Study|travel time|1|||
156832933|NCT05160766|566141462|FG000|Overall Study|Withdrawal by Subject|3|||
156832934|NCT05160766|566141463|FG001|Overall Study|Withdrawal by Subject|5|||
156832935|NCT05160766|566141464|FG002|Overall Study|Withdrawal by Subject|4|||
156832936|NCT05160766|566141465|FG003|Overall Study|Withdrawal by Subject|2|||
156832937|NCT05160766|566141462|FG000|Overall Study|Death|0|||
156832938|NCT05160766|566141463|FG001|Overall Study|Death|0|||
156832939|NCT05160766|566141464|FG002|Overall Study|Death|2|||
156466654|NCT04505722|564803923|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
156466655|NCT04505722|564803924|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
156466656|NCT04505722|564803925|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
156466657|NCT04505722|564803923|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
156466658|NCT04505722|564803924|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
156466659|NCT04505722|564803925|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
156466660|NCT04505722|564803923|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
156466661|NCT04505722|564803924|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
156466662|NCT04505722|564803925|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
156466663|NCT03473223|564803926|FG000|Overall Study|Lost to Follow-up|1|||
156466664|NCT03473223|564803927|FG001|Overall Study|Lost to Follow-up|1|||
156466665|NCT03473223|564803926|FG000|Overall Study|Withdrawal by Subject|47|||
156466666|NCT03473223|564803927|FG001|Overall Study|Withdrawal by Subject|42|||
156466667|NCT03473223|564803926|FG000|Overall Study|Indirect contact|32|||
156466668|NCT03473223|564803927|FG001|Overall Study|Indirect contact|29|||
156466669|NCT03473223|564803926|FG000|Overall Study|Other (Not specified)|32|||
156466670|NCT03473223|564803927|FG001|Overall Study|Other (Not specified)|20|||
156466671|NCT04755595|564803928|FG000|Overall Study|Lost to Follow-up|1|||
156466672|NCT00319696|564803929|FG000|Overall Study|Adverse Event|36|||
156466673|NCT00319696|564803929|FG000|Overall Study|withdrawal of consent|14|||
156466674|NCT00319696|564803929|FG000|Overall Study|administrative|7|||
156466675|NCT00319696|564803929|FG000|Overall Study|Lost to Follow-up|3|||
156466676|NCT04530487|564804551|FG000|Overall Study|Death|1|||
156466677|NCT00210106|564804564|FG000|Overall Study|Death|1|||
156466678|NCT00210106|564804564|FG000|Overall Study|Protocol Violation|13|||
156466679|NCT00786864|564804565|FG000|Overall Study|Lost to Follow-up|0|||
156466680|NCT00786864|564804566|FG001|Overall Study|Lost to Follow-up|1|||
156832940|NCT05160766|566141465|FG003|Overall Study|Death|5|||
156832941|NCT05160766|566141462|FG000|Overall Study|Lost to Follow-up|0|||
156466681|NCT00786864|564804565|FG000|Overall Study|Sustained serious back injury|1|||
156466682|NCT00786864|564804566|FG001|Overall Study|Sustained serious back injury|0|||
156466683|NCT02422615|564804571|FG000|Treatment Period|Progressive disease|314|||
156832942|NCT05160766|566141463|FG001|Overall Study|Lost to Follow-up|0|||
156832943|NCT05160766|566141464|FG002|Overall Study|Lost to Follow-up|1|||
156832944|NCT05160766|566141465|FG003|Overall Study|Lost to Follow-up|2|||
156466684|NCT02422615|564804572|FG001|Treatment Period|Progressive disease|200|||
156466685|NCT02422615|564804571|FG000|Treatment Period|Adverse Event|51|||
156466686|NCT02422615|564804572|FG001|Treatment Period|Adverse Event|9|||
156466687|NCT02422615|564804571|FG000|Treatment Period|Physician Decision|32|||
156466688|NCT02422615|564804572|FG001|Treatment Period|Physician Decision|8|||
156832945|NCT05160766|566141462|FG000|Overall Study|No show|0|||
156832946|NCT05160766|566141463|FG001|Overall Study|No show|0|||
156832947|NCT05160766|566141464|FG002|Overall Study|No show|1|||
156832948|NCT05160766|566141465|FG003|Overall Study|No show|1|||
156832949|NCT05160766|566141462|FG000|Overall Study|Physician Decision|0|||
156832950|NCT05160766|566141463|FG001|Overall Study|Physician Decision|0|||
156466689|NCT02422615|564804571|FG000|Treatment Period|Subject/guardian decision|38|||
156466690|NCT02422615|564804572|FG001|Treatment Period|Subject/guardian decision|8|||
156466691|NCT02422615|564804571|FG000|Treatment Period|Death|2|||
156466692|NCT02422615|564804572|FG001|Treatment Period|Death|1|||
156466693|NCT02422615|564804571|FG000|Treatment Period|Technical problems|0|||
156466694|NCT02422615|564804572|FG001|Treatment Period|Technical problems|1|||
156466695|NCT02422615|564804571|FG000|Treatment Period|Protocol deviation|1|||
156466696|NCT02422615|564804572|FG001|Treatment Period|Protocol deviation|1|||
156466697|NCT02422615|564804571|FG000|Treatment Period|Study terminated as per protocol|46|||
156466698|NCT02422615|564804572|FG001|Treatment Period|Study terminated as per protocol|14|||
156466699|NCT02422615|564804571|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
156466700|NCT02422615|564804572|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156466701|NCT02422615|564804571|FG000|Post-treatment Efficacy Follow-up|Death|2|||
156466702|NCT02422615|564804572|FG001|Post-treatment Efficacy Follow-up|Death|1|||
156466703|NCT02422615|564804571|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156466704|NCT02422615|564804572|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156466705|NCT02422615|564804571|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
156466706|NCT02422615|564804572|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
156466707|NCT02422615|564804571|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
156466708|NCT02422615|564804572|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
156466709|NCT02422615|564804571|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
156466710|NCT02422615|564804572|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
156466711|NCT01288443|564804573|FG000|Overall Study|Adverse Event|0|||
156466712|NCT01288443|564804574|FG001|Overall Study|Adverse Event|0|||
156466713|NCT01288443|564804575|FG002|Overall Study|Adverse Event|1|||
156466714|NCT01288443|564804576|FG003|Overall Study|Adverse Event|1|||
156466715|NCT01288443|564804577|FG004|Overall Study|Adverse Event|3|||
156466716|NCT01288443|564804578|FG005|Overall Study|Adverse Event|1|||
156466717|NCT01288443|564804573|FG000|Overall Study|Poor compliance to protocol|0|||
156466718|NCT01288443|564804574|FG001|Overall Study|Poor compliance to protocol|0|||
156466719|NCT01288443|564804575|FG002|Overall Study|Poor compliance to protocol|0|||
156466720|NCT01288443|564804576|FG003|Overall Study|Poor compliance to protocol|0|||
156466721|NCT01288443|564804577|FG004|Overall Study|Poor compliance to protocol|0|||
156466722|NCT01288443|564804578|FG005|Overall Study|Poor compliance to protocol|1|||
156466723|NCT01288443|564804573|FG000|Overall Study|Participant Moved|0|||
156466724|NCT01288443|564804574|FG001|Overall Study|Participant Moved|0|||
156832951|NCT05160766|566141464|FG002|Overall Study|Physician Decision|0|||
156832952|NCT05160766|566141465|FG003|Overall Study|Physician Decision|1|||
156832953|NCT05160766|566141462|FG000|Overall Study|Protocol Violation|0|||
156832954|NCT05160766|566141463|FG001|Overall Study|Protocol Violation|0|||
156832955|NCT05160766|566141464|FG002|Overall Study|Protocol Violation|1|||
156832956|NCT05160766|566141465|FG003|Overall Study|Protocol Violation|0|||
156832957|NCT04284813|566141472|FG000|Overall Study|Withdrawal by Subject|1|||
156832958|NCT03106415|566141473|FG000|Phase 1|Withdrawal by Subject|1|||
156832959|NCT03106415|566141474|FG001|Phase 1|Withdrawal by Subject|0|||
156832960|NCT03106415|566141475|FG002|Phase 1|Withdrawal by Subject|0|||
156832961|NCT03106415|566141473|FG000|Phase 1|Adverse Event|1|||
156832962|NCT03106415|566141474|FG001|Phase 1|Adverse Event|1|||
156832963|NCT03106415|566141475|FG002|Phase 1|Adverse Event|0|||
156832964|NCT03106415|566141473|FG000|Phase 1|Protocol Violation|0|||
156832965|NCT03106415|566141474|FG001|Phase 1|Protocol Violation|1|||
156832966|NCT03106415|566141475|FG002|Phase 1|Protocol Violation|0|||
156832967|NCT01804582|566141476|FG000|Overall Study|Lost to Follow-up|47|||
156832968|NCT01804582|566141477|FG001|Overall Study|Lost to Follow-up|56|||
156832969|NCT01804582|566141476|FG000|Overall Study|Physician Decision|2|||
156832970|NCT01804582|566141477|FG001|Overall Study|Physician Decision|0|||
156832971|NCT00708734|566141480|FG000|Overall Study|scheduling conflict|2|||
156832972|NCT00708734|566141480|FG000|Overall Study|moved|1|||
156832973|NCT00708734|566141480|FG000|Overall Study|leg injury|1|||
156832974|NCT00708734|566141480|FG000|Overall Study|knee replacement|1|||
156832975|NCT00708734|566141480|FG000|Overall Study|vertigo|1|||
156832976|NCT00708734|566141480|FG000|Overall Study|leg fracture|1|||
156832977|NCT02634606|566141481|FG000|Overall Study|unable to obtain the drug at start|13|||
156832978|NCT00685373|566141487|FG000|Overall Study|Adverse Event|3|||
156832979|NCT00685373|566141487|FG000|Overall Study|Withdrawal by Subject|5|||
156466725|NCT01288443|564804575|FG002|Overall Study|Participant Moved|0|||
156466726|NCT01288443|564804576|FG003|Overall Study|Participant Moved|1|||
156466727|NCT01288443|564804577|FG004|Overall Study|Participant Moved|2|||
156466728|NCT01288443|564804578|FG005|Overall Study|Participant Moved|1|||
156466729|NCT01288443|564804573|FG000|Overall Study|Consent withdrawn by Participant|0|||
156466730|NCT01288443|564804574|FG001|Overall Study|Consent withdrawn by Participant|0|||
156832980|NCT00685373|566141487|FG000|Overall Study|Lack of Efficacy|3|||
156832981|NCT00685373|566141487|FG000|Overall Study|Condition no longer requires study drug|1|||
156832982|NCT00685373|566141487|FG000|Overall Study|Lost to Follow-up|2|||
156832983|NCT00685373|566141487|FG000|Overall Study|Protocol Violation|1|||
156832984|NCT02758301|566141488|FG000|Overall Study|Death|12|||
156466731|NCT01288443|564804575|FG002|Overall Study|Consent withdrawn by Participant|0|||
156466732|NCT01288443|564804576|FG003|Overall Study|Consent withdrawn by Participant|0|||
156466733|NCT01288443|564804577|FG004|Overall Study|Consent withdrawn by Participant|0|||
156466734|NCT01288443|564804578|FG005|Overall Study|Consent withdrawn by Participant|1|||
156466735|NCT01288443|564804573|FG000|Overall Study|Lost to Follow-up|0|||
156466736|NCT01288443|564804574|FG001|Overall Study|Lost to Follow-up|1|||
156466737|NCT01288443|564804575|FG002|Overall Study|Lost to Follow-up|0|||
156466738|NCT01288443|564804576|FG003|Overall Study|Lost to Follow-up|0|||
156466739|NCT01288443|564804577|FG004|Overall Study|Lost to Follow-up|0|||
156466740|NCT01288443|564804578|FG005|Overall Study|Lost to Follow-up|0|||
156466741|NCT01288443|564804573|FG000|Overall Study|Study drug auto-injector administration|0|||
156466742|NCT01288443|564804574|FG001|Overall Study|Study drug auto-injector administration|0|||
156466743|NCT01288443|564804575|FG002|Overall Study|Study drug auto-injector administration|0|||
156466744|NCT01288443|564804576|FG003|Overall Study|Study drug auto-injector administration|0|||
156466745|NCT01288443|564804577|FG004|Overall Study|Study drug auto-injector administration|1|||
156466746|NCT01288443|564804578|FG005|Overall Study|Study drug auto-injector administration|1|||
156466747|NCT01288443|564804573|FG000|Overall Study|Other than above|0|||
156466748|NCT01288443|564804574|FG001|Overall Study|Other than above|0|||
156466749|NCT01288443|564804575|FG002|Overall Study|Other than above|0|||
156466750|NCT01288443|564804576|FG003|Overall Study|Other than above|2|||
156466751|NCT01288443|564804577|FG004|Overall Study|Other than above|1|||
156466752|NCT01288443|564804578|FG005|Overall Study|Other than above|0|||
156466753|NCT04876417|564804581|FG000|Overall Study|Lost to Follow-up|5|||
156466754|NCT04876417|564804582|FG001|Overall Study|Lost to Follow-up|8|||
156466755|NCT04876417|564804583|FG002|Overall Study|Lost to Follow-up|0|||
156466756|NCT04876417|564804584|FG003|Overall Study|Lost to Follow-up|0|||
156466757|NCT03875313|564804587|FG000|Overall Study|Withdrawal by Subject|1|||
156466758|NCT03875313|564804588|FG001|Overall Study|Withdrawal by Subject|3|||
156466759|NCT03875313|564804589|FG002|Overall Study|Withdrawal by Subject|0|||
156466760|NCT03875313|564804590|FG003|Overall Study|Withdrawal by Subject|0|||
156466761|NCT03875313|564804591|FG004|Overall Study|Withdrawal by Subject|0|||
156466762|NCT03875313|564804587|FG000|Overall Study|Death|0|||
156466763|NCT03875313|564804588|FG001|Overall Study|Death|0|||
156466764|NCT03875313|564804589|FG002|Overall Study|Death|0|||
156466765|NCT03875313|564804590|FG003|Overall Study|Death|0|||
156466766|NCT03875313|564804591|FG004|Overall Study|Death|1|||
156466767|NCT03875313|564804587|FG000|Overall Study|Lost to Follow-up|0|||
156466768|NCT03875313|564804588|FG001|Overall Study|Lost to Follow-up|0|||
156466769|NCT03875313|564804589|FG002|Overall Study|Lost to Follow-up|0|||
156466770|NCT03875313|564804590|FG003|Overall Study|Lost to Follow-up|0|||
156466771|NCT03875313|564804591|FG004|Overall Study|Lost to Follow-up|1|||
156466772|NCT03875313|564804587|FG000|Overall Study|Study Termination by Sponsor|0|||
156466773|NCT03875313|564804588|FG001|Overall Study|Study Termination by Sponsor|1|||
156466774|NCT03875313|564804589|FG002|Overall Study|Study Termination by Sponsor|1|||
156466775|NCT03875313|564804590|FG003|Overall Study|Study Termination by Sponsor|0|||
156466776|NCT03875313|564804591|FG004|Overall Study|Study Termination by Sponsor|1|||
156466777|NCT03875313|564804587|FG000|Overall Study|New Anticancer Treatment|0|||
156466778|NCT03875313|564804588|FG001|Overall Study|New Anticancer Treatment|1|||
156466779|NCT03875313|564804589|FG002|Overall Study|New Anticancer Treatment|2|||
156466780|NCT03875313|564804590|FG003|Overall Study|New Anticancer Treatment|1|||
156466781|NCT03875313|564804591|FG004|Overall Study|New Anticancer Treatment|0|||
156466782|NCT03875313|564804587|FG000|Overall Study|Other, Not Specified|2|||
156466783|NCT03875313|564804588|FG001|Overall Study|Other, Not Specified|11|||
156466784|NCT03875313|564804589|FG002|Overall Study|Other, Not Specified|3|||
156466785|NCT03875313|564804590|FG003|Overall Study|Other, Not Specified|3|||
156466786|NCT03875313|564804591|FG004|Overall Study|Other, Not Specified|1|||
156466787|NCT03213457|564804592|FG000|Screening Period|Withdrawal by Subject|0|||
156466788|NCT03213457|564804593|FG001|Screening Period|Withdrawal by Subject|1|||
156466789|NCT03213457|564804594|FG002|Screening Period|Withdrawal by Subject|0|||
156466790|NCT03213457|564804592|FG000|Screening Period|Other|1|||
156466791|NCT03213457|564804593|FG001|Screening Period|Other|0|||
156466792|NCT03213457|564804594|FG002|Screening Period|Other|0|||
156466793|NCT03213457|564804592|FG000|Double-Blind Period|Adverse Event|3|||
156466794|NCT03213457|564804593|FG001|Double-Blind Period|Adverse Event|2|||
156466795|NCT03213457|564804594|FG002|Double-Blind Period|Adverse Event|7|||
156466796|NCT03213457|564804592|FG000|Double-Blind Period|Withdrawal by Subject|14|||
156466797|NCT03213457|564804593|FG001|Double-Blind Period|Withdrawal by Subject|2|||
156466798|NCT03213457|564804594|FG002|Double-Blind Period|Withdrawal by Subject|14|||
156466799|NCT03213457|564804592|FG000|Double-Blind Period|Lost to Follow-up|2|||
156466800|NCT03213457|564804593|FG001|Double-Blind Period|Lost to Follow-up|3|||
156466801|NCT03213457|564804594|FG002|Double-Blind Period|Lost to Follow-up|9|||
156466802|NCT03213457|564804592|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
156466803|NCT03213457|564804593|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
156466804|NCT03213457|564804594|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
156541346|NCT01987960|565074546|FG002|Period 2|Withdrawal by Subject|1|||
156832985|NCT02758301|566141489|FG001|Overall Study|Death|0|||
156339905|NCT01817530|564342244|FG003|Overall Study|Surgery or Invasive Intervention|0|||
156466805|NCT03213457|564804592|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
156466806|NCT03213457|564804593|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
156466807|NCT03213457|564804594|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
156832986|NCT02758301|566141488|FG000|Overall Study|Physician Decision|10|||
156832987|NCT02758301|566141489|FG001|Overall Study|Physician Decision|1|||
156832988|NCT02758301|566141488|FG000|Overall Study|Withdrawal by Subject|5|||
156832989|NCT02758301|566141489|FG001|Overall Study|Withdrawal by Subject|6|||
156832990|NCT02758301|566141488|FG000|Overall Study|Lost to Follow-up|7|||
156832991|NCT02758301|566141489|FG001|Overall Study|Lost to Follow-up|0|||
156832992|NCT02758301|566141488|FG000|Overall Study|Protocol Violation|0|||
156832993|NCT02758301|566141489|FG001|Overall Study|Protocol Violation|1|||
156832994|NCT00582738|566141490|FG000|Overall Study|Administrative Problems|7|||
156832995|NCT00582738|566141491|FG001|Overall Study|Administrative Problems|8|||
156832996|NCT00582738|566141490|FG000|Overall Study|Adverse Event|0|||
156832997|NCT00582738|566141491|FG001|Overall Study|Adverse Event|5|||
156466808|NCT03213457|564804592|FG000|Double-Blind Period|Pregnancy|5|||
156466809|NCT03213457|564804593|FG001|Double-Blind Period|Pregnancy|0|||
156466810|NCT03213457|564804594|FG002|Double-Blind Period|Pregnancy|0|||
156466811|NCT03213457|564804592|FG000|Double-Blind Period|Other|10|||
156466812|NCT03213457|564804593|FG001|Double-Blind Period|Other|3|||
156541347|NCT01987960|565074547|FG003|Period 2|Withdrawal by Subject|0|||
156832998|NCT00582738|566141490|FG000|Overall Study|Graft Lost|0|||
156832999|NCT00582738|566141491|FG001|Overall Study|Graft Lost|1|||
156833000|NCT00582738|566141490|FG000|Overall Study|Other|1|||
156833001|NCT00582738|566141491|FG001|Overall Study|Other|0|||
156833002|NCT00582738|566141490|FG000|Overall Study|Protocol Violation|1|||
156833003|NCT00582738|566141491|FG001|Overall Study|Protocol Violation|1|||
156833004|NCT00582738|566141490|FG000|Overall Study|Withdrawal by Subject|0|||
156833005|NCT00582738|566141491|FG001|Overall Study|Withdrawal by Subject|3|||
156833006|NCT01167907|566141494|FG000|Overall Study|Protocol Violation|1|||
156833007|NCT01167907|566141495|FG001|Overall Study|Protocol Violation|0|||
156833008|NCT01167907|566141494|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
156833009|NCT01167907|566141495|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
156833010|NCT01873729|566141498|FG000|Overall Study|Withdrawal by Subject|1|||
156833011|NCT01741532|566141499|FG000|Overall Study|Adverse Event|4|||
156833012|NCT01741532|566141500|FG001|Overall Study|Adverse Event|0|||
156833013|NCT01741532|566141499|FG000|Overall Study|Withdrawal by Subject|1|||
156833014|NCT01741532|566141500|FG001|Overall Study|Withdrawal by Subject|1|||
156466813|NCT03213457|564804594|FG002|Double-Blind Period|Other|17|||
156466814|NCT03213457|564804592|FG000|Open-Label Period|Adverse Event|1|||
156466815|NCT03213457|564804593|FG001|Open-Label Period|Adverse Event|2|||
156466816|NCT03213457|564804594|FG002|Open-Label Period|Adverse Event|2|||
156466817|NCT03213457|564804592|FG000|Open-Label Period|Withdrawal by Subject|12|||
156466818|NCT03213457|564804593|FG001|Open-Label Period|Withdrawal by Subject|5|||
156466819|NCT03213457|564804594|FG002|Open-Label Period|Withdrawal by Subject|24|||
156466820|NCT03213457|564804592|FG000|Open-Label Period|Lost to Follow-up|1|||
156466821|NCT03213457|564804593|FG001|Open-Label Period|Lost to Follow-up|2|||
156466822|NCT03213457|564804594|FG002|Open-Label Period|Lost to Follow-up|8|||
156466823|NCT03213457|564804592|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
156466824|NCT03213457|564804593|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
156466825|NCT03213457|564804594|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
156466826|NCT03213457|564804592|FG000|Open-Label Period|Non-compliance with study procedures|1|||
156466827|NCT03213457|564804593|FG001|Open-Label Period|Non-compliance with study procedures|1|||
156466828|NCT03213457|564804594|FG002|Open-Label Period|Non-compliance with study procedures|2|||
156466829|NCT03213457|564804592|FG000|Open-Label Period|Exclusionary medications|0|||
156466830|NCT03213457|564804593|FG001|Open-Label Period|Exclusionary medications|0|||
156466831|NCT03213457|564804594|FG002|Open-Label Period|Exclusionary medications|1|||
156466832|NCT03213457|564804592|FG000|Open-Label Period|Other|1|||
156466833|NCT03213457|564804593|FG001|Open-Label Period|Other|1|||
156466834|NCT03213457|564804594|FG002|Open-Label Period|Other|6|||
156466835|NCT03213457|564804592|FG000|Follow-Up Period|Adverse Event|16|||
156466836|NCT03213457|564804593|FG001|Follow-Up Period|Adverse Event|8|||
156466837|NCT03213457|564804594|FG002|Follow-Up Period|Adverse Event|37|||
156466838|NCT03213457|564804592|FG000|Follow-Up Period|Withdrawal by Subject|18|||
156466839|NCT03213457|564804593|FG001|Follow-Up Period|Withdrawal by Subject|11|||
156466840|NCT03213457|564804594|FG002|Follow-Up Period|Withdrawal by Subject|55|||
156466841|NCT03213457|564804592|FG000|Follow-Up Period|Lost to Follow-up|28|||
156466842|NCT03213457|564804593|FG001|Follow-Up Period|Lost to Follow-up|15|||
156466843|NCT03213457|564804594|FG002|Follow-Up Period|Lost to Follow-up|50|||
156833015|NCT01741532|566141499|FG000|Overall Study|Protocol Violation|0|||
156833016|NCT01741532|566141500|FG001|Overall Study|Protocol Violation|1|||
156833017|NCT01741532|566141499|FG000|Overall Study|Worsening of the disease|3|||
156833018|NCT01741532|566141500|FG001|Overall Study|Worsening of the disease|1|||
156833019|NCT01741532|566141499|FG000|Overall Study|Sponsor decision|1|||
156833020|NCT01741532|566141500|FG001|Overall Study|Sponsor decision|0|||
156833021|NCT01741532|566141499|FG000|Overall Study|Medical event|1|||
156833022|NCT01741532|566141500|FG001|Overall Study|Medical event|0|||
156833023|NCT01066780|566141501|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
156833024|NCT01066780|566141502|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
156833025|NCT00613080|566141503|FG000|Overall Study|Ineligible / no protocol treatment|11|||
156833026|NCT03099148|566141504|FG000|Wash-out|scheduling conflict|0|||
156466844|NCT03213457|564804592|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
156466845|NCT03213457|564804593|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
156466846|NCT03213457|564804594|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
156466847|NCT03213457|564804592|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
156466848|NCT03213457|564804593|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
156466849|NCT03213457|564804594|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
156466850|NCT03213457|564804592|FG000|Follow-Up Period|Pregnancy|7|||
156466851|NCT03213457|564804593|FG001|Follow-Up Period|Pregnancy|0|||
156466852|NCT03213457|564804594|FG002|Follow-Up Period|Pregnancy|18|||
156466853|NCT03213457|564804592|FG000|Follow-Up Period|Exclusionary medications|1|||
156466854|NCT03213457|564804593|FG001|Follow-Up Period|Exclusionary medications|1|||
156466855|NCT03213457|564804594|FG002|Follow-Up Period|Exclusionary medications|5|||
156466856|NCT03213457|564804592|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
156466857|NCT03213457|564804593|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
156466858|NCT03213457|564804594|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
156466859|NCT03213457|564804592|FG000|Follow-Up Period|Other|14|||
156466860|NCT03213457|564804593|FG001|Follow-Up Period|Other|10|||
156466861|NCT03213457|564804594|FG002|Follow-Up Period|Other|31|||
156466862|NCT04059406|564804599|FG000|Overall Study|Early Treatment Termination|5|||
156466863|NCT04059406|564804600|FG001|Overall Study|Early Treatment Termination|5|||
156466864|NCT04059406|564804601|FG002|Overall Study|Early Treatment Termination|15|||
156466865|NCT04305327|564804607|FG000|Overall Study|Study early termination|2|||
156466866|NCT04305327|564804608|FG001|Overall Study|Study early termination|5|||
156466867|NCT04305327|564804609|FG002|Overall Study|Study early termination|2|||
156466868|NCT04305327|564804610|FG003|Overall Study|Study early termination|2|||
156466869|NCT04305327|564804607|FG000|Overall Study|Withdrawal by Subject|0|||
156466870|NCT04305327|564804608|FG001|Overall Study|Withdrawal by Subject|1|||
156466871|NCT04305327|564804609|FG002|Overall Study|Withdrawal by Subject|0|||
156466872|NCT04305327|564804610|FG003|Overall Study|Withdrawal by Subject|0|||
156833027|NCT03099148|566141505|FG001|Wash-out|scheduling conflict|1|||
156833028|NCT03099148|566141506|FG002|Wash-out|scheduling conflict|0|||
156833029|NCT03099148|566141507|FG003|Wash-out|scheduling conflict|0|||
156833030|NCT03099148|566141504|FG000|Wash-out|Adverse Event|0|||
156833031|NCT03099148|566141505|FG001|Wash-out|Adverse Event|1|||
156833032|NCT03099148|566141506|FG002|Wash-out|Adverse Event|0|||
156833033|NCT03099148|566141507|FG003|Wash-out|Adverse Event|0|||
156833034|NCT02124772|566141509|FG000|Overall Study|Lack of Efficacy|2|||
156833035|NCT02124772|566141510|FG001|Overall Study|Lack of Efficacy|0|||
156833036|NCT02124772|566141511|FG002|Overall Study|Lack of Efficacy|0|||
156833037|NCT02124772|566141512|FG003|Overall Study|Lack of Efficacy|1|||
156466873|NCT04977583|564805654|FG000|Overall Study|Lost to Follow-up|8|||
156466874|NCT04977583|564805655|FG001|Overall Study|Lost to Follow-up|4|||
156466875|NCT04977583|564805656|FG002|Overall Study|Lost to Follow-up|13|||
156466876|NCT04977583|564805654|FG000|Overall Study|Withdrawal by Subject|3|||
156833038|NCT02124772|566141513|FG004|Overall Study|Lack of Efficacy|2|||
156833039|NCT02124772|566141514|FG005|Overall Study|Lack of Efficacy|3|||
156833040|NCT02124772|566141515|FG006|Overall Study|Lack of Efficacy|0|||
156833041|NCT02124772|566141516|FG007|Overall Study|Lack of Efficacy|2|||
156833042|NCT02124772|566141517|FG008|Overall Study|Lack of Efficacy|0|||
156833043|NCT02124772|566141518|FG009|Overall Study|Lack of Efficacy|1|||
156833044|NCT02124772|566141519|FG010|Overall Study|Lack of Efficacy|0|||
156833045|NCT02124772|566141520|FG011|Overall Study|Lack of Efficacy|0|||
156833046|NCT02124772|566141521|FG012|Overall Study|Lack of Efficacy|1|||
156833047|NCT02124772|566141509|FG000|Overall Study|Adverse Event|1|||
156833048|NCT02124772|566141510|FG001|Overall Study|Adverse Event|4|||
156833049|NCT02124772|566141511|FG002|Overall Study|Adverse Event|1|||
156833050|NCT02124772|566141512|FG003|Overall Study|Adverse Event|5|||
156833051|NCT02124772|566141513|FG004|Overall Study|Adverse Event|2|||
156833052|NCT02124772|566141514|FG005|Overall Study|Adverse Event|1|||
156833053|NCT02124772|566141515|FG006|Overall Study|Adverse Event|1|||
156833054|NCT02124772|566141516|FG007|Overall Study|Adverse Event|5|||
156833055|NCT02124772|566141517|FG008|Overall Study|Adverse Event|0|||
156833056|NCT02124772|566141518|FG009|Overall Study|Adverse Event|3|||
156833057|NCT02124772|566141519|FG010|Overall Study|Adverse Event|1|||
156833058|NCT02124772|566141520|FG011|Overall Study|Adverse Event|3|||
156833059|NCT02124772|566141521|FG012|Overall Study|Adverse Event|1|||
156833060|NCT02124772|566141509|FG000|Overall Study|Withdrawal consent|0|||
156833061|NCT02124772|566141510|FG001|Overall Study|Withdrawal consent|1|||
156833062|NCT02124772|566141511|FG002|Overall Study|Withdrawal consent|1|||
156833063|NCT02124772|566141512|FG003|Overall Study|Withdrawal consent|1|||
156833064|NCT02124772|566141513|FG004|Overall Study|Withdrawal consent|0|||
156833065|NCT02124772|566141514|FG005|Overall Study|Withdrawal consent|1|||
156833066|NCT02124772|566141515|FG006|Overall Study|Withdrawal consent|1|||
156833067|NCT02124772|566141516|FG007|Overall Study|Withdrawal consent|0|||
156833068|NCT02124772|566141517|FG008|Overall Study|Withdrawal consent|0|||
156833069|NCT02124772|566141518|FG009|Overall Study|Withdrawal consent|1|||
156833070|NCT02124772|566141519|FG010|Overall Study|Withdrawal consent|0|||
156833071|NCT02124772|566141520|FG011|Overall Study|Withdrawal consent|1|||
156833072|NCT02124772|566141521|FG012|Overall Study|Withdrawal consent|0|||
156833073|NCT02124772|566141509|FG000|Overall Study|Investigator discretion|0|||
156833074|NCT02124772|566141510|FG001|Overall Study|Investigator discretion|2|||
156833075|NCT02124772|566141511|FG002|Overall Study|Investigator discretion|2|||
156833076|NCT02124772|566141512|FG003|Overall Study|Investigator discretion|1|||
156833077|NCT02124772|566141513|FG004|Overall Study|Investigator discretion|1|||
156833078|NCT02124772|566141514|FG005|Overall Study|Investigator discretion|0|||
156833079|NCT02124772|566141515|FG006|Overall Study|Investigator discretion|1|||
156833080|NCT02124772|566141516|FG007|Overall Study|Investigator discretion|0|||
156833081|NCT02124772|566141517|FG008|Overall Study|Investigator discretion|0|||
156833082|NCT02124772|566141518|FG009|Overall Study|Investigator discretion|1|||
156833083|NCT02124772|566141519|FG010|Overall Study|Investigator discretion|0|||
156833084|NCT02124772|566141520|FG011|Overall Study|Investigator discretion|1|||
156833085|NCT02124772|566141521|FG012|Overall Study|Investigator discretion|0|||
156833086|NCT02124772|566141509|FG000|Overall Study|Progressive disease|0|||
156833087|NCT02124772|566141510|FG001|Overall Study|Progressive disease|0|||
156833088|NCT02124772|566141511|FG002|Overall Study|Progressive disease|0|||
156833089|NCT02124772|566141512|FG003|Overall Study|Progressive disease|0|||
156833090|NCT02124772|566141513|FG004|Overall Study|Progressive disease|0|||
156833091|NCT02124772|566141514|FG005|Overall Study|Progressive disease|0|||
156833092|NCT02124772|566141515|FG006|Overall Study|Progressive disease|1|||
156833093|NCT02124772|566141516|FG007|Overall Study|Progressive disease|1|||
156833094|NCT02124772|566141517|FG008|Overall Study|Progressive disease|0|||
156833095|NCT02124772|566141518|FG009|Overall Study|Progressive disease|0|||
156833096|NCT02124772|566141519|FG010|Overall Study|Progressive disease|0|||
156833097|NCT02124772|566141520|FG011|Overall Study|Progressive disease|0|||
156833098|NCT02124772|566141521|FG012|Overall Study|Progressive disease|0|||
156833099|NCT02124772|566141509|FG000|Overall Study|Other|0|||
156833100|NCT02124772|566141510|FG001|Overall Study|Other|7|||
156833101|NCT02124772|566141511|FG002|Overall Study|Other|2|||
156833102|NCT02124772|566141512|FG003|Overall Study|Other|5|||
156833103|NCT02124772|566141513|FG004|Overall Study|Other|4|||
156833104|NCT02124772|566141514|FG005|Overall Study|Other|3|||
156833105|NCT02124772|566141515|FG006|Overall Study|Other|4|||
156833106|NCT02124772|566141516|FG007|Overall Study|Other|1|||
156833107|NCT02124772|566141517|FG008|Overall Study|Other|1|||
156833108|NCT02124772|566141518|FG009|Overall Study|Other|1|||
156833109|NCT02124772|566141519|FG010|Overall Study|Other|1|||
156833110|NCT02124772|566141520|FG011|Overall Study|Other|1|||
156833111|NCT02124772|566141521|FG012|Overall Study|Other|0|||
156833112|NCT01827332|566141522|FG000|Overall Study|Lost to Follow-up|2|||
156833113|NCT01827332|566141523|FG001|Overall Study|Lost to Follow-up|1|||
156833114|NCT02725593|566141524|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
156833115|NCT02725593|566141525|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
156833116|NCT02725593|566141524|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
156833117|NCT02725593|566141525|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
156833118|NCT02725593|566141524|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
156339906|NCT01817530|564342245|FG004|Overall Study|Surgery or Invasive Intervention|1|||
156339907|NCT01817530|564342246|FG005|Overall Study|Surgery or Invasive Intervention|1|||
156466877|NCT04977583|564805655|FG001|Overall Study|Withdrawal by Subject|2|||
156466878|NCT04977583|564805656|FG002|Overall Study|Withdrawal by Subject|1|||
156466879|NCT00146172|564805668|FG000|Overall Study|Adverse Event|0|||
156466880|NCT00146172|564805669|FG001|Overall Study|Adverse Event|0|||
156466881|NCT00146172|564805670|FG002|Overall Study|Adverse Event|1|||
156466882|NCT00146172|564805671|FG003|Overall Study|Adverse Event|1|||
156466883|NCT00146172|564805672|FG004|Overall Study|Adverse Event|0|||
156466884|NCT00146172|564805673|FG005|Overall Study|Adverse Event|2|||
156466885|NCT00146172|564805674|FG006|Overall Study|Adverse Event|3|||
156466886|NCT00146172|564805675|FG007|Overall Study|Adverse Event|10|||
156466887|NCT00146172|564805668|FG000|Overall Study|Lost to Follow-up|0|||
156466888|NCT00146172|564805669|FG001|Overall Study|Lost to Follow-up|0|||
156466889|NCT00146172|564805670|FG002|Overall Study|Lost to Follow-up|0|||
156466890|NCT00146172|564805671|FG003|Overall Study|Lost to Follow-up|0|||
156466891|NCT00146172|564805672|FG004|Overall Study|Lost to Follow-up|0|||
156466892|NCT00146172|564805673|FG005|Overall Study|Lost to Follow-up|0|||
156466893|NCT00146172|564805674|FG006|Overall Study|Lost to Follow-up|0|||
156466894|NCT00146172|564805675|FG007|Overall Study|Lost to Follow-up|1|||
156466895|NCT00146172|564805668|FG000|Overall Study|Disease Progression|2|||
156466896|NCT00146172|564805669|FG001|Overall Study|Disease Progression|4|||
156466897|NCT00146172|564805670|FG002|Overall Study|Disease Progression|2|||
156466898|NCT00146172|564805671|FG003|Overall Study|Disease Progression|5|||
156466899|NCT00146172|564805672|FG004|Overall Study|Disease Progression|2|||
156466900|NCT00146172|564805673|FG005|Overall Study|Disease Progression|2|||
156466901|NCT00146172|564805674|FG006|Overall Study|Disease Progression|1|||
156466902|NCT00146172|564805675|FG007|Overall Study|Disease Progression|22|||
156466903|NCT00146172|564805668|FG000|Overall Study|Death|0|||
156466904|NCT00146172|564805669|FG001|Overall Study|Death|0|||
156339908|NCT01817530|564342247|FG006|Overall Study|Surgery or Invasive Intervention|1|||
156339909|NCT01817530|564342248|FG007|Overall Study|Surgery or Invasive Intervention|0|||
156339910|NCT01817530|564342241|FG000|Overall Study|Consent Withdrawn by Subject|3|||
156339911|NCT01817530|564342242|FG001|Overall Study|Consent Withdrawn by Subject|4|||
156339912|NCT01817530|564342243|FG002|Overall Study|Consent Withdrawn by Subject|7|||
156339913|NCT01817530|564342244|FG003|Overall Study|Consent Withdrawn by Subject|3|||
156339914|NCT01817530|564342245|FG004|Overall Study|Consent Withdrawn by Subject|5|||
156339915|NCT01817530|564342246|FG005|Overall Study|Consent Withdrawn by Subject|3|||
156339916|NCT01817530|564342247|FG006|Overall Study|Consent Withdrawn by Subject|3|||
156466905|NCT00146172|564805670|FG002|Overall Study|Death|0|||
156466906|NCT00146172|564805671|FG003|Overall Study|Death|0|||
156466907|NCT00146172|564805672|FG004|Overall Study|Death|0|||
156466908|NCT00146172|564805673|FG005|Overall Study|Death|0|||
156466909|NCT00146172|564805674|FG006|Overall Study|Death|1|||
156466910|NCT00146172|564805675|FG007|Overall Study|Death|0|||
156466911|NCT00146172|564805668|FG000|Overall Study|Physician Decision|0|||
156466912|NCT00146172|564805669|FG001|Overall Study|Physician Decision|0|||
156833119|NCT02725593|566141525|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
156833120|NCT02725593|566141524|FG000|Long Term Extension|Withdrawal by Subject|1|||
156833121|NCT02725593|566141525|FG001|Long Term Extension|Withdrawal by Subject|3|||
156833122|NCT01522404|566141526|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
156833123|NCT01522404|566141527|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
156833124|NCT01522404|566141526|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
156833125|NCT01522404|566141527|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
156833126|NCT01522404|566141526|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
156833127|NCT01522404|566141527|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
156466913|NCT00146172|564805670|FG002|Overall Study|Physician Decision|0|||
156466914|NCT00146172|564805671|FG003|Overall Study|Physician Decision|0|||
156833128|NCT02698371|566141528|FG000|All Participants Flow|Lost to Follow-up|3|||
156833129|NCT02698371|566141528|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
156833130|NCT02698371|566141528|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
156833131|NCT02698371|566141528|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
156833132|NCT02698371|566141528|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
156833133|NCT02698371|566141528|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
156833134|NCT02698371|566141528|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
156833135|NCT01440881|566141534|FG000|Overall Study|Death|0|||
156833136|NCT01440881|566141535|FG001|Overall Study|Death|1|||
156833137|NCT02644356|566141538|FG000|Overall Study|Withdrawal by Subject|2|||
156833138|NCT02210091|566141539|FG000|Overall Study|Physician Decision|0|||
156833139|NCT02210091|566141540|FG001|Overall Study|Physician Decision|1|||
156833140|NCT02210091|566141539|FG000|Overall Study|Withdrawal by Sponsor|0|||
156833141|NCT02210091|566141540|FG001|Overall Study|Withdrawal by Sponsor|1|||
156833142|NCT02290938|566141541|FG000|Overall Study|Lost to Follow-up|14|||
156833143|NCT02290938|566141542|FG001|Overall Study|Lost to Follow-up|43|||
156833144|NCT00897390|566141543|FG000|Overall Study|Adverse Event|2|||
156833145|NCT00897390|566141543|FG000|Overall Study|No Longer Met Study Criteria|1|||
156833146|NCT00897390|566141543|FG000|Overall Study|Personal Reasons|1|||
156466915|NCT00146172|564805672|FG004|Overall Study|Physician Decision|0|||
156466916|NCT00146172|564805673|FG005|Overall Study|Physician Decision|0|||
156466917|NCT00146172|564805674|FG006|Overall Study|Physician Decision|0|||
156466918|NCT00146172|564805675|FG007|Overall Study|Physician Decision|1|||
156466919|NCT00146172|564805668|FG000|Overall Study|Withdrawal by Subject|0|||
156466920|NCT00146172|564805669|FG001|Overall Study|Withdrawal by Subject|0|||
156466921|NCT00146172|564805670|FG002|Overall Study|Withdrawal by Subject|0|||
156466922|NCT00146172|564805671|FG003|Overall Study|Withdrawal by Subject|0|||
156466923|NCT00146172|564805672|FG004|Overall Study|Withdrawal by Subject|0|||
156466924|NCT00146172|564805673|FG005|Overall Study|Withdrawal by Subject|1|||
156466925|NCT00146172|564805674|FG006|Overall Study|Withdrawal by Subject|1|||
156466926|NCT00146172|564805675|FG007|Overall Study|Withdrawal by Subject|4|||
156466927|NCT00146172|564805668|FG000|Overall Study|Symptomatic Deterioration|1|||
156466928|NCT00146172|564805669|FG001|Overall Study|Symptomatic Deterioration|0|||
156466929|NCT00146172|564805670|FG002|Overall Study|Symptomatic Deterioration|1|||
156466930|NCT00146172|564805671|FG003|Overall Study|Symptomatic Deterioration|0|||
156466931|NCT00146172|564805672|FG004|Overall Study|Symptomatic Deterioration|1|||
156466932|NCT00146172|564805673|FG005|Overall Study|Symptomatic Deterioration|2|||
156466933|NCT00146172|564805674|FG006|Overall Study|Symptomatic Deterioration|0|||
156466934|NCT00146172|564805675|FG007|Overall Study|Symptomatic Deterioration|2|||
156466935|NCT02760654|564805676|FG000|Overall Study|Lost to Follow-up|3|||
156466936|NCT02760654|564805677|FG001|Overall Study|Lost to Follow-up|3|||
156466937|NCT02760654|564805676|FG000|Overall Study|Withdrawal by Subject|4|||
156466938|NCT02760654|564805677|FG001|Overall Study|Withdrawal by Subject|3|||
156466939|NCT01036724|564805678|FG000|Overall Study|Adverse Event|1|||
156466940|NCT01036724|564805679|FG001|Overall Study|Adverse Event|2|||
156466941|NCT01036724|564805678|FG000|Overall Study|Lack of Efficacy|1|||
156466942|NCT01036724|564805679|FG001|Overall Study|Lack of Efficacy|1|||
156466943|NCT01036724|564805678|FG000|Overall Study|Protocol Violation|4|||
156466944|NCT01036724|564805679|FG001|Overall Study|Protocol Violation|5|||
156466945|NCT02438137|564805684|FG000|Overall Study|Lost to Follow-up|3|||
156466946|NCT02438137|564805685|FG001|Overall Study|Lost to Follow-up|2|||
156466947|NCT02438137|564805684|FG000|Overall Study|Adverse Event|1|||
156466948|NCT02438137|564805685|FG001|Overall Study|Adverse Event|0|||
156466949|NCT02438137|564805684|FG000|Overall Study|Withdrawal by Subject|4|||
156466950|NCT02438137|564805685|FG001|Overall Study|Withdrawal by Subject|3|||
156466951|NCT02438137|564805684|FG000|Overall Study|Physician Decision|0|||
156466952|NCT02438137|564805685|FG001|Overall Study|Physician Decision|1|||
156466953|NCT00692913|564805686|FG000|Overall Study|Adverse Event|8|||
156466954|NCT00692913|564805687|FG001|Overall Study|Adverse Event|4|||
156466955|NCT00692913|564805686|FG000|Overall Study|Lost to Follow-up|3|||
156466956|NCT00692913|564805687|FG001|Overall Study|Lost to Follow-up|5|||
156466957|NCT00692913|564805686|FG000|Overall Study|Physician Decision|2|||
156466958|NCT00692913|564805687|FG001|Overall Study|Physician Decision|0|||
156833147|NCT00897390|566141543|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
156833148|NCT01023672|566143115|FG000|Overall Study|Worsening disease|2|||
156466959|NCT00692913|564805686|FG000|Overall Study|Protocol Violation|1|||
156466960|NCT00692913|564805687|FG001|Overall Study|Protocol Violation|1|||
156466961|NCT00692913|564805686|FG000|Overall Study|Withdrawal by Subject|15|||
156466962|NCT00692913|564805687|FG001|Overall Study|Withdrawal by Subject|20|||
156466963|NCT02291913|564805688|FG000|Overall Study|Progressive Disease|32|||
156466964|NCT02291913|564805688|FG000|Overall Study|Adverse Event|11|||
156466965|NCT02291913|564805688|FG000|Overall Study|Death|2|||
156466966|NCT02291913|564805688|FG000|Overall Study|Physician Decision|1|||
156466967|NCT02291913|564805688|FG000|Overall Study|Withdrawal by Subject|1|||
156833149|NCT01023672|566143115|FG000|Overall Study|Death|1|||
156833150|NCT01282294|566143116|FG000|Overall Study|Lost to Follow-up|14|||
156833151|NCT01282294|566143116|FG000|Overall Study|Screening failure|1|||
156833152|NCT01282294|566143116|FG000|Overall Study|Adverse Event|1|||
156541348|NCT01987960|565074544|FG000|Period 2|Administrative or other reason|0|||
156541349|NCT01987960|565074545|FG001|Period 2|Administrative or other reason|5|||
156541350|NCT01987960|565074546|FG002|Period 2|Administrative or other reason|7|||
156541351|NCT01987960|565074547|FG003|Period 2|Administrative or other reason|0|||
156541352|NCT01987960|565074544|FG000|Period 3|Adverse Event|0|||
156541353|NCT01987960|565074545|FG001|Period 3|Adverse Event|0|||
156541354|NCT01987960|565074546|FG002|Period 3|Adverse Event|0|||
156466968|NCT02291913|564805688|FG000|Overall Study|Protocol Violation|1|||
156466969|NCT03621735|564805689|FG000|Overall Study|Withdrawal by Subject|13|||
156466970|NCT03621735|564805690|FG001|Overall Study|Withdrawal by Subject|13|||
156466971|NCT01092416|564805693|FG000|Enrollment|Atherectomy device not inserted|3|||
156466972|NCT01092416|564805693|FG000|30-Day Follow-up|Death|2|||
156466973|NCT01092416|564805693|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
156466974|NCT01092416|564805693|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
156466975|NCT01092416|564805693|FG000|12-Month Follow-up|Death|16|||
156466976|NCT01092416|564805693|FG000|12-Month Follow-up|Lost to Follow-up|4|||
156466977|NCT01092416|564805693|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
156466978|NCT01092416|564805693|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
156466979|NCT01092416|564805693|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
156466980|NCT03709706|564805694|FG000|Overall Study|Adverse Event|0|||
156466981|NCT03709706|564805695|FG001|Overall Study|Adverse Event|1|||
156466982|NCT03709706|564805694|FG000|Overall Study|Physician Decision|14|||
156466983|NCT03709706|564805695|FG001|Overall Study|Physician Decision|8|||
156466984|NCT03709706|564805694|FG000|Overall Study|Withdrawal by Subject|2|||
156466985|NCT03709706|564805695|FG001|Overall Study|Withdrawal by Subject|1|||
156466986|NCT03709706|564805694|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
156466987|NCT03709706|564805695|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
156466988|NCT01105975|564805696|FG000|Overall Study|Adverse Event|2|||
156466989|NCT01105975|564805697|FG001|Overall Study|Adverse Event|1|||
156466990|NCT01105975|564805698|FG002|Overall Study|Adverse Event|5|||
156466991|NCT01105975|564805699|FG003|Overall Study|Adverse Event|1|||
156466992|NCT01105975|564805700|FG004|Overall Study|Adverse Event|0|||
156466993|NCT01105975|564805701|FG005|Overall Study|Adverse Event|1|||
156466994|NCT01105975|564805702|FG006|Overall Study|Adverse Event|2|||
156466995|NCT01105975|564805703|FG007|Overall Study|Adverse Event|4|||
156466996|NCT01105975|564805704|FG008|Overall Study|Adverse Event|1|||
156466997|NCT01105975|564805705|FG009|Overall Study|Adverse Event|4|||
156466998|NCT01105975|564805696|FG000|Overall Study|Withdrawal by Subject|2|||
156466999|NCT01105975|564805697|FG001|Overall Study|Withdrawal by Subject|2|||
156467000|NCT01105975|564805698|FG002|Overall Study|Withdrawal by Subject|2|||
156467001|NCT01105975|564805699|FG003|Overall Study|Withdrawal by Subject|0|||
156467002|NCT01105975|564805700|FG004|Overall Study|Withdrawal by Subject|4|||
156339917|NCT01817530|564342248|FG007|Overall Study|Consent Withdrawn by Subject|10|||
156339918|NCT01817530|564342241|FG000|Overall Study|Lost to Follow-up|1|||
156467003|NCT01105975|564805701|FG005|Overall Study|Withdrawal by Subject|1|||
156467004|NCT01105975|564805702|FG006|Overall Study|Withdrawal by Subject|2|||
156467005|NCT01105975|564805703|FG007|Overall Study|Withdrawal by Subject|1|||
156467006|NCT01105975|564805704|FG008|Overall Study|Withdrawal by Subject|0|||
156467007|NCT01105975|564805705|FG009|Overall Study|Withdrawal by Subject|3|||
156467008|NCT01105975|564805696|FG000|Overall Study|Lost to Follow-up|1|||
156541355|NCT01987960|565074547|FG003|Period 3|Adverse Event|7|||
156541356|NCT01987960|565074544|FG000|Period 3|Non-compliance with IMP|0|||
156541357|NCT01987960|565074545|FG001|Period 3|Non-compliance with IMP|0|||
156467009|NCT01105975|564805697|FG001|Overall Study|Lost to Follow-up|0|||
156467010|NCT01105975|564805698|FG002|Overall Study|Lost to Follow-up|0|||
156467011|NCT01105975|564805699|FG003|Overall Study|Lost to Follow-up|1|||
156541358|NCT01987960|565074546|FG002|Period 3|Non-compliance with IMP|0|||
156541359|NCT01987960|565074547|FG003|Period 3|Non-compliance with IMP|1|||
156833153|NCT01282294|566143116|FG000|Overall Study|Patient non-compliance|2|||
156833154|NCT01282294|566143116|FG000|Overall Study|Physician Decision|1|||
156833155|NCT02408523|566143117|FG000|Overall Study|Adverse Event|4|||
156833156|NCT02408523|566143118|FG001|Overall Study|Adverse Event|10|||
156833157|NCT02408523|566143117|FG000|Overall Study|Lack of Efficacy|0|||
156833158|NCT02408523|566143118|FG001|Overall Study|Lack of Efficacy|1|||
156833159|NCT02408523|566143117|FG000|Overall Study|Protocol Violation|1|||
156833160|NCT02408523|566143118|FG001|Overall Study|Protocol Violation|2|||
156833161|NCT02408523|566143117|FG000|Overall Study|Lost to Follow-up|2|||
156833162|NCT02408523|566143118|FG001|Overall Study|Lost to Follow-up|3|||
156833163|NCT02408523|566143117|FG000|Overall Study|Withdrawal by Subject|3|||
156833164|NCT02408523|566143118|FG001|Overall Study|Withdrawal by Subject|1|||
156833165|NCT02408523|566143117|FG000|Overall Study|Sponsor request|1|||
156833166|NCT02408523|566143118|FG001|Overall Study|Sponsor request|0|||
156833167|NCT02408523|566143117|FG000|Overall Study|Did not satisfy extension conditions|0|||
156833168|NCT02408523|566143118|FG001|Overall Study|Did not satisfy extension conditions|1|||
156833169|NCT02905006|566143119|FG000|Overall Study|Adverse Event|1|||
156833170|NCT02905006|566143120|FG001|Overall Study|Adverse Event|1|||
156833171|NCT02905006|566143121|FG002|Overall Study|Adverse Event|1|||
156833172|NCT02905006|566143122|FG003|Overall Study|Adverse Event|1|||
156833173|NCT02905006|566143123|FG004|Overall Study|Adverse Event|0|||
156833174|NCT02905006|566143124|FG005|Overall Study|Adverse Event|1|||
156833175|NCT02905006|566143119|FG000|Overall Study|Lack of Efficacy|1|||
156833176|NCT02905006|566143120|FG001|Overall Study|Lack of Efficacy|0|||
156833177|NCT02905006|566143121|FG002|Overall Study|Lack of Efficacy|0|||
156833178|NCT02905006|566143122|FG003|Overall Study|Lack of Efficacy|0|||
156833179|NCT02905006|566143123|FG004|Overall Study|Lack of Efficacy|0|||
156833180|NCT02905006|566143124|FG005|Overall Study|Lack of Efficacy|0|||
156833181|NCT02905006|566143119|FG000|Overall Study|Protocol Violation|2|||
156833182|NCT02905006|566143120|FG001|Overall Study|Protocol Violation|0|||
156833183|NCT02905006|566143121|FG002|Overall Study|Protocol Violation|0|||
156833184|NCT02905006|566143122|FG003|Overall Study|Protocol Violation|0|||
156833185|NCT02905006|566143123|FG004|Overall Study|Protocol Violation|0|||
156833186|NCT02905006|566143124|FG005|Overall Study|Protocol Violation|0|||
156833187|NCT02905006|566143119|FG000|Overall Study|Lost to Follow-up|0|||
156833188|NCT02905006|566143120|FG001|Overall Study|Lost to Follow-up|0|||
156833189|NCT02905006|566143121|FG002|Overall Study|Lost to Follow-up|0|||
156833190|NCT02905006|566143122|FG003|Overall Study|Lost to Follow-up|1|||
156833191|NCT02905006|566143123|FG004|Overall Study|Lost to Follow-up|1|||
156833192|NCT02905006|566143124|FG005|Overall Study|Lost to Follow-up|0|||
156833193|NCT02905006|566143119|FG000|Overall Study|Withdrawal by Subject|0|||
156833194|NCT02905006|566143120|FG001|Overall Study|Withdrawal by Subject|0|||
156833195|NCT02905006|566143121|FG002|Overall Study|Withdrawal by Subject|1|||
156833196|NCT02905006|566143122|FG003|Overall Study|Withdrawal by Subject|1|||
156833197|NCT02905006|566143123|FG004|Overall Study|Withdrawal by Subject|0|||
156833198|NCT02905006|566143124|FG005|Overall Study|Withdrawal by Subject|1|||
156833199|NCT02905006|566143119|FG000|Overall Study|Screening exclusion criteria met|1|||
156833200|NCT02905006|566143120|FG001|Overall Study|Screening exclusion criteria met|0|||
156833201|NCT02905006|566143121|FG002|Overall Study|Screening exclusion criteria met|0|||
156833202|NCT02905006|566143122|FG003|Overall Study|Screening exclusion criteria met|0|||
156833203|NCT02905006|566143123|FG004|Overall Study|Screening exclusion criteria met|0|||
156833204|NCT02905006|566143124|FG005|Overall Study|Screening exclusion criteria met|0|||
156833205|NCT02905006|566143119|FG000|Overall Study|Lab withdrawal criterion met|0|||
156833206|NCT02905006|566143120|FG001|Overall Study|Lab withdrawal criterion met|1|||
156833207|NCT02905006|566143121|FG002|Overall Study|Lab withdrawal criterion met|2|||
156833208|NCT02905006|566143122|FG003|Overall Study|Lab withdrawal criterion met|2|||
156833209|NCT02905006|566143123|FG004|Overall Study|Lab withdrawal criterion met|2|||
156833210|NCT02905006|566143124|FG005|Overall Study|Lab withdrawal criterion met|1|||
156833211|NCT02905006|566143119|FG000|Overall Study|Positive for Tuberculosis|0|||
156833212|NCT02905006|566143120|FG001|Overall Study|Positive for Tuberculosis|1|||
156833213|NCT02905006|566143121|FG002|Overall Study|Positive for Tuberculosis|0|||
156833214|NCT02905006|566143122|FG003|Overall Study|Positive for Tuberculosis|0|||
156833215|NCT02905006|566143123|FG004|Overall Study|Positive for Tuberculosis|0|||
156833216|NCT02905006|566143124|FG005|Overall Study|Positive for Tuberculosis|0|||
156833217|NCT02905006|566143119|FG000|Overall Study|Subject positive for Hep B|0|||
156833218|NCT02905006|566143120|FG001|Overall Study|Subject positive for Hep B|0|||
156833219|NCT02905006|566143121|FG002|Overall Study|Subject positive for Hep B|1|||
156833220|NCT02905006|566143122|FG003|Overall Study|Subject positive for Hep B|0|||
156833221|NCT02905006|566143123|FG004|Overall Study|Subject positive for Hep B|0|||
156833222|NCT02905006|566143124|FG005|Overall Study|Subject positive for Hep B|0|||
156833223|NCT02905006|566143119|FG000|Overall Study|Patient moved abroad|0|||
156833224|NCT02905006|566143120|FG001|Overall Study|Patient moved abroad|0|||
156833225|NCT02905006|566143121|FG002|Overall Study|Patient moved abroad|0|||
156833226|NCT02905006|566143122|FG003|Overall Study|Patient moved abroad|1|||
156833227|NCT02905006|566143123|FG004|Overall Study|Patient moved abroad|0|||
156833228|NCT02905006|566143124|FG005|Overall Study|Patient moved abroad|0|||
156833229|NCT02905006|566143119|FG000|Overall Study|Patient randomized by mistake|0|||
156833230|NCT02905006|566143120|FG001|Overall Study|Patient randomized by mistake|0|||
156833231|NCT02905006|566143121|FG002|Overall Study|Patient randomized by mistake|0|||
156833232|NCT02905006|566143122|FG003|Overall Study|Patient randomized by mistake|0|||
156833233|NCT02905006|566143123|FG004|Overall Study|Patient randomized by mistake|0|||
156833234|NCT02905006|566143124|FG005|Overall Study|Patient randomized by mistake|1|||
156833235|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
156833236|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
156833237|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
156833238|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
156833239|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
156833240|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
156833241|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
156833242|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
156833243|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
156833244|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
156833245|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
156833246|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
156833247|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
156833248|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
156833249|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
156833250|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
156833251|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
156833252|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
156833253|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
156833254|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
156833255|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
156833256|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
156833257|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
156833258|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
156833259|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
156541360|NCT01987960|565074544|FG000|Period 3|Protocol Violation|0|||
156541361|NCT01987960|565074545|FG001|Period 3|Protocol Violation|0|||
156833260|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
156833261|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
156833262|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
156833263|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156833264|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156833265|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
156833266|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
156833267|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
156833268|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
156833269|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
156833270|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
156833271|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156833272|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156833273|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
156833274|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156833275|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
156833276|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
156833277|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
156833278|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
156833279|NCT02212678|566143134|FG000|Overall Study|Adverse Event|1|||
156833280|NCT06250738|566143135|FG000|Overall Study|Lost to Follow-up|1|||
156833281|NCT04030962|566143138|FG000|Stage 2|Adverse Event|0|||
156833282|NCT04030962|566143139|FG001|Stage 2|Adverse Event|0|||
156833283|NCT04030962|566143140|FG002|Stage 2|Adverse Event|0|||
156833284|NCT04030962|566143141|FG003|Stage 2|Adverse Event|0|||
156833285|NCT04030962|566143142|FG004|Stage 2|Adverse Event|0|||
156833286|NCT04030962|566143143|FG005|Stage 2|Adverse Event|0|||
156833287|NCT04030962|566143144|FG006|Stage 2|Adverse Event|0|||
156833288|NCT04030962|566143145|FG007|Stage 2|Adverse Event|0|||
156833289|NCT04030962|566143146|FG008|Stage 2|Adverse Event|1|||
156541362|NCT01987960|565074546|FG002|Period 3|Protocol Violation|0|||
156541363|NCT01987960|565074547|FG003|Period 3|Protocol Violation|6|||
156833290|NCT04030962|566143147|FG009|Stage 2|Adverse Event|0|||
156833291|NCT04030962|566143148|FG010|Stage 2|Adverse Event|1|||
156833292|NCT04030962|566143149|FG011|Stage 2|Adverse Event|1|||
156833293|NCT04030962|566143150|FG012|Stage 2|Adverse Event|1|||
156833294|NCT04030962|566143138|FG000|Stage 2|Withdrawal by Subject|0|||
156833295|NCT04030962|566143139|FG001|Stage 2|Withdrawal by Subject|0|||
156833296|NCT04030962|566143140|FG002|Stage 2|Withdrawal by Subject|0|||
156833297|NCT04030962|566143141|FG003|Stage 2|Withdrawal by Subject|0|||
156833298|NCT04030962|566143142|FG004|Stage 2|Withdrawal by Subject|0|||
156833299|NCT04030962|566143143|FG005|Stage 2|Withdrawal by Subject|0|||
156833300|NCT04030962|566143144|FG006|Stage 2|Withdrawal by Subject|0|||
156833301|NCT04030962|566143145|FG007|Stage 2|Withdrawal by Subject|0|||
156833302|NCT04030962|566143146|FG008|Stage 2|Withdrawal by Subject|1|||
156833303|NCT04030962|566143147|FG009|Stage 2|Withdrawal by Subject|0|||
156833304|NCT04030962|566143148|FG010|Stage 2|Withdrawal by Subject|0|||
156833305|NCT04030962|566143149|FG011|Stage 2|Withdrawal by Subject|2|||
156833306|NCT04030962|566143150|FG012|Stage 2|Withdrawal by Subject|1|||
156339919|NCT01817530|564342242|FG001|Overall Study|Lost to Follow-up|4|||
156339920|NCT01817530|564342243|FG002|Overall Study|Lost to Follow-up|2|||
156339921|NCT01817530|564342244|FG003|Overall Study|Lost to Follow-up|1|||
156339922|NCT01817530|564342245|FG004|Overall Study|Lost to Follow-up|3|||
156339923|NCT01817530|564342246|FG005|Overall Study|Lost to Follow-up|2|||
156339924|NCT01817530|564342247|FG006|Overall Study|Lost to Follow-up|8|||
156339925|NCT01817530|564342248|FG007|Overall Study|Lost to Follow-up|4|||
156339926|NCT00566995|564342249|FG000|Overall Study|Toxicity|4|||
156339927|NCT00566995|564342249|FG000|Overall Study|Withdrew consent|3|||
156339928|NCT02339584|564342250|FG000|Overall Study|Adverse Event|11|||
156339929|NCT02339584|564342251|FG001|Overall Study|Adverse Event|7|||
156339930|NCT02339584|564342250|FG000|Overall Study|Lack of Efficacy|0|||
156339931|NCT02339584|564342251|FG001|Overall Study|Lack of Efficacy|1|||
156339932|NCT02339584|564342250|FG000|Overall Study|Physician Decision|1|||
156339933|NCT02339584|564342251|FG001|Overall Study|Physician Decision|2|||
156339934|NCT02339584|564342250|FG000|Overall Study|Protocol Violation|1|||
156339935|NCT02339584|564342251|FG001|Overall Study|Protocol Violation|1|||
156339936|NCT02339584|564342250|FG000|Overall Study|Withdrawal by Subject|2|||
156339937|NCT02339584|564342251|FG001|Overall Study|Withdrawal by Subject|4|||
156339938|NCT02610725|564342252|FG000|Overall Study|Lost to Follow-up|197|||
156339939|NCT02610725|564342252|FG000|Overall Study|self-reported contraindication|9|||
156339940|NCT04094883|564342253|FG000|Overall Study|Withdrawal by Subject|1|||
156339941|NCT00228384|564342254|FG000|Overall Study|Death|9|||
156339942|NCT00228384|564342255|FG001|Overall Study|Death|3|||
156339943|NCT00228384|564342254|FG000|Overall Study|Lost to Follow-up|6|||
156339944|NCT00228384|564342255|FG001|Overall Study|Lost to Follow-up|10|||
156339945|NCT00228384|564342254|FG000|Overall Study|Surgical Intervention (bypass)|5|||
156339946|NCT00228384|564342255|FG001|Overall Study|Surgical Intervention (bypass)|5|||
156339947|NCT00228384|564342254|FG000|Overall Study|Withdrawal by Subject|9|||
156339948|NCT00228384|564342255|FG001|Overall Study|Withdrawal by Subject|10|||
156339949|NCT00228384|564342254|FG000|Overall Study|Physician Decision|0|||
156339950|NCT00228384|564342255|FG001|Overall Study|Physician Decision|1|||
156339951|NCT01084083|564342256|FG000|Overall Study|Adverse Event|5|||
156339952|NCT01084083|564342256|FG000|Overall Study|Death|1|||
156339953|NCT01084083|564342256|FG000|Overall Study|Withdrawal by Subject|2|||
156339954|NCT01084083|564342256|FG000|Overall Study|Complicating disease|1|||
156339955|NCT01084083|564342256|FG000|Overall Study|Other|2|||
156339956|NCT01084083|564342256|FG000|Overall Study|Never started assigned therapy|1|||
156339957|NCT01466153|564342260|FG000|Overall Study|Disease Progression|2|||
156339958|NCT01466153|564342261|FG001|Overall Study|Disease Progression|2|||
156339959|NCT01466153|564342262|FG002|Overall Study|Disease Progression|0|||
156339960|NCT01466153|564342260|FG000|Overall Study|Adverse Event|14|||
156339961|NCT01466153|564342261|FG001|Overall Study|Adverse Event|13|||
156833307|NCT04030962|566143138|FG000|Stage 2|Lost to Follow-up|0|||
156833308|NCT04030962|566143139|FG001|Stage 2|Lost to Follow-up|0|||
156339962|NCT01466153|564342262|FG002|Overall Study|Adverse Event|17|||
156833309|NCT04030962|566143140|FG002|Stage 2|Lost to Follow-up|0|||
156833310|NCT04030962|566143141|FG003|Stage 2|Lost to Follow-up|0|||
156339963|NCT01466153|564342260|FG000|Overall Study|Withdrawal of Consent|2|||
156339964|NCT01466153|564342261|FG001|Overall Study|Withdrawal of Consent|0|||
156467012|NCT01105975|564805700|FG004|Overall Study|Lost to Follow-up|1|||
156833311|NCT04030962|566143142|FG004|Stage 2|Lost to Follow-up|0|||
156833312|NCT04030962|566143143|FG005|Stage 2|Lost to Follow-up|0|||
156833313|NCT04030962|566143144|FG006|Stage 2|Lost to Follow-up|0|||
156833314|NCT04030962|566143145|FG007|Stage 2|Lost to Follow-up|0|||
156833315|NCT04030962|566143146|FG008|Stage 2|Lost to Follow-up|1|||
156833316|NCT04030962|566143147|FG009|Stage 2|Lost to Follow-up|0|||
156833317|NCT04030962|566143148|FG010|Stage 2|Lost to Follow-up|0|||
156833318|NCT04030962|566143149|FG011|Stage 2|Lost to Follow-up|0|||
156833319|NCT04030962|566143150|FG012|Stage 2|Lost to Follow-up|0|||
156833320|NCT04030962|566143138|FG000|Stage 2|Technical Problems|0|||
156833321|NCT04030962|566143139|FG001|Stage 2|Technical Problems|0|||
156833322|NCT04030962|566143140|FG002|Stage 2|Technical Problems|0|||
156833323|NCT04030962|566143141|FG003|Stage 2|Technical Problems|0|||
156833324|NCT04030962|566143142|FG004|Stage 2|Technical Problems|0|||
156833325|NCT04030962|566143143|FG005|Stage 2|Technical Problems|0|||
156833326|NCT04030962|566143144|FG006|Stage 2|Technical Problems|0|||
156833327|NCT04030962|566143145|FG007|Stage 2|Technical Problems|0|||
156833328|NCT04030962|566143146|FG008|Stage 2|Technical Problems|0|||
156833329|NCT04030962|566143147|FG009|Stage 2|Technical Problems|0|||
156833330|NCT04030962|566143148|FG010|Stage 2|Technical Problems|0|||
156833331|NCT04030962|566143149|FG011|Stage 2|Technical Problems|1|||
156833332|NCT04030962|566143150|FG012|Stage 2|Technical Problems|0|||
156833333|NCT05601102|566143151|FG000|Overall Study|Death|1|||
156833334|NCT05601102|566143152|FG001|Overall Study|Death|2|||
156833335|NCT05601102|566143151|FG000|Overall Study|Withdrawal by Subject|1|||
156833336|NCT05601102|566143152|FG001|Overall Study|Withdrawal by Subject|1|||
156833337|NCT05601102|566143151|FG000|Overall Study|Lost to Follow-up|0|||
156833338|NCT05601102|566143152|FG001|Overall Study|Lost to Follow-up|2|||
156833339|NCT05288166|566143158|FG000|Overall Study|Adverse Event|1|||
156833340|NCT05288166|566143159|FG001|Overall Study|Adverse Event|0|||
156833341|NCT05288166|566143158|FG000|Overall Study|Lost to Follow-up|2|||
156833342|NCT05288166|566143159|FG001|Overall Study|Lost to Follow-up|0|||
156833343|NCT05288166|566143158|FG000|Overall Study|Physician Decision|0|||
156833344|NCT05288166|566143159|FG001|Overall Study|Physician Decision|2|||
156833345|NCT05288166|566143158|FG000|Overall Study|Screen Failure|1|||
156833346|NCT05288166|566143159|FG001|Overall Study|Screen Failure|1|||
156833347|NCT05288166|566143158|FG000|Overall Study|Withdrawal by Subject|4|||
156833348|NCT05288166|566143159|FG001|Overall Study|Withdrawal by Subject|2|||
156833349|NCT05288166|566143158|FG000|Overall Study|On Study Treatment|408|||
156833350|NCT05288166|566143159|FG001|Overall Study|On Study Treatment|418|||
156833351|NCT01114360|566143160|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
156833352|NCT01114360|566143161|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
156833353|NCT03344172|566143164|FG000|Overall Study|Received <1 dose of treatment|1|||
156833354|NCT03344172|566143165|FG001|Overall Study|Received <1 dose of treatment|0|||
156833355|NCT00385723|566143167|FG000|Overall Study|Lost to Follow-up|1|||
156833356|NCT00385723|566143168|FG001|Overall Study|Lost to Follow-up|1|||
156833357|NCT00385723|566143169|FG002|Overall Study|Lost to Follow-up|0|||
156833358|NCT00385723|566143167|FG000|Overall Study|Withdrawal by Subject|1|||
156833359|NCT00385723|566143168|FG001|Overall Study|Withdrawal by Subject|0|||
156833360|NCT00385723|566143169|FG002|Overall Study|Withdrawal by Subject|2|||
156833361|NCT01390779|566143170|FG000|Overall Study|Physician Decision|1|||
156833362|NCT03455829|566143171|FG000|Overall Study|Death|2|||
156833363|NCT03455829|566143172|FG001|Overall Study|Death|3|||
156833364|NCT03455829|566143173|FG002|Overall Study|Death|2|||
156833365|NCT03455829|566143174|FG003|Overall Study|Death|4|||
156833366|NCT03455829|566143175|FG004|Overall Study|Death|2|||
156833367|NCT03455829|566143171|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
156833368|NCT03455829|566143172|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
156833369|NCT03455829|566143173|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
156833370|NCT03455829|566143174|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
156833371|NCT03455829|566143175|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
156833372|NCT03455829|566143171|FG000|Overall Study|Disease progression|0|||
156833373|NCT03455829|566143172|FG001|Overall Study|Disease progression|0|||
156833374|NCT03455829|566143173|FG002|Overall Study|Disease progression|0|||
156833375|NCT03455829|566143174|FG003|Overall Study|Disease progression|1|||
156833376|NCT03455829|566143175|FG004|Overall Study|Disease progression|1|||
156833377|NCT03689712|566143187|FG000|Overall Study|Adverse Event|1|||
156833378|NCT03689712|566143188|FG001|Overall Study|Adverse Event|0|||
156833379|NCT03689712|566143187|FG000|Overall Study|Death|20|||
156833380|NCT03689712|566143188|FG001|Overall Study|Death|10|||
156833381|NCT03689712|566143187|FG000|Overall Study|Lost to Follow-up|6|||
156833382|NCT03689712|566143188|FG001|Overall Study|Lost to Follow-up|6|||
156833383|NCT03689712|566143187|FG000|Overall Study|Other|1|||
156833384|NCT03689712|566143188|FG001|Overall Study|Other|0|||
156833385|NCT03689712|566143187|FG000|Overall Study|Patient Non-Compliance|0|||
156833386|NCT03689712|566143188|FG001|Overall Study|Patient Non-Compliance|1|||
156833387|NCT03689712|566143187|FG000|Overall Study|Withdrawal by Subject|20|||
156833388|NCT03689712|566143188|FG001|Overall Study|Withdrawal by Subject|4|||
156833389|NCT03689712|566143187|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
156833390|NCT03689712|566143188|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
156833391|NCT03689712|566143187|FG000|Overall Study|Randomized but not Treated|13|||
156833392|NCT03689712|566143188|FG001|Overall Study|Randomized but not Treated|7|||
156833393|NCT03689712|566143187|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
156833394|NCT03689712|566143188|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
156833395|NCT00689793|566143189|FG000|Overall Study|Lost to Follow-up|4|||
156833396|NCT00689793|566143190|FG001|Overall Study|Lost to Follow-up|5|||
156833397|NCT00413010|566143196|FG000|Overall Study|Adverse Event|8|||
156833398|NCT00413010|566143197|FG001|Overall Study|Adverse Event|4|||
156833399|NCT00413010|566143196|FG000|Overall Study|Laboratory abnormality|0|||
156467013|NCT01105975|564805701|FG005|Overall Study|Lost to Follow-up|0|||
156467014|NCT01105975|564805702|FG006|Overall Study|Lost to Follow-up|0|||
156467015|NCT01105975|564805703|FG007|Overall Study|Lost to Follow-up|0|||
156467016|NCT01105975|564805704|FG008|Overall Study|Lost to Follow-up|1|||
156467017|NCT01105975|564805705|FG009|Overall Study|Lost to Follow-up|0|||
156467018|NCT01105975|564805696|FG000|Overall Study|Physician Decision|0|||
156467019|NCT01105975|564805697|FG001|Overall Study|Physician Decision|0|||
156467020|NCT01105975|564805698|FG002|Overall Study|Physician Decision|0|||
156467021|NCT01105975|564805699|FG003|Overall Study|Physician Decision|0|||
156467022|NCT01105975|564805700|FG004|Overall Study|Physician Decision|0|||
156467023|NCT01105975|564805701|FG005|Overall Study|Physician Decision|0|||
156467024|NCT01105975|564805702|FG006|Overall Study|Physician Decision|2|||
156467025|NCT01105975|564805703|FG007|Overall Study|Physician Decision|0|||
156467026|NCT01105975|564805704|FG008|Overall Study|Physician Decision|0|||
156467027|NCT01105975|564805705|FG009|Overall Study|Physician Decision|0|||
156467028|NCT01105975|564805696|FG000|Overall Study|Protocol Violation|0|||
156467029|NCT01105975|564805697|FG001|Overall Study|Protocol Violation|2|||
156467030|NCT01105975|564805698|FG002|Overall Study|Protocol Violation|2|||
156467031|NCT01105975|564805699|FG003|Overall Study|Protocol Violation|0|||
156467032|NCT01105975|564805700|FG004|Overall Study|Protocol Violation|1|||
156467033|NCT01105975|564805701|FG005|Overall Study|Protocol Violation|1|||
156467034|NCT01105975|564805702|FG006|Overall Study|Protocol Violation|1|||
156467035|NCT01105975|564805703|FG007|Overall Study|Protocol Violation|1|||
156467036|NCT01105975|564805704|FG008|Overall Study|Protocol Violation|2|||
156467037|NCT01105975|564805705|FG009|Overall Study|Protocol Violation|2|||
156467038|NCT01105975|564805696|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
156467039|NCT01105975|564805697|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
156467040|NCT01105975|564805698|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
156467041|NCT01105975|564805699|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
156467042|NCT01105975|564805700|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
156467043|NCT01105975|564805701|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
156467044|NCT01105975|564805702|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
156467045|NCT01105975|564805703|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
156467046|NCT01105975|564805704|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
156467047|NCT01105975|564805705|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
156467048|NCT04868617|564805706|FG000|Overall Study|Death|1|||
156467049|NCT04868617|564805707|FG001|Overall Study|Death|0|||
156467050|NCT04868617|564805706|FG000|Overall Study|Adverse Event|1|||
156467051|NCT04868617|564805707|FG001|Overall Study|Adverse Event|0|||
156467052|NCT04868617|564805706|FG000|Overall Study|Withdrawal by Subject|1|||
156467053|NCT04868617|564805707|FG001|Overall Study|Withdrawal by Subject|0|||
156467054|NCT04868617|564805706|FG000|Overall Study|Device deficiency|1|||
156467055|NCT04868617|564805707|FG001|Overall Study|Device deficiency|0|||
156467056|NCT02502526|564805708|FG000|Overall Study|Lost to Follow-up|2|||
156467057|NCT02502526|564805709|FG001|Overall Study|Lost to Follow-up|2|||
156467058|NCT02502526|564805710|FG002|Overall Study|Lost to Follow-up|3|||
156467059|NCT02502526|564805708|FG000|Overall Study|Withdrawal by Subject|0|||
156467060|NCT02502526|564805709|FG001|Overall Study|Withdrawal by Subject|1|||
156467061|NCT02502526|564805710|FG002|Overall Study|Withdrawal by Subject|1|||
156467062|NCT02502526|564805708|FG000|Overall Study|Disqualified due to cataract grading|0|||
156467063|NCT02502526|564805709|FG001|Overall Study|Disqualified due to cataract grading|0|||
156833400|NCT00413010|566143197|FG001|Overall Study|Laboratory abnormality|2|||
156833401|NCT00413010|566143196|FG000|Overall Study|Lack of Efficacy|0|||
156833402|NCT00413010|566143197|FG001|Overall Study|Lack of Efficacy|3|||
156467064|NCT02502526|564805710|FG002|Overall Study|Disqualified due to cataract grading|1|||
156467065|NCT02502526|564805708|FG000|Overall Study|Enrollment suspension|4|||
156467066|NCT02502526|564805709|FG001|Overall Study|Enrollment suspension|1|||
156467067|NCT02502526|564805710|FG002|Overall Study|Enrollment suspension|1|||
156467068|NCT02964741|564805711|FG000|Overall Study|Protocol Violation|1|||
156467069|NCT02964741|564805712|FG001|Overall Study|Protocol Violation|0|||
156467070|NCT02964741|564805713|FG002|Overall Study|Protocol Violation|0|||
156467071|NCT02964741|564805711|FG000|Overall Study|Withdrawal by Subject|0|||
156467072|NCT02964741|564805712|FG001|Overall Study|Withdrawal by Subject|1|||
156467073|NCT02964741|564805713|FG002|Overall Study|Withdrawal by Subject|0|||
156467074|NCT02964741|564805711|FG000|Overall Study|claustrophobia|1|||
156467075|NCT02964741|564805712|FG001|Overall Study|claustrophobia|0|||
156833403|NCT00413010|566143196|FG000|Overall Study|Lost to Follow-up|3|||
156467076|NCT02964741|564805713|FG002|Overall Study|claustrophobia|0|||
156467077|NCT01074294|564805717|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
156467078|NCT01074294|564805718|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
156467079|NCT01074294|564805719|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
156467080|NCT01074294|564805720|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
156467081|NCT01074294|564805717|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
156467082|NCT01074294|564805718|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
156467083|NCT01074294|564805719|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
156467084|NCT01074294|564805720|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
156467085|NCT01074294|564805717|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
156467086|NCT01074294|564805718|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
156467087|NCT01074294|564805719|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
156467088|NCT01074294|564805720|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
156467089|NCT01074294|564805717|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
156467090|NCT01074294|564805718|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
156467091|NCT01074294|564805719|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
156467092|NCT01074294|564805720|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
156467093|NCT01074294|564805717|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
156467094|NCT01074294|564805718|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
156467095|NCT01074294|564805719|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
156467096|NCT01074294|564805720|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
156467097|NCT01074294|564805717|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
156467098|NCT01074294|564805718|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
156467099|NCT01074294|564805719|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
156467100|NCT01074294|564805720|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
156467101|NCT01074294|564805717|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
156467102|NCT01074294|564805718|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
156467103|NCT01074294|564805719|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
156467104|NCT01074294|564805720|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
156467105|NCT01074294|564805717|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
156467106|NCT01074294|564805718|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
156467107|NCT01074294|564805719|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
156467108|NCT01074294|564805720|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
156467109|NCT01074294|564805717|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
156467110|NCT01074294|564805718|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
156833404|NCT00413010|566143197|FG001|Overall Study|Lost to Follow-up|0|||
156833405|NCT00413010|566143196|FG000|Overall Study|Withdrawal by Subject|7|||
156833406|NCT00413010|566143197|FG001|Overall Study|Withdrawal by Subject|2|||
156833407|NCT00413010|566143196|FG000|Overall Study|Due to termination of the study|54|||
156833408|NCT00413010|566143197|FG001|Overall Study|Due to termination of the study|52|||
156833409|NCT00875056|566143198|FG000|Overall Study|Adverse Event|6|||
156833410|NCT00875056|566143199|FG001|Overall Study|Adverse Event|1|||
156833411|NCT00875056|566143200|FG002|Overall Study|Adverse Event|2|||
156833412|NCT00875056|566143198|FG000|Overall Study|Progressive Disease|14|||
156833413|NCT00875056|566143199|FG001|Overall Study|Progressive Disease|8|||
156833414|NCT00875056|566143200|FG002|Overall Study|Progressive Disease|3|||
156833415|NCT00875056|566143198|FG000|Overall Study|Withdrawal by Subject|3|||
156833416|NCT00875056|566143199|FG001|Overall Study|Withdrawal by Subject|0|||
156833417|NCT00875056|566143200|FG002|Overall Study|Withdrawal by Subject|1|||
156833418|NCT01842581|566143205|FG000|Overall Study|Adverse Event|6|||
156833419|NCT01842581|566143206|FG001|Overall Study|Adverse Event|4|||
156833420|NCT01842581|566143205|FG000|Overall Study|HE breakthrough|26|||
156833421|NCT01842581|566143206|FG001|Overall Study|HE breakthrough|13|||
156833422|NCT01842581|566143205|FG000|Overall Study|Liver transplant|2|||
156833423|NCT01842581|566143206|FG001|Overall Study|Liver transplant|0|||
156833424|NCT01842581|566143205|FG000|Overall Study|Lost to Follow-up|2|||
156833425|NCT01842581|566143206|FG001|Overall Study|Lost to Follow-up|5|||
156833426|NCT01842581|566143205|FG000|Overall Study|Withdrawal by Subject|5|||
156833427|NCT01842581|566143206|FG001|Overall Study|Withdrawal by Subject|7|||
156833428|NCT01842581|566143205|FG000|Overall Study|Other than specified|3|||
156833429|NCT01842581|566143206|FG001|Overall Study|Other than specified|1|||
156833430|NCT05432167|566143207|FG000|Overall Study|Adverse Event|0|||
156833431|NCT05432167|566143208|FG001|Overall Study|Adverse Event|2|||
156833432|NCT05432167|566143209|FG002|Overall Study|Adverse Event|1|||
156467111|NCT01074294|564805719|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
156467112|NCT01074294|564805720|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
156541364|NCT01987960|565074544|FG000|Period 3|Withdrawal by Subject|0|||
156833433|NCT05432167|566143207|FG000|Overall Study|Lost to Follow-up|3|||
156467113|NCT01074294|564805717|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
156467114|NCT01074294|564805718|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
156467115|NCT01074294|564805719|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
156467116|NCT01074294|564805720|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
156467117|NCT01074294|564805717|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
156467118|NCT01074294|564805718|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
156467119|NCT01074294|564805719|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
156467120|NCT01074294|564805720|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
156467121|NCT01074294|564805717|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
156467122|NCT01074294|564805718|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
156467123|NCT01074294|564805719|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
156467124|NCT01074294|564805720|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
156467125|NCT01074294|564805717|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
156467126|NCT01074294|564805718|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
156467127|NCT01074294|564805719|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
156833434|NCT05432167|566143208|FG001|Overall Study|Lost to Follow-up|3|||
156833435|NCT05432167|566143209|FG002|Overall Study|Lost to Follow-up|2|||
156833436|NCT05432167|566143207|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
156833437|NCT05432167|566143208|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
156833438|NCT05432167|566143209|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
156833439|NCT05432167|566143207|FG000|Overall Study|Physician Decision|1|||
156833440|NCT05432167|566143208|FG001|Overall Study|Physician Decision|0|||
156833441|NCT05432167|566143209|FG002|Overall Study|Physician Decision|0|||
156833442|NCT05432167|566143207|FG000|Overall Study|Withdrawal by Subject|7|||
156833443|NCT05432167|566143208|FG001|Overall Study|Withdrawal by Subject|4|||
156833444|NCT05432167|566143209|FG002|Overall Study|Withdrawal by Subject|11|||
156833445|NCT05432167|566143207|FG000|Overall Study|Other|0|||
156833446|NCT05432167|566143208|FG001|Overall Study|Other|0|||
156833447|NCT05432167|566143209|FG002|Overall Study|Other|1|||
156833448|NCT01995552|566143210|FG000|Overall Study|Protocol Violation|1|||
156833449|NCT01995552|566143210|FG000|Overall Study|Lack of Efficacy|15|||
156833450|NCT01995552|566143210|FG000|Overall Study|Death|1|||
156833451|NCT00283868|566143213|FG000|Overall Study|Lost to Follow-up|7|||
156833452|NCT00283868|566143214|FG001|Overall Study|Lost to Follow-up|8|||
156833453|NCT00353873|566143215|FG000|Overall Study|Protocol Violation|1|||
156833454|NCT00353873|566143216|FG001|Overall Study|Protocol Violation|2|||
156833455|NCT00353873|566143215|FG000|Overall Study|Exacerbation|1|||
156833456|NCT00353873|566143216|FG001|Overall Study|Exacerbation|0|||
156833457|NCT00353873|566143215|FG000|Overall Study|Adverse Event|1|||
156833458|NCT00353873|566143216|FG001|Overall Study|Adverse Event|0|||
156833459|NCT00353873|566143215|FG000|Overall Study|Physician Decision|2|||
156833460|NCT00353873|566143216|FG001|Overall Study|Physician Decision|0|||
156833461|NCT00353873|566143215|FG000|Overall Study|Withdrawal by Subject|1|||
156833462|NCT00353873|566143216|FG001|Overall Study|Withdrawal by Subject|1|||
156833463|NCT03743064|566143218|FG000|Overall Study|Adverse Event|7|||
156833464|NCT03743064|566143219|FG001|Overall Study|Adverse Event|9|||
156833465|NCT03743064|566143218|FG000|Overall Study|Death|25|||
156833466|NCT03743064|566143219|FG001|Overall Study|Death|28|||
156833467|NCT03743064|566143218|FG000|Overall Study|Lost to Follow-up|3|||
156833468|NCT03743064|566143219|FG001|Overall Study|Lost to Follow-up|6|||
156833469|NCT03743064|566143218|FG000|Overall Study|Withdrawal by Subject|28|||
156833470|NCT03743064|566143219|FG001|Overall Study|Withdrawal by Subject|25|||
156833471|NCT03743064|566143218|FG000|Overall Study|Physician Decision|2|||
156833472|NCT03743064|566143219|FG001|Overall Study|Physician Decision|4|||
156833473|NCT03743064|566143218|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
156833474|NCT03743064|566143219|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
156833475|NCT00870194|566143220|FG000|Overall Study|Adverse Event|10|||
156339965|NCT01466153|564342262|FG002|Overall Study|Withdrawal of Consent|0|||
156833476|NCT00870194|566143221|FG001|Overall Study|Adverse Event|5|||
156833477|NCT00870194|566143220|FG000|Overall Study|Lack of Efficacy|0|||
156833478|NCT00870194|566143221|FG001|Overall Study|Lack of Efficacy|1|||
156833479|NCT00870194|566143220|FG000|Overall Study|Lost to Follow-up|2|||
156833480|NCT00870194|566143221|FG001|Overall Study|Lost to Follow-up|0|||
156833481|NCT00870194|566143220|FG000|Overall Study|Physician Decision|3|||
156833482|NCT00870194|566143221|FG001|Overall Study|Physician Decision|1|||
156833483|NCT00870194|566143220|FG000|Overall Study|Protocol Violation|3|||
156833484|NCT00870194|566143221|FG001|Overall Study|Protocol Violation|3|||
156833485|NCT00870194|566143220|FG000|Overall Study|Entry Criteria Not Met|1|||
156833486|NCT00870194|566143221|FG001|Overall Study|Entry Criteria Not Met|2|||
156833487|NCT00870194|566143220|FG000|Overall Study|Subject Decision|7|||
156833488|NCT00870194|566143221|FG001|Overall Study|Subject Decision|2|||
156833489|NCT02573246|566143223|FG000|Overall Study|Lost to Follow-up|2|||
156833490|NCT02573246|566143224|FG001|Overall Study|Lost to Follow-up|0|||
156833491|NCT02573246|566143225|FG002|Overall Study|Lost to Follow-up|0|||
156833492|NCT02573246|566143226|FG003|Overall Study|Lost to Follow-up|0|||
156833493|NCT02573246|566143227|FG004|Overall Study|Lost to Follow-up|1|||
156833494|NCT02573246|566143223|FG000|Overall Study|Withdrawal by Subject|0|||
156833495|NCT02573246|566143224|FG001|Overall Study|Withdrawal by Subject|0|||
156833496|NCT02573246|566143225|FG002|Overall Study|Withdrawal by Subject|0|||
156541365|NCT01987960|565074545|FG001|Period 3|Withdrawal by Subject|0|||
156541366|NCT01987960|565074546|FG002|Period 3|Withdrawal by Subject|0|||
156833497|NCT02573246|566143226|FG003|Overall Study|Withdrawal by Subject|0|||
156339966|NCT01466153|564342260|FG000|Overall Study|Investigator Discretion|3|||
156339967|NCT01466153|564342261|FG001|Overall Study|Investigator Discretion|2|||
156339968|NCT01466153|564342262|FG002|Overall Study|Investigator Discretion|2|||
156339969|NCT01466153|564342260|FG000|Overall Study|Randomized-Not Treated|2|||
156339970|NCT01466153|564342261|FG001|Overall Study|Randomized-Not Treated|3|||
156339971|NCT01466153|564342262|FG002|Overall Study|Randomized-Not Treated|4|||
156339972|NCT01466153|564342260|FG000|Overall Study|Other-Unspecified|6|||
156339973|NCT01466153|564342261|FG001|Overall Study|Other-Unspecified|4|||
156339974|NCT01466153|564342262|FG002|Overall Study|Other-Unspecified|2|||
156339975|NCT01980940|564342263|FG000|Overall Study|Protocol Violation|0|||
156339976|NCT01980940|564342264|FG001|Overall Study|Protocol Violation|0|||
156339977|NCT01980940|564342265|FG002|Overall Study|Protocol Violation|0|||
156339978|NCT01980940|564342266|FG003|Overall Study|Protocol Violation|0|||
156339979|NCT01980940|564342267|FG004|Overall Study|Protocol Violation|0|||
156339980|NCT01980940|564342268|FG005|Overall Study|Protocol Violation|2|||
156339981|NCT01980940|564342269|FG006|Overall Study|Protocol Violation|0|||
156339982|NCT01980940|564342270|FG007|Overall Study|Protocol Violation|0|||
156339983|NCT00837811|564342271|FG000|Overall Study|Adverse Event|4|||
156339984|NCT00837811|564342272|FG001|Overall Study|Adverse Event|6|||
156339985|NCT00837811|564342273|FG002|Overall Study|Adverse Event|0|||
156339986|NCT00837811|564342271|FG000|Overall Study|Death|1|||
156339987|NCT00837811|564342272|FG001|Overall Study|Death|1|||
156339988|NCT00837811|564342273|FG002|Overall Study|Death|0|||
156339989|NCT00837811|564342271|FG000|Overall Study|Lack of Efficacy|0|||
156339990|NCT00837811|564342272|FG001|Overall Study|Lack of Efficacy|11|||
156339991|NCT00837811|564342273|FG002|Overall Study|Lack of Efficacy|0|||
156339992|NCT00837811|564342271|FG000|Overall Study|Lost to Follow-up|1|||
156339993|NCT00837811|564342272|FG001|Overall Study|Lost to Follow-up|3|||
156339994|NCT00837811|564342273|FG002|Overall Study|Lost to Follow-up|0|||
156339995|NCT00837811|564342271|FG000|Overall Study|Physician Decision|0|||
156339996|NCT00837811|564342272|FG001|Overall Study|Physician Decision|2|||
156339997|NCT00837811|564342273|FG002|Overall Study|Physician Decision|1|||
156339998|NCT00837811|564342271|FG000|Overall Study|Withdrawal by Subject|1|||
156339999|NCT00837811|564342272|FG001|Overall Study|Withdrawal by Subject|9|||
156340000|NCT00837811|564342273|FG002|Overall Study|Withdrawal by Subject|0|||
156340001|NCT00837811|564342271|FG000|Overall Study|Sponsor Decision|0|||
156340002|NCT00837811|564342272|FG001|Overall Study|Sponsor Decision|2|||
156340003|NCT00837811|564342273|FG002|Overall Study|Sponsor Decision|0|||
156340004|NCT05695209|564342277|FG000|3-months|Withdrawal by Subject|2|||
156340005|NCT05695209|564342278|FG001|3-months|Withdrawal by Subject|0|||
156340006|NCT05695209|564342277|FG000|3-months|Unable to contact for 3-month data collection|0|||
156340007|NCT05695209|564342278|FG001|3-months|Unable to contact for 3-month data collection|1|||
156340008|NCT05695209|564342277|FG000|6-months|Lost to Follow-up|1|||
156340009|NCT05695209|564342278|FG001|6-months|Lost to Follow-up|1|||
156340010|NCT04362072|564342284|FG000|Treatment|Adverse Event|1|||
156340011|NCT04362072|564342284|FG000|Treatment|Death|9|||
156340012|NCT04362072|564342284|FG000|Treatment|Physician Decision|2|||
156340013|NCT04362072|564342284|FG000|Treatment|Progressive disease|27|||
156340014|NCT04362072|564342284|FG000|Treatment|Withdrawal by Subject|4|||
156340015|NCT04362072|564342284|FG000|Treatment|Global deterioration of health status|1|||
156340016|NCT04362072|564342284|FG000|Treatment|Switched to commercial Lorlatinib|13|||
156340017|NCT04362072|564342284|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
156340018|NCT04362072|564342284|FG000|Treatment|Other|3|||
156340019|NCT04362072|564342284|FG000|Follow up|Death|2|||
156340020|NCT04362072|564342284|FG000|Follow up|Other|2|||
156340021|NCT01133522|564342285|FG000|Overall Study|Withdrawal by Subject|0|||
156340022|NCT01133522|564342286|FG001|Overall Study|Withdrawal by Subject|1|||
156340023|NCT01133522|564342287|FG002|Overall Study|Withdrawal by Subject|0|||
156340024|NCT01133522|564342288|FG003|Overall Study|Withdrawal by Subject|1|||
156541367|NCT01987960|565074547|FG003|Period 3|Withdrawal by Subject|9|||
156340025|NCT01133522|564342289|FG004|Overall Study|Withdrawal by Subject|0|||
156340026|NCT01133522|564342290|FG005|Overall Study|Withdrawal by Subject|0|||
156833498|NCT02573246|566143227|FG004|Overall Study|Withdrawal by Subject|1|||
156340027|NCT01133522|564342291|FG006|Overall Study|Withdrawal by Subject|0|||
156340028|NCT01133522|564342292|FG007|Overall Study|Withdrawal by Subject|0|||
156541368|NCT01987960|565074544|FG000|Period 3|Lost to Follow-up|0|||
156833499|NCT02573246|566143223|FG000|Overall Study|Physician Decision|1|||
156467128|NCT01074294|564805720|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
156467129|NCT00640159|564805721|FG000|Overall Study|Lost to Follow-up|2|||
156467130|NCT00112359|564805722|FG000|Overall Study|Unrelated adverse event|16|||
156467131|NCT00112359|564805723|FG001|Overall Study|Unrelated adverse event|8|||
156467132|NCT00112359|564805722|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
156467133|NCT00112359|564805723|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
156467134|NCT00112359|564805722|FG000|Overall Study|Related adverse event|5|||
156467135|NCT00112359|564805723|FG001|Overall Study|Related adverse event|3|||
156467136|NCT00112359|564805722|FG000|Overall Study|Lost to Follow-up|0|||
156467137|NCT00112359|564805723|FG001|Overall Study|Lost to Follow-up|1|||
156467138|NCT00112359|564805722|FG000|Overall Study|Personal/administrative|1|||
156467139|NCT00112359|564805723|FG001|Overall Study|Personal/administrative|1|||
156467140|NCT00112359|564805722|FG000|Overall Study|Other|3|||
156467141|NCT00112359|564805723|FG001|Overall Study|Other|0|||
156467142|NCT00312208|564805724|FG000|Overall Study|Adverse Event|97|||
156467143|NCT00312208|564805725|FG001|Overall Study|Adverse Event|61|||
156467144|NCT00312208|564805724|FG000|Overall Study|Protocol Violation|5|||
156467145|NCT00312208|564805725|FG001|Overall Study|Protocol Violation|3|||
156467146|NCT00312208|564805724|FG000|Overall Study|Death|2|||
156467147|NCT00312208|564805725|FG001|Overall Study|Death|1|||
156467148|NCT00312208|564805724|FG000|Overall Study|Lack of Efficacy|7|||
156467149|NCT00312208|564805725|FG001|Overall Study|Lack of Efficacy|4|||
156467150|NCT00312208|564805724|FG000|Overall Study|Lost to Follow-up|3|||
156467151|NCT00312208|564805725|FG001|Overall Study|Lost to Follow-up|5|||
156467152|NCT00312208|564805724|FG000|Overall Study|Withdrawal by Subject|53|||
156467153|NCT00312208|564805725|FG001|Overall Study|Withdrawal by Subject|42|||
156467154|NCT00312208|564805724|FG000|Overall Study|Other|5|||
156467155|NCT00312208|564805725|FG001|Overall Study|Other|7|||
156467156|NCT01315132|564805726|FG000|Overall Study|not treated due to disease progression|1|||
156467157|NCT03275285|564805734|FG000|Overall Study|Ongoing|45|||
156467158|NCT03275285|564805735|FG001|Overall Study|Ongoing|69|||
156467159|NCT00115934|564805736|FG000|Overall Study|Lost to Follow-up|1|||
156467160|NCT00115934|564805737|FG001|Overall Study|Lost to Follow-up|0|||
156467161|NCT00115934|564805736|FG000|Overall Study|Did not receive intervention|3|||
156467162|NCT00115934|564805737|FG001|Overall Study|Did not receive intervention|2|||
156467163|NCT00747565|564805738|FG000|Overall Study|Withdrawal by Subject|10|||
156467164|NCT00747565|564805739|FG001|Overall Study|Withdrawal by Subject|6|||
156467165|NCT00747565|564805738|FG000|Overall Study|Lost to Follow-up|4|||
156467166|NCT00747565|564805739|FG001|Overall Study|Lost to Follow-up|1|||
156467167|NCT03777657|564805740|FG000|Overall Study|Death|397|||
156467168|NCT03777657|564805741|FG001|Overall Study|Death|431|||
156467169|NCT03777657|564805740|FG000|Overall Study|Study Closed by Sponsor|77|||
156467170|NCT03777657|564805741|FG001|Overall Study|Study Closed by Sponsor|38|||
156467171|NCT03777657|564805740|FG000|Overall Study|Withdrawal by Subject|20|||
156467172|NCT03777657|564805741|FG001|Overall Study|Withdrawal by Subject|17|||
156467173|NCT03777657|564805740|FG000|Overall Study|Lost to Follow-up|6|||
156467174|NCT03777657|564805741|FG001|Overall Study|Lost to Follow-up|10|||
156467175|NCT00319020|564805748|FG000|Overall Study|Death|2|||
156467176|NCT00319020|564805749|FG001|Overall Study|Death|2|||
156467177|NCT00319020|564805748|FG000|Overall Study|Withdrawal by Subject|4|||
156467178|NCT00319020|564805749|FG001|Overall Study|Withdrawal by Subject|1|||
156467179|NCT00319020|564805748|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
156467180|NCT00319020|564805749|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
156467181|NCT00319020|564805748|FG000|Overall Study|Administrative reason|0|||
156467182|NCT00319020|564805749|FG001|Overall Study|Administrative reason|5|||
156467183|NCT00319020|564805748|FG000|Overall Study|Disease progression|0|||
156467184|NCT00319020|564805749|FG001|Overall Study|Disease progression|2|||
156467185|NCT00319020|564805748|FG000|Overall Study|Transplant|0|||
156833500|NCT02573246|566143224|FG001|Overall Study|Physician Decision|1|||
156833501|NCT02573246|566143225|FG002|Overall Study|Physician Decision|3|||
156833502|NCT02573246|566143226|FG003|Overall Study|Physician Decision|2|||
156833503|NCT02573246|566143227|FG004|Overall Study|Physician Decision|2|||
156833504|NCT03149003|566143228|FG000|Overall Study|Randomized but not treated|0|||
156467186|NCT00319020|564805749|FG001|Overall Study|Transplant|1|||
156467187|NCT00319020|564805748|FG000|Overall Study|Treatment failure|0|||
156467188|NCT00319020|564805749|FG001|Overall Study|Treatment failure|1|||
156467189|NCT00319020|564805748|FG000|Overall Study|Adverse Event|0|||
156467190|NCT00319020|564805749|FG001|Overall Study|Adverse Event|1|||
156467191|NCT02549352|564805752|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
156467192|NCT02549352|564805753|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
156467193|NCT02549352|564805752|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
156467194|NCT02549352|564805753|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
156467195|NCT02549352|564805752|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
156467196|NCT02549352|564805753|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
156467197|NCT02549352|564805752|FG000|12-month Follow-up|Withdrawal by Subject|4|||
156833505|NCT03149003|566143229|FG001|Overall Study|Randomized but not treated|1|||
156833506|NCT03149003|566143230|FG002|Overall Study|Randomized but not treated|18|||
156833507|NCT01443130|566143231|FG000|Overall Study|Lost to Follow-up|44|||
156340029|NCT01133522|564342293|FG008|Overall Study|Withdrawal by Subject|0|||
156340030|NCT01133522|564342294|FG009|Overall Study|Withdrawal by Subject|0|||
156340031|NCT01133522|564342285|FG000|Overall Study|Physician Decision|0|||
156340032|NCT01133522|564342286|FG001|Overall Study|Physician Decision|0|||
156340033|NCT01133522|564342287|FG002|Overall Study|Physician Decision|0|||
156340034|NCT01133522|564342288|FG003|Overall Study|Physician Decision|0|||
156340035|NCT01133522|564342289|FG004|Overall Study|Physician Decision|1|||
156340036|NCT01133522|564342290|FG005|Overall Study|Physician Decision|0|||
156340037|NCT01133522|564342291|FG006|Overall Study|Physician Decision|0|||
156833508|NCT01443130|566143232|FG001|Overall Study|Lost to Follow-up|42|||
156833509|NCT01443130|566143233|FG002|Overall Study|Lost to Follow-up|50|||
156833510|NCT01443130|566143234|FG003|Overall Study|Lost to Follow-up|23|||
156833511|NCT01443130|566143235|FG004|Overall Study|Lost to Follow-up|25|||
156833512|NCT01443130|566143236|FG005|Overall Study|Lost to Follow-up|21|||
156833513|NCT01443130|566143231|FG000|Overall Study|Death|0|||
156833514|NCT01443130|566143232|FG001|Overall Study|Death|1|||
156833515|NCT01443130|566143233|FG002|Overall Study|Death|0|||
156833516|NCT01443130|566143234|FG003|Overall Study|Death|7|||
156833517|NCT01443130|566143235|FG004|Overall Study|Death|10|||
156833518|NCT01443130|566143236|FG005|Overall Study|Death|8|||
156833519|NCT01443130|566143231|FG000|Overall Study|Adverse Event|2|||
156340038|NCT01133522|564342292|FG007|Overall Study|Physician Decision|0|||
156340039|NCT01133522|564342293|FG008|Overall Study|Physician Decision|0|||
156340040|NCT01133522|564342294|FG009|Overall Study|Physician Decision|0|||
156340041|NCT04731363|564342300|FG000|Overall Study|Could not obtain samples|0|||
156340042|NCT04731363|564342301|FG001|Overall Study|Could not obtain samples|1|||
156340043|NCT04731363|564342302|FG002|Overall Study|Could not obtain samples|0|||
156340044|NCT04731363|564342303|FG003|Overall Study|Could not obtain samples|0|||
156340045|NCT04731363|564342300|FG000|Overall Study|Physician Decision|0|||
156340046|NCT04731363|564342301|FG001|Overall Study|Physician Decision|1|||
156340047|NCT04731363|564342302|FG002|Overall Study|Physician Decision|0|||
156340048|NCT04731363|564342303|FG003|Overall Study|Physician Decision|0|||
156340049|NCT01918774|564344265|FG000|Overall Study|Lost prior to first CBTw session|4|||
156340050|NCT01918774|564344265|FG000|Overall Study|Lost to Follow-up|1|||
156340051|NCT00717197|564344270|FG000|Overall Study|Unable to purchase study drug|5|||
156340052|NCT00717197|564344270|FG000|Overall Study|Tumor Progression|1|||
156340053|NCT00717197|564344270|FG000|Overall Study|Physician Decision|1|||
156340054|NCT00982137|564344271|FG000|Overall Study|Lost to Follow-up|0|||
156340055|NCT00982137|564344272|FG001|Overall Study|Lost to Follow-up|0|||
156340056|NCT00982137|564344273|FG002|Overall Study|Lost to Follow-up|0|||
156340057|NCT00982137|564344274|FG003|Overall Study|Lost to Follow-up|1|||
156340058|NCT00982137|564344271|FG000|Overall Study|Withdrawal by Subject|0|||
156340059|NCT00982137|564344272|FG001|Overall Study|Withdrawal by Subject|1|||
156340060|NCT00982137|564344273|FG002|Overall Study|Withdrawal by Subject|0|||
156340061|NCT00982137|564344274|FG003|Overall Study|Withdrawal by Subject|0|||
156340062|NCT01898806|564344277|FG000|Overall Study|Withdrawal by Subject|2|||
156340063|NCT01898806|564344277|FG000|Overall Study|Physician Decision|1|||
156340064|NCT03003390|564344278|FG000|Overall Study|Physician Decision|2|||
156340065|NCT03003390|564344279|FG001|Overall Study|Physician Decision|0|||
156340066|NCT03003390|564344278|FG000|Overall Study|Parent refused intervention|2|||
156467198|NCT02549352|564805753|FG001|12-month Follow-up|Withdrawal by Subject|5|||
156467199|NCT02549352|564805752|FG000|12-month Follow-up|Lost to Follow-up|3|||
156833520|NCT01443130|566143232|FG001|Overall Study|Adverse Event|1|||
156833521|NCT01443130|566143233|FG002|Overall Study|Adverse Event|1|||
156833522|NCT01443130|566143234|FG003|Overall Study|Adverse Event|0|||
156833523|NCT01443130|566143235|FG004|Overall Study|Adverse Event|0|||
156833524|NCT01443130|566143236|FG005|Overall Study|Adverse Event|0|||
156833525|NCT01443130|566143231|FG000|Overall Study|Protocol Violation|2|||
156833526|NCT01443130|566143232|FG001|Overall Study|Protocol Violation|1|||
156833527|NCT01443130|566143233|FG002|Overall Study|Protocol Violation|3|||
156833528|NCT01443130|566143234|FG003|Overall Study|Protocol Violation|2|||
156833529|NCT01443130|566143235|FG004|Overall Study|Protocol Violation|2|||
156833530|NCT01443130|566143236|FG005|Overall Study|Protocol Violation|3|||
156833531|NCT01443130|566143231|FG000|Overall Study|Withdrawal by Subject|15|||
156833532|NCT01443130|566143232|FG001|Overall Study|Withdrawal by Subject|14|||
156833533|NCT01443130|566143233|FG002|Overall Study|Withdrawal by Subject|12|||
156340067|NCT03003390|564344279|FG001|Overall Study|Parent refused intervention|0|||
156340068|NCT02469298|564344296|FG000|Overall Study|Protocol Violation|0|||
156340069|NCT02469298|564344297|FG001|Overall Study|Protocol Violation|1|||
156340070|NCT02469298|564344298|FG002|Overall Study|Protocol Violation|1|||
156340071|NCT02469298|564344299|FG003|Overall Study|Protocol Violation|0|||
156340072|NCT02469298|564344296|FG000|Overall Study|Lost to Follow-up|1|||
156833534|NCT01443130|566143234|FG003|Overall Study|Withdrawal by Subject|7|||
156833535|NCT01443130|566143235|FG004|Overall Study|Withdrawal by Subject|7|||
156541369|NCT01987960|565074545|FG001|Period 3|Lost to Follow-up|0|||
156833536|NCT01443130|566143236|FG005|Overall Study|Withdrawal by Subject|2|||
156833537|NCT01443130|566143231|FG000|Overall Study|Death of Subject's Infant|5|||
156467200|NCT02549352|564805753|FG001|12-month Follow-up|Lost to Follow-up|2|||
156467201|NCT02549352|564805752|FG000|12-month Follow-up|Death|0|||
156467202|NCT02549352|564805753|FG001|12-month Follow-up|Death|1|||
156467203|NCT02549352|564805752|FG000|12-month Follow-up|Protocol Violation|0|||
156467204|NCT02549352|564805753|FG001|12-month Follow-up|Protocol Violation|1|||
156467205|NCT02549352|564805752|FG000|12-month Follow-up|Other|1|||
156467206|NCT02549352|564805753|FG001|12-month Follow-up|Other|3|||
156467207|NCT04980300|564805754|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
156467208|NCT04980300|564805755|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
156467209|NCT04980300|564805754|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
156467210|NCT04980300|564805755|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
156467211|NCT04980300|564805754|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
156467212|NCT04980300|564805755|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
156467213|NCT04980300|564805754|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
156467214|NCT04980300|564805755|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
156467215|NCT05864209|564806627|FG000|Overall Study|Lost to Follow-up|2|||
156467216|NCT05864209|564806628|FG001|Overall Study|Lost to Follow-up|3|||
156467217|NCT02722434|564806631|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
156833538|NCT01443130|566143232|FG001|Overall Study|Death of Subject's Infant|10|||
156833539|NCT01443130|566143233|FG002|Overall Study|Death of Subject's Infant|11|||
156833540|NCT01443130|566143234|FG003|Overall Study|Death of Subject's Infant|0|||
156833541|NCT01443130|566143235|FG004|Overall Study|Death of Subject's Infant|0|||
156833542|NCT01443130|566143236|FG005|Overall Study|Death of Subject's Infant|0|||
156833543|NCT00364533|566143237|FG000|Overall Study|Adverse Event|8|||
156833544|NCT00364533|566143238|FG001|Overall Study|Adverse Event|7|||
156833545|NCT00364533|566143239|FG002|Overall Study|Adverse Event|15|||
156833546|NCT00364533|566143240|FG003|Overall Study|Adverse Event|5|||
156833547|NCT00364533|566143241|FG004|Overall Study|Adverse Event|2|||
156833548|NCT00364533|566143237|FG000|Overall Study|Withdrawal by Subject|4|||
156833549|NCT00364533|566143238|FG001|Overall Study|Withdrawal by Subject|8|||
156833550|NCT00364533|566143239|FG002|Overall Study|Withdrawal by Subject|6|||
156833551|NCT00364533|566143240|FG003|Overall Study|Withdrawal by Subject|6|||
156833552|NCT00364533|566143241|FG004|Overall Study|Withdrawal by Subject|6|||
156833553|NCT00364533|566143237|FG000|Overall Study|Lack of Efficacy|22|||
156833554|NCT00364533|566143238|FG001|Overall Study|Lack of Efficacy|22|||
156833555|NCT00364533|566143239|FG002|Overall Study|Lack of Efficacy|21|||
156833556|NCT00364533|566143240|FG003|Overall Study|Lack of Efficacy|17|||
156833557|NCT00364533|566143241|FG004|Overall Study|Lack of Efficacy|42|||
156833558|NCT00364533|566143237|FG000|Overall Study|Subject discharged from hospital|4|||
156833559|NCT00364533|566143238|FG001|Overall Study|Subject discharged from hospital|1|||
156833560|NCT00364533|566143239|FG002|Overall Study|Subject discharged from hospital|2|||
156833561|NCT00364533|566143240|FG003|Overall Study|Subject discharged from hospital|3|||
156833562|NCT00364533|566143241|FG004|Overall Study|Subject discharged from hospital|1|||
156833563|NCT00364533|566143237|FG000|Overall Study|Variations in drug compliance|2|||
156833564|NCT00364533|566143238|FG001|Overall Study|Variations in drug compliance|1|||
156833565|NCT00364533|566143239|FG002|Overall Study|Variations in drug compliance|1|||
156833566|NCT00364533|566143240|FG003|Overall Study|Variations in drug compliance|0|||
156833567|NCT00364533|566143241|FG004|Overall Study|Variations in drug compliance|0|||
156833568|NCT00364533|566143237|FG000|Overall Study|Non-compliance|1|||
156833569|NCT00364533|566143238|FG001|Overall Study|Non-compliance|0|||
156833570|NCT00364533|566143239|FG002|Overall Study|Non-compliance|0|||
156833571|NCT00364533|566143240|FG003|Overall Study|Non-compliance|0|||
156833572|NCT00364533|566143241|FG004|Overall Study|Non-compliance|0|||
156833573|NCT00364533|566143237|FG000|Overall Study|Protocol Violation|1|||
156833574|NCT00364533|566143238|FG001|Overall Study|Protocol Violation|1|||
156833575|NCT00364533|566143239|FG002|Overall Study|Protocol Violation|0|||
156833576|NCT00364533|566143240|FG003|Overall Study|Protocol Violation|0|||
156833577|NCT00364533|566143241|FG004|Overall Study|Protocol Violation|0|||
156833578|NCT02639338|566143250|FG000|Overall Study|Lost to Follow-up|2|||
156833579|NCT02639338|566143251|FG001|Overall Study|Lost to Follow-up|2|||
156833580|NCT02639338|566143250|FG000|Overall Study|Withdrew Consent|1|||
156833581|NCT02639338|566143251|FG001|Overall Study|Withdrew Consent|2|||
156833582|NCT02639338|566143250|FG000|Overall Study|Death|1|||
156833583|NCT02639338|566143251|FG001|Overall Study|Death|0|||
156833584|NCT02639338|566143250|FG000|Overall Study|Randomized but Not Treated|0|||
156833585|NCT02639338|566143251|FG001|Overall Study|Randomized but Not Treated|1|||
156833586|NCT00493636|566143252|FG000|Overall Study|Withdrawal by Subject|1|||
156833587|NCT00493636|566143253|FG001|Overall Study|Withdrawal by Subject|0|||
156833588|NCT00493636|566143252|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
156467218|NCT02722434|564806632|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
156467219|NCT02722434|564806631|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
156833589|NCT00493636|566143253|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
156833590|NCT00493636|566143252|FG000|Overall Study|Mis-randomization|1|||
156833591|NCT00493636|566143253|FG001|Overall Study|Mis-randomization|1|||
156833592|NCT02900170|566143255|FG000|Overall Study|Lost to Follow-up|8|||
156833593|NCT02012686|566143260|FG000|Overall Study|muscle contraction|0|||
156833594|NCT02012686|566143261|FG001|Overall Study|muscle contraction|1|||
156833595|NCT02012686|566143260|FG000|Overall Study|electrocardiography monitoring noise|0|||
156833596|NCT02012686|566143261|FG001|Overall Study|electrocardiography monitoring noise|1|||
156833597|NCT01703065|566143264|FG000|Overall Study|Lack of Efficacy|1|||
156833598|NCT01703065|566143265|FG001|Overall Study|Lack of Efficacy|0|||
156833599|NCT02635347|566143266|FG000|Overall Study|Failed screening|20|||
156833600|NCT02635347|566143267|FG001|Overall Study|Failed screening|7|||
156833601|NCT03759041|566143272|FG000|Overall Study|Withdrawal by Subject|4|||
156833602|NCT03759041|566143273|FG001|Overall Study|Withdrawal by Subject|10|||
156833603|NCT03759041|566143274|FG002|Overall Study|Withdrawal by Subject|10|||
156833604|NCT03759041|566143272|FG000|Overall Study|Adverse Event|1|||
156833605|NCT03759041|566143273|FG001|Overall Study|Adverse Event|3|||
156833606|NCT03759041|566143274|FG002|Overall Study|Adverse Event|4|||
156833607|NCT03759041|566143272|FG000|Overall Study|Lack of Efficacy|0|||
156467220|NCT02722434|564806632|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
156467221|NCT04559698|564806633|FG000|Overall Study|Lost to Follow-up|14|||
156467222|NCT04559698|564806634|FG001|Overall Study|Lost to Follow-up|15|||
156467223|NCT04559698|564806633|FG000|Overall Study|Withdrawal by Subject|0|||
156467224|NCT04559698|564806634|FG001|Overall Study|Withdrawal by Subject|1|||
156467225|NCT03437733|564806635|FG000|Overall Study|Eligibility criteria not met|0|||
156467226|NCT03437733|564806636|FG001|Overall Study|Eligibility criteria not met|3|||
156467227|NCT01982682|564806637|FG000|Overall Study|Physician Decision|1|||
156467228|NCT03876457|564806639|FG000|Overall Study|Lost to Follow-up|1|||
156467229|NCT03876457|564806640|FG001|Overall Study|Lost to Follow-up|3|||
156467230|NCT01574716|564806642|FG000|Part 1|Death|3|||
156467231|NCT01574716|564806643|FG001|Part 1|Death|1|||
156467232|NCT01574716|564806644|FG002|Part 1|Death|8|||
156467233|NCT01574716|564806645|FG003|Part 1|Death|0|||
156467234|NCT01574716|564806646|FG004|Part 1|Death|0|||
156467235|NCT01574716|564806642|FG000|Part 1|Discontinuation of study by sponsor|0|||
156467236|NCT01574716|564806643|FG001|Part 1|Discontinuation of study by sponsor|0|||
156467237|NCT01574716|564806644|FG002|Part 1|Discontinuation of study by sponsor|1|||
156467238|NCT01574716|564806645|FG003|Part 1|Discontinuation of study by sponsor|0|||
156467239|NCT01574716|564806646|FG004|Part 1|Discontinuation of study by sponsor|0|||
156467240|NCT01574716|564806642|FG000|Part 1|Withdrawal by Subject|0|||
156467241|NCT01574716|564806643|FG001|Part 1|Withdrawal by Subject|2|||
156467242|NCT01574716|564806644|FG002|Part 1|Withdrawal by Subject|0|||
156467243|NCT01574716|564806645|FG003|Part 1|Withdrawal by Subject|0|||
156340073|NCT02469298|564344297|FG001|Overall Study|Lost to Follow-up|0|||
156467244|NCT01574716|564806646|FG004|Part 1|Withdrawal by Subject|0|||
156467245|NCT01574716|564806642|FG000|Part 1|Lost to Follow-up|0|||
156467246|NCT01574716|564806643|FG001|Part 1|Lost to Follow-up|1|||
156467247|NCT01574716|564806644|FG002|Part 1|Lost to Follow-up|0|||
156467248|NCT01574716|564806645|FG003|Part 1|Lost to Follow-up|0|||
156467249|NCT01574716|564806646|FG004|Part 1|Lost to Follow-up|0|||
156467250|NCT01574716|564806642|FG000|Part 2|Progressive disease|0|||
156467251|NCT01574716|564806643|FG001|Part 2|Progressive disease|0|||
156833608|NCT03759041|566143273|FG001|Overall Study|Lack of Efficacy|0|||
156833609|NCT03759041|566143274|FG002|Overall Study|Lack of Efficacy|1|||
156833610|NCT03759041|566143272|FG000|Overall Study|Study Terminated by Sponsor|15|||
156833611|NCT03759041|566143273|FG001|Overall Study|Study Terminated by Sponsor|16|||
156833612|NCT03759041|566143274|FG002|Overall Study|Study Terminated by Sponsor|10|||
156833613|NCT03759041|566143272|FG000|Overall Study|Other reason for discontinuation|0|||
156467252|NCT01574716|564806644|FG002|Part 2|Progressive disease|0|||
156467253|NCT01574716|564806645|FG003|Part 2|Progressive disease|1|||
156467254|NCT01574716|564806646|FG004|Part 2|Progressive disease|0|||
156467255|NCT01574716|564806642|FG000|Part 2|Death|0|||
156833614|NCT03759041|566143273|FG001|Overall Study|Other reason for discontinuation|2|||
156833615|NCT03759041|566143274|FG002|Overall Study|Other reason for discontinuation|1|||
156833616|NCT03759041|566143272|FG000|Overall Study|Lost to Follow-up|7|||
156833617|NCT03759041|566143273|FG001|Overall Study|Lost to Follow-up|2|||
156833618|NCT03759041|566143274|FG002|Overall Study|Lost to Follow-up|2|||
156833619|NCT03759041|566143272|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
156833620|NCT03759041|566143273|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
156833621|NCT03759041|566143274|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
156833622|NCT02449018|566143275|FG000|Overall Study|Abnormal laboratory value|0|||
156833623|NCT02449018|566143276|FG001|Overall Study|Abnormal laboratory value|1|||
156833624|NCT02449018|566143275|FG000|Overall Study|Administrative problems|1|||
156833625|NCT02449018|566143276|FG001|Overall Study|Administrative problems|0|||
156833626|NCT02449018|566143275|FG000|Overall Study|Adverse Event|5|||
156833627|NCT02449018|566143276|FG001|Overall Study|Adverse Event|1|||
156833628|NCT02449018|566143275|FG000|Overall Study|Protocol deviation|4|||
156833629|NCT02449018|566143276|FG001|Overall Study|Protocol deviation|0|||
156833630|NCT02449018|566143275|FG000|Overall Study|Patient decision|2|||
156833631|NCT02449018|566143276|FG001|Overall Study|Patient decision|0|||
156833632|NCT00525824|566143281|FG000|Overall Study|Adverse Event|7|||
156833633|NCT00525824|566143282|FG001|Overall Study|Adverse Event|11|||
156833634|NCT00525824|566143283|FG002|Overall Study|Adverse Event|6|||
156833635|NCT00525824|566143284|FG003|Overall Study|Adverse Event|7|||
156833636|NCT00525824|566143281|FG000|Overall Study|Withdrawal by Subject|5|||
156833637|NCT00525824|566143282|FG001|Overall Study|Withdrawal by Subject|9|||
156833638|NCT00525824|566143283|FG002|Overall Study|Withdrawal by Subject|3|||
156833639|NCT00525824|566143284|FG003|Overall Study|Withdrawal by Subject|4|||
156833640|NCT00525824|566143281|FG000|Overall Study|Lost to Follow-up|4|||
156833641|NCT00525824|566143282|FG001|Overall Study|Lost to Follow-up|2|||
156833642|NCT00525824|566143283|FG002|Overall Study|Lost to Follow-up|4|||
156833643|NCT00525824|566143284|FG003|Overall Study|Lost to Follow-up|0|||
156833644|NCT00525824|566143281|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
156833645|NCT00525824|566143282|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
156833646|NCT00525824|566143283|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
156833647|NCT00525824|566143284|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
156833648|NCT00525824|566143281|FG000|Overall Study|Severe non-compliance|0|||
156833649|NCT00525824|566143282|FG001|Overall Study|Severe non-compliance|1|||
156833650|NCT00525824|566143283|FG002|Overall Study|Severe non-compliance|1|||
156833651|NCT00525824|566143284|FG003|Overall Study|Severe non-compliance|1|||
156833652|NCT00525824|566143281|FG000|Overall Study|Safety reasons|1|||
156833653|NCT00525824|566143282|FG001|Overall Study|Safety reasons|0|||
156833654|NCT00525824|566143283|FG002|Overall Study|Safety reasons|1|||
156833655|NCT00525824|566143284|FG003|Overall Study|Safety reasons|0|||
156833656|NCT00525824|566143281|FG000|Overall Study|Other|1|||
156833657|NCT00525824|566143282|FG001|Overall Study|Other|3|||
156833658|NCT00525824|566143283|FG002|Overall Study|Other|3|||
156833659|NCT00525824|566143284|FG003|Overall Study|Other|1|||
156833660|NCT05011513|566144358|FG000|Overall Study|Death|0|||
156833661|NCT05011513|566144359|FG001|Overall Study|Death|1|||
156833662|NCT05011513|566144358|FG000|Overall Study|Lost to Follow-up|4|||
156467256|NCT01574716|564806643|FG001|Part 2|Death|0|||
156833663|NCT05011513|566144359|FG001|Overall Study|Lost to Follow-up|0|||
156833664|NCT05011513|566144358|FG000|Overall Study|Withdrawal by Subject|18|||
156833665|NCT05011513|566144359|FG001|Overall Study|Withdrawal by Subject|17|||
156833666|NCT05011513|566144358|FG000|Overall Study|Other|4|||
156833667|NCT05011513|566144359|FG001|Overall Study|Other|2|||
156833668|NCT03495102|566144360|FG000|Overall Study|Adverse Event|5|||
156833669|NCT03495102|566144361|FG001|Overall Study|Adverse Event|7|||
156833670|NCT03495102|566144362|FG002|Overall Study|Adverse Event|10|||
156833671|NCT03495102|566144360|FG000|Overall Study|Death|3|||
156833672|NCT03495102|566144361|FG001|Overall Study|Death|4|||
156833673|NCT03495102|566144362|FG002|Overall Study|Death|4|||
156833674|NCT03495102|566144360|FG000|Overall Study|Lost to Follow-up|15|||
156467257|NCT01574716|564806644|FG002|Part 2|Death|0|||
156467258|NCT01574716|564806645|FG003|Part 2|Death|76|||
156467259|NCT01574716|564806646|FG004|Part 2|Death|35|||
156833675|NCT03495102|566144361|FG001|Overall Study|Lost to Follow-up|16|||
156833676|NCT03495102|566144362|FG002|Overall Study|Lost to Follow-up|17|||
156833677|NCT03495102|566144360|FG000|Overall Study|Physician Decision|2|||
156833678|NCT03495102|566144361|FG001|Overall Study|Physician Decision|0|||
156833679|NCT03495102|566144362|FG002|Overall Study|Physician Decision|2|||
156833680|NCT03495102|566144360|FG000|Overall Study|Withdrawal by Subject|25|||
156467260|NCT01574716|564806642|FG000|Part 2|Discontinuation of study by sponsor|0|||
156467261|NCT01574716|564806643|FG001|Part 2|Discontinuation of study by sponsor|0|||
156467262|NCT01574716|564806644|FG002|Part 2|Discontinuation of study by sponsor|0|||
156467263|NCT01574716|564806645|FG003|Part 2|Discontinuation of study by sponsor|51|||
156467264|NCT01574716|564806646|FG004|Part 2|Discontinuation of study by sponsor|31|||
156467265|NCT01574716|564806642|FG000|Part 2|Withdrawal by Subject|0|||
156467266|NCT01574716|564806643|FG001|Part 2|Withdrawal by Subject|0|||
156467267|NCT01574716|564806644|FG002|Part 2|Withdrawal by Subject|0|||
156467268|NCT01574716|564806645|FG003|Part 2|Withdrawal by Subject|5|||
156467269|NCT01574716|564806646|FG004|Part 2|Withdrawal by Subject|4|||
156467270|NCT01574716|564806642|FG000|Part 2|Brain metastases|0|||
156467271|NCT01574716|564806643|FG001|Part 2|Brain metastases|0|||
156467272|NCT01574716|564806644|FG002|Part 2|Brain metastases|0|||
156467273|NCT01574716|564806645|FG003|Part 2|Brain metastases|1|||
156467274|NCT01574716|564806646|FG004|Part 2|Brain metastases|0|||
156467275|NCT01574716|564806642|FG000|Part 2|Lost to Follow-up|0|||
156467276|NCT01574716|564806643|FG001|Part 2|Lost to Follow-up|0|||
156467277|NCT01574716|564806644|FG002|Part 2|Lost to Follow-up|0|||
156467278|NCT01574716|564806645|FG003|Part 2|Lost to Follow-up|3|||
156467279|NCT01574716|564806646|FG004|Part 2|Lost to Follow-up|0|||
156467280|NCT00945321|564806647|FG000|Period 1|Adverse Event|0|||
156467281|NCT00945321|564806648|FG001|Period 1|Adverse Event|0|||
156467282|NCT00945321|564806649|FG002|Period 1|Adverse Event|0|||
156467283|NCT00945321|564806650|FG003|Period 1|Adverse Event|0|||
156467284|NCT00945321|564806651|FG004|Period 1|Adverse Event|1|||
156467285|NCT00945321|564806652|FG005|Period 1|Adverse Event|0|||
156467286|NCT00945321|564806647|FG000|Period 4|Lost to Follow-up|0|||
156467287|NCT00945321|564806648|FG001|Period 4|Lost to Follow-up|0|||
156833681|NCT03495102|566144361|FG001|Overall Study|Withdrawal by Subject|36|||
156833682|NCT03495102|566144362|FG002|Overall Study|Withdrawal by Subject|18|||
156833683|NCT03495102|566144360|FG000|Overall Study|Protocol Violation|1|||
156833684|NCT03495102|566144361|FG001|Overall Study|Protocol Violation|1|||
156833685|NCT03495102|566144362|FG002|Overall Study|Protocol Violation|0|||
156833686|NCT03495102|566144360|FG000|Overall Study|Site Closure|3|||
156833687|NCT03495102|566144361|FG001|Overall Study|Site Closure|1|||
156833688|NCT03495102|566144362|FG002|Overall Study|Site Closure|2|||
156833689|NCT03495102|566144360|FG000|Overall Study|Non-compliance|1|||
156833690|NCT03495102|566144361|FG001|Overall Study|Non-compliance|0|||
156833691|NCT03495102|566144362|FG002|Overall Study|Non-compliance|0|||
156833692|NCT03495102|566144360|FG000|Overall Study|Participant Duplicated at Another Site|0|||
156833693|NCT03495102|566144361|FG001|Overall Study|Participant Duplicated at Another Site|0|||
156833694|NCT03495102|566144362|FG002|Overall Study|Participant Duplicated at Another Site|1|||
156833695|NCT03495102|566144360|FG000|Overall Study|Primary Care Physician Recommendation|0|||
156833696|NCT03495102|566144361|FG001|Overall Study|Primary Care Physician Recommendation|1|||
156833697|NCT03495102|566144362|FG002|Overall Study|Primary Care Physician Recommendation|0|||
156833698|NCT03495102|566144360|FG000|Overall Study|Relocated to Another Country|0|||
156833699|NCT03495102|566144361|FG001|Overall Study|Relocated to Another Country|1|||
156833700|NCT03495102|566144362|FG002|Overall Study|Relocated to Another Country|0|||
156833701|NCT03495102|566144360|FG000|Overall Study|Participant was in Rehabilitation|1|||
156833702|NCT03495102|566144361|FG001|Overall Study|Participant was in Rehabilitation|0|||
156833703|NCT03495102|566144362|FG002|Overall Study|Participant was in Rehabilitation|0|||
156833704|NCT01161537|566144365|FG000|Part B|Withdrawal by Subject|2|||
156833705|NCT00358436|566144368|FG000|Overall Study|Adverse Event|29|||
156833706|NCT00358436|566144369|FG001|Overall Study|Adverse Event|13|||
156833707|NCT00358436|566144368|FG000|Overall Study|Lack of Efficacy|34|||
156833708|NCT00358436|566144369|FG001|Overall Study|Lack of Efficacy|36|||
156833709|NCT00358436|566144368|FG000|Overall Study|Lost to Follow-up|11|||
156833710|NCT00358436|566144369|FG001|Overall Study|Lost to Follow-up|6|||
156833711|NCT00358436|566144368|FG000|Overall Study|Protocol Violation|8|||
156833712|NCT00358436|566144369|FG001|Overall Study|Protocol Violation|3|||
156833713|NCT00358436|566144368|FG000|Overall Study|Withdrawal by Subject|40|||
156833714|NCT00358436|566144369|FG001|Overall Study|Withdrawal by Subject|17|||
156833715|NCT00358436|566144368|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
156833716|NCT00358436|566144369|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
156833717|NCT00358436|566144368|FG000|Overall Study|COPD exacerbation|22|||
156833718|NCT00358436|566144369|FG001|Overall Study|COPD exacerbation|10|||
156833719|NCT00358436|566144368|FG000|Overall Study|Other|6|||
156467288|NCT00945321|564806649|FG002|Period 4|Lost to Follow-up|0|||
156467289|NCT00945321|564806650|FG003|Period 4|Lost to Follow-up|0|||
156467290|NCT00945321|564806651|FG004|Period 4|Lost to Follow-up|0|||
156467291|NCT00945321|564806652|FG005|Period 4|Lost to Follow-up|1|||
156467292|NCT00605306|564806654|FG000|Overall Study|Adverse Event|0|||
156467293|NCT00605306|564806655|FG001|Overall Study|Adverse Event|1|||
156467294|NCT01750684|564806656|FG000|Overall Study|Death|1|||
156467295|NCT01750684|564806657|FG001|Overall Study|Death|0|||
156467296|NCT01750684|564806656|FG000|Overall Study|Non-compliance with Study Drug|0|||
156833720|NCT00358436|566144369|FG001|Overall Study|Other|1|||
156833721|NCT01286077|566144372|FG000|Overall Study|Adverse Event|2|||
156833722|NCT01286077|566144373|FG001|Overall Study|Adverse Event|0|||
156833723|NCT01286077|566144372|FG000|Overall Study|Death|1|||
156833724|NCT01286077|566144373|FG001|Overall Study|Death|0|||
156833725|NCT01286077|566144372|FG000|Overall Study|Protocol Violation|1|||
156833726|NCT01286077|566144373|FG001|Overall Study|Protocol Violation|1|||
156833727|NCT01286077|566144372|FG000|Overall Study|Withdrawal by Subject|0|||
156833728|NCT01286077|566144373|FG001|Overall Study|Withdrawal by Subject|2|||
156833729|NCT01286077|566144372|FG000|Overall Study|Intercurrent illness|1|||
156833730|NCT01286077|566144373|FG001|Overall Study|Intercurrent illness|0|||
156833731|NCT01286077|566144372|FG000|Overall Study|Non-compliance|1|||
156833732|NCT01286077|566144373|FG001|Overall Study|Non-compliance|0|||
156833733|NCT01286077|566144372|FG000|Overall Study|The subject starts with alternative MMY|0|||
156833734|NCT01286077|566144373|FG001|Overall Study|The subject starts with alternative MMY|3|||
156833735|NCT01286077|566144372|FG000|Overall Study|Patient's decision to stop treatment|3|||
156833736|NCT01286077|566144373|FG001|Overall Study|Patient's decision to stop treatment|0|||
156833737|NCT01286077|566144372|FG000|Overall Study|Progression of disease|0|||
156833738|NCT01286077|566144373|FG001|Overall Study|Progression of disease|1|||
156833739|NCT01286077|566144372|FG000|Overall Study|refill medication not received in time|1|||
156833740|NCT01286077|566144373|FG001|Overall Study|refill medication not received in time|0|||
156833741|NCT02654236|566144374|FG000|Overall Study|Withdrawal by Subject|0|||
156833742|NCT02654236|566144375|FG001|Overall Study|Withdrawal by Subject|0|||
156833743|NCT02654236|566144376|FG002|Overall Study|Withdrawal by Subject|2|||
156833744|NCT01549873|566144377|FG000|Overall Study|Physician Decision|0|||
156833745|NCT01549873|566144378|FG001|Overall Study|Physician Decision|1|||
156833746|NCT00701805|566144379|FG000|Overall Study|Withdrawal by Subject|3|||
156833747|NCT00701805|566144380|FG001|Overall Study|Withdrawal by Subject|1|||
156833748|NCT00701805|566144381|FG002|Overall Study|Withdrawal by Subject|4|||
156833749|NCT00701805|566144382|FG003|Overall Study|Withdrawal by Subject|3|||
156833750|NCT00701805|566144379|FG000|Overall Study|Adverse Event|0|||
156833751|NCT00701805|566144380|FG001|Overall Study|Adverse Event|1|||
156833752|NCT00701805|566144381|FG002|Overall Study|Adverse Event|1|||
156833753|NCT00701805|566144382|FG003|Overall Study|Adverse Event|0|||
156833754|NCT00701805|566144379|FG000|Overall Study|Missed 7 consecutive doses|0|||
156833755|NCT00701805|566144380|FG001|Overall Study|Missed 7 consecutive doses|1|||
156833756|NCT00701805|566144381|FG002|Overall Study|Missed 7 consecutive doses|0|||
156833757|NCT00701805|566144382|FG003|Overall Study|Missed 7 consecutive doses|0|||
156833758|NCT00701805|566144379|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
156833759|NCT00701805|566144380|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
156833760|NCT00701805|566144381|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
156833761|NCT00701805|566144382|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
156833762|NCT00701805|566144379|FG000|Overall Study|Physician decision, change of therapy|0|||
156833763|NCT00701805|566144380|FG001|Overall Study|Physician decision, change of therapy|0|||
156833764|NCT00701805|566144381|FG002|Overall Study|Physician decision, change of therapy|0|||
156833765|NCT00701805|566144382|FG003|Overall Study|Physician decision, change of therapy|1|||
156833766|NCT00701805|566144379|FG000|Overall Study|Difficult to travel to dialysis site|0|||
156833767|NCT00701805|566144380|FG001|Overall Study|Difficult to travel to dialysis site|0|||
156833768|NCT00701805|566144381|FG002|Overall Study|Difficult to travel to dialysis site|1|||
156833769|NCT00701805|566144382|FG003|Overall Study|Difficult to travel to dialysis site|0|||
156833770|NCT00701805|566144379|FG000|Overall Study|Resumption criteria were not met|0|||
156833771|NCT00701805|566144380|FG001|Overall Study|Resumption criteria were not met|1|||
156833772|NCT00701805|566144381|FG002|Overall Study|Resumption criteria were not met|0|||
156833773|NCT00701805|566144382|FG003|Overall Study|Resumption criteria were not met|0|||
156833774|NCT04435600|566144388|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833775|NCT04435600|566144389|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833776|NCT04435600|566144390|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
156833777|NCT04435600|566144391|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833778|NCT04435600|566144392|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833779|NCT04435600|566144393|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833780|NCT04435600|566144394|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833781|NCT04435600|566144395|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833782|NCT04435600|566144396|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833783|NCT04435600|566144397|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833784|NCT04435600|566144388|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833785|NCT04435600|566144389|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833786|NCT04435600|566144390|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833787|NCT04435600|566144391|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833788|NCT04435600|566144392|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833789|NCT04435600|566144393|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833790|NCT04435600|566144394|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833791|NCT04435600|566144395|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833792|NCT04435600|566144396|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833793|NCT04435600|566144397|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
156833794|NCT04435600|566144388|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833795|NCT04435600|566144389|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833796|NCT04435600|566144390|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833797|NCT04435600|566144391|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833798|NCT04435600|566144392|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833799|NCT04435600|566144393|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833800|NCT04435600|566144394|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833801|NCT04435600|566144395|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833802|NCT04435600|566144396|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833803|NCT04435600|566144397|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
156467297|NCT01750684|564806657|FG001|Overall Study|Non-compliance with Study Drug|1|||
156467298|NCT01750684|564806656|FG000|Overall Study|Withdrawn by Sponsor|0|||
156467299|NCT01750684|564806657|FG001|Overall Study|Withdrawn by Sponsor|1|||
156467300|NCT01750684|564806656|FG000|Overall Study|Protocol Violation|1|||
156467301|NCT01750684|564806657|FG001|Overall Study|Protocol Violation|0|||
156467302|NCT02185794|564806659|FG000|Overall Study|Enrolled but Never Dosed|1|||
156467303|NCT02185794|564806660|FG001|Overall Study|Enrolled but Never Dosed|6|||
156467304|NCT02185794|564806661|FG002|Overall Study|Enrolled but Never Dosed|3|||
156467305|NCT02185794|564806662|FG003|Overall Study|Enrolled but Never Dosed|1|||
156467306|NCT02185794|564806663|FG004|Overall Study|Enrolled but Never Dosed|1|||
156833804|NCT04435600|566144388|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833805|NCT04435600|566144389|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833806|NCT04435600|566144390|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833807|NCT04435600|566144391|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833808|NCT04435600|566144392|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833809|NCT04435600|566144393|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833810|NCT04435600|566144394|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833811|NCT04435600|566144395|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833812|NCT04435600|566144396|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833813|NCT04435600|566144397|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
156833814|NCT02797184|566144398|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
156833815|NCT02797184|566144399|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
156833816|NCT00673881|566144411|FG000|Overall Study|Withdrawal by Subject|1|||
156833817|NCT03968159|566144414|FG000|Overall Study|Adverse Event|4|||
156340074|NCT02469298|564344298|FG002|Overall Study|Lost to Follow-up|1|||
156833818|NCT03968159|566144415|FG001|Overall Study|Adverse Event|4|||
156467307|NCT02185794|564806664|FG005|Overall Study|Enrolled but Never Dosed|0|||
156467308|NCT02185794|564806659|FG000|Overall Study|Investigator's Discretion|1|||
156833819|NCT03968159|566144414|FG000|Overall Study|Lost to Follow-up|1|||
156833820|NCT03968159|566144415|FG001|Overall Study|Lost to Follow-up|1|||
156833821|NCT03968159|566144414|FG000|Overall Study|Use of prohibited medication|0|||
156833822|NCT03968159|566144415|FG001|Overall Study|Use of prohibited medication|1|||
156833823|NCT03968159|566144414|FG000|Overall Study|Protocol Violation|2|||
156833824|NCT03968159|566144415|FG001|Overall Study|Protocol Violation|2|||
156833825|NCT03968159|566144414|FG000|Overall Study|Withdrawal by Subject|4|||
156833826|NCT03968159|566144415|FG001|Overall Study|Withdrawal by Subject|6|||
156833827|NCT03968159|566144414|FG000|Overall Study|Lack of Efficacy|0|||
156833828|NCT03968159|566144415|FG001|Overall Study|Lack of Efficacy|1|||
156833829|NCT03968159|566144414|FG000|Overall Study|Not further specified|2|||
156833830|NCT03968159|566144415|FG001|Overall Study|Not further specified|0|||
156833831|NCT01299571|566144418|FG000|Overall Study|Protocol Violation|107|||
156833832|NCT02258529|566144419|FG000|Overall Study|Study Terminated by Sponsor|9|||
156833833|NCT02258529|566144419|FG000|Overall Study|Adverse Event|1|||
156833834|NCT00443781|566144420|FG000|Overall Study|Lost to Follow-up|10|||
156833835|NCT00443781|566144420|FG000|Overall Study|Physician Decision|2|||
156833836|NCT00443781|566144420|FG000|Overall Study|Protocol Violation|1|||
156833837|NCT00443781|566144420|FG000|Overall Study|Withdrawal by Subject|6|||
156833838|NCT00443781|566144420|FG000|Overall Study|Unable to comply with study follow up|2|||
156833839|NCT00443781|566144420|FG000|Overall Study|Investigator terminated participation|1|||
156833840|NCT00443781|566144420|FG000|Overall Study|Insurance not covered|2|||
156833841|NCT00443781|566144420|FG000|Overall Study|PD/FAD not done|1|||
156833842|NCT00430937|566144421|FG000|Overall Study|Adverse Event|3|||
156833843|NCT00430937|566144422|FG001|Overall Study|Adverse Event|8|||
156833844|NCT00430937|566144421|FG000|Overall Study|Death|0|||
156833845|NCT00430937|566144422|FG001|Overall Study|Death|1|||
156833846|NCT00430937|566144421|FG000|Overall Study|Lost to Follow-up|6|||
156833847|NCT00430937|566144422|FG001|Overall Study|Lost to Follow-up|6|||
156833848|NCT00430937|566144421|FG000|Overall Study|Withdrawal by Subject|5|||
156833849|NCT00430937|566144422|FG001|Overall Study|Withdrawal by Subject|2|||
156833850|NCT00430937|566144421|FG000|Overall Study|Protocol Violation|3|||
156833851|NCT00430937|566144422|FG001|Overall Study|Protocol Violation|2|||
156833852|NCT00430937|566144421|FG000|Overall Study|Lack of Efficacy|6|||
156833853|NCT00430937|566144422|FG001|Overall Study|Lack of Efficacy|5|||
156833854|NCT00430937|566144421|FG000|Overall Study|Inappropriate enrollment|2|||
156833855|NCT00430937|566144422|FG001|Overall Study|Inappropriate enrollment|1|||
156833856|NCT00430937|566144421|FG000|Overall Study|Administrative reasons|1|||
156833857|NCT00430937|566144422|FG001|Overall Study|Administrative reasons|0|||
156833858|NCT00430937|566144421|FG000|Overall Study|Protocol discontinuation criteria met|1|||
156833859|NCT00430937|566144422|FG001|Overall Study|Protocol discontinuation criteria met|2|||
156833860|NCT00430937|566144421|FG000|Overall Study|Unable to classify|0|||
156833861|NCT00430937|566144422|FG001|Overall Study|Unable to classify|1|||
156833862|NCT01515475|566144426|FG000|Overall Study|Lost to Follow-up|20|||
156833863|NCT01515475|566144427|FG001|Overall Study|Lost to Follow-up|15|||
156833864|NCT01515475|566144428|FG002|Overall Study|Lost to Follow-up|12|||
156833865|NCT01515475|566144429|FG003|Overall Study|Lost to Follow-up|12|||
156833866|NCT02066129|566144430|FG000|Overall Study|Lost to Follow-up|13|||
156833867|NCT02066129|566144431|FG001|Overall Study|Lost to Follow-up|12|||
156833868|NCT02066129|566144430|FG000|Overall Study|Withdrawal by Subject|7|||
156833869|NCT02066129|566144431|FG001|Overall Study|Withdrawal by Subject|10|||
156833870|NCT02066129|566144430|FG000|Overall Study|Lack of Efficacy|8|||
156833871|NCT02066129|566144431|FG001|Overall Study|Lack of Efficacy|10|||
156833872|NCT02066129|566144430|FG000|Overall Study|Physician Decision|1|||
156833873|NCT02066129|566144431|FG001|Overall Study|Physician Decision|1|||
156833874|NCT02642965|566144432|FG000|Overall Study|Lack of Efficacy|4|||
156833875|NCT02642965|566144432|FG000|Overall Study|Physician Decision|9|||
156833876|NCT01814670|566144438|FG000|Overall Study|Protocol Violation|12|||
156833877|NCT00973102|566144439|FG000|Overall Study|Protocol Violation|1|||
156833878|NCT00973102|566144440|FG001|Overall Study|Protocol Violation|0|||
156833879|NCT00973102|566144439|FG000|Overall Study|Prisoner|0|||
156833880|NCT00973102|566144440|FG001|Overall Study|Prisoner|1|||
156833881|NCT02360293|566144441|FG000|Overall Study|Lost to Follow-up|73|||
156833882|NCT02360293|566144442|FG001|Overall Study|Lost to Follow-up|95|||
156833883|NCT02360293|566144441|FG000|Overall Study|Withdrawal by Subject|2|||
156833884|NCT02360293|566144442|FG001|Overall Study|Withdrawal by Subject|1|||
156833885|NCT02360293|566144441|FG000|Overall Study|Excluded|1|||
156833886|NCT02360293|566144442|FG001|Overall Study|Excluded|0|||
156833887|NCT00966719|566144443|FG000|Overall Study|Lost to Follow-up|6|||
156833888|NCT00966719|566144444|FG001|Overall Study|Lost to Follow-up|11|||
156833889|NCT03242018|566144445|FG000|Overall Study|Adverse Event|7|||
156833890|NCT03242018|566144446|FG001|Overall Study|Adverse Event|7|||
156833891|NCT03242018|566144447|FG002|Overall Study|Adverse Event|6|||
156833892|NCT03242018|566144445|FG000|Overall Study|Lost to Follow-up|2|||
156833893|NCT03242018|566144446|FG001|Overall Study|Lost to Follow-up|2|||
156833894|NCT03242018|566144447|FG002|Overall Study|Lost to Follow-up|2|||
156833895|NCT03242018|566144445|FG000|Overall Study|At the Participant's Own Request|5|||
156833896|NCT03242018|566144446|FG001|Overall Study|At the Participant's Own Request|1|||
156833897|NCT03242018|566144447|FG002|Overall Study|At the Participant's Own Request|4|||
156833898|NCT03242018|566144445|FG000|Overall Study|Reason Not Specified|3|||
156833899|NCT03242018|566144446|FG001|Overall Study|Reason Not Specified|4|||
156833900|NCT03242018|566144447|FG002|Overall Study|Reason Not Specified|1|||
156833901|NCT03242018|566144445|FG000|Overall Study|Study Terminated by Sponsor|1|||
156833902|NCT03242018|566144446|FG001|Overall Study|Study Terminated by Sponsor|0|||
156833903|NCT03242018|566144447|FG002|Overall Study|Study Terminated by Sponsor|1|||
156833904|NCT00687609|566144449|FG000|Overall Study|Physician Decision|1|||
156833905|NCT00687609|566144449|FG000|Overall Study|Withdrawal by Subject|2|||
156833906|NCT00160199|566144450|FG000|Overall Study|Adverse Event|5|||
156833907|NCT00160199|566144451|FG001|Overall Study|Adverse Event|14|||
156833908|NCT00160199|566144450|FG000|Overall Study|Lack of Efficacy|0|||
156833909|NCT00160199|566144451|FG001|Overall Study|Lack of Efficacy|1|||
156833910|NCT00160199|566144450|FG000|Overall Study|Lost to Follow-up|7|||
156833911|NCT00160199|566144451|FG001|Overall Study|Lost to Follow-up|7|||
156833912|NCT00160199|566144450|FG000|Overall Study|Withdrawal by Subject|4|||
156833913|NCT00160199|566144451|FG001|Overall Study|Withdrawal by Subject|6|||
156833914|NCT00160199|566144450|FG000|Overall Study|Administrative|0|||
156833915|NCT00160199|566144451|FG001|Overall Study|Administrative|1|||
156833916|NCT00160199|566144450|FG000|Overall Study|Protocol Violation|8|||
156833917|NCT00160199|566144451|FG001|Overall Study|Protocol Violation|8|||
156833918|NCT03089944|566144452|FG000|Overall Study|Lost to Follow-up|8|||
156833919|NCT03089944|566144452|FG000|Overall Study|Withdrew Consent|2|||
156833920|NCT03089944|566144452|FG000|Overall Study|Adverse Event|1|||
156833921|NCT03089944|566144452|FG000|Overall Study|Other|1|||
156833922|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
156833923|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
156833924|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
156833925|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
156833926|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
156833927|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
156833928|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
156833929|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
156833930|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
156833931|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
156833932|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
156833933|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
156833934|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
156833935|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
156833936|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
156833937|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
156833938|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
156833939|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
156833940|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
156833941|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
156833942|NCT03689244|566144453|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
156833943|NCT03689244|566144454|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
156833944|NCT03689244|566144455|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
156833945|NCT03689244|566144456|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
156833946|NCT03689244|566144453|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
156833947|NCT03689244|566144454|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
156833948|NCT03689244|566144455|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
156833949|NCT03689244|566144456|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
156833950|NCT03689244|566144453|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
156833951|NCT03689244|566144454|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
156833952|NCT03689244|566144455|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
156833953|NCT03689244|566144456|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
156833954|NCT02308488|566144459|FG000|Overall Study|Withdrawal by Subject|2|||
156833955|NCT01541917|566144460|FG000|Overall Study|Lost to Follow-up|2|||
156833956|NCT01541917|566144461|FG001|Overall Study|Lost to Follow-up|2|||
156833957|NCT01541917|566144460|FG000|Overall Study|Withdrawal by Subject|13|||
156833958|NCT01541917|566144461|FG001|Overall Study|Withdrawal by Subject|7|||
156833959|NCT01739803|566144462|FG000|Overall Study|Lost to Follow-up|9|||
156833960|NCT01739803|566144463|FG001|Overall Study|Lost to Follow-up|6|||
156833961|NCT01565564|566144470|FG000|Overall Study|Lost to Follow-up|5|||
156833962|NCT01565564|566144471|FG001|Overall Study|Lost to Follow-up|1|||
156833963|NCT00969436|566144473|FG000|Overall Study|Protocol Violation|1|||
156833964|NCT00969436|566144474|FG001|Overall Study|Protocol Violation|3|||
156833965|NCT00969436|566144475|FG002|Overall Study|Protocol Violation|0|||
156833966|NCT00969436|566144473|FG000|Overall Study|Migrated/moved from study area|12|||
156833967|NCT00969436|566144474|FG001|Overall Study|Migrated/moved from study area|10|||
156833968|NCT00969436|566144475|FG002|Overall Study|Migrated/moved from study area|2|||
156833969|NCT00969436|566144473|FG000|Overall Study|Father - serious health problem|0|||
156833970|NCT00969436|566144474|FG001|Overall Study|Father - serious health problem|0|||
156833971|NCT00969436|566144475|FG002|Overall Study|Father - serious health problem|1|||
156833972|NCT00969436|566144473|FG000|Overall Study|Parents personal problem|0|||
156833973|NCT00969436|566144474|FG001|Overall Study|Parents personal problem|0|||
156833974|NCT00969436|566144475|FG002|Overall Study|Parents personal problem|1|||
156833975|NCT00969436|566144473|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
156833976|NCT00969436|566144474|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
156833977|NCT00969436|566144475|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
156833978|NCT00969436|566144473|FG000|Overall Study|Withdrawal by Subject|3|||
156833979|NCT00969436|566144474|FG001|Overall Study|Withdrawal by Subject|0|||
156833980|NCT00969436|566144475|FG002|Overall Study|Withdrawal by Subject|2|||
156833981|NCT00969436|566144473|FG000|Overall Study|Lost to Follow-up|8|||
156833982|NCT00969436|566144474|FG001|Overall Study|Lost to Follow-up|8|||
156833983|NCT00969436|566144475|FG002|Overall Study|Lost to Follow-up|5|||
156833984|NCT02544373|566144478|FG000|Overall Study|Lost to Follow-up|5|||
156833985|NCT02544373|566144479|FG001|Overall Study|Lost to Follow-up|3|||
156833986|NCT02544373|566144478|FG000|Overall Study|Withdrawal by Subject|8|||
156833987|NCT02544373|566144479|FG001|Overall Study|Withdrawal by Subject|2|||
156833988|NCT03667690|566145602|FG000|Overall Study|Adverse Event|0|||
156833989|NCT03667690|566145603|FG001|Overall Study|Adverse Event|3|||
156833990|NCT03667690|566145602|FG000|Overall Study|Death|22|||
156833991|NCT03667690|566145603|FG001|Overall Study|Death|21|||
156833992|NCT03667690|566145602|FG000|Overall Study|Lost to Follow-up|4|||
156833993|NCT03667690|566145603|FG001|Overall Study|Lost to Follow-up|5|||
156833994|NCT03667690|566145602|FG000|Overall Study|Withdrawal by Subject|7|||
156833995|NCT03667690|566145603|FG001|Overall Study|Withdrawal by Subject|8|||
156833996|NCT03667690|566145602|FG000|Overall Study|Subject could not return for additional investigational product|1|||
156833997|NCT03667690|566145603|FG001|Overall Study|Subject could not return for additional investigational product|0|||
156833998|NCT03667690|566145602|FG000|Overall Study|Subject discharged to hospice care|2|||
156833999|NCT03667690|566145603|FG001|Overall Study|Subject discharged to hospice care|0|||
156834000|NCT03667690|566145602|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
156834001|NCT03667690|566145603|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
156834002|NCT03667690|566145602|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
156834003|NCT03667690|566145603|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
156834004|NCT03667690|566145602|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
156834005|NCT03667690|566145603|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
156834006|NCT03667690|566145602|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
156834007|NCT03667690|566145603|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
156834008|NCT03667690|566145602|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
156834009|NCT03667690|566145603|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
156834010|NCT01350115|566145607|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
156834011|NCT01350115|566145608|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
156834012|NCT01350115|566145607|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
156834013|NCT01350115|566145608|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
156834014|NCT01350115|566145607|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
156834015|NCT01350115|566145608|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
156834016|NCT04327024|566145609|FG000|Overall Study|Death|1|||
156834017|NCT04327024|566145610|FG001|Overall Study|Death|2|||
156834018|NCT04327024|566145611|FG002|Overall Study|Death|1|||
156834019|NCT04327024|566145609|FG000|Overall Study|Non-compliance with study drug|0|||
156834020|NCT04327024|566145610|FG001|Overall Study|Non-compliance with study drug|1|||
156834021|NCT04327024|566145611|FG002|Overall Study|Non-compliance with study drug|0|||
156834022|NCT04327024|566145609|FG000|Overall Study|Withdrawal by Subject|1|||
156834023|NCT04327024|566145610|FG001|Overall Study|Withdrawal by Subject|1|||
156834024|NCT04327024|566145611|FG002|Overall Study|Withdrawal by Subject|2|||
156834025|NCT00837759|566145615|FG000|Overall Study|Protocol Violation|3|||
156834026|NCT00837759|566145615|FG000|Overall Study|Lost to Follow-up|1|||
156834027|NCT01597635|566145616|FG000|Part A|Adverse Event|3|||
156834028|NCT01597635|566145617|FG001|Part A|Adverse Event|0|||
156834029|NCT01597635|566145618|FG002|Part A|Adverse Event|0|||
156834030|NCT01597635|566145616|FG000|Part B|Adverse Event|0|||
156834031|NCT01597635|566145617|FG001|Part B|Adverse Event|0|||
156834032|NCT01597635|566145618|FG002|Part B|Adverse Event|1|||
156834033|NCT01597635|566145616|FG000|Part B|Protocol Violation|0|||
156834034|NCT01597635|566145617|FG001|Part B|Protocol Violation|1|||
156834035|NCT01597635|566145618|FG002|Part B|Protocol Violation|0|||
156834036|NCT01597635|566145616|FG000|Part B|Protocol-defined stopping criteria|0|||
156834037|NCT01597635|566145617|FG001|Part B|Protocol-defined stopping criteria|4|||
156834038|NCT01597635|566145618|FG002|Part B|Protocol-defined stopping criteria|3|||
156834039|NCT01597635|566145616|FG000|Part B|Withdrawal by Subject|0|||
156834040|NCT01597635|566145617|FG001|Part B|Withdrawal by Subject|1|||
156834041|NCT01597635|566145618|FG002|Part B|Withdrawal by Subject|0|||
156834042|NCT01073930|566145619|FG000|Overall Study|Withdrawal by Subject|3|||
156834043|NCT01073930|566145620|FG001|Overall Study|Withdrawal by Subject|2|||
156834044|NCT01073930|566145619|FG000|Overall Study|Lost to Follow-up|0|||
156834045|NCT01073930|566145620|FG001|Overall Study|Lost to Follow-up|1|||
156834046|NCT01073930|566145619|FG000|Overall Study|Adverse Event|0|||
156834047|NCT01073930|566145620|FG001|Overall Study|Adverse Event|1|||
156834048|NCT01073930|566145619|FG000|Overall Study|Noncompliance with study drug|0|||
156834049|NCT01073930|566145620|FG001|Overall Study|Noncompliance with study drug|1|||
156834050|NCT01073930|566145619|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
156541370|NCT01987960|565074546|FG002|Period 3|Lost to Follow-up|0|||
156541371|NCT01987960|565074547|FG003|Period 3|Lost to Follow-up|5|||
156541372|NCT01987960|565074544|FG000|Period 3|Administrative or other reason|0|||
156541373|NCT01987960|565074545|FG001|Period 3|Administrative or other reason|0|||
156541374|NCT01987960|565074546|FG002|Period 3|Administrative or other reason|0|||
156541375|NCT01987960|565074547|FG003|Period 3|Administrative or other reason|43|||
156541376|NCT04085523|565074553|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
156541377|NCT04085523|565074554|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
156541378|NCT04085523|565074555|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
156541379|NCT04085523|565074556|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
156541380|NCT04085523|565074557|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
156541381|NCT04085523|565074558|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
156541382|NCT04722042|565074559|FG000|Overall Study|Withdrawal by Subject|2|||
156541383|NCT04722042|565074560|FG001|Overall Study|Withdrawal by Subject|1|||
156541384|NCT04722042|565074561|FG002|Overall Study|Withdrawal by Subject|0|||
156541385|NCT02046096|565074562|FG000|Overall Study|Death|28|||
156541386|NCT02046096|565074563|FG001|Overall Study|Death|45|||
156541387|NCT02046096|565074562|FG000|Overall Study|Lost to Follow-up|9|||
156541388|NCT02046096|565074563|FG001|Overall Study|Lost to Follow-up|20|||
156541389|NCT02046096|565074562|FG000|Overall Study|Withdrawal by Subject|5|||
156541390|NCT02046096|565074563|FG001|Overall Study|Withdrawal by Subject|17|||
156834051|NCT01073930|566145620|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
156834052|NCT01192568|566145621|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
156834053|NCT01192568|566145622|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
156834054|NCT01192568|566145623|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
156834055|NCT01192568|566145624|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
156834056|NCT01192568|566145621|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
156834057|NCT01192568|566145622|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
156834058|NCT01192568|566145623|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
156834059|NCT01192568|566145624|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
156834060|NCT02783170|566145629|FG000|Overall Study|Randomized but not Vaccinated|1|||
156834061|NCT02783170|566145630|FG001|Overall Study|Randomized but not Vaccinated|0|||
156834062|NCT00541346|566145631|FG000|Follow-up|Adverse Event|1|||
156834063|NCT02008773|566145632|FG000|Overall Study|Adverse Event|3|||
156834064|NCT02008773|566145633|FG001|Overall Study|Adverse Event|3|||
156834065|NCT02008773|566145634|FG002|Overall Study|Adverse Event|1|||
156834066|NCT02008773|566145635|FG003|Overall Study|Adverse Event|2|||
156834067|NCT02008773|566145632|FG000|Overall Study|Medication Non-compliance|2|||
156834068|NCT02008773|566145633|FG001|Overall Study|Medication Non-compliance|1|||
156834069|NCT02008773|566145634|FG002|Overall Study|Medication Non-compliance|3|||
156834070|NCT02008773|566145635|FG003|Overall Study|Medication Non-compliance|2|||
156834071|NCT02008773|566145632|FG000|Overall Study|Withdrawal by Subject|8|||
156834072|NCT02008773|566145633|FG001|Overall Study|Withdrawal by Subject|4|||
156834073|NCT02008773|566145634|FG002|Overall Study|Withdrawal by Subject|7|||
156834074|NCT02008773|566145635|FG003|Overall Study|Withdrawal by Subject|6|||
156834075|NCT02008773|566145632|FG000|Overall Study|Lost to Follow-up|0|||
156834076|NCT02008773|566145633|FG001|Overall Study|Lost to Follow-up|1|||
156834077|NCT02008773|566145634|FG002|Overall Study|Lost to Follow-up|3|||
156834078|NCT02008773|566145635|FG003|Overall Study|Lost to Follow-up|2|||
156834079|NCT04938037|566145636|FG000|Overall Study|Lost to Follow-up|4|||
156834080|NCT04938037|566145637|FG001|Overall Study|Lost to Follow-up|3|||
156834081|NCT03320330|566145640|FG000|Overall Study|Lack of Efficacy|5|||
156834082|NCT03320330|566145641|FG001|Overall Study|Lack of Efficacy|5|||
156834083|NCT03320330|566145642|FG002|Overall Study|Lack of Efficacy|14|||
156834084|NCT03320330|566145640|FG000|Overall Study|Physician Decision|1|||
156541391|NCT02046096|565074562|FG000|Overall Study|Other endpoint|2|||
156541392|NCT02046096|565074563|FG001|Overall Study|Other endpoint|19|||
156541393|NCT04969276|565074565|FG000|Overall Study|Protocol Deviation|0|||
156541394|NCT04969276|565074566|FG001|Overall Study|Protocol Deviation|1|||
156834085|NCT03320330|566145641|FG001|Overall Study|Physician Decision|0|||
156834086|NCT03320330|566145642|FG002|Overall Study|Physician Decision|0|||
156834087|NCT03323736|566145643|FG000|Overall Study|Screen Failure|14|||
156834088|NCT03323736|566145644|FG001|Overall Study|Screen Failure|9|||
156834089|NCT03323736|566145645|FG002|Overall Study|Screen Failure|1|||
156541395|NCT04969276|565074567|FG002|Overall Study|Protocol Deviation|0|||
156541396|NCT04969276|565074565|FG000|Overall Study|Withdrawal by Subject|1|||
156541397|NCT04969276|565074566|FG001|Overall Study|Withdrawal by Subject|10|||
156541398|NCT04969276|565074567|FG002|Overall Study|Withdrawal by Subject|0|||
156834090|NCT03323736|566145643|FG000|Overall Study|Withdrawal Before Treatment|3|||
156834091|NCT03323736|566145644|FG001|Overall Study|Withdrawal Before Treatment|1|||
156834092|NCT03323736|566145645|FG002|Overall Study|Withdrawal Before Treatment|1|||
156834093|NCT03323736|566145643|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
156834094|NCT03323736|566145644|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
156834095|NCT03323736|566145645|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
156834096|NCT01806064|566145647|FG000|Overall Study|Randomized Not Enrolled|0|||
156834097|NCT01806064|566145648|FG001|Overall Study|Randomized Not Enrolled|0|||
156834098|NCT01806064|566145649|FG002|Overall Study|Randomized Not Enrolled|0|||
156834099|NCT01806064|566145650|FG003|Overall Study|Randomized Not Enrolled|1|||
156834100|NCT01806064|566145651|FG004|Overall Study|Randomized Not Enrolled|2|||
156834101|NCT05063539|566145657|FG000|Overall Study|Adverse Event|1|||
156834102|NCT05063539|566145658|FG001|Overall Study|Adverse Event|2|||
156834103|NCT05063539|566145659|FG002|Overall Study|Adverse Event|1|||
156834104|NCT05063539|566145657|FG000|Overall Study|Death|0|||
156834105|NCT05063539|566145658|FG001|Overall Study|Death|1|||
156834106|NCT05063539|566145659|FG002|Overall Study|Death|1|||
156834107|NCT05063539|566145657|FG000|Overall Study|Lost to Follow-up|0|||
156834108|NCT05063539|566145658|FG001|Overall Study|Lost to Follow-up|1|||
156834109|NCT05063539|566145659|FG002|Overall Study|Lost to Follow-up|0|||
156834110|NCT05063539|566145657|FG000|Overall Study|Physician Decision|4|||
156834111|NCT05063539|566145658|FG001|Overall Study|Physician Decision|3|||
156834112|NCT05063539|566145659|FG002|Overall Study|Physician Decision|1|||
156834113|NCT05063539|566145657|FG000|Overall Study|Progressive Disease|0|||
156834114|NCT05063539|566145658|FG001|Overall Study|Progressive Disease|2|||
156834115|NCT05063539|566145659|FG002|Overall Study|Progressive Disease|0|||
156834116|NCT05063539|566145657|FG000|Overall Study|Withdrawal by Subject|17|||
156834117|NCT05063539|566145658|FG001|Overall Study|Withdrawal by Subject|26|||
156834118|NCT05063539|566145659|FG002|Overall Study|Withdrawal by Subject|14|||
156834119|NCT05063539|566145657|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
156834120|NCT05063539|566145658|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
156834121|NCT05063539|566145659|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
156834122|NCT05063539|566145657|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
156834123|NCT05063539|566145658|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
156834124|NCT05063539|566145659|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
156834125|NCT05063539|566145657|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
156834126|NCT05063539|566145658|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
156834127|NCT05063539|566145659|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
156834128|NCT05063539|566145657|FG000|Overall Study|Discontinued due to Common Close Design|0|||
156834129|NCT05063539|566145658|FG001|Overall Study|Discontinued due to Common Close Design|1|||
156834130|NCT05063539|566145659|FG002|Overall Study|Discontinued due to Common Close Design|0|||
156834131|NCT05063539|566145657|FG000|Overall Study|Participant not co-operative|0|||
156834132|NCT05063539|566145658|FG001|Overall Study|Participant not co-operative|1|||
156834133|NCT05063539|566145659|FG002|Overall Study|Participant not co-operative|0|||
156834134|NCT05063539|566145657|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
156834135|NCT05063539|566145658|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
156834136|NCT05063539|566145659|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
156834137|NCT05063539|566145657|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
156834138|NCT05063539|566145658|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
156834139|NCT05063539|566145659|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
156834140|NCT04256512|566145660|FG000|Overall Study|Withdrawal by Subject|1|||
156834141|NCT02804750|566145666|FG000|Period 1|Adverse Event|0|||
156834142|NCT02804750|566145667|FG001|Period 1|Adverse Event|2|||
156834143|NCT02804750|566145666|FG000|Period 1|Withdrawal by Subject|0|||
156834144|NCT02804750|566145667|FG001|Period 1|Withdrawal by Subject|1|||
156834145|NCT02804750|566145666|FG000|Period 2|Adverse Event|1|||
156834146|NCT02804750|566145667|FG001|Period 2|Adverse Event|0|||
156834147|NCT02804750|566145666|FG000|Period 3|Adverse Event|0|||
156834148|NCT02804750|566145667|FG001|Period 3|Adverse Event|2|||
156834149|NCT02804750|566145666|FG000|Period 4|Adverse Event|0|||
156834150|NCT02804750|566145667|FG001|Period 4|Adverse Event|5|||
156834151|NCT04692077|566145671|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
156834152|NCT01751139|566145676|FG000|Overall Study|Other|135|||
156834153|NCT01751139|566145676|FG000|Overall Study|Sponsor study termination|1609|||
156834154|NCT01751139|566145676|FG000|Overall Study|Lost to Follow-up|240|||
156834155|NCT01751139|566145676|FG000|Overall Study|Withdrawal by Subject|251|||
156834156|NCT01751139|566145676|FG000|Overall Study|Adverse Event|1|||
156834157|NCT01751139|566145676|FG000|Overall Study|Death|31|||
156834158|NCT03199391|566145677|FG000|Overall Study|Death|1|||
156834159|NCT03199391|566145677|FG000|Overall Study|Lost to Follow-up|3|||
156834160|NCT03199391|566145677|FG000|Overall Study|Adverse Event|2|||
156834161|NCT03199391|566145677|FG000|Overall Study|Withdrawal by Subject|10|||
156834162|NCT01867086|566145678|FG000|Overall Study|Disease Progression|1|||
156834163|NCT03826342|566145679|FG000|Overall Study|Withdrawal by Subject|8|||
156834164|NCT03826342|566145680|FG001|Overall Study|Withdrawal by Subject|1|||
156834165|NCT03826342|566145679|FG000|Overall Study|Lost to Follow-up|7|||
156834166|NCT03826342|566145680|FG001|Overall Study|Lost to Follow-up|7|||
156834167|NCT03826342|566145679|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
156834168|NCT03826342|566145680|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
156834169|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Death|1|||
156834170|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Death|0|||
156834171|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Death|0|||
156834172|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Death|0|||
156834173|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
156834174|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
156834175|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
156834176|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
156834177|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
156834178|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
156834179|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
156834180|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
156834181|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
156834182|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
156834183|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
156834184|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
156834185|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Other|8|||
156834186|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Other|5|||
156834187|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Other|0|||
156834188|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Other|0|||
156834189|NCT04271475|566145685|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
156834190|NCT04271475|566145686|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
156834191|NCT04271475|566145687|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
156834192|NCT04271475|566145688|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
156834193|NCT04271475|566145685|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
156834194|NCT04271475|566145686|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
156834195|NCT04271475|566145687|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
156834196|NCT04271475|566145688|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
156834197|NCT02337634|566145689|FG000|Overall Study|Protocol Violation|3|||
156834198|NCT02337634|566145690|FG001|Overall Study|Protocol Violation|1|||
156834199|NCT02337634|566145689|FG000|Overall Study|Lost to Follow-up|1|||
156834200|NCT02337634|566145690|FG001|Overall Study|Lost to Follow-up|0|||
156834201|NCT02428205|566145694|FG000|Overall Study|Lack of Efficacy|1|||
156834202|NCT02428205|566145695|FG001|Overall Study|Lack of Efficacy|0|||
156834203|NCT02428205|566145694|FG000|Overall Study|Lost to Follow-up|1|||
156834204|NCT02428205|566145695|FG001|Overall Study|Lost to Follow-up|1|||
156834205|NCT02428205|566145694|FG000|Overall Study|Worse behavior|0|||
156834206|NCT02428205|566145695|FG001|Overall Study|Worse behavior|1|||
156834207|NCT01818284|566145696|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
156834208|NCT01818284|566145697|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
156834209|NCT01818284|566145696|FG000|Overall Study|Death|0|||
156834210|NCT01818284|566145697|FG001|Overall Study|Death|2|||
156834211|NCT02888743|566145698|FG000|Overall Study|Withdrawal by Subject|1|||
156834212|NCT02888743|566145699|FG001|Overall Study|Withdrawal by Subject|2|||
156834213|NCT02888743|566145700|FG002|Overall Study|Withdrawal by Subject|2|||
156834214|NCT02888743|566145701|FG003|Overall Study|Withdrawal by Subject|0|||
156834215|NCT02888743|566145702|FG004|Overall Study|Withdrawal by Subject|1|||
156834216|NCT02888743|566145698|FG000|Overall Study|Disease progression before treatment|2|||
156834217|NCT02888743|566145699|FG001|Overall Study|Disease progression before treatment|0|||
156834218|NCT02888743|566145700|FG002|Overall Study|Disease progression before treatment|2|||
156834219|NCT02888743|566145701|FG003|Overall Study|Disease progression before treatment|0|||
156834220|NCT02888743|566145702|FG004|Overall Study|Disease progression before treatment|0|||
156834221|NCT02888743|566145698|FG000|Overall Study|Patient ineligible|1|||
156834222|NCT02888743|566145699|FG001|Overall Study|Patient ineligible|2|||
156834223|NCT02888743|566145700|FG002|Overall Study|Patient ineligible|0|||
156834224|NCT02888743|566145701|FG003|Overall Study|Patient ineligible|0|||
156834225|NCT02888743|566145702|FG004|Overall Study|Patient ineligible|0|||
156834226|NCT00527319|566145703|FG000|Overall Study|Withdrawal by Subject|5|||
156834227|NCT00527319|566145704|FG001|Overall Study|Withdrawal by Subject|0|||
156834228|NCT00527319|566145705|FG002|Overall Study|Withdrawal by Subject|1|||
156834229|NCT00527319|566145703|FG000|Overall Study|Lost to Follow-up|1|||
156834230|NCT00527319|566145704|FG001|Overall Study|Lost to Follow-up|0|||
156834231|NCT00527319|566145705|FG002|Overall Study|Lost to Follow-up|0|||
156834232|NCT00527319|566145703|FG000|Overall Study|Death|0|||
156834233|NCT00527319|566145704|FG001|Overall Study|Death|3|||
156834234|NCT00527319|566145705|FG002|Overall Study|Death|1|||
156834235|NCT00527319|566145703|FG000|Overall Study|Intercurrent Medical Illness|0|||
156834236|NCT00527319|566145704|FG001|Overall Study|Intercurrent Medical Illness|1|||
156834237|NCT00527319|566145705|FG002|Overall Study|Intercurrent Medical Illness|3|||
156834238|NCT00527319|566145703|FG000|Overall Study|Adverse Event|0|||
156834239|NCT00527319|566145704|FG001|Overall Study|Adverse Event|0|||
156834240|NCT00527319|566145705|FG002|Overall Study|Adverse Event|1|||
156834241|NCT01300351|566145710|FG000|Overall Study|Did not receive treatment|2|||
156834242|NCT01300351|566145711|FG001|Overall Study|Did not receive treatment|0|||
156834243|NCT01300351|566145710|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
156834244|NCT01300351|566145711|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
156834245|NCT01300351|566145710|FG000|Overall Study|Lost to Follow-up|0|||
156834246|NCT01300351|566145711|FG001|Overall Study|Lost to Follow-up|1|||
156834247|NCT01300351|566145710|FG000|Overall Study|Adverse Event|0|||
156834248|NCT01300351|566145711|FG001|Overall Study|Adverse Event|4|||
156834249|NCT01300351|566145710|FG000|Overall Study|Withdrawal by Subject|7|||
156834250|NCT01300351|566145711|FG001|Overall Study|Withdrawal by Subject|10|||
156834251|NCT05824936|566145714|FG000|Overall Study|Lost to Follow-up|1|||
156834252|NCT00096018|566145715|FG000|Overall Study|Became Ineligible (not treated)|0|||
156834253|NCT00096018|566145716|FG001|Overall Study|Became Ineligible (not treated)|3|||
156834254|NCT00096018|566145715|FG000|Overall Study|Miscellaneous (not treated)|0|||
156834255|NCT00096018|566145716|FG001|Overall Study|Miscellaneous (not treated)|2|||
156834256|NCT00096018|566145715|FG000|Overall Study|Adverse Event|0|||
156834257|NCT00096018|566145716|FG001|Overall Study|Adverse Event|5|||
156834258|NCT00096018|566145715|FG000|Overall Study|Death|0|||
156834259|NCT00096018|566145716|FG001|Overall Study|Death|1|||
156834260|NCT00096018|566145715|FG000|Overall Study|Withdrawal by Subject|0|||
156834261|NCT00096018|566145716|FG001|Overall Study|Withdrawal by Subject|2|||
156834262|NCT00096018|566145715|FG000|Overall Study|Miscellaneous|2|||
156834263|NCT00096018|566145716|FG001|Overall Study|Miscellaneous|1|||
156834264|NCT03779503|566145717|FG000|First Intervention|Adverse Event|0|||
156834265|NCT03779503|566145718|FG001|First Intervention|Adverse Event|1|||
156834266|NCT03779503|566145717|FG000|First Intervention|Withdrawal by Subject|1|||
156834267|NCT03779503|566145718|FG001|First Intervention|Withdrawal by Subject|0|||
156834268|NCT00864851|566145719|FG000|Overall Study|Withdrawal by Subject|0|||
156834269|NCT00864851|566145720|FG001|Overall Study|Withdrawal by Subject|1|||
156834270|NCT00864851|566145721|FG002|Overall Study|Withdrawal by Subject|0|||
156834271|NCT00864851|566145719|FG000|Overall Study|Physician Decision|1|||
156834272|NCT00864851|566145720|FG001|Overall Study|Physician Decision|0|||
156834273|NCT00864851|566145721|FG002|Overall Study|Physician Decision|0|||
156834274|NCT00864851|566145719|FG000|Overall Study|Death|1|||
156834275|NCT00864851|566145720|FG001|Overall Study|Death|0|||
156834276|NCT00864851|566145721|FG002|Overall Study|Death|0|||
156834277|NCT00864851|566145719|FG000|Overall Study|Patient uncooperative|1|||
156834278|NCT00864851|566145720|FG001|Overall Study|Patient uncooperative|0|||
156834279|NCT00864851|566145721|FG002|Overall Study|Patient uncooperative|0|||
156834280|NCT02066415|566145722|FG000|Overall Study|Decision by Sponsor|5|||
156834281|NCT02066415|566145723|FG001|Overall Study|Decision by Sponsor|4|||
156834282|NCT02066415|566145724|FG002|Overall Study|Decision by Sponsor|2|||
156834283|NCT02066415|566145722|FG000|Overall Study|Withdrawal by Subject|9|||
156834284|NCT02066415|566145723|FG001|Overall Study|Withdrawal by Subject|1|||
156834285|NCT02066415|566145724|FG002|Overall Study|Withdrawal by Subject|4|||
156834286|NCT02066415|566145722|FG000|Overall Study|Lost to Follow-up|7|||
156834287|NCT02066415|566145723|FG001|Overall Study|Lost to Follow-up|2|||
156834288|NCT02066415|566145724|FG002|Overall Study|Lost to Follow-up|2|||
156834289|NCT02006069|566145726|FG000|Overall Study|MPP other programming|239|||
156834290|NCT02006069|566145727|FG001|Overall Study|MPP other programming|0|||
156834291|NCT02006069|566145726|FG000|Overall Study|RV only pacing|0|||
156834292|NCT02006069|566145727|FG001|Overall Study|RV only pacing|3|||
156834293|NCT02276547|566145730|FG000|Overall Study|Death|2|||
156834294|NCT02276547|566145730|FG000|Overall Study|Explant|2|||
156834295|NCT01439126|566145731|FG000|Overall Study|Adverse Event|2|||
156834296|NCT01439126|566145732|FG001|Overall Study|Adverse Event|0|||
156834297|NCT01439126|566145731|FG000|Overall Study|Withdrawal by Subject|5|||
156834298|NCT01439126|566145732|FG001|Overall Study|Withdrawal by Subject|21|||
156834299|NCT01439126|566145731|FG000|Overall Study|Protocol Violation|6|||
156834300|NCT01439126|566145732|FG001|Overall Study|Protocol Violation|4|||
156834301|NCT01439126|566145731|FG000|Overall Study|Lost to Follow-up|6|||
156834302|NCT01439126|566145732|FG001|Overall Study|Lost to Follow-up|3|||
156834303|NCT01439126|566145731|FG000|Overall Study|Other-Use of prohibited treatment|0|||
156834304|NCT01439126|566145732|FG001|Overall Study|Other-Use of prohibited treatment|2|||
156834305|NCT01439126|566145731|FG000|Overall Study|Other-Miscellaneous|12|||
156467309|NCT02185794|564806660|FG001|Overall Study|Investigator's Discretion|0|||
156467310|NCT02185794|564806661|FG002|Overall Study|Investigator's Discretion|1|||
156467311|NCT02185794|564806662|FG003|Overall Study|Investigator's Discretion|2|||
156467312|NCT02185794|564806663|FG004|Overall Study|Investigator's Discretion|2|||
156467313|NCT02185794|564806664|FG005|Overall Study|Investigator's Discretion|15|||
156467314|NCT02185794|564806659|FG000|Overall Study|Withdrew Consent|2|||
156834306|NCT01439126|566145732|FG001|Overall Study|Other-Miscellaneous|12|||
156834307|NCT01216683|566147122|FG000|Induction|Never started treatment|0|||
156834308|NCT01216683|566147123|FG001|Induction|Never started treatment|6|||
156834309|NCT01216683|566147124|FG002|Induction|Never started treatment|3|||
156834310|NCT01216683|566147122|FG000|Induction|Lack of Efficacy|4|||
156834311|NCT01216683|566147123|FG001|Induction|Lack of Efficacy|3|||
156834312|NCT01216683|566147124|FG002|Induction|Lack of Efficacy|7|||
156834313|NCT01216683|566147122|FG000|Induction|Adverse Event|0|||
156834314|NCT01216683|566147123|FG001|Induction|Adverse Event|5|||
156834315|NCT01216683|566147124|FG002|Induction|Adverse Event|5|||
156834316|NCT01216683|566147122|FG000|Induction|Death|0|||
156834317|NCT01216683|566147123|FG001|Induction|Death|0|||
156834318|NCT01216683|566147124|FG002|Induction|Death|2|||
156834319|NCT01216683|566147122|FG000|Induction|Withdrawal by Subject|0|||
156834320|NCT01216683|566147123|FG001|Induction|Withdrawal by Subject|4|||
156834321|NCT01216683|566147124|FG002|Induction|Withdrawal by Subject|2|||
156834322|NCT01216683|566147122|FG000|Induction|Other disease|0|||
156834323|NCT01216683|566147123|FG001|Induction|Other disease|1|||
156834324|NCT01216683|566147124|FG002|Induction|Other disease|2|||
156834325|NCT01216683|566147122|FG000|Continuation|Lack of Efficacy|3|||
156834326|NCT01216683|566147123|FG001|Continuation|Lack of Efficacy|2|||
156834327|NCT01216683|566147124|FG002|Continuation|Lack of Efficacy|7|||
156834328|NCT01216683|566147122|FG000|Continuation|Adverse Event|5|||
156834329|NCT01216683|566147123|FG001|Continuation|Adverse Event|3|||
156834330|NCT01216683|566147124|FG002|Continuation|Adverse Event|16|||
156834331|NCT01216683|566147122|FG000|Continuation|Death|1|||
156834332|NCT01216683|566147123|FG001|Continuation|Death|0|||
156834333|NCT01216683|566147124|FG002|Continuation|Death|2|||
156834334|NCT01216683|566147122|FG000|Continuation|Withdrawal by Subject|4|||
156834335|NCT01216683|566147123|FG001|Continuation|Withdrawal by Subject|5|||
156834336|NCT01216683|566147124|FG002|Continuation|Withdrawal by Subject|9|||
156834337|NCT01216683|566147122|FG000|Continuation|Other diseases|0|||
156834338|NCT01216683|566147123|FG001|Continuation|Other diseases|2|||
156834339|NCT01216683|566147124|FG002|Continuation|Other diseases|1|||
156834340|NCT01216683|566147122|FG000|Continuation|Physician Decision|1|||
156834341|NCT01216683|566147123|FG001|Continuation|Physician Decision|0|||
156834342|NCT01216683|566147124|FG002|Continuation|Physician Decision|1|||
156834343|NCT01216683|566147122|FG000|Continuation|Non-compliance|1|||
156834344|NCT01216683|566147123|FG001|Continuation|Non-compliance|0|||
156834345|NCT01216683|566147124|FG002|Continuation|Non-compliance|1|||
156834346|NCT01216683|566147122|FG000|Continuation|Insurance change|0|||
156834347|NCT01216683|566147123|FG001|Continuation|Insurance change|1|||
156834348|NCT01216683|566147124|FG002|Continuation|Insurance change|0|||
156834349|NCT01216683|566147122|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
156834350|NCT01216683|566147123|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
156834351|NCT01216683|566147124|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
156834352|NCT01216683|566147122|FG000|Continuation|Not reported|0|||
156467315|NCT02185794|564806660|FG001|Overall Study|Withdrew Consent|5|||
156467316|NCT02185794|564806661|FG002|Overall Study|Withdrew Consent|10|||
156467317|NCT02185794|564806662|FG003|Overall Study|Withdrew Consent|2|||
156467318|NCT02185794|564806663|FG004|Overall Study|Withdrew Consent|0|||
156467319|NCT02185794|564806664|FG005|Overall Study|Withdrew Consent|0|||
156467320|NCT02185794|564806659|FG000|Overall Study|Lost to Follow-up|1|||
156467321|NCT02185794|564806660|FG001|Overall Study|Lost to Follow-up|2|||
156467322|NCT02185794|564806661|FG002|Overall Study|Lost to Follow-up|2|||
156467323|NCT02185794|564806662|FG003|Overall Study|Lost to Follow-up|3|||
156467324|NCT02185794|564806663|FG004|Overall Study|Lost to Follow-up|0|||
156834353|NCT01216683|566147123|FG001|Continuation|Not reported|0|||
156834354|NCT01216683|566147124|FG002|Continuation|Not reported|1|||
156834355|NCT01216683|566147122|FG000|Continuation|Never started treatment|0|||
156834356|NCT01216683|566147123|FG001|Continuation|Never started treatment|1|||
156834357|NCT01216683|566147124|FG002|Continuation|Never started treatment|5|||
156834358|NCT01949090|566147130|FG000|Overall Study|Serious Adverse Event|0|||
156834359|NCT01949090|566147131|FG001|Overall Study|Serious Adverse Event|1|||
156834360|NCT01949090|566147132|FG002|Overall Study|Serious Adverse Event|2|||
156834361|NCT01949090|566147133|FG003|Overall Study|Serious Adverse Event|0|||
156834362|NCT01949090|566147134|FG004|Overall Study|Serious Adverse Event|1|||
156834363|NCT01949090|566147130|FG000|Overall Study|Withdrawal by Subject|2|||
156834364|NCT01949090|566147131|FG001|Overall Study|Withdrawal by Subject|0|||
156834365|NCT01949090|566147132|FG002|Overall Study|Withdrawal by Subject|0|||
156834366|NCT01949090|566147133|FG003|Overall Study|Withdrawal by Subject|0|||
156834367|NCT01949090|566147134|FG004|Overall Study|Withdrawal by Subject|1|||
156834368|NCT01949090|566147130|FG000|Overall Study|Protocol non-compliance|0|||
156834369|NCT01949090|566147131|FG001|Overall Study|Protocol non-compliance|0|||
156834370|NCT01949090|566147132|FG002|Overall Study|Protocol non-compliance|0|||
156834371|NCT01949090|566147133|FG003|Overall Study|Protocol non-compliance|0|||
156834372|NCT01949090|566147134|FG004|Overall Study|Protocol non-compliance|1|||
156834373|NCT01949090|566147130|FG000|Overall Study|Lost to Follow-up|2|||
156834374|NCT01949090|566147131|FG001|Overall Study|Lost to Follow-up|1|||
156834375|NCT01949090|566147132|FG002|Overall Study|Lost to Follow-up|0|||
156834376|NCT01949090|566147133|FG003|Overall Study|Lost to Follow-up|1|||
156834377|NCT01949090|566147134|FG004|Overall Study|Lost to Follow-up|1|||
156834378|NCT01533922|566147135|FG000|Overall Study|Adverse Event|5|||
156834379|NCT01533922|566147136|FG001|Overall Study|Adverse Event|8|||
156834380|NCT01533922|566147137|FG002|Overall Study|Adverse Event|6|||
156834381|NCT01533922|566147138|FG003|Overall Study|Adverse Event|3|||
156834382|NCT01533922|566147139|FG004|Overall Study|Adverse Event|4|||
156834383|NCT01533922|566147135|FG000|Overall Study|Lack of Efficacy|0|||
156834384|NCT01533922|566147136|FG001|Overall Study|Lack of Efficacy|0|||
156834385|NCT01533922|566147137|FG002|Overall Study|Lack of Efficacy|1|||
156834386|NCT01533922|566147138|FG003|Overall Study|Lack of Efficacy|0|||
156834387|NCT01533922|566147139|FG004|Overall Study|Lack of Efficacy|0|||
156834388|NCT01533922|566147135|FG000|Overall Study|Protocol Violation|0|||
156834389|NCT01533922|566147136|FG001|Overall Study|Protocol Violation|3|||
156467325|NCT02185794|564806664|FG005|Overall Study|Lost to Follow-up|1|||
156467326|NCT00336505|564806665|FG000|Overall Study|Adverse Event|10|||
156467327|NCT00336505|564806666|FG001|Overall Study|Adverse Event|9|||
156467328|NCT00336505|564806665|FG000|Overall Study|Lack of Efficacy|8|||
156467329|NCT00336505|564806666|FG001|Overall Study|Lack of Efficacy|4|||
156467330|NCT00336505|564806665|FG000|Overall Study|Lost to Follow-up|7|||
156467331|NCT00336505|564806666|FG001|Overall Study|Lost to Follow-up|4|||
156467332|NCT00336505|564806665|FG000|Overall Study|Withdrawal by Subject|5|||
156467333|NCT00336505|564806666|FG001|Overall Study|Withdrawal by Subject|3|||
156467334|NCT00336505|564806665|FG000|Overall Study|Other|7|||
156467335|NCT00336505|564806666|FG001|Overall Study|Other|7|||
156467336|NCT00366249|564806667|FG000|Overall Study|Adverse Event|53|||
156467337|NCT00366249|564806668|FG001|Overall Study|Adverse Event|28|||
156467338|NCT00366249|564806667|FG000|Overall Study|Death|0|||
156834390|NCT01533922|566147137|FG002|Overall Study|Protocol Violation|0|||
156834391|NCT01533922|566147138|FG003|Overall Study|Protocol Violation|0|||
156834392|NCT01533922|566147139|FG004|Overall Study|Protocol Violation|1|||
156834393|NCT01533922|566147135|FG000|Overall Study|Withdrawal by Subject|3|||
156834394|NCT01533922|566147136|FG001|Overall Study|Withdrawal by Subject|1|||
156467339|NCT00366249|564806668|FG001|Overall Study|Death|1|||
156467340|NCT00366249|564806667|FG000|Overall Study|Physician Decision|5|||
156834395|NCT01533922|566147137|FG002|Overall Study|Withdrawal by Subject|2|||
156834396|NCT01533922|566147138|FG003|Overall Study|Withdrawal by Subject|2|||
156834397|NCT01533922|566147139|FG004|Overall Study|Withdrawal by Subject|1|||
156834398|NCT01533922|566147135|FG000|Overall Study|Other reason not defined above|2|||
156834399|NCT01533922|566147136|FG001|Overall Study|Other reason not defined above|0|||
156834400|NCT01533922|566147137|FG002|Overall Study|Other reason not defined above|1|||
156467341|NCT00366249|564806668|FG001|Overall Study|Physician Decision|2|||
156834401|NCT01533922|566147138|FG003|Overall Study|Other reason not defined above|0|||
156834402|NCT01533922|566147139|FG004|Overall Study|Other reason not defined above|0|||
156834403|NCT03242252|566147141|FG000|Overall Study|At the Participant's own Request|18|||
156834404|NCT03242252|566147142|FG001|Overall Study|At the Participant's own Request|10|||
156834405|NCT03242252|566147143|FG002|Overall Study|At the Participant's own Request|15|||
156834406|NCT03242252|566147141|FG000|Overall Study|Adverse Event|8|||
156834407|NCT03242252|566147142|FG001|Overall Study|Adverse Event|6|||
156834408|NCT03242252|566147143|FG002|Overall Study|Adverse Event|9|||
156834409|NCT03242252|566147141|FG000|Overall Study|Poor Compliance to Protocol|0|||
156834410|NCT03242252|566147142|FG001|Overall Study|Poor Compliance to Protocol|2|||
156834411|NCT03242252|566147143|FG002|Overall Study|Poor Compliance to Protocol|3|||
156834412|NCT03242252|566147141|FG000|Overall Study|Study Terminated by Sponsor|1|||
156834413|NCT03242252|566147142|FG001|Overall Study|Study Terminated by Sponsor|0|||
156834414|NCT03242252|566147143|FG002|Overall Study|Study Terminated by Sponsor|0|||
156834415|NCT03242252|566147141|FG000|Overall Study|Reason not Specified|4|||
156834416|NCT03242252|566147142|FG001|Overall Study|Reason not Specified|4|||
156834417|NCT03242252|566147143|FG002|Overall Study|Reason not Specified|1|||
156834418|NCT03242252|566147141|FG000|Overall Study|Lost to Follow-up|5|||
156834419|NCT03242252|566147142|FG001|Overall Study|Lost to Follow-up|1|||
156834420|NCT03242252|566147143|FG002|Overall Study|Lost to Follow-up|4|||
156834421|NCT01267175|566147146|FG000|Overall Study|Withdrawal by Subject|1|||
156834422|NCT01267175|566147146|FG000|Overall Study|Lost to Follow-up|1|||
156834423|NCT00895661|566147147|FG000|Overall Study|Death|1|||
156834424|NCT00895661|566147147|FG000|Overall Study|reason unknown|2|||
156834425|NCT02989805|566147150|FG000|Overall Study|invalid consent|6|||
156834426|NCT02989805|566147151|FG001|Overall Study|invalid consent|4|||
156834427|NCT00286221|566147152|FG000|Overall Study|Protocol Violation|2|||
156834428|NCT00286221|566147153|FG001|Overall Study|Protocol Violation|1|||
156834429|NCT00286221|566147154|FG002|Overall Study|Protocol Violation|6|||
156834430|NCT00286221|566147155|FG003|Overall Study|Protocol Violation|4|||
156834431|NCT00286221|566147152|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
156834432|NCT00286221|566147153|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
156834433|NCT00286221|566147154|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
156834434|NCT00286221|566147155|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
156834435|NCT00286221|566147152|FG000|Overall Study|Inability to trigger PCA|2|||
156834436|NCT00286221|566147153|FG001|Overall Study|Inability to trigger PCA|0|||
156834437|NCT00286221|566147154|FG002|Overall Study|Inability to trigger PCA|0|||
156834438|NCT00286221|566147155|FG003|Overall Study|Inability to trigger PCA|0|||
156834439|NCT00286221|566147152|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
156834440|NCT00286221|566147153|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
156834441|NCT00286221|566147154|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
156834442|NCT00286221|566147155|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
156834443|NCT02771626|566147157|FG000|Overall Study|Adverse Event|1|||
156834444|NCT02771626|566147158|FG001|Overall Study|Adverse Event|5|||
156834445|NCT02771626|566147159|FG002|Overall Study|Adverse Event|3|||
156834446|NCT02771626|566147160|FG003|Overall Study|Adverse Event|0|||
156834447|NCT02771626|566147161|FG004|Overall Study|Adverse Event|1|||
156834448|NCT02771626|566147162|FG005|Overall Study|Adverse Event|1|||
156834449|NCT02771626|566147157|FG000|Overall Study|Radiologic Disease Progression|6|||
156834450|NCT02771626|566147158|FG001|Overall Study|Radiologic Disease Progression|13|||
156834451|NCT02771626|566147159|FG002|Overall Study|Radiologic Disease Progression|10|||
156834452|NCT02771626|566147160|FG003|Overall Study|Radiologic Disease Progression|7|||
156834453|NCT02771626|566147161|FG004|Overall Study|Radiologic Disease Progression|28|||
156834454|NCT02771626|566147162|FG005|Overall Study|Radiologic Disease Progression|15|||
156834455|NCT02771626|566147157|FG000|Overall Study|Symptomatic Deterioration|0|||
156834456|NCT02771626|566147158|FG001|Overall Study|Symptomatic Deterioration|4|||
156834457|NCT02771626|566147159|FG002|Overall Study|Symptomatic Deterioration|2|||
156834458|NCT02771626|566147160|FG003|Overall Study|Symptomatic Deterioration|0|||
156834459|NCT02771626|566147161|FG004|Overall Study|Symptomatic Deterioration|5|||
156834460|NCT02771626|566147162|FG005|Overall Study|Symptomatic Deterioration|2|||
156834461|NCT02771626|566147157|FG000|Overall Study|Participant Request|0|||
156834462|NCT02771626|566147158|FG001|Overall Study|Participant Request|1|||
156834463|NCT02771626|566147159|FG002|Overall Study|Participant Request|0|||
156834464|NCT02771626|566147160|FG003|Overall Study|Participant Request|2|||
156834465|NCT02771626|566147161|FG004|Overall Study|Participant Request|0|||
156834466|NCT02771626|566147162|FG005|Overall Study|Participant Request|1|||
156834467|NCT02771626|566147157|FG000|Overall Study|Investigator Decision|0|||
156834468|NCT02771626|566147158|FG001|Overall Study|Investigator Decision|1|||
156834469|NCT02771626|566147159|FG002|Overall Study|Investigator Decision|0|||
156834470|NCT02771626|566147160|FG003|Overall Study|Investigator Decision|0|||
156834471|NCT02771626|566147161|FG004|Overall Study|Investigator Decision|1|||
156834472|NCT02771626|566147162|FG005|Overall Study|Investigator Decision|0|||
156834473|NCT02771626|566147157|FG000|Overall Study|Study Termination by Sponsor|0|||
156834474|NCT02771626|566147158|FG001|Overall Study|Study Termination by Sponsor|2|||
156834475|NCT02771626|566147159|FG002|Overall Study|Study Termination by Sponsor|1|||
156834476|NCT02771626|566147160|FG003|Overall Study|Study Termination by Sponsor|0|||
156834477|NCT02771626|566147161|FG004|Overall Study|Study Termination by Sponsor|1|||
156834478|NCT02771626|566147162|FG005|Overall Study|Study Termination by Sponsor|0|||
156834479|NCT02771626|566147157|FG000|Overall Study|Informed Consent Withdrawn|0|||
156834480|NCT02771626|566147158|FG001|Overall Study|Informed Consent Withdrawn|0|||
156834481|NCT02771626|566147159|FG002|Overall Study|Informed Consent Withdrawn|1|||
156834482|NCT02771626|566147160|FG003|Overall Study|Informed Consent Withdrawn|0|||
156834483|NCT02771626|566147161|FG004|Overall Study|Informed Consent Withdrawn|1|||
156834484|NCT02771626|566147162|FG005|Overall Study|Informed Consent Withdrawn|1|||
156834485|NCT02771626|566147157|FG000|Overall Study|Other, Not Specified|1|||
156834486|NCT02771626|566147158|FG001|Overall Study|Other, Not Specified|0|||
156834487|NCT02771626|566147159|FG002|Overall Study|Other, Not Specified|0|||
156834488|NCT02771626|566147160|FG003|Overall Study|Other, Not Specified|0|||
156834489|NCT02771626|566147161|FG004|Overall Study|Other, Not Specified|0|||
156834490|NCT02771626|566147162|FG005|Overall Study|Other, Not Specified|1|||
156834491|NCT02553538|566147163|FG000|Overall Study|Could Not Reach by Telephone|133|||
156834492|NCT02553538|566147164|FG001|Overall Study|Could Not Reach by Telephone|0|||
156834493|NCT02553538|566147163|FG000|Overall Study|Died or Left Network|54|||
156834494|NCT02553538|566147164|FG001|Overall Study|Died or Left Network|56|||
156834495|NCT02690649|566147165|FG000|Overall Study|Withdrawal by Subject|1|||
156834496|NCT02690649|566147166|FG001|Overall Study|Withdrawal by Subject|1|||
156834497|NCT02690649|566147165|FG000|Overall Study|Protocol Violation|0|||
156834498|NCT02690649|566147166|FG001|Overall Study|Protocol Violation|3|||
156834499|NCT00106691|566147167|FG000|Overall Study|Adverse Event|60|||
156834500|NCT00106691|566147168|FG001|Overall Study|Adverse Event|64|||
156834501|NCT00106691|566147167|FG000|Overall Study|Lost to Follow-up|23|||
156834502|NCT00106691|566147168|FG001|Overall Study|Lost to Follow-up|18|||
156834503|NCT00106691|566147167|FG000|Overall Study|Physician Decision|18|||
156834504|NCT00106691|566147168|FG001|Overall Study|Physician Decision|21|||
156834505|NCT00106691|566147167|FG000|Overall Study|Protocol Violation|13|||
156834506|NCT00106691|566147168|FG001|Overall Study|Protocol Violation|18|||
156834507|NCT00106691|566147167|FG000|Overall Study|Withdrawal by Subject|75|||
156834508|NCT00106691|566147168|FG001|Overall Study|Withdrawal by Subject|70|||
156834509|NCT00106691|566147167|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
156834510|NCT00106691|566147168|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
156834511|NCT00106691|566147167|FG000|Overall Study|QTc>480|3|||
156834512|NCT00106691|566147168|FG001|Overall Study|QTc>480|1|||
156834513|NCT00106691|566147167|FG000|Overall Study|mililtary deployment|2|||
156834514|NCT00106691|566147168|FG001|Overall Study|mililtary deployment|0|||
156834515|NCT00106691|566147167|FG000|Overall Study|Study Site Closing/PI Moved|1|||
156834516|NCT00106691|566147168|FG001|Overall Study|Study Site Closing/PI Moved|2|||
156834517|NCT00106691|566147167|FG000|Overall Study|Cardiologist recommendation|1|||
156834518|NCT00106691|566147168|FG001|Overall Study|Cardiologist recommendation|0|||
156834519|NCT00106691|566147167|FG000|Overall Study|Pt. moved to another state|1|||
156834520|NCT00106691|566147168|FG001|Overall Study|Pt. moved to another state|0|||
156834521|NCT00106691|566147167|FG000|Overall Study|Taking exclusionary avodart|1|||
156834522|NCT00106691|566147168|FG001|Overall Study|Taking exclusionary avodart|0|||
156834523|NCT00106691|566147167|FG000|Overall Study|Not able to discontinue plavix|0|||
156834524|NCT00106691|566147168|FG001|Overall Study|Not able to discontinue plavix|1|||
156834525|NCT01754194|566147169|FG000|Overall Study|Lost to Follow-up|39|||
156834526|NCT01754194|566147170|FG001|Overall Study|Lost to Follow-up|14|||
156834527|NCT01754194|566147169|FG000|Overall Study|Withdrawal by Subject|4|||
156834528|NCT01754194|566147170|FG001|Overall Study|Withdrawal by Subject|5|||
156834529|NCT01754194|566147169|FG000|Overall Study|Other|9|||
156834530|NCT01754194|566147170|FG001|Overall Study|Other|8|||
156834531|NCT00530920|566147171|FG000|Overall Study|Randomized but not treated|0|||
156834532|NCT00530920|566147172|FG001|Overall Study|Randomized but not treated|2|||
156834533|NCT00530920|566147173|FG002|Overall Study|Randomized but not treated|0|||
156834534|NCT00530920|566147171|FG000|Overall Study|Adverse Event|0|||
156834535|NCT00530920|566147172|FG001|Overall Study|Adverse Event|0|||
156834536|NCT00530920|566147173|FG002|Overall Study|Adverse Event|3|||
156834537|NCT00530920|566147171|FG000|Overall Study|Withdrawal by Subject|0|||
156834538|NCT00530920|566147172|FG001|Overall Study|Withdrawal by Subject|0|||
156834539|NCT00530920|566147173|FG002|Overall Study|Withdrawal by Subject|1|||
156834540|NCT00907296|566147174|FG000|Overall Study|Ineligibility Determined|1|||
156834541|NCT00907296|566147175|FG001|Overall Study|Ineligibility Determined|0|||
156834542|NCT00907296|566147176|FG002|Overall Study|Ineligibility Determined|0|||
156834543|NCT00907296|566147177|FG003|Overall Study|Ineligibility Determined|1|||
156834544|NCT00907296|566147178|FG004|Overall Study|Ineligibility Determined|0|||
156834545|NCT00907296|566147179|FG005|Overall Study|Ineligibility Determined|0|||
156834546|NCT00907296|566147180|FG006|Overall Study|Ineligibility Determined|0|||
156834547|NCT00907296|566147181|FG007|Overall Study|Ineligibility Determined|1|||
156467342|NCT00366249|564806667|FG000|Overall Study|Lost to Follow-up|2|||
156467343|NCT00366249|564806668|FG001|Overall Study|Lost to Follow-up|0|||
156467344|NCT00366249|564806667|FG000|Overall Study|Protocol Violation|1|||
156467345|NCT00366249|564806668|FG001|Overall Study|Protocol Violation|2|||
156467346|NCT00366249|564806667|FG000|Overall Study|Withdrawal by Subject|18|||
156467347|NCT00366249|564806668|FG001|Overall Study|Withdrawal by Subject|4|||
156467348|NCT00366249|564806667|FG000|Overall Study|Lack of Efficacy|21|||
156467349|NCT00366249|564806668|FG001|Overall Study|Lack of Efficacy|21|||
156467350|NCT00366249|564806667|FG000|Overall Study|Most due to osteomylitis status|31|||
156467351|NCT00366249|564806668|FG001|Overall Study|Most due to osteomylitis status|20|||
156467352|NCT00246805|564806669|FG000|Phase 1|Lost to Follow-up|1|||
156467353|NCT00246805|564806670|FG001|Phase 1|Lost to Follow-up|0|||
156834548|NCT00907296|566147182|FG008|Overall Study|Ineligibility Determined|0|||
156834549|NCT00907296|566147183|FG009|Overall Study|Ineligibility Determined|0|||
156834550|NCT00907296|566147174|FG000|Overall Study|Protocol Deviation|0|||
156834551|NCT00907296|566147175|FG001|Overall Study|Protocol Deviation|1|||
156834552|NCT00907296|566147176|FG002|Overall Study|Protocol Deviation|0|||
156834553|NCT00907296|566147177|FG003|Overall Study|Protocol Deviation|0|||
156834554|NCT00907296|566147178|FG004|Overall Study|Protocol Deviation|0|||
156834555|NCT00907296|566147179|FG005|Overall Study|Protocol Deviation|0|||
156834556|NCT00907296|566147180|FG006|Overall Study|Protocol Deviation|0|||
156834557|NCT00907296|566147181|FG007|Overall Study|Protocol Deviation|0|||
156834558|NCT00907296|566147182|FG008|Overall Study|Protocol Deviation|0|||
156834559|NCT00907296|566147183|FG009|Overall Study|Protocol Deviation|0|||
156834560|NCT00907296|566147174|FG000|Overall Study|Noncompliance|1|||
156834561|NCT00907296|566147175|FG001|Overall Study|Noncompliance|1|||
156834562|NCT00907296|566147176|FG002|Overall Study|Noncompliance|1|||
156834563|NCT00907296|566147177|FG003|Overall Study|Noncompliance|0|||
156834564|NCT00907296|566147178|FG004|Overall Study|Noncompliance|0|||
156834565|NCT00907296|566147179|FG005|Overall Study|Noncompliance|1|||
156834566|NCT00907296|566147180|FG006|Overall Study|Noncompliance|0|||
156834567|NCT00907296|566147181|FG007|Overall Study|Noncompliance|2|||
156834568|NCT00907296|566147182|FG008|Overall Study|Noncompliance|0|||
156834569|NCT00907296|566147183|FG009|Overall Study|Noncompliance|0|||
156834570|NCT00907296|566147174|FG000|Overall Study|Adverse Event|2|||
156834571|NCT00907296|566147175|FG001|Overall Study|Adverse Event|0|||
156834572|NCT00907296|566147176|FG002|Overall Study|Adverse Event|0|||
156834573|NCT00907296|566147177|FG003|Overall Study|Adverse Event|0|||
156834574|NCT00907296|566147178|FG004|Overall Study|Adverse Event|0|||
156467354|NCT03183050|564806671|FG000|Overall Study|Lost to Follow-up|23|||
156467355|NCT00686595|564806675|FG000|Overall Study|Adverse Event|3|||
156467356|NCT00686595|564806675|FG000|Overall Study|Protocol Violation|1|||
156467357|NCT00686595|564806675|FG000|Overall Study|Lost to Follow-up|1|||
156467358|NCT00686595|564806675|FG000|Overall Study|Lack of Efficacy|1|||
156467359|NCT00686595|564806675|FG000|Overall Study|Poor Compliance|1|||
156467360|NCT02797132|564806676|FG000|Part A (15 Days)|Adverse Event|1|||
156834575|NCT00907296|566147179|FG005|Overall Study|Adverse Event|0|||
156834576|NCT00907296|566147180|FG006|Overall Study|Adverse Event|1|||
156834577|NCT00907296|566147181|FG007|Overall Study|Adverse Event|0|||
156834578|NCT00907296|566147182|FG008|Overall Study|Adverse Event|0|||
156834579|NCT00907296|566147183|FG009|Overall Study|Adverse Event|1|||
156834580|NCT00907296|566147174|FG000|Overall Study|Withdrawal by Subject|7|||
156834581|NCT00907296|566147175|FG001|Overall Study|Withdrawal by Subject|2|||
156834582|NCT00907296|566147176|FG002|Overall Study|Withdrawal by Subject|1|||
156834583|NCT00907296|566147177|FG003|Overall Study|Withdrawal by Subject|1|||
156834584|NCT00907296|566147178|FG004|Overall Study|Withdrawal by Subject|1|||
156834585|NCT00907296|566147179|FG005|Overall Study|Withdrawal by Subject|5|||
156834586|NCT00907296|566147180|FG006|Overall Study|Withdrawal by Subject|3|||
156834587|NCT00907296|566147181|FG007|Overall Study|Withdrawal by Subject|2|||
156834588|NCT00907296|566147182|FG008|Overall Study|Withdrawal by Subject|4|||
156834589|NCT00907296|566147183|FG009|Overall Study|Withdrawal by Subject|2|||
156834590|NCT00907296|566147174|FG000|Overall Study|Lost to Follow-up|9|||
156834591|NCT00907296|566147175|FG001|Overall Study|Lost to Follow-up|1|||
156834592|NCT00907296|566147176|FG002|Overall Study|Lost to Follow-up|0|||
156834593|NCT00907296|566147177|FG003|Overall Study|Lost to Follow-up|2|||
156834594|NCT00907296|566147178|FG004|Overall Study|Lost to Follow-up|0|||
156834595|NCT00907296|566147179|FG005|Overall Study|Lost to Follow-up|3|||
156834596|NCT00907296|566147180|FG006|Overall Study|Lost to Follow-up|2|||
156834597|NCT00907296|566147181|FG007|Overall Study|Lost to Follow-up|2|||
156834598|NCT00907296|566147182|FG008|Overall Study|Lost to Follow-up|0|||
156834599|NCT00907296|566147183|FG009|Overall Study|Lost to Follow-up|4|||
156834600|NCT02392403|566147185|FG000|Overall Study|Adverse Event|1|||
156834601|NCT02392403|566147185|FG000|Overall Study|Death|1|||
156834602|NCT02392403|566147185|FG000|Overall Study|Withdrawal by Subject|1|||
156834603|NCT02776033|566147190|FG000|Overall Study|Withdrawal by Subject|0|||
156834604|NCT02776033|566147191|FG001|Overall Study|Withdrawal by Subject|0|||
156834605|NCT02776033|566147192|FG002|Overall Study|Withdrawal by Subject|2|||
156834606|NCT02776033|566147190|FG000|Overall Study|Physician Decision|2|||
156834607|NCT02776033|566147191|FG001|Overall Study|Physician Decision|0|||
156834608|NCT02776033|566147192|FG002|Overall Study|Physician Decision|0|||
156834609|NCT02776033|566147190|FG000|Overall Study|Lost to Follow-up|1|||
156834610|NCT02776033|566147191|FG001|Overall Study|Lost to Follow-up|0|||
156834611|NCT02776033|566147192|FG002|Overall Study|Lost to Follow-up|0|||
156834612|NCT02776033|566147190|FG000|Overall Study|Adverse Event|1|||
156834613|NCT02776033|566147191|FG001|Overall Study|Adverse Event|2|||
156834614|NCT02776033|566147192|FG002|Overall Study|Adverse Event|0|||
156834615|NCT02616393|566147196|FG000|Overall Study|Death|5|||
156834616|NCT02616393|566147197|FG001|Overall Study|Death|12|||
156834617|NCT02616393|566147198|FG002|Overall Study|Death|1|||
156834618|NCT02616393|566147196|FG000|Overall Study|Termination by Sponsor|4|||
156834619|NCT02616393|566147197|FG001|Overall Study|Termination by Sponsor|5|||
156834620|NCT02616393|566147198|FG002|Overall Study|Termination by Sponsor|2|||
156834621|NCT02616393|566147196|FG000|Overall Study|Other|3|||
156834622|NCT02616393|566147197|FG001|Overall Study|Other|0|||
156834623|NCT02616393|566147198|FG002|Overall Study|Other|0|||
156834624|NCT02616393|566147196|FG000|Overall Study|Withdrawal by Subject|1|||
156834625|NCT02616393|566147197|FG001|Overall Study|Withdrawal by Subject|1|||
156834626|NCT02616393|566147198|FG002|Overall Study|Withdrawal by Subject|0|||
156834627|NCT02616393|566147196|FG000|Overall Study|Lost to Follow-up|0|||
156834628|NCT02616393|566147197|FG001|Overall Study|Lost to Follow-up|2|||
156834629|NCT02616393|566147198|FG002|Overall Study|Lost to Follow-up|0|||
156834630|NCT02445573|566147202|FG000|Overall Study|Withdrawal by Subject|1|||
156834631|NCT02445573|566147203|FG001|Overall Study|Withdrawal by Subject|1|||
156467361|NCT02797132|564806676|FG000|Part B (24 Weeks)|Adverse Event|3|||
156467362|NCT01342367|564806678|FG000|Overall Study|Death|1|||
156834632|NCT02445573|566147202|FG000|Overall Study|Lost to Follow-up|0|||
156834633|NCT02445573|566147203|FG001|Overall Study|Lost to Follow-up|1|||
156834634|NCT04047420|566147204|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
156834635|NCT04047420|566147204|FG000|Washout Period|Refused Participation|2|||
156834636|NCT03757130|566147205|FG000|Overall Study|Lost to Follow-up|0|||
156467363|NCT01342367|564806679|FG001|Overall Study|Death|0|||
156834637|NCT03757130|566147206|FG001|Overall Study|Lost to Follow-up|0|||
156834638|NCT03757130|566147207|FG002|Overall Study|Lost to Follow-up|0|||
156834639|NCT03757130|566147208|FG003|Overall Study|Lost to Follow-up|1|||
156467364|NCT01342367|564806678|FG000|Overall Study|Withdrawal by Subject|1|||
156834640|NCT03757130|566147209|FG004|Overall Study|Lost to Follow-up|0|||
156834641|NCT03757130|566147210|FG005|Overall Study|Lost to Follow-up|0|||
156834642|NCT03757130|566147211|FG006|Overall Study|Lost to Follow-up|0|||
156467365|NCT01342367|564806679|FG001|Overall Study|Withdrawal by Subject|2|||
156467366|NCT01961609|564806680|FG000|Initiation|Missing|3|||
156834643|NCT03757130|566147212|FG007|Overall Study|Lost to Follow-up|1|||
156834644|NCT03757130|566147205|FG000|Overall Study|Withdrawal by Subject|0|||
156834645|NCT03757130|566147206|FG001|Overall Study|Withdrawal by Subject|0|||
156834646|NCT03757130|566147207|FG002|Overall Study|Withdrawal by Subject|0|||
156834647|NCT03757130|566147208|FG003|Overall Study|Withdrawal by Subject|0|||
156834648|NCT03757130|566147209|FG004|Overall Study|Withdrawal by Subject|0|||
156834649|NCT03757130|566147210|FG005|Overall Study|Withdrawal by Subject|0|||
156834650|NCT03757130|566147211|FG006|Overall Study|Withdrawal by Subject|1|||
156834651|NCT03757130|566147212|FG007|Overall Study|Withdrawal by Subject|0|||
156834652|NCT01639755|566147213|FG000|Overall Study|Study Ongoing|15|||
156834653|NCT01639755|566147213|FG000|Overall Study|Patient had device explantation|4|||
156834654|NCT02391961|566147215|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
156834655|NCT02391961|566147216|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
156834656|NCT02391961|566147215|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
156834657|NCT02391961|566147216|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
156834658|NCT02391961|566147215|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156834659|NCT02391961|566147216|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156834660|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
156834661|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
156834662|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
156834663|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
156834664|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
156834665|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
156834666|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
156834667|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
156834668|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
156834669|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
156834670|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
156834671|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
156834672|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
156834673|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
156834674|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
156834675|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
156834676|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
156834677|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
156834678|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
156834679|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
156834680|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
156834681|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
156834682|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
156834683|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
156834684|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
156834685|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
156834686|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
156834687|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
156834688|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
156834689|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
156834690|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Other Reason|1|||
156834691|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Other Reason|0|||
156834692|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Other Reason|0|||
156834693|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Other Reason|0|||
156834694|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Other Reason|0|||
156834695|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
156834696|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
156834697|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
156834698|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
156834699|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
156834700|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
156834701|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
156834702|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
156834703|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
156834704|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
156834705|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
156834706|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
156834707|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
156834708|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
156834709|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
156834710|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
156834711|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
156834712|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
156834713|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
156834714|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
156834715|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
156834716|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
156834717|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
156834718|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
156834719|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
156834720|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
156834721|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
156834722|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
156834723|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
156834724|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
156834725|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
156834726|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
156834727|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
156834728|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
156834729|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
156834730|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
156834731|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
156834732|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
156834733|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
156834734|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
156834735|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Death|0|||
156834736|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Death|0|||
156834737|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Death|0|||
156834738|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Death|1|||
156834739|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Death|0|||
156834740|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Missing|0|||
156467367|NCT01961609|564806681|FG001|Initiation|Missing|2|||
156467368|NCT01961609|564806682|FG002|Initiation|Missing|0|||
156467369|NCT01961609|564806683|FG003|Initiation|Missing|0|||
156467370|NCT01961609|564806680|FG000|Initiation|Protocol deviation|1|||
156467371|NCT01961609|564806681|FG001|Initiation|Protocol deviation|0|||
156467372|NCT01961609|564806682|FG002|Initiation|Protocol deviation|0|||
156467373|NCT01961609|564806683|FG003|Initiation|Protocol deviation|0|||
156467374|NCT01961609|564806680|FG000|Initiation|Death|0|||
156467375|NCT01961609|564806681|FG001|Initiation|Death|1|||
156834741|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Missing|0|||
156834742|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Missing|1|||
156834743|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Missing|0|||
156834744|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Missing|0|||
156834745|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
156834746|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
156834747|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
156834748|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
156834749|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
156834750|NCT03263780|566147222|FG000|Overall Study|Withdrawal by Subject|3|||
156834751|NCT03263780|566147222|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
156834752|NCT03995355|566147225|FG000|Overall Study|Adverse Event|1|||
156834753|NCT03995355|566147226|FG001|Overall Study|Adverse Event|0|||
156834754|NCT03995355|566147225|FG000|Overall Study|Withdrawal by Subject|1|||
156834755|NCT03995355|566147226|FG001|Overall Study|Withdrawal by Subject|0|||
156834756|NCT03995355|566147225|FG000|Overall Study|Scheduling Issues|0|||
156834757|NCT03995355|566147226|FG001|Overall Study|Scheduling Issues|1|||
156834758|NCT00249613|566147227|FG000|12 Month Follow-up|Death|1|||
156834759|NCT00249613|566147228|FG001|12 Month Follow-up|Death|1|||
156834760|NCT00249613|566147227|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
156834761|NCT00249613|566147228|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
156834762|NCT00249613|566147227|FG000|12 Month Follow-up|Lost to Follow-up|10|||
156834763|NCT00249613|566147228|FG001|12 Month Follow-up|Lost to Follow-up|8|||
156834764|NCT00094107|566147229|FG000|Overall Study|Lack of Efficacy|23|||
156834765|NCT00094107|566147229|FG000|Overall Study|Death|5|||
156834766|NCT00094107|566147229|FG000|Overall Study|Adverse Event|3|||
156834767|NCT00094107|566147229|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
156834768|NCT00806442|566147254|FG000|Overall Study|Lost to Follow-up|3|||
156834769|NCT00806442|566147255|FG001|Overall Study|Lost to Follow-up|2|||
156834770|NCT00806442|566147254|FG000|Overall Study|Withdrawal by Subject|1|||
156834771|NCT00806442|566147255|FG001|Overall Study|Withdrawal by Subject|5|||
156834772|NCT01455220|566147258|FG000|Overall Study|screen fail|30|||
156834773|NCT00267150|566147259|FG000|Overall Study|Adverse Event|1|||
156834774|NCT00424190|566147261|FG000|Overall Study|Withdrew consent|3|||
156834775|NCT00424190|566147262|FG001|Overall Study|Withdrew consent|4|||
156834776|NCT00424190|566147261|FG000|Overall Study|Death|3|||
156834777|NCT00424190|566147262|FG001|Overall Study|Death|0|||
156834778|NCT00424190|566147261|FG000|Overall Study|Noncompliance|1|||
156834779|NCT00424190|566147262|FG001|Overall Study|Noncompliance|2|||
156834780|NCT00424190|566147261|FG000|Overall Study|Request of sponsor or investigator|0|||
156834781|NCT00424190|566147262|FG001|Overall Study|Request of sponsor or investigator|2|||
156834782|NCT00424190|566147261|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
156834783|NCT00424190|566147262|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
156834784|NCT00424190|566147261|FG000|Overall Study|Other|15|||
156834785|NCT00424190|566147262|FG001|Overall Study|Other|21|||
156834786|NCT00351273|566147263|FG000|Overall Study|Lost to Follow-up|1|||
156834787|NCT00351273|566147264|FG001|Overall Study|Lost to Follow-up|2|||
156834788|NCT00351273|566147265|FG002|Overall Study|Lost to Follow-up|5|||
156834789|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
156834790|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
156834791|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
156834792|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
156834793|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
156467376|NCT01961609|564806682|FG002|Initiation|Death|0|||
156467377|NCT01961609|564806683|FG003|Initiation|Death|0|||
156834794|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
156834795|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
156834796|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
156834797|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
156834798|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
156834799|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
156834800|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
156834801|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
156340075|NCT02469298|564344299|FG003|Overall Study|Lost to Follow-up|0|||
156467378|NCT01961609|564806680|FG000|Initiation|Administrative problems|1|||
156467379|NCT01961609|564806681|FG001|Initiation|Administrative problems|0|||
156467380|NCT01961609|564806682|FG002|Initiation|Administrative problems|0|||
156834802|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
156834803|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
156834804|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
156834805|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
156834806|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
156834807|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
156834808|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
156834809|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
156834810|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
156834811|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
156834812|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
156834813|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
156834814|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
156834815|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
156834816|NCT01672866|566147266|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
156834817|NCT01672866|566147267|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
156834818|NCT01672866|566147268|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
156834819|NCT01672866|566147266|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
156834820|NCT01672866|566147267|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
156834821|NCT01672866|566147268|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
156834822|NCT01672866|566147266|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
156834823|NCT01672866|566147267|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
156834824|NCT01672866|566147268|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
156834825|NCT01672866|566147266|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
156834826|NCT01672866|566147267|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
156834827|NCT01672866|566147268|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
156834828|NCT00619489|566147271|FG000|Overall Study|Adverse Event|0|||
156834829|NCT00619489|566147272|FG001|Overall Study|Adverse Event|7|||
156834830|NCT00619489|566147271|FG000|Overall Study|Withdrawal by Subject|1|||
156834831|NCT00619489|566147272|FG001|Overall Study|Withdrawal by Subject|1|||
156834832|NCT00619489|566147271|FG000|Overall Study|Lack of Efficacy|0|||
156834833|NCT00619489|566147272|FG001|Overall Study|Lack of Efficacy|11|||
156834834|NCT00619489|566147271|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
156834835|NCT00619489|566147272|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
156834836|NCT01638559|566147276|FG000|Overall Study|Lost to Follow-up|1|||
156834837|NCT01638559|566147276|FG000|Overall Study|Withdrawal by Subject|1|||
156834838|NCT01638559|566147276|FG000|Overall Study|Subject declined to travel for biopsy|1|||
156834839|NCT02593825|566149229|FG000|Intervention|Lost to Follow-up|10|||
156834840|NCT02593825|566149230|FG001|Intervention|Lost to Follow-up|12|||
156834841|NCT06359080|566149231|FG000|Overall Study|Withdrawal by Subject|3|||
156834842|NCT00511134|566149232|FG000|Overall Study|Withdrawal by Subject|0|||
156834843|NCT00511134|566149233|FG001|Overall Study|Withdrawal by Subject|2|||
156834844|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
156834845|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
156834846|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
156834847|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
156834848|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
156834849|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
156834850|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
156834851|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
156834852|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
156834853|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
156834854|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
156834855|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
156834856|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
156834857|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
156834858|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
156834859|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
156834860|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
156834861|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
156834862|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
156834863|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
156834864|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
156834865|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
156834866|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
156834867|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
156834868|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
156834869|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
156834870|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
156834871|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
156834872|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
156834873|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
156834874|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
156834875|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
156834876|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
156834877|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
156834878|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
156834879|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
156834880|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
156834881|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
156834882|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
156834883|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
156834884|NCT02198794|566149234|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
156834885|NCT02198794|566149235|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
156834886|NCT02198794|566149236|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
156834887|NCT02198794|566149237|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
156834888|NCT02198794|566149234|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
156834889|NCT02198794|566149235|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
156834890|NCT02198794|566149236|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
156834891|NCT02198794|566149237|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
156834892|NCT02198794|566149234|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
156834893|NCT02198794|566149235|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
156834894|NCT02198794|566149236|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
156834895|NCT02198794|566149237|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
156834896|NCT02198794|566149234|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
156834897|NCT02198794|566149235|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
156834898|NCT02198794|566149236|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
156834899|NCT02198794|566149237|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
156834900|NCT02198794|566149234|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
156834901|NCT02198794|566149235|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
156834902|NCT02198794|566149236|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
156834903|NCT02198794|566149237|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
156834904|NCT00477152|566149238|FG000|Overall Study|Parent withdrew consent|2|||
156834905|NCT00477152|566149238|FG000|Overall Study|Adverse Event|1|||
156834906|NCT01918332|566149239|FG000|Overall Study|Adverse Event|0|||
156834907|NCT01918332|566149240|FG001|Overall Study|Adverse Event|0|||
156834908|NCT01918332|566149241|FG002|Overall Study|Adverse Event|0|||
156834909|NCT01918332|566149242|FG003|Overall Study|Adverse Event|1|||
156834910|NCT01918332|566149239|FG000|Overall Study|Withdrawal by Subject|2|||
156834911|NCT01918332|566149240|FG001|Overall Study|Withdrawal by Subject|3|||
156834912|NCT01918332|566149241|FG002|Overall Study|Withdrawal by Subject|2|||
156834913|NCT01918332|566149242|FG003|Overall Study|Withdrawal by Subject|3|||
156834914|NCT01918332|566149239|FG000|Overall Study|Protocol Violation|6|||
156834915|NCT01918332|566149240|FG001|Overall Study|Protocol Violation|2|||
156834916|NCT01918332|566149241|FG002|Overall Study|Protocol Violation|6|||
156834917|NCT01918332|566149242|FG003|Overall Study|Protocol Violation|3|||
156834918|NCT01918332|566149239|FG000|Overall Study|lipid result by central lab did not meet|0|||
156834919|NCT01918332|566149240|FG001|Overall Study|lipid result by central lab did not meet|0|||
156467381|NCT01961609|564806683|FG003|Initiation|Administrative problems|0|||
156467382|NCT01961609|564806680|FG000|Initiation|Withdrawal by Subject|1|||
156834920|NCT01918332|566149241|FG002|Overall Study|lipid result by central lab did not meet|1|||
156834921|NCT01918332|566149242|FG003|Overall Study|lipid result by central lab did not meet|0|||
156834922|NCT00483041|566149245|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
156834923|NCT00483041|566149246|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
156834924|NCT02648217|566149249|FG000|Overall Study|Adverse Event|0|||
156834925|NCT02648217|566149250|FG001|Overall Study|Adverse Event|1|||
156467383|NCT01961609|564806681|FG001|Initiation|Withdrawal by Subject|2|||
156467384|NCT01961609|564806682|FG002|Initiation|Withdrawal by Subject|0|||
156467385|NCT01961609|564806683|FG003|Initiation|Withdrawal by Subject|0|||
156467386|NCT01961609|564806680|FG000|Initiation|Lack of Efficacy|2|||
156467387|NCT01961609|564806681|FG001|Initiation|Lack of Efficacy|1|||
156834926|NCT02648217|566149249|FG000|Overall Study|Lost to Follow-up|1|||
156834927|NCT02648217|566149250|FG001|Overall Study|Lost to Follow-up|1|||
156834928|NCT02648217|566149249|FG000|Overall Study|Withdrawal by Subject|4|||
156834929|NCT02648217|566149250|FG001|Overall Study|Withdrawal by Subject|3|||
156834930|NCT02648217|566149249|FG000|Overall Study|Unclassified|5|||
156834931|NCT02648217|566149250|FG001|Overall Study|Unclassified|0|||
156467388|NCT01961609|564806682|FG002|Initiation|Lack of Efficacy|0|||
156834932|NCT00316888|566149253|FG000|Overall Study|Adverse Event|4|||
156834933|NCT00316888|566149254|FG001|Overall Study|Adverse Event|5|||
156834934|NCT00316888|566149253|FG000|Overall Study|Withdrawal by Subject|2|||
156834935|NCT00316888|566149254|FG001|Overall Study|Withdrawal by Subject|2|||
156834936|NCT00316888|566149253|FG000|Overall Study|Not start protocol therapy|0|||
156834937|NCT00316888|566149254|FG001|Overall Study|Not start protocol therapy|1|||
156834938|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
156834939|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
156834940|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
156834941|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
156834942|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
156834943|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
156834944|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
156834945|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
156834946|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
156834947|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
156834948|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
156834949|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
156834950|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
156834951|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
156834952|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
156834953|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
156834954|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
156834955|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
156834956|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
156834957|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
156834958|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
156834959|NCT01302054|566149255|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
156834960|NCT01302054|566149256|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
156834961|NCT01302054|566149257|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
156834962|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156834963|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
156834964|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
156834965|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156834966|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
156834967|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156834968|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156834969|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
156834970|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
156834971|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
156834972|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
156834973|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
156834974|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156834975|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
156834976|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
156834977|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
156834978|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
156834979|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
156834980|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Other|0|||
156834981|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Other|4|||
156834982|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Other|9|||
156834983|NCT02713867|566149258|FG000|Randomization|Other Reason|2|||
156834984|NCT02713867|566149259|FG001|Randomization|Other Reason|1|||
156834985|NCT02713867|566149258|FG000|Randomization|Participant Withdrew consent|0|||
156834986|NCT02713867|566149259|FG001|Randomization|Participant Withdrew consent|2|||
156834987|NCT02713867|566149258|FG000|Treatment Period|Other Reasons|22|||
156834988|NCT02713867|566149259|FG001|Treatment Period|Other Reasons|28|||
156834989|NCT02713867|566149258|FG000|Treatment Period|Administrative reason by sponsor|21|||
156834990|NCT02713867|566149259|FG001|Treatment Period|Administrative reason by sponsor|16|||
156834991|NCT02713867|566149258|FG000|Treatment Period|No longer meets study criteria|2|||
156834992|NCT02713867|566149259|FG001|Treatment Period|No longer meets study criteria|1|||
156834993|NCT02713867|566149258|FG000|Treatment Period|Poor/Non Compliance|1|||
156834994|NCT02713867|566149259|FG001|Treatment Period|Poor/Non Compliance|0|||
156834995|NCT02713867|566149258|FG000|Treatment Period|Maximum Clinical Benefit|5|||
156834996|NCT02713867|566149259|FG001|Treatment Period|Maximum Clinical Benefit|6|||
156834997|NCT02713867|566149258|FG000|Treatment Period|Withdrew consent|3|||
156834998|NCT02713867|566149259|FG001|Treatment Period|Withdrew consent|6|||
156834999|NCT02713867|566149258|FG000|Treatment Period|Requested to Discontinue|8|||
156835000|NCT02713867|566149259|FG001|Treatment Period|Requested to Discontinue|8|||
156467389|NCT01961609|564806683|FG003|Initiation|Lack of Efficacy|0|||
156467390|NCT01961609|564806680|FG000|Initiation|Abnormal lab values|0|||
156467391|NCT01961609|564806681|FG001|Initiation|Abnormal lab values|1|||
156835001|NCT02713867|566149258|FG000|Treatment Period|AE unrelated to Study Drug|11|||
156835002|NCT02713867|566149259|FG001|Treatment Period|AE unrelated to Study Drug|10|||
156835003|NCT02713867|566149258|FG000|Treatment Period|Death|7|||
156835004|NCT02713867|566149259|FG001|Treatment Period|Death|3|||
156835005|NCT02713867|566149258|FG000|Treatment Period|Study Drug Toxicity|16|||
156835006|NCT02713867|566149259|FG001|Treatment Period|Study Drug Toxicity|19|||
156835007|NCT02713867|566149258|FG000|Treatment Period|Disease Progression|82|||
156835008|NCT02713867|566149259|FG001|Treatment Period|Disease Progression|83|||
156835009|NCT00857948|566149260|FG000|Overall Study|Withdrawal by Subject|2|||
156835010|NCT00857948|566149261|FG001|Overall Study|Withdrawal by Subject|0|||
156835011|NCT00857948|566149262|FG002|Overall Study|Withdrawal by Subject|0|||
156835012|NCT00857948|566149263|FG003|Overall Study|Withdrawal by Subject|0|||
156835013|NCT00857948|566149260|FG000|Overall Study|Protocol Violation|1|||
156835014|NCT00857948|566149261|FG001|Overall Study|Protocol Violation|0|||
156835015|NCT00857948|566149262|FG002|Overall Study|Protocol Violation|1|||
156835016|NCT00857948|566149263|FG003|Overall Study|Protocol Violation|0|||
156835017|NCT02715726|566149264|FG000|Overall Study|Adverse Event|2|||
156835018|NCT02715726|566149265|FG001|Overall Study|Adverse Event|6|||
156835019|NCT02715726|566149264|FG000|Overall Study|Protocol Violation|1|||
156835020|NCT02715726|566149265|FG001|Overall Study|Protocol Violation|0|||
156835021|NCT02715726|566149264|FG000|Overall Study|Death|2|||
156835022|NCT02715726|566149265|FG001|Overall Study|Death|1|||
156835023|NCT02715726|566149264|FG000|Overall Study|Participant moved|1|||
156835024|NCT02715726|566149265|FG001|Overall Study|Participant moved|3|||
156835025|NCT02715726|566149264|FG000|Overall Study|Other than specified above|11|||
156835026|NCT02715726|566149265|FG001|Overall Study|Other than specified above|15|||
156835027|NCT02715726|566149264|FG000|Overall Study|Randomized but not treated|1|||
156835028|NCT02715726|566149265|FG001|Overall Study|Randomized but not treated|2|||
156835029|NCT03230292|566149268|FG000|Overall Study|Adverse Event|1|||
156835030|NCT03230292|566149268|FG000|Overall Study|Protocol Violation|1|||
156835031|NCT03230292|566149268|FG000|Overall Study|Lost to Follow-up|1|||
156835032|NCT03230292|566149268|FG000|Overall Study|Withdrawal by Subject|3|||
156835033|NCT02855944|566149269|FG000|Period 1: Treatment|Ongoing|14|||
156835034|NCT02855944|566149270|FG001|Period 1: Treatment|Ongoing|0|||
156835035|NCT02855944|566149269|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
156835036|NCT02855944|566149270|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
156835037|NCT02855944|566149269|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
156835038|NCT02855944|566149270|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
156835039|NCT03262116|566149274|FG000|Overall Study|Physician Decision|0|||
156835040|NCT03262116|566149275|FG001|Overall Study|Physician Decision|2|||
156835041|NCT03262116|566149276|FG002|Overall Study|Physician Decision|1|||
156835042|NCT03262116|566149277|FG003|Overall Study|Physician Decision|1|||
156835043|NCT03262116|566149278|FG004|Overall Study|Physician Decision|1|||
156835044|NCT03262116|566149279|FG005|Overall Study|Physician Decision|2|||
156835045|NCT02365285|566149280|FG000|Overall Study|Physician Decision|0|||
156835046|NCT02365285|566149281|FG001|Overall Study|Physician Decision|1|||
156835047|NCT02365285|566149282|FG002|Overall Study|Physician Decision|1|||
156835048|NCT02365285|566149283|FG003|Overall Study|Physician Decision|0|||
156835049|NCT02365285|566149280|FG000|Overall Study|Adverse Event|0|||
156835050|NCT02365285|566149281|FG001|Overall Study|Adverse Event|0|||
156835051|NCT02365285|566149282|FG002|Overall Study|Adverse Event|0|||
156835052|NCT02365285|566149283|FG003|Overall Study|Adverse Event|2|||
156835053|NCT02608450|566149289|FG000|Overall Study|Lost to Follow-up|39|||
156835054|NCT02608450|566149290|FG001|Overall Study|Lost to Follow-up|32|||
156835055|NCT02608450|566149289|FG000|Overall Study|Withdrawal by Subject|21|||
156835056|NCT02608450|566149290|FG001|Overall Study|Withdrawal by Subject|15|||
156835057|NCT02608450|566149289|FG000|Overall Study|Adverse Event|3|||
156835058|NCT02608450|566149290|FG001|Overall Study|Adverse Event|6|||
156835059|NCT02608450|566149289|FG000|Overall Study|Withdrawal by parent|2|||
156835060|NCT02608450|566149290|FG001|Overall Study|Withdrawal by parent|3|||
156835061|NCT02608450|566149289|FG000|Overall Study|Lack of Efficacy|0|||
156835062|NCT02608450|566149290|FG001|Overall Study|Lack of Efficacy|3|||
156835063|NCT02608450|566149289|FG000|Overall Study|Noncompliance with study drug|0|||
156835064|NCT02608450|566149290|FG001|Overall Study|Noncompliance with study drug|2|||
156835065|NCT02608450|566149289|FG000|Overall Study|Physician Decision|0|||
156835066|NCT02608450|566149290|FG001|Overall Study|Physician Decision|1|||
156835067|NCT02608450|566149289|FG000|Overall Study|Pregnancy|0|||
156835068|NCT02608450|566149290|FG001|Overall Study|Pregnancy|1|||
156835069|NCT02608450|566149289|FG000|Overall Study|Progressive disease|1|||
156835070|NCT02608450|566149290|FG001|Overall Study|Progressive disease|0|||
156835071|NCT02608450|566149289|FG000|Overall Study|Multiple reasons|0|||
156835072|NCT02608450|566149290|FG001|Overall Study|Multiple reasons|2|||
156835073|NCT00635089|566149292|FG000|Overall Study|Adverse Event|7|||
156835074|NCT00635089|566149292|FG000|Overall Study|Lack of Efficacy|28|||
156835075|NCT00635089|566149292|FG000|Overall Study|Protocol Deviation|4|||
156835076|NCT00635089|566149292|FG000|Overall Study|Lost to Follow-up|8|||
156835077|NCT00635089|566149292|FG000|Overall Study|Other|31|||
156835078|NCT01617447|566149293|FG000|Overall Study|Adverse Event|0|||
156835079|NCT01617447|566149294|FG001|Overall Study|Adverse Event|1|||
156835080|NCT01617447|566149293|FG000|Overall Study|Physician Decision|0|||
156835081|NCT01617447|566149294|FG001|Overall Study|Physician Decision|2|||
156835082|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
156835083|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
156835084|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
156835085|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
156835086|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
156835087|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
156835088|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
156835089|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
156835090|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
156835091|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
156835092|NCT02636946|566149296|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
156835093|NCT02636946|566149297|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
156835094|NCT01283542|566149298|FG000|Main Phase|Acute or progressive vision loss|1|||
156835095|NCT01283542|566149298|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
156835096|NCT01283542|566149298|FG000|Main Phase|abnormal laboratory values|5|||
156835097|NCT01283542|566149298|FG000|Extension Phase|Physician Decision|1|||
156835098|NCT01283542|566149298|FG000|Extension Phase|Adverse Event|1|||
156835099|NCT01283542|566149298|FG000|Extension Phase|Administrative problems|1|||
156835100|NCT05059977|566149299|FG000|Overall Study|Withdrawal by Subject|0|||
156835101|NCT05059977|566149300|FG001|Overall Study|Withdrawal by Subject|0|||
156835102|NCT05059977|566149301|FG002|Overall Study|Withdrawal by Subject|1|||
156835103|NCT00576472|566149302|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835104|NCT00576472|566149303|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835105|NCT00576472|566149304|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835106|NCT00576472|566149305|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
156835107|NCT00576472|566149306|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835108|NCT00576472|566149307|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835109|NCT00576472|566149308|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835110|NCT00576472|566149309|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835111|NCT00576472|566149310|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835112|NCT00576472|566149311|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835113|NCT00576472|566149312|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835114|NCT00576472|566149313|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835115|NCT00576472|566149314|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835116|NCT00576472|566149315|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835117|NCT00576472|566149316|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835118|NCT00576472|566149302|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
156835119|NCT00576472|566149303|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
156835120|NCT00576472|566149304|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
156835121|NCT00576472|566149305|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
156835122|NCT00576472|566149306|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
156835123|NCT00576472|566149307|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
156835124|NCT00576472|566149308|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
156835125|NCT00576472|566149309|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
156835126|NCT00576472|566149310|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
156835127|NCT00576472|566149311|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
156835128|NCT00576472|566149312|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
156835129|NCT00576472|566149313|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
156835130|NCT00576472|566149314|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
156835131|NCT00576472|566149315|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
156835132|NCT00576472|566149316|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
156835133|NCT00576472|566149302|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835134|NCT00576472|566149303|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835135|NCT00576472|566149304|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835136|NCT00576472|566149305|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
156835137|NCT00576472|566149306|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835138|NCT00576472|566149307|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835139|NCT00576472|566149308|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835140|NCT00576472|566149309|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835141|NCT00576472|566149310|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835142|NCT00576472|566149311|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835143|NCT00576472|566149312|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835144|NCT00576472|566149313|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835145|NCT00576472|566149314|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835146|NCT00576472|566149315|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835147|NCT00576472|566149316|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835148|NCT00576472|566149302|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
156835149|NCT00576472|566149303|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
156835150|NCT00576472|566149304|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
156835151|NCT00576472|566149305|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
156835152|NCT00576472|566149306|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
156835153|NCT00576472|566149307|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
156835154|NCT00576472|566149308|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
156835155|NCT00576472|566149309|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
156835156|NCT00576472|566149310|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
156835157|NCT00576472|566149311|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
156835158|NCT00576472|566149312|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
156835159|NCT00576472|566149313|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
156835160|NCT00576472|566149314|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
156835161|NCT00576472|566149315|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
156835162|NCT00576472|566149316|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
156835163|NCT00576472|566149302|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835164|NCT00576472|566149303|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835165|NCT00576472|566149304|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835166|NCT00576472|566149305|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
156467392|NCT01961609|564806682|FG002|Initiation|Abnormal lab values|0|||
156467393|NCT01961609|564806683|FG003|Initiation|Abnormal lab values|0|||
156835167|NCT00576472|566149306|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835168|NCT00576472|566149307|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835169|NCT00576472|566149308|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835170|NCT00576472|566149309|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835171|NCT00576472|566149310|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835172|NCT00576472|566149311|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835173|NCT00576472|566149312|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835174|NCT00576472|566149313|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835175|NCT00576472|566149314|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835176|NCT00576472|566149315|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835177|NCT00576472|566149316|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835178|NCT00576472|566149302|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
156467394|NCT01961609|564806680|FG000|Initiation|Adverse Event|3|||
156467395|NCT01961609|564806681|FG001|Initiation|Adverse Event|5|||
156467396|NCT01961609|564806682|FG002|Initiation|Adverse Event|0|||
156467397|NCT01961609|564806683|FG003|Initiation|Adverse Event|0|||
156835179|NCT00576472|566149303|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835180|NCT00576472|566149304|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835181|NCT00576472|566149305|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835182|NCT00576472|566149306|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835183|NCT00576472|566149307|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835184|NCT00576472|566149308|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
156835185|NCT00576472|566149309|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835186|NCT00576472|566149310|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835187|NCT00576472|566149311|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835188|NCT00576472|566149312|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835189|NCT00576472|566149313|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835190|NCT00576472|566149314|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835191|NCT00576472|566149315|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835192|NCT00576472|566149316|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835193|NCT00576472|566149302|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
156835194|NCT00576472|566149303|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
156835195|NCT00576472|566149304|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
156835196|NCT00576472|566149305|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
156835197|NCT00576472|566149306|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
156835198|NCT00576472|566149307|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
156340076|NCT02469298|564344296|FG000|Overall Study|Physician Decision|0|||
156340077|NCT02469298|564344297|FG001|Overall Study|Physician Decision|0|||
156835199|NCT00576472|566149308|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
156835200|NCT00576472|566149309|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
156835201|NCT00576472|566149310|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
156835202|NCT00576472|566149311|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
156835203|NCT00576472|566149312|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
156835204|NCT00576472|566149313|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
156835205|NCT00576472|566149314|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
156835206|NCT00576472|566149315|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
156835207|NCT00576472|566149316|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
156835208|NCT00576472|566149302|FG000|MPH Cross Over Phase|Physician Decision|0|||
156835209|NCT00576472|566149303|FG001|MPH Cross Over Phase|Physician Decision|0|||
156835210|NCT00576472|566149304|FG002|MPH Cross Over Phase|Physician Decision|0|||
156835211|NCT00576472|566149305|FG003|MPH Cross Over Phase|Physician Decision|0|||
156835212|NCT00576472|566149306|FG004|MPH Cross Over Phase|Physician Decision|0|||
156835213|NCT00576472|566149307|FG005|MPH Cross Over Phase|Physician Decision|0|||
156835214|NCT00576472|566149308|FG006|MPH Cross Over Phase|Physician Decision|4|||
156835215|NCT00576472|566149309|FG007|MPH Cross Over Phase|Physician Decision|0|||
156835216|NCT00576472|566149310|FG008|MPH Cross Over Phase|Physician Decision|0|||
156835217|NCT00576472|566149311|FG009|MPH Cross Over Phase|Physician Decision|0|||
156835218|NCT00576472|566149312|FG010|MPH Cross Over Phase|Physician Decision|0|||
156835219|NCT00576472|566149313|FG011|MPH Cross Over Phase|Physician Decision|0|||
156835220|NCT00576472|566149314|FG012|MPH Cross Over Phase|Physician Decision|0|||
156835221|NCT00576472|566149315|FG013|MPH Cross Over Phase|Physician Decision|0|||
156835222|NCT00576472|566149316|FG014|MPH Cross Over Phase|Physician Decision|0|||
156835223|NCT00576472|566149302|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835224|NCT00576472|566149303|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835225|NCT00576472|566149304|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835226|NCT00576472|566149305|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835227|NCT00576472|566149306|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835228|NCT00576472|566149307|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835229|NCT00576472|566149308|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835230|NCT00576472|566149309|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835231|NCT00576472|566149310|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
156835232|NCT00576472|566149311|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835233|NCT00576472|566149312|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
156835234|NCT00576472|566149313|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
156835235|NCT00576472|566149314|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835236|NCT00576472|566149315|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835237|NCT00576472|566149316|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835238|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835239|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835240|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156340078|NCT02469298|564344298|FG002|Overall Study|Physician Decision|0|||
156340079|NCT02469298|564344299|FG003|Overall Study|Physician Decision|1|||
156340080|NCT02469298|564344296|FG000|Overall Study|Withdrawal by Subject|0|||
156835241|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835242|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835243|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835244|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835245|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835246|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835247|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835248|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835249|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835250|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835251|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
156835252|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835253|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
156835254|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
156835255|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
156835256|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
156835257|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
156835258|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
156835259|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
156835260|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
156835261|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
156835262|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
156835263|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
156835264|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
156835265|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
156835266|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
156835267|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
156835268|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
156835269|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
156835270|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
156835271|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
156835272|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
156835273|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
156835274|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
156835275|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
156835276|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
156835277|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
156835278|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
156835279|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
156835280|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
156835281|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
156835282|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
156835283|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Side effects|0|||
156835284|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Side effects|0|||
156835285|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Side effects|0|||
156835286|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Side effects|0|||
156835287|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Side effects|0|||
156835288|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Side effects|0|||
156835289|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Side effects|0|||
156835290|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Side effects|0|||
156835291|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Side effects|0|||
156835292|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Side effects|0|||
156835293|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Side effects|0|||
156835294|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Side effects|0|||
156835295|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Side effects|0|||
156835296|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Side effects|0|||
156835297|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Side effects|8|||
156835298|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835299|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835300|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835301|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835302|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835303|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835304|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835305|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835306|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835307|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835308|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835309|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835310|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835311|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835312|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
156835313|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
156835314|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
156835315|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
156835316|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
156835317|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
156835318|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
156835319|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
156835320|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
156835321|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
156835322|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
156835323|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
156835324|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
156835325|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
156835326|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
156835327|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
156835328|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835329|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835330|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835331|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835332|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835333|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835334|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835335|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835336|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835337|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835338|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835339|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835340|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835341|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835342|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
156835343|NCT04405245|566149317|FG000|Overall Study|Adverse Event|0|||
156835344|NCT04405245|566149318|FG001|Overall Study|Adverse Event|1|||
156835345|NCT04405245|566149319|FG002|Overall Study|Adverse Event|0|||
156835346|NCT03443427|566149321|FG000|Overall Study|Adverse Event|2|||
156835347|NCT03443427|566149322|FG001|Overall Study|Adverse Event|3|||
156835348|NCT03443427|566149321|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
156835349|NCT03443427|566149322|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
156835350|NCT03443427|566149321|FG000|Overall Study|Other|4|||
156835351|NCT03443427|566149322|FG001|Overall Study|Other|6|||
156835352|NCT02576860|566149325|FG000|Overall Study|Adverse Event|6|||
156835353|NCT02576860|566149326|FG001|Overall Study|Adverse Event|6|||
156835354|NCT02576860|566149325|FG000|Overall Study|Lost to Follow-up|5|||
156835355|NCT02576860|566149326|FG001|Overall Study|Lost to Follow-up|7|||
156835356|NCT02576860|566149325|FG000|Overall Study|Physician Decision|0|||
156835357|NCT02576860|566149326|FG001|Overall Study|Physician Decision|1|||
156835358|NCT02576860|566149325|FG000|Overall Study|Protocol Violation|0|||
156835359|NCT02576860|566149326|FG001|Overall Study|Protocol Violation|2|||
156835360|NCT02576860|566149325|FG000|Overall Study|Withdrawal by Subject|13|||
156835361|NCT02576860|566149326|FG001|Overall Study|Withdrawal by Subject|8|||
156835362|NCT02576860|566149325|FG000|Overall Study|Disallowed medication|1|||
156835363|NCT02576860|566149326|FG001|Overall Study|Disallowed medication|0|||
156835364|NCT00780273|566149327|FG000|Overall Study|Death|1|||
156835365|NCT00780273|566149327|FG000|Overall Study|Lost to Follow-up|1|||
156835366|NCT00477269|566149328|FG000|Core Study|Adverse Event|6|||
156835367|NCT00477269|566149329|FG001|Core Study|Adverse Event|4|||
156835368|NCT00477269|566149330|FG002|Core Study|Adverse Event|0|||
156835369|NCT00477269|566149328|FG000|Core Study|Death|3|||
156835370|NCT00477269|566149329|FG001|Core Study|Death|3|||
156835371|NCT00477269|566149330|FG002|Core Study|Death|0|||
156835372|NCT00477269|566149328|FG000|Core Study|Withdrawn Consent|0|||
156835373|NCT00477269|566149329|FG001|Core Study|Withdrawn Consent|1|||
156835374|NCT00477269|566149330|FG002|Core Study|Withdrawn Consent|0|||
156835375|NCT00477269|566149328|FG000|Open Label Extension|Adverse Event|0|||
156835376|NCT00477269|566149329|FG001|Open Label Extension|Adverse Event|0|||
156835377|NCT00477269|566149330|FG002|Open Label Extension|Adverse Event|4|||
156835378|NCT00477269|566149328|FG000|Open Label Extension|Abnormal laboratory values|0|||
156835379|NCT00477269|566149329|FG001|Open Label Extension|Abnormal laboratory values|0|||
156835380|NCT00477269|566149330|FG002|Open Label Extension|Abnormal laboratory values|1|||
156835381|NCT00477269|566149328|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
156835382|NCT00477269|566149329|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
156835383|NCT00477269|566149330|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
156835384|NCT00477269|566149328|FG000|Open Label Extension|Adminiatrative problems|0|||
156835385|NCT00477269|566149329|FG001|Open Label Extension|Adminiatrative problems|0|||
156835386|NCT00477269|566149330|FG002|Open Label Extension|Adminiatrative problems|2|||
156835387|NCT00477269|566149328|FG000|Open Label Extension|Death|0|||
156835388|NCT00477269|566149329|FG001|Open Label Extension|Death|0|||
156835389|NCT00477269|566149330|FG002|Open Label Extension|Death|4|||
156835390|NCT01792518|566149333|FG000|Overall Study|Adverse Event|3|||
156835391|NCT01792518|566149334|FG001|Overall Study|Adverse Event|4|||
156835392|NCT01792518|566149333|FG000|Overall Study|Protocol Violation|0|||
156835393|NCT01792518|566149334|FG001|Overall Study|Protocol Violation|1|||
156835394|NCT01792518|566149333|FG000|Overall Study|Lost to Follow-up|3|||
156835395|NCT01792518|566149334|FG001|Overall Study|Lost to Follow-up|1|||
156835396|NCT01792518|566149333|FG000|Overall Study|Withdrawal by Subject|2|||
156835397|NCT01792518|566149334|FG001|Overall Study|Withdrawal by Subject|0|||
156835398|NCT01792518|566149333|FG000|Overall Study|Other Reason|0|||
156835399|NCT01792518|566149334|FG001|Overall Study|Other Reason|1|||
156835400|NCT01504204|566149337|FG000|Overall Study|Lost to Follow-up|1|||
156835401|NCT01504204|566149338|FG001|Overall Study|Lost to Follow-up|1|||
156835402|NCT00654004|566149347|FG000|Overall Study|Lost to Follow-up|1|||
156835403|NCT00654004|566149348|FG001|Overall Study|Lost to Follow-up|0|||
156835404|NCT01571453|566149351|FG000|Overall Study|Adverse Event|14|||
156835405|NCT01571453|566149352|FG001|Overall Study|Adverse Event|32|||
156835406|NCT01571453|566149351|FG000|Overall Study|Lack of Efficacy|8|||
156835407|NCT01571453|566149352|FG001|Overall Study|Lack of Efficacy|3|||
156835408|NCT01571453|566149351|FG000|Overall Study|Non-compliance|2|||
156835409|NCT01571453|566149352|FG001|Overall Study|Non-compliance|4|||
156835410|NCT01571453|566149351|FG000|Overall Study|Protocol Violation|1|||
156835411|NCT01571453|566149352|FG001|Overall Study|Protocol Violation|5|||
156835412|NCT01571453|566149351|FG000|Overall Study|Withdrawal of consent|5|||
156835413|NCT01571453|566149352|FG001|Overall Study|Withdrawal of consent|13|||
156835414|NCT01571453|566149351|FG000|Overall Study|Lost to Follow-up|4|||
156835415|NCT01571453|566149352|FG001|Overall Study|Lost to Follow-up|2|||
156835416|NCT01571453|566149351|FG000|Overall Study|Administrative or other reason(s)|4|||
156835417|NCT01571453|566149352|FG001|Overall Study|Administrative or other reason(s)|3|||
156835418|NCT00444067|566149356|FG000|Overall Study|Lost to Follow-up|0|||
156835419|NCT00444067|566149357|FG001|Overall Study|Lost to Follow-up|1|||
156835420|NCT02528357|566149358|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835421|NCT02528357|566149359|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
156835422|NCT02528357|566149360|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835423|NCT02528357|566149361|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835424|NCT02528357|566149362|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835425|NCT02528357|566149363|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835426|NCT02528357|566149364|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835427|NCT02528357|566149365|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835428|NCT02528357|566149366|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835429|NCT02528357|566149367|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835430|NCT02528357|566149368|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835431|NCT02528357|566149369|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835432|NCT02528357|566149370|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835433|NCT02528357|566149371|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835434|NCT02528357|566149372|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835435|NCT02528357|566149373|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835436|NCT02528357|566149374|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835437|NCT02528357|566149375|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835438|NCT02528357|566149376|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835439|NCT02528357|566149358|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835440|NCT02528357|566149359|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835441|NCT02528357|566149360|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835442|NCT02528357|566149361|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
156835443|NCT02528357|566149362|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835444|NCT02528357|566149363|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
156835445|NCT02528357|566149364|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835446|NCT02528357|566149365|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
156835447|NCT02528357|566149366|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835448|NCT02528357|566149367|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835449|NCT02528357|566149368|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835450|NCT02528357|566149369|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835451|NCT02528357|566149370|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835452|NCT02528357|566149371|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835453|NCT02528357|566149372|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835454|NCT02528357|566149373|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835455|NCT02528357|566149374|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835456|NCT02528357|566149375|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835457|NCT02528357|566149376|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835458|NCT02528357|566149358|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835459|NCT02528357|566149359|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835460|NCT02528357|566149360|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
156835461|NCT02528357|566149361|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835462|NCT02528357|566149362|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
156835463|NCT02528357|566149363|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835464|NCT02528357|566149364|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
156835465|NCT02528357|566149365|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
156835466|NCT02528357|566149366|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835467|NCT02528357|566149367|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835468|NCT02528357|566149368|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835469|NCT02528357|566149369|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835470|NCT02528357|566149370|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835471|NCT02528357|566149371|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835472|NCT02528357|566149372|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835473|NCT02528357|566149373|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835474|NCT02528357|566149374|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835475|NCT02528357|566149375|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835476|NCT02528357|566149376|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835477|NCT02528357|566149358|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835478|NCT02528357|566149359|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835479|NCT02528357|566149360|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835480|NCT02528357|566149361|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835481|NCT02528357|566149362|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835482|NCT02528357|566149363|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835483|NCT02528357|566149364|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835484|NCT02528357|566149365|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835485|NCT02528357|566149366|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835486|NCT02528357|566149367|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835487|NCT02528357|566149368|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835488|NCT02528357|566149369|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835489|NCT02528357|566149370|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835490|NCT02528357|566149371|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835491|NCT02528357|566149372|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835492|NCT02528357|566149373|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835493|NCT02528357|566149374|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835494|NCT02528357|566149375|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835495|NCT02528357|566149376|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835496|NCT02528357|566149358|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835497|NCT02528357|566149359|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835498|NCT02528357|566149360|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835499|NCT02528357|566149361|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156467398|NCT01961609|564806680|FG000|Initiation|Randomized but not treated|1|||
156835500|NCT02528357|566149362|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835501|NCT02528357|566149363|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835502|NCT02528357|566149364|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835503|NCT02528357|566149365|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835504|NCT02528357|566149366|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835505|NCT02528357|566149367|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835506|NCT02528357|566149368|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835507|NCT02528357|566149369|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835508|NCT02528357|566149370|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835509|NCT02528357|566149371|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
156835510|NCT02528357|566149372|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
156835511|NCT02528357|566149373|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835512|NCT02528357|566149374|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835513|NCT02528357|566149375|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835514|NCT02528357|566149376|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835515|NCT02528357|566149358|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835516|NCT02528357|566149359|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835517|NCT02528357|566149360|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835518|NCT02528357|566149361|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156467399|NCT01961609|564806681|FG001|Initiation|Randomized but not treated|1|||
156467400|NCT01961609|564806682|FG002|Initiation|Randomized but not treated|0|||
156467401|NCT01961609|564806683|FG003|Initiation|Randomized but not treated|0|||
156467402|NCT01961609|564806680|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
156835519|NCT02528357|566149362|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835520|NCT02528357|566149363|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835521|NCT02528357|566149364|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835522|NCT02528357|566149365|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835523|NCT02528357|566149366|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835524|NCT02528357|566149367|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835525|NCT02528357|566149368|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835526|NCT02528357|566149369|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835527|NCT02528357|566149370|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835528|NCT02528357|566149371|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
156835529|NCT02528357|566149372|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835530|NCT02528357|566149373|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835531|NCT02528357|566149374|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835532|NCT02528357|566149375|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835533|NCT02528357|566149376|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835534|NCT02528357|566149358|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835535|NCT02528357|566149359|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835536|NCT02528357|566149360|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835537|NCT02528357|566149361|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835538|NCT02528357|566149362|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835539|NCT02528357|566149363|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835540|NCT02528357|566149364|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835541|NCT02528357|566149365|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835542|NCT02528357|566149366|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835543|NCT02528357|566149367|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835544|NCT02528357|566149368|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
156835545|NCT02528357|566149369|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835546|NCT02528357|566149370|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
156835547|NCT02528357|566149371|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
156835548|NCT02528357|566149372|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
156835549|NCT02528357|566149373|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835550|NCT02528357|566149374|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835551|NCT02528357|566149375|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835552|NCT02528357|566149376|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835553|NCT02528357|566149358|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835554|NCT02528357|566149359|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835555|NCT02528357|566149360|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835556|NCT02528357|566149361|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835557|NCT02528357|566149362|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156467403|NCT01961609|564806681|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
156467404|NCT01961609|564806682|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
156467405|NCT01961609|564806683|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
156467406|NCT01961609|564806680|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
156467407|NCT01961609|564806681|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
156467408|NCT01961609|564806682|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
156467409|NCT01961609|564806683|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
156467410|NCT01961609|564806680|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
156467411|NCT01961609|564806681|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
156467412|NCT01961609|564806682|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
156467413|NCT01961609|564806683|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
156467414|NCT01961609|564806680|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
156467415|NCT01961609|564806681|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
156467416|NCT01961609|564806682|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
156467417|NCT01961609|564806683|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
156467418|NCT01961609|564806680|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
156467419|NCT01961609|564806681|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
156467420|NCT01961609|564806682|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
156467421|NCT01961609|564806683|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
156467422|NCT01961609|564806680|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
156467423|NCT01961609|564806681|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
156467424|NCT01961609|564806682|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
156467425|NCT01961609|564806683|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
156467426|NCT01961609|564806680|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
156467427|NCT01961609|564806681|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
156467428|NCT01961609|564806682|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
156467429|NCT01961609|564806683|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
156467430|NCT01961609|564806680|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
156467431|NCT01961609|564806681|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
156467432|NCT01961609|564806682|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
156467433|NCT01961609|564806683|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
156467434|NCT01961609|564806680|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
156467435|NCT01961609|564806681|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
156467436|NCT01961609|564806682|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
156467437|NCT01961609|564806683|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
156467438|NCT01961609|564806680|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
156467439|NCT01961609|564806681|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
156467440|NCT01961609|564806682|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
156467441|NCT01961609|564806683|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
156467442|NCT01961609|564806680|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
156467443|NCT01961609|564806681|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
156835558|NCT02528357|566149363|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835559|NCT02528357|566149364|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835560|NCT02528357|566149365|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835561|NCT02528357|566149366|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835562|NCT02528357|566149367|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835563|NCT02528357|566149368|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835564|NCT02528357|566149369|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
156835565|NCT02528357|566149370|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
156835566|NCT02528357|566149371|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835567|NCT02528357|566149372|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835568|NCT02528357|566149373|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835569|NCT02528357|566149374|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835570|NCT02528357|566149375|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156863434|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
156863435|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156467444|NCT01961609|564806682|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
156467445|NCT01961609|564806683|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
156467446|NCT01961609|564806680|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
156467447|NCT01961609|564806681|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
156467448|NCT01961609|564806682|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
156467449|NCT01961609|564806683|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
156835571|NCT02528357|566149376|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835572|NCT02528357|566149358|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156467450|NCT02284113|564806684|FG000|Overall Study|Adverse Event|1|||
156467451|NCT02284113|564806685|FG001|Overall Study|Adverse Event|0|||
156467452|NCT02284113|564806684|FG000|Overall Study|non-compliance|0|||
156835573|NCT02528357|566149359|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835574|NCT02528357|566149360|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835575|NCT02528357|566149361|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835576|NCT02528357|566149362|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835577|NCT02528357|566149363|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835578|NCT02528357|566149364|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835579|NCT02528357|566149365|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835580|NCT02528357|566149366|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835581|NCT02528357|566149367|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835582|NCT02528357|566149368|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835583|NCT02528357|566149369|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835584|NCT02528357|566149370|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835585|NCT02528357|566149371|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835586|NCT02528357|566149372|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835587|NCT02528357|566149373|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835588|NCT02528357|566149374|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
156835589|NCT02528357|566149375|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835590|NCT02528357|566149376|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835591|NCT02528357|566149358|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835592|NCT02528357|566149359|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835593|NCT02528357|566149360|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835594|NCT02528357|566149361|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835595|NCT02528357|566149362|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835596|NCT02528357|566149363|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156467453|NCT02284113|564806685|FG001|Overall Study|non-compliance|1|||
156467454|NCT02284113|564806684|FG000|Overall Study|Withdrawal by Subject|0|||
156467455|NCT02284113|564806685|FG001|Overall Study|Withdrawal by Subject|1|||
156467456|NCT02284113|564806684|FG000|Overall Study|not provided|0|||
156467457|NCT02284113|564806685|FG001|Overall Study|not provided|1|||
156835597|NCT02528357|566149364|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835598|NCT02528357|566149365|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835599|NCT02528357|566149366|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835600|NCT02528357|566149367|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835601|NCT02528357|566149368|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835602|NCT02528357|566149369|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835603|NCT02528357|566149370|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835604|NCT02528357|566149371|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835605|NCT02528357|566149372|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835606|NCT02528357|566149373|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835607|NCT02528357|566149374|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835608|NCT02528357|566149375|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
156835609|NCT02528357|566149376|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
156835610|NCT03869333|566149387|FG000|Overall Study|Lost to Follow-up|1|||
156835611|NCT03869333|566149388|FG001|Overall Study|Lost to Follow-up|0|||
156835612|NCT03869333|566149389|FG002|Overall Study|Lost to Follow-up|0|||
156835613|NCT03869333|566149390|FG003|Overall Study|Lost to Follow-up|0|||
156835614|NCT03869333|566149387|FG000|Overall Study|Pregnancy|1|||
156467458|NCT02284113|564806684|FG000|Overall Study|surgery cancelled|2|||
156467459|NCT02284113|564806685|FG001|Overall Study|surgery cancelled|0|||
156467460|NCT04191824|564806686|FG000|Overall Study|Death|13|||
156467461|NCT04191824|564806687|FG001|Overall Study|Death|12|||
156467462|NCT04191824|564806686|FG000|Overall Study|Lost to Follow-up|456|||
156467463|NCT04191824|564806687|FG001|Overall Study|Lost to Follow-up|435|||
156467464|NCT04191824|564806686|FG000|Overall Study|Physician Decision|2|||
156467465|NCT04191824|564806687|FG001|Overall Study|Physician Decision|1|||
156467466|NCT04191824|564806686|FG000|Overall Study|Protocol Violation|0|||
156835615|NCT03869333|566149388|FG001|Overall Study|Pregnancy|0|||
156835616|NCT03869333|566149389|FG002|Overall Study|Pregnancy|0|||
156835617|NCT03869333|566149390|FG003|Overall Study|Pregnancy|0|||
156835618|NCT03869333|566149387|FG000|Overall Study|Physician Decision|0|||
156835619|NCT03869333|566149388|FG001|Overall Study|Physician Decision|1|||
156835620|NCT03869333|566149389|FG002|Overall Study|Physician Decision|0|||
156835621|NCT03869333|566149390|FG003|Overall Study|Physician Decision|0|||
156835622|NCT01927055|566149391|FG000|Open-label|Adverse Event|6|||
156835623|NCT01927055|566149392|FG001|Open-label|Adverse Event|0|||
156835624|NCT01927055|566149393|FG002|Open-label|Adverse Event|0|||
156835625|NCT01927055|566149391|FG000|Open-label|Withdrawal by Subject|1|||
156835626|NCT01927055|566149392|FG001|Open-label|Withdrawal by Subject|0|||
156835627|NCT01927055|566149393|FG002|Open-label|Withdrawal by Subject|0|||
156835628|NCT01927055|566149391|FG000|Open-label|Study Stopped|4|||
156835629|NCT01927055|566149392|FG001|Open-label|Study Stopped|0|||
156835630|NCT01927055|566149393|FG002|Open-label|Study Stopped|0|||
156835631|NCT01927055|566149391|FG000|Open-label|Supine Hypertension|4|||
156835632|NCT01927055|566149392|FG001|Open-label|Supine Hypertension|0|||
156835633|NCT01927055|566149393|FG002|Open-label|Supine Hypertension|0|||
156835634|NCT01927055|566149391|FG000|Open-label|Difficulty attending study visits|1|||
156835635|NCT01927055|566149392|FG001|Open-label|Difficulty attending study visits|0|||
156835636|NCT01927055|566149393|FG002|Open-label|Difficulty attending study visits|0|||
156835637|NCT01927055|566149391|FG000|Double-Blind|Adverse Event|0|||
156835638|NCT01927055|566149392|FG001|Double-Blind|Adverse Event|1|||
156835639|NCT01927055|566149393|FG002|Double-Blind|Adverse Event|1|||
156835640|NCT01927055|566149391|FG000|Double-Blind|Protocol Violation|0|||
156835641|NCT01927055|566149392|FG001|Double-Blind|Protocol Violation|0|||
156835642|NCT01927055|566149393|FG002|Double-Blind|Protocol Violation|1|||
156835643|NCT01927055|566149391|FG000|Double-Blind|Withdrawal by Subject|0|||
156835644|NCT01927055|566149392|FG001|Double-Blind|Withdrawal by Subject|2|||
156835645|NCT01927055|566149393|FG002|Double-Blind|Withdrawal by Subject|3|||
156835646|NCT01927055|566149391|FG000|Double-Blind|Study Stopped|0|||
156835647|NCT01927055|566149392|FG001|Double-Blind|Study Stopped|7|||
156835648|NCT01927055|566149393|FG002|Double-Blind|Study Stopped|7|||
156835649|NCT01927055|566149391|FG000|Double-Blind|Supine Hypertension|0|||
156835650|NCT01927055|566149392|FG001|Double-Blind|Supine Hypertension|0|||
156835651|NCT01927055|566149393|FG002|Double-Blind|Supine Hypertension|1|||
156835652|NCT01927055|566149391|FG000|Double-Blind|Extended Vacation|0|||
156835653|NCT01927055|566149392|FG001|Double-Blind|Extended Vacation|1|||
156835654|NCT01927055|566149393|FG002|Double-Blind|Extended Vacation|0|||
156835655|NCT01378429|566149395|FG000|Overall Study|Noncompliance with study drug|1|||
156835656|NCT01378429|566149396|FG001|Overall Study|Noncompliance with study drug|0|||
156835657|NCT02241187|566149397|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
156835658|NCT02966015|566149398|FG000|Inclusion Visit|did not answer questionnaire|8|||
156835659|NCT02966015|566149399|FG001|Inclusion Visit|did not answer questionnaire|3|||
156835660|NCT02356887|566149400|FG000|Overall Study|poor compliance|2|||
156835661|NCT00199888|566149401|FG000|Overall Study|Lost to Follow-up|1|||
156835662|NCT04208087|566149402|FG000|Overall Study|Adverse Event|1|||
156835663|NCT04208087|566149403|FG001|Overall Study|Adverse Event|0|||
156835664|NCT04208087|566149404|FG002|Overall Study|Adverse Event|0|||
156835665|NCT04208087|566149405|FG003|Overall Study|Adverse Event|0|||
156835666|NCT04208087|566149406|FG004|Overall Study|Adverse Event|0|||
156835667|NCT04208087|566149402|FG000|Overall Study|Withdrawal by Subject|0|||
156835668|NCT04208087|566149403|FG001|Overall Study|Withdrawal by Subject|0|||
156835669|NCT04208087|566149404|FG002|Overall Study|Withdrawal by Subject|1|||
156835670|NCT04208087|566149405|FG003|Overall Study|Withdrawal by Subject|0|||
156835671|NCT04208087|566149406|FG004|Overall Study|Withdrawal by Subject|0|||
156340081|NCT02469298|564344297|FG001|Overall Study|Withdrawal by Subject|0|||
156340082|NCT02469298|564344298|FG002|Overall Study|Withdrawal by Subject|0|||
156340083|NCT02469298|564344299|FG003|Overall Study|Withdrawal by Subject|1|||
156340084|NCT03000439|564344302|FG000|Open Label Part 1|Adverse Event|6|||
156340085|NCT03000439|564344303|FG001|Open Label Part 1|Adverse Event|0|||
156835672|NCT04208087|566149402|FG000|Overall Study|Other|0|||
156340086|NCT03000439|564344304|FG002|Open Label Part 1|Adverse Event|0|||
156835673|NCT04208087|566149403|FG001|Overall Study|Other|0|||
156835674|NCT04208087|566149404|FG002|Overall Study|Other|0|||
156835675|NCT04208087|566149405|FG003|Overall Study|Other|0|||
156340087|NCT03000439|564344305|FG003|Open Label Part 1|Adverse Event|0|||
156340088|NCT03000439|564344302|FG000|Open Label Part 1|Other|2|||
156340089|NCT03000439|564344303|FG001|Open Label Part 1|Other|0|||
156835676|NCT04208087|566149406|FG004|Overall Study|Other|1|||
156835677|NCT01198509|566149407|FG000|Overall Study|Withdrawal by Subject|1|||
156835678|NCT01198509|566149408|FG001|Overall Study|Withdrawal by Subject|0|||
156835679|NCT01198509|566149409|FG002|Overall Study|Withdrawal by Subject|0|||
156835680|NCT01198509|566149410|FG003|Overall Study|Withdrawal by Subject|0|||
156835681|NCT01198509|566149411|FG004|Overall Study|Withdrawal by Subject|0|||
156835682|NCT01198509|566149412|FG005|Overall Study|Withdrawal by Subject|0|||
156835683|NCT00330668|566149413|FG000|BID Dosing Period|Adverse Event|1|||
156835684|NCT00330668|566149413|FG000|BID Dosing Period|Lost to Follow-up|7|||
156835685|NCT00330668|566149413|FG000|BID Dosing Period|Non-Compliance|5|||
156835686|NCT00330668|566149413|FG000|BID Dosing Period|Withdrawal by Subject|19|||
156835687|NCT00330668|566149413|FG000|BID Dosing Period|Sponsor's decision|1|||
156835688|NCT00330668|566149413|FG000|BID Dosing Period|Other|3|||
156835689|NCT00330668|566149413|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
156835690|NCT00330668|566149413|FG000|QD Dosing Period|Other|1|||
156835691|NCT00330668|566149413|FG000|QD Dosing Period|Withdrawal by Subject|1|||
156835692|NCT00330668|566149413|FG000|QD Dosing Period|Lost to Follow-up|2|||
156835693|NCT02621073|566149419|FG000|Overall Study|Lost to Follow-up|0|||
156835694|NCT02621073|566149420|FG001|Overall Study|Lost to Follow-up|1|||
156835695|NCT02621073|566149419|FG000|Overall Study|Physician Decision|3|||
156835696|NCT02621073|566149420|FG001|Overall Study|Physician Decision|2|||
156835697|NCT01012323|566149422|FG000|Overall Study|Investigator Judgment|1|||
156835698|NCT00495755|566149423|FG000|Overall Study|Adverse Event|3|||
156835699|NCT02920957|566149424|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
156835700|NCT02920957|566149425|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
156835701|NCT02920957|566149424|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
156835702|NCT02920957|566149425|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
156835703|NCT02920957|566149424|FG000|First Intervention : 1 Month|Adverse Event|1|||
156835704|NCT02920957|566149425|FG001|First Intervention : 1 Month|Adverse Event|0|||
156835705|NCT02920957|566149424|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
156835706|NCT02920957|566149425|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
156835707|NCT01789606|566149426|FG000|Overall Study|Participant not Purchased the Product|0|||
156835708|NCT01789606|566149427|FG001|Overall Study|Participant not Purchased the Product|20|||
156835709|NCT01789606|566149426|FG000|Overall Study|Withdrawal by Subject|0|||
156835710|NCT01789606|566149427|FG001|Overall Study|Withdrawal by Subject|1|||
156835711|NCT01789606|566149426|FG000|Overall Study|Ineligible|6|||
156835712|NCT01789606|566149427|FG001|Overall Study|Ineligible|2|||
156835713|NCT01789606|566149426|FG000|Overall Study|Administrative Reasons|17|||
156835714|NCT01789606|566149427|FG001|Overall Study|Administrative Reasons|6|||
156835715|NCT01789606|566149426|FG000|Overall Study|No Study Medication Taken|0|||
156835716|NCT01789606|566149427|FG001|Overall Study|No Study Medication Taken|1|||
156835717|NCT01789606|566149426|FG000|Overall Study|Protocol Violation|0|||
156835718|NCT01789606|566149427|FG001|Overall Study|Protocol Violation|55|||
156835719|NCT01789606|566149426|FG000|Overall Study|Adverse Event|0|||
156835720|NCT01789606|566149427|FG001|Overall Study|Adverse Event|3|||
156835721|NCT01789606|566149426|FG000|Overall Study|Lost to Follow-up|0|||
156835722|NCT01789606|566149427|FG001|Overall Study|Lost to Follow-up|14|||
156835723|NCT01789606|566149426|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
156835724|NCT01789606|566149427|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
156835725|NCT03180307|566149428|FG000|Overall Study|Lost to Follow-up|2|||
156835726|NCT03180307|566149429|FG001|Overall Study|Lost to Follow-up|0|||
156835727|NCT03180307|566149428|FG000|Overall Study|Death|1|||
156835728|NCT03180307|566149429|FG001|Overall Study|Death|0|||
156835729|NCT03180307|566149428|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
156835730|NCT03180307|566149429|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
156835731|NCT01563172|566149432|FG000|Overall Study|Adverse Event|5|||
156835732|NCT01563172|566149432|FG000|Overall Study|Lost to Follow-up|2|||
156835733|NCT01563172|566149432|FG000|Overall Study|Other (Protocol deviation)|5|||
156835734|NCT01563172|566149432|FG000|Overall Study|Other (Not specified)|1|||
156863411|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
156863412|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
156863413|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
156863414|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
156863415|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
156863416|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
156863417|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
156863418|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
156863419|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
156863420|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
156863421|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
156863422|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
156863423|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
156863424|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
156863425|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
156863426|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
156863427|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
156863428|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
156863429|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
156835735|NCT03268941|566151464|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835736|NCT03268941|566151465|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835737|NCT03268941|566151466|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835738|NCT03268941|566151467|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
156835739|NCT03268941|566151468|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835740|NCT03268941|566151469|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835741|NCT03268941|566151470|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835742|NCT03268941|566151464|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835743|NCT03268941|566151465|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835744|NCT03268941|566151466|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835745|NCT03268941|566151467|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
156835746|NCT03268941|566151468|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835747|NCT03268941|566151469|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835748|NCT03268941|566151470|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835749|NCT03268941|566151464|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
156835750|NCT03268941|566151465|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835751|NCT03268941|566151466|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835752|NCT03268941|566151467|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835753|NCT03268941|566151468|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835754|NCT03268941|566151469|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835755|NCT03268941|566151470|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835756|NCT03268941|566151464|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
156835757|NCT03268941|566151465|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
156835758|NCT03268941|566151466|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
156835759|NCT03268941|566151467|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
156835760|NCT03268941|566151468|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
156835761|NCT03268941|566151469|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
156835762|NCT03268941|566151470|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
156835763|NCT03268941|566151464|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835764|NCT03268941|566151465|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835765|NCT03268941|566151466|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835766|NCT03268941|566151467|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835767|NCT03268941|566151468|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835768|NCT03268941|566151469|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835769|NCT03268941|566151470|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
156835770|NCT02720692|566151475|FG000|Overall Study|Withdrawal by Subject|3|||
156835771|NCT02720692|566151476|FG001|Overall Study|Withdrawal by Subject|0|||
156835772|NCT02720692|566151475|FG000|Overall Study|Physician Decision|1|||
156835773|NCT02720692|566151476|FG001|Overall Study|Physician Decision|0|||
156835774|NCT02720692|566151475|FG000|Overall Study|Lost to Follow-up|8|||
156835775|NCT02720692|566151476|FG001|Overall Study|Lost to Follow-up|3|||
156835776|NCT02720692|566151475|FG000|Overall Study|Subject unable to return for visit|1|||
156835777|NCT02720692|566151476|FG001|Overall Study|Subject unable to return for visit|0|||
156835778|NCT03878758|566151477|FG000|Overall Study|Withdrawal by Subject|1|||
156835779|NCT03878758|566151477|FG000|Overall Study|Protocol defined|2|||
156835780|NCT03878758|566151477|FG000|Overall Study|Improper consent documentation|1|||
156835781|NCT01769196|566151478|FG000|Overall Study|Adverse Event|24|||
156835782|NCT01769196|566151479|FG001|Overall Study|Adverse Event|20|||
156835783|NCT01769196|566151478|FG000|Overall Study|Death|21|||
156835784|NCT01769196|566151479|FG001|Overall Study|Death|26|||
156835785|NCT01769196|566151478|FG000|Overall Study|Investigator Discretion|7|||
156835786|NCT01769196|566151479|FG001|Overall Study|Investigator Discretion|3|||
156835787|NCT01769196|566151478|FG000|Overall Study|Lack of Efficacy|3|||
156835788|NCT01769196|566151479|FG001|Overall Study|Lack of Efficacy|2|||
156835789|NCT01769196|566151478|FG000|Overall Study|Progressive disease|11|||
156835790|NCT01769196|566151479|FG001|Overall Study|Progressive disease|6|||
156835791|NCT01769196|566151478|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
156467467|NCT04191824|564806687|FG001|Overall Study|Protocol Violation|2|||
156467468|NCT04191824|564806686|FG000|Overall Study|Withdrawal by Subject|16|||
156467469|NCT04191824|564806687|FG001|Overall Study|Withdrawal by Subject|18|||
156467470|NCT04191824|564806686|FG000|Overall Study|Early site closure|24|||
156467471|NCT04191824|564806687|FG001|Overall Study|Early site closure|22|||
156467472|NCT01218009|564806690|FG000|Overall Study|Protocol Violation|2|||
156467473|NCT01218009|564806691|FG001|Overall Study|Protocol Violation|1|||
156835792|NCT01769196|566151479|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
156467474|NCT01218009|564806690|FG000|Overall Study|Withdrawal by Subject|3|||
156541399|NCT04969276|565074565|FG000|Overall Study|Lost to Follow-up|0|||
156835793|NCT01769196|566151478|FG000|Overall Study|Protocol Violation|0|||
156835794|NCT01769196|566151479|FG001|Overall Study|Protocol Violation|3|||
156835795|NCT01769196|566151478|FG000|Overall Study|Study terminated by sponsor|160|||
156835796|NCT01769196|566151479|FG001|Overall Study|Study terminated by sponsor|161|||
156835797|NCT01769196|566151478|FG000|Overall Study|Participant never dosed with study drug|1|||
156835798|NCT01769196|566151479|FG001|Overall Study|Participant never dosed with study drug|0|||
156467475|NCT01218009|564806691|FG001|Overall Study|Withdrawal by Subject|1|||
156835799|NCT01769196|566151478|FG000|Overall Study|Withdrew consent|36|||
156835800|NCT01769196|566151479|FG001|Overall Study|Withdrew consent|40|||
156835801|NCT00765063|566151480|FG000|Overall Study|Lack of Efficacy|5|||
156835802|NCT00765063|566151480|FG000|Overall Study|Withdrawal by Subject|1|||
156835803|NCT00765063|566151480|FG000|Overall Study|Other|16|||
156835804|NCT00765063|566151480|FG000|Overall Study|Protocol Violation|6|||
156835805|NCT00765063|566151480|FG000|Overall Study|Adverse Event|4|||
156835806|NCT03614325|566151481|FG000|Overall Study|Withdrawal by Subject|0|||
156835807|NCT03614325|566151482|FG001|Overall Study|Withdrawal by Subject|2|||
156835808|NCT03614325|566151481|FG000|Overall Study|Surgery Cancelled|2|||
156835809|NCT03614325|566151482|FG001|Overall Study|Surgery Cancelled|1|||
156835810|NCT03614325|566151481|FG000|Overall Study|Lost to Follow-up|2|||
156835811|NCT03614325|566151482|FG001|Overall Study|Lost to Follow-up|1|||
156835812|NCT03614325|566151481|FG000|Overall Study|Surgery never scheduled|1|||
156835813|NCT03614325|566151482|FG001|Overall Study|Surgery never scheduled|0|||
156835814|NCT00652951|566151489|FG000|Booster Phase|Adverse event, non-fatal|0|||
156835815|NCT00652951|566151490|FG001|Booster Phase|Adverse event, non-fatal|1|||
156835816|NCT00652951|566151491|FG002|Booster Phase|Adverse event, non-fatal|0|||
156835817|NCT00652951|566151489|FG000|Booster Phase|Other|1|||
156835818|NCT00652951|566151490|FG001|Booster Phase|Other|0|||
156835819|NCT00652951|566151491|FG002|Booster Phase|Other|0|||
156835820|NCT01022424|566151492|FG000|Overall Study|Adverse Event|1|||
156835821|NCT01022424|566151492|FG000|Overall Study|Physician Decision|1|||
156835822|NCT01022424|566151492|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
156835823|NCT01206582|566151493|FG000|Overall Study|Withdrew prior to study|1|||
156835824|NCT01206582|566151494|FG001|Overall Study|Withdrew prior to study|0|||
156835825|NCT01206582|566151493|FG000|Overall Study|Discontinued intervention before week 8|1|||
156835826|NCT01206582|566151494|FG001|Overall Study|Discontinued intervention before week 8|2|||
156835827|NCT02522325|566151495|FG000|Overall Study|Adverse Event|0|||
156835828|NCT02522325|566151496|FG001|Overall Study|Adverse Event|1|||
156835829|NCT02100969|566151499|FG000|Overall Study|Did not pass screening phase|1|||
156835850|NCT01629953|566151502|FG000|Overall Study|Death|3|||
156835851|NCT01629953|566151503|FG001|Overall Study|Death|1|||
156835852|NCT01629953|566151502|FG000|Overall Study|Lost to Follow-up|10|||
156835853|NCT01629953|566151503|FG001|Overall Study|Lost to Follow-up|14|||
156835854|NCT00720343|566151504|FG000|Overall Study|Lost to Follow-up|1|||
156835855|NCT00720343|566151505|FG001|Overall Study|Lost to Follow-up|0|||
156835856|NCT00720343|566151504|FG000|Overall Study|Protocol Violation|0|||
156835857|NCT00720343|566151505|FG001|Overall Study|Protocol Violation|2|||
156835858|NCT03459365|566151508|FG000|Overall Study|Withdrawal by Subject|6|||
156835859|NCT03459365|566151508|FG000|Overall Study|Protocol Violation|8|||
156835860|NCT00707954|566151509|FG000|Overall Study|Physician Decision|0|||
156835861|NCT00707954|566151510|FG001|Overall Study|Physician Decision|0|||
156835862|NCT00707954|566151511|FG002|Overall Study|Physician Decision|0|||
156835863|NCT00707954|566151512|FG003|Overall Study|Physician Decision|0|||
156835864|NCT00707954|566151513|FG004|Overall Study|Physician Decision|1|||
156835865|NCT00344500|566151515|FG000|Overall Study|Adverse Event|6|||
156835866|NCT00344500|566151516|FG001|Overall Study|Adverse Event|2|||
156835867|NCT00344500|566151517|FG002|Overall Study|Adverse Event|0|||
156835868|NCT00344500|566151515|FG000|Overall Study|Lost to Follow-up|5|||
156835869|NCT00344500|566151516|FG001|Overall Study|Lost to Follow-up|13|||
156835870|NCT00344500|566151517|FG002|Overall Study|Lost to Follow-up|1|||
156835871|NCT00344500|566151515|FG000|Overall Study|Withdrawal by Subject|7|||
156835872|NCT00344500|566151516|FG001|Overall Study|Withdrawal by Subject|10|||
156835873|NCT00344500|566151517|FG002|Overall Study|Withdrawal by Subject|0|||
156835874|NCT00344500|566151515|FG000|Overall Study|Protocol Violation|4|||
156835875|NCT00344500|566151516|FG001|Overall Study|Protocol Violation|7|||
156835876|NCT00344500|566151517|FG002|Overall Study|Protocol Violation|1|||
156835877|NCT00344500|566151515|FG000|Overall Study|Not Noted|1|||
156835878|NCT00344500|566151516|FG001|Overall Study|Not Noted|3|||
156835879|NCT00344500|566151517|FG002|Overall Study|Not Noted|0|||
156835880|NCT00599755|566151518|FG000|Overall Study|Adverse Event|11|||
156835881|NCT00599755|566151518|FG000|Overall Study|Withdrawal by Subject|2|||
156835882|NCT00599755|566151518|FG000|Overall Study|Progression of Disease|3|||
156835883|NCT00599755|566151518|FG000|Overall Study|Other Reason|2|||
156835884|NCT00599755|566151518|FG000|Overall Study|No data available|1|||
156835885|NCT04037254|566151519|FG000|Overall Study|Protocol Violation|1|||
156835886|NCT04037254|566151520|FG001|Overall Study|Protocol Violation|0|||
156835887|NCT04037254|566151521|FG002|Overall Study|Protocol Violation|0|||
156835888|NCT04037254|566151522|FG003|Overall Study|Protocol Violation|0|||
156835889|NCT04037254|566151523|FG004|Overall Study|Protocol Violation|0|||
156835890|NCT04037254|566151519|FG000|Overall Study|Withdrawal by Subject|0|||
156835891|NCT04037254|566151520|FG001|Overall Study|Withdrawal by Subject|0|||
156835892|NCT04037254|566151521|FG002|Overall Study|Withdrawal by Subject|1|||
156835893|NCT04037254|566151522|FG003|Overall Study|Withdrawal by Subject|0|||
156835894|NCT04037254|566151523|FG004|Overall Study|Withdrawal by Subject|0|||
156835895|NCT04037254|566151519|FG000|Overall Study|Delayed or incomplete treatment|0|||
156835896|NCT04037254|566151520|FG001|Overall Study|Delayed or incomplete treatment|2|||
156835897|NCT04037254|566151521|FG002|Overall Study|Delayed or incomplete treatment|1|||
156835898|NCT04037254|566151522|FG003|Overall Study|Delayed or incomplete treatment|0|||
156835899|NCT04037254|566151523|FG004|Overall Study|Delayed or incomplete treatment|0|||
156835900|NCT01306656|566151524|FG000|Overall Study|Lost to Follow-up|1|||
156835901|NCT01306656|566151525|FG001|Overall Study|Lost to Follow-up|0|||
156835902|NCT02504580|566151529|FG000|Overall Study|Other|1|||
156835903|NCT02504580|566151530|FG001|Overall Study|Other|0|||
156835904|NCT02504580|566151531|FG002|Overall Study|Other|0|||
156835905|NCT02504580|566151532|FG003|Overall Study|Other|2|||
156835906|NCT02504580|566151533|FG004|Overall Study|Other|1|||
156835907|NCT02504580|566151534|FG005|Overall Study|Other|1|||
156835908|NCT02504580|566151535|FG006|Overall Study|Other|1|||
156835909|NCT02504580|566151536|FG007|Overall Study|Other|2|||
156835910|NCT02504580|566151537|FG008|Overall Study|Other|0|||
156835911|NCT02504580|566151538|FG009|Overall Study|Other|0|||
156835912|NCT02504580|566151539|FG010|Overall Study|Other|0|||
156835913|NCT02504580|566151540|FG011|Overall Study|Other|2|||
156835914|NCT02504580|566151529|FG000|Overall Study|Subject refusal to continue|0|||
156835915|NCT02504580|566151530|FG001|Overall Study|Subject refusal to continue|1|||
156835916|NCT02504580|566151531|FG002|Overall Study|Subject refusal to continue|0|||
156835917|NCT02504580|566151532|FG003|Overall Study|Subject refusal to continue|0|||
156835918|NCT02504580|566151533|FG004|Overall Study|Subject refusal to continue|0|||
156835919|NCT02504580|566151534|FG005|Overall Study|Subject refusal to continue|0|||
156835920|NCT02504580|566151535|FG006|Overall Study|Subject refusal to continue|0|||
156835921|NCT02504580|566151536|FG007|Overall Study|Subject refusal to continue|0|||
156835922|NCT02504580|566151537|FG008|Overall Study|Subject refusal to continue|0|||
156835923|NCT02504580|566151538|FG009|Overall Study|Subject refusal to continue|0|||
156835924|NCT02504580|566151539|FG010|Overall Study|Subject refusal to continue|0|||
156835925|NCT02504580|566151540|FG011|Overall Study|Subject refusal to continue|0|||
156835926|NCT04736628|566151543|FG000|Overall Study|Not treated|0|||
156835927|NCT04736628|566151544|FG001|Overall Study|Not treated|0|||
156835928|NCT04736628|566151545|FG002|Overall Study|Not treated|0|||
156467476|NCT01218009|564806690|FG000|Overall Study|Sponsor terminated study|161|||
156467477|NCT01218009|564806691|FG001|Overall Study|Sponsor terminated study|163|||
156467478|NCT01324310|564806692|FG000|Overall Study|Adverse Event|1|||
156467479|NCT01324310|564806692|FG000|Overall Study|Disease Progression|1|||
156467480|NCT03170882|564806693|FG000|Overall Study|Death|17|||
156467481|NCT03170882|564806694|FG001|Overall Study|Death|29|||
156835929|NCT04736628|566151546|FG003|Overall Study|Not treated|2|||
156835930|NCT04736628|566151543|FG000|Overall Study|Other reason than listed|1|||
156835931|NCT04736628|566151544|FG001|Overall Study|Other reason than listed|2|||
156467482|NCT03170882|564806693|FG000|Overall Study|Lost to Follow-up|0|||
156467483|NCT03170882|564806694|FG001|Overall Study|Lost to Follow-up|1|||
156835932|NCT04736628|566151545|FG002|Overall Study|Other reason than listed|2|||
156835933|NCT04736628|566151546|FG003|Overall Study|Other reason than listed|3|||
156835934|NCT04736628|566151543|FG000|Overall Study|Protocol deviation|0|||
156835935|NCT04736628|566151544|FG001|Overall Study|Protocol deviation|0|||
156835936|NCT04736628|566151545|FG002|Overall Study|Protocol deviation|0|||
156835937|NCT04736628|566151546|FG003|Overall Study|Protocol deviation|1|||
156835938|NCT04736628|566151543|FG000|Overall Study|Burden of study procedures|1|||
156835939|NCT04736628|566151544|FG001|Overall Study|Burden of study procedures|0|||
156835940|NCT04736628|566151545|FG002|Overall Study|Burden of study procedures|0|||
156467484|NCT03170882|564806693|FG000|Overall Study|Withdrawal by Subject|4|||
156835941|NCT04736628|566151546|FG003|Overall Study|Burden of study procedures|1|||
156835942|NCT04736628|566151543|FG000|Overall Study|Change of residence|0|||
156835943|NCT04736628|566151544|FG001|Overall Study|Change of residence|1|||
156835944|NCT04736628|566151545|FG002|Overall Study|Change of residence|0|||
156835945|NCT04736628|566151546|FG003|Overall Study|Change of residence|0|||
156835946|NCT04736628|566151543|FG000|Overall Study|Perceived lack of efficacy|1|||
156835947|NCT04736628|566151544|FG001|Overall Study|Perceived lack of efficacy|0|||
156835948|NCT04736628|566151545|FG002|Overall Study|Perceived lack of efficacy|0|||
156835949|NCT04736628|566151546|FG003|Overall Study|Perceived lack of efficacy|1|||
156835950|NCT04736628|566151543|FG000|Overall Study|Adverse Event|3|||
156835951|NCT04736628|566151544|FG001|Overall Study|Adverse Event|2|||
156835952|NCT04736628|566151545|FG002|Overall Study|Adverse Event|4|||
156835953|NCT04736628|566151546|FG003|Overall Study|Adverse Event|3|||
156835954|NCT00680368|566151547|FG000|Overall Study|not supervised, not eligible|15|||
156835955|NCT04094584|566151549|FG000|Overall Study|No interest in study|88|||
156835956|NCT04094584|566151549|FG000|Overall Study|Unwilling to undergo screening tests|36|||
156835957|NCT04094584|566151549|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
156835958|NCT04094584|566151549|FG000|Overall Study|Opioid use|7|||
156835959|NCT04094584|566151549|FG000|Overall Study|Need for major surgery in study period|4|||
156835960|NCT04094584|566151549|FG000|Overall Study|eligible but declined enrollment|4|||
156835961|NCT04094584|566151549|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
156835962|NCT04094584|566151549|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
156835963|NCT04094584|566151549|FG000|Overall Study|Lost to Follow-up|3|||
156835964|NCT04094584|566151549|FG000|Overall Study|Withdrawal by Subject|2|||
156835965|NCT00652899|566151553|FG000|Overall Study|Death|1|||
156835966|NCT00652899|566151553|FG000|Overall Study|Treating physician decision|1|||
156835967|NCT04135859|566151554|FG000|Overall Study|Withdrawal by Subject|1|||
156835968|NCT04135859|566151555|FG001|Overall Study|Withdrawal by Subject|0|||
156835969|NCT04135859|566151554|FG000|Overall Study|Withdrawal due to screening failure|1|||
156835970|NCT04135859|566151555|FG001|Overall Study|Withdrawal due to screening failure|2|||
156835971|NCT04135859|566151554|FG000|Overall Study|Did not complete stress test|3|||
156835972|NCT04135859|566151555|FG001|Overall Study|Did not complete stress test|3|||
156835973|NCT04135859|566151554|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
156835974|NCT04135859|566151555|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
156835975|NCT01600053|566151556|FG000|Overall Study|Adverse Event|2|||
156835976|NCT01600053|566151556|FG000|Overall Study|trial will not meet the interim endpoint|9|||
156835977|NCT01565941|566151557|FG000|Overall Study|Withdrawn by parent/guardian|3|||
156835978|NCT01565941|566151558|FG001|Overall Study|Withdrawn by parent/guardian|2|||
156835979|NCT01565941|566151557|FG000|Overall Study|Randomized; did not receive intevention|8|||
156835980|NCT01565941|566151558|FG001|Overall Study|Randomized; did not receive intevention|2|||
156835981|NCT03629912|566151564|FG000|Overall Study|Lost to Follow-up|19|||
156835982|NCT03629912|566151565|FG001|Overall Study|Lost to Follow-up|7|||
156835983|NCT03629912|566151566|FG002|Overall Study|Lost to Follow-up|5|||
156835984|NCT03629912|566151567|FG003|Overall Study|Lost to Follow-up|1|||
156835985|NCT03629912|566151564|FG000|Overall Study|Withdrawal by Subject|6|||
156835986|NCT03629912|566151565|FG001|Overall Study|Withdrawal by Subject|0|||
156835987|NCT03629912|566151566|FG002|Overall Study|Withdrawal by Subject|1|||
156835988|NCT03629912|566151567|FG003|Overall Study|Withdrawal by Subject|2|||
156835989|NCT03629912|566151564|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
156835990|NCT03629912|566151565|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
156835991|NCT03629912|566151566|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
156835992|NCT03629912|566151567|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
156835993|NCT03629912|566151564|FG000|Overall Study|Death|1|||
156835994|NCT03629912|566151565|FG001|Overall Study|Death|0|||
156835995|NCT03629912|566151566|FG002|Overall Study|Death|0|||
156835996|NCT03629912|566151567|FG003|Overall Study|Death|0|||
156835997|NCT02049138|566151573|FG000|Overall Study|Adverse Event|46|||
156835998|NCT02049138|566151574|FG001|Overall Study|Adverse Event|25|||
156835999|NCT02049138|566151575|FG002|Overall Study|Adverse Event|1|||
156836000|NCT02049138|566151573|FG000|Overall Study|Withdrawal by Subject|57|||
156836001|NCT02049138|566151574|FG001|Overall Study|Withdrawal by Subject|21|||
156836002|NCT02049138|566151575|FG002|Overall Study|Withdrawal by Subject|5|||
156836003|NCT02049138|566151573|FG000|Overall Study|Lost to Follow-up|18|||
156836004|NCT02049138|566151574|FG001|Overall Study|Lost to Follow-up|5|||
156836005|NCT02049138|566151575|FG002|Overall Study|Lost to Follow-up|1|||
156340090|NCT03000439|564344304|FG002|Open Label Part 1|Other|0|||
156340091|NCT03000439|564344305|FG003|Open Label Part 1|Other|0|||
156836006|NCT02049138|566151573|FG000|Overall Study|Lack of Efficacy|10|||
156836007|NCT02049138|566151574|FG001|Overall Study|Lack of Efficacy|26|||
156836008|NCT02049138|566151575|FG002|Overall Study|Lack of Efficacy|1|||
156836009|NCT02049138|566151573|FG000|Overall Study|Non-Compliance|15|||
156836010|NCT02049138|566151574|FG001|Overall Study|Non-Compliance|6|||
156836011|NCT02049138|566151575|FG002|Overall Study|Non-Compliance|0|||
156541400|NCT04969276|565074566|FG001|Overall Study|Lost to Follow-up|1|||
156340092|NCT03000439|564344302|FG000|Open Label Part 1|Insufficient clinical response|16|||
156836012|NCT02049138|566151573|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
156836013|NCT02049138|566151574|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
156836014|NCT02049138|566151575|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
156836015|NCT02049138|566151573|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
156836016|NCT02049138|566151574|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
156836017|NCT02049138|566151575|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
156836018|NCT02049138|566151573|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
156836019|NCT02049138|566151574|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
156836020|NCT02049138|566151575|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
156836021|NCT02049138|566151573|FG000|Overall Study|Other|15|||
156836022|NCT02049138|566151574|FG001|Overall Study|Other|13|||
156836023|NCT02049138|566151575|FG002|Overall Study|Other|0|||
156836024|NCT02049138|566151573|FG000|Overall Study|Missing|0|||
156836025|NCT02049138|566151574|FG001|Overall Study|Missing|1|||
156836026|NCT02049138|566151575|FG002|Overall Study|Missing|0|||
156836027|NCT05086510|566151576|FG000|Overall Study|Lost to Follow-up|0|||
156836028|NCT05086510|566151577|FG001|Overall Study|Lost to Follow-up|2|||
156836029|NCT05086510|566151576|FG000|Overall Study|Death|0|||
156836030|NCT05086510|566151577|FG001|Overall Study|Death|2|||
156836031|NCT00521222|566151578|FG000|Overall Study|Lost to Follow-up|0|||
156836032|NCT00521222|566151579|FG001|Overall Study|Lost to Follow-up|0|||
156836033|NCT00521222|566151580|FG002|Overall Study|Lost to Follow-up|1|||
156836034|NCT00521222|566151581|FG003|Overall Study|Lost to Follow-up|1|||
156836035|NCT00521222|566151578|FG000|Overall Study|Withdrawal by Subject|0|||
156836036|NCT00521222|566151579|FG001|Overall Study|Withdrawal by Subject|0|||
156836037|NCT00521222|566151580|FG002|Overall Study|Withdrawal by Subject|2|||
156836038|NCT00521222|566151581|FG003|Overall Study|Withdrawal by Subject|0|||
156836039|NCT00521222|566151578|FG000|Overall Study|Physician Decision|0|||
156836040|NCT00521222|566151579|FG001|Overall Study|Physician Decision|1|||
156836041|NCT00521222|566151580|FG002|Overall Study|Physician Decision|0|||
156836042|NCT00521222|566151581|FG003|Overall Study|Physician Decision|1|||
156836043|NCT02598128|566151584|FG000|Period A: Days -7 to -1|Adverse Event|1|||
156836044|NCT02598128|566151585|FG001|Period A: Days -7 to -1|Adverse Event|0|||
156836045|NCT02598128|566151586|FG002|Period A: Days -7 to -1|Adverse Event|0|||
156836046|NCT02598128|566151587|FG003|Period A: Days -7 to -1|Adverse Event|0|||
156836047|NCT01064687|566151588|FG000|Overall Study|Adverse Event|9|||
156836048|NCT01064687|566151589|FG001|Overall Study|Adverse Event|4|||
156836049|NCT01064687|566151590|FG002|Overall Study|Adverse Event|10|||
156836050|NCT01064687|566151591|FG003|Overall Study|Adverse Event|3|||
156836051|NCT01064687|566151588|FG000|Overall Study|Death|1|||
156836052|NCT01064687|566151589|FG001|Overall Study|Death|1|||
156836053|NCT01064687|566151590|FG002|Overall Study|Death|0|||
156836054|NCT01064687|566151591|FG003|Overall Study|Death|0|||
156541401|NCT04969276|565074567|FG002|Overall Study|Lost to Follow-up|0|||
156836055|NCT01064687|566151588|FG000|Overall Study|Entry Criteria Not Met|3|||
156836056|NCT01064687|566151589|FG001|Overall Study|Entry Criteria Not Met|0|||
156836057|NCT01064687|566151590|FG002|Overall Study|Entry Criteria Not Met|0|||
156836058|NCT01064687|566151591|FG003|Overall Study|Entry Criteria Not Met|0|||
156836059|NCT01064687|566151588|FG000|Overall Study|Lack of Efficacy|1|||
156836060|NCT01064687|566151589|FG001|Overall Study|Lack of Efficacy|0|||
156836061|NCT01064687|566151590|FG002|Overall Study|Lack of Efficacy|2|||
156836062|NCT01064687|566151591|FG003|Overall Study|Lack of Efficacy|3|||
156836063|NCT01064687|566151588|FG000|Overall Study|Lost to Follow-up|7|||
156836064|NCT01064687|566151589|FG001|Overall Study|Lost to Follow-up|10|||
156836065|NCT01064687|566151590|FG002|Overall Study|Lost to Follow-up|13|||
156836066|NCT01064687|566151591|FG003|Overall Study|Lost to Follow-up|5|||
156836067|NCT01064687|566151588|FG000|Overall Study|Physician Decision|2|||
156836068|NCT01064687|566151589|FG001|Overall Study|Physician Decision|2|||
156836069|NCT01064687|566151590|FG002|Overall Study|Physician Decision|0|||
156836070|NCT01064687|566151591|FG003|Overall Study|Physician Decision|0|||
156836071|NCT01064687|566151588|FG000|Overall Study|Protocol Violation|1|||
156836072|NCT01064687|566151589|FG001|Overall Study|Protocol Violation|1|||
156836073|NCT01064687|566151590|FG002|Overall Study|Protocol Violation|0|||
156836074|NCT01064687|566151591|FG003|Overall Study|Protocol Violation|1|||
156836075|NCT01064687|566151588|FG000|Overall Study|Sponsor Decision|0|||
156836076|NCT01064687|566151589|FG001|Overall Study|Sponsor Decision|0|||
156836077|NCT01064687|566151590|FG002|Overall Study|Sponsor Decision|3|||
156836078|NCT01064687|566151591|FG003|Overall Study|Sponsor Decision|0|||
156836079|NCT01064687|566151588|FG000|Overall Study|Withdrawal by Subject|9|||
156836080|NCT01064687|566151589|FG001|Overall Study|Withdrawal by Subject|7|||
156836081|NCT01064687|566151590|FG002|Overall Study|Withdrawal by Subject|12|||
156836082|NCT01064687|566151591|FG003|Overall Study|Withdrawal by Subject|5|||
156836083|NCT01064687|566151588|FG000|Overall Study|Treatment Noncompliance|1|||
156836084|NCT01064687|566151589|FG001|Overall Study|Treatment Noncompliance|1|||
156836085|NCT01064687|566151590|FG002|Overall Study|Treatment Noncompliance|1|||
156836086|NCT01064687|566151591|FG003|Overall Study|Treatment Noncompliance|0|||
156836087|NCT05219669|566151594|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836088|NCT05219669|566151595|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836089|NCT05219669|566151596|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
156836090|NCT05219669|566151597|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836091|NCT05219669|566151598|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836092|NCT05219669|566151599|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836093|NCT03134183|566151601|FG000|Overall Study|Withdrawal by Subject|1|||
156836094|NCT03134183|566151602|FG001|Overall Study|Withdrawal by Subject|1|||
156836095|NCT02177838|566151603|FG000|Overall Study|Withdrawal by Subject|1|||
156836096|NCT02177838|566151603|FG000|Overall Study|Physician Decision|1|||
156836097|NCT02177838|566151603|FG000|Overall Study|Death|1|||
156836098|NCT02404649|566151604|FG000|Overall Study|Adverse Event|1|||
156836099|NCT02404649|566151605|FG001|Overall Study|Adverse Event|2|||
156836100|NCT01595581|566151615|FG000|Overall Study|Withdrawal by Subject|1|||
156836101|NCT01595581|566151616|FG001|Overall Study|Withdrawal by Subject|0|||
156836102|NCT01969721|566151619|FG000|Overall Study|Adverse Event|3|||
156836103|NCT01969721|566151620|FG001|Overall Study|Adverse Event|8|||
156836104|NCT01969721|566151621|FG002|Overall Study|Adverse Event|3|||
156836105|NCT01969721|566151622|FG003|Overall Study|Adverse Event|2|||
156836106|NCT01969721|566151619|FG000|Overall Study|Lack of Efficacy|0|||
156836107|NCT01969721|566151620|FG001|Overall Study|Lack of Efficacy|0|||
156836108|NCT01969721|566151621|FG002|Overall Study|Lack of Efficacy|1|||
156836109|NCT01969721|566151622|FG003|Overall Study|Lack of Efficacy|0|||
156836110|NCT01969721|566151619|FG000|Overall Study|Non compliant with protocol|1|||
156836111|NCT01969721|566151620|FG001|Overall Study|Non compliant with protocol|1|||
156836112|NCT01969721|566151621|FG002|Overall Study|Non compliant with protocol|0|||
156836113|NCT01969721|566151622|FG003|Overall Study|Non compliant with protocol|2|||
156836114|NCT01969721|566151619|FG000|Overall Study|Other not defined above|0|||
156836115|NCT01969721|566151620|FG001|Overall Study|Other not defined above|2|||
156836116|NCT01969721|566151621|FG002|Overall Study|Other not defined above|0|||
156467485|NCT03170882|564806694|FG001|Overall Study|Withdrawal by Subject|7|||
156467486|NCT03170882|564806693|FG000|Overall Study|Reason not Specified|28|||
156467487|NCT03170882|564806694|FG001|Overall Study|Reason not Specified|36|||
156467488|NCT01371994|564806698|FG000|Overall Study|Adverse Event|3|||
156836117|NCT01969721|566151622|FG003|Overall Study|Other not defined above|0|||
156836118|NCT01969721|566151619|FG000|Overall Study|Discontinued during washout periods.|0|||
156836119|NCT01969721|566151620|FG001|Overall Study|Discontinued during washout periods.|1|||
156836120|NCT01969721|566151621|FG002|Overall Study|Discontinued during washout periods.|1|||
156836121|NCT01969721|566151622|FG003|Overall Study|Discontinued during washout periods.|2|||
156836122|NCT02273960|566151623|FG000|Short Term Period|Lost to Follow-up|1|||
156836123|NCT02273960|566151624|FG001|Short Term Period|Lost to Follow-up|0|||
156836124|NCT02273960|566151625|FG002|Short Term Period|Lost to Follow-up|0|||
156836125|NCT02273960|566151626|FG003|Short Term Period|Lost to Follow-up|0|||
156836126|NCT02273960|566151623|FG000|Short Term Period|Lack of Efficacy|0|||
156836127|NCT02273960|566151624|FG001|Short Term Period|Lack of Efficacy|0|||
156836128|NCT02273960|566151625|FG002|Short Term Period|Lack of Efficacy|0|||
156836129|NCT02273960|566151626|FG003|Short Term Period|Lack of Efficacy|1|||
156836130|NCT02273960|566151623|FG000|Short Term Period|ST complete, not entering LTE|4|||
156836131|NCT02273960|566151624|FG001|Short Term Period|ST complete, not entering LTE|6|||
156836132|NCT02273960|566151625|FG002|Short Term Period|ST complete, not entering LTE|4|||
156836133|NCT02273960|566151626|FG003|Short Term Period|ST complete, not entering LTE|5|||
156836134|NCT02273960|566151623|FG000|Long Term Extension|Death|0|||
156836135|NCT02273960|566151624|FG001|Long Term Extension|Death|0|||
156836136|NCT02273960|566151625|FG002|Long Term Extension|Death|0|||
156836137|NCT02273960|566151626|FG003|Long Term Extension|Death|1|||
156836138|NCT01105377|566151632|FG000|Overall Study|Withdrawal by Subject|0|||
156836139|NCT01105377|566151633|FG001|Overall Study|Withdrawal by Subject|1|||
156836140|NCT00483002|566151635|FG000|Overall Study|Adverse Event|68|||
156836141|NCT00483002|566151635|FG000|Overall Study|Lack of Efficacy|555|||
156836142|NCT00483002|566151635|FG000|Overall Study|Lost to Follow-up|962|||
156836143|NCT00483002|566151635|FG000|Overall Study|Other|2|||
156836144|NCT00483002|566151635|FG000|Overall Study|Other|967|||
156836145|NCT02014584|566151636|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156467489|NCT01371994|564806699|FG001|Overall Study|Adverse Event|6|||
156467490|NCT01371994|564806698|FG000|Overall Study|Lack of Efficacy|3|||
156467491|NCT01371994|564806699|FG001|Overall Study|Lack of Efficacy|0|||
156836146|NCT02014584|566151637|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
156836147|NCT02014584|566151638|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156836148|NCT02014584|566151639|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156467492|NCT01371994|564806698|FG000|Overall Study|Withdrawal by Subject|13|||
156467493|NCT01371994|564806699|FG001|Overall Study|Withdrawal by Subject|7|||
156467494|NCT01371994|564806698|FG000|Overall Study|Lost to Follow-up|1|||
156836149|NCT02014584|566151640|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156836150|NCT02014584|566151641|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156836151|NCT02014584|566151636|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
156836152|NCT02014584|566151637|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
156836153|NCT02014584|566151638|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156467495|NCT01371994|564806699|FG001|Overall Study|Lost to Follow-up|1|||
156467496|NCT01371994|564806698|FG000|Overall Study|Protocol Violation|24|||
156467497|NCT01371994|564806699|FG001|Overall Study|Protocol Violation|17|||
156467498|NCT01371994|564806698|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
156467499|NCT01371994|564806699|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
156467500|NCT01371994|564806698|FG000|Overall Study|Physician Decision|1|||
156467501|NCT01371994|564806699|FG001|Overall Study|Physician Decision|1|||
156467502|NCT01371994|564806698|FG000|Overall Study|Miscellaneous Reasons|6|||
156467503|NCT01371994|564806699|FG001|Overall Study|Miscellaneous Reasons|4|||
156467504|NCT00087685|564806700|FG000|Overall Study|Adverse Event|5|||
156836154|NCT02014584|566151639|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156836155|NCT02014584|566151640|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156836156|NCT02014584|566151641|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156836157|NCT02014584|566151636|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836158|NCT02014584|566151637|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836159|NCT02014584|566151638|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
156836160|NCT02014584|566151639|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836161|NCT02014584|566151640|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836162|NCT02014584|566151641|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836163|NCT02014584|566151636|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
156836164|NCT02014584|566151637|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
156836165|NCT02014584|566151638|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
156836166|NCT02014584|566151639|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
156836167|NCT02014584|566151640|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
156836168|NCT02014584|566151641|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
156836169|NCT02014584|566151636|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836170|NCT02014584|566151637|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836171|NCT02014584|566151638|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836172|NCT02014584|566151639|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836173|NCT02014584|566151640|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
156836174|NCT02014584|566151641|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836175|NCT02651220|566151642|FG000|Overall Study|Adverse Event|1|||
156836176|NCT02651220|566151643|FG001|Overall Study|Adverse Event|5|||
156836177|NCT02651220|566151644|FG002|Overall Study|Adverse Event|1|||
156836178|NCT02651220|566151642|FG000|Overall Study|Lost to Follow-up|8|||
156836179|NCT02651220|566151643|FG001|Overall Study|Lost to Follow-up|14|||
156836180|NCT02651220|566151644|FG002|Overall Study|Lost to Follow-up|14|||
156836181|NCT02651220|566151642|FG000|Overall Study|Non-Compliance with Study Drug|4|||
156836182|NCT02651220|566151643|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156836183|NCT02651220|566151644|FG002|Overall Study|Non-Compliance with Study Drug|1|||
156836184|NCT02651220|566151642|FG000|Overall Study|Pregnancy|1|||
156836185|NCT02651220|566151643|FG001|Overall Study|Pregnancy|0|||
156836186|NCT02651220|566151644|FG002|Overall Study|Pregnancy|1|||
156836187|NCT02651220|566151642|FG000|Overall Study|Protocol Violation|0|||
156836188|NCT02651220|566151643|FG001|Overall Study|Protocol Violation|0|||
156836189|NCT02651220|566151644|FG002|Overall Study|Protocol Violation|1|||
156836190|NCT02651220|566151642|FG000|Overall Study|Withdrawal by Subject|5|||
156836191|NCT02651220|566151643|FG001|Overall Study|Withdrawal by Subject|6|||
156836192|NCT02651220|566151644|FG002|Overall Study|Withdrawal by Subject|8|||
156836193|NCT02651220|566151642|FG000|Overall Study|Miscellaneous|4|||
156836194|NCT02651220|566151643|FG001|Overall Study|Miscellaneous|1|||
156836195|NCT02651220|566151644|FG002|Overall Study|Miscellaneous|2|||
156836196|NCT02651220|566151642|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156836197|NCT02651220|566151643|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156836198|NCT02651220|566151644|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
156836199|NCT00447122|566151645|FG000|Overall Study|worsening medical condition -came off|0|||
156836200|NCT00447122|566151646|FG001|Overall Study|worsening medical condition -came off|1|||
156836201|NCT00447122|566151647|FG002|Overall Study|worsening medical condition -came off|0|||
156836202|NCT00447122|566151648|FG003|Overall Study|worsening medical condition -came off|0|||
156836203|NCT01439373|566151653|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
156836204|NCT01439373|566151654|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
156836205|NCT01439373|566151653|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
156836206|NCT01439373|566151654|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
156836207|NCT04046250|566151657|FG000|Overall Study|Death|0|||
156836208|NCT04046250|566151658|FG001|Overall Study|Death|1|||
156836209|NCT04046250|566151657|FG000|Overall Study|Withdrawal by Subject|3|||
156467505|NCT00087685|564806700|FG000|Overall Study|Non-Compliance|1|||
156467506|NCT00087685|564806700|FG000|Overall Study|Progressive Disease|5|||
156467507|NCT00087685|564806700|FG000|Overall Study|Withdrawal by Subject|3|||
156467508|NCT03891758|564806702|FG000|Overall Study|Adverse Event|2|||
156467509|NCT03891758|564806703|FG001|Overall Study|Adverse Event|0|||
156836210|NCT04046250|566151658|FG001|Overall Study|Withdrawal by Subject|3|||
156467510|NCT03891758|564806702|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156467511|NCT03891758|564806703|FG001|Overall Study|Withdrawal by parent/guardian|2|||
156467512|NCT01983683|564806704|FG000|Overall Study|Withdrawal by Subject|14|||
156467513|NCT01983683|564806705|FG001|Overall Study|Withdrawal by Subject|18|||
156467514|NCT01983683|564806704|FG000|Overall Study|Death|11|||
156467515|NCT01983683|564806705|FG001|Overall Study|Death|15|||
156467516|NCT01983683|564806704|FG000|Overall Study|Physician Decision|8|||
156467517|NCT01983683|564806705|FG001|Overall Study|Physician Decision|9|||
156467518|NCT01983683|564806704|FG000|Overall Study|Lost to Follow-up|4|||
156467519|NCT01983683|564806705|FG001|Overall Study|Lost to Follow-up|8|||
156467520|NCT01983683|564806704|FG000|Overall Study|Sponsor Decision|1|||
156467521|NCT01983683|564806705|FG001|Overall Study|Sponsor Decision|1|||
156467522|NCT00536120|564807395|FG000|Overall Study|Lost to Follow-up|1|||
156467523|NCT00536120|564807396|FG001|Overall Study|Lost to Follow-up|0|||
156467524|NCT00536120|564807395|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
156467525|NCT00536120|564807396|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
156467526|NCT00536120|564807395|FG000|Overall Study|Non-compliance|1|||
156467527|NCT00536120|564807396|FG001|Overall Study|Non-compliance|0|||
156467528|NCT00536120|564807395|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
156467529|NCT00536120|564807396|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
156467530|NCT00536120|564807395|FG000|Overall Study|Steroid Use|0|||
156467531|NCT00536120|564807396|FG001|Overall Study|Steroid Use|2|||
156467532|NCT00536120|564807395|FG000|Overall Study|Missed Study Visit|0|||
156467533|NCT00536120|564807396|FG001|Overall Study|Missed Study Visit|1|||
156467534|NCT04989816|564807397|FG000|Overall Study|Death|77|||
156467535|NCT04989816|564807397|FG000|Overall Study|Lost to Follow-up|3|||
156467536|NCT01184326|564807401|FG000|Overall Study|Adverse Event|1|||
156467537|NCT01184326|564807402|FG001|Overall Study|Adverse Event|2|||
156467538|NCT01184326|564807403|FG002|Overall Study|Adverse Event|0|||
156467539|NCT01184326|564807401|FG000|Overall Study|Death|0|||
156467540|NCT01184326|564807402|FG001|Overall Study|Death|0|||
156467541|NCT01184326|564807403|FG002|Overall Study|Death|1|||
156467542|NCT01184326|564807401|FG000|Overall Study|Withdrawal by Subject|0|||
156467543|NCT01184326|564807402|FG001|Overall Study|Withdrawal by Subject|0|||
156467544|NCT01184326|564807403|FG002|Overall Study|Withdrawal by Subject|1|||
156467545|NCT01184326|564807401|FG000|Overall Study|Physician Decision|1|||
156467546|NCT01184326|564807402|FG001|Overall Study|Physician Decision|1|||
156467547|NCT01184326|564807403|FG002|Overall Study|Physician Decision|0|||
156467548|NCT01184326|564807401|FG000|Overall Study|Disease Progression|1|||
156467549|NCT01184326|564807402|FG001|Overall Study|Disease Progression|3|||
156467550|NCT01184326|564807403|FG002|Overall Study|Disease Progression|12|||
156467551|NCT01084694|564807404|FG000|Overall Study|Withdrawal by Subject|2|||
156467552|NCT01084694|564807405|FG001|Overall Study|Withdrawal by Subject|1|||
156467553|NCT01084694|564807404|FG000|Overall Study|Death|2|||
156467554|NCT01084694|564807405|FG001|Overall Study|Death|12|||
156467555|NCT01084694|564807404|FG000|Overall Study|eligibility not maintained|2|||
156467556|NCT01084694|564807405|FG001|Overall Study|eligibility not maintained|7|||
156467557|NCT04017611|564807411|FG000|Overall Study|Withdrawn prior to completion|1|||
156467558|NCT00777049|564807422|FG000|Overall Study|Withdrawal by Subject|1|||
156467559|NCT00777049|564807423|FG001|Overall Study|Withdrawal by Subject|0|||
156467560|NCT00777049|564807422|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
156467561|NCT00777049|564807423|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
156467562|NCT00609869|564807424|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
156467563|NCT00609869|564807424|FG000|Overall Study|Severe hematologic toxicity|1|||
156467564|NCT00609869|564807424|FG000|Overall Study|Withdrawal by Subject|1|||
156467565|NCT00609869|564807424|FG000|Overall Study|Seizures|1|||
156467566|NCT00609869|564807424|FG000|Overall Study|Severe tumor flare reaction|1|||
156467567|NCT00609869|564807424|FG000|Overall Study|Hepatitis B infection|1|||
156467568|NCT00609869|564807424|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
156467569|NCT00609869|564807424|FG000|Overall Study|Mantle cell: not evaluable|4|||
156467570|NCT03478969|564807425|FG000|Overall Study|Withdrawal by Subject|4|||
156467571|NCT03478969|564807426|FG001|Overall Study|Withdrawal by Subject|7|||
156467572|NCT03478969|564807427|FG002|Overall Study|Withdrawal by Subject|6|||
156467573|NCT03478969|564807425|FG000|Overall Study|Adverse Event|2|||
156467574|NCT03478969|564807426|FG001|Overall Study|Adverse Event|0|||
156467575|NCT03478969|564807427|FG002|Overall Study|Adverse Event|1|||
156467576|NCT03478969|564807425|FG000|Overall Study|Pregnancy|1|||
156467577|NCT03478969|564807426|FG001|Overall Study|Pregnancy|0|||
156467578|NCT03478969|564807427|FG002|Overall Study|Pregnancy|0|||
156467579|NCT03478969|564807425|FG000|Overall Study|Personal Reasons|1|||
156467580|NCT03478969|564807426|FG001|Overall Study|Personal Reasons|0|||
156467581|NCT03478969|564807427|FG002|Overall Study|Personal Reasons|1|||
156467582|NCT03478969|564807425|FG000|Overall Study|Covid-19|1|||
156467583|NCT03478969|564807426|FG001|Overall Study|Covid-19|4|||
156467584|NCT03478969|564807427|FG002|Overall Study|Covid-19|3|||
156467585|NCT03478969|564807425|FG000|Overall Study|Multiple Reasons|0|||
156467586|NCT03478969|564807426|FG001|Overall Study|Multiple Reasons|1|||
156467587|NCT03478969|564807427|FG002|Overall Study|Multiple Reasons|1|||
156467588|NCT03478969|564807425|FG000|Overall Study|Eligibility Criteria|0|||
156467589|NCT03478969|564807426|FG001|Overall Study|Eligibility Criteria|0|||
156340093|NCT03000439|564344303|FG001|Open Label Part 1|Insufficient clinical response|0|||
156340094|NCT03000439|564344304|FG002|Open Label Part 1|Insufficient clinical response|0|||
156340095|NCT03000439|564344305|FG003|Open Label Part 1|Insufficient clinical response|0|||
156340096|NCT03000439|564344302|FG000|Open Label Part 2|Other|0|||
156340097|NCT03000439|564344303|FG001|Open Label Part 2|Other|5|||
156340098|NCT03000439|564344304|FG002|Open Label Part 2|Other|0|||
156340099|NCT03000439|564344305|FG003|Open Label Part 2|Other|0|||
156340100|NCT03000439|564344302|FG000|Open Label Part 2|Insufficient clinical response|0|||
156340101|NCT03000439|564344303|FG001|Open Label Part 2|Insufficient clinical response|12|||
156340102|NCT03000439|564344304|FG002|Open Label Part 2|Insufficient clinical response|0|||
156340103|NCT03000439|564344305|FG003|Open Label Part 2|Insufficient clinical response|0|||
156340104|NCT03000439|564344302|FG000|Double Blind Phase|Adverse Event|0|||
156340105|NCT03000439|564344303|FG001|Double Blind Phase|Adverse Event|0|||
156340106|NCT03000439|564344304|FG002|Double Blind Phase|Adverse Event|2|||
156340107|NCT03000439|564344305|FG003|Double Blind Phase|Adverse Event|1|||
156340108|NCT03000439|564344302|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
156340109|NCT03000439|564344303|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
156340110|NCT03000439|564344304|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
156340111|NCT03000439|564344305|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
156340112|NCT03000439|564344302|FG000|Double Blind Phase|Other|0|||
156340113|NCT03000439|564344303|FG001|Double Blind Phase|Other|0|||
156340114|NCT03000439|564344304|FG002|Double Blind Phase|Other|10|||
156467590|NCT03478969|564807427|FG002|Overall Study|Eligibility Criteria|5|||
156467591|NCT03478969|564807425|FG000|Overall Study|Lost to Follow-up|0|||
156836211|NCT03834220|566151663|FG000|Overall Study|Adverse Event|1|||
156836212|NCT03834220|566151664|FG001|Overall Study|Adverse Event|0|||
156836213|NCT03834220|566151665|FG002|Overall Study|Adverse Event|0|||
156836214|NCT03834220|566151663|FG000|Overall Study|Death|8|||
156836215|NCT03834220|566151664|FG001|Overall Study|Death|1|||
156836216|NCT03834220|566151665|FG002|Overall Study|Death|17|||
156836217|NCT03834220|566151663|FG000|Overall Study|Reason not Specified|9|||
156836218|NCT03834220|566151664|FG001|Overall Study|Reason not Specified|0|||
156836219|NCT03834220|566151665|FG002|Overall Study|Reason not Specified|6|||
156836220|NCT03834220|566151663|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
156836221|NCT03834220|566151664|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
156836222|NCT03834220|566151665|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
156836223|NCT03834220|566151663|FG000|Overall Study|Withdrawal of Consent|2|||
156836224|NCT03834220|566151664|FG001|Overall Study|Withdrawal of Consent|2|||
156836225|NCT03834220|566151665|FG002|Overall Study|Withdrawal of Consent|2|||
156836226|NCT02593318|566151668|FG000|Overall Study|Withdrawal by Subject|1|||
156836227|NCT02593318|566151669|FG001|Overall Study|Withdrawal by Subject|1|||
156836228|NCT03684694|566151671|FG000|Phase 1|Withdrawal by Subject|1|||
156836229|NCT03684694|566151672|FG001|Phase 1|Withdrawal by Subject|0|||
156836230|NCT03684694|566151673|FG002|Phase 1|Withdrawal by Subject|0|||
156836231|NCT03684694|566151674|FG003|Phase 1|Withdrawal by Subject|0|||
156836232|NCT03684694|566151675|FG004|Phase 1|Withdrawal by Subject|0|||
156836233|NCT03684694|566151676|FG005|Phase 1|Withdrawal by Subject|0|||
156836234|NCT03684694|566151671|FG000|Phase 1|Investigator/Sponsor Decision|12|||
156836235|NCT03684694|566151672|FG001|Phase 1|Investigator/Sponsor Decision|2|||
156836236|NCT03684694|566151673|FG002|Phase 1|Investigator/Sponsor Decision|1|||
156836237|NCT03684694|566151674|FG003|Phase 1|Investigator/Sponsor Decision|0|||
156836238|NCT03684694|566151675|FG004|Phase 1|Investigator/Sponsor Decision|0|||
156340115|NCT03000439|564344305|FG003|Double Blind Phase|Other|11|||
156467592|NCT03478969|564807426|FG001|Overall Study|Lost to Follow-up|0|||
156836239|NCT03684694|566151676|FG005|Phase 1|Investigator/Sponsor Decision|0|||
156340116|NCT03000439|564344302|FG000|Double Blind Phase|Insufficient clinical response|0|||
156340117|NCT03000439|564344303|FG001|Double Blind Phase|Insufficient clinical response|0|||
156340118|NCT03000439|564344304|FG002|Double Blind Phase|Insufficient clinical response|0|||
156467593|NCT03478969|564807427|FG002|Overall Study|Lost to Follow-up|1|||
156467594|NCT01436175|564807428|FG000|Overall Study|Adverse Event|111|||
156467595|NCT01436175|564807428|FG000|Overall Study|Protocol Violation|49|||
156836240|NCT03684694|566151671|FG000|Phase 1|Death|24|||
156836241|NCT03684694|566151672|FG001|Phase 1|Death|0|||
156836242|NCT03684694|566151673|FG002|Phase 1|Death|3|||
156836243|NCT03684694|566151674|FG003|Phase 1|Death|0|||
156836244|NCT03684694|566151675|FG004|Phase 1|Death|0|||
156836245|NCT03684694|566151676|FG005|Phase 1|Death|0|||
156836246|NCT03684694|566151671|FG000|Phase 1|Lost to Follow-up|0|||
156836247|NCT03684694|566151672|FG001|Phase 1|Lost to Follow-up|0|||
156836248|NCT03684694|566151673|FG002|Phase 1|Lost to Follow-up|1|||
156836249|NCT03684694|566151674|FG003|Phase 1|Lost to Follow-up|0|||
156836250|NCT03684694|566151675|FG004|Phase 1|Lost to Follow-up|0|||
156836251|NCT03684694|566151676|FG005|Phase 1|Lost to Follow-up|0|||
156836252|NCT03684694|566151671|FG000|Phase 1|Miscellaneous|0|||
156836253|NCT03684694|566151672|FG001|Phase 1|Miscellaneous|1|||
156836254|NCT03684694|566151673|FG002|Phase 1|Miscellaneous|0|||
156836255|NCT03684694|566151674|FG003|Phase 1|Miscellaneous|0|||
156836256|NCT03684694|566151675|FG004|Phase 1|Miscellaneous|0|||
156836257|NCT03684694|566151676|FG005|Phase 1|Miscellaneous|0|||
156836258|NCT03684694|566151671|FG000|Phase 2|Withdrawal by Subject|0|||
156836259|NCT03684694|566151672|FG001|Phase 2|Withdrawal by Subject|0|||
156836260|NCT03684694|566151673|FG002|Phase 2|Withdrawal by Subject|0|||
156836261|NCT03684694|566151674|FG003|Phase 2|Withdrawal by Subject|0|||
156836262|NCT03684694|566151675|FG004|Phase 2|Withdrawal by Subject|0|||
156836263|NCT03684694|566151676|FG005|Phase 2|Withdrawal by Subject|1|||
156836264|NCT03684694|566151671|FG000|Phase 2|Investigator/Sponsor Decision|0|||
156836265|NCT03684694|566151672|FG001|Phase 2|Investigator/Sponsor Decision|0|||
156836266|NCT03684694|566151673|FG002|Phase 2|Investigator/Sponsor Decision|0|||
156836267|NCT03684694|566151674|FG003|Phase 2|Investigator/Sponsor Decision|17|||
156836268|NCT03684694|566151675|FG004|Phase 2|Investigator/Sponsor Decision|16|||
156836269|NCT03684694|566151676|FG005|Phase 2|Investigator/Sponsor Decision|6|||
156836270|NCT03684694|566151671|FG000|Phase 2|Death|0|||
156836271|NCT03684694|566151672|FG001|Phase 2|Death|0|||
156836272|NCT03684694|566151673|FG002|Phase 2|Death|0|||
156836273|NCT03684694|566151674|FG003|Phase 2|Death|28|||
156836274|NCT03684694|566151675|FG004|Phase 2|Death|14|||
156836275|NCT03684694|566151676|FG005|Phase 2|Death|3|||
156836276|NCT03684694|566151671|FG000|Phase 2|Lost to Follow-up|0|||
156836277|NCT03684694|566151672|FG001|Phase 2|Lost to Follow-up|0|||
156836278|NCT03684694|566151673|FG002|Phase 2|Lost to Follow-up|0|||
156836279|NCT03684694|566151674|FG003|Phase 2|Lost to Follow-up|1|||
156836280|NCT03684694|566151675|FG004|Phase 2|Lost to Follow-up|0|||
156836281|NCT03684694|566151676|FG005|Phase 2|Lost to Follow-up|0|||
156836282|NCT03684694|566151671|FG000|Phase 2|Miscellaneous|0|||
156836283|NCT03684694|566151672|FG001|Phase 2|Miscellaneous|0|||
156836284|NCT03684694|566151673|FG002|Phase 2|Miscellaneous|0|||
156836285|NCT03684694|566151674|FG003|Phase 2|Miscellaneous|3|||
156467596|NCT01436175|564807428|FG000|Overall Study|Withdrawal by Subject|108|||
156467597|NCT01436175|564807428|FG000|Overall Study|Lost to Follow-up|89|||
156467598|NCT01436175|564807428|FG000|Overall Study|Lack of Efficacy|24|||
156467599|NCT01436175|564807428|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
156467600|NCT01436175|564807428|FG000|Overall Study|Other|826|||
156467601|NCT03066609|564807431|FG000|INDUCTION|Pregnancy|0|||
156467602|NCT03066609|564807432|FG001|INDUCTION|Pregnancy|0|||
156467603|NCT03066609|564807433|FG002|INDUCTION|Pregnancy|1|||
156467604|NCT03066609|564807434|FG003|INDUCTION|Pregnancy|0|||
156467605|NCT03066609|564807431|FG000|INDUCTION|Lack of Efficacy|0|||
156467606|NCT03066609|564807432|FG001|INDUCTION|Lack of Efficacy|0|||
156467607|NCT03066609|564807433|FG002|INDUCTION|Lack of Efficacy|1|||
156467608|NCT03066609|564807434|FG003|INDUCTION|Lack of Efficacy|0|||
156467609|NCT03066609|564807431|FG000|INDUCTION|Adverse Event|2|||
156467610|NCT03066609|564807432|FG001|INDUCTION|Adverse Event|2|||
156467611|NCT03066609|564807433|FG002|INDUCTION|Adverse Event|0|||
156467612|NCT03066609|564807434|FG003|INDUCTION|Adverse Event|0|||
156467613|NCT03066609|564807431|FG000|MAINTENANCE|Adverse Event|0|||
156467614|NCT03066609|564807432|FG001|MAINTENANCE|Adverse Event|0|||
156467615|NCT03066609|564807433|FG002|MAINTENANCE|Adverse Event|0|||
156467616|NCT03066609|564807434|FG003|MAINTENANCE|Adverse Event|1|||
156467617|NCT03066609|564807431|FG000|MAINTENANCE|Withdrawal by Subject|4|||
156467618|NCT03066609|564807432|FG001|MAINTENANCE|Withdrawal by Subject|2|||
156467619|NCT03066609|564807433|FG002|MAINTENANCE|Withdrawal by Subject|1|||
156467620|NCT03066609|564807434|FG003|MAINTENANCE|Withdrawal by Subject|1|||
156467621|NCT03066609|564807431|FG000|MAINTENANCE|Lost to Follow-up|0|||
156836286|NCT03684694|566151675|FG004|Phase 2|Miscellaneous|0|||
156836287|NCT03684694|566151676|FG005|Phase 2|Miscellaneous|0|||
156836288|NCT02100475|566153739|FG000|Overall Study|Unclassified|1|||
156836289|NCT02100475|566153740|FG001|Overall Study|Unclassified|2|||
156836290|NCT02100475|566153739|FG000|Overall Study|Withdrawal criteria|1|||
156836291|NCT02100475|566153740|FG001|Overall Study|Withdrawal criteria|0|||
156836292|NCT01673620|566153743|FG000|Overall Study|Adverse Event|1|||
156836293|NCT01673620|566153744|FG001|Overall Study|Adverse Event|0|||
156836294|NCT00528801|566153745|FG000|Overall Study|Withdrawal by Subject|1|||
156836295|NCT00528801|566153746|FG001|Overall Study|Withdrawal by Subject|1|||
156836296|NCT00528801|566153745|FG000|Overall Study|Protocol Violation|11|||
156836297|NCT00528801|566153746|FG001|Overall Study|Protocol Violation|5|||
156836298|NCT00528801|566153745|FG000|Overall Study|Lost to Follow-up|15|||
156836299|NCT00528801|566153746|FG001|Overall Study|Lost to Follow-up|4|||
156836300|NCT00528801|566153745|FG000|Overall Study|Administrative Reasons|0|||
156836301|NCT00528801|566153746|FG001|Overall Study|Administrative Reasons|1|||
156467622|NCT03066609|564807432|FG001|MAINTENANCE|Lost to Follow-up|1|||
156467623|NCT03066609|564807433|FG002|MAINTENANCE|Lost to Follow-up|1|||
156467624|NCT03066609|564807434|FG003|MAINTENANCE|Lost to Follow-up|0|||
156467625|NCT03066609|564807431|FG000|MAINTENANCE|Pregnancy|1|||
156467626|NCT03066609|564807432|FG001|MAINTENANCE|Pregnancy|0|||
156467627|NCT03066609|564807433|FG002|MAINTENANCE|Pregnancy|0|||
156467628|NCT03066609|564807434|FG003|MAINTENANCE|Pregnancy|0|||
156836302|NCT01939366|566153751|FG000|Overall Study|Adverse Event|8|||
156836303|NCT01939366|566153752|FG001|Overall Study|Adverse Event|17|||
156836304|NCT01939366|566153753|FG002|Overall Study|Adverse Event|30|||
156836305|NCT01939366|566153754|FG003|Overall Study|Adverse Event|8|||
156836306|NCT01939366|566153755|FG004|Overall Study|Adverse Event|5|||
156836307|NCT01939366|566153751|FG000|Overall Study|Lack of Efficacy|2|||
156836308|NCT01939366|566153752|FG001|Overall Study|Lack of Efficacy|1|||
156836309|NCT01939366|566153753|FG002|Overall Study|Lack of Efficacy|1|||
156836310|NCT01939366|566153754|FG003|Overall Study|Lack of Efficacy|1|||
156836311|NCT01939366|566153755|FG004|Overall Study|Lack of Efficacy|3|||
156836312|NCT01939366|566153751|FG000|Overall Study|Lost to Follow-up|1|||
156836313|NCT01939366|566153752|FG001|Overall Study|Lost to Follow-up|1|||
156836314|NCT01939366|566153753|FG002|Overall Study|Lost to Follow-up|0|||
156836315|NCT01939366|566153754|FG003|Overall Study|Lost to Follow-up|0|||
156836316|NCT01939366|566153755|FG004|Overall Study|Lost to Follow-up|0|||
156836317|NCT01939366|566153751|FG000|Overall Study|Withdrawal by Subject|1|||
156836318|NCT01939366|566153752|FG001|Overall Study|Withdrawal by Subject|0|||
156836319|NCT01939366|566153753|FG002|Overall Study|Withdrawal by Subject|2|||
156836320|NCT01939366|566153754|FG003|Overall Study|Withdrawal by Subject|2|||
156836321|NCT01939366|566153755|FG004|Overall Study|Withdrawal by Subject|3|||
156836322|NCT01939366|566153751|FG000|Overall Study|Inclusion criteria not met|0|||
156836323|NCT01939366|566153752|FG001|Overall Study|Inclusion criteria not met|1|||
156836324|NCT01939366|566153753|FG002|Overall Study|Inclusion criteria not met|1|||
156836325|NCT01939366|566153754|FG003|Overall Study|Inclusion criteria not met|0|||
156836326|NCT01939366|566153755|FG004|Overall Study|Inclusion criteria not met|1|||
156836327|NCT01939366|566153751|FG000|Overall Study|Other|0|||
156836328|NCT01939366|566153752|FG001|Overall Study|Other|0|||
156836329|NCT01939366|566153753|FG002|Overall Study|Other|2|||
156836330|NCT01939366|566153754|FG003|Overall Study|Other|2|||
156836331|NCT01939366|566153755|FG004|Overall Study|Other|1|||
156836332|NCT01939366|566153751|FG000|Overall Study|Protocol Violation|0|||
156836333|NCT01939366|566153752|FG001|Overall Study|Protocol Violation|0|||
156836334|NCT01939366|566153753|FG002|Overall Study|Protocol Violation|0|||
156836335|NCT01939366|566153754|FG003|Overall Study|Protocol Violation|1|||
156836336|NCT01939366|566153755|FG004|Overall Study|Protocol Violation|0|||
156836337|NCT01939366|566153751|FG000|Overall Study|Sponsor decision|0|||
156836338|NCT01939366|566153752|FG001|Overall Study|Sponsor decision|0|||
156836339|NCT01939366|566153753|FG002|Overall Study|Sponsor decision|0|||
156836340|NCT01939366|566153754|FG003|Overall Study|Sponsor decision|0|||
156836341|NCT01939366|566153755|FG004|Overall Study|Sponsor decision|2|||
156836342|NCT01939366|566153751|FG000|Overall Study|GCP non-compliance at site|2|||
156836343|NCT01939366|566153752|FG001|Overall Study|GCP non-compliance at site|3|||
156836344|NCT01939366|566153753|FG002|Overall Study|GCP non-compliance at site|2|||
156836345|NCT01939366|566153754|FG003|Overall Study|GCP non-compliance at site|3|||
156836346|NCT01939366|566153755|FG004|Overall Study|GCP non-compliance at site|3|||
156836347|NCT02252965|566153756|FG000|Overall Study|Adverse Event|9|||
156836348|NCT02252965|566153757|FG001|Overall Study|Adverse Event|14|||
156836349|NCT02252965|566153756|FG000|Overall Study|Lost to Follow-up|16|||
156836350|NCT02252965|566153757|FG001|Overall Study|Lost to Follow-up|8|||
156836351|NCT02252965|566153756|FG000|Overall Study|Protocol Violation|4|||
156836352|NCT02252965|566153757|FG001|Overall Study|Protocol Violation|5|||
156836353|NCT02252965|566153756|FG000|Overall Study|Lack of Efficacy|0|||
156836354|NCT02252965|566153757|FG001|Overall Study|Lack of Efficacy|2|||
156836355|NCT02252965|566153756|FG000|Overall Study|Withdrawal by Subject|7|||
156836356|NCT02252965|566153757|FG001|Overall Study|Withdrawal by Subject|9|||
156836357|NCT02252965|566153756|FG000|Overall Study|Other|4|||
156836358|NCT02252965|566153757|FG001|Overall Study|Other|5|||
156836359|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
156836360|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
156836361|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
156836362|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
156836363|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
156836364|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
156836365|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
156836366|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
156836367|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
156836368|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
156836369|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
156836370|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
156836371|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
156836372|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
156836373|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
156836374|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
156836375|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
156836376|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
156836377|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
156836378|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
156836379|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
156836380|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
156836381|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
156836382|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
156836383|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
156836384|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
156836385|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
156340119|NCT03000439|564344305|FG003|Double Blind Phase|Insufficient clinical response|2|||
156340120|NCT02501473|564344308|FG000|Overall Study|Study Terminated|2|||
156340121|NCT02501473|564344309|FG001|Overall Study|Study Terminated|3|||
156340122|NCT02501473|564344310|FG002|Overall Study|Study Terminated|7|||
156340123|NCT02501473|564344311|FG003|Overall Study|Study Terminated|9|||
156340124|NCT02501473|564344312|FG004|Overall Study|Study Terminated|2|||
156340125|NCT02501473|564344313|FG005|Overall Study|Study Terminated|10|||
156836386|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
156340126|NCT02501473|564344314|FG006|Overall Study|Study Terminated|1|||
156340127|NCT02501473|564344315|FG007|Overall Study|Study Terminated|0|||
156340128|NCT02501473|564344308|FG000|Overall Study|Withdrawal by Subject|0|||
156340129|NCT02501473|564344309|FG001|Overall Study|Withdrawal by Subject|0|||
156340130|NCT02501473|564344310|FG002|Overall Study|Withdrawal by Subject|3|||
156836387|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
156836388|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
156836389|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
156836390|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
156836391|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
156836392|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
156836393|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
156836394|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
156836395|NCT02615691|566153767|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
156836396|NCT02615691|566153767|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
156836397|NCT02615691|566153767|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
156836398|NCT02615691|566153767|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
156836399|NCT04201093|566153768|FG000|Overall Study|Adverse Event|6|||
156836400|NCT04201093|566153769|FG001|Overall Study|Adverse Event|29|||
156836401|NCT04201093|566153770|FG002|Overall Study|Adverse Event|35|||
156340131|NCT02501473|564344311|FG003|Overall Study|Withdrawal by Subject|3|||
156340132|NCT02501473|564344312|FG004|Overall Study|Withdrawal by Subject|2|||
156340133|NCT02501473|564344313|FG005|Overall Study|Withdrawal by Subject|2|||
156340134|NCT02501473|564344314|FG006|Overall Study|Withdrawal by Subject|0|||
156340135|NCT02501473|564344315|FG007|Overall Study|Withdrawal by Subject|0|||
156340136|NCT02501473|564344308|FG000|Overall Study|Death|0|||
156340137|NCT02501473|564344309|FG001|Overall Study|Death|0|||
156340138|NCT02501473|564344310|FG002|Overall Study|Death|1|||
156340139|NCT02501473|564344311|FG003|Overall Study|Death|1|||
156340140|NCT02501473|564344312|FG004|Overall Study|Death|0|||
156340141|NCT02501473|564344313|FG005|Overall Study|Death|1|||
156340142|NCT02501473|564344314|FG006|Overall Study|Death|0|||
156340143|NCT02501473|564344315|FG007|Overall Study|Death|0|||
156340144|NCT02501473|564344308|FG000|Overall Study|Lost to Follow-up|1|||
156340145|NCT02501473|564344309|FG001|Overall Study|Lost to Follow-up|0|||
156836402|NCT04201093|566153768|FG000|Overall Study|Death|2|||
156836403|NCT04201093|566153769|FG001|Overall Study|Death|1|||
156836404|NCT04201093|566153770|FG002|Overall Study|Death|0|||
156836405|NCT04201093|566153768|FG000|Overall Study|Lack of Efficacy|5|||
156836406|NCT04201093|566153769|FG001|Overall Study|Lack of Efficacy|1|||
156836407|NCT04201093|566153770|FG002|Overall Study|Lack of Efficacy|2|||
156836408|NCT04201093|566153768|FG000|Overall Study|Lost to Follow-up|0|||
156836409|NCT04201093|566153769|FG001|Overall Study|Lost to Follow-up|0|||
156836410|NCT04201093|566153770|FG002|Overall Study|Lost to Follow-up|1|||
156836411|NCT04201093|566153768|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
156836412|NCT04201093|566153769|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
156836413|NCT04201093|566153770|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
156836414|NCT04201093|566153768|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
156836415|NCT04201093|566153769|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
156836416|NCT04201093|566153770|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
156340146|NCT02501473|564344310|FG002|Overall Study|Lost to Follow-up|1|||
156340147|NCT02501473|564344311|FG003|Overall Study|Lost to Follow-up|0|||
156340148|NCT02501473|564344312|FG004|Overall Study|Lost to Follow-up|0|||
156340149|NCT02501473|564344313|FG005|Overall Study|Lost to Follow-up|1|||
156340150|NCT02501473|564344314|FG006|Overall Study|Lost to Follow-up|0|||
156340151|NCT02501473|564344315|FG007|Overall Study|Lost to Follow-up|0|||
156340152|NCT02501473|564344308|FG000|Overall Study|Reason not specified|0|||
156467629|NCT03066609|564807431|FG000|MAINTENANCE|Lack of Efficacy|2|||
156340153|NCT02501473|564344309|FG001|Overall Study|Reason not specified|0|||
156340154|NCT02501473|564344310|FG002|Overall Study|Reason not specified|1|||
156340155|NCT02501473|564344311|FG003|Overall Study|Reason not specified|1|||
156340156|NCT02501473|564344312|FG004|Overall Study|Reason not specified|0|||
156836417|NCT04201093|566153768|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
156836418|NCT04201093|566153769|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
156836419|NCT04201093|566153770|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
156836420|NCT04201093|566153768|FG000|Overall Study|Physician Decision|1|||
156836421|NCT04201093|566153769|FG001|Overall Study|Physician Decision|0|||
156836422|NCT04201093|566153770|FG002|Overall Study|Physician Decision|0|||
156836423|NCT04201093|566153768|FG000|Overall Study|Protocol Deviation|1|||
156836424|NCT04201093|566153769|FG001|Overall Study|Protocol Deviation|0|||
156836425|NCT04201093|566153770|FG002|Overall Study|Protocol Deviation|0|||
156836426|NCT04201093|566153768|FG000|Overall Study|Site Terminated by Sponsor|5|||
156836427|NCT04201093|566153769|FG001|Overall Study|Site Terminated by Sponsor|3|||
156836428|NCT04201093|566153770|FG002|Overall Study|Site Terminated by Sponsor|1|||
156836429|NCT04201093|566153768|FG000|Overall Study|Withdrawal by Subject|7|||
156836430|NCT04201093|566153769|FG001|Overall Study|Withdrawal by Subject|8|||
156836431|NCT04201093|566153770|FG002|Overall Study|Withdrawal by Subject|15|||
156836432|NCT04201093|566153768|FG000|Overall Study|Other|0|||
156836433|NCT04201093|566153769|FG001|Overall Study|Other|1|||
156836434|NCT04201093|566153770|FG002|Overall Study|Other|2|||
156836435|NCT01276223|566153771|FG000|Overall Study|Adverse Event|7|||
156836436|NCT01276223|566153772|FG001|Overall Study|Adverse Event|4|||
156836437|NCT01276223|566153773|FG002|Overall Study|Adverse Event|1|||
156836438|NCT01276223|566153771|FG000|Overall Study|Lost to Follow-up|0|||
156836439|NCT01276223|566153772|FG001|Overall Study|Lost to Follow-up|0|||
156836440|NCT01276223|566153773|FG002|Overall Study|Lost to Follow-up|1|||
156836441|NCT01276223|566153771|FG000|Overall Study|Other|0|||
156836442|NCT01276223|566153772|FG001|Overall Study|Other|0|||
156836443|NCT01276223|566153773|FG002|Overall Study|Other|1|||
156836444|NCT01276223|566153771|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
156836445|NCT01276223|566153772|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
156836446|NCT01276223|566153773|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
156836447|NCT01276223|566153771|FG000|Overall Study|Protocol Violation|1|||
156836448|NCT01276223|566153772|FG001|Overall Study|Protocol Violation|0|||
156836449|NCT01276223|566153773|FG002|Overall Study|Protocol Violation|0|||
156836450|NCT04279613|566153774|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
156836451|NCT04279613|566153775|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
156836452|NCT04279613|566153776|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
156836453|NCT04279613|566153777|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
156836454|NCT04279613|566153778|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
156836455|NCT04279613|566153774|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
156836456|NCT04279613|566153775|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
156836457|NCT04279613|566153776|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
156836458|NCT04279613|566153777|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
156836459|NCT04279613|566153778|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
156836460|NCT04279613|566153774|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
156836461|NCT04279613|566153775|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
156836462|NCT04279613|566153776|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
156836463|NCT04279613|566153777|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
156836464|NCT04279613|566153778|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
156836465|NCT04279613|566153774|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
156836466|NCT04279613|566153775|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
156836467|NCT04279613|566153776|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
156836468|NCT04279613|566153777|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
156836469|NCT04279613|566153778|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
156836470|NCT04279613|566153774|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
156836471|NCT04279613|566153775|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
156836472|NCT04279613|566153776|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
156836473|NCT04279613|566153777|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
156836474|NCT04279613|566153778|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
156836475|NCT02478164|566153779|FG000|Overall Study|Lack of Efficacy|13|||
156836476|NCT02478164|566153779|FG000|Overall Study|Adverse Event|1|||
156836477|NCT02478164|566153779|FG000|Overall Study|Withdrawal by Subject|1|||
156836478|NCT04051827|566153780|FG000|Overall Study|Death|1|||
156836479|NCT04051827|566153780|FG000|Overall Study|Withdrawal by Subject|4|||
156836480|NCT04051827|566153780|FG000|Overall Study|Progressive disease|16|||
156836481|NCT04051827|566153780|FG000|Overall Study|Physician Decision|1|||
156836482|NCT04051827|566153780|FG000|Overall Study|Other|4|||
156836483|NCT05779007|566153781|FG000|Overall Study|not meeting eligibility criteria|3517|||
156836484|NCT05779007|566153782|FG001|Overall Study|not meeting eligibility criteria|2009|||
156836485|NCT01424566|566153783|FG000|Single-blind Treatment|Adverse Event|71|||
156836486|NCT01424566|566153784|FG001|Single-blind Treatment|Adverse Event|0|||
156836487|NCT01424566|566153785|FG002|Single-blind Treatment|Adverse Event|0|||
156836488|NCT01424566|566153783|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
156836489|NCT01424566|566153784|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
156836490|NCT01424566|566153785|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
156836491|NCT01424566|566153783|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
156836492|NCT01424566|566153784|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
156836493|NCT01424566|566153785|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
156836494|NCT01424566|566153783|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
156836495|NCT01424566|566153784|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
156836496|NCT01424566|566153785|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
156836497|NCT01424566|566153783|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
156836498|NCT01424566|566153784|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
156836499|NCT01424566|566153785|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
156836500|NCT01424566|566153783|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
156836501|NCT01424566|566153784|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
156836502|NCT01424566|566153785|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
156836503|NCT01424566|566153783|FG000|Double-blind Treatment|Adverse Event|0|||
156836504|NCT01424566|566153784|FG001|Double-blind Treatment|Adverse Event|21|||
156836505|NCT01424566|566153785|FG002|Double-blind Treatment|Adverse Event|13|||
156836506|NCT01424566|566153783|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
156836507|NCT01424566|566153784|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
156836508|NCT01424566|566153785|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
156836509|NCT01424566|566153783|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
156836510|NCT01424566|566153784|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
156836511|NCT01424566|566153785|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
156836512|NCT01424566|566153783|FG000|Double-blind Treatment|Lack of Efficacy|0|||
156836513|NCT01424566|566153784|FG001|Double-blind Treatment|Lack of Efficacy|1|||
156836514|NCT01424566|566153785|FG002|Double-blind Treatment|Lack of Efficacy|1|||
156836515|NCT01116427|566153790|FG000|Core Phase|Adverse Event|0|||
156836516|NCT01116427|566153791|FG001|Core Phase|Adverse Event|1|||
156836517|NCT01116427|566153790|FG000|Core Phase|Lost to Follow-up|1|||
156836518|NCT01116427|566153791|FG001|Core Phase|Lost to Follow-up|0|||
156836519|NCT01116427|566153790|FG000|Core Phase|Withdrawal by Subject|3|||
156836520|NCT01116427|566153791|FG001|Core Phase|Withdrawal by Subject|0|||
156836521|NCT01116427|566153790|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
156836522|NCT01116427|566153791|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
156836523|NCT01116427|566153790|FG000|Extension Phase|Adverse Event|1|||
156836524|NCT01116427|566153791|FG001|Extension Phase|Adverse Event|1|||
156836525|NCT01116427|566153790|FG000|Extension Phase|Lost to Follow-up|2|||
156836526|NCT01116427|566153791|FG001|Extension Phase|Lost to Follow-up|0|||
156836527|NCT01116427|566153790|FG000|Extension Phase|Withdrawal by Subject|5|||
156836528|NCT01116427|566153791|FG001|Extension Phase|Withdrawal by Subject|1|||
156836529|NCT01116427|566153790|FG000|Extension Phase|Not using appropriate birth control|1|||
156836530|NCT01116427|566153791|FG001|Extension Phase|Not using appropriate birth control|0|||
156836531|NCT00791557|566153792|FG000|Overall Study|Adverse Event|1|||
156836532|NCT01079936|566153793|FG000|Phase I: MTD|First Remission Status|2|||
156836533|NCT01079936|566153794|FG001|Phase I: MTD|First Remission Status|0|||
156836534|NCT01079936|566153795|FG002|Phase I: MTD|First Remission Status|0|||
156836535|NCT01079936|566153796|FG003|Phase I: MTD|First Remission Status|0|||
156836536|NCT01079936|566153797|FG004|Phase I: MTD|First Remission Status|0|||
156836537|NCT01079936|566153793|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
156836538|NCT01079936|566153794|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
156836539|NCT01079936|566153795|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
156836540|NCT01079936|566153796|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
156836541|NCT01079936|566153797|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
156836542|NCT01079936|566153793|FG000|Phase II|Adverse Event|0|||
156836543|NCT01079936|566153794|FG001|Phase II|Adverse Event|0|||
156836544|NCT01079936|566153795|FG002|Phase II|Adverse Event|1|||
156836545|NCT01079936|566153796|FG003|Phase II|Adverse Event|0|||
156836546|NCT01079936|566153797|FG004|Phase II|Adverse Event|0|||
156836547|NCT01079936|566153793|FG000|Phase II|Insurance Issue|0|||
156836548|NCT01079936|566153794|FG001|Phase II|Insurance Issue|0|||
156836549|NCT01079936|566153795|FG002|Phase II|Insurance Issue|0|||
156836550|NCT01079936|566153796|FG003|Phase II|Insurance Issue|0|||
156836551|NCT01079936|566153797|FG004|Phase II|Insurance Issue|1|||
156836552|NCT02322190|566153798|FG000|Overall Study|Death on study|1|||
156836553|NCT02322190|566153799|FG001|Overall Study|Death on study|0|||
156836554|NCT03344640|566153800|FG000|Overall Study|Adverse Event|1|||
156836555|NCT03344640|566153801|FG001|Overall Study|Adverse Event|0|||
156836556|NCT03344640|566153800|FG000|Overall Study|Physician Decision|1|||
156836557|NCT03344640|566153801|FG001|Overall Study|Physician Decision|1|||
156836558|NCT03344640|566153800|FG000|Overall Study|Withdrawal by Subject|1|||
156836559|NCT03344640|566153801|FG001|Overall Study|Withdrawal by Subject|2|||
156836560|NCT03344640|566153800|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
156467630|NCT03066609|564807432|FG001|MAINTENANCE|Lack of Efficacy|1|||
156836561|NCT03344640|566153801|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
156836562|NCT00657371|566153802|FG000|Overall Study|Poor bowel preparation|15|||
156836563|NCT00657371|566153802|FG000|Overall Study|Unable to intubate the cecum|5|||
156836564|NCT00657371|566153802|FG000|Overall Study|Protocol Violation|2|||
156836565|NCT00657371|566153802|FG000|Overall Study|Device- related reasons|13|||
156836566|NCT00657371|566153802|FG000|Overall Study|Pre-existing medical condition|4|||
156836567|NCT00129961|566153812|FG000|Overall Study|Adverse Event|1|||
156836568|NCT00129961|566153813|FG001|Overall Study|Adverse Event|0|||
156836569|NCT00129961|566153812|FG000|Overall Study|Death|1|||
156836570|NCT00129961|566153813|FG001|Overall Study|Death|1|||
156836571|NCT00129961|566153812|FG000|Overall Study|Withdrawal by Sponsor|14|||
156836572|NCT00129961|566153813|FG001|Overall Study|Withdrawal by Sponsor|20|||
156836573|NCT00129961|566153812|FG000|Overall Study|Physician Decision|1|||
156836574|NCT00129961|566153813|FG001|Overall Study|Physician Decision|0|||
156836575|NCT00129961|566153812|FG000|Overall Study|Withdrawal by Subject|2|||
156836576|NCT00129961|566153813|FG001|Overall Study|Withdrawal by Subject|1|||
156836577|NCT00129961|566153812|FG000|Overall Study|Missing Record|0|||
156836578|NCT00129961|566153813|FG001|Overall Study|Missing Record|1|||
156836579|NCT01985360|566153814|FG000|Overall Study|Withdrawal by Subject|4|||
156836580|NCT01985360|566153815|FG001|Overall Study|Withdrawal by Subject|0|||
156836581|NCT01985360|566153814|FG000|Overall Study|Lost to Follow-up|5|||
156836582|NCT01985360|566153815|FG001|Overall Study|Lost to Follow-up|3|||
156836583|NCT03691779|566153820|FG000|Part B (24 Weeks)|Adverse Event|0|||
156836584|NCT03691779|566153821|FG001|Part B (24 Weeks)|Adverse Event|1|||
156836585|NCT03691779|566153820|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
156836586|NCT03691779|566153821|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
156836587|NCT04881747|566153822|FG000|Period 2 Washout|Adverse Event|1|||
156836588|NCT04881747|566153823|FG001|Period 2 Washout|Adverse Event|0|||
156836589|NCT04881747|566153824|FG002|Period 2 Washout|Adverse Event|0|||
156836590|NCT04881747|566153825|FG003|Period 2 Washout|Adverse Event|0|||
156836591|NCT04881747|566153826|FG004|Period 2 Washout|Adverse Event|1|||
156836592|NCT04881747|566153827|FG005|Period 2 Washout|Adverse Event|0|||
156836593|NCT04881747|566153822|FG000|Period 2 Washout|Withdrawal by Subject|1|||
156836594|NCT04881747|566153823|FG001|Period 2 Washout|Withdrawal by Subject|0|||
156836595|NCT04881747|566153824|FG002|Period 2 Washout|Withdrawal by Subject|0|||
156836596|NCT04881747|566153825|FG003|Period 2 Washout|Withdrawal by Subject|1|||
156836597|NCT04881747|566153826|FG004|Period 2 Washout|Withdrawal by Subject|0|||
156836598|NCT04881747|566153827|FG005|Period 2 Washout|Withdrawal by Subject|0|||
156836599|NCT00162266|566153837|FG000|Double-Blind Period|Adverse Event|5|||
156836600|NCT00162266|566153838|FG001|Double-Blind Period|Adverse Event|9|||
156836601|NCT00162266|566153839|FG002|Double-Blind Period|Adverse Event|11|||
156836602|NCT00162266|566153840|FG003|Double-Blind Period|Adverse Event|0|||
156836603|NCT00162266|566153837|FG000|Double-Blind Period|Death|0|||
156836604|NCT00162266|566153838|FG001|Double-Blind Period|Death|1|||
156836605|NCT00162266|566153839|FG002|Double-Blind Period|Death|0|||
156467631|NCT03066609|564807433|FG002|MAINTENANCE|Lack of Efficacy|0|||
156836606|NCT00162266|566153840|FG003|Double-Blind Period|Death|0|||
156836607|NCT00162266|566153837|FG000|Double-Blind Period|Lost to Follow-up|1|||
156836608|NCT00162266|566153838|FG001|Double-Blind Period|Lost to Follow-up|2|||
156836609|NCT00162266|566153839|FG002|Double-Blind Period|Lost to Follow-up|0|||
156836610|NCT00162266|566153840|FG003|Double-Blind Period|Lost to Follow-up|0|||
156836611|NCT00162266|566153837|FG000|Double-Blind Period|Other Reason|1|||
156836612|NCT00162266|566153838|FG001|Double-Blind Period|Other Reason|0|||
156836613|NCT00162266|566153839|FG002|Double-Blind Period|Other Reason|1|||
156836614|NCT00162266|566153840|FG003|Double-Blind Period|Other Reason|0|||
156836615|NCT00162266|566153837|FG000|Double-Blind Period|Lack of Efficacy|13|||
156467632|NCT03066609|564807434|FG003|MAINTENANCE|Lack of Efficacy|1|||
156467633|NCT03066609|564807431|FG000|OVERALL STUDY|Adverse Event|2|||
156836616|NCT00162266|566153838|FG001|Double-Blind Period|Lack of Efficacy|17|||
156836617|NCT00162266|566153839|FG002|Double-Blind Period|Lack of Efficacy|30|||
156836618|NCT00162266|566153840|FG003|Double-Blind Period|Lack of Efficacy|0|||
156836619|NCT00162266|566153837|FG000|Double-Blind Period|Withdrawal by Subject|5|||
156836620|NCT00162266|566153838|FG001|Double-Blind Period|Withdrawal by Subject|2|||
156836621|NCT00162266|566153839|FG002|Double-Blind Period|Withdrawal by Subject|6|||
156467634|NCT03066609|564807432|FG001|OVERALL STUDY|Adverse Event|2|||
156836622|NCT00162266|566153840|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156836623|NCT00162266|566153837|FG000|Open-Label Period|Death|0|||
156836624|NCT00162266|566153838|FG001|Open-Label Period|Death|0|||
156836625|NCT00162266|566153839|FG002|Open-Label Period|Death|0|||
156836626|NCT00162266|566153840|FG003|Open-Label Period|Death|7|||
156836627|NCT00162266|566153837|FG000|Open-Label Period|Adverse Event|0|||
156836628|NCT00162266|566153838|FG001|Open-Label Period|Adverse Event|0|||
156836629|NCT00162266|566153839|FG002|Open-Label Period|Adverse Event|0|||
156836630|NCT00162266|566153840|FG003|Open-Label Period|Adverse Event|46|||
156836631|NCT00162266|566153837|FG000|Open-Label Period|Lack of Efficacy|0|||
156836632|NCT00162266|566153838|FG001|Open-Label Period|Lack of Efficacy|0|||
156836633|NCT00162266|566153839|FG002|Open-Label Period|Lack of Efficacy|0|||
156836634|NCT00162266|566153840|FG003|Open-Label Period|Lack of Efficacy|26|||
156836635|NCT00162266|566153837|FG000|Open-Label Period|Lost to Follow-up|0|||
156836636|NCT00162266|566153838|FG001|Open-Label Period|Lost to Follow-up|0|||
156836637|NCT00162266|566153839|FG002|Open-Label Period|Lost to Follow-up|0|||
156836638|NCT00162266|566153840|FG003|Open-Label Period|Lost to Follow-up|3|||
156836639|NCT00162266|566153837|FG000|Open-Label Period|Withdrawal by Subject|0|||
156836640|NCT00162266|566153838|FG001|Open-Label Period|Withdrawal by Subject|0|||
156836641|NCT00162266|566153839|FG002|Open-Label Period|Withdrawal by Subject|0|||
156836642|NCT00162266|566153840|FG003|Open-Label Period|Withdrawal by Subject|31|||
156836643|NCT00162266|566153837|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
156836644|NCT00162266|566153838|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
156836645|NCT00162266|566153839|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
156836646|NCT00162266|566153840|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
156836647|NCT00162266|566153837|FG000|Open-Label Period|Other Reasons|0|||
156836648|NCT00162266|566153838|FG001|Open-Label Period|Other Reasons|0|||
156836649|NCT00162266|566153839|FG002|Open-Label Period|Other Reasons|0|||
156836650|NCT00162266|566153840|FG003|Open-Label Period|Other Reasons|15|||
156836651|NCT02299076|566153841|FG000|Overall Study|Fraudulent Entries|20|||
156836652|NCT02299076|566153842|FG001|Overall Study|Fraudulent Entries|14|||
156836653|NCT01839656|566153843|FG000|Overall Study|Withdrawal by Subject|1|||
156836654|NCT01839656|566153844|FG001|Overall Study|Withdrawal by Subject|1|||
156836655|NCT01839656|566153843|FG000|Overall Study|Adverse event, serious fatal|1|||
156836656|NCT01839656|566153844|FG001|Overall Study|Adverse event, serious fatal|4|||
156836657|NCT01839656|566153843|FG000|Overall Study|Early study closure|0|||
156836658|NCT01839656|566153844|FG001|Overall Study|Early study closure|11|||
156836659|NCT01839656|566153843|FG000|Overall Study|Adverse Event|1|||
156836660|NCT01839656|566153844|FG001|Overall Study|Adverse Event|0|||
156836661|NCT00499746|566153845|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
156836662|NCT00499746|566153845|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
156836663|NCT00499746|566153845|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
156836664|NCT00499746|566153845|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
156836665|NCT00558272|566153848|FG000|Overall Study|Adverse Event|10|||
156836666|NCT00558272|566153849|FG001|Overall Study|Adverse Event|0|||
156836667|NCT00558272|566153848|FG000|Overall Study|Death|1|||
156836668|NCT00558272|566153849|FG001|Overall Study|Death|0|||
156836669|NCT00558272|566153848|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
156836670|NCT00558272|566153849|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
156836671|NCT00558272|566153848|FG000|Overall Study|AZ study team decision|0|||
156836672|NCT00558272|566153849|FG001|Overall Study|AZ study team decision|1|||
156836673|NCT00558272|566153848|FG000|Overall Study|Incorrectly enrolled|1|||
156836674|NCT00558272|566153849|FG001|Overall Study|Incorrectly enrolled|0|||
156836675|NCT00558272|566153848|FG000|Overall Study|Withdrawal by Subject|0|||
156836676|NCT00558272|566153849|FG001|Overall Study|Withdrawal by Subject|1|||
156836677|NCT04311463|566153850|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
156836678|NCT04311463|566153851|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
156836679|NCT04311463|566153850|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
156836680|NCT04311463|566153851|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
156836681|NCT04311463|566153850|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
156836682|NCT04311463|566153851|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
156836683|NCT00737633|566153858|FG000|Overall Study|Study terminated by sponsor|44|||
156836684|NCT00737633|566153859|FG001|Overall Study|Study terminated by sponsor|55|||
156836685|NCT00737633|566153858|FG000|Overall Study|Lost to Follow-up|0|||
156836686|NCT00737633|566153859|FG001|Overall Study|Lost to Follow-up|1|||
156836687|NCT00737633|566153858|FG000|Overall Study|protocol non-compliance|0|||
156836688|NCT00737633|566153859|FG001|Overall Study|protocol non-compliance|1|||
156836689|NCT02745535|566153860|FG000|Overall Study|Death|1|||
156836690|NCT02745535|566153860|FG000|Overall Study|Adverse Event|3|||
156836691|NCT02745535|566153860|FG000|Overall Study|Lost to Follow-up|2|||
156836692|NCT00377364|566153865|FG000|Overall Study|Lost to Follow-up|1|||
156836693|NCT00377364|566153866|FG001|Overall Study|Lost to Follow-up|0|||
156836694|NCT00377364|566153865|FG000|Overall Study|Withdrawal by Subject|1|||
156836695|NCT00377364|566153866|FG001|Overall Study|Withdrawal by Subject|0|||
156836696|NCT01291277|566153867|FG000|Overall Study|Death|2|||
156836697|NCT01291277|566153868|FG001|Overall Study|Death|2|||
156836698|NCT01291277|566153867|FG000|Overall Study|Lost to Follow-up|3|||
156836699|NCT01291277|566153868|FG001|Overall Study|Lost to Follow-up|1|||
156836700|NCT02963701|566153875|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
156836701|NCT02963701|566153876|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
156836702|NCT03480009|566153877|FG000|Overall Study|Lost to Follow-up|4|||
156836703|NCT03480009|566153878|FG001|Overall Study|Lost to Follow-up|5|||
156836704|NCT03480009|566153879|FG002|Overall Study|Lost to Follow-up|4|||
156836705|NCT03480009|566153880|FG003|Overall Study|Lost to Follow-up|0|||
156836706|NCT00637572|566153883|FG000|Overall Study|Adverse Event|1|||
156467635|NCT03066609|564807433|FG002|OVERALL STUDY|Adverse Event|0|||
156836707|NCT00637572|566153884|FG001|Overall Study|Adverse Event|2|||
156836708|NCT00637572|566153883|FG000|Overall Study|Death|0|||
156836709|NCT00637572|566153884|FG001|Overall Study|Death|1|||
156836710|NCT00637572|566153883|FG000|Overall Study|Lost to Follow-up|0|||
156836711|NCT00637572|566153884|FG001|Overall Study|Lost to Follow-up|1|||
156836712|NCT00637572|566153883|FG000|Overall Study|Physician Decision|1|||
156836713|NCT00637572|566153884|FG001|Overall Study|Physician Decision|1|||
156836714|NCT00637572|566153883|FG000|Overall Study|Withdrawal by Subject|0|||
156836715|NCT00637572|566153884|FG001|Overall Study|Withdrawal by Subject|2|||
156836716|NCT00637572|566153883|FG000|Overall Study|Illicit Drug Use|1|||
156836717|NCT00637572|566153884|FG001|Overall Study|Illicit Drug Use|0|||
156836718|NCT01345682|566153885|FG000|Overall Study|Progressive disease per RECIST|226|||
156836719|NCT01345682|566153886|FG001|Overall Study|Progressive disease per RECIST|93|||
156836720|NCT01345682|566153885|FG000|Overall Study|Worsening of underlying cancer disease|23|||
156836721|NCT01345682|566153886|FG001|Overall Study|Worsening of underlying cancer disease|12|||
156836722|NCT01345682|566153885|FG000|Overall Study|Adverse Event|51|||
156836723|NCT01345682|566153886|FG001|Overall Study|Adverse Event|41|||
156836724|NCT01345682|566153885|FG000|Overall Study|Non-compliance with protocol|0|||
156836725|NCT01345682|566153886|FG001|Overall Study|Non-compliance with protocol|1|||
156836726|NCT01345682|566153885|FG000|Overall Study|Lost to Follow-up|0|||
156836727|NCT01345682|566153886|FG001|Overall Study|Lost to Follow-up|1|||
156836728|NCT01345682|566153885|FG000|Overall Study|Refused to continue trial medication|16|||
156836729|NCT01345682|566153886|FG001|Overall Study|Refused to continue trial medication|9|||
156836730|NCT01345682|566153885|FG000|Overall Study|Not treated|2|||
156836731|NCT01345682|566153886|FG001|Overall Study|Not treated|1|||
156836732|NCT01345682|566153885|FG000|Overall Study|Reason other than those specified above|4|||
156836733|NCT01345682|566153886|FG001|Overall Study|Reason other than those specified above|3|||
156836734|NCT00896649|566153887|FG000|Overall Study|Physician Decision|1|||
156836735|NCT00896649|566153887|FG000|Overall Study|Pregnancy|1|||
156836736|NCT00896649|566153887|FG000|Overall Study|missing documentation|1|||
156836737|NCT00896649|566153887|FG000|Overall Study|technical difficulties|2|||
156836738|NCT01075984|566153888|FG000|Treatment Phase|Adverse Event|0|||
156836739|NCT01075984|566153889|FG001|Treatment Phase|Adverse Event|1|||
156836740|NCT01075984|566153890|FG002|Treatment Phase|Adverse Event|3|||
156836741|NCT01075984|566153891|FG003|Treatment Phase|Adverse Event|7|||
156836742|NCT01075984|566153892|FG004|Treatment Phase|Adverse Event|35|||
156836743|NCT01075984|566153888|FG000|Treatment Phase|Protocol Violation|0|||
156836744|NCT01075984|566153889|FG001|Treatment Phase|Protocol Violation|0|||
156836745|NCT01075984|566153890|FG002|Treatment Phase|Protocol Violation|1|||
156836746|NCT01075984|566153891|FG003|Treatment Phase|Protocol Violation|0|||
156836747|NCT01075984|566153892|FG004|Treatment Phase|Protocol Violation|3|||
156836748|NCT01075984|566153888|FG000|Treatment Phase|Withdrawal by Subject|0|||
156836749|NCT01075984|566153889|FG001|Treatment Phase|Withdrawal by Subject|0|||
156836750|NCT01075984|566153890|FG002|Treatment Phase|Withdrawal by Subject|2|||
156836751|NCT01075984|566153891|FG003|Treatment Phase|Withdrawal by Subject|0|||
156836752|NCT01075984|566153892|FG004|Treatment Phase|Withdrawal by Subject|15|||
156836753|NCT01075984|566153888|FG000|Treatment Phase|Treatment Failure|0|||
156836754|NCT01075984|566153889|FG001|Treatment Phase|Treatment Failure|0|||
156836755|NCT01075984|566153890|FG002|Treatment Phase|Treatment Failure|1|||
156836756|NCT01075984|566153891|FG003|Treatment Phase|Treatment Failure|0|||
156836757|NCT01075984|566153892|FG004|Treatment Phase|Treatment Failure|5|||
156836758|NCT01075984|566153888|FG000|Treatment Phase|Progression of disease|0|||
156836759|NCT01075984|566153889|FG001|Treatment Phase|Progression of disease|0|||
156836760|NCT01075984|566153890|FG002|Treatment Phase|Progression of disease|0|||
156836761|NCT01075984|566153891|FG003|Treatment Phase|Progression of disease|0|||
156836762|NCT01075984|566153892|FG004|Treatment Phase|Progression of disease|2|||
156836763|NCT01075984|566153888|FG000|Follow-up Phase|Protocol Violation|0|||
156836764|NCT01075984|566153889|FG001|Follow-up Phase|Protocol Violation|0|||
156836765|NCT01075984|566153890|FG002|Follow-up Phase|Protocol Violation|1|||
156836766|NCT01075984|566153891|FG003|Follow-up Phase|Protocol Violation|0|||
156836767|NCT01075984|566153892|FG004|Follow-up Phase|Protocol Violation|3|||
156836768|NCT01075984|566153888|FG000|Follow-up Phase|Adverse Event|0|||
156836769|NCT01075984|566153889|FG001|Follow-up Phase|Adverse Event|0|||
156836770|NCT01075984|566153890|FG002|Follow-up Phase|Adverse Event|0|||
156836771|NCT01075984|566153891|FG003|Follow-up Phase|Adverse Event|2|||
156836772|NCT01075984|566153892|FG004|Follow-up Phase|Adverse Event|27|||
156836773|NCT01075984|566153888|FG000|Follow-up Phase|Administrative|0|||
156836774|NCT01075984|566153889|FG001|Follow-up Phase|Administrative|0|||
156467636|NCT03066609|564807434|FG003|OVERALL STUDY|Adverse Event|1|||
156836775|NCT01075984|566153890|FG002|Follow-up Phase|Administrative|0|||
156836776|NCT01075984|566153891|FG003|Follow-up Phase|Administrative|0|||
156836777|NCT01075984|566153892|FG004|Follow-up Phase|Administrative|1|||
156836778|NCT01075984|566153888|FG000|Follow-up Phase|Withdrawal by Subject|0|||
156467637|NCT03066609|564807431|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
156836779|NCT01075984|566153889|FG001|Follow-up Phase|Withdrawal by Subject|0|||
156836780|NCT01075984|566153890|FG002|Follow-up Phase|Withdrawal by Subject|0|||
156836781|NCT01075984|566153891|FG003|Follow-up Phase|Withdrawal by Subject|0|||
156836782|NCT01075984|566153892|FG004|Follow-up Phase|Withdrawal by Subject|10|||
156836783|NCT01075984|566153888|FG000|Follow-up Phase|Progression of disease|0|||
156836784|NCT01075984|566153889|FG001|Follow-up Phase|Progression of disease|0|||
156836785|NCT01075984|566153890|FG002|Follow-up Phase|Progression of disease|0|||
156836786|NCT01075984|566153891|FG003|Follow-up Phase|Progression of disease|0|||
156836787|NCT01075984|566153892|FG004|Follow-up Phase|Progression of disease|2|||
156836788|NCT01075984|566153888|FG000|Follow-up Phase|Treatment failure|0|||
156836789|NCT01075984|566153889|FG001|Follow-up Phase|Treatment failure|0|||
156836790|NCT01075984|566153890|FG002|Follow-up Phase|Treatment failure|0|||
156836791|NCT01075984|566153891|FG003|Follow-up Phase|Treatment failure|0|||
156836792|NCT01075984|566153892|FG004|Follow-up Phase|Treatment failure|4|||
156836793|NCT03652675|566153893|FG000|Overall Study|Lost to Follow-up|4|||
156836794|NCT03652675|566153894|FG001|Overall Study|Lost to Follow-up|4|||
156836795|NCT03101085|566153896|FG000|Overall Study|Lost to Follow-up|0|||
156836796|NCT03101085|566153897|FG001|Overall Study|Lost to Follow-up|1|||
156836797|NCT02986854|566153898|FG000|Overall Study|Withdrawal by Subject|0|||
156836798|NCT02986854|566153899|FG001|Overall Study|Withdrawal by Subject|1|||
156836799|NCT02986854|566153900|FG002|Overall Study|Withdrawal by Subject|1|||
156836800|NCT02986854|566153898|FG000|Overall Study|Lost to Follow-up|3|||
156836801|NCT02986854|566153899|FG001|Overall Study|Lost to Follow-up|11|||
156836802|NCT02986854|566153900|FG002|Overall Study|Lost to Follow-up|2|||
156836803|NCT03442296|566153908|FG000|3 Month Follow-up|Death|3|||
156836804|NCT03442296|566153909|FG001|3 Month Follow-up|Death|1|||
156836805|NCT03442296|566153908|FG000|3 Month Follow-up|Lost to Follow-up|1|||
156836806|NCT03442296|566153909|FG001|3 Month Follow-up|Lost to Follow-up|1|||
156836807|NCT03442296|566153908|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
156836808|NCT03442296|566153909|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
156836809|NCT03442296|566153908|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
156836810|NCT03442296|566153909|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
156836811|NCT03442296|566153908|FG000|12 Month Follow-up|Incomplete measurement|1|||
156836812|NCT03442296|566153909|FG001|12 Month Follow-up|Incomplete measurement|1|||
156836813|NCT02409342|566153910|FG000|Overall Study|Death|211|||
156836814|NCT02409342|566153911|FG001|Overall Study|Death|201|||
156836815|NCT02409342|566153910|FG000|Overall Study|Withdrawal by Subject|24|||
156836816|NCT02409342|566153911|FG001|Overall Study|Withdrawal by Subject|17|||
156836817|NCT02409342|566153910|FG000|Overall Study|Study Terminated By Sponsor|48|||
156836818|NCT02409342|566153911|FG001|Overall Study|Study Terminated By Sponsor|59|||
156836819|NCT02409342|566153910|FG000|Overall Study|Lost to Follow-up|3|||
156836820|NCT02409342|566153911|FG001|Overall Study|Lost to Follow-up|5|||
156836821|NCT02409342|566153910|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
156836822|NCT02409342|566153911|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
156836823|NCT02409342|566153910|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
156836824|NCT02409342|566153911|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
156836825|NCT02409342|566153910|FG000|Overall Study|Sponsor Decision|1|||
156836826|NCT02409342|566153911|FG001|Overall Study|Sponsor Decision|0|||
156836827|NCT00279812|566153912|FG000|Overall Study|Protocol Violation|1|||
156836828|NCT00279812|566153913|FG001|Overall Study|Protocol Violation|1|||
156836829|NCT00279812|566153914|FG002|Overall Study|Protocol Violation|0|||
156836830|NCT00279812|566153915|FG003|Overall Study|Protocol Violation|0|||
156836831|NCT00279812|566153916|FG004|Overall Study|Protocol Violation|1|||
156836832|NCT00279812|566153917|FG005|Overall Study|Protocol Violation|0|||
156836833|NCT00279812|566153912|FG000|Overall Study|Withdrawal by Subject|0|||
156836834|NCT00279812|566153913|FG001|Overall Study|Withdrawal by Subject|4|||
156836835|NCT00279812|566153914|FG002|Overall Study|Withdrawal by Subject|2|||
156836836|NCT00279812|566153915|FG003|Overall Study|Withdrawal by Subject|0|||
156836837|NCT00279812|566153916|FG004|Overall Study|Withdrawal by Subject|0|||
156836838|NCT00279812|566153917|FG005|Overall Study|Withdrawal by Subject|0|||
156836839|NCT00279812|566153912|FG000|Overall Study|Adverse Event|0|||
156836840|NCT00279812|566153913|FG001|Overall Study|Adverse Event|1|||
156836841|NCT00279812|566153914|FG002|Overall Study|Adverse Event|1|||
156836842|NCT00279812|566153915|FG003|Overall Study|Adverse Event|0|||
156836843|NCT00279812|566153916|FG004|Overall Study|Adverse Event|2|||
156836844|NCT00279812|566153917|FG005|Overall Study|Adverse Event|1|||
156836845|NCT01274429|566153918|FG000|Overall Study|Study closed do to lack of funding|5|||
156836846|NCT04576897|566153923|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
156836847|NCT00527332|566153924|FG000|Overall Study|Protocol Violation|4|||
156836848|NCT00527332|566153925|FG001|Overall Study|Protocol Violation|8|||
156836849|NCT00527332|566153924|FG000|Overall Study|Withdrew consent|5|||
156836850|NCT00527332|566153925|FG001|Overall Study|Withdrew consent|1|||
156836851|NCT00372697|566155567|FG000|Overall Study|Protocol Violation|1|||
156836852|NCT00372697|566155568|FG001|Overall Study|Protocol Violation|1|||
156836853|NCT03221842|566155569|FG000|Period 1 (Open-label)|Adverse Event|4|||
156836854|NCT03221842|566155570|FG001|Period 1 (Open-label)|Adverse Event|0|||
156836855|NCT03221842|566155569|FG000|Period 1 (Open-label)|Physician Decision|2|||
156836856|NCT03221842|566155570|FG001|Period 1 (Open-label)|Physician Decision|0|||
156836857|NCT03221842|566155569|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
156340157|NCT02501473|564344313|FG005|Overall Study|Reason not specified|0|||
156836858|NCT03221842|566155570|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
156836859|NCT03221842|566155569|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
156836860|NCT03221842|566155570|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
156836861|NCT03221842|566155569|FG000|Period 1 (Open-label)|Other|2|||
156836862|NCT03221842|566155570|FG001|Period 1 (Open-label)|Other|0|||
156836863|NCT03221842|566155569|FG000|Period 2 (Randomized, Blinded)|Death|0|||
156836864|NCT03221842|566155570|FG001|Period 2 (Randomized, Blinded)|Death|1|||
156836865|NCT03221842|566155569|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
156836866|NCT03221842|566155570|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
156836867|NCT00448747|566155571|FG000|Overall Study|collapsed veins|1|||
156836868|NCT00448747|566155572|FG001|Overall Study|collapsed veins|0|||
156836869|NCT00387725|566155573|FG000|Overall Study|Adverse Event|0|||
156836870|NCT00387725|566155574|FG001|Overall Study|Adverse Event|0|||
156836871|NCT00387725|566155575|FG002|Overall Study|Adverse Event|0|||
156836872|NCT00387725|566155576|FG003|Overall Study|Adverse Event|1|||
156836873|NCT00387725|566155573|FG000|Overall Study|Protocol Violation|0|||
156836874|NCT00387725|566155574|FG001|Overall Study|Protocol Violation|1|||
156836875|NCT00387725|566155575|FG002|Overall Study|Protocol Violation|0|||
156836876|NCT00387725|566155576|FG003|Overall Study|Protocol Violation|0|||
156836877|NCT00387725|566155573|FG000|Overall Study|Withdrawal by Subject|1|||
156836878|NCT00387725|566155574|FG001|Overall Study|Withdrawal by Subject|0|||
156836879|NCT00387725|566155575|FG002|Overall Study|Withdrawal by Subject|1|||
156836880|NCT00387725|566155576|FG003|Overall Study|Withdrawal by Subject|0|||
156836881|NCT00387725|566155573|FG000|Overall Study|Parent/legal guardian request|0|||
156836882|NCT00387725|566155574|FG001|Overall Study|Parent/legal guardian request|0|||
156340158|NCT02501473|564344314|FG006|Overall Study|Reason not specified|0|||
156340159|NCT02501473|564344315|FG007|Overall Study|Reason not specified|0|||
156340160|NCT01581931|564344316|FG000|Washout|Adverse Event|0|||
156340161|NCT01581931|564344317|FG001|Washout|Adverse Event|1|||
156340162|NCT01389817|564344320|FG000|Overall Study|Physician Decision|1|||
156340163|NCT01389817|564344321|FG001|Overall Study|Physician Decision|0|||
156340164|NCT01389817|564344320|FG000|Overall Study|Lost to Follow-up|1|||
156340165|NCT01389817|564344321|FG001|Overall Study|Lost to Follow-up|0|||
156340166|NCT01389817|564344320|FG000|Overall Study|Withdrawal by Subject|2|||
156340167|NCT01389817|564344321|FG001|Overall Study|Withdrawal by Subject|0|||
156340168|NCT01749137|564344322|FG000|Overall Study|Adverse Event|4|||
156340169|NCT01749137|564344323|FG001|Overall Study|Adverse Event|4|||
156340170|NCT01749137|564344322|FG000|Overall Study|Lost to Follow-up|2|||
156340171|NCT01749137|564344323|FG001|Overall Study|Lost to Follow-up|3|||
156340172|NCT01749137|564344322|FG000|Overall Study|Physician Decision|1|||
156340173|NCT01749137|564344323|FG001|Overall Study|Physician Decision|0|||
156340174|NCT01749137|564344322|FG000|Overall Study|Withdrawal by Subject|8|||
156340175|NCT01749137|564344323|FG001|Overall Study|Withdrawal by Subject|4|||
156340176|NCT00691015|564344327|FG000|Overall Study|Refused further treatment|1|||
156340177|NCT04160195|564344330|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
156340178|NCT04160195|564344331|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
156340179|NCT03130257|564344334|FG000|Overall Study|Withdrawal by Subject|1|||
156340180|NCT03130257|564344335|FG001|Overall Study|Withdrawal by Subject|0|||
156340181|NCT03130257|564344336|FG002|Overall Study|Withdrawal by Subject|2|||
156340182|NCT02064894|564344337|FG000|Overall Study|Withdrawal by Subject|43|||
156340183|NCT02064894|564344338|FG001|Overall Study|Withdrawal by Subject|102|||
156340184|NCT02064894|564344339|FG002|Overall Study|Withdrawal by Subject|115|||
156340185|NCT03716024|564344340|FG000|Overall Study|Randomized, not Treated|7|||
156340186|NCT03716024|564344341|FG001|Overall Study|Randomized, not Treated|8|||
156836883|NCT00387725|566155575|FG002|Overall Study|Parent/legal guardian request|1|||
156836884|NCT00387725|566155576|FG003|Overall Study|Parent/legal guardian request|1|||
156836885|NCT00568126|566155577|FG000|Overall Study|Adverse Event|3|||
156836886|NCT00568126|566155578|FG001|Overall Study|Adverse Event|0|||
156836887|NCT00568126|566155577|FG000|Overall Study|Withdrawal by Subject|2|||
156836888|NCT00568126|566155578|FG001|Overall Study|Withdrawal by Subject|3|||
156836889|NCT00568126|566155577|FG000|Overall Study|Lost to Follow-up|4|||
156836890|NCT00568126|566155578|FG001|Overall Study|Lost to Follow-up|3|||
156340187|NCT03716024|564344340|FG000|Overall Study|Adverse Event|1|||
156340188|NCT03716024|564344341|FG001|Overall Study|Adverse Event|2|||
156340189|NCT03716024|564344340|FG000|Overall Study|Treatment Failure|1|||
156836891|NCT00568126|566155577|FG000|Overall Study|Lack of Efficacy|0|||
156836892|NCT00568126|566155578|FG001|Overall Study|Lack of Efficacy|1|||
156836893|NCT00568126|566155577|FG000|Overall Study|Physician Decision|2|||
156836894|NCT00568126|566155578|FG001|Overall Study|Physician Decision|2|||
156836895|NCT00527982|566155580|FG000|Overall Study|Physician Decision|1|||
156836896|NCT00527982|566155581|FG001|Overall Study|Physician Decision|0|||
156836897|NCT00007020|566155582|FG000|Overall Study|Death|16|||
156836898|NCT00007020|566155582|FG000|Overall Study|Lost to Follow-up|13|||
156836899|NCT00007020|566155582|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
156836900|NCT00007020|566155582|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
156836901|NCT00007020|566155582|FG000|Overall Study|Pt cared for by outside physician|4|||
156836902|NCT00007020|566155582|FG000|Overall Study|No evidence of treatment|6|||
156836903|NCT00881504|566155583|FG000|Overall Study|Withdrawal by Subject|1|||
156836904|NCT02017522|566155584|FG000|Overall Study|Withdrawal by Subject|1|||
156836905|NCT02596230|566155585|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
156836906|NCT02596230|566155586|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
156836907|NCT02596230|566155587|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
156836908|NCT02596230|566155588|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
156836909|NCT02596230|566155589|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
156836910|NCT02596230|566155585|FG000|Objective 2, One Year|Lost to Follow-up|0|||
156836911|NCT02596230|566155586|FG001|Objective 2, One Year|Lost to Follow-up|41|||
156836912|NCT02596230|566155587|FG002|Objective 2, One Year|Lost to Follow-up|41|||
156836913|NCT02596230|566155588|FG003|Objective 2, One Year|Lost to Follow-up|32|||
156836914|NCT02596230|566155589|FG004|Objective 2, One Year|Lost to Follow-up|46|||
156836915|NCT02596230|566155585|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
156836916|NCT02596230|566155586|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
156836917|NCT02596230|566155587|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
156836918|NCT02596230|566155588|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
156836919|NCT02596230|566155589|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
156836920|NCT02596230|566155585|FG000|Objective 2, One Year|Adverse drug reaction|0|||
156836921|NCT02596230|566155586|FG001|Objective 2, One Year|Adverse drug reaction|1|||
156836922|NCT02596230|566155587|FG002|Objective 2, One Year|Adverse drug reaction|0|||
156836923|NCT02596230|566155588|FG003|Objective 2, One Year|Adverse drug reaction|0|||
156836924|NCT02596230|566155589|FG004|Objective 2, One Year|Adverse drug reaction|0|||
156836925|NCT02596230|566155585|FG000|Objective 2, One Year|Death|0|||
156836926|NCT02596230|566155586|FG001|Objective 2, One Year|Death|12|||
156836927|NCT02596230|566155587|FG002|Objective 2, One Year|Death|41|||
156836928|NCT02596230|566155588|FG003|Objective 2, One Year|Death|21|||
156836929|NCT02596230|566155589|FG004|Objective 2, One Year|Death|30|||
156836930|NCT02596230|566155585|FG000|Objective 2, One Year|Other|0|||
156836931|NCT02596230|566155586|FG001|Objective 2, One Year|Other|3|||
156836932|NCT02596230|566155587|FG002|Objective 2, One Year|Other|2|||
156836933|NCT02596230|566155588|FG003|Objective 2, One Year|Other|0|||
156836934|NCT02596230|566155589|FG004|Objective 2, One Year|Other|0|||
156836935|NCT00771615|566155590|FG000|Overall Study|Withdrawal by Subject|0|||
156836936|NCT00771615|566155591|FG001|Overall Study|Withdrawal by Subject|1|||
156836937|NCT00771615|566155592|FG002|Overall Study|Withdrawal by Subject|0|||
156836938|NCT00771615|566155593|FG003|Overall Study|Withdrawal by Subject|0|||
156836939|NCT00771615|566155594|FG004|Overall Study|Withdrawal by Subject|0|||
156836940|NCT00771615|566155595|FG005|Overall Study|Withdrawal by Subject|0|||
156836941|NCT00771615|566155596|FG006|Overall Study|Withdrawal by Subject|0|||
156836942|NCT00771615|566155597|FG007|Overall Study|Withdrawal by Subject|1|||
156836943|NCT00771615|566155598|FG008|Overall Study|Withdrawal by Subject|0|||
156836944|NCT00771615|566155590|FG000|Overall Study|Lost to Follow-up|1|||
156836945|NCT00771615|566155591|FG001|Overall Study|Lost to Follow-up|1|||
156836946|NCT00771615|566155592|FG002|Overall Study|Lost to Follow-up|1|||
156836947|NCT00771615|566155593|FG003|Overall Study|Lost to Follow-up|1|||
156836948|NCT00771615|566155594|FG004|Overall Study|Lost to Follow-up|0|||
156836949|NCT00771615|566155595|FG005|Overall Study|Lost to Follow-up|1|||
156836950|NCT00771615|566155596|FG006|Overall Study|Lost to Follow-up|1|||
156836951|NCT00771615|566155597|FG007|Overall Study|Lost to Follow-up|0|||
156836952|NCT00771615|566155598|FG008|Overall Study|Lost to Follow-up|0|||
156836953|NCT02704689|566155600|FG000|Overall Study|Physician Decision|1|||
156836954|NCT02704689|566155600|FG000|Overall Study|Study device not implanted|2|||
156836955|NCT00802893|566155601|FG000|Overall Study|study terminated|3|||
156836956|NCT00320424|566155602|FG000|Overall Study|Adverse Event|3|||
156836957|NCT00320424|566155602|FG000|Overall Study|Other|3|||
156836958|NCT03270891|566155604|FG000|Overall Study|Lost to Follow-up|3|||
156836959|NCT03270891|566155605|FG001|Overall Study|Lost to Follow-up|6|||
156836960|NCT03270891|566155606|FG002|Overall Study|Lost to Follow-up|0|||
156836961|NCT03270891|566155604|FG000|Overall Study|Withdrawal by Subject|1|||
156836962|NCT03270891|566155605|FG001|Overall Study|Withdrawal by Subject|0|||
156836963|NCT03270891|566155606|FG002|Overall Study|Withdrawal by Subject|0|||
156836964|NCT03270891|566155604|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
156340190|NCT03716024|564344341|FG001|Overall Study|Treatment Failure|0|||
156836965|NCT03270891|566155605|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
156836966|NCT03270891|566155606|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
156836967|NCT02540668|566155607|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
156836968|NCT02540668|566155608|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
156836969|NCT00849108|566155609|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
156836970|NCT00849108|566155610|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
156836971|NCT00849108|566155609|FG000|Cohort 2 Efficacy|Adverse Event|0|||
156836972|NCT00849108|566155610|FG001|Cohort 2 Efficacy|Adverse Event|1|||
156836973|NCT00849108|566155609|FG000|Cohort 2 Efficacy|Other|0|||
156836974|NCT00849108|566155610|FG001|Cohort 2 Efficacy|Other|9|||
156836975|NCT02708485|566155613|FG000|Overall Study|Withdrawal by Subject|3|||
156836976|NCT02708485|566155614|FG001|Overall Study|Withdrawal by Subject|2|||
156836977|NCT00231413|566155615|FG000|Overall Study|Non-serious AE|0|||
156836978|NCT00231413|566155616|FG001|Overall Study|Non-serious AE|0|||
156836979|NCT00231413|566155617|FG002|Overall Study|Non-serious AE|1|||
156836980|NCT00231413|566155618|FG003|Overall Study|Non-serious AE|0|||
156836981|NCT00231413|566155619|FG004|Overall Study|Non-serious AE|0|||
156836982|NCT00231413|566155620|FG005|Overall Study|Non-serious AE|0|||
156836983|NCT00231413|566155621|FG006|Overall Study|Non-serious AE|1|||
156836984|NCT00231413|566155615|FG000|Overall Study|Withdrawal by Subject|3|||
156836985|NCT00231413|566155616|FG001|Overall Study|Withdrawal by Subject|1|||
156836986|NCT00231413|566155617|FG002|Overall Study|Withdrawal by Subject|4|||
156836987|NCT00231413|566155618|FG003|Overall Study|Withdrawal by Subject|2|||
156836988|NCT00231413|566155619|FG004|Overall Study|Withdrawal by Subject|2|||
156836989|NCT00231413|566155620|FG005|Overall Study|Withdrawal by Subject|0|||
156836990|NCT00231413|566155621|FG006|Overall Study|Withdrawal by Subject|3|||
156836991|NCT00231413|566155615|FG000|Overall Study|Migrated/moved from study area|0|||
156836992|NCT00231413|566155616|FG001|Overall Study|Migrated/moved from study area|0|||
156836993|NCT00231413|566155617|FG002|Overall Study|Migrated/moved from study area|1|||
156836994|NCT00231413|566155618|FG003|Overall Study|Migrated/moved from study area|0|||
156836995|NCT00231413|566155619|FG004|Overall Study|Migrated/moved from study area|0|||
156836996|NCT00231413|566155620|FG005|Overall Study|Migrated/moved from study area|1|||
156836997|NCT00231413|566155621|FG006|Overall Study|Migrated/moved from study area|0|||
156836998|NCT00231413|566155615|FG000|Overall Study|Lost to Follow-up|4|||
156836999|NCT00231413|566155616|FG001|Overall Study|Lost to Follow-up|4|||
156837000|NCT00231413|566155617|FG002|Overall Study|Lost to Follow-up|1|||
156837001|NCT00231413|566155618|FG003|Overall Study|Lost to Follow-up|1|||
156837002|NCT00231413|566155619|FG004|Overall Study|Lost to Follow-up|1|||
156837003|NCT00231413|566155620|FG005|Overall Study|Lost to Follow-up|4|||
156837004|NCT00231413|566155621|FG006|Overall Study|Lost to Follow-up|0|||
156837005|NCT00231413|566155615|FG000|Overall Study|Pregnancy|1|||
156837006|NCT00231413|566155616|FG001|Overall Study|Pregnancy|0|||
156837007|NCT00231413|566155617|FG002|Overall Study|Pregnancy|0|||
156837008|NCT00231413|566155618|FG003|Overall Study|Pregnancy|0|||
156837009|NCT00231413|566155619|FG004|Overall Study|Pregnancy|0|||
156837010|NCT00231413|566155620|FG005|Overall Study|Pregnancy|0|||
156837011|NCT00231413|566155621|FG006|Overall Study|Pregnancy|0|||
156837012|NCT01100528|566155625|FG000|Overall Study|Death|1|||
156837013|NCT01100528|566155625|FG000|Overall Study|Withdrawal by Subject|2|||
156837014|NCT01659255|566155626|FG000|Overall Study|Adverse Event|0|||
156837015|NCT01659255|566155627|FG001|Overall Study|Adverse Event|0|||
156837016|NCT01659255|566155628|FG002|Overall Study|Adverse Event|0|||
156837017|NCT01659255|566155629|FG003|Overall Study|Adverse Event|0|||
156837018|NCT01659255|566155630|FG004|Overall Study|Adverse Event|0|||
156837019|NCT01659255|566155631|FG005|Overall Study|Adverse Event|1|||
156837020|NCT01659255|566155632|FG006|Overall Study|Adverse Event|1|||
156837021|NCT01659255|566155633|FG007|Overall Study|Adverse Event|0|||
156837022|NCT01659255|566155634|FG008|Overall Study|Adverse Event|0|||
156837023|NCT01659255|566155635|FG009|Overall Study|Adverse Event|1|||
156837024|NCT01659255|566155636|FG010|Overall Study|Adverse Event|0|||
156837025|NCT01659255|566155637|FG011|Overall Study|Adverse Event|1|||
156837026|NCT01659255|566155638|FG012|Overall Study|Adverse Event|0|||
156837027|NCT01659255|566155639|FG013|Overall Study|Adverse Event|2|||
156837028|NCT01659255|566155640|FG014|Overall Study|Adverse Event|0|||
156837029|NCT01659255|566155641|FG015|Overall Study|Adverse Event|1|||
156837030|NCT01659255|566155642|FG016|Overall Study|Adverse Event|0|||
156837031|NCT01659255|566155626|FG000|Overall Study|Death|0|||
156837032|NCT01659255|566155627|FG001|Overall Study|Death|1|||
156340191|NCT03716024|564344340|FG000|Overall Study|Lost to Follow-up|2|||
156340192|NCT03716024|564344341|FG001|Overall Study|Lost to Follow-up|6|||
156837033|NCT01659255|566155628|FG002|Overall Study|Death|0|||
156837034|NCT01659255|566155629|FG003|Overall Study|Death|0|||
156837035|NCT01659255|566155630|FG004|Overall Study|Death|0|||
156837036|NCT01659255|566155631|FG005|Overall Study|Death|0|||
156837037|NCT01659255|566155632|FG006|Overall Study|Death|0|||
156837038|NCT01659255|566155633|FG007|Overall Study|Death|1|||
156837039|NCT01659255|566155634|FG008|Overall Study|Death|1|||
156837040|NCT01659255|566155635|FG009|Overall Study|Death|0|||
156837041|NCT01659255|566155636|FG010|Overall Study|Death|0|||
156467638|NCT03066609|564807432|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
156467639|NCT03066609|564807433|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
156467640|NCT03066609|564807434|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
156467641|NCT03066609|564807431|FG000|OVERALL STUDY|Lost to Follow-up|1|||
156467642|NCT03066609|564807432|FG001|OVERALL STUDY|Lost to Follow-up|1|||
156467643|NCT03066609|564807433|FG002|OVERALL STUDY|Lost to Follow-up|1|||
156467644|NCT03066609|564807434|FG003|OVERALL STUDY|Lost to Follow-up|1|||
156467645|NCT03066609|564807431|FG000|OVERALL STUDY|Pregnancy|1|||
156467646|NCT03066609|564807432|FG001|OVERALL STUDY|Pregnancy|0|||
156467647|NCT03066609|564807433|FG002|OVERALL STUDY|Pregnancy|1|||
156467648|NCT03066609|564807434|FG003|OVERALL STUDY|Pregnancy|0|||
156467649|NCT03066609|564807431|FG000|OVERALL STUDY|Lack of Efficacy|2|||
156467650|NCT03066609|564807432|FG001|OVERALL STUDY|Lack of Efficacy|1|||
156467651|NCT03066609|564807433|FG002|OVERALL STUDY|Lack of Efficacy|1|||
156467652|NCT03066609|564807434|FG003|OVERALL STUDY|Lack of Efficacy|1|||
156467653|NCT03066609|564807431|FG000|OVERALL STUDY|discontinued follow up|0|||
156467654|NCT03066609|564807432|FG001|OVERALL STUDY|discontinued follow up|2|||
156837042|NCT01659255|566155637|FG011|Overall Study|Death|0|||
156837043|NCT01659255|566155638|FG012|Overall Study|Death|1|||
156837044|NCT01659255|566155639|FG013|Overall Study|Death|1|||
156837045|NCT01659255|566155640|FG014|Overall Study|Death|2|||
156837046|NCT01659255|566155641|FG015|Overall Study|Death|1|||
156837047|NCT01659255|566155642|FG016|Overall Study|Death|0|||
156837048|NCT01659255|566155626|FG000|Overall Study|Progressive Disease|2|||
156837049|NCT01659255|566155627|FG001|Overall Study|Progressive Disease|0|||
156837050|NCT01659255|566155628|FG002|Overall Study|Progressive Disease|0|||
156837051|NCT01659255|566155629|FG003|Overall Study|Progressive Disease|0|||
156837052|NCT01659255|566155630|FG004|Overall Study|Progressive Disease|0|||
156837053|NCT01659255|566155631|FG005|Overall Study|Progressive Disease|0|||
156837054|NCT01659255|566155632|FG006|Overall Study|Progressive Disease|0|||
156837055|NCT01659255|566155633|FG007|Overall Study|Progressive Disease|1|||
156837056|NCT01659255|566155634|FG008|Overall Study|Progressive Disease|0|||
156837057|NCT01659255|566155635|FG009|Overall Study|Progressive Disease|2|||
156837058|NCT01659255|566155636|FG010|Overall Study|Progressive Disease|2|||
156837059|NCT01659255|566155637|FG011|Overall Study|Progressive Disease|3|||
156837060|NCT01659255|566155638|FG012|Overall Study|Progressive Disease|5|||
156837061|NCT01659255|566155639|FG013|Overall Study|Progressive Disease|13|||
156837062|NCT01659255|566155640|FG014|Overall Study|Progressive Disease|6|||
156837063|NCT01659255|566155641|FG015|Overall Study|Progressive Disease|2|||
156837064|NCT01659255|566155642|FG016|Overall Study|Progressive Disease|3|||
156837065|NCT01659255|566155626|FG000|Overall Study|Withdrew Consent|0|||
156837066|NCT01659255|566155627|FG001|Overall Study|Withdrew Consent|0|||
156837067|NCT01659255|566155628|FG002|Overall Study|Withdrew Consent|0|||
156837068|NCT01659255|566155629|FG003|Overall Study|Withdrew Consent|0|||
156837069|NCT01659255|566155630|FG004|Overall Study|Withdrew Consent|0|||
156837070|NCT01659255|566155631|FG005|Overall Study|Withdrew Consent|0|||
156837071|NCT01659255|566155632|FG006|Overall Study|Withdrew Consent|0|||
156837072|NCT01659255|566155633|FG007|Overall Study|Withdrew Consent|0|||
156837073|NCT01659255|566155634|FG008|Overall Study|Withdrew Consent|0|||
156837074|NCT01659255|566155635|FG009|Overall Study|Withdrew Consent|0|||
156837075|NCT01659255|566155636|FG010|Overall Study|Withdrew Consent|1|||
156837076|NCT01659255|566155637|FG011|Overall Study|Withdrew Consent|0|||
156837077|NCT01659255|566155638|FG012|Overall Study|Withdrew Consent|0|||
156837078|NCT01659255|566155639|FG013|Overall Study|Withdrew Consent|1|||
156837079|NCT01659255|566155640|FG014|Overall Study|Withdrew Consent|0|||
156837080|NCT01659255|566155641|FG015|Overall Study|Withdrew Consent|0|||
156837081|NCT01659255|566155642|FG016|Overall Study|Withdrew Consent|0|||
156837082|NCT01659255|566155626|FG000|Overall Study|Investigator Decision|0|||
156837083|NCT01659255|566155627|FG001|Overall Study|Investigator Decision|0|||
156837084|NCT01659255|566155628|FG002|Overall Study|Investigator Decision|0|||
156837085|NCT01659255|566155629|FG003|Overall Study|Investigator Decision|0|||
156837086|NCT01659255|566155630|FG004|Overall Study|Investigator Decision|0|||
156837087|NCT01659255|566155631|FG005|Overall Study|Investigator Decision|0|||
156837088|NCT01659255|566155632|FG006|Overall Study|Investigator Decision|0|||
156837089|NCT01659255|566155633|FG007|Overall Study|Investigator Decision|0|||
156837090|NCT01659255|566155634|FG008|Overall Study|Investigator Decision|0|||
156837091|NCT01659255|566155635|FG009|Overall Study|Investigator Decision|0|||
156837092|NCT01659255|566155636|FG010|Overall Study|Investigator Decision|0|||
156467655|NCT03066609|564807433|FG002|OVERALL STUDY|discontinued follow up|0|||
156467656|NCT03066609|564807434|FG003|OVERALL STUDY|discontinued follow up|0|||
156467657|NCT03885232|564807435|FG000|Overall Study|Lost to Follow-up|74|||
156467658|NCT03885232|564807436|FG001|Overall Study|Lost to Follow-up|32|||
156467659|NCT03885232|564807435|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
156837093|NCT01659255|566155637|FG011|Overall Study|Investigator Decision|0|||
156837094|NCT01659255|566155638|FG012|Overall Study|Investigator Decision|1|||
156467660|NCT03885232|564807436|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
156837095|NCT01659255|566155639|FG013|Overall Study|Investigator Decision|1|||
156837096|NCT01659255|566155640|FG014|Overall Study|Investigator Decision|0|||
156837097|NCT01659255|566155641|FG015|Overall Study|Investigator Decision|0|||
156837098|NCT01659255|566155642|FG016|Overall Study|Investigator Decision|0|||
156467661|NCT02397096|564807437|FG000|Day 1 to Week 24|Adverse Event|7|||
156467662|NCT02397096|564807438|FG001|Day 1 to Week 24|Adverse Event|1|||
156467663|NCT02397096|564807437|FG000|Day 1 to Week 24|Death|1|||
156837099|NCT01659255|566155626|FG000|Overall Study|Sponsor's Decision|0|||
156837100|NCT01659255|566155627|FG001|Overall Study|Sponsor's Decision|0|||
156837101|NCT01659255|566155628|FG002|Overall Study|Sponsor's Decision|0|||
156837102|NCT01659255|566155629|FG003|Overall Study|Sponsor's Decision|0|||
156837103|NCT01659255|566155630|FG004|Overall Study|Sponsor's Decision|0|||
156837104|NCT01659255|566155631|FG005|Overall Study|Sponsor's Decision|0|||
156837105|NCT01659255|566155632|FG006|Overall Study|Sponsor's Decision|1|||
156837106|NCT01659255|566155633|FG007|Overall Study|Sponsor's Decision|0|||
156837107|NCT01659255|566155634|FG008|Overall Study|Sponsor's Decision|0|||
156837108|NCT01659255|566155635|FG009|Overall Study|Sponsor's Decision|0|||
156837109|NCT01659255|566155636|FG010|Overall Study|Sponsor's Decision|0|||
156837110|NCT01659255|566155637|FG011|Overall Study|Sponsor's Decision|0|||
156837111|NCT01659255|566155638|FG012|Overall Study|Sponsor's Decision|0|||
156837112|NCT01659255|566155639|FG013|Overall Study|Sponsor's Decision|0|||
156837113|NCT01659255|566155640|FG014|Overall Study|Sponsor's Decision|0|||
156837114|NCT01659255|566155641|FG015|Overall Study|Sponsor's Decision|0|||
156837115|NCT01659255|566155642|FG016|Overall Study|Sponsor's Decision|0|||
156837116|NCT01659255|566155626|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837117|NCT01659255|566155627|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837118|NCT01659255|566155628|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837119|NCT01659255|566155629|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837120|NCT01659255|566155630|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837121|NCT01659255|566155631|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837122|NCT01659255|566155632|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837123|NCT01659255|566155633|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837124|NCT01659255|566155634|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837125|NCT01659255|566155635|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837126|NCT01659255|566155636|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837127|NCT01659255|566155637|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837128|NCT01659255|566155638|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837129|NCT01659255|566155639|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837130|NCT01659255|566155640|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837131|NCT01659255|566155641|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
156837132|NCT01659255|566155642|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837133|NCT01659255|566155626|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
156837134|NCT01659255|566155627|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
156837135|NCT01659255|566155628|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
156837136|NCT01659255|566155629|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
156837137|NCT01659255|566155630|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
156837138|NCT01659255|566155631|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
156837139|NCT01659255|566155632|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
156837140|NCT01659255|566155633|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
156837141|NCT01659255|566155634|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
156467664|NCT02397096|564807438|FG001|Day 1 to Week 24|Death|0|||
156467665|NCT02397096|564807437|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
156837142|NCT01659255|566155635|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
156837143|NCT01659255|566155636|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
156467666|NCT02397096|564807438|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
156467667|NCT02397096|564807437|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
156837144|NCT01659255|566155637|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
156837145|NCT01659255|566155638|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
156837146|NCT01659255|566155639|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
156837147|NCT01659255|566155640|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
156837148|NCT01659255|566155641|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
156467668|NCT02397096|564807438|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
156837149|NCT01659255|566155642|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
156837150|NCT02211313|566155643|FG000|Overall Study|Treatment Failure|5|||
156837151|NCT02211313|566155644|FG001|Overall Study|Treatment Failure|2|||
156837152|NCT02211313|566155643|FG000|Overall Study|No Follow up Questionnaires|1|||
156837153|NCT02211313|566155644|FG001|Overall Study|No Follow up Questionnaires|1|||
156837154|NCT01423916|566155645|FG000|Overall Study|Adverse Event|5|||
156837155|NCT01423916|566155646|FG001|Overall Study|Adverse Event|9|||
156837156|NCT01423916|566155647|FG002|Overall Study|Adverse Event|2|||
156837157|NCT01423916|566155645|FG000|Overall Study|Met Withdrawal Criteria|1|||
156837158|NCT01423916|566155646|FG001|Overall Study|Met Withdrawal Criteria|1|||
156837159|NCT01423916|566155647|FG002|Overall Study|Met Withdrawal Criteria|1|||
156837160|NCT01423916|566155645|FG000|Overall Study|Physician Decision|1|||
156837161|NCT01423916|566155646|FG001|Overall Study|Physician Decision|0|||
156837162|NCT01423916|566155647|FG002|Overall Study|Physician Decision|1|||
156837163|NCT01423916|566155645|FG000|Overall Study|Withdrawal by Subject|3|||
156837164|NCT01423916|566155646|FG001|Overall Study|Withdrawal by Subject|10|||
156837165|NCT01423916|566155647|FG002|Overall Study|Withdrawal by Subject|3|||
156837166|NCT01423916|566155645|FG000|Overall Study|Protocol Deviation|1|||
156837167|NCT01423916|566155646|FG001|Overall Study|Protocol Deviation|0|||
156837168|NCT01423916|566155647|FG002|Overall Study|Protocol Deviation|0|||
156837169|NCT03316950|566155648|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
156837170|NCT03316950|566155649|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
156837171|NCT03316950|566155650|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
156837172|NCT03316950|566155651|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
156837173|NCT03316950|566155648|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
156837174|NCT03316950|566155649|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
156837175|NCT03316950|566155650|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
156837176|NCT03316950|566155651|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
156837177|NCT03316950|566155648|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
156837178|NCT03316950|566155649|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
156837179|NCT03316950|566155650|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
156837180|NCT03316950|566155651|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
156837181|NCT02809053|566155655|FG000|Overall Study|Death|0|||
156837182|NCT02809053|566155656|FG001|Overall Study|Death|1|||
156837183|NCT02809053|566155655|FG000|Overall Study|Lost to Follow-up|3|||
156837184|NCT02809053|566155656|FG001|Overall Study|Lost to Follow-up|1|||
156837185|NCT02809053|566155655|FG000|Overall Study|Withdrawal by Subject|2|||
156837186|NCT02809053|566155656|FG001|Overall Study|Withdrawal by Subject|3|||
156837187|NCT02809053|566155655|FG000|Overall Study|Disease Progression|2|||
156837188|NCT02809053|566155656|FG001|Overall Study|Disease Progression|1|||
156837189|NCT00551291|566155660|FG000|Overall Study|Physician Decision|1|||
156837190|NCT01943552|566155662|FG000|Overall Study|Adverse Event|3|||
156837191|NCT01943552|566155663|FG001|Overall Study|Adverse Event|2|||
156837192|NCT01943552|566155662|FG000|Overall Study|Withdrawal by Subject|6|||
156837193|NCT01943552|566155663|FG001|Overall Study|Withdrawal by Subject|6|||
156837194|NCT01943552|566155662|FG000|Overall Study|Other Reasons|16|||
156837195|NCT01943552|566155663|FG001|Overall Study|Other Reasons|17|||
156837196|NCT01177969|566155664|FG000|Overall Study|Protocol Violation|2|||
156837197|NCT01177969|566155665|FG001|Overall Study|Protocol Violation|1|||
156837198|NCT01177969|566155664|FG000|Overall Study|Withdrawal by Subject|1|||
156837199|NCT01177969|566155665|FG001|Overall Study|Withdrawal by Subject|2|||
156837200|NCT00908037|566155667|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837201|NCT00908037|566155668|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837202|NCT00908037|566155669|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837203|NCT00908037|566155670|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837204|NCT00908037|566155671|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
156837205|NCT00908037|566155672|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837206|NCT00908037|566155673|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
156837207|NCT00908037|566155674|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837208|NCT00908037|566155675|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
156837209|NCT00908037|566155676|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837210|NCT00908037|566155677|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156467669|NCT02397096|564807437|FG000|Day 1 to Week 24|Physician Decision|2|||
156837211|NCT00908037|566155678|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837212|NCT00908037|566155667|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837213|NCT00908037|566155668|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837214|NCT00908037|566155669|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837215|NCT00908037|566155670|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837216|NCT00908037|566155671|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
156837217|NCT00908037|566155672|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837218|NCT00908037|566155673|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837219|NCT00908037|566155674|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156467670|NCT02397096|564807438|FG001|Day 1 to Week 24|Physician Decision|3|||
156467671|NCT02397096|564807437|FG000|Day 1 to Week 24|Protocol Violation|1|||
156467672|NCT02397096|564807438|FG001|Day 1 to Week 24|Protocol Violation|4|||
156467673|NCT02397096|564807437|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
156467674|NCT02397096|564807438|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
156467675|NCT02397096|564807437|FG000|Day 1 to Week 24|Randomized, not treated|3|||
156467676|NCT02397096|564807438|FG001|Day 1 to Week 24|Randomized, not treated|0|||
156467677|NCT02397096|564807437|FG000|Week 24 to Week 48|Adverse Event|6|||
156467678|NCT02397096|564807438|FG001|Week 24 to Week 48|Adverse Event|2|||
156837220|NCT00908037|566155675|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
156837221|NCT00908037|566155676|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837222|NCT00908037|566155677|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837223|NCT00908037|566155678|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837224|NCT00908037|566155667|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837225|NCT00908037|566155668|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837226|NCT00908037|566155669|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837227|NCT00908037|566155670|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
156837228|NCT00908037|566155671|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837229|NCT00908037|566155672|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837230|NCT00908037|566155673|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
156837231|NCT00908037|566155674|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837232|NCT00908037|566155675|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837233|NCT00908037|566155676|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837234|NCT00908037|566155677|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837235|NCT00908037|566155678|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837236|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837237|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837238|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837239|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837240|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837241|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837242|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837243|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837244|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837245|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837246|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837247|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
156837248|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837249|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837250|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837251|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837252|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837253|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156467679|NCT02397096|564807437|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
156467680|NCT02397096|564807438|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
156467681|NCT02397096|564807437|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
156837254|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837255|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837256|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837257|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
156837258|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837259|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
156837260|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156467682|NCT02397096|564807438|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
156467683|NCT02397096|564807437|FG000|Week 24 to Week 48|Physician Decision|2|||
156837261|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837262|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837263|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837264|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837265|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837266|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837267|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837268|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837269|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
156837270|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837271|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837272|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837273|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837274|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837275|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837276|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837277|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837278|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837279|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837280|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837281|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837282|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
156837283|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837284|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837285|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837286|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837287|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837288|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837289|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837290|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837291|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837292|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837293|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
156837294|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837295|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837296|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837297|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837298|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837299|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837300|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837301|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837302|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837303|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837304|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837305|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837306|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
156837307|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837308|NCT01475162|566155679|FG000|Overall Study|Physician Decision|1|||
156837309|NCT01475162|566155679|FG000|Overall Study|Death|10|||
156837310|NCT01475162|566155679|FG000|Overall Study|Study closed for safety|3|||
156837311|NCT02565810|566155680|FG000|Overall Study|Withdrawal by Subject|1|||
156837312|NCT01147900|566155681|FG000|At Year 10|Lost to Follow-up|0|||
156837313|NCT01147900|566155682|FG001|At Year 10|Lost to Follow-up|1|||
156837314|NCT01147900|566155683|FG002|At Year 10|Lost to Follow-up|0|||
156837315|NCT02358044|566155684|FG000|Overall Study|Adverse Event|0|||
156837316|NCT02358044|566155685|FG001|Overall Study|Adverse Event|1|||
156837317|NCT02358044|566155684|FG000|Overall Study|Lost to Follow-up|2|||
156837318|NCT02358044|566155685|FG001|Overall Study|Lost to Follow-up|1|||
156837319|NCT02358044|566155684|FG000|Overall Study|Physician Decision|0|||
156837320|NCT02358044|566155685|FG001|Overall Study|Physician Decision|1|||
156837321|NCT02358044|566155684|FG000|Overall Study|Withdrawal by Subject|0|||
156837322|NCT02358044|566155685|FG001|Overall Study|Withdrawal by Subject|4|||
156837323|NCT00903331|566155688|FG000|Overall Study|Death|4|||
156837324|NCT00903331|566155689|FG001|Overall Study|Death|8|||
156467684|NCT02397096|564807438|FG001|Week 24 to Week 48|Physician Decision|1|||
156467685|NCT02397096|564807437|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
156467686|NCT02397096|564807438|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
156467687|NCT02397096|564807437|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
156467688|NCT02397096|564807438|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
156467689|NCT02397096|564807437|FG000|Study Extension 1|Adverse Event|7|||
156467690|NCT02397096|564807438|FG001|Study Extension 1|Adverse Event|5|||
156467691|NCT02397096|564807437|FG000|Study Extension 1|Death|1|||
156467692|NCT02397096|564807438|FG001|Study Extension 1|Death|0|||
156467693|NCT02397096|564807437|FG000|Study Extension 1|Lack of Efficacy|2|||
156467694|NCT02397096|564807438|FG001|Study Extension 1|Lack of Efficacy|5|||
156467695|NCT02397096|564807437|FG000|Study Extension 1|Lost to Follow-up|2|||
156467696|NCT02397096|564807438|FG001|Study Extension 1|Lost to Follow-up|3|||
156467697|NCT02397096|564807437|FG000|Study Extension 1|Non-compliance with study drug|3|||
156467698|NCT02397096|564807438|FG001|Study Extension 1|Non-compliance with study drug|0|||
156467699|NCT02397096|564807437|FG000|Study Extension 1|Physician Decision|4|||
156467700|NCT02397096|564807438|FG001|Study Extension 1|Physician Decision|2|||
156467701|NCT02397096|564807437|FG000|Study Extension 1|Pregnancy|1|||
156467702|NCT02397096|564807438|FG001|Study Extension 1|Pregnancy|0|||
156467703|NCT02397096|564807437|FG000|Study Extension 1|Protocol Violation|0|||
156467704|NCT02397096|564807438|FG001|Study Extension 1|Protocol Violation|1|||
156467705|NCT02397096|564807437|FG000|Study Extension 1|Withdrawal by Subject|21|||
156467706|NCT02397096|564807438|FG001|Study Extension 1|Withdrawal by Subject|7|||
156467707|NCT02397096|564807437|FG000|Study Extension 2|Adverse Event|3|||
156467708|NCT02397096|564807438|FG001|Study Extension 2|Adverse Event|3|||
156467709|NCT02397096|564807437|FG000|Study Extension 2|Availability of study medication locally|152|||
156467710|NCT02397096|564807438|FG001|Study Extension 2|Availability of study medication locally|64|||
156467711|NCT02397096|564807437|FG000|Study Extension 2|Death|2|||
156467712|NCT02397096|564807438|FG001|Study Extension 2|Death|0|||
156467713|NCT02397096|564807437|FG000|Study Extension 2|Lack of Efficacy|1|||
156467714|NCT02397096|564807438|FG001|Study Extension 2|Lack of Efficacy|0|||
156467715|NCT02397096|564807437|FG000|Study Extension 2|Lost to Follow-up|2|||
156467716|NCT02397096|564807438|FG001|Study Extension 2|Lost to Follow-up|1|||
156467717|NCT02397096|564807437|FG000|Study Extension 2|Non-compliance with study drug|1|||
156467718|NCT02397096|564807438|FG001|Study Extension 2|Non-compliance with study drug|0|||
156467719|NCT02397096|564807437|FG000|Study Extension 2|Physician Decision|2|||
156467720|NCT02397096|564807438|FG001|Study Extension 2|Physician Decision|5|||
156467721|NCT02397096|564807437|FG000|Study Extension 2|Pregnancy|1|||
156467722|NCT02397096|564807438|FG001|Study Extension 2|Pregnancy|0|||
156467723|NCT02397096|564807437|FG000|Study Extension 2|Withdrawal by Subject|10|||
156467724|NCT02397096|564807438|FG001|Study Extension 2|Withdrawal by Subject|3|||
156467725|NCT02397096|564807437|FG000|Study Extension 3|Adverse Event|1|||
156467726|NCT02397096|564807438|FG001|Study Extension 3|Adverse Event|0|||
156467727|NCT02397096|564807437|FG000|Study Extension 3|Availability of study medication locally|11|||
156467728|NCT02397096|564807438|FG001|Study Extension 3|Availability of study medication locally|3|||
156467729|NCT02397096|564807437|FG000|Study Extension 3|Lost to Follow-up|1|||
156467730|NCT02397096|564807438|FG001|Study Extension 3|Lost to Follow-up|0|||
156467731|NCT02397096|564807437|FG000|Study Extension 3|Withdrawal by Subject|2|||
156467732|NCT02397096|564807438|FG001|Study Extension 3|Withdrawal by Subject|1|||
156467733|NCT05139992|564807439|FG000|Overall Study|Withdrawal by Subject|12|||
156467734|NCT05139992|564807439|FG000|Overall Study|Lost to Follow-up|6|||
156467735|NCT05521516|564807440|FG000|Overall Study|Withdrawal by Subject|1|||
156467736|NCT05521516|564807441|FG001|Overall Study|Withdrawal by Subject|1|||
156467737|NCT02500576|564807443|FG000|Overall Study|Adverse Event|0|||
156467738|NCT02500576|564807444|FG001|Overall Study|Adverse Event|1|||
156467739|NCT02500576|564807443|FG000|Overall Study|Death|2|||
156467740|NCT02500576|564807444|FG001|Overall Study|Death|1|||
156467741|NCT02500576|564807443|FG000|Overall Study|Lack of Efficacy|5|||
156467742|NCT02500576|564807444|FG001|Overall Study|Lack of Efficacy|5|||
156467743|NCT02500576|564807443|FG000|Overall Study|Withdrawal by Subject|1|||
156467744|NCT02500576|564807444|FG001|Overall Study|Withdrawal by Subject|1|||
156467745|NCT04882917|564807453|FG000|Overall Study|Adverse Event|0|||
156467746|NCT04882917|564807454|FG001|Overall Study|Adverse Event|1|||
156467747|NCT04882917|564807455|FG002|Overall Study|Adverse Event|2|||
156467748|NCT04882917|564807456|FG003|Overall Study|Adverse Event|2|||
156467749|NCT04882917|564807453|FG000|Overall Study|Withdrawal by Subject|1|||
156467750|NCT04882917|564807454|FG001|Overall Study|Withdrawal by Subject|0|||
156467751|NCT04882917|564807455|FG002|Overall Study|Withdrawal by Subject|2|||
156467752|NCT04882917|564807456|FG003|Overall Study|Withdrawal by Subject|1|||
156467753|NCT04882917|564807453|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
156467754|NCT04882917|564807454|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
156467755|NCT04882917|564807455|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
156467756|NCT04882917|564807456|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
156467757|NCT00227266|564807457|FG000|Overall Study|Withdrawal by Subject|0|||
156467758|NCT00227266|564807458|FG001|Overall Study|Withdrawal by Subject|0|||
156467759|NCT00227266|564807459|FG002|Overall Study|Withdrawal by Subject|1|||
156837325|NCT00903331|566155688|FG000|Overall Study|Withdrawal of consent|1|||
156837326|NCT00903331|566155689|FG001|Overall Study|Withdrawal of consent|8|||
156837327|NCT00903331|566155688|FG000|Overall Study|Lung transplant|0|||
156837328|NCT00903331|566155689|FG001|Overall Study|Lung transplant|2|||
156837329|NCT04109976|566155693|FG000|Overall Study|Withdrawal by Subject|1|||
156837330|NCT04109976|566155694|FG001|Overall Study|Withdrawal by Subject|0|||
156837331|NCT00257660|566155695|FG000|Overall Study|Lack of Efficacy|5|||
156837332|NCT00257660|566155696|FG001|Overall Study|Lack of Efficacy|23|||
156837333|NCT00257660|566155695|FG000|Overall Study|Withdrawal by Subject|2|||
156837334|NCT00257660|566155696|FG001|Overall Study|Withdrawal by Subject|0|||
156837335|NCT00257660|566155695|FG000|Overall Study|Lost to Follow-up|1|||
156837336|NCT00257660|566155696|FG001|Overall Study|Lost to Follow-up|0|||
156837337|NCT00257660|566155695|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
156837338|NCT00257660|566155696|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
156837339|NCT00257660|566155695|FG000|Overall Study|No longer wanted to do blood draws|1|||
156837340|NCT00257660|566155696|FG001|Overall Study|No longer wanted to do blood draws|0|||
156837341|NCT00491608|566155697|FG000|Overall Study|Death|2|||
156837342|NCT00491608|566155697|FG000|Overall Study|Withdrawal by Subject|1|||
156837343|NCT00025155|566155700|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
156837344|NCT00025155|566155700|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
156837345|NCT00552760|566155703|FG000|Overall Study|Adverse Event|3|||
156837346|NCT00552760|566155704|FG001|Overall Study|Adverse Event|5|||
156837347|NCT00552760|566155703|FG000|Overall Study|Relapsed- Depressed Event|10|||
156837348|NCT00552760|566155704|FG001|Overall Study|Relapsed- Depressed Event|16|||
156837349|NCT00552760|566155703|FG000|Overall Study|Relapse- Manic Event|3|||
156837350|NCT00552760|566155704|FG001|Overall Study|Relapse- Manic Event|3|||
156837351|NCT00552760|566155703|FG000|Overall Study|Relapsed- Mixed Event|3|||
156837352|NCT00552760|566155704|FG001|Overall Study|Relapsed- Mixed Event|5|||
156837353|NCT00552760|566155703|FG000|Overall Study|Protocol Violation|0|||
156837354|NCT00552760|566155704|FG001|Overall Study|Protocol Violation|1|||
156837355|NCT00552760|566155703|FG000|Overall Study|Lost to Follow-up|1|||
156837356|NCT00552760|566155704|FG001|Overall Study|Lost to Follow-up|1|||
156837357|NCT00552760|566155703|FG000|Overall Study|Non-compliance|1|||
156837358|NCT00552760|566155704|FG001|Overall Study|Non-compliance|1|||
156837359|NCT00552760|566155703|FG000|Overall Study|Medical Condition|1|||
156837360|NCT00552760|566155704|FG001|Overall Study|Medical Condition|1|||
156837361|NCT00552760|566155703|FG000|Overall Study|Withdrawal by Subject|3|||
156837362|NCT00552760|566155704|FG001|Overall Study|Withdrawal by Subject|0|||
156837363|NCT00552760|566155703|FG000|Overall Study|Medication Change|1|||
156837364|NCT00552760|566155704|FG001|Overall Study|Medication Change|0|||
156467760|NCT00227266|564807457|FG000|Overall Study|Protocol Violation|1|||
156467761|NCT00227266|564807458|FG001|Overall Study|Protocol Violation|0|||
156467762|NCT00227266|564807459|FG002|Overall Study|Protocol Violation|1|||
156467763|NCT00227266|564807457|FG000|Overall Study|Excessive weight gain|0|||
156467764|NCT00227266|564807458|FG001|Overall Study|Excessive weight gain|0|||
156467765|NCT00227266|564807459|FG002|Overall Study|Excessive weight gain|2|||
156467766|NCT03959423|564807463|FG000|Overall Study|Withdrawal by Subject|2|||
156467767|NCT03959423|564807464|FG001|Overall Study|Withdrawal by Subject|3|||
156467768|NCT03959423|564807463|FG000|Overall Study|Physician Decision|0|||
156467769|NCT03959423|564807464|FG001|Overall Study|Physician Decision|1|||
156467770|NCT03959423|564807463|FG000|Overall Study|Lost to Follow-up|1|||
156467771|NCT03959423|564807464|FG001|Overall Study|Lost to Follow-up|0|||
156467772|NCT03959423|564807463|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
156467773|NCT03959423|564807464|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156467774|NCT04926740|564807465|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
156467775|NCT04926740|564807466|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
156467776|NCT04926740|564807465|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
156467777|NCT04926740|564807466|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
156467778|NCT01470144|564807469|FG000|Overall Study|Adverse Event|2|||
156837365|NCT03426631|566155707|FG000|Overall Study|Lost to Follow-up|0|||
156837366|NCT03426631|566155708|FG001|Overall Study|Lost to Follow-up|1|||
156837367|NCT00343382|566155711|FG000|Overall Study|Adverse Event|2|||
156837368|NCT00343382|566155712|FG001|Overall Study|Adverse Event|10|||
156837369|NCT00343382|566155713|FG002|Overall Study|Adverse Event|7|||
156837370|NCT00343382|566155711|FG000|Overall Study|Withdrawal by Subject|1|||
156837371|NCT00343382|566155712|FG001|Overall Study|Withdrawal by Subject|2|||
156467779|NCT01470144|564807469|FG000|Overall Study|Death|1|||
156467780|NCT01470144|564807469|FG000|Overall Study|Lung transplant|6|||
156467781|NCT01470144|564807469|FG000|Overall Study|Patient's and investigator's decision|1|||
156467782|NCT00593840|564807470|FG000|Overall Study|Withdrawal by Subject|1|||
156467783|NCT01128595|564808457|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156467784|NCT01128595|564808458|FG001|Treatment Period 3|Withdrawal by Subject|1|||
156467785|NCT01128595|564808459|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156467786|NCT01128595|564808460|FG003|Treatment Period 3|Withdrawal by Subject|0|||
156837372|NCT00343382|566155713|FG002|Overall Study|Withdrawal by Subject|6|||
156837373|NCT00343382|566155711|FG000|Overall Study|Other Reason Not Specified|1|||
156837374|NCT00343382|566155712|FG001|Overall Study|Other Reason Not Specified|2|||
156837375|NCT00343382|566155713|FG002|Overall Study|Other Reason Not Specified|4|||
156837376|NCT02337725|566155718|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
156837377|NCT02337725|566155719|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
156837378|NCT02337725|566155718|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
156837379|NCT02337725|566155719|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
156837380|NCT02337725|566155718|FG000|Overall Study|Major Protocol Deviation|0|||
156837381|NCT02337725|566155719|FG001|Overall Study|Major Protocol Deviation|1|||
156837382|NCT02337725|566155718|FG000|Overall Study|Voluntary Withdrawal|14|||
156837383|NCT02337725|566155719|FG001|Overall Study|Voluntary Withdrawal|3|||
156837384|NCT02337725|566155718|FG000|Overall Study|Lack of Efficacy|4|||
156837385|NCT02337725|566155719|FG001|Overall Study|Lack of Efficacy|0|||
156837386|NCT00710385|566155724|FG000|Overall Study|Did not qualify|1|||
156837387|NCT00710385|566155724|FG000|Overall Study|Withdrawal by Subject|1|||
156837388|NCT00710385|566155724|FG000|Overall Study|Undisclosed back pain|1|||
156837389|NCT00710385|566155724|FG000|Overall Study|Physician Decision|1|||
156837390|NCT00710385|566155724|FG000|Overall Study|Undisclosed excessive methadone use|1|||
156837391|NCT01264770|566155725|FG000|Overall Study|Not reported|0|||
156837392|NCT01264770|566155726|FG001|Overall Study|Not reported|0|||
156837393|NCT01264770|566155727|FG002|Overall Study|Not reported|1|||
156837394|NCT01264770|566155728|FG003|Overall Study|Not reported|0|||
156837395|NCT01264770|566155729|FG004|Overall Study|Not reported|0|||
156837396|NCT01264770|566155730|FG005|Overall Study|Not reported|0|||
156837397|NCT01264770|566155725|FG000|Overall Study|e.g., change in circumstances|8|||
156837398|NCT01264770|566155726|FG001|Overall Study|e.g., change in circumstances|3|||
156837399|NCT01264770|566155727|FG002|Overall Study|e.g., change in circumstances|3|||
156837400|NCT01264770|566155728|FG003|Overall Study|e.g., change in circumstances|3|||
156837401|NCT01264770|566155729|FG004|Overall Study|e.g., change in circumstances|4|||
156837402|NCT01264770|566155730|FG005|Overall Study|e.g., change in circumstances|4|||
156837403|NCT01264770|566155725|FG000|Overall Study|Severe non-compliance to protocol|0|||
156837404|NCT01264770|566155726|FG001|Overall Study|Severe non-compliance to protocol|0|||
156837405|NCT01264770|566155727|FG002|Overall Study|Severe non-compliance to protocol|1|||
156837406|NCT01264770|566155728|FG003|Overall Study|Severe non-compliance to protocol|1|||
156837407|NCT01264770|566155729|FG004|Overall Study|Severe non-compliance to protocol|0|||
156837408|NCT01264770|566155730|FG005|Overall Study|Severe non-compliance to protocol|0|||
156837409|NCT01264770|566155725|FG000|Overall Study|Lack of therapeutic response|1|||
156837410|NCT01264770|566155726|FG001|Overall Study|Lack of therapeutic response|0|||
156837411|NCT01264770|566155727|FG002|Overall Study|Lack of therapeutic response|2|||
156837412|NCT01264770|566155728|FG003|Overall Study|Lack of therapeutic response|1|||
156837413|NCT01264770|566155729|FG004|Overall Study|Lack of therapeutic response|1|||
156837414|NCT01264770|566155730|FG005|Overall Study|Lack of therapeutic response|0|||
156837415|NCT01264770|566155725|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
156837416|NCT01264770|566155726|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
156837417|NCT01264770|566155727|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
156837418|NCT01264770|566155728|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
156837419|NCT01264770|566155729|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
156837420|NCT01264770|566155730|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
156837421|NCT01264770|566155725|FG000|Overall Study|Lost to Follow-up|0|||
156837422|NCT01264770|566155726|FG001|Overall Study|Lost to Follow-up|0|||
156837423|NCT01264770|566155727|FG002|Overall Study|Lost to Follow-up|1|||
156467787|NCT01561300|564808462|FG000|Run in on Placebo|Adverse Event|1|||
156467788|NCT01561300|564808463|FG001|Run in on Placebo|Adverse Event|0|||
156467789|NCT01185600|564808464|FG000|Overall Study|Adverse Event|1|||
156467790|NCT01185600|564808465|FG001|Overall Study|Adverse Event|1|||
156837424|NCT01264770|566155728|FG003|Overall Study|Lost to Follow-up|1|||
156837425|NCT01264770|566155729|FG004|Overall Study|Lost to Follow-up|0|||
156837426|NCT01264770|566155730|FG005|Overall Study|Lost to Follow-up|0|||
156837427|NCT01264770|566155725|FG000|Overall Study|Adverse Event|7|||
156837428|NCT01264770|566155726|FG001|Overall Study|Adverse Event|7|||
156837429|NCT01264770|566155727|FG002|Overall Study|Adverse Event|8|||
156837430|NCT01264770|566155728|FG003|Overall Study|Adverse Event|0|||
156837431|NCT01264770|566155729|FG004|Overall Study|Adverse Event|2|||
156837432|NCT01264770|566155730|FG005|Overall Study|Adverse Event|1|||
156837433|NCT03109184|566157913|FG000|Overall Study|Lost to Follow-up|6|||
156467791|NCT01185600|564808464|FG000|Overall Study|Death|0|||
156340193|NCT03716024|564344340|FG000|Overall Study|Withdrawal by Subject|0|||
156340194|NCT03716024|564344341|FG001|Overall Study|Withdrawal by Subject|1|||
156340195|NCT03716024|564344340|FG000|Overall Study|Missing Reason|0|||
156340196|NCT03716024|564344341|FG001|Overall Study|Missing Reason|1|||
156340197|NCT04343261|564344342|FG000|Overall Study|Adverse Event|1|||
156340198|NCT04343261|564344342|FG000|Overall Study|received inadequate amount of antibodies|7|||
156340199|NCT03600818|564344343|FG000|Overall Study|Adverse Event|4|||
156340200|NCT03600818|564344344|FG001|Overall Study|Adverse Event|7|||
156340201|NCT03600818|564344343|FG000|Overall Study|Lack of Efficacy|9|||
156340202|NCT03600818|564344344|FG001|Overall Study|Lack of Efficacy|4|||
156340203|NCT03600818|564344343|FG000|Overall Study|Withdrawal by Subject|4|||
156340204|NCT03600818|564344344|FG001|Overall Study|Withdrawal by Subject|3|||
156340205|NCT03600818|564344343|FG000|Overall Study|Other-unspecified|5|||
156340206|NCT03600818|564344344|FG001|Overall Study|Other-unspecified|3|||
156340207|NCT03600818|564344343|FG000|Overall Study|Randomized and not treated|0|||
156340208|NCT03600818|564344344|FG001|Overall Study|Randomized and not treated|1|||
156340209|NCT04930965|564344347|FG000|Overall Study|Lost to Follow-up|7|||
156340210|NCT04930965|564344348|FG001|Overall Study|Lost to Follow-up|5|||
156340211|NCT04377620|564344349|FG000|Overall Study|Death|42|||
156340212|NCT04377620|564344350|FG001|Overall Study|Death|48|||
156340213|NCT04377620|564344351|FG002|Overall Study|Death|36|||
156340214|NCT04377620|564344349|FG000|Overall Study|Withdrawal by Subject|0|||
156340215|NCT04377620|564344350|FG001|Overall Study|Withdrawal by Subject|2|||
156340216|NCT04377620|564344351|FG002|Overall Study|Withdrawal by Subject|0|||
156340217|NCT01488370|564344352|FG000|Overall Study|Protocol Violation|0|||
156340218|NCT01488370|564344353|FG001|Overall Study|Protocol Violation|1|||
156340219|NCT01488370|564344354|FG002|Overall Study|Protocol Violation|1|||
156340220|NCT04189081|564344355|FG000|Overall Study|Lost to Follow-up|1|||
156340221|NCT04189081|564344356|FG001|Overall Study|Lost to Follow-up|0|||
156340222|NCT04189081|564344357|FG002|Overall Study|Lost to Follow-up|0|||
156340223|NCT04189081|564344355|FG000|Overall Study|Withdrawal by Subject|0|||
156340224|NCT04189081|564344356|FG001|Overall Study|Withdrawal by Subject|0|||
156340225|NCT04189081|564344357|FG002|Overall Study|Withdrawal by Subject|1|||
156340226|NCT00044083|564344358|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
156340227|NCT00044083|564344359|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
156340228|NCT00044083|564344358|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
156340229|NCT00044083|564344359|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
156340230|NCT00044083|564344358|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
156340231|NCT00044083|564344359|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
156340232|NCT00044083|564344358|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
156340233|NCT00044083|564344359|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
156340234|NCT00044083|564344358|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
156340235|NCT00044083|564344359|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
156340236|NCT00044083|564344358|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
156340237|NCT00044083|564344359|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
156340238|NCT00044083|564344358|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
156340239|NCT00044083|564344359|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
156340240|NCT00044083|564344358|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
156340241|NCT00044083|564344359|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
156340242|NCT00044083|564344358|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
156340243|NCT00044083|564344359|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
156340244|NCT00044083|564344358|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
156340245|NCT00044083|564344359|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
156340246|NCT02228460|564344368|FG000|Overall Study|Adverse Event|1|||
156340247|NCT02228460|564344368|FG000|Overall Study|Lost to Follow-up|1|||
156340248|NCT01243892|564344369|FG000|Overall Study|Did not meet eligibility criteria|2|||
156340249|NCT01243892|564344370|FG001|Overall Study|Did not meet eligibility criteria|0|||
156340250|NCT00119106|564344371|FG000|Overall Study|HIV infected at baseline|179|||
156340251|NCT00119106|564344372|FG001|Overall Study|HIV infected at baseline|178|||
156340252|NCT01866293|564344373|FG000|Overall Study|Adverse Event|2|||
156837434|NCT03109184|566157914|FG001|Overall Study|Lost to Follow-up|6|||
156340253|NCT01010061|564344374|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
156340254|NCT01010061|564344375|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
156340255|NCT01010061|564344374|FG000|Overall Study|Disease Progression|2|||
156340256|NCT01010061|564344375|FG001|Overall Study|Disease Progression|8|||
156340257|NCT01010061|564344374|FG000|Overall Study|Withdrew Consent|5|||
156340258|NCT01010061|564344375|FG001|Overall Study|Withdrew Consent|1|||
156340259|NCT01010061|564344374|FG000|Overall Study|Death|3|||
156340260|NCT01010061|564344375|FG001|Overall Study|Death|6|||
156340261|NCT01010061|564344374|FG000|Overall Study|Administrative/Other|0|||
156340262|NCT01010061|564344375|FG001|Overall Study|Administrative/Other|1|||
156340263|NCT01010061|564344374|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
156340264|NCT01010061|564344375|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
156837435|NCT03109184|566157913|FG000|Overall Study|Withdrawal by Subject|1|||
156837436|NCT03109184|566157914|FG001|Overall Study|Withdrawal by Subject|1|||
156837437|NCT02503501|566157915|FG000|Overall Study|Physician Decision|1|||
156837438|NCT02503501|566157916|FG001|Overall Study|Physician Decision|0|||
156837439|NCT02503501|566157915|FG000|Overall Study|Protocol Violation|0|||
156837440|NCT02503501|566157916|FG001|Overall Study|Protocol Violation|1|||
156837441|NCT02503501|566157915|FG000|Overall Study|Withdrawal by Subject|0|||
156837442|NCT02503501|566157916|FG001|Overall Study|Withdrawal by Subject|2|||
156837443|NCT01740401|566157917|FG000|Overall Study|Progression of disease|6|||
156837444|NCT01740401|566157917|FG000|Overall Study|Adverse Event|2|||
156837445|NCT01740401|566157917|FG000|Overall Study|Did not reach primary endpoint|2|||
156340265|NCT01010061|564344374|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156837446|NCT02806960|566157918|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
156837447|NCT02806960|566157919|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
156340266|NCT01010061|564344375|FG001|Overall Study|Insufficient Therapeutic Response|5|||
156837448|NCT02806960|566157920|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
156837449|NCT02806960|566157921|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
156837450|NCT00321464|566157922|FG000|Overall Study|Death|169|||
156837451|NCT00321464|566157923|FG001|Overall Study|Death|174|||
156340267|NCT01010061|564344374|FG000|Overall Study|Violation of Selection Criteria|0|||
156467792|NCT01185600|564808465|FG001|Overall Study|Death|1|||
156467793|NCT01185600|564808464|FG000|Overall Study|Lost to Follow-up|0|||
156837452|NCT00321464|566157922|FG000|Overall Study|Disease progression|124|||
156837453|NCT00321464|566157923|FG001|Overall Study|Disease progression|124|||
156837454|NCT00321464|566157922|FG000|Overall Study|Withdrawal by Subject|117|||
156837455|NCT00321464|566157923|FG001|Overall Study|Withdrawal by Subject|118|||
156837456|NCT00321464|566157922|FG000|Overall Study|Participant request|57|||
156837457|NCT00321464|566157923|FG001|Overall Study|Participant request|61|||
156837458|NCT00321464|566157922|FG000|Overall Study|Adverse Event|43|||
156837459|NCT00321464|566157923|FG001|Overall Study|Adverse Event|28|||
156837460|NCT00321464|566157922|FG000|Overall Study|Physician Decision|15|||
156467794|NCT01185600|564808465|FG001|Overall Study|Lost to Follow-up|5|||
156467795|NCT01185600|564808464|FG000|Overall Study|Physician Decision|29|||
156467796|NCT01185600|564808465|FG001|Overall Study|Physician Decision|35|||
156467797|NCT01185600|564808464|FG000|Overall Study|Withdrawal by Subject|1|||
156467798|NCT01185600|564808465|FG001|Overall Study|Withdrawal by Subject|1|||
156467799|NCT01185600|564808464|FG000|Overall Study|Hold by DSMB|1|||
156467800|NCT01185600|564808465|FG001|Overall Study|Hold by DSMB|2|||
156467801|NCT05405244|564808466|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
156467802|NCT05405244|564808467|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
156467803|NCT05405244|564808466|FG000|Washout (2 Weeks)|Adverse Event|2|||
156467804|NCT05405244|564808467|FG001|Washout (2 Weeks)|Adverse Event|0|||
156467805|NCT05405244|564808466|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
156467806|NCT05405244|564808467|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
156467807|NCT00739934|564808468|FG000|Voriconazole IV|Adverse Event|6|||
156467808|NCT00739934|564808468|FG000|Voriconazole Oral|Other|3|||
156467809|NCT04353492|564808474|FG000|Overall Study|Subject decision|24|||
156467810|NCT04353492|564808474|FG000|Overall Study|Physician Decision|5|||
156467811|NCT04353492|564808474|FG000|Overall Study|Adverse Event|3|||
156467812|NCT04353492|564808474|FG000|Overall Study|Pregnancy|3|||
156467813|NCT04353492|564808474|FG000|Overall Study|Lost to Follow-up|2|||
156467814|NCT04353492|564808474|FG000|Overall Study|Protocol deviation|1|||
156467815|NCT04353492|564808474|FG000|Overall Study|Technical problems|1|||
156467816|NCT04250194|564808475|FG000|Overall Study|Declined to schedule biopsy|6|||
156467817|NCT04250194|564808476|FG001|Overall Study|Declined to schedule biopsy|10|||
156467818|NCT04250194|564808475|FG000|Overall Study|Medically Unfit for Biopsy|2|||
156467819|NCT04250194|564808476|FG001|Overall Study|Medically Unfit for Biopsy|1|||
156467820|NCT04250194|564808475|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
156467821|NCT04250194|564808476|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
156467822|NCT04250194|564808475|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
156837461|NCT00321464|566157923|FG001|Overall Study|Physician Decision|14|||
156837462|NCT00321464|566157922|FG000|Overall Study|Noncompliance|4|||
156837463|NCT00321464|566157923|FG001|Overall Study|Noncompliance|10|||
156467823|NCT04250194|564808476|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
156467824|NCT04250194|564808475|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
156837464|NCT00321464|566157922|FG000|Overall Study|Lost to Follow-up|7|||
156837465|NCT00321464|566157923|FG001|Overall Study|Lost to Follow-up|8|||
156837466|NCT00321464|566157922|FG000|Overall Study|Protocol deviation|0|||
156837467|NCT00321464|566157923|FG001|Overall Study|Protocol deviation|2|||
156837468|NCT00321464|566157922|FG000|Overall Study|Ineligibility determined|2|||
156837469|NCT00321464|566157923|FG001|Overall Study|Ineligibility determined|1|||
156837470|NCT00321464|566157922|FG000|Overall Study|Other|21|||
156837471|NCT00321464|566157923|FG001|Overall Study|Other|18|||
156837472|NCT01209078|566157924|FG000|Overall Study|Adverse Event|5|||
156837473|NCT01209078|566157925|FG001|Overall Study|Adverse Event|0|||
156837474|NCT01209078|566157924|FG000|Overall Study|Lost to Follow-up|4|||
156837475|NCT01209078|566157925|FG001|Overall Study|Lost to Follow-up|0|||
156837476|NCT01209078|566157924|FG000|Overall Study|Physician Decision|5|||
156837477|NCT01209078|566157925|FG001|Overall Study|Physician Decision|2|||
156837478|NCT01209078|566157924|FG000|Overall Study|Withdrawal by Subject|2|||
156837479|NCT01209078|566157925|FG001|Overall Study|Withdrawal by Subject|1|||
156837480|NCT02207491|566157928|FG000|Overall Study|Adverse Event|20|||
156837481|NCT02207491|566157929|FG001|Overall Study|Adverse Event|4|||
156837482|NCT02207491|566157928|FG000|Overall Study|Withdrawal by Subject|3|||
156837483|NCT02207491|566157929|FG001|Overall Study|Withdrawal by Subject|2|||
156837484|NCT02207491|566157928|FG000|Overall Study|Non-compliant|0|||
156837485|NCT02207491|566157929|FG001|Overall Study|Non-compliant|1|||
156837486|NCT02207491|566157928|FG000|Overall Study|Lost to Follow-up|0|||
156837487|NCT02207491|566157929|FG001|Overall Study|Lost to Follow-up|1|||
156837488|NCT02207491|566157928|FG000|Overall Study|Lack of Efficacy|3|||
156837489|NCT02207491|566157929|FG001|Overall Study|Lack of Efficacy|0|||
156837490|NCT02207491|566157928|FG000|Overall Study|Physician Decision|2|||
156837491|NCT02207491|566157929|FG001|Overall Study|Physician Decision|0|||
156837492|NCT02207491|566157928|FG000|Overall Study|Protocol Violation|3|||
156837493|NCT02207491|566157929|FG001|Overall Study|Protocol Violation|5|||
156837494|NCT00126776|566157930|FG000|Overall Study|follow up complete on all patients|0|||
156837495|NCT00126776|566157931|FG001|Overall Study|follow up complete on all patients|0|||
156837496|NCT05856227|566157943|FG000|Overall Study|Adverse Event|0|||
156837497|NCT05856227|566157944|FG001|Overall Study|Adverse Event|1|||
156837498|NCT05856227|566157943|FG000|Overall Study|Due to Investigator absence|1|||
156837499|NCT05856227|566157944|FG001|Overall Study|Due to Investigator absence|0|||
156837500|NCT05856227|566157943|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
156837501|NCT05856227|566157944|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
156837502|NCT05011058|566157945|FG000|Overall Study|Sponsor Decision|2|||
156837503|NCT05011058|566157946|FG001|Overall Study|Sponsor Decision|0|||
156837504|NCT05011058|566157947|FG002|Overall Study|Sponsor Decision|14|||
156837505|NCT05011058|566157948|FG003|Overall Study|Sponsor Decision|0|||
156837506|NCT05011058|566157949|FG004|Overall Study|Sponsor Decision|0|||
156837507|NCT05011058|566157950|FG005|Overall Study|Sponsor Decision|1|||
156837508|NCT05011058|566157951|FG006|Overall Study|Sponsor Decision|0|||
156837509|NCT05011058|566157952|FG007|Overall Study|Sponsor Decision|5|||
156837510|NCT01272869|566157953|FG000|Period 2 (14 Days)|Adverse Event|1|||
156837511|NCT01272869|566157954|FG001|Period 2 (14 Days)|Adverse Event|0|||
156837512|NCT01571232|566157955|FG000|Overall Study|Lost to Follow-up|0|||
156837513|NCT01571232|566157956|FG001|Overall Study|Lost to Follow-up|1|||
156837514|NCT01571232|566157955|FG000|Overall Study|Withdrawal by Subject|1|||
156837515|NCT01571232|566157956|FG001|Overall Study|Withdrawal by Subject|0|||
156837516|NCT02455076|566157957|FG000|Inpatient|Withdrawal by Subject|1|||
156837517|NCT02455076|566157958|FG001|Inpatient|Withdrawal by Subject|0|||
156837518|NCT02455076|566157959|FG002|Inpatient|Withdrawal by Subject|0|||
156837519|NCT02455076|566157960|FG003|Inpatient|Withdrawal by Subject|0|||
156837520|NCT02455076|566157961|FG004|Inpatient|Withdrawal by Subject|0|||
156837521|NCT02455076|566157957|FG000|Inpatient|Discharged <24 h after admission|0|||
156837522|NCT02455076|566157958|FG001|Inpatient|Discharged <24 h after admission|1|||
156837523|NCT02455076|566157959|FG002|Inpatient|Discharged <24 h after admission|0|||
156837524|NCT02455076|566157960|FG003|Inpatient|Discharged <24 h after admission|0|||
156837525|NCT02455076|566157961|FG004|Inpatient|Discharged <24 h after admission|0|||
156837526|NCT02455076|566157957|FG000|Inpatient|Adverse Event|3|||
156837527|NCT02455076|566157958|FG001|Inpatient|Adverse Event|0|||
156837528|NCT02455076|566157959|FG002|Inpatient|Adverse Event|0|||
156837529|NCT02455076|566157960|FG003|Inpatient|Adverse Event|0|||
156837530|NCT02455076|566157961|FG004|Inpatient|Adverse Event|0|||
156837531|NCT02455076|566157957|FG000|Outpatient|Adverse Event|0|||
156837532|NCT02455076|566157958|FG001|Outpatient|Adverse Event|0|||
156837533|NCT02455076|566157959|FG002|Outpatient|Adverse Event|0|||
156837534|NCT02455076|566157960|FG003|Outpatient|Adverse Event|5|||
156837535|NCT02455076|566157961|FG004|Outpatient|Adverse Event|0|||
156837536|NCT02455076|566157957|FG000|Outpatient|Lost to Follow-up|0|||
156837537|NCT02455076|566157958|FG001|Outpatient|Lost to Follow-up|0|||
156837538|NCT02455076|566157959|FG002|Outpatient|Lost to Follow-up|0|||
156837539|NCT02455076|566157960|FG003|Outpatient|Lost to Follow-up|1|||
156837540|NCT02455076|566157961|FG004|Outpatient|Lost to Follow-up|12|||
156541402|NCT01538628|565074575|FG000|Overall Study|Withdrawal by Subject|1|||
156837541|NCT03908476|566157962|FG000|Overall Study|Death|3|||
156837542|NCT03908476|566157963|FG001|Overall Study|Death|0|||
156837543|NCT03908476|566157962|FG000|Overall Study|Lost to Follow-up|3|||
156837544|NCT03908476|566157963|FG001|Overall Study|Lost to Follow-up|1|||
156837545|NCT03908476|566157962|FG000|Overall Study|Withdrawal by Subject|7|||
156467825|NCT04250194|564808476|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
156467826|NCT01500200|564808477|FG000|Stage 1|Adverse Event|1|||
156467827|NCT01500200|564808478|FG001|Stage 1|Adverse Event|4|||
156467828|NCT01500200|564808479|FG002|Stage 1|Adverse Event|5|||
156837546|NCT03908476|566157963|FG001|Overall Study|Withdrawal by Subject|1|||
156837547|NCT03908476|566157962|FG000|Overall Study|Physician Decision|2|||
156837548|NCT03908476|566157963|FG001|Overall Study|Physician Decision|0|||
156837549|NCT03908476|566157962|FG000|Overall Study|System Explanted and not Replaced|4|||
156837550|NCT03908476|566157963|FG001|Overall Study|System Explanted and not Replaced|0|||
156837551|NCT03908476|566157962|FG000|Overall Study|Intrathecal Pump|1|||
156837552|NCT03908476|566157963|FG001|Overall Study|Intrathecal Pump|0|||
156837553|NCT03908476|566157962|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
156837554|NCT03908476|566157963|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
156837555|NCT05194267|566157964|FG000|Overall Study|Withdrawal by Subject|2|||
156837556|NCT02868229|566157965|FG000|Overall Study|Adverse Event|1|||
156837557|NCT02868229|566157966|FG001|Overall Study|Adverse Event|0|||
156837558|NCT02868229|566157967|FG002|Overall Study|Adverse Event|0|||
156837559|NCT02868229|566157968|FG003|Overall Study|Adverse Event|1|||
156837560|NCT02868229|566157965|FG000|Overall Study|Death|0|||
156837561|NCT02868229|566157966|FG001|Overall Study|Death|0|||
156837562|NCT02868229|566157967|FG002|Overall Study|Death|1|||
156837563|NCT02868229|566157968|FG003|Overall Study|Death|1|||
156837564|NCT02868229|566157965|FG000|Overall Study|Missed dose|0|||
156837565|NCT02868229|566157966|FG001|Overall Study|Missed dose|0|||
156837566|NCT02868229|566157967|FG002|Overall Study|Missed dose|0|||
156837567|NCT02868229|566157968|FG003|Overall Study|Missed dose|3|||
156837568|NCT06151288|566157969|FG000|Overall Study|Lost to Follow-up|4|||
156837569|NCT06151288|566157970|FG001|Overall Study|Lost to Follow-up|2|||
156837570|NCT06151288|566157971|FG002|Overall Study|Lost to Follow-up|4|||
156837571|NCT06151288|566157972|FG003|Overall Study|Lost to Follow-up|3|||
156837572|NCT06151288|566157969|FG000|Overall Study|Withdrawal by Subject|4|||
156837573|NCT06151288|566157970|FG001|Overall Study|Withdrawal by Subject|5|||
156837574|NCT06151288|566157971|FG002|Overall Study|Withdrawal by Subject|1|||
156837575|NCT06151288|566157972|FG003|Overall Study|Withdrawal by Subject|1|||
156837576|NCT03194438|566157979|FG000|Overall Study|Withdrawal by Subject|2|||
156837577|NCT02717130|566157980|FG000|Overall Study|Withdrawal by Subject|1|||
156837578|NCT02717130|566157980|FG000|Overall Study|Adverse Event|1|||
156837579|NCT02717130|566157980|FG000|Overall Study|Physician Decision|1|||
156837580|NCT02717130|566157980|FG000|Overall Study|Study Closure|4|||
156837581|NCT00548717|566157981|FG000|Overall Study|Death|5|||
156837582|NCT00548717|566157982|FG001|Overall Study|Death|2|||
156837583|NCT00548717|566157981|FG000|Overall Study|Relapse|3|||
156837584|NCT00548717|566157982|FG001|Overall Study|Relapse|0|||
156837585|NCT00548717|566157981|FG000|Overall Study|Alternative treatment for GVHD|1|||
156837586|NCT00548717|566157982|FG001|Overall Study|Alternative treatment for GVHD|0|||
156837587|NCT02712424|566157983|FG000|Overall Study|Lost to Follow-up|34|||
156837588|NCT02712424|566157984|FG001|Overall Study|Lost to Follow-up|32|||
156837589|NCT02723175|566157985|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
156837590|NCT02723175|566157986|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
156467829|NCT01500200|564808480|FG003|Stage 1|Adverse Event|0|||
156837591|NCT02723175|566157985|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
156837592|NCT02723175|566157986|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
156837593|NCT03022981|566157987|FG000|Overall Study|Adverse Event|0|||
156837594|NCT03022981|566157988|FG001|Overall Study|Adverse Event|1|||
156837595|NCT03022981|566157989|FG002|Overall Study|Adverse Event|0|||
156837596|NCT03022981|566157987|FG000|Overall Study|Investigator's Discretion|0|||
156837597|NCT03022981|566157988|FG001|Overall Study|Investigator's Discretion|1|||
156837598|NCT03022981|566157989|FG002|Overall Study|Investigator's Discretion|2|||
156837599|NCT03022981|566157987|FG000|Overall Study|Lost to Follow-up|6|||
156837600|NCT03022981|566157988|FG001|Overall Study|Lost to Follow-up|2|||
156837601|NCT03022981|566157989|FG002|Overall Study|Lost to Follow-up|1|||
156837602|NCT03022981|566157987|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156837603|NCT03022981|566157988|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156837604|NCT03022981|566157989|FG002|Overall Study|Non-Compliance With Study Drug|2|||
156340268|NCT01010061|564344375|FG001|Overall Study|Violation of Selection Criteria|1|||
156837605|NCT03022981|566157987|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
156837606|NCT03022981|566157988|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
156837607|NCT03022981|566157989|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
156837608|NCT03615066|566157991|FG000|Main Study|Withdrew Consent|0|||
156837609|NCT03615066|566157992|FG001|Main Study|Withdrew Consent|1|||
156837610|NCT03615066|566157993|FG002|Main Study|Withdrew Consent|1|||
156837611|NCT03615066|566157991|FG000|Main Study|Lost to Follow-up|0|||
156837612|NCT03615066|566157992|FG001|Main Study|Lost to Follow-up|0|||
156837613|NCT03615066|566157993|FG002|Main Study|Lost to Follow-up|1|||
156837614|NCT03615066|566157991|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
156340269|NCT01010061|564344374|FG000|Overall Study|Did Not Receive Treatment|2|||
156837615|NCT03615066|566157992|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
156837616|NCT03615066|566157993|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
156837617|NCT03615066|566157991|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
156837618|NCT03615066|566157992|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
156837619|NCT03615066|566157993|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
156837620|NCT03615066|566157991|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
156837621|NCT03615066|566157992|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
156837622|NCT03615066|566157993|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
156837623|NCT00924404|566157994|FG000|Overall Study|Lost to Follow-up|6|||
156837624|NCT00924404|566157995|FG001|Overall Study|Lost to Follow-up|4|||
156837625|NCT03831945|566157996|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
156837626|NCT03831945|566157997|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
156837627|NCT03831945|566157996|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
156837628|NCT03831945|566157997|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
156837629|NCT03831945|566157996|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
156837630|NCT03831945|566157997|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
156837631|NCT02437084|566157998|FG000|Overall Study|Withdrawal by Subject|2|||
156837632|NCT02437084|566157998|FG000|Overall Study|Physician Decision|1|||
156837633|NCT00587847|566157999|FG000|Overall Study|Lack of Efficacy|5|||
156837634|NCT00587847|566157999|FG000|Overall Study|Adverse Event|2|||
156837635|NCT02613169|566158000|FG000|Overall Study|Withdrawal by Subject|4|||
156837636|NCT02613169|566158001|FG001|Overall Study|Withdrawal by Subject|1|||
156837637|NCT02613169|566158000|FG000|Overall Study|Lost to Follow-up|0|||
156837638|NCT02613169|566158001|FG001|Overall Study|Lost to Follow-up|5|||
156837639|NCT02613169|566158000|FG000|Overall Study|HIV|0|||
156837640|NCT02613169|566158001|FG001|Overall Study|HIV|2|||
156837641|NCT02613169|566158000|FG000|Overall Study|No TB infection endpoint|14|||
156837642|NCT02613169|566158001|FG001|Overall Study|No TB infection endpoint|9|||
156837643|NCT04032080|566158002|FG000|Overall Study|Death|6|||
156837644|NCT00884832|566158003|FG000|Overall Study|Withdrawal by Subject|0|||
156837645|NCT00884832|566158004|FG001|Overall Study|Withdrawal by Subject|1|||
156837646|NCT01600092|566158012|FG000|Overall Study|Adverse Event|2|||
156837647|NCT01600092|566158013|FG001|Overall Study|Adverse Event|0|||
156837648|NCT01600092|566158012|FG000|Overall Study|Lost to Follow-up|4|||
156837649|NCT01600092|566158013|FG001|Overall Study|Lost to Follow-up|6|||
156837650|NCT01600092|566158012|FG000|Overall Study|Withdrawal by parent/guardian|8|||
156837651|NCT01600092|566158013|FG001|Overall Study|Withdrawal by parent/guardian|6|||
156837652|NCT01600092|566158012|FG000|Overall Study|Physician Decision|1|||
156837653|NCT01600092|566158013|FG001|Overall Study|Physician Decision|1|||
156837654|NCT01600092|566158012|FG000|Overall Study|Randomized but not vaccinated|3|||
156837655|NCT01600092|566158013|FG001|Overall Study|Randomized but not vaccinated|3|||
156837656|NCT02976103|566158014|FG000|Overall Study|Withdrawal by Subject|1|||
156837657|NCT02976103|566158015|FG001|Overall Study|Withdrawal by Subject|0|||
156837658|NCT02976103|566158014|FG000|Overall Study|Lost to Follow-up|12|||
156837659|NCT02976103|566158015|FG001|Overall Study|Lost to Follow-up|8|||
156837660|NCT00079677|566158016|FG000|Overall Study|Adverse Event|5|||
156837661|NCT00079677|566158017|FG001|Overall Study|Adverse Event|6|||
156837662|NCT00079677|566158016|FG000|Overall Study|Lack of Efficacy|1|||
156837663|NCT00079677|566158017|FG001|Overall Study|Lack of Efficacy|0|||
156837664|NCT00079677|566158016|FG000|Overall Study|Lost to Follow-up|2|||
156837665|NCT00079677|566158017|FG001|Overall Study|Lost to Follow-up|2|||
156837666|NCT00079677|566158016|FG000|Overall Study|Physician Decision|3|||
156837667|NCT00079677|566158017|FG001|Overall Study|Physician Decision|0|||
156837668|NCT00079677|566158016|FG000|Overall Study|Protocol Violation|2|||
156837669|NCT00079677|566158017|FG001|Overall Study|Protocol Violation|3|||
156837670|NCT00079677|566158016|FG000|Overall Study|Withdrawal by Subject|5|||
156837671|NCT00079677|566158017|FG001|Overall Study|Withdrawal by Subject|3|||
156837672|NCT00079677|566158016|FG000|Overall Study|Miscellaneous|2|||
156837673|NCT00079677|566158017|FG001|Overall Study|Miscellaneous|0|||
156837674|NCT01300455|566158018|FG000|Washout|Withdrawal by Subject|1|||
156837675|NCT01300455|566158019|FG001|Washout|Withdrawal by Subject|0|||
156837676|NCT00084487|566158020|FG000|Overall Study|Death|1|||
156837677|NCT00845065|566158028|FG000|Overall Study|Adverse Event|3|||
156467830|NCT01500200|564808481|FG004|Stage 1|Adverse Event|0|||
156467831|NCT01500200|564808482|FG005|Stage 1|Adverse Event|0|||
156467832|NCT01500200|564808477|FG000|Stage 1|Lost to Follow-up|2|||
156467833|NCT01500200|564808478|FG001|Stage 1|Lost to Follow-up|2|||
156467834|NCT01500200|564808479|FG002|Stage 1|Lost to Follow-up|1|||
156467835|NCT01500200|564808480|FG003|Stage 1|Lost to Follow-up|0|||
156467836|NCT01500200|564808481|FG004|Stage 1|Lost to Follow-up|0|||
156467837|NCT01500200|564808482|FG005|Stage 1|Lost to Follow-up|0|||
156467838|NCT01500200|564808477|FG000|Stage 1|Withdrawal by Subject|3|||
156467839|NCT01500200|564808478|FG001|Stage 1|Withdrawal by Subject|0|||
156467840|NCT01500200|564808479|FG002|Stage 1|Withdrawal by Subject|0|||
156837678|NCT00845065|566158029|FG001|Overall Study|Adverse Event|23|||
156467841|NCT01500200|564808480|FG003|Stage 1|Withdrawal by Subject|0|||
156467842|NCT01500200|564808481|FG004|Stage 1|Withdrawal by Subject|0|||
156467843|NCT01500200|564808482|FG005|Stage 1|Withdrawal by Subject|0|||
156467844|NCT01500200|564808477|FG000|Stage 1|Noncompliance with Study Drug|1|||
156467845|NCT01500200|564808478|FG001|Stage 1|Noncompliance with Study Drug|0|||
156467846|NCT01500200|564808479|FG002|Stage 1|Noncompliance with Study Drug|0|||
156467847|NCT01500200|564808480|FG003|Stage 1|Noncompliance with Study Drug|0|||
156467848|NCT01500200|564808481|FG004|Stage 1|Noncompliance with Study Drug|0|||
156467849|NCT01500200|564808482|FG005|Stage 1|Noncompliance with Study Drug|0|||
156467850|NCT01500200|564808477|FG000|Stage 1|Physician Decision|1|||
156467851|NCT01500200|564808478|FG001|Stage 1|Physician Decision|0|||
156467852|NCT01500200|564808479|FG002|Stage 1|Physician Decision|0|||
156467853|NCT01500200|564808480|FG003|Stage 1|Physician Decision|0|||
156467854|NCT01500200|564808481|FG004|Stage 1|Physician Decision|0|||
156467855|NCT01500200|564808482|FG005|Stage 1|Physician Decision|0|||
156467856|NCT01500200|564808477|FG000|Stage 2|Adverse Event|0|||
156467857|NCT01500200|564808478|FG001|Stage 2|Adverse Event|0|||
156467858|NCT01500200|564808479|FG002|Stage 2|Adverse Event|0|||
156467859|NCT01500200|564808480|FG003|Stage 2|Adverse Event|0|||
156467860|NCT01500200|564808481|FG004|Stage 2|Adverse Event|5|||
156467861|NCT01500200|564808482|FG005|Stage 2|Adverse Event|4|||
156467862|NCT01952366|564808483|FG000|Overall Study|Death|22|||
156467863|NCT01952366|564808483|FG000|Overall Study|Withdrawal by Subject|9|||
156467864|NCT00623194|564808484|FG000|Overall Study|Lack of Efficacy|1|||
156467865|NCT00623194|564808484|FG000|Overall Study|Protocol Violation|3|||
156467866|NCT00623194|564808484|FG000|Overall Study|Unclassified|1|||
156467867|NCT00857766|564808485|FG000|Overall Study|Adverse Event|13|||
156467868|NCT00857766|564808486|FG001|Overall Study|Adverse Event|12|||
156467869|NCT00857766|564808485|FG000|Overall Study|Protocol Violation|11|||
156467870|NCT00857766|564808486|FG001|Overall Study|Protocol Violation|11|||
156467871|NCT00857766|564808485|FG000|Overall Study|Lost to Follow-up|1|||
156467872|NCT00857766|564808486|FG001|Overall Study|Lost to Follow-up|0|||
156467873|NCT00857766|564808485|FG000|Overall Study|Investigator Discretion|2|||
156467874|NCT00857766|564808486|FG001|Overall Study|Investigator Discretion|3|||
156837679|NCT00845065|566158028|FG000|Overall Study|Lack of Efficacy|43|||
156837680|NCT00845065|566158029|FG001|Overall Study|Lack of Efficacy|21|||
156837681|NCT00845065|566158028|FG000|Overall Study|Non-Medical Reasons|1|||
156837682|NCT00845065|566158029|FG001|Overall Study|Non-Medical Reasons|11|||
156837683|NCT02228096|566158033|FG000|Overall Study|Study terminated by Sponsor|24|||
156837684|NCT02228096|566158033|FG000|Overall Study|Lack of Efficacy|18|||
156837685|NCT02228096|566158033|FG000|Overall Study|Death|12|||
156837686|NCT02228096|566158033|FG000|Overall Study|Physician Decision|3|||
156837687|NCT02228096|566158033|FG000|Overall Study|Subject/guardian decision|2|||
156837688|NCT02228096|566158033|FG000|Overall Study|New therapy for study indication|1|||
156837689|NCT02228096|566158033|FG000|Overall Study|Enrolled, not infused|11|||
156837690|NCT02265796|566158034|FG000|Overall Study|Death|1|||
156467875|NCT00857766|564808485|FG000|Overall Study|Participant Withdrew Consent|4|||
156467876|NCT00857766|564808486|FG001|Overall Study|Participant Withdrew Consent|4|||
156467877|NCT01212744|564808489|FG000|Overall Study|Withdrawal by Subject|1|||
156467878|NCT02167451|564808491|FG000|Overall Study|Withdrawal by Subject|1|||
156467879|NCT00571649|564808492|FG000|Treatment Period|Adverse Event|438|||
156467880|NCT00571649|564808493|FG001|Treatment Period|Adverse Event|385|||
156467881|NCT00571649|564808492|FG000|Treatment Period|Clinical endpoint reached|50|||
156837691|NCT02265796|566158035|FG001|Overall Study|Death|0|||
156837692|NCT02265796|566158034|FG000|Overall Study|started on excluded medication|1|||
156837693|NCT02265796|566158035|FG001|Overall Study|started on excluded medication|0|||
156467882|NCT00571649|564808493|FG001|Treatment Period|Clinical endpoint reached|56|||
156467883|NCT00571649|564808492|FG000|Treatment Period|Withdrawal by Subject|285|||
156467884|NCT00571649|564808493|FG001|Treatment Period|Withdrawal by Subject|255|||
156837694|NCT02265796|566158034|FG000|Overall Study|Withdrawal by Subject|1|||
156837695|NCT02265796|566158035|FG001|Overall Study|Withdrawal by Subject|1|||
156837696|NCT00952614|566158038|FG000|Overall Study|Death|3|||
156837697|NCT00952614|566158038|FG000|Overall Study|Lost to Follow-up|3|||
156837698|NCT00952614|566158038|FG000|Overall Study|other reason|1|||
156837699|NCT01624090|566158043|FG000|Overall Study|DLT, taken off therapy|0|||
156837700|NCT01624090|566158044|FG001|Overall Study|DLT, taken off therapy|1|||
156837701|NCT01624090|566158045|FG002|Overall Study|DLT, taken off therapy|0|||
156837702|NCT01624090|566158046|FG003|Overall Study|DLT, taken off therapy|0|||
156837703|NCT01624090|566158043|FG000|Overall Study|Withdrew prior to treatment|0|||
156837704|NCT01624090|566158044|FG001|Overall Study|Withdrew prior to treatment|1|||
156837705|NCT01624090|566158045|FG002|Overall Study|Withdrew prior to treatment|0|||
156837706|NCT01624090|566158046|FG003|Overall Study|Withdrew prior to treatment|0|||
156837707|NCT01624090|566158043|FG000|Overall Study|Died on study|0|||
156837708|NCT01624090|566158044|FG001|Overall Study|Died on study|0|||
156467885|NCT00571649|564808492|FG000|Treatment Period|Death|76|||
156467886|NCT00571649|564808493|FG001|Treatment Period|Death|59|||
156467887|NCT00571649|564808492|FG000|Treatment Period|Physician Decision|8|||
156467888|NCT00571649|564808493|FG001|Treatment Period|Physician Decision|9|||
156467889|NCT00571649|564808492|FG000|Treatment Period|Lost to Follow-up|43|||
156467890|NCT00571649|564808493|FG001|Treatment Period|Lost to Follow-up|41|||
156467891|NCT00571649|564808492|FG000|Treatment Period|Non-compliant with study medication|88|||
156467892|NCT00571649|564808493|FG001|Treatment Period|Non-compliant with study medication|89|||
156467893|NCT00571649|564808492|FG000|Treatment Period|Patient convenience|11|||
156467894|NCT00571649|564808493|FG001|Treatment Period|Patient convenience|13|||
156467895|NCT00571649|564808492|FG000|Treatment Period|Protocol Violation|90|||
156467896|NCT00571649|564808493|FG001|Treatment Period|Protocol Violation|92|||
156467897|NCT00571649|564808492|FG000|Treatment Period|Technical problems|3|||
156467898|NCT00571649|564808493|FG001|Treatment Period|Technical problems|5|||
156467899|NCT00571649|564808492|FG000|Follow-up Period|Adverse Event|46|||
156467900|NCT00571649|564808493|FG001|Follow-up Period|Adverse Event|40|||
156467901|NCT00571649|564808492|FG000|Follow-up Period|Clinical endpoint reached|5|||
156467902|NCT00571649|564808493|FG001|Follow-up Period|Clinical endpoint reached|2|||
156467903|NCT00571649|564808492|FG000|Follow-up Period|Withdrawal by Subject|119|||
156467904|NCT00571649|564808493|FG001|Follow-up Period|Withdrawal by Subject|115|||
156467905|NCT00571649|564808492|FG000|Follow-up Period|Death|132|||
156467906|NCT00571649|564808493|FG001|Follow-up Period|Death|133|||
156467907|NCT00571649|564808492|FG000|Follow-up Period|Physician Decision|7|||
156467908|NCT00571649|564808493|FG001|Follow-up Period|Physician Decision|13|||
156467909|NCT00571649|564808492|FG000|Follow-up Period|Lost to Follow-up|95|||
156467910|NCT00571649|564808493|FG001|Follow-up Period|Lost to Follow-up|92|||
156467911|NCT00571649|564808492|FG000|Follow-up Period|Patient convenience|136|||
156467912|NCT00571649|564808493|FG001|Follow-up Period|Patient convenience|121|||
156467913|NCT00571649|564808492|FG000|Follow-up Period|Protocol Violation|5|||
156467914|NCT00571649|564808493|FG001|Follow-up Period|Protocol Violation|12|||
156467915|NCT01218659|564808494|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
156467916|NCT01218659|564808495|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
156467917|NCT01218659|564808496|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
156467918|NCT01218659|564808494|FG000|18-Month Randomized Period|Did not receive study drug|0|||
156467919|NCT01218659|564808495|FG001|18-Month Randomized Period|Did not receive study drug|3|||
156467920|NCT01218659|564808496|FG002|18-Month Randomized Period|Did not receive study drug|0|||
156467921|NCT01218659|564808494|FG000|12-Month OLE|Withdrawal by Subject|0|||
156467922|NCT01218659|564808495|FG001|12-Month OLE|Withdrawal by Subject|0|||
156467923|NCT01218659|564808496|FG002|12-Month OLE|Withdrawal by Subject|2|||
156837709|NCT01624090|566158045|FG002|Overall Study|Died on study|2|||
156837710|NCT01624090|566158046|FG003|Overall Study|Died on study|0|||
156837711|NCT01624090|566158043|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
156837712|NCT01624090|566158044|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
156837713|NCT01624090|566158045|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
156837714|NCT01624090|566158046|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
156837715|NCT01624090|566158043|FG000|Overall Study|Dose escalated|0|||
156467924|NCT01218659|564808494|FG000|12-Month OLE|Physician Decision|0|||
156837716|NCT01624090|566158044|FG001|Overall Study|Dose escalated|0|||
156837717|NCT01624090|566158045|FG002|Overall Study|Dose escalated|3|||
156837718|NCT01624090|566158046|FG003|Overall Study|Dose escalated|0|||
156837719|NCT01403116|566158047|FG000|Overall Study|Adverse Event|7|||
156837720|NCT01403116|566158048|FG001|Overall Study|Adverse Event|4|||
156837721|NCT01403116|566158047|FG000|Overall Study|Lost to Follow-up|7|||
156837722|NCT01403116|566158048|FG001|Overall Study|Lost to Follow-up|5|||
156837723|NCT01403116|566158047|FG000|Overall Study|Withdrawal by Subject|12|||
156837724|NCT01403116|566158048|FG001|Overall Study|Withdrawal by Subject|15|||
156837725|NCT01403116|566158047|FG000|Overall Study|Non-compliance of study drug|3|||
156837726|NCT01403116|566158048|FG001|Overall Study|Non-compliance of study drug|0|||
156340270|NCT01010061|564344375|FG001|Overall Study|Did Not Receive Treatment|2|||
156340271|NCT03982368|564344378|FG000|Overall Study|Adverse Event|6|||
156340272|NCT03982368|564344379|FG001|Overall Study|Adverse Event|4|||
156340273|NCT03982368|564344380|FG002|Overall Study|Adverse Event|3|||
156340274|NCT03982368|564344378|FG000|Overall Study|Lost to Follow-up|2|||
156340275|NCT03982368|564344379|FG001|Overall Study|Lost to Follow-up|1|||
156340276|NCT03982368|564344380|FG002|Overall Study|Lost to Follow-up|0|||
156340277|NCT03982368|564344378|FG000|Overall Study|Withdrawal by Subject|1|||
156340278|NCT03982368|564344379|FG001|Overall Study|Withdrawal by Subject|2|||
156340279|NCT03982368|564344380|FG002|Overall Study|Withdrawal by Subject|0|||
156340280|NCT03982368|564344378|FG000|Overall Study|unknow|4|||
156340281|NCT03982368|564344379|FG001|Overall Study|unknow|0|||
156340282|NCT03982368|564344380|FG002|Overall Study|unknow|2|||
156340283|NCT00518284|564344381|FG000|Overall Study|Adverse Event|0|||
156340284|NCT00518284|564344382|FG001|Overall Study|Adverse Event|1|||
156340285|NCT00518284|564344383|FG002|Overall Study|Adverse Event|0|||
156340286|NCT00518284|564344384|FG003|Overall Study|Adverse Event|0|||
156340287|NCT00518284|564344381|FG000|Overall Study|Study Termination|0|||
156837727|NCT01403116|566158047|FG000|Overall Study|Protocol Violation|0|||
156837728|NCT01403116|566158048|FG001|Overall Study|Protocol Violation|1|||
156837729|NCT01403116|566158047|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
156837730|NCT01403116|566158048|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
156837731|NCT01403116|566158047|FG000|Overall Study|Hct >54%|2|||
156837732|NCT01403116|566158048|FG001|Overall Study|Hct >54%|0|||
156837733|NCT01403116|566158047|FG000|Overall Study|unable to keep appointments|0|||
156837734|NCT01403116|566158048|FG001|Overall Study|unable to keep appointments|2|||
156837735|NCT01895309|566158049|FG000|Overall Study|Adverse Event|13|||
156837736|NCT01895309|566158050|FG001|Overall Study|Adverse Event|17|||
156837737|NCT01895309|566158049|FG000|Overall Study|Protocol Violation|1|||
156837738|NCT01895309|566158050|FG001|Overall Study|Protocol Violation|0|||
156340288|NCT00518284|564344382|FG001|Overall Study|Study Termination|2|||
156340289|NCT00518284|564344383|FG002|Overall Study|Study Termination|1|||
156837739|NCT01895309|566158049|FG000|Overall Study|Lack of Efficacy|1|||
156837740|NCT01895309|566158050|FG001|Overall Study|Lack of Efficacy|3|||
156837741|NCT01895309|566158049|FG000|Overall Study|Lost to Follow-up|1|||
156837742|NCT01895309|566158050|FG001|Overall Study|Lost to Follow-up|3|||
156837743|NCT01895309|566158049|FG000|Overall Study|Physician Decision|15|||
156340290|NCT00518284|564344384|FG003|Overall Study|Study Termination|2|||
156340291|NCT03768414|564344385|FG000|Overall Study|Adverse Event or side effects|72|||
156340292|NCT03768414|564344386|FG001|Overall Study|Adverse Event or side effects|28|||
156340293|NCT03768414|564344385|FG000|Overall Study|Refusal unrelated to adverse event|33|||
156340294|NCT03768414|564344386|FG001|Overall Study|Refusal unrelated to adverse event|33|||
156340295|NCT03768414|564344385|FG000|Overall Study|Progression/relapse|132|||
156340296|NCT03768414|564344386|FG001|Overall Study|Progression/relapse|60|||
156340297|NCT03768414|564344385|FG000|Overall Study|Death|9|||
156340298|NCT03768414|564344386|FG001|Overall Study|Death|6|||
156340299|NCT03768414|564344385|FG000|Overall Study|Other - not protocol specified|45|||
156340300|NCT03768414|564344386|FG001|Overall Study|Other - not protocol specified|18|||
156340301|NCT03768414|564344385|FG000|Overall Study|Reason under review|3|||
156340302|NCT03768414|564344386|FG001|Overall Study|Reason under review|2|||
156340303|NCT02571777|564344388|FG000|Overall Study|Subject/guardian decision|34|||
156340304|NCT02571777|564344389|FG001|Overall Study|Subject/guardian decision|26|||
156340305|NCT02571777|564344390|FG002|Overall Study|Subject/guardian decision|26|||
156340306|NCT02571777|564344391|FG003|Overall Study|Subject/guardian decision|25|||
156340307|NCT02571777|564344392|FG004|Overall Study|Subject/guardian decision|27|||
156340308|NCT02571777|564344388|FG000|Overall Study|Protocol Deviation|2|||
156340309|NCT02571777|564344389|FG001|Overall Study|Protocol Deviation|3|||
156340310|NCT02571777|564344390|FG002|Overall Study|Protocol Deviation|4|||
156340311|NCT02571777|564344391|FG003|Overall Study|Protocol Deviation|8|||
156340312|NCT02571777|564344392|FG004|Overall Study|Protocol Deviation|4|||
156340313|NCT02571777|564344388|FG000|Overall Study|Death|1|||
156340314|NCT02571777|564344389|FG001|Overall Study|Death|1|||
156340315|NCT02571777|564344390|FG002|Overall Study|Death|4|||
156340316|NCT02571777|564344391|FG003|Overall Study|Death|0|||
156340317|NCT02571777|564344392|FG004|Overall Study|Death|0|||
156340318|NCT02571777|564344388|FG000|Overall Study|Lost to Follow-up|1|||
156340319|NCT02571777|564344389|FG001|Overall Study|Lost to Follow-up|1|||
156340320|NCT02571777|564344390|FG002|Overall Study|Lost to Follow-up|2|||
156340321|NCT02571777|564344391|FG003|Overall Study|Lost to Follow-up|0|||
156340322|NCT02571777|564344392|FG004|Overall Study|Lost to Follow-up|1|||
156467925|NCT01218659|564808495|FG001|12-Month OLE|Physician Decision|0|||
156467926|NCT01218659|564808496|FG002|12-Month OLE|Physician Decision|1|||
156837744|NCT01895309|566158050|FG001|Overall Study|Physician Decision|10|||
156837745|NCT01895309|566158049|FG000|Overall Study|Withdrawal by Subject|9|||
156837746|NCT01895309|566158050|FG001|Overall Study|Withdrawal by Subject|18|||
156837747|NCT00042666|566158051|FG000|Overall Study|Adverse Event|2|||
156340323|NCT02571777|564344388|FG000|Overall Study|Physician Decision|1|||
156340324|NCT02571777|564344389|FG001|Overall Study|Physician Decision|7|||
156340325|NCT02571777|564344390|FG002|Overall Study|Physician Decision|5|||
156837748|NCT00042666|566158051|FG000|Overall Study|Death|4|||
156837749|NCT00042666|566158051|FG000|Overall Study|Protocol Violation|1|||
156837750|NCT00042666|566158051|FG000|Overall Study|Participant/Physician Perception|1|||
156837751|NCT00042666|566158051|FG000|Overall Study|Progressive Disease|41|||
156837752|NCT00042666|566158051|FG000|Overall Study|Other|1|||
156837753|NCT00042666|566158051|FG000|Overall Study|Other|4|||
156837754|NCT01555125|566158054|FG000|Induction Period|Lost to Follow-up|0|||
156837755|NCT01555125|566158055|FG001|Induction Period|Lost to Follow-up|2|||
156837756|NCT01555125|566158056|FG002|Induction Period|Lost to Follow-up|0|||
156837757|NCT01555125|566158057|FG003|Induction Period|Lost to Follow-up|0|||
156837758|NCT01555125|566158058|FG004|Induction Period|Lost to Follow-up|0|||
156837759|NCT01555125|566158054|FG000|Induction Period|Adverse Event|0|||
156837760|NCT01555125|566158055|FG001|Induction Period|Adverse Event|1|||
156467927|NCT01218659|564808494|FG000|12-Month OLE|Lost to Follow-up|0|||
156467928|NCT01218659|564808495|FG001|12-Month OLE|Lost to Follow-up|0|||
156467929|NCT01218659|564808496|FG002|12-Month OLE|Lost to Follow-up|1|||
156467930|NCT01218659|564808494|FG000|12-Month OLE|Pregnancy|0|||
156467931|NCT01218659|564808495|FG001|12-Month OLE|Pregnancy|0|||
156467932|NCT01218659|564808496|FG002|12-Month OLE|Pregnancy|1|||
156467933|NCT01218659|564808494|FG000|12-Month OLE|Lack of Efficacy|0|||
156467934|NCT01218659|564808495|FG001|12-Month OLE|Lack of Efficacy|0|||
156467935|NCT01218659|564808496|FG002|12-Month OLE|Lack of Efficacy|1|||
156467936|NCT01218659|564808494|FG000|12-Month OLE|Declined to participate in the OLE|0|||
156467937|NCT01218659|564808495|FG001|12-Month OLE|Declined to participate in the OLE|0|||
156467938|NCT01218659|564808496|FG002|12-Month OLE|Declined to participate in the OLE|4|||
156837761|NCT01555125|566158056|FG002|Induction Period|Adverse Event|0|||
156837762|NCT01555125|566158057|FG003|Induction Period|Adverse Event|0|||
156837763|NCT01555125|566158058|FG004|Induction Period|Adverse Event|1|||
156837764|NCT01555125|566158054|FG000|Induction Period|Subject / guardian decision|0|||
156837765|NCT01555125|566158055|FG001|Induction Period|Subject / guardian decision|0|||
156837766|NCT01555125|566158056|FG002|Induction Period|Subject / guardian decision|0|||
156837767|NCT01555125|566158057|FG003|Induction Period|Subject / guardian decision|0|||
156837768|NCT01555125|566158058|FG004|Induction Period|Subject / guardian decision|2|||
156837769|NCT01555125|566158054|FG000|Induction Period|Death|1|||
156837770|NCT01555125|566158055|FG001|Induction Period|Death|0|||
156837771|NCT01555125|566158056|FG002|Induction Period|Death|0|||
156837772|NCT01555125|566158057|FG003|Induction Period|Death|0|||
156837773|NCT01555125|566158058|FG004|Induction Period|Death|0|||
156837774|NCT01555125|566158054|FG000|Maintenance Period|Adverse Event|1|||
156837775|NCT01555125|566158055|FG001|Maintenance Period|Adverse Event|1|||
156837776|NCT01555125|566158056|FG002|Maintenance Period|Adverse Event|0|||
156837777|NCT01555125|566158057|FG003|Maintenance Period|Adverse Event|0|||
156837778|NCT01555125|566158058|FG004|Maintenance Period|Adverse Event|0|||
156837779|NCT01555125|566158054|FG000|Maintenance Period|Subject / guardian decision|1|||
156837780|NCT01555125|566158055|FG001|Maintenance Period|Subject / guardian decision|2|||
156837781|NCT01555125|566158056|FG002|Maintenance Period|Subject / guardian decision|0|||
156837782|NCT01555125|566158057|FG003|Maintenance Period|Subject / guardian decision|0|||
156837783|NCT01555125|566158058|FG004|Maintenance Period|Subject / guardian decision|0|||
156837784|NCT01555125|566158054|FG000|Maintenance Period|Lost to Follow-up|2|||
156837785|NCT01555125|566158055|FG001|Maintenance Period|Lost to Follow-up|0|||
156837786|NCT01555125|566158056|FG002|Maintenance Period|Lost to Follow-up|0|||
156837787|NCT01555125|566158057|FG003|Maintenance Period|Lost to Follow-up|1|||
156837788|NCT01555125|566158058|FG004|Maintenance Period|Lost to Follow-up|0|||
156837789|NCT01555125|566158054|FG000|Maintenance Period|Lack of Efficacy|6|||
156837790|NCT01555125|566158055|FG001|Maintenance Period|Lack of Efficacy|1|||
156837791|NCT01555125|566158056|FG002|Maintenance Period|Lack of Efficacy|3|||
156837792|NCT01555125|566158057|FG003|Maintenance Period|Lack of Efficacy|0|||
156837793|NCT01555125|566158058|FG004|Maintenance Period|Lack of Efficacy|0|||
156837794|NCT01555125|566158054|FG000|Maintenance Period|Physician Decision|0|||
156837795|NCT01555125|566158055|FG001|Maintenance Period|Physician Decision|0|||
156837796|NCT01555125|566158056|FG002|Maintenance Period|Physician Decision|1|||
156340326|NCT02571777|564344391|FG003|Overall Study|Physician Decision|2|||
156467939|NCT03355573|564808503|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
156837797|NCT01555125|566158057|FG003|Maintenance Period|Physician Decision|0|||
156837798|NCT01555125|566158058|FG004|Maintenance Period|Physician Decision|0|||
156837799|NCT01555125|566158054|FG000|Maintenance Period|Death|0|||
156837800|NCT01555125|566158055|FG001|Maintenance Period|Death|0|||
156837801|NCT01555125|566158056|FG002|Maintenance Period|Death|0|||
156837802|NCT01555125|566158057|FG003|Maintenance Period|Death|1|||
156837803|NCT01555125|566158058|FG004|Maintenance Period|Death|0|||
156837804|NCT01555125|566158054|FG000|Extension|Adverse Event|1|||
156837805|NCT01555125|566158055|FG001|Extension|Adverse Event|2|||
156837806|NCT01555125|566158056|FG002|Extension|Adverse Event|1|||
156837807|NCT01555125|566158057|FG003|Extension|Adverse Event|1|||
156467940|NCT03355573|564808503|FG000|Overall Study|Sponsor's decision|1|||
156467941|NCT03355573|564808503|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
156837808|NCT01555125|566158058|FG004|Extension|Adverse Event|0|||
156837809|NCT01555125|566158054|FG000|Extension|Protocol deviation|1|||
156837810|NCT01555125|566158055|FG001|Extension|Protocol deviation|0|||
156467942|NCT03355573|564808503|FG000|Overall Study|PI's decision|2|||
156467943|NCT03355573|564808503|FG000|Overall Study|Withdrawal by Subject|23|||
156467944|NCT03355573|564808503|FG000|Overall Study|Lost to Follow-up|4|||
156467945|NCT03355573|564808503|FG000|Overall Study|Lack of Efficacy|2|||
156467946|NCT03355573|564808503|FG000|Overall Study|Adverse Event, non-fatal|17|||
156467947|NCT03355573|564808503|FG000|Overall Study|Adverse Event, serious fatal|2|||
156467948|NCT01566890|564808504|FG000|Overall Study|Adverse Event|1|||
156467949|NCT01566890|564808505|FG001|Overall Study|Adverse Event|0|||
156467950|NCT01566890|564808506|FG002|Overall Study|Adverse Event|0|||
156467951|NCT01566890|564808507|FG003|Overall Study|Adverse Event|0|||
156467952|NCT01566890|564808508|FG004|Overall Study|Adverse Event|0|||
156467953|NCT01566890|564808504|FG000|Overall Study|Withdrawal by Subject|3|||
156467954|NCT01566890|564808505|FG001|Overall Study|Withdrawal by Subject|1|||
156467955|NCT01566890|564808506|FG002|Overall Study|Withdrawal by Subject|1|||
156467956|NCT01566890|564808507|FG003|Overall Study|Withdrawal by Subject|1|||
156467957|NCT01566890|564808508|FG004|Overall Study|Withdrawal by Subject|0|||
156467958|NCT01566890|564808504|FG000|Overall Study|Screen failure|6|||
156467959|NCT01566890|564808505|FG001|Overall Study|Screen failure|0|||
156467960|NCT01566890|564808506|FG002|Overall Study|Screen failure|1|||
156467961|NCT01566890|564808507|FG003|Overall Study|Screen failure|1|||
156467962|NCT01566890|564808508|FG004|Overall Study|Screen failure|0|||
156467963|NCT01566890|564808504|FG000|Overall Study|Incomplete CEU data|1|||
156467964|NCT01566890|564808505|FG001|Overall Study|Incomplete CEU data|3|||
156467965|NCT01566890|564808506|FG002|Overall Study|Incomplete CEU data|5|||
156467966|NCT01566890|564808507|FG003|Overall Study|Incomplete CEU data|8|||
156467967|NCT01566890|564808508|FG004|Overall Study|Incomplete CEU data|0|||
156467968|NCT01566890|564808504|FG000|Overall Study|Lost to Follow-up|0|||
156467969|NCT01566890|564808505|FG001|Overall Study|Lost to Follow-up|0|||
156467970|NCT01566890|564808506|FG002|Overall Study|Lost to Follow-up|4|||
156467971|NCT01566890|564808507|FG003|Overall Study|Lost to Follow-up|4|||
156467972|NCT01566890|564808508|FG004|Overall Study|Lost to Follow-up|0|||
156467973|NCT01566890|564808504|FG000|Overall Study|Other|0|||
156467974|NCT01566890|564808505|FG001|Overall Study|Other|0|||
156467975|NCT01566890|564808506|FG002|Overall Study|Other|0|||
156467976|NCT01566890|564808507|FG003|Overall Study|Other|0|||
156467977|NCT01566890|564808508|FG004|Overall Study|Other|7|||
156467978|NCT00523419|564808514|FG000|Overall Study|Adverse Event|1|||
156467979|NCT00523419|564808514|FG000|Overall Study|Withdrawal by Subject|1|||
156467980|NCT00523419|564808514|FG000|Overall Study|Physician Decision|2|||
156467981|NCT00523419|564808514|FG000|Overall Study|Progressive Disease|22|||
156467982|NCT00523419|564808514|FG000|Overall Study|Death due to Study Disease|4|||
156467983|NCT00523419|564808514|FG000|Overall Study|Death due to Adverse Event|2|||
156467984|NCT00822120|564808515|FG000|Initial Registration|Adverse Event|1|||
156467985|NCT00822120|564808516|FG001|Initial Registration|Adverse Event|0|||
156467986|NCT00822120|564808517|FG002|Initial Registration|Adverse Event|0|||
156467987|NCT00822120|564808518|FG003|Initial Registration|Adverse Event|0|||
156467988|NCT00822120|564808519|FG004|Initial Registration|Adverse Event|0|||
156467989|NCT00822120|564808520|FG005|Initial Registration|Adverse Event|0|||
156467990|NCT00822120|564808515|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
156467991|NCT00822120|564808516|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
156467992|NCT00822120|564808517|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
156467993|NCT00822120|564808518|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
156467994|NCT00822120|564808519|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
156467995|NCT00822120|564808520|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
156467996|NCT00822120|564808515|FG000|Initial Registration|Reasons not Protocol Specified|2|||
156467997|NCT00822120|564808516|FG001|Initial Registration|Reasons not Protocol Specified|0|||
156837811|NCT01555125|566158056|FG002|Extension|Protocol deviation|0|||
156837812|NCT01555125|566158057|FG003|Extension|Protocol deviation|0|||
156837813|NCT01555125|566158058|FG004|Extension|Protocol deviation|0|||
156837814|NCT01555125|566158054|FG000|Extension|Lack of Efficacy|7|||
156467998|NCT00822120|564808517|FG002|Initial Registration|Reasons not Protocol Specified|0|||
156467999|NCT00822120|564808518|FG003|Initial Registration|Reasons not Protocol Specified|0|||
156468000|NCT00822120|564808519|FG004|Initial Registration|Reasons not Protocol Specified|0|||
156468001|NCT00822120|564808520|FG005|Initial Registration|Reasons not Protocol Specified|0|||
156468002|NCT00822120|564808515|FG000|Initial Registration|Ineligible|22|||
156468003|NCT00822120|564808516|FG001|Initial Registration|Ineligible|1|||
156468004|NCT00822120|564808517|FG002|Initial Registration|Ineligible|0|||
156468005|NCT00822120|564808518|FG003|Initial Registration|Ineligible|0|||
156468006|NCT00822120|564808519|FG004|Initial Registration|Ineligible|0|||
156837815|NCT01555125|566158055|FG001|Extension|Lack of Efficacy|6|||
156837816|NCT01555125|566158056|FG002|Extension|Lack of Efficacy|3|||
156468007|NCT00822120|564808520|FG005|Initial Registration|Ineligible|0|||
156468008|NCT00822120|564808515|FG000|PET-directed Therapy|Adverse Event|0|||
156468009|NCT00822120|564808516|FG001|PET-directed Therapy|Adverse Event|0|||
156468010|NCT00822120|564808517|FG002|PET-directed Therapy|Adverse Event|0|||
156468011|NCT00822120|564808518|FG003|PET-directed Therapy|Adverse Event|1|||
156837817|NCT01555125|566158057|FG003|Extension|Lack of Efficacy|0|||
156837818|NCT01555125|566158058|FG004|Extension|Lack of Efficacy|0|||
156837819|NCT01555125|566158054|FG000|Extension|Lost to Follow-up|2|||
156837820|NCT01555125|566158055|FG001|Extension|Lost to Follow-up|1|||
156837821|NCT01555125|566158056|FG002|Extension|Lost to Follow-up|2|||
156837822|NCT01555125|566158057|FG003|Extension|Lost to Follow-up|0|||
156837823|NCT01555125|566158058|FG004|Extension|Lost to Follow-up|0|||
156837824|NCT01555125|566158054|FG000|Extension|Study terminated by sponsor|32|||
156837825|NCT01555125|566158055|FG001|Extension|Study terminated by sponsor|33|||
156837826|NCT01555125|566158056|FG002|Extension|Study terminated by sponsor|16|||
156837827|NCT01555125|566158057|FG003|Extension|Study terminated by sponsor|20|||
156837828|NCT01555125|566158058|FG004|Extension|Study terminated by sponsor|0|||
156837829|NCT01555125|566158054|FG000|Extension|Subject/guardian decision|1|||
156837830|NCT01555125|566158055|FG001|Extension|Subject/guardian decision|9|||
156837831|NCT01555125|566158056|FG002|Extension|Subject/guardian decision|1|||
156837832|NCT01555125|566158057|FG003|Extension|Subject/guardian decision|0|||
156837833|NCT01555125|566158058|FG004|Extension|Subject/guardian decision|0|||
156837834|NCT01555125|566158054|FG000|Extension|Technical Problems|1|||
156837835|NCT01555125|566158055|FG001|Extension|Technical Problems|0|||
156837836|NCT01555125|566158056|FG002|Extension|Technical Problems|0|||
156837837|NCT01555125|566158057|FG003|Extension|Technical Problems|1|||
156837838|NCT01555125|566158058|FG004|Extension|Technical Problems|0|||
156837839|NCT01555125|566158054|FG000|Follow-Up Period|Lost to Follow-up|1|||
156837840|NCT01555125|566158055|FG001|Follow-Up Period|Lost to Follow-up|0|||
156837841|NCT01555125|566158056|FG002|Follow-Up Period|Lost to Follow-up|0|||
156837842|NCT01555125|566158057|FG003|Follow-Up Period|Lost to Follow-up|0|||
156837843|NCT01555125|566158058|FG004|Follow-Up Period|Lost to Follow-up|0|||
156837844|NCT01555125|566158054|FG000|Follow-Up Period|Subject / guardian decision|3|||
156837845|NCT01555125|566158055|FG001|Follow-Up Period|Subject / guardian decision|1|||
156837846|NCT01555125|566158056|FG002|Follow-Up Period|Subject / guardian decision|1|||
156837847|NCT01555125|566158057|FG003|Follow-Up Period|Subject / guardian decision|1|||
156837848|NCT01555125|566158058|FG004|Follow-Up Period|Subject / guardian decision|0|||
156837849|NCT04268745|566158059|FG000|Overall Study|Lost to Follow-up|2|||
156837850|NCT04268745|566158060|FG001|Overall Study|Lost to Follow-up|3|||
156837851|NCT04268745|566158059|FG000|Overall Study|Withdrawal by Subject|4|||
156837852|NCT04268745|566158060|FG001|Overall Study|Withdrawal by Subject|2|||
156837853|NCT04268745|566158059|FG000|Overall Study|Death in the family|1|||
156837854|NCT04268745|566158060|FG001|Overall Study|Death in the family|0|||
156837855|NCT05327361|566158064|FG000|Overall Study|Lost to Follow-up|4|||
156837856|NCT00626405|566158065|FG000|Overall Study|Deemed Ineligible|1|||
156837857|NCT00626405|566158066|FG001|Overall Study|Deemed Ineligible|0|||
156837858|NCT00626405|566158065|FG000|Overall Study|Withdrawal by Subject|0|||
156837859|NCT00626405|566158066|FG001|Overall Study|Withdrawal by Subject|1|||
156837860|NCT01174173|566158067|FG000|Overall Study|drug-drug interaction|1|||
156837861|NCT01041287|566159460|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
156837862|NCT01041287|566159461|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
156837863|NCT01041287|566159460|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
156837864|NCT01041287|566159461|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
156837865|NCT00785980|566159462|FG000|7 Day Washout Period|Protocol Violation|3|||
156837866|NCT01815840|566159463|FG000|Overall Study|Missing|1|||
156837867|NCT01815840|566159464|FG001|Overall Study|Missing|0|||
156837868|NCT01815840|566159463|FG000|Overall Study|Withdrew Consent|31|||
156837869|NCT01815840|566159464|FG001|Overall Study|Withdrew Consent|30|||
156837870|NCT01815840|566159463|FG000|Overall Study|Administrative/Other|1|||
156837871|NCT01815840|566159464|FG001|Overall Study|Administrative/Other|3|||
156837872|NCT01815840|566159463|FG000|Overall Study|Adverse Event|10|||
156837873|NCT01815840|566159464|FG001|Overall Study|Adverse Event|16|||
156837874|NCT01815840|566159463|FG000|Overall Study|Death|2|||
156837875|NCT01815840|566159464|FG001|Overall Study|Death|2|||
156837876|NCT01815840|566159463|FG000|Overall Study|Disease progression|3|||
156837877|NCT01815840|566159464|FG001|Overall Study|Disease progression|2|||
156837878|NCT01815840|566159463|FG000|Overall Study|Investigators Decision|2|||
156837879|NCT01815840|566159464|FG001|Overall Study|Investigators Decision|3|||
156837880|NCT01815840|566159463|FG000|Overall Study|Lost to Follow-up|3|||
156837881|NCT01815840|566159464|FG001|Overall Study|Lost to Follow-up|6|||
156837882|NCT01815840|566159463|FG000|Overall Study|Refused Treatment|5|||
156837883|NCT01815840|566159464|FG001|Overall Study|Refused Treatment|1|||
156837884|NCT01815840|566159463|FG000|Overall Study|Sponsor Termination Treatment|1|||
156837885|NCT01815840|566159464|FG001|Overall Study|Sponsor Termination Treatment|0|||
156837886|NCT01286740|566159470|FG000|Overall Study|Enrolled but not treated|1|||
156837887|NCT01286740|566159470|FG000|Overall Study|Protocol Violation|1|||
156837888|NCT01646203|566159471|FG000|Overall Study|Adverse Event|2|||
156340327|NCT02571777|564344392|FG004|Overall Study|Physician Decision|4|||
156837889|NCT01646203|566159472|FG001|Overall Study|Adverse Event|0|||
156837890|NCT01646203|566159473|FG002|Overall Study|Adverse Event|1|||
156837891|NCT01646203|566159471|FG000|Overall Study|Withdrawal by Subject|0|||
156837892|NCT01646203|566159472|FG001|Overall Study|Withdrawal by Subject|1|||
156468012|NCT00822120|564808519|FG004|PET-directed Therapy|Adverse Event|0|||
156468013|NCT00822120|564808520|FG005|PET-directed Therapy|Adverse Event|0|||
156468014|NCT00822120|564808515|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
156468015|NCT00822120|564808516|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
156468016|NCT00822120|564808517|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
156468017|NCT00822120|564808518|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
156468018|NCT00822120|564808519|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
156468019|NCT00822120|564808520|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
156468020|NCT00822120|564808515|FG000|PET-directed Therapy|Death|0|||
156468021|NCT00822120|564808516|FG001|PET-directed Therapy|Death|0|||
156468022|NCT00822120|564808517|FG002|PET-directed Therapy|Death|0|||
156468023|NCT00822120|564808518|FG003|PET-directed Therapy|Death|2|||
156468024|NCT00822120|564808519|FG004|PET-directed Therapy|Death|0|||
156468025|NCT00822120|564808520|FG005|PET-directed Therapy|Death|0|||
156468026|NCT00822120|564808515|FG000|PET-directed Therapy|Protocol Violation|0|||
156468027|NCT00822120|564808516|FG001|PET-directed Therapy|Protocol Violation|0|||
156468028|NCT00822120|564808517|FG002|PET-directed Therapy|Protocol Violation|0|||
156468029|NCT00822120|564808518|FG003|PET-directed Therapy|Protocol Violation|6|||
156468030|NCT00822120|564808519|FG004|PET-directed Therapy|Protocol Violation|0|||
156468031|NCT00822120|564808520|FG005|PET-directed Therapy|Protocol Violation|0|||
156468032|NCT01437319|564808522|FG000|Phase I|Lost to Follow-up|2|||
156468033|NCT01437319|564808523|FG001|Phase I|Lost to Follow-up|0|||
156468034|NCT01437319|564808524|FG002|Phase I|Lost to Follow-up|0|||
156468035|NCT01437319|564808522|FG000|Phase I|Protocol Violation|1|||
156468036|NCT01437319|564808523|FG001|Phase I|Protocol Violation|0|||
156468037|NCT01437319|564808524|FG002|Phase I|Protocol Violation|0|||
156468038|NCT01437319|564808522|FG000|Phase I|Study related symptoms/complaints|27|||
156468039|NCT01437319|564808523|FG001|Phase I|Study related symptoms/complaints|0|||
156468040|NCT01437319|564808524|FG002|Phase I|Study related symptoms/complaints|0|||
156468041|NCT01437319|564808522|FG000|Phase I|Withdrawal by Subject|25|||
156468042|NCT01437319|564808523|FG001|Phase I|Withdrawal by Subject|0|||
156468043|NCT01437319|564808524|FG002|Phase I|Withdrawal by Subject|0|||
156468044|NCT01437319|564808522|FG000|Phase II|Withdrawal by Subject|0|||
156468045|NCT01437319|564808523|FG001|Phase II|Withdrawal by Subject|8|||
156468046|NCT01437319|564808524|FG002|Phase II|Withdrawal by Subject|16|||
156468047|NCT01437319|564808522|FG000|Phase II|Lost to Follow-up|0|||
156468048|NCT01437319|564808523|FG001|Phase II|Lost to Follow-up|7|||
156837893|NCT01646203|566159473|FG002|Overall Study|Withdrawal by Subject|0|||
156837894|NCT01646203|566159471|FG000|Overall Study|Physician's Decision|0|||
156837895|NCT01646203|566159472|FG001|Overall Study|Physician's Decision|1|||
156837896|NCT01646203|566159473|FG002|Overall Study|Physician's Decision|0|||
156837897|NCT04676867|566159474|FG000|Overall Study|Screen failure|0|||
156837898|NCT04676867|566159475|FG001|Overall Study|Screen failure|0|||
156837899|NCT04676867|566159476|FG002|Overall Study|Screen failure|6|||
156837900|NCT04676867|566159477|FG003|Overall Study|Screen failure|2|||
156837901|NCT04676867|566159474|FG000|Overall Study|Death|0|||
156837902|NCT04676867|566159475|FG001|Overall Study|Death|0|||
156837903|NCT04676867|566159476|FG002|Overall Study|Death|1|||
156837904|NCT04676867|566159477|FG003|Overall Study|Death|0|||
156837905|NCT04676867|566159474|FG000|Overall Study|Withdrawal by Subject|2|||
156837906|NCT04676867|566159475|FG001|Overall Study|Withdrawal by Subject|2|||
156837907|NCT04676867|566159476|FG002|Overall Study|Withdrawal by Subject|4|||
156837908|NCT04676867|566159477|FG003|Overall Study|Withdrawal by Subject|4|||
156837909|NCT04676867|566159474|FG000|Overall Study|Lost to Follow-up|1|||
156837910|NCT04676867|566159475|FG001|Overall Study|Lost to Follow-up|0|||
156837911|NCT04676867|566159476|FG002|Overall Study|Lost to Follow-up|0|||
156837912|NCT04676867|566159477|FG003|Overall Study|Lost to Follow-up|0|||
156837913|NCT02294734|566159481|FG000|Overall Study|Adverse Event|5|||
156837914|NCT02294734|566159482|FG001|Overall Study|Adverse Event|5|||
156837915|NCT02294734|566159481|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
156837916|NCT02294734|566159482|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
156468049|NCT01437319|564808524|FG002|Phase II|Lost to Follow-up|2|||
156468050|NCT01437319|564808522|FG000|Phase II|Study related symptoms/complaints|0|||
156468051|NCT01437319|564808523|FG001|Phase II|Study related symptoms/complaints|28|||
156837917|NCT02294734|566159481|FG000|Overall Study|Lost to Follow-up|2|||
156468052|NCT01437319|564808524|FG002|Phase II|Study related symptoms/complaints|19|||
156468053|NCT01437319|564808522|FG000|Phase II|Protocol Violation|0|||
156468054|NCT01437319|564808523|FG001|Phase II|Protocol Violation|1|||
156468055|NCT01437319|564808524|FG002|Phase II|Protocol Violation|0|||
156468056|NCT00811941|564808525|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
156837918|NCT02294734|566159482|FG001|Overall Study|Lost to Follow-up|0|||
156837919|NCT02294734|566159481|FG000|Overall Study|Physician Decision|2|||
156837920|NCT02294734|566159482|FG001|Overall Study|Physician Decision|1|||
156837921|NCT02294734|566159481|FG000|Overall Study|Withdrawal by Subject|4|||
156468057|NCT00811941|564808526|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
156468058|NCT00811941|564808525|FG000|All Treated Patients|Adverse Event|2|||
156468059|NCT00811941|564808526|FG001|All Treated Patients|Adverse Event|43|||
156468060|NCT00811941|564808525|FG000|All Treated Patients|Lack of Efficacy|2|||
156468061|NCT00811941|564808526|FG001|All Treated Patients|Lack of Efficacy|3|||
156468062|NCT00811941|564808525|FG000|All Treated Patients|Non-compliance|1|||
156468063|NCT00811941|564808526|FG001|All Treated Patients|Non-compliance|8|||
156468064|NCT00811941|564808525|FG000|All Treated Patients|Protocol Violation|5|||
156468065|NCT00811941|564808526|FG001|All Treated Patients|Protocol Violation|17|||
156468066|NCT00811941|564808525|FG000|All Treated Patients|Withdrawal by Subject|35|||
156468067|NCT00811941|564808526|FG001|All Treated Patients|Withdrawal by Subject|94|||
156468068|NCT00811941|564808525|FG000|All Treated Patients|Lost to Follow-up|3|||
156837922|NCT02294734|566159482|FG001|Overall Study|Withdrawal by Subject|2|||
156837923|NCT02335424|566159483|FG000|Overall Study|Withdrawal by Subject|19|||
156837924|NCT02335424|566159483|FG000|Overall Study|Adverse Event|25|||
156837925|NCT02335424|566159483|FG000|Overall Study|Death|273|||
156837926|NCT02335424|566159483|FG000|Overall Study|Lost to Follow-up|3|||
156837927|NCT02335424|566159483|FG000|Overall Study|Physician Decision|13|||
156837928|NCT02335424|566159483|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
156837929|NCT02335424|566159483|FG000|Overall Study|Protocol Violation|1|||
156837930|NCT02335424|566159483|FG000|Overall Study|Screen failure|1|||
156837931|NCT03157583|566159484|FG000|Overall Study|Other (did not meet study criteria)|1|||
156837932|NCT01141478|566159485|FG000|Overall Study|Withdrawal by Subject|1|||
156837933|NCT01141478|566159486|FG001|Overall Study|Withdrawal by Subject|1|||
156837934|NCT00290498|566159491|FG000|Overall Study|Death|2|||
156837935|NCT00290498|566159492|FG001|Overall Study|Death|0|||
156837936|NCT00290498|566159491|FG000|Overall Study|Physician Decision|1|||
156837937|NCT00290498|566159492|FG001|Overall Study|Physician Decision|0|||
156837938|NCT00290498|566159491|FG000|Overall Study|Withdrawal by Subject|1|||
156837939|NCT00290498|566159492|FG001|Overall Study|Withdrawal by Subject|0|||
156837940|NCT00290498|566159491|FG000|Overall Study|Ineligible|3|||
156837941|NCT00290498|566159492|FG001|Overall Study|Ineligible|0|||
156837942|NCT00290498|566159491|FG000|Overall Study|Non-Compliance|1|||
156837943|NCT00290498|566159492|FG001|Overall Study|Non-Compliance|0|||
156837944|NCT03847909|566159495|FG000|Overall Study|Withdrawal by Subject|1|||
156837945|NCT03847909|566159496|FG001|Overall Study|Withdrawal by Subject|1|||
156837946|NCT00490022|566159497|FG000|Overall Study|Adverse Event|0|||
156837947|NCT00490022|566159498|FG001|Overall Study|Adverse Event|2|||
156837948|NCT00490022|566159497|FG000|Overall Study|Withdrawal by Subject|1|||
156837949|NCT00490022|566159498|FG001|Overall Study|Withdrawal by Subject|0|||
156837950|NCT00490022|566159497|FG000|Overall Study|Subject failed to disclose concommitant|0|||
156837951|NCT00490022|566159498|FG001|Overall Study|Subject failed to disclose concommitant|1|||
156837952|NCT04268173|566159499|FG000|Overall Study|Lost to Follow-up|75|||
156837953|NCT04268173|566159500|FG001|Overall Study|Lost to Follow-up|108|||
156837954|NCT00869401|566159501|FG000|Overall Study|Withdrawal by Subject|0|||
156837955|NCT00869401|566159502|FG001|Overall Study|Withdrawal by Subject|0|||
156837956|NCT00869401|566159503|FG002|Overall Study|Withdrawal by Subject|0|||
156837957|NCT00869401|566159504|FG003|Overall Study|Withdrawal by Subject|5|||
156837958|NCT00869401|566159505|FG004|Overall Study|Withdrawal by Subject|3|||
156837959|NCT00545103|566159506|FG000|Overall Study|Lack of Efficacy|48|||
156837960|NCT00545103|566159507|FG001|Overall Study|Lack of Efficacy|45|||
156837961|NCT00545103|566159508|FG002|Overall Study|Lack of Efficacy|31|||
156837962|NCT00545103|566159509|FG003|Overall Study|Lack of Efficacy|27|||
156837963|NCT00545103|566159506|FG000|Overall Study|Withdrawal by Subject|6|||
156468069|NCT00811941|564808526|FG001|All Treated Patients|Lost to Follow-up|12|||
156468070|NCT00811941|564808525|FG000|All Treated Patients|Other Reason|4|||
156468071|NCT00811941|564808526|FG001|All Treated Patients|Other Reason|14|||
156468072|NCT00942266|564808534|FG000|Overall Study|Withdrawal by Subject|1|||
156468073|NCT00942266|564808535|FG001|Overall Study|Withdrawal by Subject|0|||
156837964|NCT00545103|566159507|FG001|Overall Study|Withdrawal by Subject|10|||
156837965|NCT00545103|566159508|FG002|Overall Study|Withdrawal by Subject|18|||
156837966|NCT00545103|566159509|FG003|Overall Study|Withdrawal by Subject|22|||
156837967|NCT00545103|566159506|FG000|Overall Study|Adverse Event|11|||
156837968|NCT00545103|566159507|FG001|Overall Study|Adverse Event|12|||
156340328|NCT02571777|564344388|FG000|Overall Study|Pregnancy|0|||
156837969|NCT00545103|566159508|FG002|Overall Study|Adverse Event|17|||
156837970|NCT00545103|566159509|FG003|Overall Study|Adverse Event|10|||
156837971|NCT00545103|566159506|FG000|Overall Study|Lost to Follow-up|4|||
156837972|NCT00545103|566159507|FG001|Overall Study|Lost to Follow-up|6|||
156837973|NCT00545103|566159508|FG002|Overall Study|Lost to Follow-up|3|||
156837974|NCT00545103|566159509|FG003|Overall Study|Lost to Follow-up|4|||
156837975|NCT00545103|566159506|FG000|Overall Study|Protocol Violation|1|||
156837976|NCT00545103|566159507|FG001|Overall Study|Protocol Violation|2|||
156837977|NCT00545103|566159508|FG002|Overall Study|Protocol Violation|3|||
156837978|NCT00545103|566159509|FG003|Overall Study|Protocol Violation|0|||
156837979|NCT00545103|566159506|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
156837980|NCT00545103|566159507|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
156837981|NCT00545103|566159508|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
156468074|NCT00942266|564808534|FG000|Overall Study|Adverse Event|2|||
156468075|NCT00942266|564808535|FG001|Overall Study|Adverse Event|1|||
156468076|NCT00942266|564808534|FG000|Overall Study|Disease Progression|38|||
156468077|NCT00942266|564808535|FG001|Overall Study|Disease Progression|11|||
156468078|NCT00942266|564808534|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
156468079|NCT00942266|564808535|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
156468080|NCT00942266|564808534|FG000|Overall Study|Intercurrent illness|0|||
156468081|NCT00942266|564808535|FG001|Overall Study|Intercurrent illness|1|||
156468082|NCT00942266|564808534|FG000|Overall Study|Physician Decision|2|||
156468083|NCT00942266|564808535|FG001|Overall Study|Physician Decision|0|||
156468084|NCT00942266|564808534|FG000|Overall Study|medical deterioration (pneumonia)|0|||
156468085|NCT00942266|564808535|FG001|Overall Study|medical deterioration (pneumonia)|1|||
156468086|NCT00918203|564808552|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
156468087|NCT00918203|564808553|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
156468088|NCT00918203|564808554|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
156468089|NCT00918203|564808552|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
156468090|NCT00918203|564808553|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
156468091|NCT00918203|564808554|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
156468092|NCT00918203|564808552|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
156468093|NCT00918203|564808553|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
156468094|NCT00918203|564808554|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
156837982|NCT00545103|566159509|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
156837983|NCT00545103|566159506|FG000|Overall Study|Difficult to open package|0|||
156837984|NCT00545103|566159507|FG001|Overall Study|Difficult to open package|0|||
156837985|NCT00545103|566159508|FG002|Overall Study|Difficult to open package|0|||
156837986|NCT00545103|566159509|FG003|Overall Study|Difficult to open package|1|||
156837987|NCT00545103|566159506|FG000|Overall Study|Investigational product not taken|1|||
156837988|NCT00545103|566159507|FG001|Overall Study|Investigational product not taken|0|||
156837989|NCT00545103|566159508|FG002|Overall Study|Investigational product not taken|0|||
156837990|NCT00545103|566159509|FG003|Overall Study|Investigational product not taken|1|||
156837991|NCT00545103|566159506|FG000|Overall Study|Wish to start a family|0|||
156837992|NCT00545103|566159507|FG001|Overall Study|Wish to start a family|0|||
156837993|NCT00545103|566159508|FG002|Overall Study|Wish to start a family|0|||
156837994|NCT00545103|566159509|FG003|Overall Study|Wish to start a family|1|||
156837995|NCT00545103|566159506|FG000|Overall Study|Diverticulitis crisis|0|||
156837996|NCT00545103|566159507|FG001|Overall Study|Diverticulitis crisis|0|||
156837997|NCT00545103|566159508|FG002|Overall Study|Diverticulitis crisis|0|||
156837998|NCT00545103|566159509|FG003|Overall Study|Diverticulitis crisis|1|||
156837999|NCT00545103|566159506|FG000|Overall Study|Personal reasons|1|||
156838000|NCT00545103|566159507|FG001|Overall Study|Personal reasons|0|||
156838001|NCT00545103|566159508|FG002|Overall Study|Personal reasons|0|||
156838002|NCT00545103|566159509|FG003|Overall Study|Personal reasons|0|||
156838003|NCT00545103|566159506|FG000|Overall Study|Subject's decision|1|||
156838004|NCT00545103|566159507|FG001|Overall Study|Subject's decision|0|||
156838005|NCT00545103|566159508|FG002|Overall Study|Subject's decision|0|||
156838006|NCT00545103|566159509|FG003|Overall Study|Subject's decision|0|||
156838007|NCT00545103|566159506|FG000|Overall Study|Noncompliance|0|||
156838008|NCT00545103|566159507|FG001|Overall Study|Noncompliance|1|||
156838009|NCT00545103|566159508|FG002|Overall Study|Noncompliance|0|||
156838010|NCT00545103|566159509|FG003|Overall Study|Noncompliance|0|||
156838011|NCT00545103|566159506|FG000|Overall Study|Investigator decision|0|||
156838012|NCT00545103|566159507|FG001|Overall Study|Investigator decision|0|||
156838013|NCT00545103|566159508|FG002|Overall Study|Investigator decision|1|||
156838014|NCT00545103|566159509|FG003|Overall Study|Investigator decision|0|||
156838015|NCT00545103|566159506|FG000|Overall Study|Subject moved|0|||
156838016|NCT00545103|566159507|FG001|Overall Study|Subject moved|1|||
156838017|NCT00545103|566159508|FG002|Overall Study|Subject moved|0|||
156838018|NCT00545103|566159509|FG003|Overall Study|Subject moved|0|||
156838019|NCT00545103|566159506|FG000|Overall Study|Use of prohibited medication|0|||
156838020|NCT00545103|566159507|FG001|Overall Study|Use of prohibited medication|0|||
156838021|NCT00545103|566159508|FG002|Overall Study|Use of prohibited medication|1|||
156838022|NCT00545103|566159509|FG003|Overall Study|Use of prohibited medication|0|||
156838023|NCT00545103|566159506|FG000|Overall Study|Does not want to take study drug anymore|1|||
156838024|NCT00545103|566159507|FG001|Overall Study|Does not want to take study drug anymore|0|||
156838025|NCT00545103|566159508|FG002|Overall Study|Does not want to take study drug anymore|1|||
156838026|NCT00545103|566159509|FG003|Overall Study|Does not want to take study drug anymore|0|||
156838027|NCT00545103|566159506|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
156838028|NCT00545103|566159507|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
156838029|NCT00545103|566159508|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
156838030|NCT00545103|566159509|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
156838031|NCT00545103|566159506|FG000|Overall Study|Death|0|||
156838032|NCT00545103|566159507|FG001|Overall Study|Death|1|||
156838033|NCT00545103|566159508|FG002|Overall Study|Death|0|||
156838034|NCT00545103|566159509|FG003|Overall Study|Death|0|||
156838035|NCT01953913|566159510|FG000|Overall Study|Disease Progression|349|||
156838036|NCT01953913|566159510|FG000|Overall Study|Worsening of underlying cancer|22|||
156838037|NCT01953913|566159510|FG000|Overall Study|Adverse Event|20|||
156838038|NCT01953913|566159510|FG000|Overall Study|Protocol Violation|6|||
156838039|NCT01953913|566159510|FG000|Overall Study|Lost to Follow-up|4|||
156838040|NCT01953913|566159510|FG000|Overall Study|Withdrawal by Subject|32|||
156838041|NCT01953913|566159510|FG000|Overall Study|Other than listed|108|||
156838042|NCT01953913|566159510|FG000|Overall Study|Not Treated|1|||
156838043|NCT05026853|566159511|FG000|Overall Study|Cancelled appointment|1|||
156838044|NCT05026853|566159512|FG001|Overall Study|Cancelled appointment|0|||
156838045|NCT05026853|566159511|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
156838046|NCT05026853|566159512|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
156838047|NCT05026853|566159511|FG000|Overall Study|Did not complete 12-week survey|16|||
156838048|NCT05026853|566159512|FG001|Overall Study|Did not complete 12-week survey|16|||
156838049|NCT01732913|566159513|FG000|Overall Study|Study Terminated by Sponsor|105|||
156838050|NCT01732913|566159514|FG001|Overall Study|Study Terminated by Sponsor|55|||
156838051|NCT01732913|566159513|FG000|Overall Study|Withdrawal by Subject|27|||
156838052|NCT01732913|566159514|FG001|Overall Study|Withdrawal by Subject|4|||
156838053|NCT01732913|566159513|FG000|Overall Study|Physician Decision|14|||
156838054|NCT01732913|566159514|FG001|Overall Study|Physician Decision|7|||
156838055|NCT01732913|566159513|FG000|Overall Study|Other|7|||
156838056|NCT01732913|566159514|FG001|Overall Study|Other|1|||
156838057|NCT01732913|566159513|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
156838058|NCT01732913|566159514|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
156838059|NCT01353911|566159515|FG000|Overall Study|Lost to Follow-up|2|||
156838060|NCT01353911|566159516|FG001|Overall Study|Lost to Follow-up|6|||
156468095|NCT00918203|564808552|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
156468096|NCT00918203|564808553|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
156838061|NCT01353911|566159517|FG002|Overall Study|Lost to Follow-up|4|||
156838062|NCT01353911|566159518|FG003|Overall Study|Lost to Follow-up|0|||
156838063|NCT01353911|566159519|FG004|Overall Study|Lost to Follow-up|4|||
156838064|NCT01353911|566159520|FG005|Overall Study|Lost to Follow-up|4|||
156838065|NCT01353911|566159521|FG006|Overall Study|Lost to Follow-up|3|||
156838066|NCT01353911|566159522|FG007|Overall Study|Lost to Follow-up|6|||
156838067|NCT01353911|566159515|FG000|Overall Study|Withdrawal by Subject|2|||
156838068|NCT01353911|566159516|FG001|Overall Study|Withdrawal by Subject|3|||
156838069|NCT01353911|566159517|FG002|Overall Study|Withdrawal by Subject|4|||
156838070|NCT01353911|566159518|FG003|Overall Study|Withdrawal by Subject|2|||
156838071|NCT01353911|566159519|FG004|Overall Study|Withdrawal by Subject|2|||
156838072|NCT01353911|566159520|FG005|Overall Study|Withdrawal by Subject|3|||
156838073|NCT01353911|566159521|FG006|Overall Study|Withdrawal by Subject|3|||
156838074|NCT01353911|566159522|FG007|Overall Study|Withdrawal by Subject|9|||
156838075|NCT01353911|566159515|FG000|Overall Study|Status Not Recorded|4|||
156838076|NCT01353911|566159516|FG001|Overall Study|Status Not Recorded|0|||
156838077|NCT01353911|566159517|FG002|Overall Study|Status Not Recorded|1|||
156838078|NCT01353911|566159518|FG003|Overall Study|Status Not Recorded|0|||
156838079|NCT01353911|566159519|FG004|Overall Study|Status Not Recorded|0|||
156838080|NCT01353911|566159520|FG005|Overall Study|Status Not Recorded|0|||
156838081|NCT01353911|566159521|FG006|Overall Study|Status Not Recorded|0|||
156838082|NCT01353911|566159522|FG007|Overall Study|Status Not Recorded|0|||
156838083|NCT03233438|566159523|FG000|Overall Study|Lost to Follow-up|4|||
156838084|NCT03233438|566159524|FG001|Overall Study|Lost to Follow-up|9|||
156838085|NCT03233438|566159523|FG000|Overall Study|Withdrawal by Subject|2|||
156838086|NCT03233438|566159524|FG001|Overall Study|Withdrawal by Subject|1|||
156838087|NCT03233438|566159523|FG000|Overall Study|No recording of dalbavancin|0|||
156838088|NCT03233438|566159524|FG001|Overall Study|No recording of dalbavancin|1|||
156838089|NCT02925741|566159526|FG000|Overall Study|Withdrawal by Subject|11|||
156838090|NCT02925741|566159527|FG001|Overall Study|Withdrawal by Subject|0|||
156838091|NCT00413374|566159530|FG000|Overall Study|Ineligible due to screening criteria.|3|||
156838092|NCT00413374|566159531|FG001|Overall Study|Ineligible due to screening criteria.|0|||
156838093|NCT00413374|566159530|FG000|Overall Study|Adverse Event|1|||
156838094|NCT00413374|566159531|FG001|Overall Study|Adverse Event|0|||
156838095|NCT00413374|566159530|FG000|Overall Study|Lost to Follow-up|1|||
156838096|NCT00413374|566159531|FG001|Overall Study|Lost to Follow-up|0|||
156838097|NCT00413374|566159530|FG000|Overall Study|Surgery|1|||
156838098|NCT00413374|566159531|FG001|Overall Study|Surgery|0|||
156838099|NCT00295932|566159534|FG000|Overall Study|Not Treated|0|||
156838100|NCT00295932|566159535|FG001|Overall Study|Not Treated|0|||
156838101|NCT00295932|566159536|FG002|Overall Study|Not Treated|0|||
156838102|NCT00295932|566159537|FG003|Overall Study|Not Treated|0|||
156838103|NCT00295932|566159538|FG004|Overall Study|Not Treated|0|||
156838104|NCT00295932|566159539|FG005|Overall Study|Not Treated|0|||
156838105|NCT00295932|566159540|FG006|Overall Study|Not Treated|0|||
156838106|NCT00295932|566159541|FG007|Overall Study|Not Treated|0|||
156838107|NCT00295932|566159542|FG008|Overall Study|Not Treated|0|||
156838108|NCT00295932|566159543|FG009|Overall Study|Not Treated|0|||
156838109|NCT00295932|566159544|FG010|Overall Study|Not Treated|1|||
156838110|NCT00500760|566159546|FG000|Overall Study|Death|32|||
156838111|NCT00500760|566159547|FG001|Overall Study|Death|15|||
156838112|NCT00500760|566159546|FG000|Overall Study|Withdrawal by Subject|5|||
156838113|NCT00500760|566159547|FG001|Overall Study|Withdrawal by Subject|7|||
156838114|NCT00500760|566159546|FG000|Overall Study|Administrative decision|2|||
156838115|NCT00500760|566159547|FG001|Overall Study|Administrative decision|0|||
156838116|NCT00500760|566159546|FG000|Overall Study|Lost to Follow-up|3|||
156838117|NCT00500760|566159547|FG001|Overall Study|Lost to Follow-up|0|||
156838118|NCT00500760|566159546|FG000|Overall Study|Other|1|||
156838119|NCT00500760|566159547|FG001|Overall Study|Other|2|||
156838120|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
156838121|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
156838122|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
156838123|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
156838124|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
156838125|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
156838126|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838127|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838128|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838129|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838130|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838131|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
156838132|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
156838133|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
156838134|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838135|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
156838136|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
156838137|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838138|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838139|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838140|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838141|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838142|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838143|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
156838144|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
156838145|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
156838146|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
156838147|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
156838148|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838149|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838150|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838151|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838152|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838153|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
156838154|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
156838155|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
156838156|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838157|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
156838158|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
156838159|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838160|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838161|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838162|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838163|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838164|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838165|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156340329|NCT02571777|564344389|FG001|Overall Study|Pregnancy|0|||
156340330|NCT02571777|564344390|FG002|Overall Study|Pregnancy|0|||
156838166|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
156838167|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838168|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838169|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
156838170|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838171|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838172|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838173|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838174|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838175|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
156838176|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838177|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838178|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838179|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838180|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838181|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838182|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156468097|NCT00918203|564808554|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
156468098|NCT03357952|564808557|FG000|Overall Study|Withdrawal by Subject|0|||
156468099|NCT03357952|564808558|FG001|Overall Study|Withdrawal by Subject|1|||
156468100|NCT03357952|564808557|FG000|Overall Study|Sponsor Decision|9|||
156468101|NCT03357952|564808558|FG001|Overall Study|Sponsor Decision|0|||
156468102|NCT01830595|564808559|FG000|First Period|Withdrawal by Subject|1|||
156468103|NCT01830595|564808560|FG001|First Period|Withdrawal by Subject|3|||
156468104|NCT01830595|564808559|FG000|Washout|Withdrawal by Subject|2|||
156468105|NCT01830595|564808560|FG001|Washout|Withdrawal by Subject|2|||
156468106|NCT05018143|564808561|FG000|Overall Study|Lost to Follow-up|5|||
156468107|NCT05018143|564808562|FG001|Overall Study|Lost to Follow-up|4|||
156468108|NCT05018143|564808561|FG000|Overall Study|Withdrawal by Subject|0|||
156468109|NCT05018143|564808562|FG001|Overall Study|Withdrawal by Subject|1|||
156468110|NCT06688357|564808563|FG000|Overall Study|Adverse Event|0|||
156468111|NCT06688357|564808564|FG001|Overall Study|Adverse Event|1|||
156468112|NCT05116774|564808565|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
156468113|NCT05116774|564808566|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
156468114|NCT05116774|564808565|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
156468115|NCT05116774|564808566|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
156468116|NCT05116774|564808565|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
156468117|NCT05116774|564808566|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
156468118|NCT05116774|564808565|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
156468119|NCT05116774|564808566|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
156468120|NCT03280030|564808567|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
156468121|NCT03280030|564808568|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
156468122|NCT03280030|564808569|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
156468123|NCT03280030|564808567|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
156468124|NCT03280030|564808568|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
156468125|NCT03280030|564808569|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
156468126|NCT03280030|564808567|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
156468127|NCT03280030|564808568|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
156468128|NCT03280030|564808569|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
156468129|NCT03280030|564808567|FG000|Part 2 - Efficacy|Adverse Event|0|||
156468130|NCT03280030|564808568|FG001|Part 2 - Efficacy|Adverse Event|4|||
156468131|NCT03280030|564808569|FG002|Part 2 - Efficacy|Adverse Event|6|||
156468132|NCT03280030|564808567|FG000|Part 2 - Efficacy|Death|0|||
156468133|NCT03280030|564808568|FG001|Part 2 - Efficacy|Death|3|||
156468134|NCT03280030|564808569|FG002|Part 2 - Efficacy|Death|0|||
156468135|NCT03280030|564808567|FG000|Part 2 - Efficacy|Physician Decision|0|||
156468136|NCT03280030|564808568|FG001|Part 2 - Efficacy|Physician Decision|10|||
156468137|NCT03280030|564808569|FG002|Part 2 - Efficacy|Physician Decision|16|||
156468138|NCT03280030|564808567|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
156468139|NCT03280030|564808568|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
156468140|NCT03280030|564808569|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
156468141|NCT03280030|564808567|FG000|Part 2 - Efficacy|Progressive disease|0|||
156468142|NCT03280030|564808568|FG001|Part 2 - Efficacy|Progressive disease|7|||
156468143|NCT03280030|564808569|FG002|Part 2 - Efficacy|Progressive disease|5|||
156468144|NCT05601882|564808570|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
156468145|NCT05601882|564808571|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
156468146|NCT05601882|564808572|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
156468147|NCT05601882|564808573|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
156468148|NCT05601882|564808570|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
156468149|NCT05601882|564808571|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
156468150|NCT05601882|564808572|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
156468151|NCT05601882|564808573|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
156838183|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156468152|NCT05601882|564808570|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
156468153|NCT05601882|564808571|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
156468154|NCT05601882|564808572|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
156468155|NCT05601882|564808573|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
156468156|NCT05601882|564808570|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
156468157|NCT05601882|564808571|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
156468158|NCT05601882|564808572|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
156468159|NCT05601882|564808573|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
156468160|NCT05601882|564808570|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
156468161|NCT05601882|564808571|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
156468162|NCT05601882|564808572|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
156468163|NCT05601882|564808573|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
156468164|NCT05601882|564808570|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
156468165|NCT05601882|564808571|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
156468166|NCT05601882|564808572|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
156468167|NCT05601882|564808573|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
156468168|NCT03834740|564808576|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
156468169|NCT03834740|564808577|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
156468170|NCT03834740|564808578|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
156468171|NCT01208974|564808579|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
156468172|NCT01208974|564808580|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
156468173|NCT01208974|564808581|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
156468174|NCT01208974|564808582|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
156468175|NCT01208974|564808579|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
156468176|NCT01208974|564808580|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
156468177|NCT01208974|564808581|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
156468178|NCT01208974|564808582|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
156468179|NCT01208974|564808579|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
156468180|NCT01208974|564808580|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
156468181|NCT01208974|564808581|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
156468182|NCT01208974|564808582|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
156468183|NCT03691493|564808583|FG000|Overall Study|Withdrawal by Subject|1|||
156468184|NCT04503681|564810078|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
156468185|NCT04503681|564810079|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
156468186|NCT03352713|564810082|FG000|Overall Study|Lost to Follow-up|8|||
156468187|NCT03352713|564810082|FG000|Overall Study|Withdrawn by investigator|5|||
156468188|NCT03352713|564810082|FG000|Overall Study|Completed 0 EMAs|8|||
156468189|NCT03352713|564810082|FG000|Overall Study|Device incompatible/stolen|5|||
156468190|NCT01812759|564810083|FG000|Overall Study|Physician Decision|0|||
156468191|NCT01812759|564810084|FG001|Overall Study|Physician Decision|0|||
156468192|NCT01812759|564810085|FG002|Overall Study|Physician Decision|1|||
156468193|NCT04213807|564810086|FG000|Overall Study|Physician Decision|0|||
156468194|NCT04213807|564810087|FG001|Overall Study|Physician Decision|0|||
156468195|NCT04213807|564810088|FG002|Overall Study|Physician Decision|1|||
156468196|NCT03442777|564810089|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
156468197|NCT03442777|564810090|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
156468198|NCT03442777|564810091|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
156468199|NCT02866942|564810092|FG000|Overall Study|Invalid consent|1|||
156468200|NCT03418922|564810094|FG000|Overall Study|Withdrawal by Subject|0|||
156468201|NCT03418922|564810095|FG001|Overall Study|Withdrawal by Subject|2|||
156468202|NCT03418922|564810094|FG000|Overall Study|Adverse Event|2|||
156468203|NCT03418922|564810095|FG001|Overall Study|Adverse Event|2|||
156468204|NCT03418922|564810094|FG000|Overall Study|Death|0|||
156468205|NCT03418922|564810095|FG001|Overall Study|Death|1|||
156468206|NCT03418922|564810094|FG000|Overall Study|Physician Decision|0|||
156468207|NCT03418922|564810095|FG001|Overall Study|Physician Decision|1|||
156468208|NCT03577106|564810096|FG000|Overall Study|Withdrawal by Subject|3|||
156838184|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838185|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838186|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838187|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838188|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
156838189|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838190|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838191|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838192|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838193|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156468209|NCT00754065|564810099|FG000|Overall Study|Never received treatment|12|||
156838194|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838195|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838196|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838197|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
156838198|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838199|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
156838200|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
156838201|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
156838202|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
156838203|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838204|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838205|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838206|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156468210|NCT00754065|564810100|FG001|Overall Study|Never received treatment|2|||
156468211|NCT00754065|564810099|FG000|Overall Study|Adverse Event|19|||
156468212|NCT00754065|564810100|FG001|Overall Study|Adverse Event|25|||
156468213|NCT00754065|564810099|FG000|Overall Study|Lost to Follow-up|7|||
156468214|NCT00754065|564810100|FG001|Overall Study|Lost to Follow-up|11|||
156838207|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838208|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838209|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838210|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838211|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838212|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838213|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838214|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
156838215|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
156838216|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
156838217|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
156838218|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
156838219|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838220|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838221|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838222|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838223|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838224|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838225|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
156838226|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
156838227|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
156838228|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
156838229|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
156838230|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838231|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838232|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838233|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838234|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838235|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838236|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
156838237|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
156838238|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
156838239|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
156838240|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
156838241|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838242|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838243|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838244|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838245|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838246|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838247|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
156838248|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156468215|NCT00754065|564810099|FG000|Overall Study|Protocol Violation|12|||
156468216|NCT00754065|564810100|FG001|Overall Study|Protocol Violation|10|||
156468217|NCT00754065|564810099|FG000|Overall Study|Withdrawal by Subject|4|||
156468218|NCT00754065|564810100|FG001|Overall Study|Withdrawal by Subject|5|||
156468219|NCT00754065|564810099|FG000|Overall Study|Pregnancy|6|||
156468220|NCT00754065|564810100|FG001|Overall Study|Pregnancy|0|||
156468221|NCT00754065|564810099|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
156468222|NCT00754065|564810100|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
156468223|NCT04860505|564810103|FG000|Overall Study|Lost to Follow-up|2|||
156468224|NCT01988402|564810104|FG000|Overall Study|Adverse Event|1|||
156468225|NCT01988402|564810105|FG001|Overall Study|Adverse Event|2|||
156468226|NCT01988402|564810104|FG000|Overall Study|Withdrawal by Subject|1|||
156468227|NCT01988402|564810105|FG001|Overall Study|Withdrawal by Subject|0|||
156468228|NCT01759862|564810109|FG000|Overall Study|Physician Decision|3|||
156468229|NCT01759862|564810110|FG001|Overall Study|Physician Decision|1|||
156468230|NCT01759862|564810109|FG000|Overall Study|Adverse Event|0|||
156468231|NCT01759862|564810110|FG001|Overall Study|Adverse Event|1|||
156468232|NCT04060212|564810111|FG000|Overall Study|Withdrawal by Subject|7|||
156468233|NCT01499849|564810112|FG000|Overall Study|Adverse Event|28|||
156468234|NCT01499849|564810113|FG001|Overall Study|Adverse Event|32|||
156468235|NCT01499849|564810112|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
156468236|NCT01499849|564810113|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
156468237|NCT01499849|564810112|FG000|Overall Study|Withdrawal by Subject|43|||
156468238|NCT01499849|564810113|FG001|Overall Study|Withdrawal by Subject|43|||
156468239|NCT01499849|564810112|FG000|Overall Study|Death|5|||
156468240|NCT01499849|564810113|FG001|Overall Study|Death|7|||
156468241|NCT01499849|564810112|FG000|Overall Study|Disease Progression|11|||
156468242|NCT01499849|564810113|FG001|Overall Study|Disease Progression|10|||
156468243|NCT01499849|564810112|FG000|Overall Study|Protocol Violation|11|||
156468244|NCT01499849|564810113|FG001|Overall Study|Protocol Violation|11|||
156468245|NCT01499849|564810112|FG000|Overall Study|Physician Decision|20|||
156468246|NCT01499849|564810113|FG001|Overall Study|Physician Decision|19|||
156838249|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
156838250|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838251|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
156838252|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156340331|NCT02571777|564344391|FG003|Overall Study|Pregnancy|2|||
156340332|NCT02571777|564344392|FG004|Overall Study|Pregnancy|0|||
156340333|NCT03706079|564344393|FG000|Predecessor Study|Death|0|||
156340334|NCT03706079|564344394|FG001|Predecessor Study|Death|2|||
156340335|NCT03706079|564344395|FG002|Predecessor Study|Death|0|||
156340336|NCT03706079|564344396|FG003|Predecessor Study|Death|1|||
156340337|NCT03706079|564344397|FG004|Predecessor Study|Death|0|||
156340338|NCT03706079|564344398|FG005|Predecessor Study|Death|0|||
156340339|NCT03706079|564344393|FG000|Predecessor Study|Lost to Follow-up|5|||
156838253|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838254|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838255|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838256|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838257|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838258|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
156838259|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838260|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
156838261|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
156340340|NCT03706079|564344394|FG001|Predecessor Study|Lost to Follow-up|2|||
156340341|NCT03706079|564344395|FG002|Predecessor Study|Lost to Follow-up|0|||
156340342|NCT03706079|564344396|FG003|Predecessor Study|Lost to Follow-up|0|||
156468247|NCT01499849|564810112|FG000|Overall Study|Lack of Efficacy|3|||
156468248|NCT01499849|564810113|FG001|Overall Study|Lack of Efficacy|4|||
156468249|NCT01499849|564810112|FG000|Overall Study|Lost to Follow-up|6|||
156468250|NCT01499849|564810113|FG001|Overall Study|Lost to Follow-up|3|||
156468251|NCT01499849|564810112|FG000|Overall Study|Other Reasons|27|||
156468252|NCT01499849|564810113|FG001|Overall Study|Other Reasons|30|||
156468253|NCT00622700|564810114|FG000|Core Treatment Period|Randomized but Not Treated|0|||
156468254|NCT00622700|564810115|FG001|Core Treatment Period|Randomized but Not Treated|2|||
156838262|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
156838263|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838264|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838265|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838266|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838267|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156340343|NCT03706079|564344397|FG004|Predecessor Study|Lost to Follow-up|1|||
156340344|NCT03706079|564344398|FG005|Predecessor Study|Lost to Follow-up|0|||
156340345|NCT03706079|564344393|FG000|Predecessor Study|Withdrawal by Subject|8|||
156468255|NCT00622700|564810116|FG002|Core Treatment Period|Randomized but Not Treated|2|||
156468256|NCT00622700|564810117|FG003|Core Treatment Period|Randomized but Not Treated|0|||
156468257|NCT00622700|564810118|FG004|Core Treatment Period|Randomized but Not Treated|0|||
156468258|NCT00622700|564810119|FG005|Core Treatment Period|Randomized but Not Treated|0|||
156468259|NCT00622700|564810120|FG006|Core Treatment Period|Randomized but Not Treated|0|||
156468260|NCT00622700|564810114|FG000|Core Treatment Period|Adverse Event|18|||
156468261|NCT00622700|564810115|FG001|Core Treatment Period|Adverse Event|25|||
156838268|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838269|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
156838270|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838271|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
156838272|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838273|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838274|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838275|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838276|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838277|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838278|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838279|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838280|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838281|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838282|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
156838283|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838284|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838285|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838286|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838287|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838288|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838289|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838290|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838291|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
156838292|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838293|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838294|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838295|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838296|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838297|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838298|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838299|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838300|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838301|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838302|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838303|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838304|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
156838305|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
156838306|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
156838307|NCT03332160|566159559|FG000|Overall Study|Withdrawal by Subject|1|||
156838308|NCT03332160|566159560|FG001|Overall Study|Withdrawal by Subject|1|||
156838309|NCT03332160|566159559|FG000|Overall Study|Adverse Event|0|||
156838310|NCT03332160|566159560|FG001|Overall Study|Adverse Event|1|||
156468262|NCT00622700|564810116|FG002|Core Treatment Period|Adverse Event|18|||
156468263|NCT00622700|564810117|FG003|Core Treatment Period|Adverse Event|0|||
156838311|NCT03332160|566159559|FG000|Overall Study|Developed Exclusion Criteria|0|||
156838312|NCT03332160|566159560|FG001|Overall Study|Developed Exclusion Criteria|1|||
156838313|NCT03332160|566159559|FG000|Overall Study|Non-adherence to treatment|0|||
156838314|NCT03332160|566159560|FG001|Overall Study|Non-adherence to treatment|2|||
156838315|NCT01561963|566159561|FG000|Overall Study|Adverse Event|1|||
156838316|NCT04598269|566159562|FG000|Overall Study|Adverse Event|0|||
156838317|NCT04598269|566159563|FG001|Overall Study|Adverse Event|3|||
156838318|NCT04598269|566159562|FG000|Overall Study|Withdrawal by Subject|1|||
156838319|NCT04598269|566159563|FG001|Overall Study|Withdrawal by Subject|4|||
156838320|NCT04598269|566159562|FG000|Overall Study|Lost to Follow-up|1|||
156838321|NCT04598269|566159563|FG001|Overall Study|Lost to Follow-up|0|||
156838322|NCT04598269|566159562|FG000|Overall Study|Not Treated|2|||
156838323|NCT04598269|566159563|FG001|Overall Study|Not Treated|0|||
156838324|NCT03040986|566159572|FG000|Overall Study|Hospice|1|||
156838325|NCT03040986|566159573|FG001|Overall Study|Hospice|0|||
156838326|NCT03040986|566159572|FG000|Overall Study|Adverse Event|2|||
156838327|NCT03040986|566159573|FG001|Overall Study|Adverse Event|1|||
156838328|NCT03040986|566159572|FG000|Overall Study|Disease progression on study|3|||
156838329|NCT03040986|566159573|FG001|Overall Study|Disease progression on study|1|||
156838330|NCT02383433|566159574|FG000|Overall Study|Disease progression|2|||
156468264|NCT00622700|564810118|FG004|Core Treatment Period|Adverse Event|0|||
156468265|NCT00622700|564810119|FG005|Core Treatment Period|Adverse Event|0|||
156838331|NCT02477553|566159575|FG000|Overall Study|Screening up-to-date|12|||
156838332|NCT02477553|566159576|FG001|Overall Study|Screening up-to-date|13|||
156838333|NCT02477553|566159575|FG000|Overall Study|No MD visit|1|||
156838334|NCT02477553|566159576|FG001|Overall Study|No MD visit|1|||
156838335|NCT02477553|566159575|FG000|Overall Study|Workup consistent w/CRC|1|||
156838336|NCT02477553|566159576|FG001|Overall Study|Workup consistent w/CRC|1|||
156838337|NCT02477553|566159575|FG000|Overall Study|Technical issues with intervention|2|||
156838338|NCT02477553|566159576|FG001|Overall Study|Technical issues with intervention|0|||
156838339|NCT02477553|566159575|FG000|Overall Study|Elevated risk for CRC|2|||
156838340|NCT02477553|566159576|FG001|Overall Study|Elevated risk for CRC|2|||
156838341|NCT02477553|566159575|FG000|Overall Study|MD advised against screening|1|||
156838342|NCT02477553|566159576|FG001|Overall Study|MD advised against screening|3|||
156838343|NCT02477553|566159575|FG000|Overall Study|patient deceased|1|||
156838344|NCT02477553|566159576|FG001|Overall Study|patient deceased|0|||
156838345|NCT04023682|566159581|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
156838346|NCT00695864|566159589|FG000|Placebo|Withdrawal by Subject|1|||
156838347|NCT00695864|566159589|FG000|Placebo|Physician Decision|4|||
156838348|NCT00772109|566159593|FG000|Overall Study|Serious adverse event|1|||
156838349|NCT00772109|566159594|FG001|Overall Study|Serious adverse event|0|||
156838350|NCT00772109|566159595|FG002|Overall Study|Serious adverse event|1|||
156838351|NCT00772109|566159596|FG003|Overall Study|Serious adverse event|0|||
156838352|NCT00772109|566159593|FG000|Overall Study|Protocol Violation|5|||
156838353|NCT00772109|566159594|FG001|Overall Study|Protocol Violation|8|||
156838354|NCT00772109|566159595|FG002|Overall Study|Protocol Violation|7|||
156838355|NCT00772109|566159596|FG003|Overall Study|Protocol Violation|6|||
156838356|NCT00772109|566159593|FG000|Overall Study|Lost to Follow-up|7|||
156838357|NCT00772109|566159594|FG001|Overall Study|Lost to Follow-up|3|||
156838358|NCT00772109|566159595|FG002|Overall Study|Lost to Follow-up|5|||
156838359|NCT00772109|566159596|FG003|Overall Study|Lost to Follow-up|9|||
156838360|NCT00772109|566159593|FG000|Overall Study|Withdrawal by Subject|8|||
156838361|NCT00772109|566159594|FG001|Overall Study|Withdrawal by Subject|8|||
156838362|NCT00772109|566159595|FG002|Overall Study|Withdrawal by Subject|6|||
156838363|NCT00772109|566159596|FG003|Overall Study|Withdrawal by Subject|16|||
156838364|NCT00752726|566159597|FG000|Overall Study|Lost to Follow-up|2|||
156838365|NCT00752726|566159598|FG001|Overall Study|Lost to Follow-up|1|||
156838366|NCT00752726|566159597|FG000|Overall Study|Adverse Event|3|||
156838367|NCT00752726|566159598|FG001|Overall Study|Adverse Event|0|||
156838368|NCT00752726|566159597|FG000|Overall Study|Withdrawal by Subject|5|||
156838369|NCT00752726|566159598|FG001|Overall Study|Withdrawal by Subject|10|||
156838370|NCT00752726|566159597|FG000|Overall Study|Other Reason|1|||
156838371|NCT00752726|566159598|FG001|Overall Study|Other Reason|2|||
156838372|NCT04232215|566159599|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
156838373|NCT04232215|566159600|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156838374|NCT00410605|566159601|FG000|Overall Study|Adverse Event|12|||
156838375|NCT00410605|566159601|FG000|Overall Study|Physician Decision|3|||
156838376|NCT00410605|566159601|FG000|Overall Study|Withdrawal by Subject|5|||
156838377|NCT00410605|566159601|FG000|Overall Study|Started Non-Protocol Therapy|3|||
156838378|NCT00410605|566159601|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
156838379|NCT00410605|566159601|FG000|Overall Study|Transferred to another Institution|1|||
156838380|NCT01887353|566159604|FG000|Overall Study|Study stopped early|4|||
156838381|NCT01887353|566159605|FG001|Overall Study|Study stopped early|3|||
156838382|NCT02039856|566159606|FG000|Overall Study|Death|5|||
156838383|NCT02039856|566159607|FG001|Overall Study|Death|3|||
156838384|NCT02039856|566159606|FG000|Overall Study|Partial survey completion|61|||
156838385|NCT02039856|566159607|FG001|Overall Study|Partial survey completion|26|||
156838386|NCT02039856|566159606|FG000|Overall Study|Lost to Follow-up|388|||
156838387|NCT02039856|566159607|FG001|Overall Study|Lost to Follow-up|206|||
156838388|NCT02039856|566159606|FG000|Overall Study|Withdrawal by Subject|1573|||
156838389|NCT02039856|566159607|FG001|Overall Study|Withdrawal by Subject|618|||
156838390|NCT02666105|566159608|FG000|Overall Study|Death|1|||
156838391|NCT00602420|566161469|FG000|Overall Study|Death|1|||
156838392|NCT00602420|566161470|FG001|Overall Study|Death|4|||
156838393|NCT00602420|566161469|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
156838394|NCT00602420|566161470|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
156838395|NCT00602420|566161469|FG000|Overall Study|Withdrawal by Subject|18|||
156838396|NCT00602420|566161470|FG001|Overall Study|Withdrawal by Subject|17|||
156838397|NCT00602420|566161469|FG000|Overall Study|Adverse Event|1|||
156838398|NCT00602420|566161470|FG001|Overall Study|Adverse Event|0|||
156838399|NCT00649428|566161479|FG000|Overall Study|Adverse Event|2|||
156838400|NCT00649428|566161480|FG001|Overall Study|Adverse Event|2|||
156838401|NCT00649428|566161479|FG000|Overall Study|Withdrawal by Subject|6|||
156838402|NCT00649428|566161480|FG001|Overall Study|Withdrawal by Subject|6|||
156838403|NCT00649428|566161479|FG000|Overall Study|Lost to Follow-up|1|||
156838404|NCT00649428|566161480|FG001|Overall Study|Lost to Follow-up|3|||
156838405|NCT00649428|566161479|FG000|Overall Study|Insufficient manufacturing yield|5|||
156838406|NCT00649428|566161480|FG001|Overall Study|Insufficient manufacturing yield|1|||
156838407|NCT00649428|566161479|FG000|Overall Study|Protocol Violation|6|||
156838408|NCT00649428|566161480|FG001|Overall Study|Protocol Violation|2|||
156838409|NCT00649428|566161479|FG000|Overall Study|Physician Decision|0|||
156838410|NCT00649428|566161480|FG001|Overall Study|Physician Decision|1|||
156838411|NCT02315560|566161481|FG000|Overall Study|noncompliance by subjects|3|||
156838412|NCT02008227|566161482|FG000|Overall Study|Lost to Follow-up|7|||
156838413|NCT02008227|566161483|FG001|Overall Study|Lost to Follow-up|9|||
156838414|NCT02008227|566161482|FG000|Overall Study|Death|494|||
156838415|NCT02008227|566161483|FG001|Overall Study|Death|485|||
156838416|NCT02008227|566161482|FG000|Overall Study|Withdrawal by Subject|67|||
156838417|NCT02008227|566161483|FG001|Overall Study|Withdrawal by Subject|36|||
156838418|NCT02008227|566161482|FG000|Overall Study|Study Terminated By Sponsor|44|||
156838419|NCT02008227|566161483|FG001|Overall Study|Study Terminated By Sponsor|83|||
156838420|NCT04599465|566161484|FG000|Overall Study|Physician Decision|1|||
156838421|NCT04599465|566161484|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
156838422|NCT00742417|566161485|FG000|Randomized|Withdrawal by legal representative|0|||
156838423|NCT00742417|566161486|FG001|Randomized|Withdrawal by legal representative|1|||
156838424|NCT00742417|566161485|FG000|Randomized|Withdrawal by Subject|1|||
156838425|NCT00742417|566161486|FG001|Randomized|Withdrawal by Subject|0|||
156838426|NCT00742417|566161485|FG000|Randomized|Physician Decision|1|||
156838427|NCT00742417|566161486|FG001|Randomized|Physician Decision|0|||
156838428|NCT00742417|566161485|FG000|Intensive Period|Withdrawal by Subject|1|||
156838429|NCT00742417|566161486|FG001|Intensive Period|Withdrawal by Subject|1|||
156838430|NCT00742417|566161485|FG000|Intensive Period|Adverse Event|2|||
156838431|NCT00742417|566161486|FG001|Intensive Period|Adverse Event|0|||
156838432|NCT00965575|566161491|FG000|Overall Study|subject unwillingness to swallow study c|1|||
156838433|NCT00965575|566161492|FG001|Overall Study|subject unwillingness to swallow study c|0|||
156838434|NCT00306527|566161495|FG000|Overall Study|Lost to Follow-up|3|||
156838435|NCT00306527|566161496|FG001|Overall Study|Lost to Follow-up|4|||
156838436|NCT00306527|566161497|FG002|Overall Study|Lost to Follow-up|3|||
156838437|NCT00306527|566161498|FG003|Overall Study|Lost to Follow-up|0|||
156838438|NCT00306527|566161495|FG000|Overall Study|Withdrawal by Subject|2|||
156838439|NCT00306527|566161496|FG001|Overall Study|Withdrawal by Subject|3|||
156340346|NCT03706079|564344394|FG001|Predecessor Study|Withdrawal by Subject|15|||
156340347|NCT03706079|564344395|FG002|Predecessor Study|Withdrawal by Subject|0|||
156468266|NCT00622700|564810120|FG006|Core Treatment Period|Adverse Event|0|||
156468267|NCT00622700|564810114|FG000|Core Treatment Period|Lack of Efficacy|19|||
156838440|NCT00306527|566161497|FG002|Overall Study|Withdrawal by Subject|0|||
156838441|NCT00306527|566161498|FG003|Overall Study|Withdrawal by Subject|3|||
156340348|NCT03706079|564344396|FG003|Predecessor Study|Withdrawal by Subject|5|||
156340349|NCT03706079|564344397|FG004|Predecessor Study|Withdrawal by Subject|2|||
156340350|NCT03706079|564344398|FG005|Predecessor Study|Withdrawal by Subject|0|||
156340351|NCT03706079|564344393|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
156340352|NCT03706079|564344394|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
156340353|NCT03706079|564344395|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
156340354|NCT03706079|564344396|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
156340355|NCT03706079|564344397|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
156340356|NCT03706079|564344398|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
156340357|NCT03706079|564344393|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156340358|NCT03706079|564344394|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156468268|NCT00622700|564810115|FG001|Core Treatment Period|Lack of Efficacy|6|||
156838442|NCT00306527|566161495|FG000|Overall Study|Adverse Event|0|||
156838443|NCT00306527|566161496|FG001|Overall Study|Adverse Event|0|||
156838444|NCT00306527|566161497|FG002|Overall Study|Adverse Event|1|||
156838445|NCT00306527|566161498|FG003|Overall Study|Adverse Event|1|||
156838446|NCT00306527|566161495|FG000|Overall Study|Death|1|||
156838447|NCT00306527|566161496|FG001|Overall Study|Death|0|||
156838448|NCT00306527|566161497|FG002|Overall Study|Death|1|||
156838449|NCT00306527|566161498|FG003|Overall Study|Death|2|||
156838450|NCT02702180|566161499|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
156838451|NCT02702180|566161500|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
156340359|NCT03706079|564344395|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156340360|NCT03706079|564344396|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156340361|NCT03706079|564344397|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156340362|NCT03706079|564344398|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
156340363|NCT03706079|564344393|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
156340364|NCT03706079|564344394|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
156340365|NCT03706079|564344395|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
156340366|NCT03706079|564344396|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
156340367|NCT03706079|564344397|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
156340368|NCT03706079|564344398|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
156340369|NCT03706079|564344393|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
156340370|NCT03706079|564344394|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
156340371|NCT03706079|564344395|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
156340372|NCT03706079|564344396|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
156340373|NCT03706079|564344397|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
156340374|NCT03706079|564344398|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
156340375|NCT03706079|564344393|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
156340376|NCT03706079|564344394|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
156340377|NCT03706079|564344395|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
156340378|NCT03706079|564344396|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
156340379|NCT03706079|564344397|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
156340380|NCT03706079|564344398|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
156340381|NCT03706079|564344393|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
156340382|NCT03706079|564344394|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
156340383|NCT03706079|564344395|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
156340384|NCT03706079|564344396|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
156340385|NCT03706079|564344397|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
156340386|NCT03706079|564344398|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
156340387|NCT03706079|564344393|FG000|Long Term Extension (DESTINATION)|Death|8|||
156340388|NCT03706079|564344394|FG001|Long Term Extension (DESTINATION)|Death|2|||
156340389|NCT03706079|564344395|FG002|Long Term Extension (DESTINATION)|Death|2|||
156340390|NCT03706079|564344396|FG003|Long Term Extension (DESTINATION)|Death|1|||
156340391|NCT03706079|564344397|FG004|Long Term Extension (DESTINATION)|Death|0|||
156340392|NCT03706079|564344398|FG005|Long Term Extension (DESTINATION)|Death|0|||
156340393|NCT00801632|564344399|FG000|Overall Study|Re-transplant|1|||
156340394|NCT00915278|564344406|FG000|Overall Study|Death|1|||
156340395|NCT00915278|564344407|FG001|Overall Study|Death|0|||
156468269|NCT00622700|564810116|FG002|Core Treatment Period|Lack of Efficacy|12|||
156468270|NCT00622700|564810117|FG003|Core Treatment Period|Lack of Efficacy|0|||
156468271|NCT00622700|564810118|FG004|Core Treatment Period|Lack of Efficacy|0|||
156468272|NCT00622700|564810119|FG005|Core Treatment Period|Lack of Efficacy|0|||
156468273|NCT00622700|564810120|FG006|Core Treatment Period|Lack of Efficacy|0|||
156468274|NCT00622700|564810114|FG000|Core Treatment Period|Lost to Follow-up|1|||
156468275|NCT00622700|564810115|FG001|Core Treatment Period|Lost to Follow-up|1|||
156468276|NCT00622700|564810116|FG002|Core Treatment Period|Lost to Follow-up|1|||
156468277|NCT00622700|564810117|FG003|Core Treatment Period|Lost to Follow-up|0|||
156468278|NCT00622700|564810118|FG004|Core Treatment Period|Lost to Follow-up|0|||
156468279|NCT00622700|564810119|FG005|Core Treatment Period|Lost to Follow-up|0|||
156468280|NCT00622700|564810120|FG006|Core Treatment Period|Lost to Follow-up|0|||
156468281|NCT00622700|564810114|FG000|Core Treatment Period|Death|1|||
156468282|NCT00622700|564810115|FG001|Core Treatment Period|Death|0|||
156468283|NCT00622700|564810116|FG002|Core Treatment Period|Death|0|||
156468284|NCT00622700|564810117|FG003|Core Treatment Period|Death|0|||
156468285|NCT00622700|564810118|FG004|Core Treatment Period|Death|0|||
156468286|NCT00622700|564810119|FG005|Core Treatment Period|Death|0|||
156468287|NCT00622700|564810120|FG006|Core Treatment Period|Death|0|||
156468288|NCT00622700|564810114|FG000|Core Treatment Period|Progressive Disease|3|||
156838452|NCT02702180|566161501|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156838453|NCT02702180|566161499|FG000|Double-blind Treatment Period|Adverse Event|0|||
156340396|NCT00915278|564344408|FG002|Overall Study|Death|0|||
156340397|NCT00915278|564344409|FG003|Overall Study|Death|0|||
156340398|NCT00915278|564344410|FG004|Overall Study|Death|0|||
156340399|NCT00915278|564344411|FG005|Overall Study|Death|0|||
156340400|NCT00915278|564344406|FG000|Overall Study|Lost to Follow-up|0|||
156468289|NCT00622700|564810115|FG001|Core Treatment Period|Progressive Disease|1|||
156838454|NCT02702180|566161500|FG001|Double-blind Treatment Period|Adverse Event|0|||
156838455|NCT02702180|566161501|FG002|Double-blind Treatment Period|Adverse Event|1|||
156468290|NCT00622700|564810116|FG002|Core Treatment Period|Progressive Disease|0|||
156468291|NCT00622700|564810117|FG003|Core Treatment Period|Progressive Disease|0|||
156468292|NCT00622700|564810118|FG004|Core Treatment Period|Progressive Disease|0|||
156468293|NCT00622700|564810119|FG005|Core Treatment Period|Progressive Disease|0|||
156468294|NCT00622700|564810120|FG006|Core Treatment Period|Progressive Disease|0|||
156468295|NCT00622700|564810114|FG000|Core Treatment Period|Withdrawal by Subject|12|||
156468296|NCT00622700|564810115|FG001|Core Treatment Period|Withdrawal by Subject|18|||
156468297|NCT00622700|564810116|FG002|Core Treatment Period|Withdrawal by Subject|15|||
156468298|NCT00622700|564810117|FG003|Core Treatment Period|Withdrawal by Subject|0|||
156468299|NCT00622700|564810118|FG004|Core Treatment Period|Withdrawal by Subject|0|||
156468300|NCT00622700|564810119|FG005|Core Treatment Period|Withdrawal by Subject|0|||
156468301|NCT00622700|564810120|FG006|Core Treatment Period|Withdrawal by Subject|0|||
156468302|NCT00622700|564810114|FG000|Core Treatment Period|Other than specified above|2|||
156468303|NCT00622700|564810115|FG001|Core Treatment Period|Other than specified above|2|||
156468304|NCT00622700|564810116|FG002|Core Treatment Period|Other than specified above|5|||
156468305|NCT00622700|564810117|FG003|Core Treatment Period|Other than specified above|0|||
156468306|NCT00622700|564810118|FG004|Core Treatment Period|Other than specified above|0|||
156468307|NCT00622700|564810119|FG005|Core Treatment Period|Other than specified above|0|||
156468308|NCT00622700|564810120|FG006|Core Treatment Period|Other than specified above|0|||
156468309|NCT00622700|564810114|FG000|Extension Treatment Period|Adverse Event|0|||
156468310|NCT00622700|564810115|FG001|Extension Treatment Period|Adverse Event|0|||
156468311|NCT00622700|564810116|FG002|Extension Treatment Period|Adverse Event|0|||
156468312|NCT00622700|564810117|FG003|Extension Treatment Period|Adverse Event|5|||
156340401|NCT00915278|564344407|FG001|Overall Study|Lost to Follow-up|1|||
156468313|NCT00622700|564810118|FG004|Extension Treatment Period|Adverse Event|9|||
156468314|NCT00622700|564810119|FG005|Extension Treatment Period|Adverse Event|6|||
156468315|NCT00622700|564810120|FG006|Extension Treatment Period|Adverse Event|8|||
156468316|NCT00622700|564810114|FG000|Extension Treatment Period|Lack of Efficacy|0|||
156468317|NCT00622700|564810115|FG001|Extension Treatment Period|Lack of Efficacy|0|||
156468318|NCT00622700|564810116|FG002|Extension Treatment Period|Lack of Efficacy|0|||
156468319|NCT00622700|564810117|FG003|Extension Treatment Period|Lack of Efficacy|2|||
156468320|NCT00622700|564810118|FG004|Extension Treatment Period|Lack of Efficacy|8|||
156468321|NCT00622700|564810119|FG005|Extension Treatment Period|Lack of Efficacy|1|||
156468322|NCT00622700|564810120|FG006|Extension Treatment Period|Lack of Efficacy|9|||
156468323|NCT00622700|564810114|FG000|Extension Treatment Period|Protocol Violation|0|||
156468324|NCT00622700|564810115|FG001|Extension Treatment Period|Protocol Violation|0|||
156468325|NCT00622700|564810116|FG002|Extension Treatment Period|Protocol Violation|0|||
156468326|NCT00622700|564810117|FG003|Extension Treatment Period|Protocol Violation|0|||
156468327|NCT00622700|564810118|FG004|Extension Treatment Period|Protocol Violation|0|||
156468328|NCT00622700|564810119|FG005|Extension Treatment Period|Protocol Violation|2|||
156468329|NCT00622700|564810120|FG006|Extension Treatment Period|Protocol Violation|0|||
156468330|NCT00622700|564810114|FG000|Extension Treatment Period|Lost to Follow-up|0|||
156468331|NCT00622700|564810115|FG001|Extension Treatment Period|Lost to Follow-up|0|||
156468332|NCT00622700|564810116|FG002|Extension Treatment Period|Lost to Follow-up|0|||
156468333|NCT00622700|564810117|FG003|Extension Treatment Period|Lost to Follow-up|0|||
156468334|NCT00622700|564810118|FG004|Extension Treatment Period|Lost to Follow-up|1|||
156468335|NCT00622700|564810119|FG005|Extension Treatment Period|Lost to Follow-up|0|||
156468336|NCT00622700|564810120|FG006|Extension Treatment Period|Lost to Follow-up|0|||
156468337|NCT00622700|564810114|FG000|Extension Treatment Period|Progressive Disease|0|||
156468338|NCT00622700|564810115|FG001|Extension Treatment Period|Progressive Disease|0|||
156468339|NCT00622700|564810116|FG002|Extension Treatment Period|Progressive Disease|0|||
156468340|NCT00622700|564810117|FG003|Extension Treatment Period|Progressive Disease|1|||
156838456|NCT02702180|566161499|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
156838457|NCT02702180|566161500|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
156838458|NCT02702180|566161501|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
156838459|NCT02702180|566161499|FG000|Double-blind Treatment Period|Protocol Violation|0|||
156838460|NCT02702180|566161500|FG001|Double-blind Treatment Period|Protocol Violation|0|||
156838461|NCT02702180|566161501|FG002|Double-blind Treatment Period|Protocol Violation|2|||
156838462|NCT02702180|566161499|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
156838463|NCT02702180|566161500|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
156838464|NCT02702180|566161501|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
156838465|NCT02702180|566161499|FG000|Open-label Treatment Period|Withdrawn in error|0|||
156468341|NCT00622700|564810118|FG004|Extension Treatment Period|Progressive Disease|2|||
156468342|NCT00622700|564810119|FG005|Extension Treatment Period|Progressive Disease|0|||
156468343|NCT00622700|564810120|FG006|Extension Treatment Period|Progressive Disease|2|||
156468344|NCT00622700|564810114|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
156468345|NCT00622700|564810115|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
156468346|NCT00622700|564810116|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
156468347|NCT00622700|564810117|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
156468348|NCT00622700|564810118|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
156468349|NCT00622700|564810119|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
156468350|NCT00622700|564810120|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
156468351|NCT00622700|564810114|FG000|Extension Treatment Period|Missing|0|||
156468352|NCT00622700|564810115|FG001|Extension Treatment Period|Missing|0|||
156468353|NCT00622700|564810116|FG002|Extension Treatment Period|Missing|0|||
156468354|NCT00622700|564810117|FG003|Extension Treatment Period|Missing|2|||
156468355|NCT00622700|564810118|FG004|Extension Treatment Period|Missing|3|||
156838466|NCT02702180|566161500|FG001|Open-label Treatment Period|Withdrawn in error|0|||
156838467|NCT02702180|566161501|FG002|Open-label Treatment Period|Withdrawn in error|1|||
156838468|NCT02352753|566161502|FG000|6-Month Dosing Period|Decision by sponsor|2|||
156838469|NCT02352753|566161502|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
156838470|NCT02352753|566161502|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
156838471|NCT02352753|566161502|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
156838472|NCT02352753|566161502|FG000|3-Month Dosing Period|Decision by sponsor|14|||
156838473|NCT02352753|566161502|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
156838474|NCT00539305|566161503|FG000|Overall Study|Adverse Event|1|||
156838475|NCT00539305|566161504|FG001|Overall Study|Adverse Event|0|||
156468356|NCT00622700|564810119|FG005|Extension Treatment Period|Missing|1|||
156468357|NCT00622700|564810120|FG006|Extension Treatment Period|Missing|0|||
156468358|NCT00622700|564810114|FG000|Extension Treatment Period|Other than specified above|0|||
156468359|NCT00622700|564810115|FG001|Extension Treatment Period|Other than specified above|0|||
156468360|NCT00622700|564810116|FG002|Extension Treatment Period|Other than specified above|0|||
156468361|NCT00622700|564810117|FG003|Extension Treatment Period|Other than specified above|0|||
156468362|NCT00622700|564810118|FG004|Extension Treatment Period|Other than specified above|0|||
156468363|NCT00622700|564810119|FG005|Extension Treatment Period|Other than specified above|1|||
156468364|NCT00622700|564810120|FG006|Extension Treatment Period|Other than specified above|1|||
156468365|NCT02646618|564810123|FG000|Overall Study|Lost to Follow-up|10|||
156468366|NCT02646618|564810124|FG001|Overall Study|Lost to Follow-up|14|||
156468367|NCT04035447|564810125|FG000|Treatment Period|Lost to Follow-up|6|||
156468368|NCT04035447|564810126|FG001|Treatment Period|Lost to Follow-up|5|||
156468369|NCT04035447|564810125|FG000|Treatment Period|Physician Decision|0|||
156468370|NCT04035447|564810126|FG001|Treatment Period|Physician Decision|2|||
156468371|NCT00274261|564810127|FG000|Overall Study|Adverse Event|19|||
156468372|NCT00274261|564810128|FG001|Overall Study|Adverse Event|11|||
156468373|NCT00274261|564810127|FG000|Overall Study|Pregnancy|114|||
156468374|NCT00274261|564810128|FG001|Overall Study|Pregnancy|83|||
156468375|NCT00274261|564810127|FG000|Overall Study|Withdrawal by Subject|179|||
156468376|NCT00274261|564810128|FG001|Overall Study|Withdrawal by Subject|126|||
156468377|NCT00274261|564810127|FG000|Overall Study|Protocol Violation|71|||
156468378|NCT00274261|564810128|FG001|Overall Study|Protocol Violation|42|||
156468379|NCT00274261|564810127|FG000|Overall Study|Lost to Follow-up|106|||
156468380|NCT00274261|564810128|FG001|Overall Study|Lost to Follow-up|75|||
156468381|NCT03500549|564810129|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
156468382|NCT03500549|564810130|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
156468383|NCT03500549|564810129|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
156468384|NCT03500549|564810130|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
156468385|NCT05509816|564810131|FG000|Overall Study|Lost to Follow-up|1|||
156838476|NCT00539305|566161503|FG000|Overall Study|Substance Use|0|||
156838477|NCT00539305|566161504|FG001|Overall Study|Substance Use|1|||
156838478|NCT00539305|566161503|FG000|Overall Study|Withdrawal by Subject|0|||
156838479|NCT00539305|566161504|FG001|Overall Study|Withdrawal by Subject|1|||
156838480|NCT00679172|566161508|FG000|Overall Study|Non-compliance|1|||
156838481|NCT00679172|566161509|FG001|Overall Study|Non-compliance|1|||
156468386|NCT00589875|564810135|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
156468387|NCT00589875|564810135|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
156838482|NCT00679172|566161510|FG002|Overall Study|Non-compliance|0|||
156838483|NCT00679172|566161511|FG003|Overall Study|Non-compliance|1|||
156838484|NCT00679172|566161512|FG004|Overall Study|Non-compliance|0|||
156838485|NCT00679172|566161508|FG000|Overall Study|Other not specified|0|||
156838486|NCT00679172|566161509|FG001|Overall Study|Other not specified|0|||
156838487|NCT00679172|566161510|FG002|Overall Study|Other not specified|1|||
156838488|NCT00679172|566161511|FG003|Overall Study|Other not specified|0|||
156838489|NCT00679172|566161512|FG004|Overall Study|Other not specified|0|||
156838490|NCT00417963|566161513|FG000|Overall Study|Lost to Follow-up|3|||
156838491|NCT00417963|566161513|FG000|Overall Study|Withdrawal by Subject|18|||
156838492|NCT00417963|566161513|FG000|Overall Study|Death|17|||
156838493|NCT00417963|566161513|FG000|Overall Study|Study device could not be deployed|3|||
156838494|NCT00704288|566161516|FG000|Overall Treatment Period|Adverse Event|11|||
156838495|NCT00704288|566161517|FG001|Overall Treatment Period|Adverse Event|8|||
156838496|NCT00704288|566161518|FG002|Overall Treatment Period|Adverse Event|22|||
156838497|NCT00704288|566161516|FG000|Overall Treatment Period|Death|0|||
156838498|NCT00704288|566161517|FG001|Overall Treatment Period|Death|0|||
156838499|NCT00704288|566161518|FG002|Overall Treatment Period|Death|1|||
156838500|NCT00704288|566161516|FG000|Overall Treatment Period|Physician Decision|0|||
156838501|NCT00704288|566161517|FG001|Overall Treatment Period|Physician Decision|2|||
156838502|NCT00704288|566161518|FG002|Overall Treatment Period|Physician Decision|0|||
156838503|NCT00704288|566161516|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
156838504|NCT00704288|566161517|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
156838505|NCT00704288|566161518|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
156838506|NCT00704288|566161516|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
156838507|NCT00704288|566161517|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
156838508|NCT00704288|566161518|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
156838509|NCT00704288|566161516|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
156838510|NCT00704288|566161517|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
156838511|NCT00704288|566161518|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
156838512|NCT00704288|566161516|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
156838513|NCT00704288|566161517|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
156838514|NCT00704288|566161518|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
156838515|NCT00704288|566161516|FG000|Overall Treatment Period|Roll-over to another study|1|||
156838516|NCT00704288|566161517|FG001|Overall Treatment Period|Roll-over to another study|0|||
156838517|NCT00704288|566161518|FG002|Overall Treatment Period|Roll-over to another study|4|||
156838518|NCT00704288|566161516|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
156838519|NCT00704288|566161517|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
156838520|NCT00704288|566161518|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
156838521|NCT00704288|566161516|FG000|Extended Post Treatment Follow Up Period|Death|41|||
156838522|NCT00704288|566161517|FG001|Extended Post Treatment Follow Up Period|Death|50|||
156838523|NCT00704288|566161518|FG002|Extended Post Treatment Follow Up Period|Death|93|||
156838524|NCT00704288|566161516|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
156838525|NCT00704288|566161517|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
156838526|NCT00704288|566161518|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
156838527|NCT00704288|566161516|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
156838528|NCT00704288|566161517|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
156838529|NCT00704288|566161518|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
156838530|NCT00704288|566161516|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
156838531|NCT00704288|566161517|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
156838532|NCT00704288|566161518|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
156838533|NCT01055314|566161519|FG000|Overall Study|Adverse Event|7|||
156838534|NCT01055314|566161520|FG001|Overall Study|Adverse Event|4|||
156838535|NCT01055314|566161519|FG000|Overall Study|Death|2|||
156838536|NCT01055314|566161520|FG001|Overall Study|Death|1|||
156838537|NCT01055314|566161519|FG000|Overall Study|Lack of Efficacy|11|||
156340402|NCT00915278|564344408|FG002|Overall Study|Lost to Follow-up|0|||
156838538|NCT01055314|566161520|FG001|Overall Study|Lack of Efficacy|19|||
156838539|NCT01055314|566161519|FG000|Overall Study|Physician Decision|10|||
156838540|NCT01055314|566161520|FG001|Overall Study|Physician Decision|5|||
156838541|NCT01055314|566161519|FG000|Overall Study|Withdrawal by Subject|1|||
156340403|NCT00915278|564344409|FG003|Overall Study|Lost to Follow-up|0|||
156340404|NCT00915278|564344410|FG004|Overall Study|Lost to Follow-up|0|||
156340405|NCT00915278|564344411|FG005|Overall Study|Lost to Follow-up|0|||
156340406|NCT00915278|564344406|FG000|Overall Study|Withdrawal by Subject|0|||
156838542|NCT01055314|566161520|FG001|Overall Study|Withdrawal by Subject|0|||
156838543|NCT01055314|566161519|FG000|Overall Study|Ineligible|3|||
156838544|NCT01055314|566161520|FG001|Overall Study|Ineligible|5|||
156838545|NCT01055314|566161519|FG000|Overall Study|Refusal of further protocol therapy|10|||
156838546|NCT01055314|566161520|FG001|Overall Study|Refusal of further protocol therapy|4|||
156838547|NCT01055314|566161519|FG000|Overall Study|No treatment|1|||
156838548|NCT01055314|566161520|FG001|Overall Study|No treatment|0|||
156838549|NCT00434642|566161521|FG000|Blinded Treatment Phase|Adverse Event|12|||
156838550|NCT00434642|566161522|FG001|Blinded Treatment Phase|Adverse Event|58|||
156838551|NCT00434642|566161521|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
156838552|NCT00434642|566161522|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
156838553|NCT00434642|566161521|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
156468388|NCT02016872|564810138|FG000|Overall Study|Withdrawal by Subject|10|||
156468389|NCT02016872|564810138|FG000|Overall Study|Death Progression|2|||
156468390|NCT02016872|564810138|FG000|Overall Study|No FMISO scan|1|||
156468391|NCT02016872|564810138|FG000|Overall Study|Ineligible|2|||
156468392|NCT03222609|564810139|FG000|Overall Study|Withdrew consent|2|||
156468393|NCT03222609|564810140|FG001|Overall Study|Withdrew consent|3|||
156468394|NCT03222609|564810141|FG002|Overall Study|Withdrew consent|4|||
156468395|NCT03222609|564810142|FG003|Overall Study|Withdrew consent|2|||
156468396|NCT03222609|564810139|FG000|Overall Study|Lost to Follow-up|1|||
156468397|NCT03222609|564810140|FG001|Overall Study|Lost to Follow-up|0|||
156468398|NCT03222609|564810141|FG002|Overall Study|Lost to Follow-up|0|||
156468399|NCT03222609|564810142|FG003|Overall Study|Lost to Follow-up|0|||
156468400|NCT03222609|564810139|FG000|Overall Study|Death|16|||
156468401|NCT03222609|564810140|FG001|Overall Study|Death|13|||
156468402|NCT03222609|564810141|FG002|Overall Study|Death|9|||
156468403|NCT03222609|564810142|FG003|Overall Study|Death|6|||
156468404|NCT03222609|564810139|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
156468405|NCT03222609|564810140|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
156468406|NCT03222609|564810141|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
156468407|NCT03222609|564810142|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
156468408|NCT03789110|564810143|FG000|Overall Study|Adverse Event|2|||
156468409|NCT03789110|564810143|FG000|Overall Study|Physician Decision|1|||
156468410|NCT03789110|564810143|FG000|Overall Study|Withdrawal by Subject|2|||
156468411|NCT03789110|564810143|FG000|Overall Study|Lack of Efficacy|22|||
156468412|NCT03789110|564810143|FG000|Overall Study|still on treatment|3|||
156468413|NCT00545545|564810144|FG000|Overall Study|Progressive Neoplastic Disease|1|||
156468414|NCT00545545|564810145|FG001|Overall Study|Progressive Neoplastic Disease|5|||
156468415|NCT00545545|564810146|FG002|Overall Study|Progressive Neoplastic Disease|0|||
156468416|NCT00545545|564810147|FG003|Overall Study|Progressive Neoplastic Disease|4|||
156468417|NCT00545545|564810148|FG004|Overall Study|Progressive Neoplastic Disease|8|||
156468418|NCT00545545|564810149|FG005|Overall Study|Progressive Neoplastic Disease|7|||
156468419|NCT00545545|564810144|FG000|Overall Study|Withdrawal by Subject|0|||
156468420|NCT00545545|564810145|FG001|Overall Study|Withdrawal by Subject|1|||
156468421|NCT00545545|564810146|FG002|Overall Study|Withdrawal by Subject|0|||
156468422|NCT00545545|564810147|FG003|Overall Study|Withdrawal by Subject|0|||
156468423|NCT00545545|564810148|FG004|Overall Study|Withdrawal by Subject|0|||
156468424|NCT00545545|564810149|FG005|Overall Study|Withdrawal by Subject|0|||
156468425|NCT00545545|564810144|FG000|Overall Study|Physician Decision|1|||
156468426|NCT00545545|564810145|FG001|Overall Study|Physician Decision|0|||
156468427|NCT00545545|564810146|FG002|Overall Study|Physician Decision|0|||
156468428|NCT00545545|564810147|FG003|Overall Study|Physician Decision|0|||
156468429|NCT00545545|564810148|FG004|Overall Study|Physician Decision|0|||
156468430|NCT00545545|564810149|FG005|Overall Study|Physician Decision|1|||
156468431|NCT00545545|564810144|FG000|Overall Study|Irinotecan intolerance|1|||
156468432|NCT00545545|564810145|FG001|Overall Study|Irinotecan intolerance|1|||
156468433|NCT00545545|564810146|FG002|Overall Study|Irinotecan intolerance|0|||
156468434|NCT00545545|564810147|FG003|Overall Study|Irinotecan intolerance|0|||
156468435|NCT00545545|564810148|FG004|Overall Study|Irinotecan intolerance|0|||
156468436|NCT00545545|564810149|FG005|Overall Study|Irinotecan intolerance|0|||
156468437|NCT00545545|564810144|FG000|Overall Study|No target lesions to track post surgery|0|||
156468438|NCT00545545|564810145|FG001|Overall Study|No target lesions to track post surgery|0|||
156468439|NCT00545545|564810146|FG002|Overall Study|No target lesions to track post surgery|0|||
156468440|NCT00545545|564810147|FG003|Overall Study|No target lesions to track post surgery|0|||
156468441|NCT00545545|564810148|FG004|Overall Study|No target lesions to track post surgery|1|||
156838554|NCT00434642|566161522|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
156468442|NCT00545545|564810149|FG005|Overall Study|No target lesions to track post surgery|1|||
156468443|NCT05827068|564810159|FG000|Overall Study|Lost to Follow-up|1|||
156468444|NCT05827068|564810160|FG001|Overall Study|Lost to Follow-up|4|||
156468445|NCT05827068|564810161|FG002|Overall Study|Lost to Follow-up|1|||
156468446|NCT05827068|564810162|FG003|Overall Study|Lost to Follow-up|1|||
156468447|NCT05827068|564810163|FG004|Overall Study|Lost to Follow-up|2|||
156468448|NCT05827068|564810164|FG005|Overall Study|Lost to Follow-up|4|||
156468449|NCT05827068|564810165|FG006|Overall Study|Lost to Follow-up|1|||
156468450|NCT05827068|564810159|FG000|Overall Study|Withdrawal by Subject|4|||
156541403|NCT01538628|565074576|FG001|Overall Study|Withdrawal by Subject|1|||
156838555|NCT00434642|566161521|FG000|Blinded Treatment Phase|Physician Decision|19|||
156468451|NCT05827068|564810160|FG001|Overall Study|Withdrawal by Subject|0|||
156468452|NCT05827068|564810161|FG002|Overall Study|Withdrawal by Subject|1|||
156838556|NCT00434642|566161522|FG001|Blinded Treatment Phase|Physician Decision|27|||
156838557|NCT00434642|566161521|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
156838558|NCT00434642|566161522|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
156838559|NCT00434642|566161521|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
156838560|NCT00434642|566161522|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
156838561|NCT00434642|566161521|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
156838562|NCT00434642|566161522|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
156838563|NCT00434642|566161521|FG000|Open-label Treatment Phase|Adverse Event|0|||
156838564|NCT00434642|566161522|FG001|Open-label Treatment Phase|Adverse Event|5|||
156838565|NCT00434642|566161521|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
156838566|NCT00434642|566161522|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
156838567|NCT02241343|566161525|FG000|Overall Study|Adverse Event|1|||
156838568|NCT04680975|566161526|FG000|Overall Study|Adverse Event|3|||
156838569|NCT04680975|566161526|FG000|Overall Study|Death|1|||
156838570|NCT04680975|566161526|FG000|Overall Study|Progressive Disease|1|||
156838571|NCT04680975|566161526|FG000|Overall Study|Withdrawal by Subject|1|||
156838572|NCT00753454|566161527|FG000|Overall Study|Adverse Event|4|||
156838573|NCT00753454|566161527|FG000|Overall Study|Lack of Efficacy|1|||
156838574|NCT00753454|566161527|FG000|Overall Study|Lost to Follow-up|3|||
156838575|NCT00753454|566161527|FG000|Overall Study|Withdrawal by Subject|5|||
156838576|NCT00753454|566161527|FG000|Overall Study|Investigator Decision|1|||
156838577|NCT03927144|566161528|FG000|Core Phase|Adverse Event|9|||
156468453|NCT05827068|564810162|FG003|Overall Study|Withdrawal by Subject|2|||
156838578|NCT03927144|566161529|FG001|Core Phase|Adverse Event|5|||
156838579|NCT03927144|566161528|FG000|Core Phase|Lost to Follow-up|3|||
156838580|NCT03927144|566161529|FG001|Core Phase|Lost to Follow-up|2|||
156838581|NCT03927144|566161528|FG000|Core Phase|New Therapy for Study Indication|0|||
156838582|NCT03927144|566161529|FG001|Core Phase|New Therapy for Study Indication|1|||
156838583|NCT03927144|566161528|FG000|Core Phase|No Longer Clinically Benefiting|4|||
156838584|NCT03927144|566161529|FG001|Core Phase|No Longer Clinically Benefiting|4|||
156838585|NCT03927144|566161528|FG000|Core Phase|Physician Decision|2|||
156468454|NCT05827068|564810163|FG004|Overall Study|Withdrawal by Subject|3|||
156838586|NCT03927144|566161529|FG001|Core Phase|Physician Decision|8|||
156838587|NCT03927144|566161528|FG000|Core Phase|Protocol Violation|2|||
156838588|NCT03927144|566161529|FG001|Core Phase|Protocol Violation|2|||
156838589|NCT03927144|566161528|FG000|Core Phase|Withdrawal by Subject|16|||
156838590|NCT03927144|566161529|FG001|Core Phase|Withdrawal by Subject|40|||
156838591|NCT03927144|566161528|FG000|Extension Phase|Adverse Event|2|||
156838592|NCT03927144|566161529|FG001|Extension Phase|Adverse Event|1|||
156468455|NCT05827068|564810164|FG005|Overall Study|Withdrawal by Subject|0|||
156468456|NCT05827068|564810165|FG006|Overall Study|Withdrawal by Subject|1|||
156468457|NCT05827068|564810159|FG000|Overall Study|Physician Decision|0|||
156468458|NCT05827068|564810160|FG001|Overall Study|Physician Decision|0|||
156468459|NCT05827068|564810161|FG002|Overall Study|Physician Decision|0|||
156468460|NCT05827068|564810162|FG003|Overall Study|Physician Decision|0|||
156468461|NCT05827068|564810163|FG004|Overall Study|Physician Decision|1|||
156468462|NCT05827068|564810164|FG005|Overall Study|Physician Decision|0|||
156468463|NCT05827068|564810165|FG006|Overall Study|Physician Decision|1|||
156468464|NCT05827068|564810159|FG000|Overall Study|Other Than Specified|0|||
156468465|NCT05827068|564810160|FG001|Overall Study|Other Than Specified|1|||
156468466|NCT05827068|564810161|FG002|Overall Study|Other Than Specified|0|||
156468467|NCT05827068|564810162|FG003|Overall Study|Other Than Specified|0|||
156468468|NCT05827068|564810163|FG004|Overall Study|Other Than Specified|0|||
156468469|NCT05827068|564810164|FG005|Overall Study|Other Than Specified|0|||
156468470|NCT05827068|564810165|FG006|Overall Study|Other Than Specified|0|||
156468471|NCT05786612|564810170|FG000|Overall Study|Adverse Event|1|||
156468472|NCT05786612|564810171|FG001|Overall Study|Adverse Event|2|||
156468473|NCT05786612|564810170|FG000|Overall Study|one screening failure|0|||
156468474|NCT05786612|564810171|FG001|Overall Study|one screening failure|2|||
156468475|NCT05630833|564810176|FG000|Overall Study|Adverse Event|3|||
156838593|NCT03927144|566161528|FG000|Extension Phase|No longer clinically benefiting|4|||
156838594|NCT03927144|566161529|FG001|Extension Phase|No longer clinically benefiting|5|||
156838595|NCT03927144|566161528|FG000|Extension Phase|Pregnancy|1|||
156838596|NCT03927144|566161529|FG001|Extension Phase|Pregnancy|0|||
156838597|NCT03927144|566161528|FG000|Extension Phase|Protocol Violation|0|||
156468476|NCT05630833|564810177|FG001|Overall Study|Adverse Event|0|||
156468477|NCT05630833|564810176|FG000|Overall Study|Lack of Efficacy|0|||
156468478|NCT05630833|564810177|FG001|Overall Study|Lack of Efficacy|1|||
156838598|NCT03927144|566161529|FG001|Extension Phase|Protocol Violation|1|||
156838599|NCT03927144|566161528|FG000|Extension Phase|Withdrawal by Subject|8|||
156838600|NCT03927144|566161529|FG001|Extension Phase|Withdrawal by Subject|3|||
156838601|NCT03909152|566161530|FG000|Overall Study|Adverse Event|14|||
156838602|NCT03909152|566161531|FG001|Overall Study|Adverse Event|5|||
156838603|NCT03909152|566161532|FG002|Overall Study|Adverse Event|1|||
156838604|NCT03909152|566161533|FG003|Overall Study|Adverse Event|14|||
156468479|NCT05630833|564810176|FG000|Overall Study|Lost to Follow-up|1|||
156468480|NCT05630833|564810177|FG001|Overall Study|Lost to Follow-up|0|||
156838605|NCT02702414|566161538|FG000|Overall Study|Death|96|||
156838606|NCT02702414|566161539|FG001|Overall Study|Death|42|||
156838607|NCT02702414|566161538|FG000|Overall Study|Lost to Follow-up|0|||
156838608|NCT02702414|566161539|FG001|Overall Study|Lost to Follow-up|1|||
156838609|NCT02702414|566161538|FG000|Overall Study|Withdrawal by Subject|0|||
156838610|NCT02702414|566161539|FG001|Overall Study|Withdrawal by Subject|1|||
156838611|NCT02702414|566161538|FG000|Overall Study|Protocol Violation|1|||
156838612|NCT02702414|566161539|FG001|Overall Study|Protocol Violation|0|||
156838613|NCT02702414|566161538|FG000|Overall Study|Sponsor Decision|8|||
156838614|NCT02702414|566161539|FG001|Overall Study|Sponsor Decision|7|||
156838615|NCT04541628|566161540|FG000|Overall Study|Study Terminated|1|||
156838616|NCT04541628|566161541|FG001|Overall Study|Study Terminated|1|||
156838617|NCT04541628|566161542|FG002|Overall Study|Study Terminated|1|||
156838618|NCT02271945|566161546|FG000|Overall Study|Death|3|||
156838619|NCT02271945|566161547|FG001|Overall Study|Death|3|||
156838620|NCT02271945|566161546|FG000|Overall Study|Withdrawal by Subject|1|||
156838621|NCT02271945|566161547|FG001|Overall Study|Withdrawal by Subject|1|||
156838622|NCT02271945|566161546|FG000|Overall Study|Other|1|||
156838623|NCT02271945|566161547|FG001|Overall Study|Other|1|||
156838624|NCT04099511|566161549|FG000|Overall Study|Lost to Follow-up|2|||
156838625|NCT04099511|566161550|FG001|Overall Study|Lost to Follow-up|2|||
156838626|NCT04099511|566161549|FG000|Overall Study|Withdrawal by Subject|8|||
156838627|NCT04099511|566161550|FG001|Overall Study|Withdrawal by Subject|4|||
156838628|NCT04369950|566161551|FG000|Overall Study|Protocol Violation|2|||
156838629|NCT04369950|566161552|FG001|Overall Study|Protocol Violation|2|||
156468481|NCT05630833|564810176|FG000|Overall Study|Withdrawal by Subject|3|||
156468482|NCT05630833|564810177|FG001|Overall Study|Withdrawal by Subject|1|||
156468483|NCT05704725|564810178|FG000|Overall Study|Lost to Follow-up|0|||
156468484|NCT05704725|564810179|FG001|Overall Study|Lost to Follow-up|1|||
156468485|NCT05704725|564810178|FG000|Overall Study|Withdrawal by Subject|1|||
156468486|NCT05704725|564810179|FG001|Overall Study|Withdrawal by Subject|0|||
156468487|NCT00490139|564810180|FG000|Overall Study|Lost to Follow-up|249|||
156468488|NCT00490139|564810181|FG001|Overall Study|Lost to Follow-up|216|||
156468489|NCT00490139|564810182|FG002|Overall Study|Lost to Follow-up|205|||
156468490|NCT00490139|564810183|FG003|Overall Study|Lost to Follow-up|229|||
156468491|NCT00490139|564810180|FG000|Overall Study|Withdrawal by Subject|333|||
156468492|NCT00490139|564810181|FG001|Overall Study|Withdrawal by Subject|322|||
156468493|NCT00490139|564810182|FG002|Overall Study|Withdrawal by Subject|396|||
156468494|NCT00490139|564810183|FG003|Overall Study|Withdrawal by Subject|295|||
156468495|NCT00490139|564810180|FG000|Overall Study|Patient did not sign ICF 12|169|||
156468496|NCT00490139|564810181|FG001|Overall Study|Patient did not sign ICF 12|176|||
156468497|NCT00490139|564810182|FG002|Overall Study|Patient did not sign ICF 12|139|||
156468498|NCT00490139|564810183|FG003|Overall Study|Patient did not sign ICF 12|167|||
156468499|NCT00490139|564810180|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
156468500|NCT00490139|564810181|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
156468501|NCT00490139|564810182|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
156468502|NCT00490139|564810183|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
156468503|NCT00490139|564810180|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
156468504|NCT00490139|564810181|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
156468505|NCT00490139|564810182|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
156468506|NCT00490139|564810183|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
156468507|NCT00490139|564810180|FG000|Overall Study|Other reasons as defined per protocol|98|||
156468508|NCT00490139|564810181|FG001|Overall Study|Other reasons as defined per protocol|84|||
156468509|NCT00490139|564810182|FG002|Overall Study|Other reasons as defined per protocol|82|||
156468510|NCT00490139|564810183|FG003|Overall Study|Other reasons as defined per protocol|105|||
156468511|NCT03664804|564810185|FG000|Overall Study|Withdrawal by Subject|7|||
156468512|NCT05529992|564810186|FG000|Overall Study|Withdrawal by Subject|1|||
156838630|NCT02473367|566161553|FG000|Wait 1|Withdrawal by Subject|1|||
156838631|NCT02473367|566161553|FG000|Period 4|Lost to Follow-up|1|||
156468513|NCT06140290|564810187|FG000|Period 1|Adverse Event|1|||
156838632|NCT04816721|566161554|FG000|Overall Study|Withdrawal by Subject|0|||
156838633|NCT04816721|566161555|FG001|Overall Study|Withdrawal by Subject|2|||
156838634|NCT04816721|566161556|FG002|Overall Study|Withdrawal by Subject|0|||
156468514|NCT06140290|564810188|FG001|Period 1|Adverse Event|0|||
156468515|NCT06140290|564810187|FG000|Period 2|Assigned but not treated|0|||
156468516|NCT06140290|564810188|FG001|Period 2|Assigned but not treated|1|||
156541404|NCT01538628|565074575|FG000|Overall Study|Lost to Follow-up|0|||
156838635|NCT04816721|566161557|FG003|Overall Study|Withdrawal by Subject|1|||
156838636|NCT04816721|566161558|FG004|Overall Study|Withdrawal by Subject|1|||
156838637|NCT04816721|566161559|FG005|Overall Study|Withdrawal by Subject|0|||
156838638|NCT04816721|566161560|FG006|Overall Study|Withdrawal by Subject|0|||
156838639|NCT04816721|566161561|FG007|Overall Study|Withdrawal by Subject|0|||
156468517|NCT06140290|564810187|FG000|Period 2|Withdrawal by Subject|0|||
156468518|NCT06140290|564810188|FG001|Period 2|Withdrawal by Subject|1|||
156468519|NCT02798471|564810191|FG000|Overall Study|Adverse Event|7|||
156838640|NCT04816721|566161554|FG000|Overall Study|Miscellaneous|0|||
156468520|NCT02798471|564810192|FG001|Overall Study|Adverse Event|2|||
156468521|NCT02798471|564810191|FG000|Overall Study|Physician Decision|3|||
156468522|NCT02798471|564810192|FG001|Overall Study|Physician Decision|7|||
156468523|NCT02798471|564810191|FG000|Overall Study|Death|2|||
156468524|NCT02798471|564810192|FG001|Overall Study|Death|3|||
156468525|NCT02798471|564810191|FG000|Overall Study|Lost to Follow-up|0|||
156468526|NCT02798471|564810192|FG001|Overall Study|Lost to Follow-up|1|||
156468527|NCT02798471|564810191|FG000|Overall Study|Other|5|||
156468528|NCT02798471|564810192|FG001|Overall Study|Other|3|||
156468529|NCT02798471|564810191|FG000|Overall Study|Subject withdrew consent|0|||
156468530|NCT02798471|564810192|FG001|Overall Study|Subject withdrew consent|6|||
156468531|NCT02798471|564810191|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
156468532|NCT02798471|564810192|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
156468533|NCT02798471|564810191|FG000|Overall Study|Randomized, but not treated|0|||
156468534|NCT02798471|564810192|FG001|Overall Study|Randomized, but not treated|2|||
156468535|NCT06056310|564811520|FG000|Overall Study|Other Reasons|2|||
156468536|NCT06056310|564811520|FG000|Overall Study|Sponsor Request|16|||
156468537|NCT03758638|564811525|FG000|Overall Study|Pregnancy|17|||
156468538|NCT03758638|564811526|FG001|Overall Study|Pregnancy|25|||
156468539|NCT03758638|564811525|FG000|Overall Study|Lost to Follow-up|60|||
156468540|NCT03758638|564811526|FG001|Overall Study|Lost to Follow-up|54|||
156468541|NCT03758638|564811525|FG000|Overall Study|Protocol Violation|2|||
156468542|NCT03758638|564811526|FG001|Overall Study|Protocol Violation|0|||
156468543|NCT03758638|564811525|FG000|Overall Study|Withdrawal by Subject|8|||
156468544|NCT03758638|564811526|FG001|Overall Study|Withdrawal by Subject|2|||
156468545|NCT03758638|564811525|FG000|Overall Study|Providers not included in the primary outcome.|183|||
156468546|NCT03758638|564811526|FG001|Overall Study|Providers not included in the primary outcome.|128|||
156468547|NCT00372775|564811528|FG000|Overall Study|Adverse Event|8|||
156468548|NCT00372775|564811528|FG000|Overall Study|Death|15|||
156468549|NCT00372775|564811528|FG000|Overall Study|Objective progression or relapse|30|||
156468550|NCT00372775|564811528|FG000|Overall Study|Global deterioration of health status|6|||
156468551|NCT00372775|564811528|FG000|Overall Study|Withdrawal by Subject|1|||
156468552|NCT00372775|564811528|FG000|Overall Study|Other|1|||
156468553|NCT00372775|564811528|FG000|Overall Study|Not Treated|2|||
156468554|NCT00790569|564811529|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
156468555|NCT00790569|564811530|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
156468556|NCT00790569|564811531|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
156468557|NCT00790569|564811529|FG000|End of Treatment (6 Month Interview)|Death|0|||
156468558|NCT00790569|564811530|FG001|End of Treatment (6 Month Interview)|Death|2|||
156468559|NCT00790569|564811531|FG002|End of Treatment (6 Month Interview)|Death|1|||
156468560|NCT00790569|564811529|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
156468561|NCT00790569|564811530|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
156468562|NCT00790569|564811531|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
156468563|NCT00790569|564811529|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
156468564|NCT00790569|564811530|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
156468565|NCT00790569|564811531|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
156468566|NCT00790569|564811529|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
156468567|NCT00790569|564811530|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
156468568|NCT00790569|564811531|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
156468569|NCT00790569|564811529|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
156468570|NCT00790569|564811530|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
156468571|NCT00790569|564811531|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
156468572|NCT01627561|564811532|FG000|Overall Study|Lost to Follow-up|1|||
156468573|NCT01627561|564811533|FG001|Overall Study|Lost to Follow-up|0|||
156468574|NCT01627561|564811532|FG000|Overall Study|Withdrawal by Subject|0|||
156468575|NCT01627561|564811533|FG001|Overall Study|Withdrawal by Subject|1|||
156468576|NCT01627561|564811532|FG000|Overall Study|Migrated/moved from study area|0|||
156468577|NCT01627561|564811533|FG001|Overall Study|Migrated/moved from study area|2|||
156468578|NCT00724126|564811534|FG000|Overall Study|Adverse Event|2|||
156468579|NCT00724126|564811535|FG001|Overall Study|Adverse Event|0|||
156468580|NCT00724126|564811534|FG000|Overall Study|Withdrawal by Subject|8|||
156468581|NCT00724126|564811535|FG001|Overall Study|Withdrawal by Subject|6|||
156468582|NCT00724126|564811534|FG000|Overall Study|Lost to Follow-up|6|||
156468583|NCT00724126|564811535|FG001|Overall Study|Lost to Follow-up|6|||
156468584|NCT00724126|564811534|FG000|Overall Study|Noncompliance|2|||
156468585|NCT00724126|564811535|FG001|Overall Study|Noncompliance|1|||
156468586|NCT00724126|564811534|FG000|Overall Study|Subject randomized although ineligible|1|||
156468587|NCT00724126|564811535|FG001|Overall Study|Subject randomized although ineligible|1|||
156468588|NCT00724126|564811534|FG000|Overall Study|Subject had to leave vicinity of site|0|||
156468589|NCT00724126|564811535|FG001|Overall Study|Subject had to leave vicinity of site|1|||
156468590|NCT01579318|564811536|FG000|Overall Study|Disease Progression|1|||
156468591|NCT03601715|564811539|FG000|Second Intervention|Lost to Follow-up|1|||
156838641|NCT04816721|566161555|FG001|Overall Study|Miscellaneous|0|||
156838642|NCT04816721|566161556|FG002|Overall Study|Miscellaneous|0|||
156838643|NCT04816721|566161557|FG003|Overall Study|Miscellaneous|0|||
156838644|NCT04816721|566161558|FG004|Overall Study|Miscellaneous|0|||
156838645|NCT04816721|566161559|FG005|Overall Study|Miscellaneous|1|||
156838646|NCT04816721|566161560|FG006|Overall Study|Miscellaneous|0|||
156838647|NCT04816721|566161561|FG007|Overall Study|Miscellaneous|0|||
156838648|NCT04816721|566161554|FG000|Overall Study|Lost to Follow-up|0|||
156838649|NCT04816721|566161555|FG001|Overall Study|Lost to Follow-up|0|||
156838650|NCT04816721|566161556|FG002|Overall Study|Lost to Follow-up|0|||
156838651|NCT04816721|566161557|FG003|Overall Study|Lost to Follow-up|1|||
156838652|NCT04816721|566161558|FG004|Overall Study|Lost to Follow-up|0|||
156838653|NCT04816721|566161559|FG005|Overall Study|Lost to Follow-up|0|||
156838654|NCT04816721|566161560|FG006|Overall Study|Lost to Follow-up|0|||
156838655|NCT04816721|566161561|FG007|Overall Study|Lost to Follow-up|0|||
156838656|NCT00975143|566161566|FG000|Overall Study|Adverse Event|19|||
156838657|NCT00975143|566161567|FG001|Overall Study|Adverse Event|15|||
156838658|NCT00975143|566161566|FG000|Overall Study|Withdrawal by Subject|15|||
156838659|NCT00975143|566161567|FG001|Overall Study|Withdrawal by Subject|15|||
156838660|NCT00975143|566161566|FG000|Overall Study|Lost to Follow-up|20|||
156838661|NCT00975143|566161567|FG001|Overall Study|Lost to Follow-up|16|||
156838662|NCT00975143|566161566|FG000|Overall Study|Non-compliance|5|||
156838663|NCT00975143|566161567|FG001|Overall Study|Non-compliance|8|||
156838664|NCT00975143|566161566|FG000|Overall Study|Physician Decision|1|||
156838665|NCT00975143|566161567|FG001|Overall Study|Physician Decision|2|||
156838666|NCT00975143|566161566|FG000|Overall Study|Details not available|10|||
156838667|NCT00975143|566161567|FG001|Overall Study|Details not available|4|||
156838668|NCT02345330|566161569|FG000|Overall Study|Death|1|||
156838669|NCT02345330|566161569|FG000|Overall Study|Progressive Disease|2|||
156838670|NCT00494507|566161572|FG000|Double-Blind Phase|Adverse Event|2|||
156838671|NCT00494507|566161573|FG001|Double-Blind Phase|Adverse Event|0|||
156838672|NCT00494507|566161574|FG002|Double-Blind Phase|Adverse Event|1|||
156838673|NCT00494507|566161575|FG003|Double-Blind Phase|Adverse Event|0|||
156838674|NCT00494507|566161572|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
156838675|NCT00494507|566161573|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
156838676|NCT00494507|566161574|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156838677|NCT00494507|566161575|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156838678|NCT00494507|566161572|FG000|Double-Blind Phase|Subject Non-compliance|0|||
156838679|NCT00494507|566161573|FG001|Double-Blind Phase|Subject Non-compliance|0|||
156838680|NCT00494507|566161574|FG002|Double-Blind Phase|Subject Non-compliance|1|||
156838681|NCT00494507|566161575|FG003|Double-Blind Phase|Subject Non-compliance|0|||
156838682|NCT00494507|566161572|FG000|Double-Blind Phase|Negative DNA test|0|||
156838683|NCT00494507|566161573|FG001|Double-Blind Phase|Negative DNA test|0|||
156838684|NCT00494507|566161574|FG002|Double-Blind Phase|Negative DNA test|0|||
156838685|NCT00494507|566161575|FG003|Double-Blind Phase|Negative DNA test|1|||
156838686|NCT00494507|566161572|FG000|Open-Label Phase|Adverse Event|0|||
156838687|NCT00494507|566161573|FG001|Open-Label Phase|Adverse Event|1|||
156838688|NCT00494507|566161574|FG002|Open-Label Phase|Adverse Event|5|||
156838689|NCT00494507|566161575|FG003|Open-Label Phase|Adverse Event|3|||
156838690|NCT00494507|566161572|FG000|Open-Label Phase|Worsening Disease|0|||
156838691|NCT00494507|566161573|FG001|Open-Label Phase|Worsening Disease|0|||
156838692|NCT00494507|566161574|FG002|Open-Label Phase|Worsening Disease|0|||
156838693|NCT00494507|566161575|FG003|Open-Label Phase|Worsening Disease|2|||
156838694|NCT00454181|566161576|FG000|Overall Study|Adverse Event|1|||
156838695|NCT00454181|566161577|FG001|Overall Study|Adverse Event|1|||
156838696|NCT00454181|566161576|FG000|Overall Study|Lost to Follow-up|11|||
156838697|NCT00454181|566161577|FG001|Overall Study|Lost to Follow-up|1|||
156838698|NCT00454181|566161576|FG000|Overall Study|Protocol Violation|1|||
156838699|NCT00454181|566161577|FG001|Overall Study|Protocol Violation|1|||
156838700|NCT00454181|566161576|FG000|Overall Study|Withdrawal by Subject|2|||
156838701|NCT00454181|566161577|FG001|Overall Study|Withdrawal by Subject|0|||
156838702|NCT03729245|566161578|FG000|Overall Study|Lost to Follow-up|5|||
156838703|NCT03729245|566161579|FG001|Overall Study|Lost to Follow-up|6|||
156838704|NCT03729245|566161578|FG000|Overall Study|Withdrawal by Subject|16|||
156838705|NCT03729245|566161579|FG001|Overall Study|Withdrawal by Subject|19|||
156838706|NCT03729245|566161578|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
156838707|NCT03729245|566161579|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
156838708|NCT02096263|566161580|FG000|Overall Study|Adverse Event|1|||
156838709|NCT02096263|566161581|FG001|Overall Study|Adverse Event|0|||
156838710|NCT02096263|566161582|FG002|Overall Study|Adverse Event|1|||
156838711|NCT02096263|566161580|FG000|Overall Study|Lost to Follow-up|14|||
156838712|NCT02096263|566161581|FG001|Overall Study|Lost to Follow-up|18|||
156838713|NCT02096263|566161582|FG002|Overall Study|Lost to Follow-up|15|||
156838714|NCT02096263|566161580|FG000|Overall Study|Other|7|||
156838715|NCT02096263|566161581|FG001|Overall Study|Other|9|||
156838716|NCT02096263|566161582|FG002|Overall Study|Other|6|||
156838717|NCT02096263|566161580|FG000|Overall Study|Sponsor study termination|0|||
156838718|NCT02096263|566161581|FG001|Overall Study|Sponsor study termination|0|||
156838719|NCT02096263|566161582|FG002|Overall Study|Sponsor study termination|1|||
156838720|NCT02096263|566161580|FG000|Overall Study|Protocol Violation|7|||
156838721|NCT02096263|566161581|FG001|Overall Study|Protocol Violation|2|||
156838722|NCT02096263|566161582|FG002|Overall Study|Protocol Violation|8|||
156838723|NCT02096263|566161580|FG000|Overall Study|Withdrawal by Subject|5|||
156838724|NCT02096263|566161581|FG001|Overall Study|Withdrawal by Subject|7|||
156838725|NCT02096263|566161582|FG002|Overall Study|Withdrawal by Subject|8|||
156838726|NCT03178669|566161583|FG000|Overall Study|Adverse Event|4|||
156838727|NCT03178669|566161584|FG001|Overall Study|Adverse Event|1|||
156838728|NCT03178669|566161585|FG002|Overall Study|Adverse Event|4|||
156838729|NCT03178669|566161586|FG003|Overall Study|Adverse Event|2|||
156838730|NCT03178669|566161587|FG004|Overall Study|Adverse Event|2|||
156838731|NCT03178669|566161583|FG000|Overall Study|Lack of Efficacy|0|||
156838732|NCT03178669|566161584|FG001|Overall Study|Lack of Efficacy|0|||
156838733|NCT03178669|566161585|FG002|Overall Study|Lack of Efficacy|2|||
156838734|NCT03178669|566161586|FG003|Overall Study|Lack of Efficacy|0|||
156838735|NCT03178669|566161587|FG004|Overall Study|Lack of Efficacy|1|||
156468592|NCT03601715|564811540|FG001|Second Intervention|Lost to Follow-up|1|||
156468593|NCT03601715|564811541|FG002|Second Intervention|Lost to Follow-up|0|||
156468594|NCT02347332|564811542|FG000|Overall Study|Not treated|5|||
156468595|NCT02347332|564811543|FG001|Overall Study|Not treated|2|||
156468596|NCT02347332|564811542|FG000|Overall Study|Progressive disease|141|||
156468597|NCT02347332|564811543|FG001|Overall Study|Progressive disease|159|||
156468598|NCT02347332|564811542|FG000|Overall Study|Adverse Event|50|||
156468599|NCT02347332|564811543|FG001|Overall Study|Adverse Event|41|||
156468600|NCT02347332|564811542|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
156468601|NCT02347332|564811543|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
156468602|NCT02347332|564811542|FG000|Overall Study|Protocol Violation|1|||
156468603|NCT02347332|564811543|FG001|Overall Study|Protocol Violation|1|||
156468604|NCT02347332|564811542|FG000|Overall Study|Lost to Follow-up|2|||
156468605|NCT02347332|564811543|FG001|Overall Study|Lost to Follow-up|1|||
156468606|NCT02347332|564811542|FG000|Overall Study|Physician Decision|4|||
156468607|NCT02347332|564811543|FG001|Overall Study|Physician Decision|3|||
156468608|NCT02347332|564811542|FG000|Overall Study|Withdrawal by Subject|20|||
156468609|NCT02347332|564811543|FG001|Overall Study|Withdrawal by Subject|14|||
156468610|NCT02347332|564811542|FG000|Overall Study|Protocol requirement|1|||
156468611|NCT02347332|564811543|FG001|Overall Study|Protocol requirement|1|||
156468612|NCT02347332|564811542|FG000|Overall Study|Switch Post-Trial program|0|||
156468613|NCT02347332|564811543|FG001|Overall Study|Switch Post-Trial program|1|||
156468614|NCT01478594|564811544|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
156468615|NCT01478594|564811545|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
156468616|NCT01478594|564811544|FG000|Overall Study|Death|45|||
156468617|NCT01478594|564811545|FG001|Overall Study|Death|18|||
156468618|NCT01478594|564811544|FG000|Overall Study|Lost to Follow-up|3|||
156468619|NCT01478594|564811545|FG001|Overall Study|Lost to Follow-up|1|||
156468620|NCT01478594|564811544|FG000|Overall Study|Withdrawal by Subject|9|||
156468621|NCT01478594|564811545|FG001|Overall Study|Withdrawal by Subject|3|||
156468622|NCT01478594|564811544|FG000|Overall Study|Study Closed by Sponsor|8|||
156468623|NCT01478594|564811545|FG001|Overall Study|Study Closed by Sponsor|5|||
156468624|NCT01313884|564811546|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
156468625|NCT01970007|564811547|FG000|Overall Study|Death|5|||
156468626|NCT01970007|564811547|FG000|Overall Study|Withdrawal by Subject|23|||
156468627|NCT01970007|564811547|FG000|Overall Study|Lost to Follow-up|24|||
156468628|NCT01970007|564811547|FG000|Overall Study|"Other endpoint"|3|||
156468629|NCT00776009|564811548|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
156468630|NCT00776009|564811549|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
156468631|NCT00776009|564811550|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
156468632|NCT00776009|564811551|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
156468633|NCT00776009|564811552|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
156468634|NCT00776009|564811553|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
156468635|NCT00776009|564811548|FG000|Period 1: First Intervention|Protocol Violation|0|||
156468636|NCT00776009|564811549|FG001|Period 1: First Intervention|Protocol Violation|1|||
156468637|NCT00776009|564811550|FG002|Period 1: First Intervention|Protocol Violation|0|||
156468638|NCT00776009|564811551|FG003|Period 1: First Intervention|Protocol Violation|0|||
156468639|NCT00776009|564811552|FG004|Period 1: First Intervention|Protocol Violation|1|||
156468640|NCT00776009|564811553|FG005|Period 1: First Intervention|Protocol Violation|0|||
156468641|NCT00776009|564811548|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
156468642|NCT00776009|564811549|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
156468643|NCT00776009|564811550|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
156838736|NCT03178669|566161583|FG000|Overall Study|Physician Decision|0|||
156838737|NCT03178669|566161584|FG001|Overall Study|Physician Decision|0|||
156468644|NCT00776009|564811551|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
156838738|NCT03178669|566161585|FG002|Overall Study|Physician Decision|0|||
156838739|NCT03178669|566161586|FG003|Overall Study|Physician Decision|0|||
156838740|NCT03178669|566161587|FG004|Overall Study|Physician Decision|1|||
156468645|NCT00776009|564811552|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
156468646|NCT00776009|564811553|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
156468647|NCT00776009|564811548|FG000|Period 2: Second Intervention|Protocol Violation|1|||
156468648|NCT00776009|564811549|FG001|Period 2: Second Intervention|Protocol Violation|0|||
156468649|NCT00776009|564811550|FG002|Period 2: Second Intervention|Protocol Violation|1|||
156468650|NCT00776009|564811551|FG003|Period 2: Second Intervention|Protocol Violation|0|||
156468651|NCT00776009|564811552|FG004|Period 2: Second Intervention|Protocol Violation|0|||
156468652|NCT00776009|564811553|FG005|Period 2: Second Intervention|Protocol Violation|0|||
156468653|NCT00776009|564811548|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
156468654|NCT00776009|564811549|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
156468655|NCT00776009|564811550|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
156468656|NCT00776009|564811551|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
156468657|NCT00776009|564811552|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
156468658|NCT00776009|564811553|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
156468659|NCT01640951|564811554|FG000|Overall Study|Adverse Event|8|||
156468660|NCT01640951|564811555|FG001|Overall Study|Adverse Event|3|||
156468661|NCT01640951|564811556|FG002|Overall Study|Adverse Event|10|||
156468662|NCT01640951|564811557|FG003|Overall Study|Adverse Event|6|||
156468663|NCT01640951|564811558|FG004|Overall Study|Adverse Event|1|||
156468664|NCT01640951|564811559|FG005|Overall Study|Adverse Event|11|||
156468665|NCT01640951|564811560|FG006|Overall Study|Adverse Event|1|||
156468666|NCT01640951|564811561|FG007|Overall Study|Adverse Event|3|||
156468667|NCT01640951|564811554|FG000|Overall Study|Lack of Efficacy|20|||
156468668|NCT01640951|564811555|FG001|Overall Study|Lack of Efficacy|1|||
156468669|NCT01640951|564811556|FG002|Overall Study|Lack of Efficacy|7|||
156468670|NCT01640951|564811557|FG003|Overall Study|Lack of Efficacy|14|||
156468671|NCT01640951|564811558|FG004|Overall Study|Lack of Efficacy|0|||
156468672|NCT01640951|564811559|FG005|Overall Study|Lack of Efficacy|6|||
156468673|NCT01640951|564811560|FG006|Overall Study|Lack of Efficacy|5|||
156468674|NCT01640951|564811561|FG007|Overall Study|Lack of Efficacy|6|||
156468675|NCT01640951|564811554|FG000|Overall Study|Lost to Follow-up|1|||
156468676|NCT01640951|564811555|FG001|Overall Study|Lost to Follow-up|0|||
156468677|NCT01640951|564811556|FG002|Overall Study|Lost to Follow-up|6|||
156468678|NCT01640951|564811557|FG003|Overall Study|Lost to Follow-up|2|||
156468679|NCT01640951|564811558|FG004|Overall Study|Lost to Follow-up|2|||
156468680|NCT01640951|564811559|FG005|Overall Study|Lost to Follow-up|3|||
156468681|NCT01640951|564811560|FG006|Overall Study|Lost to Follow-up|1|||
156468682|NCT01640951|564811561|FG007|Overall Study|Lost to Follow-up|1|||
156468683|NCT01640951|564811554|FG000|Overall Study|Non-compliance with study treatment|0|||
156468684|NCT01640951|564811555|FG001|Overall Study|Non-compliance with study treatment|0|||
156468685|NCT01640951|564811556|FG002|Overall Study|Non-compliance with study treatment|1|||
156468686|NCT01640951|564811557|FG003|Overall Study|Non-compliance with study treatment|1|||
156468687|NCT01640951|564811558|FG004|Overall Study|Non-compliance with study treatment|1|||
156468688|NCT01640951|564811559|FG005|Overall Study|Non-compliance with study treatment|4|||
156468689|NCT01640951|564811560|FG006|Overall Study|Non-compliance with study treatment|1|||
156468690|NCT01640951|564811561|FG007|Overall Study|Non-compliance with study treatment|0|||
156541405|NCT01538628|565074576|FG001|Overall Study|Lost to Follow-up|1|||
156541406|NCT01357577|565074577|FG000|Overall Study|Lost to Follow-up|20|||
156541407|NCT01357577|565074578|FG001|Overall Study|Lost to Follow-up|16|||
156468691|NCT01640951|564811554|FG000|Overall Study|Physician Decision|2|||
156468692|NCT01640951|564811555|FG001|Overall Study|Physician Decision|5|||
156468693|NCT01640951|564811556|FG002|Overall Study|Physician Decision|2|||
156541408|NCT01357577|565074577|FG000|Overall Study|Withdrawal by Subject|16|||
156468694|NCT01640951|564811557|FG003|Overall Study|Physician Decision|2|||
156541409|NCT01357577|565074578|FG001|Overall Study|Withdrawal by Subject|8|||
156468695|NCT01640951|564811558|FG004|Overall Study|Physician Decision|2|||
156541410|NCT01357577|565074577|FG000|Overall Study|look at data in database?|1|||
156340407|NCT00915278|564344407|FG001|Overall Study|Withdrawal by Subject|1|||
156340408|NCT00915278|564344408|FG002|Overall Study|Withdrawal by Subject|0|||
156340409|NCT00915278|564344409|FG003|Overall Study|Withdrawal by Subject|0|||
156340410|NCT00915278|564344410|FG004|Overall Study|Withdrawal by Subject|1|||
156340411|NCT00915278|564344411|FG005|Overall Study|Withdrawal by Subject|4|||
156340412|NCT00915278|564344406|FG000|Overall Study|Adverse Event|4|||
156340413|NCT00915278|564344407|FG001|Overall Study|Adverse Event|1|||
156340414|NCT00915278|564344408|FG002|Overall Study|Adverse Event|0|||
156340415|NCT00915278|564344409|FG003|Overall Study|Adverse Event|0|||
156340416|NCT00915278|564344410|FG004|Overall Study|Adverse Event|0|||
156340417|NCT00915278|564344411|FG005|Overall Study|Adverse Event|0|||
156340418|NCT00915278|564344406|FG000|Overall Study|Progressive disease/clinical progression|0|||
156340419|NCT00915278|564344407|FG001|Overall Study|Progressive disease/clinical progression|0|||
156340420|NCT00915278|564344408|FG002|Overall Study|Progressive disease/clinical progression|0|||
156340421|NCT00915278|564344409|FG003|Overall Study|Progressive disease/clinical progression|3|||
156340422|NCT00915278|564344410|FG004|Overall Study|Progressive disease/clinical progression|1|||
156468696|NCT01640951|564811559|FG005|Overall Study|Physician Decision|3|||
156468697|NCT01640951|564811560|FG006|Overall Study|Physician Decision|3|||
156468698|NCT01640951|564811561|FG007|Overall Study|Physician Decision|0|||
156468699|NCT01640951|564811554|FG000|Overall Study|Pregnancy|3|||
156468700|NCT01640951|564811555|FG001|Overall Study|Pregnancy|0|||
156468701|NCT01640951|564811556|FG002|Overall Study|Pregnancy|0|||
156468702|NCT01640951|564811557|FG003|Overall Study|Pregnancy|4|||
156468703|NCT01640951|564811558|FG004|Overall Study|Pregnancy|0|||
156468704|NCT01640951|564811559|FG005|Overall Study|Pregnancy|0|||
156468705|NCT01640951|564811560|FG006|Overall Study|Pregnancy|2|||
156468706|NCT01640951|564811561|FG007|Overall Study|Pregnancy|0|||
156468707|NCT01640951|564811554|FG000|Overall Study|Protocol Deviation|0|||
156468708|NCT01640951|564811555|FG001|Overall Study|Protocol Deviation|1|||
156468709|NCT01640951|564811556|FG002|Overall Study|Protocol Deviation|2|||
156468710|NCT01640951|564811557|FG003|Overall Study|Protocol Deviation|1|||
156468711|NCT01640951|564811558|FG004|Overall Study|Protocol Deviation|0|||
156468712|NCT01640951|564811559|FG005|Overall Study|Protocol Deviation|1|||
156468713|NCT01640951|564811560|FG006|Overall Study|Protocol Deviation|0|||
156468714|NCT01640951|564811561|FG007|Overall Study|Protocol Deviation|0|||
156468715|NCT01640951|564811554|FG000|Overall Study|Subject/Guardian decision|12|||
156468716|NCT01640951|564811555|FG001|Overall Study|Subject/Guardian decision|4|||
156468717|NCT01640951|564811556|FG002|Overall Study|Subject/Guardian decision|13|||
156468718|NCT01640951|564811557|FG003|Overall Study|Subject/Guardian decision|15|||
156468719|NCT01640951|564811558|FG004|Overall Study|Subject/Guardian decision|7|||
156468720|NCT01640951|564811559|FG005|Overall Study|Subject/Guardian decision|19|||
156468721|NCT01640951|564811560|FG006|Overall Study|Subject/Guardian decision|5|||
156468722|NCT01640951|564811561|FG007|Overall Study|Subject/Guardian decision|4|||
156468723|NCT01640951|564811554|FG000|Overall Study|Death|0|||
156468724|NCT01640951|564811555|FG001|Overall Study|Death|1|||
156468725|NCT01640951|564811556|FG002|Overall Study|Death|1|||
156468726|NCT01640951|564811557|FG003|Overall Study|Death|0|||
156468727|NCT01640951|564811558|FG004|Overall Study|Death|0|||
156468728|NCT01640951|564811559|FG005|Overall Study|Death|0|||
156468729|NCT01640951|564811560|FG006|Overall Study|Death|0|||
156468730|NCT01640951|564811561|FG007|Overall Study|Death|2|||
156468731|NCT00582972|564811562|FG000|Overall Study|Protocol Violation|2|||
156468732|NCT00293397|564811566|FG000|Overall Study|Death|2|||
156468733|NCT03631407|564811569|FG000|Overall Study|Withdrawal by Subject|3|||
156468734|NCT03631407|564811570|FG001|Overall Study|Withdrawal by Subject|2|||
156468735|NCT03631407|564811569|FG000|Overall Study|Sponsor Decision|0|||
156468736|NCT03631407|564811570|FG001|Overall Study|Sponsor Decision|2|||
156468737|NCT03631407|564811569|FG000|Overall Study|Death|16|||
156468738|NCT03631407|564811570|FG001|Overall Study|Death|16|||
156468739|NCT03631407|564811569|FG000|Overall Study|Randomized by mistake without study treatment|1|||
156468740|NCT03631407|564811570|FG001|Overall Study|Randomized by mistake without study treatment|0|||
156468741|NCT03304587|564811578|FG000|Overall Study|Headache after intervention|0|||
156468742|NCT03304587|564811579|FG001|Overall Study|Headache after intervention|1|||
156468743|NCT03304587|564811578|FG000|Overall Study|Withdrawal by Subject|1|||
156468744|NCT03304587|564811579|FG001|Overall Study|Withdrawal by Subject|0|||
156468745|NCT01458366|564811581|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
156468746|NCT01458366|564811582|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
156468747|NCT01458366|564811583|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
156468748|NCT01458366|564811584|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
156468749|NCT01458366|564811585|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
156468750|NCT01458366|564811581|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
156468751|NCT01458366|564811582|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
156468752|NCT01458366|564811583|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
156468753|NCT01458366|564811584|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
156838741|NCT03178669|566161583|FG000|Overall Study|Withdrawal by Subject|1|||
156838742|NCT03178669|566161584|FG001|Overall Study|Withdrawal by Subject|0|||
156468754|NCT01458366|564811585|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
156468755|NCT04647487|564811586|FG000|Overall Study|Protocol Deviation|0|||
156468756|NCT04647487|564811587|FG001|Overall Study|Protocol Deviation|0|||
156468757|NCT04647487|564811588|FG002|Overall Study|Protocol Deviation|1|||
156468758|NCT04647487|564811586|FG000|Overall Study|Withdrawal by Subject|1|||
156468759|NCT04647487|564811587|FG001|Overall Study|Withdrawal by Subject|0|||
156838743|NCT03178669|566161585|FG002|Overall Study|Withdrawal by Subject|1|||
156468760|NCT04647487|564811588|FG002|Overall Study|Withdrawal by Subject|2|||
156468761|NCT03840902|564811589|FG000|Overall Study|Randomized but not treated|1|||
156468762|NCT03840902|564811590|FG001|Overall Study|Randomized but not treated|1|||
156468763|NCT00174252|564811591|FG000|Overall Study|Protocol Violation|2|||
156468764|NCT02107261|564811598|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
156468765|NCT02107261|564811599|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
156468766|NCT02107261|564811598|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
156468767|NCT02107261|564811599|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
156468768|NCT04337931|564811601|FG000|Overall Study|Death|4|||
156468769|NCT04337931|564811602|FG001|Overall Study|Death|1|||
156838744|NCT03178669|566161586|FG003|Overall Study|Withdrawal by Subject|1|||
156468770|NCT04337931|564811603|FG002|Overall Study|Death|7|||
156468771|NCT04337931|564811601|FG000|Overall Study|Withdrawal by Subject|0|||
156468772|NCT04337931|564811602|FG001|Overall Study|Withdrawal by Subject|1|||
156468773|NCT04337931|564811603|FG002|Overall Study|Withdrawal by Subject|0|||
156468774|NCT04337931|564811601|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
156468775|NCT04337931|564811602|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
156468776|NCT04337931|564811603|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
156468777|NCT04337931|564811601|FG000|Overall Study|Study terminated by sponsor|3|||
156468778|NCT04337931|564811602|FG001|Overall Study|Study terminated by sponsor|6|||
156468779|NCT04337931|564811603|FG002|Overall Study|Study terminated by sponsor|2|||
156468780|NCT04337931|564811601|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
156468781|NCT04337931|564811602|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
156468782|NCT04337931|564811603|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
156468783|NCT04337931|564811601|FG000|Overall Study|Colorectal cancer treatment|1|||
156468784|NCT04337931|564811602|FG001|Overall Study|Colorectal cancer treatment|0|||
156468785|NCT04337931|564811603|FG002|Overall Study|Colorectal cancer treatment|0|||
156468786|NCT04337931|564811601|FG000|Overall Study|Participant decision|0|||
156468787|NCT04337931|564811602|FG001|Overall Study|Participant decision|1|||
156468788|NCT04337931|564811603|FG002|Overall Study|Participant decision|0|||
156468789|NCT01738438|564811604|FG000|Overall Study|Disease Progression|32|||
156468790|NCT01738438|564811604|FG000|Overall Study|Adverse Event|3|||
156468791|NCT02130557|564811606|FG000|Overall Study|Withdrawal by Subject|12|||
156468792|NCT02130557|564811607|FG001|Overall Study|Withdrawal by Subject|12|||
156468793|NCT02130557|564811606|FG000|Overall Study|Investigator Request|0|||
156468794|NCT02130557|564811607|FG001|Overall Study|Investigator Request|2|||
156468795|NCT02130557|564811606|FG000|Overall Study|Deceased|14|||
156468796|NCT02130557|564811607|FG001|Overall Study|Deceased|14|||
156468797|NCT02130557|564811606|FG000|Overall Study|Lost to Follow-up|6|||
156468798|NCT02130557|564811607|FG001|Overall Study|Lost to Follow-up|7|||
156468799|NCT02130557|564811606|FG000|Overall Study|Other|2|||
156468800|NCT02130557|564811607|FG001|Overall Study|Other|1|||
156468801|NCT02130557|564811606|FG000|Overall Study|Missing|2|||
156468802|NCT02130557|564811607|FG001|Overall Study|Missing|1|||
156468803|NCT01532999|564811608|FG000|Overall Study|Lost to Follow-up|14|||
156468804|NCT01532999|564811609|FG001|Overall Study|Lost to Follow-up|8|||
156468805|NCT01532999|564811608|FG000|Overall Study|Physician Decision|1|||
156468806|NCT01532999|564811609|FG001|Overall Study|Physician Decision|2|||
156468807|NCT01532999|564811608|FG000|Overall Study|Withdrawal by Subject|5|||
156468808|NCT01532999|564811609|FG001|Overall Study|Withdrawal by Subject|0|||
156468809|NCT01532999|564811608|FG000|Overall Study|Relocated|2|||
156468810|NCT01532999|564811609|FG001|Overall Study|Relocated|0|||
156468811|NCT01532999|564811608|FG000|Overall Study|should not have been randomized|1|||
156468812|NCT01532999|564811609|FG001|Overall Study|should not have been randomized|0|||
156468813|NCT01532999|564811608|FG000|Overall Study|substantial noncompliance|2|||
156468814|NCT01532999|564811609|FG001|Overall Study|substantial noncompliance|0|||
156468815|NCT01532999|564811608|FG000|Overall Study|no show for week 9 assessments|6|||
156468816|NCT01532999|564811609|FG001|Overall Study|no show for week 9 assessments|4|||
156468817|NCT01532999|564811608|FG000|Overall Study|Adverse Event|0|||
156468818|NCT01532999|564811609|FG001|Overall Study|Adverse Event|1|||
156468819|NCT01532999|564811608|FG000|Overall Study|incarcerated|0|||
156468820|NCT01532999|564811609|FG001|Overall Study|incarcerated|1|||
156468821|NCT01532999|564811608|FG000|Overall Study|New job|0|||
156468822|NCT01532999|564811609|FG001|Overall Study|New job|2|||
156468823|NCT02928172|564811610|FG000|Overall Study|Device did not record data|1|||
156468824|NCT02408887|564811611|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
156468825|NCT02408887|564811612|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
156468826|NCT02408887|564811611|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
156468827|NCT02408887|564811612|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
156838745|NCT03178669|566161587|FG004|Overall Study|Withdrawal by Subject|0|||
156838746|NCT03178669|566161583|FG000|Overall Study|Lost to Follow-up|0|||
156838747|NCT03178669|566161584|FG001|Overall Study|Lost to Follow-up|0|||
156838748|NCT03178669|566161585|FG002|Overall Study|Lost to Follow-up|0|||
156340423|NCT00915278|564344411|FG005|Overall Study|Progressive disease/clinical progression|2|||
156340424|NCT00915278|564344406|FG000|Overall Study|Infusion related AEs|0|||
156340425|NCT00915278|564344407|FG001|Overall Study|Infusion related AEs|0|||
156838749|NCT03178669|566161586|FG003|Overall Study|Lost to Follow-up|1|||
156838750|NCT03178669|566161587|FG004|Overall Study|Lost to Follow-up|0|||
156838751|NCT00694304|566161591|FG000|Overall Study|Adverse Event|42|||
156838752|NCT00694304|566161591|FG000|Overall Study|Lack of Efficacy|35|||
156838753|NCT00694304|566161591|FG000|Overall Study|Non-compliance With Study Product|16|||
156838754|NCT00694304|566161591|FG000|Overall Study|Protocol Violation|6|||
156838755|NCT00694304|566161591|FG000|Overall Study|Withdrawal of Consent|61|||
156838756|NCT00694304|566161591|FG000|Overall Study|Lost to Follow-up|15|||
156838757|NCT00694304|566161591|FG000|Overall Study|Administrative or Other Reasons|32|||
156838758|NCT01459913|566161594|FG000|Overall Study|Adverse Event|0|||
156838759|NCT01459913|566161595|FG001|Overall Study|Adverse Event|0|||
156838760|NCT01459913|566161596|FG002|Overall Study|Adverse Event|0|||
156838761|NCT01459913|566161597|FG003|Overall Study|Adverse Event|3|||
156838762|NCT01459913|566161594|FG000|Overall Study|Withdrawal by Subject|4|||
156838763|NCT01459913|566161595|FG001|Overall Study|Withdrawal by Subject|0|||
156838764|NCT01459913|566161596|FG002|Overall Study|Withdrawal by Subject|0|||
156838765|NCT01459913|566161597|FG003|Overall Study|Withdrawal by Subject|5|||
156838766|NCT01459913|566161594|FG000|Overall Study|Lost to Follow-up|7|||
156838767|NCT01459913|566161595|FG001|Overall Study|Lost to Follow-up|4|||
156838768|NCT01459913|566161596|FG002|Overall Study|Lost to Follow-up|1|||
156838769|NCT01459913|566161597|FG003|Overall Study|Lost to Follow-up|8|||
156838770|NCT01459913|566161594|FG000|Overall Study|Death|0|||
156838771|NCT01459913|566161595|FG001|Overall Study|Death|0|||
156838772|NCT01459913|566161596|FG002|Overall Study|Death|0|||
156838773|NCT01459913|566161597|FG003|Overall Study|Death|1|||
156838774|NCT01459913|566161594|FG000|Overall Study|Non- Compliance|0|||
156838775|NCT01459913|566161595|FG001|Overall Study|Non- Compliance|0|||
156838776|NCT01459913|566161596|FG002|Overall Study|Non- Compliance|0|||
156838777|NCT01459913|566161597|FG003|Overall Study|Non- Compliance|3|||
156838778|NCT01459913|566161594|FG000|Overall Study|Physician Decision|0|||
156838779|NCT01459913|566161595|FG001|Overall Study|Physician Decision|1|||
156838780|NCT01459913|566161596|FG002|Overall Study|Physician Decision|0|||
156838781|NCT01459913|566161597|FG003|Overall Study|Physician Decision|0|||
156838782|NCT01459913|566161594|FG000|Overall Study|Study Terminated by Sponsor|30|||
156838783|NCT01459913|566161595|FG001|Overall Study|Study Terminated by Sponsor|15|||
156838784|NCT01459913|566161596|FG002|Overall Study|Study Terminated by Sponsor|9|||
156838785|NCT01459913|566161597|FG003|Overall Study|Study Terminated by Sponsor|11|||
156838786|NCT01459913|566161594|FG000|Overall Study|Other|0|||
156838787|NCT01459913|566161595|FG001|Overall Study|Other|0|||
156838788|NCT01459913|566161596|FG002|Overall Study|Other|3|||
156340426|NCT00915278|564344408|FG002|Overall Study|Infusion related AEs|0|||
156340427|NCT00915278|564344409|FG003|Overall Study|Infusion related AEs|0|||
156340428|NCT00915278|564344410|FG004|Overall Study|Infusion related AEs|0|||
156340429|NCT00915278|564344411|FG005|Overall Study|Infusion related AEs|2|||
156340430|NCT00915278|564344406|FG000|Overall Study|Admission to hospice|0|||
156340431|NCT00915278|564344407|FG001|Overall Study|Admission to hospice|0|||
156340432|NCT00915278|564344408|FG002|Overall Study|Admission to hospice|1|||
156340433|NCT00915278|564344409|FG003|Overall Study|Admission to hospice|0|||
156340434|NCT00915278|564344410|FG004|Overall Study|Admission to hospice|0|||
156340435|NCT00915278|564344411|FG005|Overall Study|Admission to hospice|0|||
156340436|NCT01702961|564344412|FG000|Overall Study|Additional treatment|3|||
156340437|NCT01702961|564344412|FG000|Overall Study|Progressive disease|5|||
156340438|NCT01702961|564344412|FG000|Overall Study|Relapse|20|||
156340439|NCT01702961|564344412|FG000|Overall Study|Death|6|||
156340440|NCT01702961|564344412|FG000|Overall Study|Lost to Follow-up|2|||
156340441|NCT01702961|564344412|FG000|Overall Study|Ongoing|11|||
156340442|NCT00602797|564344415|FG000|Overall Study|Adverse Event|1|||
156340443|NCT01201850|564344418|FG000|Overall Study|Tumor progression|4|||
156340444|NCT02465515|564344419|FG000|Overall Study|Investigator site closed|4|||
156468828|NCT03333109|564811614|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
156468829|NCT03333109|564811615|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
156838789|NCT01459913|566161597|FG003|Overall Study|Other|1|||
156838790|NCT01459913|566161594|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
156838791|NCT01459913|566161595|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
156838792|NCT01459913|566161596|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
156838793|NCT01459913|566161597|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
156838794|NCT00454649|566161600|FG000|Overall Study|Lack of Efficacy|2|||
156838795|NCT00454649|566161601|FG001|Overall Study|Lack of Efficacy|2|||
156838796|NCT00454649|566161602|FG002|Overall Study|Lack of Efficacy|10|||
156838797|NCT00454649|566161603|FG003|Overall Study|Lack of Efficacy|3|||
156838798|NCT00454649|566161604|FG004|Overall Study|Lack of Efficacy|0|||
156340445|NCT02465515|564344420|FG001|Overall Study|Investigator site closed|5|||
156340446|NCT02465515|564344419|FG000|Overall Study|Withdrawal by Subject|74|||
156340447|NCT02465515|564344420|FG001|Overall Study|Withdrawal by Subject|43|||
156340448|NCT02465515|564344419|FG000|Overall Study|Physician Decision|8|||
156340449|NCT02465515|564344420|FG001|Overall Study|Physician Decision|12|||
156340450|NCT02465515|564344419|FG000|Overall Study|Lost to Follow-up|68|||
156340451|NCT02465515|564344420|FG001|Overall Study|Lost to Follow-up|51|||
156340452|NCT00629707|564344421|FG000|Overall Study|Withdrawal by Subject|0|||
156340453|NCT00629707|564344422|FG001|Overall Study|Withdrawal by Subject|1|||
156838799|NCT00454649|566161605|FG005|Overall Study|Lack of Efficacy|4|||
156838800|NCT00454649|566161606|FG006|Overall Study|Lack of Efficacy|5|||
156838801|NCT00454649|566161607|FG007|Overall Study|Lack of Efficacy|13|||
156838802|NCT00454649|566161608|FG008|Overall Study|Lack of Efficacy|10|||
156838803|NCT00454649|566161609|FG009|Overall Study|Lack of Efficacy|2|||
156838804|NCT00454649|566161600|FG000|Overall Study|Adverse Event|0|||
156838805|NCT00454649|566161601|FG001|Overall Study|Adverse Event|1|||
156838806|NCT00454649|566161602|FG002|Overall Study|Adverse Event|3|||
156838807|NCT00454649|566161603|FG003|Overall Study|Adverse Event|0|||
156838808|NCT00454649|566161604|FG004|Overall Study|Adverse Event|1|||
156838809|NCT00454649|566161605|FG005|Overall Study|Adverse Event|2|||
156838810|NCT00454649|566161606|FG006|Overall Study|Adverse Event|3|||
156838811|NCT00454649|566161607|FG007|Overall Study|Adverse Event|4|||
156340454|NCT00629707|564344421|FG000|Overall Study|Physician Decision|0|||
156340455|NCT00629707|564344422|FG001|Overall Study|Physician Decision|1|||
156340456|NCT00751933|564344423|FG000|Overall Study|Withdrawal by Subject|0|||
156340457|NCT00751933|564344424|FG001|Overall Study|Withdrawal by Subject|1|||
156340458|NCT00751933|564344425|FG002|Overall Study|Withdrawal by Subject|0|||
156340459|NCT00751933|564344426|FG003|Overall Study|Withdrawal by Subject|0|||
156838812|NCT00454649|566161608|FG008|Overall Study|Adverse Event|6|||
156838813|NCT00454649|566161609|FG009|Overall Study|Adverse Event|2|||
156838814|NCT00454649|566161600|FG000|Overall Study|Lost to Follow-up|0|||
156838815|NCT00454649|566161601|FG001|Overall Study|Lost to Follow-up|0|||
156838816|NCT00454649|566161602|FG002|Overall Study|Lost to Follow-up|1|||
156838817|NCT00454649|566161603|FG003|Overall Study|Lost to Follow-up|0|||
156838818|NCT00454649|566161604|FG004|Overall Study|Lost to Follow-up|0|||
156838819|NCT00454649|566161605|FG005|Overall Study|Lost to Follow-up|0|||
156838820|NCT00454649|566161606|FG006|Overall Study|Lost to Follow-up|1|||
156838821|NCT00454649|566161607|FG007|Overall Study|Lost to Follow-up|0|||
156838822|NCT00454649|566161608|FG008|Overall Study|Lost to Follow-up|0|||
156838823|NCT00454649|566161609|FG009|Overall Study|Lost to Follow-up|0|||
156838824|NCT00454649|566161600|FG000|Overall Study|Other|1|||
156838825|NCT00454649|566161601|FG001|Overall Study|Other|1|||
156838826|NCT00454649|566161602|FG002|Overall Study|Other|5|||
156838827|NCT00454649|566161603|FG003|Overall Study|Other|3|||
156838828|NCT00454649|566161604|FG004|Overall Study|Other|0|||
156838829|NCT00454649|566161605|FG005|Overall Study|Other|0|||
156838830|NCT00454649|566161606|FG006|Overall Study|Other|0|||
156838831|NCT00454649|566161607|FG007|Overall Study|Other|0|||
156838832|NCT00454649|566161608|FG008|Overall Study|Other|3|||
156838833|NCT00454649|566161609|FG009|Overall Study|Other|1|||
156838834|NCT00454649|566161600|FG000|Overall Study|Withdrawal by Subject|0|||
156838835|NCT00454649|566161601|FG001|Overall Study|Withdrawal by Subject|0|||
156838836|NCT00454649|566161602|FG002|Overall Study|Withdrawal by Subject|0|||
156838837|NCT00454649|566161603|FG003|Overall Study|Withdrawal by Subject|0|||
156838838|NCT00454649|566161604|FG004|Overall Study|Withdrawal by Subject|0|||
156838839|NCT00454649|566161605|FG005|Overall Study|Withdrawal by Subject|1|||
156838840|NCT00454649|566161606|FG006|Overall Study|Withdrawal by Subject|0|||
156838841|NCT00454649|566161607|FG007|Overall Study|Withdrawal by Subject|2|||
156838842|NCT00454649|566161608|FG008|Overall Study|Withdrawal by Subject|1|||
156838843|NCT00454649|566161609|FG009|Overall Study|Withdrawal by Subject|0|||
156340460|NCT00751933|564344423|FG000|Overall Study|Physician Decision|0|||
156340461|NCT00751933|564344424|FG001|Overall Study|Physician Decision|0|||
156340462|NCT00751933|564344425|FG002|Overall Study|Physician Decision|1|||
156340463|NCT00751933|564344426|FG003|Overall Study|Physician Decision|1|||
156340464|NCT03846804|564344427|FG000|Overall Study|Refused blood draw|1|||
156340465|NCT03846804|564344427|FG000|Overall Study|Protocol Violation|1|||
156340466|NCT02657369|564344428|FG000|Overall Study|Death|27|||
156340467|NCT02657369|564344428|FG000|Overall Study|Study terminated by sponsor|7|||
156838844|NCT02925728|566161610|FG000|Overall Study|Death|3|||
156838845|NCT02925728|566161611|FG001|Overall Study|Death|5|||
156838846|NCT02925728|566161610|FG000|Overall Study|Physician Decision|1|||
156838847|NCT02925728|566161611|FG001|Overall Study|Physician Decision|0|||
156838848|NCT02925728|566161610|FG000|Overall Study|Withdrawal by Subject|1|||
156838849|NCT02925728|566161611|FG001|Overall Study|Withdrawal by Subject|0|||
156838850|NCT02102399|566161612|FG000|Overall Study|Withdrawal by Subject|6|||
156838851|NCT02102399|566161613|FG001|Overall Study|Withdrawal by Subject|4|||
156838852|NCT00086411|566161616|FG000|Overall Study|Lost to Follow-up|11|||
156838853|NCT00086411|566161617|FG001|Overall Study|Lost to Follow-up|11|||
156838854|NCT00086411|566161618|FG002|Overall Study|Lost to Follow-up|13|||
156838855|NCT00086411|566161619|FG003|Overall Study|Lost to Follow-up|12|||
156468830|NCT03333109|564811616|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156468831|NCT03333109|564811614|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156468832|NCT03333109|564811615|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156468833|NCT03333109|564811616|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
156468834|NCT03333109|564811614|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
156468835|NCT03333109|564811615|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
156468836|NCT03333109|564811616|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
156468837|NCT03333109|564811614|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
156468838|NCT03333109|564811615|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
156468839|NCT03333109|564811616|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
156468840|NCT03333109|564811614|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
156468841|NCT03333109|564811615|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
156468842|NCT03333109|564811616|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
156468843|NCT03333109|564811614|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
156468844|NCT03333109|564811615|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
156468845|NCT03333109|564811616|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
156468846|NCT03333109|564811614|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
156468847|NCT03333109|564811615|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
156468848|NCT03333109|564811616|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
156468849|NCT03333109|564811614|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
156468850|NCT03333109|564811615|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
156468851|NCT03333109|564811616|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
156468852|NCT04066075|564811617|FG000|Overall Study|Lost to Follow-up|3|||
156468853|NCT04066075|564811618|FG001|Overall Study|Lost to Follow-up|3|||
156468854|NCT04066075|564811617|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
156468855|NCT04066075|564811618|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
156468856|NCT04066075|564811617|FG000|Overall Study|Withdrawal by Subject|2|||
156468857|NCT04066075|564811618|FG001|Overall Study|Withdrawal by Subject|2|||
156838856|NCT00718770|566161620|FG000|Overall Study|Adverse Event|1|||
156838857|NCT00718770|566161620|FG000|Overall Study|Lack of Efficacy|1|||
156838858|NCT00718770|566161620|FG000|Overall Study|Lack of Efficacy|1|||
156838859|NCT00718770|566161620|FG000|Overall Study|Adverse Event|1|||
156838860|NCT00718770|566161620|FG000|Overall Study|Lack of Efficacy|1|||
156838861|NCT00718770|566161620|FG000|Overall Study|Adverse Event|1|||
156838862|NCT00718770|566161620|FG000|Overall Study|Lack of Efficacy|1|||
156838863|NCT00718770|566161620|FG000|Overall Study|Adverse Event|1|||
156838864|NCT02540291|566161626|FG000|Overall Study|Death|7|||
156838865|NCT02540291|566161627|FG001|Overall Study|Death|7|||
156838866|NCT02540291|566161628|FG002|Overall Study|Death|5|||
156838867|NCT02540291|566161629|FG003|Overall Study|Death|7|||
156838868|NCT02540291|566161626|FG000|Overall Study|Lost to Follow-up|0|||
156838869|NCT02540291|566161627|FG001|Overall Study|Lost to Follow-up|0|||
156838870|NCT02540291|566161628|FG002|Overall Study|Lost to Follow-up|1|||
156838871|NCT02540291|566161629|FG003|Overall Study|Lost to Follow-up|0|||
156838872|NCT02540291|566161626|FG000|Overall Study|Withdrawal Of Consent|0|||
156838873|NCT02540291|566161627|FG001|Overall Study|Withdrawal Of Consent|1|||
156838874|NCT02540291|566161628|FG002|Overall Study|Withdrawal Of Consent|0|||
156838875|NCT02540291|566161629|FG003|Overall Study|Withdrawal Of Consent|0|||
156838876|NCT02540291|566161626|FG000|Overall Study|Study Terminated By Sponsor|1|||
156838877|NCT02540291|566161627|FG001|Overall Study|Study Terminated By Sponsor|0|||
156838878|NCT02540291|566161628|FG002|Overall Study|Study Terminated By Sponsor|0|||
156838879|NCT02540291|566161629|FG003|Overall Study|Study Terminated By Sponsor|0|||
156838880|NCT02540291|566161626|FG000|Overall Study|Other|0|||
156838881|NCT02540291|566161627|FG001|Overall Study|Other|0|||
156838882|NCT02540291|566161628|FG002|Overall Study|Other|1|||
156468858|NCT00309166|564811619|FG000|Overall Study|Adverse event, non-fatal|1|||
156838883|NCT02540291|566161629|FG003|Overall Study|Other|0|||
156838884|NCT01879072|566161643|FG000|Overall Study|Withdrawal by Subject|121|||
156838885|NCT01879072|566161643|FG000|Overall Study|Not Transplanted|30|||
156838886|NCT04667104|566161652|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
156838887|NCT04667104|566161653|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
156838888|NCT04667104|566161654|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
156838889|NCT01078168|566161655|FG000|Overall Study|Physician Decision|0|||
156838890|NCT01078168|566161656|FG001|Overall Study|Physician Decision|1|||
156838891|NCT01264419|566161657|FG000|Overall Study|Lost to Follow-up|3|||
156838892|NCT04566601|566163275|FG000|Overall Study|Other than listed|13|||
156838893|NCT04566601|566163276|FG001|Overall Study|Other than listed|4|||
156838894|NCT04566601|566163277|FG002|Overall Study|Other than listed|2|||
156838895|NCT04566601|566163278|FG003|Overall Study|Other than listed|1|||
156838896|NCT04566601|566163279|FG004|Overall Study|Other than listed|4|||
156838897|NCT04566601|566163275|FG000|Overall Study|Protocol deviation|3|||
156838898|NCT04566601|566163276|FG001|Overall Study|Protocol deviation|0|||
156838899|NCT04566601|566163277|FG002|Overall Study|Protocol deviation|1|||
156838900|NCT04566601|566163278|FG003|Overall Study|Protocol deviation|1|||
156838901|NCT04566601|566163279|FG004|Overall Study|Protocol deviation|1|||
156838902|NCT04566601|566163275|FG000|Overall Study|Technical problems|0|||
156838903|NCT04566601|566163276|FG001|Overall Study|Technical problems|0|||
156838904|NCT04566601|566163277|FG002|Overall Study|Technical problems|1|||
156838905|NCT04566601|566163278|FG003|Overall Study|Technical problems|0|||
156838906|NCT04566601|566163279|FG004|Overall Study|Technical problems|0|||
156838907|NCT04566601|566163275|FG000|Overall Study|No reason available|3|||
156838908|NCT04566601|566163276|FG001|Overall Study|No reason available|2|||
156838909|NCT04566601|566163277|FG002|Overall Study|No reason available|7|||
156838910|NCT04566601|566163278|FG003|Overall Study|No reason available|1|||
156838911|NCT04566601|566163279|FG004|Overall Study|No reason available|5|||
156838912|NCT04566601|566163275|FG000|Overall Study|Burden of study procedures|3|||
156838913|NCT04566601|566163276|FG001|Overall Study|Burden of study procedures|0|||
156838914|NCT04566601|566163277|FG002|Overall Study|Burden of study procedures|0|||
156838915|NCT04566601|566163278|FG003|Overall Study|Burden of study procedures|3|||
156838916|NCT04566601|566163279|FG004|Overall Study|Burden of study procedures|1|||
156838917|NCT04566601|566163275|FG000|Overall Study|Change of residence|2|||
156838918|NCT04566601|566163276|FG001|Overall Study|Change of residence|2|||
156838919|NCT04566601|566163277|FG002|Overall Study|Change of residence|0|||
156838920|NCT04566601|566163278|FG003|Overall Study|Change of residence|1|||
156838921|NCT04566601|566163279|FG004|Overall Study|Change of residence|2|||
156838922|NCT04566601|566163275|FG000|Overall Study|Perceived lack of efficacy|2|||
156838923|NCT04566601|566163276|FG001|Overall Study|Perceived lack of efficacy|0|||
156838924|NCT04566601|566163277|FG002|Overall Study|Perceived lack of efficacy|1|||
156838925|NCT04566601|566163278|FG003|Overall Study|Perceived lack of efficacy|1|||
156838926|NCT04566601|566163279|FG004|Overall Study|Perceived lack of efficacy|2|||
156838927|NCT04566601|566163275|FG000|Overall Study|Adverse Event|7|||
156838928|NCT04566601|566163276|FG001|Overall Study|Adverse Event|4|||
156838929|NCT04566601|566163277|FG002|Overall Study|Adverse Event|6|||
156838930|NCT04566601|566163278|FG003|Overall Study|Adverse Event|5|||
156838931|NCT04566601|566163279|FG004|Overall Study|Adverse Event|12|||
156838932|NCT02814175|566163282|FG000|Part 1|Adverse Event|2|||
156838933|NCT02814175|566163283|FG001|Part 1|Adverse Event|3|||
156838934|NCT02814175|566163284|FG002|Part 1|Adverse Event|0|||
156838935|NCT02814175|566163285|FG003|Part 1|Adverse Event|0|||
156838936|NCT02814175|566163286|FG004|Part 1|Adverse Event|0|||
156838937|NCT02814175|566163287|FG005|Part 1|Adverse Event|0|||
156838938|NCT02814175|566163282|FG000|Part 1|Withdrawal Consent|8|||
156838939|NCT02814175|566163283|FG001|Part 1|Withdrawal Consent|1|||
156838940|NCT02814175|566163284|FG002|Part 1|Withdrawal Consent|0|||
156838941|NCT02814175|566163285|FG003|Part 1|Withdrawal Consent|0|||
156838942|NCT02814175|566163286|FG004|Part 1|Withdrawal Consent|0|||
156838943|NCT02814175|566163287|FG005|Part 1|Withdrawal Consent|0|||
156838944|NCT02814175|566163282|FG000|Part 1|Lost to Follow-up|1|||
156838945|NCT02814175|566163283|FG001|Part 1|Lost to Follow-up|0|||
156838946|NCT02814175|566163284|FG002|Part 1|Lost to Follow-up|0|||
156838947|NCT02814175|566163285|FG003|Part 1|Lost to Follow-up|0|||
156838948|NCT02814175|566163286|FG004|Part 1|Lost to Follow-up|0|||
156838949|NCT02814175|566163287|FG005|Part 1|Lost to Follow-up|0|||
156838950|NCT02814175|566163282|FG000|Part 1|Lack of Efficacy|1|||
156838951|NCT02814175|566163283|FG001|Part 1|Lack of Efficacy|2|||
156838952|NCT02814175|566163284|FG002|Part 1|Lack of Efficacy|0|||
156838953|NCT02814175|566163285|FG003|Part 1|Lack of Efficacy|0|||
156838954|NCT02814175|566163286|FG004|Part 1|Lack of Efficacy|0|||
156838955|NCT02814175|566163287|FG005|Part 1|Lack of Efficacy|0|||
156838956|NCT02814175|566163282|FG000|Part 2|Adverse Event|0|||
156838957|NCT02814175|566163283|FG001|Part 2|Adverse Event|0|||
156838958|NCT02814175|566163284|FG002|Part 2|Adverse Event|0|||
156838959|NCT02814175|566163285|FG003|Part 2|Adverse Event|1|||
156838960|NCT02814175|566163286|FG004|Part 2|Adverse Event|1|||
156838961|NCT02814175|566163287|FG005|Part 2|Adverse Event|2|||
156838962|NCT02814175|566163282|FG000|Part 2|Withdrawal Consent|0|||
156838963|NCT02814175|566163283|FG001|Part 2|Withdrawal Consent|0|||
156838964|NCT02814175|566163284|FG002|Part 2|Withdrawal Consent|0|||
156838965|NCT02814175|566163285|FG003|Part 2|Withdrawal Consent|2|||
156838966|NCT02814175|566163286|FG004|Part 2|Withdrawal Consent|1|||
156838967|NCT02814175|566163287|FG005|Part 2|Withdrawal Consent|1|||
156838968|NCT02814175|566163282|FG000|Part 2|Lost to Follow-up|0|||
156838969|NCT02814175|566163283|FG001|Part 2|Lost to Follow-up|0|||
156838970|NCT02814175|566163284|FG002|Part 2|Lost to Follow-up|0|||
156838971|NCT02814175|566163285|FG003|Part 2|Lost to Follow-up|1|||
156838972|NCT02814175|566163286|FG004|Part 2|Lost to Follow-up|0|||
156838973|NCT02814175|566163287|FG005|Part 2|Lost to Follow-up|0|||
156838974|NCT02814175|566163282|FG000|Part 2|Lack of Efficacy|0|||
156838975|NCT02814175|566163283|FG001|Part 2|Lack of Efficacy|0|||
156838976|NCT02814175|566163284|FG002|Part 2|Lack of Efficacy|0|||
156838977|NCT02814175|566163285|FG003|Part 2|Lack of Efficacy|0|||
156838978|NCT02814175|566163286|FG004|Part 2|Lack of Efficacy|0|||
156838979|NCT02814175|566163287|FG005|Part 2|Lack of Efficacy|3|||
156838980|NCT01971008|566163295|FG000|Overall Study|Protocol Violation|2|||
156838981|NCT01971008|566163296|FG001|Overall Study|Protocol Violation|1|||
156838982|NCT00924508|566163297|FG000|Overall Study|Withdrawal by Subject|3|||
156838983|NCT03775512|566163298|FG000|Overall Study|Death|1|||
156838984|NCT03775512|566163299|FG001|Overall Study|Death|1|||
156838985|NCT03775512|566163298|FG000|Overall Study|Withdrawal by Subject|7|||
156838986|NCT03775512|566163299|FG001|Overall Study|Withdrawal by Subject|4|||
156838987|NCT03775512|566163298|FG000|Overall Study|Lost to Follow-up|5|||
156838988|NCT03775512|566163299|FG001|Overall Study|Lost to Follow-up|5|||
156838989|NCT03775512|566163298|FG000|Overall Study|Excluded before Catheter insertion|14|||
156838990|NCT03775512|566163299|FG001|Overall Study|Excluded before Catheter insertion|5|||
156838991|NCT03775512|566163298|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
156468859|NCT00309166|564811620|FG001|Overall Study|Adverse event, non-fatal|0|||
156468860|NCT00309166|564811619|FG000|Overall Study|Withdrawal by Subject|4|||
156468861|NCT00309166|564811620|FG001|Overall Study|Withdrawal by Subject|3|||
156468862|NCT00701701|564811621|FG000|Overall Study|Withdrawal by Subject|0|||
156468863|NCT00701701|564811622|FG001|Overall Study|Withdrawal by Subject|1|||
156468864|NCT00701701|564811621|FG000|Overall Study|Adverse Event|0|||
156468865|NCT00701701|564811622|FG001|Overall Study|Adverse Event|1|||
156468866|NCT03593226|564811641|FG000|Overall Study|Disease progression|6|||
156468867|NCT03593226|564811642|FG001|Overall Study|Disease progression|13|||
156468868|NCT03593226|564811643|FG002|Overall Study|Disease progression|5|||
156468869|NCT03593226|564811644|FG003|Overall Study|Disease progression|6|||
156468870|NCT03593226|564811641|FG000|Overall Study|Adverse Event|0|||
156468871|NCT03593226|564811642|FG001|Overall Study|Adverse Event|1|||
156468872|NCT03593226|564811643|FG002|Overall Study|Adverse Event|0|||
156468873|NCT03593226|564811644|FG003|Overall Study|Adverse Event|0|||
156468874|NCT03593226|564811641|FG000|Overall Study|Withdrawal by Subject|0|||
156468875|NCT03593226|564811642|FG001|Overall Study|Withdrawal by Subject|4|||
156468876|NCT03593226|564811643|FG002|Overall Study|Withdrawal by Subject|1|||
156468877|NCT03593226|564811644|FG003|Overall Study|Withdrawal by Subject|0|||
156468878|NCT03593226|564811641|FG000|Overall Study|Physician Decision|0|||
156468879|NCT03593226|564811642|FG001|Overall Study|Physician Decision|1|||
156468880|NCT03593226|564811643|FG002|Overall Study|Physician Decision|0|||
156468881|NCT03593226|564811644|FG003|Overall Study|Physician Decision|0|||
156468882|NCT03593226|564811641|FG000|Overall Study|Clinical disease progression|0|||
156468883|NCT03593226|564811642|FG001|Overall Study|Clinical disease progression|0|||
156468884|NCT03593226|564811643|FG002|Overall Study|Clinical disease progression|1|||
156468885|NCT03593226|564811644|FG003|Overall Study|Clinical disease progression|0|||
156468886|NCT04517435|564811645|FG000|Overall Study|Withdrawal by Subject|0|||
156468887|NCT04517435|564811646|FG001|Overall Study|Withdrawal by Subject|0|||
156468888|NCT04517435|564811647|FG002|Overall Study|Withdrawal by Subject|1|||
156468889|NCT04517435|564811645|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
156468890|NCT04517435|564811646|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
156468891|NCT04517435|564811647|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
156468892|NCT06191679|564811648|FG000|Baseline|Lost to Follow-up|1|||
156468893|NCT06191679|564811649|FG001|Baseline|Lost to Follow-up|0|||
156468894|NCT06191679|564811650|FG002|Baseline|Lost to Follow-up|1|||
156468895|NCT06191679|564811651|FG003|Baseline|Lost to Follow-up|0|||
156468896|NCT06191679|564811648|FG000|Allocation to Group|Withdrawal by Subject|0|||
156468897|NCT06191679|564811649|FG001|Allocation to Group|Withdrawal by Subject|1|||
156468898|NCT06191679|564811650|FG002|Allocation to Group|Withdrawal by Subject|2|||
156468899|NCT06191679|564811651|FG003|Allocation to Group|Withdrawal by Subject|0|||
156468900|NCT06191679|564811648|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
156468901|NCT06191679|564811649|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
156468902|NCT06191679|564811650|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
156468903|NCT06191679|564811651|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
156468904|NCT06191679|564811648|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
156468905|NCT06191679|564811649|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
156838992|NCT03775512|566163299|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
156838993|NCT03775512|566163298|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
156838994|NCT03775512|566163299|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
156838995|NCT00495625|566163300|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
156838996|NCT01610336|566163301|FG000|Overall Study|Progressive Disease|4|||
156468906|NCT06191679|564811650|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
156468907|NCT06191679|564811651|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
156468908|NCT06191679|564811648|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
156468909|NCT06191679|564811649|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
156468910|NCT06191679|564811650|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
156468911|NCT06191679|564811651|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
156838997|NCT01610336|566163302|FG001|Overall Study|Progressive Disease|6|||
156838998|NCT01610336|566163303|FG002|Overall Study|Progressive Disease|6|||
156838999|NCT01610336|566163304|FG003|Overall Study|Progressive Disease|5|||
156839000|NCT01610336|566163305|FG004|Overall Study|Progressive Disease|3|||
156839001|NCT01610336|566163306|FG005|Overall Study|Progressive Disease|10|||
156839002|NCT01610336|566163307|FG006|Overall Study|Progressive Disease|1|||
156839003|NCT01610336|566163308|FG007|Overall Study|Progressive Disease|6|||
156839004|NCT01610336|566163309|FG008|Overall Study|Progressive Disease|6|||
156839005|NCT01610336|566163310|FG009|Overall Study|Progressive Disease|40|||
156839006|NCT01610336|566163311|FG010|Overall Study|Progressive Disease|36|||
156839007|NCT01610336|566163301|FG000|Overall Study|Adverse Event|0|||
156839008|NCT01610336|566163302|FG001|Overall Study|Adverse Event|0|||
156839009|NCT01610336|566163303|FG002|Overall Study|Adverse Event|0|||
156340468|NCT02605824|564344429|FG000|Overall Study|Physician Decision|1|||
156839010|NCT01610336|566163304|FG003|Overall Study|Adverse Event|1|||
156340469|NCT02605824|564344430|FG001|Overall Study|Physician Decision|0|||
156340470|NCT04875195|564344431|FG000|Overall Study|Death|9|||
156839011|NCT01610336|566163305|FG004|Overall Study|Adverse Event|1|||
156839012|NCT01610336|566163306|FG005|Overall Study|Adverse Event|1|||
156839013|NCT01610336|566163307|FG006|Overall Study|Adverse Event|0|||
156340471|NCT04875195|564344432|FG001|Overall Study|Death|3|||
156839014|NCT01610336|566163308|FG007|Overall Study|Adverse Event|0|||
156839015|NCT01610336|566163309|FG008|Overall Study|Adverse Event|2|||
156839016|NCT01610336|566163310|FG009|Overall Study|Adverse Event|8|||
156839017|NCT01610336|566163311|FG010|Overall Study|Adverse Event|6|||
156839018|NCT01610336|566163301|FG000|Overall Study|Subject/Guardian decision|1|||
156839019|NCT01610336|566163302|FG001|Overall Study|Subject/Guardian decision|1|||
156839020|NCT01610336|566163303|FG002|Overall Study|Subject/Guardian decision|0|||
156839021|NCT01610336|566163304|FG003|Overall Study|Subject/Guardian decision|1|||
156839022|NCT01610336|566163305|FG004|Overall Study|Subject/Guardian decision|0|||
156839023|NCT01610336|566163306|FG005|Overall Study|Subject/Guardian decision|0|||
156839024|NCT01610336|566163307|FG006|Overall Study|Subject/Guardian decision|0|||
156839025|NCT01610336|566163308|FG007|Overall Study|Subject/Guardian decision|1|||
156839026|NCT01610336|566163309|FG008|Overall Study|Subject/Guardian decision|0|||
156839027|NCT01610336|566163310|FG009|Overall Study|Subject/Guardian decision|2|||
156839028|NCT01610336|566163311|FG010|Overall Study|Subject/Guardian decision|2|||
156839029|NCT01610336|566163301|FG000|Overall Study|Death|0|||
156839030|NCT01610336|566163302|FG001|Overall Study|Death|0|||
156839031|NCT01610336|566163303|FG002|Overall Study|Death|0|||
156839032|NCT01610336|566163304|FG003|Overall Study|Death|0|||
156839033|NCT01610336|566163305|FG004|Overall Study|Death|0|||
156839034|NCT01610336|566163306|FG005|Overall Study|Death|1|||
156839035|NCT01610336|566163307|FG006|Overall Study|Death|3|||
156839036|NCT01610336|566163308|FG007|Overall Study|Death|0|||
156839037|NCT01610336|566163309|FG008|Overall Study|Death|0|||
156839038|NCT01610336|566163310|FG009|Overall Study|Death|1|||
156839039|NCT01610336|566163311|FG010|Overall Study|Death|2|||
156839040|NCT01610336|566163301|FG000|Overall Study|Non-Compliance with study treatment|0|||
156839041|NCT01610336|566163302|FG001|Overall Study|Non-Compliance with study treatment|0|||
156839042|NCT01610336|566163303|FG002|Overall Study|Non-Compliance with study treatment|0|||
156839043|NCT01610336|566163304|FG003|Overall Study|Non-Compliance with study treatment|0|||
156839044|NCT01610336|566163305|FG004|Overall Study|Non-Compliance with study treatment|0|||
156839045|NCT01610336|566163306|FG005|Overall Study|Non-Compliance with study treatment|0|||
156839046|NCT01610336|566163307|FG006|Overall Study|Non-Compliance with study treatment|0|||
156839047|NCT01610336|566163308|FG007|Overall Study|Non-Compliance with study treatment|0|||
156839048|NCT01610336|566163309|FG008|Overall Study|Non-Compliance with study treatment|0|||
156839049|NCT01610336|566163310|FG009|Overall Study|Non-Compliance with study treatment|1|||
156839050|NCT01610336|566163311|FG010|Overall Study|Non-Compliance with study treatment|0|||
156839051|NCT01610336|566163301|FG000|Overall Study|Physician Decision|0|||
156839052|NCT01610336|566163302|FG001|Overall Study|Physician Decision|0|||
156839053|NCT01610336|566163303|FG002|Overall Study|Physician Decision|0|||
156839054|NCT01610336|566163304|FG003|Overall Study|Physician Decision|0|||
156839055|NCT01610336|566163305|FG004|Overall Study|Physician Decision|0|||
156839056|NCT01610336|566163306|FG005|Overall Study|Physician Decision|0|||
156839057|NCT01610336|566163307|FG006|Overall Study|Physician Decision|1|||
156839058|NCT01610336|566163308|FG007|Overall Study|Physician Decision|0|||
156839059|NCT01610336|566163309|FG008|Overall Study|Physician Decision|0|||
156839060|NCT01610336|566163310|FG009|Overall Study|Physician Decision|0|||
156839061|NCT01610336|566163311|FG010|Overall Study|Physician Decision|0|||
156839062|NCT01610336|566163301|FG000|Overall Study|Protocol Deviation|0|||
156839063|NCT01610336|566163302|FG001|Overall Study|Protocol Deviation|0|||
156839064|NCT01610336|566163303|FG002|Overall Study|Protocol Deviation|0|||
156839065|NCT01610336|566163304|FG003|Overall Study|Protocol Deviation|0|||
156839066|NCT01610336|566163305|FG004|Overall Study|Protocol Deviation|0|||
156839067|NCT01610336|566163306|FG005|Overall Study|Protocol Deviation|0|||
156839068|NCT01610336|566163307|FG006|Overall Study|Protocol Deviation|0|||
156839069|NCT01610336|566163308|FG007|Overall Study|Protocol Deviation|0|||
156839070|NCT01610336|566163309|FG008|Overall Study|Protocol Deviation|0|||
156839071|NCT01610336|566163310|FG009|Overall Study|Protocol Deviation|1|||
156839072|NCT01610336|566163311|FG010|Overall Study|Protocol Deviation|0|||
156839073|NCT01610336|566163301|FG000|Overall Study|Transfer to another trial|0|||
156839074|NCT01610336|566163302|FG001|Overall Study|Transfer to another trial|0|||
156839075|NCT01610336|566163303|FG002|Overall Study|Transfer to another trial|0|||
156839076|NCT01610336|566163304|FG003|Overall Study|Transfer to another trial|0|||
156839077|NCT01610336|566163305|FG004|Overall Study|Transfer to another trial|0|||
156839078|NCT01610336|566163306|FG005|Overall Study|Transfer to another trial|0|||
156839079|NCT01610336|566163307|FG006|Overall Study|Transfer to another trial|0|||
156839080|NCT01610336|566163308|FG007|Overall Study|Transfer to another trial|0|||
156839081|NCT01610336|566163309|FG008|Overall Study|Transfer to another trial|0|||
156839082|NCT01610336|566163310|FG009|Overall Study|Transfer to another trial|0|||
156839083|NCT01610336|566163311|FG010|Overall Study|Transfer to another trial|1|||
156839084|NCT02629822|566163312|FG000|Base Study|Lost to Follow-up|2|||
156839085|NCT02629822|566163312|FG000|Base Study|Non-Compliance With Study Drug|1|||
156839086|NCT02629822|566163312|FG000|Extension Study|Adverse Event|1|||
156839087|NCT02629822|566163312|FG000|Extension Study|Lost to Follow-up|1|||
156839088|NCT03679624|566163313|FG000|Overall Study|Adverse Event|1|||
156839089|NCT03679624|566163314|FG001|Overall Study|Adverse Event|0|||
156839090|NCT01912339|566163315|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
156839091|NCT01912339|566163316|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
156839092|NCT01912339|566163317|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
156839093|NCT01912339|566163315|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
156839094|NCT01912339|566163316|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
156839095|NCT01912339|566163317|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
156839096|NCT01912339|566163315|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
156839097|NCT01912339|566163316|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
156839098|NCT01912339|566163317|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
156839099|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
156839100|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
156839101|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
156839102|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
156839103|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
156839104|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
156839105|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
156839106|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
156839107|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
156839108|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
156839109|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
156839110|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
156839111|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
156839112|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
156839113|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
156839114|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
156839115|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
156839116|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
156839117|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
156839118|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
156839119|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
156839120|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
156839121|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
156839122|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
156839123|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
156839124|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
156839125|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
156468912|NCT05464732|564811652|FG000|Overall Study|Lost to Follow-up|0|||
156468913|NCT05464732|564811653|FG001|Overall Study|Lost to Follow-up|1|||
156468914|NCT05464732|564811652|FG000|Overall Study|Adverse Event|1|||
156468915|NCT05464732|564811653|FG001|Overall Study|Adverse Event|0|||
156468916|NCT02678689|564811655|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
156541411|NCT01357577|565074578|FG001|Overall Study|look at data in database?|2|||
156541412|NCT01439282|565075405|FG000|Overall Study|Adverse Event|5|||
156541413|NCT01439282|565075406|FG001|Overall Study|Adverse Event|0|||
156839126|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
156468917|NCT02678689|564811656|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
156468918|NCT02761187|564811657|FG000|Overall Study|Too ill to Participate|13|||
156468919|NCT02761187|564811658|FG001|Overall Study|Too ill to Participate|8|||
156468920|NCT02761187|564811657|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
156468921|NCT02761187|564811658|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
156468922|NCT02761187|564811657|FG000|Overall Study|Patient withdrew consent|64|||
156468923|NCT02761187|564811658|FG001|Overall Study|Patient withdrew consent|58|||
156468924|NCT02761187|564811657|FG000|Overall Study|Physician discretion|4|||
156468925|NCT02761187|564811658|FG001|Overall Study|Physician discretion|8|||
156468926|NCT02761187|564811657|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
156468927|NCT02761187|564811658|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
156468928|NCT02761187|564811657|FG000|Overall Study|On Hospice|20|||
156468929|NCT02761187|564811658|FG001|Overall Study|On Hospice|26|||
156468930|NCT02761187|564811657|FG000|Overall Study|Deceased|474|||
156468931|NCT02761187|564811658|FG001|Overall Study|Deceased|642|||
156839127|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
156541414|NCT01439282|565075405|FG000|Overall Study|Withdrawal by Subject|2|||
156541415|NCT01439282|565075406|FG001|Overall Study|Withdrawal by Subject|0|||
156541416|NCT01439282|565075405|FG000|Overall Study|Other|1|||
156839128|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
156839129|NCT00741013|566163318|FG000|Overall Study|Adverse Event|1|||
156839130|NCT00741013|566163319|FG001|Overall Study|Adverse Event|0|||
156839131|NCT00741013|566163320|FG002|Overall Study|Adverse Event|0|||
156839132|NCT00741013|566163318|FG000|Overall Study|Withdrawal by Subject|0|||
156839133|NCT00741013|566163319|FG001|Overall Study|Withdrawal by Subject|0|||
156839134|NCT00741013|566163320|FG002|Overall Study|Withdrawal by Subject|1|||
156839135|NCT00741013|566163318|FG000|Overall Study|Discovered failed screen after enrolled|0|||
156839136|NCT00741013|566163319|FG001|Overall Study|Discovered failed screen after enrolled|2|||
156839137|NCT00741013|566163320|FG002|Overall Study|Discovered failed screen after enrolled|0|||
156839138|NCT00082407|566163322|FG000|Overall Study|Adverse Event|20|||
156839139|NCT00082407|566163323|FG001|Overall Study|Adverse Event|0|||
156839140|NCT00082407|566163322|FG000|Overall Study|Protocol Violation|14|||
156839141|NCT00082407|566163323|FG001|Overall Study|Protocol Violation|12|||
156839142|NCT00082407|566163322|FG000|Overall Study|Patient Decision|13|||
156839143|NCT00082407|566163323|FG001|Overall Study|Patient Decision|6|||
156839144|NCT00082407|566163322|FG000|Overall Study|Physician Decision|5|||
156839145|NCT00082407|566163323|FG001|Overall Study|Physician Decision|3|||
156839146|NCT00082407|566163322|FG000|Overall Study|Loss of Glucose Control|2|||
156839147|NCT00082407|566163323|FG001|Overall Study|Loss of Glucose Control|2|||
156839148|NCT00082407|566163322|FG000|Overall Study|Death|2|||
156839149|NCT00082407|566163323|FG001|Overall Study|Death|1|||
156839150|NCT00082407|566163322|FG000|Overall Study|Lost to Follow-up|0|||
156839151|NCT00082407|566163323|FG001|Overall Study|Lost to Follow-up|3|||
156839152|NCT03464019|566163324|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
156839153|NCT03464019|566163325|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
156839154|NCT03464019|566163326|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
156839155|NCT03464019|566163324|FG000|NODE-301 Part 1|Ablation|0|||
156839156|NCT03464019|566163325|FG001|NODE-301 Part 1|Ablation|0|||
156839157|NCT03464019|566163326|FG002|NODE-301 Part 1|Ablation|16|||
156839158|NCT03464019|566163324|FG000|NODE-301 Part 1|Test Dose Failure|0|||
156468932|NCT02761187|564811657|FG000|Overall Study|Lost to Follow-up|73|||
156468933|NCT02761187|564811658|FG001|Overall Study|Lost to Follow-up|63|||
156468934|NCT02761187|564811657|FG000|Overall Study|Due to study discontinued at site|100|||
156468935|NCT02761187|564811658|FG001|Overall Study|Due to study discontinued at site|85|||
156468936|NCT02761187|564811657|FG000|Overall Study|Reason not Specified|1484|||
156468937|NCT02761187|564811658|FG001|Overall Study|Reason not Specified|937|||
156468938|NCT03277989|564811660|FG000|Overall Study|Lost to Follow-up|6|||
156468939|NCT03277989|564811660|FG000|Overall Study|Adverse Event|6|||
156468940|NCT03277989|564811660|FG000|Overall Study|Withdrawal by Subject|3|||
156468941|NCT03277989|564811660|FG000|Overall Study|Didn't Receive Study Device|7|||
156468942|NCT03277989|564811660|FG000|Overall Study|Site Closure|26|||
156468943|NCT03277989|564811660|FG000|Overall Study|Sponsor Closure|107|||
156468944|NCT03459196|564812922|FG000|Overall Study|Subject didn't receive study catheter|2|||
156468945|NCT00092534|564812925|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
156468946|NCT00092534|564812926|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
156468947|NCT00092534|564812927|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156468948|NCT00092534|564812928|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156468949|NCT00092534|564812929|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156468950|NCT00092534|564812925|FG000|Base Study Vaccination Period|Adverse Event|3|||
156468951|NCT00092534|564812926|FG001|Base Study Vaccination Period|Adverse Event|1|||
156468952|NCT00092534|564812927|FG002|Base Study Vaccination Period|Adverse Event|0|||
156468953|NCT00092534|564812928|FG003|Base Study Vaccination Period|Adverse Event|0|||
156468954|NCT00092534|564812929|FG004|Base Study Vaccination Period|Adverse Event|0|||
156468955|NCT00092534|564812925|FG000|Base Study Vaccination Period|Death|5|||
156468956|NCT00092534|564812926|FG001|Base Study Vaccination Period|Death|4|||
156468957|NCT00092534|564812927|FG002|Base Study Vaccination Period|Death|0|||
156468958|NCT00092534|564812928|FG003|Base Study Vaccination Period|Death|0|||
156468959|NCT00092534|564812929|FG004|Base Study Vaccination Period|Death|0|||
156468960|NCT00092534|564812925|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
156468961|NCT00092534|564812926|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
156468962|NCT00092534|564812927|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
156468963|NCT00092534|564812928|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
156839159|NCT03464019|566163325|FG001|NODE-301 Part 1|Test Dose Failure|0|||
156839160|NCT03464019|566163326|FG002|NODE-301 Part 1|Test Dose Failure|8|||
156839161|NCT03464019|566163324|FG000|NODE-301 Part 1|Adverse Event|0|||
156468964|NCT00092534|564812929|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
156468965|NCT00092534|564812925|FG000|Base Study Vaccination Period|Physician Decision|1|||
156468966|NCT00092534|564812926|FG001|Base Study Vaccination Period|Physician Decision|0|||
156541417|NCT01439282|565075406|FG001|Overall Study|Other|1|||
156839162|NCT03464019|566163325|FG001|NODE-301 Part 1|Adverse Event|0|||
156839163|NCT03464019|566163326|FG002|NODE-301 Part 1|Adverse Event|5|||
156839164|NCT03464019|566163324|FG000|NODE-301 Part 1|Physician Decision|0|||
156839165|NCT03464019|566163325|FG001|NODE-301 Part 1|Physician Decision|0|||
156839166|NCT03464019|566163326|FG002|NODE-301 Part 1|Physician Decision|4|||
156839167|NCT03464019|566163324|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
156839168|NCT03464019|566163325|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
156839169|NCT03464019|566163326|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
156839170|NCT03464019|566163324|FG000|NODE-301 Part 1|Protocol Violation|0|||
156839171|NCT03464019|566163325|FG001|NODE-301 Part 1|Protocol Violation|0|||
156839172|NCT03464019|566163326|FG002|NODE-301 Part 1|Protocol Violation|2|||
156839173|NCT03464019|566163324|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
156839174|NCT03464019|566163325|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
156839175|NCT03464019|566163326|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
156839176|NCT03464019|566163324|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
156839177|NCT03464019|566163325|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
156839178|NCT03464019|566163326|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
156839179|NCT03464019|566163324|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
156839180|NCT03464019|566163325|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
156839181|NCT03464019|566163326|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
156839182|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
156839183|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
156839184|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
156839185|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
156839186|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
156839187|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
156839188|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
156839189|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
156839190|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
156340472|NCT04875195|564344431|FG000|Overall Study|Withdrawal by Subject|2|||
156340473|NCT04875195|564344432|FG001|Overall Study|Withdrawal by Subject|1|||
156340474|NCT04875195|564344431|FG000|Overall Study|Ongoing in study|49|||
156340475|NCT04875195|564344432|FG001|Overall Study|Ongoing in study|2|||
156340476|NCT03288129|564344436|FG000|Overall Study|Adverse Event|10|||
156340477|NCT03288129|564344436|FG000|Overall Study|Lost to Follow-up|3|||
156340478|NCT03288129|564344436|FG000|Overall Study|Withdrawal by Subject|3|||
156340479|NCT03288129|564344436|FG000|Overall Study|Withdrawal of consent/assent|1|||
156340480|NCT03288129|564344436|FG000|Overall Study|Other|5|||
156340481|NCT01744197|564344437|FG000|Overall Study|Received 1 patch|2|||
156340482|NCT01744197|564344438|FG001|Overall Study|Received 1 patch|1|||
156340483|NCT01744197|564344437|FG000|Overall Study|No patch received|2|||
156839191|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
156340484|NCT01744197|564344438|FG001|Overall Study|No patch received|2|||
156340485|NCT04706091|564344439|FG000|Treatment 2|Withdrawal by Subject|1|||
156340486|NCT04706091|564344440|FG001|Treatment 2|Withdrawal by Subject|0|||
156340487|NCT03329573|564344441|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
156340488|NCT03329573|564344442|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
156340489|NCT03329573|564344443|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
156340490|NCT03329573|564344444|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
156340491|NCT03329573|564344441|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
156340492|NCT03329573|564344442|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
156340493|NCT03329573|564344443|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156340494|NCT03329573|564344444|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156340495|NCT03329573|564344441|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
156340496|NCT03329573|564344442|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
156340497|NCT03329573|564344443|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
156340498|NCT03329573|564344444|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
156340499|NCT03329573|564344441|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
156340500|NCT03329573|564344442|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
156340501|NCT03329573|564344443|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
156340502|NCT03329573|564344444|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
156340503|NCT02777333|564344445|FG000|Overall Study|Withdrawal by Subject|0|||
156340504|NCT02777333|564344446|FG001|Overall Study|Withdrawal by Subject|1|||
156340505|NCT02777333|564344445|FG000|Overall Study|Lost to Follow-up|0|||
156468967|NCT00092534|564812927|FG002|Base Study Vaccination Period|Physician Decision|0|||
156468968|NCT00092534|564812928|FG003|Base Study Vaccination Period|Physician Decision|0|||
156839192|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
156839193|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
156839194|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
156839195|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
156839196|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
156340506|NCT02777333|564344446|FG001|Overall Study|Lost to Follow-up|1|||
156340507|NCT04997304|564344447|FG000|Overall Study|Lost to Follow-up|11|||
156340508|NCT04997304|564344447|FG000|Overall Study|Death|1|||
156468969|NCT00092534|564812929|FG004|Base Study Vaccination Period|Physician Decision|0|||
156468970|NCT00092534|564812925|FG000|Base Study Vaccination Period|Pregnancy|9|||
156468971|NCT00092534|564812926|FG001|Base Study Vaccination Period|Pregnancy|7|||
156468972|NCT00092534|564812927|FG002|Base Study Vaccination Period|Pregnancy|0|||
156468973|NCT00092534|564812928|FG003|Base Study Vaccination Period|Pregnancy|0|||
156468974|NCT00092534|564812929|FG004|Base Study Vaccination Period|Pregnancy|0|||
156468975|NCT00092534|564812925|FG000|Base Study Vaccination Period|Protocol Violation|2|||
156468976|NCT00092534|564812926|FG001|Base Study Vaccination Period|Protocol Violation|1|||
156468977|NCT00092534|564812927|FG002|Base Study Vaccination Period|Protocol Violation|0|||
156468978|NCT00092534|564812928|FG003|Base Study Vaccination Period|Protocol Violation|0|||
156468979|NCT00092534|564812929|FG004|Base Study Vaccination Period|Protocol Violation|0|||
156468980|NCT00092534|564812925|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
156468981|NCT00092534|564812926|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
156468982|NCT00092534|564812927|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
156468983|NCT00092534|564812928|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
156468984|NCT00092534|564812929|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
156468985|NCT00092534|564812925|FG000|Base Study Vaccination Period|Moved|14|||
156839197|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
156839198|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
156839199|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
156839200|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
156839201|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
156468986|NCT00092534|564812926|FG001|Base Study Vaccination Period|Moved|12|||
156468987|NCT00092534|564812927|FG002|Base Study Vaccination Period|Moved|0|||
156468988|NCT00092534|564812928|FG003|Base Study Vaccination Period|Moved|0|||
156468989|NCT00092534|564812929|FG004|Base Study Vaccination Period|Moved|0|||
156468990|NCT00092534|564812925|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
156468991|NCT00092534|564812926|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
156468992|NCT00092534|564812927|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
156468993|NCT00092534|564812928|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
156541418|NCT04419610|565075407|FG000|Overall Study|Withdrawal by Subject|3|||
156839202|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
156839203|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
156839204|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
156839205|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
156839206|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
156839207|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
156839208|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
156839209|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
156839210|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
156839211|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
156839212|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
156839213|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
156839214|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
156839215|NCT01754493|566163327|FG000|Overall Study|Adverse Event|1|||
156839216|NCT01754493|566163327|FG000|Overall Study|Lost to Follow-up|3|||
156839217|NCT01754493|566163327|FG000|Overall Study|Withdrawal by Subject|1|||
156839218|NCT01754493|566163327|FG000|Overall Study|Moved out of town|1|||
156839219|NCT01754493|566163327|FG000|Overall Study|Scheduling conflict|1|||
156839220|NCT00767806|566163328|FG000|Overall Study|Adverse Event|30|||
156839221|NCT00767806|566163329|FG001|Overall Study|Adverse Event|11|||
156839222|NCT00767806|566163328|FG000|Overall Study|Withdrawal by Subject|8|||
156839223|NCT00767806|566163329|FG001|Overall Study|Withdrawal by Subject|13|||
156839224|NCT00767806|566163328|FG000|Overall Study|Protocol Violation|6|||
156839225|NCT00767806|566163329|FG001|Overall Study|Protocol Violation|5|||
156839226|NCT00767806|566163328|FG000|Overall Study|Lack of Efficacy|1|||
156839227|NCT00767806|566163329|FG001|Overall Study|Lack of Efficacy|9|||
156468994|NCT00092534|564812929|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
156468995|NCT00092534|564812925|FG000|Base Study Vaccination Period|Travel|1|||
156541419|NCT04419610|565075408|FG001|Overall Study|Withdrawal by Subject|1|||
156839228|NCT00767806|566163328|FG000|Overall Study|Physician Decision|4|||
156839229|NCT00767806|566163329|FG001|Overall Study|Physician Decision|3|||
156468996|NCT00092534|564812926|FG001|Base Study Vaccination Period|Travel|0|||
156468997|NCT00092534|564812927|FG002|Base Study Vaccination Period|Travel|0|||
156468998|NCT00092534|564812928|FG003|Base Study Vaccination Period|Travel|0|||
156468999|NCT00092534|564812929|FG004|Base Study Vaccination Period|Travel|0|||
156469000|NCT00092534|564812925|FG000|Base Study Vaccination Period|Site Closed|0|||
156469001|NCT00092534|564812926|FG001|Base Study Vaccination Period|Site Closed|1|||
156469002|NCT00092534|564812927|FG002|Base Study Vaccination Period|Site Closed|0|||
156469003|NCT00092534|564812928|FG003|Base Study Vaccination Period|Site Closed|0|||
156469004|NCT00092534|564812929|FG004|Base Study Vaccination Period|Site Closed|0|||
156469005|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Adverse Event|2|||
156469006|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Adverse Event|4|||
156469007|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Adverse Event|0|||
156469008|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Adverse Event|0|||
156469009|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Adverse Event|0|||
156469010|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Death|2|||
156469011|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Death|1|||
156469012|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Death|0|||
156469013|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Death|0|||
156469014|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Death|0|||
156469015|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
156469016|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
156469017|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
156469018|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
156469019|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
156469020|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Pregnancy|6|||
156469021|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Pregnancy|10|||
156469022|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Pregnancy|0|||
156469023|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Pregnancy|0|||
156469024|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Pregnancy|0|||
156469025|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
156469026|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
156469027|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
156469028|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
156469029|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
156839230|NCT00767806|566163328|FG000|Overall Study|Lost to Follow-up|1|||
156839231|NCT00767806|566163329|FG001|Overall Study|Lost to Follow-up|4|||
156839232|NCT00767806|566163328|FG000|Overall Study|Entry Criteria Not Met|1|||
156839233|NCT00767806|566163329|FG001|Overall Study|Entry Criteria Not Met|1|||
156839234|NCT00767806|566163328|FG000|Overall Study|Sponsor Decision|0|||
156839235|NCT00767806|566163329|FG001|Overall Study|Sponsor Decision|1|||
156839236|NCT02489942|566163330|FG000|Overall Study|Request by patient|602|||
156839237|NCT02489942|566163330|FG000|Overall Study|Improvement/remission|157|||
156839238|NCT02489942|566163330|FG000|Overall Study|No change/Progressive disease|263|||
156839239|NCT02489942|566163330|FG000|Overall Study|Adverse Event|522|||
156839240|NCT02489942|566163330|FG000|Overall Study|Other personal reasons|1218|||
156839241|NCT02489942|566163330|FG000|Overall Study|Lost to Follow-up|456|||
156839242|NCT02489942|566163330|FG000|Overall Study|Not continuously investigated|7|||
156839243|NCT02489942|566163330|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
156839244|NCT02489942|566163330|FG000|Overall Study|Multiple registration|1|||
156839245|NCT02489942|566163330|FG000|Overall Study|No patient visit after entry|100|||
156839246|NCT02489942|566163330|FG000|Overall Study|No treatment with Jardiance|2|||
156839247|NCT02489942|566163330|FG000|Overall Study|Patient received Jardiance before registration|1|||
156839248|NCT02489942|566163330|FG000|Overall Study|No CRF collected|86|||
156839249|NCT00858208|566163331|FG000|Overall Study|Adverse Event|3|||
156839250|NCT00858208|566163331|FG000|Overall Study|Lost to Follow-up|26|||
156839251|NCT00858208|566163331|FG000|Overall Study|Participant refused|40|||
156839252|NCT00858208|566163331|FG000|Overall Study|Other|10|||
156839253|NCT01272635|566163332|FG000|Overall Study|Lost to Follow-up|31|||
156839254|NCT01272635|566163333|FG001|Overall Study|Lost to Follow-up|20|||
156839255|NCT01272635|566163334|FG002|Overall Study|Lost to Follow-up|31|||
156839256|NCT01272635|566163335|FG003|Overall Study|Lost to Follow-up|23|||
156839257|NCT01543776|566163338|FG000|Overall Study|Withdrawal by Subject|2|||
156839258|NCT01543776|566163339|FG001|Overall Study|Withdrawal by Subject|2|||
156839259|NCT00567359|566163340|FG000|Overall Study|Withdrawal by Subject|1|||
156469030|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
156469031|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
156469032|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
156469033|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
156839260|NCT02397057|566163341|FG000|Overall Study|Withdrawal by Subject|6|||
156839261|NCT02397057|566163342|FG001|Overall Study|Withdrawal by Subject|7|||
156839262|NCT02397057|566163341|FG000|Overall Study|Lost to Follow-up|4|||
156839263|NCT02397057|566163342|FG001|Overall Study|Lost to Follow-up|3|||
156839264|NCT02397057|566163341|FG000|Overall Study|Death|1|||
156839265|NCT02397057|566163342|FG001|Overall Study|Death|0|||
156839266|NCT02397057|566163341|FG000|Overall Study|Adverse Event|0|||
156839267|NCT02397057|566163342|FG001|Overall Study|Adverse Event|1|||
156469034|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
156469035|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Moved|62|||
156469036|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Moved|58|||
156541420|NCT04419610|565075407|FG000|Overall Study|Adverse Event|1|||
156541421|NCT04419610|565075408|FG001|Overall Study|Adverse Event|0|||
156541422|NCT04419610|565075407|FG000|Overall Study|discharged early|1|||
156541423|NCT04419610|565075408|FG001|Overall Study|discharged early|1|||
156541424|NCT00307151|565075411|FG000|Overall Study|Death|4|||
156541425|NCT00307151|565075412|FG001|Overall Study|Death|3|||
156541426|NCT00307151|565075413|FG002|Overall Study|Death|10|||
156541427|NCT00307151|565075414|FG003|Overall Study|Death|3|||
156541428|NCT00307151|565075411|FG000|Overall Study|Severe debilitation, unable to continue|1|||
156541429|NCT00307151|565075412|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156541430|NCT00307151|565075413|FG002|Overall Study|Severe debilitation, unable to continue|0|||
156541431|NCT00307151|565075414|FG003|Overall Study|Severe debilitation, unable to continue|0|||
156541432|NCT00307151|565075411|FG000|Overall Study|Subject unable to get to clinic|1|||
156541433|NCT00307151|565075412|FG001|Overall Study|Subject unable to get to clinic|0|||
156541434|NCT00307151|565075413|FG002|Overall Study|Subject unable to get to clinic|6|||
156541435|NCT00307151|565075414|FG003|Overall Study|Subject unable to get to clinic|2|||
156541436|NCT00307151|565075411|FG000|Overall Study|Withdrew consent|0|||
156541437|NCT00307151|565075412|FG001|Overall Study|Withdrew consent|1|||
156541438|NCT00307151|565075413|FG002|Overall Study|Withdrew consent|1|||
156541439|NCT00307151|565075414|FG003|Overall Study|Withdrew consent|3|||
156541440|NCT00307151|565075411|FG000|Overall Study|Not willing to adhere to study reqs|2|||
156469037|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Moved|0|||
156469038|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Moved|0|||
156469039|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Moved|0|||
156469040|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Travel|10|||
156469041|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Travel|7|||
156469042|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Travel|0|||
156469043|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Travel|0|||
156469044|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Travel|0|||
156469045|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Site Closed|0|||
156469046|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Site Closed|2|||
156469047|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Site Closed|0|||
156469048|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Site Closed|0|||
156469049|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Site Closed|0|||
156469050|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
156469051|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
156469052|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
156469053|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
156469054|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
156469055|NCT00092534|564812925|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
156469056|NCT00092534|564812926|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
156469057|NCT00092534|564812927|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
156469058|NCT00092534|564812928|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
156469059|NCT00092534|564812929|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
156469060|NCT00092534|564812925|FG000|Base Study EXT|Lost to Follow-up|0|||
156469061|NCT00092534|564812926|FG001|Base Study EXT|Lost to Follow-up|0|||
156469062|NCT00092534|564812927|FG002|Base Study EXT|Lost to Follow-up|41|||
156469063|NCT00092534|564812928|FG003|Base Study EXT|Lost to Follow-up|0|||
156469064|NCT00092534|564812929|FG004|Base Study EXT|Lost to Follow-up|0|||
156469065|NCT00092534|564812925|FG000|Base Study EXT|Physician Decision|0|||
156469066|NCT00092534|564812926|FG001|Base Study EXT|Physician Decision|0|||
156469067|NCT00092534|564812927|FG002|Base Study EXT|Physician Decision|1|||
156469068|NCT00092534|564812928|FG003|Base Study EXT|Physician Decision|0|||
156469069|NCT00092534|564812929|FG004|Base Study EXT|Physician Decision|0|||
156469070|NCT00092534|564812925|FG000|Base Study EXT|Pregnancy|0|||
156469071|NCT00092534|564812926|FG001|Base Study EXT|Pregnancy|0|||
156541441|NCT00307151|565075412|FG001|Overall Study|Not willing to adhere to study reqs|0|||
156541442|NCT00307151|565075413|FG002|Overall Study|Not willing to adhere to study reqs|2|||
156541443|NCT00307151|565075414|FG003|Overall Study|Not willing to adhere to study reqs|2|||
156469072|NCT00092534|564812927|FG002|Base Study EXT|Pregnancy|12|||
156541444|NCT00307151|565075411|FG000|Overall Study|Clinic unable to contact subject|3|||
156541445|NCT00307151|565075412|FG001|Overall Study|Clinic unable to contact subject|3|||
156541446|NCT00307151|565075413|FG002|Overall Study|Clinic unable to contact subject|1|||
156469073|NCT00092534|564812928|FG003|Base Study EXT|Pregnancy|0|||
156469074|NCT00092534|564812929|FG004|Base Study EXT|Pregnancy|0|||
156469075|NCT00092534|564812925|FG000|Base Study EXT|Withdrawal by Subject|0|||
156469076|NCT00092534|564812926|FG001|Base Study EXT|Withdrawal by Subject|0|||
156541447|NCT00307151|565075414|FG003|Overall Study|Clinic unable to contact subject|1|||
156541448|NCT02966509|565075420|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
156541449|NCT02966509|565075421|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
156839268|NCT02397057|566163341|FG000|Overall Study|Physician Decision|0|||
156469077|NCT00092534|564812927|FG002|Base Study EXT|Withdrawal by Subject|18|||
156469078|NCT00092534|564812928|FG003|Base Study EXT|Withdrawal by Subject|0|||
156469079|NCT00092534|564812929|FG004|Base Study EXT|Withdrawal by Subject|0|||
156469080|NCT00092534|564812925|FG000|Base Study EXT|Participant moved|0|||
156469081|NCT00092534|564812926|FG001|Base Study EXT|Participant moved|0|||
156469082|NCT00092534|564812927|FG002|Base Study EXT|Participant moved|6|||
156469083|NCT00092534|564812928|FG003|Base Study EXT|Participant moved|0|||
156469084|NCT00092534|564812929|FG004|Base Study EXT|Participant moved|0|||
156839269|NCT02397057|566163342|FG001|Overall Study|Physician Decision|1|||
156839270|NCT02397057|566163341|FG000|Overall Study|Subject did not receive study drug|0|||
156839271|NCT02397057|566163342|FG001|Overall Study|Subject did not receive study drug|1|||
156839272|NCT04395690|566163344|FG000|Overall Study|Lost to Follow-up|1|||
156839273|NCT04395690|566163345|FG001|Overall Study|Lost to Follow-up|1|||
156469085|NCT00092534|564812925|FG000|Base Study EXT|Travel|0|||
156469086|NCT00092534|564812926|FG001|Base Study EXT|Travel|0|||
156469087|NCT00092534|564812927|FG002|Base Study EXT|Travel|2|||
156469088|NCT00092534|564812928|FG003|Base Study EXT|Travel|0|||
156469089|NCT00092534|564812929|FG004|Base Study EXT|Travel|0|||
156469090|NCT00092534|564812925|FG000|Base Study EXT|Site closed|0|||
156469091|NCT00092534|564812926|FG001|Base Study EXT|Site closed|0|||
156469092|NCT00092534|564812927|FG002|Base Study EXT|Site closed|21|||
156469093|NCT00092534|564812928|FG003|Base Study EXT|Site closed|0|||
156469094|NCT00092534|564812929|FG004|Base Study EXT|Site closed|0|||
156469095|NCT00092534|564812925|FG000|Base Study EXT|Study ended|0|||
156469096|NCT00092534|564812926|FG001|Base Study EXT|Study ended|0|||
156469097|NCT00092534|564812927|FG002|Base Study EXT|Study ended|29|||
156469098|NCT00092534|564812928|FG003|Base Study EXT|Study ended|0|||
156469099|NCT00092534|564812929|FG004|Base Study EXT|Study ended|0|||
156469100|NCT00092534|564812925|FG000|Base Study EXT|Protocol Violation|0|||
156469101|NCT00092534|564812926|FG001|Base Study EXT|Protocol Violation|0|||
156469102|NCT00092534|564812927|FG002|Base Study EXT|Protocol Violation|15|||
156469103|NCT00092534|564812928|FG003|Base Study EXT|Protocol Violation|0|||
156469104|NCT00092534|564812929|FG004|Base Study EXT|Protocol Violation|0|||
156469105|NCT00092534|564812925|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
156469106|NCT00092534|564812926|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
156469107|NCT00092534|564812927|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
156469108|NCT00092534|564812928|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
156469109|NCT00092534|564812929|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
156469110|NCT03083366|564812930|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
156469111|NCT03083366|564812931|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
156469112|NCT03083366|564812930|FG000|Enrollment Period|Lack of Efficacy|1|||
156469113|NCT03083366|564812931|FG001|Enrollment Period|Lack of Efficacy|0|||
156469114|NCT02036970|564812937|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
156469115|NCT02036970|564812938|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
156469116|NCT02036970|564812939|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
156469117|NCT02036970|564812940|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
156469118|NCT02036970|564812941|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
156469119|NCT02036970|564812942|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
156469120|NCT02036970|564812943|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
156469121|NCT02036970|564812944|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
156469122|NCT02036970|564812945|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
156469123|NCT02036970|564812946|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
156469124|NCT02036970|564812937|FG000|Part 1: Day 1 Through Week 16|Death|0|||
156469125|NCT02036970|564812938|FG001|Part 1: Day 1 Through Week 16|Death|0|||
156469126|NCT02036970|564812939|FG002|Part 1: Day 1 Through Week 16|Death|0|||
156469127|NCT02036970|564812940|FG003|Part 1: Day 1 Through Week 16|Death|0|||
156469128|NCT02036970|564812941|FG004|Part 1: Day 1 Through Week 16|Death|0|||
156469129|NCT02036970|564812942|FG005|Part 1: Day 1 Through Week 16|Death|0|||
156469130|NCT02036970|564812943|FG006|Part 1: Day 1 Through Week 16|Death|0|||
156469131|NCT02036970|564812944|FG007|Part 1: Day 1 Through Week 16|Death|0|||
156469132|NCT02036970|564812945|FG008|Part 1: Day 1 Through Week 16|Death|1|||
156469133|NCT02036970|564812946|FG009|Part 1: Day 1 Through Week 16|Death|0|||
156469134|NCT02036970|564812937|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
156469135|NCT02036970|564812938|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
156469136|NCT02036970|564812939|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
156469137|NCT02036970|564812940|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
156469138|NCT02036970|564812941|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
156469139|NCT02036970|564812942|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
156469140|NCT02036970|564812943|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
156469141|NCT02036970|564812944|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
156469142|NCT02036970|564812945|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
156469143|NCT02036970|564812946|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
156541450|NCT02966509|565075420|FG000|Baseline Satisfaction Survey|Death|0|||
156469144|NCT02036970|564812937|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
156469145|NCT02036970|564812938|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
156839274|NCT01554514|566163351|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
156839275|NCT01554514|566163351|FG000|Overall Study|Physician Decision|1|||
156469146|NCT02036970|564812939|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
156839276|NCT00549770|566163352|FG000|Overall Study|Protocol deviation|1|||
156839277|NCT00549770|566163353|FG001|Overall Study|Protocol deviation|1|||
156839278|NCT00549770|566163354|FG002|Overall Study|Protocol deviation|1|||
156839279|NCT00549770|566163355|FG003|Overall Study|Protocol deviation|2|||
156839280|NCT00549770|566163356|FG004|Overall Study|Protocol deviation|2|||
156839281|NCT00549770|566163357|FG005|Overall Study|Protocol deviation|2|||
156839282|NCT00549770|566163358|FG006|Overall Study|Protocol deviation|1|||
156839283|NCT00549770|566163359|FG007|Overall Study|Protocol deviation|2|||
156340509|NCT04997304|564344447|FG000|Overall Study|Withdrawal by Subject|14|||
156469147|NCT02036970|564812940|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
156469148|NCT02036970|564812941|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
156469149|NCT02036970|564812942|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
156469150|NCT02036970|564812943|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
156469151|NCT02036970|564812944|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
156469152|NCT02036970|564812945|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
156469153|NCT02036970|564812946|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
156469154|NCT02036970|564812937|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469155|NCT02036970|564812938|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469156|NCT02036970|564812939|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469157|NCT02036970|564812940|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
156469158|NCT02036970|564812941|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469159|NCT02036970|564812942|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469160|NCT02036970|564812943|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469161|NCT02036970|564812944|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469162|NCT02036970|564812945|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469163|NCT02036970|564812946|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
156469164|NCT02036970|564812937|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
156469165|NCT02036970|564812938|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
156469166|NCT02036970|564812939|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
156469167|NCT02036970|564812940|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
156469168|NCT02036970|564812941|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
156469169|NCT02036970|564812942|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
156469170|NCT02036970|564812943|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
156469171|NCT02036970|564812944|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
156469172|NCT02036970|564812945|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
156469173|NCT02036970|564812946|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
156469174|NCT02036970|564812937|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469175|NCT02036970|564812938|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469176|NCT02036970|564812939|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469177|NCT02036970|564812940|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469178|NCT02036970|564812941|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469179|NCT02036970|564812942|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469180|NCT02036970|564812943|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469181|NCT02036970|564812944|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
156469182|NCT02036970|564812945|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469183|NCT02036970|564812946|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
156469184|NCT02036970|564812937|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
156469185|NCT02036970|564812938|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
156469186|NCT02036970|564812939|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
156469187|NCT02036970|564812940|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
156469188|NCT02036970|564812941|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
156469189|NCT02036970|564812942|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
156469190|NCT02036970|564812943|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
156469191|NCT02036970|564812944|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
156469192|NCT02036970|564812945|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
156469193|NCT02036970|564812946|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
156469194|NCT02036970|564812937|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
156469195|NCT02036970|564812938|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
156469196|NCT02036970|564812939|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
156469197|NCT02036970|564812940|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
156469198|NCT02036970|564812941|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
156469199|NCT02036970|564812942|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
156469200|NCT02036970|564812943|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
156469201|NCT02036970|564812944|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
156469202|NCT02036970|564812945|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
156839284|NCT00549770|566163352|FG000|Overall Study|Administrative problems|0|||
156340510|NCT01606800|564346398|FG000|Overall Study|Adverse Event|3|||
156469203|NCT02036970|564812946|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
156839285|NCT00549770|566163353|FG001|Overall Study|Administrative problems|1|||
156839286|NCT00549770|566163354|FG002|Overall Study|Administrative problems|0|||
156839287|NCT00549770|566163355|FG003|Overall Study|Administrative problems|0|||
156340511|NCT01606800|564346399|FG001|Overall Study|Adverse Event|1|||
156340512|NCT01606800|564346398|FG000|Overall Study|Participant withdrew consent|0|||
156839288|NCT00549770|566163356|FG004|Overall Study|Administrative problems|0|||
156839289|NCT00549770|566163357|FG005|Overall Study|Administrative problems|0|||
156839290|NCT00549770|566163358|FG006|Overall Study|Administrative problems|0|||
156839291|NCT00549770|566163359|FG007|Overall Study|Administrative problems|1|||
156839292|NCT00549770|566163352|FG000|Overall Study|Lost to Follow-up|0|||
156839293|NCT00549770|566163353|FG001|Overall Study|Lost to Follow-up|0|||
156839294|NCT00549770|566163354|FG002|Overall Study|Lost to Follow-up|2|||
156839295|NCT00549770|566163355|FG003|Overall Study|Lost to Follow-up|2|||
156839296|NCT00549770|566163356|FG004|Overall Study|Lost to Follow-up|3|||
156839297|NCT00549770|566163357|FG005|Overall Study|Lost to Follow-up|2|||
156839298|NCT00549770|566163358|FG006|Overall Study|Lost to Follow-up|0|||
156839299|NCT00549770|566163359|FG007|Overall Study|Lost to Follow-up|0|||
156839300|NCT00549770|566163352|FG000|Overall Study|Withdrawal by Subject|4|||
156839301|NCT00549770|566163353|FG001|Overall Study|Withdrawal by Subject|6|||
156839302|NCT00549770|566163354|FG002|Overall Study|Withdrawal by Subject|4|||
156839303|NCT00549770|566163355|FG003|Overall Study|Withdrawal by Subject|5|||
156839304|NCT00549770|566163356|FG004|Overall Study|Withdrawal by Subject|6|||
156839305|NCT00549770|566163357|FG005|Overall Study|Withdrawal by Subject|6|||
156839306|NCT00549770|566163358|FG006|Overall Study|Withdrawal by Subject|4|||
156340513|NCT01606800|564346399|FG001|Overall Study|Participant withdrew consent|1|||
156469204|NCT02702843|564812947|FG000|Overall Study|Insufficient data to analyze|15|||
156469205|NCT02702843|564812948|FG001|Overall Study|Insufficient data to analyze|23|||
156469206|NCT05802173|564812949|FG000|Overall Study|Withdrawal by Subject|2|||
156469207|NCT05802173|564812950|FG001|Overall Study|Withdrawal by Subject|0|||
156469208|NCT05802173|564812951|FG002|Overall Study|Withdrawal by Subject|0|||
156469209|NCT05802173|564812949|FG000|Overall Study|Protocol Violation|1|||
156469210|NCT05802173|564812950|FG001|Overall Study|Protocol Violation|0|||
156469211|NCT05802173|564812951|FG002|Overall Study|Protocol Violation|0|||
156469212|NCT05802173|564812949|FG000|Overall Study|Lost to Follow-up|0|||
156469213|NCT05802173|564812950|FG001|Overall Study|Lost to Follow-up|6|||
156469214|NCT05802173|564812951|FG002|Overall Study|Lost to Follow-up|4|||
156469215|NCT05802173|564812949|FG000|Overall Study|non-compliance|0|||
156469216|NCT05802173|564812950|FG001|Overall Study|non-compliance|1|||
156469217|NCT05802173|564812951|FG002|Overall Study|non-compliance|0|||
156469218|NCT03752684|564812953|FG000|Overall Study|Lost to Follow-up|4|||
156469219|NCT00360269|564812954|FG000|Overall Study|Lost to Follow-up|7|||
156469220|NCT00360269|564812955|FG001|Overall Study|Lost to Follow-up|9|||
156469221|NCT00360269|564812954|FG000|Overall Study|Physician Decision|1|||
156469222|NCT00360269|564812955|FG001|Overall Study|Physician Decision|2|||
156469223|NCT00360269|564812954|FG000|Overall Study|Adverse Event|1|||
156469224|NCT00360269|564812955|FG001|Overall Study|Adverse Event|0|||
156469225|NCT00360269|564812954|FG000|Overall Study|Withdrawal by Subject|1|||
156839307|NCT00549770|566163359|FG007|Overall Study|Withdrawal by Subject|9|||
156839308|NCT00549770|566163352|FG000|Overall Study|Lack of Efficacy|1|||
156839309|NCT00549770|566163353|FG001|Overall Study|Lack of Efficacy|0|||
156469226|NCT00360269|564812955|FG001|Overall Study|Withdrawal by Subject|1|||
156469227|NCT00048932|564812956|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
156469228|NCT00048932|564812957|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
156469229|NCT00048932|564812958|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
156469230|NCT00048932|564812956|FG000|Double Blind Period (DB)|Adverse Event|51|||
156469231|NCT00048932|564812957|FG001|Double Blind Period (DB)|Adverse Event|19|||
156469232|NCT00048932|564812958|FG002|Double Blind Period (DB)|Adverse Event|0|||
156469233|NCT00048932|564812956|FG000|Double Blind Period (DB)|Death|5|||
156469234|NCT00048932|564812957|FG001|Double Blind Period (DB)|Death|3|||
156469235|NCT00048932|564812958|FG002|Double Blind Period (DB)|Death|0|||
156469236|NCT00048932|564812956|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
156469237|NCT00048932|564812957|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
156469238|NCT00048932|564812958|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
156469239|NCT00048932|564812956|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
156469240|NCT00048932|564812957|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
156469241|NCT00048932|564812958|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
156469242|NCT00048932|564812956|FG000|Double Blind Period (DB)|Relocation|1|||
156839310|NCT00549770|566163354|FG002|Overall Study|Lack of Efficacy|2|||
156839311|NCT00549770|566163355|FG003|Overall Study|Lack of Efficacy|3|||
156340514|NCT01606800|564346398|FG000|Overall Study|Missing completion status|2|||
156469243|NCT00048932|564812957|FG001|Double Blind Period (DB)|Relocation|0|||
156469244|NCT00048932|564812958|FG002|Double Blind Period (DB)|Relocation|0|||
156469245|NCT00048932|564812956|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
156469246|NCT00048932|564812957|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
156469247|NCT00048932|564812958|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
156469248|NCT00048932|564812956|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
156839312|NCT00549770|566163356|FG004|Overall Study|Lack of Efficacy|5|||
156839313|NCT00549770|566163357|FG005|Overall Study|Lack of Efficacy|1|||
156839314|NCT00549770|566163358|FG006|Overall Study|Lack of Efficacy|3|||
156839315|NCT00549770|566163359|FG007|Overall Study|Lack of Efficacy|8|||
156839316|NCT00549770|566163352|FG000|Overall Study|Abnormal test procedure results|0|||
156839317|NCT00549770|566163353|FG001|Overall Study|Abnormal test procedure results|0|||
156839318|NCT00549770|566163354|FG002|Overall Study|Abnormal test procedure results|0|||
156839319|NCT00549770|566163355|FG003|Overall Study|Abnormal test procedure results|2|||
156839320|NCT00549770|566163356|FG004|Overall Study|Abnormal test procedure results|0|||
156839321|NCT00549770|566163357|FG005|Overall Study|Abnormal test procedure results|1|||
156839322|NCT00549770|566163358|FG006|Overall Study|Abnormal test procedure results|1|||
156839323|NCT00549770|566163359|FG007|Overall Study|Abnormal test procedure results|1|||
156469249|NCT00048932|564812957|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
156469250|NCT00048932|564812958|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
156469251|NCT00048932|564812956|FG000|Double Blind Period (DB)|Pregnancy|1|||
156469252|NCT00048932|564812957|FG001|Double Blind Period (DB)|Pregnancy|0|||
156469253|NCT00048932|564812958|FG002|Double Blind Period (DB)|Pregnancy|0|||
156469254|NCT00048932|564812956|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
156469255|NCT00048932|564812957|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
156469256|NCT00048932|564812958|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
156469257|NCT00048932|564812956|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
156469258|NCT00048932|564812957|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
156469259|NCT00048932|564812958|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
156469260|NCT00048932|564812956|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
156469261|NCT00048932|564812957|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
156469262|NCT00048932|564812958|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
156469263|NCT00048932|564812956|FG000|Open Label Period (OL)|Death|0|||
156469264|NCT00048932|564812957|FG001|Open Label Period (OL)|Death|0|||
156469265|NCT00048932|564812958|FG002|Open Label Period (OL)|Death|25|||
156469266|NCT00048932|564812956|FG000|Open Label Period (OL)|Adverse Event|0|||
156469267|NCT00048932|564812957|FG001|Open Label Period (OL)|Adverse Event|0|||
156469268|NCT00048932|564812958|FG002|Open Label Period (OL)|Adverse Event|103|||
156469269|NCT00048932|564812956|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
156469270|NCT00048932|564812957|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
156469271|NCT00048932|564812958|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
156469272|NCT00048932|564812956|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
156469273|NCT00048932|564812957|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
156469274|NCT00048932|564812958|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
156469275|NCT00048932|564812956|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
156469276|NCT00048932|564812957|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
156469277|NCT00048932|564812958|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
156469278|NCT00048932|564812956|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
156469279|NCT00048932|564812957|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
156469280|NCT00048932|564812958|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
156839324|NCT00549770|566163352|FG000|Overall Study|Abnormal laboratory values|0|||
156839325|NCT00549770|566163353|FG001|Overall Study|Abnormal laboratory values|0|||
156839326|NCT00549770|566163354|FG002|Overall Study|Abnormal laboratory values|0|||
156839327|NCT00549770|566163355|FG003|Overall Study|Abnormal laboratory values|0|||
156839328|NCT00549770|566163356|FG004|Overall Study|Abnormal laboratory values|0|||
156839329|NCT00549770|566163357|FG005|Overall Study|Abnormal laboratory values|1|||
156839330|NCT00549770|566163358|FG006|Overall Study|Abnormal laboratory values|0|||
156839331|NCT00549770|566163359|FG007|Overall Study|Abnormal laboratory values|0|||
156839332|NCT00549770|566163352|FG000|Overall Study|Adverse Event|1|||
156839333|NCT00549770|566163353|FG001|Overall Study|Adverse Event|3|||
156839334|NCT00549770|566163354|FG002|Overall Study|Adverse Event|1|||
156839335|NCT00549770|566163355|FG003|Overall Study|Adverse Event|2|||
156839336|NCT00549770|566163356|FG004|Overall Study|Adverse Event|1|||
156839337|NCT00549770|566163357|FG005|Overall Study|Adverse Event|0|||
156839338|NCT00549770|566163358|FG006|Overall Study|Adverse Event|5|||
156839339|NCT00549770|566163359|FG007|Overall Study|Adverse Event|4|||
156839340|NCT00847015|566163360|FG000|Overall Study|Withdrawal by Subject|1|||
156839341|NCT00847015|566163360|FG000|Overall Study|declined any surgery|1|||
156839342|NCT00847015|566163360|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
156839343|NCT01641822|566163361|FG000|Run-in Phase|Noncompliance with study drug|1|||
156839344|NCT01641822|566163362|FG001|Run-in Phase|Noncompliance with study drug|0|||
156839345|NCT01641822|566163363|FG002|Run-in Phase|Noncompliance with study drug|0|||
156839346|NCT01641822|566163361|FG000|Run-in Phase|Adverse Event|3|||
156839347|NCT01641822|566163362|FG001|Run-in Phase|Adverse Event|0|||
156839348|NCT01641822|566163363|FG002|Run-in Phase|Adverse Event|0|||
156839349|NCT01641822|566163361|FG000|Run-in Phase|Withdrew consent|1|||
156839350|NCT01641822|566163362|FG001|Run-in Phase|Withdrew consent|0|||
156839351|NCT01641822|566163363|FG002|Run-in Phase|Withdrew consent|0|||
156839352|NCT01641822|566163361|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
156839353|NCT01641822|566163362|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
156839354|NCT01641822|566163363|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
156839355|NCT01641822|566163361|FG000|Comparative Phase|Noncompliance with study drug|0|||
156839356|NCT01641822|566163362|FG001|Comparative Phase|Noncompliance with study drug|1|||
156839357|NCT01641822|566163363|FG002|Comparative Phase|Noncompliance with study drug|0|||
156839358|NCT01641822|566163361|FG000|Comparative Phase|Investigator's discretion|0|||
156839359|NCT01641822|566163362|FG001|Comparative Phase|Investigator's discretion|0|||
156839360|NCT01641822|566163363|FG002|Comparative Phase|Investigator's discretion|1|||
156839361|NCT01641822|566163361|FG000|Comparative Phase|Pregnancy|0|||
156839362|NCT01641822|566163362|FG001|Comparative Phase|Pregnancy|0|||
156839363|NCT01641822|566163363|FG002|Comparative Phase|Pregnancy|1|||
156839364|NCT01641822|566163361|FG000|Comparative Phase|Adverse event, serious fatal|0|||
156469281|NCT00048932|564812956|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
156469282|NCT00048932|564812957|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
156469283|NCT00048932|564812958|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
156469284|NCT00048932|564812956|FG000|Open Label Period (OL)|Pregnancy|0|||
156469285|NCT00048932|564812957|FG001|Open Label Period (OL)|Pregnancy|0|||
156469286|NCT00048932|564812958|FG002|Open Label Period (OL)|Pregnancy|6|||
156469287|NCT00048932|564812956|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
156469288|NCT00048932|564812957|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
156469289|NCT00048932|564812958|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
156469290|NCT00048932|564812956|FG000|Open Label Period (OL)|Investigator Retiring|0|||
156469291|NCT00048932|564812957|FG001|Open Label Period (OL)|Investigator Retiring|0|||
156469292|NCT00048932|564812958|FG002|Open Label Period (OL)|Investigator Retiring|2|||
156469293|NCT00048932|564812956|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
156469294|NCT00048932|564812957|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
156469295|NCT00048932|564812958|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
156469296|NCT00048932|564812956|FG000|Open Label Period (OL)|Participant Relocated|0|||
156469297|NCT00048932|564812957|FG001|Open Label Period (OL)|Participant Relocated|0|||
156469298|NCT00048932|564812958|FG002|Open Label Period (OL)|Participant Relocated|6|||
156469299|NCT00048932|564812956|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
156469300|NCT00048932|564812957|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
156839365|NCT01641822|566163362|FG001|Comparative Phase|Adverse event, serious fatal|1|||
156839366|NCT01641822|566163363|FG002|Comparative Phase|Adverse event, serious fatal|0|||
156839367|NCT01641822|566163361|FG000|Comparative Phase|Withdrew consent|0|||
156839368|NCT01641822|566163362|FG001|Comparative Phase|Withdrew consent|3|||
156839369|NCT01641822|566163363|FG002|Comparative Phase|Withdrew consent|7|||
156839370|NCT01641822|566163361|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
156839371|NCT01641822|566163362|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
156839372|NCT01641822|566163363|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
156839373|NCT00454584|566163364|FG000|Controlled Period|Adverse Event|5|||
156839374|NCT00454584|566163365|FG001|Controlled Period|Adverse Event|2|||
156839375|NCT00454584|566163366|FG002|Controlled Period|Adverse Event|1|||
156839376|NCT00454584|566163367|FG003|Controlled Period|Adverse Event|0|||
156839377|NCT00454584|566163368|FG004|Controlled Period|Adverse Event|0|||
156839378|NCT00454584|566163369|FG005|Controlled Period|Adverse Event|0|||
156469301|NCT00048932|564812958|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
156469302|NCT00048932|564812956|FG000|Open Label Period (OL)|Site Closure|0|||
156469303|NCT00048932|564812957|FG001|Open Label Period (OL)|Site Closure|0|||
156469304|NCT00048932|564812958|FG002|Open Label Period (OL)|Site Closure|3|||
156469305|NCT00048932|564812956|FG000|Open Label Period (OL)|Trial Terminated|0|||
156469306|NCT00048932|564812957|FG001|Open Label Period (OL)|Trial Terminated|0|||
156469307|NCT00048932|564812958|FG002|Open Label Period (OL)|Trial Terminated|1|||
156469308|NCT00048932|564812956|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
156469309|NCT00048932|564812957|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
156469310|NCT00048932|564812958|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
156469311|NCT00048932|564812956|FG000|Open Label Period (OL)|Patient Decision|0|||
156469312|NCT00048932|564812957|FG001|Open Label Period (OL)|Patient Decision|0|||
156469313|NCT00048932|564812958|FG002|Open Label Period (OL)|Patient Decision|4|||
156469314|NCT00048932|564812956|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
156469315|NCT00048932|564812957|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
156469316|NCT00048932|564812958|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
156839379|NCT00454584|566163364|FG000|Controlled Period|Lost to Follow-up|1|||
156839380|NCT00454584|566163365|FG001|Controlled Period|Lost to Follow-up|2|||
156839381|NCT00454584|566163366|FG002|Controlled Period|Lost to Follow-up|2|||
156839382|NCT00454584|566163367|FG003|Controlled Period|Lost to Follow-up|0|||
156839383|NCT00454584|566163368|FG004|Controlled Period|Lost to Follow-up|0|||
156839384|NCT00454584|566163369|FG005|Controlled Period|Lost to Follow-up|0|||
156839385|NCT00454584|566163364|FG000|Controlled Period|Other|5|||
156839386|NCT00454584|566163365|FG001|Controlled Period|Other|4|||
156839387|NCT00454584|566163366|FG002|Controlled Period|Other|2|||
156839388|NCT00454584|566163367|FG003|Controlled Period|Other|0|||
156839389|NCT00454584|566163368|FG004|Controlled Period|Other|0|||
156839390|NCT00454584|566163369|FG005|Controlled Period|Other|0|||
156839391|NCT00454584|566163364|FG000|After Controlled Period|Adverse Event|0|||
156839392|NCT00454584|566163365|FG001|After Controlled Period|Adverse Event|0|||
156839393|NCT00454584|566163366|FG002|After Controlled Period|Adverse Event|0|||
156839394|NCT00454584|566163367|FG003|After Controlled Period|Adverse Event|9|||
156839395|NCT00454584|566163368|FG004|After Controlled Period|Adverse Event|3|||
156839396|NCT00454584|566163369|FG005|After Controlled Period|Adverse Event|9|||
156839397|NCT00454584|566163364|FG000|After Controlled Period|Lack of Efficacy|0|||
156839398|NCT00454584|566163365|FG001|After Controlled Period|Lack of Efficacy|0|||
156839399|NCT00454584|566163366|FG002|After Controlled Period|Lack of Efficacy|0|||
156839400|NCT00454584|566163367|FG003|After Controlled Period|Lack of Efficacy|1|||
156839401|NCT00454584|566163368|FG004|After Controlled Period|Lack of Efficacy|0|||
156839402|NCT00454584|566163369|FG005|After Controlled Period|Lack of Efficacy|0|||
156839403|NCT00454584|566163364|FG000|After Controlled Period|Lost to Follow-up|0|||
156839404|NCT00454584|566163365|FG001|After Controlled Period|Lost to Follow-up|0|||
156839405|NCT00454584|566163366|FG002|After Controlled Period|Lost to Follow-up|0|||
156839406|NCT00454584|566163367|FG003|After Controlled Period|Lost to Follow-up|2|||
156839407|NCT00454584|566163368|FG004|After Controlled Period|Lost to Follow-up|4|||
156839408|NCT00454584|566163369|FG005|After Controlled Period|Lost to Follow-up|6|||
156839409|NCT00454584|566163364|FG000|After Controlled Period|Other|0|||
156839410|NCT00454584|566163365|FG001|After Controlled Period|Other|0|||
156839411|NCT00454584|566163366|FG002|After Controlled Period|Other|0|||
156839412|NCT00454584|566163367|FG003|After Controlled Period|Other|1|||
156839413|NCT00454584|566163368|FG004|After Controlled Period|Other|0|||
156839414|NCT00454584|566163369|FG005|After Controlled Period|Other|0|||
156839415|NCT00454584|566163364|FG000|After Controlled Period|Other|0|||
156839416|NCT00454584|566163365|FG001|After Controlled Period|Other|0|||
156839417|NCT00454584|566163366|FG002|After Controlled Period|Other|0|||
156839418|NCT00454584|566163367|FG003|After Controlled Period|Other|13|||
156839419|NCT00454584|566163368|FG004|After Controlled Period|Other|5|||
156839420|NCT00454584|566163369|FG005|After Controlled Period|Other|17|||
156469317|NCT00048932|564812956|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
156469318|NCT00048932|564812957|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
156469319|NCT00048932|564812958|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
156469320|NCT00048932|564812956|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
156469321|NCT00048932|564812957|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
156839421|NCT02760810|566163370|FG000|Overall Study|Protocol Violation|1|||
156839422|NCT02421601|566163371|FG000|Overall Study|Adverse Event|4|||
156839423|NCT02421601|566163371|FG000|Overall Study|Lack of Efficacy|5|||
156839424|NCT02421601|566163371|FG000|Overall Study|Physician Decision|1|||
156839425|NCT02421601|566163371|FG000|Overall Study|Withdrawal by Subject|31|||
156839426|NCT02421601|566163371|FG000|Overall Study|Others|41|||
156839427|NCT01581619|566163372|FG000|Overall Study|Withdrawal by Subject|1|||
156839428|NCT01581619|566163372|FG000|Overall Study|Lost to Follow-up|1|||
156839429|NCT02250664|566163375|FG000|Overall Study|Lost to Follow-up|18|||
156469322|NCT00048932|564812958|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
156469323|NCT00048932|564812956|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
156469324|NCT00048932|564812957|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
156469325|NCT00048932|564812958|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
156469326|NCT00048932|564812956|FG000|Open Label Period (OL)|Investigator Decision|0|||
156469327|NCT00048932|564812957|FG001|Open Label Period (OL)|Investigator Decision|0|||
156469328|NCT00048932|564812958|FG002|Open Label Period (OL)|Investigator Decision|4|||
156469329|NCT00048932|564812956|FG000|Open Label Period (OL)|Site Staff Issues|0|||
156469330|NCT00048932|564812957|FG001|Open Label Period (OL)|Site Staff Issues|0|||
156469331|NCT00048932|564812958|FG002|Open Label Period (OL)|Site Staff Issues|2|||
156469332|NCT00048932|564812956|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
156469333|NCT00048932|564812957|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
156469334|NCT00048932|564812958|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
156469335|NCT00048932|564812956|FG000|Open Label Period (OL)|Participant Surgery|0|||
156839430|NCT02250664|566163376|FG001|Overall Study|Lost to Follow-up|28|||
156839431|NCT02250664|566163377|FG002|Overall Study|Lost to Follow-up|33|||
156839432|NCT02250664|566163375|FG000|Overall Study|Personal Reasons|7|||
156839433|NCT02250664|566163376|FG001|Overall Study|Personal Reasons|8|||
156839434|NCT02250664|566163377|FG002|Overall Study|Personal Reasons|14|||
156839435|NCT02250664|566163375|FG000|Overall Study|Adverse Event|6|||
156839436|NCT02250664|566163376|FG001|Overall Study|Adverse Event|3|||
156839437|NCT02250664|566163377|FG002|Overall Study|Adverse Event|8|||
156839438|NCT02250664|566163375|FG000|Overall Study|Incarcerated|2|||
156839439|NCT02250664|566163376|FG001|Overall Study|Incarcerated|1|||
156839440|NCT02250664|566163377|FG002|Overall Study|Incarcerated|2|||
156839441|NCT02250664|566163375|FG000|Overall Study|Withdrawal by Subject|0|||
156839442|NCT02250664|566163376|FG001|Overall Study|Withdrawal by Subject|1|||
156839443|NCT02250664|566163377|FG002|Overall Study|Withdrawal by Subject|2|||
156839444|NCT02250664|566163375|FG000|Overall Study|Death|0|||
156839445|NCT02250664|566163376|FG001|Overall Study|Death|1|||
156839446|NCT02250664|566163377|FG002|Overall Study|Death|1|||
156839447|NCT02250664|566163375|FG000|Overall Study|Physician Decision|1|||
156839448|NCT02250664|566163376|FG001|Overall Study|Physician Decision|3|||
156839449|NCT02250664|566163377|FG002|Overall Study|Physician Decision|1|||
156839450|NCT02250664|566163375|FG000|Overall Study|Protocol Violation|1|||
156839451|NCT02250664|566163376|FG001|Overall Study|Protocol Violation|0|||
156839452|NCT02250664|566163377|FG002|Overall Study|Protocol Violation|1|||
156839453|NCT02250664|566163375|FG000|Overall Study|Reason unknown|1|||
156839454|NCT02250664|566163376|FG001|Overall Study|Reason unknown|0|||
156839455|NCT02250664|566163377|FG002|Overall Study|Reason unknown|0|||
156839456|NCT01716104|566163379|FG000|Overall Study|Do not meet inclusion criteria|6|||
156839457|NCT01716104|566163380|FG001|Overall Study|Do not meet inclusion criteria|7|||
156839458|NCT00117793|566163381|FG000|Overall Study|Withdrawal by Subject|12|||
156839459|NCT01753401|566163388|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
156839460|NCT01753401|566163389|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
156839461|NCT01753401|566163390|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
156839462|NCT01753401|566163391|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
156839463|NCT01753401|566163388|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
156839464|NCT01753401|566163389|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
156839465|NCT01753401|566163390|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
156839466|NCT01753401|566163391|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
156839467|NCT01753401|566163388|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
156839468|NCT01753401|566163389|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
156839469|NCT01753401|566163390|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
156839470|NCT01753401|566163391|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
156839471|NCT01753401|566163388|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
156839472|NCT01753401|566163389|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
156839473|NCT01753401|566163390|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
156839474|NCT01753401|566163391|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
156839475|NCT01753401|566163388|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
156839476|NCT01753401|566163389|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
156839477|NCT01753401|566163390|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
156469336|NCT00048932|564812957|FG001|Open Label Period (OL)|Participant Surgery|0|||
156469337|NCT00048932|564812958|FG002|Open Label Period (OL)|Participant Surgery|1|||
156469338|NCT02568215|564812963|FG000|Overall Study|Death|1|||
156839478|NCT01753401|566163391|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
156839479|NCT01753401|566163388|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
156839480|NCT01753401|566163389|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
156839481|NCT01753401|566163390|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
156839482|NCT01753401|566163391|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
156839483|NCT01753401|566163388|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
156839484|NCT01753401|566163389|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
156340515|NCT01606800|564346399|FG001|Overall Study|Missing completion status|0|||
156839485|NCT01753401|566163390|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
156839486|NCT01753401|566163391|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
156469339|NCT02568215|564812964|FG001|Overall Study|Death|2|||
156469340|NCT02568215|564812965|FG002|Overall Study|Death|0|||
156469341|NCT02568215|564812963|FG000|Overall Study|Physician Decision|2|||
156469342|NCT02568215|564812964|FG001|Overall Study|Physician Decision|2|||
156469343|NCT02568215|564812965|FG002|Overall Study|Physician Decision|2|||
156469344|NCT02568215|564812963|FG000|Overall Study|Lost to Follow-up|29|||
156469345|NCT02568215|564812964|FG001|Overall Study|Lost to Follow-up|32|||
156469346|NCT02568215|564812965|FG002|Overall Study|Lost to Follow-up|41|||
156469347|NCT02568215|564812963|FG000|Overall Study|Withdrawal by Subject|21|||
156469348|NCT02568215|564812964|FG001|Overall Study|Withdrawal by Subject|19|||
156469349|NCT02568215|564812965|FG002|Overall Study|Withdrawal by Subject|22|||
156469350|NCT02568215|564812963|FG000|Overall Study|Protocol Violation|1|||
156469351|NCT02568215|564812964|FG001|Overall Study|Protocol Violation|1|||
156469352|NCT02568215|564812965|FG002|Overall Study|Protocol Violation|0|||
156469353|NCT02568215|564812963|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
156469354|NCT02568215|564812964|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
156469355|NCT02568215|564812965|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
156469356|NCT02568215|564812963|FG000|Overall Study|Other|0|||
156469357|NCT02568215|564812964|FG001|Overall Study|Other|1|||
156469358|NCT02568215|564812965|FG002|Overall Study|Other|4|||
156469359|NCT03244800|564812966|FG000|Overall Study|Adverse Event|0|||
156469360|NCT03244800|564812967|FG001|Overall Study|Adverse Event|1|||
156469361|NCT03244800|564812968|FG002|Overall Study|Adverse Event|0|||
156469362|NCT03244800|564812969|FG003|Overall Study|Adverse Event|1|||
156469363|NCT03244800|564812966|FG000|Overall Study|Withdrew treatment|0|||
156469364|NCT03244800|564812967|FG001|Overall Study|Withdrew treatment|0|||
156469365|NCT03244800|564812968|FG002|Overall Study|Withdrew treatment|0|||
156469366|NCT03244800|564812969|FG003|Overall Study|Withdrew treatment|1|||
156469367|NCT00890591|564812977|FG000|Overall Study|Lack of Efficacy|20|||
156839487|NCT00581360|566163392|FG000|Overall Study|Withdrawal by Subject|1|||
156839488|NCT03129360|566163393|FG000|Overall Study|Did not meet entry criteria|0|||
156839489|NCT03129360|566163394|FG001|Overall Study|Did not meet entry criteria|2|||
156839490|NCT03129360|566163395|FG002|Overall Study|Did not meet entry criteria|1|||
156839491|NCT03129360|566163393|FG000|Overall Study|Excluded due to motion in scanner|1|||
156839492|NCT03129360|566163394|FG001|Overall Study|Excluded due to motion in scanner|0|||
156839493|NCT03129360|566163395|FG002|Overall Study|Excluded due to motion in scanner|0|||
156839494|NCT00599638|566163396|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
156839495|NCT00599638|566163397|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
156839496|NCT00599638|566163398|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
156839497|NCT00599638|566163399|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
156839498|NCT00599638|566163396|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
156839499|NCT00599638|566163397|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
156839500|NCT00599638|566163398|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
156839501|NCT00599638|566163399|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
156839502|NCT00599638|566163396|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
156839503|NCT00599638|566163397|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
156839504|NCT00599638|566163398|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
156839505|NCT00599638|566163399|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
156839506|NCT00599638|566163396|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
156839507|NCT00599638|566163397|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
156839508|NCT00599638|566163398|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
156541451|NCT02966509|565075421|FG001|Baseline Satisfaction Survey|Death|1|||
156541452|NCT02966509|565075420|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
156839509|NCT00599638|566163399|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
156839510|NCT00599638|566163396|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
156839511|NCT00599638|566163397|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
156839512|NCT00599638|566163398|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
156839513|NCT00599638|566163399|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
156839514|NCT00599638|566163396|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
156839515|NCT00599638|566163397|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
156839516|NCT00599638|566163398|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
156839517|NCT00599638|566163399|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
156839518|NCT00599638|566163396|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
156469368|NCT02941549|564812978|FG000|Overall Study|Adverse Event|1|||
156469369|NCT02941549|564812979|FG001|Overall Study|Adverse Event|0|||
156469370|NCT02941549|564812980|FG002|Overall Study|Adverse Event|0|||
156469371|NCT02941549|564812978|FG000|Overall Study|Withdrawal by Subject|2|||
156469372|NCT02941549|564812979|FG001|Overall Study|Withdrawal by Subject|1|||
156469373|NCT02941549|564812980|FG002|Overall Study|Withdrawal by Subject|2|||
156469374|NCT03451422|564812987|FG000|Overall Study|Lost to Follow-up|0|||
156469375|NCT03451422|564812988|FG001|Overall Study|Lost to Follow-up|0|||
156469376|NCT03451422|564812989|FG002|Overall Study|Lost to Follow-up|0|||
156469377|NCT03451422|564812990|FG003|Overall Study|Lost to Follow-up|0|||
156469378|NCT03451422|564812991|FG004|Overall Study|Lost to Follow-up|0|||
156469379|NCT03451422|564812992|FG005|Overall Study|Lost to Follow-up|1|||
156469380|NCT03451422|564812987|FG000|Overall Study|Decision by sponsor|1|||
156469381|NCT03451422|564812988|FG001|Overall Study|Decision by sponsor|0|||
156469382|NCT03451422|564812989|FG002|Overall Study|Decision by sponsor|1|||
156469383|NCT03451422|564812990|FG003|Overall Study|Decision by sponsor|0|||
156469384|NCT03451422|564812991|FG004|Overall Study|Decision by sponsor|0|||
156469385|NCT03451422|564812992|FG005|Overall Study|Decision by sponsor|0|||
156469386|NCT03451422|564812987|FG000|Overall Study|Withdrawal by Subject|0|||
156469387|NCT03451422|564812988|FG001|Overall Study|Withdrawal by Subject|0|||
156469388|NCT03451422|564812989|FG002|Overall Study|Withdrawal by Subject|2|||
156469389|NCT03451422|564812990|FG003|Overall Study|Withdrawal by Subject|3|||
156469390|NCT03451422|564812991|FG004|Overall Study|Withdrawal by Subject|2|||
156469391|NCT03451422|564812992|FG005|Overall Study|Withdrawal by Subject|1|||
156469392|NCT04545619|564812993|FG000|Overall Study|due to equipment challenges|1|||
156469393|NCT04384172|564812996|FG000|Overall Study|Lost to Follow-up|0|||
156469394|NCT04384172|564812997|FG001|Overall Study|Lost to Follow-up|2|||
156469395|NCT04384172|564812996|FG000|Overall Study|Pregnancy|1|||
156469396|NCT04384172|564812997|FG001|Overall Study|Pregnancy|0|||
156469397|NCT04384172|564812996|FG000|Overall Study|Withdrawal by Subject|0|||
156469398|NCT04384172|564812997|FG001|Overall Study|Withdrawal by Subject|1|||
156469399|NCT04949542|564812998|FG000|Overall Study|Lost to Follow-up|4|||
156469400|NCT04949542|564812999|FG001|Overall Study|Lost to Follow-up|1|||
156469401|NCT01536093|564813002|FG000|Overall Study|Death|1|||
156469402|NCT01536093|564813003|FG001|Overall Study|Death|2|||
156469403|NCT01536093|564813002|FG000|Overall Study|absence of maternal colostrum|2|||
156469404|NCT01536093|564813003|FG001|Overall Study|absence of maternal colostrum|0|||
156469405|NCT01536093|564813002|FG000|Overall Study|Withdrawal by Subject|0|||
156469406|NCT01536093|564813003|FG001|Overall Study|Withdrawal by Subject|1|||
156469407|NCT01211184|564813004|FG000|Overall Study|Withdrawal by Subject|0|||
156469408|NCT01211184|564813005|FG001|Overall Study|Withdrawal by Subject|2|||
156469409|NCT01211184|564813006|FG002|Overall Study|Withdrawal by Subject|1|||
156469410|NCT01421667|564813007|FG000|Overall Study|Withdrawal by Subject|0|||
156469411|NCT01421667|564813008|FG001|Overall Study|Withdrawal by Subject|1|||
156469412|NCT01421667|564813009|FG002|Overall Study|Withdrawal by Subject|2|||
156469413|NCT01421667|564813010|FG003|Overall Study|Withdrawal by Subject|1|||
156469414|NCT01421667|564813007|FG000|Overall Study|Lost to Follow-up|0|||
156469415|NCT01421667|564813008|FG001|Overall Study|Lost to Follow-up|1|||
156469416|NCT01421667|564813009|FG002|Overall Study|Lost to Follow-up|0|||
156469417|NCT01421667|564813010|FG003|Overall Study|Lost to Follow-up|0|||
156469418|NCT00503906|564813011|FG000|Overall Study|Withdrawal by Subject|1|||
156469419|NCT03802994|564813012|FG000|Overall Study|Lost to Follow-up|0|||
156469420|NCT03802994|564813013|FG001|Overall Study|Lost to Follow-up|2|||
156469421|NCT03802994|564813014|FG002|Overall Study|Lost to Follow-up|3|||
156469422|NCT03802994|564813015|FG003|Overall Study|Lost to Follow-up|2|||
156469423|NCT03802994|564813016|FG004|Overall Study|Lost to Follow-up|2|||
156469424|NCT00983294|564813017|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
156469425|NCT00983294|564813017|FG000|Colchicine With Azithromycin|Adverse Event|1|||
156469426|NCT00390884|564813018|FG000|Overall Study|Withdrawal by Subject|2|||
156469427|NCT00390884|564813019|FG001|Overall Study|Withdrawal by Subject|2|||
156469428|NCT00756574|564813020|FG000|Overall Study|Withdrawal by Subject|9|||
156469429|NCT00756574|564813021|FG001|Overall Study|Withdrawal by Subject|7|||
156469430|NCT00756574|564813020|FG000|Overall Study|Lost to Follow-up|4|||
156839519|NCT00599638|566163397|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
156839520|NCT00599638|566163398|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
156839521|NCT00599638|566163399|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
156839522|NCT00599638|566163396|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
156839523|NCT00599638|566163397|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
156469431|NCT00756574|564813021|FG001|Overall Study|Lost to Follow-up|4|||
156469432|NCT04622332|564813022|FG000|Overall Study|Withdrawal by Subject|4|||
156469433|NCT04622332|564813023|FG001|Overall Study|Withdrawal by Subject|2|||
156469434|NCT04622332|564813022|FG000|Overall Study|Physician Decision|1|||
156469435|NCT04622332|564813023|FG001|Overall Study|Physician Decision|1|||
156469436|NCT04622332|564813022|FG000|Overall Study|Adverse Event|0|||
156469437|NCT04622332|564813023|FG001|Overall Study|Adverse Event|2|||
156469438|NCT04622332|564813022|FG000|Overall Study|Protocol Violation|0|||
156469439|NCT04622332|564813023|FG001|Overall Study|Protocol Violation|1|||
156469440|NCT05966155|564813024|FG000|Overall Study|Death|1|||
156469441|NCT05966155|564813025|FG001|Overall Study|Death|2|||
156469442|NCT05966155|564813024|FG000|Overall Study|Lost to Follow-up|63|||
156469443|NCT05966155|564813025|FG001|Overall Study|Lost to Follow-up|67|||
156839524|NCT00599638|566163398|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
156469444|NCT05966155|564813024|FG000|Overall Study|Protocol Violation|1|||
156469445|NCT05966155|564813025|FG001|Overall Study|Protocol Violation|0|||
156469446|NCT05966155|564813024|FG000|Overall Study|Withdrawal by Subject|8|||
156469447|NCT05966155|564813025|FG001|Overall Study|Withdrawal by Subject|9|||
156541453|NCT02966509|565075421|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
156541454|NCT02966509|565075420|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
156541455|NCT02966509|565075421|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
156541456|NCT02966509|565075420|FG000|6 Month Satisfaction Decision Survey|Death|22|||
156541457|NCT02966509|565075421|FG001|6 Month Satisfaction Decision Survey|Death|25|||
156541458|NCT02966509|565075420|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
156541459|NCT02966509|565075421|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
156541460|NCT02966509|565075420|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
156541461|NCT02966509|565075421|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
156541462|NCT02966509|565075420|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
156541463|NCT02966509|565075421|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
156541464|NCT02966509|565075420|FG000|6 Month Satisfaction Survey|Death|36|||
156541465|NCT02966509|565075421|FG001|6 Month Satisfaction Survey|Death|33|||
156541466|NCT02966509|565075420|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
156541467|NCT02966509|565075421|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
156839525|NCT00599638|566163399|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
156839526|NCT00599638|566163396|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
156839527|NCT00599638|566163397|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
156839528|NCT00599638|566163398|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
156839529|NCT00599638|566163399|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
156839530|NCT03006887|566163403|FG000|Overall Study|Adverse Event|1|||
156839531|NCT03836677|566163404|FG000|Period 1|Adverse Event|0|||
156839532|NCT03836677|566163405|FG001|Period 1|Adverse Event|1|||
156839533|NCT03836677|566163404|FG000|Period 2|Severe non-compliance to protocol|1|||
156839534|NCT03836677|566163405|FG001|Period 2|Severe non-compliance to protocol|0|||
156839535|NCT02895945|566163406|FG000|Overall Study|Physician Decision|2|||
156839536|NCT02895945|566163407|FG001|Overall Study|Physician Decision|1|||
156839537|NCT00462748|566163408|FG000|Overall Study|Adverse Event|7|||
156839538|NCT00462748|566163409|FG001|Overall Study|Adverse Event|5|||
156839539|NCT00462748|566163410|FG002|Overall Study|Adverse Event|9|||
156839540|NCT00462748|566163408|FG000|Overall Study|Protocol Violation|0|||
156839541|NCT00462748|566163409|FG001|Overall Study|Protocol Violation|2|||
156839542|NCT00462748|566163410|FG002|Overall Study|Protocol Violation|1|||
156839543|NCT00462748|566163408|FG000|Overall Study|Withdrew consent|3|||
156839544|NCT00462748|566163409|FG001|Overall Study|Withdrew consent|3|||
156839545|NCT00462748|566163410|FG002|Overall Study|Withdrew consent|0|||
156839546|NCT00462748|566163408|FG000|Overall Study|Lost to Follow-up|1|||
156839547|NCT00462748|566163409|FG001|Overall Study|Lost to Follow-up|1|||
156839548|NCT00462748|566163410|FG002|Overall Study|Lost to Follow-up|1|||
156839549|NCT00462748|566163408|FG000|Overall Study|Discontinued after 41 days Rx|1|||
156839550|NCT00462748|566163409|FG001|Overall Study|Discontinued after 41 days Rx|0|||
156839551|NCT00462748|566163410|FG002|Overall Study|Discontinued after 41 days Rx|0|||
156839552|NCT01818492|566163411|FG000|Overall Study|Adverse Event|2|||
156839553|NCT01818492|566163411|FG000|Overall Study|Death|3|||
156839554|NCT01818492|566163411|FG000|Overall Study|Withdrawal by Subject|1|||
156839555|NCT01818492|566163411|FG000|Overall Study|Additional therapy when not allowed PP|4|||
156839556|NCT01729208|566163412|FG000|Baseline|Physician Decision|5|||
156839557|NCT01729208|566163413|FG001|Baseline|Physician Decision|4|||
156839558|NCT01729208|566163412|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
156839559|NCT01729208|566163413|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
156839560|NCT01729208|566163412|FG000|12 Months Follow-up|Lost to Follow-up|3|||
156839561|NCT01729208|566163413|FG001|12 Months Follow-up|Lost to Follow-up|3|||
156839562|NCT01729208|566163412|FG000|24 Months Follow-up|Lost to Follow-up|3|||
156839563|NCT01729208|566163413|FG001|24 Months Follow-up|Lost to Follow-up|0|||
156839564|NCT01729208|566163412|FG000|36 Months Follow-up|Physician Decision|1|||
156839565|NCT01729208|566163413|FG001|36 Months Follow-up|Physician Decision|0|||
156839566|NCT01729208|566163412|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
156839567|NCT01729208|566163413|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
156340516|NCT02370160|564346401|FG000|Overall Study|Death|3|||
156541468|NCT02966509|565075420|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
156839568|NCT00082381|566163414|FG000|Overall Study|Adverse Event|27|||
156839569|NCT00082381|566163415|FG001|Overall Study|Adverse Event|2|||
156839570|NCT00082381|566163414|FG000|Overall Study|Lost to Follow-up|5|||
156839571|NCT00082381|566163415|FG001|Overall Study|Lost to Follow-up|7|||
156839572|NCT00082381|566163414|FG000|Overall Study|Patient Decision|8|||
156839573|NCT00082381|566163415|FG001|Overall Study|Patient Decision|4|||
156541469|NCT02966509|565075421|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
156839574|NCT00082381|566163414|FG000|Overall Study|Physician Decision|1|||
156839575|NCT00082381|566163415|FG001|Overall Study|Physician Decision|2|||
156839576|NCT00082381|566163414|FG000|Overall Study|Protocol Violation|10|||
156839577|NCT00082381|566163415|FG001|Overall Study|Protocol Violation|11|||
156839578|NCT00082381|566163414|FG000|Overall Study|Loss of Glucose Control|4|||
156839579|NCT00082381|566163415|FG001|Overall Study|Loss of Glucose Control|0|||
156839580|NCT02428413|566163416|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
156839581|NCT02428413|566163417|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
156839582|NCT02428413|566163416|FG000|Overall Study|Protocol Violation|1|||
156839583|NCT02428413|566163417|FG001|Overall Study|Protocol Violation|2|||
156839584|NCT02428413|566163416|FG000|Overall Study|Case Cancelled|2|||
156839585|NCT02428413|566163417|FG001|Overall Study|Case Cancelled|0|||
156839586|NCT02428413|566163416|FG000|Overall Study|Missed Cases|1|||
156839587|NCT02428413|566163417|FG001|Overall Study|Missed Cases|2|||
156839588|NCT02428413|566163416|FG000|Overall Study|Nurse Refusal|1|||
156839589|NCT02428413|566163417|FG001|Overall Study|Nurse Refusal|0|||
156839590|NCT00109577|566163418|FG000|Overall Study|Withdrawal by Subject|3|||
156839591|NCT00109577|566163419|FG001|Overall Study|Withdrawal by Subject|3|||
156839592|NCT04891107|566163420|FG000|Overall Study|Physician Decision|1|||
156839593|NCT04891107|566163420|FG000|Overall Study|Withdrawal by Subject|1|||
156839594|NCT04891107|566163420|FG000|Overall Study|Screen failure after consent|1|||
156839595|NCT00565136|566163421|FG000|Overall Study|Lost to Follow-up|1|||
156839596|NCT00565136|566163421|FG000|Overall Study|Withdrawal by Subject|1|||
156839597|NCT00565136|566163421|FG000|Overall Study|Protocol Violation|1|||
156839598|NCT05096312|566163424|FG000|Overall Study|Lost to Follow-up|2|||
156839599|NCT05096312|566163425|FG001|Overall Study|Lost to Follow-up|4|||
156839600|NCT05096312|566163424|FG000|Overall Study|Adverse Event|1|||
156839601|NCT05096312|566163425|FG001|Overall Study|Adverse Event|0|||
156839602|NCT00576576|566163426|FG000|Overall Study|Lost to Follow-up|6|||
156839603|NCT00576576|566163426|FG000|Overall Study|Protocol Violation|1|||
156839604|NCT03135210|566163427|FG000|Overall Study|Death|0|||
156839605|NCT03135210|566163428|FG001|Overall Study|Death|1|||
156839606|NCT04512976|566165350|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839607|NCT04512976|566165351|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839608|NCT04512976|566165352|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839609|NCT04512976|566165353|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839610|NCT04512976|566165354|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839611|NCT04512976|566165355|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
156839612|NCT05249569|566165360|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
156839613|NCT01192412|566165363|FG000|Overall Study|Lost to Follow-up|2|||
156839614|NCT01192412|566165364|FG001|Overall Study|Lost to Follow-up|1|||
156839615|NCT01192412|566165363|FG000|Overall Study|Withdrawal by Subject|2|||
156839616|NCT01192412|566165364|FG001|Overall Study|Withdrawal by Subject|1|||
156839617|NCT00859937|566165365|FG000|Overall Study|Protocol Violation|1|||
156839618|NCT00859937|566165366|FG001|Overall Study|Protocol Violation|0|||
156839619|NCT00615030|566165367|FG000|Period I|Administrative problem|0|||
156839620|NCT00615030|566165368|FG001|Period I|Administrative problem|0|||
156839621|NCT00615030|566165369|FG002|Period I|Administrative problem|0|||
156839622|NCT00615030|566165370|FG003|Period I|Administrative problem|0|||
156839623|NCT00615030|566165371|FG004|Period I|Administrative problem|1|||
156839624|NCT00615030|566165372|FG005|Period I|Administrative problem|0|||
156839625|NCT00615030|566165373|FG006|Period I|Administrative problem|0|||
156839626|NCT00615030|566165374|FG007|Period I|Administrative problem|0|||
156839627|NCT00615030|566165375|FG008|Period I|Administrative problem|0|||
156839628|NCT00615030|566165376|FG009|Period I|Administrative problem|0|||
156839629|NCT00615030|566165377|FG010|Period I|Administrative problem|0|||
156469448|NCT05966155|564813024|FG000|Overall Study|Enrolled Erroneously|0|||
156469449|NCT05966155|564813025|FG001|Overall Study|Enrolled Erroneously|1|||
156469450|NCT05966155|564813024|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
156469451|NCT05966155|564813025|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
156469452|NCT02744066|564813035|FG000|Overall Study|Withdrawal by parent|0|||
156469453|NCT02744066|564813036|FG001|Overall Study|Withdrawal by parent|1|||
156469454|NCT02744066|564813035|FG000|Overall Study|Discharged from NICU prior to completion|0|||
156469455|NCT02744066|564813036|FG001|Overall Study|Discharged from NICU prior to completion|4|||
156469456|NCT01675492|564813041|FG000|Overall Study|study completed early - product approval|42|||
156469457|NCT03656718|564813042|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
156839630|NCT00615030|566165378|FG011|Period I|Administrative problem|0|||
156839631|NCT00615030|566165367|FG000|Period I|Protocol deviation|1|||
156839632|NCT00615030|566165368|FG001|Period I|Protocol deviation|0|||
156839633|NCT00615030|566165369|FG002|Period I|Protocol deviation|0|||
156839634|NCT00615030|566165370|FG003|Period I|Protocol deviation|0|||
156839635|NCT00615030|566165371|FG004|Period I|Protocol deviation|0|||
156839636|NCT00615030|566165372|FG005|Period I|Protocol deviation|0|||
156839637|NCT00615030|566165373|FG006|Period I|Protocol deviation|0|||
156839638|NCT00615030|566165374|FG007|Period I|Protocol deviation|0|||
156839639|NCT00615030|566165375|FG008|Period I|Protocol deviation|0|||
156839640|NCT00615030|566165376|FG009|Period I|Protocol deviation|0|||
156839641|NCT00615030|566165377|FG010|Period I|Protocol deviation|0|||
156839642|NCT00615030|566165378|FG011|Period I|Protocol deviation|0|||
156839643|NCT00615030|566165367|FG000|Period I|Subject withdrew consent|0|||
156839644|NCT00615030|566165368|FG001|Period I|Subject withdrew consent|0|||
156839645|NCT00615030|566165369|FG002|Period I|Subject withdrew consent|0|||
156839646|NCT00615030|566165370|FG003|Period I|Subject withdrew consent|0|||
156839647|NCT00615030|566165371|FG004|Period I|Subject withdrew consent|0|||
156469458|NCT03656718|564813043|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
156469459|NCT03656718|564813044|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
156469460|NCT03656718|564813045|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
156469461|NCT03656718|564813046|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
156469462|NCT03656718|564813047|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
156469463|NCT03656718|564813048|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
156469464|NCT03656718|564813042|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
156469465|NCT03656718|564813043|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
156469466|NCT03656718|564813044|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
156469467|NCT03656718|564813045|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
156469468|NCT03656718|564813046|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
156469469|NCT03656718|564813047|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
156839648|NCT00615030|566165372|FG005|Period I|Subject withdrew consent|0|||
156839649|NCT00615030|566165373|FG006|Period I|Subject withdrew consent|0|||
156839650|NCT00615030|566165374|FG007|Period I|Subject withdrew consent|0|||
156839651|NCT00615030|566165375|FG008|Period I|Subject withdrew consent|1|||
156839652|NCT00615030|566165376|FG009|Period I|Subject withdrew consent|0|||
156839653|NCT00615030|566165377|FG010|Period I|Subject withdrew consent|1|||
156839654|NCT00615030|566165378|FG011|Period I|Subject withdrew consent|1|||
156839655|NCT00615030|566165367|FG000|Period I|Abnormal laboratory value(s)|0|||
156839656|NCT00615030|566165368|FG001|Period I|Abnormal laboratory value(s)|0|||
156839657|NCT00615030|566165369|FG002|Period I|Abnormal laboratory value(s)|0|||
156839658|NCT00615030|566165370|FG003|Period I|Abnormal laboratory value(s)|0|||
156839659|NCT00615030|566165371|FG004|Period I|Abnormal laboratory value(s)|0|||
156839660|NCT00615030|566165372|FG005|Period I|Abnormal laboratory value(s)|1|||
156839661|NCT00615030|566165373|FG006|Period I|Abnormal laboratory value(s)|0|||
156839662|NCT00615030|566165374|FG007|Period I|Abnormal laboratory value(s)|0|||
156839663|NCT00615030|566165375|FG008|Period I|Abnormal laboratory value(s)|0|||
156839664|NCT00615030|566165376|FG009|Period I|Abnormal laboratory value(s)|0|||
156839665|NCT00615030|566165377|FG010|Period I|Abnormal laboratory value(s)|0|||
156839666|NCT00615030|566165378|FG011|Period I|Abnormal laboratory value(s)|0|||
156839667|NCT00615030|566165367|FG000|Period II|Adverse Event|0|||
156839668|NCT00615030|566165368|FG001|Period II|Adverse Event|0|||
156839669|NCT00615030|566165369|FG002|Period II|Adverse Event|1|||
156839670|NCT00615030|566165370|FG003|Period II|Adverse Event|0|||
156839671|NCT00615030|566165371|FG004|Period II|Adverse Event|0|||
156839672|NCT00615030|566165372|FG005|Period II|Adverse Event|0|||
156839673|NCT00615030|566165373|FG006|Period II|Adverse Event|0|||
156839674|NCT00615030|566165374|FG007|Period II|Adverse Event|0|||
156839675|NCT00615030|566165375|FG008|Period II|Adverse Event|1|||
156839676|NCT00615030|566165376|FG009|Period II|Adverse Event|0|||
156469470|NCT03656718|564813048|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
156469471|NCT03656718|564813042|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
156469472|NCT03656718|564813043|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
156469473|NCT03656718|564813044|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
156469474|NCT03656718|564813045|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
156469475|NCT03656718|564813046|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
156469476|NCT03656718|564813047|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
156469477|NCT03656718|564813048|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
156469478|NCT03656718|564813042|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
156469479|NCT03656718|564813043|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
156469480|NCT03656718|564813044|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
156839677|NCT00615030|566165377|FG010|Period II|Adverse Event|0|||
156839678|NCT00615030|566165378|FG011|Period II|Adverse Event|0|||
156839679|NCT00615030|566165367|FG000|Period II|Subject withdrew consent|0|||
156340517|NCT02370160|564346402|FG001|Overall Study|Death|4|||
156340518|NCT02370160|564346403|FG002|Overall Study|Death|1|||
156469481|NCT03656718|564813045|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
156469482|NCT03656718|564813046|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
156839680|NCT00615030|566165368|FG001|Period II|Subject withdrew consent|0|||
156839681|NCT00615030|566165369|FG002|Period II|Subject withdrew consent|0|||
156839682|NCT00615030|566165370|FG003|Period II|Subject withdrew consent|1|||
156839683|NCT00615030|566165371|FG004|Period II|Subject withdrew consent|0|||
156839684|NCT00615030|566165372|FG005|Period II|Subject withdrew consent|0|||
156839685|NCT00615030|566165373|FG006|Period II|Subject withdrew consent|1|||
156839686|NCT00615030|566165374|FG007|Period II|Subject withdrew consent|0|||
156340519|NCT03797014|564346406|FG000|Overall Study|Withdrawal by Subject|1|||
156839687|NCT00615030|566165375|FG008|Period II|Subject withdrew consent|0|||
156839688|NCT00615030|566165376|FG009|Period II|Subject withdrew consent|0|||
156839689|NCT00615030|566165377|FG010|Period II|Subject withdrew consent|0|||
156839690|NCT00615030|566165378|FG011|Period II|Subject withdrew consent|0|||
156839691|NCT00615030|566165367|FG000|Period III|Administrative problems|1|||
156839692|NCT00615030|566165368|FG001|Period III|Administrative problems|0|||
156839693|NCT00615030|566165369|FG002|Period III|Administrative problems|0|||
156839694|NCT00615030|566165370|FG003|Period III|Administrative problems|1|||
156839695|NCT00615030|566165371|FG004|Period III|Administrative problems|0|||
156839696|NCT00615030|566165372|FG005|Period III|Administrative problems|0|||
156839697|NCT00615030|566165373|FG006|Period III|Administrative problems|0|||
156839698|NCT00615030|566165374|FG007|Period III|Administrative problems|0|||
156839699|NCT00615030|566165375|FG008|Period III|Administrative problems|0|||
156839700|NCT00615030|566165376|FG009|Period III|Administrative problems|0|||
156839701|NCT00615030|566165377|FG010|Period III|Administrative problems|0|||
156839702|NCT00615030|566165378|FG011|Period III|Administrative problems|0|||
156839703|NCT00151476|566165379|FG000|FAP Identified Subjects|Protocol Violation|0|||
156839704|NCT00151476|566165380|FG001|FAP Identified Subjects|Protocol Violation|1|||
156839705|NCT00151476|566165379|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
156839706|NCT00151476|566165380|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
156839707|NCT00151476|566165379|FG000|FAP Analyzed Subjects|Other study participation|0|||
156839708|NCT00151476|566165380|FG001|FAP Analyzed Subjects|Other study participation|1|||
156839709|NCT03446456|566165381|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
156839710|NCT03446456|566165382|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
156839711|NCT03446456|566165381|FG000|Overall Study|Lost to Follow-up|1|||
156839712|NCT03446456|566165382|FG001|Overall Study|Lost to Follow-up|3|||
156839713|NCT03446456|566165381|FG000|Overall Study|Participant failed the toxicology test|1|||
156839714|NCT03446456|566165382|FG001|Overall Study|Participant failed the toxicology test|0|||
156839715|NCT03446456|566165381|FG000|Overall Study|Break down of the experimental equipment|1|||
156839716|NCT03446456|566165382|FG001|Overall Study|Break down of the experimental equipment|0|||
156839717|NCT00308074|566165397|FG000|Overall Study|Withdrawal by Subject|1|||
156839718|NCT03002311|566165398|FG000|Overall Study|Lost to Follow-up|13|||
156839719|NCT03002311|566165399|FG001|Overall Study|Lost to Follow-up|26|||
156839720|NCT03002311|566165398|FG000|Overall Study|Referral provider called to schedule app|3|||
156839721|NCT03002311|566165399|FG001|Overall Study|Referral provider called to schedule app|3|||
156839722|NCT03002311|566165398|FG000|Overall Study|Physician Decision|3|||
156839723|NCT03002311|566165399|FG001|Overall Study|Physician Decision|1|||
156839724|NCT01329939|566165403|FG000|Overall Study|Lost to Follow-up|3|||
156839725|NCT01329939|566165404|FG001|Overall Study|Lost to Follow-up|0|||
156839726|NCT01329939|566165405|FG002|Overall Study|Lost to Follow-up|1|||
156839727|NCT01329939|566165406|FG003|Overall Study|Lost to Follow-up|2|||
156839728|NCT01329939|566165403|FG000|Overall Study|Withdrawal by Subject|0|||
156839729|NCT01329939|566165404|FG001|Overall Study|Withdrawal by Subject|1|||
156839730|NCT01329939|566165405|FG002|Overall Study|Withdrawal by Subject|0|||
156839731|NCT01329939|566165406|FG003|Overall Study|Withdrawal by Subject|0|||
156839732|NCT01329939|566165403|FG000|Overall Study|Adverse Event|0|||
156839733|NCT01329939|566165404|FG001|Overall Study|Adverse Event|0|||
156839734|NCT01329939|566165405|FG002|Overall Study|Adverse Event|0|||
156839735|NCT01329939|566165406|FG003|Overall Study|Adverse Event|3|||
156839736|NCT03722524|566165407|FG000|Overall Study|Protocol Violation|86|||
156839737|NCT03722524|566165407|FG000|Overall Study|Adverse Event|7|||
156839738|NCT03722524|566165407|FG000|Overall Study|Lost to Follow-up|1|||
156839739|NCT03722524|566165407|FG000|Overall Study|Reason is not stated|1|||
156839740|NCT03722524|566165407|FG000|Overall Study|Physician Decision|1|||
156839741|NCT03722524|566165407|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
156839742|NCT00989963|566165409|FG000|Overall Study|Adverse Event|1|||
156839743|NCT00989963|566165410|FG001|Overall Study|Adverse Event|1|||
156340520|NCT03797014|564346406|FG000|Overall Study|Lost to Follow-up|1|||
156340521|NCT03797014|564346406|FG000|Overall Study|Protocol Violation|1|||
156340522|NCT03305575|564346411|FG000|Overall Study|Physician Decision|1|||
156469483|NCT03656718|564813047|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
156469484|NCT03656718|564813048|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
156839744|NCT00989963|566165411|FG002|Overall Study|Adverse Event|1|||
156839745|NCT01240200|566165418|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
156839746|NCT01240200|566165419|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
156839747|NCT01529034|566165422|FG000|Overall Study|Discontinued prior to study treatment|14|||
156839748|NCT01529034|566165422|FG000|Overall Study|Site closure|62|||
156839749|NCT01529034|566165422|FG000|Overall Study|Study termination|29|||
156839750|NCT01529034|566165422|FG000|Overall Study|Withdrawal by Subject|25|||
156839751|NCT01529034|566165422|FG000|Overall Study|No treated SCs within protocol window|13|||
156541470|NCT02966509|565075420|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
156839752|NCT01529034|566165422|FG000|Overall Study|Noncompliance|8|||
156839753|NCT01529034|566165422|FG000|Overall Study|Caregiver no longer available|7|||
156839754|NCT01529034|566165422|FG000|Overall Study|Adverse Event|4|||
156839755|NCT01529034|566165422|FG000|Overall Study|Protocol Violation|4|||
156839756|NCT01529034|566165422|FG000|Overall Study|Lack of Efficacy|4|||
156839757|NCT01529034|566165422|FG000|Overall Study|Investigator no longer available|2|||
156839758|NCT01529034|566165422|FG000|Overall Study|Study drug not available|2|||
156839759|NCT04588389|566165423|FG000|Overall Study|Issues with anesthesia during surgery|2|||
156839760|NCT04588389|566165424|FG001|Overall Study|Issues with anesthesia during surgery|0|||
156839761|NCT04588389|566165425|FG002|Overall Study|Issues with anesthesia during surgery|0|||
156839762|NCT00719680|566165429|FG000|Overall Study|Adverse Event|1|||
156839763|NCT00719680|566165429|FG000|Overall Study|Lost to Follow-up|1|||
156839764|NCT00719680|566165429|FG000|Overall Study|Withdrawal by Subject|3|||
156839765|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
156839766|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
156839767|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
156839768|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
156839769|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
156839770|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
156839771|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Death|1|||
156839772|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Death|4|||
156839773|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
156839774|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
156839775|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Not eligible|1|||
156839776|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Not eligible|2|||
156839777|NCT00658814|566165430|FG000|Consolidation Therapy|Not protocol specified|0|||
156839778|NCT00658814|566165431|FG001|Consolidation Therapy|Not protocol specified|1|||
156839779|NCT00658814|566165430|FG000|Consolidation Therapy|Not eligible|2|||
156839780|NCT00658814|566165431|FG001|Consolidation Therapy|Not eligible|2|||
156839781|NCT00658814|566165430|FG000|Maintenance Therapy|Adverse Event|1|||
156839782|NCT00658814|566165431|FG001|Maintenance Therapy|Adverse Event|1|||
156839783|NCT00658814|566165430|FG000|Maintenance Therapy|Not protocol specified|1|||
156839784|NCT00658814|566165431|FG001|Maintenance Therapy|Not protocol specified|0|||
156839785|NCT00658814|566165430|FG000|Maintenance Therapy|Not eligible|1|||
156839786|NCT00658814|566165431|FG001|Maintenance Therapy|Not eligible|0|||
156839787|NCT02911142|566165432|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
156839788|NCT02911142|566165432|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
156839789|NCT02911142|566165432|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
156839790|NCT02911142|566165432|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
156839791|NCT04071158|566165433|FG000|Overall Study|Lost to Follow-up|1|||
156839792|NCT04071158|566165434|FG001|Overall Study|Lost to Follow-up|2|||
156839793|NCT04071158|566165435|FG002|Overall Study|Lost to Follow-up|3|||
156839794|NCT04071158|566165436|FG003|Overall Study|Lost to Follow-up|3|||
156839795|NCT04071158|566165437|FG004|Overall Study|Lost to Follow-up|5|||
156839796|NCT04071158|566165433|FG000|Overall Study|Randomized but not treated|2|||
156839797|NCT04071158|566165434|FG001|Overall Study|Randomized but not treated|2|||
156839798|NCT04071158|566165435|FG002|Overall Study|Randomized but not treated|0|||
156839799|NCT04071158|566165436|FG003|Overall Study|Randomized but not treated|0|||
156839800|NCT04071158|566165437|FG004|Overall Study|Randomized but not treated|0|||
156839801|NCT01178099|566165438|FG000|Overall Study|Physician Decision|0|||
156839802|NCT01178099|566165439|FG001|Overall Study|Physician Decision|1|||
156839803|NCT02678923|566165452|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
156839804|NCT02678923|566165453|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
156839805|NCT02678923|566165452|FG000|Overall Study|Withdrawal by Subject|3|||
156839806|NCT02678923|566165453|FG001|Overall Study|Withdrawal by Subject|2|||
156839807|NCT02678923|566165452|FG000|Overall Study|Lost to Follow-up|1|||
156839808|NCT02678923|566165453|FG001|Overall Study|Lost to Follow-up|0|||
156839809|NCT02678923|566165452|FG000|Overall Study|Did Not Return for Study Visits|1|||
156839810|NCT02678923|566165453|FG001|Overall Study|Did Not Return for Study Visits|0|||
156839811|NCT00455143|566165454|FG000|Overall Study|Physician Decision|1|||
156839812|NCT00455143|566165454|FG000|Overall Study|Withdrawal by Subject|1|||
156839813|NCT00455143|566165454|FG000|Overall Study|Staff was not avail to follow patient|2|||
156839814|NCT00455143|566165454|FG000|Overall Study|No longer met Inclusion Criteria|1|||
156839815|NCT00455143|566165454|FG000|Overall Study|Surgical time, staff not available|1|||
156839816|NCT03266172|566165455|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
156839817|NCT03266172|566165456|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
156839818|NCT03266172|566165457|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
156839819|NCT03266172|566165455|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
156839820|NCT03266172|566165456|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
156839821|NCT03266172|566165457|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
156839822|NCT03266172|566165455|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
156839823|NCT03266172|566165456|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
156839824|NCT03266172|566165457|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
156839825|NCT03266172|566165455|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
156839826|NCT03266172|566165456|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
156839827|NCT03266172|566165457|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
156839828|NCT03266172|566165455|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
156839829|NCT03266172|566165456|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
156839830|NCT03266172|566165457|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
156340523|NCT03305575|564346412|FG001|Overall Study|Physician Decision|0|||
156340524|NCT00105469|564346413|FG000|Overall Study|Adverse Event|9|||
156340525|NCT00105469|564346414|FG001|Overall Study|Adverse Event|8|||
156340526|NCT00105469|564346413|FG000|Overall Study|Protocol Violation|4|||
156340527|NCT00105469|564346414|FG001|Overall Study|Protocol Violation|0|||
156340528|NCT00105469|564346413|FG000|Overall Study|Withdrawal by Subject|2|||
156340529|NCT00105469|564346414|FG001|Overall Study|Withdrawal by Subject|3|||
156340530|NCT00105469|564346413|FG000|Overall Study|Lost to Follow-up|1|||
156340531|NCT00105469|564346414|FG001|Overall Study|Lost to Follow-up|0|||
156340532|NCT00105469|564346413|FG000|Overall Study|Lack of Efficacy|2|||
156340533|NCT00105469|564346414|FG001|Overall Study|Lack of Efficacy|0|||
156340534|NCT00105469|564346413|FG000|Overall Study|Other Reason|4|||
156340535|NCT00105469|564346414|FG001|Overall Study|Other Reason|0|||
156340536|NCT04980040|564346415|FG000|Overall Study|Violated the Inclusion Criteria|260|||
156340537|NCT04980040|564346415|FG000|Overall Study|Violated the Administration & Dosage|225|||
156340538|NCT04980040|564346415|FG000|Overall Study|Lost to Safety-Follow-up|4|||
156340539|NCT04980040|564346415|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
156340540|NCT01408485|564346416|FG000|Overall Study|Withdrawal by Subject|21|||
156839831|NCT03266172|566165455|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
156839832|NCT03266172|566165456|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
156839833|NCT03266172|566165457|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
156839834|NCT05222555|566165459|FG000|Overall Study|Ongoing|2|||
156839835|NCT05222555|566165460|FG001|Overall Study|Ongoing|18|||
156839836|NCT05222555|566165459|FG000|Overall Study|Adverse Event|1|||
156839837|NCT05222555|566165460|FG001|Overall Study|Adverse Event|1|||
156839838|NCT05222555|566165459|FG000|Overall Study|Death|0|||
156839839|NCT05222555|566165460|FG001|Overall Study|Death|6|||
156839840|NCT05222555|566165459|FG000|Overall Study|Withdrawal by Subject|0|||
156839841|NCT05222555|566165460|FG001|Overall Study|Withdrawal by Subject|11|||
156839842|NCT00300365|566165461|FG000|Overall Study|Lost to Follow-up|1|||
156839843|NCT00300365|566165462|FG001|Overall Study|Lost to Follow-up|0|||
156839844|NCT00300365|566165461|FG000|Overall Study|Physician Decision|2|||
156839845|NCT00300365|566165462|FG001|Overall Study|Physician Decision|0|||
156839846|NCT00300365|566165461|FG000|Overall Study|Withdrawal by Subject|1|||
156839847|NCT00300365|566165462|FG001|Overall Study|Withdrawal by Subject|0|||
156839848|NCT00300365|566165461|FG000|Overall Study|Adverse Event|0|||
156839849|NCT00300365|566165462|FG001|Overall Study|Adverse Event|2|||
156839850|NCT01966445|566165465|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839851|NCT01966445|566165466|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839852|NCT01966445|566165467|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839853|NCT01966445|566165468|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
156839854|NCT01966445|566165469|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839855|NCT01966445|566165470|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
156839856|NCT01966445|566165471|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839857|NCT01966445|566165465|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
156839858|NCT01966445|566165466|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
156839859|NCT01966445|566165467|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
156839860|NCT01966445|566165468|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
156839861|NCT01966445|566165469|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
156839862|NCT01966445|566165470|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
156839863|NCT01966445|566165471|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
156839864|NCT01966445|566165465|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
156839865|NCT01966445|566165466|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
156839866|NCT01966445|566165467|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
156839867|NCT01966445|566165468|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
156839868|NCT01966445|566165469|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
156839869|NCT01966445|566165470|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
156839870|NCT01966445|566165471|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
156839871|NCT01966445|566165465|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839872|NCT01966445|566165466|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839873|NCT01966445|566165467|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839874|NCT01966445|566165468|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839875|NCT01966445|566165469|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839876|NCT01966445|566165470|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156340541|NCT01508650|564346417|FG000|Overall Study|Lost to Follow-up|0|||
156340542|NCT01508650|564346418|FG001|Overall Study|Lost to Follow-up|3|||
156340543|NCT03095066|564346419|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
156839877|NCT01966445|566165471|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
156839878|NCT01966445|566165465|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839879|NCT01966445|566165466|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839880|NCT01966445|566165467|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839881|NCT01966445|566165468|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156469485|NCT03656718|564813042|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
156469486|NCT03656718|564813043|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
156469487|NCT03656718|564813044|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
156469488|NCT03656718|564813045|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
156469489|NCT03656718|564813046|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
156469490|NCT03656718|564813047|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
156469491|NCT03656718|564813048|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
156469492|NCT03656718|564813042|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
156469493|NCT03656718|564813043|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
156469494|NCT03656718|564813044|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
156469495|NCT03656718|564813045|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
156469496|NCT03656718|564813046|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
156469497|NCT03656718|564813047|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
156469498|NCT03656718|564813048|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
156469499|NCT03656718|564813042|FG000|Treatment Period Part C|Disease progression|0|||
156469500|NCT03656718|564813043|FG001|Treatment Period Part C|Disease progression|0|||
156469501|NCT03656718|564813044|FG002|Treatment Period Part C|Disease progression|0|||
156469502|NCT03656718|564813045|FG003|Treatment Period Part C|Disease progression|0|||
156469503|NCT03656718|564813046|FG004|Treatment Period Part C|Disease progression|12|||
156469504|NCT03656718|564813047|FG005|Treatment Period Part C|Disease progression|0|||
156469505|NCT03656718|564813048|FG006|Treatment Period Part C|Disease progression|0|||
156469506|NCT03656718|564813042|FG000|Treatment Period Part C|Death|0|||
156469507|NCT03656718|564813043|FG001|Treatment Period Part C|Death|0|||
156469508|NCT03656718|564813044|FG002|Treatment Period Part C|Death|0|||
156469509|NCT03656718|564813045|FG003|Treatment Period Part C|Death|0|||
156469510|NCT03656718|564813046|FG004|Treatment Period Part C|Death|1|||
156469511|NCT03656718|564813047|FG005|Treatment Period Part C|Death|0|||
156469512|NCT03656718|564813048|FG006|Treatment Period Part C|Death|0|||
156469513|NCT03656718|564813042|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
156469514|NCT03656718|564813043|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
156469515|NCT03656718|564813044|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
156469516|NCT03656718|564813045|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
156469517|NCT03656718|564813046|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
156469518|NCT03656718|564813047|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
156469519|NCT03656718|564813048|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
156469520|NCT03656718|564813042|FG000|Treatment Period Part C|Other reasons|0|||
156469521|NCT03656718|564813043|FG001|Treatment Period Part C|Other reasons|0|||
156469522|NCT03656718|564813044|FG002|Treatment Period Part C|Other reasons|0|||
156469523|NCT03656718|564813045|FG003|Treatment Period Part C|Other reasons|0|||
156469524|NCT03656718|564813046|FG004|Treatment Period Part C|Other reasons|1|||
156469525|NCT03656718|564813047|FG005|Treatment Period Part C|Other reasons|0|||
156469526|NCT03656718|564813048|FG006|Treatment Period Part C|Other reasons|0|||
156469527|NCT03656718|564813042|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
156469528|NCT03656718|564813043|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
156469529|NCT03656718|564813044|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
156469530|NCT03656718|564813045|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
156839882|NCT01966445|566165469|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839883|NCT01966445|566165470|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839884|NCT01966445|566165471|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
156839885|NCT01374178|566165472|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
156839886|NCT01374178|566165473|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
156839887|NCT01374178|566165472|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
156839888|NCT01374178|566165473|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
156839889|NCT04856904|566165476|FG000|Overall Study|Physician Decision|1|||
156839890|NCT04856904|566165477|FG001|Overall Study|Physician Decision|1|||
156839891|NCT04856904|566165476|FG000|Overall Study|Withdrawal by Subject|13|||
156839892|NCT04856904|566165477|FG001|Overall Study|Withdrawal by Subject|13|||
156839893|NCT04856904|566165476|FG000|Overall Study|Adverse Event|1|||
156839894|NCT04856904|566165477|FG001|Overall Study|Adverse Event|1|||
156469531|NCT03656718|564813046|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
156839895|NCT04856904|566165476|FG000|Overall Study|Non-compliance with study drug|1|||
156469532|NCT03656718|564813047|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
156469533|NCT03656718|564813048|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
156469534|NCT03211247|564813049|FG000|Overall Study|Adverse Event|8|||
156839896|NCT04856904|566165477|FG001|Overall Study|Non-compliance with study drug|1|||
156839897|NCT04856904|566165476|FG000|Overall Study|Lost to Follow-up|4|||
156839898|NCT04856904|566165477|FG001|Overall Study|Lost to Follow-up|4|||
156839899|NCT04856904|566165476|FG000|Overall Study|Withdrawal by Subject|1|||
156839900|NCT04856904|566165477|FG001|Overall Study|Withdrawal by Subject|1|||
156839901|NCT04856904|566165476|FG000|Overall Study|Protocol Violation|1|||
156839902|NCT04856904|566165477|FG001|Overall Study|Protocol Violation|1|||
156839903|NCT01422824|566165478|FG000|Overall Study|Case record form not evaluated|1|||
156839904|NCT01422824|566165478|FG000|Overall Study|Lost to Follow-up|37|||
156839905|NCT00902174|566165479|FG000|Overall Study|Adverse Event|27|||
156839906|NCT00902174|566165480|FG001|Overall Study|Adverse Event|7|||
156839907|NCT00902174|566165479|FG000|Overall Study|Lack of Efficacy|1|||
156839908|NCT00902174|566165480|FG001|Overall Study|Lack of Efficacy|5|||
156839909|NCT00902174|566165479|FG000|Overall Study|Death|2|||
156839910|NCT00902174|566165480|FG001|Overall Study|Death|2|||
156839911|NCT00902174|566165479|FG000|Overall Study|Withdrawal by Subject|2|||
156839912|NCT00902174|566165480|FG001|Overall Study|Withdrawal by Subject|1|||
156839913|NCT00902174|566165479|FG000|Overall Study|Abnormal labs|1|||
156839914|NCT00902174|566165480|FG001|Overall Study|Abnormal labs|1|||
156839915|NCT00902174|566165479|FG000|Overall Study|Protocol Violation|1|||
156839916|NCT00902174|566165480|FG001|Overall Study|Protocol Violation|1|||
156839917|NCT00902174|566165479|FG000|Overall Study|Administration problem|0|||
156839918|NCT00902174|566165480|FG001|Overall Study|Administration problem|1|||
156839919|NCT01375608|566165481|FG000|Overall Study|Withdrawal by Subject|2|||
156839920|NCT03429543|566165482|FG000|Overall Study|Adverse Event|1|||
156839921|NCT03429543|566165483|FG001|Overall Study|Adverse Event|1|||
156839922|NCT03429543|566165484|FG002|Overall Study|Adverse Event|0|||
156839923|NCT03429543|566165485|FG003|Overall Study|Adverse Event|0|||
156839924|NCT03429543|566165486|FG004|Overall Study|Adverse Event|0|||
156839925|NCT03429543|566165487|FG005|Overall Study|Adverse Event|2|||
156839926|NCT03429543|566165488|FG006|Overall Study|Adverse Event|0|||
156839927|NCT03429543|566165482|FG000|Overall Study|Lost to Follow-up|1|||
156839928|NCT03429543|566165483|FG001|Overall Study|Lost to Follow-up|0|||
156839929|NCT03429543|566165484|FG002|Overall Study|Lost to Follow-up|0|||
156839930|NCT03429543|566165485|FG003|Overall Study|Lost to Follow-up|0|||
156839931|NCT03429543|566165486|FG004|Overall Study|Lost to Follow-up|1|||
156839932|NCT03429543|566165487|FG005|Overall Study|Lost to Follow-up|0|||
156469535|NCT03211247|564813050|FG001|Overall Study|Adverse Event|0|||
156469536|NCT03211247|564813051|FG002|Overall Study|Adverse Event|1|||
156469537|NCT03211247|564813052|FG003|Overall Study|Adverse Event|0|||
156469538|NCT03211247|564813053|FG004|Overall Study|Adverse Event|0|||
156469539|NCT03211247|564813049|FG000|Overall Study|Lost to Follow-up|2|||
156469540|NCT03211247|564813050|FG001|Overall Study|Lost to Follow-up|1|||
156469541|NCT03211247|564813051|FG002|Overall Study|Lost to Follow-up|0|||
156469542|NCT03211247|564813052|FG003|Overall Study|Lost to Follow-up|0|||
156469543|NCT03211247|564813053|FG004|Overall Study|Lost to Follow-up|0|||
156469544|NCT03211247|564813049|FG000|Overall Study|Physician Decision|1|||
156469545|NCT03211247|564813050|FG001|Overall Study|Physician Decision|2|||
156469546|NCT03211247|564813051|FG002|Overall Study|Physician Decision|0|||
156469547|NCT03211247|564813052|FG003|Overall Study|Physician Decision|0|||
156469548|NCT03211247|564813053|FG004|Overall Study|Physician Decision|0|||
156469549|NCT03211247|564813049|FG000|Overall Study|Non-compliance with study drug|2|||
156469550|NCT03211247|564813050|FG001|Overall Study|Non-compliance with study drug|0|||
156469551|NCT03211247|564813051|FG002|Overall Study|Non-compliance with study drug|0|||
156469552|NCT03211247|564813052|FG003|Overall Study|Non-compliance with study drug|0|||
156469553|NCT03211247|564813053|FG004|Overall Study|Non-compliance with study drug|0|||
156469554|NCT03211247|564813049|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
156839933|NCT03429543|566165488|FG006|Overall Study|Lost to Follow-up|0|||
156839934|NCT03429543|566165482|FG000|Overall Study|Withdrawal by Subject|5|||
156839935|NCT03429543|566165483|FG001|Overall Study|Withdrawal by Subject|0|||
156839936|NCT03429543|566165484|FG002|Overall Study|Withdrawal by Subject|1|||
156839937|NCT03429543|566165485|FG003|Overall Study|Withdrawal by Subject|2|||
156839938|NCT03429543|566165486|FG004|Overall Study|Withdrawal by Subject|6|||
156839939|NCT03429543|566165487|FG005|Overall Study|Withdrawal by Subject|3|||
156469555|NCT03211247|564813050|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
156839940|NCT03429543|566165488|FG006|Overall Study|Withdrawal by Subject|1|||
156340544|NCT03095066|564346420|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
156469556|NCT03211247|564813051|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
156839941|NCT03429543|566165482|FG000|Overall Study|Other reason than listed|0|||
156839942|NCT03429543|566165483|FG001|Overall Study|Other reason than listed|1|||
156839943|NCT03429543|566165484|FG002|Overall Study|Other reason than listed|0|||
156839944|NCT03429543|566165485|FG003|Overall Study|Other reason than listed|0|||
156839945|NCT03429543|566165486|FG004|Overall Study|Other reason than listed|4|||
156469557|NCT03211247|564813052|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
156469558|NCT03211247|564813053|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
156839946|NCT03429543|566165487|FG005|Overall Study|Other reason than listed|4|||
156839947|NCT03429543|566165488|FG006|Overall Study|Other reason than listed|0|||
156839948|NCT03429543|566165482|FG000|Overall Study|Not treated|0|||
156469559|NCT03211247|564813049|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
156469560|NCT03211247|564813050|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
156469561|NCT03211247|564813051|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
156469562|NCT03211247|564813052|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
156469563|NCT03211247|564813053|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
156469564|NCT03211247|564813049|FG000|Overall Study|Protocol Violation|0|||
156469565|NCT03211247|564813050|FG001|Overall Study|Protocol Violation|1|||
156469566|NCT03211247|564813051|FG002|Overall Study|Protocol Violation|0|||
156469567|NCT03211247|564813052|FG003|Overall Study|Protocol Violation|0|||
156469568|NCT03211247|564813053|FG004|Overall Study|Protocol Violation|0|||
156469569|NCT02415127|564813054|FG000|Overall Study|Adverse Event|1|||
156469570|NCT02415127|564813055|FG001|Overall Study|Adverse Event|0|||
156469571|NCT04153890|564813058|FG000|Overall Study|Lost to Follow-up|9|||
156469572|NCT04153890|564813059|FG001|Overall Study|Lost to Follow-up|0|||
156469573|NCT04153890|564813060|FG002|Overall Study|Lost to Follow-up|9|||
156469574|NCT04153890|564813061|FG003|Overall Study|Lost to Follow-up|0|||
156469575|NCT04153890|564813058|FG000|Overall Study|Death|0|||
156469576|NCT04153890|564813059|FG001|Overall Study|Death|2|||
156469577|NCT04153890|564813060|FG002|Overall Study|Death|0|||
156469578|NCT04153890|564813061|FG003|Overall Study|Death|0|||
156469579|NCT04153890|564813058|FG000|Overall Study|Withdrawal by Subject|0|||
156469580|NCT04153890|564813059|FG001|Overall Study|Withdrawal by Subject|0|||
156469581|NCT04153890|564813060|FG002|Overall Study|Withdrawal by Subject|0|||
156469582|NCT04153890|564813061|FG003|Overall Study|Withdrawal by Subject|2|||
156469583|NCT03997474|564813064|FG000|Overall Study|Death|6|||
156469584|NCT03997474|564813065|FG001|Overall Study|Death|2|||
156469585|NCT03997474|564813066|FG002|Overall Study|Death|1|||
156469586|NCT03997474|564813064|FG000|Overall Study|Physician Decision|2|||
156469587|NCT03997474|564813065|FG001|Overall Study|Physician Decision|0|||
156469588|NCT03997474|564813066|FG002|Overall Study|Physician Decision|0|||
156839949|NCT03429543|566165483|FG001|Overall Study|Not treated|0|||
156839950|NCT03429543|566165484|FG002|Overall Study|Not treated|0|||
156839951|NCT03429543|566165485|FG003|Overall Study|Not treated|0|||
156839952|NCT03429543|566165486|FG004|Overall Study|Not treated|1|||
156839953|NCT03429543|566165487|FG005|Overall Study|Not treated|0|||
156839954|NCT03429543|566165488|FG006|Overall Study|Not treated|0|||
156839955|NCT03322423|566165490|FG000|Period 1|Subject no longer eligible|0|||
156839956|NCT03322423|566165491|FG001|Period 1|Subject no longer eligible|1|||
156839957|NCT03322423|566165490|FG000|Period 1|Withdrawal by Subject|0|||
156839958|NCT03322423|566165491|FG001|Period 1|Withdrawal by Subject|1|||
156839959|NCT03322423|566165490|FG000|Period 1|Incorrect Lens Dispensed|1|||
156839960|NCT03322423|566165491|FG001|Period 1|Incorrect Lens Dispensed|0|||
156839961|NCT03322423|566165490|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
156839962|NCT03322423|566165491|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
156839963|NCT03322423|566165490|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
156839964|NCT03322423|566165491|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
156839965|NCT03322423|566165490|FG000|Period 2|Protocol Violation|1|||
156839966|NCT03322423|566165491|FG001|Period 2|Protocol Violation|0|||
156839967|NCT03322423|566165490|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
156839968|NCT03322423|566165491|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
156839969|NCT02453555|566165494|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
156469589|NCT03997474|564813064|FG000|Overall Study|study terminated by sponsor|1|||
156469590|NCT03997474|564813065|FG001|Overall Study|study terminated by sponsor|0|||
156469591|NCT03997474|564813066|FG002|Overall Study|study terminated by sponsor|1|||
156469592|NCT05037513|564813070|FG000|Intervention Period|Lost to Follow-up|1|||
156469593|NCT05037513|564813071|FG001|Intervention Period|Lost to Follow-up|2|||
156469594|NCT05037513|564813070|FG000|Follow Up Period|Lost to Follow-up|16|||
156469595|NCT05037513|564813071|FG001|Follow Up Period|Lost to Follow-up|21|||
156469596|NCT05037513|564813070|FG000|Follow Up Period|Death|0|||
156839970|NCT02453555|566165495|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
156469597|NCT05037513|564813071|FG001|Follow Up Period|Death|1|||
156469598|NCT05037513|564813070|FG000|Follow Up Period|Incarcerated|4|||
156469599|NCT05037513|564813071|FG001|Follow Up Period|Incarcerated|2|||
156469600|NCT03367156|564814804|FG000|Overall Study|Lack of interest|3|||
156839971|NCT02453555|566165496|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
156469601|NCT03367156|564814805|FG001|Overall Study|Lack of interest|1|||
156469602|NCT03367156|564814804|FG000|Overall Study|Death|2|||
156469603|NCT03367156|564814805|FG001|Overall Study|Death|0|||
156469604|NCT03367156|564814804|FG000|Overall Study|Lost to Follow-up|2|||
156839972|NCT02453555|566165497|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
156839973|NCT02453555|566165498|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
156839974|NCT02453555|566165499|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
156469605|NCT03367156|564814805|FG001|Overall Study|Lost to Follow-up|1|||
156469606|NCT03367156|564814804|FG000|Overall Study|Became ineligible|1|||
156469607|NCT03367156|564814805|FG001|Overall Study|Became ineligible|2|||
156469608|NCT03367156|564814804|FG000|Overall Study|Hospitalization|1|||
156469609|NCT03367156|564814805|FG001|Overall Study|Hospitalization|0|||
156839975|NCT02453555|566165494|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
156839976|NCT02453555|566165495|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839977|NCT02453555|566165496|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839978|NCT02453555|566165497|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839979|NCT02453555|566165498|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839980|NCT02453555|566165499|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839981|NCT02453555|566165494|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
156839982|NCT02453555|566165495|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
156839983|NCT02453555|566165496|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156839984|NCT02453555|566165497|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156839985|NCT02453555|566165498|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156839986|NCT02453555|566165499|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156839987|NCT02453555|566165494|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
156839988|NCT02453555|566165495|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
156839989|NCT02453555|566165496|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
156839990|NCT02453555|566165497|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
156839991|NCT02453555|566165498|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
156839992|NCT02453555|566165499|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
156839993|NCT02453555|566165494|FG000|Extension Period|Adverse Event|0|||
156839994|NCT02453555|566165495|FG001|Extension Period|Adverse Event|0|||
156839995|NCT02453555|566165496|FG002|Extension Period|Adverse Event|1|||
156839996|NCT02453555|566165497|FG003|Extension Period|Adverse Event|2|||
156839997|NCT02453555|566165498|FG004|Extension Period|Adverse Event|1|||
156839998|NCT02453555|566165499|FG005|Extension Period|Adverse Event|1|||
156839999|NCT02453555|566165494|FG000|Extension Period|Protocol Violation|0|||
156840000|NCT02453555|566165495|FG001|Extension Period|Protocol Violation|0|||
156840001|NCT02453555|566165496|FG002|Extension Period|Protocol Violation|1|||
156840002|NCT02453555|566165497|FG003|Extension Period|Protocol Violation|0|||
156840003|NCT02453555|566165498|FG004|Extension Period|Protocol Violation|0|||
156840004|NCT02453555|566165499|FG005|Extension Period|Protocol Violation|0|||
156840005|NCT02453555|566165494|FG000|Extension Period|Withdrawal by Subject|0|||
156840006|NCT02453555|566165495|FG001|Extension Period|Withdrawal by Subject|0|||
156840007|NCT02453555|566165496|FG002|Extension Period|Withdrawal by Subject|1|||
156840008|NCT02453555|566165497|FG003|Extension Period|Withdrawal by Subject|0|||
156840009|NCT02453555|566165498|FG004|Extension Period|Withdrawal by Subject|0|||
156840010|NCT02453555|566165499|FG005|Extension Period|Withdrawal by Subject|0|||
156840011|NCT03689855|566165507|FG000|Overall Study|Adverse Event|3|||
156840012|NCT03689855|566165507|FG000|Overall Study|Withdrawal by Subject|1|||
156840013|NCT02409719|566165508|FG000|Overall Study|Lost to Follow-up|3|||
156840014|NCT02409719|566165509|FG001|Overall Study|Lost to Follow-up|3|||
156840015|NCT02879578|566165510|FG000|Overall Study|Adverse Event|1|||
156840016|NCT02879578|566165511|FG001|Overall Study|Adverse Event|2|||
156840017|NCT02879578|566165512|FG002|Overall Study|Adverse Event|14|||
156840018|NCT02879578|566165510|FG000|Overall Study|Protocol Violation|0|||
156840019|NCT02879578|566165511|FG001|Overall Study|Protocol Violation|1|||
156840020|NCT02879578|566165512|FG002|Overall Study|Protocol Violation|1|||
156840021|NCT02879578|566165510|FG000|Overall Study|Withdrawal by Subject|8|||
156840022|NCT02879578|566165511|FG001|Overall Study|Withdrawal by Subject|6|||
156840023|NCT02879578|566165512|FG002|Overall Study|Withdrawal by Subject|9|||
156840024|NCT02879578|566165510|FG000|Overall Study|Lost to Follow-up|1|||
156840025|NCT02879578|566165511|FG001|Overall Study|Lost to Follow-up|0|||
156469610|NCT03367156|564814804|FG000|Overall Study|Concerned about Treatment|11|||
156469611|NCT03367156|564814805|FG001|Overall Study|Concerned about Treatment|3|||
156469612|NCT03367156|564814804|FG000|Overall Study|Started new treatment|4|||
156469613|NCT03367156|564814805|FG001|Overall Study|Started new treatment|1|||
156840026|NCT02879578|566165512|FG002|Overall Study|Lost to Follow-up|4|||
156840027|NCT02879578|566165510|FG000|Overall Study|Physician Decision|0|||
156840028|NCT02879578|566165511|FG001|Overall Study|Physician Decision|0|||
156840029|NCT02879578|566165512|FG002|Overall Study|Physician Decision|4|||
156469614|NCT03762850|564814806|FG000|Overall Study|Death|0|||
156469615|NCT03762850|564814807|FG001|Overall Study|Death|1|||
156840030|NCT03517566|566165516|FG000|Overall Study|Adverse Event|5|||
156840031|NCT03517566|566165517|FG001|Overall Study|Adverse Event|2|||
156840032|NCT03517566|566165518|FG002|Overall Study|Adverse Event|2|||
156469616|NCT03762850|564814806|FG000|Overall Study|Lost to Follow-up|0|||
156840033|NCT03517566|566165519|FG003|Overall Study|Adverse Event|8|||
156840034|NCT03517566|566165520|FG004|Overall Study|Adverse Event|7|||
156840035|NCT03517566|566165516|FG000|Overall Study|Lack of Efficacy|3|||
156840036|NCT03517566|566165517|FG001|Overall Study|Lack of Efficacy|2|||
156840037|NCT03517566|566165518|FG002|Overall Study|Lack of Efficacy|1|||
156840038|NCT03517566|566165519|FG003|Overall Study|Lack of Efficacy|1|||
156840039|NCT03517566|566165520|FG004|Overall Study|Lack of Efficacy|4|||
156840040|NCT03517566|566165516|FG000|Overall Study|Lost to Follow-up|3|||
156469617|NCT03762850|564814807|FG001|Overall Study|Lost to Follow-up|1|||
156840041|NCT03517566|566165517|FG001|Overall Study|Lost to Follow-up|1|||
156840042|NCT03517566|566165518|FG002|Overall Study|Lost to Follow-up|1|||
156840043|NCT03517566|566165519|FG003|Overall Study|Lost to Follow-up|1|||
156840044|NCT03517566|566165520|FG004|Overall Study|Lost to Follow-up|0|||
156840045|NCT03517566|566165516|FG000|Overall Study|Physician Decision|1|||
156840046|NCT03517566|566165517|FG001|Overall Study|Physician Decision|1|||
156840047|NCT03517566|566165518|FG002|Overall Study|Physician Decision|0|||
156840048|NCT03517566|566165519|FG003|Overall Study|Physician Decision|1|||
156840049|NCT03517566|566165520|FG004|Overall Study|Physician Decision|0|||
156840050|NCT03517566|566165516|FG000|Overall Study|Pregnancy|0|||
156840051|NCT03517566|566165517|FG001|Overall Study|Pregnancy|1|||
156840052|NCT03517566|566165518|FG002|Overall Study|Pregnancy|0|||
156840053|NCT03517566|566165519|FG003|Overall Study|Pregnancy|0|||
156840054|NCT03517566|566165520|FG004|Overall Study|Pregnancy|0|||
156840055|NCT03517566|566165516|FG000|Overall Study|Protocol Deviation|0|||
156840056|NCT03517566|566165517|FG001|Overall Study|Protocol Deviation|1|||
156840057|NCT03517566|566165518|FG002|Overall Study|Protocol Deviation|0|||
156840058|NCT03517566|566165519|FG003|Overall Study|Protocol Deviation|1|||
156840059|NCT03517566|566165520|FG004|Overall Study|Protocol Deviation|1|||
156840060|NCT03517566|566165516|FG000|Overall Study|Study terminated by Sponsor|11|||
156840061|NCT03517566|566165517|FG001|Overall Study|Study terminated by Sponsor|5|||
156840062|NCT03517566|566165518|FG002|Overall Study|Study terminated by Sponsor|6|||
156840063|NCT03517566|566165519|FG003|Overall Study|Study terminated by Sponsor|14|||
156840064|NCT03517566|566165520|FG004|Overall Study|Study terminated by Sponsor|12|||
156840065|NCT03517566|566165516|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
156840066|NCT03517566|566165517|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
156840067|NCT03517566|566165518|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
156840068|NCT03517566|566165519|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
156840069|NCT03517566|566165520|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
156840070|NCT04566692|566165521|FG000|Overall Study|Adverse Event|2|||
156840071|NCT04566692|566165522|FG001|Overall Study|Adverse Event|0|||
156840072|NCT04566692|566165521|FG000|Overall Study|Withdrawal by Subject|1|||
156840073|NCT04566692|566165522|FG001|Overall Study|Withdrawal by Subject|1|||
156840074|NCT00671437|566165523|FG000|Overall Study|Progressive disease before C1 week 8|8|||
156840075|NCT00671437|566165523|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
156840076|NCT00671437|566165523|FG000|Overall Study|Adverse Event|3|||
156840077|NCT00671437|566165523|FG000|Overall Study|Ineligible post-hoc|1|||
156840078|NCT00590577|566165524|FG000|Overall Study|Lack of Efficacy|31|||
156840079|NCT00590577|566165525|FG001|Overall Study|Lack of Efficacy|28|||
156840080|NCT00590577|566165526|FG002|Overall Study|Lack of Efficacy|23|||
156840081|NCT00590577|566165527|FG003|Overall Study|Lack of Efficacy|45|||
156840082|NCT00590577|566165524|FG000|Overall Study|Withdrawal by Subject|23|||
156840083|NCT00590577|566165525|FG001|Overall Study|Withdrawal by Subject|28|||
156840084|NCT00590577|566165526|FG002|Overall Study|Withdrawal by Subject|30|||
156840085|NCT00590577|566165527|FG003|Overall Study|Withdrawal by Subject|26|||
156840086|NCT00590577|566165524|FG000|Overall Study|Adverse Event|10|||
156840087|NCT00590577|566165525|FG001|Overall Study|Adverse Event|10|||
156840088|NCT00590577|566165526|FG002|Overall Study|Adverse Event|13|||
156840089|NCT00590577|566165527|FG003|Overall Study|Adverse Event|11|||
156840090|NCT00590577|566165524|FG000|Overall Study|Lost to Follow-up|12|||
156840091|NCT00590577|566165525|FG001|Overall Study|Lost to Follow-up|6|||
156840092|NCT00590577|566165526|FG002|Overall Study|Lost to Follow-up|6|||
156840093|NCT00590577|566165527|FG003|Overall Study|Lost to Follow-up|9|||
156340545|NCT03095066|564346421|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156340546|NCT03095066|564346422|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156340547|NCT03095066|564346423|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156340548|NCT03095066|564346424|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156840094|NCT00590577|566165524|FG000|Overall Study|Pregnancy|0|||
156840095|NCT00590577|566165525|FG001|Overall Study|Pregnancy|1|||
156840096|NCT00590577|566165526|FG002|Overall Study|Pregnancy|0|||
156840097|NCT00590577|566165527|FG003|Overall Study|Pregnancy|0|||
156840098|NCT00590577|566165524|FG000|Overall Study|Various reasons|1|||
156840099|NCT00590577|566165525|FG001|Overall Study|Various reasons|3|||
156840100|NCT00590577|566165526|FG002|Overall Study|Various reasons|1|||
156840101|NCT00590577|566165527|FG003|Overall Study|Various reasons|2|||
156840102|NCT04349033|566165529|FG000|Overall Study|Lost to Follow-up|3|||
156840103|NCT04349033|566165530|FG001|Overall Study|Lost to Follow-up|1|||
156840104|NCT04349033|566165531|FG002|Overall Study|Lost to Follow-up|1|||
156840105|NCT01704456|566165532|FG000|Overall Study|Lost to Follow-up|8|||
156840106|NCT01704456|566165533|FG001|Overall Study|Lost to Follow-up|14|||
156840107|NCT04583956|566165534|FG000|Overall Study|Death|9|||
156840108|NCT04583956|566165535|FG001|Overall Study|Death|11|||
156840109|NCT04583956|566165534|FG000|Overall Study|Lost to Follow-up|7|||
156340549|NCT03095066|564346425|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156340550|NCT03095066|564346426|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156840110|NCT04583956|566165535|FG001|Overall Study|Lost to Follow-up|9|||
156840111|NCT04583956|566165534|FG000|Overall Study|Protocol Violation|2|||
156840112|NCT04583956|566165535|FG001|Overall Study|Protocol Violation|0|||
156840113|NCT04583956|566165534|FG000|Overall Study|Withdrawal by Subject|0|||
156840114|NCT04583956|566165535|FG001|Overall Study|Withdrawal by Subject|2|||
156840115|NCT04583956|566165534|FG000|Overall Study|Randomized but not dosed|2|||
156840116|NCT04583956|566165535|FG001|Overall Study|Randomized but not dosed|3|||
156840117|NCT04583956|566165534|FG000|Overall Study|Withdrawal of consent before product administration|1|||
156840118|NCT04583956|566165535|FG001|Overall Study|Withdrawal of consent before product administration|0|||
156840119|NCT00915551|566165536|FG000|Overall Study|Withdrawal by Subject|0|||
156840120|NCT00915551|566165537|FG001|Overall Study|Withdrawal by Subject|1|||
156840121|NCT05066165|566167829|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
156840122|NCT05066165|566167830|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
156840123|NCT05066165|566167829|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
156840124|NCT05066165|566167830|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
156840125|NCT03210961|566167831|FG000|Overall Study|Adverse Event|0|||
156840126|NCT03210961|566167832|FG001|Overall Study|Adverse Event|0|||
156840127|NCT03210961|566167833|FG002|Overall Study|Adverse Event|0|||
156840128|NCT03210961|566167834|FG003|Overall Study|Adverse Event|0|||
156840129|NCT03210961|566167835|FG004|Overall Study|Adverse Event|0|||
156840130|NCT03210961|566167836|FG005|Overall Study|Adverse Event|0|||
156840131|NCT03210961|566167837|FG006|Overall Study|Adverse Event|0|||
156840132|NCT03210961|566167838|FG007|Overall Study|Adverse Event|0|||
156840133|NCT03210961|566167839|FG008|Overall Study|Adverse Event|0|||
156840134|NCT03210961|566167840|FG009|Overall Study|Adverse Event|0|||
156840135|NCT03210961|566167841|FG010|Overall Study|Adverse Event|0|||
156840136|NCT03210961|566167842|FG011|Overall Study|Adverse Event|0|||
156840137|NCT03210961|566167843|FG012|Overall Study|Adverse Event|0|||
156840138|NCT03210961|566167844|FG013|Overall Study|Adverse Event|1|||
156840139|NCT03210961|566167845|FG014|Overall Study|Adverse Event|0|||
156840140|NCT03210961|566167831|FG000|Overall Study|Lost to Follow-up|0|||
156840141|NCT03210961|566167832|FG001|Overall Study|Lost to Follow-up|0|||
156840142|NCT03210961|566167833|FG002|Overall Study|Lost to Follow-up|0|||
156840143|NCT03210961|566167834|FG003|Overall Study|Lost to Follow-up|0|||
156840144|NCT03210961|566167835|FG004|Overall Study|Lost to Follow-up|0|||
156840145|NCT03210961|566167836|FG005|Overall Study|Lost to Follow-up|0|||
156840146|NCT03210961|566167837|FG006|Overall Study|Lost to Follow-up|0|||
156840147|NCT03210961|566167838|FG007|Overall Study|Lost to Follow-up|0|||
156840148|NCT03210961|566167839|FG008|Overall Study|Lost to Follow-up|0|||
156840149|NCT03210961|566167840|FG009|Overall Study|Lost to Follow-up|0|||
156840150|NCT03210961|566167841|FG010|Overall Study|Lost to Follow-up|0|||
156840151|NCT03210961|566167842|FG011|Overall Study|Lost to Follow-up|0|||
156840152|NCT03210961|566167843|FG012|Overall Study|Lost to Follow-up|0|||
156840153|NCT03210961|566167844|FG013|Overall Study|Lost to Follow-up|0|||
156840154|NCT03210961|566167845|FG014|Overall Study|Lost to Follow-up|1|||
156840155|NCT03210961|566167831|FG000|Overall Study|Withdrawal by Subject|0|||
156840156|NCT03210961|566167832|FG001|Overall Study|Withdrawal by Subject|0|||
156840157|NCT03210961|566167833|FG002|Overall Study|Withdrawal by Subject|0|||
156840158|NCT03210961|566167834|FG003|Overall Study|Withdrawal by Subject|0|||
156840159|NCT03210961|566167835|FG004|Overall Study|Withdrawal by Subject|0|||
156840160|NCT03210961|566167836|FG005|Overall Study|Withdrawal by Subject|0|||
156840161|NCT03210961|566167837|FG006|Overall Study|Withdrawal by Subject|0|||
156840162|NCT03210961|566167838|FG007|Overall Study|Withdrawal by Subject|0|||
156840163|NCT03210961|566167839|FG008|Overall Study|Withdrawal by Subject|0|||
156840164|NCT03210961|566167840|FG009|Overall Study|Withdrawal by Subject|0|||
156840165|NCT03210961|566167841|FG010|Overall Study|Withdrawal by Subject|0|||
156840166|NCT03210961|566167842|FG011|Overall Study|Withdrawal by Subject|0|||
156469618|NCT03762850|564814806|FG000|Overall Study|Physician Decision|0|||
156469619|NCT03762850|564814807|FG001|Overall Study|Physician Decision|1|||
156469620|NCT03762850|564814806|FG000|Overall Study|Withdrawal by Subject|4|||
156469621|NCT03762850|564814807|FG001|Overall Study|Withdrawal by Subject|9|||
156469622|NCT02232737|564814812|FG000|Overall Study|Lost to Follow-up|18|||
156469623|NCT02232737|564814813|FG001|Overall Study|Lost to Follow-up|28|||
156840167|NCT03210961|566167843|FG012|Overall Study|Withdrawal by Subject|0|||
156840168|NCT03210961|566167844|FG013|Overall Study|Withdrawal by Subject|0|||
156840169|NCT03210961|566167845|FG014|Overall Study|Withdrawal by Subject|1|||
156840170|NCT03210961|566167831|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840171|NCT03210961|566167832|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840172|NCT03210961|566167833|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840173|NCT03210961|566167834|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840174|NCT03210961|566167835|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840175|NCT03210961|566167836|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840176|NCT03210961|566167837|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840177|NCT03210961|566167838|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840178|NCT03210961|566167839|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840179|NCT03210961|566167840|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840180|NCT03210961|566167841|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840181|NCT03210961|566167842|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
156469624|NCT02232737|564814814|FG002|Overall Study|Lost to Follow-up|33|||
156840182|NCT03210961|566167843|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840183|NCT03210961|566167844|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
156840184|NCT03210961|566167845|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840185|NCT03210961|566167831|FG000|Overall Study|Other|0|||
156840186|NCT03210961|566167832|FG001|Overall Study|Other|0|||
156840187|NCT03210961|566167833|FG002|Overall Study|Other|0|||
156840188|NCT03210961|566167834|FG003|Overall Study|Other|1|||
156840189|NCT03210961|566167835|FG004|Overall Study|Other|0|||
156840190|NCT03210961|566167836|FG005|Overall Study|Other|0|||
156840191|NCT03210961|566167837|FG006|Overall Study|Other|1|||
156840192|NCT03210961|566167838|FG007|Overall Study|Other|0|||
156840193|NCT03210961|566167839|FG008|Overall Study|Other|0|||
156840194|NCT03210961|566167840|FG009|Overall Study|Other|0|||
156840195|NCT03210961|566167841|FG010|Overall Study|Other|1|||
156840196|NCT03210961|566167842|FG011|Overall Study|Other|0|||
156840197|NCT03210961|566167843|FG012|Overall Study|Other|2|||
156840198|NCT03210961|566167844|FG013|Overall Study|Other|2|||
156840199|NCT03210961|566167845|FG014|Overall Study|Other|0|||
156840200|NCT02467582|566167846|FG000|Allocation|Withdrawal by Subject|1|||
156840201|NCT02467582|566167847|FG001|Allocation|Withdrawal by Subject|0|||
156840202|NCT02467582|566167846|FG000|Follow-up|Death|5|||
156840203|NCT02467582|566167847|FG001|Follow-up|Death|4|||
156840204|NCT02467582|566167846|FG000|Follow-up|Lost to Follow-up|6|||
156840205|NCT02467582|566167847|FG001|Follow-up|Lost to Follow-up|5|||
156840206|NCT01370265|566167848|FG000|First Intervention|Adverse Event|1|||
156840207|NCT01370265|566167849|FG001|First Intervention|Adverse Event|1|||
156840208|NCT03343626|566167850|FG000|Overall Study|Lost to Follow-up|4|||
156840209|NCT03343626|566167851|FG001|Overall Study|Lost to Follow-up|3|||
156840210|NCT03343626|566167852|FG002|Overall Study|Lost to Follow-up|2|||
156840211|NCT03343626|566167853|FG003|Overall Study|Lost to Follow-up|5|||
156840212|NCT03343626|566167854|FG004|Overall Study|Lost to Follow-up|4|||
156840213|NCT03343626|566167855|FG005|Overall Study|Lost to Follow-up|4|||
156840214|NCT03343626|566167856|FG006|Overall Study|Lost to Follow-up|4|||
156840215|NCT03343626|566167857|FG007|Overall Study|Lost to Follow-up|7|||
156840216|NCT03343626|566167850|FG000|Overall Study|Withdrawal of Consent|2|||
156840217|NCT03343626|566167851|FG001|Overall Study|Withdrawal of Consent|1|||
156840218|NCT03343626|566167852|FG002|Overall Study|Withdrawal of Consent|0|||
156840219|NCT03343626|566167853|FG003|Overall Study|Withdrawal of Consent|3|||
156840220|NCT03343626|566167854|FG004|Overall Study|Withdrawal of Consent|3|||
156840221|NCT03343626|566167855|FG005|Overall Study|Withdrawal of Consent|1|||
156840222|NCT03343626|566167856|FG006|Overall Study|Withdrawal of Consent|1|||
156840223|NCT03343626|566167857|FG007|Overall Study|Withdrawal of Consent|2|||
156840224|NCT03343626|566167850|FG000|Overall Study|Reason not Specified|0|||
156840225|NCT03343626|566167851|FG001|Overall Study|Reason not Specified|1|||
156840226|NCT03343626|566167852|FG002|Overall Study|Reason not Specified|0|||
156840227|NCT03343626|566167853|FG003|Overall Study|Reason not Specified|0|||
156469625|NCT02232737|564814812|FG000|Overall Study|Personal reasons|7|||
156840228|NCT03343626|566167854|FG004|Overall Study|Reason not Specified|0|||
156840229|NCT03343626|566167855|FG005|Overall Study|Reason not Specified|0|||
156840230|NCT03343626|566167856|FG006|Overall Study|Reason not Specified|0|||
156840231|NCT03343626|566167857|FG007|Overall Study|Reason not Specified|1|||
156840232|NCT03343626|566167850|FG000|Overall Study|Data Entry Error|0|||
156469626|NCT02232737|564814813|FG001|Overall Study|Personal reasons|8|||
156469627|NCT02232737|564814814|FG002|Overall Study|Personal reasons|14|||
156469628|NCT02232737|564814812|FG000|Overall Study|Adverse Event|6|||
156469629|NCT02232737|564814813|FG001|Overall Study|Adverse Event|3|||
156840233|NCT03343626|566167851|FG001|Overall Study|Data Entry Error|0|||
156840234|NCT03343626|566167852|FG002|Overall Study|Data Entry Error|0|||
156469630|NCT02232737|564814814|FG002|Overall Study|Adverse Event|8|||
156469631|NCT02232737|564814812|FG000|Overall Study|Incarcerated|2|||
156469632|NCT02232737|564814813|FG001|Overall Study|Incarcerated|1|||
156840235|NCT03343626|566167853|FG003|Overall Study|Data Entry Error|0|||
156840236|NCT03343626|566167854|FG004|Overall Study|Data Entry Error|0|||
156840237|NCT03343626|566167855|FG005|Overall Study|Data Entry Error|0|||
156840238|NCT03343626|566167856|FG006|Overall Study|Data Entry Error|0|||
156840239|NCT03343626|566167857|FG007|Overall Study|Data Entry Error|1|||
156840240|NCT00703924|566167858|FG000|Overall Study|Withdrawal by Subject|1|||
156840241|NCT00703924|566167859|FG001|Overall Study|Withdrawal by Subject|1|||
156840242|NCT03592368|566167862|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
156840243|NCT03592368|566167863|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
156840244|NCT03592368|566167864|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
156840245|NCT03592368|566167865|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
156840246|NCT03592368|566167862|FG000|Overall Study|Adverse Event|0|||
156840247|NCT03592368|566167863|FG001|Overall Study|Adverse Event|0|||
156840248|NCT03592368|566167864|FG002|Overall Study|Adverse Event|0|||
156840249|NCT03592368|566167865|FG003|Overall Study|Adverse Event|1|||
156840250|NCT03592368|566167862|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
156840251|NCT03592368|566167863|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
156840252|NCT03592368|566167864|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
156840253|NCT03592368|566167865|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
156840254|NCT03831100|566167866|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
156840255|NCT03831100|566167867|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
156840256|NCT01732770|566167879|FG000|Overall Study|Lost to Follow-up|2|||
156840257|NCT01732770|566167880|FG001|Overall Study|Lost to Follow-up|3|||
156840258|NCT01732770|566167879|FG000|Overall Study|Withdrawal by Subject|5|||
156840259|NCT01732770|566167880|FG001|Overall Study|Withdrawal by Subject|3|||
156840260|NCT01732770|566167879|FG000|Overall Study|Decision by Sponsor|2|||
156840261|NCT01732770|566167880|FG001|Overall Study|Decision by Sponsor|2|||
156840262|NCT01732770|566167879|FG000|Overall Study|Death|1|||
156840263|NCT01732770|566167880|FG001|Overall Study|Death|0|||
156840264|NCT03047031|566167884|FG000|Overall Study|Other than listed|1|||
156840265|NCT03047031|566167885|FG001|Overall Study|Other than listed|0|||
156840266|NCT03047031|566167886|FG002|Overall Study|Other than listed|0|||
156840267|NCT03047031|566167884|FG000|Overall Study|Lost to Follow-up|4|||
156840268|NCT03047031|566167885|FG001|Overall Study|Lost to Follow-up|0|||
156840269|NCT03047031|566167886|FG002|Overall Study|Lost to Follow-up|0|||
156840270|NCT03047031|566167884|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
156840271|NCT03047031|566167885|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
156840272|NCT03047031|566167886|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
156840273|NCT03047031|566167884|FG000|Overall Study|Adverse Event|1|||
156840274|NCT03047031|566167885|FG001|Overall Study|Adverse Event|0|||
156840275|NCT03047031|566167886|FG002|Overall Study|Adverse Event|0|||
156840276|NCT03047031|566167884|FG000|Overall Study|Withdrawal by Subject|2|||
156840277|NCT03047031|566167885|FG001|Overall Study|Withdrawal by Subject|0|||
156840278|NCT03047031|566167886|FG002|Overall Study|Withdrawal by Subject|0|||
156840279|NCT03047031|566167884|FG000|Overall Study|Change to other medication|2|||
156840280|NCT03047031|566167885|FG001|Overall Study|Change to other medication|0|||
156840281|NCT03047031|566167886|FG002|Overall Study|Change to other medication|0|||
156840282|NCT03047031|566167884|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
156840283|NCT03047031|566167885|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
156840284|NCT03047031|566167886|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
156840285|NCT01450098|566167894|FG000|Period 3|Protocol Violation|0|||
156840286|NCT01450098|566167895|FG001|Period 3|Protocol Violation|1|||
156840287|NCT01450098|566167894|FG000|Period 3|Withdrawal by Subject|0|||
156840288|NCT01450098|566167895|FG001|Period 3|Withdrawal by Subject|2|||
156840289|NCT03229109|566167906|FG000|Overall Study|Withdrawal by Subject|0|||
156840290|NCT03229109|566167907|FG001|Overall Study|Withdrawal by Subject|0|||
156840291|NCT03229109|566167908|FG002|Overall Study|Withdrawal by Subject|0|||
156840292|NCT03229109|566167909|FG003|Overall Study|Withdrawal by Subject|1|||
156840293|NCT03416127|566167912|FG000|Overall Study|Withdrawal by Subject|0|||
156840294|NCT03416127|566167913|FG001|Overall Study|Withdrawal by Subject|1|||
156840295|NCT03416127|566167914|FG002|Overall Study|Withdrawal by Subject|1|||
156840296|NCT03387020|566167918|FG000|Overall Study|Adverse Event|0|||
156840297|NCT03387020|566167919|FG001|Overall Study|Adverse Event|2|||
156840298|NCT03387020|566167920|FG002|Overall Study|Adverse Event|0|||
156840299|NCT03387020|566167918|FG000|Overall Study|Withdrawal by Subject|2|||
156840300|NCT03387020|566167919|FG001|Overall Study|Withdrawal by Subject|0|||
156840301|NCT03387020|566167920|FG002|Overall Study|Withdrawal by Subject|0|||
156840302|NCT01452919|566167921|FG000|Open-Label Treatment|Adverse Event|5|||
156840303|NCT01452919|566167922|FG001|Open-Label Treatment|Adverse Event|0|||
156840304|NCT01452919|566167923|FG002|Open-Label Treatment|Adverse Event|0|||
156840305|NCT01452919|566167921|FG000|Open-Label Treatment|Lost to Follow-up|4|||
156840306|NCT01452919|566167922|FG001|Open-Label Treatment|Lost to Follow-up|0|||
156840307|NCT01452919|566167923|FG002|Open-Label Treatment|Lost to Follow-up|0|||
156840308|NCT01452919|566167921|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
156840309|NCT01452919|566167922|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
156840310|NCT01452919|566167923|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
156840311|NCT01452919|566167921|FG000|Open-Label Treatment|Protocol Violation|4|||
156840312|NCT01452919|566167922|FG001|Open-Label Treatment|Protocol Violation|0|||
156469633|NCT02232737|564814814|FG002|Overall Study|Incarcerated|2|||
156469634|NCT02232737|564814812|FG000|Overall Study|Withdrawal by Subject|0|||
156469635|NCT02232737|564814813|FG001|Overall Study|Withdrawal by Subject|1|||
156840313|NCT01452919|566167923|FG002|Open-Label Treatment|Protocol Violation|0|||
156840314|NCT01452919|566167921|FG000|Open-Label Treatment|Sponsor Decision|1|||
156840315|NCT01452919|566167922|FG001|Open-Label Treatment|Sponsor Decision|0|||
156840316|NCT01452919|566167923|FG002|Open-Label Treatment|Sponsor Decision|0|||
156840317|NCT01452919|566167921|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
156840318|NCT01452919|566167922|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
156840319|NCT01452919|566167923|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
156340551|NCT03095066|564346419|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
156340552|NCT03095066|564346420|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
156840320|NCT01452919|566167921|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
156840321|NCT01452919|566167922|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
156840322|NCT01452919|566167923|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
156840323|NCT01452919|566167921|FG000|Randomization Treatment|Adverse Event|0|||
156840324|NCT01452919|566167922|FG001|Randomization Treatment|Adverse Event|0|||
156840325|NCT01452919|566167923|FG002|Randomization Treatment|Adverse Event|2|||
156840326|NCT01452919|566167921|FG000|Randomization Treatment|Sponsor Decision|0|||
156840327|NCT01452919|566167922|FG001|Randomization Treatment|Sponsor Decision|1|||
156840328|NCT01452919|566167923|FG002|Randomization Treatment|Sponsor Decision|0|||
156840329|NCT01452919|566167921|FG000|Randomization Treatment|Withdrawal by Subject|0|||
156840330|NCT01452919|566167922|FG001|Randomization Treatment|Withdrawal by Subject|1|||
156840331|NCT01452919|566167923|FG002|Randomization Treatment|Withdrawal by Subject|0|||
156840332|NCT01452919|566167921|FG000|Randomization Treatment|Subject is moving or has moved|0|||
156840333|NCT01452919|566167922|FG001|Randomization Treatment|Subject is moving or has moved|1|||
156840334|NCT01452919|566167923|FG002|Randomization Treatment|Subject is moving or has moved|0|||
156840335|NCT02421588|566167924|FG000|Overall Study|Non-treatment-related AE|8|||
156840336|NCT02421588|566167925|FG001|Overall Study|Non-treatment-related AE|8|||
156840337|NCT02421588|566167924|FG000|Overall Study|Progressive disease|152|||
156840338|NCT02421588|566167925|FG001|Overall Study|Progressive disease|135|||
156840339|NCT02421588|566167924|FG000|Overall Study|Death|11|||
156840340|NCT02421588|566167925|FG001|Overall Study|Death|3|||
156840341|NCT02421588|566167924|FG000|Overall Study|Physician Decision|8|||
156840342|NCT02421588|566167925|FG001|Overall Study|Physician Decision|17|||
156840343|NCT02421588|566167924|FG000|Overall Study|Other reason not specified|3|||
156840344|NCT02421588|566167925|FG001|Overall Study|Other reason not specified|1|||
156840345|NCT02421588|566167924|FG000|Overall Study|Symptomatic deterioration|13|||
156840346|NCT02421588|566167925|FG001|Overall Study|Symptomatic deterioration|19|||
156840347|NCT02421588|566167924|FG000|Overall Study|Treatment-related AE|10|||
156840348|NCT02421588|566167925|FG001|Overall Study|Treatment-related AE|14|||
156840349|NCT02421588|566167924|FG000|Overall Study|Withdrawal by Subject|14|||
156840350|NCT02421588|566167925|FG001|Overall Study|Withdrawal by Subject|16|||
156840351|NCT02421588|566167924|FG000|Overall Study|Not treated|2|||
156840352|NCT02421588|566167925|FG001|Overall Study|Not treated|8|||
156840353|NCT01359943|566167926|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
156840354|NCT01359943|566167927|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
156840355|NCT01359943|566167928|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
156840356|NCT01359943|566167926|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
156840357|NCT01359943|566167927|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
156840358|NCT01359943|566167928|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
156840359|NCT01359943|566167926|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
156840360|NCT01359943|566167927|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
156840361|NCT01359943|566167928|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
156840362|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
156840363|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
156840364|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
156840365|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
156840366|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
156840367|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
156840368|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
156840369|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
156840370|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
156840371|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
156840372|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
156840373|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
156840374|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
156840375|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
156840376|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
156840377|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
156840378|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
156840379|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
156840380|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
156840381|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
156840382|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
156840383|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
156840384|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
156840385|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
156840386|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
156840387|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
156840388|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
156840389|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
156840390|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
156840391|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
156840392|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
156840393|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
156840394|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
156840395|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
156840396|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
156840397|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
156840398|NCT02516592|566167929|FG000|Overall Study|Patient withdrew consent|5|||
156840399|NCT02516592|566167930|FG001|Overall Study|Patient withdrew consent|2|||
156840400|NCT02516592|566167929|FG000|Overall Study|Protocol deviation|4|||
156840401|NCT02516592|566167930|FG001|Overall Study|Protocol deviation|4|||
156840402|NCT02516592|566167929|FG000|Overall Study|Lost to Follow-up|2|||
156840403|NCT02516592|566167930|FG001|Overall Study|Lost to Follow-up|3|||
156840404|NCT02516592|566167929|FG000|Overall Study|Patient/guardian decision|2|||
156840405|NCT02516592|566167930|FG001|Overall Study|Patient/guardian decision|1|||
156840406|NCT02516592|566167929|FG000|Overall Study|Adverse Event|1|||
156840407|NCT02516592|566167930|FG001|Overall Study|Adverse Event|2|||
156840408|NCT02516592|566167929|FG000|Overall Study|Abnormal test procedure result|1|||
156840409|NCT02516592|566167930|FG001|Overall Study|Abnormal test procedure result|0|||
156840410|NCT02516592|566167929|FG000|Overall Study|Death|1|||
156840411|NCT02516592|566167930|FG001|Overall Study|Death|1|||
156840412|NCT00098306|566167933|FG000|Double Blind|Randomized, not treated|9|||
156840413|NCT00098306|566167934|FG001|Double Blind|Randomized, not treated|5|||
156840414|NCT00098306|566167935|FG002|Double Blind|Randomized, not treated|2|||
156840415|NCT00098306|566167936|FG003|Double Blind|Randomized, not treated|0|||
156840416|NCT00098306|566167937|FG004|Double Blind|Randomized, not treated|0|||
156840417|NCT00098306|566167938|FG005|Double Blind|Randomized, not treated|0|||
156340553|NCT03095066|564346421|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156340554|NCT03095066|564346422|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156840418|NCT00098306|566167939|FG006|Double Blind|Randomized, not treated|0|||
156340555|NCT03095066|564346423|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156840419|NCT00098306|566167933|FG000|Double Blind|Ongoing at cut-off date|151|||
156840420|NCT00098306|566167934|FG001|Double Blind|Ongoing at cut-off date|166|||
156840421|NCT00098306|566167935|FG002|Double Blind|Ongoing at cut-off date|72|||
156840422|NCT00098306|566167936|FG003|Double Blind|Ongoing at cut-off date|0|||
156469636|NCT02232737|564814814|FG002|Overall Study|Withdrawal by Subject|2|||
156469637|NCT02232737|564814812|FG000|Overall Study|Death|0|||
156469638|NCT02232737|564814813|FG001|Overall Study|Death|1|||
156469639|NCT02232737|564814814|FG002|Overall Study|Death|1|||
156469640|NCT02232737|564814812|FG000|Overall Study|Physician Decision|1|||
156840423|NCT00098306|566167937|FG004|Double Blind|Ongoing at cut-off date|0|||
156840424|NCT00098306|566167938|FG005|Double Blind|Ongoing at cut-off date|0|||
156840425|NCT00098306|566167939|FG006|Double Blind|Ongoing at cut-off date|0|||
156840426|NCT00098306|566167933|FG000|Double Blind|Adverse Event|11|||
156840427|NCT00098306|566167934|FG001|Double Blind|Adverse Event|10|||
156840428|NCT00098306|566167935|FG002|Double Blind|Adverse Event|6|||
156840429|NCT00098306|566167936|FG003|Double Blind|Adverse Event|0|||
156840430|NCT00098306|566167937|FG004|Double Blind|Adverse Event|0|||
156840431|NCT00098306|566167938|FG005|Double Blind|Adverse Event|0|||
156840432|NCT00098306|566167939|FG006|Double Blind|Adverse Event|0|||
156840433|NCT00098306|566167933|FG000|Double Blind|Lack of Efficacy|43|||
156840434|NCT00098306|566167934|FG001|Double Blind|Lack of Efficacy|34|||
156840435|NCT00098306|566167935|FG002|Double Blind|Lack of Efficacy|17|||
156840436|NCT00098306|566167936|FG003|Double Blind|Lack of Efficacy|0|||
156840437|NCT00098306|566167937|FG004|Double Blind|Lack of Efficacy|0|||
156840438|NCT00098306|566167938|FG005|Double Blind|Lack of Efficacy|0|||
156469641|NCT02232737|564814813|FG001|Overall Study|Physician Decision|3|||
156469642|NCT02232737|564814814|FG002|Overall Study|Physician Decision|1|||
156469643|NCT02232737|564814812|FG000|Overall Study|Protocol Violation|1|||
156469644|NCT02232737|564814813|FG001|Overall Study|Protocol Violation|0|||
156840439|NCT00098306|566167939|FG006|Double Blind|Lack of Efficacy|0|||
156840440|NCT00098306|566167933|FG000|Double Blind|Death|1|||
156840441|NCT00098306|566167934|FG001|Double Blind|Death|4|||
156840442|NCT00098306|566167935|FG002|Double Blind|Death|1|||
156469645|NCT02232737|564814814|FG002|Overall Study|Protocol Violation|1|||
156469646|NCT02232737|564814812|FG000|Overall Study|Reason unknown|1|||
156469647|NCT02232737|564814813|FG001|Overall Study|Reason unknown|0|||
156469648|NCT02232737|564814814|FG002|Overall Study|Reason unknown|0|||
156469649|NCT00065182|564814823|FG000|Overall Study|Adverse Event|24|||
156469650|NCT00065182|564814824|FG001|Overall Study|Adverse Event|17|||
156469651|NCT00065182|564814823|FG000|Overall Study|Lost to Follow-up|0|||
156541471|NCT02966509|565075421|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
156541472|NCT02966509|565075420|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
156840443|NCT00098306|566167936|FG003|Double Blind|Death|0|||
156840444|NCT00098306|566167937|FG004|Double Blind|Death|0|||
156840445|NCT00098306|566167938|FG005|Double Blind|Death|0|||
156840446|NCT00098306|566167939|FG006|Double Blind|Death|0|||
156840447|NCT00098306|566167933|FG000|Double Blind|Participant defaulted|19|||
156840448|NCT00098306|566167934|FG001|Double Blind|Participant defaulted|18|||
156840449|NCT00098306|566167935|FG002|Double Blind|Participant defaulted|11|||
156840450|NCT00098306|566167936|FG003|Double Blind|Participant defaulted|0|||
156840451|NCT00098306|566167937|FG004|Double Blind|Participant defaulted|0|||
156840452|NCT00098306|566167938|FG005|Double Blind|Participant defaulted|0|||
156840453|NCT00098306|566167939|FG006|Double Blind|Participant defaulted|0|||
156840454|NCT00098306|566167933|FG000|Double Blind|Un-specified|7|||
156840455|NCT00098306|566167934|FG001|Double Blind|Un-specified|3|||
156840456|NCT00098306|566167935|FG002|Double Blind|Un-specified|11|||
156840457|NCT00098306|566167936|FG003|Double Blind|Un-specified|0|||
156840458|NCT00098306|566167937|FG004|Double Blind|Un-specified|0|||
156840459|NCT00098306|566167938|FG005|Double Blind|Un-specified|0|||
156840460|NCT00098306|566167939|FG006|Double Blind|Un-specified|0|||
156840461|NCT00098306|566167933|FG000|Open Label|Lack of Efficacy|0|||
156840462|NCT00098306|566167934|FG001|Open Label|Lack of Efficacy|0|||
156840463|NCT00098306|566167935|FG002|Open Label|Lack of Efficacy|0|||
156840464|NCT00098306|566167936|FG003|Open Label|Lack of Efficacy|13|||
156840465|NCT00098306|566167937|FG004|Open Label|Lack of Efficacy|0|||
156840466|NCT00098306|566167938|FG005|Open Label|Lack of Efficacy|0|||
156840467|NCT00098306|566167939|FG006|Open Label|Lack of Efficacy|0|||
156840468|NCT00098306|566167933|FG000|Open Label|Adverse Event|0|||
156840469|NCT00098306|566167934|FG001|Open Label|Adverse Event|0|||
156840470|NCT00098306|566167935|FG002|Open Label|Adverse Event|0|||
156840471|NCT00098306|566167936|FG003|Open Label|Adverse Event|2|||
156840472|NCT00098306|566167937|FG004|Open Label|Adverse Event|0|||
156469652|NCT00065182|564814824|FG001|Overall Study|Lost to Follow-up|4|||
156840473|NCT00098306|566167938|FG005|Open Label|Adverse Event|0|||
156840474|NCT00098306|566167939|FG006|Open Label|Adverse Event|0|||
156840475|NCT00098306|566167933|FG000|Open Label|Death|0|||
156840476|NCT00098306|566167934|FG001|Open Label|Death|0|||
156469653|NCT00065182|564814823|FG000|Overall Study|Protocol Violation|3|||
156469654|NCT00065182|564814824|FG001|Overall Study|Protocol Violation|4|||
156469655|NCT00065182|564814823|FG000|Overall Study|Serious adverse events (SAE)|1|||
156840477|NCT00098306|566167935|FG002|Open Label|Death|0|||
156840478|NCT00098306|566167936|FG003|Open Label|Death|4|||
156840479|NCT00098306|566167937|FG004|Open Label|Death|0|||
156840480|NCT00098306|566167938|FG005|Open Label|Death|0|||
156840481|NCT00098306|566167939|FG006|Open Label|Death|0|||
156840482|NCT00098306|566167933|FG000|Open Label|Participant defaulted|0|||
156840483|NCT00098306|566167934|FG001|Open Label|Participant defaulted|0|||
156840484|NCT00098306|566167935|FG002|Open Label|Participant defaulted|0|||
156840485|NCT00098306|566167936|FG003|Open Label|Participant defaulted|24|||
156840486|NCT00098306|566167937|FG004|Open Label|Participant defaulted|0|||
156340556|NCT03095066|564346424|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156340557|NCT03095066|564346425|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156340558|NCT03095066|564346426|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156340559|NCT03095066|564346419|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
156340560|NCT03095066|564346420|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
156340561|NCT03095066|564346421|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156340562|NCT03095066|564346422|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156340563|NCT03095066|564346423|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156340564|NCT03095066|564346424|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156340565|NCT03095066|564346425|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156340566|NCT03095066|564346426|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156340567|NCT03095066|564346419|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156840487|NCT00098306|566167938|FG005|Open Label|Participant defaulted|0|||
156840488|NCT00098306|566167939|FG006|Open Label|Participant defaulted|0|||
156840489|NCT00098306|566167933|FG000|Open Label|Un-specified|0|||
156840490|NCT00098306|566167934|FG001|Open Label|Un-specified|0|||
156840491|NCT00098306|566167935|FG002|Open Label|Un-specified|0|||
156840492|NCT00098306|566167936|FG003|Open Label|Un-specified|15|||
156340568|NCT03095066|564346420|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
156340569|NCT03095066|564346421|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156340570|NCT03095066|564346422|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156340571|NCT03095066|564346423|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156340572|NCT03095066|564346424|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156340573|NCT03095066|564346425|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156340574|NCT03095066|564346426|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156340575|NCT03095066|564346419|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
156340576|NCT03095066|564346420|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
156340577|NCT03095066|564346421|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156340578|NCT03095066|564346422|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156340579|NCT03095066|564346423|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156340580|NCT03095066|564346424|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156340581|NCT03095066|564346425|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156340582|NCT03095066|564346426|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156340583|NCT03095066|564346419|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
156340584|NCT03095066|564346420|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156340585|NCT03095066|564346421|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156340586|NCT03095066|564346422|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156340587|NCT03095066|564346423|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156340588|NCT03095066|564346424|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156340589|NCT03095066|564346425|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156469656|NCT00065182|564814824|FG001|Overall Study|Serious adverse events (SAE)|0|||
156469657|NCT00065182|564814823|FG000|Overall Study|Sponsor Decision|11|||
156469658|NCT00065182|564814824|FG001|Overall Study|Sponsor Decision|7|||
156469659|NCT00065182|564814823|FG000|Overall Study|Withdrawal by Subject|8|||
156840493|NCT00098306|566167937|FG004|Open Label|Un-specified|0|||
156840494|NCT00098306|566167938|FG005|Open Label|Un-specified|0|||
156840495|NCT00098306|566167939|FG006|Open Label|Un-specified|0|||
156840496|NCT00098306|566167933|FG000|Open Label|Ongoing at cut-off date|0|||
156840497|NCT00098306|566167934|FG001|Open Label|Ongoing at cut-off date|0|||
156840498|NCT00098306|566167935|FG002|Open Label|Ongoing at cut-off date|0|||
156840499|NCT00098306|566167936|FG003|Open Label|Ongoing at cut-off date|269|||
156840500|NCT00098306|566167937|FG004|Open Label|Ongoing at cut-off date|62|||
156840501|NCT00098306|566167938|FG005|Open Label|Ongoing at cut-off date|0|||
156840502|NCT00098306|566167939|FG006|Open Label|Ongoing at cut-off date|0|||
156840503|NCT00098306|566167933|FG000|Observational Phase|Death|0|||
156840504|NCT00098306|566167934|FG001|Observational Phase|Death|0|||
156840505|NCT00098306|566167935|FG002|Observational Phase|Death|0|||
156840506|NCT00098306|566167936|FG003|Observational Phase|Death|0|||
156840507|NCT00098306|566167937|FG004|Observational Phase|Death|0|||
156840508|NCT00098306|566167938|FG005|Observational Phase|Death|5|||
156469660|NCT00065182|564814824|FG001|Overall Study|Withdrawal by Subject|3|||
156469661|NCT00065182|564814823|FG000|Overall Study|No clinical benefit|1|||
156840509|NCT00098306|566167939|FG006|Observational Phase|Death|4|||
156840510|NCT00098306|566167933|FG000|Observational Phase|Participant defaulted|0|||
156840511|NCT00098306|566167934|FG001|Observational Phase|Participant defaulted|0|||
156840512|NCT00098306|566167935|FG002|Observational Phase|Participant defaulted|0|||
156840513|NCT00098306|566167936|FG003|Observational Phase|Participant defaulted|0|||
156840514|NCT00098306|566167937|FG004|Observational Phase|Participant defaulted|0|||
156469662|NCT00065182|564814824|FG001|Overall Study|No clinical benefit|0|||
156469663|NCT00065182|564814823|FG000|Overall Study|Death|0|||
156469664|NCT00065182|564814824|FG001|Overall Study|Death|1|||
156469665|NCT00065182|564814823|FG000|Overall Study|Decline in Status|0|||
156469666|NCT00065182|564814824|FG001|Overall Study|Decline in Status|1|||
156469667|NCT03738228|564814825|FG000|Overall Study|Never received study treatment|2|||
156469668|NCT03738228|564814826|FG001|Overall Study|Never received study treatment|2|||
156469669|NCT01641900|564814827|FG000|Overall Study|Withdrawal by Subject|2|||
156469670|NCT01641900|564814828|FG001|Overall Study|Withdrawal by Subject|2|||
156469671|NCT00713596|564814829|FG000|Overall Study|Study was terminated|2|||
156469672|NCT00713596|564814830|FG001|Overall Study|Study was terminated|3|||
156469673|NCT00713596|564814831|FG002|Overall Study|Study was terminated|2|||
156469674|NCT03712371|564814832|FG000|Overall Study|Lack of Efficacy|0|||
156469675|NCT03712371|564814833|FG001|Overall Study|Lack of Efficacy|0|||
156469676|NCT03712371|564814834|FG002|Overall Study|Lack of Efficacy|0|||
156469677|NCT03712371|564814835|FG003|Overall Study|Lack of Efficacy|1|||
156469678|NCT02463448|564814838|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
156469679|NCT02463448|564814838|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
156469680|NCT02463448|564814838|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
156469681|NCT02463448|564814838|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
156469682|NCT02275611|564814842|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
156469683|NCT02275611|564814843|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
156469684|NCT02275611|564814844|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
156469685|NCT02275611|564814845|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
156469686|NCT02101775|564814846|FG000|Overall Study|Adverse Event|4|||
156469687|NCT02101775|564814847|FG001|Overall Study|Adverse Event|0|||
156469688|NCT02101775|564814848|FG002|Overall Study|Adverse Event|0|||
156469689|NCT02101775|564814846|FG000|Overall Study|Admission to Hospital|0|||
156469690|NCT02101775|564814847|FG001|Overall Study|Admission to Hospital|1|||
156469691|NCT02101775|564814848|FG002|Overall Study|Admission to Hospital|0|||
156469692|NCT03611556|564814849|FG000|Overall Study|Death|7|||
156469693|NCT03611556|564814850|FG001|Overall Study|Death|7|||
156469694|NCT03611556|564814851|FG002|Overall Study|Death|3|||
156469695|NCT03611556|564814852|FG003|Overall Study|Death|8|||
156469696|NCT03611556|564814853|FG004|Overall Study|Death|47|||
156469697|NCT03611556|564814854|FG005|Overall Study|Death|32|||
156469698|NCT03611556|564814855|FG006|Overall Study|Death|53|||
156469699|NCT03611556|564814849|FG000|Overall Study|Withdrawal by Subject|0|||
156469700|NCT03611556|564814850|FG001|Overall Study|Withdrawal by Subject|0|||
156469701|NCT03611556|564814851|FG002|Overall Study|Withdrawal by Subject|0|||
156469702|NCT03611556|564814852|FG003|Overall Study|Withdrawal by Subject|0|||
156469703|NCT03611556|564814853|FG004|Overall Study|Withdrawal by Subject|4|||
156469704|NCT03611556|564814854|FG005|Overall Study|Withdrawal by Subject|2|||
156469705|NCT03611556|564814855|FG006|Overall Study|Withdrawal by Subject|4|||
156469706|NCT03611556|564814849|FG000|Overall Study|Sponsor decision|0|||
156469707|NCT03611556|564814850|FG001|Overall Study|Sponsor decision|0|||
156469708|NCT03611556|564814851|FG002|Overall Study|Sponsor decision|0|||
156469709|NCT03611556|564814852|FG003|Overall Study|Sponsor decision|0|||
156469710|NCT03611556|564814853|FG004|Overall Study|Sponsor decision|9|||
156469711|NCT03611556|564814854|FG005|Overall Study|Sponsor decision|4|||
156469712|NCT03611556|564814855|FG006|Overall Study|Sponsor decision|12|||
156469713|NCT03611556|564814849|FG000|Overall Study|Reasons|0|||
156469714|NCT03611556|564814850|FG001|Overall Study|Reasons|0|||
156469715|NCT03611556|564814851|FG002|Overall Study|Reasons|0|||
156469716|NCT03611556|564814852|FG003|Overall Study|Reasons|0|||
156469717|NCT03611556|564814853|FG004|Overall Study|Reasons|2|||
156469718|NCT03611556|564814854|FG005|Overall Study|Reasons|0|||
156469719|NCT03611556|564814855|FG006|Overall Study|Reasons|1|||
156469720|NCT02844439|564814856|FG000|Overall Study|Withdrawal by Subject|1|||
156469721|NCT02844439|564814856|FG000|Overall Study|Lost to Follow-up|2|||
156469722|NCT02844439|564814856|FG000|Overall Study|Termination by Sponsor|4|||
156541473|NCT02966509|565075421|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
156840515|NCT00098306|566167938|FG005|Observational Phase|Participant defaulted|34|||
156469723|NCT02844439|564814856|FG000|Overall Study|Death|28|||
156469724|NCT02844439|564814856|FG000|Overall Study|Other|5|||
156469725|NCT05036278|564814859|FG000|Overall Study|Withdrawal by Subject|1|||
156469726|NCT05036278|564814859|FG000|Overall Study|Adverse Event|1|||
156469727|NCT02787005|564814862|FG000|Overall Study|Adverse Event|24|||
156469728|NCT02787005|564814863|FG001|Overall Study|Adverse Event|9|||
156469729|NCT02787005|564814864|FG002|Overall Study|Adverse Event|9|||
156469730|NCT02787005|564814865|FG003|Overall Study|Adverse Event|7|||
156469731|NCT02787005|564814866|FG004|Overall Study|Adverse Event|2|||
156469732|NCT02787005|564814862|FG000|Overall Study|Death|100|||
156469733|NCT02787005|564814863|FG001|Overall Study|Death|53|||
156469734|NCT02787005|564814864|FG002|Overall Study|Death|48|||
156469735|NCT02787005|564814865|FG003|Overall Study|Death|69|||
156469736|NCT02787005|564814866|FG004|Overall Study|Death|38|||
156469737|NCT02787005|564814862|FG000|Overall Study|Sponsor Decision|7|||
156469738|NCT02787005|564814863|FG001|Overall Study|Sponsor Decision|4|||
156469739|NCT02787005|564814864|FG002|Overall Study|Sponsor Decision|0|||
156469740|NCT02787005|564814865|FG003|Overall Study|Sponsor Decision|4|||
156469741|NCT02787005|564814866|FG004|Overall Study|Sponsor Decision|5|||
156469742|NCT02787005|564814862|FG000|Overall Study|Withdrawal by Subject|2|||
156469743|NCT02787005|564814863|FG001|Overall Study|Withdrawal by Subject|1|||
156469744|NCT02787005|564814864|FG002|Overall Study|Withdrawal by Subject|1|||
156469745|NCT02787005|564814865|FG003|Overall Study|Withdrawal by Subject|0|||
156469746|NCT02787005|564814866|FG004|Overall Study|Withdrawal by Subject|1|||
156840516|NCT00098306|566167939|FG006|Observational Phase|Participant defaulted|18|||
156840517|NCT00098306|566167933|FG000|Observational Phase|Un-specified|0|||
156840518|NCT00098306|566167934|FG001|Observational Phase|Un-specified|0|||
156840519|NCT00098306|566167935|FG002|Observational Phase|Un-specified|0|||
156840520|NCT00098306|566167936|FG003|Observational Phase|Un-specified|0|||
156840521|NCT00098306|566167937|FG004|Observational Phase|Un-specified|0|||
156840522|NCT00098306|566167938|FG005|Observational Phase|Un-specified|7|||
156840523|NCT00098306|566167939|FG006|Observational Phase|Un-specified|4|||
156840524|NCT00619099|566167940|FG000|Overall Study|Progressive Disease|7|||
156469747|NCT02787005|564814862|FG000|Overall Study|Screen Failure|0|||
156469748|NCT02787005|564814863|FG001|Overall Study|Screen Failure|2|||
156469749|NCT02787005|564814864|FG002|Overall Study|Screen Failure|0|||
156469750|NCT02787005|564814865|FG003|Overall Study|Screen Failure|0|||
156469751|NCT02787005|564814866|FG004|Overall Study|Screen Failure|1|||
156469752|NCT02787005|564814862|FG000|Overall Study|Lost to Follow-up|0|||
156469753|NCT02787005|564814863|FG001|Overall Study|Lost to Follow-up|0|||
156469754|NCT02787005|564814864|FG002|Overall Study|Lost to Follow-up|0|||
156469755|NCT02787005|564814865|FG003|Overall Study|Lost to Follow-up|1|||
156469756|NCT02787005|564814866|FG004|Overall Study|Lost to Follow-up|0|||
156469757|NCT05580003|564814868|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469758|NCT05580003|564814869|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156840525|NCT00619099|566167941|FG001|Overall Study|Progressive Disease|5|||
156840526|NCT00619099|566167940|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
156840527|NCT00619099|566167941|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
156840528|NCT00619099|566167940|FG000|Overall Study|Adverse Event|4|||
156840529|NCT00619099|566167941|FG001|Overall Study|Adverse Event|3|||
156840530|NCT00619099|566167940|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
156840531|NCT00619099|566167941|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
156840532|NCT00619099|566167940|FG000|Overall Study|Withdrawal by Subject|10|||
156840533|NCT00619099|566167941|FG001|Overall Study|Withdrawal by Subject|2|||
156840534|NCT00619099|566167940|FG000|Overall Study|Physician Decision|9|||
156840535|NCT00619099|566167941|FG001|Overall Study|Physician Decision|6|||
156840536|NCT00885482|566167942|FG000|Overall Study|Pregnancy|1|||
156469759|NCT05580003|564814870|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469760|NCT05580003|564814871|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469761|NCT05580003|564814872|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469762|NCT05580003|564814873|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469763|NCT05580003|564814874|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
156469764|NCT05580003|564814875|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469765|NCT05580003|564814876|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469766|NCT05580003|564814877|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469767|NCT05580003|564814878|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469768|NCT05580003|564814879|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469769|NCT05580003|564814880|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469770|NCT05580003|564814881|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469771|NCT05580003|564814882|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469772|NCT05580003|564814883|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156840537|NCT00885482|566167942|FG000|Overall Study|Lack of Efficacy|1|||
156840538|NCT00885482|566167942|FG000|Overall Study|Death|1|||
156469773|NCT05580003|564814884|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469774|NCT05580003|564814885|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156840539|NCT00885482|566167942|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
156840540|NCT00989781|566167943|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
156840541|NCT00989781|566167944|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
156840542|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
156840543|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
156541474|NCT02966509|565075420|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
156541475|NCT02966509|565075421|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
156541476|NCT01321710|565075422|FG000|Overall Study|Lost to Follow-up|4|||
156541477|NCT01321710|565075423|FG001|Overall Study|Lost to Follow-up|5|||
156541478|NCT01321710|565075424|FG002|Overall Study|Lost to Follow-up|0|||
156541479|NCT01761292|565075426|FG000|Part 1|Adverse Event|1|||
156541480|NCT01761292|565075426|FG000|Part 1|not receiving treatment in Part 1|1|||
156840544|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
156840545|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
156840546|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
156840547|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
156840548|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
156840549|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
156840550|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
156840551|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
156840552|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
156840553|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
156840554|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
156840555|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
156840556|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
156840557|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
156840558|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
156840559|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
156840560|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
156840561|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
156840562|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
156840563|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
156840564|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
156840565|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
156840566|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
156840567|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
156840568|NCT01532869|566167945|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
156840569|NCT01532869|566167946|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
156840570|NCT01532869|566167945|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
156840571|NCT01532869|566167946|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
156840572|NCT01532869|566167945|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
156840573|NCT01532869|566167946|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
156840574|NCT01532869|566167945|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
156840575|NCT01532869|566167946|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
156840576|NCT02438813|566167947|FG000|Overall Study|Patient Decision|59|||
156840577|NCT02438813|566167947|FG000|Overall Study|Patient Lost to Follow-Up|137|||
156840578|NCT02438813|566167947|FG000|Overall Study|Study Ended by Sponsor|80|||
156840579|NCT02438813|566167947|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
156840580|NCT00778895|566167948|FG000|Active Phase|Adverse Event|3|||
156840581|NCT00778895|566167949|FG001|Active Phase|Adverse Event|1|||
156840582|NCT00778895|566167950|FG002|Active Phase|Adverse Event|0|||
156840583|NCT00778895|566167948|FG000|Active Phase|Withdrawal by Subject|1|||
156840584|NCT00778895|566167949|FG001|Active Phase|Withdrawal by Subject|4|||
156840585|NCT00778895|566167950|FG002|Active Phase|Withdrawal by Subject|0|||
156840586|NCT00778895|566167948|FG000|Active Phase|Lost to Follow-up|1|||
156840587|NCT00778895|566167949|FG001|Active Phase|Lost to Follow-up|1|||
156840588|NCT00778895|566167950|FG002|Active Phase|Lost to Follow-up|0|||
156840589|NCT00778895|566167948|FG000|Active Phase|Other|2|||
156840590|NCT00778895|566167949|FG001|Active Phase|Other|0|||
156840591|NCT00778895|566167950|FG002|Active Phase|Other|0|||
156840592|NCT00778895|566167948|FG000|ESFU Phase|Adverse Event|2|||
156840593|NCT00778895|566167949|FG001|ESFU Phase|Adverse Event|1|||
156840594|NCT00778895|566167950|FG002|ESFU Phase|Adverse Event|0|||
156840595|NCT00778895|566167948|FG000|ESFU Phase|Withdrawal by Subject|1|||
156840596|NCT00778895|566167949|FG001|ESFU Phase|Withdrawal by Subject|4|||
156840597|NCT00778895|566167950|FG002|ESFU Phase|Withdrawal by Subject|0|||
156840598|NCT00778895|566167948|FG000|ESFU Phase|Lost to Follow-up|6|||
156840599|NCT00778895|566167949|FG001|ESFU Phase|Lost to Follow-up|7|||
156840600|NCT00778895|566167950|FG002|ESFU Phase|Lost to Follow-up|2|||
156541481|NCT01761292|565075426|FG000|Extension 1|Withdrawal by Subject|1|||
156541482|NCT03332498|565075427|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
156840601|NCT00778895|566167948|FG000|ESFU Phase|Other|2|||
156840602|NCT00778895|566167949|FG001|ESFU Phase|Other|0|||
156840603|NCT00778895|566167950|FG002|ESFU Phase|Other|0|||
156840604|NCT01805037|566167954|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
156541483|NCT03332498|565075428|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
156469775|NCT05580003|564814886|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469776|NCT05580003|564814887|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469777|NCT05580003|564814888|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469778|NCT05580003|564814889|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469779|NCT05580003|564814890|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469780|NCT05580003|564814891|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469781|NCT05580003|564814892|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469782|NCT05580003|564814893|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469783|NCT05580003|564814894|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469784|NCT05580003|564814895|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156469785|NCT05580003|564814868|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469786|NCT05580003|564814869|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469787|NCT05580003|564814870|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469788|NCT05580003|564814871|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469789|NCT05580003|564814872|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469790|NCT05580003|564814873|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
156469791|NCT05580003|564814874|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469792|NCT05580003|564814875|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469793|NCT05580003|564814876|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469794|NCT05580003|564814877|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469795|NCT05580003|564814878|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469796|NCT05580003|564814879|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156541484|NCT03332498|565075429|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
156840605|NCT01805037|566167955|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
156840606|NCT01805037|566167954|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
156840607|NCT01805037|566167955|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
156840608|NCT01805037|566167954|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
156840609|NCT01805037|566167955|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
156840610|NCT01805037|566167954|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
156840611|NCT01805037|566167955|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
156840612|NCT01805037|566167954|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
156840613|NCT01805037|566167955|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
156840614|NCT01805037|566167954|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
156840615|NCT01805037|566167955|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
156840616|NCT01805037|566167954|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
156840617|NCT01805037|566167955|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
156840618|NCT01805037|566167954|FG000|Follow Up (up to 3 Years)|Death|0|||
156840619|NCT01805037|566167955|FG001|Follow Up (up to 3 Years)|Death|2|||
156840620|NCT01805037|566167954|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
156840621|NCT01805037|566167955|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
156840622|NCT01805037|566167954|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
156840623|NCT01805037|566167955|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
156840624|NCT01270256|566167956|FG000|Overall Study|Withdrawal by Subject|1|||
156840625|NCT01270256|566167957|FG001|Overall Study|Withdrawal by Subject|0|||
156840626|NCT01183468|566167958|FG000|Overall Study|Lost to Follow-up|2|||
156840627|NCT01183468|566167959|FG001|Overall Study|Lost to Follow-up|1|||
156840628|NCT01183468|566167960|FG002|Overall Study|Lost to Follow-up|0|||
156840629|NCT01183468|566167961|FG003|Overall Study|Lost to Follow-up|0|||
156840630|NCT01183468|566167958|FG000|Overall Study|Physician Decision|1|||
156840631|NCT01183468|566167959|FG001|Overall Study|Physician Decision|0|||
156840632|NCT01183468|566167960|FG002|Overall Study|Physician Decision|0|||
156840633|NCT01183468|566167961|FG003|Overall Study|Physician Decision|0|||
156840634|NCT01183468|566167958|FG000|Overall Study|Withdrawal by Subject|0|||
156840635|NCT01183468|566167959|FG001|Overall Study|Withdrawal by Subject|1|||
156840636|NCT01183468|566167960|FG002|Overall Study|Withdrawal by Subject|0|||
156840637|NCT01183468|566167961|FG003|Overall Study|Withdrawal by Subject|0|||
156840638|NCT03927404|566167962|FG000|Overall Study|Withdrawal by Subject|1|||
156541485|NCT01648790|565075430|FG000|Treatment 3|Withdrawal by Subject|0|||
156840639|NCT01229449|566167965|FG000|Overall Study|Withdrawal by Subject|0|||
156840640|NCT01229449|566167966|FG001|Overall Study|Withdrawal by Subject|3|||
156840641|NCT01229449|566167967|FG002|Overall Study|Withdrawal by Subject|0|||
156840642|NCT01229449|566167968|FG003|Overall Study|Withdrawal by Subject|1|||
156840643|NCT01229449|566167969|FG004|Overall Study|Withdrawal by Subject|1|||
156469797|NCT05580003|564814880|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469798|NCT05580003|564814881|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469799|NCT05580003|564814882|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469800|NCT05580003|564814883|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469801|NCT05580003|564814884|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469802|NCT05580003|564814885|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469803|NCT05580003|564814886|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469804|NCT05580003|564814887|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469805|NCT05580003|564814888|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469806|NCT05580003|564814889|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469807|NCT05580003|564814890|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469808|NCT05580003|564814891|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469809|NCT05580003|564814892|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469810|NCT05580003|564814893|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469811|NCT05580003|564814894|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469812|NCT05580003|564814895|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
156469813|NCT05580003|564814868|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469814|NCT05580003|564814869|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469815|NCT05580003|564814870|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469816|NCT05580003|564814871|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
156469817|NCT05580003|564814872|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469818|NCT05580003|564814873|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469819|NCT05580003|564814874|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469820|NCT05580003|564814875|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469821|NCT05580003|564814876|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469822|NCT05580003|564814877|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469823|NCT05580003|564814878|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469824|NCT05580003|564814879|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469825|NCT05580003|564814880|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469826|NCT05580003|564814881|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469827|NCT05580003|564814882|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469828|NCT05580003|564814883|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469829|NCT05580003|564814884|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469830|NCT05580003|564814885|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469831|NCT05580003|564814886|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469832|NCT05580003|564814887|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469833|NCT05580003|564814888|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469834|NCT05580003|564814889|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469835|NCT05580003|564814890|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469836|NCT05580003|564814891|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469837|NCT05580003|564814892|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469838|NCT05580003|564814893|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469839|NCT05580003|564814894|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469840|NCT05580003|564814895|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
156469841|NCT05580003|564814868|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469842|NCT05580003|564814869|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
156469843|NCT05580003|564814870|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469844|NCT05580003|564814871|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469845|NCT05580003|564814872|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469846|NCT05580003|564814873|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469847|NCT05580003|564814874|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469848|NCT05580003|564814875|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469849|NCT05580003|564814876|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469850|NCT05580003|564814877|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469851|NCT05580003|564814878|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469852|NCT05580003|564814879|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469853|NCT05580003|564814880|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469854|NCT05580003|564814881|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469855|NCT05580003|564814882|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469856|NCT05580003|564814883|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156541486|NCT01648790|565075431|FG001|Treatment 3|Withdrawal by Subject|0|||
156541487|NCT01648790|565075432|FG002|Treatment 3|Withdrawal by Subject|0|||
156469857|NCT05580003|564814884|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469858|NCT05580003|564814885|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469859|NCT05580003|564814886|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156541488|NCT01648790|565075433|FG003|Treatment 3|Withdrawal by Subject|1|||
156840644|NCT01229449|566167965|FG000|Overall Study|Lost to Follow-up|1|||
156840645|NCT01229449|566167966|FG001|Overall Study|Lost to Follow-up|1|||
156840646|NCT01229449|566167967|FG002|Overall Study|Lost to Follow-up|1|||
156840647|NCT01229449|566167968|FG003|Overall Study|Lost to Follow-up|0|||
156840648|NCT01229449|566167969|FG004|Overall Study|Lost to Follow-up|0|||
156840649|NCT01229449|566167965|FG000|Overall Study|Physician Decision|0|||
156840650|NCT01229449|566167966|FG001|Overall Study|Physician Decision|0|||
156840651|NCT01229449|566167967|FG002|Overall Study|Physician Decision|1|||
156840652|NCT01229449|566167968|FG003|Overall Study|Physician Decision|0|||
156840653|NCT01229449|566167969|FG004|Overall Study|Physician Decision|0|||
156840654|NCT03203291|566167971|FG000|Overall Study|Withdrawal by Subject|1|||
156840655|NCT01300260|566167972|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
156840656|NCT01300260|566167973|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
156840657|NCT01300260|566167972|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
156840658|NCT01300260|566167973|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
156840659|NCT01300260|566167972|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
156469860|NCT05580003|564814887|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156840660|NCT01300260|566167973|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
156840661|NCT05098509|566167979|FG000|Overall Study|Withdrawal by Subject|0|||
156840662|NCT05098509|566167980|FG001|Overall Study|Withdrawal by Subject|0|||
156840663|NCT05098509|566167981|FG002|Overall Study|Withdrawal by Subject|1|||
156840664|NCT05098509|566167982|FG003|Overall Study|Withdrawal by Subject|0|||
156840665|NCT05098509|566167979|FG000|Overall Study|Early study termination|1|||
156840666|NCT05098509|566167980|FG001|Overall Study|Early study termination|1|||
156840667|NCT05098509|566167981|FG002|Overall Study|Early study termination|1|||
156840668|NCT05098509|566167982|FG003|Overall Study|Early study termination|0|||
156840669|NCT03157037|566167986|FG000|Overall Study|Death|1|||
156840670|NCT00324233|566167987|FG000|First Period|unable to insert catheter|1|||
156840671|NCT00324233|566167988|FG001|First Period|unable to insert catheter|0|||
156840672|NCT00324233|566167987|FG000|Second Period|unable to insert catheter|1|||
156840673|NCT00324233|566167988|FG001|Second Period|unable to insert catheter|1|||
156840674|NCT00324233|566167987|FG000|Second Period|Protocol Violation|4|||
156840675|NCT00324233|566167988|FG001|Second Period|Protocol Violation|6|||
156840676|NCT01069705|566167993|FG000|Overall Study|Adverse Event|1|||
156840677|NCT01069705|566167993|FG000|Overall Study|Withdrawal by Subject|2|||
156840678|NCT02607228|566167994|FG000|Overall Study|Progressive Disease|4|||
156840679|NCT02607228|566167995|FG001|Overall Study|Progressive Disease|3|||
156840680|NCT02607228|566167996|FG002|Overall Study|Progressive Disease|1|||
156840681|NCT02607228|566167997|FG003|Overall Study|Progressive Disease|5|||
156840682|NCT02607228|566167998|FG004|Overall Study|Progressive Disease|4|||
156840683|NCT02607228|566167999|FG005|Overall Study|Progressive Disease|3|||
156840684|NCT02607228|566168000|FG006|Overall Study|Progressive Disease|1|||
156840685|NCT02607228|566167994|FG000|Overall Study|Adverse Event|1|||
156840686|NCT02607228|566167995|FG001|Overall Study|Adverse Event|0|||
156840687|NCT02607228|566167996|FG002|Overall Study|Adverse Event|1|||
156840688|NCT02607228|566167997|FG003|Overall Study|Adverse Event|0|||
156840689|NCT02607228|566167998|FG004|Overall Study|Adverse Event|1|||
156840690|NCT02607228|566167999|FG005|Overall Study|Adverse Event|1|||
156840691|NCT02607228|566168000|FG006|Overall Study|Adverse Event|1|||
156840692|NCT02607228|566167994|FG000|Overall Study|Investigator's Discretion|0|||
156840693|NCT02607228|566167995|FG001|Overall Study|Investigator's Discretion|0|||
156840694|NCT02607228|566167996|FG002|Overall Study|Investigator's Discretion|1|||
156840695|NCT02607228|566167997|FG003|Overall Study|Investigator's Discretion|0|||
156840696|NCT02607228|566167998|FG004|Overall Study|Investigator's Discretion|0|||
156840697|NCT02607228|566167999|FG005|Overall Study|Investigator's Discretion|1|||
156840698|NCT02607228|566168000|FG006|Overall Study|Investigator's Discretion|0|||
156840699|NCT02607228|566167994|FG000|Overall Study|Withdrew Consent|0|||
156840700|NCT02607228|566167995|FG001|Overall Study|Withdrew Consent|1|||
156840701|NCT02607228|566167996|FG002|Overall Study|Withdrew Consent|0|||
156840702|NCT02607228|566167997|FG003|Overall Study|Withdrew Consent|0|||
156840703|NCT02607228|566167998|FG004|Overall Study|Withdrew Consent|0|||
156840704|NCT02607228|566167999|FG005|Overall Study|Withdrew Consent|1|||
156840705|NCT02607228|566168000|FG006|Overall Study|Withdrew Consent|0|||
156840706|NCT02607228|566167994|FG000|Overall Study|Study Terminated by Sponsor|0|||
156840707|NCT02607228|566167995|FG001|Overall Study|Study Terminated by Sponsor|0|||
156840708|NCT02607228|566167996|FG002|Overall Study|Study Terminated by Sponsor|0|||
156840709|NCT02607228|566167997|FG003|Overall Study|Study Terminated by Sponsor|1|||
156840710|NCT02607228|566167998|FG004|Overall Study|Study Terminated by Sponsor|0|||
156840711|NCT02607228|566167999|FG005|Overall Study|Study Terminated by Sponsor|0|||
156840712|NCT02607228|566168000|FG006|Overall Study|Study Terminated by Sponsor|0|||
156840713|NCT03908970|566168001|FG000|Overall Study|Adverse Event|7|||
156840714|NCT03908970|566168002|FG001|Overall Study|Adverse Event|21|||
156840715|NCT03908970|566168001|FG000|Overall Study|Physician Decision|1|||
156541489|NCT01648790|565075434|FG004|Treatment 3|Withdrawal by Subject|0|||
156840716|NCT03908970|566168002|FG001|Overall Study|Physician Decision|4|||
156840717|NCT03908970|566168001|FG000|Overall Study|Withdrawal by Subject|9|||
156840718|NCT03908970|566168002|FG001|Overall Study|Withdrawal by Subject|22|||
156840719|NCT04407234|566168003|FG000|Overall Study|Adverse Event|3|||
156840720|NCT04407234|566168004|FG001|Overall Study|Adverse Event|3|||
156840721|NCT00727558|566168010|FG000|Overall Study|Lens issue|0|||
156840722|NCT00727558|566168011|FG001|Overall Study|Lens issue|1|||
156840723|NCT00727558|566168010|FG000|Overall Study|Adverse Event|0|||
156840724|NCT00727558|566168011|FG001|Overall Study|Adverse Event|1|||
156840725|NCT00727558|566168010|FG000|Overall Study|Subject unable to return for follow-up|1|||
156840726|NCT00727558|566168011|FG001|Overall Study|Subject unable to return for follow-up|1|||
156840727|NCT00727558|566168010|FG000|Overall Study|Lost to Follow-up|1|||
156840728|NCT00727558|566168011|FG001|Overall Study|Lost to Follow-up|0|||
156840729|NCT01123707|566168016|FG000|Overall Study|Lost to Follow-up|3|||
156469861|NCT05580003|564814888|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469862|NCT05580003|564814889|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469863|NCT05580003|564814890|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469864|NCT05580003|564814891|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469865|NCT05580003|564814892|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469866|NCT05580003|564814893|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469867|NCT05580003|564814894|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469868|NCT05580003|564814895|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156469869|NCT05580003|564814868|FG000|Part 2 (up to 10 Days)|Other|0|||
156469870|NCT05580003|564814869|FG001|Part 2 (up to 10 Days)|Other|0|||
156469871|NCT05580003|564814870|FG002|Part 2 (up to 10 Days)|Other|0|||
156469872|NCT05580003|564814871|FG003|Part 2 (up to 10 Days)|Other|0|||
156469873|NCT05580003|564814872|FG004|Part 2 (up to 10 Days)|Other|0|||
156469874|NCT05580003|564814873|FG005|Part 2 (up to 10 Days)|Other|0|||
156840730|NCT01123707|566168017|FG001|Overall Study|Lost to Follow-up|1|||
156840731|NCT01123707|566168018|FG002|Overall Study|Lost to Follow-up|3|||
156840732|NCT01123707|566168019|FG003|Overall Study|Lost to Follow-up|2|||
156840733|NCT01123707|566168016|FG000|Overall Study|Adverse Event|5|||
156840734|NCT01123707|566168017|FG001|Overall Study|Adverse Event|7|||
156840735|NCT01123707|566168018|FG002|Overall Study|Adverse Event|5|||
156840736|NCT01123707|566168019|FG003|Overall Study|Adverse Event|3|||
156840737|NCT01123707|566168016|FG000|Overall Study|Sponsor Discontinued Study|30|||
156840738|NCT01123707|566168017|FG001|Overall Study|Sponsor Discontinued Study|24|||
156840739|NCT01123707|566168018|FG002|Overall Study|Sponsor Discontinued Study|25|||
156840740|NCT01123707|566168019|FG003|Overall Study|Sponsor Discontinued Study|40|||
156840741|NCT01123707|566168016|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
156840742|NCT01123707|566168017|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
156840743|NCT01123707|566168018|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
156840744|NCT01123707|566168019|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
156840745|NCT01123707|566168016|FG000|Overall Study|Investigator Withdrew Participant|0|||
156840746|NCT01123707|566168017|FG001|Overall Study|Investigator Withdrew Participant|1|||
156840747|NCT01123707|566168018|FG002|Overall Study|Investigator Withdrew Participant|1|||
156840748|NCT01123707|566168019|FG003|Overall Study|Investigator Withdrew Participant|1|||
156840749|NCT01123707|566168016|FG000|Overall Study|Subject Withdrew Consent|4|||
156840750|NCT01123707|566168017|FG001|Overall Study|Subject Withdrew Consent|5|||
156840751|NCT01123707|566168018|FG002|Overall Study|Subject Withdrew Consent|1|||
156840752|NCT01123707|566168019|FG003|Overall Study|Subject Withdrew Consent|2|||
156840753|NCT01123707|566168016|FG000|Overall Study|Lack of Efficacy|1|||
156840754|NCT01123707|566168017|FG001|Overall Study|Lack of Efficacy|2|||
156840755|NCT01123707|566168018|FG002|Overall Study|Lack of Efficacy|1|||
156840756|NCT01123707|566168019|FG003|Overall Study|Lack of Efficacy|0|||
156840757|NCT01123707|566168016|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
156840758|NCT01123707|566168017|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
156840759|NCT01123707|566168018|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
156840760|NCT01123707|566168019|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
156840761|NCT00488826|566168024|FG000|Overall Study|Withdrawal by Subject|40|||
156840762|NCT00488826|566168025|FG001|Overall Study|Withdrawal by Subject|35|||
156840763|NCT00488826|566168026|FG002|Overall Study|Withdrawal by Subject|19|||
156840764|NCT00488826|566168024|FG000|Overall Study|Protocol Violation|0|||
156840765|NCT00488826|566168025|FG001|Overall Study|Protocol Violation|0|||
156840766|NCT00488826|566168026|FG002|Overall Study|Protocol Violation|2|||
156840767|NCT00488826|566168024|FG000|Overall Study|Adverse Event|9|||
156840768|NCT00488826|566168025|FG001|Overall Study|Adverse Event|15|||
156840769|NCT00488826|566168026|FG002|Overall Study|Adverse Event|4|||
156840770|NCT00488826|566168024|FG000|Overall Study|Lost to Follow-up|5|||
156840771|NCT00488826|566168025|FG001|Overall Study|Lost to Follow-up|1|||
156840772|NCT00488826|566168026|FG002|Overall Study|Lost to Follow-up|0|||
156840773|NCT00488826|566168024|FG000|Overall Study|Protocol Deviations|2|||
156840774|NCT00488826|566168025|FG001|Overall Study|Protocol Deviations|1|||
156840775|NCT00488826|566168026|FG002|Overall Study|Protocol Deviations|1|||
156840776|NCT02725866|566168027|FG000|Overall Study|Failure to return|6|||
156840777|NCT02725866|566168027|FG000|Overall Study|Withdrew consent|3|||
156840778|NCT02725866|566168027|FG000|Overall Study|Insufficient virological response|1|||
156840779|NCT02725866|566168027|FG000|Overall Study|Other, not specified|4|||
156340590|NCT03095066|564346426|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156340591|NCT03095066|564346419|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
156340592|NCT03095066|564346420|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
156340593|NCT03095066|564346421|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156340594|NCT03095066|564346422|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156340595|NCT03095066|564346423|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156340596|NCT03095066|564346424|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156340597|NCT03095066|564346425|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156340598|NCT03095066|564346426|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156340599|NCT03095066|564346419|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
156340600|NCT03095066|564346420|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
156340601|NCT03095066|564346421|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156340602|NCT03095066|564346422|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156340603|NCT03095066|564346423|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156340604|NCT03095066|564346424|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156340605|NCT03095066|564346425|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156340606|NCT03095066|564346426|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156340607|NCT03095066|564346419|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156340608|NCT03095066|564346420|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156340609|NCT03095066|564346421|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
156340610|NCT03095066|564346422|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156340611|NCT03095066|564346423|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156340612|NCT03095066|564346424|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156340613|NCT03095066|564346425|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156340614|NCT03095066|564346426|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
156340615|NCT03095066|564346419|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156340616|NCT03095066|564346420|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156340617|NCT03095066|564346421|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
156340618|NCT03095066|564346422|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156340619|NCT03095066|564346423|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156340620|NCT03095066|564346424|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156340621|NCT03095066|564346425|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156340622|NCT03095066|564346426|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
156340623|NCT03095066|564346419|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156340624|NCT03095066|564346420|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156340625|NCT03095066|564346421|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
156340626|NCT03095066|564346422|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156340627|NCT03095066|564346423|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156340628|NCT03095066|564346424|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156340629|NCT03095066|564346425|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156340630|NCT03095066|564346426|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
156340631|NCT03095066|564346419|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156340632|NCT03095066|564346420|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156340633|NCT03095066|564346421|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
156340634|NCT03095066|564346422|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156340635|NCT03095066|564346423|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156340636|NCT03095066|564346424|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156340637|NCT03095066|564346425|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156340638|NCT03095066|564346426|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
156340639|NCT03095066|564346419|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156340640|NCT03095066|564346420|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156340641|NCT03095066|564346421|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
156340642|NCT03095066|564346422|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156340643|NCT03095066|564346423|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156340644|NCT03095066|564346424|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156469875|NCT05580003|564814874|FG006|Part 2 (up to 10 Days)|Other|0|||
156469876|NCT05580003|564814875|FG007|Part 2 (up to 10 Days)|Other|0|||
156469877|NCT05580003|564814876|FG008|Part 2 (up to 10 Days)|Other|0|||
156469878|NCT05580003|564814877|FG009|Part 2 (up to 10 Days)|Other|1|||
156340645|NCT03095066|564346425|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156340646|NCT03095066|564346426|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156340647|NCT03095066|564346419|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156340648|NCT03095066|564346420|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156340649|NCT03095066|564346421|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
156469879|NCT05580003|564814878|FG010|Part 2 (up to 10 Days)|Other|0|||
156469880|NCT05580003|564814879|FG011|Part 2 (up to 10 Days)|Other|0|||
156469881|NCT05580003|564814880|FG012|Part 2 (up to 10 Days)|Other|0|||
156840780|NCT00605345|566168034|FG000|Overall Study|Withdrawal by Subject|1|||
156840781|NCT00605345|566168035|FG001|Overall Study|Withdrawal by Subject|0|||
156840782|NCT00605345|566168034|FG000|Overall Study|Adverse Event|0|||
156840783|NCT00605345|566168035|FG001|Overall Study|Adverse Event|1|||
156840784|NCT00605345|566168034|FG000|Overall Study|Protocol Violation|0|||
156840785|NCT00605345|566168035|FG001|Overall Study|Protocol Violation|2|||
156840786|NCT02577016|566168036|FG000|Overall Study|Adverse Event|2|||
156840787|NCT02577016|566168037|FG001|Overall Study|Adverse Event|1|||
156840788|NCT02577016|566168036|FG000|Overall Study|Physician Decision|0|||
156840789|NCT02577016|566168037|FG001|Overall Study|Physician Decision|1|||
156840790|NCT02126839|566168038|FG000|Overall Study|Adverse Event|0|||
156840791|NCT02126839|566168039|FG001|Overall Study|Adverse Event|1|||
156840792|NCT02126839|566168038|FG000|Overall Study|Withdrawal by Subject|1|||
156840793|NCT02126839|566168039|FG001|Overall Study|Withdrawal by Subject|0|||
156840794|NCT02126839|566168038|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156840795|NCT02126839|566168039|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156840796|NCT02126839|566168038|FG000|Overall Study|Protocol Violation|2|||
156840797|NCT02126839|566168039|FG001|Overall Study|Protocol Violation|3|||
156840798|NCT02126839|566168038|FG000|Overall Study|Sponsor request|0|||
156840799|NCT02126839|566168039|FG001|Overall Study|Sponsor request|1|||
156840800|NCT02126839|566168038|FG000|Overall Study|Lost to Follow-up|1|||
156840801|NCT02126839|566168039|FG001|Overall Study|Lost to Follow-up|4|||
156840802|NCT02126839|566168038|FG000|Overall Study|Other|5|||
156840803|NCT02126839|566168039|FG001|Overall Study|Other|5|||
156840804|NCT00411632|566168040|FG000|Overall Study|Death|1|||
156840805|NCT01108523|566168041|FG000|Overall Study|Protocol Violation|4|||
156840806|NCT00761527|566168044|FG000|Overall Study|Adverse Event|3|||
156840807|NCT00761527|566168044|FG000|Overall Study|Poor Compliance|8|||
156469882|NCT05580003|564814881|FG013|Part 2 (up to 10 Days)|Other|0|||
156469883|NCT05580003|564814882|FG014|Part 2 (up to 10 Days)|Other|0|||
156469884|NCT05580003|564814883|FG015|Part 2 (up to 10 Days)|Other|0|||
156469885|NCT05580003|564814884|FG016|Part 2 (up to 10 Days)|Other|0|||
156469886|NCT05580003|564814885|FG017|Part 2 (up to 10 Days)|Other|0|||
156469887|NCT05580003|564814886|FG018|Part 2 (up to 10 Days)|Other|0|||
156469888|NCT05580003|564814887|FG019|Part 2 (up to 10 Days)|Other|0|||
156469889|NCT05580003|564814888|FG020|Part 2 (up to 10 Days)|Other|0|||
156469890|NCT05580003|564814889|FG021|Part 2 (up to 10 Days)|Other|0|||
156469891|NCT05580003|564814890|FG022|Part 2 (up to 10 Days)|Other|0|||
156469892|NCT05580003|564814891|FG023|Part 2 (up to 10 Days)|Other|0|||
156469893|NCT05580003|564814892|FG024|Part 2 (up to 10 Days)|Other|0|||
156840808|NCT00761527|566168044|FG000|Overall Study|Lost to Follow-up|9|||
156840809|NCT00761527|566168044|FG000|Overall Study|Unknown reason|2|||
156840810|NCT00687531|566168045|FG000|Overall Study|Did not meet protocol eligibility|104|||
156840811|NCT00687531|566168045|FG000|Overall Study|Adverse Event|5|||
156840812|NCT00687531|566168045|FG000|Overall Study|Lost to Follow-up|26|||
156840813|NCT02353728|566168046|FG000|Overall Study|Subject non-compliance|1|||
156840814|NCT00895310|566168047|FG000|Overall Study|Withdrawal by Subject|1|||
156840815|NCT00659230|566168048|FG000|Overall Study|Lost to Follow-up|2|||
156840816|NCT00659230|566168049|FG001|Overall Study|Lost to Follow-up|5|||
156840817|NCT00659230|566168048|FG000|Overall Study|Lost source documentation|5|||
156840818|NCT00659230|566168049|FG001|Overall Study|Lost source documentation|4|||
156840819|NCT00659230|566168048|FG000|Overall Study|Did not return post-randomization|2|||
156840820|NCT00659230|566168049|FG001|Overall Study|Did not return post-randomization|3|||
156840821|NCT01031979|566169949|FG000|Overall Study|Lost to Follow-up|5|||
156840822|NCT01031979|566169950|FG001|Overall Study|Lost to Follow-up|4|||
156840823|NCT02454478|566169953|FG000|Overall Study|Incomplete DLT Evaluation|1|||
156840824|NCT01959841|566169957|FG000|Overall Study|Adverse Event|1|||
156840825|NCT01959841|566169958|FG001|Overall Study|Adverse Event|3|||
156840826|NCT01959841|566169959|FG002|Overall Study|Adverse Event|2|||
156840827|NCT01959841|566169957|FG000|Overall Study|Lack of Efficacy|5|||
156840828|NCT01959841|566169958|FG001|Overall Study|Lack of Efficacy|0|||
156840829|NCT01959841|566169959|FG002|Overall Study|Lack of Efficacy|0|||
156340650|NCT03095066|564346422|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156840830|NCT01959841|566169957|FG000|Overall Study|Lost to Follow-up|1|||
156340651|NCT03095066|564346423|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156840831|NCT01959841|566169958|FG001|Overall Study|Lost to Follow-up|1|||
156840832|NCT01959841|566169959|FG002|Overall Study|Lost to Follow-up|0|||
156840833|NCT01959841|566169957|FG000|Overall Study|Physician Decision|0|||
156840834|NCT01959841|566169958|FG001|Overall Study|Physician Decision|2|||
156840835|NCT01959841|566169959|FG002|Overall Study|Physician Decision|3|||
156840836|NCT01959841|566169957|FG000|Overall Study|Protocol Violation|16|||
156840837|NCT01959841|566169958|FG001|Overall Study|Protocol Violation|23|||
156840838|NCT01959841|566169959|FG002|Overall Study|Protocol Violation|16|||
156840839|NCT01959841|566169957|FG000|Overall Study|Withdrawal by Subject|7|||
156840840|NCT01959841|566169958|FG001|Overall Study|Withdrawal by Subject|7|||
156840841|NCT01959841|566169959|FG002|Overall Study|Withdrawal by Subject|5|||
156840842|NCT01959841|566169957|FG000|Overall Study|Clinical laboratory value|2|||
156840843|NCT01959841|566169958|FG001|Overall Study|Clinical laboratory value|6|||
156840844|NCT01959841|566169959|FG002|Overall Study|Clinical laboratory value|6|||
156840845|NCT01959841|566169957|FG000|Overall Study|Platelet count below on day1 or 4|11|||
156840846|NCT01959841|566169958|FG001|Overall Study|Platelet count below on day1 or 4|15|||
156840847|NCT01959841|566169959|FG002|Overall Study|Platelet count below on day1 or 4|11|||
156840848|NCT00780416|566169960|FG000|Overall Study|Physician Decision|3|||
156840849|NCT00780416|566169961|FG001|Overall Study|Physician Decision|3|||
156840850|NCT00780416|566169960|FG000|Overall Study|Protocol Violation|1|||
156840851|NCT00780416|566169961|FG001|Overall Study|Protocol Violation|0|||
156840852|NCT00780416|566169960|FG000|Overall Study|Withdrawal by Subject|8|||
156840853|NCT00780416|566169961|FG001|Overall Study|Withdrawal by Subject|6|||
156840854|NCT00666224|566169964|FG000|Double-Blind|Adverse Event|15|||
156840855|NCT00666224|566169965|FG001|Double-Blind|Adverse Event|5|||
156840856|NCT00666224|566169964|FG000|Double-Blind|Lost to Follow-up|2|||
156840857|NCT00666224|566169965|FG001|Double-Blind|Lost to Follow-up|2|||
156840858|NCT00666224|566169964|FG000|Double-Blind|Withdrawal by Subject|18|||
156840859|NCT00666224|566169965|FG001|Double-Blind|Withdrawal by Subject|14|||
156840860|NCT00666224|566169964|FG000|Double-Blind|Physician Decision|0|||
156840861|NCT00666224|566169965|FG001|Double-Blind|Physician Decision|3|||
156840862|NCT00666224|566169964|FG000|Double-Blind|Sponsor decision|1|||
156840863|NCT00666224|566169965|FG001|Double-Blind|Sponsor decision|0|||
156840864|NCT00666224|566169964|FG000|Double-Blind|Pregnancy|3|||
156840865|NCT00666224|566169965|FG001|Double-Blind|Pregnancy|2|||
156840866|NCT00666224|566169964|FG000|Double-Blind|Noncompliance|1|||
156840867|NCT00666224|566169965|FG001|Double-Blind|Noncompliance|0|||
156840868|NCT00666224|566169964|FG000|Double-Blind|Death|1|||
156840869|NCT00666224|566169965|FG001|Double-Blind|Death|0|||
156840870|NCT00666224|566169964|FG000|Double-Blind|Undefined/Unknown|4|||
156840871|NCT00666224|566169965|FG001|Double-Blind|Undefined/Unknown|1|||
156840872|NCT00666224|566169964|FG000|Open-Label|Adverse Event|8|||
156840873|NCT00666224|566169965|FG001|Open-Label|Adverse Event|43|||
156840874|NCT00666224|566169964|FG000|Open-Label|Lost to Follow-up|4|||
156840875|NCT00666224|566169965|FG001|Open-Label|Lost to Follow-up|5|||
156840876|NCT00666224|566169964|FG000|Open-Label|Withdrawal by Subject|12|||
156840877|NCT00666224|566169965|FG001|Open-Label|Withdrawal by Subject|25|||
156840878|NCT00666224|566169964|FG000|Open-Label|Physician Decision|7|||
156840879|NCT00666224|566169965|FG001|Open-Label|Physician Decision|5|||
156840880|NCT00666224|566169964|FG000|Open-Label|Pregnancy|1|||
156840881|NCT00666224|566169965|FG001|Open-Label|Pregnancy|5|||
156840882|NCT00666224|566169964|FG000|Open-Label|Noncompliance|2|||
156840883|NCT00666224|566169965|FG001|Open-Label|Noncompliance|1|||
156840884|NCT00666224|566169964|FG000|Open-Label|Undefined/Unknown|1|||
156840885|NCT00666224|566169965|FG001|Open-Label|Undefined/Unknown|1|||
156840886|NCT03521141|566169966|FG000|Overall Study|Death|1|||
156840887|NCT03521141|566169967|FG001|Overall Study|Death|0|||
156840888|NCT03521141|566169968|FG002|Overall Study|Death|1|||
156840889|NCT03828617|566169974|FG000|Overall Study|Lost to Follow-up|22|||
156840890|NCT03828617|566169975|FG001|Overall Study|Lost to Follow-up|12|||
156840891|NCT03828617|566169976|FG002|Overall Study|Lost to Follow-up|23|||
156840892|NCT03828617|566169977|FG003|Overall Study|Lost to Follow-up|7|||
156840893|NCT03828617|566169974|FG000|Overall Study|No longer met eligibility criteria|0|||
156840894|NCT03828617|566169975|FG001|Overall Study|No longer met eligibility criteria|1|||
156840895|NCT03828617|566169976|FG002|Overall Study|No longer met eligibility criteria|1|||
156840896|NCT03828617|566169977|FG003|Overall Study|No longer met eligibility criteria|3|||
156840897|NCT03828617|566169974|FG000|Overall Study|Protocol Violation|0|||
156840898|NCT03828617|566169975|FG001|Overall Study|Protocol Violation|2|||
156840899|NCT03828617|566169976|FG002|Overall Study|Protocol Violation|0|||
156840900|NCT03828617|566169977|FG003|Overall Study|Protocol Violation|0|||
156840901|NCT03828617|566169974|FG000|Overall Study|Withdrawal by Subject|2|||
156840902|NCT03828617|566169975|FG001|Overall Study|Withdrawal by Subject|0|||
156840903|NCT03828617|566169976|FG002|Overall Study|Withdrawal by Subject|2|||
156840904|NCT03828617|566169977|FG003|Overall Study|Withdrawal by Subject|0|||
156840905|NCT03354273|566169979|FG000|Overall Study|Adverse Event|5|||
156840906|NCT03354273|566169979|FG000|Overall Study|Screen Failure|21|||
156840907|NCT03354273|566169979|FG000|Overall Study|Withdrawal by Subject|34|||
156840908|NCT03354273|566169979|FG000|Overall Study|Technical Problems|30|||
156840909|NCT03354273|566169979|FG000|Overall Study|Lost to Follow-up|4|||
156840910|NCT03354273|566169979|FG000|Overall Study|Investigator Decision|3|||
156840911|NCT03354273|566169979|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
156840912|NCT03354273|566169979|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
156840913|NCT03354273|566169979|FG000|Overall Study|COVID-19 Restrictions|9|||
156840914|NCT03354273|566169979|FG000|Overall Study|Other|5|||
156840915|NCT04207749|566169982|FG000|Overall Study|Lost to Follow-up|0|||
156840916|NCT04207749|566169983|FG001|Overall Study|Lost to Follow-up|2|||
156840917|NCT04207749|566169982|FG000|Overall Study|Protocol Violation|0|||
156840918|NCT04207749|566169983|FG001|Overall Study|Protocol Violation|1|||
156840919|NCT04207749|566169982|FG000|Overall Study|Withdrawal by Subject|3|||
156840920|NCT04207749|566169983|FG001|Overall Study|Withdrawal by Subject|0|||
156840921|NCT04207749|566169982|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
156840922|NCT04207749|566169983|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
156840923|NCT00655629|566169984|FG000|Overall Study|Adverse Event|4|||
156840924|NCT00655629|566169985|FG001|Overall Study|Adverse Event|1|||
156840925|NCT00655629|566169984|FG000|Overall Study|Lack of Efficacy|2|||
156840926|NCT00655629|566169985|FG001|Overall Study|Lack of Efficacy|12|||
156840927|NCT00655629|566169984|FG000|Overall Study|Lost to Follow-up|4|||
156840928|NCT00655629|566169985|FG001|Overall Study|Lost to Follow-up|3|||
156840929|NCT00655629|566169984|FG000|Overall Study|Protocol Violation|5|||
156840930|NCT00655629|566169985|FG001|Overall Study|Protocol Violation|3|||
156840931|NCT00655629|566169984|FG000|Overall Study|consent withdrawn|6|||
156840932|NCT00655629|566169985|FG001|Overall Study|consent withdrawn|4|||
156840933|NCT00705367|566169986|FG000|Long-term Extension Period|Adverse Event|2|||
156840934|NCT00705367|566169987|FG001|Long-term Extension Period|Adverse Event|0|||
156340652|NCT03095066|564346424|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156340653|NCT03095066|564346425|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156340654|NCT03095066|564346426|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
156340655|NCT03095066|564346419|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156340656|NCT03095066|564346420|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156340657|NCT03095066|564346421|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156340658|NCT03095066|564346422|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156340659|NCT03095066|564346423|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156340660|NCT03095066|564346424|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156340661|NCT03095066|564346425|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156340662|NCT03095066|564346426|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
156340663|NCT03095066|564346419|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156340664|NCT03095066|564346420|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156340665|NCT03095066|564346421|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156340666|NCT03095066|564346422|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156340667|NCT03095066|564346423|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156340668|NCT03095066|564346424|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
156340669|NCT03095066|564346425|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156340670|NCT03095066|564346426|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156340671|NCT03095066|564346419|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156340672|NCT03095066|564346420|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156340673|NCT03095066|564346421|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156340674|NCT03095066|564346422|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156340675|NCT03095066|564346423|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
156340676|NCT03095066|564346424|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156340677|NCT03095066|564346425|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
156340678|NCT03095066|564346426|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156340679|NCT03095066|564346419|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156340680|NCT03095066|564346420|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156340681|NCT03095066|564346421|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156340682|NCT03095066|564346422|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156340683|NCT03095066|564346423|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
156340684|NCT03095066|564346424|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156340685|NCT03095066|564346425|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156340686|NCT03095066|564346426|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
156340687|NCT03095066|564346419|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156340688|NCT03095066|564346420|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156340689|NCT03095066|564346421|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156340690|NCT03095066|564346422|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156340691|NCT03095066|564346423|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
156340692|NCT03095066|564346424|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156340693|NCT03095066|564346425|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156340694|NCT03095066|564346426|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
156340695|NCT03095066|564346419|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156340696|NCT03095066|564346420|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156340697|NCT03095066|564346421|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156340698|NCT03095066|564346422|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
156340699|NCT03095066|564346423|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156340700|NCT03095066|564346424|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
156340701|NCT03095066|564346425|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156340702|NCT03095066|564346426|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156340703|NCT00160693|564346427|FG000|Overall Study|Adverse Event|97|||
156340704|NCT00160693|564346427|FG000|Overall Study|Lack of Efficacy|30|||
156340705|NCT00160693|564346427|FG000|Overall Study|Protocol Violation|24|||
156340706|NCT00160693|564346427|FG000|Overall Study|Lost to Follow-up|15|||
156340707|NCT00160693|564346427|FG000|Overall Study|Withdrawal by Subject|54|||
156340708|NCT00160693|564346427|FG000|Overall Study|Study terminated by sponsor|15|||
156340709|NCT05988619|564346428|FG000|Overall Study|Lost to Follow-up|1|||
156340710|NCT05988619|564346429|FG001|Overall Study|Lost to Follow-up|4|||
156340711|NCT05988619|564346428|FG000|Overall Study|Withdrawal by Subject|2|||
156541490|NCT03810911|565075435|FG000|Overall Study|Death|1|||
156541491|NCT03810911|565075436|FG001|Overall Study|Death|1|||
156541492|NCT03810911|565075435|FG000|Overall Study|Withdrawal by Subject|1|||
156541493|NCT03810911|565075436|FG001|Overall Study|Withdrawal by Subject|1|||
156340712|NCT05988619|564346429|FG001|Overall Study|Withdrawal by Subject|9|||
156340713|NCT00726232|564346432|FG000|Initial Phase (Dose-finding)|Death|0|||
156340714|NCT00726232|564346433|FG001|Initial Phase (Dose-finding)|Death|0|||
156340715|NCT00726232|564346434|FG002|Initial Phase (Dose-finding)|Death|0|||
156340716|NCT00726232|564346435|FG003|Initial Phase (Dose-finding)|Death|0|||
156340717|NCT00726232|564346436|FG004|Initial Phase (Dose-finding)|Death|1|||
156340718|NCT00726232|564346437|FG005|Initial Phase (Dose-finding)|Death|0|||
156340719|NCT00726232|564346438|FG006|Initial Phase (Dose-finding)|Death|0|||
156541494|NCT04770532|565075437|FG000|Overall Study|Withdrawal by Subject|0|||
156840935|NCT00705367|566169986|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
156840936|NCT00705367|566169987|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
156840937|NCT00705367|566169986|FG000|Long-term Extension Period|Lack of Efficacy|1|||
156840938|NCT00705367|566169987|FG001|Long-term Extension Period|Lack of Efficacy|0|||
156840939|NCT00705367|566169986|FG000|Long-term Extension Period|No longer met study criteria|1|||
156840940|NCT00705367|566169987|FG001|Long-term Extension Period|No longer met study criteria|0|||
156840941|NCT00705367|566169986|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
156840942|NCT00705367|566169987|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
156840943|NCT01835223|566169990|FG000|Overall Study|Adverse Event|1|||
156840944|NCT01835223|566169991|FG001|Overall Study|Adverse Event|0|||
156840945|NCT01835223|566169990|FG000|Overall Study|Withdrawal by Subject|2|||
156840946|NCT01835223|566169991|FG001|Overall Study|Withdrawal by Subject|0|||
156840947|NCT01835223|566169990|FG000|Overall Study|Disease progression|2|||
156840948|NCT01835223|566169991|FG001|Overall Study|Disease progression|1|||
156840949|NCT01835223|566169990|FG000|Overall Study|Became Inelligible|4|||
156840950|NCT01835223|566169991|FG001|Overall Study|Became Inelligible|0|||
156840951|NCT00303485|566169992|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
156840952|NCT00303485|566169993|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
156840953|NCT00303485|566169992|FG000|Overall Study|Failure to return|0|||
156840954|NCT00303485|566169993|FG001|Overall Study|Failure to return|1|||
156840955|NCT00303485|566169992|FG000|Overall Study|Withdrawal by Subject|1|||
156840956|NCT00303485|566169993|FG001|Overall Study|Withdrawal by Subject|0|||
156840957|NCT01959139|566169994|FG000|Phase II|Disease progression|0|||
156840958|NCT01959139|566169995|FG001|Phase II|Disease progression|0|||
156840959|NCT01959139|566169996|FG002|Phase II|Disease progression|26|||
156840960|NCT01959139|566169997|FG003|Phase II|Disease progression|34|||
156840961|NCT01959139|566169994|FG000|Phase II|Adverse Event|0|||
156840962|NCT01959139|566169995|FG001|Phase II|Adverse Event|0|||
156840963|NCT01959139|566169996|FG002|Phase II|Adverse Event|10|||
156840964|NCT01959139|566169997|FG003|Phase II|Adverse Event|11|||
156840965|NCT01959139|566169994|FG000|Phase II|Patient Refusal|0|||
156840966|NCT01959139|566169995|FG001|Phase II|Patient Refusal|0|||
156840967|NCT01959139|566169996|FG002|Phase II|Patient Refusal|5|||
156840968|NCT01959139|566169997|FG003|Phase II|Patient Refusal|4|||
156840969|NCT01959139|566169994|FG000|Phase II|Death|0|||
156840970|NCT01959139|566169995|FG001|Phase II|Death|0|||
156840971|NCT01959139|566169996|FG002|Phase II|Death|3|||
156840972|NCT01959139|566169997|FG003|Phase II|Death|1|||
156840973|NCT01959139|566169994|FG000|Phase II|Other/Unknown|0|||
156840974|NCT01959139|566169995|FG001|Phase II|Other/Unknown|0|||
156840975|NCT01959139|566169996|FG002|Phase II|Other/Unknown|8|||
156840976|NCT01959139|566169997|FG003|Phase II|Other/Unknown|5|||
156840977|NCT01959139|566169994|FG000|Phase II|On treatment|0|||
156840978|NCT01959139|566169995|FG001|Phase II|On treatment|0|||
156840979|NCT01959139|566169996|FG002|Phase II|On treatment|4|||
156840980|NCT01959139|566169997|FG003|Phase II|On treatment|0|||
156840981|NCT01378325|566170003|FG000|Overall Study|Protocol Violation|0|||
156840982|NCT01378325|566170004|FG001|Overall Study|Protocol Violation|1|||
156840983|NCT01559675|566170005|FG000|Overall Study|Protocol Violation|1|||
156840984|NCT01559675|566170006|FG001|Overall Study|Protocol Violation|2|||
156840985|NCT01559675|566170005|FG000|Overall Study|2nd operation on same patient excluded|14|||
156840986|NCT01559675|566170006|FG001|Overall Study|2nd operation on same patient excluded|12|||
156840987|NCT01496469|566170007|FG000|Overall Study|Adverse Event|1|||
156840988|NCT01496469|566170008|FG001|Overall Study|Adverse Event|0|||
156840989|NCT01496469|566170007|FG000|Overall Study|Protocol Violation|2|||
156840990|NCT01496469|566170008|FG001|Overall Study|Protocol Violation|0|||
156840991|NCT01496469|566170007|FG000|Overall Study|Lost to Follow-up|1|||
156840992|NCT01496469|566170008|FG001|Overall Study|Lost to Follow-up|1|||
156840993|NCT01496469|566170007|FG000|Overall Study|Withdrawal by Subject|4|||
156840994|NCT01496469|566170008|FG001|Overall Study|Withdrawal by Subject|4|||
156840995|NCT01496469|566170007|FG000|Overall Study|BP exceeds protocol limits|1|||
156840996|NCT01496469|566170008|FG001|Overall Study|BP exceeds protocol limits|2|||
156840997|NCT01496469|566170007|FG000|Overall Study|Other|1|||
156840998|NCT01496469|566170008|FG001|Overall Study|Other|1|||
156840999|NCT00193180|566170012|FG000|Overall Study|Lack of Efficacy|1|||
156841000|NCT00193180|566170012|FG000|Overall Study|Adverse Event|8|||
156841001|NCT00193180|566170012|FG000|Overall Study|Protocol Violation|1|||
156841002|NCT02942485|566170013|FG000|Overall Study|Lost to Follow-up|1|||
156841003|NCT02942485|566170014|FG001|Overall Study|Lost to Follow-up|0|||
156841004|NCT04302545|566170021|FG000|Overall Study|Lost to Follow-up|3|||
156841005|NCT04302545|566170022|FG001|Overall Study|Lost to Follow-up|4|||
156841006|NCT01110382|566170024|FG000|Overall Study|Withdrawal by Subject|0|||
156841007|NCT01110382|566170025|FG001|Overall Study|Withdrawal by Subject|1|||
156841008|NCT01110382|566170024|FG000|Overall Study|Protocol Violation|0|||
156841009|NCT01110382|566170025|FG001|Overall Study|Protocol Violation|1|||
156841010|NCT00077649|566170026|FG000|Overall Study|Adverse Event|5|||
156841011|NCT00077649|566170027|FG001|Overall Study|Adverse Event|1|||
156541495|NCT04770532|565075438|FG001|Overall Study|Withdrawal by Subject|3|||
156841012|NCT00077649|566170028|FG002|Overall Study|Adverse Event|7|||
156841013|NCT00077649|566170029|FG003|Overall Study|Adverse Event|9|||
156841014|NCT00077649|566170026|FG000|Overall Study|Lack of Efficacy|5|||
156841015|NCT00077649|566170027|FG001|Overall Study|Lack of Efficacy|3|||
156841016|NCT00077649|566170028|FG002|Overall Study|Lack of Efficacy|3|||
156841017|NCT00077649|566170029|FG003|Overall Study|Lack of Efficacy|2|||
156841018|NCT00077649|566170026|FG000|Overall Study|Withdrawal by Subject|0|||
156841019|NCT00077649|566170027|FG001|Overall Study|Withdrawal by Subject|1|||
156841020|NCT00077649|566170028|FG002|Overall Study|Withdrawal by Subject|1|||
156841021|NCT00077649|566170029|FG003|Overall Study|Withdrawal by Subject|2|||
156841022|NCT00077649|566170026|FG000|Overall Study|Lost to Follow-up|2|||
156841023|NCT00077649|566170027|FG001|Overall Study|Lost to Follow-up|2|||
156841024|NCT00077649|566170028|FG002|Overall Study|Lost to Follow-up|3|||
156841025|NCT00077649|566170029|FG003|Overall Study|Lost to Follow-up|2|||
156841026|NCT00077649|566170026|FG000|Overall Study|Abnormality of Laboratory Test|1|||
156841027|NCT00077649|566170027|FG001|Overall Study|Abnormality of Laboratory Test|2|||
156841028|NCT00077649|566170028|FG002|Overall Study|Abnormality of Laboratory Test|1|||
156841029|NCT00077649|566170029|FG003|Overall Study|Abnormality of Laboratory Test|2|||
156841030|NCT00077649|566170026|FG000|Overall Study|Randomized but never dosed|1|||
156841031|NCT00077649|566170027|FG001|Overall Study|Randomized but never dosed|0|||
156841032|NCT00077649|566170028|FG002|Overall Study|Randomized but never dosed|0|||
156841033|NCT00077649|566170029|FG003|Overall Study|Randomized but never dosed|0|||
156841034|NCT00470418|566170030|FG000|Overall Study|Withdrawal by Subject|1|||
156841035|NCT00470418|566170031|FG001|Overall Study|Withdrawal by Subject|0|||
156841036|NCT03688100|566170036|FG000|Overall Study|Lost to Follow-up|21|||
156841037|NCT03688100|566170037|FG001|Overall Study|Lost to Follow-up|15|||
156841038|NCT03688100|566170038|FG002|Overall Study|Lost to Follow-up|15|||
156841039|NCT03688100|566170039|FG003|Overall Study|Lost to Follow-up|18|||
156841040|NCT03688100|566170036|FG000|Overall Study|Withdrawal by Subject|19|||
156841041|NCT03688100|566170037|FG001|Overall Study|Withdrawal by Subject|16|||
156841042|NCT03688100|566170038|FG002|Overall Study|Withdrawal by Subject|0|||
156841043|NCT03688100|566170039|FG003|Overall Study|Withdrawal by Subject|0|||
156841044|NCT03688100|566170036|FG000|Overall Study|Death|36|||
156841045|NCT03688100|566170037|FG001|Overall Study|Death|27|||
156841046|NCT03688100|566170038|FG002|Overall Study|Death|0|||
156841047|NCT03688100|566170039|FG003|Overall Study|Death|0|||
156841048|NCT02479139|566170045|FG000|Overall Study|Lost to Follow-up|2|||
156841049|NCT02479139|566170046|FG001|Overall Study|Lost to Follow-up|4|||
156841050|NCT02479139|566170047|FG002|Overall Study|Lost to Follow-up|4|||
156841051|NCT02479139|566170048|FG003|Overall Study|Lost to Follow-up|2|||
156841052|NCT02479139|566170049|FG004|Overall Study|Lost to Follow-up|3|||
156841053|NCT02479139|566170050|FG005|Overall Study|Lost to Follow-up|5|||
156841054|NCT02479139|566170045|FG000|Overall Study|Withdrew Consent|5|||
156841055|NCT02479139|566170046|FG001|Overall Study|Withdrew Consent|6|||
156841056|NCT02479139|566170047|FG002|Overall Study|Withdrew Consent|1|||
156841057|NCT02479139|566170048|FG003|Overall Study|Withdrew Consent|4|||
156841058|NCT02479139|566170049|FG004|Overall Study|Withdrew Consent|1|||
156841059|NCT02479139|566170050|FG005|Overall Study|Withdrew Consent|1|||
156841060|NCT02479139|566170045|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841061|NCT02479139|566170046|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841062|NCT02479139|566170047|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
156841063|NCT02479139|566170048|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841064|NCT02479139|566170049|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841065|NCT02479139|566170050|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841066|NCT02479139|566170045|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156841067|NCT02479139|566170046|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156841068|NCT02479139|566170047|FG002|Overall Study|Other Miscellaneous Reasons|1|||
156841069|NCT02479139|566170048|FG003|Overall Study|Other Miscellaneous Reasons|1|||
156841070|NCT02479139|566170049|FG004|Overall Study|Other Miscellaneous Reasons|1|||
156841071|NCT02479139|566170050|FG005|Overall Study|Other Miscellaneous Reasons|0|||
156841072|NCT00764673|566170051|FG000|Overall Study|Death|1|||
156841073|NCT00764673|566170051|FG000|Overall Study|Lost to Follow-up|3|||
156841074|NCT00764673|566170051|FG000|Overall Study|Withdrawal by Subject|6|||
156841075|NCT00764673|566170051|FG000|Overall Study|Revision of Device|2|||
156841076|NCT01438177|566170052|FG000|Overall Study|Withdrawal by Subject|1|||
156841077|NCT01438177|566170052|FG000|Overall Study|Initiation of new therapy|1|||
156841078|NCT01727336|566170053|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
156841079|NCT01727336|566170054|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
156841080|NCT01727336|566170055|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
156841081|NCT01727336|566170056|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
156841082|NCT01727336|566170057|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
156841083|NCT01727336|566170058|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
156841084|NCT01727336|566170053|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
156340720|NCT00726232|564346439|FG007|Initial Phase (Dose-finding)|Death|0|||
156340721|NCT00726232|564346432|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
156340722|NCT00726232|564346433|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
156841085|NCT01727336|566170054|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
156841086|NCT01727336|566170055|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
156841087|NCT01727336|566170056|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
156841088|NCT01727336|566170057|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
156841089|NCT01727336|566170058|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
156340723|NCT00726232|564346434|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
156340724|NCT00726232|564346435|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
156340725|NCT00726232|564346436|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
156340726|NCT00726232|564346437|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
156340727|NCT00726232|564346438|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
156340728|NCT00726232|564346439|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
156340729|NCT00726232|564346432|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
156340730|NCT00726232|564346433|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156340731|NCT00726232|564346434|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156340732|NCT00726232|564346435|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
156340733|NCT00726232|564346436|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156340734|NCT00726232|564346437|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
156340735|NCT00726232|564346438|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156340736|NCT00726232|564346439|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156340737|NCT00726232|564346432|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
156340738|NCT00726232|564346433|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
156340739|NCT00726232|564346434|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
156340740|NCT00726232|564346435|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
156340741|NCT00726232|564346436|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
156340742|NCT00726232|564346437|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
156340743|NCT00726232|564346438|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
156340744|NCT00726232|564346439|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
156340745|NCT00726232|564346432|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
156340746|NCT00726232|564346433|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
156340747|NCT00726232|564346434|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
156340748|NCT00726232|564346435|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
156340749|NCT00726232|564346436|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
156340750|NCT00726232|564346437|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
156340751|NCT00726232|564346438|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
156340752|NCT00726232|564346439|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
156340753|NCT00726232|564346432|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
156340754|NCT00726232|564346433|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
156340755|NCT00726232|564346434|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
156340756|NCT00726232|564346435|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
156340757|NCT00726232|564346436|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
156340758|NCT00726232|564346437|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
156340759|NCT00726232|564346438|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
156340760|NCT00726232|564346439|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
156340761|NCT00726232|564346432|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
156340762|NCT00726232|564346433|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
156340763|NCT00726232|564346434|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
156340764|NCT00726232|564346435|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
156340765|NCT00726232|564346436|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
156340766|NCT00726232|564346437|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
156340767|NCT00726232|564346438|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
156340768|NCT00726232|564346439|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
156340769|NCT00726232|564346432|FG000|Expansion Phase|Death|0|||
156340770|NCT00726232|564346433|FG001|Expansion Phase|Death|0|||
156340771|NCT00726232|564346434|FG002|Expansion Phase|Death|0|||
156340772|NCT00726232|564346435|FG003|Expansion Phase|Death|0|||
156340773|NCT00726232|564346436|FG004|Expansion Phase|Death|0|||
156340774|NCT00726232|564346437|FG005|Expansion Phase|Death|0|||
156340775|NCT00726232|564346438|FG006|Expansion Phase|Death|0|||
156340776|NCT00726232|564346439|FG007|Expansion Phase|Death|1|||
156841090|NCT01727336|566170053|FG000|Part 2 Blinded|Death|0|||
156841091|NCT01727336|566170054|FG001|Part 2 Blinded|Death|0|||
156340777|NCT00726232|564346432|FG000|Expansion Phase|Adverse Event|0|||
156340778|NCT00726232|564346433|FG001|Expansion Phase|Adverse Event|0|||
156340779|NCT00726232|564346434|FG002|Expansion Phase|Adverse Event|0|||
156340780|NCT00726232|564346435|FG003|Expansion Phase|Adverse Event|0|||
156340781|NCT00726232|564346436|FG004|Expansion Phase|Adverse Event|0|||
156340782|NCT00726232|564346437|FG005|Expansion Phase|Adverse Event|0|||
156841092|NCT01727336|566170055|FG002|Part 2 Blinded|Death|0|||
156841093|NCT01727336|566170056|FG003|Part 2 Blinded|Death|0|||
156469894|NCT05580003|564814893|FG025|Part 2 (up to 10 Days)|Other|0|||
156469895|NCT05580003|564814894|FG026|Part 2 (up to 10 Days)|Other|0|||
156469896|NCT05580003|564814895|FG027|Part 2 (up to 10 Days)|Other|0|||
156841094|NCT01727336|566170057|FG004|Part 2 Blinded|Death|20|||
156841095|NCT01727336|566170058|FG005|Part 2 Blinded|Death|16|||
156841096|NCT01727336|566170053|FG000|Part 2 Blinded|Lack of Efficacy|0|||
156841097|NCT01727336|566170054|FG001|Part 2 Blinded|Lack of Efficacy|0|||
156841098|NCT01727336|566170055|FG002|Part 2 Blinded|Lack of Efficacy|0|||
156541496|NCT04770532|565075437|FG000|Overall Study|Physician Decision|1|||
156469897|NCT05580003|564814868|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469898|NCT05580003|564814869|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469899|NCT05580003|564814870|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469900|NCT05580003|564814871|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469901|NCT05580003|564814872|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469902|NCT05580003|564814873|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469903|NCT05580003|564814874|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469904|NCT05580003|564814875|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469905|NCT05580003|564814876|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469906|NCT05580003|564814877|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469907|NCT05580003|564814878|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469908|NCT05580003|564814879|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156541497|NCT04770532|565075438|FG001|Overall Study|Physician Decision|0|||
156541498|NCT04770532|565075437|FG000|Overall Study|Death|2|||
156541499|NCT04770532|565075438|FG001|Overall Study|Death|2|||
156541500|NCT02953340|565075439|FG000|Overall Study|Death|0|||
156541501|NCT02953340|565075440|FG001|Overall Study|Death|1|||
156841099|NCT01727336|566170056|FG003|Part 2 Blinded|Lack of Efficacy|0|||
156841100|NCT01727336|566170057|FG004|Part 2 Blinded|Lack of Efficacy|42|||
156841101|NCT01727336|566170058|FG005|Part 2 Blinded|Lack of Efficacy|44|||
156841102|NCT01727336|566170053|FG000|Part 2 Blinded|Lost to Follow-up|0|||
156469909|NCT05580003|564814880|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469910|NCT05580003|564814881|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469911|NCT05580003|564814882|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156541502|NCT02953340|565075439|FG000|Overall Study|Investigator Decision|3|||
156841103|NCT01727336|566170054|FG001|Part 2 Blinded|Lost to Follow-up|0|||
156841104|NCT01727336|566170055|FG002|Part 2 Blinded|Lost to Follow-up|0|||
156841105|NCT01727336|566170056|FG003|Part 2 Blinded|Lost to Follow-up|0|||
156841106|NCT01727336|566170057|FG004|Part 2 Blinded|Lost to Follow-up|0|||
156841107|NCT01727336|566170058|FG005|Part 2 Blinded|Lost to Follow-up|1|||
156841108|NCT01727336|566170053|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
156841109|NCT01727336|566170054|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
156841110|NCT01727336|566170055|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
156841111|NCT01727336|566170056|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
156841112|NCT01727336|566170057|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
156841113|NCT01727336|566170058|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
156841114|NCT01727336|566170053|FG000|Part 2 Blinded|use of prohibited medications|0|||
156841115|NCT01727336|566170054|FG001|Part 2 Blinded|use of prohibited medications|0|||
156841116|NCT01727336|566170055|FG002|Part 2 Blinded|use of prohibited medications|0|||
156841117|NCT01727336|566170056|FG003|Part 2 Blinded|use of prohibited medications|0|||
156841118|NCT01727336|566170057|FG004|Part 2 Blinded|use of prohibited medications|1|||
156841119|NCT01727336|566170058|FG005|Part 2 Blinded|use of prohibited medications|3|||
156841120|NCT00084656|566170061|FG000|Overall Study|Other reasons|0|||
156841121|NCT00084656|566170062|FG001|Overall Study|Other reasons|12|||
156841122|NCT00084656|566170063|FG002|Overall Study|Other reasons|11|||
156841123|NCT00084656|566170061|FG000|Overall Study|Withdrawal by Subject|15|||
156841124|NCT00084656|566170062|FG001|Overall Study|Withdrawal by Subject|4|||
156841125|NCT00084656|566170063|FG002|Overall Study|Withdrawal by Subject|4|||
156841126|NCT00084656|566170061|FG000|Overall Study|Disease relapse|0|||
156841127|NCT00084656|566170062|FG001|Overall Study|Disease relapse|9|||
156841128|NCT00084656|566170063|FG002|Overall Study|Disease relapse|10|||
156841129|NCT00084656|566170061|FG000|Overall Study|Disease progression|9|||
156841130|NCT00084656|566170062|FG001|Overall Study|Disease progression|0|||
156841131|NCT00084656|566170063|FG002|Overall Study|Disease progression|0|||
156841132|NCT00084656|566170061|FG000|Overall Study|Lost to Follow-up|1|||
156841133|NCT00084656|566170062|FG001|Overall Study|Lost to Follow-up|0|||
156841134|NCT00084656|566170063|FG002|Overall Study|Lost to Follow-up|1|||
156841135|NCT02772978|566170064|FG000|Overall Study|Withdrawal by Subject|1|||
156841136|NCT02772978|566170065|FG001|Overall Study|Withdrawal by Subject|1|||
156841137|NCT01331291|566170066|FG000|Overall Study|Lack of Efficacy|2|||
156841138|NCT01331291|566170067|FG001|Overall Study|Lack of Efficacy|8|||
156841139|NCT01331291|566170066|FG000|Overall Study|Death|0|||
156841140|NCT01331291|566170067|FG001|Overall Study|Death|1|||
156841141|NCT01026220|566170068|FG000|Induction|Death|1|||
156841142|NCT01026220|566170069|FG001|Induction|Death|0|||
156841143|NCT01026220|566170070|FG002|Induction|Death|0|||
156841144|NCT01026220|566170068|FG000|Induction|Lack of Efficacy|2|||
156841145|NCT01026220|566170069|FG001|Induction|Lack of Efficacy|0|||
156841146|NCT01026220|566170070|FG002|Induction|Lack of Efficacy|0|||
156841147|NCT01026220|566170068|FG000|Induction|Physician Decision|12|||
156841148|NCT01026220|566170069|FG001|Induction|Physician Decision|0|||
156841149|NCT01026220|566170070|FG002|Induction|Physician Decision|0|||
156841150|NCT01026220|566170068|FG000|Induction|Withdrawal by Subject|9|||
156841151|NCT01026220|566170069|FG001|Induction|Withdrawal by Subject|0|||
156841152|NCT01026220|566170070|FG002|Induction|Withdrawal by Subject|0|||
156841153|NCT01026220|566170068|FG000|Induction|Ineligible|1|||
156841154|NCT01026220|566170069|FG001|Induction|Ineligible|0|||
156841155|NCT01026220|566170070|FG002|Induction|Ineligible|0|||
156841156|NCT01026220|566170068|FG000|Consolidation Maintenance|Death|0|||
156841157|NCT01026220|566170069|FG001|Consolidation Maintenance|Death|1|||
156841158|NCT01026220|566170070|FG002|Consolidation Maintenance|Death|0|||
156841159|NCT01026220|566170068|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
156841160|NCT01026220|566170069|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
156841161|NCT01026220|566170070|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
156841162|NCT01026220|566170068|FG000|Consolidation Maintenance|Physician Decision|0|||
156841163|NCT01026220|566170069|FG001|Consolidation Maintenance|Physician Decision|2|||
156841164|NCT01026220|566170070|FG002|Consolidation Maintenance|Physician Decision|7|||
156841165|NCT01026220|566170068|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
156841166|NCT01026220|566170069|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
156841167|NCT01026220|566170070|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
156841168|NCT00409344|566170074|FG000|Overall Study|no enrollment|0|||
156841169|NCT00409344|566170075|FG001|Overall Study|no enrollment|0|||
156841170|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
156841171|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
156841172|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
156841173|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
156841174|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
156841175|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
156841176|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
156841177|NCT01389323|566170081|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
156841178|NCT01389323|566170081|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
156841179|NCT01389323|566170081|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
156841180|NCT01389323|566170081|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
156841181|NCT04033068|566170082|FG000|Overall Study|Withdrawal by Subject|0|||
156841182|NCT04033068|566170083|FG001|Overall Study|Withdrawal by Subject|0|||
156841183|NCT04033068|566170084|FG002|Overall Study|Withdrawal by Subject|1|||
156841184|NCT04033068|566170085|FG003|Overall Study|Withdrawal by Subject|0|||
156841185|NCT04033068|566170082|FG000|Overall Study|Lost to Follow-up|0|||
156340783|NCT00726232|564346438|FG006|Expansion Phase|Adverse Event|6|||
156340784|NCT00726232|564346439|FG007|Expansion Phase|Adverse Event|11|||
156340785|NCT00726232|564346432|FG000|Expansion Phase|Withdrawal by Subject|0|||
156340786|NCT00726232|564346433|FG001|Expansion Phase|Withdrawal by Subject|0|||
156340787|NCT00726232|564346434|FG002|Expansion Phase|Withdrawal by Subject|0|||
156340788|NCT00726232|564346435|FG003|Expansion Phase|Withdrawal by Subject|0|||
156340789|NCT00726232|564346436|FG004|Expansion Phase|Withdrawal by Subject|0|||
156340790|NCT00726232|564346437|FG005|Expansion Phase|Withdrawal by Subject|0|||
156340791|NCT00726232|564346438|FG006|Expansion Phase|Withdrawal by Subject|2|||
156340792|NCT00726232|564346439|FG007|Expansion Phase|Withdrawal by Subject|3|||
156340793|NCT00726232|564346432|FG000|Expansion Phase|Disease progression|0|||
156340794|NCT00726232|564346433|FG001|Expansion Phase|Disease progression|0|||
156340795|NCT00726232|564346434|FG002|Expansion Phase|Disease progression|0|||
156340796|NCT00726232|564346435|FG003|Expansion Phase|Disease progression|0|||
156340797|NCT00726232|564346436|FG004|Expansion Phase|Disease progression|0|||
156340798|NCT00726232|564346437|FG005|Expansion Phase|Disease progression|0|||
156340799|NCT00726232|564346438|FG006|Expansion Phase|Disease progression|4|||
156340800|NCT00726232|564346439|FG007|Expansion Phase|Disease progression|0|||
156340801|NCT00726232|564346432|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
156340802|NCT00726232|564346433|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
156340803|NCT00726232|564346434|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
156340804|NCT00726232|564346435|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
156340805|NCT00726232|564346436|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
156340806|NCT00726232|564346437|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
156340807|NCT00726232|564346438|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
156340808|NCT00726232|564346439|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
156340809|NCT00726232|564346432|FG000|Expansion Phase|Per Investigator: lack of response|0|||
156340810|NCT00726232|564346433|FG001|Expansion Phase|Per Investigator: lack of response|0|||
156340811|NCT00726232|564346434|FG002|Expansion Phase|Per Investigator: lack of response|0|||
156340812|NCT00726232|564346435|FG003|Expansion Phase|Per Investigator: lack of response|0|||
156340813|NCT00726232|564346436|FG004|Expansion Phase|Per Investigator: lack of response|0|||
156340814|NCT00726232|564346437|FG005|Expansion Phase|Per Investigator: lack of response|0|||
156340815|NCT00726232|564346438|FG006|Expansion Phase|Per Investigator: lack of response|1|||
156340816|NCT00726232|564346439|FG007|Expansion Phase|Per Investigator: lack of response|7|||
156340817|NCT00726232|564346432|FG000|Expansion Phase|Unspecified reason|0|||
156340818|NCT00726232|564346433|FG001|Expansion Phase|Unspecified reason|0|||
156340819|NCT00726232|564346434|FG002|Expansion Phase|Unspecified reason|0|||
156340820|NCT00726232|564346435|FG003|Expansion Phase|Unspecified reason|0|||
156340821|NCT00726232|564346436|FG004|Expansion Phase|Unspecified reason|0|||
156340822|NCT00726232|564346437|FG005|Expansion Phase|Unspecified reason|0|||
156340823|NCT00726232|564346438|FG006|Expansion Phase|Unspecified reason|1|||
156340824|NCT00726232|564346439|FG007|Expansion Phase|Unspecified reason|0|||
156340825|NCT00709761|564346440|FG000|Overall Study|Withdrawal by Subject|8|||
156340826|NCT00709761|564346440|FG000|Overall Study|study closed/terminated|17|||
156340827|NCT00709761|564346440|FG000|Overall Study|Lost to Follow-up|2|||
156340828|NCT03478930|564346441|FG000|Overall Study|Adverse Event|0|||
156340829|NCT03478930|564346442|FG001|Overall Study|Adverse Event|1|||
156340830|NCT03478930|564346441|FG000|Overall Study|Lack of Efficacy|3|||
156340831|NCT03478930|564346442|FG001|Overall Study|Lack of Efficacy|3|||
156541503|NCT02953340|565075440|FG001|Overall Study|Investigator Decision|3|||
156841186|NCT04033068|566170083|FG001|Overall Study|Lost to Follow-up|1|||
156841187|NCT04033068|566170084|FG002|Overall Study|Lost to Follow-up|0|||
156841188|NCT04033068|566170085|FG003|Overall Study|Lost to Follow-up|0|||
156841189|NCT04033068|566170082|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
156841190|NCT04033068|566170083|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
156841191|NCT04033068|566170084|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
156841192|NCT04033068|566170085|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
156841193|NCT01717326|566170086|FG000|Overall Study|Death|0|||
156841194|NCT01717326|566170087|FG001|Overall Study|Death|0|||
156841195|NCT01717326|566170088|FG002|Overall Study|Death|0|||
156841196|NCT01717326|566170089|FG003|Overall Study|Death|0|||
156841197|NCT01717326|566170090|FG004|Overall Study|Death|0|||
156841198|NCT01717326|566170091|FG005|Overall Study|Death|0|||
156841199|NCT01717326|566170092|FG006|Overall Study|Death|0|||
156841200|NCT01717326|566170093|FG007|Overall Study|Death|0|||
156841201|NCT01717326|566170094|FG008|Overall Study|Death|0|||
156841202|NCT01717326|566170095|FG009|Overall Study|Death|0|||
156841203|NCT01717326|566170096|FG010|Overall Study|Death|1|||
156841204|NCT01717326|566170097|FG011|Overall Study|Death|0|||
156841205|NCT01717326|566170098|FG012|Overall Study|Death|0|||
156841206|NCT01717326|566170099|FG013|Overall Study|Death|0|||
156841207|NCT01717326|566170100|FG014|Overall Study|Death|0|||
156841208|NCT01717326|566170101|FG015|Overall Study|Death|0|||
156841209|NCT01717326|566170102|FG016|Overall Study|Death|0|||
156841210|NCT01717326|566170103|FG017|Overall Study|Death|0|||
156841211|NCT01717326|566170104|FG018|Overall Study|Death|0|||
156841212|NCT01717326|566170105|FG019|Overall Study|Death|0|||
156841213|NCT01717326|566170086|FG000|Overall Study|Lost to Follow-up|3|||
156841214|NCT01717326|566170087|FG001|Overall Study|Lost to Follow-up|0|||
156841215|NCT01717326|566170088|FG002|Overall Study|Lost to Follow-up|0|||
156841216|NCT01717326|566170089|FG003|Overall Study|Lost to Follow-up|2|||
156841217|NCT01717326|566170090|FG004|Overall Study|Lost to Follow-up|1|||
156841218|NCT01717326|566170091|FG005|Overall Study|Lost to Follow-up|0|||
156841219|NCT01717326|566170092|FG006|Overall Study|Lost to Follow-up|1|||
156841220|NCT01717326|566170093|FG007|Overall Study|Lost to Follow-up|0|||
156841221|NCT01717326|566170094|FG008|Overall Study|Lost to Follow-up|0|||
156841222|NCT01717326|566170095|FG009|Overall Study|Lost to Follow-up|0|||
156841223|NCT01717326|566170096|FG010|Overall Study|Lost to Follow-up|1|||
156841224|NCT01717326|566170097|FG011|Overall Study|Lost to Follow-up|0|||
156841225|NCT01717326|566170098|FG012|Overall Study|Lost to Follow-up|0|||
156841226|NCT01717326|566170099|FG013|Overall Study|Lost to Follow-up|0|||
156841227|NCT01717326|566170100|FG014|Overall Study|Lost to Follow-up|0|||
156841228|NCT01717326|566170101|FG015|Overall Study|Lost to Follow-up|2|||
156841229|NCT01717326|566170102|FG016|Overall Study|Lost to Follow-up|1|||
156841230|NCT01717326|566170103|FG017|Overall Study|Lost to Follow-up|0|||
156841231|NCT01717326|566170104|FG018|Overall Study|Lost to Follow-up|2|||
156841232|NCT01717326|566170105|FG019|Overall Study|Lost to Follow-up|3|||
156841233|NCT01717326|566170086|FG000|Overall Study|Physician Decision|0|||
156340832|NCT03478930|564346441|FG000|Overall Study|Withdrawal by Subject|6|||
156340833|NCT03478930|564346442|FG001|Overall Study|Withdrawal by Subject|5|||
156340834|NCT00553644|564346445|FG000|Overall Study|Adverse Event|17|||
156340835|NCT00553644|564346445|FG000|Overall Study|Withdrawal by Subject|4|||
156469912|NCT05580003|564814883|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156841234|NCT01717326|566170087|FG001|Overall Study|Physician Decision|0|||
156841235|NCT01717326|566170088|FG002|Overall Study|Physician Decision|0|||
156841236|NCT01717326|566170089|FG003|Overall Study|Physician Decision|0|||
156841237|NCT01717326|566170090|FG004|Overall Study|Physician Decision|0|||
156841238|NCT01717326|566170091|FG005|Overall Study|Physician Decision|0|||
156841239|NCT01717326|566170092|FG006|Overall Study|Physician Decision|0|||
156841240|NCT01717326|566170093|FG007|Overall Study|Physician Decision|0|||
156841241|NCT01717326|566170094|FG008|Overall Study|Physician Decision|0|||
156841242|NCT01717326|566170095|FG009|Overall Study|Physician Decision|1|||
156841243|NCT01717326|566170096|FG010|Overall Study|Physician Decision|0|||
156841244|NCT01717326|566170097|FG011|Overall Study|Physician Decision|0|||
156340836|NCT00553644|564346445|FG000|Overall Study|Physician Decision|1|||
156340837|NCT00553644|564346445|FG000|Overall Study|Alternative therapy|6|||
156340838|NCT00705484|564346446|FG000|Overall Study|Adverse Event|28|||
156340839|NCT00705484|564346447|FG001|Overall Study|Adverse Event|27|||
156340840|NCT00705484|564346446|FG000|Overall Study|Lost to Follow-up|169|||
156340841|NCT00705484|564346447|FG001|Overall Study|Lost to Follow-up|250|||
156340842|NCT00705484|564346446|FG000|Overall Study|Withdrawal by Subject|96|||
156340843|NCT00705484|564346447|FG001|Overall Study|Withdrawal by Subject|72|||
156340844|NCT00705484|564346446|FG000|Overall Study|Administrative|89|||
156340845|NCT00705484|564346447|FG001|Overall Study|Administrative|59|||
156340846|NCT02197247|564346448|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
156340847|NCT02197247|564346448|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
156340848|NCT02197247|564346448|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
156340849|NCT02197247|564346448|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
156340850|NCT02197247|564346448|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
156340851|NCT02197247|564346448|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
156340852|NCT02197247|564346448|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
156340853|NCT02197247|564346448|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
156340854|NCT02499783|564346451|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
156340855|NCT02499783|564346452|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
156340856|NCT02499783|564346453|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
156340857|NCT02499783|564346451|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
156340858|NCT02499783|564346452|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
156340859|NCT02499783|564346453|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
156340860|NCT02499783|564346451|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
156340861|NCT02499783|564346452|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
156340862|NCT02499783|564346453|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
156340863|NCT02499783|564346451|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
156340864|NCT02499783|564346452|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
156340865|NCT02499783|564346453|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
156340866|NCT02499783|564346451|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
156340867|NCT02499783|564346452|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
156340868|NCT02499783|564346453|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
156340869|NCT02499783|564346451|FG000|DB Period: Weeks 0-8|Other|1|||
156340870|NCT02499783|564346452|FG001|DB Period: Weeks 0-8|Other|1|||
156340871|NCT02499783|564346453|FG002|DB Period: Weeks 0-8|Other|0|||
156340872|NCT02499783|564346451|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
156340873|NCT02499783|564346452|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
156340874|NCT02499783|564346453|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
156340875|NCT02499783|564346451|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
156340876|NCT02499783|564346452|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
156340877|NCT02499783|564346453|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
156340878|NCT02499783|564346451|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
156340879|NCT02499783|564346452|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
156340880|NCT02499783|564346453|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
156340881|NCT02499783|564346451|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
156340882|NCT02499783|564346452|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
156340883|NCT02499783|564346453|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
156340884|NCT03066804|564346454|FG000|Overall Study|Physician Decision|0|||
156340885|NCT03066804|564346455|FG001|Overall Study|Physician Decision|4|||
156340886|NCT03066804|564346454|FG000|Overall Study|Death|23|||
156340887|NCT03066804|564346455|FG001|Overall Study|Death|17|||
156340888|NCT03066804|564346454|FG000|Overall Study|Withdrawal by Subject|19|||
156340889|NCT03066804|564346455|FG001|Overall Study|Withdrawal by Subject|25|||
156340890|NCT03066804|564346454|FG000|Overall Study|Lost to Follow-up|2|||
156340891|NCT03066804|564346455|FG001|Overall Study|Lost to Follow-up|0|||
156469913|NCT05580003|564814884|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469914|NCT05580003|564814885|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156340892|NCT03066804|564346454|FG000|Overall Study|Adverse Event|2|||
156340893|NCT03066804|564346455|FG001|Overall Study|Adverse Event|3|||
156340894|NCT03066804|564346454|FG000|Overall Study|Technical problems|5|||
156340895|NCT03066804|564346455|FG001|Overall Study|Technical problems|1|||
156340896|NCT03470441|564346460|FG000|Overall Study|Death|0|||
156469915|NCT05580003|564814886|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469916|NCT05580003|564814887|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
156340897|NCT03470441|564346461|FG001|Overall Study|Death|1|||
156340898|NCT03470441|564346462|FG002|Overall Study|Death|1|||
156340899|NCT03470441|564346463|FG003|Overall Study|Death|0|||
156340900|NCT03470441|564346460|FG000|Overall Study|Adverse Event|0|||
156340901|NCT03470441|564346461|FG001|Overall Study|Adverse Event|0|||
156340902|NCT03470441|564346462|FG002|Overall Study|Adverse Event|0|||
156340903|NCT03470441|564346463|FG003|Overall Study|Adverse Event|1|||
156340904|NCT03470441|564346460|FG000|Overall Study|Withdrawal by Subject|1|||
156469917|NCT05580003|564814888|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156340905|NCT03470441|564346461|FG001|Overall Study|Withdrawal by Subject|4|||
156340906|NCT03470441|564346462|FG002|Overall Study|Withdrawal by Subject|1|||
156340907|NCT03470441|564346463|FG003|Overall Study|Withdrawal by Subject|3|||
156340908|NCT00329238|564346464|FG000|Overall Study|Adverse Event|147|||
156340909|NCT00329238|564346465|FG001|Overall Study|Adverse Event|129|||
156340910|NCT00329238|564346464|FG000|Overall Study|Protocol Violation|23|||
156340911|NCT00329238|564346465|FG001|Overall Study|Protocol Violation|34|||
156340912|NCT00329238|564346464|FG000|Overall Study|Lost to Follow-up|2|||
156340913|NCT00329238|564346465|FG001|Overall Study|Lost to Follow-up|6|||
156340914|NCT00329238|564346464|FG000|Overall Study|Withdrawal by Subject|64|||
156340915|NCT00329238|564346465|FG001|Overall Study|Withdrawal by Subject|58|||
156340916|NCT00329238|564346464|FG000|Overall Study|Other reason (not specified)|40|||
156340917|NCT00329238|564346465|FG001|Overall Study|Other reason (not specified)|54|||
156340918|NCT01203098|564346473|FG000|Overall Study|Adverse Event|3|||
156340919|NCT01203098|564346474|FG001|Overall Study|Adverse Event|1|||
156340920|NCT01203098|564346475|FG002|Overall Study|Adverse Event|7|||
156340921|NCT01203098|564346473|FG000|Overall Study|Lost to Follow-up|0|||
156340922|NCT01203098|564346474|FG001|Overall Study|Lost to Follow-up|0|||
156340923|NCT01203098|564346475|FG002|Overall Study|Lost to Follow-up|1|||
156340924|NCT01203098|564346473|FG000|Overall Study|Physician Decision|2|||
156340925|NCT01203098|564346474|FG001|Overall Study|Physician Decision|2|||
156340926|NCT01203098|564346475|FG002|Overall Study|Physician Decision|0|||
156340927|NCT01203098|564346473|FG000|Overall Study|Withdrawal by Subject|1|||
156340928|NCT01203098|564346474|FG001|Overall Study|Withdrawal by Subject|1|||
156340929|NCT01203098|564346475|FG002|Overall Study|Withdrawal by Subject|3|||
156340930|NCT03851705|564346483|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
156340931|NCT03851705|564346484|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156340932|NCT03851705|564346485|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156340933|NCT03851705|564346486|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156340934|NCT03851705|564346483|FG000|Part 1: Double-Blind Period|Other reason|1|||
156340935|NCT03851705|564346484|FG001|Part 1: Double-Blind Period|Other reason|0|||
156340936|NCT03851705|564346485|FG002|Part 1: Double-Blind Period|Other reason|0|||
156340937|NCT03851705|564346486|FG003|Part 1: Double-Blind Period|Other reason|0|||
156340938|NCT03851705|564346483|FG000|Part 2: Open-Label Period|Other reason|0|||
156340939|NCT03851705|564346484|FG001|Part 2: Open-Label Period|Other reason|0|||
156340940|NCT03851705|564346485|FG002|Part 2: Open-Label Period|Other reason|0|||
156340941|NCT03851705|564346486|FG003|Part 2: Open-Label Period|Other reason|1|||
156340942|NCT03851705|564346483|FG000|Part 2: Open-Label Period|Death|0|||
156340943|NCT03851705|564346484|FG001|Part 2: Open-Label Period|Death|0|||
156340944|NCT03851705|564346485|FG002|Part 2: Open-Label Period|Death|3|||
156340945|NCT03851705|564346486|FG003|Part 2: Open-Label Period|Death|0|||
156340946|NCT03851705|564346483|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
156340947|NCT03851705|564346484|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
156340948|NCT03851705|564346485|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
156340949|NCT03851705|564346486|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
156340950|NCT00621582|564346487|FG000|Overall Study|Adverse Event|7|||
156340951|NCT00621582|564346487|FG000|Overall Study|Protocol Violation|57|||
156340952|NCT00621582|564346487|FG000|Overall Study|Lost to Follow-up|24|||
156340953|NCT00621582|564346487|FG000|Overall Study|issues not identified by investigators|18|||
156340954|NCT03617185|564346488|FG000|Baseline|Lost to Follow-up|0|||
156340955|NCT03617185|564346489|FG001|Baseline|Lost to Follow-up|2|||
156340956|NCT03617185|564346490|FG002|Baseline|Lost to Follow-up|1|||
156340957|NCT03617185|564346491|FG003|Baseline|Lost to Follow-up|1|||
156340958|NCT03617185|564346488|FG000|Baseline|Withdrawal by Subject|0|||
156340959|NCT03617185|564346489|FG001|Baseline|Withdrawal by Subject|1|||
156340960|NCT03617185|564346490|FG002|Baseline|Withdrawal by Subject|0|||
156340961|NCT03617185|564346491|FG003|Baseline|Withdrawal by Subject|1|||
156340962|NCT03617185|564346488|FG000|Baseline|Driving Distance/Travel|0|||
156340963|NCT03617185|564346489|FG001|Baseline|Driving Distance/Travel|0|||
156340964|NCT03617185|564346490|FG002|Baseline|Driving Distance/Travel|2|||
156340965|NCT03617185|564346491|FG003|Baseline|Driving Distance/Travel|0|||
156340966|NCT03617185|564346488|FG000|Baseline|Family Obligations|0|||
156340967|NCT03617185|564346489|FG001|Baseline|Family Obligations|0|||
156340968|NCT03617185|564346490|FG002|Baseline|Family Obligations|0|||
156340969|NCT03617185|564346491|FG003|Baseline|Family Obligations|1|||
156340970|NCT03617185|564346488|FG000|3 Months|Lost to Follow-up|4|||
156340971|NCT03617185|564346489|FG001|3 Months|Lost to Follow-up|1|||
156340972|NCT03617185|564346490|FG002|3 Months|Lost to Follow-up|0|||
156340973|NCT03617185|564346491|FG003|3 Months|Lost to Follow-up|2|||
156340974|NCT03617185|564346488|FG000|3 Months|Withdrawal by Subject|1|||
156340975|NCT03617185|564346489|FG001|3 Months|Withdrawal by Subject|3|||
156340976|NCT03617185|564346490|FG002|3 Months|Withdrawal by Subject|0|||
156340977|NCT03617185|564346491|FG003|3 Months|Withdrawal by Subject|0|||
156340978|NCT03617185|564346488|FG000|3 Months|Driving Distance/Travel|1|||
156340979|NCT03617185|564346489|FG001|3 Months|Driving Distance/Travel|0|||
156340980|NCT03617185|564346490|FG002|3 Months|Driving Distance/Travel|0|||
156841245|NCT01717326|566170098|FG012|Overall Study|Physician Decision|0|||
156841246|NCT01717326|566170099|FG013|Overall Study|Physician Decision|0|||
156841247|NCT01717326|566170100|FG014|Overall Study|Physician Decision|0|||
156841248|NCT01717326|566170101|FG015|Overall Study|Physician Decision|0|||
156841249|NCT01717326|566170102|FG016|Overall Study|Physician Decision|0|||
156841250|NCT01717326|566170103|FG017|Overall Study|Physician Decision|0|||
156841251|NCT01717326|566170104|FG018|Overall Study|Physician Decision|0|||
156841252|NCT01717326|566170105|FG019|Overall Study|Physician Decision|0|||
156841253|NCT01717326|566170086|FG000|Overall Study|Protocol Violation|0|||
156841254|NCT01717326|566170087|FG001|Overall Study|Protocol Violation|0|||
156841255|NCT01717326|566170088|FG002|Overall Study|Protocol Violation|0|||
156841256|NCT01717326|566170089|FG003|Overall Study|Protocol Violation|0|||
156841257|NCT01717326|566170090|FG004|Overall Study|Protocol Violation|1|||
156841258|NCT01717326|566170091|FG005|Overall Study|Protocol Violation|0|||
156841259|NCT01717326|566170092|FG006|Overall Study|Protocol Violation|0|||
156841260|NCT01717326|566170093|FG007|Overall Study|Protocol Violation|0|||
156841261|NCT01717326|566170094|FG008|Overall Study|Protocol Violation|0|||
156841262|NCT01717326|566170095|FG009|Overall Study|Protocol Violation|0|||
156841263|NCT01717326|566170096|FG010|Overall Study|Protocol Violation|0|||
156841264|NCT01717326|566170097|FG011|Overall Study|Protocol Violation|0|||
156841265|NCT01717326|566170098|FG012|Overall Study|Protocol Violation|0|||
156841266|NCT01717326|566170099|FG013|Overall Study|Protocol Violation|0|||
156340981|NCT03617185|564346491|FG003|3 Months|Driving Distance/Travel|0|||
156541504|NCT02953340|565075439|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
156541505|NCT02953340|565075440|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
156841267|NCT01717326|566170100|FG014|Overall Study|Protocol Violation|0|||
156841268|NCT01717326|566170101|FG015|Overall Study|Protocol Violation|0|||
156841269|NCT01717326|566170102|FG016|Overall Study|Protocol Violation|0|||
156841270|NCT01717326|566170103|FG017|Overall Study|Protocol Violation|0|||
156841271|NCT01717326|566170104|FG018|Overall Study|Protocol Violation|0|||
156841272|NCT01717326|566170105|FG019|Overall Study|Protocol Violation|0|||
156841273|NCT01717326|566170086|FG000|Overall Study|Withdrawal by Subject|0|||
156841274|NCT01717326|566170087|FG001|Overall Study|Withdrawal by Subject|1|||
156841275|NCT01717326|566170088|FG002|Overall Study|Withdrawal by Subject|0|||
156841276|NCT01717326|566170089|FG003|Overall Study|Withdrawal by Subject|0|||
156841277|NCT01717326|566170090|FG004|Overall Study|Withdrawal by Subject|0|||
156841278|NCT01717326|566170091|FG005|Overall Study|Withdrawal by Subject|0|||
156841279|NCT01717326|566170092|FG006|Overall Study|Withdrawal by Subject|0|||
156841280|NCT01717326|566170093|FG007|Overall Study|Withdrawal by Subject|0|||
156841281|NCT01717326|566170094|FG008|Overall Study|Withdrawal by Subject|0|||
156841282|NCT01717326|566170095|FG009|Overall Study|Withdrawal by Subject|1|||
156841283|NCT01717326|566170096|FG010|Overall Study|Withdrawal by Subject|0|||
156841284|NCT01717326|566170097|FG011|Overall Study|Withdrawal by Subject|0|||
156841285|NCT01717326|566170098|FG012|Overall Study|Withdrawal by Subject|1|||
156841286|NCT01717326|566170099|FG013|Overall Study|Withdrawal by Subject|0|||
156841287|NCT01717326|566170100|FG014|Overall Study|Withdrawal by Subject|0|||
156841288|NCT01717326|566170101|FG015|Overall Study|Withdrawal by Subject|1|||
156841289|NCT01717326|566170102|FG016|Overall Study|Withdrawal by Subject|0|||
156841290|NCT01717326|566170103|FG017|Overall Study|Withdrawal by Subject|0|||
156841291|NCT01717326|566170104|FG018|Overall Study|Withdrawal by Subject|2|||
156841292|NCT01717326|566170105|FG019|Overall Study|Withdrawal by Subject|3|||
156841293|NCT00428844|566170110|FG000|Completed Study Drug Treatment|Adverse Event|2|||
156841294|NCT00428844|566170111|FG001|Completed Study Drug Treatment|Adverse Event|4|||
156841295|NCT00428844|566170112|FG002|Completed Study Drug Treatment|Adverse Event|4|||
156841296|NCT00428844|566170110|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
156841297|NCT00428844|566170111|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
156841298|NCT00428844|566170112|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
156841299|NCT00428844|566170110|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
156841300|NCT00428844|566170111|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
156841301|NCT00428844|566170112|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
156841302|NCT00428844|566170110|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
156841303|NCT00428844|566170111|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
156841304|NCT00428844|566170112|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
156841305|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
156841306|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
156841307|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
156841308|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
156841309|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
156841310|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
156841311|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
156841312|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
156841313|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
156841314|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
156841315|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
156841316|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
156841317|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
156841318|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
156841319|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
156841320|NCT02292706|566170115|FG000|Overall Study|Lost to Follow-up|20|||
156841321|NCT02292706|566170116|FG001|Overall Study|Lost to Follow-up|44|||
156841322|NCT02292706|566170117|FG002|Overall Study|Lost to Follow-up|24|||
156841323|NCT02292706|566170118|FG003|Overall Study|Lost to Follow-up|61|||
156841324|NCT02292706|566170119|FG004|Overall Study|Lost to Follow-up|21|||
156841325|NCT02292706|566170120|FG005|Overall Study|Lost to Follow-up|52|||
156841326|NCT02292706|566170121|FG006|Overall Study|Lost to Follow-up|25|||
156841327|NCT02292706|566170122|FG007|Overall Study|Lost to Follow-up|0|||
156841328|NCT02292706|566170115|FG000|Overall Study|Withdrew consent|15|||
156841329|NCT02292706|566170116|FG001|Overall Study|Withdrew consent|56|||
156841330|NCT02292706|566170117|FG002|Overall Study|Withdrew consent|43|||
156841331|NCT02292706|566170118|FG003|Overall Study|Withdrew consent|36|||
156841332|NCT02292706|566170119|FG004|Overall Study|Withdrew consent|13|||
156841333|NCT02292706|566170120|FG005|Overall Study|Withdrew consent|51|||
156841334|NCT02292706|566170121|FG006|Overall Study|Withdrew consent|20|||
156841335|NCT02292706|566170122|FG007|Overall Study|Withdrew consent|0|||
156841336|NCT02292706|566170115|FG000|Overall Study|Death|3|||
156841337|NCT02292706|566170116|FG001|Overall Study|Death|11|||
156841338|NCT02292706|566170117|FG002|Overall Study|Death|16|||
156841339|NCT02292706|566170118|FG003|Overall Study|Death|22|||
156841340|NCT02292706|566170119|FG004|Overall Study|Death|8|||
156841341|NCT02292706|566170120|FG005|Overall Study|Death|17|||
156841342|NCT02292706|566170121|FG006|Overall Study|Death|3|||
156841343|NCT02292706|566170122|FG007|Overall Study|Death|0|||
156841344|NCT02292706|566170115|FG000|Overall Study|Study terminated by sponsor|0|||
156841345|NCT02292706|566170116|FG001|Overall Study|Study terminated by sponsor|9|||
156841346|NCT02292706|566170117|FG002|Overall Study|Study terminated by sponsor|4|||
156841347|NCT02292706|566170118|FG003|Overall Study|Study terminated by sponsor|21|||
156841348|NCT02292706|566170119|FG004|Overall Study|Study terminated by sponsor|11|||
156841349|NCT02292706|566170120|FG005|Overall Study|Study terminated by sponsor|13|||
156841350|NCT02292706|566170121|FG006|Overall Study|Study terminated by sponsor|3|||
156841351|NCT02292706|566170122|FG007|Overall Study|Study terminated by sponsor|0|||
156841352|NCT02292706|566170115|FG000|Overall Study|Investigator's discretion|4|||
156841353|NCT02292706|566170116|FG001|Overall Study|Investigator's discretion|9|||
156841354|NCT02292706|566170117|FG002|Overall Study|Investigator's discretion|7|||
156841355|NCT02292706|566170118|FG003|Overall Study|Investigator's discretion|11|||
156841356|NCT02292706|566170119|FG004|Overall Study|Investigator's discretion|4|||
156469918|NCT05580003|564814889|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469919|NCT05580003|564814890|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156841357|NCT02292706|566170120|FG005|Overall Study|Investigator's discretion|10|||
156841358|NCT02292706|566170121|FG006|Overall Study|Investigator's discretion|1|||
156841359|NCT02292706|566170122|FG007|Overall Study|Investigator's discretion|0|||
156841360|NCT02292706|566170115|FG000|Overall Study|Liver transplant|1|||
156841361|NCT02292706|566170116|FG001|Overall Study|Liver transplant|1|||
156841362|NCT02292706|566170117|FG002|Overall Study|Liver transplant|11|||
156841363|NCT02292706|566170118|FG003|Overall Study|Liver transplant|16|||
156841364|NCT02292706|566170119|FG004|Overall Study|Liver transplant|5|||
156841365|NCT02292706|566170120|FG005|Overall Study|Liver transplant|6|||
156841366|NCT02292706|566170121|FG006|Overall Study|Liver transplant|5|||
156841367|NCT02292706|566170122|FG007|Overall Study|Liver transplant|0|||
156841368|NCT02292706|566170115|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
156841369|NCT02292706|566170116|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
156841370|NCT02292706|566170117|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
156841371|NCT02292706|566170118|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
156841372|NCT02292706|566170119|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
156841373|NCT02292706|566170120|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
156841374|NCT02292706|566170121|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
156841375|NCT02292706|566170122|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
156841376|NCT02292706|566170115|FG000|Overall Study|Subject terminated by sponsor|1|||
156841377|NCT02292706|566170116|FG001|Overall Study|Subject terminated by sponsor|0|||
156841378|NCT02292706|566170117|FG002|Overall Study|Subject terminated by sponsor|0|||
156841379|NCT02292706|566170118|FG003|Overall Study|Subject terminated by sponsor|2|||
156841380|NCT02292706|566170119|FG004|Overall Study|Subject terminated by sponsor|1|||
156841381|NCT02292706|566170120|FG005|Overall Study|Subject terminated by sponsor|0|||
156841382|NCT02292706|566170121|FG006|Overall Study|Subject terminated by sponsor|0|||
156841383|NCT02292706|566170122|FG007|Overall Study|Subject terminated by sponsor|0|||
156841384|NCT02292706|566170115|FG000|Overall Study|Missing|0|||
156841385|NCT02292706|566170116|FG001|Overall Study|Missing|0|||
156841386|NCT02292706|566170117|FG002|Overall Study|Missing|1|||
156841387|NCT02292706|566170118|FG003|Overall Study|Missing|1|||
156841388|NCT02292706|566170119|FG004|Overall Study|Missing|0|||
156841389|NCT02292706|566170120|FG005|Overall Study|Missing|1|||
156841390|NCT02292706|566170121|FG006|Overall Study|Missing|0|||
156841391|NCT02292706|566170122|FG007|Overall Study|Missing|0|||
156841392|NCT02292706|566170115|FG000|Overall Study|Virologic relapse or reinfection|1|||
156841393|NCT02292706|566170116|FG001|Overall Study|Virologic relapse or reinfection|0|||
156469920|NCT05580003|564814891|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469921|NCT05580003|564814892|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469922|NCT05580003|564814893|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156469923|NCT05580003|564814894|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156841394|NCT02292706|566170117|FG002|Overall Study|Virologic relapse or reinfection|0|||
156841395|NCT02292706|566170118|FG003|Overall Study|Virologic relapse or reinfection|1|||
156841396|NCT02292706|566170119|FG004|Overall Study|Virologic relapse or reinfection|0|||
156841397|NCT02292706|566170120|FG005|Overall Study|Virologic relapse or reinfection|1|||
156841398|NCT02292706|566170121|FG006|Overall Study|Virologic relapse or reinfection|0|||
156841399|NCT02292706|566170122|FG007|Overall Study|Virologic relapse or reinfection|0|||
156841400|NCT01990612|566170125|FG000|Overall Study|Lost to Follow-up|2|||
156841401|NCT01990612|566170126|FG001|Overall Study|Lost to Follow-up|1|||
156841402|NCT01990612|566170125|FG000|Overall Study|Withdrawal by Subject|5|||
156841403|NCT01990612|566170126|FG001|Overall Study|Withdrawal by Subject|2|||
156841404|NCT02188849|566170128|FG000|Overall Study|Lost to Follow-up|3|||
156841405|NCT02188849|566170129|FG001|Overall Study|Lost to Follow-up|8|||
156841406|NCT03208088|566170131|FG000|Period 2|Withdrawal by Subject|0|||
156841407|NCT03208088|566170132|FG001|Period 2|Withdrawal by Subject|0|||
156841408|NCT03208088|566170133|FG002|Period 2|Withdrawal by Subject|0|||
156841409|NCT03208088|566170134|FG003|Period 2|Withdrawal by Subject|0|||
156841410|NCT03208088|566170135|FG004|Period 2|Withdrawal by Subject|0|||
156841411|NCT03208088|566170136|FG005|Period 2|Withdrawal by Subject|0|||
156841412|NCT03208088|566170137|FG006|Period 2|Withdrawal by Subject|0|||
156841413|NCT03208088|566170138|FG007|Period 2|Withdrawal by Subject|0|||
156841414|NCT03208088|566170139|FG008|Period 2|Withdrawal by Subject|1|||
156841415|NCT03208088|566170140|FG009|Period 2|Withdrawal by Subject|0|||
156841416|NCT03208088|566170131|FG000|Period 3|Unsatisfactory Test Article|0|||
156841417|NCT03208088|566170132|FG001|Period 3|Unsatisfactory Test Article|0|||
156841418|NCT03208088|566170133|FG002|Period 3|Unsatisfactory Test Article|0|||
156841419|NCT03208088|566170134|FG003|Period 3|Unsatisfactory Test Article|1|||
156469924|NCT05580003|564814895|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
156841420|NCT03208088|566170135|FG004|Period 3|Unsatisfactory Test Article|0|||
156841421|NCT03208088|566170136|FG005|Period 3|Unsatisfactory Test Article|0|||
156841422|NCT03208088|566170137|FG006|Period 3|Unsatisfactory Test Article|0|||
156841423|NCT03208088|566170138|FG007|Period 3|Unsatisfactory Test Article|0|||
156841424|NCT03208088|566170139|FG008|Period 3|Unsatisfactory Test Article|0|||
156841425|NCT03208088|566170140|FG009|Period 3|Unsatisfactory Test Article|0|||
156841426|NCT03208088|566170131|FG000|Period 4|Unsatisfactory Test Article|0|||
156841427|NCT03208088|566170132|FG001|Period 4|Unsatisfactory Test Article|0|||
156841428|NCT03208088|566170133|FG002|Period 4|Unsatisfactory Test Article|0|||
156841429|NCT03208088|566170134|FG003|Period 4|Unsatisfactory Test Article|1|||
156841430|NCT03208088|566170135|FG004|Period 4|Unsatisfactory Test Article|0|||
156841431|NCT03208088|566170136|FG005|Period 4|Unsatisfactory Test Article|0|||
156841432|NCT03208088|566170137|FG006|Period 4|Unsatisfactory Test Article|0|||
156841433|NCT03208088|566170138|FG007|Period 4|Unsatisfactory Test Article|0|||
156841434|NCT03208088|566170139|FG008|Period 4|Unsatisfactory Test Article|0|||
156841435|NCT03208088|566170140|FG009|Period 4|Unsatisfactory Test Article|0|||
156841436|NCT00812565|566170143|FG000|Overall Study|Did Not Receive Study Medication|1|||
156841437|NCT00812565|566170144|FG001|Overall Study|Did Not Receive Study Medication|1|||
156841438|NCT00812565|566170145|FG002|Overall Study|Did Not Receive Study Medication|0|||
156841439|NCT00812565|566170146|FG003|Overall Study|Did Not Receive Study Medication|0|||
156841440|NCT00812565|566170147|FG004|Overall Study|Did Not Receive Study Medication|0|||
156841441|NCT00812565|566170148|FG005|Overall Study|Did Not Receive Study Medication|0|||
156841442|NCT00812565|566170149|FG006|Overall Study|Did Not Receive Study Medication|0|||
156841443|NCT00812565|566170150|FG007|Overall Study|Did Not Receive Study Medication|0|||
156841444|NCT00812565|566170143|FG000|Overall Study|Adverse Event|0|||
156841445|NCT00812565|566170144|FG001|Overall Study|Adverse Event|0|||
156841446|NCT00812565|566170145|FG002|Overall Study|Adverse Event|0|||
156841447|NCT00812565|566170146|FG003|Overall Study|Adverse Event|2|||
156841448|NCT00812565|566170147|FG004|Overall Study|Adverse Event|0|||
156841449|NCT00812565|566170148|FG005|Overall Study|Adverse Event|0|||
156841450|NCT00812565|566170149|FG006|Overall Study|Adverse Event|0|||
156841451|NCT00812565|566170150|FG007|Overall Study|Adverse Event|1|||
156841452|NCT00812565|566170143|FG000|Overall Study|Did Not Come to Study Visit|1|||
156841453|NCT00812565|566170144|FG001|Overall Study|Did Not Come to Study Visit|0|||
156841454|NCT00812565|566170145|FG002|Overall Study|Did Not Come to Study Visit|0|||
156841455|NCT00812565|566170146|FG003|Overall Study|Did Not Come to Study Visit|0|||
156841456|NCT00812565|566170147|FG004|Overall Study|Did Not Come to Study Visit|0|||
156340982|NCT03617185|564346488|FG000|3 Months|Family Obligations|0|||
156340983|NCT03617185|564346489|FG001|3 Months|Family Obligations|0|||
156340984|NCT03617185|564346490|FG002|3 Months|Family Obligations|0|||
156340985|NCT03617185|564346491|FG003|3 Months|Family Obligations|1|||
156340986|NCT03617185|564346488|FG000|12 Months|Lost to Follow-up|3|||
156340987|NCT03617185|564346489|FG001|12 Months|Lost to Follow-up|1|||
156340988|NCT03617185|564346490|FG002|12 Months|Lost to Follow-up|3|||
156340989|NCT03617185|564346491|FG003|12 Months|Lost to Follow-up|0|||
156340990|NCT03617185|564346488|FG000|12 Months|Withdrawal by Subject|0|||
156340991|NCT03617185|564346489|FG001|12 Months|Withdrawal by Subject|0|||
156340992|NCT03617185|564346490|FG002|12 Months|Withdrawal by Subject|0|||
156340993|NCT03617185|564346491|FG003|12 Months|Withdrawal by Subject|1|||
156841457|NCT00812565|566170148|FG005|Overall Study|Did Not Come to Study Visit|0|||
156841458|NCT00812565|566170149|FG006|Overall Study|Did Not Come to Study Visit|0|||
156841459|NCT00812565|566170150|FG007|Overall Study|Did Not Come to Study Visit|0|||
156841460|NCT00812565|566170143|FG000|Overall Study|Withdrawal of Consent|1|||
156841461|NCT00812565|566170144|FG001|Overall Study|Withdrawal of Consent|0|||
156340994|NCT03617185|564346488|FG000|12 Months|Driving Distance/Travel|0|||
156340995|NCT03617185|564346489|FG001|12 Months|Driving Distance/Travel|0|||
156340996|NCT03617185|564346490|FG002|12 Months|Driving Distance/Travel|1|||
156340997|NCT03617185|564346491|FG003|12 Months|Driving Distance/Travel|0|||
156340998|NCT01387932|564346493|FG000|Randomized and Treated|Physician Decision|3|||
156340999|NCT01387932|564346494|FG001|Randomized and Treated|Physician Decision|2|||
156341000|NCT01387932|564346493|FG000|Randomized and Treated|Withdrawal by Subject|4|||
156341001|NCT01387932|564346494|FG001|Randomized and Treated|Withdrawal by Subject|2|||
156341002|NCT01387932|564346493|FG000|Survival Follow-up|Liver Transplant|24|||
156341003|NCT01387932|564346494|FG001|Survival Follow-up|Liver Transplant|28|||
156341004|NCT01387932|564346493|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
156341005|NCT01387932|564346494|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
156341006|NCT01387932|564346493|FG000|Survival Follow-up|Withdrawal by Subject|2|||
156341007|NCT01387932|564346494|FG001|Survival Follow-up|Withdrawal by Subject|4|||
156469925|NCT05580003|564814868|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469926|NCT05580003|564814869|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156841462|NCT00812565|566170145|FG002|Overall Study|Withdrawal of Consent|0|||
156841463|NCT00812565|566170146|FG003|Overall Study|Withdrawal of Consent|0|||
156841464|NCT00812565|566170147|FG004|Overall Study|Withdrawal of Consent|1|||
156841465|NCT00812565|566170148|FG005|Overall Study|Withdrawal of Consent|0|||
156841466|NCT00812565|566170149|FG006|Overall Study|Withdrawal of Consent|0|||
156841467|NCT00812565|566170150|FG007|Overall Study|Withdrawal of Consent|0|||
156841468|NCT00812565|566170143|FG000|Overall Study|Reason Not Specified|0|||
156841469|NCT00812565|566170144|FG001|Overall Study|Reason Not Specified|0|||
156841470|NCT00812565|566170145|FG002|Overall Study|Reason Not Specified|0|||
156841471|NCT00812565|566170146|FG003|Overall Study|Reason Not Specified|0|||
156841472|NCT00812565|566170147|FG004|Overall Study|Reason Not Specified|0|||
156841473|NCT00812565|566170148|FG005|Overall Study|Reason Not Specified|1|||
156841474|NCT00812565|566170149|FG006|Overall Study|Reason Not Specified|0|||
156841475|NCT00812565|566170150|FG007|Overall Study|Reason Not Specified|0|||
156841476|NCT00422383|566170153|FG000|Overall Study|Adverse Event|5|||
156841477|NCT00422383|566170154|FG001|Overall Study|Adverse Event|3|||
156841478|NCT00422383|566170155|FG002|Overall Study|Adverse Event|1|||
156841479|NCT00422383|566170156|FG003|Overall Study|Adverse Event|1|||
156841480|NCT00422383|566170157|FG004|Overall Study|Adverse Event|0|||
156841481|NCT00422383|566170153|FG000|Overall Study|Lack of Efficacy|4|||
156841482|NCT00422383|566170154|FG001|Overall Study|Lack of Efficacy|4|||
156841483|NCT00422383|566170155|FG002|Overall Study|Lack of Efficacy|2|||
156841484|NCT00422383|566170156|FG003|Overall Study|Lack of Efficacy|1|||
156841485|NCT00422383|566170157|FG004|Overall Study|Lack of Efficacy|1|||
156841486|NCT00422383|566170153|FG000|Overall Study|Lost to Follow-up|0|||
156841487|NCT00422383|566170154|FG001|Overall Study|Lost to Follow-up|1|||
156841488|NCT00422383|566170155|FG002|Overall Study|Lost to Follow-up|0|||
156841489|NCT00422383|566170156|FG003|Overall Study|Lost to Follow-up|0|||
156841490|NCT00422383|566170157|FG004|Overall Study|Lost to Follow-up|1|||
156841491|NCT00422383|566170153|FG000|Overall Study|Protocol Violation|1|||
156841492|NCT00422383|566170154|FG001|Overall Study|Protocol Violation|1|||
156841493|NCT00422383|566170155|FG002|Overall Study|Protocol Violation|1|||
156841494|NCT00422383|566170156|FG003|Overall Study|Protocol Violation|0|||
156841495|NCT00422383|566170157|FG004|Overall Study|Protocol Violation|0|||
156841496|NCT00422383|566170153|FG000|Overall Study|Withdrawal by Subject|5|||
156841497|NCT00422383|566170154|FG001|Overall Study|Withdrawal by Subject|5|||
156841498|NCT00422383|566170155|FG002|Overall Study|Withdrawal by Subject|0|||
156841499|NCT00422383|566170156|FG003|Overall Study|Withdrawal by Subject|0|||
156841500|NCT00422383|566170157|FG004|Overall Study|Withdrawal by Subject|1|||
156841501|NCT00566254|566170158|FG000|Overall Study|Adverse Event|3|||
156841502|NCT00566254|566170159|FG001|Overall Study|Adverse Event|1|||
156841503|NCT00566254|566170158|FG000|Overall Study|Protocol Violation|1|||
156841504|NCT00566254|566170159|FG001|Overall Study|Protocol Violation|3|||
156841505|NCT00566254|566170158|FG000|Overall Study|Withdrawal by Subject|1|||
156841506|NCT00566254|566170159|FG001|Overall Study|Withdrawal by Subject|2|||
156341008|NCT01387932|564346493|FG000|Survival Follow-up|Lost to Follow-up|6|||
156469927|NCT05580003|564814870|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469928|NCT05580003|564814871|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469929|NCT05580003|564814872|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156841507|NCT00566254|566170158|FG000|Overall Study|Lack of Efficacy|5|||
156841508|NCT00566254|566170159|FG001|Overall Study|Lack of Efficacy|6|||
156469930|NCT05580003|564814873|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469931|NCT05580003|564814874|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156841509|NCT00566254|566170158|FG000|Overall Study|Other|0|||
156341009|NCT01387932|564346494|FG001|Survival Follow-up|Lost to Follow-up|5|||
156841510|NCT00566254|566170159|FG001|Overall Study|Other|2|||
156841511|NCT01793883|566170160|FG000|Overall Study|Withdrawal by Subject|3|||
156841512|NCT01793883|566170161|FG001|Overall Study|Withdrawal by Subject|7|||
156841513|NCT01793883|566170162|FG002|Overall Study|Withdrawal by Subject|3|||
156841514|NCT01793883|566170160|FG000|Overall Study|Subject noncompliance|0|||
156841515|NCT01793883|566170161|FG001|Overall Study|Subject noncompliance|1|||
156341010|NCT01964430|564346495|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
156541506|NCT02953340|565075439|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
156841516|NCT01793883|566170162|FG002|Overall Study|Subject noncompliance|1|||
156841517|NCT01793883|566170160|FG000|Overall Study|Lost to Follow-up|5|||
156841518|NCT01793883|566170161|FG001|Overall Study|Lost to Follow-up|1|||
156841519|NCT01793883|566170162|FG002|Overall Study|Lost to Follow-up|3|||
156841520|NCT01793883|566170160|FG000|Overall Study|Randomized in error|1|||
156841521|NCT01793883|566170161|FG001|Overall Study|Randomized in error|0|||
156841522|NCT01793883|566170162|FG002|Overall Study|Randomized in error|0|||
156841523|NCT01793883|566170160|FG000|Overall Study|Unable to complete spriometry|1|||
156841524|NCT01793883|566170161|FG001|Overall Study|Unable to complete spriometry|0|||
156841525|NCT01793883|566170162|FG002|Overall Study|Unable to complete spriometry|0|||
156841526|NCT01793883|566170160|FG000|Overall Study|Unable to complete measurements|1|||
156841527|NCT01793883|566170161|FG001|Overall Study|Unable to complete measurements|0|||
156841528|NCT01793883|566170162|FG002|Overall Study|Unable to complete measurements|0|||
156841529|NCT01793883|566170160|FG000|Overall Study|Met exclusion criteria|1|||
156841530|NCT01793883|566170161|FG001|Overall Study|Met exclusion criteria|0|||
156841531|NCT01793883|566170162|FG002|Overall Study|Met exclusion criteria|0|||
156841532|NCT01793883|566170160|FG000|Overall Study|Dosing error|0|||
156841533|NCT01793883|566170161|FG001|Overall Study|Dosing error|1|||
156841534|NCT01793883|566170162|FG002|Overall Study|Dosing error|0|||
156841535|NCT01793883|566170160|FG000|Overall Study|Respiratory distress during spirometry|0|||
156841536|NCT01793883|566170161|FG001|Overall Study|Respiratory distress during spirometry|0|||
156841537|NCT01793883|566170162|FG002|Overall Study|Respiratory distress during spirometry|1|||
156841538|NCT00891228|566172265|FG000|Overall Study|Adverse Event|0|||
156841539|NCT00891228|566172266|FG001|Overall Study|Adverse Event|2|||
156841540|NCT00891228|566172267|FG002|Overall Study|Adverse Event|3|||
156841541|NCT00891228|566172265|FG000|Overall Study|Withdrawal by Subject|2|||
156841542|NCT00891228|566172266|FG001|Overall Study|Withdrawal by Subject|4|||
156841543|NCT00891228|566172267|FG002|Overall Study|Withdrawal by Subject|5|||
156841544|NCT00891228|566172265|FG000|Overall Study|Protocol Violation|3|||
156841545|NCT00891228|566172266|FG001|Overall Study|Protocol Violation|1|||
156841546|NCT00891228|566172267|FG002|Overall Study|Protocol Violation|2|||
156841547|NCT00891228|566172265|FG000|Overall Study|Physician Decision|2|||
156841548|NCT00891228|566172266|FG001|Overall Study|Physician Decision|1|||
156841549|NCT00891228|566172267|FG002|Overall Study|Physician Decision|0|||
156841550|NCT00891228|566172265|FG000|Overall Study|Lost to Follow-up|4|||
156841551|NCT00891228|566172266|FG001|Overall Study|Lost to Follow-up|4|||
156841552|NCT00891228|566172267|FG002|Overall Study|Lost to Follow-up|5|||
156841553|NCT00891228|566172265|FG000|Overall Study|Pregnancy|0|||
156841554|NCT00891228|566172266|FG001|Overall Study|Pregnancy|1|||
156841555|NCT00891228|566172267|FG002|Overall Study|Pregnancy|0|||
156841556|NCT02688985|566172276|FG000|Overall Study|Adverse Event|1|||
156841557|NCT02688985|566172277|FG001|Overall Study|Adverse Event|2|||
156841558|NCT02688985|566172278|FG002|Overall Study|Adverse Event|2|||
156841559|NCT02688985|566172279|FG003|Overall Study|Adverse Event|0|||
156841560|NCT02688985|566172280|FG004|Overall Study|Adverse Event|0|||
156841561|NCT02688985|566172276|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
156841562|NCT02688985|566172277|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
156841563|NCT02688985|566172278|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
156841564|NCT02688985|566172279|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
156841565|NCT02688985|566172280|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
156841566|NCT02688985|566172276|FG000|Overall Study|Death|0|||
156841567|NCT02688985|566172277|FG001|Overall Study|Death|0|||
156841568|NCT02688985|566172278|FG002|Overall Study|Death|0|||
156841569|NCT02688985|566172279|FG003|Overall Study|Death|0|||
156841570|NCT02688985|566172280|FG004|Overall Study|Death|1|||
156841571|NCT02688985|566172276|FG000|Overall Study|Lack of Efficacy|0|||
156841572|NCT02688985|566172277|FG001|Overall Study|Lack of Efficacy|0|||
156841573|NCT02688985|566172278|FG002|Overall Study|Lack of Efficacy|0|||
156841574|NCT02688985|566172279|FG003|Overall Study|Lack of Efficacy|0|||
156841575|NCT02688985|566172280|FG004|Overall Study|Lack of Efficacy|1|||
156841576|NCT02688985|566172276|FG000|Overall Study|Lost to Follow-up|2|||
156841577|NCT02688985|566172277|FG001|Overall Study|Lost to Follow-up|0|||
156841578|NCT02688985|566172278|FG002|Overall Study|Lost to Follow-up|1|||
156841579|NCT02688985|566172279|FG003|Overall Study|Lost to Follow-up|1|||
156841580|NCT02688985|566172280|FG004|Overall Study|Lost to Follow-up|1|||
156841581|NCT02688985|566172276|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156841582|NCT02688985|566172277|FG001|Overall Study|Non-Compliance With Study Drug|3|||
156841583|NCT02688985|566172278|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156841584|NCT02688985|566172279|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156841585|NCT02688985|566172280|FG004|Overall Study|Non-Compliance With Study Drug|1|||
156841586|NCT02688985|566172276|FG000|Overall Study|Other|3|||
156841587|NCT02688985|566172277|FG001|Overall Study|Other|4|||
156841588|NCT02688985|566172278|FG002|Overall Study|Other|1|||
156841589|NCT02688985|566172279|FG003|Overall Study|Other|0|||
156841590|NCT02688985|566172280|FG004|Overall Study|Other|0|||
156841591|NCT02688985|566172276|FG000|Overall Study|Physician Decision|2|||
156841592|NCT02688985|566172277|FG001|Overall Study|Physician Decision|2|||
156841593|NCT02688985|566172278|FG002|Overall Study|Physician Decision|0|||
156841594|NCT02688985|566172279|FG003|Overall Study|Physician Decision|0|||
156841595|NCT02688985|566172280|FG004|Overall Study|Physician Decision|1|||
156841596|NCT02688985|566172276|FG000|Overall Study|Pregnancy|0|||
156841597|NCT02688985|566172277|FG001|Overall Study|Pregnancy|0|||
156841598|NCT02688985|566172278|FG002|Overall Study|Pregnancy|2|||
156841599|NCT02688985|566172279|FG003|Overall Study|Pregnancy|1|||
156841600|NCT02688985|566172280|FG004|Overall Study|Pregnancy|0|||
156841601|NCT02688985|566172276|FG000|Overall Study|Study Terminated By Sponsor|0|||
156841602|NCT02688985|566172277|FG001|Overall Study|Study Terminated By Sponsor|0|||
156841603|NCT02688985|566172278|FG002|Overall Study|Study Terminated By Sponsor|0|||
156841604|NCT02688985|566172279|FG003|Overall Study|Study Terminated By Sponsor|1|||
156841605|NCT02688985|566172280|FG004|Overall Study|Study Terminated By Sponsor|0|||
156841606|NCT02688985|566172276|FG000|Overall Study|Withdrawal by Subject|2|||
156841607|NCT02688985|566172277|FG001|Overall Study|Withdrawal by Subject|8|||
156841608|NCT02688985|566172278|FG002|Overall Study|Withdrawal by Subject|7|||
156841609|NCT02688985|566172279|FG003|Overall Study|Withdrawal by Subject|1|||
156841610|NCT02688985|566172280|FG004|Overall Study|Withdrawal by Subject|4|||
156841611|NCT00930553|566172283|FG000|Overall Study|Adverse Event|1|||
156841612|NCT00930553|566172283|FG000|Overall Study|Lack of Efficacy|7|||
156841613|NCT00930553|566172283|FG000|Overall Study|Physician Decision|39|||
156841614|NCT00930553|566172283|FG000|Overall Study|Protocol Violation|1|||
156841615|NCT00930553|566172283|FG000|Overall Study|Pregnancy|1|||
156841616|NCT00930553|566172283|FG000|Overall Study|Withdrawal by Subject|88|||
156841617|NCT00930553|566172283|FG000|Overall Study|Lost to Follow-up|25|||
156841618|NCT00930553|566172283|FG000|Overall Study|Death|9|||
156841619|NCT00930553|566172283|FG000|Overall Study|Study terminated by sponsor|24|||
156841620|NCT00930553|566172283|FG000|Overall Study|Other than specified above|28|||
156841621|NCT01964963|566172284|FG000|Overall Study|Case Report Forms Uncollected|888|||
156841622|NCT01964963|566172284|FG000|Overall Study|Protocol Deviation|50|||
156841623|NCT01964963|566172284|FG000|Overall Study|Data Reliability was not Assured|5|||
156841624|NCT01726582|566172285|FG000|Overall Study|Physician Decision|99|||
156841625|NCT01726582|566172285|FG000|Overall Study|Death|85|||
156841626|NCT01235234|566172286|FG000|Overall Study|Adverse Event|2|||
156841627|NCT01235234|566172287|FG001|Overall Study|Adverse Event|2|||
156841628|NCT01235234|566172288|FG002|Overall Study|Adverse Event|1|||
156469932|NCT05580003|564814875|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156841629|NCT02630472|566172289|FG000|Overall Study|Physician Decision|10|||
156841630|NCT02630472|566172290|FG001|Overall Study|Physician Decision|0|||
156841631|NCT00787189|566172291|FG000|Overall Study|Lost to Follow-up|2|||
156841632|NCT00787189|566172292|FG001|Overall Study|Lost to Follow-up|2|||
156841633|NCT01279616|566172293|FG000|Overall Study|donor could not be located|5|||
156841634|NCT01279616|566172293|FG000|Overall Study|no signs of sickle cell disease|2|||
156841635|NCT00183625|566172294|FG000|Overall Study|Withdrawal by Subject|18|||
156841636|NCT00183625|566172295|FG001|Overall Study|Withdrawal by Subject|18|||
156841637|NCT00183625|566172296|FG002|Overall Study|Withdrawal by Subject|19|||
156841638|NCT00183625|566172297|FG003|Overall Study|Withdrawal by Subject|14|||
156841639|NCT01369641|566172300|FG000|Overall Study|Withdrawal by Subject|1|||
156841640|NCT00842543|566172301|FG000|Overall Study|Withdrawal by Subject|2|||
156841641|NCT00842543|566172302|FG001|Overall Study|Withdrawal by Subject|0|||
156841642|NCT00842543|566172303|FG002|Overall Study|Withdrawal by Subject|3|||
156841643|NCT00842543|566172304|FG003|Overall Study|Withdrawal by Subject|4|||
156841644|NCT01483183|566172313|FG000|Overall Study|Physician Decision|0|||
156841645|NCT01483183|566172314|FG001|Overall Study|Physician Decision|0|||
156841646|NCT01483183|566172315|FG002|Overall Study|Physician Decision|0|||
156841647|NCT01483183|566172316|FG003|Overall Study|Physician Decision|0|||
156841648|NCT01483183|566172317|FG004|Overall Study|Physician Decision|0|||
156841649|NCT01483183|566172318|FG005|Overall Study|Physician Decision|0|||
156841650|NCT01483183|566172319|FG006|Overall Study|Physician Decision|2|||
156841651|NCT01483183|566172320|FG007|Overall Study|Physician Decision|0|||
156841652|NCT01483183|566172321|FG008|Overall Study|Physician Decision|0|||
156841653|NCT01483183|566172322|FG009|Overall Study|Physician Decision|0|||
156841654|NCT01483183|566172313|FG000|Overall Study|Withdrawal by Subject|0|||
156841655|NCT01483183|566172314|FG001|Overall Study|Withdrawal by Subject|0|||
156841656|NCT01483183|566172315|FG002|Overall Study|Withdrawal by Subject|0|||
156841657|NCT01483183|566172316|FG003|Overall Study|Withdrawal by Subject|0|||
156841658|NCT01483183|566172317|FG004|Overall Study|Withdrawal by Subject|0|||
156841659|NCT01483183|566172318|FG005|Overall Study|Withdrawal by Subject|0|||
156841660|NCT01483183|566172319|FG006|Overall Study|Withdrawal by Subject|0|||
156841661|NCT01483183|566172320|FG007|Overall Study|Withdrawal by Subject|0|||
156841662|NCT01483183|566172321|FG008|Overall Study|Withdrawal by Subject|0|||
156341011|NCT01964430|564346496|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
156341012|NCT01964430|564346495|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
156341013|NCT01964430|564346496|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
156341014|NCT01964430|564346495|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
156341015|NCT01964430|564346496|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
156341016|NCT01964430|564346495|FG000|Treatment Period|Adverse Event|71|||
156341017|NCT01964430|564346496|FG001|Treatment Period|Adverse Event|37|||
156341018|NCT01964430|564346495|FG000|Treatment Period|Withdrawal by Subject|36|||
156341019|NCT01964430|564346496|FG001|Treatment Period|Withdrawal by Subject|27|||
156341020|NCT01964430|564346495|FG000|Treatment Period|Death|1|||
156341021|NCT01964430|564346496|FG001|Treatment Period|Death|3|||
156341022|NCT01964430|564346495|FG000|Treatment Period|Protocol Deviation|0|||
156341023|NCT01964430|564346496|FG001|Treatment Period|Protocol Deviation|1|||
156341024|NCT01964430|564346495|FG000|Treatment Period|Physician Decision|5|||
156341025|NCT01964430|564346496|FG001|Treatment Period|Physician Decision|4|||
156841663|NCT01483183|566172322|FG009|Overall Study|Withdrawal by Subject|1|||
156341026|NCT01964430|564346495|FG000|Treatment Period|Disease Relapse|28|||
156341027|NCT01964430|564346496|FG001|Treatment Period|Disease Relapse|38|||
156341028|NCT01964430|564346495|FG000|Treatment Period|Other reasons|1|||
156341029|NCT01964430|564346496|FG001|Treatment Period|Other reasons|3|||
156341030|NCT02591290|564346497|FG000|Overall Study|Withdrawal by Subject|2|||
156841664|NCT00239928|566172323|FG000|Overall Study|Lack of Efficacy|1|||
156841665|NCT00239928|566172323|FG000|Overall Study|Adverse Event|4|||
156841666|NCT00239928|566172323|FG000|Overall Study|Not need to continue study|3|||
156841667|NCT00239928|566172323|FG000|Overall Study|Withdrawal by Subject|2|||
156841668|NCT02524158|566172324|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
156841669|NCT02524158|566172325|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
156841670|NCT02524158|566172324|FG000|12-weeks Assessment|Lost to Follow-up|18|||
156841671|NCT02524158|566172325|FG001|12-weeks Assessment|Lost to Follow-up|12|||
156841672|NCT02524158|566172324|FG000|6-month Assessment|Withdrawal by Subject|1|||
156841673|NCT02524158|566172325|FG001|6-month Assessment|Withdrawal by Subject|1|||
156841674|NCT02524158|566172324|FG000|6-month Assessment|Lost to Follow-up|21|||
156841675|NCT02524158|566172325|FG001|6-month Assessment|Lost to Follow-up|20|||
156841676|NCT02718716|566172327|FG000|Overall Study|Lack of Efficacy|1|||
156341031|NCT02571075|564346498|FG000|Overall Study|Lost to Follow-up|20|||
156341032|NCT02571075|564346499|FG001|Overall Study|Lost to Follow-up|24|||
156341033|NCT02197520|564346505|FG000|Period 1|Withdrawal by Subject|1|||
156341034|NCT02197520|564346506|FG001|Period 1|Withdrawal by Subject|0|||
156341035|NCT02197520|564346505|FG000|Period 2|Adverse Event|0|||
156341036|NCT02197520|564346506|FG001|Period 2|Adverse Event|2|||
156341037|NCT02197520|564346505|FG000|Period 2|Withdrawal by Subject|1|||
156841677|NCT02718716|566172328|FG001|Overall Study|Lack of Efficacy|0|||
156341038|NCT02197520|564346506|FG001|Period 2|Withdrawal by Subject|0|||
156341039|NCT00913497|564346507|FG000|Overall Study|Adverse Event|1|||
156341040|NCT00913497|564346507|FG000|Overall Study|Withdrawal by Subject|2|||
156341041|NCT01306942|564346508|FG000|Phase I|Adverse Event|2|||
156341042|NCT01306942|564346509|FG001|Phase I|Adverse Event|2|||
156841678|NCT02718716|566172329|FG002|Overall Study|Lack of Efficacy|0|||
156841679|NCT02718716|566172330|FG003|Overall Study|Lack of Efficacy|0|||
156841680|NCT02718716|566172331|FG004|Overall Study|Lack of Efficacy|0|||
156841681|NCT03550404|566172332|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
156841682|NCT03550404|566172333|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
156841683|NCT03550404|566172334|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
156841684|NCT03550404|566172332|FG000|Phase 2|Vacated position|1|||
156841685|NCT03550404|566172333|FG001|Phase 2|Vacated position|0|||
156841686|NCT03550404|566172334|FG002|Phase 2|Vacated position|0|||
156841687|NCT00820222|566172336|FG000|Overall Study|Lost to Follow-up|10|||
156841688|NCT00820222|566172337|FG001|Overall Study|Lost to Follow-up|9|||
156841689|NCT00820222|566172336|FG000|Overall Study|Withdrawal by Subject|19|||
156841690|NCT00820222|566172337|FG001|Overall Study|Withdrawal by Subject|21|||
156841691|NCT00820222|566172336|FG000|Overall Study|Physician Decision|93|||
156841692|NCT00820222|566172337|FG001|Overall Study|Physician Decision|88|||
156841693|NCT00820222|566172336|FG000|Overall Study|Sponsor Terminated Study|43|||
156841694|NCT00820222|566172337|FG001|Overall Study|Sponsor Terminated Study|65|||
156341043|NCT01306942|564346510|FG002|Phase I|Adverse Event|0|||
156341044|NCT01306942|564346511|FG003|Phase I|Adverse Event|0|||
156841695|NCT00820222|566172336|FG000|Overall Study|Unkown|11|||
156841696|NCT00820222|566172337|FG001|Overall Study|Unkown|7|||
156841697|NCT02690714|566172338|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
156841698|NCT02690714|566172338|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
156841699|NCT00293020|566172339|FG000|Overall Study|Withdrawal by Subject|34|||
156841700|NCT00293020|566172339|FG000|Overall Study|Adverse Event|30|||
156841701|NCT00293020|566172339|FG000|Overall Study|Death|32|||
156841702|NCT00293020|566172339|FG000|Overall Study|Lack of Efficacy|12|||
156841703|NCT00293020|566172339|FG000|Overall Study|Lost to Follow-up|4|||
156841704|NCT00293020|566172339|FG000|Overall Study|Protocol Violation|6|||
156841705|NCT00293020|566172339|FG000|Overall Study|Physician Decision|21|||
156841706|NCT00293020|566172339|FG000|Overall Study|Other Reason|22|||
156841707|NCT00293020|566172339|FG000|Overall Study|No dose taken|1|||
156841708|NCT01147848|566172340|FG000|Run-in Period|Screen Failure|623|||
156841709|NCT01147848|566172341|FG001|Run-in Period|Screen Failure|0|||
156841710|NCT01147848|566172342|FG002|Run-in Period|Screen Failure|0|||
156841711|NCT01147848|566172340|FG000|Run-in Period|Run-in Failure|135|||
156841712|NCT01147848|566172341|FG001|Run-in Period|Run-in Failure|0|||
156841713|NCT01147848|566172342|FG002|Run-in Period|Run-in Failure|0|||
156841714|NCT01147848|566172340|FG000|Randomized Phase|Adverse Event|0|||
156841715|NCT01147848|566172341|FG001|Randomized Phase|Adverse Event|6|||
156841716|NCT01147848|566172342|FG002|Randomized Phase|Adverse Event|8|||
156841717|NCT01147848|566172340|FG000|Randomized Phase|Lack of Efficacy|0|||
156841718|NCT01147848|566172341|FG001|Randomized Phase|Lack of Efficacy|20|||
156841719|NCT01147848|566172342|FG002|Randomized Phase|Lack of Efficacy|11|||
156841720|NCT01147848|566172340|FG000|Randomized Phase|Protocol Violation|0|||
156841721|NCT01147848|566172341|FG001|Randomized Phase|Protocol Violation|7|||
156841722|NCT01147848|566172342|FG002|Randomized Phase|Protocol Violation|10|||
156841723|NCT01147848|566172340|FG000|Randomized Phase|Lost to Follow-up|0|||
156841724|NCT01147848|566172341|FG001|Randomized Phase|Lost to Follow-up|5|||
156841725|NCT01147848|566172342|FG002|Randomized Phase|Lost to Follow-up|7|||
156841726|NCT01147848|566172340|FG000|Randomized Phase|Physician Decision|0|||
156841727|NCT01147848|566172341|FG001|Randomized Phase|Physician Decision|0|||
156841728|NCT01147848|566172342|FG002|Randomized Phase|Physician Decision|1|||
156841729|NCT01147848|566172340|FG000|Randomized Phase|Withdrawal by Subject|0|||
156841730|NCT01147848|566172341|FG001|Randomized Phase|Withdrawal by Subject|7|||
156841731|NCT01147848|566172342|FG002|Randomized Phase|Withdrawal by Subject|9|||
156841732|NCT02540265|566172343|FG000|Overall Study|Lost to Follow-up|0|||
156841733|NCT02540265|566172344|FG001|Overall Study|Lost to Follow-up|0|||
156841734|NCT02540265|566172345|FG002|Overall Study|Lost to Follow-up|1|||
156841735|NCT01972789|566172359|FG000|Overall Study|Adverse Event|11|||
156841736|NCT01972789|566172360|FG001|Overall Study|Adverse Event|4|||
156841737|NCT01972789|566172359|FG000|Overall Study|Subject withdrew consent|14|||
156841738|NCT01972789|566172360|FG001|Overall Study|Subject withdrew consent|12|||
156841739|NCT01972789|566172359|FG000|Overall Study|Lost to Follow-up|4|||
156841740|NCT01972789|566172360|FG001|Overall Study|Lost to Follow-up|7|||
156841741|NCT01972789|566172359|FG000|Overall Study|Death|7|||
156841742|NCT01972789|566172360|FG001|Overall Study|Death|5|||
156841743|NCT01972789|566172359|FG000|Overall Study|Protocol deviation|1|||
156841744|NCT01972789|566172360|FG001|Overall Study|Protocol deviation|0|||
156841745|NCT01972789|566172359|FG000|Overall Study|Physician Decision|3|||
156841746|NCT01972789|566172360|FG001|Overall Study|Physician Decision|2|||
156341045|NCT01306942|564346508|FG000|Phase I|Physician Decision|3|||
156841747|NCT00666965|566172363|FG000|Overall Study|Adverse Event|0|||
156841748|NCT00666965|566172364|FG001|Overall Study|Adverse Event|2|||
156841749|NCT00666965|566172365|FG002|Overall Study|Adverse Event|1|||
156841750|NCT00666965|566172366|FG003|Overall Study|Adverse Event|9|||
156841751|NCT00666965|566172363|FG000|Overall Study|Lack of Efficacy|1|||
156841752|NCT00666965|566172364|FG001|Overall Study|Lack of Efficacy|1|||
156841753|NCT00666965|566172365|FG002|Overall Study|Lack of Efficacy|0|||
156841754|NCT00666965|566172366|FG003|Overall Study|Lack of Efficacy|0|||
156841755|NCT00666965|566172363|FG000|Overall Study|Protocol Violation|0|||
156841756|NCT00666965|566172364|FG001|Overall Study|Protocol Violation|0|||
156841757|NCT00666965|566172365|FG002|Overall Study|Protocol Violation|0|||
156841758|NCT00666965|566172366|FG003|Overall Study|Protocol Violation|2|||
156841759|NCT00666965|566172363|FG000|Overall Study|Discontinuation criteria|2|||
156841760|NCT00666965|566172364|FG001|Overall Study|Discontinuation criteria|1|||
156841761|NCT00666965|566172365|FG002|Overall Study|Discontinuation criteria|1|||
156841762|NCT00666965|566172366|FG003|Overall Study|Discontinuation criteria|2|||
156841763|NCT00666965|566172363|FG000|Overall Study|Withdrawal by Subject|0|||
156841764|NCT00666965|566172364|FG001|Overall Study|Withdrawal by Subject|0|||
156841765|NCT00666965|566172365|FG002|Overall Study|Withdrawal by Subject|0|||
156841766|NCT00666965|566172366|FG003|Overall Study|Withdrawal by Subject|2|||
156841767|NCT03596450|566172367|FG000|Overall Study|Death|9|||
156841768|NCT03596450|566172368|FG001|Overall Study|Death|9|||
156841769|NCT03596450|566172367|FG000|Overall Study|Protocol Violation|18|||
156841770|NCT03596450|566172368|FG001|Overall Study|Protocol Violation|26|||
156841771|NCT03596450|566172367|FG000|Overall Study|Lost to Follow-up|50|||
156841772|NCT03596450|566172368|FG001|Overall Study|Lost to Follow-up|56|||
156841773|NCT03596450|566172367|FG000|Overall Study|Adverse Event|14|||
156841774|NCT03596450|566172368|FG001|Overall Study|Adverse Event|7|||
156841775|NCT03596450|566172367|FG000|Overall Study|Withdrawal by Subject|38|||
156841776|NCT03596450|566172368|FG001|Overall Study|Withdrawal by Subject|36|||
156841777|NCT03596450|566172367|FG000|Overall Study|Accidentally Randomized|2|||
156841778|NCT03596450|566172368|FG001|Overall Study|Accidentally Randomized|0|||
156841779|NCT03596450|566172367|FG000|Overall Study|Other reasons|48|||
156841780|NCT03596450|566172368|FG001|Overall Study|Other reasons|53|||
156841781|NCT03596450|566172367|FG000|Overall Study|Pregnancy|2|||
156841782|NCT03596450|566172368|FG001|Overall Study|Pregnancy|0|||
156841783|NCT00498355|566172369|FG000|Overall Study|Lost to Follow-up|1|||
156841784|NCT04496453|566172370|FG000|Overall Study|Lost to Follow-up|6|||
156841785|NCT04058886|566172375|FG000|Overall Study|Withdrawal by Subject|4|||
156841786|NCT04058886|566172375|FG000|Overall Study|Inadequate deafness interpreter service|1|||
156841787|NCT03624127|566172378|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
156841788|NCT03624127|566172379|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
156841789|NCT03624127|566172380|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
156841790|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
156841791|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
156841792|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
156841793|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Death|0|||
156841794|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Death|1|||
156841795|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Death|0|||
156841796|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
156841797|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
156841798|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
156841799|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
156841800|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
156841801|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
156841802|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
156841803|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
156841804|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
156841805|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
156841806|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
156841807|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
156841808|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
156841809|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
156841810|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
156841811|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
156469933|NCT05580003|564814876|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469934|NCT05580003|564814877|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469935|NCT05580003|564814878|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469936|NCT05580003|564814879|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156841812|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
156841813|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
156841814|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
156841815|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
156841816|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
156841817|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
156841818|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
156841819|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
156841820|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
156841821|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
156841822|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
156841823|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
156841824|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
156841825|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
156841826|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
156841827|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
156841828|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
156841829|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
156841830|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
156841831|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
156841832|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
156841833|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
156841834|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
156841835|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
156841836|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
156841837|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
156841838|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
156841839|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
156841840|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
156841841|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
156841842|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
156841843|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
156841844|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
156841845|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
156841846|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
156841847|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
156841848|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
156841849|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
156841850|NCT04390841|566172381|FG000|Overall Study|Withdrawal by Subject|2|||
156841851|NCT02999633|566172384|FG000|Overall Study|Adverse Event|2|||
156841852|NCT02999633|566172384|FG000|Overall Study|Progressive disease|12|||
156841853|NCT03262441|566172385|FG000|Overall Study|Withdrawal by Subject|1|||
156841854|NCT03238924|566172395|FG000|Overall Study|Withdrawal by Subject|2|||
156841855|NCT03238924|566172396|FG001|Overall Study|Withdrawal by Subject|2|||
156841856|NCT03576716|566172399|FG000|Overall Study|Withdrawal by Subject|0|||
156841857|NCT03576716|566172400|FG001|Overall Study|Withdrawal by Subject|1|||
156841858|NCT00559988|566172401|FG000|Overall Study|Death|147|||
156841859|NCT00559988|566172402|FG001|Overall Study|Death|140|||
156841860|NCT00559988|566172401|FG000|Overall Study|Withdrawal by Subject|152|||
156841861|NCT00559988|566172402|FG001|Overall Study|Withdrawal by Subject|139|||
156841862|NCT00559988|566172401|FG000|Overall Study|Lost to Follow-up|42|||
156341046|NCT01306942|564346509|FG001|Phase I|Physician Decision|1|||
156341047|NCT01306942|564346510|FG002|Phase I|Physician Decision|0|||
156341048|NCT01306942|564346511|FG003|Phase I|Physician Decision|0|||
156341049|NCT01306942|564346508|FG000|Phase II|Adverse Event|0|||
156841863|NCT00559988|566172402|FG001|Overall Study|Lost to Follow-up|56|||
156841864|NCT00559988|566172401|FG000|Overall Study|ICD device explanted|10|||
156841865|NCT00559988|566172402|FG001|Overall Study|ICD device explanted|17|||
156841866|NCT02891382|566172403|FG000|Overall Study|Lost to Follow-up|3|||
156841867|NCT02891382|566172404|FG001|Overall Study|Lost to Follow-up|4|||
156841868|NCT02891382|566172405|FG002|Overall Study|Lost to Follow-up|5|||
156841869|NCT02891382|566172406|FG003|Overall Study|Lost to Follow-up|3|||
156841870|NCT02891382|566172407|FG004|Overall Study|Lost to Follow-up|4|||
156841871|NCT02249182|566172408|FG000|Treatment Phase|Lost to Follow-up|4|||
156841872|NCT02249182|566172409|FG001|Treatment Phase|Lost to Follow-up|0|||
156841873|NCT02249182|566172410|FG002|Treatment Phase|Lost to Follow-up|0|||
156841874|NCT02249182|566172411|FG003|Treatment Phase|Lost to Follow-up|0|||
156841875|NCT02249182|566172412|FG004|Treatment Phase|Lost to Follow-up|0|||
156841876|NCT01455194|566172413|FG000|Overall Study|Screen Failure|20|||
156841877|NCT01455194|566172414|FG001|Overall Study|Screen Failure|0|||
156841878|NCT01455194|566172415|FG002|Overall Study|Screen Failure|0|||
156841879|NCT01455194|566172416|FG003|Overall Study|Screen Failure|0|||
156841880|NCT01455194|566172413|FG000|Overall Study|Randomisation Failure|90|||
156841881|NCT01455194|566172414|FG001|Overall Study|Randomisation Failure|0|||
156841882|NCT01455194|566172415|FG002|Overall Study|Randomisation Failure|0|||
156841883|NCT01455194|566172416|FG003|Overall Study|Randomisation Failure|0|||
156841884|NCT01455194|566172413|FG000|Overall Study|Deterioration in asthma|12|||
156841885|NCT01455194|566172414|FG001|Overall Study|Deterioration in asthma|6|||
156841886|NCT01455194|566172415|FG002|Overall Study|Deterioration in asthma|14|||
156841887|NCT01455194|566172416|FG003|Overall Study|Deterioration in asthma|9|||
156841888|NCT01455194|566172413|FG000|Overall Study|Adverse Event|1|||
156841889|NCT01455194|566172414|FG001|Overall Study|Adverse Event|1|||
156841890|NCT01455194|566172415|FG002|Overall Study|Adverse Event|1|||
156841891|NCT01455194|566172416|FG003|Overall Study|Adverse Event|3|||
156841892|NCT01455194|566172413|FG000|Overall Study|Withdrawal by Subject|21|||
156841893|NCT01455194|566172414|FG001|Overall Study|Withdrawal by Subject|16|||
156841894|NCT01455194|566172415|FG002|Overall Study|Withdrawal by Subject|12|||
156841895|NCT01455194|566172416|FG003|Overall Study|Withdrawal by Subject|9|||
156841896|NCT01455194|566172413|FG000|Overall Study|Lost to Follow-up|2|||
156841897|NCT01455194|566172414|FG001|Overall Study|Lost to Follow-up|0|||
156841898|NCT01455194|566172415|FG002|Overall Study|Lost to Follow-up|1|||
156841899|NCT01455194|566172416|FG003|Overall Study|Lost to Follow-up|1|||
156841900|NCT01455194|566172413|FG000|Overall Study|Pregnancy|0|||
156841901|NCT01455194|566172414|FG001|Overall Study|Pregnancy|1|||
156841902|NCT01455194|566172415|FG002|Overall Study|Pregnancy|1|||
156841903|NCT01455194|566172416|FG003|Overall Study|Pregnancy|0|||
156841904|NCT01455194|566172413|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
156841905|NCT01455194|566172414|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
156841906|NCT01455194|566172415|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
156841907|NCT01455194|566172416|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
156841908|NCT01455194|566172413|FG000|Overall Study|Miscellaneous|4|||
156841909|NCT01455194|566172414|FG001|Overall Study|Miscellaneous|5|||
156841910|NCT01455194|566172415|FG002|Overall Study|Miscellaneous|1|||
156841911|NCT01455194|566172416|FG003|Overall Study|Miscellaneous|4|||
156841912|NCT02516228|566172417|FG000|Overall Study|Lost to Follow-up|1|||
156841913|NCT02516228|566172417|FG000|Overall Study|Withdrawal by Subject|1|||
156841914|NCT02516228|566172417|FG000|Overall Study|Physician Decision|1|||
156841915|NCT03916484|566172418|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156841916|NCT03916484|566172419|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
156841917|NCT03916484|566172420|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156841918|NCT03916484|566172421|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156841919|NCT03916484|566172418|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
156841920|NCT03916484|566172419|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
156841921|NCT03916484|566172420|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
156841922|NCT03916484|566172421|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
156841923|NCT00504894|566172422|FG000|Overall Study|fMRI technical problems|1|||
156841924|NCT00504894|566172423|FG001|Overall Study|fMRI technical problems|1|||
156841925|NCT00504894|566172424|FG002|Overall Study|fMRI technical problems|0|||
156841926|NCT00504894|566172422|FG000|Overall Study|Withdrawal by Subject|0|||
156841927|NCT00504894|566172423|FG001|Overall Study|Withdrawal by Subject|1|||
156841928|NCT00504894|566172424|FG002|Overall Study|Withdrawal by Subject|0|||
156841929|NCT00504894|566172422|FG000|Overall Study|Infusion technical problems|0|||
156841930|NCT00504894|566172423|FG001|Overall Study|Infusion technical problems|1|||
156841931|NCT00504894|566172424|FG002|Overall Study|Infusion technical problems|0|||
156841932|NCT00504894|566172422|FG000|Overall Study|poor subject data|2|||
156841933|NCT00504894|566172423|FG001|Overall Study|poor subject data|0|||
156841934|NCT00504894|566172424|FG002|Overall Study|poor subject data|0|||
156841935|NCT05090852|566172425|FG000|Overall Study|Physician Decision|5|||
156841936|NCT01196416|566172426|FG000|Overall Study|Withdrawal by Subject|2|||
156841937|NCT00148941|566172427|FG000|Overall Study|Lost to Follow-up|17|||
156841938|NCT00148941|566172428|FG001|Overall Study|Lost to Follow-up|24|||
156841939|NCT00148941|566172429|FG002|Overall Study|Lost to Follow-up|18|||
156841940|NCT00148941|566172430|FG003|Overall Study|Lost to Follow-up|22|||
156841941|NCT00148941|566172427|FG000|Overall Study|Withdrawal by Subject|1|||
156841942|NCT00148941|566172428|FG001|Overall Study|Withdrawal by Subject|0|||
156841943|NCT00148941|566172429|FG002|Overall Study|Withdrawal by Subject|1|||
156841944|NCT00148941|566172430|FG003|Overall Study|Withdrawal by Subject|0|||
156841945|NCT00148941|566172427|FG000|Overall Study|Other|0|||
156841946|NCT00148941|566172428|FG001|Overall Study|Other|0|||
156341050|NCT01306942|564346509|FG001|Phase II|Adverse Event|0|||
156341051|NCT01306942|564346510|FG002|Phase II|Adverse Event|0|||
156341052|NCT01306942|564346511|FG003|Phase II|Adverse Event|6|||
156341053|NCT01306942|564346508|FG000|Phase II|Physician Decision|2|||
156341054|NCT01306942|564346509|FG001|Phase II|Physician Decision|0|||
156341055|NCT01306942|564346510|FG002|Phase II|Physician Decision|0|||
156341056|NCT01306942|564346511|FG003|Phase II|Physician Decision|5|||
156341057|NCT01306942|564346508|FG000|Phase II|Withdrawal by Subject|0|||
156341058|NCT01306942|564346509|FG001|Phase II|Withdrawal by Subject|0|||
156341059|NCT01306942|564346510|FG002|Phase II|Withdrawal by Subject|0|||
156341060|NCT01306942|564346511|FG003|Phase II|Withdrawal by Subject|2|||
156341061|NCT01306942|564346508|FG000|Phase II|Death|0|||
156341062|NCT01306942|564346509|FG001|Phase II|Death|0|||
156341063|NCT01306942|564346510|FG002|Phase II|Death|0|||
156341064|NCT01306942|564346511|FG003|Phase II|Death|1|||
156341065|NCT01306942|564346508|FG000|Phase II|Not finished treatment|0|||
156341066|NCT01306942|564346509|FG001|Phase II|Not finished treatment|0|||
156341067|NCT01306942|564346510|FG002|Phase II|Not finished treatment|0|||
156341068|NCT01306942|564346511|FG003|Phase II|Not finished treatment|1|||
156841947|NCT00148941|566172429|FG002|Overall Study|Other|1|||
156841948|NCT00148941|566172430|FG003|Overall Study|Other|2|||
156841949|NCT02673684|566172431|FG000|Overall Study|Study not completed d/t loss of funding|9|||
156841950|NCT02673684|566172432|FG001|Overall Study|Study not completed d/t loss of funding|8|||
156841951|NCT04356040|566172435|FG000|Overall Study|Death|2|||
156841952|NCT04356040|566172436|FG001|Overall Study|Death|0|||
156841953|NCT04356040|566172435|FG000|Overall Study|Lost to Follow-up|1|||
156841954|NCT04356040|566172436|FG001|Overall Study|Lost to Follow-up|0|||
156841955|NCT04356040|566172435|FG000|Overall Study|Physician Decision|0|||
156841956|NCT04356040|566172436|FG001|Overall Study|Physician Decision|1|||
156841957|NCT04356040|566172435|FG000|Overall Study|Withdrawal by Subject|13|||
156841958|NCT04356040|566172436|FG001|Overall Study|Withdrawal by Subject|1|||
156841959|NCT04356040|566172435|FG000|Overall Study|Enrollment Pause|10|||
156841960|NCT04356040|566172436|FG001|Overall Study|Enrollment Pause|0|||
156841961|NCT04356040|566172435|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
156841962|NCT04356040|566172436|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
156841963|NCT04356040|566172435|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
156841964|NCT04356040|566172436|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
156841965|NCT04356040|566172435|FG000|Overall Study|PI left institution|3|||
156841966|NCT04356040|566172436|FG001|Overall Study|PI left institution|0|||
156841967|NCT01092663|566172437|FG000|Overall Study|Withdrawal by Subject|3|||
156841968|NCT01092663|566172438|FG001|Overall Study|Withdrawal by Subject|2|||
156841969|NCT01092663|566172437|FG000|Overall Study|Glucose >300mg/dL|1|||
156841970|NCT01092663|566172438|FG001|Overall Study|Glucose >300mg/dL|0|||
156841971|NCT01092663|566172437|FG000|Overall Study|High fasting triglyceride|2|||
156841972|NCT01092663|566172438|FG001|Overall Study|High fasting triglyceride|0|||
156841973|NCT01092663|566172437|FG000|Overall Study|Adverse Event|1|||
156841974|NCT01092663|566172438|FG001|Overall Study|Adverse Event|1|||
156841975|NCT01092663|566172437|FG000|Overall Study|Protocol Violation|0|||
156841976|NCT01092663|566172438|FG001|Overall Study|Protocol Violation|1|||
156841977|NCT01008904|566172439|FG000|Overall Study|Lost to Follow-up|1|||
156841978|NCT01008904|566172439|FG000|Overall Study|Adverse Event|2|||
156841979|NCT01008904|566172439|FG000|Overall Study|unexpected unrelated surgery|1|||
156841980|NCT00788710|566172440|FG000|Overall Study|Adverse Event|1|||
156841981|NCT00788710|566172441|FG001|Overall Study|Adverse Event|3|||
156841982|NCT00788710|566172442|FG002|Overall Study|Adverse Event|4|||
156841983|NCT00788710|566172440|FG000|Overall Study|Lack of Efficacy|0|||
156841984|NCT00788710|566172441|FG001|Overall Study|Lack of Efficacy|0|||
156841985|NCT00788710|566172442|FG002|Overall Study|Lack of Efficacy|1|||
156841986|NCT00788710|566172440|FG000|Overall Study|Lost to Follow-up|0|||
156841987|NCT00788710|566172441|FG001|Overall Study|Lost to Follow-up|1|||
156841988|NCT00788710|566172442|FG002|Overall Study|Lost to Follow-up|0|||
156841989|NCT00788710|566172440|FG000|Overall Study|Physician Decision|2|||
156841990|NCT00788710|566172441|FG001|Overall Study|Physician Decision|1|||
156841991|NCT00788710|566172442|FG002|Overall Study|Physician Decision|0|||
156841992|NCT00788710|566172440|FG000|Overall Study|Protocol Violation|0|||
156341069|NCT01306942|564346508|FG000|Phase II|Protocol Violation|0|||
156841993|NCT00788710|566172441|FG001|Overall Study|Protocol Violation|1|||
156841994|NCT00788710|566172442|FG002|Overall Study|Protocol Violation|1|||
156341070|NCT01306942|564346509|FG001|Phase II|Protocol Violation|0|||
156341071|NCT01306942|564346510|FG002|Phase II|Protocol Violation|0|||
156341072|NCT01306942|564346511|FG003|Phase II|Protocol Violation|1|||
156841995|NCT00788710|566172440|FG000|Overall Study|Withdrawal by Subject|2|||
156341073|NCT03190915|564346512|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
156341074|NCT03190915|564346512|FG000|Overall Study|Progressive Disease|3|||
156841996|NCT00788710|566172441|FG001|Overall Study|Withdrawal by Subject|2|||
156841997|NCT00788710|566172442|FG002|Overall Study|Withdrawal by Subject|0|||
156841998|NCT00360568|566172444|FG000|Overall Study|Adverse Event|1|||
156841999|NCT00360568|566172445|FG001|Overall Study|Adverse Event|2|||
156341075|NCT04431453|564346513|FG000|Overall Study|Withdrew Consent|0|||
156842000|NCT00360568|566172444|FG000|Overall Study|Lack of Efficacy|1|||
156842001|NCT00360568|566172445|FG001|Overall Study|Lack of Efficacy|0|||
156842002|NCT00360568|566172444|FG000|Overall Study|Withdrawal by Subject|0|||
156842003|NCT00360568|566172445|FG001|Overall Study|Withdrawal by Subject|3|||
156842004|NCT01008449|566172448|FG000|Overall Study|Lost to Follow-up|29|||
156842005|NCT01008449|566172449|FG001|Overall Study|Lost to Follow-up|19|||
156842006|NCT01220180|566172450|FG000|Overall Study|Lost to Follow-up|76|||
156842007|NCT01220180|566172450|FG000|Overall Study|Other|72|||
156842008|NCT01220180|566172450|FG000|Overall Study|Adverse Event|35|||
156842009|NCT01220180|566172450|FG000|Overall Study|Lack of Efficacy|22|||
156842010|NCT01220180|566172450|FG000|Overall Study|Death|1|||
156842011|NCT01220180|566172450|FG000|Overall Study|Randomized but not treated|1|||
156842012|NCT02262754|566172452|FG000|Overall Study|Adverse Event|3|||
156842013|NCT02262754|566172453|FG001|Overall Study|Adverse Event|4|||
156842014|NCT02262754|566172454|FG002|Overall Study|Adverse Event|0|||
156842015|NCT02262754|566172452|FG000|Overall Study|Lack of Efficacy|2|||
156842016|NCT02262754|566172453|FG001|Overall Study|Lack of Efficacy|0|||
156842017|NCT02262754|566172454|FG002|Overall Study|Lack of Efficacy|1|||
156842018|NCT02262754|566172452|FG000|Overall Study|Lost to Follow-up|0|||
156842019|NCT02262754|566172453|FG001|Overall Study|Lost to Follow-up|0|||
156842020|NCT02262754|566172454|FG002|Overall Study|Lost to Follow-up|1|||
156842021|NCT02262754|566172452|FG000|Overall Study|No longer meets eligibility criteria|0|||
156842022|NCT02262754|566172453|FG001|Overall Study|No longer meets eligibility criteria|1|||
156842023|NCT02262754|566172454|FG002|Overall Study|No longer meets eligibility criteria|0|||
156842024|NCT02262754|566172452|FG000|Overall Study|Study terminated by sponsor|5|||
156842025|NCT02262754|566172453|FG001|Overall Study|Study terminated by sponsor|4|||
156842026|NCT02262754|566172454|FG002|Overall Study|Study terminated by sponsor|4|||
156842027|NCT02262754|566172452|FG000|Overall Study|Protocol Violation|1|||
156842028|NCT02262754|566172453|FG001|Overall Study|Protocol Violation|0|||
156842029|NCT02262754|566172454|FG002|Overall Study|Protocol Violation|0|||
156842030|NCT02262754|566172452|FG000|Overall Study|Withdrawal by Subject|1|||
156842031|NCT02262754|566172453|FG001|Overall Study|Withdrawal by Subject|0|||
156842032|NCT02262754|566172454|FG002|Overall Study|Withdrawal by Subject|1|||
156842033|NCT02262754|566172452|FG000|Overall Study|Other|4|||
156842034|NCT02262754|566172453|FG001|Overall Study|Other|0|||
156842035|NCT02262754|566172454|FG002|Overall Study|Other|2|||
156842036|NCT01299116|566172458|FG000|Overall Study|Lost to Follow-up|65|||
156842037|NCT01299116|566172459|FG001|Overall Study|Lost to Follow-up|9|||
156842038|NCT01299116|566172460|FG002|Overall Study|Lost to Follow-up|11|||
156842039|NCT04079114|566172462|FG000|Overall Study|Study prematuely terminated.|166|||
156842040|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
156842041|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
156842042|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
156842043|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
156842044|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
156842045|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
156842046|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
156842047|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
156842048|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Death|0|||
156842049|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Death|1|||
156842050|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
156842051|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
156842052|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Other|0|||
156842053|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Other|2|||
156842054|NCT03281304|566172466|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
156842055|NCT03281304|566172467|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
156842056|NCT01114438|566172468|FG000|Overall Study|Adverse Event|10|||
156842057|NCT01114438|566172468|FG000|Overall Study|concomitant medication|1|||
156842058|NCT01114438|566172468|FG000|Overall Study|Physician Decision|1|||
156842059|NCT01114438|566172468|FG000|Overall Study|Withdrawal by Subject|2|||
156842060|NCT02611817|566174177|FG000|Open-label Induction Phase|Reason not Specified|9|||
156842061|NCT02611817|566174178|FG001|Open-label Induction Phase|Reason not Specified|0|||
156842062|NCT02611817|566174179|FG002|Open-label Induction Phase|Reason not Specified|0|||
156842063|NCT02611817|566174177|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
156842064|NCT02611817|566174178|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
156842065|NCT02611817|566174179|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
156842066|NCT02611817|566174177|FG000|Open-label Induction Phase|Pregnancy|1|||
156842067|NCT02611817|566174178|FG001|Open-label Induction Phase|Pregnancy|0|||
156842068|NCT02611817|566174179|FG002|Open-label Induction Phase|Pregnancy|0|||
156842069|NCT02611817|566174177|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
156842070|NCT02611817|566174178|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
156469937|NCT05580003|564814880|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156842071|NCT02611817|566174179|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
156842072|NCT02611817|566174177|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
156842073|NCT02611817|566174178|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
156842074|NCT02611817|566174179|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
156842075|NCT02611817|566174177|FG000|Open-label Induction Phase|Protocol Violation|5|||
156842076|NCT02611817|566174178|FG001|Open-label Induction Phase|Protocol Violation|0|||
156842077|NCT02611817|566174179|FG002|Open-label Induction Phase|Protocol Violation|0|||
156842078|NCT02611817|566174177|FG000|Open-label Induction Phase|Adverse Event|16|||
156842079|NCT02611817|566174178|FG001|Open-label Induction Phase|Adverse Event|0|||
156842080|NCT02611817|566174179|FG002|Open-label Induction Phase|Adverse Event|0|||
156842081|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
156842082|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
156842083|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
156842084|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
156842085|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
156842086|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
156842087|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
156842088|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
156842089|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
156842090|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
156842091|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
156842092|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
156842093|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
156842094|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
156842095|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
156842096|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
156842097|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
156842098|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
156842099|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
156842100|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
156842101|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
156842102|NCT03077919|566174180|FG000|Overall Study|Lost to Follow-up|4|||
156842103|NCT03077919|566174181|FG001|Overall Study|Lost to Follow-up|1|||
156842104|NCT03738618|566174182|FG000|Overall Study|Protocol deviation|23|||
156842105|NCT03738618|566174183|FG001|Overall Study|Protocol deviation|0|||
156842106|NCT03738618|566174182|FG000|Overall Study|Adverse Event|4|||
156842107|NCT03738618|566174183|FG001|Overall Study|Adverse Event|0|||
156842108|NCT03738618|566174182|FG000|Overall Study|Lost to Follow-up|2|||
156842109|NCT03738618|566174183|FG001|Overall Study|Lost to Follow-up|0|||
156842110|NCT03738618|566174182|FG000|Overall Study|Randomization failure|1|||
156842111|NCT03738618|566174183|FG001|Overall Study|Randomization failure|0|||
156842112|NCT03738618|566174182|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
156842113|NCT03738618|566174183|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
156842114|NCT03738618|566174182|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
156842115|NCT03738618|566174183|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
156842116|NCT00826618|566174184|FG000|Overall Study|Withdrawal by Subject|1|||
156842117|NCT01363661|566174187|FG000|Overall Study|Adverse Event|9|||
156842118|NCT01363661|566174188|FG001|Overall Study|Adverse Event|2|||
156842119|NCT01363661|566174187|FG000|Overall Study|Withdrawal by Subject|1|||
156842120|NCT01363661|566174188|FG001|Overall Study|Withdrawal by Subject|1|||
156842121|NCT01363661|566174187|FG000|Overall Study|Protocol Violation|1|||
156842122|NCT01363661|566174188|FG001|Overall Study|Protocol Violation|0|||
156842123|NCT01363661|566174187|FG000|Overall Study|Lost to Follow-up|3|||
156842124|NCT01363661|566174188|FG001|Overall Study|Lost to Follow-up|1|||
156842125|NCT02219334|566174191|FG000|Overall Study|Withdrawal by Subject|1|||
156842126|NCT02219334|566174192|FG001|Overall Study|Withdrawal by Subject|0|||
156842127|NCT02219334|566174191|FG000|Overall Study|Protocol Violation|7|||
156842128|NCT02219334|566174192|FG001|Overall Study|Protocol Violation|3|||
156842129|NCT03704688|566174201|FG000|Overall Study|Adverse Event|0|||
156842130|NCT03704688|566174202|FG001|Overall Study|Adverse Event|0|||
156842131|NCT03704688|566174203|FG002|Overall Study|Adverse Event|0|||
156842132|NCT03704688|566174204|FG003|Overall Study|Adverse Event|4|||
156842133|NCT03704688|566174205|FG004|Overall Study|Adverse Event|1|||
156842134|NCT03704688|566174206|FG005|Overall Study|Adverse Event|0|||
156842135|NCT03704688|566174201|FG000|Overall Study|Disease Progression|0|||
156842136|NCT03704688|566174202|FG001|Overall Study|Disease Progression|0|||
156842137|NCT03704688|566174203|FG002|Overall Study|Disease Progression|0|||
156842138|NCT03704688|566174204|FG003|Overall Study|Disease Progression|3|||
156842139|NCT03704688|566174205|FG004|Overall Study|Disease Progression|1|||
156842140|NCT03704688|566174206|FG005|Overall Study|Disease Progression|0|||
156842141|NCT03704688|566174201|FG000|Overall Study|Death|0|||
156842142|NCT03704688|566174202|FG001|Overall Study|Death|0|||
156842143|NCT03704688|566174203|FG002|Overall Study|Death|0|||
156469938|NCT05580003|564814881|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156842144|NCT03704688|566174204|FG003|Overall Study|Death|0|||
156842145|NCT03704688|566174205|FG004|Overall Study|Death|3|||
156842146|NCT03704688|566174206|FG005|Overall Study|Death|0|||
156842147|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842148|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842149|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
156842150|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
156842151|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
156842152|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842153|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
156842154|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
156842155|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
156842156|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842157|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842158|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842159|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842160|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
156842161|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
156842162|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
156842163|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
156469939|NCT05580003|564814882|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469940|NCT05580003|564814883|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469941|NCT05580003|564814884|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156842164|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
156842165|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
156842166|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
156842167|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
156341076|NCT04431453|564346514|FG001|Overall Study|Withdrew Consent|1|||
156341077|NCT04431453|564346515|FG002|Overall Study|Withdrew Consent|0|||
156341078|NCT04431453|564346516|FG003|Overall Study|Withdrew Consent|2|||
156341079|NCT04431453|564346517|FG004|Overall Study|Withdrew Consent|0|||
156341080|NCT04431453|564346518|FG005|Overall Study|Withdrew Consent|0|||
156341081|NCT04431453|564346519|FG006|Overall Study|Withdrew Consent|0|||
156341082|NCT04431453|564346520|FG007|Overall Study|Withdrew Consent|0|||
156341083|NCT04431453|564346513|FG000|Overall Study|Death|1|||
156341084|NCT04431453|564346514|FG001|Overall Study|Death|0|||
156341085|NCT04431453|564346515|FG002|Overall Study|Death|0|||
156341086|NCT04431453|564346516|FG003|Overall Study|Death|0|||
156341087|NCT04431453|564346517|FG004|Overall Study|Death|0|||
156341088|NCT04431453|564346518|FG005|Overall Study|Death|0|||
156341089|NCT04431453|564346519|FG006|Overall Study|Death|0|||
156341090|NCT04431453|564346520|FG007|Overall Study|Death|1|||
156341091|NCT04431453|564346513|FG000|Overall Study|Lost to Follow-up|0|||
156341092|NCT04431453|564346514|FG001|Overall Study|Lost to Follow-up|0|||
156341093|NCT04431453|564346515|FG002|Overall Study|Lost to Follow-up|1|||
156341094|NCT04431453|564346516|FG003|Overall Study|Lost to Follow-up|1|||
156341095|NCT04431453|564346517|FG004|Overall Study|Lost to Follow-up|0|||
156341096|NCT04431453|564346518|FG005|Overall Study|Lost to Follow-up|0|||
156341097|NCT04431453|564346519|FG006|Overall Study|Lost to Follow-up|0|||
156341098|NCT04431453|564346520|FG007|Overall Study|Lost to Follow-up|0|||
156341099|NCT04431453|564346513|FG000|Overall Study|Enrolled but Never Treated|0|||
156341100|NCT04431453|564346514|FG001|Overall Study|Enrolled but Never Treated|0|||
156341101|NCT04431453|564346515|FG002|Overall Study|Enrolled but Never Treated|0|||
156341102|NCT04431453|564346516|FG003|Overall Study|Enrolled but Never Treated|0|||
156341103|NCT04431453|564346517|FG004|Overall Study|Enrolled but Never Treated|1|||
156341104|NCT04431453|564346518|FG005|Overall Study|Enrolled but Never Treated|0|||
156341105|NCT04431453|564346519|FG006|Overall Study|Enrolled but Never Treated|0|||
156341106|NCT04431453|564346520|FG007|Overall Study|Enrolled but Never Treated|0|||
156341107|NCT03385564|564346521|FG000|Overall Study|Adverse Event|0|||
156341108|NCT03385564|564346522|FG001|Overall Study|Adverse Event|0|||
156341109|NCT03385564|564346523|FG002|Overall Study|Adverse Event|3|||
156341110|NCT03385564|564346524|FG003|Overall Study|Adverse Event|3|||
156341111|NCT03385564|564346521|FG000|Overall Study|Other than listed|0|||
156341112|NCT03385564|564346522|FG001|Overall Study|Other than listed|0|||
156341113|NCT03385564|564346523|FG002|Overall Study|Other than listed|0|||
156341114|NCT03385564|564346524|FG003|Overall Study|Other than listed|5|||
156341115|NCT03385564|564346521|FG000|Overall Study|Withdrawal by Subject|0|||
156341116|NCT03385564|564346522|FG001|Overall Study|Withdrawal by Subject|1|||
156341117|NCT03385564|564346523|FG002|Overall Study|Withdrawal by Subject|1|||
156341118|NCT03385564|564346524|FG003|Overall Study|Withdrawal by Subject|0|||
156341119|NCT03385564|564346521|FG000|Overall Study|Lack of Efficacy|0|||
156341120|NCT03385564|564346522|FG001|Overall Study|Lack of Efficacy|0|||
156341121|NCT03385564|564346523|FG002|Overall Study|Lack of Efficacy|0|||
156341122|NCT03385564|564346524|FG003|Overall Study|Lack of Efficacy|1|||
156341123|NCT03385564|564346521|FG000|Overall Study|Death|0|||
156341124|NCT03385564|564346522|FG001|Overall Study|Death|0|||
156341125|NCT03385564|564346523|FG002|Overall Study|Death|1|||
156341126|NCT03385564|564346524|FG003|Overall Study|Death|0|||
156341127|NCT00622401|564346525|FG000|Overall Study|Disease progression prior to treatment|3|||
156341128|NCT00622401|564346526|FG001|Overall Study|Disease progression prior to treatment|2|||
156341129|NCT00622401|564346527|FG002|Overall Study|Disease progression prior to treatment|0|||
156341130|NCT03087643|564346540|FG000|Overall Study|Withdrawal by Subject|2|||
156341131|NCT03087643|564346541|FG001|Overall Study|Withdrawal by Subject|4|||
156341132|NCT03087643|564346540|FG000|Overall Study|Death|2|||
156341133|NCT03087643|564346541|FG001|Overall Study|Death|2|||
156341134|NCT01546883|564346546|FG000|Overall Study|Withdrawal by Subject|3|||
156341135|NCT01546883|564346546|FG000|Overall Study|Adverse Event|4|||
156341136|NCT01546883|564346546|FG000|Overall Study|Lost to Follow-up|2|||
156341137|NCT01546883|564346546|FG000|Overall Study|early closure of study|2|||
156341138|NCT01546883|564346546|FG000|Overall Study|other unrelated illness|1|||
156341139|NCT02021773|564346547|FG000|Overall Study|Adverse Event|1|||
156341140|NCT02021773|564346548|FG001|Overall Study|Adverse Event|4|||
156341141|NCT02021773|564346549|FG002|Overall Study|Adverse Event|3|||
156341142|NCT02021773|564346547|FG000|Overall Study|Lack of Efficacy|2|||
156341143|NCT02021773|564346548|FG001|Overall Study|Lack of Efficacy|2|||
156341144|NCT02021773|564346549|FG002|Overall Study|Lack of Efficacy|2|||
156341145|NCT02021773|564346547|FG000|Overall Study|Protocol Violation|2|||
156341146|NCT02021773|564346548|FG001|Overall Study|Protocol Violation|3|||
156341147|NCT02021773|564346549|FG002|Overall Study|Protocol Violation|1|||
156341148|NCT02021773|564346547|FG000|Overall Study|Withdrawal by Subject|3|||
156341149|NCT02021773|564346548|FG001|Overall Study|Withdrawal by Subject|4|||
156341150|NCT02021773|564346549|FG002|Overall Study|Withdrawal by Subject|5|||
156341151|NCT02021773|564346547|FG000|Overall Study|Lost to Follow-up|1|||
156341152|NCT02021773|564346548|FG001|Overall Study|Lost to Follow-up|3|||
156341153|NCT02021773|564346549|FG002|Overall Study|Lost to Follow-up|0|||
156341154|NCT02021773|564346547|FG000|Overall Study|Reason not specified|3|||
156341155|NCT02021773|564346548|FG001|Overall Study|Reason not specified|0|||
156842168|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
156842169|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
156842170|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
156842171|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
156842172|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
156842173|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842174|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
156842175|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
156842176|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842177|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842178|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
156842179|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
156842180|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842181|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842182|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842183|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842184|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842185|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842186|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842187|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
156842188|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
156842189|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842190|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842191|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842192|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
156842193|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842194|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
156842195|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842196|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842197|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842198|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842199|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842200|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842201|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842202|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
156842203|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842204|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842205|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842206|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
156842207|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842208|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842209|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842210|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842211|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842212|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842213|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842214|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842215|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
156842216|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842217|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842218|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
156842219|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842220|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842221|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842222|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842223|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842224|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842225|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842226|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
156842227|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842228|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842229|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842230|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842231|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842232|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156341156|NCT02021773|564346549|FG002|Overall Study|Reason not specified|0|||
156341157|NCT02243696|564346551|FG000|Overall Study|Death|282|||
156341158|NCT02243696|564346551|FG000|Overall Study|Withdrawal by Subject|79|||
156341159|NCT02243696|564346551|FG000|Overall Study|Lost to Follow-up|57|||
156341160|NCT02243696|564346551|FG000|Overall Study|Subject No Longer has Study System|42|||
156341161|NCT02243696|564346551|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
156341162|NCT02243696|564346551|FG000|Overall Study|Study Terminated for EP PASSION|961|||
156341163|NCT00622284|564346552|FG000|Overall Study|Lack of Efficacy|45|||
156341164|NCT00622284|564346553|FG001|Overall Study|Lack of Efficacy|15|||
156341165|NCT00622284|564346552|FG000|Overall Study|Adverse Event|61|||
156341166|NCT00622284|564346553|FG001|Overall Study|Adverse Event|90|||
156341167|NCT00622284|564346552|FG000|Overall Study|Protocol Violation|12|||
156341168|NCT00622284|564346553|FG001|Overall Study|Protocol Violation|5|||
156341169|NCT00622284|564346552|FG000|Overall Study|Lost to Follow-up|11|||
156341170|NCT00622284|564346553|FG001|Overall Study|Lost to Follow-up|13|||
156341171|NCT00622284|564346552|FG000|Overall Study|Withdrawal by Subject|27|||
156341172|NCT00622284|564346553|FG001|Overall Study|Withdrawal by Subject|24|||
156341173|NCT00622284|564346552|FG000|Overall Study|Other reason (not specified)|33|||
156341174|NCT00622284|564346553|FG001|Overall Study|Other reason (not specified)|24|||
156341175|NCT02412618|564346554|FG000|Overall Study|Withdrawal by Subject|1|||
156341176|NCT02412618|564346555|FG001|Overall Study|Withdrawal by Subject|1|||
156341177|NCT02412618|564346554|FG000|Overall Study|Expulsion|1|||
156341178|NCT02412618|564346555|FG001|Overall Study|Expulsion|1|||
156341179|NCT01253408|564346556|FG000|Overall Study|Adverse Event|0|||
156341180|NCT01253408|564346557|FG001|Overall Study|Adverse Event|1|||
156341181|NCT01253408|564346558|FG002|Overall Study|Adverse Event|0|||
156341182|NCT03408483|564346559|FG000|Overall Study|Physician Decision|3|||
156341183|NCT03408483|564346560|FG001|Overall Study|Physician Decision|3|||
156341184|NCT03408483|564346559|FG000|Overall Study|Lost to Follow-up|3|||
156341185|NCT03408483|564346560|FG001|Overall Study|Lost to Follow-up|0|||
156341186|NCT00478231|564346561|FG000|Overall Study|Death|7|||
156341187|NCT00478231|564346561|FG000|Overall Study|Lack of Efficacy|47|||
156341188|NCT00478231|564346561|FG000|Overall Study|Lost to Follow-up|7|||
156341189|NCT00478231|564346561|FG000|Overall Study|Withdrawal by Subject|6|||
156341190|NCT00478231|564346561|FG000|Overall Study|Other|9|||
156341191|NCT00478231|564346561|FG000|Overall Study|Adverse Event|5|||
156341192|NCT00478231|564346561|FG000|Overall Study|Randomized, not treated|3|||
156341193|NCT01273597|564346566|FG000|Overall Study|Adverse Event|5|||
156341194|NCT01273597|564346566|FG000|Overall Study|Underwent Kidney Transplantation|2|||
156341195|NCT01273597|564346566|FG000|Overall Study|Reason Not Reported|1|||
156341196|NCT03715530|564346567|FG000|Overall Study|Lost to Follow-up|3|||
156341197|NCT03715530|564346568|FG001|Overall Study|Lost to Follow-up|1|||
156341198|NCT03715530|564346569|FG002|Overall Study|Lost to Follow-up|2|||
156341199|NCT01594762|564346570|FG000|Overall Study|Withdrawal by Subject|1|||
156341200|NCT01594762|564346571|FG001|Overall Study|Withdrawal by Subject|0|||
156341201|NCT01594762|564346570|FG000|Overall Study|Lost to Follow-up|10|||
156341202|NCT01594762|564346571|FG001|Overall Study|Lost to Follow-up|10|||
156341203|NCT01446289|564346572|FG000|Overall Study|Withdrawal by Subject|1|||
156469942|NCT05580003|564814885|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469943|NCT05580003|564814886|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469944|NCT05580003|564814887|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469945|NCT05580003|564814888|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
156469946|NCT05580003|564814889|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469947|NCT05580003|564814890|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469948|NCT05580003|564814891|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469949|NCT05580003|564814892|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156341204|NCT01446289|564346573|FG001|Overall Study|Withdrawal by Subject|0|||
156341205|NCT01446289|564346574|FG002|Overall Study|Withdrawal by Subject|1|||
156341206|NCT01446289|564346575|FG003|Overall Study|Withdrawal by Subject|0|||
156541507|NCT02953340|565075440|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
156341207|NCT02617628|564346578|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
156341208|NCT02617628|564346579|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
156341209|NCT05372419|564346590|FG000|Overall Study|Protocol Deviation|1|||
156341210|NCT05372419|564346590|FG000|Overall Study|Withdrawal by Subject|5|||
156341211|NCT05372419|564346590|FG000|Overall Study|Lost to Follow-up|7|||
156341212|NCT01648101|564348439|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
156341213|NCT01648101|564348440|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
156341214|NCT01648101|564348441|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
156341215|NCT01648101|564348439|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
156341216|NCT01648101|564348440|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
156341217|NCT01648101|564348441|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
156341218|NCT01648101|564348439|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
156341219|NCT01648101|564348440|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
156341220|NCT01648101|564348441|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
156341221|NCT01648101|564348439|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
156341222|NCT01648101|564348440|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
156341223|NCT01648101|564348441|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
156341224|NCT01648101|564348439|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
156341225|NCT01648101|564348440|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
156341226|NCT01648101|564348441|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
156341227|NCT01648101|564348439|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
156341228|NCT01648101|564348440|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
156341229|NCT01648101|564348441|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
156341230|NCT01648101|564348439|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
156341231|NCT01648101|564348440|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
156341232|NCT01648101|564348441|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
156341233|NCT01648101|564348439|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
156341234|NCT01648101|564348440|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
156341235|NCT01648101|564348441|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
156341236|NCT01648101|564348439|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
156469950|NCT05580003|564814893|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469951|NCT05580003|564814894|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469952|NCT05580003|564814895|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
156469953|NCT05580003|564814868|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469954|NCT05580003|564814869|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469955|NCT05580003|564814870|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469956|NCT05580003|564814871|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469957|NCT05580003|564814872|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156341237|NCT01648101|564348440|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
156341238|NCT01648101|564348441|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
156341239|NCT01648101|564348439|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
156341240|NCT01648101|564348440|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
156341241|NCT01648101|564348441|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
156341242|NCT01648101|564348439|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
156341243|NCT01648101|564348440|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
156341244|NCT01648101|564348441|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
156341245|NCT03311724|564348444|FG000|Overall Study|Physician Decision|0|||
156341246|NCT03311724|564348445|FG001|Overall Study|Physician Decision|0|||
156341247|NCT03311724|564348446|FG002|Overall Study|Physician Decision|0|||
156341248|NCT03311724|564348447|FG003|Overall Study|Physician Decision|1|||
156341249|NCT03311724|564348444|FG000|Overall Study|Protocol Violation|1|||
156341250|NCT03311724|564348445|FG001|Overall Study|Protocol Violation|0|||
156341251|NCT03311724|564348446|FG002|Overall Study|Protocol Violation|1|||
156341252|NCT03311724|564348447|FG003|Overall Study|Protocol Violation|0|||
156341253|NCT03311724|564348444|FG000|Overall Study|Withdrawal by Subject|1|||
156341254|NCT03311724|564348445|FG001|Overall Study|Withdrawal by Subject|1|||
156341255|NCT03311724|564348446|FG002|Overall Study|Withdrawal by Subject|0|||
156341256|NCT03311724|564348447|FG003|Overall Study|Withdrawal by Subject|0|||
156341257|NCT03311724|564348444|FG000|Overall Study|Lost to Follow-up|1|||
156341258|NCT03311724|564348445|FG001|Overall Study|Lost to Follow-up|0|||
156341259|NCT03311724|564348446|FG002|Overall Study|Lost to Follow-up|0|||
156341260|NCT03311724|564348447|FG003|Overall Study|Lost to Follow-up|0|||
156341261|NCT03311724|564348444|FG000|Overall Study|Sponsor Decision|0|||
156341262|NCT03311724|564348445|FG001|Overall Study|Sponsor Decision|0|||
156341263|NCT03311724|564348446|FG002|Overall Study|Sponsor Decision|1|||
156341264|NCT03311724|564348447|FG003|Overall Study|Sponsor Decision|0|||
156469958|NCT05580003|564814873|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469959|NCT05580003|564814874|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156541508|NCT02953340|565075439|FG000|Overall Study|Withdrawal by Subject|9|||
156541509|NCT02953340|565075440|FG001|Overall Study|Withdrawal by Subject|9|||
156541510|NCT02953340|565075439|FG000|Overall Study|Sponsor decision|0|||
156341265|NCT04487730|564348452|FG000|Overall Study|Withdrawal by Subject|3|||
156341266|NCT04487730|564348453|FG001|Overall Study|Withdrawal by Subject|1|||
156842233|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156341267|NCT04487730|564348452|FG000|Overall Study|Lost to Follow-up|0|||
156341268|NCT04487730|564348453|FG001|Overall Study|Lost to Follow-up|1|||
156341269|NCT04487730|564348452|FG000|Overall Study|Physician Decision|0|||
156341270|NCT04487730|564348453|FG001|Overall Study|Physician Decision|1|||
156541511|NCT02953340|565075440|FG001|Overall Study|Sponsor decision|2|||
156341271|NCT00907777|564348454|FG000|Overall Study|Withdrawal by Subject|0|||
156341272|NCT00907777|564348455|FG001|Overall Study|Withdrawal by Subject|1|||
156341273|NCT03364023|564348458|FG000|Overall Study|Lost to Follow-up|3|||
156341274|NCT03364023|564348458|FG000|Overall Study|Death|14|||
156341275|NCT01970397|564348459|FG000|Overall Study|Adverse Event|0|||
156341276|NCT01970397|564348460|FG001|Overall Study|Adverse Event|1|||
156341277|NCT01970397|564348459|FG000|Overall Study|Lost to Follow-up|0|||
156341278|NCT01970397|564348460|FG001|Overall Study|Lost to Follow-up|1|||
156341279|NCT01970397|564348459|FG000|Overall Study|Personal Reasons|1|||
156341280|NCT01970397|564348460|FG001|Overall Study|Personal Reasons|2|||
156341281|NCT01970397|564348459|FG000|Overall Study|Protocol Violation|1|||
156341282|NCT01970397|564348460|FG001|Overall Study|Protocol Violation|1|||
156341283|NCT01751867|564348461|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
156341284|NCT01751867|564348462|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
156341285|NCT01751867|564348461|FG000|Overall Study|Diease Progression|4|||
156341286|NCT01751867|564348462|FG001|Overall Study|Diease Progression|18|||
156341287|NCT01751867|564348461|FG000|Overall Study|Adverse Event|8|||
156341288|NCT01751867|564348462|FG001|Overall Study|Adverse Event|15|||
156341289|NCT01751867|564348461|FG000|Overall Study|Poor Compliance|0|||
156341290|NCT01751867|564348462|FG001|Overall Study|Poor Compliance|5|||
156341291|NCT01751867|564348461|FG000|Overall Study|Withdrawal by Subject|3|||
156341292|NCT01751867|564348462|FG001|Overall Study|Withdrawal by Subject|1|||
156341293|NCT01751867|564348461|FG000|Overall Study|Physician Decision|4|||
156341294|NCT01751867|564348462|FG001|Overall Study|Physician Decision|7|||
156341295|NCT01751867|564348461|FG000|Overall Study|Protocol Violation|0|||
156341296|NCT01751867|564348462|FG001|Overall Study|Protocol Violation|2|||
156341297|NCT01751867|564348461|FG000|Overall Study|Death|0|||
156341298|NCT01751867|564348462|FG001|Overall Study|Death|5|||
156341299|NCT01751867|564348461|FG000|Overall Study|Other|11|||
156341300|NCT01751867|564348462|FG001|Overall Study|Other|37|||
156341301|NCT01751867|564348461|FG000|Overall Study|Randomized but not treated.|2|||
156341302|NCT01751867|564348462|FG001|Overall Study|Randomized but not treated.|1|||
156341303|NCT01976338|564348465|FG000|Overall Study|Physician Decision|0|||
156341304|NCT01976338|564348466|FG001|Overall Study|Physician Decision|1|||
156341305|NCT01976338|564348465|FG000|Overall Study|Lost to Follow-up|3|||
156341306|NCT01976338|564348466|FG001|Overall Study|Lost to Follow-up|0|||
156341307|NCT01976338|564348465|FG000|Overall Study|Withdrawal by Subject|5|||
156341308|NCT01976338|564348466|FG001|Overall Study|Withdrawal by Subject|2|||
156341309|NCT01976338|564348465|FG000|Overall Study|Adverse Event|5|||
156341310|NCT01976338|564348466|FG001|Overall Study|Adverse Event|1|||
156341311|NCT04213079|564348467|FG000|Overall Study|Lost to Follow-up|0|||
156341312|NCT04213079|564348468|FG001|Overall Study|Lost to Follow-up|2|||
156341313|NCT00587054|564348472|FG000|Overall Study|Patient not treated|9|||
156341314|NCT01471171|564348474|FG000|Treatment Period 1|Adverse Event|4|||
156341315|NCT01471171|564348475|FG001|Treatment Period 1|Adverse Event|1|||
156341316|NCT01471171|564348474|FG000|Treatment Period 2|Adverse Event|1|||
156341317|NCT01471171|564348475|FG001|Treatment Period 2|Adverse Event|0|||
156469960|NCT05580003|564814875|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469961|NCT05580003|564814876|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469962|NCT05580003|564814877|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469963|NCT05580003|564814878|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469964|NCT05580003|564814879|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469965|NCT05580003|564814880|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469966|NCT05580003|564814881|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469967|NCT05580003|564814882|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469968|NCT05580003|564814883|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469969|NCT05580003|564814884|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469970|NCT05580003|564814885|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469971|NCT05580003|564814886|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469972|NCT05580003|564814887|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156842234|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156341318|NCT02864498|564348476|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
156341319|NCT02864498|564348477|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
156842235|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156341320|NCT02864498|564348478|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
156341321|NCT02864498|564348476|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
156341322|NCT02864498|564348477|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
156341323|NCT02864498|564348478|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
156341324|NCT02864498|564348476|FG000|Overall Study|Investigator Discretion|0|||
156341325|NCT02864498|564348477|FG001|Overall Study|Investigator Discretion|2|||
156341326|NCT02864498|564348478|FG002|Overall Study|Investigator Discretion|1|||
156842236|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156341327|NCT02864498|564348476|FG000|Overall Study|Lost to Follow-up|8|||
156341328|NCT02864498|564348477|FG001|Overall Study|Lost to Follow-up|6|||
156341329|NCT02864498|564348478|FG002|Overall Study|Lost to Follow-up|3|||
156842237|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842238|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
156842239|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842240|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842241|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842242|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842243|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842244|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842245|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842246|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842247|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842248|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842249|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842250|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842251|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842252|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842253|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842254|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842255|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842256|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842257|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
156842258|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842259|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842260|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842261|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842262|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842263|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842264|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842265|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842266|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842267|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842268|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842269|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842270|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842271|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842272|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842273|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842274|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
156842275|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
156842276|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
156842277|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842278|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842279|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842280|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842281|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842282|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842283|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842284|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842285|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842286|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842287|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
156842288|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
156842289|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842290|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842291|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842292|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842293|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842294|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842295|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842296|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842297|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842298|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842299|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
156842300|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
156842301|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842302|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
156842303|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842304|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842305|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842306|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842307|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842308|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842309|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842310|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842311|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842312|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842313|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
156842314|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842315|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842316|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842317|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156469973|NCT05580003|564814888|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469974|NCT05580003|564814889|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
156842318|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842319|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842320|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842321|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842322|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156541512|NCT02953340|565075439|FG000|Overall Study|Lost to Follow-up|3|||
156469975|NCT05580003|564814890|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156341330|NCT02864498|564348476|FG000|Overall Study|Lack of Efficacy|5|||
156341331|NCT02864498|564348477|FG001|Overall Study|Lack of Efficacy|3|||
156341332|NCT02864498|564348478|FG002|Overall Study|Lack of Efficacy|3|||
156341333|NCT02864498|564348476|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
156341334|NCT02864498|564348477|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
156341335|NCT02864498|564348478|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
156341336|NCT02864498|564348476|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
156341337|NCT02864498|564348477|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
156341338|NCT02864498|564348478|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
156341339|NCT02864498|564348476|FG000|Overall Study|Subject moved out of the country.|0|||
156341340|NCT02864498|564348477|FG001|Overall Study|Subject moved out of the country.|0|||
156341341|NCT02864498|564348478|FG002|Overall Study|Subject moved out of the country.|1|||
156341342|NCT00407797|564348479|FG000|Overall Study|Lost to Follow-up|2|||
156341343|NCT00407797|564348479|FG000|Overall Study|Adverse Event|6|||
156341344|NCT00407797|564348479|FG000|Overall Study|Other|7|||
156341345|NCT00407797|564348479|FG000|Overall Study|Withdrawal by Subject|3|||
156341346|NCT01812174|564348480|FG000|Overall Study|Death|1|||
156341347|NCT01812174|564348481|FG001|Overall Study|Death|0|||
156341348|NCT01812174|564348480|FG000|Overall Study|Protocol Violation|2|||
156341349|NCT01812174|564348481|FG001|Overall Study|Protocol Violation|0|||
156341350|NCT00555971|564348483|FG000|Overall Study|Adverse Event|1|||
156341351|NCT00555971|564348484|FG001|Overall Study|Adverse Event|1|||
156341352|NCT05469178|564348485|FG000|Overall Study|Death|1|||
156341353|NCT05469178|564348486|FG001|Overall Study|Death|1|||
156341354|NCT05469178|564348487|FG002|Overall Study|Death|3|||
156341355|NCT05469178|564348488|FG003|Overall Study|Death|6|||
156341356|NCT05469178|564348485|FG000|Overall Study|Lack of Efficacy|2|||
156341357|NCT05469178|564348486|FG001|Overall Study|Lack of Efficacy|2|||
156341358|NCT05469178|564348487|FG002|Overall Study|Lack of Efficacy|1|||
156341359|NCT05469178|564348488|FG003|Overall Study|Lack of Efficacy|10|||
156341360|NCT05393895|564348489|FG000|Overall Study|Adverse Event|2|||
156341361|NCT05393895|564348490|FG001|Overall Study|Adverse Event|3|||
156341362|NCT05393895|564348489|FG000|Overall Study|Lost to Follow-up|4|||
156341363|NCT05393895|564348490|FG001|Overall Study|Lost to Follow-up|3|||
156842323|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842324|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842325|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156341364|NCT05393895|564348489|FG000|Overall Study|Protocol Violation|1|||
156341365|NCT05393895|564348490|FG001|Overall Study|Protocol Violation|0|||
156341366|NCT05393895|564348489|FG000|Overall Study|Withdrawal by Subject|1|||
156341367|NCT05393895|564348490|FG001|Overall Study|Withdrawal by Subject|4|||
156341368|NCT02083783|564348491|FG000|Overall Study|Withdrawal by Subject|1|||
156341369|NCT02083783|564348492|FG001|Overall Study|Withdrawal by Subject|0|||
156341370|NCT02256631|564348495|FG000|Overall Study|Lost to Follow-up|1|||
156341371|NCT02256631|564348496|FG001|Overall Study|Lost to Follow-up|1|||
156341372|NCT02256631|564348497|FG002|Overall Study|Lost to Follow-up|0|||
156341373|NCT02256631|564348498|FG003|Overall Study|Lost to Follow-up|2|||
156341374|NCT02256631|564348499|FG004|Overall Study|Lost to Follow-up|0|||
156341375|NCT02256631|564348500|FG005|Overall Study|Lost to Follow-up|4|||
156341376|NCT02256631|564348501|FG006|Overall Study|Lost to Follow-up|1|||
156341377|NCT02256631|564348495|FG000|Overall Study|Withdrawal by Subject|0|||
156341378|NCT02256631|564348496|FG001|Overall Study|Withdrawal by Subject|0|||
156341379|NCT02256631|564348497|FG002|Overall Study|Withdrawal by Subject|0|||
156341380|NCT02256631|564348498|FG003|Overall Study|Withdrawal by Subject|1|||
156341381|NCT02256631|564348499|FG004|Overall Study|Withdrawal by Subject|1|||
156341382|NCT02256631|564348500|FG005|Overall Study|Withdrawal by Subject|0|||
156341383|NCT02256631|564348501|FG006|Overall Study|Withdrawal by Subject|1|||
156341384|NCT02256631|564348495|FG000|Overall Study|Unable to get to clinic|0|||
156469976|NCT05580003|564814891|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469977|NCT05580003|564814892|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156469978|NCT05580003|564814893|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156842326|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842327|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156341385|NCT02256631|564348496|FG001|Overall Study|Unable to get to clinic|2|||
156341386|NCT02256631|564348497|FG002|Overall Study|Unable to get to clinic|0|||
156469979|NCT05580003|564814894|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156842328|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
156842329|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842330|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156341387|NCT02256631|564348498|FG003|Overall Study|Unable to get to clinic|1|||
156341388|NCT02256631|564348499|FG004|Overall Study|Unable to get to clinic|0|||
156341389|NCT02256631|564348500|FG005|Overall Study|Unable to get to clinic|1|||
156341390|NCT02256631|564348501|FG006|Overall Study|Unable to get to clinic|2|||
156341391|NCT01427972|564348502|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156842331|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842332|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842333|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842334|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842335|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842336|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842337|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842338|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
156842339|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842340|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842341|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842342|NCT03671304|566174221|FG000|Overall Study|study terminated|7|||
156842343|NCT00596830|566174226|FG000|Overall Study|Death|258|||
156842344|NCT00596830|566174227|FG001|Overall Study|Death|247|||
156842345|NCT00596830|566174226|FG000|Overall Study|Lost to Follow-up|7|||
156842346|NCT00596830|566174227|FG001|Overall Study|Lost to Follow-up|11|||
156842347|NCT00596830|566174226|FG000|Overall Study|Withdrawal by Subject|22|||
156842348|NCT00596830|566174227|FG001|Overall Study|Withdrawal by Subject|12|||
156842349|NCT00596830|566174226|FG000|Overall Study|Study terminated by sponsor|51|||
156842350|NCT00596830|566174227|FG001|Overall Study|Study terminated by sponsor|62|||
156842351|NCT00596830|566174226|FG000|Overall Study|Follow-up was discontinued|1|||
156842352|NCT00596830|566174227|FG001|Overall Study|Follow-up was discontinued|0|||
156842353|NCT00596830|566174226|FG000|Overall Study|Randomized but not treated|3|||
156842354|NCT00596830|566174227|FG001|Overall Study|Randomized but not treated|7|||
156842355|NCT00887926|566174228|FG000|Overall Study|Withdrawal by Subject|0|||
156842356|NCT00887926|566174229|FG001|Overall Study|Withdrawal by Subject|1|||
156842357|NCT00887926|566174230|FG002|Overall Study|Withdrawal by Subject|0|||
156842358|NCT00887926|566174231|FG003|Overall Study|Withdrawal by Subject|0|||
156842359|NCT02097030|566174232|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
156842360|NCT02097030|566174233|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
156842361|NCT02097030|566174232|FG000|First Intervention (3 Days)|Visual Acuity|0|||
156842362|NCT02097030|566174233|FG001|First Intervention (3 Days)|Visual Acuity|1|||
156842363|NCT04869358|566174234|FG000|Overall Study|Wish to have children.|1|||
156842364|NCT04869358|566174235|FG001|Overall Study|Wish to have children.|0|||
156842365|NCT04869358|566174236|FG002|Overall Study|Wish to have children.|0|||
156842366|NCT04869358|566174237|FG003|Overall Study|Wish to have children.|0|||
156842367|NCT01336023|566174239|FG000|Week 0 to Week 26|Adverse Event|8|||
156842368|NCT01336023|566174240|FG001|Week 0 to Week 26|Adverse Event|10|||
156842369|NCT01336023|566174241|FG002|Week 0 to Week 26|Adverse Event|24|||
156842370|NCT01336023|566174239|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
156842371|NCT01336023|566174240|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
156842372|NCT01336023|566174241|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
156842373|NCT01336023|566174239|FG000|Week 0 to Week 26|Protocol Violation|1|||
156842374|NCT01336023|566174240|FG001|Week 0 to Week 26|Protocol Violation|2|||
156842375|NCT01336023|566174241|FG002|Week 0 to Week 26|Protocol Violation|0|||
156842376|NCT01336023|566174239|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
156842377|NCT01336023|566174240|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
156842378|NCT01336023|566174241|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
156842379|NCT01336023|566174239|FG000|Week 0 to Week 26|Unclassified|5|||
156842380|NCT01336023|566174240|FG001|Week 0 to Week 26|Unclassified|16|||
156842381|NCT01336023|566174241|FG002|Week 0 to Week 26|Unclassified|9|||
156842382|NCT01336023|566174239|FG000|Week 27 to 52|Adverse Event|1|||
156842383|NCT01336023|566174240|FG001|Week 27 to 52|Adverse Event|5|||
156842384|NCT01336023|566174241|FG002|Week 27 to 52|Adverse Event|2|||
156341392|NCT01427972|564348503|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156341393|NCT01427972|564348504|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156341394|NCT01427972|564348505|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156842385|NCT01336023|566174239|FG000|Week 27 to 52|Protocol Violation|0|||
156842386|NCT01336023|566174240|FG001|Week 27 to 52|Protocol Violation|2|||
156842387|NCT01336023|566174241|FG002|Week 27 to 52|Protocol Violation|1|||
156842388|NCT01336023|566174239|FG000|Week 27 to 52|Withdrawal Criteria|14|||
156842389|NCT01336023|566174240|FG001|Week 27 to 52|Withdrawal Criteria|19|||
156842390|NCT01336023|566174241|FG002|Week 27 to 52|Withdrawal Criteria|16|||
156842391|NCT01336023|566174239|FG000|Week 27 to 52|Unclassified|13|||
156842392|NCT01336023|566174240|FG001|Week 27 to 52|Unclassified|18|||
156842393|NCT01336023|566174241|FG002|Week 27 to 52|Unclassified|9|||
156341395|NCT01427972|564348506|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156842394|NCT01894022|566174244|FG000|Overall Study|Death|1|||
156842395|NCT01894022|566174245|FG001|Overall Study|Death|0|||
156842396|NCT01894022|566174244|FG000|Overall Study|Adverse Event, non-fatal|1|||
156842397|NCT01894022|566174245|FG001|Overall Study|Adverse Event, non-fatal|0|||
156842398|NCT01894022|566174244|FG000|Overall Study|Study Closed/terminated|7|||
156842399|NCT01894022|566174245|FG001|Overall Study|Study Closed/terminated|10|||
156842400|NCT00235716|566174248|FG000|Overall Study|Death|26|||
156341396|NCT01427972|564348507|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156341397|NCT01427972|564348508|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156341398|NCT01427972|564348509|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
156341399|NCT01427972|564348510|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156341400|NCT01427972|564348511|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156341401|NCT01427972|564348512|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156341402|NCT01427972|564348513|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156469980|NCT05580003|564814895|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156842401|NCT00235716|566174249|FG001|Overall Study|Death|39|||
156842402|NCT00235716|566174250|FG002|Overall Study|Death|32|||
156842403|NCT00235716|566174251|FG003|Overall Study|Death|31|||
156341403|NCT01427972|564348502|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341404|NCT01427972|564348503|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341405|NCT01427972|564348504|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341406|NCT01427972|564348505|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341407|NCT01427972|564348506|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341408|NCT01427972|564348507|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
156341409|NCT01427972|564348508|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341410|NCT01427972|564348509|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341411|NCT01427972|564348510|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341412|NCT01427972|564348511|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341413|NCT01427972|564348512|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341414|NCT01427972|564348513|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156341415|NCT01427972|564348502|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341416|NCT01427972|564348503|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
156341417|NCT01427972|564348504|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341418|NCT01427972|564348505|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341419|NCT01427972|564348506|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341420|NCT01427972|564348507|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341421|NCT01427972|564348508|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341422|NCT01427972|564348509|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341423|NCT01427972|564348510|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341424|NCT01427972|564348511|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341425|NCT01427972|564348512|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341426|NCT01427972|564348513|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156341427|NCT00530946|564348514|FG000|Overall Study|Adverse Event|1|||
156341428|NCT00530946|564348515|FG001|Overall Study|Adverse Event|2|||
156341429|NCT00530946|564348516|FG002|Overall Study|Adverse Event|1|||
156341430|NCT00530946|564348517|FG003|Overall Study|Adverse Event|1|||
156341431|NCT00530946|564348514|FG000|Overall Study|Protocol Violation|0|||
156341432|NCT00530946|564348515|FG001|Overall Study|Protocol Violation|0|||
156341433|NCT00530946|564348516|FG002|Overall Study|Protocol Violation|0|||
156341434|NCT00530946|564348517|FG003|Overall Study|Protocol Violation|1|||
156341435|NCT00530946|564348514|FG000|Overall Study|Noncompliance|1|||
156341436|NCT00530946|564348515|FG001|Overall Study|Noncompliance|0|||
156341437|NCT00530946|564348516|FG002|Overall Study|Noncompliance|0|||
156341438|NCT00530946|564348517|FG003|Overall Study|Noncompliance|0|||
156341439|NCT01534962|564348518|FG000|Overall Study|Randomized but did not start treatment|2|||
156341440|NCT01534962|564348519|FG001|Overall Study|Randomized but did not start treatment|0|||
156341441|NCT01534962|564348520|FG002|Overall Study|Randomized but did not start treatment|0|||
156341442|NCT01534962|564348521|FG003|Overall Study|Randomized but did not start treatment|1|||
156341443|NCT01534962|564348518|FG000|Overall Study|Discontinued at AF recurrence|35|||
156341444|NCT01534962|564348519|FG001|Overall Study|Discontinued at AF recurrence|26|||
156341445|NCT01534962|564348520|FG002|Overall Study|Discontinued at AF recurrence|24|||
156341446|NCT01534962|564348521|FG003|Overall Study|Discontinued at AF recurrence|31|||
156341447|NCT04545385|564348526|FG000|Overall Study|Withdrawal by Subject|2|||
156341448|NCT04545385|564348527|FG001|Overall Study|Withdrawal by Subject|0|||
156341449|NCT04545385|564348526|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
156842404|NCT00235716|566174248|FG000|Overall Study|Withdrawal by Subject|23|||
156842405|NCT00235716|566174249|FG001|Overall Study|Withdrawal by Subject|19|||
156842406|NCT00235716|566174250|FG002|Overall Study|Withdrawal by Subject|17|||
156842407|NCT00235716|566174251|FG003|Overall Study|Withdrawal by Subject|18|||
156842408|NCT00235716|566174248|FG000|Overall Study|Lost to Follow-up|12|||
156842409|NCT00235716|566174249|FG001|Overall Study|Lost to Follow-up|7|||
156842410|NCT00235716|566174250|FG002|Overall Study|Lost to Follow-up|14|||
156842411|NCT00235716|566174251|FG003|Overall Study|Lost to Follow-up|10|||
156842412|NCT00235716|566174248|FG000|Overall Study|Adverse Event|1|||
156341450|NCT04545385|564348527|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
156341451|NCT04545385|564348526|FG000|Overall Study|Study termination|10|||
156341452|NCT04545385|564348527|FG001|Overall Study|Study termination|10|||
156842413|NCT00235716|566174249|FG001|Overall Study|Adverse Event|1|||
156842414|NCT00235716|566174250|FG002|Overall Study|Adverse Event|1|||
156842415|NCT00235716|566174251|FG003|Overall Study|Adverse Event|0|||
156842416|NCT00235716|566174248|FG000|Overall Study|Physician Decision|0|||
156842417|NCT00235716|566174249|FG001|Overall Study|Physician Decision|1|||
156842418|NCT00235716|566174250|FG002|Overall Study|Physician Decision|1|||
156842419|NCT00235716|566174251|FG003|Overall Study|Physician Decision|3|||
156842420|NCT01545050|566174252|FG000|Overall Study|Lack of Efficacy|0|||
156842421|NCT01545050|566174253|FG001|Overall Study|Lack of Efficacy|0|||
156842422|NCT01545050|566174254|FG002|Overall Study|Lack of Efficacy|0|||
156842423|NCT01545050|566174255|FG003|Overall Study|Lack of Efficacy|3|||
156842424|NCT01545050|566174256|FG004|Overall Study|Lack of Efficacy|2|||
156842425|NCT01545050|566174252|FG000|Overall Study|Adverse Event|1|||
156842426|NCT01545050|566174253|FG001|Overall Study|Adverse Event|1|||
156842427|NCT01545050|566174254|FG002|Overall Study|Adverse Event|2|||
156842428|NCT01545050|566174255|FG003|Overall Study|Adverse Event|2|||
156842429|NCT01545050|566174256|FG004|Overall Study|Adverse Event|0|||
156842430|NCT01545050|566174252|FG000|Overall Study|Discontinued study treatment|1|||
156842431|NCT01545050|566174253|FG001|Overall Study|Discontinued study treatment|0|||
156842432|NCT01545050|566174254|FG002|Overall Study|Discontinued study treatment|0|||
156842433|NCT01545050|566174255|FG003|Overall Study|Discontinued study treatment|0|||
156842434|NCT01545050|566174256|FG004|Overall Study|Discontinued study treatment|0|||
156842435|NCT01545050|566174252|FG000|Overall Study|Withdrawal by Subject|1|||
156842436|NCT01545050|566174253|FG001|Overall Study|Withdrawal by Subject|0|||
156842437|NCT01545050|566174254|FG002|Overall Study|Withdrawal by Subject|0|||
156842438|NCT01545050|566174255|FG003|Overall Study|Withdrawal by Subject|2|||
156842439|NCT01545050|566174256|FG004|Overall Study|Withdrawal by Subject|1|||
156842440|NCT01545050|566174252|FG000|Overall Study|Participant no longer meets study criteria|0|||
156842441|NCT01545050|566174253|FG001|Overall Study|Participant no longer meets study criteria|2|||
156842442|NCT01545050|566174254|FG002|Overall Study|Participant no longer meets study criteria|0|||
156842443|NCT01545050|566174255|FG003|Overall Study|Participant no longer meets study criteria|0|||
156842444|NCT01545050|566174256|FG004|Overall Study|Participant no longer meets study criteria|1|||
156842445|NCT01545050|566174252|FG000|Overall Study|Administrative reason by sponsor|4|||
156842446|NCT01545050|566174253|FG001|Overall Study|Administrative reason by sponsor|2|||
156842447|NCT01545050|566174254|FG002|Overall Study|Administrative reason by sponsor|3|||
156842448|NCT01545050|566174255|FG003|Overall Study|Administrative reason by sponsor|5|||
156842449|NCT01545050|566174256|FG004|Overall Study|Administrative reason by sponsor|5|||
156842450|NCT03235089|566174257|FG000|Overall Study|Lost to Follow-up|1|||
156842451|NCT03235089|566174258|FG001|Overall Study|Lost to Follow-up|1|||
156842452|NCT03235089|566174257|FG000|Overall Study|Physician Decision|2|||
156842453|NCT03235089|566174258|FG001|Overall Study|Physician Decision|2|||
156842454|NCT01364389|566174259|FG000|Overall Study|Withdrawal by Subject|0|||
156842455|NCT01364389|566174260|FG001|Overall Study|Withdrawal by Subject|1|||
156842456|NCT01364389|566174261|FG002|Overall Study|Withdrawal by Subject|0|||
156842457|NCT01364389|566174259|FG000|Overall Study|Protocol deviation|0|||
156842458|NCT01364389|566174260|FG001|Overall Study|Protocol deviation|0|||
156842459|NCT01364389|566174261|FG002|Overall Study|Protocol deviation|1|||
156842460|NCT01364389|566174259|FG000|Overall Study|Administrative problems|1|||
156842461|NCT01364389|566174260|FG001|Overall Study|Administrative problems|0|||
156842462|NCT01364389|566174261|FG002|Overall Study|Administrative problems|0|||
156842463|NCT01364389|566174259|FG000|Overall Study|Adverse Event|1|||
156842464|NCT01364389|566174260|FG001|Overall Study|Adverse Event|0|||
156842465|NCT01364389|566174261|FG002|Overall Study|Adverse Event|0|||
156842466|NCT01534195|566174262|FG000|Overall Study|Withdrawal by Subject|1|||
156842467|NCT01534195|566174263|FG001|Overall Study|Withdrawal by Subject|1|||
156842468|NCT00629798|566174266|FG000|Overall Study|Not Treated|4|||
156842469|NCT02554981|566174267|FG000|Overall Study|Adverse Event|1|||
156842470|NCT02554981|566174267|FG000|Overall Study|Administrative Reasons|1|||
156842471|NCT02554981|566174267|FG000|Overall Study|Other Miscellaneous Reasons|3|||
156842472|NCT03043651|566174273|FG000|Overall Study|Death|1|||
156842473|NCT03043651|566174273|FG000|Overall Study|Progressive Disease|2|||
156842474|NCT03043651|566174273|FG000|Overall Study|Adverse Event|2|||
156842475|NCT03043651|566174273|FG000|Overall Study|Withdrawal by Subject|4|||
156842476|NCT03043651|566174273|FG000|Overall Study|Study Terminated by Sponsor|39|||
156842477|NCT01630889|566174274|FG000|Overall Study|Death|2|||
156842478|NCT01630889|566174274|FG000|Overall Study|Withdrawal by Subject|1|||
156842479|NCT01630889|566174274|FG000|Overall Study|Other than Specified|2|||
156842480|NCT01630889|566174274|FG000|Overall Study|Lost to Follow-up|4|||
156842481|NCT01630889|566174274|FG000|Overall Study|Other|1|||
156842482|NCT02980133|566174275|FG000|Overall Study|Other than specified|1|||
156842483|NCT02980133|566174276|FG001|Overall Study|Other than specified|1|||
156842484|NCT02980133|566174277|FG002|Overall Study|Other than specified|2|||
156842485|NCT02980133|566174278|FG003|Overall Study|Other than specified|2|||
156842486|NCT02980133|566174275|FG000|Overall Study|Lost to Follow-up|0|||
156842487|NCT02980133|566174276|FG001|Overall Study|Lost to Follow-up|0|||
156842488|NCT02980133|566174277|FG002|Overall Study|Lost to Follow-up|1|||
156842489|NCT02980133|566174278|FG003|Overall Study|Lost to Follow-up|3|||
156842490|NCT02980133|566174275|FG000|Overall Study|Protocol Violation|0|||
156842491|NCT02980133|566174276|FG001|Overall Study|Protocol Violation|1|||
156842492|NCT02980133|566174277|FG002|Overall Study|Protocol Violation|0|||
156842493|NCT02980133|566174278|FG003|Overall Study|Protocol Violation|0|||
156842494|NCT02980133|566174275|FG000|Overall Study|Withdrawal by parent/guardian|6|||
156842495|NCT02980133|566174276|FG001|Overall Study|Withdrawal by parent/guardian|3|||
156341453|NCT04545385|564348526|FG000|Overall Study|Sponsor decision|2|||
156341454|NCT04545385|564348527|FG001|Overall Study|Sponsor decision|2|||
156341455|NCT04545385|564348526|FG000|Overall Study|Other than specified|1|||
156341456|NCT04545385|564348527|FG001|Overall Study|Other than specified|0|||
156341457|NCT01128842|564348532|FG000|Overall Study|Adverse Event|1|||
156341458|NCT01128842|564348532|FG000|Overall Study|Disease Progression|6|||
156341459|NCT03322631|564348533|FG000|Overall Study|Withdrawal by Subject|0|||
156341460|NCT03322631|564348534|FG001|Overall Study|Withdrawal by Subject|1|||
156341461|NCT03322631|564348535|FG002|Overall Study|Withdrawal by Subject|0|||
156341462|NCT03322631|564348536|FG003|Overall Study|Withdrawal by Subject|0|||
156341463|NCT03322631|564348533|FG000|Overall Study|Adverse Event|0|||
156341464|NCT03322631|564348534|FG001|Overall Study|Adverse Event|0|||
156341465|NCT03322631|564348535|FG002|Overall Study|Adverse Event|1|||
156341466|NCT03322631|564348536|FG003|Overall Study|Adverse Event|0|||
156341467|NCT02378961|564348537|FG000|Overall Study|Lack of Efficacy|4|||
156341468|NCT02378961|564348538|FG001|Overall Study|Lack of Efficacy|2|||
156341469|NCT02378961|564348539|FG002|Overall Study|Lack of Efficacy|0|||
156341470|NCT02378961|564348540|FG003|Overall Study|Lack of Efficacy|1|||
156341471|NCT02378961|564348537|FG000|Overall Study|Death|0|||
156341472|NCT02378961|564348538|FG001|Overall Study|Death|0|||
156341473|NCT02378961|564348539|FG002|Overall Study|Death|1|||
156341474|NCT02378961|564348540|FG003|Overall Study|Death|0|||
156341475|NCT04528732|564348548|FG000|Overall Study|Death|1|||
156341476|NCT04528732|564348549|FG001|Overall Study|Death|0|||
156341477|NCT04528732|564348550|FG002|Overall Study|Death|1|||
156341478|NCT04528732|564348548|FG000|Overall Study|Lost to Follow-up|0|||
156341479|NCT04528732|564348549|FG001|Overall Study|Lost to Follow-up|1|||
156341480|NCT04528732|564348550|FG002|Overall Study|Lost to Follow-up|2|||
156341481|NCT05399641|564348551|FG000|Overall Study|Adverse Event|0|||
156341482|NCT05399641|564348552|FG001|Overall Study|Adverse Event|1|||
156341483|NCT05399641|564348553|FG002|Overall Study|Adverse Event|1|||
156341484|NCT05399641|564348551|FG000|Overall Study|Lost to Follow-up|1|||
156341485|NCT05399641|564348552|FG001|Overall Study|Lost to Follow-up|2|||
156341486|NCT05399641|564348553|FG002|Overall Study|Lost to Follow-up|2|||
156341487|NCT05399641|564348551|FG000|Overall Study|Physician Decision|1|||
156341488|NCT05399641|564348552|FG001|Overall Study|Physician Decision|3|||
156341489|NCT05399641|564348553|FG002|Overall Study|Physician Decision|3|||
156341490|NCT05399641|564348551|FG000|Overall Study|Withdrawal by Subject|4|||
156341491|NCT05399641|564348552|FG001|Overall Study|Withdrawal by Subject|11|||
156341492|NCT05399641|564348553|FG002|Overall Study|Withdrawal by Subject|7|||
156341493|NCT05399641|564348551|FG000|Overall Study|Reason not defined|3|||
156341494|NCT05399641|564348552|FG001|Overall Study|Reason not defined|5|||
156341495|NCT05399641|564348553|FG002|Overall Study|Reason not defined|6|||
156341496|NCT02094677|564348554|FG000|Overall Study|Screening|3|||
156341497|NCT02094677|564348555|FG001|Overall Study|Screening|1|||
156341498|NCT01300650|564348556|FG000|Overall Study|Adverse Event|1|||
156341499|NCT04967443|564348563|FG000|Open Label Treatment|Death|1|||
156341500|NCT04967443|564348564|FG001|Open Label Treatment|Death|0|||
156341501|NCT04967443|564348565|FG002|Open Label Treatment|Death|0|||
156842496|NCT02980133|566174277|FG002|Overall Study|Withdrawal by parent/guardian|3|||
156341502|NCT04967443|564348566|FG003|Open Label Treatment|Death|0|||
156341503|NCT04967443|564348567|FG004|Open Label Treatment|Death|0|||
156341504|NCT04967443|564348568|FG005|Open Label Treatment|Death|0|||
156341505|NCT04967443|564348569|FG006|Open Label Treatment|Death|0|||
156341506|NCT04967443|564348570|FG007|Open Label Treatment|Death|0|||
156341507|NCT04967443|564348563|FG000|Open Label Treatment|Lost to Follow-up|0|||
156341508|NCT04967443|564348564|FG001|Open Label Treatment|Lost to Follow-up|0|||
156341509|NCT04967443|564348565|FG002|Open Label Treatment|Lost to Follow-up|1|||
156341510|NCT04967443|564348566|FG003|Open Label Treatment|Lost to Follow-up|0|||
156341511|NCT04967443|564348567|FG004|Open Label Treatment|Lost to Follow-up|0|||
156341512|NCT04967443|564348568|FG005|Open Label Treatment|Lost to Follow-up|0|||
156341513|NCT04967443|564348569|FG006|Open Label Treatment|Lost to Follow-up|0|||
156341514|NCT04967443|564348570|FG007|Open Label Treatment|Lost to Follow-up|0|||
156341515|NCT04967443|564348563|FG000|Open Label Treatment|Withdrawal by Subject|0|||
156341516|NCT04967443|564348564|FG001|Open Label Treatment|Withdrawal by Subject|1|||
156341517|NCT04967443|564348565|FG002|Open Label Treatment|Withdrawal by Subject|0|||
156341518|NCT04967443|564348566|FG003|Open Label Treatment|Withdrawal by Subject|1|||
156842497|NCT02980133|566174278|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156341519|NCT04967443|564348567|FG004|Open Label Treatment|Withdrawal by Subject|0|||
156341520|NCT04967443|564348568|FG005|Open Label Treatment|Withdrawal by Subject|1|||
156341521|NCT04967443|564348569|FG006|Open Label Treatment|Withdrawal by Subject|2|||
156341522|NCT04967443|564348570|FG007|Open Label Treatment|Withdrawal by Subject|3|||
156341523|NCT04967443|564348563|FG000|Follow-Up|Death|1|||
156341524|NCT04967443|564348564|FG001|Follow-Up|Death|0|||
156341525|NCT04967443|564348565|FG002|Follow-Up|Death|0|||
156341526|NCT04967443|564348566|FG003|Follow-Up|Death|0|||
156341527|NCT04967443|564348567|FG004|Follow-Up|Death|0|||
156341528|NCT04967443|564348568|FG005|Follow-Up|Death|0|||
156341529|NCT04967443|564348569|FG006|Follow-Up|Death|0|||
156341530|NCT04967443|564348570|FG007|Follow-Up|Death|0|||
156341531|NCT04967443|564348563|FG000|Follow-Up|Lost to Follow-up|0|||
156341532|NCT04967443|564348564|FG001|Follow-Up|Lost to Follow-up|0|||
156341533|NCT04967443|564348565|FG002|Follow-Up|Lost to Follow-up|1|||
156341534|NCT04967443|564348566|FG003|Follow-Up|Lost to Follow-up|1|||
156341535|NCT04967443|564348567|FG004|Follow-Up|Lost to Follow-up|0|||
156341536|NCT04967443|564348568|FG005|Follow-Up|Lost to Follow-up|0|||
156341537|NCT04967443|564348569|FG006|Follow-Up|Lost to Follow-up|0|||
156341538|NCT04967443|564348570|FG007|Follow-Up|Lost to Follow-up|0|||
156341539|NCT04967443|564348563|FG000|Follow-Up|Withdrawal by Subject|0|||
156341540|NCT04967443|564348564|FG001|Follow-Up|Withdrawal by Subject|1|||
156341541|NCT04967443|564348565|FG002|Follow-Up|Withdrawal by Subject|0|||
156341542|NCT04967443|564348566|FG003|Follow-Up|Withdrawal by Subject|1|||
156341543|NCT04967443|564348567|FG004|Follow-Up|Withdrawal by Subject|0|||
156341544|NCT04967443|564348568|FG005|Follow-Up|Withdrawal by Subject|1|||
156341545|NCT04967443|564348569|FG006|Follow-Up|Withdrawal by Subject|2|||
156341546|NCT04967443|564348570|FG007|Follow-Up|Withdrawal by Subject|3|||
156341547|NCT02405780|564348571|FG000|Period I|Adverse Event|8|||
156341548|NCT02405780|564348572|FG001|Period I|Adverse Event|0|||
156341549|NCT02405780|564348573|FG002|Period I|Adverse Event|3|||
156469981|NCT05580003|564814868|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469982|NCT05580003|564814869|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469983|NCT05580003|564814870|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469984|NCT05580003|564814871|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469985|NCT05580003|564814872|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156842498|NCT02980133|566174275|FG000|Overall Study|Withdrawal by Subject|0|||
156842499|NCT02980133|566174276|FG001|Overall Study|Withdrawal by Subject|0|||
156842500|NCT02980133|566174277|FG002|Overall Study|Withdrawal by Subject|1|||
156842501|NCT02980133|566174278|FG003|Overall Study|Withdrawal by Subject|0|||
156842502|NCT02974842|566174279|FG000|Overall Study|Withdrawal by Subject|4|||
156842503|NCT02974842|566174279|FG000|Overall Study|Screen failures|4|||
156842504|NCT01068158|566174289|FG000|Overall Study|Withdrawal by Subject|1|||
156842505|NCT01068158|566174290|FG001|Overall Study|Withdrawal by Subject|2|||
156842506|NCT01068158|566174289|FG000|Overall Study|Lost to Follow-up|7|||
156842507|NCT01068158|566174290|FG001|Overall Study|Lost to Follow-up|0|||
156842508|NCT01068158|566174289|FG000|Overall Study|Protocol Violation|0|||
156842509|NCT01068158|566174290|FG001|Overall Study|Protocol Violation|2|||
156842510|NCT01959243|566174297|FG000|Overall Study|Investigator Decision|3|||
156842511|NCT01959243|566174298|FG001|Overall Study|Investigator Decision|0|||
156842512|NCT01959243|566174297|FG000|Overall Study|Adverse Event|5|||
156842513|NCT01959243|566174298|FG001|Overall Study|Adverse Event|2|||
156842514|NCT01959243|566174297|FG000|Overall Study|Administrative reasons|2|||
156469986|NCT05580003|564814873|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469987|NCT05580003|564814874|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469988|NCT05580003|564814875|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156842515|NCT01959243|566174298|FG001|Overall Study|Administrative reasons|1|||
156842516|NCT01959243|566174297|FG000|Overall Study|Lost to Follow-up|3|||
156842517|NCT01959243|566174298|FG001|Overall Study|Lost to Follow-up|1|||
156842518|NCT01368081|566174299|FG000|Overall Study|Adverse Event|4|||
156842519|NCT01368081|566174300|FG001|Overall Study|Adverse Event|4|||
156842520|NCT01368081|566174301|FG002|Overall Study|Adverse Event|3|||
156842521|NCT01368081|566174302|FG003|Overall Study|Adverse Event|2|||
156842522|NCT01368081|566174303|FG004|Overall Study|Adverse Event|2|||
156842523|NCT01368081|566174304|FG005|Overall Study|Adverse Event|5|||
156842524|NCT01368081|566174305|FG006|Overall Study|Adverse Event|6|||
156842525|NCT01368081|566174306|FG007|Overall Study|Adverse Event|2|||
156842526|NCT01368081|566174307|FG008|Overall Study|Adverse Event|3|||
156842527|NCT01368081|566174308|FG009|Overall Study|Adverse Event|5|||
156842528|NCT01368081|566174309|FG010|Overall Study|Adverse Event|6|||
156842529|NCT01368081|566174310|FG011|Overall Study|Adverse Event|1|||
156842530|NCT01368081|566174311|FG012|Overall Study|Adverse Event|3|||
156842531|NCT01368081|566174299|FG000|Overall Study|Lack of Efficacy|0|||
156842532|NCT01368081|566174300|FG001|Overall Study|Lack of Efficacy|1|||
156842533|NCT01368081|566174301|FG002|Overall Study|Lack of Efficacy|0|||
156842534|NCT01368081|566174302|FG003|Overall Study|Lack of Efficacy|1|||
156842535|NCT01368081|566174303|FG004|Overall Study|Lack of Efficacy|0|||
156842536|NCT01368081|566174304|FG005|Overall Study|Lack of Efficacy|0|||
156842537|NCT01368081|566174305|FG006|Overall Study|Lack of Efficacy|0|||
156842538|NCT01368081|566174306|FG007|Overall Study|Lack of Efficacy|2|||
156842539|NCT01368081|566174307|FG008|Overall Study|Lack of Efficacy|0|||
156842540|NCT01368081|566174308|FG009|Overall Study|Lack of Efficacy|0|||
156842541|NCT01368081|566174309|FG010|Overall Study|Lack of Efficacy|0|||
156842542|NCT01368081|566174310|FG011|Overall Study|Lack of Efficacy|0|||
156842543|NCT01368081|566174311|FG012|Overall Study|Lack of Efficacy|0|||
156842544|NCT01368081|566174299|FG000|Overall Study|Protocol Violation|0|||
156842545|NCT01368081|566174300|FG001|Overall Study|Protocol Violation|0|||
156842546|NCT01368081|566174301|FG002|Overall Study|Protocol Violation|0|||
156842547|NCT01368081|566174302|FG003|Overall Study|Protocol Violation|0|||
156842548|NCT01368081|566174303|FG004|Overall Study|Protocol Violation|0|||
156842549|NCT01368081|566174304|FG005|Overall Study|Protocol Violation|1|||
156842550|NCT01368081|566174305|FG006|Overall Study|Protocol Violation|0|||
156469989|NCT05580003|564814876|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156842551|NCT01368081|566174306|FG007|Overall Study|Protocol Violation|1|||
156341550|NCT02405780|564348574|FG003|Period I|Adverse Event|7|||
156842552|NCT01368081|566174307|FG008|Overall Study|Protocol Violation|0|||
156842553|NCT01368081|566174308|FG009|Overall Study|Protocol Violation|0|||
156842554|NCT01368081|566174309|FG010|Overall Study|Protocol Violation|0|||
156842555|NCT01368081|566174310|FG011|Overall Study|Protocol Violation|0|||
156842556|NCT01368081|566174311|FG012|Overall Study|Protocol Violation|0|||
156842557|NCT01368081|566174299|FG000|Overall Study|Lost to Follow-up|0|||
156842558|NCT01368081|566174300|FG001|Overall Study|Lost to Follow-up|0|||
156842559|NCT01368081|566174301|FG002|Overall Study|Lost to Follow-up|0|||
156842560|NCT01368081|566174302|FG003|Overall Study|Lost to Follow-up|0|||
156842561|NCT01368081|566174303|FG004|Overall Study|Lost to Follow-up|0|||
156842562|NCT01368081|566174304|FG005|Overall Study|Lost to Follow-up|0|||
156842563|NCT01368081|566174305|FG006|Overall Study|Lost to Follow-up|0|||
156842564|NCT01368081|566174306|FG007|Overall Study|Lost to Follow-up|0|||
156842565|NCT01368081|566174307|FG008|Overall Study|Lost to Follow-up|0|||
156842566|NCT01368081|566174308|FG009|Overall Study|Lost to Follow-up|0|||
156842567|NCT01368081|566174309|FG010|Overall Study|Lost to Follow-up|0|||
156842568|NCT01368081|566174310|FG011|Overall Study|Lost to Follow-up|0|||
156842569|NCT01368081|566174311|FG012|Overall Study|Lost to Follow-up|1|||
156842570|NCT01368081|566174299|FG000|Overall Study|Withdrawal by Subject|4|||
156842571|NCT01368081|566174300|FG001|Overall Study|Withdrawal by Subject|4|||
156842572|NCT01368081|566174301|FG002|Overall Study|Withdrawal by Subject|1|||
156842573|NCT01368081|566174302|FG003|Overall Study|Withdrawal by Subject|1|||
156842574|NCT01368081|566174303|FG004|Overall Study|Withdrawal by Subject|0|||
156842575|NCT01368081|566174304|FG005|Overall Study|Withdrawal by Subject|3|||
156842576|NCT01368081|566174305|FG006|Overall Study|Withdrawal by Subject|4|||
156842577|NCT01368081|566174306|FG007|Overall Study|Withdrawal by Subject|2|||
156842578|NCT01368081|566174307|FG008|Overall Study|Withdrawal by Subject|5|||
156842579|NCT01368081|566174308|FG009|Overall Study|Withdrawal by Subject|4|||
156842580|NCT01368081|566174309|FG010|Overall Study|Withdrawal by Subject|3|||
156842581|NCT01368081|566174310|FG011|Overall Study|Withdrawal by Subject|2|||
156842582|NCT01368081|566174311|FG012|Overall Study|Withdrawal by Subject|0|||
156842583|NCT01368081|566174299|FG000|Overall Study|Other reason not defined above|2|||
156469990|NCT05580003|564814877|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156842584|NCT01368081|566174300|FG001|Overall Study|Other reason not defined above|0|||
156842585|NCT01368081|566174301|FG002|Overall Study|Other reason not defined above|0|||
156842586|NCT01368081|566174302|FG003|Overall Study|Other reason not defined above|1|||
156842587|NCT01368081|566174303|FG004|Overall Study|Other reason not defined above|0|||
156842588|NCT01368081|566174304|FG005|Overall Study|Other reason not defined above|1|||
156842589|NCT01368081|566174305|FG006|Overall Study|Other reason not defined above|2|||
156842590|NCT01368081|566174306|FG007|Overall Study|Other reason not defined above|0|||
156842591|NCT01368081|566174307|FG008|Overall Study|Other reason not defined above|0|||
156842592|NCT01368081|566174308|FG009|Overall Study|Other reason not defined above|1|||
156842593|NCT01368081|566174309|FG010|Overall Study|Other reason not defined above|0|||
156842594|NCT01368081|566174310|FG011|Overall Study|Other reason not defined above|0|||
156842595|NCT01368081|566174311|FG012|Overall Study|Other reason not defined above|3|||
156842596|NCT02596945|566174312|FG000|Overall Study|No documentation of study drug dosing|3|||
156842597|NCT02596945|566174312|FG000|Overall Study|Other|32|||
156842598|NCT02596945|566174312|FG000|Overall Study|Change to hemodialysis|15|||
156842599|NCT02596945|566174312|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
156842600|NCT02596945|566174312|FG000|Overall Study|Withdrawal by Subject|1|||
156842601|NCT02596945|566174312|FG000|Overall Study|Missing|1|||
156842602|NCT00238238|566174313|FG000|Overall Study|Withdrawal by Subject|0|||
156842603|NCT00238238|566174314|FG001|Overall Study|Withdrawal by Subject|3|||
156842604|NCT00238238|566174315|FG002|Overall Study|Withdrawal by Subject|0|||
156842605|NCT01007838|566174316|FG000|Overall Study|Withdrawal by Subject|1|||
156842606|NCT01007838|566174317|FG001|Overall Study|Withdrawal by Subject|0|||
156842607|NCT01007838|566174318|FG002|Overall Study|Withdrawal by Subject|0|||
156842608|NCT01007838|566174319|FG003|Overall Study|Withdrawal by Subject|0|||
156842609|NCT01007838|566174316|FG000|Overall Study|Physician Decision|1|||
156842610|NCT01007838|566174317|FG001|Overall Study|Physician Decision|0|||
156842611|NCT01007838|566174318|FG002|Overall Study|Physician Decision|0|||
156842612|NCT01007838|566174319|FG003|Overall Study|Physician Decision|0|||
156842613|NCT01007838|566174316|FG000|Overall Study|Started home haemodialysis|1|||
156842614|NCT01007838|566174317|FG001|Overall Study|Started home haemodialysis|0|||
156842615|NCT01007838|566174318|FG002|Overall Study|Started home haemodialysis|0|||
156842616|NCT01007838|566174319|FG003|Overall Study|Started home haemodialysis|0|||
156842617|NCT02277119|566174323|FG000|Overall Study|Lack of Efficacy|1|||
156842618|NCT02277119|566174324|FG001|Overall Study|Lack of Efficacy|1|||
156842619|NCT02277119|566174325|FG002|Overall Study|Lack of Efficacy|1|||
156842620|NCT02277119|566174323|FG000|Overall Study|Protocol Violation|2|||
156842621|NCT02277119|566174324|FG001|Overall Study|Protocol Violation|3|||
156842622|NCT02277119|566174325|FG002|Overall Study|Protocol Violation|7|||
156842623|NCT01345669|566174326|FG000|Overall Study|Primary tumour recurrence|53|||
156842624|NCT01345669|566174327|FG001|Overall Study|Primary tumour recurrence|32|||
156842625|NCT01345669|566174326|FG000|Overall Study|Second primary tumour|4|||
156842626|NCT01345669|566174327|FG001|Overall Study|Second primary tumour|3|||
156842627|NCT01345669|566174326|FG000|Overall Study|Adverse Event|63|||
156842628|NCT01345669|566174327|FG001|Overall Study|Adverse Event|9|||
156842629|NCT01345669|566174326|FG000|Overall Study|Protocol Violation|3|||
156842630|NCT01345669|566174327|FG001|Overall Study|Protocol Violation|1|||
156842631|NCT01345669|566174326|FG000|Overall Study|Lost to Follow-up|1|||
156842632|NCT01345669|566174327|FG001|Overall Study|Lost to Follow-up|1|||
156842633|NCT01345669|566174326|FG000|Overall Study|Withdrawal by Subject|52|||
156842634|NCT01345669|566174327|FG001|Overall Study|Withdrawal by Subject|13|||
156842635|NCT01345669|566174326|FG000|Overall Study|Other Reasons|111|||
156842636|NCT01345669|566174327|FG001|Overall Study|Other Reasons|60|||
156842637|NCT04699461|566174328|FG000|Overall Study|Withdrawal by Subject|1|||
156842638|NCT04699461|566174329|FG001|Overall Study|Withdrawal by Subject|0|||
156842639|NCT04699461|566174328|FG000|Overall Study|Study termination by sponsor|2|||
156842640|NCT04699461|566174329|FG001|Overall Study|Study termination by sponsor|1|||
156842641|NCT04699461|566174328|FG000|Overall Study|Death|1|||
156842642|NCT04699461|566174329|FG001|Overall Study|Death|0|||
156842643|NCT04699461|566174328|FG000|Overall Study|Radiographic progression|0|||
156842644|NCT04699461|566174329|FG001|Overall Study|Radiographic progression|1|||
156842645|NCT02478255|566174331|FG000|Overall Study|Physician Decision|6|||
156842646|NCT02478255|566174332|FG001|Overall Study|Physician Decision|0|||
156842647|NCT02478255|566174331|FG000|Overall Study|Withdrawal by Subject|2|||
156842648|NCT02478255|566174332|FG001|Overall Study|Withdrawal by Subject|0|||
156842649|NCT03068767|566174338|FG000|Overall Study|Lost to Follow-up|7|||
156842650|NCT03068767|566174339|FG001|Overall Study|Lost to Follow-up|3|||
156842651|NCT03068767|566174338|FG000|Overall Study|Protocol Violation|3|||
156842652|NCT03068767|566174339|FG001|Overall Study|Protocol Violation|0|||
156842653|NCT00061633|566174342|FG000|Overall Study|Adverse Event|1|||
156842654|NCT00061633|566174343|FG001|Overall Study|Adverse Event|2|||
156842655|NCT00061633|566174342|FG000|Overall Study|Withdrawal by Subject|2|||
156842656|NCT00061633|566174343|FG001|Overall Study|Withdrawal by Subject|2|||
156842657|NCT00061633|566174342|FG000|Overall Study|Lost to Follow-up|1|||
156842658|NCT00061633|566174343|FG001|Overall Study|Lost to Follow-up|4|||
156842659|NCT00061633|566174342|FG000|Overall Study|Other|1|||
156842660|NCT00061633|566174343|FG001|Overall Study|Other|1|||
156842661|NCT00061633|566174342|FG000|Overall Study|Never received study treatment|0|||
156842662|NCT00061633|566174343|FG001|Overall Study|Never received study treatment|2|||
156842663|NCT01431963|566174344|FG000|Overall Study|Adverse Event|18|||
156842664|NCT01431963|566174344|FG000|Overall Study|Lack of Efficacy|7|||
156842665|NCT01431963|566174344|FG000|Overall Study|Protocol Violation|1|||
156842666|NCT01431963|566174344|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
156842667|NCT01431963|566174344|FG000|Overall Study|Physician Decision|4|||
156842668|NCT01431963|566174344|FG000|Overall Study|Withdrawal by Subject|3|||
156842669|NCT01487265|566177340|FG000|Overall Study|Adverse Event|8|||
156842670|NCT01487265|566177340|FG000|Overall Study|Withdrawal by Subject|5|||
156842671|NCT01487265|566177340|FG000|Overall Study|Disease Progression|21|||
156842672|NCT01487265|566177340|FG000|Overall Study|Death|2|||
156842673|NCT01487265|566177340|FG000|Overall Study|Still on Treatment|1|||
156842674|NCT03499314|566177341|FG000|Overall Study|Time Commitment|1|||
156842675|NCT03499314|566177342|FG001|Overall Study|Time Commitment|2|||
156842676|NCT03499314|566177341|FG000|Overall Study|Medical issue unrelated to research study|1|||
156842677|NCT03499314|566177342|FG001|Overall Study|Medical issue unrelated to research study|1|||
156842678|NCT01618695|566177343|FG000|Core Phase|Adverse Event|4|||
156842679|NCT01618695|566177344|FG001|Core Phase|Adverse Event|5|||
156842680|NCT01618695|566177345|FG002|Core Phase|Adverse Event|15|||
156842681|NCT01618695|566177346|FG003|Core Phase|Adverse Event|20|||
156842682|NCT01618695|566177343|FG000|Core Phase|Lost to Follow-up|0|||
156842683|NCT01618695|566177344|FG001|Core Phase|Lost to Follow-up|0|||
156842684|NCT01618695|566177345|FG002|Core Phase|Lost to Follow-up|1|||
156842685|NCT01618695|566177346|FG003|Core Phase|Lost to Follow-up|0|||
156842686|NCT01618695|566177343|FG000|Core Phase|Withdrawal by Subject|16|||
156842687|NCT01618695|566177344|FG001|Core Phase|Withdrawal by Subject|11|||
156842688|NCT01618695|566177345|FG002|Core Phase|Withdrawal by Subject|9|||
156842689|NCT01618695|566177346|FG003|Core Phase|Withdrawal by Subject|13|||
156842690|NCT01618695|566177343|FG000|Core Phase|Pregnancy|2|||
156842691|NCT01618695|566177344|FG001|Core Phase|Pregnancy|0|||
156842692|NCT01618695|566177345|FG002|Core Phase|Pregnancy|0|||
156842693|NCT01618695|566177346|FG003|Core Phase|Pregnancy|0|||
156842694|NCT01618695|566177343|FG000|Core Phase|Lack of Efficacy|1|||
156842695|NCT01618695|566177344|FG001|Core Phase|Lack of Efficacy|2|||
156842696|NCT01618695|566177345|FG002|Core Phase|Lack of Efficacy|1|||
156842697|NCT01618695|566177346|FG003|Core Phase|Lack of Efficacy|1|||
156842698|NCT01618695|566177343|FG000|Core Phase|Other than specified|1|||
156842699|NCT01618695|566177344|FG001|Core Phase|Other than specified|2|||
156842700|NCT01618695|566177345|FG002|Core Phase|Other than specified|2|||
156842701|NCT01618695|566177346|FG003|Core Phase|Other than specified|2|||
156842702|NCT01618695|566177343|FG000|Core Phase|Not treated|1|||
156842703|NCT01618695|566177344|FG001|Core Phase|Not treated|0|||
156842704|NCT01618695|566177345|FG002|Core Phase|Not treated|2|||
156842705|NCT01618695|566177346|FG003|Core Phase|Not treated|0|||
156842706|NCT01618695|566177343|FG000|Extension Phase|Lack of Efficacy|17|||
156842707|NCT01618695|566177344|FG001|Extension Phase|Lack of Efficacy|33|||
156842708|NCT01618695|566177345|FG002|Extension Phase|Lack of Efficacy|26|||
156842709|NCT01618695|566177346|FG003|Extension Phase|Lack of Efficacy|24|||
156842710|NCT01618695|566177343|FG000|Extension Phase|Pregnancy|2|||
156842711|NCT01618695|566177344|FG001|Extension Phase|Pregnancy|0|||
156842712|NCT01618695|566177345|FG002|Extension Phase|Pregnancy|1|||
156842713|NCT01618695|566177346|FG003|Extension Phase|Pregnancy|1|||
156842714|NCT01618695|566177343|FG000|Extension Phase|Withdrawal by Subject|43|||
156842715|NCT01618695|566177344|FG001|Extension Phase|Withdrawal by Subject|48|||
156842716|NCT01618695|566177345|FG002|Extension Phase|Withdrawal by Subject|42|||
156842717|NCT01618695|566177346|FG003|Extension Phase|Withdrawal by Subject|33|||
156842718|NCT01618695|566177343|FG000|Extension Phase|Adverse Event|18|||
156842719|NCT01618695|566177344|FG001|Extension Phase|Adverse Event|16|||
156842720|NCT01618695|566177345|FG002|Extension Phase|Adverse Event|9|||
156842721|NCT01618695|566177346|FG003|Extension Phase|Adverse Event|20|||
156842722|NCT01618695|566177343|FG000|Extension Phase|Lost to Follow-up|2|||
156842723|NCT01618695|566177344|FG001|Extension Phase|Lost to Follow-up|1|||
156842724|NCT01618695|566177345|FG002|Extension Phase|Lost to Follow-up|1|||
156842725|NCT01618695|566177346|FG003|Extension Phase|Lost to Follow-up|1|||
156842726|NCT01618695|566177343|FG000|Extension Phase|Other than specified|13|||
156842727|NCT01618695|566177344|FG001|Extension Phase|Other than specified|18|||
156842728|NCT01618695|566177345|FG002|Extension Phase|Other than specified|13|||
156842729|NCT01618695|566177346|FG003|Extension Phase|Other than specified|18|||
156842730|NCT02291419|566177348|FG000|Overall Study|Early study termination|1|||
156842731|NCT02291419|566177349|FG001|Overall Study|Early study termination|5|||
156842732|NCT00931606|566177352|FG000|Overall Study|Death|1|||
156842733|NCT00931606|566177353|FG001|Overall Study|Death|3|||
156842734|NCT00931606|566177354|FG002|Overall Study|Death|2|||
156842735|NCT00931606|566177355|FG003|Overall Study|Death|0|||
156842736|NCT00931606|566177352|FG000|Overall Study|Lost to Follow-up|0|||
156842737|NCT00931606|566177353|FG001|Overall Study|Lost to Follow-up|1|||
156842738|NCT00931606|566177354|FG002|Overall Study|Lost to Follow-up|0|||
156842739|NCT00931606|566177355|FG003|Overall Study|Lost to Follow-up|0|||
156842740|NCT00931606|566177352|FG000|Overall Study|Physician Decision|0|||
156842741|NCT00931606|566177353|FG001|Overall Study|Physician Decision|0|||
156842742|NCT00931606|566177354|FG002|Overall Study|Physician Decision|3|||
156842743|NCT00931606|566177355|FG003|Overall Study|Physician Decision|0|||
156842744|NCT00931606|566177352|FG000|Overall Study|Sponsor Decision|1|||
156842745|NCT00931606|566177353|FG001|Overall Study|Sponsor Decision|4|||
156842746|NCT00931606|566177354|FG002|Overall Study|Sponsor Decision|0|||
156842747|NCT00931606|566177355|FG003|Overall Study|Sponsor Decision|2|||
156842748|NCT00931606|566177352|FG000|Overall Study|Withdrawal by Subject|3|||
156842749|NCT00931606|566177353|FG001|Overall Study|Withdrawal by Subject|1|||
156842750|NCT00931606|566177354|FG002|Overall Study|Withdrawal by Subject|1|||
156842751|NCT00931606|566177355|FG003|Overall Study|Withdrawal by Subject|1|||
156842752|NCT00871338|566177356|FG000|Prior to Booster|Withdrawal by Subject|1|||
156842753|NCT00871338|566177357|FG001|Prior to Booster|Withdrawal by Subject|3|||
156842754|NCT00871338|566177356|FG000|Prior to Booster|Lost to Follow-up|1|||
156842755|NCT00871338|566177357|FG001|Prior to Booster|Lost to Follow-up|0|||
156842756|NCT02391363|566177358|FG000|Overall Study|Lost to Follow-up|5|||
156842757|NCT02391363|566177359|FG001|Overall Study|Lost to Follow-up|5|||
156842758|NCT02391363|566177358|FG000|Overall Study|Withdrawal by Subject|6|||
156842759|NCT02391363|566177359|FG001|Overall Study|Withdrawal by Subject|3|||
156842760|NCT01016600|566177360|FG000|Overall Study|Did not start treatment|1|||
156842761|NCT01016600|566177361|FG001|Overall Study|Did not start treatment|0|||
156842762|NCT01016600|566177362|FG002|Overall Study|Did not start treatment|0|||
156842763|NCT01016600|566177363|FG003|Overall Study|Did not start treatment|0|||
156842764|NCT00872599|566177364|FG000|Second Washout Period|Adverse Event|1|||
156842765|NCT00872599|566177365|FG001|Second Washout Period|Adverse Event|1|||
156842766|NCT01271725|566177368|FG000|Part A|Progressive disease according to RECIST|8|||
156842767|NCT01271725|566177369|FG001|Part A|Progressive disease according to RECIST|0|||
156842768|NCT01271725|566177368|FG000|Part A|Clinical signs/symptoms of progression|2|||
156842769|NCT01271725|566177369|FG001|Part A|Clinical signs/symptoms of progression|0|||
156842770|NCT01271725|566177368|FG000|Part A|Other Adverse Event|8|||
156842771|NCT01271725|566177369|FG001|Part A|Other Adverse Event|0|||
156842772|NCT01271725|566177368|FG000|Part A|Lost to Follow-up|1|||
156842773|NCT01271725|566177369|FG001|Part A|Lost to Follow-up|0|||
156842774|NCT01271725|566177368|FG000|Part A|Withdrawal by Subject|12|||
156842775|NCT01271725|566177369|FG001|Part A|Withdrawal by Subject|0|||
156842776|NCT01271725|566177368|FG000|Part A|Other than specified|3|||
156842777|NCT01271725|566177369|FG001|Part A|Other than specified|0|||
156842778|NCT01271725|566177368|FG000|Part A|Protocol Violation|1|||
156842779|NCT01271725|566177369|FG001|Part A|Protocol Violation|0|||
156842780|NCT01271725|566177368|FG000|Part B|Other than specified|0|||
156842781|NCT01271725|566177369|FG001|Part B|Other than specified|2|||
156842782|NCT01271725|566177368|FG000|Part B|Clinical signs/symptoms of progression|0|||
156842783|NCT01271725|566177369|FG001|Part B|Clinical signs/symptoms of progression|2|||
156842784|NCT01271725|566177368|FG000|Part B|Other Adverse Event|0|||
156842785|NCT01271725|566177369|FG001|Part B|Other Adverse Event|1|||
156842786|NCT01271725|566177368|FG000|Part B|Protocol Violation|0|||
156842787|NCT01271725|566177369|FG001|Part B|Protocol Violation|1|||
156842788|NCT01271725|566177368|FG000|Part B|Withdrawal by Subject|0|||
156842789|NCT01271725|566177369|FG001|Part B|Withdrawal by Subject|6|||
156842790|NCT00801229|566177370|FG000|Signed Consent|Withdrawal by Subject|2|||
156842791|NCT00801229|566177371|FG001|Signed Consent|Withdrawal by Subject|2|||
156842792|NCT00801229|566177370|FG000|Signed Consent|Found Ineligible|1|||
156842793|NCT00801229|566177371|FG001|Signed Consent|Found Ineligible|1|||
156842794|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
156842795|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
156842796|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
156842797|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
156842798|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
156842799|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
156842800|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
156842801|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
156842802|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
156842803|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
156842804|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Adverse Event|1|||
156842805|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Adverse Event|1|||
156842806|NCT03826186|566177372|FG000|Overall Study|Protocol Violation|2|||
156842807|NCT03826186|566177373|FG001|Overall Study|Protocol Violation|0|||
156842808|NCT03826186|566177372|FG000|Overall Study|Withdrawal by Subject|1|||
156842809|NCT03826186|566177373|FG001|Overall Study|Withdrawal by Subject|0|||
156842810|NCT02737475|566177376|FG000|Overall Study|Other reasons|0|||
156842811|NCT02737475|566177377|FG001|Overall Study|Other reasons|0|||
156842812|NCT02737475|566177378|FG002|Overall Study|Other reasons|0|||
156842813|NCT02737475|566177379|FG003|Overall Study|Other reasons|0|||
156842814|NCT02737475|566177380|FG004|Overall Study|Other reasons|1|||
156842815|NCT02737475|566177381|FG005|Overall Study|Other reasons|1|||
156842816|NCT02737475|566177382|FG006|Overall Study|Other reasons|0|||
156842817|NCT02737475|566177383|FG007|Overall Study|Other reasons|0|||
156842818|NCT02737475|566177384|FG008|Overall Study|Other reasons|1|||
156842819|NCT02737475|566177385|FG009|Overall Study|Other reasons|0|||
156842820|NCT02737475|566177386|FG010|Overall Study|Other reasons|1|||
156842821|NCT02737475|566177387|FG011|Overall Study|Other reasons|0|||
156842822|NCT02737475|566177388|FG012|Overall Study|Other reasons|0|||
156842823|NCT02737475|566177389|FG013|Overall Study|Other reasons|0|||
156842824|NCT02737475|566177390|FG014|Overall Study|Other reasons|0|||
156842825|NCT02737475|566177391|FG015|Overall Study|Other reasons|0|||
156842826|NCT02737475|566177392|FG016|Overall Study|Other reasons|0|||
156842827|NCT02737475|566177393|FG017|Overall Study|Other reasons|0|||
156842828|NCT02737475|566177394|FG018|Overall Study|Other reasons|0|||
156842829|NCT02737475|566177395|FG019|Overall Study|Other reasons|0|||
156842830|NCT02737475|566177396|FG020|Overall Study|Other reasons|0|||
156842831|NCT02737475|566177397|FG021|Overall Study|Other reasons|1|||
156842832|NCT02737475|566177398|FG022|Overall Study|Other reasons|0|||
156842833|NCT02737475|566177399|FG023|Overall Study|Other reasons|1|||
156842834|NCT02737475|566177400|FG024|Overall Study|Other reasons|1|||
156842835|NCT02737475|566177401|FG025|Overall Study|Other reasons|1|||
156842836|NCT02737475|566177402|FG026|Overall Study|Other reasons|0|||
156842837|NCT02737475|566177376|FG000|Overall Study|Death|1|||
156842838|NCT02737475|566177377|FG001|Overall Study|Death|0|||
156842839|NCT02737475|566177378|FG002|Overall Study|Death|0|||
156842840|NCT02737475|566177379|FG003|Overall Study|Death|1|||
156842841|NCT02737475|566177380|FG004|Overall Study|Death|0|||
156842842|NCT02737475|566177381|FG005|Overall Study|Death|0|||
156842843|NCT02737475|566177382|FG006|Overall Study|Death|0|||
156842844|NCT02737475|566177383|FG007|Overall Study|Death|2|||
156842845|NCT02737475|566177384|FG008|Overall Study|Death|0|||
156842846|NCT02737475|566177385|FG009|Overall Study|Death|0|||
156842847|NCT02737475|566177386|FG010|Overall Study|Death|0|||
156842848|NCT02737475|566177387|FG011|Overall Study|Death|4|||
156842849|NCT02737475|566177388|FG012|Overall Study|Death|2|||
156842850|NCT02737475|566177389|FG013|Overall Study|Death|2|||
156842851|NCT02737475|566177390|FG014|Overall Study|Death|0|||
156842852|NCT02737475|566177391|FG015|Overall Study|Death|2|||
156842853|NCT02737475|566177392|FG016|Overall Study|Death|2|||
156842854|NCT02737475|566177393|FG017|Overall Study|Death|2|||
156842855|NCT02737475|566177394|FG018|Overall Study|Death|1|||
156842856|NCT02737475|566177395|FG019|Overall Study|Death|0|||
156842857|NCT02737475|566177396|FG020|Overall Study|Death|0|||
156842858|NCT02737475|566177397|FG021|Overall Study|Death|0|||
156842859|NCT02737475|566177398|FG022|Overall Study|Death|0|||
156842860|NCT02737475|566177399|FG023|Overall Study|Death|0|||
156842861|NCT02737475|566177400|FG024|Overall Study|Death|0|||
156842862|NCT02737475|566177401|FG025|Overall Study|Death|0|||
156842863|NCT02737475|566177402|FG026|Overall Study|Death|0|||
156842864|NCT02737475|566177376|FG000|Overall Study|Participant withdrew consent|0|||
156842865|NCT02737475|566177377|FG001|Overall Study|Participant withdrew consent|0|||
156842866|NCT02737475|566177378|FG002|Overall Study|Participant withdrew consent|0|||
156842867|NCT02737475|566177379|FG003|Overall Study|Participant withdrew consent|0|||
156842868|NCT02737475|566177380|FG004|Overall Study|Participant withdrew consent|0|||
156842869|NCT02737475|566177381|FG005|Overall Study|Participant withdrew consent|2|||
156842870|NCT02737475|566177382|FG006|Overall Study|Participant withdrew consent|0|||
156842871|NCT02737475|566177383|FG007|Overall Study|Participant withdrew consent|0|||
156842872|NCT02737475|566177384|FG008|Overall Study|Participant withdrew consent|0|||
156842873|NCT02737475|566177385|FG009|Overall Study|Participant withdrew consent|0|||
156842874|NCT02737475|566177386|FG010|Overall Study|Participant withdrew consent|0|||
156842875|NCT02737475|566177387|FG011|Overall Study|Participant withdrew consent|0|||
156842876|NCT02737475|566177388|FG012|Overall Study|Participant withdrew consent|0|||
156842877|NCT02737475|566177389|FG013|Overall Study|Participant withdrew consent|0|||
156842878|NCT02737475|566177390|FG014|Overall Study|Participant withdrew consent|1|||
156842879|NCT02737475|566177391|FG015|Overall Study|Participant withdrew consent|0|||
156842880|NCT02737475|566177392|FG016|Overall Study|Participant withdrew consent|0|||
156842881|NCT02737475|566177393|FG017|Overall Study|Participant withdrew consent|2|||
156842882|NCT02737475|566177394|FG018|Overall Study|Participant withdrew consent|1|||
156842883|NCT02737475|566177395|FG019|Overall Study|Participant withdrew consent|0|||
156842884|NCT02737475|566177396|FG020|Overall Study|Participant withdrew consent|2|||
156842885|NCT02737475|566177397|FG021|Overall Study|Participant withdrew consent|0|||
156842886|NCT02737475|566177398|FG022|Overall Study|Participant withdrew consent|0|||
156842887|NCT02737475|566177399|FG023|Overall Study|Participant withdrew consent|0|||
156842888|NCT02737475|566177400|FG024|Overall Study|Participant withdrew consent|0|||
156842889|NCT02737475|566177401|FG025|Overall Study|Participant withdrew consent|0|||
156842890|NCT02737475|566177402|FG026|Overall Study|Participant withdrew consent|0|||
156842891|NCT02737475|566177376|FG000|Overall Study|Lost to Follow-up|0|||
156842892|NCT02737475|566177377|FG001|Overall Study|Lost to Follow-up|0|||
156842893|NCT02737475|566177378|FG002|Overall Study|Lost to Follow-up|0|||
156842894|NCT02737475|566177379|FG003|Overall Study|Lost to Follow-up|0|||
156842895|NCT02737475|566177380|FG004|Overall Study|Lost to Follow-up|0|||
156842896|NCT02737475|566177381|FG005|Overall Study|Lost to Follow-up|0|||
156842897|NCT02737475|566177382|FG006|Overall Study|Lost to Follow-up|0|||
156842898|NCT02737475|566177383|FG007|Overall Study|Lost to Follow-up|0|||
156842899|NCT02737475|566177384|FG008|Overall Study|Lost to Follow-up|0|||
156842900|NCT02737475|566177385|FG009|Overall Study|Lost to Follow-up|0|||
156842901|NCT02737475|566177386|FG010|Overall Study|Lost to Follow-up|0|||
156842902|NCT02737475|566177387|FG011|Overall Study|Lost to Follow-up|0|||
156842903|NCT02737475|566177388|FG012|Overall Study|Lost to Follow-up|0|||
156842904|NCT02737475|566177389|FG013|Overall Study|Lost to Follow-up|0|||
156842905|NCT02737475|566177390|FG014|Overall Study|Lost to Follow-up|0|||
156842906|NCT02737475|566177391|FG015|Overall Study|Lost to Follow-up|1|||
156842907|NCT02737475|566177392|FG016|Overall Study|Lost to Follow-up|0|||
156842908|NCT02737475|566177393|FG017|Overall Study|Lost to Follow-up|0|||
156842909|NCT02737475|566177394|FG018|Overall Study|Lost to Follow-up|0|||
156842910|NCT02737475|566177395|FG019|Overall Study|Lost to Follow-up|0|||
156842911|NCT02737475|566177396|FG020|Overall Study|Lost to Follow-up|0|||
156842912|NCT02737475|566177397|FG021|Overall Study|Lost to Follow-up|0|||
156842913|NCT02737475|566177398|FG022|Overall Study|Lost to Follow-up|0|||
156842914|NCT02737475|566177399|FG023|Overall Study|Lost to Follow-up|0|||
156842915|NCT02737475|566177400|FG024|Overall Study|Lost to Follow-up|0|||
156842916|NCT02737475|566177401|FG025|Overall Study|Lost to Follow-up|0|||
156842917|NCT02737475|566177402|FG026|Overall Study|Lost to Follow-up|0|||
156842918|NCT02737475|566177376|FG000|Overall Study|Disease Progression|0|||
156842919|NCT02737475|566177377|FG001|Overall Study|Disease Progression|0|||
156842920|NCT02737475|566177378|FG002|Overall Study|Disease Progression|0|||
156842921|NCT02737475|566177379|FG003|Overall Study|Disease Progression|0|||
156842922|NCT02737475|566177380|FG004|Overall Study|Disease Progression|0|||
156842923|NCT02737475|566177381|FG005|Overall Study|Disease Progression|0|||
156842924|NCT02737475|566177382|FG006|Overall Study|Disease Progression|0|||
156842925|NCT02737475|566177383|FG007|Overall Study|Disease Progression|0|||
156842926|NCT02737475|566177384|FG008|Overall Study|Disease Progression|0|||
156842927|NCT02737475|566177385|FG009|Overall Study|Disease Progression|0|||
156842928|NCT02737475|566177386|FG010|Overall Study|Disease Progression|0|||
156842929|NCT02737475|566177387|FG011|Overall Study|Disease Progression|0|||
156842930|NCT02737475|566177388|FG012|Overall Study|Disease Progression|0|||
156842931|NCT02737475|566177389|FG013|Overall Study|Disease Progression|0|||
156842932|NCT02737475|566177390|FG014|Overall Study|Disease Progression|0|||
156842933|NCT02737475|566177391|FG015|Overall Study|Disease Progression|0|||
156842934|NCT02737475|566177392|FG016|Overall Study|Disease Progression|0|||
156842935|NCT02737475|566177393|FG017|Overall Study|Disease Progression|0|||
156842936|NCT02737475|566177394|FG018|Overall Study|Disease Progression|0|||
156469991|NCT05580003|564814878|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469992|NCT05580003|564814879|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469993|NCT05580003|564814880|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469994|NCT05580003|564814881|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469995|NCT05580003|564814882|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156842937|NCT02737475|566177395|FG019|Overall Study|Disease Progression|0|||
156842938|NCT02737475|566177396|FG020|Overall Study|Disease Progression|0|||
156842939|NCT02737475|566177397|FG021|Overall Study|Disease Progression|0|||
156842940|NCT02737475|566177398|FG022|Overall Study|Disease Progression|0|||
156842941|NCT02737475|566177399|FG023|Overall Study|Disease Progression|0|||
156842942|NCT02737475|566177400|FG024|Overall Study|Disease Progression|0|||
156842943|NCT02737475|566177401|FG025|Overall Study|Disease Progression|0|||
156842944|NCT02737475|566177402|FG026|Overall Study|Disease Progression|1|||
156842945|NCT02950480|566177409|FG000|Overall Study|Withdrawal by Subject|1|||
156842946|NCT02950480|566177410|FG001|Overall Study|Withdrawal by Subject|0|||
156842947|NCT02255461|566177418|FG000|Overall Study|Adverse Event|0|||
156842948|NCT02255461|566177419|FG001|Overall Study|Adverse Event|1|||
156842949|NCT02255461|566177420|FG002|Overall Study|Adverse Event|0|||
156842950|NCT02255461|566177421|FG003|Overall Study|Adverse Event|0|||
156842951|NCT02255461|566177422|FG004|Overall Study|Adverse Event|1|||
156842952|NCT02255461|566177418|FG000|Overall Study|Withdrawal by Subject|0|||
156842953|NCT02255461|566177419|FG001|Overall Study|Withdrawal by Subject|0|||
156842954|NCT02255461|566177420|FG002|Overall Study|Withdrawal by Subject|1|||
156842955|NCT02255461|566177421|FG003|Overall Study|Withdrawal by Subject|0|||
156842956|NCT02255461|566177422|FG004|Overall Study|Withdrawal by Subject|1|||
156842957|NCT02255461|566177418|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
156842958|NCT02255461|566177419|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
156842959|NCT02255461|566177420|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
156842960|NCT02255461|566177421|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
156842961|NCT02255461|566177422|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
156842962|NCT01357551|566177426|FG000|Overall Study|Withdrawal by Subject|6|||
156842963|NCT01357551|566177427|FG001|Overall Study|Withdrawal by Subject|4|||
156842964|NCT01357551|566177426|FG000|Overall Study|Death|0|||
156842965|NCT01357551|566177427|FG001|Overall Study|Death|1|||
156842966|NCT01357551|566177426|FG000|Overall Study|Lost to Follow-up|16|||
156842967|NCT01357551|566177427|FG001|Overall Study|Lost to Follow-up|6|||
156842968|NCT00711971|566177436|FG000|Overall Study|Lost to Follow-up|3|||
156842969|NCT00711971|566177437|FG001|Overall Study|Lost to Follow-up|4|||
156842970|NCT00711971|566177438|FG002|Overall Study|Lost to Follow-up|1|||
156842971|NCT04774926|566177439|FG000|Overall Study|Adverse Event|15|||
156842972|NCT04774926|566177439|FG000|Overall Study|Lost to Follow-up|3|||
156842973|NCT04774926|566177439|FG000|Overall Study|Physician Decision|6|||
156842974|NCT04774926|566177439|FG000|Overall Study|Withdrawal by Subject|3|||
156842975|NCT04774926|566177439|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
156842976|NCT01393639|566177440|FG000|Overall Study|Protocol Violation|0|||
156842977|NCT01393639|566177441|FG001|Overall Study|Protocol Violation|0|||
156842978|NCT01393639|566177442|FG002|Overall Study|Protocol Violation|0|||
156842979|NCT01393639|566177443|FG003|Overall Study|Protocol Violation|1|||
156842980|NCT01393639|566177444|FG004|Overall Study|Protocol Violation|0|||
156842981|NCT01393639|566177445|FG005|Overall Study|Protocol Violation|0|||
156842982|NCT01393639|566177446|FG006|Overall Study|Protocol Violation|0|||
156842983|NCT01393639|566177440|FG000|Overall Study|Other|0|||
156842984|NCT01393639|566177441|FG001|Overall Study|Other|2|||
156842985|NCT01393639|566177442|FG002|Overall Study|Other|0|||
156842986|NCT01393639|566177443|FG003|Overall Study|Other|2|||
156842987|NCT01393639|566177444|FG004|Overall Study|Other|1|||
156842988|NCT01393639|566177445|FG005|Overall Study|Other|0|||
156842989|NCT01393639|566177446|FG006|Overall Study|Other|1|||
156842990|NCT01393639|566177440|FG000|Overall Study|Withdrawal by Subject|1|||
156842991|NCT01393639|566177441|FG001|Overall Study|Withdrawal by Subject|1|||
156842992|NCT01393639|566177442|FG002|Overall Study|Withdrawal by Subject|0|||
156842993|NCT01393639|566177443|FG003|Overall Study|Withdrawal by Subject|0|||
156842994|NCT01393639|566177444|FG004|Overall Study|Withdrawal by Subject|0|||
156842995|NCT01393639|566177445|FG005|Overall Study|Withdrawal by Subject|0|||
156842996|NCT01393639|566177446|FG006|Overall Study|Withdrawal by Subject|1|||
156842997|NCT01393639|566177440|FG000|Overall Study|Medication error without associated AE|0|||
156842998|NCT01393639|566177441|FG001|Overall Study|Medication error without associated AE|0|||
156842999|NCT01393639|566177442|FG002|Overall Study|Medication error without associated AE|0|||
156843000|NCT01393639|566177443|FG003|Overall Study|Medication error without associated AE|0|||
156843001|NCT01393639|566177444|FG004|Overall Study|Medication error without associated AE|0|||
156843002|NCT01393639|566177445|FG005|Overall Study|Medication error without associated AE|0|||
156843003|NCT01393639|566177446|FG006|Overall Study|Medication error without associated AE|1|||
156843004|NCT01393639|566177440|FG000|Overall Study|Lost to Follow-up|0|||
156843005|NCT01393639|566177441|FG001|Overall Study|Lost to Follow-up|1|||
156843006|NCT01393639|566177442|FG002|Overall Study|Lost to Follow-up|0|||
156843007|NCT01393639|566177443|FG003|Overall Study|Lost to Follow-up|0|||
156843008|NCT01393639|566177444|FG004|Overall Study|Lost to Follow-up|0|||
156843009|NCT01393639|566177445|FG005|Overall Study|Lost to Follow-up|0|||
156843010|NCT01393639|566177446|FG006|Overall Study|Lost to Follow-up|1|||
156843011|NCT01393639|566177440|FG000|Overall Study|Lack of Efficacy|0|||
156341551|NCT02405780|564348571|FG000|Period I|Medical reasons|1|||
156843012|NCT01393639|566177441|FG001|Overall Study|Lack of Efficacy|0|||
156843013|NCT01393639|566177442|FG002|Overall Study|Lack of Efficacy|0|||
156843014|NCT01393639|566177443|FG003|Overall Study|Lack of Efficacy|0|||
156843015|NCT01393639|566177444|FG004|Overall Study|Lack of Efficacy|0|||
156843016|NCT01393639|566177445|FG005|Overall Study|Lack of Efficacy|0|||
156843017|NCT01393639|566177446|FG006|Overall Study|Lack of Efficacy|1|||
156843018|NCT01393639|566177440|FG000|Overall Study|Adverse Event|2|||
156843019|NCT01393639|566177441|FG001|Overall Study|Adverse Event|3|||
156843020|NCT01393639|566177442|FG002|Overall Study|Adverse Event|1|||
156843021|NCT01393639|566177443|FG003|Overall Study|Adverse Event|2|||
156843022|NCT01393639|566177444|FG004|Overall Study|Adverse Event|0|||
156341552|NCT02405780|564348572|FG001|Period I|Medical reasons|1|||
156843023|NCT01393639|566177445|FG005|Overall Study|Adverse Event|2|||
156843024|NCT01393639|566177446|FG006|Overall Study|Adverse Event|3|||
156843025|NCT03626545|566177447|FG000|Overall Study|Progressive disease|3|||
156843026|NCT03626545|566177448|FG001|Overall Study|Progressive disease|82|||
156843027|NCT03626545|566177449|FG002|Overall Study|Progressive disease|85|||
156843028|NCT03626545|566177447|FG000|Overall Study|Adverse Event|3|||
156843029|NCT03626545|566177448|FG001|Overall Study|Adverse Event|13|||
156843030|NCT03626545|566177449|FG002|Overall Study|Adverse Event|10|||
156843031|NCT03626545|566177447|FG000|Overall Study|Physician Decision|1|||
156843032|NCT03626545|566177448|FG001|Overall Study|Physician Decision|18|||
156843033|NCT03626545|566177449|FG002|Overall Study|Physician Decision|14|||
156843034|NCT03626545|566177447|FG000|Overall Study|Subject Decision|0|||
156843035|NCT03626545|566177448|FG001|Overall Study|Subject Decision|5|||
156843036|NCT03626545|566177449|FG002|Overall Study|Subject Decision|5|||
156843037|NCT03626545|566177447|FG000|Overall Study|Death|1|||
156843038|NCT03626545|566177448|FG001|Overall Study|Death|1|||
156843039|NCT03626545|566177449|FG002|Overall Study|Death|1|||
156843040|NCT03626545|566177447|FG000|Overall Study|Protocol Deviation|0|||
156843041|NCT03626545|566177448|FG001|Overall Study|Protocol Deviation|1|||
156843042|NCT03626545|566177449|FG002|Overall Study|Protocol Deviation|1|||
156843043|NCT03626545|566177447|FG000|Overall Study|Guardian Decision|0|||
156843044|NCT03626545|566177448|FG001|Overall Study|Guardian Decision|0|||
156843045|NCT03626545|566177449|FG002|Overall Study|Guardian Decision|1|||
156843046|NCT00793325|566177451|FG000|Overall Study|Protocol Violation|18|||
156843047|NCT00793325|566177451|FG000|Overall Study|Lost to Follow-up|1|||
156843048|NCT01832155|566177454|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
156843049|NCT01832155|566177455|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
156843050|NCT01832155|566177454|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
156843051|NCT01832155|566177455|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
156341553|NCT02405780|564348573|FG002|Period I|Medical reasons|0|||
156341554|NCT02405780|564348574|FG003|Period I|Medical reasons|1|||
156341555|NCT02405780|564348571|FG000|Period I|Screening Failure|1|||
156341556|NCT02405780|564348572|FG001|Period I|Screening Failure|0|||
156341557|NCT02405780|564348573|FG002|Period I|Screening Failure|1|||
156341558|NCT02405780|564348574|FG003|Period I|Screening Failure|0|||
156341559|NCT02405780|564348571|FG000|Period I|Withdrawal by Subject|9|||
156341560|NCT02405780|564348572|FG001|Period I|Withdrawal by Subject|1|||
156341561|NCT02405780|564348573|FG002|Period I|Withdrawal by Subject|3|||
156341562|NCT02405780|564348574|FG003|Period I|Withdrawal by Subject|4|||
156341563|NCT02405780|564348571|FG000|Period I|Non-compliance with study procedures|8|||
156341564|NCT02405780|564348572|FG001|Period I|Non-compliance with study procedures|6|||
156469996|NCT05580003|564814883|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469997|NCT05580003|564814884|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469998|NCT05580003|564814885|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156469999|NCT05580003|564814886|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156341565|NCT02405780|564348573|FG002|Period I|Non-compliance with study procedures|8|||
156341566|NCT02405780|564348574|FG003|Period I|Non-compliance with study procedures|11|||
156341567|NCT02405780|564348571|FG000|Period II|Adverse Event|3|||
156341568|NCT02405780|564348572|FG001|Period II|Adverse Event|5|||
156843052|NCT00847886|566177456|FG000|Overall Study|Adverse Event|0|||
156843053|NCT00847886|566177457|FG001|Overall Study|Adverse Event|1|||
156843054|NCT00413036|566177458|FG000|Overall Study|Adverse Event|44|||
156843055|NCT00413036|566177458|FG000|Overall Study|Lack of Efficacy|129|||
156843056|NCT00413036|566177458|FG000|Overall Study|Withdrawal by Subject|7|||
156843057|NCT00413036|566177458|FG000|Overall Study|Death|9|||
156843058|NCT00413036|566177458|FG000|Overall Study|Other|26|||
156843059|NCT00413036|566177458|FG000|Overall Study|Missing|2|||
156843060|NCT03250182|566177463|FG000|Overall Study|Withdrawal by Subject|1|||
156843061|NCT03668613|566177467|FG000|Overall Study|Adverse Event|1|||
156843062|NCT03668613|566177468|FG001|Overall Study|Adverse Event|2|||
156843063|NCT03668613|566177467|FG000|Overall Study|Lack of Efficacy|5|||
156843064|NCT03668613|566177468|FG001|Overall Study|Lack of Efficacy|1|||
156843065|NCT03668613|566177467|FG000|Overall Study|Pregnancy|0|||
156843066|NCT03668613|566177468|FG001|Overall Study|Pregnancy|2|||
156843067|NCT03668613|566177467|FG000|Overall Study|Protocol Violation|1|||
156843068|NCT03668613|566177468|FG001|Overall Study|Protocol Violation|0|||
156843069|NCT03668613|566177467|FG000|Overall Study|Physician Decision|1|||
156843070|NCT03668613|566177468|FG001|Overall Study|Physician Decision|0|||
156843071|NCT03668613|566177467|FG000|Overall Study|Withdrawal by Subject|2|||
156843072|NCT03668613|566177468|FG001|Overall Study|Withdrawal by Subject|1|||
156843073|NCT03668613|566177467|FG000|Overall Study|Guardian decision|1|||
156843074|NCT03668613|566177468|FG001|Overall Study|Guardian decision|0|||
156843075|NCT01858740|566177471|FG000|Overall Study|Death|4|||
156843076|NCT03386487|566177472|FG000|Overall Study|Lost to Follow-up|5|||
156843077|NCT03386487|566177473|FG001|Overall Study|Lost to Follow-up|6|||
156843078|NCT03386487|566177472|FG000|Overall Study|Withdrawal by Subject|11|||
156843079|NCT03386487|566177473|FG001|Overall Study|Withdrawal by Subject|7|||
156843080|NCT03386487|566177472|FG000|Overall Study|Physician Decision|11|||
156843081|NCT03386487|566177473|FG001|Overall Study|Physician Decision|8|||
156843082|NCT01068769|566177474|FG000|Overall Study|Ineligible|1|||
156843083|NCT04776317|566177477|FG000|Overall Study|Physician Decision|0|||
156843084|NCT04776317|566177478|FG001|Overall Study|Physician Decision|1|||
156843085|NCT04776317|566177479|FG002|Overall Study|Physician Decision|0|||
156843086|NCT04776317|566177480|FG003|Overall Study|Physician Decision|0|||
156843087|NCT04776317|566177481|FG004|Overall Study|Physician Decision|0|||
156843088|NCT04776317|566177482|FG005|Overall Study|Physician Decision|0|||
156843089|NCT04776317|566177483|FG006|Overall Study|Physician Decision|0|||
156843090|NCT04776317|566177484|FG007|Overall Study|Physician Decision|0|||
156341569|NCT02405780|564348573|FG002|Period II|Adverse Event|4|||
156341570|NCT02405780|564348574|FG003|Period II|Adverse Event|11|||
156341571|NCT02405780|564348571|FG000|Period II|Medical reason|0|||
156341572|NCT02405780|564348572|FG001|Period II|Medical reason|1|||
156341573|NCT02405780|564348573|FG002|Period II|Medical reason|0|||
156341574|NCT02405780|564348574|FG003|Period II|Medical reason|0|||
156341575|NCT02405780|564348571|FG000|Period II|Pregnancy|0|||
156341576|NCT02405780|564348572|FG001|Period II|Pregnancy|0|||
156341577|NCT02405780|564348573|FG002|Period II|Pregnancy|1|||
156341578|NCT02405780|564348574|FG003|Period II|Pregnancy|0|||
156843091|NCT04776317|566177485|FG008|Overall Study|Physician Decision|0|||
156843092|NCT04776317|566177486|FG009|Overall Study|Physician Decision|0|||
156843093|NCT04776317|566177487|FG010|Overall Study|Physician Decision|0|||
156341579|NCT02405780|564348571|FG000|Period II|Withdrawal by Subject|7|||
156341580|NCT02405780|564348572|FG001|Period II|Withdrawal by Subject|4|||
156341581|NCT02405780|564348573|FG002|Period II|Withdrawal by Subject|0|||
156843094|NCT04776317|566177488|FG011|Overall Study|Physician Decision|0|||
156843095|NCT04776317|566177489|FG012|Overall Study|Physician Decision|0|||
156843096|NCT04776317|566177490|FG013|Overall Study|Physician Decision|0|||
156843097|NCT04776317|566177491|FG014|Overall Study|Physician Decision|0|||
156843098|NCT04776317|566177477|FG000|Overall Study|Protocol Violation|0|||
156843099|NCT04776317|566177478|FG001|Overall Study|Protocol Violation|0|||
156843100|NCT04776317|566177479|FG002|Overall Study|Protocol Violation|1|||
156843101|NCT04776317|566177480|FG003|Overall Study|Protocol Violation|0|||
156470000|NCT05580003|564814887|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156843102|NCT04776317|566177481|FG004|Overall Study|Protocol Violation|0|||
156843103|NCT04776317|566177482|FG005|Overall Study|Protocol Violation|0|||
156843104|NCT04776317|566177483|FG006|Overall Study|Protocol Violation|0|||
156843105|NCT04776317|566177484|FG007|Overall Study|Protocol Violation|0|||
156843106|NCT04776317|566177485|FG008|Overall Study|Protocol Violation|0|||
156843107|NCT04776317|566177486|FG009|Overall Study|Protocol Violation|0|||
156843108|NCT04776317|566177487|FG010|Overall Study|Protocol Violation|0|||
156843109|NCT04776317|566177488|FG011|Overall Study|Protocol Violation|0|||
156843110|NCT04776317|566177489|FG012|Overall Study|Protocol Violation|0|||
156843111|NCT04776317|566177490|FG013|Overall Study|Protocol Violation|0|||
156843112|NCT04776317|566177491|FG014|Overall Study|Protocol Violation|0|||
156843113|NCT04776317|566177477|FG000|Overall Study|Withdrawal by Subject|0|||
156843114|NCT04776317|566177478|FG001|Overall Study|Withdrawal by Subject|0|||
156843115|NCT04776317|566177479|FG002|Overall Study|Withdrawal by Subject|0|||
156843116|NCT04776317|566177480|FG003|Overall Study|Withdrawal by Subject|0|||
156843117|NCT04776317|566177481|FG004|Overall Study|Withdrawal by Subject|1|||
156843118|NCT04776317|566177482|FG005|Overall Study|Withdrawal by Subject|0|||
156843119|NCT04776317|566177483|FG006|Overall Study|Withdrawal by Subject|0|||
156843120|NCT04776317|566177484|FG007|Overall Study|Withdrawal by Subject|0|||
156843121|NCT04776317|566177485|FG008|Overall Study|Withdrawal by Subject|0|||
156843122|NCT04776317|566177486|FG009|Overall Study|Withdrawal by Subject|0|||
156843123|NCT04776317|566177487|FG010|Overall Study|Withdrawal by Subject|0|||
156843124|NCT04776317|566177488|FG011|Overall Study|Withdrawal by Subject|0|||
156843125|NCT04776317|566177489|FG012|Overall Study|Withdrawal by Subject|0|||
156843126|NCT04776317|566177490|FG013|Overall Study|Withdrawal by Subject|0|||
156843127|NCT04776317|566177491|FG014|Overall Study|Withdrawal by Subject|0|||
156843128|NCT01067144|566177492|FG000|Treatment|Did not receive allocated intervention|4|||
156843129|NCT01067144|566177493|FG001|Treatment|Did not receive allocated intervention|7|||
156843130|NCT01067144|566177492|FG000|Follow-up|Lost to Follow-up|22|||
156843131|NCT01067144|566177493|FG001|Follow-up|Lost to Follow-up|12|||
156843132|NCT01067144|566177492|FG000|Follow-up|Censored owing to second surgery|19|||
156470001|NCT05580003|564814888|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156470002|NCT05580003|564814889|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156470003|NCT05580003|564814890|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156843133|NCT01067144|566177493|FG001|Follow-up|Censored owing to second surgery|28|||
156843134|NCT01067144|566177492|FG000|Follow-up|Withdrawal by Subject|18|||
156843135|NCT01067144|566177493|FG001|Follow-up|Withdrawal by Subject|14|||
156843136|NCT01067144|566177492|FG000|Follow-up|Surgery cancelled|0|||
156843137|NCT01067144|566177493|FG001|Follow-up|Surgery cancelled|1|||
156843138|NCT01067144|566177492|FG000|Follow-up|Death|0|||
156843139|NCT01067144|566177493|FG001|Follow-up|Death|1|||
156843140|NCT01843062|566177497|FG000|Overall Study|Protocol Violation|1|||
156843141|NCT01843062|566177498|FG001|Overall Study|Protocol Violation|0|||
156843142|NCT01843062|566177497|FG000|Overall Study|New treatment following progression|2|||
156843143|NCT01843062|566177498|FG001|Overall Study|New treatment following progression|0|||
156843144|NCT01843062|566177497|FG000|Overall Study|Pregnancy|1|||
156843145|NCT01843062|566177498|FG001|Overall Study|Pregnancy|0|||
156843146|NCT01843062|566177497|FG000|Overall Study|Adverse Event|2|||
156843147|NCT01843062|566177498|FG001|Overall Study|Adverse Event|0|||
156843148|NCT01843062|566177497|FG000|Overall Study|Incorrect randomisation|1|||
156843149|NCT01843062|566177498|FG001|Overall Study|Incorrect randomisation|0|||
156843150|NCT01843062|566177497|FG000|Overall Study|Withdrawal by Subject|12|||
156843151|NCT01843062|566177498|FG001|Overall Study|Withdrawal by Subject|3|||
156843152|NCT01843062|566177497|FG000|Overall Study|Death|1|||
156843153|NCT01843062|566177498|FG001|Overall Study|Death|2|||
156843154|NCT01843062|566177497|FG000|Overall Study|Lost to Follow-up|2|||
156843155|NCT01843062|566177498|FG001|Overall Study|Lost to Follow-up|4|||
156843156|NCT00129467|566177510|FG000|Received Intervention|Death|1|||
156843157|NCT00129467|566177511|FG001|Received Intervention|Death|1|||
156843158|NCT00129467|566177510|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
156843159|NCT00129467|566177511|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
156843160|NCT00129467|566177510|FG000|Received Intervention|Delirium|2|||
156843161|NCT00129467|566177511|FG001|Received Intervention|Delirium|0|||
156843162|NCT00129467|566177510|FG000|Received Intervention|Withdrawal by Subject|1|||
156843163|NCT00129467|566177511|FG001|Received Intervention|Withdrawal by Subject|0|||
156843164|NCT00129467|566177510|FG000|Received Intervention|Nausea|1|||
156843165|NCT00129467|566177511|FG001|Received Intervention|Nausea|0|||
156843166|NCT00129467|566177510|FG000|Received Intervention|Intolerance to citalopram|0|||
156843167|NCT00129467|566177511|FG001|Received Intervention|Intolerance to citalopram|1|||
156843168|NCT00129467|566177510|FG000|Received Intervention|Dizzyness, fatigue|0|||
156843169|NCT00129467|566177511|FG001|Received Intervention|Dizzyness, fatigue|1|||
156843170|NCT00129467|566177510|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
156843171|NCT00129467|566177511|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
156843172|NCT00129467|566177510|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
156843173|NCT00129467|566177511|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
156843174|NCT00699335|566177521|FG000|Overall Study|Combination of multiple reasons|176|||
156843175|NCT00699335|566177521|FG000|Overall Study|Missing data|52|||
156843176|NCT01817959|566177522|FG000|Overall Study|Graft loss|1|||
156843177|NCT01817959|566177523|FG001|Overall Study|Graft loss|1|||
156843178|NCT01817959|566177522|FG000|Overall Study|forbidden medication|1|||
156843179|NCT01817959|566177523|FG001|Overall Study|forbidden medication|1|||
156843180|NCT01817959|566177522|FG000|Overall Study|Adverse Event|1|||
156843181|NCT01817959|566177523|FG001|Overall Study|Adverse Event|0|||
156843182|NCT01817959|566177522|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
156843183|NCT01817959|566177523|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
156843184|NCT02301624|566177527|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
156843185|NCT02301624|566177528|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
156843186|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
156843187|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
156843188|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Adverse Event|2|||
156843189|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Adverse Event|5|||
156843190|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Physician Decision|3|||
156843191|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Physician Decision|3|||
156843192|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Death|2|||
156843193|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Death|1|||
156843194|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
156843195|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
156843196|NCT00547521|566177529|FG000|Short Term Study (4 Months)|Adverse Event|1|||
156843197|NCT00547521|566177530|FG001|Short Term Study (4 Months)|Adverse Event|0|||
156843198|NCT00547521|566177529|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
156843199|NCT00547521|566177530|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
156843200|NCT00547521|566177529|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
156843201|NCT00547521|566177530|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
156843202|NCT00547521|566177529|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
156843203|NCT00547521|566177530|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
156843204|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
156843205|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
156843206|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
156843207|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
156843208|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
156843209|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
156843210|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
156843211|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
156843212|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Other|0|||
156843213|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Other|2|||
156843214|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
156843215|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
156843216|NCT02475278|566179476|FG000|Overall Study|Lost to Follow-up|1|||
156341582|NCT02405780|564348574|FG003|Period II|Withdrawal by Subject|3|||
156341583|NCT02405780|564348571|FG000|Period II|Non-compliance with study procedures|5|||
156843217|NCT02475278|566179476|FG000|Overall Study|Reason Not Specified|1|||
156843218|NCT01946152|566179477|FG000|Overall Study|Adverse Event|1|||
156843219|NCT01946152|566179478|FG001|Overall Study|Adverse Event|0|||
156843220|NCT01946152|566179479|FG002|Overall Study|Adverse Event|0|||
156843221|NCT01946152|566179480|FG003|Overall Study|Adverse Event|0|||
156843222|NCT01946152|566179477|FG000|Overall Study|Withdrawal by Subject|0|||
156843223|NCT01946152|566179478|FG001|Overall Study|Withdrawal by Subject|2|||
156843224|NCT01946152|566179479|FG002|Overall Study|Withdrawal by Subject|0|||
156843225|NCT01946152|566179480|FG003|Overall Study|Withdrawal by Subject|0|||
156843226|NCT01946152|566179477|FG000|Overall Study|Progression|0|||
156843227|NCT01946152|566179478|FG001|Overall Study|Progression|1|||
156843228|NCT01946152|566179479|FG002|Overall Study|Progression|4|||
156843229|NCT01946152|566179480|FG003|Overall Study|Progression|7|||
156843230|NCT01946152|566179477|FG000|Overall Study|Physician Decision|0|||
156843231|NCT01946152|566179478|FG001|Overall Study|Physician Decision|0|||
156843232|NCT01946152|566179479|FG002|Overall Study|Physician Decision|1|||
156843233|NCT01946152|566179480|FG003|Overall Study|Physician Decision|0|||
156843234|NCT01946152|566179477|FG000|Overall Study|Second malignancy|0|||
156843235|NCT01946152|566179478|FG001|Overall Study|Second malignancy|0|||
156843236|NCT01946152|566179479|FG002|Overall Study|Second malignancy|1|||
156843237|NCT01946152|566179480|FG003|Overall Study|Second malignancy|0|||
156843238|NCT01946152|566179477|FG000|Overall Study|Adverse Event|0|||
156843239|NCT01946152|566179478|FG001|Overall Study|Adverse Event|0|||
156843240|NCT01946152|566179479|FG002|Overall Study|Adverse Event|0|||
156843241|NCT01946152|566179480|FG003|Overall Study|Adverse Event|1|||
156843242|NCT03712787|566179481|FG000|Overall Study|Adverse Event|2|||
156843243|NCT03712787|566179482|FG001|Overall Study|Adverse Event|3|||
156843244|NCT03712787|566179483|FG002|Overall Study|Adverse Event|0|||
156843245|NCT03712787|566179484|FG003|Overall Study|Adverse Event|4|||
156843246|NCT03712787|566179481|FG000|Overall Study|Withdrawal by Subject|4|||
156843247|NCT03712787|566179482|FG001|Overall Study|Withdrawal by Subject|14|||
156843248|NCT03712787|566179483|FG002|Overall Study|Withdrawal by Subject|12|||
156843249|NCT03712787|566179484|FG003|Overall Study|Withdrawal by Subject|8|||
156843250|NCT03712787|566179481|FG000|Overall Study|Lost to Follow-up|1|||
156843251|NCT03712787|566179482|FG001|Overall Study|Lost to Follow-up|1|||
156843252|NCT03712787|566179483|FG002|Overall Study|Lost to Follow-up|2|||
156843253|NCT03712787|566179484|FG003|Overall Study|Lost to Follow-up|1|||
156843254|NCT03712787|566179481|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
156843255|NCT03712787|566179482|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
156843256|NCT03712787|566179483|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
156843257|NCT03712787|566179484|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
156843258|NCT03712787|566179481|FG000|Overall Study|COVID-19 Infection|0|||
156843259|NCT03712787|566179482|FG001|Overall Study|COVID-19 Infection|1|||
156843260|NCT03712787|566179483|FG002|Overall Study|COVID-19 Infection|0|||
156843261|NCT03712787|566179484|FG003|Overall Study|COVID-19 Infection|0|||
156843262|NCT03712787|566179481|FG000|Overall Study|Other, Not Specified|79|||
156843263|NCT03712787|566179482|FG001|Overall Study|Other, Not Specified|77|||
156843264|NCT03712787|566179483|FG002|Overall Study|Other, Not Specified|74|||
156843265|NCT03712787|566179484|FG003|Overall Study|Other, Not Specified|78|||
156843266|NCT01865448|566179485|FG000|Overall Study|Adverse Event|1|||
156843267|NCT01865448|566179486|FG001|Overall Study|Adverse Event|1|||
156843268|NCT01865448|566179485|FG000|Overall Study|Pregnancy|0|||
156843269|NCT01865448|566179486|FG001|Overall Study|Pregnancy|1|||
156843270|NCT01865448|566179485|FG000|Overall Study|dropout unrelated to study|1|||
156843271|NCT01865448|566179486|FG001|Overall Study|dropout unrelated to study|1|||
156843272|NCT00799266|566179487|FG000|Overall Study|Adverse Event|0|||
156843273|NCT00799266|566179488|FG001|Overall Study|Adverse Event|1|||
156843274|NCT00799266|566179487|FG000|Overall Study|Subject withdrew consent|3|||
156843275|NCT00799266|566179488|FG001|Overall Study|Subject withdrew consent|0|||
156843276|NCT04794270|566179489|FG000|Period 1|Non Compliance|1|||
156843277|NCT04794270|566179490|FG001|Period 1|Non Compliance|0|||
156843278|NCT04794270|566179489|FG000|Period 1|Adverse Event|1|||
156843279|NCT04794270|566179490|FG001|Period 1|Adverse Event|0|||
156843280|NCT04794270|566179489|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
156843281|NCT04794270|566179490|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
156843282|NCT00265317|566179494|FG000|Lead-In|Objective progression or relapse|6|||
156843283|NCT00265317|566179495|FG001|Lead-In|Objective progression or relapse|11|||
156843284|NCT00265317|566179496|FG002|Lead-In|Objective progression or relapse|0|||
156843285|NCT00265317|566179497|FG003|Lead-In|Objective progression or relapse|0|||
156843286|NCT00265317|566179494|FG000|Lead-In|Adverse Event|2|||
156843287|NCT00265317|566179495|FG001|Lead-In|Adverse Event|1|||
156843288|NCT00265317|566179496|FG002|Lead-In|Adverse Event|0|||
156843289|NCT00265317|566179497|FG003|Lead-In|Adverse Event|0|||
156843290|NCT00265317|566179494|FG000|Lead-In|Death|3|||
156843291|NCT00265317|566179495|FG001|Lead-In|Death|5|||
156843292|NCT00265317|566179496|FG002|Lead-In|Death|0|||
156843293|NCT00265317|566179497|FG003|Lead-In|Death|0|||
156843294|NCT00265317|566179494|FG000|Lead-In|Withdrawal/other than adverse event|1|||
156843295|NCT00265317|566179495|FG001|Lead-In|Withdrawal/other than adverse event|0|||
156843296|NCT00265317|566179496|FG002|Lead-In|Withdrawal/other than adverse event|0|||
156843297|NCT00265317|566179497|FG003|Lead-In|Withdrawal/other than adverse event|0|||
156843298|NCT00265317|566179494|FG000|Phase 2|Objective progression or relapse|0|||
156843299|NCT00265317|566179495|FG001|Phase 2|Objective progression or relapse|0|||
156843300|NCT00265317|566179496|FG002|Phase 2|Objective progression or relapse|37|||
156843301|NCT00265317|566179497|FG003|Phase 2|Objective progression or relapse|38|||
156843302|NCT00265317|566179494|FG000|Phase 2|Global deterioration of health status|0|||
156843303|NCT00265317|566179495|FG001|Phase 2|Global deterioration of health status|0|||
156843304|NCT00265317|566179496|FG002|Phase 2|Global deterioration of health status|3|||
156843305|NCT00265317|566179497|FG003|Phase 2|Global deterioration of health status|0|||
156843306|NCT00265317|566179494|FG000|Phase 2|Adverse Event|0|||
156843307|NCT00265317|566179495|FG001|Phase 2|Adverse Event|0|||
156843308|NCT00265317|566179496|FG002|Phase 2|Adverse Event|7|||
156843309|NCT00265317|566179497|FG003|Phase 2|Adverse Event|5|||
156843310|NCT00265317|566179494|FG000|Phase 2|Death|0|||
156843311|NCT00265317|566179495|FG001|Phase 2|Death|0|||
156843312|NCT00265317|566179496|FG002|Phase 2|Death|12|||
156843313|NCT00265317|566179497|FG003|Phase 2|Death|15|||
156843314|NCT00265317|566179494|FG000|Phase 2|Protocol Violation|0|||
156843315|NCT00265317|566179495|FG001|Phase 2|Protocol Violation|0|||
156843316|NCT00265317|566179496|FG002|Phase 2|Protocol Violation|1|||
156843317|NCT00265317|566179497|FG003|Phase 2|Protocol Violation|4|||
156843318|NCT00265317|566179494|FG000|Phase 2|Lost to Follow-up|0|||
156843319|NCT00265317|566179495|FG001|Phase 2|Lost to Follow-up|0|||
156843320|NCT00265317|566179496|FG002|Phase 2|Lost to Follow-up|0|||
156843321|NCT00265317|566179497|FG003|Phase 2|Lost to Follow-up|1|||
156843322|NCT00265317|566179494|FG000|Phase 2|Withdrawal/other than adverse event|0|||
156843323|NCT00265317|566179495|FG001|Phase 2|Withdrawal/other than adverse event|0|||
156843324|NCT00265317|566179496|FG002|Phase 2|Withdrawal/other than adverse event|2|||
156843325|NCT00265317|566179497|FG003|Phase 2|Withdrawal/other than adverse event|1|||
156843326|NCT00265317|566179494|FG000|Phase 2|Study terminated by sponsor|0|||
156843327|NCT00265317|566179495|FG001|Phase 2|Study terminated by sponsor|0|||
156843328|NCT00265317|566179496|FG002|Phase 2|Study terminated by sponsor|1|||
156843329|NCT00265317|566179497|FG003|Phase 2|Study terminated by sponsor|0|||
156843330|NCT00265317|566179494|FG000|Phase 2|Other|0|||
156843331|NCT00265317|566179495|FG001|Phase 2|Other|0|||
156843332|NCT00265317|566179496|FG002|Phase 2|Other|1|||
156843333|NCT00265317|566179497|FG003|Phase 2|Other|1|||
156843334|NCT00732875|566179498|FG000|Overall Study|Adverse Event|16|||
156843335|NCT00732875|566179498|FG000|Overall Study|Withdrawal by Subject|6|||
156843336|NCT00732875|566179498|FG000|Overall Study|Lack of Efficacy|13|||
156843337|NCT02300259|566179499|FG000|Period 1|Adverse Event|0|||
156843338|NCT02300259|566179500|FG001|Period 1|Adverse Event|0|||
156843339|NCT02300259|566179501|FG002|Period 1|Adverse Event|1|||
156843340|NCT02300259|566179499|FG000|Period 1|Withdrawal by Subject|0|||
156843341|NCT02300259|566179500|FG001|Period 1|Withdrawal by Subject|0|||
156843342|NCT02300259|566179501|FG002|Period 1|Withdrawal by Subject|1|||
156843343|NCT02300259|566179499|FG000|Period 2|Adverse Event|1|||
156843344|NCT02300259|566179500|FG001|Period 2|Adverse Event|0|||
156843345|NCT02300259|566179501|FG002|Period 2|Adverse Event|0|||
156843346|NCT02300259|566179499|FG000|Period 2|Withdrawal by Subject|0|||
156843347|NCT02300259|566179500|FG001|Period 2|Withdrawal by Subject|0|||
156843348|NCT02300259|566179501|FG002|Period 2|Withdrawal by Subject|1|||
156843349|NCT02510001|566179502|FG000|Overall Study|Early disease progression|0|||
156843350|NCT02510001|566179503|FG001|Overall Study|Early disease progression|0|||
156843351|NCT02510001|566179504|FG002|Overall Study|Early disease progression|0|||
156843352|NCT02510001|566179505|FG003|Overall Study|Early disease progression|1|||
156843353|NCT02510001|566179506|FG004|Overall Study|Early disease progression|1|||
156843354|NCT02510001|566179507|FG005|Overall Study|Early disease progression|1|||
156843355|NCT02510001|566179508|FG006|Overall Study|Early disease progression|0|||
156843356|NCT02510001|566179509|FG007|Overall Study|Early disease progression|0|||
156843357|NCT02510001|566179502|FG000|Overall Study|Adverse Event|0|||
156470004|NCT05580003|564814891|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156470005|NCT05580003|564814892|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156470006|NCT05580003|564814893|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156843358|NCT02510001|566179503|FG001|Overall Study|Adverse Event|0|||
156843359|NCT02510001|566179504|FG002|Overall Study|Adverse Event|0|||
156843360|NCT02510001|566179505|FG003|Overall Study|Adverse Event|1|||
156843361|NCT02510001|566179506|FG004|Overall Study|Adverse Event|2|||
156843362|NCT02510001|566179507|FG005|Overall Study|Adverse Event|1|||
156843363|NCT02510001|566179508|FG006|Overall Study|Adverse Event|2|||
156843364|NCT02510001|566179509|FG007|Overall Study|Adverse Event|5|||
156843365|NCT02510001|566179502|FG000|Overall Study|Physician Decision|0|||
156843366|NCT02510001|566179503|FG001|Overall Study|Physician Decision|0|||
156470007|NCT05580003|564814894|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156470008|NCT05580003|564814895|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
156843367|NCT02510001|566179504|FG002|Overall Study|Physician Decision|0|||
156843368|NCT02510001|566179505|FG003|Overall Study|Physician Decision|0|||
156843369|NCT02510001|566179506|FG004|Overall Study|Physician Decision|1|||
156843370|NCT02510001|566179507|FG005|Overall Study|Physician Decision|0|||
156843371|NCT02510001|566179508|FG006|Overall Study|Physician Decision|0|||
156843372|NCT02510001|566179509|FG007|Overall Study|Physician Decision|0|||
156843373|NCT02510001|566179502|FG000|Overall Study|Withdrawal by Subject|0|||
156843374|NCT02510001|566179503|FG001|Overall Study|Withdrawal by Subject|0|||
156843375|NCT02510001|566179504|FG002|Overall Study|Withdrawal by Subject|0|||
156843376|NCT02510001|566179505|FG003|Overall Study|Withdrawal by Subject|0|||
156843377|NCT02510001|566179506|FG004|Overall Study|Withdrawal by Subject|0|||
156843378|NCT02510001|566179507|FG005|Overall Study|Withdrawal by Subject|0|||
156843379|NCT02510001|566179508|FG006|Overall Study|Withdrawal by Subject|0|||
156843380|NCT02510001|566179509|FG007|Overall Study|Withdrawal by Subject|2|||
156843381|NCT01504841|566179511|FG000|Overall Study|Withdrawal by Subject|1|||
156843382|NCT01504841|566179512|FG001|Overall Study|Withdrawal by Subject|1|||
156843383|NCT01504841|566179513|FG002|Overall Study|Withdrawal by Subject|0|||
156843384|NCT03149055|566179518|FG000|Overall Study|Not treated|4|||
156843385|NCT04440813|566179519|FG000|Overall Study|Lost to Follow-up|5|||
156843386|NCT04440813|566179520|FG001|Overall Study|Lost to Follow-up|5|||
156843387|NCT00291018|566179523|FG000|Overall Study|Not Consented or Declined PAS|12|||
156843388|NCT00291018|566179524|FG001|Overall Study|Not Consented or Declined PAS|15|||
156843389|NCT00291018|566179525|FG002|Overall Study|Not Consented or Declined PAS|15|||
156843390|NCT00291018|566179523|FG000|Overall Study|Death|3|||
156843391|NCT00291018|566179524|FG001|Overall Study|Death|3|||
156843392|NCT00291018|566179525|FG002|Overall Study|Death|4|||
156843393|NCT00291018|566179523|FG000|Overall Study|Withdrawal by Subject|2|||
156843394|NCT00291018|566179524|FG001|Overall Study|Withdrawal by Subject|8|||
156843395|NCT00291018|566179525|FG002|Overall Study|Withdrawal by Subject|1|||
156843396|NCT00291018|566179523|FG000|Overall Study|Failures|5|||
156843397|NCT00291018|566179524|FG001|Overall Study|Failures|12|||
156843398|NCT00291018|566179525|FG002|Overall Study|Failures|5|||
156843399|NCT00291018|566179523|FG000|Overall Study|Lost to Follow-up|3|||
156843400|NCT00291018|566179524|FG001|Overall Study|Lost to Follow-up|4|||
156843401|NCT00291018|566179525|FG002|Overall Study|Lost to Follow-up|18|||
156843402|NCT00630344|566179526|FG000|Overall Study|Adverse Event|5|||
156843403|NCT00630344|566179526|FG000|Overall Study|Progressive Disease|19|||
156843404|NCT00630344|566179526|FG000|Overall Study|Physician Decision|9|||
156843405|NCT00630344|566179526|FG000|Overall Study|Withdrawal by Subject|1|||
156843406|NCT00630344|566179526|FG000|Overall Study|Intercurrent Illness|1|||
156843407|NCT00630344|566179526|FG000|Overall Study|Other|1|||
156843408|NCT01440816|566179527|FG000|Overall Study|Disease Progression|0|||
156843409|NCT01440816|566179528|FG001|Overall Study|Disease Progression|9|||
156843410|NCT01440816|566179527|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
156843411|NCT01440816|566179528|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
156843412|NCT02462720|566179529|FG000|Part 2|Withdrawal by Subject|1|||
156843413|NCT02462720|566179530|FG001|Part 2|Withdrawal by Subject|0|||
156843414|NCT02462720|566179529|FG000|Part 2|Protocol Violation|0|||
156843415|NCT02462720|566179530|FG001|Part 2|Protocol Violation|1|||
156843416|NCT01835158|566179534|FG000|Overall Study|Withdrawal by Subject|1|||
156843417|NCT01835158|566179535|FG001|Overall Study|Withdrawal by Subject|6|||
156843418|NCT03078855|566179541|FG000|Overall Study|Lack of Efficacy|62|||
156843419|NCT03078855|566179542|FG001|Overall Study|Lack of Efficacy|31|||
156843420|NCT03078855|566179541|FG000|Overall Study|Death|1|||
156843421|NCT03078855|566179542|FG001|Overall Study|Death|0|||
156843422|NCT03078855|566179541|FG000|Overall Study|Withdrawal by Subject|12|||
156843423|NCT03078855|566179542|FG001|Overall Study|Withdrawal by Subject|6|||
156843424|NCT03078855|566179541|FG000|Overall Study|Physician Decision|3|||
156843425|NCT03078855|566179542|FG001|Overall Study|Physician Decision|2|||
156341584|NCT02405780|564348572|FG001|Period II|Non-compliance with study procedures|2|||
156843426|NCT03078855|566179541|FG000|Overall Study|Second Malignancy|4|||
156843427|NCT03078855|566179542|FG001|Overall Study|Second Malignancy|0|||
156341585|NCT02405780|564348573|FG002|Period II|Non-compliance with study procedures|7|||
156843428|NCT03078855|566179541|FG000|Overall Study|Ineligible|2|||
156843429|NCT03078855|566179542|FG001|Overall Study|Ineligible|0|||
156341586|NCT02405780|564348574|FG003|Period II|Non-compliance with study procedures|4|||
156843430|NCT03078855|566179541|FG000|Overall Study|Withdrew before day 1 treatment|2|||
156843431|NCT03078855|566179542|FG001|Overall Study|Withdrew before day 1 treatment|1|||
156341587|NCT01654536|564348575|FG000|Overall Study|Lost to Follow-up|5|||
156843432|NCT00391027|566179543|FG000|Overall Study|Adverse Event|8|||
156843433|NCT00391027|566179544|FG001|Overall Study|Adverse Event|8|||
156843434|NCT00391027|566179543|FG000|Overall Study|Lack of Efficacy|3|||
156843435|NCT00391027|566179544|FG001|Overall Study|Lack of Efficacy|0|||
156843436|NCT00391027|566179543|FG000|Overall Study|Withdrawal by Subject|10|||
156843437|NCT00391027|566179544|FG001|Overall Study|Withdrawal by Subject|1|||
156843438|NCT00391027|566179543|FG000|Overall Study|Other|4|||
156843439|NCT00391027|566179544|FG001|Overall Study|Other|3|||
156843440|NCT03194646|566179545|FG000|Overall Study|Adverse Event|24|||
156843441|NCT03194646|566179546|FG001|Overall Study|Adverse Event|25|||
156843442|NCT03194646|566179547|FG002|Overall Study|Adverse Event|14|||
156843443|NCT03194646|566179548|FG003|Overall Study|Adverse Event|17|||
156843444|NCT03194646|566179545|FG000|Overall Study|Lack of Efficacy|4|||
156843445|NCT03194646|566179546|FG001|Overall Study|Lack of Efficacy|2|||
156843446|NCT03194646|566179547|FG002|Overall Study|Lack of Efficacy|2|||
156843447|NCT03194646|566179548|FG003|Overall Study|Lack of Efficacy|12|||
156843448|NCT03194646|566179545|FG000|Overall Study|Lost to Follow-up|30|||
156843449|NCT03194646|566179546|FG001|Overall Study|Lost to Follow-up|22|||
156843450|NCT03194646|566179547|FG002|Overall Study|Lost to Follow-up|12|||
156843451|NCT03194646|566179548|FG003|Overall Study|Lost to Follow-up|35|||
156843452|NCT03194646|566179545|FG000|Overall Study|Non-compliance with study drug|4|||
156843453|NCT03194646|566179546|FG001|Overall Study|Non-compliance with study drug|0|||
156843454|NCT03194646|566179547|FG002|Overall Study|Non-compliance with study drug|1|||
156843455|NCT03194646|566179548|FG003|Overall Study|Non-compliance with study drug|1|||
156843456|NCT03194646|566179545|FG000|Overall Study|Other|89|||
156843457|NCT03194646|566179546|FG001|Overall Study|Other|68|||
156843458|NCT03194646|566179547|FG002|Overall Study|Other|34|||
156843459|NCT03194646|566179548|FG003|Overall Study|Other|31|||
156843460|NCT03194646|566179545|FG000|Overall Study|Physician Decision|7|||
156843461|NCT03194646|566179546|FG001|Overall Study|Physician Decision|9|||
156843462|NCT03194646|566179547|FG002|Overall Study|Physician Decision|5|||
156843463|NCT03194646|566179548|FG003|Overall Study|Physician Decision|4|||
156843464|NCT03194646|566179545|FG000|Overall Study|Pregnancy|4|||
156843465|NCT03194646|566179546|FG001|Overall Study|Pregnancy|5|||
156843466|NCT03194646|566179547|FG002|Overall Study|Pregnancy|1|||
156843467|NCT03194646|566179548|FG003|Overall Study|Pregnancy|2|||
156843468|NCT03194646|566179545|FG000|Overall Study|Protocol Violation|4|||
156843469|NCT03194646|566179546|FG001|Overall Study|Protocol Violation|2|||
156843470|NCT03194646|566179547|FG002|Overall Study|Protocol Violation|1|||
156843471|NCT03194646|566179548|FG003|Overall Study|Protocol Violation|1|||
156843472|NCT03194646|566179545|FG000|Overall Study|Site terminated by sponsor|0|||
156843473|NCT03194646|566179546|FG001|Overall Study|Site terminated by sponsor|0|||
156843474|NCT03194646|566179547|FG002|Overall Study|Site terminated by sponsor|2|||
156843475|NCT03194646|566179548|FG003|Overall Study|Site terminated by sponsor|0|||
156843476|NCT03194646|566179545|FG000|Overall Study|Study terminated by sponsor|62|||
156843477|NCT03194646|566179546|FG001|Overall Study|Study terminated by sponsor|61|||
156843478|NCT03194646|566179547|FG002|Overall Study|Study terminated by sponsor|30|||
156843479|NCT03194646|566179548|FG003|Overall Study|Study terminated by sponsor|34|||
156843480|NCT03194646|566179545|FG000|Overall Study|Withdrawal by Subject|75|||
156843481|NCT03194646|566179546|FG001|Overall Study|Withdrawal by Subject|74|||
156843482|NCT03194646|566179547|FG002|Overall Study|Withdrawal by Subject|36|||
156843483|NCT03194646|566179548|FG003|Overall Study|Withdrawal by Subject|131|||
156843484|NCT03194646|566179545|FG000|Overall Study|Missing|1|||
156843485|NCT03194646|566179546|FG001|Overall Study|Missing|0|||
156843486|NCT03194646|566179547|FG002|Overall Study|Missing|1|||
156843487|NCT03194646|566179548|FG003|Overall Study|Missing|12|||
156843488|NCT04164732|566179550|FG000|Treatment run-in Period|Adverse Event|4|||
156843489|NCT04164732|566179551|FG001|Treatment run-in Period|Adverse Event|0|||
156843490|NCT04164732|566179552|FG002|Treatment run-in Period|Adverse Event|0|||
156843491|NCT04164732|566179550|FG000|Treatment run-in Period|Physician Decision|1|||
156843492|NCT04164732|566179551|FG001|Treatment run-in Period|Physician Decision|0|||
156843493|NCT04164732|566179552|FG002|Treatment run-in Period|Physician Decision|0|||
156843494|NCT04164732|566179550|FG000|Treatment run-in Period|Screen Failure|1|||
156843495|NCT04164732|566179551|FG001|Treatment run-in Period|Screen Failure|0|||
156843496|NCT04164732|566179552|FG002|Treatment run-in Period|Screen Failure|0|||
156843497|NCT04164732|566179550|FG000|Randomized Treatment Period|Adverse Event|0|||
156843498|NCT04164732|566179551|FG001|Randomized Treatment Period|Adverse Event|1|||
156843499|NCT04164732|566179552|FG002|Randomized Treatment Period|Adverse Event|0|||
156843500|NCT04164732|566179550|FG000|Randomized Treatment Period|Protocol Deviation|0|||
156843501|NCT04164732|566179551|FG001|Randomized Treatment Period|Protocol Deviation|1|||
156843502|NCT04164732|566179552|FG002|Randomized Treatment Period|Protocol Deviation|1|||
156843503|NCT04164732|566179550|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
156843504|NCT04164732|566179551|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
156341588|NCT01654536|564348576|FG001|Overall Study|Lost to Follow-up|5|||
156843505|NCT04164732|566179552|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
156843506|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
156843507|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
156843508|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
156843509|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
156843510|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Death|2|||
156843511|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Death|2|||
156843512|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Death|0|||
156843513|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Death|0|||
156843514|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
156843515|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
156843516|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
156843517|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
156843518|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
156843519|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
156843520|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
156843521|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
156843522|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
156843523|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
156843524|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
156843525|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
156843526|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
156843527|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
156843528|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
156843529|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
156843530|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
156843531|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
156843532|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
156843533|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
156843534|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
156341589|NCT01654536|564348575|FG000|Overall Study|Physician Decision|12|||
156341590|NCT01654536|564348576|FG001|Overall Study|Physician Decision|8|||
156341591|NCT01654536|564348575|FG000|Overall Study|Withdrawal by Subject|27|||
156341592|NCT01654536|564348576|FG001|Overall Study|Withdrawal by Subject|25|||
156470009|NCT05580003|564814868|FG000|Part 6 Period 2 (Day 1)|Other|0|||
156470010|NCT05580003|564814869|FG001|Part 6 Period 2 (Day 1)|Other|0|||
156470011|NCT05580003|564814870|FG002|Part 6 Period 2 (Day 1)|Other|0|||
156470012|NCT05580003|564814871|FG003|Part 6 Period 2 (Day 1)|Other|0|||
156843535|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
156843536|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
156843537|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
156843538|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
156843539|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
156843540|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
156843541|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
156843542|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Death|0|||
156843543|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Death|0|||
156843544|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Death|0|||
156843545|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Death|1|||
156843546|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
156843547|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
156843548|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
156843549|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
156843550|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
156843551|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
156843552|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
156843553|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
156843554|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
156843555|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
156470013|NCT05580003|564814872|FG004|Part 6 Period 2 (Day 1)|Other|0|||
156843556|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
156843557|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
156843558|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
156843559|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
156843560|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
156843561|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
156843562|NCT01009086|566179557|FG000|Overall Study|Lack of Efficacy|16|||
156843563|NCT01009086|566179558|FG001|Overall Study|Lack of Efficacy|15|||
156843564|NCT01009086|566179559|FG002|Overall Study|Lack of Efficacy|9|||
156843565|NCT01009086|566179557|FG000|Overall Study|Lost to Follow-up|4|||
156843566|NCT01009086|566179558|FG001|Overall Study|Lost to Follow-up|5|||
156843567|NCT01009086|566179559|FG002|Overall Study|Lost to Follow-up|3|||
156843568|NCT01009086|566179557|FG000|Overall Study|Adverse Event|12|||
156843569|NCT01009086|566179558|FG001|Overall Study|Adverse Event|11|||
156843570|NCT01009086|566179559|FG002|Overall Study|Adverse Event|8|||
156843571|NCT01009086|566179557|FG000|Overall Study|Withdrawal by Subject|9|||
156843572|NCT01009086|566179558|FG001|Overall Study|Withdrawal by Subject|11|||
156843573|NCT01009086|566179559|FG002|Overall Study|Withdrawal by Subject|13|||
156843574|NCT01009086|566179557|FG000|Overall Study|Other|3|||
156843575|NCT01009086|566179558|FG001|Overall Study|Other|5|||
156843576|NCT01009086|566179559|FG002|Overall Study|Other|1|||
156843577|NCT01361178|566179561|FG000|Overall Study|Death|13|||
156843578|NCT01361178|566179562|FG001|Overall Study|Death|0|||
156843579|NCT00767819|566179563|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
156843580|NCT00767819|566179564|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
156843581|NCT00767819|566179565|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156843582|NCT00767819|566179563|FG000|Overall Study|Withdrawal by Subject|1|||
156843583|NCT00767819|566179564|FG001|Overall Study|Withdrawal by Subject|1|||
156843584|NCT00767819|566179565|FG002|Overall Study|Withdrawal by Subject|0|||
156843585|NCT00767819|566179563|FG000|Overall Study|Administrative problems|0|||
156843586|NCT00767819|566179564|FG001|Overall Study|Administrative problems|1|||
156843587|NCT00767819|566179565|FG002|Overall Study|Administrative problems|0|||
156843588|NCT00767819|566179563|FG000|Overall Study|Death|2|||
156843589|NCT00767819|566179564|FG001|Overall Study|Death|3|||
156843590|NCT00767819|566179565|FG002|Overall Study|Death|0|||
156843591|NCT00767819|566179563|FG000|Overall Study|Adverse Event|2|||
156843592|NCT00767819|566179564|FG001|Overall Study|Adverse Event|0|||
156843593|NCT00767819|566179565|FG002|Overall Study|Adverse Event|0|||
156843594|NCT00767819|566179563|FG000|Overall Study|Abnormal lab values|1|||
156843595|NCT00767819|566179564|FG001|Overall Study|Abnormal lab values|0|||
156470014|NCT05580003|564814873|FG005|Part 6 Period 2 (Day 1)|Other|0|||
156470015|NCT05580003|564814874|FG006|Part 6 Period 2 (Day 1)|Other|0|||
156470016|NCT05580003|564814875|FG007|Part 6 Period 2 (Day 1)|Other|0|||
156470017|NCT05580003|564814876|FG008|Part 6 Period 2 (Day 1)|Other|0|||
156470018|NCT05580003|564814877|FG009|Part 6 Period 2 (Day 1)|Other|0|||
156470019|NCT05580003|564814878|FG010|Part 6 Period 2 (Day 1)|Other|0|||
156470020|NCT05580003|564814879|FG011|Part 6 Period 2 (Day 1)|Other|0|||
156470021|NCT05580003|564814880|FG012|Part 6 Period 2 (Day 1)|Other|0|||
156470022|NCT05580003|564814881|FG013|Part 6 Period 2 (Day 1)|Other|0|||
156843596|NCT00767819|566179565|FG002|Overall Study|Abnormal lab values|0|||
156843597|NCT00767819|566179563|FG000|Overall Study|Lost to Follow-up|1|||
156843598|NCT00767819|566179564|FG001|Overall Study|Lost to Follow-up|0|||
156843599|NCT00767819|566179565|FG002|Overall Study|Lost to Follow-up|0|||
156843600|NCT04294147|566179566|FG000|Overall Study|Protocol Violation|2|||
156843601|NCT04294147|566179567|FG001|Overall Study|Protocol Violation|0|||
156843602|NCT03916081|566179572|FG000|Overall Study|Adverse Event|1|||
156470023|NCT05580003|564814882|FG014|Part 6 Period 2 (Day 1)|Other|0|||
156470024|NCT05580003|564814883|FG015|Part 6 Period 2 (Day 1)|Other|0|||
156470025|NCT05580003|564814884|FG016|Part 6 Period 2 (Day 1)|Other|0|||
156470026|NCT05580003|564814885|FG017|Part 6 Period 2 (Day 1)|Other|0|||
156843603|NCT03916081|566179573|FG001|Overall Study|Adverse Event|0|||
156843604|NCT03916081|566179574|FG002|Overall Study|Adverse Event|0|||
156843605|NCT03916081|566179572|FG000|Overall Study|Physician Decision|0|||
156470027|NCT05580003|564814886|FG018|Part 6 Period 2 (Day 1)|Other|0|||
156470028|NCT05580003|564814887|FG019|Part 6 Period 2 (Day 1)|Other|0|||
156470029|NCT05580003|564814888|FG020|Part 6 Period 2 (Day 1)|Other|0|||
156470030|NCT05580003|564814889|FG021|Part 6 Period 2 (Day 1)|Other|0|||
156470031|NCT05580003|564814890|FG022|Part 6 Period 2 (Day 1)|Other|0|||
156470032|NCT05580003|564814891|FG023|Part 6 Period 2 (Day 1)|Other|0|||
156470033|NCT05580003|564814892|FG024|Part 6 Period 2 (Day 1)|Other|1|||
156470034|NCT05580003|564814893|FG025|Part 6 Period 2 (Day 1)|Other|0|||
156470035|NCT05580003|564814894|FG026|Part 6 Period 2 (Day 1)|Other|0|||
156843606|NCT03916081|566179573|FG001|Overall Study|Physician Decision|0|||
156843607|NCT03916081|566179574|FG002|Overall Study|Physician Decision|1|||
156843608|NCT03916081|566179572|FG000|Overall Study|Lost to Follow-up|0|||
156843609|NCT03916081|566179573|FG001|Overall Study|Lost to Follow-up|1|||
156843610|NCT03916081|566179574|FG002|Overall Study|Lost to Follow-up|0|||
156843611|NCT03916081|566179572|FG000|Overall Study|Withdrawal by Subject|3|||
156843612|NCT03916081|566179573|FG001|Overall Study|Withdrawal by Subject|0|||
156843613|NCT03916081|566179574|FG002|Overall Study|Withdrawal by Subject|1|||
156843614|NCT03916081|566179572|FG000|Overall Study|Worsening of AD|0|||
156843615|NCT03916081|566179573|FG001|Overall Study|Worsening of AD|0|||
156843616|NCT03916081|566179574|FG002|Overall Study|Worsening of AD|1|||
156843617|NCT01371305|566179578|FG000|Overall Study|Adverse Event|0|||
156843618|NCT01371305|566179579|FG001|Overall Study|Adverse Event|0|||
156843619|NCT01371305|566179580|FG002|Overall Study|Adverse Event|0|||
156843620|NCT01371305|566179581|FG003|Overall Study|Adverse Event|2|||
156843621|NCT01371305|566179582|FG004|Overall Study|Adverse Event|1|||
156843622|NCT01371305|566179583|FG005|Overall Study|Adverse Event|0|||
156843623|NCT01371305|566179578|FG000|Overall Study|Study terminated by sponsor|0|||
156843624|NCT01371305|566179579|FG001|Overall Study|Study terminated by sponsor|0|||
156843625|NCT01371305|566179580|FG002|Overall Study|Study terminated by sponsor|0|||
156843626|NCT01371305|566179581|FG003|Overall Study|Study terminated by sponsor|0|||
156843627|NCT01371305|566179582|FG004|Overall Study|Study terminated by sponsor|3|||
156843628|NCT01371305|566179583|FG005|Overall Study|Study terminated by sponsor|1|||
156843629|NCT01371305|566179578|FG000|Overall Study|Subject request|0|||
156843630|NCT01371305|566179579|FG001|Overall Study|Subject request|0|||
156843631|NCT01371305|566179580|FG002|Overall Study|Subject request|0|||
156843632|NCT01371305|566179581|FG003|Overall Study|Subject request|0|||
156843633|NCT01371305|566179582|FG004|Overall Study|Subject request|0|||
156843634|NCT01371305|566179583|FG005|Overall Study|Subject request|1|||
156843635|NCT04038567|566179584|FG000|Overall Study|Lost to Follow-up|6|||
156843636|NCT04038567|566179585|FG001|Overall Study|Lost to Follow-up|4|||
156843637|NCT04038567|566179586|FG002|Overall Study|Lost to Follow-up|5|||
156843638|NCT04038567|566179587|FG003|Overall Study|Lost to Follow-up|4|||
156843639|NCT04038567|566179588|FG004|Overall Study|Lost to Follow-up|6|||
156843640|NCT04038567|566179589|FG005|Overall Study|Lost to Follow-up|4|||
156843641|NCT04038567|566179590|FG006|Overall Study|Lost to Follow-up|4|||
156843642|NCT04038567|566179591|FG007|Overall Study|Lost to Follow-up|1|||
156843643|NCT04038567|566179584|FG000|Overall Study|Withdrawal by Subject|2|||
156843644|NCT04038567|566179585|FG001|Overall Study|Withdrawal by Subject|1|||
156843645|NCT04038567|566179586|FG002|Overall Study|Withdrawal by Subject|1|||
156843646|NCT04038567|566179587|FG003|Overall Study|Withdrawal by Subject|1|||
156843647|NCT04038567|566179588|FG004|Overall Study|Withdrawal by Subject|4|||
156843648|NCT04038567|566179589|FG005|Overall Study|Withdrawal by Subject|1|||
156843649|NCT04038567|566179590|FG006|Overall Study|Withdrawal by Subject|1|||
156843650|NCT04038567|566179591|FG007|Overall Study|Withdrawal by Subject|1|||
156843651|NCT04038567|566179584|FG000|Overall Study|missed survey window|1|||
156843652|NCT04038567|566179585|FG001|Overall Study|missed survey window|2|||
156843653|NCT04038567|566179586|FG002|Overall Study|missed survey window|0|||
156843654|NCT04038567|566179587|FG003|Overall Study|missed survey window|0|||
156843655|NCT04038567|566179588|FG004|Overall Study|missed survey window|1|||
156843656|NCT04038567|566179589|FG005|Overall Study|missed survey window|1|||
156843657|NCT04038567|566179590|FG006|Overall Study|missed survey window|2|||
156843658|NCT04038567|566179591|FG007|Overall Study|missed survey window|2|||
156843659|NCT04038567|566179584|FG000|Overall Study|technical issues|0|||
156843660|NCT04038567|566179585|FG001|Overall Study|technical issues|0|||
156843661|NCT04038567|566179586|FG002|Overall Study|technical issues|0|||
156843662|NCT04038567|566179587|FG003|Overall Study|technical issues|0|||
156470036|NCT05580003|564814895|FG027|Part 6 Period 2 (Day 1)|Other|0|||
156843663|NCT04038567|566179588|FG004|Overall Study|technical issues|0|||
156843664|NCT04038567|566179589|FG005|Overall Study|technical issues|0|||
156470037|NCT03516812|564814896|FG000|Overall Study|Adverse Event|4|||
156470038|NCT03516812|564814896|FG000|Overall Study|Lack of Efficacy|2|||
156470039|NCT04795167|564814897|FG000|Overall Study|Death|1|||
156843665|NCT04038567|566179590|FG006|Overall Study|technical issues|1|||
156843666|NCT04038567|566179591|FG007|Overall Study|technical issues|0|||
156470040|NCT04795167|564814898|FG001|Overall Study|Death|18|||
156843667|NCT04038567|566179584|FG000|Overall Study|Medical issues (i.e., illness)|0|||
156843668|NCT04038567|566179585|FG001|Overall Study|Medical issues (i.e., illness)|1|||
156843669|NCT04038567|566179586|FG002|Overall Study|Medical issues (i.e., illness)|2|||
156843670|NCT04038567|566179587|FG003|Overall Study|Medical issues (i.e., illness)|1|||
156843671|NCT04038567|566179588|FG004|Overall Study|Medical issues (i.e., illness)|1|||
156843672|NCT04038567|566179589|FG005|Overall Study|Medical issues (i.e., illness)|1|||
156843673|NCT04038567|566179590|FG006|Overall Study|Medical issues (i.e., illness)|0|||
156843674|NCT04038567|566179591|FG007|Overall Study|Medical issues (i.e., illness)|0|||
156843675|NCT04038567|566179584|FG000|Overall Study|Death|0|||
156843676|NCT04038567|566179585|FG001|Overall Study|Death|0|||
156843677|NCT04038567|566179586|FG002|Overall Study|Death|0|||
156843678|NCT04038567|566179587|FG003|Overall Study|Death|1|||
156843679|NCT04038567|566179588|FG004|Overall Study|Death|1|||
156843680|NCT04038567|566179589|FG005|Overall Study|Death|0|||
156843681|NCT04038567|566179590|FG006|Overall Study|Death|0|||
156843682|NCT04038567|566179591|FG007|Overall Study|Death|1|||
156843683|NCT02726022|566179592|FG000|Overall Study|Adverse Event|14|||
156843684|NCT02726022|566179592|FG000|Overall Study|Treatment Failure|8|||
156843685|NCT02726022|566179592|FG000|Overall Study|Poor Compliance|13|||
156843686|NCT02726022|566179592|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
156843687|NCT03244826|566179602|FG000|Overall Study|Withdrawal by Subject|2|||
156843688|NCT03244826|566179603|FG001|Overall Study|Withdrawal by Subject|0|||
156843689|NCT03244826|566179602|FG000|Overall Study|Transplant delayed or withdrawn|12|||
156843690|NCT03244826|566179603|FG001|Overall Study|Transplant delayed or withdrawn|10|||
156843691|NCT04356352|566179604|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
156843692|NCT04356352|566179605|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
156843693|NCT04356352|566179606|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
156843694|NCT04356352|566179604|FG000|Overall Study|Protocol Violation|0|||
156843695|NCT04356352|566179605|FG001|Overall Study|Protocol Violation|3|||
156843696|NCT04356352|566179606|FG002|Overall Study|Protocol Violation|1|||
156843697|NCT00416455|566179609|FG000|Overall Study|PET / CT not done|3|||
156843698|NCT00416455|566179610|FG001|Overall Study|PET / CT not done|5|||
156843699|NCT00416455|566179609|FG000|Overall Study|PET / CT poor quality|2|||
156843700|NCT00416455|566179610|FG001|Overall Study|PET / CT poor quality|1|||
156843701|NCT00416455|566179609|FG000|Overall Study|Inadequate pathology|11|||
156843702|NCT00416455|566179610|FG001|Overall Study|Inadequate pathology|2|||
156843703|NCT02456857|566179611|FG000|Overall Study|Disease Progression|4|||
156843704|NCT00781859|566179612|FG000|Overall Study|Adverse Event|2|||
156843705|NCT00781859|566179613|FG001|Overall Study|Adverse Event|2|||
156843706|NCT00781859|566179612|FG000|Overall Study|Withdrawal by Subject|8|||
156843707|NCT00781859|566179613|FG001|Overall Study|Withdrawal by Subject|4|||
156843708|NCT00781859|566179612|FG000|Overall Study|Lost to Follow-up|6|||
156843709|NCT00781859|566179613|FG001|Overall Study|Lost to Follow-up|3|||
156843710|NCT00781859|566179612|FG000|Overall Study|Death|3|||
156843711|NCT00781859|566179613|FG001|Overall Study|Death|0|||
156843712|NCT01983774|566179614|FG000|Overall Study|Lung Transplant|0|||
156843713|NCT01983774|566179615|FG001|Overall Study|Lung Transplant|1|||
156843714|NCT01983774|566179614|FG000|Overall Study|Lost to Follow-up|1|||
156843715|NCT01983774|566179615|FG001|Overall Study|Lost to Follow-up|0|||
156843716|NCT01138501|566179616|FG000|Overall Study|Protocol Violation|2|||
156843717|NCT01138501|566179616|FG000|Overall Study|Withdrawal by Subject|3|||
156843718|NCT01339897|566179617|FG000|Overall Study|Adverse Event|1|||
156843719|NCT01339897|566179618|FG001|Overall Study|Adverse Event|0|||
156843720|NCT01339897|566179619|FG002|Overall Study|Adverse Event|0|||
156843721|NCT01339897|566179620|FG003|Overall Study|Adverse Event|1|||
156843722|NCT00847197|566179622|FG000|Overall Study|Adverse Event|21|||
156843723|NCT00847197|566179623|FG001|Overall Study|Adverse Event|3|||
156843724|NCT00847197|566179622|FG000|Overall Study|Protocol Violation|0|||
156843725|NCT00847197|566179623|FG001|Overall Study|Protocol Violation|1|||
156843726|NCT00847197|566179622|FG000|Overall Study|Withdrawal by Subject|3|||
156843727|NCT00847197|566179623|FG001|Overall Study|Withdrawal by Subject|1|||
156843728|NCT01990859|566179624|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
156843729|NCT01990859|566179624|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
156843730|NCT00622388|566179627|FG000|Overall Study|Disease Progression|47|||
156843731|NCT00622388|566179627|FG000|Overall Study|Adverse Event|6|||
156843732|NCT00622388|566179627|FG000|Overall Study|Protocol Violation|3|||
156843733|NCT00622388|566179627|FG000|Overall Study|Participant Refusal|1|||
156843734|NCT00622388|566179627|FG000|Overall Study|Death|3|||
156843735|NCT00622388|566179627|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
156843736|NCT00622388|566179627|FG000|Overall Study|Took Prohibited Medication|2|||
156843737|NCT00622388|566179627|FG000|Overall Study|Withdrew Consent|1|||
156341593|NCT00668707|564348577|FG000|Overall Study|Cancer Recurrence|58|||
156341594|NCT00668707|564348578|FG001|Overall Study|Cancer Recurrence|58|||
156843738|NCT00622388|566179627|FG000|Overall Study|Insurance Expired|1|||
156843739|NCT00348309|566179628|FG000|Overall Study|Adverse Event|56|||
156843740|NCT00348309|566179629|FG001|Overall Study|Adverse Event|28|||
156843741|NCT00348309|566179630|FG002|Overall Study|Adverse Event|63|||
156843742|NCT00348309|566179628|FG000|Overall Study|Lost to Follow-up|6|||
156843743|NCT00348309|566179629|FG001|Overall Study|Lost to Follow-up|7|||
156843744|NCT00348309|566179630|FG002|Overall Study|Lost to Follow-up|4|||
156843745|NCT00348309|566179628|FG000|Overall Study|Protocol Violation|7|||
156843746|NCT00348309|566179629|FG001|Overall Study|Protocol Violation|12|||
156843747|NCT00348309|566179630|FG002|Overall Study|Protocol Violation|7|||
156843748|NCT00348309|566179628|FG000|Overall Study|Withdrawal by Subject|33|||
156843749|NCT00348309|566179629|FG001|Overall Study|Withdrawal by Subject|37|||
156843750|NCT00348309|566179630|FG002|Overall Study|Withdrawal by Subject|40|||
156843751|NCT00348309|566179628|FG000|Overall Study|Non-compliance|8|||
156843752|NCT00348309|566179629|FG001|Overall Study|Non-compliance|6|||
156843753|NCT00348309|566179630|FG002|Overall Study|Non-compliance|8|||
156843754|NCT00348309|566179628|FG000|Overall Study|Death of caregiver|1|||
156843755|NCT00348309|566179629|FG001|Overall Study|Death of caregiver|0|||
156843756|NCT00348309|566179630|FG002|Overall Study|Death of caregiver|1|||
156843757|NCT00348309|566179628|FG000|Overall Study|Lack of insight, dementia|1|||
156843758|NCT00348309|566179629|FG001|Overall Study|Lack of insight, dementia|0|||
156843759|NCT00348309|566179630|FG002|Overall Study|Lack of insight, dementia|0|||
156843760|NCT00348309|566179628|FG000|Overall Study|Wrong bottle allocated|1|||
156843761|NCT00348309|566179629|FG001|Overall Study|Wrong bottle allocated|0|||
156843762|NCT00348309|566179630|FG002|Overall Study|Wrong bottle allocated|0|||
156843763|NCT00348309|566179628|FG000|Overall Study|Caregiver sick|1|||
156843764|NCT00348309|566179629|FG001|Overall Study|Caregiver sick|0|||
156843765|NCT00348309|566179630|FG002|Overall Study|Caregiver sick|0|||
156843766|NCT00348309|566179628|FG000|Overall Study|Use of prohibited medication|5|||
156843767|NCT00348309|566179629|FG001|Overall Study|Use of prohibited medication|2|||
156843768|NCT00348309|566179630|FG002|Overall Study|Use of prohibited medication|2|||
156843769|NCT00348309|566179628|FG000|Overall Study|Caregiver withdrawal|3|||
156843770|NCT00348309|566179629|FG001|Overall Study|Caregiver withdrawal|0|||
156843771|NCT00348309|566179630|FG002|Overall Study|Caregiver withdrawal|7|||
156843772|NCT00348309|566179628|FG000|Overall Study|Unable to complete ET visit|1|||
156843773|NCT00348309|566179629|FG001|Overall Study|Unable to complete ET visit|0|||
156843774|NCT00348309|566179630|FG002|Overall Study|Unable to complete ET visit|0|||
156843775|NCT00348309|566179628|FG000|Overall Study|PI closing medical practice|1|||
156843776|NCT00348309|566179629|FG001|Overall Study|PI closing medical practice|0|||
156843777|NCT00348309|566179630|FG002|Overall Study|PI closing medical practice|0|||
156843778|NCT00348309|566179628|FG000|Overall Study|Principal investigator's decision|1|||
156843779|NCT00348309|566179629|FG001|Overall Study|Principal investigator's decision|0|||
156843780|NCT00348309|566179630|FG002|Overall Study|Principal investigator's decision|0|||
156843781|NCT00348309|566179628|FG000|Overall Study|No disponibility of medication|1|||
156843782|NCT00348309|566179629|FG001|Overall Study|No disponibility of medication|0|||
156843783|NCT00348309|566179630|FG002|Overall Study|No disponibility of medication|0|||
156843784|NCT00348309|566179628|FG000|Overall Study|Worsened neurodegenerative disease|1|||
156843785|NCT00348309|566179629|FG001|Overall Study|Worsened neurodegenerative disease|0|||
156843786|NCT00348309|566179630|FG002|Overall Study|Worsened neurodegenerative disease|0|||
156843787|NCT00348309|566179628|FG000|Overall Study|Cognitive and behaviour worsening|2|||
156843788|NCT00348309|566179629|FG001|Overall Study|Cognitive and behaviour worsening|0|||
156843789|NCT00348309|566179630|FG002|Overall Study|Cognitive and behaviour worsening|0|||
156843790|NCT00348309|566179628|FG000|Overall Study|Worsening of alzheimer|1|||
156843791|NCT00348309|566179629|FG001|Overall Study|Worsening of alzheimer|0|||
156843792|NCT00348309|566179630|FG002|Overall Study|Worsening of alzheimer|1|||
156843793|NCT00348309|566179628|FG000|Overall Study|Did not appear in time for Visit 3|1|||
156843794|NCT00348309|566179629|FG001|Overall Study|Did not appear in time for Visit 3|0|||
156843795|NCT00348309|566179630|FG002|Overall Study|Did not appear in time for Visit 3|0|||
156843796|NCT00348309|566179628|FG000|Overall Study|Participant died|2|||
156843797|NCT00348309|566179629|FG001|Overall Study|Participant died|1|||
156843798|NCT00348309|566179630|FG002|Overall Study|Participant died|1|||
156843799|NCT00348309|566179628|FG000|Overall Study|Decision of sponsor|1|||
156843800|NCT00348309|566179629|FG001|Overall Study|Decision of sponsor|0|||
156843801|NCT00348309|566179630|FG002|Overall Study|Decision of sponsor|0|||
156843802|NCT00348309|566179628|FG000|Overall Study|Ineffectiveness of treatment|0|||
156843803|NCT00348309|566179629|FG001|Overall Study|Ineffectiveness of treatment|1|||
156843804|NCT00348309|566179630|FG002|Overall Study|Ineffectiveness of treatment|0|||
156843805|NCT00348309|566179628|FG000|Overall Study|A foul of exclusion criteria|0|||
156843806|NCT00348309|566179629|FG001|Overall Study|A foul of exclusion criteria|1|||
156843807|NCT00348309|566179630|FG002|Overall Study|A foul of exclusion criteria|0|||
156843808|NCT00348309|566179628|FG000|Overall Study|Participant was hospitalized|0|||
156843809|NCT00348309|566179629|FG001|Overall Study|Participant was hospitalized|1|||
156843810|NCT00348309|566179630|FG002|Overall Study|Participant was hospitalized|0|||
156843811|NCT00348309|566179628|FG000|Overall Study|Sponsor refuseal|0|||
156843812|NCT00348309|566179629|FG001|Overall Study|Sponsor refuseal|1|||
156843813|NCT00348309|566179630|FG002|Overall Study|Sponsor refuseal|1|||
156843814|NCT00348309|566179628|FG000|Overall Study|Forgot often medication|0|||
156843815|NCT00348309|566179629|FG001|Overall Study|Forgot often medication|1|||
156843816|NCT00348309|566179630|FG002|Overall Study|Forgot often medication|0|||
156843817|NCT00348309|566179628|FG000|Overall Study|Medical Monitor decision|0|||
156843818|NCT00348309|566179629|FG001|Overall Study|Medical Monitor decision|0|||
156843819|NCT00348309|566179630|FG002|Overall Study|Medical Monitor decision|1|||
156843820|NCT00348309|566179628|FG000|Overall Study|Increased dose of Aricept|0|||
156843821|NCT00348309|566179629|FG001|Overall Study|Increased dose of Aricept|0|||
156843822|NCT00348309|566179630|FG002|Overall Study|Increased dose of Aricept|1|||
156843823|NCT00348309|566179628|FG000|Overall Study|Site closure|0|||
156843824|NCT00348309|566179629|FG001|Overall Study|Site closure|0|||
156843825|NCT00348309|566179630|FG002|Overall Study|Site closure|1|||
156843826|NCT00348309|566179628|FG000|Overall Study|Adverse event not attended|0|||
156843827|NCT00348309|566179629|FG001|Overall Study|Adverse event not attended|0|||
156843828|NCT00348309|566179630|FG002|Overall Study|Adverse event not attended|1|||
156843829|NCT00348309|566179628|FG000|Overall Study|ECG abnormal|0|||
156843830|NCT00348309|566179629|FG001|Overall Study|ECG abnormal|0|||
156843831|NCT00348309|566179630|FG002|Overall Study|ECG abnormal|2|||
156843832|NCT00348309|566179628|FG000|Overall Study|Cardiologist recommendations|0|||
156843833|NCT00348309|566179629|FG001|Overall Study|Cardiologist recommendations|0|||
156843834|NCT00348309|566179630|FG002|Overall Study|Cardiologist recommendations|1|||
156843835|NCT00348309|566179628|FG000|Overall Study|HCV career|0|||
156843836|NCT00348309|566179629|FG001|Overall Study|HCV career|0|||
156843837|NCT00348309|566179630|FG002|Overall Study|HCV career|1|||
156843838|NCT01894243|566179631|FG000|Overall Study|Adverse Event|0|||
156843839|NCT01894243|566179632|FG001|Overall Study|Adverse Event|1|||
156843840|NCT01894243|566179633|FG002|Overall Study|Adverse Event|2|||
156843841|NCT01894243|566179631|FG000|Overall Study|Death|0|||
156843842|NCT01894243|566179632|FG001|Overall Study|Death|0|||
156843843|NCT01894243|566179633|FG002|Overall Study|Death|3|||
156843844|NCT01894243|566179631|FG000|Overall Study|Lack of Efficacy|3|||
156843845|NCT01894243|566179632|FG001|Overall Study|Lack of Efficacy|3|||
156843846|NCT01894243|566179633|FG002|Overall Study|Lack of Efficacy|1|||
156843847|NCT01894243|566179631|FG000|Overall Study|Condition under investigation worsened|8|||
156843848|NCT01894243|566179632|FG001|Overall Study|Condition under investigation worsened|6|||
156843849|NCT01894243|566179633|FG002|Overall Study|Condition under investigation worsened|2|||
156843850|NCT01894243|566179631|FG000|Overall Study|Subject decision|1|||
156843851|NCT01894243|566179632|FG001|Overall Study|Subject decision|0|||
156843852|NCT01894243|566179633|FG002|Overall Study|Subject decision|0|||
156843853|NCT01894243|566179631|FG000|Overall Study|Other|1|||
156843854|NCT01894243|566179632|FG001|Overall Study|Other|0|||
156843855|NCT01894243|566179633|FG002|Overall Study|Other|0|||
156843856|NCT01743040|566179634|FG000|Overall Study|Death|1|||
156843857|NCT01743040|566179634|FG000|Overall Study|Lost to Follow-up|66|||
156843858|NCT01743040|566179634|FG000|Overall Study|Physician Decision|40|||
156843859|NCT01743040|566179634|FG000|Overall Study|Protocol Violation|1|||
156843860|NCT01743040|566179634|FG000|Overall Study|Withdrawal by Subject|121|||
156843861|NCT01067469|566179635|FG000|Overall Study|Withdrawal by Subject|0|||
156843862|NCT01067469|566179636|FG001|Overall Study|Withdrawal by Subject|1|||
156843863|NCT01067469|566179635|FG000|Overall Study|Disease Progression|0|||
156843864|NCT01067469|566179636|FG001|Overall Study|Disease Progression|1|||
156843865|NCT04006392|566179637|FG000|Overall Study|Lost to Follow-up|0|||
156843866|NCT04006392|566179638|FG001|Overall Study|Lost to Follow-up|1|||
156843867|NCT04378114|566179639|FG000|Overall Study|Withdrawal by Subject|5|||
156843868|NCT01730586|566179644|FG000|Overall Study|Progressive Disease|2|||
156843869|NCT01730586|566179644|FG000|Overall Study|Inadequate Trial|8|||
156843870|NCT01730586|566179644|FG000|Overall Study|Adverse Event|2|||
156843871|NCT01730586|566179644|FG000|Overall Study|Hospice|1|||
156843872|NCT00660179|566181892|FG000|Overall Study|Death|44|||
156843873|NCT00660179|566181893|FG001|Overall Study|Death|47|||
156470041|NCT04795167|564814899|FG002|Overall Study|Death|1|||
156470042|NCT04795167|564814897|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
156843874|NCT00660179|566181894|FG002|Overall Study|Death|34|||
156843875|NCT00660179|566181892|FG000|Overall Study|Withdrawal of consent|4|||
156843876|NCT00660179|566181893|FG001|Overall Study|Withdrawal of consent|6|||
156843877|NCT00660179|566181894|FG002|Overall Study|Withdrawal of consent|4|||
156843878|NCT00660179|566181892|FG000|Overall Study|Lost to Follow-up|7|||
156843879|NCT00660179|566181893|FG001|Overall Study|Lost to Follow-up|5|||
156843880|NCT00660179|566181894|FG002|Overall Study|Lost to Follow-up|2|||
156843881|NCT00660179|566181892|FG000|Overall Study|Administrative reason|0|||
156843882|NCT00660179|566181893|FG001|Overall Study|Administrative reason|0|||
156843883|NCT00660179|566181894|FG002|Overall Study|Administrative reason|1|||
156843884|NCT00660179|566181892|FG000|Overall Study|Incorrect randomization|1|||
156843885|NCT00660179|566181893|FG001|Overall Study|Incorrect randomization|0|||
156843886|NCT00660179|566181894|FG002|Overall Study|Incorrect randomization|0|||
156843887|NCT00100789|566181898|FG000|Overall Study|Adverse Event|10|||
156843888|NCT00100789|566181898|FG000|Overall Study|Withdrawal by Subject|1|||
156843889|NCT00100789|566181898|FG000|Overall Study|Progression/relapse|42|||
156843890|NCT00100789|566181898|FG000|Overall Study|Death|2|||
156843891|NCT00100789|566181898|FG000|Overall Study|Not protocol specified|5|||
156843892|NCT00100789|566181898|FG000|Overall Study|Ineligible|3|||
156843893|NCT00100789|566181898|FG000|Overall Study|Never received treatment|1|||
156843894|NCT03472950|566181899|FG000|Overall Study|Lost to Follow-up|0|||
156843895|NCT03472950|566181900|FG001|Overall Study|Lost to Follow-up|1|||
156843896|NCT03472950|566181899|FG000|Overall Study|Adverse Event|0|||
156843897|NCT03472950|566181900|FG001|Overall Study|Adverse Event|3|||
156843898|NCT01393821|566181901|FG000|Overall Study|Cancel|1|||
156843899|NCT01393821|566181902|FG001|Overall Study|Cancel|1|||
156843900|NCT01393821|566181901|FG000|Overall Study|not evaluable for primary endpoint|4|||
156843901|NCT01393821|566181902|FG001|Overall Study|not evaluable for primary endpoint|2|||
156843902|NCT00894361|566181909|FG000|Overall Study|deaths and less than 2 years followup|24|||
156843903|NCT00894361|566181910|FG001|Overall Study|deaths and less than 2 years followup|64|||
156843904|NCT00286494|566181915|FG000|Overall Study|Hyperglycemic rescue|12|||
156843905|NCT00286494|566181916|FG001|Overall Study|Hyperglycemic rescue|19|||
156843906|NCT00286494|566181917|FG002|Overall Study|Hyperglycemic rescue|18|||
156843907|NCT00286494|566181915|FG000|Overall Study|Withdrawal by Subject|2|||
156843908|NCT00286494|566181916|FG001|Overall Study|Withdrawal by Subject|10|||
156843909|NCT00286494|566181917|FG002|Overall Study|Withdrawal by Subject|9|||
156843910|NCT00286494|566181915|FG000|Overall Study|Adverse Event|3|||
156843911|NCT00286494|566181916|FG001|Overall Study|Adverse Event|8|||
156843912|NCT00286494|566181917|FG002|Overall Study|Adverse Event|6|||
156843913|NCT00286494|566181915|FG000|Overall Study|Physician Decision|5|||
156843914|NCT00286494|566181916|FG001|Overall Study|Physician Decision|5|||
156843915|NCT00286494|566181917|FG002|Overall Study|Physician Decision|1|||
156843916|NCT00286494|566181915|FG000|Overall Study|Lost to Follow-up|3|||
156843917|NCT00286494|566181916|FG001|Overall Study|Lost to Follow-up|1|||
156843918|NCT00286494|566181917|FG002|Overall Study|Lost to Follow-up|3|||
156843919|NCT00286494|566181915|FG000|Overall Study|Protocol Violation|1|||
156843920|NCT00286494|566181916|FG001|Overall Study|Protocol Violation|1|||
156843921|NCT00286494|566181917|FG002|Overall Study|Protocol Violation|2|||
156843922|NCT04207060|566181918|FG000|Overall Study|Lost to Follow-up|2|||
156843923|NCT04207060|566181919|FG001|Overall Study|Lost to Follow-up|0|||
156843924|NCT05438576|566181920|FG000|Overall Study|Death|1|||
156341595|NCT00668707|564348577|FG000|Overall Study|Withdrawal by Subject|117|||
156843925|NCT05438576|566181921|FG001|Overall Study|Death|1|||
156843926|NCT05438576|566181920|FG000|Overall Study|Withdrawal by Subject|4|||
156843927|NCT05438576|566181921|FG001|Overall Study|Withdrawal by Subject|2|||
156843928|NCT05438576|566181920|FG000|Overall Study|Not Eligible|2|||
156843929|NCT05438576|566181921|FG001|Overall Study|Not Eligible|1|||
156843930|NCT05438576|566181920|FG000|Overall Study|Did not complete baseline testing|22|||
156843931|NCT05438576|566181921|FG001|Overall Study|Did not complete baseline testing|4|||
156843932|NCT02881762|566181922|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156843933|NCT02881762|566181923|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156843934|NCT00296140|566181924|FG000|Overall Study|Lost to Follow-up|1|||
156843935|NCT00296140|566181925|FG001|Overall Study|Lost to Follow-up|0|||
156843936|NCT00296140|566181924|FG000|Overall Study|Withdrawal by Subject|1|||
156843937|NCT00296140|566181925|FG001|Overall Study|Withdrawal by Subject|0|||
156843938|NCT00296140|566181924|FG000|Overall Study|Discharge to Nursing Home|1|||
156843939|NCT00296140|566181925|FG001|Overall Study|Discharge to Nursing Home|0|||
156843940|NCT00880191|566181932|FG000|Overall Study|Refused further treatment|4|||
156843941|NCT00880191|566181933|FG001|Overall Study|Refused further treatment|1|||
156843942|NCT00880191|566181932|FG000|Overall Study|Adverse Event|8|||
156843943|NCT00880191|566181933|FG001|Overall Study|Adverse Event|6|||
156843944|NCT00880191|566181932|FG000|Overall Study|Hospitalization/efficacy|1|||
156843945|NCT00880191|566181933|FG001|Overall Study|Hospitalization/efficacy|1|||
156843946|NCT00774800|566181935|FG000|Intervention 4|Withdrawal by Subject|1|||
156843947|NCT01919801|566181936|FG000|Overall Study|Withdrawal by Subject|1|||
156843948|NCT01919801|566181937|FG001|Overall Study|Withdrawal by Subject|0|||
156843949|NCT01919801|566181936|FG000|Overall Study|Physician Decision|0|||
156843950|NCT01919801|566181937|FG001|Overall Study|Physician Decision|1|||
156843951|NCT01919801|566181936|FG000|Overall Study|Lost to Follow-up|0|||
156843952|NCT01919801|566181937|FG001|Overall Study|Lost to Follow-up|1|||
156843953|NCT01919801|566181936|FG000|Overall Study|Other|0|||
156843954|NCT01919801|566181937|FG001|Overall Study|Other|1|||
156843955|NCT01677858|566181938|FG000|Overall Study|Adverse Event|0|||
156843956|NCT01677858|566181939|FG001|Overall Study|Adverse Event|0|||
156843957|NCT01677858|566181940|FG002|Overall Study|Adverse Event|2|||
156843958|NCT01677858|566181941|FG003|Overall Study|Adverse Event|3|||
156843959|NCT01677858|566181942|FG004|Overall Study|Adverse Event|13|||
156843960|NCT01677858|566181938|FG000|Overall Study|Death|0|||
156843961|NCT01677858|566181939|FG001|Overall Study|Death|0|||
156843962|NCT01677858|566181940|FG002|Overall Study|Death|0|||
156843963|NCT01677858|566181941|FG003|Overall Study|Death|0|||
156843964|NCT01677858|566181942|FG004|Overall Study|Death|1|||
156843965|NCT01677858|566181938|FG000|Overall Study|Physician Decision|1|||
156843966|NCT01677858|566181939|FG001|Overall Study|Physician Decision|0|||
156843967|NCT01677858|566181940|FG002|Overall Study|Physician Decision|2|||
156843968|NCT01677858|566181941|FG003|Overall Study|Physician Decision|0|||
156843969|NCT01677858|566181942|FG004|Overall Study|Physician Decision|12|||
156843970|NCT01677858|566181938|FG000|Overall Study|Progressive Disease|2|||
156843971|NCT01677858|566181939|FG001|Overall Study|Progressive Disease|1|||
156843972|NCT01677858|566181940|FG002|Overall Study|Progressive Disease|9|||
156843973|NCT01677858|566181941|FG003|Overall Study|Progressive Disease|3|||
156843974|NCT01677858|566181942|FG004|Overall Study|Progressive Disease|43|||
156843975|NCT01677858|566181938|FG000|Overall Study|Withdrawal by Subject|0|||
156843976|NCT01677858|566181939|FG001|Overall Study|Withdrawal by Subject|1|||
156843977|NCT01677858|566181940|FG002|Overall Study|Withdrawal by Subject|1|||
156843978|NCT01677858|566181941|FG003|Overall Study|Withdrawal by Subject|0|||
156843979|NCT01677858|566181942|FG004|Overall Study|Withdrawal by Subject|15|||
156843980|NCT01677858|566181938|FG000|Overall Study|Lost to Follow-up|0|||
156843981|NCT01677858|566181939|FG001|Overall Study|Lost to Follow-up|0|||
156843982|NCT01677858|566181940|FG002|Overall Study|Lost to Follow-up|0|||
156843983|NCT01677858|566181941|FG003|Overall Study|Lost to Follow-up|0|||
156843984|NCT01677858|566181942|FG004|Overall Study|Lost to Follow-up|1|||
156843985|NCT01331109|566181943|FG000|Overall Study|Adverse Event|6|||
156843986|NCT01331109|566181943|FG000|Overall Study|Lack of Efficacy|2|||
156843987|NCT01331109|566181943|FG000|Overall Study|Protocol Violation|3|||
156843988|NCT01331109|566181943|FG000|Overall Study|Withdrawal by Subject|7|||
156843989|NCT01331109|566181943|FG000|Overall Study|Lost to Follow-up|1|||
156843990|NCT01331109|566181943|FG000|Overall Study|Study Terminated by Sponsor|38|||
156843991|NCT00988091|566181944|FG000|Double-blind Period|Withdrawal by Subject|15|||
156843992|NCT00988091|566181945|FG001|Double-blind Period|Withdrawal by Subject|13|||
156843993|NCT00988091|566181944|FG000|Double-blind Period|Lost to Follow-up|12|||
156843994|NCT00988091|566181945|FG001|Double-blind Period|Lost to Follow-up|14|||
156843995|NCT00988091|566181944|FG000|Double-blind Period|Other|8|||
156843996|NCT00988091|566181945|FG001|Double-blind Period|Other|8|||
156843997|NCT00988091|566181944|FG000|Double-blind Period|Adverse Event|6|||
156843998|NCT00988091|566181945|FG001|Double-blind Period|Adverse Event|9|||
156843999|NCT00988091|566181944|FG000|Double-blind Period|Use of exclusionary medication|2|||
156844000|NCT00988091|566181945|FG001|Double-blind Period|Use of exclusionary medication|3|||
156844001|NCT00988091|566181944|FG000|Open-label Period|Adverse Event|4|||
156844002|NCT00988091|566181945|FG001|Open-label Period|Adverse Event|7|||
156844003|NCT00988091|566181944|FG000|Open-label Period|Use of exclusionary medication|1|||
156844004|NCT00988091|566181945|FG001|Open-label Period|Use of exclusionary medication|1|||
156844005|NCT00988091|566181944|FG000|Open-label Period|Protocol Violation|1|||
156844006|NCT00988091|566181945|FG001|Open-label Period|Protocol Violation|1|||
156844007|NCT00988091|566181944|FG000|Open-label Period|Withdrawal by Subject|10|||
156844008|NCT00988091|566181945|FG001|Open-label Period|Withdrawal by Subject|16|||
156844009|NCT00988091|566181944|FG000|Open-label Period|Lost to Follow-up|3|||
156844010|NCT00988091|566181945|FG001|Open-label Period|Lost to Follow-up|5|||
156844011|NCT00988091|566181944|FG000|Open-label Period|Other|2|||
156844012|NCT00988091|566181945|FG001|Open-label Period|Other|3|||
156844013|NCT00773747|566181946|FG000|Overall Study|Lack of Efficacy|112|||
156844014|NCT00773747|566181947|FG001|Overall Study|Lack of Efficacy|144|||
156844015|NCT00773747|566181946|FG000|Overall Study|Physician Decision|26|||
156844016|NCT00773747|566181947|FG001|Overall Study|Physician Decision|18|||
156844017|NCT00773747|566181946|FG000|Overall Study|Lost to Follow-up|0|||
156844018|NCT00773747|566181947|FG001|Overall Study|Lost to Follow-up|1|||
156844019|NCT00773747|566181946|FG000|Overall Study|Protocol Violation|2|||
156844020|NCT00773747|566181947|FG001|Overall Study|Protocol Violation|2|||
156844021|NCT00773747|566181946|FG000|Overall Study|Withdrawal by Subject|89|||
156844022|NCT00773747|566181947|FG001|Overall Study|Withdrawal by Subject|61|||
156844023|NCT00773747|566181946|FG000|Overall Study|Adverse Event|61|||
156844024|NCT00773747|566181947|FG001|Overall Study|Adverse Event|62|||
156844025|NCT00773747|566181946|FG000|Overall Study|Death|5|||
156844026|NCT00773747|566181947|FG001|Overall Study|Death|8|||
156844027|NCT00773747|566181946|FG000|Overall Study|Not Treated|2|||
156844028|NCT00773747|566181947|FG001|Overall Study|Not Treated|0|||
156844029|NCT00994422|566181950|FG000|Overall Study|Lost to Follow-up|7|||
156844030|NCT00994422|566181951|FG001|Overall Study|Lost to Follow-up|1|||
156844031|NCT02669212|566181952|FG000|Overall Study|Lost to Follow-up|1|||
156844032|NCT02669212|566181953|FG001|Overall Study|Lost to Follow-up|0|||
156844033|NCT02669212|566181952|FG000|Overall Study|Medical Condition|3|||
156844034|NCT02669212|566181953|FG001|Overall Study|Medical Condition|4|||
156844035|NCT02669212|566181952|FG000|Overall Study|Withdrawal by Subject|0|||
156844036|NCT02669212|566181953|FG001|Overall Study|Withdrawal by Subject|2|||
156844037|NCT02669212|566181952|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
156844038|NCT02669212|566181953|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
156844039|NCT03549104|566181954|FG000|Overall Study|Withdrawal by Subject|5|||
156844040|NCT03549104|566181955|FG001|Overall Study|Withdrawal by Subject|2|||
156844041|NCT03549104|566181954|FG000|Overall Study|Covid shelter in place|1|||
156844042|NCT03549104|566181955|FG001|Overall Study|Covid shelter in place|2|||
156844043|NCT03422536|566181956|FG000|Randomized|Physician Decision|1|||
156844044|NCT03422536|566181957|FG001|Randomized|Physician Decision|1|||
156844045|NCT03422536|566181956|FG000|Allocation - Received Intervention|Disease progression|19|||
156844046|NCT03422536|566181957|FG001|Allocation - Received Intervention|Disease progression|25|||
156844047|NCT03422536|566181956|FG000|Allocation - Received Intervention|Death|1|||
156844048|NCT03422536|566181957|FG001|Allocation - Received Intervention|Death|3|||
156844049|NCT03422536|566181956|FG000|Allocation - Received Intervention|Adverse Event|1|||
156844050|NCT03422536|566181957|FG001|Allocation - Received Intervention|Adverse Event|0|||
156844051|NCT03422536|566181956|FG000|Allocation - Received Intervention|Physician Decision|1|||
156844052|NCT03422536|566181957|FG001|Allocation - Received Intervention|Physician Decision|1|||
156844053|NCT03422536|566181956|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
156844054|NCT03422536|566181957|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
156844055|NCT03422536|566181956|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
156844056|NCT03422536|566181957|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
156844057|NCT00532298|566181958|FG000|Overall Study|Adverse Event|1|||
156844058|NCT00532298|566181959|FG001|Overall Study|Adverse Event|0|||
156844059|NCT00532298|566181960|FG002|Overall Study|Adverse Event|0|||
156844060|NCT00532298|566181961|FG003|Overall Study|Adverse Event|0|||
156844061|NCT00532298|566181962|FG004|Overall Study|Adverse Event|1|||
156844062|NCT00532298|566181963|FG005|Overall Study|Adverse Event|1|||
156844063|NCT00532298|566181958|FG000|Overall Study|Lost to Follow-up|1|||
156470043|NCT04795167|564814898|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
156844064|NCT00532298|566181959|FG001|Overall Study|Lost to Follow-up|1|||
156844065|NCT00532298|566181960|FG002|Overall Study|Lost to Follow-up|1|||
156844066|NCT00532298|566181961|FG003|Overall Study|Lost to Follow-up|0|||
156844067|NCT00532298|566181962|FG004|Overall Study|Lost to Follow-up|0|||
156844068|NCT00532298|566181963|FG005|Overall Study|Lost to Follow-up|1|||
156844069|NCT00479856|566181964|FG000|Overall Study|Adverse Event|1|||
156844070|NCT00479856|566181964|FG000|Overall Study|Withdrawal by Subject|1|||
156844071|NCT00479856|566181964|FG000|Overall Study|Physician Decision|1|||
156844072|NCT01973998|566181965|FG000|Overall Study|Death|2|||
156844073|NCT01973998|566181966|FG001|Overall Study|Death|2|||
156844074|NCT02141360|566181967|FG000|Overall Study|Withdrawal by Subject|6|||
156844075|NCT02141360|566181968|FG001|Overall Study|Withdrawal by Subject|0|||
156470044|NCT04795167|564814899|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
156470045|NCT01753999|564814900|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
156844076|NCT02141360|566181969|FG002|Overall Study|Withdrawal by Subject|0|||
156844077|NCT02141360|566181967|FG000|Overall Study|Study Terminated before Visit|1|||
156844078|NCT02141360|566181968|FG001|Overall Study|Study Terminated before Visit|0|||
156844079|NCT02141360|566181969|FG002|Overall Study|Study Terminated before Visit|0|||
156844080|NCT00646399|566181970|FG000|Overall Study|Death|63|||
156844081|NCT00646399|566181971|FG001|Overall Study|Death|53|||
156844082|NCT00646399|566181970|FG000|Overall Study|Withdrawal by Subject|9|||
156844083|NCT00646399|566181971|FG001|Overall Study|Withdrawal by Subject|10|||
156844084|NCT00646399|566181970|FG000|Overall Study|Other Reason|11|||
156341596|NCT00668707|564348578|FG001|Overall Study|Withdrawal by Subject|100|||
156844085|NCT00646399|566181971|FG001|Overall Study|Other Reason|11|||
156844086|NCT00395850|566181978|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
156844087|NCT00395850|566181979|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
156844088|NCT00395850|566181980|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
156844089|NCT00395850|566181981|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
156844090|NCT00395850|566181978|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
156844091|NCT00395850|566181979|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
156844092|NCT00395850|566181980|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
156844093|NCT00395850|566181981|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
156844094|NCT00395850|566181978|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
156844095|NCT00395850|566181979|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
156844096|NCT00395850|566181980|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
156844097|NCT00395850|566181981|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
156844098|NCT00395850|566181978|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
156844099|NCT00395850|566181979|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
156844100|NCT00395850|566181980|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
156844101|NCT00395850|566181981|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
156844102|NCT00395850|566181978|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
156844103|NCT00395850|566181979|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
156844104|NCT00395850|566181980|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
156844105|NCT00395850|566181981|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
156844106|NCT00395850|566181978|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
156844107|NCT00395850|566181979|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
156844108|NCT00395850|566181980|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
156844109|NCT00395850|566181981|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
156844110|NCT00395850|566181978|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
156844111|NCT00395850|566181979|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
156844112|NCT00395850|566181980|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
156844113|NCT00395850|566181981|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
156844114|NCT01424228|566181982|FG000|Overall Study|Withdrawal by Subject|27|||
156844115|NCT01424228|566181983|FG001|Overall Study|Withdrawal by Subject|11|||
156844116|NCT01424228|566181982|FG000|Overall Study|Adverse Event|10|||
156844117|NCT01424228|566181983|FG001|Overall Study|Adverse Event|14|||
156844118|NCT01424228|566181982|FG000|Overall Study|Sponsor's decision|9|||
156844119|NCT01424228|566181983|FG001|Overall Study|Sponsor's decision|12|||
156844120|NCT01424228|566181982|FG000|Overall Study|Lack of Efficacy|5|||
156844121|NCT01424228|566181983|FG001|Overall Study|Lack of Efficacy|7|||
156844122|NCT01424228|566181982|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
156844123|NCT01424228|566181983|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
156341597|NCT00668707|564348577|FG000|Overall Study|Lost to Follow-up|3|||
156341598|NCT00668707|564348578|FG001|Overall Study|Lost to Follow-up|6|||
156341599|NCT00668707|564348577|FG000|Overall Study|Protocol Violation|10|||
156341600|NCT00668707|564348578|FG001|Overall Study|Protocol Violation|12|||
156341601|NCT00668707|564348577|FG000|Overall Study|Death|11|||
156844124|NCT01424228|566181982|FG000|Overall Study|Non-compliance|2|||
156844125|NCT01424228|566181983|FG001|Overall Study|Non-compliance|0|||
156341602|NCT00668707|564348578|FG001|Overall Study|Death|4|||
156844126|NCT01424228|566181982|FG000|Overall Study|Worsening of symptoms|1|||
156844127|NCT01424228|566181983|FG001|Overall Study|Worsening of symptoms|0|||
156844128|NCT01424228|566181982|FG000|Overall Study|Unplanned journey|0|||
156844129|NCT01424228|566181983|FG001|Overall Study|Unplanned journey|1|||
156844130|NCT00844558|566181986|FG000|Overall Study|Withdrawal by Subject|9|||
156844131|NCT00844558|566181987|FG001|Overall Study|Withdrawal by Subject|2|||
156844132|NCT00844558|566181986|FG000|Overall Study|Death|1|||
156844133|NCT00844558|566181987|FG001|Overall Study|Death|0|||
156844134|NCT00844558|566181986|FG000|Overall Study|Protocol Violation|1|||
156844135|NCT00844558|566181987|FG001|Overall Study|Protocol Violation|1|||
156341603|NCT02784431|564348583|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
156844136|NCT00844558|566181986|FG000|Overall Study|Lost to Follow-up|0|||
156844137|NCT00844558|566181987|FG001|Overall Study|Lost to Follow-up|1|||
156341604|NCT02784431|564348583|FG000|Overall Study|Early Study Termination|19|||
156341605|NCT00361569|564348584|FG000|Overall Study|Protocol Violation|3|||
156341606|NCT00361569|564348585|FG001|Overall Study|Protocol Violation|2|||
156470046|NCT01753999|564814901|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
156341607|NCT00361569|564348586|FG002|Overall Study|Protocol Violation|4|||
156341608|NCT00361569|564348587|FG003|Overall Study|Protocol Violation|2|||
156470047|NCT01753999|564814900|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
156341609|NCT00361569|564348584|FG000|Overall Study|Withdrawal by Subject|2|||
156844138|NCT00844558|566181986|FG000|Overall Study|Physician Decision|1|||
156844139|NCT00844558|566181987|FG001|Overall Study|Physician Decision|0|||
156844140|NCT00932165|566181988|FG000|Overall Study|Lost to Follow-up|1|||
156844141|NCT00588094|566181989|FG000|Overall Study|Adverse Event|3|||
156844142|NCT00588094|566181989|FG000|Overall Study|Progression of Disease|2|||
156844143|NCT02951429|566181996|FG000|Overall Study|Adverse Event|3|||
156844144|NCT02951429|566181997|FG001|Overall Study|Adverse Event|7|||
156844145|NCT02951429|566181996|FG000|Overall Study|Death|28|||
156844146|NCT02951429|566181997|FG001|Overall Study|Death|36|||
156844147|NCT02951429|566181996|FG000|Overall Study|Lack of Efficacy|0|||
156844148|NCT02951429|566181997|FG001|Overall Study|Lack of Efficacy|1|||
156844149|NCT02951429|566181996|FG000|Overall Study|Lost to Follow-up|0|||
156844150|NCT02951429|566181997|FG001|Overall Study|Lost to Follow-up|1|||
156844151|NCT02951429|566181996|FG000|Overall Study|Lung Transplantation|9|||
156844152|NCT02951429|566181997|FG001|Overall Study|Lung Transplantation|6|||
156844153|NCT02951429|566181996|FG000|Overall Study|Other|1|||
156844154|NCT02951429|566181997|FG001|Overall Study|Other|3|||
156844155|NCT02951429|566181996|FG000|Overall Study|Progressive Disease|1|||
156844156|NCT02951429|566181997|FG001|Overall Study|Progressive Disease|1|||
156844157|NCT02951429|566181996|FG000|Overall Study|Withdrawal by Subject|7|||
156844158|NCT02951429|566181997|FG001|Overall Study|Withdrawal by Subject|11|||
156844159|NCT02951429|566181996|FG000|Overall Study|Participant ongoing in the study|23|||
156844160|NCT02951429|566181997|FG001|Overall Study|Participant ongoing in the study|17|||
156844161|NCT02202538|566182000|FG000|Overall Study|Withdrawal by Subject|5|||
156844162|NCT02202538|566182000|FG000|Overall Study|Did not meet all inclusion criteria|2|||
156844163|NCT02202538|566182000|FG000|Overall Study|Investigator Decision|1|||
156844164|NCT01457846|566182001|FG000|Overall Study|Death before treatment|1|||
156844165|NCT01457846|566182002|FG001|Overall Study|Death before treatment|2|||
156844166|NCT01457846|566182001|FG000|Overall Study|Did not receive treatment|0|||
156844167|NCT01457846|566182002|FG001|Overall Study|Did not receive treatment|1|||
156844168|NCT01457846|566182001|FG000|Overall Study|Death|27|||
156844169|NCT01457846|566182002|FG001|Overall Study|Death|16|||
156844170|NCT01457846|566182001|FG000|Overall Study|Unclassified reason for not completed|11|||
156844171|NCT01457846|566182002|FG001|Overall Study|Unclassified reason for not completed|10|||
156844172|NCT01457846|566182001|FG000|Overall Study|Withdrawal by Subject|1|||
156844173|NCT01457846|566182002|FG001|Overall Study|Withdrawal by Subject|1|||
156844174|NCT01457846|566182001|FG000|Overall Study|Lost to Follow-up|1|||
156844175|NCT01457846|566182002|FG001|Overall Study|Lost to Follow-up|0|||
156844176|NCT01853878|566182003|FG000|Overall Study|Recurrence|2|||
156844177|NCT01853878|566182004|FG001|Overall Study|Recurrence|0|||
156844178|NCT01853878|566182003|FG000|Overall Study|Adverse Event|2|||
156844179|NCT01853878|566182004|FG001|Overall Study|Adverse Event|0|||
156844180|NCT01853878|566182003|FG000|Overall Study|Withdrawal by Subject|3|||
156844181|NCT01853878|566182004|FG001|Overall Study|Withdrawal by Subject|1|||
156844182|NCT01853878|566182003|FG000|Overall Study|Migrated/moved from the study area|1|||
156844183|NCT01853878|566182004|FG001|Overall Study|Migrated/moved from the study area|0|||
156844184|NCT01853878|566182003|FG000|Overall Study|Other|55|||
156844185|NCT01853878|566182004|FG001|Overall Study|Other|43|||
156844186|NCT01846741|566182005|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
156844187|NCT05392803|566182009|FG000|Overall Study|Lost to Follow-up|0|||
156844188|NCT05392803|566182010|FG001|Overall Study|Lost to Follow-up|2|||
156844189|NCT01240135|566182011|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
156844190|NCT01240135|566182012|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
156844191|NCT01240135|566182011|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
156844192|NCT01240135|566182012|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
156844193|NCT01628965|566182013|FG000|Overall Study|Adverse Event|30|||
156844194|NCT01628965|566182013|FG000|Overall Study|Lack of Efficacy|7|||
156844195|NCT01628965|566182013|FG000|Overall Study|Withdrawal by Subject|3|||
156844196|NCT01628965|566182013|FG000|Overall Study|Lost to Follow-up|1|||
156844197|NCT01628965|566182013|FG000|Overall Study|Discontinuation criteria|8|||
156844198|NCT02828020|566182019|FG000|Treatment Period|Adverse Event|3|||
156844199|NCT02828020|566182020|FG001|Treatment Period|Adverse Event|1|||
156844200|NCT02828020|566182021|FG002|Treatment Period|Adverse Event|1|||
156844201|NCT02828020|566182019|FG000|Treatment Period|Withdrawal of Consent|10|||
156844202|NCT02828020|566182020|FG001|Treatment Period|Withdrawal of Consent|14|||
156844203|NCT02828020|566182021|FG002|Treatment Period|Withdrawal of Consent|9|||
156844204|NCT02828020|566182019|FG000|Treatment Period|Lost to Follow-up|21|||
156844205|NCT02828020|566182020|FG001|Treatment Period|Lost to Follow-up|24|||
156844206|NCT02828020|566182021|FG002|Treatment Period|Lost to Follow-up|18|||
156844207|NCT02828020|566182019|FG000|Treatment Period|Lack of Qualifying Event|44|||
156844208|NCT02828020|566182020|FG001|Treatment Period|Lack of Qualifying Event|53|||
156844209|NCT02828020|566182021|FG002|Treatment Period|Lack of Qualifying Event|43|||
156844210|NCT02828020|566182019|FG000|Treatment Period|Pregnancy|0|||
156844211|NCT02828020|566182020|FG001|Treatment Period|Pregnancy|2|||
156844212|NCT02828020|566182021|FG002|Treatment Period|Pregnancy|0|||
156844213|NCT02828020|566182019|FG000|Treatment Period|Protocol Violation|2|||
156844214|NCT02828020|566182020|FG001|Treatment Period|Protocol Violation|4|||
156844215|NCT02828020|566182021|FG002|Treatment Period|Protocol Violation|7|||
156844216|NCT02828020|566182019|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
156844217|NCT02828020|566182020|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
156844218|NCT02828020|566182021|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
156844219|NCT02828020|566182019|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
156844220|NCT02828020|566182020|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
156844221|NCT02828020|566182021|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
156844222|NCT02828020|566182019|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
156844223|NCT02828020|566182020|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
156844224|NCT02828020|566182021|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
156844225|NCT02828020|566182019|FG000|Safety Follow-up Period|Protocol Violation|0|||
156844226|NCT02828020|566182020|FG001|Safety Follow-up Period|Protocol Violation|2|||
156844227|NCT02828020|566182021|FG002|Safety Follow-up Period|Protocol Violation|1|||
156844228|NCT02828020|566182019|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
156844229|NCT02828020|566182020|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
156844230|NCT02828020|566182021|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
156844231|NCT03688620|566182022|FG000|Overall Study|Other|0|||
156844232|NCT03688620|566182023|FG001|Overall Study|Other|0|||
156844233|NCT03688620|566182024|FG002|Overall Study|Other|1|||
156844234|NCT03688620|566182022|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
156844235|NCT03688620|566182023|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
156844236|NCT03688620|566182024|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
156844237|NCT03688620|566182022|FG000|Overall Study|Lost to Follow-up|16|||
156844238|NCT03688620|566182023|FG001|Overall Study|Lost to Follow-up|0|||
156844239|NCT03688620|566182024|FG002|Overall Study|Lost to Follow-up|1|||
156844240|NCT03688620|566182022|FG000|Overall Study|Withdrawal by Subject|0|||
156844241|NCT03688620|566182023|FG001|Overall Study|Withdrawal by Subject|0|||
156844242|NCT03688620|566182024|FG002|Overall Study|Withdrawal by Subject|6|||
156844243|NCT01183065|566182025|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
156844244|NCT00330681|566182027|FG000|Overall Study|Adverse Event|3|||
156844245|NCT00330681|566182028|FG001|Overall Study|Adverse Event|6|||
156844246|NCT00330681|566182027|FG000|Overall Study|Protocol Violation|0|||
156844247|NCT00330681|566182028|FG001|Overall Study|Protocol Violation|1|||
156844248|NCT00330681|566182027|FG000|Overall Study|Withdrawal by Subject|5|||
156844249|NCT00330681|566182028|FG001|Overall Study|Withdrawal by Subject|5|||
156844250|NCT00330681|566182027|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
156844251|NCT00330681|566182028|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
156844252|NCT02578186|566182032|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
156844253|NCT02578186|566182033|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
156844254|NCT02578186|566182032|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
156844255|NCT02578186|566182033|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
156844256|NCT03657095|566182034|FG000|Overall Study|Withdrawal by Subject|1|||
156844257|NCT03657095|566182035|FG001|Overall Study|Withdrawal by Subject|1|||
156844258|NCT03657095|566182034|FG000|Overall Study|Adverse Event|0|||
156844259|NCT03657095|566182035|FG001|Overall Study|Adverse Event|3|||
156844260|NCT03657095|566182034|FG000|Overall Study|Study Terminated by Sponsor|58|||
156844261|NCT03657095|566182035|FG001|Overall Study|Study Terminated by Sponsor|49|||
156844262|NCT00828750|566182036|FG000|Overall Study|Lack of Efficacy|3|||
156844263|NCT00828750|566182036|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
156844264|NCT00830180|566182037|FG000|Overall Study|Adverse Event|6|||
156844265|NCT00830180|566182037|FG000|Overall Study|Death|11|||
156844266|NCT00830180|566182037|FG000|Overall Study|Insufficient clinical response|1|||
156844267|NCT00830180|566182037|FG000|Overall Study|Withdrawal by Subject|5|||
156844268|NCT00830180|566182037|FG000|Overall Study|Progressive disease|2|||
156844269|NCT00830180|566182037|FG000|Overall Study|Other - Unspecified|1|||
156844270|NCT01832532|566182038|FG000|Overall Study|Withdrawal by Subject|5|||
156844271|NCT01832532|566182039|FG001|Overall Study|Withdrawal by Subject|2|||
156844272|NCT03824587|566182045|FG000|Run-in Period|Screen Failure|0|||
156844273|NCT03824587|566182046|FG001|Run-in Period|Screen Failure|275|||
156844274|NCT03824587|566182045|FG000|Treatment Period|Adverse Event|4|||
156844275|NCT03824587|566182046|FG001|Treatment Period|Adverse Event|1|||
156844276|NCT03824587|566182045|FG000|Treatment Period|Withdrawal by Subject|0|||
156844277|NCT03824587|566182046|FG001|Treatment Period|Withdrawal by Subject|1|||
156844278|NCT03824587|566182045|FG000|Treatment Period|Kidney Transplant|1|||
156844279|NCT03824587|566182046|FG001|Treatment Period|Kidney Transplant|1|||
156541513|NCT02953340|565075440|FG001|Overall Study|Lost to Follow-up|2|||
156844280|NCT01300572|566182047|FG000|Overall Study|HAMA + post dosimetry|1|||
156844281|NCT03597061|566182048|FG000|Overall Study|Lost to Follow-up|1|||
156844282|NCT03597061|566182049|FG001|Overall Study|Lost to Follow-up|0|||
156844283|NCT03597061|566182048|FG000|Overall Study|Protocol Violation|0|||
156844284|NCT03597061|566182049|FG001|Overall Study|Protocol Violation|1|||
156844285|NCT05111249|566183389|FG000|Overall Study|Lost to Follow-up|0|||
156844286|NCT05111249|566183390|FG001|Overall Study|Lost to Follow-up|2|||
156844287|NCT05111249|566183389|FG000|Overall Study|Physician Decision|0|||
156844288|NCT05111249|566183390|FG001|Overall Study|Physician Decision|1|||
156844289|NCT05111249|566183389|FG000|Overall Study|Participant decision|1|||
156844290|NCT05111249|566183390|FG001|Overall Study|Participant decision|5|||
156844291|NCT02813889|566183391|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
156844292|NCT02813889|566183392|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
156844293|NCT05128578|566183393|FG000|Overall Study|Withdrawal by Subject|9|||
156844294|NCT05128578|566183393|FG000|Overall Study|Lost to Follow-up|5|||
156844295|NCT01504412|566183404|FG000|Overall Study|Adverse Event|1|||
156844296|NCT01504412|566183405|FG001|Overall Study|Adverse Event|8|||
156844297|NCT01504412|566183406|FG002|Overall Study|Adverse Event|1|||
156844298|NCT01504412|566183407|FG003|Overall Study|Adverse Event|7|||
156844299|NCT01504412|566183408|FG004|Overall Study|Adverse Event|10|||
156844300|NCT01504412|566183404|FG000|Overall Study|Withdrawal by Subject|2|||
156844301|NCT01504412|566183405|FG001|Overall Study|Withdrawal by Subject|1|||
156844302|NCT01504412|566183406|FG002|Overall Study|Withdrawal by Subject|1|||
156844303|NCT01504412|566183407|FG003|Overall Study|Withdrawal by Subject|5|||
156844304|NCT01504412|566183408|FG004|Overall Study|Withdrawal by Subject|1|||
156844305|NCT01504412|566183404|FG000|Overall Study|Other|2|||
156844306|NCT01504412|566183405|FG001|Overall Study|Other|1|||
156844307|NCT01504412|566183406|FG002|Overall Study|Other|1|||
156844308|NCT01504412|566183407|FG003|Overall Study|Other|6|||
156844309|NCT01504412|566183408|FG004|Overall Study|Other|1|||
156844310|NCT01504412|566183404|FG000|Overall Study|Lost to Follow-up|0|||
156844311|NCT01504412|566183405|FG001|Overall Study|Lost to Follow-up|2|||
156844312|NCT01504412|566183406|FG002|Overall Study|Lost to Follow-up|0|||
156844313|NCT01504412|566183407|FG003|Overall Study|Lost to Follow-up|0|||
156844314|NCT01504412|566183408|FG004|Overall Study|Lost to Follow-up|0|||
156844315|NCT01504412|566183404|FG000|Overall Study|Lack of Efficacy|0|||
156844316|NCT01504412|566183405|FG001|Overall Study|Lack of Efficacy|0|||
156844317|NCT01504412|566183406|FG002|Overall Study|Lack of Efficacy|1|||
156844318|NCT01504412|566183407|FG003|Overall Study|Lack of Efficacy|0|||
156844319|NCT01504412|566183408|FG004|Overall Study|Lack of Efficacy|1|||
156844320|NCT01504412|566183404|FG000|Overall Study|Death|0|||
156844321|NCT01504412|566183405|FG001|Overall Study|Death|0|||
156844322|NCT01504412|566183406|FG002|Overall Study|Death|0|||
156844323|NCT01504412|566183407|FG003|Overall Study|Death|1|||
156844324|NCT01504412|566183408|FG004|Overall Study|Death|0|||
156844325|NCT05362058|566183409|FG000|Treatment Period|Adverse Event|3|||
156844326|NCT05362058|566183410|FG001|Treatment Period|Adverse Event|3|||
156844327|NCT05362058|566183409|FG000|Treatment Period|Assigned treatment by mistake|3|||
156844328|NCT05362058|566183410|FG001|Treatment Period|Assigned treatment by mistake|4|||
156844329|NCT05362058|566183409|FG000|Treatment Period|Death|1|||
156844330|NCT05362058|566183410|FG001|Treatment Period|Death|1|||
156844331|NCT05362058|566183409|FG000|Treatment Period|Lost to Follow-up|6|||
156844332|NCT05362058|566183410|FG001|Treatment Period|Lost to Follow-up|3|||
156844333|NCT05362058|566183409|FG000|Treatment Period|Non-compliance with study drug|0|||
156844334|NCT05362058|566183410|FG001|Treatment Period|Non-compliance with study drug|1|||
156844335|NCT05362058|566183409|FG000|Treatment Period|Physician Decision|1|||
156844336|NCT05362058|566183410|FG001|Treatment Period|Physician Decision|0|||
156844337|NCT05362058|566183409|FG000|Treatment Period|Protocol deviation|1|||
156844338|NCT05362058|566183410|FG001|Treatment Period|Protocol deviation|0|||
156844339|NCT05362058|566183409|FG000|Treatment Period|Withdrawal by Subject|10|||
156844340|NCT05362058|566183410|FG001|Treatment Period|Withdrawal by Subject|11|||
156844341|NCT05362058|566183409|FG000|Follow-Up Period|Death|1|||
156844342|NCT05362058|566183410|FG001|Follow-Up Period|Death|0|||
156844343|NCT05362058|566183409|FG000|Follow-Up Period|Lost to Follow-up|2|||
156844344|NCT05362058|566183410|FG001|Follow-Up Period|Lost to Follow-up|1|||
156844345|NCT05362058|566183409|FG000|Follow-Up Period|Protocol deviation|1|||
156844346|NCT05362058|566183410|FG001|Follow-Up Period|Protocol deviation|1|||
156844347|NCT05362058|566183409|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156844348|NCT05362058|566183410|FG001|Follow-Up Period|Withdrawal by Subject|3|||
156844349|NCT00398567|566183411|FG000|Overall Study|Disease Progression|3|||
156844350|NCT00398567|566183412|FG001|Overall Study|Disease Progression|4|||
156844351|NCT00398567|566183413|FG002|Overall Study|Disease Progression|27|||
156844352|NCT00398567|566183411|FG000|Overall Study|Withdrawal by Subject|1|||
156844353|NCT00398567|566183412|FG001|Overall Study|Withdrawal by Subject|0|||
156844354|NCT00398567|566183413|FG002|Overall Study|Withdrawal by Subject|4|||
156844355|NCT00398567|566183411|FG000|Overall Study|Adverse Event|0|||
156844356|NCT00398567|566183412|FG001|Overall Study|Adverse Event|0|||
156844357|NCT00398567|566183413|FG002|Overall Study|Adverse Event|2|||
156844358|NCT00398567|566183411|FG000|Overall Study|Protocol Violation|0|||
156844359|NCT00398567|566183412|FG001|Overall Study|Protocol Violation|0|||
156844360|NCT00398567|566183413|FG002|Overall Study|Protocol Violation|1|||
156844361|NCT03437577|566183416|FG000|Pre-Randomization|Withdrawal by Subject|0|||
156844362|NCT03437577|566183417|FG001|Pre-Randomization|Withdrawal by Subject|0|||
156844363|NCT03437577|566183418|FG002|Pre-Randomization|Withdrawal by Subject|10|||
156844364|NCT03437577|566183416|FG000|Post-Randomization|Physician Decision|0|||
156844365|NCT03437577|566183417|FG001|Post-Randomization|Physician Decision|2|||
156844366|NCT03437577|566183418|FG002|Post-Randomization|Physician Decision|0|||
156844367|NCT04273893|566183421|FG000|Overall Study|Withdrawal by Subject|0|||
156844368|NCT04273893|566183422|FG001|Overall Study|Withdrawal by Subject|2|||
156844369|NCT04273893|566183421|FG000|Overall Study|Treatment of Disease Progression|0|||
156844370|NCT04273893|566183422|FG001|Overall Study|Treatment of Disease Progression|2|||
156844371|NCT04273893|566183421|FG000|Overall Study|Death|1|||
156844372|NCT04273893|566183422|FG001|Overall Study|Death|2|||
156844373|NCT04273893|566183421|FG000|Overall Study|Lost to Follow-up|0|||
156844374|NCT04273893|566183422|FG001|Overall Study|Lost to Follow-up|2|||
156844375|NCT04273893|566183421|FG000|Overall Study|Physician Decision|1|||
156844376|NCT04273893|566183422|FG001|Overall Study|Physician Decision|0|||
156844377|NCT01036321|566183427|FG000|Overall Study|Ineligible after randomization|0|||
156844378|NCT01036321|566183428|FG001|Overall Study|Ineligible after randomization|1|||
156844379|NCT01036321|566183427|FG000|Overall Study|Withdrawal by Subject|3|||
156844380|NCT01036321|566183428|FG001|Overall Study|Withdrawal by Subject|2|||
156844381|NCT01036321|566183427|FG000|Overall Study|Adverse Event|2|||
156844382|NCT01036321|566183428|FG001|Overall Study|Adverse Event|1|||
156844383|NCT00381693|566183429|FG000|Overall Study|Death|1|||
156844384|NCT00381693|566183429|FG000|Overall Study|Adverse Event|4|||
156844385|NCT00381693|566183429|FG000|Overall Study|Patient Choice|1|||
156844386|NCT00381693|566183429|FG000|Overall Study|Progression|2|||
156844387|NCT02598297|566183430|FG000|Overall Study|Study terminated by Sponsor|21|||
156844388|NCT02598297|566183431|FG001|Overall Study|Study terminated by Sponsor|23|||
156844389|NCT02598297|566183430|FG000|Overall Study|Adverse Event|1|||
156844390|NCT02598297|566183431|FG001|Overall Study|Adverse Event|1|||
156844391|NCT02598297|566183430|FG000|Overall Study|Physician Decision|1|||
156844392|NCT02598297|566183431|FG001|Overall Study|Physician Decision|0|||
156844393|NCT02598297|566183430|FG000|Overall Study|Subject/guardian decision|1|||
156844394|NCT02598297|566183431|FG001|Overall Study|Subject/guardian decision|0|||
156844395|NCT02598297|566183430|FG000|Overall Study|Followed for survival|1|||
156844396|NCT02598297|566183431|FG001|Overall Study|Followed for survival|0|||
156844397|NCT00887549|566183440|FG000|Induction Therapy|Adverse Event|8|||
156844398|NCT00887549|566183440|FG000|Induction Therapy|Physician Decision|1|||
156844399|NCT00887549|566183440|FG000|Induction Therapy|Progressive Disease|13|||
156844400|NCT00887549|566183440|FG000|Induction Therapy|Death due to Study Disease|4|||
156844401|NCT00887549|566183440|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
156844402|NCT00887549|566183440|FG000|Maintenance Therapy|Adverse Event|16|||
156844403|NCT00887549|566183440|FG000|Maintenance Therapy|Physician Decision|1|||
156844404|NCT00887549|566183440|FG000|Maintenance Therapy|Progressive Disease|25|||
156844405|NCT00887549|566183440|FG000|Maintenance Therapy|Death due to adverse event|1|||
156844406|NCT05173012|566183441|FG000|Overall Study|Adverse Event|2|||
156844407|NCT05173012|566183442|FG001|Overall Study|Adverse Event|3|||
156844408|NCT05173012|566183443|FG002|Overall Study|Adverse Event|4|||
156844409|NCT05173012|566183444|FG003|Overall Study|Adverse Event|13|||
156844410|NCT05173012|566183445|FG004|Overall Study|Adverse Event|0|||
156844411|NCT05173012|566183446|FG005|Overall Study|Adverse Event|0|||
156844412|NCT05173012|566183447|FG006|Overall Study|Adverse Event|2|||
156844413|NCT05173012|566183448|FG007|Overall Study|Adverse Event|4|||
156844414|NCT05173012|566183441|FG000|Overall Study|Lost to Follow-up|0|||
156844415|NCT05173012|566183442|FG001|Overall Study|Lost to Follow-up|0|||
156844416|NCT05173012|566183443|FG002|Overall Study|Lost to Follow-up|0|||
156844417|NCT05173012|566183444|FG003|Overall Study|Lost to Follow-up|1|||
156844418|NCT05173012|566183445|FG004|Overall Study|Lost to Follow-up|0|||
156844419|NCT05173012|566183446|FG005|Overall Study|Lost to Follow-up|0|||
156844420|NCT05173012|566183447|FG006|Overall Study|Lost to Follow-up|0|||
156844421|NCT05173012|566183448|FG007|Overall Study|Lost to Follow-up|0|||
156844422|NCT05173012|566183441|FG000|Overall Study|Withdrawal by Subject|1|||
156844423|NCT05173012|566183442|FG001|Overall Study|Withdrawal by Subject|0|||
156844424|NCT05173012|566183443|FG002|Overall Study|Withdrawal by Subject|1|||
156844425|NCT05173012|566183444|FG003|Overall Study|Withdrawal by Subject|3|||
156844426|NCT05173012|566183445|FG004|Overall Study|Withdrawal by Subject|1|||
156844427|NCT05173012|566183446|FG005|Overall Study|Withdrawal by Subject|0|||
156844428|NCT05173012|566183447|FG006|Overall Study|Withdrawal by Subject|1|||
156844429|NCT05173012|566183448|FG007|Overall Study|Withdrawal by Subject|0|||
156470048|NCT01753999|564814901|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
156470049|NCT01753999|564814900|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
156844430|NCT05173012|566183441|FG000|Overall Study|Protocol Deviation|0|||
156844431|NCT05173012|566183442|FG001|Overall Study|Protocol Deviation|0|||
156844432|NCT05173012|566183443|FG002|Overall Study|Protocol Deviation|0|||
156844433|NCT05173012|566183444|FG003|Overall Study|Protocol Deviation|1|||
156844434|NCT05173012|566183445|FG004|Overall Study|Protocol Deviation|0|||
156844435|NCT05173012|566183446|FG005|Overall Study|Protocol Deviation|0|||
156844436|NCT05173012|566183447|FG006|Overall Study|Protocol Deviation|0|||
156844437|NCT05173012|566183448|FG007|Overall Study|Protocol Deviation|0|||
156844438|NCT05173012|566183441|FG000|Overall Study|Other|0|||
156844439|NCT05173012|566183442|FG001|Overall Study|Other|0|||
156844440|NCT05173012|566183443|FG002|Overall Study|Other|0|||
156844441|NCT05173012|566183444|FG003|Overall Study|Other|2|||
156844442|NCT05173012|566183445|FG004|Overall Study|Other|0|||
156844443|NCT05173012|566183446|FG005|Overall Study|Other|0|||
156844444|NCT05173012|566183447|FG006|Overall Study|Other|0|||
156844445|NCT05173012|566183448|FG007|Overall Study|Other|0|||
156844446|NCT02936843|566183449|FG000|Overall Study|Lost to Follow-up|3|||
156844447|NCT02936843|566183450|FG001|Overall Study|Lost to Follow-up|1|||
156844448|NCT02936843|566183449|FG000|Overall Study|Withdrawal by Subject|1|||
156844449|NCT02936843|566183450|FG001|Overall Study|Withdrawal by Subject|1|||
156844450|NCT00517361|566183458|FG000|Overall Study|Death|6|||
156844451|NCT00517361|566183458|FG000|Overall Study|The study was terminated|5|||
156844452|NCT01856582|566183470|FG000|Overall Study|Died prior to Boost infusion|1|||
156844453|NCT04124705|566183471|FG000|Titration Period|Adverse Event|9|||
156844454|NCT04124705|566183472|FG001|Titration Period|Adverse Event|5|||
156844455|NCT04124705|566183471|FG000|Titration Period|Withdrawal by Subject|6|||
156844456|NCT04124705|566183472|FG001|Titration Period|Withdrawal by Subject|3|||
156844457|NCT04124705|566183471|FG000|Titration Period|Lost to Follow-up|0|||
156844458|NCT04124705|566183472|FG001|Titration Period|Lost to Follow-up|1|||
156844459|NCT04124705|566183471|FG000|Titration Period|Death|1|||
156844460|NCT04124705|566183472|FG001|Titration Period|Death|1|||
156844461|NCT04124705|566183471|FG000|Titration Period|Lack of Efficacy|2|||
156844462|NCT04124705|566183472|FG001|Titration Period|Lack of Efficacy|0|||
156844463|NCT04124705|566183471|FG000|Titration Period|Physician Decision|2|||
156844464|NCT04124705|566183472|FG001|Titration Period|Physician Decision|0|||
156844465|NCT04124705|566183471|FG000|Titration Period|Non-compliance with Study Drug|2|||
156844466|NCT04124705|566183472|FG001|Titration Period|Non-compliance with Study Drug|0|||
156844467|NCT04124705|566183471|FG000|Titration Period|Other|4|||
156844468|NCT04124705|566183472|FG001|Titration Period|Other|9|||
156844469|NCT04124705|566183471|FG000|Stabilization Period|Adverse Event|4|||
156844470|NCT04124705|566183472|FG001|Stabilization Period|Adverse Event|2|||
156844471|NCT04124705|566183471|FG000|Stabilization Period|Withdrawal by Subject|1|||
156844472|NCT04124705|566183472|FG001|Stabilization Period|Withdrawal by Subject|1|||
156844473|NCT04124705|566183471|FG000|Stabilization Period|Lost to Follow-up|0|||
156844474|NCT04124705|566183472|FG001|Stabilization Period|Lost to Follow-up|1|||
156844475|NCT04124705|566183471|FG000|Stabilization Period|Lack of Efficacy|4|||
156844476|NCT04124705|566183472|FG001|Stabilization Period|Lack of Efficacy|2|||
156844477|NCT04124705|566183471|FG000|Stabilization Period|Protocol Deviation|0|||
156844478|NCT04124705|566183472|FG001|Stabilization Period|Protocol Deviation|2|||
156844479|NCT04124705|566183471|FG000|Stabilization Period|Other|2|||
156844480|NCT04124705|566183472|FG001|Stabilization Period|Other|2|||
156844481|NCT00661622|566183475|FG000|Overall Study|Protocol Violation|1|||
156844482|NCT00661622|566183476|FG001|Overall Study|Protocol Violation|0|||
156844483|NCT04427072|566183477|FG000|Randomized Treatment Phase|Progressive disease|9|||
156844484|NCT04427072|566183478|FG001|Randomized Treatment Phase|Progressive disease|4|||
156844485|NCT04427072|566183477|FG000|Randomized Treatment Phase|Adverse Event|3|||
156844486|NCT04427072|566183478|FG001|Randomized Treatment Phase|Adverse Event|1|||
156844487|NCT04427072|566183477|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
156844488|NCT04427072|566183478|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
156844489|NCT04427072|566183477|FG000|Randomized Treatment Phase|Death|0|||
156844490|NCT04427072|566183478|FG001|Randomized Treatment Phase|Death|1|||
156341610|NCT00361569|564348585|FG001|Overall Study|Withdrawal by Subject|1|||
156341611|NCT00361569|564348586|FG002|Overall Study|Withdrawal by Subject|9|||
156341612|NCT00361569|564348587|FG003|Overall Study|Withdrawal by Subject|14|||
156541514|NCT02953340|565075439|FG000|Overall Study|Reason not specified|2|||
156844491|NCT04427072|566183477|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
156844492|NCT04427072|566183478|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
156844493|NCT04427072|566183477|FG000|Extension Treatment Phase|Progressive disease|0|||
156844494|NCT04427072|566183478|FG001|Extension Treatment Phase|Progressive disease|5|||
156844495|NCT05232864|566183479|FG000|Overall Study|Adverse Event|0|||
156844496|NCT05232864|566183480|FG001|Overall Study|Adverse Event|1|||
156844497|NCT05232864|566183479|FG000|Overall Study|Study terminated by sponsor|16|||
156844498|NCT05232864|566183480|FG001|Overall Study|Study terminated by sponsor|14|||
156844499|NCT04765202|566183485|FG000|Overall Study|Lost to Follow-up|1|||
156844500|NCT04765202|566183486|FG001|Overall Study|Lost to Follow-up|1|||
156844501|NCT04765202|566183487|FG002|Overall Study|Lost to Follow-up|2|||
156844502|NCT04765202|566183488|FG003|Overall Study|Lost to Follow-up|2|||
156844503|NCT04765202|566183485|FG000|Overall Study|Physician Decision|0|||
156844504|NCT04765202|566183486|FG001|Overall Study|Physician Decision|0|||
156844505|NCT04765202|566183487|FG002|Overall Study|Physician Decision|1|||
156844506|NCT04765202|566183488|FG003|Overall Study|Physician Decision|1|||
156844507|NCT04929249|566183489|FG000|Overall Study|Adverse Event|2|||
156844508|NCT04929249|566183490|FG001|Overall Study|Adverse Event|1|||
156844509|NCT04929249|566183489|FG000|Overall Study|Death|2|||
156844510|NCT04929249|566183490|FG001|Overall Study|Death|1|||
156844511|NCT04929249|566183489|FG000|Overall Study|Lost to Follow-up|3|||
156844512|NCT04929249|566183490|FG001|Overall Study|Lost to Follow-up|11|||
156844513|NCT04929249|566183489|FG000|Overall Study|Technical problems|0|||
156844514|NCT04929249|566183490|FG001|Overall Study|Technical problems|1|||
156844515|NCT04929249|566183489|FG000|Overall Study|Subject decision|6|||
156844516|NCT04929249|566183490|FG001|Overall Study|Subject decision|8|||
156844517|NCT04929249|566183489|FG000|Overall Study|Withdrew consent|0|||
156844518|NCT04929249|566183490|FG001|Overall Study|Withdrew consent|8|||
156844519|NCT02160145|566183493|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
156844520|NCT02160145|566183494|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
156844521|NCT02160145|566183495|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
156844522|NCT02160145|566183493|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
156844523|NCT02160145|566183494|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
156844524|NCT02160145|566183495|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
156844525|NCT02160145|566183493|FG000|Randomized Double-blind Period|Subject decision|0|||
156844526|NCT02160145|566183494|FG001|Randomized Double-blind Period|Subject decision|21|||
156844527|NCT02160145|566183495|FG002|Randomized Double-blind Period|Subject decision|20|||
156844528|NCT02160145|566183493|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
156844529|NCT02160145|566183494|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
156844530|NCT02160145|566183495|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
156844531|NCT02160145|566183493|FG000|Randomized Double-blind Period|Physician Decision|0|||
156844532|NCT02160145|566183494|FG001|Randomized Double-blind Period|Physician Decision|7|||
156844533|NCT02160145|566183495|FG002|Randomized Double-blind Period|Physician Decision|5|||
156844534|NCT02332291|566183496|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
156844535|NCT02332291|566183497|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
156844536|NCT02332291|566183496|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
156844537|NCT02332291|566183497|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
156844538|NCT02332291|566183496|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
156844539|NCT02332291|566183497|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
156844540|NCT02332291|566183496|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
156844541|NCT02332291|566183497|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
156844542|NCT02332291|566183496|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
156844543|NCT02332291|566183497|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
156844544|NCT02332291|566183496|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
156844545|NCT02332291|566183497|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
156844546|NCT02540993|566183502|FG000|Overall Study|Lost to Follow-up|5|||
156844547|NCT02540993|566183503|FG001|Overall Study|Lost to Follow-up|3|||
156844548|NCT02540993|566183502|FG000|Overall Study|Withdrawal by Subject|4|||
156844549|NCT02540993|566183503|FG001|Overall Study|Withdrawal by Subject|6|||
156844550|NCT02540993|566183502|FG000|Overall Study|GCP violations|33|||
156844551|NCT02540993|566183503|FG001|Overall Study|GCP violations|27|||
156844552|NCT00392990|566183506|FG000|Treatment on Study|Adverse Event|3|||
156844553|NCT00392990|566183507|FG001|Treatment on Study|Adverse Event|1|||
156844554|NCT00392990|566183506|FG000|Follow up for 2 Years|Death|4|||
156844555|NCT00392990|566183507|FG001|Follow up for 2 Years|Death|0|||
156844556|NCT00825812|566183508|FG000|Overall Study|Never entered follow up|0|||
156844557|NCT00825812|566183509|FG001|Overall Study|Never entered follow up|0|||
156470050|NCT01753999|564814901|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
156844558|NCT00825812|566183510|FG002|Overall Study|Never entered follow up|0|||
156844559|NCT00825812|566183511|FG003|Overall Study|Never entered follow up|1|||
156844560|NCT00825812|566183508|FG000|Overall Study|Adverse Event|0|||
156844561|NCT00825812|566183509|FG001|Overall Study|Adverse Event|0|||
156844562|NCT00825812|566183510|FG002|Overall Study|Adverse Event|0|||
156844563|NCT00825812|566183511|FG003|Overall Study|Adverse Event|1|||
156844564|NCT00825812|566183508|FG000|Overall Study|Subject withdrew consent|0|||
156470051|NCT01753999|564814900|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
156470052|NCT01753999|564814901|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
156470053|NCT01753999|564814900|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
156844565|NCT00825812|566183509|FG001|Overall Study|Subject withdrew consent|0|||
156844566|NCT00825812|566183510|FG002|Overall Study|Subject withdrew consent|3|||
156470054|NCT01753999|564814901|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
156844567|NCT00825812|566183511|FG003|Overall Study|Subject withdrew consent|2|||
156844568|NCT00825812|566183508|FG000|Overall Study|Non-compliance with protocol|0|||
156844569|NCT00825812|566183509|FG001|Overall Study|Non-compliance with protocol|0|||
156844570|NCT00825812|566183510|FG002|Overall Study|Non-compliance with protocol|0|||
156844571|NCT00825812|566183511|FG003|Overall Study|Non-compliance with protocol|1|||
156844572|NCT00825812|566183508|FG000|Overall Study|Administrative|0|||
156844573|NCT00825812|566183509|FG001|Overall Study|Administrative|1|||
156844574|NCT00825812|566183510|FG002|Overall Study|Administrative|3|||
156844575|NCT00825812|566183511|FG003|Overall Study|Administrative|5|||
156844576|NCT00991406|566183512|FG000|Overall Study|One participant did not respond to FES.|1|||
156844577|NCT02006979|566183513|FG000|Overall Study|Withdrawal by Subject|1|||
156844578|NCT02006979|566183514|FG001|Overall Study|Withdrawal by Subject|1|||
156844579|NCT02006979|566183513|FG000|Overall Study|Protocol Violation|0|||
156844580|NCT02006979|566183514|FG001|Overall Study|Protocol Violation|1|||
156844581|NCT02038075|566183515|FG000|Overall Study|Withdrawal by Subject|3|||
156844582|NCT02038075|566183516|FG001|Overall Study|Withdrawal by Subject|0|||
156844583|NCT03477838|566183517|FG000|Overall Study|Lost to Follow-up|14|||
156844584|NCT02519595|566183519|FG000|Overall Study|Protocol Violation|8|||
156844585|NCT02519595|566183520|FG001|Overall Study|Protocol Violation|22|||
156844586|NCT02519595|566183521|FG002|Overall Study|Protocol Violation|16|||
156844587|NCT00850538|566183524|FG000|Overall Study|unable/unwilling to complete MRI|13|||
156844588|NCT00850538|566183524|FG000|Overall Study|specimen missed due to scheduling error|14|||
156844589|NCT00850538|566183524|FG000|Overall Study|specimen unusable|7|||
156844590|NCT00850538|566183524|FG000|Overall Study|Withdrawal by Subject|3|||
156844591|NCT00850538|566183524|FG000|Overall Study|radiology error|2|||
156844592|NCT00850538|566183524|FG000|Overall Study|Protocol Violation|2|||
156844593|NCT03188510|566183525|FG000|Overall Study|Inappropriate behavior with site staff|0|||
156844594|NCT03188510|566183526|FG001|Overall Study|Inappropriate behavior with site staff|1|||
156844595|NCT03188510|566183527|FG002|Overall Study|Inappropriate behavior with site staff|0|||
156844596|NCT01736618|566183530|FG000|Overall Study|Death|294|||
156844597|NCT01736618|566183530|FG000|Overall Study|Lost to Follow-up|193|||
156844598|NCT01736618|566183530|FG000|Overall Study|Withdrawal by Subject|54|||
156844599|NCT01736618|566183530|FG000|Overall Study|Subject unable to be followed at study location|223|||
156844600|NCT01736618|566183530|FG000|Overall Study|Physician Decision|33|||
156844601|NCT01736618|566183530|FG000|Overall Study|Transplant or removal of target organ|19|||
156844602|NCT01736618|566183530|FG000|Overall Study|Change in indication or condition|78|||
156844603|NCT01736618|566183530|FG000|Overall Study|Study device explant|103|||
156844604|NCT01736618|566183530|FG000|Overall Study|Unable to complete implant|2|||
156844605|NCT04167137|566183532|FG000|Overall Study|Disease progression|1|||
156844606|NCT04167137|566183533|FG001|Overall Study|Disease progression|1|||
156844607|NCT04167137|566183534|FG002|Overall Study|Disease progression|3|||
156844608|NCT04167137|566183535|FG003|Overall Study|Disease progression|3|||
156844609|NCT04167137|566183536|FG004|Overall Study|Disease progression|2|||
156844610|NCT04167137|566183537|FG005|Overall Study|Disease progression|3|||
156844611|NCT04167137|566183538|FG006|Overall Study|Disease progression|2|||
156844612|NCT04167137|566183539|FG007|Overall Study|Disease progression|2|||
156844613|NCT04167137|566183532|FG000|Overall Study|Withdrawal by Subject|1|||
156844614|NCT04167137|566183533|FG001|Overall Study|Withdrawal by Subject|0|||
156844615|NCT04167137|566183534|FG002|Overall Study|Withdrawal by Subject|0|||
156844616|NCT04167137|566183535|FG003|Overall Study|Withdrawal by Subject|1|||
156844617|NCT04167137|566183536|FG004|Overall Study|Withdrawal by Subject|0|||
156844618|NCT04167137|566183537|FG005|Overall Study|Withdrawal by Subject|2|||
156844619|NCT04167137|566183538|FG006|Overall Study|Withdrawal by Subject|1|||
156844620|NCT04167137|566183539|FG007|Overall Study|Withdrawal by Subject|0|||
156844621|NCT04167137|566183532|FG000|Overall Study|Adverse Event|0|||
156844622|NCT04167137|566183533|FG001|Overall Study|Adverse Event|0|||
156844623|NCT04167137|566183534|FG002|Overall Study|Adverse Event|0|||
156844624|NCT04167137|566183535|FG003|Overall Study|Adverse Event|0|||
156844625|NCT04167137|566183536|FG004|Overall Study|Adverse Event|0|||
156844626|NCT04167137|566183537|FG005|Overall Study|Adverse Event|1|||
156844627|NCT04167137|566183538|FG006|Overall Study|Adverse Event|0|||
156844628|NCT04167137|566183539|FG007|Overall Study|Adverse Event|1|||
156844629|NCT04167137|566183532|FG000|Overall Study|Physician Decision|0|||
156341613|NCT00361569|564348584|FG000|Overall Study|Adverse Event|3|||
156470055|NCT01753999|564814900|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
156844630|NCT04167137|566183533|FG001|Overall Study|Physician Decision|0|||
156844631|NCT04167137|566183534|FG002|Overall Study|Physician Decision|0|||
156844632|NCT04167137|566183535|FG003|Overall Study|Physician Decision|1|||
156844633|NCT04167137|566183536|FG004|Overall Study|Physician Decision|0|||
156844634|NCT04167137|566183537|FG005|Overall Study|Physician Decision|0|||
156844635|NCT04167137|566183538|FG006|Overall Study|Physician Decision|1|||
156844636|NCT04167137|566183539|FG007|Overall Study|Physician Decision|0|||
156844637|NCT04167137|566183532|FG000|Overall Study|Death|0|||
156844638|NCT04167137|566183533|FG001|Overall Study|Death|1|||
156844639|NCT04167137|566183534|FG002|Overall Study|Death|0|||
156844640|NCT04167137|566183535|FG003|Overall Study|Death|0|||
156844641|NCT04167137|566183536|FG004|Overall Study|Death|0|||
156844642|NCT04167137|566183537|FG005|Overall Study|Death|0|||
156844643|NCT04167137|566183538|FG006|Overall Study|Death|0|||
156844644|NCT04167137|566183539|FG007|Overall Study|Death|0|||
156844645|NCT04167137|566183532|FG000|Overall Study|Study terminated by Sponsor|0|||
156844646|NCT04167137|566183533|FG001|Overall Study|Study terminated by Sponsor|0|||
156844647|NCT04167137|566183534|FG002|Overall Study|Study terminated by Sponsor|0|||
156844648|NCT04167137|566183535|FG003|Overall Study|Study terminated by Sponsor|0|||
156844649|NCT04167137|566183536|FG004|Overall Study|Study terminated by Sponsor|0|||
156844650|NCT04167137|566183537|FG005|Overall Study|Study terminated by Sponsor|0|||
156844651|NCT04167137|566183538|FG006|Overall Study|Study terminated by Sponsor|0|||
156844652|NCT04167137|566183539|FG007|Overall Study|Study terminated by Sponsor|1|||
156844653|NCT02461745|566183545|FG000|Overall Study|Lack of Efficacy|9|||
156844654|NCT02461745|566183546|FG001|Overall Study|Lack of Efficacy|1|||
156844655|NCT02461745|566183545|FG000|Overall Study|Lost to Follow-up|2|||
156844656|NCT02461745|566183546|FG001|Overall Study|Lost to Follow-up|2|||
156844657|NCT02461745|566183545|FG000|Overall Study|Withdrawal by Subject|3|||
156844658|NCT02461745|566183546|FG001|Overall Study|Withdrawal by Subject|1|||
156844659|NCT02921087|566183547|FG000|Overall Study|Withdrawal by Subject|0|||
156844660|NCT02921087|566183548|FG001|Overall Study|Withdrawal by Subject|1|||
156844661|NCT00211887|566183549|FG000|Overall Study|Adverse Event|8|||
156844662|NCT00211887|566183550|FG001|Overall Study|Adverse Event|4|||
156844663|NCT00211887|566183551|FG002|Overall Study|Adverse Event|6|||
156844664|NCT00211887|566183549|FG000|Overall Study|Death|1|||
156844665|NCT00211887|566183550|FG001|Overall Study|Death|1|||
156844666|NCT00211887|566183551|FG002|Overall Study|Death|1|||
156844667|NCT00211887|566183549|FG000|Overall Study|Lost to Follow-up|28|||
156844668|NCT00211887|566183550|FG001|Overall Study|Lost to Follow-up|13|||
156844669|NCT00211887|566183551|FG002|Overall Study|Lost to Follow-up|9|||
156844670|NCT00211887|566183549|FG000|Overall Study|Non-medical reason|31|||
156844671|NCT00211887|566183550|FG001|Overall Study|Non-medical reason|14|||
156844672|NCT00211887|566183551|FG002|Overall Study|Non-medical reason|8|||
156844673|NCT00211887|566183549|FG000|Overall Study|Other medical reason|15|||
156844674|NCT00211887|566183550|FG001|Overall Study|Other medical reason|11|||
156844675|NCT00211887|566183551|FG002|Overall Study|Other medical reason|7|||
156844676|NCT00211887|566183549|FG000|Overall Study|Side effects|19|||
156844677|NCT00211887|566183550|FG001|Overall Study|Side effects|13|||
156844678|NCT00211887|566183551|FG002|Overall Study|Side effects|5|||
156844679|NCT03058692|566185390|FG000|Overall Study|Lost to Follow-up|2|||
156844680|NCT03058692|566185391|FG001|Overall Study|Lost to Follow-up|1|||
156844681|NCT03058692|566185390|FG000|Overall Study|Withdrawal by Subject|1|||
156844682|NCT03058692|566185391|FG001|Overall Study|Withdrawal by Subject|1|||
156844683|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
156844684|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
156844685|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
156844686|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
156844687|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
156844688|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
156844689|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
156844690|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
156844691|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
156844692|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
156844693|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
156844694|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
156844695|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
156844696|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
156844697|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
156844698|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
156844699|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
156844700|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
156844701|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
156844702|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
156541515|NCT02953340|565075440|FG001|Overall Study|Reason not specified|2|||
156844703|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
156844704|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
156844705|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
156844706|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
156844707|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
156844708|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
156844709|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
156844710|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
156844711|NCT03777059|566185392|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
156844712|NCT03777059|566185393|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
156844713|NCT03777059|566185394|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
156844714|NCT03777059|566185395|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
156844715|NCT03777059|566185392|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
156844716|NCT03777059|566185393|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
156844717|NCT03777059|566185394|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
156844718|NCT03777059|566185395|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
156844719|NCT03777059|566185392|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
156844720|NCT03777059|566185393|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
156844721|NCT03777059|566185394|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
156844722|NCT03777059|566185395|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
156844723|NCT03777059|566185392|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
156844724|NCT03777059|566185393|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
156844725|NCT03777059|566185394|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
156844726|NCT03777059|566185395|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
156844727|NCT01702025|566185400|FG000|Overall Study|Equipment failure|1|||
156844728|NCT01702025|566185401|FG001|Overall Study|Equipment failure|0|||
156844729|NCT01702025|566185402|FG002|Overall Study|Equipment failure|0|||
156844730|NCT01702025|566185403|FG003|Overall Study|Equipment failure|0|||
156844731|NCT01702025|566185400|FG000|Overall Study|Adverse Event|1|||
156844732|NCT01702025|566185401|FG001|Overall Study|Adverse Event|1|||
156844733|NCT01702025|566185402|FG002|Overall Study|Adverse Event|1|||
156844734|NCT01702025|566185403|FG003|Overall Study|Adverse Event|0|||
156844735|NCT02679755|566185404|FG000|Overall Study|Death|0|||
156844736|NCT02679755|566185405|FG001|Overall Study|Death|3|||
156844737|NCT02679755|566185404|FG000|Overall Study|Global deterioration of health status|1|||
156844738|NCT02679755|566185405|FG001|Overall Study|Global deterioration of health status|8|||
156844739|NCT02679755|566185404|FG000|Overall Study|Lost to Follow-up|1|||
156844740|NCT02679755|566185405|FG001|Overall Study|Lost to Follow-up|0|||
156844741|NCT02679755|566185404|FG000|Overall Study|Objective progression or relapse|24|||
156844742|NCT02679755|566185405|FG001|Overall Study|Objective progression or relapse|83|||
156844743|NCT02679755|566185404|FG000|Overall Study|Not defined|0|||
156844744|NCT02679755|566185405|FG001|Overall Study|Not defined|2|||
156844745|NCT02679755|566185404|FG000|Overall Study|Withdrawal by participant|6|||
156844746|NCT02679755|566185405|FG001|Overall Study|Withdrawal by participant|3|||
156844747|NCT02679755|566185404|FG000|Overall Study|Adverse Event|1|||
156844748|NCT02679755|566185405|FG001|Overall Study|Adverse Event|4|||
156844749|NCT02679755|566185404|FG000|Overall Study|Adverse events not related to study drug|1|||
156844750|NCT02679755|566185405|FG001|Overall Study|Adverse events not related to study drug|2|||
156844751|NCT01061359|566185406|FG000|Overall Study|Death|32|||
156844752|NCT01061359|566185406|FG000|Overall Study|Lost to Follow-up|1072|||
156844753|NCT01061359|566185406|FG000|Overall Study|Relapse|187|||
156844754|NCT01061359|566185406|FG000|Overall Study|Secondary neoplasm|11|||
156844755|NCT02610777|566185407|FG000|Overall Study|Lost to Follow-up|1|||
156844756|NCT02610777|566185408|FG001|Overall Study|Lost to Follow-up|0|||
156844757|NCT02610777|566185407|FG000|Overall Study|Site Terminated by Sponsor|9|||
156844758|NCT02610777|566185408|FG001|Overall Study|Site Terminated by Sponsor|8|||
156844759|NCT02610777|566185407|FG000|Overall Study|Withdrawal by Subject|2|||
156844760|NCT02610777|566185408|FG001|Overall Study|Withdrawal by Subject|2|||
156844761|NCT02610777|566185407|FG000|Overall Study|Reason not Specified|0|||
156844762|NCT02610777|566185408|FG001|Overall Study|Reason not Specified|1|||
156844763|NCT02610777|566185407|FG000|Overall Study|Death|50|||
156844764|NCT02610777|566185408|FG001|Overall Study|Death|47|||
156844765|NCT00411671|566185411|FG000|Overall Study|Adverse Event|15|||
156844766|NCT00411671|566185411|FG000|Overall Study|Death|2|||
156844767|NCT00411671|566185411|FG000|Overall Study|Lost to Follow-up|3|||
156844768|NCT04737278|566185412|FG000|Overall Study|Lost to Follow-up|1|||
156844769|NCT04737278|566185413|FG001|Overall Study|Lost to Follow-up|1|||
156844770|NCT04737278|566185412|FG000|Overall Study|Withdrawal by Subject|1|||
156844771|NCT04737278|566185413|FG001|Overall Study|Withdrawal by Subject|0|||
156844772|NCT04737278|566185412|FG000|Overall Study|Protocol Violation|1|||
156844773|NCT04737278|566185413|FG001|Overall Study|Protocol Violation|1|||
156341614|NCT00361569|564348585|FG001|Overall Study|Adverse Event|5|||
156844774|NCT04737278|566185412|FG000|Overall Study|failure to complete questionnaire|1|||
156844775|NCT04737278|566185413|FG001|Overall Study|failure to complete questionnaire|1|||
156844776|NCT00546000|566185418|FG000|Overall Study|Adverse Event|1|||
156844777|NCT00546000|566185418|FG000|Overall Study|Lost to Follow-up|1|||
156844778|NCT00546000|566185418|FG000|Overall Study|Baseline HPA Axis Supression|2|||
156844779|NCT03688074|566185423|FG000|Overall Study|Adverse Event|0|||
156844780|NCT03688074|566185424|FG001|Overall Study|Adverse Event|1|||
156844781|NCT03688074|566185423|FG000|Overall Study|Other|1|||
156844782|NCT03688074|566185424|FG001|Overall Study|Other|0|||
156844783|NCT01362608|566185427|FG000|Overall Study|Protocol Violation|0|||
156844784|NCT01362608|566185428|FG001|Overall Study|Protocol Violation|1|||
156844785|NCT01362608|566185427|FG000|Overall Study|Lost to Follow-up|3|||
156844786|NCT01362608|566185428|FG001|Overall Study|Lost to Follow-up|1|||
156844787|NCT01362608|566185427|FG000|Overall Study|Withdrawal by Subject|1|||
156844788|NCT01362608|566185428|FG001|Overall Study|Withdrawal by Subject|2|||
156844789|NCT01362608|566185427|FG000|Overall Study|Lack of Efficacy|0|||
156844790|NCT01362608|566185428|FG001|Overall Study|Lack of Efficacy|2|||
156844791|NCT01362608|566185427|FG000|Overall Study|Adverse Event|0|||
156844792|NCT01362608|566185428|FG001|Overall Study|Adverse Event|2|||
156844793|NCT03056339|566185434|FG000|Overall Study|Failed Requirements|0|||
156844794|NCT03056339|566185435|FG001|Overall Study|Failed Requirements|2|||
156844795|NCT03056339|566185436|FG002|Overall Study|Failed Requirements|7|||
156844796|NCT03056339|566185437|FG003|Overall Study|Failed Requirements|1|||
156844797|NCT01128244|566185442|FG000|Overall Study|Adverse Event|1|||
156844798|NCT01128244|566185442|FG000|Overall Study|Scheduling conflict|2|||
156844799|NCT04171219|566185448|FG000|Overall Study|Adverse Event|1|||
156844800|NCT04171219|566185449|FG001|Overall Study|Adverse Event|0|||
156844801|NCT04171219|566185448|FG000|Overall Study|Death|0|||
156844802|NCT04171219|566185449|FG001|Overall Study|Death|1|||
156844803|NCT04171219|566185448|FG000|Overall Study|Lack of Efficacy|9|||
156844804|NCT04171219|566185449|FG001|Overall Study|Lack of Efficacy|13|||
156844805|NCT04171219|566185448|FG000|Overall Study|Withdrawal by Subject|1|||
156844806|NCT04171219|566185449|FG001|Overall Study|Withdrawal by Subject|2|||
156844807|NCT04171219|566185448|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
156844808|NCT04171219|566185449|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
156844809|NCT04171219|566185448|FG000|Overall Study|Clinical PD/Patient choice|1|||
156844810|NCT04171219|566185449|FG001|Overall Study|Clinical PD/Patient choice|0|||
156844811|NCT04171219|566185448|FG000|Overall Study|Toxicity/ Patient choice|1|||
156844812|NCT04171219|566185449|FG001|Overall Study|Toxicity/ Patient choice|0|||
156844813|NCT04809285|566185454|FG000|Phase 1|Lost to Follow-up|6|||
156844814|NCT04809285|566185454|FG000|Phase 1|Protocol Violation|2|||
156844815|NCT04809285|566185454|FG000|Phase 1|Physician Decision|3|||
156844816|NCT04809285|566185454|FG000|Phase 1|Withdrawal by Subject|29|||
156844817|NCT04809285|566185454|FG000|Phase 2|Protocol Violation|3|||
156844818|NCT04809285|566185454|FG000|Phase 2|Withdrawal by Subject|4|||
156844819|NCT02974257|566185455|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
156844820|NCT02974257|566185456|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
156844821|NCT02974257|566185455|FG000|Overall Study|Clinical indication for thiamine|1|||
156844822|NCT02974257|566185456|FG001|Overall Study|Clinical indication for thiamine|0|||
156844823|NCT02974257|566185455|FG000|Overall Study|Already on thiamine|1|||
156844824|NCT02974257|566185456|FG001|Overall Study|Already on thiamine|0|||
156844825|NCT02974257|566185455|FG000|Overall Study|Extubated prior to study drug|0|||
156844826|NCT02974257|566185456|FG001|Overall Study|Extubated prior to study drug|1|||
156844827|NCT02974257|566185455|FG000|Overall Study|Death|0|||
156844828|NCT02974257|566185456|FG001|Overall Study|Death|1|||
156844829|NCT03526146|566185457|FG000|Overall Study|Lost to Follow-up|5|||
156844830|NCT03526146|566185457|FG000|Overall Study|Withdrawal by Subject|6|||
156844831|NCT03526146|566185457|FG000|Overall Study|class canceled due to COVID-19|4|||
156844832|NCT00699608|566185462|FG000|First Intervention|Withdrawal by Subject|0|||
156844833|NCT00699608|566185463|FG001|First Intervention|Withdrawal by Subject|0|||
156844834|NCT00699608|566185464|FG002|First Intervention|Withdrawal by Subject|1|||
156844835|NCT00699608|566185465|FG003|First Intervention|Withdrawal by Subject|0|||
156844836|NCT00699608|566185466|FG004|First Intervention|Withdrawal by Subject|0|||
156844837|NCT00699608|566185467|FG005|First Intervention|Withdrawal by Subject|0|||
156844838|NCT00699608|566185462|FG000|First Intervention|Protocol Violation|0|||
156541516|NCT04707157|565075441|FG000|Overall Study|Adverse Event|12|||
156844839|NCT00699608|566185463|FG001|First Intervention|Protocol Violation|0|||
156844840|NCT00699608|566185464|FG002|First Intervention|Protocol Violation|0|||
156844841|NCT00699608|566185465|FG003|First Intervention|Protocol Violation|0|||
156844842|NCT00699608|566185466|FG004|First Intervention|Protocol Violation|1|||
156844843|NCT00699608|566185467|FG005|First Intervention|Protocol Violation|0|||
156844844|NCT00699608|566185462|FG000|Second Intervention|Adverse Event|0|||
156844845|NCT00699608|566185463|FG001|Second Intervention|Adverse Event|0|||
156844846|NCT00699608|566185464|FG002|Second Intervention|Adverse Event|1|||
156844847|NCT00699608|566185465|FG003|Second Intervention|Adverse Event|0|||
156844848|NCT00699608|566185466|FG004|Second Intervention|Adverse Event|0|||
156844849|NCT00699608|566185467|FG005|Second Intervention|Adverse Event|0|||
156470056|NCT01753999|564814901|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
156844850|NCT00699608|566185462|FG000|Second Intervention|Withdrawal by Subject|0|||
156844851|NCT00699608|566185463|FG001|Second Intervention|Withdrawal by Subject|0|||
156844852|NCT00699608|566185464|FG002|Second Intervention|Withdrawal by Subject|0|||
156844853|NCT00699608|566185465|FG003|Second Intervention|Withdrawal by Subject|1|||
156844854|NCT00699608|566185466|FG004|Second Intervention|Withdrawal by Subject|0|||
156844855|NCT00699608|566185467|FG005|Second Intervention|Withdrawal by Subject|0|||
156844856|NCT02837029|566185468|FG000|Screening|Failed to meet screening requirements.|7|||
156844857|NCT02837029|566185469|FG001|Screening|Failed to meet screening requirements.|3|||
156844858|NCT02837029|566185470|FG002|Screening|Failed to meet screening requirements.|0|||
156844859|NCT02837029|566185468|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
156844860|NCT02837029|566185469|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
156844861|NCT02837029|566185470|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
156844862|NCT02837029|566185468|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
156844863|NCT02837029|566185469|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
156844864|NCT02837029|566185470|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
156844865|NCT02837029|566185468|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
156844866|NCT02837029|566185469|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
156844867|NCT02837029|566185470|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
156844868|NCT02837029|566185468|FG000|Cycle 2 and Beyond|Adverse Event|1|||
156844869|NCT02837029|566185469|FG001|Cycle 2 and Beyond|Adverse Event|0|||
156844870|NCT02837029|566185470|FG002|Cycle 2 and Beyond|Adverse Event|0|||
156844871|NCT02837029|566185468|FG000|2 Year Follow-up|Death|6|||
156844872|NCT02837029|566185469|FG001|2 Year Follow-up|Death|7|||
156844873|NCT02837029|566185470|FG002|2 Year Follow-up|Death|0|||
156844874|NCT02644343|566185471|FG000|Overall Study|Withdrawal by Subject|1|||
156844875|NCT02206035|566185478|FG000|Overall Study|Physician Decision|10|||
156844876|NCT02206035|566185479|FG001|Overall Study|Physician Decision|0|||
156844877|NCT02206035|566185480|FG002|Overall Study|Physician Decision|175|||
156844878|NCT00377858|566185481|FG000|Overall Study|Withdrawal by Subject|12|||
156844879|NCT00377858|566185482|FG001|Overall Study|Withdrawal by Subject|11|||
156844880|NCT00377858|566185481|FG000|Overall Study|Lost to Follow-up|6|||
156844881|NCT00377858|566185482|FG001|Overall Study|Lost to Follow-up|1|||
156844882|NCT00377858|566185481|FG000|Overall Study|Physician Decision|5|||
156844883|NCT00377858|566185482|FG001|Overall Study|Physician Decision|5|||
156844884|NCT00377858|566185481|FG000|Overall Study|Protocol Violation|3|||
156844885|NCT00377858|566185482|FG001|Overall Study|Protocol Violation|4|||
156844886|NCT00377858|566185481|FG000|Overall Study|Adverse Event|2|||
156844887|NCT00377858|566185482|FG001|Overall Study|Adverse Event|1|||
156844888|NCT00377858|566185481|FG000|Overall Study|Entry Criteria Not Met|2|||
156844889|NCT00377858|566185482|FG001|Overall Study|Entry Criteria Not Met|0|||
156844890|NCT00377858|566185481|FG000|Overall Study|Sponsor Decision|1|||
156844891|NCT00377858|566185482|FG001|Overall Study|Sponsor Decision|2|||
156844892|NCT00377858|566185481|FG000|Overall Study|Death|0|||
156844893|NCT00377858|566185482|FG001|Overall Study|Death|3|||
156844894|NCT03534141|566185483|FG000|Overall Study|Enrolled in other clinical trial|1|||
156844895|NCT03534141|566185484|FG001|Overall Study|Enrolled in other clinical trial|0|||
156844896|NCT03534141|566185483|FG000|Overall Study|Liver transplant aborted after randomization|0|||
156844897|NCT03534141|566185484|FG001|Overall Study|Liver transplant aborted after randomization|2|||
156844898|NCT03534141|566185483|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
156844899|NCT03534141|566185484|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
156844900|NCT01824355|566185485|FG000|Overall Study|Adverse Event|2|||
156844901|NCT01824355|566185485|FG000|Overall Study|unevaluable reference method results per|1|||
156844902|NCT01636986|566185486|FG000|Overall Study|Withdrawal by Subject|0|||
156844903|NCT01636986|566185487|FG001|Overall Study|Withdrawal by Subject|1|||
156844904|NCT01636986|566185486|FG000|Overall Study|Corneal Staining|0|||
156844905|NCT01636986|566185487|FG001|Overall Study|Corneal Staining|1|||
156844906|NCT01620762|566185497|FG000|Overall Study|Protocol Violation|1|||
156844907|NCT01620762|566185498|FG001|Overall Study|Protocol Violation|1|||
156844908|NCT01620762|566185499|FG002|Overall Study|Protocol Violation|1|||
156844909|NCT01620762|566185497|FG000|Overall Study|Adverse Event|9|||
156844910|NCT01620762|566185498|FG001|Overall Study|Adverse Event|5|||
156844911|NCT01620762|566185499|FG002|Overall Study|Adverse Event|2|||
156844912|NCT01620762|566185497|FG000|Overall Study|Withdrawal by Subject|23|||
156844913|NCT01620762|566185498|FG001|Overall Study|Withdrawal by Subject|26|||
156844914|NCT01620762|566185499|FG002|Overall Study|Withdrawal by Subject|27|||
156844915|NCT01620762|566185497|FG000|Overall Study|Lost to Follow-up|11|||
156844916|NCT01620762|566185498|FG001|Overall Study|Lost to Follow-up|17|||
156844917|NCT01620762|566185499|FG002|Overall Study|Lost to Follow-up|10|||
156844918|NCT01620762|566185497|FG000|Overall Study|Protocol deviation|1|||
156844919|NCT01620762|566185498|FG001|Overall Study|Protocol deviation|1|||
156844920|NCT01620762|566185499|FG002|Overall Study|Protocol deviation|6|||
156844921|NCT01620762|566185497|FG000|Overall Study|Subject deterioration|0|||
156844922|NCT01620762|566185498|FG001|Overall Study|Subject deterioration|1|||
156844923|NCT01620762|566185499|FG002|Overall Study|Subject deterioration|1|||
156844924|NCT01620762|566185497|FG000|Overall Study|Non-specified|3|||
156844925|NCT01620762|566185498|FG001|Overall Study|Non-specified|6|||
156844926|NCT01620762|566185499|FG002|Overall Study|Non-specified|5|||
156844927|NCT01620762|566185497|FG000|Overall Study|Use of prohibted therapies|0|||
156844928|NCT01620762|566185498|FG001|Overall Study|Use of prohibted therapies|1|||
156844929|NCT01620762|566185499|FG002|Overall Study|Use of prohibted therapies|1|||
156844930|NCT00705146|566185504|FG000|Overall Study|Lost to Follow-up|1|||
156844931|NCT00705146|566185505|FG001|Overall Study|Lost to Follow-up|1|||
156844932|NCT00095173|566185506|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
156844933|NCT00095173|566185507|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844934|NCT00095173|566185508|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844935|NCT00095173|566185509|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844936|NCT00095173|566185510|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844937|NCT00095173|566185511|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844938|NCT00095173|566185506|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
156844939|NCT00095173|566185507|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844940|NCT00095173|566185508|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844941|NCT00095173|566185509|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844942|NCT00095173|566185510|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844943|NCT00095173|566185511|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844944|NCT00095173|566185506|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
156844945|NCT00095173|566185507|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844946|NCT00095173|566185508|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844947|NCT00095173|566185509|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844948|NCT00095173|566185510|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844949|NCT00095173|566185511|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844950|NCT00095173|566185506|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
156844951|NCT00095173|566185507|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
156844952|NCT00095173|566185508|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
156844953|NCT00095173|566185509|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
156844954|NCT00095173|566185510|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
156844955|NCT00095173|566185511|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
156844956|NCT00095173|566185506|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
156844957|NCT00095173|566185507|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
156844958|NCT00095173|566185508|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
156844959|NCT00095173|566185509|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
156844960|NCT00095173|566185510|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
156844961|NCT00095173|566185511|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
156844962|NCT00095173|566185506|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844963|NCT00095173|566185507|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
156844964|NCT00095173|566185508|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844965|NCT00095173|566185509|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844966|NCT00095173|566185510|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844967|NCT00095173|566185511|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844968|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Death|0|||
156844969|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Death|0|||
156844970|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Death|0|||
156844971|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Death|0|||
156541517|NCT04707157|565075442|FG001|Overall Study|Adverse Event|3|||
156844972|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Death|0|||
156844973|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Death|1|||
156844974|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
156844975|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
156844976|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
156844977|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
156844978|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
156844979|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
156844980|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
156844981|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
156844982|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
156844983|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
156844984|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
156844985|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
156844986|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
156844987|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
156844988|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
156844989|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
156844990|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
156844991|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
156541518|NCT04707157|565075441|FG000|Overall Study|Lost to Follow-up|2|||
156844992|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
156844993|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
156844994|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
156844995|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
156844996|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
156844997|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
156844998|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
156844999|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
156845000|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
156845001|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
156845002|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
156845003|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
156845004|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
156845005|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
156845006|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
156845007|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
156845008|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
156845009|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
156845010|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
156845011|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
156845012|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
156845013|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
156845014|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
156845015|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
156845016|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Other|0|||
156845017|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Other|0|||
156845018|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Other|0|||
156845019|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Other|4|||
156845020|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Other|6|||
156845021|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Other|8|||
156845022|NCT01620528|566185513|FG000|Treatment Period|Did Not Receive Study Drug|0|||
156845023|NCT01620528|566185514|FG001|Treatment Period|Did Not Receive Study Drug|0|||
156845024|NCT01620528|566185515|FG002|Treatment Period|Did Not Receive Study Drug|1|||
156845025|NCT01620528|566185513|FG000|Treatment Period|Withdrawal by Subject|35|||
156845026|NCT01620528|566185514|FG001|Treatment Period|Withdrawal by Subject|21|||
156845027|NCT01620528|566185515|FG002|Treatment Period|Withdrawal by Subject|16|||
156845028|NCT01620528|566185513|FG000|Treatment Period|Adverse Event|17|||
156845029|NCT01620528|566185514|FG001|Treatment Period|Adverse Event|13|||
156845030|NCT01620528|566185515|FG002|Treatment Period|Adverse Event|21|||
156845031|NCT01620528|566185513|FG000|Treatment Period|Lost to Follow-up|16|||
156845032|NCT01620528|566185514|FG001|Treatment Period|Lost to Follow-up|8|||
156845033|NCT01620528|566185515|FG002|Treatment Period|Lost to Follow-up|14|||
156845034|NCT01620528|566185513|FG000|Treatment Period|Other|9|||
156845035|NCT01620528|566185514|FG001|Treatment Period|Other|5|||
156845036|NCT01620528|566185515|FG002|Treatment Period|Other|7|||
156845037|NCT01620528|566185513|FG000|Treatment Period|Subject Noncompliant|11|||
156845038|NCT01620528|566185514|FG001|Treatment Period|Subject Noncompliant|2|||
156845039|NCT01620528|566185515|FG002|Treatment Period|Subject Noncompliant|2|||
156845040|NCT01620528|566185513|FG000|Treatment Period|Pregnancy|7|||
156845041|NCT01620528|566185514|FG001|Treatment Period|Pregnancy|2|||
156845042|NCT01620528|566185515|FG002|Treatment Period|Pregnancy|2|||
156845043|NCT01620528|566185513|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
156845044|NCT01620528|566185514|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
156845045|NCT01620528|566185515|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
156845046|NCT01620528|566185513|FG000|Treatment Period|Exclusionary Medication Received|0|||
156845047|NCT01620528|566185514|FG001|Treatment Period|Exclusionary Medication Received|1|||
156845048|NCT01620528|566185515|FG002|Treatment Period|Exclusionary Medication Received|0|||
156845049|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
156845050|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
156845051|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
156845052|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
156845053|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
156541519|NCT04707157|565075442|FG001|Overall Study|Lost to Follow-up|0|||
156541520|NCT04707157|565075441|FG000|Overall Study|Sponsor's decision|1|||
156845054|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
156845055|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
156845056|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
156845057|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
156541521|NCT04707157|565075442|FG001|Overall Study|Sponsor's decision|0|||
156845058|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
156845059|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
156845060|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
156845061|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Other|6|||
156845062|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Other|4|||
156845063|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Other|2|||
156845064|NCT03997825|566185527|FG000|Overall Study|Death|3|||
156845065|NCT03997825|566185527|FG000|Overall Study|Lost to Follow-up|10|||
156845066|NCT03997825|566185527|FG000|Overall Study|Withdrawal by Subject|3|||
156845067|NCT03997825|566185527|FG000|Overall Study|Refused participation|1|||
156341615|NCT00361569|564348586|FG002|Overall Study|Adverse Event|2|||
156341616|NCT00361569|564348587|FG003|Overall Study|Adverse Event|2|||
156341617|NCT00361569|564348584|FG000|Overall Study|Lost to Follow-up|2|||
156341618|NCT00361569|564348585|FG001|Overall Study|Lost to Follow-up|3|||
156341619|NCT00361569|564348586|FG002|Overall Study|Lost to Follow-up|3|||
156341620|NCT00361569|564348587|FG003|Overall Study|Lost to Follow-up|2|||
156845068|NCT01153698|566185528|FG000|Overall Study|Adverse Event|12|||
156845069|NCT01153698|566185528|FG000|Overall Study|Lost to Follow-up|4|||
156845070|NCT01153698|566185528|FG000|Overall Study|Withdrawal by Subject|2|||
156845071|NCT01153698|566185528|FG000|Overall Study|Switch to other anticoagulants|4|||
156845072|NCT01153698|566185528|FG000|Overall Study|Other|2|||
156845073|NCT01153698|566185528|FG000|Overall Study|Not treated with Pradaxa|5|||
156845074|NCT00465647|566185529|FG000|Overall Study|Administrative|2|||
156845075|NCT00465647|566185530|FG001|Overall Study|Administrative|2|||
156845076|NCT00465647|566185531|FG002|Overall Study|Administrative|3|||
156845077|NCT00465647|566185532|FG003|Overall Study|Administrative|2|||
156845078|NCT00465647|566185529|FG000|Overall Study|Adverse Event|2|||
156845079|NCT00465647|566185530|FG001|Overall Study|Adverse Event|0|||
156845080|NCT00465647|566185531|FG002|Overall Study|Adverse Event|3|||
156845081|NCT00465647|566185532|FG003|Overall Study|Adverse Event|2|||
156845082|NCT00465647|566185529|FG000|Overall Study|Withdrawal by Subject|1|||
156845083|NCT00465647|566185530|FG001|Overall Study|Withdrawal by Subject|2|||
156845084|NCT00465647|566185531|FG002|Overall Study|Withdrawal by Subject|2|||
156845085|NCT00465647|566185532|FG003|Overall Study|Withdrawal by Subject|7|||
156845086|NCT00465647|566185529|FG000|Overall Study|"The other reasons included loss of IV"|8|||
156845087|NCT00465647|566185530|FG001|Overall Study|"The other reasons included loss of IV"|4|||
156845088|NCT00465647|566185531|FG002|Overall Study|"The other reasons included loss of IV"|3|||
156845089|NCT00465647|566185532|FG003|Overall Study|"The other reasons included loss of IV"|2|||
156845090|NCT02220712|566185533|FG000|Overall Study|Adverse Event|1|||
156845091|NCT02220712|566185533|FG000|Overall Study|Withdrawal by Subject|2|||
156845092|NCT02220712|566185533|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
156845093|NCT00760838|566185534|FG000|Overall Study|Adverse Event|1|||
156845094|NCT00760838|566185535|FG001|Overall Study|Adverse Event|1|||
156845095|NCT00760838|566185534|FG000|Overall Study|Lack of Efficacy|1|||
156845096|NCT00760838|566185535|FG001|Overall Study|Lack of Efficacy|0|||
156845097|NCT00760838|566185534|FG000|Overall Study|Lost to Follow-up|2|||
156845098|NCT00760838|566185535|FG001|Overall Study|Lost to Follow-up|0|||
156845099|NCT00760838|566185534|FG000|Overall Study|Withdrawal by Subject|1|||
156845100|NCT00760838|566185535|FG001|Overall Study|Withdrawal by Subject|1|||
156845101|NCT00986362|566185538|FG000|Overall Study|Death|2|||
156845102|NCT00986362|566185539|FG001|Overall Study|Death|0|||
156845103|NCT00986362|566185538|FG000|Overall Study|Lost to Follow-up|0|||
156845104|NCT00986362|566185539|FG001|Overall Study|Lost to Follow-up|1|||
156845105|NCT01748825|566185540|FG000|Dose Escalation|Refused further treatment|2|||
156845106|NCT01748825|566185541|FG001|Dose Escalation|Refused further treatment|2|||
156845107|NCT01748825|566185542|FG002|Dose Escalation|Refused further treatment|0|||
156845108|NCT01748825|566185543|FG003|Dose Escalation|Refused further treatment|0|||
156845109|NCT01748825|566185544|FG004|Dose Escalation|Refused further treatment|1|||
156845110|NCT01748825|566185545|FG005|Dose Escalation|Refused further treatment|2|||
156845111|NCT01748825|566185546|FG006|Dose Escalation|Refused further treatment|0|||
156845112|NCT01748825|566185547|FG007|Dose Escalation|Refused further treatment|0|||
156845113|NCT01748825|566185548|FG008|Dose Escalation|Refused further treatment|0|||
156845114|NCT01748825|566185549|FG009|Dose Escalation|Refused further treatment|0|||
156845115|NCT01748825|566185540|FG000|Dose Escalation|Switched to alternative treatment|0|||
156845116|NCT01748825|566185541|FG001|Dose Escalation|Switched to alternative treatment|0|||
156845117|NCT01748825|566185542|FG002|Dose Escalation|Switched to alternative treatment|0|||
156845118|NCT01748825|566185543|FG003|Dose Escalation|Switched to alternative treatment|1|||
156845119|NCT01748825|566185544|FG004|Dose Escalation|Switched to alternative treatment|0|||
156341621|NCT00361569|564348584|FG000|Overall Study|Not specified by investigator|2|||
156845120|NCT01748825|566185545|FG005|Dose Escalation|Switched to alternative treatment|0|||
156845121|NCT01748825|566185546|FG006|Dose Escalation|Switched to alternative treatment|0|||
156845122|NCT01748825|566185547|FG007|Dose Escalation|Switched to alternative treatment|0|||
156845123|NCT01748825|566185548|FG008|Dose Escalation|Switched to alternative treatment|0|||
156341622|NCT00361569|564348585|FG001|Overall Study|Not specified by investigator|0|||
156845124|NCT01748825|566185549|FG009|Dose Escalation|Switched to alternative treatment|0|||
156845125|NCT01748825|566185540|FG000|Dose Escalation|Adverse Event|0|||
156845126|NCT01748825|566185541|FG001|Dose Escalation|Adverse Event|0|||
156845127|NCT01748825|566185542|FG002|Dose Escalation|Adverse Event|0|||
156845128|NCT01748825|566185543|FG003|Dose Escalation|Adverse Event|0|||
156845129|NCT01748825|566185544|FG004|Dose Escalation|Adverse Event|0|||
156845130|NCT01748825|566185545|FG005|Dose Escalation|Adverse Event|0|||
156845131|NCT01748825|566185546|FG006|Dose Escalation|Adverse Event|1|||
156845132|NCT01748825|566185547|FG007|Dose Escalation|Adverse Event|0|||
156845133|NCT01748825|566185548|FG008|Dose Escalation|Adverse Event|0|||
156845134|NCT01748825|566185549|FG009|Dose Escalation|Adverse Event|0|||
156845135|NCT01748825|566185540|FG000|Dose Expansion|Refused further treatment|0|||
156845136|NCT01748825|566185541|FG001|Dose Expansion|Refused further treatment|0|||
156845137|NCT01748825|566185542|FG002|Dose Expansion|Refused further treatment|0|||
156845138|NCT01748825|566185543|FG003|Dose Expansion|Refused further treatment|0|||
156845139|NCT01748825|566185544|FG004|Dose Expansion|Refused further treatment|0|||
156845140|NCT01748825|566185545|FG005|Dose Expansion|Refused further treatment|0|||
156845141|NCT01748825|566185546|FG006|Dose Expansion|Refused further treatment|0|||
156845142|NCT01748825|566185547|FG007|Dose Expansion|Refused further treatment|0|||
156845143|NCT01748825|566185548|FG008|Dose Expansion|Refused further treatment|1|||
156845144|NCT01748825|566185549|FG009|Dose Expansion|Refused further treatment|1|||
156845145|NCT01748825|566185540|FG000|Dose Expansion|Switched to alternative treatment|0|||
156845146|NCT01748825|566185541|FG001|Dose Expansion|Switched to alternative treatment|0|||
156845147|NCT01748825|566185542|FG002|Dose Expansion|Switched to alternative treatment|0|||
156845148|NCT01748825|566185543|FG003|Dose Expansion|Switched to alternative treatment|0|||
156845149|NCT01748825|566185544|FG004|Dose Expansion|Switched to alternative treatment|0|||
156845150|NCT01748825|566185545|FG005|Dose Expansion|Switched to alternative treatment|0|||
156845151|NCT01748825|566185546|FG006|Dose Expansion|Switched to alternative treatment|0|||
156845152|NCT01748825|566185547|FG007|Dose Expansion|Switched to alternative treatment|0|||
156845153|NCT01748825|566185548|FG008|Dose Expansion|Switched to alternative treatment|0|||
156845154|NCT01748825|566185549|FG009|Dose Expansion|Switched to alternative treatment|1|||
156341623|NCT00361569|564348586|FG002|Overall Study|Not specified by investigator|0|||
156341624|NCT00361569|564348587|FG003|Overall Study|Not specified by investigator|1|||
156341625|NCT00826943|564348588|FG000|Overall Study|Withdrawal by Subject|0|||
156845155|NCT01748825|566185540|FG000|Dose Expansion|Adverse Event|0|||
156845156|NCT01748825|566185541|FG001|Dose Expansion|Adverse Event|0|||
156845157|NCT01748825|566185542|FG002|Dose Expansion|Adverse Event|0|||
156845158|NCT01748825|566185543|FG003|Dose Expansion|Adverse Event|0|||
156845159|NCT01748825|566185544|FG004|Dose Expansion|Adverse Event|0|||
156845160|NCT01748825|566185545|FG005|Dose Expansion|Adverse Event|0|||
156845161|NCT01748825|566185546|FG006|Dose Expansion|Adverse Event|0|||
156845162|NCT01748825|566185547|FG007|Dose Expansion|Adverse Event|0|||
156845163|NCT01748825|566185548|FG008|Dose Expansion|Adverse Event|0|||
156845164|NCT01748825|566185549|FG009|Dose Expansion|Adverse Event|3|||
156845165|NCT01748825|566185540|FG000|Dose Expansion|Physician Decision|0|||
156845166|NCT01748825|566185541|FG001|Dose Expansion|Physician Decision|0|||
156845167|NCT01748825|566185542|FG002|Dose Expansion|Physician Decision|0|||
156845168|NCT01748825|566185543|FG003|Dose Expansion|Physician Decision|0|||
156845169|NCT01748825|566185544|FG004|Dose Expansion|Physician Decision|0|||
156845170|NCT01748825|566185545|FG005|Dose Expansion|Physician Decision|0|||
156845171|NCT01748825|566185546|FG006|Dose Expansion|Physician Decision|0|||
156845172|NCT01748825|566185547|FG007|Dose Expansion|Physician Decision|0|||
156341626|NCT00826943|564348589|FG001|Overall Study|Withdrawal by Subject|0|||
156845173|NCT01748825|566185548|FG008|Dose Expansion|Physician Decision|1|||
156845174|NCT01748825|566185549|FG009|Dose Expansion|Physician Decision|0|||
156845175|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Adverse Event|33|||
156845176|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
156845177|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
156845178|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
156845179|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Physician Decision|6|||
156341627|NCT00826943|564348590|FG002|Overall Study|Withdrawal by Subject|0|||
156845180|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
156845181|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
156845182|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
156845183|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
156845184|NCT00965419|566185550|FG000|Follow-up Phase|Adverse Event|9|||
156845185|NCT00965419|566185550|FG000|Follow-up Phase|Protocol Violation|4|||
156845186|NCT00965419|566185550|FG000|Follow-up Phase|Withdrawal by Subject|8|||
156845187|NCT00965419|566185550|FG000|Follow-up Phase|Physician Decision|4|||
156845188|NCT00965419|566185550|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
156845189|NCT00965419|566185550|FG000|Follow-up Phase|Lack of Efficacy|28|||
156341628|NCT00826943|564348591|FG003|Overall Study|Withdrawal by Subject|0|||
156845190|NCT01363908|566187593|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
156845191|NCT01363908|566187594|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
156341629|NCT00826943|564348592|FG004|Overall Study|Withdrawal by Subject|1|||
156845192|NCT01363908|566187593|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
156845193|NCT01363908|566187594|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
156845194|NCT01363908|566187593|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
156845195|NCT01363908|566187594|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
156845196|NCT01363908|566187593|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
156845197|NCT01363908|566187594|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
156845198|NCT02034877|566187595|FG000|Overall Study|Lost to Follow-up|0|||
156845199|NCT02034877|566187596|FG001|Overall Study|Lost to Follow-up|3|||
156845200|NCT02034877|566187595|FG000|Overall Study|No Longer Willing to Participate|0|||
156845201|NCT02034877|566187596|FG001|Overall Study|No Longer Willing to Participate|3|||
156845202|NCT00536471|566187597|FG000|Overall Study|Lost to Follow-up|48|||
156845203|NCT00536471|566187598|FG001|Overall Study|Lost to Follow-up|23|||
156845204|NCT00536471|566187599|FG002|Overall Study|Lost to Follow-up|48|||
156845205|NCT00536471|566187600|FG003|Overall Study|Lost to Follow-up|22|||
156845206|NCT00536471|566187597|FG000|Overall Study|Adverse Event|32|||
156845207|NCT00536471|566187598|FG001|Overall Study|Adverse Event|16|||
156845208|NCT00536471|566187599|FG002|Overall Study|Adverse Event|28|||
156845209|NCT00536471|566187600|FG003|Overall Study|Adverse Event|13|||
156845210|NCT00536471|566187597|FG000|Overall Study|Withdrawal by Subject|40|||
156845211|NCT00536471|566187598|FG001|Overall Study|Withdrawal by Subject|24|||
156845212|NCT00536471|566187599|FG002|Overall Study|Withdrawal by Subject|43|||
156845213|NCT00536471|566187600|FG003|Overall Study|Withdrawal by Subject|21|||
156845214|NCT00536471|566187597|FG000|Overall Study|Lack of Efficacy|17|||
156845215|NCT00536471|566187598|FG001|Overall Study|Lack of Efficacy|18|||
156845216|NCT00536471|566187599|FG002|Overall Study|Lack of Efficacy|11|||
156845217|NCT00536471|566187600|FG003|Overall Study|Lack of Efficacy|9|||
156845218|NCT00536471|566187597|FG000|Overall Study|Protocol Violation|8|||
156845219|NCT00536471|566187598|FG001|Overall Study|Protocol Violation|1|||
156845220|NCT00536471|566187599|FG002|Overall Study|Protocol Violation|2|||
156845221|NCT00536471|566187600|FG003|Overall Study|Protocol Violation|3|||
156845222|NCT00536471|566187597|FG000|Overall Study|Physician Decision|11|||
156845223|NCT00536471|566187598|FG001|Overall Study|Physician Decision|1|||
156845224|NCT00536471|566187599|FG002|Overall Study|Physician Decision|3|||
156845225|NCT00536471|566187600|FG003|Overall Study|Physician Decision|2|||
156845226|NCT00536471|566187597|FG000|Overall Study|Death|0|||
156845227|NCT00536471|566187598|FG001|Overall Study|Death|0|||
156845228|NCT00536471|566187599|FG002|Overall Study|Death|1|||
156845229|NCT00536471|566187600|FG003|Overall Study|Death|2|||
156845230|NCT00536471|566187597|FG000|Overall Study|Sponsor Decision|0|||
156845231|NCT00536471|566187598|FG001|Overall Study|Sponsor Decision|1|||
156845232|NCT00536471|566187599|FG002|Overall Study|Sponsor Decision|3|||
156845233|NCT00536471|566187600|FG003|Overall Study|Sponsor Decision|2|||
156845234|NCT04878211|566187606|FG000|Overall Study|Lost to Follow-up|0|||
156845235|NCT04878211|566187607|FG001|Overall Study|Lost to Follow-up|0|||
156470057|NCT03890289|564814902|FG000|Overall Study|Adverse Event|1|||
156470058|NCT03890289|564814902|FG000|Overall Study|Physician Decision|1|||
156470059|NCT03890289|564814902|FG000|Overall Study|Lack of Efficacy|2|||
156470060|NCT02392234|564814909|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
156470061|NCT02392234|564814910|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
156470062|NCT02392234|564814911|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
156470063|NCT02392234|564814912|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
156470064|NCT02392234|564814913|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
156845236|NCT04878211|566187608|FG002|Overall Study|Lost to Follow-up|0|||
156845237|NCT04878211|566187609|FG003|Overall Study|Lost to Follow-up|1|||
156845238|NCT04878211|566187610|FG004|Overall Study|Lost to Follow-up|0|||
156845239|NCT04878211|566187611|FG005|Overall Study|Lost to Follow-up|1|||
156845240|NCT04878211|566187606|FG000|Overall Study|Protocol deviation|1|||
156845241|NCT04878211|566187607|FG001|Overall Study|Protocol deviation|0|||
156845242|NCT04878211|566187608|FG002|Overall Study|Protocol deviation|0|||
156845243|NCT04878211|566187609|FG003|Overall Study|Protocol deviation|0|||
156845244|NCT04878211|566187610|FG004|Overall Study|Protocol deviation|0|||
156845245|NCT04878211|566187611|FG005|Overall Study|Protocol deviation|0|||
156845246|NCT04878211|566187606|FG000|Overall Study|Study terminated by sponsor|0|||
156845247|NCT04878211|566187607|FG001|Overall Study|Study terminated by sponsor|0|||
156470065|NCT02392234|564814914|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
156845248|NCT04878211|566187608|FG002|Overall Study|Study terminated by sponsor|0|||
156845249|NCT04878211|566187609|FG003|Overall Study|Study terminated by sponsor|0|||
156845250|NCT04878211|566187610|FG004|Overall Study|Study terminated by sponsor|9|||
156845251|NCT04878211|566187611|FG005|Overall Study|Study terminated by sponsor|4|||
156470066|NCT02392234|564814909|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
156470067|NCT02392234|564814910|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
156845252|NCT04878211|566187606|FG000|Overall Study|Subject decision|0|||
156845253|NCT04878211|566187607|FG001|Overall Study|Subject decision|0|||
156845254|NCT04878211|566187608|FG002|Overall Study|Subject decision|0|||
156845255|NCT04878211|566187609|FG003|Overall Study|Subject decision|0|||
156845256|NCT04878211|566187610|FG004|Overall Study|Subject decision|1|||
156845257|NCT04878211|566187611|FG005|Overall Study|Subject decision|0|||
156470068|NCT02392234|564814911|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
156470069|NCT02392234|564814912|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
156470070|NCT02392234|564814913|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
156470071|NCT02392234|564814914|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
156470072|NCT02392234|564814909|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156470073|NCT02392234|564814910|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156470074|NCT02392234|564814911|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156470075|NCT02392234|564814912|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156470076|NCT02392234|564814913|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156470077|NCT02392234|564814914|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
156470078|NCT02392234|564814909|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
156470079|NCT02392234|564814910|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
156470080|NCT02392234|564814911|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
156470081|NCT02392234|564814912|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
156470082|NCT02392234|564814913|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
156470083|NCT02392234|564814914|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
156845258|NCT03574779|566187618|FG000|Overall Study|Screening failure|13|||
156845259|NCT03574779|566187619|FG001|Overall Study|Screening failure|83|||
156845260|NCT02783599|566187620|FG000|Overall Study|Progressive disease|23|||
156845261|NCT02783599|566187620|FG000|Overall Study|Surgical Resection|10|||
156845262|NCT02783599|566187620|FG000|Overall Study|Adverse Event|4|||
156845263|NCT02783599|566187620|FG000|Overall Study|Physician Decision|2|||
156845264|NCT02783599|566187620|FG000|Overall Study|Death|1|||
156845265|NCT00856544|566187628|FG000|Overall Study|Randomized but not treated|3|||
156845266|NCT00856544|566187629|FG001|Overall Study|Randomized but not treated|0|||
156845267|NCT00856544|566187630|FG002|Overall Study|Randomized but not treated|0|||
156845268|NCT00856544|566187631|FG003|Overall Study|Randomized but not treated|0|||
156845269|NCT00856544|566187628|FG000|Overall Study|Death|0|||
156845270|NCT00856544|566187629|FG001|Overall Study|Death|2|||
156845271|NCT00856544|566187630|FG002|Overall Study|Death|0|||
156845272|NCT00856544|566187631|FG003|Overall Study|Death|0|||
156845273|NCT00856544|566187628|FG000|Overall Study|Adverse Event|20|||
156845274|NCT00856544|566187629|FG001|Overall Study|Adverse Event|29|||
156845275|NCT00856544|566187630|FG002|Overall Study|Adverse Event|2|||
156845276|NCT00856544|566187631|FG003|Overall Study|Adverse Event|3|||
156845277|NCT00856544|566187628|FG000|Overall Study|Lack of Efficacy|16|||
156845278|NCT00856544|566187629|FG001|Overall Study|Lack of Efficacy|12|||
156845279|NCT00856544|566187630|FG002|Overall Study|Lack of Efficacy|3|||
156845280|NCT00856544|566187631|FG003|Overall Study|Lack of Efficacy|3|||
156845281|NCT00856544|566187628|FG000|Overall Study|Other|9|||
156845282|NCT00856544|566187629|FG001|Overall Study|Other|16|||
156845283|NCT00856544|566187630|FG002|Overall Study|Other|1|||
156845284|NCT00856544|566187631|FG003|Overall Study|Other|6|||
156845285|NCT00856544|566187628|FG000|Overall Study|Lost to Follow-up|1|||
156845286|NCT00856544|566187629|FG001|Overall Study|Lost to Follow-up|2|||
156845287|NCT00856544|566187630|FG002|Overall Study|Lost to Follow-up|2|||
156845288|NCT00856544|566187631|FG003|Overall Study|Lost to Follow-up|0|||
156845289|NCT00856544|566187628|FG000|Overall Study|Withdrawal by Subject|8|||
156845290|NCT00856544|566187629|FG001|Overall Study|Withdrawal by Subject|5|||
156845291|NCT00856544|566187630|FG002|Overall Study|Withdrawal by Subject|0|||
156845292|NCT00856544|566187631|FG003|Overall Study|Withdrawal by Subject|1|||
156845293|NCT01564732|566187632|FG000|Overall Study|Early termination by the study sponsor|6|||
156845294|NCT01564732|566187633|FG001|Overall Study|Early termination by the study sponsor|5|||
156845295|NCT01687101|566187638|FG000|Overall Study|Lost to Follow-up|7|||
156845296|NCT00394706|566187642|FG000|Overall Study|Withdrawal by Subject|2|||
156845297|NCT00394706|566187643|FG001|Overall Study|Withdrawal by Subject|0|||
156845298|NCT00394706|566187644|FG002|Overall Study|Withdrawal by Subject|1|||
156845299|NCT00394706|566187645|FG003|Overall Study|Withdrawal by Subject|0|||
156845300|NCT00394706|566187646|FG004|Overall Study|Withdrawal by Subject|0|||
156470084|NCT02392234|564814909|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
156470085|NCT02392234|564814910|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
156470086|NCT02392234|564814911|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
156845301|NCT00394706|566187647|FG005|Overall Study|Withdrawal by Subject|2|||
156845302|NCT00394706|566187648|FG006|Overall Study|Withdrawal by Subject|1|||
156845303|NCT00394706|566187649|FG007|Overall Study|Withdrawal by Subject|0|||
156845304|NCT00394706|566187642|FG000|Overall Study|Lost to Follow-up|2|||
156845305|NCT00394706|566187643|FG001|Overall Study|Lost to Follow-up|2|||
156845306|NCT00394706|566187644|FG002|Overall Study|Lost to Follow-up|8|||
156845307|NCT00394706|566187645|FG003|Overall Study|Lost to Follow-up|1|||
156845308|NCT00394706|566187646|FG004|Overall Study|Lost to Follow-up|2|||
156845309|NCT00394706|566187647|FG005|Overall Study|Lost to Follow-up|5|||
156845310|NCT00394706|566187648|FG006|Overall Study|Lost to Follow-up|2|||
156845311|NCT00394706|566187649|FG007|Overall Study|Lost to Follow-up|0|||
156845312|NCT02003534|566187654|FG000|Overall Study|Lost to Follow-up|47|||
156845313|NCT03920254|566187655|FG000|Overall Study|Adverse Event|1|||
156845314|NCT03920254|566187656|FG001|Overall Study|Adverse Event|0|||
156845315|NCT03920254|566187657|FG002|Overall Study|Adverse Event|0|||
156845316|NCT03920254|566187655|FG000|Overall Study|Physician Decision|0|||
156845317|NCT03920254|566187656|FG001|Overall Study|Physician Decision|1|||
156845318|NCT03920254|566187657|FG002|Overall Study|Physician Decision|2|||
156845319|NCT03920254|566187655|FG000|Overall Study|Study Terminated By Sponsor|12|||
156845320|NCT03920254|566187656|FG001|Overall Study|Study Terminated By Sponsor|17|||
156845321|NCT03920254|566187657|FG002|Overall Study|Study Terminated By Sponsor|12|||
156845322|NCT03920254|566187655|FG000|Overall Study|Withdrawal by Subject|0|||
156845323|NCT03920254|566187656|FG001|Overall Study|Withdrawal by Subject|0|||
156845324|NCT03920254|566187657|FG002|Overall Study|Withdrawal by Subject|1|||
156845325|NCT03040674|566187658|FG000|Overall Study|Lost to Follow-up|225|||
156845326|NCT03040674|566187658|FG000|Overall Study|Death|23|||
156845327|NCT05274269|566187659|FG000|Overall Study|Adverse Event|0|||
156845328|NCT05274269|566187660|FG001|Overall Study|Adverse Event|3|||
156845329|NCT05274269|566187659|FG000|Overall Study|Death|0|||
156845330|NCT05274269|566187660|FG001|Overall Study|Death|1|||
156845331|NCT05274269|566187659|FG000|Overall Study|Other|0|||
156845332|NCT05274269|566187660|FG001|Overall Study|Other|2|||
156845333|NCT05274269|566187659|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156845334|NCT05274269|566187660|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
156845335|NCT01934010|566187661|FG000|Overall Study|Adverse Event|1|||
156845336|NCT01934010|566187662|FG001|Overall Study|Adverse Event|1|||
156845337|NCT01934010|566187663|FG002|Overall Study|Adverse Event|0|||
156845338|NCT01934010|566187661|FG000|Overall Study|Withdrawal by Subject|15|||
156845339|NCT01934010|566187662|FG001|Overall Study|Withdrawal by Subject|6|||
156845340|NCT01934010|566187663|FG002|Overall Study|Withdrawal by Subject|2|||
156845341|NCT01934010|566187661|FG000|Overall Study|Lost to Follow-up|7|||
156845342|NCT01934010|566187662|FG001|Overall Study|Lost to Follow-up|4|||
156845343|NCT01934010|566187663|FG002|Overall Study|Lost to Follow-up|0|||
156845344|NCT04112303|566187664|FG000|Overall Study|Death|1|||
156845345|NCT01685697|566187665|FG000|Overall Study|Protocol Violation|3|||
156470087|NCT02392234|564814912|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
156470088|NCT02392234|564814913|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
156470089|NCT02392234|564814914|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
156470090|NCT02392234|564814909|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
156470091|NCT02392234|564814910|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
156470092|NCT02392234|564814911|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
156470093|NCT02392234|564814912|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
156470094|NCT02392234|564814913|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
156470095|NCT02392234|564814914|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
156470096|NCT02392234|564814909|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
156470097|NCT02392234|564814910|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
156470098|NCT02392234|564814911|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
156541522|NCT04707157|565075441|FG000|Overall Study|Physician Decision|8|||
156341630|NCT00826943|564348593|FG005|Overall Study|Withdrawal by Subject|0|||
156845346|NCT01685697|566187666|FG001|Overall Study|Protocol Violation|3|||
156845347|NCT02703324|566187667|FG000|Period Two|Withdrawal by Subject|0|||
156845348|NCT02703324|566187668|FG001|Period Two|Withdrawal by Subject|0|||
156845349|NCT02703324|566187669|FG002|Period Two|Withdrawal by Subject|1|||
156845350|NCT02703324|566187670|FG003|Period Two|Withdrawal by Subject|0|||
156845351|NCT02703324|566187671|FG004|Period Two|Withdrawal by Subject|0|||
156845352|NCT02703324|566187672|FG005|Period Two|Withdrawal by Subject|0|||
156845353|NCT04303572|566187675|FG000|Overall Study|Study closed due to poor enrollment|1|||
156845354|NCT06312592|566187676|FG000|Overall Study|Lost to Follow-up|29|||
156845355|NCT06312592|566187677|FG001|Overall Study|Lost to Follow-up|13|||
156845356|NCT01948063|566187680|FG000|Overall Study|Boston MCI halted research protocol|0|||
156341631|NCT00074152|564348594|FG000|Overall Study|Death|21|||
156845357|NCT01948063|566187681|FG001|Overall Study|Boston MCI halted research protocol|1|||
156845358|NCT01948063|566187680|FG000|Overall Study|Discovered an enrollment in other study|0|||
156845359|NCT01948063|566187681|FG001|Overall Study|Discovered an enrollment in other study|1|||
156845360|NCT01948063|566187680|FG000|Overall Study|Blood samples were accidentally thawed|1|||
156845361|NCT01948063|566187681|FG001|Overall Study|Blood samples were accidentally thawed|0|||
156845362|NCT01858766|566187682|FG000|Overall Study|Randomized but Never Treated|0|||
156845363|NCT01858766|566187683|FG001|Overall Study|Randomized but Never Treated|0|||
156845364|NCT01858766|566187684|FG002|Overall Study|Randomized but Never Treated|0|||
156845365|NCT01858766|566187685|FG003|Overall Study|Randomized but Never Treated|0|||
156845366|NCT01858766|566187686|FG004|Overall Study|Randomized but Never Treated|0|||
156845367|NCT01858766|566187687|FG005|Overall Study|Randomized but Never Treated|1|||
156845368|NCT01858766|566187688|FG006|Overall Study|Randomized but Never Treated|0|||
156845369|NCT01858766|566187689|FG007|Overall Study|Randomized but Never Treated|0|||
156845370|NCT01858766|566187690|FG008|Overall Study|Randomized but Never Treated|0|||
156845371|NCT01858766|566187691|FG009|Overall Study|Randomized but Never Treated|0|||
156845372|NCT01858766|566187692|FG010|Overall Study|Randomized but Never Treated|0|||
156845373|NCT01858766|566187693|FG011|Overall Study|Randomized but Never Treated|0|||
156845374|NCT01858766|566187694|FG012|Overall Study|Randomized but Never Treated|0|||
156845375|NCT01858766|566187695|FG013|Overall Study|Randomized but Never Treated|0|||
156845376|NCT01858766|566187696|FG014|Overall Study|Randomized but Never Treated|0|||
156845377|NCT01858766|566187697|FG015|Overall Study|Randomized but Never Treated|0|||
156845378|NCT01858766|566187698|FG016|Overall Study|Randomized but Never Treated|0|||
156845379|NCT01858766|566187699|FG017|Overall Study|Randomized but Never Treated|1|||
156845380|NCT01858766|566187700|FG018|Overall Study|Randomized but Never Treated|0|||
156845381|NCT01858766|566187682|FG000|Overall Study|Death|0|||
156845382|NCT01858766|566187683|FG001|Overall Study|Death|0|||
156845383|NCT01858766|566187684|FG002|Overall Study|Death|1|||
156845384|NCT01858766|566187685|FG003|Overall Study|Death|0|||
156845385|NCT01858766|566187686|FG004|Overall Study|Death|0|||
156845386|NCT01858766|566187687|FG005|Overall Study|Death|0|||
156845387|NCT01858766|566187688|FG006|Overall Study|Death|0|||
156845388|NCT01858766|566187689|FG007|Overall Study|Death|0|||
156845389|NCT01858766|566187690|FG008|Overall Study|Death|0|||
156845390|NCT01858766|566187691|FG009|Overall Study|Death|0|||
156845391|NCT01858766|566187692|FG010|Overall Study|Death|0|||
156845392|NCT01858766|566187693|FG011|Overall Study|Death|0|||
156845393|NCT01858766|566187694|FG012|Overall Study|Death|0|||
156845394|NCT01858766|566187695|FG013|Overall Study|Death|0|||
156845395|NCT01858766|566187696|FG014|Overall Study|Death|0|||
156845396|NCT01858766|566187697|FG015|Overall Study|Death|0|||
156845397|NCT01858766|566187698|FG016|Overall Study|Death|0|||
156845398|NCT01858766|566187699|FG017|Overall Study|Death|0|||
156845399|NCT01858766|566187700|FG018|Overall Study|Death|0|||
156845400|NCT01858766|566187682|FG000|Overall Study|Lack of Efficacy|1|||
156845401|NCT01858766|566187683|FG001|Overall Study|Lack of Efficacy|0|||
156845402|NCT01858766|566187684|FG002|Overall Study|Lack of Efficacy|0|||
156845403|NCT01858766|566187685|FG003|Overall Study|Lack of Efficacy|0|||
156845404|NCT01858766|566187686|FG004|Overall Study|Lack of Efficacy|1|||
156845405|NCT01858766|566187687|FG005|Overall Study|Lack of Efficacy|2|||
156845406|NCT01858766|566187688|FG006|Overall Study|Lack of Efficacy|0|||
156845407|NCT01858766|566187689|FG007|Overall Study|Lack of Efficacy|0|||
156845408|NCT01858766|566187690|FG008|Overall Study|Lack of Efficacy|0|||
156845409|NCT01858766|566187691|FG009|Overall Study|Lack of Efficacy|0|||
156845410|NCT01858766|566187692|FG010|Overall Study|Lack of Efficacy|0|||
156845411|NCT01858766|566187693|FG011|Overall Study|Lack of Efficacy|3|||
156845412|NCT01858766|566187694|FG012|Overall Study|Lack of Efficacy|5|||
156845413|NCT01858766|566187695|FG013|Overall Study|Lack of Efficacy|3|||
156470099|NCT02392234|564814912|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
156470100|NCT02392234|564814913|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
156470101|NCT02392234|564814914|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
156470102|NCT02392234|564814909|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
156470103|NCT02392234|564814910|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
156845414|NCT01858766|566187696|FG014|Overall Study|Lack of Efficacy|5|||
156845415|NCT01858766|566187697|FG015|Overall Study|Lack of Efficacy|5|||
156845416|NCT01858766|566187698|FG016|Overall Study|Lack of Efficacy|2|||
156845417|NCT01858766|566187699|FG017|Overall Study|Lack of Efficacy|3|||
156845418|NCT01858766|566187700|FG018|Overall Study|Lack of Efficacy|3|||
156845419|NCT01858766|566187682|FG000|Overall Study|Lost to Follow-up|0|||
156845420|NCT01858766|566187683|FG001|Overall Study|Lost to Follow-up|0|||
156845421|NCT01858766|566187684|FG002|Overall Study|Lost to Follow-up|0|||
156845422|NCT01858766|566187685|FG003|Overall Study|Lost to Follow-up|0|||
156845423|NCT01858766|566187686|FG004|Overall Study|Lost to Follow-up|0|||
156845424|NCT01858766|566187687|FG005|Overall Study|Lost to Follow-up|1|||
156845425|NCT01858766|566187688|FG006|Overall Study|Lost to Follow-up|0|||
156845426|NCT01858766|566187689|FG007|Overall Study|Lost to Follow-up|2|||
156845427|NCT01858766|566187690|FG008|Overall Study|Lost to Follow-up|0|||
156845428|NCT01858766|566187691|FG009|Overall Study|Lost to Follow-up|0|||
156845429|NCT01858766|566187692|FG010|Overall Study|Lost to Follow-up|0|||
156845430|NCT01858766|566187693|FG011|Overall Study|Lost to Follow-up|1|||
156341632|NCT00074152|564348595|FG001|Overall Study|Death|9|||
156341633|NCT00074152|564348594|FG000|Overall Study|Lack of Efficacy|34|||
156341634|NCT00074152|564348595|FG001|Overall Study|Lack of Efficacy|24|||
156341635|NCT03547583|564348596|FG000|Overall Study|Adverse Event|16|||
156341636|NCT03547583|564348597|FG001|Overall Study|Adverse Event|11|||
156341637|NCT03547583|564348598|FG002|Overall Study|Adverse Event|10|||
156341638|NCT03547583|564348596|FG000|Overall Study|Death|11|||
156341639|NCT03547583|564348597|FG001|Overall Study|Death|7|||
156341640|NCT03547583|564348598|FG002|Overall Study|Death|4|||
156341641|NCT03547583|564348596|FG000|Overall Study|Lost to Follow-up|1|||
156341642|NCT03547583|564348597|FG001|Overall Study|Lost to Follow-up|0|||
156341643|NCT03547583|564348598|FG002|Overall Study|Lost to Follow-up|0|||
156341644|NCT03547583|564348596|FG000|Overall Study|Non-compliance with study drug|0|||
156341645|NCT03547583|564348597|FG001|Overall Study|Non-compliance with study drug|0|||
156341646|NCT03547583|564348598|FG002|Overall Study|Non-compliance with study drug|1|||
156341647|NCT03547583|564348596|FG000|Overall Study|Physician Decision|1|||
156341648|NCT03547583|564348597|FG001|Overall Study|Physician Decision|0|||
156470104|NCT02392234|564814911|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
156845431|NCT01858766|566187694|FG012|Overall Study|Lost to Follow-up|0|||
156845432|NCT01858766|566187695|FG013|Overall Study|Lost to Follow-up|0|||
156845433|NCT01858766|566187696|FG014|Overall Study|Lost to Follow-up|3|||
156845434|NCT01858766|566187697|FG015|Overall Study|Lost to Follow-up|1|||
156845435|NCT01858766|566187698|FG016|Overall Study|Lost to Follow-up|1|||
156845436|NCT01858766|566187699|FG017|Overall Study|Lost to Follow-up|0|||
156845437|NCT01858766|566187700|FG018|Overall Study|Lost to Follow-up|1|||
156845438|NCT01858766|566187682|FG000|Overall Study|Withdrew Consent|0|||
156845439|NCT01858766|566187683|FG001|Overall Study|Withdrew Consent|0|||
156845440|NCT01858766|566187684|FG002|Overall Study|Withdrew Consent|0|||
156845441|NCT01858766|566187685|FG003|Overall Study|Withdrew Consent|0|||
156845442|NCT01858766|566187686|FG004|Overall Study|Withdrew Consent|0|||
156845443|NCT01858766|566187687|FG005|Overall Study|Withdrew Consent|0|||
156845444|NCT01858766|566187688|FG006|Overall Study|Withdrew Consent|0|||
156845445|NCT01858766|566187689|FG007|Overall Study|Withdrew Consent|0|||
156845446|NCT01858766|566187690|FG008|Overall Study|Withdrew Consent|0|||
156845447|NCT01858766|566187691|FG009|Overall Study|Withdrew Consent|0|||
156845448|NCT01858766|566187692|FG010|Overall Study|Withdrew Consent|0|||
156845449|NCT01858766|566187693|FG011|Overall Study|Withdrew Consent|1|||
156845450|NCT01858766|566187694|FG012|Overall Study|Withdrew Consent|0|||
156845451|NCT01858766|566187695|FG013|Overall Study|Withdrew Consent|0|||
156845452|NCT01858766|566187696|FG014|Overall Study|Withdrew Consent|0|||
156845453|NCT01858766|566187697|FG015|Overall Study|Withdrew Consent|0|||
156845454|NCT01858766|566187698|FG016|Overall Study|Withdrew Consent|0|||
156845455|NCT01858766|566187699|FG017|Overall Study|Withdrew Consent|0|||
156845456|NCT01858766|566187700|FG018|Overall Study|Withdrew Consent|0|||
156845457|NCT03517228|566187701|FG000|Overall Study|Withdrawal by Subject|2|||
156845458|NCT03517228|566187701|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
156845459|NCT03517228|566187701|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
156845460|NCT03517228|566187701|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
156845461|NCT03517228|566187701|FG000|Overall Study|Canceled due to device being updated|1|||
156845462|NCT03517228|566187701|FG000|Overall Study|No V Cares in stock|1|||
156845463|NCT03517228|566187701|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
156845464|NCT01979952|566187711|FG000|Overall Study|Adverse Event|4|||
156845465|NCT01979952|566187712|FG001|Overall Study|Adverse Event|5|||
156845466|NCT01979952|566187711|FG000|Overall Study|Protocol Violation|1|||
156845467|NCT01979952|566187712|FG001|Overall Study|Protocol Violation|0|||
156845468|NCT01979952|566187711|FG000|Overall Study|Withdrawal by Subject|2|||
156845469|NCT01979952|566187712|FG001|Overall Study|Withdrawal by Subject|1|||
156845470|NCT01979952|566187711|FG000|Overall Study|Other than specified above|1|||
156845471|NCT01979952|566187712|FG001|Overall Study|Other than specified above|0|||
156341649|NCT03547583|564348598|FG002|Overall Study|Physician Decision|3|||
156341650|NCT03547583|564348596|FG000|Overall Study|Protocol Violation|2|||
156341651|NCT03547583|564348597|FG001|Overall Study|Protocol Violation|1|||
156341652|NCT03547583|564348598|FG002|Overall Study|Protocol Violation|1|||
156470105|NCT02392234|564814912|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
156845472|NCT03781414|566187713|FG000|Overall Study|Study terminated by sponsor|39|||
156470106|NCT02392234|564814913|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
156845473|NCT03781414|566187714|FG001|Overall Study|Study terminated by sponsor|34|||
156341653|NCT03547583|564348596|FG000|Overall Study|Withdrawal by Subject|12|||
156341654|NCT03547583|564348597|FG001|Overall Study|Withdrawal by Subject|19|||
156341655|NCT03547583|564348598|FG002|Overall Study|Withdrawal by Subject|10|||
156341656|NCT03547583|564348596|FG000|Overall Study|Other|2|||
156341657|NCT03547583|564348597|FG001|Overall Study|Other|2|||
156341658|NCT03547583|564348598|FG002|Overall Study|Other|3|||
156845474|NCT03781414|566187715|FG002|Overall Study|Study terminated by sponsor|25|||
156845475|NCT03781414|566187713|FG000|Overall Study|Adverse Event|3|||
156845476|NCT03781414|566187714|FG001|Overall Study|Adverse Event|6|||
156845477|NCT03781414|566187715|FG002|Overall Study|Adverse Event|3|||
156845478|NCT03781414|566187713|FG000|Overall Study|Physician Decision|2|||
156845479|NCT03781414|566187714|FG001|Overall Study|Physician Decision|0|||
156845480|NCT03781414|566187715|FG002|Overall Study|Physician Decision|1|||
156845481|NCT03781414|566187713|FG000|Overall Study|Withdrawal by Subject|2|||
156845482|NCT03781414|566187714|FG001|Overall Study|Withdrawal by Subject|3|||
156845483|NCT03781414|566187715|FG002|Overall Study|Withdrawal by Subject|3|||
156845484|NCT03781414|566187713|FG000|Overall Study|Death|1|||
156845485|NCT03781414|566187714|FG001|Overall Study|Death|4|||
156845486|NCT03781414|566187715|FG002|Overall Study|Death|0|||
156845487|NCT03781414|566187713|FG000|Overall Study|Lost to Follow-up|1|||
156845488|NCT03781414|566187714|FG001|Overall Study|Lost to Follow-up|1|||
156845489|NCT03781414|566187715|FG002|Overall Study|Lost to Follow-up|0|||
156845490|NCT00245037|566187718|FG000|Overall Study|Death|17|||
156845491|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
156845492|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845493|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845494|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845495|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845496|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845497|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
156845498|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845499|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845500|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845501|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845502|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845503|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
156845504|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845505|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845506|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845507|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845508|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845509|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
156845510|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845511|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845512|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845513|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845514|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845515|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
156845516|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845517|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845518|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845519|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845520|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845521|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
156845522|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845523|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845524|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845525|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845526|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845527|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
156470107|NCT02392234|564814914|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
156470108|NCT02029235|564814920|FG000|Overall Study|Non-compliance with study meds or diary|4|||
156470109|NCT02029235|564814921|FG001|Overall Study|Non-compliance with study meds or diary|1|||
156470110|NCT02816398|564814922|FG000|Overall Study|Death|5|||
156470111|NCT02816398|564814922|FG000|Overall Study|Lack of Efficacy|8|||
156470112|NCT02816398|564814922|FG000|Overall Study|Lost to Follow-up|1|||
156470113|NCT01387516|564814923|FG000|Overall Study|Lost to Follow-up|4|||
156845528|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
156845529|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
156845530|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
156845531|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
156845532|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
156341659|NCT01949506|564348606|FG000|Overall Study|Physician Decision|1|||
156470114|NCT01387516|564814924|FG001|Overall Study|Lost to Follow-up|4|||
156470115|NCT01387516|564814925|FG002|Overall Study|Lost to Follow-up|2|||
156341660|NCT03307967|564348607|FG000|Overall Study|Lost to Follow-up|4|||
156341661|NCT02915016|564348608|FG000|Overall Study|Lost to Follow-up|4|||
156341662|NCT02915016|564348609|FG001|Overall Study|Lost to Follow-up|2|||
156341663|NCT02915016|564348610|FG002|Overall Study|Lost to Follow-up|5|||
156341664|NCT02915016|564348611|FG003|Overall Study|Lost to Follow-up|3|||
156341665|NCT02915016|564348612|FG004|Overall Study|Lost to Follow-up|5|||
156341666|NCT02915016|564348613|FG005|Overall Study|Lost to Follow-up|2|||
156341667|NCT02915016|564348614|FG006|Overall Study|Lost to Follow-up|8|||
156341668|NCT02915016|564348615|FG007|Overall Study|Lost to Follow-up|2|||
156341669|NCT02915016|564348608|FG000|Overall Study|Physician Decision|0|||
156341670|NCT02915016|564348609|FG001|Overall Study|Physician Decision|0|||
156341671|NCT02915016|564348610|FG002|Overall Study|Physician Decision|1|||
156341672|NCT02915016|564348611|FG003|Overall Study|Physician Decision|0|||
156341673|NCT02915016|564348612|FG004|Overall Study|Physician Decision|0|||
156341674|NCT02915016|564348613|FG005|Overall Study|Physician Decision|1|||
156341675|NCT02915016|564348614|FG006|Overall Study|Physician Decision|2|||
156341676|NCT02915016|564348615|FG007|Overall Study|Physician Decision|0|||
156341677|NCT02915016|564348608|FG000|Overall Study|Withdrawal by Subject|2|||
156341678|NCT02915016|564348609|FG001|Overall Study|Withdrawal by Subject|0|||
156341679|NCT02915016|564348610|FG002|Overall Study|Withdrawal by Subject|1|||
156341680|NCT02915016|564348611|FG003|Overall Study|Withdrawal by Subject|0|||
156845533|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156341681|NCT02915016|564348612|FG004|Overall Study|Withdrawal by Subject|1|||
156341682|NCT02915016|564348613|FG005|Overall Study|Withdrawal by Subject|3|||
156341683|NCT02915016|564348614|FG006|Overall Study|Withdrawal by Subject|1|||
156341684|NCT02915016|564348615|FG007|Overall Study|Withdrawal by Subject|1|||
156341685|NCT02915016|564348608|FG000|Overall Study|Elected not to continue|0|||
156341686|NCT02915016|564348609|FG001|Overall Study|Elected not to continue|0|||
156341687|NCT02915016|564348610|FG002|Overall Study|Elected not to continue|0|||
156341688|NCT02915016|564348611|FG003|Overall Study|Elected not to continue|1|||
156341689|NCT02915016|564348612|FG004|Overall Study|Elected not to continue|0|||
156341690|NCT02915016|564348613|FG005|Overall Study|Elected not to continue|0|||
156341691|NCT02915016|564348614|FG006|Overall Study|Elected not to continue|1|||
156470116|NCT01387516|564814926|FG003|Overall Study|Lost to Follow-up|3|||
156470117|NCT01387516|564814923|FG000|Overall Study|Withdrawal by Subject|1|||
156470118|NCT01387516|564814924|FG001|Overall Study|Withdrawal by Subject|1|||
156470119|NCT01387516|564814925|FG002|Overall Study|Withdrawal by Subject|2|||
156470120|NCT01387516|564814926|FG003|Overall Study|Withdrawal by Subject|0|||
156845534|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
156845535|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
156845536|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
156845537|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
156845538|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156845539|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
156845540|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
156845541|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
156845542|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
156845543|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
156845544|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
156845545|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
156845546|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
156845547|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
156845548|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
156845549|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
156845550|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
156845551|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
156845552|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
156845553|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
156845554|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
156341692|NCT02915016|564348615|FG007|Overall Study|Elected not to continue|0|||
156341693|NCT02915016|564348608|FG000|Overall Study|HIV infection|1|||
156341694|NCT02915016|564348609|FG001|Overall Study|HIV infection|1|||
156470121|NCT01387516|564814923|FG000|Overall Study|Death|0|||
156470122|NCT01387516|564814924|FG001|Overall Study|Death|0|||
156341695|NCT02915016|564348610|FG002|Overall Study|HIV infection|1|||
156341696|NCT02915016|564348611|FG003|Overall Study|HIV infection|0|||
156341697|NCT02915016|564348612|FG004|Overall Study|HIV infection|1|||
156341698|NCT02915016|564348613|FG005|Overall Study|HIV infection|0|||
156341699|NCT02915016|564348614|FG006|Overall Study|HIV infection|0|||
156341700|NCT02915016|564348615|FG007|Overall Study|HIV infection|0|||
156341701|NCT02915016|564348608|FG000|Overall Study|Participant unable to adhere|0|||
156341702|NCT02915016|564348609|FG001|Overall Study|Participant unable to adhere|0|||
156341703|NCT02915016|564348610|FG002|Overall Study|Participant unable to adhere|0|||
156341704|NCT02915016|564348611|FG003|Overall Study|Participant unable to adhere|0|||
156341705|NCT02915016|564348612|FG004|Overall Study|Participant unable to adhere|0|||
156845555|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
156845556|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
156845557|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156845558|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
156845559|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156845560|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
156845561|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
156845562|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
156845563|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
156845564|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
156845565|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
156845566|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
156845567|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
156845568|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
156845569|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156845570|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
156845571|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
156845572|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
156845573|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
156845574|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
156341706|NCT02915016|564348613|FG005|Overall Study|Participant unable to adhere|0|||
156341707|NCT02915016|564348614|FG006|Overall Study|Participant unable to adhere|0|||
156470123|NCT01387516|564814925|FG002|Overall Study|Death|0|||
156470124|NCT01387516|564814926|FG003|Overall Study|Death|1|||
156470125|NCT03582475|564814927|FG000|Treatment Period|Withdrawal by Subject|0|||
156470126|NCT03582475|564814928|FG001|Treatment Period|Withdrawal by Subject|1|||
156470127|NCT03582475|564814927|FG000|Follow-up Period|Withdrawal by Subject|0|||
156470128|NCT03582475|564814928|FG001|Follow-up Period|Withdrawal by Subject|1|||
156470129|NCT03170648|564814934|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
156470130|NCT03170648|564814934|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
156470131|NCT02052440|564814935|FG000|Overall Study|Withdrawal by Subject|0|||
156470132|NCT02052440|564814936|FG001|Overall Study|Withdrawal by Subject|1|||
156470133|NCT03509909|564814937|FG000|Overall Study|Withdrawal by Subject|16|||
156470134|NCT03509909|564814938|FG001|Overall Study|Withdrawal by Subject|9|||
156470135|NCT03509909|564814937|FG000|Overall Study|Lost to Follow-up|3|||
156470136|NCT03509909|564814938|FG001|Overall Study|Lost to Follow-up|4|||
156470137|NCT03509909|564814937|FG000|Overall Study|Adverse Event|2|||
156470138|NCT03509909|564814938|FG001|Overall Study|Adverse Event|0|||
156470139|NCT01400958|564814939|FG000|Overall Study|Physician Decision|0|||
156470140|NCT01400958|564814940|FG001|Overall Study|Physician Decision|1|||
156470141|NCT01400958|564814939|FG000|Overall Study|Withdrawal by Subject|0|||
156470142|NCT01400958|564814940|FG001|Overall Study|Withdrawal by Subject|1|||
156470143|NCT01400958|564814939|FG000|Overall Study|Adverse Event|1|||
156470144|NCT01400958|564814940|FG001|Overall Study|Adverse Event|0|||
156470145|NCT04436289|564814941|FG000|Overall Study|Death prior to hospital discharge|8|||
156470146|NCT04436289|564814942|FG001|Overall Study|Death prior to hospital discharge|5|||
156470147|NCT04436289|564814943|FG002|Overall Study|Death prior to hospital discharge|0|||
156470148|NCT04436289|564814944|FG003|Overall Study|Death prior to hospital discharge|1|||
156470149|NCT04436289|564814941|FG000|Overall Study|Withdrawal by Subject|0|||
156470150|NCT04436289|564814942|FG001|Overall Study|Withdrawal by Subject|1|||
156470151|NCT04436289|564814943|FG002|Overall Study|Withdrawal by Subject|4|||
156470152|NCT04436289|564814944|FG003|Overall Study|Withdrawal by Subject|0|||
156470153|NCT04436289|564814941|FG000|Overall Study|Extended hospital stay|0|||
156470154|NCT04436289|564814942|FG001|Overall Study|Extended hospital stay|1|||
156470155|NCT04436289|564814943|FG002|Overall Study|Extended hospital stay|0|||
156470156|NCT04436289|564814944|FG003|Overall Study|Extended hospital stay|0|||
156845575|NCT01922271|566187726|FG000|WASHOUT Period|Withdrawal by Subject|1|||
156341708|NCT02915016|564348615|FG007|Overall Study|Participant unable to adhere|1|||
156341709|NCT02578316|564348616|FG000|Extension Phase|Progression of disease|6|||
156341710|NCT02166905|564348617|FG000|Overall Study|Withdrawal by Subject|1|||
156341711|NCT02166905|564348618|FG001|Overall Study|Withdrawal by Subject|0|||
156470157|NCT04436289|564814941|FG000|Overall Study|Lost to Follow-up|0|||
156470158|NCT04436289|564814942|FG001|Overall Study|Lost to Follow-up|4|||
156470159|NCT04436289|564814943|FG002|Overall Study|Lost to Follow-up|1|||
156470160|NCT04436289|564814944|FG003|Overall Study|Lost to Follow-up|3|||
156470161|NCT04801420|564814947|FG000|Overall Study|Other|1|||
156845576|NCT01922271|566187727|FG001|WASHOUT Period|Withdrawal by Subject|0|||
156845577|NCT00719355|566187728|FG000|Overall Study|Death|0|||
156845578|NCT00719355|566187729|FG001|Overall Study|Death|1|||
156845579|NCT00719355|566187728|FG000|Overall Study|Medical|14|||
156845580|NCT00719355|566187729|FG001|Overall Study|Medical|5|||
156845581|NCT00719355|566187728|FG000|Overall Study|Compliance|4|||
156845582|NCT00719355|566187729|FG001|Overall Study|Compliance|6|||
156845583|NCT00719355|566187728|FG000|Overall Study|Moved|0|||
156845584|NCT00719355|566187729|FG001|Overall Study|Moved|1|||
156845585|NCT03724890|566187730|FG000|Overall Study|Death|2|||
156845586|NCT03724890|566187731|FG001|Overall Study|Death|6|||
156845587|NCT03724890|566187732|FG002|Overall Study|Death|3|||
156845588|NCT03724890|566187733|FG003|Overall Study|Death|5|||
156845589|NCT03724890|566187734|FG004|Overall Study|Death|2|||
156845590|NCT03724890|566187735|FG005|Overall Study|Death|0|||
156845591|NCT03724890|566187736|FG006|Overall Study|Death|2|||
156845592|NCT03724890|566187737|FG007|Overall Study|Death|3|||
156845593|NCT03724890|566187738|FG008|Overall Study|Death|4|||
156845594|NCT03724890|566187739|FG009|Overall Study|Death|2|||
156845595|NCT03724890|566187740|FG010|Overall Study|Death|2|||
156845596|NCT03724890|566187730|FG000|Overall Study|Lost to Follow-up|0|||
156845597|NCT03724890|566187731|FG001|Overall Study|Lost to Follow-up|3|||
156845598|NCT03724890|566187732|FG002|Overall Study|Lost to Follow-up|0|||
156845599|NCT03724890|566187733|FG003|Overall Study|Lost to Follow-up|1|||
156845600|NCT03724890|566187734|FG004|Overall Study|Lost to Follow-up|2|||
156845601|NCT03724890|566187735|FG005|Overall Study|Lost to Follow-up|2|||
156845602|NCT03724890|566187736|FG006|Overall Study|Lost to Follow-up|1|||
156845603|NCT03724890|566187737|FG007|Overall Study|Lost to Follow-up|0|||
156845604|NCT03724890|566187738|FG008|Overall Study|Lost to Follow-up|2|||
156845605|NCT03724890|566187739|FG009|Overall Study|Lost to Follow-up|0|||
156541523|NCT04707157|565075442|FG001|Overall Study|Physician Decision|5|||
156845606|NCT03724890|566187740|FG010|Overall Study|Lost to Follow-up|0|||
156845607|NCT03724890|566187730|FG000|Overall Study|Withdrawal by Subject|1|||
156341712|NCT02166905|564348619|FG002|Overall Study|Withdrawal by Subject|0|||
156845608|NCT03724890|566187731|FG001|Overall Study|Withdrawal by Subject|2|||
156845609|NCT03724890|566187732|FG002|Overall Study|Withdrawal by Subject|1|||
156845610|NCT03724890|566187733|FG003|Overall Study|Withdrawal by Subject|0|||
156341713|NCT02166905|564348620|FG003|Overall Study|Withdrawal by Subject|0|||
156341714|NCT03278873|564348625|FG000|Overall Study|Withdrawal by Subject|0|||
156845611|NCT03724890|566187734|FG004|Overall Study|Withdrawal by Subject|0|||
156845612|NCT03724890|566187735|FG005|Overall Study|Withdrawal by Subject|1|||
156845613|NCT03724890|566187736|FG006|Overall Study|Withdrawal by Subject|0|||
156845614|NCT03724890|566187737|FG007|Overall Study|Withdrawal by Subject|0|||
156845615|NCT03724890|566187738|FG008|Overall Study|Withdrawal by Subject|2|||
156845616|NCT03724890|566187739|FG009|Overall Study|Withdrawal by Subject|2|||
156845617|NCT03724890|566187740|FG010|Overall Study|Withdrawal by Subject|1|||
156845618|NCT03724890|566187730|FG000|Overall Study|Other|1|||
156845619|NCT03724890|566187731|FG001|Overall Study|Other|0|||
156845620|NCT03724890|566187732|FG002|Overall Study|Other|0|||
156845621|NCT03724890|566187733|FG003|Overall Study|Other|0|||
156845622|NCT03724890|566187734|FG004|Overall Study|Other|0|||
156845623|NCT03724890|566187735|FG005|Overall Study|Other|0|||
156845624|NCT03724890|566187736|FG006|Overall Study|Other|0|||
156845625|NCT03724890|566187737|FG007|Overall Study|Other|1|||
156845626|NCT03724890|566187738|FG008|Overall Study|Other|1|||
156845627|NCT03724890|566187739|FG009|Overall Study|Other|0|||
156845628|NCT03724890|566187740|FG010|Overall Study|Other|2|||
156845629|NCT03664765|566187742|FG000|Overall Study|Withdrawal by Subject|4|||
156845630|NCT03664765|566187743|FG001|Overall Study|Withdrawal by Subject|1|||
156845631|NCT03664765|566187742|FG000|Overall Study|Lost to Follow-up|0|||
156845632|NCT03664765|566187743|FG001|Overall Study|Lost to Follow-up|1|||
156845633|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
156845634|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
156845635|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
156845636|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
156845637|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
156845638|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
156845639|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
156845640|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
156845641|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
156845642|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
156845643|NCT00383162|566187744|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
156845644|NCT00383162|566187745|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
156845645|NCT00383162|566187744|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
156845646|NCT00383162|566187745|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
156845647|NCT00383162|566187744|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
156845648|NCT00383162|566187745|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
156845649|NCT00383162|566187744|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
156845650|NCT00383162|566187745|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
156845651|NCT01496846|566187749|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
156845652|NCT01496846|566187750|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
156845653|NCT01496846|566187751|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
156845654|NCT01496846|566187752|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
156845655|NCT01496846|566187753|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
156845656|NCT01496846|566187754|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
156845657|NCT01772576|566187755|FG000|Overall Study|Death|15|||
156845658|NCT01772576|566187755|FG000|Overall Study|Protocol Violation|1|||
156845659|NCT01772576|566187755|FG000|Overall Study|Lost to Follow-up|3|||
156845660|NCT01772576|566187755|FG000|Overall Study|Study device not used|3|||
156845661|NCT01772576|566187755|FG000|Overall Study|Adverse Event|6|||
156845662|NCT01772576|566187755|FG000|Overall Study|Withdrawal by Subject|6|||
156845663|NCT00923845|566187756|FG000|Induction Therapy|Poor performance status|0|||
156845664|NCT00923845|566187757|FG001|Induction Therapy|Poor performance status|2|||
156845665|NCT02873338|566187766|FG000|Overall Study|Adverse Event|0|||
156845666|NCT02873338|566187767|FG001|Overall Study|Adverse Event|2|||
156845667|NCT02873338|566187768|FG002|Overall Study|Adverse Event|1|||
156845668|NCT02873338|566187766|FG000|Overall Study|Death|2|||
156845669|NCT02873338|566187767|FG001|Overall Study|Death|1|||
156845670|NCT02873338|566187768|FG002|Overall Study|Death|1|||
156845671|NCT02873338|566187766|FG000|Overall Study|Withdrawal by Subject|2|||
156845672|NCT02873338|566187767|FG001|Overall Study|Withdrawal by Subject|1|||
156845673|NCT02873338|566187768|FG002|Overall Study|Withdrawal by Subject|3|||
156845674|NCT02873338|566187766|FG000|Overall Study|Lack of Efficacy|0|||
156845675|NCT02873338|566187767|FG001|Overall Study|Lack of Efficacy|2|||
156845676|NCT02873338|566187768|FG002|Overall Study|Lack of Efficacy|0|||
156845677|NCT02873338|566187766|FG000|Overall Study|Other or Missing|14|||
156845678|NCT02873338|566187767|FG001|Overall Study|Other or Missing|15|||
156341715|NCT03278873|564348626|FG001|Overall Study|Withdrawal by Subject|1|||
156341716|NCT03278873|564348627|FG002|Overall Study|Withdrawal by Subject|0|||
156341717|NCT03278873|564348628|FG003|Overall Study|Withdrawal by Subject|0|||
156845679|NCT02873338|566187768|FG002|Overall Study|Other or Missing|13|||
156845680|NCT01620944|566187769|FG000|Overall Study|Early termination of Study|2|||
156845681|NCT01620944|566187770|FG001|Overall Study|Early termination of Study|1|||
156845682|NCT00375518|566187771|FG000|Overall Study|Withdrawal by Subject|2|||
156845683|NCT00375518|566187772|FG001|Overall Study|Withdrawal by Subject|10|||
156845684|NCT00375518|566187771|FG000|Overall Study|Patient Not Treated|6|||
156845685|NCT00375518|566187772|FG001|Overall Study|Patient Not Treated|6|||
156845686|NCT00375518|566187771|FG000|Overall Study|Death|0|||
156845687|NCT00375518|566187772|FG001|Overall Study|Death|1|||
156341718|NCT03278873|564348625|FG000|Overall Study|Sponsor's decision|0|||
156341719|NCT03278873|564348626|FG001|Overall Study|Sponsor's decision|1|||
156341720|NCT03278873|564348627|FG002|Overall Study|Sponsor's decision|0|||
156341721|NCT03278873|564348628|FG003|Overall Study|Sponsor's decision|0|||
156341722|NCT03278873|564348625|FG000|Overall Study|Early Termination|2|||
156341723|NCT03278873|564348626|FG001|Overall Study|Early Termination|6|||
156845688|NCT03170193|566187773|FG000|Overall Study|Withdrawal by Subject|0|||
156845689|NCT03170193|566187774|FG001|Overall Study|Withdrawal by Subject|0|||
156845690|NCT03170193|566187775|FG002|Overall Study|Withdrawal by Subject|0|||
156845691|NCT03170193|566187776|FG003|Overall Study|Withdrawal by Subject|1|||
156845692|NCT03170193|566187777|FG004|Overall Study|Withdrawal by Subject|0|||
156845693|NCT03170193|566187778|FG005|Overall Study|Withdrawal by Subject|0|||
156845694|NCT03170193|566187779|FG006|Overall Study|Withdrawal by Subject|0|||
156845695|NCT03170193|566187773|FG000|Overall Study|Lost to Follow-up|1|||
156845696|NCT03170193|566187774|FG001|Overall Study|Lost to Follow-up|1|||
156845697|NCT03170193|566187775|FG002|Overall Study|Lost to Follow-up|0|||
156845698|NCT03170193|566187776|FG003|Overall Study|Lost to Follow-up|0|||
156845699|NCT03170193|566187777|FG004|Overall Study|Lost to Follow-up|0|||
156845700|NCT03170193|566187778|FG005|Overall Study|Lost to Follow-up|0|||
156845701|NCT03170193|566187779|FG006|Overall Study|Lost to Follow-up|0|||
156845702|NCT03052816|566187784|FG000|Overall Study|Withdrawal by Subject|1|||
156845703|NCT03052816|566187785|FG001|Overall Study|Withdrawal by Subject|0|||
156845704|NCT03052816|566187784|FG000|Overall Study|Desired opioids|2|||
156845705|NCT03052816|566187785|FG001|Overall Study|Desired opioids|0|||
156845706|NCT03755661|566187786|FG000|Overall Study|Lost to Follow-up|1|||
156845707|NCT03755661|566187787|FG001|Overall Study|Lost to Follow-up|0|||
156845708|NCT04000581|566187788|FG000|Overall Study|Withdrawal by Subject|0|||
156845709|NCT04000581|566187789|FG001|Overall Study|Withdrawal by Subject|1|||
156845710|NCT00895453|566187793|FG000|Overall Study|Lost to Follow-up|25|||
156845711|NCT00895453|566187794|FG001|Overall Study|Lost to Follow-up|25|||
156845712|NCT00895453|566187795|FG002|Overall Study|Lost to Follow-up|23|||
156845713|NCT00619307|566187798|FG000|Overall Study|Adverse Event|0|||
156845714|NCT00619307|566187799|FG001|Overall Study|Adverse Event|1|||
156845715|NCT00619307|566187798|FG000|Overall Study|Lost to Follow-up|0|||
156845716|NCT00619307|566187799|FG001|Overall Study|Lost to Follow-up|1|||
156845717|NCT00619307|566187798|FG000|Overall Study|Protocol Violation|3|||
156845718|NCT00619307|566187799|FG001|Overall Study|Protocol Violation|0|||
156845719|NCT00619307|566187798|FG000|Overall Study|Withdrew consent|1|||
156845720|NCT00619307|566187799|FG001|Overall Study|Withdrew consent|0|||
156845721|NCT00619307|566187798|FG000|Overall Study|Severe migraine|0|||
156845722|NCT00619307|566187799|FG001|Overall Study|Severe migraine|1|||
156845723|NCT00619307|566187798|FG000|Overall Study|MS attack plus steroids|0|||
156845724|NCT00619307|566187799|FG001|Overall Study|MS attack plus steroids|1|||
156845725|NCT00118430|566187808|FG000|Overall Study|Withdrawal by Subject|6|||
156845726|NCT00118430|566187809|FG001|Overall Study|Withdrawal by Subject|2|||
156845727|NCT00118430|566187810|FG002|Overall Study|Withdrawal by Subject|0|||
156845728|NCT00118430|566187808|FG000|Overall Study|Lost to Follow-up|15|||
156845729|NCT00118430|566187809|FG001|Overall Study|Lost to Follow-up|22|||
156845730|NCT00118430|566187810|FG002|Overall Study|Lost to Follow-up|28|||
156845731|NCT00534976|566187811|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
156845732|NCT00534976|566187812|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
156845733|NCT00534976|566187811|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
156845734|NCT00534976|566187812|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
156845735|NCT00534976|566187811|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
156845736|NCT00534976|566187812|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
156845737|NCT02147288|566187813|FG000|Overall Study|post-operative hematoma|1|||
156845738|NCT02147288|566187814|FG001|Overall Study|post-operative hematoma|1|||
156845739|NCT02147288|566187815|FG002|Overall Study|post-operative hematoma|0|||
156845740|NCT02147288|566187816|FG003|Overall Study|post-operative hematoma|0|||
156845741|NCT02147288|566187817|FG004|Overall Study|post-operative hematoma|0|||
156845742|NCT02147288|566187818|FG005|Overall Study|post-operative hematoma|0|||
156845743|NCT02147288|566187819|FG006|Overall Study|post-operative hematoma|0|||
156845744|NCT02147288|566187820|FG007|Overall Study|post-operative hematoma|0|||
156845745|NCT02147288|566187821|FG008|Overall Study|post-operative hematoma|0|||
156341724|NCT03278873|564348627|FG002|Overall Study|Early Termination|0|||
156341725|NCT03278873|564348628|FG003|Overall Study|Early Termination|4|||
156341726|NCT03278873|564348625|FG000|Overall Study|Lost to Follow-up|0|||
156845746|NCT02147288|566187822|FG009|Overall Study|post-operative hematoma|0|||
156845747|NCT02147288|566187813|FG000|Overall Study|complications from concurrent hernia rep|0|||
156845748|NCT02147288|566187814|FG001|Overall Study|complications from concurrent hernia rep|1|||
156845749|NCT02147288|566187815|FG002|Overall Study|complications from concurrent hernia rep|0|||
156845750|NCT02147288|566187816|FG003|Overall Study|complications from concurrent hernia rep|0|||
156845751|NCT02147288|566187817|FG004|Overall Study|complications from concurrent hernia rep|0|||
156845752|NCT02147288|566187818|FG005|Overall Study|complications from concurrent hernia rep|0|||
156845753|NCT02147288|566187819|FG006|Overall Study|complications from concurrent hernia rep|0|||
156845754|NCT02147288|566187820|FG007|Overall Study|complications from concurrent hernia rep|0|||
156845755|NCT02147288|566187821|FG008|Overall Study|complications from concurrent hernia rep|0|||
156845756|NCT02147288|566187822|FG009|Overall Study|complications from concurrent hernia rep|0|||
156845757|NCT00861471|566187823|FG000|Overall Study|Withdrawal by Subject|1|||
156845758|NCT00861471|566187823|FG000|Overall Study|Adverse Event|2|||
156845759|NCT00861471|566187823|FG000|Overall Study|Lack of Efficacy|3|||
156845760|NCT00861471|566187823|FG000|Overall Study|treatment for lumbar laminectomy|1|||
156845761|NCT00861471|566187823|FG000|Overall Study|Physician Decision|2|||
156845762|NCT02069392|566187826|FG000|Overall Study|Withdrawal by Subject|4|||
156845763|NCT02069392|566187827|FG001|Overall Study|Withdrawal by Subject|2|||
156845764|NCT00269633|566187828|FG000|Overall Study|Withdrawal by Subject|1|||
156845765|NCT00269633|566187829|FG001|Overall Study|Withdrawal by Subject|0|||
156845766|NCT04412707|566187830|FG000|Cycle 1|Death|0|||
156845767|NCT04412707|566187831|FG001|Cycle 1|Death|3|||
156845768|NCT04412707|566187830|FG000|Cycle 1|Disease progression|1|||
156845769|NCT04412707|566187831|FG001|Cycle 1|Disease progression|2|||
156845770|NCT04412707|566187830|FG000|Cycle 2|Death|0|||
156845771|NCT04412707|566187831|FG001|Cycle 2|Death|1|||
156845772|NCT04412707|566187830|FG000|Cycle 2|Disease progression|3|||
156845773|NCT04412707|566187831|FG001|Cycle 2|Disease progression|0|||
156845774|NCT04412707|566187830|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
156845775|NCT04412707|566187831|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
156845776|NCT04412707|566187830|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
156845777|NCT04412707|566187831|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
156845778|NCT04412707|566187830|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
156845779|NCT04412707|566187831|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
156845780|NCT04412707|566187830|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
156845781|NCT04412707|566187831|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
156845782|NCT00855959|566189834|FG000|Overall Study|Adverse Event|2|||
156845783|NCT00855959|566189834|FG000|Overall Study|Lost to Follow-up|2|||
156845784|NCT00855959|566189834|FG000|Overall Study|Withdrawal by Subject|3|||
156845785|NCT00855959|566189834|FG000|Overall Study|Pregnancy|1|||
156845786|NCT00855959|566189834|FG000|Overall Study|Incorrect enrolment|1|||
156845787|NCT04014062|566189835|FG000|Period I: Dosing|Medical Grounds|4|||
156845788|NCT04014062|566189836|FG001|Period I: Dosing|Medical Grounds|5|||
156845789|NCT04014062|566189835|FG000|Period I: Dosing|Withdrawal by Subject|3|||
156845790|NCT04014062|566189836|FG001|Period I: Dosing|Withdrawal by Subject|1|||
156845791|NCT03038126|566189838|FG000|Overall Study|Death|1|||
156845792|NCT03038126|566189839|FG001|Overall Study|Death|1|||
156845793|NCT03038126|566189838|FG000|Overall Study|Withdrawal by Subject|5|||
156845794|NCT03038126|566189839|FG001|Overall Study|Withdrawal by Subject|0|||
156845795|NCT03038126|566189838|FG000|Overall Study|Lost to Follow-up|0|||
156845796|NCT03038126|566189839|FG001|Overall Study|Lost to Follow-up|1|||
156845797|NCT03038126|566189838|FG000|Overall Study|Long Term Hospitalization|2|||
156845798|NCT03038126|566189839|FG001|Overall Study|Long Term Hospitalization|0|||
156845799|NCT03038126|566189838|FG000|Overall Study|Too Ill to Participate|1|||
156845800|NCT03038126|566189839|FG001|Overall Study|Too Ill to Participate|2|||
156845801|NCT01724866|566189840|FG000|Overall Study|Adverse Event|0|||
156845802|NCT01724866|566189841|FG001|Overall Study|Adverse Event|0|||
156845803|NCT01724866|566189842|FG002|Overall Study|Adverse Event|1|||
156845804|NCT01724866|566189843|FG003|Overall Study|Adverse Event|1|||
156845805|NCT01724866|566189840|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
156845806|NCT01724866|566189841|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
156845807|NCT01724866|566189842|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
156845808|NCT01724866|566189843|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
156845809|NCT01724866|566189840|FG000|Overall Study|Investigator's Discretion|0|||
156845810|NCT01724866|566189841|FG001|Overall Study|Investigator's Discretion|1|||
156845811|NCT01724866|566189842|FG002|Overall Study|Investigator's Discretion|1|||
156845812|NCT01724866|566189843|FG003|Overall Study|Investigator's Discretion|0|||
156845813|NCT01724866|566189840|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
156845814|NCT01724866|566189841|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
156845815|NCT01724866|566189842|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
156845816|NCT01724866|566189843|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
156845817|NCT01724866|566189840|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
156845818|NCT01724866|566189841|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
156341727|NCT03278873|564348626|FG001|Overall Study|Lost to Follow-up|0|||
156541524|NCT04707157|565075441|FG000|Overall Study|Protocol Deviation|1|||
156845819|NCT01724866|566189842|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
156845820|NCT01724866|566189843|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
156845821|NCT04506502|566189847|FG000|Overall Study|Withdrawal by Subject|1|||
156845822|NCT04506502|566189847|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
156845823|NCT03350815|566189848|FG000|Period 1|Adverse Event|10|||
156845824|NCT03350815|566189849|FG001|Period 1|Adverse Event|0|||
156845825|NCT03350815|566189850|FG002|Period 1|Adverse Event|0|||
156845826|NCT03350815|566189851|FG003|Period 1|Adverse Event|0|||
156845827|NCT03350815|566189848|FG000|Period 1|Technical problems|1|||
156845828|NCT03350815|566189849|FG001|Period 1|Technical problems|0|||
156845829|NCT03350815|566189850|FG002|Period 1|Technical problems|0|||
156845830|NCT03350815|566189851|FG003|Period 1|Technical problems|0|||
156845831|NCT03350815|566189848|FG000|Period 1|Lost to Follow-up|3|||
156845832|NCT03350815|566189849|FG001|Period 1|Lost to Follow-up|0|||
156845833|NCT03350815|566189850|FG002|Period 1|Lost to Follow-up|0|||
156845834|NCT03350815|566189851|FG003|Period 1|Lost to Follow-up|0|||
156845835|NCT03350815|566189848|FG000|Period 1|Physician Decision|1|||
156845836|NCT03350815|566189849|FG001|Period 1|Physician Decision|0|||
156845837|NCT03350815|566189850|FG002|Period 1|Physician Decision|0|||
156845838|NCT03350815|566189851|FG003|Period 1|Physician Decision|0|||
156845839|NCT03350815|566189848|FG000|Period 1|Withdrawal by Subject|8|||
156845840|NCT03350815|566189849|FG001|Period 1|Withdrawal by Subject|0|||
156845841|NCT03350815|566189850|FG002|Period 1|Withdrawal by Subject|0|||
156845842|NCT03350815|566189851|FG003|Period 1|Withdrawal by Subject|0|||
156845843|NCT03350815|566189848|FG000|Period 1|Lack of Efficacy|15|||
156845844|NCT03350815|566189849|FG001|Period 1|Lack of Efficacy|0|||
156845845|NCT03350815|566189850|FG002|Period 1|Lack of Efficacy|0|||
156845846|NCT03350815|566189851|FG003|Period 1|Lack of Efficacy|0|||
156845847|NCT03350815|566189848|FG000|Period 1|Non-compliance with study treatment|2|||
156845848|NCT03350815|566189849|FG001|Period 1|Non-compliance with study treatment|0|||
156845849|NCT03350815|566189850|FG002|Period 1|Non-compliance with study treatment|0|||
156845850|NCT03350815|566189851|FG003|Period 1|Non-compliance with study treatment|0|||
156845851|NCT03350815|566189848|FG000|Period 1|Protocol Violation|3|||
156845852|NCT03350815|566189849|FG001|Period 1|Protocol Violation|0|||
156845853|NCT03350815|566189850|FG002|Period 1|Protocol Violation|0|||
156845854|NCT03350815|566189851|FG003|Period 1|Protocol Violation|0|||
156845855|NCT03350815|566189848|FG000|Period 2|Adverse Event|0|||
156845856|NCT03350815|566189849|FG001|Period 2|Adverse Event|3|||
156845857|NCT03350815|566189850|FG002|Period 2|Adverse Event|5|||
156845858|NCT03350815|566189851|FG003|Period 2|Adverse Event|0|||
156845859|NCT03350815|566189848|FG000|Period 2|Technical problem|0|||
156845860|NCT03350815|566189849|FG001|Period 2|Technical problem|1|||
156845861|NCT03350815|566189850|FG002|Period 2|Technical problem|0|||
156845862|NCT03350815|566189851|FG003|Period 2|Technical problem|0|||
156845863|NCT03350815|566189848|FG000|Period 2|Lost to Follow-up|0|||
156845864|NCT03350815|566189849|FG001|Period 2|Lost to Follow-up|3|||
156845865|NCT03350815|566189850|FG002|Period 2|Lost to Follow-up|3|||
156845866|NCT03350815|566189851|FG003|Period 2|Lost to Follow-up|0|||
156845867|NCT03350815|566189848|FG000|Period 2|Physician Decision|0|||
156845868|NCT03350815|566189849|FG001|Period 2|Physician Decision|0|||
156845869|NCT03350815|566189850|FG002|Period 2|Physician Decision|1|||
156845870|NCT03350815|566189851|FG003|Period 2|Physician Decision|0|||
156845871|NCT03350815|566189848|FG000|Period 2|Withdrawal by Subject|0|||
156845872|NCT03350815|566189849|FG001|Period 2|Withdrawal by Subject|3|||
156845873|NCT03350815|566189850|FG002|Period 2|Withdrawal by Subject|4|||
156845874|NCT03350815|566189851|FG003|Period 2|Withdrawal by Subject|0|||
156845875|NCT03350815|566189848|FG000|Period 2|Lack of Efficacy|0|||
156845876|NCT03350815|566189849|FG001|Period 2|Lack of Efficacy|6|||
156845877|NCT03350815|566189850|FG002|Period 2|Lack of Efficacy|2|||
156845878|NCT03350815|566189851|FG003|Period 2|Lack of Efficacy|0|||
156845879|NCT03350815|566189848|FG000|Period 2|Protocol Violation|0|||
156845880|NCT03350815|566189849|FG001|Period 2|Protocol Violation|0|||
156845881|NCT03350815|566189850|FG002|Period 2|Protocol Violation|1|||
156845882|NCT03350815|566189851|FG003|Period 2|Protocol Violation|0|||
156845883|NCT03350815|566189848|FG000|Period 2|New therapy for study indication|0|||
156845884|NCT03350815|566189849|FG001|Period 2|New therapy for study indication|0|||
156845885|NCT03350815|566189850|FG002|Period 2|New therapy for study indication|1|||
156845886|NCT03350815|566189851|FG003|Period 2|New therapy for study indication|0|||
156845887|NCT02517541|566189852|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
156845888|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
156845889|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
156845890|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
156845891|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
156845892|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
156845893|NCT02828436|566189853|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
156845894|NCT02828436|566189854|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
156845895|NCT02828436|566189853|FG000|Period 1|Lost to Follow-up|0|||
156845896|NCT02828436|566189854|FG001|Period 1|Lost to Follow-up|1|||
156845897|NCT02828436|566189853|FG000|Period 2|Withdrawal by Subject|4|||
156845898|NCT02828436|566189854|FG001|Period 2|Withdrawal by Subject|0|||
156845899|NCT02828436|566189853|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
156845900|NCT02828436|566189854|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
156845901|NCT02828436|566189853|FG000|Period 2|Lost to Follow-up|1|||
156845902|NCT02828436|566189854|FG001|Period 2|Lost to Follow-up|0|||
156845903|NCT05258149|566189859|FG000|Period 1|Protocol Deviation|1|||
156845904|NCT05258149|566189860|FG001|Period 1|Protocol Deviation|0|||
156845905|NCT05258149|566189859|FG000|Period 1|Adverse Event|0|||
156845906|NCT05258149|566189860|FG001|Period 1|Adverse Event|1|||
156845907|NCT05258149|566189859|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
156845908|NCT05258149|566189860|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156845909|NCT05258149|566189859|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
156845910|NCT05258149|566189860|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
156845911|NCT05258149|566189859|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
156845912|NCT05258149|566189860|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
156845913|NCT01442714|566189864|FG000|Overall Study|Death|11|||
156845914|NCT01442714|566189864|FG000|Overall Study|Withdrawal by Subject|1|||
156845915|NCT04720417|566189867|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
156845916|NCT03329092|566189868|FG000|Overall Study|Other|2|||
156845917|NCT03329092|566189869|FG001|Overall Study|Other|2|||
156845918|NCT03329092|566189868|FG000|Overall Study|Withdrawal by Subject|16|||
156845919|NCT03329092|566189869|FG001|Overall Study|Withdrawal by Subject|3|||
156845920|NCT03329092|566189868|FG000|Overall Study|Physician Decision|1|||
156845921|NCT03329092|566189869|FG001|Overall Study|Physician Decision|0|||
156845922|NCT03329092|566189868|FG000|Overall Study|Death|17|||
156845923|NCT03329092|566189869|FG001|Overall Study|Death|11|||
156845924|NCT03329092|566189868|FG000|Overall Study|Adverse Event|3|||
156845925|NCT03329092|566189869|FG001|Overall Study|Adverse Event|1|||
156845926|NCT03329092|566189868|FG000|Overall Study|Lost to Follow-up|1|||
156845927|NCT03329092|566189869|FG001|Overall Study|Lost to Follow-up|1|||
156845928|NCT03314987|566189870|FG000|Overall Study|Lost to Follow-up|13|||
156845929|NCT03314987|566189871|FG001|Overall Study|Lost to Follow-up|13|||
156845930|NCT02506192|566189872|FG000|Overall Study|Withdrawal by Subject|1|||
156845931|NCT02506192|566189873|FG001|Overall Study|Withdrawal by Subject|1|||
156845932|NCT00709618|566189874|FG000|Overall Study|Withdrawal by Subject|4|||
156845933|NCT00709618|566189874|FG000|Overall Study|Lost to Follow-up|1|||
156845934|NCT00709618|566189874|FG000|Overall Study|Study Closed/Terminated|25|||
156845935|NCT04042909|566189875|FG000|Overall Study|Withdrawal by Subject|1|||
156845936|NCT04042909|566189876|FG001|Overall Study|Withdrawal by Subject|0|||
156845937|NCT04042909|566189877|FG002|Overall Study|Withdrawal by Subject|0|||
156845938|NCT04042909|566189875|FG000|Overall Study|duplicate cases|2|||
156845939|NCT04042909|566189876|FG001|Overall Study|duplicate cases|0|||
156845940|NCT04042909|566189877|FG002|Overall Study|duplicate cases|0|||
156845941|NCT04042909|566189875|FG000|Overall Study|technical problem|0|||
156845942|NCT04042909|566189876|FG001|Overall Study|technical problem|1|||
156845943|NCT04042909|566189877|FG002|Overall Study|technical problem|0|||
156845944|NCT03785405|566189879|FG000|Overall Study|Adverse Event|16|||
156845945|NCT03785405|566189880|FG001|Overall Study|Adverse Event|1|||
156845946|NCT03785405|566189879|FG000|Overall Study|Death|6|||
156845947|NCT03785405|566189880|FG001|Overall Study|Death|4|||
156845948|NCT03785405|566189879|FG000|Overall Study|Guardian decision|4|||
156845949|NCT03785405|566189880|FG001|Overall Study|Guardian decision|1|||
156845950|NCT03785405|566189879|FG000|Overall Study|Lost to Follow-up|1|||
156845951|NCT03785405|566189880|FG001|Overall Study|Lost to Follow-up|0|||
156845952|NCT03785405|566189879|FG000|Overall Study|Physician Decision|8|||
156845953|NCT03785405|566189880|FG001|Overall Study|Physician Decision|5|||
156845954|NCT03785405|566189879|FG000|Overall Study|Participant decision|2|||
156845955|NCT03785405|566189880|FG001|Overall Study|Participant decision|0|||
156845956|NCT03785405|566189879|FG000|Overall Study|Other|1|||
156845957|NCT03785405|566189880|FG001|Overall Study|Other|0|||
156845958|NCT03785405|566189879|FG000|Overall Study|No treatment was received|0|||
156845959|NCT03785405|566189880|FG001|Overall Study|No treatment was received|1|||
156845960|NCT03705559|566189881|FG000|Overall Study|COVID Shut down|1|||
156845961|NCT00203424|566189884|FG000|Treatment Period|Withdrawal by Subject|4|||
156845962|NCT00203424|566189884|FG000|Treatment Period|Adverse Event|5|||
156845963|NCT00203424|566189884|FG000|Treatment Period|progressive disease|2|||
156845964|NCT00203424|566189884|FG000|Follow-up Period|Withdrawal by Subject|1|||
156845965|NCT00203424|566189884|FG000|Follow-up Period|progressive disease|4|||
156845966|NCT00203424|566189884|FG000|Follow-up Period|Lost to Follow-up|1|||
156845967|NCT06041919|566189885|FG000|Overall Study|Lost to Follow-up|1|||
156845968|NCT06041919|566189886|FG001|Overall Study|Lost to Follow-up|0|||
156845969|NCT06041919|566189887|FG002|Overall Study|Lost to Follow-up|0|||
156845970|NCT06041919|566189888|FG003|Overall Study|Lost to Follow-up|0|||
156845971|NCT06041919|566189889|FG004|Overall Study|Lost to Follow-up|0|||
156845972|NCT06041919|566189885|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
156845973|NCT06041919|566189886|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
156845974|NCT06041919|566189887|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
156845975|NCT06041919|566189888|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
156845976|NCT06041919|566189889|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
156845977|NCT01415401|566189895|FG000|Overall Study|Adverse Event|5|||
156845978|NCT01415401|566189895|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
156845979|NCT01415401|566189895|FG000|Overall Study|Terminated by Sponsor|1|||
156845980|NCT01147055|566189898|FG000|First Intervention Period|Lost to Follow-up|1|||
156845981|NCT01147055|566189899|FG001|First Intervention Period|Lost to Follow-up|0|||
156845982|NCT00836186|566189900|FG000|Overall Study|Blood could not be drawn|1|||
156845983|NCT04079816|566189901|FG000|Overall Study|Request of Subject|2|||
156845984|NCT04079816|566189901|FG000|Overall Study|Unable to draw samples|1|||
156845985|NCT01844778|566189907|FG000|Overall Study|Protocol deviation|0|||
156845986|NCT01844778|566189908|FG001|Overall Study|Protocol deviation|1|||
156845987|NCT01844778|566189909|FG002|Overall Study|Protocol deviation|2|||
156845988|NCT01844778|566189907|FG000|Overall Study|Withdrawal by Subject|2|||
156845989|NCT01844778|566189908|FG001|Overall Study|Withdrawal by Subject|0|||
156845990|NCT01844778|566189909|FG002|Overall Study|Withdrawal by Subject|0|||
156845991|NCT01844778|566189907|FG000|Overall Study|Adverse Event|0|||
156845992|NCT01844778|566189908|FG001|Overall Study|Adverse Event|2|||
156845993|NCT01844778|566189909|FG002|Overall Study|Adverse Event|2|||
156845994|NCT02161757|566189912|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
156845995|NCT02161757|566189913|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
156845996|NCT02161757|566189914|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
156845997|NCT02161757|566189912|FG000|Treatment Through Study Completion|Adverse Event|1|||
156845998|NCT02161757|566189913|FG001|Treatment Through Study Completion|Adverse Event|1|||
156845999|NCT02161757|566189914|FG002|Treatment Through Study Completion|Adverse Event|0|||
156846000|NCT02161757|566189912|FG000|Treatment Through Study Completion|Protocol Violation|0|||
156846001|NCT02161757|566189913|FG001|Treatment Through Study Completion|Protocol Violation|1|||
156846002|NCT02161757|566189914|FG002|Treatment Through Study Completion|Protocol Violation|2|||
156846003|NCT02161757|566189912|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
156846004|NCT02161757|566189913|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
156846005|NCT02161757|566189914|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
156846006|NCT02161757|566189912|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
156846007|NCT02161757|566189913|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
156846008|NCT02161757|566189914|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
156846009|NCT02161757|566189912|FG000|Treatment Through Study Completion|Other|20|||
156846010|NCT02161757|566189913|FG001|Treatment Through Study Completion|Other|19|||
156846011|NCT02161757|566189914|FG002|Treatment Through Study Completion|Other|12|||
156846012|NCT02161757|566189912|FG000|Treatment Through Study Completion|Death|2|||
156846013|NCT02161757|566189913|FG001|Treatment Through Study Completion|Death|1|||
156846014|NCT02161757|566189914|FG002|Treatment Through Study Completion|Death|1|||
156846015|NCT00391625|566189915|FG000|Month 14|Withdrawal by Subject|1|||
156846016|NCT00391625|566189915|FG000|Month 50|Physician Decision|1|||
156846017|NCT02106403|566189922|FG000|Follow-Up Visit 3|Other Reason|0|||
156846018|NCT02106403|566189923|FG001|Follow-Up Visit 3|Other Reason|0|||
156846019|NCT02106403|566189924|FG002|Follow-Up Visit 3|Other Reason|0|||
156846020|NCT02106403|566189925|FG003|Follow-Up Visit 3|Other Reason|0|||
156846021|NCT02106403|566189926|FG004|Follow-Up Visit 3|Other Reason|0|||
156846022|NCT02106403|566189927|FG005|Follow-Up Visit 3|Other Reason|1|||
156846023|NCT00379912|566189931|FG000|Overall Study|Lack of Efficacy|1|||
156846024|NCT00379912|566189932|FG001|Overall Study|Lack of Efficacy|0|||
156846025|NCT01128946|566189933|FG000|Period I|Protocol Violation|0|||
156846026|NCT01128946|566189934|FG001|Period I|Protocol Violation|1|||
156846027|NCT01128946|566189935|FG002|Period I|Protocol Violation|0|||
156846028|NCT01128946|566189936|FG003|Period I|Protocol Violation|0|||
156846029|NCT01128946|566189933|FG000|Period I|Withdrawal by Subject|0|||
156846030|NCT01128946|566189934|FG001|Period I|Withdrawal by Subject|0|||
156846031|NCT01128946|566189935|FG002|Period I|Withdrawal by Subject|1|||
156846032|NCT01128946|566189936|FG003|Period I|Withdrawal by Subject|1|||
156846033|NCT01128946|566189933|FG000|Period II|Protocol Violation|0|||
156846034|NCT01128946|566189934|FG001|Period II|Protocol Violation|1|||
156846035|NCT01128946|566189935|FG002|Period II|Protocol Violation|0|||
156846036|NCT01128946|566189936|FG003|Period II|Protocol Violation|0|||
156846037|NCT01128946|566189933|FG000|Period II|Withdrawal by Subject|0|||
156846038|NCT01128946|566189934|FG001|Period II|Withdrawal by Subject|0|||
156846039|NCT01128946|566189935|FG002|Period II|Withdrawal by Subject|0|||
156846040|NCT01128946|566189936|FG003|Period II|Withdrawal by Subject|1|||
156846041|NCT01128946|566189933|FG000|Period III|Protocol Violation|1|||
156846042|NCT01128946|566189934|FG001|Period III|Protocol Violation|0|||
156846043|NCT01128946|566189935|FG002|Period III|Protocol Violation|0|||
156846044|NCT01128946|566189936|FG003|Period III|Protocol Violation|0|||
156846045|NCT00145574|566189937|FG000|Double Blind|Adverse Event|0|||
156846046|NCT00145574|566189938|FG001|Double Blind|Adverse Event|3|||
156846047|NCT00145574|566189939|FG002|Double Blind|Adverse Event|1|||
156846048|NCT00145574|566189937|FG000|Double Blind|Withdrawal by Subject|1|||
156846049|NCT00145574|566189938|FG001|Double Blind|Withdrawal by Subject|1|||
156846050|NCT00145574|566189939|FG002|Double Blind|Withdrawal by Subject|1|||
156846051|NCT00145574|566189937|FG000|Double Blind|required restricted medicine|0|||
156846052|NCT00145574|566189938|FG001|Double Blind|required restricted medicine|1|||
156846053|NCT00145574|566189939|FG002|Double Blind|required restricted medicine|0|||
156846054|NCT00145574|566189937|FG000|Open Label Long-term Extension|Adverse Event|0|||
156846055|NCT00145574|566189938|FG001|Open Label Long-term Extension|Adverse Event|0|||
156846056|NCT00145574|566189939|FG002|Open Label Long-term Extension|Adverse Event|5|||
156846057|NCT00145574|566189937|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
156846058|NCT00145574|566189938|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
156846059|NCT00145574|566189939|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
156846060|NCT00145574|566189937|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
156846061|NCT00145574|566189938|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
156846062|NCT00145574|566189939|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
156846063|NCT00145574|566189937|FG000|Open Label Long-term Extension|required restricted medicine|0|||
156846064|NCT00145574|566189938|FG001|Open Label Long-term Extension|required restricted medicine|0|||
156846065|NCT00145574|566189939|FG002|Open Label Long-term Extension|required restricted medicine|1|||
156846066|NCT00621140|566189940|FG000|Overall Study|Adverse Event|4|||
156846067|NCT00621140|566189941|FG001|Overall Study|Adverse Event|5|||
156846068|NCT00621140|566189940|FG000|Overall Study|Lost to Follow-up|1|||
156846069|NCT00621140|566189941|FG001|Overall Study|Lost to Follow-up|2|||
156846070|NCT00621140|566189940|FG000|Overall Study|Withdrawal by Subject|4|||
156846071|NCT00621140|566189941|FG001|Overall Study|Withdrawal by Subject|6|||
156846072|NCT00621140|566189940|FG000|Overall Study|Other incl. lack of efficacy|6|||
156846073|NCT00621140|566189941|FG001|Overall Study|Other incl. lack of efficacy|5|||
156846074|NCT00527904|566189942|FG000|Overall Study|Adverse Event|45|||
156846075|NCT00527904|566189942|FG000|Overall Study|Withdrawal by Subject|21|||
156846076|NCT00527904|566189942|FG000|Overall Study|Lost to Follow-up|8|||
156846077|NCT00527904|566189942|FG000|Overall Study|misc|22|||
156846078|NCT00766051|566189944|FG000|Overall Study|Withdrawal by Subject|2|||
156846079|NCT00766051|566189945|FG001|Overall Study|Withdrawal by Subject|0|||
156846080|NCT00635882|566189946|FG000|Overall Study|Protocol Violation|1|||
156846081|NCT00635882|566189947|FG001|Overall Study|Protocol Violation|0|||
156846082|NCT00635882|566189948|FG002|Overall Study|Protocol Violation|0|||
156846083|NCT00635882|566189949|FG003|Overall Study|Protocol Violation|0|||
156846084|NCT00635882|566189950|FG004|Overall Study|Protocol Violation|0|||
156846085|NCT00635882|566189951|FG005|Overall Study|Protocol Violation|0|||
156846086|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
156846087|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
156846088|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
156846089|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846090|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846091|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846092|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846093|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846094|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846095|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Physician Decision|1|||
156846096|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Physician Decision|2|||
156846097|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Physician Decision|0|||
156846098|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Physician Decision|0|||
156846099|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Physician Decision|0|||
156846100|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Physician Decision|0|||
156846101|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Physician Decision|0|||
156846102|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Physician Decision|0|||
156846103|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Physician Decision|0|||
156846104|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
156846105|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
156846106|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
156846107|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
156846108|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
156846109|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
156846110|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
156846111|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
156846112|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
156846113|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
156846114|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846115|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846116|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846117|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846118|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846119|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846120|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846121|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846122|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
156846123|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
156846124|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846125|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846126|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846127|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846128|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846129|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846130|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846131|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Other than Specified|0|||
156846132|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Other than Specified|0|||
156846133|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Other than Specified|3|||
156846134|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Other than Specified|0|||
156846135|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Other than Specified|0|||
156846136|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Other than Specified|0|||
156846137|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Other than Specified|0|||
156846138|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Other than Specified|0|||
156846139|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Other than Specified|0|||
156846140|NCT04405076|566189952|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846141|NCT04405076|566189953|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846142|NCT04405076|566189954|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846143|NCT04405076|566189955|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
156846144|NCT04405076|566189956|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
156846145|NCT04405076|566189957|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
156846146|NCT04405076|566189958|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846147|NCT04405076|566189959|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846148|NCT04405076|566189960|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846149|NCT04405076|566189952|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846150|NCT04405076|566189953|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846151|NCT04405076|566189954|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846152|NCT04405076|566189955|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846153|NCT04405076|566189956|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
156846154|NCT04405076|566189957|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846155|NCT04405076|566189958|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846156|NCT04405076|566189959|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846157|NCT04405076|566189960|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846158|NCT04405076|566189952|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846159|NCT04405076|566189953|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846160|NCT04405076|566189954|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846161|NCT04405076|566189955|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
156846162|NCT04405076|566189956|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
156846163|NCT04405076|566189957|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
156846164|NCT04405076|566189958|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846165|NCT04405076|566189959|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846166|NCT04405076|566189960|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846167|NCT04405076|566189952|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846168|NCT04405076|566189953|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846169|NCT04405076|566189954|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846170|NCT04405076|566189955|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846171|NCT04405076|566189956|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846172|NCT04405076|566189957|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846173|NCT04405076|566189958|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846174|NCT04405076|566189959|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
156846175|NCT04405076|566189960|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
156846176|NCT04405076|566189952|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846177|NCT04405076|566189953|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846178|NCT04405076|566189954|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846179|NCT04405076|566189955|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846180|NCT04405076|566189956|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846181|NCT04405076|566189957|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846182|NCT04405076|566189958|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
156846183|NCT04405076|566189959|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846184|NCT04405076|566189960|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846185|NCT04310566|566189961|FG000|Period 1|Study Termination due to COVID-19|15|||
156846186|NCT04310566|566189962|FG001|Period 1|Study Termination due to COVID-19|17|||
156846187|NCT04310566|566189961|FG000|Period 1|Protocol Violation|0|||
156846188|NCT04310566|566189962|FG001|Period 1|Protocol Violation|1|||
156846189|NCT04310566|566189961|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
156846190|NCT04310566|566189962|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
156846191|NCT04310566|566189961|FG000|Period 1|Lost to Follow-up|1|||
156846192|NCT04310566|566189962|FG001|Period 1|Lost to Follow-up|0|||
156846193|NCT04310566|566189961|FG000|Period 1|Withdrawal by Subject|0|||
156846194|NCT04310566|566189962|FG001|Period 1|Withdrawal by Subject|1|||
156846195|NCT04310566|566189961|FG000|Period 2|Study Termination|7|||
156846196|NCT04310566|566189962|FG001|Period 2|Study Termination|5|||
156846197|NCT02560012|566189970|FG000|Overall Study|Study Terminated|2|||
156846198|NCT02218008|566189971|FG000|Stage 1 (S1)|Adverse Event|6|||
156846199|NCT02218008|566189972|FG001|Stage 1 (S1)|Adverse Event|5|||
156846200|NCT02218008|566189973|FG002|Stage 1 (S1)|Adverse Event|11|||
156846201|NCT02218008|566189974|FG003|Stage 1 (S1)|Adverse Event|0|||
156846202|NCT02218008|566189975|FG004|Stage 1 (S1)|Adverse Event|0|||
156846203|NCT02218008|566189976|FG005|Stage 1 (S1)|Adverse Event|0|||
156846204|NCT02218008|566189971|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
156846205|NCT02218008|566189972|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
156846206|NCT02218008|566189973|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
156846207|NCT02218008|566189974|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
156846208|NCT02218008|566189975|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
156846209|NCT02218008|566189976|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
156846210|NCT02218008|566189971|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
156846211|NCT02218008|566189972|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
156846212|NCT02218008|566189973|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
156846213|NCT02218008|566189974|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
156846214|NCT02218008|566189975|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
156846215|NCT02218008|566189976|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
156846216|NCT02218008|566189971|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
156846217|NCT02218008|566189972|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
156846218|NCT02218008|566189973|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
156846219|NCT02218008|566189974|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
156846220|NCT02218008|566189975|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
156846221|NCT02218008|566189976|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
156846222|NCT02218008|566189971|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
156846223|NCT02218008|566189972|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
156846224|NCT02218008|566189973|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
156846225|NCT02218008|566189974|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
156846226|NCT02218008|566189975|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
156846227|NCT02218008|566189976|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
156846228|NCT02218008|566189971|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
156846229|NCT02218008|566189972|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
156846230|NCT02218008|566189973|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
156846231|NCT02218008|566189974|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
156846232|NCT02218008|566189975|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
156846233|NCT02218008|566189976|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
156846234|NCT02218008|566189971|FG000|Stage 1 (S1)|Pregnancy|0|||
156846235|NCT02218008|566189972|FG001|Stage 1 (S1)|Pregnancy|0|||
156846236|NCT02218008|566189973|FG002|Stage 1 (S1)|Pregnancy|1|||
156846237|NCT02218008|566189974|FG003|Stage 1 (S1)|Pregnancy|0|||
156846238|NCT02218008|566189975|FG004|Stage 1 (S1)|Pregnancy|0|||
156846239|NCT02218008|566189976|FG005|Stage 1 (S1)|Pregnancy|0|||
156846240|NCT02218008|566189971|FG000|Stage 1 (S1)|Protocol Violation|0|||
156846241|NCT02218008|566189972|FG001|Stage 1 (S1)|Protocol Violation|0|||
156846242|NCT02218008|566189973|FG002|Stage 1 (S1)|Protocol Violation|1|||
156846243|NCT02218008|566189974|FG003|Stage 1 (S1)|Protocol Violation|0|||
156470162|NCT04801420|564814948|FG001|Overall Study|Other|2|||
156470163|NCT04801420|564814949|FG002|Overall Study|Other|1|||
156470164|NCT04801420|564814947|FG000|Overall Study|Lost to Follow-up|7|||
156470165|NCT04801420|564814948|FG001|Overall Study|Lost to Follow-up|9|||
156470166|NCT04801420|564814949|FG002|Overall Study|Lost to Follow-up|10|||
156846244|NCT02218008|566189975|FG004|Stage 1 (S1)|Protocol Violation|0|||
156846245|NCT02218008|566189976|FG005|Stage 1 (S1)|Protocol Violation|0|||
156470167|NCT04801420|564814947|FG000|Overall Study|Moved from study area|0|||
156470168|NCT04801420|564814948|FG001|Overall Study|Moved from study area|1|||
156470169|NCT04801420|564814949|FG002|Overall Study|Moved from study area|1|||
156470170|NCT04801420|564814947|FG000|Overall Study|Withdrawal by Subject|5|||
156846246|NCT02218008|566189971|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
156846247|NCT02218008|566189972|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846248|NCT02218008|566189973|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846249|NCT02218008|566189974|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846250|NCT02218008|566189975|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846251|NCT02218008|566189976|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846252|NCT02218008|566189971|FG000|Stage 2 (S2)|Adverse Event|0|||
156846253|NCT02218008|566189972|FG001|Stage 2 (S2)|Adverse Event|0|||
156846254|NCT02218008|566189973|FG002|Stage 2 (S2)|Adverse Event|0|||
156846255|NCT02218008|566189974|FG003|Stage 2 (S2)|Adverse Event|2|||
156846256|NCT02218008|566189975|FG004|Stage 2 (S2)|Adverse Event|3|||
156846257|NCT02218008|566189976|FG005|Stage 2 (S2)|Adverse Event|3|||
156846258|NCT02218008|566189971|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
156846259|NCT02218008|566189972|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
156846260|NCT02218008|566189973|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
156846261|NCT02218008|566189974|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
156846262|NCT02218008|566189975|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
156846263|NCT02218008|566189976|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
156846264|NCT02218008|566189971|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
156846265|NCT02218008|566189972|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
156846266|NCT02218008|566189973|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
156846267|NCT02218008|566189974|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
156846268|NCT02218008|566189975|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
156846269|NCT02218008|566189976|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
156846270|NCT02218008|566189971|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846271|NCT02218008|566189972|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846272|NCT02218008|566189973|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846273|NCT02218008|566189974|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
156846274|NCT02218008|566189975|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846275|NCT02218008|566189976|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846276|NCT02218008|566189971|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
156846277|NCT02218008|566189972|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
156846278|NCT02218008|566189973|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
156846279|NCT02218008|566189974|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
156846280|NCT02218008|566189975|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
156846281|NCT02218008|566189976|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
156846282|NCT00408434|566189977|FG000|Overall Study|Adverse Event|0|||
156846283|NCT00408434|566189978|FG001|Overall Study|Adverse Event|0|||
156846284|NCT00408434|566189979|FG002|Overall Study|Adverse Event|1|||
156846285|NCT00408434|566189980|FG003|Overall Study|Adverse Event|0|||
156846286|NCT00408434|566189981|FG004|Overall Study|Adverse Event|0|||
156846287|NCT00408434|566189982|FG005|Overall Study|Adverse Event|0|||
156846288|NCT00408434|566189983|FG006|Overall Study|Adverse Event|0|||
156846289|NCT00408434|566189977|FG000|Overall Study|Progressive disease|6|||
156846290|NCT00408434|566189978|FG001|Overall Study|Progressive disease|3|||
156846291|NCT00408434|566189979|FG002|Overall Study|Progressive disease|4|||
156846292|NCT00408434|566189980|FG003|Overall Study|Progressive disease|3|||
156846293|NCT00408434|566189981|FG004|Overall Study|Progressive disease|3|||
156846294|NCT00408434|566189982|FG005|Overall Study|Progressive disease|1|||
156846295|NCT00408434|566189983|FG006|Overall Study|Progressive disease|4|||
156846296|NCT00408434|566189977|FG000|Overall Study|Other|0|||
156846297|NCT00408434|566189978|FG001|Overall Study|Other|0|||
156846298|NCT00408434|566189979|FG002|Overall Study|Other|1|||
156846299|NCT00408434|566189980|FG003|Overall Study|Other|0|||
156846300|NCT00408434|566189981|FG004|Overall Study|Other|2|||
156846301|NCT00408434|566189982|FG005|Overall Study|Other|1|||
156846302|NCT00408434|566189983|FG006|Overall Study|Other|0|||
156846303|NCT00408434|566189977|FG000|Overall Study|Terminated by Investigator|0|||
156846304|NCT00408434|566189978|FG001|Overall Study|Terminated by Investigator|0|||
156846305|NCT00408434|566189979|FG002|Overall Study|Terminated by Investigator|0|||
156846306|NCT00408434|566189980|FG003|Overall Study|Terminated by Investigator|0|||
156846307|NCT00408434|566189981|FG004|Overall Study|Terminated by Investigator|1|||
156846308|NCT00408434|566189982|FG005|Overall Study|Terminated by Investigator|1|||
156846309|NCT00408434|566189983|FG006|Overall Study|Terminated by Investigator|0|||
156846310|NCT01088399|566189989|FG000|Overall Study|Adverse Event|211|||
156846311|NCT01088399|566189990|FG001|Overall Study|Adverse Event|16|||
156846312|NCT01088399|566189991|FG002|Overall Study|Adverse Event|0|||
156846313|NCT01088399|566189989|FG000|Overall Study|Death|204|||
156846314|NCT01088399|566189990|FG001|Overall Study|Death|45|||
156846315|NCT01088399|566189991|FG002|Overall Study|Death|0|||
156846316|NCT01088399|566189989|FG000|Overall Study|Lack of Efficacy|298|||
156846317|NCT01088399|566189990|FG001|Overall Study|Lack of Efficacy|7|||
156846318|NCT01088399|566189991|FG002|Overall Study|Lack of Efficacy|5|||
156846319|NCT01088399|566189989|FG000|Overall Study|Lost to Follow-up|1070|||
156846320|NCT01088399|566189990|FG001|Overall Study|Lost to Follow-up|278|||
156846321|NCT01088399|566189991|FG002|Overall Study|Lost to Follow-up|58|||
156846322|NCT01088399|566189989|FG000|Overall Study|Physician Decision|531|||
156846323|NCT01088399|566189990|FG001|Overall Study|Physician Decision|88|||
156846324|NCT01088399|566189991|FG002|Overall Study|Physician Decision|16|||
156846325|NCT01088399|566189989|FG000|Overall Study|Withdrawal by Subject|544|||
156846326|NCT01088399|566189990|FG001|Overall Study|Withdrawal by Subject|195|||
156846327|NCT01088399|566189991|FG002|Overall Study|Withdrawal by Subject|33|||
156846328|NCT01088399|566189989|FG000|Overall Study|Change to or start of somatropin therapy|234|||
156846329|NCT01088399|566189990|FG001|Overall Study|Change to or start of somatropin therapy|17|||
156846330|NCT01088399|566189991|FG002|Overall Study|Change to or start of somatropin therapy|12|||
156846331|NCT01088399|566189989|FG000|Overall Study|Sponsor decision|1573|||
156846332|NCT01088399|566189990|FG001|Overall Study|Sponsor decision|298|||
156846333|NCT01088399|566189991|FG002|Overall Study|Sponsor decision|7|||
156846334|NCT01088399|566189989|FG000|Overall Study|Protocol Violation|10|||
156846335|NCT01088399|566189990|FG001|Overall Study|Protocol Violation|1|||
156846336|NCT01088399|566189991|FG002|Overall Study|Protocol Violation|0|||
156846337|NCT01088399|566189989|FG000|Overall Study|Enrollment criteria not met|48|||
156846338|NCT01088399|566189990|FG001|Overall Study|Enrollment criteria not met|119|||
156846339|NCT01088399|566189991|FG002|Overall Study|Enrollment criteria not met|70|||
156846340|NCT01088399|566189989|FG000|Overall Study|Study summary visit not completed|2398|||
156846341|NCT01088399|566189990|FG001|Overall Study|Study summary visit not completed|283|||
156846342|NCT01088399|566189991|FG002|Overall Study|Study summary visit not completed|80|||
156846343|NCT04230213|566189996|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
156846344|NCT04230213|566189997|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
156846345|NCT04230213|566189998|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
156846346|NCT04230213|566189996|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
156846347|NCT04230213|566189997|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
156846348|NCT04230213|566189998|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
156846349|NCT04230213|566189996|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
156846350|NCT04230213|566189997|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
156846351|NCT04230213|566189998|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
156846352|NCT04230213|566189996|FG000|TP2: Week 10 to Week 16|Other|0|||
156846353|NCT04230213|566189997|FG001|TP2: Week 10 to Week 16|Other|2|||
156846354|NCT04230213|566189998|FG002|TP2: Week 10 to Week 16|Other|1|||
156846355|NCT04230213|566189996|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
156846356|NCT04230213|566189997|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
156846357|NCT04230213|566189998|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
156846358|NCT04230213|566189996|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
156846359|NCT04230213|566189997|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
156846360|NCT04230213|566189998|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
156846361|NCT04230213|566189996|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
156846362|NCT04230213|566189997|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
156846363|NCT04230213|566189998|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
156846364|NCT04230213|566189996|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
156846365|NCT04230213|566189997|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
156846366|NCT04230213|566189998|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
156846367|NCT04230213|566189996|FG000|TP3: Week 16 to Week 22|Other|0|||
156846368|NCT04230213|566189997|FG001|TP3: Week 16 to Week 22|Other|1|||
156846369|NCT04230213|566189998|FG002|TP3: Week 16 to Week 22|Other|3|||
156846370|NCT04230213|566189996|FG000|TP4: Week 22 to Week 32|Other|0|||
156846371|NCT04230213|566189997|FG001|TP4: Week 22 to Week 32|Other|5|||
156846372|NCT04230213|566189998|FG002|TP4: Week 22 to Week 32|Other|5|||
156846373|NCT04230213|566189996|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
156846374|NCT04230213|566189997|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
156846375|NCT04230213|566189998|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
156846376|NCT04230213|566189996|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
156846377|NCT04230213|566189997|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
156846378|NCT04230213|566189998|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
156846379|NCT04230213|566189996|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
156846380|NCT04230213|566189997|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
156846381|NCT04230213|566189998|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
156846382|NCT04230213|566189996|FG000|Follow up: Week 32 to Week 36|Other|0|||
156846383|NCT04230213|566189997|FG001|Follow up: Week 32 to Week 36|Other|1|||
156846384|NCT04230213|566189998|FG002|Follow up: Week 32 to Week 36|Other|1|||
156846385|NCT00615017|566191552|FG000|Overall Study|Adverse Event|0|||
156846386|NCT00615017|566191553|FG001|Overall Study|Adverse Event|1|||
156846387|NCT00615017|566191554|FG002|Overall Study|Adverse Event|2|||
156846388|NCT00615017|566191555|FG003|Overall Study|Adverse Event|0|||
156846389|NCT00615017|566191556|FG004|Overall Study|Adverse Event|0|||
156846390|NCT00615017|566191557|FG005|Overall Study|Adverse Event|1|||
156846391|NCT00615017|566191552|FG000|Overall Study|Death|0|||
156846392|NCT00615017|566191553|FG001|Overall Study|Death|0|||
156846393|NCT00615017|566191554|FG002|Overall Study|Death|2|||
156846394|NCT00615017|566191555|FG003|Overall Study|Death|0|||
156846395|NCT00615017|566191556|FG004|Overall Study|Death|1|||
156846396|NCT00615017|566191557|FG005|Overall Study|Death|1|||
156846397|NCT00615017|566191552|FG000|Overall Study|Sepsis resolved|0|||
156846398|NCT00615017|566191553|FG001|Overall Study|Sepsis resolved|0|||
156846399|NCT00615017|566191554|FG002|Overall Study|Sepsis resolved|1|||
156846400|NCT00615017|566191555|FG003|Overall Study|Sepsis resolved|0|||
156846401|NCT00615017|566191556|FG004|Overall Study|Sepsis resolved|0|||
156846402|NCT00615017|566191557|FG005|Overall Study|Sepsis resolved|0|||
156846403|NCT00615017|566191552|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
156846404|NCT00615017|566191553|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
156846405|NCT00615017|566191554|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
156846406|NCT00615017|566191555|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
156846407|NCT00615017|566191556|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
156846408|NCT00615017|566191557|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
156846409|NCT00615017|566191552|FG000|Overall Study|Physician discontinued drug|0|||
156846410|NCT00615017|566191553|FG001|Overall Study|Physician discontinued drug|0|||
156846411|NCT00615017|566191554|FG002|Overall Study|Physician discontinued drug|0|||
156846412|NCT00615017|566191555|FG003|Overall Study|Physician discontinued drug|0|||
156846413|NCT00615017|566191556|FG004|Overall Study|Physician discontinued drug|0|||
156846414|NCT00615017|566191557|FG005|Overall Study|Physician discontinued drug|1|||
156846415|NCT00806988|566191558|FG000|Overall Study|Death|15|||
156846416|NCT00806988|566191559|FG001|Overall Study|Death|16|||
156846417|NCT00806988|566191558|FG000|Overall Study|Withdrawal by Subject|8|||
156846418|NCT00806988|566191559|FG001|Overall Study|Withdrawal by Subject|8|||
156846419|NCT00806988|566191558|FG000|Overall Study|Lost to Follow-up|4|||
156846420|NCT00806988|566191559|FG001|Overall Study|Lost to Follow-up|19|||
156846421|NCT04775953|566191561|FG000|Overall Study|Lost to Follow-up|6|||
156846422|NCT04775953|566191562|FG001|Overall Study|Lost to Follow-up|11|||
156846423|NCT04775953|566191561|FG000|Overall Study|Death|5|||
156846424|NCT04775953|566191562|FG001|Overall Study|Death|4|||
156846425|NCT04775953|566191561|FG000|Overall Study|Withdrawal by Subject|3|||
156846426|NCT04775953|566191562|FG001|Overall Study|Withdrawal by Subject|3|||
156846427|NCT04775953|566191561|FG000|Overall Study|Protocol Violation|2|||
156846428|NCT04775953|566191562|FG001|Overall Study|Protocol Violation|0|||
156846429|NCT04775953|566191561|FG000|Overall Study|Participant non-compliance|0|||
156846430|NCT04775953|566191562|FG001|Overall Study|Participant non-compliance|1|||
156846431|NCT01698814|566191563|FG000|Overall Study|Adverse Event|0|||
156846432|NCT01698814|566191564|FG001|Overall Study|Adverse Event|2|||
156846433|NCT01698814|566191563|FG000|Overall Study|Lost to Follow-up|0|||
156846434|NCT01698814|566191564|FG001|Overall Study|Lost to Follow-up|1|||
156846435|NCT01698814|566191563|FG000|Overall Study|Pregnancy|1|||
156846436|NCT01698814|566191564|FG001|Overall Study|Pregnancy|0|||
156846437|NCT01698814|566191563|FG000|Overall Study|Randomized in error|1|||
156846438|NCT01698814|566191564|FG001|Overall Study|Randomized in error|0|||
156846439|NCT00368641|566191567|FG000|Overall Study|Adverse Event|2|||
156846440|NCT00368641|566191568|FG001|Overall Study|Adverse Event|1|||
156846441|NCT00368641|566191567|FG000|Overall Study|Death|1|||
156846442|NCT00368641|566191568|FG001|Overall Study|Death|0|||
156846443|NCT00368641|566191567|FG000|Overall Study|Withdrawal by Subject|1|||
156846444|NCT00368641|566191568|FG001|Overall Study|Withdrawal by Subject|0|||
156846445|NCT00368641|566191567|FG000|Overall Study|Sponsor decision to terminate study|2|||
156846446|NCT00368641|566191568|FG001|Overall Study|Sponsor decision to terminate study|5|||
156846447|NCT01424501|566191569|FG000|Overall Study|Withdrawal by Subject|1|||
156846448|NCT01424501|566191570|FG001|Overall Study|Withdrawal by Subject|0|||
156846449|NCT01424501|566191571|FG002|Overall Study|Withdrawal by Subject|1|||
156846450|NCT01424501|566191572|FG003|Overall Study|Withdrawal by Subject|0|||
156846451|NCT01424501|566191573|FG004|Overall Study|Withdrawal by Subject|0|||
156846452|NCT01424501|566191574|FG005|Overall Study|Withdrawal by Subject|0|||
156846453|NCT01424501|566191569|FG000|Overall Study|Lost to Follow-up|0|||
156846454|NCT01424501|566191570|FG001|Overall Study|Lost to Follow-up|1|||
156846455|NCT01424501|566191571|FG002|Overall Study|Lost to Follow-up|1|||
156846456|NCT01424501|566191572|FG003|Overall Study|Lost to Follow-up|0|||
156846457|NCT01424501|566191573|FG004|Overall Study|Lost to Follow-up|0|||
156846458|NCT01424501|566191574|FG005|Overall Study|Lost to Follow-up|0|||
156846459|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
156846460|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156846461|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156541525|NCT04707157|565075442|FG001|Overall Study|Protocol Deviation|0|||
156846462|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156846463|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156846464|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
156846465|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156846466|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156846467|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156846468|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156846469|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
156541526|NCT04707157|565075441|FG000|Overall Study|Withdrawal by Subject|1|||
156846470|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156846471|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156846472|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156846473|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156846474|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
156846475|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156846476|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156846477|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156846478|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156846479|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
156846480|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156846481|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156846482|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156846483|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156846484|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
156846485|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156846486|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156846487|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156846488|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156846489|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
156846490|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156846491|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156846492|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156846493|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156846494|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
156846495|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
156846496|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
156846497|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
156846498|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
156846499|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
156470171|NCT04801420|564814948|FG001|Overall Study|Withdrawal by Subject|1|||
156470172|NCT04801420|564814949|FG002|Overall Study|Withdrawal by Subject|4|||
156470173|NCT04801420|564814947|FG000|Overall Study|Individual stopping criteria reached|0|||
156470174|NCT04801420|564814948|FG001|Overall Study|Individual stopping criteria reached|1|||
156846500|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
156846501|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
156846502|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
156470175|NCT04801420|564814949|FG002|Overall Study|Individual stopping criteria reached|0|||
156846503|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
156846504|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
156846505|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
156846506|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
156846507|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
156846508|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
156846509|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156846510|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
156846511|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156846512|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
156846513|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
156846514|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
156846515|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
156846516|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
156846517|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
156846518|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
156846519|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
156846520|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
156846521|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
156846522|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
156846523|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
156846524|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156846525|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156846526|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156846527|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
156846528|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
156846529|NCT01980095|566191580|FG000|Overall Study|Lost to Follow-up|6|||
156846530|NCT01980095|566191581|FG001|Overall Study|Lost to Follow-up|7|||
156846531|NCT01980095|566191580|FG000|Overall Study|Withdrawal by Subject|2|||
156846532|NCT01980095|566191581|FG001|Overall Study|Withdrawal by Subject|3|||
156846533|NCT01980095|566191580|FG000|Overall Study|Poor compliance|5|||
156846534|NCT01980095|566191581|FG001|Overall Study|Poor compliance|0|||
156846535|NCT01980095|566191580|FG000|Overall Study|Safety issue|0|||
156846536|NCT01980095|566191581|FG001|Overall Study|Safety issue|1|||
156846537|NCT01980095|566191580|FG000|Overall Study|Study drug discontinued|1|||
156846538|NCT01980095|566191581|FG001|Overall Study|Study drug discontinued|0|||
156846539|NCT01980095|566191580|FG000|Overall Study|Randomized by mistake|1|||
156846540|NCT01980095|566191581|FG001|Overall Study|Randomized by mistake|0|||
156846541|NCT01449006|566191583|FG000|Overall Study|Lost to Follow-up|1|||
156846542|NCT01449006|566191584|FG001|Overall Study|Lost to Follow-up|0|||
156846543|NCT01449006|566191583|FG000|Overall Study|Withdrawal by Subject|1|||
156846544|NCT01449006|566191584|FG001|Overall Study|Withdrawal by Subject|0|||
156846545|NCT01449006|566191583|FG000|Overall Study|Protocol Violation|1|||
156846546|NCT01449006|566191584|FG001|Overall Study|Protocol Violation|0|||
156846547|NCT01746368|566191586|FG000|Overall Study|Lost to Follow-up|2|||
156846548|NCT01746368|566191587|FG001|Overall Study|Lost to Follow-up|0|||
156846549|NCT01746368|566191586|FG000|Overall Study|Withdrawal by Subject|0|||
156846550|NCT01746368|566191587|FG001|Overall Study|Withdrawal by Subject|1|||
156846551|NCT05636852|566191588|FG000|Overall Study|Withdrawal by Subject|1|||
156846552|NCT05636852|566191588|FG000|Overall Study|Other than specified|1|||
156846553|NCT02221674|566191591|FG000|Overall Study|Lost to Follow-up|1|||
156846554|NCT02221674|566191592|FG001|Overall Study|Lost to Follow-up|0|||
156470176|NCT04801420|564814947|FG000|Overall Study|Ongoing in the study|195|||
156846555|NCT02221674|566191593|FG002|Overall Study|Lost to Follow-up|0|||
156846556|NCT04390880|566191594|FG000|Overall Study|Withdrawal by Subject|1|||
156846557|NCT02557542|566191595|FG000|Overall Study|Poor recruitment|3|||
156846558|NCT02557542|566191596|FG001|Overall Study|Poor recruitment|0|||
156846559|NCT04698993|566191601|FG000|Overall Study|PCR results not accessible|2|||
156846560|NCT04698993|566191602|FG001|Overall Study|PCR results not accessible|7|||
156846561|NCT04698993|566191601|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
156846562|NCT04698993|566191602|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
156846563|NCT00958165|566191603|FG000|Overall Study|Lost to Follow-up|5|||
156470177|NCT04801420|564814948|FG001|Overall Study|Ongoing in the study|195|||
156846564|NCT00958165|566191603|FG000|Overall Study|Not eligible|9|||
156846565|NCT01371734|566191604|FG000|Overall Study|Other|2|||
156846566|NCT01371734|566191605|FG001|Overall Study|Other|1|||
156846567|NCT01371734|566191606|FG002|Overall Study|Other|2|||
156846568|NCT01371734|566191604|FG000|Overall Study|Withdrawal by Subject|3|||
156846569|NCT01371734|566191605|FG001|Overall Study|Withdrawal by Subject|4|||
156846570|NCT01371734|566191606|FG002|Overall Study|Withdrawal by Subject|9|||
156846571|NCT01371734|566191604|FG000|Overall Study|Lost to Follow-up|5|||
156846572|NCT01371734|566191605|FG001|Overall Study|Lost to Follow-up|3|||
156846573|NCT01371734|566191606|FG002|Overall Study|Lost to Follow-up|1|||
156846574|NCT01371734|566191604|FG000|Overall Study|Protocol Violation|3|||
156846575|NCT01371734|566191605|FG001|Overall Study|Protocol Violation|1|||
156846576|NCT01371734|566191606|FG002|Overall Study|Protocol Violation|2|||
156846577|NCT01371734|566191604|FG000|Overall Study|Adverse Event|8|||
156846578|NCT01371734|566191605|FG001|Overall Study|Adverse Event|8|||
156846579|NCT01371734|566191606|FG002|Overall Study|Adverse Event|3|||
156846580|NCT01371734|566191604|FG000|Overall Study|Lack of Efficacy|2|||
156846581|NCT01371734|566191605|FG001|Overall Study|Lack of Efficacy|2|||
156846582|NCT01371734|566191606|FG002|Overall Study|Lack of Efficacy|0|||
156846583|NCT00206440|566191607|FG000|Overall Study|Protocol Violation|1|||
156846584|NCT00206440|566191608|FG001|Overall Study|Protocol Violation|2|||
156846585|NCT00206440|566191607|FG000|Overall Study|Adverse Event|4|||
156846586|NCT00206440|566191608|FG001|Overall Study|Adverse Event|2|||
156846587|NCT01298765|566191609|FG000|Titration Period|Adverse Event|26|||
156846588|NCT01298765|566191609|FG000|Titration Period|Death|1|||
156846589|NCT01298765|566191609|FG000|Titration Period|Lack of Efficacy|21|||
156846590|NCT01298765|566191609|FG000|Titration Period|Lost to Follow-up|9|||
156846591|NCT01298765|566191609|FG000|Titration Period|Physician Decision|1|||
156846592|NCT01298765|566191609|FG000|Titration Period|Withdrawal by Subject|10|||
156846593|NCT01298765|566191609|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
156846594|NCT01298765|566191609|FG000|Long-Term Treatment Period|Adverse Event|19|||
156846595|NCT01298765|566191609|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
156846596|NCT01298765|566191609|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
156846597|NCT01298765|566191609|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
156846598|NCT01298765|566191609|FG000|Long-Term Treatment Period|Physician Decision|1|||
156846599|NCT01298765|566191609|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
156846600|NCT03565237|566191613|FG000|Overall Study|Non-compliance of Investigational Product|1|||
156846601|NCT03565237|566191613|FG000|Overall Study|Physician Decision|1|||
156846602|NCT01140061|566191616|FG000|Part I|Adverse Event|1|||
156846603|NCT01140061|566191617|FG001|Part I|Adverse Event|0|||
156846604|NCT01140061|566191618|FG002|Part I|Adverse Event|0|||
156846605|NCT01140061|566191619|FG003|Part I|Adverse Event|0|||
156846606|NCT01140061|566191620|FG004|Part I|Adverse Event|0|||
156846607|NCT01140061|566191621|FG005|Part I|Adverse Event|0|||
156846608|NCT01140061|566191622|FG006|Part I|Adverse Event|0|||
156846609|NCT01140061|566191623|FG007|Part I|Adverse Event|0|||
156846610|NCT01140061|566191624|FG008|Part I|Adverse Event|0|||
156846611|NCT01140061|566191625|FG009|Part I|Adverse Event|0|||
156846612|NCT01140061|566191616|FG000|Extension|Laboratory Adverse Event|0|||
156846613|NCT01140061|566191617|FG001|Extension|Laboratory Adverse Event|0|||
156846614|NCT01140061|566191618|FG002|Extension|Laboratory Adverse Event|0|||
156846615|NCT01140061|566191619|FG003|Extension|Laboratory Adverse Event|0|||
156846616|NCT01140061|566191620|FG004|Extension|Laboratory Adverse Event|0|||
156846617|NCT01140061|566191621|FG005|Extension|Laboratory Adverse Event|0|||
156846618|NCT01140061|566191622|FG006|Extension|Laboratory Adverse Event|0|||
156846619|NCT01140061|566191623|FG007|Extension|Laboratory Adverse Event|0|||
156846620|NCT01140061|566191624|FG008|Extension|Laboratory Adverse Event|0|||
156846621|NCT01140061|566191625|FG009|Extension|Laboratory Adverse Event|1|||
156846622|NCT00428389|566191627|FG000|Core Phase|Adverse Event|6|||
156846623|NCT00428389|566191628|FG001|Core Phase|Adverse Event|4|||
156846624|NCT00428389|566191627|FG000|Core Phase|Lack of Efficacy|2|||
156846625|NCT00428389|566191628|FG001|Core Phase|Lack of Efficacy|0|||
156846626|NCT00428389|566191627|FG000|Core Phase|Abnormal test procedure result(s)|0|||
156846627|NCT00428389|566191628|FG001|Core Phase|Abnormal test procedure result(s)|1|||
156846628|NCT00428389|566191627|FG000|Core Phase|Withdrawal by Subject|3|||
156846629|NCT00428389|566191628|FG001|Core Phase|Withdrawal by Subject|4|||
156846630|NCT00428389|566191627|FG000|Core Phase|Protocol deviation|0|||
156846631|NCT00428389|566191628|FG001|Core Phase|Protocol deviation|2|||
156470178|NCT04801420|564814949|FG002|Overall Study|Ongoing in the study|192|||
156846632|NCT00428389|566191627|FG000|Extension Phase|Adverse Event|17|||
156846633|NCT00428389|566191628|FG001|Extension Phase|Adverse Event|11|||
156470179|NCT03598907|564814950|FG000|Overall Study|Physician Decision|14|||
156846634|NCT00428389|566191627|FG000|Extension Phase|Lack of Efficacy|4|||
156846635|NCT00428389|566191628|FG001|Extension Phase|Lack of Efficacy|3|||
156846636|NCT00428389|566191627|FG000|Extension Phase|Withdrawal by Subject|6|||
156846637|NCT00428389|566191628|FG001|Extension Phase|Withdrawal by Subject|6|||
156846638|NCT00428389|566191627|FG000|Extension Phase|Lost to Follow-up|0|||
156846639|NCT00428389|566191628|FG001|Extension Phase|Lost to Follow-up|3|||
156846640|NCT00428389|566191627|FG000|Extension Phase|Death|1|||
156846641|NCT00428389|566191628|FG001|Extension Phase|Death|0|||
156846642|NCT00428389|566191627|FG000|Extension Phase|Protocol Violation|3|||
156846643|NCT00428389|566191628|FG001|Extension Phase|Protocol Violation|2|||
156846644|NCT00428389|566191627|FG000|Extension Phase|Administrative problems|1|||
156846645|NCT00428389|566191628|FG001|Extension Phase|Administrative problems|1|||
156846646|NCT02669121|566191629|FG000|Overall Study|Adverse Event|4|||
156846647|NCT02669121|566191630|FG001|Overall Study|Adverse Event|5|||
156846648|NCT02669121|566191629|FG000|Overall Study|Lost to Follow-up|15|||
156846649|NCT02669121|566191630|FG001|Overall Study|Lost to Follow-up|27|||
156846650|NCT02669121|566191629|FG000|Overall Study|Withdrawal by Subject|132|||
156846651|NCT02669121|566191630|FG001|Overall Study|Withdrawal by Subject|140|||
156846652|NCT02669121|566191629|FG000|Overall Study|Pregnancy|0|||
156846653|NCT02669121|566191630|FG001|Overall Study|Pregnancy|1|||
156846654|NCT02669121|566191629|FG000|Overall Study|Discharged from US Military Active Service|117|||
156846655|NCT02669121|566191630|FG001|Overall Study|Discharged from US Military Active Service|91|||
156846656|NCT02669121|566191629|FG000|Overall Study|Reason not Specified|22|||
156846657|NCT02669121|566191630|FG001|Overall Study|Reason not Specified|18|||
156846658|NCT02708355|566191631|FG000|Overall Study|Adverse Event|1|||
156846659|NCT02708355|566191632|FG001|Overall Study|Adverse Event|0|||
156846660|NCT02708355|566191633|FG002|Overall Study|Adverse Event|0|||
156846661|NCT04384523|566191634|FG000|Overall Study|Lost to Follow-up|0|||
156846662|NCT04384523|566191635|FG001|Overall Study|Lost to Follow-up|0|||
156846663|NCT04384523|566191636|FG002|Overall Study|Lost to Follow-up|0|||
156846664|NCT04384523|566191637|FG003|Overall Study|Lost to Follow-up|0|||
156846665|NCT04384523|566191638|FG004|Overall Study|Lost to Follow-up|0|||
156846666|NCT04384523|566191639|FG005|Overall Study|Lost to Follow-up|1|||
156846667|NCT04384523|566191634|FG000|Overall Study|Protocol Violation|0|||
156846668|NCT04384523|566191635|FG001|Overall Study|Protocol Violation|1|||
156846669|NCT04384523|566191636|FG002|Overall Study|Protocol Violation|0|||
156846670|NCT04384523|566191637|FG003|Overall Study|Protocol Violation|0|||
156846671|NCT04384523|566191638|FG004|Overall Study|Protocol Violation|0|||
156846672|NCT04384523|566191639|FG005|Overall Study|Protocol Violation|0|||
156846673|NCT04384523|566191634|FG000|Overall Study|Withdrawal by Subject|1|||
156846674|NCT04384523|566191635|FG001|Overall Study|Withdrawal by Subject|0|||
156846675|NCT04384523|566191636|FG002|Overall Study|Withdrawal by Subject|0|||
156846676|NCT04384523|566191637|FG003|Overall Study|Withdrawal by Subject|0|||
156846677|NCT04384523|566191638|FG004|Overall Study|Withdrawal by Subject|0|||
156846678|NCT04384523|566191639|FG005|Overall Study|Withdrawal by Subject|0|||
156846679|NCT03216746|566191640|FG000|Overall Study|Lost to Follow-up|6|||
156846680|NCT03216746|566191641|FG001|Overall Study|Lost to Follow-up|8|||
156846681|NCT03216746|566191642|FG002|Overall Study|Lost to Follow-up|5|||
156846682|NCT03216746|566191643|FG003|Overall Study|Lost to Follow-up|6|||
156846683|NCT01320202|566191644|FG000|Overall Study|Adverse Event|5|||
156846684|NCT01320202|566191645|FG001|Overall Study|Adverse Event|5|||
156846685|NCT01320202|566191644|FG000|Overall Study|Death|5|||
156846686|NCT01320202|566191645|FG001|Overall Study|Death|3|||
156470180|NCT03598907|564814951|FG001|Overall Study|Physician Decision|19|||
156470181|NCT02078648|564814954|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
156470182|NCT02078648|564814955|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
156470183|NCT02078648|564814954|FG000|Overall Study|Adverse Event|0|||
156470184|NCT02078648|564814955|FG001|Overall Study|Adverse Event|1|||
156470185|NCT02078648|564814954|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
156470186|NCT02078648|564814955|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
156470187|NCT02078648|564814954|FG000|Overall Study|Withdrawal by Subject|3|||
156470188|NCT02078648|564814955|FG001|Overall Study|Withdrawal by Subject|1|||
156470189|NCT02078648|564814954|FG000|Overall Study|Investigator Decision|5|||
156470190|NCT02078648|564814955|FG001|Overall Study|Investigator Decision|7|||
156470191|NCT02078648|564814954|FG000|Overall Study|Death|1|||
156470192|NCT02078648|564814955|FG001|Overall Study|Death|1|||
156470193|NCT02078648|564814954|FG000|Overall Study|Undefined|0|||
156470194|NCT02078648|564814955|FG001|Overall Study|Undefined|1|||
156470195|NCT04088227|564814956|FG000|Overall Study|Withdrawal by Subject|1|||
156470196|NCT04088227|564814957|FG001|Overall Study|Withdrawal by Subject|0|||
156470197|NCT04088227|564814956|FG000|Overall Study|Surgery postponed >5weeks|1|||
156470198|NCT04088227|564814957|FG001|Overall Study|Surgery postponed >5weeks|0|||
156470199|NCT01855750|564814958|FG000|Overall Study|Death|78|||
156470200|NCT01855750|564814959|FG001|Overall Study|Death|78|||
156470201|NCT01855750|564814958|FG000|Overall Study|Lost to Follow-up|9|||
156470202|NCT01855750|564814959|FG001|Overall Study|Lost to Follow-up|23|||
156846687|NCT01320202|566191644|FG000|Overall Study|Lost to Follow-up|1|||
156846688|NCT01320202|566191645|FG001|Overall Study|Lost to Follow-up|0|||
156846689|NCT01320202|566191644|FG000|Overall Study|Physician Decision|3|||
156846690|NCT01320202|566191645|FG001|Overall Study|Physician Decision|1|||
156846691|NCT01320202|566191644|FG000|Overall Study|Protocol Violation|2|||
156846692|NCT01320202|566191645|FG001|Overall Study|Protocol Violation|1|||
156846693|NCT01320202|566191644|FG000|Overall Study|Withdrawal by Subject|10|||
156846694|NCT01320202|566191645|FG001|Overall Study|Withdrawal by Subject|3|||
156846695|NCT01320202|566191644|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
156846696|NCT01320202|566191645|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
156846697|NCT01320202|566191644|FG000|Overall Study|kidney transplant|1|||
156846698|NCT01320202|566191645|FG001|Overall Study|kidney transplant|2|||
156846699|NCT01320202|566191644|FG000|Overall Study|blood transfusion|1|||
156846700|NCT01320202|566191645|FG001|Overall Study|blood transfusion|7|||
156846701|NCT01320202|566191644|FG000|Overall Study|moved/changed dialysis|5|||
156846702|NCT01320202|566191645|FG001|Overall Study|moved/changed dialysis|2|||
156846703|NCT01320202|566191644|FG000|Overall Study|sponsor request|2|||
156846704|NCT01320202|566191645|FG001|Overall Study|sponsor request|0|||
156846705|NCT01320202|566191644|FG000|Overall Study|ineligible|3|||
156846706|NCT01320202|566191645|FG001|Overall Study|ineligible|0|||
156846707|NCT01320202|566191644|FG000|Overall Study|regained renal function|1|||
156846708|NCT01320202|566191645|FG001|Overall Study|regained renal function|0|||
156846709|NCT04090242|566191646|FG000|Overall Study|Withdrawal by Subject|1|||
156846710|NCT04090242|566191647|FG001|Overall Study|Withdrawal by Subject|0|||
156846711|NCT02687581|566191648|FG000|Overall Study|Withdrawal by Subject|1|||
156846712|NCT02687581|566191649|FG001|Overall Study|Withdrawal by Subject|0|||
156846713|NCT02687581|566191650|FG002|Overall Study|Withdrawal by Subject|0|||
156846714|NCT02687581|566191651|FG003|Overall Study|Withdrawal by Subject|1|||
156846715|NCT02687581|566191648|FG000|Overall Study|Lost to Follow-up|2|||
156846716|NCT02687581|566191649|FG001|Overall Study|Lost to Follow-up|2|||
156846717|NCT02687581|566191650|FG002|Overall Study|Lost to Follow-up|0|||
156846718|NCT02687581|566191651|FG003|Overall Study|Lost to Follow-up|0|||
156846719|NCT02687581|566191648|FG000|Overall Study|the device is too small for the patient.|1|||
156846720|NCT02687581|566191649|FG001|Overall Study|the device is too small for the patient.|0|||
156846721|NCT02687581|566191650|FG002|Overall Study|the device is too small for the patient.|0|||
156846722|NCT02687581|566191651|FG003|Overall Study|the device is too small for the patient.|0|||
156846723|NCT00835341|566191652|FG000|Overall Study|Lost to Follow-up|3|||
156846724|NCT00835341|566191653|FG001|Overall Study|Lost to Follow-up|12|||
156846725|NCT02513472|566191655|FG000|Overall Study|Radiological Disease Progression|45|||
156846726|NCT02513472|566191656|FG001|Overall Study|Radiological Disease Progression|57|||
156846727|NCT02513472|566191655|FG000|Overall Study|Clinical Disease Progression|5|||
156846728|NCT02513472|566191656|FG001|Overall Study|Clinical Disease Progression|13|||
156846729|NCT02513472|566191655|FG000|Overall Study|Adverse Event|8|||
156846730|NCT02513472|566191656|FG001|Overall Study|Adverse Event|11|||
156846731|NCT02513472|566191655|FG000|Overall Study|Withdrawal by Subject|0|||
156846732|NCT02513472|566191656|FG001|Overall Study|Withdrawal by Subject|4|||
156846733|NCT02513472|566191655|FG000|Overall Study|Subject Choice|2|||
156846734|NCT02513472|566191656|FG001|Overall Study|Subject Choice|7|||
156846735|NCT02513472|566191655|FG000|Overall Study|Treatment Completed as per Protocol|3|||
156846736|NCT02513472|566191656|FG001|Overall Study|Treatment Completed as per Protocol|3|||
156846737|NCT02513472|566191655|FG000|Overall Study|Other|3|||
156846738|NCT02513472|566191656|FG001|Overall Study|Other|6|||
156846739|NCT01098305|566191657|FG000|Overall Study|Lost to Follow-up|31|||
156846740|NCT01098305|566191658|FG001|Overall Study|Lost to Follow-up|33|||
156470203|NCT01855750|564814958|FG000|Overall Study|Withdrawal by Subject|35|||
156470204|NCT01855750|564814959|FG001|Overall Study|Withdrawal by Subject|28|||
156470205|NCT01855750|564814958|FG000|Overall Study|Sponsor ends the study|297|||
156470206|NCT01855750|564814959|FG001|Overall Study|Sponsor ends the study|290|||
156470207|NCT05379270|564814960|FG000|Overall Study|Withdrawal by Subject|1|||
156470208|NCT05379270|564814961|FG001|Overall Study|Withdrawal by Subject|1|||
156470209|NCT03160885|564814962|FG000|Initial Treatment Period|Not dosed|2|||
156470210|NCT03160885|564814963|FG001|Initial Treatment Period|Not dosed|0|||
156470211|NCT03160885|564814964|FG002|Initial Treatment Period|Not dosed|0|||
156470212|NCT03160885|564814965|FG003|Initial Treatment Period|Not dosed|0|||
156470213|NCT03160885|564814966|FG004|Initial Treatment Period|Not dosed|0|||
156470214|NCT03160885|564814967|FG005|Initial Treatment Period|Not dosed|0|||
156470215|NCT03160885|564814968|FG006|Initial Treatment Period|Not dosed|0|||
156470216|NCT03160885|564814962|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
156470217|NCT03160885|564814963|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
156470218|NCT03160885|564814964|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156470219|NCT03160885|564814965|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156470220|NCT03160885|564814966|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156470221|NCT03160885|564814967|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156470222|NCT03160885|564814968|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
156470223|NCT03160885|564814962|FG000|Open-label Treatment|Not dosed|0|||
156470224|NCT03160885|564814963|FG001|Open-label Treatment|Not dosed|0|||
156470225|NCT03160885|564814964|FG002|Open-label Treatment|Not dosed|0|||
156470226|NCT03160885|564814965|FG003|Open-label Treatment|Not dosed|0|||
156846741|NCT01711645|566191662|FG000|Overall Study|Withdrawal by Subject|8|||
156846742|NCT01711645|566191662|FG000|Overall Study|Lost to Follow-up|6|||
156846743|NCT01711645|566191662|FG000|Overall Study|Physician Decision|5|||
156341728|NCT03278873|564348627|FG002|Overall Study|Lost to Follow-up|2|||
156846744|NCT01746173|566191667|FG000|Overall Study|Disease Progression|2|||
156846745|NCT00172042|566191668|FG000|Overall Study|Adverse Event|27|||
156846746|NCT00172042|566191669|FG001|Overall Study|Adverse Event|13|||
156846747|NCT00172042|566191668|FG000|Overall Study|Abnormal laboratory value(s)|5|||
156846748|NCT00172042|566191669|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156846749|NCT00172042|566191668|FG000|Overall Study|Abnormal test procedure(s)|0|||
156846750|NCT00172042|566191669|FG001|Overall Study|Abnormal test procedure(s)|3|||
156846751|NCT00172042|566191668|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
156846752|NCT00172042|566191669|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
156846753|NCT00172042|566191668|FG000|Overall Study|Patient no longer requires study drug|10|||
156846754|NCT00172042|566191669|FG001|Overall Study|Patient no longer requires study drug|8|||
156341729|NCT03278873|564348628|FG003|Overall Study|Lost to Follow-up|0|||
156341730|NCT03278873|564348625|FG000|Overall Study|The patient decided to withdraw via email|1|||
156341731|NCT03278873|564348626|FG001|Overall Study|The patient decided to withdraw via email|0|||
156341732|NCT03278873|564348627|FG002|Overall Study|The patient decided to withdraw via email|0|||
156341733|NCT03278873|564348628|FG003|Overall Study|The patient decided to withdraw via email|0|||
156341734|NCT03278873|564348625|FG000|Overall Study|The patient was unresponsive to contact|0|||
156341735|NCT03278873|564348626|FG001|Overall Study|The patient was unresponsive to contact|0|||
156341736|NCT03278873|564348627|FG002|Overall Study|The patient was unresponsive to contact|0|||
156341737|NCT03278873|564348628|FG003|Overall Study|The patient was unresponsive to contact|4|||
156341738|NCT03278873|564348625|FG000|Overall Study|The patient wished to participate no longer|0|||
156341739|NCT03278873|564348626|FG001|Overall Study|The patient wished to participate no longer|1|||
156341740|NCT03278873|564348627|FG002|Overall Study|The patient wished to participate no longer|0|||
156341741|NCT03278873|564348628|FG003|Overall Study|The patient wished to participate no longer|0|||
156341742|NCT03278873|564348625|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
156341743|NCT03278873|564348626|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
156341744|NCT03278873|564348627|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
156341745|NCT03278873|564348628|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
156341746|NCT05243641|564348629|FG000|Overall Study|Adverse Event|3|||
156341747|NCT05243641|564348630|FG001|Overall Study|Adverse Event|0|||
156341748|NCT05243641|564348631|FG002|Overall Study|Adverse Event|0|||
156341749|NCT05243641|564348632|FG003|Overall Study|Adverse Event|1|||
156341750|NCT05243641|564348633|FG004|Overall Study|Adverse Event|0|||
156341751|NCT05243641|564348634|FG005|Overall Study|Adverse Event|0|||
156341752|NCT05243641|564348629|FG000|Overall Study|Disease progression|4|||
156341753|NCT05243641|564348630|FG001|Overall Study|Disease progression|0|||
156341754|NCT05243641|564348631|FG002|Overall Study|Disease progression|0|||
156341755|NCT05243641|564348632|FG003|Overall Study|Disease progression|2|||
156341756|NCT05243641|564348633|FG004|Overall Study|Disease progression|0|||
156341757|NCT05243641|564348634|FG005|Overall Study|Disease progression|0|||
156341758|NCT00612690|564350241|FG000|Overall Study|Lost to Follow-up|72|||
156341759|NCT00612690|564350242|FG001|Overall Study|Lost to Follow-up|98|||
156341760|NCT00612690|564350241|FG000|Overall Study|Withdrawal by Subject|32|||
156341761|NCT00612690|564350242|FG001|Overall Study|Withdrawal by Subject|20|||
156341762|NCT00612690|564350241|FG000|Overall Study|Withdrawal by Site|11|||
156341763|NCT00612690|564350242|FG001|Overall Study|Withdrawal by Site|0|||
156341764|NCT02397278|564350247|FG000|Overall Study|Withdrawal by Subject|0|||
156341765|NCT02397278|564350248|FG001|Overall Study|Withdrawal by Subject|2|||
156341766|NCT02397278|564350247|FG000|Overall Study|Deemed ineligible following surgery|1|||
156341767|NCT02397278|564350248|FG001|Overall Study|Deemed ineligible following surgery|1|||
156341768|NCT02820753|564350258|FG000|2 Month|Withdrawal by Subject|3|||
156341769|NCT02820753|564350259|FG001|2 Month|Withdrawal by Subject|3|||
156341770|NCT02820753|564350258|FG000|2 Month|Lost to Follow-up|24|||
156470227|NCT03160885|564814966|FG004|Open-label Treatment|Not dosed|0|||
156470228|NCT03160885|564814967|FG005|Open-label Treatment|Not dosed|0|||
156341771|NCT02820753|564350259|FG001|2 Month|Lost to Follow-up|26|||
156846755|NCT00172042|566191668|FG000|Overall Study|Protocol Violation|8|||
156846756|NCT00172042|566191669|FG001|Overall Study|Protocol Violation|7|||
156846757|NCT00172042|566191668|FG000|Overall Study|Withdrawal by Subject|37|||
156846758|NCT00172042|566191669|FG001|Overall Study|Withdrawal by Subject|25|||
156846759|NCT00172042|566191668|FG000|Overall Study|Lost to Follow-up|3|||
156846760|NCT00172042|566191669|FG001|Overall Study|Lost to Follow-up|5|||
156846761|NCT00172042|566191668|FG000|Overall Study|Administrative problems|13|||
156846762|NCT00172042|566191669|FG001|Overall Study|Administrative problems|10|||
156846763|NCT00172042|566191668|FG000|Overall Study|Death|42|||
156846764|NCT00172042|566191669|FG001|Overall Study|Death|42|||
156846765|NCT01278797|566191672|FG000|Period 1|Adverse Event|0|||
156846766|NCT01278797|566191673|FG001|Period 1|Adverse Event|1|||
156846767|NCT01278797|566191672|FG000|Period 1|Protocol Violation|1|||
156846768|NCT01278797|566191673|FG001|Period 1|Protocol Violation|0|||
156846769|NCT00588354|566191674|FG000|Baseline to 2 Weeks|Adverse Event|1|||
156846770|NCT00588354|566191675|FG001|Baseline to 2 Weeks|Adverse Event|0|||
156846771|NCT00588354|566191674|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
156846772|NCT00588354|566191675|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
156846773|NCT00588354|566191674|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
156846774|NCT00588354|566191675|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
156846775|NCT04522141|566191677|FG000|Overall Study|Withdrawal by Subject|1|||
156846776|NCT04522141|566191678|FG001|Overall Study|Withdrawal by Subject|0|||
156846777|NCT03052049|566191679|FG000|Overall Study|Withdrawal by Subject|2|||
156846778|NCT02328027|566191680|FG000|Overall Study|Withdrawal by Subject|0|||
156846779|NCT02328027|566191681|FG001|Overall Study|Withdrawal by Subject|1|||
156846780|NCT03304873|566191682|FG000|Overall Study|Lost to Follow-up|1|||
156846781|NCT03304873|566191683|FG001|Overall Study|Lost to Follow-up|8|||
156846782|NCT03319212|566191684|FG000|Overall Study|Discontinued as moving out of local area|0|||
156846783|NCT03319212|566191685|FG001|Overall Study|Discontinued as moving out of local area|1|||
156846784|NCT03319212|566191684|FG000|Overall Study|Adverse Event|2|||
156846785|NCT03319212|566191685|FG001|Overall Study|Adverse Event|2|||
156846786|NCT03319212|566191684|FG000|Overall Study|Withdrawal by Subject|0|||
156846787|NCT03319212|566191685|FG001|Overall Study|Withdrawal by Subject|1|||
156846788|NCT03319212|566191684|FG000|Overall Study|Lost to Follow-up|0|||
156846789|NCT03319212|566191685|FG001|Overall Study|Lost to Follow-up|1|||
156846790|NCT03319212|566191684|FG000|Overall Study|Physician Decision|1|||
156341772|NCT02820753|564350258|FG000|2 Month|Stopped per NIH Hold|51|||
156846791|NCT03319212|566191685|FG001|Overall Study|Physician Decision|0|||
156846792|NCT00400569|566191689|FG000|Overall Study|Death|1|||
156846793|NCT00620113|566191690|FG000|Overall Study|Adverse Event|3|||
156846794|NCT00620113|566191691|FG001|Overall Study|Adverse Event|2|||
156846795|NCT00620113|566191692|FG002|Overall Study|Adverse Event|2|||
156846796|NCT00620113|566191693|FG003|Overall Study|Adverse Event|1|||
156846797|NCT00620113|566191690|FG000|Overall Study|Lack of Efficacy|2|||
156846798|NCT00620113|566191691|FG001|Overall Study|Lack of Efficacy|3|||
156846799|NCT00620113|566191692|FG002|Overall Study|Lack of Efficacy|0|||
156846800|NCT00620113|566191693|FG003|Overall Study|Lack of Efficacy|2|||
156341773|NCT02820753|564350259|FG001|2 Month|Stopped per NIH Hold|13|||
156341774|NCT02820753|564350258|FG000|6 Month|Withdrawal by Subject|2|||
156341775|NCT02820753|564350259|FG001|6 Month|Withdrawal by Subject|2|||
156341776|NCT02820753|564350258|FG000|6 Month|Lost to Follow-up|20|||
156341777|NCT02820753|564350259|FG001|6 Month|Lost to Follow-up|27|||
156341778|NCT02820753|564350258|FG000|6 Month|Stopped per NIH Hold|81|||
156846801|NCT00620113|566191690|FG000|Overall Study|Physician Decision|1|||
156846802|NCT00620113|566191691|FG001|Overall Study|Physician Decision|0|||
156846803|NCT00620113|566191692|FG002|Overall Study|Physician Decision|0|||
156846804|NCT00620113|566191693|FG003|Overall Study|Physician Decision|2|||
156846805|NCT00620113|566191690|FG000|Overall Study|Protocol Violation|2|||
156846806|NCT00620113|566191691|FG001|Overall Study|Protocol Violation|1|||
156846807|NCT00620113|566191692|FG002|Overall Study|Protocol Violation|0|||
156846808|NCT00620113|566191693|FG003|Overall Study|Protocol Violation|0|||
156846809|NCT00620113|566191690|FG000|Overall Study|Withdrawal by Subject|5|||
156846810|NCT00620113|566191691|FG001|Overall Study|Withdrawal by Subject|1|||
156846811|NCT00620113|566191692|FG002|Overall Study|Withdrawal by Subject|3|||
156846812|NCT00620113|566191693|FG003|Overall Study|Withdrawal by Subject|5|||
156846813|NCT03193736|566191694|FG000|Overall Study|Death|2|||
156846814|NCT03193736|566191694|FG000|Overall Study|Withdrawal by Subject|1|||
156846815|NCT03193736|566191694|FG000|Overall Study|Lost to Follow-up|1|||
156846816|NCT03193736|566191694|FG000|Overall Study|implant not received|1|||
156846817|NCT00852241|566191695|FG000|Overall Study|Physician Decision|18|||
156846818|NCT03848949|566191696|FG000|Overall Study|Lost to Follow-up|5|||
156846819|NCT03848949|566191697|FG001|Overall Study|Lost to Follow-up|7|||
156846820|NCT00264537|566191715|FG000|Overall Study|Death|0|||
156846821|NCT00264537|566191716|FG001|Overall Study|Death|3|||
156846822|NCT00264537|566191717|FG002|Overall Study|Death|3|||
156846823|NCT00264537|566191718|FG003|Overall Study|Death|2|||
156846824|NCT00264537|566191715|FG000|Overall Study|Lost to Follow-up|3|||
156846825|NCT00264537|566191716|FG001|Overall Study|Lost to Follow-up|4|||
156846826|NCT00264537|566191717|FG002|Overall Study|Lost to Follow-up|7|||
156846827|NCT00264537|566191718|FG003|Overall Study|Lost to Follow-up|6|||
156846828|NCT00264537|566191715|FG000|Overall Study|Adverse Event|21|||
156846829|NCT00264537|566191716|FG001|Overall Study|Adverse Event|32|||
156846830|NCT00264537|566191717|FG002|Overall Study|Adverse Event|24|||
156846831|NCT00264537|566191718|FG003|Overall Study|Adverse Event|34|||
156846832|NCT00264537|566191715|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
156846833|NCT00264537|566191716|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156846834|NCT00264537|566191717|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
156846835|NCT00264537|566191718|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
156846836|NCT00264537|566191715|FG000|Overall Study|Other|21|||
156846837|NCT00264537|566191716|FG001|Overall Study|Other|11|||
156846838|NCT00264537|566191717|FG002|Overall Study|Other|10|||
156846839|NCT00264537|566191718|FG003|Overall Study|Other|11|||
156846840|NCT00264537|566191715|FG000|Overall Study|Not treated|0|||
156846841|NCT00264537|566191716|FG001|Overall Study|Not treated|2|||
156846842|NCT00264537|566191717|FG002|Overall Study|Not treated|1|||
156846843|NCT00264537|566191718|FG003|Overall Study|Not treated|0|||
156846844|NCT02476006|566191719|FG000|Overall Study|Death|4|||
156846845|NCT02476006|566191719|FG000|Overall Study|Lack of treatment efficacy|2|||
156846846|NCT02476006|566191719|FG000|Overall Study|Pregnancy|1|||
156846847|NCT02476006|566191719|FG000|Overall Study|Participant did not wish to continue|39|||
156846848|NCT02476006|566191719|FG000|Overall Study|Adverse Event|41|||
156846849|NCT02476006|566191719|FG000|Overall Study|Poor compliance to study protocol|3|||
156846850|NCT02476006|566191719|FG000|Overall Study|Sponsor decision|6|||
156846851|NCT02476006|566191719|FG000|Overall Study|Lost to Follow-up|5|||
156846852|NCT02476006|566191719|FG000|Overall Study|Physician Decision|5|||
156846853|NCT02476006|566191719|FG000|Overall Study|Study ended treatment not available|4|||
156846854|NCT02476006|566191719|FG000|Overall Study|Switched to commercial drug|4|||
156846855|NCT02476006|566191719|FG000|Overall Study|Excluded from study|1|||
156341779|NCT02820753|564350259|FG001|6 Month|Stopped per NIH Hold|81|||
156341780|NCT02820753|564350258|FG000|6 Month|Death|0|||
156846856|NCT02476006|566191719|FG000|Overall Study|Protocol Violation|1|||
156846857|NCT02476006|566191719|FG000|Overall Study|Enrolled but not treated|4|||
156846858|NCT04306510|566192981|FG000|Overall Study|Voluntarily withdrawal|1|||
156846859|NCT04306510|566192981|FG000|Overall Study|Enrolled but Not Treated|1|||
156846860|NCT02751580|566192982|FG000|Overall Study|Lost to Follow-up|4|||
156846861|NCT02751580|566192982|FG000|Overall Study|Death|2|||
156846862|NCT03755882|566192989|FG000|Period 1|Protocol Violation|1|||
156846863|NCT03755882|566192990|FG001|Period 1|Protocol Violation|0|||
156846864|NCT03755882|566192989|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
156341781|NCT02820753|564350259|FG001|6 Month|Death|1|||
156846865|NCT03755882|566192990|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
156846866|NCT00108862|566192992|FG000|Overall Study|Death|31|||
156846867|NCT00108862|566192993|FG001|Overall Study|Death|37|||
156846868|NCT00108862|566192992|FG000|Overall Study|Withdrawal by Subject|10|||
156341782|NCT01397084|564350260|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
156341783|NCT01397084|564350260|FG000|Overall Study|Protocol Violation|2|||
156846869|NCT00108862|566192993|FG001|Overall Study|Withdrawal by Subject|6|||
156846870|NCT00108862|566192992|FG000|Overall Study|Lost to Follow-up|27|||
156846871|NCT00108862|566192993|FG001|Overall Study|Lost to Follow-up|19|||
156846872|NCT01076036|566192995|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
156846873|NCT05292131|566192996|FG000|Overall Study|Lost to Follow-up|1|||
156846874|NCT05292131|566192997|FG001|Overall Study|Lost to Follow-up|1|||
156846875|NCT05292131|566192996|FG000|Overall Study|Withdrawal by Subject|0|||
156846876|NCT05292131|566192997|FG001|Overall Study|Withdrawal by Subject|1|||
156846877|NCT00195091|566192998|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
156846878|NCT01345188|566192999|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
156846879|NCT01345188|566192999|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
156846880|NCT00475709|566193005|FG000|Overall Study|Did not meet eligibility criteria|8|||
156846881|NCT00475709|566193005|FG000|Overall Study|Death|41|||
156846882|NCT00475709|566193005|FG000|Overall Study|Device Explant|6|||
156846883|NCT00475709|566193005|FG000|Overall Study|Lost to Follow-up|21|||
156846884|NCT04752358|566193006|FG000|Overall Study|Death|2|||
156846885|NCT04752358|566193007|FG001|Overall Study|Death|1|||
156470229|NCT03160885|564814968|FG006|Open-label Treatment|Not dosed|2|||
156470230|NCT03160885|564814962|FG000|Open-label Treatment|Discontinued IMP|0|||
156470231|NCT03160885|564814963|FG001|Open-label Treatment|Discontinued IMP|0|||
156470232|NCT03160885|564814964|FG002|Open-label Treatment|Discontinued IMP|0|||
156470233|NCT03160885|564814965|FG003|Open-label Treatment|Discontinued IMP|0|||
156470234|NCT03160885|564814966|FG004|Open-label Treatment|Discontinued IMP|0|||
156470235|NCT03160885|564814967|FG005|Open-label Treatment|Discontinued IMP|0|||
156470236|NCT03160885|564814968|FG006|Open-label Treatment|Discontinued IMP|131|||
156846886|NCT00555672|566193010|FG000|Overall Study|Death|0|||
156846887|NCT00555672|566193011|FG001|Overall Study|Death|2|||
156846888|NCT00555672|566193010|FG000|Overall Study|Adverse Event|8|||
156846889|NCT00555672|566193011|FG001|Overall Study|Adverse Event|2|||
156470237|NCT03160885|564814962|FG000|Open-label Treatment|Completed Week 50|0|||
156470238|NCT03160885|564814963|FG001|Open-label Treatment|Completed Week 50|0|||
156470239|NCT03160885|564814964|FG002|Open-label Treatment|Completed Week 50|0|||
156846890|NCT00555672|566193010|FG000|Overall Study|Objective progression or relapse|11|||
156846891|NCT00555672|566193011|FG001|Overall Study|Objective progression or relapse|5|||
156846892|NCT00555672|566193010|FG000|Overall Study|Other|3|||
156470240|NCT03160885|564814965|FG003|Open-label Treatment|Completed Week 50|0|||
156470241|NCT03160885|564814966|FG004|Open-label Treatment|Completed Week 50|0|||
156846893|NCT00555672|566193011|FG001|Overall Study|Other|1|||
156846894|NCT00555672|566193010|FG000|Overall Study|Participant refused|2|||
156846895|NCT00555672|566193011|FG001|Overall Study|Participant refused|0|||
156846896|NCT04526145|566193012|FG000|Overall Study|Withdrawal by Subject|5|||
156846897|NCT03364738|566193017|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
156846898|NCT03364738|566193017|FG000|Overall Study|Withdrawal by Subject|1|||
156846899|NCT03364738|566193017|FG000|Overall Study|Adverse Event|1|||
156846900|NCT03245398|566193018|FG000|Overall Study|Travelled to another island|1|||
156846901|NCT03245398|566193019|FG001|Overall Study|Travelled to another island|0|||
156846902|NCT02576795|566193022|FG000|Overall Study|Lost to Follow-up|0|||
156846903|NCT02576795|566193023|FG001|Overall Study|Lost to Follow-up|0|||
156846904|NCT02576795|566193024|FG002|Overall Study|Lost to Follow-up|1|||
156846905|NCT02576795|566193025|FG003|Overall Study|Lost to Follow-up|0|||
156846906|NCT01702246|566193026|FG000|Overall Study|Lost to Follow-up|2|||
156846907|NCT01702246|566193026|FG000|Overall Study|Withdrawal by Subject|2|||
156846908|NCT01702246|566193026|FG000|Overall Study|Physician Decision|1|||
156846909|NCT01518374|566193027|FG000|Overall Study|Withdrawal by Subject|2|||
156846910|NCT01518374|566193027|FG000|Overall Study|Protocol Violation|3|||
156846911|NCT01518374|566193027|FG000|Overall Study|Lost to Follow-up|2|||
156846912|NCT02123823|566193028|FG000|Overall Study|Lack of Efficacy|0|||
156846913|NCT02123823|566193029|FG001|Overall Study|Lack of Efficacy|2|||
156846914|NCT02123823|566193030|FG002|Overall Study|Lack of Efficacy|8|||
156846915|NCT02123823|566193031|FG003|Overall Study|Lack of Efficacy|10|||
156846916|NCT02123823|566193028|FG000|Overall Study|Progressive disease|3|||
156846917|NCT02123823|566193029|FG001|Overall Study|Progressive disease|19|||
156846918|NCT02123823|566193030|FG002|Overall Study|Progressive disease|52|||
156846919|NCT02123823|566193031|FG003|Overall Study|Progressive disease|53|||
156846920|NCT02123823|566193028|FG000|Overall Study|Withdrawal by Subject|0|||
156846921|NCT02123823|566193029|FG001|Overall Study|Withdrawal by Subject|0|||
156846922|NCT02123823|566193030|FG002|Overall Study|Withdrawal by Subject|7|||
156846923|NCT02123823|566193031|FG003|Overall Study|Withdrawal by Subject|2|||
156846924|NCT02123823|566193028|FG000|Overall Study|Adverse Event|0|||
156846925|NCT02123823|566193029|FG001|Overall Study|Adverse Event|0|||
156846926|NCT02123823|566193030|FG002|Overall Study|Adverse Event|3|||
156846927|NCT02123823|566193031|FG003|Overall Study|Adverse Event|5|||
156846928|NCT02023996|566193041|FG000|Overall Study|Protocol Violation|6|||
156846929|NCT00465452|566193042|FG000|Overall Study|Adverse Event|1|||
156846930|NCT01635855|566193076|FG000|Overall Study|Withdrawal by Subject|4|||
156846931|NCT03828019|566193080|FG000|Overall Study|Withdrawal by Subject|3|||
156846932|NCT03828019|566193081|FG001|Overall Study|Withdrawal by Subject|8|||
156846933|NCT03828019|566193080|FG000|Overall Study|Lost to Follow-up|1|||
156846934|NCT03828019|566193081|FG001|Overall Study|Lost to Follow-up|6|||
156846935|NCT03828019|566193080|FG000|Overall Study|Incarcerated|1|||
156846936|NCT03828019|566193081|FG001|Overall Study|Incarcerated|0|||
156846937|NCT03828019|566193080|FG000|Overall Study|Adverse Event|0|||
156846938|NCT03828019|566193081|FG001|Overall Study|Adverse Event|1|||
156846939|NCT05715242|566193082|FG000|Overall Study|Lost to Follow-up|0|||
156846940|NCT05715242|566193083|FG001|Overall Study|Lost to Follow-up|0|||
156846941|NCT05715242|566193084|FG002|Overall Study|Lost to Follow-up|1|||
156846942|NCT05715242|566193085|FG003|Overall Study|Lost to Follow-up|0|||
156846943|NCT05715242|566193086|FG004|Overall Study|Lost to Follow-up|0|||
156846944|NCT05715242|566193087|FG005|Overall Study|Lost to Follow-up|1|||
156846945|NCT05715242|566193088|FG006|Overall Study|Lost to Follow-up|0|||
156846946|NCT05715242|566193089|FG007|Overall Study|Lost to Follow-up|0|||
156846947|NCT05715242|566193090|FG008|Overall Study|Lost to Follow-up|0|||
156846948|NCT05715242|566193091|FG009|Overall Study|Lost to Follow-up|0|||
156846949|NCT05715242|566193092|FG010|Overall Study|Lost to Follow-up|0|||
156846950|NCT05715242|566193093|FG011|Overall Study|Lost to Follow-up|0|||
156846951|NCT05715242|566193094|FG012|Overall Study|Lost to Follow-up|0|||
156846952|NCT05715242|566193095|FG013|Overall Study|Lost to Follow-up|0|||
156846953|NCT05715242|566193096|FG014|Overall Study|Lost to Follow-up|0|||
156846954|NCT05715242|566193097|FG015|Overall Study|Lost to Follow-up|0|||
156846955|NCT03400176|566193098|FG000|Dose Escalation|Progressive disease|1|||
156846956|NCT03400176|566193099|FG001|Dose Escalation|Progressive disease|1|||
156846957|NCT03400176|566193100|FG002|Dose Escalation|Progressive disease|0|||
156846958|NCT03400176|566193101|FG003|Dose Escalation|Progressive disease|0|||
156846959|NCT03400176|566193102|FG004|Dose Escalation|Progressive disease|1|||
156846960|NCT03400176|566193098|FG000|Dose Escalation|Patient decision|0|||
156846961|NCT03400176|566193099|FG001|Dose Escalation|Patient decision|0|||
156846962|NCT03400176|566193100|FG002|Dose Escalation|Patient decision|0|||
156846963|NCT03400176|566193101|FG003|Dose Escalation|Patient decision|0|||
156846964|NCT03400176|566193102|FG004|Dose Escalation|Patient decision|1|||
156846965|NCT03400176|566193098|FG000|Dose Expansion|Patient decision|0|||
156846966|NCT03400176|566193099|FG001|Dose Expansion|Patient decision|0|||
156846967|NCT03400176|566193100|FG002|Dose Expansion|Patient decision|0|||
156846968|NCT03400176|566193101|FG003|Dose Expansion|Patient decision|1|||
156846969|NCT03400176|566193102|FG004|Dose Expansion|Patient decision|0|||
156846970|NCT03400176|566193098|FG000|Dose Expansion|Adverse Event|0|||
156846971|NCT03400176|566193099|FG001|Dose Expansion|Adverse Event|0|||
156846972|NCT03400176|566193100|FG002|Dose Expansion|Adverse Event|0|||
156846973|NCT03400176|566193101|FG003|Dose Expansion|Adverse Event|1|||
156846974|NCT03400176|566193102|FG004|Dose Expansion|Adverse Event|0|||
156846975|NCT03400176|566193098|FG000|Dose Expansion|Physician Decision|0|||
156846976|NCT03400176|566193099|FG001|Dose Expansion|Physician Decision|0|||
156846977|NCT03400176|566193100|FG002|Dose Expansion|Physician Decision|0|||
156846978|NCT03400176|566193101|FG003|Dose Expansion|Physician Decision|1|||
156846979|NCT03400176|566193102|FG004|Dose Expansion|Physician Decision|0|||
156846980|NCT03400176|566193098|FG000|Dose Expansion|Progressive disease|0|||
156846981|NCT03400176|566193099|FG001|Dose Expansion|Progressive disease|0|||
156846982|NCT03400176|566193100|FG002|Dose Expansion|Progressive disease|1|||
156846983|NCT03400176|566193101|FG003|Dose Expansion|Progressive disease|1|||
156846984|NCT03400176|566193102|FG004|Dose Expansion|Progressive disease|0|||
156846985|NCT01090063|566193111|FG000|Screen|Screen Failed|4|||
156846986|NCT01090063|566193111|FG000|Treatment|Withdrawal by Subject|4|||
156846987|NCT00548145|566193112|FG000|Overall Study|Death|0|||
156846988|NCT00548145|566193113|FG001|Overall Study|Death|1|||
156846989|NCT00548145|566193112|FG000|Overall Study|Withdrawal by Subject|0|||
156846990|NCT00548145|566193113|FG001|Overall Study|Withdrawal by Subject|2|||
156846991|NCT00548145|566193112|FG000|Overall Study|Physician Decision|1|||
156846992|NCT00548145|566193113|FG001|Overall Study|Physician Decision|1|||
156846993|NCT00874848|566193114|FG000|Overall Study|Adverse Event|13|||
156846994|NCT00874848|566193115|FG001|Overall Study|Adverse Event|2|||
156846995|NCT00874848|566193114|FG000|Overall Study|Progressive neoplastic disease|38|||
156846996|NCT00874848|566193115|FG001|Overall Study|Progressive neoplastic disease|18|||
156846997|NCT00874848|566193114|FG000|Overall Study|Withdrawal by Subject|7|||
156846998|NCT00874848|566193115|FG001|Overall Study|Withdrawal by Subject|4|||
156846999|NCT00874848|566193114|FG000|Overall Study|Noncompliance|1|||
156847000|NCT00874848|566193115|FG001|Overall Study|Noncompliance|1|||
156847001|NCT00874848|566193114|FG000|Overall Study|Failure to comply with protocol|0|||
156847002|NCT00874848|566193115|FG001|Overall Study|Failure to comply with protocol|1|||
156847003|NCT00874848|566193114|FG000|Overall Study|Physician Decision|0|||
156847004|NCT00874848|566193115|FG001|Overall Study|Physician Decision|2|||
156847005|NCT01019369|566193120|FG000|Overall Study|Lost to Follow-up|10|||
156847006|NCT01019369|566193121|FG001|Overall Study|Lost to Follow-up|6|||
156847007|NCT01019369|566193120|FG000|Overall Study|Withdrawal by Subject|0|||
156847008|NCT01019369|566193121|FG001|Overall Study|Withdrawal by Subject|1|||
156847009|NCT04565951|566193122|FG000|Overall Study|Lost to Follow-up|66|||
156847010|NCT04565951|566193123|FG001|Overall Study|Lost to Follow-up|38|||
156847011|NCT04565951|566193122|FG000|Overall Study|Withdrawal by Subject|14|||
156847012|NCT04565951|566193123|FG001|Overall Study|Withdrawal by Subject|7|||
156847013|NCT04565951|566193122|FG000|Overall Study|Death|0|||
156847014|NCT04565951|566193123|FG001|Overall Study|Death|1|||
156847015|NCT04677504|566193125|FG000|Overall Study|Death|51|||
156847016|NCT04677504|566193126|FG001|Overall Study|Death|49|||
156847017|NCT04677504|566193125|FG000|Overall Study|Progressive Disease|1|||
156341784|NCT01397084|564350260|FG000|Overall Study|Adverse Event|2|||
156847018|NCT04677504|566193126|FG001|Overall Study|Progressive Disease|0|||
156847019|NCT04677504|566193125|FG000|Overall Study|Symptomatic Deterioration|1|||
156847020|NCT04677504|566193126|FG001|Overall Study|Symptomatic Deterioration|0|||
156847021|NCT04677504|566193125|FG000|Overall Study|Withdrawal by Subject|2|||
156847022|NCT04677504|566193126|FG001|Overall Study|Withdrawal by Subject|5|||
156847023|NCT04677504|566193125|FG000|Overall Study|Study Terminated By Sponsor|28|||
156847024|NCT04677504|566193126|FG001|Overall Study|Study Terminated By Sponsor|24|||
156847025|NCT04677504|566193125|FG000|Overall Study|Adverse Event|0|||
156847026|NCT04677504|566193126|FG001|Overall Study|Adverse Event|1|||
156847027|NCT03369236|566193127|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
156847028|NCT03369236|566193128|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
156847029|NCT03369236|566193127|FG000|Open-label Extension Period|Lack of Efficacy|2|||
156847030|NCT03369236|566193128|FG001|Open-label Extension Period|Lack of Efficacy|1|||
156847031|NCT03369236|566193127|FG000|Open-label Extension Period|Adverse Event|0|||
156847032|NCT03369236|566193128|FG001|Open-label Extension Period|Adverse Event|1|||
156847033|NCT03369236|566193127|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
156847034|NCT03369236|566193128|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
156847035|NCT00423449|566193129|FG000|Overall Study|Clinical Adverse Event|1|||
156847036|NCT00423449|566193130|FG001|Overall Study|Clinical Adverse Event|0|||
156847037|NCT00423449|566193131|FG002|Overall Study|Clinical Adverse Event|1|||
156847038|NCT00423449|566193132|FG003|Overall Study|Clinical Adverse Event|8|||
156847039|NCT00423449|566193133|FG004|Overall Study|Clinical Adverse Event|2|||
156847040|NCT00423449|566193129|FG000|Overall Study|Death|1|||
156847041|NCT00423449|566193130|FG001|Overall Study|Death|0|||
156847042|NCT00423449|566193131|FG002|Overall Study|Death|2|||
156847043|NCT00423449|566193132|FG003|Overall Study|Death|1|||
156847044|NCT00423449|566193133|FG004|Overall Study|Death|1|||
156847045|NCT00423449|566193129|FG000|Overall Study|Progressive Disease|1|||
156847046|NCT00423449|566193130|FG001|Overall Study|Progressive Disease|3|||
156847047|NCT00423449|566193131|FG002|Overall Study|Progressive Disease|8|||
156847048|NCT00423449|566193132|FG003|Overall Study|Progressive Disease|11|||
156847049|NCT00423449|566193133|FG004|Overall Study|Progressive Disease|4|||
156847050|NCT00423449|566193129|FG000|Overall Study|Laboratory Adverse Event|0|||
156847051|NCT00423449|566193130|FG001|Overall Study|Laboratory Adverse Event|1|||
156847052|NCT00423449|566193131|FG002|Overall Study|Laboratory Adverse Event|2|||
156847053|NCT00423449|566193132|FG003|Overall Study|Laboratory Adverse Event|0|||
156847054|NCT00423449|566193133|FG004|Overall Study|Laboratory Adverse Event|0|||
156847055|NCT00423449|566193129|FG000|Overall Study|Other|0|||
156847056|NCT00423449|566193130|FG001|Overall Study|Other|0|||
156847057|NCT00423449|566193131|FG002|Overall Study|Other|0|||
156847058|NCT00423449|566193132|FG003|Overall Study|Other|1|||
156847059|NCT00423449|566193133|FG004|Overall Study|Other|0|||
156847060|NCT00423449|566193129|FG000|Overall Study|Protocol Violation|0|||
156847061|NCT00423449|566193130|FG001|Overall Study|Protocol Violation|0|||
156847062|NCT00423449|566193131|FG002|Overall Study|Protocol Violation|2|||
156847063|NCT00423449|566193132|FG003|Overall Study|Protocol Violation|1|||
156847064|NCT00423449|566193133|FG004|Overall Study|Protocol Violation|0|||
156847065|NCT01153724|566193134|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156847066|NCT01153724|566193134|FG000|Treatment Period 2|Adverse Event|1|||
156847067|NCT01153724|566193134|FG000|Treatment Period 2|Other reason not defined above|1|||
156847068|NCT02697435|566193135|FG000|Overall Study|Withdrawal by Subject|1|||
156847069|NCT02697435|566193136|FG001|Overall Study|Withdrawal by Subject|0|||
156847070|NCT02697435|566193135|FG000|Overall Study|Physician Decision|0|||
156847071|NCT02697435|566193136|FG001|Overall Study|Physician Decision|4|||
156847072|NCT04371666|566193138|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
156847073|NCT04371666|566193139|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
156847074|NCT04371666|566193138|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
156847075|NCT04371666|566193139|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
156847076|NCT04371666|566193138|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
156847077|NCT04371666|566193139|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
156847078|NCT04371666|566193138|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
156847079|NCT04371666|566193139|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
156847080|NCT04371666|566193138|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
156847081|NCT04371666|566193139|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
156847082|NCT04371666|566193138|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
156847083|NCT04371666|566193139|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
156847084|NCT02092025|566193140|FG000|Overall Study|Case Report Forms Uncollected|44|||
156847085|NCT02092025|566193140|FG000|Overall Study|Protocol Deviation|24|||
156847086|NCT02927938|566193141|FG000|Overall Study|Death|0|||
156847087|NCT02927938|566193142|FG001|Overall Study|Death|1|||
156847088|NCT02927938|566193143|FG002|Overall Study|Death|0|||
156847089|NCT02927938|566193144|FG003|Overall Study|Death|4|||
156847090|NCT02927938|566193141|FG000|Overall Study|Early Study Termination|1|||
156847091|NCT02927938|566193142|FG001|Overall Study|Early Study Termination|5|||
156847092|NCT02927938|566193143|FG002|Overall Study|Early Study Termination|4|||
156847093|NCT02927938|566193144|FG003|Overall Study|Early Study Termination|3|||
156847094|NCT02834247|566193145|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
156847095|NCT02834247|566193146|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
156847096|NCT02834247|566193147|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
156847097|NCT02834247|566193148|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
156847098|NCT02834247|566193145|FG000|Dose Escalation Phase|Death|5|||
156341785|NCT01397084|564350260|FG000|Overall Study|Withdrawal by Subject|1|||
156341786|NCT01397084|564350260|FG000|Overall Study|Lost to Follow-up|1|||
156341787|NCT01397084|564350260|FG000|Overall Study|Used other proton pump inhibitor|1|||
156341788|NCT00004978|564350261|FG000|Overall Study|Death|107|||
156541527|NCT04707157|565075442|FG001|Overall Study|Withdrawal by Subject|1|||
156847099|NCT02834247|566193146|FG001|Dose Escalation Phase|Death|6|||
156847100|NCT02834247|566193147|FG002|Dose Escalation Phase|Death|5|||
156847101|NCT02834247|566193148|FG003|Dose Escalation Phase|Death|0|||
156847102|NCT02834247|566193145|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
156847103|NCT02834247|566193146|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
156847104|NCT02834247|566193147|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
156341789|NCT00004978|564350262|FG001|Overall Study|Death|116|||
156341790|NCT00004978|564350261|FG000|Overall Study|Lost to Follow-up|101|||
156341791|NCT00004978|564350262|FG001|Overall Study|Lost to Follow-up|108|||
156341792|NCT00004978|564350261|FG000|Overall Study|Withdrawal by Subject|17|||
156341793|NCT00004978|564350262|FG001|Overall Study|Withdrawal by Subject|26|||
156341794|NCT00004978|564350261|FG000|Overall Study|site closure - not in analysis cohort|19|||
156341795|NCT00004978|564350262|FG001|Overall Study|site closure - not in analysis cohort|20|||
156341796|NCT01342796|564350263|FG000|Overall Study|Withdrawal by Subject|2|||
156847105|NCT02834247|566193148|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
156847106|NCT02834247|566193145|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
156847107|NCT02834247|566193146|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
156847108|NCT02834247|566193147|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
156847109|NCT02834247|566193148|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156847110|NCT02834247|566193145|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
156847111|NCT02834247|566193146|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
156847112|NCT02834247|566193147|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
156847113|NCT02834247|566193148|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
156847114|NCT02834247|566193145|FG000|Dose Expansion Phase|Death|0|||
156847115|NCT02834247|566193146|FG001|Dose Expansion Phase|Death|0|||
156847116|NCT02834247|566193147|FG002|Dose Expansion Phase|Death|0|||
156847117|NCT02834247|566193148|FG003|Dose Expansion Phase|Death|8|||
156847118|NCT02834247|566193145|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
156847119|NCT02834247|566193146|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
156847120|NCT02834247|566193147|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
156847121|NCT02834247|566193148|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
156847122|NCT02834247|566193145|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
156847123|NCT02834247|566193146|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
156847124|NCT02834247|566193147|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
156847125|NCT02834247|566193148|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
156847126|NCT00811174|566193149|FG000|Overall Study|Protocol Violation|2|||
156847127|NCT00811174|566193149|FG000|Overall Study|Sponsors Decision|1|||
156847128|NCT04829916|566194689|FG000|Overall Study|Withdrawal by Subject|1|||
156847129|NCT04829916|566194690|FG001|Overall Study|Withdrawal by Subject|0|||
156847130|NCT04343755|566194692|FG000|Overall Study|Death|11|||
156847131|NCT04343755|566194692|FG000|Overall Study|Screen Failure|1|||
156847132|NCT03329846|566194697|FG000|Overall Study|Disease progression|4|||
156847133|NCT03329846|566194698|FG001|Overall Study|Disease progression|6|||
156847134|NCT03329846|566194697|FG000|Overall Study|Study drug toxicity|1|||
156847135|NCT03329846|566194698|FG001|Overall Study|Study drug toxicity|0|||
156847136|NCT03329846|566194697|FG000|Overall Study|Participant request to discontinue treatment|0|||
156847137|NCT03329846|566194698|FG001|Overall Study|Participant request to discontinue treatment|1|||
156847138|NCT03329846|566194697|FG000|Overall Study|Participant withdrew consent|1|||
156847139|NCT03329846|566194698|FG001|Overall Study|Participant withdrew consent|0|||
156847140|NCT03329846|566194697|FG000|Overall Study|Other reasons|2|||
156847141|NCT03329846|566194698|FG001|Overall Study|Other reasons|2|||
156847142|NCT02741596|566194699|FG000|Overall Study|Adverse Event|1|||
156847143|NCT02741596|566194700|FG001|Overall Study|Adverse Event|5|||
156847144|NCT02741596|566194699|FG000|Overall Study|Lost to Follow-up|1|||
156847145|NCT02741596|566194700|FG001|Overall Study|Lost to Follow-up|1|||
156847146|NCT02741596|566194699|FG000|Overall Study|Physician Decision|2|||
156847147|NCT02741596|566194700|FG001|Overall Study|Physician Decision|1|||
156341797|NCT01342796|564350264|FG001|Overall Study|Withdrawal by Subject|0|||
156541528|NCT04232553|565075443|FG000|Overall Study|Adverse Event|3|||
156847148|NCT02741596|566194699|FG000|Overall Study|Pregnancy|3|||
156847149|NCT02741596|566194700|FG001|Overall Study|Pregnancy|1|||
156847150|NCT02741596|566194699|FG000|Overall Study|Other (Unspecified)|0|||
156847151|NCT02741596|566194700|FG001|Overall Study|Other (Unspecified)|3|||
156847152|NCT02741596|566194699|FG000|Overall Study|Subject withdrawn-Other|17|||
156847153|NCT02741596|566194700|FG001|Overall Study|Subject withdrawn-Other|4|||
156847154|NCT02741596|566194699|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
156847155|NCT02741596|566194700|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
156847156|NCT02735343|566194703|FG000|Overall Study|screen fail|0|||
156847157|NCT02735343|566194704|FG001|Overall Study|screen fail|2|||
156847158|NCT04531241|566194707|FG000|Period 1|Withdrawal by Subject|2|||
156847159|NCT04531241|566194708|FG001|Period 1|Withdrawal by Subject|0|||
156847160|NCT04531241|566194707|FG000|Period 1|Dispesed incorrect lens power|1|||
156847161|NCT04531241|566194708|FG001|Period 1|Dispesed incorrect lens power|0|||
156847162|NCT04531241|566194707|FG000|Period 1|Protocol Violation|1|||
156847163|NCT04531241|566194708|FG001|Period 1|Protocol Violation|0|||
156341798|NCT01342796|564350263|FG000|Overall Study|Lost to Follow-up|0|||
156847164|NCT04531241|566194707|FG000|Period 1|No longer eligible|0|||
156847165|NCT04531241|566194708|FG001|Period 1|No longer eligible|1|||
156847166|NCT04531241|566194707|FG000|Period 1|Lens Discomfort|0|||
156847167|NCT04531241|566194708|FG001|Period 1|Lens Discomfort|1|||
156847168|NCT04531241|566194707|FG000|Period 2|Covid-19 Related|1|||
156341799|NCT01342796|564350264|FG001|Overall Study|Lost to Follow-up|3|||
156341800|NCT01342796|564350263|FG000|Overall Study|Inappropriate enrollment|1|||
156847169|NCT04531241|566194708|FG001|Period 2|Covid-19 Related|1|||
156847170|NCT02362464|566194709|FG000|Overall Study|Switched to alternative therapy|1|||
156847171|NCT02362464|566194709|FG000|Overall Study|Refused further treatment|1|||
156847172|NCT02362464|566194709|FG000|Overall Study|Physician Decision|4|||
156847173|NCT05870865|566194710|FG000|Randomized|Did not receive study treatment|2|||
156847174|NCT05870865|566194711|FG001|Randomized|Did not receive study treatment|4|||
156847175|NCT05870865|566194712|FG002|Randomized|Did not receive study treatment|4|||
156341801|NCT01342796|564350264|FG001|Overall Study|Inappropriate enrollment|0|||
156341802|NCT01396148|564350265|FG000|Overall Study|Patient Decision|1|||
156341803|NCT00224042|564350272|FG000|Overall Study|Adverse Event|2|||
156341804|NCT00224042|564350273|FG001|Overall Study|Adverse Event|1|||
156341805|NCT00224042|564350272|FG000|Overall Study|Protocol Violation|0|||
156341806|NCT00224042|564350273|FG001|Overall Study|Protocol Violation|1|||
156341807|NCT00224042|564350272|FG000|Overall Study|Physician Decision|0|||
156341808|NCT00224042|564350273|FG001|Overall Study|Physician Decision|1|||
156341809|NCT00224042|564350272|FG000|Overall Study|Did not meet lab incusion criteria|2|||
156341810|NCT00224042|564350273|FG001|Overall Study|Did not meet lab incusion criteria|3|||
156341811|NCT00224042|564350272|FG000|Overall Study|Other|2|||
156341812|NCT00224042|564350273|FG001|Overall Study|Other|0|||
156341813|NCT03052725|564350276|FG000|Overall Study|Adverse Event|2|||
156341814|NCT03052725|564350277|FG001|Overall Study|Adverse Event|0|||
156341815|NCT03052725|564350276|FG000|Overall Study|Withdrawal by Subject|3|||
156341816|NCT03052725|564350277|FG001|Overall Study|Withdrawal by Subject|4|||
156341817|NCT03052725|564350276|FG000|Overall Study|Pregnancy|0|||
156341818|NCT03052725|564350277|FG001|Overall Study|Pregnancy|1|||
156847176|NCT05870865|566194713|FG003|Randomized|Did not receive study treatment|3|||
156847177|NCT05870865|566194710|FG000|Treatment Period|Adverse Event|1|||
156341819|NCT03052725|564350276|FG000|Overall Study|Site closure|0|||
156847178|NCT05870865|566194711|FG001|Treatment Period|Adverse Event|1|||
156847179|NCT05870865|566194712|FG002|Treatment Period|Adverse Event|1|||
156847180|NCT05870865|566194713|FG003|Treatment Period|Adverse Event|1|||
156847181|NCT05870865|566194710|FG000|Treatment Period|Lost to Follow-up|0|||
156847182|NCT05870865|566194711|FG001|Treatment Period|Lost to Follow-up|1|||
156847183|NCT05870865|566194712|FG002|Treatment Period|Lost to Follow-up|2|||
156847184|NCT05870865|566194713|FG003|Treatment Period|Lost to Follow-up|0|||
156847185|NCT05870865|566194710|FG000|Treatment Period|Protocol Violation|0|||
156847186|NCT05870865|566194711|FG001|Treatment Period|Protocol Violation|0|||
156847187|NCT05870865|566194712|FG002|Treatment Period|Protocol Violation|0|||
156847188|NCT05870865|566194713|FG003|Treatment Period|Protocol Violation|1|||
156847189|NCT05870865|566194710|FG000|Treatment Period|Withdrawal by Subject|0|||
156847190|NCT05870865|566194711|FG001|Treatment Period|Withdrawal by Subject|1|||
156847191|NCT05870865|566194712|FG002|Treatment Period|Withdrawal by Subject|1|||
156847192|NCT05870865|566194713|FG003|Treatment Period|Withdrawal by Subject|1|||
156847193|NCT02104947|566194715|FG000|Overall Study|Withdrawal by Subject|10|||
156847194|NCT02104947|566194716|FG001|Overall Study|Withdrawal by Subject|3|||
156847195|NCT02104947|566194715|FG000|Overall Study|Lost to Follow-up|4|||
156847196|NCT02104947|566194716|FG001|Overall Study|Lost to Follow-up|4|||
156847197|NCT02104947|566194715|FG000|Overall Study|Protocol Violation|6|||
156847198|NCT02104947|566194716|FG001|Overall Study|Protocol Violation|8|||
156847199|NCT02104947|566194715|FG000|Overall Study|Adverse Event|57|||
156847200|NCT02104947|566194716|FG001|Overall Study|Adverse Event|38|||
156847201|NCT02104947|566194715|FG000|Overall Study|Other than stated above|2|||
156847202|NCT02104947|566194716|FG001|Overall Study|Other than stated above|3|||
156847203|NCT02863328|566194717|FG000|Overall Study|Lost to Follow-up|4|||
156847204|NCT02863328|566194718|FG001|Overall Study|Lost to Follow-up|10|||
156847205|NCT02863328|566194717|FG000|Overall Study|Withdrawal by Subject|7|||
156847206|NCT02863328|566194718|FG001|Overall Study|Withdrawal by Subject|12|||
156847207|NCT02863328|566194717|FG000|Overall Study|Died|0|||
156847208|NCT02863328|566194718|FG001|Overall Study|Died|1|||
156847209|NCT03301350|566194720|FG000|Overall Study|Withdrawal by Subject|4|||
156847210|NCT03301350|566194720|FG000|Overall Study|Adverse Event|1|||
156847211|NCT03301350|566194720|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
156847212|NCT03301350|566194720|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
156847213|NCT03301350|566194720|FG000|Overall Study|no detail provided|1|||
156847214|NCT00858637|566194721|FG000|Active Comparison Phase|Adverse Event|14|||
156847215|NCT00858637|566194722|FG001|Active Comparison Phase|Adverse Event|0|||
156847216|NCT00858637|566194723|FG002|Active Comparison Phase|Adverse Event|0|||
156847217|NCT00858637|566194724|FG003|Active Comparison Phase|Adverse Event|9|||
156341820|NCT03052725|564350277|FG001|Overall Study|Site closure|1|||
156847218|NCT00858637|566194725|FG004|Active Comparison Phase|Adverse Event|0|||
156341821|NCT03052725|564350276|FG000|Overall Study|Study terminated by sponsor|143|||
156341822|NCT03052725|564350277|FG001|Overall Study|Study terminated by sponsor|144|||
156341823|NCT01061177|564350279|FG000|Overall Study|Adverse Event|117|||
156341824|NCT01061177|564350279|FG000|Overall Study|Withdrawal by Subject|27|||
156847219|NCT00858637|566194726|FG005|Active Comparison Phase|Adverse Event|0|||
156847220|NCT00858637|566194721|FG000|Active Comparison Phase|Death|1|||
156847221|NCT00858637|566194722|FG001|Active Comparison Phase|Death|0|||
156847222|NCT00858637|566194723|FG002|Active Comparison Phase|Death|0|||
156847223|NCT00858637|566194724|FG003|Active Comparison Phase|Death|1|||
156847224|NCT00858637|566194725|FG004|Active Comparison Phase|Death|0|||
156847225|NCT00858637|566194726|FG005|Active Comparison Phase|Death|0|||
156847226|NCT00858637|566194721|FG000|Active Comparison Phase|Physician Decision|1|||
156847227|NCT00858637|566194722|FG001|Active Comparison Phase|Physician Decision|0|||
156847228|NCT00858637|566194723|FG002|Active Comparison Phase|Physician Decision|0|||
156847229|NCT00858637|566194724|FG003|Active Comparison Phase|Physician Decision|1|||
156847230|NCT00858637|566194725|FG004|Active Comparison Phase|Physician Decision|0|||
156847231|NCT00858637|566194726|FG005|Active Comparison Phase|Physician Decision|0|||
156847232|NCT00858637|566194721|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
156847233|NCT00858637|566194722|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
156847234|NCT00858637|566194723|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
156847235|NCT00858637|566194724|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
156847236|NCT00858637|566194725|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
156847237|NCT00858637|566194726|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
156847238|NCT00858637|566194721|FG000|Active Comparison Phase|Other Reasons|1|||
156847239|NCT00858637|566194722|FG001|Active Comparison Phase|Other Reasons|0|||
156847240|NCT00858637|566194723|FG002|Active Comparison Phase|Other Reasons|0|||
156847241|NCT00858637|566194724|FG003|Active Comparison Phase|Other Reasons|1|||
156847242|NCT00858637|566194725|FG004|Active Comparison Phase|Other Reasons|0|||
156847243|NCT00858637|566194726|FG005|Active Comparison Phase|Other Reasons|0|||
156847244|NCT00858637|566194721|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
156847245|NCT00858637|566194722|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
156847246|NCT00858637|566194723|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
156847247|NCT00858637|566194724|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
156847248|NCT00858637|566194725|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
156847249|NCT00858637|566194726|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
156847250|NCT00858637|566194721|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847251|NCT00858637|566194722|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847252|NCT00858637|566194723|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847253|NCT00858637|566194724|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847254|NCT00858637|566194725|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847255|NCT00858637|566194726|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
156847256|NCT02305238|566194727|FG000|Overall Study|Death|2|||
156847257|NCT02305238|566194728|FG001|Overall Study|Death|1|||
156847258|NCT02305238|566194729|FG002|Overall Study|Death|0|||
156847259|NCT02305238|566194727|FG000|Overall Study|Progressive disease|4|||
156847260|NCT02305238|566194728|FG001|Overall Study|Progressive disease|4|||
156847261|NCT02305238|566194729|FG002|Overall Study|Progressive disease|0|||
156847262|NCT02305238|566194727|FG000|Overall Study|Logistical difficulties|1|||
156847263|NCT02305238|566194728|FG001|Overall Study|Logistical difficulties|3|||
156847264|NCT02305238|566194729|FG002|Overall Study|Logistical difficulties|0|||
156847265|NCT02305238|566194727|FG000|Overall Study|Protocol Violation|0|||
156847266|NCT02305238|566194728|FG001|Overall Study|Protocol Violation|3|||
156847267|NCT02305238|566194729|FG002|Overall Study|Protocol Violation|0|||
156847268|NCT02305238|566194727|FG000|Overall Study|Physician Decision|2|||
156847269|NCT02305238|566194728|FG001|Overall Study|Physician Decision|1|||
156847270|NCT02305238|566194729|FG002|Overall Study|Physician Decision|0|||
156847271|NCT02305238|566194727|FG000|Overall Study|Adverse Event|4|||
156847272|NCT02305238|566194728|FG001|Overall Study|Adverse Event|2|||
156847273|NCT02305238|566194729|FG002|Overall Study|Adverse Event|0|||
156847274|NCT02305238|566194727|FG000|Overall Study|Withdrawal by Subject|3|||
156847275|NCT02305238|566194728|FG001|Overall Study|Withdrawal by Subject|4|||
156847276|NCT02305238|566194729|FG002|Overall Study|Withdrawal by Subject|0|||
156847277|NCT02305238|566194727|FG000|Overall Study|Randomized failure|0|||
156847278|NCT02305238|566194728|FG001|Overall Study|Randomized failure|0|||
156847279|NCT02305238|566194729|FG002|Overall Study|Randomized failure|8|||
156847280|NCT02305238|566194727|FG000|Overall Study|Required procedure failed|0|||
156847281|NCT02305238|566194728|FG001|Overall Study|Required procedure failed|1|||
156847282|NCT02305238|566194729|FG002|Overall Study|Required procedure failed|0|||
156847283|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
156847284|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
156847285|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
156847286|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Death|0|||
156847287|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Death|2|||
156847288|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Death|0|||
156847289|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
156847290|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
156847291|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
156847292|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
156847293|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
156847294|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
156847295|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
156847296|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
156847297|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
156847298|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
156847299|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
156847300|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
156847301|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
156847302|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
156847303|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
156847304|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Recovery|1|||
156847305|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Recovery|0|||
156847306|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Recovery|1|||
156847307|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
156847308|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
156847309|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
156847310|NCT00195663|566194730|FG000|Open-Label Extension Period|Adverse Event|21|||
156847311|NCT00195663|566194731|FG001|Open-Label Extension Period|Adverse Event|32|||
156847312|NCT00195663|566194732|FG002|Open-Label Extension Period|Adverse Event|36|||
156847313|NCT00195663|566194730|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
156847314|NCT00195663|566194731|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
156847315|NCT00195663|566194732|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
156847316|NCT00195663|566194730|FG000|Open-Label Extension Period|Recovery|0|||
156847317|NCT00195663|566194731|FG001|Open-Label Extension Period|Recovery|2|||
156847318|NCT00195663|566194732|FG002|Open-Label Extension Period|Recovery|2|||
156847319|NCT00195663|566194730|FG000|Open-Label Extension Period|Protocol Violation|3|||
156847320|NCT00195663|566194731|FG001|Open-Label Extension Period|Protocol Violation|4|||
156847321|NCT00195663|566194732|FG002|Open-Label Extension Period|Protocol Violation|4|||
156847322|NCT00195663|566194730|FG000|Open-Label Extension Period|Death|2|||
156847323|NCT00195663|566194731|FG001|Open-Label Extension Period|Death|2|||
156847324|NCT00195663|566194732|FG002|Open-Label Extension Period|Death|2|||
156847325|NCT00195663|566194730|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
156847326|NCT00195663|566194731|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
156847327|NCT00195663|566194732|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
156847328|NCT00195663|566194730|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
156847329|NCT00195663|566194731|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
156847330|NCT00195663|566194732|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
156847331|NCT00195663|566194730|FG000|Open-Label Extension Period|Administrative reasons|11|||
156847332|NCT00195663|566194731|FG001|Open-Label Extension Period|Administrative reasons|11|||
156847333|NCT00195663|566194732|FG002|Open-Label Extension Period|Administrative reasons|13|||
156847334|NCT01380834|566194733|FG000|Overall Study|Physician Decision|1|||
156847335|NCT01380834|566194734|FG001|Overall Study|Physician Decision|0|||
156847336|NCT03214406|566194735|FG000|Overall Study|did not meet enrollment criteria|9|||
156847337|NCT03214406|566194736|FG001|Overall Study|did not meet enrollment criteria|13|||
156847338|NCT03214406|566194735|FG000|Overall Study|Withdrawal by Subject|1|||
156847339|NCT03214406|566194736|FG001|Overall Study|Withdrawal by Subject|0|||
156847340|NCT03214406|566194735|FG000|Overall Study|Lost to Follow-up|0|||
156847341|NCT03214406|566194736|FG001|Overall Study|Lost to Follow-up|2|||
156847342|NCT00604695|566194737|FG000|Overall Study|Did not receive first bolus.|0|||
156847343|NCT00604695|566194738|FG001|Overall Study|Did not receive first bolus.|4|||
156847344|NCT03182907|566194748|FG000|Overall Study|Death|3|||
156847345|NCT03182907|566194749|FG001|Overall Study|Death|0|||
156847346|NCT03182907|566194748|FG000|Overall Study|Protocol Violation|4|||
156847347|NCT03182907|566194749|FG001|Overall Study|Protocol Violation|0|||
156847348|NCT03182907|566194748|FG000|Overall Study|Lost to Follow-up|1|||
156847349|NCT03182907|566194749|FG001|Overall Study|Lost to Follow-up|0|||
156847350|NCT03182907|566194748|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156847351|NCT03182907|566194749|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156847352|NCT00429169|566194750|FG000|Overall Study|Lost to Follow-up|0|||
156847353|NCT00429169|566194751|FG001|Overall Study|Lost to Follow-up|1|||
156847354|NCT00429169|566194750|FG000|Overall Study|Ineligibility discovered after entry|2|||
156847355|NCT00429169|566194751|FG001|Overall Study|Ineligibility discovered after entry|1|||
156847356|NCT00384332|566194756|FG000|Overall Study|Lost to Follow-up|4|||
156847357|NCT00384332|566194757|FG001|Overall Study|Lost to Follow-up|0|||
156847358|NCT01771250|566194758|FG000|Period 1|Met exclusion criteria|1|||
156847359|NCT01771250|566194759|FG001|Period 1|Met exclusion criteria|0|||
156847360|NCT02058563|566194760|FG000|Overall Study|Lost to Follow-up|26|||
156847361|NCT02058563|566194761|FG001|Overall Study|Lost to Follow-up|22|||
156847362|NCT02058563|566194760|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
156847363|NCT02058563|566194761|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
156847364|NCT02058563|566194760|FG000|Overall Study|Consent Withdrawal|1|||
156847365|NCT02058563|566194761|FG001|Overall Study|Consent Withdrawal|1|||
156847366|NCT02058563|566194760|FG000|Overall Study|Other (patient incarcerated)|0|||
156847367|NCT02058563|566194761|FG001|Overall Study|Other (patient incarcerated)|1|||
156847368|NCT01180296|566194762|FG000|Overall Study|Protocol Violation|1|||
156847369|NCT01180296|566194763|FG001|Overall Study|Protocol Violation|2|||
156847370|NCT00166439|566194764|FG000|Overall Study|Ineligible|5|||
156847371|NCT00483938|566194765|FG000|Overall Study|Protocol Violation|0|||
156847372|NCT00483938|566194766|FG001|Overall Study|Protocol Violation|0|||
156847373|NCT00483938|566194767|FG002|Overall Study|Protocol Violation|0|||
156847374|NCT00483938|566194768|FG003|Overall Study|Protocol Violation|0|||
156847375|NCT00483938|566194769|FG004|Overall Study|Protocol Violation|0|||
156847376|NCT00483938|566194770|FG005|Overall Study|Protocol Violation|0|||
156847377|NCT00483938|566194771|FG006|Overall Study|Protocol Violation|3|||
156847378|NCT00483938|566194765|FG000|Overall Study|Withdrawal by Subject|1|||
156847379|NCT00483938|566194766|FG001|Overall Study|Withdrawal by Subject|6|||
156847380|NCT00483938|566194767|FG002|Overall Study|Withdrawal by Subject|0|||
156847381|NCT00483938|566194768|FG003|Overall Study|Withdrawal by Subject|0|||
156847382|NCT00483938|566194769|FG004|Overall Study|Withdrawal by Subject|1|||
156847383|NCT00483938|566194770|FG005|Overall Study|Withdrawal by Subject|3|||
156847384|NCT00483938|566194771|FG006|Overall Study|Withdrawal by Subject|2|||
156847385|NCT00483938|566194765|FG000|Overall Study|Lost to Follow-up|1|||
156847386|NCT00483938|566194766|FG001|Overall Study|Lost to Follow-up|2|||
156847387|NCT00483938|566194767|FG002|Overall Study|Lost to Follow-up|0|||
156847388|NCT00483938|566194768|FG003|Overall Study|Lost to Follow-up|2|||
156847389|NCT00483938|566194769|FG004|Overall Study|Lost to Follow-up|1|||
156847390|NCT00483938|566194770|FG005|Overall Study|Lost to Follow-up|1|||
156847391|NCT00483938|566194771|FG006|Overall Study|Lost to Follow-up|3|||
156847392|NCT00483938|566194765|FG000|Overall Study|Death|0|||
156847393|NCT00483938|566194766|FG001|Overall Study|Death|2|||
156847394|NCT00483938|566194767|FG002|Overall Study|Death|0|||
156847395|NCT00483938|566194768|FG003|Overall Study|Death|0|||
156847396|NCT00483938|566194769|FG004|Overall Study|Death|0|||
156847397|NCT00483938|566194770|FG005|Overall Study|Death|0|||
156847398|NCT00483938|566194771|FG006|Overall Study|Death|0|||
156847399|NCT00483938|566194765|FG000|Overall Study|Other|3|||
156847400|NCT00483938|566194766|FG001|Overall Study|Other|9|||
156847401|NCT00483938|566194767|FG002|Overall Study|Other|0|||
156847402|NCT00483938|566194768|FG003|Overall Study|Other|4|||
156847403|NCT00483938|566194769|FG004|Overall Study|Other|0|||
156847404|NCT00483938|566194770|FG005|Overall Study|Other|4|||
156847405|NCT00483938|566194771|FG006|Overall Study|Other|32|||
156847406|NCT00106353|566194776|FG000|Part 1|Disease progression|3|||
156847407|NCT00106353|566194777|FG001|Part 1|Disease progression|4|||
156847408|NCT00106353|566194778|FG002|Part 1|Disease progression|1|||
156847409|NCT00106353|566194779|FG003|Part 1|Disease progression|3|||
156847410|NCT00106353|566194780|FG004|Part 1|Disease progression|0|||
156847411|NCT00106353|566194781|FG005|Part 1|Disease progression|0|||
156847412|NCT00106353|566194782|FG006|Part 1|Disease progression|0|||
156847413|NCT00106353|566194776|FG000|Part 1|Withdrawal by Subject|0|||
156847414|NCT00106353|566194777|FG001|Part 1|Withdrawal by Subject|0|||
156847415|NCT00106353|566194778|FG002|Part 1|Withdrawal by Subject|1|||
156847416|NCT00106353|566194779|FG003|Part 1|Withdrawal by Subject|2|||
156847417|NCT00106353|566194780|FG004|Part 1|Withdrawal by Subject|0|||
156847418|NCT00106353|566194781|FG005|Part 1|Withdrawal by Subject|0|||
156847419|NCT00106353|566194782|FG006|Part 1|Withdrawal by Subject|0|||
156847420|NCT00106353|566194776|FG000|Part 1|Symptomatic deterioration|0|||
156847421|NCT00106353|566194777|FG001|Part 1|Symptomatic deterioration|0|||
156847422|NCT00106353|566194778|FG002|Part 1|Symptomatic deterioration|1|||
156847423|NCT00106353|566194779|FG003|Part 1|Symptomatic deterioration|0|||
156847424|NCT00106353|566194780|FG004|Part 1|Symptomatic deterioration|0|||
156847425|NCT00106353|566194781|FG005|Part 1|Symptomatic deterioration|0|||
156847426|NCT00106353|566194782|FG006|Part 1|Symptomatic deterioration|0|||
156847427|NCT00106353|566194776|FG000|Part 1|Entered follow-up phase|1|||
156847428|NCT00106353|566194777|FG001|Part 1|Entered follow-up phase|1|||
156847429|NCT00106353|566194778|FG002|Part 1|Entered follow-up phase|0|||
156847430|NCT00106353|566194779|FG003|Part 1|Entered follow-up phase|1|||
156847431|NCT00106353|566194780|FG004|Part 1|Entered follow-up phase|0|||
156847432|NCT00106353|566194781|FG005|Part 1|Entered follow-up phase|0|||
156847433|NCT00106353|566194782|FG006|Part 1|Entered follow-up phase|0|||
156847434|NCT00106353|566194776|FG000|Part 1|Adverse Event|0|||
156847435|NCT00106353|566194777|FG001|Part 1|Adverse Event|0|||
156847436|NCT00106353|566194778|FG002|Part 1|Adverse Event|0|||
156847437|NCT00106353|566194779|FG003|Part 1|Adverse Event|1|||
156847438|NCT00106353|566194780|FG004|Part 1|Adverse Event|0|||
156847439|NCT00106353|566194781|FG005|Part 1|Adverse Event|0|||
156847440|NCT00106353|566194782|FG006|Part 1|Adverse Event|0|||
156847441|NCT00106353|566194776|FG000|Part 2|Disease progression|0|||
156847442|NCT00106353|566194777|FG001|Part 2|Disease progression|0|||
156847443|NCT00106353|566194778|FG002|Part 2|Disease progression|0|||
156847444|NCT00106353|566194779|FG003|Part 2|Disease progression|0|||
156847445|NCT00106353|566194780|FG004|Part 2|Disease progression|8|||
156847446|NCT00106353|566194781|FG005|Part 2|Disease progression|14|||
156847447|NCT00106353|566194782|FG006|Part 2|Disease progression|13|||
156847448|NCT00106353|566194776|FG000|Part 2|Death|0|||
156847449|NCT00106353|566194777|FG001|Part 2|Death|0|||
156847450|NCT00106353|566194778|FG002|Part 2|Death|0|||
156847451|NCT00106353|566194779|FG003|Part 2|Death|0|||
156847452|NCT00106353|566194780|FG004|Part 2|Death|3|||
156847453|NCT00106353|566194781|FG005|Part 2|Death|0|||
156847454|NCT00106353|566194782|FG006|Part 2|Death|1|||
156847455|NCT00106353|566194776|FG000|Part 2|Symptomatic deterioration|0|||
156847456|NCT00106353|566194777|FG001|Part 2|Symptomatic deterioration|0|||
156847457|NCT00106353|566194778|FG002|Part 2|Symptomatic deterioration|0|||
156847458|NCT00106353|566194779|FG003|Part 2|Symptomatic deterioration|0|||
156847459|NCT00106353|566194780|FG004|Part 2|Symptomatic deterioration|3|||
156847460|NCT00106353|566194781|FG005|Part 2|Symptomatic deterioration|0|||
156847461|NCT00106353|566194782|FG006|Part 2|Symptomatic deterioration|0|||
156847462|NCT00106353|566194776|FG000|Part 2|Adverse Event|0|||
156847463|NCT00106353|566194777|FG001|Part 2|Adverse Event|0|||
156847464|NCT00106353|566194778|FG002|Part 2|Adverse Event|0|||
156847465|NCT00106353|566194779|FG003|Part 2|Adverse Event|0|||
156847466|NCT00106353|566194780|FG004|Part 2|Adverse Event|0|||
156847467|NCT00106353|566194781|FG005|Part 2|Adverse Event|2|||
156847468|NCT00106353|566194782|FG006|Part 2|Adverse Event|1|||
156847469|NCT00106353|566194776|FG000|Part 2|Other|0|||
156847470|NCT00106353|566194777|FG001|Part 2|Other|0|||
156847471|NCT00106353|566194778|FG002|Part 2|Other|0|||
156847472|NCT00106353|566194779|FG003|Part 2|Other|0|||
156847473|NCT00106353|566194780|FG004|Part 2|Other|1|||
156847474|NCT00106353|566194781|FG005|Part 2|Other|1|||
156847475|NCT00106353|566194782|FG006|Part 2|Other|1|||
156847476|NCT00106353|566194776|FG000|Part 2|Withdrawal by Subject|0|||
156847477|NCT00106353|566194777|FG001|Part 2|Withdrawal by Subject|0|||
156847478|NCT00106353|566194778|FG002|Part 2|Withdrawal by Subject|0|||
156847479|NCT00106353|566194779|FG003|Part 2|Withdrawal by Subject|0|||
156847480|NCT00106353|566194780|FG004|Part 2|Withdrawal by Subject|1|||
156847481|NCT00106353|566194781|FG005|Part 2|Withdrawal by Subject|0|||
156847482|NCT00106353|566194782|FG006|Part 2|Withdrawal by Subject|0|||
156847483|NCT00106353|566194776|FG000|Part 2|Physician Decision|0|||
156847484|NCT00106353|566194777|FG001|Part 2|Physician Decision|0|||
156847485|NCT00106353|566194778|FG002|Part 2|Physician Decision|0|||
156847486|NCT00106353|566194779|FG003|Part 2|Physician Decision|0|||
156847487|NCT00106353|566194780|FG004|Part 2|Physician Decision|0|||
156847488|NCT00106353|566194781|FG005|Part 2|Physician Decision|1|||
156847489|NCT00106353|566194782|FG006|Part 2|Physician Decision|0|||
156847490|NCT04039217|566194783|FG000|Overall Study|Lost to Follow-up|1|||
156847491|NCT03364309|566194784|FG000|Induction Period|Adverse Event|4|||
156847492|NCT03364309|566194785|FG001|Induction Period|Adverse Event|0|||
156847493|NCT03364309|566194786|FG002|Induction Period|Adverse Event|1|||
156847494|NCT03364309|566194787|FG003|Induction Period|Adverse Event|0|||
156847495|NCT03364309|566194788|FG004|Induction Period|Adverse Event|0|||
156847496|NCT03364309|566194789|FG005|Induction Period|Adverse Event|0|||
156847497|NCT03364309|566194790|FG006|Induction Period|Adverse Event|0|||
156847498|NCT03364309|566194791|FG007|Induction Period|Adverse Event|0|||
156847499|NCT03364309|566194792|FG008|Induction Period|Adverse Event|0|||
156847500|NCT03364309|566194793|FG009|Induction Period|Adverse Event|0|||
156847501|NCT03364309|566194794|FG010|Induction Period|Adverse Event|0|||
156847502|NCT03364309|566194795|FG011|Induction Period|Adverse Event|0|||
156847503|NCT03364309|566194796|FG012|Induction Period|Adverse Event|0|||
156847504|NCT03364309|566194797|FG013|Induction Period|Adverse Event|0|||
156847505|NCT03364309|566194798|FG014|Induction Period|Adverse Event|0|||
156847506|NCT03364309|566194799|FG015|Induction Period|Adverse Event|0|||
156847507|NCT03364309|566194800|FG016|Induction Period|Adverse Event|0|||
156341825|NCT01061177|564350279|FG000|Overall Study|Disease progression|17|||
156341826|NCT01061177|564350279|FG000|Overall Study|Protocol Violation|11|||
156847508|NCT03364309|566194801|FG017|Induction Period|Adverse Event|0|||
156847509|NCT03364309|566194802|FG018|Induction Period|Adverse Event|0|||
156847510|NCT03364309|566194784|FG000|Induction Period|Withdrawal by Subject|1|||
156847511|NCT03364309|566194785|FG001|Induction Period|Withdrawal by Subject|3|||
156847512|NCT03364309|566194786|FG002|Induction Period|Withdrawal by Subject|0|||
156847513|NCT03364309|566194787|FG003|Induction Period|Withdrawal by Subject|0|||
156847514|NCT03364309|566194788|FG004|Induction Period|Withdrawal by Subject|0|||
156847515|NCT03364309|566194789|FG005|Induction Period|Withdrawal by Subject|0|||
156847516|NCT03364309|566194790|FG006|Induction Period|Withdrawal by Subject|0|||
156847517|NCT03364309|566194791|FG007|Induction Period|Withdrawal by Subject|0|||
156847518|NCT03364309|566194792|FG008|Induction Period|Withdrawal by Subject|0|||
156847519|NCT03364309|566194793|FG009|Induction Period|Withdrawal by Subject|0|||
156847520|NCT03364309|566194794|FG010|Induction Period|Withdrawal by Subject|0|||
156847521|NCT03364309|566194795|FG011|Induction Period|Withdrawal by Subject|0|||
156847522|NCT03364309|566194796|FG012|Induction Period|Withdrawal by Subject|0|||
156847523|NCT03364309|566194797|FG013|Induction Period|Withdrawal by Subject|0|||
156847524|NCT03364309|566194798|FG014|Induction Period|Withdrawal by Subject|0|||
156847525|NCT03364309|566194799|FG015|Induction Period|Withdrawal by Subject|0|||
156847526|NCT03364309|566194800|FG016|Induction Period|Withdrawal by Subject|0|||
156847527|NCT03364309|566194801|FG017|Induction Period|Withdrawal by Subject|0|||
156847528|NCT03364309|566194802|FG018|Induction Period|Withdrawal by Subject|0|||
156847529|NCT03364309|566194784|FG000|Induction Period|Lost to Follow-up|1|||
156847530|NCT03364309|566194785|FG001|Induction Period|Lost to Follow-up|0|||
156847531|NCT03364309|566194786|FG002|Induction Period|Lost to Follow-up|0|||
156847532|NCT03364309|566194787|FG003|Induction Period|Lost to Follow-up|0|||
156847533|NCT03364309|566194788|FG004|Induction Period|Lost to Follow-up|0|||
156847534|NCT03364309|566194789|FG005|Induction Period|Lost to Follow-up|0|||
156847535|NCT03364309|566194790|FG006|Induction Period|Lost to Follow-up|0|||
156847536|NCT03364309|566194791|FG007|Induction Period|Lost to Follow-up|0|||
156847537|NCT03364309|566194792|FG008|Induction Period|Lost to Follow-up|0|||
156847538|NCT03364309|566194793|FG009|Induction Period|Lost to Follow-up|0|||
156847539|NCT03364309|566194794|FG010|Induction Period|Lost to Follow-up|0|||
156847540|NCT03364309|566194795|FG011|Induction Period|Lost to Follow-up|0|||
156847541|NCT03364309|566194796|FG012|Induction Period|Lost to Follow-up|0|||
156847542|NCT03364309|566194797|FG013|Induction Period|Lost to Follow-up|0|||
156847543|NCT03364309|566194798|FG014|Induction Period|Lost to Follow-up|0|||
156847544|NCT03364309|566194799|FG015|Induction Period|Lost to Follow-up|0|||
156847545|NCT03364309|566194800|FG016|Induction Period|Lost to Follow-up|0|||
156847546|NCT03364309|566194801|FG017|Induction Period|Lost to Follow-up|0|||
156847547|NCT03364309|566194802|FG018|Induction Period|Lost to Follow-up|0|||
156341827|NCT01061177|564350279|FG000|Overall Study|Lost to Follow-up|9|||
156341828|NCT01061177|564350279|FG000|Overall Study|New cancer therapy|9|||
156341829|NCT01061177|564350279|FG000|Overall Study|Abnormal laboratory values|6|||
156847548|NCT03364309|566194784|FG000|Induction Period|Physician Decision|0|||
156847549|NCT03364309|566194785|FG001|Induction Period|Physician Decision|1|||
156847550|NCT03364309|566194786|FG002|Induction Period|Physician Decision|0|||
156847551|NCT03364309|566194787|FG003|Induction Period|Physician Decision|0|||
156847552|NCT03364309|566194788|FG004|Induction Period|Physician Decision|0|||
156847553|NCT03364309|566194789|FG005|Induction Period|Physician Decision|0|||
156847554|NCT03364309|566194790|FG006|Induction Period|Physician Decision|0|||
156847555|NCT03364309|566194791|FG007|Induction Period|Physician Decision|0|||
156847556|NCT03364309|566194792|FG008|Induction Period|Physician Decision|0|||
156847557|NCT03364309|566194793|FG009|Induction Period|Physician Decision|0|||
156847558|NCT03364309|566194794|FG010|Induction Period|Physician Decision|0|||
156847559|NCT03364309|566194795|FG011|Induction Period|Physician Decision|0|||
156847560|NCT03364309|566194796|FG012|Induction Period|Physician Decision|0|||
156847561|NCT03364309|566194797|FG013|Induction Period|Physician Decision|0|||
156847562|NCT03364309|566194798|FG014|Induction Period|Physician Decision|0|||
156847563|NCT03364309|566194799|FG015|Induction Period|Physician Decision|0|||
156847564|NCT03364309|566194800|FG016|Induction Period|Physician Decision|0|||
156847565|NCT03364309|566194801|FG017|Induction Period|Physician Decision|0|||
156847566|NCT03364309|566194802|FG018|Induction Period|Physician Decision|0|||
156847567|NCT03364309|566194784|FG000|Maintenance Period|Withdrawal by Subject|0|||
156847568|NCT03364309|566194785|FG001|Maintenance Period|Withdrawal by Subject|0|||
156847569|NCT03364309|566194786|FG002|Maintenance Period|Withdrawal by Subject|0|||
156847570|NCT03364309|566194787|FG003|Maintenance Period|Withdrawal by Subject|1|||
156847571|NCT03364309|566194788|FG004|Maintenance Period|Withdrawal by Subject|3|||
156847572|NCT03364309|566194789|FG005|Maintenance Period|Withdrawal by Subject|1|||
156847573|NCT03364309|566194790|FG006|Maintenance Period|Withdrawal by Subject|3|||
156847574|NCT03364309|566194791|FG007|Maintenance Period|Withdrawal by Subject|0|||
156847575|NCT03364309|566194792|FG008|Maintenance Period|Withdrawal by Subject|1|||
156847576|NCT03364309|566194793|FG009|Maintenance Period|Withdrawal by Subject|1|||
156847577|NCT03364309|566194794|FG010|Maintenance Period|Withdrawal by Subject|2|||
156847578|NCT03364309|566194795|FG011|Maintenance Period|Withdrawal by Subject|0|||
156847579|NCT03364309|566194796|FG012|Maintenance Period|Withdrawal by Subject|0|||
156847580|NCT03364309|566194797|FG013|Maintenance Period|Withdrawal by Subject|0|||
156847581|NCT03364309|566194798|FG014|Maintenance Period|Withdrawal by Subject|0|||
156847582|NCT03364309|566194799|FG015|Maintenance Period|Withdrawal by Subject|0|||
156847583|NCT03364309|566194800|FG016|Maintenance Period|Withdrawal by Subject|0|||
156341830|NCT01061177|564350279|FG000|Overall Study|Abnormal test procedure results|4|||
156341831|NCT01061177|564350279|FG000|Overall Study|Administratie problems|4|||
156341832|NCT01061177|564350279|FG000|Overall Study|Death|4|||
156341833|NCT03616600|564350280|FG000|Overall Study|Withdrawal by Subject|1|||
156341834|NCT03616600|564350281|FG001|Overall Study|Withdrawal by Subject|0|||
156341835|NCT03984994|564350282|FG000|Overall Study|Withdrawal by Subject|2|||
156341836|NCT03984994|564350283|FG001|Overall Study|Withdrawal by Subject|1|||
156341837|NCT03010176|564350284|FG000|Overall Study|Death|21|||
156847584|NCT03364309|566194801|FG017|Maintenance Period|Withdrawal by Subject|0|||
156847585|NCT03364309|566194802|FG018|Maintenance Period|Withdrawal by Subject|0|||
156847586|NCT03364309|566194784|FG000|Maintenance Period|Adverse Event|0|||
156847587|NCT03364309|566194785|FG001|Maintenance Period|Adverse Event|0|||
156847588|NCT03364309|566194786|FG002|Maintenance Period|Adverse Event|0|||
156847589|NCT03364309|566194787|FG003|Maintenance Period|Adverse Event|0|||
156847590|NCT03364309|566194788|FG004|Maintenance Period|Adverse Event|2|||
156847591|NCT03364309|566194789|FG005|Maintenance Period|Adverse Event|0|||
156847592|NCT03364309|566194790|FG006|Maintenance Period|Adverse Event|3|||
156847593|NCT03364309|566194791|FG007|Maintenance Period|Adverse Event|0|||
156847594|NCT03364309|566194792|FG008|Maintenance Period|Adverse Event|1|||
156847595|NCT03364309|566194793|FG009|Maintenance Period|Adverse Event|0|||
156847596|NCT03364309|566194794|FG010|Maintenance Period|Adverse Event|2|||
156847597|NCT03364309|566194795|FG011|Maintenance Period|Adverse Event|0|||
156847598|NCT03364309|566194796|FG012|Maintenance Period|Adverse Event|0|||
156847599|NCT03364309|566194797|FG013|Maintenance Period|Adverse Event|0|||
156847600|NCT03364309|566194798|FG014|Maintenance Period|Adverse Event|0|||
156847601|NCT03364309|566194799|FG015|Maintenance Period|Adverse Event|0|||
156847602|NCT03364309|566194800|FG016|Maintenance Period|Adverse Event|0|||
156847603|NCT03364309|566194801|FG017|Maintenance Period|Adverse Event|0|||
156847604|NCT03364309|566194802|FG018|Maintenance Period|Adverse Event|0|||
156847605|NCT03364309|566194784|FG000|Maintenance Period|Relapsed|0|||
156847606|NCT03364309|566194785|FG001|Maintenance Period|Relapsed|0|||
156847607|NCT03364309|566194786|FG002|Maintenance Period|Relapsed|0|||
156847608|NCT03364309|566194787|FG003|Maintenance Period|Relapsed|43|||
156847609|NCT03364309|566194788|FG004|Maintenance Period|Relapsed|7|||
156847610|NCT03364309|566194789|FG005|Maintenance Period|Relapsed|45|||
156847611|NCT03364309|566194790|FG006|Maintenance Period|Relapsed|10|||
156847612|NCT03364309|566194791|FG007|Maintenance Period|Relapsed|2|||
156847613|NCT03364309|566194792|FG008|Maintenance Period|Relapsed|0|||
156847614|NCT03364309|566194793|FG009|Maintenance Period|Relapsed|0|||
156847615|NCT03364309|566194794|FG010|Maintenance Period|Relapsed|0|||
156847616|NCT03364309|566194795|FG011|Maintenance Period|Relapsed|0|||
156847617|NCT03364309|566194796|FG012|Maintenance Period|Relapsed|0|||
156847618|NCT03364309|566194797|FG013|Maintenance Period|Relapsed|0|||
156847619|NCT03364309|566194798|FG014|Maintenance Period|Relapsed|0|||
156847620|NCT03364309|566194799|FG015|Maintenance Period|Relapsed|0|||
156847621|NCT03364309|566194800|FG016|Maintenance Period|Relapsed|0|||
156847622|NCT03364309|566194801|FG017|Maintenance Period|Relapsed|0|||
156847623|NCT03364309|566194802|FG018|Maintenance Period|Relapsed|0|||
156847624|NCT03364309|566194784|FG000|Maintenance Period|Lack of Efficacy|0|||
156847625|NCT03364309|566194785|FG001|Maintenance Period|Lack of Efficacy|0|||
156847626|NCT03364309|566194786|FG002|Maintenance Period|Lack of Efficacy|0|||
156847627|NCT03364309|566194787|FG003|Maintenance Period|Lack of Efficacy|0|||
156847628|NCT03364309|566194788|FG004|Maintenance Period|Lack of Efficacy|0|||
156847629|NCT03364309|566194789|FG005|Maintenance Period|Lack of Efficacy|0|||
156847630|NCT03364309|566194790|FG006|Maintenance Period|Lack of Efficacy|0|||
156847631|NCT03364309|566194791|FG007|Maintenance Period|Lack of Efficacy|0|||
156847632|NCT03364309|566194792|FG008|Maintenance Period|Lack of Efficacy|1|||
156847633|NCT03364309|566194793|FG009|Maintenance Period|Lack of Efficacy|3|||
156847634|NCT03364309|566194794|FG010|Maintenance Period|Lack of Efficacy|2|||
156847635|NCT03364309|566194795|FG011|Maintenance Period|Lack of Efficacy|0|||
156847636|NCT03364309|566194796|FG012|Maintenance Period|Lack of Efficacy|0|||
156847637|NCT03364309|566194797|FG013|Maintenance Period|Lack of Efficacy|0|||
156847638|NCT03364309|566194798|FG014|Maintenance Period|Lack of Efficacy|0|||
156847639|NCT03364309|566194799|FG015|Maintenance Period|Lack of Efficacy|0|||
156847640|NCT03364309|566194800|FG016|Maintenance Period|Lack of Efficacy|0|||
156847641|NCT03364309|566194801|FG017|Maintenance Period|Lack of Efficacy|0|||
156847642|NCT03364309|566194802|FG018|Maintenance Period|Lack of Efficacy|0|||
156847643|NCT03364309|566194784|FG000|Maintenance Period|Death|0|||
156847644|NCT03364309|566194785|FG001|Maintenance Period|Death|0|||
156847645|NCT03364309|566194786|FG002|Maintenance Period|Death|0|||
156847646|NCT03364309|566194787|FG003|Maintenance Period|Death|0|||
156847647|NCT03364309|566194788|FG004|Maintenance Period|Death|0|||
156847648|NCT03364309|566194789|FG005|Maintenance Period|Death|0|||
156847649|NCT03364309|566194790|FG006|Maintenance Period|Death|0|||
156847650|NCT03364309|566194791|FG007|Maintenance Period|Death|0|||
156470242|NCT03160885|564814967|FG005|Open-label Treatment|Completed Week 50|0|||
156847651|NCT03364309|566194792|FG008|Maintenance Period|Death|1|||
156847652|NCT03364309|566194793|FG009|Maintenance Period|Death|0|||
156847653|NCT03364309|566194794|FG010|Maintenance Period|Death|0|||
156847654|NCT03364309|566194795|FG011|Maintenance Period|Death|0|||
156541529|NCT04232553|565075444|FG001|Overall Study|Adverse Event|2|||
156847655|NCT03364309|566194796|FG012|Maintenance Period|Death|0|||
156847656|NCT03364309|566194797|FG013|Maintenance Period|Death|0|||
156847657|NCT03364309|566194798|FG014|Maintenance Period|Death|0|||
156847658|NCT03364309|566194799|FG015|Maintenance Period|Death|0|||
156847659|NCT03364309|566194800|FG016|Maintenance Period|Death|0|||
156847660|NCT03364309|566194801|FG017|Maintenance Period|Death|0|||
156847661|NCT03364309|566194802|FG018|Maintenance Period|Death|0|||
156847662|NCT03364309|566194784|FG000|Maintenance Period|Lost to Follow-up|0|||
156847663|NCT03364309|566194785|FG001|Maintenance Period|Lost to Follow-up|0|||
156847664|NCT03364309|566194786|FG002|Maintenance Period|Lost to Follow-up|0|||
156847665|NCT03364309|566194787|FG003|Maintenance Period|Lost to Follow-up|0|||
156847666|NCT03364309|566194788|FG004|Maintenance Period|Lost to Follow-up|0|||
156847667|NCT03364309|566194789|FG005|Maintenance Period|Lost to Follow-up|0|||
156847668|NCT03364309|566194790|FG006|Maintenance Period|Lost to Follow-up|0|||
156847669|NCT03364309|566194791|FG007|Maintenance Period|Lost to Follow-up|0|||
156847670|NCT03364309|566194792|FG008|Maintenance Period|Lost to Follow-up|1|||
156847671|NCT03364309|566194793|FG009|Maintenance Period|Lost to Follow-up|0|||
156847672|NCT03364309|566194794|FG010|Maintenance Period|Lost to Follow-up|0|||
156847673|NCT03364309|566194795|FG011|Maintenance Period|Lost to Follow-up|0|||
156847674|NCT03364309|566194796|FG012|Maintenance Period|Lost to Follow-up|0|||
156847675|NCT03364309|566194797|FG013|Maintenance Period|Lost to Follow-up|0|||
156847676|NCT03364309|566194798|FG014|Maintenance Period|Lost to Follow-up|0|||
156847677|NCT03364309|566194799|FG015|Maintenance Period|Lost to Follow-up|0|||
156847678|NCT03364309|566194800|FG016|Maintenance Period|Lost to Follow-up|0|||
156541530|NCT04232553|565075445|FG002|Overall Study|Adverse Event|1|||
156541531|NCT04232553|565075446|FG003|Overall Study|Adverse Event|2|||
156541532|NCT04232553|565075447|FG004|Overall Study|Adverse Event|1|||
156541533|NCT04232553|565075448|FG005|Overall Study|Adverse Event|1|||
156541534|NCT04232553|565075449|FG006|Overall Study|Adverse Event|0|||
156541535|NCT04232553|565075450|FG007|Overall Study|Adverse Event|0|||
156541536|NCT04232553|565075451|FG008|Overall Study|Adverse Event|0|||
156541537|NCT04232553|565075443|FG000|Overall Study|Death|0|||
156541538|NCT04232553|565075444|FG001|Overall Study|Death|1|||
156541539|NCT04232553|565075445|FG002|Overall Study|Death|0|||
156541540|NCT04232553|565075446|FG003|Overall Study|Death|1|||
156541541|NCT04232553|565075447|FG004|Overall Study|Death|0|||
156541542|NCT04232553|565075448|FG005|Overall Study|Death|0|||
156541543|NCT04232553|565075449|FG006|Overall Study|Death|0|||
156541544|NCT04232553|565075450|FG007|Overall Study|Death|0|||
156541545|NCT04232553|565075451|FG008|Overall Study|Death|0|||
156541546|NCT04232553|565075443|FG000|Overall Study|Lack of Efficacy|0|||
156541547|NCT04232553|565075444|FG001|Overall Study|Lack of Efficacy|2|||
156541548|NCT04232553|565075445|FG002|Overall Study|Lack of Efficacy|0|||
156541549|NCT04232553|565075446|FG003|Overall Study|Lack of Efficacy|0|||
156541550|NCT04232553|565075447|FG004|Overall Study|Lack of Efficacy|0|||
156541551|NCT04232553|565075448|FG005|Overall Study|Lack of Efficacy|0|||
156541552|NCT04232553|565075449|FG006|Overall Study|Lack of Efficacy|0|||
156541553|NCT04232553|565075450|FG007|Overall Study|Lack of Efficacy|0|||
156541554|NCT04232553|565075451|FG008|Overall Study|Lack of Efficacy|1|||
156541555|NCT04232553|565075443|FG000|Overall Study|Lost to Follow-up|0|||
156541556|NCT04232553|565075444|FG001|Overall Study|Lost to Follow-up|1|||
156541557|NCT04232553|565075445|FG002|Overall Study|Lost to Follow-up|0|||
156541558|NCT04232553|565075446|FG003|Overall Study|Lost to Follow-up|0|||
156847679|NCT03364309|566194801|FG017|Maintenance Period|Lost to Follow-up|0|||
156847680|NCT03364309|566194802|FG018|Maintenance Period|Lost to Follow-up|0|||
156847681|NCT03364309|566194784|FG000|Maintenance Period|Miscellaneous|0|||
156847682|NCT03364309|566194785|FG001|Maintenance Period|Miscellaneous|0|||
156847683|NCT03364309|566194786|FG002|Maintenance Period|Miscellaneous|0|||
156847684|NCT03364309|566194787|FG003|Maintenance Period|Miscellaneous|0|||
156847685|NCT03364309|566194788|FG004|Maintenance Period|Miscellaneous|0|||
156847686|NCT03364309|566194789|FG005|Maintenance Period|Miscellaneous|0|||
156847687|NCT03364309|566194790|FG006|Maintenance Period|Miscellaneous|0|||
156847688|NCT03364309|566194791|FG007|Maintenance Period|Miscellaneous|0|||
156847689|NCT03364309|566194792|FG008|Maintenance Period|Miscellaneous|1|||
156847690|NCT03364309|566194793|FG009|Maintenance Period|Miscellaneous|0|||
156847691|NCT03364309|566194794|FG010|Maintenance Period|Miscellaneous|0|||
156847692|NCT03364309|566194795|FG011|Maintenance Period|Miscellaneous|0|||
156847693|NCT03364309|566194796|FG012|Maintenance Period|Miscellaneous|0|||
156847694|NCT03364309|566194797|FG013|Maintenance Period|Miscellaneous|0|||
156847695|NCT03364309|566194798|FG014|Maintenance Period|Miscellaneous|0|||
156847696|NCT03364309|566194799|FG015|Maintenance Period|Miscellaneous|0|||
156341838|NCT03010176|564350285|FG001|Overall Study|Death|35|||
156341839|NCT03010176|564350286|FG002|Overall Study|Death|19|||
156341840|NCT03010176|564350287|FG003|Overall Study|Death|19|||
156541559|NCT04232553|565075447|FG004|Overall Study|Lost to Follow-up|1|||
156847697|NCT03364309|566194800|FG016|Maintenance Period|Miscellaneous|0|||
156847698|NCT03364309|566194801|FG017|Maintenance Period|Miscellaneous|0|||
156847699|NCT03364309|566194802|FG018|Maintenance Period|Miscellaneous|0|||
156847700|NCT03364309|566194784|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847701|NCT03364309|566194785|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847702|NCT03364309|566194786|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156341841|NCT03010176|564350288|FG004|Overall Study|Death|14|||
156541560|NCT04232553|565075448|FG005|Overall Study|Lost to Follow-up|0|||
156541561|NCT04232553|565075449|FG006|Overall Study|Lost to Follow-up|0|||
156541562|NCT04232553|565075450|FG007|Overall Study|Lost to Follow-up|0|||
156541563|NCT04232553|565075451|FG008|Overall Study|Lost to Follow-up|1|||
156541564|NCT04232553|565075443|FG000|Overall Study|Other - As reported by the investigator|0|||
156541565|NCT04232553|565075444|FG001|Overall Study|Other - As reported by the investigator|1|||
156541566|NCT04232553|565075445|FG002|Overall Study|Other - As reported by the investigator|0|||
156541567|NCT04232553|565075446|FG003|Overall Study|Other - As reported by the investigator|0|||
156847703|NCT03364309|566194787|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847704|NCT03364309|566194788|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847705|NCT03364309|566194789|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847706|NCT03364309|566194790|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847707|NCT03364309|566194791|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847708|NCT03364309|566194792|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847709|NCT03364309|566194793|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847710|NCT03364309|566194794|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847711|NCT03364309|566194795|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847712|NCT03364309|566194796|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847713|NCT03364309|566194797|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
156847714|NCT03364309|566194798|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
156847715|NCT03364309|566194799|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
156847716|NCT03364309|566194800|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847717|NCT03364309|566194801|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847718|NCT03364309|566194802|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847719|NCT03364309|566194784|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847720|NCT03364309|566194785|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847721|NCT03364309|566194786|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847722|NCT03364309|566194787|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847723|NCT03364309|566194788|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847724|NCT03364309|566194789|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847725|NCT03364309|566194790|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847726|NCT03364309|566194791|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847727|NCT03364309|566194792|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847728|NCT03364309|566194793|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847729|NCT03364309|566194794|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
156541568|NCT04232553|565075447|FG004|Overall Study|Other - As reported by the investigator|0|||
156541569|NCT04232553|565075448|FG005|Overall Study|Other - As reported by the investigator|0|||
156541570|NCT04232553|565075449|FG006|Overall Study|Other - As reported by the investigator|0|||
156541571|NCT04232553|565075450|FG007|Overall Study|Other - As reported by the investigator|0|||
156541572|NCT04232553|565075451|FG008|Overall Study|Other - As reported by the investigator|0|||
156541573|NCT04232553|565075443|FG000|Overall Study|Physician Decision|1|||
156541574|NCT04232553|565075444|FG001|Overall Study|Physician Decision|1|||
156541575|NCT04232553|565075445|FG002|Overall Study|Physician Decision|0|||
156541576|NCT04232553|565075446|FG003|Overall Study|Physician Decision|0|||
156541577|NCT04232553|565075447|FG004|Overall Study|Physician Decision|1|||
156541578|NCT04232553|565075448|FG005|Overall Study|Physician Decision|0|||
156541579|NCT04232553|565075449|FG006|Overall Study|Physician Decision|0|||
156541580|NCT04232553|565075450|FG007|Overall Study|Physician Decision|0|||
156541581|NCT04232553|565075451|FG008|Overall Study|Physician Decision|0|||
156541582|NCT04232553|565075443|FG000|Overall Study|Pregnancy|1|||
156541583|NCT04232553|565075444|FG001|Overall Study|Pregnancy|0|||
156541584|NCT04232553|565075445|FG002|Overall Study|Pregnancy|0|||
156541585|NCT04232553|565075446|FG003|Overall Study|Pregnancy|0|||
156541586|NCT04232553|565075447|FG004|Overall Study|Pregnancy|0|||
156541587|NCT04232553|565075448|FG005|Overall Study|Pregnancy|0|||
156541588|NCT04232553|565075449|FG006|Overall Study|Pregnancy|0|||
156541589|NCT04232553|565075450|FG007|Overall Study|Pregnancy|0|||
156541590|NCT04232553|565075451|FG008|Overall Study|Pregnancy|0|||
156541591|NCT04232553|565075443|FG000|Overall Study|Withdrawal by Subject|7|||
156541592|NCT04232553|565075444|FG001|Overall Study|Withdrawal by Subject|5|||
156541593|NCT04232553|565075445|FG002|Overall Study|Withdrawal by Subject|0|||
156541594|NCT04232553|565075446|FG003|Overall Study|Withdrawal by Subject|0|||
156541595|NCT04232553|565075447|FG004|Overall Study|Withdrawal by Subject|2|||
156541596|NCT04232553|565075448|FG005|Overall Study|Withdrawal by Subject|2|||
156541597|NCT04232553|565075449|FG006|Overall Study|Withdrawal by Subject|0|||
156541598|NCT04232553|565075450|FG007|Overall Study|Withdrawal by Subject|2|||
156541599|NCT04232553|565075451|FG008|Overall Study|Withdrawal by Subject|0|||
156847730|NCT03364309|566194795|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847731|NCT03364309|566194796|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847732|NCT03364309|566194797|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847733|NCT03364309|566194798|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
156847734|NCT03364309|566194799|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847735|NCT03364309|566194800|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847736|NCT03364309|566194801|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
156541600|NCT02969915|565075452|FG000|Overall Study|Death|104|||
156541601|NCT02969915|565075453|FG001|Overall Study|Death|125|||
156541602|NCT02969915|565075452|FG000|Overall Study|Lost to Follow-up|108|||
156541603|NCT02969915|565075453|FG001|Overall Study|Lost to Follow-up|112|||
156541604|NCT02969915|565075452|FG000|Overall Study|Censored due to COVID-19|481|||
156541605|NCT02969915|565075453|FG001|Overall Study|Censored due to COVID-19|471|||
156541606|NCT01378858|565075456|FG000|Overall Study|Withdrawal by Subject|4|||
156541607|NCT01378858|565075457|FG001|Overall Study|Withdrawal by Subject|4|||
156847737|NCT03364309|566194802|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847738|NCT03364309|566194784|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
156847739|NCT03364309|566194785|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
156847740|NCT03364309|566194786|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
156847741|NCT03364309|566194787|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
156847742|NCT03364309|566194788|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
156847743|NCT03364309|566194789|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
156847744|NCT03364309|566194790|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
156847745|NCT03364309|566194791|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
156847746|NCT03364309|566194792|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
156847747|NCT03364309|566194793|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
156847748|NCT03364309|566194794|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
156847749|NCT03364309|566194795|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
156847750|NCT03364309|566194796|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
156847751|NCT03364309|566194797|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
156847752|NCT03364309|566194798|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
156847753|NCT03364309|566194799|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
156847754|NCT03364309|566194800|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
156847755|NCT03364309|566194801|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
156847756|NCT03364309|566194802|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
156847757|NCT03364309|566194784|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847758|NCT03364309|566194785|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847759|NCT03364309|566194786|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847760|NCT03364309|566194787|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847761|NCT03364309|566194788|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847762|NCT03364309|566194789|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847763|NCT03364309|566194790|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847764|NCT03364309|566194791|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847765|NCT03364309|566194792|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847766|NCT03364309|566194793|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847767|NCT03364309|566194794|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847768|NCT03364309|566194795|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847769|NCT03364309|566194796|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847770|NCT03364309|566194797|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847771|NCT03364309|566194798|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847772|NCT03364309|566194799|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847773|NCT03364309|566194800|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
156847774|NCT03364309|566194801|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
156847775|NCT03364309|566194802|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
156847776|NCT03364309|566194784|FG000|Post-Treatment Followup Period|Adverse Event|0|||
156847777|NCT03364309|566194785|FG001|Post-Treatment Followup Period|Adverse Event|0|||
156847778|NCT03364309|566194786|FG002|Post-Treatment Followup Period|Adverse Event|0|||
156847779|NCT03364309|566194787|FG003|Post-Treatment Followup Period|Adverse Event|0|||
156847780|NCT03364309|566194788|FG004|Post-Treatment Followup Period|Adverse Event|0|||
156847781|NCT03364309|566194789|FG005|Post-Treatment Followup Period|Adverse Event|0|||
156847782|NCT03364309|566194790|FG006|Post-Treatment Followup Period|Adverse Event|0|||
156847783|NCT03364309|566194791|FG007|Post-Treatment Followup Period|Adverse Event|0|||
156847784|NCT03364309|566194792|FG008|Post-Treatment Followup Period|Adverse Event|0|||
156847785|NCT03364309|566194793|FG009|Post-Treatment Followup Period|Adverse Event|0|||
156847786|NCT03364309|566194794|FG010|Post-Treatment Followup Period|Adverse Event|0|||
156847787|NCT03364309|566194795|FG011|Post-Treatment Followup Period|Adverse Event|0|||
156847788|NCT03364309|566194796|FG012|Post-Treatment Followup Period|Adverse Event|0|||
156847789|NCT03364309|566194797|FG013|Post-Treatment Followup Period|Adverse Event|0|||
156847790|NCT03364309|566194798|FG014|Post-Treatment Followup Period|Adverse Event|0|||
156847791|NCT03364309|566194799|FG015|Post-Treatment Followup Period|Adverse Event|0|||
156847792|NCT03364309|566194800|FG016|Post-Treatment Followup Period|Adverse Event|2|||
156847793|NCT03364309|566194801|FG017|Post-Treatment Followup Period|Adverse Event|6|||
156847794|NCT03364309|566194802|FG018|Post-Treatment Followup Period|Adverse Event|1|||
156847795|NCT03364309|566194784|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847796|NCT03364309|566194785|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847797|NCT03364309|566194786|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847798|NCT03364309|566194787|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847799|NCT03364309|566194788|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847800|NCT03364309|566194789|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847801|NCT03364309|566194790|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847802|NCT03364309|566194791|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847803|NCT03364309|566194792|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847804|NCT03364309|566194793|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847805|NCT03364309|566194794|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
156470243|NCT03160885|564814968|FG006|Open-label Treatment|Completed Week 50|4|||
156847806|NCT03364309|566194795|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847807|NCT03364309|566194796|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847808|NCT03364309|566194797|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847809|NCT03364309|566194798|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847810|NCT03364309|566194799|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847811|NCT03364309|566194800|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847812|NCT03364309|566194801|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
156847813|NCT03364309|566194802|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847814|NCT03364309|566194784|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
156847815|NCT03364309|566194785|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
156847816|NCT03364309|566194786|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
156847817|NCT03364309|566194787|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
156847818|NCT03364309|566194788|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
156847819|NCT03364309|566194789|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
156847820|NCT03364309|566194790|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
156847821|NCT03364309|566194791|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
156847822|NCT03364309|566194792|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
156847823|NCT03364309|566194793|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
156847824|NCT03364309|566194794|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
156847825|NCT03364309|566194795|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
156847826|NCT03364309|566194796|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
156847827|NCT03364309|566194797|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
156541608|NCT02664272|565075458|FG000|Overall Study|Fluoroscopic images not made available|2|||
156541609|NCT03073980|565075459|FG000|Overall Study|Lost to Follow-up|10|||
156541610|NCT03073980|565075460|FG001|Overall Study|Lost to Follow-up|2|||
156541611|NCT03073980|565075461|FG002|Overall Study|Lost to Follow-up|9|||
156541612|NCT03073980|565075459|FG000|Overall Study|No post-procedure data|0|||
156541613|NCT03073980|565075460|FG001|Overall Study|No post-procedure data|0|||
156541614|NCT03073980|565075461|FG002|Overall Study|No post-procedure data|2|||
156541615|NCT04810689|565075462|FG000|Overall Study|Withdrawal by Subject|0|||
156541616|NCT04810689|565075463|FG001|Overall Study|Withdrawal by Subject|1|||
156541617|NCT00450723|565075467|FG000|Overall Study|Physician Decision|5|||
156541618|NCT00789880|565075470|FG000|Overall Study|Adverse Event|0|||
156541619|NCT00789880|565075471|FG001|Overall Study|Adverse Event|0|||
156541620|NCT00789880|565075472|FG002|Overall Study|Adverse Event|0|||
156541621|NCT00789880|565075473|FG003|Overall Study|Adverse Event|0|||
156541622|NCT00789880|565075474|FG004|Overall Study|Adverse Event|1|||
156541623|NCT00789880|565075475|FG005|Overall Study|Adverse Event|0|||
156541624|NCT00789880|565075470|FG000|Overall Study|Protocol Violation|0|||
156541625|NCT00789880|565075471|FG001|Overall Study|Protocol Violation|1|||
156541626|NCT00789880|565075472|FG002|Overall Study|Protocol Violation|0|||
156541627|NCT00789880|565075473|FG003|Overall Study|Protocol Violation|1|||
156541628|NCT00789880|565075474|FG004|Overall Study|Protocol Violation|0|||
156541629|NCT00789880|565075475|FG005|Overall Study|Protocol Violation|0|||
156541630|NCT00789880|565075470|FG000|Overall Study|Withdrawal by Subject|1|||
156541631|NCT00789880|565075471|FG001|Overall Study|Withdrawal by Subject|0|||
156541632|NCT00789880|565075472|FG002|Overall Study|Withdrawal by Subject|0|||
156541633|NCT00789880|565075473|FG003|Overall Study|Withdrawal by Subject|0|||
156541634|NCT00789880|565075474|FG004|Overall Study|Withdrawal by Subject|2|||
156541635|NCT00789880|565075475|FG005|Overall Study|Withdrawal by Subject|0|||
156541636|NCT06347731|565075476|FG000|Overall Study|Death|1|||
156541637|NCT06347731|565075476|FG000|Overall Study|Protocol Violation|1|||
156541638|NCT06347731|565075476|FG000|Overall Study|Withdrawal by Subject|2|||
156541639|NCT00609986|565075477|FG000|Overall Study|Did not receive transplant or treatment|8|||
156541640|NCT00609986|565075478|FG001|Overall Study|Did not receive transplant or treatment|3|||
156541641|NCT03159091|565075479|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
156541642|NCT03159091|565075480|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
156541643|NCT03159091|565075479|FG000|Overall Study|Patient has taken no dose of study drug|0|||
156541644|NCT03159091|565075480|FG001|Overall Study|Patient has taken no dose of study drug|1|||
156541645|NCT05998148|565075481|FG000|Allocation|Did not attend any appointments|1|||
156541646|NCT05998148|565075482|FG001|Allocation|Did not attend any appointments|4|||
156541647|NCT05998148|565075481|FG000|Follow-Up|Lost to Follow-up|1|||
156847828|NCT03364309|566194798|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
156541648|NCT05998148|565075482|FG001|Follow-Up|Lost to Follow-up|2|||
156541649|NCT05998148|565075481|FG000|Follow-Up|Change in insurance|1|||
156541650|NCT05998148|565075482|FG001|Follow-Up|Change in insurance|1|||
156541651|NCT02044133|565075483|FG000|Overall Study|Lost to Follow-up|1|||
156541652|NCT02044133|565075484|FG001|Overall Study|Lost to Follow-up|1|||
156847829|NCT03364309|566194799|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
156541653|NCT02044133|565075483|FG000|Overall Study|Death|1|||
156541654|NCT02044133|565075484|FG001|Overall Study|Death|0|||
156541655|NCT02044133|565075483|FG000|Overall Study|Release|3|||
156541656|NCT02044133|565075484|FG001|Overall Study|Release|4|||
156541657|NCT02044133|565075483|FG000|Overall Study|Transfer|1|||
156541658|NCT02044133|565075484|FG001|Overall Study|Transfer|0|||
156541659|NCT02044133|565075483|FG000|Overall Study|refusal of blood sampling|0|||
156541660|NCT02044133|565075484|FG001|Overall Study|refusal of blood sampling|1|||
156541661|NCT03834519|565075485|FG000|Overall Study|Lost to Follow-up|2|||
156541662|NCT03834519|565075486|FG001|Overall Study|Lost to Follow-up|1|||
156541663|NCT03834519|565075485|FG000|Overall Study|Withdrawal by Subject|5|||
156541664|NCT03834519|565075486|FG001|Overall Study|Withdrawal by Subject|8|||
156541665|NCT03834519|565075485|FG000|Overall Study|Death|368|||
156541666|NCT03834519|565075486|FG001|Overall Study|Death|174|||
156541667|NCT03834519|565075485|FG000|Overall Study|Physician Decision|5|||
156541668|NCT03834519|565075486|FG001|Overall Study|Physician Decision|1|||
156541669|NCT03834519|565075485|FG000|Overall Study|Sponsor decision|149|||
156541670|NCT03834519|565075486|FG001|Overall Study|Sponsor decision|80|||
156541671|NCT04655144|565075490|FG000|Overall Study|Consumed THC|1|||
156541672|NCT04655144|565075491|FG001|Overall Study|Consumed THC|0|||
156541673|NCT04655144|565075490|FG000|Overall Study|Unilateral embolization|0|||
156541674|NCT04655144|565075491|FG001|Overall Study|Unilateral embolization|1|||
156541675|NCT00943579|565075497|FG000|Overall Study|Adverse Event|4|||
156541676|NCT00943579|565075498|FG001|Overall Study|Adverse Event|3|||
156541677|NCT00943579|565075497|FG000|Overall Study|Lack of Efficacy|2|||
156541678|NCT00943579|565075498|FG001|Overall Study|Lack of Efficacy|2|||
156541679|NCT00418665|565075501|FG000|Treatment Period|Ineligibility determined|1|||
156541680|NCT00418665|565075502|FG001|Treatment Period|Ineligibility determined|1|||
156541681|NCT00418665|565075503|FG002|Treatment Period|Ineligibility determined|0|||
156541682|NCT00418665|565075501|FG000|Treatment Period|Adverse Event|2|||
156541683|NCT00418665|565075502|FG001|Treatment Period|Adverse Event|2|||
156541684|NCT00418665|565075503|FG002|Treatment Period|Adverse Event|0|||
156541685|NCT00418665|565075501|FG000|Treatment Period|Withdrawal by Subject|0|||
156847830|NCT03364309|566194800|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
156847831|NCT03364309|566194801|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
156541686|NCT00418665|565075502|FG001|Treatment Period|Withdrawal by Subject|3|||
156541687|NCT00418665|565075503|FG002|Treatment Period|Withdrawal by Subject|1|||
156847832|NCT03364309|566194802|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
156847833|NCT01371552|566194803|FG000|Part 1, First 3 Days|Inconvenience|0|||
156847834|NCT01371552|566194804|FG001|Part 1, First 3 Days|Inconvenience|0|||
156847835|NCT01371552|566194805|FG002|Part 1, First 3 Days|Inconvenience|1|||
156847836|NCT01371552|566194806|FG003|Part 1, First 3 Days|Inconvenience|0|||
156847837|NCT01371552|566194807|FG004|Part 1, First 3 Days|Inconvenience|0|||
156847838|NCT01371552|566194808|FG005|Part 1, First 3 Days|Inconvenience|0|||
156847839|NCT00167310|566194809|FG000|Overall Study|Protocol Violation|5|||
156847840|NCT00167310|566194810|FG001|Overall Study|Protocol Violation|3|||
156847841|NCT00167310|566194809|FG000|Overall Study|Withdrawal by Subject|3|||
156847842|NCT00167310|566194810|FG001|Overall Study|Withdrawal by Subject|7|||
156847843|NCT00615992|566194811|FG000|Overall Study|Protocol Violation|67|||
156847844|NCT01868477|566194813|FG000|Overall Study|Adverse Event|2|||
156847845|NCT01868477|566194814|FG001|Overall Study|Adverse Event|4|||
156541688|NCT00418665|565075501|FG000|Treatment Period|Requirement for alternative therapy|1|||
156541689|NCT00418665|565075502|FG001|Treatment Period|Requirement for alternative therapy|0|||
156541690|NCT00418665|565075503|FG002|Treatment Period|Requirement for alternative therapy|0|||
156541691|NCT00418665|565075501|FG000|Treatment Period|Physician Decision|1|||
156541692|NCT00418665|565075502|FG001|Treatment Period|Physician Decision|0|||
156541693|NCT00418665|565075503|FG002|Treatment Period|Physician Decision|3|||
156541694|NCT00418665|565075501|FG000|Treatment Extension|Adverse Event|1|||
156541695|NCT00418665|565075502|FG001|Treatment Extension|Adverse Event|0|||
156541696|NCT00418665|565075503|FG002|Treatment Extension|Adverse Event|0|||
156847846|NCT01868477|566194813|FG000|Overall Study|Disease progression|1|||
156847847|NCT01868477|566194814|FG001|Overall Study|Disease progression|1|||
156847848|NCT01868477|566194813|FG000|Overall Study|Withdrawal by Subject|1|||
156847849|NCT01868477|566194814|FG001|Overall Study|Withdrawal by Subject|0|||
156847850|NCT01811186|566194816|FG000|Overall Study|Adverse Event|54|||
156847851|NCT01811186|566194817|FG001|Overall Study|Adverse Event|38|||
156847852|NCT01811186|566194816|FG000|Overall Study|Protocol Violation|5|||
156847853|NCT01811186|566194817|FG001|Overall Study|Protocol Violation|6|||
156847854|NCT01811186|566194816|FG000|Overall Study|Withdrawal by Subject|5|||
156847855|NCT01811186|566194817|FG001|Overall Study|Withdrawal by Subject|10|||
156847856|NCT01811186|566194816|FG000|Overall Study|Lack of Efficacy|3|||
156541697|NCT00418665|565075501|FG000|Treatment Extension|Withdrawal by Subject|1|||
156541698|NCT00418665|565075502|FG001|Treatment Extension|Withdrawal by Subject|0|||
156541699|NCT00418665|565075503|FG002|Treatment Extension|Withdrawal by Subject|0|||
156847857|NCT01811186|566194817|FG001|Overall Study|Lack of Efficacy|6|||
156847858|NCT01811186|566194816|FG000|Overall Study|Lost to Follow-up|4|||
156847859|NCT01811186|566194817|FG001|Overall Study|Lost to Follow-up|2|||
156847860|NCT02465203|566194818|FG000|Overall Study|Protocol Violation|1|||
156847861|NCT02465203|566194819|FG001|Overall Study|Protocol Violation|1|||
156541700|NCT00418665|565075501|FG000|Treatment Extension|Requirement for alternative therapy|2|||
156847862|NCT02465203|566194820|FG002|Overall Study|Protocol Violation|1|||
156541701|NCT00418665|565075502|FG001|Treatment Extension|Requirement for alternative therapy|2|||
156847863|NCT02465203|566194818|FG000|Overall Study|Study terminated by sponsor|50|||
156847864|NCT02465203|566194819|FG001|Overall Study|Study terminated by sponsor|34|||
156847865|NCT02465203|566194820|FG002|Overall Study|Study terminated by sponsor|11|||
156847866|NCT02465203|566194818|FG000|Overall Study|New therapy for study indication|4|||
156847867|NCT02465203|566194819|FG001|Overall Study|New therapy for study indication|0|||
156847868|NCT02465203|566194820|FG002|Overall Study|New therapy for study indication|0|||
156847869|NCT02465203|566194818|FG000|Overall Study|Patient/guardian decision|1|||
156847870|NCT02465203|566194819|FG001|Overall Study|Patient/guardian decision|1|||
156847871|NCT02465203|566194820|FG002|Overall Study|Patient/guardian decision|1|||
156847872|NCT00042991|566194821|FG000|Overall Study|Adverse Event|1|||
156847873|NCT00042991|566194822|FG001|Overall Study|Adverse Event|4|||
156847874|NCT00042991|566194823|FG002|Overall Study|Adverse Event|2|||
156847875|NCT00042991|566194824|FG003|Overall Study|Adverse Event|0|||
156847876|NCT00042991|566194825|FG004|Overall Study|Adverse Event|0|||
156847877|NCT00042991|566194826|FG005|Overall Study|Adverse Event|1|||
156847878|NCT00042991|566194827|FG006|Overall Study|Adverse Event|0|||
156847879|NCT00042991|566194821|FG000|Overall Study|Withdrawal by Subject|0|||
156847880|NCT00042991|566194822|FG001|Overall Study|Withdrawal by Subject|7|||
156847881|NCT00042991|566194823|FG002|Overall Study|Withdrawal by Subject|2|||
156847882|NCT00042991|566194824|FG003|Overall Study|Withdrawal by Subject|0|||
156847883|NCT00042991|566194825|FG004|Overall Study|Withdrawal by Subject|1|||
156847884|NCT00042991|566194826|FG005|Overall Study|Withdrawal by Subject|0|||
156847885|NCT00042991|566194827|FG006|Overall Study|Withdrawal by Subject|0|||
156847886|NCT00042991|566194821|FG000|Overall Study|Disease Progression|5|||
156847887|NCT00042991|566194822|FG001|Overall Study|Disease Progression|29|||
156847888|NCT00042991|566194823|FG002|Overall Study|Disease Progression|2|||
156847889|NCT00042991|566194824|FG003|Overall Study|Disease Progression|2|||
156847890|NCT00042991|566194825|FG004|Overall Study|Disease Progression|1|||
156847891|NCT00042991|566194826|FG005|Overall Study|Disease Progression|4|||
156847892|NCT00042991|566194827|FG006|Overall Study|Disease Progression|2|||
156470244|NCT03160885|564814962|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
156470245|NCT03160885|564814963|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
156847893|NCT00042991|566194821|FG000|Overall Study|Alternative Therapy|0|||
156847894|NCT00042991|566194822|FG001|Overall Study|Alternative Therapy|0|||
156847895|NCT00042991|566194823|FG002|Overall Study|Alternative Therapy|0|||
156847896|NCT00042991|566194824|FG003|Overall Study|Alternative Therapy|0|||
156847897|NCT00042991|566194825|FG004|Overall Study|Alternative Therapy|1|||
156847898|NCT00042991|566194826|FG005|Overall Study|Alternative Therapy|0|||
156847899|NCT00042991|566194827|FG006|Overall Study|Alternative Therapy|0|||
156847900|NCT04072887|566194836|FG000|Overall Study|Withdrawal by Subject|3|||
156847901|NCT04072887|566194837|FG001|Overall Study|Withdrawal by Subject|8|||
156847902|NCT04072887|566194838|FG002|Overall Study|Withdrawal by Subject|1|||
156847903|NCT04072887|566194839|FG003|Overall Study|Withdrawal by Subject|3|||
156847904|NCT04072887|566194840|FG004|Overall Study|Withdrawal by Subject|3|||
156847905|NCT04072887|566194841|FG005|Overall Study|Withdrawal by Subject|13|||
156847906|NCT04072887|566194836|FG000|Overall Study|Adverse Event|2|||
156847907|NCT04072887|566194837|FG001|Overall Study|Adverse Event|4|||
156847908|NCT04072887|566194838|FG002|Overall Study|Adverse Event|1|||
156847909|NCT04072887|566194839|FG003|Overall Study|Adverse Event|4|||
156847910|NCT04072887|566194840|FG004|Overall Study|Adverse Event|0|||
156847911|NCT04072887|566194841|FG005|Overall Study|Adverse Event|1|||
156847912|NCT04072887|566194836|FG000|Overall Study|Physician Decision|2|||
156847913|NCT04072887|566194837|FG001|Overall Study|Physician Decision|0|||
156470246|NCT03160885|564814964|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
156470247|NCT03160885|564814965|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
156470248|NCT03160885|564814966|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
156470249|NCT03160885|564814967|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
156470250|NCT03160885|564814968|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
156470251|NCT03160885|564814962|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
156470252|NCT03160885|564814963|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
156470253|NCT03160885|564814964|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
156470254|NCT03160885|564814965|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
156847914|NCT04072887|566194838|FG002|Overall Study|Physician Decision|0|||
156847915|NCT04072887|566194839|FG003|Overall Study|Physician Decision|0|||
156847916|NCT04072887|566194840|FG004|Overall Study|Physician Decision|0|||
156847917|NCT04072887|566194841|FG005|Overall Study|Physician Decision|1|||
156847918|NCT04072887|566194836|FG000|Overall Study|Lost to Follow-up|1|||
156847919|NCT04072887|566194837|FG001|Overall Study|Lost to Follow-up|3|||
156470255|NCT03160885|564814966|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
156470256|NCT03160885|564814967|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
156470257|NCT03160885|564814968|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
156470258|NCT03160885|564814962|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
156470259|NCT03160885|564814963|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
156847920|NCT04072887|566194838|FG002|Overall Study|Lost to Follow-up|0|||
156847921|NCT04072887|566194839|FG003|Overall Study|Lost to Follow-up|0|||
156541702|NCT00418665|565075503|FG002|Treatment Extension|Requirement for alternative therapy|0|||
156541703|NCT00418665|565075501|FG000|Treatment Extension|Physician Decision|2|||
156541704|NCT00418665|565075502|FG001|Treatment Extension|Physician Decision|2|||
156541705|NCT00418665|565075503|FG002|Treatment Extension|Physician Decision|1|||
156541706|NCT00418665|565075501|FG000|Treatment Extension|Death|0|||
156541707|NCT00418665|565075502|FG001|Treatment Extension|Death|0|||
156541708|NCT00418665|565075503|FG002|Treatment Extension|Death|1|||
156541709|NCT00853749|565075504|FG000|Overall Study|Lost to Follow-up|0|||
156541710|NCT00853749|565075505|FG001|Overall Study|Lost to Follow-up|1|||
156541711|NCT01129921|565075510|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
156541712|NCT01129921|565075511|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
156541713|NCT01129921|565075510|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
156541714|NCT01129921|565075511|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
156541715|NCT01129921|565075510|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
156541716|NCT01129921|565075511|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
156541717|NCT01129921|565075510|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
156541718|NCT01129921|565075511|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
156541719|NCT00687440|565075512|FG000|Overall Study|Adverse Event|3|||
156541720|NCT00687440|565075512|FG000|Overall Study|Lost to Follow-up|3|||
156541721|NCT00687440|565075512|FG000|Overall Study|Lack of Efficacy|2|||
156541722|NCT00687440|565075512|FG000|Overall Study|Death|2|||
156541723|NCT00687440|565075512|FG000|Overall Study|Other|1|||
156541724|NCT00687440|565075512|FG000|Overall Study|Missing|1|||
156541725|NCT05937165|565075517|FG000|Overall Study|Withdrawal by Subject|0|||
156541726|NCT05937165|565075518|FG001|Overall Study|Withdrawal by Subject|1|||
156541727|NCT03703882|565076582|FG000|Overall Study|Adverse Event|1|||
156541728|NCT03703882|565076583|FG001|Overall Study|Adverse Event|0|||
156541729|NCT03703882|565076582|FG000|Overall Study|Lost to Follow-up|0|||
156541730|NCT03703882|565076583|FG001|Overall Study|Lost to Follow-up|2|||
156541731|NCT03703882|565076582|FG000|Overall Study|Non-compliance with study drug|0|||
156541732|NCT03703882|565076583|FG001|Overall Study|Non-compliance with study drug|1|||
156541733|NCT03703882|565076582|FG000|Overall Study|Physician Decision|0|||
156541734|NCT03703882|565076583|FG001|Overall Study|Physician Decision|1|||
156541735|NCT03703882|565076582|FG000|Overall Study|Progressive disease|1|||
156541736|NCT03703882|565076583|FG001|Overall Study|Progressive disease|0|||
156541737|NCT03703882|565076582|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156541738|NCT03703882|565076583|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156541739|NCT03703882|565076582|FG000|Overall Study|Starting another treatment|0|||
156541740|NCT03703882|565076583|FG001|Overall Study|Starting another treatment|1|||
156541741|NCT03703882|565076582|FG000|Overall Study|noncompliance with study procedures|0|||
156541742|NCT03703882|565076583|FG001|Overall Study|noncompliance with study procedures|1|||
156847922|NCT04072887|566194840|FG004|Overall Study|Lost to Follow-up|0|||
156847923|NCT04072887|566194841|FG005|Overall Study|Lost to Follow-up|0|||
156847924|NCT04072887|566194836|FG000|Overall Study|Death|0|||
156541743|NCT02263079|565076585|FG000|Overall Study|Physician Decision|1|||
156541744|NCT02263079|565076586|FG001|Overall Study|Physician Decision|0|||
156847925|NCT04072887|566194837|FG001|Overall Study|Death|2|||
156847926|NCT04072887|566194838|FG002|Overall Study|Death|0|||
156847927|NCT04072887|566194839|FG003|Overall Study|Death|2|||
156847928|NCT04072887|566194840|FG004|Overall Study|Death|3|||
156341842|NCT03010176|564350289|FG005|Overall Study|Death|0|||
156541745|NCT02263079|565076587|FG002|Overall Study|Physician Decision|0|||
156541746|NCT02263079|565076585|FG000|Overall Study|Withdrawal by Subject|2|||
156541747|NCT02263079|565076586|FG001|Overall Study|Withdrawal by Subject|8|||
156847929|NCT04072887|566194841|FG005|Overall Study|Death|0|||
156541748|NCT02263079|565076587|FG002|Overall Study|Withdrawal by Subject|0|||
156847930|NCT00856297|566194842|FG000|Overall Study|Unable to classify|2|||
156541749|NCT00840086|565076593|FG000|Overall Study|Adverse Event|1|||
156541750|NCT00840086|565076593|FG000|Overall Study|Protocol Violation|2|||
156847931|NCT00856297|566194843|FG001|Overall Study|Unable to classify|0|||
156847932|NCT00856297|566194844|FG002|Overall Study|Unable to classify|0|||
156341843|NCT03010176|564350284|FG000|Overall Study|Lost to Follow-up|0|||
156847933|NCT00856297|566194845|FG003|Overall Study|Unable to classify|0|||
156341844|NCT03010176|564350285|FG001|Overall Study|Lost to Follow-up|0|||
156541751|NCT00840086|565076593|FG000|Overall Study|Lost to Follow-up|1|||
156541752|NCT02554019|565076594|FG000|Overall Study|Withdrawal by Subject|1|||
156541753|NCT02554019|565076595|FG001|Overall Study|Withdrawal by Subject|0|||
156541754|NCT02554019|565076596|FG002|Overall Study|Withdrawal by Subject|2|||
156541755|NCT02554019|565076594|FG000|Overall Study|Adverse Event|1|||
156541756|NCT02554019|565076595|FG001|Overall Study|Adverse Event|0|||
156541757|NCT02554019|565076596|FG002|Overall Study|Adverse Event|0|||
156541758|NCT02463409|565076597|FG000|Overall Study|Withdrawal by Subject|1|||
156541759|NCT02463409|565076597|FG000|Overall Study|Screen failure|1|||
156541760|NCT03577730|565076598|FG000|Overall Study|Physician Decision|3|||
156541761|NCT03577730|565076599|FG001|Overall Study|Physician Decision|1|||
156541762|NCT03577730|565076598|FG000|Overall Study|Did not receive allocated intervention|1|||
156541763|NCT03577730|565076599|FG001|Overall Study|Did not receive allocated intervention|0|||
156847934|NCT00856297|566194846|FG004|Overall Study|Unable to classify|0|||
156847935|NCT02508428|566194850|FG000|Overall Study|Death|32|||
156847936|NCT02508428|566194851|FG001|Overall Study|Death|33|||
156847937|NCT02508428|566194850|FG000|Overall Study|Liner revised|3|||
156847938|NCT02508428|566194851|FG001|Overall Study|Liner revised|19|||
156847939|NCT02508428|566194850|FG000|Overall Study|Incomplete follow-up|17|||
156847940|NCT02508428|566194851|FG001|Overall Study|Incomplete follow-up|15|||
156541764|NCT03810781|565076601|FG000|Overall Study|COVID shut down|2|||
156541765|NCT02181816|565076602|FG000|Overall Study|Case Report Forms Uncollected|38|||
156541766|NCT02181816|565076602|FG000|Overall Study|Protocol Deviation|21|||
156541767|NCT00909181|565076603|FG000|Overall Study|Lost to Follow-up|39|||
156541768|NCT00909181|565076604|FG001|Overall Study|Lost to Follow-up|18|||
156541769|NCT00909181|565076605|FG002|Overall Study|Lost to Follow-up|33|||
156541770|NCT02349048|565076608|FG000|Overall Study|Withdrawal by Subject|4|||
156541771|NCT02349048|565076609|FG001|Overall Study|Withdrawal by Subject|0|||
156541772|NCT02349048|565076608|FG000|Overall Study|Lost to Follow-up|1|||
156541773|NCT02349048|565076609|FG001|Overall Study|Lost to Follow-up|0|||
156847941|NCT01574651|566194854|FG000|Overall Study|Lost to Follow-up|2|||
156541774|NCT00383084|565076618|FG000|Overall Study|Withdrawal by Subject|12|||
156541775|NCT00383084|565076619|FG001|Overall Study|Withdrawal by Subject|10|||
156541776|NCT02113436|565076620|FG000|Period 1: 8 Weeks|Adverse Event|1|||
156541777|NCT02113436|565076621|FG001|Period 1: 8 Weeks|Adverse Event|0|||
156847942|NCT01574651|566194855|FG001|Overall Study|Lost to Follow-up|4|||
156847943|NCT01574651|566194854|FG000|Overall Study|Administrative problems|0|||
156847944|NCT01574651|566194855|FG001|Overall Study|Administrative problems|1|||
156847945|NCT01574651|566194854|FG000|Overall Study|Death|3|||
156847946|NCT01574651|566194855|FG001|Overall Study|Death|3|||
156847947|NCT01574651|566194854|FG000|Overall Study|Patient's inability to use the device|0|||
156847948|NCT01574651|566194855|FG001|Overall Study|Patient's inability to use the device|1|||
156847949|NCT01574651|566194854|FG000|Overall Study|Adverse Event|36|||
156847950|NCT01574651|566194855|FG001|Overall Study|Adverse Event|27|||
156847951|NCT01574651|566194854|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156847952|NCT01574651|566194855|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156847953|NCT01574651|566194854|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156847954|NCT01574651|566194855|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156847955|NCT01574651|566194854|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
156847956|NCT01574651|566194855|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156847957|NCT01574651|566194854|FG000|Overall Study|Protocol Violation|3|||
156847958|NCT01574651|566194855|FG001|Overall Study|Protocol Violation|5|||
156847959|NCT01574651|566194854|FG000|Overall Study|Withdrawal by Subject|9|||
156847960|NCT01574651|566194855|FG001|Overall Study|Withdrawal by Subject|10|||
156847961|NCT00445770|566194856|FG000|Overall Study|Adverse Event|9|||
156847962|NCT00445770|566194857|FG001|Overall Study|Adverse Event|15|||
156847963|NCT00445770|566194858|FG002|Overall Study|Adverse Event|19|||
156541778|NCT02113436|565076622|FG002|Period 1: 8 Weeks|Adverse Event|0|||
156541779|NCT02113436|565076623|FG003|Period 1: 8 Weeks|Adverse Event|0|||
156541780|NCT02113436|565076620|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
156541781|NCT02113436|565076621|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
156541782|NCT02113436|565076622|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
156541783|NCT02113436|565076623|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
156541784|NCT02113436|565076620|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
156541785|NCT02113436|565076621|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
156541786|NCT02113436|565076622|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
156541787|NCT02113436|565076623|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
156541788|NCT02113436|565076620|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
156541789|NCT02113436|565076621|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
156541790|NCT02113436|565076622|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
156847964|NCT00445770|566194856|FG000|Overall Study|Lack of Efficacy|38|||
156847965|NCT00445770|566194857|FG001|Overall Study|Lack of Efficacy|13|||
156847966|NCT00445770|566194858|FG002|Overall Study|Lack of Efficacy|6|||
156847967|NCT00445770|566194856|FG000|Overall Study|Lost to Follow-up|0|||
156847968|NCT00445770|566194857|FG001|Overall Study|Lost to Follow-up|2|||
156541791|NCT02113436|565076623|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
156541792|NCT02113436|565076620|FG000|Period 2: 16 Weeks|Adverse Event|0|||
156847969|NCT00445770|566194858|FG002|Overall Study|Lost to Follow-up|0|||
156847970|NCT00445770|566194856|FG000|Overall Study|Other|6|||
156847971|NCT00445770|566194857|FG001|Overall Study|Other|5|||
156847972|NCT00445770|566194858|FG002|Overall Study|Other|6|||
156847973|NCT00947115|566194859|FG000|Overall Study|Missed reporting interval|3|||
156847974|NCT00947115|566194860|FG001|Overall Study|Missed reporting interval|4|||
156847975|NCT00947115|566194861|FG002|Overall Study|Missed reporting interval|2|||
156847976|NCT00947115|566194859|FG000|Overall Study|Physician Decision|0|||
156847977|NCT00947115|566194860|FG001|Overall Study|Physician Decision|2|||
156847978|NCT00947115|566194861|FG002|Overall Study|Physician Decision|0|||
156847979|NCT00947115|566194859|FG000|Overall Study|Death|0|||
156847980|NCT00947115|566194860|FG001|Overall Study|Death|1|||
156847981|NCT00947115|566194861|FG002|Overall Study|Death|1|||
156847982|NCT00947115|566194859|FG000|Overall Study|Migrated from study area|2|||
156847983|NCT00947115|566194860|FG001|Overall Study|Migrated from study area|0|||
156847984|NCT00947115|566194861|FG002|Overall Study|Migrated from study area|0|||
156847985|NCT00947115|566194859|FG000|Overall Study|Withdrawal by Subject|1|||
156847986|NCT00947115|566194860|FG001|Overall Study|Withdrawal by Subject|3|||
156847987|NCT00947115|566194861|FG002|Overall Study|Withdrawal by Subject|4|||
156847988|NCT00947115|566194859|FG000|Overall Study|Lost to Follow-up|11|||
156847989|NCT00947115|566194860|FG001|Overall Study|Lost to Follow-up|12|||
156847990|NCT00947115|566194861|FG002|Overall Study|Lost to Follow-up|8|||
156847991|NCT00934128|566194864|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
156847992|NCT00934128|566194865|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
156847993|NCT00934128|566194864|FG000|First Intervention (2 Hours)|Adverse Event|4|||
156847994|NCT00934128|566194865|FG001|First Intervention (2 Hours)|Adverse Event|1|||
156847995|NCT00934128|566194864|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
156470260|NCT03160885|564814964|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
156470261|NCT03160885|564814965|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
156470262|NCT03160885|564814966|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
156470263|NCT03160885|564814967|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
156470264|NCT03160885|564814968|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
156470265|NCT03160885|564814962|FG000|Maintenance Treatment Period|Completed Week 50|0|||
156470266|NCT03160885|564814963|FG001|Maintenance Treatment Period|Completed Week 50|0|||
156470267|NCT03160885|564814964|FG002|Maintenance Treatment Period|Completed Week 50|1|||
156470268|NCT03160885|564814965|FG003|Maintenance Treatment Period|Completed Week 50|0|||
156470269|NCT03160885|564814966|FG004|Maintenance Treatment Period|Completed Week 50|0|||
156470270|NCT03160885|564814967|FG005|Maintenance Treatment Period|Completed Week 50|0|||
156470271|NCT03160885|564814968|FG006|Maintenance Treatment Period|Completed Week 50|0|||
156470272|NCT03610581|564814969|FG000|Overall Study|Study terminated by sponsor|2|||
156470273|NCT03610581|564814970|FG001|Overall Study|Study terminated by sponsor|0|||
156470274|NCT03610581|564814969|FG000|Overall Study|Other|0|||
156470275|NCT03610581|564814970|FG001|Overall Study|Other|1|||
156470276|NCT03610581|564814969|FG000|Overall Study|Withdrawal by Subject|1|||
156470277|NCT03610581|564814970|FG001|Overall Study|Withdrawal by Subject|0|||
156470278|NCT02307682|564814971|FG000|Overall Study|Adverse Event|9|||
156470279|NCT02307682|564814972|FG001|Overall Study|Adverse Event|8|||
156470280|NCT02307682|564814973|FG002|Overall Study|Adverse Event|12|||
156470281|NCT02307682|564814971|FG000|Overall Study|Lack of Efficacy|1|||
156847996|NCT00934128|566194865|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
156847997|NCT00934128|566194864|FG000|Washout Period (1 Hour)|Patient preference|1|||
156847998|NCT00934128|566194865|FG001|Washout Period (1 Hour)|Patient preference|3|||
156847999|NCT00934128|566194864|FG000|Washout Period (1 Hour)|Pain|1|||
156848000|NCT00934128|566194865|FG001|Washout Period (1 Hour)|Pain|0|||
156848001|NCT00934128|566194864|FG000|Washout Period (1 Hour)|Too tired|1|||
156848002|NCT00934128|566194865|FG001|Washout Period (1 Hour)|Too tired|0|||
156848003|NCT00934128|566194864|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
156848004|NCT00934128|566194865|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
156848005|NCT00934128|566194864|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
156848006|NCT00934128|566194865|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
156848007|NCT03228212|566194866|FG000|Period 1|Adverse Event|1|||
156848008|NCT03228212|566194867|FG001|Period 1|Adverse Event|0|||
156848009|NCT03228212|566194866|FG000|Period 1|no longer meets eligibility criteria|0|||
156848010|NCT03228212|566194867|FG001|Period 1|no longer meets eligibility criteria|1|||
156848011|NCT03228212|566194866|FG000|Period 2|Lost to Follow-up|1|||
156848012|NCT03228212|566194867|FG001|Period 2|Lost to Follow-up|0|||
156541793|NCT02113436|565076621|FG001|Period 2: 16 Weeks|Adverse Event|0|||
156541794|NCT02113436|565076622|FG002|Period 2: 16 Weeks|Adverse Event|4|||
156541795|NCT02113436|565076623|FG003|Period 2: 16 Weeks|Adverse Event|5|||
156541796|NCT02113436|565076620|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
156541797|NCT02113436|565076621|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
156541798|NCT02113436|565076622|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
156541799|NCT02113436|565076623|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
156541800|NCT02113436|565076620|FG000|Period 2: 16 Weeks|Physician Decision|0|||
156848013|NCT01807299|566194868|FG000|Overall Study|Protocol Violation|3|||
156848014|NCT01807299|566194869|FG001|Overall Study|Protocol Violation|1|||
156848015|NCT01807299|566194870|FG002|Overall Study|Protocol Violation|0|||
156848016|NCT01807299|566194871|FG003|Overall Study|Protocol Violation|2|||
156848017|NCT01392547|566196662|FG000|Overall Study|Adverse Event|2|||
156848018|NCT01392547|566196662|FG000|Overall Study|Non-compliance|2|||
156848019|NCT01392547|566196662|FG000|Overall Study|Withdrawal criteria|3|||
156848020|NCT01392547|566196662|FG000|Overall Study|Unclassified|1|||
156848021|NCT01478971|566196673|FG000|Standard of Care Period|Adverse Event|1|||
156848022|NCT01478971|566196673|FG000|Standard of Care Period|Withdrawal by Subject|3|||
156848023|NCT01478971|566196673|FG000|Standard of Care Period|Death|8|||
156848024|NCT01478971|566196673|FG000|Standard of Care Period|Lost to Follow-up|9|||
156848025|NCT01478971|566196673|FG000|Standard of Care Period|Other|4|||
156848026|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Adverse Event|1|||
156848027|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
156848028|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Death|4|||
156848029|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
156848030|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Other|4|||
156848031|NCT04404556|566196674|FG000|Intervention|Withdrawal by Subject|15|||
156848032|NCT04404556|566196675|FG001|Intervention|Withdrawal by Subject|3|||
156848033|NCT04404556|566196674|FG000|Intervention|Did not complete all intervention sessions|2|||
156848034|NCT04404556|566196675|FG001|Intervention|Did not complete all intervention sessions|1|||
156848035|NCT04404556|566196674|FG000|Post-Intervention|Missing Data|1|||
156848036|NCT04404556|566196675|FG001|Post-Intervention|Missing Data|2|||
156848037|NCT04404556|566196674|FG000|Follow-up 1|Withdrawal by Subject|5|||
156848038|NCT04404556|566196675|FG001|Follow-up 1|Withdrawal by Subject|1|||
156848039|NCT04404556|566196674|FG000|Follow-up 1|Missing Data|4|||
156848040|NCT04404556|566196675|FG001|Follow-up 1|Missing Data|7|||
156848041|NCT04404556|566196674|FG000|Follow-up 2|Withdrawal by Subject|1|||
156848042|NCT04404556|566196675|FG001|Follow-up 2|Withdrawal by Subject|1|||
156848043|NCT04404556|566196674|FG000|Follow-up 2|Missing Data|6|||
156848044|NCT04404556|566196675|FG001|Follow-up 2|Missing Data|5|||
156848045|NCT02451917|566196680|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
156848046|NCT02451917|566196681|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
156848047|NCT02451917|566196680|FG000|First Intervention (24 Weeks)|Death|0|||
156848048|NCT02451917|566196681|FG001|First Intervention (24 Weeks)|Death|1|||
156848049|NCT02451917|566196680|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
156848050|NCT02451917|566196681|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
156848051|NCT02871635|566196682|FG000|Overall Study|Primary lack of efficacy|4|||
156848052|NCT02871635|566196683|FG001|Overall Study|Primary lack of efficacy|4|||
156848053|NCT02871635|566196682|FG000|Overall Study|Protocol Violation|3|||
156848054|NCT02871635|566196683|FG001|Overall Study|Protocol Violation|1|||
156848055|NCT02871635|566196682|FG000|Overall Study|Lost to Follow-up|1|||
156848056|NCT02871635|566196683|FG001|Overall Study|Lost to Follow-up|2|||
156848057|NCT02871635|566196682|FG000|Overall Study|Pregnancy|0|||
156848058|NCT02871635|566196683|FG001|Overall Study|Pregnancy|2|||
156848059|NCT02871635|566196682|FG000|Overall Study|Physician Decision|1|||
156848060|NCT02871635|566196683|FG001|Overall Study|Physician Decision|1|||
156848061|NCT02871635|566196682|FG000|Overall Study|Withdrawal by Subject|3|||
156848062|NCT02871635|566196683|FG001|Overall Study|Withdrawal by Subject|4|||
156341845|NCT03010176|564350286|FG002|Overall Study|Lost to Follow-up|0|||
156541801|NCT02113436|565076621|FG001|Period 2: 16 Weeks|Physician Decision|0|||
156541802|NCT02113436|565076622|FG002|Period 2: 16 Weeks|Physician Decision|2|||
156848063|NCT02871635|566196682|FG000|Overall Study|Adverse Event|4|||
156848064|NCT02871635|566196683|FG001|Overall Study|Adverse Event|4|||
156341846|NCT03010176|564350287|FG003|Overall Study|Lost to Follow-up|0|||
156541803|NCT02113436|565076623|FG003|Period 2: 16 Weeks|Physician Decision|0|||
156848065|NCT02871635|566196682|FG000|Overall Study|Secondary lack of efficacy|2|||
156848066|NCT02871635|566196683|FG001|Overall Study|Secondary lack of efficacy|1|||
156848067|NCT00502671|566196684|FG000|Overall Study|Disease Progression|13|||
156848068|NCT00502671|566196684|FG000|Overall Study|Personal Reasons|22|||
156848069|NCT00502671|566196684|FG000|Overall Study|Lost to Follow-up|7|||
156848070|NCT00502671|566196684|FG000|Overall Study|Protocol Violation|16|||
156848071|NCT00502671|566196684|FG000|Overall Study|Adverse Event|19|||
156848072|NCT01402817|566196685|FG000|Overall Study|Withdrawal by Subject|3|||
156848073|NCT01402817|566196685|FG000|Overall Study|Study Suspended by FDA|8|||
156848074|NCT00681629|566196686|FG000|Overall Study|Study termination|4|||
156848075|NCT00681629|566196687|FG001|Overall Study|Study termination|2|||
156848076|NCT00681629|566196686|FG000|Overall Study|Adverse Event|1|||
156848077|NCT00681629|566196687|FG001|Overall Study|Adverse Event|0|||
156848078|NCT00853151|566196689|FG000|Overall Study|Adverse Event|1|||
156848079|NCT00853151|566196690|FG001|Overall Study|Adverse Event|4|||
156848080|NCT00853151|566196691|FG002|Overall Study|Adverse Event|2|||
156848081|NCT00853151|566196692|FG003|Overall Study|Adverse Event|0|||
156848082|NCT00853151|566196689|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156848083|NCT00853151|566196690|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156848084|NCT00853151|566196691|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156848085|NCT00853151|566196692|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156848086|NCT00853151|566196689|FG000|Overall Study|Lost to Follow-up|2|||
156848087|NCT00853151|566196690|FG001|Overall Study|Lost to Follow-up|0|||
156848088|NCT00853151|566196691|FG002|Overall Study|Lost to Follow-up|3|||
156848089|NCT00853151|566196692|FG003|Overall Study|Lost to Follow-up|0|||
156848090|NCT00853151|566196689|FG000|Overall Study|Death|1|||
156848091|NCT00853151|566196690|FG001|Overall Study|Death|0|||
156848092|NCT00853151|566196691|FG002|Overall Study|Death|0|||
156848093|NCT00853151|566196692|FG003|Overall Study|Death|1|||
156848094|NCT00853151|566196689|FG000|Overall Study|Protocol Violation|0|||
156848095|NCT00853151|566196690|FG001|Overall Study|Protocol Violation|0|||
156848096|NCT00853151|566196691|FG002|Overall Study|Protocol Violation|0|||
156848097|NCT00853151|566196692|FG003|Overall Study|Protocol Violation|1|||
156848098|NCT00853151|566196689|FG000|Overall Study|Withdrawal by Subject|5|||
156848099|NCT00853151|566196690|FG001|Overall Study|Withdrawal by Subject|4|||
156848100|NCT00853151|566196691|FG002|Overall Study|Withdrawal by Subject|2|||
156848101|NCT00853151|566196692|FG003|Overall Study|Withdrawal by Subject|1|||
156848102|NCT00853151|566196689|FG000|Overall Study|Physician Decision|0|||
156848103|NCT00853151|566196690|FG001|Overall Study|Physician Decision|2|||
156848104|NCT00853151|566196691|FG002|Overall Study|Physician Decision|1|||
156848105|NCT00853151|566196692|FG003|Overall Study|Physician Decision|0|||
156848106|NCT00853151|566196689|FG000|Overall Study|Sponsor Decision|0|||
156848107|NCT00853151|566196690|FG001|Overall Study|Sponsor Decision|3|||
156848108|NCT00853151|566196691|FG002|Overall Study|Sponsor Decision|0|||
156848109|NCT00853151|566196692|FG003|Overall Study|Sponsor Decision|0|||
156848110|NCT01751984|566196693|FG000|Overall Study|Adverse Event|5|||
156848111|NCT01751984|566196694|FG001|Overall Study|Adverse Event|3|||
156848112|NCT01751984|566196693|FG000|Overall Study|Withdrawal by Subject|0|||
156341847|NCT03010176|564350288|FG004|Overall Study|Lost to Follow-up|1|||
156341848|NCT03010176|564350289|FG005|Overall Study|Lost to Follow-up|0|||
156341849|NCT03010176|564350284|FG000|Overall Study|Physician Decision|0|||
156341850|NCT03010176|564350285|FG001|Overall Study|Physician Decision|4|||
156341851|NCT03010176|564350286|FG002|Overall Study|Physician Decision|0|||
156341852|NCT03010176|564350287|FG003|Overall Study|Physician Decision|1|||
156341853|NCT03010176|564350288|FG004|Overall Study|Physician Decision|0|||
156341854|NCT03010176|564350289|FG005|Overall Study|Physician Decision|0|||
156341855|NCT03010176|564350284|FG000|Overall Study|Sponsor Decision|0|||
156341856|NCT03010176|564350285|FG001|Overall Study|Sponsor Decision|4|||
156341857|NCT03010176|564350286|FG002|Overall Study|Sponsor Decision|4|||
156341858|NCT03010176|564350287|FG003|Overall Study|Sponsor Decision|1|||
156341859|NCT03010176|564350288|FG004|Overall Study|Sponsor Decision|6|||
156341860|NCT03010176|564350289|FG005|Overall Study|Sponsor Decision|0|||
156341861|NCT03010176|564350284|FG000|Overall Study|Withdrawal by Subject|11|||
156341862|NCT03010176|564350285|FG001|Overall Study|Withdrawal by Subject|9|||
156470282|NCT02307682|564814972|FG001|Overall Study|Lack of Efficacy|0|||
156470283|NCT02307682|564814973|FG002|Overall Study|Lack of Efficacy|1|||
156470284|NCT02307682|564814971|FG000|Overall Study|Physician Decision|2|||
156470285|NCT02307682|564814972|FG001|Overall Study|Physician Decision|2|||
156470286|NCT02307682|564814973|FG002|Overall Study|Physician Decision|8|||
156470287|NCT02307682|564814971|FG000|Overall Study|Progressive Disease|1|||
156470288|NCT02307682|564814972|FG001|Overall Study|Progressive Disease|0|||
156470289|NCT02307682|564814973|FG002|Overall Study|Progressive Disease|0|||
156470290|NCT02307682|564814971|FG000|Overall Study|Withdrawal by Subject|26|||
156470291|NCT02307682|564814972|FG001|Overall Study|Withdrawal by Subject|34|||
156470292|NCT02307682|564814973|FG002|Overall Study|Withdrawal by Subject|23|||
156470293|NCT02307682|564814971|FG000|Overall Study|Death|9|||
156470294|NCT02307682|564814972|FG001|Overall Study|Death|7|||
156470295|NCT02307682|564814973|FG002|Overall Study|Death|12|||
156470296|NCT02307682|564814971|FG000|Overall Study|Lost to Follow-up|1|||
156470297|NCT02307682|564814972|FG001|Overall Study|Lost to Follow-up|5|||
156470298|NCT02307682|564814973|FG002|Overall Study|Lost to Follow-up|6|||
156470299|NCT02307682|564814971|FG000|Overall Study|Protocol Deviation|0|||
156470300|NCT02307682|564814972|FG001|Overall Study|Protocol Deviation|0|||
156470301|NCT02307682|564814973|FG002|Overall Study|Protocol Deviation|2|||
156470302|NCT02307682|564814971|FG000|Overall Study|Other|1|||
156470303|NCT02307682|564814972|FG001|Overall Study|Other|1|||
156848113|NCT01751984|566196694|FG001|Overall Study|Withdrawal by Subject|1|||
156341863|NCT03010176|564350286|FG002|Overall Study|Withdrawal by Subject|3|||
156341864|NCT03010176|564350287|FG003|Overall Study|Withdrawal by Subject|0|||
156341865|NCT03010176|564350288|FG004|Overall Study|Withdrawal by Subject|4|||
156341866|NCT03010176|564350289|FG005|Overall Study|Withdrawal by Subject|0|||
156341867|NCT04220866|564350290|FG000|Overall Study|Death|4|||
156341868|NCT04220866|564350291|FG001|Overall Study|Death|5|||
156470304|NCT02307682|564814973|FG002|Overall Study|Other|0|||
156470305|NCT02386098|564816203|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
156470306|NCT02386098|564816204|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
156470307|NCT02386098|564816205|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
156848114|NCT01751984|566196693|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
156848115|NCT01751984|566196694|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
156848116|NCT00950846|566196695|FG000|Overall Study|Death|6|||
156848117|NCT00950846|566196695|FG000|Overall Study|Lost to Follow-up|3|||
156541804|NCT02113436|565076620|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
156541805|NCT02113436|565076621|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
156541806|NCT02113436|565076622|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
156541807|NCT02113436|565076623|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
156541808|NCT05895552|565076627|FG000|Overall Study|Adverse Event|2|||
156541809|NCT05895552|565076628|FG001|Overall Study|Adverse Event|2|||
156541810|NCT05895552|565076629|FG002|Overall Study|Adverse Event|1|||
156541811|NCT05895552|565076627|FG000|Overall Study|Lost to Follow-up|0|||
156541812|NCT05895552|565076628|FG001|Overall Study|Lost to Follow-up|1|||
156541813|NCT05895552|565076629|FG002|Overall Study|Lost to Follow-up|0|||
156541814|NCT05895552|565076627|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156541815|NCT05895552|565076628|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156541816|NCT05895552|565076629|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156541817|NCT05895552|565076627|FG000|Overall Study|Protocol Deviation|0|||
156541818|NCT05895552|565076628|FG001|Overall Study|Protocol Deviation|0|||
156541819|NCT05895552|565076629|FG002|Overall Study|Protocol Deviation|2|||
156541820|NCT05895552|565076627|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
156541821|NCT05895552|565076628|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
156541822|NCT05895552|565076629|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
156541823|NCT05895552|565076627|FG000|Overall Study|Withdrawal by Subject|2|||
156541824|NCT05895552|565076628|FG001|Overall Study|Withdrawal by Subject|2|||
156541825|NCT05895552|565076629|FG002|Overall Study|Withdrawal by Subject|4|||
156541826|NCT04206605|565076633|FG000|Overall Study|Adverse Event|0|||
156541827|NCT04206605|565076634|FG001|Overall Study|Adverse Event|1|||
156541828|NCT04206605|565076633|FG000|Overall Study|Withdrawal by Subject|1|||
156541829|NCT04206605|565076634|FG001|Overall Study|Withdrawal by Subject|0|||
156541830|NCT00843518|565076640|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
156541831|NCT00843518|565076641|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
156541832|NCT00843518|565076640|FG000|Period 2 (Double-blind Treatment)|Death|0|||
156541833|NCT00843518|565076641|FG001|Period 2 (Double-blind Treatment)|Death|1|||
156541834|NCT00843518|565076640|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
156541835|NCT00843518|565076641|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
156541836|NCT00843518|565076640|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
156541837|NCT00843518|565076641|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
156541838|NCT00843518|565076640|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
156541839|NCT00843518|565076641|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
156541840|NCT00843518|565076640|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
156541841|NCT00843518|565076641|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
156541842|NCT00843518|565076640|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
156541843|NCT00843518|565076641|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
156541844|NCT00133991|565076642|FG000|Overall Study|Death|4|||
156541845|NCT03418129|565076648|FG000|Overall Study|Lost to Follow-up|11|||
156541846|NCT03418129|565076649|FG001|Overall Study|Lost to Follow-up|20|||
156541847|NCT03418129|565076650|FG002|Overall Study|Lost to Follow-up|15|||
156541848|NCT03418129|565076648|FG000|Overall Study|Withdrawal by Subject|3|||
156541849|NCT03418129|565076649|FG001|Overall Study|Withdrawal by Subject|6|||
156541850|NCT03418129|565076650|FG002|Overall Study|Withdrawal by Subject|4|||
156541851|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
156541852|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
156541853|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
156541854|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
156541855|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
156541856|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
156541857|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156541858|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156541859|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
156541860|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
156541861|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
156541862|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
156541863|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
156541864|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
156541865|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
156541866|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
156541867|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
156541868|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
156541869|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
156541870|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
156541871|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
156541872|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
156541873|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
156541874|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
156541875|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Death|2|||
156848118|NCT00950846|566196695|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
156848119|NCT00587158|566196696|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
156848120|NCT00587158|566196697|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
156848121|NCT00587158|566196696|FG000|Overall Study|Physician Decision|0|||
156848122|NCT00587158|566196697|FG001|Overall Study|Physician Decision|1|||
156848123|NCT00587158|566196696|FG000|Overall Study|Lost to Follow-up|1|||
156848124|NCT00587158|566196697|FG001|Overall Study|Lost to Follow-up|2|||
156848125|NCT00587158|566196696|FG000|Overall Study|Death|0|||
156848126|NCT00587158|566196697|FG001|Overall Study|Death|1|||
156848127|NCT00587158|566196696|FG000|Overall Study|Subject did not want to take study med|0|||
156848128|NCT00587158|566196697|FG001|Overall Study|Subject did not want to take study med|1|||
156541876|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Death|1|||
156541877|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Death|0|||
156541878|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Death|0|||
156541879|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
156541880|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
156541881|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
156541882|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
156541883|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
156541884|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
156541885|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
156541886|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
156541887|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
156541888|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
156541889|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
156541890|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
156541891|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
156541892|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
156541893|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
156541894|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
156541895|NCT01940471|565076653|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
156541896|NCT01940471|565076654|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
156541897|NCT01940471|565076655|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
156541898|NCT01940471|565076656|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
156541899|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
156541900|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
156541901|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
156541902|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
156541903|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
156541904|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
156541905|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
156541906|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
156541907|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
156541908|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
156541909|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
156565214|NCT03263806|565157643|FG000|Overall Study|Withdrawal by Subject|0|||
156470308|NCT02386098|564816206|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
156470309|NCT02386098|564816207|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
156470310|NCT02386098|564816203|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
156470311|NCT02386098|564816204|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
156470312|NCT02386098|564816205|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
156470313|NCT02386098|564816206|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
156470314|NCT02386098|564816207|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
156470315|NCT02386098|564816203|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
156470316|NCT02386098|564816204|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
156470317|NCT02386098|564816205|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
156470318|NCT02386098|564816206|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
156470319|NCT02386098|564816207|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
156470320|NCT02386098|564816203|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
156470321|NCT02386098|564816204|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
156470322|NCT02386098|564816205|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
156470323|NCT02386098|564816206|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
156341869|NCT04220866|564350290|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
156341870|NCT04220866|564350291|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
156341871|NCT04220866|564350290|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
156341872|NCT04220866|564350291|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
156341873|NCT04220866|564350290|FG000|Overall Study|Withdrawal by Subject|0|||
156341874|NCT04220866|564350291|FG001|Overall Study|Withdrawal by Subject|1|||
156341875|NCT03858309|564350296|FG000|Overall Study|Withdrawal by Subject|2|||
156341876|NCT03858309|564350297|FG001|Overall Study|Withdrawal by Subject|3|||
156341877|NCT03897465|564350306|FG000|Overall Study|Lost to Follow-up|2|||
156848131|NCT01136408|566196699|FG000|Overall Study|Adverse Event|4|||
156848132|NCT01136408|566196700|FG001|Overall Study|Adverse Event|8|||
156848133|NCT01136408|566196701|FG002|Overall Study|Adverse Event|4|||
156848134|NCT01136408|566196699|FG000|Overall Study|Protocol Violation|1|||
156848135|NCT01136408|566196700|FG001|Overall Study|Protocol Violation|1|||
156848136|NCT01136408|566196701|FG002|Overall Study|Protocol Violation|1|||
156848137|NCT02274792|566196702|FG000|Overall Study|Withdrawal by Subject|13|||
156848138|NCT02274792|566196702|FG000|Overall Study|Lost to Follow-up|8|||
156848139|NCT02274792|566196702|FG000|Overall Study|Protocol Specified Criteria|2|||
156848140|NCT02274792|566196702|FG000|Overall Study|Sponsor Decision|2|||
156848141|NCT01510158|566196703|FG000|Overall Study|Adverse Event|7|||
156341878|NCT03897465|564350307|FG001|Overall Study|Lost to Follow-up|1|||
156341879|NCT03897465|564350306|FG000|Overall Study|Adverse Event|2|||
156470324|NCT02386098|564816207|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
156470325|NCT02386098|564816203|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
156470326|NCT02386098|564816204|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
156470327|NCT02386098|564816205|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
156470328|NCT02386098|564816206|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
156470329|NCT02386098|564816207|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
156470330|NCT02386098|564816203|FG000|Stage 1 (96 Weeks)|Other|1|||
156470331|NCT02386098|564816204|FG001|Stage 1 (96 Weeks)|Other|0|||
156470332|NCT02386098|564816205|FG002|Stage 1 (96 Weeks)|Other|0|||
156470333|NCT02386098|564816206|FG003|Stage 1 (96 Weeks)|Other|0|||
156470334|NCT02386098|564816207|FG004|Stage 1 (96 Weeks)|Other|0|||
156470335|NCT02386098|564816203|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
156470336|NCT02386098|564816204|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
156470337|NCT02386098|564816205|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
156470338|NCT02386098|564816206|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
156470339|NCT02386098|564816207|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
156470340|NCT03002194|564816210|FG000|Overall Study|Lost to Follow-up|6|||
156470341|NCT03002194|564816210|FG000|Overall Study|Adverse Event|1|||
156470342|NCT03002194|564816210|FG000|Overall Study|Lack of Efficacy|1|||
156470343|NCT03002194|564816210|FG000|Overall Study|Withdrawal by Subject|2|||
156470344|NCT02200705|564816211|FG000|Overall Study|Excluded|12|||
156470345|NCT02200705|564816211|FG000|Overall Study|Death|21|||
156470346|NCT02200705|564816211|FG000|Overall Study|Withdrawal by Subject|22|||
156470347|NCT02200705|564816211|FG000|Overall Study|Lost to Follow-up|13|||
156470348|NCT02200705|564816211|FG000|Overall Study|Physician Decision|5|||
156470349|NCT02200705|564816211|FG000|Overall Study|Adverse Event|2|||
156470350|NCT05250115|564816212|FG000|Overall Study|Premature study end|40|||
156470351|NCT05250115|564816212|FG000|Overall Study|Adverse Event|8|||
156848142|NCT01510158|566196704|FG001|Overall Study|Adverse Event|8|||
156848143|NCT01510158|566196705|FG002|Overall Study|Adverse Event|5|||
156848144|NCT01510158|566196703|FG000|Overall Study|Gout flare|1|||
156848145|NCT01510158|566196704|FG001|Overall Study|Gout flare|0|||
156848146|NCT01510158|566196705|FG002|Overall Study|Gout flare|0|||
156848147|NCT01510158|566196703|FG000|Overall Study|Protocol Violation|17|||
156848148|NCT01510158|566196704|FG001|Overall Study|Protocol Violation|16|||
156848149|NCT01510158|566196705|FG002|Overall Study|Protocol Violation|24|||
156848150|NCT01510158|566196703|FG000|Overall Study|Sponsor terminated study.|2|||
156848151|NCT01510158|566196704|FG001|Overall Study|Sponsor terminated study.|0|||
156848152|NCT01510158|566196705|FG002|Overall Study|Sponsor terminated study.|2|||
156848153|NCT01510158|566196703|FG000|Overall Study|Lost to Follow-up|13|||
156848154|NCT01510158|566196704|FG001|Overall Study|Lost to Follow-up|16|||
156848155|NCT01510158|566196705|FG002|Overall Study|Lost to Follow-up|9|||
156848156|NCT01510158|566196703|FG000|Overall Study|Withdrawal by Subject|10|||
156848157|NCT01510158|566196704|FG001|Overall Study|Withdrawal by Subject|13|||
156848158|NCT01510158|566196705|FG002|Overall Study|Withdrawal by Subject|10|||
156341880|NCT03897465|564350307|FG001|Overall Study|Adverse Event|0|||
156470352|NCT05250115|564816212|FG000|Overall Study|Lost to Follow-up|7|||
156470353|NCT05250115|564816212|FG000|Overall Study|Withdrawal by Subject|6|||
156470354|NCT05250115|564816212|FG000|Overall Study|Withdrawal of informed consent|1|||
156470355|NCT05250115|564816212|FG000|Overall Study|Other|7|||
156470356|NCT02633215|564816216|FG000|Overall Study|Lost to Follow-up|2|||
156470357|NCT02633215|564816217|FG001|Overall Study|Lost to Follow-up|3|||
156848159|NCT01510158|566196703|FG000|Overall Study|Death|1|||
156848160|NCT01510158|566196704|FG001|Overall Study|Death|0|||
156848161|NCT01510158|566196705|FG002|Overall Study|Death|0|||
156848162|NCT03078556|566196706|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
156848163|NCT03078556|566196707|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
156848164|NCT03078556|566196708|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
156848165|NCT03078556|566196709|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
156848166|NCT03078556|566196706|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
156848167|NCT03078556|566196707|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
156848168|NCT03078556|566196708|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
156848169|NCT03078556|566196709|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
156848170|NCT03078556|566196706|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
156848171|NCT03078556|566196707|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
156848172|NCT03078556|566196708|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
156848173|NCT03078556|566196709|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
156848174|NCT03078556|566196706|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
156848175|NCT03078556|566196707|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
156848176|NCT03078556|566196708|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
156848177|NCT03078556|566196709|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
156848178|NCT00832416|566196716|FG000|Overall Study|Lack of Efficacy|17|||
156848179|NCT00832416|566196717|FG001|Overall Study|Lack of Efficacy|15|||
156848180|NCT00832416|566196718|FG002|Overall Study|Lack of Efficacy|13|||
156848181|NCT00832416|566196719|FG003|Overall Study|Lack of Efficacy|52|||
156848182|NCT00832416|566196716|FG000|Overall Study|Withdrawal by Subject|5|||
156848183|NCT00832416|566196717|FG001|Overall Study|Withdrawal by Subject|7|||
156848184|NCT00832416|566196718|FG002|Overall Study|Withdrawal by Subject|2|||
156848185|NCT00832416|566196719|FG003|Overall Study|Withdrawal by Subject|10|||
156848186|NCT00832416|566196716|FG000|Overall Study|Physician Decision|2|||
156848187|NCT00832416|566196717|FG001|Overall Study|Physician Decision|12|||
156848188|NCT00832416|566196718|FG002|Overall Study|Physician Decision|5|||
156848189|NCT00832416|566196719|FG003|Overall Study|Physician Decision|10|||
156848190|NCT00832416|566196716|FG000|Overall Study|Administrative|0|||
156848191|NCT00832416|566196717|FG001|Overall Study|Administrative|0|||
156848192|NCT00832416|566196718|FG002|Overall Study|Administrative|0|||
156848193|NCT00832416|566196719|FG003|Overall Study|Administrative|1|||
156848194|NCT00832416|566196716|FG000|Overall Study|Adverse Event|21|||
156848195|NCT00832416|566196717|FG001|Overall Study|Adverse Event|19|||
156848196|NCT00832416|566196718|FG002|Overall Study|Adverse Event|41|||
156848197|NCT00832416|566196719|FG003|Overall Study|Adverse Event|10|||
156848198|NCT00832416|566196716|FG000|Overall Study|Death|1|||
156848199|NCT00832416|566196717|FG001|Overall Study|Death|0|||
156848200|NCT00832416|566196718|FG002|Overall Study|Death|0|||
156848201|NCT00832416|566196719|FG003|Overall Study|Death|0|||
156848202|NCT02114606|566196720|FG000|Overall Study|Unable to swallow Cytosponge|6|||
156848203|NCT00981461|566196721|FG000|Overall Study|Lost to Follow-up|5|||
156341881|NCT03897465|564350306|FG000|Overall Study|complete healing by V2|1|||
156848204|NCT00981461|566196722|FG001|Overall Study|Lost to Follow-up|2|||
156848205|NCT04421482|566196729|FG000|Overall Study|Physician Decision|1|||
156848206|NCT00483405|566196732|FG000|Overall Study|Adverse Event|8|||
156848207|NCT00483405|566196732|FG000|Overall Study|Lack of Efficacy|14|||
156848208|NCT00483405|566196732|FG000|Overall Study|Death|3|||
156848209|NCT00483405|566196732|FG000|Overall Study|Withdrawal by Subject|2|||
156848210|NCT00483405|566196732|FG000|Overall Study|Other complicating disease|1|||
156848211|NCT00571038|566196733|FG000|Overall Study|Lost to Follow-up|1|||
156848212|NCT00571038|566196734|FG001|Overall Study|Lost to Follow-up|4|||
156848213|NCT00571038|566196733|FG000|Overall Study|Death|7|||
156848214|NCT00571038|566196734|FG001|Overall Study|Death|5|||
156848215|NCT00571038|566196733|FG000|Overall Study|Withdrawal by Subject|1|||
156848216|NCT00571038|566196734|FG001|Overall Study|Withdrawal by Subject|3|||
156848217|NCT00571038|566196733|FG000|Overall Study|Moved out of state|2|||
156848218|NCT00571038|566196734|FG001|Overall Study|Moved out of state|2|||
156848219|NCT03010319|566196735|FG000|Overall Study|Adverse Event|15|||
156848220|NCT03010319|566196736|FG001|Overall Study|Adverse Event|9|||
156848221|NCT03010319|566196735|FG000|Overall Study|Withdrawal by Subject|1|||
156848222|NCT03010319|566196736|FG001|Overall Study|Withdrawal by Subject|6|||
156848223|NCT03010319|566196735|FG000|Overall Study|Physician Decision|2|||
156848224|NCT03010319|566196736|FG001|Overall Study|Physician Decision|4|||
156848225|NCT03010319|566196735|FG000|Overall Study|Sponsor requested withdrawal|2|||
156848226|NCT03010319|566196736|FG001|Overall Study|Sponsor requested withdrawal|2|||
156848227|NCT03010319|566196735|FG000|Overall Study|Death|1|||
156848228|NCT03010319|566196736|FG001|Overall Study|Death|0|||
156848229|NCT03010319|566196735|FG000|Overall Study|Lost to Follow-up|0|||
156848230|NCT03010319|566196736|FG001|Overall Study|Lost to Follow-up|1|||
156848231|NCT03010319|566196735|FG000|Overall Study|Other Reason|5|||
156848232|NCT03010319|566196736|FG001|Overall Study|Other Reason|7|||
156848233|NCT02128724|566196737|FG000|Overall Study|Death|1|||
156848234|NCT02128724|566196738|FG001|Overall Study|Death|0|||
156848235|NCT02128724|566196739|FG002|Overall Study|Death|0|||
156848236|NCT02128724|566196740|FG003|Overall Study|Death|0|||
156848237|NCT02128724|566196737|FG000|Overall Study|Adverse Event|0|||
156848238|NCT02128724|566196738|FG001|Overall Study|Adverse Event|1|||
156848239|NCT02128724|566196739|FG002|Overall Study|Adverse Event|0|||
156848240|NCT02128724|566196740|FG003|Overall Study|Adverse Event|0|||
156848241|NCT02128724|566196737|FG000|Overall Study|Physician Decision|0|||
156848242|NCT02128724|566196738|FG001|Overall Study|Physician Decision|0|||
156848243|NCT02128724|566196739|FG002|Overall Study|Physician Decision|0|||
156848244|NCT02128724|566196740|FG003|Overall Study|Physician Decision|2|||
156848245|NCT02128724|566196737|FG000|Overall Study|Withdrawal by Subject|0|||
156848246|NCT02128724|566196738|FG001|Overall Study|Withdrawal by Subject|0|||
156848247|NCT02128724|566196739|FG002|Overall Study|Withdrawal by Subject|0|||
156848248|NCT02128724|566196740|FG003|Overall Study|Withdrawal by Subject|1|||
156848249|NCT05786508|566196742|FG000|Overall Study|Withdrawal by Subject|2|||
156848250|NCT05786508|566196743|FG001|Overall Study|Withdrawal by Subject|0|||
156848251|NCT04426318|566196744|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
156848252|NCT04426318|566196745|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
156470358|NCT00754325|564816218|FG000|Initial Treatment|Continuing Active Treatment|4|||
156470359|NCT00754325|564816219|FG001|Initial Treatment|Continuing Active Treatment|5|||
156470360|NCT00754325|564816218|FG000|Initial Treatment|Adverse Event|7|||
156848253|NCT02588261|566196748|FG000|Overall Study|Study Terminated by Sponsor|157|||
156848254|NCT02588261|566196749|FG001|Overall Study|Study Terminated by Sponsor|142|||
156341882|NCT03897465|564350307|FG001|Overall Study|complete healing by V2|0|||
156470361|NCT00754325|564816219|FG001|Initial Treatment|Adverse Event|6|||
156470362|NCT00754325|564816218|FG000|Initial Treatment|Withdrawal by Subject|2|||
156470363|NCT00754325|564816219|FG001|Initial Treatment|Withdrawal by Subject|2|||
156470364|NCT00754325|564816218|FG000|Initial Treatment|Physician Decision|2|||
156470365|NCT00754325|564816219|FG001|Initial Treatment|Physician Decision|0|||
156470366|NCT00754325|564816218|FG000|Initial Treatment|Sponsor Request|0|||
156470367|NCT00754325|564816219|FG001|Initial Treatment|Sponsor Request|1|||
156470368|NCT00754325|564816218|FG000|Initial Treatment|Disease Progression|35|||
156470369|NCT00754325|564816219|FG001|Initial Treatment|Disease Progression|35|||
156470370|NCT03801148|564816220|FG000|Period 1 (2 Days)|Adverse Event|1|||
156470371|NCT03801148|564816221|FG001|Period 1 (2 Days)|Adverse Event|1|||
156470372|NCT03801148|564816222|FG002|Period 1 (2 Days)|Adverse Event|0|||
156470373|NCT03801148|564816223|FG003|Period 1 (2 Days)|Adverse Event|0|||
156470374|NCT03801148|564816220|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
156470375|NCT03801148|564816221|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
156470376|NCT03801148|564816222|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
156470377|NCT03801148|564816223|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
156470378|NCT03801148|564816220|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156470379|NCT03801148|564816221|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156470380|NCT03801148|564816222|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
156470381|NCT03801148|564816223|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156470382|NCT03801148|564816220|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
156470383|NCT03801148|564816221|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
156470384|NCT03801148|564816222|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
156470385|NCT03801148|564816223|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
156470386|NCT06212752|564816224|FG000|Overall Study|Death|5|||
156470387|NCT06212752|564816225|FG001|Overall Study|Death|3|||
156470388|NCT06212752|564816224|FG000|Overall Study|Participants ongoing|23|||
156470389|NCT06212752|564816225|FG001|Overall Study|Participants ongoing|8|||
156470390|NCT04162210|564816226|FG000|Overall Study|Lost to Follow-up|4|||
156470391|NCT04162210|564816227|FG001|Overall Study|Lost to Follow-up|1|||
156470392|NCT04162210|564816226|FG000|Overall Study|Withdrawal by Subject|17|||
156470393|NCT04162210|564816227|FG001|Overall Study|Withdrawal by Subject|9|||
156470394|NCT04162210|564816226|FG000|Overall Study|Ongoing|113|||
156470395|NCT04162210|564816227|FG001|Overall Study|Ongoing|59|||
156470396|NCT00371345|564816228|FG000|Overall Study|Disease Progression|21|||
156470397|NCT00371345|564816229|FG001|Overall Study|Disease Progression|35|||
156470398|NCT00371345|564816228|FG000|Overall Study|Study Drug Toxicity|1|||
156470399|NCT00371345|564816229|FG001|Overall Study|Study Drug Toxicity|7|||
156470400|NCT00371345|564816228|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
156470401|NCT00371345|564816229|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
156470402|NCT00371345|564816228|FG000|Overall Study|Participant Request|1|||
156470403|NCT00371345|564816229|FG001|Overall Study|Participant Request|1|||
156470404|NCT00371345|564816228|FG000|Overall Study|Participant Withdrew Consent|0|||
156470405|NCT00371345|564816229|FG001|Overall Study|Participant Withdrew Consent|1|||
156470406|NCT00705406|564816230|FG000|Overall Study|Lost to Follow-up|3|||
156848255|NCT02588261|566196748|FG000|Overall Study|Protocol Deviation|1|||
156848256|NCT02588261|566196749|FG001|Overall Study|Protocol Deviation|0|||
156848257|NCT02588261|566196748|FG000|Overall Study|Death|1|||
156341883|NCT03897465|564350306|FG000|Overall Study|occurence of exclusion criterion|1|||
156470407|NCT00705406|564816231|FG001|Overall Study|Lost to Follow-up|3|||
156470408|NCT00705406|564816230|FG000|Overall Study|Did not receive study drug|1|||
156470409|NCT00705406|564816231|FG001|Overall Study|Did not receive study drug|2|||
156470410|NCT01779700|564816232|FG000|Overall Study|Adverse Event|4|||
156470411|NCT01779700|564816233|FG001|Overall Study|Adverse Event|3|||
156541910|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
156541911|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
156541912|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
156541913|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
156541914|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
156541915|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
156541916|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
156541917|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
156541918|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
156541919|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
156541920|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
156541921|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
156541922|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
156541923|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
156848258|NCT02588261|566196749|FG001|Overall Study|Death|2|||
156848259|NCT02588261|566196748|FG000|Overall Study|Withdrawal by Subject|12|||
156848260|NCT02588261|566196749|FG001|Overall Study|Withdrawal by Subject|8|||
156848261|NCT02588261|566196748|FG000|Overall Study|Noncompliance with Study Drug|0|||
156848262|NCT02588261|566196749|FG001|Overall Study|Noncompliance with Study Drug|1|||
156848263|NCT02588261|566196748|FG000|Overall Study|Miscellaneous|5|||
156848264|NCT02588261|566196749|FG001|Overall Study|Miscellaneous|4|||
156470412|NCT01779700|564816232|FG000|Overall Study|Withdrawal by Subject|0|||
156470413|NCT01779700|564816233|FG001|Overall Study|Withdrawal by Subject|2|||
156470414|NCT00442104|564816234|FG000|Overall Study|Adverse Event|5|||
156470415|NCT00442104|564816234|FG000|Overall Study|Death|2|||
156470416|NCT00442104|564816234|FG000|Overall Study|Lost to Follow-up|3|||
156470417|NCT00442104|564816234|FG000|Overall Study|Withdrawal by Subject|5|||
156470418|NCT00442104|564816234|FG000|Overall Study|Insufficient Clinical Response|10|||
156470419|NCT00442104|564816234|FG000|Overall Study|Other|21|||
156470420|NCT00442104|564816234|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
156470421|NCT00918333|564816237|FG000|Overall Study|Drug not taken per protocol|1|||
156470422|NCT00918333|564816238|FG001|Overall Study|Drug not taken per protocol|0|||
156470423|NCT00918333|564816237|FG000|Overall Study|Inadequate amount of drugs provided|1|||
156470424|NCT00918333|564816238|FG001|Overall Study|Inadequate amount of drugs provided|4|||
156470425|NCT00918333|564816237|FG000|Overall Study|Ineligible|1|||
156470426|NCT00918333|564816238|FG001|Overall Study|Ineligible|0|||
156470427|NCT00918333|564816237|FG000|Overall Study|Withdrawal by Subject|0|||
156470428|NCT00918333|564816238|FG001|Overall Study|Withdrawal by Subject|1|||
156470429|NCT04497415|564816239|FG000|Overall Study|Lost to Follow-up|43|||
156470430|NCT04497415|564816240|FG001|Overall Study|Lost to Follow-up|27|||
156470431|NCT00263757|564816241|FG000|Overall Study|Withdrawal by Subject|5|||
156470432|NCT00263757|564816242|FG001|Overall Study|Withdrawal by Subject|4|||
156470433|NCT00263757|564816241|FG000|Overall Study|Screen failure|0|||
156848265|NCT02588261|566196748|FG000|Overall Study|Progressive Disease|61|||
156848266|NCT02588261|566196749|FG001|Overall Study|Progressive Disease|82|||
156848267|NCT02588261|566196748|FG000|Overall Study|Adverse Event|29|||
156848268|NCT02588261|566196749|FG001|Overall Study|Adverse Event|24|||
156848269|NCT02588261|566196748|FG000|Overall Study|Lost to Follow-up|1|||
156848270|NCT02588261|566196749|FG001|Overall Study|Lost to Follow-up|0|||
156848271|NCT03781778|566196750|FG000|Overall Study|Withdrawal by Subject|2|||
156848272|NCT03781778|566196751|FG001|Overall Study|Withdrawal by Subject|2|||
156848273|NCT02287467|566196752|FG000|Overall Study|Protocol Violation|12|||
156848274|NCT02287467|566196753|FG001|Overall Study|Protocol Violation|9|||
156848275|NCT01456169|566196755|FG000|Overall Study|Adverse Event|1|||
156848276|NCT01456169|566196756|FG001|Overall Study|Adverse Event|2|||
156848277|NCT01456169|566196757|FG002|Overall Study|Adverse Event|7|||
156848278|NCT01456169|566196755|FG000|Overall Study|Major Protocol Deviation|3|||
156848279|NCT01456169|566196756|FG001|Overall Study|Major Protocol Deviation|2|||
156848280|NCT01456169|566196757|FG002|Overall Study|Major Protocol Deviation|3|||
156848281|NCT01456169|566196755|FG000|Overall Study|Voluntary Withdrawal|3|||
156848282|NCT01456169|566196756|FG001|Overall Study|Voluntary Withdrawal|0|||
156848283|NCT01456169|566196757|FG002|Overall Study|Voluntary Withdrawal|2|||
156848284|NCT01456169|566196755|FG000|Overall Study|Lack of Efficacy|2|||
156848285|NCT01456169|566196756|FG001|Overall Study|Lack of Efficacy|0|||
156848286|NCT01456169|566196757|FG002|Overall Study|Lack of Efficacy|0|||
156848287|NCT01456169|566196755|FG000|Overall Study|Other|1|||
156848288|NCT01456169|566196756|FG001|Overall Study|Other|1|||
156848289|NCT01456169|566196757|FG002|Overall Study|Other|0|||
156848290|NCT02292446|566196758|FG000|Overall Study|Adverse Event|12|||
156848291|NCT02292446|566196758|FG000|Overall Study|Death|1|||
156848292|NCT02292446|566196758|FG000|Overall Study|Disease progression|2|||
156848293|NCT02292446|566196758|FG000|Overall Study|Subject/guardian decision|2|||
156848294|NCT02292446|566196758|FG000|Overall Study|Withdrawal by Subject|3|||
156848295|NCT02652156|566196762|FG000|Overall Study|Physician Decision|1|||
156848296|NCT02652156|566196763|FG001|Overall Study|Physician Decision|0|||
156848297|NCT02652156|566196764|FG002|Overall Study|Physician Decision|0|||
156848298|NCT00570310|566196765|FG000|Overall Study|Adverse Event|1|||
156848299|NCT00570310|566196766|FG001|Overall Study|Adverse Event|2|||
156470434|NCT00263757|564816242|FG001|Overall Study|Screen failure|1|||
156470435|NCT00263757|564816241|FG000|Overall Study|Adverse Event|3|||
156470436|NCT00263757|564816242|FG001|Overall Study|Adverse Event|3|||
156470437|NCT03021993|564816250|FG000|Overall Study|Withdrawal by Subject|4|||
156470438|NCT03021993|564816250|FG000|Overall Study|Physician Decision|1|||
156470439|NCT03021993|564816250|FG000|Overall Study|enrolled but were not treated|1|||
156470440|NCT03021993|564816250|FG000|Overall Study|Death|3|||
156470441|NCT01588951|564816262|FG000|Overall Study|Ineligible in retrospect|0|||
156470442|NCT01588951|564816263|FG001|Overall Study|Ineligible in retrospect|0|||
156470443|NCT01588951|564816264|FG002|Overall Study|Ineligible in retrospect|1|||
156470444|NCT02499328|564816266|FG000|Overall Study|Withdrawal by Subject|1|||
156470445|NCT02499328|564816267|FG001|Overall Study|Withdrawal by Subject|1|||
156470446|NCT02499328|564816268|FG002|Overall Study|Withdrawal by Subject|5|||
156470447|NCT02499328|564816269|FG003|Overall Study|Withdrawal by Subject|3|||
156470448|NCT02499328|564816270|FG004|Overall Study|Withdrawal by Subject|5|||
156470449|NCT02499328|564816271|FG005|Overall Study|Withdrawal by Subject|0|||
156470450|NCT02499328|564816272|FG006|Overall Study|Withdrawal by Subject|0|||
156470451|NCT02499328|564816273|FG007|Overall Study|Withdrawal by Subject|0|||
156470452|NCT02499328|564816274|FG008|Overall Study|Withdrawal by Subject|2|||
156470453|NCT02499328|564816275|FG009|Overall Study|Withdrawal by Subject|2|||
156470454|NCT02499328|564816276|FG010|Overall Study|Withdrawal by Subject|0|||
156470455|NCT02499328|564816277|FG011|Overall Study|Withdrawal by Subject|3|||
156470456|NCT02499328|564816278|FG012|Overall Study|Withdrawal by Subject|7|||
156470457|NCT02499328|564816279|FG013|Overall Study|Withdrawal by Subject|3|||
156470458|NCT02499328|564816280|FG014|Overall Study|Withdrawal by Subject|1|||
156470459|NCT02499328|564816281|FG015|Overall Study|Withdrawal by Subject|0|||
156470460|NCT02499328|564816282|FG016|Overall Study|Withdrawal by Subject|0|||
156470461|NCT02499328|564816283|FG017|Overall Study|Withdrawal by Subject|3|||
156470462|NCT02499328|564816284|FG018|Overall Study|Withdrawal by Subject|0|||
156470463|NCT02499328|564816266|FG000|Overall Study|Lost to Follow-up|0|||
156470464|NCT02499328|564816267|FG001|Overall Study|Lost to Follow-up|1|||
156470465|NCT02499328|564816268|FG002|Overall Study|Lost to Follow-up|1|||
156470466|NCT02499328|564816269|FG003|Overall Study|Lost to Follow-up|2|||
156470467|NCT02499328|564816270|FG004|Overall Study|Lost to Follow-up|0|||
156470468|NCT02499328|564816271|FG005|Overall Study|Lost to Follow-up|0|||
156470469|NCT02499328|564816272|FG006|Overall Study|Lost to Follow-up|0|||
156470470|NCT02499328|564816273|FG007|Overall Study|Lost to Follow-up|2|||
156470471|NCT02499328|564816274|FG008|Overall Study|Lost to Follow-up|3|||
156470472|NCT02499328|564816275|FG009|Overall Study|Lost to Follow-up|0|||
156470473|NCT02499328|564816276|FG010|Overall Study|Lost to Follow-up|0|||
156470474|NCT02499328|564816277|FG011|Overall Study|Lost to Follow-up|0|||
156470475|NCT02499328|564816278|FG012|Overall Study|Lost to Follow-up|0|||
156470476|NCT02499328|564816279|FG013|Overall Study|Lost to Follow-up|0|||
156470477|NCT02499328|564816280|FG014|Overall Study|Lost to Follow-up|0|||
156470478|NCT02499328|564816281|FG015|Overall Study|Lost to Follow-up|0|||
156470479|NCT02499328|564816282|FG016|Overall Study|Lost to Follow-up|0|||
156470480|NCT02499328|564816283|FG017|Overall Study|Lost to Follow-up|0|||
156470481|NCT02499328|564816284|FG018|Overall Study|Lost to Follow-up|1|||
156470482|NCT02499328|564816266|FG000|Overall Study|Death|0|||
156470483|NCT02499328|564816267|FG001|Overall Study|Death|3|||
156470484|NCT02499328|564816268|FG002|Overall Study|Death|3|||
156470485|NCT02499328|564816269|FG003|Overall Study|Death|2|||
156470486|NCT02499328|564816270|FG004|Overall Study|Death|4|||
156470487|NCT02499328|564816271|FG005|Overall Study|Death|7|||
156470488|NCT02499328|564816272|FG006|Overall Study|Death|3|||
156470489|NCT02499328|564816273|FG007|Overall Study|Death|0|||
156470490|NCT02499328|564816274|FG008|Overall Study|Death|2|||
156470491|NCT02499328|564816275|FG009|Overall Study|Death|6|||
156470492|NCT02499328|564816276|FG010|Overall Study|Death|6|||
156470493|NCT02499328|564816277|FG011|Overall Study|Death|20|||
156470494|NCT02499328|564816278|FG012|Overall Study|Death|9|||
156470495|NCT02499328|564816279|FG013|Overall Study|Death|7|||
156470496|NCT02499328|564816280|FG014|Overall Study|Death|3|||
156470497|NCT02499328|564816281|FG015|Overall Study|Death|1|||
156470498|NCT02499328|564816282|FG016|Overall Study|Death|1|||
156470499|NCT02499328|564816283|FG017|Overall Study|Death|16|||
156848300|NCT00570310|566196765|FG000|Overall Study|Lack of Efficacy|1|||
156470500|NCT02499328|564816284|FG018|Overall Study|Death|5|||
156470501|NCT02499328|564816266|FG000|Overall Study|"Other"|2|||
156470502|NCT02499328|564816267|FG001|Overall Study|"Other"|2|||
156470503|NCT02499328|564816268|FG002|Overall Study|"Other"|1|||
156470504|NCT02499328|564816269|FG003|Overall Study|"Other"|3|||
156470505|NCT02499328|564816270|FG004|Overall Study|"Other"|6|||
156470506|NCT02499328|564816271|FG005|Overall Study|"Other"|2|||
156470507|NCT02499328|564816272|FG006|Overall Study|"Other"|3|||
156848301|NCT00570310|566196766|FG001|Overall Study|Lack of Efficacy|4|||
156848302|NCT00479336|566196768|FG000|Overall Study|Adverse Event|1|||
156848303|NCT00479336|566196769|FG001|Overall Study|Adverse Event|1|||
156848304|NCT00479336|566196770|FG002|Overall Study|Adverse Event|1|||
156848305|NCT00479336|566196771|FG003|Overall Study|Adverse Event|3|||
156848306|NCT00479336|566196768|FG000|Overall Study|Lack of Efficacy|1|||
156848307|NCT00479336|566196769|FG001|Overall Study|Lack of Efficacy|0|||
156848308|NCT00479336|566196770|FG002|Overall Study|Lack of Efficacy|0|||
156848309|NCT00479336|566196771|FG003|Overall Study|Lack of Efficacy|0|||
156848310|NCT00479336|566196768|FG000|Overall Study|Protocol Violation|0|||
156848311|NCT00479336|566196769|FG001|Overall Study|Protocol Violation|1|||
156848312|NCT00479336|566196770|FG002|Overall Study|Protocol Violation|0|||
156848313|NCT00479336|566196771|FG003|Overall Study|Protocol Violation|0|||
156848314|NCT00479336|566196768|FG000|Overall Study|Withdrawal by Subject|1|||
156848315|NCT00479336|566196769|FG001|Overall Study|Withdrawal by Subject|2|||
156848316|NCT00479336|566196770|FG002|Overall Study|Withdrawal by Subject|0|||
156848317|NCT00479336|566196771|FG003|Overall Study|Withdrawal by Subject|0|||
156848318|NCT00479336|566196768|FG000|Overall Study|Physician Decision|0|||
156848319|NCT00479336|566196769|FG001|Overall Study|Physician Decision|1|||
156541924|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
156541925|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
156541926|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
156541927|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
156541928|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
156541929|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
156541930|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
156541931|NCT01940471|565076653|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
156541932|NCT01940471|565076654|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
156541933|NCT01940471|565076655|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
156541934|NCT01940471|565076656|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
156541935|NCT01131520|565076657|FG000|Overall Study|Computer problem|1|||
156541936|NCT01131520|565076658|FG001|Overall Study|Computer problem|0|||
156541937|NCT01131520|565076657|FG000|Overall Study|Counselor not available|0|||
156541938|NCT01131520|565076658|FG001|Overall Study|Counselor not available|3|||
156541939|NCT01131520|565076657|FG000|Overall Study|Subject changed history after enrollment|0|||
156541940|NCT01131520|565076658|FG001|Overall Study|Subject changed history after enrollment|1|||
156541941|NCT04857996|565076663|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
156541942|NCT04857996|565076664|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
156848320|NCT00479336|566196770|FG002|Overall Study|Physician Decision|0|||
156848321|NCT00479336|566196771|FG003|Overall Study|Physician Decision|2|||
156848322|NCT00479336|566196768|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
156848323|NCT00479336|566196769|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
156848324|NCT00479336|566196770|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
156848325|NCT00479336|566196771|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
156848326|NCT03066193|566196772|FG000|Overall Study|Withdrawal by Subject|1|||
156848327|NCT04854551|566196775|FG000|Overall Study|Withdrawal by Subject|1|||
156848328|NCT04854551|566196776|FG001|Overall Study|Withdrawal by Subject|1|||
156848329|NCT01625000|566196781|FG000|Overall Study|Physician Decision|15|||
156848330|NCT01625000|566196782|FG001|Overall Study|Physician Decision|7|||
156848331|NCT01625000|566196783|FG002|Overall Study|Physician Decision|7|||
156848332|NCT01625000|566196784|FG003|Overall Study|Physician Decision|2|||
156848333|NCT01625000|566196785|FG004|Overall Study|Physician Decision|15|||
156848334|NCT01625000|566196781|FG000|Overall Study|Protocol Violation|3|||
156848335|NCT01625000|566196782|FG001|Overall Study|Protocol Violation|10|||
156848336|NCT01625000|566196783|FG002|Overall Study|Protocol Violation|4|||
156848337|NCT01625000|566196784|FG003|Overall Study|Protocol Violation|1|||
156848338|NCT01625000|566196785|FG004|Overall Study|Protocol Violation|2|||
156848339|NCT01625000|566196781|FG000|Overall Study|Withdrawal by Subject|19|||
156848340|NCT01625000|566196782|FG001|Overall Study|Withdrawal by Subject|16|||
156848341|NCT01625000|566196783|FG002|Overall Study|Withdrawal by Subject|11|||
156848342|NCT01625000|566196784|FG003|Overall Study|Withdrawal by Subject|9|||
156848343|NCT01625000|566196785|FG004|Overall Study|Withdrawal by Subject|17|||
156848344|NCT01625000|566196781|FG000|Overall Study|Adverse Event (including Death)|15|||
156848345|NCT01625000|566196782|FG001|Overall Study|Adverse Event (including Death)|19|||
156848346|NCT01625000|566196783|FG002|Overall Study|Adverse Event (including Death)|11|||
156848347|NCT01625000|566196784|FG003|Overall Study|Adverse Event (including Death)|7|||
156848348|NCT01625000|566196785|FG004|Overall Study|Adverse Event (including Death)|21|||
156848349|NCT00566852|566196786|FG000|Overall Study|Protocol Violation|22|||
156848350|NCT00566852|566196787|FG001|Overall Study|Protocol Violation|24|||
156848351|NCT00566852|566196786|FG000|Overall Study|Death|95|||
156848352|NCT00566852|566196787|FG001|Overall Study|Death|78|||
156848353|NCT00566852|566196786|FG000|Overall Study|Withdrawal by Subject|30|||
156848354|NCT00566852|566196787|FG001|Overall Study|Withdrawal by Subject|25|||
156848355|NCT00566852|566196786|FG000|Overall Study|Patient refusal|37|||
156848356|NCT00566852|566196787|FG001|Overall Study|Patient refusal|37|||
156848357|NCT00566852|566196786|FG000|Overall Study|Not tested due to disability|6|||
156848358|NCT00566852|566196787|FG001|Overall Study|Not tested due to disability|12|||
156848359|NCT00566852|566196786|FG000|Overall Study|Missing reason not specified|1|||
156848360|NCT00566852|566196787|FG001|Overall Study|Missing reason not specified|2|||
156848361|NCT00566852|566196786|FG000|Overall Study|Missing reason not reported|16|||
156848362|NCT00566852|566196787|FG001|Overall Study|Missing reason not reported|20|||
156848363|NCT00132808|566196788|FG000|Stratum I|Adverse Event|2|||
156848364|NCT00132808|566196789|FG001|Stratum I|Adverse Event|1|||
156848365|NCT00132808|566196790|FG002|Stratum I|Adverse Event|0|||
156848366|NCT00132808|566196788|FG000|Stratum I|Lost to Follow-up|3|||
156848367|NCT00132808|566196789|FG001|Stratum I|Lost to Follow-up|4|||
156848368|NCT00132808|566196790|FG002|Stratum I|Lost to Follow-up|1|||
156848369|NCT00132808|566196788|FG000|Stratum I|Withdrawal by Subject|4|||
156848370|NCT00132808|566196789|FG001|Stratum I|Withdrawal by Subject|7|||
156848371|NCT00132808|566196790|FG002|Stratum I|Withdrawal by Subject|3|||
156848372|NCT00132808|566196788|FG000|Stratum I|Abnormal test procedure result (s)|0|||
156848373|NCT00132808|566196789|FG001|Stratum I|Abnormal test procedure result (s)|0|||
156848374|NCT00132808|566196790|FG002|Stratum I|Abnormal test procedure result (s)|1|||
156848375|NCT00132808|566196788|FG000|Stratum II|Adverse Event|1|||
156848376|NCT00132808|566196789|FG001|Stratum II|Adverse Event|2|||
156848377|NCT00132808|566196790|FG002|Stratum II|Adverse Event|1|||
156848378|NCT00132808|566196788|FG000|Stratum II|Death|1|||
156848379|NCT00132808|566196789|FG001|Stratum II|Death|0|||
156848380|NCT00132808|566196790|FG002|Stratum II|Death|0|||
156848381|NCT00132808|566196788|FG000|Stratum II|Lost to Follow-up|2|||
156848382|NCT00132808|566196789|FG001|Stratum II|Lost to Follow-up|2|||
156848383|NCT00132808|566196790|FG002|Stratum II|Lost to Follow-up|1|||
156848384|NCT00132808|566196788|FG000|Stratum II|Protocol Violation|0|||
156848385|NCT00132808|566196789|FG001|Stratum II|Protocol Violation|2|||
156848386|NCT00132808|566196790|FG002|Stratum II|Protocol Violation|1|||
156848387|NCT00132808|566196788|FG000|Stratum II|Withdrawal by Subject|4|||
156848388|NCT00132808|566196789|FG001|Stratum II|Withdrawal by Subject|9|||
156541943|NCT04857996|565076663|FG000|Overall Study|Lost to Follow-up|1|||
156541944|NCT04857996|565076664|FG001|Overall Study|Lost to Follow-up|3|||
156541945|NCT04857996|565076663|FG000|Overall Study|Site Closure|1|||
156541946|NCT04857996|565076664|FG001|Overall Study|Site Closure|0|||
156541947|NCT04857996|565076663|FG000|Overall Study|Withdrawal by Subject|1|||
156541948|NCT04857996|565076664|FG001|Overall Study|Withdrawal by Subject|0|||
156541949|NCT02988661|565076665|FG000|Overall Study|Death|2|||
156541950|NCT02988661|565076666|FG001|Overall Study|Death|18|||
156541951|NCT02988661|565076665|FG000|Overall Study|Lost to Follow-up|0|||
156541952|NCT02988661|565076666|FG001|Overall Study|Lost to Follow-up|33|||
156541953|NCT02988661|565076665|FG000|Overall Study|Withdrawal by Subject|0|||
156541954|NCT02988661|565076666|FG001|Overall Study|Withdrawal by Subject|6|||
156541955|NCT02988661|565076665|FG000|Overall Study|Unable to complete the 18-month survey|1|||
156541956|NCT02988661|565076666|FG001|Overall Study|Unable to complete the 18-month survey|27|||
156541957|NCT01392677|565076667|FG000|Overall Study|Adverse Event|3|||
156541958|NCT01392677|565076668|FG001|Overall Study|Adverse Event|1|||
156541959|NCT01392677|565076667|FG000|Overall Study|Withdrawal by Subject|0|||
156541960|NCT01392677|565076668|FG001|Overall Study|Withdrawal by Subject|2|||
156541961|NCT01392677|565076667|FG000|Overall Study|Incorrect enrollment|2|||
156541962|NCT01392677|565076668|FG001|Overall Study|Incorrect enrollment|3|||
156541963|NCT01392677|565076667|FG000|Overall Study|Other reason|3|||
156541964|NCT01392677|565076668|FG001|Overall Study|Other reason|2|||
156541965|NCT01380379|565076669|FG000|Overall Study|Pregnancy|1|||
156541966|NCT05493280|565076672|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
156541967|NCT05493280|565076673|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
156541968|NCT06608368|565076674|FG000|Overall Study|Family Emergency|0|||
156541969|NCT06608368|565076675|FG001|Overall Study|Family Emergency|1|||
156541970|NCT06608368|565076676|FG002|Overall Study|Family Emergency|0|||
156541971|NCT06608368|565076674|FG000|Overall Study|Scheduling Issues|0|||
156848389|NCT00132808|566196790|FG002|Stratum II|Withdrawal by Subject|6|||
156541972|NCT06608368|565076675|FG001|Overall Study|Scheduling Issues|1|||
156541973|NCT06608368|565076676|FG002|Overall Study|Scheduling Issues|0|||
156541974|NCT03977974|565076677|FG000|Period 2|Adverse Event|0|||
156848390|NCT00577824|566196792|FG000|Overall Study|Adverse Event|6|||
156848391|NCT00577824|566196793|FG001|Overall Study|Adverse Event|18|||
156848392|NCT00577824|566196794|FG002|Overall Study|Adverse Event|1|||
156848393|NCT00577824|566196792|FG000|Overall Study|Patient decision|0|||
156848394|NCT00577824|566196793|FG001|Overall Study|Patient decision|1|||
156848395|NCT00577824|566196794|FG002|Overall Study|Patient decision|1|||
156470508|NCT02499328|564816273|FG007|Overall Study|"Other"|4|||
156470509|NCT02499328|564816274|FG008|Overall Study|"Other"|6|||
156470510|NCT02499328|564816275|FG009|Overall Study|"Other"|16|||
156470511|NCT02499328|564816276|FG010|Overall Study|"Other"|13|||
156470512|NCT02499328|564816277|FG011|Overall Study|"Other"|31|||
156470513|NCT02499328|564816278|FG012|Overall Study|"Other"|8|||
156470514|NCT02499328|564816279|FG013|Overall Study|"Other"|7|||
156470515|NCT02499328|564816280|FG014|Overall Study|"Other"|6|||
156470516|NCT02499328|564816281|FG015|Overall Study|"Other"|0|||
156470517|NCT02499328|564816282|FG016|Overall Study|"Other"|0|||
156470518|NCT02499328|564816283|FG017|Overall Study|"Other"|34|||
156470519|NCT02499328|564816284|FG018|Overall Study|"Other"|43|||
156470520|NCT02499328|564816266|FG000|Overall Study|Disease Progression|0|||
156470521|NCT02499328|564816267|FG001|Overall Study|Disease Progression|0|||
156470522|NCT02499328|564816268|FG002|Overall Study|Disease Progression|0|||
156470523|NCT02499328|564816269|FG003|Overall Study|Disease Progression|0|||
156470524|NCT02499328|564816270|FG004|Overall Study|Disease Progression|0|||
156470525|NCT02499328|564816271|FG005|Overall Study|Disease Progression|0|||
156470526|NCT02499328|564816272|FG006|Overall Study|Disease Progression|1|||
156470527|NCT02499328|564816273|FG007|Overall Study|Disease Progression|0|||
156470528|NCT02499328|564816274|FG008|Overall Study|Disease Progression|1|||
156470529|NCT02499328|564816275|FG009|Overall Study|Disease Progression|0|||
156470530|NCT02499328|564816276|FG010|Overall Study|Disease Progression|1|||
156470531|NCT02499328|564816277|FG011|Overall Study|Disease Progression|0|||
156470532|NCT02499328|564816278|FG012|Overall Study|Disease Progression|0|||
156470533|NCT02499328|564816279|FG013|Overall Study|Disease Progression|0|||
156470534|NCT02499328|564816280|FG014|Overall Study|Disease Progression|0|||
156470535|NCT02499328|564816281|FG015|Overall Study|Disease Progression|0|||
156470536|NCT02499328|564816282|FG016|Overall Study|Disease Progression|0|||
156470537|NCT02499328|564816283|FG017|Overall Study|Disease Progression|2|||
156470538|NCT02499328|564816284|FG018|Overall Study|Disease Progression|0|||
156470539|NCT02499328|564816266|FG000|Overall Study|Adverse Event|1|||
156470540|NCT02499328|564816267|FG001|Overall Study|Adverse Event|0|||
156470541|NCT02499328|564816268|FG002|Overall Study|Adverse Event|0|||
156470542|NCT02499328|564816269|FG003|Overall Study|Adverse Event|1|||
156470543|NCT02499328|564816270|FG004|Overall Study|Adverse Event|0|||
156470544|NCT02499328|564816271|FG005|Overall Study|Adverse Event|0|||
156470545|NCT02499328|564816272|FG006|Overall Study|Adverse Event|0|||
156470546|NCT02499328|564816273|FG007|Overall Study|Adverse Event|0|||
156470547|NCT02499328|564816274|FG008|Overall Study|Adverse Event|0|||
156470548|NCT02499328|564816275|FG009|Overall Study|Adverse Event|0|||
156470549|NCT02499328|564816276|FG010|Overall Study|Adverse Event|0|||
156470550|NCT02499328|564816277|FG011|Overall Study|Adverse Event|0|||
156470551|NCT02499328|564816278|FG012|Overall Study|Adverse Event|1|||
156470552|NCT02499328|564816279|FG013|Overall Study|Adverse Event|0|||
156470553|NCT02499328|564816280|FG014|Overall Study|Adverse Event|0|||
156470554|NCT02499328|564816281|FG015|Overall Study|Adverse Event|0|||
156470555|NCT02499328|564816282|FG016|Overall Study|Adverse Event|0|||
156470556|NCT02499328|564816283|FG017|Overall Study|Adverse Event|0|||
156470557|NCT02499328|564816284|FG018|Overall Study|Adverse Event|0|||
156470558|NCT03414684|564816285|FG000|First-course Treatment|Complete response|0|||
156470559|NCT03414684|564816286|FG001|First-course Treatment|Complete response|1|||
156470560|NCT03414684|564816285|FG000|First-course Treatment|Intercurrent illness|1|||
156470561|NCT03414684|564816286|FG001|First-course Treatment|Intercurrent illness|0|||
156470562|NCT03414684|564816285|FG000|First-course Treatment|Progressive Disease|31|||
156470563|NCT03414684|564816286|FG001|First-course Treatment|Progressive Disease|32|||
156470564|NCT03414684|564816285|FG000|First-course Treatment|Adverse Event|1|||
156470565|NCT03414684|564816286|FG001|First-course Treatment|Adverse Event|2|||
156470566|NCT03414684|564816285|FG000|First-course Treatment|Physician Decision|0|||
156470567|NCT03414684|564816286|FG001|First-course Treatment|Physician Decision|1|||
156470568|NCT03414684|564816285|FG000|First-course Treatment|Withdrawal by Subject|0|||
156470569|NCT03414684|564816286|FG001|First-course Treatment|Withdrawal by Subject|1|||
156470570|NCT03414684|564816285|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
156470571|NCT03414684|564816286|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
156470572|NCT03414684|564816285|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
156470573|NCT03414684|564816286|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
156470574|NCT03414684|564816285|FG000|First-course Treatment|Still on treatment|3|||
156470575|NCT03414684|564816286|FG001|First-course Treatment|Still on treatment|0|||
156470576|NCT03414684|564816285|FG000|First-course Treatment|Never started protocol therapy|2|||
156470577|NCT03414684|564816286|FG001|First-course Treatment|Never started protocol therapy|1|||
156470578|NCT03414684|564816285|FG000|Crossover Treatment|Progressive disease|0|||
156470579|NCT03414684|564816286|FG001|Crossover Treatment|Progressive disease|12|||
156470580|NCT03414684|564816285|FG000|Crossover Treatment|Adverse Event|0|||
156470581|NCT03414684|564816286|FG001|Crossover Treatment|Adverse Event|3|||
156470582|NCT03414684|564816285|FG000|Crossover Treatment|Physician Decision|0|||
156470583|NCT03414684|564816286|FG001|Crossover Treatment|Physician Decision|1|||
156470584|NCT03414684|564816285|FG000|Crossover Treatment|Still on treatment|0|||
156470585|NCT03414684|564816286|FG001|Crossover Treatment|Still on treatment|2|||
156470586|NCT05525572|564816287|FG000|Overall Study|Lost to Follow-up|2|||
156470587|NCT05251363|564816288|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
156470588|NCT05251363|564816288|FG000|Overall Study After Implant Period|Death|9|||
156470589|NCT05251363|564816288|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
156470590|NCT05251363|564816288|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
156470591|NCT05251363|564816288|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
156470592|NCT05251363|564816288|FG000|Overall Study After Implant Period|Physician Decision|1|||
156470593|NCT05251363|564816288|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
156470594|NCT03425682|564816289|FG000|Overall Study|Lost to Follow-up|2|||
156470595|NCT03425682|564816290|FG001|Overall Study|Lost to Follow-up|4|||
156470596|NCT03425682|564816289|FG000|Overall Study|Withdrawal by Subject|0|||
156470597|NCT03425682|564816290|FG001|Overall Study|Withdrawal by Subject|3|||
156470598|NCT03425682|564816289|FG000|Overall Study|Subject did not meet I/E|4|||
156470599|NCT03425682|564816290|FG001|Overall Study|Subject did not meet I/E|10|||
156470600|NCT04306367|564816291|FG000|Overall Study|Progression of Disease|9|||
156470601|NCT04306367|564816291|FG000|Overall Study|Adverse Event|3|||
156470602|NCT04306367|564816291|FG000|Overall Study|Withdrawal by Subject|1|||
156470603|NCT03227861|564816292|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
156470604|NCT03227861|564816292|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
156470605|NCT03227861|564816292|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
156470606|NCT03227861|564816292|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
156470607|NCT03227861|564816292|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
156470608|NCT03227861|564816292|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
156470609|NCT03227861|564816292|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
156470610|NCT03227861|564816292|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
156470611|NCT03227861|564816292|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
156470612|NCT03227861|564816292|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
156470613|NCT04218357|564816295|FG000|1st Allocation|Withdrawal by Subject|1|||
156470614|NCT04218357|564816296|FG001|1st Allocation|Withdrawal by Subject|0|||
156470615|NCT05349838|564816297|FG000|Overall Study|Virological Failure|1|||
156470616|NCT05349838|564816298|FG001|Overall Study|Virological Failure|2|||
156470617|NCT05349838|564816297|FG000|Overall Study|Withdrawal by Subject|2|||
156470618|NCT05349838|564816298|FG001|Overall Study|Withdrawal by Subject|3|||
156470619|NCT05349838|564816297|FG000|Overall Study|Adverse Event|3|||
156470620|NCT05349838|564816298|FG001|Overall Study|Adverse Event|1|||
156470621|NCT05349838|564816297|FG000|Overall Study|Lost to Follow-up|1|||
156470622|NCT05349838|564816298|FG001|Overall Study|Lost to Follow-up|2|||
156470623|NCT05349838|564816297|FG000|Overall Study|Other reasons|5|||
156470624|NCT05349838|564816298|FG001|Overall Study|Other reasons|1|||
156470625|NCT05071430|564816300|FG000|Overall Study|Adverse Event|1|||
156470626|NCT05071430|564816301|FG001|Overall Study|Adverse Event|2|||
156470627|NCT05071430|564816300|FG000|Overall Study|Lost to Follow-up|4|||
156470628|NCT05071430|564816301|FG001|Overall Study|Lost to Follow-up|4|||
156470629|NCT05071430|564816300|FG000|Overall Study|Protocol Violation|1|||
156470630|NCT05071430|564816301|FG001|Overall Study|Protocol Violation|0|||
156470631|NCT05071430|564816300|FG000|Overall Study|Withdrawal by Subject|3|||
156470632|NCT05071430|564816301|FG001|Overall Study|Withdrawal by Subject|2|||
156470633|NCT05071430|564816300|FG000|Overall Study|Other|1|||
156470634|NCT05071430|564816301|FG001|Overall Study|Other|1|||
156470635|NCT01958021|564816302|FG000|Treatment|Progressive disease|206|||
156470636|NCT01958021|564816303|FG001|Treatment|Progressive disease|265|||
156470637|NCT01958021|564816302|FG000|Treatment|Adverse Event|38|||
156541975|NCT03977974|565076678|FG001|Period 2|Adverse Event|0|||
156541976|NCT03977974|565076679|FG002|Period 2|Adverse Event|0|||
156541977|NCT03977974|565076680|FG003|Period 2|Adverse Event|0|||
156541978|NCT03977974|565076681|FG004|Period 2|Adverse Event|1|||
156541979|NCT03977974|565076682|FG005|Period 2|Adverse Event|0|||
156541980|NCT03977974|565076683|FG006|Period 2|Adverse Event|0|||
156541981|NCT03977974|565076684|FG007|Period 2|Adverse Event|0|||
156541982|NCT03977974|565076685|FG008|Period 2|Adverse Event|0|||
156541983|NCT03977974|565076686|FG009|Period 2|Adverse Event|0|||
156541984|NCT03977974|565076687|FG010|Period 2|Adverse Event|0|||
156541985|NCT03977974|565076688|FG011|Period 2|Adverse Event|0|||
156541986|NCT03977974|565076689|FG012|Period 2|Adverse Event|0|||
156541987|NCT04526899|565076691|FG000|Overall Study|Withdrawal by Subject|3|||
156541988|NCT04526899|565076692|FG001|Overall Study|Withdrawal by Subject|2|||
156541989|NCT04526899|565076693|FG002|Overall Study|Withdrawal by Subject|2|||
156541990|NCT04526899|565076691|FG000|Overall Study|Lost to Follow-up|3|||
156541991|NCT04526899|565076692|FG001|Overall Study|Lost to Follow-up|3|||
156541992|NCT04526899|565076693|FG002|Overall Study|Lost to Follow-up|1|||
156541993|NCT04526899|565076691|FG000|Overall Study|Investigator's decision|1|||
156541994|NCT04526899|565076692|FG001|Overall Study|Investigator's decision|0|||
156541995|NCT04526899|565076693|FG002|Overall Study|Investigator's decision|0|||
156541996|NCT04526899|565076691|FG000|Overall Study|Death|33|||
156541997|NCT04526899|565076692|FG001|Overall Study|Death|17|||
156541998|NCT04526899|565076693|FG002|Overall Study|Death|13|||
156541999|NCT04526899|565076691|FG000|Overall Study|Other|1|||
156542000|NCT04526899|565076692|FG001|Overall Study|Other|0|||
156542001|NCT04526899|565076693|FG002|Overall Study|Other|0|||
156542002|NCT04526899|565076691|FG000|Overall Study|On-Treatment|19|||
156542003|NCT04526899|565076692|FG001|Overall Study|On-Treatment|10|||
156542004|NCT04526899|565076693|FG002|Overall Study|On-Treatment|12|||
156542005|NCT04526899|565076691|FG000|Overall Study|Survival Follow-up|34|||
156542006|NCT04526899|565076692|FG001|Overall Study|Survival Follow-up|14|||
156542007|NCT04526899|565076693|FG002|Overall Study|Survival Follow-up|16|||
156542008|NCT00075400|565077818|FG000|Overall Study|Ineligible: wrong primary|1|||
156542009|NCT00075400|565077818|FG000|Overall Study|Never treated|2|||
156542010|NCT00666458|565077820|FG000|Overall Study|Adverse Event|8|||
156542011|NCT00666458|565077821|FG001|Overall Study|Adverse Event|7|||
156542012|NCT00666458|565077820|FG000|Overall Study|Withdrawal by Subject|5|||
156542013|NCT00666458|565077821|FG001|Overall Study|Withdrawal by Subject|4|||
156542014|NCT00666458|565077820|FG000|Overall Study|Lost to Follow-up|0|||
156542015|NCT00666458|565077821|FG001|Overall Study|Lost to Follow-up|3|||
156542016|NCT00666458|565077820|FG000|Overall Study|Administrative reason by sponsor|1|||
156542017|NCT00666458|565077821|FG001|Overall Study|Administrative reason by sponsor|1|||
156542018|NCT00666458|565077820|FG000|Overall Study|Incorrect enrollment|7|||
156542019|NCT00666458|565077821|FG001|Overall Study|Incorrect enrollment|1|||
156542020|NCT00666458|565077820|FG000|Overall Study|Study specific discontinuation criteria|14|||
156542021|NCT00666458|565077821|FG001|Overall Study|Study specific discontinuation criteria|7|||
156542022|NCT00666458|565077820|FG000|Overall Study|Severe non-compliance to the protocol|1|||
156542023|NCT00666458|565077821|FG001|Overall Study|Severe non-compliance to the protocol|1|||
156542024|NCT00666458|565077820|FG000|Overall Study|Safety reasons|1|||
156542025|NCT00666458|565077821|FG001|Overall Study|Safety reasons|0|||
156542026|NCT00666458|565077820|FG000|Overall Study|Medical history of anemia|1|||
156542027|NCT00666458|565077821|FG001|Overall Study|Medical history of anemia|0|||
156542028|NCT02982954|565077822|FG000|Overall Study|Death|55|||
156542029|NCT02982954|565077823|FG001|Overall Study|Death|29|||
156542030|NCT02982954|565077824|FG002|Overall Study|Death|15|||
156542031|NCT02982954|565077825|FG003|Overall Study|Death|20|||
156542032|NCT02982954|565077822|FG000|Overall Study|Lost to Follow-up|2|||
156542033|NCT02982954|565077823|FG001|Overall Study|Lost to Follow-up|1|||
156542034|NCT02982954|565077824|FG002|Overall Study|Lost to Follow-up|0|||
156542035|NCT02982954|565077825|FG003|Overall Study|Lost to Follow-up|0|||
156848396|NCT00577824|566196792|FG000|Overall Study|Protocol Violation|1|||
156848397|NCT00577824|566196793|FG001|Overall Study|Protocol Violation|1|||
156848398|NCT00577824|566196794|FG002|Overall Study|Protocol Violation|0|||
156848399|NCT00048347|566196795|FG000|Overall Study|Screen failure|2|||
156848400|NCT00595478|566196796|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
156848401|NCT00595478|566196797|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
156848402|NCT00595478|566196796|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
156848403|NCT00595478|566196797|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
156848404|NCT02713828|566196800|FG000|Overall Study|Death|2|||
156848405|NCT02713828|566196801|FG001|Overall Study|Death|0|||
156848406|NCT02713828|566196800|FG000|Overall Study|Withdrawal by Subject|1|||
156848407|NCT02713828|566196801|FG001|Overall Study|Withdrawal by Subject|0|||
156848408|NCT02713828|566196800|FG000|Overall Study|study terminated but patient allowed to|2|||
156848409|NCT02713828|566196801|FG001|Overall Study|study terminated but patient allowed to|0|||
156848410|NCT03302247|566196802|FG000|Overall Study|the study has closed prematurely|2|||
156848411|NCT03302247|566196802|FG000|Overall Study|Death|1|||
156848412|NCT03508609|566196804|FG000|Overall Study|Withdrawal by Subject|1|||
156848413|NCT01445080|566196807|FG000|Overall Study|Adverse Event|5|||
156848414|NCT01445080|566196808|FG001|Overall Study|Adverse Event|3|||
156848415|NCT01445080|566196809|FG002|Overall Study|Adverse Event|11|||
156848416|NCT01445080|566196810|FG003|Overall Study|Adverse Event|6|||
156848417|NCT01445080|566196811|FG004|Overall Study|Adverse Event|2|||
156542036|NCT02982954|565077822|FG000|Overall Study|Participant withdrew consent|7|||
156542037|NCT02982954|565077823|FG001|Overall Study|Participant withdrew consent|5|||
156542038|NCT02982954|565077824|FG002|Overall Study|Participant withdrew consent|1|||
156542039|NCT02982954|565077825|FG003|Overall Study|Participant withdrew consent|1|||
156542040|NCT02982954|565077822|FG000|Overall Study|Other reasons|42|||
156542041|NCT02982954|565077823|FG001|Overall Study|Other reasons|17|||
156542042|NCT02982954|565077824|FG002|Overall Study|Other reasons|12|||
156542043|NCT02982954|565077825|FG003|Overall Study|Other reasons|3|||
156542044|NCT02982954|565077822|FG000|Overall Study|Premature site closure|0|||
156542045|NCT02982954|565077823|FG001|Overall Study|Premature site closure|0|||
156542046|NCT02982954|565077824|FG002|Overall Study|Premature site closure|0|||
156542047|NCT02982954|565077825|FG003|Overall Study|Premature site closure|1|||
156542048|NCT00516048|565077826|FG000|Overall Study|Death|0|||
156542049|NCT00516048|565077827|FG001|Overall Study|Death|0|||
156542050|NCT00516048|565077828|FG002|Overall Study|Death|1|||
156542051|NCT00516048|565077826|FG000|Overall Study|Subject Decision|0|||
156542052|NCT00516048|565077827|FG001|Overall Study|Subject Decision|2|||
156542053|NCT00516048|565077828|FG002|Overall Study|Subject Decision|0|||
156542054|NCT00402649|565077829|FG000|Overall Study|Lost to Follow-up|1|||
156542055|NCT00402649|565077829|FG000|Overall Study|Withdrawal by Subject|1|||
156542056|NCT02634151|565077830|FG000|Overall Study|Withdrawal by Subject|1|||
156542057|NCT02634151|565077831|FG001|Overall Study|Withdrawal by Subject|0|||
156542058|NCT02634151|565077830|FG000|Overall Study|Non-Compliance|0|||
156542059|NCT02634151|565077831|FG001|Overall Study|Non-Compliance|1|||
156542060|NCT02634151|565077830|FG000|Overall Study|Other|0|||
156542061|NCT02634151|565077831|FG001|Overall Study|Other|1|||
156542062|NCT00003535|565077832|FG000|Overall Study|Not evaluable|5|||
156542063|NCT02347098|565077833|FG000|Overall Study|Death|1|||
156542064|NCT02347098|565077834|FG001|Overall Study|Death|0|||
156542065|NCT02347098|565077833|FG000|Overall Study|Withdrawal by Subject|1|||
156542066|NCT02347098|565077834|FG001|Overall Study|Withdrawal by Subject|0|||
156542067|NCT02347098|565077833|FG000|Overall Study|Lost to Follow-up|2|||
156542068|NCT02347098|565077834|FG001|Overall Study|Lost to Follow-up|2|||
156542069|NCT02347098|565077833|FG000|Overall Study|Refuse Follow-up Visit|1|||
156542070|NCT02347098|565077834|FG001|Overall Study|Refuse Follow-up Visit|5|||
156542071|NCT02347098|565077833|FG000|Overall Study|no visit due to illness|2|||
156542072|NCT02347098|565077834|FG001|Overall Study|no visit due to illness|1|||
156542073|NCT01444742|565077835|FG000|Overall Study|Death|1|||
156542074|NCT02830880|565077837|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
156542075|NCT02830880|565077837|FG000|Overall Study|Death|1|||
156542076|NCT02830880|565077837|FG000|Overall Study|Physician Decision|1|||
156542077|NCT03179891|565077844|FG000|First Intervention|Withdrawal by Subject|1|||
156848418|NCT01445080|566196812|FG005|Overall Study|Adverse Event|3|||
156848419|NCT01445080|566196813|FG006|Overall Study|Adverse Event|0|||
156848420|NCT01445080|566196814|FG007|Overall Study|Adverse Event|3|||
156848421|NCT01445080|566196815|FG008|Overall Study|Adverse Event|10|||
156542078|NCT03179891|565077845|FG001|First Intervention|Withdrawal by Subject|1|||
156542079|NCT03179891|565077844|FG000|First Intervention|Unspecified reason|1|||
156542080|NCT03179891|565077845|FG001|First Intervention|Unspecified reason|0|||
156542081|NCT03179891|565077844|FG000|First Intervention|Protocol Violation|0|||
156542082|NCT03179891|565077845|FG001|First Intervention|Protocol Violation|1|||
156848422|NCT01445080|566196807|FG000|Overall Study|Physician Decision|0|||
156848423|NCT01445080|566196808|FG001|Overall Study|Physician Decision|0|||
156848424|NCT01445080|566196809|FG002|Overall Study|Physician Decision|1|||
156848425|NCT01445080|566196810|FG003|Overall Study|Physician Decision|0|||
156848426|NCT01445080|566196811|FG004|Overall Study|Physician Decision|0|||
156848427|NCT01445080|566196812|FG005|Overall Study|Physician Decision|3|||
156341884|NCT03897465|564350307|FG001|Overall Study|occurence of exclusion criterion|1|||
156341885|NCT03897465|564350306|FG000|Overall Study|Other|1|||
156341886|NCT03897465|564350307|FG001|Overall Study|Other|0|||
156341887|NCT00521014|564350308|FG000|Overall Study|Inevaluable, not treated|1|||
156341888|NCT03132220|564350309|FG000|Overall Study|Lost to Follow-up|17|||
156341889|NCT03132220|564350310|FG001|Overall Study|Lost to Follow-up|8|||
156341890|NCT03132220|564350309|FG000|Overall Study|Withdrawal by Subject|1|||
156341891|NCT03132220|564350310|FG001|Overall Study|Withdrawal by Subject|4|||
156341892|NCT00730132|564350311|FG000|Overall Study|Protocol Violation|154|||
156341893|NCT00730132|564350311|FG000|Overall Study|Death|1|||
156341894|NCT00601458|564350312|FG000|Overall Study|Dosing Error|1|||
156341895|NCT00601458|564350313|FG001|Overall Study|Dosing Error|0|||
156341896|NCT00601458|564350314|FG002|Overall Study|Dosing Error|0|||
156341897|NCT00601458|564350312|FG000|Overall Study|Incomplete Data|0|||
156341898|NCT00601458|564350313|FG001|Overall Study|Incomplete Data|2|||
156341899|NCT00601458|564350314|FG002|Overall Study|Incomplete Data|0|||
156341900|NCT00601458|564350312|FG000|Overall Study|Protocol Violation|3|||
156341901|NCT00601458|564350313|FG001|Overall Study|Protocol Violation|2|||
156341902|NCT00601458|564350314|FG002|Overall Study|Protocol Violation|1|||
156341903|NCT00601458|564350312|FG000|Overall Study|Early Termination|0|||
156341904|NCT00601458|564350313|FG001|Overall Study|Early Termination|1|||
156341905|NCT00601458|564350314|FG002|Overall Study|Early Termination|1|||
156341906|NCT00370032|564350315|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
156341907|NCT00370032|564350316|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
156341908|NCT00370032|564350315|FG000|Washout Period|Withdrawal by Subject|0|||
156341909|NCT00370032|564350316|FG001|Washout Period|Withdrawal by Subject|1|||
156341910|NCT00370032|564350315|FG000|Washout Period|Lost to Follow-up|0|||
156341911|NCT00370032|564350316|FG001|Washout Period|Lost to Follow-up|1|||
156470638|NCT01958021|564816303|FG001|Treatment|Adverse Event|10|||
156470639|NCT01958021|564816302|FG000|Treatment|Subject/guardian decision|29|||
156470640|NCT01958021|564816303|FG001|Treatment|Subject/guardian decision|25|||
156470641|NCT01958021|564816302|FG000|Treatment|Physician Decision|28|||
156470642|NCT01958021|564816303|FG001|Treatment|Physician Decision|21|||
156470643|NCT01958021|564816302|FG000|Treatment|Death|6|||
156470644|NCT01958021|564816303|FG001|Treatment|Death|1|||
156470645|NCT01958021|564816302|FG000|Treatment|Protocol deviation|3|||
156470646|NCT01958021|564816303|FG001|Treatment|Protocol deviation|1|||
156470647|NCT01958021|564816302|FG000|Treatment|Sponsor decision|24|||
156470648|NCT01958021|564816303|FG001|Treatment|Sponsor decision|11|||
156470649|NCT01958021|564816302|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
156470650|NCT01958021|564816303|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156470651|NCT01958021|564816302|FG000|Post-treatment Efficacy Follow-up|Death|1|||
156470652|NCT01958021|564816303|FG001|Post-treatment Efficacy Follow-up|Death|0|||
156470653|NCT01958021|564816302|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
156470654|NCT01958021|564816303|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156470655|NCT01958021|564816302|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156470656|NCT01958021|564816303|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156470657|NCT01958021|564816302|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
156470658|NCT01958021|564816303|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
156470659|NCT01958021|564816302|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
156470660|NCT01958021|564816303|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
156470661|NCT01958021|564816302|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
156470662|NCT01958021|564816303|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
156470663|NCT02157116|564817827|FG000|Overall Study|Withdrawal by Subject|4|||
156470664|NCT02157116|564817827|FG000|Overall Study|Physician Decision|3|||
156470665|NCT02157116|564817827|FG000|Overall Study|Failed Screening|2|||
156470666|NCT00975585|564817828|FG000|Overall Study|Adverse Event|0|||
156470667|NCT00975585|564817829|FG001|Overall Study|Adverse Event|4|||
156470668|NCT00975585|564817828|FG000|Overall Study|Lost to Follow-up|3|||
156848428|NCT01445080|566196813|FG006|Overall Study|Physician Decision|2|||
156848429|NCT01445080|566196814|FG007|Overall Study|Physician Decision|2|||
156341912|NCT00370032|564350315|FG000|Washout Period|Adverse Event|1|||
156341913|NCT00370032|564350316|FG001|Washout Period|Adverse Event|0|||
156341914|NCT00370032|564350315|FG000|Follow-up Period|Withdrawal by Subject|1|||
156341915|NCT00370032|564350316|FG001|Follow-up Period|Withdrawal by Subject|0|||
156341916|NCT00518986|564350317|FG000|Overall Study|Adverse Event|12|||
156341917|NCT00518986|564350318|FG001|Overall Study|Adverse Event|7|||
156341918|NCT00518986|564350317|FG000|Overall Study|Lack of Efficacy|0|||
156341919|NCT00518986|564350318|FG001|Overall Study|Lack of Efficacy|2|||
156341920|NCT00518986|564350317|FG000|Overall Study|Lost to Follow-up|3|||
156470669|NCT00975585|564817829|FG001|Overall Study|Lost to Follow-up|5|||
156470670|NCT00975585|564817828|FG000|Overall Study|Withdrawal by Subject|2|||
156848430|NCT01445080|566196815|FG008|Overall Study|Physician Decision|0|||
156848431|NCT01445080|566196807|FG000|Overall Study|Withdrawal by Subject|1|||
156848432|NCT01445080|566196808|FG001|Overall Study|Withdrawal by Subject|0|||
156848433|NCT01445080|566196809|FG002|Overall Study|Withdrawal by Subject|0|||
156542083|NCT01278745|565077848|FG000|Overall Study|Death|2|||
156542084|NCT01278745|565077849|FG001|Overall Study|Death|5|||
156542085|NCT01278745|565077850|FG002|Overall Study|Death|7|||
156542086|NCT01278745|565077851|FG003|Overall Study|Death|0|||
156542087|NCT01278745|565077848|FG000|Overall Study|Physician Decision|1|||
156542088|NCT01278745|565077849|FG001|Overall Study|Physician Decision|0|||
156542089|NCT01278745|565077850|FG002|Overall Study|Physician Decision|0|||
156542090|NCT01278745|565077851|FG003|Overall Study|Physician Decision|9|||
156542091|NCT01278745|565077848|FG000|Overall Study|Withdrawal by Subject|1|||
156542092|NCT01278745|565077849|FG001|Overall Study|Withdrawal by Subject|1|||
156542093|NCT01278745|565077850|FG002|Overall Study|Withdrawal by Subject|5|||
156542094|NCT01278745|565077851|FG003|Overall Study|Withdrawal by Subject|1|||
156542095|NCT01278745|565077848|FG000|Overall Study|Sponsor Decision|1|||
156542096|NCT01278745|565077849|FG001|Overall Study|Sponsor Decision|0|||
156542097|NCT01278745|565077850|FG002|Overall Study|Sponsor Decision|62|||
156542098|NCT01278745|565077851|FG003|Overall Study|Sponsor Decision|6|||
156542099|NCT01278745|565077848|FG000|Overall Study|Ineligible|0|||
156542100|NCT01278745|565077849|FG001|Overall Study|Ineligible|0|||
156542101|NCT01278745|565077850|FG002|Overall Study|Ineligible|42|||
156542102|NCT01278745|565077851|FG003|Overall Study|Ineligible|61|||
156542103|NCT01278745|565077848|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
156542104|NCT01278745|565077849|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
156542105|NCT01278745|565077850|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
156542106|NCT01278745|565077851|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
156542107|NCT01148537|565077852|FG000|Overall Study|Withdrawal by Subject|1|||
156542108|NCT01148537|565077853|FG001|Overall Study|Withdrawal by Subject|0|||
156542109|NCT01148537|565077854|FG002|Overall Study|Withdrawal by Subject|2|||
156542110|NCT01148537|565077852|FG000|Overall Study|Adverse Event|2|||
156542111|NCT01148537|565077853|FG001|Overall Study|Adverse Event|0|||
156542112|NCT01148537|565077854|FG002|Overall Study|Adverse Event|1|||
156542113|NCT05630001|565077855|FG000|Overall Study|Adverse Event|1|||
156542114|NCT05374525|565077857|FG000|Overall Study|Adverse Event|5|||
156542115|NCT05374525|565077858|FG001|Overall Study|Adverse Event|6|||
156542116|NCT05374525|565077857|FG000|Overall Study|Lost to Follow-up|3|||
156542117|NCT05374525|565077858|FG001|Overall Study|Lost to Follow-up|3|||
156542118|NCT05374525|565077857|FG000|Overall Study|Physician Decision|2|||
156542119|NCT05374525|565077858|FG001|Overall Study|Physician Decision|2|||
156542120|NCT05374525|565077857|FG000|Overall Study|Withdrawal by Subject|26|||
156542121|NCT05374525|565077858|FG001|Overall Study|Withdrawal by Subject|8|||
156542122|NCT01349101|565077861|FG000|Overall Study|Disease Progression|1|||
156542123|NCT01349101|565077862|FG001|Overall Study|Disease Progression|1|||
156542124|NCT01349101|565077861|FG000|Overall Study|Death|3|||
156848434|NCT01445080|566196810|FG003|Overall Study|Withdrawal by Subject|1|||
156848435|NCT01445080|566196811|FG004|Overall Study|Withdrawal by Subject|0|||
156848436|NCT01445080|566196812|FG005|Overall Study|Withdrawal by Subject|0|||
156848437|NCT01445080|566196813|FG006|Overall Study|Withdrawal by Subject|0|||
156848438|NCT01445080|566196814|FG007|Overall Study|Withdrawal by Subject|0|||
156848439|NCT01445080|566196815|FG008|Overall Study|Withdrawal by Subject|2|||
156848440|NCT01445080|566196807|FG000|Overall Study|Ineligible/Inevaluable|1|||
156848441|NCT01445080|566196808|FG001|Overall Study|Ineligible/Inevaluable|2|||
156848442|NCT01445080|566196809|FG002|Overall Study|Ineligible/Inevaluable|0|||
156848443|NCT01445080|566196810|FG003|Overall Study|Ineligible/Inevaluable|1|||
156848444|NCT01445080|566196811|FG004|Overall Study|Ineligible/Inevaluable|2|||
156848445|NCT01445080|566196812|FG005|Overall Study|Ineligible/Inevaluable|3|||
156848446|NCT01445080|566196813|FG006|Overall Study|Ineligible/Inevaluable|0|||
156848447|NCT01445080|566196814|FG007|Overall Study|Ineligible/Inevaluable|0|||
156848448|NCT01445080|566196815|FG008|Overall Study|Ineligible/Inevaluable|6|||
156848449|NCT03887221|566196816|FG000|Overall Study|Protocol Violation|1|||
156848450|NCT03887221|566196817|FG001|Overall Study|Protocol Violation|0|||
156848451|NCT02487030|566196818|FG000|Overall Study|Lack of Efficacy|2|||
156848452|NCT02487030|566196819|FG001|Overall Study|Lack of Efficacy|4|||
156848453|NCT02487030|566196820|FG002|Overall Study|Lack of Efficacy|1|||
156848454|NCT02487030|566196821|FG003|Overall Study|Lack of Efficacy|0|||
156848455|NCT02487030|566196822|FG004|Overall Study|Lack of Efficacy|1|||
156848456|NCT02487030|566196823|FG005|Overall Study|Lack of Efficacy|0|||
156848457|NCT02487030|566196824|FG006|Overall Study|Lack of Efficacy|0|||
156848458|NCT02487030|566196818|FG000|Overall Study|Lost to Follow-up|0|||
156848459|NCT02487030|566196819|FG001|Overall Study|Lost to Follow-up|0|||
156542125|NCT01349101|565077862|FG001|Overall Study|Death|8|||
156542126|NCT01843842|565077865|FG000|Overall Study|Do not meet inclusion criteria|1|||
156542127|NCT01843842|565077866|FG001|Overall Study|Do not meet inclusion criteria|1|||
156542128|NCT01376778|565077867|FG000|Overall Study|Lost to Follow-up|3|||
156542129|NCT01376778|565077868|FG001|Overall Study|Lost to Follow-up|2|||
156848460|NCT02487030|566196820|FG002|Overall Study|Lost to Follow-up|1|||
156848461|NCT02487030|566196821|FG003|Overall Study|Lost to Follow-up|1|||
156848462|NCT02487030|566196822|FG004|Overall Study|Lost to Follow-up|0|||
156341921|NCT00518986|564350318|FG001|Overall Study|Lost to Follow-up|2|||
156341922|NCT00518986|564350317|FG000|Overall Study|Physician Decision|0|||
156341923|NCT00518986|564350318|FG001|Overall Study|Physician Decision|3|||
156341924|NCT00518986|564350317|FG000|Overall Study|Protocol Violation|5|||
156341925|NCT00518986|564350318|FG001|Overall Study|Protocol Violation|7|||
156341926|NCT00518986|564350317|FG000|Overall Study|Withdrawal by Subject|4|||
156341927|NCT00518986|564350318|FG001|Overall Study|Withdrawal by Subject|4|||
156341928|NCT00518986|564350317|FG000|Overall Study|Non-Specific|2|||
156470671|NCT00975585|564817829|FG001|Overall Study|Withdrawal by Subject|1|||
156470672|NCT00975585|564817828|FG000|Overall Study|Lens issue|2|||
156470673|NCT00975585|564817829|FG001|Overall Study|Lens issue|2|||
156470674|NCT01953224|564817830|FG000|Overall Study|Lost to Follow-up|1|||
156848463|NCT02487030|566196823|FG005|Overall Study|Lost to Follow-up|1|||
156848464|NCT02487030|566196824|FG006|Overall Study|Lost to Follow-up|0|||
156848465|NCT02487030|566196818|FG000|Overall Study|Adverse Event|0|||
156848466|NCT02487030|566196819|FG001|Overall Study|Adverse Event|0|||
156848467|NCT02487030|566196820|FG002|Overall Study|Adverse Event|0|||
156848468|NCT02487030|566196821|FG003|Overall Study|Adverse Event|1|||
156848469|NCT02487030|566196822|FG004|Overall Study|Adverse Event|0|||
156848470|NCT02487030|566196823|FG005|Overall Study|Adverse Event|0|||
156848471|NCT02487030|566196824|FG006|Overall Study|Adverse Event|0|||
156848472|NCT02487030|566196818|FG000|Overall Study|Death|0|||
156848473|NCT02487030|566196819|FG001|Overall Study|Death|0|||
156848474|NCT02487030|566196820|FG002|Overall Study|Death|0|||
156848475|NCT02487030|566196821|FG003|Overall Study|Death|0|||
156848476|NCT02487030|566196822|FG004|Overall Study|Death|1|||
156848477|NCT02487030|566196823|FG005|Overall Study|Death|0|||
156848478|NCT02487030|566196824|FG006|Overall Study|Death|0|||
156470675|NCT01953224|564817831|FG001|Overall Study|Lost to Follow-up|1|||
156470676|NCT01953224|564817830|FG000|Overall Study|Withdrawal by Subject|1|||
156848479|NCT02123576|566196825|FG000|Overall Study|Adverse Event|1|||
156848480|NCT02123576|566196826|FG001|Overall Study|Adverse Event|0|||
156848481|NCT00999544|566199028|FG000|Overall Study|Withdrawal by Subject|1|||
156848482|NCT02936635|566199030|FG000|Overall Study|Adverse Event|43|||
156848483|NCT02936635|566199031|FG001|Overall Study|Adverse Event|25|||
156848484|NCT02936635|566199030|FG000|Overall Study|Progressive Disease|10|||
156848485|NCT02936635|566199031|FG001|Overall Study|Progressive Disease|18|||
156848486|NCT02936635|566199030|FG000|Overall Study|Sponsor Discretion|10|||
156848487|NCT02936635|566199031|FG001|Overall Study|Sponsor Discretion|16|||
156848488|NCT02936635|566199030|FG000|Overall Study|Death|9|||
156848489|NCT02936635|566199031|FG001|Overall Study|Death|15|||
156848490|NCT02936635|566199030|FG000|Overall Study|Withdrawal by Subject|8|||
156848491|NCT02936635|566199031|FG001|Overall Study|Withdrawal by Subject|15|||
156848492|NCT02936635|566199030|FG000|Overall Study|Physician Decision|2|||
156848493|NCT02936635|566199031|FG001|Overall Study|Physician Decision|9|||
156848494|NCT02936635|566199030|FG000|Overall Study|Lost to Follow-up|1|||
156848495|NCT02936635|566199031|FG001|Overall Study|Lost to Follow-up|2|||
156848496|NCT02936635|566199030|FG000|Overall Study|Protocol Violation|1|||
156848497|NCT02936635|566199031|FG001|Overall Study|Protocol Violation|0|||
156848498|NCT02936635|566199030|FG000|Overall Study|Lack of effect/Entry into other study|31|||
156848499|NCT02936635|566199031|FG001|Overall Study|Lack of effect/Entry into other study|65|||
156848500|NCT02407223|566199032|FG000|Overall Study|Adverse Event|1|||
156848501|NCT02407223|566199033|FG001|Overall Study|Adverse Event|0|||
156848502|NCT02407223|566199034|FG002|Overall Study|Adverse Event|1|||
156848503|NCT02407223|566199032|FG000|Overall Study|Lack of Efficacy|6|||
156470677|NCT01953224|564817831|FG001|Overall Study|Withdrawal by Subject|2|||
156470678|NCT00683800|564817832|FG000|Overall Study|Adverse Event|195|||
156848504|NCT02407223|566199033|FG001|Overall Study|Lack of Efficacy|6|||
156848505|NCT02407223|566199034|FG002|Overall Study|Lack of Efficacy|4|||
156848506|NCT02407223|566199032|FG000|Overall Study|Lost to Follow-up|1|||
156848507|NCT02407223|566199033|FG001|Overall Study|Lost to Follow-up|0|||
156848508|NCT02407223|566199034|FG002|Overall Study|Lost to Follow-up|2|||
156848509|NCT02407223|566199032|FG000|Overall Study|Withdrawal by Subject|2|||
156341929|NCT00518986|564350318|FG001|Overall Study|Non-Specific|1|||
156470679|NCT00683800|564817833|FG001|Overall Study|Adverse Event|102|||
156848510|NCT02407223|566199033|FG001|Overall Study|Withdrawal by Subject|4|||
156848511|NCT02407223|566199034|FG002|Overall Study|Withdrawal by Subject|4|||
156848512|NCT02407223|566199032|FG000|Overall Study|Study Terminated by Sponsor|77|||
156848513|NCT02407223|566199033|FG001|Overall Study|Study Terminated by Sponsor|80|||
156848514|NCT02407223|566199034|FG002|Overall Study|Study Terminated by Sponsor|86|||
156341930|NCT00968513|564350319|FG000|Overall Study|Death|4|||
156470680|NCT00683800|564817832|FG000|Overall Study|Death|0|||
156848515|NCT02407223|566199032|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
156848516|NCT02407223|566199033|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
156848517|NCT02407223|566199034|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
156848518|NCT02407223|566199032|FG000|Overall Study|Other|29|||
156341931|NCT00968513|564350320|FG001|Overall Study|Death|10|||
156470681|NCT00683800|564817833|FG001|Overall Study|Death|1|||
156848519|NCT02407223|566199033|FG001|Overall Study|Other|27|||
156848520|NCT02407223|566199034|FG002|Overall Study|Other|25|||
156470682|NCT00683800|564817832|FG000|Overall Study|Lost to Follow-up|57|||
156470683|NCT00683800|564817833|FG001|Overall Study|Lost to Follow-up|44|||
156470684|NCT00683800|564817832|FG000|Overall Study|Other|5|||
156470685|NCT00683800|564817833|FG001|Overall Study|Other|2|||
156470686|NCT00683800|564817832|FG000|Overall Study|Protocol Violation|13|||
156470687|NCT00683800|564817833|FG001|Overall Study|Protocol Violation|16|||
156848521|NCT00447226|566199035|FG000|12-Week Open-label Phase|Adverse Event|0|||
156848522|NCT00447226|566199036|FG001|12-Week Open-label Phase|Adverse Event|3|||
156848523|NCT00447226|566199035|FG000|12-Week Open-label Phase|Protocol Violation|0|||
156848524|NCT00447226|566199036|FG001|12-Week Open-label Phase|Protocol Violation|1|||
156848525|NCT00447226|566199035|FG000|12-Week Open-label Phase|Disease Progression|0|||
156848526|NCT00447226|566199036|FG001|12-Week Open-label Phase|Disease Progression|20|||
156848527|NCT00447226|566199035|FG000|12-Week Open-label Phase|Physician Decision|0|||
156848528|NCT00447226|566199036|FG001|12-Week Open-label Phase|Physician Decision|1|||
156848529|NCT00447226|566199035|FG000|Double-blind Phase|Disease Progression|4|||
156848530|NCT00447226|566199036|FG001|Double-blind Phase|Disease Progression|3|||
156848531|NCT01410890|566199044|FG000|Overall Study|Withdrawal by Subject|0|||
156848532|NCT01410890|566199045|FG001|Overall Study|Withdrawal by Subject|1|||
156848533|NCT00412893|566199046|FG000|Overall Study|Adverse Event|31|||
156848534|NCT00412893|566199047|FG001|Overall Study|Adverse Event|53|||
156848535|NCT00412893|566199046|FG000|Overall Study|Death|17|||
156848536|NCT00412893|566199047|FG001|Overall Study|Death|21|||
156848537|NCT00412893|566199046|FG000|Overall Study|Insufficient Therapeutic Response|39|||
156848538|NCT00412893|566199047|FG001|Overall Study|Insufficient Therapeutic Response|23|||
156848539|NCT00412893|566199046|FG000|Overall Study|Lost to Follow-up|2|||
156848540|NCT00412893|566199047|FG001|Overall Study|Lost to Follow-up|1|||
156848541|NCT00412893|566199046|FG000|Overall Study|Violation of Selection at Entry|17|||
156848542|NCT00412893|566199047|FG001|Overall Study|Violation of Selection at Entry|10|||
156848543|NCT00412893|566199046|FG000|Overall Study|Other Protocol Violation|10|||
156848544|NCT00412893|566199047|FG001|Overall Study|Other Protocol Violation|6|||
156848545|NCT00412893|566199046|FG000|Overall Study|Did Not Cooperate|12|||
156848546|NCT00412893|566199047|FG001|Overall Study|Did Not Cooperate|9|||
156848547|NCT00412893|566199046|FG000|Overall Study|Administrative Reason|12|||
156848548|NCT00412893|566199047|FG001|Overall Study|Administrative Reason|15|||
156848549|NCT00412893|566199046|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
156848550|NCT00412893|566199047|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
156848551|NCT03951077|566199048|FG000|Overall Study|Adverse Event|1|||
156848552|NCT03951077|566199049|FG001|Overall Study|Adverse Event|0|||
156848553|NCT03951077|566199050|FG002|Overall Study|Adverse Event|0|||
156848554|NCT03951077|566199051|FG003|Overall Study|Adverse Event|0|||
156848555|NCT03951077|566199052|FG004|Overall Study|Adverse Event|0|||
156848556|NCT03951077|566199053|FG005|Overall Study|Adverse Event|0|||
156848557|NCT03951077|566199048|FG000|Overall Study|Withdrawal by Subject|3|||
156848558|NCT03951077|566199049|FG001|Overall Study|Withdrawal by Subject|3|||
156848559|NCT03951077|566199050|FG002|Overall Study|Withdrawal by Subject|0|||
156848560|NCT03951077|566199051|FG003|Overall Study|Withdrawal by Subject|3|||
156848561|NCT03951077|566199052|FG004|Overall Study|Withdrawal by Subject|3|||
156848562|NCT03951077|566199053|FG005|Overall Study|Withdrawal by Subject|2|||
156848563|NCT03951077|566199048|FG000|Overall Study|Lost to Follow-up|1|||
156848564|NCT03951077|566199049|FG001|Overall Study|Lost to Follow-up|1|||
156848565|NCT03951077|566199050|FG002|Overall Study|Lost to Follow-up|2|||
156848566|NCT03951077|566199051|FG003|Overall Study|Lost to Follow-up|3|||
156848567|NCT03951077|566199052|FG004|Overall Study|Lost to Follow-up|2|||
156848568|NCT03951077|566199053|FG005|Overall Study|Lost to Follow-up|3|||
156848569|NCT03951077|566199048|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
156848570|NCT03951077|566199049|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
156848571|NCT03951077|566199050|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
156848572|NCT03951077|566199051|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
156848573|NCT03951077|566199052|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
156848574|NCT03951077|566199053|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
156848575|NCT03951077|566199048|FG000|Overall Study|Other, Not Specified|12|||
156848576|NCT03951077|566199049|FG001|Overall Study|Other, Not Specified|10|||
156848577|NCT03951077|566199050|FG002|Overall Study|Other, Not Specified|10|||
156848578|NCT03951077|566199051|FG003|Overall Study|Other, Not Specified|5|||
156848579|NCT03951077|566199052|FG004|Overall Study|Other, Not Specified|9|||
156848580|NCT03951077|566199053|FG005|Overall Study|Other, Not Specified|6|||
156848581|NCT03951077|566199048|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
156470688|NCT00683800|564817832|FG000|Overall Study|Withdrawal by Subject|66|||
156470689|NCT00683800|564817833|FG001|Overall Study|Withdrawal by Subject|64|||
156848582|NCT03951077|566199049|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
156848583|NCT03951077|566199050|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
156470690|NCT00683800|564817832|FG000|Overall Study|Lack of Efficacy|61|||
156470691|NCT00683800|564817833|FG001|Overall Study|Lack of Efficacy|104|||
156470692|NCT00683800|564817832|FG000|Overall Study|Randomized, not treated|35|||
156848584|NCT03951077|566199051|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
156848585|NCT03951077|566199052|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
156848586|NCT03951077|566199053|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
156848587|NCT00086047|566199055|FG000|Overall Study|Lost to Follow-up|7|||
156848588|NCT00086047|566199056|FG001|Overall Study|Lost to Follow-up|6|||
156848589|NCT00086047|566199055|FG000|Overall Study|Physician Decision|0|||
156848590|NCT00086047|566199056|FG001|Overall Study|Physician Decision|1|||
156848591|NCT01395901|566199057|FG000|Overall Study|Lost to Follow-up|4|||
156848592|NCT01395901|566199058|FG001|Overall Study|Lost to Follow-up|0|||
156848593|NCT01395901|566199057|FG000|Overall Study|Randomized but not received study drug|5|||
156848594|NCT01395901|566199058|FG001|Overall Study|Randomized but not received study drug|4|||
156341932|NCT00968513|564350321|FG002|Overall Study|Death|15|||
156341933|NCT01328431|564350322|FG000|Baseline|Protocol Violation|0|||
156341934|NCT01328431|564350323|FG001|Baseline|Protocol Violation|2|||
156341935|NCT01328431|564350322|FG000|1 Month (1M)|Lost to Follow-up|55|||
156341936|NCT01328431|564350323|FG001|1 Month (1M)|Lost to Follow-up|58|||
156341937|NCT01328431|564350322|FG000|3 Month (3M)|Death|2|||
156341938|NCT01328431|564350323|FG001|3 Month (3M)|Death|2|||
156848595|NCT01395901|566199057|FG000|Overall Study|Adverse Event|0|||
156848596|NCT01395901|566199058|FG001|Overall Study|Adverse Event|1|||
156341939|NCT01328431|564350322|FG000|3 Month (3M)|Lost to Follow-up|75|||
156341940|NCT01328431|564350323|FG001|3 Month (3M)|Lost to Follow-up|70|||
156341941|NCT01328431|564350322|FG000|12 Month (12M)|Death|2|||
156848597|NCT01395901|566199057|FG000|Overall Study|Withdrawal of consent|1|||
156848598|NCT01395901|566199058|FG001|Overall Study|Withdrawal of consent|0|||
156848599|NCT03579940|566199063|FG000|Period 2|Withdrawal by Subject|0|||
156848600|NCT03579940|566199064|FG001|Period 2|Withdrawal by Subject|0|||
156848601|NCT03579940|566199065|FG002|Period 2|Withdrawal by Subject|1|||
156848602|NCT03579940|566199066|FG003|Period 2|Withdrawal by Subject|0|||
156848603|NCT03579940|566199067|FG004|Period 2|Withdrawal by Subject|0|||
156848604|NCT03579940|566199068|FG005|Period 2|Withdrawal by Subject|0|||
156848605|NCT03579940|566199069|FG006|Period 2|Withdrawal by Subject|0|||
156848606|NCT03579940|566199070|FG007|Period 2|Withdrawal by Subject|0|||
156848607|NCT03579940|566199071|FG008|Period 2|Withdrawal by Subject|0|||
156848608|NCT03579940|566199072|FG009|Period 2|Withdrawal by Subject|0|||
156848609|NCT03579940|566199073|FG010|Period 2|Withdrawal by Subject|0|||
156848610|NCT01217944|566199074|FG000|Overall Study|Protocol Violation|1|||
156848611|NCT01217944|566199075|FG001|Overall Study|Protocol Violation|1|||
156848612|NCT01217944|566199076|FG002|Overall Study|Protocol Violation|0|||
156848613|NCT01217944|566199074|FG000|Overall Study|Lost to Follow-up|3|||
156848614|NCT01217944|566199075|FG001|Overall Study|Lost to Follow-up|1|||
156848615|NCT01217944|566199076|FG002|Overall Study|Lost to Follow-up|0|||
156848616|NCT01217944|566199074|FG000|Overall Study|Withdrawal by Subject|1|||
156848617|NCT01217944|566199075|FG001|Overall Study|Withdrawal by Subject|2|||
156848618|NCT01217944|566199076|FG002|Overall Study|Withdrawal by Subject|0|||
156848619|NCT01217944|566199074|FG000|Overall Study|Lack of Efficacy|1|||
156848620|NCT01217944|566199075|FG001|Overall Study|Lack of Efficacy|0|||
156848621|NCT01217944|566199076|FG002|Overall Study|Lack of Efficacy|0|||
156848622|NCT00496080|566199083|FG000|Overall Study|Lost to Follow-up|9|||
156848623|NCT00496080|566199083|FG000|Overall Study|Surgical re-intervention|7|||
156848624|NCT00496080|566199083|FG000|Overall Study|Withdrawal by Subject|5|||
156848625|NCT00496080|566199083|FG000|Overall Study|Physician Decision|6|||
156848626|NCT04098809|566199084|FG000|Overall Study|Withdrawal by Subject|1|||
156848627|NCT04098809|566199085|FG001|Overall Study|Withdrawal by Subject|3|||
156848628|NCT04098809|566199084|FG000|Overall Study|Physician Decision|2|||
156848629|NCT04098809|566199085|FG001|Overall Study|Physician Decision|1|||
156848630|NCT02021643|566199086|FG000|Overall Study|Enrolled but Never Treated|1|||
156848631|NCT02021643|566199087|FG001|Overall Study|Enrolled but Never Treated|0|||
156848632|NCT02021643|566199088|FG002|Overall Study|Enrolled but Never Treated|0|||
156848633|NCT02021643|566199089|FG003|Overall Study|Enrolled but Never Treated|0|||
156848634|NCT02021643|566199086|FG000|Overall Study|Adverse Event|0|||
156848635|NCT02021643|566199087|FG001|Overall Study|Adverse Event|1|||
156848636|NCT02021643|566199088|FG002|Overall Study|Adverse Event|0|||
156848637|NCT02021643|566199089|FG003|Overall Study|Adverse Event|0|||
156848638|NCT02021643|566199086|FG000|Overall Study|Death|0|||
156848639|NCT02021643|566199087|FG001|Overall Study|Death|1|||
156848640|NCT02021643|566199088|FG002|Overall Study|Death|0|||
156848641|NCT02021643|566199089|FG003|Overall Study|Death|0|||
156848642|NCT02021643|566199086|FG000|Overall Study|Investigator's Discretion|1|||
156848643|NCT02021643|566199087|FG001|Overall Study|Investigator's Discretion|0|||
156848644|NCT02021643|566199088|FG002|Overall Study|Investigator's Discretion|0|||
156848645|NCT02021643|566199089|FG003|Overall Study|Investigator's Discretion|0|||
156848646|NCT02021643|566199086|FG000|Overall Study|Lack of Efficacy|7|||
156848647|NCT02021643|566199087|FG001|Overall Study|Lack of Efficacy|6|||
156848648|NCT02021643|566199088|FG002|Overall Study|Lack of Efficacy|0|||
156848649|NCT02021643|566199089|FG003|Overall Study|Lack of Efficacy|12|||
156848650|NCT02021643|566199086|FG000|Overall Study|Lost to Follow-up|0|||
156848651|NCT02021643|566199087|FG001|Overall Study|Lost to Follow-up|1|||
156848652|NCT02021643|566199088|FG002|Overall Study|Lost to Follow-up|0|||
156848653|NCT02021643|566199089|FG003|Overall Study|Lost to Follow-up|0|||
156848654|NCT02021643|566199086|FG000|Overall Study|Withdrew Consent|0|||
156848655|NCT02021643|566199087|FG001|Overall Study|Withdrew Consent|1|||
156848656|NCT02021643|566199088|FG002|Overall Study|Withdrew Consent|0|||
156848657|NCT02021643|566199089|FG003|Overall Study|Withdrew Consent|0|||
156848658|NCT02631551|566199090|FG000|Overall Study|Adverse Event|1|||
156848659|NCT02631551|566199091|FG001|Overall Study|Adverse Event|2|||
156848660|NCT02631551|566199092|FG002|Overall Study|Adverse Event|4|||
156848661|NCT02631551|566199093|FG003|Overall Study|Adverse Event|0|||
156848662|NCT02631551|566199090|FG000|Overall Study|Lack of Efficacy|0|||
156848663|NCT02631551|566199091|FG001|Overall Study|Lack of Efficacy|0|||
156848664|NCT02631551|566199092|FG002|Overall Study|Lack of Efficacy|1|||
156848665|NCT02631551|566199093|FG003|Overall Study|Lack of Efficacy|0|||
156848666|NCT02631551|566199090|FG000|Overall Study|Lost to Follow-up|1|||
156848667|NCT02631551|566199091|FG001|Overall Study|Lost to Follow-up|2|||
156848668|NCT02631551|566199092|FG002|Overall Study|Lost to Follow-up|0|||
156848669|NCT02631551|566199093|FG003|Overall Study|Lost to Follow-up|3|||
156848670|NCT02631551|566199090|FG000|Overall Study|Withdrawal by Subject|2|||
156848671|NCT02631551|566199091|FG001|Overall Study|Withdrawal by Subject|2|||
156848672|NCT02631551|566199092|FG002|Overall Study|Withdrawal by Subject|0|||
156848673|NCT02631551|566199093|FG003|Overall Study|Withdrawal by Subject|5|||
156848674|NCT02631551|566199090|FG000|Overall Study|Protocol deviation|3|||
156848675|NCT02631551|566199091|FG001|Overall Study|Protocol deviation|6|||
156848676|NCT02631551|566199092|FG002|Overall Study|Protocol deviation|3|||
156848677|NCT02631551|566199093|FG003|Overall Study|Protocol deviation|0|||
156848678|NCT02631551|566199090|FG000|Overall Study|Non-compliance with study procedures|0|||
156848679|NCT02631551|566199091|FG001|Overall Study|Non-compliance with study procedures|0|||
156848680|NCT02631551|566199092|FG002|Overall Study|Non-compliance with study procedures|1|||
156848681|NCT02631551|566199093|FG003|Overall Study|Non-compliance with study procedures|1|||
156848682|NCT02631551|566199090|FG000|Overall Study|Non-compliance with study drug|1|||
156848683|NCT02631551|566199091|FG001|Overall Study|Non-compliance with study drug|0|||
156848684|NCT02631551|566199092|FG002|Overall Study|Non-compliance with study drug|0|||
156848685|NCT02631551|566199093|FG003|Overall Study|Non-compliance with study drug|0|||
156848686|NCT02631551|566199090|FG000|Overall Study|Other, specific reasons not collected|5|||
156848687|NCT02631551|566199091|FG001|Overall Study|Other, specific reasons not collected|7|||
156848688|NCT02631551|566199092|FG002|Overall Study|Other, specific reasons not collected|2|||
156848689|NCT02631551|566199093|FG003|Overall Study|Other, specific reasons not collected|2|||
156848690|NCT02859246|566199097|FG000|Overall Study|Screen fails|3|||
156848691|NCT02859246|566199097|FG000|Overall Study|Adverse Event|1|||
156848692|NCT02859246|566199097|FG000|Overall Study|Withdrawal by Subject|1|||
156848693|NCT05280717|566199098|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
156848694|NCT05280717|566199099|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
156848695|NCT05280717|566199100|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
156848696|NCT05280717|566199101|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
156848697|NCT05280717|566199102|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
156848698|NCT05280717|566199103|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
156848699|NCT05280717|566199104|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
156848700|NCT05280717|566199098|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
156848701|NCT05280717|566199099|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848702|NCT05280717|566199100|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848703|NCT05280717|566199101|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848704|NCT05280717|566199102|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848705|NCT05280717|566199103|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848706|NCT05280717|566199104|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848707|NCT05280717|566199098|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848708|NCT05280717|566199099|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
156848709|NCT05280717|566199100|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848710|NCT05280717|566199101|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848711|NCT05280717|566199102|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848712|NCT05280717|566199103|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848713|NCT05280717|566199104|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848714|NCT05280717|566199098|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848715|NCT05280717|566199099|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848716|NCT05280717|566199100|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
156848717|NCT05280717|566199101|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848718|NCT05280717|566199102|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848719|NCT05280717|566199103|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848720|NCT05280717|566199104|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848721|NCT05280717|566199098|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848722|NCT05280717|566199099|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848723|NCT05280717|566199100|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848724|NCT05280717|566199101|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848725|NCT05280717|566199102|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156341942|NCT01328431|564350323|FG001|12 Month (12M)|Death|6|||
156341943|NCT01328431|564350322|FG000|12 Month (12M)|Lost to Follow-up|82|||
156341944|NCT01328431|564350323|FG001|12 Month (12M)|Lost to Follow-up|91|||
156341945|NCT05466682|564350327|FG000|Overall Study|Withdrawal by Subject|0|||
156341946|NCT05466682|564350328|FG001|Overall Study|Withdrawal by Subject|2|||
156470693|NCT00683800|564817833|FG001|Overall Study|Randomized, not treated|33|||
156341947|NCT05466682|564350327|FG000|Overall Study|Lost to Follow-up|2|||
156341948|NCT05466682|564350328|FG001|Overall Study|Lost to Follow-up|1|||
156341949|NCT02801396|564350329|FG000|Period 1|Withdrawal by Subject|0|||
156341950|NCT02801396|564350330|FG001|Period 1|Withdrawal by Subject|0|||
156341951|NCT02801396|564350331|FG002|Period 1|Withdrawal by Subject|0|||
156341952|NCT02801396|564350332|FG003|Period 1|Withdrawal by Subject|0|||
156341953|NCT02801396|564350333|FG004|Period 1|Withdrawal by Subject|1|||
156341954|NCT02801396|564350334|FG005|Period 1|Withdrawal by Subject|0|||
156341955|NCT03208244|564350335|FG000|Overall Study|Death|1|||
156341956|NCT03943147|564350336|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
156848726|NCT05280717|566199103|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
156848727|NCT05280717|566199104|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848728|NCT05280717|566199098|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848729|NCT05280717|566199099|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848730|NCT05280717|566199100|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848731|NCT05280717|566199101|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848732|NCT05280717|566199102|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848733|NCT05280717|566199103|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
156848734|NCT05280717|566199104|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156470694|NCT01359150|564817834|FG000|Overall Study|Lack of Efficacy|1|||
156470695|NCT01359150|564817835|FG001|Overall Study|Lack of Efficacy|1|||
156470696|NCT01359150|564817834|FG000|Overall Study|Withdrawal by Subject|1|||
156470697|NCT01359150|564817835|FG001|Overall Study|Withdrawal by Subject|1|||
156470698|NCT01359150|564817834|FG000|Overall Study|Adverse Event|4|||
156341957|NCT03943147|564350337|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
156341958|NCT03943147|564350336|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
156341959|NCT03943147|564350337|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
156470699|NCT01359150|564817835|FG001|Overall Study|Adverse Event|3|||
156470700|NCT01359150|564817834|FG000|Overall Study|Other|1|||
156470701|NCT01359150|564817835|FG001|Overall Study|Other|0|||
156848735|NCT00080301|566199105|FG000|Overall Study|Randomized but Never Treated|5|||
156848736|NCT00080301|566199106|FG001|Overall Study|Randomized but Never Treated|10|||
156848737|NCT00080301|566199105|FG000|Overall Study|Still on Treatment as of CSR date|0|||
156848738|NCT00080301|566199106|FG001|Overall Study|Still on Treatment as of CSR date|1|||
156848739|NCT04390243|566199110|FG000|Overall Study|Death|1|||
156848740|NCT04390243|566199110|FG000|Overall Study|Disease Progression|4|||
156848741|NCT04390243|566199110|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
156848742|NCT01521507|566199117|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
156848743|NCT01521507|566199118|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
156848744|NCT01521507|566199117|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
156848745|NCT01521507|566199118|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
156848746|NCT01521507|566199117|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
156848747|NCT01521507|566199118|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
156848748|NCT01521507|566199117|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
156848749|NCT01521507|566199118|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
156848750|NCT01521507|566199117|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
156848751|NCT01521507|566199118|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
156848752|NCT01521507|566199117|FG000|Stage 2: Observational Design|Physician Decision|1|||
156848753|NCT01521507|566199118|FG001|Stage 2: Observational Design|Physician Decision|0|||
156848754|NCT01196026|566199119|FG000|Overall Study|Withdrawal by Subject|1|||
156848755|NCT01196026|566199120|FG001|Overall Study|Withdrawal by Subject|4|||
156848756|NCT01196026|566199121|FG002|Overall Study|Withdrawal by Subject|0|||
156848757|NCT01196026|566199122|FG003|Overall Study|Withdrawal by Subject|0|||
156848758|NCT01196026|566199123|FG004|Overall Study|Withdrawal by Subject|0|||
156848759|NCT01196026|566199124|FG005|Overall Study|Withdrawal by Subject|0|||
156848760|NCT01196026|566199119|FG000|Overall Study|Lost to Follow-up|0|||
156848761|NCT01196026|566199120|FG001|Overall Study|Lost to Follow-up|3|||
156848762|NCT01196026|566199121|FG002|Overall Study|Lost to Follow-up|0|||
156848763|NCT01196026|566199122|FG003|Overall Study|Lost to Follow-up|0|||
156848764|NCT01196026|566199123|FG004|Overall Study|Lost to Follow-up|1|||
156848765|NCT01196026|566199124|FG005|Overall Study|Lost to Follow-up|0|||
156848766|NCT01196026|566199119|FG000|Overall Study|Other|0|||
156848767|NCT01196026|566199120|FG001|Overall Study|Other|1|||
156848768|NCT01196026|566199121|FG002|Overall Study|Other|0|||
156848769|NCT01196026|566199122|FG003|Overall Study|Other|0|||
156848770|NCT01196026|566199123|FG004|Overall Study|Other|0|||
156848771|NCT01196026|566199124|FG005|Overall Study|Other|0|||
156848772|NCT04034004|566199125|FG000|Overall Study|Withdrawal by Subject|1|||
156848773|NCT04034004|566199126|FG001|Overall Study|Withdrawal by Subject|2|||
156848774|NCT04034004|566199127|FG002|Overall Study|Withdrawal by Subject|2|||
156848775|NCT04034004|566199128|FG003|Overall Study|Withdrawal by Subject|3|||
156848776|NCT04034004|566199125|FG000|Overall Study|could not find vein to administer IV|2|||
156848777|NCT04034004|566199126|FG001|Overall Study|could not find vein to administer IV|1|||
156848778|NCT04034004|566199127|FG002|Overall Study|could not find vein to administer IV|0|||
156848779|NCT04034004|566199128|FG003|Overall Study|could not find vein to administer IV|0|||
156848780|NCT04034004|566199125|FG000|Overall Study|nurse accidentally unblinded subject|0|||
156848781|NCT04034004|566199126|FG001|Overall Study|nurse accidentally unblinded subject|0|||
156848782|NCT04034004|566199127|FG002|Overall Study|nurse accidentally unblinded subject|0|||
156848783|NCT04034004|566199128|FG003|Overall Study|nurse accidentally unblinded subject|1|||
156848784|NCT04317040|566199129|FG000|Overall Study|Lost to Follow-up|2|||
156848785|NCT04317040|566199130|FG001|Overall Study|Lost to Follow-up|0|||
156848786|NCT04317040|566199129|FG000|Overall Study|Death|16|||
156848787|NCT04317040|566199130|FG001|Overall Study|Death|18|||
156848788|NCT04317040|566199129|FG000|Overall Study|Withdrawal by Subject|0|||
156848789|NCT04317040|566199130|FG001|Overall Study|Withdrawal by Subject|1|||
156848790|NCT04317040|566199129|FG000|Overall Study|Incomplete assessments|0|||
156848791|NCT04317040|566199130|FG001|Overall Study|Incomplete assessments|1|||
156848792|NCT02518971|566199131|FG000|Overall Study|Lost to Follow-up|0|||
156848793|NCT02518971|566199132|FG001|Overall Study|Lost to Follow-up|1|||
156848794|NCT02518971|566199131|FG000|Overall Study|Physician Decision|6|||
156848795|NCT02518971|566199132|FG001|Overall Study|Physician Decision|6|||
156848796|NCT02518971|566199131|FG000|Overall Study|Protocol Violation|6|||
156848797|NCT02518971|566199132|FG001|Overall Study|Protocol Violation|4|||
156848798|NCT02518971|566199131|FG000|Overall Study|Withdrawal by Subject|4|||
156848799|NCT02518971|566199132|FG001|Overall Study|Withdrawal by Subject|5|||
156848800|NCT02518971|566199131|FG000|Overall Study|Side effects|1|||
156848801|NCT02518971|566199132|FG001|Overall Study|Side effects|0|||
156848802|NCT02518971|566199131|FG000|Overall Study|medication lost in mail|0|||
156848803|NCT02518971|566199132|FG001|Overall Study|medication lost in mail|1|||
156848804|NCT02518971|566199131|FG000|Overall Study|eligibility criteria no longer met|6|||
156848805|NCT02518971|566199132|FG001|Overall Study|eligibility criteria no longer met|3|||
156848806|NCT00757237|566199133|FG000|Overall Study|Lost to Follow-up|0|||
156848807|NCT00757237|566199134|FG001|Overall Study|Lost to Follow-up|1|||
156542130|NCT00632099|565077869|FG000|Overall Study|Lost to Follow-up|3|||
156848808|NCT00757237|566199133|FG000|Overall Study|Protocol Violation|0|||
156848809|NCT00757237|566199134|FG001|Overall Study|Protocol Violation|2|||
156848810|NCT00757237|566199133|FG000|Overall Study|Physician Decision|2|||
156848811|NCT00757237|566199134|FG001|Overall Study|Physician Decision|3|||
156848812|NCT00757237|566199133|FG000|Overall Study|Withdrawal by Subject|8|||
156848813|NCT00757237|566199134|FG001|Overall Study|Withdrawal by Subject|12|||
156848814|NCT00757237|566199133|FG000|Overall Study|Safety or Tolerability|3|||
156848815|NCT00757237|566199134|FG001|Overall Study|Safety or Tolerability|5|||
156848816|NCT00757237|566199133|FG000|Overall Study|Other|0|||
156848817|NCT00757237|566199134|FG001|Overall Study|Other|2|||
156848818|NCT05150990|566199139|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
156848819|NCT05150990|566199140|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
156848820|NCT05150990|566199139|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
156848821|NCT05150990|566199140|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
156848822|NCT05150990|566199139|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
156848823|NCT05150990|566199140|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
156848824|NCT05150990|566199139|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
156848825|NCT05150990|566199140|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
156848826|NCT05150990|566199139|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
156848827|NCT05150990|566199140|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
156848828|NCT05150990|566199139|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
156848829|NCT05150990|566199140|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
156848830|NCT05150990|566199139|FG000|Overall Study|Death (unrelated to the intervention)|1|||
156848831|NCT05150990|566199140|FG001|Overall Study|Death (unrelated to the intervention)|2|||
156848832|NCT01843023|566199141|FG000|Overall Study|Death|1|||
156848833|NCT01843023|566199142|FG001|Overall Study|Death|0|||
156848834|NCT01843023|566199141|FG000|Overall Study|Lost to Follow-up|24|||
156848835|NCT01843023|566199142|FG001|Overall Study|Lost to Follow-up|29|||
156848836|NCT01843023|566199141|FG000|Overall Study|Withdrawal by Subject|8|||
156848837|NCT01843023|566199142|FG001|Overall Study|Withdrawal by Subject|6|||
156848838|NCT01397461|566199144|FG000|Overall Study|Withdrawal by Subject|2|||
156848839|NCT01397461|566199145|FG001|Overall Study|Withdrawal by Subject|1|||
156848840|NCT01397461|566199146|FG002|Overall Study|Withdrawal by Subject|0|||
156848841|NCT01397461|566199144|FG000|Overall Study|Lost to Follow-up|0|||
156848842|NCT01397461|566199145|FG001|Overall Study|Lost to Follow-up|2|||
156848843|NCT01397461|566199146|FG002|Overall Study|Lost to Follow-up|1|||
156848844|NCT01397461|566199144|FG000|Overall Study|Lack of Efficacy|0|||
156848845|NCT01397461|566199145|FG001|Overall Study|Lack of Efficacy|3|||
156848846|NCT01397461|566199146|FG002|Overall Study|Lack of Efficacy|0|||
156848847|NCT01397461|566199144|FG000|Overall Study|Not treated|0|||
156848848|NCT01397461|566199145|FG001|Overall Study|Not treated|0|||
156848849|NCT01397461|566199146|FG002|Overall Study|Not treated|1|||
156848850|NCT04980612|566199163|FG000|Overall Study|Withdrawal by Subject|7|||
156848851|NCT04980612|566199164|FG001|Overall Study|Withdrawal by Subject|5|||
156848852|NCT01514201|566199167|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
156848853|NCT01514201|566199168|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848854|NCT01514201|566199169|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848855|NCT01514201|566199170|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848856|NCT01514201|566199167|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848857|NCT01514201|566199168|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
156848858|NCT01514201|566199169|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
156848859|NCT01514201|566199170|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848860|NCT01514201|566199167|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
156848861|NCT01514201|566199168|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
156848862|NCT01514201|566199169|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
156848863|NCT01514201|566199170|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
156848864|NCT01514201|566199167|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
156848865|NCT01514201|566199168|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
156848866|NCT01514201|566199169|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848867|NCT01514201|566199170|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848868|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
156848869|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
156848870|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
156848871|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
156848872|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
156848873|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
156542131|NCT00632099|565077870|FG001|Overall Study|Lost to Follow-up|3|||
156542132|NCT03374189|565077873|FG000|Overall Study|Lost to Follow-up|1|||
156848874|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
156848875|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
156848876|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
156848877|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
156848878|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
156848879|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
156848880|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848881|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848882|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848883|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
156848884|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
156848885|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
156848886|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
156848887|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
156848888|NCT01514201|566199167|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848889|NCT01514201|566199168|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848890|NCT01514201|566199169|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848891|NCT01514201|566199170|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
156848892|NCT01514201|566199167|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848893|NCT01514201|566199168|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848894|NCT01514201|566199169|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848895|NCT01514201|566199170|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
156848896|NCT01514201|566199167|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
156848897|NCT01514201|566199168|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
156848898|NCT01514201|566199169|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
156848899|NCT01514201|566199170|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
156848900|NCT00637416|566199175|FG000|Overall Study|Lost to Follow-up|1|||
156848901|NCT00637416|566199176|FG001|Overall Study|Lost to Follow-up|1|||
156848902|NCT00637416|566199175|FG000|Overall Study|Unable to take study drug|0|||
156848903|NCT00637416|566199176|FG001|Overall Study|Unable to take study drug|1|||
156848904|NCT02715609|566199188|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
156848905|NCT02715609|566199189|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
156848906|NCT02715609|566199190|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
156848907|NCT02715609|566199188|FG000|Overall Study|Withdrawal by Subject|0|||
156848908|NCT02715609|566199189|FG001|Overall Study|Withdrawal by Subject|0|||
156848909|NCT02715609|566199190|FG002|Overall Study|Withdrawal by Subject|1|||
156848910|NCT00310817|566199191|FG000|Overall Study|AE or Death|3|||
156848911|NCT00310817|566199192|FG001|Overall Study|AE or Death|1|||
156848912|NCT00310817|566199193|FG002|Overall Study|AE or Death|0|||
156848913|NCT00310817|566199194|FG003|Overall Study|AE or Death|0|||
156848914|NCT00310817|566199191|FG000|Overall Study|Withdrawal by Subject|1|||
156848915|NCT00310817|566199192|FG001|Overall Study|Withdrawal by Subject|4|||
156848916|NCT00310817|566199193|FG002|Overall Study|Withdrawal by Subject|6|||
156848917|NCT00310817|566199194|FG003|Overall Study|Withdrawal by Subject|7|||
156848918|NCT00310817|566199191|FG000|Overall Study|Lost to Follow-up|2|||
156848919|NCT00310817|566199192|FG001|Overall Study|Lost to Follow-up|1|||
156848920|NCT00310817|566199193|FG002|Overall Study|Lost to Follow-up|0|||
156848921|NCT00310817|566199194|FG003|Overall Study|Lost to Follow-up|0|||
156848922|NCT00310817|566199191|FG000|Overall Study|Inappropriate Enrollment|1|||
156848923|NCT00310817|566199192|FG001|Overall Study|Inappropriate Enrollment|0|||
156848924|NCT00310817|566199193|FG002|Overall Study|Inappropriate Enrollment|1|||
156848925|NCT00310817|566199194|FG003|Overall Study|Inappropriate Enrollment|0|||
156848926|NCT00310817|566199191|FG000|Overall Study|Protocol Violation|1|||
156848927|NCT00310817|566199192|FG001|Overall Study|Protocol Violation|1|||
156848928|NCT00310817|566199193|FG002|Overall Study|Protocol Violation|1|||
156848929|NCT00310817|566199194|FG003|Overall Study|Protocol Violation|1|||
156848930|NCT00310817|566199191|FG000|Overall Study|Unable to classify|3|||
156848931|NCT00310817|566199192|FG001|Overall Study|Unable to classify|1|||
156848932|NCT00310817|566199193|FG002|Overall Study|Unable to classify|0|||
156848933|NCT00310817|566199194|FG003|Overall Study|Unable to classify|0|||
156848934|NCT04300309|566199200|FG000|Overall Study|Lost to Follow-up|1|||
156848935|NCT04300309|566199201|FG001|Overall Study|Lost to Follow-up|0|||
156848936|NCT04607837|566199203|FG000|Overall Study|Adverse Event|8|||
156848937|NCT04607837|566199204|FG001|Overall Study|Adverse Event|2|||
156848938|NCT04607837|566199203|FG000|Overall Study|Withdrawal by Subject|8|||
156848939|NCT04607837|566199204|FG001|Overall Study|Withdrawal by Subject|7|||
156848940|NCT04607837|566199203|FG000|Overall Study|Physician Decision|2|||
156848941|NCT04607837|566199204|FG001|Overall Study|Physician Decision|0|||
156848942|NCT04607837|566199203|FG000|Overall Study|Lack of Efficacy|2|||
156848943|NCT04607837|566199204|FG001|Overall Study|Lack of Efficacy|0|||
156341960|NCT03943147|564350336|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
156341961|NCT03943147|564350337|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
156848944|NCT04607837|566199203|FG000|Overall Study|Participant terminated by sponsor|1|||
156848945|NCT04607837|566199204|FG001|Overall Study|Participant terminated by sponsor|0|||
156848946|NCT04607837|566199203|FG000|Overall Study|Disease worsening|36|||
156848947|NCT04607837|566199204|FG001|Overall Study|Disease worsening|36|||
156848948|NCT04607837|566199203|FG000|Overall Study|Other|1|||
156848949|NCT04607837|566199204|FG001|Overall Study|Other|0|||
156848950|NCT00367835|566199205|FG000|Overall Study|Adverse Event|14|||
156848951|NCT00367835|566199206|FG001|Overall Study|Adverse Event|1|||
156848952|NCT00367835|566199205|FG000|Overall Study|Protocol Violation|1|||
156848953|NCT00367835|566199206|FG001|Overall Study|Protocol Violation|7|||
156848954|NCT00367835|566199205|FG000|Overall Study|Withdrawal by Subject|7|||
156848955|NCT00367835|566199206|FG001|Overall Study|Withdrawal by Subject|6|||
156848956|NCT00367835|566199205|FG000|Overall Study|Lost to Follow-up|1|||
156848957|NCT00367835|566199206|FG001|Overall Study|Lost to Follow-up|4|||
156848958|NCT00367835|566199205|FG000|Overall Study|Lack of Efficacy|3|||
156848959|NCT00367835|566199206|FG001|Overall Study|Lack of Efficacy|12|||
156848960|NCT00367835|566199205|FG000|Overall Study|Subject in juvenile detention center|1|||
156848961|NCT00367835|566199206|FG001|Overall Study|Subject in juvenile detention center|0|||
156848962|NCT00367835|566199205|FG000|Overall Study|refused blood collection|1|||
156848963|NCT00367835|566199206|FG001|Overall Study|refused blood collection|0|||
156848964|NCT00367835|566199205|FG000|Overall Study|Did not respond to calls|1|||
156848965|NCT00367835|566199206|FG001|Overall Study|Did not respond to calls|0|||
156848966|NCT00367835|566199205|FG000|Overall Study|History of lead poisoning|0|||
156848967|NCT00367835|566199206|FG001|Overall Study|History of lead poisoning|1|||
156848968|NCT04346654|566199208|FG000|Overall Study|Adverse Event|2|||
156848969|NCT04346654|566199209|FG001|Overall Study|Adverse Event|0|||
156848970|NCT04346654|566199208|FG000|Overall Study|Non-response|1|||
156848971|NCT04346654|566199209|FG001|Overall Study|Non-response|1|||
156848972|NCT04346654|566199208|FG000|Overall Study|Withdrawal by Subject|2|||
156848973|NCT04346654|566199209|FG001|Overall Study|Withdrawal by Subject|0|||
156848974|NCT04346654|566199208|FG000|Overall Study|Lost to Follow-up|0|||
156848975|NCT04346654|566199209|FG001|Overall Study|Lost to Follow-up|1|||
156848976|NCT04346654|566199208|FG000|Overall Study|Pregnancy|0|||
156848977|NCT04346654|566199209|FG001|Overall Study|Pregnancy|1|||
156848978|NCT04209205|566199218|FG000|Overall Study|Adverse Event|2|||
156848979|NCT04209205|566199219|FG001|Overall Study|Adverse Event|3|||
156848980|NCT04209205|566199218|FG000|Overall Study|Lost to Follow-up|3|||
156848981|NCT04209205|566199219|FG001|Overall Study|Lost to Follow-up|1|||
156848982|NCT04209205|566199218|FG000|Overall Study|Physician Decision|1|||
156848983|NCT04209205|566199219|FG001|Overall Study|Physician Decision|1|||
156848984|NCT04209205|566199218|FG000|Overall Study|Subject decision|10|||
156848985|NCT04209205|566199219|FG001|Overall Study|Subject decision|10|||
156848986|NCT04209205|566199218|FG000|Overall Study|Progressive disease|1|||
156848987|NCT04209205|566199219|FG001|Overall Study|Progressive disease|0|||
156848988|NCT04209205|566199218|FG000|Overall Study|Protocol deviation|0|||
156848989|NCT04209205|566199219|FG001|Overall Study|Protocol deviation|1|||
156848990|NCT04209205|566199218|FG000|Overall Study|New therapy for study indication|1|||
156848991|NCT04209205|566199219|FG001|Overall Study|New therapy for study indication|0|||
156848992|NCT04209205|566199218|FG000|Overall Study|Adverse event - placebo not switched|0|||
156848993|NCT04209205|566199219|FG001|Overall Study|Adverse event - placebo not switched|1|||
156848994|NCT04209205|566199218|FG000|Overall Study|Subject decision - placebo not switched|0|||
156848995|NCT04209205|566199219|FG001|Overall Study|Subject decision - placebo not switched|5|||
156848996|NCT04209205|566199218|FG000|Overall Study|Death - placebo not switched|0|||
156848997|NCT04209205|566199219|FG001|Overall Study|Death - placebo not switched|1|||
156848998|NCT05236257|566199220|FG000|Overall Study|Ongoing with study treatment|29|||
156848999|NCT05236257|566199221|FG001|Overall Study|Ongoing with study treatment|1|||
156849000|NCT05236257|566199220|FG000|Overall Study|Discontinued study treatment|22|||
156849001|NCT05236257|566199221|FG001|Overall Study|Discontinued study treatment|41|||
156849002|NCT02343406|566199225|FG000|Overall Study|Progressive disease|72|||
156849003|NCT02343406|566199226|FG001|Overall Study|Progressive disease|70|||
156849004|NCT02343406|566199227|FG002|Overall Study|Progressive disease|43|||
156849005|NCT02343406|566199228|FG003|Overall Study|Progressive disease|15|||
156849006|NCT02343406|566199229|FG004|Overall Study|Progressive disease|5|||
156849007|NCT02343406|566199225|FG000|Overall Study|Adverse Event|6|||
156849008|NCT02343406|566199226|FG001|Overall Study|Adverse Event|8|||
156849009|NCT02343406|566199227|FG002|Overall Study|Adverse Event|6|||
156849010|NCT02343406|566199228|FG003|Overall Study|Adverse Event|3|||
156849011|NCT02343406|566199229|FG004|Overall Study|Adverse Event|0|||
156849012|NCT02343406|566199225|FG000|Overall Study|Withdrawal by Subject|6|||
156849013|NCT02343406|566199226|FG001|Overall Study|Withdrawal by Subject|4|||
156849014|NCT02343406|566199227|FG002|Overall Study|Withdrawal by Subject|8|||
156849015|NCT02343406|566199228|FG003|Overall Study|Withdrawal by Subject|3|||
156849016|NCT02343406|566199229|FG004|Overall Study|Withdrawal by Subject|0|||
156470702|NCT01619059|564817840|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
156849017|NCT02343406|566199225|FG000|Overall Study|Death|2|||
156849018|NCT02343406|566199226|FG001|Overall Study|Death|1|||
156849019|NCT02343406|566199227|FG002|Overall Study|Death|0|||
156849020|NCT02343406|566199228|FG003|Overall Study|Death|0|||
156849021|NCT02343406|566199229|FG004|Overall Study|Death|0|||
156849022|NCT02343406|566199225|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
156849023|NCT02343406|566199226|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
156849024|NCT02343406|566199227|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
156849025|NCT02343406|566199228|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
156849026|NCT02343406|566199229|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
156849027|NCT02343406|566199225|FG000|Overall Study|Other primary malignancy|0|||
156849028|NCT02343406|566199226|FG001|Overall Study|Other primary malignancy|1|||
156849029|NCT02343406|566199227|FG002|Overall Study|Other primary malignancy|0|||
156849030|NCT02343406|566199228|FG003|Overall Study|Other primary malignancy|0|||
156849031|NCT02343406|566199229|FG004|Overall Study|Other primary malignancy|0|||
156849032|NCT02343406|566199225|FG000|Overall Study|Other, not specified|2|||
156849033|NCT02343406|566199226|FG001|Overall Study|Other, not specified|1|||
156849034|NCT02343406|566199227|FG002|Overall Study|Other, not specified|1|||
156849035|NCT02343406|566199228|FG003|Overall Study|Other, not specified|4|||
156849036|NCT02343406|566199229|FG004|Overall Study|Other, not specified|0|||
156849037|NCT01746225|566199232|FG000|Overall Study|Death|1|||
156849038|NCT01746225|566199233|FG001|Overall Study|Death|0|||
156849039|NCT01746225|566199234|FG002|Overall Study|Death|1|||
156849040|NCT01746225|566199232|FG000|Overall Study|Withdrawal by Subject|5|||
156849041|NCT01746225|566199233|FG001|Overall Study|Withdrawal by Subject|15|||
156849042|NCT01746225|566199234|FG002|Overall Study|Withdrawal by Subject|19|||
156849043|NCT01746225|566199232|FG000|Overall Study|Physician Decision|14|||
156849044|NCT01746225|566199233|FG001|Overall Study|Physician Decision|11|||
156849045|NCT01746225|566199234|FG002|Overall Study|Physician Decision|3|||
156849046|NCT01746225|566199232|FG000|Overall Study|Adverse Event|15|||
156849047|NCT01746225|566199233|FG001|Overall Study|Adverse Event|12|||
156849048|NCT01746225|566199234|FG002|Overall Study|Adverse Event|17|||
156849049|NCT01746225|566199232|FG000|Overall Study|Continuing Treatment|5|||
156849050|NCT01746225|566199233|FG001|Overall Study|Continuing Treatment|8|||
156849051|NCT01746225|566199234|FG002|Overall Study|Continuing Treatment|3|||
156849052|NCT00999518|566199235|FG000|Overall Study|Adverse Event|1|||
156849053|NCT00999518|566199236|FG001|Overall Study|Adverse Event|6|||
156849054|NCT00999518|566199237|FG002|Overall Study|Adverse Event|3|||
156849055|NCT00999518|566199238|FG003|Overall Study|Adverse Event|1|||
156849056|NCT00999518|566199239|FG004|Overall Study|Adverse Event|2|||
156849057|NCT00999518|566199235|FG000|Overall Study|Lack of Efficacy|2|||
156849058|NCT00999518|566199236|FG001|Overall Study|Lack of Efficacy|0|||
156849059|NCT00999518|566199237|FG002|Overall Study|Lack of Efficacy|0|||
156849060|NCT00999518|566199238|FG003|Overall Study|Lack of Efficacy|2|||
156849061|NCT00999518|566199239|FG004|Overall Study|Lack of Efficacy|2|||
156849062|NCT00999518|566199235|FG000|Overall Study|Lost to Follow-up|0|||
156849063|NCT00999518|566199236|FG001|Overall Study|Lost to Follow-up|0|||
156849064|NCT00999518|566199237|FG002|Overall Study|Lost to Follow-up|0|||
156849065|NCT00999518|566199238|FG003|Overall Study|Lost to Follow-up|4|||
156849066|NCT00999518|566199239|FG004|Overall Study|Lost to Follow-up|1|||
156849067|NCT00999518|566199235|FG000|Overall Study|Did not meet entrance criteria|0|||
156849068|NCT00999518|566199236|FG001|Overall Study|Did not meet entrance criteria|0|||
156849069|NCT00999518|566199237|FG002|Overall Study|Did not meet entrance criteria|0|||
156849070|NCT00999518|566199238|FG003|Overall Study|Did not meet entrance criteria|0|||
156849071|NCT00999518|566199239|FG004|Overall Study|Did not meet entrance criteria|1|||
156849072|NCT00999518|566199235|FG000|Overall Study|Study terminated by sponsor|10|||
156849073|NCT00999518|566199236|FG001|Overall Study|Study terminated by sponsor|6|||
156849074|NCT00999518|566199237|FG002|Overall Study|Study terminated by sponsor|5|||
156849075|NCT00999518|566199238|FG003|Overall Study|Study terminated by sponsor|5|||
156849076|NCT00999518|566199239|FG004|Overall Study|Study terminated by sponsor|9|||
156849077|NCT00999518|566199235|FG000|Overall Study|Pregnancy|0|||
156849078|NCT00999518|566199236|FG001|Overall Study|Pregnancy|0|||
156849079|NCT00999518|566199237|FG002|Overall Study|Pregnancy|1|||
156849080|NCT00999518|566199238|FG003|Overall Study|Pregnancy|0|||
156849081|NCT00999518|566199239|FG004|Overall Study|Pregnancy|0|||
156849082|NCT00999518|566199235|FG000|Overall Study|Protocol Violation|0|||
156849083|NCT00999518|566199236|FG001|Overall Study|Protocol Violation|1|||
156849084|NCT00999518|566199237|FG002|Overall Study|Protocol Violation|0|||
156849085|NCT00999518|566199238|FG003|Overall Study|Protocol Violation|0|||
156849086|NCT00999518|566199239|FG004|Overall Study|Protocol Violation|2|||
156849087|NCT00999518|566199235|FG000|Overall Study|Withdrawal by Subject|5|||
156849088|NCT00999518|566199236|FG001|Overall Study|Withdrawal by Subject|4|||
156849089|NCT00999518|566199237|FG002|Overall Study|Withdrawal by Subject|10|||
156849090|NCT00999518|566199238|FG003|Overall Study|Withdrawal by Subject|6|||
156849091|NCT00999518|566199239|FG004|Overall Study|Withdrawal by Subject|1|||
156849092|NCT00999518|566199235|FG000|Overall Study|Other|5|||
156849093|NCT00999518|566199236|FG001|Overall Study|Other|7|||
156849094|NCT00999518|566199237|FG002|Overall Study|Other|1|||
156849095|NCT00999518|566199238|FG003|Overall Study|Other|4|||
156849096|NCT00999518|566199239|FG004|Overall Study|Other|5|||
156849097|NCT00999518|566199235|FG000|Overall Study|Randomized but not Treated|1|||
156849098|NCT00999518|566199236|FG001|Overall Study|Randomized but not Treated|1|||
156849099|NCT00999518|566199237|FG002|Overall Study|Randomized but not Treated|2|||
156849100|NCT00999518|566199238|FG003|Overall Study|Randomized but not Treated|0|||
156849101|NCT00999518|566199239|FG004|Overall Study|Randomized but not Treated|1|||
156849102|NCT03857542|566199243|FG000|Overall Study|Adverse Event|1|||
156849103|NCT03857542|566199244|FG001|Overall Study|Adverse Event|3|||
156849104|NCT03857542|566199243|FG000|Overall Study|Withdrawal by Subject|2|||
156849105|NCT03857542|566199244|FG001|Overall Study|Withdrawal by Subject|1|||
156849106|NCT03857542|566199243|FG000|Overall Study|Lost to Follow-up|2|||
156849107|NCT03857542|566199244|FG001|Overall Study|Lost to Follow-up|1|||
156849108|NCT03857542|566199243|FG000|Overall Study|Reason not Specified|1|||
156849109|NCT03857542|566199244|FG001|Overall Study|Reason not Specified|0|||
156849110|NCT04864639|566200924|FG000|Overall Study|Death|1|||
156849111|NCT04864639|566200924|FG000|Overall Study|Lost to Follow-up|1|||
156849112|NCT03449758|566200925|FG000|Overall Study|Major protocol deviation|1|||
156849113|NCT03449758|566200925|FG000|Overall Study|Treatment inefficacy|5|||
156849114|NCT03449758|566200925|FG000|Overall Study|Adverse Event|9|||
156849115|NCT03449758|566200925|FG000|Overall Study|Consent withdrawal|1|||
156849116|NCT03449758|566200925|FG000|Overall Study|Other unspecified reason|3|||
156849117|NCT00584012|566200931|FG000|Overall Study|Withdrawal by Subject|1|||
156849118|NCT02451943|566200935|FG000|Overall Study|Withdrawal by Subject|13|||
156849119|NCT02451943|566200936|FG001|Overall Study|Withdrawal by Subject|16|||
156849120|NCT02451943|566200935|FG000|Overall Study|Lost to Follow-up|3|||
156849121|NCT02451943|566200936|FG001|Overall Study|Lost to Follow-up|4|||
156849122|NCT02451943|566200935|FG000|Overall Study|Sponsor Decision|0|||
156849123|NCT02451943|566200936|FG001|Overall Study|Sponsor Decision|4|||
156849124|NCT03937713|566200937|FG000|Overall Study|Withdrawal by Subject|3|||
156849125|NCT03937713|566200938|FG001|Overall Study|Withdrawal by Subject|6|||
156849126|NCT03937713|566200937|FG000|Overall Study|Lost to Follow-up|1|||
156849127|NCT03937713|566200938|FG001|Overall Study|Lost to Follow-up|0|||
156849128|NCT00763386|566200941|FG000|Overall Study|Adverse Event|43|||
156849129|NCT00763386|566200942|FG001|Overall Study|Adverse Event|33|||
156849130|NCT00763386|566200941|FG000|Overall Study|Death|1|||
156849131|NCT00763386|566200942|FG001|Overall Study|Death|2|||
156849132|NCT00763386|566200941|FG000|Overall Study|Lost to Follow-up|3|||
156849133|NCT00763386|566200942|FG001|Overall Study|Lost to Follow-up|3|||
156849134|NCT00763386|566200941|FG000|Overall Study|Withdrawal by Subject|0|||
156849135|NCT00763386|566200942|FG001|Overall Study|Withdrawal by Subject|1|||
156849136|NCT00763386|566200941|FG000|Overall Study|CRF missing|0|||
156849137|NCT00763386|566200942|FG001|Overall Study|CRF missing|1|||
156849138|NCT00763386|566200941|FG000|Overall Study|Study Prosthesis Removed|1|||
156849139|NCT00763386|566200942|FG001|Overall Study|Study Prosthesis Removed|0|||
156849140|NCT00922623|566200943|FG000|Overall Study|Other|4|||
156849141|NCT00922623|566200943|FG000|Overall Study|Lost to Follow-up|1|||
156849142|NCT02420379|566200944|FG000|Overall Study|Withdrawal by Subject|0|||
156849143|NCT02420379|566200945|FG001|Overall Study|Withdrawal by Subject|3|||
156849144|NCT02420379|566200944|FG000|Overall Study|Unable to complete due to schooling|0|||
156849145|NCT02420379|566200945|FG001|Overall Study|Unable to complete due to schooling|1|||
156849146|NCT02420379|566200944|FG000|Overall Study|Transitioned to commercial drug|1|||
156849147|NCT02420379|566200945|FG001|Overall Study|Transitioned to commercial drug|0|||
156849148|NCT04640311|566200951|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
156849149|NCT04640311|566200952|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849150|NCT04640311|566200953|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849151|NCT04640311|566200954|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849152|NCT04640311|566200955|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849153|NCT04640311|566200956|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849154|NCT04640311|566200957|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849155|NCT04640311|566200958|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849156|NCT04640311|566200959|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849157|NCT04640311|566200960|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849158|NCT04640311|566200961|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849159|NCT04640311|566200962|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849160|NCT04640311|566200963|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849161|NCT04640311|566200951|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849162|NCT04640311|566200952|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
156849163|NCT04640311|566200953|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849164|NCT04640311|566200954|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849165|NCT04640311|566200955|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849166|NCT04640311|566200956|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849167|NCT04640311|566200957|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849168|NCT04640311|566200958|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849169|NCT04640311|566200959|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849170|NCT04640311|566200960|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849171|NCT04640311|566200961|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849172|NCT04640311|566200962|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849173|NCT04640311|566200963|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849174|NCT04640311|566200951|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849175|NCT04640311|566200952|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
156849176|NCT04640311|566200953|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849177|NCT04640311|566200954|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849178|NCT04640311|566200955|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849179|NCT04640311|566200956|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849180|NCT04640311|566200957|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849181|NCT04640311|566200958|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849182|NCT04640311|566200959|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849183|NCT04640311|566200960|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849184|NCT04640311|566200961|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849185|NCT04640311|566200962|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849186|NCT04640311|566200963|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849187|NCT04640311|566200951|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
156849188|NCT04640311|566200952|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
156849189|NCT04640311|566200953|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
156849190|NCT04640311|566200954|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156470703|NCT01619059|564817841|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
156849191|NCT04640311|566200955|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849192|NCT04640311|566200956|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849193|NCT04640311|566200957|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849194|NCT04640311|566200958|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849195|NCT04640311|566200959|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849196|NCT04640311|566200960|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849197|NCT04640311|566200961|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849198|NCT04640311|566200962|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849199|NCT04640311|566200963|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849200|NCT04640311|566200951|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849201|NCT04640311|566200952|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849202|NCT04640311|566200953|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
156849203|NCT04640311|566200954|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849204|NCT04640311|566200955|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849205|NCT04640311|566200956|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849206|NCT04640311|566200957|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849207|NCT04640311|566200958|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156470704|NCT01619059|564817840|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
156470705|NCT01619059|564817841|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
156849208|NCT04640311|566200959|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849209|NCT04640311|566200960|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849210|NCT04640311|566200961|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849211|NCT04640311|566200962|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849212|NCT04640311|566200963|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849213|NCT04640311|566200951|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849214|NCT04640311|566200952|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849215|NCT04640311|566200953|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849216|NCT04640311|566200954|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
156849217|NCT04640311|566200955|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849218|NCT04640311|566200956|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849219|NCT04640311|566200957|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
156849220|NCT04640311|566200958|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849221|NCT04640311|566200959|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849222|NCT04640311|566200960|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849223|NCT04640311|566200961|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849224|NCT04640311|566200962|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849225|NCT04640311|566200963|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849226|NCT04640311|566200951|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849227|NCT04640311|566200952|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849228|NCT04640311|566200953|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849229|NCT04640311|566200954|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849230|NCT04640311|566200955|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849231|NCT04640311|566200956|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
156849232|NCT04640311|566200957|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849233|NCT04640311|566200958|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849234|NCT04640311|566200959|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
156849235|NCT04640311|566200960|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849236|NCT04640311|566200961|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849237|NCT04640311|566200962|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849238|NCT04640311|566200963|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849239|NCT04640311|566200951|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849240|NCT04640311|566200952|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849241|NCT04640311|566200953|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849242|NCT04640311|566200954|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849243|NCT04640311|566200955|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849244|NCT04640311|566200956|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849245|NCT04640311|566200957|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
156849246|NCT04640311|566200958|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849247|NCT04640311|566200959|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849248|NCT04640311|566200960|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849249|NCT04640311|566200961|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
156849250|NCT04640311|566200962|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849251|NCT04640311|566200963|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849252|NCT04640311|566200951|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849253|NCT04640311|566200952|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849254|NCT04640311|566200953|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849255|NCT04640311|566200954|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849256|NCT04640311|566200955|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849257|NCT04640311|566200956|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849258|NCT04640311|566200957|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849259|NCT04640311|566200958|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849260|NCT04640311|566200959|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849261|NCT04640311|566200960|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849262|NCT04640311|566200961|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156341962|NCT03943147|564350336|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
156341963|NCT03943147|564350337|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
156341964|NCT03943147|564350336|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
156341965|NCT03943147|564350337|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
156341966|NCT03943147|564350336|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
156341967|NCT03943147|564350337|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
156341968|NCT02695329|564350338|FG000|Overall Study|Adverse Event|1|||
156341969|NCT02695329|564350339|FG001|Overall Study|Adverse Event|0|||
156341970|NCT02695329|564350338|FG000|Overall Study|Poor X-ray quality for measurement|4|||
156341971|NCT02695329|564350339|FG001|Overall Study|Poor X-ray quality for measurement|5|||
156341972|NCT01382212|564350340|FG000|Overall Study|Kidney transplant|1|||
156341973|NCT01382212|564350340|FG000|Overall Study|Withdrew consent|1|||
156341974|NCT00393029|564350341|FG000|Overall Study|Not treated|0|||
156341975|NCT00393029|564350342|FG001|Overall Study|Not treated|1|||
156341976|NCT00382252|564350343|FG000|Overall Study|Death|4|||
156341977|NCT00382252|564350343|FG000|Overall Study|Protocol Violation|8|||
156341978|NCT00382252|564350343|FG000|Overall Study|Not treated by RFA|1|||
156341979|NCT03338998|564350345|FG000|Treatment Period|Withdrawal by Subject|1|||
156341980|NCT03338998|564350346|FG001|Treatment Period|Withdrawal by Subject|1|||
156341981|NCT03338998|564350345|FG000|Treatment Period|Adverse Event|0|||
156341982|NCT03338998|564350346|FG001|Treatment Period|Adverse Event|2|||
156341983|NCT03338998|564350345|FG000|Treatment Period|Protocol deviation|1|||
156341984|NCT03338998|564350346|FG001|Treatment Period|Protocol deviation|0|||
156341985|NCT03338998|564350345|FG000|Treatment Period|Physician Decision|2|||
156341986|NCT03338998|564350346|FG001|Treatment Period|Physician Decision|0|||
156341987|NCT03338998|564350345|FG000|Treatment Period|Subject failed swallow test|4|||
156341988|NCT03338998|564350346|FG001|Treatment Period|Subject failed swallow test|0|||
156341989|NCT03338998|564350345|FG000|Safety Follow-Up Period|Adverse Event|0|||
156341990|NCT03338998|564350346|FG001|Safety Follow-Up Period|Adverse Event|1|||
156341991|NCT03338998|564350345|FG000|Safety Follow-Up Period|Protocol deviation|1|||
156341992|NCT03338998|564350346|FG001|Safety Follow-Up Period|Protocol deviation|0|||
156341993|NCT03338998|564350345|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
156341994|NCT03338998|564350346|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
156341995|NCT00039130|564350347|FG000|Overall Study|Adverse Event|11|||
156341996|NCT00039130|564350347|FG000|Overall Study|Death|9|||
156341997|NCT00039130|564350347|FG000|Overall Study|Withdrawal by Subject|3|||
156341998|NCT00039130|564350347|FG000|Overall Study|Progression|2|||
156341999|NCT00039130|564350347|FG000|Overall Study|Subsequent treatment|2|||
156342000|NCT00039130|564350347|FG000|Overall Study|Physician Decision|3|||
156342001|NCT02612727|564350348|FG000|Overall Study|Parent request|4|||
156342002|NCT02612727|564350349|FG001|Overall Study|Parent request|1|||
156342003|NCT02612727|564350348|FG000|Overall Study|Needed treatment incompatible with PT|1|||
156342004|NCT02612727|564350349|FG001|Overall Study|Needed treatment incompatible with PT|1|||
156342005|NCT02612727|564350348|FG000|Overall Study|Direct hyperbilirubinemia|0|||
156849263|NCT04640311|566200962|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
156849264|NCT04640311|566200963|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849265|NCT01641601|566200964|FG000|Overall Study|Study discontinued.|3|||
156849266|NCT01641601|566200965|FG001|Overall Study|Study discontinued.|5|||
156849267|NCT01799226|566200970|FG000|Overall Study|Withdrawal by Subject|1|||
156849268|NCT01799226|566200971|FG001|Overall Study|Withdrawal by Subject|0|||
156849269|NCT01799226|566200970|FG000|Overall Study|Disqualified at Day 14|1|||
156849270|NCT01799226|566200971|FG001|Overall Study|Disqualified at Day 14|0|||
156849271|NCT02178995|566200972|FG000|Double Blind|Adverse Event|0|||
156849272|NCT02178995|566200973|FG001|Double Blind|Adverse Event|0|||
156849273|NCT02178995|566200974|FG002|Double Blind|Adverse Event|0|||
156849274|NCT02178995|566200975|FG003|Double Blind|Adverse Event|0|||
156849275|NCT02178995|566200976|FG004|Double Blind|Adverse Event|0|||
156849276|NCT02178995|566200977|FG005|Double Blind|Adverse Event|1|||
156849277|NCT02178995|566200978|FG006|Double Blind|Adverse Event|0|||
156849278|NCT02178995|566200979|FG007|Double Blind|Adverse Event|1|||
156849279|NCT02178995|566200980|FG008|Double Blind|Adverse Event|1|||
156849280|NCT02178995|566200972|FG000|Double Blind|Lost to Follow-up|0|||
156849281|NCT02178995|566200973|FG001|Double Blind|Lost to Follow-up|1|||
156342006|NCT02612727|564350349|FG001|Overall Study|Direct hyperbilirubinemia|2|||
156342007|NCT01063868|564350350|FG000|Overall Study|Adverse Event|9|||
156342008|NCT01063868|564350351|FG001|Overall Study|Adverse Event|7|||
156342009|NCT01063868|564350350|FG000|Overall Study|Withdrawal by Subject|3|||
156342010|NCT01063868|564350351|FG001|Overall Study|Withdrawal by Subject|1|||
156342011|NCT01063868|564350350|FG000|Overall Study|Study Terminated By Sponsor|23|||
156342012|NCT01063868|564350351|FG001|Overall Study|Study Terminated By Sponsor|4|||
156849282|NCT02178995|566200974|FG002|Double Blind|Lost to Follow-up|0|||
156849283|NCT02178995|566200975|FG003|Double Blind|Lost to Follow-up|0|||
156849284|NCT02178995|566200976|FG004|Double Blind|Lost to Follow-up|0|||
156849285|NCT02178995|566200977|FG005|Double Blind|Lost to Follow-up|0|||
156849286|NCT02178995|566200978|FG006|Double Blind|Lost to Follow-up|0|||
156849287|NCT02178995|566200979|FG007|Double Blind|Lost to Follow-up|1|||
156849288|NCT02178995|566200980|FG008|Double Blind|Lost to Follow-up|0|||
156849289|NCT02178995|566200972|FG000|Open Label|Adverse Event|2|||
156849290|NCT02178995|566200973|FG001|Open Label|Adverse Event|0|||
156849291|NCT02178995|566200974|FG002|Open Label|Adverse Event|0|||
156849292|NCT02178995|566200975|FG003|Open Label|Adverse Event|0|||
156849293|NCT02178995|566200976|FG004|Open Label|Adverse Event|0|||
156849294|NCT02178995|566200977|FG005|Open Label|Adverse Event|0|||
156849295|NCT02178995|566200978|FG006|Open Label|Adverse Event|0|||
156849296|NCT02178995|566200979|FG007|Open Label|Adverse Event|0|||
156849297|NCT02178995|566200980|FG008|Open Label|Adverse Event|0|||
156849298|NCT01388907|566200981|FG000|Overall Study|Adverse Event|2|||
156849299|NCT01388907|566200982|FG001|Overall Study|Adverse Event|0|||
156849300|NCT03361293|566200983|FG000|Overall Study|Lost to Follow-up|0|||
156849301|NCT03361293|566200984|FG001|Overall Study|Lost to Follow-up|2|||
156849302|NCT03361293|566200983|FG000|Overall Study|Withdrawal by Subject|1|||
156849303|NCT03361293|566200984|FG001|Overall Study|Withdrawal by Subject|3|||
156849304|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
156849305|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
156849306|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
156849307|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
156849308|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
156849309|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
156849310|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
156849311|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
156849312|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
156849313|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
156849314|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
156849315|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
156849316|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
156849317|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
156849318|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
156849319|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
156849320|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
156849321|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
156849322|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
156849323|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
156849324|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
156849325|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
156849326|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
156849327|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
156849328|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
156849329|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
156849330|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
156849331|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
156849332|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
156849333|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
156849334|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
156849335|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
156849336|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
156849337|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
156849338|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
156849339|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
156849340|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
156849341|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
156849342|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
156849343|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Technical problems|0|||
156849344|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Technical problems|0|||
156849345|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Technical problems|0|||
156849346|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Technical problems|1|||
156849347|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
156849348|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
156849349|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
156849350|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
156849351|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
156849352|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
156849353|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
156849354|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
156849355|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
156849356|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
156849357|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
156849358|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
156849359|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Death|0|||
156849360|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Death|3|||
156849361|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Death|1|||
156849362|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Death|0|||
156849363|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
156849364|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
156849365|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
156849366|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
156849367|NCT02152761|566200988|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
156849368|NCT02152761|566200989|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
156849369|NCT02152761|566200990|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
156849370|NCT02152761|566200991|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
156849371|NCT02152761|566200988|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
156849372|NCT02152761|566200989|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
156849373|NCT02152761|566200990|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
156849374|NCT02152761|566200991|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
156849375|NCT02152761|566200988|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
156849376|NCT02152761|566200989|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
156849377|NCT02152761|566200990|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
156849378|NCT02152761|566200991|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
156849379|NCT02152761|566200988|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
156849380|NCT02152761|566200989|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
156849381|NCT02152761|566200990|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
156849382|NCT02152761|566200991|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
156849383|NCT01957202|566200992|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849384|NCT01957202|566200993|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
156849385|NCT01957202|566200994|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849386|NCT01957202|566200995|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849387|NCT01957202|566200996|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849388|NCT01957202|566200997|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849389|NCT01957202|566200998|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849390|NCT01957202|566200999|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849391|NCT01957202|566201000|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849392|NCT01957202|566201001|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849393|NCT01957202|566201002|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849394|NCT01957202|566201003|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849395|NCT01957202|566201004|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849396|NCT01957202|566201005|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849397|NCT01957202|566201006|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849398|NCT01957202|566201007|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849399|NCT01957202|566201008|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
156849400|NCT01957202|566201009|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849401|NCT01957202|566200992|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849402|NCT01957202|566200993|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
156342019|NCT04518306|564350359|FG000|Double-Blind Period|Run in failure|0|||
156342020|NCT04518306|564350360|FG001|Double-Blind Period|Run in failure|0|||
156342021|NCT04518306|564350361|FG002|Double-Blind Period|Run in failure|1|||
156849403|NCT01957202|566200994|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849404|NCT01957202|566200995|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849405|NCT01957202|566200996|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849406|NCT01957202|566200997|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
156342022|NCT04518306|564350359|FG000|Double-Blind Period|Adverse Event|0|||
156470706|NCT01619059|564817840|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
156542133|NCT03374189|565077874|FG001|Overall Study|Lost to Follow-up|0|||
156849407|NCT01957202|566200998|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849408|NCT01957202|566200999|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849409|NCT01957202|566201000|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849410|NCT01957202|566201001|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849411|NCT01957202|566201002|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849412|NCT01957202|566201003|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849413|NCT01957202|566201004|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849414|NCT01957202|566201005|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849415|NCT01957202|566201006|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849416|NCT01957202|566201007|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849417|NCT01957202|566201008|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
156849418|NCT01957202|566201009|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849419|NCT01797263|566201010|FG000|Overall Study|Withdrawal by Subject|21|||
156849420|NCT01797263|566201011|FG001|Overall Study|Withdrawal by Subject|25|||
156849421|NCT01797263|566201010|FG000|Overall Study|Death|1|||
156849422|NCT01797263|566201011|FG001|Overall Study|Death|0|||
156849423|NCT01797263|566201010|FG000|Overall Study|Lost to Follow-up|15|||
156849424|NCT01797263|566201011|FG001|Overall Study|Lost to Follow-up|15|||
156849425|NCT02342223|566201012|FG000|Overall Study|Lost to Follow-up|1|||
156849426|NCT01200368|566201013|FG000|Infant Series|Adverse Event|2|||
156849427|NCT01200368|566201014|FG001|Infant Series|Adverse Event|2|||
156849428|NCT01200368|566201015|FG002|Infant Series|Adverse Event|3|||
156849429|NCT01200368|566201013|FG000|Infant Series|Withdrawal by Subject|0|||
156849430|NCT01200368|566201014|FG001|Infant Series|Withdrawal by Subject|2|||
156849431|NCT01200368|566201015|FG002|Infant Series|Withdrawal by Subject|2|||
156849432|NCT01200368|566201013|FG000|Infant Series|Did not meet entrance criteria|0|||
156849433|NCT01200368|566201014|FG001|Infant Series|Did not meet entrance criteria|1|||
156849434|NCT01200368|566201015|FG002|Infant Series|Did not meet entrance criteria|0|||
156849435|NCT01200368|566201013|FG000|Infant Series|Randomized, not vaccinated|0|||
156849436|NCT01200368|566201014|FG001|Infant Series|Randomized, not vaccinated|1|||
156849437|NCT01200368|566201015|FG002|Infant Series|Randomized, not vaccinated|1|||
156849438|NCT01200368|566201013|FG000|Infant Series|Other|1|||
156849439|NCT01200368|566201014|FG001|Infant Series|Other|0|||
156849440|NCT01200368|566201015|FG002|Infant Series|Other|0|||
156849441|NCT01200368|566201013|FG000|After Infant Series|Adverse Event|6|||
156849442|NCT01200368|566201014|FG001|After Infant Series|Adverse Event|6|||
156849443|NCT01200368|566201015|FG002|After Infant Series|Adverse Event|3|||
156849444|NCT01200368|566201013|FG000|After Infant Series|Withdrawal by Subject|10|||
156849445|NCT01200368|566201014|FG001|After Infant Series|Withdrawal by Subject|8|||
156849446|NCT01200368|566201015|FG002|After Infant Series|Withdrawal by Subject|4|||
156849447|NCT01200368|566201013|FG000|After Infant Series|Lost to Follow-up|1|||
156849448|NCT01200368|566201014|FG001|After Infant Series|Lost to Follow-up|0|||
156849449|NCT01200368|566201015|FG002|After Infant Series|Lost to Follow-up|0|||
156849450|NCT01200368|566201013|FG000|After Infant Series|Other|1|||
156849451|NCT01200368|566201014|FG001|After Infant Series|Other|2|||
156849452|NCT01200368|566201015|FG002|After Infant Series|Other|2|||
156849453|NCT01200368|566201013|FG000|Toddler Dose|Adverse Event|0|||
156849454|NCT01200368|566201014|FG001|Toddler Dose|Adverse Event|3|||
156849455|NCT01200368|566201015|FG002|Toddler Dose|Adverse Event|1|||
156849456|NCT01290757|566201016|FG000|Overall Study|Adverse Event|1|||
156849457|NCT01290757|566201017|FG001|Overall Study|Adverse Event|0|||
156849458|NCT01290757|566201016|FG000|Overall Study|Protocol Violation|1|||
156849459|NCT01290757|566201017|FG001|Overall Study|Protocol Violation|1|||
156849460|NCT01290757|566201016|FG000|Overall Study|Other|0|||
156849461|NCT01290757|566201017|FG001|Overall Study|Other|1|||
156849462|NCT00991939|566201019|FG000|Overall Study|Lost to Follow-up|0|||
156849463|NCT00991939|566201020|FG001|Overall Study|Lost to Follow-up|1|||
156849464|NCT00991939|566201019|FG000|Overall Study|Withdrawal by Subject|1|||
156849465|NCT00991939|566201020|FG001|Overall Study|Withdrawal by Subject|0|||
156849466|NCT00991939|566201019|FG000|Overall Study|Entire study terminated|4|||
156849467|NCT00991939|566201020|FG001|Overall Study|Entire study terminated|1|||
156849468|NCT00740584|566201021|FG000|Overall Study|Withdrawal by Subject|1|||
156849469|NCT00181766|566201031|FG000|Overall Study|Lost to Follow-up|6|||
156849470|NCT00181766|566201031|FG000|Overall Study|Adverse Event|4|||
156849471|NCT00181766|566201031|FG000|Overall Study|non-compliance|2|||
156849472|NCT00687804|566201039|FG000|Core Study|Adverse Event|5|||
156849473|NCT00687804|566201040|FG001|Core Study|Adverse Event|3|||
156849474|NCT00687804|566201041|FG002|Core Study|Adverse Event|3|||
156849475|NCT00687804|566201039|FG000|Core Study|Abnormal laboratory value(s)|1|||
156849476|NCT00687804|566201040|FG001|Core Study|Abnormal laboratory value(s)|0|||
156849477|NCT00687804|566201041|FG002|Core Study|Abnormal laboratory value(s)|0|||
156849478|NCT00687804|566201039|FG000|Core Study|Lack of Efficacy|1|||
156849479|NCT00687804|566201040|FG001|Core Study|Lack of Efficacy|1|||
156849480|NCT00687804|566201041|FG002|Core Study|Lack of Efficacy|1|||
156849481|NCT00687804|566201039|FG000|Core Study|Withdrawal by Subject|4|||
156849482|NCT00687804|566201040|FG001|Core Study|Withdrawal by Subject|7|||
156849483|NCT00687804|566201041|FG002|Core Study|Withdrawal by Subject|7|||
156849484|NCT00687804|566201039|FG000|Core Study|Lost to Follow-up|0|||
156849485|NCT00687804|566201040|FG001|Core Study|Lost to Follow-up|1|||
156849486|NCT00687804|566201041|FG002|Core Study|Lost to Follow-up|0|||
156849487|NCT00687804|566201039|FG000|Core Study|Death|2|||
156849488|NCT00687804|566201040|FG001|Core Study|Death|2|||
156849489|NCT00687804|566201041|FG002|Core Study|Death|2|||
156849490|NCT00687804|566201039|FG000|Core Study|Protocol Violation|1|||
156849491|NCT00687804|566201040|FG001|Core Study|Protocol Violation|1|||
156849492|NCT00687804|566201041|FG002|Core Study|Protocol Violation|0|||
156849493|NCT00687804|566201039|FG000|Open-Label Extension Study|Adverse Event|2|||
156849494|NCT00687804|566201040|FG001|Open-Label Extension Study|Adverse Event|2|||
156849495|NCT00687804|566201041|FG002|Open-Label Extension Study|Adverse Event|2|||
156849496|NCT00687804|566201039|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
156849497|NCT00687804|566201040|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
156849498|NCT00687804|566201041|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
156849499|NCT00687804|566201039|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
156849500|NCT00687804|566201040|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
156849501|NCT00687804|566201041|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
156849502|NCT00687804|566201039|FG000|Open-Label Extension Study|Administrative problems|1|||
156849503|NCT00687804|566201040|FG001|Open-Label Extension Study|Administrative problems|1|||
156849504|NCT00687804|566201041|FG002|Open-Label Extension Study|Administrative problems|0|||
156849505|NCT00687804|566201039|FG000|Open-Label Extension Study|Death|2|||
156849506|NCT00687804|566201040|FG001|Open-Label Extension Study|Death|3|||
156849507|NCT00687804|566201041|FG002|Open-Label Extension Study|Death|3|||
156849508|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
156849509|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
156849510|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
156849511|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
156849512|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
156849513|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
156849514|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
156849515|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
156849516|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
156849517|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
156849518|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
156849519|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
156849520|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
156849521|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
156849522|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
156849523|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
156849524|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
156849525|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
156849526|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
156849527|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
156849528|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
156849529|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
156849530|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
156849531|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
156849532|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
156849533|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
156849534|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
156849535|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
156849536|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
156849537|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
156849538|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
156849539|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
156849540|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
156849541|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
156849542|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
156849543|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
156849544|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
156849545|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
156849546|NCT03188432|566201044|FG000|Overall Study|Death|3|||
156849547|NCT03188432|566201044|FG000|Overall Study|Withdrawal by Subject|15|||
156849548|NCT03188432|566201044|FG000|Overall Study|Did not complete protocol treatment|9|||
156849549|NCT00413218|566201048|FG000|Overall Study|Randomized but didn't receive study drug|2|||
156849550|NCT00413218|566201049|FG001|Overall Study|Randomized but didn't receive study drug|8|||
156849551|NCT00413218|566201048|FG000|Overall Study|Death|57|||
156849552|NCT00413218|566201049|FG001|Overall Study|Death|56|||
156849553|NCT00413218|566201048|FG000|Overall Study|Lost to Follow-up|14|||
156849554|NCT00413218|566201049|FG001|Overall Study|Lost to Follow-up|17|||
156849555|NCT00413218|566201048|FG000|Overall Study|Admin|20|||
156849556|NCT00413218|566201049|FG001|Overall Study|Admin|14|||
156849557|NCT00413218|566201048|FG000|Overall Study|Missing|1|||
156849558|NCT00413218|566201049|FG001|Overall Study|Missing|0|||
156849559|NCT00413218|566201048|FG000|Overall Study|Withdrawal by Subject|9|||
156849560|NCT00413218|566201049|FG001|Overall Study|Withdrawal by Subject|1|||
156849561|NCT01502228|566201054|FG000|Overall Study|Death|1|||
156849562|NCT05730387|566201055|FG000|Overall Study|Stillbirth|0|||
156342023|NCT04518306|564350360|FG001|Double-Blind Period|Adverse Event|2|||
156342024|NCT04518306|564350361|FG002|Double-Blind Period|Adverse Event|2|||
156342025|NCT04518306|564350359|FG000|Double-Blind Period|Lost to Follow-up|1|||
156342026|NCT04518306|564350360|FG001|Double-Blind Period|Lost to Follow-up|2|||
156342027|NCT04518306|564350361|FG002|Double-Blind Period|Lost to Follow-up|2|||
156849563|NCT05730387|566201056|FG001|Overall Study|Stillbirth|262|||
156849564|NCT05730387|566201055|FG000|Overall Study|Died during or after delivery|2|||
156849565|NCT05730387|566201056|FG001|Overall Study|Died during or after delivery|85|||
156849566|NCT05730387|566201055|FG000|Overall Study|Died after being admitted|0|||
156849567|NCT05730387|566201056|FG001|Overall Study|Died after being admitted|44|||
156849568|NCT05730387|566201055|FG000|Overall Study|Lost to Follow-up|69|||
156849569|NCT05730387|566201056|FG001|Overall Study|Lost to Follow-up|77|||
156849570|NCT02728089|566201057|FG000|Overall Study|Physician Decision|2|||
156849571|NCT02728089|566201057|FG000|Overall Study|Withdrawal by Subject|1|||
156849572|NCT04669301|566201058|FG000|Overall Study|Lost to Follow-up|0|||
156849573|NCT04669301|566201059|FG001|Overall Study|Lost to Follow-up|1|||
156849574|NCT04669301|566201060|FG002|Overall Study|Lost to Follow-up|0|||
156849575|NCT04669301|566201058|FG000|Overall Study|Withdrawal by Subject|3|||
156849576|NCT04669301|566201059|FG001|Overall Study|Withdrawal by Subject|2|||
156849577|NCT04669301|566201060|FG002|Overall Study|Withdrawal by Subject|0|||
156849578|NCT01221350|566201063|FG000|Overall Study|Discontinued intervention (GERD)|1|||
156849579|NCT01221350|566201064|FG001|Overall Study|Discontinued intervention (GERD)|0|||
156849580|NCT01221350|566201063|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
156849581|NCT01221350|566201064|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
156849582|NCT01221350|566201063|FG000|Overall Study|Withdrawal by Subject|4|||
156849583|NCT01221350|566201064|FG001|Overall Study|Withdrawal by Subject|2|||
156849584|NCT05888181|566201066|FG000|Overall Study|Lost to Follow-up|1|||
156849585|NCT05888181|566201067|FG001|Overall Study|Lost to Follow-up|1|||
156849586|NCT05888181|566201068|FG002|Overall Study|Lost to Follow-up|0|||
156849587|NCT04137731|566201071|FG000|Overall Study|Surgery Cancellation|1|||
156849588|NCT04137731|566201072|FG001|Overall Study|Surgery Cancellation|2|||
156849589|NCT04137731|566201071|FG000|Overall Study|Withdrawal by Subject|2|||
156849590|NCT04137731|566201072|FG001|Overall Study|Withdrawal by Subject|0|||
156849591|NCT04137731|566201071|FG000|Overall Study|Protocol Violation|0|||
156849592|NCT04137731|566201072|FG001|Overall Study|Protocol Violation|1|||
156849593|NCT00362648|566201074|FG000|Overall Study|Adverse Event|12|||
156849594|NCT00362648|566201075|FG001|Overall Study|Adverse Event|21|||
156849595|NCT00362648|566201076|FG002|Overall Study|Adverse Event|1|||
156849596|NCT00362648|566201077|FG003|Overall Study|Adverse Event|0|||
156849597|NCT00362648|566201074|FG000|Overall Study|Lost to Follow-up|62|||
156849598|NCT00362648|566201075|FG001|Overall Study|Lost to Follow-up|69|||
156849599|NCT00362648|566201076|FG002|Overall Study|Lost to Follow-up|4|||
156849600|NCT00362648|566201077|FG003|Overall Study|Lost to Follow-up|3|||
156849601|NCT00362648|566201074|FG000|Overall Study|Protocol Violation|4|||
156849602|NCT00362648|566201075|FG001|Overall Study|Protocol Violation|2|||
156849603|NCT00362648|566201076|FG002|Overall Study|Protocol Violation|2|||
156849604|NCT00362648|566201077|FG003|Overall Study|Protocol Violation|2|||
156849605|NCT00362648|566201074|FG000|Overall Study|Withdrawal by Subject|48|||
156849606|NCT00362648|566201075|FG001|Overall Study|Withdrawal by Subject|42|||
156849607|NCT00362648|566201076|FG002|Overall Study|Withdrawal by Subject|2|||
156849608|NCT00362648|566201077|FG003|Overall Study|Withdrawal by Subject|6|||
156849609|NCT02204072|566201078|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
156849610|NCT02204072|566201079|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
156849611|NCT02204072|566201080|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
156849612|NCT02204072|566201081|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
156849613|NCT02204072|566201082|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
156849614|NCT02204072|566201078|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
156849615|NCT02204072|566201079|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
156342028|NCT04518306|564350359|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
156342029|NCT04518306|564350360|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
156342030|NCT04518306|564350361|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
156849616|NCT02204072|566201080|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
156849617|NCT02204072|566201081|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
156849618|NCT02204072|566201082|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
156849619|NCT02204072|566201078|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
156849620|NCT02204072|566201079|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
156849621|NCT02204072|566201080|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
156849622|NCT02204072|566201081|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
156849623|NCT02204072|566201082|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
156342031|NCT04518306|564350359|FG000|Double-Blind Period|Other|0|||
156342032|NCT04518306|564350360|FG001|Double-Blind Period|Other|2|||
156849624|NCT02204072|566201078|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
156849625|NCT02204072|566201079|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
156849626|NCT02204072|566201080|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
156849627|NCT02204072|566201081|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
156849628|NCT02204072|566201082|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
156849629|NCT03983304|566201083|FG000|Overall Study|Withdrawal by Subject|5|||
156849630|NCT03983304|566201083|FG000|Overall Study|Lost to Follow-up|2|||
156849631|NCT01587040|566201084|FG000|Overall Study|Protocol Violation|0|||
156849632|NCT01587040|566201085|FG001|Overall Study|Protocol Violation|0|||
156849633|NCT01587040|566201086|FG002|Overall Study|Protocol Violation|1|||
156849634|NCT01587040|566201087|FG003|Overall Study|Protocol Violation|0|||
156849635|NCT01587040|566201084|FG000|Overall Study|Adverse Event|0|||
156849636|NCT01587040|566201085|FG001|Overall Study|Adverse Event|1|||
156849637|NCT01587040|566201086|FG002|Overall Study|Adverse Event|10|||
156849638|NCT01587040|566201087|FG003|Overall Study|Adverse Event|0|||
156849639|NCT01587040|566201084|FG000|Overall Study|Disease progression|12|||
156849640|NCT01587040|566201085|FG001|Overall Study|Disease progression|1|||
156849641|NCT01587040|566201086|FG002|Overall Study|Disease progression|15|||
156849642|NCT01587040|566201087|FG003|Overall Study|Disease progression|3|||
156849643|NCT01587040|566201084|FG000|Overall Study|Other than specified|5|||
156849644|NCT01587040|566201085|FG001|Overall Study|Other than specified|1|||
156849645|NCT01587040|566201086|FG002|Overall Study|Other than specified|11|||
156849646|NCT01587040|566201087|FG003|Overall Study|Other than specified|1|||
156849647|NCT00286429|566201096|FG000|Overall Study|Adverse Event|4|||
156849648|NCT00286429|566201097|FG001|Overall Study|Adverse Event|1|||
156849649|NCT00286429|566201098|FG002|Overall Study|Adverse Event|6|||
156849650|NCT00286429|566201096|FG000|Overall Study|Lack of Efficacy|52|||
156849651|NCT00286429|566201097|FG001|Overall Study|Lack of Efficacy|27|||
156849652|NCT00286429|566201098|FG002|Overall Study|Lack of Efficacy|25|||
156849653|NCT00286429|566201096|FG000|Overall Study|Lost to Follow-up|2|||
156849654|NCT00286429|566201097|FG001|Overall Study|Lost to Follow-up|4|||
156849655|NCT00286429|566201098|FG002|Overall Study|Lost to Follow-up|3|||
156849656|NCT00286429|566201096|FG000|Overall Study|Physician Decision|10|||
156849657|NCT00286429|566201097|FG001|Overall Study|Physician Decision|7|||
156849658|NCT00286429|566201098|FG002|Overall Study|Physician Decision|7|||
156849659|NCT00286429|566201096|FG000|Overall Study|Protocol Violation|3|||
156849660|NCT00286429|566201097|FG001|Overall Study|Protocol Violation|5|||
156849661|NCT00286429|566201098|FG002|Overall Study|Protocol Violation|4|||
156849662|NCT00286429|566201096|FG000|Overall Study|Withdrawal by Subject|3|||
156849663|NCT00286429|566201097|FG001|Overall Study|Withdrawal by Subject|2|||
156849664|NCT00286429|566201098|FG002|Overall Study|Withdrawal by Subject|6|||
156849665|NCT00286429|566201096|FG000|Overall Study|Administrative Error|1|||
156849666|NCT00286429|566201097|FG001|Overall Study|Administrative Error|1|||
156849667|NCT00286429|566201098|FG002|Overall Study|Administrative Error|1|||
156849668|NCT00286429|566201096|FG000|Overall Study|Administrative Decision|0|||
156849669|NCT00286429|566201097|FG001|Overall Study|Administrative Decision|1|||
156849670|NCT00286429|566201098|FG002|Overall Study|Administrative Decision|0|||
156849671|NCT03197376|566201102|FG000|Primary and Booster Phase|Adverse Event|0|||
156849672|NCT03197376|566201103|FG001|Primary and Booster Phase|Adverse Event|0|||
156849673|NCT03197376|566201104|FG002|Primary and Booster Phase|Adverse Event|0|||
156849674|NCT03197376|566201105|FG003|Primary and Booster Phase|Adverse Event|1|||
156849675|NCT03197376|566201102|FG000|Primary and Booster Phase|Death|1|||
156849676|NCT03197376|566201103|FG001|Primary and Booster Phase|Death|0|||
156849677|NCT03197376|566201104|FG002|Primary and Booster Phase|Death|0|||
156849678|NCT03197376|566201105|FG003|Primary and Booster Phase|Death|2|||
156849679|NCT03197376|566201102|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
156849680|NCT03197376|566201103|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
156849681|NCT03197376|566201104|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
156849682|NCT03197376|566201105|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
156849683|NCT03197376|566201102|FG000|Primary and Booster Phase|Physician Decision|1|||
156849684|NCT03197376|566201103|FG001|Primary and Booster Phase|Physician Decision|0|||
156849685|NCT03197376|566201104|FG002|Primary and Booster Phase|Physician Decision|1|||
156849686|NCT03197376|566201105|FG003|Primary and Booster Phase|Physician Decision|3|||
156849687|NCT03197376|566201102|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
156849688|NCT03197376|566201103|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
156849689|NCT03197376|566201104|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
156849690|NCT03197376|566201105|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
156849691|NCT03197376|566201102|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
156849692|NCT03197376|566201103|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
156849693|NCT03197376|566201104|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
156849694|NCT03197376|566201105|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
156849695|NCT03197376|566201102|FG000|Primary and Booster Phase|Not vaccine related|1|||
156849696|NCT03197376|566201103|FG001|Primary and Booster Phase|Not vaccine related|2|||
156849697|NCT03197376|566201104|FG002|Primary and Booster Phase|Not vaccine related|0|||
156849698|NCT03197376|566201105|FG003|Primary and Booster Phase|Not vaccine related|6|||
156470707|NCT01619059|564817841|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
156470708|NCT01619059|564817840|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
156849699|NCT03197376|566201102|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
156849700|NCT03197376|566201103|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
156849701|NCT03197376|566201104|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
156849702|NCT03197376|566201105|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
156849703|NCT03197376|566201102|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
156849704|NCT03197376|566201103|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
156849705|NCT03197376|566201104|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
156849706|NCT03197376|566201105|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
156849707|NCT03197376|566201102|FG000|Immune Persistence Phase|Not vaccine related|1|||
156849708|NCT03197376|566201103|FG001|Immune Persistence Phase|Not vaccine related|0|||
156849709|NCT03197376|566201104|FG002|Immune Persistence Phase|Not vaccine related|1|||
156849710|NCT03197376|566201105|FG003|Immune Persistence Phase|Not vaccine related|1|||
156849711|NCT01594931|566203014|FG000|Overall Study|Adverse Event|3|||
156849712|NCT01594931|566203015|FG001|Overall Study|Adverse Event|1|||
156849713|NCT01594931|566203016|FG002|Overall Study|Adverse Event|1|||
156849714|NCT01594931|566203014|FG000|Overall Study|Withdrawal by Subject|2|||
156849715|NCT01594931|566203015|FG001|Overall Study|Withdrawal by Subject|1|||
156849716|NCT01594931|566203016|FG002|Overall Study|Withdrawal by Subject|1|||
156849717|NCT01594931|566203014|FG000|Overall Study|Lack of Efficacy|7|||
156849718|NCT01594931|566203015|FG001|Overall Study|Lack of Efficacy|2|||
156849719|NCT01594931|566203016|FG002|Overall Study|Lack of Efficacy|2|||
156849720|NCT01594931|566203014|FG000|Overall Study|Lost to Follow-up|4|||
156849721|NCT01594931|566203015|FG001|Overall Study|Lost to Follow-up|3|||
156470709|NCT01619059|564817841|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
156470710|NCT01619059|564817840|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
156470711|NCT01619059|564817841|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
156849722|NCT01594931|566203016|FG002|Overall Study|Lost to Follow-up|3|||
156470712|NCT01619059|564817840|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
156849723|NCT01594931|566203014|FG000|Overall Study|Protocol Violation|2|||
156849724|NCT01594931|566203015|FG001|Overall Study|Protocol Violation|1|||
156849725|NCT01594931|566203016|FG002|Overall Study|Protocol Violation|0|||
156849726|NCT01594931|566203014|FG000|Overall Study|No defiined|11|||
156849727|NCT01594931|566203015|FG001|Overall Study|No defiined|4|||
156849728|NCT01594931|566203016|FG002|Overall Study|No defiined|7|||
156849729|NCT01525615|566203019|FG000|Overall Study|Adverse Event|11|||
156849730|NCT01525615|566203020|FG001|Overall Study|Adverse Event|7|||
156849731|NCT01525615|566203021|FG002|Overall Study|Adverse Event|5|||
156849732|NCT01525615|566203019|FG000|Overall Study|Lost to Follow-up|1|||
156849733|NCT01525615|566203020|FG001|Overall Study|Lost to Follow-up|0|||
156849734|NCT01525615|566203021|FG002|Overall Study|Lost to Follow-up|0|||
156849735|NCT01525615|566203019|FG000|Overall Study|Withdrawal by Subject|1|||
156849736|NCT01525615|566203020|FG001|Overall Study|Withdrawal by Subject|0|||
156849737|NCT01525615|566203021|FG002|Overall Study|Withdrawal by Subject|0|||
156849738|NCT01525615|566203019|FG000|Overall Study|Other reason not described above|1|||
156849739|NCT01525615|566203020|FG001|Overall Study|Other reason not described above|0|||
156849740|NCT01525615|566203021|FG002|Overall Study|Other reason not described above|1|||
156849741|NCT04050618|566203022|FG000|First Intervention|Withdrawal by Subject|2|||
156849742|NCT04050618|566203023|FG001|First Intervention|Withdrawal by Subject|0|||
156849743|NCT04050618|566203022|FG000|Second Intervention|Withdrawal by Subject|1|||
156849744|NCT04050618|566203023|FG001|Second Intervention|Withdrawal by Subject|0|||
156849745|NCT01101035|566203029|FG000|Overall Study|Adverse Event|191|||
156849746|NCT01101035|566203030|FG001|Overall Study|Adverse Event|172|||
156849747|NCT01101035|566203029|FG000|Overall Study|Major Protocol Deviation|52|||
156849748|NCT01101035|566203030|FG001|Overall Study|Major Protocol Deviation|46|||
156849749|NCT01101035|566203029|FG000|Overall Study|Lost to Follow-up|226|||
156849750|NCT01101035|566203030|FG001|Overall Study|Lost to Follow-up|223|||
156849751|NCT01101035|566203029|FG000|Overall Study|Voluntary Withdrawal|595|||
156849752|NCT01101035|566203030|FG001|Overall Study|Voluntary Withdrawal|587|||
156849753|NCT01101035|566203029|FG000|Overall Study|Reason not Specified|333|||
156849754|NCT01101035|566203030|FG001|Overall Study|Reason not Specified|363|||
156849755|NCT00217425|566203035|FG000|Overall Study|Never started treatment|2|||
156849756|NCT00217425|566203035|FG000|Overall Study|Patient ineligible|5|||
156849757|NCT00217425|566203035|FG000|Overall Study|Lack of Efficacy|13|||
156849758|NCT00217425|566203035|FG000|Overall Study|Adverse Event|8|||
156849759|NCT00217425|566203035|FG000|Overall Study|Withdrawal by Subject|4|||
156849760|NCT00217425|566203035|FG000|Overall Study|Other complicating disease|1|||
156849761|NCT00217425|566203035|FG000|Overall Study|Other|4|||
156849762|NCT00671034|566203037|FG000|Overall Study|Adverse Event|5|||
156849763|NCT00671034|566203038|FG001|Overall Study|Adverse Event|7|||
156849764|NCT00671034|566203039|FG002|Overall Study|Adverse Event|1|||
156849765|NCT00671034|566203037|FG000|Overall Study|Death|3|||
156849766|NCT00671034|566203038|FG001|Overall Study|Death|2|||
156849767|NCT00671034|566203039|FG002|Overall Study|Death|1|||
156849768|NCT00671034|566203037|FG000|Overall Study|Physician Decision|12|||
156849769|NCT00671034|566203038|FG001|Overall Study|Physician Decision|4|||
156849770|NCT00671034|566203039|FG002|Overall Study|Physician Decision|5|||
156849771|NCT00671034|566203037|FG000|Overall Study|VHR ALL feature|8|||
156849772|NCT00671034|566203038|FG001|Overall Study|VHR ALL feature|3|||
156849773|NCT00671034|566203039|FG002|Overall Study|VHR ALL feature|5|||
156849774|NCT00671034|566203037|FG000|Overall Study|Refusal|5|||
156849775|NCT00671034|566203038|FG001|Overall Study|Refusal|3|||
156849776|NCT00671034|566203039|FG002|Overall Study|Refusal|5|||
156849777|NCT00671034|566203037|FG000|Overall Study|includes Alternative therapy, etc.|6|||
156849778|NCT00671034|566203038|FG001|Overall Study|includes Alternative therapy, etc.|1|||
156849779|NCT00671034|566203039|FG002|Overall Study|includes Alternative therapy, etc.|7|||
156849780|NCT00713544|566203040|FG000|Overall Study|Adverse Event|5|||
156849781|NCT00713544|566203041|FG001|Overall Study|Adverse Event|3|||
156849782|NCT00713544|566203042|FG002|Overall Study|Adverse Event|7|||
156849783|NCT00713544|566203043|FG003|Overall Study|Adverse Event|7|||
156849784|NCT00713544|566203044|FG004|Overall Study|Adverse Event|3|||
156849785|NCT00713544|566203045|FG005|Overall Study|Adverse Event|5|||
156849786|NCT00713544|566203040|FG000|Overall Study|Withdrawal by Subject|2|||
156342033|NCT04518306|564350361|FG002|Double-Blind Period|Other|0|||
156342034|NCT04518306|564350359|FG000|Double-Blind Period|Missing|0|||
156849787|NCT00713544|566203041|FG001|Overall Study|Withdrawal by Subject|0|||
156849788|NCT00713544|566203042|FG002|Overall Study|Withdrawal by Subject|3|||
156849789|NCT00713544|566203043|FG003|Overall Study|Withdrawal by Subject|2|||
156342035|NCT04518306|564350360|FG001|Double-Blind Period|Missing|1|||
156342036|NCT04518306|564350361|FG002|Double-Blind Period|Missing|0|||
156849790|NCT00713544|566203044|FG004|Overall Study|Withdrawal by Subject|3|||
156849791|NCT00713544|566203045|FG005|Overall Study|Withdrawal by Subject|1|||
156849792|NCT00713544|566203040|FG000|Overall Study|Protocol Violation|0|||
156849793|NCT00713544|566203041|FG001|Overall Study|Protocol Violation|0|||
156849794|NCT00713544|566203042|FG002|Overall Study|Protocol Violation|0|||
156849795|NCT00713544|566203043|FG003|Overall Study|Protocol Violation|0|||
156849796|NCT00713544|566203044|FG004|Overall Study|Protocol Violation|0|||
156849797|NCT00713544|566203045|FG005|Overall Study|Protocol Violation|1|||
156849798|NCT00713544|566203040|FG000|Overall Study|Physician Decision|0|||
156849799|NCT00713544|566203041|FG001|Overall Study|Physician Decision|0|||
156849800|NCT00713544|566203042|FG002|Overall Study|Physician Decision|0|||
156849801|NCT00713544|566203043|FG003|Overall Study|Physician Decision|0|||
156849802|NCT00713544|566203044|FG004|Overall Study|Physician Decision|0|||
156849803|NCT00713544|566203045|FG005|Overall Study|Physician Decision|2|||
156849804|NCT00713544|566203040|FG000|Overall Study|Lack of Efficacy|0|||
156849805|NCT00713544|566203041|FG001|Overall Study|Lack of Efficacy|1|||
156849806|NCT00713544|566203042|FG002|Overall Study|Lack of Efficacy|0|||
156849807|NCT00713544|566203043|FG003|Overall Study|Lack of Efficacy|1|||
156849808|NCT00713544|566203044|FG004|Overall Study|Lack of Efficacy|1|||
156849809|NCT00713544|566203045|FG005|Overall Study|Lack of Efficacy|0|||
156849810|NCT00713544|566203040|FG000|Overall Study|Lost to Follow-up|0|||
156849811|NCT00713544|566203041|FG001|Overall Study|Lost to Follow-up|0|||
156849812|NCT00713544|566203042|FG002|Overall Study|Lost to Follow-up|1|||
156849813|NCT00713544|566203043|FG003|Overall Study|Lost to Follow-up|0|||
156849814|NCT00713544|566203044|FG004|Overall Study|Lost to Follow-up|0|||
156849815|NCT00713544|566203045|FG005|Overall Study|Lost to Follow-up|0|||
156849816|NCT00713544|566203040|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849817|NCT00713544|566203041|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
156849818|NCT00713544|566203042|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849819|NCT00713544|566203043|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849820|NCT00713544|566203044|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849821|NCT00713544|566203045|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849822|NCT00713544|566203040|FG000|Overall Study|Incorrect enrollment|0|||
156849823|NCT00713544|566203041|FG001|Overall Study|Incorrect enrollment|1|||
156849824|NCT00713544|566203042|FG002|Overall Study|Incorrect enrollment|0|||
156849825|NCT00713544|566203043|FG003|Overall Study|Incorrect enrollment|0|||
156849826|NCT00713544|566203044|FG004|Overall Study|Incorrect enrollment|0|||
156849827|NCT00713544|566203045|FG005|Overall Study|Incorrect enrollment|0|||
156849828|NCT00713544|566203040|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
156849829|NCT00713544|566203041|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
156849830|NCT00713544|566203042|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
156849831|NCT00713544|566203043|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
156849832|NCT00713544|566203044|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
156849833|NCT00713544|566203045|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
156849834|NCT00269919|566203046|FG000|Overall Study|Other|26|||
156849835|NCT00269919|566203046|FG000|Overall Study|Started but not treated|1|||
156849836|NCT00786799|566203047|FG000|Overall Study|Lost to Follow-up|1|||
156849837|NCT00786799|566203048|FG001|Overall Study|Lost to Follow-up|1|||
156849838|NCT02544503|566203049|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
156849839|NCT02544503|566203050|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
156849840|NCT02544503|566203049|FG000|Overall Study|Lost to Follow-up|9|||
156849841|NCT02544503|566203050|FG001|Overall Study|Lost to Follow-up|0|||
156849842|NCT02544503|566203049|FG000|Overall Study|Withdrawal by Subject|1|||
156849843|NCT02544503|566203050|FG001|Overall Study|Withdrawal by Subject|0|||
156849844|NCT02380287|566203051|FG000|Overall Study|Adverse Event|0|||
156849845|NCT02380287|566203052|FG001|Overall Study|Adverse Event|0|||
156849846|NCT02380287|566203053|FG002|Overall Study|Adverse Event|1|||
156849847|NCT02380287|566203054|FG003|Overall Study|Adverse Event|0|||
156849848|NCT02380287|566203055|FG004|Overall Study|Adverse Event|0|||
156849849|NCT02380287|566203056|FG005|Overall Study|Adverse Event|0|||
156849850|NCT02380287|566203057|FG006|Overall Study|Adverse Event|0|||
156849851|NCT02380287|566203058|FG007|Overall Study|Adverse Event|0|||
156849852|NCT04473963|566203059|FG000|Overall Study|Withdrawal by Subject|1|||
156849853|NCT04473963|566203060|FG001|Overall Study|Withdrawal by Subject|1|||
156849854|NCT04473963|566203061|FG002|Overall Study|Withdrawal by Subject|0|||
156470713|NCT01619059|564817841|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
156849855|NCT04473963|566203059|FG000|Overall Study|Not inducible in AF|0|||
156849856|NCT04473963|566203060|FG001|Overall Study|Not inducible in AF|0|||
156849857|NCT04473963|566203061|FG002|Overall Study|Not inducible in AF|2|||
156849858|NCT01550757|566203062|FG000|Overall Study|Lost to Follow-up|21|||
156849859|NCT01550757|566203063|FG001|Overall Study|Lost to Follow-up|14|||
156849860|NCT01550757|566203064|FG002|Overall Study|Lost to Follow-up|42|||
156849861|NCT01550757|566203065|FG003|Overall Study|Lost to Follow-up|53|||
156849862|NCT01550757|566203062|FG000|Overall Study|Withdrawal by Subject|2|||
156342037|NCT03268954|564350362|FG000|Overall Study|Withdrawal by Subject|27|||
156470714|NCT01619059|564817840|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
156849863|NCT01550757|566203063|FG001|Overall Study|Withdrawal by Subject|0|||
156849864|NCT01550757|566203064|FG002|Overall Study|Withdrawal by Subject|3|||
156849865|NCT01550757|566203065|FG003|Overall Study|Withdrawal by Subject|1|||
156849866|NCT01426958|566203066|FG000|Overall Study|Adverse Event|2|||
156849867|NCT00855816|566203071|FG000|Overall Study|Withdrawal by Subject|22|||
156849868|NCT00855816|566203072|FG001|Overall Study|Withdrawal by Subject|15|||
156849869|NCT00855816|566203071|FG000|Overall Study|Lost to Follow-up|3|||
156849870|NCT00855816|566203072|FG001|Overall Study|Lost to Follow-up|5|||
156849871|NCT00855816|566203071|FG000|Overall Study|Death|1|||
156849872|NCT00855816|566203072|FG001|Overall Study|Death|0|||
156849873|NCT00855816|566203071|FG000|Overall Study|Became ineligible|0|||
156849874|NCT00855816|566203072|FG001|Overall Study|Became ineligible|1|||
156849875|NCT01965704|566203073|FG000|Overall Study|Withdrawal by Subject|2|||
156849876|NCT01965704|566203074|FG001|Overall Study|Withdrawal by Subject|2|||
156849877|NCT01965704|566203075|FG002|Overall Study|Withdrawal by Subject|1|||
156849878|NCT01965704|566203076|FG003|Overall Study|Withdrawal by Subject|1|||
156849879|NCT01965704|566203073|FG000|Overall Study|Delivered at home|1|||
156849880|NCT01965704|566203074|FG001|Overall Study|Delivered at home|1|||
156849881|NCT01965704|566203075|FG002|Overall Study|Delivered at home|0|||
156849882|NCT01965704|566203076|FG003|Overall Study|Delivered at home|0|||
156849883|NCT01965704|566203073|FG000|Overall Study|Experienced complications|0|||
156849884|NCT01965704|566203074|FG001|Overall Study|Experienced complications|0|||
156849885|NCT01965704|566203075|FG002|Overall Study|Experienced complications|2|||
156849886|NCT01965704|566203076|FG003|Overall Study|Experienced complications|2|||
156849887|NCT01965704|566203073|FG000|Overall Study|Adverse Event|0|||
156849888|NCT01965704|566203074|FG001|Overall Study|Adverse Event|0|||
156849889|NCT01965704|566203075|FG002|Overall Study|Adverse Event|1|||
156849890|NCT01965704|566203076|FG003|Overall Study|Adverse Event|1|||
156849891|NCT01965704|566203073|FG000|Overall Study|Did not meet inclusion criteria|0|||
156849892|NCT01965704|566203074|FG001|Overall Study|Did not meet inclusion criteria|0|||
156849893|NCT01965704|566203075|FG002|Overall Study|Did not meet inclusion criteria|1|||
156849894|NCT01965704|566203076|FG003|Overall Study|Did not meet inclusion criteria|1|||
156849895|NCT03672292|566203082|FG000|Overall Study|Adverse Event|3|||
156849896|NCT03672292|566203083|FG001|Overall Study|Adverse Event|1|||
156849897|NCT03672292|566203082|FG000|Overall Study|Physician Decision|0|||
156849898|NCT03672292|566203083|FG001|Overall Study|Physician Decision|1|||
156849899|NCT03672292|566203082|FG000|Overall Study|Withdrawal by Subject|1|||
156849900|NCT03672292|566203083|FG001|Overall Study|Withdrawal by Subject|2|||
156849901|NCT00799903|566203084|FG000|Overall Study|Investigator Site Closed|25|||
156849902|NCT00799903|566203085|FG001|Overall Study|Investigator Site Closed|23|||
156849903|NCT00799903|566203084|FG000|Overall Study|Withdrawal by Subject|179|||
156849904|NCT00799903|566203085|FG001|Overall Study|Withdrawal by Subject|175|||
156849905|NCT00799903|566203084|FG000|Overall Study|Lost to Follow-up|69|||
156849906|NCT00799903|566203085|FG001|Overall Study|Lost to Follow-up|80|||
156849907|NCT03088917|566203086|FG000|Overall Study|In care/cured elsewhere|15|||
156849908|NCT03088917|566203086|FG000|Overall Study|Refuse re-evaluation|13|||
156849909|NCT03088917|566203086|FG000|Overall Study|Contact not established|13|||
156849910|NCT03088917|566203086|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
156849911|NCT03088917|566203086|FG000|Overall Study|Moved outside study region|50|||
156849912|NCT02524171|566203087|FG000|6-month Follow-up|Lost to Follow-up|53|||
156849913|NCT02524171|566203088|FG001|6-month Follow-up|Lost to Follow-up|45|||
156849914|NCT02524171|566203087|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
156849915|NCT02524171|566203088|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
156849916|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Progressive disease|50|||
156849917|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Progressive disease|110|||
156849918|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Progressive disease|0|||
156849919|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Progressive disease|0|||
156849920|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
156849921|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
156849922|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156849923|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156849924|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Adverse Event|7|||
156849925|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Adverse Event|7|||
156849926|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Adverse Event|0|||
156849927|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Adverse Event|0|||
156849928|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Other|1|||
156849929|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Other|3|||
156849930|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Other|0|||
156849931|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Other|0|||
156849932|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Physician Decision|6|||
156849933|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Physician Decision|3|||
156849934|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Physician Decision|0|||
156849935|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Physician Decision|0|||
156849936|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Death|1|||
156849937|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Death|1|||
156849938|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Death|0|||
156849939|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Death|0|||
156849940|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
156849941|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
156849942|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
156849943|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
156849944|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
156849945|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
156849946|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
156849947|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
156849948|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
156849949|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
156849950|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
156849951|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
156849952|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
156849953|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
156849954|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
156849955|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
156849956|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Other|0|||
156849957|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Other|0|||
156849958|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Other|4|||
156849959|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Other|7|||
156849960|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
156849961|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
156849962|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
156849963|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
156849964|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Death|0|||
156849965|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Death|0|||
156849966|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Death|2|||
156849967|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Death|7|||
156849968|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
156849969|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
156849970|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
156849971|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
156849972|NCT02753946|566203097|FG000|Overall Study|Adverse Event|7|||
156849973|NCT02753946|566203098|FG001|Overall Study|Adverse Event|6|||
156849974|NCT02753946|566203097|FG000|Overall Study|Withdrawal by Subject|6|||
156849975|NCT02753946|566203098|FG001|Overall Study|Withdrawal by Subject|1|||
156849976|NCT02753946|566203097|FG000|Overall Study|Lack of Efficacy|1|||
156849977|NCT02753946|566203098|FG001|Overall Study|Lack of Efficacy|0|||
156849978|NCT02753946|566203097|FG000|Overall Study|Physician Decision|0|||
156849979|NCT02753946|566203098|FG001|Overall Study|Physician Decision|2|||
156849980|NCT02868554|566203103|FG000|Overall Study|Lost to Follow-up|3|||
156849981|NCT02868554|566203104|FG001|Overall Study|Lost to Follow-up|0|||
156849982|NCT02868554|566203105|FG002|Overall Study|Lost to Follow-up|1|||
156849983|NCT00216671|566203106|FG000|Overall Study|Adverse Event|4|||
156849984|NCT00216671|566203107|FG001|Overall Study|Adverse Event|9|||
156849985|NCT00216671|566203106|FG000|Overall Study|Pregnancy|0|||
156849986|NCT00216671|566203107|FG001|Overall Study|Pregnancy|1|||
156849987|NCT00216671|566203106|FG000|Overall Study|Withdrawal by Subject|4|||
156849988|NCT00216671|566203107|FG001|Overall Study|Withdrawal by Subject|2|||
156849989|NCT00216671|566203106|FG000|Overall Study|Refused Injections|3|||
156849990|NCT00216671|566203107|FG001|Overall Study|Refused Injections|13|||
156849991|NCT00216671|566203106|FG000|Overall Study|No Need to Continue Medication|1|||
156849992|NCT00216671|566203107|FG001|Overall Study|No Need to Continue Medication|1|||
156849993|NCT00216671|566203106|FG000|Overall Study|Insufficient Response|9|||
156849994|NCT00216671|566203107|FG001|Overall Study|Insufficient Response|4|||
156849995|NCT00216671|566203106|FG000|Overall Study|Lost to Follow-up|3|||
156849996|NCT00216671|566203107|FG001|Overall Study|Lost to Follow-up|5|||
156849997|NCT00216671|566203106|FG000|Overall Study|Non compliant|2|||
156849998|NCT00216671|566203107|FG001|Overall Study|Non compliant|2|||
156849999|NCT00216671|566203106|FG000|Overall Study|Ineligible|0|||
156850000|NCT00216671|566203107|FG001|Overall Study|Ineligible|2|||
156850001|NCT00216671|566203106|FG000|Overall Study|Physician Decision|1|||
156850002|NCT00216671|566203107|FG001|Overall Study|Physician Decision|1|||
156850003|NCT00216671|566203106|FG000|Overall Study|Protocol Violation|3|||
156850004|NCT00216671|566203107|FG001|Overall Study|Protocol Violation|5|||
156850005|NCT00216671|566203106|FG000|Overall Study|Relapse|1|||
156850006|NCT00216671|566203107|FG001|Overall Study|Relapse|0|||
156850007|NCT00216671|566203106|FG000|Overall Study|Investigator Illness|0|||
156342038|NCT03268954|564350363|FG001|Overall Study|Withdrawal by Subject|17|||
156850008|NCT00216671|566203107|FG001|Overall Study|Investigator Illness|1|||
156850009|NCT00216671|566203106|FG000|Overall Study|Patient Moved|0|||
156850010|NCT00216671|566203107|FG001|Overall Study|Patient Moved|1|||
156850011|NCT00216671|566203106|FG000|Overall Study|Ineligible, no efficacy data|2|||
156850012|NCT00216671|566203107|FG001|Overall Study|Ineligible, no efficacy data|2|||
156850013|NCT00216671|566203106|FG000|Overall Study|Insufficient Response Adverse Event|2|||
156850014|NCT00216671|566203107|FG001|Overall Study|Insufficient Response Adverse Event|1|||
156850015|NCT02714569|566203108|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
156342039|NCT03268954|564350362|FG000|Overall Study|Lost to Follow-up|2|||
156342040|NCT03268954|564350363|FG001|Overall Study|Lost to Follow-up|3|||
156342041|NCT03268954|564350362|FG000|Overall Study|Reason Not Specified|3|||
156342042|NCT03268954|564350363|FG001|Overall Study|Reason Not Specified|8|||
156342043|NCT05358444|564350366|FG000|Overall Study|Withdrawal by Subject|0|||
156342044|NCT05358444|564350367|FG001|Overall Study|Withdrawal by Subject|1|||
156850016|NCT02714569|566203109|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
156850017|NCT02714569|566203110|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
156850018|NCT02714569|566203111|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
156850019|NCT02714569|566203112|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
156850020|NCT02714569|566203113|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
156850021|NCT02714569|566203114|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
156850022|NCT02714569|566203115|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
156850023|NCT02714569|566203116|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
156850024|NCT02714569|566203117|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
156850025|NCT02714569|566203118|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
156850026|NCT02714569|566203108|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850027|NCT02714569|566203109|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850028|NCT02714569|566203110|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850029|NCT02714569|566203111|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
156850030|NCT02714569|566203112|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850031|NCT02714569|566203113|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850032|NCT02714569|566203114|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850033|NCT02714569|566203115|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850034|NCT02714569|566203116|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850035|NCT02714569|566203117|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850036|NCT02714569|566203118|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850037|NCT02714569|566203108|FG000|Part A Third Intervention|Adverse Event|0|||
156850038|NCT02714569|566203109|FG001|Part A Third Intervention|Adverse Event|0|||
156850039|NCT02714569|566203110|FG002|Part A Third Intervention|Adverse Event|1|||
156850040|NCT02714569|566203111|FG003|Part A Third Intervention|Adverse Event|0|||
156850041|NCT02714569|566203112|FG004|Part A Third Intervention|Adverse Event|0|||
156850042|NCT02714569|566203113|FG005|Part A Third Intervention|Adverse Event|0|||
156850043|NCT02714569|566203114|FG006|Part A Third Intervention|Adverse Event|0|||
156850044|NCT02714569|566203115|FG007|Part A Third Intervention|Adverse Event|0|||
156850045|NCT02714569|566203116|FG008|Part A Third Intervention|Adverse Event|0|||
156850046|NCT02714569|566203117|FG009|Part A Third Intervention|Adverse Event|0|||
156850047|NCT02714569|566203118|FG010|Part A Third Intervention|Adverse Event|0|||
156342045|NCT05358444|564350366|FG000|Overall Study|Lost to Follow-up|0|||
156342046|NCT05358444|564350367|FG001|Overall Study|Lost to Follow-up|3|||
156342047|NCT02801331|564350368|FG000|Overall Study|Transferred to another hospital|8|||
156342048|NCT02801331|564350369|FG001|Overall Study|Transferred to another hospital|7|||
156342049|NCT02801331|564350368|FG000|Overall Study|Withdrawal by Subject|0|||
156342050|NCT02801331|564350369|FG001|Overall Study|Withdrawal by Subject|4|||
156342051|NCT02801331|564350368|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
156342052|NCT02801331|564350369|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
156342053|NCT02443987|564350370|FG000|Overall Study|Bladder injury|1|||
156342054|NCT02443987|564350371|FG001|Overall Study|Bladder injury|1|||
156342055|NCT02443987|564350370|FG000|Overall Study|Other|0|||
156342056|NCT02443987|564350371|FG001|Overall Study|Other|1|||
156342057|NCT04698187|564350377|FG000|Overall Study|Withdrawal by Subject|7|||
156342058|NCT04698187|564350377|FG000|Overall Study|Death|21|||
156542134|NCT01517893|565077875|FG000|Overall Study|Withdrawal by Subject|3|||
156850048|NCT02714569|566203108|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
156850049|NCT02714569|566203109|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156342059|NCT04698187|564350377|FG000|Overall Study|Sponsor Decision|15|||
156342060|NCT04698187|564350377|FG000|Overall Study|In-transit Disease|1|||
156342061|NCT03820986|564350378|FG000|Overall Study|Death|201|||
156850050|NCT02714569|566203110|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850051|NCT02714569|566203111|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850052|NCT02714569|566203112|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850053|NCT02714569|566203113|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
156850054|NCT02714569|566203114|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850055|NCT02714569|566203115|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850056|NCT02714569|566203116|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850057|NCT02714569|566203117|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850058|NCT02714569|566203118|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850059|NCT02714569|566203108|FG000|Part B (Overall)|Lost to Follow-up|0|||
156850060|NCT02714569|566203109|FG001|Part B (Overall)|Lost to Follow-up|0|||
156850061|NCT02714569|566203110|FG002|Part B (Overall)|Lost to Follow-up|0|||
156850062|NCT02714569|566203111|FG003|Part B (Overall)|Lost to Follow-up|0|||
156850063|NCT02714569|566203112|FG004|Part B (Overall)|Lost to Follow-up|0|||
156850064|NCT02714569|566203113|FG005|Part B (Overall)|Lost to Follow-up|0|||
156850065|NCT02714569|566203114|FG006|Part B (Overall)|Lost to Follow-up|1|||
156850066|NCT02714569|566203115|FG007|Part B (Overall)|Lost to Follow-up|0|||
156850067|NCT02714569|566203116|FG008|Part B (Overall)|Lost to Follow-up|0|||
156850068|NCT02714569|566203117|FG009|Part B (Overall)|Lost to Follow-up|0|||
156850069|NCT02714569|566203118|FG010|Part B (Overall)|Lost to Follow-up|0|||
156850070|NCT02714569|566203108|FG000|Part B (Overall)|Withdrawal by Subject|0|||
156850071|NCT02714569|566203109|FG001|Part B (Overall)|Withdrawal by Subject|0|||
156850072|NCT02714569|566203110|FG002|Part B (Overall)|Withdrawal by Subject|0|||
156850073|NCT02714569|566203111|FG003|Part B (Overall)|Withdrawal by Subject|0|||
156850074|NCT02714569|566203112|FG004|Part B (Overall)|Withdrawal by Subject|0|||
156850075|NCT02714569|566203113|FG005|Part B (Overall)|Withdrawal by Subject|0|||
156850076|NCT02714569|566203114|FG006|Part B (Overall)|Withdrawal by Subject|0|||
156850077|NCT02714569|566203115|FG007|Part B (Overall)|Withdrawal by Subject|1|||
156850078|NCT02714569|566203116|FG008|Part B (Overall)|Withdrawal by Subject|0|||
156850079|NCT02714569|566203117|FG009|Part B (Overall)|Withdrawal by Subject|1|||
156850080|NCT02714569|566203118|FG010|Part B (Overall)|Withdrawal by Subject|0|||
156850081|NCT02714569|566203108|FG000|Part B (Overall)|Adverse Event|0|||
156850082|NCT02714569|566203109|FG001|Part B (Overall)|Adverse Event|0|||
156850083|NCT02714569|566203110|FG002|Part B (Overall)|Adverse Event|0|||
156850084|NCT02714569|566203111|FG003|Part B (Overall)|Adverse Event|0|||
156850085|NCT02714569|566203112|FG004|Part B (Overall)|Adverse Event|0|||
156850086|NCT02714569|566203113|FG005|Part B (Overall)|Adverse Event|0|||
156850087|NCT02714569|566203114|FG006|Part B (Overall)|Adverse Event|0|||
156850088|NCT02714569|566203115|FG007|Part B (Overall)|Adverse Event|0|||
156850089|NCT02714569|566203116|FG008|Part B (Overall)|Adverse Event|0|||
156850090|NCT02714569|566203117|FG009|Part B (Overall)|Adverse Event|1|||
156850091|NCT02714569|566203118|FG010|Part B (Overall)|Adverse Event|0|||
156850092|NCT00226811|566203122|FG000|Overall Study|Death|8|||
156850093|NCT00226811|566203122|FG000|Overall Study|Adverse Event|11|||
156850094|NCT00226811|566203122|FG000|Overall Study|Lack of Efficacy|55|||
156850095|NCT00226811|566203122|FG000|Overall Study|Withdrawal by Subject|2|||
156850096|NCT01633541|566203130|FG000|Overall Study|Death|1|||
156850097|NCT01633541|566203131|FG001|Overall Study|Death|0|||
156850098|NCT01010971|566203132|FG000|Overall Study|Adverse Event|2|||
156850099|NCT01010971|566203133|FG001|Overall Study|Adverse Event|4|||
156470715|NCT01619059|564817841|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
156470716|NCT01619059|564817840|FG000|Long-Term (LT) Treatment Period|Death|1|||
156850100|NCT01010971|566203134|FG002|Overall Study|Adverse Event|3|||
156850101|NCT01010971|566203132|FG000|Overall Study|Withdrawal by Subject|0|||
156850102|NCT01010971|566203133|FG001|Overall Study|Withdrawal by Subject|2|||
156850103|NCT01010971|566203134|FG002|Overall Study|Withdrawal by Subject|5|||
156850104|NCT01010971|566203132|FG000|Overall Study|Lost to Follow-up|0|||
156342062|NCT03820986|564350379|FG001|Overall Study|Death|175|||
156850105|NCT01010971|566203133|FG001|Overall Study|Lost to Follow-up|2|||
156850106|NCT01010971|566203134|FG002|Overall Study|Lost to Follow-up|3|||
156850107|NCT01010971|566203132|FG000|Overall Study|Other|1|||
156850108|NCT01010971|566203133|FG001|Overall Study|Other|0|||
156850109|NCT01010971|566203134|FG002|Overall Study|Other|2|||
156850110|NCT05447663|566203135|FG000|Overall Study|Study terminated by Sponsor|5|||
156342063|NCT03820986|564350378|FG000|Overall Study|Lost to Follow-up|1|||
156342064|NCT03820986|564350379|FG001|Overall Study|Lost to Follow-up|1|||
156342065|NCT03820986|564350378|FG000|Overall Study|Physician Decision|1|||
156342066|NCT03820986|564350379|FG001|Overall Study|Physician Decision|0|||
156342067|NCT03820986|564350378|FG000|Overall Study|Sponsor Decision|122|||
156342068|NCT03820986|564350379|FG001|Overall Study|Sponsor Decision|160|||
156342069|NCT03820986|564350378|FG000|Overall Study|Withdrawal by Subject|9|||
156342070|NCT03820986|564350379|FG001|Overall Study|Withdrawal by Subject|4|||
156342071|NCT03069378|564350380|FG000|Overall Study|Withdrawal by Subject|1|||
156342072|NCT02993146|564350381|FG000|Overall Study|Withdrawal by Subject|0|||
156342073|NCT02993146|564350382|FG001|Overall Study|Withdrawal by Subject|0|||
156850111|NCT05447663|566203135|FG000|Overall Study|Death|2|||
156850112|NCT05447663|566203135|FG000|Overall Study|Withdrawal by Subject|1|||
156850113|NCT01100320|566203136|FG000|Period 1|Withdrawal by Subject|2|||
156850114|NCT01100320|566203137|FG001|Period 1|Withdrawal by Subject|4|||
156850115|NCT01100320|566203136|FG000|Period 1|Positive Drug Screen|1|||
156850116|NCT01100320|566203137|FG001|Period 1|Positive Drug Screen|1|||
156850117|NCT01100320|566203136|FG000|Period 1|Adverse Event|2|||
156850118|NCT01100320|566203137|FG001|Period 1|Adverse Event|2|||
156850119|NCT01100320|566203136|FG000|Period 2|Withdrawal by Subject|1|||
156850120|NCT01100320|566203137|FG001|Period 2|Withdrawal by Subject|1|||
156850121|NCT04181762|566203138|FG000|Overall Study|Adverse Event|1|||
156850122|NCT04181762|566203139|FG001|Overall Study|Adverse Event|3|||
156850123|NCT04181762|566203138|FG000|Overall Study|Lost to Follow-up|1|||
156850124|NCT04181762|566203139|FG001|Overall Study|Lost to Follow-up|1|||
156850125|NCT04181762|566203138|FG000|Overall Study|Physician Decision|1|||
156850126|NCT04181762|566203139|FG001|Overall Study|Physician Decision|3|||
156850127|NCT04181762|566203138|FG000|Overall Study|Pregnancy|0|||
156850128|NCT04181762|566203139|FG001|Overall Study|Pregnancy|1|||
156850129|NCT04181762|566203138|FG000|Overall Study|Lack of Efficacy|2|||
156850130|NCT04181762|566203139|FG001|Overall Study|Lack of Efficacy|2|||
156850131|NCT04181762|566203138|FG000|Overall Study|Study terminated by sponsor|95|||
156850132|NCT04181762|566203139|FG001|Overall Study|Study terminated by sponsor|97|||
156850133|NCT04181762|566203138|FG000|Overall Study|Subject decision|11|||
156850134|NCT04181762|566203139|FG001|Overall Study|Subject decision|4|||
156850135|NCT04181762|566203138|FG000|Overall Study|Death|1|||
156850136|NCT04181762|566203139|FG001|Overall Study|Death|1|||
156850137|NCT04181762|566203138|FG000|Overall Study|Protocol deviation|1|||
156850138|NCT04181762|566203139|FG001|Overall Study|Protocol deviation|0|||
156850139|NCT04181762|566203138|FG000|Overall Study|Withdrawal of informed consent|1|||
156850140|NCT04181762|566203139|FG001|Overall Study|Withdrawal of informed consent|3|||
156850141|NCT04752332|566203144|FG000|Overall Study|Adverse Event|3|||
156850142|NCT04752332|566203145|FG001|Overall Study|Adverse Event|1|||
156850143|NCT04752332|566203144|FG000|Overall Study|Disease Relapse|1|||
156850144|NCT04752332|566203145|FG001|Overall Study|Disease Relapse|0|||
156850145|NCT04752332|566203144|FG000|Overall Study|Non-compliance With Study Drug|2|||
156850146|NCT04752332|566203145|FG001|Overall Study|Non-compliance With Study Drug|0|||
156850147|NCT04752332|566203144|FG000|Overall Study|Physician Decision|2|||
156850148|NCT04752332|566203145|FG001|Overall Study|Physician Decision|1|||
156850149|NCT04752332|566203144|FG000|Overall Study|Protocol Violation|1|||
156850150|NCT04752332|566203145|FG001|Overall Study|Protocol Violation|1|||
156850151|NCT04752332|566203144|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
156850152|NCT04752332|566203145|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
156850153|NCT04752332|566203144|FG000|Overall Study|Study Terminated by Sponsor|10|||
156850154|NCT04752332|566203145|FG001|Overall Study|Study Terminated by Sponsor|48|||
156850155|NCT04752332|566203144|FG000|Overall Study|Withdrawal by Subject|11|||
156850156|NCT04752332|566203145|FG001|Overall Study|Withdrawal by Subject|3|||
156342074|NCT02993146|564350383|FG002|Overall Study|Withdrawal by Subject|1|||
156342075|NCT02993146|564350384|FG003|Overall Study|Withdrawal by Subject|1|||
156342076|NCT01397708|564350385|FG000|Overall Study|Withdrawal by Subject|0|||
156342077|NCT01397708|564350386|FG001|Overall Study|Withdrawal by Subject|0|||
156342078|NCT01397708|564350387|FG002|Overall Study|Withdrawal by Subject|1|||
156470717|NCT01619059|564817841|FG001|Long-Term (LT) Treatment Period|Death|0|||
156470718|NCT01619059|564817840|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
156470719|NCT01619059|564817841|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
156470720|NCT01619059|564817840|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
156850157|NCT02915978|566203146|FG000|Overall Study|Adverse Event|2|||
156342079|NCT01397708|564350388|FG003|Overall Study|Withdrawal by Subject|0|||
156342080|NCT01397708|564350389|FG004|Overall Study|Withdrawal by Subject|0|||
156470721|NCT01619059|564817841|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
156850158|NCT02915978|566203147|FG001|Overall Study|Adverse Event|1|||
156850159|NCT02915978|566203148|FG002|Overall Study|Adverse Event|0|||
156850160|NCT00924443|566203149|FG000|Overall Study|Physician Decision|2|||
156850161|NCT00924443|566203149|FG000|Overall Study|Protocol Violation|1|||
156850162|NCT02451124|566203154|FG000|Overall Study|Withdrawal by Subject|1|||
156850163|NCT01248949|566203155|FG000|Overall Study|Lost to Follow-up|2|||
156850164|NCT01248949|566203156|FG001|Overall Study|Lost to Follow-up|2|||
156850165|NCT01248949|566203157|FG002|Overall Study|Lost to Follow-up|2|||
156850166|NCT01248949|566203158|FG003|Overall Study|Lost to Follow-up|1|||
156850167|NCT01248949|566203159|FG004|Overall Study|Lost to Follow-up|0|||
156850168|NCT01248949|566203155|FG000|Overall Study|Withdrawal by Subject|5|||
156850169|NCT01248949|566203156|FG001|Overall Study|Withdrawal by Subject|3|||
156850170|NCT01248949|566203157|FG002|Overall Study|Withdrawal by Subject|11|||
156850171|NCT01248949|566203158|FG003|Overall Study|Withdrawal by Subject|3|||
156850172|NCT01248949|566203159|FG004|Overall Study|Withdrawal by Subject|1|||
156850173|NCT01248949|566203155|FG000|Overall Study|Death|22|||
156850174|NCT01248949|566203156|FG001|Overall Study|Death|7|||
156850175|NCT01248949|566203157|FG002|Overall Study|Death|21|||
156850176|NCT01248949|566203158|FG003|Overall Study|Death|6|||
156850177|NCT01248949|566203159|FG004|Overall Study|Death|2|||
156850178|NCT01248949|566203155|FG000|Overall Study|Alternative Therapy|1|||
156470722|NCT01170208|564817842|FG000|Overall Study|Withdrawal by Subject|5|||
156470723|NCT01170208|564817843|FG001|Overall Study|Withdrawal by Subject|0|||
156470724|NCT01170208|564817844|FG002|Overall Study|Withdrawal by Subject|1|||
156470725|NCT01170208|564817842|FG000|Overall Study|Protocol Violation|1|||
156470726|NCT01170208|564817843|FG001|Overall Study|Protocol Violation|0|||
156470727|NCT01170208|564817844|FG002|Overall Study|Protocol Violation|1|||
156470728|NCT03113409|564817845|FG000|Overall Study|Withdrawal by Subject|5|||
156470729|NCT03113409|564817846|FG001|Overall Study|Withdrawal by Subject|0|||
156470730|NCT03113409|564817847|FG002|Overall Study|Withdrawal by Subject|0|||
156470731|NCT00388726|564817850|FG000|Overall Study|Adverse Event|50|||
156470732|NCT00388726|564817851|FG001|Overall Study|Adverse Event|24|||
156470733|NCT00388726|564817850|FG000|Overall Study|Progressive Disease|336|||
156470734|NCT00388726|564817851|FG001|Overall Study|Progressive Disease|153|||
156470735|NCT00388726|564817850|FG000|Overall Study|Clinical Progression|61|||
156470736|NCT00388726|564817851|FG001|Overall Study|Clinical Progression|36|||
156470737|NCT00388726|564817850|FG000|Overall Study|Withdrawal by Subject|10|||
156470738|NCT00388726|564817851|FG001|Overall Study|Withdrawal by Subject|7|||
156470739|NCT00388726|564817850|FG000|Overall Study|Administrative|6|||
156470740|NCT00388726|564817851|FG001|Overall Study|Administrative|9|||
156470741|NCT00388726|564817850|FG000|Overall Study|Physician Decision|18|||
156470742|NCT00388726|564817851|FG001|Overall Study|Physician Decision|13|||
156470743|NCT00388726|564817850|FG000|Overall Study|Death|3|||
156470744|NCT00388726|564817851|FG001|Overall Study|Death|2|||
156470745|NCT02406092|564817852|FG000|Overall Study|Screen failure|10|||
156470746|NCT02406092|564817853|FG001|Overall Study|Screen failure|7|||
156470747|NCT02406092|564817852|FG000|Overall Study|Death|22|||
156470748|NCT02406092|564817853|FG001|Overall Study|Death|5|||
156470749|NCT02406092|564817852|FG000|Overall Study|Lost to Follow-up|4|||
156470750|NCT02406092|564817853|FG001|Overall Study|Lost to Follow-up|1|||
156470751|NCT02406092|564817852|FG000|Overall Study|Adverse Event|1|||
156470752|NCT02406092|564817853|FG001|Overall Study|Adverse Event|0|||
156470753|NCT02406092|564817852|FG000|Overall Study|Withdrawal by Subject|1|||
156470754|NCT02406092|564817853|FG001|Overall Study|Withdrawal by Subject|0|||
156470755|NCT03041233|564817854|FG000|Overall Study|Death|5|||
156470756|NCT03041233|564817854|FG000|Overall Study|Physician Decision|1|||
156470757|NCT03041233|564817854|FG000|Overall Study|Lost to Follow-up|16|||
156850179|NCT01248949|566203156|FG001|Overall Study|Alternative Therapy|0|||
156850180|NCT01248949|566203157|FG002|Overall Study|Alternative Therapy|0|||
156850181|NCT01248949|566203158|FG003|Overall Study|Alternative Therapy|0|||
156850182|NCT01248949|566203159|FG004|Overall Study|Alternative Therapy|0|||
156850183|NCT01248949|566203155|FG000|Overall Study|Alternative Therapy.|1|||
156850184|NCT01248949|566203156|FG001|Overall Study|Alternative Therapy.|0|||
156850185|NCT01248949|566203157|FG002|Overall Study|Alternative Therapy.|0|||
156850186|NCT01248949|566203158|FG003|Overall Study|Alternative Therapy.|0|||
156850187|NCT01248949|566203159|FG004|Overall Study|Alternative Therapy.|0|||
156850188|NCT01248949|566203155|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
156850189|NCT01248949|566203156|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
156850190|NCT01248949|566203157|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
156850191|NCT01248949|566203158|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
156850192|NCT01248949|566203159|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
156850193|NCT01248949|566203155|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
156850194|NCT01248949|566203156|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
156850195|NCT01248949|566203157|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
156470758|NCT03041233|564817854|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
156470759|NCT03041233|564817854|FG000|Overall Study|Sponsor Request|1|||
156470760|NCT03041233|564817854|FG000|Overall Study|Duplicate subject|1|||
156470761|NCT03041233|564817854|FG000|Overall Study|Re-ablation|1|||
156470762|NCT00853593|564817858|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
156470763|NCT00853593|564817858|FG000|Overall Study|Model 4396 lead not attempted|29|||
156470764|NCT00853593|564817858|FG000|Overall Study|Implant not attempted|4|||
156470765|NCT00641537|564817859|FG000|96-week Period|Adverse Event|0|||
156470766|NCT00641537|564817860|FG001|96-week Period|Adverse Event|1|||
156470767|NCT00641537|564817861|FG002|96-week Period|Adverse Event|3|||
156470768|NCT00641537|564817862|FG003|96-week Period|Adverse Event|0|||
156470769|NCT00641537|564817863|FG004|96-week Period|Adverse Event|2|||
156850196|NCT01248949|566203158|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
156850197|NCT01248949|566203159|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
156850198|NCT01248949|566203155|FG000|Overall Study|Participant Went To Hospice|0|||
156850199|NCT01248949|566203156|FG001|Overall Study|Participant Went To Hospice|0|||
156850200|NCT01248949|566203157|FG002|Overall Study|Participant Went To Hospice|1|||
156850201|NCT01248949|566203158|FG003|Overall Study|Participant Went To Hospice|0|||
156850202|NCT01248949|566203159|FG004|Overall Study|Participant Went To Hospice|0|||
156850203|NCT01248949|566203155|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
156470770|NCT00641537|564817864|FG005|96-week Period|Adverse Event|0|||
156470771|NCT00641537|564817865|FG006|96-week Period|Adverse Event|0|||
156470772|NCT00641537|564817866|FG007|96-week Period|Adverse Event|0|||
156470773|NCT00641537|564817859|FG000|96-week Period|Lost to Follow-up|3|||
156470774|NCT00641537|564817860|FG001|96-week Period|Lost to Follow-up|1|||
156470775|NCT00641537|564817861|FG002|96-week Period|Lost to Follow-up|2|||
156470776|NCT00641537|564817862|FG003|96-week Period|Lost to Follow-up|2|||
156470777|NCT00641537|564817863|FG004|96-week Period|Lost to Follow-up|4|||
156470778|NCT00641537|564817864|FG005|96-week Period|Lost to Follow-up|0|||
156470779|NCT00641537|564817865|FG006|96-week Period|Lost to Follow-up|1|||
156470780|NCT00641537|564817866|FG007|96-week Period|Lost to Follow-up|0|||
156470781|NCT00641537|564817859|FG000|96-week Period|Protocol Violation|0|||
156470782|NCT00641537|564817860|FG001|96-week Period|Protocol Violation|1|||
156470783|NCT00641537|564817861|FG002|96-week Period|Protocol Violation|0|||
156470784|NCT00641537|564817862|FG003|96-week Period|Protocol Violation|1|||
156470785|NCT00641537|564817863|FG004|96-week Period|Protocol Violation|0|||
156470786|NCT00641537|564817864|FG005|96-week Period|Protocol Violation|1|||
156470787|NCT00641537|564817865|FG006|96-week Period|Protocol Violation|0|||
156470788|NCT00641537|564817866|FG007|96-week Period|Protocol Violation|0|||
156470789|NCT00641537|564817859|FG000|96-week Period|Death|2|||
156470790|NCT00641537|564817860|FG001|96-week Period|Death|0|||
156470791|NCT00641537|564817861|FG002|96-week Period|Death|1|||
156470792|NCT00641537|564817862|FG003|96-week Period|Death|0|||
156470793|NCT00641537|564817863|FG004|96-week Period|Death|0|||
156470794|NCT00641537|564817864|FG005|96-week Period|Death|0|||
156470795|NCT00641537|564817865|FG006|96-week Period|Death|0|||
156470796|NCT00641537|564817866|FG007|96-week Period|Death|0|||
156470797|NCT00641537|564817859|FG000|96-week Period|Other|4|||
156470798|NCT00641537|564817860|FG001|96-week Period|Other|7|||
156470799|NCT00641537|564817861|FG002|96-week Period|Other|14|||
156470800|NCT00641537|564817862|FG003|96-week Period|Other|9|||
156470801|NCT00641537|564817863|FG004|96-week Period|Other|11|||
156470802|NCT00641537|564817864|FG005|96-week Period|Other|6|||
156470803|NCT00641537|564817865|FG006|96-week Period|Other|4|||
156470804|NCT00641537|564817866|FG007|96-week Period|Other|6|||
156470805|NCT00641537|564817859|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
156470806|NCT00641537|564817860|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
156470807|NCT00641537|564817861|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
156470808|NCT00641537|564817862|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
156470809|NCT00641537|564817863|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
156470810|NCT00641537|564817864|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
156470811|NCT00641537|564817865|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
156470812|NCT00641537|564817866|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
156470813|NCT00641537|564817859|FG000|24-Week Supplemental Follow-up Period|Other|0|||
156470814|NCT00641537|564817860|FG001|24-Week Supplemental Follow-up Period|Other|2|||
156470815|NCT00641537|564817861|FG002|24-Week Supplemental Follow-up Period|Other|2|||
156470816|NCT00641537|564817862|FG003|24-Week Supplemental Follow-up Period|Other|1|||
156470817|NCT00641537|564817863|FG004|24-Week Supplemental Follow-up Period|Other|3|||
156470818|NCT00641537|564817864|FG005|24-Week Supplemental Follow-up Period|Other|0|||
156470819|NCT00641537|564817865|FG006|24-Week Supplemental Follow-up Period|Other|1|||
156470820|NCT00641537|564817866|FG007|24-Week Supplemental Follow-up Period|Other|1|||
156542135|NCT01517893|565077876|FG001|Overall Study|Withdrawal by Subject|0|||
156542136|NCT03462576|565077877|FG000|Overall Study|Protocol Violation|5|||
156850204|NCT01248949|566203156|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
156850205|NCT01248949|566203157|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
156850206|NCT01248949|566203158|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
156470821|NCT03229408|564817867|FG000|Overall Study|Withdrawal by Subject|4|||
156850207|NCT01248949|566203159|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
156470822|NCT03229408|564817868|FG001|Overall Study|Withdrawal by Subject|1|||
156470823|NCT03229408|564817867|FG000|Overall Study|Adverse Event|2|||
156470824|NCT03229408|564817868|FG001|Overall Study|Adverse Event|0|||
156470825|NCT03229408|564817867|FG000|Overall Study|Pregnancy|0|||
156470826|NCT03229408|564817868|FG001|Overall Study|Pregnancy|1|||
156470827|NCT03229408|564817867|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
156470828|NCT03229408|564817868|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
156542137|NCT03462576|565077878|FG001|Overall Study|Protocol Violation|11|||
156850208|NCT01248949|566203155|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
156470829|NCT01706159|564817873|FG000|Overall Study|Withdrawal Criteria|2|||
156470830|NCT01706159|564817874|FG001|Overall Study|Withdrawal Criteria|1|||
156470831|NCT01706159|564817873|FG000|Overall Study|Unclassified|6|||
156470832|NCT01706159|564817874|FG001|Overall Study|Unclassified|1|||
156470833|NCT03362190|564817875|FG000|Overall Study|Adverse Event|0|||
156470834|NCT03362190|564817876|FG001|Overall Study|Adverse Event|0|||
156470835|NCT03362190|564817877|FG002|Overall Study|Adverse Event|0|||
156470836|NCT03362190|564817878|FG003|Overall Study|Adverse Event|1|||
156470837|NCT03362190|564817875|FG000|Overall Study|Withdrawal by Subject|0|||
156470838|NCT03362190|564817876|FG001|Overall Study|Withdrawal by Subject|0|||
156470839|NCT03362190|564817877|FG002|Overall Study|Withdrawal by Subject|0|||
156470840|NCT03362190|564817878|FG003|Overall Study|Withdrawal by Subject|1|||
156470841|NCT03683576|564817880|FG000|Overall Study|Withdrawal by Subject|2|||
156470842|NCT03683576|564817881|FG001|Overall Study|Withdrawal by Subject|0|||
156470843|NCT03683576|564817882|FG002|Overall Study|Withdrawal by Subject|8|||
156470844|NCT03683576|564817883|FG003|Overall Study|Withdrawal by Subject|3|||
156470845|NCT03683576|564817880|FG000|Overall Study|Adverse Event|3|||
156470846|NCT03683576|564817881|FG001|Overall Study|Adverse Event|0|||
156470847|NCT03683576|564817882|FG002|Overall Study|Adverse Event|0|||
156470848|NCT03683576|564817883|FG003|Overall Study|Adverse Event|4|||
156470849|NCT03683576|564817880|FG000|Overall Study|Lack of Efficacy|1|||
156850209|NCT01248949|566203156|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
156850210|NCT01248949|566203157|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
156850211|NCT01248949|566203158|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
156850212|NCT01248949|566203159|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
156470850|NCT03683576|564817881|FG001|Overall Study|Lack of Efficacy|0|||
156470851|NCT03683576|564817882|FG002|Overall Study|Lack of Efficacy|1|||
156470852|NCT03683576|564817883|FG003|Overall Study|Lack of Efficacy|1|||
156850213|NCT01248949|566203155|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
156470853|NCT03683576|564817880|FG000|Overall Study|Lost to Follow-up|0|||
156470854|NCT03683576|564817881|FG001|Overall Study|Lost to Follow-up|1|||
156470855|NCT03683576|564817882|FG002|Overall Study|Lost to Follow-up|2|||
156470856|NCT03683576|564817883|FG003|Overall Study|Lost to Follow-up|0|||
156470857|NCT03683576|564817880|FG000|Overall Study|Other, Not Specified|0|||
156470858|NCT03683576|564817881|FG001|Overall Study|Other, Not Specified|2|||
156470859|NCT03683576|564817882|FG002|Overall Study|Other, Not Specified|0|||
156470860|NCT03683576|564817883|FG003|Overall Study|Other, Not Specified|0|||
156470861|NCT03683576|564817880|FG000|Overall Study|Protocol Violation|0|||
156470862|NCT03683576|564817881|FG001|Overall Study|Protocol Violation|1|||
156470863|NCT03683576|564817882|FG002|Overall Study|Protocol Violation|1|||
156470864|NCT03683576|564817883|FG003|Overall Study|Protocol Violation|0|||
156470865|NCT03488719|564817886|FG000|Overall Study|Adverse Event|0|||
156470866|NCT03488719|564817887|FG001|Overall Study|Adverse Event|4|||
156470867|NCT03488719|564817888|FG002|Overall Study|Adverse Event|2|||
156470868|NCT03488719|564817886|FG000|Overall Study|Other|0|||
156470869|NCT03488719|564817887|FG001|Overall Study|Other|0|||
156470870|NCT03488719|564817888|FG002|Overall Study|Other|5|||
156470871|NCT04038580|564817892|FG000|Washout 1|Death|0|||
156470872|NCT04038580|564817893|FG001|Washout 1|Death|0|||
156470873|NCT04038580|564817894|FG002|Washout 1|Death|0|||
156470874|NCT04038580|564817895|FG003|Washout 1|Death|1|||
156470875|NCT04038580|564817896|FG004|Washout 1|Death|0|||
156470876|NCT04038580|564817897|FG005|Washout 1|Death|0|||
156470877|NCT04038580|564817892|FG000|Washout 1|Withdrawal by Subject|0|||
156470878|NCT04038580|564817893|FG001|Washout 1|Withdrawal by Subject|0|||
156470879|NCT04038580|564817894|FG002|Washout 1|Withdrawal by Subject|0|||
156470880|NCT04038580|564817895|FG003|Washout 1|Withdrawal by Subject|0|||
156470881|NCT04038580|564817896|FG004|Washout 1|Withdrawal by Subject|1|||
156470882|NCT04038580|564817897|FG005|Washout 1|Withdrawal by Subject|0|||
156470883|NCT04038580|564817892|FG000|Wash-out 2|Withdrawal by Subject|1|||
156850214|NCT01248949|566203156|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
156850215|NCT01248949|566203157|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
156850216|NCT01248949|566203158|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
156850217|NCT01248949|566203159|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
156342081|NCT01397708|564350390|FG005|Overall Study|Withdrawal by Subject|0|||
156342082|NCT01397708|564350391|FG006|Overall Study|Withdrawal by Subject|0|||
156342083|NCT01397708|564350392|FG007|Overall Study|Withdrawal by Subject|1|||
156470884|NCT04038580|564817893|FG001|Wash-out 2|Withdrawal by Subject|0|||
156470885|NCT04038580|564817894|FG002|Wash-out 2|Withdrawal by Subject|0|||
156470886|NCT04038580|564817895|FG003|Wash-out 2|Withdrawal by Subject|2|||
156470887|NCT04038580|564817896|FG004|Wash-out 2|Withdrawal by Subject|0|||
156470888|NCT04038580|564817897|FG005|Wash-out 2|Withdrawal by Subject|1|||
156470889|NCT04038580|564817892|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
156470890|NCT04038580|564817893|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
156470891|NCT04038580|564817894|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
156470892|NCT04038580|564817895|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
156470893|NCT04038580|564817896|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
156470894|NCT04038580|564817897|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
156470895|NCT04038580|564817892|FG000|Wash-out 3|Withdrawal by Subject|1|||
156470896|NCT04038580|564817893|FG001|Wash-out 3|Withdrawal by Subject|0|||
156470897|NCT04038580|564817894|FG002|Wash-out 3|Withdrawal by Subject|2|||
156470898|NCT04038580|564817895|FG003|Wash-out 3|Withdrawal by Subject|0|||
156470899|NCT04038580|564817896|FG004|Wash-out 3|Withdrawal by Subject|0|||
156470900|NCT04038580|564817897|FG005|Wash-out 3|Withdrawal by Subject|0|||
156470901|NCT03477175|564817898|FG000|Overall Study|Unable to travel due to COVID-19|0|||
156470902|NCT03477175|564817899|FG001|Overall Study|Unable to travel due to COVID-19|1|||
156470903|NCT03477175|564817898|FG000|Overall Study|Physician Decision|1|||
156470904|NCT03477175|564817899|FG001|Overall Study|Physician Decision|0|||
156470905|NCT03477175|564817898|FG000|Overall Study|Transitioned to commercial drug|6|||
156470906|NCT03477175|564817899|FG001|Overall Study|Transitioned to commercial drug|6|||
156470907|NCT03477175|564817898|FG000|Overall Study|Lost to Follow-up|1|||
156470908|NCT03477175|564817899|FG001|Overall Study|Lost to Follow-up|1|||
156470909|NCT03477175|564817898|FG000|Overall Study|Withdrawal by Subject|3|||
156470910|NCT03477175|564817899|FG001|Overall Study|Withdrawal by Subject|1|||
156470911|NCT03477175|564817898|FG000|Overall Study|Adverse Event|1|||
156470912|NCT03477175|564817899|FG001|Overall Study|Adverse Event|5|||
156470913|NCT03477175|564817898|FG000|Overall Study|Disease Progression|7|||
156470914|NCT03477175|564817899|FG001|Overall Study|Disease Progression|7|||
156470915|NCT04021862|564817900|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
156470916|NCT04021862|564817901|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
156470917|NCT04021862|564817902|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
156470918|NCT04021862|564817903|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
156470919|NCT04021862|564817904|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
156470920|NCT04021862|564817905|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
156470921|NCT04021862|564817900|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
156470922|NCT04021862|564817901|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
156470923|NCT04021862|564817902|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
156470924|NCT04021862|564817903|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
156470925|NCT04021862|564817904|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
156470926|NCT04021862|564817905|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
156470927|NCT04021862|564817900|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
156850218|NCT01248949|566203155|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
156850219|NCT01248949|566203156|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
156850220|NCT01248949|566203157|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
156850221|NCT01248949|566203158|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
156850222|NCT01248949|566203159|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
156850223|NCT03245775|566203164|FG000|Overall Study|Lost to Follow-up|25|||
156850224|NCT03245775|566203165|FG001|Overall Study|Lost to Follow-up|26|||
156850225|NCT03245775|566203166|FG002|Overall Study|Lost to Follow-up|16|||
156850226|NCT03245775|566203167|FG003|Overall Study|Lost to Follow-up|16|||
156850227|NCT00186901|566203170|FG000|Overall Study|Pregnancy|6|||
156850228|NCT00186901|566203171|FG001|Overall Study|Pregnancy|3|||
156850229|NCT00186901|566203172|FG002|Overall Study|Pregnancy|0|||
156850230|NCT00186901|566203170|FG000|Overall Study|Lost to Follow-up|6|||
156850231|NCT00186901|566203171|FG001|Overall Study|Lost to Follow-up|3|||
156850232|NCT00186901|566203172|FG002|Overall Study|Lost to Follow-up|0|||
156850233|NCT00186901|566203170|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
156850234|NCT00186901|566203171|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
156850235|NCT00186901|566203172|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
156850236|NCT00186901|566203170|FG000|Overall Study|ALL relapse or second malignancy|1|||
156850237|NCT00186901|566203171|FG001|Overall Study|ALL relapse or second malignancy|2|||
156850238|NCT00186901|566203172|FG002|Overall Study|ALL relapse or second malignancy|0|||
156850239|NCT00186901|566203170|FG000|Overall Study|Withdrawal by Subject|4|||
156850240|NCT00186901|566203171|FG001|Overall Study|Withdrawal by Subject|5|||
156850241|NCT00186901|566203172|FG002|Overall Study|Withdrawal by Subject|0|||
156850242|NCT00186901|566203170|FG000|Overall Study|Open label|3|||
156850243|NCT00186901|566203171|FG001|Overall Study|Open label|2|||
156850244|NCT00186901|566203172|FG002|Overall Study|Open label|0|||
156850245|NCT00186901|566203170|FG000|Overall Study|Limited adherence to study requirements|20|||
156342084|NCT01397708|564350385|FG000|Overall Study|Death|0|||
156850246|NCT00186901|566203171|FG001|Overall Study|Limited adherence to study requirements|23|||
156850247|NCT00186901|566203172|FG002|Overall Study|Limited adherence to study requirements|0|||
156342085|NCT01397708|564350386|FG001|Overall Study|Death|0|||
156470928|NCT04021862|564817901|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
156470929|NCT04021862|564817902|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
156470930|NCT04021862|564817903|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
156470931|NCT04021862|564817904|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
156470932|NCT04021862|564817905|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
156470933|NCT04021862|564817900|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
156470934|NCT04021862|564817901|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
156470935|NCT04021862|564817902|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
156470936|NCT04021862|564817903|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
156470937|NCT04021862|564817904|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
156470938|NCT04021862|564817905|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
156470939|NCT04021862|564817900|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
156850248|NCT00186901|566203170|FG000|Overall Study|Bone Mineral Density > 0|0|||
156850249|NCT00186901|566203171|FG001|Overall Study|Bone Mineral Density > 0|0|||
156850250|NCT00186901|566203172|FG002|Overall Study|Bone Mineral Density > 0|149|||
156850251|NCT00782483|566203176|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
156850252|NCT01052077|566203177|FG000|Phase A|Lost to Follow-up|22|||
156850253|NCT01052077|566203178|FG001|Phase A|Lost to Follow-up|0|||
156850254|NCT01052077|566203179|FG002|Phase A|Lost to Follow-up|0|||
156850255|NCT01052077|566203180|FG003|Phase A|Lost to Follow-up|0|||
156850256|NCT01052077|566203177|FG000|Phase A|Adverse Event|32|||
156850257|NCT01052077|566203178|FG001|Phase A|Adverse Event|0|||
156850258|NCT01052077|566203179|FG002|Phase A|Adverse Event|0|||
156850259|NCT01052077|566203180|FG003|Phase A|Adverse Event|0|||
156850260|NCT01052077|566203177|FG000|Phase A|Met Withdrawal Criteria|26|||
156850261|NCT01052077|566203178|FG001|Phase A|Met Withdrawal Criteria|0|||
156850262|NCT01052077|566203179|FG002|Phase A|Met Withdrawal Criteria|0|||
156850263|NCT01052077|566203180|FG003|Phase A|Met Withdrawal Criteria|0|||
156850264|NCT01052077|566203177|FG000|Phase A|Physician Decision|10|||
156850265|NCT01052077|566203178|FG001|Phase A|Physician Decision|0|||
156850266|NCT01052077|566203179|FG002|Phase A|Physician Decision|0|||
156850267|NCT01052077|566203180|FG003|Phase A|Physician Decision|0|||
156850268|NCT01052077|566203177|FG000|Phase A|Withdrawal by Subject|29|||
156850269|NCT01052077|566203178|FG001|Phase A|Withdrawal by Subject|0|||
156850270|NCT01052077|566203179|FG002|Phase A|Withdrawal by Subject|0|||
156850271|NCT01052077|566203180|FG003|Phase A|Withdrawal by Subject|0|||
156850272|NCT01052077|566203177|FG000|Phase A|Protocol Deviation|27|||
156850273|NCT01052077|566203178|FG001|Phase A|Protocol Deviation|0|||
156850274|NCT01052077|566203179|FG002|Phase A|Protocol Deviation|0|||
156850275|NCT01052077|566203180|FG003|Phase A|Protocol Deviation|0|||
156850276|NCT01052077|566203177|FG000|Phase B|Lost to Follow-up|0|||
156850277|NCT01052077|566203178|FG001|Phase B|Lost to Follow-up|2|||
156850278|NCT01052077|566203179|FG002|Phase B|Lost to Follow-up|3|||
156850279|NCT01052077|566203180|FG003|Phase B|Lost to Follow-up|0|||
156850280|NCT01052077|566203177|FG000|Phase B|Adverse Event|0|||
156850281|NCT01052077|566203178|FG001|Phase B|Adverse Event|9|||
156470940|NCT04021862|564817901|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
156470941|NCT04021862|564817902|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
156470942|NCT04021862|564817903|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
156470943|NCT04021862|564817904|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
156470944|NCT04021862|564817905|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
156470945|NCT03371017|564817906|FG000|Overall Study|Physician Decision|0|||
156470946|NCT03371017|564817907|FG001|Overall Study|Physician Decision|1|||
156470947|NCT03371017|564817906|FG000|Overall Study|Reason not Specified|0|||
156470948|NCT03371017|564817907|FG001|Overall Study|Reason not Specified|1|||
156470949|NCT03371017|564817906|FG000|Overall Study|Lost to Follow-up|13|||
156470950|NCT03371017|564817907|FG001|Overall Study|Lost to Follow-up|16|||
156470951|NCT03371017|564817906|FG000|Overall Study|Death|228|||
156470952|NCT03371017|564817907|FG001|Overall Study|Death|215|||
156470953|NCT03371017|564817906|FG000|Overall Study|Withdrawal by Subject|20|||
156470954|NCT03371017|564817907|FG001|Overall Study|Withdrawal by Subject|25|||
156470955|NCT03371017|564817906|FG000|Overall Study|Study Ended by Sponsor|37|||
156470956|NCT03371017|564817907|FG001|Overall Study|Study Ended by Sponsor|38|||
156470957|NCT03371017|564817906|FG000|Overall Study|Protocol Deviation|0|||
156470958|NCT03371017|564817907|FG001|Overall Study|Protocol Deviation|1|||
156470959|NCT00489307|564817910|FG000|Overall Study|Death|1|||
156850282|NCT01052077|566203179|FG002|Phase B|Adverse Event|2|||
156850283|NCT01052077|566203180|FG003|Phase B|Adverse Event|0|||
156850284|NCT01052077|566203177|FG000|Phase B|Met Withdrawal Criteria|0|||
156850285|NCT01052077|566203178|FG001|Phase B|Met Withdrawal Criteria|2|||
156850286|NCT01052077|566203179|FG002|Phase B|Met Withdrawal Criteria|1|||
156850287|NCT01052077|566203180|FG003|Phase B|Met Withdrawal Criteria|0|||
156850288|NCT01052077|566203177|FG000|Phase B|Physician Decision|0|||
156470960|NCT00489307|564817911|FG001|Overall Study|Death|1|||
156470961|NCT00489307|564817910|FG000|Overall Study|Lost to Follow-up|2|||
156470962|NCT00489307|564817911|FG001|Overall Study|Lost to Follow-up|2|||
156470963|NCT00489307|564817910|FG000|Overall Study|Physician Decision|1|||
156470964|NCT00489307|564817911|FG001|Overall Study|Physician Decision|0|||
156470965|NCT00489307|564817910|FG000|Overall Study|Withdrawal by Subject|2|||
156470966|NCT00489307|564817911|FG001|Overall Study|Withdrawal by Subject|4|||
156470967|NCT00489307|564817910|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
156542138|NCT03462576|565077879|FG002|Overall Study|Protocol Violation|7|||
156850289|NCT01052077|566203178|FG001|Phase B|Physician Decision|1|||
156850290|NCT01052077|566203179|FG002|Phase B|Physician Decision|1|||
156850291|NCT01052077|566203180|FG003|Phase B|Physician Decision|0|||
156470968|NCT00489307|564817911|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
156470969|NCT00489307|564817910|FG000|Overall Study|Surgery after assignment|1|||
156470970|NCT00489307|564817911|FG001|Overall Study|Surgery after assignment|0|||
156470971|NCT00489307|564817910|FG000|Overall Study|Did not fill up the forms|2|||
156470972|NCT00489307|564817911|FG001|Overall Study|Did not fill up the forms|1|||
156470973|NCT00489307|564817910|FG000|Overall Study|Patient or family refusal|5|||
156470974|NCT00489307|564817911|FG001|Overall Study|Patient or family refusal|9|||
156470975|NCT03835754|564817912|FG000|Overall Study|Death|4|||
156470976|NCT02751528|564817917|FG000|Overall Study|Withdrawal by Subject|1|||
156470977|NCT02751528|564817917|FG000|Overall Study|Adverse Event|1|||
156470978|NCT05485805|564817918|FG000|Overall Study|Withdrawal by Subject|1|||
156470979|NCT05485805|564817919|FG001|Overall Study|Withdrawal by Subject|2|||
156470980|NCT05485805|564817920|FG002|Overall Study|Withdrawal by Subject|2|||
156470981|NCT05485805|564817921|FG003|Overall Study|Withdrawal by Subject|0|||
156470982|NCT05485805|564817922|FG004|Overall Study|Withdrawal by Subject|2|||
156470983|NCT05485805|564817918|FG000|Overall Study|Adverse Event|0|||
156470984|NCT05485805|564817919|FG001|Overall Study|Adverse Event|1|||
156470985|NCT05485805|564817920|FG002|Overall Study|Adverse Event|0|||
156470986|NCT05485805|564817921|FG003|Overall Study|Adverse Event|0|||
156470987|NCT05485805|564817922|FG004|Overall Study|Adverse Event|0|||
156470988|NCT05485805|564817918|FG000|Overall Study|Lost to Follow-up|1|||
156470989|NCT05485805|564817919|FG001|Overall Study|Lost to Follow-up|1|||
156470990|NCT05485805|564817920|FG002|Overall Study|Lost to Follow-up|3|||
156470991|NCT05485805|564817921|FG003|Overall Study|Lost to Follow-up|1|||
156470992|NCT05485805|564817922|FG004|Overall Study|Lost to Follow-up|0|||
156470993|NCT05810285|564817926|FG000|Overall Study|Death|4|||
156470994|NCT05810285|564817927|FG001|Overall Study|Death|21|||
156470995|NCT05810285|564817926|FG000|Overall Study|Adverse Event|18|||
156470996|NCT05810285|564817927|FG001|Overall Study|Adverse Event|16|||
156470997|NCT04484623|564817928|FG000|Overall Study|Lost to Follow-up|0|||
156470998|NCT04484623|564817929|FG001|Overall Study|Lost to Follow-up|1|||
156470999|NCT04484623|564817928|FG000|Overall Study|Protocol Deviation|1|||
156471000|NCT04484623|564817929|FG001|Overall Study|Protocol Deviation|0|||
156471001|NCT04484623|564817928|FG000|Overall Study|Physician Decision|1|||
156471002|NCT04484623|564817929|FG001|Overall Study|Physician Decision|0|||
156471003|NCT04484623|564817928|FG000|Overall Study|Withdrawal by Subject|11|||
156471004|NCT04484623|564817929|FG001|Overall Study|Withdrawal by Subject|8|||
156471005|NCT04484623|564817928|FG000|Overall Study|Ongoing|94|||
156471006|NCT04484623|564817929|FG001|Overall Study|Ongoing|84|||
156471007|NCT05470114|564817930|FG000|Overall Study|Withdrawal by Subject|1|||
156471008|NCT05470114|564817931|FG001|Overall Study|Withdrawal by Subject|0|||
156471009|NCT05470114|564817930|FG000|Overall Study|Lost to Follow-up|1|||
156471010|NCT05470114|564817931|FG001|Overall Study|Lost to Follow-up|0|||
156471011|NCT04649047|564817936|FG000|Overall Study|Withdrawal by Subject|3|||
156471012|NCT02488408|564817937|FG000|Part A|Adverse Event|2|||
156471013|NCT02488408|564817938|FG001|Part A|Adverse Event|0|||
156471014|NCT02488408|564817939|FG002|Part A|Adverse Event|0|||
156471015|NCT02488408|564817940|FG003|Part A|Adverse Event|0|||
156471016|NCT02488408|564817941|FG004|Part A|Adverse Event|0|||
156471017|NCT02488408|564817942|FG005|Part A|Adverse Event|0|||
156471018|NCT02488408|564817943|FG006|Part A|Adverse Event|0|||
156471019|NCT02488408|564817944|FG007|Part A|Adverse Event|0|||
156471020|NCT02488408|564817945|FG008|Part A|Adverse Event|0|||
156471021|NCT02488408|564817946|FG009|Part A|Adverse Event|0|||
156471022|NCT02488408|564817937|FG000|Part A|Death|1|||
156471023|NCT02488408|564817938|FG001|Part A|Death|5|||
156471024|NCT02488408|564817939|FG002|Part A|Death|0|||
156471025|NCT02488408|564817940|FG003|Part A|Death|0|||
156471026|NCT02488408|564817941|FG004|Part A|Death|3|||
156471027|NCT02488408|564817942|FG005|Part A|Death|0|||
156471028|NCT02488408|564817943|FG006|Part A|Death|0|||
156471029|NCT02488408|564817944|FG007|Part A|Death|0|||
156471030|NCT02488408|564817945|FG008|Part A|Death|0|||
156471031|NCT02488408|564817946|FG009|Part A|Death|0|||
156471032|NCT02488408|564817937|FG000|Part A|Disease Progression|2|||
156471033|NCT02488408|564817938|FG001|Part A|Disease Progression|8|||
156471034|NCT02488408|564817939|FG002|Part A|Disease Progression|2|||
156471035|NCT02488408|564817940|FG003|Part A|Disease Progression|3|||
156471036|NCT02488408|564817941|FG004|Part A|Disease Progression|4|||
156471037|NCT02488408|564817942|FG005|Part A|Disease Progression|0|||
156471038|NCT02488408|564817943|FG006|Part A|Disease Progression|0|||
156471039|NCT02488408|564817944|FG007|Part A|Disease Progression|0|||
156471040|NCT02488408|564817945|FG008|Part A|Disease Progression|0|||
156471041|NCT02488408|564817946|FG009|Part A|Disease Progression|0|||
156471042|NCT02488408|564817937|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
156471043|NCT02488408|564817938|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
156471044|NCT02488408|564817939|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
156471045|NCT02488408|564817940|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
156342086|NCT01397708|564350387|FG002|Overall Study|Death|1|||
156342087|NCT01397708|564350388|FG003|Overall Study|Death|1|||
156342088|NCT01397708|564350389|FG004|Overall Study|Death|0|||
156342089|NCT01397708|564350390|FG005|Overall Study|Death|0|||
156471046|NCT02488408|564817941|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
156471047|NCT02488408|564817942|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
156471048|NCT02488408|564817943|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
156471049|NCT02488408|564817944|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
156471050|NCT02488408|564817945|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
156471051|NCT02488408|564817946|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
156471052|NCT02488408|564817937|FG000|Part A|Investigator Decision|0|||
156471053|NCT02488408|564817938|FG001|Part A|Investigator Decision|1|||
156471054|NCT02488408|564817939|FG002|Part A|Investigator Decision|1|||
156471055|NCT02488408|564817940|FG003|Part A|Investigator Decision|0|||
156471056|NCT02488408|564817941|FG004|Part A|Investigator Decision|0|||
156471057|NCT02488408|564817942|FG005|Part A|Investigator Decision|0|||
156471058|NCT02488408|564817943|FG006|Part A|Investigator Decision|0|||
156471059|NCT02488408|564817944|FG007|Part A|Investigator Decision|0|||
156471060|NCT02488408|564817945|FG008|Part A|Investigator Decision|0|||
156471061|NCT02488408|564817946|FG009|Part A|Investigator Decision|0|||
156471062|NCT02488408|564817937|FG000|Part A|Withdrawal by Subject|0|||
156471063|NCT02488408|564817938|FG001|Part A|Withdrawal by Subject|0|||
156471064|NCT02488408|564817939|FG002|Part A|Withdrawal by Subject|2|||
156471065|NCT02488408|564817940|FG003|Part A|Withdrawal by Subject|0|||
156471066|NCT02488408|564817941|FG004|Part A|Withdrawal by Subject|0|||
156471067|NCT02488408|564817942|FG005|Part A|Withdrawal by Subject|0|||
156471068|NCT02488408|564817943|FG006|Part A|Withdrawal by Subject|0|||
156471069|NCT02488408|564817944|FG007|Part A|Withdrawal by Subject|0|||
156342090|NCT01397708|564350391|FG006|Overall Study|Death|0|||
156342091|NCT01397708|564350392|FG007|Overall Study|Death|0|||
156342092|NCT01397708|564350385|FG000|Overall Study|Lost to Follow-up|0|||
156342093|NCT01397708|564350386|FG001|Overall Study|Lost to Follow-up|0|||
156342094|NCT01397708|564350387|FG002|Overall Study|Lost to Follow-up|0|||
156342095|NCT01397708|564350388|FG003|Overall Study|Lost to Follow-up|0|||
156342096|NCT01397708|564350389|FG004|Overall Study|Lost to Follow-up|1|||
156342097|NCT01397708|564350390|FG005|Overall Study|Lost to Follow-up|0|||
156342098|NCT01397708|564350391|FG006|Overall Study|Lost to Follow-up|0|||
156342099|NCT01397708|564350392|FG007|Overall Study|Lost to Follow-up|0|||
156342100|NCT01397708|564350385|FG000|Overall Study|Other|0|||
156342101|NCT01397708|564350386|FG001|Overall Study|Other|0|||
156342102|NCT01397708|564350387|FG002|Overall Study|Other|0|||
156342103|NCT01397708|564350388|FG003|Overall Study|Other|0|||
156471070|NCT02488408|564817945|FG008|Part A|Withdrawal by Subject|0|||
156471071|NCT02488408|564817946|FG009|Part A|Withdrawal by Subject|0|||
156471072|NCT02488408|564817937|FG000|Part A|Other|1|||
156342104|NCT01397708|564350389|FG004|Overall Study|Other|0|||
156342105|NCT01397708|564350390|FG005|Overall Study|Other|0|||
156342106|NCT01397708|564350391|FG006|Overall Study|Other|1|||
156342107|NCT01397708|564350392|FG007|Overall Study|Other|0|||
156342108|NCT04524689|564350395|FG000|Overall Study|Withdrawal by Subject|1|||
156342109|NCT04524689|564350396|FG001|Overall Study|Withdrawal by Subject|1|||
156342110|NCT04524689|564350397|FG002|Overall Study|Withdrawal by Subject|0|||
156342111|NCT04524689|564350398|FG003|Overall Study|Withdrawal by Subject|0|||
156342112|NCT04524689|564350399|FG004|Overall Study|Withdrawal by Subject|2|||
156342113|NCT04524689|564350400|FG005|Overall Study|Withdrawal by Subject|0|||
156342114|NCT04524689|564350395|FG000|Overall Study|Study terminated by Sponsor|6|||
156342115|NCT04524689|564350396|FG001|Overall Study|Study terminated by Sponsor|0|||
156342116|NCT04524689|564350397|FG002|Overall Study|Study terminated by Sponsor|1|||
156342117|NCT04524689|564350398|FG003|Overall Study|Study terminated by Sponsor|0|||
156342118|NCT04524689|564350399|FG004|Overall Study|Study terminated by Sponsor|4|||
156471073|NCT02488408|564817938|FG001|Part A|Other|0|||
156471074|NCT02488408|564817939|FG002|Part A|Other|0|||
156342119|NCT04524689|564350400|FG005|Overall Study|Study terminated by Sponsor|0|||
156471075|NCT02488408|564817940|FG003|Part A|Other|0|||
156342120|NCT04524689|564350395|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
156342121|NCT04524689|564350396|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
156342122|NCT04524689|564350397|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
156342123|NCT04524689|564350398|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
156342124|NCT04524689|564350399|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
156342125|NCT04524689|564350400|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
156342126|NCT02513394|564350403|FG000|Overall Study|Withdrawal by Subject|11|||
156471076|NCT02488408|564817941|FG004|Part A|Other|0|||
156471077|NCT02488408|564817942|FG005|Part A|Other|0|||
156471078|NCT02488408|564817943|FG006|Part A|Other|0|||
156471079|NCT02488408|564817944|FG007|Part A|Other|0|||
156471080|NCT02488408|564817945|FG008|Part A|Other|0|||
156471081|NCT02488408|564817946|FG009|Part A|Other|0|||
156471082|NCT02488408|564817937|FG000|Part B|Adverse Event|0|||
156471083|NCT02488408|564817938|FG001|Part B|Adverse Event|0|||
156471084|NCT02488408|564817939|FG002|Part B|Adverse Event|0|||
156471085|NCT02488408|564817940|FG003|Part B|Adverse Event|0|||
156471086|NCT02488408|564817941|FG004|Part B|Adverse Event|0|||
156850292|NCT01052077|566203177|FG000|Phase B|Withdrawal by Subject|0|||
156850293|NCT01052077|566203178|FG001|Phase B|Withdrawal by Subject|0|||
156850294|NCT01052077|566203179|FG002|Phase B|Withdrawal by Subject|5|||
156850295|NCT01052077|566203180|FG003|Phase B|Withdrawal by Subject|0|||
156850296|NCT01052077|566203177|FG000|Phase B|Protocol Deviation|0|||
156850297|NCT01052077|566203178|FG001|Phase B|Protocol Deviation|3|||
156850298|NCT01052077|566203179|FG002|Phase B|Protocol Deviation|4|||
156850299|NCT01052077|566203180|FG003|Phase B|Protocol Deviation|0|||
156850300|NCT01052077|566203177|FG000|Phase B|Lack of Efficacy|0|||
156850301|NCT01052077|566203178|FG001|Phase B|Lack of Efficacy|1|||
156850302|NCT01052077|566203179|FG002|Phase B|Lack of Efficacy|0|||
156850303|NCT01052077|566203180|FG003|Phase B|Lack of Efficacy|0|||
156850304|NCT01052077|566203177|FG000|Phase A+|Lost to Follow-up|0|||
156850305|NCT01052077|566203178|FG001|Phase A+|Lost to Follow-up|0|||
156850306|NCT01052077|566203179|FG002|Phase A+|Lost to Follow-up|0|||
156850307|NCT01052077|566203180|FG003|Phase A+|Lost to Follow-up|8|||
156850308|NCT01052077|566203177|FG000|Phase A+|Adverse Event|0|||
156850309|NCT01052077|566203178|FG001|Phase A+|Adverse Event|0|||
156850310|NCT01052077|566203179|FG002|Phase A+|Adverse Event|0|||
156850311|NCT01052077|566203180|FG003|Phase A+|Adverse Event|4|||
156850312|NCT01052077|566203177|FG000|Phase A+|Met Withdrawal Criteria|0|||
156850313|NCT01052077|566203178|FG001|Phase A+|Met Withdrawal Criteria|0|||
156850314|NCT01052077|566203179|FG002|Phase A+|Met Withdrawal Criteria|0|||
156850315|NCT01052077|566203180|FG003|Phase A+|Met Withdrawal Criteria|2|||
156850316|NCT01052077|566203177|FG000|Phase A+|Withdrawal by Subject|0|||
156850317|NCT01052077|566203178|FG001|Phase A+|Withdrawal by Subject|0|||
156850318|NCT01052077|566203179|FG002|Phase A+|Withdrawal by Subject|0|||
156850319|NCT01052077|566203180|FG003|Phase A+|Withdrawal by Subject|7|||
156850320|NCT01099397|566203184|FG000|Overall Study|Lost to Follow-up|4|||
156850321|NCT01099397|566203184|FG000|Overall Study|Protocol Violation|4|||
156850322|NCT01099397|566203184|FG000|Overall Study|Withdrawal by Subject|5|||
156850323|NCT02363959|566203185|FG000|Overall Study|Medical instability|1|||
156850324|NCT02363959|566203186|FG001|Overall Study|Medical instability|0|||
156850325|NCT00003199|566203188|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
156850326|NCT00003199|566203188|FG000|Overall Study|Lack of insurance clearance|2|||
156850327|NCT00003199|566203188|FG000|Overall Study|Screen fail|15|||
156850328|NCT00940498|566203189|FG000|Overall Study|Death|2|||
156850329|NCT00940498|566203190|FG001|Overall Study|Death|0|||
156850330|NCT00940498|566203191|FG002|Overall Study|Death|0|||
156850331|NCT00940498|566203192|FG003|Overall Study|Death|1|||
156850332|NCT00940498|566203193|FG004|Overall Study|Death|5|||
156850333|NCT00940498|566203194|FG005|Overall Study|Death|0|||
156850334|NCT00940498|566203195|FG006|Overall Study|Death|1|||
156850335|NCT00940498|566203196|FG007|Overall Study|Death|0|||
156850336|NCT00940498|566203189|FG000|Overall Study|Lost to Follow-up|1|||
156850337|NCT00940498|566203190|FG001|Overall Study|Lost to Follow-up|1|||
156850338|NCT00940498|566203191|FG002|Overall Study|Lost to Follow-up|2|||
156850339|NCT00940498|566203192|FG003|Overall Study|Lost to Follow-up|0|||
156850340|NCT00940498|566203193|FG004|Overall Study|Lost to Follow-up|1|||
156850341|NCT00940498|566203194|FG005|Overall Study|Lost to Follow-up|0|||
156850342|NCT00940498|566203195|FG006|Overall Study|Lost to Follow-up|0|||
156850343|NCT00940498|566203196|FG007|Overall Study|Lost to Follow-up|1|||
156850344|NCT00940498|566203189|FG000|Overall Study|Disease Progression|0|||
156850345|NCT00940498|566203190|FG001|Overall Study|Disease Progression|0|||
156850346|NCT00940498|566203191|FG002|Overall Study|Disease Progression|1|||
156850347|NCT00940498|566203192|FG003|Overall Study|Disease Progression|1|||
156850348|NCT00940498|566203193|FG004|Overall Study|Disease Progression|0|||
156850349|NCT00940498|566203194|FG005|Overall Study|Disease Progression|1|||
156850350|NCT00940498|566203195|FG006|Overall Study|Disease Progression|0|||
156850351|NCT00940498|566203196|FG007|Overall Study|Disease Progression|0|||
156850352|NCT00940498|566203189|FG000|Overall Study|Physician Decision|0|||
156471087|NCT02488408|564817942|FG005|Part B|Adverse Event|2|||
156471088|NCT02488408|564817943|FG006|Part B|Adverse Event|2|||
156471089|NCT02488408|564817944|FG007|Part B|Adverse Event|7|||
156850353|NCT00940498|566203190|FG001|Overall Study|Physician Decision|0|||
156850354|NCT00940498|566203191|FG002|Overall Study|Physician Decision|0|||
156850355|NCT00940498|566203192|FG003|Overall Study|Physician Decision|0|||
156850356|NCT00940498|566203193|FG004|Overall Study|Physician Decision|2|||
156850357|NCT00940498|566203194|FG005|Overall Study|Physician Decision|0|||
156850358|NCT00940498|566203195|FG006|Overall Study|Physician Decision|0|||
156850359|NCT00940498|566203196|FG007|Overall Study|Physician Decision|0|||
156850360|NCT00940498|566203189|FG000|Overall Study|Not treated due to disease related pain|0|||
156850361|NCT00940498|566203190|FG001|Overall Study|Not treated due to disease related pain|0|||
156850362|NCT00940498|566203191|FG002|Overall Study|Not treated due to disease related pain|0|||
156471090|NCT02488408|564817945|FG008|Part B|Adverse Event|2|||
156850363|NCT00940498|566203192|FG003|Overall Study|Not treated due to disease related pain|0|||
156850364|NCT00940498|566203193|FG004|Overall Study|Not treated due to disease related pain|1|||
156850365|NCT00940498|566203194|FG005|Overall Study|Not treated due to disease related pain|0|||
156850366|NCT00940498|566203195|FG006|Overall Study|Not treated due to disease related pain|0|||
156850367|NCT00940498|566203196|FG007|Overall Study|Not treated due to disease related pain|0|||
156471091|NCT02488408|564817946|FG009|Part B|Adverse Event|2|||
156471092|NCT02488408|564817937|FG000|Part B|Death|0|||
156471093|NCT02488408|564817938|FG001|Part B|Death|0|||
156471094|NCT02488408|564817939|FG002|Part B|Death|0|||
156471095|NCT02488408|564817940|FG003|Part B|Death|0|||
156471096|NCT02488408|564817941|FG004|Part B|Death|0|||
156471097|NCT02488408|564817942|FG005|Part B|Death|3|||
156471098|NCT02488408|564817943|FG006|Part B|Death|1|||
156471099|NCT02488408|564817944|FG007|Part B|Death|2|||
156471100|NCT02488408|564817945|FG008|Part B|Death|2|||
156471101|NCT02488408|564817946|FG009|Part B|Death|2|||
156471102|NCT02488408|564817937|FG000|Part B|Death due to Disease Progression|0|||
156471103|NCT02488408|564817938|FG001|Part B|Death due to Disease Progression|0|||
156471104|NCT02488408|564817939|FG002|Part B|Death due to Disease Progression|0|||
156471105|NCT02488408|564817940|FG003|Part B|Death due to Disease Progression|0|||
156471106|NCT02488408|564817941|FG004|Part B|Death due to Disease Progression|0|||
156471107|NCT02488408|564817942|FG005|Part B|Death due to Disease Progression|2|||
156471108|NCT02488408|564817943|FG006|Part B|Death due to Disease Progression|2|||
156471109|NCT02488408|564817944|FG007|Part B|Death due to Disease Progression|1|||
156471110|NCT02488408|564817945|FG008|Part B|Death due to Disease Progression|1|||
156850368|NCT02709330|566203197|FG000|Overall Study|Death|5|||
156850369|NCT02709330|566203198|FG001|Overall Study|Death|0|||
156850370|NCT02709330|566203197|FG000|Overall Study|Lost to Follow-up|2|||
156850371|NCT02709330|566203198|FG001|Overall Study|Lost to Follow-up|0|||
156850372|NCT02709330|566203197|FG000|Overall Study|Physician Decision|2|||
156850373|NCT02709330|566203198|FG001|Overall Study|Physician Decision|0|||
156850374|NCT02709330|566203197|FG000|Overall Study|Withdrawal by Subject|4|||
156471111|NCT02488408|564817946|FG009|Part B|Death due to Disease Progression|1|||
156471112|NCT02488408|564817937|FG000|Part B|Disease Progression|0|||
156471113|NCT02488408|564817938|FG001|Part B|Disease Progression|0|||
156471114|NCT02488408|564817939|FG002|Part B|Disease Progression|0|||
156471115|NCT02488408|564817940|FG003|Part B|Disease Progression|0|||
156471116|NCT02488408|564817941|FG004|Part B|Disease Progression|0|||
156471117|NCT02488408|564817942|FG005|Part B|Disease Progression|6|||
156471118|NCT02488408|564817943|FG006|Part B|Disease Progression|9|||
156471119|NCT02488408|564817944|FG007|Part B|Disease Progression|7|||
156471120|NCT02488408|564817945|FG008|Part B|Disease Progression|9|||
156471121|NCT02488408|564817946|FG009|Part B|Disease Progression|11|||
156471122|NCT02488408|564817937|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
156471123|NCT02488408|564817938|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
156471124|NCT02488408|564817939|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
156471125|NCT02488408|564817940|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
156471126|NCT02488408|564817941|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
156471127|NCT02488408|564817942|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
156471128|NCT02488408|564817943|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
156471129|NCT02488408|564817944|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
156471130|NCT02488408|564817945|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
156471131|NCT02488408|564817946|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
156471132|NCT02488408|564817937|FG000|Part B|Investigator Decision|0|||
156471133|NCT02488408|564817938|FG001|Part B|Investigator Decision|0|||
156471134|NCT02488408|564817939|FG002|Part B|Investigator Decision|0|||
156471135|NCT02488408|564817940|FG003|Part B|Investigator Decision|0|||
156471136|NCT02488408|564817941|FG004|Part B|Investigator Decision|0|||
156471137|NCT02488408|564817942|FG005|Part B|Investigator Decision|0|||
156471138|NCT02488408|564817943|FG006|Part B|Investigator Decision|1|||
156471139|NCT02488408|564817944|FG007|Part B|Investigator Decision|0|||
156471140|NCT02488408|564817945|FG008|Part B|Investigator Decision|2|||
156471141|NCT02488408|564817946|FG009|Part B|Investigator Decision|1|||
156850375|NCT02709330|566203198|FG001|Overall Study|Withdrawal by Subject|0|||
156850376|NCT00859547|566204521|FG000|Overall Study|Lost to Follow-up|1|||
156850377|NCT00859547|566204521|FG000|Overall Study|Parent withdrew consent|1|||
156850378|NCT01473732|566204522|FG000|Overall Study|Adverse Event|1|||
156850379|NCT01473732|566204523|FG001|Overall Study|Adverse Event|0|||
156471142|NCT00719888|564817947|FG000|Overall Study|Death|24|||
156471143|NCT00719888|564817948|FG001|Overall Study|Death|9|||
156471144|NCT00719888|564817947|FG000|Overall Study|Relapse|8|||
156471145|NCT00719888|564817948|FG001|Overall Study|Relapse|3|||
156471146|NCT00719888|564817947|FG000|Overall Study|Physician Decision|1|||
156471147|NCT00719888|564817948|FG001|Overall Study|Physician Decision|0|||
156471148|NCT00719888|564817947|FG000|Overall Study|Withdrawal by Subject|1|||
156471149|NCT00719888|564817948|FG001|Overall Study|Withdrawal by Subject|0|||
156471150|NCT05886777|564817949|FG000|Overall Study|Lost to Follow-up|1|||
156471151|NCT05886777|564817950|FG001|Overall Study|Lost to Follow-up|0|||
156471152|NCT05886777|564817951|FG002|Overall Study|Lost to Follow-up|2|||
156850380|NCT01473732|566204522|FG000|Overall Study|Death|1|||
156471153|NCT05886777|564817952|FG003|Overall Study|Lost to Follow-up|1|||
156471154|NCT05886777|564817953|FG004|Overall Study|Lost to Follow-up|0|||
156471155|NCT05886777|564817954|FG005|Overall Study|Lost to Follow-up|2|||
156850381|NCT01473732|566204523|FG001|Overall Study|Death|0|||
156850382|NCT00997035|566204527|FG000|3-week Followup Visit|Lost to Follow-up|9|||
156850383|NCT00997035|566204528|FG001|3-week Followup Visit|Lost to Follow-up|6|||
156850384|NCT00997035|566204527|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
156850385|NCT00997035|566204528|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
156850386|NCT02471014|566204529|FG000|Overall Study|Lost to Follow-up|2|||
156850387|NCT02471014|566204530|FG001|Overall Study|Lost to Follow-up|2|||
156850388|NCT04685798|566204531|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
156850389|NCT00824473|566204537|FG000|Overall Study|Adverse Event|4|||
156850390|NCT00824473|566204538|FG001|Overall Study|Adverse Event|5|||
156850391|NCT00824473|566204537|FG000|Overall Study|Lack of Efficacy|2|||
156850392|NCT00824473|566204538|FG001|Overall Study|Lack of Efficacy|2|||
156850393|NCT00824473|566204537|FG000|Overall Study|Protocol Violation|2|||
156850394|NCT00824473|566204538|FG001|Overall Study|Protocol Violation|0|||
156850395|NCT00824473|566204537|FG000|Overall Study|Non-Compliance|4|||
156850396|NCT00824473|566204538|FG001|Overall Study|Non-Compliance|2|||
156850397|NCT00824473|566204537|FG000|Overall Study|Withdrawal by Subject|2|||
156850398|NCT00824473|566204538|FG001|Overall Study|Withdrawal by Subject|3|||
156471156|NCT05886777|564817955|FG006|Overall Study|Lost to Follow-up|0|||
156471157|NCT05886777|564817949|FG000|Overall Study|Other|0|||
156471158|NCT05886777|564817950|FG001|Overall Study|Other|2|||
156471159|NCT05886777|564817951|FG002|Overall Study|Other|1|||
156471160|NCT05886777|564817952|FG003|Overall Study|Other|0|||
156471161|NCT05886777|564817953|FG004|Overall Study|Other|0|||
156471162|NCT05886777|564817954|FG005|Overall Study|Other|0|||
156471163|NCT05886777|564817955|FG006|Overall Study|Other|0|||
156471164|NCT05886777|564817949|FG000|Overall Study|Withdrawal by Subject|1|||
156471165|NCT05886777|564817950|FG001|Overall Study|Withdrawal by Subject|0|||
156471166|NCT05886777|564817951|FG002|Overall Study|Withdrawal by Subject|1|||
156471167|NCT05886777|564817952|FG003|Overall Study|Withdrawal by Subject|4|||
156471168|NCT05886777|564817953|FG004|Overall Study|Withdrawal by Subject|3|||
156471169|NCT05886777|564817954|FG005|Overall Study|Withdrawal by Subject|1|||
156850399|NCT00824473|566204537|FG000|Overall Study|Other|1|||
156850400|NCT00824473|566204538|FG001|Overall Study|Other|1|||
156850401|NCT03594773|566204540|FG000|Overall Study|Withdrawal by Subject|3|||
156850402|NCT03594773|566204541|FG001|Overall Study|Withdrawal by Subject|2|||
156850403|NCT03594773|566204540|FG000|Overall Study|Lost to Follow-up|3|||
156850404|NCT03594773|566204541|FG001|Overall Study|Lost to Follow-up|4|||
156850405|NCT02640547|566204542|FG000|Overall Study|Failure to Return|1|||
156850406|NCT02640547|566204542|FG000|Overall Study|Withdrawal by Subject|1|||
156471170|NCT05886777|564817955|FG006|Overall Study|Withdrawal by Subject|1|||
156471171|NCT05886777|564817949|FG000|Overall Study|Protocol Violation|0|||
156471172|NCT05886777|564817950|FG001|Overall Study|Protocol Violation|0|||
156471173|NCT05886777|564817951|FG002|Overall Study|Protocol Violation|1|||
156471174|NCT05886777|564817952|FG003|Overall Study|Protocol Violation|0|||
156471175|NCT05886777|564817953|FG004|Overall Study|Protocol Violation|0|||
156471176|NCT05886777|564817954|FG005|Overall Study|Protocol Violation|0|||
156471177|NCT05886777|564817955|FG006|Overall Study|Protocol Violation|0|||
156471178|NCT05886777|564817949|FG000|Overall Study|No longer met eligibility criteria|0|||
156471179|NCT05886777|564817950|FG001|Overall Study|No longer met eligibility criteria|1|||
156471180|NCT05886777|564817951|FG002|Overall Study|No longer met eligibility criteria|0|||
156471181|NCT05886777|564817952|FG003|Overall Study|No longer met eligibility criteria|0|||
156471182|NCT05886777|564817953|FG004|Overall Study|No longer met eligibility criteria|0|||
156471183|NCT05886777|564817954|FG005|Overall Study|No longer met eligibility criteria|0|||
156471184|NCT05886777|564817955|FG006|Overall Study|No longer met eligibility criteria|0|||
156471185|NCT03773107|564817956|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
156471186|NCT03773107|564817957|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
156471187|NCT03773107|564817958|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
156471188|NCT03773107|564817959|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
156471189|NCT07204444|564817961|FG000|Overall Study|Medical/Hospitalization|6|||
156471190|NCT07204444|564817962|FG001|Overall Study|Medical/Hospitalization|9|||
156471191|NCT07204444|564817963|FG002|Overall Study|Medical/Hospitalization|6|||
156471192|NCT07204444|564817961|FG000|Overall Study|Treatment Provider Issue|1|||
156471193|NCT07204444|564817962|FG001|Overall Study|Treatment Provider Issue|3|||
156471194|NCT07204444|564817963|FG002|Overall Study|Treatment Provider Issue|0|||
156471195|NCT07204444|564817961|FG000|Overall Study|Withdrawal by Subject|11|||
156471196|NCT07204444|564817962|FG001|Overall Study|Withdrawal by Subject|5|||
156471197|NCT07204444|564817963|FG002|Overall Study|Withdrawal by Subject|5|||
156471198|NCT07204444|564817961|FG000|Overall Study|Death|3|||
156471199|NCT07204444|564817962|FG001|Overall Study|Death|6|||
156471200|NCT07204444|564817963|FG002|Overall Study|Death|1|||
156471201|NCT07204444|564817961|FG000|Overall Study|Unable To Reach|29|||
156471202|NCT07204444|564817962|FG001|Overall Study|Unable To Reach|26|||
156471203|NCT07204444|564817963|FG002|Overall Study|Unable To Reach|17|||
156471204|NCT07204444|564817961|FG000|Overall Study|Protocol Deviation|3|||
156471205|NCT07204444|564817962|FG001|Overall Study|Protocol Deviation|2|||
156471206|NCT07204444|564817963|FG002|Overall Study|Protocol Deviation|0|||
156471207|NCT05199571|564819503|FG000|Treatment Period|Participant decision|3|||
156471208|NCT05199571|564819503|FG000|Treatment Period|Physician Decision|1|||
156471209|NCT05199571|564819503|FG000|Post-treatment Follow up Period|Participant decision|3|||
156471210|NCT05029284|564819506|FG000|Overall Study|Lost to Follow-up|1|||
156471211|NCT02972034|564819507|FG000|Overall Study|Death|11|||
156471212|NCT02972034|564819508|FG001|Overall Study|Death|1|||
156471213|NCT02972034|564819509|FG002|Overall Study|Death|3|||
156471214|NCT02972034|564819510|FG003|Overall Study|Death|3|||
156471215|NCT02972034|564819511|FG004|Overall Study|Death|2|||
156471216|NCT02972034|564819512|FG005|Overall Study|Death|2|||
156471217|NCT02972034|564819513|FG006|Overall Study|Death|3|||
156471218|NCT02972034|564819514|FG007|Overall Study|Death|4|||
156471219|NCT02972034|564819515|FG008|Overall Study|Death|8|||
156471220|NCT02972034|564819516|FG009|Overall Study|Death|11|||
156471221|NCT02972034|564819517|FG010|Overall Study|Death|3|||
156471222|NCT02972034|564819518|FG011|Overall Study|Death|2|||
156471223|NCT02972034|564819519|FG012|Overall Study|Death|11|||
156471224|NCT02972034|564819520|FG013|Overall Study|Death|10|||
156471225|NCT02972034|564819521|FG014|Overall Study|Death|9|||
156471226|NCT02972034|564819507|FG000|Overall Study|Lost to Follow-up|0|||
156471227|NCT02972034|564819508|FG001|Overall Study|Lost to Follow-up|0|||
156471228|NCT02972034|564819509|FG002|Overall Study|Lost to Follow-up|0|||
156471229|NCT02972034|564819510|FG003|Overall Study|Lost to Follow-up|0|||
156850407|NCT02640547|566204542|FG000|Overall Study|Death|6|||
156850408|NCT02640547|566204542|FG000|Overall Study|Miscellaneous|3|||
156471230|NCT02972034|564819511|FG004|Overall Study|Lost to Follow-up|1|||
156471231|NCT02972034|564819512|FG005|Overall Study|Lost to Follow-up|0|||
156471232|NCT02972034|564819513|FG006|Overall Study|Lost to Follow-up|0|||
156471233|NCT02972034|564819514|FG007|Overall Study|Lost to Follow-up|1|||
156471234|NCT02972034|564819515|FG008|Overall Study|Lost to Follow-up|0|||
156471235|NCT02972034|564819516|FG009|Overall Study|Lost to Follow-up|0|||
156471236|NCT02972034|564819517|FG010|Overall Study|Lost to Follow-up|0|||
156471237|NCT02972034|564819518|FG011|Overall Study|Lost to Follow-up|0|||
156471238|NCT02972034|564819519|FG012|Overall Study|Lost to Follow-up|0|||
156471239|NCT02972034|564819520|FG013|Overall Study|Lost to Follow-up|0|||
156471240|NCT02972034|564819521|FG014|Overall Study|Lost to Follow-up|1|||
156471241|NCT02972034|564819507|FG000|Overall Study|Physician Decision|0|||
156471242|NCT02972034|564819508|FG001|Overall Study|Physician Decision|0|||
156471243|NCT02972034|564819509|FG002|Overall Study|Physician Decision|0|||
156471244|NCT02972034|564819510|FG003|Overall Study|Physician Decision|0|||
156471245|NCT02972034|564819511|FG004|Overall Study|Physician Decision|0|||
156471246|NCT02972034|564819512|FG005|Overall Study|Physician Decision|0|||
156471247|NCT02972034|564819513|FG006|Overall Study|Physician Decision|0|||
156471248|NCT02972034|564819514|FG007|Overall Study|Physician Decision|1|||
156471249|NCT02972034|564819515|FG008|Overall Study|Physician Decision|0|||
156471250|NCT02972034|564819516|FG009|Overall Study|Physician Decision|0|||
156471251|NCT02972034|564819517|FG010|Overall Study|Physician Decision|1|||
156471252|NCT02972034|564819518|FG011|Overall Study|Physician Decision|0|||
156471253|NCT02972034|564819519|FG012|Overall Study|Physician Decision|0|||
156471254|NCT02972034|564819520|FG013|Overall Study|Physician Decision|0|||
156471255|NCT02972034|564819521|FG014|Overall Study|Physician Decision|0|||
156471256|NCT02972034|564819507|FG000|Overall Study|Sponsor Decision|0|||
156471257|NCT02972034|564819508|FG001|Overall Study|Sponsor Decision|0|||
156850409|NCT00193206|566204543|FG000|Preoperative Therapy|Lack of Efficacy|2|||
156471258|NCT02972034|564819509|FG002|Overall Study|Sponsor Decision|0|||
156471259|NCT02972034|564819510|FG003|Overall Study|Sponsor Decision|1|||
156471260|NCT02972034|564819511|FG004|Overall Study|Sponsor Decision|0|||
156471261|NCT02972034|564819512|FG005|Overall Study|Sponsor Decision|0|||
156471262|NCT02972034|564819513|FG006|Overall Study|Sponsor Decision|1|||
156471263|NCT02972034|564819514|FG007|Overall Study|Sponsor Decision|1|||
156471264|NCT02972034|564819515|FG008|Overall Study|Sponsor Decision|1|||
156471265|NCT02972034|564819516|FG009|Overall Study|Sponsor Decision|2|||
156471266|NCT02972034|564819517|FG010|Overall Study|Sponsor Decision|2|||
156471267|NCT02972034|564819518|FG011|Overall Study|Sponsor Decision|0|||
156471268|NCT02972034|564819519|FG012|Overall Study|Sponsor Decision|1|||
156471269|NCT02972034|564819520|FG013|Overall Study|Sponsor Decision|0|||
156471270|NCT02972034|564819521|FG014|Overall Study|Sponsor Decision|1|||
156471271|NCT02972034|564819507|FG000|Overall Study|Withdrawal by Subject|3|||
156471272|NCT02972034|564819508|FG001|Overall Study|Withdrawal by Subject|0|||
156471273|NCT02972034|564819509|FG002|Overall Study|Withdrawal by Subject|0|||
156471274|NCT02972034|564819510|FG003|Overall Study|Withdrawal by Subject|0|||
156471275|NCT02972034|564819511|FG004|Overall Study|Withdrawal by Subject|1|||
156471276|NCT02972034|564819512|FG005|Overall Study|Withdrawal by Subject|1|||
156471277|NCT02972034|564819513|FG006|Overall Study|Withdrawal by Subject|0|||
156471278|NCT02972034|564819514|FG007|Overall Study|Withdrawal by Subject|0|||
156471279|NCT02972034|564819515|FG008|Overall Study|Withdrawal by Subject|1|||
156471280|NCT02972034|564819516|FG009|Overall Study|Withdrawal by Subject|1|||
156471281|NCT02972034|564819517|FG010|Overall Study|Withdrawal by Subject|2|||
156471282|NCT02972034|564819518|FG011|Overall Study|Withdrawal by Subject|1|||
156471283|NCT02972034|564819519|FG012|Overall Study|Withdrawal by Subject|1|||
156471284|NCT02972034|564819520|FG013|Overall Study|Withdrawal by Subject|1|||
156471285|NCT02972034|564819521|FG014|Overall Study|Withdrawal by Subject|0|||
156471286|NCT02972034|564819507|FG000|Overall Study|Screen Failure|0|||
156471287|NCT02972034|564819508|FG001|Overall Study|Screen Failure|0|||
156471288|NCT02972034|564819509|FG002|Overall Study|Screen Failure|0|||
156471289|NCT02972034|564819510|FG003|Overall Study|Screen Failure|0|||
156471290|NCT02972034|564819511|FG004|Overall Study|Screen Failure|0|||
156471291|NCT02972034|564819512|FG005|Overall Study|Screen Failure|0|||
156471292|NCT02972034|564819513|FG006|Overall Study|Screen Failure|0|||
156471293|NCT02972034|564819514|FG007|Overall Study|Screen Failure|0|||
156471294|NCT02972034|564819515|FG008|Overall Study|Screen Failure|0|||
156471295|NCT02972034|564819516|FG009|Overall Study|Screen Failure|0|||
156471296|NCT02972034|564819517|FG010|Overall Study|Screen Failure|0|||
156471297|NCT02972034|564819518|FG011|Overall Study|Screen Failure|0|||
156471298|NCT02972034|564819519|FG012|Overall Study|Screen Failure|1|||
156471299|NCT02972034|564819520|FG013|Overall Study|Screen Failure|0|||
156471300|NCT02972034|564819521|FG014|Overall Study|Screen Failure|0|||
156471301|NCT03861052|564819522|FG000|Overall Study|Adverse Event|1|||
156850410|NCT00193206|566204543|FG000|Preoperative Therapy|Adverse Event|2|||
156542139|NCT03462576|565077877|FG000|Overall Study|Device Malfunction|0|||
156850411|NCT00193206|566204543|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
156471302|NCT03861052|564819523|FG001|Overall Study|Adverse Event|1|||
156471303|NCT03861052|564819524|FG002|Overall Study|Adverse Event|2|||
156471304|NCT03861052|564819525|FG003|Overall Study|Adverse Event|4|||
156471305|NCT03861052|564819522|FG000|Overall Study|Lost to Follow-up|0|||
156471306|NCT03861052|564819523|FG001|Overall Study|Lost to Follow-up|0|||
156471307|NCT03861052|564819524|FG002|Overall Study|Lost to Follow-up|0|||
156471308|NCT03861052|564819525|FG003|Overall Study|Lost to Follow-up|1|||
156471309|NCT03861052|564819522|FG000|Overall Study|Physician Decision|0|||
156471310|NCT03861052|564819523|FG001|Overall Study|Physician Decision|1|||
156471311|NCT03861052|564819524|FG002|Overall Study|Physician Decision|0|||
156471312|NCT03861052|564819525|FG003|Overall Study|Physician Decision|0|||
156471313|NCT03861052|564819522|FG000|Overall Study|Withdrawal by Subject|2|||
156471314|NCT03861052|564819523|FG001|Overall Study|Withdrawal by Subject|5|||
156342127|NCT02513394|564350404|FG001|Overall Study|Withdrawal by Subject|23|||
156471315|NCT03861052|564819524|FG002|Overall Study|Withdrawal by Subject|3|||
156850412|NCT00193206|566204543|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
156850413|NCT00193206|566204543|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
156850414|NCT00193206|566204543|FG000|Postoperative Therapy|Physician Decision|3|||
156850415|NCT00193206|566204543|FG000|Postoperative Therapy|Intercurrent Illness|2|||
156850416|NCT00193206|566204543|FG000|Postoperative Therapy|Lack of Efficacy|1|||
156850417|NCT00193206|566204543|FG000|Postoperative Therapy|Protocol Violation|1|||
156850418|NCT01461707|566204550|FG000|Overall Study|Withdrawal by Subject|1|||
156850419|NCT01461707|566204551|FG001|Overall Study|Withdrawal by Subject|0|||
156850420|NCT00337207|566204554|FG000|Overall Study|Withdrawal by Subject|3|||
156850421|NCT00837213|566204555|FG000|Overall Study|Lost to Follow-up|3|||
156471316|NCT03861052|564819525|FG003|Overall Study|Withdrawal by Subject|0|||
156471317|NCT03861052|564819522|FG000|Overall Study|Relocation to other city|1|||
156471318|NCT03861052|564819523|FG001|Overall Study|Relocation to other city|0|||
156471319|NCT03861052|564819524|FG002|Overall Study|Relocation to other city|0|||
156471320|NCT03861052|564819525|FG003|Overall Study|Relocation to other city|0|||
156471321|NCT03009344|564819526|FG000|Overall Study|Lack of Efficacy|5|||
156471322|NCT03009344|564819526|FG000|Overall Study|Withdrawal by Subject|1|||
156471323|NCT03009344|564819526|FG000|Overall Study|Adverse Event|1|||
156471324|NCT00378898|564819527|FG000|Overall Study|Withdrawal by Subject|10|||
156471325|NCT00378898|564819528|FG001|Overall Study|Withdrawal by Subject|5|||
156471326|NCT00378898|564819527|FG000|Overall Study|Protocol Violation|1|||
156471327|NCT00378898|564819528|FG001|Overall Study|Protocol Violation|1|||
156471328|NCT03116464|564819532|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
156471329|NCT00454194|564819540|FG000|Overall Study|Adverse Event|7|||
156471330|NCT00454194|564819541|FG001|Overall Study|Adverse Event|2|||
156471331|NCT00454194|564819540|FG000|Overall Study|Withdrawal by Subject|12|||
156471332|NCT00454194|564819541|FG001|Overall Study|Withdrawal by Subject|8|||
156471333|NCT00454194|564819540|FG000|Overall Study|Other Medical Problems|1|||
156471334|NCT00454194|564819541|FG001|Overall Study|Other Medical Problems|2|||
156471335|NCT00454194|564819540|FG000|Overall Study|Other Unspecified Reason|2|||
156471336|NCT00454194|564819541|FG001|Overall Study|Other Unspecified Reason|2|||
156471337|NCT00229658|564819559|FG000|Overall Study|Administrative|2|||
156471338|NCT00229658|564819560|FG001|Overall Study|Administrative|1|||
156471339|NCT00229658|564819559|FG000|Overall Study|Investigator decision|13|||
156471340|NCT00229658|564819560|FG001|Overall Study|Investigator decision|10|||
156850422|NCT00837213|566204556|FG001|Overall Study|Lost to Follow-up|2|||
156850423|NCT00837213|566204555|FG000|Overall Study|Withdrawal by Subject|2|||
156850424|NCT00837213|566204556|FG001|Overall Study|Withdrawal by Subject|2|||
156850425|NCT00837213|566204555|FG000|Overall Study|not stated|1|||
156850426|NCT00837213|566204556|FG001|Overall Study|not stated|1|||
156850427|NCT01684202|566204558|FG000|Dose-escalation Period|Adverse Event|0|||
156850428|NCT01684202|566204559|FG001|Dose-escalation Period|Adverse Event|1|||
156850429|NCT01684202|566204560|FG002|Dose-escalation Period|Adverse Event|0|||
156850430|NCT01684202|566204561|FG003|Dose-escalation Period|Adverse Event|0|||
156850431|NCT01684202|566204558|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
156850432|NCT01684202|566204559|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
156850433|NCT01684202|566204560|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
156850434|NCT01684202|566204561|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
156850435|NCT01684202|566204558|FG000|Maintenance Period|Adverse Event|1|||
156850436|NCT01684202|566204559|FG001|Maintenance Period|Adverse Event|1|||
156850437|NCT01684202|566204560|FG002|Maintenance Period|Adverse Event|1|||
156850438|NCT01684202|566204561|FG003|Maintenance Period|Adverse Event|1|||
156342128|NCT02513394|564350403|FG000|Overall Study|Ineligible|1|||
156342129|NCT02513394|564350404|FG001|Overall Study|Ineligible|0|||
156850439|NCT01684202|566204558|FG000|Maintenance Period|Physician Decision|0|||
156342130|NCT05766423|564350405|FG000|Overall Study|Withdrawal by Subject|1|||
156542140|NCT03462576|565077878|FG001|Overall Study|Device Malfunction|0|||
156471341|NCT00229658|564819559|FG000|Overall Study|Other|80|||
156471342|NCT00229658|564819560|FG001|Overall Study|Other|60|||
156471343|NCT00229658|564819559|FG000|Overall Study|Lost to Follow-up|82|||
156471344|NCT00229658|564819560|FG001|Overall Study|Lost to Follow-up|55|||
156471345|NCT00229658|564819559|FG000|Overall Study|Serious Adverse Event|2|||
156542141|NCT03462576|565077879|FG002|Overall Study|Device Malfunction|1|||
156850440|NCT01684202|566204559|FG001|Maintenance Period|Physician Decision|1|||
156542142|NCT00715026|565077882|FG000|Overall Study|Withdrawal by Subject|5|||
156850441|NCT01684202|566204560|FG002|Maintenance Period|Physician Decision|0|||
156850442|NCT01684202|566204561|FG003|Maintenance Period|Physician Decision|0|||
156850443|NCT01684202|566204558|FG000|Maintenance Period|Withdrawal by Subject|0|||
156850444|NCT01684202|566204559|FG001|Maintenance Period|Withdrawal by Subject|1|||
156850445|NCT01684202|566204560|FG002|Maintenance Period|Withdrawal by Subject|0|||
156850446|NCT01684202|566204561|FG003|Maintenance Period|Withdrawal by Subject|0|||
156850447|NCT00191308|566204562|FG000|Overall Study|Adverse Event|1|||
156471346|NCT00229658|564819560|FG001|Overall Study|Serious Adverse Event|2|||
156471347|NCT00229658|564819559|FG000|Overall Study|Withdrawal of consent|46|||
156850448|NCT00466921|566204563|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
156850449|NCT00466921|566204563|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
156850450|NCT00466921|566204563|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
156850451|NCT00466921|566204563|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
156542143|NCT00715026|565077882|FG000|Overall Study|Lost to Follow-up|3|||
156542144|NCT00715026|565077882|FG000|Overall Study|Protocol Violation|1|||
156542145|NCT00715026|565077882|FG000|Overall Study|Surgery done on non-study consented hip|1|||
156542146|NCT00750737|565077890|FG000|Overall Study|Withdrawal by Subject|3|||
156850452|NCT00466921|566204563|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
156850453|NCT00466921|566204563|FG000|Follow up for a Minimum of 1 Year|Death|6|||
156850454|NCT00779025|566204564|FG000|Overall Study|Withdrawal by Subject|1|||
156850455|NCT03710642|566204565|FG000|Overall Study|Adverse Event|5|||
156850456|NCT03710642|566204566|FG001|Overall Study|Adverse Event|1|||
156850457|NCT03710642|566204565|FG000|Overall Study|non-site physician recommendation|1|||
156850458|NCT03710642|566204566|FG001|Overall Study|non-site physician recommendation|0|||
156850459|NCT03710642|566204565|FG000|Overall Study|Participant unwilling or unable to participate|1|||
156850460|NCT03710642|566204566|FG001|Overall Study|Participant unwilling or unable to participate|1|||
156342131|NCT05766423|564350406|FG001|Overall Study|Withdrawal by Subject|0|||
156542147|NCT00750737|565077891|FG001|Overall Study|Withdrawal by Subject|3|||
156542148|NCT00271596|565077892|FG000|Overall Study|Protocol Violation|1|||
156542149|NCT00271596|565077893|FG001|Overall Study|Protocol Violation|0|||
156542150|NCT00271596|565077892|FG000|Overall Study|Withdrawal by Subject|0|||
156542151|NCT00271596|565077893|FG001|Overall Study|Withdrawal by Subject|1|||
156542152|NCT00865904|565077897|FG000|Overall Study|Randomized but not Treated|2|||
156542153|NCT00865904|565077898|FG001|Overall Study|Randomized but not Treated|0|||
156542154|NCT00865904|565077899|FG002|Overall Study|Randomized but not Treated|0|||
156542155|NCT00865904|565077900|FG003|Overall Study|Randomized but not Treated|1|||
156542156|NCT00865904|565077901|FG004|Overall Study|Randomized but not Treated|1|||
156542157|NCT00589420|565077902|FG000|Overall Study|screen failure|1|||
156542158|NCT02973087|565077905|FG000|Overall Study|Withdrawal by Subject|2|||
156542159|NCT02973087|565077906|FG001|Overall Study|Withdrawal by Subject|1|||
156542160|NCT02973087|565077905|FG000|Overall Study|Adverse Event|1|||
156542161|NCT02973087|565077906|FG001|Overall Study|Adverse Event|0|||
156542162|NCT02973087|565077905|FG000|Overall Study|other|1|||
156542163|NCT02973087|565077906|FG001|Overall Study|other|1|||
156542164|NCT03302975|565077907|FG000|Overall Study|Lost to Follow-up|4|||
156542165|NCT01436084|565077908|FG000|Overall Study|Disease Progression|2|||
156542166|NCT01436084|565077908|FG000|Overall Study|Withdrawal by Subject|1|||
156542167|NCT01436084|565077908|FG000|Overall Study|Early Closure of Study|1|||
156542168|NCT00388973|565079254|FG000|Overall Study|Adverse Event|16|||
156542169|NCT00388973|565079255|FG001|Overall Study|Adverse Event|6|||
156850461|NCT03710642|566204565|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
156850462|NCT03710642|566204566|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
156850463|NCT03710642|566204565|FG000|Overall Study|NA-no code provided|1|||
156342132|NCT05766423|564350405|FG000|Overall Study|Consented, not scheduled|3|||
156342133|NCT05766423|564350406|FG001|Overall Study|Consented, not scheduled|5|||
156342134|NCT01664533|564352548|FG000|Overall Study|Death|42|||
156342135|NCT01664533|564352548|FG000|Overall Study|Lost to Follow-up|3|||
156342136|NCT01664533|564352548|FG000|Overall Study|Study termination|9|||
156342137|NCT01664533|564352548|FG000|Overall Study|Protocol Violation|3|||
156342138|NCT05255068|564352550|FG000|Overall Study|Lost to Follow-up|0|||
156342139|NCT05255068|564352551|FG001|Overall Study|Lost to Follow-up|1|||
156342140|NCT02871297|564352559|FG000|Overall Study|Adverse Event|34|||
156342141|NCT02871297|564352559|FG000|Overall Study|Lack of Efficacy|10|||
156342142|NCT02871297|564352559|FG000|Overall Study|Non-compliance with study drug|15|||
156342143|NCT02871297|564352559|FG000|Overall Study|Protocol Violation|3|||
156342144|NCT02871297|564352559|FG000|Overall Study|Withdrawal by Subject|20|||
156342145|NCT02871297|564352559|FG000|Overall Study|Lost to Follow-up|13|||
156342146|NCT02871297|564352559|FG000|Overall Study|Rolled over to 13546A|2|||
156342147|NCT02871297|564352559|FG000|Overall Study|Other than specified|39|||
156342148|NCT02966028|564352563|FG000|Overall Study|Adverse Event|7|||
156342149|NCT02966028|564352564|FG001|Overall Study|Adverse Event|13|||
156342150|NCT02966028|564352565|FG002|Overall Study|Adverse Event|10|||
156342151|NCT02966028|564352563|FG000|Overall Study|Physician Decision|1|||
156342152|NCT02966028|564352564|FG001|Overall Study|Physician Decision|0|||
156342153|NCT02966028|564352565|FG002|Overall Study|Physician Decision|2|||
156342154|NCT02966028|564352563|FG000|Overall Study|Withdrawal by Subject|7|||
156342155|NCT02966028|564352564|FG001|Overall Study|Withdrawal by Subject|5|||
156342156|NCT02966028|564352565|FG002|Overall Study|Withdrawal by Subject|5|||
156542170|NCT00388973|565079254|FG000|Overall Study|Lack of Efficacy|1|||
156542171|NCT00388973|565079255|FG001|Overall Study|Lack of Efficacy|12|||
156342157|NCT02966028|564352563|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
156342158|NCT02966028|564352564|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
156342159|NCT02966028|564352565|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
156342160|NCT04115839|564352566|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
156471348|NCT00229658|564819560|FG001|Overall Study|Withdrawal of consent|39|||
156471349|NCT00205179|564819561|FG000|Overall Study|Death|0|||
156471350|NCT00205179|564819562|FG001|Overall Study|Death|2|||
156850464|NCT03710642|566204566|FG001|Overall Study|NA-no code provided|0|||
156850465|NCT03710642|566204565|FG000|Overall Study|Withdrawal by Subject|1|||
156471351|NCT00205179|564819561|FG000|Overall Study|Physician Decision|1|||
156471352|NCT00205179|564819562|FG001|Overall Study|Physician Decision|1|||
156471353|NCT00205179|564819561|FG000|Overall Study|Adverse Event|1|||
156471354|NCT00205179|564819562|FG001|Overall Study|Adverse Event|1|||
156471355|NCT00463229|564819563|FG000|Overall Study|Lost to Follow-up|5|||
156471356|NCT00463229|564819564|FG001|Overall Study|Lost to Follow-up|7|||
156471357|NCT00463229|564819563|FG000|Overall Study|Death|4|||
156471358|NCT00463229|564819564|FG001|Overall Study|Death|3|||
156471359|NCT01700205|564819571|FG000|Overall Study|Withdrawal by Subject|13|||
156471360|NCT01700205|564819572|FG001|Overall Study|Withdrawal by Subject|13|||
156471361|NCT01700205|564819571|FG000|Overall Study|Protocol Violation|2|||
156471362|NCT01700205|564819572|FG001|Overall Study|Protocol Violation|2|||
156471363|NCT01728324|564819573|FG000|Termination of DBV|Adverse Event|14|||
156471364|NCT01728324|564819574|FG001|Termination of DBV|Adverse Event|13|||
156471365|NCT01728324|564819575|FG002|Termination of DBV|Adverse Event|4|||
156850466|NCT03710642|566204566|FG001|Overall Study|Withdrawal by Subject|0|||
156850467|NCT02741635|566204567|FG000|Overall Study|Withdrawal by Subject|1|||
156850468|NCT01427933|566204568|FG000|Overall Study|Withdrawal by Subject|5|||
156850469|NCT01427933|566204569|FG001|Overall Study|Withdrawal by Subject|8|||
156850470|NCT01427933|566204568|FG000|Overall Study|Lost to Follow-up|1|||
156850471|NCT01427933|566204569|FG001|Overall Study|Lost to Follow-up|5|||
156850472|NCT01427933|566204568|FG000|Overall Study|Other|1|||
156850473|NCT01427933|566204569|FG001|Overall Study|Other|0|||
156471366|NCT01728324|564819573|FG000|Termination of DBV|Lack of Efficacy|14|||
156471367|NCT01728324|564819574|FG001|Termination of DBV|Lack of Efficacy|12|||
156471368|NCT01728324|564819575|FG002|Termination of DBV|Lack of Efficacy|8|||
156471369|NCT01728324|564819573|FG000|Termination of DBV|Withdrawal by Subject|9|||
156471370|NCT01728324|564819574|FG001|Termination of DBV|Withdrawal by Subject|6|||
156471371|NCT01728324|564819575|FG002|Termination of DBV|Withdrawal by Subject|2|||
156471372|NCT01728324|564819573|FG000|Termination of DBV|Other than stated|1|||
156471373|NCT01728324|564819574|FG001|Termination of DBV|Other than stated|3|||
156471374|NCT01728324|564819575|FG002|Termination of DBV|Other than stated|0|||
156471375|NCT01728324|564819573|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
156471376|NCT01728324|564819574|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
156471377|NCT01728324|564819575|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
156471378|NCT01728324|564819573|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
156471379|NCT01728324|564819574|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
156471380|NCT01728324|564819575|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
156471381|NCT01728324|564819573|FG000|Termination of FDV|Adverse Event|14|||
156471382|NCT01728324|564819574|FG001|Termination of FDV|Adverse Event|13|||
156471383|NCT01728324|564819575|FG002|Termination of FDV|Adverse Event|4|||
156471384|NCT01728324|564819573|FG000|Termination of FDV|Lack of Efficacy|14|||
156471385|NCT01728324|564819574|FG001|Termination of FDV|Lack of Efficacy|12|||
156471386|NCT01728324|564819575|FG002|Termination of FDV|Lack of Efficacy|8|||
156471387|NCT01728324|564819573|FG000|Termination of FDV|Withdrawal by Subject|9|||
156471388|NCT01728324|564819574|FG001|Termination of FDV|Withdrawal by Subject|6|||
156471389|NCT01728324|564819575|FG002|Termination of FDV|Withdrawal by Subject|2|||
156471390|NCT01728324|564819573|FG000|Termination of FDV|Other than stated|1|||
156471391|NCT01728324|564819574|FG001|Termination of FDV|Other than stated|3|||
156850474|NCT01427933|566204568|FG000|Overall Study|Investigator's Decision|1|||
156850475|NCT01427933|566204569|FG001|Overall Study|Investigator's Decision|0|||
156850476|NCT03386721|566204570|FG000|Overall Study|Death|12|||
156850477|NCT03386721|566204571|FG001|Overall Study|Death|21|||
156850478|NCT03386721|566204572|FG002|Overall Study|Death|2|||
156850479|NCT03386721|566204573|FG003|Overall Study|Death|5|||
156342161|NCT04115839|564352567|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
156342162|NCT04115839|564352568|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
156342163|NCT04115839|564352569|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
156471392|NCT01728324|564819575|FG002|Termination of FDV|Other than stated|0|||
156471393|NCT01728324|564819573|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
156471394|NCT01728324|564819574|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
156471395|NCT01728324|564819575|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
156471396|NCT01728324|564819573|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
156471397|NCT01728324|564819574|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
156471398|NCT01728324|564819575|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
156471399|NCT01728324|564819573|FG000|Termination of RBV|Adverse Event|15|||
156471400|NCT01728324|564819574|FG001|Termination of RBV|Adverse Event|16|||
156471401|NCT01728324|564819575|FG002|Termination of RBV|Adverse Event|5|||
156471402|NCT01728324|564819573|FG000|Termination of RBV|Lack of Efficacy|14|||
156471403|NCT01728324|564819574|FG001|Termination of RBV|Lack of Efficacy|11|||
156850480|NCT03386721|566204574|FG004|Overall Study|Death|1|||
156850481|NCT03386721|566204575|FG005|Overall Study|Death|12|||
156850482|NCT03386721|566204576|FG006|Overall Study|Death|1|||
156850483|NCT03386721|566204577|FG007|Overall Study|Death|1|||
156850484|NCT03386721|566204578|FG008|Overall Study|Death|12|||
156850485|NCT03386721|566204579|FG009|Overall Study|Death|20|||
156850486|NCT03386721|566204580|FG010|Overall Study|Death|21|||
156850487|NCT03386721|566204581|FG011|Overall Study|Death|21|||
156850488|NCT03386721|566204582|FG012|Overall Study|Death|14|||
156850489|NCT03386721|566204583|FG013|Overall Study|Death|2|||
156850490|NCT03386721|566204584|FG014|Overall Study|Death|1|||
156850491|NCT03386721|566204570|FG000|Overall Study|Lost to Follow-up|1|||
156850492|NCT03386721|566204571|FG001|Overall Study|Lost to Follow-up|3|||
156850493|NCT03386721|566204572|FG002|Overall Study|Lost to Follow-up|0|||
156850494|NCT03386721|566204573|FG003|Overall Study|Lost to Follow-up|0|||
156850495|NCT03386721|566204574|FG004|Overall Study|Lost to Follow-up|0|||
156850496|NCT03386721|566204575|FG005|Overall Study|Lost to Follow-up|2|||
156850497|NCT03386721|566204576|FG006|Overall Study|Lost to Follow-up|1|||
156850498|NCT03386721|566204577|FG007|Overall Study|Lost to Follow-up|0|||
156850499|NCT03386721|566204578|FG008|Overall Study|Lost to Follow-up|1|||
156850500|NCT03386721|566204579|FG009|Overall Study|Lost to Follow-up|2|||
156850501|NCT03386721|566204580|FG010|Overall Study|Lost to Follow-up|1|||
156850502|NCT03386721|566204581|FG011|Overall Study|Lost to Follow-up|0|||
156850503|NCT03386721|566204582|FG012|Overall Study|Lost to Follow-up|0|||
156850504|NCT03386721|566204583|FG013|Overall Study|Lost to Follow-up|0|||
156850505|NCT03386721|566204584|FG014|Overall Study|Lost to Follow-up|0|||
156850506|NCT03386721|566204570|FG000|Overall Study|Reason not specified|3|||
156850507|NCT03386721|566204571|FG001|Overall Study|Reason not specified|0|||
156850508|NCT03386721|566204572|FG002|Overall Study|Reason not specified|0|||
156850509|NCT03386721|566204573|FG003|Overall Study|Reason not specified|0|||
156850510|NCT03386721|566204574|FG004|Overall Study|Reason not specified|0|||
156850511|NCT03386721|566204575|FG005|Overall Study|Reason not specified|3|||
156850512|NCT03386721|566204576|FG006|Overall Study|Reason not specified|1|||
156850513|NCT03386721|566204577|FG007|Overall Study|Reason not specified|0|||
156850514|NCT03386721|566204578|FG008|Overall Study|Reason not specified|0|||
156850515|NCT03386721|566204579|FG009|Overall Study|Reason not specified|1|||
156850516|NCT03386721|566204580|FG010|Overall Study|Reason not specified|2|||
156850517|NCT03386721|566204581|FG011|Overall Study|Reason not specified|6|||
156850518|NCT03386721|566204582|FG012|Overall Study|Reason not specified|1|||
156850519|NCT03386721|566204583|FG013|Overall Study|Reason not specified|0|||
156850520|NCT03386721|566204584|FG014|Overall Study|Reason not specified|0|||
156850521|NCT03386721|566204570|FG000|Overall Study|Progressive Disease|0|||
156850522|NCT03386721|566204571|FG001|Overall Study|Progressive Disease|0|||
156850523|NCT03386721|566204572|FG002|Overall Study|Progressive Disease|1|||
156850524|NCT03386721|566204573|FG003|Overall Study|Progressive Disease|0|||
156850525|NCT03386721|566204574|FG004|Overall Study|Progressive Disease|0|||
156850526|NCT03386721|566204575|FG005|Overall Study|Progressive Disease|1|||
156850527|NCT03386721|566204576|FG006|Overall Study|Progressive Disease|0|||
156850528|NCT03386721|566204577|FG007|Overall Study|Progressive Disease|0|||
156850529|NCT03386721|566204578|FG008|Overall Study|Progressive Disease|2|||
156850530|NCT03386721|566204579|FG009|Overall Study|Progressive Disease|1|||
156850531|NCT03386721|566204580|FG010|Overall Study|Progressive Disease|1|||
156850532|NCT03386721|566204581|FG011|Overall Study|Progressive Disease|0|||
156850533|NCT03386721|566204582|FG012|Overall Study|Progressive Disease|1|||
156850534|NCT03386721|566204583|FG013|Overall Study|Progressive Disease|0|||
156850535|NCT03386721|566204584|FG014|Overall Study|Progressive Disease|0|||
156850536|NCT03386721|566204570|FG000|Overall Study|Site Terminated by Sponsor|5|||
156850537|NCT03386721|566204571|FG001|Overall Study|Site Terminated by Sponsor|5|||
156850538|NCT03386721|566204572|FG002|Overall Study|Site Terminated by Sponsor|0|||
156850539|NCT03386721|566204573|FG003|Overall Study|Site Terminated by Sponsor|0|||
156850540|NCT03386721|566204574|FG004|Overall Study|Site Terminated by Sponsor|1|||
156850541|NCT03386721|566204575|FG005|Overall Study|Site Terminated by Sponsor|3|||
156850542|NCT03386721|566204576|FG006|Overall Study|Site Terminated by Sponsor|0|||
156850543|NCT03386721|566204577|FG007|Overall Study|Site Terminated by Sponsor|1|||
156850544|NCT03386721|566204578|FG008|Overall Study|Site Terminated by Sponsor|4|||
156850545|NCT03386721|566204579|FG009|Overall Study|Site Terminated by Sponsor|5|||
156850546|NCT03386721|566204580|FG010|Overall Study|Site Terminated by Sponsor|3|||
156850547|NCT03386721|566204581|FG011|Overall Study|Site Terminated by Sponsor|11|||
156850548|NCT03386721|566204582|FG012|Overall Study|Site Terminated by Sponsor|6|||
156850549|NCT03386721|566204583|FG013|Overall Study|Site Terminated by Sponsor|0|||
156850550|NCT03386721|566204584|FG014|Overall Study|Site Terminated by Sponsor|0|||
156850551|NCT03386721|566204570|FG000|Overall Study|Symptomatic Deterioration|0|||
156850552|NCT03386721|566204571|FG001|Overall Study|Symptomatic Deterioration|0|||
156850553|NCT03386721|566204572|FG002|Overall Study|Symptomatic Deterioration|0|||
156850554|NCT03386721|566204573|FG003|Overall Study|Symptomatic Deterioration|0|||
156850555|NCT03386721|566204574|FG004|Overall Study|Symptomatic Deterioration|0|||
156850556|NCT03386721|566204575|FG005|Overall Study|Symptomatic Deterioration|0|||
156850557|NCT03386721|566204576|FG006|Overall Study|Symptomatic Deterioration|0|||
156850558|NCT03386721|566204577|FG007|Overall Study|Symptomatic Deterioration|0|||
156850559|NCT03386721|566204578|FG008|Overall Study|Symptomatic Deterioration|1|||
156850560|NCT03386721|566204579|FG009|Overall Study|Symptomatic Deterioration|0|||
156850561|NCT03386721|566204580|FG010|Overall Study|Symptomatic Deterioration|0|||
156850562|NCT03386721|566204581|FG011|Overall Study|Symptomatic Deterioration|1|||
156850563|NCT03386721|566204582|FG012|Overall Study|Symptomatic Deterioration|0|||
156850564|NCT03386721|566204583|FG013|Overall Study|Symptomatic Deterioration|0|||
156850565|NCT03386721|566204584|FG014|Overall Study|Symptomatic Deterioration|0|||
156850566|NCT03386721|566204570|FG000|Overall Study|Withdrawal by Subject|1|||
156850567|NCT03386721|566204571|FG001|Overall Study|Withdrawal by Subject|2|||
156850568|NCT03386721|566204572|FG002|Overall Study|Withdrawal by Subject|0|||
156850569|NCT03386721|566204573|FG003|Overall Study|Withdrawal by Subject|0|||
156850570|NCT03386721|566204574|FG004|Overall Study|Withdrawal by Subject|0|||
156850571|NCT03386721|566204575|FG005|Overall Study|Withdrawal by Subject|0|||
156850572|NCT03386721|566204576|FG006|Overall Study|Withdrawal by Subject|0|||
156850573|NCT03386721|566204577|FG007|Overall Study|Withdrawal by Subject|0|||
156850574|NCT03386721|566204578|FG008|Overall Study|Withdrawal by Subject|2|||
156850575|NCT03386721|566204579|FG009|Overall Study|Withdrawal by Subject|1|||
156850576|NCT03386721|566204580|FG010|Overall Study|Withdrawal by Subject|3|||
156850577|NCT03386721|566204581|FG011|Overall Study|Withdrawal by Subject|2|||
156850578|NCT03386721|566204582|FG012|Overall Study|Withdrawal by Subject|3|||
156850579|NCT03386721|566204583|FG013|Overall Study|Withdrawal by Subject|0|||
156850580|NCT03386721|566204584|FG014|Overall Study|Withdrawal by Subject|0|||
156850581|NCT00700713|566204585|FG000|Overall Study|Protocol Violation|1|||
156850582|NCT00700713|566204586|FG001|Overall Study|Protocol Violation|0|||
156850583|NCT00700713|566204587|FG002|Overall Study|Protocol Violation|1|||
156850584|NCT00700713|566204585|FG000|Overall Study|Withdrawal by Subject|0|||
156850585|NCT00700713|566204586|FG001|Overall Study|Withdrawal by Subject|0|||
156850586|NCT00700713|566204587|FG002|Overall Study|Withdrawal by Subject|1|||
156850587|NCT05729568|566204590|FG000|Overall Study|Still on Study|52|||
156850588|NCT05729568|566204591|FG001|Overall Study|Still on Study|26|||
156850589|NCT05729568|566204590|FG000|Overall Study|Randomized but Never Treated|3|||
156850590|NCT05729568|566204591|FG001|Overall Study|Randomized but Never Treated|0|||
156850591|NCT05729568|566204590|FG000|Overall Study|Adverse Event|0|||
156850592|NCT05729568|566204591|FG001|Overall Study|Adverse Event|1|||
156542172|NCT00388973|565079254|FG000|Overall Study|Protocol Violation|3|||
156850593|NCT05729568|566204590|FG000|Overall Study|Investigator's Discretion|1|||
156850594|NCT05729568|566204591|FG001|Overall Study|Investigator's Discretion|0|||
156850595|NCT01369784|566204594|FG000|Overall Study|Protocol Violation|12|||
156850596|NCT00596752|566204597|FG000|Overall Study|Other Reason|44|||
156850597|NCT00596752|566204598|FG001|Overall Study|Other Reason|49|||
156850598|NCT00596752|566204597|FG000|Overall Study|Adverse Event|34|||
156850599|NCT00596752|566204598|FG001|Overall Study|Adverse Event|34|||
156850600|NCT00596752|566204597|FG000|Overall Study|Lost to Follow-up|22|||
156850601|NCT00596752|566204598|FG001|Overall Study|Lost to Follow-up|38|||
156850602|NCT00596752|566204597|FG000|Overall Study|Withdrawal by Subject|12|||
156850603|NCT00596752|566204598|FG001|Overall Study|Withdrawal by Subject|9|||
156850604|NCT00596752|566204597|FG000|Overall Study|Unsatisfactory Compliance|9|||
156850605|NCT00596752|566204598|FG001|Overall Study|Unsatisfactory Compliance|6|||
156850606|NCT00596752|566204597|FG000|Overall Study|Lack of Efficacy|4|||
156850607|NCT00596752|566204598|FG001|Overall Study|Lack of Efficacy|7|||
156850608|NCT00596752|566204597|FG000|Overall Study|Protocol Violation|1|||
156850609|NCT00596752|566204598|FG001|Overall Study|Protocol Violation|0|||
156850610|NCT04797780|566204601|FG000|Overall Study|Lost to Follow-up|1|||
156850611|NCT04797780|566204602|FG001|Overall Study|Lost to Follow-up|1|||
156850612|NCT04797780|566204601|FG000|Overall Study|Withdrawal by Subject|14|||
156850613|NCT04797780|566204602|FG001|Overall Study|Withdrawal by Subject|9|||
156850614|NCT04797780|566204601|FG000|Overall Study|Death|49|||
156850615|NCT04797780|566204602|FG001|Overall Study|Death|20|||
156850616|NCT02586727|566204603|FG000|Overall Study|Lost to Follow-up|1|||
156850617|NCT02586727|566204604|FG001|Overall Study|Lost to Follow-up|0|||
156850618|NCT05167825|566204605|FG000|Overall Study|Ongoing|3|||
156850619|NCT02534909|566204617|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
156850620|NCT02326597|566204620|FG000|Overall Study|Lost to Follow-up|42|||
156850621|NCT02326597|566204621|FG001|Overall Study|Lost to Follow-up|32|||
156850622|NCT02119663|566204624|FG000|Overall Study|Disease progression|26|||
156850623|NCT02119663|566204625|FG001|Overall Study|Disease progression|27|||
156850624|NCT02119663|566204624|FG000|Overall Study|Adverse Event|5|||
156850625|NCT02119663|566204625|FG001|Overall Study|Adverse Event|5|||
156850626|NCT02119663|566204624|FG000|Overall Study|Death|3|||
156542173|NCT00388973|565079255|FG001|Overall Study|Protocol Violation|0|||
156850627|NCT02119663|566204625|FG001|Overall Study|Death|2|||
156850628|NCT02119663|566204624|FG000|Overall Study|Physician Decision|1|||
156850629|NCT02119663|566204625|FG001|Overall Study|Physician Decision|2|||
156850630|NCT02119663|566204624|FG000|Overall Study|Other unspecified|2|||
156850631|NCT02119663|566204625|FG001|Overall Study|Other unspecified|0|||
156850632|NCT02119663|566204624|FG000|Overall Study|Subject decision|0|||
156850633|NCT02119663|566204625|FG001|Overall Study|Subject decision|1|||
156850634|NCT02119663|566204624|FG000|Overall Study|Study Terminated by the Sponsor|3|||
156850635|NCT02119663|566204625|FG001|Overall Study|Study Terminated by the Sponsor|4|||
156850636|NCT01870726|566204626|FG000|Overall Study|Withdrawal of informed consent|0|||
156850637|NCT01870726|566204627|FG001|Overall Study|Withdrawal of informed consent|0|||
156850638|NCT01870726|566204628|FG002|Overall Study|Withdrawal of informed consent|0|||
156850639|NCT01870726|566204629|FG003|Overall Study|Withdrawal of informed consent|1|||
156850640|NCT01870726|566204630|FG004|Overall Study|Withdrawal of informed consent|0|||
156850641|NCT01870726|566204631|FG005|Overall Study|Withdrawal of informed consent|0|||
156850642|NCT01870726|566204632|FG006|Overall Study|Withdrawal of informed consent|0|||
156850643|NCT01870726|566204626|FG000|Overall Study|Withdrawal by Subject|0|||
156850644|NCT01870726|566204627|FG001|Overall Study|Withdrawal by Subject|1|||
156850645|NCT01870726|566204628|FG002|Overall Study|Withdrawal by Subject|0|||
156850646|NCT01870726|566204629|FG003|Overall Study|Withdrawal by Subject|0|||
156850647|NCT01870726|566204630|FG004|Overall Study|Withdrawal by Subject|0|||
156850648|NCT01870726|566204631|FG005|Overall Study|Withdrawal by Subject|0|||
156850649|NCT01870726|566204632|FG006|Overall Study|Withdrawal by Subject|0|||
156850650|NCT01870726|566204626|FG000|Overall Study|Adverse Event|0|||
156850651|NCT01870726|566204627|FG001|Overall Study|Adverse Event|0|||
156850652|NCT01870726|566204628|FG002|Overall Study|Adverse Event|0|||
156850653|NCT01870726|566204629|FG003|Overall Study|Adverse Event|0|||
156850654|NCT01870726|566204630|FG004|Overall Study|Adverse Event|1|||
156850655|NCT01870726|566204631|FG005|Overall Study|Adverse Event|1|||
156850656|NCT01870726|566204632|FG006|Overall Study|Adverse Event|0|||
156850657|NCT01870726|566204626|FG000|Overall Study|Progressive disease|5|||
156850658|NCT01870726|566204627|FG001|Overall Study|Progressive disease|5|||
156850659|NCT01870726|566204628|FG002|Overall Study|Progressive disease|4|||
156850660|NCT01870726|566204629|FG003|Overall Study|Progressive disease|5|||
156850661|NCT01870726|566204630|FG004|Overall Study|Progressive disease|6|||
156850662|NCT01870726|566204631|FG005|Overall Study|Progressive disease|4|||
156850663|NCT01870726|566204632|FG006|Overall Study|Progressive disease|10|||
156850664|NCT02978833|566204635|FG000|Overall Study|Study terminated|1|||
156850665|NCT02978833|566204636|FG001|Overall Study|Study terminated|1|||
156850666|NCT01123395|566204637|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
156850667|NCT01123395|566204638|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
156850668|NCT03691571|566204639|FG000|Overall Study|Withdrawal by Subject|9|||
156850669|NCT03691571|566204640|FG001|Overall Study|Withdrawal by Subject|2|||
156850670|NCT04186871|566204641|FG000|Overall Study|Lack of Efficacy|0|||
156850671|NCT04186871|566204642|FG001|Overall Study|Lack of Efficacy|1|||
156850672|NCT04186871|566204643|FG002|Overall Study|Lack of Efficacy|0|||
156850673|NCT04186871|566204644|FG003|Overall Study|Lack of Efficacy|0|||
156850674|NCT04186871|566204645|FG004|Overall Study|Lack of Efficacy|1|||
156850675|NCT04186871|566204646|FG005|Overall Study|Lack of Efficacy|1|||
156850676|NCT04186871|566204641|FG000|Overall Study|Adverse Event|1|||
156850677|NCT04186871|566204642|FG001|Overall Study|Adverse Event|1|||
156850678|NCT04186871|566204643|FG002|Overall Study|Adverse Event|0|||
156850679|NCT04186871|566204644|FG003|Overall Study|Adverse Event|0|||
156850680|NCT04186871|566204645|FG004|Overall Study|Adverse Event|0|||
156850681|NCT04186871|566204646|FG005|Overall Study|Adverse Event|2|||
156850682|NCT04186871|566204641|FG000|Overall Study|Study terminated by sponsor|1|||
156850683|NCT04186871|566204642|FG001|Overall Study|Study terminated by sponsor|2|||
156850684|NCT04186871|566204643|FG002|Overall Study|Study terminated by sponsor|0|||
156850685|NCT04186871|566204644|FG003|Overall Study|Study terminated by sponsor|1|||
156471404|NCT01728324|564819575|FG002|Termination of RBV|Lack of Efficacy|7|||
156471405|NCT01728324|564819573|FG000|Termination of RBV|Withdrawal by Subject|9|||
156471406|NCT01728324|564819574|FG001|Termination of RBV|Withdrawal by Subject|5|||
156471407|NCT01728324|564819575|FG002|Termination of RBV|Withdrawal by Subject|2|||
156471408|NCT01728324|564819573|FG000|Termination of RBV|Other than stated|1|||
156471409|NCT01728324|564819574|FG001|Termination of RBV|Other than stated|3|||
156471410|NCT01728324|564819575|FG002|Termination of RBV|Other than stated|1|||
156471411|NCT01728324|564819573|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
156471412|NCT01728324|564819574|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
156471413|NCT01728324|564819575|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
156471414|NCT01728324|564819573|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
156471415|NCT01728324|564819574|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
156471416|NCT01728324|564819575|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
156471417|NCT03745313|564819582|FG000|At 30 Days Follow-up|Death|2|||
156471418|NCT03745313|564819582|FG000|At 6 Months Follow-up|Death|1|||
156471419|NCT03745313|564819582|FG000|At 6 Months Follow-up|Missed Visit|1|||
156471420|NCT03745313|564819582|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
156471421|NCT03745313|564819582|FG000|At 1 Year Follow-up|Death|2|||
156471422|NCT03745313|564819582|FG000|At 1 Year Follow-up|Missed Visit|2|||
156471423|NCT03745313|564819582|FG000|At 2 Year Follow-up|Missed Visit|1|||
156471424|NCT02235298|564819590|FG000|Overall Study|Lost to Follow-up|6|||
156471425|NCT02235298|564819591|FG001|Overall Study|Lost to Follow-up|5|||
156471426|NCT02235298|564819590|FG000|Overall Study|Adverse Event|2|||
156471427|NCT02235298|564819591|FG001|Overall Study|Adverse Event|2|||
156471428|NCT02235298|564819590|FG000|Overall Study|Withdrawal by Subject|0|||
156471429|NCT02235298|564819591|FG001|Overall Study|Withdrawal by Subject|1|||
156471430|NCT02628626|564819594|FG000|Overall Study|Withdrawal by Subject|2|||
156471431|NCT02628626|564819595|FG001|Overall Study|Withdrawal by Subject|2|||
156471432|NCT01593020|564819596|FG000|Overall Study|Adverse Event|1|||
156471433|NCT01593020|564819597|FG001|Overall Study|Adverse Event|1|||
156471434|NCT01593020|564819596|FG000|Overall Study|Death|0|||
156850686|NCT04186871|566204645|FG004|Overall Study|Study terminated by sponsor|0|||
156850687|NCT04186871|566204646|FG005|Overall Study|Study terminated by sponsor|0|||
156850688|NCT04186871|566204641|FG000|Overall Study|Other reasons|0|||
156850689|NCT04186871|566204642|FG001|Overall Study|Other reasons|0|||
156850690|NCT04186871|566204643|FG002|Overall Study|Other reasons|0|||
156850691|NCT04186871|566204644|FG003|Overall Study|Other reasons|0|||
156850692|NCT04186871|566204645|FG004|Overall Study|Other reasons|0|||
156850693|NCT04186871|566204646|FG005|Overall Study|Other reasons|1|||
156471435|NCT01593020|564819597|FG001|Overall Study|Death|1|||
156471436|NCT01593020|564819596|FG000|Overall Study|Ineligible|1|||
156471437|NCT01593020|564819597|FG001|Overall Study|Ineligible|0|||
156471438|NCT02454959|564819598|FG000|Overall Study|Protocol-Specified Criteria|3|||
156471439|NCT02454959|564819598|FG000|Overall Study|Physician Decision|1|||
156471440|NCT02454959|564819598|FG000|Overall Study|Withdrawal by Subject|3|||
156471441|NCT02454959|564819598|FG000|Overall Study|Adverse Event|2|||
156471442|NCT02350634|564819599|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
156471443|NCT03102034|564819610|FG000|Overall Study|Withdrawal by Subject|1|||
156471444|NCT03102034|564819611|FG001|Overall Study|Withdrawal by Subject|0|||
156471445|NCT03611075|564819615|FG000|Overall Study|Physician Decision|0|||
156471446|NCT03611075|564819616|FG001|Overall Study|Physician Decision|1|||
156471447|NCT03611075|564819617|FG002|Overall Study|Physician Decision|1|||
156471448|NCT03611075|564819618|FG003|Overall Study|Physician Decision|0|||
156471449|NCT03611075|564819619|FG004|Overall Study|Physician Decision|0|||
156471450|NCT03611075|564819620|FG005|Overall Study|Physician Decision|0|||
156471451|NCT03611075|564819621|FG006|Overall Study|Physician Decision|0|||
156471452|NCT03611075|564819622|FG007|Overall Study|Physician Decision|0|||
156850694|NCT04186871|566204641|FG000|Overall Study|Withdrawal by Subject|0|||
156471453|NCT03611075|564819623|FG008|Overall Study|Physician Decision|0|||
156471454|NCT03611075|564819615|FG000|Overall Study|Lost to Follow-up|1|||
156471455|NCT03611075|564819616|FG001|Overall Study|Lost to Follow-up|0|||
156471456|NCT03611075|564819617|FG002|Overall Study|Lost to Follow-up|0|||
156471457|NCT03611075|564819618|FG003|Overall Study|Lost to Follow-up|2|||
156850695|NCT04186871|566204642|FG001|Overall Study|Withdrawal by Subject|0|||
156850696|NCT04186871|566204643|FG002|Overall Study|Withdrawal by Subject|0|||
156471458|NCT03611075|564819619|FG004|Overall Study|Lost to Follow-up|0|||
156471459|NCT03611075|564819620|FG005|Overall Study|Lost to Follow-up|0|||
156471460|NCT03611075|564819621|FG006|Overall Study|Lost to Follow-up|0|||
156471461|NCT03611075|564819622|FG007|Overall Study|Lost to Follow-up|0|||
156471462|NCT03611075|564819623|FG008|Overall Study|Lost to Follow-up|0|||
156471463|NCT03611075|564819615|FG000|Overall Study|Withdrawal by Subject|0|||
156471464|NCT03611075|564819616|FG001|Overall Study|Withdrawal by Subject|1|||
156471465|NCT03611075|564819617|FG002|Overall Study|Withdrawal by Subject|1|||
156471466|NCT03611075|564819618|FG003|Overall Study|Withdrawal by Subject|1|||
156471467|NCT03611075|564819619|FG004|Overall Study|Withdrawal by Subject|0|||
156471468|NCT03611075|564819620|FG005|Overall Study|Withdrawal by Subject|0|||
156471469|NCT03611075|564819621|FG006|Overall Study|Withdrawal by Subject|1|||
156471470|NCT03611075|564819622|FG007|Overall Study|Withdrawal by Subject|0|||
156471471|NCT03611075|564819623|FG008|Overall Study|Withdrawal by Subject|0|||
156471472|NCT03611075|564819615|FG000|Overall Study|Reason unknown|0|||
156471473|NCT03611075|564819616|FG001|Overall Study|Reason unknown|0|||
156471474|NCT03611075|564819617|FG002|Overall Study|Reason unknown|0|||
156471475|NCT03611075|564819618|FG003|Overall Study|Reason unknown|1|||
156471476|NCT03611075|564819619|FG004|Overall Study|Reason unknown|0|||
156471477|NCT03611075|564819620|FG005|Overall Study|Reason unknown|0|||
156471478|NCT03611075|564819621|FG006|Overall Study|Reason unknown|1|||
156471479|NCT03611075|564819622|FG007|Overall Study|Reason unknown|0|||
156471480|NCT03611075|564819623|FG008|Overall Study|Reason unknown|0|||
156471481|NCT02972359|564819624|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
156471482|NCT02972359|564819624|FG000|Overall Study|Lack of Efficacy|1|||
156471483|NCT02972359|564819624|FG000|Overall Study|Adverse Event|4|||
156471484|NCT02972359|564819624|FG000|Overall Study|Death|1|||
156471485|NCT02972359|564819624|FG000|Overall Study|Withdrawal by Subject|30|||
156471486|NCT02972359|564819624|FG000|Overall Study|Protocol Violation|1|||
156850697|NCT04186871|566204644|FG003|Overall Study|Withdrawal by Subject|0|||
156850698|NCT04186871|566204645|FG004|Overall Study|Withdrawal by Subject|0|||
156850699|NCT04186871|566204646|FG005|Overall Study|Withdrawal by Subject|1|||
156850700|NCT04186871|566204641|FG000|Overall Study|Lost to Follow-up|0|||
156850701|NCT04186871|566204642|FG001|Overall Study|Lost to Follow-up|0|||
156850702|NCT04186871|566204643|FG002|Overall Study|Lost to Follow-up|0|||
156850703|NCT04186871|566204644|FG003|Overall Study|Lost to Follow-up|0|||
156850704|NCT04186871|566204645|FG004|Overall Study|Lost to Follow-up|0|||
156850705|NCT04186871|566204646|FG005|Overall Study|Lost to Follow-up|1|||
156850706|NCT01546688|566204647|FG000|Overall Study|Adverse Event|0|||
156850707|NCT01546688|566204648|FG001|Overall Study|Adverse Event|4|||
156850708|NCT01546688|566204647|FG000|Overall Study|Withdrawal by Subject|2|||
156471487|NCT02972359|564819624|FG000|Overall Study|Lost to Follow-up|26|||
156471488|NCT02972359|564819624|FG000|Overall Study|Other reasons|5|||
156471489|NCT02972359|564819624|FG000|Overall Study|Missing|1|||
156471490|NCT02063659|564819625|FG000|Double-Blind Treatment Period|Adverse Event|1|||
156471491|NCT02063659|564819626|FG001|Double-Blind Treatment Period|Adverse Event|2|||
156471492|NCT02063659|564819627|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156471493|NCT02063659|564819628|FG003|Double-Blind Treatment Period|Adverse Event|0|||
156471494|NCT02063659|564819625|FG000|Double-Blind Treatment Period|Physician Decision|1|||
156542174|NCT00388973|565079254|FG000|Overall Study|Withdrawal by Subject|14|||
156542175|NCT00388973|565079255|FG001|Overall Study|Withdrawal by Subject|17|||
156542176|NCT00388973|565079254|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
156542177|NCT00388973|565079255|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
156850709|NCT01546688|566204648|FG001|Overall Study|Withdrawal by Subject|1|||
156850710|NCT01546688|566204647|FG000|Overall Study|Lack of Efficacy|1|||
156471495|NCT02063659|564819626|FG001|Double-Blind Treatment Period|Physician Decision|0|||
156471496|NCT02063659|564819627|FG002|Double-Blind Treatment Period|Physician Decision|0|||
156850711|NCT01546688|566204648|FG001|Overall Study|Lack of Efficacy|0|||
156850712|NCT03543137|566204649|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
156850713|NCT03543137|566204650|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
156471497|NCT02063659|564819628|FG003|Double-Blind Treatment Period|Physician Decision|0|||
156471498|NCT02063659|564819625|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
156471499|NCT02063659|564819626|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
156471500|NCT02063659|564819627|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
156471501|NCT02063659|564819628|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
156850714|NCT03543137|566204649|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
156850715|NCT03543137|566204650|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
156850716|NCT03543137|566204649|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
156471502|NCT02063659|564819625|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
156471503|NCT02063659|564819626|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
156471504|NCT02063659|564819627|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
156471505|NCT02063659|564819628|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
156471506|NCT02063659|564819625|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
156471507|NCT02063659|564819626|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
156471508|NCT02063659|564819627|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
156471509|NCT02063659|564819628|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
156471510|NCT02063659|564819625|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
156471511|NCT02063659|564819626|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
156471512|NCT02063659|564819627|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
156471513|NCT02063659|564819628|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
156471514|NCT02063659|564819625|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
156471515|NCT02063659|564819626|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
156471516|NCT02063659|564819627|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
156471517|NCT02063659|564819628|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
156471518|NCT02063659|564819625|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
156471519|NCT02063659|564819626|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
156471520|NCT02063659|564819627|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
156471521|NCT02063659|564819628|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
156471522|NCT04300023|564819635|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
156471523|NCT04300023|564819636|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
156471524|NCT05025384|564819643|FG000|Overall Study|Physician Decision|5|||
156471525|NCT05025384|564819644|FG001|Overall Study|Physician Decision|6|||
156471526|NCT02830204|564819645|FG000|Overall Study|Death|9|||
156471527|NCT02830204|564819645|FG000|Overall Study|Withdrawal by Subject|1|||
156471528|NCT02517268|564819648|FG000|Overall Study|Withdrawal by Subject|1|||
156471529|NCT02517268|564819649|FG001|Overall Study|Withdrawal by Subject|0|||
156471530|NCT02401815|564819652|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471531|NCT02401815|564819653|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471532|NCT02401815|564819654|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471533|NCT02401815|564819655|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
156471534|NCT02401815|564819656|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471535|NCT02401815|564819657|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471536|NCT02401815|564819658|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471537|NCT02401815|564819659|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471538|NCT02401815|564819660|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471539|NCT02401815|564819661|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
156471540|NCT02401815|564819652|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
156471541|NCT02401815|564819653|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
156471542|NCT02401815|564819654|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
156471543|NCT02401815|564819655|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
156471544|NCT02401815|564819656|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
156471545|NCT02401815|564819657|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
156471546|NCT02401815|564819658|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
156471547|NCT02401815|564819659|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
156471548|NCT02401815|564819660|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
156471549|NCT02401815|564819661|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
156471550|NCT02401815|564819652|FG000|Dose Escalation (up to 670 Days)|Death|1|||
156471551|NCT02401815|564819653|FG001|Dose Escalation (up to 670 Days)|Death|2|||
156471552|NCT02401815|564819654|FG002|Dose Escalation (up to 670 Days)|Death|3|||
156471553|NCT02401815|564819655|FG003|Dose Escalation (up to 670 Days)|Death|5|||
156471554|NCT02401815|564819656|FG004|Dose Escalation (up to 670 Days)|Death|4|||
156850717|NCT03543137|566204650|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
156850718|NCT00983385|566204651|FG000|Observation Period|Not eligible to be dosed|20|||
156471555|NCT02401815|564819657|FG005|Dose Escalation (up to 670 Days)|Death|0|||
156471556|NCT02401815|564819658|FG006|Dose Escalation (up to 670 Days)|Death|0|||
156850719|NCT00983385|566204651|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
156850720|NCT00930930|566204652|FG000|Overall Study|Death|1|||
156850721|NCT00930930|566204653|FG001|Overall Study|Death|0|||
156850722|NCT00930930|566204652|FG000|Overall Study|Physician Decision|1|||
156471557|NCT02401815|564819659|FG007|Dose Escalation (up to 670 Days)|Death|0|||
156471558|NCT02401815|564819660|FG008|Dose Escalation (up to 670 Days)|Death|0|||
156471559|NCT02401815|564819661|FG009|Dose Escalation (up to 670 Days)|Death|0|||
156471560|NCT02401815|564819652|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
156471561|NCT02401815|564819653|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
156471562|NCT02401815|564819654|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
156850723|NCT00930930|566204653|FG001|Overall Study|Physician Decision|0|||
156850724|NCT00930930|566204652|FG000|Overall Study|Adverse Event|13|||
156850725|NCT00930930|566204653|FG001|Overall Study|Adverse Event|3|||
156850726|NCT00930930|566204652|FG000|Overall Study|Withdrawal by Subject|3|||
156850727|NCT00930930|566204653|FG001|Overall Study|Withdrawal by Subject|1|||
156850728|NCT00930930|566204652|FG000|Overall Study|Disease progression|2|||
156850729|NCT00930930|566204653|FG001|Overall Study|Disease progression|3|||
156850730|NCT00930930|566204652|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
156850731|NCT00930930|566204653|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
156850732|NCT00930930|566204652|FG000|Overall Study|patients not compliant|1|||
156850733|NCT00930930|566204653|FG001|Overall Study|patients not compliant|1|||
156850734|NCT00900029|566204654|FG000|Overall Study|Lost to Follow-up|0|||
156850735|NCT00900029|566204655|FG001|Overall Study|Lost to Follow-up|2|||
156850736|NCT00900029|566204656|FG002|Overall Study|Lost to Follow-up|1|||
156850737|NCT00900029|566204657|FG003|Overall Study|Lost to Follow-up|4|||
156850738|NCT00900029|566204658|FG004|Overall Study|Lost to Follow-up|4|||
156850739|NCT00900029|566204654|FG000|Overall Study|Withdrawal by Subject|2|||
156850740|NCT00900029|566204655|FG001|Overall Study|Withdrawal by Subject|2|||
156850741|NCT00900029|566204656|FG002|Overall Study|Withdrawal by Subject|1|||
156850742|NCT00900029|566204657|FG003|Overall Study|Withdrawal by Subject|1|||
156850743|NCT00900029|566204658|FG004|Overall Study|Withdrawal by Subject|1|||
156850744|NCT00900029|566204654|FG000|Overall Study|Adverse Event|0|||
156850745|NCT00900029|566204655|FG001|Overall Study|Adverse Event|0|||
156850746|NCT00900029|566204656|FG002|Overall Study|Adverse Event|1|||
156850747|NCT00900029|566204657|FG003|Overall Study|Adverse Event|1|||
156850748|NCT00900029|566204658|FG004|Overall Study|Adverse Event|1|||
156850749|NCT00900029|566204654|FG000|Overall Study|Death|1|||
156850750|NCT00900029|566204655|FG001|Overall Study|Death|0|||
156850751|NCT00900029|566204656|FG002|Overall Study|Death|0|||
156850752|NCT00900029|566204657|FG003|Overall Study|Death|1|||
156850753|NCT00900029|566204658|FG004|Overall Study|Death|0|||
156850754|NCT02587819|566204661|FG000|Overall Study|Adverse Event|1|||
156850755|NCT02587819|566204661|FG000|Overall Study|Lost to Follow-up|1|||
156850756|NCT01929226|566206165|FG000|Overall Study|Lost to Follow-up|4|||
156850757|NCT01929226|566206166|FG001|Overall Study|Lost to Follow-up|0|||
156850758|NCT01929226|566206165|FG000|Overall Study|Withdrawal by Subject|1|||
156850759|NCT01929226|566206166|FG001|Overall Study|Withdrawal by Subject|1|||
156850760|NCT03790111|566206169|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
156850761|NCT03811340|566206172|FG000|Overall Study|subjects did not complete the survey.|90|||
156850762|NCT00280917|566206173|FG000|Overall Study|Adverse Event|1|||
156850763|NCT00280917|566206174|FG001|Overall Study|Adverse Event|1|||
156850764|NCT00280917|566206175|FG002|Overall Study|Adverse Event|4|||
156850765|NCT00280917|566206176|FG003|Overall Study|Adverse Event|1|||
156850766|NCT00280917|566206173|FG000|Overall Study|Change Therapy|1|||
156850767|NCT00280917|566206174|FG001|Overall Study|Change Therapy|2|||
156850768|NCT00280917|566206175|FG002|Overall Study|Change Therapy|0|||
156850769|NCT00280917|566206176|FG003|Overall Study|Change Therapy|0|||
156850770|NCT00280917|566206173|FG000|Overall Study|Withdrawal by Subject|0|||
156850771|NCT00280917|566206174|FG001|Overall Study|Withdrawal by Subject|2|||
156850772|NCT00280917|566206175|FG002|Overall Study|Withdrawal by Subject|0|||
156850773|NCT00280917|566206176|FG003|Overall Study|Withdrawal by Subject|1|||
156850774|NCT00280917|566206173|FG000|Overall Study|Noncompliance|0|||
156850775|NCT00280917|566206174|FG001|Overall Study|Noncompliance|1|||
156850776|NCT00280917|566206175|FG002|Overall Study|Noncompliance|2|||
156850777|NCT00280917|566206176|FG003|Overall Study|Noncompliance|0|||
156850778|NCT03529110|566206177|FG000|Overall Study|Progressive Disease|66|||
156342164|NCT04115839|564352570|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
156342165|NCT04115839|564352571|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
156342166|NCT04115839|564352572|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
156342167|NCT04115839|564352566|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
156342168|NCT04115839|564352567|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
156342169|NCT04115839|564352568|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
156342170|NCT04115839|564352569|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
156342171|NCT04115839|564352570|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
156342172|NCT04115839|564352571|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
156342173|NCT04115839|564352572|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
156342174|NCT04115839|564352566|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
156342175|NCT04115839|564352567|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156342176|NCT04115839|564352568|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156850779|NCT03529110|566206178|FG001|Overall Study|Progressive Disease|158|||
156850780|NCT03529110|566206177|FG000|Overall Study|Clinical Progression|4|||
156850781|NCT03529110|566206178|FG001|Overall Study|Clinical Progression|12|||
156850782|NCT03529110|566206177|FG000|Overall Study|Adverse Event|35|||
156342177|NCT04115839|564352569|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156850783|NCT03529110|566206178|FG001|Overall Study|Adverse Event|17|||
156850784|NCT03529110|566206177|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
156850785|NCT03529110|566206178|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
156850786|NCT03529110|566206177|FG000|Overall Study|Lack of Efficacy|3|||
156850787|NCT03529110|566206178|FG001|Overall Study|Lack of Efficacy|3|||
156850788|NCT03529110|566206177|FG000|Overall Study|Physician Decision|2|||
156850789|NCT03529110|566206178|FG001|Overall Study|Physician Decision|8|||
156850790|NCT03529110|566206177|FG000|Overall Study|Miscellaneous|2|||
156850791|NCT03529110|566206178|FG001|Overall Study|Miscellaneous|5|||
156850792|NCT05104450|566206179|FG000|Overall Study|Death|1|||
156850793|NCT05104450|566206180|FG001|Overall Study|Death|2|||
156850794|NCT05104450|566206179|FG000|Overall Study|Withdrawal by Subject|3|||
156850795|NCT05104450|566206180|FG001|Overall Study|Withdrawal by Subject|1|||
156850796|NCT00330759|566206190|FG000|Overall Study|Death|316|||
156850797|NCT00330759|566206191|FG001|Overall Study|Death|310|||
156850798|NCT00330759|566206190|FG000|Overall Study|Disease progression|104|||
156850799|NCT00330759|566206191|FG001|Overall Study|Disease progression|126|||
156850800|NCT00330759|566206190|FG000|Overall Study|Withdrawal by Subject|143|||
156850801|NCT00330759|566206191|FG001|Overall Study|Withdrawal by Subject|124|||
156850802|NCT00330759|566206190|FG000|Overall Study|Adverse Event|48|||
156850803|NCT00330759|566206191|FG001|Overall Study|Adverse Event|36|||
156850804|NCT00330759|566206190|FG000|Overall Study|Participant request|31|||
156850805|NCT00330759|566206191|FG001|Overall Study|Participant request|22|||
156850806|NCT00330759|566206190|FG000|Overall Study|Lost to Follow-up|16|||
156342178|NCT04115839|564352570|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156471563|NCT02401815|564819655|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
156471564|NCT02401815|564819656|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
156471565|NCT02401815|564819657|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
156471566|NCT02401815|564819658|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
156850807|NCT00330759|566206191|FG001|Overall Study|Lost to Follow-up|22|||
156850808|NCT00330759|566206190|FG000|Overall Study|Noncompliance|15|||
156850809|NCT00330759|566206191|FG001|Overall Study|Noncompliance|17|||
156850810|NCT00330759|566206190|FG000|Overall Study|Physician Decision|1|||
156850811|NCT00330759|566206191|FG001|Overall Study|Physician Decision|2|||
156850812|NCT00330759|566206190|FG000|Overall Study|Protocol deviation|0|||
156850813|NCT00330759|566206191|FG001|Overall Study|Protocol deviation|2|||
156850814|NCT00330759|566206190|FG000|Overall Study|Ineligibility determined|2|||
156850815|NCT00330759|566206191|FG001|Overall Study|Ineligibility determined|1|||
156850816|NCT00330759|566206190|FG000|Overall Study|Other|36|||
156850817|NCT00330759|566206191|FG001|Overall Study|Other|44|||
156850818|NCT00592904|566206216|FG000|Overall Study|Adverse Event|15|||
156850819|NCT00592904|566206217|FG001|Overall Study|Adverse Event|25|||
156850820|NCT00592904|566206218|FG002|Overall Study|Adverse Event|13|||
156850821|NCT00592904|566206219|FG003|Overall Study|Adverse Event|5|||
156850822|NCT00592904|566206216|FG000|Overall Study|Protocol Violation|1|||
156850823|NCT00592904|566206217|FG001|Overall Study|Protocol Violation|1|||
156850824|NCT00592904|566206218|FG002|Overall Study|Protocol Violation|0|||
156850825|NCT00592904|566206219|FG003|Overall Study|Protocol Violation|1|||
156850826|NCT00592904|566206216|FG000|Overall Study|Withdrawal by Subject|4|||
156850827|NCT00592904|566206217|FG001|Overall Study|Withdrawal by Subject|16|||
156850828|NCT00592904|566206218|FG002|Overall Study|Withdrawal by Subject|1|||
156850829|NCT00592904|566206219|FG003|Overall Study|Withdrawal by Subject|2|||
156850830|NCT00592904|566206216|FG000|Overall Study|Lack of Efficacy|2|||
156850831|NCT00592904|566206217|FG001|Overall Study|Lack of Efficacy|7|||
156850832|NCT00592904|566206218|FG002|Overall Study|Lack of Efficacy|2|||
156850833|NCT00592904|566206219|FG003|Overall Study|Lack of Efficacy|3|||
156850834|NCT00592904|566206216|FG000|Overall Study|Physician Decision|0|||
156850835|NCT00592904|566206217|FG001|Overall Study|Physician Decision|3|||
156850836|NCT00592904|566206218|FG002|Overall Study|Physician Decision|1|||
156850837|NCT00592904|566206219|FG003|Overall Study|Physician Decision|0|||
156850838|NCT00592904|566206216|FG000|Overall Study|Other|3|||
156471567|NCT02401815|564819659|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
156471568|NCT02401815|564819660|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
156471569|NCT02401815|564819661|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
156471570|NCT02401815|564819652|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
156471571|NCT02401815|564819653|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
156342179|NCT04115839|564352571|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156471572|NCT02401815|564819654|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
156471573|NCT02401815|564819655|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
156850839|NCT00592904|566206217|FG001|Overall Study|Other|3|||
156850840|NCT00592904|566206218|FG002|Overall Study|Other|0|||
156850841|NCT00592904|566206219|FG003|Overall Study|Other|0|||
156850842|NCT01172535|566206220|FG000|Overall Study|Death|3|||
156850843|NCT01172535|566206220|FG000|Overall Study|Withdrawal by Subject|2|||
156850844|NCT01172535|566206220|FG000|Overall Study|Lost to Follow-up|1|||
156850845|NCT01172535|566206220|FG000|Overall Study|Ineligible at study entry|1|||
156850846|NCT01172535|566206220|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
156850847|NCT01479868|566206223|FG000|Overall Study|Adverse Event|1|||
156850848|NCT01479868|566206223|FG000|Overall Study|Lost to Follow-up|4|||
156850849|NCT01479868|566206223|FG000|Overall Study|Protocol Violation|1|||
156850850|NCT01479868|566206223|FG000|Overall Study|Withdrawal by Subject|1|||
156850851|NCT01479868|566206223|FG000|Overall Study|Sponsor's Decision|1|||
156850852|NCT01479868|566206223|FG000|Overall Study|Initiation of new HCV Therapy|1|||
156850853|NCT01618669|566206224|FG000|Overall Study|Lost to Follow-up|1|||
156850854|NCT01618669|566206225|FG001|Overall Study|Lost to Follow-up|1|||
156850855|NCT01618669|566206224|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
156850856|NCT01618669|566206225|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
156850857|NCT01618669|566206224|FG000|Overall Study|Adverse Event|16|||
156850858|NCT01618669|566206225|FG001|Overall Study|Adverse Event|7|||
156850859|NCT01618669|566206224|FG000|Overall Study|Protocol Violation|5|||
156850860|NCT01618669|566206225|FG001|Overall Study|Protocol Violation|3|||
156850861|NCT01618669|566206224|FG000|Overall Study|Withdrawal by Subject|9|||
156850862|NCT01618669|566206225|FG001|Overall Study|Withdrawal by Subject|9|||
156850863|NCT01618669|566206224|FG000|Overall Study|Miscellaneous Reason|0|||
156850864|NCT01618669|566206225|FG001|Overall Study|Miscellaneous Reason|1|||
156850865|NCT01177007|566206226|FG000|Overall Study|Lost to Follow-up|2|||
156850866|NCT01177007|566206226|FG000|Overall Study|Death|4|||
156850867|NCT01177007|566206226|FG000|Overall Study|Entered hospice care|5|||
156850868|NCT01177007|566206226|FG000|Overall Study|Required additional Y90 treatment|6|||
156850869|NCT01177007|566206226|FG000|Overall Study|Change in treatment modality|21|||
156850870|NCT02336230|566206234|FG000|Overall Study|Adverse Event|1|||
156850871|NCT02336230|566206234|FG000|Overall Study|Withdrawal of consent|1|||
156850872|NCT02336230|566206234|FG000|Overall Study|Death|9|||
156850873|NCT02336230|566206234|FG000|Overall Study|Dose not received due to shipping delay|1|||
156850874|NCT02336230|566206234|FG000|Overall Study|Discontinuation of MSC infusion|1|||
156850875|NCT03305770|566206242|FG000|Overall Study|Physician Decision - prior to dispense|0|||
156850876|NCT03305770|566206243|FG001|Overall Study|Physician Decision - prior to dispense|1|||
156850877|NCT03305770|566206242|FG000|Overall Study|Subject moved|1|||
156850878|NCT03305770|566206243|FG001|Overall Study|Subject moved|0|||
156850879|NCT03539601|566206244|FG000|Overall Study|Withdraw by parent/guardian|1|||
156850880|NCT03539601|566206245|FG001|Overall Study|Withdraw by parent/guardian|0|||
156850881|NCT03539601|566206246|FG002|Overall Study|Withdraw by parent/guardian|1|||
156850882|NCT03539601|566206247|FG003|Overall Study|Withdraw by parent/guardian|0|||
156850883|NCT03539601|566206244|FG000|Overall Study|Adverse Event|0|||
156850884|NCT03539601|566206245|FG001|Overall Study|Adverse Event|2|||
156850885|NCT03539601|566206246|FG002|Overall Study|Adverse Event|0|||
156850886|NCT03539601|566206247|FG003|Overall Study|Adverse Event|0|||
156850887|NCT03539601|566206244|FG000|Overall Study|Lost to Follow-up|2|||
156850888|NCT03539601|566206245|FG001|Overall Study|Lost to Follow-up|4|||
156850889|NCT03539601|566206246|FG002|Overall Study|Lost to Follow-up|5|||
156850890|NCT03539601|566206247|FG003|Overall Study|Lost to Follow-up|0|||
156850891|NCT03539601|566206244|FG000|Overall Study|Withdrawal by Subject|2|||
156850892|NCT03539601|566206245|FG001|Overall Study|Withdrawal by Subject|0|||
156850893|NCT03539601|566206246|FG002|Overall Study|Withdrawal by Subject|0|||
156850894|NCT03539601|566206247|FG003|Overall Study|Withdrawal by Subject|1|||
156850895|NCT03539601|566206244|FG000|Overall Study|Randomized but not treated|1|||
156850896|NCT03539601|566206245|FG001|Overall Study|Randomized but not treated|1|||
156850897|NCT03539601|566206246|FG002|Overall Study|Randomized but not treated|0|||
156850898|NCT03539601|566206247|FG003|Overall Study|Randomized but not treated|0|||
156850899|NCT01970306|566206248|FG000|Overall Study|Not eligible|3|||
156850900|NCT01970306|566206248|FG000|Overall Study|Not able to be treated|9|||
156850901|NCT03472326|566206249|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
156850902|NCT03472326|566206250|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
156342180|NCT04115839|564352572|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156471574|NCT02401815|564819656|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
156471575|NCT02401815|564819657|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
156471576|NCT02401815|564819658|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
156471577|NCT02401815|564819659|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
156471578|NCT02401815|564819660|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
156850903|NCT03472326|566206251|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
156850904|NCT03472326|566206252|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
156850905|NCT03472326|566206249|FG000|Part 2: Combination Therapy|Pregnancy|0|||
156850906|NCT03472326|566206250|FG001|Part 2: Combination Therapy|Pregnancy|0|||
156850907|NCT03472326|566206251|FG002|Part 2: Combination Therapy|Pregnancy|0|||
156850908|NCT03472326|566206252|FG003|Part 2: Combination Therapy|Pregnancy|1|||
156850909|NCT04739436|566206253|FG000|Overall Study|Lost to Follow-up|21|||
156850910|NCT04739436|566206254|FG001|Overall Study|Lost to Follow-up|23|||
156850911|NCT04739436|566206253|FG000|Overall Study|Withdrawal by Subject|4|||
156850912|NCT04739436|566206254|FG001|Overall Study|Withdrawal by Subject|6|||
156850913|NCT04739436|566206253|FG000|Overall Study|not randomized properly|1|||
156850914|NCT04739436|566206254|FG001|Overall Study|not randomized properly|0|||
156850915|NCT00428948|566206256|FG000|Overall Study|Lost to Follow-up|15|||
156850916|NCT00428948|566206257|FG001|Overall Study|Lost to Follow-up|8|||
156850917|NCT00428948|566206256|FG000|Overall Study|Adverse Event|148|||
156850918|NCT00428948|566206257|FG001|Overall Study|Adverse Event|24|||
156850919|NCT00428948|566206256|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
156850920|NCT00428948|566206257|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
156850921|NCT00428948|566206256|FG000|Overall Study|Investigator Withdrew Subject|3|||
156850922|NCT00428948|566206257|FG001|Overall Study|Investigator Withdrew Subject|4|||
156850923|NCT00428948|566206256|FG000|Overall Study|Subject Withdrew Consent|50|||
156850924|NCT00428948|566206257|FG001|Overall Study|Subject Withdrew Consent|30|||
156850925|NCT00428948|566206256|FG000|Overall Study|Protocol Deviation|1|||
156850926|NCT00428948|566206257|FG001|Overall Study|Protocol Deviation|1|||
156850927|NCT03622814|566206259|FG000|Overall Study|Lost to Follow-up|8|||
156850928|NCT03622814|566206260|FG001|Overall Study|Lost to Follow-up|14|||
156850929|NCT04417361|566206261|FG000|Overall Study|Withdrawal by Subject|1|||
156850930|NCT04417361|566206262|FG001|Overall Study|Withdrawal by Subject|0|||
156850931|NCT04417361|566206261|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
156850932|NCT04417361|566206262|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
156850933|NCT00892775|566206263|FG000|Overall Study|Protocol Violation|1|||
156850934|NCT00892775|566206264|FG001|Overall Study|Protocol Violation|0|||
156850935|NCT00892775|566206263|FG000|Overall Study|Subject difficulties with blood drawing|1|||
156850936|NCT00892775|566206264|FG001|Overall Study|Subject difficulties with blood drawing|0|||
156850937|NCT00892775|566206263|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
156850938|NCT00892775|566206264|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
156850939|NCT00892775|566206263|FG000|Overall Study|Migrated/ moved from study area|1|||
156850940|NCT00892775|566206264|FG001|Overall Study|Migrated/ moved from study area|0|||
156850941|NCT00892775|566206263|FG000|Overall Study|Withdrawal by Subject|0|||
156850942|NCT00892775|566206264|FG001|Overall Study|Withdrawal by Subject|1|||
156850943|NCT00892775|566206263|FG000|Overall Study|Lost to Follow-up|1|||
156850944|NCT00892775|566206264|FG001|Overall Study|Lost to Follow-up|0|||
156850945|NCT00699660|566206265|FG000|Overall Study|Lost to Follow-up|4|||
156850946|NCT00699660|566206266|FG001|Overall Study|Lost to Follow-up|2|||
156850947|NCT00699660|566206265|FG000|Overall Study|missing reports and recording failures|10|||
156850948|NCT00699660|566206266|FG001|Overall Study|missing reports and recording failures|6|||
156850949|NCT00250276|566206273|FG000|Overall Study|Serious Adverse Event|0|||
156850950|NCT00250276|566206274|FG001|Overall Study|Serious Adverse Event|0|||
156850951|NCT00250276|566206275|FG002|Overall Study|Serious Adverse Event|1|||
156850952|NCT00250276|566206276|FG003|Overall Study|Serious Adverse Event|0|||
156850953|NCT00250276|566206273|FG000|Overall Study|Non-serious Adverse Event|2|||
156850954|NCT00250276|566206274|FG001|Overall Study|Non-serious Adverse Event|0|||
156850955|NCT00250276|566206275|FG002|Overall Study|Non-serious Adverse Event|0|||
156850956|NCT00250276|566206276|FG003|Overall Study|Non-serious Adverse Event|2|||
156850957|NCT00250276|566206273|FG000|Overall Study|Protocol Violation|0|||
156850958|NCT00250276|566206274|FG001|Overall Study|Protocol Violation|1|||
156850959|NCT00250276|566206275|FG002|Overall Study|Protocol Violation|0|||
156850960|NCT00250276|566206276|FG003|Overall Study|Protocol Violation|0|||
156850961|NCT00250276|566206273|FG000|Overall Study|Withdrawal by Subject|1|||
156850962|NCT00250276|566206274|FG001|Overall Study|Withdrawal by Subject|2|||
156850963|NCT00250276|566206275|FG002|Overall Study|Withdrawal by Subject|3|||
156850964|NCT00250276|566206276|FG003|Overall Study|Withdrawal by Subject|2|||
156850965|NCT00250276|566206273|FG000|Overall Study|Migrated/moved from study area|3|||
156850966|NCT00250276|566206274|FG001|Overall Study|Migrated/moved from study area|0|||
156850967|NCT00250276|566206275|FG002|Overall Study|Migrated/moved from study area|2|||
156850968|NCT00250276|566206276|FG003|Overall Study|Migrated/moved from study area|7|||
156471579|NCT02401815|564819661|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
156471580|NCT02401815|564819652|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471581|NCT02401815|564819653|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471582|NCT02401815|564819654|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471583|NCT02401815|564819655|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471584|NCT02401815|564819656|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471585|NCT02401815|564819657|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
156471586|NCT02401815|564819658|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471587|NCT02401815|564819659|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471588|NCT02401815|564819660|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471589|NCT02401815|564819661|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
156471590|NCT02401815|564819652|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471591|NCT02401815|564819653|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471592|NCT02401815|564819654|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471593|NCT02401815|564819655|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471594|NCT02401815|564819656|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156850969|NCT00250276|566206273|FG000|Overall Study|Lost to Follow-up|11|||
156850970|NCT00250276|566206274|FG001|Overall Study|Lost to Follow-up|18|||
156850971|NCT00250276|566206275|FG002|Overall Study|Lost to Follow-up|13|||
156850972|NCT00250276|566206276|FG003|Overall Study|Lost to Follow-up|8|||
156850973|NCT00555217|566206277|FG000|Overall Study|Withdrawal by Subject|35|||
156850974|NCT00555217|566206278|FG001|Overall Study|Withdrawal by Subject|31|||
156850975|NCT00555217|566206277|FG000|Overall Study|Lost to Follow-up|19|||
156850976|NCT00555217|566206278|FG001|Overall Study|Lost to Follow-up|20|||
156850977|NCT00555217|566206277|FG000|Overall Study|close out sites|21|||
156850978|NCT00555217|566206278|FG001|Overall Study|close out sites|17|||
156850979|NCT00950248|566206286|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
156850980|NCT00950248|566206287|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
156850981|NCT00950248|566206288|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
156850982|NCT00950248|566206286|FG000|Year 1: Baseline|worsening of symptoms|2|||
156850983|NCT00950248|566206287|FG001|Year 1: Baseline|worsening of symptoms|0|||
156850984|NCT00950248|566206288|FG002|Year 1: Baseline|worsening of symptoms|0|||
156850985|NCT00950248|566206286|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
156850986|NCT00950248|566206287|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
156850987|NCT00950248|566206288|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
156850988|NCT00950248|566206286|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
156850989|NCT00950248|566206287|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
156850990|NCT00950248|566206288|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
156850991|NCT00950248|566206286|FG000|Year 2&3 Treatment Randomization|Death|0|||
156850992|NCT00950248|566206287|FG001|Year 2&3 Treatment Randomization|Death|0|||
156850993|NCT00950248|566206288|FG002|Year 2&3 Treatment Randomization|Death|1|||
156850994|NCT00950248|566206286|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
156850995|NCT00950248|566206287|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
156850996|NCT00950248|566206288|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
156850997|NCT01657292|566206292|FG000|Overall Study|Adverse Event|6|||
156850998|NCT01657292|566206292|FG000|Overall Study|Withdrawal by Subject|2|||
156850999|NCT01657292|566206292|FG000|Overall Study|Violation of eligibility criteria|1|||
156851000|NCT01657292|566206292|FG000|Overall Study|Change of therapy|1|||
156851001|NCT00650845|566206294|FG000|Overall Study|Withdrawal by Subject|5|||
156851002|NCT00650845|566206295|FG001|Overall Study|Withdrawal by Subject|0|||
156851003|NCT00650845|566206294|FG000|Overall Study|Protocol Violation|0|||
156851004|NCT00650845|566206295|FG001|Overall Study|Protocol Violation|13|||
156851005|NCT01900652|566206296|FG000|Overall Study|Progressive Disease|1|||
156851006|NCT01900652|566206297|FG001|Overall Study|Progressive Disease|0|||
156851007|NCT01900652|566206296|FG000|Overall Study|Consent withdrawn by subject|1|||
156851008|NCT01900652|566206297|FG001|Overall Study|Consent withdrawn by subject|1|||
156851009|NCT01900652|566206296|FG000|Overall Study|Death|3|||
156471595|NCT02401815|564819657|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156851010|NCT01900652|566206297|FG001|Overall Study|Death|0|||
156851011|NCT01900652|566206296|FG000|Overall Study|Adverse Event|2|||
156851012|NCT01900652|566206297|FG001|Overall Study|Adverse Event|1|||
156851013|NCT01900652|566206296|FG000|Overall Study|Physician Decision|1|||
156851014|NCT01900652|566206297|FG001|Overall Study|Physician Decision|1|||
156471596|NCT02401815|564819658|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
156851015|NCT03761810|566206298|FG000|Overall Study|Adverse Event|12|||
156851016|NCT03761810|566206299|FG001|Overall Study|Adverse Event|0|||
156851017|NCT03761810|566206298|FG000|Overall Study|Lost to Follow-up|15|||
156851018|NCT03761810|566206299|FG001|Overall Study|Lost to Follow-up|7|||
156851019|NCT03761810|566206298|FG000|Overall Study|Pregnancy|1|||
156851020|NCT03761810|566206299|FG001|Overall Study|Pregnancy|0|||
156851021|NCT03761810|566206298|FG000|Overall Study|Withdrawal by Subject|14|||
156851022|NCT03761810|566206299|FG001|Overall Study|Withdrawal by Subject|5|||
156851023|NCT03761810|566206298|FG000|Overall Study|Physician Decision|1|||
156851024|NCT03761810|566206299|FG001|Overall Study|Physician Decision|0|||
156851025|NCT03761810|566206298|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
156851026|NCT03761810|566206299|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156851027|NCT03761810|566206298|FG000|Overall Study|Other Than Specified|1|||
156851028|NCT03761810|566206299|FG001|Overall Study|Other Than Specified|0|||
156851029|NCT04178720|566206300|FG000|Overall Study|Withdrawal by Subject|2|||
156851030|NCT04178720|566206301|FG001|Overall Study|Withdrawal by Subject|0|||
156851031|NCT04178720|566206300|FG000|Overall Study|Relocation|0|||
156851032|NCT04178720|566206301|FG001|Overall Study|Relocation|1|||
156851033|NCT00869518|566206302|FG000|Overall Study|Lost to Follow-up|1|||
156851034|NCT00869518|566206303|FG001|Overall Study|Lost to Follow-up|1|||
156851035|NCT03566082|566206304|FG000|Overall Study|Death|7|||
156851036|NCT03566082|566206304|FG000|Overall Study|Failures (revision required)|2|||
156851037|NCT03566082|566206304|FG000|Overall Study|Lost to Follow-up|8|||
156851038|NCT03922620|566206305|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
156851039|NCT03922620|566206306|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
156851040|NCT02663622|566206307|FG000|Overall Study|Death|3|||
156851041|NCT02663622|566206308|FG001|Overall Study|Death|1|||
156851042|NCT02663622|566206309|FG002|Overall Study|Death|1|||
156851043|NCT02663622|566206310|FG003|Overall Study|Death|8|||
156851044|NCT02663622|566206307|FG000|Overall Study|Protocol Violation|0|||
156851045|NCT02663622|566206308|FG001|Overall Study|Protocol Violation|0|||
156851046|NCT02663622|566206309|FG002|Overall Study|Protocol Violation|0|||
156851047|NCT02663622|566206310|FG003|Overall Study|Protocol Violation|1|||
156851048|NCT04618744|566206313|FG000|Overall Study|Adverse Event|0|||
156851049|NCT04618744|566206314|FG001|Overall Study|Adverse Event|1|||
156851050|NCT04618744|566206313|FG000|Overall Study|Withdrawal by Subject|0|||
156851051|NCT04618744|566206314|FG001|Overall Study|Withdrawal by Subject|1|||
156851052|NCT00511238|566206315|FG000|Overall Study|Adverse Event|13|||
156851053|NCT00511238|566206316|FG001|Overall Study|Adverse Event|33|||
156851054|NCT00511238|566206315|FG000|Overall Study|Withdrawal by Subject|2|||
156851055|NCT00511238|566206316|FG001|Overall Study|Withdrawal by Subject|22|||
156851056|NCT00511238|566206315|FG000|Overall Study|Progressive Disease|23|||
156851057|NCT00511238|566206316|FG001|Overall Study|Progressive Disease|157|||
156851058|NCT00511238|566206315|FG000|Overall Study|various reasons|4|||
156851059|NCT00511238|566206316|FG001|Overall Study|various reasons|14|||
156851060|NCT00163020|566206317|FG000|Overall Study|Lost to Follow-up|0|||
156851061|NCT00163020|566206318|FG001|Overall Study|Lost to Follow-up|2|||
156851062|NCT03456076|566208968|FG000|Overall Study|Withdrawal by Subject|5|||
156851063|NCT03456076|566208969|FG001|Overall Study|Withdrawal by Subject|9|||
156851064|NCT03456076|566208968|FG000|Overall Study|Protocol deviation|0|||
156851065|NCT03456076|566208969|FG001|Overall Study|Protocol deviation|1|||
156471597|NCT02401815|564819659|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471598|NCT02401815|564819660|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471599|NCT02401815|564819661|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471600|NCT02401815|564819652|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
156471601|NCT02401815|564819653|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
156471602|NCT02401815|564819654|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
156471603|NCT02401815|564819655|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
156851066|NCT03456076|566208968|FG000|Overall Study|Lost to Follow-up|0|||
156851067|NCT03456076|566208969|FG001|Overall Study|Lost to Follow-up|1|||
156851068|NCT03456076|566208968|FG000|Overall Study|Death|2|||
156851069|NCT03456076|566208969|FG001|Overall Study|Death|5|||
156851070|NCT03456076|566208968|FG000|Overall Study|Study ongoing|123|||
156851071|NCT03456076|566208969|FG001|Overall Study|Study ongoing|111|||
156851072|NCT03906071|566208970|FG000|Overall Study|Death|180|||
156851073|NCT03906071|566208971|FG001|Overall Study|Death|185|||
156851074|NCT03906071|566208970|FG000|Overall Study|Lost to Follow-up|3|||
156851075|NCT03906071|566208971|FG001|Overall Study|Lost to Follow-up|3|||
156851076|NCT03906071|566208970|FG000|Overall Study|Withdrawal by Subject|15|||
156851077|NCT03906071|566208971|FG001|Overall Study|Withdrawal by Subject|27|||
156851078|NCT03906071|566208970|FG000|Overall Study|Other|2|||
156851079|NCT03906071|566208971|FG001|Overall Study|Other|1|||
156851080|NCT01359904|566208972|FG000|Overall Study|Withdrawal by Subject|1|||
156851081|NCT01359904|566208973|FG001|Overall Study|Withdrawal by Subject|0|||
156851082|NCT03191630|566208976|FG000|Overall Study|Lost to Follow-up|7|||
156851083|NCT03191630|566208977|FG001|Overall Study|Lost to Follow-up|7|||
156471604|NCT02401815|564819656|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
156471605|NCT02401815|564819657|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
156471606|NCT02401815|564819658|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
156471607|NCT02401815|564819659|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
156471608|NCT02401815|564819660|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
156471609|NCT02401815|564819661|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
156471610|NCT02401815|564819652|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471611|NCT02401815|564819653|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471612|NCT02401815|564819654|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471613|NCT02401815|564819655|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471614|NCT02401815|564819656|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471615|NCT02401815|564819657|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
156471616|NCT02401815|564819658|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471617|NCT02401815|564819659|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471618|NCT02401815|564819660|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471619|NCT02401815|564819661|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
156471620|NCT02401815|564819652|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
156471621|NCT02401815|564819653|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
156471622|NCT02401815|564819654|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
156471623|NCT02401815|564819655|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
156471624|NCT02401815|564819656|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
156471625|NCT02401815|564819657|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
156471626|NCT02401815|564819658|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
156471627|NCT02401815|564819659|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
156471628|NCT02401815|564819660|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
156471629|NCT02401815|564819661|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
156471630|NCT02401815|564819652|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471631|NCT02401815|564819653|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471632|NCT02401815|564819654|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471633|NCT02401815|564819655|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471634|NCT02401815|564819656|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471635|NCT02401815|564819657|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471636|NCT02401815|564819658|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471637|NCT02401815|564819659|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
156471638|NCT02401815|564819660|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
156471639|NCT02401815|564819661|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
156471640|NCT02401815|564819652|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471641|NCT02401815|564819653|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471642|NCT02401815|564819654|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471643|NCT02401815|564819655|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471644|NCT02401815|564819656|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471645|NCT02401815|564819657|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471646|NCT02401815|564819658|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471647|NCT02401815|564819659|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471648|NCT02401815|564819660|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
156471649|NCT02401815|564819661|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
156471650|NCT02401815|564819652|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471651|NCT02401815|564819653|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471652|NCT02401815|564819654|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471653|NCT02401815|564819655|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471654|NCT02401815|564819656|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471655|NCT02401815|564819657|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471656|NCT02401815|564819658|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471657|NCT02401815|564819659|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471658|NCT02401815|564819660|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
156542178|NCT00388973|565079254|FG000|Overall Study|Did not complete 61 days of treatment|5|||
156342181|NCT04115839|564352566|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156471659|NCT02401815|564819661|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
156471660|NCT02401815|564819652|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
156471661|NCT02401815|564819653|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
156471662|NCT02401815|564819654|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
156471663|NCT02401815|564819655|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
156471664|NCT02401815|564819656|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
156471665|NCT02401815|564819657|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
156471666|NCT02401815|564819658|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
156471667|NCT02401815|564819659|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
156471668|NCT02401815|564819660|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
156471669|NCT02401815|564819661|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
156471670|NCT05815342|564820636|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
156471671|NCT05815342|564820636|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
156471672|NCT05815342|564820636|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
156471673|NCT05815342|564820636|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
156471674|NCT05815342|564820636|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
156471675|NCT00345046|564820639|FG000|Overall Study|Protocol Violation|1|||
156471676|NCT00345046|564820640|FG001|Overall Study|Protocol Violation|1|||
156471677|NCT00345046|564820641|FG002|Overall Study|Protocol Violation|2|||
156471678|NCT03689946|564820642|FG000|Overall Study|Withdrawal by Subject|3|||
156471679|NCT03689946|564820642|FG000|Overall Study|Lost to Follow-up|3|||
156471680|NCT03689946|564820642|FG000|Overall Study|Data corruption|2|||
156471681|NCT01555138|564820643|FG000|Overall Study|Death|0|||
156471682|NCT01555138|564820644|FG001|Overall Study|Death|1|||
156471683|NCT01555138|564820643|FG000|Overall Study|Lost to Follow-up|1|||
156471684|NCT01555138|564820644|FG001|Overall Study|Lost to Follow-up|0|||
156471685|NCT01555138|564820643|FG000|Overall Study|Abnormal Lab reults|1|||
156471686|NCT01555138|564820644|FG001|Overall Study|Abnormal Lab reults|3|||
156471687|NCT01555138|564820643|FG000|Overall Study|Lack of Efficacy|2|||
156471688|NCT01555138|564820644|FG001|Overall Study|Lack of Efficacy|2|||
156471689|NCT01555138|564820643|FG000|Overall Study|Protocol Violation|5|||
156471690|NCT01555138|564820644|FG001|Overall Study|Protocol Violation|3|||
156471691|NCT01555138|564820643|FG000|Overall Study|Administrative problems|8|||
156471692|NCT01555138|564820644|FG001|Overall Study|Administrative problems|0|||
156471693|NCT01555138|564820643|FG000|Overall Study|Withdrawal by Subject|16|||
156471694|NCT01555138|564820644|FG001|Overall Study|Withdrawal by Subject|15|||
156471695|NCT01555138|564820643|FG000|Overall Study|Adverse Event|14|||
156471696|NCT01555138|564820644|FG001|Overall Study|Adverse Event|14|||
156471697|NCT00512252|564820648|FG000|Overall Study|Lost to Follow-up|0|||
156471698|NCT00512252|564820649|FG001|Overall Study|Lost to Follow-up|0|||
156471699|NCT00512252|564820650|FG002|Overall Study|Lost to Follow-up|1|||
156471700|NCT00512252|564820648|FG000|Overall Study|Protocol Violation|0|||
156471701|NCT00512252|564820649|FG001|Overall Study|Protocol Violation|0|||
156471702|NCT00512252|564820650|FG002|Overall Study|Protocol Violation|1|||
156471703|NCT00512252|564820648|FG000|Overall Study|Death|0|||
156471704|NCT00512252|564820649|FG001|Overall Study|Death|0|||
156471705|NCT00512252|564820650|FG002|Overall Study|Death|1|||
156471706|NCT02357966|564820651|FG000|Overall Study|Death|0|||
156471707|NCT02357966|564820652|FG001|Overall Study|Death|0|||
156471708|NCT02357966|564820653|FG002|Overall Study|Death|1|||
156471709|NCT02357966|564820654|FG003|Overall Study|Death|0|||
156471710|NCT02357966|564820655|FG004|Overall Study|Death|2|||
156471711|NCT02357966|564820656|FG005|Overall Study|Death|0|||
156471712|NCT02357966|564820651|FG000|Overall Study|Physician Decision|1|||
156471713|NCT02357966|564820652|FG001|Overall Study|Physician Decision|0|||
156471714|NCT02357966|564820653|FG002|Overall Study|Physician Decision|0|||
156542179|NCT00388973|565079255|FG001|Overall Study|Did not complete 61 days of treatment|4|||
156342182|NCT04115839|564352567|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156471715|NCT02357966|564820654|FG003|Overall Study|Physician Decision|0|||
156471716|NCT02357966|564820655|FG004|Overall Study|Physician Decision|1|||
156471717|NCT02357966|564820656|FG005|Overall Study|Physician Decision|0|||
156471718|NCT04608409|564820659|FG000|Overall Study|Physician Decision|1|||
156471719|NCT04608409|564820660|FG001|Overall Study|Physician Decision|1|||
156471720|NCT04608409|564820661|FG002|Overall Study|Physician Decision|2|||
156471721|NCT01787032|564820662|FG000|Overall Study|Protocol Violation|0|||
156471722|NCT01787032|564820663|FG001|Overall Study|Protocol Violation|0|||
156471723|NCT01787032|564820664|FG002|Overall Study|Protocol Violation|0|||
156471724|NCT01787032|564820665|FG003|Overall Study|Protocol Violation|0|||
156471725|NCT01787032|564820666|FG004|Overall Study|Protocol Violation|1|||
156471726|NCT01787032|564820667|FG005|Overall Study|Protocol Violation|1|||
156471727|NCT02040870|564820668|FG000|Overall Study|Completed treatment phase|6|||
156471728|NCT02040870|564820668|FG000|Overall Study|Adverse Event|7|||
156471729|NCT02040870|564820668|FG000|Overall Study|Progressive disease|58|||
156471730|NCT02040870|564820668|FG000|Overall Study|Physician Decision|6|||
156471731|NCT02040870|564820668|FG000|Overall Study|Subject/guardian decision|10|||
156471732|NCT02040870|564820668|FG000|Overall Study|Lost to Follow-up|3|||
156471733|NCT02040870|564820668|FG000|Overall Study|Death|13|||
156471734|NCT04941482|564820676|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
156471735|NCT04941482|564820677|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
156471736|NCT00687219|564820679|FG000|Overall Study|Adverse Event|8|||
156471737|NCT00687219|564820679|FG000|Overall Study|Discontinuance criteria met|7|||
156471738|NCT00687219|564820679|FG000|Overall Study|HCV-RNA positive conversion|34|||
156471739|NCT00687219|564820679|FG000|Overall Study|Withdrawal by Subject|1|||
156471740|NCT00687219|564820679|FG000|Overall Study|Lack of Efficacy|1|||
156471741|NCT01367236|564820680|FG000|Overall Study|Withdrawal by Subject|3|||
156471742|NCT01367236|564820681|FG001|Overall Study|Withdrawal by Subject|1|||
156471743|NCT04827732|564820689|FG000|Overall Study|Did not start treatment|0|||
156471744|NCT04827732|564820690|FG001|Overall Study|Did not start treatment|1|||
156471745|NCT04827732|564820691|FG002|Overall Study|Did not start treatment|0|||
156471746|NCT04827732|564820692|FG003|Overall Study|Did not start treatment|1|||
156471747|NCT04057131|564820695|FG000|Overall Study|Protocol Violation|24|||
156471748|NCT04686266|564820698|FG000|Overall Study|Withdrawal by Subject|0|||
156471749|NCT04686266|564820699|FG001|Overall Study|Withdrawal by Subject|1|||
156471750|NCT05613907|564820704|FG000|Overall Study|Lost to Follow-up|5|||
156471751|NCT05613907|564820704|FG000|Overall Study|Death|3|||
156471752|NCT05613907|564820704|FG000|Overall Study|Withdrawal by Subject|2|||
156471753|NCT00748709|564820714|FG000|Overall Study|Progressive disease|15|||
156471754|NCT00748709|564820714|FG000|Overall Study|Drug reducing Toxity|2|||
156471755|NCT00748709|564820714|FG000|Overall Study|Other Adverse Event|1|||
156471756|NCT00748709|564820714|FG000|Overall Study|Withdrawal by Subject|1|||
156471757|NCT00748709|564820714|FG000|Overall Study|Other Reasons|1|||
156471758|NCT03789656|564820715|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
156471759|NCT03789656|564820716|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
156471760|NCT03789656|564820717|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
156471761|NCT03789656|564820718|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
156471762|NCT03789656|564820719|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
156471763|NCT03789656|564820715|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
156471764|NCT03789656|564820716|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
156471765|NCT03789656|564820717|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
156471766|NCT03789656|564820718|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
156471767|NCT03789656|564820719|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
156471768|NCT03789656|564820715|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
156471769|NCT03789656|564820716|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
156471770|NCT03789656|564820717|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
156471771|NCT03789656|564820718|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
156471772|NCT03789656|564820719|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
156471773|NCT03789656|564820715|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
156471774|NCT03789656|564820716|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
156471775|NCT03789656|564820717|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
156471776|NCT03789656|564820718|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
156471777|NCT03789656|564820719|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
156471778|NCT05325294|564820725|FG000|Overall Study|Adverse Event|3|||
156471779|NCT05325294|564820726|FG001|Overall Study|Adverse Event|3|||
156471780|NCT05325294|564820725|FG000|Overall Study|Physician Decision|0|||
156471781|NCT05325294|564820726|FG001|Overall Study|Physician Decision|1|||
156471782|NCT05325294|564820725|FG000|Overall Study|Withdrawal by Subject|0|||
156471783|NCT05325294|564820726|FG001|Overall Study|Withdrawal by Subject|3|||
156342183|NCT04115839|564352568|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
156471784|NCT05325294|564820725|FG000|Overall Study|Lost to Follow-up|1|||
156471785|NCT05325294|564820726|FG001|Overall Study|Lost to Follow-up|0|||
156471786|NCT05325294|564820725|FG000|Overall Study|Sponsor Request|0|||
156471787|NCT05325294|564820726|FG001|Overall Study|Sponsor Request|2|||
156471788|NCT00491894|564820727|FG000|Overall Study|Adverse Event|14|||
156471789|NCT00491894|564820727|FG000|Overall Study|Withdrawal by Subject|5|||
156471790|NCT00491894|564820727|FG000|Overall Study|Death|3|||
156471791|NCT00491894|564820727|FG000|Overall Study|Lost to Follow-up|3|||
156471792|NCT00491894|564820727|FG000|Overall Study|Lack of Efficacy|2|||
156471793|NCT00491894|564820727|FG000|Overall Study|Other-Failed to meet any criteria|2|||
156471794|NCT00491894|564820727|FG000|Overall Study|Physician Decision|2|||
156471795|NCT00491894|564820727|FG000|Overall Study|Protocol Violation|2|||
156471796|NCT00491894|564820727|FG000|Overall Study|Other-Intake of prohibited medication|1|||
156471797|NCT01563185|564820728|FG000|Overall Study|Withdrawal by Subject|1|||
156471798|NCT01563185|564820728|FG000|Overall Study|Non-Compliance with study drug|1|||
156471799|NCT04577651|564820729|FG000|Overall Study|Screen Failure|7|||
156471800|NCT04577651|564820729|FG000|Overall Study|Adverse Event|1|||
156471801|NCT04577651|564820729|FG000|Overall Study|Death|1|||
156471802|NCT04577651|564820729|FG000|Overall Study|Physician Decision|1|||
156471803|NCT04577651|564820729|FG000|Overall Study|Withdrawal by Subject|3|||
156471804|NCT05422339|564821912|FG000|Overall Study|Withdrawal by Subject|17|||
156471805|NCT05422339|564821913|FG001|Overall Study|Withdrawal by Subject|15|||
156471806|NCT04172675|564821914|FG000|Overall Study|Withdrawal by Subject|7|||
156471807|NCT04172675|564821915|FG001|Overall Study|Withdrawal by Subject|5|||
156471808|NCT04172675|564821916|FG002|Overall Study|Withdrawal by Subject|1|||
156471809|NCT04172675|564821917|FG003|Overall Study|Withdrawal by Subject|4|||
156471810|NCT03070392|564821924|FG000|Overall Study|Not Treated|7|||
156471811|NCT03070392|564821925|FG001|Overall Study|Not Treated|0|||
156471812|NCT03070392|564821926|FG002|Overall Study|Not Treated|3|||
156471813|NCT03070392|564821927|FG003|Overall Study|Not Treated|12|||
156471814|NCT03070392|564821924|FG000|Overall Study|Death|3|||
156471815|NCT03070392|564821925|FG001|Overall Study|Death|0|||
156471816|NCT03070392|564821926|FG002|Overall Study|Death|0|||
156471817|NCT03070392|564821927|FG003|Overall Study|Death|1|||
156471818|NCT03070392|564821924|FG000|Overall Study|Withdrawal by Subject|7|||
156471819|NCT03070392|564821925|FG001|Overall Study|Withdrawal by Subject|0|||
156471820|NCT03070392|564821926|FG002|Overall Study|Withdrawal by Subject|0|||
156851084|NCT03018691|566208979|FG000|Overall Study|Adverse Event|1|||
156851085|NCT03018691|566208980|FG001|Overall Study|Adverse Event|1|||
156851086|NCT03018691|566208981|FG002|Overall Study|Adverse Event|4|||
156851087|NCT03018691|566208979|FG000|Overall Study|Lack of Efficacy|0|||
156851088|NCT03018691|566208980|FG001|Overall Study|Lack of Efficacy|0|||
156851089|NCT03018691|566208981|FG002|Overall Study|Lack of Efficacy|1|||
156851090|NCT03018691|566208979|FG000|Overall Study|Withdrawal by Subject|0|||
156851091|NCT03018691|566208980|FG001|Overall Study|Withdrawal by Subject|0|||
156851092|NCT03018691|566208981|FG002|Overall Study|Withdrawal by Subject|1|||
156851093|NCT03018691|566208979|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156851094|NCT03018691|566208980|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156851095|NCT03018691|566208981|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156851096|NCT03369418|566208983|FG000|Overall Study|Withdrawal by Subject|3|||
156851097|NCT03369418|566208984|FG001|Overall Study|Withdrawal by Subject|3|||
156851098|NCT01485094|566208985|FG000|Overall Study|Adverse Event|1|||
156851099|NCT01485094|566208986|FG001|Overall Study|Adverse Event|1|||
156851100|NCT01485094|566208987|FG002|Overall Study|Adverse Event|1|||
156851101|NCT01485094|566208985|FG000|Overall Study|Lost to Follow-up|1|||
156851102|NCT01485094|566208986|FG001|Overall Study|Lost to Follow-up|0|||
156851103|NCT01485094|566208987|FG002|Overall Study|Lost to Follow-up|0|||
156342184|NCT04115839|564352569|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156342185|NCT04115839|564352570|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156471821|NCT03070392|564821927|FG003|Overall Study|Withdrawal by Subject|3|||
156471822|NCT03070392|564821924|FG000|Overall Study|Physician Decision|1|||
156471823|NCT03070392|564821925|FG001|Overall Study|Physician Decision|0|||
156851104|NCT01485094|566208985|FG000|Overall Study|Withdrawal by Subject|1|||
156851105|NCT01485094|566208986|FG001|Overall Study|Withdrawal by Subject|1|||
156851106|NCT01485094|566208987|FG002|Overall Study|Withdrawal by Subject|0|||
156471824|NCT03070392|564821926|FG002|Overall Study|Physician Decision|0|||
156851107|NCT01450761|566208988|FG000|Randomization|Subject no longer meets study criteria|1|||
156851108|NCT01450761|566208989|FG001|Randomization|Subject no longer meets study criteria|2|||
156851109|NCT01450761|566208988|FG000|Randomization|Withdrawal by Subject|2|||
156851110|NCT01450761|566208989|FG001|Randomization|Withdrawal by Subject|0|||
156851111|NCT01450761|566208988|FG000|Randomization|Disease progression|0|||
156851112|NCT01450761|566208989|FG001|Randomization|Disease progression|2|||
156851113|NCT01450761|566208988|FG000|Randomization|Adverse Event unrelated to study drug|1|||
156851114|NCT01450761|566208989|FG001|Randomization|Adverse Event unrelated to study drug|0|||
156851115|NCT01450761|566208988|FG000|Randomization|Other|0|||
156851116|NCT01450761|566208989|FG001|Randomization|Other|1|||
156851117|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Disease progression|33|||
156851118|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Disease progression|32|||
156851119|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
156851120|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
156851121|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
156471825|NCT03070392|564821927|FG003|Overall Study|Physician Decision|2|||
156471826|NCT03070392|564821924|FG000|Overall Study|Progressive Disease|154|||
156471827|NCT03070392|564821925|FG001|Overall Study|Progressive Disease|6|||
156471828|NCT03070392|564821926|FG002|Overall Study|Progressive Disease|2|||
156471829|NCT03070392|564821927|FG003|Overall Study|Progressive Disease|70|||
156471830|NCT03070392|564821924|FG000|Overall Study|Adverse Event|6|||
156471831|NCT03070392|564821925|FG001|Overall Study|Adverse Event|1|||
156471832|NCT03070392|564821926|FG002|Overall Study|Adverse Event|1|||
156471833|NCT03070392|564821927|FG003|Overall Study|Adverse Event|3|||
156471834|NCT03070392|564821924|FG000|Overall Study|Alternate anticancer treatment|1|||
156471835|NCT03070392|564821925|FG001|Overall Study|Alternate anticancer treatment|0|||
156471836|NCT03070392|564821926|FG002|Overall Study|Alternate anticancer treatment|0|||
156471837|NCT03070392|564821927|FG003|Overall Study|Alternate anticancer treatment|1|||
156471838|NCT03070392|564821924|FG000|Overall Study|Ongoing|73|||
156471839|NCT03070392|564821925|FG001|Overall Study|Ongoing|0|||
156471840|NCT03070392|564821926|FG002|Overall Study|Ongoing|0|||
156471841|NCT03070392|564821927|FG003|Overall Study|Ongoing|11|||
156471842|NCT02534233|564821930|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
156471843|NCT00925548|564821934|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
156471844|NCT00925548|564821935|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
156471845|NCT01278030|564821936|FG000|Overall Study|Withdrawal by Subject|8|||
156471846|NCT01278030|564821937|FG001|Overall Study|Withdrawal by Subject|4|||
156471847|NCT00458783|564821939|FG000|Overall Study|Protocol Violation|1228|||
156471848|NCT00458783|564821940|FG001|Overall Study|Protocol Violation|1220|||
156471849|NCT01737398|564821941|FG000|Overall Study|Adverse event or SAE|16|||
156471850|NCT01737398|564821942|FG001|Overall Study|Adverse event or SAE|1|||
156471851|NCT01737398|564821941|FG000|Overall Study|Stopping rule met|2|||
156471852|NCT01737398|564821942|FG001|Overall Study|Stopping rule met|1|||
156471853|NCT01737398|564821941|FG000|Overall Study|Voluntary withdrawal|2|||
156471854|NCT01737398|564821942|FG001|Overall Study|Voluntary withdrawal|3|||
156471855|NCT01737398|564821941|FG000|Overall Study|Ineligibility|1|||
156471856|NCT01737398|564821942|FG001|Overall Study|Ineligibility|0|||
156471857|NCT01737398|564821941|FG000|Overall Study|Liver transplant|1|||
156471858|NCT01737398|564821942|FG001|Overall Study|Liver transplant|0|||
156471859|NCT01737398|564821941|FG000|Overall Study|Disease progression|2|||
156471860|NCT01737398|564821942|FG001|Overall Study|Disease progression|3|||
156471861|NCT01737398|564821941|FG000|Overall Study|Sponsor's decision|2|||
156471862|NCT01737398|564821942|FG001|Overall Study|Sponsor's decision|0|||
156471863|NCT02372799|564821945|FG000|Treatment Period|Adverse Event|3|||
156471864|NCT02372799|564821946|FG001|Treatment Period|Adverse Event|10|||
156471865|NCT02372799|564821947|FG002|Treatment Period|Adverse Event|6|||
156471866|NCT02372799|564821945|FG000|Treatment Period|Insufficient therapeutic response|2|||
156471867|NCT02372799|564821946|FG001|Treatment Period|Insufficient therapeutic response|2|||
156471868|NCT02372799|564821947|FG002|Treatment Period|Insufficient therapeutic response|0|||
156471869|NCT02372799|564821945|FG000|Treatment Period|Withdrawal by Subject|10|||
156471870|NCT02372799|564821946|FG001|Treatment Period|Withdrawal by Subject|10|||
156471871|NCT02372799|564821947|FG002|Treatment Period|Withdrawal by Subject|2|||
156471872|NCT02372799|564821945|FG000|Treatment Period|Lost to Follow-up|11|||
156471873|NCT02372799|564821946|FG001|Treatment Period|Lost to Follow-up|5|||
156471874|NCT02372799|564821947|FG002|Treatment Period|Lost to Follow-up|3|||
156471875|NCT02372799|564821945|FG000|Treatment Period|Protocol Violation|3|||
156471876|NCT02372799|564821946|FG001|Treatment Period|Protocol Violation|0|||
156471877|NCT02372799|564821947|FG002|Treatment Period|Protocol Violation|0|||
156471878|NCT02372799|564821945|FG000|Treatment Period|Non-compliance with study drug|4|||
156471879|NCT02372799|564821946|FG001|Treatment Period|Non-compliance with study drug|4|||
156471880|NCT02372799|564821947|FG002|Treatment Period|Non-compliance with study drug|4|||
156471881|NCT02372799|564821945|FG000|Treatment Period|Miscellaneous Reasons|1|||
156471882|NCT02372799|564821946|FG001|Treatment Period|Miscellaneous Reasons|1|||
156471883|NCT02372799|564821947|FG002|Treatment Period|Miscellaneous Reasons|0|||
156471884|NCT02372799|564821945|FG000|Down-taper Period|Lost to Follow-up|1|||
156471885|NCT02372799|564821946|FG001|Down-taper Period|Lost to Follow-up|2|||
156471886|NCT02372799|564821947|FG002|Down-taper Period|Lost to Follow-up|2|||
156471887|NCT00089609|564821948|FG000|Overall Study|Withdrawal by Subject|3|||
156471888|NCT00089609|564821949|FG001|Overall Study|Withdrawal by Subject|1|||
156851122|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
156851123|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
156851124|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
156471889|NCT03220724|564821955|FG000|Overall Study|Lost to Follow-up|2|||
156471890|NCT03220724|564821956|FG001|Overall Study|Lost to Follow-up|2|||
156471891|NCT03220724|564821957|FG002|Overall Study|Lost to Follow-up|0|||
156471892|NCT03220724|564821958|FG003|Overall Study|Lost to Follow-up|3|||
156471893|NCT03220724|564821959|FG004|Overall Study|Lost to Follow-up|1|||
156471894|NCT03220724|564821960|FG005|Overall Study|Lost to Follow-up|0|||
156471895|NCT03220724|564821961|FG006|Overall Study|Lost to Follow-up|2|||
156471896|NCT03220724|564821962|FG007|Overall Study|Lost to Follow-up|1|||
156471897|NCT03220724|564821963|FG008|Overall Study|Lost to Follow-up|0|||
156471898|NCT03220724|564821955|FG000|Overall Study|Withdrawal by Subject|1|||
156471899|NCT03220724|564821956|FG001|Overall Study|Withdrawal by Subject|0|||
156471900|NCT03220724|564821957|FG002|Overall Study|Withdrawal by Subject|1|||
156471901|NCT03220724|564821958|FG003|Overall Study|Withdrawal by Subject|0|||
156471902|NCT03220724|564821959|FG004|Overall Study|Withdrawal by Subject|0|||
156851125|NCT01450761|566208988|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
156851126|NCT01450761|566208989|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
156851127|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Death|3|||
156851128|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Death|3|||
156851129|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Other|2|||
156851130|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Other|2|||
156851131|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
156851132|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
156851133|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
156851134|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
156851135|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
156851136|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
156851137|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
156851138|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
156851139|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
156851140|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
156851141|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
156851142|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
156851143|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Death|5|||
156851144|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Death|6|||
156851145|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
156851146|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
156851147|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
156851148|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
156851149|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
156851150|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
156851151|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
156851152|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
156851153|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
156851154|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
156851155|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
156851156|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
156851157|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
156851158|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
156851159|NCT03801174|566208994|FG000|Overall Study|Withdrawal by Subject|14|||
156851160|NCT03801174|566208995|FG001|Overall Study|Withdrawal by Subject|15|||
156851161|NCT03801174|566208994|FG000|Overall Study|Death|1|||
156851162|NCT03801174|566208995|FG001|Overall Study|Death|0|||
156851163|NCT03801174|566208994|FG000|Overall Study|Pregnancy|2|||
156471903|NCT03220724|564821960|FG005|Overall Study|Withdrawal by Subject|0|||
156471904|NCT03220724|564821961|FG006|Overall Study|Withdrawal by Subject|0|||
156471905|NCT03220724|564821962|FG007|Overall Study|Withdrawal by Subject|0|||
156471906|NCT03220724|564821963|FG008|Overall Study|Withdrawal by Subject|0|||
156471907|NCT01613417|564821964|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
156471908|NCT01613417|564821965|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
156471909|NCT00047385|564821967|FG000|Overall Study|Death before any screening|2|||
156471910|NCT00047385|564821968|FG001|Overall Study|Death before any screening|5|||
156471911|NCT00047385|564821967|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
156471912|NCT00047385|564821968|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
156471913|NCT00047385|564821967|FG000|Overall Study|Eligible for screening but had no screen|260|||
156471914|NCT00047385|564821968|FG001|Overall Study|Eligible for screening but had no screen|492|||
156471915|NCT03392194|564821969|FG000|Overall Study|Withdrawal by Subject|1|||
156471916|NCT03392194|564821970|FG001|Overall Study|Withdrawal by Subject|2|||
156851164|NCT03801174|566208995|FG001|Overall Study|Pregnancy|2|||
156851165|NCT03801174|566208994|FG000|Overall Study|Lost to Follow-up|19|||
156851166|NCT03801174|566208995|FG001|Overall Study|Lost to Follow-up|10|||
156851167|NCT03801174|566208994|FG000|Overall Study|Other|4|||
156851168|NCT03801174|566208995|FG001|Overall Study|Other|3|||
156851169|NCT03801174|566208994|FG000|Overall Study|Lack of Efficacy|4|||
156471917|NCT03392194|564821969|FG000|Overall Study|Conflicts with personal schedule|1|||
156471918|NCT03392194|564821970|FG001|Overall Study|Conflicts with personal schedule|0|||
156471919|NCT03865732|564821971|FG000|Overall Study|Adverse Event|0|||
156471920|NCT03865732|564821972|FG001|Overall Study|Adverse Event|1|||
156542180|NCT00388973|565079254|FG000|Overall Study|Left region|0|||
156471921|NCT03345979|564821976|FG000|Overall Study|Withdrawal by Subject|20|||
156471922|NCT03345979|564821977|FG001|Overall Study|Withdrawal by Subject|31|||
156471923|NCT03345979|564821976|FG000|Overall Study|Adverse Event|10|||
156471924|NCT03345979|564821977|FG001|Overall Study|Adverse Event|11|||
156471925|NCT03345979|564821976|FG000|Overall Study|Lost to Follow-up|8|||
156471926|NCT03345979|564821977|FG001|Overall Study|Lost to Follow-up|9|||
156471927|NCT03345979|564821976|FG000|Overall Study|Lack of Efficacy|4|||
156471928|NCT03345979|564821977|FG001|Overall Study|Lack of Efficacy|2|||
156471929|NCT03345979|564821976|FG000|Overall Study|Protocol Violation|1|||
156471930|NCT03345979|564821977|FG001|Overall Study|Protocol Violation|3|||
156471931|NCT03345979|564821976|FG000|Overall Study|Physician Decision|0|||
156471932|NCT03345979|564821977|FG001|Overall Study|Physician Decision|2|||
156471933|NCT00620854|564821978|FG000|Washout 1|Withdrawal by Subject|0|||
156471934|NCT00620854|564821979|FG001|Washout 1|Withdrawal by Subject|0|||
156471935|NCT00620854|564821980|FG002|Washout 1|Withdrawal by Subject|1|||
156471936|NCT00620854|564821981|FG003|Washout 1|Withdrawal by Subject|1|||
156471937|NCT00620854|564821982|FG004|Washout 1|Withdrawal by Subject|0|||
156471938|NCT00620854|564821983|FG005|Washout 1|Withdrawal by Subject|0|||
156471939|NCT00734578|564821986|FG000|Overall Study|Adverse Event|4|||
156471940|NCT00734578|564821987|FG001|Overall Study|Adverse Event|6|||
156471941|NCT00734578|564821988|FG002|Overall Study|Adverse Event|1|||
156471942|NCT00734578|564821986|FG000|Overall Study|Protocol Violation|8|||
156471943|NCT00734578|564821987|FG001|Overall Study|Protocol Violation|6|||
156851170|NCT03801174|566208995|FG001|Overall Study|Lack of Efficacy|0|||
156851171|NCT03801174|566208994|FG000|Overall Study|Unwilling to complete activities|5|||
156851172|NCT03801174|566208995|FG001|Overall Study|Unwilling to complete activities|6|||
156851173|NCT03801174|566208994|FG000|Overall Study|Moved out of area|3|||
156851174|NCT03801174|566208995|FG001|Overall Study|Moved out of area|0|||
156851175|NCT04435366|566208999|FG000|Year 1 (12 Months)|Adverse Event|3|||
156851176|NCT04435366|566209000|FG001|Year 1 (12 Months)|Adverse Event|0|||
156851177|NCT04435366|566209001|FG002|Year 1 (12 Months)|Adverse Event|2|||
156851178|NCT04435366|566208999|FG000|Year 1 (12 Months)|Death|2|||
156851179|NCT04435366|566209000|FG001|Year 1 (12 Months)|Death|0|||
156851180|NCT04435366|566209001|FG002|Year 1 (12 Months)|Death|1|||
156851181|NCT04435366|566208999|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
156851182|NCT04435366|566209000|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
156851183|NCT04435366|566209001|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
156851184|NCT04435366|566208999|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
156851185|NCT04435366|566209000|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
156851186|NCT04435366|566209001|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
156851187|NCT04435366|566208999|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
156851188|NCT04435366|566209000|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
156851189|NCT04435366|566209001|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
156851190|NCT04435366|566208999|FG000|Year 1 (12 Months)|Not treated|0|||
156851191|NCT04435366|566209000|FG001|Year 1 (12 Months)|Not treated|0|||
156851192|NCT04435366|566209001|FG002|Year 1 (12 Months)|Not treated|1|||
156851193|NCT04435366|566208999|FG000|Year 2 (12 Months)|Death|1|||
156851194|NCT04435366|566209000|FG001|Year 2 (12 Months)|Death|4|||
156851195|NCT04435366|566209001|FG002|Year 2 (12 Months)|Death|6|||
156851196|NCT04435366|566208999|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
156851197|NCT04435366|566209000|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
156851198|NCT04435366|566209001|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
156851199|NCT04435366|566208999|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
156851200|NCT04435366|566209000|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
156851201|NCT04435366|566209001|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
156851202|NCT04435366|566208999|FG000|Year 2 (12 Months)|Adverse Event|2|||
156851203|NCT04435366|566209000|FG001|Year 2 (12 Months)|Adverse Event|1|||
156851204|NCT04435366|566209001|FG002|Year 2 (12 Months)|Adverse Event|6|||
156851205|NCT04112810|566209002|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
156851206|NCT01687296|566209003|FG000|Overall Study|Lack of Efficacy|1|||
156851207|NCT01687296|566209004|FG001|Overall Study|Lack of Efficacy|1|||
156851208|NCT01687296|566209003|FG000|Overall Study|Protocol Violation|0|||
156851209|NCT01687296|566209004|FG001|Overall Study|Protocol Violation|1|||
156851210|NCT01687296|566209003|FG000|Overall Study|Withdrawal by Subject|6|||
156851211|NCT01687296|566209004|FG001|Overall Study|Withdrawal by Subject|3|||
156851212|NCT01508169|566209005|FG000|Overall Study|Adverse Event|1|||
156851213|NCT01508169|566209006|FG001|Overall Study|Adverse Event|0|||
156851214|NCT01508169|566209005|FG000|Overall Study|Withdrawal by Subject|1|||
156851215|NCT01508169|566209006|FG001|Overall Study|Withdrawal by Subject|0|||
156471944|NCT00734578|564821988|FG002|Overall Study|Protocol Violation|3|||
156471945|NCT00734578|564821986|FG000|Overall Study|Withdrawal by Subject|7|||
156471946|NCT00734578|564821987|FG001|Overall Study|Withdrawal by Subject|8|||
156471947|NCT00734578|564821988|FG002|Overall Study|Withdrawal by Subject|11|||
156471948|NCT00734578|564821986|FG000|Overall Study|Lost to Follow-up|9|||
156851216|NCT01508169|566209005|FG000|Overall Study|Lost to Follow-up|1|||
156851217|NCT01508169|566209006|FG001|Overall Study|Lost to Follow-up|2|||
156471949|NCT00734578|564821987|FG001|Overall Study|Lost to Follow-up|3|||
156471950|NCT00734578|564821988|FG002|Overall Study|Lost to Follow-up|5|||
156851218|NCT03600740|566209015|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
156851219|NCT01702558|566209016|FG000|Overall Study|Withdrawal by Subject|0|||
156471951|NCT00734578|564821986|FG000|Overall Study|Lack of Efficacy|3|||
156471952|NCT00734578|564821987|FG001|Overall Study|Lack of Efficacy|2|||
156471953|NCT00734578|564821988|FG002|Overall Study|Lack of Efficacy|5|||
156471954|NCT00734578|564821986|FG000|Overall Study|Randomized in error|1|||
156471955|NCT00734578|564821987|FG001|Overall Study|Randomized in error|0|||
156471956|NCT00734578|564821988|FG002|Overall Study|Randomized in error|0|||
156471957|NCT00734578|564821986|FG000|Overall Study|Exclusion criteria|1|||
156471958|NCT00734578|564821987|FG001|Overall Study|Exclusion criteria|0|||
156471959|NCT00734578|564821988|FG002|Overall Study|Exclusion criteria|0|||
156471960|NCT00999596|564821989|FG000|Overall Study|Statistical population not required|101|||
156471961|NCT02095145|564821990|FG000|Overall Study|Withdrawal by Subject|1|||
156471962|NCT02095145|564821991|FG001|Overall Study|Withdrawal by Subject|0|||
156471963|NCT02085941|564821993|FG000|Overall Study|Lack of Efficacy|1|||
156471964|NCT02085941|564821994|FG001|Overall Study|Lack of Efficacy|0|||
156471965|NCT02085941|564821993|FG000|Overall Study|Death|6|||
156471966|NCT02085941|564821994|FG001|Overall Study|Death|1|||
156471967|NCT02085941|564821993|FG000|Overall Study|Lost to Follow-up|1|||
156471968|NCT02085941|564821994|FG001|Overall Study|Lost to Follow-up|0|||
156471969|NCT02085941|564821993|FG000|Overall Study|Physician Decision|0|||
156471970|NCT02085941|564821994|FG001|Overall Study|Physician Decision|2|||
156471971|NCT00093496|564821998|FG000|Overall Study|Protocol Violation|1|||
156471972|NCT00093496|564821999|FG001|Overall Study|Protocol Violation|3|||
156471973|NCT00586313|564822000|FG000|Overall Study|Lack of Efficacy|2|||
156471974|NCT01932970|564822004|FG000|Overall Study|Withdrawal by Subject|5|||
156471975|NCT01932970|564822004|FG000|Overall Study|Death|1|||
156471976|NCT01932970|564822004|FG000|Overall Study|Lost to Follow-up|2|||
156471977|NCT01932970|564822004|FG000|Overall Study|Protocol Specified Criteria|10|||
156471978|NCT03205566|564822006|FG000|Phase 1|Protocol Violation|1|||
156471979|NCT03205566|564822007|FG001|Phase 1|Protocol Violation|1|||
156471980|NCT03184987|564822008|FG000|Overall Study|Withdrawal by Subject|0|||
156471981|NCT03184987|564822009|FG001|Overall Study|Withdrawal by Subject|1|||
156471982|NCT03184987|564822010|FG002|Overall Study|Withdrawal by Subject|2|||
156471983|NCT03184987|564822008|FG000|Overall Study|Physician Decision|0|||
156471984|NCT03184987|564822009|FG001|Overall Study|Physician Decision|0|||
156471985|NCT03184987|564822010|FG002|Overall Study|Physician Decision|1|||
156851220|NCT01702558|566209017|FG001|Overall Study|Withdrawal by Subject|0|||
156851221|NCT01702558|566209018|FG002|Overall Study|Withdrawal by Subject|0|||
156851222|NCT01702558|566209019|FG003|Overall Study|Withdrawal by Subject|12|||
156851223|NCT01702558|566209020|FG004|Overall Study|Withdrawal by Subject|4|||
156851224|NCT01702558|566209016|FG000|Overall Study|Lost to Follow-up|0|||
156851225|NCT01702558|566209017|FG001|Overall Study|Lost to Follow-up|0|||
156851226|NCT01702558|566209018|FG002|Overall Study|Lost to Follow-up|0|||
156851227|NCT01702558|566209019|FG003|Overall Study|Lost to Follow-up|3|||
156851228|NCT01702558|566209020|FG004|Overall Study|Lost to Follow-up|0|||
156851229|NCT01702558|566209016|FG000|Overall Study|Death|4|||
156851230|NCT01702558|566209017|FG001|Overall Study|Death|3|||
156851231|NCT01702558|566209018|FG002|Overall Study|Death|3|||
156851232|NCT01702558|566209019|FG003|Overall Study|Death|16|||
156851233|NCT01702558|566209020|FG004|Overall Study|Death|20|||
156851234|NCT01702558|566209016|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
156851235|NCT01702558|566209017|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
156851236|NCT01702558|566209018|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
156851237|NCT01702558|566209019|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
156851238|NCT01702558|566209020|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
156851239|NCT01702558|566209016|FG000|Overall Study|Study Terminated by Sponsor|0|||
156851240|NCT01702558|566209017|FG001|Overall Study|Study Terminated by Sponsor|1|||
156851241|NCT01702558|566209018|FG002|Overall Study|Study Terminated by Sponsor|0|||
156851242|NCT01702558|566209019|FG003|Overall Study|Study Terminated by Sponsor|0|||
156851243|NCT01702558|566209020|FG004|Overall Study|Study Terminated by Sponsor|1|||
156851244|NCT01702558|566209016|FG000|Overall Study|Other|0|||
156471986|NCT03184987|564822008|FG000|Overall Study|Adverse Event|1|||
156851245|NCT01702558|566209017|FG001|Overall Study|Other|0|||
156851246|NCT01702558|566209018|FG002|Overall Study|Other|0|||
156851247|NCT01702558|566209019|FG003|Overall Study|Other|16|||
156471987|NCT03184987|564822009|FG001|Overall Study|Adverse Event|0|||
156851248|NCT01702558|566209020|FG004|Overall Study|Other|17|||
156851249|NCT03259087|566209023|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
156471988|NCT03184987|564822010|FG002|Overall Study|Adverse Event|1|||
156471989|NCT00853580|564822011|FG000|Overall Study|Lost to Follow-up|3|||
156471990|NCT00853580|564822012|FG001|Overall Study|Lost to Follow-up|5|||
156471991|NCT00853580|564822011|FG000|Overall Study|Protocol Violation|2|||
156471992|NCT00853580|564822012|FG001|Overall Study|Protocol Violation|1|||
156851250|NCT03259087|566209024|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
156471993|NCT00853580|564822011|FG000|Overall Study|Withdrawal by Subject|2|||
156471994|NCT00853580|564822012|FG001|Overall Study|Withdrawal by Subject|8|||
156471995|NCT00853580|564822011|FG000|Overall Study|Commenced contraindicated therapy|0|||
156851251|NCT03259087|566209025|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
156851252|NCT03259087|566209026|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
156471996|NCT00853580|564822012|FG001|Overall Study|Commenced contraindicated therapy|2|||
156471997|NCT01767467|564822013|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
156471998|NCT01767467|564822014|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
156471999|NCT01767467|564822013|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
156472000|NCT01767467|564822014|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
156472001|NCT01767467|564822013|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
156472002|NCT01767467|564822014|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
156472003|NCT01767467|564822013|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
156472004|NCT01767467|564822014|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
156472005|NCT01767467|564822013|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
156472006|NCT01767467|564822014|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
156472007|NCT01767467|564822013|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
156472008|NCT01767467|564822014|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
156472009|NCT01767467|564822013|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
156472010|NCT01767467|564822014|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
156472011|NCT01767467|564822013|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
156472012|NCT01767467|564822014|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
156472013|NCT01767467|564822013|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
156472014|NCT01767467|564822014|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
156472015|NCT01767467|564822013|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
156472016|NCT01767467|564822014|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
156472017|NCT01767467|564822013|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
156472018|NCT01767467|564822014|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
156472019|NCT01767467|564822013|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
156472020|NCT01767467|564822014|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
156472021|NCT01767467|564822013|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
156472022|NCT01767467|564822014|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
156472023|NCT01767467|564822013|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
156342186|NCT04115839|564352571|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156342187|NCT04115839|564352572|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156342188|NCT04115839|564352566|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
156342189|NCT04115839|564352567|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
156342190|NCT04115839|564352568|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
156472024|NCT01767467|564822014|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
156472025|NCT04971733|564822017|FG000|Overall Study|Adverse Event|1|||
156472026|NCT04971733|564822018|FG001|Overall Study|Adverse Event|1|||
156472027|NCT04971733|564822017|FG000|Overall Study|Subject choice|2|||
156472028|NCT04971733|564822018|FG001|Overall Study|Subject choice|0|||
156472029|NCT04971733|564822017|FG000|Overall Study|Withdrawal by Subject|1|||
156472030|NCT04971733|564822018|FG001|Overall Study|Withdrawal by Subject|0|||
156472031|NCT04971733|564822017|FG000|Overall Study|Other|1|||
156472032|NCT04971733|564822018|FG001|Overall Study|Other|0|||
156472033|NCT01160354|564822021|FG000|Overall Study|Death|0|||
156472034|NCT01160354|564822022|FG001|Overall Study|Death|1|||
156472035|NCT01160354|564822023|FG002|Overall Study|Death|1|||
156472036|NCT00600353|564822027|FG000|Overall Study|history of malignancy within 5 years|1|||
156472037|NCT00600353|564822028|FG001|Overall Study|history of malignancy within 5 years|0|||
156472038|NCT00600353|564822027|FG000|Overall Study|History of prepartive regimen|0|||
156472039|NCT00600353|564822028|FG001|Overall Study|History of prepartive regimen|1|||
156472040|NCT04200664|564822029|FG000|Overall Study|Withdrawal by Subject|1|||
156472041|NCT04200664|564822030|FG001|Overall Study|Withdrawal by Subject|0|||
156472042|NCT04200664|564822031|FG002|Overall Study|Withdrawal by Subject|0|||
156472043|NCT05293717|564822039|FG000|Overall Study|Physician Decision|1|||
156472044|NCT03678688|564823367|FG000|Overall Study|Reason not Specified|0|||
156472045|NCT03678688|564823368|FG001|Overall Study|Reason not Specified|0|||
156472046|NCT03678688|564823369|FG002|Overall Study|Reason not Specified|3|||
156472047|NCT03678688|564823370|FG003|Overall Study|Reason not Specified|0|||
156472048|NCT03678688|564823371|FG004|Overall Study|Reason not Specified|1|||
156472049|NCT03678688|564823372|FG005|Overall Study|Reason not Specified|0|||
156472050|NCT03678688|564823373|FG006|Overall Study|Reason not Specified|0|||
156472051|NCT03678688|564823374|FG007|Overall Study|Reason not Specified|0|||
156472052|NCT03678688|564823375|FG008|Overall Study|Reason not Specified|0|||
156472053|NCT03678688|564823367|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
156472054|NCT03678688|564823368|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
156472055|NCT03678688|564823369|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
156472056|NCT03678688|564823370|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
156472057|NCT03678688|564823371|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
156472058|NCT03678688|564823372|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
156472059|NCT03678688|564823373|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
156472060|NCT03678688|564823374|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
156342191|NCT04115839|564352569|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
156342192|NCT04115839|564352570|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
156472061|NCT03678688|564823375|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
156472062|NCT03678688|564823367|FG000|Overall Study|Covid Related Adverse Event|0|||
156472063|NCT03678688|564823368|FG001|Overall Study|Covid Related Adverse Event|0|||
156472064|NCT03678688|564823369|FG002|Overall Study|Covid Related Adverse Event|0|||
156472065|NCT03678688|564823370|FG003|Overall Study|Covid Related Adverse Event|0|||
156472066|NCT03678688|564823371|FG004|Overall Study|Covid Related Adverse Event|0|||
156472067|NCT03678688|564823372|FG005|Overall Study|Covid Related Adverse Event|3|||
156472068|NCT03678688|564823373|FG006|Overall Study|Covid Related Adverse Event|1|||
156472069|NCT03678688|564823374|FG007|Overall Study|Covid Related Adverse Event|1|||
156472070|NCT03678688|564823375|FG008|Overall Study|Covid Related Adverse Event|0|||
156472071|NCT03678688|564823367|FG000|Overall Study|Physician Decision|0|||
156472072|NCT03678688|564823368|FG001|Overall Study|Physician Decision|0|||
156472073|NCT03678688|564823369|FG002|Overall Study|Physician Decision|0|||
156472074|NCT03678688|564823370|FG003|Overall Study|Physician Decision|0|||
156472075|NCT03678688|564823371|FG004|Overall Study|Physician Decision|0|||
156472076|NCT03678688|564823372|FG005|Overall Study|Physician Decision|1|||
156472077|NCT03678688|564823373|FG006|Overall Study|Physician Decision|0|||
156472078|NCT03678688|564823374|FG007|Overall Study|Physician Decision|0|||
156472079|NCT03678688|564823375|FG008|Overall Study|Physician Decision|0|||
156472080|NCT03678688|564823367|FG000|Overall Study|Withdrawal by Subject|0|||
156472081|NCT03678688|564823368|FG001|Overall Study|Withdrawal by Subject|0|||
156472082|NCT03678688|564823369|FG002|Overall Study|Withdrawal by Subject|0|||
156472083|NCT03678688|564823370|FG003|Overall Study|Withdrawal by Subject|0|||
156472084|NCT03678688|564823371|FG004|Overall Study|Withdrawal by Subject|0|||
156472085|NCT03678688|564823372|FG005|Overall Study|Withdrawal by Subject|0|||
156472086|NCT03678688|564823373|FG006|Overall Study|Withdrawal by Subject|2|||
156472087|NCT03678688|564823374|FG007|Overall Study|Withdrawal by Subject|1|||
156472088|NCT03678688|564823375|FG008|Overall Study|Withdrawal by Subject|0|||
156472089|NCT00551421|564823376|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
156472090|NCT03136159|564823377|FG000|Overall Study|chorioamnionitis|2|||
156472091|NCT03136159|564823378|FG001|Overall Study|chorioamnionitis|0|||
156472092|NCT03136159|564823377|FG000|Overall Study|vertical skin incision|1|||
156472093|NCT03136159|564823378|FG001|Overall Study|vertical skin incision|0|||
156472094|NCT03136159|564823377|FG000|Overall Study|additional dressing|1|||
156472095|NCT03136159|564823378|FG001|Overall Study|additional dressing|0|||
156472096|NCT03136159|564823377|FG000|Overall Study|never got dressing placed|1|||
156472097|NCT03136159|564823378|FG001|Overall Study|never got dressing placed|0|||
156472098|NCT03823703|564823379|FG000|Overall Study|Sponsor request|0|||
156472099|NCT03823703|564823380|FG001|Overall Study|Sponsor request|3|||
156472100|NCT03823703|564823381|FG002|Overall Study|Sponsor request|4|||
156472101|NCT03823703|564823379|FG000|Overall Study|Adverse Event|3|||
156472102|NCT03823703|564823380|FG001|Overall Study|Adverse Event|1|||
156472103|NCT03823703|564823381|FG002|Overall Study|Adverse Event|0|||
156472104|NCT03823703|564823379|FG000|Overall Study|Withdrawal by Subject|0|||
156472105|NCT03823703|564823380|FG001|Overall Study|Withdrawal by Subject|1|||
156472106|NCT03823703|564823381|FG002|Overall Study|Withdrawal by Subject|0|||
156472107|NCT00357994|564823382|FG000|Overall Study|Adverse Event|1|||
156472108|NCT00357994|564823383|FG001|Overall Study|Adverse Event|2|||
156472109|NCT00357994|564823382|FG000|Overall Study|Lack of Efficacy|0|||
156472110|NCT00357994|564823383|FG001|Overall Study|Lack of Efficacy|1|||
156472111|NCT00357994|564823382|FG000|Overall Study|Protocol Violation|1|||
156472112|NCT00357994|564823383|FG001|Overall Study|Protocol Violation|0|||
156472113|NCT00745875|564823390|FG000|Overall Study|Continuing study treatment|4|||
156472114|NCT00745875|564823391|FG001|Overall Study|Continuing study treatment|4|||
156472115|NCT01833455|564823392|FG000|Overall Study|Withdrawal by Subject|1|||
156472116|NCT01833455|564823393|FG001|Overall Study|Withdrawal by Subject|0|||
156472117|NCT02000752|564823398|FG000|Overall Study|Dystocic delivery|19|||
156472118|NCT02000752|564823399|FG001|Overall Study|Dystocic delivery|8|||
156472119|NCT02000752|564823398|FG000|Overall Study|Shift Changes|12|||
156851253|NCT03259087|566209027|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
156851254|NCT03259087|566209023|FG000|Period 2 of Part 2|Adverse Event|0|||
156851255|NCT03259087|566209024|FG001|Period 2 of Part 2|Adverse Event|0|||
156851256|NCT03259087|566209025|FG002|Period 2 of Part 2|Adverse Event|0|||
156851257|NCT03259087|566209026|FG003|Period 2 of Part 2|Adverse Event|0|||
156851258|NCT03259087|566209027|FG004|Period 2 of Part 2|Adverse Event|1|||
156851259|NCT04524858|566209028|FG000|Overall Study|Adverse Event|1|||
156851260|NCT02396212|566209029|FG000|Overall Study|Adverse Event|1|||
156851261|NCT02396212|566209029|FG000|Overall Study|Lack of Efficacy|2|||
156851262|NCT01623115|566209030|FG000|Overall Study|Randomized but not treated|0|||
156472120|NCT02000752|564823399|FG001|Overall Study|Shift Changes|5|||
156472121|NCT00019604|564823401|FG000|Overall Study|Death|1|||
156472122|NCT00019604|564823401|FG000|Overall Study|Progressive disease|23|||
156472123|NCT00019604|564823401|FG000|Overall Study|Refused treatment|1|||
156472124|NCT00019604|564823401|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
156472125|NCT00019604|564823401|FG000|Overall Study|Going to have liver transplant|1|||
156472126|NCT00019604|564823401|FG000|Overall Study|Move to a different study|1|||
156851263|NCT01623115|566209031|FG001|Overall Study|Randomized but not treated|1|||
156851264|NCT01623115|566209030|FG000|Overall Study|Physician Decision|1|||
156851265|NCT01623115|566209031|FG001|Overall Study|Physician Decision|0|||
156851266|NCT01623115|566209030|FG000|Overall Study|Participants moved|1|||
156472127|NCT00019604|564823401|FG000|Overall Study|Non compliant on systemic CH|1|||
156851267|NCT01623115|566209031|FG001|Overall Study|Participants moved|5|||
156851268|NCT01623115|566209030|FG000|Overall Study|Adverse Event|10|||
156472128|NCT00019604|564823401|FG000|Overall Study|Non compliant|1|||
156472129|NCT00019604|564823401|FG000|Overall Study|Resectable disease|1|||
156472130|NCT00019604|564823401|FG000|Overall Study|Started new chemo regimen|1|||
156472131|NCT00019604|564823401|FG000|Overall Study|Pt going to immunotherapy study|1|||
156472132|NCT00019604|564823401|FG000|Overall Study|Too much disease|1|||
156472133|NCT00019604|564823401|FG000|Overall Study|Unable to evaluate|1|||
156472134|NCT00019604|564823401|FG000|Overall Study|Details for other not available|4|||
156472135|NCT02203799|564823425|FG000|Overall Study|Withdrawal by Subject|3|||
156472136|NCT03335488|564823426|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
156472137|NCT03335488|564823427|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
156472138|NCT03335488|564823426|FG000|Safety Extension Period|Adverse Event|1|||
156472139|NCT03335488|564823427|FG001|Safety Extension Period|Adverse Event|0|||
156472140|NCT03335488|564823426|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
156472141|NCT03335488|564823427|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
156472142|NCT01953692|564823428|FG000|Overall Study|Adverse Event|5|||
156472143|NCT01953692|564823429|FG001|Overall Study|Adverse Event|2|||
156472144|NCT01953692|564823430|FG002|Overall Study|Adverse Event|4|||
156472145|NCT01953692|564823431|FG003|Overall Study|Adverse Event|2|||
156472146|NCT01953692|564823432|FG004|Overall Study|Adverse Event|1|||
156472147|NCT01953692|564823433|FG005|Overall Study|Adverse Event|2|||
156472148|NCT01953692|564823434|FG006|Overall Study|Adverse Event|0|||
156472149|NCT01953692|564823435|FG007|Overall Study|Adverse Event|0|||
156472150|NCT01953692|564823436|FG008|Overall Study|Adverse Event|0|||
156472151|NCT01953692|564823428|FG000|Overall Study|Clinical Progression|0|||
156472152|NCT01953692|564823429|FG001|Overall Study|Clinical Progression|15|||
156472153|NCT01953692|564823430|FG002|Overall Study|Clinical Progression|7|||
156472154|NCT01953692|564823431|FG003|Overall Study|Clinical Progression|5|||
156472155|NCT01953692|564823432|FG004|Overall Study|Clinical Progression|0|||
156472156|NCT01953692|564823433|FG005|Overall Study|Clinical Progression|7|||
156472157|NCT01953692|564823434|FG006|Overall Study|Clinical Progression|20|||
156472158|NCT01953692|564823435|FG007|Overall Study|Clinical Progression|3|||
156472159|NCT01953692|564823436|FG008|Overall Study|Clinical Progression|3|||
156472160|NCT01953692|564823428|FG000|Overall Study|Death|5|||
156472161|NCT01953692|564823429|FG001|Overall Study|Death|0|||
156472162|NCT01953692|564823430|FG002|Overall Study|Death|2|||
156472163|NCT01953692|564823431|FG003|Overall Study|Death|2|||
156472164|NCT01953692|564823432|FG004|Overall Study|Death|1|||
156472165|NCT01953692|564823433|FG005|Overall Study|Death|3|||
156472166|NCT01953692|564823434|FG006|Overall Study|Death|6|||
156472167|NCT01953692|564823435|FG007|Overall Study|Death|2|||
156472168|NCT01953692|564823436|FG008|Overall Study|Death|1|||
156472169|NCT01953692|564823428|FG000|Overall Study|Excluded Medication|1|||
156472170|NCT01953692|564823429|FG001|Overall Study|Excluded Medication|0|||
156472171|NCT01953692|564823430|FG002|Overall Study|Excluded Medication|0|||
156472172|NCT01953692|564823431|FG003|Overall Study|Excluded Medication|0|||
156472173|NCT01953692|564823432|FG004|Overall Study|Excluded Medication|0|||
156472174|NCT01953692|564823433|FG005|Overall Study|Excluded Medication|0|||
156472175|NCT01953692|564823434|FG006|Overall Study|Excluded Medication|0|||
156472176|NCT01953692|564823435|FG007|Overall Study|Excluded Medication|0|||
156472177|NCT01953692|564823436|FG008|Overall Study|Excluded Medication|0|||
156472178|NCT01953692|564823428|FG000|Overall Study|Lost to Follow-up|1|||
156472179|NCT01953692|564823429|FG001|Overall Study|Lost to Follow-up|0|||
156472180|NCT01953692|564823430|FG002|Overall Study|Lost to Follow-up|3|||
156472181|NCT01953692|564823431|FG003|Overall Study|Lost to Follow-up|1|||
156472182|NCT01953692|564823432|FG004|Overall Study|Lost to Follow-up|0|||
156472183|NCT01953692|564823433|FG005|Overall Study|Lost to Follow-up|1|||
156472184|NCT01953692|564823434|FG006|Overall Study|Lost to Follow-up|0|||
156472185|NCT01953692|564823435|FG007|Overall Study|Lost to Follow-up|0|||
156472186|NCT01953692|564823436|FG008|Overall Study|Lost to Follow-up|0|||
156472187|NCT01953692|564823428|FG000|Overall Study|Physician Decision|11|||
156472188|NCT01953692|564823429|FG001|Overall Study|Physician Decision|4|||
156472189|NCT01953692|564823430|FG002|Overall Study|Physician Decision|2|||
156472190|NCT01953692|564823431|FG003|Overall Study|Physician Decision|2|||
156472191|NCT01953692|564823432|FG004|Overall Study|Physician Decision|1|||
156472192|NCT01953692|564823433|FG005|Overall Study|Physician Decision|2|||
156472193|NCT01953692|564823434|FG006|Overall Study|Physician Decision|4|||
156472194|NCT01953692|564823435|FG007|Overall Study|Physician Decision|1|||
156472195|NCT01953692|564823436|FG008|Overall Study|Physician Decision|0|||
156472196|NCT01953692|564823428|FG000|Overall Study|Protocol Violation|0|||
156472197|NCT01953692|564823429|FG001|Overall Study|Protocol Violation|2|||
156472198|NCT01953692|564823430|FG002|Overall Study|Protocol Violation|1|||
156472199|NCT01953692|564823431|FG003|Overall Study|Protocol Violation|0|||
156472200|NCT01953692|564823432|FG004|Overall Study|Protocol Violation|0|||
156472201|NCT01953692|564823433|FG005|Overall Study|Protocol Violation|0|||
156472202|NCT01953692|564823434|FG006|Overall Study|Protocol Violation|0|||
156472203|NCT01953692|564823435|FG007|Overall Study|Protocol Violation|1|||
156542181|NCT00388973|565079255|FG001|Overall Study|Left region|1|||
156472204|NCT01953692|564823436|FG008|Overall Study|Protocol Violation|0|||
156472205|NCT01953692|564823428|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
156851269|NCT01623115|566209031|FG001|Overall Study|Adverse Event|13|||
156472206|NCT01953692|564823429|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
156472207|NCT01953692|564823430|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
156472208|NCT01953692|564823431|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
156472209|NCT01953692|564823432|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
156472210|NCT01953692|564823433|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
156472211|NCT01953692|564823434|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
156472212|NCT01953692|564823435|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
156472213|NCT01953692|564823436|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
156472214|NCT01953692|564823428|FG000|Overall Study|Withdrawal by Subject|4|||
156472215|NCT01953692|564823429|FG001|Overall Study|Withdrawal by Subject|2|||
156472216|NCT01953692|564823430|FG002|Overall Study|Withdrawal by Subject|1|||
156472217|NCT01953692|564823431|FG003|Overall Study|Withdrawal by Subject|2|||
156472218|NCT01953692|564823432|FG004|Overall Study|Withdrawal by Subject|0|||
156472219|NCT01953692|564823433|FG005|Overall Study|Withdrawal by Subject|3|||
156472220|NCT01953692|564823434|FG006|Overall Study|Withdrawal by Subject|2|||
156472221|NCT01953692|564823435|FG007|Overall Study|Withdrawal by Subject|1|||
156472222|NCT01953692|564823436|FG008|Overall Study|Withdrawal by Subject|1|||
156472223|NCT01801007|564823439|FG000|Overall Study|Adverse Event|2|||
156472224|NCT01801007|564823439|FG000|Overall Study|Lost to Follow-up|4|||
156472225|NCT01801007|564823439|FG000|Overall Study|Withdrawal by Subject|5|||
156472226|NCT02743819|564823440|FG000|Overall Study|Lack of Efficacy|5|||
156472227|NCT02743819|564823440|FG000|Overall Study|Death|2|||
156472228|NCT02743819|564823440|FG000|Overall Study|Adverse Event|1|||
156472229|NCT00145470|564823441|FG000|Overall Study|Adverse Event|19|||
156851270|NCT01623115|566209030|FG000|Overall Study|Poor compliance to protocol|4|||
156851271|NCT01623115|566209031|FG001|Overall Study|Poor compliance to protocol|10|||
156851272|NCT01623115|566209030|FG000|Overall Study|Consent withdrawn by participant|2|||
156851273|NCT01623115|566209031|FG001|Overall Study|Consent withdrawn by participant|6|||
156851274|NCT01623115|566209030|FG000|Overall Study|Related to study drug administration|0|||
156851275|NCT01623115|566209031|FG001|Overall Study|Related to study drug administration|2|||
156851276|NCT01623115|566209030|FG000|Overall Study|Last visit outside protocol visit window|14|||
156472230|NCT00145470|564823442|FG001|Overall Study|Adverse Event|25|||
156472231|NCT00145470|564823441|FG000|Overall Study|Lack of Efficacy|27|||
156472232|NCT00145470|564823442|FG001|Overall Study|Lack of Efficacy|13|||
156472233|NCT00145470|564823441|FG000|Overall Study|Withdrawal by Subject|36|||
156472234|NCT00145470|564823442|FG001|Overall Study|Withdrawal by Subject|34|||
156472235|NCT00145470|564823441|FG000|Overall Study|Lost to Follow-up|21|||
156472236|NCT00145470|564823442|FG001|Overall Study|Lost to Follow-up|17|||
156472237|NCT00145470|564823441|FG000|Overall Study|Reason Not Reported|9|||
156472238|NCT00145470|564823442|FG001|Overall Study|Reason Not Reported|9|||
156472239|NCT00676091|564823444|FG000|Infant Series|Parent or legal guardian request|10|||
156472240|NCT00676091|564823445|FG001|Infant Series|Parent or legal guardian request|8|||
156472241|NCT00676091|564823444|FG000|Infant Series|Protocol Violation|6|||
156472242|NCT00676091|564823445|FG001|Infant Series|Protocol Violation|3|||
156472243|NCT00676091|564823444|FG000|Infant Series|Adverse Event|2|||
156472244|NCT00676091|564823445|FG001|Infant Series|Adverse Event|3|||
156472245|NCT00676091|564823444|FG000|Infant Series|Failed to return|1|||
156472246|NCT00676091|564823445|FG001|Infant Series|Failed to return|3|||
156472247|NCT00676091|564823444|FG000|Infant Series|Lost to Follow-up|1|||
156472248|NCT00676091|564823445|FG001|Infant Series|Lost to Follow-up|0|||
156472249|NCT00676091|564823444|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
156472250|NCT00676091|564823445|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
156472251|NCT00676091|564823444|FG000|After Infant Series|Adverse Event|0|||
156472252|NCT00676091|564823445|FG001|After Infant Series|Adverse Event|1|||
156472253|NCT00676091|564823444|FG000|After Infant Series|Protocol Violation|0|||
156472254|NCT00676091|564823445|FG001|After Infant Series|Protocol Violation|1|||
156472255|NCT00676091|564823444|FG000|After Infant Series|Failed to return|1|||
156472256|NCT00676091|564823445|FG001|After Infant Series|Failed to return|1|||
156851277|NCT01623115|566209031|FG001|Overall Study|Last visit outside protocol visit window|26|||
156851278|NCT01623115|566209030|FG000|Overall Study|Site closure|1|||
156851279|NCT01623115|566209031|FG001|Overall Study|Site closure|7|||
156851280|NCT01623115|566209030|FG000|Overall Study|Death|0|||
156851281|NCT01623115|566209031|FG001|Overall Study|Death|4|||
156851282|NCT01623115|566209030|FG000|Overall Study|Other than specified above|0|||
156851283|NCT01623115|566209031|FG001|Overall Study|Other than specified above|3|||
156851284|NCT04950465|566209032|FG000|Overall Study|Lost to Follow-up|1|||
156851285|NCT04950465|566209033|FG001|Overall Study|Lost to Follow-up|0|||
156472257|NCT00676091|564823444|FG000|Toddler Dose|Failed to return|2|||
156472258|NCT00676091|564823445|FG001|Toddler Dose|Failed to return|0|||
156472259|NCT00676091|564823444|FG000|Toddler Dose|Parent or legal guardian request|1|||
156472260|NCT00676091|564823445|FG001|Toddler Dose|Parent or legal guardian request|0|||
156472261|NCT00914966|564823451|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
156472262|NCT00914966|564823451|FG000|Step 1: 1500 Units|Physician Decision|1|||
156472263|NCT00914966|564823451|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
156472264|NCT01701401|564823452|FG000|Overall Study|Randomized But Not Treated|3|||
156472265|NCT01701401|564823453|FG001|Overall Study|Randomized But Not Treated|1|||
156472266|NCT01701401|564823454|FG002|Overall Study|Randomized But Not Treated|0|||
156472267|NCT01701401|564823455|FG003|Overall Study|Randomized But Not Treated|1|||
156472268|NCT01701401|564823452|FG000|Overall Study|Lost to Follow-up|5|||
156472269|NCT01701401|564823453|FG001|Overall Study|Lost to Follow-up|5|||
156472270|NCT01701401|564823454|FG002|Overall Study|Lost to Follow-up|1|||
156472271|NCT01701401|564823455|FG003|Overall Study|Lost to Follow-up|3|||
156472272|NCT01701401|564823452|FG000|Overall Study|Withdrew Consent|0|||
156472273|NCT01701401|564823453|FG001|Overall Study|Withdrew Consent|3|||
156472274|NCT01701401|564823454|FG002|Overall Study|Withdrew Consent|1|||
156472275|NCT01701401|564823455|FG003|Overall Study|Withdrew Consent|2|||
156472276|NCT01701401|564823452|FG000|Overall Study|Lack of Efficacy|1|||
156472277|NCT01701401|564823453|FG001|Overall Study|Lack of Efficacy|0|||
156472278|NCT01701401|564823454|FG002|Overall Study|Lack of Efficacy|2|||
156472279|NCT01701401|564823455|FG003|Overall Study|Lack of Efficacy|0|||
156472280|NCT01701401|564823452|FG000|Overall Study|Adverse Event|1|||
156472281|NCT01701401|564823453|FG001|Overall Study|Adverse Event|0|||
156472282|NCT01701401|564823454|FG002|Overall Study|Adverse Event|0|||
156472283|NCT01701401|564823455|FG003|Overall Study|Adverse Event|0|||
156472284|NCT01701401|564823452|FG000|Overall Study|Protocol Violation|0|||
156472285|NCT01701401|564823453|FG001|Overall Study|Protocol Violation|0|||
156472286|NCT01701401|564823454|FG002|Overall Study|Protocol Violation|1|||
156472287|NCT01701401|564823455|FG003|Overall Study|Protocol Violation|0|||
156472288|NCT04762277|564823459|FG000|Overall Study|Withdrawal by Subject|0|||
156472289|NCT04762277|564823460|FG001|Overall Study|Withdrawal by Subject|2|||
156472290|NCT04762277|564823459|FG000|Overall Study|Protocol Violation|0|||
156472291|NCT04762277|564823460|FG001|Overall Study|Protocol Violation|1|||
156472292|NCT04762277|564823459|FG000|Overall Study|Adverse Event|1|||
156472293|NCT04762277|564823460|FG001|Overall Study|Adverse Event|0|||
156472294|NCT05824559|564823461|FG000|Overall Study|Adverse Event|2|||
156472295|NCT05824559|564823461|FG000|Overall Study|Physician Decision|2|||
156472296|NCT05824559|564823461|FG000|Overall Study|Progressive Disease|16|||
156472297|NCT05824559|564823461|FG000|Overall Study|Study Terminated by Sponsor|1|||
156472298|NCT05824559|564823461|FG000|Overall Study|Withdrawal by Subject|2|||
156472299|NCT01690624|564823462|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
156472300|NCT01690624|564823463|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
156472301|NCT01690624|564823464|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
156472302|NCT01690624|564823465|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
156472303|NCT01690624|564823462|FG000|Overall Study|Adverse event (other than DLT)|3|||
156472304|NCT01690624|564823463|FG001|Overall Study|Adverse event (other than DLT)|1|||
156472305|NCT01690624|564823464|FG002|Overall Study|Adverse event (other than DLT)|1|||
156472306|NCT01690624|564823465|FG003|Overall Study|Adverse event (other than DLT)|1|||
156472307|NCT01690624|564823462|FG000|Overall Study|Withdrawal by Subject|0|||
156472308|NCT01690624|564823463|FG001|Overall Study|Withdrawal by Subject|0|||
156342193|NCT04115839|564352571|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
156542182|NCT00388973|565079254|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
156542183|NCT00388973|565079255|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
156472309|NCT01690624|564823464|FG002|Overall Study|Withdrawal by Subject|1|||
156342194|NCT04115839|564352572|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
156472310|NCT01690624|564823465|FG003|Overall Study|Withdrawal by Subject|0|||
156472311|NCT01690624|564823462|FG000|Overall Study|Sponsor is ending trial|0|||
156472312|NCT01690624|564823463|FG001|Overall Study|Sponsor is ending trial|0|||
156472313|NCT01690624|564823464|FG002|Overall Study|Sponsor is ending trial|0|||
156472314|NCT01690624|564823465|FG003|Overall Study|Sponsor is ending trial|1|||
156472315|NCT01690624|564823462|FG000|Overall Study|Physician Decision|0|||
156472316|NCT01690624|564823463|FG001|Overall Study|Physician Decision|0|||
156472317|NCT01690624|564823464|FG002|Overall Study|Physician Decision|0|||
156472318|NCT01690624|564823465|FG003|Overall Study|Physician Decision|1|||
156472319|NCT01690624|564823462|FG000|Overall Study|Withdrawal by Subject|0|||
156472320|NCT01690624|564823463|FG001|Overall Study|Withdrawal by Subject|1|||
156472321|NCT01690624|564823464|FG002|Overall Study|Withdrawal by Subject|0|||
156472322|NCT01690624|564823465|FG003|Overall Study|Withdrawal by Subject|0|||
156472323|NCT01690624|564823462|FG000|Overall Study|Lack of Efficacy|1|||
156472324|NCT01690624|564823463|FG001|Overall Study|Lack of Efficacy|1|||
156851286|NCT04950465|566209034|FG002|Overall Study|Lost to Follow-up|0|||
156851287|NCT01788566|566209049|FG000|Overall Study|Death|4|||
156851288|NCT01788566|566209049|FG000|Overall Study|Adverse Event|1|||
156851289|NCT01788566|566209049|FG000|Overall Study|Clinical Progressive Disease|3|||
156851290|NCT01338818|566209050|FG000|Overall Study|Adverse Event|8|||
156851291|NCT01338818|566209050|FG000|Overall Study|Lack of Efficacy|5|||
156851292|NCT01338818|566209050|FG000|Overall Study|no longer require study drug|1|||
156851293|NCT01338818|566209050|FG000|Overall Study|Withdrawal by Subject|11|||
156851294|NCT01338818|566209050|FG000|Overall Study|Lost to Follow-up|4|||
156851295|NCT01338818|566209050|FG000|Overall Study|Administrative problems|3|||
156851296|NCT01338818|566209050|FG000|Overall Study|Protocol Deviation|4|||
156851297|NCT00580723|566209053|FG000|Overall Study|Did not want to participate in extension|3|||
156851298|NCT00580723|566209053|FG000|Overall Study|Lost to Follow-up|5|||
156851299|NCT05202418|566209054|FG000|Overall Study|Withdrawal by Subject|2|||
156851300|NCT05202418|566209055|FG001|Overall Study|Withdrawal by Subject|1|||
156851301|NCT05202418|566209054|FG000|Overall Study|Lost to Follow-up|1|||
156851302|NCT05202418|566209055|FG001|Overall Study|Lost to Follow-up|1|||
156851303|NCT02562716|566209056|FG000|Overall Study|Adverse Event|7|||
156851304|NCT02562716|566209057|FG001|Overall Study|Adverse Event|14|||
156851305|NCT02562716|566209056|FG000|Overall Study|Withdrawal unrelated to AE|7|||
156851306|NCT02562716|566209057|FG001|Overall Study|Withdrawal unrelated to AE|1|||
156851307|NCT02562716|566209056|FG000|Overall Study|Progression|8|||
156851308|NCT02562716|566209057|FG001|Overall Study|Progression|10|||
156851309|NCT02562716|566209056|FG000|Overall Study|Death|2|||
156851310|NCT02562716|566209057|FG001|Overall Study|Death|1|||
156851311|NCT02562716|566209056|FG000|Overall Study|Not protocol specified|4|||
156851312|NCT02562716|566209057|FG001|Overall Study|Not protocol specified|2|||
156851313|NCT00684996|566209058|FG000|Overall Study|Adverse Event|1|||
156851314|NCT00684996|566209058|FG000|Overall Study|Refusal unrelated to adverse event|1|||
156851315|NCT00684996|566209058|FG000|Overall Study|Progression/relapse|2|||
156851316|NCT00684996|566209058|FG000|Overall Study|Other reasons not protocol specified|1|||
156851317|NCT00556998|566209059|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
156851318|NCT00556998|566209059|FG000|Voriconazole Intravenous (IV)|Other|4|||
156851319|NCT00556998|566209059|FG000|Voriconazole Oral|Adverse Event|1|||
156851320|NCT00556998|566209059|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
156851321|NCT02519439|566209062|FG000|Overall Study|Study Termination|19|||
156851322|NCT02519439|566209062|FG000|Overall Study|Withdrawal by Subject|1|||
156851323|NCT02519439|566209062|FG000|Overall Study|Adverse Event|1|||
156851324|NCT01539759|566209065|FG000|Overall Study|Lost to Follow-up|6|||
156472325|NCT01690624|564823464|FG002|Overall Study|Lack of Efficacy|3|||
156472326|NCT01690624|564823465|FG003|Overall Study|Lack of Efficacy|0|||
156472327|NCT04445831|564823466|FG000|Overall Study|Withdrawal by Subject|2|||
156472328|NCT04445831|564823467|FG001|Overall Study|Withdrawal by Subject|1|||
156851325|NCT01539759|566209066|FG001|Overall Study|Lost to Follow-up|8|||
156851326|NCT01078441|566209067|FG000|Overall Study|Withdrawal by Subject|1|||
156851327|NCT01425801|566209068|FG000|Period 1|Withdrawal by Subject|0|||
156851328|NCT01425801|566209069|FG001|Period 1|Withdrawal by Subject|0|||
156851329|NCT01425801|566209070|FG002|Period 1|Withdrawal by Subject|0|||
156851330|NCT01425801|566209071|FG003|Period 1|Withdrawal by Subject|0|||
156851331|NCT01425801|566209072|FG004|Period 1|Withdrawal by Subject|1|||
156851332|NCT01425801|566209073|FG005|Period 1|Withdrawal by Subject|0|||
156851333|NCT01425801|566209068|FG000|Period 2|Withdrawal by Subject|0|||
156851334|NCT01425801|566209069|FG001|Period 2|Withdrawal by Subject|0|||
156851335|NCT01425801|566209070|FG002|Period 2|Withdrawal by Subject|0|||
156851336|NCT01425801|566209071|FG003|Period 2|Withdrawal by Subject|0|||
156851337|NCT01425801|566209072|FG004|Period 2|Withdrawal by Subject|1|||
156851338|NCT01425801|566209073|FG005|Period 2|Withdrawal by Subject|0|||
156851339|NCT01425801|566209068|FG000|Period 3|Stability criteria not fullfilled|0|||
156851340|NCT01425801|566209069|FG001|Period 3|Stability criteria not fullfilled|0|||
156851341|NCT01425801|566209070|FG002|Period 3|Stability criteria not fullfilled|1|||
156851342|NCT01425801|566209071|FG003|Period 3|Stability criteria not fullfilled|0|||
156851343|NCT01425801|566209072|FG004|Period 3|Stability criteria not fullfilled|0|||
156851344|NCT01425801|566209073|FG005|Period 3|Stability criteria not fullfilled|0|||
156851345|NCT01425801|566209068|FG000|Period 4|Not able to maintain visit schedule|0|||
156851346|NCT01425801|566209069|FG001|Period 4|Not able to maintain visit schedule|0|||
156851347|NCT01425801|566209070|FG002|Period 4|Not able to maintain visit schedule|1|||
156851348|NCT01425801|566209071|FG003|Period 4|Not able to maintain visit schedule|0|||
156851349|NCT01425801|566209072|FG004|Period 4|Not able to maintain visit schedule|0|||
156851350|NCT01425801|566209073|FG005|Period 4|Not able to maintain visit schedule|0|||
156851351|NCT02175017|566209074|FG000|Overall Study|Did not receive the investigational product|1|||
156851352|NCT02175017|566209075|FG001|Overall Study|Did not receive the investigational product|2|||
156851353|NCT02175017|566209074|FG000|Overall Study|Withdrawal by Subject|6|||
156851354|NCT02175017|566209075|FG001|Overall Study|Withdrawal by Subject|3|||
156851355|NCT02175017|566209074|FG000|Overall Study|Met an exclusion criteria|0|||
156851356|NCT02175017|566209075|FG001|Overall Study|Met an exclusion criteria|1|||
156851357|NCT02175017|566209074|FG000|Overall Study|Adverse Event|3|||
156851358|NCT02175017|566209075|FG001|Overall Study|Adverse Event|10|||
156851359|NCT02175017|566209074|FG000|Overall Study|Disease progression|20|||
156851360|NCT02175017|566209075|FG001|Overall Study|Disease progression|27|||
156851361|NCT02175017|566209074|FG000|Overall Study|Other than above reasons|3|||
156851362|NCT02175017|566209075|FG001|Overall Study|Other than above reasons|0|||
156851363|NCT04961541|566209076|FG000|Overall Study|Adverse Event|0|||
156851364|NCT04961541|566209077|FG001|Overall Study|Adverse Event|0|||
156851365|NCT04961541|566209078|FG002|Overall Study|Adverse Event|0|||
156851366|NCT04961541|566209079|FG003|Overall Study|Adverse Event|0|||
156851367|NCT04961541|566209080|FG004|Overall Study|Adverse Event|0|||
156851368|NCT04961541|566209081|FG005|Overall Study|Adverse Event|1|||
156851369|NCT04961541|566209082|FG006|Overall Study|Adverse Event|0|||
156851370|NCT04961541|566209083|FG007|Overall Study|Adverse Event|0|||
156851371|NCT04961541|566209084|FG008|Overall Study|Adverse Event|0|||
156851372|NCT04961541|566209085|FG009|Overall Study|Adverse Event|0|||
156851373|NCT04961541|566209086|FG010|Overall Study|Adverse Event|0|||
156851374|NCT04961541|566209087|FG011|Overall Study|Adverse Event|0|||
156851375|NCT04961541|566209088|FG012|Overall Study|Adverse Event|0|||
156851376|NCT04961541|566209089|FG013|Overall Study|Adverse Event|0|||
156851377|NCT04961541|566209076|FG000|Overall Study|Lost to Follow-up|0|||
156851378|NCT04961541|566209077|FG001|Overall Study|Lost to Follow-up|0|||
156851379|NCT04961541|566209078|FG002|Overall Study|Lost to Follow-up|3|||
156851380|NCT04961541|566209079|FG003|Overall Study|Lost to Follow-up|0|||
156851381|NCT04961541|566209080|FG004|Overall Study|Lost to Follow-up|0|||
156851382|NCT04961541|566209081|FG005|Overall Study|Lost to Follow-up|0|||
156851383|NCT04961541|566209082|FG006|Overall Study|Lost to Follow-up|1|||
156851384|NCT04961541|566209083|FG007|Overall Study|Lost to Follow-up|1|||
156851385|NCT04961541|566209084|FG008|Overall Study|Lost to Follow-up|0|||
156851386|NCT04961541|566209085|FG009|Overall Study|Lost to Follow-up|1|||
156851387|NCT04961541|566209086|FG010|Overall Study|Lost to Follow-up|0|||
156851388|NCT04961541|566209087|FG011|Overall Study|Lost to Follow-up|0|||
156851389|NCT04961541|566209088|FG012|Overall Study|Lost to Follow-up|1|||
156851390|NCT04961541|566209089|FG013|Overall Study|Lost to Follow-up|0|||
156851391|NCT04961541|566209076|FG000|Overall Study|Withdrawal by Subject|0|||
156851392|NCT04961541|566209077|FG001|Overall Study|Withdrawal by Subject|0|||
156851393|NCT04961541|566209078|FG002|Overall Study|Withdrawal by Subject|1|||
156851394|NCT04961541|566209079|FG003|Overall Study|Withdrawal by Subject|1|||
156851395|NCT04961541|566209080|FG004|Overall Study|Withdrawal by Subject|0|||
156851396|NCT04961541|566209081|FG005|Overall Study|Withdrawal by Subject|0|||
156851397|NCT04961541|566209082|FG006|Overall Study|Withdrawal by Subject|0|||
156851398|NCT04961541|566209083|FG007|Overall Study|Withdrawal by Subject|0|||
156851399|NCT04961541|566209084|FG008|Overall Study|Withdrawal by Subject|0|||
156851400|NCT04961541|566209085|FG009|Overall Study|Withdrawal by Subject|1|||
156851401|NCT04961541|566209086|FG010|Overall Study|Withdrawal by Subject|0|||
156851402|NCT04961541|566209087|FG011|Overall Study|Withdrawal by Subject|0|||
156851403|NCT04961541|566209088|FG012|Overall Study|Withdrawal by Subject|0|||
156851404|NCT04961541|566209089|FG013|Overall Study|Withdrawal by Subject|0|||
156851405|NCT02330055|566209092|FG000|Overall Study|technical issues|2|||
156851406|NCT02330055|566209093|FG001|Overall Study|technical issues|0|||
156851407|NCT02330055|566209092|FG000|Overall Study|participant forgot to wear device|5|||
156851408|NCT02330055|566209093|FG001|Overall Study|participant forgot to wear device|5|||
156851409|NCT02330055|566209092|FG000|Overall Study|data for less than 60 minutes|3|||
156851410|NCT02330055|566209093|FG001|Overall Study|data for less than 60 minutes|3|||
156851411|NCT02330055|566209092|FG000|Overall Study|participant did not sleep|0|||
156851412|NCT02330055|566209093|FG001|Overall Study|participant did not sleep|1|||
156851413|NCT00550953|566209094|FG000|Overall Study|Adverse Event|4|||
156851414|NCT00550953|566209095|FG001|Overall Study|Adverse Event|3|||
156851415|NCT00550953|566209094|FG000|Overall Study|Not able to visit the site|2|||
156851416|NCT00550953|566209095|FG001|Overall Study|Not able to visit the site|3|||
156851417|NCT03797586|566209096|FG000|Overall Study|Lost to Follow-up|3|||
156851418|NCT03797586|566209097|FG001|Overall Study|Lost to Follow-up|6|||
156851419|NCT03797586|566209096|FG000|Overall Study|Death|1|||
156851420|NCT03797586|566209097|FG001|Overall Study|Death|1|||
156851421|NCT03797586|566209096|FG000|Overall Study|Adverse Event|0|||
156851422|NCT03797586|566209097|FG001|Overall Study|Adverse Event|2|||
156851423|NCT02959437|566209098|FG000|Overall Study|Death|33|||
156851424|NCT02959437|566209099|FG001|Overall Study|Death|3|||
156851425|NCT02959437|566209100|FG002|Overall Study|Death|0|||
156851426|NCT02959437|566209101|FG003|Overall Study|Death|0|||
156851427|NCT02959437|566209098|FG000|Overall Study|Lost to Follow-up|3|||
156851428|NCT02959437|566209099|FG001|Overall Study|Lost to Follow-up|1|||
156851429|NCT02959437|566209100|FG002|Overall Study|Lost to Follow-up|0|||
156851430|NCT02959437|566209101|FG003|Overall Study|Lost to Follow-up|0|||
156851431|NCT02959437|566209098|FG000|Overall Study|Withdrawal by Subject|11|||
156472329|NCT04445831|564823468|FG002|Overall Study|Withdrawal by Subject|1|||
156472330|NCT04445831|564823469|FG003|Overall Study|Withdrawal by Subject|0|||
156472331|NCT04445831|564823470|FG004|Overall Study|Withdrawal by Subject|0|||
156472332|NCT04445831|564823471|FG005|Overall Study|Withdrawal by Subject|0|||
156851432|NCT02959437|566209099|FG001|Overall Study|Withdrawal by Subject|3|||
156851433|NCT02959437|566209100|FG002|Overall Study|Withdrawal by Subject|0|||
156472333|NCT04445831|564823472|FG006|Overall Study|Withdrawal by Subject|0|||
156851434|NCT02959437|566209101|FG003|Overall Study|Withdrawal by Subject|0|||
156851435|NCT02959437|566209098|FG000|Overall Study|Progressive Disease|9|||
156851436|NCT02959437|566209099|FG001|Overall Study|Progressive Disease|1|||
156851437|NCT02959437|566209100|FG002|Overall Study|Progressive Disease|0|||
156851438|NCT02959437|566209101|FG003|Overall Study|Progressive Disease|0|||
156851439|NCT02959437|566209098|FG000|Overall Study|Study Terminated by Sponsor|4|||
156851440|NCT02959437|566209099|FG001|Overall Study|Study Terminated by Sponsor|0|||
156851441|NCT02959437|566209100|FG002|Overall Study|Study Terminated by Sponsor|0|||
156851442|NCT02959437|566209101|FG003|Overall Study|Study Terminated by Sponsor|0|||
156851443|NCT02959437|566209098|FG000|Overall Study|Other Unspecified|2|||
156851444|NCT02959437|566209099|FG001|Overall Study|Other Unspecified|0|||
156851445|NCT02959437|566209100|FG002|Overall Study|Other Unspecified|0|||
156851446|NCT02959437|566209101|FG003|Overall Study|Other Unspecified|0|||
156851447|NCT01219985|566209102|FG000|Overall Study|Physician Decision|20|||
156851448|NCT02680665|566209103|FG000|Overall Study|No visit after the first prescription|5|||
156851449|NCT02905266|566209104|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
156851450|NCT02905266|566209105|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
156851451|NCT02905266|566209104|FG000|Treatment Phase Part 1|Disease Progression|6|||
156851452|NCT02905266|566209105|FG001|Treatment Phase Part 1|Disease Progression|7|||
156851453|NCT02905266|566209104|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
156851454|NCT02905266|566209105|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
156851455|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
156851456|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
156851457|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
156851458|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
156851459|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
156851460|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
156851461|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Death|0|||
156851462|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Death|1|||
156851463|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
156851464|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
156851465|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
156851466|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
156851467|NCT02905266|566209104|FG000|Maintenance Phase Part 2|Disease Progression|9|||
156851468|NCT02905266|566209105|FG001|Maintenance Phase Part 2|Disease Progression|2|||
156851469|NCT02905266|566209104|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
156851470|NCT02905266|566209105|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
156851471|NCT02905266|566209104|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
156851472|NCT02905266|566209105|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
156851473|NCT02292719|566209106|FG000|Overall Study|Withdrawal by Subject|0|||
156851474|NCT02292719|566209107|FG001|Overall Study|Withdrawal by Subject|0|||
156851475|NCT02292719|566209108|FG002|Overall Study|Withdrawal by Subject|0|||
156851476|NCT02292719|566209109|FG003|Overall Study|Withdrawal by Subject|1|||
156851477|NCT02292719|566209110|FG004|Overall Study|Withdrawal by Subject|1|||
156851478|NCT02292719|566209111|FG005|Overall Study|Withdrawal by Subject|0|||
156851479|NCT02292719|566209106|FG000|Overall Study|Subject enrolled in new study.|0|||
156851480|NCT02292719|566209107|FG001|Overall Study|Subject enrolled in new study.|0|||
156851481|NCT02292719|566209108|FG002|Overall Study|Subject enrolled in new study.|1|||
156851482|NCT02292719|566209109|FG003|Overall Study|Subject enrolled in new study.|0|||
156851483|NCT02292719|566209110|FG004|Overall Study|Subject enrolled in new study.|0|||
156851484|NCT02292719|566209111|FG005|Overall Study|Subject enrolled in new study.|0|||
156851485|NCT02940496|566209112|FG000|Overall Study|Adverse Event|1|||
156851486|NCT02940496|566209113|FG001|Overall Study|Adverse Event|0|||
156851487|NCT02940496|566209112|FG000|Overall Study|Death|2|||
156851488|NCT02940496|566209113|FG001|Overall Study|Death|0|||
156851489|NCT02940496|566209112|FG000|Overall Study|Hospice Care|1|||
156851490|NCT02940496|566209113|FG001|Overall Study|Hospice Care|0|||
156472334|NCT04445831|564823466|FG000|Overall Study|Subject withdrawal by caregiver|0|||
156472335|NCT04445831|564823467|FG001|Overall Study|Subject withdrawal by caregiver|1|||
156472336|NCT04445831|564823468|FG002|Overall Study|Subject withdrawal by caregiver|0|||
156472337|NCT04445831|564823469|FG003|Overall Study|Subject withdrawal by caregiver|0|||
156851491|NCT02940496|566209112|FG000|Overall Study|No MRE Done|1|||
156472338|NCT04445831|564823470|FG004|Overall Study|Subject withdrawal by caregiver|0|||
156851492|NCT02940496|566209113|FG001|Overall Study|No MRE Done|0|||
156851493|NCT02940496|566209112|FG000|Overall Study|MRE Failure|1|||
156851494|NCT02940496|566209113|FG001|Overall Study|MRE Failure|0|||
156851495|NCT04089761|566209120|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
156851496|NCT04089761|566209120|FG000|"Run In Phase"|Lost to Follow-up|1|||
156851497|NCT04089761|566209120|FG000|"Treatment Phase"|No evaluable data|5|||
156851498|NCT04089761|566209120|FG000|"Treatment Phase"|Lost to Follow-up|1|||
156472339|NCT04445831|564823471|FG005|Overall Study|Subject withdrawal by caregiver|0|||
156472340|NCT04445831|564823472|FG006|Overall Study|Subject withdrawal by caregiver|0|||
156472341|NCT04701203|564823475|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
156472342|NCT04701203|564823476|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
156472343|NCT04701203|564823477|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
156472344|NCT04701203|564823475|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
156472345|NCT04701203|564823476|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
156472346|NCT04701203|564823477|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
156472347|NCT04701203|564823475|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
156472348|NCT04701203|564823476|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
156472349|NCT04701203|564823477|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
156472350|NCT04701203|564823475|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
156472351|NCT04701203|564823476|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
156472352|NCT04701203|564823477|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
156472353|NCT02434328|564823480|FG000|Overall Study|Adverse Event|9|||
156472354|NCT02434328|564823481|FG001|Overall Study|Adverse Event|4|||
156472355|NCT02434328|564823480|FG000|Overall Study|Lack of Efficacy|0|||
156472356|NCT02434328|564823481|FG001|Overall Study|Lack of Efficacy|2|||
156472357|NCT02434328|564823480|FG000|Overall Study|Physician Decision|0|||
156472358|NCT02434328|564823481|FG001|Overall Study|Physician Decision|1|||
156472359|NCT02434328|564823480|FG000|Overall Study|Withdrawal by Subject|12|||
156472360|NCT02434328|564823481|FG001|Overall Study|Withdrawal by Subject|21|||
156472361|NCT02434328|564823480|FG000|Overall Study|Death|4|||
156472362|NCT02434328|564823481|FG001|Overall Study|Death|7|||
156472363|NCT02434328|564823480|FG000|Overall Study|Lost to Follow-up|1|||
156472364|NCT02434328|564823481|FG001|Overall Study|Lost to Follow-up|6|||
156472365|NCT02434328|564823480|FG000|Overall Study|Other|4|||
156472366|NCT02434328|564823481|FG001|Overall Study|Other|1|||
156472367|NCT03147287|564823482|FG000|Overall Study|Randomized Not Treated|2|||
156472368|NCT03147287|564823483|FG001|Overall Study|Randomized Not Treated|1|||
156472369|NCT03147287|564823484|FG002|Overall Study|Randomized Not Treated|1|||
156472370|NCT03147287|564823482|FG000|Overall Study|Progressive Disease RECIST|31|||
156472371|NCT03147287|564823483|FG001|Overall Study|Progressive Disease RECIST|72|||
156472372|NCT03147287|564823484|FG002|Overall Study|Progressive Disease RECIST|32|||
156472373|NCT03147287|564823482|FG000|Overall Study|Progressive Disease not RECIST|13|||
156472374|NCT03147287|564823483|FG001|Overall Study|Progressive Disease not RECIST|21|||
156472375|NCT03147287|564823484|FG002|Overall Study|Progressive Disease not RECIST|13|||
156472376|NCT03147287|564823482|FG000|Overall Study|Physician Decision|1|||
156472377|NCT03147287|564823483|FG001|Overall Study|Physician Decision|2|||
156472378|NCT03147287|564823484|FG002|Overall Study|Physician Decision|1|||
156472379|NCT03147287|564823482|FG000|Overall Study|Intercurrent illness|0|||
156472380|NCT03147287|564823483|FG001|Overall Study|Intercurrent illness|1|||
156472381|NCT03147287|564823484|FG002|Overall Study|Intercurrent illness|0|||
156472382|NCT03147287|564823482|FG000|Overall Study|Withdrawal by Subject|2|||
156472383|NCT03147287|564823483|FG001|Overall Study|Withdrawal by Subject|3|||
156472384|NCT03147287|564823484|FG002|Overall Study|Withdrawal by Subject|2|||
156472385|NCT03147287|564823482|FG000|Overall Study|Patient Non-Compliance|0|||
156472386|NCT03147287|564823483|FG001|Overall Study|Patient Non-Compliance|2|||
156472387|NCT03147287|564823484|FG002|Overall Study|Patient Non-Compliance|0|||
156472388|NCT03147287|564823482|FG000|Overall Study|Patient moved|0|||
156472389|NCT03147287|564823483|FG001|Overall Study|Patient moved|1|||
156472390|NCT03147287|564823484|FG002|Overall Study|Patient moved|0|||
156472391|NCT03147287|564823482|FG000|Overall Study|Arm A crossover without PD|1|||
156472392|NCT03147287|564823483|FG001|Overall Study|Arm A crossover without PD|0|||
156472393|NCT03147287|564823484|FG002|Overall Study|Arm A crossover without PD|0|||
156472394|NCT03147287|564823482|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
156472395|NCT03147287|564823483|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
156472396|NCT03147287|564823484|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
156472397|NCT04323800|564825481|FG000|Overall Study|Withdrawal by Subject|4|||
156472398|NCT04323800|564825482|FG001|Overall Study|Withdrawal by Subject|4|||
156472399|NCT04323800|564825481|FG000|Overall Study|Incomplete transfusion|1|||
156472400|NCT04323800|564825482|FG001|Overall Study|Incomplete transfusion|0|||
156342195|NCT04115839|564352566|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156342196|NCT04115839|564352567|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156472401|NCT04323800|564825481|FG000|Overall Study|Other|0|||
156472402|NCT04323800|564825482|FG001|Overall Study|Other|1|||
156472403|NCT04323800|564825481|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
156472404|NCT04323800|564825482|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
156472405|NCT00489554|564825483|FG000|Overall Study|Adverse Event|2|||
156851499|NCT00770601|566209121|FG000|Overall Study|Withdrawal by Subject|1|||
156472406|NCT00489554|564825483|FG000|Overall Study|Withdrawal by Subject|1|||
156472407|NCT00489554|564825483|FG000|Overall Study|Lost to Follow-up|1|||
156472408|NCT01732757|564825484|FG000|Overall Study|Lost to Follow-up|1|||
156472409|NCT01732757|564825485|FG001|Overall Study|Lost to Follow-up|0|||
156472410|NCT01732757|564825486|FG002|Overall Study|Lost to Follow-up|0|||
156472411|NCT00731692|564825487|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
156472412|NCT00731692|564825488|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
156472413|NCT00731692|564825489|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
156472414|NCT00731692|564825487|FG000|Core Study (36 Months)|Physician Decision|1|||
156472415|NCT00731692|564825488|FG001|Core Study (36 Months)|Physician Decision|0|||
156472416|NCT00731692|564825489|FG002|Core Study (36 Months)|Physician Decision|2|||
156472417|NCT00731692|564825487|FG000|Core Study (36 Months)|Death|2|||
156472418|NCT00731692|564825488|FG001|Core Study (36 Months)|Death|1|||
156472419|NCT00731692|564825489|FG002|Core Study (36 Months)|Death|2|||
156472420|NCT00731692|564825487|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
156472421|NCT00731692|564825488|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
156472422|NCT00731692|564825489|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
156472423|NCT00731692|564825487|FG000|Core Study (36 Months)|Administrative|2|||
156472424|NCT00731692|564825488|FG001|Core Study (36 Months)|Administrative|2|||
156472425|NCT00731692|564825489|FG002|Core Study (36 Months)|Administrative|6|||
156472426|NCT00731692|564825487|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
156472427|NCT00731692|564825488|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
156472428|NCT00731692|564825489|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
156472429|NCT00731692|564825487|FG000|Core Study (36 Months)|Protocol Violation|4|||
156472430|NCT00731692|564825488|FG001|Core Study (36 Months)|Protocol Violation|5|||
156472431|NCT00731692|564825489|FG002|Core Study (36 Months)|Protocol Violation|8|||
156472432|NCT00731692|564825487|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
156472433|NCT00731692|564825488|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
156472434|NCT00731692|564825489|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
156472435|NCT00731692|564825487|FG000|Core Study (36 Months)|Adverse Event|25|||
156472436|NCT00731692|564825488|FG001|Core Study (36 Months)|Adverse Event|28|||
156472437|NCT00731692|564825489|FG002|Core Study (36 Months)|Adverse Event|29|||
156472438|NCT00731692|564825487|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
156472439|NCT00731692|564825488|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
156472440|NCT00731692|564825489|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
156472441|NCT00731692|564825487|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
156472442|NCT00731692|564825488|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
156472443|NCT00731692|564825489|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
156472444|NCT00731692|564825487|FG000|Extension Phase|Abnormal test procedure|0|||
156472445|NCT00731692|564825488|FG001|Extension Phase|Abnormal test procedure|0|||
156472446|NCT00731692|564825489|FG002|Extension Phase|Abnormal test procedure|1|||
156472447|NCT00731692|564825487|FG000|Extension Phase|Abnormal lab values|0|||
156472448|NCT00731692|564825488|FG001|Extension Phase|Abnormal lab values|0|||
156472449|NCT00731692|564825489|FG002|Extension Phase|Abnormal lab values|1|||
156472450|NCT00731692|564825487|FG000|Extension Phase|Lost to Follow-up|0|||
156472451|NCT00731692|564825488|FG001|Extension Phase|Lost to Follow-up|1|||
156472452|NCT00731692|564825489|FG002|Extension Phase|Lost to Follow-up|4|||
156472453|NCT00731692|564825487|FG000|Extension Phase|Withdrawal by Subject|4|||
156472454|NCT00731692|564825488|FG001|Extension Phase|Withdrawal by Subject|5|||
156472455|NCT00731692|564825489|FG002|Extension Phase|Withdrawal by Subject|3|||
156472456|NCT00731692|564825487|FG000|Extension Phase|Adverse Event|1|||
156472457|NCT00731692|564825488|FG001|Extension Phase|Adverse Event|1|||
156472458|NCT00731692|564825489|FG002|Extension Phase|Adverse Event|15|||
156472459|NCT00747006|564825490|FG000|Overall Study|Adverse Event|1|||
156472460|NCT00747006|564825491|FG001|Overall Study|Adverse Event|0|||
156472461|NCT00747006|564825492|FG002|Overall Study|Adverse Event|0|||
156472462|NCT00747006|564825490|FG000|Overall Study|Lost to Follow-up|0|||
156472463|NCT00747006|564825491|FG001|Overall Study|Lost to Follow-up|1|||
156472464|NCT00747006|564825492|FG002|Overall Study|Lost to Follow-up|0|||
156851500|NCT00434109|566209122|FG000|Overall Study|Physician Decision|9|||
156851501|NCT00434109|566209122|FG000|Overall Study|Adverse Event|5|||
156851502|NCT00434109|566209122|FG000|Overall Study|Protocol Violation|1|||
156851503|NCT00434109|566209122|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
156472465|NCT00747006|564825490|FG000|Overall Study|Physician Decision|2|||
156472466|NCT00747006|564825491|FG001|Overall Study|Physician Decision|0|||
156472467|NCT00747006|564825492|FG002|Overall Study|Physician Decision|1|||
156472468|NCT02132949|564825497|FG000|Overall Study|Death|7|||
156472469|NCT02132949|564825498|FG001|Overall Study|Death|13|||
156472470|NCT02132949|564825497|FG000|Overall Study|Lost to Follow-up|14|||
156472471|NCT02132949|564825498|FG001|Overall Study|Lost to Follow-up|4|||
156472472|NCT02132949|564825497|FG000|Overall Study|Withdrawal by Subject|6|||
156472473|NCT02132949|564825498|FG001|Overall Study|Withdrawal by Subject|5|||
156472474|NCT02132949|564825497|FG000|Overall Study|Noncompliance|5|||
156472475|NCT02132949|564825498|FG001|Overall Study|Noncompliance|1|||
156472476|NCT02132949|564825497|FG000|Overall Study|Physician Decision|3|||
156472477|NCT02132949|564825498|FG001|Overall Study|Physician Decision|1|||
156472478|NCT02132949|564825497|FG000|Overall Study|Disease Progression|3|||
156472479|NCT02132949|564825498|FG001|Overall Study|Disease Progression|0|||
156472480|NCT02132949|564825497|FG000|Overall Study|Adverse Event|2|||
156472481|NCT02132949|564825498|FG001|Overall Study|Adverse Event|1|||
156472482|NCT02132949|564825497|FG000|Overall Study|Withdrew Prior to Treatment|1|||
156472483|NCT02132949|564825498|FG001|Overall Study|Withdrew Prior to Treatment|2|||
156472484|NCT02132949|564825497|FG000|Overall Study|Reason Unspecified|0|||
156472485|NCT02132949|564825498|FG001|Overall Study|Reason Unspecified|1|||
156472486|NCT01583166|564825499|FG000|Overall Study|Withdrawal by Subject|4|||
156472487|NCT01583166|564825500|FG001|Overall Study|Withdrawal by Subject|6|||
156472488|NCT04652869|564825501|FG000|Overall Study|Withdrawal by Subject|0|||
156472489|NCT04652869|564825502|FG001|Overall Study|Withdrawal by Subject|2|||
156472490|NCT04652869|564825503|FG002|Overall Study|Withdrawal by Subject|0|||
156472491|NCT01372085|564825504|FG000|Washout Period 2|Physician Decision|0|||
156472492|NCT01372085|564825505|FG001|Washout Period 2|Physician Decision|0|||
156472493|NCT01372085|564825506|FG002|Washout Period 2|Physician Decision|0|||
156472494|NCT01372085|564825507|FG003|Washout Period 2|Physician Decision|0|||
156472495|NCT01372085|564825508|FG004|Washout Period 2|Physician Decision|1|||
156472496|NCT01372085|564825509|FG005|Washout Period 2|Physician Decision|0|||
156472497|NCT01372085|564825510|FG006|Washout Period 2|Physician Decision|0|||
156472498|NCT01372085|564825511|FG007|Washout Period 2|Physician Decision|0|||
156472499|NCT01372085|564825512|FG008|Washout Period 2|Physician Decision|0|||
156472500|NCT01372085|564825513|FG009|Washout Period 2|Physician Decision|0|||
156851504|NCT00103740|566209123|FG000|Period 1 - Core|Adverse Event|1|||
156851505|NCT00103740|566209124|FG001|Period 1 - Core|Adverse Event|0|||
156851506|NCT00103740|566209123|FG000|Period 1 - Core|Protocol Violation|3|||
156851507|NCT00103740|566209124|FG001|Period 1 - Core|Protocol Violation|2|||
156851508|NCT00103740|566209123|FG000|Period 1 - Core|Patient withdrew consent|3|||
156851509|NCT00103740|566209124|FG001|Period 1 - Core|Patient withdrew consent|2|||
156851510|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
156851511|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
156851512|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
156851513|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
156851514|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
156851515|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
156851516|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Death|6|||
156851517|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Death|2|||
156851518|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
156851519|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
156851520|NCT01463306|566209125|FG000|Overall Study|Adverse Event|6|||
156851521|NCT01463306|566209126|FG001|Overall Study|Adverse Event|9|||
156851522|NCT01463306|566209127|FG002|Overall Study|Adverse Event|3|||
156851523|NCT01463306|566209125|FG000|Overall Study|Death|3|||
156851524|NCT01463306|566209126|FG001|Overall Study|Death|3|||
156851525|NCT01463306|566209127|FG002|Overall Study|Death|0|||
156851526|NCT01463306|566209125|FG000|Overall Study|Lack of Efficacy|22|||
156851527|NCT01463306|566209126|FG001|Overall Study|Lack of Efficacy|16|||
156851528|NCT01463306|566209127|FG002|Overall Study|Lack of Efficacy|1|||
156851529|NCT01463306|566209125|FG000|Overall Study|Lost to Follow-up|5|||
156851530|NCT01463306|566209126|FG001|Overall Study|Lost to Follow-up|2|||
156851531|NCT01463306|566209127|FG002|Overall Study|Lost to Follow-up|0|||
156851532|NCT01463306|566209125|FG000|Overall Study|Protocol Violation|4|||
156851533|NCT01463306|566209126|FG001|Overall Study|Protocol Violation|0|||
156851534|NCT01463306|566209127|FG002|Overall Study|Protocol Violation|0|||
156851535|NCT01463306|566209125|FG000|Overall Study|Withdrawal by Subject|19|||
156851536|NCT01463306|566209126|FG001|Overall Study|Withdrawal by Subject|9|||
156851537|NCT01463306|566209127|FG002|Overall Study|Withdrawal by Subject|1|||
156851538|NCT01463306|566209125|FG000|Overall Study|Other|26|||
156851539|NCT01463306|566209126|FG001|Overall Study|Other|13|||
156851540|NCT01463306|566209127|FG002|Overall Study|Other|0|||
156851541|NCT01463306|566209125|FG000|Overall Study|Approval expiry at site|1|||
156851542|NCT01463306|566209126|FG001|Overall Study|Approval expiry at site|0|||
156851543|NCT01463306|566209127|FG002|Overall Study|Approval expiry at site|0|||
156851544|NCT01633788|566211612|FG000|Overall Study|Adverse Event|1|||
156851545|NCT01633788|566211613|FG001|Overall Study|Adverse Event|3|||
156342197|NCT04115839|564352568|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156342198|NCT04115839|564352569|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
156472501|NCT01372085|564825504|FG000|Washout Period 3|Withdrawal by Subject|0|||
156472502|NCT01372085|564825505|FG001|Washout Period 3|Withdrawal by Subject|0|||
156851546|NCT01633788|566211614|FG002|Overall Study|Adverse Event|3|||
156851547|NCT01633788|566211615|FG003|Overall Study|Adverse Event|3|||
156472503|NCT01372085|564825506|FG002|Washout Period 3|Withdrawal by Subject|0|||
156851548|NCT01633788|566211612|FG000|Overall Study|Lost to Follow-up|2|||
156851549|NCT01633788|566211613|FG001|Overall Study|Lost to Follow-up|2|||
156851550|NCT01633788|566211614|FG002|Overall Study|Lost to Follow-up|2|||
156472504|NCT01372085|564825507|FG003|Washout Period 3|Withdrawal by Subject|0|||
156851551|NCT01633788|566211615|FG003|Overall Study|Lost to Follow-up|0|||
156851552|NCT01633788|566211612|FG000|Overall Study|Personal Reasons|3|||
156851553|NCT01633788|566211613|FG001|Overall Study|Personal Reasons|1|||
156851554|NCT01633788|566211614|FG002|Overall Study|Personal Reasons|1|||
156851555|NCT01633788|566211615|FG003|Overall Study|Personal Reasons|3|||
156851556|NCT01633788|566211612|FG000|Overall Study|Protocol Violation|1|||
156851557|NCT01633788|566211613|FG001|Overall Study|Protocol Violation|0|||
156851558|NCT01633788|566211614|FG002|Overall Study|Protocol Violation|1|||
156851559|NCT01633788|566211615|FG003|Overall Study|Protocol Violation|0|||
156851560|NCT01633788|566211612|FG000|Overall Study|Other Reasons|0|||
156851561|NCT01633788|566211613|FG001|Overall Study|Other Reasons|2|||
156851562|NCT01633788|566211614|FG002|Overall Study|Other Reasons|3|||
156851563|NCT01633788|566211615|FG003|Overall Study|Other Reasons|7|||
156851564|NCT01389882|566211618|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
156851565|NCT01389882|566211619|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
156851566|NCT01389882|566211618|FG000|Overall Study|Withdrawal by Subject|0|||
156851567|NCT01389882|566211619|FG001|Overall Study|Withdrawal by Subject|1|||
156851568|NCT00936702|566211620|FG000|Overall Study|Disease progression|34|||
156851569|NCT00936702|566211620|FG000|Overall Study|Adverse Event|8|||
156851570|NCT00936702|566211620|FG000|Overall Study|Withdrawal by Subject|2|||
156851571|NCT00936702|566211620|FG000|Overall Study|Alternative Treatment|1|||
156851572|NCT00936702|566211620|FG000|Overall Study|Other|1|||
156851573|NCT02532465|566211621|FG000|Overall Study|Protocol Violation|1|||
156851574|NCT02532465|566211622|FG001|Overall Study|Protocol Violation|0|||
156851575|NCT02532465|566211621|FG000|Overall Study|Lack of Efficacy|0|||
156851576|NCT02532465|566211622|FG001|Overall Study|Lack of Efficacy|1|||
156851577|NCT00354679|566211627|FG000|Overall Study|Patient Not Treated|1|||
156851578|NCT00466440|566211628|FG000|Overall Study|Adverse Event|0|||
156851579|NCT00466440|566211629|FG001|Overall Study|Adverse Event|3|||
156851580|NCT00466440|566211630|FG002|Overall Study|Adverse Event|1|||
156851581|NCT00466440|566211628|FG000|Overall Study|Death|1|||
156851582|NCT00466440|566211629|FG001|Overall Study|Death|1|||
156851583|NCT00466440|566211630|FG002|Overall Study|Death|0|||
156851584|NCT00466440|566211628|FG000|Overall Study|Progressive disease|13|||
156851585|NCT00466440|566211629|FG001|Overall Study|Progressive disease|5|||
156851586|NCT00466440|566211630|FG002|Overall Study|Progressive disease|4|||
156851587|NCT00466440|566211628|FG000|Overall Study|Lost to Follow-up|0|||
156851588|NCT00466440|566211629|FG001|Overall Study|Lost to Follow-up|1|||
156851589|NCT00466440|566211630|FG002|Overall Study|Lost to Follow-up|0|||
156851590|NCT00466440|566211628|FG000|Overall Study|Physician Decision|0|||
156851591|NCT00466440|566211629|FG001|Overall Study|Physician Decision|1|||
156851592|NCT00466440|566211630|FG002|Overall Study|Physician Decision|2|||
156851593|NCT00466440|566211628|FG000|Overall Study|Protocol entry criteria not met|0|||
156851594|NCT00466440|566211629|FG001|Overall Study|Protocol entry criteria not met|0|||
156851595|NCT00466440|566211630|FG002|Overall Study|Protocol entry criteria not met|4|||
156851596|NCT00466440|566211628|FG000|Overall Study|Withdrawal by Subject|0|||
156851597|NCT00466440|566211629|FG001|Overall Study|Withdrawal by Subject|1|||
156851598|NCT00466440|566211630|FG002|Overall Study|Withdrawal by Subject|0|||
156851599|NCT00466440|566211628|FG000|Overall Study|Sponsor decision|0|||
156851600|NCT00466440|566211629|FG001|Overall Study|Sponsor decision|0|||
156851601|NCT00466440|566211630|FG002|Overall Study|Sponsor decision|1|||
156851602|NCT03187132|566211636|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
156851603|NCT03187132|566211637|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
156851604|NCT03187132|566211636|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
156851605|NCT03187132|566211637|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
156851606|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
156851607|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
156851608|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
156851609|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
156851610|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
156851611|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
156851612|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
156851613|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
156851614|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
156851615|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
156851616|NCT03187132|566211636|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
156851617|NCT03187132|566211637|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
156851618|NCT03187132|566211636|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
156342199|NCT04115839|564352570|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
156851619|NCT03187132|566211637|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
156851620|NCT03187132|566211636|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
156851621|NCT03187132|566211637|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
156851622|NCT03187132|566211636|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
156851623|NCT03187132|566211637|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
156851624|NCT02045095|566211638|FG000|Overall Study|Other|0|||
156851625|NCT02045095|566211639|FG001|Overall Study|Other|0|||
156851626|NCT02045095|566211640|FG002|Overall Study|Other|1|||
156851627|NCT02045095|566211641|FG003|Overall Study|Other|0|||
156851628|NCT02045095|566211642|FG004|Overall Study|Other|0|||
156851629|NCT02045095|566211643|FG005|Overall Study|Other|2|||
156851630|NCT02045095|566211644|FG006|Overall Study|Other|0|||
156851631|NCT02045095|566211638|FG000|Overall Study|Progressive Disease|3|||
156851632|NCT02045095|566211639|FG001|Overall Study|Progressive Disease|3|||
156851633|NCT02045095|566211640|FG002|Overall Study|Progressive Disease|2|||
156851634|NCT02045095|566211641|FG003|Overall Study|Progressive Disease|4|||
156851635|NCT02045095|566211642|FG004|Overall Study|Progressive Disease|2|||
156851636|NCT02045095|566211643|FG005|Overall Study|Progressive Disease|4|||
156851637|NCT02045095|566211644|FG006|Overall Study|Progressive Disease|1|||
156851638|NCT02045095|566211638|FG000|Overall Study|Withdrawal by Subject|0|||
156851639|NCT02045095|566211639|FG001|Overall Study|Withdrawal by Subject|0|||
156851640|NCT02045095|566211640|FG002|Overall Study|Withdrawal by Subject|0|||
156851641|NCT02045095|566211641|FG003|Overall Study|Withdrawal by Subject|0|||
156851642|NCT02045095|566211642|FG004|Overall Study|Withdrawal by Subject|3|||
156851643|NCT02045095|566211643|FG005|Overall Study|Withdrawal by Subject|0|||
156851644|NCT02045095|566211644|FG006|Overall Study|Withdrawal by Subject|0|||
156851645|NCT02045095|566211638|FG000|Overall Study|Adverse Event|0|||
156851646|NCT02045095|566211639|FG001|Overall Study|Adverse Event|1|||
156851647|NCT02045095|566211640|FG002|Overall Study|Adverse Event|1|||
156851648|NCT02045095|566211641|FG003|Overall Study|Adverse Event|0|||
156851649|NCT02045095|566211642|FG004|Overall Study|Adverse Event|0|||
156851650|NCT02045095|566211643|FG005|Overall Study|Adverse Event|2|||
156851651|NCT02045095|566211644|FG006|Overall Study|Adverse Event|0|||
156851652|NCT02525588|566211645|FG000|Overall Study|Death|3|||
156851653|NCT02525588|566211646|FG001|Overall Study|Death|1|||
156851654|NCT02525588|566211645|FG000|Overall Study|Lost to Follow-up|2|||
156851655|NCT02525588|566211646|FG001|Overall Study|Lost to Follow-up|0|||
156851656|NCT02525588|566211645|FG000|Overall Study|Withdrawal by Subject|1|||
156851657|NCT02525588|566211646|FG001|Overall Study|Withdrawal by Subject|1|||
156851658|NCT02525588|566211645|FG000|Overall Study|Adverse Event|0|||
156851659|NCT02525588|566211646|FG001|Overall Study|Adverse Event|1|||
156851660|NCT00714415|566211656|FG000|Overall Study|Lack of Efficacy|1|||
156851661|NCT00714415|566211657|FG001|Overall Study|Lack of Efficacy|0|||
156851662|NCT00714415|566211656|FG000|Overall Study|Death|1|||
156851663|NCT00714415|566211657|FG001|Overall Study|Death|0|||
156851664|NCT01818596|566211660|FG000|Overall Study|Enrolled but Not Treated|4|||
156851665|NCT01818596|566211661|FG001|Overall Study|Enrolled but Not Treated|0|||
156851666|NCT01818596|566211660|FG000|Overall Study|Adverse Event|7|||
156851667|NCT01818596|566211661|FG001|Overall Study|Adverse Event|0|||
156851668|NCT01818596|566211660|FG000|Overall Study|Death|3|||
156851669|NCT01818596|566211661|FG001|Overall Study|Death|0|||
156851670|NCT01818596|566211660|FG000|Overall Study|Investigator's Discretion|4|||
156851671|NCT01818596|566211661|FG001|Overall Study|Investigator's Discretion|0|||
156851672|NCT01818596|566211660|FG000|Overall Study|Protocol Violation|1|||
156851673|NCT01818596|566211661|FG001|Overall Study|Protocol Violation|0|||
156851674|NCT01818596|566211660|FG000|Overall Study|Withdrew Consent|5|||
156851675|NCT01818596|566211661|FG001|Overall Study|Withdrew Consent|0|||
156851676|NCT01818596|566211660|FG000|Overall Study|Lost to Follow-up|7|||
156851677|NCT01818596|566211661|FG001|Overall Study|Lost to Follow-up|0|||
156851678|NCT02073682|566211670|FG000|Overall Study|Low Creatinine Clearance|1|||
156851679|NCT02073682|566211671|FG001|Overall Study|Low Creatinine Clearance|2|||
156851680|NCT02073682|566211670|FG000|Overall Study|Death|86|||
156851681|NCT02073682|566211671|FG001|Overall Study|Death|100|||
156851682|NCT02073682|566211670|FG000|Overall Study|Cancer Cured|10|||
156851683|NCT02073682|566211671|FG001|Overall Study|Cancer Cured|15|||
156851684|NCT02073682|566211670|FG000|Overall Study|ID: Patient Noncompliance|1|||
156851685|NCT02073682|566211671|FG001|Overall Study|ID: Patient Noncompliance|2|||
156851686|NCT02073682|566211670|FG000|Overall Study|ID: Palliative Treatment Only|10|||
156851687|NCT02073682|566211671|FG001|Overall Study|ID: Palliative Treatment Only|7|||
156851688|NCT02073682|566211670|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
156851689|NCT02073682|566211671|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
156851690|NCT02073682|566211670|FG000|Overall Study|Platelet Count <50,000/mL|1|||
156851691|NCT02073682|566211671|FG001|Overall Study|Platelet Count <50,000/mL|2|||
156851692|NCT02073682|566211670|FG000|Overall Study|Surgery/Medical Procedure|3|||
156851693|NCT02073682|566211671|FG001|Overall Study|Surgery/Medical Procedure|1|||
156851694|NCT02073682|566211670|FG000|Overall Study|Withdrawal by Subject|6|||
156851695|NCT02073682|566211671|FG001|Overall Study|Withdrawal by Subject|8|||
156851696|NCT02073682|566211670|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
156851697|NCT02073682|566211671|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
156851698|NCT02073682|566211670|FG000|Overall Study|Cancer Progression|53|||
156851699|NCT02073682|566211671|FG001|Overall Study|Cancer Progression|33|||
156851700|NCT02073682|566211670|FG000|Overall Study|Protocol Violation|1|||
156851701|NCT02073682|566211671|FG001|Overall Study|Protocol Violation|0|||
156851702|NCT02073682|566211670|FG000|Overall Study|Adverse Event|79|||
156851703|NCT02073682|566211671|FG001|Overall Study|Adverse Event|62|||
156851704|NCT02073682|566211670|FG000|Overall Study|No reason provided|11|||
156851705|NCT02073682|566211671|FG001|Overall Study|No reason provided|9|||
156851706|NCT02073682|566211670|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
156851707|NCT02073682|566211671|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
156851708|NCT02073682|566211670|FG000|Overall Study|Lost to Follow-up|1|||
156851709|NCT02073682|566211671|FG001|Overall Study|Lost to Follow-up|1|||
156851710|NCT02073682|566211670|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
156851711|NCT02073682|566211671|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
156851712|NCT03461146|566211672|FG000|Overall Study|Adverse Event|2|||
156851713|NCT03461146|566211672|FG000|Overall Study|Physician Decision|1|||
156851714|NCT02478463|566211684|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
156851715|NCT02478463|566211684|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
156851716|NCT02478463|566211684|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
156851717|NCT01620086|566211685|FG000|Overall Study|Withdrawal by Subject|3|||
156851718|NCT01620086|566211686|FG001|Overall Study|Withdrawal by Subject|3|||
156851719|NCT01620086|566211687|FG002|Overall Study|Withdrawal by Subject|0|||
156851720|NCT01620086|566211685|FG000|Overall Study|failed study criteria|1|||
156851721|NCT01620086|566211686|FG001|Overall Study|failed study criteria|4|||
156851722|NCT01620086|566211687|FG002|Overall Study|failed study criteria|0|||
156851723|NCT01620086|566211685|FG000|Overall Study|Physician Decision|1|||
156851724|NCT01620086|566211686|FG001|Overall Study|Physician Decision|0|||
156851725|NCT01620086|566211687|FG002|Overall Study|Physician Decision|0|||
156851726|NCT03030417|566211689|FG000|Dose Expansion|Disease progression before treatment|0|||
156851727|NCT03030417|566211690|FG001|Dose Expansion|Disease progression before treatment|0|||
156851728|NCT03030417|566211691|FG002|Dose Expansion|Disease progression before treatment|0|||
156851729|NCT03030417|566211692|FG003|Dose Expansion|Disease progression before treatment|0|||
156851730|NCT03030417|566211693|FG004|Dose Expansion|Disease progression before treatment|0|||
156851731|NCT03030417|566211694|FG005|Dose Expansion|Disease progression before treatment|0|||
156851732|NCT03030417|566211695|FG006|Dose Expansion|Disease progression before treatment|0|||
156851733|NCT03030417|566211696|FG007|Dose Expansion|Disease progression before treatment|0|||
156851734|NCT03030417|566211697|FG008|Dose Expansion|Disease progression before treatment|0|||
156851735|NCT03030417|566211698|FG009|Dose Expansion|Disease progression before treatment|0|||
156851736|NCT03030417|566211699|FG010|Dose Expansion|Disease progression before treatment|0|||
156851737|NCT03030417|566211700|FG011|Dose Expansion|Disease progression before treatment|0|||
156851738|NCT03030417|566211701|FG012|Dose Expansion|Disease progression before treatment|1|||
156851739|NCT01076959|566211706|FG000|Overall Study|Adverse Event|767|||
156542184|NCT01652885|565079256|FG000|Overall Study|Adverse Event|1|||
156542185|NCT00075023|565079257|FG000|Pilot Study|Physician Decision|1|||
156851740|NCT01076959|566211706|FG000|Overall Study|Lack of Efficacy|849|||
156851741|NCT01076959|566211706|FG000|Overall Study|Non-compliance|274|||
156851742|NCT01076959|566211706|FG000|Overall Study|Lost to Follow-up|241|||
156851743|NCT01076959|566211706|FG000|Overall Study|Other|119|||
156851744|NCT04915729|566211707|FG000|Overall Study|Lost to Follow-up|20|||
156851745|NCT04915729|566211708|FG001|Overall Study|Lost to Follow-up|10|||
156851746|NCT04915729|566211707|FG000|Overall Study|Withdrawal by Subject|12|||
156851747|NCT04915729|566211708|FG001|Overall Study|Withdrawal by Subject|5|||
156851748|NCT04915729|566211707|FG000|Overall Study|Death|34|||
156851749|NCT04915729|566211708|FG001|Overall Study|Death|44|||
156851750|NCT04915729|566211707|FG000|Overall Study|not treated|3|||
156851751|NCT04915729|566211708|FG001|Overall Study|not treated|6|||
156851752|NCT04915729|566211707|FG000|Overall Study|Investigator removed subject|1|||
156851753|NCT04915729|566211708|FG001|Overall Study|Investigator removed subject|2|||
156851754|NCT04915729|566211707|FG000|Overall Study|questionnaire result not evaluated|1|||
156851755|NCT04915729|566211708|FG001|Overall Study|questionnaire result not evaluated|0|||
156851756|NCT04915729|566211707|FG000|Overall Study|refuse of hospital visit|1|||
156851757|NCT04915729|566211708|FG001|Overall Study|refuse of hospital visit|3|||
156851758|NCT04915729|566211707|FG000|Overall Study|Subject withdrew|1|||
156851759|NCT04915729|566211708|FG001|Overall Study|Subject withdrew|0|||
156851760|NCT03575403|566211710|FG000|Overall Study|Adverse Event|1|||
156851761|NCT03575403|566211711|FG001|Overall Study|Adverse Event|0|||
156851762|NCT03575403|566211712|FG002|Overall Study|Adverse Event|0|||
156851763|NCT03575403|566211710|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
156851764|NCT03575403|566211711|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
156851765|NCT03575403|566211712|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
156851766|NCT03066596|566211713|FG000|Overall Study|Withdrawal by Subject|4|||
156851767|NCT03066596|566211714|FG001|Overall Study|Withdrawal by Subject|2|||
156851768|NCT03066596|566211713|FG000|Overall Study|Lost to Follow-up|14|||
156851769|NCT03066596|566211714|FG001|Overall Study|Lost to Follow-up|10|||
156851770|NCT00773513|566211715|FG000|Overall Study|Renal Transplant|254|||
156851771|NCT00773513|566211716|FG001|Overall Study|Renal Transplant|263|||
156851772|NCT00773513|566211715|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
156851773|NCT00773513|566211716|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
156851774|NCT00773513|566211715|FG000|Overall Study|Withdrew Consent|68|||
156851775|NCT00773513|566211716|FG001|Overall Study|Withdrew Consent|69|||
156851776|NCT00773513|566211715|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
156851777|NCT00773513|566211716|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
156851778|NCT00773513|566211715|FG000|Overall Study|Failure to Return|22|||
156851779|NCT00773513|566211716|FG001|Overall Study|Failure to Return|8|||
156851780|NCT00773513|566211715|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156851781|NCT00773513|566211716|FG001|Overall Study|Insufficient Therapeutic Response|18|||
156851782|NCT00773513|566211715|FG000|Overall Study|Reason Not Specified|159|||
156851783|NCT00773513|566211716|FG001|Overall Study|Reason Not Specified|126|||
156851784|NCT00773513|566211715|FG000|Overall Study|Death|531|||
156851785|NCT00773513|566211716|FG001|Overall Study|Death|545|||
156851786|NCT02864901|566211717|FG000|Overall Study|Withdrawal by Subject|1|||
156851787|NCT02864901|566211718|FG001|Overall Study|Withdrawal by Subject|0|||
156851788|NCT03359174|566211723|FG000|Overall Study|Adverse Event|1|||
156851789|NCT04445662|566211726|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
156851790|NCT04445662|566211727|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
156851791|NCT04445662|566211726|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
156851792|NCT04445662|566211727|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
156851793|NCT04445662|566211726|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
156851794|NCT04445662|566211727|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
156851795|NCT04445662|566211726|FG000|Post-treatment (12-24 weeks)|Death|1|||
156851796|NCT04445662|566211727|FG001|Post-treatment (12-24 weeks)|Death|0|||
156851797|NCT05973006|566211728|FG000|Overall Study|Early termination|3|||
156851798|NCT05973006|566211729|FG001|Overall Study|Early termination|9|||
156851799|NCT01807598|566211730|FG000|Overall Study|Withdrawal by Subject|4|||
156851800|NCT01807598|566211730|FG000|Overall Study|Adverse Event|1|||
156851801|NCT01807598|566211730|FG000|Overall Study|Other Physician Decision|1|||
156851802|NCT02488005|566211731|FG000|Overall Study|Lost to Follow-up|2|||
156851803|NCT04170543|566211736|FG000|Overall Study|Death|1|||
156851804|NCT04170543|566211737|FG001|Overall Study|Death|1|||
156851805|NCT04170543|566211738|FG002|Overall Study|Death|1|||
156851806|NCT04170543|566211739|FG003|Overall Study|Death|1|||
156851807|NCT04170543|566211740|FG004|Overall Study|Death|1|||
156851808|NCT04170543|566211736|FG000|Overall Study|Lost to Follow-up|3|||
156851809|NCT04170543|566211737|FG001|Overall Study|Lost to Follow-up|3|||
156851810|NCT04170543|566211738|FG002|Overall Study|Lost to Follow-up|0|||
156851811|NCT04170543|566211739|FG003|Overall Study|Lost to Follow-up|3|||
156851812|NCT04170543|566211740|FG004|Overall Study|Lost to Follow-up|1|||
156851813|NCT04170543|566211736|FG000|Overall Study|Withdrawal by Subject|13|||
156851814|NCT04170543|566211737|FG001|Overall Study|Withdrawal by Subject|6|||
156851815|NCT04170543|566211738|FG002|Overall Study|Withdrawal by Subject|5|||
156851816|NCT04170543|566211739|FG003|Overall Study|Withdrawal by Subject|4|||
156851817|NCT04170543|566211740|FG004|Overall Study|Withdrawal by Subject|9|||
156851818|NCT04170543|566211736|FG000|Overall Study|Not able to transition to phase 2b|8|||
156851819|NCT04170543|566211737|FG001|Overall Study|Not able to transition to phase 2b|0|||
156851820|NCT04170543|566211738|FG002|Overall Study|Not able to transition to phase 2b|10|||
156851821|NCT04170543|566211739|FG003|Overall Study|Not able to transition to phase 2b|0|||
156851822|NCT04170543|566211740|FG004|Overall Study|Not able to transition to phase 2b|6|||
156851823|NCT04170543|566211736|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
156851824|NCT04170543|566211737|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
156851825|NCT04170543|566211738|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
156851826|NCT04170543|566211739|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
156851827|NCT04170543|566211740|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
156851828|NCT04170543|566211736|FG000|Overall Study|Not Treated|0|||
156851829|NCT04170543|566211737|FG001|Overall Study|Not Treated|0|||
156851830|NCT04170543|566211738|FG002|Overall Study|Not Treated|0|||
156851831|NCT04170543|566211739|FG003|Overall Study|Not Treated|0|||
156851832|NCT04170543|566211740|FG004|Overall Study|Not Treated|2|||
156851833|NCT04170543|566211736|FG000|Overall Study|(CRF)|16|||
156851834|NCT04170543|566211737|FG001|Overall Study|(CRF)|15|||
156851835|NCT04170543|566211738|FG002|Overall Study|(CRF)|12|||
156851836|NCT04170543|566211739|FG003|Overall Study|(CRF)|17|||
156851837|NCT04170543|566211740|FG004|Overall Study|(CRF)|17|||
156851838|NCT04170543|566211736|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
156851839|NCT04170543|566211737|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
156851840|NCT04170543|566211738|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
156851841|NCT04170543|566211739|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
156851842|NCT04170543|566211740|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
156851843|NCT04378270|566211744|FG000|Overall Study|Lack of Efficacy|1|||
156851844|NCT04378270|566211744|FG000|Overall Study|Withdrawal by Subject|1|||
156851845|NCT04378270|566211744|FG000|Overall Study|Screen Failure|1|||
156851846|NCT04378270|566211744|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
156851847|NCT01156714|566211745|FG000|Overall Study|Withdrawal by Subject|9|||
156851848|NCT01156714|566211746|FG001|Overall Study|Withdrawal by Subject|4|||
156851849|NCT01156714|566211747|FG002|Overall Study|Withdrawal by Subject|3|||
156851850|NCT01236521|566211748|FG000|Overall Study|Withdrawal by Subject|12|||
156472505|NCT01372085|564825508|FG004|Washout Period 3|Withdrawal by Subject|0|||
156472506|NCT01372085|564825509|FG005|Washout Period 3|Withdrawal by Subject|2|||
156472507|NCT01372085|564825510|FG006|Washout Period 3|Withdrawal by Subject|0|||
156472508|NCT01372085|564825511|FG007|Washout Period 3|Withdrawal by Subject|0|||
156472509|NCT01372085|564825512|FG008|Washout Period 3|Withdrawal by Subject|0|||
156472510|NCT01372085|564825513|FG009|Washout Period 3|Withdrawal by Subject|0|||
156851851|NCT01236521|566211749|FG001|Overall Study|Withdrawal by Subject|17|||
156851852|NCT01236521|566211748|FG000|Overall Study|Death|2|||
156851853|NCT01236521|566211749|FG001|Overall Study|Death|1|||
156851854|NCT01236521|566211748|FG000|Overall Study|Lost to Follow-up|9|||
156851855|NCT01236521|566211749|FG001|Overall Study|Lost to Follow-up|7|||
156851856|NCT03201419|566211751|FG000|Overall Study|Adverse Event|3|||
156851857|NCT03201419|566211752|FG001|Overall Study|Adverse Event|1|||
156851858|NCT03201419|566211753|FG002|Overall Study|Adverse Event|0|||
156851859|NCT03201419|566211754|FG003|Overall Study|Adverse Event|0|||
156851860|NCT03201419|566211755|FG004|Overall Study|Adverse Event|1|||
156851861|NCT03201419|566211756|FG005|Overall Study|Adverse Event|1|||
156851862|NCT03201419|566211757|FG006|Overall Study|Adverse Event|5|||
156851863|NCT03201419|566211758|FG007|Overall Study|Adverse Event|0|||
156851864|NCT03201419|566211759|FG008|Overall Study|Adverse Event|0|||
156851865|NCT03201419|566211751|FG000|Overall Study|Lost to Follow-up|1|||
156851866|NCT03201419|566211752|FG001|Overall Study|Lost to Follow-up|0|||
156851867|NCT03201419|566211753|FG002|Overall Study|Lost to Follow-up|0|||
156851868|NCT03201419|566211754|FG003|Overall Study|Lost to Follow-up|0|||
156851869|NCT03201419|566211755|FG004|Overall Study|Lost to Follow-up|0|||
156851870|NCT03201419|566211756|FG005|Overall Study|Lost to Follow-up|0|||
156851871|NCT03201419|566211757|FG006|Overall Study|Lost to Follow-up|0|||
156851872|NCT03201419|566211758|FG007|Overall Study|Lost to Follow-up|0|||
156851873|NCT03201419|566211759|FG008|Overall Study|Lost to Follow-up|0|||
156851874|NCT03201419|566211751|FG000|Overall Study|Protocol Deviation|0|||
156851875|NCT03201419|566211752|FG001|Overall Study|Protocol Deviation|0|||
156851876|NCT03201419|566211753|FG002|Overall Study|Protocol Deviation|0|||
156851877|NCT03201419|566211754|FG003|Overall Study|Protocol Deviation|0|||
156851878|NCT03201419|566211755|FG004|Overall Study|Protocol Deviation|0|||
156851879|NCT03201419|566211756|FG005|Overall Study|Protocol Deviation|0|||
156851880|NCT03201419|566211757|FG006|Overall Study|Protocol Deviation|1|||
156851881|NCT03201419|566211758|FG007|Overall Study|Protocol Deviation|0|||
156851882|NCT03201419|566211759|FG008|Overall Study|Protocol Deviation|0|||
156851883|NCT03201419|566211751|FG000|Overall Study|Withdrawal by Subject|4|||
156851884|NCT03201419|566211752|FG001|Overall Study|Withdrawal by Subject|2|||
156851885|NCT03201419|566211753|FG002|Overall Study|Withdrawal by Subject|1|||
156851886|NCT03201419|566211754|FG003|Overall Study|Withdrawal by Subject|0|||
156851887|NCT03201419|566211755|FG004|Overall Study|Withdrawal by Subject|0|||
156851888|NCT03201419|566211756|FG005|Overall Study|Withdrawal by Subject|0|||
156851889|NCT03201419|566211757|FG006|Overall Study|Withdrawal by Subject|0|||
156851890|NCT03201419|566211758|FG007|Overall Study|Withdrawal by Subject|1|||
156851891|NCT03201419|566211759|FG008|Overall Study|Withdrawal by Subject|2|||
156851892|NCT03201419|566211751|FG000|Overall Study|Other|0|||
156472511|NCT00562094|564825514|FG000|Overall Study|Lost to Follow-up|62|||
156472512|NCT03960645|564825515|FG000|Overall Study|Protocol Violation|1|||
156472513|NCT03960645|564825516|FG001|Overall Study|Protocol Violation|0|||
156472514|NCT03732807|564825521|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
156851893|NCT03201419|566211752|FG001|Overall Study|Other|0|||
156851894|NCT03201419|566211753|FG002|Overall Study|Other|1|||
156851895|NCT03201419|566211754|FG003|Overall Study|Other|0|||
156851896|NCT03201419|566211755|FG004|Overall Study|Other|0|||
156851897|NCT03201419|566211756|FG005|Overall Study|Other|0|||
156851898|NCT03201419|566211757|FG006|Overall Study|Other|0|||
156851899|NCT03201419|566211758|FG007|Overall Study|Other|0|||
156851900|NCT03201419|566211759|FG008|Overall Study|Other|0|||
156851901|NCT02701283|566211760|FG000|Overall Study|Death|25|||
156851902|NCT02701283|566211761|FG001|Overall Study|Death|29|||
156851903|NCT02701283|566211762|FG002|Overall Study|Death|19|||
156851904|NCT02701283|566211760|FG000|Overall Study|Lost to Follow-up|3|||
156851905|NCT02701283|566211761|FG001|Overall Study|Lost to Follow-up|8|||
156851906|NCT02701283|566211762|FG002|Overall Study|Lost to Follow-up|1|||
156851907|NCT02701283|566211760|FG000|Overall Study|Withdrawal by Subject|12|||
156851908|NCT02701283|566211761|FG001|Overall Study|Withdrawal by Subject|41|||
156851909|NCT02701283|566211762|FG002|Overall Study|Withdrawal by Subject|1|||
156851910|NCT02701283|566211760|FG000|Overall Study|Missed 2-year visit|22|||
156851911|NCT02701283|566211761|FG001|Overall Study|Missed 2-year visit|27|||
156472515|NCT03732807|564825522|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
156472516|NCT03732807|564825523|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
156472517|NCT03732807|564825524|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
156851912|NCT02701283|566211762|FG002|Overall Study|Missed 2-year visit|0|||
156851913|NCT02701283|566211760|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
156851914|NCT02701283|566211761|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
156851915|NCT02701283|566211762|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
156851916|NCT04544956|566211763|FG000|Overall Study|Withdrawal by Subject|1|||
156851917|NCT04266795|566211764|FG000|Overall Study|Adverse Event|10|||
156851918|NCT04266795|566211765|FG001|Overall Study|Adverse Event|19|||
156851919|NCT04266795|566211764|FG000|Overall Study|Death|7|||
156851920|NCT04266795|566211765|FG001|Overall Study|Death|8|||
156851921|NCT04266795|566211764|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
156851922|NCT04266795|566211765|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
156851923|NCT04266795|566211764|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156851924|NCT04266795|566211765|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156851925|NCT04266795|566211764|FG000|Overall Study|Progressive Disease|12|||
156851926|NCT04266795|566211765|FG001|Overall Study|Progressive Disease|9|||
156851927|NCT04266795|566211764|FG000|Overall Study|Withdrawal by Patient|5|||
156851928|NCT04266795|566211765|FG001|Overall Study|Withdrawal by Patient|6|||
156851929|NCT04266795|566211764|FG000|Overall Study|Disease Relapse|3|||
156851930|NCT04266795|566211765|FG001|Overall Study|Disease Relapse|6|||
156851931|NCT04266795|566211764|FG000|Overall Study|Reason not Specified|12|||
156851932|NCT04266795|566211765|FG001|Overall Study|Reason not Specified|10|||
156851933|NCT04266795|566211764|FG000|Overall Study|Participants Ongoing on Treatment|25|||
156851934|NCT04266795|566211765|FG001|Overall Study|Participants Ongoing on Treatment|23|||
156851935|NCT03043872|566211766|FG000|Overall Study|Withdrawal by Subject|6|||
156851936|NCT03043872|566211767|FG001|Overall Study|Withdrawal by Subject|6|||
156851937|NCT03043872|566211768|FG002|Overall Study|Withdrawal by Subject|15|||
156851938|NCT03043872|566211766|FG000|Overall Study|Lost to Follow-up|2|||
156851939|NCT03043872|566211767|FG001|Overall Study|Lost to Follow-up|1|||
156851940|NCT03043872|566211768|FG002|Overall Study|Lost to Follow-up|1|||
156851941|NCT03043872|566211766|FG000|Overall Study|Death|270|||
156851942|NCT03043872|566211767|FG001|Overall Study|Death|269|||
156851943|NCT03043872|566211768|FG002|Overall Study|Death|296|||
156851944|NCT03868943|566211771|FG000|Overall Study|Adverse Event|1|||
156851945|NCT04896593|566211772|FG000|Overall Study|Withdrawal by Subject|2|||
156851946|NCT04896593|566211772|FG000|Overall Study|Lost to Follow-up|1|||
156851947|NCT04896593|566211772|FG000|Overall Study|Did not complete onboarding|2|||
156851948|NCT02777827|566211773|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851949|NCT02777827|566211774|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851950|NCT02777827|566211775|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
156851951|NCT02777827|566211776|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851952|NCT02777827|566211777|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851953|NCT02777827|566211778|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851954|NCT04551066|566211779|FG000|Overall Study|Death|5|||
156851955|NCT04551066|566211780|FG001|Overall Study|Death|3|||
156851956|NCT04551066|566211779|FG000|Overall Study|Lost to Follow-up|1|||
156851957|NCT04551066|566211780|FG001|Overall Study|Lost to Follow-up|0|||
156851958|NCT04551066|566211779|FG000|Overall Study|Sponsor Decision|104|||
156851959|NCT04551066|566211780|FG001|Overall Study|Sponsor Decision|117|||
156851960|NCT04551066|566211779|FG000|Overall Study|Withdrawal by Subject|8|||
156851961|NCT04551066|566211780|FG001|Overall Study|Withdrawal by Subject|2|||
156851962|NCT04551066|566211779|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
156851963|NCT04551066|566211780|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
156851964|NCT04551066|566211779|FG000|Overall Study|Adverse Event|2|||
156851965|NCT04551066|566211780|FG001|Overall Study|Adverse Event|0|||
156851966|NCT04551066|566211779|FG000|Overall Study|Physician Decision|2|||
156851967|NCT04551066|566211780|FG001|Overall Study|Physician Decision|0|||
156851968|NCT04551066|566211779|FG000|Overall Study|Protocol Violation|1|||
156851969|NCT04551066|566211780|FG001|Overall Study|Protocol Violation|0|||
156851970|NCT04551066|566211779|FG000|Overall Study|Lack of Efficacy|0|||
156851971|NCT04551066|566211780|FG001|Overall Study|Lack of Efficacy|1|||
156851972|NCT04551066|566211779|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
156851973|NCT04551066|566211780|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
156851974|NCT00369577|566211781|FG000|Overall Study|Withdrawal by Subject|0|||
156851975|NCT00369577|566211782|FG001|Overall Study|Withdrawal by Subject|0|||
156851976|NCT00369577|566211783|FG002|Overall Study|Withdrawal by Subject|1|||
156851977|NCT00398320|566211784|FG000|Overall Study|Death|1|||
156851978|NCT00398320|566211784|FG000|Overall Study|Adverse Event|4|||
156851979|NCT00398320|566211784|FG000|Overall Study|Physician Decision|1|||
156851980|NCT00064792|566211785|FG000|Overall Study|Withdrawal by Subject|2|||
156851981|NCT00064792|566211786|FG001|Overall Study|Withdrawal by Subject|0|||
156851982|NCT00064792|566211785|FG000|Overall Study|Adverse Event|3|||
156851983|NCT00064792|566211786|FG001|Overall Study|Adverse Event|0|||
156851984|NCT03915470|566211789|FG000|Overall Study|Death|3|||
156851985|NCT03915470|566211790|FG001|Overall Study|Death|1|||
156851986|NCT03915470|566211789|FG000|Overall Study|Adverse Event|1|||
156851987|NCT03915470|566211790|FG001|Overall Study|Adverse Event|0|||
156851988|NCT03915470|566211789|FG000|Overall Study|Physician Decision|1|||
156851989|NCT03915470|566211790|FG001|Overall Study|Physician Decision|0|||
156851990|NCT03915470|566211789|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
156851991|NCT03915470|566211790|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
156851992|NCT03160898|566211791|FG000|Overall Study|Adverse Event|4|||
156851993|NCT03160898|566211792|FG001|Overall Study|Adverse Event|8|||
156851994|NCT03160898|566211793|FG002|Overall Study|Adverse Event|7|||
156851995|NCT03160898|566211794|FG003|Overall Study|Adverse Event|10|||
156851996|NCT03160898|566211791|FG000|Overall Study|Death|1|||
156851997|NCT03160898|566211792|FG001|Overall Study|Death|0|||
156851998|NCT03160898|566211793|FG002|Overall Study|Death|0|||
156851999|NCT03160898|566211794|FG003|Overall Study|Death|1|||
156852000|NCT03160898|566211791|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
156852001|NCT03160898|566211792|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
156852002|NCT03160898|566211793|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
156852003|NCT03160898|566211794|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
156852004|NCT03160898|566211791|FG000|Overall Study|Lost to Follow-up|1|||
156852005|NCT03160898|566211792|FG001|Overall Study|Lost to Follow-up|1|||
156852006|NCT03160898|566211793|FG002|Overall Study|Lost to Follow-up|1|||
156852007|NCT03160898|566211794|FG003|Overall Study|Lost to Follow-up|2|||
156852008|NCT03160898|566211791|FG000|Overall Study|Physician Decision|1|||
156852009|NCT03160898|566211792|FG001|Overall Study|Physician Decision|0|||
156852010|NCT03160898|566211793|FG002|Overall Study|Physician Decision|0|||
156852011|NCT03160898|566211794|FG003|Overall Study|Physician Decision|1|||
156852012|NCT03160898|566211791|FG000|Overall Study|Progressive Disease|4|||
156852013|NCT03160898|566211792|FG001|Overall Study|Progressive Disease|1|||
156852014|NCT03160898|566211793|FG002|Overall Study|Progressive Disease|2|||
156852015|NCT03160898|566211794|FG003|Overall Study|Progressive Disease|1|||
156852016|NCT03160898|566211791|FG000|Overall Study|Protocol Violation|1|||
156852017|NCT03160898|566211792|FG001|Overall Study|Protocol Violation|0|||
156852018|NCT03160898|566211793|FG002|Overall Study|Protocol Violation|2|||
156852019|NCT03160898|566211794|FG003|Overall Study|Protocol Violation|0|||
156852020|NCT03160898|566211791|FG000|Overall Study|Sponsor Discretion|2|||
156852021|NCT03160898|566211792|FG001|Overall Study|Sponsor Discretion|0|||
156852022|NCT03160898|566211793|FG002|Overall Study|Sponsor Discretion|0|||
156852023|NCT03160898|566211794|FG003|Overall Study|Sponsor Discretion|0|||
156852024|NCT03160898|566211791|FG000|Overall Study|Withdrawal by Subject|1|||
156852025|NCT03160898|566211792|FG001|Overall Study|Withdrawal by Subject|3|||
156852026|NCT03160898|566211793|FG002|Overall Study|Withdrawal by Subject|2|||
156852027|NCT03160898|566211794|FG003|Overall Study|Withdrawal by Subject|1|||
156852028|NCT03160898|566211791|FG000|Overall Study|Other|2|||
156852029|NCT03160898|566211792|FG001|Overall Study|Other|0|||
156852030|NCT03160898|566211793|FG002|Overall Study|Other|2|||
156852031|NCT03160898|566211794|FG003|Overall Study|Other|2|||
156852032|NCT03405818|566211797|FG000|Overall Study|Withdrawal by Subject|4|||
156852033|NCT03405818|566211797|FG000|Overall Study|Lost to Follow-up|4|||
156852034|NCT00291486|566211804|FG000|Overall Study|Adverse Event|0|||
156852035|NCT00291486|566211805|FG001|Overall Study|Adverse Event|3|||
156852036|NCT00291486|566211806|FG002|Overall Study|Adverse Event|0|||
156472518|NCT03732807|564825525|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
156472519|NCT03732807|564825526|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
156472520|NCT03732807|564825527|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
156472521|NCT03732807|564825521|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
156852037|NCT00291486|566211807|FG003|Overall Study|Adverse Event|1|||
156852038|NCT00291486|566211808|FG004|Overall Study|Adverse Event|0|||
156852039|NCT00291486|566211804|FG000|Overall Study|Withdrawal by Subject|0|||
156852040|NCT00291486|566211805|FG001|Overall Study|Withdrawal by Subject|0|||
156852041|NCT00291486|566211806|FG002|Overall Study|Withdrawal by Subject|0|||
156852042|NCT00291486|566211807|FG003|Overall Study|Withdrawal by Subject|0|||
156852043|NCT00291486|566211808|FG004|Overall Study|Withdrawal by Subject|1|||
156852044|NCT00291486|566211804|FG000|Overall Study|Disease progression|1|||
156852045|NCT00291486|566211805|FG001|Overall Study|Disease progression|0|||
156852046|NCT00291486|566211806|FG002|Overall Study|Disease progression|1|||
156852047|NCT00291486|566211807|FG003|Overall Study|Disease progression|0|||
156852048|NCT00291486|566211808|FG004|Overall Study|Disease progression|0|||
156852049|NCT01045694|566211809|FG000|Overall Study|Withdrawal by Subject|2|||
156852050|NCT04725500|566211810|FG000|Screening|Screen Failure|26|||
156852051|NCT04725500|566211810|FG000|Screening|Withdrawal by Subject|1|||
156852052|NCT04725500|566211810|FG000|2 Week Take Home|Screen Fail|5|||
156852053|NCT01045967|566213724|FG000|Second Intervention|Protocol Violation|0|||
156852054|NCT01045967|566213725|FG001|Second Intervention|Protocol Violation|1|||
156852055|NCT00985673|566213726|FG000|Overall Study|Lost to Follow-up|6|||
156852056|NCT00985673|566213727|FG001|Overall Study|Lost to Follow-up|7|||
156852057|NCT00985673|566213728|FG002|Overall Study|Lost to Follow-up|6|||
156852058|NCT00985673|566213729|FG003|Overall Study|Lost to Follow-up|10|||
156852059|NCT00985673|566213730|FG004|Overall Study|Lost to Follow-up|5|||
156852060|NCT00985673|566213731|FG005|Overall Study|Lost to Follow-up|3|||
156852061|NCT00985673|566213726|FG000|Overall Study|Withdrawal by Subject|0|||
156852062|NCT00985673|566213727|FG001|Overall Study|Withdrawal by Subject|4|||
156852063|NCT00985673|566213728|FG002|Overall Study|Withdrawal by Subject|5|||
156852064|NCT00985673|566213729|FG003|Overall Study|Withdrawal by Subject|2|||
156852065|NCT00985673|566213730|FG004|Overall Study|Withdrawal by Subject|2|||
156852066|NCT00985673|566213731|FG005|Overall Study|Withdrawal by Subject|3|||
156852067|NCT00985673|566213726|FG000|Overall Study|Other|1|||
156852068|NCT00985673|566213727|FG001|Overall Study|Other|0|||
156852069|NCT00985673|566213728|FG002|Overall Study|Other|1|||
156852070|NCT00985673|566213729|FG003|Overall Study|Other|0|||
156852071|NCT00985673|566213730|FG004|Overall Study|Other|1|||
156852072|NCT00985673|566213731|FG005|Overall Study|Other|0|||
156852073|NCT02252146|566213732|FG000|Overall Study|Lack of Efficacy|4|||
156852074|NCT02252146|566213732|FG000|Overall Study|Entered hospice care|1|||
156852075|NCT02252146|566213732|FG000|Overall Study|Inability to travel to study site|1|||
156852076|NCT00531284|566213733|FG000|Overall Study|Progressive Disease|1|||
156852077|NCT00531284|566213734|FG001|Overall Study|Progressive Disease|3|||
156852078|NCT00531284|566213735|FG002|Overall Study|Progressive Disease|5|||
156852079|NCT00531284|566213736|FG003|Overall Study|Progressive Disease|42|||
156852080|NCT00531284|566213737|FG004|Overall Study|Progressive Disease|4|||
156852081|NCT00531284|566213738|FG005|Overall Study|Progressive Disease|4|||
156852082|NCT00531284|566213739|FG006|Overall Study|Progressive Disease|3|||
156852083|NCT00531284|566213740|FG007|Overall Study|Progressive Disease|8|||
156852084|NCT00531284|566213741|FG008|Overall Study|Progressive Disease|6|||
156852085|NCT00531284|566213742|FG009|Overall Study|Progressive Disease|3|||
156852086|NCT00531284|566213743|FG010|Overall Study|Progressive Disease|3|||
156852087|NCT00531284|566213744|FG011|Overall Study|Progressive Disease|14|||
156852088|NCT00531284|566213745|FG012|Overall Study|Progressive Disease|2|||
156852089|NCT00531284|566213746|FG013|Overall Study|Progressive Disease|1|||
156852090|NCT00531284|566213747|FG014|Overall Study|Progressive Disease|2|||
156852091|NCT00531284|566213748|FG015|Overall Study|Progressive Disease|11|||
156852092|NCT00531284|566213749|FG016|Overall Study|Progressive Disease|5|||
156852093|NCT00531284|566213733|FG000|Overall Study|Adverse Event|0|||
156852094|NCT00531284|566213734|FG001|Overall Study|Adverse Event|1|||
156852095|NCT00531284|566213735|FG002|Overall Study|Adverse Event|1|||
156852096|NCT00531284|566213736|FG003|Overall Study|Adverse Event|7|||
156852097|NCT00531284|566213737|FG004|Overall Study|Adverse Event|0|||
156852098|NCT00531284|566213738|FG005|Overall Study|Adverse Event|2|||
156852099|NCT00531284|566213739|FG006|Overall Study|Adverse Event|3|||
156852100|NCT00531284|566213740|FG007|Overall Study|Adverse Event|2|||
156852101|NCT00531284|566213741|FG008|Overall Study|Adverse Event|3|||
156852102|NCT00531284|566213742|FG009|Overall Study|Adverse Event|0|||
156852103|NCT00531284|566213743|FG010|Overall Study|Adverse Event|0|||
156852104|NCT00531284|566213744|FG011|Overall Study|Adverse Event|5|||
156852105|NCT00531284|566213745|FG012|Overall Study|Adverse Event|0|||
156852106|NCT00531284|566213746|FG013|Overall Study|Adverse Event|1|||
156852107|NCT00531284|566213747|FG014|Overall Study|Adverse Event|1|||
156852108|NCT00531284|566213748|FG015|Overall Study|Adverse Event|0|||
156852109|NCT00531284|566213749|FG016|Overall Study|Adverse Event|2|||
156852110|NCT00531284|566213733|FG000|Overall Study|Withdrawal by Subject|1|||
156852111|NCT00531284|566213734|FG001|Overall Study|Withdrawal by Subject|0|||
156852112|NCT00531284|566213735|FG002|Overall Study|Withdrawal by Subject|0|||
156852113|NCT00531284|566213736|FG003|Overall Study|Withdrawal by Subject|4|||
156852114|NCT00531284|566213737|FG004|Overall Study|Withdrawal by Subject|0|||
156852115|NCT00531284|566213738|FG005|Overall Study|Withdrawal by Subject|0|||
156852116|NCT00531284|566213739|FG006|Overall Study|Withdrawal by Subject|0|||
156852117|NCT00531284|566213740|FG007|Overall Study|Withdrawal by Subject|0|||
156852118|NCT00531284|566213741|FG008|Overall Study|Withdrawal by Subject|0|||
156852119|NCT00531284|566213742|FG009|Overall Study|Withdrawal by Subject|0|||
156852120|NCT00531284|566213743|FG010|Overall Study|Withdrawal by Subject|0|||
156852121|NCT00531284|566213744|FG011|Overall Study|Withdrawal by Subject|3|||
156852122|NCT00531284|566213745|FG012|Overall Study|Withdrawal by Subject|0|||
156852123|NCT00531284|566213746|FG013|Overall Study|Withdrawal by Subject|1|||
156852124|NCT00531284|566213747|FG014|Overall Study|Withdrawal by Subject|0|||
156852125|NCT00531284|566213748|FG015|Overall Study|Withdrawal by Subject|1|||
156852126|NCT00531284|566213749|FG016|Overall Study|Withdrawal by Subject|1|||
156852127|NCT00531284|566213733|FG000|Overall Study|Other|1|||
156852128|NCT00531284|566213734|FG001|Overall Study|Other|0|||
156852129|NCT00531284|566213735|FG002|Overall Study|Other|0|||
156852130|NCT00531284|566213736|FG003|Overall Study|Other|10|||
156852131|NCT00531284|566213737|FG004|Overall Study|Other|2|||
156852132|NCT00531284|566213738|FG005|Overall Study|Other|1|||
156852133|NCT00531284|566213739|FG006|Overall Study|Other|0|||
156852134|NCT00531284|566213740|FG007|Overall Study|Other|0|||
156852135|NCT00531284|566213741|FG008|Overall Study|Other|2|||
156852136|NCT00531284|566213742|FG009|Overall Study|Other|1|||
156852137|NCT00531284|566213743|FG010|Overall Study|Other|0|||
156852138|NCT00531284|566213744|FG011|Overall Study|Other|2|||
156852139|NCT00531284|566213745|FG012|Overall Study|Other|0|||
156852140|NCT00531284|566213746|FG013|Overall Study|Other|0|||
156852141|NCT00531284|566213747|FG014|Overall Study|Other|1|||
156852142|NCT00531284|566213748|FG015|Overall Study|Other|0|||
156852143|NCT00531284|566213749|FG016|Overall Study|Other|0|||
156852144|NCT03057496|566213750|FG000|Overall Study|Withdrawal by Subject|8|||
156852145|NCT03057496|566213750|FG000|Overall Study|Lost to Follow-up|5|||
156852146|NCT03057496|566213750|FG000|Overall Study|Did not use device during home trial|3|||
156852147|NCT03057496|566213750|FG000|Overall Study|Device failure|2|||
156852148|NCT03493945|566213751|FG000|Phase I Dose Escalation|Ineligible|0|||
156852149|NCT03493945|566213752|FG001|Phase I Dose Escalation|Ineligible|0|||
156852150|NCT03493945|566213753|FG002|Phase I Dose Escalation|Ineligible|1|||
156852151|NCT03493945|566213754|FG003|Phase I Dose Escalation|Ineligible|0|||
156852152|NCT03493945|566213755|FG004|Phase I Dose Escalation|Ineligible|0|||
156852153|NCT03493945|566213756|FG005|Phase I Dose Escalation|Ineligible|0|||
156852154|NCT03493945|566213757|FG006|Phase I Dose Escalation|Ineligible|0|||
156852155|NCT03493945|566213751|FG000|Phase I Dose Escalation|New therapy|0|||
156852156|NCT03493945|566213752|FG001|Phase I Dose Escalation|New therapy|1|||
156852157|NCT03493945|566213753|FG002|Phase I Dose Escalation|New therapy|0|||
156852158|NCT03493945|566213754|FG003|Phase I Dose Escalation|New therapy|0|||
156852159|NCT03493945|566213755|FG004|Phase I Dose Escalation|New therapy|0|||
156852160|NCT03493945|566213756|FG005|Phase I Dose Escalation|New therapy|0|||
156852161|NCT03493945|566213757|FG006|Phase I Dose Escalation|New therapy|0|||
156852162|NCT03493945|566213751|FG000|Phase II Dose Expansion|Refused further treatment|0|||
156852163|NCT03493945|566213752|FG001|Phase II Dose Expansion|Refused further treatment|0|||
156852164|NCT03493945|566213753|FG002|Phase II Dose Expansion|Refused further treatment|0|||
156852165|NCT03493945|566213754|FG003|Phase II Dose Expansion|Refused further treatment|0|||
156852166|NCT03493945|566213755|FG004|Phase II Dose Expansion|Refused further treatment|1|||
156852167|NCT03493945|566213756|FG005|Phase II Dose Expansion|Refused further treatment|1|||
156852168|NCT03493945|566213757|FG006|Phase II Dose Expansion|Refused further treatment|0|||
156852169|NCT03493945|566213751|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852170|NCT03493945|566213752|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852171|NCT03493945|566213753|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852172|NCT03493945|566213754|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
156852173|NCT03493945|566213755|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852174|NCT03493945|566213756|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852175|NCT03493945|566213757|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852176|NCT01584232|566213758|FG000|Overall Study|Adverse Event|3|||
156852177|NCT01584232|566213759|FG001|Overall Study|Adverse Event|1|||
156472522|NCT03732807|564825522|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
156472523|NCT03732807|564825523|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
156472524|NCT03732807|564825524|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
156472525|NCT03732807|564825525|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
156472526|NCT03732807|564825526|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
156852178|NCT01584232|566213758|FG000|Overall Study|Withdrawal by Subject|2|||
156852179|NCT01584232|566213759|FG001|Overall Study|Withdrawal by Subject|1|||
156852180|NCT01584232|566213758|FG000|Overall Study|Physician Decision|2|||
156852181|NCT01584232|566213759|FG001|Overall Study|Physician Decision|1|||
156852182|NCT01584232|566213758|FG000|Overall Study|Lost to Follow-up|1|||
156852183|NCT01584232|566213759|FG001|Overall Study|Lost to Follow-up|0|||
156852184|NCT02152631|566213761|FG000|Overall Study|Adverse Event|32|||
156852185|NCT02152631|566213762|FG001|Overall Study|Adverse Event|4|||
156342200|NCT04115839|564352571|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156342201|NCT04115839|564352572|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156852186|NCT02152631|566213761|FG000|Overall Study|Withdrawal by Subject|13|||
156852187|NCT02152631|566213762|FG001|Overall Study|Withdrawal by Subject|16|||
156852188|NCT02152631|566213761|FG000|Overall Study|Noncompliance with study drug|1|||
156852189|NCT02152631|566213762|FG001|Overall Study|Noncompliance with study drug|0|||
156852190|NCT02152631|566213761|FG000|Overall Study|Physician Decision|1|||
156852191|NCT02152631|566213762|FG001|Overall Study|Physician Decision|2|||
156852192|NCT02152631|566213761|FG000|Overall Study|Lost to Follow-up|0|||
156852193|NCT02152631|566213762|FG001|Overall Study|Lost to Follow-up|1|||
156852194|NCT02152631|566213761|FG000|Overall Study|On Treatment|19|||
156852195|NCT02152631|566213762|FG001|Overall Study|On Treatment|3|||
156852196|NCT03310723|566213773|FG000|Overall Study|Withdrawal by Subject|0|||
156852197|NCT03310723|566213774|FG001|Overall Study|Withdrawal by Subject|1|||
156852198|NCT03310723|566213773|FG000|Overall Study|Protocol Violation|0|||
156852199|NCT03310723|566213774|FG001|Overall Study|Protocol Violation|2|||
156852200|NCT02098746|566213775|FG000|Overall Study|Changes of Investigator|2|||
156852201|NCT02098746|566213775|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156852202|NCT02098746|566213775|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
156852203|NCT02098746|566213775|FG000|Overall Study|Data Not Available After Treatment|1|||
156852204|NCT01121146|566213779|FG000|Overall Study|Death|17|||
156852205|NCT01121146|566213780|FG001|Overall Study|Death|15|||
156852206|NCT01121146|566213779|FG000|Overall Study|Adverse Event|2|||
156852207|NCT01121146|566213780|FG001|Overall Study|Adverse Event|11|||
156852208|NCT01121146|566213779|FG000|Overall Study|Lost to Follow-up|7|||
156852209|NCT01121146|566213780|FG001|Overall Study|Lost to Follow-up|16|||
156852210|NCT01132807|566213785|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
156852211|NCT01132807|566213786|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
156852212|NCT01132807|566213787|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
156852213|NCT01132807|566213785|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
156852214|NCT01132807|566213786|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
156852215|NCT01132807|566213787|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
156852216|NCT00742183|566213788|FG000|Overall Study|Adverse Event|2|||
156852217|NCT00742183|566213789|FG001|Overall Study|Adverse Event|2|||
156852218|NCT00742183|566213788|FG000|Overall Study|Death|1|||
156852219|NCT00742183|566213789|FG001|Overall Study|Death|0|||
156852220|NCT00742183|566213788|FG000|Overall Study|Physician Decision|0|||
156852221|NCT00742183|566213789|FG001|Overall Study|Physician Decision|2|||
156852222|NCT00742183|566213788|FG000|Overall Study|Lost to Follow-up|4|||
156852223|NCT00742183|566213789|FG001|Overall Study|Lost to Follow-up|4|||
156852224|NCT00742183|566213788|FG000|Overall Study|Required skin-graft|1|||
156852225|NCT00742183|566213789|FG001|Overall Study|Required skin-graft|1|||
156852226|NCT00742183|566213788|FG000|Overall Study|Withdrawal by Subject|1|||
156852227|NCT00742183|566213789|FG001|Overall Study|Withdrawal by Subject|0|||
156852228|NCT00742183|566213788|FG000|Overall Study|Lack of Efficacy|0|||
156342202|NCT00790023|564352580|FG000|Overall Study|Adverse Event|2|||
156342203|NCT00790023|564352581|FG001|Overall Study|Adverse Event|1|||
156342204|NCT00790023|564352582|FG002|Overall Study|Adverse Event|4|||
156472527|NCT03732807|564825527|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
156472528|NCT03732807|564825521|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
156472529|NCT03732807|564825522|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
156472530|NCT03732807|564825523|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
156472531|NCT03732807|564825524|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
156472532|NCT03732807|564825525|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
156472533|NCT03732807|564825526|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
156472534|NCT03732807|564825527|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
156472535|NCT03732807|564825521|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
156472536|NCT03732807|564825522|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
156472537|NCT03732807|564825523|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
156542186|NCT00075023|565079258|FG001|Pilot Study|Physician Decision|2|||
156542187|NCT00075023|565079257|FG000|Pilot Study|Withdrawal by Subject|1|||
156542188|NCT00075023|565079258|FG001|Pilot Study|Withdrawal by Subject|0|||
156852229|NCT00742183|566213789|FG001|Overall Study|Lack of Efficacy|3|||
156342205|NCT00790023|564352580|FG000|Overall Study|Protocol Violation|2|||
156342206|NCT00790023|564352581|FG001|Overall Study|Protocol Violation|4|||
156472538|NCT03732807|564825524|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
156342207|NCT00790023|564352582|FG002|Overall Study|Protocol Violation|2|||
156852230|NCT01080807|566213795|FG000|Overall Study|Adverse Event|9|||
156852231|NCT01080807|566213796|FG001|Overall Study|Adverse Event|1|||
156852232|NCT01080807|566213795|FG000|Overall Study|Lack of Efficacy|0|||
156852233|NCT01080807|566213796|FG001|Overall Study|Lack of Efficacy|1|||
156852234|NCT01080807|566213795|FG000|Overall Study|Withdrawal by Subject|7|||
156852235|NCT01080807|566213796|FG001|Overall Study|Withdrawal by Subject|2|||
156852236|NCT01080807|566213795|FG000|Overall Study|Protocol Violation|7|||
156852237|NCT01080807|566213796|FG001|Overall Study|Protocol Violation|6|||
156852238|NCT01080807|566213795|FG000|Overall Study|Lost to Follow-up|6|||
156852239|NCT01080807|566213796|FG001|Overall Study|Lost to Follow-up|4|||
156852240|NCT01080807|566213795|FG000|Overall Study|Noncompliance with drug administration|1|||
156852241|NCT01080807|566213796|FG001|Overall Study|Noncompliance with drug administration|1|||
156852242|NCT01080807|566213795|FG000|Overall Study|Noncompliance to study procedures|1|||
156852243|NCT01080807|566213796|FG001|Overall Study|Noncompliance to study procedures|1|||
156852244|NCT01080807|566213795|FG000|Overall Study|Began working day shift|0|||
156852245|NCT01080807|566213796|FG001|Overall Study|Began working day shift|2|||
156852246|NCT01080807|566213795|FG000|Overall Study|Laid off or terminated from job|1|||
156852247|NCT01080807|566213796|FG001|Overall Study|Laid off or terminated from job|2|||
156852248|NCT01080807|566213795|FG000|Overall Study|Stopped working consistent night shifts|0|||
156852249|NCT01080807|566213796|FG001|Overall Study|Stopped working consistent night shifts|1|||
156852250|NCT01080807|566213795|FG000|Overall Study|Work schedule changing|1|||
156852251|NCT01080807|566213796|FG001|Overall Study|Work schedule changing|1|||
156852252|NCT01080807|566213795|FG000|Overall Study|Work schedule and travel|0|||
156852253|NCT01080807|566213796|FG001|Overall Study|Work schedule and travel|1|||
156852254|NCT01080807|566213795|FG000|Overall Study|Switched to first shift|1|||
156852255|NCT01080807|566213796|FG001|Overall Study|Switched to first shift|0|||
156852256|NCT01080807|566213795|FG000|Overall Study|Moved away without notifying center|1|||
156852257|NCT01080807|566213796|FG001|Overall Study|Moved away without notifying center|0|||
156852258|NCT01020786|566213807|FG000|Induction Period|Entry Criteria Not Met|2|||
156852259|NCT01020786|566213807|FG000|Induction Period|Adverse Event|10|||
156852260|NCT01020786|566213807|FG000|Induction Period|Progressive Disease|31|||
156852261|NCT01020786|566213807|FG000|Induction Period|Investigator Decision|3|||
156852262|NCT01020786|566213807|FG000|Induction Period|Withdrawal by Subject|3|||
156852263|NCT01020786|566213807|FG000|Maintenance Period|Adverse Event|8|||
156852264|NCT01020786|566213807|FG000|Maintenance Period|Progressive Disease|43|||
156852265|NCT01020786|566213807|FG000|Maintenance Period|Withdrawal by Subject|8|||
156852266|NCT01020786|566213807|FG000|Maintenance Period|Sponsor Decision|1|||
156852267|NCT04497116|566213808|FG000|Overall Study|Lost to Follow-up|1|||
156852268|NCT04497116|566213809|FG001|Overall Study|Lost to Follow-up|0|||
156852269|NCT04497116|566213810|FG002|Overall Study|Lost to Follow-up|0|||
156852270|NCT04497116|566213811|FG003|Overall Study|Lost to Follow-up|0|||
156852271|NCT04497116|566213812|FG004|Overall Study|Lost to Follow-up|0|||
156852272|NCT04497116|566213813|FG005|Overall Study|Lost to Follow-up|0|||
156852273|NCT04497116|566213814|FG006|Overall Study|Lost to Follow-up|0|||
156852274|NCT04497116|566213815|FG007|Overall Study|Lost to Follow-up|3|||
156852275|NCT04497116|566213816|FG008|Overall Study|Lost to Follow-up|3|||
156852276|NCT04497116|566213817|FG009|Overall Study|Lost to Follow-up|0|||
156852277|NCT04497116|566213818|FG010|Overall Study|Lost to Follow-up|0|||
156852278|NCT04497116|566213819|FG011|Overall Study|Lost to Follow-up|0|||
156852279|NCT04497116|566213820|FG012|Overall Study|Lost to Follow-up|0|||
156852280|NCT04497116|566213821|FG013|Overall Study|Lost to Follow-up|0|||
156852281|NCT04497116|566213822|FG014|Overall Study|Lost to Follow-up|0|||
156472539|NCT03732807|564825525|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
156472540|NCT03732807|564825526|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
156472541|NCT03732807|564825527|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
156472542|NCT03732807|564825521|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
156472543|NCT03732807|564825522|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
156472544|NCT03732807|564825523|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
156472545|NCT03732807|564825524|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
156472546|NCT03732807|564825525|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
156472547|NCT03732807|564825526|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
156472548|NCT03732807|564825527|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
156472549|NCT03732807|564825521|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
156472550|NCT03732807|564825522|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
156472551|NCT03732807|564825523|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
156472552|NCT03732807|564825524|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
156472553|NCT03732807|564825525|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
156472554|NCT03732807|564825526|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
156852282|NCT04497116|566213823|FG015|Overall Study|Lost to Follow-up|0|||
156852283|NCT04497116|566213824|FG016|Overall Study|Lost to Follow-up|0|||
156852284|NCT04497116|566213825|FG017|Overall Study|Lost to Follow-up|0|||
156852285|NCT04497116|566213826|FG018|Overall Study|Lost to Follow-up|0|||
156852286|NCT04497116|566213827|FG019|Overall Study|Lost to Follow-up|0|||
156852287|NCT04497116|566213828|FG020|Overall Study|Lost to Follow-up|0|||
156852288|NCT04497116|566213829|FG021|Overall Study|Lost to Follow-up|0|||
156852289|NCT04497116|566213830|FG022|Overall Study|Lost to Follow-up|1|||
156472555|NCT03732807|564825527|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
156852290|NCT04497116|566213831|FG023|Overall Study|Lost to Follow-up|0|||
156852291|NCT04497116|566213832|FG024|Overall Study|Lost to Follow-up|0|||
156852292|NCT04497116|566213808|FG000|Overall Study|Sponsor decision to terminate study|0|||
156852293|NCT04497116|566213809|FG001|Overall Study|Sponsor decision to terminate study|0|||
156852294|NCT04497116|566213810|FG002|Overall Study|Sponsor decision to terminate study|0|||
156852295|NCT04497116|566213811|FG003|Overall Study|Sponsor decision to terminate study|0|||
156852296|NCT04497116|566213812|FG004|Overall Study|Sponsor decision to terminate study|0|||
156852297|NCT04497116|566213813|FG005|Overall Study|Sponsor decision to terminate study|0|||
156852298|NCT04497116|566213814|FG006|Overall Study|Sponsor decision to terminate study|1|||
156852299|NCT04497116|566213815|FG007|Overall Study|Sponsor decision to terminate study|0|||
156852300|NCT04497116|566213816|FG008|Overall Study|Sponsor decision to terminate study|0|||
156852301|NCT04497116|566213817|FG009|Overall Study|Sponsor decision to terminate study|1|||
156852302|NCT04497116|566213818|FG010|Overall Study|Sponsor decision to terminate study|0|||
156852303|NCT04497116|566213819|FG011|Overall Study|Sponsor decision to terminate study|0|||
156852304|NCT04497116|566213820|FG012|Overall Study|Sponsor decision to terminate study|0|||
156852305|NCT04497116|566213821|FG013|Overall Study|Sponsor decision to terminate study|0|||
156852306|NCT04497116|566213822|FG014|Overall Study|Sponsor decision to terminate study|0|||
156852307|NCT04497116|566213823|FG015|Overall Study|Sponsor decision to terminate study|0|||
156852308|NCT04497116|566213824|FG016|Overall Study|Sponsor decision to terminate study|0|||
156852309|NCT04497116|566213825|FG017|Overall Study|Sponsor decision to terminate study|0|||
156852310|NCT04497116|566213826|FG018|Overall Study|Sponsor decision to terminate study|0|||
156852311|NCT04497116|566213827|FG019|Overall Study|Sponsor decision to terminate study|1|||
156852312|NCT04497116|566213828|FG020|Overall Study|Sponsor decision to terminate study|0|||
156852313|NCT04497116|566213829|FG021|Overall Study|Sponsor decision to terminate study|0|||
156852314|NCT04497116|566213830|FG022|Overall Study|Sponsor decision to terminate study|0|||
156852315|NCT04497116|566213831|FG023|Overall Study|Sponsor decision to terminate study|0|||
156852316|NCT04497116|566213832|FG024|Overall Study|Sponsor decision to terminate study|0|||
156852317|NCT04497116|566213808|FG000|Overall Study|Death|4|||
156852318|NCT04497116|566213809|FG001|Overall Study|Death|5|||
156852319|NCT04497116|566213810|FG002|Overall Study|Death|2|||
156852320|NCT04497116|566213811|FG003|Overall Study|Death|2|||
156852321|NCT04497116|566213812|FG004|Overall Study|Death|1|||
156852322|NCT04497116|566213813|FG005|Overall Study|Death|1|||
156852323|NCT04497116|566213814|FG006|Overall Study|Death|3|||
156852324|NCT04497116|566213815|FG007|Overall Study|Death|10|||
156852325|NCT04497116|566213816|FG008|Overall Study|Death|37|||
156852326|NCT04497116|566213817|FG009|Overall Study|Death|17|||
156852327|NCT04497116|566213818|FG010|Overall Study|Death|2|||
156852328|NCT04497116|566213819|FG011|Overall Study|Death|1|||
156852329|NCT04497116|566213820|FG012|Overall Study|Death|1|||
156852330|NCT04497116|566213821|FG013|Overall Study|Death|3|||
156852331|NCT04497116|566213822|FG014|Overall Study|Death|18|||
156852332|NCT04497116|566213823|FG015|Overall Study|Death|3|||
156852333|NCT04497116|566213824|FG016|Overall Study|Death|2|||
156852334|NCT04497116|566213825|FG017|Overall Study|Death|1|||
156852335|NCT04497116|566213826|FG018|Overall Study|Death|4|||
156852336|NCT04497116|566213827|FG019|Overall Study|Death|17|||
156852337|NCT04497116|566213828|FG020|Overall Study|Death|1|||
156852338|NCT04497116|566213829|FG021|Overall Study|Death|0|||
156852339|NCT04497116|566213830|FG022|Overall Study|Death|3|||
156852340|NCT04497116|566213831|FG023|Overall Study|Death|5|||
156852341|NCT04497116|566213832|FG024|Overall Study|Death|4|||
156852342|NCT04497116|566213808|FG000|Overall Study|Withdrawal by Subject|1|||
156852343|NCT04497116|566213809|FG001|Overall Study|Withdrawal by Subject|0|||
156852344|NCT04497116|566213810|FG002|Overall Study|Withdrawal by Subject|1|||
156852345|NCT04497116|566213811|FG003|Overall Study|Withdrawal by Subject|0|||
156852346|NCT04497116|566213812|FG004|Overall Study|Withdrawal by Subject|0|||
156852347|NCT04497116|566213813|FG005|Overall Study|Withdrawal by Subject|0|||
156852348|NCT04497116|566213814|FG006|Overall Study|Withdrawal by Subject|0|||
156852349|NCT04497116|566213815|FG007|Overall Study|Withdrawal by Subject|7|||
156852350|NCT04497116|566213816|FG008|Overall Study|Withdrawal by Subject|14|||
156852351|NCT04497116|566213817|FG009|Overall Study|Withdrawal by Subject|3|||
156852352|NCT04497116|566213818|FG010|Overall Study|Withdrawal by Subject|3|||
156852353|NCT04497116|566213819|FG011|Overall Study|Withdrawal by Subject|0|||
156852354|NCT04497116|566213820|FG012|Overall Study|Withdrawal by Subject|1|||
156852355|NCT04497116|566213821|FG013|Overall Study|Withdrawal by Subject|0|||
156852356|NCT04497116|566213822|FG014|Overall Study|Withdrawal by Subject|7|||
156852357|NCT04497116|566213823|FG015|Overall Study|Withdrawal by Subject|1|||
156852358|NCT04497116|566213824|FG016|Overall Study|Withdrawal by Subject|3|||
156852359|NCT04497116|566213825|FG017|Overall Study|Withdrawal by Subject|1|||
156852360|NCT04497116|566213826|FG018|Overall Study|Withdrawal by Subject|1|||
156852361|NCT04497116|566213827|FG019|Overall Study|Withdrawal by Subject|5|||
156852362|NCT04497116|566213828|FG020|Overall Study|Withdrawal by Subject|2|||
156852363|NCT04497116|566213829|FG021|Overall Study|Withdrawal by Subject|2|||
156852364|NCT04497116|566213830|FG022|Overall Study|Withdrawal by Subject|2|||
156852365|NCT04497116|566213831|FG023|Overall Study|Withdrawal by Subject|4|||
156852366|NCT04497116|566213832|FG024|Overall Study|Withdrawal by Subject|3|||
156852367|NCT04497116|566213808|FG000|Overall Study|Physician Decision|0|||
156852368|NCT04497116|566213809|FG001|Overall Study|Physician Decision|0|||
156852369|NCT04497116|566213810|FG002|Overall Study|Physician Decision|0|||
156852370|NCT04497116|566213811|FG003|Overall Study|Physician Decision|0|||
156852371|NCT04497116|566213812|FG004|Overall Study|Physician Decision|0|||
156852372|NCT04497116|566213813|FG005|Overall Study|Physician Decision|0|||
156852373|NCT04497116|566213814|FG006|Overall Study|Physician Decision|0|||
156852374|NCT04497116|566213815|FG007|Overall Study|Physician Decision|0|||
156852375|NCT04497116|566213816|FG008|Overall Study|Physician Decision|0|||
156852376|NCT04497116|566213817|FG009|Overall Study|Physician Decision|0|||
156852377|NCT04497116|566213818|FG010|Overall Study|Physician Decision|0|||
156852378|NCT04497116|566213819|FG011|Overall Study|Physician Decision|0|||
156852379|NCT04497116|566213820|FG012|Overall Study|Physician Decision|0|||
156852380|NCT04497116|566213821|FG013|Overall Study|Physician Decision|0|||
156852381|NCT04497116|566213822|FG014|Overall Study|Physician Decision|0|||
156852382|NCT04497116|566213823|FG015|Overall Study|Physician Decision|0|||
156852383|NCT04497116|566213824|FG016|Overall Study|Physician Decision|0|||
156852384|NCT04497116|566213825|FG017|Overall Study|Physician Decision|0|||
156852385|NCT04497116|566213826|FG018|Overall Study|Physician Decision|0|||
156852386|NCT04497116|566213827|FG019|Overall Study|Physician Decision|0|||
156852387|NCT04497116|566213828|FG020|Overall Study|Physician Decision|0|||
156852388|NCT04497116|566213829|FG021|Overall Study|Physician Decision|0|||
156852389|NCT04497116|566213830|FG022|Overall Study|Physician Decision|0|||
156852390|NCT04497116|566213831|FG023|Overall Study|Physician Decision|1|||
156852391|NCT04497116|566213832|FG024|Overall Study|Physician Decision|0|||
156852392|NCT04497116|566213808|FG000|Overall Study|Clinical Progression Related|0|||
156852393|NCT04497116|566213809|FG001|Overall Study|Clinical Progression Related|0|||
156852394|NCT04497116|566213810|FG002|Overall Study|Clinical Progression Related|0|||
156852395|NCT04497116|566213811|FG003|Overall Study|Clinical Progression Related|0|||
156852396|NCT04497116|566213812|FG004|Overall Study|Clinical Progression Related|0|||
156852397|NCT04497116|566213813|FG005|Overall Study|Clinical Progression Related|0|||
156852398|NCT04497116|566213814|FG006|Overall Study|Clinical Progression Related|0|||
156852399|NCT04497116|566213815|FG007|Overall Study|Clinical Progression Related|0|||
156852400|NCT04497116|566213816|FG008|Overall Study|Clinical Progression Related|0|||
156852401|NCT04497116|566213817|FG009|Overall Study|Clinical Progression Related|1|||
156852402|NCT04497116|566213818|FG010|Overall Study|Clinical Progression Related|0|||
156852403|NCT04497116|566213819|FG011|Overall Study|Clinical Progression Related|0|||
156852404|NCT04497116|566213820|FG012|Overall Study|Clinical Progression Related|0|||
156852405|NCT04497116|566213821|FG013|Overall Study|Clinical Progression Related|0|||
156852406|NCT04497116|566213822|FG014|Overall Study|Clinical Progression Related|0|||
156852407|NCT04497116|566213823|FG015|Overall Study|Clinical Progression Related|0|||
156852408|NCT04497116|566213824|FG016|Overall Study|Clinical Progression Related|0|||
156852409|NCT04497116|566213825|FG017|Overall Study|Clinical Progression Related|0|||
156852410|NCT04497116|566213826|FG018|Overall Study|Clinical Progression Related|0|||
156852411|NCT04497116|566213827|FG019|Overall Study|Clinical Progression Related|0|||
156852412|NCT04497116|566213828|FG020|Overall Study|Clinical Progression Related|0|||
156852413|NCT04497116|566213829|FG021|Overall Study|Clinical Progression Related|0|||
156852414|NCT04497116|566213830|FG022|Overall Study|Clinical Progression Related|0|||
156852415|NCT04497116|566213831|FG023|Overall Study|Clinical Progression Related|0|||
156852416|NCT04497116|566213832|FG024|Overall Study|Clinical Progression Related|0|||
156852417|NCT05963022|566213833|FG000|Overall Study|Adverse Event|0|||
156852418|NCT05963022|566213834|FG001|Overall Study|Adverse Event|1|||
156852419|NCT05963022|566213835|FG002|Overall Study|Adverse Event|1|||
156852420|NCT05963022|566213836|FG003|Overall Study|Adverse Event|0|||
156852421|NCT05963022|566213833|FG000|Overall Study|Protocol Violation|0|||
156852422|NCT05963022|566213834|FG001|Overall Study|Protocol Violation|3|||
156852423|NCT05963022|566213835|FG002|Overall Study|Protocol Violation|0|||
156852424|NCT05963022|566213836|FG003|Overall Study|Protocol Violation|0|||
156852425|NCT05963022|566213833|FG000|Overall Study|Pregnancy|0|||
156852426|NCT05963022|566213834|FG001|Overall Study|Pregnancy|1|||
156852427|NCT05963022|566213835|FG002|Overall Study|Pregnancy|1|||
156852428|NCT05963022|566213836|FG003|Overall Study|Pregnancy|1|||
156852429|NCT05963022|566213833|FG000|Overall Study|Withdrawal by Subject|0|||
156852430|NCT05963022|566213834|FG001|Overall Study|Withdrawal by Subject|0|||
156852431|NCT05963022|566213835|FG002|Overall Study|Withdrawal by Subject|2|||
156342208|NCT00790023|564352580|FG000|Overall Study|Withdrawal by Subject|2|||
156342209|NCT00790023|564352581|FG001|Overall Study|Withdrawal by Subject|0|||
156342210|NCT00790023|564352582|FG002|Overall Study|Withdrawal by Subject|6|||
156342211|NCT00790023|564352580|FG000|Overall Study|Lost to Follow-up|0|||
156342212|NCT00790023|564352581|FG001|Overall Study|Lost to Follow-up|0|||
156342213|NCT00790023|564352582|FG002|Overall Study|Lost to Follow-up|1|||
156342214|NCT00790023|564352580|FG000|Overall Study|Other|5|||
156342215|NCT00790023|564352581|FG001|Overall Study|Other|5|||
156342216|NCT00790023|564352582|FG002|Overall Study|Other|8|||
156852432|NCT05963022|566213836|FG003|Overall Study|Withdrawal by Subject|1|||
156852433|NCT05963022|566213833|FG000|Overall Study|Lost to Follow-up|0|||
156852434|NCT05963022|566213834|FG001|Overall Study|Lost to Follow-up|0|||
156852435|NCT05963022|566213835|FG002|Overall Study|Lost to Follow-up|0|||
156342217|NCT00573469|564352583|FG000|Overall Study|Adverse Event|1|||
156342218|NCT00573469|564352584|FG001|Overall Study|Adverse Event|1|||
156342219|NCT00573469|564352585|FG002|Overall Study|Adverse Event|1|||
156852436|NCT05963022|566213836|FG003|Overall Study|Lost to Follow-up|1|||
156852437|NCT05963022|566213833|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
156852438|NCT05963022|566213834|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
156852439|NCT05963022|566213835|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
156852440|NCT05963022|566213836|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
156852441|NCT02698826|566213837|FG000|Overall Study|Death|13|||
156852442|NCT02698826|566213837|FG000|Overall Study|Adverse Event|1|||
156852443|NCT02915263|566213840|FG000|Overall Study|Covid|3|||
156852444|NCT02915263|566213841|FG001|Overall Study|Covid|2|||
156852445|NCT01358825|566213842|FG000|Overall Study|Blood sample not drawn|0|||
156852446|NCT01358825|566213843|FG001|Overall Study|Blood sample not drawn|1|||
156852447|NCT01879683|566213844|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
156852448|NCT03571204|566213845|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
156852449|NCT03571204|566213846|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
156852450|NCT03571204|566213847|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
156852451|NCT03571204|566213845|FG000|Overall Study|Physician Decision|0|||
156852452|NCT03571204|566213846|FG001|Overall Study|Physician Decision|1|||
156852453|NCT03571204|566213847|FG002|Overall Study|Physician Decision|0|||
156852454|NCT02721875|566213848|FG000|Overall Study|Progressive disease/relapse|1|||
156852455|NCT02721875|566213849|FG001|Overall Study|Progressive disease/relapse|0|||
156852456|NCT02888106|566213850|FG000|Overall Study|Withdrawal by Subject|1|||
156852457|NCT02888106|566213851|FG001|Overall Study|Withdrawal by Subject|2|||
156852458|NCT02888106|566213852|FG002|Overall Study|Withdrawal by Subject|0|||
156852459|NCT02888106|566213853|FG003|Overall Study|Withdrawal by Subject|1|||
156852460|NCT02888106|566213854|FG004|Overall Study|Withdrawal by Subject|0|||
156852461|NCT02888106|566213855|FG005|Overall Study|Withdrawal by Subject|0|||
156852462|NCT02888106|566213850|FG000|Overall Study|Lost to Follow-up|1|||
156852463|NCT02888106|566213851|FG001|Overall Study|Lost to Follow-up|0|||
156852464|NCT02888106|566213852|FG002|Overall Study|Lost to Follow-up|0|||
156852465|NCT02888106|566213853|FG003|Overall Study|Lost to Follow-up|1|||
156852466|NCT02888106|566213854|FG004|Overall Study|Lost to Follow-up|0|||
156852467|NCT02888106|566213855|FG005|Overall Study|Lost to Follow-up|1|||
156852468|NCT02888106|566213850|FG000|Overall Study|Adverse Event|2|||
156852469|NCT02888106|566213851|FG001|Overall Study|Adverse Event|0|||
156852470|NCT02888106|566213852|FG002|Overall Study|Adverse Event|0|||
156852471|NCT02888106|566213853|FG003|Overall Study|Adverse Event|0|||
156852472|NCT02888106|566213854|FG004|Overall Study|Adverse Event|0|||
156852473|NCT02888106|566213855|FG005|Overall Study|Adverse Event|0|||
156852474|NCT02888106|566213850|FG000|Overall Study|Withdrawal of consent|0|||
156852475|NCT02888106|566213851|FG001|Overall Study|Withdrawal of consent|0|||
156852476|NCT02888106|566213852|FG002|Overall Study|Withdrawal of consent|0|||
156852477|NCT02888106|566213853|FG003|Overall Study|Withdrawal of consent|0|||
156852478|NCT02888106|566213854|FG004|Overall Study|Withdrawal of consent|1|||
156852479|NCT02888106|566213855|FG005|Overall Study|Withdrawal of consent|0|||
156852480|NCT02888106|566213850|FG000|Overall Study|Pregnancy|1|||
156852481|NCT02888106|566213851|FG001|Overall Study|Pregnancy|0|||
156852482|NCT02888106|566213852|FG002|Overall Study|Pregnancy|0|||
156852483|NCT02888106|566213853|FG003|Overall Study|Pregnancy|0|||
156852484|NCT02888106|566213854|FG004|Overall Study|Pregnancy|0|||
156852485|NCT02888106|566213855|FG005|Overall Study|Pregnancy|0|||
156852486|NCT00857285|566213856|FG000|Overall Study|Adverse Event|4|||
156852487|NCT00857285|566213857|FG001|Overall Study|Adverse Event|2|||
156852488|NCT00857285|566213856|FG000|Overall Study|Lack of Efficacy|0|||
156852489|NCT00857285|566213857|FG001|Overall Study|Lack of Efficacy|2|||
156852490|NCT00857285|566213856|FG000|Overall Study|Protocol Violation|3|||
156852491|NCT00857285|566213857|FG001|Overall Study|Protocol Violation|1|||
156852492|NCT00857285|566213856|FG000|Overall Study|Withdrawal by Subject|4|||
156852493|NCT00857285|566213857|FG001|Overall Study|Withdrawal by Subject|0|||
156852494|NCT00857285|566213856|FG000|Overall Study|Randomization criteria not met|1|||
156852495|NCT00857285|566213857|FG001|Overall Study|Randomization criteria not met|1|||
156852496|NCT02491983|566213860|FG000|Overall Study|Physician Decision|1|||
156852497|NCT02491983|566213861|FG001|Overall Study|Physician Decision|0|||
156852498|NCT02491983|566213860|FG000|Overall Study|Not meet selection criteria|1|||
156852499|NCT02491983|566213861|FG001|Overall Study|Not meet selection criteria|0|||
156852500|NCT02491983|566213860|FG000|Overall Study|Withdrawal by Subject|0|||
156852501|NCT02491983|566213861|FG001|Overall Study|Withdrawal by Subject|1|||
156852502|NCT00782717|566213863|FG000|Overall Study|Adverse Event|2|||
156852503|NCT00782717|566213864|FG001|Overall Study|Adverse Event|5|||
156852504|NCT00782717|566213863|FG000|Overall Study|Patient decision unrelated to AE|6|||
156852505|NCT00782717|566213864|FG001|Overall Study|Patient decision unrelated to AE|3|||
156852506|NCT00782717|566213863|FG000|Overall Study|Noncompliance|2|||
156852507|NCT00782717|566213864|FG001|Overall Study|Noncompliance|1|||
156852508|NCT00782717|566213863|FG000|Overall Study|Treatment failure|3|||
156852509|NCT00782717|566213864|FG001|Overall Study|Treatment failure|14|||
156852510|NCT00782717|566213863|FG000|Overall Study|Enrollment close prior to surgery|1|||
156852511|NCT00782717|566213864|FG001|Overall Study|Enrollment close prior to surgery|0|||
156852512|NCT00782717|566213863|FG000|Overall Study|Did not meet entrance criteria|1|||
156852513|NCT00782717|566213864|FG001|Overall Study|Did not meet entrance criteria|3|||
156852514|NCT00782717|566213863|FG000|Overall Study|Exited in error|0|||
156852515|NCT00782717|566213864|FG001|Overall Study|Exited in error|2|||
156852516|NCT02446717|566213865|FG000|Overall Study|Adverse Event|0|||
156852517|NCT02446717|566213866|FG001|Overall Study|Adverse Event|0|||
156852518|NCT02446717|566213867|FG002|Overall Study|Adverse Event|1|||
156852519|NCT02446717|566213868|FG003|Overall Study|Adverse Event|0|||
156852520|NCT02446717|566213869|FG004|Overall Study|Adverse Event|0|||
156852521|NCT02446717|566213865|FG000|Overall Study|Lost to Follow-up|0|||
156852522|NCT02446717|566213866|FG001|Overall Study|Lost to Follow-up|1|||
156852523|NCT02446717|566213867|FG002|Overall Study|Lost to Follow-up|1|||
156852524|NCT02446717|566213868|FG003|Overall Study|Lost to Follow-up|0|||
156852525|NCT02446717|566213869|FG004|Overall Study|Lost to Follow-up|1|||
156852526|NCT02446717|566213865|FG000|Overall Study|Withdrew consent|0|||
156852527|NCT02446717|566213866|FG001|Overall Study|Withdrew consent|0|||
156852528|NCT02446717|566213867|FG002|Overall Study|Withdrew consent|0|||
156852529|NCT02446717|566213868|FG003|Overall Study|Withdrew consent|1|||
156852530|NCT02446717|566213869|FG004|Overall Study|Withdrew consent|0|||
156852531|NCT01332994|566213874|FG000|Overall Study|Adverse Event|34|||
156852532|NCT01332994|566213874|FG000|Overall Study|Death|1|||
156852533|NCT01332994|566213874|FG000|Overall Study|Lack of Efficacy|1|||
156852534|NCT01332994|566213874|FG000|Overall Study|Lost to Follow-up|4|||
156852535|NCT01332994|566213874|FG000|Overall Study|Protocol Violation|6|||
156852536|NCT01332994|566213874|FG000|Overall Study|Withdrawal by Subject|15|||
156852537|NCT01332994|566213874|FG000|Overall Study|Administrative Problem|2|||
156852538|NCT01332994|566213874|FG000|Overall Study|Other|8|||
156852539|NCT04661150|566213881|FG000|Overall Study|Ongoing in study|19|||
156852540|NCT04661150|566213882|FG001|Overall Study|Ongoing in study|20|||
156852541|NCT04661150|566213881|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
156852542|NCT04661150|566213882|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
156852543|NCT04661150|566213881|FG000|Overall Study|Death|2|||
156852544|NCT04661150|566213882|FG001|Overall Study|Death|0|||
156852545|NCT04965688|566213883|FG000|Overall Study|Withdrawal by Subject|2|||
156852546|NCT05864586|566213884|FG000|Overall Study|Ineligible|4|||
156852547|NCT05864586|566213885|FG001|Overall Study|Ineligible|12|||
156852548|NCT05864586|566213884|FG000|Overall Study|Pregnancy|0|||
156852549|NCT05864586|566213885|FG001|Overall Study|Pregnancy|1|||
156852550|NCT05864586|566213884|FG000|Overall Study|Withdrawal by Subject|0|||
156852551|NCT05864586|566213885|FG001|Overall Study|Withdrawal by Subject|1|||
156852552|NCT03635424|566213886|FG000|Overall Study|Adverse Event|1|||
156852553|NCT03635424|566213886|FG000|Overall Study|Death|1|||
156852554|NCT03635424|566213886|FG000|Overall Study|Device not implanted|1|||
156852555|NCT05907395|566213887|FG000|Period 1|No longer met eligibility criteria|0|||
156852556|NCT05907395|566213888|FG001|Period 1|No longer met eligibility criteria|1|||
156852557|NCT05907395|566213889|FG002|Period 1|No longer met eligibility criteria|0|||
156852558|NCT05907395|566213890|FG003|Period 1|No longer met eligibility criteria|0|||
156852559|NCT05907395|566213891|FG004|Period 1|No longer met eligibility criteria|0|||
156852560|NCT05907395|566213892|FG005|Period 1|No longer met eligibility criteria|1|||
156852561|NCT05907395|566213893|FG006|Period 1|No longer met eligibility criteria|1|||
156852562|NCT05907395|566213894|FG007|Period 1|No longer met eligibility criteria|0|||
156852563|NCT05907395|566213895|FG008|Period 1|No longer met eligibility criteria|0|||
156852564|NCT05907395|566213896|FG009|Period 1|No longer met eligibility criteria|0|||
156852565|NCT05907395|566213897|FG010|Period 1|No longer met eligibility criteria|0|||
156852566|NCT05907395|566213898|FG011|Period 1|No longer met eligibility criteria|0|||
156852567|NCT05907395|566213887|FG000|Period 2|Adverse Event|0|||
156852568|NCT05907395|566213888|FG001|Period 2|Adverse Event|0|||
156852569|NCT05907395|566213889|FG002|Period 2|Adverse Event|0|||
156852570|NCT05907395|566213890|FG003|Period 2|Adverse Event|1|||
156852571|NCT05907395|566213891|FG004|Period 2|Adverse Event|0|||
156852572|NCT05907395|566213892|FG005|Period 2|Adverse Event|0|||
156852573|NCT05907395|566213893|FG006|Period 2|Adverse Event|0|||
156852574|NCT05907395|566213894|FG007|Period 2|Adverse Event|1|||
156852575|NCT05907395|566213895|FG008|Period 2|Adverse Event|0|||
156852576|NCT05907395|566213896|FG009|Period 2|Adverse Event|0|||
156852577|NCT05907395|566213897|FG010|Period 2|Adverse Event|0|||
156852578|NCT05907395|566213898|FG011|Period 2|Adverse Event|0|||
156852579|NCT05907395|566213887|FG000|Period 2|Personal reason|0|||
156852580|NCT05907395|566213888|FG001|Period 2|Personal reason|0|||
156852581|NCT05907395|566213889|FG002|Period 2|Personal reason|0|||
156852582|NCT05907395|566213890|FG003|Period 2|Personal reason|0|||
156852583|NCT05907395|566213891|FG004|Period 2|Personal reason|0|||
156852584|NCT05907395|566213892|FG005|Period 2|Personal reason|0|||
156852585|NCT05907395|566213893|FG006|Period 2|Personal reason|0|||
156852586|NCT05907395|566213894|FG007|Period 2|Personal reason|0|||
156852587|NCT05907395|566213895|FG008|Period 2|Personal reason|0|||
156852588|NCT05907395|566213896|FG009|Period 2|Personal reason|1|||
156852589|NCT05907395|566213897|FG010|Period 2|Personal reason|0|||
156852590|NCT05907395|566213898|FG011|Period 2|Personal reason|0|||
156852591|NCT05907395|566213887|FG000|Period 3|Adverse Event|0|||
156852592|NCT05907395|566213888|FG001|Period 3|Adverse Event|0|||
156852593|NCT05907395|566213889|FG002|Period 3|Adverse Event|0|||
156852594|NCT05907395|566213890|FG003|Period 3|Adverse Event|0|||
156852595|NCT05907395|566213891|FG004|Period 3|Adverse Event|1|||
156852596|NCT05907395|566213892|FG005|Period 3|Adverse Event|0|||
156852597|NCT05907395|566213893|FG006|Period 3|Adverse Event|0|||
156852598|NCT05907395|566213894|FG007|Period 3|Adverse Event|0|||
156852599|NCT05907395|566213895|FG008|Period 3|Adverse Event|0|||
156852600|NCT05907395|566213896|FG009|Period 3|Adverse Event|0|||
156852601|NCT05907395|566213897|FG010|Period 3|Adverse Event|0|||
156852602|NCT05907395|566213898|FG011|Period 3|Adverse Event|0|||
156852603|NCT00992459|566213905|FG000|Overall Study|Withdrawal by Subject|0|||
156852604|NCT00992459|566213906|FG001|Overall Study|Withdrawal by Subject|1|||
156852605|NCT00992459|566213905|FG000|Overall Study|Adverse Event|1|||
156852606|NCT00992459|566213906|FG001|Overall Study|Adverse Event|0|||
156852607|NCT00543387|566213911|FG000|Panel 1 + Panel 2|Adverse Event|0|||
156852608|NCT00543387|566213912|FG001|Panel 1 + Panel 2|Adverse Event|1|||
156852609|NCT00543387|566213913|FG002|Panel 1 + Panel 2|Adverse Event|0|||
156852610|NCT00543387|566213914|FG003|Panel 1 + Panel 2|Adverse Event|0|||
156852611|NCT00543387|566213915|FG004|Panel 1 + Panel 2|Adverse Event|0|||
156852612|NCT00543387|566213916|FG005|Panel 1 + Panel 2|Adverse Event|0|||
156852613|NCT00543387|566213917|FG006|Panel 1 + Panel 2|Adverse Event|0|||
156852614|NCT00543387|566213918|FG007|Panel 1 + Panel 2|Adverse Event|1|||
156852615|NCT00543387|566213919|FG008|Panel 1 + Panel 2|Adverse Event|1|||
156852616|NCT00543387|566213920|FG009|Panel 1 + Panel 2|Adverse Event|0|||
156852617|NCT00543387|566213921|FG010|Panel 1 + Panel 2|Adverse Event|0|||
156852618|NCT00543387|566213911|FG000|Panel 1 + Panel 2|Physician Decision|0|||
156852619|NCT00543387|566213912|FG001|Panel 1 + Panel 2|Physician Decision|0|||
156852620|NCT00543387|566213913|FG002|Panel 1 + Panel 2|Physician Decision|1|||
156852621|NCT00543387|566213914|FG003|Panel 1 + Panel 2|Physician Decision|0|||
156852622|NCT00543387|566213915|FG004|Panel 1 + Panel 2|Physician Decision|0|||
156852623|NCT00543387|566213916|FG005|Panel 1 + Panel 2|Physician Decision|0|||
156852624|NCT00543387|566213917|FG006|Panel 1 + Panel 2|Physician Decision|0|||
156852625|NCT00543387|566213918|FG007|Panel 1 + Panel 2|Physician Decision|1|||
156852626|NCT00543387|566213919|FG008|Panel 1 + Panel 2|Physician Decision|0|||
156852627|NCT00543387|566213920|FG009|Panel 1 + Panel 2|Physician Decision|0|||
156852628|NCT00543387|566213921|FG010|Panel 1 + Panel 2|Physician Decision|0|||
156852629|NCT00543387|566213911|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
156852630|NCT00543387|566213912|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
156852631|NCT00543387|566213913|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
156852632|NCT00543387|566213914|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
156852633|NCT00543387|566213915|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
156852634|NCT00543387|566213916|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
156852635|NCT00543387|566213917|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
156852636|NCT00543387|566213918|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
156852637|NCT00543387|566213919|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
156852638|NCT00543387|566213920|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
156852639|NCT00543387|566213921|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
156852640|NCT00543387|566213911|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852641|NCT00543387|566213912|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852642|NCT00543387|566213913|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852643|NCT00543387|566213914|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852644|NCT00543387|566213915|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852645|NCT00543387|566213916|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852646|NCT00543387|566213917|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
156852647|NCT00543387|566213918|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852648|NCT00543387|566213919|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852649|NCT00543387|566213920|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852650|NCT00543387|566213921|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852651|NCT00543387|566213911|FG000|Crossover Participants|Progressive Disease|0|||
156852652|NCT00543387|566213912|FG001|Crossover Participants|Progressive Disease|0|||
156852653|NCT00543387|566213913|FG002|Crossover Participants|Progressive Disease|0|||
156852654|NCT00543387|566213914|FG003|Crossover Participants|Progressive Disease|0|||
156852655|NCT00543387|566213915|FG004|Crossover Participants|Progressive Disease|0|||
156852656|NCT00543387|566213916|FG005|Crossover Participants|Progressive Disease|0|||
156852657|NCT00543387|566213917|FG006|Crossover Participants|Progressive Disease|0|||
156852658|NCT00543387|566213918|FG007|Crossover Participants|Progressive Disease|0|||
156852659|NCT00543387|566213919|FG008|Crossover Participants|Progressive Disease|0|||
156852660|NCT00543387|566213920|FG009|Crossover Participants|Progressive Disease|1|||
156852661|NCT00543387|566213921|FG010|Crossover Participants|Progressive Disease|2|||
156852662|NCT00543387|566213911|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
156852663|NCT00543387|566213912|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
156852664|NCT00543387|566213913|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
156852665|NCT00543387|566213914|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
156852666|NCT00543387|566213915|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
156852667|NCT00543387|566213916|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
156852668|NCT00543387|566213917|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
156852669|NCT00543387|566213918|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
156342220|NCT00573469|564352583|FG000|Overall Study|Withdrawal by Subject|0|||
156342221|NCT00573469|564352584|FG001|Overall Study|Withdrawal by Subject|2|||
156852670|NCT00543387|566213919|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
156852671|NCT00543387|566213920|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
156852672|NCT00543387|566213921|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
156852673|NCT00549445|566213922|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
156852674|NCT00549445|566213923|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
156852675|NCT03932760|566213926|FG000|Overall Study|Became Ineligible|2|||
156852676|NCT03932760|566213927|FG001|Overall Study|Became Ineligible|5|||
156852677|NCT03932760|566213926|FG000|Overall Study|Withdrawal by Subject|6|||
156852678|NCT03932760|566213927|FG001|Overall Study|Withdrawal by Subject|6|||
156852679|NCT01223183|566213931|FG000|Imaging Day 1|Physician Decision|0|||
156852680|NCT01223183|566213932|FG001|Imaging Day 1|Physician Decision|1|||
156852681|NCT01223183|566213931|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
156852682|NCT01223183|566213932|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
156852683|NCT01223183|566213931|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
156852684|NCT01223183|566213932|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
156852685|NCT03772665|566213934|FG000|Overall Study|Protocol Violation|1|||
156852686|NCT03772665|566213935|FG001|Overall Study|Protocol Violation|0|||
156852687|NCT03553758|566215279|FG000|Overall Study|Lost to Follow-up|1|||
156852688|NCT01467505|566215283|FG000|Overall Study|Adverse Event|1|||
156852689|NCT01467505|566215284|FG001|Overall Study|Adverse Event|0|||
156852690|NCT01467505|566215283|FG000|Overall Study|Withdrawal by Subject|4|||
156852691|NCT01467505|566215284|FG001|Overall Study|Withdrawal by Subject|0|||
156852692|NCT01467505|566215283|FG000|Overall Study|Study Terminated by Sponsor|28|||
156852693|NCT01467505|566215284|FG001|Overall Study|Study Terminated by Sponsor|3|||
156852694|NCT02719171|566215285|FG000|Overall Study|Adverse Event|1|||
156852695|NCT02719171|566215286|FG001|Overall Study|Adverse Event|2|||
156852696|NCT02719171|566215287|FG002|Overall Study|Adverse Event|0|||
156852697|NCT02719171|566215288|FG003|Overall Study|Adverse Event|0|||
156852698|NCT02719171|566215289|FG004|Overall Study|Adverse Event|2|||
156852699|NCT02719171|566215285|FG000|Overall Study|Lost to Follow-up|0|||
156852700|NCT02719171|566215286|FG001|Overall Study|Lost to Follow-up|0|||
156852701|NCT02719171|566215287|FG002|Overall Study|Lost to Follow-up|1|||
156852702|NCT02719171|566215288|FG003|Overall Study|Lost to Follow-up|0|||
156852703|NCT02719171|566215289|FG004|Overall Study|Lost to Follow-up|0|||
156852704|NCT02719171|566215285|FG000|Overall Study|Subject Withdrawal|0|||
156852705|NCT02719171|566215286|FG001|Overall Study|Subject Withdrawal|2|||
156852706|NCT02719171|566215287|FG002|Overall Study|Subject Withdrawal|2|||
156852707|NCT02719171|566215288|FG003|Overall Study|Subject Withdrawal|1|||
156852708|NCT02719171|566215289|FG004|Overall Study|Subject Withdrawal|0|||
156852709|NCT02719171|566215285|FG000|Overall Study|Other|0|||
156852710|NCT02719171|566215286|FG001|Overall Study|Other|0|||
156852711|NCT02719171|566215287|FG002|Overall Study|Other|0|||
156852712|NCT02719171|566215288|FG003|Overall Study|Other|1|||
156852713|NCT02719171|566215289|FG004|Overall Study|Other|0|||
156852714|NCT02807623|566215290|FG000|Overall Study|Lost to Follow-up|23|||
156852715|NCT02807623|566215291|FG001|Overall Study|Lost to Follow-up|18|||
156852716|NCT02807623|566215292|FG002|Overall Study|Lost to Follow-up|22|||
156852717|NCT02807623|566215290|FG000|Overall Study|Drug intolerance|0|||
156852718|NCT02807623|566215291|FG001|Overall Study|Drug intolerance|1|||
156852719|NCT02807623|566215292|FG002|Overall Study|Drug intolerance|0|||
156852720|NCT02807623|566215290|FG000|Overall Study|incomplete blood draw|0|||
156852721|NCT02807623|566215291|FG001|Overall Study|incomplete blood draw|2|||
156852722|NCT02807623|566215292|FG002|Overall Study|incomplete blood draw|1|||
156852723|NCT02614729|566215293|FG000|Overall Study|Withdrawal by Subject|1|||
156852724|NCT02614729|566215294|FG001|Overall Study|Withdrawal by Subject|0|||
156852725|NCT00227721|566215295|FG000|Overall Study|On study, but never treated.|1|||
156852726|NCT02219464|566215308|FG000|Overall Study|Withdrawal by Subject|1|||
156852727|NCT02219464|566215309|FG001|Overall Study|Withdrawal by Subject|0|||
156852728|NCT02219464|566215308|FG000|Overall Study|case cancelled|1|||
156852729|NCT02219464|566215309|FG001|Overall Study|case cancelled|0|||
156852730|NCT02219464|566215308|FG000|Overall Study|catheter malfunction|1|||
156852731|NCT02219464|566215309|FG001|Overall Study|catheter malfunction|0|||
156852732|NCT01380769|566215312|FG000|Overall Study|Withdrawal by Subject|7|||
156852733|NCT01380769|566215313|FG001|Overall Study|Withdrawal by Subject|11|||
156852734|NCT01380769|566215312|FG000|Overall Study|Physician Decision|1|||
156852735|NCT01380769|566215313|FG001|Overall Study|Physician Decision|1|||
156852736|NCT01380769|566215312|FG000|Overall Study|Adverse Event|1|||
156852737|NCT01380769|566215313|FG001|Overall Study|Adverse Event|1|||
156852738|NCT01380769|566215312|FG000|Overall Study|Protocol Violation|0|||
156852739|NCT01380769|566215313|FG001|Overall Study|Protocol Violation|1|||
156852740|NCT03922581|566215317|FG000|Overall Study|Lost to Follow-up|20|||
156852741|NCT03922581|566215318|FG001|Overall Study|Lost to Follow-up|9|||
156852742|NCT03922581|566215317|FG000|Overall Study|Physician Decision|1|||
156852743|NCT03922581|566215318|FG001|Overall Study|Physician Decision|1|||
156852744|NCT03922581|566215317|FG000|Overall Study|Withdrawal by Subject|1|||
156852745|NCT03922581|566215318|FG001|Overall Study|Withdrawal by Subject|0|||
156852746|NCT00764699|566215321|FG000|Overall Study|PI left and study terminated|3|||
156852747|NCT01508312|566215327|FG000|Overall Study|Lost to Follow-up|1|||
156852748|NCT01508312|566215328|FG001|Overall Study|Lost to Follow-up|0|||
156472556|NCT03732807|564825521|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
156472557|NCT03732807|564825522|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
156472558|NCT03732807|564825523|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
156472559|NCT03732807|564825524|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
156472560|NCT03732807|564825525|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
156852749|NCT01508312|566215329|FG002|Overall Study|Lost to Follow-up|0|||
156852750|NCT01508312|566215330|FG003|Overall Study|Lost to Follow-up|0|||
156852751|NCT01508312|566215327|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
156852752|NCT01508312|566215328|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
156852753|NCT01508312|566215329|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
156852754|NCT01508312|566215330|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
156852755|NCT01508312|566215327|FG000|Overall Study|Adverse Event|0|||
156852756|NCT01508312|566215328|FG001|Overall Study|Adverse Event|0|||
156852757|NCT01508312|566215329|FG002|Overall Study|Adverse Event|2|||
156852758|NCT01508312|566215330|FG003|Overall Study|Adverse Event|0|||
156852759|NCT01508312|566215327|FG000|Overall Study|Lack of Efficacy|0|||
156852760|NCT01508312|566215328|FG001|Overall Study|Lack of Efficacy|0|||
156852761|NCT01508312|566215329|FG002|Overall Study|Lack of Efficacy|1|||
156852762|NCT01508312|566215330|FG003|Overall Study|Lack of Efficacy|0|||
156852763|NCT01508312|566215327|FG000|Overall Study|Withdrawal by Subject|0|||
156852764|NCT01508312|566215328|FG001|Overall Study|Withdrawal by Subject|0|||
156852765|NCT01508312|566215329|FG002|Overall Study|Withdrawal by Subject|1|||
156852766|NCT01508312|566215330|FG003|Overall Study|Withdrawal by Subject|0|||
156852767|NCT02223715|566215331|FG000|Overall Study|Death|31|||
156852768|NCT02223715|566215331|FG000|Overall Study|Lost to Follow-up|73|||
156852769|NCT02222558|566215332|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
156852770|NCT02222558|566215333|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
156852771|NCT02222558|566215334|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
156852772|NCT02222558|566215335|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
156852773|NCT02222558|566215336|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
156852774|NCT02222558|566215337|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
156852775|NCT02222558|566215332|FG000|Period 3|Withdrawal by Subject|0|||
156852776|NCT02222558|566215333|FG001|Period 3|Withdrawal by Subject|0|||
156852777|NCT02222558|566215334|FG002|Period 3|Withdrawal by Subject|0|||
156852778|NCT02222558|566215335|FG003|Period 3|Withdrawal by Subject|0|||
156852779|NCT02222558|566215336|FG004|Period 3|Withdrawal by Subject|0|||
156852780|NCT02222558|566215337|FG005|Period 3|Withdrawal by Subject|1|||
156852781|NCT01745367|566215338|FG000|Overall Study|Death|1|||
156852782|NCT01745367|566215339|FG001|Overall Study|Death|0|||
156852783|NCT01745367|566215338|FG000|Overall Study|Withdrawal by Subject|1|||
156852784|NCT01745367|566215339|FG001|Overall Study|Withdrawal by Subject|2|||
156852785|NCT01745367|566215338|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
156852786|NCT01745367|566215339|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
156852787|NCT01745367|566215338|FG000|Overall Study|Other Reasons Unspecified|0|||
156852788|NCT01745367|566215339|FG001|Overall Study|Other Reasons Unspecified|2|||
156852789|NCT02322281|566215342|FG000|Overall Study|Progressive Disease|42|||
156852790|NCT02322281|566215343|FG001|Overall Study|Progressive Disease|14|||
156852791|NCT02322281|566215344|FG002|Overall Study|Progressive Disease|49|||
156852792|NCT02322281|566215342|FG000|Overall Study|Adverse Event|3|||
156852793|NCT02322281|566215343|FG001|Overall Study|Adverse Event|4|||
156852794|NCT02322281|566215344|FG002|Overall Study|Adverse Event|6|||
156852795|NCT02322281|566215342|FG000|Overall Study|Death|3|||
156852796|NCT02322281|566215343|FG001|Overall Study|Death|3|||
156852797|NCT02322281|566215344|FG002|Overall Study|Death|3|||
156342222|NCT00573469|564352585|FG002|Overall Study|Withdrawal by Subject|0|||
156342223|NCT00573469|564352583|FG000|Overall Study|Other|5|||
156342224|NCT00573469|564352584|FG001|Overall Study|Other|1|||
156342225|NCT00573469|564352585|FG002|Overall Study|Other|3|||
156852798|NCT02322281|566215342|FG000|Overall Study|Withdrawal by Subject|1|||
156852799|NCT02322281|566215343|FG001|Overall Study|Withdrawal by Subject|1|||
156852800|NCT02322281|566215344|FG002|Overall Study|Withdrawal by Subject|6|||
156852801|NCT02322281|566215342|FG000|Overall Study|Physician Decision|2|||
156852802|NCT02322281|566215343|FG001|Overall Study|Physician Decision|0|||
156852803|NCT02322281|566215344|FG002|Overall Study|Physician Decision|5|||
156852804|NCT02322281|566215342|FG000|Overall Study|Study Terminated by Sponsor|2|||
156852805|NCT02322281|566215343|FG001|Overall Study|Study Terminated by Sponsor|0|||
156852806|NCT02322281|566215344|FG002|Overall Study|Study Terminated by Sponsor|0|||
156852807|NCT02322281|566215342|FG000|Overall Study|Missing|0|||
156852808|NCT02322281|566215343|FG001|Overall Study|Missing|0|||
156852809|NCT02322281|566215344|FG002|Overall Study|Missing|1|||
156852810|NCT02322281|566215342|FG000|Overall Study|Miscellaneous|0|||
156852811|NCT02322281|566215343|FG001|Overall Study|Miscellaneous|0|||
156852812|NCT02322281|566215344|FG002|Overall Study|Miscellaneous|4|||
156852813|NCT02107703|566215345|FG000|Overall Study|Withdrawal by Subject|46|||
156852814|NCT02107703|566215346|FG001|Overall Study|Withdrawal by Subject|21|||
156852815|NCT02107703|566215345|FG000|Overall Study|Lost to Follow-up|20|||
156852816|NCT02107703|566215346|FG001|Overall Study|Lost to Follow-up|9|||
156852817|NCT02107703|566215345|FG000|Overall Study|On study treatment/follow up|48|||
156852818|NCT02107703|566215346|FG001|Overall Study|On study treatment/follow up|5|||
156852819|NCT02366312|566215347|FG000|Overall Study|Lost to Follow-up|0|||
156852820|NCT02366312|566215348|FG001|Overall Study|Lost to Follow-up|1|||
156852821|NCT00965081|566215349|FG000|Overall Study|Adverse Event|14|||
156852822|NCT00965081|566215350|FG001|Overall Study|Adverse Event|9|||
156852823|NCT00965081|566215349|FG000|Overall Study|Lack of Efficacy|2|||
156852824|NCT00965081|566215350|FG001|Overall Study|Lack of Efficacy|5|||
156852825|NCT00965081|566215349|FG000|Overall Study|Lost to Follow-up|4|||
156852826|NCT00965081|566215350|FG001|Overall Study|Lost to Follow-up|5|||
156852827|NCT00965081|566215349|FG000|Overall Study|Physician Decision|2|||
156852828|NCT00965081|566215350|FG001|Overall Study|Physician Decision|0|||
156852829|NCT00965081|566215349|FG000|Overall Study|Protocol Violation|2|||
156852830|NCT00965081|566215350|FG001|Overall Study|Protocol Violation|5|||
156852831|NCT00965081|566215349|FG000|Overall Study|Sponsor Decision|1|||
156852832|NCT00965081|566215350|FG001|Overall Study|Sponsor Decision|0|||
156852833|NCT00965081|566215349|FG000|Overall Study|Withdrawal by Subject|4|||
156852834|NCT00965081|566215350|FG001|Overall Study|Withdrawal by Subject|7|||
156852835|NCT00965081|566215349|FG000|Overall Study|Switched to Rescue Arm|5|||
156852836|NCT00965081|566215350|FG001|Overall Study|Switched to Rescue Arm|12|||
156852837|NCT03901144|566215356|FG000|Overall Study|Lost to Follow-up|1|||
156852838|NCT03901144|566215357|FG001|Overall Study|Lost to Follow-up|1|||
156852839|NCT03901144|566215358|FG002|Overall Study|Lost to Follow-up|1|||
156852840|NCT03901144|566215359|FG003|Overall Study|Lost to Follow-up|1|||
156852841|NCT02021565|566215360|FG000|Baseline Through Intervention|Death|0|||
156852842|NCT02021565|566215361|FG001|Baseline Through Intervention|Death|1|||
156852843|NCT02021565|566215360|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
156852844|NCT02021565|566215361|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
156852845|NCT02021565|566215360|FG000|Baseline Through Intervention|Protocol Violation|0|||
156852846|NCT02021565|566215361|FG001|Baseline Through Intervention|Protocol Violation|7|||
156852847|NCT02021565|566215360|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
156852848|NCT02021565|566215361|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
156852849|NCT02021565|566215360|FG000|3-month Follow-up|Death|3|||
156852850|NCT02021565|566215361|FG001|3-month Follow-up|Death|0|||
156852851|NCT02021565|566215360|FG000|3-month Follow-up|Withdrawal by Subject|4|||
156852852|NCT02021565|566215361|FG001|3-month Follow-up|Withdrawal by Subject|0|||
156852853|NCT02021565|566215360|FG000|3-month Follow-up|Protocol Violation|3|||
156852854|NCT02021565|566215361|FG001|3-month Follow-up|Protocol Violation|2|||
156852855|NCT05114473|566215364|FG000|Overall Study|Lost to Follow-up|2|||
156852856|NCT05114473|566215365|FG001|Overall Study|Lost to Follow-up|2|||
156852857|NCT05114473|566215366|FG002|Overall Study|Lost to Follow-up|0|||
156852858|NCT00279916|566215370|FG000|Overall Study|Withdrawal by Subject|4|||
156852859|NCT00279916|566215371|FG001|Overall Study|Withdrawal by Subject|3|||
156852860|NCT00279916|566215370|FG000|Overall Study|Lost to Follow-up|3|||
156852861|NCT00279916|566215371|FG001|Overall Study|Lost to Follow-up|2|||
156852862|NCT00731679|566215373|FG000|Overall Study|Adverse Event|7|||
156852863|NCT00731679|566215374|FG001|Overall Study|Adverse Event|8|||
156852864|NCT00731679|566215373|FG000|Overall Study|Withdrawal by Subject|8|||
156852865|NCT00731679|566215374|FG001|Overall Study|Withdrawal by Subject|8|||
156852866|NCT00731679|566215373|FG000|Overall Study|Lost to Follow-up|7|||
156852867|NCT00731679|566215374|FG001|Overall Study|Lost to Follow-up|8|||
156852868|NCT00731679|566215373|FG000|Overall Study|Noncompliance|0|||
156852869|NCT00731679|566215374|FG001|Overall Study|Noncompliance|1|||
156852870|NCT00731679|566215373|FG000|Overall Study|Pregnancy|0|||
156852871|NCT00731679|566215374|FG001|Overall Study|Pregnancy|1|||
156852872|NCT03384940|566215377|FG000|Overall Study|Progressive disease|36|||
156852873|NCT03384940|566215378|FG001|Overall Study|Progressive disease|11|||
156852874|NCT03384940|566215379|FG002|Overall Study|Progressive disease|13|||
156852875|NCT03384940|566215377|FG000|Overall Study|Clinical progression|4|||
156342226|NCT01338792|564352586|FG000|Overall Study|Adverse Event|2|||
156852876|NCT03384940|566215378|FG001|Overall Study|Clinical progression|0|||
156852877|NCT03384940|566215379|FG002|Overall Study|Clinical progression|3|||
156852878|NCT03384940|566215377|FG000|Overall Study|Adverse Event|7|||
156852879|NCT03384940|566215378|FG001|Overall Study|Adverse Event|1|||
156852880|NCT03384940|566215379|FG002|Overall Study|Adverse Event|1|||
156852881|NCT03384940|566215377|FG000|Overall Study|Withdrawal by Subject|3|||
156852882|NCT03384940|566215378|FG001|Overall Study|Withdrawal by Subject|1|||
156852883|NCT03384940|566215379|FG002|Overall Study|Withdrawal by Subject|0|||
156852884|NCT03384940|566215377|FG000|Overall Study|Physician Decision|1|||
156852885|NCT03384940|566215378|FG001|Overall Study|Physician Decision|1|||
156852886|NCT03384940|566215379|FG002|Overall Study|Physician Decision|0|||
156852887|NCT03384940|566215377|FG000|Overall Study|Death|2|||
156852888|NCT03384940|566215378|FG001|Overall Study|Death|1|||
156852889|NCT03384940|566215379|FG002|Overall Study|Death|0|||
156852890|NCT03384940|566215377|FG000|Overall Study|Other|0|||
156852891|NCT03384940|566215378|FG001|Overall Study|Other|0|||
156852892|NCT03384940|566215379|FG002|Overall Study|Other|1|||
156852893|NCT03089580|566215385|FG000|Overall Study|Lost to Follow-up|2|||
156852894|NCT03087513|566215386|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
156852895|NCT04628780|566215387|FG000|Overall Study|Death|0|||
156852896|NCT04628780|566215388|FG001|Overall Study|Death|1|||
156852897|NCT04628780|566215389|FG002|Overall Study|Death|0|||
156852898|NCT04628780|566215390|FG003|Overall Study|Death|0|||
156852899|NCT04628780|566215391|FG004|Overall Study|Death|1|||
156852900|NCT04628780|566215392|FG005|Overall Study|Death|0|||
156852901|NCT04628780|566215387|FG000|Overall Study|Physician Decision|2|||
156852902|NCT04628780|566215388|FG001|Overall Study|Physician Decision|0|||
156852903|NCT04628780|566215389|FG002|Overall Study|Physician Decision|0|||
156852904|NCT04628780|566215390|FG003|Overall Study|Physician Decision|0|||
156852905|NCT04628780|566215391|FG004|Overall Study|Physician Decision|2|||
156852906|NCT04628780|566215392|FG005|Overall Study|Physician Decision|0|||
156852907|NCT04628780|566215387|FG000|Overall Study|Progressive disease|2|||
156852908|NCT04628780|566215388|FG001|Overall Study|Progressive disease|2|||
156852909|NCT04628780|566215389|FG002|Overall Study|Progressive disease|2|||
156852910|NCT04628780|566215390|FG003|Overall Study|Progressive disease|3|||
156852911|NCT04628780|566215391|FG004|Overall Study|Progressive disease|9|||
156852912|NCT04628780|566215392|FG005|Overall Study|Progressive disease|4|||
156852913|NCT04628780|566215387|FG000|Overall Study|Withdrawal by Subject|0|||
156852914|NCT04628780|566215388|FG001|Overall Study|Withdrawal by Subject|1|||
156852915|NCT04628780|566215389|FG002|Overall Study|Withdrawal by Subject|2|||
156852916|NCT04628780|566215390|FG003|Overall Study|Withdrawal by Subject|0|||
156852917|NCT04628780|566215391|FG004|Overall Study|Withdrawal by Subject|3|||
156852918|NCT04628780|566215392|FG005|Overall Study|Withdrawal by Subject|1|||
156852919|NCT04628780|566215387|FG000|Overall Study|Global deterioration of health status|0|||
156852920|NCT04628780|566215388|FG001|Overall Study|Global deterioration of health status|0|||
156852921|NCT04628780|566215389|FG002|Overall Study|Global deterioration of health status|0|||
156852922|NCT04628780|566215390|FG003|Overall Study|Global deterioration of health status|0|||
156852923|NCT04628780|566215391|FG004|Overall Study|Global deterioration of health status|1|||
156852924|NCT04628780|566215392|FG005|Overall Study|Global deterioration of health status|1|||
156852925|NCT03269994|566215393|FG000|Overall Study|Withdrawal by Subject|4|||
156852926|NCT03269994|566215394|FG001|Overall Study|Withdrawal by Subject|5|||
156852927|NCT03269994|566215393|FG000|Overall Study|Unresectable at surgery|39|||
156852928|NCT03269994|566215394|FG001|Overall Study|Unresectable at surgery|58|||
156852929|NCT03269994|566215393|FG000|Overall Study|Patient canceled surgery|5|||
156852930|NCT03269994|566215394|FG001|Overall Study|Patient canceled surgery|14|||
156852931|NCT03269994|566215393|FG000|Overall Study|Preoperative progression|14|||
156852932|NCT03269994|566215394|FG001|Overall Study|Preoperative progression|9|||
156852933|NCT03269994|566215393|FG000|Overall Study|Preoperative infection|10|||
156852934|NCT03269994|566215394|FG001|Overall Study|Preoperative infection|4|||
156852935|NCT03269994|566215393|FG000|Overall Study|Kidney insufficiency|1|||
156852936|NCT03269994|566215394|FG001|Overall Study|Kidney insufficiency|0|||
156852937|NCT03269994|566215393|FG000|Overall Study|Drug allergy|0|||
156852938|NCT03269994|566215394|FG001|Overall Study|Drug allergy|2|||
156852939|NCT03269994|566215393|FG000|Overall Study|Operation changed to different resection|9|||
156852940|NCT03269994|566215394|FG001|Overall Study|Operation changed to different resection|0|||
156852941|NCT03269994|566215393|FG000|Overall Study|Preoperative steroid|0|||
156852942|NCT03269994|566215394|FG001|Overall Study|Preoperative steroid|3|||
156472561|NCT03732807|564825526|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
156472562|NCT03732807|564825527|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
156852943|NCT03269994|566215393|FG000|Overall Study|Accrual Closed|2|||
156852944|NCT03269994|566215394|FG001|Overall Study|Accrual Closed|0|||
156852945|NCT03269994|566215393|FG000|Overall Study|Operation changed to different resection|0|||
156852946|NCT03269994|566215394|FG001|Overall Study|Operation changed to different resection|10|||
156852947|NCT04303559|566215395|FG000|Overall Study|Study closed due to poor enrollment.|1|||
156852948|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
156852949|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
156852950|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
156852951|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
156852952|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
156852953|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
156852954|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
156852955|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
156852956|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
156852957|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
156852958|NCT01987102|566215398|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
156852959|NCT01987102|566215399|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
156852960|NCT01288989|566215400|FG000|Overall Study|Death|0|||
156852961|NCT01288989|566215401|FG001|Overall Study|Death|0|||
156852962|NCT01288989|566215402|FG002|Overall Study|Death|0|||
156852963|NCT01288989|566215403|FG003|Overall Study|Death|1|||
156852964|NCT01288989|566215404|FG004|Overall Study|Death|0|||
156852965|NCT01288989|566215400|FG000|Overall Study|Dose limiting toxicity|1|||
156852966|NCT01288989|566215401|FG001|Overall Study|Dose limiting toxicity|0|||
156852967|NCT01288989|566215402|FG002|Overall Study|Dose limiting toxicity|0|||
156852968|NCT01288989|566215403|FG003|Overall Study|Dose limiting toxicity|0|||
156852969|NCT01288989|566215404|FG004|Overall Study|Dose limiting toxicity|0|||
156852970|NCT01288989|566215400|FG000|Overall Study|Adverse Event|0|||
156852971|NCT01288989|566215401|FG001|Overall Study|Adverse Event|0|||
156852972|NCT01288989|566215402|FG002|Overall Study|Adverse Event|0|||
156852973|NCT01288989|566215403|FG003|Overall Study|Adverse Event|0|||
156852974|NCT01288989|566215404|FG004|Overall Study|Adverse Event|2|||
156852975|NCT01288989|566215400|FG000|Overall Study|Physician Decision|0|||
156852976|NCT01288989|566215401|FG001|Overall Study|Physician Decision|0|||
156852977|NCT01288989|566215402|FG002|Overall Study|Physician Decision|0|||
156852978|NCT01288989|566215403|FG003|Overall Study|Physician Decision|0|||
156852979|NCT01288989|566215404|FG004|Overall Study|Physician Decision|1|||
156852980|NCT01288989|566215400|FG000|Overall Study|Withdrawal by Subject|0|||
156852981|NCT01288989|566215401|FG001|Overall Study|Withdrawal by Subject|0|||
156852982|NCT01288989|566215402|FG002|Overall Study|Withdrawal by Subject|0|||
156852983|NCT01288989|566215403|FG003|Overall Study|Withdrawal by Subject|0|||
156852984|NCT01288989|566215404|FG004|Overall Study|Withdrawal by Subject|3|||
156852985|NCT01327599|566215405|FG000|Overall Study|Adverse Event|1|||
156852986|NCT01327599|566215405|FG000|Overall Study|Could Not Attend Visit|1|||
156852987|NCT01327599|566215405|FG000|Overall Study|Withdrawal of Consent|1|||
156852988|NCT01132313|566215406|FG000|Overall Study|Lack of Efficacy|1|||
156852989|NCT01132313|566215407|FG001|Overall Study|Lack of Efficacy|0|||
156852990|NCT01132313|566215408|FG002|Overall Study|Lack of Efficacy|0|||
156852991|NCT01132313|566215409|FG003|Overall Study|Lack of Efficacy|0|||
156852992|NCT01132313|566215410|FG004|Overall Study|Lack of Efficacy|0|||
156852993|NCT01132313|566215411|FG005|Overall Study|Lack of Efficacy|0|||
156852994|NCT01132313|566215412|FG006|Overall Study|Lack of Efficacy|0|||
156852995|NCT01132313|566215413|FG007|Overall Study|Lack of Efficacy|3|||
156852996|NCT01132313|566215414|FG008|Overall Study|Lack of Efficacy|14|||
156852997|NCT01132313|566215415|FG009|Overall Study|Lack of Efficacy|16|||
156852998|NCT01132313|566215416|FG010|Overall Study|Lack of Efficacy|0|||
156852999|NCT01132313|566215417|FG011|Overall Study|Lack of Efficacy|0|||
156853000|NCT01132313|566215406|FG000|Overall Study|Not treated|2|||
156853001|NCT01132313|566215407|FG001|Overall Study|Not treated|0|||
156853002|NCT01132313|566215408|FG002|Overall Study|Not treated|0|||
156472563|NCT03732807|564825521|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
156472564|NCT03732807|564825522|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
156472565|NCT03732807|564825523|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
156472566|NCT03732807|564825524|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
156472567|NCT03732807|564825525|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
156472568|NCT03732807|564825526|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
156472569|NCT03732807|564825527|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
156472570|NCT03732807|564825521|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
156472571|NCT03732807|564825522|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
156472572|NCT03732807|564825523|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
156472573|NCT03732807|564825524|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
156472574|NCT03732807|564825525|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
156853003|NCT01132313|566215409|FG003|Overall Study|Not treated|0|||
156853004|NCT01132313|566215410|FG004|Overall Study|Not treated|2|||
156853005|NCT01132313|566215411|FG005|Overall Study|Not treated|1|||
156853006|NCT01132313|566215412|FG006|Overall Study|Not treated|3|||
156853007|NCT01132313|566215413|FG007|Overall Study|Not treated|0|||
156853008|NCT01132313|566215414|FG008|Overall Study|Not treated|0|||
156853009|NCT01132313|566215415|FG009|Overall Study|Not treated|0|||
156853010|NCT01132313|566215416|FG010|Overall Study|Not treated|0|||
156853011|NCT01132313|566215417|FG011|Overall Study|Not treated|0|||
156853012|NCT01132313|566215406|FG000|Overall Study|Adverse Event|0|||
156853013|NCT01132313|566215407|FG001|Overall Study|Adverse Event|0|||
156853014|NCT01132313|566215408|FG002|Overall Study|Adverse Event|4|||
156853015|NCT01132313|566215409|FG003|Overall Study|Adverse Event|10|||
156853016|NCT01132313|566215410|FG004|Overall Study|Adverse Event|19|||
156853017|NCT01132313|566215411|FG005|Overall Study|Adverse Event|6|||
156853018|NCT01132313|566215412|FG006|Overall Study|Adverse Event|5|||
156853019|NCT01132313|566215413|FG007|Overall Study|Adverse Event|3|||
156853020|NCT01132313|566215414|FG008|Overall Study|Adverse Event|7|||
156853021|NCT01132313|566215415|FG009|Overall Study|Adverse Event|2|||
156853022|NCT01132313|566215416|FG010|Overall Study|Adverse Event|0|||
156853023|NCT01132313|566215417|FG011|Overall Study|Adverse Event|0|||
156853024|NCT01132313|566215406|FG000|Overall Study|Protocol Violation|0|||
156853025|NCT01132313|566215407|FG001|Overall Study|Protocol Violation|0|||
156853026|NCT01132313|566215408|FG002|Overall Study|Protocol Violation|0|||
156853027|NCT01132313|566215409|FG003|Overall Study|Protocol Violation|1|||
156853028|NCT01132313|566215410|FG004|Overall Study|Protocol Violation|0|||
156853029|NCT01132313|566215411|FG005|Overall Study|Protocol Violation|0|||
156853030|NCT01132313|566215412|FG006|Overall Study|Protocol Violation|0|||
156853031|NCT01132313|566215413|FG007|Overall Study|Protocol Violation|0|||
156853032|NCT01132313|566215414|FG008|Overall Study|Protocol Violation|0|||
156853033|NCT01132313|566215415|FG009|Overall Study|Protocol Violation|0|||
156853034|NCT01132313|566215416|FG010|Overall Study|Protocol Violation|0|||
156853035|NCT01132313|566215417|FG011|Overall Study|Protocol Violation|0|||
156853036|NCT01132313|566215406|FG000|Overall Study|Lost to Follow-up|0|||
156853037|NCT01132313|566215407|FG001|Overall Study|Lost to Follow-up|0|||
156853038|NCT01132313|566215408|FG002|Overall Study|Lost to Follow-up|1|||
156853039|NCT01132313|566215409|FG003|Overall Study|Lost to Follow-up|0|||
156853040|NCT01132313|566215410|FG004|Overall Study|Lost to Follow-up|0|||
156853041|NCT01132313|566215411|FG005|Overall Study|Lost to Follow-up|0|||
156853042|NCT01132313|566215412|FG006|Overall Study|Lost to Follow-up|0|||
156853043|NCT01132313|566215413|FG007|Overall Study|Lost to Follow-up|1|||
156853044|NCT01132313|566215414|FG008|Overall Study|Lost to Follow-up|0|||
156853045|NCT01132313|566215415|FG009|Overall Study|Lost to Follow-up|0|||
156853046|NCT01132313|566215416|FG010|Overall Study|Lost to Follow-up|0|||
156853047|NCT01132313|566215417|FG011|Overall Study|Lost to Follow-up|0|||
156853048|NCT01132313|566215406|FG000|Overall Study|Withdrawal by Subject|0|||
156853049|NCT01132313|566215407|FG001|Overall Study|Withdrawal by Subject|0|||
156853050|NCT01132313|566215408|FG002|Overall Study|Withdrawal by Subject|3|||
156853051|NCT01132313|566215409|FG003|Overall Study|Withdrawal by Subject|3|||
156853052|NCT01132313|566215410|FG004|Overall Study|Withdrawal by Subject|6|||
156853053|NCT01132313|566215411|FG005|Overall Study|Withdrawal by Subject|0|||
156853054|NCT01132313|566215412|FG006|Overall Study|Withdrawal by Subject|1|||
156853055|NCT01132313|566215413|FG007|Overall Study|Withdrawal by Subject|0|||
156853056|NCT01132313|566215414|FG008|Overall Study|Withdrawal by Subject|0|||
156853057|NCT01132313|566215415|FG009|Overall Study|Withdrawal by Subject|2|||
156853058|NCT01132313|566215416|FG010|Overall Study|Withdrawal by Subject|0|||
156853059|NCT01132313|566215417|FG011|Overall Study|Withdrawal by Subject|0|||
156853060|NCT01132313|566215406|FG000|Overall Study|Lack of antiviral response|0|||
156472575|NCT03732807|564825526|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
156472576|NCT03732807|564825527|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
156472577|NCT03732807|564825521|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
156472578|NCT03732807|564825522|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
156853061|NCT01132313|566215407|FG001|Overall Study|Lack of antiviral response|0|||
156853062|NCT01132313|566215408|FG002|Overall Study|Lack of antiviral response|12|||
156853063|NCT01132313|566215409|FG003|Overall Study|Lack of antiviral response|18|||
156853064|NCT01132313|566215410|FG004|Overall Study|Lack of antiviral response|18|||
156853065|NCT01132313|566215411|FG005|Overall Study|Lack of antiviral response|18|||
156853066|NCT01132313|566215412|FG006|Overall Study|Lack of antiviral response|21|||
156853067|NCT01132313|566215413|FG007|Overall Study|Lack of antiviral response|0|||
156853068|NCT01132313|566215414|FG008|Overall Study|Lack of antiviral response|0|||
156853069|NCT01132313|566215415|FG009|Overall Study|Lack of antiviral response|0|||
156853070|NCT01132313|566215416|FG010|Overall Study|Lack of antiviral response|1|||
156853071|NCT01132313|566215417|FG011|Overall Study|Lack of antiviral response|0|||
156853072|NCT01132313|566215406|FG000|Overall Study|Other reason not defined above|0|||
156853073|NCT01132313|566215407|FG001|Overall Study|Other reason not defined above|0|||
156853074|NCT01132313|566215408|FG002|Overall Study|Other reason not defined above|0|||
156853075|NCT01132313|566215409|FG003|Overall Study|Other reason not defined above|0|||
156853076|NCT01132313|566215410|FG004|Overall Study|Other reason not defined above|0|||
156853077|NCT01132313|566215411|FG005|Overall Study|Other reason not defined above|0|||
156853078|NCT01132313|566215412|FG006|Overall Study|Other reason not defined above|0|||
156853079|NCT01132313|566215413|FG007|Overall Study|Other reason not defined above|1|||
156853080|NCT01132313|566215414|FG008|Overall Study|Other reason not defined above|0|||
156853081|NCT01132313|566215415|FG009|Overall Study|Other reason not defined above|0|||
156853082|NCT01132313|566215416|FG010|Overall Study|Other reason not defined above|0|||
156853083|NCT01132313|566215417|FG011|Overall Study|Other reason not defined above|0|||
156853084|NCT00165672|566215423|FG000|Overall Study|Adverse Event|0|||
156853085|NCT00165672|566215424|FG001|Overall Study|Adverse Event|1|||
156853086|NCT00176462|566215427|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
156853087|NCT00176462|566215428|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
156853088|NCT00176462|566215427|FG000|Induction (4 Weeks)|Death|1|||
156853089|NCT00176462|566215428|FG001|Induction (4 Weeks)|Death|2|||
156853090|NCT00176462|566215427|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
156853091|NCT00176462|566215428|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
156853092|NCT00176462|566215427|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
156853093|NCT00176462|566215428|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
156853094|NCT00176462|566215427|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
156853095|NCT00176462|566215428|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
156853096|NCT00176462|566215427|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
156853097|NCT00176462|566215428|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
156853098|NCT00176462|566215427|FG000|Consolidation (12 Weeks)|Not documented|0|||
156853099|NCT00176462|566215428|FG001|Consolidation (12 Weeks)|Not documented|1|||
156853100|NCT00176462|566215427|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
156853101|NCT00176462|566215428|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
156853102|NCT00176462|566215427|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
156853103|NCT00176462|566215428|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
156853124|NCT02539797|566217785|FG000|Overall Study|Lost to Follow-up|0|||
156853125|NCT02539797|566217786|FG001|Overall Study|Lost to Follow-up|1|||
156853126|NCT02539797|566217787|FG002|Overall Study|Lost to Follow-up|0|||
156853127|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
156853128|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
156853129|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
156853130|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
156853131|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
156853132|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
156853133|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
156853134|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
156853135|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
156853136|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
156853137|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
156853138|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
156853139|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
156853140|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
156853141|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
156853142|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
156853143|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
156853144|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
156342227|NCT01338792|564352586|FG000|Overall Study|Death|1|||
156853145|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
156853146|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
156342228|NCT01338792|564352586|FG000|Overall Study|Withdrawal by Subject|1|||
156853147|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
156853148|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
156853149|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
156853150|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
156853151|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
156853152|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
156853153|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
156853154|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
156853155|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
156853156|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
156853157|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
156853158|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
156853159|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
156853160|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
156853161|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
156853162|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
156853163|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
156853164|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
156853165|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
156853166|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
156853167|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156853168|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156853169|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
156853170|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
156853171|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156853172|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156853173|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156853174|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
156853175|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156853176|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156853177|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156853178|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156853179|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
156853180|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
156853181|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156853182|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
156853183|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
156853184|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
156853185|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
156342229|NCT01652703|564352587|FG000|Overall Study|Withdrawal by Subject|0|||
156342230|NCT01652703|564352588|FG001|Overall Study|Withdrawal by Subject|1|||
156472579|NCT03732807|564825523|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
156472580|NCT03732807|564825524|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
156472581|NCT03732807|564825525|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
156472582|NCT03732807|564825526|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
156342231|NCT01652703|564352589|FG002|Overall Study|Withdrawal by Subject|3|||
156342232|NCT01652703|564352590|FG003|Overall Study|Withdrawal by Subject|1|||
156342233|NCT01652703|564352591|FG004|Overall Study|Withdrawal by Subject|0|||
156853186|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
156853187|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156853188|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156853189|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
156853190|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
156853191|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156853192|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156853193|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156853194|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
156853195|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
156853196|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156853197|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156853198|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156853199|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
156853200|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
156853201|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156853202|NCT02831764|566217788|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156853203|NCT02831764|566217789|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156853204|NCT02831764|566217790|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156853205|NCT02831764|566217791|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156853206|NCT02831764|566217792|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
156853207|NCT02831764|566217788|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156853208|NCT02831764|566217789|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156853209|NCT02831764|566217790|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156853210|NCT02831764|566217791|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156853211|NCT02831764|566217792|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
156853212|NCT02831764|566217788|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156853213|NCT02831764|566217789|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156853214|NCT02831764|566217790|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156853215|NCT02831764|566217791|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156853216|NCT02831764|566217792|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
156853217|NCT02831764|566217788|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156853218|NCT02831764|566217789|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156853219|NCT02831764|566217790|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156853220|NCT02831764|566217791|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156853221|NCT02831764|566217792|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
156853222|NCT02796677|566217798|FG000|Overall Study|Adverse Event|11|||
156853223|NCT02796677|566217799|FG001|Overall Study|Adverse Event|22|||
156853224|NCT02796677|566217800|FG002|Overall Study|Adverse Event|14|||
156853225|NCT02796677|566217801|FG003|Overall Study|Adverse Event|14|||
156853226|NCT02796677|566217798|FG000|Overall Study|Protocol Violation|7|||
156853227|NCT02796677|566217799|FG001|Overall Study|Protocol Violation|5|||
156853228|NCT02796677|566217800|FG002|Overall Study|Protocol Violation|4|||
156853229|NCT02796677|566217801|FG003|Overall Study|Protocol Violation|8|||
156853230|NCT02796677|566217798|FG000|Overall Study|Lost to Follow-up|1|||
156853231|NCT02796677|566217799|FG001|Overall Study|Lost to Follow-up|5|||
156853232|NCT02796677|566217800|FG002|Overall Study|Lost to Follow-up|2|||
156853233|NCT02796677|566217801|FG003|Overall Study|Lost to Follow-up|2|||
156853234|NCT02796677|566217798|FG000|Overall Study|Lack of Efficacy|7|||
156853235|NCT02796677|566217799|FG001|Overall Study|Lack of Efficacy|9|||
156853236|NCT02796677|566217800|FG002|Overall Study|Lack of Efficacy|14|||
156853237|NCT02796677|566217801|FG003|Overall Study|Lack of Efficacy|20|||
156853238|NCT02796677|566217798|FG000|Overall Study|Withdrawal by Subject|4|||
156853239|NCT02796677|566217799|FG001|Overall Study|Withdrawal by Subject|14|||
156853240|NCT02796677|566217800|FG002|Overall Study|Withdrawal by Subject|6|||
156853241|NCT02796677|566217801|FG003|Overall Study|Withdrawal by Subject|7|||
156853242|NCT02796677|566217798|FG000|Overall Study|Progressive disease|6|||
156853243|NCT02796677|566217799|FG001|Overall Study|Progressive disease|15|||
156853244|NCT02796677|566217800|FG002|Overall Study|Progressive disease|13|||
156853245|NCT02796677|566217801|FG003|Overall Study|Progressive disease|18|||
156853246|NCT02796677|566217798|FG000|Overall Study|Reason not mentioned|2|||
156853247|NCT02796677|566217799|FG001|Overall Study|Reason not mentioned|3|||
156853248|NCT02796677|566217800|FG002|Overall Study|Reason not mentioned|0|||
156853249|NCT02796677|566217801|FG003|Overall Study|Reason not mentioned|5|||
156853250|NCT04002960|566217803|FG000|Overall Study|Withdrawn prior to Completion|2|||
156342234|NCT01652703|564352592|FG005|Overall Study|Withdrawal by Subject|1|||
156853251|NCT00961181|566217804|FG000|Overall Study|Death|2|||
156853252|NCT00961181|566217804|FG000|Overall Study|Withdrawal by Subject|2|||
156853253|NCT00961181|566217804|FG000|Overall Study|Lost to Follow-up|1|||
156853254|NCT01777308|566217807|FG000|Overall Study|Withdrawal by Subject|5|||
156853255|NCT01777308|566217808|FG001|Overall Study|Withdrawal by Subject|1|||
156853256|NCT01777308|566217807|FG000|Overall Study|Migrated/moved from study area|1|||
156853257|NCT01777308|566217808|FG001|Overall Study|Migrated/moved from study area|0|||
156853258|NCT01777308|566217807|FG000|Overall Study|Lost to Follow-up|7|||
156853259|NCT01777308|566217808|FG001|Overall Study|Lost to Follow-up|2|||
156853260|NCT01777308|566217807|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
156853261|NCT01777308|566217808|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
156853262|NCT03212326|566217809|FG000|Overall Study|Physician Decision|4|||
156853263|NCT00383786|566217821|FG000|Overall Study|Protocol Violation|2|||
156853264|NCT00383786|566217822|FG001|Overall Study|Protocol Violation|6|||
156853265|NCT00383786|566217821|FG000|Overall Study|Withdrawal by Subject|2|||
156853266|NCT00383786|566217822|FG001|Overall Study|Withdrawal by Subject|5|||
156853267|NCT00383786|566217821|FG000|Overall Study|Physician Decision|0|||
156853268|NCT00383786|566217822|FG001|Overall Study|Physician Decision|1|||
156853269|NCT02544321|566217829|FG000|Overall Study|Withdrawal by Subject|1|||
156853270|NCT02544321|566217830|FG001|Overall Study|Withdrawal by Subject|2|||
156853271|NCT02544321|566217829|FG000|Overall Study|Adverse Event|1|||
156853272|NCT02544321|566217830|FG001|Overall Study|Adverse Event|1|||
156853273|NCT02544321|566217829|FG000|Overall Study|Protocol Violation|0|||
156853274|NCT02544321|566217830|FG001|Overall Study|Protocol Violation|1|||
156853275|NCT01517750|566217831|FG000|Overall Study|Lost to Follow-up|1|||
156853276|NCT01517750|566217832|FG001|Overall Study|Lost to Follow-up|2|||
156853277|NCT01517750|566217833|FG002|Overall Study|Lost to Follow-up|4|||
156853278|NCT01517750|566217834|FG003|Overall Study|Lost to Follow-up|1|||
156853279|NCT01307319|566217835|FG000|Overall Study|Adverse Event|2|||
156853280|NCT01307319|566217836|FG001|Overall Study|Adverse Event|2|||
156853281|NCT01307319|566217837|FG002|Overall Study|Adverse Event|1|||
156853282|NCT01307319|566217835|FG000|Overall Study|Lost to Follow-up|1|||
156853283|NCT01307319|566217836|FG001|Overall Study|Lost to Follow-up|0|||
156853284|NCT01307319|566217837|FG002|Overall Study|Lost to Follow-up|1|||
156853285|NCT01307319|566217835|FG000|Overall Study|Protocol Violation|1|||
156853286|NCT01307319|566217836|FG001|Overall Study|Protocol Violation|1|||
156853287|NCT01307319|566217837|FG002|Overall Study|Protocol Violation|0|||
156853288|NCT01307319|566217835|FG000|Overall Study|Withdrawal by Subject|0|||
156853289|NCT01307319|566217836|FG001|Overall Study|Withdrawal by Subject|1|||
156853290|NCT01307319|566217837|FG002|Overall Study|Withdrawal by Subject|2|||
156853291|NCT01307319|566217835|FG000|Overall Study|Other|0|||
156853292|NCT01307319|566217836|FG001|Overall Study|Other|4|||
156853293|NCT01307319|566217837|FG002|Overall Study|Other|3|||
156853294|NCT02735239|566217838|FG000|Overall Study|Adverse Event|0|||
156853295|NCT02735239|566217839|FG001|Overall Study|Adverse Event|0|||
156853296|NCT02735239|566217840|FG002|Overall Study|Adverse Event|4|||
156853297|NCT02735239|566217841|FG003|Overall Study|Adverse Event|0|||
156853298|NCT02735239|566217842|FG004|Overall Study|Adverse Event|0|||
156853299|NCT02735239|566217843|FG005|Overall Study|Adverse Event|0|||
156853300|NCT02735239|566217838|FG000|Overall Study|Death|1|||
156853301|NCT02735239|566217839|FG001|Overall Study|Death|1|||
156853302|NCT02735239|566217840|FG002|Overall Study|Death|0|||
156853303|NCT02735239|566217841|FG003|Overall Study|Death|0|||
156853304|NCT02735239|566217842|FG004|Overall Study|Death|0|||
156853305|NCT02735239|566217843|FG005|Overall Study|Death|0|||
156853306|NCT02735239|566217838|FG000|Overall Study|Physician Decision|0|||
156853307|NCT02735239|566217839|FG001|Overall Study|Physician Decision|0|||
156853308|NCT02735239|566217840|FG002|Overall Study|Physician Decision|1|||
156853309|NCT02735239|566217841|FG003|Overall Study|Physician Decision|0|||
156853310|NCT02735239|566217842|FG004|Overall Study|Physician Decision|0|||
156853311|NCT02735239|566217843|FG005|Overall Study|Physician Decision|0|||
156853312|NCT02735239|566217838|FG000|Overall Study|Progressive disease|3|||
156853313|NCT02735239|566217839|FG001|Overall Study|Progressive disease|1|||
156853314|NCT02735239|566217840|FG002|Overall Study|Progressive disease|3|||
156853315|NCT02735239|566217841|FG003|Overall Study|Progressive disease|0|||
156853316|NCT02735239|566217842|FG004|Overall Study|Progressive disease|0|||
156853317|NCT02735239|566217843|FG005|Overall Study|Progressive disease|2|||
156853318|NCT02735239|566217838|FG000|Overall Study|Withdrawal by Subject|0|||
156853319|NCT02735239|566217839|FG001|Overall Study|Withdrawal by Subject|1|||
156853320|NCT02735239|566217840|FG002|Overall Study|Withdrawal by Subject|0|||
156853321|NCT02735239|566217841|FG003|Overall Study|Withdrawal by Subject|0|||
156853322|NCT02735239|566217842|FG004|Overall Study|Withdrawal by Subject|0|||
156853323|NCT02735239|566217843|FG005|Overall Study|Withdrawal by Subject|0|||
156342235|NCT01652703|564352587|FG000|Overall Study|Other|0|||
156853324|NCT00527735|566217847|FG000|Overall Study|Disease progression|47|||
156342236|NCT01652703|564352588|FG001|Overall Study|Other|0|||
156853325|NCT00527735|566217848|FG001|Overall Study|Disease progression|61|||
156342237|NCT01652703|564352589|FG002|Overall Study|Other|0|||
156853326|NCT00527735|566217849|FG002|Overall Study|Disease progression|53|||
156853327|NCT00527735|566217847|FG000|Overall Study|Death|23|||
156853328|NCT00527735|566217848|FG001|Overall Study|Death|13|||
156853329|NCT00527735|566217849|FG002|Overall Study|Death|15|||
156853330|NCT00527735|566217847|FG000|Overall Study|Completed treatment in treatment phase|14|||
156853331|NCT00527735|566217848|FG001|Overall Study|Completed treatment in treatment phase|13|||
156853332|NCT00527735|566217849|FG002|Overall Study|Completed treatment in treatment phase|18|||
156853333|NCT00527735|566217847|FG000|Overall Study|Adverse Event|10|||
156853334|NCT00527735|566217848|FG001|Overall Study|Adverse Event|6|||
156853335|NCT00527735|566217849|FG002|Overall Study|Adverse Event|7|||
156853336|NCT00527735|566217847|FG000|Overall Study|Not identified|5|||
156853337|NCT00527735|566217848|FG001|Overall Study|Not identified|5|||
156853338|NCT00527735|566217849|FG002|Overall Study|Not identified|5|||
156853339|NCT00527735|566217847|FG000|Overall Study|Withdrawal by Subject|5|||
156853340|NCT00527735|566217848|FG001|Overall Study|Withdrawal by Subject|4|||
156853341|NCT00527735|566217849|FG002|Overall Study|Withdrawal by Subject|3|||
156853342|NCT00527735|566217847|FG000|Overall Study|No longer met study criteria|2|||
156853343|NCT00527735|566217848|FG001|Overall Study|No longer met study criteria|2|||
156853344|NCT00527735|566217849|FG002|Overall Study|No longer met study criteria|1|||
156853345|NCT00527735|566217847|FG000|Overall Study|Lost to Follow-up|0|||
156853346|NCT00527735|566217848|FG001|Overall Study|Lost to Follow-up|0|||
156853347|NCT00527735|566217849|FG002|Overall Study|Lost to Follow-up|3|||
156853348|NCT00527735|566217847|FG000|Overall Study|Poor compliance or noncompliance|0|||
156853349|NCT00527735|566217848|FG001|Overall Study|Poor compliance or noncompliance|1|||
156853350|NCT00527735|566217849|FG002|Overall Study|Poor compliance or noncompliance|1|||
156853351|NCT00527735|566217847|FG000|Overall Study|Completed treatment during maintenance|2|||
156853352|NCT00527735|566217848|FG001|Overall Study|Completed treatment during maintenance|2|||
156853353|NCT00527735|566217849|FG002|Overall Study|Completed treatment during maintenance|1|||
156853354|NCT01855412|566217850|FG000|Overall Study|Death|77|||
156853355|NCT01855412|566217851|FG001|Overall Study|Death|123|||
156853356|NCT01855412|566217852|FG002|Overall Study|Death|30|||
156853357|NCT01855412|566217850|FG000|Overall Study|Lost to Follow-up|28|||
156853358|NCT01855412|566217851|FG001|Overall Study|Lost to Follow-up|46|||
156853359|NCT01855412|566217852|FG002|Overall Study|Lost to Follow-up|15|||
156853360|NCT01855412|566217850|FG000|Overall Study|Withdrawal by Subject|77|||
156853361|NCT01855412|566217851|FG001|Overall Study|Withdrawal by Subject|123|||
156853362|NCT01855412|566217852|FG002|Overall Study|Withdrawal by Subject|24|||
156853363|NCT01855412|566217850|FG000|Overall Study|Physician Decision|25|||
156853364|NCT01855412|566217851|FG001|Overall Study|Physician Decision|31|||
156853365|NCT01855412|566217852|FG002|Overall Study|Physician Decision|3|||
156853366|NCT01855412|566217850|FG000|Overall Study|Site Closure|4|||
156853367|NCT01855412|566217851|FG001|Overall Study|Site Closure|18|||
156853368|NCT01855412|566217852|FG002|Overall Study|Site Closure|1|||
156853369|NCT01855412|566217850|FG000|Overall Study|Reason not Specified|1|||
156853370|NCT01855412|566217851|FG001|Overall Study|Reason not Specified|2|||
156853371|NCT01855412|566217852|FG002|Overall Study|Reason not Specified|3|||
156853372|NCT00404651|566217853|FG000|Overall Study|Serious Adverse Event|0|||
156853373|NCT00404651|566217854|FG001|Overall Study|Serious Adverse Event|0|||
156853374|NCT00404651|566217855|FG002|Overall Study|Serious Adverse Event|2|||
156853375|NCT00404651|566217856|FG003|Overall Study|Serious Adverse Event|0|||
156853376|NCT00404651|566217853|FG000|Overall Study|Protocol Violation|10|||
156853377|NCT00404651|566217854|FG001|Overall Study|Protocol Violation|5|||
156853378|NCT00404651|566217855|FG002|Overall Study|Protocol Violation|14|||
156853379|NCT00404651|566217856|FG003|Overall Study|Protocol Violation|5|||
156853380|NCT00404651|566217853|FG000|Overall Study|Lost to Follow-up|15|||
156853381|NCT00404651|566217854|FG001|Overall Study|Lost to Follow-up|11|||
156853382|NCT00404651|566217855|FG002|Overall Study|Lost to Follow-up|13|||
156853383|NCT00404651|566217856|FG003|Overall Study|Lost to Follow-up|10|||
156853384|NCT00404651|566217853|FG000|Overall Study|Withdrawal by Subject|14|||
156853385|NCT00404651|566217854|FG001|Overall Study|Withdrawal by Subject|12|||
156853386|NCT00404651|566217855|FG002|Overall Study|Withdrawal by Subject|16|||
156853387|NCT00404651|566217856|FG003|Overall Study|Withdrawal by Subject|6|||
156853388|NCT03347123|566217859|FG000|Overall Study|Death|1|||
156853389|NCT03347123|566217860|FG001|Overall Study|Death|2|||
156342238|NCT01652703|564352590|FG003|Overall Study|Other|1|||
156853390|NCT03347123|566217861|FG002|Overall Study|Death|0|||
156342239|NCT01652703|564352591|FG004|Overall Study|Other|1|||
156342240|NCT01652703|564352592|FG005|Overall Study|Other|1|||
156342241|NCT00062374|564352596|FG000|Overall Study|Not treated|12|||
156853391|NCT03347123|566217862|FG003|Overall Study|Death|0|||
156853392|NCT03347123|566217863|FG004|Overall Study|Death|0|||
156853393|NCT03347123|566217864|FG005|Overall Study|Death|0|||
156342242|NCT02155608|564352597|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
156853394|NCT03347123|566217865|FG006|Overall Study|Death|0|||
156853395|NCT03347123|566217859|FG000|Overall Study|Withdrawal by Subject|1|||
156853396|NCT03347123|566217860|FG001|Overall Study|Withdrawal by Subject|0|||
156853397|NCT03347123|566217861|FG002|Overall Study|Withdrawal by Subject|0|||
156853398|NCT03347123|566217862|FG003|Overall Study|Withdrawal by Subject|0|||
156853399|NCT03347123|566217863|FG004|Overall Study|Withdrawal by Subject|0|||
156853400|NCT03347123|566217864|FG005|Overall Study|Withdrawal by Subject|0|||
156853401|NCT03347123|566217865|FG006|Overall Study|Withdrawal by Subject|0|||
156853402|NCT03347123|566217859|FG000|Overall Study|Reason not Specified|3|||
156853403|NCT03347123|566217860|FG001|Overall Study|Reason not Specified|4|||
156853404|NCT03347123|566217861|FG002|Overall Study|Reason not Specified|0|||
156853405|NCT03347123|566217862|FG003|Overall Study|Reason not Specified|0|||
156853406|NCT03347123|566217863|FG004|Overall Study|Reason not Specified|0|||
156853407|NCT03347123|566217864|FG005|Overall Study|Reason not Specified|0|||
156853408|NCT03347123|566217865|FG006|Overall Study|Reason not Specified|0|||
156853409|NCT01276639|566217874|FG000|Week 0 to 16|Death|1|||
156853410|NCT01276639|566217875|FG001|Week 0 to 16|Death|0|||
156853411|NCT01276639|566217876|FG002|Week 0 to 16|Death|0|||
156853412|NCT01276639|566217877|FG003|Week 0 to 16|Death|0|||
156853413|NCT01276639|566217878|FG004|Week 0 to 16|Death|0|||
156853414|NCT01276639|566217874|FG000|Week 0 to 16|Adverse Event|11|||
156853415|NCT01276639|566217875|FG001|Week 0 to 16|Adverse Event|8|||
156853416|NCT01276639|566217876|FG002|Week 0 to 16|Adverse Event|11|||
156853417|NCT01276639|566217877|FG003|Week 0 to 16|Adverse Event|0|||
156853418|NCT01276639|566217878|FG004|Week 0 to 16|Adverse Event|0|||
156853419|NCT01276639|566217874|FG000|Week 0 to 16|Lack of Efficacy|20|||
156853420|NCT01276639|566217875|FG001|Week 0 to 16|Lack of Efficacy|15|||
156853421|NCT01276639|566217876|FG002|Week 0 to 16|Lack of Efficacy|25|||
156853422|NCT01276639|566217877|FG003|Week 0 to 16|Lack of Efficacy|0|||
156853423|NCT01276639|566217878|FG004|Week 0 to 16|Lack of Efficacy|0|||
156853424|NCT01276639|566217874|FG000|Week 0 to 16|Lost to Follow-up|3|||
156853425|NCT01276639|566217875|FG001|Week 0 to 16|Lost to Follow-up|5|||
156853426|NCT01276639|566217876|FG002|Week 0 to 16|Lost to Follow-up|3|||
156853427|NCT01276639|566217877|FG003|Week 0 to 16|Lost to Follow-up|0|||
156853428|NCT01276639|566217878|FG004|Week 0 to 16|Lost to Follow-up|0|||
156853429|NCT01276639|566217874|FG000|Week 0 to 16|Withdrawal by Subject|8|||
156853430|NCT01276639|566217875|FG001|Week 0 to 16|Withdrawal by Subject|5|||
156853431|NCT01276639|566217876|FG002|Week 0 to 16|Withdrawal by Subject|4|||
156853432|NCT01276639|566217877|FG003|Week 0 to 16|Withdrawal by Subject|0|||
156853433|NCT01276639|566217878|FG004|Week 0 to 16|Withdrawal by Subject|0|||
156853434|NCT01276639|566217874|FG000|Week 0 to 16|Other|7|||
156853435|NCT01276639|566217875|FG001|Week 0 to 16|Other|7|||
156853436|NCT01276639|566217876|FG002|Week 0 to 16|Other|2|||
156853437|NCT01276639|566217877|FG003|Week 0 to 16|Other|0|||
156853438|NCT01276639|566217878|FG004|Week 0 to 16|Other|0|||
156853439|NCT01276639|566217874|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
156853440|NCT01276639|566217875|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
156853441|NCT01276639|566217876|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
156853442|NCT01276639|566217877|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
156853443|NCT01276639|566217878|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
156853444|NCT01276639|566217874|FG000|Week 16 to 52|Death|1|||
156853445|NCT01276639|566217875|FG001|Week 16 to 52|Death|0|||
156853446|NCT01276639|566217876|FG002|Week 16 to 52|Death|0|||
156853447|NCT01276639|566217877|FG003|Week 16 to 52|Death|0|||
156853448|NCT01276639|566217878|FG004|Week 16 to 52|Death|0|||
156853449|NCT01276639|566217874|FG000|Week 16 to 52|Adverse Event|10|||
156853450|NCT01276639|566217875|FG001|Week 16 to 52|Adverse Event|13|||
156853451|NCT01276639|566217876|FG002|Week 16 to 52|Adverse Event|0|||
156853452|NCT01276639|566217877|FG003|Week 16 to 52|Adverse Event|1|||
156853453|NCT01276639|566217878|FG004|Week 16 to 52|Adverse Event|3|||
156853454|NCT01276639|566217874|FG000|Week 16 to 52|Lack of Efficacy|99|||
156853455|NCT01276639|566217875|FG001|Week 16 to 52|Lack of Efficacy|71|||
156853456|NCT01276639|566217876|FG002|Week 16 to 52|Lack of Efficacy|0|||
156853457|NCT01276639|566217877|FG003|Week 16 to 52|Lack of Efficacy|14|||
156853458|NCT01276639|566217878|FG004|Week 16 to 52|Lack of Efficacy|13|||
156853459|NCT01276639|566217874|FG000|Week 16 to 52|Lost to Follow-up|3|||
156853460|NCT01276639|566217875|FG001|Week 16 to 52|Lost to Follow-up|1|||
156853461|NCT01276639|566217876|FG002|Week 16 to 52|Lost to Follow-up|0|||
156853462|NCT01276639|566217877|FG003|Week 16 to 52|Lost to Follow-up|0|||
156853463|NCT01276639|566217878|FG004|Week 16 to 52|Lost to Follow-up|1|||
156853464|NCT01276639|566217874|FG000|Week 16 to 52|Withdrawal by Subject|4|||
156853465|NCT01276639|566217875|FG001|Week 16 to 52|Withdrawal by Subject|4|||
156853466|NCT01276639|566217876|FG002|Week 16 to 52|Withdrawal by Subject|0|||
156342243|NCT02155608|564352598|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
156342244|NCT02155608|564352597|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
156472583|NCT03732807|564825527|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
156853467|NCT01276639|566217877|FG003|Week 16 to 52|Withdrawal by Subject|0|||
156853468|NCT01276639|566217878|FG004|Week 16 to 52|Withdrawal by Subject|1|||
156853469|NCT01276639|566217874|FG000|Week 16 to 52|Other|10|||
156853470|NCT01276639|566217875|FG001|Week 16 to 52|Other|12|||
156853471|NCT01276639|566217876|FG002|Week 16 to 52|Other|0|||
156853472|NCT01276639|566217877|FG003|Week 16 to 52|Other|1|||
156853473|NCT01276639|566217878|FG004|Week 16 to 52|Other|3|||
156853474|NCT03431441|566217879|FG000|Overall Study|Withdrawal by Subject|2|||
156853475|NCT03431441|566217879|FG000|Overall Study|Adverse Event|2|||
156853476|NCT03431441|566217879|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
156853477|NCT05030350|566217883|FG000|Overall Study|Adverse Event|13|||
156853478|NCT05030350|566217883|FG000|Overall Study|Lack of Efficacy|8|||
156853479|NCT05030350|566217883|FG000|Overall Study|Lost to Follow-up|35|||
156853480|NCT05030350|566217883|FG000|Overall Study|Pregnancy|2|||
156853481|NCT05030350|566217883|FG000|Overall Study|Protocol Violation|2|||
156853482|NCT05030350|566217883|FG000|Overall Study|Withdrawal by Subject|60|||
156853483|NCT05030350|566217883|FG000|Overall Study|Study terminated by sponsor|349|||
156853484|NCT05030350|566217883|FG000|Overall Study|Positive Drug Screen|4|||
156853485|NCT05030350|566217883|FG000|Overall Study|Other|8|||
156853486|NCT03654690|566217884|FG000|Overall Study|Withdrawal by Subject|1|||
156853487|NCT03654690|566217885|FG001|Overall Study|Withdrawal by Subject|0|||
156853488|NCT03654690|566217886|FG002|Overall Study|Withdrawal by Subject|0|||
156853489|NCT02711137|566217887|FG000|Overall Study|Death|1|||
156853490|NCT02711137|566217888|FG001|Overall Study|Death|4|||
156853491|NCT02711137|566217889|FG002|Overall Study|Death|5|||
156853492|NCT02711137|566217890|FG003|Overall Study|Death|5|||
156853493|NCT02711137|566217891|FG004|Overall Study|Death|3|||
156853494|NCT02711137|566217892|FG005|Overall Study|Death|1|||
156853495|NCT02711137|566217893|FG006|Overall Study|Death|61|||
156853496|NCT02711137|566217894|FG007|Overall Study|Death|3|||
156853497|NCT02711137|566217895|FG008|Overall Study|Death|0|||
156853498|NCT02711137|566217896|FG009|Overall Study|Death|1|||
156853499|NCT02711137|566217897|FG010|Overall Study|Death|1|||
156853500|NCT02711137|566217898|FG011|Overall Study|Death|1|||
156853501|NCT02711137|566217899|FG012|Overall Study|Death|0|||
156853502|NCT02711137|566217900|FG013|Overall Study|Death|0|||
156853503|NCT02711137|566217901|FG014|Overall Study|Death|0|||
156853504|NCT02711137|566217887|FG000|Overall Study|Study Terminated by Sponsor|0|||
156853505|NCT02711137|566217888|FG001|Overall Study|Study Terminated by Sponsor|0|||
156853506|NCT02711137|566217889|FG002|Overall Study|Study Terminated by Sponsor|1|||
156853507|NCT02711137|566217890|FG003|Overall Study|Study Terminated by Sponsor|0|||
156853508|NCT02711137|566217891|FG004|Overall Study|Study Terminated by Sponsor|0|||
156853509|NCT02711137|566217892|FG005|Overall Study|Study Terminated by Sponsor|0|||
156853510|NCT02711137|566217893|FG006|Overall Study|Study Terminated by Sponsor|1|||
156853511|NCT02711137|566217894|FG007|Overall Study|Study Terminated by Sponsor|0|||
156853512|NCT02711137|566217895|FG008|Overall Study|Study Terminated by Sponsor|0|||
156853513|NCT02711137|566217896|FG009|Overall Study|Study Terminated by Sponsor|0|||
156853514|NCT02711137|566217897|FG010|Overall Study|Study Terminated by Sponsor|0|||
156853515|NCT02711137|566217898|FG011|Overall Study|Study Terminated by Sponsor|0|||
156853516|NCT02711137|566217899|FG012|Overall Study|Study Terminated by Sponsor|0|||
156853517|NCT02711137|566217900|FG013|Overall Study|Study Terminated by Sponsor|0|||
156853518|NCT02711137|566217901|FG014|Overall Study|Study Terminated by Sponsor|0|||
156853519|NCT02711137|566217887|FG000|Overall Study|Physician Decision|1|||
156853520|NCT02711137|566217888|FG001|Overall Study|Physician Decision|0|||
156853521|NCT02711137|566217889|FG002|Overall Study|Physician Decision|2|||
156853522|NCT02711137|566217890|FG003|Overall Study|Physician Decision|1|||
156853523|NCT02711137|566217891|FG004|Overall Study|Physician Decision|1|||
156853524|NCT02711137|566217892|FG005|Overall Study|Physician Decision|0|||
156853525|NCT02711137|566217893|FG006|Overall Study|Physician Decision|12|||
156853526|NCT02711137|566217894|FG007|Overall Study|Physician Decision|2|||
156853527|NCT02711137|566217895|FG008|Overall Study|Physician Decision|1|||
156853528|NCT02711137|566217896|FG009|Overall Study|Physician Decision|1|||
156853529|NCT02711137|566217897|FG010|Overall Study|Physician Decision|3|||
156853530|NCT02711137|566217898|FG011|Overall Study|Physician Decision|2|||
156853531|NCT02711137|566217899|FG012|Overall Study|Physician Decision|1|||
156853532|NCT02711137|566217900|FG013|Overall Study|Physician Decision|1|||
156853533|NCT02711137|566217901|FG014|Overall Study|Physician Decision|2|||
156853534|NCT02711137|566217887|FG000|Overall Study|Other|0|||
156853535|NCT02711137|566217888|FG001|Overall Study|Other|1|||
156853536|NCT02711137|566217889|FG002|Overall Study|Other|0|||
156853537|NCT02711137|566217890|FG003|Overall Study|Other|0|||
156853538|NCT02711137|566217891|FG004|Overall Study|Other|0|||
156853539|NCT02711137|566217892|FG005|Overall Study|Other|0|||
156853540|NCT02711137|566217893|FG006|Overall Study|Other|3|||
156853541|NCT02711137|566217894|FG007|Overall Study|Other|0|||
156853542|NCT02711137|566217895|FG008|Overall Study|Other|0|||
156853543|NCT02711137|566217896|FG009|Overall Study|Other|0|||
156853544|NCT02711137|566217897|FG010|Overall Study|Other|0|||
156853545|NCT02711137|566217898|FG011|Overall Study|Other|0|||
156853546|NCT02711137|566217899|FG012|Overall Study|Other|0|||
156853547|NCT02711137|566217900|FG013|Overall Study|Other|0|||
156853548|NCT02711137|566217901|FG014|Overall Study|Other|1|||
156853549|NCT02711137|566217887|FG000|Overall Study|Withdrawal by Subject|1|||
156853550|NCT02711137|566217888|FG001|Overall Study|Withdrawal by Subject|0|||
156853551|NCT02711137|566217889|FG002|Overall Study|Withdrawal by Subject|0|||
156853552|NCT02711137|566217890|FG003|Overall Study|Withdrawal by Subject|1|||
156853553|NCT02711137|566217891|FG004|Overall Study|Withdrawal by Subject|1|||
156853554|NCT02711137|566217892|FG005|Overall Study|Withdrawal by Subject|0|||
156853555|NCT02711137|566217893|FG006|Overall Study|Withdrawal by Subject|7|||
156853556|NCT02711137|566217894|FG007|Overall Study|Withdrawal by Subject|0|||
156853557|NCT02711137|566217895|FG008|Overall Study|Withdrawal by Subject|0|||
156853558|NCT02711137|566217896|FG009|Overall Study|Withdrawal by Subject|0|||
156853559|NCT02711137|566217897|FG010|Overall Study|Withdrawal by Subject|0|||
156853560|NCT02711137|566217898|FG011|Overall Study|Withdrawal by Subject|0|||
156853561|NCT02711137|566217899|FG012|Overall Study|Withdrawal by Subject|0|||
156853562|NCT02711137|566217900|FG013|Overall Study|Withdrawal by Subject|1|||
156853563|NCT02711137|566217901|FG014|Overall Study|Withdrawal by Subject|0|||
156853564|NCT02711137|566217887|FG000|Overall Study|Lost to Follow-up|1|||
156853565|NCT02711137|566217888|FG001|Overall Study|Lost to Follow-up|0|||
156853566|NCT02711137|566217889|FG002|Overall Study|Lost to Follow-up|0|||
156853567|NCT02711137|566217890|FG003|Overall Study|Lost to Follow-up|0|||
156853568|NCT02711137|566217891|FG004|Overall Study|Lost to Follow-up|0|||
156853569|NCT02711137|566217892|FG005|Overall Study|Lost to Follow-up|0|||
156853570|NCT02711137|566217893|FG006|Overall Study|Lost to Follow-up|2|||
156853571|NCT02711137|566217894|FG007|Overall Study|Lost to Follow-up|0|||
156853572|NCT02711137|566217895|FG008|Overall Study|Lost to Follow-up|0|||
156853573|NCT02711137|566217896|FG009|Overall Study|Lost to Follow-up|0|||
156853574|NCT02711137|566217897|FG010|Overall Study|Lost to Follow-up|0|||
156853575|NCT02711137|566217898|FG011|Overall Study|Lost to Follow-up|0|||
156853576|NCT02711137|566217899|FG012|Overall Study|Lost to Follow-up|0|||
156853577|NCT02711137|566217900|FG013|Overall Study|Lost to Follow-up|0|||
156853578|NCT02711137|566217901|FG014|Overall Study|Lost to Follow-up|0|||
156853579|NCT03985761|566217902|FG000|Overall Study|Withdrawal by Subject|2|||
156853580|NCT03985761|566217903|FG001|Overall Study|Withdrawal by Subject|3|||
156853581|NCT03400852|566217904|FG000|Blinded Treatment Period|Physician Decision|0|||
156853582|NCT03400852|566217905|FG001|Blinded Treatment Period|Physician Decision|1|||
156853583|NCT03400852|566217906|FG002|Blinded Treatment Period|Physician Decision|0|||
156853584|NCT03400852|566217904|FG000|Blinded Treatment Period|Adverse Event|1|||
156853585|NCT03400852|566217905|FG001|Blinded Treatment Period|Adverse Event|1|||
156853586|NCT03400852|566217906|FG002|Blinded Treatment Period|Adverse Event|0|||
156853587|NCT03400852|566217904|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
156853588|NCT03400852|566217905|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
156853589|NCT03400852|566217906|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
156853590|NCT03400852|566217904|FG000|Open Label Period|Physician Decision|0|||
156853591|NCT03400852|566217905|FG001|Open Label Period|Physician Decision|0|||
156853592|NCT03400852|566217906|FG002|Open Label Period|Physician Decision|1|||
156853593|NCT03400852|566217904|FG000|Open Label Period|Study terminated by sponsor|0|||
156853594|NCT03400852|566217905|FG001|Open Label Period|Study terminated by sponsor|0|||
156853595|NCT03400852|566217906|FG002|Open Label Period|Study terminated by sponsor|21|||
156853596|NCT01285401|566217907|FG000|Overall Study|Prematurely withdrawn from the study|17|||
156853597|NCT01285401|566217908|FG001|Overall Study|Prematurely withdrawn from the study|29|||
156853598|NCT03719131|566217913|FG000|Overall Study|Death|1|||
156853599|NCT03719131|566217914|FG001|Overall Study|Death|2|||
156853600|NCT01544920|566217915|FG000|Overall Study|Adverse Event|0|||
156853601|NCT01544920|566217916|FG001|Overall Study|Adverse Event|3|||
156853602|NCT01544920|566217915|FG000|Overall Study|Death|0|||
156853603|NCT01544920|566217916|FG001|Overall Study|Death|1|||
156853604|NCT01544920|566217915|FG000|Overall Study|Lost to Follow-up|11|||
156853605|NCT01544920|566217916|FG001|Overall Study|Lost to Follow-up|12|||
156853606|NCT01544920|566217915|FG000|Overall Study|Protocol Violation|0|||
156853607|NCT01544920|566217916|FG001|Overall Study|Protocol Violation|2|||
156853608|NCT01544920|566217915|FG000|Overall Study|Physician Decision|4|||
156853609|NCT01544920|566217916|FG001|Overall Study|Physician Decision|1|||
156853610|NCT01544920|566217915|FG000|Overall Study|Withdrawal by Subject|4|||
156853611|NCT01544920|566217916|FG001|Overall Study|Withdrawal by Subject|4|||
156853612|NCT02420093|566217917|FG000|Overall Study|Withdrawal by Subject|1|||
156853613|NCT02420093|566217918|FG001|Overall Study|Withdrawal by Subject|1|||
156472584|NCT03732807|564825521|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
156472585|NCT03732807|564825522|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
156853614|NCT03244917|566217921|FG000|Overall Study|Lost to Follow-up|2|||
156853615|NCT03244917|566217922|FG001|Overall Study|Lost to Follow-up|2|||
156853616|NCT03001557|566217924|FG000|Core Phase|Randomized but not treated|0|||
156853617|NCT03001557|566217925|FG001|Core Phase|Randomized but not treated|0|||
156853618|NCT03001557|566217926|FG002|Core Phase|Randomized but not treated|1|||
156853619|NCT03001557|566217927|FG003|Core Phase|Randomized but not treated|0|||
156853620|NCT03001557|566217928|FG004|Core Phase|Randomized but not treated|0|||
156853621|NCT03001557|566217929|FG005|Core Phase|Randomized but not treated|0|||
156853622|NCT03001557|566217930|FG006|Core Phase|Randomized but not treated|0|||
156853623|NCT03001557|566217931|FG007|Core Phase|Randomized but not treated|0|||
156853624|NCT03001557|566217924|FG000|Extension Phase|Adverse Event|0|||
156853625|NCT03001557|566217925|FG001|Extension Phase|Adverse Event|0|||
156853626|NCT03001557|566217926|FG002|Extension Phase|Adverse Event|0|||
156853627|NCT03001557|566217927|FG003|Extension Phase|Adverse Event|0|||
156853628|NCT03001557|566217928|FG004|Extension Phase|Adverse Event|0|||
156853629|NCT03001557|566217929|FG005|Extension Phase|Adverse Event|2|||
156853630|NCT03001557|566217930|FG006|Extension Phase|Adverse Event|0|||
156853631|NCT03001557|566217931|FG007|Extension Phase|Adverse Event|0|||
156853632|NCT03001557|566217924|FG000|Extension Phase|Withdrawal by Subject|0|||
156472586|NCT03732807|564825523|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
156853633|NCT03001557|566217925|FG001|Extension Phase|Withdrawal by Subject|0|||
156853634|NCT03001557|566217926|FG002|Extension Phase|Withdrawal by Subject|0|||
156853635|NCT03001557|566217927|FG003|Extension Phase|Withdrawal by Subject|0|||
156853636|NCT03001557|566217928|FG004|Extension Phase|Withdrawal by Subject|0|||
156853637|NCT03001557|566217929|FG005|Extension Phase|Withdrawal by Subject|1|||
156853638|NCT03001557|566217930|FG006|Extension Phase|Withdrawal by Subject|5|||
156853639|NCT03001557|566217931|FG007|Extension Phase|Withdrawal by Subject|2|||
156853640|NCT03001557|566217924|FG000|Extension Phase|Lost to Follow-up|0|||
156853641|NCT03001557|566217925|FG001|Extension Phase|Lost to Follow-up|0|||
156853642|NCT03001557|566217926|FG002|Extension Phase|Lost to Follow-up|0|||
156853643|NCT03001557|566217927|FG003|Extension Phase|Lost to Follow-up|0|||
156853644|NCT03001557|566217928|FG004|Extension Phase|Lost to Follow-up|0|||
156853645|NCT03001557|566217929|FG005|Extension Phase|Lost to Follow-up|0|||
156853646|NCT03001557|566217930|FG006|Extension Phase|Lost to Follow-up|2|||
156853647|NCT03001557|566217931|FG007|Extension Phase|Lost to Follow-up|1|||
156853648|NCT03001557|566217924|FG000|Extension Phase|Administrative Reason|0|||
156853649|NCT03001557|566217925|FG001|Extension Phase|Administrative Reason|0|||
156853650|NCT03001557|566217926|FG002|Extension Phase|Administrative Reason|0|||
156853651|NCT03001557|566217927|FG003|Extension Phase|Administrative Reason|0|||
156853652|NCT03001557|566217928|FG004|Extension Phase|Administrative Reason|0|||
156853653|NCT03001557|566217929|FG005|Extension Phase|Administrative Reason|1|||
156853654|NCT03001557|566217930|FG006|Extension Phase|Administrative Reason|3|||
156853655|NCT03001557|566217931|FG007|Extension Phase|Administrative Reason|3|||
156853656|NCT03001557|566217924|FG000|Extension Phase|Loss of caregiver|0|||
156853657|NCT03001557|566217925|FG001|Extension Phase|Loss of caregiver|0|||
156853658|NCT03001557|566217926|FG002|Extension Phase|Loss of caregiver|0|||
156853659|NCT03001557|566217927|FG003|Extension Phase|Loss of caregiver|0|||
156853660|NCT03001557|566217928|FG004|Extension Phase|Loss of caregiver|0|||
156853661|NCT03001557|566217929|FG005|Extension Phase|Loss of caregiver|0|||
156472587|NCT03732807|564825524|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
156472588|NCT03732807|564825525|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
156472589|NCT03732807|564825526|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
156853662|NCT03001557|566217930|FG006|Extension Phase|Loss of caregiver|1|||
156853663|NCT03001557|566217931|FG007|Extension Phase|Loss of caregiver|0|||
156853664|NCT03001557|566217924|FG000|Extension Phase|Others|0|||
156853665|NCT03001557|566217925|FG001|Extension Phase|Others|0|||
156853666|NCT03001557|566217926|FG002|Extension Phase|Others|0|||
156853667|NCT03001557|566217927|FG003|Extension Phase|Others|0|||
156853668|NCT03001557|566217928|FG004|Extension Phase|Others|0|||
156853669|NCT03001557|566217929|FG005|Extension Phase|Others|1|||
156853670|NCT03001557|566217930|FG006|Extension Phase|Others|3|||
156853671|NCT03001557|566217931|FG007|Extension Phase|Others|0|||
156853672|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
156853673|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
156853674|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Death|1|||
156853675|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Death|2|||
156853676|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
156853677|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
156853678|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
156853679|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
156853680|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
156853681|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
156853682|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
156472590|NCT03732807|564825527|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
156853683|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
156853684|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
156853685|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
156853686|NCT01794000|566217932|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
156853687|NCT01794000|566217933|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156853688|NCT01272232|566217936|FG000|Weeks 0-56|Adverse Event|39|||
156853689|NCT01272232|566217937|FG001|Weeks 0-56|Adverse Event|18|||
156853690|NCT01272232|566217938|FG002|Weeks 0-56|Adverse Event|7|||
156853691|NCT01272232|566217936|FG000|Weeks 0-56|Lack of Efficacy|0|||
156853692|NCT01272232|566217937|FG001|Weeks 0-56|Lack of Efficacy|0|||
156853693|NCT01272232|566217938|FG002|Weeks 0-56|Lack of Efficacy|3|||
156853694|NCT01272232|566217936|FG000|Weeks 0-56|Protocol Violation|12|||
156853695|NCT01272232|566217937|FG001|Weeks 0-56|Protocol Violation|8|||
156853696|NCT01272232|566217938|FG002|Weeks 0-56|Protocol Violation|13|||
156853697|NCT01272232|566217936|FG000|Weeks 0-56|Withdrawal criteria|32|||
156853698|NCT01272232|566217937|FG001|Weeks 0-56|Withdrawal criteria|14|||
156853699|NCT01272232|566217938|FG002|Weeks 0-56|Withdrawal criteria|37|||
156853700|NCT01272232|566217936|FG000|Weeks 0-56|Unclassified|16|||
156853701|NCT01272232|566217937|FG001|Weeks 0-56|Unclassified|7|||
156342245|NCT02155608|564352598|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
156342246|NCT03555591|564352599|FG000|Overall Study|Protocol Violation|77|||
156853702|NCT01272232|566217938|FG002|Weeks 0-56|Unclassified|12|||
156853703|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
156853704|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
156853705|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
156853706|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
156853707|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
156853708|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
156853709|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
156853710|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
156853711|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
156853712|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
156853713|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
156853714|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
156853715|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
156853716|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
156853717|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
156853718|NCT02159066|566217939|FG000|Part I|Adverse Event|7|||
156853719|NCT02159066|566217940|FG001|Part I|Adverse Event|5|||
156853720|NCT02159066|566217941|FG002|Part I|Adverse Event|0|||
156853721|NCT02159066|566217942|FG003|Part I|Adverse Event|0|||
156853722|NCT02159066|566217943|FG004|Part I|Adverse Event|0|||
156853723|NCT02159066|566217944|FG005|Part I|Adverse Event|0|||
156853724|NCT02159066|566217939|FG000|Part I|Death|11|||
156853725|NCT02159066|566217940|FG001|Part I|Death|9|||
156853726|NCT02159066|566217941|FG002|Part I|Death|0|||
156853727|NCT02159066|566217942|FG003|Part I|Death|0|||
156853728|NCT02159066|566217943|FG004|Part I|Death|0|||
156853729|NCT02159066|566217944|FG005|Part I|Death|0|||
156853730|NCT02159066|566217939|FG000|Part I|Progressive Disease|37|||
156853731|NCT02159066|566217940|FG001|Part I|Progressive Disease|46|||
156853732|NCT02159066|566217941|FG002|Part I|Progressive Disease|0|||
156853733|NCT02159066|566217942|FG003|Part I|Progressive Disease|0|||
156853734|NCT02159066|566217943|FG004|Part I|Progressive Disease|0|||
156853735|NCT02159066|566217944|FG005|Part I|Progressive Disease|0|||
156853736|NCT02159066|566217939|FG000|Part I|New Therapy for Study Indication|5|||
156853737|NCT02159066|566217940|FG001|Part I|New Therapy for Study Indication|4|||
156853738|NCT02159066|566217941|FG002|Part I|New Therapy for Study Indication|0|||
156853739|NCT02159066|566217942|FG003|Part I|New Therapy for Study Indication|0|||
156853740|NCT02159066|566217943|FG004|Part I|New Therapy for Study Indication|0|||
156853741|NCT02159066|566217944|FG005|Part I|New Therapy for Study Indication|0|||
156853742|NCT02159066|566217939|FG000|Part I|Termination of participants from the study|3|||
156853743|NCT02159066|566217940|FG001|Part I|Termination of participants from the study|3|||
156853744|NCT02159066|566217941|FG002|Part I|Termination of participants from the study|0|||
156853745|NCT02159066|566217942|FG003|Part I|Termination of participants from the study|0|||
156853746|NCT02159066|566217943|FG004|Part I|Termination of participants from the study|0|||
156853747|NCT02159066|566217944|FG005|Part I|Termination of participants from the study|0|||
156853748|NCT02159066|566217939|FG000|Part I|Physician Decision|2|||
156853749|NCT02159066|566217940|FG001|Part I|Physician Decision|9|||
156853750|NCT02159066|566217941|FG002|Part I|Physician Decision|0|||
156853751|NCT02159066|566217942|FG003|Part I|Physician Decision|0|||
156853752|NCT02159066|566217943|FG004|Part I|Physician Decision|0|||
156853753|NCT02159066|566217944|FG005|Part I|Physician Decision|0|||
156853754|NCT02159066|566217939|FG000|Part I|Participant/Guardian Decision|9|||
156853755|NCT02159066|566217940|FG001|Part I|Participant/Guardian Decision|3|||
156853756|NCT02159066|566217941|FG002|Part I|Participant/Guardian Decision|0|||
156853757|NCT02159066|566217942|FG003|Part I|Participant/Guardian Decision|0|||
156853758|NCT02159066|566217943|FG004|Part I|Participant/Guardian Decision|0|||
156853759|NCT02159066|566217944|FG005|Part I|Participant/Guardian Decision|0|||
156853760|NCT02159066|566217939|FG000|Part I|Missing Data|1|||
156853761|NCT02159066|566217940|FG001|Part I|Missing Data|0|||
156853762|NCT02159066|566217941|FG002|Part I|Missing Data|0|||
156853763|NCT02159066|566217942|FG003|Part I|Missing Data|0|||
156853764|NCT02159066|566217943|FG004|Part I|Missing Data|0|||
156853765|NCT02159066|566217944|FG005|Part I|Missing Data|0|||
156853766|NCT02159066|566217939|FG000|Part II|Adverse Event|0|||
156853767|NCT02159066|566217940|FG001|Part II|Adverse Event|0|||
156853768|NCT02159066|566217941|FG002|Part II|Adverse Event|1|||
156853769|NCT02159066|566217942|FG003|Part II|Adverse Event|0|||
156853770|NCT02159066|566217943|FG004|Part II|Adverse Event|1|||
156853771|NCT02159066|566217944|FG005|Part II|Adverse Event|1|||
156853772|NCT02159066|566217939|FG000|Part II|Death|0|||
156853773|NCT02159066|566217940|FG001|Part II|Death|0|||
156853774|NCT02159066|566217941|FG002|Part II|Death|1|||
156853775|NCT02159066|566217942|FG003|Part II|Death|0|||
156853776|NCT02159066|566217943|FG004|Part II|Death|2|||
156853777|NCT02159066|566217944|FG005|Part II|Death|1|||
156853778|NCT02159066|566217939|FG000|Part II|Progressive Disease|0|||
156853779|NCT02159066|566217940|FG001|Part II|Progressive Disease|0|||
156853780|NCT02159066|566217941|FG002|Part II|Progressive Disease|35|||
156853781|NCT02159066|566217942|FG003|Part II|Progressive Disease|1|||
156853782|NCT02159066|566217943|FG004|Part II|Progressive Disease|7|||
156853783|NCT02159066|566217944|FG005|Part II|Progressive Disease|4|||
156853784|NCT02159066|566217939|FG000|Part II|New Therapy for Study Indication|0|||
156853785|NCT02159066|566217940|FG001|Part II|New Therapy for Study Indication|0|||
156853786|NCT02159066|566217941|FG002|Part II|New Therapy for Study Indication|0|||
156853787|NCT02159066|566217942|FG003|Part II|New Therapy for Study Indication|0|||
156853788|NCT02159066|566217943|FG004|Part II|New Therapy for Study Indication|1|||
156853789|NCT02159066|566217944|FG005|Part II|New Therapy for Study Indication|0|||
156853790|NCT02159066|566217939|FG000|Part II|Physician Decision|0|||
156853791|NCT02159066|566217940|FG001|Part II|Physician Decision|0|||
156853792|NCT02159066|566217941|FG002|Part II|Physician Decision|1|||
156853793|NCT02159066|566217942|FG003|Part II|Physician Decision|0|||
156853794|NCT02159066|566217943|FG004|Part II|Physician Decision|0|||
156853795|NCT02159066|566217944|FG005|Part II|Physician Decision|0|||
156853796|NCT02159066|566217939|FG000|Part II|Participant/Guardian Decision|0|||
156853797|NCT02159066|566217940|FG001|Part II|Participant/Guardian Decision|0|||
156853798|NCT02159066|566217941|FG002|Part II|Participant/Guardian Decision|0|||
156853799|NCT02159066|566217942|FG003|Part II|Participant/Guardian Decision|0|||
156853800|NCT02159066|566217943|FG004|Part II|Participant/Guardian Decision|2|||
156853801|NCT02159066|566217944|FG005|Part II|Participant/Guardian Decision|0|||
156853802|NCT01367834|566217945|FG000|Overall Study|Withdrawal by Subject|2|||
156853803|NCT01367834|566217946|FG001|Overall Study|Withdrawal by Subject|2|||
156853804|NCT01367834|566217945|FG000|Overall Study|Study was ended.|0|||
156853805|NCT01367834|566217946|FG001|Overall Study|Study was ended.|1|||
156853806|NCT01569841|566217951|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
156853807|NCT01569841|566217952|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
156853808|NCT01859923|566217953|FG000|Overall Study|Adverse Event|0|||
156853809|NCT01859923|566217954|FG001|Overall Study|Adverse Event|0|||
156853810|NCT01859923|566217955|FG002|Overall Study|Adverse Event|1|||
156853811|NCT01859923|566217956|FG003|Overall Study|Adverse Event|1|||
156853812|NCT00113841|566217971|FG000|Overall Study|Disease progression|0|||
156853813|NCT00113841|566217972|FG001|Overall Study|Disease progression|2|||
156853814|NCT00113841|566217971|FG000|Overall Study|Non-compliant|1|||
156853815|NCT00113841|566217972|FG001|Overall Study|Non-compliant|0|||
156853816|NCT00866814|566217973|FG000|Overall Study|Lost to Follow-up|12|||
156853817|NCT00866814|566217973|FG000|Overall Study|Adverse Event|2|||
156853818|NCT00866814|566217973|FG000|Overall Study|Physician Decision|1|||
156853819|NCT00866814|566217973|FG000|Overall Study|Death|1|||
156853820|NCT00866814|566217973|FG000|Overall Study|No longer wished to participate|1|||
156853821|NCT00866814|566217973|FG000|Overall Study|Unable to meet follow-up requirements|2|||
156853822|NCT00866814|566217973|FG000|Overall Study|Moved to area without study site|1|||
156853823|NCT04491136|566217974|FG000|Overall Study|Patient withdraw informed consent|9|||
156853824|NCT04491136|566217974|FG000|Overall Study|Adverse Event|2|||
156853825|NCT04491136|566217974|FG000|Overall Study|Death|3|||
156853826|NCT04491136|566217974|FG000|Overall Study|Lost to Follow-up|3|||
156853827|NCT04491136|566217974|FG000|Overall Study|Physician Decision|45|||
156853828|NCT04491136|566217974|FG000|Overall Study|sponsor terminated the study early|16|||
156853829|NCT04491136|566217974|FG000|Overall Study|Patient/guardian's decision|1|||
156853830|NCT00319254|566217977|FG000|Overall Study|Withdrawal by Subject|4|||
156853831|NCT00319254|566217977|FG000|Overall Study|Death|46|||
156853832|NCT00319254|566217977|FG000|Overall Study|Lost to Follow-up|2|||
156853833|NCT00319254|566217977|FG000|Overall Study|Enrolled, Not Treated|2|||
156853834|NCT01712204|566217981|FG000|Overall Study|Adverse Event|3|||
156853835|NCT01712204|566217982|FG001|Overall Study|Adverse Event|1|||
156853836|NCT01712204|566217981|FG000|Overall Study|Withdrawal by Subject|3|||
156853837|NCT01712204|566217982|FG001|Overall Study|Withdrawal by Subject|3|||
156853838|NCT01712204|566217981|FG000|Overall Study|Lost to Follow-up|1|||
156853839|NCT01712204|566217982|FG001|Overall Study|Lost to Follow-up|0|||
156853840|NCT01712204|566217981|FG000|Overall Study|Protocol Violation|1|||
156853841|NCT01712204|566217982|FG001|Overall Study|Protocol Violation|1|||
156853842|NCT02452424|566217985|FG000|Overall Study|Death|2|||
156853843|NCT02452424|566217986|FG001|Overall Study|Death|2|||
156853844|NCT02452424|566217987|FG002|Overall Study|Death|2|||
156853845|NCT02452424|566217988|FG003|Overall Study|Death|6|||
156853846|NCT02452424|566217989|FG004|Overall Study|Death|2|||
156853847|NCT02452424|566217990|FG005|Overall Study|Death|0|||
156853848|NCT02452424|566217991|FG006|Overall Study|Death|5|||
156853849|NCT02452424|566217992|FG007|Overall Study|Death|1|||
156853850|NCT02452424|566217993|FG008|Overall Study|Death|3|||
156853851|NCT02452424|566217994|FG009|Overall Study|Death|1|||
156853852|NCT02452424|566217995|FG010|Overall Study|Death|0|||
156853853|NCT02452424|566217985|FG000|Overall Study|Lost to Follow-up|0|||
156853854|NCT02452424|566217986|FG001|Overall Study|Lost to Follow-up|1|||
156853855|NCT02452424|566217987|FG002|Overall Study|Lost to Follow-up|1|||
156853856|NCT02452424|566217988|FG003|Overall Study|Lost to Follow-up|0|||
156853857|NCT02452424|566217989|FG004|Overall Study|Lost to Follow-up|0|||
156853858|NCT02452424|566217990|FG005|Overall Study|Lost to Follow-up|0|||
156853859|NCT02452424|566217991|FG006|Overall Study|Lost to Follow-up|0|||
156853860|NCT02452424|566217992|FG007|Overall Study|Lost to Follow-up|0|||
156853861|NCT02452424|566217993|FG008|Overall Study|Lost to Follow-up|0|||
156853862|NCT02452424|566217994|FG009|Overall Study|Lost to Follow-up|0|||
156853863|NCT02452424|566217995|FG010|Overall Study|Lost to Follow-up|0|||
156853864|NCT02452424|566217985|FG000|Overall Study|Withdrawal by Subject|0|||
156853865|NCT02452424|566217986|FG001|Overall Study|Withdrawal by Subject|0|||
156853866|NCT02452424|566217987|FG002|Overall Study|Withdrawal by Subject|3|||
156853867|NCT02452424|566217988|FG003|Overall Study|Withdrawal by Subject|2|||
156853868|NCT02452424|566217989|FG004|Overall Study|Withdrawal by Subject|0|||
156853869|NCT02452424|566217990|FG005|Overall Study|Withdrawal by Subject|0|||
156853870|NCT02452424|566217991|FG006|Overall Study|Withdrawal by Subject|1|||
156853871|NCT02452424|566217992|FG007|Overall Study|Withdrawal by Subject|0|||
156853872|NCT02452424|566217993|FG008|Overall Study|Withdrawal by Subject|1|||
156853873|NCT02452424|566217994|FG009|Overall Study|Withdrawal by Subject|1|||
156853874|NCT02452424|566217995|FG010|Overall Study|Withdrawal by Subject|0|||
156853875|NCT02452424|566217985|FG000|Overall Study|Other|0|||
156853876|NCT02452424|566217986|FG001|Overall Study|Other|0|||
156853877|NCT02452424|566217987|FG002|Overall Study|Other|1|||
156853878|NCT02452424|566217988|FG003|Overall Study|Other|0|||
156853879|NCT02452424|566217989|FG004|Overall Study|Other|0|||
156853880|NCT02452424|566217990|FG005|Overall Study|Other|1|||
156853881|NCT02452424|566217991|FG006|Overall Study|Other|4|||
156853882|NCT02452424|566217992|FG007|Overall Study|Other|3|||
156853883|NCT02452424|566217993|FG008|Overall Study|Other|0|||
156853884|NCT02452424|566217994|FG009|Overall Study|Other|0|||
156853885|NCT02452424|566217995|FG010|Overall Study|Other|1|||
156853886|NCT02452424|566217985|FG000|Overall Study|Progressive disease (per RECIST)|0|||
156853887|NCT02452424|566217986|FG001|Overall Study|Progressive disease (per RECIST)|0|||
156853888|NCT02452424|566217987|FG002|Overall Study|Progressive disease (per RECIST)|0|||
156853889|NCT02452424|566217988|FG003|Overall Study|Progressive disease (per RECIST)|0|||
156853890|NCT02452424|566217989|FG004|Overall Study|Progressive disease (per RECIST)|0|||
156853891|NCT02452424|566217990|FG005|Overall Study|Progressive disease (per RECIST)|0|||
156853892|NCT02452424|566217991|FG006|Overall Study|Progressive disease (per RECIST)|0|||
156853893|NCT02452424|566217992|FG007|Overall Study|Progressive disease (per RECIST)|0|||
156853894|NCT02452424|566217993|FG008|Overall Study|Progressive disease (per RECIST)|2|||
156853895|NCT02452424|566217994|FG009|Overall Study|Progressive disease (per RECIST)|0|||
156853896|NCT02452424|566217995|FG010|Overall Study|Progressive disease (per RECIST)|0|||
156853897|NCT02452424|566217985|FG000|Overall Study|Adverse Event|0|||
156853898|NCT02452424|566217986|FG001|Overall Study|Adverse Event|0|||
156853899|NCT02452424|566217987|FG002|Overall Study|Adverse Event|0|||
156853900|NCT02452424|566217988|FG003|Overall Study|Adverse Event|0|||
156853901|NCT02452424|566217989|FG004|Overall Study|Adverse Event|0|||
156853902|NCT02452424|566217990|FG005|Overall Study|Adverse Event|0|||
156853903|NCT02452424|566217991|FG006|Overall Study|Adverse Event|0|||
156853904|NCT02452424|566217992|FG007|Overall Study|Adverse Event|0|||
156853905|NCT02452424|566217993|FG008|Overall Study|Adverse Event|0|||
156853906|NCT02452424|566217994|FG009|Overall Study|Adverse Event|0|||
156853907|NCT02452424|566217995|FG010|Overall Study|Adverse Event|1|||
156853908|NCT01059318|566217996|FG000|Core Study (26 Week)|Adverse Event|3|||
156853909|NCT01059318|566217996|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
156853910|NCT01059318|566217996|FG000|Extension (36 Week)|Adverse Event|3|||
156853911|NCT03790917|566217999|FG000|Overall Study|Death|1|||
156853912|NCT02679287|566218003|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
156853913|NCT02679287|566218004|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
156853914|NCT02679287|566218003|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
156853915|NCT02679287|566218004|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
156853916|NCT02679287|566218003|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
156853917|NCT02679287|566218004|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
156853918|NCT02679287|566218003|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
156853919|NCT02679287|566218004|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
156853920|NCT02679287|566218003|FG000|Period 2|Work/Scheduling Conflict|1|||
156853921|NCT02679287|566218004|FG001|Period 2|Work/Scheduling Conflict|0|||
156853922|NCT02679287|566218003|FG000|Period 2|Disliked Mobile System|2|||
156853923|NCT02679287|566218004|FG001|Period 2|Disliked Mobile System|0|||
156853924|NCT02679287|566218003|FG000|Period 3|Work/Scheduling Conflict|0|||
156853925|NCT02679287|566218004|FG001|Period 3|Work/Scheduling Conflict|1|||
156853926|NCT01150097|566218005|FG000|Months 24 to 36 Post-transplantation|Death|2|||
156853927|NCT01150097|566218006|FG001|Months 24 to 36 Post-transplantation|Death|0|||
156853928|NCT01150097|566218007|FG002|Months 24 to 36 Post-transplantation|Death|0|||
156853929|NCT01150097|566218005|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
156853930|NCT01150097|566218006|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
156853931|NCT01150097|566218007|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
156853932|NCT01150097|566218005|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
156853933|NCT01150097|566218006|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
156853934|NCT01150097|566218007|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
156853935|NCT01150097|566218005|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
156853936|NCT01150097|566218006|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
156853937|NCT01150097|566218007|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
156853938|NCT01150097|566218005|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
156853939|NCT01150097|566218006|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
156853940|NCT01150097|566218007|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
156853941|NCT01150097|566218005|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
156853942|NCT01150097|566218006|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
156853943|NCT01150097|566218007|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
156853944|NCT01150097|566218005|FG000|Months 24 to 48 Post-transplantation|Death|2|||
156853945|NCT01150097|566218006|FG001|Months 24 to 48 Post-transplantation|Death|0|||
156853946|NCT01150097|566218007|FG002|Months 24 to 48 Post-transplantation|Death|0|||
156853947|NCT01408459|566218008|FG000|Overall Study|Withdrawal by Subject|1|||
156853948|NCT01408459|566218009|FG001|Overall Study|Withdrawal by Subject|1|||
156853949|NCT00984256|566219556|FG000|Overall Study|Withdrawal by Subject|0|||
156853950|NCT00984256|566219557|FG001|Overall Study|Withdrawal by Subject|1|||
156853951|NCT01131507|566219562|FG000|Overall Study|Adverse Event|1|||
156853952|NCT01131507|566219562|FG000|Overall Study|Lost to Follow-up|1|||
156853953|NCT01131507|566219562|FG000|Overall Study|Withdrawal by Subject|1|||
156853954|NCT01790594|566219563|FG000|Overall Study|Death|1|||
156853955|NCT01790594|566219564|FG001|Overall Study|Death|0|||
156853956|NCT01790594|566219565|FG002|Overall Study|Death|0|||
156853957|NCT01790594|566219563|FG000|Overall Study|Physician Decision|2|||
156853958|NCT01790594|566219564|FG001|Overall Study|Physician Decision|1|||
156853959|NCT01790594|566219565|FG002|Overall Study|Physician Decision|0|||
156853960|NCT01790594|566219563|FG000|Overall Study|Withdrawal by Subject|2|||
156853961|NCT01790594|566219564|FG001|Overall Study|Withdrawal by Subject|0|||
156853962|NCT01790594|566219565|FG002|Overall Study|Withdrawal by Subject|0|||
156853963|NCT01790594|566219563|FG000|Overall Study|Transplant was not done|0|||
156853964|NCT01790594|566219564|FG001|Overall Study|Transplant was not done|0|||
156853965|NCT01790594|566219565|FG002|Overall Study|Transplant was not done|3|||
156853966|NCT01790594|566219563|FG000|Overall Study|Terminated prior to week 76|0|||
156853967|NCT01790594|566219564|FG001|Overall Study|Terminated prior to week 76|2|||
156853968|NCT01790594|566219565|FG002|Overall Study|Terminated prior to week 76|0|||
156853969|NCT02038153|566219566|FG000|Overall Study|Withdrawal by Subject|1|||
156853970|NCT02647281|566219567|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853971|NCT02647281|566219568|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853972|NCT02647281|566219569|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853973|NCT02647281|566219570|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853974|NCT02647281|566219571|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853975|NCT02647281|566219572|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853976|NCT02647281|566219573|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853977|NCT02647281|566219574|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853978|NCT02647281|566219575|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
156853979|NCT00796666|566219581|FG000|Overall Study|Death|2|||
156853980|NCT00796666|566219582|FG001|Overall Study|Death|4|||
156853981|NCT00796666|566219581|FG000|Overall Study|Withdrawal by Subject|2|||
156853982|NCT00796666|566219582|FG001|Overall Study|Withdrawal by Subject|0|||
156853983|NCT00796666|566219581|FG000|Overall Study|Adverse Event|7|||
156853984|NCT00796666|566219582|FG001|Overall Study|Adverse Event|5|||
156853985|NCT00796666|566219581|FG000|Overall Study|Protocol Violation|1|||
156853986|NCT00796666|566219582|FG001|Overall Study|Protocol Violation|0|||
156853987|NCT00796666|566219581|FG000|Overall Study|Other|1|||
156853988|NCT00796666|566219582|FG001|Overall Study|Other|0|||
156853989|NCT00796666|566219581|FG000|Overall Study|Terminated by sponsor|53|||
156472591|NCT03732807|564825521|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
156472592|NCT03732807|564825522|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
156472593|NCT03732807|564825523|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
156472594|NCT03732807|564825524|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
156472595|NCT03732807|564825525|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
156853990|NCT00796666|566219582|FG001|Overall Study|Terminated by sponsor|55|||
156472596|NCT03732807|564825526|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
156853991|NCT00796666|566219581|FG000|Overall Study|Randomized and not treated|1|||
156853992|NCT00796666|566219582|FG001|Overall Study|Randomized and not treated|0|||
156853993|NCT02576639|566219584|FG000|Overall Study|Withdrawal by Subject|1|||
156853994|NCT02576639|566219585|FG001|Overall Study|Withdrawal by Subject|2|||
156853995|NCT02576639|566219586|FG002|Overall Study|Withdrawal by Subject|1|||
156853996|NCT02576639|566219587|FG003|Overall Study|Withdrawal by Subject|0|||
156853997|NCT02576639|566219588|FG004|Overall Study|Withdrawal by Subject|1|||
156542189|NCT04342871|565079259|FG000|Overall Study|Death|4|||
156853998|NCT02576639|566219584|FG000|Overall Study|Adverse Event|1|||
156853999|NCT02576639|566219585|FG001|Overall Study|Adverse Event|0|||
156854000|NCT02576639|566219586|FG002|Overall Study|Adverse Event|1|||
156854001|NCT02576639|566219587|FG003|Overall Study|Adverse Event|1|||
156854002|NCT02576639|566219588|FG004|Overall Study|Adverse Event|2|||
156854003|NCT02576639|566219584|FG000|Overall Study|Physician Decision|0|||
156854004|NCT02576639|566219585|FG001|Overall Study|Physician Decision|0|||
156854005|NCT02576639|566219586|FG002|Overall Study|Physician Decision|0|||
156854006|NCT02576639|566219587|FG003|Overall Study|Physician Decision|0|||
156854007|NCT02576639|566219588|FG004|Overall Study|Physician Decision|1|||
156854008|NCT01135134|566219589|FG000|Overall Study|Adverse Event|1|||
156854009|NCT01135134|566219590|FG001|Overall Study|Adverse Event|1|||
156854010|NCT01135134|566219589|FG000|Overall Study|Did not meet protocol eligibility|1|||
156854011|NCT01135134|566219590|FG001|Overall Study|Did not meet protocol eligibility|0|||
156854012|NCT00255190|566219591|FG000|Overall Study|Adverse Event|17|||
156854013|NCT00255190|566219592|FG001|Overall Study|Adverse Event|36|||
156854014|NCT00255190|566219591|FG000|Overall Study|Protocol Violation|2|||
156854015|NCT00255190|566219592|FG001|Overall Study|Protocol Violation|2|||
156854016|NCT00255190|566219591|FG000|Overall Study|Lost to Follow-up|10|||
156854017|NCT00255190|566219592|FG001|Overall Study|Lost to Follow-up|27|||
156854018|NCT00255190|566219591|FG000|Overall Study|Withdrew Consent|17|||
156854019|NCT00255190|566219592|FG001|Overall Study|Withdrew Consent|48|||
156854020|NCT00255190|566219591|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
156854021|NCT00255190|566219592|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
156854022|NCT00255190|566219591|FG000|Overall Study|Erosive esophagitis not healed|0|||
156854023|NCT00255190|566219592|FG001|Overall Study|Erosive esophagitis not healed|20|||
156854024|NCT00255190|566219591|FG000|Overall Study|Various|4|||
156854025|NCT00255190|566219592|FG001|Overall Study|Various|23|||
156854026|NCT00628030|566219597|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
156854027|NCT00628030|566219598|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
156854028|NCT00628030|566219597|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
156854029|NCT00628030|566219598|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
156854030|NCT00628030|566219597|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
156854031|NCT00628030|566219598|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
156854032|NCT01156480|566219600|FG000|Overall Study|change in diagnosis|0|||
156854033|NCT01156480|566219601|FG001|Overall Study|change in diagnosis|1|||
156854034|NCT04537793|566219602|FG000|Part B (24 Weeks)|Adverse Event|0|||
156854035|NCT04537793|566219603|FG001|Part B (24 Weeks)|Adverse Event|1|||
156854036|NCT01255423|566219604|FG000|Overall Study|Abnormal Laboratory value|3|||
156854037|NCT01255423|566219605|FG001|Overall Study|Abnormal Laboratory value|2|||
156854038|NCT01255423|566219604|FG000|Overall Study|Use of prohibited medications|0|||
156854039|NCT01255423|566219605|FG001|Overall Study|Use of prohibited medications|1|||
156854040|NCT00988598|566219606|FG000|Overall Study|Withdrawal by Subject|2|||
156854041|NCT00988598|566219607|FG001|Overall Study|Withdrawal by Subject|0|||
156854042|NCT01176058|566219611|FG000|Overall Study|Adverse Event|1|||
156854043|NCT01176058|566219612|FG001|Overall Study|Adverse Event|0|||
156854044|NCT01176058|566219611|FG000|Overall Study|Insufficient clinical response|2|||
156854045|NCT01176058|566219612|FG001|Overall Study|Insufficient clinical response|2|||
156854046|NCT01176058|566219611|FG000|Overall Study|Insufficient mycological response|0|||
156854047|NCT01176058|566219612|FG001|Overall Study|Insufficient mycological response|1|||
156854048|NCT01176058|566219611|FG000|Overall Study|Withdrawal by Subject|1|||
156854049|NCT01176058|566219612|FG001|Overall Study|Withdrawal by Subject|0|||
156854050|NCT00256724|566219615|FG000|Overall Study|Physician Decision|2|||
156854051|NCT00256724|566219616|FG001|Overall Study|Physician Decision|5|||
156854052|NCT00256724|566219615|FG000|Overall Study|Protocol Violation|3|||
156854053|NCT00256724|566219616|FG001|Overall Study|Protocol Violation|3|||
156854054|NCT01217463|566219617|FG000|Overall Study|Adverse Event|8|||
156854055|NCT01217463|566219618|FG001|Overall Study|Adverse Event|5|||
156854056|NCT01217463|566219617|FG000|Overall Study|Physician Decision|0|||
156854057|NCT01217463|566219618|FG001|Overall Study|Physician Decision|1|||
156854058|NCT01217463|566219617|FG000|Overall Study|Withdrawal by Subject|3|||
156854059|NCT01217463|566219618|FG001|Overall Study|Withdrawal by Subject|0|||
156854060|NCT01217463|566219617|FG000|Overall Study|Surgery on the Target Limb|0|||
156854061|NCT01217463|566219618|FG001|Overall Study|Surgery on the Target Limb|1|||
156854062|NCT01217463|566219617|FG000|Overall Study|Patient Non-compliant|1|||
156854063|NCT01217463|566219618|FG001|Overall Study|Patient Non-compliant|0|||
156342247|NCT01532414|564352600|FG000|Overall Study|Lost to Follow-up|3|||
156342248|NCT01532414|564352601|FG001|Overall Study|Lost to Follow-up|0|||
156854064|NCT01217463|566219617|FG000|Overall Study|Other|1|||
156854065|NCT01217463|566219618|FG001|Overall Study|Other|1|||
156342249|NCT01532414|564352602|FG002|Overall Study|Lost to Follow-up|1|||
156854066|NCT01858363|566219627|FG000|Overall Study|Death|35|||
156854067|NCT01858363|566219628|FG001|Overall Study|Death|9|||
156854068|NCT01858363|566219627|FG000|Overall Study|Withdrawal by Subject|28|||
156854069|NCT01858363|566219628|FG001|Overall Study|Withdrawal by Subject|14|||
156854070|NCT01858363|566219627|FG000|Overall Study|Lost to Follow-up|13|||
156342250|NCT01532414|564352600|FG000|Overall Study|Withdrawal by Subject|3|||
156854071|NCT01858363|566219628|FG001|Overall Study|Lost to Follow-up|3|||
156854072|NCT00057863|566219637|FG000|Overall Study|Death|1|||
156854073|NCT00057863|566219637|FG000|Overall Study|Withdrawal by Subject|2|||
156854074|NCT00764361|566219638|FG000|Overall Study|Withdrawal by Subject|2|||
156854075|NCT00764361|566219639|FG001|Overall Study|Withdrawal by Subject|3|||
156854076|NCT00764361|566219638|FG000|Overall Study|Adverse Event|0|||
156854077|NCT00764361|566219639|FG001|Overall Study|Adverse Event|1|||
156854078|NCT02090426|566219640|FG000|Overall Study|Lost to Follow-up|12|||
156854079|NCT02090426|566219641|FG001|Overall Study|Lost to Follow-up|6|||
156854080|NCT02079038|566219645|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
156854081|NCT02079038|566219646|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
156854082|NCT02079038|566219645|FG000|Modified Intent to Treat Population|Death|1|||
156854083|NCT02079038|566219646|FG001|Modified Intent to Treat Population|Death|0|||
156854084|NCT02079038|566219645|FG000|Completed 6 Months|Lost to Follow-up|2|||
156854085|NCT02079038|566219646|FG001|Completed 6 Months|Lost to Follow-up|1|||
156854086|NCT01141712|566219647|FG000|Overall Study|Disease progression|3|||
156854087|NCT01308736|566219648|FG000|Overall Study|Did not attend a single session|6|||
156854088|NCT01308736|566219649|FG001|Overall Study|Did not attend a single session|5|||
156854089|NCT03634085|566219650|FG000|Overall Study|Adverse Event|1|||
156854090|NCT03634085|566219651|FG001|Overall Study|Adverse Event|0|||
156854091|NCT03634085|566219650|FG000|Overall Study|Withdrawal by Subject|0|||
156854092|NCT03634085|566219651|FG001|Overall Study|Withdrawal by Subject|2|||
156854093|NCT03948334|566219660|FG000|Overall Study|Adverse Event|1|||
156854094|NCT03948334|566219661|FG001|Overall Study|Adverse Event|4|||
156854095|NCT03948334|566219660|FG000|Overall Study|Lack of Efficacy|2|||
156854096|NCT03948334|566219661|FG001|Overall Study|Lack of Efficacy|0|||
156854097|NCT03948334|566219660|FG000|Overall Study|Lost to Follow-up|1|||
156854098|NCT03948334|566219661|FG001|Overall Study|Lost to Follow-up|0|||
156854099|NCT03948334|566219660|FG000|Overall Study|Physician Decision|1|||
156854100|NCT03948334|566219661|FG001|Overall Study|Physician Decision|0|||
156854101|NCT03948334|566219660|FG000|Overall Study|Pregnancy|0|||
156854102|NCT03948334|566219661|FG001|Overall Study|Pregnancy|1|||
156854103|NCT03948334|566219660|FG000|Overall Study|Protocol Deviation|1|||
156854104|NCT03948334|566219661|FG001|Overall Study|Protocol Deviation|0|||
156854105|NCT03948334|566219660|FG000|Overall Study|Study terminated by Sponsor|50|||
156854106|NCT03948334|566219661|FG001|Overall Study|Study terminated by Sponsor|51|||
156854107|NCT03948334|566219660|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
156854108|NCT03948334|566219661|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
156854109|NCT03775486|566219666|FG000|Initial Therapy Phase|Other reason provided|0|||
156854110|NCT03775486|566219667|FG001|Initial Therapy Phase|Other reason provided|15|||
156854111|NCT03775486|566219666|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
156854112|NCT03775486|566219667|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
156854113|NCT03775486|566219666|FG000|Initial Therapy Phase|Protocol Violation|0|||
156854114|NCT03775486|566219667|FG001|Initial Therapy Phase|Protocol Violation|2|||
156854115|NCT03775486|566219666|FG000|Initial Therapy Phase|Adverse Event|0|||
156854116|NCT03775486|566219667|FG001|Initial Therapy Phase|Adverse Event|34|||
156854117|NCT03775486|566219666|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
156472597|NCT03732807|564825527|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
156854118|NCT03775486|566219667|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
156854119|NCT03775486|566219666|FG000|Maintenance Phase|Withdrawal by Subject|13|||
156854120|NCT03775486|566219667|FG001|Maintenance Phase|Withdrawal by Subject|12|||
156854121|NCT03775486|566219666|FG000|Maintenance Phase|Death|44|||
156854122|NCT03775486|566219667|FG001|Maintenance Phase|Death|45|||
156854123|NCT05477485|566219668|FG000|Overall Study|Lost to Follow-up|0|||
156854124|NCT05477485|566219669|FG001|Overall Study|Lost to Follow-up|4|||
156854125|NCT03116685|566219670|FG000|Overall Study|Physician Decision|0|||
156854126|NCT03116685|566219671|FG001|Overall Study|Physician Decision|1|||
156854127|NCT05081219|566219672|FG000|Overall Study|Withdrawal by Subject|4|||
156854128|NCT05081219|566219673|FG001|Overall Study|Withdrawal by Subject|0|||
156854129|NCT05081219|566219674|FG002|Overall Study|Withdrawal by Subject|0|||
156854130|NCT05081219|566219675|FG003|Overall Study|Withdrawal by Subject|1|||
156854131|NCT00801216|566219676|FG000|Overall Study|Screening Failure|2|||
156472598|NCT03732807|564825521|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
156854132|NCT05274958|566219677|FG000|Overall Study|Only completed 1 set of PROMs|22|||
156854133|NCT05274958|566219678|FG001|Overall Study|Only completed 1 set of PROMs|35|||
156854134|NCT06235905|566219679|FG000|Overall Study|Adverse Event|1|||
156854135|NCT06235905|566219679|FG000|Overall Study|Non-compliant with protocol procedures|1|||
156854136|NCT01505374|566219681|FG000|Overall Study|Lost to Follow-up|1|||
156854137|NCT01505374|566219682|FG001|Overall Study|Lost to Follow-up|0|||
156854138|NCT00320515|566219684|FG000|Overall Study|Death|33|||
156854139|NCT00320515|566219684|FG000|Overall Study|Lost to Follow-up|6|||
156854140|NCT00320515|566219684|FG000|Overall Study|Physician Decision|2|||
156854141|NCT00320515|566219684|FG000|Overall Study|Withdrawal by Subject|8|||
156854142|NCT01114828|566219685|FG000|Overall Study|Adverse Event|1|||
156854143|NCT01114828|566219686|FG001|Overall Study|Adverse Event|1|||
156854144|NCT01114828|566219685|FG000|Overall Study|Lack of Efficacy|0|||
156854145|NCT01114828|566219686|FG001|Overall Study|Lack of Efficacy|2|||
156854146|NCT01114828|566219685|FG000|Overall Study|Protocol Violation|2|||
156854147|NCT01114828|566219686|FG001|Overall Study|Protocol Violation|0|||
156854148|NCT01114828|566219685|FG000|Overall Study|Withdrawal by Subject|0|||
156854149|NCT01114828|566219686|FG001|Overall Study|Withdrawal by Subject|1|||
156854150|NCT00851786|566219689|FG000|Overall Study|Withdrawal by Subject|0|||
156854151|NCT00851786|566219690|FG001|Overall Study|Withdrawal by Subject|1|||
156854152|NCT00851786|566219689|FG000|Overall Study|Protocol Violation|0|||
156854153|NCT00851786|566219690|FG001|Overall Study|Protocol Violation|1|||
156854154|NCT00851786|566219689|FG000|Overall Study|Lost to Follow-up|1|||
156854155|NCT00851786|566219690|FG001|Overall Study|Lost to Follow-up|0|||
156854156|NCT00851786|566219689|FG000|Overall Study|Incarceration|1|||
156854157|NCT00851786|566219690|FG001|Overall Study|Incarceration|0|||
156854158|NCT00851786|566219689|FG000|Overall Study|Site Closure|1|||
156854159|NCT00851786|566219690|FG001|Overall Study|Site Closure|0|||
156854160|NCT00851786|566219689|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
156854161|NCT00851786|566219690|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
156854162|NCT04177212|566219692|FG000|Overall Study|Withdrawal by Subject|9|||
156854163|NCT04177212|566219693|FG001|Overall Study|Withdrawal by Subject|7|||
156854164|NCT04177212|566219692|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
156854165|NCT04177212|566219693|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
156854166|NCT04177212|566219692|FG000|Overall Study|Physician Decision|1|||
156854167|NCT04177212|566219693|FG001|Overall Study|Physician Decision|0|||
156854168|NCT04177212|566219692|FG000|Overall Study|Lost to Follow-up|0|||
156854169|NCT04177212|566219693|FG001|Overall Study|Lost to Follow-up|3|||
156854170|NCT04177212|566219692|FG000|Overall Study|Adverse Event|0|||
156854171|NCT04177212|566219693|FG001|Overall Study|Adverse Event|1|||
156854172|NCT04177212|566219692|FG000|Overall Study|Other|1|||
156854173|NCT04177212|566219693|FG001|Overall Study|Other|2|||
156854174|NCT01792115|566219694|FG000|Overall Study|Lost to Follow-up|0|||
156854175|NCT01792115|566219695|FG001|Overall Study|Lost to Follow-up|1|||
156854176|NCT01792115|566219696|FG002|Overall Study|Lost to Follow-up|0|||
156854177|NCT01279681|566219697|FG000|Overall Study|Disease Progression|9|||
156854178|NCT01279681|566219698|FG001|Overall Study|Disease Progression|6|||
156854179|NCT01279681|566219697|FG000|Overall Study|Withdrawal by Subject|3|||
156854180|NCT01279681|566219698|FG001|Overall Study|Withdrawal by Subject|4|||
156854181|NCT01279681|566219697|FG000|Overall Study|Adverse Event|2|||
156854182|NCT01279681|566219698|FG001|Overall Study|Adverse Event|3|||
156854183|NCT01279681|566219697|FG000|Overall Study|Death|0|||
156854184|NCT01279681|566219698|FG001|Overall Study|Death|1|||
156854185|NCT01279681|566219697|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
156854186|NCT01279681|566219698|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
156854187|NCT01279681|566219697|FG000|Overall Study|Physician Decision|1|||
156854188|NCT01279681|566219698|FG001|Overall Study|Physician Decision|0|||
156854189|NCT01279681|566219697|FG000|Overall Study|Other Reason|0|||
156854190|NCT01279681|566219698|FG001|Overall Study|Other Reason|2|||
156854191|NCT01943591|566219699|FG000|Overall Study|Lost to Follow-up|3|||
156854192|NCT01943591|566219700|FG001|Overall Study|Lost to Follow-up|4|||
156854193|NCT01943591|566219699|FG000|Overall Study|Death|2|||
156854194|NCT01943591|566219700|FG001|Overall Study|Death|7|||
156854195|NCT00496015|566221962|FG000|Overall Study|Other|1|||
156854196|NCT00496015|566221963|FG001|Overall Study|Other|0|||
156854197|NCT00496015|566221964|FG002|Overall Study|Other|0|||
156854198|NCT00496015|566221965|FG003|Overall Study|Other|1|||
156854199|NCT00496015|566221966|FG004|Overall Study|Other|0|||
156854200|NCT02730728|566221968|FG000|Overall Study|Withdrawal by Subject|0|||
156854201|NCT02730728|566221969|FG001|Overall Study|Withdrawal by Subject|1|||
156854202|NCT02730728|566221970|FG002|Overall Study|Withdrawal by Subject|0|||
156854203|NCT02730728|566221968|FG000|Overall Study|Lack of Efficacy|0|||
156854204|NCT02730728|566221969|FG001|Overall Study|Lack of Efficacy|1|||
156854205|NCT02730728|566221970|FG002|Overall Study|Lack of Efficacy|1|||
156854206|NCT00346216|566221972|FG000|Overall Study|Other|181|||
156854207|NCT00346216|566221973|FG001|Overall Study|Other|231|||
156854208|NCT00346216|566221974|FG002|Overall Study|Other|205|||
156854209|NCT00346216|566221972|FG000|Overall Study|No longer willing to participate|600|||
156854210|NCT00346216|566221973|FG001|Overall Study|No longer willing to participate|606|||
156854211|NCT00346216|566221974|FG002|Overall Study|No longer willing to participate|585|||
156854212|NCT00346216|566221972|FG000|Overall Study|Withdrawal by Subject|661|||
156854213|NCT00346216|566221973|FG001|Overall Study|Withdrawal by Subject|692|||
156854214|NCT00346216|566221974|FG002|Overall Study|Withdrawal by Subject|651|||
156854215|NCT00346216|566221972|FG000|Overall Study|Lost to Follow-up|611|||
156854216|NCT00346216|566221973|FG001|Overall Study|Lost to Follow-up|588|||
156854217|NCT00346216|566221974|FG002|Overall Study|Lost to Follow-up|542|||
156854218|NCT00346216|566221972|FG000|Overall Study|Physician Decision|80|||
156854219|NCT00346216|566221973|FG001|Overall Study|Physician Decision|76|||
156854220|NCT00346216|566221974|FG002|Overall Study|Physician Decision|59|||
156854221|NCT00346216|566221972|FG000|Overall Study|Does not meet entrance criteria|13|||
156854222|NCT00346216|566221973|FG001|Overall Study|Does not meet entrance criteria|10|||
156854223|NCT00346216|566221974|FG002|Overall Study|Does not meet entrance criteria|8|||
156854224|NCT00346216|566221972|FG000|Overall Study|Death|189|||
156854225|NCT00346216|566221973|FG001|Overall Study|Death|192|||
156854226|NCT00346216|566221974|FG002|Overall Study|Death|228|||
156854227|NCT00346216|566221972|FG000|Overall Study|Study terminated by sponsor|11|||
156854228|NCT00346216|566221973|FG001|Overall Study|Study terminated by sponsor|4|||
156854229|NCT00346216|566221974|FG002|Overall Study|Study terminated by sponsor|8|||
156854230|NCT00346216|566221972|FG000|Overall Study|Missing Subject Summary Status|62|||
156854231|NCT00346216|566221973|FG001|Overall Study|Missing Subject Summary Status|61|||
156854232|NCT00346216|566221974|FG002|Overall Study|Missing Subject Summary Status|62|||
156854233|NCT03956550|566221980|FG000|Overall Study|Sponsor decision|65|||
156854234|NCT03956550|566221981|FG001|Overall Study|Sponsor decision|66|||
156854235|NCT03956550|566221982|FG002|Overall Study|Sponsor decision|64|||
156854236|NCT03956550|566221980|FG000|Overall Study|Adverse Event|0|||
156854237|NCT03956550|566221981|FG001|Overall Study|Adverse Event|1|||
156854238|NCT03956550|566221982|FG002|Overall Study|Adverse Event|0|||
156854239|NCT03956550|566221980|FG000|Overall Study|Withdrawal by Subject|5|||
156854240|NCT03956550|566221981|FG001|Overall Study|Withdrawal by Subject|5|||
156854241|NCT03956550|566221982|FG002|Overall Study|Withdrawal by Subject|6|||
156854242|NCT04244253|566221983|FG000|Overall Study|Adverse Event|2|||
156854243|NCT04244253|566221984|FG001|Overall Study|Adverse Event|2|||
156854244|NCT04244253|566221985|FG002|Overall Study|Adverse Event|4|||
156854245|NCT04244253|566221983|FG000|Overall Study|Protocol Violation|1|||
156854246|NCT04244253|566221984|FG001|Overall Study|Protocol Violation|2|||
156854247|NCT04244253|566221985|FG002|Overall Study|Protocol Violation|1|||
156854248|NCT04244253|566221983|FG000|Overall Study|Withdrawal by Subject|0|||
156854249|NCT04244253|566221984|FG001|Overall Study|Withdrawal by Subject|1|||
156854250|NCT04244253|566221985|FG002|Overall Study|Withdrawal by Subject|6|||
156854251|NCT04244253|566221983|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156854252|NCT04244253|566221984|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156854253|NCT04244253|566221985|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156854254|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
156854255|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
156854256|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
156854257|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854258|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854259|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854260|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854261|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854262|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854263|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854264|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854265|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854266|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
156854267|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854268|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854269|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854270|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
156854271|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854272|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854273|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
156854274|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
156854275|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
156854276|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
156854277|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854278|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
156854279|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854280|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854281|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
156854282|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854283|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
156854284|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
156854285|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
156854286|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
156854287|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
156854288|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
156854289|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
156854290|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
156854291|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
156854292|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
156854293|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
156854294|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
156854295|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
156854296|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
156854297|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
156854298|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
156854299|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
156854300|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854301|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854302|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
156854303|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854304|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854305|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854306|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854307|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854308|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854309|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
156854310|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854311|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854312|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854313|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854314|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854315|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854316|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854317|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854318|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854319|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854320|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854321|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854322|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854323|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854324|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854325|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854326|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854327|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854328|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854329|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854330|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854331|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854332|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
156854333|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854334|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854335|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854336|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854337|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854338|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854339|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
156854340|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854341|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854342|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854343|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854344|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854345|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854346|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854347|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854348|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854349|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854350|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854351|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854352|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854353|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854354|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854355|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
156854356|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
156854357|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854358|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
156854359|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
156854360|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
156854361|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
156854362|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
156854363|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
156854364|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
156854365|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
156854366|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
156854367|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
156854368|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
156854369|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
156854370|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
156854371|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
156854372|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
156854373|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
156854374|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854375|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854376|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854377|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854378|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
156854379|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
156854380|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
156854381|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
156854382|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854383|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
156854384|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854385|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854386|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
156854387|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854388|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
156854389|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854390|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854391|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854392|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
156854393|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854394|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854395|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854396|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854397|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854398|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854399|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854400|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854401|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854402|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854403|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854404|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854405|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854406|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854407|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854408|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156854409|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156854410|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854411|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156472599|NCT03732807|564825522|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
156472600|NCT03732807|564825523|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
156854412|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854413|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156854414|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854415|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854416|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854417|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156854418|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854419|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854420|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854421|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854422|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
156854423|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854424|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854425|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854426|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854427|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854428|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854429|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
156854430|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854431|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854432|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854433|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854434|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854435|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854436|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854437|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854438|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854439|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854440|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854441|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156342251|NCT01532414|564352601|FG001|Overall Study|Withdrawal by Subject|0|||
156342252|NCT01532414|564352602|FG002|Overall Study|Withdrawal by Subject|0|||
156342253|NCT01532414|564352600|FG000|Overall Study|No V6 semen sample|0|||
156854442|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854443|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854444|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854445|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854446|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
156854447|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854448|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854449|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854450|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854451|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854452|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854453|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854454|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854455|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854456|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854457|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854458|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854459|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854460|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854461|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
156854462|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854463|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
156854464|NCT03480152|566222015|FG000|Phase I|Signed consent. Died before treatment.|1|||
156854465|NCT03480152|566222016|FG001|Phase I|Signed consent. Died before treatment.|0|||
156854466|NCT03480152|566222017|FG002|Phase I|Signed consent. Died before treatment.|0|||
156854467|NCT04276233|566222018|FG000|Overall Study|Adverse Event|1|||
156854468|NCT04276233|566222018|FG000|Overall Study|Lost to Follow-up|3|||
156854469|NCT04276233|566222018|FG000|Overall Study|Physician Decision|4|||
156854470|NCT04276233|566222018|FG000|Overall Study|Withdrawal by Subject|2|||
156854471|NCT01946139|566222019|FG000|Overall Study|Withdrawal by Subject|8|||
156854472|NCT01946139|566222019|FG000|Overall Study|ineligible|8|||
156854473|NCT01946139|566222019|FG000|Overall Study|Specimens not available|4|||
156854474|NCT00101686|566222020|FG000|Overall Study|Progressive Disease|37|||
156854475|NCT00101686|566222021|FG001|Overall Study|Progressive Disease|28|||
156342254|NCT01532414|564352601|FG001|Overall Study|No V6 semen sample|1|||
156854476|NCT00101686|566222022|FG002|Overall Study|Progressive Disease|37|||
156854477|NCT00101686|566222023|FG003|Overall Study|Progressive Disease|38|||
156854478|NCT00101686|566222024|FG004|Overall Study|Progressive Disease|28|||
156854479|NCT00101686|566222025|FG005|Overall Study|Progressive Disease|25|||
156854480|NCT00101686|566222026|FG006|Overall Study|Progressive Disease|5|||
156854481|NCT00101686|566222027|FG007|Overall Study|Progressive Disease|7|||
156854482|NCT00101686|566222028|FG008|Overall Study|Progressive Disease|10|||
156854483|NCT00101686|566222029|FG009|Overall Study|Progressive Disease|8|||
156854484|NCT00101686|566222020|FG000|Overall Study|initiation other anti-cancer treatment|4|||
156854485|NCT00101686|566222021|FG001|Overall Study|initiation other anti-cancer treatment|3|||
156854486|NCT00101686|566222022|FG002|Overall Study|initiation other anti-cancer treatment|4|||
156854487|NCT00101686|566222023|FG003|Overall Study|initiation other anti-cancer treatment|3|||
156854488|NCT00101686|566222024|FG004|Overall Study|initiation other anti-cancer treatment|1|||
156854489|NCT00101686|566222025|FG005|Overall Study|initiation other anti-cancer treatment|1|||
156854490|NCT00101686|566222026|FG006|Overall Study|initiation other anti-cancer treatment|2|||
156854491|NCT00101686|566222027|FG007|Overall Study|initiation other anti-cancer treatment|2|||
156854492|NCT00101686|566222028|FG008|Overall Study|initiation other anti-cancer treatment|3|||
156854493|NCT00101686|566222029|FG009|Overall Study|initiation other anti-cancer treatment|3|||
156854494|NCT00101686|566222020|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
156854495|NCT00101686|566222021|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
156854496|NCT00101686|566222022|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
156854497|NCT00101686|566222023|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
156854498|NCT00101686|566222024|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
156854499|NCT00101686|566222025|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
156854500|NCT00101686|566222026|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
156854501|NCT00101686|566222027|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
156854502|NCT00101686|566222028|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
156854503|NCT00101686|566222029|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
156854504|NCT00101686|566222020|FG000|Overall Study|unacceptable toxicity|3|||
156854505|NCT00101686|566222021|FG001|Overall Study|unacceptable toxicity|9|||
156854506|NCT00101686|566222022|FG002|Overall Study|unacceptable toxicity|10|||
156854507|NCT00101686|566222023|FG003|Overall Study|unacceptable toxicity|6|||
156854508|NCT00101686|566222024|FG004|Overall Study|unacceptable toxicity|16|||
156854509|NCT00101686|566222025|FG005|Overall Study|unacceptable toxicity|10|||
156854510|NCT00101686|566222026|FG006|Overall Study|unacceptable toxicity|4|||
156854511|NCT00101686|566222027|FG007|Overall Study|unacceptable toxicity|2|||
156854512|NCT00101686|566222028|FG008|Overall Study|unacceptable toxicity|1|||
156854513|NCT00101686|566222029|FG009|Overall Study|unacceptable toxicity|4|||
156854514|NCT00101686|566222020|FG000|Overall Study|Randomized but did not receive treament|1|||
156854515|NCT00101686|566222021|FG001|Overall Study|Randomized but did not receive treament|6|||
156854516|NCT00101686|566222022|FG002|Overall Study|Randomized but did not receive treament|2|||
156854517|NCT00101686|566222023|FG003|Overall Study|Randomized but did not receive treament|2|||
156854518|NCT00101686|566222024|FG004|Overall Study|Randomized but did not receive treament|2|||
156854519|NCT00101686|566222025|FG005|Overall Study|Randomized but did not receive treament|2|||
156854520|NCT00101686|566222026|FG006|Overall Study|Randomized but did not receive treament|0|||
156854521|NCT00101686|566222027|FG007|Overall Study|Randomized but did not receive treament|1|||
156854522|NCT00101686|566222028|FG008|Overall Study|Randomized but did not receive treament|0|||
156854523|NCT00101686|566222029|FG009|Overall Study|Randomized but did not receive treament|1|||
156854524|NCT00101686|566222020|FG000|Overall Study|intercurrent non-cancer related illness|0|||
156854525|NCT00101686|566222021|FG001|Overall Study|intercurrent non-cancer related illness|0|||
156854526|NCT00101686|566222022|FG002|Overall Study|intercurrent non-cancer related illness|2|||
156854527|NCT00101686|566222023|FG003|Overall Study|intercurrent non-cancer related illness|0|||
156854528|NCT00101686|566222024|FG004|Overall Study|intercurrent non-cancer related illness|1|||
156854529|NCT00101686|566222025|FG005|Overall Study|intercurrent non-cancer related illness|3|||
156854530|NCT00101686|566222026|FG006|Overall Study|intercurrent non-cancer related illness|1|||
156854531|NCT00101686|566222027|FG007|Overall Study|intercurrent non-cancer related illness|0|||
156854532|NCT00101686|566222028|FG008|Overall Study|intercurrent non-cancer related illness|1|||
156854533|NCT00101686|566222029|FG009|Overall Study|intercurrent non-cancer related illness|1|||
156854534|NCT00101686|566222020|FG000|Overall Study|Physician Decision|10|||
156854535|NCT00101686|566222021|FG001|Overall Study|Physician Decision|13|||
156854536|NCT00101686|566222022|FG002|Overall Study|Physician Decision|6|||
156854537|NCT00101686|566222023|FG003|Overall Study|Physician Decision|7|||
156854538|NCT00101686|566222024|FG004|Overall Study|Physician Decision|8|||
156854539|NCT00101686|566222025|FG005|Overall Study|Physician Decision|9|||
156854540|NCT00101686|566222026|FG006|Overall Study|Physician Decision|5|||
156854541|NCT00101686|566222027|FG007|Overall Study|Physician Decision|5|||
156854542|NCT00101686|566222028|FG008|Overall Study|Physician Decision|1|||
156472601|NCT03732807|564825524|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
156854543|NCT00101686|566222029|FG009|Overall Study|Physician Decision|1|||
156854544|NCT00101686|566222020|FG000|Overall Study|Other|1|||
156854545|NCT00101686|566222021|FG001|Overall Study|Other|4|||
156854546|NCT00101686|566222022|FG002|Overall Study|Other|1|||
156854547|NCT00101686|566222023|FG003|Overall Study|Other|6|||
156854548|NCT00101686|566222024|FG004|Overall Study|Other|2|||
156854549|NCT00101686|566222025|FG005|Overall Study|Other|12|||
156854550|NCT00101686|566222026|FG006|Overall Study|Other|1|||
156854551|NCT00101686|566222027|FG007|Overall Study|Other|5|||
156854552|NCT00101686|566222028|FG008|Overall Study|Other|3|||
156854553|NCT00101686|566222029|FG009|Overall Study|Other|3|||
156854554|NCT00101686|566222020|FG000|Overall Study|Withdrawal by Subject|9|||
156854555|NCT00101686|566222021|FG001|Overall Study|Withdrawal by Subject|8|||
156854556|NCT00101686|566222022|FG002|Overall Study|Withdrawal by Subject|6|||
156854557|NCT00101686|566222023|FG003|Overall Study|Withdrawal by Subject|8|||
156854558|NCT00101686|566222024|FG004|Overall Study|Withdrawal by Subject|8|||
156854559|NCT00101686|566222025|FG005|Overall Study|Withdrawal by Subject|7|||
156854560|NCT00101686|566222026|FG006|Overall Study|Withdrawal by Subject|7|||
156854561|NCT00101686|566222027|FG007|Overall Study|Withdrawal by Subject|7|||
156854562|NCT00101686|566222028|FG008|Overall Study|Withdrawal by Subject|8|||
156854563|NCT00101686|566222029|FG009|Overall Study|Withdrawal by Subject|9|||
156854564|NCT00296816|566222030|FG000|Overall Study|Disease Progression|37|||
156854565|NCT00296816|566222030|FG000|Overall Study|Adverse Event|18|||
156854566|NCT00296816|566222030|FG000|Overall Study|Investigator/Participant request|5|||
156854567|NCT00296816|566222030|FG000|Overall Study|Non-compliance|1|||
156854568|NCT00296816|566222030|FG000|Overall Study|Missing for end of treatment|4|||
156854569|NCT00296816|566222030|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
156854570|NCT00296816|566222030|FG000|Overall Study|Poor performance status|1|||
156854571|NCT00296816|566222030|FG000|Overall Study|Relocation to Florida|1|||
156854572|NCT00296816|566222030|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
156854573|NCT00296816|566222030|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
156854574|NCT00296816|566222030|FG000|Overall Study|Neuropathy/patient preference|1|||
156854575|NCT00296816|566222030|FG000|Overall Study|Proteinuria|1|||
156854576|NCT00296816|566222030|FG000|Overall Study|ineligibility due to radiation treatment|1|||
156854577|NCT00985465|566222031|FG000|Overall Study|Withdrawal by Subject|1|||
156854578|NCT00985465|566222032|FG001|Overall Study|Withdrawal by Subject|2|||
156854579|NCT00985465|566222031|FG000|Overall Study|Considered to be part of the other group|0|||
156854580|NCT00985465|566222032|FG001|Overall Study|Considered to be part of the other group|1|||
156854581|NCT04701333|566222033|FG000|Overall Study|Lost to Follow-up|3|||
156854582|NCT04701333|566222034|FG001|Overall Study|Lost to Follow-up|7|||
156854583|NCT04701333|566222033|FG000|Overall Study|Withdrawal by Subject|0|||
156854584|NCT04701333|566222034|FG001|Overall Study|Withdrawal by Subject|1|||
156854585|NCT01012258|566222035|FG000|Overall Study|Death|14|||
156854586|NCT01012258|566222035|FG000|Overall Study|Lost to Follow-up|1|||
156854587|NCT01012258|566222035|FG000|Overall Study|Adverse Event|1|||
156854588|NCT01012258|566222035|FG000|Overall Study|Progressive Disease (PD)|18|||
156854589|NCT01012258|566222035|FG000|Overall Study|Symptomatic Deterioration|1|||
156854590|NCT01012258|566222035|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
156854591|NCT01012258|566222035|FG000|Overall Study|Another Tumor Discovered|1|||
156854592|NCT01012258|566222035|FG000|Overall Study|Ongoing|29|||
156854593|NCT01292187|566222036|FG000|Overall Study|Adverse Event|10|||
156854594|NCT01292187|566222037|FG001|Overall Study|Adverse Event|5|||
156854595|NCT01292187|566222036|FG000|Overall Study|Withdrawal by Subject|6|||
156854596|NCT01292187|566222037|FG001|Overall Study|Withdrawal by Subject|5|||
156854597|NCT01292187|566222036|FG000|Overall Study|All other reasons|1|||
156854598|NCT01292187|566222037|FG001|Overall Study|All other reasons|3|||
156854599|NCT01814527|566222039|FG000|Overall Study|RTP greater than 30 days|6|||
156854600|NCT01814527|566222040|FG001|Overall Study|RTP greater than 30 days|1|||
156854601|NCT00687401|566222043|FG000|Overall Study|Protocol Violation|7|||
156342255|NCT01532414|564352602|FG002|Overall Study|No V6 semen sample|0|||
156342256|NCT01532414|564352600|FG000|Overall Study|Adverse Event|0|||
156342257|NCT01532414|564352601|FG001|Overall Study|Adverse Event|1|||
156342258|NCT01532414|564352602|FG002|Overall Study|Adverse Event|1|||
156342259|NCT01532414|564352600|FG000|Overall Study|Unable to complete 24 hour PK|0|||
156342260|NCT01532414|564352601|FG001|Overall Study|Unable to complete 24 hour PK|0|||
156342261|NCT01532414|564352602|FG002|Overall Study|Unable to complete 24 hour PK|1|||
156342262|NCT01532414|564352600|FG000|Overall Study|Withdrawn by sponsor|1|||
156342263|NCT01532414|564352601|FG001|Overall Study|Withdrawn by sponsor|0|||
156342264|NCT01532414|564352602|FG002|Overall Study|Withdrawn by sponsor|0|||
156854602|NCT00687401|566222043|FG000|Overall Study|Adverse Event|6|||
156854603|NCT00687401|566222043|FG000|Overall Study|Lack of Efficacy|6|||
156854604|NCT00687401|566222043|FG000|Overall Study|Withdrawal by Subject|4|||
156854605|NCT00687401|566222043|FG000|Overall Study|Did not return for visit|3|||
156854606|NCT00687401|566222043|FG000|Overall Study|For reasons different from those above|4|||
156854607|NCT02366195|566222044|FG000|Overall Study|Protocol-specified criteria|3|||
156854608|NCT02366195|566222044|FG000|Overall Study|Withdrawal by Subject|9|||
156854609|NCT02366195|566222044|FG000|Overall Study|Lost to Follow-up|1|||
156854610|NCT02366195|566222044|FG000|Overall Study|Death|41|||
156854611|NCT02520726|566222045|FG000|Overall Study|Lost to Follow-up|3|||
156854612|NCT02520726|566222046|FG001|Overall Study|Lost to Follow-up|2|||
156854613|NCT00721396|566222049|FG000|Overall Study|Adverse Event|4|||
156854614|NCT00721396|566222050|FG001|Overall Study|Adverse Event|7|||
156854615|NCT00721396|566222051|FG002|Overall Study|Adverse Event|2|||
156854616|NCT00721396|566222052|FG003|Overall Study|Adverse Event|0|||
156854617|NCT00721396|566222049|FG000|Overall Study|Withdrawal by Subject|12|||
156854618|NCT00721396|566222050|FG001|Overall Study|Withdrawal by Subject|15|||
156854619|NCT00721396|566222051|FG002|Overall Study|Withdrawal by Subject|3|||
156854620|NCT00721396|566222052|FG003|Overall Study|Withdrawal by Subject|7|||
156854621|NCT00721396|566222049|FG000|Overall Study|Lost to Follow-up|7|||
156854622|NCT00721396|566222050|FG001|Overall Study|Lost to Follow-up|9|||
156854623|NCT00721396|566222051|FG002|Overall Study|Lost to Follow-up|3|||
156854624|NCT00721396|566222052|FG003|Overall Study|Lost to Follow-up|3|||
156854625|NCT00721396|566222049|FG000|Overall Study|Protocol Violation|4|||
156854626|NCT00721396|566222050|FG001|Overall Study|Protocol Violation|3|||
156854627|NCT00721396|566222051|FG002|Overall Study|Protocol Violation|1|||
156854628|NCT00721396|566222052|FG003|Overall Study|Protocol Violation|0|||
156854629|NCT00721396|566222049|FG000|Overall Study|Inappropriate enrollment|0|||
156854630|NCT00721396|566222050|FG001|Overall Study|Inappropriate enrollment|2|||
156854631|NCT00721396|566222051|FG002|Overall Study|Inappropriate enrollment|0|||
156854632|NCT00721396|566222052|FG003|Overall Study|Inappropriate enrollment|0|||
156854633|NCT00721396|566222049|FG000|Overall Study|Administrative reason|3|||
156854634|NCT00721396|566222050|FG001|Overall Study|Administrative reason|0|||
156854635|NCT00721396|566222051|FG002|Overall Study|Administrative reason|1|||
156854636|NCT00721396|566222052|FG003|Overall Study|Administrative reason|0|||
156854637|NCT00148759|566222053|FG000|Overall Study|Withdrawal by Subject|1|||
156854638|NCT00148759|566222054|FG001|Overall Study|Withdrawal by Subject|1|||
156854639|NCT00148759|566222053|FG000|Overall Study|Lost to Follow-up|1|||
156854640|NCT00148759|566222054|FG001|Overall Study|Lost to Follow-up|0|||
156854641|NCT00430716|566222058|FG000|Double Blind Phase|Death|1|||
156854642|NCT00430716|566222059|FG001|Double Blind Phase|Death|0|||
156854643|NCT00430716|566222060|FG002|Double Blind Phase|Death|0|||
156854644|NCT00430716|566222058|FG000|Double Blind Phase|No longer willing to participate|2|||
156854645|NCT00430716|566222059|FG001|Double Blind Phase|No longer willing to participate|1|||
156854646|NCT00430716|566222060|FG002|Double Blind Phase|No longer willing to participate|1|||
156854647|NCT00430716|566222058|FG000|Double Blind Phase|Other|0|||
156854648|NCT00430716|566222059|FG001|Double Blind Phase|Other|2|||
156854649|NCT00430716|566222060|FG002|Double Blind Phase|Other|0|||
156854650|NCT00430716|566222058|FG000|Double Blind Phase|Study terminated by sponsor|1|||
156854651|NCT00430716|566222059|FG001|Double Blind Phase|Study terminated by sponsor|1|||
156854652|NCT00430716|566222060|FG002|Double Blind Phase|Study terminated by sponsor|2|||
156854653|NCT00430716|566222058|FG000|Double Blind Phase|Adverse Event|1|||
156854654|NCT00430716|566222059|FG001|Double Blind Phase|Adverse Event|1|||
156854655|NCT00430716|566222060|FG002|Double Blind Phase|Adverse Event|3|||
156854656|NCT00430716|566222058|FG000|Double Blind Phase|Not treated|1|||
156854657|NCT00430716|566222059|FG001|Double Blind Phase|Not treated|0|||
156854658|NCT00430716|566222060|FG002|Double Blind Phase|Not treated|0|||
156854659|NCT00430716|566222058|FG000|Open Label Phase|Lost to Follow-up|1|||
156854660|NCT00430716|566222059|FG001|Open Label Phase|Lost to Follow-up|0|||
156854661|NCT00430716|566222060|FG002|Open Label Phase|Lost to Follow-up|1|||
156854662|NCT00430716|566222058|FG000|Open Label Phase|No longer willing to participate|0|||
156854663|NCT00430716|566222059|FG001|Open Label Phase|No longer willing to participate|1|||
156854664|NCT00430716|566222060|FG002|Open Label Phase|No longer willing to participate|1|||
156854665|NCT00430716|566222058|FG000|Open Label Phase|Other|3|||
156854666|NCT00430716|566222059|FG001|Open Label Phase|Other|1|||
156854667|NCT00430716|566222060|FG002|Open Label Phase|Other|1|||
156854668|NCT00430716|566222058|FG000|Open Label Phase|Protocol Violation|1|||
156854669|NCT00430716|566222059|FG001|Open Label Phase|Protocol Violation|0|||
156854670|NCT00430716|566222060|FG002|Open Label Phase|Protocol Violation|0|||
156854671|NCT00430716|566222058|FG000|Open Label Phase|Study terminated by sponsor|4|||
156854672|NCT00430716|566222059|FG001|Open Label Phase|Study terminated by sponsor|5|||
156854673|NCT00430716|566222060|FG002|Open Label Phase|Study terminated by sponsor|4|||
156854674|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
156854675|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
156472602|NCT03732807|564825525|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
156472603|NCT03732807|564825526|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
156472604|NCT03732807|564825527|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
156472605|NCT03732807|564825521|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
156854676|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
156854677|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
156854678|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
156854679|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
156854680|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
156854681|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
156854682|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
156472606|NCT03732807|564825522|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
156472607|NCT03732807|564825523|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
156472608|NCT03732807|564825524|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
156472609|NCT03732807|564825525|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
156472610|NCT03732807|564825526|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
156854683|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
156854684|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
156854685|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
156854686|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
156854687|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
156854688|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
156854689|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
156854690|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
156854691|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
156854692|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
156854693|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
156854694|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
156854695|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
156854696|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
156854697|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
156854698|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
156854699|NCT01329978|566222066|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
156854700|NCT01329978|566222067|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
156854701|NCT01329978|566222068|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
156854702|NCT01329978|566222069|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
156854703|NCT01329978|566222070|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
156854704|NCT01329978|566222066|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
156854705|NCT01329978|566222067|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
156854706|NCT01329978|566222068|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
156854707|NCT01329978|566222069|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
156854708|NCT01329978|566222070|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
156854709|NCT01188772|566222074|FG000|Overall Study|Randomized but Not Treated|0|||
156854710|NCT01188772|566222075|FG001|Overall Study|Randomized but Not Treated|1|||
156854711|NCT01188772|566222076|FG002|Overall Study|Randomized but Not Treated|0|||
156854712|NCT01188772|566222077|FG003|Overall Study|Randomized but Not Treated|0|||
156854713|NCT01188772|566222074|FG000|Overall Study|Adverse Event|0|||
156854714|NCT01188772|566222075|FG001|Overall Study|Adverse Event|1|||
156854715|NCT01188772|566222076|FG002|Overall Study|Adverse Event|2|||
156854716|NCT01188772|566222077|FG003|Overall Study|Adverse Event|0|||
156854717|NCT01188772|566222074|FG000|Overall Study|Lost to Follow-up|4|||
156854718|NCT01188772|566222075|FG001|Overall Study|Lost to Follow-up|1|||
156854719|NCT01188772|566222076|FG002|Overall Study|Lost to Follow-up|1|||
156854720|NCT01188772|566222077|FG003|Overall Study|Lost to Follow-up|1|||
156854721|NCT01188772|566222074|FG000|Overall Study|Non-responder|0|||
156854722|NCT01188772|566222075|FG001|Overall Study|Non-responder|0|||
156854723|NCT01188772|566222076|FG002|Overall Study|Non-responder|3|||
156854724|NCT01188772|566222077|FG003|Overall Study|Non-responder|0|||
156854725|NCT01188772|566222074|FG000|Overall Study|Physician Decision|0|||
156854726|NCT01188772|566222075|FG001|Overall Study|Physician Decision|0|||
156854727|NCT01188772|566222076|FG002|Overall Study|Physician Decision|1|||
156472611|NCT03732807|564825527|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
156472612|NCT03737110|564825528|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
156472613|NCT03737110|564825529|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
156472614|NCT03737110|564825530|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
156854728|NCT01188772|566222077|FG003|Overall Study|Physician Decision|0|||
156854729|NCT01188772|566222074|FG000|Overall Study|Terminated by Sponsor|0|||
156854730|NCT01188772|566222075|FG001|Overall Study|Terminated by Sponsor|0|||
156854731|NCT01188772|566222076|FG002|Overall Study|Terminated by Sponsor|1|||
156854732|NCT01188772|566222077|FG003|Overall Study|Terminated by Sponsor|0|||
156854733|NCT01188772|566222074|FG000|Overall Study|Treatment Failure|0|||
156854734|NCT01188772|566222075|FG001|Overall Study|Treatment Failure|0|||
156854735|NCT01188772|566222076|FG002|Overall Study|Treatment Failure|1|||
156854736|NCT01188772|566222077|FG003|Overall Study|Treatment Failure|0|||
156472615|NCT03737110|564825531|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
156854737|NCT01188772|566222074|FG000|Overall Study|Virologic Failure|1|||
156854738|NCT01188772|566222075|FG001|Overall Study|Virologic Failure|0|||
156854739|NCT01188772|566222076|FG002|Overall Study|Virologic Failure|0|||
156854740|NCT01188772|566222077|FG003|Overall Study|Virologic Failure|0|||
156854741|NCT01188772|566222074|FG000|Overall Study|Withdrawal by Subject|0|||
156854742|NCT01188772|566222075|FG001|Overall Study|Withdrawal by Subject|0|||
156472616|NCT03737110|564825532|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
156472617|NCT03737110|564825533|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
156472618|NCT03737110|564825528|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
156854743|NCT01188772|566222076|FG002|Overall Study|Withdrawal by Subject|2|||
156854744|NCT01188772|566222077|FG003|Overall Study|Withdrawal by Subject|0|||
156854745|NCT03081884|566222081|FG000|Overall Study|deferred prostate cancer treatment|1|||
156854746|NCT03081884|566222081|FG000|Overall Study|metastasis managed with systemic therapy|3|||
156854747|NCT02294058|566222082|FG000|Overall Study|Adverse Event|16|||
156854748|NCT02294058|566222083|FG001|Overall Study|Adverse Event|7|||
156854749|NCT02294058|566222084|FG002|Overall Study|Adverse Event|13|||
156854750|NCT02294058|566222082|FG000|Overall Study|Lack of Efficacy|3|||
156854751|NCT02294058|566222083|FG001|Overall Study|Lack of Efficacy|3|||
156854752|NCT02294058|566222084|FG002|Overall Study|Lack of Efficacy|0|||
156854753|NCT02294058|566222082|FG000|Overall Study|Lost to Follow-up|1|||
156854754|NCT02294058|566222083|FG001|Overall Study|Lost to Follow-up|0|||
156854755|NCT02294058|566222084|FG002|Overall Study|Lost to Follow-up|2|||
156854756|NCT02294058|566222082|FG000|Overall Study|Withdrawal by Subject|10|||
156854757|NCT02294058|566222083|FG001|Overall Study|Withdrawal by Subject|14|||
156854758|NCT02294058|566222084|FG002|Overall Study|Withdrawal by Subject|13|||
156854759|NCT02294058|566222082|FG000|Overall Study|Physician Decision|2|||
156854760|NCT02294058|566222083|FG001|Overall Study|Physician Decision|1|||
156854761|NCT02294058|566222084|FG002|Overall Study|Physician Decision|0|||
156854762|NCT02294058|566222082|FG000|Overall Study|Miscellaneous|4|||
156854763|NCT02294058|566222083|FG001|Overall Study|Miscellaneous|1|||
156854764|NCT02294058|566222084|FG002|Overall Study|Miscellaneous|1|||
156854765|NCT03957551|566222091|FG000|Overall Study|Adverse Event|2|||
156854766|NCT03957551|566222092|FG001|Overall Study|Adverse Event|2|||
156854767|NCT03957551|566222093|FG002|Overall Study|Adverse Event|6|||
156854768|NCT03957551|566222091|FG000|Overall Study|Physician Decision|1|||
156854769|NCT03957551|566222092|FG001|Overall Study|Physician Decision|0|||
156854770|NCT03957551|566222093|FG002|Overall Study|Physician Decision|2|||
156854771|NCT03957551|566222091|FG000|Overall Study|Withdrawal by Subject|1|||
156854772|NCT03957551|566222092|FG001|Overall Study|Withdrawal by Subject|0|||
156854773|NCT03957551|566222093|FG002|Overall Study|Withdrawal by Subject|2|||
156854774|NCT03957551|566222091|FG000|Overall Study|Disease progression|1|||
156854775|NCT03957551|566222092|FG001|Overall Study|Disease progression|0|||
156854776|NCT03957551|566222093|FG002|Overall Study|Disease progression|8|||
156854777|NCT02717494|566222096|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
156854778|NCT02717494|566222097|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
156854779|NCT02717494|566222098|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
156854780|NCT02717494|566222096|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
156854781|NCT02717494|566222097|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
156854782|NCT02717494|566222098|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
156854783|NCT02717494|566222096|FG000|First Intervention (Step 1)|Death|0|||
156854784|NCT02717494|566222097|FG001|First Intervention (Step 1)|Death|0|||
156854785|NCT02717494|566222098|FG002|First Intervention (Step 1)|Death|1|||
156854786|NCT02717494|566222096|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
156854787|NCT02717494|566222097|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
156854788|NCT02717494|566222098|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
156854789|NCT00154297|566222101|FG000|Overall Study|Death|5|||
156854790|NCT00154297|566222102|FG001|Overall Study|Death|2|||
156854791|NCT00154297|566222101|FG000|Overall Study|Withdrawal by Subject|0|||
156854792|NCT00154297|566222102|FG001|Overall Study|Withdrawal by Subject|5|||
156854793|NCT00154297|566222101|FG000|Overall Study|Lost to Follow-up|3|||
156854794|NCT00154297|566222102|FG001|Overall Study|Lost to Follow-up|0|||
156472619|NCT03737110|564825529|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
156854795|NCT00650767|566222105|FG000|Overall Study|Adverse Event|0|||
156854796|NCT00650767|566222106|FG001|Overall Study|Adverse Event|3|||
156854797|NCT00650767|566222107|FG002|Overall Study|Adverse Event|10|||
156854798|NCT00650767|566222108|FG003|Overall Study|Adverse Event|8|||
156854799|NCT00650767|566222105|FG000|Overall Study|Death|1|||
156854800|NCT00650767|566222106|FG001|Overall Study|Death|0|||
156854801|NCT00650767|566222107|FG002|Overall Study|Death|0|||
156854802|NCT00650767|566222108|FG003|Overall Study|Death|0|||
156854803|NCT00650767|566222105|FG000|Overall Study|Withdrawal by Subject|2|||
156854804|NCT00650767|566222106|FG001|Overall Study|Withdrawal by Subject|4|||
156854805|NCT00650767|566222107|FG002|Overall Study|Withdrawal by Subject|3|||
156854806|NCT00650767|566222108|FG003|Overall Study|Withdrawal by Subject|3|||
156854807|NCT00650767|566222105|FG000|Overall Study|Lost to Follow-up|1|||
156854808|NCT00650767|566222106|FG001|Overall Study|Lost to Follow-up|1|||
156854809|NCT00650767|566222107|FG002|Overall Study|Lost to Follow-up|1|||
156854810|NCT00650767|566222108|FG003|Overall Study|Lost to Follow-up|0|||
156854811|NCT00650767|566222105|FG000|Overall Study|Other|1|||
156854812|NCT00650767|566222106|FG001|Overall Study|Other|1|||
156342265|NCT00684593|564352603|FG000|Overall Study|Adverse Event|0|||
156854813|NCT00650767|566222107|FG002|Overall Study|Other|0|||
156854814|NCT00650767|566222108|FG003|Overall Study|Other|0|||
156854815|NCT03649074|566222109|FG000|Overall Study|Lost to Follow-up|2|||
156854816|NCT03649074|566222110|FG001|Overall Study|Lost to Follow-up|1|||
156854817|NCT03649074|566222109|FG000|Overall Study|Adverse Event|1|||
156854818|NCT03649074|566222110|FG001|Overall Study|Adverse Event|0|||
156854819|NCT03649074|566222109|FG000|Overall Study|Physician Decision|1|||
156854820|NCT03649074|566222110|FG001|Overall Study|Physician Decision|0|||
156854821|NCT03649074|566222109|FG000|Overall Study|Withdrawal by Subject|0|||
156854822|NCT03649074|566222110|FG001|Overall Study|Withdrawal by Subject|2|||
156854823|NCT03649074|566222109|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
156854824|NCT03649074|566222110|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
156854825|NCT03649074|566222109|FG000|Overall Study|Other|1|||
156854826|NCT03649074|566222110|FG001|Overall Study|Other|0|||
156854827|NCT01125800|566222113|FG000|Phase I|Protocol Violation|0|||
156854828|NCT01125800|566222114|FG001|Phase I|Protocol Violation|3|||
156854829|NCT01125800|566222115|FG002|Phase I|Protocol Violation|1|||
156854830|NCT01125800|566222116|FG003|Phase I|Protocol Violation|1|||
156854831|NCT01125800|566222117|FG004|Phase I|Protocol Violation|0|||
156854832|NCT01125800|566222113|FG000|Phase I|Adverse Event|2|||
156854833|NCT01125800|566222114|FG001|Phase I|Adverse Event|2|||
156854834|NCT01125800|566222115|FG002|Phase I|Adverse Event|1|||
156854835|NCT01125800|566222116|FG003|Phase I|Adverse Event|7|||
156854836|NCT01125800|566222117|FG004|Phase I|Adverse Event|0|||
156854837|NCT01125800|566222113|FG000|Phase I|Administrative problems|1|||
156854838|NCT01125800|566222114|FG001|Phase I|Administrative problems|0|||
156854839|NCT01125800|566222115|FG002|Phase I|Administrative problems|0|||
156854840|NCT01125800|566222116|FG003|Phase I|Administrative problems|0|||
156854841|NCT01125800|566222117|FG004|Phase I|Administrative problems|0|||
156854842|NCT01125800|566222113|FG000|Phase I|Withdrawal by Subject|0|||
156854843|NCT01125800|566222114|FG001|Phase I|Withdrawal by Subject|0|||
156854844|NCT01125800|566222115|FG002|Phase I|Withdrawal by Subject|1|||
156854845|NCT01125800|566222116|FG003|Phase I|Withdrawal by Subject|0|||
156854846|NCT01125800|566222117|FG004|Phase I|Withdrawal by Subject|0|||
156854847|NCT01125800|566222113|FG000|Phase I|Disease progression|5|||
156854848|NCT01125800|566222114|FG001|Phase I|Disease progression|4|||
156854849|NCT01125800|566222115|FG002|Phase I|Disease progression|1|||
156854850|NCT01125800|566222116|FG003|Phase I|Disease progression|3|||
156854851|NCT01125800|566222117|FG004|Phase I|Disease progression|0|||
156854852|NCT01125800|566222113|FG000|Phase II|Protocol Violation|0|||
156854853|NCT01125800|566222114|FG001|Phase II|Protocol Violation|0|||
156854854|NCT01125800|566222115|FG002|Phase II|Protocol Violation|0|||
156854855|NCT01125800|566222116|FG003|Phase II|Protocol Violation|0|||
156854856|NCT01125800|566222117|FG004|Phase II|Protocol Violation|1|||
156854857|NCT01125800|566222113|FG000|Phase II|Adverse Event|0|||
156854858|NCT01125800|566222114|FG001|Phase II|Adverse Event|0|||
156854859|NCT01125800|566222115|FG002|Phase II|Adverse Event|0|||
156854860|NCT01125800|566222116|FG003|Phase II|Adverse Event|0|||
156854861|NCT01125800|566222117|FG004|Phase II|Adverse Event|2|||
156854862|NCT01125800|566222113|FG000|Phase II|Disease progression|0|||
156854863|NCT01125800|566222114|FG001|Phase II|Disease progression|0|||
156854864|NCT01125800|566222115|FG002|Phase II|Disease progression|0|||
156854865|NCT01125800|566222116|FG003|Phase II|Disease progression|1|||
156854866|NCT01125800|566222117|FG004|Phase II|Disease progression|8|||
156854867|NCT04332107|566222121|FG000|Day 3|Lost to Follow-up|23|||
156342266|NCT00684593|564352604|FG001|Overall Study|Adverse Event|2|||
156342267|NCT02599129|564352607|FG000|Overall Study|Lack of Efficacy|2|||
156854868|NCT04332107|566222122|FG001|Day 3|Lost to Follow-up|14|||
156854869|NCT04332107|566222121|FG000|Day 3|Missing outcome data|3|||
156854870|NCT04332107|566222122|FG001|Day 3|Missing outcome data|6|||
156854871|NCT04332107|566222121|FG000|Day 14|Lost to Follow-up|13|||
156854872|NCT04332107|566222122|FG001|Day 14|Lost to Follow-up|4|||
156854873|NCT04332107|566222121|FG000|Day 14|Missing outcome data|4|||
156854874|NCT04332107|566222122|FG001|Day 14|Missing outcome data|4|||
156854875|NCT04332107|566222121|FG000|Day 21|Lost to Follow-up|10|||
156854876|NCT04332107|566222122|FG001|Day 21|Lost to Follow-up|2|||
156854877|NCT00717249|566222123|FG000|Overall Study|Lens Discomfort|4|||
156854878|NCT00717249|566222124|FG001|Overall Study|Lens Discomfort|1|||
156854879|NCT00717249|566222123|FG000|Overall Study|Unsatisfactory visual Response|0|||
156342268|NCT02599129|564352608|FG001|Overall Study|Lack of Efficacy|2|||
156854880|NCT00717249|566222124|FG001|Overall Study|Unsatisfactory visual Response|2|||
156854881|NCT00717249|566222123|FG000|Overall Study|Adverse Event|4|||
156854882|NCT00717249|566222124|FG001|Overall Study|Adverse Event|2|||
156854883|NCT00717249|566222123|FG000|Overall Study|Lost to Follow-up|2|||
156854884|NCT00717249|566222124|FG001|Overall Study|Lost to Follow-up|0|||
156854885|NCT00717249|566222123|FG000|Overall Study|Withdrawal by Subject|1|||
156854886|NCT00717249|566222124|FG001|Overall Study|Withdrawal by Subject|2|||
156854887|NCT00717249|566222123|FG000|Overall Study|Pregnancy|6|||
156854888|NCT00717249|566222124|FG001|Overall Study|Pregnancy|3|||
156854889|NCT00717249|566222123|FG000|Overall Study|Protocol Violation|0|||
156854890|NCT00717249|566222124|FG001|Overall Study|Protocol Violation|2|||
156854891|NCT00717249|566222123|FG000|Overall Study|Subject became Ineligible|1|||
156854892|NCT00717249|566222124|FG001|Overall Study|Subject became Ineligible|1|||
156854893|NCT00717249|566222123|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
156854894|NCT00717249|566222124|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
156854895|NCT00717249|566222123|FG000|Overall Study|Gastric Surgery|0|||
156854896|NCT00717249|566222124|FG001|Overall Study|Gastric Surgery|1|||
156854897|NCT00717249|566222123|FG000|Overall Study|Diagnosed with Diabetes|1|||
156854898|NCT00717249|566222124|FG001|Overall Study|Diagnosed with Diabetes|0|||
156854899|NCT00717249|566222123|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
156854900|NCT00717249|566222124|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
156854901|NCT00717249|566222123|FG000|Overall Study|Subject relocated|1|||
156854902|NCT00717249|566222124|FG001|Overall Study|Subject relocated|0|||
156854903|NCT00717249|566222123|FG000|Overall Study|Headaches|1|||
156854904|NCT00717249|566222124|FG001|Overall Study|Headaches|0|||
156854905|NCT01808196|566222128|FG000|Overall Study|Lost to Follow-up|1|||
156854906|NCT03370718|566222129|FG000|Overall Study|Withdrawal by Subject|1|||
156854907|NCT01670721|566222130|FG000|Overall Study|Participant's decision|15|||
156854908|NCT01670721|566222130|FG000|Overall Study|Other than specified above|38|||
156854909|NCT00479713|566222131|FG000|Overall Study|Adverse Event|8|||
156854910|NCT00479713|566222132|FG001|Overall Study|Adverse Event|6|||
156854911|NCT00479713|566222131|FG000|Overall Study|Death|1|||
156854912|NCT00479713|566222132|FG001|Overall Study|Death|0|||
156854913|NCT00479713|566222131|FG000|Overall Study|Lost to Follow-up|0|||
156854914|NCT00479713|566222132|FG001|Overall Study|Lost to Follow-up|1|||
156854915|NCT00479713|566222131|FG000|Overall Study|Protocol Violation|0|||
156854916|NCT00479713|566222132|FG001|Overall Study|Protocol Violation|1|||
156854917|NCT00479713|566222131|FG000|Overall Study|Withdrawal by Subject|4|||
156854918|NCT00479713|566222132|FG001|Overall Study|Withdrawal by Subject|1|||
156854919|NCT00141102|566222137|FG000|Overall Study|Adverse Event|233|||
156854920|NCT00141102|566222138|FG001|Overall Study|Adverse Event|305|||
156854921|NCT00141102|566222137|FG000|Overall Study|Laboratory Abnormality|9|||
156854922|NCT00141102|566222138|FG001|Overall Study|Laboratory Abnormality|33|||
156854923|NCT00141102|566222137|FG000|Overall Study|Lack of Efficacy|21|||
156854924|NCT00141102|566222138|FG001|Overall Study|Lack of Efficacy|26|||
156854925|NCT00141102|566222137|FG000|Overall Study|Lost to Follow-up|29|||
156854926|NCT00141102|566222138|FG001|Overall Study|Lost to Follow-up|32|||
156854927|NCT00141102|566222137|FG000|Overall Study|Other|87|||
156854928|NCT00141102|566222138|FG001|Overall Study|Other|76|||
156854929|NCT00141102|566222137|FG000|Overall Study|Withdrawal by Subject|112|||
156854930|NCT00141102|566222138|FG001|Overall Study|Withdrawal by Subject|142|||
156854931|NCT00141102|566222137|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
156854932|NCT00141102|566222138|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
156854933|NCT00141102|566222137|FG000|Overall Study|Death|2|||
156854934|NCT00141102|566222138|FG001|Overall Study|Death|2|||
156854935|NCT03061201|566222139|FG000|Overall Study|Participants Terminated at Month 36|0|||
156854936|NCT03061201|566222140|FG001|Overall Study|Participants Terminated at Month 36|1|||
156854937|NCT03061201|566222141|FG002|Overall Study|Participants Terminated at Month 36|0|||
156854938|NCT03061201|566222142|FG003|Overall Study|Participants Terminated at Month 36|1|||
156854939|NCT03061201|566222139|FG000|Overall Study|Lost to Follow-up|1|||
156854940|NCT03061201|566222140|FG001|Overall Study|Lost to Follow-up|0|||
156854941|NCT03061201|566222141|FG002|Overall Study|Lost to Follow-up|0|||
156854942|NCT03061201|566222142|FG003|Overall Study|Lost to Follow-up|0|||
156854943|NCT01572480|566222143|FG000|Participants Enrolled|Withdrawal by Subject|1|||
156854944|NCT01572480|566222143|FG000|Drug Administration|Discontinued drug/Off Study|1|||
156854945|NCT01572480|566222143|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
156854946|NCT01572480|566222143|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
156854947|NCT05481359|566222144|FG000|Overall Study|Lost to Follow-up|3|||
156854948|NCT05481359|566222144|FG000|Overall Study|Withdrawal by Subject|1|||
156854949|NCT00348673|566222146|FG000|Stage 1|Randomized but not Treated|0|||
156342269|NCT02599129|564352607|FG000|Overall Study|Lost to Follow-up|1|||
156342270|NCT02599129|564352608|FG001|Overall Study|Lost to Follow-up|0|||
156854950|NCT00348673|566222147|FG001|Stage 1|Randomized but not Treated|0|||
156854951|NCT00348673|566222148|FG002|Stage 1|Randomized but not Treated|1|||
156854952|NCT00348673|566222149|FG003|Stage 1|Randomized but not Treated|0|||
156854953|NCT00348673|566222150|FG004|Stage 1|Randomized but not Treated|0|||
156854954|NCT00348673|566222151|FG005|Stage 1|Randomized but not Treated|0|||
156854955|NCT00348673|566222152|FG006|Stage 1|Randomized but not Treated|0|||
156854956|NCT00348673|566222153|FG007|Stage 1|Randomized but not Treated|0|||
156342271|NCT02599129|564352607|FG000|Overall Study|Withdrawal by Subject|2|||
156854957|NCT00348673|566222154|FG008|Stage 1|Randomized but not Treated|0|||
156854958|NCT00794950|566222156|FG000|BCG Induction|Withdrawal by Subject|2|||
156854959|NCT00794950|566222156|FG000|BCG Induction|ineligible|3|||
156854960|NCT00794950|566222156|FG000|BCG Induction|noncompliant w. BCG|1|||
156854961|NCT00794950|566222156|FG000|BCG Induction|Adverse Event|1|||
156854962|NCT00794950|566222156|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
156854963|NCT00794950|566222156|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
156854964|NCT00794950|566222156|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
156854965|NCT00794950|566222156|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
156854966|NCT02485704|566222157|FG000|Overall Study|Lost to Follow-up|4|||
156854967|NCT02485704|566222158|FG001|Overall Study|Lost to Follow-up|5|||
156854968|NCT02485704|566222157|FG000|Overall Study|Withdrawal by Subject|0|||
156854969|NCT02485704|566222158|FG001|Overall Study|Withdrawal by Subject|3|||
156854970|NCT02485704|566222157|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
156854971|NCT02485704|566222158|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
156854972|NCT03798717|566223397|FG000|Overall Study|Failed Screening|0|||
156854973|NCT03798717|566223398|FG001|Overall Study|Failed Screening|0|||
156854974|NCT03798717|566223399|FG002|Overall Study|Failed Screening|0|||
156854975|NCT03798717|566223400|FG003|Overall Study|Failed Screening|0|||
156854976|NCT03798717|566223401|FG004|Overall Study|Failed Screening|0|||
156854977|NCT03798717|566223402|FG005|Overall Study|Failed Screening|1|||
156854978|NCT03798717|566223397|FG000|Overall Study|Physician Decision|1|||
156854979|NCT03798717|566223398|FG001|Overall Study|Physician Decision|0|||
156854980|NCT03798717|566223399|FG002|Overall Study|Physician Decision|1|||
156854981|NCT03798717|566223400|FG003|Overall Study|Physician Decision|0|||
156854982|NCT03798717|566223401|FG004|Overall Study|Physician Decision|0|||
156854983|NCT03798717|566223402|FG005|Overall Study|Physician Decision|0|||
156854984|NCT03798717|566223397|FG000|Overall Study|Withdrawal by Subject|0|||
156854985|NCT03798717|566223398|FG001|Overall Study|Withdrawal by Subject|0|||
156854986|NCT03798717|566223399|FG002|Overall Study|Withdrawal by Subject|0|||
156854987|NCT03798717|566223400|FG003|Overall Study|Withdrawal by Subject|1|||
156854988|NCT03798717|566223401|FG004|Overall Study|Withdrawal by Subject|0|||
156854989|NCT03798717|566223402|FG005|Overall Study|Withdrawal by Subject|0|||
156854990|NCT03798717|566223397|FG000|Overall Study|Lost to Follow-up|1|||
156854991|NCT03798717|566223398|FG001|Overall Study|Lost to Follow-up|0|||
156854992|NCT03798717|566223399|FG002|Overall Study|Lost to Follow-up|0|||
156854993|NCT03798717|566223400|FG003|Overall Study|Lost to Follow-up|1|||
156854994|NCT03798717|566223401|FG004|Overall Study|Lost to Follow-up|0|||
156854995|NCT03798717|566223402|FG005|Overall Study|Lost to Follow-up|0|||
156854996|NCT03798717|566223397|FG000|Overall Study|Adverse Event|0|||
156854997|NCT03798717|566223398|FG001|Overall Study|Adverse Event|1|||
156854998|NCT03798717|566223399|FG002|Overall Study|Adverse Event|0|||
156854999|NCT03798717|566223400|FG003|Overall Study|Adverse Event|0|||
156855000|NCT03798717|566223401|FG004|Overall Study|Adverse Event|0|||
156855001|NCT03798717|566223402|FG005|Overall Study|Adverse Event|0|||
156855002|NCT03798717|566223397|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855003|NCT03798717|566223398|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855004|NCT03798717|566223399|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855005|NCT03798717|566223400|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855006|NCT03798717|566223401|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
156855007|NCT03798717|566223402|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855008|NCT04388111|566223407|FG000|Overall Study|Lost to Follow-up|5|||
156855009|NCT04388111|566223408|FG001|Overall Study|Lost to Follow-up|3|||
156855010|NCT04388111|566223407|FG000|Overall Study|Adverse Event|1|||
156855011|NCT04388111|566223408|FG001|Overall Study|Adverse Event|1|||
156855012|NCT04388111|566223407|FG000|Overall Study|Protocol Violation|2|||
156855013|NCT04388111|566223408|FG001|Overall Study|Protocol Violation|4|||
156855014|NCT04388111|566223407|FG000|Overall Study|Withdrawal by Subject|1|||
156855015|NCT04388111|566223408|FG001|Overall Study|Withdrawal by Subject|0|||
156855016|NCT01474317|566223416|FG000|Overall Study|Adverse Event|1|||
156855017|NCT01474317|566223416|FG000|Overall Study|Subject ineligible for study|1|||
156855018|NCT00387881|566223417|FG000|Overall Study|Lost to Follow-up|23|||
156855019|NCT00387881|566223418|FG001|Overall Study|Lost to Follow-up|23|||
156855020|NCT00387881|566223417|FG000|Overall Study|Protocol Violation|2|||
156855021|NCT00387881|566223418|FG001|Overall Study|Protocol Violation|12|||
156855022|NCT00387881|566223417|FG000|Overall Study|Withdrawal by Subject|15|||
156855023|NCT00387881|566223418|FG001|Overall Study|Withdrawal by Subject|18|||
156855024|NCT00387881|566223417|FG000|Overall Study|Sponsor terminated Study|0|||
156855025|NCT00387881|566223418|FG001|Overall Study|Sponsor terminated Study|1|||
156342272|NCT02599129|564352608|FG001|Overall Study|Withdrawal by Subject|1|||
156855026|NCT00387881|566223417|FG000|Overall Study|Not eligible|6|||
156855027|NCT00387881|566223418|FG001|Overall Study|Not eligible|7|||
156855028|NCT00387881|566223417|FG000|Overall Study|No opportunity to treat headache|32|||
156855029|NCT00387881|566223418|FG001|Overall Study|No opportunity to treat headache|34|||
156855030|NCT00387881|566223417|FG000|Overall Study|Not otherwise specified|11|||
156855031|NCT00387881|566223418|FG001|Overall Study|Not otherwise specified|7|||
156855032|NCT00453154|566223419|FG000|Double BIind Maintenance|Adverse Event|0|||
156855033|NCT00453154|566223420|FG001|Double BIind Maintenance|Adverse Event|0|||
156855034|NCT00453154|566223421|FG002|Double BIind Maintenance|Adverse Event|3|||
156855035|NCT00453154|566223422|FG003|Double BIind Maintenance|Adverse Event|12|||
156855036|NCT00453154|566223419|FG000|Double BIind Maintenance|Death|0|||
156855037|NCT00453154|566223420|FG001|Double BIind Maintenance|Death|0|||
156855038|NCT00453154|566223421|FG002|Double BIind Maintenance|Death|2|||
156855039|NCT00453154|566223422|FG003|Double BIind Maintenance|Death|1|||
156855040|NCT00453154|566223419|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
156855041|NCT00453154|566223420|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
156855042|NCT00453154|566223421|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
156855043|NCT00453154|566223422|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
156855044|NCT00453154|566223419|FG000|Double BIind Maintenance|Progression|0|||
156855045|NCT00453154|566223420|FG001|Double BIind Maintenance|Progression|0|||
156855046|NCT00453154|566223421|FG002|Double BIind Maintenance|Progression|29|||
156855047|NCT00453154|566223422|FG003|Double BIind Maintenance|Progression|26|||
156855048|NCT00453154|566223419|FG000|Double BIind Maintenance|Medical Issues|0|||
156855049|NCT00453154|566223420|FG001|Double BIind Maintenance|Medical Issues|0|||
156855050|NCT00453154|566223421|FG002|Double BIind Maintenance|Medical Issues|3|||
156855051|NCT00453154|566223422|FG003|Double BIind Maintenance|Medical Issues|1|||
156855052|NCT00453154|566223419|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
156855053|NCT00453154|566223420|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
156855054|NCT00453154|566223421|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
156855055|NCT00453154|566223422|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
156855056|NCT05473026|566223425|FG000|Overall Study|Lost to Follow-up|5|||
156855057|NCT05473026|566223426|FG001|Overall Study|Lost to Follow-up|2|||
156855058|NCT01050634|566223427|FG000|Overall Study|Enrolled, but Not Treated|56|||
156855059|NCT01050634|566223427|FG000|Overall Study|Death|2|||
156855060|NCT01050634|566223427|FG000|Overall Study|Adverse Event|42|||
156855061|NCT01050634|566223427|FG000|Overall Study|Lost to Follow-up|2|||
156855062|NCT01050634|566223427|FG000|Overall Study|Other|21|||
156855063|NCT01050634|566223427|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
156855064|NCT00248495|566223433|FG000|Overall Study|Withdrawal by Subject|1|||
156855065|NCT05470387|566223434|FG000|Overall Study|Protocol Violation|0|||
156855066|NCT05470387|566223435|FG001|Overall Study|Protocol Violation|3|||
156855067|NCT03367858|566223436|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
156855068|NCT03367858|566223437|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
156855069|NCT03367858|566223436|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
156855070|NCT03367858|566223437|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
156855071|NCT03367858|566223436|FG000|3 Month Follow Up|Lost to Follow-up|8|||
156855072|NCT03367858|566223437|FG001|3 Month Follow Up|Lost to Follow-up|3|||
156855073|NCT03367858|566223436|FG000|3 Month Follow Up|Moved out of study area|2|||
156855074|NCT03367858|566223437|FG001|3 Month Follow Up|Moved out of study area|6|||
156855075|NCT03367858|566223436|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
156855076|NCT03367858|566223437|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
156855077|NCT03367858|566223436|FG000|3 Month Follow Up|MRI contraindication|2|||
156855078|NCT03367858|566223437|FG001|3 Month Follow Up|MRI contraindication|1|||
156855079|NCT03367858|566223436|FG000|3 Month Follow Up|Incarcerated|0|||
156855080|NCT03367858|566223437|FG001|3 Month Follow Up|Incarcerated|1|||
156855081|NCT03367858|566223436|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
156855082|NCT03367858|566223437|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
156855083|NCT03367858|566223436|FG000|6 Month Follow Up|Lost to Follow-up|5|||
156855084|NCT03367858|566223437|FG001|6 Month Follow Up|Lost to Follow-up|2|||
156855085|NCT03367858|566223436|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
156855086|NCT03367858|566223437|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
156855087|NCT03367858|566223436|FG000|12 Month Follow Up|Lost to Follow-up|3|||
156855088|NCT03367858|566223437|FG001|12 Month Follow Up|Lost to Follow-up|3|||
156855089|NCT03367858|566223436|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
156855090|NCT03367858|566223437|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
156855091|NCT01054456|566223438|FG000|Overall Study|Other|1|||
156855092|NCT01774799|566223441|FG000|Overall Study|Lost to Follow-up|1|||
156855093|NCT01774799|566223442|FG001|Overall Study|Lost to Follow-up|1|||
156855094|NCT01774799|566223443|FG002|Overall Study|Lost to Follow-up|0|||
156855095|NCT01774799|566223444|FG003|Overall Study|Lost to Follow-up|0|||
156855096|NCT06172348|566223445|FG000|Treatment Period 2|Adverse Event|0|||
156855097|NCT06172348|566223446|FG001|Treatment Period 2|Adverse Event|0|||
156855098|NCT06172348|566223447|FG002|Treatment Period 2|Adverse Event|1|||
156855099|NCT06172348|566223448|FG003|Treatment Period 2|Adverse Event|0|||
156855100|NCT06172348|566223449|FG004|Treatment Period 2|Adverse Event|0|||
156855101|NCT06172348|566223450|FG005|Treatment Period 2|Adverse Event|0|||
156855102|NCT04037891|566223451|FG000|Open-label Period|Withdrawal by Subject|1|||
156855103|NCT04037891|566223452|FG001|Open-label Period|Withdrawal by Subject|0|||
156855104|NCT04037891|566223453|FG002|Open-label Period|Withdrawal by Subject|0|||
156855105|NCT04037891|566223451|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
156855106|NCT04037891|566223452|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
156855107|NCT04037891|566223453|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
156855108|NCT04194944|566223454|FG000|Overall Study|Lost to Follow-up|3|||
156855109|NCT04194944|566223455|FG001|Overall Study|Lost to Follow-up|0|||
156855110|NCT04194944|566223454|FG000|Overall Study|Withdrawal by Subject|2|||
156855111|NCT04194944|566223455|FG001|Overall Study|Withdrawal by Subject|2|||
156855112|NCT04194944|566223454|FG000|Overall Study|On Treatment|93|||
156855113|NCT04194944|566223455|FG001|Overall Study|On Treatment|30|||
156855114|NCT03446313|566223456|FG000|Overall Study|Lost to Follow-up|1|||
156855115|NCT03446313|566223457|FG001|Overall Study|Lost to Follow-up|2|||
156855116|NCT03446313|566223456|FG000|Overall Study|Failed primary screening|3|||
156855117|NCT03446313|566223457|FG001|Overall Study|Failed primary screening|0|||
156855118|NCT03446313|566223456|FG000|Overall Study|Diagnosed with terminal cancer|1|||
156855119|NCT03446313|566223457|FG001|Overall Study|Diagnosed with terminal cancer|0|||
156855120|NCT03446313|566223456|FG000|Overall Study|Excluded from analysis|1|||
156855121|NCT03446313|566223457|FG001|Overall Study|Excluded from analysis|1|||
156855122|NCT03100149|566223458|FG000|Overall Study|Adverse Event|0|||
156855123|NCT03100149|566223459|FG001|Overall Study|Adverse Event|1|||
156855124|NCT03100149|566223460|FG002|Overall Study|Adverse Event|0|||
156855125|NCT03100149|566223458|FG000|Overall Study|Participant Moved out of Country|0|||
156855126|NCT03100149|566223459|FG001|Overall Study|Participant Moved out of Country|0|||
156855127|NCT03100149|566223460|FG002|Overall Study|Participant Moved out of Country|1|||
156855128|NCT03100149|566223458|FG000|Overall Study|Withdrawal by Subject|0|||
156855129|NCT03100149|566223459|FG001|Overall Study|Withdrawal by Subject|3|||
156855130|NCT03100149|566223460|FG002|Overall Study|Withdrawal by Subject|1|||
156855131|NCT05214768|566223463|FG000|Induction Period|Withdrawal by Subject|1|||
156855132|NCT05214768|566223464|FG001|Induction Period|Withdrawal by Subject|0|||
156855133|NCT05214768|566223465|FG002|Induction Period|Withdrawal by Subject|0|||
156855134|NCT05214768|566223466|FG003|Induction Period|Withdrawal by Subject|0|||
156855135|NCT05214768|566223467|FG004|Induction Period|Withdrawal by Subject|0|||
156855136|NCT05214768|566223468|FG005|Induction Period|Withdrawal by Subject|0|||
156855137|NCT05214768|566223463|FG000|Induction Period|Physician Decision|1|||
156855138|NCT05214768|566223464|FG001|Induction Period|Physician Decision|0|||
156855139|NCT05214768|566223465|FG002|Induction Period|Physician Decision|0|||
156855140|NCT05214768|566223466|FG003|Induction Period|Physician Decision|0|||
156342273|NCT00617773|564352609|FG000|Overall Study|Physician Decision|1|||
156342274|NCT00617773|564352609|FG000|Overall Study|Lack of compliance with the protocol|1|||
156472620|NCT03737110|564825530|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
156472621|NCT03737110|564825531|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
156472622|NCT03737110|564825532|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
156472623|NCT03737110|564825533|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
156472624|NCT03737110|564825528|FG000|Run-in (RI) Period|Adverse Event|4|||
156855141|NCT05214768|566223467|FG004|Induction Period|Physician Decision|0|||
156855142|NCT05214768|566223468|FG005|Induction Period|Physician Decision|0|||
156855143|NCT05214768|566223463|FG000|Maintenance Period|Other Reasons|0|||
156855144|NCT05214768|566223464|FG001|Maintenance Period|Other Reasons|0|||
156855145|NCT05214768|566223465|FG002|Maintenance Period|Other Reasons|1|||
156472625|NCT03737110|564825529|FG001|Run-in (RI) Period|Adverse Event|0|||
156472626|NCT03737110|564825530|FG002|Run-in (RI) Period|Adverse Event|0|||
156472627|NCT03737110|564825531|FG003|Run-in (RI) Period|Adverse Event|0|||
156472628|NCT03737110|564825532|FG004|Run-in (RI) Period|Adverse Event|0|||
156855146|NCT05214768|566223466|FG003|Maintenance Period|Other Reasons|1|||
156855147|NCT05214768|566223467|FG004|Maintenance Period|Other Reasons|0|||
156855148|NCT05214768|566223468|FG005|Maintenance Period|Other Reasons|0|||
156855149|NCT05214768|566223463|FG000|Maintenance Period|Withdrawal by Subject|0|||
156855150|NCT05214768|566223464|FG001|Maintenance Period|Withdrawal by Subject|0|||
156855151|NCT05214768|566223465|FG002|Maintenance Period|Withdrawal by Subject|0|||
156855152|NCT05214768|566223466|FG003|Maintenance Period|Withdrawal by Subject|1|||
156855153|NCT05214768|566223467|FG004|Maintenance Period|Withdrawal by Subject|0|||
156855154|NCT05214768|566223468|FG005|Maintenance Period|Withdrawal by Subject|0|||
156855155|NCT05214768|566223463|FG000|Maintenance Period|Lack of Efficacy|0|||
156855156|NCT05214768|566223464|FG001|Maintenance Period|Lack of Efficacy|0|||
156855157|NCT05214768|566223465|FG002|Maintenance Period|Lack of Efficacy|1|||
156855158|NCT05214768|566223466|FG003|Maintenance Period|Lack of Efficacy|0|||
156855159|NCT05214768|566223467|FG004|Maintenance Period|Lack of Efficacy|1|||
156855160|NCT05214768|566223468|FG005|Maintenance Period|Lack of Efficacy|0|||
156855161|NCT05214768|566223463|FG000|Open Label Extension Period|Physician Decision|0|||
156855162|NCT05214768|566223464|FG001|Open Label Extension Period|Physician Decision|0|||
156855163|NCT05214768|566223465|FG002|Open Label Extension Period|Physician Decision|0|||
156855164|NCT05214768|566223466|FG003|Open Label Extension Period|Physician Decision|0|||
156855165|NCT05214768|566223467|FG004|Open Label Extension Period|Physician Decision|0|||
156855166|NCT05214768|566223468|FG005|Open Label Extension Period|Physician Decision|1|||
156855167|NCT05214768|566223463|FG000|Open Label Extension Period|Lack of Efficacy|0|||
156855168|NCT05214768|566223464|FG001|Open Label Extension Period|Lack of Efficacy|0|||
156855169|NCT05214768|566223465|FG002|Open Label Extension Period|Lack of Efficacy|0|||
156855170|NCT05214768|566223466|FG003|Open Label Extension Period|Lack of Efficacy|0|||
156855171|NCT05214768|566223467|FG004|Open Label Extension Period|Lack of Efficacy|0|||
156855172|NCT05214768|566223468|FG005|Open Label Extension Period|Lack of Efficacy|1|||
156855173|NCT05214768|566223463|FG000|Open Label Extension Period|Ongoing Study|0|||
156855174|NCT05214768|566223464|FG001|Open Label Extension Period|Ongoing Study|0|||
156855175|NCT05214768|566223465|FG002|Open Label Extension Period|Ongoing Study|0|||
156855176|NCT05214768|566223466|FG003|Open Label Extension Period|Ongoing Study|0|||
156855177|NCT05214768|566223467|FG004|Open Label Extension Period|Ongoing Study|0|||
156855178|NCT05214768|566223468|FG005|Open Label Extension Period|Ongoing Study|42|||
156855179|NCT05579977|566223478|FG000|Treatment Phase|Other|0|||
156855180|NCT05579977|566223479|FG001|Treatment Phase|Other|0|||
156855181|NCT05579977|566223480|FG002|Treatment Phase|Other|0|||
156855182|NCT05579977|566223481|FG003|Treatment Phase|Other|2|||
156855183|NCT05579977|566223482|FG004|Treatment Phase|Other|1|||
156855184|NCT05579977|566223483|FG005|Treatment Phase|Other|2|||
156855185|NCT05579977|566223484|FG006|Treatment Phase|Other|1|||
156855186|NCT05579977|566223485|FG007|Treatment Phase|Other|2|||
156855187|NCT05579977|566223486|FG008|Treatment Phase|Other|2|||
156855188|NCT05579977|566223487|FG009|Treatment Phase|Other|1|||
156855189|NCT05579977|566223488|FG010|Treatment Phase|Other|0|||
156855190|NCT05579977|566223489|FG011|Treatment Phase|Other|0|||
156855191|NCT05579977|566223490|FG012|Treatment Phase|Other|3|||
156855192|NCT05579977|566223478|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
156855193|NCT05579977|566223479|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
156855194|NCT05579977|566223480|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
156855195|NCT05579977|566223481|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
156855196|NCT05579977|566223482|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
156855197|NCT05579977|566223483|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
156855198|NCT05579977|566223484|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
156855199|NCT05579977|566223485|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
156855200|NCT05579977|566223486|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
156855201|NCT05579977|566223487|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
156342275|NCT00617773|564352609|FG000|Overall Study|Withdrawal by Subject|1|||
156472629|NCT03737110|564825533|FG005|Run-in (RI) Period|Adverse Event|0|||
156472630|NCT03737110|564825528|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
156472631|NCT03737110|564825529|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
156855202|NCT05579977|566223488|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
156855203|NCT05579977|566223489|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
156855204|NCT05579977|566223490|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
156855205|NCT05579977|566223478|FG000|Treatment Phase|Withdrawal by Subject|2|||
156855206|NCT05579977|566223479|FG001|Treatment Phase|Withdrawal by Subject|0|||
156855207|NCT05579977|566223480|FG002|Treatment Phase|Withdrawal by Subject|0|||
156855208|NCT05579977|566223481|FG003|Treatment Phase|Withdrawal by Subject|1|||
156855209|NCT05579977|566223482|FG004|Treatment Phase|Withdrawal by Subject|2|||
156342276|NCT00617773|564352609|FG000|Overall Study|Death|1|||
156855210|NCT05579977|566223483|FG005|Treatment Phase|Withdrawal by Subject|0|||
156855211|NCT05579977|566223484|FG006|Treatment Phase|Withdrawal by Subject|1|||
156855212|NCT05579977|566223485|FG007|Treatment Phase|Withdrawal by Subject|8|||
156855213|NCT05579977|566223486|FG008|Treatment Phase|Withdrawal by Subject|3|||
156342277|NCT00617773|564352609|FG000|Overall Study|Progressive disease|19|||
156342278|NCT00617773|564352609|FG000|Overall Study|Protocol Violation|1|||
156342279|NCT01029795|564352610|FG000|Overall Study|Entry Criteria Not Met|2|||
156342280|NCT01029795|564352611|FG001|Overall Study|Entry Criteria Not Met|1|||
156342281|NCT01029795|564352610|FG000|Overall Study|Physician Decision|2|||
156342282|NCT01029795|564352611|FG001|Overall Study|Physician Decision|1|||
156342283|NCT01029795|564352610|FG000|Overall Study|Sponsor Decision|11|||
156342284|NCT01029795|564352611|FG001|Overall Study|Sponsor Decision|17|||
156342285|NCT01029795|564352610|FG000|Overall Study|Withdrawal by Subject|1|||
156342286|NCT01029795|564352611|FG001|Overall Study|Withdrawal by Subject|3|||
156342287|NCT03217175|564352612|FG000|Overall Study|Physician Decision|4|||
156342288|NCT03217175|564352613|FG001|Overall Study|Physician Decision|1|||
156342289|NCT05526716|564352620|FG000|Overall Study|Death|1|||
156342290|NCT05526716|564352621|FG001|Overall Study|Death|2|||
156342291|NCT05526716|564352620|FG000|Overall Study|Lost to Follow-up|17|||
156342292|NCT05526716|564352621|FG001|Overall Study|Lost to Follow-up|15|||
156342293|NCT05526716|564352620|FG000|Overall Study|Physician Decision|0|||
156342294|NCT05526716|564352621|FG001|Overall Study|Physician Decision|1|||
156342295|NCT05526716|564352620|FG000|Overall Study|Randomized by mistake without study treatment|0|||
156342296|NCT05526716|564352621|FG001|Overall Study|Randomized by mistake without study treatment|1|||
156342297|NCT05526716|564352620|FG000|Overall Study|Withdrawal by Subject|12|||
156342298|NCT05526716|564352621|FG001|Overall Study|Withdrawal by Subject|12|||
156342299|NCT05526716|564352620|FG000|Overall Study|Not reported|0|||
156342300|NCT05526716|564352621|FG001|Overall Study|Not reported|2|||
156342301|NCT05035550|564352629|FG000|Overall Study|Withdrawal by Subject|3|||
156342302|NCT05035550|564352630|FG001|Overall Study|Withdrawal by Subject|0|||
156342303|NCT04932096|564352631|FG000|Overall Study|Withdrawal by Subject|1|||
156342304|NCT04932096|564352632|FG001|Overall Study|Withdrawal by Subject|1|||
156342305|NCT04932096|564352631|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
156342306|NCT04932096|564352632|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
156542190|NCT04342871|565079259|FG000|Overall Study|Clinical deterioration/illness progression|2|||
156855214|NCT05579977|566223487|FG009|Treatment Phase|Withdrawal by Subject|3|||
156855215|NCT05579977|566223488|FG010|Treatment Phase|Withdrawal by Subject|5|||
156855216|NCT05579977|566223489|FG011|Treatment Phase|Withdrawal by Subject|1|||
156855217|NCT05579977|566223490|FG012|Treatment Phase|Withdrawal by Subject|3|||
156855218|NCT05579977|566223478|FG000|Treatment Phase|Study terminated by sponsor|70|||
156855219|NCT05579977|566223479|FG001|Treatment Phase|Study terminated by sponsor|70|||
156855220|NCT05579977|566223480|FG002|Treatment Phase|Study terminated by sponsor|61|||
156855221|NCT05579977|566223481|FG003|Treatment Phase|Study terminated by sponsor|59|||
156855222|NCT05579977|566223482|FG004|Treatment Phase|Study terminated by sponsor|63|||
156855223|NCT05579977|566223483|FG005|Treatment Phase|Study terminated by sponsor|53|||
156855224|NCT05579977|566223484|FG006|Treatment Phase|Study terminated by sponsor|66|||
156855225|NCT05579977|566223485|FG007|Treatment Phase|Study terminated by sponsor|48|||
156855226|NCT05579977|566223486|FG008|Treatment Phase|Study terminated by sponsor|47|||
156855227|NCT05579977|566223487|FG009|Treatment Phase|Study terminated by sponsor|37|||
156855228|NCT05579977|566223488|FG010|Treatment Phase|Study terminated by sponsor|44|||
156855229|NCT05579977|566223489|FG011|Treatment Phase|Study terminated by sponsor|36|||
156855230|NCT05579977|566223490|FG012|Treatment Phase|Study terminated by sponsor|32|||
156855231|NCT05579977|566223478|FG000|Treatment Phase|Pregnancy|0|||
156855232|NCT05579977|566223479|FG001|Treatment Phase|Pregnancy|0|||
156855233|NCT05579977|566223480|FG002|Treatment Phase|Pregnancy|0|||
156855234|NCT05579977|566223481|FG003|Treatment Phase|Pregnancy|0|||
156855235|NCT05579977|566223482|FG004|Treatment Phase|Pregnancy|0|||
156855236|NCT05579977|566223483|FG005|Treatment Phase|Pregnancy|0|||
156855237|NCT05579977|566223484|FG006|Treatment Phase|Pregnancy|0|||
156855238|NCT05579977|566223485|FG007|Treatment Phase|Pregnancy|0|||
156855239|NCT05579977|566223486|FG008|Treatment Phase|Pregnancy|0|||
156855240|NCT05579977|566223487|FG009|Treatment Phase|Pregnancy|1|||
156855241|NCT05579977|566223488|FG010|Treatment Phase|Pregnancy|0|||
156855242|NCT05579977|566223489|FG011|Treatment Phase|Pregnancy|0|||
156855243|NCT05579977|566223490|FG012|Treatment Phase|Pregnancy|0|||
156342307|NCT00429273|564352633|FG000|Overall Study|Lost to Follow-up|1|||
156342308|NCT00429273|564352634|FG001|Overall Study|Lost to Follow-up|2|||
156342309|NCT00429273|564352635|FG002|Overall Study|Lost to Follow-up|2|||
156342310|NCT00429273|564352633|FG000|Overall Study|Physician Decision|6|||
156342311|NCT00429273|564352634|FG001|Overall Study|Physician Decision|5|||
156342312|NCT00429273|564352635|FG002|Overall Study|Physician Decision|5|||
156855244|NCT05579977|566223478|FG000|Treatment Phase|Physician Decision|0|||
156855245|NCT05579977|566223479|FG001|Treatment Phase|Physician Decision|0|||
156855246|NCT05579977|566223480|FG002|Treatment Phase|Physician Decision|0|||
156855247|NCT05579977|566223481|FG003|Treatment Phase|Physician Decision|0|||
156855248|NCT05579977|566223482|FG004|Treatment Phase|Physician Decision|0|||
156855249|NCT05579977|566223483|FG005|Treatment Phase|Physician Decision|0|||
156472632|NCT03737110|564825530|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
156472633|NCT03737110|564825531|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
156472634|NCT03737110|564825532|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
156472635|NCT03737110|564825533|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
156855250|NCT05579977|566223484|FG006|Treatment Phase|Physician Decision|0|||
156855251|NCT05579977|566223485|FG007|Treatment Phase|Physician Decision|0|||
156855252|NCT05579977|566223486|FG008|Treatment Phase|Physician Decision|0|||
156855253|NCT05579977|566223487|FG009|Treatment Phase|Physician Decision|0|||
156855254|NCT05579977|566223488|FG010|Treatment Phase|Physician Decision|0|||
156855255|NCT05579977|566223489|FG011|Treatment Phase|Physician Decision|1|||
156855256|NCT05579977|566223490|FG012|Treatment Phase|Physician Decision|0|||
156855257|NCT05579977|566223478|FG000|Treatment Phase|Lost to Follow-up|0|||
156855258|NCT05579977|566223479|FG001|Treatment Phase|Lost to Follow-up|0|||
156855259|NCT05579977|566223480|FG002|Treatment Phase|Lost to Follow-up|0|||
156855260|NCT05579977|566223481|FG003|Treatment Phase|Lost to Follow-up|1|||
156855261|NCT05579977|566223482|FG004|Treatment Phase|Lost to Follow-up|1|||
156855262|NCT05579977|566223483|FG005|Treatment Phase|Lost to Follow-up|1|||
156855263|NCT05579977|566223484|FG006|Treatment Phase|Lost to Follow-up|0|||
156855264|NCT05579977|566223485|FG007|Treatment Phase|Lost to Follow-up|1|||
156855265|NCT05579977|566223486|FG008|Treatment Phase|Lost to Follow-up|2|||
156855266|NCT05579977|566223487|FG009|Treatment Phase|Lost to Follow-up|2|||
156855267|NCT05579977|566223488|FG010|Treatment Phase|Lost to Follow-up|1|||
156855268|NCT05579977|566223489|FG011|Treatment Phase|Lost to Follow-up|4|||
156855269|NCT05579977|566223490|FG012|Treatment Phase|Lost to Follow-up|3|||
156855270|NCT05579977|566223478|FG000|Treatment Phase|Death|1|||
156855271|NCT05579977|566223479|FG001|Treatment Phase|Death|0|||
156855272|NCT05579977|566223480|FG002|Treatment Phase|Death|0|||
156855273|NCT05579977|566223481|FG003|Treatment Phase|Death|0|||
156855274|NCT05579977|566223482|FG004|Treatment Phase|Death|0|||
156855275|NCT05579977|566223483|FG005|Treatment Phase|Death|0|||
156855276|NCT05579977|566223484|FG006|Treatment Phase|Death|0|||
156855277|NCT05579977|566223485|FG007|Treatment Phase|Death|0|||
156855278|NCT05579977|566223486|FG008|Treatment Phase|Death|0|||
156855279|NCT05579977|566223487|FG009|Treatment Phase|Death|0|||
156855280|NCT05579977|566223488|FG010|Treatment Phase|Death|0|||
156855281|NCT05579977|566223489|FG011|Treatment Phase|Death|0|||
156855282|NCT05579977|566223490|FG012|Treatment Phase|Death|0|||
156855283|NCT05579977|566223478|FG000|Treatment Phase|Adverse Event|0|||
156855284|NCT05579977|566223479|FG001|Treatment Phase|Adverse Event|3|||
156855285|NCT05579977|566223480|FG002|Treatment Phase|Adverse Event|11|||
156855286|NCT05579977|566223481|FG003|Treatment Phase|Adverse Event|10|||
156855287|NCT05579977|566223482|FG004|Treatment Phase|Adverse Event|5|||
156855288|NCT05579977|566223483|FG005|Treatment Phase|Adverse Event|17|||
156855289|NCT05579977|566223484|FG006|Treatment Phase|Adverse Event|5|||
156855290|NCT05579977|566223485|FG007|Treatment Phase|Adverse Event|5|||
156855291|NCT05579977|566223486|FG008|Treatment Phase|Adverse Event|12|||
156855292|NCT05579977|566223487|FG009|Treatment Phase|Adverse Event|20|||
156855293|NCT05579977|566223488|FG010|Treatment Phase|Adverse Event|15|||
156855294|NCT05579977|566223489|FG011|Treatment Phase|Adverse Event|24|||
156855295|NCT05579977|566223490|FG012|Treatment Phase|Adverse Event|23|||
156855296|NCT05579977|566223478|FG000|Treatment Phase|Randomized not treated|0|||
156855297|NCT05579977|566223479|FG001|Treatment Phase|Randomized not treated|0|||
156855298|NCT05579977|566223480|FG002|Treatment Phase|Randomized not treated|0|||
156855299|NCT05579977|566223481|FG003|Treatment Phase|Randomized not treated|0|||
156855300|NCT05579977|566223482|FG004|Treatment Phase|Randomized not treated|1|||
156855301|NCT05579977|566223483|FG005|Treatment Phase|Randomized not treated|0|||
156855302|NCT05579977|566223484|FG006|Treatment Phase|Randomized not treated|0|||
156855303|NCT05579977|566223485|FG007|Treatment Phase|Randomized not treated|0|||
156855304|NCT05579977|566223486|FG008|Treatment Phase|Randomized not treated|0|||
156855305|NCT05579977|566223487|FG009|Treatment Phase|Randomized not treated|0|||
156855306|NCT05579977|566223488|FG010|Treatment Phase|Randomized not treated|0|||
156472636|NCT03737110|564825528|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
156855307|NCT05579977|566223489|FG011|Treatment Phase|Randomized not treated|0|||
156855308|NCT05579977|566223490|FG012|Treatment Phase|Randomized not treated|0|||
156855309|NCT05579977|566223478|FG000|Follow up|Death|1|||
156855310|NCT05579977|566223479|FG001|Follow up|Death|0|||
156855311|NCT05579977|566223480|FG002|Follow up|Death|0|||
156855312|NCT05579977|566223481|FG003|Follow up|Death|0|||
156855313|NCT05579977|566223482|FG004|Follow up|Death|0|||
156855314|NCT05579977|566223483|FG005|Follow up|Death|0|||
156855315|NCT05579977|566223484|FG006|Follow up|Death|0|||
156855316|NCT05579977|566223485|FG007|Follow up|Death|0|||
156855317|NCT05579977|566223486|FG008|Follow up|Death|0|||
156855318|NCT05579977|566223487|FG009|Follow up|Death|0|||
156855319|NCT05579977|566223488|FG010|Follow up|Death|0|||
156855320|NCT05579977|566223489|FG011|Follow up|Death|0|||
156855321|NCT05579977|566223490|FG012|Follow up|Death|0|||
156855322|NCT05579977|566223478|FG000|Follow up|Lost to Follow-up|0|||
156855323|NCT05579977|566223479|FG001|Follow up|Lost to Follow-up|0|||
156855324|NCT05579977|566223480|FG002|Follow up|Lost to Follow-up|0|||
156855325|NCT05579977|566223481|FG003|Follow up|Lost to Follow-up|1|||
156855326|NCT05579977|566223482|FG004|Follow up|Lost to Follow-up|1|||
156855327|NCT05579977|566223483|FG005|Follow up|Lost to Follow-up|2|||
156855328|NCT05579977|566223484|FG006|Follow up|Lost to Follow-up|1|||
156855329|NCT05579977|566223485|FG007|Follow up|Lost to Follow-up|1|||
156855330|NCT05579977|566223486|FG008|Follow up|Lost to Follow-up|3|||
156855331|NCT05579977|566223487|FG009|Follow up|Lost to Follow-up|2|||
156855332|NCT05579977|566223488|FG010|Follow up|Lost to Follow-up|2|||
156855333|NCT05579977|566223489|FG011|Follow up|Lost to Follow-up|4|||
156855334|NCT05579977|566223490|FG012|Follow up|Lost to Follow-up|4|||
156855335|NCT05579977|566223478|FG000|Follow up|Withdrawal by Subject|2|||
156855336|NCT05579977|566223479|FG001|Follow up|Withdrawal by Subject|0|||
156855337|NCT05579977|566223480|FG002|Follow up|Withdrawal by Subject|0|||
156855338|NCT05579977|566223481|FG003|Follow up|Withdrawal by Subject|0|||
156855339|NCT05579977|566223482|FG004|Follow up|Withdrawal by Subject|1|||
156855340|NCT05579977|566223483|FG005|Follow up|Withdrawal by Subject|0|||
156855341|NCT05579977|566223484|FG006|Follow up|Withdrawal by Subject|1|||
156855342|NCT05579977|566223485|FG007|Follow up|Withdrawal by Subject|4|||
156855343|NCT05579977|566223486|FG008|Follow up|Withdrawal by Subject|2|||
156855344|NCT05579977|566223487|FG009|Follow up|Withdrawal by Subject|3|||
156855345|NCT05579977|566223488|FG010|Follow up|Withdrawal by Subject|3|||
156855346|NCT05579977|566223489|FG011|Follow up|Withdrawal by Subject|1|||
156855347|NCT05579977|566223490|FG012|Follow up|Withdrawal by Subject|3|||
156855348|NCT01611194|566223492|FG000|Overall Study|Lost to Follow-up|0|||
156855349|NCT01611194|566223493|FG001|Overall Study|Lost to Follow-up|1|||
156855350|NCT01611194|566223492|FG000|Overall Study|Withdrawal by Subject|0|||
156855351|NCT01611194|566223493|FG001|Overall Study|Withdrawal by Subject|1|||
156855352|NCT01611194|566223492|FG000|Overall Study|drug use|0|||
156855353|NCT01611194|566223493|FG001|Overall Study|drug use|1|||
156855354|NCT00452790|566223494|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
156855355|NCT00452790|566223495|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
156855356|NCT00452790|566223494|FG000|Infant Series|Parent/legal guardian request|8|||
156855357|NCT00452790|566223495|FG001|Infant Series|Parent/legal guardian request|6|||
156855358|NCT00452790|566223494|FG000|Infant Series|Failed to return|4|||
156855359|NCT00452790|566223495|FG001|Infant Series|Failed to return|1|||
156855360|NCT00452790|566223494|FG000|Infant Series|Protocol Violation|1|||
156855361|NCT00452790|566223495|FG001|Infant Series|Protocol Violation|3|||
156855362|NCT00452790|566223494|FG000|Infant Series|Lost to Follow-up|2|||
156855363|NCT00452790|566223495|FG001|Infant Series|Lost to Follow-up|2|||
156855364|NCT00452790|566223494|FG000|Infant Series|Adverse Event|1|||
156855365|NCT00452790|566223495|FG001|Infant Series|Adverse Event|2|||
156855366|NCT00452790|566223494|FG000|Infant Series|Other reasons|1|||
156855367|NCT00452790|566223495|FG001|Infant Series|Other reasons|2|||
156855368|NCT00452790|566223494|FG000|Infant Series|Investigator request|0|||
156855369|NCT00452790|566223495|FG001|Infant Series|Investigator request|1|||
156855370|NCT00452790|566223494|FG000|Infant Series|Death|0|||
156855371|NCT00452790|566223495|FG001|Infant Series|Death|1|||
156855372|NCT00452790|566223494|FG000|After Infant Series|Investigator request|10|||
156855373|NCT00452790|566223495|FG001|After Infant Series|Investigator request|10|||
156855374|NCT00452790|566223494|FG000|After Infant Series|Adverse Event|4|||
156855375|NCT00452790|566223495|FG001|After Infant Series|Adverse Event|1|||
156855376|NCT00452790|566223494|FG000|After Infant Series|Parent/legal guardian request|1|||
156855377|NCT00452790|566223495|FG001|After Infant Series|Parent/legal guardian request|3|||
156855378|NCT00452790|566223494|FG000|After Infant Series|Lost to Follow-up|4|||
156855379|NCT00452790|566223495|FG001|After Infant Series|Lost to Follow-up|0|||
156855380|NCT00452790|566223494|FG000|After Infant Series|Failed to return|1|||
156855381|NCT00452790|566223495|FG001|After Infant Series|Failed to return|0|||
156855382|NCT00452790|566223494|FG000|After Infant Series|Other reasons|1|||
156855383|NCT00452790|566223495|FG001|After Infant Series|Other reasons|0|||
156855384|NCT00452790|566223494|FG000|Toddler Dose|Failed to return|0|||
156855385|NCT00452790|566223495|FG001|Toddler Dose|Failed to return|1|||
156855386|NCT00452790|566223494|FG000|Toddler Dose|Parent/legal guardian request|0|||
156855387|NCT00452790|566223495|FG001|Toddler Dose|Parent/legal guardian request|1|||
156855388|NCT01871519|566223504|FG000|Overall Study|Death|26|||
156472637|NCT03737110|564825529|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
156855389|NCT01871519|566223504|FG000|Overall Study|Lost to Follow-up|15|||
156472638|NCT03737110|564825530|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
156855390|NCT01871519|566223504|FG000|Overall Study|Withdrawal by Subject|49|||
156855391|NCT00350844|566223507|FG000|Overall Study|Lost to Follow-up|1|||
156855392|NCT01420926|566223508|FG000|Overall Study|Adverse Event|6|||
156855393|NCT01420926|566223509|FG001|Overall Study|Adverse Event|4|||
156855394|NCT01420926|566223508|FG000|Overall Study|Death|18|||
156855395|NCT01420926|566223509|FG001|Overall Study|Death|17|||
156855396|NCT01420926|566223508|FG000|Overall Study|Withdrawal by Subject|11|||
156855397|NCT01420926|566223509|FG001|Overall Study|Withdrawal by Subject|17|||
156855398|NCT01420926|566223508|FG000|Overall Study|Non-protocol treatment|17|||
156855399|NCT01420926|566223509|FG001|Overall Study|Non-protocol treatment|20|||
156855400|NCT01420926|566223508|FG000|Overall Study|Physician Decision|8|||
156855401|NCT01420926|566223509|FG001|Overall Study|Physician Decision|5|||
156855402|NCT01232868|566225145|FG000|Overall Study|Lost to Follow-up|2|||
156855403|NCT01232868|566225146|FG001|Overall Study|Lost to Follow-up|4|||
156855404|NCT04481243|566225147|FG000|Overall Study|Withdrawal by Subject|4|||
156855405|NCT04564846|566225148|FG000|Overall Study|Withdrawal by Subject|2|||
156855406|NCT04564846|566225149|FG001|Overall Study|Withdrawal by Subject|1|||
156855407|NCT04564846|566225148|FG000|Overall Study|Physician Decision|0|||
156855408|NCT04564846|566225149|FG001|Overall Study|Physician Decision|1|||
156855409|NCT04564846|566225148|FG000|Overall Study|Lost to Follow-up|0|||
156855410|NCT04564846|566225149|FG001|Overall Study|Lost to Follow-up|1|||
156855411|NCT04564846|566225148|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
156855412|NCT04564846|566225149|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
156855413|NCT04564846|566225148|FG000|Overall Study|Subject non-compliance|1|||
156855414|NCT04564846|566225149|FG001|Overall Study|Subject non-compliance|0|||
156855415|NCT01169103|566225159|FG000|Overall Study|Lost to Follow-up|3|||
156855416|NCT01169103|566225160|FG001|Overall Study|Lost to Follow-up|3|||
156855417|NCT01169103|566225159|FG000|Overall Study|Withdrawal by Subject|3|||
156855418|NCT01169103|566225160|FG001|Overall Study|Withdrawal by Subject|1|||
156855419|NCT03360682|566225165|FG000|Overall Study|Adverse Event|3|||
156855420|NCT01363700|566225168|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
156855421|NCT01363700|566225169|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
156855422|NCT01363700|566225170|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
156855423|NCT01363700|566225171|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
156855424|NCT01363700|566225172|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
156855425|NCT03827655|566225173|FG000|Overall Study|Death|0|||
156855426|NCT03827655|566225174|FG001|Overall Study|Death|0|||
156855427|NCT03827655|566225175|FG002|Overall Study|Death|0|||
156855428|NCT03827655|566225176|FG003|Overall Study|Death|0|||
156855429|NCT03827655|566225177|FG004|Overall Study|Death|1|||
156855430|NCT03827655|566225173|FG000|Overall Study|Protocol Deviation|1|||
156855431|NCT03827655|566225174|FG001|Overall Study|Protocol Deviation|0|||
156855432|NCT03827655|566225175|FG002|Overall Study|Protocol Deviation|1|||
156855433|NCT03827655|566225176|FG003|Overall Study|Protocol Deviation|1|||
156855434|NCT03827655|566225177|FG004|Overall Study|Protocol Deviation|0|||
156855435|NCT03827655|566225173|FG000|Overall Study|Withdrawal by Subject|3|||
156855436|NCT03827655|566225174|FG001|Overall Study|Withdrawal by Subject|2|||
156855437|NCT03827655|566225175|FG002|Overall Study|Withdrawal by Subject|2|||
156855438|NCT03827655|566225176|FG003|Overall Study|Withdrawal by Subject|0|||
156855439|NCT03827655|566225177|FG004|Overall Study|Withdrawal by Subject|1|||
156855440|NCT03827655|566225173|FG000|Overall Study|Reason not Specified|3|||
156855441|NCT03827655|566225174|FG001|Overall Study|Reason not Specified|1|||
156855442|NCT03827655|566225175|FG002|Overall Study|Reason not Specified|1|||
156855443|NCT03827655|566225176|FG003|Overall Study|Reason not Specified|1|||
156342313|NCT00429273|564352633|FG000|Overall Study|Adverse Event|1|||
156342314|NCT00429273|564352634|FG001|Overall Study|Adverse Event|1|||
156472639|NCT03737110|564825531|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
156855444|NCT03827655|566225177|FG004|Overall Study|Reason not Specified|1|||
156472640|NCT03737110|564825532|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
156472641|NCT03737110|564825533|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
156472642|NCT03737110|564825528|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
156855445|NCT03649217|566225178|FG000|Overall Study|subject had severe ataxia not initially found|1|||
156855446|NCT03649217|566225178|FG000|Overall Study|subject had cognitive issues not initially found|1|||
156855447|NCT02552966|566225179|FG000|Overall Study|Lost to Follow-up|2|||
156855448|NCT02552966|566225179|FG000|Overall Study|Withdrawal by Subject|3|||
156855449|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855450|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855451|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855452|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
156855453|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855454|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855455|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855456|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855457|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855458|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855459|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
156855460|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
156855461|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855462|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
156855463|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
156472643|NCT03737110|564825529|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
156472644|NCT03737110|564825530|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
156472645|NCT03737110|564825531|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
156855464|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
156855465|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855466|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855467|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855468|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855469|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
156855470|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
156855471|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
156855472|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
156855473|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
156855474|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
156855475|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
156855476|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
156855477|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
156855478|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
156855479|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
156855480|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855481|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
156855482|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855483|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
156855484|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
156855485|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855486|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855487|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855488|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855489|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
156855490|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855491|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
156855492|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855493|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
156472646|NCT03737110|564825532|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
156472647|NCT03737110|564825533|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
156855494|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855495|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855496|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855497|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855498|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156472648|NCT03737110|564825528|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
156855499|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
156855500|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855501|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855502|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855503|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
156855504|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
156855505|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855506|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855507|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855508|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855509|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855510|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855511|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
156855512|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855513|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855514|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855515|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855516|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855517|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855518|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855519|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855520|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855521|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855522|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855523|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855524|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855525|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
156855526|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855527|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855528|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855529|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855530|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855531|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855532|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855533|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855534|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855535|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
156855536|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855537|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
156855538|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
156855539|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855540|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855541|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855542|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855543|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855544|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855545|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
156855546|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
156855547|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
156855548|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
156855549|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855550|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855551|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855552|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855553|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855554|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855555|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
156855556|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855557|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
156855558|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
156472649|NCT03737110|564825529|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
156855559|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855560|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156472650|NCT03737110|564825530|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
156472651|NCT03737110|564825531|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
156472652|NCT03737110|564825532|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
156472653|NCT03737110|564825533|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
156855561|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855562|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855563|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855564|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855565|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
156855566|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855567|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
156855568|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855569|NCT01433172|566225202|FG000|Overall Study|Withdrawal by Subject|0|||
156855570|NCT01433172|566225203|FG001|Overall Study|Withdrawal by Subject|1|||
156855571|NCT01433172|566225204|FG002|Overall Study|Withdrawal by Subject|0|||
156855572|NCT01433172|566225202|FG000|Overall Study|Disease Progression|0|||
156855573|NCT01433172|566225203|FG001|Overall Study|Disease Progression|0|||
156855574|NCT01433172|566225204|FG002|Overall Study|Disease Progression|1|||
156855575|NCT01433172|566225202|FG000|Overall Study|Death|0|||
156855576|NCT01433172|566225203|FG001|Overall Study|Death|2|||
156855577|NCT01433172|566225204|FG002|Overall Study|Death|0|||
156855578|NCT01391663|566225205|FG000|Overall Study|Withdrawal by Subject|0|||
156855579|NCT01391663|566225206|FG001|Overall Study|Withdrawal by Subject|0|||
156855580|NCT01391663|566225207|FG002|Overall Study|Withdrawal by Subject|1|||
156855581|NCT01391663|566225208|FG003|Overall Study|Withdrawal by Subject|0|||
156855582|NCT00510835|566225212|FG000|Overall Study|Withdrawal by Subject|6|||
156855583|NCT00510835|566225213|FG001|Overall Study|Withdrawal by Subject|2|||
156855584|NCT00510835|566225214|FG002|Overall Study|Withdrawal by Subject|2|||
156855585|NCT03084796|566225215|FG000|Overall Study|Adverse Event|4|||
156855586|NCT03084796|566225216|FG001|Overall Study|Adverse Event|5|||
156855587|NCT03084796|566225217|FG002|Overall Study|Adverse Event|6|||
156855588|NCT03084796|566225218|FG003|Overall Study|Adverse Event|2|||
156855589|NCT03084796|566225219|FG004|Overall Study|Adverse Event|3|||
156855590|NCT03084796|566225220|FG005|Overall Study|Adverse Event|5|||
156855591|NCT03084796|566225215|FG000|Overall Study|Withdrawal by Subject|3|||
156855592|NCT03084796|566225216|FG001|Overall Study|Withdrawal by Subject|5|||
156855593|NCT03084796|566225217|FG002|Overall Study|Withdrawal by Subject|2|||
156855594|NCT03084796|566225218|FG003|Overall Study|Withdrawal by Subject|1|||
156855595|NCT03084796|566225219|FG004|Overall Study|Withdrawal by Subject|3|||
156855596|NCT03084796|566225220|FG005|Overall Study|Withdrawal by Subject|0|||
156855597|NCT03084796|566225215|FG000|Overall Study|Protocol Violation|0|||
156855598|NCT03084796|566225216|FG001|Overall Study|Protocol Violation|0|||
156855599|NCT03084796|566225217|FG002|Overall Study|Protocol Violation|1|||
156855600|NCT03084796|566225218|FG003|Overall Study|Protocol Violation|0|||
156855601|NCT03084796|566225219|FG004|Overall Study|Protocol Violation|1|||
156855602|NCT03084796|566225220|FG005|Overall Study|Protocol Violation|1|||
156855603|NCT03084796|566225215|FG000|Overall Study|Lack of Efficacy|0|||
156855604|NCT03084796|566225216|FG001|Overall Study|Lack of Efficacy|0|||
156855605|NCT03084796|566225217|FG002|Overall Study|Lack of Efficacy|1|||
156855606|NCT03084796|566225218|FG003|Overall Study|Lack of Efficacy|0|||
156855607|NCT03084796|566225219|FG004|Overall Study|Lack of Efficacy|1|||
156472654|NCT03737110|564825528|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
156855608|NCT03084796|566225220|FG005|Overall Study|Lack of Efficacy|0|||
156855609|NCT03084796|566225215|FG000|Overall Study|Lost to Follow-up|0|||
156855610|NCT03084796|566225216|FG001|Overall Study|Lost to Follow-up|0|||
156855611|NCT03084796|566225217|FG002|Overall Study|Lost to Follow-up|1|||
156855612|NCT03084796|566225218|FG003|Overall Study|Lost to Follow-up|1|||
156855613|NCT03084796|566225219|FG004|Overall Study|Lost to Follow-up|3|||
156855614|NCT03084796|566225220|FG005|Overall Study|Lost to Follow-up|1|||
156855615|NCT03084796|566225215|FG000|Overall Study|Randomization error|0|||
156855616|NCT03084796|566225216|FG001|Overall Study|Randomization error|0|||
156855617|NCT03084796|566225217|FG002|Overall Study|Randomization error|1|||
156855618|NCT03084796|566225218|FG003|Overall Study|Randomization error|0|||
156472655|NCT03737110|564825529|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
156855619|NCT03084796|566225219|FG004|Overall Study|Randomization error|0|||
156855620|NCT03084796|566225220|FG005|Overall Study|Randomization error|0|||
156855621|NCT02741245|566225229|FG000|Overall Study|Adverse Event|0|||
156855622|NCT02741245|566225230|FG001|Overall Study|Adverse Event|0|||
156855623|NCT02741245|566225231|FG002|Overall Study|Adverse Event|0|||
156855624|NCT02741245|566225232|FG003|Overall Study|Adverse Event|2|||
156855625|NCT02741245|566225233|FG004|Overall Study|Adverse Event|2|||
156855626|NCT02741245|566225229|FG000|Overall Study|Protocol Violation|0|||
156855627|NCT02741245|566225230|FG001|Overall Study|Protocol Violation|1|||
156855628|NCT02741245|566225231|FG002|Overall Study|Protocol Violation|0|||
156855629|NCT02741245|566225232|FG003|Overall Study|Protocol Violation|1|||
156855630|NCT02741245|566225233|FG004|Overall Study|Protocol Violation|0|||
156855631|NCT02741245|566225229|FG000|Overall Study|Withdrawal by Subject|0|||
156855632|NCT02741245|566225230|FG001|Overall Study|Withdrawal by Subject|0|||
156855633|NCT02741245|566225231|FG002|Overall Study|Withdrawal by Subject|0|||
156855634|NCT02741245|566225232|FG003|Overall Study|Withdrawal by Subject|1|||
156855635|NCT02741245|566225233|FG004|Overall Study|Withdrawal by Subject|0|||
156855636|NCT01787461|566225237|FG000|Overall Study|Adverse Event|4|||
156855637|NCT01787461|566225238|FG001|Overall Study|Adverse Event|3|||
156855638|NCT01787461|566225237|FG000|Overall Study|Lost to Follow-up|3|||
156855639|NCT01787461|566225238|FG001|Overall Study|Lost to Follow-up|2|||
156855640|NCT01787461|566225237|FG000|Overall Study|No longer met eligibility criteria|1|||
156855641|NCT01787461|566225238|FG001|Overall Study|No longer met eligibility criteria|0|||
156855642|NCT01787461|566225237|FG000|Overall Study|Withdrawal by Subject|3|||
156855643|NCT01787461|566225238|FG001|Overall Study|Withdrawal by Subject|4|||
156855644|NCT01787461|566225237|FG000|Overall Study|Protocol Violation|3|||
156855645|NCT01787461|566225238|FG001|Overall Study|Protocol Violation|0|||
156855646|NCT00152503|566225239|FG000|Overall Study|Adverse Event|4|||
156855647|NCT03259555|566225240|FG000|Overall Study|Adverse Event|6|||
156855648|NCT03259555|566225241|FG001|Overall Study|Adverse Event|4|||
156855649|NCT03259555|566225240|FG000|Overall Study|Lack of Efficacy|6|||
156855650|NCT03259555|566225241|FG001|Overall Study|Lack of Efficacy|4|||
156855651|NCT03259555|566225240|FG000|Overall Study|Lost to Follow-up|0|||
156855652|NCT03259555|566225241|FG001|Overall Study|Lost to Follow-up|2|||
156855653|NCT03259555|566225240|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156855654|NCT03259555|566225241|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156855655|NCT03259555|566225240|FG000|Overall Study|Progressive Disease|0|||
156855656|NCT03259555|566225241|FG001|Overall Study|Progressive Disease|2|||
156855657|NCT03259555|566225240|FG000|Overall Study|Withdrawal by Subject|19|||
156855658|NCT03259555|566225241|FG001|Overall Study|Withdrawal by Subject|16|||
156855659|NCT03259555|566225240|FG000|Overall Study|Physician Decision|1|||
156855660|NCT03259555|566225241|FG001|Overall Study|Physician Decision|2|||
156855661|NCT03259555|566225240|FG000|Overall Study|Other|1|||
156855662|NCT03259555|566225241|FG001|Overall Study|Other|0|||
156855663|NCT02800863|566225242|FG000|Overall Study|Adverse Event|14|||
156855664|NCT02800863|566225242|FG000|Overall Study|Another Device Implanted|1|||
156855665|NCT02800863|566225242|FG000|Overall Study|Device Explanted|1|||
156855666|NCT02800863|566225242|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
156855667|NCT02800863|566225242|FG000|Overall Study|Health Issues|1|||
156855668|NCT02800863|566225242|FG000|Overall Study|Insurance Denial|8|||
156855669|NCT02800863|566225242|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
156855670|NCT02800863|566225242|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
156855671|NCT02800863|566225242|FG000|Overall Study|Screen Failure|1|||
156855672|NCT02800863|566225242|FG000|Overall Study|Sponsor Request|6|||
156855673|NCT02800863|566225242|FG000|Overall Study|Death|3|||
156855674|NCT02800863|566225242|FG000|Overall Study|Subject Implant at Another Facility|1|||
156855675|NCT02800863|566225242|FG000|Overall Study|Lost to Follow-up|26|||
156855676|NCT02800863|566225242|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
156855677|NCT02800863|566225242|FG000|Overall Study|Subject and/or Family Request|64|||
156855678|NCT02800863|566225242|FG000|Overall Study|Trial Failure|81|||
156855679|NCT02800863|566225242|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
156855680|NCT00607087|566225243|FG000|Overall Study|Withdrawal by Subject|9|||
156855681|NCT00607087|566225244|FG001|Overall Study|Withdrawal by Subject|4|||
156855682|NCT00607087|566225245|FG002|Overall Study|Withdrawal by Subject|4|||
156855683|NCT00607087|566225243|FG000|Overall Study|Adverse Event|3|||
156855684|NCT00607087|566225244|FG001|Overall Study|Adverse Event|2|||
156855685|NCT00607087|566225245|FG002|Overall Study|Adverse Event|3|||
156855686|NCT00607087|566225243|FG000|Overall Study|Other reason|1|||
156855687|NCT00607087|566225244|FG001|Overall Study|Other reason|5|||
156855688|NCT00607087|566225245|FG002|Overall Study|Other reason|2|||
156855689|NCT00607087|566225243|FG000|Overall Study|Poor compliance to protocol|1|||
156855690|NCT00607087|566225244|FG001|Overall Study|Poor compliance to protocol|0|||
156855691|NCT00607087|566225245|FG002|Overall Study|Poor compliance to protocol|1|||
156855692|NCT00607087|566225243|FG000|Overall Study|Lost to Follow-up|1|||
156855693|NCT00607087|566225244|FG001|Overall Study|Lost to Follow-up|0|||
156855694|NCT00607087|566225245|FG002|Overall Study|Lost to Follow-up|0|||
156542191|NCT04342871|565079259|FG000|Overall Study|Did not complete baseline assessments|5|||
156855695|NCT00607087|566225243|FG000|Period 1|Withdrawal by Subject|7|||
156855696|NCT00607087|566225244|FG001|Period 1|Withdrawal by Subject|2|||
156855697|NCT00607087|566225245|FG002|Period 1|Withdrawal by Subject|3|||
156855698|NCT00607087|566225243|FG000|Period 1|Adverse Event|3|||
156855699|NCT00607087|566225244|FG001|Period 1|Adverse Event|0|||
156855700|NCT00607087|566225245|FG002|Period 1|Adverse Event|0|||
156855701|NCT00607087|566225243|FG000|Period 1|Poor compliance to protocol|1|||
156472656|NCT03737110|564825530|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
156472657|NCT03737110|564825531|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
156472658|NCT03737110|564825532|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
156472659|NCT03737110|564825533|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
156472660|NCT00599196|564825538|FG000|Overall Study|Lack of Efficacy|22|||
156472661|NCT00599196|564825538|FG000|Overall Study|Adverse Event|93|||
156855702|NCT00607087|566225244|FG001|Period 1|Poor compliance to protocol|0|||
156855703|NCT00607087|566225245|FG002|Period 1|Poor compliance to protocol|0|||
156855704|NCT00607087|566225243|FG000|Period 1|Lost to Follow-up|1|||
156855705|NCT00607087|566225244|FG001|Period 1|Lost to Follow-up|0|||
156855706|NCT00607087|566225245|FG002|Period 1|Lost to Follow-up|0|||
156855707|NCT00607087|566225243|FG000|Period 1|Other reason|0|||
156855708|NCT00607087|566225244|FG001|Period 1|Other reason|4|||
156855709|NCT00607087|566225245|FG002|Period 1|Other reason|2|||
156855710|NCT00607087|566225243|FG000|Period 2|Withdrawal by Subject|0|||
156855711|NCT00607087|566225244|FG001|Period 2|Withdrawal by Subject|1|||
156855712|NCT00607087|566225245|FG002|Period 2|Withdrawal by Subject|1|||
156855713|NCT00607087|566225243|FG000|Period 2|Other reason|1|||
156855714|NCT00607087|566225244|FG001|Period 2|Other reason|1|||
156855715|NCT00607087|566225245|FG002|Period 2|Other reason|0|||
156855716|NCT00607087|566225243|FG000|Period 2|Adverse Event|0|||
156855717|NCT00607087|566225244|FG001|Period 2|Adverse Event|1|||
156855718|NCT00607087|566225245|FG002|Period 2|Adverse Event|3|||
156855719|NCT00607087|566225243|FG000|Period 2|Poor compliance to protocol|0|||
156855720|NCT00607087|566225244|FG001|Period 2|Poor compliance to protocol|0|||
156855721|NCT00607087|566225245|FG002|Period 2|Poor compliance to protocol|1|||
156342315|NCT00429273|564352635|FG002|Overall Study|Adverse Event|2|||
156855722|NCT00607087|566225243|FG000|Period 3|Withdrawal by Subject|2|||
156855723|NCT00607087|566225244|FG001|Period 3|Withdrawal by Subject|1|||
156855724|NCT00607087|566225245|FG002|Period 3|Withdrawal by Subject|0|||
156855725|NCT00607087|566225243|FG000|Period 3|Adverse Event|0|||
156855726|NCT00607087|566225244|FG001|Period 3|Adverse Event|1|||
156855727|NCT00607087|566225245|FG002|Period 3|Adverse Event|0|||
156855728|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
156855729|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
156855730|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
156855731|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
156855732|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
156855733|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
156855734|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
156855735|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
156855736|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
156855737|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
156855738|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
156855739|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
156855740|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
156855741|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
156855742|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
156855743|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
156855744|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
156855745|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
156855746|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
156855747|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
156855748|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
156855749|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
156855750|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
156855751|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
156855752|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
156472662|NCT00599196|564825538|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
156472663|NCT00599196|564825538|FG000|Overall Study|Subject withdrew consent|43|||
156472664|NCT00599196|564825538|FG000|Overall Study|Study ended per sponsor|197|||
156472665|NCT00599196|564825538|FG000|Overall Study|Lost to Follow-up|17|||
156472666|NCT00599196|564825538|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
156855753|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
156855754|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
156855755|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
156472667|NCT00599196|564825538|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
156472668|NCT00599196|564825538|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
156855756|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
156342316|NCT01438957|564352636|FG000|Overall Study|Physician Decision|1|||
156855757|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
156855758|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
156855759|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
156855760|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
156855761|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
156855762|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
156855763|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
156855764|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
156855765|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
156855766|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
156855767|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
156855768|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
156855769|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
156855770|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
156855771|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
156855772|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
156855773|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
156855774|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
156855775|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
156855776|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
156855777|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
156855778|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
156855779|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
156855780|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
156855781|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
156855782|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
156855783|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
156855784|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
156855785|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
156855786|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
156855787|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
156855788|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
156855789|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
156855790|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
156855791|NCT04393493|566225250|FG000|First 4 Days of Intervention|Early improvement|5|||
156855792|NCT04393493|566225251|FG001|First 4 Days of Intervention|Early improvement|7|||
156855793|NCT02910466|566225252|FG000|Overall Study|Adverse Event|1|||
156855794|NCT02910466|566225252|FG000|Overall Study|Withdrawal by Subject|3|||
156855795|NCT02910466|566225252|FG000|Overall Study|Lost to Follow-up|5|||
156855796|NCT02910466|566225252|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
156855797|NCT02910466|566225252|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
156855798|NCT05051579|566225256|FG000|Overall Study|Withdrawal by Subject|3|||
156855799|NCT05051579|566225257|FG001|Overall Study|Withdrawal by Subject|5|||
156342317|NCT01438957|564352637|FG001|Overall Study|Physician Decision|1|||
156342318|NCT01438957|564352638|FG002|Overall Study|Physician Decision|0|||
156342319|NCT01438957|564352639|FG003|Overall Study|Physician Decision|1|||
156342320|NCT01438957|564352640|FG004|Overall Study|Physician Decision|0|||
156855800|NCT05051579|566225258|FG002|Overall Study|Withdrawal by Subject|2|||
156855801|NCT05051579|566225259|FG003|Overall Study|Withdrawal by Subject|1|||
156855802|NCT05051579|566225260|FG004|Overall Study|Withdrawal by Subject|4|||
156855803|NCT05051579|566225261|FG005|Overall Study|Withdrawal by Subject|0|||
156855804|NCT05051579|566225262|FG006|Overall Study|Withdrawal by Subject|4|||
156855805|NCT05051579|566225256|FG000|Overall Study|Lost to Follow-up|1|||
156855806|NCT05051579|566225257|FG001|Overall Study|Lost to Follow-up|0|||
156855807|NCT05051579|566225258|FG002|Overall Study|Lost to Follow-up|0|||
156855808|NCT05051579|566225259|FG003|Overall Study|Lost to Follow-up|0|||
156855809|NCT05051579|566225260|FG004|Overall Study|Lost to Follow-up|1|||
156855810|NCT05051579|566225261|FG005|Overall Study|Lost to Follow-up|0|||
156855811|NCT05051579|566225262|FG006|Overall Study|Lost to Follow-up|1|||
156855812|NCT05051579|566225256|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855813|NCT05051579|566225257|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855814|NCT05051579|566225258|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855815|NCT05051579|566225259|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855816|NCT05051579|566225260|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855817|NCT05051579|566225261|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855818|NCT05051579|566225262|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
156855819|NCT05051579|566225256|FG000|Overall Study|Adverse Event|2|||
156855820|NCT05051579|566225257|FG001|Overall Study|Adverse Event|1|||
156855821|NCT05051579|566225258|FG002|Overall Study|Adverse Event|0|||
156855822|NCT05051579|566225259|FG003|Overall Study|Adverse Event|4|||
156855823|NCT05051579|566225260|FG004|Overall Study|Adverse Event|1|||
156855824|NCT05051579|566225261|FG005|Overall Study|Adverse Event|2|||
156855825|NCT05051579|566225262|FG006|Overall Study|Adverse Event|0|||
156855826|NCT05051579|566225256|FG000|Overall Study|Inadvertent Enrollment|0|||
156855827|NCT05051579|566225257|FG001|Overall Study|Inadvertent Enrollment|0|||
156855828|NCT05051579|566225258|FG002|Overall Study|Inadvertent Enrollment|0|||
156855829|NCT05051579|566225259|FG003|Overall Study|Inadvertent Enrollment|0|||
156855830|NCT05051579|566225260|FG004|Overall Study|Inadvertent Enrollment|0|||
156855831|NCT05051579|566225261|FG005|Overall Study|Inadvertent Enrollment|0|||
156855832|NCT05051579|566225262|FG006|Overall Study|Inadvertent Enrollment|1|||
156855833|NCT05051579|566225256|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855834|NCT05051579|566225257|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
156855835|NCT05051579|566225258|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156342321|NCT00840450|564352641|FG000|Overall Study|Adverse Event|1|||
156855836|NCT05051579|566225259|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855837|NCT05051579|566225260|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855838|NCT05051579|566225261|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855839|NCT05051579|566225262|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855840|NCT05051579|566225256|FG000|Overall Study|Sponsor Decision|0|||
156855841|NCT05051579|566225257|FG001|Overall Study|Sponsor Decision|0|||
156855842|NCT05051579|566225258|FG002|Overall Study|Sponsor Decision|0|||
156855843|NCT05051579|566225259|FG003|Overall Study|Sponsor Decision|0|||
156855844|NCT05051579|566225260|FG004|Overall Study|Sponsor Decision|1|||
156855845|NCT05051579|566225261|FG005|Overall Study|Sponsor Decision|0|||
156855846|NCT05051579|566225262|FG006|Overall Study|Sponsor Decision|0|||
156855847|NCT05051579|566225256|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855848|NCT05051579|566225257|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855849|NCT05051579|566225258|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855850|NCT05051579|566225259|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855851|NCT05051579|566225260|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
156855852|NCT05051579|566225261|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855853|NCT05051579|566225262|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855854|NCT03799341|566225265|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
156342322|NCT00840450|564352641|FG000|Overall Study|Lack of Efficacy|2|||
156342323|NCT00520936|564352647|FG000|Overall Study|Physician Decision|0|||
156342324|NCT00520936|564352648|FG001|Overall Study|Physician Decision|2|||
156342325|NCT00520936|564352649|FG002|Overall Study|Physician Decision|1|||
156342326|NCT00520936|564352650|FG003|Overall Study|Physician Decision|0|||
156342327|NCT00520936|564352651|FG004|Overall Study|Physician Decision|0|||
156855855|NCT03799341|566225266|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
156342328|NCT00520936|564352652|FG005|Overall Study|Physician Decision|0|||
156855856|NCT03799341|566225267|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
156855857|NCT03799341|566225265|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
156855858|NCT03799341|566225266|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
156855859|NCT03799341|566225267|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
156855860|NCT03799341|566225265|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
156855861|NCT03799341|566225266|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
156855862|NCT03799341|566225267|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
156855863|NCT03799341|566225265|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
156855864|NCT03799341|566225266|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
156855865|NCT03799341|566225267|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
156855866|NCT03799341|566225265|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
156855867|NCT03799341|566225266|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
156855868|NCT03799341|566225267|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
156855869|NCT03799341|566225265|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
156855870|NCT03799341|566225266|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
156855871|NCT03799341|566225267|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
156855872|NCT04539938|566225268|FG000|Overall Study|Death|30|||
156855873|NCT04539938|566225268|FG000|Overall Study|Withdrawal by Subject|4|||
156855874|NCT02360228|566225282|FG000|Overall Study|Withdrawal by Subject|1|||
156855875|NCT02360228|566225283|FG001|Overall Study|Withdrawal by Subject|0|||
156855876|NCT02360228|566225284|FG002|Overall Study|Withdrawal by Subject|0|||
156855877|NCT02360228|566225282|FG000|Overall Study|Self-discontinued medication|0|||
156855878|NCT02360228|566225283|FG001|Overall Study|Self-discontinued medication|1|||
156855879|NCT02360228|566225284|FG002|Overall Study|Self-discontinued medication|0|||
156855880|NCT02360228|566225282|FG000|Overall Study|Unstable symptoms during screening|0|||
156855881|NCT02360228|566225283|FG001|Overall Study|Unstable symptoms during screening|0|||
156855882|NCT02360228|566225284|FG002|Overall Study|Unstable symptoms during screening|1|||
156855883|NCT00865345|566226823|FG000|Overall Study|Withdrawal by Subject|2|||
156855884|NCT03737123|566226824|FG000|Study Treatment|Adverse Event|2|||
156855885|NCT03737123|566226825|FG001|Study Treatment|Adverse Event|0|||
156855886|NCT03737123|566226824|FG000|Study Treatment|Disease Progression|2|||
156855887|NCT03737123|566226825|FG001|Study Treatment|Disease Progression|0|||
156855888|NCT03737123|566226824|FG000|Study Treatment|Withdrawal by Subject|2|||
156855889|NCT03737123|566226825|FG001|Study Treatment|Withdrawal by Subject|0|||
156855890|NCT03737123|566226824|FG000|Follow up|Death|1|||
156855891|NCT03737123|566226825|FG001|Follow up|Death|0|||
156855892|NCT03737123|566226824|FG000|Follow up|Withdrawal by Subject|1|||
156855893|NCT03737123|566226825|FG001|Follow up|Withdrawal by Subject|0|||
156855894|NCT03737123|566226824|FG000|Follow up|Termination of study|4|||
156855895|NCT03737123|566226825|FG001|Follow up|Termination of study|0|||
156855896|NCT01519323|566226826|FG000|Overall Study|Death|3|||
156855897|NCT01519323|566226827|FG001|Overall Study|Death|2|||
156855898|NCT01519323|566226826|FG000|Overall Study|Study terminated by sponsor|0|||
156855899|NCT01519323|566226827|FG001|Overall Study|Study terminated by sponsor|1|||
156855900|NCT00445549|566226828|FG000|Overall Study|progressive disease|12|||
156855901|NCT03629886|566226834|FG000|Overall Study|Migrated / moved from the study area|0|||
156855902|NCT03629886|566226835|FG001|Overall Study|Migrated / moved from the study area|55|||
156855903|NCT03629886|566226834|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
156855904|NCT03629886|566226835|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
156855905|NCT03629886|566226834|FG000|Overall Study|Study vaccine not administrated|0|||
156855906|NCT03629886|566226835|FG001|Overall Study|Study vaccine not administrated|3|||
156855907|NCT03629886|566226834|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
156855908|NCT03629886|566226835|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
156855909|NCT03629886|566226834|FG000|Overall Study|Refused vaccination step of the study|0|||
156342329|NCT00520936|564352653|FG006|Overall Study|Physician Decision|0|||
156855910|NCT03629886|566226835|FG001|Overall Study|Refused vaccination step of the study|44|||
156855911|NCT03683173|566226836|FG000|Completed Follow-up|Unavailable|235|||
156855912|NCT03683173|566226837|FG001|Completed Follow-up|Unavailable|217|||
156855913|NCT03683173|566226836|FG000|Completed Follow-up|Refused|69|||
156855914|NCT03683173|566226837|FG001|Completed Follow-up|Refused|59|||
156855915|NCT03683173|566226836|FG000|Completed Follow-up|Disconnected phone|65|||
156855916|NCT03683173|566226837|FG001|Completed Follow-up|Disconnected phone|95|||
156855917|NCT03683173|566226836|FG000|Completed Follow-up|Health issue/deceased|10|||
156855918|NCT03683173|566226837|FG001|Completed Follow-up|Health issue/deceased|4|||
156855919|NCT03683173|566226836|FG000|Completed Follow-up|Moved away|8|||
156855920|NCT03683173|566226837|FG001|Completed Follow-up|Moved away|1|||
156855921|NCT01535807|566226838|FG000|Overall Study|Withdrawal by Subject|1|||
156855922|NCT01535807|566226839|FG001|Overall Study|Withdrawal by Subject|1|||
156855923|NCT01535807|566226838|FG000|Overall Study|Data collection error|1|||
156855924|NCT01535807|566226839|FG001|Overall Study|Data collection error|1|||
156855925|NCT01329263|566226844|FG000|Overall Study|Lost to Follow-up|4|||
156855926|NCT01329263|566226845|FG001|Overall Study|Lost to Follow-up|21|||
156855927|NCT01329263|566226844|FG000|Overall Study|Withdrawal by Subject|1|||
156855928|NCT01329263|566226845|FG001|Overall Study|Withdrawal by Subject|2|||
156855929|NCT01702844|566226855|FG000|Overall Study|Adverse Event|9|||
156855930|NCT01702844|566226855|FG000|Overall Study|Death|1|||
156855931|NCT01702844|566226855|FG000|Overall Study|Withdrawal by Subject|3|||
156855932|NCT01702844|566226855|FG000|Overall Study|Physician Decision|6|||
156855933|NCT02995980|566226856|FG000|Overall Study|Lost to Follow-up|14|||
156855934|NCT00981149|566226858|FG000|Overall Study|Lost to Follow-up|1|||
156855935|NCT00981149|566226859|FG001|Overall Study|Lost to Follow-up|2|||
156855936|NCT00981149|566226858|FG000|Overall Study|Withdrawal by Subject|1|||
156855937|NCT00981149|566226859|FG001|Overall Study|Withdrawal by Subject|1|||
156855938|NCT01220167|566226862|FG000|Period 3|Urine positive for substance abuse|0|||
156855939|NCT01220167|566226863|FG001|Period 3|Urine positive for substance abuse|1|||
156855940|NCT01220167|566226864|FG002|Period 3|Urine positive for substance abuse|0|||
156855941|NCT00667628|566226865|FG000|Overall Study|Lost to Follow-up|1|||
156855942|NCT00667628|566226866|FG001|Overall Study|Lost to Follow-up|0|||
156855943|NCT00667628|566226865|FG000|Overall Study|Death|6|||
156855944|NCT00667628|566226866|FG001|Overall Study|Death|6|||
156855945|NCT00667628|566226865|FG000|Overall Study|Investigator Considers in Best Interest|1|||
156855946|NCT00667628|566226866|FG001|Overall Study|Investigator Considers in Best Interest|0|||
156855947|NCT00667628|566226865|FG000|Overall Study|Sponsor Terminated Study|17|||
156855948|NCT00667628|566226866|FG001|Overall Study|Sponsor Terminated Study|21|||
156855949|NCT00622505|566226867|FG000|Overall Study|Adverse Event|9|||
156855950|NCT00622505|566226868|FG001|Overall Study|Adverse Event|7|||
156855951|NCT00622505|566226867|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
156855952|NCT00622505|566226868|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
156855953|NCT00622505|566226867|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
156855954|NCT00622505|566226868|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156855955|NCT00622505|566226867|FG000|Overall Study|Withdrawal by Subject|12|||
156855956|NCT00622505|566226868|FG001|Overall Study|Withdrawal by Subject|5|||
156855957|NCT00622505|566226867|FG000|Overall Study|Administrative Problems|2|||
156855958|NCT00622505|566226868|FG001|Overall Study|Administrative Problems|4|||
156855959|NCT00622505|566226867|FG000|Overall Study|Death|2|||
156855960|NCT00622505|566226868|FG001|Overall Study|Death|2|||
156855961|NCT00619515|566226869|FG000|Overall Study|Study Termination by IRB|73|||
156855962|NCT04862065|566226874|FG000|Screening|Protocol Violation|54|||
156855963|NCT04862065|566226875|FG001|Screening|Protocol Violation|0|||
156855964|NCT04862065|566226876|FG002|Screening|Protocol Violation|0|||
156855965|NCT04862065|566226874|FG000|Screening|Insufficient Sample|1|||
156855966|NCT04862065|566226875|FG001|Screening|Insufficient Sample|0|||
156855967|NCT04862065|566226876|FG002|Screening|Insufficient Sample|0|||
156855968|NCT04862065|566226874|FG000|Follow-Up|Lost to Follow-up|3|||
156855969|NCT04862065|566226875|FG001|Follow-Up|Lost to Follow-up|0|||
156855970|NCT04862065|566226876|FG002|Follow-Up|Lost to Follow-up|0|||
156855971|NCT01453140|566226877|FG000|Overall Study|Adverse Event|3|||
156855972|NCT02634333|566226878|FG000|Overall Study|Completed out of Window|3|||
156855973|NCT02634333|566226879|FG001|Overall Study|Completed out of Window|2|||
156855974|NCT02634333|566226878|FG000|Overall Study|Missed Visit|5|||
156855975|NCT02634333|566226879|FG001|Overall Study|Missed Visit|2|||
156855976|NCT02634333|566226878|FG000|Overall Study|Lost to Follow-up|12|||
156855977|NCT02634333|566226879|FG001|Overall Study|Lost to Follow-up|7|||
156855978|NCT02634333|566226878|FG000|Overall Study|Withdrawal by Subject|9|||
156855979|NCT02634333|566226879|FG001|Overall Study|Withdrawal by Subject|13|||
156855980|NCT02634333|566226878|FG000|Overall Study|Death|11|||
156855981|NCT02634333|566226879|FG001|Overall Study|Death|8|||
156855982|NCT02611479|566226880|FG000|Baseline Enrollment|Exited study|13|||
156855983|NCT02611479|566226880|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
156855984|NCT02611479|566226880|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
156855985|NCT02611479|566226880|FG000|Data Cleaning|No baseline function or pain metrics|2|||
156855986|NCT00743249|566226881|FG000|Overall Study|Adverse Event|0|||
156855987|NCT00743249|566226882|FG001|Overall Study|Adverse Event|4|||
156855988|NCT00743249|566226881|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
156855989|NCT00743249|566226882|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
156855990|NCT00743249|566226881|FG000|Overall Study|Unsuccessful insertion of stent|2|||
156855991|NCT00743249|566226882|FG001|Overall Study|Unsuccessful insertion of stent|1|||
156855992|NCT02748863|566226886|FG000|Treatment Period 1|Adverse Event|0|||
156855993|NCT02748863|566226887|FG001|Treatment Period 1|Adverse Event|1|||
156855994|NCT02748863|566226888|FG002|Treatment Period 1|Adverse Event|0|||
156855995|NCT02748863|566226889|FG003|Treatment Period 1|Adverse Event|0|||
156855996|NCT02748863|566226890|FG004|Treatment Period 1|Adverse Event|0|||
156855997|NCT02748863|566226886|FG000|Treatment Period 1|Lack of Efficacy|0|||
156855998|NCT02748863|566226887|FG001|Treatment Period 1|Lack of Efficacy|0|||
156855999|NCT02748863|566226888|FG002|Treatment Period 1|Lack of Efficacy|1|||
156856000|NCT02748863|566226889|FG003|Treatment Period 1|Lack of Efficacy|0|||
156856001|NCT02748863|566226890|FG004|Treatment Period 1|Lack of Efficacy|0|||
156856002|NCT02748863|566226886|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156856003|NCT02748863|566226887|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156856004|NCT02748863|566226888|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156856005|NCT02748863|566226889|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156856006|NCT02748863|566226890|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156856007|NCT02748863|566226886|FG000|Treatment Period 2|Lost to Follow-up|2|||
156856008|NCT02748863|566226887|FG001|Treatment Period 2|Lost to Follow-up|0|||
156856009|NCT02748863|566226888|FG002|Treatment Period 2|Lost to Follow-up|0|||
156856010|NCT02748863|566226889|FG003|Treatment Period 2|Lost to Follow-up|0|||
156856011|NCT02748863|566226890|FG004|Treatment Period 2|Lost to Follow-up|0|||
156856012|NCT02748863|566226886|FG000|Treatment Period 2|Adverse Event|3|||
156856013|NCT02748863|566226887|FG001|Treatment Period 2|Adverse Event|2|||
156856014|NCT02748863|566226888|FG002|Treatment Period 2|Adverse Event|0|||
156856015|NCT02748863|566226889|FG003|Treatment Period 2|Adverse Event|2|||
156856016|NCT02748863|566226890|FG004|Treatment Period 2|Adverse Event|0|||
156856017|NCT02748863|566226886|FG000|Treatment Period 2|Lack of Efficacy|0|||
156856018|NCT02748863|566226887|FG001|Treatment Period 2|Lack of Efficacy|1|||
156856019|NCT02748863|566226888|FG002|Treatment Period 2|Lack of Efficacy|0|||
156856020|NCT02748863|566226889|FG003|Treatment Period 2|Lack of Efficacy|0|||
156856021|NCT02748863|566226890|FG004|Treatment Period 2|Lack of Efficacy|0|||
156856022|NCT02748863|566226886|FG000|Treatment Period 2|Pregnancy|0|||
156856023|NCT02748863|566226887|FG001|Treatment Period 2|Pregnancy|0|||
156856024|NCT02748863|566226888|FG002|Treatment Period 2|Pregnancy|0|||
156856025|NCT02748863|566226889|FG003|Treatment Period 2|Pregnancy|0|||
156856026|NCT02748863|566226890|FG004|Treatment Period 2|Pregnancy|1|||
156856027|NCT00657046|566226892|FG000|Overall Study|Adverse Event|1|||
156856028|NCT00657046|566226893|FG001|Overall Study|Adverse Event|1|||
156856029|NCT00657046|566226894|FG002|Overall Study|Adverse Event|0|||
156856030|NCT00657046|566226892|FG000|Overall Study|Protocol Violation|2|||
156856031|NCT00657046|566226893|FG001|Overall Study|Protocol Violation|2|||
156856032|NCT00657046|566226894|FG002|Overall Study|Protocol Violation|0|||
156856033|NCT00657046|566226892|FG000|Overall Study|Withdrawal by Subject|1|||
156856034|NCT00657046|566226893|FG001|Overall Study|Withdrawal by Subject|0|||
156856035|NCT00657046|566226894|FG002|Overall Study|Withdrawal by Subject|0|||
156856036|NCT00657046|566226892|FG000|Overall Study|Death|0|||
156856037|NCT00657046|566226893|FG001|Overall Study|Death|0|||
156856038|NCT00657046|566226894|FG002|Overall Study|Death|1|||
156856039|NCT00657046|566226892|FG000|Overall Study|Surgery|0|||
156856040|NCT00657046|566226893|FG001|Overall Study|Surgery|0|||
156856041|NCT00657046|566226894|FG002|Overall Study|Surgery|1|||
156856042|NCT04678115|566226897|FG000|Overall Study|Lost to Follow-up|1|||
156856043|NCT04678115|566226898|FG001|Overall Study|Lost to Follow-up|0|||
156856044|NCT00890825|566226899|FG000|Overall Study|Withdrawal by Subject|1|||
156856045|NCT00890825|566226900|FG001|Overall Study|Withdrawal by Subject|0|||
156856046|NCT00890825|566226899|FG000|Overall Study|Alive at data cut off (DCO)|13|||
156856047|NCT00890825|566226900|FG001|Overall Study|Alive at data cut off (DCO)|14|||
156856048|NCT00844376|566226901|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
156856049|NCT00844376|566226902|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
156856050|NCT02920892|566226903|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
156856051|NCT02920892|566226904|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
156856052|NCT02920892|566226905|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
156856053|NCT02920892|566226903|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
156856054|NCT02920892|566226904|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
156856055|NCT02920892|566226905|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
156856056|NCT02920892|566226903|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
156856057|NCT02920892|566226904|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
156856058|NCT02920892|566226905|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
156856059|NCT02920892|566226903|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
156856060|NCT02920892|566226904|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
156856061|NCT02920892|566226905|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
156856062|NCT02920892|566226903|FG000|Placebo-Controlled Period|Physician Decision|0|||
156856063|NCT02920892|566226904|FG001|Placebo-Controlled Period|Physician Decision|0|||
156856064|NCT02920892|566226905|FG002|Placebo-Controlled Period|Physician Decision|1|||
156856065|NCT02920892|566226903|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
156856066|NCT02920892|566226904|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
156856067|NCT02920892|566226905|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
156856068|NCT02920892|566226903|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156856069|NCT02920892|566226904|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
156856070|NCT02920892|566226905|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
156856071|NCT02920892|566226903|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
156856072|NCT02920892|566226904|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
156856073|NCT02920892|566226905|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
156856074|NCT01092728|566226906|FG000|Overall Study|Withdrawal by Subject|2|||
156856075|NCT01092728|566226907|FG001|Overall Study|Withdrawal by Subject|0|||
156856076|NCT01092728|566226906|FG000|Overall Study|Adverse Event|0|||
156856077|NCT01092728|566226907|FG001|Overall Study|Adverse Event|1|||
156856078|NCT01092728|566226906|FG000|Overall Study|Disease Progression|1|||
156856079|NCT01092728|566226907|FG001|Overall Study|Disease Progression|13|||
156856080|NCT01092728|566226906|FG000|Overall Study|Prohibited Concomitant Medications|1|||
156856081|NCT01092728|566226907|FG001|Overall Study|Prohibited Concomitant Medications|0|||
156856082|NCT02336607|566226908|FG000|Overall Study|Physician Decision|1|||
156856083|NCT02336607|566226909|FG001|Overall Study|Physician Decision|4|||
156856084|NCT02336607|566226910|FG002|Overall Study|Physician Decision|3|||
156856085|NCT02336607|566226911|FG003|Overall Study|Physician Decision|15|||
156856086|NCT02336607|566226908|FG000|Overall Study|Lack of Efficacy|1|||
156856087|NCT02336607|566226909|FG001|Overall Study|Lack of Efficacy|0|||
156856088|NCT02336607|566226910|FG002|Overall Study|Lack of Efficacy|0|||
156856089|NCT02336607|566226911|FG003|Overall Study|Lack of Efficacy|2|||
156856090|NCT02336607|566226908|FG000|Overall Study|Lost to Follow-up|2|||
156856091|NCT02336607|566226909|FG001|Overall Study|Lost to Follow-up|1|||
156856092|NCT02336607|566226910|FG002|Overall Study|Lost to Follow-up|0|||
156856093|NCT02336607|566226911|FG003|Overall Study|Lost to Follow-up|21|||
156856094|NCT02336607|566226908|FG000|Overall Study|Protocol Violation|0|||
156856095|NCT02336607|566226909|FG001|Overall Study|Protocol Violation|1|||
156856096|NCT02336607|566226910|FG002|Overall Study|Protocol Violation|1|||
156856097|NCT02336607|566226911|FG003|Overall Study|Protocol Violation|3|||
156856098|NCT02336607|566226908|FG000|Overall Study|Adverse Event|0|||
156856099|NCT02336607|566226909|FG001|Overall Study|Adverse Event|2|||
156856100|NCT02336607|566226910|FG002|Overall Study|Adverse Event|2|||
156856101|NCT02336607|566226911|FG003|Overall Study|Adverse Event|26|||
156342330|NCT00520936|564352654|FG007|Overall Study|Physician Decision|0|||
156342331|NCT00520936|564352647|FG000|Overall Study|Withdrawal by Subject|0|||
156342332|NCT00520936|564352648|FG001|Overall Study|Withdrawal by Subject|0|||
156342333|NCT00520936|564352649|FG002|Overall Study|Withdrawal by Subject|0|||
156342334|NCT00520936|564352650|FG003|Overall Study|Withdrawal by Subject|0|||
156342335|NCT00520936|564352651|FG004|Overall Study|Withdrawal by Subject|0|||
156472669|NCT00599196|564825538|FG000|Overall Study|Other: Pt Moved To Australia|1|||
156472670|NCT00599196|564825538|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
156472671|NCT00599196|564825538|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
156472672|NCT01009645|564825539|FG000|Overall Study|Lost to Follow-up|2|||
156472673|NCT01009645|564825540|FG001|Overall Study|Lost to Follow-up|8|||
156856102|NCT02336607|566226908|FG000|Overall Study|Withdrawal by Subject|0|||
156856103|NCT02336607|566226909|FG001|Overall Study|Withdrawal by Subject|2|||
156856104|NCT02336607|566226910|FG002|Overall Study|Withdrawal by Subject|0|||
156856105|NCT02336607|566226911|FG003|Overall Study|Withdrawal by Subject|20|||
156856106|NCT01721161|566226912|FG000|Overall Study|Adverse Event|2|||
156856107|NCT01721161|566226913|FG001|Overall Study|Adverse Event|3|||
156856108|NCT01721161|566226912|FG000|Overall Study|Lost to Follow-up|1|||
156856109|NCT01721161|566226913|FG001|Overall Study|Lost to Follow-up|2|||
156856110|NCT01721161|566226912|FG000|Overall Study|Withdrawal by Subject|1|||
156856111|NCT01721161|566226913|FG001|Overall Study|Withdrawal by Subject|1|||
156856112|NCT01721161|566226912|FG000|Overall Study|Other|0|||
156856113|NCT01721161|566226913|FG001|Overall Study|Other|1|||
156856114|NCT01454596|566226916|FG000|Overall Study|Death|0|||
156856115|NCT01454596|566226917|FG001|Overall Study|Death|0|||
156856116|NCT01454596|566226918|FG002|Overall Study|Death|0|||
156856117|NCT01454596|566226919|FG003|Overall Study|Death|0|||
156856118|NCT01454596|566226920|FG004|Overall Study|Death|0|||
156856119|NCT01454596|566226921|FG005|Overall Study|Death|0|||
156856120|NCT01454596|566226922|FG006|Overall Study|Death|0|||
156856121|NCT01454596|566226923|FG007|Overall Study|Death|0|||
156856122|NCT01454596|566226924|FG008|Overall Study|Death|0|||
156856123|NCT01454596|566226925|FG009|Overall Study|Death|1|||
156856124|NCT01454596|566226926|FG010|Overall Study|Death|1|||
156856125|NCT01454596|566226927|FG011|Overall Study|Death|0|||
156856126|NCT00614380|566226934|FG000|Overall Study|Adverse Event|14|||
156856127|NCT00614380|566226935|FG001|Overall Study|Adverse Event|4|||
156856128|NCT00614380|566226936|FG002|Overall Study|Adverse Event|0|||
156856129|NCT00614380|566226937|FG003|Overall Study|Adverse Event|0|||
156856130|NCT00614380|566226934|FG000|Overall Study|Lost to Follow-up|6|||
156856131|NCT00614380|566226935|FG001|Overall Study|Lost to Follow-up|1|||
156856132|NCT00614380|566226936|FG002|Overall Study|Lost to Follow-up|0|||
156856133|NCT00614380|566226937|FG003|Overall Study|Lost to Follow-up|0|||
156856134|NCT00614380|566226934|FG000|Overall Study|Non compliant with the protocol|12|||
156856135|NCT00614380|566226935|FG001|Overall Study|Non compliant with the protocol|2|||
156856136|NCT00614380|566226936|FG002|Overall Study|Non compliant with the protocol|1|||
156856137|NCT00614380|566226937|FG003|Overall Study|Non compliant with the protocol|2|||
156856138|NCT00614380|566226934|FG000|Overall Study|Consent withdrawn|3|||
156856139|NCT00614380|566226935|FG001|Overall Study|Consent withdrawn|1|||
156856140|NCT00614380|566226936|FG002|Overall Study|Consent withdrawn|0|||
156856141|NCT00614380|566226937|FG003|Overall Study|Consent withdrawn|0|||
156856142|NCT01506271|566226942|FG000|Overall Study|Progressive disease|0|||
156856143|NCT01506271|566226943|FG001|Overall Study|Progressive disease|1|||
156856144|NCT01506271|566226944|FG002|Overall Study|Progressive disease|0|||
156856145|NCT01506271|566226942|FG000|Overall Study|Protocol Violation|3|||
156856146|NCT01506271|566226943|FG001|Overall Study|Protocol Violation|1|||
156856147|NCT01506271|566226944|FG002|Overall Study|Protocol Violation|0|||
156856148|NCT01506271|566226942|FG000|Overall Study|Death|0|||
156856149|NCT01506271|566226943|FG001|Overall Study|Death|1|||
156856150|NCT01506271|566226944|FG002|Overall Study|Death|0|||
156856151|NCT01506271|566226942|FG000|Overall Study|Adverse Event|0|||
156856152|NCT01506271|566226943|FG001|Overall Study|Adverse Event|2|||
156856153|NCT01506271|566226944|FG002|Overall Study|Adverse Event|0|||
156472674|NCT01009645|564825541|FG002|Overall Study|Lost to Follow-up|4|||
156472675|NCT01009645|564825542|FG003|Overall Study|Lost to Follow-up|5|||
156856154|NCT01506271|566226942|FG000|Overall Study|Insufficient supply of study drug|1|||
156856155|NCT01506271|566226943|FG001|Overall Study|Insufficient supply of study drug|0|||
156856156|NCT01506271|566226944|FG002|Overall Study|Insufficient supply of study drug|0|||
156856157|NCT01506271|566226942|FG000|Overall Study|Withdrawal by Subject|0|||
156856158|NCT01506271|566226943|FG001|Overall Study|Withdrawal by Subject|1|||
156856159|NCT01506271|566226944|FG002|Overall Study|Withdrawal by Subject|1|||
156856160|NCT01506271|566226942|FG000|Overall Study|Lost to Follow-up|0|||
156856161|NCT01506271|566226943|FG001|Overall Study|Lost to Follow-up|1|||
156856162|NCT01506271|566226944|FG002|Overall Study|Lost to Follow-up|2|||
156856163|NCT04908397|566226948|FG000|Overall Study|Withdrawal by Subject|2|||
156856164|NCT03318549|566226949|FG000|Overall Study|Withdrawal by Subject|5|||
156342336|NCT00520936|564352652|FG005|Overall Study|Withdrawal by Subject|0|||
156856165|NCT03318549|566226950|FG001|Overall Study|Withdrawal by Subject|19|||
156856166|NCT03318549|566226951|FG002|Overall Study|Withdrawal by Subject|2|||
156472676|NCT01079806|564825547|FG000|Day 1 to Week 96|Adverse Event|0|||
156472677|NCT01079806|564825548|FG001|Day 1 to Week 96|Adverse Event|3|||
156472678|NCT01079806|564825547|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
156856167|NCT03318549|566226952|FG003|Overall Study|Withdrawal by Subject|0|||
156856168|NCT03318549|566226953|FG004|Overall Study|Withdrawal by Subject|0|||
156856169|NCT03318549|566226954|FG005|Overall Study|Withdrawal by Subject|0|||
156856170|NCT03318549|566226955|FG006|Overall Study|Withdrawal by Subject|0|||
156856171|NCT03318549|566226949|FG000|Overall Study|Physician Decision|0|||
156856172|NCT03318549|566226950|FG001|Overall Study|Physician Decision|4|||
156856173|NCT03318549|566226951|FG002|Overall Study|Physician Decision|1|||
156856174|NCT03318549|566226952|FG003|Overall Study|Physician Decision|0|||
156856175|NCT03318549|566226953|FG004|Overall Study|Physician Decision|0|||
156856176|NCT03318549|566226954|FG005|Overall Study|Physician Decision|0|||
156856177|NCT03318549|566226955|FG006|Overall Study|Physician Decision|0|||
156856178|NCT03318549|566226949|FG000|Overall Study|Lost to Follow-up|0|||
156856179|NCT03318549|566226950|FG001|Overall Study|Lost to Follow-up|3|||
156856180|NCT03318549|566226951|FG002|Overall Study|Lost to Follow-up|3|||
156856181|NCT03318549|566226952|FG003|Overall Study|Lost to Follow-up|0|||
156856182|NCT03318549|566226953|FG004|Overall Study|Lost to Follow-up|0|||
156856183|NCT03318549|566226954|FG005|Overall Study|Lost to Follow-up|0|||
156856184|NCT03318549|566226955|FG006|Overall Study|Lost to Follow-up|0|||
156856185|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
156856186|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
156856187|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
156856188|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
156856189|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
156856190|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
156856191|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Death|7|||
156856192|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Death|5|||
156856193|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Death|6|||
156856194|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
156856195|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
156856196|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
156856197|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
156856198|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
156856199|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
156856200|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Other|1|||
156856201|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Other|0|||
156856202|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Other|0|||
156856203|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
156856204|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
156856205|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
156856206|NCT00104650|566226956|FG000|Follow-up Period|Physician Decision|1|||
156856207|NCT00104650|566226957|FG001|Follow-up Period|Physician Decision|1|||
156856208|NCT00104650|566226958|FG002|Follow-up Period|Physician Decision|0|||
156856209|NCT00104650|566226956|FG000|Follow-up Period|Adverse Event|1|||
156856210|NCT00104650|566226957|FG001|Follow-up Period|Adverse Event|0|||
156856211|NCT00104650|566226958|FG002|Follow-up Period|Adverse Event|1|||
156856212|NCT00104650|566226956|FG000|Follow-up Period|Withdrawal by Subject|0|||
156856213|NCT00104650|566226957|FG001|Follow-up Period|Withdrawal by Subject|3|||
156856214|NCT00104650|566226958|FG002|Follow-up Period|Withdrawal by Subject|3|||
156856215|NCT00104650|566226956|FG000|Follow-up Period|Death|6|||
156856216|NCT00104650|566226957|FG001|Follow-up Period|Death|6|||
156856217|NCT00104650|566226958|FG002|Follow-up Period|Death|4|||
156856218|NCT00104650|566226956|FG000|Follow-up Period|Disease progression|3|||
156856219|NCT00104650|566226957|FG001|Follow-up Period|Disease progression|1|||
156856220|NCT00104650|566226958|FG002|Follow-up Period|Disease progression|0|||
156856221|NCT00104650|566226956|FG000|Follow-up Period|Lost to Follow-up|0|||
156856222|NCT00104650|566226957|FG001|Follow-up Period|Lost to Follow-up|1|||
156856223|NCT00104650|566226958|FG002|Follow-up Period|Lost to Follow-up|2|||
156856224|NCT00104650|566226956|FG000|Follow-up Period|Other|0|||
156856225|NCT00104650|566226957|FG001|Follow-up Period|Other|1|||
156856226|NCT00104650|566226958|FG002|Follow-up Period|Other|0|||
156856227|NCT03515824|566226959|FG000|Overall Study|Death|3|||
156856228|NCT03515824|566226960|FG001|Overall Study|Death|2|||
156856229|NCT03515824|566226961|FG002|Overall Study|Death|6|||
156856230|NCT03515824|566226962|FG003|Overall Study|Death|0|||
156856231|NCT03515824|566226959|FG000|Overall Study|Lost to Follow-up|0|||
156856232|NCT03515824|566226960|FG001|Overall Study|Lost to Follow-up|1|||
156856233|NCT03515824|566226961|FG002|Overall Study|Lost to Follow-up|1|||
156856234|NCT03515824|566226962|FG003|Overall Study|Lost to Follow-up|0|||
156856235|NCT03515824|566226959|FG000|Overall Study|Study terminated by sponsor|0|||
156856236|NCT03515824|566226960|FG001|Overall Study|Study terminated by sponsor|1|||
156856237|NCT03515824|566226961|FG002|Overall Study|Study terminated by sponsor|6|||
156856238|NCT03515824|566226962|FG003|Overall Study|Study terminated by sponsor|0|||
156856239|NCT03515824|566226959|FG000|Overall Study|Status not recorded|0|||
156856240|NCT03515824|566226960|FG001|Overall Study|Status not recorded|0|||
156856241|NCT03515824|566226961|FG002|Overall Study|Status not recorded|2|||
156856242|NCT03515824|566226962|FG003|Overall Study|Status not recorded|0|||
156856243|NCT00920855|566226963|FG000|Overall Study|Adverse Event|1|||
156856244|NCT00920855|566226964|FG001|Overall Study|Adverse Event|1|||
156856245|NCT00920855|566226965|FG002|Overall Study|Adverse Event|4|||
156856246|NCT00920855|566226963|FG000|Overall Study|Withdrawal by Subject|2|||
156856247|NCT00920855|566226964|FG001|Overall Study|Withdrawal by Subject|1|||
156856248|NCT00920855|566226965|FG002|Overall Study|Withdrawal by Subject|6|||
156856249|NCT00920855|566226963|FG000|Overall Study|Disease progression|2|||
156856250|NCT00920855|566226964|FG001|Overall Study|Disease progression|1|||
156856251|NCT00920855|566226965|FG002|Overall Study|Disease progression|10|||
156856252|NCT00920855|566226963|FG000|Overall Study|Noncompliance to study medication|0|||
156856253|NCT00920855|566226964|FG001|Overall Study|Noncompliance to study medication|0|||
156856254|NCT00920855|566226965|FG002|Overall Study|Noncompliance to study medication|1|||
156856255|NCT00920855|566226963|FG000|Overall Study|Response plateau; started maintenance|0|||
156856256|NCT00920855|566226964|FG001|Overall Study|Response plateau; started maintenance|0|||
156856257|NCT00920855|566226965|FG002|Overall Study|Response plateau; started maintenance|1|||
156856258|NCT01894607|566226966|FG000|Overall Study|Ineligible|1|||
156856259|NCT00539994|566226968|FG000|Overall Study|Lost to Follow-up|2|||
156856260|NCT00539994|566226969|FG001|Overall Study|Lost to Follow-up|1|||
156856261|NCT00539994|566226970|FG002|Overall Study|Lost to Follow-up|0|||
156856262|NCT00539994|566226968|FG000|Overall Study|Withdrawal by Subject|1|||
156856263|NCT00539994|566226969|FG001|Overall Study|Withdrawal by Subject|0|||
156856264|NCT00539994|566226970|FG002|Overall Study|Withdrawal by Subject|1|||
156856265|NCT00539994|566226968|FG000|Overall Study|Physician Decision|0|||
156856266|NCT00539994|566226969|FG001|Overall Study|Physician Decision|0|||
156856267|NCT00539994|566226970|FG002|Overall Study|Physician Decision|1|||
156856268|NCT05470985|566226973|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
156856269|NCT05470985|566226974|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
156856270|NCT05470985|566226973|FG000|Double Blind Treatment Period|Physician Decision|0|||
156856271|NCT05470985|566226974|FG001|Double Blind Treatment Period|Physician Decision|1|||
156856272|NCT05470985|566226973|FG000|Long Term Extension|Adverse Event|0|||
156856273|NCT05470985|566226974|FG001|Long Term Extension|Adverse Event|1|||
156856274|NCT05470985|566226973|FG000|Long Term Extension|Study terminated by sponsor|2|||
156856275|NCT05470985|566226974|FG001|Long Term Extension|Study terminated by sponsor|0|||
156856276|NCT01917747|566226975|FG000|Overall Study|Withdrawal by Subject|1|||
156856277|NCT01917747|566226976|FG001|Overall Study|Withdrawal by Subject|2|||
156856278|NCT01917747|566226975|FG000|Overall Study|Lost to Follow-up|18|||
156856279|NCT01917747|566226976|FG001|Overall Study|Lost to Follow-up|9|||
156856280|NCT01116648|566226984|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
156856281|NCT01116648|566226985|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
156856282|NCT01116648|566226986|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
156856283|NCT01116648|566226987|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
156856284|NCT01116648|566226988|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
156856285|NCT01116648|566226989|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
156856286|NCT01116648|566226990|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
156856287|NCT01116648|566226991|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
156856288|NCT01116648|566226992|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
156856289|NCT01116648|566226993|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
156856290|NCT01116648|566226994|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
156856291|NCT01116648|566226995|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
156856292|NCT01116648|566226996|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
156856293|NCT01116648|566226997|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
156856294|NCT01116648|566226998|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
156856295|NCT00990106|566226999|FG000|Overall Study|"too busy to continue"|1|||
156856296|NCT00990106|566227000|FG001|Overall Study|"too busy to continue"|2|||
156856297|NCT00990106|566226999|FG000|Overall Study|Lost to Follow-up|1|||
156856298|NCT00990106|566227000|FG001|Overall Study|Lost to Follow-up|3|||
156856299|NCT00990106|566226999|FG000|Overall Study|Withdrawal by Subject|2|||
156856300|NCT00990106|566227000|FG001|Overall Study|Withdrawal by Subject|1|||
156856301|NCT00990106|566226999|FG000|Overall Study|opted for open label prazosin|1|||
156856302|NCT00990106|566227000|FG001|Overall Study|opted for open label prazosin|1|||
156856303|NCT00990106|566226999|FG000|Overall Study|relocation/deployment|4|||
156856304|NCT00990106|566227000|FG001|Overall Study|relocation/deployment|1|||
156856305|NCT00990106|566226999|FG000|Overall Study|started exclusionary medication|0|||
156856306|NCT00990106|566227000|FG001|Overall Study|started exclusionary medication|1|||
156856307|NCT00990106|566226999|FG000|Overall Study|planned major surgery|0|||
156856308|NCT00990106|566227000|FG001|Overall Study|planned major surgery|1|||
156856309|NCT00990106|566226999|FG000|Overall Study|scheduling conflicts|0|||
156856310|NCT00990106|566227000|FG001|Overall Study|scheduling conflicts|2|||
156856311|NCT03858049|566228484|FG000|Overall Study|Adverse Event|16|||
156856312|NCT03858049|566228485|FG001|Overall Study|Adverse Event|9|||
156856313|NCT03858049|566228484|FG000|Overall Study|Other|1|||
156856314|NCT03858049|566228485|FG001|Overall Study|Other|1|||
156856315|NCT02079740|566228486|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
156856316|NCT02079740|566228487|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
156856317|NCT02079740|566228488|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
156856318|NCT02079740|566228489|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
156856319|NCT02079740|566228490|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
156856320|NCT02079740|566228491|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
156856321|NCT02079740|566228492|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
156856322|NCT02079740|566228493|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
156856323|NCT02079740|566228494|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
156856324|NCT02079740|566228495|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
156856325|NCT02079740|566228496|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
156856326|NCT02079740|566228497|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
156856327|NCT02079740|566228498|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
156856328|NCT02079740|566228486|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
156856329|NCT02079740|566228487|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
156856330|NCT02079740|566228488|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
156856331|NCT02079740|566228489|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
156856332|NCT02079740|566228490|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
156856333|NCT02079740|566228491|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
156856334|NCT02079740|566228492|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
156856335|NCT02079740|566228493|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
156856336|NCT02079740|566228494|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
156856337|NCT02079740|566228495|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
156856338|NCT02079740|566228496|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
156856339|NCT02079740|566228497|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
156856340|NCT02079740|566228498|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
156856341|NCT02079740|566228486|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856342|NCT02079740|566228487|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856343|NCT02079740|566228488|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856344|NCT02079740|566228489|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856345|NCT02079740|566228490|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856346|NCT02079740|566228491|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856347|NCT02079740|566228492|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856348|NCT02079740|566228493|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
156856349|NCT02079740|566228494|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856350|NCT02079740|566228495|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856351|NCT02079740|566228496|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856352|NCT02079740|566228497|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856353|NCT02079740|566228498|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856354|NCT02079740|566228486|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856355|NCT02079740|566228487|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856356|NCT02079740|566228488|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856357|NCT02079740|566228489|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856358|NCT02079740|566228490|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856359|NCT02079740|566228491|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856360|NCT02079740|566228492|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856361|NCT02079740|566228493|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
156856362|NCT02079740|566228494|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856363|NCT02079740|566228495|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856364|NCT02079740|566228496|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856365|NCT02079740|566228497|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856366|NCT02079740|566228498|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856367|NCT02079740|566228486|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856368|NCT02079740|566228487|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856369|NCT02079740|566228488|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856370|NCT02079740|566228489|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856371|NCT02079740|566228490|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856372|NCT02079740|566228491|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856373|NCT02079740|566228492|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856374|NCT02079740|566228493|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856375|NCT02079740|566228494|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856376|NCT02079740|566228495|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
156856377|NCT02079740|566228496|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856378|NCT02079740|566228497|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
156856379|NCT02079740|566228498|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
156856380|NCT04617782|566228499|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
156856381|NCT04617782|566228499|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
156856382|NCT04617782|566228499|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
156856383|NCT04617782|566228499|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
156856384|NCT04617782|566228499|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
156856385|NCT04617782|566228499|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
156856386|NCT01405768|566228508|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
156856387|NCT01405768|566228509|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
156856388|NCT05482308|566228515|FG000|Overall Study|Withdrawal by Subject|1|||
156856389|NCT05482308|566228516|FG001|Overall Study|Withdrawal by Subject|0|||
156856390|NCT05482308|566228515|FG000|Overall Study|No longer meets eligibility criteria|0|||
156856391|NCT05482308|566228516|FG001|Overall Study|No longer meets eligibility criteria|1|||
156856392|NCT03016312|566228517|FG000|Overall Study|discontinued before the treatment started|0|||
156856393|NCT03016312|566228518|FG001|Overall Study|discontinued before the treatment started|1|||
156856394|NCT03016312|566228517|FG000|Overall Study|Withdrawal by Subject|37|||
156856395|NCT03016312|566228518|FG001|Overall Study|Withdrawal by Subject|44|||
156856396|NCT03016312|566228517|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
156856397|NCT03016312|566228518|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
156856398|NCT03016312|566228517|FG000|Overall Study|Physician Decision|1|||
156856399|NCT03016312|566228518|FG001|Overall Study|Physician Decision|3|||
156856400|NCT03016312|566228517|FG000|Overall Study|Lost to Follow-up|12|||
156856401|NCT03016312|566228518|FG001|Overall Study|Lost to Follow-up|12|||
156856402|NCT03016312|566228517|FG000|Overall Study|Death|210|||
156856403|NCT03016312|566228518|FG001|Overall Study|Death|184|||
156856404|NCT03016312|566228517|FG000|Overall Study|loss to contact|1|||
156856405|NCT03016312|566228518|FG001|Overall Study|loss to contact|0|||
156856406|NCT03016312|566228517|FG000|Overall Study|started a new cancer therapy|1|||
156856407|NCT03016312|566228518|FG001|Overall Study|started a new cancer therapy|0|||
156856408|NCT01631435|566228520|FG000|Overall Study|Adverse Event|2|||
156856409|NCT01631435|566228520|FG000|Overall Study|Withdrawal by Subject|2|||
156856410|NCT01631435|566228520|FG000|Overall Study|incomplete study procedure|5|||
156856411|NCT01421017|566228521|FG000|Overall Study|Withdrawal by Subject|2|||
156856412|NCT01421017|566228522|FG001|Overall Study|Withdrawal by Subject|0|||
156856413|NCT01421017|566228523|FG002|Overall Study|Withdrawal by Subject|0|||
156856414|NCT01421017|566228521|FG000|Overall Study|POD|0|||
156856415|NCT01421017|566228522|FG001|Overall Study|POD|6|||
156856416|NCT01421017|566228523|FG002|Overall Study|POD|3|||
156856417|NCT02313766|566228524|FG000|Overall Study|surgery cancelled|1|||
156856418|NCT02313766|566228525|FG001|Overall Study|surgery cancelled|0|||
156856419|NCT02313766|566228526|FG002|Overall Study|surgery cancelled|0|||
156856420|NCT02313766|566228524|FG000|Overall Study|Lost to Follow-up|0|||
156856421|NCT02313766|566228525|FG001|Overall Study|Lost to Follow-up|2|||
156856422|NCT02313766|566228526|FG002|Overall Study|Lost to Follow-up|0|||
156856423|NCT02313766|566228524|FG000|Overall Study|Adverse Event|0|||
156856424|NCT02313766|566228525|FG001|Overall Study|Adverse Event|1|||
156856425|NCT02313766|566228526|FG002|Overall Study|Adverse Event|0|||
156856426|NCT00416624|566228529|FG000|Overall Study|Withdrawal by Subject|1|||
156856427|NCT00416624|566228530|FG001|Overall Study|Withdrawal by Subject|6|||
156856428|NCT00416624|566228531|FG002|Overall Study|Withdrawal by Subject|4|||
156856429|NCT00416624|566228532|FG003|Overall Study|Withdrawal by Subject|9|||
156856430|NCT00416624|566228529|FG000|Overall Study|Death|4|||
156856431|NCT00416624|566228530|FG001|Overall Study|Death|7|||
156856432|NCT00416624|566228531|FG002|Overall Study|Death|7|||
156856433|NCT00416624|566228532|FG003|Overall Study|Death|1|||
156856434|NCT00416624|566228529|FG000|Overall Study|Adverse Event|8|||
156856435|NCT00416624|566228530|FG001|Overall Study|Adverse Event|3|||
156856436|NCT00416624|566228531|FG002|Overall Study|Adverse Event|2|||
156856437|NCT00416624|566228532|FG003|Overall Study|Adverse Event|2|||
156856438|NCT00416624|566228529|FG000|Overall Study|Other|8|||
156856439|NCT00416624|566228530|FG001|Overall Study|Other|11|||
156856440|NCT00416624|566228531|FG002|Overall Study|Other|5|||
156856441|NCT00416624|566228532|FG003|Overall Study|Other|5|||
156856442|NCT00416624|566228529|FG000|Overall Study|Cancel|1|||
156856443|NCT00416624|566228530|FG001|Overall Study|Cancel|0|||
156856444|NCT00416624|566228531|FG002|Overall Study|Cancel|0|||
156856445|NCT00416624|566228532|FG003|Overall Study|Cancel|0|||
156856446|NCT01005251|566228533|FG000|Overall Study|Withdrawal by Subject|2|||
156856447|NCT01005251|566228534|FG001|Overall Study|Withdrawal by Subject|5|||
156856448|NCT01005251|566228535|FG002|Overall Study|Withdrawal by Subject|3|||
156856449|NCT01005251|566228536|FG003|Overall Study|Withdrawal by Subject|4|||
156856450|NCT01005251|566228537|FG004|Overall Study|Withdrawal by Subject|9|||
156856451|NCT01005251|566228533|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
156856452|NCT01005251|566228534|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156856453|NCT01005251|566228535|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
156856454|NCT01005251|566228536|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156856455|NCT01005251|566228537|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
156856456|NCT01005251|566228533|FG000|Overall Study|Adverse Event|2|||
156856457|NCT01005251|566228534|FG001|Overall Study|Adverse Event|6|||
156856458|NCT01005251|566228535|FG002|Overall Study|Adverse Event|8|||
156856459|NCT01005251|566228536|FG003|Overall Study|Adverse Event|5|||
156856460|NCT01005251|566228537|FG004|Overall Study|Adverse Event|4|||
156856461|NCT01005251|566228533|FG000|Overall Study|Protocol Violation|1|||
156856462|NCT01005251|566228534|FG001|Overall Study|Protocol Violation|0|||
156856463|NCT01005251|566228535|FG002|Overall Study|Protocol Violation|0|||
156856464|NCT01005251|566228536|FG003|Overall Study|Protocol Violation|0|||
156856465|NCT01005251|566228537|FG004|Overall Study|Protocol Violation|2|||
156856466|NCT01005251|566228533|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
156342337|NCT00520936|564352653|FG006|Overall Study|Withdrawal by Subject|0|||
156342338|NCT00520936|564352654|FG007|Overall Study|Withdrawal by Subject|1|||
156342339|NCT00520936|564352647|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
156342340|NCT00520936|564352648|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
156342341|NCT00520936|564352649|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
156342342|NCT00520936|564352650|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
156342343|NCT00520936|564352651|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
156342344|NCT00520936|564352652|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
156342345|NCT00520936|564352653|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
156342346|NCT00520936|564352654|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
156342347|NCT00520936|564352647|FG000|Overall Study|Death|0|||
156342348|NCT00520936|564352648|FG001|Overall Study|Death|0|||
156342349|NCT00520936|564352649|FG002|Overall Study|Death|0|||
156342350|NCT00520936|564352650|FG003|Overall Study|Death|0|||
156342351|NCT00520936|564352651|FG004|Overall Study|Death|0|||
156342352|NCT00520936|564352652|FG005|Overall Study|Death|0|||
156342353|NCT00520936|564352653|FG006|Overall Study|Death|1|||
156342354|NCT00520936|564352654|FG007|Overall Study|Death|0|||
156342355|NCT00520936|564352647|FG000|Overall Study|Protocol Violation|0|||
156342356|NCT00520936|564352648|FG001|Overall Study|Protocol Violation|1|||
156342357|NCT00520936|564352649|FG002|Overall Study|Protocol Violation|1|||
156342358|NCT00520936|564352650|FG003|Overall Study|Protocol Violation|0|||
156342359|NCT00520936|564352651|FG004|Overall Study|Protocol Violation|1|||
156342360|NCT00520936|564352652|FG005|Overall Study|Protocol Violation|0|||
156342361|NCT00520936|564352653|FG006|Overall Study|Protocol Violation|1|||
156342362|NCT00520936|564352654|FG007|Overall Study|Protocol Violation|0|||
156342363|NCT04182763|564352662|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
156342364|NCT04182763|564352663|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
156342365|NCT04182763|564352664|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
156472679|NCT01079806|564825548|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
156472680|NCT01079806|564825547|FG000|Day 1 to Week 96|Pregnancy|0|||
156856467|NCT01005251|566228534|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
156856468|NCT01005251|566228535|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
156856469|NCT01005251|566228536|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
156856470|NCT01005251|566228537|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
156856471|NCT01005251|566228533|FG000|Overall Study|Lost to Follow-up|1|||
156856472|NCT01005251|566228534|FG001|Overall Study|Lost to Follow-up|4|||
156856473|NCT01005251|566228535|FG002|Overall Study|Lost to Follow-up|2|||
156856474|NCT01005251|566228536|FG003|Overall Study|Lost to Follow-up|0|||
156856475|NCT01005251|566228537|FG004|Overall Study|Lost to Follow-up|0|||
156856476|NCT01005251|566228533|FG000|Overall Study|Physician Decision|0|||
156856477|NCT01005251|566228534|FG001|Overall Study|Physician Decision|0|||
156856478|NCT01005251|566228535|FG002|Overall Study|Physician Decision|0|||
156856479|NCT01005251|566228536|FG003|Overall Study|Physician Decision|0|||
156856480|NCT01005251|566228537|FG004|Overall Study|Physician Decision|2|||
156856481|NCT01005251|566228533|FG000|Overall Study|Patient moved|1|||
156856482|NCT01005251|566228534|FG001|Overall Study|Patient moved|0|||
156856483|NCT01005251|566228535|FG002|Overall Study|Patient moved|0|||
156856484|NCT01005251|566228536|FG003|Overall Study|Patient moved|0|||
156856485|NCT01005251|566228537|FG004|Overall Study|Patient moved|0|||
156856486|NCT01005251|566228533|FG000|Overall Study|Wrong drug dispensed|0|||
156856487|NCT01005251|566228534|FG001|Overall Study|Wrong drug dispensed|1|||
156856488|NCT01005251|566228535|FG002|Overall Study|Wrong drug dispensed|0|||
156856489|NCT01005251|566228536|FG003|Overall Study|Wrong drug dispensed|0|||
156856490|NCT01005251|566228537|FG004|Overall Study|Wrong drug dispensed|0|||
156856491|NCT01005251|566228533|FG000|Overall Study|Randomized in error|0|||
156856492|NCT01005251|566228534|FG001|Overall Study|Randomized in error|0|||
156856493|NCT01005251|566228535|FG002|Overall Study|Randomized in error|1|||
156856494|NCT01005251|566228536|FG003|Overall Study|Randomized in error|1|||
156472681|NCT01079806|564825548|FG001|Day 1 to Week 96|Pregnancy|1|||
156472682|NCT01079806|564825547|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
156472683|NCT01079806|564825548|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
156472684|NCT01079806|564825547|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
156472685|NCT01079806|564825548|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
156542192|NCT04342871|565079259|FG000|Overall Study|Lost to Follow-up|13|||
156856495|NCT01005251|566228537|FG004|Overall Study|Randomized in error|0|||
156856496|NCT01005251|566228533|FG000|Overall Study|Lack of Efficacy|0|||
156856497|NCT01005251|566228534|FG001|Overall Study|Lack of Efficacy|0|||
156342366|NCT04182763|564352665|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
156342367|NCT04182763|564352666|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
156856498|NCT01005251|566228535|FG002|Overall Study|Lack of Efficacy|1|||
156472686|NCT01079806|564825547|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
156472687|NCT01079806|564825548|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
156472688|NCT01079806|564825547|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
156472689|NCT01079806|564825548|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
156472690|NCT01079806|564825547|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
156472691|NCT01079806|564825548|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
156542193|NCT01429584|565079264|FG000|Overall Study|Withdrawal by Subject|1|||
156856499|NCT01005251|566228536|FG003|Overall Study|Lack of Efficacy|1|||
156856500|NCT01005251|566228537|FG004|Overall Study|Lack of Efficacy|0|||
156856501|NCT02193776|566228538|FG000|Overall Study|Consent withdrawn|1|||
156856502|NCT02193776|566228539|FG001|Overall Study|Consent withdrawn|0|||
156856503|NCT02193776|566228540|FG002|Overall Study|Consent withdrawn|0|||
156856504|NCT02193776|566228541|FG003|Overall Study|Consent withdrawn|0|||
156856505|NCT02193776|566228538|FG000|Overall Study|Failure to comply with protocol|0|||
156856506|NCT02193776|566228539|FG001|Overall Study|Failure to comply with protocol|1|||
156856507|NCT02193776|566228540|FG002|Overall Study|Failure to comply with protocol|0|||
156856508|NCT02193776|566228541|FG003|Overall Study|Failure to comply with protocol|0|||
156856509|NCT02193776|566228538|FG000|Overall Study|Investigator/Sponsor decision|1|||
156856510|NCT02193776|566228539|FG001|Overall Study|Investigator/Sponsor decision|1|||
156856511|NCT02193776|566228540|FG002|Overall Study|Investigator/Sponsor decision|0|||
156856512|NCT02193776|566228541|FG003|Overall Study|Investigator/Sponsor decision|0|||
156856513|NCT02193776|566228538|FG000|Overall Study|Death|1|||
156856514|NCT02193776|566228539|FG001|Overall Study|Death|0|||
156856515|NCT02193776|566228540|FG002|Overall Study|Death|0|||
156856516|NCT02193776|566228541|FG003|Overall Study|Death|0|||
156856517|NCT02193776|566228538|FG000|Overall Study|Adverse event/Specific toxicity|5|||
156856518|NCT02193776|566228539|FG001|Overall Study|Adverse event/Specific toxicity|5|||
156856519|NCT02193776|566228540|FG002|Overall Study|Adverse event/Specific toxicity|2|||
156856520|NCT02193776|566228541|FG003|Overall Study|Adverse event/Specific toxicity|2|||
156856521|NCT00657540|566228543|FG000|Overall Study|Lost to Follow-up|1|||
156856522|NCT00657540|566228544|FG001|Overall Study|Lost to Follow-up|4|||
156856523|NCT01458639|566228545|FG000|Overall Study|Physician Decision|4|||
156856524|NCT01458639|566228545|FG000|Overall Study|Equipment issue|1|||
156856525|NCT01458639|566228545|FG000|Overall Study|Inability to obtain subject blood sample|1|||
156856526|NCT04245111|566228546|FG000|Overall Study|Lost to Follow-up|5|||
156856527|NCT04245111|566228547|FG001|Overall Study|Lost to Follow-up|1|||
156856528|NCT04245111|566228548|FG002|Overall Study|Lost to Follow-up|1|||
156856529|NCT01755234|566228549|FG000|Overall Study|Lost to Follow-up|11|||
156856530|NCT01755234|566228550|FG001|Overall Study|Lost to Follow-up|6|||
156856531|NCT01755234|566228549|FG000|Overall Study|Change in surgical case|2|||
156856532|NCT01755234|566228550|FG001|Overall Study|Change in surgical case|1|||
156856533|NCT01755234|566228549|FG000|Overall Study|case cancelled|1|||
156856534|NCT01755234|566228550|FG001|Overall Study|case cancelled|0|||
156856535|NCT01755234|566228549|FG000|Overall Study|Withdrawal by Subject|0|||
156856536|NCT01755234|566228550|FG001|Overall Study|Withdrawal by Subject|1|||
156856537|NCT01755234|566228549|FG000|Overall Study|unblinded|1|||
156856538|NCT01755234|566228550|FG001|Overall Study|unblinded|0|||
156856539|NCT03812380|566228551|FG000|Overall Study|Protocol Violation|3|||
156856540|NCT03812380|566228552|FG001|Overall Study|Protocol Violation|3|||
156856541|NCT03812380|566228551|FG000|Overall Study|Withdrawal by Subject|5|||
156856542|NCT03812380|566228552|FG001|Overall Study|Withdrawal by Subject|4|||
156856543|NCT03812380|566228551|FG000|Overall Study|Early termination of study|14|||
156856544|NCT03812380|566228552|FG001|Overall Study|Early termination of study|14|||
156856545|NCT01960140|566228553|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
156856546|NCT00231777|566228554|FG000|Overall Study|Lost to Follow-up|3|||
156856547|NCT00231777|566228555|FG001|Overall Study|Lost to Follow-up|0|||
156856548|NCT00231777|566228554|FG000|Overall Study|Other|3|||
156856549|NCT00231777|566228555|FG001|Overall Study|Other|2|||
156856550|NCT03935126|566228558|FG000|Overall Study|Study termination by sponsor|3|||
156856551|NCT01091675|566228563|FG000|Overall Study|Adverse Event|7|||
156856552|NCT01091675|566228563|FG000|Overall Study|Lack of Efficacy|27|||
156856553|NCT00689390|566228566|FG000|Overall Study|Adverse Event|19|||
156856554|NCT00689390|566228567|FG001|Overall Study|Adverse Event|0|||
156856555|NCT00689390|566228566|FG000|Overall Study|Lost to Follow-up|179|||
156856556|NCT00689390|566228567|FG001|Overall Study|Lost to Follow-up|7|||
156856557|NCT00689390|566228566|FG000|Overall Study|Withdrawal by Subject|117|||
156856558|NCT00689390|566228567|FG001|Overall Study|Withdrawal by Subject|3|||
156856559|NCT00689390|566228566|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
156856560|NCT00689390|566228567|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
156856561|NCT00689390|566228566|FG000|Overall Study|Non-Compliance With Protocol|21|||
156856562|NCT00689390|566228567|FG001|Overall Study|Non-Compliance With Protocol|0|||
156856563|NCT00689390|566228566|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
156856564|NCT00689390|566228567|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
156856565|NCT00689390|566228566|FG000|Overall Study|Administrative|37|||
156856566|NCT00689390|566228567|FG001|Overall Study|Administrative|0|||
156856567|NCT00462306|566228570|FG000|Overall Study|insufficient data|0|||
156342368|NCT04182763|564352662|FG000|Double-Blind Period, initial 6 months|Death|0|||
156342369|NCT04182763|564352663|FG001|Double-Blind Period, initial 6 months|Death|1|||
156342370|NCT04182763|564352664|FG002|Double-Blind Period, initial 6 months|Death|0|||
156342371|NCT04182763|564352665|FG003|Double-Blind Period, initial 6 months|Death|0|||
156472692|NCT01079806|564825547|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
156856568|NCT00462306|566228571|FG001|Overall Study|insufficient data|13|||
156856569|NCT03253679|566228574|FG000|Overall Study|Screen Failure|1|||
156856570|NCT04816214|566228575|FG000|Overall Study|Progressive Disease|4|||
156856571|NCT04816214|566228576|FG001|Overall Study|Progressive Disease|0|||
156856572|NCT04816214|566228577|FG002|Overall Study|Progressive Disease|0|||
156856573|NCT04816214|566228575|FG000|Overall Study|Death|1|||
156856574|NCT04816214|566228576|FG001|Overall Study|Death|0|||
156856575|NCT04816214|566228577|FG002|Overall Study|Death|0|||
156856576|NCT04816214|566228575|FG000|Overall Study|Study Terminated by Sponsor|1|||
156856577|NCT04816214|566228576|FG001|Overall Study|Study Terminated by Sponsor|0|||
156856578|NCT04816214|566228577|FG002|Overall Study|Study Terminated by Sponsor|0|||
156856579|NCT04879628|566228578|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
156856580|NCT04879628|566228579|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
156856581|NCT04879628|566228580|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
156856582|NCT04879628|566228581|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
156856583|NCT04879628|566228578|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
156856584|NCT04879628|566228579|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
156856585|NCT04879628|566228580|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
156856586|NCT04879628|566228581|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
156856587|NCT04879628|566228578|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
156856588|NCT04879628|566228579|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
156856589|NCT04879628|566228580|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
156856590|NCT04879628|566228581|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
156856591|NCT04879628|566228578|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
156856592|NCT04879628|566228579|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
156856593|NCT04879628|566228580|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
156856594|NCT04879628|566228581|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
156856595|NCT00360412|566228587|FG000|Overall Study|Adverse Event|37|||
156856596|NCT00360412|566228588|FG001|Overall Study|Adverse Event|65|||
156856597|NCT00360412|566228587|FG000|Overall Study|Protocol Violation|2|||
156856598|NCT00360412|566228588|FG001|Overall Study|Protocol Violation|5|||
156856599|NCT00360412|566228587|FG000|Overall Study|Patient withdrew consent|27|||
156856600|NCT00360412|566228588|FG001|Overall Study|Patient withdrew consent|52|||
156856601|NCT00360412|566228587|FG000|Overall Study|Lack of therapeutic efficacy|46|||
156856602|NCT00360412|566228588|FG001|Overall Study|Lack of therapeutic efficacy|61|||
156856603|NCT00360412|566228587|FG000|Overall Study|Physician Decision|2|||
156856604|NCT00360412|566228588|FG001|Overall Study|Physician Decision|4|||
156856605|NCT00360412|566228587|FG000|Overall Study|Other|5|||
156856606|NCT00360412|566228588|FG001|Overall Study|Other|6|||
156856607|NCT00360412|566228587|FG000|Overall Study|Study termination by Sponsor|214|||
156856608|NCT00360412|566228588|FG001|Overall Study|Study termination by Sponsor|469|||
156856609|NCT03863509|566228589|FG000|Overall Study|COVID-19 shutdown period|0|||
156856610|NCT03863509|566228590|FG001|Overall Study|COVID-19 shutdown period|4|||
156856611|NCT03863509|566228591|FG002|Overall Study|COVID-19 shutdown period|0|||
156856612|NCT03863509|566228589|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
156856613|NCT03863509|566228590|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
156856614|NCT03863509|566228591|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
156856615|NCT03863509|566228589|FG000|Overall Study|Lost to Follow-up|8|||
156856616|NCT03863509|566228590|FG001|Overall Study|Lost to Follow-up|0|||
156856617|NCT03863509|566228591|FG002|Overall Study|Lost to Follow-up|2|||
156856618|NCT03863509|566228589|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
156856619|NCT03863509|566228590|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
156856620|NCT03863509|566228591|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
156856621|NCT03863509|566228589|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
156856622|NCT03863509|566228590|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
156856623|NCT03863509|566228591|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
156856624|NCT03861273|566228592|FG000|Screening Phase (3 Weeks)|Other|1|||
156856625|NCT03861273|566228592|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
156856626|NCT03861273|566228592|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
156856627|NCT03861273|566228592|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
156856628|NCT03861273|566228592|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
156342372|NCT04182763|564352666|FG004|Double-Blind Period, initial 6 months|Death|0|||
156472693|NCT01079806|564825548|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
156472694|NCT01079806|564825547|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
156472695|NCT01079806|564825548|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
156472696|NCT02788981|564825549|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
156472697|NCT02788981|564825550|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
156472698|NCT00795184|564825552|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
156472699|NCT00795184|564825553|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
156472700|NCT03781375|564825554|FG000|Double-blind Phase|Adverse Event|0|||
156472701|NCT03781375|564825555|FG001|Double-blind Phase|Adverse Event|1|||
156472702|NCT03781375|564825554|FG000|Double-blind Phase|Lack of Response|6|||
156856629|NCT00191334|566228595|FG000|Overall Study|Adverse Event|4|||
156856630|NCT00191334|566228595|FG000|Overall Study|Disease Progression or Relapse|8|||
156856631|NCT00191334|566228595|FG000|Overall Study|Physician Decision|1|||
156856632|NCT00191334|566228595|FG000|Overall Study|Withdrawal by Subject|4|||
156856633|NCT03064490|566228596|FG000|Overall Study|Physician Decision|5|||
156856634|NCT02926638|566228599|FG000|Overall Study|Progression|2|||
156856635|NCT02926638|566228600|FG001|Overall Study|Progression|5|||
156856636|NCT02926638|566228599|FG000|Overall Study|Ineligible|1|||
156856637|NCT02926638|566228600|FG001|Overall Study|Ineligible|0|||
156856638|NCT02926638|566228599|FG000|Overall Study|Not protocol specified|1|||
156856639|NCT02926638|566228600|FG001|Overall Study|Not protocol specified|0|||
156856640|NCT02464410|566228601|FG000|Overall Study|Death|3|||
156856641|NCT02464410|566228602|FG001|Overall Study|Death|4|||
156856642|NCT02464410|566228601|FG000|Overall Study|Lost to Follow-up|7|||
156856643|NCT02464410|566228602|FG001|Overall Study|Lost to Follow-up|9|||
156856644|NCT02464410|566228601|FG000|Overall Study|Withdrawal by Subject|12|||
156856645|NCT02464410|566228602|FG001|Overall Study|Withdrawal by Subject|3|||
156856646|NCT01928927|566228604|FG000|Overall Study|Lost to Follow-up|1|||
156856647|NCT01928927|566228605|FG001|Overall Study|Lost to Follow-up|0|||
156856648|NCT01928927|566228604|FG000|Overall Study|Withdrawal by Subject|1|||
156856649|NCT01928927|566228605|FG001|Overall Study|Withdrawal by Subject|1|||
156856650|NCT01063153|566228606|FG000|Overall Study|Found Ineligible During Screening|2|||
156856651|NCT01063153|566228607|FG001|Overall Study|Found Ineligible During Screening|0|||
156856652|NCT01063153|566228606|FG000|Overall Study|Lost to Follow-up|0|||
156856653|NCT01063153|566228607|FG001|Overall Study|Lost to Follow-up|7|||
156856654|NCT01063153|566228606|FG000|Overall Study|Withdrawal by Subject|0|||
156856655|NCT01063153|566228607|FG001|Overall Study|Withdrawal by Subject|1|||
156856656|NCT01063153|566228606|FG000|Overall Study|Physician Decision|0|||
156856657|NCT01063153|566228607|FG001|Overall Study|Physician Decision|4|||
156856658|NCT01777776|566228608|FG000|Overall Study|Adverse Event|2|||
156856659|NCT01777776|566228609|FG001|Overall Study|Adverse Event|4|||
156856660|NCT01777776|566228610|FG002|Overall Study|Adverse Event|0|||
156856661|NCT01777776|566228611|FG003|Overall Study|Adverse Event|0|||
156856662|NCT01777776|566228608|FG000|Overall Study|Disease Progression|4|||
156472703|NCT03781375|564825555|FG001|Double-blind Phase|Lack of Response|2|||
156472704|NCT03781375|564825554|FG000|Double-blind Phase|Other|1|||
156472705|NCT03781375|564825555|FG001|Double-blind Phase|Other|3|||
156472706|NCT03781375|564825554|FG000|Open-label Phase|Protocol Issues|0|||
156472707|NCT03781375|564825555|FG001|Open-label Phase|Protocol Issues|1|||
156472708|NCT03781375|564825554|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
156472709|NCT03781375|564825555|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
156472710|NCT03781375|564825554|FG000|Open-label Phase|Other|2|||
156472711|NCT03781375|564825555|FG001|Open-label Phase|Other|2|||
156472712|NCT03489369|564825578|FG000|Overall Study|Documented Progressive Disease|3|||
156472713|NCT03489369|564825579|FG001|Overall Study|Documented Progressive Disease|2|||
156472714|NCT03489369|564825580|FG002|Overall Study|Documented Progressive Disease|3|||
156472715|NCT03489369|564825581|FG003|Overall Study|Documented Progressive Disease|6|||
156472716|NCT03489369|564825578|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
156472717|NCT03489369|564825579|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
156472718|NCT03489369|564825580|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
156472719|NCT03489369|564825581|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
156472720|NCT02106884|564825584|FG000|Overall Study|Change of diagnosis/exclusion|0|||
156472721|NCT02106884|564825585|FG001|Overall Study|Change of diagnosis/exclusion|1|||
156472722|NCT02384382|564825586|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
156472723|NCT02384382|564825586|FG000|Overall Study|Death|1|||
156472724|NCT02384382|564825586|FG000|Overall Study|Adverse Event|1|||
156472725|NCT02384382|564825586|FG000|Overall Study|Disease progression|16|||
156856663|NCT01777776|566228609|FG001|Overall Study|Disease Progression|8|||
156856664|NCT01777776|566228610|FG002|Overall Study|Disease Progression|6|||
156856665|NCT01777776|566228611|FG003|Overall Study|Disease Progression|3|||
156856666|NCT01777776|566228608|FG000|Overall Study|Withdrawal by Subject|0|||
156856667|NCT01777776|566228609|FG001|Overall Study|Withdrawal by Subject|0|||
156856668|NCT01777776|566228610|FG002|Overall Study|Withdrawal by Subject|0|||
156856669|NCT01777776|566228611|FG003|Overall Study|Withdrawal by Subject|1|||
156856670|NCT00383552|566230713|FG000|Overall Study|Adverse Event|7|||
156856671|NCT00383552|566230714|FG001|Overall Study|Adverse Event|6|||
156856672|NCT00383552|566230715|FG002|Overall Study|Adverse Event|9|||
156856673|NCT00383552|566230716|FG003|Overall Study|Adverse Event|6|||
156856674|NCT00383552|566230713|FG000|Overall Study|Lack of Efficacy|4|||
156856675|NCT00383552|566230714|FG001|Overall Study|Lack of Efficacy|13|||
156856676|NCT00383552|566230715|FG002|Overall Study|Lack of Efficacy|29|||
156856677|NCT00383552|566230716|FG003|Overall Study|Lack of Efficacy|42|||
156856678|NCT00383552|566230713|FG000|Overall Study|Lost to Follow-up|0|||
156856679|NCT00383552|566230714|FG001|Overall Study|Lost to Follow-up|1|||
156856680|NCT00383552|566230715|FG002|Overall Study|Lost to Follow-up|5|||
156856681|NCT00383552|566230716|FG003|Overall Study|Lost to Follow-up|1|||
156856682|NCT00383552|566230713|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
156856683|NCT00383552|566230714|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
156856684|NCT00383552|566230715|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
156856685|NCT00383552|566230716|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
156856686|NCT00383552|566230713|FG000|Overall Study|Did not wish to continue (related)|1|||
156856687|NCT00383552|566230714|FG001|Overall Study|Did not wish to continue (related)|0|||
156856688|NCT00383552|566230715|FG002|Overall Study|Did not wish to continue (related)|2|||
156856689|NCT00383552|566230716|FG003|Overall Study|Did not wish to continue (related)|3|||
156856690|NCT00383552|566230713|FG000|Overall Study|Noncompliance with the protocol|11|||
156856691|NCT00383552|566230714|FG001|Overall Study|Noncompliance with the protocol|6|||
156856692|NCT00383552|566230715|FG002|Overall Study|Noncompliance with the protocol|8|||
156856693|NCT00383552|566230716|FG003|Overall Study|Noncompliance with the protocol|10|||
156856694|NCT00383552|566230713|FG000|Overall Study|Did not meet protocol eligibility|8|||
156856695|NCT00383552|566230714|FG001|Overall Study|Did not meet protocol eligibility|6|||
156856696|NCT00383552|566230715|FG002|Overall Study|Did not meet protocol eligibility|2|||
156856697|NCT00383552|566230716|FG003|Overall Study|Did not meet protocol eligibility|3|||
156856698|NCT00383552|566230713|FG000|Overall Study|Administrative|1|||
156856699|NCT00383552|566230714|FG001|Overall Study|Administrative|0|||
156856700|NCT00383552|566230715|FG002|Overall Study|Administrative|1|||
156856701|NCT00383552|566230716|FG003|Overall Study|Administrative|1|||
156856702|NCT03096834|566230717|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
156856703|NCT03096834|566230718|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
156856704|NCT03096834|566230719|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
156856705|NCT03096834|566230720|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
156856706|NCT03096834|566230717|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
156856707|NCT03096834|566230718|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
156856708|NCT03096834|566230719|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
156856709|NCT03096834|566230720|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
156856710|NCT03096834|566230717|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
156856711|NCT03096834|566230718|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
156856712|NCT03096834|566230719|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
156856713|NCT03096834|566230720|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
156856714|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
156856715|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
156856716|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
156856717|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
156856718|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
156856719|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
156856720|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
156856721|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
156856722|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
156856723|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
156856724|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
156856725|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
156856726|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
156856727|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
156856728|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
156856729|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
156856730|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
156856731|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
156856732|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
156856733|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
156856734|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
156472726|NCT01822756|564825589|FG000|Overall Study|Adverse Event|0|||
156472727|NCT01822756|564825590|FG001|Overall Study|Adverse Event|0|||
156472728|NCT01822756|564825591|FG002|Overall Study|Adverse Event|0|||
156472729|NCT01822756|564825592|FG003|Overall Study|Adverse Event|2|||
156856735|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
156856736|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
156856737|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
156856738|NCT03096834|566230717|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
156856739|NCT03096834|566230718|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
156856740|NCT03096834|566230719|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
156856741|NCT03096834|566230720|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
156856742|NCT03096834|566230717|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
156856743|NCT03096834|566230718|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
156856744|NCT03096834|566230719|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
156856745|NCT03096834|566230720|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
156856746|NCT03096834|566230717|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
156856747|NCT03096834|566230718|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
156856748|NCT03096834|566230719|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
156856749|NCT03096834|566230720|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
156856750|NCT00966654|566230721|FG000|Overall Study|Study was terminated,PI left institution|12|||
156856751|NCT01600326|566230728|FG000|Overall Study|Lost to Follow-up|1|||
156856752|NCT01600326|566230729|FG001|Overall Study|Lost to Follow-up|1|||
156856753|NCT04456504|566230730|FG000|Overall Study|Lost to Follow-up|2|||
156856754|NCT00762359|566230731|FG000|Overall Study|Adverse Event|20|||
156856755|NCT00762359|566230732|FG001|Overall Study|Adverse Event|23|||
156856756|NCT00762359|566230731|FG000|Overall Study|Protocol Violation|21|||
156856757|NCT00762359|566230732|FG001|Overall Study|Protocol Violation|13|||
156856758|NCT00762359|566230731|FG000|Overall Study|Withdrawal by Subject|13|||
156856759|NCT00762359|566230732|FG001|Overall Study|Withdrawal by Subject|10|||
156856760|NCT00762359|566230731|FG000|Overall Study|Lack of Efficacy|0|||
156856761|NCT00762359|566230732|FG001|Overall Study|Lack of Efficacy|4|||
156856762|NCT00762359|566230731|FG000|Overall Study|Institution closed|2|||
156856763|NCT00762359|566230732|FG001|Overall Study|Institution closed|3|||
156856764|NCT00762359|566230731|FG000|Overall Study|Physician Decision|2|||
156856765|NCT00762359|566230732|FG001|Overall Study|Physician Decision|3|||
156856766|NCT00762359|566230731|FG000|Overall Study|Removal|0|||
156856767|NCT00762359|566230732|FG001|Overall Study|Removal|1|||
156856768|NCT00762359|566230731|FG000|Overall Study|Withdrew consent|1|||
156856769|NCT00762359|566230732|FG001|Overall Study|Withdrew consent|0|||
156856770|NCT00882440|566230733|FG000|Overall Study|Adverse Event|2|||
156856771|NCT00882440|566230734|FG001|Overall Study|Adverse Event|2|||
156856772|NCT00882440|566230735|FG002|Overall Study|Adverse Event|2|||
156856773|NCT00882440|566230736|FG003|Overall Study|Adverse Event|1|||
156856774|NCT00882440|566230737|FG004|Overall Study|Adverse Event|1|||
156856775|NCT00882440|566230738|FG005|Overall Study|Adverse Event|4|||
156856776|NCT00882440|566230739|FG006|Overall Study|Adverse Event|2|||
156856777|NCT00882440|566230733|FG000|Overall Study|Lack of Efficacy|3|||
156856778|NCT00882440|566230734|FG001|Overall Study|Lack of Efficacy|5|||
156856779|NCT00882440|566230735|FG002|Overall Study|Lack of Efficacy|2|||
156856780|NCT00882440|566230736|FG003|Overall Study|Lack of Efficacy|0|||
156856781|NCT00882440|566230737|FG004|Overall Study|Lack of Efficacy|0|||
156856782|NCT00882440|566230738|FG005|Overall Study|Lack of Efficacy|3|||
156856783|NCT00882440|566230739|FG006|Overall Study|Lack of Efficacy|0|||
156856784|NCT00882440|566230733|FG000|Overall Study|Lost to Follow-up|2|||
156856785|NCT00882440|566230734|FG001|Overall Study|Lost to Follow-up|0|||
156856786|NCT00882440|566230735|FG002|Overall Study|Lost to Follow-up|1|||
156856787|NCT00882440|566230736|FG003|Overall Study|Lost to Follow-up|1|||
156856788|NCT00882440|566230737|FG004|Overall Study|Lost to Follow-up|1|||
156856789|NCT00882440|566230738|FG005|Overall Study|Lost to Follow-up|0|||
156856790|NCT00882440|566230739|FG006|Overall Study|Lost to Follow-up|1|||
156856791|NCT00882440|566230733|FG000|Overall Study|Protocol Violation|0|||
156856792|NCT00882440|566230734|FG001|Overall Study|Protocol Violation|0|||
156856793|NCT00882440|566230735|FG002|Overall Study|Protocol Violation|1|||
156856794|NCT00882440|566230736|FG003|Overall Study|Protocol Violation|1|||
156856795|NCT00882440|566230737|FG004|Overall Study|Protocol Violation|1|||
156856796|NCT00882440|566230738|FG005|Overall Study|Protocol Violation|0|||
156856797|NCT00882440|566230739|FG006|Overall Study|Protocol Violation|0|||
156856798|NCT00882440|566230733|FG000|Overall Study|Withdrawal by Subject|2|||
156856799|NCT00882440|566230734|FG001|Overall Study|Withdrawal by Subject|1|||
156856800|NCT00882440|566230735|FG002|Overall Study|Withdrawal by Subject|1|||
156856801|NCT00882440|566230736|FG003|Overall Study|Withdrawal by Subject|0|||
156856802|NCT00882440|566230737|FG004|Overall Study|Withdrawal by Subject|6|||
156856803|NCT00882440|566230738|FG005|Overall Study|Withdrawal by Subject|0|||
156856804|NCT00882440|566230739|FG006|Overall Study|Withdrawal by Subject|1|||
156856805|NCT00882440|566230733|FG000|Overall Study|Patient Uncooperative|2|||
156856806|NCT00882440|566230734|FG001|Overall Study|Patient Uncooperative|0|||
156856807|NCT00882440|566230735|FG002|Overall Study|Patient Uncooperative|0|||
156472730|NCT01822756|564825593|FG004|Overall Study|Adverse Event|0|||
156472731|NCT01822756|564825589|FG000|Overall Study|Disease progression|11|||
156856808|NCT00882440|566230736|FG003|Overall Study|Patient Uncooperative|0|||
156856809|NCT00882440|566230737|FG004|Overall Study|Patient Uncooperative|1|||
156856810|NCT00882440|566230738|FG005|Overall Study|Patient Uncooperative|0|||
156856811|NCT00882440|566230739|FG006|Overall Study|Patient Uncooperative|0|||
156856812|NCT01342913|566230740|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
156856813|NCT01342913|566230741|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156856814|NCT01342913|566230742|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156856815|NCT01342913|566230740|FG000|2-week Run-in Period|Physician Decision|6|||
156472732|NCT01822756|564825590|FG001|Overall Study|Disease progression|1|||
156472733|NCT01822756|564825591|FG002|Overall Study|Disease progression|7|||
156472734|NCT01822756|564825592|FG003|Overall Study|Disease progression|2|||
156472735|NCT01822756|564825593|FG004|Overall Study|Disease progression|6|||
156472736|NCT01822756|564825589|FG000|Overall Study|Death|2|||
156472737|NCT01822756|564825590|FG001|Overall Study|Death|2|||
156472738|NCT01822756|564825591|FG002|Overall Study|Death|1|||
156472739|NCT01822756|564825592|FG003|Overall Study|Death|0|||
156472740|NCT01822756|564825593|FG004|Overall Study|Death|0|||
156472741|NCT01822756|564825589|FG000|Overall Study|Lost to Follow-up|1|||
156472742|NCT01822756|564825590|FG001|Overall Study|Lost to Follow-up|0|||
156472743|NCT01822756|564825591|FG002|Overall Study|Lost to Follow-up|1|||
156472744|NCT01822756|564825592|FG003|Overall Study|Lost to Follow-up|0|||
156472745|NCT01822756|564825593|FG004|Overall Study|Lost to Follow-up|1|||
156472746|NCT01822756|564825589|FG000|Overall Study|Physician Decision|0|||
156472747|NCT01822756|564825590|FG001|Overall Study|Physician Decision|1|||
156472748|NCT01822756|564825591|FG002|Overall Study|Physician Decision|0|||
156472749|NCT01822756|564825592|FG003|Overall Study|Physician Decision|0|||
156472750|NCT01822756|564825593|FG004|Overall Study|Physician Decision|0|||
156472751|NCT01822756|564825589|FG000|Overall Study|disease progression & patient preference|2|||
156472752|NCT01822756|564825590|FG001|Overall Study|disease progression & patient preference|0|||
156472753|NCT01822756|564825591|FG002|Overall Study|disease progression & patient preference|1|||
156342373|NCT04182763|564352662|FG000|Open-Label Period, subsequent 18 months|Death|3|||
156342374|NCT04182763|564352663|FG001|Open-Label Period, subsequent 18 months|Death|2|||
156472754|NCT01822756|564825592|FG003|Overall Study|disease progression & patient preference|0|||
156472755|NCT01822756|564825593|FG004|Overall Study|disease progression & patient preference|0|||
156472756|NCT02091752|564825594|FG000|Overall Study|Study terminated by Sponsor|2|||
156472757|NCT02091752|564825594|FG000|Overall Study|Adverse Event|1|||
156472758|NCT02630966|564825601|FG000|Overall Study|Adverse Event|1|||
156472759|NCT02630966|564825602|FG001|Overall Study|Adverse Event|3|||
156472760|NCT02630966|564825601|FG000|Overall Study|Significant Protocol Deviation|0|||
156472761|NCT02630966|564825602|FG001|Overall Study|Significant Protocol Deviation|2|||
156472762|NCT02630966|564825601|FG000|Overall Study|Voluntary Withdrawal|1|||
156472763|NCT02630966|564825602|FG001|Overall Study|Voluntary Withdrawal|1|||
156472764|NCT02630966|564825601|FG000|Overall Study|Lack of Efficacy|0|||
156472765|NCT02630966|564825602|FG001|Overall Study|Lack of Efficacy|2|||
156472766|NCT00665392|564825603|FG000|Overall Study|not treated|1|||
156856816|NCT01342913|566230741|FG001|2-week Run-in Period|Physician Decision|0|||
156856817|NCT01342913|566230742|FG002|2-week Run-in Period|Physician Decision|0|||
156856818|NCT01342913|566230740|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
156856819|NCT01342913|566230741|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156856820|NCT01342913|566230742|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156856821|NCT01342913|566230740|FG000|2-week Run-in Period|Adverse Event|2|||
156856822|NCT01342913|566230741|FG001|2-week Run-in Period|Adverse Event|0|||
156856823|NCT01342913|566230742|FG002|2-week Run-in Period|Adverse Event|0|||
156856824|NCT01342913|566230740|FG000|2-week Run-in Period|Protocol Violation|5|||
156856825|NCT01342913|566230741|FG001|2-week Run-in Period|Protocol Violation|0|||
156856826|NCT01342913|566230742|FG002|2-week Run-in Period|Protocol Violation|0|||
156856827|NCT01342913|566230740|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
156856828|NCT01342913|566230741|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
156856829|NCT01342913|566230742|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
156856830|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156856831|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Adverse Event|3|||
156856832|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Adverse Event|6|||
156856833|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156856834|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
156856835|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
156856836|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156856837|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
156856838|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
156856839|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156856840|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
156856841|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
156856842|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Physician Decision|0|||
156856843|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Physician Decision|2|||
156856844|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Physician Decision|0|||
156856845|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156856846|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156856847|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156856853|NCT04319198|566230748|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
156856854|NCT04319198|566230749|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
156856855|NCT04319198|566230750|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
156856856|NCT04319198|566230748|FG000|Overall Study|Death|0|||
156856857|NCT04319198|566230749|FG001|Overall Study|Death|3|||
156856858|NCT04319198|566230750|FG002|Overall Study|Death|3|||
156856859|NCT04319198|566230748|FG000|Overall Study|Reason Not Specified|0|||
156856860|NCT04319198|566230749|FG001|Overall Study|Reason Not Specified|2|||
156856861|NCT04319198|566230750|FG002|Overall Study|Reason Not Specified|4|||
156856862|NCT04319198|566230748|FG000|Overall Study|Withdrawal of Consent|0|||
156472767|NCT00243867|564825609|FG000|Overall Study|Adverse Event|24|||
156856863|NCT04319198|566230749|FG001|Overall Study|Withdrawal of Consent|0|||
156856864|NCT04319198|566230750|FG002|Overall Study|Withdrawal of Consent|5|||
156856865|NCT04319198|566230748|FG000|Overall Study|Site Terminated by Sponsor|0|||
156856866|NCT04319198|566230749|FG001|Overall Study|Site Terminated by Sponsor|1|||
156856867|NCT04319198|566230750|FG002|Overall Study|Site Terminated by Sponsor|0|||
156856868|NCT02123134|566230760|FG000|Overall Study|Withdrawal of consent|3|||
156856869|NCT02123134|566230761|FG001|Overall Study|Withdrawal of consent|2|||
156856870|NCT02123134|566230760|FG000|Overall Study|Administrative decision|0|||
156856871|NCT02123134|566230761|FG001|Overall Study|Administrative decision|1|||
156342375|NCT04182763|564352664|FG002|Open-Label Period, subsequent 18 months|Death|2|||
156856872|NCT00962208|566230762|FG000|Overall Study|Could not achieve good vision|9|||
156342376|NCT04182763|564352665|FG003|Open-Label Period, subsequent 18 months|Death|0|||
156342377|NCT04182763|564352666|FG004|Open-Label Period, subsequent 18 months|Death|1|||
156342378|NCT04182763|564352662|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
156542194|NCT01429584|565079265|FG001|Overall Study|Withdrawal by Subject|0|||
156542195|NCT01429584|565079264|FG000|Overall Study|Protocol Violation|0|||
156542196|NCT01429584|565079265|FG001|Overall Study|Protocol Violation|1|||
156856873|NCT00962208|566230763|FG001|Overall Study|Could not achieve good vision|0|||
156856874|NCT00962208|566230762|FG000|Overall Study|Contraindicated to continue study|5|||
156856875|NCT00962208|566230763|FG001|Overall Study|Contraindicated to continue study|1|||
156856876|NCT00962208|566230762|FG000|Overall Study|Lost to Follow-up|0|||
156856877|NCT00962208|566230763|FG001|Overall Study|Lost to Follow-up|9|||
156856878|NCT01731912|566230770|FG000|Overall Study|noncompliance|2|||
156856879|NCT00141453|566230771|FG000|Overall Study|Protocol Violation|6|||
156856880|NCT00141453|566230772|FG001|Overall Study|Protocol Violation|5|||
156856881|NCT02043938|566230773|FG000|Overall Study|Withdrawal by Subject|7|||
156856882|NCT02043938|566230773|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
156856883|NCT02043938|566230773|FG000|Overall Study|No show by subject|1|||
156856884|NCT02043938|566230773|FG000|Overall Study|Investigator decision|1|||
156856885|NCT03010527|566230776|FG000|Overall Study|Death|0|||
156856886|NCT03010527|566230777|FG001|Overall Study|Death|0|||
156856887|NCT03010527|566230778|FG002|Overall Study|Death|1|||
156856888|NCT03010527|566230776|FG000|Overall Study|Adverse Event|0|||
156856889|NCT03010527|566230777|FG001|Overall Study|Adverse Event|4|||
156856890|NCT03010527|566230778|FG002|Overall Study|Adverse Event|2|||
156472768|NCT00243867|564825610|FG001|Overall Study|Adverse Event|34|||
156472769|NCT00243867|564825609|FG000|Overall Study|Lack of Efficacy|115|||
156472770|NCT00243867|564825610|FG001|Overall Study|Lack of Efficacy|78|||
156472771|NCT00243867|564825609|FG000|Overall Study|Withdrawal by Subject|11|||
156472772|NCT00243867|564825610|FG001|Overall Study|Withdrawal by Subject|23|||
156472773|NCT00243867|564825609|FG000|Overall Study|Lost to Follow-up|2|||
156472774|NCT00243867|564825610|FG001|Overall Study|Lost to Follow-up|1|||
156472775|NCT00243867|564825609|FG000|Overall Study|Physician Decision|2|||
156472776|NCT00243867|564825610|FG001|Overall Study|Physician Decision|7|||
156472777|NCT00243867|564825609|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
156472778|NCT00243867|564825610|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
156472779|NCT03389802|564825634|FG000|Overall Study|Lack of Efficacy|3|||
156472780|NCT03389802|564825635|FG001|Overall Study|Lack of Efficacy|3|||
156342379|NCT04182763|564352663|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
156472781|NCT03389802|564825636|FG002|Overall Study|Lack of Efficacy|13|||
156472782|NCT03389802|564825637|FG003|Overall Study|Lack of Efficacy|6|||
156472783|NCT03389802|564825638|FG004|Overall Study|Lack of Efficacy|1|||
156472784|NCT03389802|564825634|FG000|Overall Study|Adverse Event|0|||
156472785|NCT03389802|564825635|FG001|Overall Study|Adverse Event|0|||
156472786|NCT03389802|564825636|FG002|Overall Study|Adverse Event|1|||
156472787|NCT03389802|564825637|FG003|Overall Study|Adverse Event|0|||
156542197|NCT02018822|565079266|FG000|Overall Study|filling replaced by crown|0|||
156472788|NCT03389802|564825638|FG004|Overall Study|Adverse Event|4|||
156472789|NCT03389802|564825634|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
156472790|NCT03389802|564825635|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
156472791|NCT03389802|564825636|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
156472792|NCT03389802|564825637|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
156856891|NCT03010527|566230776|FG000|Overall Study|Protocol Violation|0|||
156856892|NCT03010527|566230777|FG001|Overall Study|Protocol Violation|1|||
156856893|NCT03010527|566230778|FG002|Overall Study|Protocol Violation|0|||
156856894|NCT03010527|566230776|FG000|Overall Study|Lost to Follow-up|0|||
156856895|NCT03010527|566230777|FG001|Overall Study|Lost to Follow-up|2|||
156856896|NCT03010527|566230778|FG002|Overall Study|Lost to Follow-up|1|||
156856897|NCT03010527|566230776|FG000|Overall Study|Withdrawal by Subject|0|||
156856898|NCT03010527|566230777|FG001|Overall Study|Withdrawal by Subject|3|||
156856899|NCT03010527|566230778|FG002|Overall Study|Withdrawal by Subject|4|||
156856900|NCT03010527|566230776|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
156856901|NCT03010527|566230777|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
156856902|NCT03010527|566230778|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
156856903|NCT03010527|566230776|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
156856904|NCT03010527|566230777|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
156856905|NCT03010527|566230778|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
156856906|NCT03010527|566230776|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
156856907|NCT03010527|566230777|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
156856908|NCT03010527|566230778|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
156856909|NCT02656017|566230779|FG000|Overall Study|Study burden|3|||
156856910|NCT02656017|566230780|FG001|Overall Study|Study burden|3|||
156856911|NCT02656017|566230779|FG000|Overall Study|Adverse Event|2|||
156856912|NCT02656017|566230780|FG001|Overall Study|Adverse Event|1|||
156856913|NCT02656017|566230779|FG000|Overall Study|Unable/unwilling to take study medication|2|||
156856914|NCT02656017|566230780|FG001|Overall Study|Unable/unwilling to take study medication|1|||
156856915|NCT02656017|566230779|FG000|Overall Study|Began Tolvaptan|1|||
156856916|NCT02656017|566230780|FG001|Overall Study|Began Tolvaptan|1|||
156856917|NCT02656017|566230779|FG000|Overall Study|Withdrawal by Subject|1|||
156856918|NCT02656017|566230780|FG001|Overall Study|Withdrawal by Subject|0|||
156856919|NCT06039579|566230783|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856920|NCT06039579|566230784|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856921|NCT06039579|566230785|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856922|NCT06039579|566230786|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856923|NCT06039579|566230787|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856924|NCT06039579|566230788|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856925|NCT06039579|566230789|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856926|NCT06039579|566230790|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
156856927|NCT02792231|566230795|FG000|Overall Study|Patient/guardian decision|32|||
156856928|NCT02792231|566230796|FG001|Overall Study|Patient/guardian decision|42|||
156856929|NCT02792231|566230795|FG000|Overall Study|Adverse Event|15|||
156856930|NCT02792231|566230796|FG001|Overall Study|Adverse Event|11|||
156856931|NCT02792231|566230795|FG000|Overall Study|Physician Decision|14|||
156856932|NCT02792231|566230796|FG001|Overall Study|Physician Decision|12|||
156856933|NCT02792231|566230795|FG000|Overall Study|Lack of Efficacy|7|||
156856934|NCT02792231|566230796|FG001|Overall Study|Lack of Efficacy|9|||
156856935|NCT02792231|566230795|FG000|Overall Study|Lost to Follow-up|9|||
156856936|NCT02792231|566230796|FG001|Overall Study|Lost to Follow-up|5|||
156856937|NCT02792231|566230795|FG000|Overall Study|Pregnancy|1|||
156856938|NCT02792231|566230796|FG001|Overall Study|Pregnancy|3|||
156856939|NCT02792231|566230795|FG000|Overall Study|Non-compliance with study treatment|2|||
156856940|NCT02792231|566230796|FG001|Overall Study|Non-compliance with study treatment|1|||
156856941|NCT02792231|566230795|FG000|Overall Study|Protocol deviation|2|||
156856942|NCT02792231|566230796|FG001|Overall Study|Protocol deviation|0|||
156856943|NCT02792231|566230795|FG000|Overall Study|Technical problems|0|||
156856944|NCT02792231|566230796|FG001|Overall Study|Technical problems|1|||
156856945|NCT02469623|566230797|FG000|Overall Study|Not consented for long-term follow-up|4|||
156856946|NCT02469623|566230797|FG000|Overall Study|Lost to Follow-up|4|||
156856947|NCT02469623|566230797|FG000|Overall Study|Withdrawal by Subject|2|||
156856948|NCT02469623|566230797|FG000|Overall Study|Death|3|||
156856949|NCT04073186|566230798|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
156856950|NCT04073186|566230798|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
156856951|NCT04073186|566230798|FG000|First Wearing Cycle|Protocol Violation|1|||
156856952|NCT04073186|566230798|FG000|First Wearing Cycle|Lens Discomfort|2|||
156856953|NCT04073186|566230798|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
156856954|NCT04073186|566230798|FG000|Second Wearing Cycle|Adverse Event|1|||
156856955|NCT03309878|566230799|FG000|Overall Study|Adverse Event|1|||
156856956|NCT03309878|566230800|FG001|Overall Study|Adverse Event|0|||
156342380|NCT04182763|564352664|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
156856957|NCT03309878|566230801|FG002|Overall Study|Adverse Event|0|||
156856958|NCT03309878|566230802|FG003|Overall Study|Adverse Event|0|||
156856959|NCT03309878|566230799|FG000|Overall Study|Did not maintain eligibility|2|||
156342381|NCT04182763|564352665|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
156342382|NCT04182763|564352666|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
156472793|NCT03389802|564825638|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
156472794|NCT02426138|564825639|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
156472795|NCT02426138|564825640|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
156472796|NCT04677738|564825641|FG000|Overall Study|Withdrawal by Subject|4|||
156472797|NCT04677738|564825642|FG001|Overall Study|Withdrawal by Subject|2|||
156472798|NCT01683409|564825648|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
156342383|NCT04182763|564352662|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
156342384|NCT04182763|564352663|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
156342385|NCT04182763|564352664|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
156342386|NCT04182763|564352665|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
156472799|NCT01683409|564825649|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
156856960|NCT03309878|566230800|FG001|Overall Study|Did not maintain eligibility|1|||
156856961|NCT03309878|566230801|FG002|Overall Study|Did not maintain eligibility|0|||
156856962|NCT03309878|566230802|FG003|Overall Study|Did not maintain eligibility|0|||
156856963|NCT03309878|566230799|FG000|Overall Study|Withdrawal by Subject|0|||
156856964|NCT03309878|566230800|FG001|Overall Study|Withdrawal by Subject|1|||
156856965|NCT03309878|566230801|FG002|Overall Study|Withdrawal by Subject|0|||
156856966|NCT03309878|566230802|FG003|Overall Study|Withdrawal by Subject|0|||
156856967|NCT01884077|566230803|FG000|Overall Study|screen fail|0|||
156856968|NCT01884077|566230804|FG001|Overall Study|screen fail|2|||
156856969|NCT01884077|566230803|FG000|Overall Study|canceled surgery|2|||
156856970|NCT01884077|566230804|FG001|Overall Study|canceled surgery|0|||
156856971|NCT01884077|566230803|FG000|Overall Study|Lost to Follow-up|0|||
156856972|NCT01884077|566230804|FG001|Overall Study|Lost to Follow-up|4|||
156856973|NCT01884077|566230803|FG000|Overall Study|study closed|6|||
156856974|NCT01884077|566230804|FG001|Overall Study|study closed|4|||
156856975|NCT00473434|566230805|FG000|Overall Study|Physician Decision|3|||
156856976|NCT00473434|566230805|FG000|Overall Study|Withdrawal by Subject|9|||
156856977|NCT00473434|566230805|FG000|Overall Study|Compliance|3|||
156856978|NCT00473434|566230805|FG000|Overall Study|Lack of Efficacy|3|||
156856979|NCT00473434|566230805|FG000|Overall Study|Adverse Event|3|||
156856980|NCT00473434|566230805|FG000|Overall Study|Patient was selling medication to others|1|||
156856981|NCT00473434|566230805|FG000|Overall Study|Safety evaluation|1|||
156856982|NCT00473434|566230805|FG000|Overall Study|Reason not specified|6|||
156856983|NCT00473434|566230805|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
156856984|NCT00473434|566230805|FG000|Overall Study|Switching to trial medication|1|||
156856985|NCT00473434|566230805|FG000|Overall Study|No longer required|1|||
156856986|NCT02836652|566230806|FG000|Overall Study|Death|3|||
156856987|NCT02836652|566230807|FG001|Overall Study|Death|3|||
156856988|NCT02836652|566230806|FG000|Overall Study|Transplant/Explant|3|||
156856989|NCT02836652|566230807|FG001|Overall Study|Transplant/Explant|4|||
156856990|NCT02836652|566230806|FG000|Overall Study|Withdrawn|9|||
156856991|NCT02836652|566230807|FG001|Overall Study|Withdrawn|9|||
156856992|NCT02836652|566230806|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
156856993|NCT02836652|566230807|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
156856994|NCT02349633|566230808|FG000|Overall Study|Death|0|||
156856995|NCT02349633|566230809|FG001|Overall Study|Death|1|||
156856996|NCT02349633|566230810|FG002|Overall Study|Death|0|||
156856997|NCT02349633|566230811|FG003|Overall Study|Death|0|||
156856998|NCT02349633|566230812|FG004|Overall Study|Death|0|||
156856999|NCT02349633|566230813|FG005|Overall Study|Death|1|||
156857000|NCT02349633|566230814|FG006|Overall Study|Death|1|||
156857001|NCT02349633|566230815|FG007|Overall Study|Death|1|||
156857002|NCT02349633|566230816|FG008|Overall Study|Death|0|||
156857003|NCT02349633|566230817|FG009|Overall Study|Death|1|||
156857004|NCT02349633|566230818|FG010|Overall Study|Death|0|||
156857005|NCT02349633|566230819|FG011|Overall Study|Death|0|||
156857006|NCT02349633|566230820|FG012|Overall Study|Death|0|||
156857007|NCT02349633|566230821|FG013|Overall Study|Death|0|||
156857008|NCT02349633|566230808|FG000|Overall Study|Withdrawal by Subject|0|||
156857009|NCT02349633|566230809|FG001|Overall Study|Withdrawal by Subject|0|||
156857010|NCT02349633|566230810|FG002|Overall Study|Withdrawal by Subject|0|||
156857011|NCT02349633|566230811|FG003|Overall Study|Withdrawal by Subject|1|||
156857012|NCT02349633|566230812|FG004|Overall Study|Withdrawal by Subject|0|||
156857013|NCT02349633|566230813|FG005|Overall Study|Withdrawal by Subject|0|||
156857014|NCT02349633|566230814|FG006|Overall Study|Withdrawal by Subject|0|||
156857015|NCT02349633|566230815|FG007|Overall Study|Withdrawal by Subject|2|||
156857016|NCT02349633|566230816|FG008|Overall Study|Withdrawal by Subject|2|||
156857017|NCT02349633|566230817|FG009|Overall Study|Withdrawal by Subject|1|||
156857018|NCT02349633|566230818|FG010|Overall Study|Withdrawal by Subject|0|||
156857019|NCT02349633|566230819|FG011|Overall Study|Withdrawal by Subject|0|||
156857020|NCT02349633|566230820|FG012|Overall Study|Withdrawal by Subject|0|||
156857021|NCT02349633|566230821|FG013|Overall Study|Withdrawal by Subject|0|||
156857022|NCT02349633|566230808|FG000|Overall Study|Withdrawal of informed consent|0|||
156342387|NCT04182763|564352666|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
156857023|NCT02349633|566230809|FG001|Overall Study|Withdrawal of informed consent|0|||
156857024|NCT02349633|566230810|FG002|Overall Study|Withdrawal of informed consent|0|||
156857025|NCT02349633|566230811|FG003|Overall Study|Withdrawal of informed consent|1|||
156857026|NCT02349633|566230812|FG004|Overall Study|Withdrawal of informed consent|1|||
156857027|NCT02349633|566230813|FG005|Overall Study|Withdrawal of informed consent|0|||
156857028|NCT02349633|566230814|FG006|Overall Study|Withdrawal of informed consent|0|||
156857029|NCT02349633|566230815|FG007|Overall Study|Withdrawal of informed consent|3|||
156857030|NCT02349633|566230816|FG008|Overall Study|Withdrawal of informed consent|0|||
156857031|NCT02349633|566230817|FG009|Overall Study|Withdrawal of informed consent|0|||
156857032|NCT02349633|566230818|FG010|Overall Study|Withdrawal of informed consent|0|||
156857033|NCT02349633|566230819|FG011|Overall Study|Withdrawal of informed consent|0|||
156857034|NCT02349633|566230820|FG012|Overall Study|Withdrawal of informed consent|0|||
156857035|NCT02349633|566230821|FG013|Overall Study|Withdrawal of informed consent|0|||
156472800|NCT01683409|564825650|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
156472801|NCT01683409|564825651|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
156472802|NCT01683409|564825652|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
156472803|NCT01683409|564825648|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
156342388|NCT01539538|564352668|FG000|Overall Study|Adverse Event|13|||
156342389|NCT01539538|564352669|FG001|Overall Study|Adverse Event|18|||
156342390|NCT01539538|564352668|FG000|Overall Study|Lack of Efficacy|13|||
156342391|NCT01539538|564352669|FG001|Overall Study|Lack of Efficacy|16|||
156857036|NCT02349633|566230808|FG000|Overall Study|Transition to compassionate use|0|||
156857037|NCT02349633|566230809|FG001|Overall Study|Transition to compassionate use|0|||
156857038|NCT02349633|566230810|FG002|Overall Study|Transition to compassionate use|0|||
156857039|NCT02349633|566230811|FG003|Overall Study|Transition to compassionate use|0|||
156857040|NCT02349633|566230812|FG004|Overall Study|Transition to compassionate use|1|||
156857041|NCT02349633|566230813|FG005|Overall Study|Transition to compassionate use|0|||
156857042|NCT02349633|566230814|FG006|Overall Study|Transition to compassionate use|0|||
156857043|NCT02349633|566230815|FG007|Overall Study|Transition to compassionate use|3|||
156857044|NCT02349633|566230816|FG008|Overall Study|Transition to compassionate use|0|||
156857045|NCT02349633|566230817|FG009|Overall Study|Transition to compassionate use|1|||
156857046|NCT02349633|566230818|FG010|Overall Study|Transition to compassionate use|0|||
156857047|NCT02349633|566230819|FG011|Overall Study|Transition to compassionate use|0|||
156857048|NCT02349633|566230820|FG012|Overall Study|Transition to compassionate use|0|||
156857049|NCT02349633|566230821|FG013|Overall Study|Transition to compassionate use|0|||
156857050|NCT02349633|566230808|FG000|Overall Study|Early termination of survival follow-up|0|||
156857051|NCT02349633|566230809|FG001|Overall Study|Early termination of survival follow-up|0|||
156857052|NCT02349633|566230810|FG002|Overall Study|Early termination of survival follow-up|0|||
156857053|NCT02349633|566230811|FG003|Overall Study|Early termination of survival follow-up|0|||
156857054|NCT02349633|566230812|FG004|Overall Study|Early termination of survival follow-up|0|||
156857055|NCT02349633|566230813|FG005|Overall Study|Early termination of survival follow-up|0|||
156857056|NCT02349633|566230814|FG006|Overall Study|Early termination of survival follow-up|0|||
156857057|NCT02349633|566230815|FG007|Overall Study|Early termination of survival follow-up|4|||
156857058|NCT02349633|566230816|FG008|Overall Study|Early termination of survival follow-up|0|||
156857059|NCT02349633|566230817|FG009|Overall Study|Early termination of survival follow-up|0|||
156857060|NCT02349633|566230818|FG010|Overall Study|Early termination of survival follow-up|0|||
156857061|NCT02349633|566230819|FG011|Overall Study|Early termination of survival follow-up|0|||
156857062|NCT02349633|566230820|FG012|Overall Study|Early termination of survival follow-up|0|||
156857063|NCT02349633|566230821|FG013|Overall Study|Early termination of survival follow-up|0|||
156857064|NCT02349633|566230808|FG000|Overall Study|Termination by sponsor|0|||
156857065|NCT02349633|566230809|FG001|Overall Study|Termination by sponsor|0|||
156857066|NCT02349633|566230810|FG002|Overall Study|Termination by sponsor|0|||
156857067|NCT02349633|566230811|FG003|Overall Study|Termination by sponsor|0|||
156857068|NCT02349633|566230812|FG004|Overall Study|Termination by sponsor|0|||
156857069|NCT02349633|566230813|FG005|Overall Study|Termination by sponsor|0|||
156857070|NCT02349633|566230814|FG006|Overall Study|Termination by sponsor|0|||
156857071|NCT02349633|566230815|FG007|Overall Study|Termination by sponsor|1|||
156857072|NCT02349633|566230816|FG008|Overall Study|Termination by sponsor|0|||
156857073|NCT02349633|566230817|FG009|Overall Study|Termination by sponsor|2|||
156857074|NCT02349633|566230818|FG010|Overall Study|Termination by sponsor|0|||
156857075|NCT02349633|566230819|FG011|Overall Study|Termination by sponsor|0|||
156857076|NCT02349633|566230820|FG012|Overall Study|Termination by sponsor|0|||
156857077|NCT02349633|566230821|FG013|Overall Study|Termination by sponsor|0|||
156857078|NCT02349633|566230808|FG000|Overall Study|Other|0|||
156857079|NCT02349633|566230809|FG001|Overall Study|Other|0|||
156857080|NCT02349633|566230810|FG002|Overall Study|Other|0|||
156857081|NCT02349633|566230811|FG003|Overall Study|Other|0|||
156857082|NCT02349633|566230812|FG004|Overall Study|Other|0|||
156857083|NCT02349633|566230813|FG005|Overall Study|Other|0|||
156857084|NCT02349633|566230814|FG006|Overall Study|Other|0|||
156857085|NCT02349633|566230815|FG007|Overall Study|Other|2|||
156857086|NCT02349633|566230816|FG008|Overall Study|Other|0|||
156857087|NCT02349633|566230817|FG009|Overall Study|Other|0|||
156857088|NCT02349633|566230818|FG010|Overall Study|Other|0|||
156857089|NCT02349633|566230819|FG011|Overall Study|Other|0|||
156857090|NCT02349633|566230820|FG012|Overall Study|Other|0|||
156857091|NCT02349633|566230821|FG013|Overall Study|Other|0|||
156857092|NCT01008943|566230827|FG000|Overall Study|Withdrawal by Subject|1|||
156857093|NCT00861705|566230828|FG000|Overall Study|Never Began Treatment|7|||
156857094|NCT00861705|566230829|FG001|Overall Study|Never Began Treatment|3|||
156342392|NCT01539538|564352668|FG000|Overall Study|Withdrawal by Subject|2|||
156857095|NCT00861705|566230830|FG002|Overall Study|Never Began Treatment|0|||
156857096|NCT00861705|566230831|FG003|Overall Study|Never Began Treatment|1|||
156857097|NCT05789745|566230832|FG000|Overall Study|Withdrawal by Subject|0|||
156857098|NCT05789745|566230833|FG001|Overall Study|Withdrawal by Subject|0|||
156857099|NCT05789745|566230834|FG002|Overall Study|Withdrawal by Subject|0|||
156857100|NCT05789745|566230835|FG003|Overall Study|Withdrawal by Subject|0|||
156342393|NCT01539538|564352669|FG001|Overall Study|Withdrawal by Subject|3|||
156857101|NCT05789745|566230836|FG004|Overall Study|Withdrawal by Subject|1|||
156342394|NCT01539538|564352668|FG000|Overall Study|PCA no longer required or PCA problem|3|||
156857102|NCT04663321|566230837|FG000|Overall Study|Study terminated by Sponsor|2|||
156542198|NCT02018822|565079267|FG001|Overall Study|filling replaced by crown|1|||
156542199|NCT02018822|565079268|FG002|Overall Study|filling replaced by crown|0|||
156472804|NCT01683409|564825649|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
156472805|NCT01683409|564825650|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
156472806|NCT01683409|564825651|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
156472807|NCT01683409|564825652|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
156472808|NCT01683409|564825648|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
156472809|NCT01683409|564825649|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
156472810|NCT01683409|564825650|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
156472811|NCT01683409|564825651|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
156472812|NCT01683409|564825652|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
156472813|NCT01683409|564825648|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
156472814|NCT01683409|564825649|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
156472815|NCT01683409|564825650|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
156472816|NCT01683409|564825651|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
156472817|NCT01683409|564825652|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
156472818|NCT01683409|564825648|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
156472819|NCT01683409|564825649|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
156472820|NCT01683409|564825650|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
156472821|NCT01683409|564825651|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
156472822|NCT01683409|564825652|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
156472823|NCT01683409|564825648|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
156472824|NCT01683409|564825649|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
156857103|NCT04663321|566230838|FG001|Overall Study|Study terminated by Sponsor|1|||
156857104|NCT04663321|566230839|FG002|Overall Study|Study terminated by Sponsor|2|||
156857105|NCT04663321|566230837|FG000|Overall Study|Withdrawal by Subject|10|||
156857106|NCT04663321|566230838|FG001|Overall Study|Withdrawal by Subject|3|||
156857107|NCT04663321|566230839|FG002|Overall Study|Withdrawal by Subject|2|||
156857108|NCT04663321|566230837|FG000|Overall Study|Not provided|0|||
156857109|NCT04663321|566230838|FG001|Overall Study|Not provided|0|||
156857110|NCT04663321|566230839|FG002|Overall Study|Not provided|1|||
156857111|NCT03294590|566230840|FG000|Overall Study|Lost to Follow-up|105|||
156857112|NCT03294590|566230841|FG001|Overall Study|Lost to Follow-up|107|||
156857113|NCT01962441|566230842|FG000|Randomized Period|Randomized but Never Treated|4|||
156857114|NCT01962441|566230843|FG001|Randomized Period|Randomized but Never Treated|2|||
156857115|NCT01962441|566230844|FG002|Randomized Period|Randomized but Never Treated|3|||
156857116|NCT01962441|566230842|FG000|Randomized Period|Lost to Follow-up|2|||
156857117|NCT01962441|566230843|FG001|Randomized Period|Lost to Follow-up|4|||
156857118|NCT01962441|566230844|FG002|Randomized Period|Lost to Follow-up|4|||
156857119|NCT01962441|566230842|FG000|Randomized Period|Withdrew Consent|3|||
156857120|NCT01962441|566230843|FG001|Randomized Period|Withdrew Consent|3|||
156857121|NCT01962441|566230844|FG002|Randomized Period|Withdrew Consent|2|||
156857122|NCT01962441|566230842|FG000|Randomized Period|Adverse Event|1|||
156857123|NCT01962441|566230843|FG001|Randomized Period|Adverse Event|1|||
156857124|NCT01962441|566230844|FG002|Randomized Period|Adverse Event|0|||
156857125|NCT01962441|566230842|FG000|Randomized Period|Death|0|||
156857126|NCT01962441|566230843|FG001|Randomized Period|Death|0|||
156857127|NCT01962441|566230844|FG002|Randomized Period|Death|2|||
156857128|NCT01962441|566230842|FG000|Randomized Period|Protocol Violation|0|||
156857129|NCT01962441|566230843|FG001|Randomized Period|Protocol Violation|1|||
156857130|NCT01962441|566230844|FG002|Randomized Period|Protocol Violation|0|||
156857131|NCT01962441|566230842|FG000|Retreatment Substudy|Lack of Efficacy|1|||
156857132|NCT01962441|566230843|FG001|Retreatment Substudy|Lack of Efficacy|0|||
156857133|NCT01962441|566230844|FG002|Retreatment Substudy|Lack of Efficacy|0|||
156857134|NCT01962441|566230842|FG000|Retreatment Substudy|Lost to Follow-up|1|||
156857135|NCT01962441|566230843|FG001|Retreatment Substudy|Lost to Follow-up|0|||
156857136|NCT01962441|566230844|FG002|Retreatment Substudy|Lost to Follow-up|0|||
156857137|NCT02055898|566230845|FG000|First Intervention (5 Days)|Physician Decision|2|||
156857138|NCT02055898|566230846|FG001|First Intervention (5 Days)|Physician Decision|0|||
156857139|NCT02055898|566230845|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
156857140|NCT02055898|566230846|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
156857141|NCT02269124|566230847|FG000|Overall Study|Lost to Follow-up|1|||
156857142|NCT02269124|566230848|FG001|Overall Study|Lost to Follow-up|0|||
156857143|NCT02269124|566230847|FG000|Overall Study|Withdrawal by Subject|0|||
156857144|NCT02269124|566230848|FG001|Overall Study|Withdrawal by Subject|2|||
156857145|NCT03452540|566230849|FG000|Overall Study|Adverse Event|1|||
156857146|NCT03452540|566230849|FG000|Overall Study|Withdrawal by Subject|1|||
156857147|NCT03452540|566230849|FG000|Overall Study|Other SAE and AE|2|||
156342395|NCT01539538|564352669|FG001|Overall Study|PCA no longer required or PCA problem|7|||
156472825|NCT01683409|564825650|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
156857148|NCT01009060|566230856|FG000|Overall Study|Adverse Event|1|||
156857149|NCT01009060|566230857|FG001|Overall Study|Adverse Event|2|||
156857150|NCT01009060|566230856|FG000|Overall Study|Protocol Violation|0|||
156857151|NCT01009060|566230857|FG001|Overall Study|Protocol Violation|1|||
156857152|NCT01009060|566230856|FG000|Overall Study|Lost to Follow-up|1|||
156857153|NCT01009060|566230857|FG001|Overall Study|Lost to Follow-up|0|||
156857154|NCT01009060|566230856|FG000|Overall Study|Physician Decision|1|||
156857155|NCT01009060|566230857|FG001|Overall Study|Physician Decision|1|||
156857156|NCT01009060|566230856|FG000|Overall Study|Withdrawal by Subject|1|||
156857157|NCT01009060|566230857|FG001|Overall Study|Withdrawal by Subject|1|||
156857158|NCT00739401|566230863|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
156857159|NCT00739401|566230863|FG000|Overall Study|Death|3|||
156857160|NCT00739401|566230863|FG000|Overall Study|Withdrawal by Subject|4|||
156857161|NCT01239381|566230864|FG000|Overall Study|Protocol Violation|1|||
156857162|NCT01239381|566230864|FG000|Overall Study|Withdrawal by Subject|1|||
156857163|NCT03275740|566230865|FG000|Overall Study|Adverse Event|0|||
156857164|NCT03275740|566230866|FG001|Overall Study|Adverse Event|0|||
156857165|NCT03275740|566230867|FG002|Overall Study|Adverse Event|0|||
156857166|NCT03275740|566230868|FG003|Overall Study|Adverse Event|0|||
156857167|NCT03275740|566230869|FG004|Overall Study|Adverse Event|1|||
156857168|NCT03275740|566230870|FG005|Overall Study|Adverse Event|0|||
156857169|NCT03275740|566230871|FG006|Overall Study|Adverse Event|0|||
156857170|NCT03275740|566230872|FG007|Overall Study|Adverse Event|0|||
156857171|NCT03275740|566230873|FG008|Overall Study|Adverse Event|0|||
156857172|NCT03275740|566230874|FG009|Overall Study|Adverse Event|0|||
156857173|NCT03275740|566230875|FG010|Overall Study|Adverse Event|0|||
156857174|NCT03275740|566230876|FG011|Overall Study|Adverse Event|0|||
156857175|NCT03275740|566230865|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857176|NCT03275740|566230866|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857177|NCT03275740|566230867|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857178|NCT03275740|566230868|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857179|NCT03275740|566230869|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857180|NCT03275740|566230870|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
156857181|NCT03275740|566230871|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857182|NCT03275740|566230872|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857183|NCT03275740|566230873|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857184|NCT03275740|566230874|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857185|NCT03275740|566230875|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857186|NCT03275740|566230876|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857187|NCT03275740|566230865|FG000|Overall Study|Withdrawal by Subject|0|||
156857188|NCT03275740|566230866|FG001|Overall Study|Withdrawal by Subject|0|||
156857189|NCT03275740|566230867|FG002|Overall Study|Withdrawal by Subject|0|||
156857190|NCT03275740|566230868|FG003|Overall Study|Withdrawal by Subject|0|||
156857191|NCT03275740|566230869|FG004|Overall Study|Withdrawal by Subject|0|||
156857192|NCT03275740|566230870|FG005|Overall Study|Withdrawal by Subject|0|||
156857193|NCT03275740|566230871|FG006|Overall Study|Withdrawal by Subject|0|||
156857194|NCT03275740|566230872|FG007|Overall Study|Withdrawal by Subject|0|||
156857195|NCT03275740|566230873|FG008|Overall Study|Withdrawal by Subject|1|||
156857196|NCT03275740|566230874|FG009|Overall Study|Withdrawal by Subject|1|||
156857197|NCT03275740|566230875|FG010|Overall Study|Withdrawal by Subject|0|||
156542200|NCT02018822|565079266|FG000|Overall Study|Physician Decision|0|||
156542201|NCT02018822|565079267|FG001|Overall Study|Physician Decision|1|||
156542202|NCT02018822|565079268|FG002|Overall Study|Physician Decision|1|||
156857198|NCT03275740|566230876|FG011|Overall Study|Withdrawal by Subject|0|||
156857199|NCT00988884|566230877|FG000|Overall Study|Adverse Event|0|||
156857200|NCT00988884|566230878|FG001|Overall Study|Adverse Event|1|||
156472826|NCT01683409|564825651|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
156472827|NCT01683409|564825652|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
156472828|NCT01683409|564825648|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
156472829|NCT01683409|564825649|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
156472830|NCT01683409|564825650|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
156857201|NCT00988884|566230877|FG000|Overall Study|Lost to Follow-up|20|||
156857202|NCT00988884|566230878|FG001|Overall Study|Lost to Follow-up|16|||
156857203|NCT00988884|566230877|FG000|Overall Study|Protocol Violation|0|||
156857204|NCT00988884|566230878|FG001|Overall Study|Protocol Violation|1|||
156857205|NCT00988884|566230877|FG000|Overall Study|Withdrawal by Subject|15|||
156857206|NCT00988884|566230878|FG001|Overall Study|Withdrawal by Subject|18|||
156857207|NCT02738008|566230879|FG000|Overall Study|Study Terminated by Sponsor|1|||
156857208|NCT02738008|566230880|FG001|Overall Study|Study Terminated by Sponsor|5|||
156857209|NCT02738008|566230881|FG002|Overall Study|Study Terminated by Sponsor|3|||
156857210|NCT02738008|566230879|FG000|Overall Study|Adverse Event|0|||
156857211|NCT02738008|566230880|FG001|Overall Study|Adverse Event|1|||
156857212|NCT02738008|566230881|FG002|Overall Study|Adverse Event|2|||
156857213|NCT04621448|566230882|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
156857214|NCT04621448|566230883|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
156857215|NCT04621448|566230884|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
156857216|NCT04621448|566230885|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
156857217|NCT04621448|566230882|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
156857218|NCT04621448|566230883|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
156857219|NCT04621448|566230884|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
156857220|NCT04621448|566230885|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
156857221|NCT04621448|566230882|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
156857222|NCT04621448|566230883|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
156857223|NCT04621448|566230884|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
156857224|NCT04621448|566230885|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
156857225|NCT04621448|566230882|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
156857226|NCT04621448|566230883|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
156857227|NCT04621448|566230884|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
156857228|NCT04621448|566230885|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
156857229|NCT04486235|566230892|FG000|Overall Study|Pregnancy|1|||
156857230|NCT04486235|566230893|FG001|Overall Study|Pregnancy|0|||
156857231|NCT04486235|566230892|FG000|Overall Study|Lost to Follow-up|1|||
156857232|NCT04486235|566230893|FG001|Overall Study|Lost to Follow-up|0|||
156857233|NCT04590014|566230894|FG000|Overall Study|Withdrawal by Subject|1|||
156857234|NCT04590014|566230895|FG001|Overall Study|Withdrawal by Subject|0|||
156857235|NCT00468299|566230896|FG000|Overall Study|Withdrawal by Subject|0|||
156857236|NCT00468299|566230897|FG001|Overall Study|Withdrawal by Subject|1|||
156857237|NCT01216202|566230898|FG000|Overall Study|Withdrawal by Subject|8|||
156857238|NCT01216202|566230899|FG001|Overall Study|Withdrawal by Subject|0|||
156857239|NCT01216202|566230898|FG000|Overall Study|Death|0|||
156857240|NCT01216202|566230899|FG001|Overall Study|Death|2|||
156857241|NCT01216202|566230898|FG000|Overall Study|Lost to Follow-up|14|||
156857242|NCT01216202|566230899|FG001|Overall Study|Lost to Follow-up|0|||
156857243|NCT03546621|566230900|FG000|Overall Study|Withdrawal by Subject|0|||
156857244|NCT03546621|566230901|FG001|Overall Study|Withdrawal by Subject|1|||
156857245|NCT03546621|566230902|FG002|Overall Study|Withdrawal by Subject|2|||
156857246|NCT03546621|566230903|FG003|Overall Study|Withdrawal by Subject|1|||
156857247|NCT03546621|566230900|FG000|Overall Study|Lost to Follow-up|0|||
156857248|NCT03546621|566230901|FG001|Overall Study|Lost to Follow-up|1|||
156857249|NCT03546621|566230902|FG002|Overall Study|Lost to Follow-up|0|||
156857250|NCT03546621|566230903|FG003|Overall Study|Lost to Follow-up|0|||
156857251|NCT03546621|566230900|FG000|Overall Study|Adverse Event|0|||
156857252|NCT03546621|566230901|FG001|Overall Study|Adverse Event|1|||
156857253|NCT03546621|566230902|FG002|Overall Study|Adverse Event|0|||
156857254|NCT03546621|566230903|FG003|Overall Study|Adverse Event|1|||
156857255|NCT03546621|566230900|FG000|Overall Study|Progressive disease|0|||
156857256|NCT03546621|566230901|FG001|Overall Study|Progressive disease|0|||
156857257|NCT03546621|566230902|FG002|Overall Study|Progressive disease|0|||
156857258|NCT03546621|566230903|FG003|Overall Study|Progressive disease|1|||
156857259|NCT00660192|566230909|FG000|Overall Study|Lost to Follow-up|2|||
156857260|NCT00660192|566230910|FG001|Overall Study|Lost to Follow-up|3|||
156857261|NCT00377520|566230911|FG000|Overall Study|Ineligible (Prior radiation)|1|||
156857262|NCT02775916|566230912|FG000|Overall Study|Adverse Event|1|||
156857263|NCT02775916|566230913|FG001|Overall Study|Adverse Event|0|||
156857264|NCT02775916|566230912|FG000|Overall Study|Subject/Guardian Decision|2|||
156857265|NCT02775916|566230913|FG001|Overall Study|Subject/Guardian Decision|0|||
156857266|NCT00179621|566232447|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
156857267|NCT00179621|566232448|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
156857268|NCT00179621|566232449|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
156857269|NCT00179621|566232450|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
156857270|NCT00179621|566232447|FG000|Double-Blind Period|Adverse Event|2|||
156857271|NCT00179621|566232448|FG001|Double-Blind Period|Adverse Event|7|||
156857272|NCT00179621|566232449|FG002|Double-Blind Period|Adverse Event|4|||
156472831|NCT01683409|564825651|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
156472832|NCT01683409|564825652|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
156472833|NCT01683409|564825648|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
156472834|NCT01683409|564825649|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
156472835|NCT01683409|564825650|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
156472836|NCT01683409|564825651|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
156472837|NCT01683409|564825652|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
156472838|NCT01683409|564825648|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
156472839|NCT01683409|564825649|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
156472840|NCT01683409|564825650|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
156472841|NCT01683409|564825651|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
156472842|NCT01683409|564825652|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
156472843|NCT01683409|564825648|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
156472844|NCT01683409|564825649|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
156472845|NCT01683409|564825650|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
156472846|NCT01683409|564825651|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
156472847|NCT01683409|564825652|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
156472848|NCT01683409|564825648|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
156857273|NCT00179621|566232450|FG003|Double-Blind Period|Adverse Event|0|||
156857274|NCT00179621|566232447|FG000|Double-Blind Period|Withdrawal by Subject|2|||
156857275|NCT00179621|566232448|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156857276|NCT00179621|566232449|FG002|Double-Blind Period|Withdrawal by Subject|3|||
156857277|NCT00179621|566232450|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156857278|NCT00179621|566232447|FG000|Double-Blind Period|Death|0|||
156857279|NCT00179621|566232448|FG001|Double-Blind Period|Death|1|||
156857280|NCT00179621|566232449|FG002|Double-Blind Period|Death|2|||
156857281|NCT00179621|566232450|FG003|Double-Blind Period|Death|0|||
156857282|NCT00179621|566232447|FG000|Double-Blind Period|Protocol Violation|1|||
156857283|NCT00179621|566232448|FG001|Double-Blind Period|Protocol Violation|0|||
156857284|NCT00179621|566232449|FG002|Double-Blind Period|Protocol Violation|0|||
156857285|NCT00179621|566232450|FG003|Double-Blind Period|Protocol Violation|0|||
156857286|NCT00179621|566232447|FG000|Double-Blind Period|Other|0|||
156857287|NCT00179621|566232448|FG001|Double-Blind Period|Other|2|||
156857288|NCT00179621|566232449|FG002|Double-Blind Period|Other|2|||
156857289|NCT00179621|566232450|FG003|Double-Blind Period|Other|0|||
156857290|NCT00179621|566232447|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
156857291|NCT00179621|566232448|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
156857292|NCT00179621|566232449|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
156857293|NCT00179621|566232450|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
156857294|NCT00179621|566232447|FG000|Open-Label Period|Adverse Event|0|||
156857295|NCT00179621|566232448|FG001|Open-Label Period|Adverse Event|6|||
156857296|NCT00179621|566232449|FG002|Open-Label Period|Adverse Event|5|||
156857297|NCT00179621|566232450|FG003|Open-Label Period|Adverse Event|6|||
156857298|NCT00179621|566232447|FG000|Open-Label Period|Withdrawal by Subject|0|||
156857299|NCT00179621|566232448|FG001|Open-Label Period|Withdrawal by Subject|2|||
156857300|NCT00179621|566232449|FG002|Open-Label Period|Withdrawal by Subject|2|||
156857301|NCT00179621|566232450|FG003|Open-Label Period|Withdrawal by Subject|2|||
156857302|NCT00179621|566232447|FG000|Open-Label Period|Death|0|||
156857303|NCT00179621|566232448|FG001|Open-Label Period|Death|0|||
156857304|NCT00179621|566232449|FG002|Open-Label Period|Death|1|||
156857305|NCT00179621|566232450|FG003|Open-Label Period|Death|2|||
156857306|NCT00179621|566232447|FG000|Open-Label Period|Other|0|||
156857307|NCT00179621|566232448|FG001|Open-Label Period|Other|1|||
156857308|NCT00179621|566232449|FG002|Open-Label Period|Other|1|||
156857309|NCT00179621|566232450|FG003|Open-Label Period|Other|2|||
156857310|NCT02426580|566232457|FG000|Overall Study|Death|2|||
156857311|NCT02426580|566232458|FG001|Overall Study|Death|2|||
156857312|NCT02426580|566232457|FG000|Overall Study|Lost to Follow-up|0|||
156857313|NCT02426580|566232458|FG001|Overall Study|Lost to Follow-up|9|||
156857314|NCT02426580|566232457|FG000|Overall Study|transfer to hemodialysis|5|||
156857315|NCT02426580|566232458|FG001|Overall Study|transfer to hemodialysis|5|||
156857316|NCT02426580|566232457|FG000|Overall Study|Kidney transplant|3|||
156857317|NCT02426580|566232458|FG001|Overall Study|Kidney transplant|0|||
156857318|NCT02426580|566232457|FG000|Overall Study|Allergic to egg white|1|||
156857319|NCT02426580|566232458|FG001|Overall Study|Allergic to egg white|0|||
156857320|NCT02869633|566232459|FG000|Overall Study|Death|2|||
156857321|NCT02869633|566232460|FG001|Overall Study|Death|1|||
156857322|NCT02869633|566232459|FG000|Overall Study|Patient refused follow-up|1|||
156857323|NCT02869633|566232460|FG001|Overall Study|Patient refused follow-up|0|||
156857324|NCT02869633|566232459|FG000|Overall Study|Provider discretion|1|||
156857325|NCT02869633|566232460|FG001|Overall Study|Provider discretion|0|||
156857326|NCT02869633|566232459|FG000|Overall Study|Investigator decision|1|||
156857327|NCT02869633|566232460|FG001|Overall Study|Investigator decision|0|||
156857328|NCT02869633|566232459|FG000|Overall Study|Lost to Follow-up|0|||
156857329|NCT02869633|566232460|FG001|Overall Study|Lost to Follow-up|1|||
156472849|NCT01683409|564825649|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
156857330|NCT02869633|566232459|FG000|Overall Study|Not eligible|6|||
156342396|NCT00847379|564352670|FG000|Overall Study|Study terminated by Sponsor|59|||
156342397|NCT00847379|564352671|FG001|Overall Study|Study terminated by Sponsor|57|||
156342398|NCT00847379|564352672|FG002|Overall Study|Study terminated by Sponsor|57|||
156342399|NCT00378378|564352673|FG000|Overall Study|Withdrawal by Subject|0|||
156342400|NCT00378378|564352674|FG001|Overall Study|Withdrawal by Subject|1|||
156342401|NCT00378378|564352675|FG002|Overall Study|Withdrawal by Subject|0|||
156342402|NCT00378378|564352673|FG000|Overall Study|Treatment Failure|0|||
156342403|NCT00378378|564352674|FG001|Overall Study|Treatment Failure|0|||
156342404|NCT00378378|564352675|FG002|Overall Study|Treatment Failure|1|||
156342405|NCT00378378|564352673|FG000|Overall Study|Non-compliance with protocol|0|||
156342406|NCT00378378|564352674|FG001|Overall Study|Non-compliance with protocol|0|||
156342407|NCT00378378|564352675|FG002|Overall Study|Non-compliance with protocol|1|||
156342408|NCT01336764|564352676|FG000|Overall Study|Withdrawal by Subject|5|||
156342409|NCT01336764|564352677|FG001|Overall Study|Withdrawal by Subject|5|||
156342410|NCT01626391|564352678|FG000|Overall Study|Physician Decision|1|||
156342411|NCT01626391|564352679|FG001|Overall Study|Physician Decision|0|||
156342412|NCT01626391|564352678|FG000|Overall Study|Withdrawal by Subject|1|||
156342413|NCT01626391|564352679|FG001|Overall Study|Withdrawal by Subject|0|||
156342414|NCT05683249|564352680|FG000|Overall Study|Adverse Event|3|||
156342415|NCT05683249|564352681|FG001|Overall Study|Adverse Event|1|||
156342416|NCT05683249|564352680|FG000|Overall Study|Lack of Efficacy|0|||
156342417|NCT05683249|564352681|FG001|Overall Study|Lack of Efficacy|2|||
156342418|NCT05683249|564352680|FG000|Overall Study|Lost to Follow-up|6|||
156342419|NCT05683249|564352681|FG001|Overall Study|Lost to Follow-up|5|||
156342420|NCT05683249|564352680|FG000|Overall Study|Non-compliance with Study Drug|2|||
156342421|NCT05683249|564352681|FG001|Overall Study|Non-compliance with Study Drug|0|||
156342422|NCT05683249|564352680|FG000|Overall Study|Protocol Violation|6|||
156342423|NCT05683249|564352681|FG001|Overall Study|Protocol Violation|3|||
156342424|NCT05683249|564352680|FG000|Overall Study|Withdrawal by Subject|9|||
156472850|NCT01683409|564825650|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
156472851|NCT01683409|564825651|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
156472852|NCT01683409|564825652|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
156472853|NCT00553332|564825654|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
156472854|NCT00467272|564825661|FG000|Overall Study|Pneumonia|2|||
156472855|NCT00467272|564825661|FG000|Overall Study|Thrombophlebitis|1|||
156342425|NCT05683249|564352681|FG001|Overall Study|Withdrawal by Subject|8|||
156342426|NCT05683249|564352680|FG000|Overall Study|Other|0|||
156342427|NCT05683249|564352681|FG001|Overall Study|Other|2|||
156472856|NCT04745676|564825664|FG000|Overall Study|Death|1|||
156472857|NCT04745676|564825665|FG001|Overall Study|Death|0|||
156342428|NCT01930123|564352682|FG000|Overall Study|Adverse Event|1|||
156342429|NCT01930123|564352683|FG001|Overall Study|Adverse Event|0|||
156342430|NCT01930123|564352682|FG000|Overall Study|Physician Decision|21|||
156342431|NCT01930123|564352683|FG001|Overall Study|Physician Decision|8|||
156472858|NCT04745676|564825666|FG002|Overall Study|Death|0|||
156857331|NCT02869633|566232460|FG001|Overall Study|Not eligible|1|||
156857332|NCT02869633|566232459|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
156857333|NCT02869633|566232460|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
156857334|NCT02869633|566232459|FG000|Overall Study|Withdrawal by Subject|0|||
156857335|NCT02869633|566232460|FG001|Overall Study|Withdrawal by Subject|1|||
156857336|NCT03287791|566232461|FG000|Overall Study|Insufficient Therapeutic Response|0|||
156857337|NCT03287791|566232462|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156857338|NCT03287791|566232463|FG002|Overall Study|Insufficient Therapeutic Response|1|||
156857339|NCT03287791|566232461|FG000|Overall Study|Adverse Event|0|||
156857340|NCT03287791|566232462|FG001|Overall Study|Adverse Event|4|||
156857341|NCT03287791|566232463|FG002|Overall Study|Adverse Event|3|||
156342432|NCT01930123|564352682|FG000|Overall Study|Withdrawal by Subject|1|||
156342433|NCT01930123|564352683|FG001|Overall Study|Withdrawal by Subject|0|||
156342434|NCT03310021|564352688|FG000|Overall Study|Withdrawal by Subject|0|||
156472859|NCT00989196|564825667|FG000|Treatment Period|Lost to Follow-up|1|||
156857342|NCT03287791|566232461|FG000|Overall Study|Withdrawal by Subject|12|||
156342435|NCT03310021|564352689|FG001|Overall Study|Withdrawal by Subject|0|||
156342436|NCT03310021|564352690|FG002|Overall Study|Withdrawal by Subject|0|||
156342437|NCT03310021|564352691|FG003|Overall Study|Withdrawal by Subject|0|||
156342438|NCT03310021|564352692|FG004|Overall Study|Withdrawal by Subject|0|||
156342439|NCT03310021|564352693|FG005|Overall Study|Withdrawal by Subject|0|||
156342440|NCT03310021|564352694|FG006|Overall Study|Withdrawal by Subject|1|||
156342441|NCT03310021|564352695|FG007|Overall Study|Withdrawal by Subject|0|||
156342442|NCT03310021|564352696|FG008|Overall Study|Withdrawal by Subject|0|||
156472860|NCT00989196|564825668|FG001|Treatment Period|Lost to Follow-up|0|||
156472861|NCT04912856|564825674|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
156342443|NCT03310021|564352697|FG009|Overall Study|Withdrawal by Subject|0|||
156542203|NCT02018822|565079266|FG000|Overall Study|Lost to Follow-up|6|||
156342444|NCT03310021|564352698|FG010|Overall Study|Withdrawal by Subject|0|||
156542204|NCT02018822|565079267|FG001|Overall Study|Lost to Follow-up|6|||
156542205|NCT02018822|565079268|FG002|Overall Study|Lost to Follow-up|5|||
156542206|NCT03201458|565079269|FG000|Overall Study|No longer eligible|2|||
156857343|NCT03287791|566232462|FG001|Overall Study|Withdrawal by Subject|12|||
156857344|NCT03287791|566232463|FG002|Overall Study|Withdrawal by Subject|17|||
156857345|NCT03287791|566232461|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
156857346|NCT03287791|566232462|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
156857347|NCT03287791|566232463|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
156857348|NCT03287791|566232461|FG000|Overall Study|Lost to Follow-up|8|||
156857349|NCT03287791|566232462|FG001|Overall Study|Lost to Follow-up|14|||
156857350|NCT03287791|566232463|FG002|Overall Study|Lost to Follow-up|11|||
156857351|NCT03287791|566232461|FG000|Overall Study|Protocol Violation|7|||
156857352|NCT03287791|566232462|FG001|Overall Study|Protocol Violation|2|||
156857353|NCT03287791|566232463|FG002|Overall Study|Protocol Violation|1|||
156857354|NCT03287791|566232461|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
156857355|NCT03287791|566232462|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
156857356|NCT03287791|566232463|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
156857357|NCT03287791|566232461|FG000|Overall Study|Too much time between 2 visits|0|||
156857358|NCT03287791|566232462|FG001|Overall Study|Too much time between 2 visits|1|||
156857359|NCT03287791|566232463|FG002|Overall Study|Too much time between 2 visits|0|||
156857360|NCT03287791|566232461|FG000|Overall Study|Non-compliance|0|||
156857361|NCT03287791|566232462|FG001|Overall Study|Non-compliance|1|||
156857362|NCT03287791|566232463|FG002|Overall Study|Non-compliance|0|||
156857363|NCT03287791|566232461|FG000|Overall Study|Did not meet inclusion criteria|1|||
156857364|NCT03287791|566232462|FG001|Overall Study|Did not meet inclusion criteria|0|||
156857365|NCT03287791|566232463|FG002|Overall Study|Did not meet inclusion criteria|0|||
156857366|NCT01381016|566232465|FG000|Overall Study|Lost to Follow-up|1|||
156857367|NCT01381016|566232466|FG001|Overall Study|Lost to Follow-up|1|||
156857368|NCT01381016|566232465|FG000|Overall Study|Screen Failure|2|||
156857369|NCT01381016|566232466|FG001|Overall Study|Screen Failure|2|||
156857370|NCT01381016|566232465|FG000|Overall Study|Withdrawal by Subject|0|||
156857371|NCT01381016|566232466|FG001|Overall Study|Withdrawal by Subject|1|||
156857372|NCT01381016|566232465|FG000|Overall Study|Physician Decision|0|||
156857373|NCT01381016|566232466|FG001|Overall Study|Physician Decision|2|||
156857374|NCT04607668|566232471|FG000|Overall Study|Death|49|||
156857375|NCT04607668|566232472|FG001|Overall Study|Death|26|||
156857376|NCT04607668|566232471|FG000|Overall Study|Lost to Follow-up|3|||
156857377|NCT04607668|566232472|FG001|Overall Study|Lost to Follow-up|4|||
156857378|NCT04607668|566232471|FG000|Overall Study|Study terminated by Sponsor|92|||
156857379|NCT04607668|566232472|FG001|Overall Study|Study terminated by Sponsor|114|||
156857380|NCT04607668|566232471|FG000|Overall Study|Withdrawal by Subject|12|||
156857381|NCT04607668|566232472|FG001|Overall Study|Withdrawal by Subject|11|||
156857382|NCT04607668|566232471|FG000|Overall Study|Other, unspecified|8|||
156857383|NCT04607668|566232472|FG001|Overall Study|Other, unspecified|7|||
156857384|NCT01838694|566232473|FG000|Overall Study|Adverse Event|0|||
156857385|NCT01838694|566232474|FG001|Overall Study|Adverse Event|1|||
156857386|NCT01096316|566232475|FG000|Overall Study|Lost to Follow-up|15|||
156857387|NCT01096316|566232476|FG001|Overall Study|Lost to Follow-up|9|||
156857388|NCT06418152|566232477|FG000|Overall Study|Frequent DBS setting changes|1|||
156857389|NCT06418152|566232477|FG000|Overall Study|Withdrawal by Subject|2|||
156857390|NCT02529852|566232482|FG000|Overall Study|Withdrawal by Subject|2|||
156857391|NCT00718510|566232484|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
156857392|NCT00718510|566232485|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156857393|NCT00718510|566232484|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
156857394|NCT00718510|566232485|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
156857395|NCT02201524|566232486|FG000|Overall Study|Adverse Event|0|||
156857396|NCT02201524|566232487|FG001|Overall Study|Adverse Event|2|||
156857397|NCT02201524|566232488|FG002|Overall Study|Adverse Event|1|||
156857398|NCT02201524|566232489|FG003|Overall Study|Adverse Event|0|||
156857399|NCT02201524|566232486|FG000|Overall Study|Insufficient clinical response|1|||
156857400|NCT02201524|566232487|FG001|Overall Study|Insufficient clinical response|0|||
156857401|NCT02201524|566232488|FG002|Overall Study|Insufficient clinical response|0|||
156857402|NCT02201524|566232489|FG003|Overall Study|Insufficient clinical response|0|||
156857403|NCT02201524|566232486|FG000|Overall Study|Lost to Follow-up|0|||
156857404|NCT02201524|566232487|FG001|Overall Study|Lost to Follow-up|0|||
156857405|NCT02201524|566232488|FG002|Overall Study|Lost to Follow-up|2|||
156857406|NCT02201524|566232489|FG003|Overall Study|Lost to Follow-up|0|||
156857407|NCT02201524|566232486|FG000|Overall Study|No longer meets eligibility criteria|0|||
156857408|NCT02201524|566232487|FG001|Overall Study|No longer meets eligibility criteria|0|||
156857409|NCT02201524|566232488|FG002|Overall Study|No longer meets eligibility criteria|0|||
156857410|NCT02201524|566232489|FG003|Overall Study|No longer meets eligibility criteria|2|||
156857411|NCT02201524|566232486|FG000|Overall Study|Protocol Violation|0|||
156857412|NCT02201524|566232487|FG001|Overall Study|Protocol Violation|0|||
156857413|NCT02201524|566232488|FG002|Overall Study|Protocol Violation|0|||
156857414|NCT02201524|566232489|FG003|Overall Study|Protocol Violation|1|||
156857415|NCT02201524|566232486|FG000|Overall Study|Withdrawal by Subject|0|||
156857416|NCT02201524|566232487|FG001|Overall Study|Withdrawal by Subject|0|||
156857417|NCT02201524|566232488|FG002|Overall Study|Withdrawal by Subject|1|||
156472862|NCT04912856|564825675|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
156472863|NCT04912856|564825674|FG000|Overall Study|Not reported in synoptic CSR.|0|||
156472864|NCT04912856|564825675|FG001|Overall Study|Not reported in synoptic CSR.|1|||
156472865|NCT00302211|564825676|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
156472866|NCT00302211|564825677|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
156472867|NCT00302211|564825678|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
156472868|NCT00302211|564825679|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
156472869|NCT00302211|564825680|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
156857418|NCT02201524|566232489|FG003|Overall Study|Withdrawal by Subject|1|||
156857419|NCT02201524|566232486|FG000|Overall Study|Other|1|||
156857420|NCT02201524|566232487|FG001|Overall Study|Other|1|||
156857421|NCT02201524|566232488|FG002|Overall Study|Other|0|||
156857422|NCT02201524|566232489|FG003|Overall Study|Other|0|||
156857423|NCT00423657|566232490|FG000|Overall Study|Withdrew consent|10|||
156857424|NCT00423657|566232491|FG001|Overall Study|Withdrew consent|8|||
156857425|NCT00423657|566232490|FG000|Overall Study|Non-compliance|0|||
156857426|NCT00423657|566232491|FG001|Overall Study|Non-compliance|1|||
156857427|NCT00423657|566232490|FG000|Overall Study|Other|15|||
156857428|NCT00423657|566232491|FG001|Overall Study|Other|16|||
156857429|NCT00423657|566232490|FG000|Overall Study|Request of sponsor/investigator|1|||
156857430|NCT00423657|566232491|FG001|Overall Study|Request of sponsor/investigator|0|||
156857431|NCT02314052|566232492|FG000|Cycle One|Adverse Event|0|||
156857432|NCT02314052|566232493|FG001|Cycle One|Adverse Event|0|||
156857433|NCT02314052|566232494|FG002|Cycle One|Adverse Event|0|||
156857434|NCT02314052|566232495|FG003|Cycle One|Adverse Event|1|||
156857435|NCT02314052|566232496|FG004|Cycle One|Adverse Event|0|||
156857436|NCT02314052|566232497|FG005|Cycle One|Adverse Event|0|||
156857437|NCT00474955|566232498|FG000|Overall Study|Adverse Event|2|||
156857438|NCT00474955|566232498|FG000|Overall Study|Drug unavailability|1|||
156857439|NCT00474955|566232498|FG000|Overall Study|Personal reasons|5|||
156857440|NCT02653326|566232499|FG000|Overall Study|Lost to Follow-up|10|||
156857441|NCT02653326|566232500|FG001|Overall Study|Lost to Follow-up|7|||
156857442|NCT02422498|566232501|FG000|Overall Study|Inevaluable|4|||
156857443|NCT01620060|566232505|FG000|Overall Study|Adverse Event|9|||
156857444|NCT01620060|566232505|FG000|Overall Study|Protocol Violation|1|||
156857445|NCT01620060|566232505|FG000|Overall Study|Withdrawal by Subject|1|||
156857446|NCT01620060|566232505|FG000|Overall Study|Did not comply with Study Produre|1|||
156857447|NCT01620060|566232505|FG000|Overall Study|Family emergency|1|||
156857448|NCT01620060|566232505|FG000|Overall Study|Per Sponsor Decision|2|||
156857449|NCT04664153|566232508|FG000|Overall Study|Lack of Efficacy|0|||
156857450|NCT04664153|566232509|FG001|Overall Study|Lack of Efficacy|0|||
156857451|NCT04664153|566232510|FG002|Overall Study|Lack of Efficacy|1|||
156857452|NCT04664153|566232511|FG003|Overall Study|Lack of Efficacy|0|||
156857453|NCT04664153|566232508|FG000|Overall Study|Physician Decision|0|||
156857454|NCT04664153|566232509|FG001|Overall Study|Physician Decision|0|||
156857455|NCT04664153|566232510|FG002|Overall Study|Physician Decision|1|||
156857456|NCT04664153|566232511|FG003|Overall Study|Physician Decision|0|||
156857457|NCT04664153|566232508|FG000|Overall Study|Withdrawal by Subject|3|||
156857458|NCT04664153|566232509|FG001|Overall Study|Withdrawal by Subject|2|||
156857459|NCT04664153|566232510|FG002|Overall Study|Withdrawal by Subject|1|||
156857460|NCT04664153|566232511|FG003|Overall Study|Withdrawal by Subject|2|||
156857461|NCT04664153|566232508|FG000|Overall Study|Other|0|||
156857462|NCT04664153|566232509|FG001|Overall Study|Other|1|||
156857463|NCT04664153|566232510|FG002|Overall Study|Other|0|||
156857464|NCT04664153|566232511|FG003|Overall Study|Other|0|||
156857465|NCT04664153|566232508|FG000|Overall Study|Adverse Event|4|||
156857466|NCT04664153|566232509|FG001|Overall Study|Adverse Event|0|||
156857467|NCT04664153|566232510|FG002|Overall Study|Adverse Event|1|||
156857468|NCT04664153|566232511|FG003|Overall Study|Adverse Event|0|||
156857469|NCT01045460|566232512|FG000|Overall Study|Physician Decision|3|||
156857470|NCT01045460|566232513|FG001|Overall Study|Physician Decision|2|||
156857471|NCT01045460|566232512|FG000|Overall Study|Lost to Follow-up|0|||
156857472|NCT01045460|566232513|FG001|Overall Study|Lost to Follow-up|1|||
156857473|NCT01045460|566232512|FG000|Overall Study|Lack of Efficacy|3|||
156857474|NCT01045460|566232513|FG001|Overall Study|Lack of Efficacy|0|||
156857475|NCT00097500|566232514|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
156472870|NCT00302211|564825676|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
156857476|NCT00097500|566232515|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
156857477|NCT00097500|566232514|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
156472871|NCT00302211|564825677|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
156857478|NCT00097500|566232515|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
156857479|NCT00097500|566232514|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
156542207|NCT03201458|565079270|FG001|Overall Study|No longer eligible|5|||
156857480|NCT00097500|566232515|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
156857481|NCT00097500|566232514|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
156857482|NCT00097500|566232515|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
156857483|NCT00097500|566232514|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
156857484|NCT00097500|566232515|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
156857485|NCT00097500|566232514|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
156542208|NCT03201458|565079269|FG000|Overall Study|Health event before starting|1|||
156857486|NCT00097500|566232515|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
156857487|NCT00097500|566232514|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
156857488|NCT00097500|566232515|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
156857489|NCT00524485|566232519|FG000|Overall Study|Withdrawal by Subject|5|||
156857490|NCT01600885|566232522|FG000|First Period|Adverse Event|1|||
156857491|NCT01600885|566232523|FG001|First Period|Adverse Event|1|||
156857492|NCT01600885|566232522|FG000|First Period|moved out of area|1|||
156857493|NCT01600885|566232523|FG001|First Period|moved out of area|0|||
156857494|NCT00642356|566232529|FG000|Overall Study|Adverse Event|1|||
156857495|NCT00642356|566232530|FG001|Overall Study|Adverse Event|0|||
156857496|NCT00642356|566232529|FG000|Overall Study|Protocol Violation|0|||
156857497|NCT00642356|566232530|FG001|Overall Study|Protocol Violation|3|||
156857498|NCT00642356|566232529|FG000|Overall Study|Lack of Efficacy|1|||
156857499|NCT00642356|566232530|FG001|Overall Study|Lack of Efficacy|0|||
156857500|NCT04551989|566232533|FG000|Overall Study|Adverse Event|4|||
156857501|NCT04551989|566232533|FG000|Overall Study|Protocol Violation|3|||
156857502|NCT04551989|566232533|FG000|Overall Study|Lost to Follow-up|1|||
156857503|NCT04551989|566232533|FG000|Overall Study|Physician Decision|3|||
156857504|NCT04201431|566232534|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
156857505|NCT04201431|566232535|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
156857506|NCT04201431|566232536|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
156857507|NCT02694744|566232541|FG000|Overall Study|Adverse Event|2|||
156857508|NCT02694744|566232542|FG001|Overall Study|Adverse Event|1|||
156857509|NCT02694744|566232541|FG000|Overall Study|Withdrawal by Subject|2|||
156857510|NCT02694744|566232542|FG001|Overall Study|Withdrawal by Subject|1|||
156857511|NCT02694744|566232541|FG000|Overall Study|Physician Decision|1|||
156857512|NCT02694744|566232542|FG001|Overall Study|Physician Decision|2|||
156857513|NCT02694744|566232541|FG000|Overall Study|Lost to Follow-up|1|||
156857514|NCT02694744|566232542|FG001|Overall Study|Lost to Follow-up|0|||
156857515|NCT02694744|566232541|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
156857516|NCT02694744|566232542|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
156857517|NCT00686777|566232543|FG000|Overall Study|Adverse Event|2|||
156857518|NCT00686777|566232543|FG000|Overall Study|Pregnancy|1|||
156857519|NCT00686777|566232543|FG000|Overall Study|Withdrawal by Subject|2|||
156857520|NCT00686777|566232543|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
156857521|NCT00686777|566232543|FG000|Overall Study|No Visit|1|||
156857522|NCT00667888|566232544|FG000|Overall Study|Death|1|||
156857523|NCT00667888|566232545|FG001|Overall Study|Death|1|||
156857524|NCT00667888|566232544|FG000|Overall Study|Withdrawal by Subject|6|||
156857525|NCT00667888|566232545|FG001|Overall Study|Withdrawal by Subject|3|||
156857526|NCT00667888|566232544|FG000|Overall Study|Proceed with other treatment|3|||
156857527|NCT00667888|566232545|FG001|Overall Study|Proceed with other treatment|3|||
156857528|NCT00667888|566232544|FG000|Overall Study|Ineligible after SIM|0|||
156857529|NCT00667888|566232545|FG001|Overall Study|Ineligible after SIM|2|||
156857530|NCT01945021|566232546|FG000|Overall Study|Adverse Event|1|||
156857531|NCT01945021|566232546|FG000|Overall Study|Withdrawal of consent|12|||
156857532|NCT01945021|566232546|FG000|Overall Study|Lost to Follow-up|5|||
156857533|NCT01945021|566232546|FG000|Overall Study|Death|65|||
156857534|NCT00499681|566232547|FG000|Overall Study|toxicity|0|||
156857535|NCT00499681|566232548|FG001|Overall Study|toxicity|1|||
156857536|NCT00499681|566232547|FG000|Overall Study|disease progression|0|||
156857537|NCT00499681|566232548|FG001|Overall Study|disease progression|1|||
156857538|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
156857539|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
156857540|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Disease progression|75|||
156857541|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Disease progression|59|||
156857542|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Adverse Event|16|||
156857543|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Adverse Event|16|||
156857544|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Death|2|||
156857545|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Death|3|||
156857546|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
156857547|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
156857548|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Other|3|||
156857549|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Other|0|||
156857550|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Adverse Event|2|||
156857551|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Adverse Event|3|||
156857552|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Death|1|||
156857553|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Death|3|||
156857554|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
156857555|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
156857556|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
156857557|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
156542209|NCT03201458|565079270|FG001|Overall Study|Health event before starting|0|||
156342445|NCT03310021|564352699|FG011|Overall Study|Withdrawal by Subject|0|||
156342446|NCT03310021|564352700|FG012|Overall Study|Withdrawal by Subject|0|||
156342447|NCT03310021|564352701|FG013|Overall Study|Withdrawal by Subject|0|||
156472872|NCT00302211|564825678|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
156472873|NCT00302211|564825679|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
156472874|NCT00302211|564825680|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
156472875|NCT00302211|564825676|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
156342448|NCT03310021|564352702|FG014|Overall Study|Withdrawal by Subject|0|||
156342449|NCT03310021|564352703|FG015|Overall Study|Withdrawal by Subject|0|||
156342450|NCT03310021|564352704|FG016|Overall Study|Withdrawal by Subject|0|||
156342451|NCT03310021|564352705|FG017|Overall Study|Withdrawal by Subject|0|||
156342452|NCT03310021|564352706|FG018|Overall Study|Withdrawal by Subject|0|||
156472876|NCT00302211|564825677|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
156472877|NCT00302211|564825678|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
156472878|NCT00302211|564825679|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
156472879|NCT00302211|564825680|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
156472880|NCT00302211|564825676|FG000|Double Blind Period (New Patients)|Disease progression|0|||
156472881|NCT00302211|564825677|FG001|Double Blind Period (New Patients)|Disease progression|1|||
156472882|NCT00302211|564825678|FG002|Double Blind Period (New Patients)|Disease progression|1|||
156472883|NCT00302211|564825679|FG003|Double Blind Period (New Patients)|Disease progression|0|||
156472884|NCT00302211|564825680|FG004|Double Blind Period (New Patients)|Disease progression|0|||
156472885|NCT00302211|564825676|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
156472886|NCT00302211|564825677|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
156472887|NCT00302211|564825678|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
156472888|NCT00302211|564825679|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
156542210|NCT03201458|565079269|FG000|Overall Study|Physician Decision|1|||
156342453|NCT03310021|564352707|FG019|Overall Study|Withdrawal by Subject|0|||
156342454|NCT03310021|564352688|FG000|Overall Study|Lost to Follow-up|0|||
156342455|NCT03310021|564352689|FG001|Overall Study|Lost to Follow-up|0|||
156342456|NCT03310021|564352690|FG002|Overall Study|Lost to Follow-up|0|||
156342457|NCT03310021|564352691|FG003|Overall Study|Lost to Follow-up|0|||
156342458|NCT03310021|564352692|FG004|Overall Study|Lost to Follow-up|0|||
156342459|NCT03310021|564352693|FG005|Overall Study|Lost to Follow-up|0|||
156342460|NCT03310021|564352694|FG006|Overall Study|Lost to Follow-up|0|||
156342461|NCT03310021|564352695|FG007|Overall Study|Lost to Follow-up|0|||
156342462|NCT03310021|564352696|FG008|Overall Study|Lost to Follow-up|0|||
156342463|NCT03310021|564352697|FG009|Overall Study|Lost to Follow-up|0|||
156342464|NCT03310021|564352698|FG010|Overall Study|Lost to Follow-up|1|||
156342465|NCT03310021|564352699|FG011|Overall Study|Lost to Follow-up|0|||
156342466|NCT03310021|564352700|FG012|Overall Study|Lost to Follow-up|0|||
156342467|NCT03310021|564352701|FG013|Overall Study|Lost to Follow-up|0|||
156342468|NCT03310021|564352702|FG014|Overall Study|Lost to Follow-up|0|||
156342469|NCT03310021|564352703|FG015|Overall Study|Lost to Follow-up|0|||
156342470|NCT03310021|564352704|FG016|Overall Study|Lost to Follow-up|0|||
156342471|NCT03310021|564352705|FG017|Overall Study|Lost to Follow-up|0|||
156342472|NCT03310021|564352706|FG018|Overall Study|Lost to Follow-up|0|||
156342473|NCT03310021|564352707|FG019|Overall Study|Lost to Follow-up|0|||
156342474|NCT02002091|564352712|FG000|Screening|Lost to Follow-up|10|||
156342475|NCT02002091|564352713|FG001|Screening|Lost to Follow-up|12|||
156342476|NCT02002091|564352712|FG000|Screening|Death|3|||
156342477|NCT02002091|564352713|FG001|Screening|Death|2|||
156342478|NCT00390468|564352721|FG000|Overall Study|Protocol Violation|2|||
156342479|NCT00390468|564352721|FG000|Overall Study|Lack of Efficacy|1|||
156342480|NCT04502693|564352722|FG000|Overall Study|Adverse Event|7|||
156342481|NCT04502693|564352723|FG001|Overall Study|Adverse Event|6|||
156342482|NCT04502693|564352724|FG002|Overall Study|Adverse Event|11|||
156342483|NCT04502693|564352725|FG003|Overall Study|Adverse Event|1|||
156342484|NCT04502693|564352722|FG000|Overall Study|Lost to Follow-up|32|||
156342485|NCT04502693|564352723|FG001|Overall Study|Lost to Follow-up|36|||
156342486|NCT04502693|564352724|FG002|Overall Study|Lost to Follow-up|69|||
156342487|NCT04502693|564352725|FG003|Overall Study|Lost to Follow-up|4|||
156342488|NCT04502693|564352722|FG000|Overall Study|Protocol Violation|8|||
156342489|NCT04502693|564352723|FG001|Overall Study|Protocol Violation|8|||
156342490|NCT04502693|564352724|FG002|Overall Study|Protocol Violation|16|||
156342491|NCT04502693|564352725|FG003|Overall Study|Protocol Violation|1|||
156342492|NCT04502693|564352722|FG000|Overall Study|Withdrawal by Subject|46|||
156342493|NCT04502693|564352723|FG001|Overall Study|Withdrawal by Subject|38|||
156342494|NCT04502693|564352724|FG002|Overall Study|Withdrawal by Subject|54|||
156342495|NCT04502693|564352725|FG003|Overall Study|Withdrawal by Subject|7|||
156342496|NCT04502693|564352722|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
156342497|NCT04502693|564352723|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
156342498|NCT04502693|564352724|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
156342499|NCT04502693|564352725|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156342500|NCT04502693|564352722|FG000|Overall Study|Other|1|||
156342501|NCT04502693|564352723|FG001|Overall Study|Other|0|||
156342502|NCT04502693|564352724|FG002|Overall Study|Other|1|||
156342503|NCT04502693|564352725|FG003|Overall Study|Other|1|||
156342504|NCT03736447|564352730|FG000|Overall Study|Adverse Event|5|||
156342505|NCT03736447|564352731|FG001|Overall Study|Adverse Event|1|||
156342506|NCT03736447|564352730|FG000|Overall Study|Withdrawal by Subject|5|||
156542211|NCT03201458|565079270|FG001|Overall Study|Physician Decision|0|||
156342507|NCT03736447|564352731|FG001|Overall Study|Withdrawal by Subject|1|||
156342508|NCT03736447|564352730|FG000|Overall Study|Lost to Follow-up|1|||
156342509|NCT03736447|564352731|FG001|Overall Study|Lost to Follow-up|0|||
156342510|NCT03736447|564352730|FG000|Overall Study|Physician Decision|1|||
156542212|NCT03625687|565079277|FG000|Overall Study|Death|1|||
156472889|NCT00302211|564825680|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
156472890|NCT00302211|564825676|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
156542213|NCT01543828|565079278|FG000|Treatment 2|Lost to Follow-up|1|||
156472891|NCT00302211|564825677|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
156472892|NCT00302211|564825678|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
156472893|NCT00302211|564825679|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
156472894|NCT00302211|564825680|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
156472895|NCT00302211|564825676|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
156472896|NCT00302211|564825677|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
156472897|NCT00302211|564825678|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
156472898|NCT00302211|564825679|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
156472899|NCT00302211|564825680|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
156472900|NCT00302211|564825676|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
156472901|NCT00302211|564825677|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
156472902|NCT00302211|564825678|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
156472903|NCT00302211|564825679|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
156472904|NCT00302211|564825680|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
156472905|NCT00302211|564825676|FG000|Open Label-Patients From Double-Blind|Death|0|||
156472906|NCT00302211|564825677|FG001|Open Label-Patients From Double-Blind|Death|0|||
156472907|NCT00302211|564825678|FG002|Open Label-Patients From Double-Blind|Death|0|||
156472908|NCT00302211|564825679|FG003|Open Label-Patients From Double-Blind|Death|1|||
156472909|NCT00302211|564825680|FG004|Open Label-Patients From Double-Blind|Death|1|||
156472910|NCT00302211|564825676|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
156472911|NCT00302211|564825677|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
156472912|NCT00302211|564825678|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
156472913|NCT00302211|564825679|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
156542214|NCT01543828|565079279|FG001|Treatment 2|Lost to Follow-up|0|||
156542215|NCT01069172|565079282|FG000|Overall Study|Withdrawal by Subject|1|||
156472914|NCT00302211|564825680|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
156542216|NCT01069172|565079283|FG001|Overall Study|Withdrawal by Subject|0|||
156472915|NCT00302211|564825676|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
156472916|NCT00302211|564825677|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
156472917|NCT00302211|564825678|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
156542217|NCT00711425|565079286|FG000|Overall Study|Protocol Violation|1|||
156472918|NCT00302211|564825679|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
156542218|NCT00711425|565079286|FG000|Overall Study|Death|2|||
156472919|NCT00302211|564825680|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
156472920|NCT00302211|564825676|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
156472921|NCT00302211|564825677|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
156472922|NCT00302211|564825678|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
156472923|NCT00302211|564825679|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
156472924|NCT00302211|564825680|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
156342511|NCT03736447|564352731|FG001|Overall Study|Physician Decision|0|||
156342512|NCT03736447|564352730|FG000|Overall Study|Continued commitment to study treatment|3|||
156472925|NCT02556918|564827458|FG000|Overall Study|Protocol Violation|5|||
156472926|NCT02556918|564827459|FG001|Overall Study|Protocol Violation|6|||
156857558|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Disease progression|103|||
156857559|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Disease progression|122|||
156857560|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Other|3|||
156857561|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Other|0|||
156857562|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
156857563|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
156857564|NCT00883779|566232549|FG000|Off-study Phase|Death|185|||
156857565|NCT00883779|566232550|FG001|Off-study Phase|Death|174|||
156857566|NCT00883779|566232549|FG000|Off-study Phase|Refused treatment|1|||
156857567|NCT00883779|566232550|FG001|Off-study Phase|Refused treatment|1|||
156857568|NCT00883779|566232549|FG000|Off-study Phase|Failure to return|5|||
156857569|NCT00883779|566232550|FG001|Off-study Phase|Failure to return|6|||
156857570|NCT00883779|566232549|FG000|Off-study Phase|Other|18|||
156857571|NCT00883779|566232550|FG001|Off-study Phase|Other|21|||
156857572|NCT04575155|566232551|FG000|2 Month|Withdrawal by Subject|1|||
156857573|NCT04575155|566232552|FG001|2 Month|Withdrawal by Subject|1|||
156857574|NCT04575155|566232551|FG000|2 Month|Lost to Follow-up|5|||
156857575|NCT04575155|566232552|FG001|2 Month|Lost to Follow-up|3|||
156857576|NCT04575155|566232551|FG000|2 Month|Ineligible|1|||
156857577|NCT04575155|566232552|FG001|2 Month|Ineligible|0|||
156857578|NCT06237049|566232554|FG000|Overall Study|Death|0|||
156857579|NCT06237049|566232555|FG001|Overall Study|Death|0|||
156857580|NCT06237049|566232556|FG002|Overall Study|Death|0|||
156857581|NCT06237049|566232557|FG003|Overall Study|Death|1|||
156857582|NCT06237049|566232554|FG000|Overall Study|Lost to Follow-up|11|||
156857583|NCT06237049|566232555|FG001|Overall Study|Lost to Follow-up|5|||
156857584|NCT06237049|566232556|FG002|Overall Study|Lost to Follow-up|8|||
156857585|NCT06237049|566232557|FG003|Overall Study|Lost to Follow-up|8|||
156857586|NCT06237049|566232554|FG000|Overall Study|Protocol Violation|0|||
156857587|NCT06237049|566232555|FG001|Overall Study|Protocol Violation|1|||
156857588|NCT06237049|566232556|FG002|Overall Study|Protocol Violation|0|||
156857589|NCT06237049|566232557|FG003|Overall Study|Protocol Violation|1|||
156857590|NCT06237049|566232554|FG000|Overall Study|Withdrawal by Subject|4|||
156857591|NCT06237049|566232555|FG001|Overall Study|Withdrawal by Subject|2|||
156857592|NCT06237049|566232556|FG002|Overall Study|Withdrawal by Subject|1|||
156857593|NCT06237049|566232557|FG003|Overall Study|Withdrawal by Subject|0|||
156857594|NCT03748823|566232558|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
156857595|NCT03748823|566232559|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
156857596|NCT03748823|566232558|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
156857597|NCT03748823|566232559|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
156857598|NCT03748823|566232558|FG000|Extension Period|Withdrawal by Subject|9|||
156857599|NCT03748823|566232559|FG001|Extension Period|Withdrawal by Subject|12|||
156857600|NCT03748823|566232558|FG000|Extension Period|Death|2|||
156857601|NCT03748823|566232559|FG001|Extension Period|Death|2|||
156857602|NCT03748823|566232558|FG000|Extension Period|Other than Specified|0|||
156857603|NCT03748823|566232559|FG001|Extension Period|Other than Specified|1|||
156857604|NCT03748823|566232558|FG000|Extension Period|Protocol Violation|1|||
156857605|NCT03748823|566232559|FG001|Extension Period|Protocol Violation|0|||
156857606|NCT03748823|566232558|FG000|Extension Period|Lost to Follow-up|0|||
156857607|NCT03748823|566232559|FG001|Extension Period|Lost to Follow-up|1|||
156857608|NCT03748823|566232558|FG000|Extension Period|Lack of Efficacy|0|||
156857609|NCT03748823|566232559|FG001|Extension Period|Lack of Efficacy|1|||
156857610|NCT03748823|566232558|FG000|Extension Period|Physician Decision|1|||
156857611|NCT03748823|566232559|FG001|Extension Period|Physician Decision|2|||
156857612|NCT00982735|566232563|FG000|Overall Study|Lost to Follow-up|6|||
156857613|NCT00982735|566232563|FG000|Overall Study|Patient ineligible for trial|224|||
156857614|NCT02898454|566232565|FG000|Overall Study|Adverse Event|4|||
156857615|NCT02898454|566232566|FG001|Overall Study|Adverse Event|1|||
156857616|NCT02898454|566232567|FG002|Overall Study|Adverse Event|2|||
156472927|NCT02556918|564827458|FG000|Overall Study|Withdrawal by Subject|4|||
156472928|NCT02556918|564827459|FG001|Overall Study|Withdrawal by Subject|4|||
156472929|NCT04511702|564827469|FG000|Overall Study|Lost to Follow-up|3|||
156472930|NCT04511702|564827470|FG001|Overall Study|Lost to Follow-up|0|||
156472931|NCT04511702|564827471|FG002|Overall Study|Lost to Follow-up|4|||
156472932|NCT04511702|564827469|FG000|Overall Study|Withdrawal by Subject|17|||
156857617|NCT02898454|566232565|FG000|Overall Study|Protocol Violation|1|||
156857618|NCT02898454|566232566|FG001|Overall Study|Protocol Violation|0|||
156857619|NCT02898454|566232567|FG002|Overall Study|Protocol Violation|1|||
156857620|NCT02898454|566232565|FG000|Overall Study|Lack of Efficacy|4|||
156857621|NCT02898454|566232566|FG001|Overall Study|Lack of Efficacy|1|||
156857622|NCT02898454|566232567|FG002|Overall Study|Lack of Efficacy|0|||
156857623|NCT02898454|566232565|FG000|Overall Study|Withdrawal by Subject|6|||
156857624|NCT02898454|566232566|FG001|Overall Study|Withdrawal by Subject|3|||
156857625|NCT02898454|566232567|FG002|Overall Study|Withdrawal by Subject|3|||
156857626|NCT02898454|566232565|FG000|Overall Study|Lost to Follow-up|1|||
156857627|NCT02898454|566232566|FG001|Overall Study|Lost to Follow-up|0|||
156857628|NCT02898454|566232567|FG002|Overall Study|Lost to Follow-up|0|||
156472933|NCT04511702|564827470|FG001|Overall Study|Withdrawal by Subject|1|||
156472934|NCT04511702|564827471|FG002|Overall Study|Withdrawal by Subject|8|||
156472935|NCT05349721|564827472|FG000|Part A (24 Weeks)|Adverse Event|9|||
156472936|NCT05349721|564827473|FG001|Part A (24 Weeks)|Adverse Event|2|||
156472937|NCT05349721|564827472|FG000|Part A (24 Weeks)|Death|8|||
156472938|NCT05349721|564827473|FG001|Part A (24 Weeks)|Death|3|||
156472939|NCT05349721|564827472|FG000|Part A (24 Weeks)|Disease Progression|1|||
156472940|NCT05349721|564827473|FG001|Part A (24 Weeks)|Disease Progression|1|||
156472941|NCT05349721|564827472|FG000|Part A (24 Weeks)|Screen Failure|2|||
156472942|NCT05349721|564827473|FG001|Part A (24 Weeks)|Screen Failure|0|||
156472943|NCT05349721|564827472|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
156857629|NCT02898454|566232565|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
156857630|NCT02898454|566232566|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
156857631|NCT02898454|566232567|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
156857632|NCT02343263|566232568|FG000|Overall Study|Physician Decision|5|||
156857633|NCT02343263|566232569|FG001|Overall Study|Physician Decision|3|||
156857634|NCT02343263|566232570|FG002|Overall Study|Physician Decision|1|||
156857635|NCT03040141|566232571|FG000|Overall Study|Death|1|||
156857636|NCT03040141|566232572|FG001|Overall Study|Death|2|||
156857637|NCT03040141|566232573|FG002|Overall Study|Death|3|||
156857638|NCT03040141|566232571|FG000|Overall Study|Withdrawal by Subject|3|||
156857639|NCT03040141|566232572|FG001|Overall Study|Withdrawal by Subject|1|||
156857640|NCT03040141|566232573|FG002|Overall Study|Withdrawal by Subject|1|||
156857641|NCT03040141|566232571|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
156857642|NCT03040141|566232572|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
156857643|NCT03040141|566232573|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
156857644|NCT03040141|566232571|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
156857645|NCT03040141|566232572|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
156857646|NCT03040141|566232573|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
156857647|NCT01384734|566232575|FG000|Overall Study|Adverse Event|0|||
156857648|NCT01384734|566232576|FG001|Overall Study|Adverse Event|3|||
156857649|NCT01384734|566232577|FG002|Overall Study|Adverse Event|0|||
156857650|NCT01384734|566232578|FG003|Overall Study|Adverse Event|2|||
156857651|NCT01384734|566232579|FG004|Overall Study|Adverse Event|7|||
156857652|NCT01384734|566232575|FG000|Overall Study|Death|1|||
156857653|NCT01384734|566232576|FG001|Overall Study|Death|0|||
156857654|NCT01384734|566232577|FG002|Overall Study|Death|1|||
156857655|NCT01384734|566232578|FG003|Overall Study|Death|0|||
156857656|NCT01384734|566232579|FG004|Overall Study|Death|0|||
156857657|NCT01384734|566232575|FG000|Overall Study|Continuation criteria not met|0|||
156857658|NCT01384734|566232576|FG001|Overall Study|Continuation criteria not met|0|||
156857659|NCT01384734|566232577|FG002|Overall Study|Continuation criteria not met|1|||
156857660|NCT01384734|566232578|FG003|Overall Study|Continuation criteria not met|1|||
156857661|NCT01384734|566232579|FG004|Overall Study|Continuation criteria not met|0|||
156857662|NCT01384734|566232575|FG000|Overall Study|Lack of Efficacy|3|||
156857663|NCT01384734|566232576|FG001|Overall Study|Lack of Efficacy|7|||
156857664|NCT01384734|566232577|FG002|Overall Study|Lack of Efficacy|4|||
156857665|NCT01384734|566232578|FG003|Overall Study|Lack of Efficacy|4|||
156857666|NCT01384734|566232579|FG004|Overall Study|Lack of Efficacy|2|||
156857667|NCT01384734|566232575|FG000|Overall Study|Lost to Follow-up|5|||
156857668|NCT01384734|566232576|FG001|Overall Study|Lost to Follow-up|3|||
156857669|NCT01384734|566232577|FG002|Overall Study|Lost to Follow-up|3|||
156342513|NCT03736447|564352731|FG001|Overall Study|Continued commitment to study treatment|0|||
156342514|NCT03736447|564352730|FG000|Overall Study|Taste aversion to study product|0|||
156857670|NCT01384734|566232578|FG003|Overall Study|Lost to Follow-up|8|||
156857671|NCT01384734|566232579|FG004|Overall Study|Lost to Follow-up|5|||
156857672|NCT01384734|566232575|FG000|Overall Study|Non-compliance with study drug|1|||
156857673|NCT01384734|566232576|FG001|Overall Study|Non-compliance with study drug|2|||
156857674|NCT01384734|566232577|FG002|Overall Study|Non-compliance with study drug|6|||
156857675|NCT01384734|566232578|FG003|Overall Study|Non-compliance with study drug|0|||
156857676|NCT01384734|566232579|FG004|Overall Study|Non-compliance with study drug|2|||
156857677|NCT01384734|566232575|FG000|Overall Study|Pregnancy|0|||
156857678|NCT01384734|566232576|FG001|Overall Study|Pregnancy|1|||
156857679|NCT01384734|566232577|FG002|Overall Study|Pregnancy|0|||
156857680|NCT01384734|566232578|FG003|Overall Study|Pregnancy|0|||
156857681|NCT01384734|566232579|FG004|Overall Study|Pregnancy|1|||
156857682|NCT01384734|566232575|FG000|Overall Study|Sponsor terminated|0|||
156857683|NCT01384734|566232576|FG001|Overall Study|Sponsor terminated|0|||
156857684|NCT01384734|566232577|FG002|Overall Study|Sponsor terminated|0|||
156857685|NCT01384734|566232578|FG003|Overall Study|Sponsor terminated|0|||
156857686|NCT01384734|566232579|FG004|Overall Study|Sponsor terminated|1|||
156857687|NCT01384734|566232575|FG000|Overall Study|Withdrawal by Subject|5|||
156857688|NCT01384734|566232576|FG001|Overall Study|Withdrawal by Subject|5|||
156857689|NCT01384734|566232577|FG002|Overall Study|Withdrawal by Subject|6|||
156857690|NCT01384734|566232578|FG003|Overall Study|Withdrawal by Subject|7|||
156857691|NCT01384734|566232579|FG004|Overall Study|Withdrawal by Subject|9|||
156342515|NCT03736447|564352731|FG001|Overall Study|Taste aversion to study product|1|||
156342516|NCT00968201|564352732|FG000|Base Study - (Period II)|Adverse Event|8|||
156542219|NCT00711425|565079286|FG000|Overall Study|Lost to Follow-up|1|||
156472944|NCT05349721|564827473|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
156472945|NCT05349721|564827472|FG000|Part A (24 Weeks)|Other Than Specified|5|||
156472946|NCT05349721|564827473|FG001|Part A (24 Weeks)|Other Than Specified|1|||
156472947|NCT05349721|564827472|FG000|Part B (28 Weeks)|Adverse Event|3|||
156472948|NCT05349721|564827473|FG001|Part B (28 Weeks)|Adverse Event|0|||
156472949|NCT05349721|564827472|FG000|Part B (28 Weeks)|Death|21|||
156472950|NCT05349721|564827473|FG001|Part B (28 Weeks)|Death|11|||
156472951|NCT05349721|564827472|FG000|Part B (28 Weeks)|Disease Progression|2|||
156472952|NCT05349721|564827473|FG001|Part B (28 Weeks)|Disease Progression|1|||
156857692|NCT01384734|566232575|FG000|Overall Study|Investigator relocating|0|||
156857693|NCT01384734|566232576|FG001|Overall Study|Investigator relocating|2|||
156857694|NCT01384734|566232577|FG002|Overall Study|Investigator relocating|0|||
156857695|NCT01384734|566232578|FG003|Overall Study|Investigator relocating|3|||
156857696|NCT01384734|566232579|FG004|Overall Study|Investigator relocating|1|||
156857697|NCT01384734|566232575|FG000|Overall Study|Unable to come back for visit|1|||
156857698|NCT01384734|566232576|FG001|Overall Study|Unable to come back for visit|0|||
156857699|NCT01384734|566232577|FG002|Overall Study|Unable to come back for visit|1|||
156857700|NCT01384734|566232578|FG003|Overall Study|Unable to come back for visit|1|||
156857701|NCT01384734|566232579|FG004|Overall Study|Unable to come back for visit|0|||
156857702|NCT01384734|566232575|FG000|Overall Study|Prison|0|||
156857703|NCT01384734|566232576|FG001|Overall Study|Prison|0|||
156857704|NCT01384734|566232577|FG002|Overall Study|Prison|1|||
156857705|NCT01384734|566232578|FG003|Overall Study|Prison|0|||
156857706|NCT01384734|566232579|FG004|Overall Study|Prison|0|||
156857707|NCT01384734|566232575|FG000|Overall Study|As per Exclusion criteria|0|||
156857708|NCT01384734|566232576|FG001|Overall Study|As per Exclusion criteria|1|||
156857709|NCT01384734|566232577|FG002|Overall Study|As per Exclusion criteria|0|||
156857710|NCT01384734|566232578|FG003|Overall Study|As per Exclusion criteria|0|||
156857711|NCT01384734|566232579|FG004|Overall Study|As per Exclusion criteria|0|||
156857712|NCT01384734|566232575|FG000|Overall Study|Missed End of treatment visit|0|||
156857713|NCT01384734|566232576|FG001|Overall Study|Missed End of treatment visit|0|||
156857714|NCT01384734|566232577|FG002|Overall Study|Missed End of treatment visit|0|||
156857715|NCT01384734|566232578|FG003|Overall Study|Missed End of treatment visit|1|||
156857716|NCT01384734|566232579|FG004|Overall Study|Missed End of treatment visit|0|||
156857717|NCT01384734|566232575|FG000|Overall Study|Adhesion problem|0|||
156857718|NCT01384734|566232576|FG001|Overall Study|Adhesion problem|0|||
156857719|NCT01384734|566232577|FG002|Overall Study|Adhesion problem|0|||
156857720|NCT01384734|566232578|FG003|Overall Study|Adhesion problem|1|||
156857721|NCT01384734|566232579|FG004|Overall Study|Adhesion problem|0|||
156857722|NCT01384734|566232575|FG000|Overall Study|Early termination|0|||
156857723|NCT01384734|566232576|FG001|Overall Study|Early termination|0|||
156857724|NCT01384734|566232577|FG002|Overall Study|Early termination|0|||
156857725|NCT01384734|566232578|FG003|Overall Study|Early termination|0|||
156857726|NCT01384734|566232579|FG004|Overall Study|Early termination|1|||
156857727|NCT01384734|566232575|FG000|Overall Study|Physician Decision|1|||
156857728|NCT01384734|566232576|FG001|Overall Study|Physician Decision|0|||
156857729|NCT01384734|566232577|FG002|Overall Study|Physician Decision|0|||
156857730|NCT01384734|566232578|FG003|Overall Study|Physician Decision|0|||
156857731|NCT01384734|566232579|FG004|Overall Study|Physician Decision|0|||
156857732|NCT02922725|566232580|FG000|Overall Study|Withdrawal by Subject|1|||
156857733|NCT02922725|566232581|FG001|Overall Study|Withdrawal by Subject|0|||
156857734|NCT02922725|566232582|FG002|Overall Study|Withdrawal by Subject|0|||
156857735|NCT01300234|566232583|FG000|Overall Study|Adverse Event|1|||
156857736|NCT01300234|566232584|FG001|Overall Study|Adverse Event|1|||
156857737|NCT01300234|566232583|FG000|Overall Study|Protocol Violation|2|||
156857738|NCT01300234|566232584|FG001|Overall Study|Protocol Violation|3|||
156857739|NCT01300234|566232583|FG000|Overall Study|Withdrawal by Subject|5|||
156857740|NCT01300234|566232584|FG001|Overall Study|Withdrawal by Subject|9|||
156857741|NCT01300234|566232583|FG000|Overall Study|Lost to Follow-up|14|||
156857742|NCT01300234|566232584|FG001|Overall Study|Lost to Follow-up|12|||
156857743|NCT01300234|566232583|FG000|Overall Study|Pregnancy|2|||
156857744|NCT01300234|566232584|FG001|Overall Study|Pregnancy|1|||
156857745|NCT01300234|566232583|FG000|Overall Study|Participant reached stopping critera|2|||
156857746|NCT01300234|566232584|FG001|Overall Study|Participant reached stopping critera|0|||
156857747|NCT01300234|566232583|FG000|Overall Study|Participant stopped medication|1|||
156857748|NCT01300234|566232584|FG001|Overall Study|Participant stopped medication|1|||
156857749|NCT01300234|566232583|FG000|Overall Study|Participant refused return to hospital|1|||
156857750|NCT01300234|566232584|FG001|Overall Study|Participant refused return to hospital|0|||
156472953|NCT05349721|564827472|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
156472954|NCT05349721|564827473|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
156472955|NCT05349721|564827472|FG000|Part B (28 Weeks)|Physician Decision|1|||
156472956|NCT05349721|564827473|FG001|Part B (28 Weeks)|Physician Decision|0|||
156857751|NCT04612725|566232586|FG000|Overall Study|Adverse Event|1|||
156857752|NCT04612725|566232587|FG001|Overall Study|Adverse Event|3|||
156857753|NCT04612725|566232588|FG002|Overall Study|Adverse Event|1|||
156857754|NCT04612725|566232589|FG003|Overall Study|Adverse Event|0|||
156857755|NCT04612725|566232590|FG004|Overall Study|Adverse Event|1|||
156857756|NCT04612725|566232586|FG000|Overall Study|Lost to Follow-up|0|||
156857757|NCT04612725|566232587|FG001|Overall Study|Lost to Follow-up|1|||
156857758|NCT04612725|566232588|FG002|Overall Study|Lost to Follow-up|0|||
156472957|NCT05349721|564827472|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
156857759|NCT04612725|566232589|FG003|Overall Study|Lost to Follow-up|0|||
156857760|NCT04612725|566232590|FG004|Overall Study|Lost to Follow-up|0|||
156857761|NCT04612725|566232586|FG000|Overall Study|Physician Decision|2|||
156857762|NCT04612725|566232587|FG001|Overall Study|Physician Decision|0|||
156857763|NCT04612725|566232588|FG002|Overall Study|Physician Decision|0|||
156857764|NCT04612725|566232589|FG003|Overall Study|Physician Decision|0|||
156857765|NCT04612725|566232590|FG004|Overall Study|Physician Decision|0|||
156857766|NCT04612725|566232586|FG000|Overall Study|Study terminated by sponsor|3|||
156857767|NCT04612725|566232587|FG001|Overall Study|Study terminated by sponsor|1|||
156857768|NCT04612725|566232588|FG002|Overall Study|Study terminated by sponsor|2|||
156857769|NCT04612725|566232589|FG003|Overall Study|Study terminated by sponsor|4|||
156857770|NCT04612725|566232590|FG004|Overall Study|Study terminated by sponsor|5|||
156857771|NCT04612725|566232586|FG000|Overall Study|Withdrawal by Subject|8|||
156857772|NCT04612725|566232587|FG001|Overall Study|Withdrawal by Subject|3|||
156857773|NCT04612725|566232588|FG002|Overall Study|Withdrawal by Subject|5|||
156857774|NCT04612725|566232589|FG003|Overall Study|Withdrawal by Subject|1|||
156857775|NCT04612725|566232590|FG004|Overall Study|Withdrawal by Subject|9|||
156857776|NCT04612725|566232586|FG000|Overall Study|Other|0|||
156857777|NCT04612725|566232587|FG001|Overall Study|Other|0|||
156857778|NCT04612725|566232588|FG002|Overall Study|Other|0|||
156857779|NCT04612725|566232589|FG003|Overall Study|Other|0|||
156857780|NCT04612725|566232590|FG004|Overall Study|Other|1|||
156857781|NCT00948064|566234622|FG000|Phase I|No treatment received|1|||
156857782|NCT00948064|566234623|FG001|Phase I|No treatment received|0|||
156857783|NCT00948064|566234624|FG002|Phase I|No treatment received|0|||
156857784|NCT00948064|566234622|FG000|Phase II|Physician Decision|0|||
156857785|NCT00948064|566234623|FG001|Phase II|Physician Decision|0|||
156857786|NCT00948064|566234624|FG002|Phase II|Physician Decision|1|||
156857787|NCT00948064|566234622|FG000|Phase II|Withdrawal by Subject|0|||
156857788|NCT00948064|566234623|FG001|Phase II|Withdrawal by Subject|1|||
156857789|NCT00948064|566234624|FG002|Phase II|Withdrawal by Subject|0|||
156857790|NCT02973100|566234625|FG000|Overall Study|Adverse Event|1|||
156857791|NCT02973100|566234626|FG001|Overall Study|Adverse Event|2|||
156857792|NCT02973100|566234627|FG002|Overall Study|Adverse Event|1|||
156857793|NCT02973100|566234628|FG003|Overall Study|Adverse Event|2|||
156857794|NCT02973100|566234625|FG000|Overall Study|Lost to Follow-up|3|||
156857795|NCT02973100|566234626|FG001|Overall Study|Lost to Follow-up|1|||
156857796|NCT02973100|566234627|FG002|Overall Study|Lost to Follow-up|1|||
156857797|NCT02973100|566234628|FG003|Overall Study|Lost to Follow-up|0|||
156857798|NCT02973100|566234625|FG000|Overall Study|Withdrawal by Subject|3|||
156857799|NCT02973100|566234626|FG001|Overall Study|Withdrawal by Subject|5|||
156857800|NCT02973100|566234627|FG002|Overall Study|Withdrawal by Subject|1|||
156857801|NCT02973100|566234628|FG003|Overall Study|Withdrawal by Subject|4|||
156857802|NCT02973100|566234625|FG000|Overall Study|Notification of change in address|0|||
156857803|NCT02973100|566234626|FG001|Overall Study|Notification of change in address|0|||
156857804|NCT02973100|566234627|FG002|Overall Study|Notification of change in address|0|||
156857805|NCT02973100|566234628|FG003|Overall Study|Notification of change in address|1|||
156857806|NCT02973100|566234625|FG000|Overall Study|Failed to attend Safety followup period|0|||
156857807|NCT02973100|566234626|FG001|Overall Study|Failed to attend Safety followup period|0|||
156857808|NCT02973100|566234627|FG002|Overall Study|Failed to attend Safety followup period|1|||
156857809|NCT02973100|566234628|FG003|Overall Study|Failed to attend Safety followup period|0|||
156857810|NCT01419236|566234631|FG000|Overall Study|Adverse Event|1|||
156857811|NCT01419236|566234632|FG001|Overall Study|Adverse Event|0|||
156857812|NCT01419236|566234631|FG000|Overall Study|Lack of Efficacy|0|||
156857813|NCT01419236|566234632|FG001|Overall Study|Lack of Efficacy|1|||
156857814|NCT01419236|566234631|FG000|Overall Study|Lost to Follow-up|1|||
156857815|NCT01419236|566234632|FG001|Overall Study|Lost to Follow-up|0|||
156857816|NCT01419236|566234631|FG000|Overall Study|Physician Decision|1|||
156857817|NCT01419236|566234632|FG001|Overall Study|Physician Decision|0|||
156857818|NCT01419236|566234631|FG000|Overall Study|Withdrawal by Subject|1|||
156857819|NCT01419236|566234632|FG001|Overall Study|Withdrawal by Subject|4|||
156857820|NCT01419236|566234631|FG000|Overall Study|Entry Criteria Not Met|1|||
156857821|NCT01419236|566234632|FG001|Overall Study|Entry Criteria Not Met|0|||
156857822|NCT01393158|566234634|FG000|Overall Study|Adverse Event|1|||
156857823|NCT01393158|566234635|FG001|Overall Study|Adverse Event|0|||
156857824|NCT04233801|566234637|FG000|Overall Study|Other than listed|0|||
156857825|NCT04233801|566234638|FG001|Overall Study|Other than listed|0|||
156857826|NCT04233801|566234639|FG002|Overall Study|Other than listed|1|||
156857827|NCT04233801|566234637|FG000|Overall Study|Withdrawal by Subject|0|||
156857828|NCT04233801|566234638|FG001|Overall Study|Withdrawal by Subject|2|||
156857829|NCT04233801|566234639|FG002|Overall Study|Withdrawal by Subject|3|||
156857830|NCT01690052|566234644|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
156857831|NCT01690052|566234645|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
156857832|NCT01453049|566234646|FG000|Overall Study|Protocol Violation|2|||
156857833|NCT01453049|566234647|FG001|Overall Study|Protocol Violation|5|||
156857834|NCT01453049|566234646|FG000|Overall Study|Lost to Follow-up|2|||
156857835|NCT01453049|566234647|FG001|Overall Study|Lost to Follow-up|1|||
156857836|NCT01453049|566234646|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
156342517|NCT00968201|564352733|FG001|Base Study - (Period II)|Adverse Event|0|||
156472958|NCT05349721|564827473|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
156472959|NCT05349721|564827472|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
156472960|NCT05349721|564827473|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
156472961|NCT05349721|564827472|FG000|Part B (28 Weeks)|Other Than Specified|4|||
156472962|NCT05349721|564827473|FG001|Part B (28 Weeks)|Other Than Specified|2|||
156472963|NCT05349721|564827472|FG000|Part C (108 Weeks)|Death|0|||
156472964|NCT05349721|564827473|FG001|Part C (108 Weeks)|Death|1|||
156472965|NCT05349721|564827472|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
156472966|NCT05349721|564827473|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
156472967|NCT05349721|564827472|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
156472968|NCT05349721|564827473|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
156472969|NCT05349721|564827472|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
156472970|NCT05349721|564827473|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
156472971|NCT03137459|564827476|FG000|2-month Assessment|Withdrawal by Subject|13|||
156472972|NCT03137459|564827477|FG001|2-month Assessment|Withdrawal by Subject|3|||
156472973|NCT03137459|564827476|FG000|2-month Assessment|Unable to reach|42|||
156472974|NCT03137459|564827477|FG001|2-month Assessment|Unable to reach|32|||
156472975|NCT03137459|564827476|FG000|2-month Assessment|Refused assessment|7|||
156472976|NCT03137459|564827477|FG001|2-month Assessment|Refused assessment|5|||
156472977|NCT03137459|564827476|FG000|2-month Assessment|Acutely ill|6|||
156472978|NCT03137459|564827477|FG001|2-month Assessment|Acutely ill|2|||
156472979|NCT03137459|564827476|FG000|4-month Assessment|Death|4|||
156472980|NCT03137459|564827477|FG001|4-month Assessment|Death|2|||
156472981|NCT03137459|564827476|FG000|4-month Assessment|Withdrawal by Subject|4|||
156472982|NCT03137459|564827477|FG001|4-month Assessment|Withdrawal by Subject|2|||
156472983|NCT03137459|564827476|FG000|4-month Assessment|Unable to reach|44|||
156472984|NCT03137459|564827477|FG001|4-month Assessment|Unable to reach|29|||
156472985|NCT03137459|564827476|FG000|4-month Assessment|Refused assessment|24|||
156472986|NCT03137459|564827477|FG001|4-month Assessment|Refused assessment|10|||
156342518|NCT00968201|564352734|FG002|Base Study - (Period II)|Adverse Event|16|||
156472987|NCT03137459|564827476|FG000|4-month Assessment|Acutely ill|2|||
156472988|NCT03137459|564827477|FG001|4-month Assessment|Acutely ill|3|||
156472989|NCT03137459|564827476|FG000|6-months|Lost to Follow-up|14|||
156472990|NCT03137459|564827477|FG001|6-months|Lost to Follow-up|11|||
156472991|NCT03137459|564827476|FG000|6-months|Death|0|||
156472992|NCT03137459|564827477|FG001|6-months|Death|2|||
156472993|NCT03137459|564827476|FG000|6-months|Refused assessment|6|||
156472994|NCT03137459|564827477|FG001|6-months|Refused assessment|3|||
156472995|NCT03137459|564827476|FG000|6-months|Acutely ill|1|||
156472996|NCT03137459|564827477|FG001|6-months|Acutely ill|1|||
156857837|NCT01453049|566234647|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
156857838|NCT01453049|566234646|FG000|Overall Study|Withdrawal by Subject|1|||
156857839|NCT01453049|566234647|FG001|Overall Study|Withdrawal by Subject|0|||
156857840|NCT01453049|566234646|FG000|Overall Study|Randomized in Error|1|||
156857841|NCT01453049|566234647|FG001|Overall Study|Randomized in Error|0|||
156857842|NCT02421172|566234648|FG000|Period 1|Adverse Event|1|||
156857843|NCT02421172|566234649|FG001|Period 1|Adverse Event|0|||
156857844|NCT02421172|566234650|FG002|Period 1|Adverse Event|0|||
156857845|NCT02421172|566234651|FG003|Period 1|Adverse Event|0|||
156857846|NCT02421172|566234652|FG004|Period 1|Adverse Event|0|||
156857847|NCT02421172|566234648|FG000|Period 1|Lost to Follow-up|3|||
156857848|NCT02421172|566234649|FG001|Period 1|Lost to Follow-up|1|||
156857849|NCT02421172|566234650|FG002|Period 1|Lost to Follow-up|0|||
156857850|NCT02421172|566234651|FG003|Period 1|Lost to Follow-up|0|||
156857851|NCT02421172|566234652|FG004|Period 1|Lost to Follow-up|0|||
156857852|NCT02421172|566234648|FG000|Period 1|Patient/guardian decision|0|||
156857853|NCT02421172|566234649|FG001|Period 1|Patient/guardian decision|1|||
156857854|NCT02421172|566234650|FG002|Period 1|Patient/guardian decision|0|||
156857855|NCT02421172|566234651|FG003|Period 1|Patient/guardian decision|0|||
156857856|NCT02421172|566234652|FG004|Period 1|Patient/guardian decision|0|||
156857857|NCT02421172|566234648|FG000|Period 2|Adverse Event|0|||
156857858|NCT02421172|566234649|FG001|Period 2|Adverse Event|0|||
156857859|NCT02421172|566234650|FG002|Period 2|Adverse Event|4|||
156857860|NCT02421172|566234651|FG003|Period 2|Adverse Event|0|||
156857861|NCT02421172|566234652|FG004|Period 2|Adverse Event|0|||
156857862|NCT02421172|566234648|FG000|Period 2|Lost to Follow-up|0|||
156857863|NCT02421172|566234649|FG001|Period 2|Lost to Follow-up|0|||
156857864|NCT02421172|566234650|FG002|Period 2|Lost to Follow-up|0|||
156857865|NCT02421172|566234651|FG003|Period 2|Lost to Follow-up|1|||
156857866|NCT02421172|566234652|FG004|Period 2|Lost to Follow-up|0|||
156857867|NCT02421172|566234648|FG000|Period 2|Patient/guardian decision|0|||
156857868|NCT02421172|566234649|FG001|Period 2|Patient/guardian decision|0|||
156857869|NCT02421172|566234650|FG002|Period 2|Patient/guardian decision|3|||
156857870|NCT02421172|566234651|FG003|Period 2|Patient/guardian decision|2|||
156857871|NCT02421172|566234652|FG004|Period 2|Patient/guardian decision|1|||
156857872|NCT00928486|566234653|FG000|Overall Study|Adverse Event|2|||
156857873|NCT00928486|566234653|FG000|Overall Study|Disease Progression|7|||
156857874|NCT00928486|566234653|FG000|Overall Study|Withdrawal by Subject|1|||
156857875|NCT00683878|566234658|FG000|Overall Study|Lack of Efficacy|3|||
156857876|NCT00683878|566234659|FG001|Overall Study|Lack of Efficacy|0|||
156857877|NCT00683878|566234660|FG002|Overall Study|Lack of Efficacy|1|||
156857878|NCT00683878|566234658|FG000|Overall Study|Adverse Event|4|||
156857879|NCT00683878|566234659|FG001|Overall Study|Adverse Event|3|||
156857880|NCT00683878|566234660|FG002|Overall Study|Adverse Event|3|||
156857881|NCT00683878|566234658|FG000|Overall Study|Withdrawal by Subject|9|||
156857882|NCT00683878|566234659|FG001|Overall Study|Withdrawal by Subject|8|||
156857883|NCT00683878|566234660|FG002|Overall Study|Withdrawal by Subject|6|||
156857884|NCT00683878|566234658|FG000|Overall Study|Death|0|||
156857885|NCT00683878|566234659|FG001|Overall Study|Death|1|||
156857886|NCT00683878|566234660|FG002|Overall Study|Death|0|||
156857887|NCT00683878|566234658|FG000|Overall Study|Lost to Follow-up|4|||
156857888|NCT00683878|566234659|FG001|Overall Study|Lost to Follow-up|2|||
156857889|NCT00683878|566234660|FG002|Overall Study|Lost to Follow-up|4|||
156857890|NCT00683878|566234658|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
156857891|NCT00683878|566234659|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
156857892|NCT00683878|566234660|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
156857893|NCT04024891|566234661|FG000|Overall Study|Pregnancy|0|||
156857894|NCT04024891|566234662|FG001|Overall Study|Pregnancy|1|||
156857895|NCT03095651|566234670|FG000|Overall Study|Lost to Follow-up|1|||
156857896|NCT03095651|566234671|FG001|Overall Study|Lost to Follow-up|1|||
156857897|NCT03095651|566234672|FG002|Overall Study|Lost to Follow-up|0|||
156857898|NCT03095651|566234673|FG003|Overall Study|Lost to Follow-up|1|||
156472997|NCT00799409|564827478|FG000|Overall Study|Withdrawal by Subject|1|||
156472998|NCT00799409|564827479|FG001|Overall Study|Withdrawal by Subject|0|||
156857899|NCT03095651|566234674|FG004|Overall Study|Lost to Follow-up|0|||
156857900|NCT03095651|566234675|FG005|Overall Study|Lost to Follow-up|0|||
156857901|NCT03095651|566234676|FG006|Overall Study|Lost to Follow-up|0|||
156857902|NCT03095651|566234677|FG007|Overall Study|Lost to Follow-up|0|||
156857903|NCT03095651|566234670|FG000|Overall Study|Withdrawal by Subject|0|||
156857904|NCT03095651|566234671|FG001|Overall Study|Withdrawal by Subject|0|||
156857905|NCT03095651|566234672|FG002|Overall Study|Withdrawal by Subject|0|||
156342519|NCT00968201|564352732|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
156342520|NCT00968201|564352733|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
156342521|NCT00968201|564352734|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
156342522|NCT00968201|564352732|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
156342523|NCT00968201|564352733|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
156342524|NCT00968201|564352734|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
156342525|NCT00968201|564352732|FG000|Base Study - (Period II)|Protocol Violation|12|||
156342526|NCT00968201|564352733|FG001|Base Study - (Period II)|Protocol Violation|0|||
156342527|NCT00968201|564352734|FG002|Base Study - (Period II)|Protocol Violation|12|||
156342528|NCT00968201|564352732|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
156342529|NCT00968201|564352733|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
156342530|NCT00968201|564352734|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
156342531|NCT00968201|564352732|FG000|Base Study - (Period II)|Site Error|0|||
156342532|NCT00968201|564352733|FG001|Base Study - (Period II)|Site Error|0|||
156342533|NCT00968201|564352734|FG002|Base Study - (Period II)|Site Error|1|||
156342534|NCT00968201|564352732|FG000|Extension Study - (Period III)|Adverse Event|0|||
156342535|NCT00968201|564352733|FG001|Extension Study - (Period III)|Adverse Event|5|||
156342536|NCT00968201|564352734|FG002|Extension Study - (Period III)|Adverse Event|22|||
156342537|NCT00968201|564352732|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
156342538|NCT00968201|564352733|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
156342539|NCT00968201|564352734|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
156342540|NCT00968201|564352732|FG000|Extension Study - (Period III)|Protocol Violation|0|||
156342541|NCT00968201|564352733|FG001|Extension Study - (Period III)|Protocol Violation|17|||
156342542|NCT00968201|564352734|FG002|Extension Study - (Period III)|Protocol Violation|14|||
156342543|NCT00968201|564352732|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
156342544|NCT00968201|564352733|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
156342545|NCT00968201|564352734|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
156342546|NCT00968201|564352732|FG000|Extension Study - (Period III)|Patient Relocated|0|||
156342547|NCT00968201|564352733|FG001|Extension Study - (Period III)|Patient Relocated|1|||
156342548|NCT00968201|564352734|FG002|Extension Study - (Period III)|Patient Relocated|1|||
156342549|NCT00968201|564352732|FG000|Extension Study - (Period III)|Noncompliance|0|||
156342550|NCT00968201|564352733|FG001|Extension Study - (Period III)|Noncompliance|0|||
156342551|NCT00968201|564352734|FG002|Extension Study - (Period III)|Noncompliance|3|||
156342552|NCT00968201|564352732|FG000|Extension Study - (Period III)|Other|0|||
156342553|NCT00968201|564352733|FG001|Extension Study - (Period III)|Other|0|||
156342554|NCT00968201|564352734|FG002|Extension Study - (Period III)|Other|2|||
156342555|NCT00968201|564352732|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
156342556|NCT00968201|564352733|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
156857906|NCT03095651|566234673|FG003|Overall Study|Withdrawal by Subject|0|||
156857907|NCT03095651|566234674|FG004|Overall Study|Withdrawal by Subject|0|||
156857908|NCT03095651|566234675|FG005|Overall Study|Withdrawal by Subject|1|||
156857909|NCT03095651|566234676|FG006|Overall Study|Withdrawal by Subject|0|||
156857910|NCT03095651|566234677|FG007|Overall Study|Withdrawal by Subject|0|||
156857911|NCT02891174|566234678|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
156857912|NCT02891174|566234679|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
156857913|NCT02891174|566234678|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
156857914|NCT02891174|566234679|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
156857915|NCT02891174|566234678|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
156857916|NCT02891174|566234679|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
156857917|NCT02891174|566234678|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
156857918|NCT02891174|566234679|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
156472999|NCT00799409|564827480|FG002|Overall Study|Withdrawal by Subject|0|||
156473000|NCT00799409|564827478|FG000|Overall Study|Lost to Follow-up|1|||
156473001|NCT00799409|564827479|FG001|Overall Study|Lost to Follow-up|0|||
156473002|NCT00799409|564827480|FG002|Overall Study|Lost to Follow-up|0|||
156473003|NCT00799409|564827478|FG000|Overall Study|Optimal Dose Not Achieved|2|||
156473004|NCT00799409|564827479|FG001|Overall Study|Optimal Dose Not Achieved|0|||
156473005|NCT00799409|564827480|FG002|Overall Study|Optimal Dose Not Achieved|0|||
156473006|NCT00799409|564827478|FG000|Overall Study|Failure to follow study protocol)|1|||
156473007|NCT00799409|564827479|FG001|Overall Study|Failure to follow study protocol)|0|||
156473008|NCT00799409|564827480|FG002|Overall Study|Failure to follow study protocol)|0|||
156473009|NCT00799409|564827478|FG000|Overall Study|Did not attend lab school day 1|1|||
156473010|NCT00799409|564827479|FG001|Overall Study|Did not attend lab school day 1|0|||
156473011|NCT00799409|564827480|FG002|Overall Study|Did not attend lab school day 1|0|||
156473012|NCT00799409|564827478|FG000|Overall Study|medication compliance|1|||
156473013|NCT00799409|564827479|FG001|Overall Study|medication compliance|0|||
156473014|NCT00799409|564827480|FG002|Overall Study|medication compliance|0|||
156473015|NCT04921358|564827482|FG000|Overall Study|Withdrawal by Subject|6|||
156473016|NCT04921358|564827483|FG001|Overall Study|Withdrawal by Subject|13|||
156473017|NCT04921358|564827482|FG000|Overall Study|Lost to Follow-up|3|||
156473018|NCT04921358|564827483|FG001|Overall Study|Lost to Follow-up|6|||
156473019|NCT04921358|564827482|FG000|Overall Study|Study Terminated by Sponsor|86|||
156473020|NCT04921358|564827483|FG001|Overall Study|Study Terminated by Sponsor|89|||
156473021|NCT04921358|564827482|FG000|Overall Study|Death|92|||
156473022|NCT04921358|564827483|FG001|Overall Study|Death|82|||
156473023|NCT02278796|564827484|FG000|Overall Study|Death|2|||
156473024|NCT02278796|564827485|FG001|Overall Study|Death|3|||
156342557|NCT00968201|564352734|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
156342558|NCT02619175|564352735|FG000|Overall Study|Withdrawal by Subject|1|||
156342559|NCT02619175|564352736|FG001|Overall Study|Withdrawal by Subject|0|||
156473025|NCT04926857|564827486|FG000|Overall Study|Withdrawal by Subject|40|||
156473026|NCT04926857|564827486|FG000|Overall Study|Death|9|||
156473027|NCT04926857|564827486|FG000|Overall Study|Study product no longer in use|44|||
156473028|NCT04926857|564827486|FG000|Overall Study|Inadequate data to address primary objective|16|||
156473029|NCT02310581|564827487|FG000|Overall Study|Adverse Event|1|||
156857919|NCT02891174|566234678|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
156857920|NCT02891174|566234679|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
156857921|NCT02891174|566234678|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
156857922|NCT02891174|566234679|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
156857923|NCT02891174|566234678|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
156857924|NCT02891174|566234679|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
156857925|NCT02250326|566234687|FG000|Treatment|Death|1|||
156857926|NCT02250326|566234688|FG001|Treatment|Death|13|||
156857927|NCT02250326|566234689|FG002|Treatment|Death|2|||
156857928|NCT02250326|566234687|FG000|Treatment|Adverse Event|8|||
156857929|NCT02250326|566234688|FG001|Treatment|Adverse Event|8|||
156857930|NCT02250326|566234689|FG002|Treatment|Adverse Event|9|||
156857931|NCT02250326|566234687|FG000|Treatment|Progressive Disease|42|||
156857932|NCT02250326|566234688|FG001|Treatment|Progressive Disease|40|||
156857933|NCT02250326|566234689|FG002|Treatment|Progressive Disease|47|||
156857934|NCT02250326|566234687|FG000|Treatment|Symptomatic Deterioration|9|||
156857935|NCT02250326|566234688|FG001|Treatment|Symptomatic Deterioration|4|||
156857936|NCT02250326|566234689|FG002|Treatment|Symptomatic Deterioration|10|||
156857937|NCT02250326|566234687|FG000|Treatment|Withdrawal by Subject|11|||
156857938|NCT02250326|566234688|FG001|Treatment|Withdrawal by Subject|6|||
156857939|NCT02250326|566234689|FG002|Treatment|Withdrawal by Subject|4|||
156857940|NCT02250326|566234687|FG000|Treatment|Other reasons|8|||
156857941|NCT02250326|566234688|FG001|Treatment|Other reasons|7|||
156857942|NCT02250326|566234689|FG002|Treatment|Other reasons|7|||
156857943|NCT02250326|566234687|FG000|Extension Period|Progressive Disease|0|||
156857944|NCT02250326|566234688|FG001|Extension Period|Progressive Disease|2|||
156857945|NCT02250326|566234689|FG002|Extension Period|Progressive Disease|0|||
156857946|NCT02250326|566234687|FG000|Extension Period|Withdrawal by Subject|0|||
156857947|NCT02250326|566234688|FG001|Extension Period|Withdrawal by Subject|1|||
156857948|NCT02250326|566234689|FG002|Extension Period|Withdrawal by Subject|0|||
156857949|NCT02250326|566234687|FG000|Extension Period|Withdrawal by investigator|0|||
156857950|NCT02250326|566234688|FG001|Extension Period|Withdrawal by investigator|1|||
156857951|NCT02250326|566234689|FG002|Extension Period|Withdrawal by investigator|0|||
156857952|NCT01693029|566234690|FG000|Overall Study|Withdrawal by Subject|15|||
156857953|NCT01693029|566234691|FG001|Overall Study|Withdrawal by Subject|22|||
156857954|NCT01693029|566234690|FG000|Overall Study|Kidney transplantation|7|||
156857955|NCT01693029|566234691|FG001|Overall Study|Kidney transplantation|7|||
156857956|NCT01693029|566234690|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
156857957|NCT01693029|566234691|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
156857958|NCT01693029|566234690|FG000|Overall Study|Protocol Violation|6|||
156857959|NCT01693029|566234691|FG001|Overall Study|Protocol Violation|7|||
156857960|NCT01693029|566234690|FG000|Overall Study|Change in dialysis modality|2|||
156857961|NCT01693029|566234691|FG001|Overall Study|Change in dialysis modality|1|||
156857962|NCT01693029|566234690|FG000|Overall Study|Physician Decision|0|||
156857963|NCT01693029|566234691|FG001|Overall Study|Physician Decision|2|||
156857964|NCT01693029|566234690|FG000|Overall Study|Lost to Follow-up|0|||
156857965|NCT01693029|566234691|FG001|Overall Study|Lost to Follow-up|1|||
156857966|NCT01693029|566234690|FG000|Overall Study|Adverse Event|1|||
156857967|NCT01693029|566234691|FG001|Overall Study|Adverse Event|6|||
156857968|NCT01693029|566234690|FG000|Overall Study|Death|5|||
156857969|NCT01693029|566234691|FG001|Overall Study|Death|8|||
156857970|NCT01693029|566234690|FG000|Overall Study|Non-compliance|2|||
156857971|NCT01693029|566234691|FG001|Overall Study|Non-compliance|1|||
156857972|NCT05801991|566234692|FG000|Overall Study|Lost to Follow-up|1|||
156857973|NCT05801991|566234693|FG001|Overall Study|Lost to Follow-up|0|||
156857974|NCT01451723|566234694|FG000|Overall Study|study halted|6|||
156857975|NCT01451723|566234695|FG001|Overall Study|study halted|5|||
156857976|NCT00833040|566234696|FG000|Overall Study|Adverse Event|0|||
156857977|NCT00833040|566234697|FG001|Overall Study|Adverse Event|0|||
156857978|NCT00833040|566234698|FG002|Overall Study|Adverse Event|0|||
156857979|NCT00833040|566234699|FG003|Overall Study|Adverse Event|0|||
156857980|NCT00833040|566234700|FG004|Overall Study|Adverse Event|0|||
156857981|NCT00833040|566234701|FG005|Overall Study|Adverse Event|1|||
156857982|NCT03489863|566234706|FG000|Overall Study|Withdrawal by Subject|0|||
156857983|NCT03489863|566234707|FG001|Overall Study|Withdrawal by Subject|1|||
156857984|NCT05196828|566234710|FG000|Overall Study|Withdrawal by Subject|2|||
156857985|NCT05196828|566234711|FG001|Overall Study|Withdrawal by Subject|0|||
156857986|NCT05196828|566234710|FG000|Overall Study|Lost to Follow-up|0|||
156857987|NCT05196828|566234711|FG001|Overall Study|Lost to Follow-up|4|||
156857988|NCT05196828|566234710|FG000|Overall Study|Adverse Event|1|||
156857989|NCT05196828|566234711|FG001|Overall Study|Adverse Event|0|||
156473030|NCT02310581|564827488|FG001|Overall Study|Adverse Event|1|||
156473031|NCT02310581|564827489|FG002|Overall Study|Adverse Event|1|||
156473032|NCT02310581|564827490|FG003|Overall Study|Adverse Event|0|||
156473033|NCT02310581|564827487|FG000|Overall Study|Withdrawal by Subject|2|||
156473034|NCT02310581|564827488|FG001|Overall Study|Withdrawal by Subject|1|||
156473035|NCT02310581|564827489|FG002|Overall Study|Withdrawal by Subject|0|||
156473036|NCT02310581|564827490|FG003|Overall Study|Withdrawal by Subject|1|||
156473037|NCT00887224|564827491|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
156473038|NCT00887224|564827492|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
156473039|NCT00887224|564827493|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
156473040|NCT00887224|564827491|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
156473041|NCT00887224|564827492|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
156473042|NCT00887224|564827493|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
156473043|NCT00887224|564827491|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
156473044|NCT00887224|564827492|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
156473045|NCT00887224|564827493|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
156473046|NCT00887224|564827491|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
156473047|NCT00887224|564827492|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
156473048|NCT00887224|564827493|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
156473049|NCT00887224|564827491|FG000|Open-label Response (OLR) Phase|Other|1|||
156473050|NCT00887224|564827492|FG001|Open-label Response (OLR) Phase|Other|0|||
156473051|NCT00887224|564827493|FG002|Open-label Response (OLR) Phase|Other|0|||
156473052|NCT00887224|564827491|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
156473053|NCT00887224|564827492|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
156473054|NCT00887224|564827493|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
156473055|NCT00887224|564827491|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
156473056|NCT00887224|564827492|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
156473057|NCT00887224|564827493|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
156473058|NCT00887224|564827491|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
156473059|NCT00887224|564827492|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
156473060|NCT00887224|564827493|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
156473061|NCT00887224|564827491|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
156473062|NCT00887224|564827492|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
156473063|NCT00887224|564827493|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
156473064|NCT00887224|564827491|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
156473065|NCT00887224|564827492|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
156473066|NCT00887224|564827493|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
156473067|NCT00887224|564827491|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
156473068|NCT00887224|564827492|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
156473069|NCT00887224|564827493|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
156473070|NCT00887224|564827491|FG000|Open-label Stability (OLS) Phase|Other|1|||
156857990|NCT02763644|566234712|FG000|Overall Study|Patient/guardian decision|1|||
156857991|NCT02763644|566234713|FG001|Overall Study|Patient/guardian decision|0|||
156857992|NCT02763644|566234712|FG000|Overall Study|Death|1|||
156857993|NCT02763644|566234713|FG001|Overall Study|Death|1|||
156857994|NCT02763644|566234712|FG000|Overall Study|Adverse Event|1|||
156857995|NCT02763644|566234713|FG001|Overall Study|Adverse Event|1|||
156857996|NCT02648204|566234714|FG000|Overall Study|Withdrawal by Subject|12|||
156857997|NCT02648204|566234715|FG001|Overall Study|Withdrawal by Subject|8|||
156857998|NCT02648204|566234716|FG002|Overall Study|Withdrawal by Subject|2|||
156857999|NCT02648204|566234717|FG003|Overall Study|Withdrawal by Subject|6|||
156858000|NCT02648204|566234714|FG000|Overall Study|Lost to Follow-up|5|||
156858001|NCT02648204|566234715|FG001|Overall Study|Lost to Follow-up|8|||
156858002|NCT02648204|566234716|FG002|Overall Study|Lost to Follow-up|4|||
156858003|NCT02648204|566234717|FG003|Overall Study|Lost to Follow-up|6|||
156858004|NCT02648204|566234714|FG000|Overall Study|Missing follow-up information|4|||
156858005|NCT02648204|566234715|FG001|Overall Study|Missing follow-up information|4|||
156858006|NCT02648204|566234716|FG002|Overall Study|Missing follow-up information|4|||
156858007|NCT02648204|566234717|FG003|Overall Study|Missing follow-up information|2|||
156858008|NCT02648204|566234714|FG000|Overall Study|Death|1|||
156858009|NCT02648204|566234715|FG001|Overall Study|Death|1|||
156858010|NCT02648204|566234716|FG002|Overall Study|Death|2|||
156858011|NCT02648204|566234717|FG003|Overall Study|Death|2|||
156858012|NCT02648204|566234714|FG000|Overall Study|Adverse Event|0|||
156858013|NCT02648204|566234715|FG001|Overall Study|Adverse Event|0|||
156858014|NCT02648204|566234716|FG002|Overall Study|Adverse Event|1|||
156858015|NCT02648204|566234717|FG003|Overall Study|Adverse Event|0|||
156858016|NCT02356159|566234718|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858017|NCT02356159|566234719|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858018|NCT02356159|566234720|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858019|NCT02356159|566234721|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858020|NCT02356159|566234722|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858021|NCT02356159|566234723|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
156858022|NCT01582061|566234724|FG000|Overall Study|Lack of Efficacy|3|||
156858023|NCT01582061|566234725|FG001|Overall Study|Lack of Efficacy|23|||
156858024|NCT01582061|566234724|FG000|Overall Study|Adverse Event|12|||
156858025|NCT01582061|566234725|FG001|Overall Study|Adverse Event|8|||
156858026|NCT01582061|566234724|FG000|Overall Study|Withdrawal by Subject|10|||
156858027|NCT01582061|566234725|FG001|Overall Study|Withdrawal by Subject|4|||
156858028|NCT01582061|566234724|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156858029|NCT01582061|566234725|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156858030|NCT01582061|566234724|FG000|Overall Study|Death|0|||
156858031|NCT01582061|566234725|FG001|Overall Study|Death|1|||
156858032|NCT01582061|566234724|FG000|Overall Study|condition no longer requires study drug|1|||
156858033|NCT01582061|566234725|FG001|Overall Study|condition no longer requires study drug|0|||
156858034|NCT01582061|566234724|FG000|Overall Study|Lost to Follow-up|1|||
156858035|NCT01582061|566234725|FG001|Overall Study|Lost to Follow-up|0|||
156858036|NCT00005906|566234726|FG000|Overall Study|Lack of Efficacy|3|||
156858037|NCT00088530|566234727|FG000|Overall Study|Progressive/Relapsed Disease|28|||
156858038|NCT00088530|566234728|FG001|Overall Study|Progressive/Relapsed Disease|39|||
156858039|NCT00088530|566234727|FG000|Overall Study|Adverse Event|15|||
156858040|NCT00088530|566234728|FG001|Overall Study|Adverse Event|9|||
156858041|NCT00088530|566234727|FG000|Overall Study|Withdrawal by Subject|2|||
156473071|NCT00887224|564827492|FG001|Open-label Stability (OLS) Phase|Other|0|||
156473072|NCT00887224|564827493|FG002|Open-label Stability (OLS) Phase|Other|0|||
156342560|NCT02619175|564352735|FG000|Overall Study|foot pain|1|||
156858042|NCT00088530|566234728|FG001|Overall Study|Withdrawal by Subject|5|||
156858043|NCT00088530|566234727|FG000|Overall Study|Lost to Follow-up|2|||
156858044|NCT00088530|566234728|FG001|Overall Study|Lost to Follow-up|0|||
156858045|NCT00088530|566234727|FG000|Overall Study|Physician Decision|2|||
156858046|NCT00088530|566234728|FG001|Overall Study|Physician Decision|0|||
156858047|NCT00088530|566234727|FG000|Overall Study|Sponsor decision|0|||
156858048|NCT00088530|566234728|FG001|Overall Study|Sponsor decision|1|||
156858049|NCT00088530|566234727|FG000|Overall Study|Patient never treated|1|||
156858050|NCT00088530|566234728|FG001|Overall Study|Patient never treated|0|||
156858051|NCT00300755|566234729|FG000|Overall Study|Adverse Event|1|||
156858052|NCT00300755|566234730|FG001|Overall Study|Adverse Event|2|||
156858053|NCT00300755|566234731|FG002|Overall Study|Adverse Event|1|||
156858054|NCT00300755|566234729|FG000|Overall Study|Withdrawal by Subject|0|||
156858055|NCT00300755|566234730|FG001|Overall Study|Withdrawal by Subject|2|||
156858056|NCT00300755|566234731|FG002|Overall Study|Withdrawal by Subject|0|||
156858057|NCT00300755|566234729|FG000|Overall Study|Protocol Violation|0|||
156858058|NCT00300755|566234730|FG001|Overall Study|Protocol Violation|0|||
156858059|NCT00300755|566234731|FG002|Overall Study|Protocol Violation|1|||
156858060|NCT04571944|566234732|FG000|Overall Study|Death|1|||
156858061|NCT04571944|566234733|FG001|Overall Study|Death|0|||
156858062|NCT04571944|566234732|FG000|Overall Study|Withdrawal by Subject|3|||
156858063|NCT04571944|566234733|FG001|Overall Study|Withdrawal by Subject|0|||
156858064|NCT04571944|566234732|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
156858065|NCT04571944|566234733|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
156858066|NCT02163902|566234734|FG000|Overall Study|Subject's Request|3|||
156858067|NCT02163902|566234735|FG001|Overall Study|Subject's Request|4|||
156858068|NCT02163902|566234734|FG000|Overall Study|Lost to Follow-up|6|||
156858069|NCT02163902|566234735|FG001|Overall Study|Lost to Follow-up|7|||
156858070|NCT02163902|566234734|FG000|Overall Study|Administrative Decision|2|||
156858071|NCT02163902|566234735|FG001|Overall Study|Administrative Decision|2|||
156858072|NCT02140047|566234736|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156858073|NCT02140047|566234737|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156858074|NCT02140047|566234738|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156858075|NCT03119259|566234739|FG000|Overall Study|Withdrawn as no longer eligible|1|||
156858076|NCT03119259|566234740|FG001|Overall Study|Withdrawn as no longer eligible|0|||
156858077|NCT03119259|566234739|FG000|Overall Study|Withdrawal by Subject|4|||
156858078|NCT03119259|566234740|FG001|Overall Study|Withdrawal by Subject|2|||
156858079|NCT03119259|566234739|FG000|Overall Study|Lost to Follow-up|0|||
156858080|NCT03119259|566234740|FG001|Overall Study|Lost to Follow-up|1|||
156858081|NCT03915717|566234747|FG000|Overall Study|EchoMark Not Implanted|6|||
156858082|NCT04079296|566234748|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
156858083|NCT04079296|566234749|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
156858084|NCT04079296|566234750|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
156858085|NCT04079296|566234751|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
156858086|NCT04079296|566234752|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
156858087|NCT04079296|566234748|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
156858088|NCT04079296|566234749|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
156858089|NCT04079296|566234750|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
156858090|NCT04079296|566234751|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
156858091|NCT04079296|566234752|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
156858092|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
156858093|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
156858094|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
156858095|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
156858096|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
156858097|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
156858098|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
156858099|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
156858100|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
156858101|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
156858102|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
156858103|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
156858104|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
156858105|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
156858106|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
156858107|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
156858108|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
156858109|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
156858110|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
156858111|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
156858112|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
156858113|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
156858114|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
156858115|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
156858116|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
156858117|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Death|0|||
156858118|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Death|0|||
156858119|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Death|0|||
156858120|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Death|1|||
156858121|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Death|0|||
156858122|NCT00467740|566234753|FG000|Overall Study|Adverse Event|0|||
156858123|NCT00467740|566234754|FG001|Overall Study|Adverse Event|0|||
156858124|NCT00467740|566234755|FG002|Overall Study|Adverse Event|1|||
156858125|NCT00467740|566234756|FG003|Overall Study|Adverse Event|0|||
156858126|NCT00467740|566234757|FG004|Overall Study|Adverse Event|0|||
156858127|NCT00467740|566234753|FG000|Overall Study|Protocol Violation|0|||
156858128|NCT00467740|566234754|FG001|Overall Study|Protocol Violation|0|||
156858129|NCT00467740|566234755|FG002|Overall Study|Protocol Violation|1|||
156858130|NCT00467740|566234756|FG003|Overall Study|Protocol Violation|0|||
156858131|NCT00467740|566234757|FG004|Overall Study|Protocol Violation|0|||
156858132|NCT00467740|566234753|FG000|Overall Study|Lost to Follow-up|0|||
156858133|NCT00467740|566234754|FG001|Overall Study|Lost to Follow-up|1|||
156858134|NCT00467740|566234755|FG002|Overall Study|Lost to Follow-up|0|||
156858135|NCT00467740|566234756|FG003|Overall Study|Lost to Follow-up|0|||
156858136|NCT00467740|566234757|FG004|Overall Study|Lost to Follow-up|0|||
156858137|NCT00467740|566234753|FG000|Overall Study|Withdrawal by Subject|1|||
156858138|NCT00467740|566234754|FG001|Overall Study|Withdrawal by Subject|1|||
156858139|NCT00467740|566234755|FG002|Overall Study|Withdrawal by Subject|0|||
156858140|NCT00467740|566234756|FG003|Overall Study|Withdrawal by Subject|1|||
156858141|NCT00467740|566234757|FG004|Overall Study|Withdrawal by Subject|0|||
156858142|NCT00467740|566234753|FG000|Overall Study|Lack of Efficacy|0|||
156858143|NCT00467740|566234754|FG001|Overall Study|Lack of Efficacy|1|||
156858144|NCT00467740|566234755|FG002|Overall Study|Lack of Efficacy|0|||
156858145|NCT00467740|566234756|FG003|Overall Study|Lack of Efficacy|0|||
156858146|NCT00467740|566234757|FG004|Overall Study|Lack of Efficacy|0|||
156858147|NCT03550378|566234761|FG000|Overall Study|Death|0|||
156858148|NCT03550378|566234762|FG001|Overall Study|Death|1|||
156858149|NCT00626275|566234763|FG000|Part A - Treatment Period 1|Adverse Event|1|||
156858150|NCT00626275|566234764|FG001|Part A - Treatment Period 1|Adverse Event|0|||
156858151|NCT00626275|566234765|FG002|Part A - Treatment Period 1|Adverse Event|0|||
156858152|NCT00626275|566234766|FG003|Part A - Treatment Period 1|Adverse Event|0|||
156858153|NCT00626275|566234767|FG004|Part A - Treatment Period 1|Adverse Event|0|||
156858154|NCT00626275|566234768|FG005|Part A - Treatment Period 1|Adverse Event|0|||
156858155|NCT00626275|566234769|FG006|Part A - Treatment Period 1|Adverse Event|0|||
156858156|NCT00626275|566234770|FG007|Part A - Treatment Period 1|Adverse Event|0|||
156858157|NCT00626275|566234763|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858158|NCT00626275|566234764|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858159|NCT00626275|566234765|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
156858160|NCT00626275|566234766|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858161|NCT00626275|566234767|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858162|NCT00626275|566234768|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858163|NCT00626275|566234769|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858164|NCT00626275|566234770|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858165|NCT00626275|566234763|FG000|Part B|Lost to Follow-up|0|||
156858166|NCT00626275|566234764|FG001|Part B|Lost to Follow-up|0|||
156858167|NCT00626275|566234765|FG002|Part B|Lost to Follow-up|0|||
156858168|NCT00626275|566234766|FG003|Part B|Lost to Follow-up|0|||
156858169|NCT00626275|566234767|FG004|Part B|Lost to Follow-up|0|||
156858170|NCT00626275|566234768|FG005|Part B|Lost to Follow-up|0|||
156858171|NCT00626275|566234769|FG006|Part B|Lost to Follow-up|1|||
156858172|NCT00626275|566234770|FG007|Part B|Lost to Follow-up|0|||
156858173|NCT00626275|566234763|FG000|Part B|Withdrawal by Subject|0|||
156858174|NCT00626275|566234764|FG001|Part B|Withdrawal by Subject|0|||
156858175|NCT00626275|566234765|FG002|Part B|Withdrawal by Subject|0|||
156858176|NCT00626275|566234766|FG003|Part B|Withdrawal by Subject|0|||
156858177|NCT00626275|566234767|FG004|Part B|Withdrawal by Subject|0|||
156858178|NCT00626275|566234768|FG005|Part B|Withdrawal by Subject|0|||
156858179|NCT00626275|566234769|FG006|Part B|Withdrawal by Subject|0|||
156858180|NCT00626275|566234770|FG007|Part B|Withdrawal by Subject|1|||
156858181|NCT01362348|566234771|FG000|Overall Study|Protocol-defined stopping criteria|9|||
156858182|NCT01362348|566234771|FG000|Overall Study|Study closed/terminated|5|||
156858183|NCT00399516|566234772|FG000|Overall Study|Lost to Follow-up|2|||
156858184|NCT00539981|566234775|FG000|Overall Study|Adverse events (AE)|3|||
156858185|NCT00539981|566234776|FG001|Overall Study|Adverse events (AE)|3|||
156858186|NCT00539981|566234775|FG000|Overall Study|Lost to Follow-up|260|||
156858187|NCT00539981|566234776|FG001|Overall Study|Lost to Follow-up|251|||
156858188|NCT00539981|566234775|FG000|Overall Study|Withdrew consent|22|||
156858189|NCT00539981|566234776|FG001|Overall Study|Withdrew consent|14|||
156858190|NCT00539981|566234775|FG000|Overall Study|Death|1|||
156858191|NCT00539981|566234776|FG001|Overall Study|Death|1|||
156858192|NCT00539981|566234775|FG000|Overall Study|Other reason-unspecified|9|||
156858193|NCT00539981|566234776|FG001|Overall Study|Other reason-unspecified|13|||
156858194|NCT02051764|566234779|FG000|Overall Study|Study terminated by sponsor|0|||
156858195|NCT02051764|566234780|FG001|Overall Study|Study terminated by sponsor|7|||
156858196|NCT03289208|566234784|FG000|Overall Study|Adverse Event|1|||
156858197|NCT03289208|566234785|FG001|Overall Study|Adverse Event|0|||
156858198|NCT03289208|566234786|FG002|Overall Study|Adverse Event|0|||
156858199|NCT00647296|566234787|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858200|NCT00647296|566234788|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858201|NCT00647296|566234789|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858202|NCT00647296|566234790|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
156858203|NCT00647296|566234787|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
156858204|NCT00647296|566234788|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
156858205|NCT00647296|566234789|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
156858206|NCT00647296|566234790|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
156858207|NCT00647296|566234787|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
156858208|NCT00647296|566234788|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
156858209|NCT00647296|566234789|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
156858210|NCT00647296|566234790|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
156858211|NCT00647296|566234787|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
156858212|NCT00647296|566234788|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
156858213|NCT00647296|566234789|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
156858214|NCT00647296|566234790|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
156858215|NCT00647296|566234787|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
156858216|NCT00647296|566234788|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
156858217|NCT00647296|566234789|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
156858218|NCT00647296|566234790|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
156858219|NCT00647296|566234787|FG000|Part 2: 4-week Placebo Washout|Death|3|||
156858220|NCT00647296|566234788|FG001|Part 2: 4-week Placebo Washout|Death|0|||
156858221|NCT00647296|566234789|FG002|Part 2: 4-week Placebo Washout|Death|0|||
156858222|NCT00647296|566234790|FG003|Part 2: 4-week Placebo Washout|Death|0|||
156858223|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858224|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
156858225|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858226|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
156858227|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
156858228|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
156858229|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
156858230|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
156858231|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
156858232|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
156858233|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
156858234|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
156858235|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
156858236|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
156858237|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
156858238|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
156473073|NCT00887224|564827491|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
156473074|NCT00887224|564827492|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
156473075|NCT00887224|564827493|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
156473076|NCT00887224|564827491|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
156473077|NCT00887224|564827492|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
156858239|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
156858240|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
156858241|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
156858242|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
156858243|NCT00871871|566234791|FG000|Part I|Adverse Event|0|||
156858244|NCT00871871|566234792|FG001|Part I|Adverse Event|2|||
156858245|NCT00871871|566234793|FG002|Part I|Adverse Event|0|||
156858246|NCT00871871|566234794|FG003|Part I|Adverse Event|0|||
156858247|NCT00871871|566234791|FG000|Part I|Withdrawal by Subject|3|||
156858248|NCT00871871|566234792|FG001|Part I|Withdrawal by Subject|0|||
156858249|NCT00871871|566234793|FG002|Part I|Withdrawal by Subject|0|||
156858250|NCT00871871|566234794|FG003|Part I|Withdrawal by Subject|0|||
156858251|NCT00871871|566234791|FG000|Part I|Laboratory abnormality|0|||
156858252|NCT00871871|566234792|FG001|Part I|Laboratory abnormality|1|||
156858253|NCT00871871|566234793|FG002|Part I|Laboratory abnormality|0|||
156858254|NCT00871871|566234794|FG003|Part I|Laboratory abnormality|0|||
156858255|NCT00871871|566234791|FG000|Part II|Lack of Efficacy|0|||
156858256|NCT00871871|566234792|FG001|Part II|Lack of Efficacy|0|||
156858257|NCT00871871|566234793|FG002|Part II|Lack of Efficacy|1|||
156858258|NCT00871871|566234794|FG003|Part II|Lack of Efficacy|0|||
156858259|NCT00871871|566234791|FG000|Part II|Withdrawal by Subject|0|||
156858260|NCT00871871|566234792|FG001|Part II|Withdrawal by Subject|0|||
156858261|NCT00871871|566234793|FG002|Part II|Withdrawal by Subject|2|||
156858262|NCT00871871|566234794|FG003|Part II|Withdrawal by Subject|1|||
156858263|NCT00871871|566234791|FG000|Part II|Adverse Event|0|||
156858264|NCT00871871|566234792|FG001|Part II|Adverse Event|0|||
156858265|NCT00871871|566234793|FG002|Part II|Adverse Event|1|||
156858266|NCT00871871|566234794|FG003|Part II|Adverse Event|2|||
156858267|NCT00871871|566234791|FG000|Part II|Protocol Violation|0|||
156858268|NCT00871871|566234792|FG001|Part II|Protocol Violation|0|||
156858269|NCT00871871|566234793|FG002|Part II|Protocol Violation|0|||
156858270|NCT00871871|566234794|FG003|Part II|Protocol Violation|1|||
156858271|NCT02354235|566234795|FG000|Overall Study|Adverse Event|2|||
156858272|NCT02354235|566234796|FG001|Overall Study|Adverse Event|2|||
156858273|NCT02354235|566234795|FG000|Overall Study|Physician Decision|0|||
156858274|NCT02354235|566234796|FG001|Overall Study|Physician Decision|1|||
156858275|NCT02354235|566234795|FG000|Overall Study|Withdrawal by Subject|1|||
156858276|NCT02354235|566234796|FG001|Overall Study|Withdrawal by Subject|3|||
156858277|NCT02354235|566234795|FG000|Overall Study|Conflict with the stopping criteria|0|||
156858278|NCT02354235|566234796|FG001|Overall Study|Conflict with the stopping criteria|1|||
156858279|NCT03069352|566234797|FG000|Overall Study|Ongoing|12|||
156858280|NCT03069352|566234798|FG001|Overall Study|Ongoing|40|||
156858281|NCT02621424|566234799|FG000|Overall Study|Withdrawal by Subject|1|||
156858282|NCT02621424|566234800|FG001|Overall Study|Withdrawal by Subject|2|||
156858283|NCT05148234|566234801|FG000|Phase I|Ineligible|0|||
156858284|NCT05148234|566234802|FG001|Phase I|Ineligible|0|||
156858285|NCT05148234|566234803|FG002|Phase I|Ineligible|0|||
156473078|NCT00887224|564827493|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
156473079|NCT00887224|564827491|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
156473080|NCT00887224|564827492|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
156473081|NCT00887224|564827493|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
156473082|NCT00887224|564827491|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
156473083|NCT00887224|564827492|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
156858286|NCT05148234|566234804|FG003|Phase I|Ineligible|0|||
156858287|NCT05148234|566234805|FG004|Phase I|Ineligible|0|||
156858288|NCT05148234|566234806|FG005|Phase I|Ineligible|0|||
156858289|NCT05148234|566234807|FG006|Phase I|Ineligible|0|||
156858290|NCT05148234|566234808|FG007|Phase I|Ineligible|1|||
156858291|NCT05148234|566234801|FG000|Phase I|Company closed the trial.|0|||
156858292|NCT05148234|566234802|FG001|Phase I|Company closed the trial.|1|||
156858293|NCT05148234|566234803|FG002|Phase I|Company closed the trial.|0|||
156858294|NCT05148234|566234804|FG003|Phase I|Company closed the trial.|0|||
156858295|NCT05148234|566234805|FG004|Phase I|Company closed the trial.|0|||
156858296|NCT05148234|566234806|FG005|Phase I|Company closed the trial.|0|||
156858297|NCT05148234|566234807|FG006|Phase I|Company closed the trial.|0|||
156473084|NCT00887224|564827493|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
156473085|NCT00887224|564827491|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
156473086|NCT00887224|564827492|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
156473087|NCT00887224|564827493|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
156342561|NCT02619175|564352736|FG001|Overall Study|foot pain|0|||
156473088|NCT00887224|564827491|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
156542220|NCT05879107|565079287|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
156542221|NCT05879107|565079288|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
156858298|NCT05148234|566234808|FG007|Phase I|Company closed the trial.|0|||
156858299|NCT04750642|566234810|FG000|Overall Study|Adverse Event|1|||
156858300|NCT04750642|566234811|FG001|Overall Study|Adverse Event|0|||
156858301|NCT04750642|566234810|FG000|Overall Study|Withdrawal by Subject|0|||
156858302|NCT04750642|566234811|FG001|Overall Study|Withdrawal by Subject|1|||
156858303|NCT04750642|566234810|FG000|Overall Study|Protocol Violation|0|||
156858304|NCT04750642|566234811|FG001|Overall Study|Protocol Violation|1|||
156858305|NCT01650194|566234813|FG000|Overall Study|Progressive Disease (PD)|35|||
156858306|NCT01650194|566234813|FG000|Overall Study|Withdrawal by Subject|2|||
156858307|NCT01650194|566234813|FG000|Overall Study|Miscellaneous|10|||
156858308|NCT03409796|566236594|FG000|Overall Study|Adverse Event|2|||
156858309|NCT03409796|566236595|FG001|Overall Study|Adverse Event|0|||
156858310|NCT03409796|566236594|FG000|Overall Study|Other|0|||
156858311|NCT03409796|566236595|FG001|Overall Study|Other|1|||
156858312|NCT00740220|566236596|FG000|Overall Study|screen failures (non-COPD patients)|9|||
156858313|NCT00633477|566236597|FG000|Overall Study|Death|1|||
156858314|NCT00633477|566236598|FG001|Overall Study|Death|0|||
156858315|NCT00633477|566236597|FG000|Overall Study|Randomized but not treated|1|||
156858316|NCT00633477|566236598|FG001|Overall Study|Randomized but not treated|0|||
156858317|NCT00770653|566236602|FG000|Overall Study|Adverse Event|13|||
156858318|NCT00770653|566236603|FG001|Overall Study|Adverse Event|5|||
156858319|NCT00770653|566236602|FG000|Overall Study|Protocol Violation|8|||
156858320|NCT00770653|566236603|FG001|Overall Study|Protocol Violation|6|||
156858321|NCT00770653|566236602|FG000|Overall Study|Withdrawal by Subject|4|||
156858322|NCT00770653|566236603|FG001|Overall Study|Withdrawal by Subject|7|||
156858323|NCT00770653|566236602|FG000|Overall Study|Lack of Compliance|1|||
156858324|NCT00770653|566236603|FG001|Overall Study|Lack of Compliance|4|||
156858325|NCT00770653|566236602|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
156858326|NCT00770653|566236603|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
156858327|NCT00770653|566236602|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
156858328|NCT00770653|566236603|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
156858329|NCT00770653|566236602|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
156858330|NCT00770653|566236603|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
156858331|NCT00770653|566236602|FG000|Overall Study|Lost to Follow-up|1|||
156858332|NCT00770653|566236603|FG001|Overall Study|Lost to Follow-up|2|||
156858333|NCT00770653|566236602|FG000|Overall Study|Physician Decision|1|||
156858334|NCT00770653|566236603|FG001|Overall Study|Physician Decision|0|||
156858335|NCT04906499|566236609|FG000|Overall Study|Lack of time|1|||
156858336|NCT00644423|566236612|FG000|Overall Study|Lost to Follow-up|1|||
156858337|NCT00644423|566236613|FG001|Overall Study|Lost to Follow-up|1|||
156858338|NCT01908426|566236614|FG000|Overall Study|Adverse Event|98|||
156858339|NCT01908426|566236615|FG001|Overall Study|Adverse Event|11|||
156858340|NCT01908426|566236614|FG000|Overall Study|Clinical Deterioration|72|||
156858341|NCT01908426|566236615|FG001|Overall Study|Clinical Deterioration|38|||
156858342|NCT01908426|566236614|FG000|Overall Study|Lack of Efficacy|3|||
156858343|NCT01908426|566236615|FG001|Overall Study|Lack of Efficacy|0|||
156858344|NCT01908426|566236614|FG000|Overall Study|Lost to Follow-up|0|||
156858345|NCT01908426|566236615|FG001|Overall Study|Lost to Follow-up|1|||
156858346|NCT01908426|566236614|FG000|Overall Study|Physician Decision|3|||
156858347|NCT01908426|566236615|FG001|Overall Study|Physician Decision|3|||
156858348|NCT01908426|566236614|FG000|Overall Study|Withdrawal by Subject|11|||
156858349|NCT01908426|566236615|FG001|Overall Study|Withdrawal by Subject|6|||
156858350|NCT01908426|566236614|FG000|Overall Study|Progressive Disease|206|||
156858351|NCT01908426|566236615|FG001|Overall Study|Progressive Disease|152|||
156473089|NCT00887224|564827492|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
156473090|NCT00887224|564827493|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
156473091|NCT00887224|564827491|FG000|OL Taper Phase / OL Follow Up|Other|30|||
156473092|NCT00887224|564827492|FG001|OL Taper Phase / OL Follow Up|Other|0|||
156473093|NCT00887224|564827493|FG002|OL Taper Phase / OL Follow Up|Other|0|||
156473094|NCT00887224|564827491|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
156473095|NCT00887224|564827492|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
156473096|NCT00887224|564827493|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
156473097|NCT00887224|564827491|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
156858352|NCT01908426|566236614|FG000|Overall Study|Protocol Violation|1|||
156858353|NCT01908426|566236615|FG001|Overall Study|Protocol Violation|0|||
156858354|NCT01908426|566236614|FG000|Overall Study|No Study Treatment Given|3|||
156858355|NCT01908426|566236615|FG001|Overall Study|No Study Treatment Given|0|||
156858356|NCT03525444|566236616|FG000|Overall Study|Adverse Event|0|||
156858357|NCT03525444|566236617|FG001|Overall Study|Adverse Event|1|||
156858358|NCT03525444|566236616|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156858359|NCT03525444|566236617|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
156858360|NCT03525444|566236616|FG000|Overall Study|Other|0|||
156858361|NCT03525444|566236617|FG001|Overall Study|Other|1|||
156858362|NCT00262860|566236620|FG000|Overall Study|Adverse Event|2|||
156858363|NCT00878501|566236629|FG000|Overall Study|Adverse Event|11|||
156858364|NCT00878501|566236630|FG001|Overall Study|Adverse Event|3|||
156858365|NCT00878501|566236631|FG002|Overall Study|Adverse Event|3|||
156858366|NCT00878501|566236629|FG000|Overall Study|Lack of Efficacy|2|||
156858367|NCT00878501|566236630|FG001|Overall Study|Lack of Efficacy|1|||
156858368|NCT00878501|566236631|FG002|Overall Study|Lack of Efficacy|0|||
156858369|NCT00878501|566236629|FG000|Overall Study|Withdrawal by Subject|2|||
156858370|NCT00878501|566236630|FG001|Overall Study|Withdrawal by Subject|1|||
156858371|NCT00878501|566236631|FG002|Overall Study|Withdrawal by Subject|2|||
156858372|NCT00878501|566236629|FG000|Overall Study|Protocol Violation|0|||
156858373|NCT00878501|566236630|FG001|Overall Study|Protocol Violation|0|||
156858374|NCT00878501|566236631|FG002|Overall Study|Protocol Violation|1|||
156858375|NCT00878501|566236629|FG000|Overall Study|Incorrect enrolment|1|||
156858376|NCT00878501|566236630|FG001|Overall Study|Incorrect enrolment|2|||
156858377|NCT00878501|566236631|FG002|Overall Study|Incorrect enrolment|0|||
156858378|NCT00878501|566236629|FG000|Overall Study|Intake of prohibited concom. medication|0|||
156858379|NCT00878501|566236630|FG001|Overall Study|Intake of prohibited concom. medication|0|||
156858380|NCT00878501|566236631|FG002|Overall Study|Intake of prohibited concom. medication|1|||
156858381|NCT00878501|566236629|FG000|Overall Study|Mis-randomisation of patient|1|||
156858382|NCT00878501|566236630|FG001|Overall Study|Mis-randomisation of patient|0|||
156858383|NCT00878501|566236631|FG002|Overall Study|Mis-randomisation of patient|0|||
156342562|NCT00844831|564354318|FG000|Overall Study|Withdrawal by Subject|4|||
156342563|NCT00844831|564354318|FG000|Overall Study|Adverse Event|1|||
156342564|NCT00844831|564354318|FG000|Overall Study|Physician Decision|1|||
156342565|NCT00540514|564354320|FG000|Overall Study|Still on treatment|3|||
156342566|NCT00540514|564354321|FG001|Overall Study|Still on treatment|0|||
156342567|NCT00540514|564354320|FG000|Overall Study|Unacceptable Toxicity|61|||
156342568|NCT00540514|564354321|FG001|Overall Study|Unacceptable Toxicity|62|||
156473098|NCT00887224|564827492|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
156473099|NCT00887224|564827493|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
156473100|NCT00887224|564827491|FG000|Double-blind (DB) Phase|Adverse Event|0|||
156473101|NCT00887224|564827492|FG001|Double-blind (DB) Phase|Adverse Event|7|||
156473102|NCT00887224|564827493|FG002|Double-blind (DB) Phase|Adverse Event|2|||
156473103|NCT00887224|564827491|FG000|Double-blind (DB) Phase|Failed to return|0|||
156473104|NCT00887224|564827492|FG001|Double-blind (DB) Phase|Failed to return|2|||
156473105|NCT00887224|564827493|FG002|Double-blind (DB) Phase|Failed to return|2|||
156473106|NCT00887224|564827491|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
156473107|NCT00887224|564827492|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
156473108|NCT00887224|564827493|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
156473109|NCT00887224|564827491|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
156473110|NCT00887224|564827492|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
156473111|NCT00887224|564827493|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
156473112|NCT00887224|564827491|FG000|Double-blind (DB) Phase|Other|0|||
156473113|NCT00887224|564827492|FG001|Double-blind (DB) Phase|Other|2|||
156473114|NCT00887224|564827493|FG002|Double-blind (DB) Phase|Other|0|||
156473115|NCT00887224|564827491|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
156473116|NCT00887224|564827492|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
156473117|NCT00887224|564827493|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
156473118|NCT00887224|564827491|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
156473119|NCT00887224|564827492|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
156473120|NCT00887224|564827493|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
156858384|NCT00878501|566236629|FG000|Overall Study|Administrative|0|||
156858385|NCT00878501|566236630|FG001|Overall Study|Administrative|0|||
156858386|NCT00878501|566236631|FG002|Overall Study|Administrative|1|||
156858387|NCT04416204|566236634|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
156858388|NCT04416204|566236635|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
156858389|NCT04416204|566236636|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
156858390|NCT04416204|566236637|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
156858391|NCT01959503|566236641|FG000|Overall Study|Death|2|||
156858392|NCT01959503|566236642|FG001|Overall Study|Death|1|||
156858393|NCT01959503|566236641|FG000|Overall Study|Randomized but not treated|1|||
156858394|NCT01959503|566236642|FG001|Overall Study|Randomized but not treated|1|||
156858395|NCT02173769|566236644|FG000|Overall Study|Protocol Violation|4|||
156858396|NCT03224130|566236645|FG000|Overall Study|consent issue|0|||
156858397|NCT03224130|566236646|FG001|Overall Study|consent issue|1|||
156858398|NCT04124939|566236656|FG000|Overall Study|Lost to Follow-up|1|||
156858399|NCT04124939|566236657|FG001|Overall Study|Lost to Follow-up|3|||
156858400|NCT02210000|566236659|FG000|Overall Study|Study Terminated|11|||
156858401|NCT02210000|566236660|FG001|Overall Study|Study Terminated|12|||
156858402|NCT02210000|566236659|FG000|Overall Study|Withdrawal by Subject|7|||
156858403|NCT02210000|566236660|FG001|Overall Study|Withdrawal by Subject|1|||
156858404|NCT02210000|566236659|FG000|Overall Study|Adverse Event|1|||
156858405|NCT02210000|566236660|FG001|Overall Study|Adverse Event|5|||
156858406|NCT02210000|566236659|FG000|Overall Study|Lost to Follow-up|0|||
156858407|NCT02210000|566236660|FG001|Overall Study|Lost to Follow-up|2|||
156858408|NCT02210000|566236659|FG000|Overall Study|Physician Decision|0|||
156858409|NCT02210000|566236660|FG001|Overall Study|Physician Decision|1|||
156858410|NCT00308139|566236661|FG000|Overall Study|Adverse Event|20|||
156858411|NCT00308139|566236662|FG001|Overall Study|Adverse Event|14|||
156858412|NCT00308139|566236661|FG000|Overall Study|Lost to Follow-up|13|||
156858413|NCT00308139|566236662|FG001|Overall Study|Lost to Follow-up|8|||
156858414|NCT00308139|566236661|FG000|Overall Study|Protocol Violation|3|||
156858415|NCT00308139|566236662|FG001|Overall Study|Protocol Violation|2|||
156858416|NCT00308139|566236661|FG000|Overall Study|Withdrawal of Consent|40|||
156858417|NCT00308139|566236662|FG001|Overall Study|Withdrawal of Consent|42|||
156858418|NCT00308139|566236661|FG000|Overall Study|Investigator Decision|11|||
156858419|NCT00308139|566236662|FG001|Overall Study|Investigator Decision|10|||
156858420|NCT00308139|566236661|FG000|Overall Study|Loss of Glucose Control|5|||
156858421|NCT00308139|566236662|FG001|Overall Study|Loss of Glucose Control|7|||
156858422|NCT00308139|566236661|FG000|Overall Study|Administrative|1|||
156858423|NCT00308139|566236662|FG001|Overall Study|Administrative|4|||
156858424|NCT00308139|566236661|FG000|Overall Study|Other|1|||
156858425|NCT00308139|566236662|FG001|Overall Study|Other|0|||
156858426|NCT01751061|566236668|FG000|Overall Study|Death|1|||
156858427|NCT01751061|566236669|FG001|Overall Study|Death|0|||
156858428|NCT01751061|566236668|FG000|Overall Study|patient death|5|||
156858429|NCT01751061|566236669|FG001|Overall Study|patient death|0|||
156858430|NCT01751061|566236668|FG000|Overall Study|Lost to Follow-up|40|||
156858431|NCT01751061|566236669|FG001|Overall Study|Lost to Follow-up|25|||
156858432|NCT01751061|566236668|FG000|Overall Study|patient regained decisional capacity|4|||
156858433|NCT01751061|566236669|FG001|Overall Study|patient regained decisional capacity|8|||
156858434|NCT01751061|566236668|FG000|Overall Study|Withdrawal by Subject|4|||
156858435|NCT01751061|566236669|FG001|Overall Study|Withdrawal by Subject|1|||
156858436|NCT01751061|566236668|FG000|Overall Study|Physician Decision|2|||
156858437|NCT01751061|566236669|FG001|Overall Study|Physician Decision|0|||
156858438|NCT00768989|566236674|FG000|Prior to Week 24|Withdrawal by Subject|1|||
156858439|NCT00768989|566236675|FG001|Prior to Week 24|Withdrawal by Subject|0|||
156858440|NCT00768989|566236674|FG000|Prior to Week 24|Adverse Event|3|||
156858441|NCT00768989|566236675|FG001|Prior to Week 24|Adverse Event|0|||
156858442|NCT00768989|566236674|FG000|Prior to Week 24|Lost to Follow-up|0|||
156858443|NCT00768989|566236675|FG001|Prior to Week 24|Lost to Follow-up|1|||
156858444|NCT00768989|566236674|FG000|Prior to Week 24|Protocol Violation|0|||
156858445|NCT00768989|566236675|FG001|Prior to Week 24|Protocol Violation|2|||
156858446|NCT00768989|566236674|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
156473121|NCT00887224|564827491|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
156473122|NCT00887224|564827492|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
156473123|NCT00887224|564827493|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
156473124|NCT00887224|564827491|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
156473125|NCT00887224|564827492|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
156473126|NCT00887224|564827493|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
156473127|NCT00887224|564827491|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
156342569|NCT00540514|564354320|FG000|Overall Study|Adverse Event|20|||
156342570|NCT00540514|564354321|FG001|Overall Study|Adverse Event|24|||
156342571|NCT00540514|564354320|FG000|Overall Study|Physician Decision|86|||
156342572|NCT00540514|564354321|FG001|Overall Study|Physician Decision|99|||
156342573|NCT00540514|564354320|FG000|Overall Study|Protocol Deviation|3|||
156342574|NCT00540514|564354321|FG001|Overall Study|Protocol Deviation|4|||
156342575|NCT00540514|564354320|FG000|Overall Study|Lost to Follow-up|1|||
156342576|NCT00540514|564354321|FG001|Overall Study|Lost to Follow-up|1|||
156342577|NCT00540514|564354320|FG000|Overall Study|Withdrawal by Subject|65|||
156342578|NCT00540514|564354321|FG001|Overall Study|Withdrawal by Subject|67|||
156342579|NCT00540514|564354320|FG000|Overall Study|Excluded prior to treatment|7|||
156342580|NCT00540514|564354321|FG001|Overall Study|Excluded prior to treatment|7|||
156342581|NCT00540514|564354320|FG000|Overall Study|Paclitaxel not available|0|||
156342582|NCT00540514|564354321|FG001|Overall Study|Paclitaxel not available|2|||
156342583|NCT03156543|564354322|FG000|Overall Study|Withdrawal by Subject|1|||
156342584|NCT03156543|564354323|FG001|Overall Study|Withdrawal by Subject|0|||
156342585|NCT03291808|564354324|FG000|Overall Study|Lost to Follow-up|6|||
156473128|NCT00887224|564827492|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
156542222|NCT05879107|565079287|FG000|Overall Study|Migrated / moved from the study area|1|||
156858447|NCT00768989|566236675|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
156858448|NCT00768989|566236674|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
156858449|NCT00768989|566236675|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
156858450|NCT00768989|566236674|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
156858451|NCT00768989|566236675|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
156858452|NCT00768989|566236674|FG000|On or After Week 36|Lack of Efficacy|1|||
156858453|NCT00768989|566236675|FG001|On or After Week 36|Lack of Efficacy|0|||
156858454|NCT00768989|566236674|FG000|On or After Week 36|Adverse Event|0|||
156858455|NCT00768989|566236675|FG001|On or After Week 36|Adverse Event|1|||
156858456|NCT00768989|566236674|FG000|On or After Week 36|Lost to Follow-up|1|||
156858457|NCT00768989|566236675|FG001|On or After Week 36|Lost to Follow-up|0|||
156858458|NCT00768989|566236674|FG000|On or After Week 36|Poor Compliance|1|||
156858459|NCT00768989|566236675|FG001|On or After Week 36|Poor Compliance|0|||
156858460|NCT00768989|566236674|FG000|On or After Week 36|Protocol Violation|1|||
156858461|NCT00768989|566236675|FG001|On or After Week 36|Protocol Violation|0|||
156858462|NCT00768989|566236674|FG000|On or After Week 36|Did not attend termination visit|2|||
156858463|NCT00768989|566236675|FG001|On or After Week 36|Did not attend termination visit|0|||
156858464|NCT00768989|566236674|FG000|On or After Week 36|Sponsor Termination|45|||
156858465|NCT00768989|566236675|FG001|On or After Week 36|Sponsor Termination|26|||
156858466|NCT02153086|566236676|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
156858467|NCT02153086|566236676|FG000|Overall Study|Other|2|||
156858468|NCT00791388|566236677|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
156858469|NCT00791388|566236678|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
156858470|NCT00791388|566236679|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
156858471|NCT00791388|566236680|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
156858472|NCT00791388|566236681|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
156858473|NCT00791388|566236677|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
156858474|NCT00791388|566236678|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
156858475|NCT00791388|566236679|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
156858476|NCT00791388|566236680|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
156858477|NCT00791388|566236681|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
156858478|NCT00791388|566236677|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
156858479|NCT00791388|566236678|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
156858480|NCT00791388|566236679|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
156858481|NCT00791388|566236680|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
156858482|NCT00791388|566236681|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
156858483|NCT01194830|566236682|FG000|Overall Study|Adverse Event|3|||
156858484|NCT01194830|566236683|FG001|Overall Study|Adverse Event|2|||
156858485|NCT01194830|566236682|FG000|Overall Study|Protocol Violation|5|||
156858486|NCT01194830|566236683|FG001|Overall Study|Protocol Violation|4|||
156858487|NCT01194830|566236682|FG000|Overall Study|Lost to Follow-up|9|||
156858488|NCT01194830|566236683|FG001|Overall Study|Lost to Follow-up|7|||
156858489|NCT01194830|566236682|FG000|Overall Study|Withdrawal by Subject|2|||
156858490|NCT01194830|566236683|FG001|Overall Study|Withdrawal by Subject|1|||
156858491|NCT01194830|566236682|FG000|Overall Study|Lack of Efficacy|1|||
156858492|NCT01194830|566236683|FG001|Overall Study|Lack of Efficacy|1|||
156858493|NCT01194830|566236682|FG000|Overall Study|Non-compliance issues|4|||
156858494|NCT01194830|566236683|FG001|Overall Study|Non-compliance issues|4|||
156858495|NCT01194830|566236682|FG000|Overall Study|Other Reason|12|||
156858496|NCT01194830|566236683|FG001|Overall Study|Other Reason|8|||
156858497|NCT03115359|566236684|FG000|Overall Study|Withdrawal by Subject|29|||
156858498|NCT03115359|566236685|FG001|Overall Study|Withdrawal by Subject|39|||
156858499|NCT03115359|566236684|FG000|Overall Study|Scheduling conflict|25|||
156858500|NCT03115359|566236685|FG001|Overall Study|Scheduling conflict|23|||
156858501|NCT03115359|566236684|FG000|Overall Study|Personal reasons including health|12|||
156858502|NCT03115359|566236685|FG001|Overall Study|Personal reasons including health|9|||
156858503|NCT03115359|566236684|FG000|Overall Study|Transportation barriers|3|||
156858504|NCT03115359|566236685|FG001|Overall Study|Transportation barriers|0|||
156858505|NCT03115359|566236684|FG000|Overall Study|No longer interested|5|||
156858506|NCT03115359|566236685|FG001|Overall Study|No longer interested|4|||
156858507|NCT03115359|566236684|FG000|Overall Study|No reason provided|45|||
156858508|NCT03115359|566236685|FG001|Overall Study|No reason provided|47|||
156858509|NCT01317472|566236686|FG000|Overall Study|Withdrawal by Subject|1|||
156858510|NCT01317472|566236687|FG001|Overall Study|Withdrawal by Subject|0|||
156858511|NCT01317472|566236686|FG000|Overall Study|Unrelated hospitalization|1|||
156858512|NCT01317472|566236687|FG001|Overall Study|Unrelated hospitalization|0|||
156858513|NCT01815918|566236688|FG000|Overall Study|Patient samples not analyzable|3|||
156858514|NCT01815918|566236689|FG001|Overall Study|Patient samples not analyzable|4|||
156858515|NCT01815918|566236688|FG000|Overall Study|Lack of Efficacy|15|||
156858516|NCT01815918|566236689|FG001|Overall Study|Lack of Efficacy|15|||
156858517|NCT03206216|566236699|FG000|Overall Study|Withdrawal by Subject|0|||
156858518|NCT03206216|566236700|FG001|Overall Study|Withdrawal by Subject|1|||
156858519|NCT02174731|566236701|FG000|Overall Study|Participant decision|67|||
156473129|NCT00887224|564827493|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
156473130|NCT00887224|564827491|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
156473131|NCT00887224|564827492|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
156473132|NCT00887224|564827493|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
156473133|NCT00887224|564827491|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
156473134|NCT00887224|564827492|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
156473135|NCT00887224|564827493|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
156473136|NCT00887224|564827491|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
156473137|NCT00887224|564827492|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
156473138|NCT00887224|564827493|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
156473139|NCT00887224|564827491|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
156473140|NCT00887224|564827492|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
156473141|NCT00887224|564827493|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
156473142|NCT03883828|564827494|FG000|Overall Study|Did not start radiotherapy|1|||
156473143|NCT03883828|564827495|FG001|Overall Study|Did not start radiotherapy|2|||
156473144|NCT04938453|564827496|FG000|Washout Period 1|Adverse Event|1|||
156473145|NCT04938453|564827497|FG001|Washout Period 1|Adverse Event|0|||
156473146|NCT04938453|564827496|FG000|Washout Period 1|Physician Decision|0|||
156473147|NCT04938453|564827497|FG001|Washout Period 1|Physician Decision|1|||
156473148|NCT01428583|564827499|FG000|Overall Study|Adverse Event|75|||
156473149|NCT01428583|564827499|FG000|Overall Study|Withdrawal by Subject|51|||
156858520|NCT02174731|566236702|FG001|Overall Study|Participant decision|64|||
156858521|NCT02174731|566236701|FG000|Overall Study|Incorrect enrolment before randomization|0|||
156858522|NCT02174731|566236702|FG001|Overall Study|Incorrect enrolment before randomization|1|||
156858523|NCT02174731|566236701|FG000|Overall Study|Missing|2|||
156858524|NCT02174731|566236702|FG001|Overall Study|Missing|0|||
156858525|NCT00325897|566236703|FG000|Overall Study|Lost to Follow-up|12|||
156858526|NCT00325897|566236704|FG001|Overall Study|Lost to Follow-up|13|||
156858527|NCT02903160|566236705|FG000|Overall Study|Adverse Event|2|||
156858528|NCT02903160|566236705|FG000|Overall Study|Death|1|||
156858529|NCT02903160|566236705|FG000|Overall Study|Lost to Follow-up|2|||
156858530|NCT02903160|566236705|FG000|Overall Study|Withdrawal by Subject|1|||
156858531|NCT02903160|566236705|FG000|Overall Study|Medical Insurance Barriers|1|||
156858532|NCT01664910|566236708|FG000|Overall Study|Adverse Event|0|||
156858533|NCT01664910|566236709|FG001|Overall Study|Adverse Event|0|||
156858534|NCT01664910|566236710|FG002|Overall Study|Adverse Event|1|||
156858535|NCT02240485|566236711|FG000|3 Months Post-admission|Lost to Follow-up|1|||
156858536|NCT02240485|566236712|FG001|3 Months Post-admission|Lost to Follow-up|5|||
156858537|NCT02240485|566236711|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
156858538|NCT02240485|566236712|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
156858539|NCT02240485|566236711|FG000|9 Months Post-admission|Lost to Follow-up|3|||
156858540|NCT02240485|566236712|FG001|9 Months Post-admission|Lost to Follow-up|1|||
156858541|NCT02240485|566236711|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
156858542|NCT02240485|566236712|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
156858543|NCT02240485|566236711|FG000|18 Months Post-admission|Lost to Follow-up|1|||
156858544|NCT02240485|566236712|FG001|18 Months Post-admission|Lost to Follow-up|1|||
156858545|NCT02240485|566236711|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
156858546|NCT02240485|566236712|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
156858547|NCT02525471|566236713|FG000|Overall Study|Screen Failure|6|||
156858548|NCT02525471|566236713|FG000|Overall Study|Withdrawal by Subject|4|||
156858549|NCT02525471|566236713|FG000|Overall Study|Death|1|||
156858550|NCT00867165|566236714|FG000|Overall Study|Adverse Event|3|||
156858551|NCT00867165|566236715|FG001|Overall Study|Adverse Event|0|||
156858552|NCT00867165|566236714|FG000|Overall Study|Withdrawal by Subject|1|||
156858553|NCT00867165|566236715|FG001|Overall Study|Withdrawal by Subject|0|||
156858554|NCT01759420|566236716|FG000|Overall Study|Screen failure|5|||
156858555|NCT01759420|566236716|FG000|Overall Study|Inaccurate EKG machine readings|1|||
156342586|NCT03291808|564354324|FG000|Overall Study|Research burden|4|||
156342587|NCT00638378|564354325|FG000|Overall Study|Death|2|||
156342588|NCT00638378|564354325|FG000|Overall Study|Adverse Event|1|||
156342589|NCT00638378|564354325|FG000|Overall Study|Disease progression|15|||
156342590|NCT00638378|564354325|FG000|Overall Study|Physician Decision|4|||
156342591|NCT02674529|564354326|FG000|Overall Study|Lost to Follow-up|1|||
156342592|NCT02674529|564354327|FG001|Overall Study|Lost to Follow-up|2|||
156342593|NCT02674529|564354326|FG000|Overall Study|Withdrawal by Subject|2|||
156342594|NCT02674529|564354327|FG001|Overall Study|Withdrawal by Subject|1|||
156342595|NCT02674529|564354326|FG000|Overall Study|Physician Decision|0|||
156342596|NCT02674529|564354327|FG001|Overall Study|Physician Decision|1|||
156342597|NCT02674529|564354326|FG000|Overall Study|Protocol Violation|0|||
156342598|NCT02674529|564354327|FG001|Overall Study|Protocol Violation|1|||
156342599|NCT02891850|564354328|FG000|Overall Study|Adverse Event|3|||
156342600|NCT02891850|564354329|FG001|Overall Study|Adverse Event|0|||
156342601|NCT02891850|564354328|FG000|Overall Study|Death|0|||
156342602|NCT02891850|564354329|FG001|Overall Study|Death|4|||
156342603|NCT02891850|564354328|FG000|Overall Study|Physician Decision|1|||
156342604|NCT02891850|564354329|FG001|Overall Study|Physician Decision|0|||
156342605|NCT02891850|564354328|FG000|Overall Study|Pregnancy|1|||
156342606|NCT02891850|564354329|FG001|Overall Study|Pregnancy|0|||
156342607|NCT02891850|564354328|FG000|Overall Study|Withdrawal by Subject|2|||
156342608|NCT02891850|564354329|FG001|Overall Study|Withdrawal by Subject|3|||
156342609|NCT01892293|564354332|FG000|Overall Study|Apheresed but not treated|4|||
156342610|NCT03602482|564354337|FG000|Overall Study|Withdrawal by Subject|6|||
156342611|NCT03602482|564354338|FG001|Overall Study|Withdrawal by Subject|7|||
156342612|NCT03602482|564354339|FG002|Overall Study|Withdrawal by Subject|0|||
156342613|NCT03602482|564354340|FG003|Overall Study|Withdrawal by Subject|0|||
156342614|NCT02601469|564354343|FG000|Overall Study|Enrolled in Error|1|||
156342615|NCT02601469|564354344|FG001|Overall Study|Enrolled in Error|0|||
156342616|NCT03808545|564354345|FG000|Overall Study|Withdrawal by Subject|1|||
156342617|NCT03808545|564354346|FG001|Overall Study|Withdrawal by Subject|1|||
156342618|NCT02161731|564354347|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
156342619|NCT02161731|564354348|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
156342620|NCT02161731|564354347|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
156342621|NCT02161731|564354348|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
156342622|NCT00618072|564354349|FG000|Overall Study|Lost to Follow-up|2|||
156342623|NCT00618072|564354350|FG001|Overall Study|Lost to Follow-up|0|||
156342624|NCT00618072|564354351|FG002|Overall Study|Lost to Follow-up|3|||
156342625|NCT00618072|564354349|FG000|Overall Study|Physician Decision|0|||
156342626|NCT00618072|564354350|FG001|Overall Study|Physician Decision|1|||
156342627|NCT00618072|564354351|FG002|Overall Study|Physician Decision|1|||
156473150|NCT01428583|564827499|FG000|Overall Study|Lack of Efficacy|37|||
156473151|NCT01428583|564827499|FG000|Overall Study|Lost to Follow-up|17|||
156858556|NCT01129622|566236719|FG000|Overall Study|Withdrawal by Subject|2|||
156858557|NCT00591006|566236720|FG000|Overall Study|Withdrawal by Subject|0|||
156858558|NCT00591006|566236721|FG001|Overall Study|Withdrawal by Subject|0|||
156858559|NCT00591006|566236722|FG002|Overall Study|Withdrawal by Subject|0|||
156858560|NCT00591006|566236723|FG003|Overall Study|Withdrawal by Subject|0|||
156858561|NCT00591006|566236724|FG004|Overall Study|Withdrawal by Subject|0|||
156858562|NCT00591006|566236725|FG005|Overall Study|Withdrawal by Subject|0|||
156858563|NCT00591006|566236726|FG006|Overall Study|Withdrawal by Subject|0|||
156858564|NCT00591006|566236727|FG007|Overall Study|Withdrawal by Subject|0|||
156858565|NCT00591006|566236728|FG008|Overall Study|Withdrawal by Subject|0|||
156858566|NCT00591006|566236729|FG009|Overall Study|Withdrawal by Subject|0|||
156542223|NCT05879107|565079288|FG001|Overall Study|Migrated / moved from the study area|1|||
156542224|NCT05879107|565079287|FG000|Overall Study|Lost to Follow-up|8|||
156542225|NCT05879107|565079288|FG001|Overall Study|Lost to Follow-up|13|||
156473152|NCT01428583|564827499|FG000|Overall Study|Death|1|||
156473153|NCT01428583|564827499|FG000|Overall Study|Pregnancy|1|||
156473154|NCT01428583|564827499|FG000|Overall Study|Protocol Violation|1|||
156473155|NCT01428583|564827499|FG000|Overall Study|Physician Decision|12|||
156473156|NCT01428583|564827499|FG000|Overall Study|Non-compliant|25|||
156473157|NCT01428583|564827499|FG000|Overall Study|Confirmed positive urine drug test|8|||
156473158|NCT01428583|564827499|FG000|Overall Study|Sponsor's request|3|||
156473159|NCT01428583|564827499|FG000|Overall Study|Other|6|||
156473160|NCT00878189|564827503|FG000|Overall Study|Death|0|||
156473161|NCT00878189|564827504|FG001|Overall Study|Death|1|||
156473162|NCT00878189|564827505|FG002|Overall Study|Death|0|||
156473163|NCT00878189|564827506|FG003|Overall Study|Death|1|||
156473164|NCT00878189|564827507|FG004|Overall Study|Death|0|||
156473165|NCT00878189|564827508|FG005|Overall Study|Death|0|||
156473166|NCT00878189|564827509|FG006|Overall Study|Death|0|||
156473167|NCT00878189|564827510|FG007|Overall Study|Death|0|||
156473168|NCT00878189|564827511|FG008|Overall Study|Death|1|||
156473169|NCT00878189|564827503|FG000|Overall Study|Participant Refused to Follow-up|0|||
156473170|NCT00878189|564827504|FG001|Overall Study|Participant Refused to Follow-up|0|||
156473171|NCT00878189|564827505|FG002|Overall Study|Participant Refused to Follow-up|0|||
156473172|NCT00878189|564827506|FG003|Overall Study|Participant Refused to Follow-up|0|||
156473173|NCT00878189|564827507|FG004|Overall Study|Participant Refused to Follow-up|0|||
156473174|NCT00878189|564827508|FG005|Overall Study|Participant Refused to Follow-up|4|||
156473175|NCT00878189|564827509|FG006|Overall Study|Participant Refused to Follow-up|0|||
156473176|NCT00878189|564827510|FG007|Overall Study|Participant Refused to Follow-up|0|||
156473177|NCT00878189|564827511|FG008|Overall Study|Participant Refused to Follow-up|0|||
156473178|NCT00878189|564827503|FG000|Overall Study|Other|3|||
156473179|NCT00878189|564827504|FG001|Overall Study|Other|2|||
156473180|NCT00878189|564827505|FG002|Overall Study|Other|4|||
156473181|NCT00878189|564827506|FG003|Overall Study|Other|7|||
156473182|NCT00878189|564827507|FG004|Overall Study|Other|4|||
156542226|NCT05879107|565079287|FG000|Overall Study|Death|0|||
156473183|NCT00878189|564827508|FG005|Overall Study|Other|18|||
156473184|NCT00878189|564827509|FG006|Overall Study|Other|15|||
156473185|NCT00878189|564827510|FG007|Overall Study|Other|3|||
156473186|NCT00878189|564827511|FG008|Overall Study|Other|4|||
156473187|NCT00878189|564827503|FG000|Overall Study|Lost to Follow-up|0|||
156473188|NCT00878189|564827504|FG001|Overall Study|Lost to Follow-up|0|||
156473189|NCT00878189|564827505|FG002|Overall Study|Lost to Follow-up|0|||
156473190|NCT00878189|564827506|FG003|Overall Study|Lost to Follow-up|0|||
156473191|NCT00878189|564827507|FG004|Overall Study|Lost to Follow-up|0|||
156473192|NCT00878189|564827508|FG005|Overall Study|Lost to Follow-up|1|||
156473193|NCT00878189|564827509|FG006|Overall Study|Lost to Follow-up|1|||
156473194|NCT00878189|564827510|FG007|Overall Study|Lost to Follow-up|0|||
156473195|NCT00878189|564827511|FG008|Overall Study|Lost to Follow-up|0|||
156473196|NCT00878189|564827503|FG000|Overall Study|Objection Progression or Relapse|0|||
156473197|NCT00878189|564827504|FG001|Overall Study|Objection Progression or Relapse|0|||
156473198|NCT00878189|564827505|FG002|Overall Study|Objection Progression or Relapse|0|||
156473199|NCT00878189|564827506|FG003|Overall Study|Objection Progression or Relapse|0|||
156473200|NCT00878189|564827507|FG004|Overall Study|Objection Progression or Relapse|0|||
156473201|NCT00878189|564827508|FG005|Overall Study|Objection Progression or Relapse|0|||
156473202|NCT00878189|564827509|FG006|Overall Study|Objection Progression or Relapse|0|||
156473203|NCT00878189|564827510|FG007|Overall Study|Objection Progression or Relapse|0|||
156542227|NCT05879107|565079288|FG001|Overall Study|Death|2|||
156542228|NCT05879107|565079287|FG000|Overall Study|Other|0|||
156542229|NCT05879107|565079288|FG001|Overall Study|Other|3|||
156542230|NCT03901079|565079289|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
156858567|NCT00591006|566236730|FG010|Overall Study|Withdrawal by Subject|0|||
156858568|NCT00591006|566236731|FG011|Overall Study|Withdrawal by Subject|0|||
156542231|NCT00841568|565079290|FG000|Overall Study|Adverse Event|1|||
156858569|NCT00591006|566236732|FG012|Overall Study|Withdrawal by Subject|0|||
156858570|NCT00591006|566236733|FG013|Overall Study|Withdrawal by Subject|0|||
156858571|NCT00591006|566236734|FG014|Overall Study|Withdrawal by Subject|0|||
156858572|NCT00591006|566236735|FG015|Overall Study|Withdrawal by Subject|1|||
156858573|NCT00591006|566236736|FG016|Overall Study|Withdrawal by Subject|0|||
156858574|NCT00591006|566236737|FG017|Overall Study|Withdrawal by Subject|0|||
156858575|NCT00591006|566236738|FG018|Overall Study|Withdrawal by Subject|0|||
156858576|NCT00591006|566236739|FG019|Overall Study|Withdrawal by Subject|0|||
156858577|NCT00591006|566236740|FG020|Overall Study|Withdrawal by Subject|0|||
156858578|NCT00591006|566236741|FG021|Overall Study|Withdrawal by Subject|0|||
156858579|NCT00591006|566236742|FG022|Overall Study|Withdrawal by Subject|0|||
156858580|NCT00591006|566236743|FG023|Overall Study|Withdrawal by Subject|1|||
156858581|NCT00591006|566236720|FG000|Overall Study|Adverse Event|0|||
156858582|NCT00591006|566236721|FG001|Overall Study|Adverse Event|0|||
156858583|NCT00591006|566236722|FG002|Overall Study|Adverse Event|0|||
156858584|NCT00591006|566236723|FG003|Overall Study|Adverse Event|0|||
156858585|NCT00591006|566236724|FG004|Overall Study|Adverse Event|0|||
156858586|NCT00591006|566236725|FG005|Overall Study|Adverse Event|0|||
156858587|NCT00591006|566236726|FG006|Overall Study|Adverse Event|0|||
156473204|NCT00878189|564827511|FG008|Overall Study|Objection Progression or Relapse|3|||
156542232|NCT00841568|565079290|FG000|Overall Study|Death|1|||
156858588|NCT00591006|566236727|FG007|Overall Study|Adverse Event|0|||
156858589|NCT00591006|566236728|FG008|Overall Study|Adverse Event|0|||
156858590|NCT00591006|566236729|FG009|Overall Study|Adverse Event|0|||
156858591|NCT00591006|566236730|FG010|Overall Study|Adverse Event|0|||
156473205|NCT01124045|564827512|FG000|Overall Study|Lost to Follow-up|0|||
156473206|NCT01124045|564827513|FG001|Overall Study|Lost to Follow-up|1|||
156473207|NCT01124045|564827512|FG000|Overall Study|Physician Decision|0|||
156473208|NCT01124045|564827513|FG001|Overall Study|Physician Decision|2|||
156473209|NCT05553366|564827520|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
156473210|NCT05553366|564827521|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
156473211|NCT05553366|564827522|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
156473212|NCT05553366|564827520|FG000|Overall Study|Lost to Follow-up|3|||
156473213|NCT05553366|564827521|FG001|Overall Study|Lost to Follow-up|3|||
156473214|NCT05553366|564827522|FG002|Overall Study|Lost to Follow-up|3|||
156473215|NCT05553366|564827520|FG000|Overall Study|Other non-compliance|1|||
156473216|NCT05553366|564827521|FG001|Overall Study|Other non-compliance|1|||
156473217|NCT05553366|564827522|FG002|Overall Study|Other non-compliance|0|||
156473218|NCT05553366|564827520|FG000|Overall Study|Randomized but not dosed|0|||
156473219|NCT05553366|564827521|FG001|Overall Study|Randomized but not dosed|0|||
156473220|NCT05553366|564827522|FG002|Overall Study|Randomized but not dosed|2|||
156473221|NCT00249769|564827523|FG000|Overall Study|Withdrawal by Subject|1|||
156473222|NCT00249769|564827524|FG001|Overall Study|Withdrawal by Subject|10|||
156473223|NCT00249769|564827525|FG002|Overall Study|Withdrawal by Subject|6|||
156473224|NCT00249769|564827523|FG000|Overall Study|Migration from Study Area|1|||
156473225|NCT00249769|564827524|FG001|Overall Study|Migration from Study Area|3|||
156473226|NCT00249769|564827525|FG002|Overall Study|Migration from Study Area|14|||
156542233|NCT00841568|565079290|FG000|Overall Study|Withdrawal by Subject|2|||
156858592|NCT00591006|566236731|FG011|Overall Study|Adverse Event|0|||
156858593|NCT00591006|566236732|FG012|Overall Study|Adverse Event|0|||
156858594|NCT00591006|566236733|FG013|Overall Study|Adverse Event|0|||
156858595|NCT00591006|566236734|FG014|Overall Study|Adverse Event|0|||
156858596|NCT00591006|566236735|FG015|Overall Study|Adverse Event|0|||
156858597|NCT00591006|566236736|FG016|Overall Study|Adverse Event|0|||
156858598|NCT00591006|566236737|FG017|Overall Study|Adverse Event|0|||
156858599|NCT00591006|566236738|FG018|Overall Study|Adverse Event|0|||
156858600|NCT00591006|566236739|FG019|Overall Study|Adverse Event|0|||
156858601|NCT00591006|566236740|FG020|Overall Study|Adverse Event|0|||
156858602|NCT00591006|566236741|FG021|Overall Study|Adverse Event|0|||
156858603|NCT00591006|566236742|FG022|Overall Study|Adverse Event|1|||
156858604|NCT00591006|566236743|FG023|Overall Study|Adverse Event|0|||
156858605|NCT03071263|566236744|FG000|Overall Study|Adverse Event|1|||
156858606|NCT03071263|566236745|FG001|Overall Study|Adverse Event|3|||
156858607|NCT03071263|566236744|FG000|Overall Study|Withdrawal by Subject|1|||
156858608|NCT03071263|566236745|FG001|Overall Study|Withdrawal by Subject|3|||
156858609|NCT03071263|566236744|FG000|Overall Study|Physician Decision|1|||
156858610|NCT03071263|566236745|FG001|Overall Study|Physician Decision|0|||
156858611|NCT03071263|566236744|FG000|Overall Study|Participant moved to another city|0|||
156858612|NCT03071263|566236745|FG001|Overall Study|Participant moved to another city|1|||
156858613|NCT04158583|566236752|FG000|Overall Study|Withdrawal by Subject|1|||
156858614|NCT04158583|566236753|FG001|Overall Study|Withdrawal by Subject|1|||
156858615|NCT04158583|566236754|FG002|Overall Study|Withdrawal by Subject|0|||
156858616|NCT04158583|566236755|FG003|Overall Study|Withdrawal by Subject|0|||
156858617|NCT04158583|566236756|FG004|Overall Study|Withdrawal by Subject|1|||
156858618|NCT04158583|566236757|FG005|Overall Study|Withdrawal by Subject|0|||
156858619|NCT04158583|566236758|FG006|Overall Study|Withdrawal by Subject|0|||
156858620|NCT04158583|566236759|FG007|Overall Study|Withdrawal by Subject|0|||
156858621|NCT04158583|566236760|FG008|Overall Study|Withdrawal by Subject|2|||
156858622|NCT04158583|566236761|FG009|Overall Study|Withdrawal by Subject|0|||
156858623|NCT04158583|566236752|FG000|Overall Study|Study Terminated by Sponsor|0|||
156858624|NCT04158583|566236753|FG001|Overall Study|Study Terminated by Sponsor|0|||
156858625|NCT04158583|566236754|FG002|Overall Study|Study Terminated by Sponsor|0|||
156858626|NCT04158583|566236755|FG003|Overall Study|Study Terminated by Sponsor|1|||
156858627|NCT04158583|566236756|FG004|Overall Study|Study Terminated by Sponsor|0|||
156858628|NCT04158583|566236757|FG005|Overall Study|Study Terminated by Sponsor|0|||
156858629|NCT04158583|566236758|FG006|Overall Study|Study Terminated by Sponsor|0|||
156858630|NCT04158583|566236759|FG007|Overall Study|Study Terminated by Sponsor|0|||
156858631|NCT04158583|566236760|FG008|Overall Study|Study Terminated by Sponsor|0|||
156858632|NCT04158583|566236761|FG009|Overall Study|Study Terminated by Sponsor|0|||
156858633|NCT04158583|566236752|FG000|Overall Study|Progressive Disease|1|||
156858634|NCT04158583|566236753|FG001|Overall Study|Progressive Disease|0|||
156858635|NCT04158583|566236754|FG002|Overall Study|Progressive Disease|3|||
156473227|NCT00249769|564827523|FG000|Overall Study|Miscellaneous|0|||
156473228|NCT00249769|564827524|FG001|Overall Study|Miscellaneous|2|||
156473229|NCT00249769|564827525|FG002|Overall Study|Miscellaneous|2|||
156342628|NCT02468414|564354352|FG000|Overall Study|Early Study Termination by Sponsor|1|||
156473230|NCT00249769|564827523|FG000|Overall Study|Adverse Event|0|||
156342629|NCT02468414|564354353|FG001|Overall Study|Early Study Termination by Sponsor|0|||
156342630|NCT02468414|564354352|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
156473231|NCT00249769|564827524|FG001|Overall Study|Adverse Event|0|||
156473232|NCT00249769|564827525|FG002|Overall Study|Adverse Event|1|||
156473233|NCT00249769|564827523|FG000|Overall Study|Physician Decision|0|||
156473234|NCT00249769|564827524|FG001|Overall Study|Physician Decision|0|||
156342631|NCT02468414|564354353|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
156473235|NCT00249769|564827525|FG002|Overall Study|Physician Decision|2|||
156473236|NCT00249769|564827523|FG000|Overall Study|Lost to Follow-up|0|||
156473237|NCT00249769|564827524|FG001|Overall Study|Lost to Follow-up|0|||
156473238|NCT00249769|564827525|FG002|Overall Study|Lost to Follow-up|3|||
156473239|NCT02022657|564827530|FG000|Overall Study|Withdrawal by Subject|2|||
156473240|NCT02022657|564827531|FG001|Overall Study|Withdrawal by Subject|0|||
156473241|NCT02022657|564827532|FG002|Overall Study|Withdrawal by Subject|1|||
156473242|NCT02022657|564827533|FG003|Overall Study|Withdrawal by Subject|0|||
156473243|NCT02022657|564827534|FG004|Overall Study|Withdrawal by Subject|0|||
156473244|NCT02022657|564827535|FG005|Overall Study|Withdrawal by Subject|0|||
156473245|NCT02022657|564827530|FG000|Overall Study|Physician Decision|0|||
156542234|NCT00841568|565079290|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
156542235|NCT03002155|565079291|FG000|Overall Study|Lost to Follow-up|1|||
156542236|NCT03002155|565079292|FG001|Overall Study|Lost to Follow-up|2|||
156342632|NCT02468414|564354352|FG000|Overall Study|Screen Failure|1|||
156473246|NCT02022657|564827531|FG001|Overall Study|Physician Decision|0|||
156473247|NCT02022657|564827532|FG002|Overall Study|Physician Decision|0|||
156473248|NCT02022657|564827533|FG003|Overall Study|Physician Decision|0|||
156473249|NCT02022657|564827534|FG004|Overall Study|Physician Decision|0|||
156473250|NCT02022657|564827535|FG005|Overall Study|Physician Decision|1|||
156473251|NCT03274076|564827536|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
156473252|NCT03274076|564827537|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
156473253|NCT03274076|564827538|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
156473254|NCT03274076|564827539|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
156473255|NCT03274076|564827536|FG000|24 Weeks Open Label|Adverse Event|0|||
156473256|NCT03274076|564827537|FG001|24 Weeks Open Label|Adverse Event|0|||
156473257|NCT03274076|564827538|FG002|24 Weeks Open Label|Adverse Event|2|||
156473258|NCT03274076|564827539|FG003|24 Weeks Open Label|Adverse Event|0|||
156473259|NCT03274076|564827536|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
156473260|NCT03274076|564827537|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
156473261|NCT03274076|564827538|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
156473262|NCT03274076|564827539|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
156342633|NCT02468414|564354353|FG001|Overall Study|Screen Failure|0|||
156542237|NCT03002155|565079291|FG000|Overall Study|Withdrawal by Subject|1|||
156342634|NCT02151591|564354355|FG000|Overall Study|Lost to Follow-up|6|||
156342635|NCT02151591|564354356|FG001|Overall Study|Lost to Follow-up|3|||
156473263|NCT01530334|564827540|FG000|Overall Study|Adverse Event|3|||
156342636|NCT03633695|564354361|FG000|Overall Study|Lost to Follow-up|4|||
156473264|NCT01530334|564827540|FG000|Overall Study|unknown reason|1|||
156473265|NCT01530334|564827540|FG000|Overall Study|Progressive disease|47|||
156473266|NCT01629589|564827541|FG000|Overall Study|Protocol Violation|4|||
156473267|NCT01629589|564827542|FG001|Overall Study|Protocol Violation|2|||
156473268|NCT01629589|564827541|FG000|Overall Study|Lost to Follow-up|2|||
156473269|NCT01629589|564827542|FG001|Overall Study|Lost to Follow-up|1|||
156473270|NCT01629589|564827541|FG000|Overall Study|Withdrawal by Subject|2|||
156473271|NCT01629589|564827542|FG001|Overall Study|Withdrawal by Subject|3|||
156473272|NCT01629589|564827541|FG000|Overall Study|Did not receive study vaccine|0|||
156473273|NCT01629589|564827542|FG001|Overall Study|Did not receive study vaccine|1|||
156473274|NCT02079649|564827544|FG000|Overall Study|Lost to Follow-up|0|||
156473275|NCT02079649|564827545|FG001|Overall Study|Lost to Follow-up|0|||
156473276|NCT02079649|564827546|FG002|Overall Study|Lost to Follow-up|0|||
156473277|NCT02079649|564827547|FG003|Overall Study|Lost to Follow-up|1|||
156473278|NCT02079649|564827544|FG000|Overall Study|Withdrawal by Subject|0|||
156473279|NCT02079649|564827545|FG001|Overall Study|Withdrawal by Subject|0|||
156473280|NCT02079649|564827546|FG002|Overall Study|Withdrawal by Subject|0|||
156473281|NCT02079649|564827547|FG003|Overall Study|Withdrawal by Subject|1|||
156473282|NCT02079649|564827544|FG000|Overall Study|Randomization error (prior to treatment)|1|||
156858636|NCT04158583|566236755|FG003|Overall Study|Progressive Disease|5|||
156858637|NCT04158583|566236756|FG004|Overall Study|Progressive Disease|0|||
156858638|NCT04158583|566236757|FG005|Overall Study|Progressive Disease|1|||
156858639|NCT04158583|566236758|FG006|Overall Study|Progressive Disease|6|||
156858640|NCT04158583|566236759|FG007|Overall Study|Progressive Disease|2|||
156858641|NCT04158583|566236760|FG008|Overall Study|Progressive Disease|1|||
156858642|NCT04158583|566236761|FG009|Overall Study|Progressive Disease|2|||
156858643|NCT04158583|566236752|FG000|Overall Study|Lost to Follow-up|0|||
156858644|NCT04158583|566236753|FG001|Overall Study|Lost to Follow-up|0|||
156858645|NCT04158583|566236754|FG002|Overall Study|Lost to Follow-up|1|||
156858646|NCT04158583|566236755|FG003|Overall Study|Lost to Follow-up|1|||
156858647|NCT04158583|566236756|FG004|Overall Study|Lost to Follow-up|1|||
156858648|NCT04158583|566236757|FG005|Overall Study|Lost to Follow-up|0|||
156858649|NCT04158583|566236758|FG006|Overall Study|Lost to Follow-up|0|||
156858650|NCT04158583|566236759|FG007|Overall Study|Lost to Follow-up|0|||
156858651|NCT04158583|566236760|FG008|Overall Study|Lost to Follow-up|0|||
156858652|NCT04158583|566236761|FG009|Overall Study|Lost to Follow-up|0|||
156858653|NCT04158583|566236752|FG000|Overall Study|Due To Patient Status|0|||
156858654|NCT04158583|566236753|FG001|Overall Study|Due To Patient Status|0|||
156858655|NCT04158583|566236754|FG002|Overall Study|Due To Patient Status|0|||
156858656|NCT04158583|566236755|FG003|Overall Study|Due To Patient Status|0|||
156858657|NCT04158583|566236756|FG004|Overall Study|Due To Patient Status|0|||
156858658|NCT04158583|566236757|FG005|Overall Study|Due To Patient Status|0|||
156858659|NCT04158583|566236758|FG006|Overall Study|Due To Patient Status|0|||
156858660|NCT04158583|566236759|FG007|Overall Study|Due To Patient Status|0|||
156858661|NCT04158583|566236760|FG008|Overall Study|Due To Patient Status|1|||
156858662|NCT04158583|566236761|FG009|Overall Study|Due To Patient Status|0|||
156858663|NCT04158583|566236752|FG000|Overall Study|Death|3|||
156858664|NCT04158583|566236753|FG001|Overall Study|Death|4|||
156858665|NCT04158583|566236754|FG002|Overall Study|Death|2|||
156858666|NCT04158583|566236755|FG003|Overall Study|Death|2|||
156858667|NCT04158583|566236756|FG004|Overall Study|Death|4|||
156858668|NCT04158583|566236757|FG005|Overall Study|Death|3|||
156858669|NCT04158583|566236758|FG006|Overall Study|Death|5|||
156858670|NCT04158583|566236759|FG007|Overall Study|Death|2|||
156858671|NCT04158583|566236760|FG008|Overall Study|Death|0|||
156858672|NCT04158583|566236761|FG009|Overall Study|Death|1|||
156858673|NCT04158583|566236752|FG000|Overall Study|Clinical Progression Disease|0|||
156858674|NCT04158583|566236753|FG001|Overall Study|Clinical Progression Disease|0|||
156858675|NCT04158583|566236754|FG002|Overall Study|Clinical Progression Disease|0|||
156858676|NCT04158583|566236755|FG003|Overall Study|Clinical Progression Disease|1|||
156858677|NCT04158583|566236756|FG004|Overall Study|Clinical Progression Disease|0|||
156858678|NCT04158583|566236757|FG005|Overall Study|Clinical Progression Disease|0|||
156858679|NCT04158583|566236758|FG006|Overall Study|Clinical Progression Disease|0|||
156858680|NCT04158583|566236759|FG007|Overall Study|Clinical Progression Disease|0|||
156858681|NCT04158583|566236760|FG008|Overall Study|Clinical Progression Disease|0|||
156858682|NCT04158583|566236761|FG009|Overall Study|Clinical Progression Disease|0|||
156858683|NCT04158583|566236752|FG000|Overall Study|Clinical Progression|0|||
156858684|NCT04158583|566236753|FG001|Overall Study|Clinical Progression|0|||
156858685|NCT04158583|566236754|FG002|Overall Study|Clinical Progression|0|||
156858686|NCT04158583|566236755|FG003|Overall Study|Clinical Progression|0|||
156858687|NCT04158583|566236756|FG004|Overall Study|Clinical Progression|1|||
156858688|NCT04158583|566236757|FG005|Overall Study|Clinical Progression|0|||
156858689|NCT04158583|566236758|FG006|Overall Study|Clinical Progression|2|||
156858690|NCT04158583|566236759|FG007|Overall Study|Clinical Progression|0|||
156858691|NCT04158583|566236760|FG008|Overall Study|Clinical Progression|0|||
156858692|NCT04158583|566236761|FG009|Overall Study|Clinical Progression|0|||
156342637|NCT03633695|564354362|FG001|Overall Study|Lost to Follow-up|5|||
156342638|NCT03633695|564354361|FG000|Overall Study|Discontinued|8|||
156342639|NCT03633695|564354362|FG001|Overall Study|Discontinued|4|||
156342640|NCT02380677|564354370|FG000|Overall Study|Adverse Event|0|||
156342641|NCT02380677|564354371|FG001|Overall Study|Adverse Event|0|||
156342642|NCT02380677|564354372|FG002|Overall Study|Adverse Event|0|||
156342643|NCT02380677|564354373|FG003|Overall Study|Adverse Event|1|||
156342644|NCT02380677|564354374|FG004|Overall Study|Adverse Event|1|||
156342645|NCT02380677|564354375|FG005|Overall Study|Adverse Event|4|||
156342646|NCT02380677|564354376|FG006|Overall Study|Adverse Event|2|||
156342647|NCT02380677|564354377|FG007|Overall Study|Adverse Event|2|||
156473283|NCT02079649|564827545|FG001|Overall Study|Randomization error (prior to treatment)|0|||
156473284|NCT02079649|564827546|FG002|Overall Study|Randomization error (prior to treatment)|1|||
156473285|NCT02079649|564827547|FG003|Overall Study|Randomization error (prior to treatment)|0|||
156473286|NCT03739866|564827550|FG000|Overall Study|Lost to Follow-up|0|||
156473287|NCT03739866|564827551|FG001|Overall Study|Lost to Follow-up|0|||
156473288|NCT03739866|564827552|FG002|Overall Study|Lost to Follow-up|0|||
156342648|NCT02380677|564354378|FG008|Overall Study|Adverse Event|2|||
156342649|NCT02380677|564354379|FG009|Overall Study|Adverse Event|1|||
156342650|NCT02380677|564354380|FG010|Overall Study|Adverse Event|2|||
156342651|NCT02380677|564354381|FG011|Overall Study|Adverse Event|1|||
156342652|NCT02380677|564354370|FG000|Overall Study|Physician Decision|1|||
156342653|NCT02380677|564354371|FG001|Overall Study|Physician Decision|0|||
156473289|NCT03739866|564827553|FG003|Overall Study|Lost to Follow-up|1|||
156473290|NCT03739866|564827554|FG004|Overall Study|Lost to Follow-up|0|||
156342654|NCT02380677|564354372|FG002|Overall Study|Physician Decision|1|||
156342655|NCT02380677|564354373|FG003|Overall Study|Physician Decision|1|||
156342656|NCT02380677|564354374|FG004|Overall Study|Physician Decision|0|||
156473291|NCT03739866|564827555|FG005|Overall Study|Lost to Follow-up|0|||
156473292|NCT03739866|564827556|FG006|Overall Study|Lost to Follow-up|0|||
156473293|NCT03739866|564827557|FG007|Overall Study|Lost to Follow-up|0|||
156473294|NCT03739866|564827550|FG000|Overall Study|Enrolled but not treated|0|||
156473295|NCT03739866|564827551|FG001|Overall Study|Enrolled but not treated|0|||
156473296|NCT03739866|564827552|FG002|Overall Study|Enrolled but not treated|1|||
156473297|NCT03739866|564827553|FG003|Overall Study|Enrolled but not treated|0|||
156473298|NCT03739866|564827554|FG004|Overall Study|Enrolled but not treated|1|||
156473299|NCT03739866|564827555|FG005|Overall Study|Enrolled but not treated|0|||
156473300|NCT03739866|564827556|FG006|Overall Study|Enrolled but not treated|0|||
156473301|NCT03739866|564827557|FG007|Overall Study|Enrolled but not treated|0|||
156473302|NCT00836498|564827558|FG000|Overall Study|Adverse Event|1|||
156473303|NCT00836498|564827559|FG001|Overall Study|Adverse Event|0|||
156473304|NCT00836498|564827558|FG000|Overall Study|Lost to Follow-up|1|||
156473305|NCT00836498|564827559|FG001|Overall Study|Lost to Follow-up|0|||
156473306|NCT00836498|564827558|FG000|Overall Study|Withdrawal by Subject|2|||
156473307|NCT00836498|564827559|FG001|Overall Study|Withdrawal by Subject|1|||
156473308|NCT01034306|564827560|FG000|Overall Study|Adverse Event|1|||
156473309|NCT01034306|564827561|FG001|Overall Study|Adverse Event|0|||
156473310|NCT01034306|564827560|FG000|Overall Study|Lost to Follow-up|0|||
156473311|NCT01034306|564827561|FG001|Overall Study|Lost to Follow-up|1|||
156473312|NCT01034306|564827560|FG000|Overall Study|Withdrawal by Subject|2|||
156473313|NCT01034306|564827561|FG001|Overall Study|Withdrawal by Subject|2|||
156473314|NCT01034306|564827560|FG000|Overall Study|hospitalized and decided to stop|1|||
156473315|NCT01034306|564827561|FG001|Overall Study|hospitalized and decided to stop|0|||
156473316|NCT01034306|564827560|FG000|Overall Study|Noncomplience|1|||
156473317|NCT01034306|564827561|FG001|Overall Study|Noncomplience|0|||
156473318|NCT03057600|564827562|FG000|Overall Study|Adverse Event|0|||
156473319|NCT03057600|564827563|FG001|Overall Study|Adverse Event|0|||
156473320|NCT03057600|564827564|FG002|Overall Study|Adverse Event|4|||
156473321|NCT03057600|564827565|FG003|Overall Study|Adverse Event|0|||
156473322|NCT03057600|564827562|FG000|Overall Study|Radiologic Disease Progression|8|||
156473323|NCT03057600|564827563|FG001|Overall Study|Radiologic Disease Progression|7|||
156473324|NCT03057600|564827564|FG002|Overall Study|Radiologic Disease Progression|13|||
156473325|NCT03057600|564827565|FG003|Overall Study|Radiologic Disease Progression|10|||
156473326|NCT03057600|564827562|FG000|Overall Study|Symptomatic Deterioration|0|||
156473327|NCT03057600|564827563|FG001|Overall Study|Symptomatic Deterioration|1|||
156473328|NCT03057600|564827564|FG002|Overall Study|Symptomatic Deterioration|1|||
156342657|NCT02380677|564354375|FG005|Overall Study|Physician Decision|0|||
156473329|NCT03057600|564827565|FG003|Overall Study|Symptomatic Deterioration|0|||
156473330|NCT03057600|564827562|FG000|Overall Study|Investigator Decision|0|||
156473331|NCT03057600|564827563|FG001|Overall Study|Investigator Decision|0|||
156473332|NCT03057600|564827564|FG002|Overall Study|Investigator Decision|1|||
156473333|NCT03057600|564827565|FG003|Overall Study|Investigator Decision|0|||
156473334|NCT03057600|564827562|FG000|Overall Study|Study Termination by Sponsor|0|||
156473335|NCT03057600|564827563|FG001|Overall Study|Study Termination by Sponsor|0|||
156473336|NCT03057600|564827564|FG002|Overall Study|Study Termination by Sponsor|0|||
156473337|NCT03057600|564827565|FG003|Overall Study|Study Termination by Sponsor|2|||
156473338|NCT03057600|564827562|FG000|Overall Study|Withdrawal by Subject|0|||
156473339|NCT03057600|564827563|FG001|Overall Study|Withdrawal by Subject|1|||
156342658|NCT02380677|564354376|FG006|Overall Study|Physician Decision|0|||
156473340|NCT03057600|564827564|FG002|Overall Study|Withdrawal by Subject|0|||
156473341|NCT03057600|564827565|FG003|Overall Study|Withdrawal by Subject|0|||
156473342|NCT03057600|564827562|FG000|Overall Study|Other, Not Specified|1|||
156342659|NCT02380677|564354377|FG007|Overall Study|Physician Decision|0|||
156473343|NCT03057600|564827563|FG001|Overall Study|Other, Not Specified|1|||
156342660|NCT02380677|564354378|FG008|Overall Study|Physician Decision|0|||
156342661|NCT02380677|564354379|FG009|Overall Study|Physician Decision|0|||
156342662|NCT02380677|564354380|FG010|Overall Study|Physician Decision|0|||
156342663|NCT02380677|564354381|FG011|Overall Study|Physician Decision|0|||
156342664|NCT02380677|564354370|FG000|Overall Study|Lack of Efficacy|0|||
156342665|NCT02380677|564354371|FG001|Overall Study|Lack of Efficacy|1|||
156342666|NCT02380677|564354372|FG002|Overall Study|Lack of Efficacy|2|||
156342667|NCT02380677|564354373|FG003|Overall Study|Lack of Efficacy|0|||
156342668|NCT02380677|564354374|FG004|Overall Study|Lack of Efficacy|4|||
156342669|NCT02380677|564354375|FG005|Overall Study|Lack of Efficacy|1|||
156342670|NCT02380677|564354376|FG006|Overall Study|Lack of Efficacy|1|||
156342671|NCT02380677|564354377|FG007|Overall Study|Lack of Efficacy|2|||
156342672|NCT02380677|564354378|FG008|Overall Study|Lack of Efficacy|2|||
156342673|NCT02380677|564354379|FG009|Overall Study|Lack of Efficacy|0|||
156342674|NCT02380677|564354380|FG010|Overall Study|Lack of Efficacy|2|||
156473344|NCT03057600|564827564|FG002|Overall Study|Other, Not Specified|1|||
156858693|NCT04158583|566236752|FG000|Overall Study|Clinical Deterioration|0|||
156858694|NCT04158583|566236753|FG001|Overall Study|Clinical Deterioration|0|||
156858695|NCT04158583|566236754|FG002|Overall Study|Clinical Deterioration|0|||
156858696|NCT04158583|566236755|FG003|Overall Study|Clinical Deterioration|1|||
156858697|NCT04158583|566236756|FG004|Overall Study|Clinical Deterioration|0|||
156858698|NCT04158583|566236757|FG005|Overall Study|Clinical Deterioration|0|||
156858699|NCT04158583|566236758|FG006|Overall Study|Clinical Deterioration|0|||
156858700|NCT04158583|566236759|FG007|Overall Study|Clinical Deterioration|0|||
156858701|NCT04158583|566236760|FG008|Overall Study|Clinical Deterioration|0|||
156858702|NCT04158583|566236761|FG009|Overall Study|Clinical Deterioration|1|||
156858703|NCT02412306|566238562|FG000|Overall Study|Lost to Follow-up|0|||
156858704|NCT02412306|566238563|FG001|Overall Study|Lost to Follow-up|1|||
156858705|NCT02412306|566238564|FG002|Overall Study|Lost to Follow-up|0|||
156858706|NCT02412306|566238565|FG003|Overall Study|Lost to Follow-up|0|||
156858707|NCT02412306|566238566|FG004|Overall Study|Lost to Follow-up|0|||
156858708|NCT02412306|566238562|FG000|Overall Study|Withdrawal by Subject|0|||
156858709|NCT02412306|566238563|FG001|Overall Study|Withdrawal by Subject|0|||
156858710|NCT02412306|566238564|FG002|Overall Study|Withdrawal by Subject|1|||
156858711|NCT02412306|566238565|FG003|Overall Study|Withdrawal by Subject|0|||
156858712|NCT02412306|566238566|FG004|Overall Study|Withdrawal by Subject|0|||
156858713|NCT02412306|566238562|FG000|Overall Study|Death|5|||
156858714|NCT02412306|566238563|FG001|Overall Study|Death|7|||
156858715|NCT02412306|566238564|FG002|Overall Study|Death|15|||
156858716|NCT02412306|566238565|FG003|Overall Study|Death|0|||
156858717|NCT02412306|566238566|FG004|Overall Study|Death|2|||
156858718|NCT00443040|566238574|FG000|Overall Study|Withdrawal by Subject|1|||
156858719|NCT00443040|566238575|FG001|Overall Study|Withdrawal by Subject|0|||
156858720|NCT00443040|566238576|FG002|Overall Study|Withdrawal by Subject|0|||
156858721|NCT00443040|566238574|FG000|Overall Study|Converted to an open laparotomy|3|||
156858722|NCT00443040|566238575|FG001|Overall Study|Converted to an open laparotomy|0|||
156858723|NCT00443040|566238576|FG002|Overall Study|Converted to an open laparotomy|1|||
156858724|NCT00866177|566238577|FG000|Overall Study|Withdrawal by Subject|1|||
156858725|NCT00866177|566238577|FG000|Overall Study|Not Treated|151|||
156858726|NCT00435409|566238580|FG000|Overall Study|Protocol Violation|1|||
156858727|NCT00435409|566238581|FG001|Overall Study|Protocol Violation|2|||
156858728|NCT00435409|566238582|FG002|Overall Study|Protocol Violation|0|||
156858729|NCT00435409|566238580|FG000|Overall Study|Lost to Follow-up|1|||
156858730|NCT00435409|566238581|FG001|Overall Study|Lost to Follow-up|2|||
156858731|NCT00435409|566238582|FG002|Overall Study|Lost to Follow-up|0|||
156858732|NCT00435409|566238580|FG000|Overall Study|Death|8|||
156858733|NCT00435409|566238581|FG001|Overall Study|Death|6|||
156858734|NCT00435409|566238582|FG002|Overall Study|Death|6|||
156858735|NCT00435409|566238580|FG000|Overall Study|Objective progression or relapse|158|||
156858736|NCT00435409|566238581|FG001|Overall Study|Objective progression or relapse|93|||
156858737|NCT00435409|566238582|FG002|Overall Study|Objective progression or relapse|58|||
156858738|NCT00435409|566238580|FG000|Overall Study|Global deterioration of health status|0|||
156858739|NCT00435409|566238581|FG001|Overall Study|Global deterioration of health status|0|||
156858740|NCT00435409|566238582|FG002|Overall Study|Global deterioration of health status|4|||
156858741|NCT00435409|566238580|FG000|Overall Study|Withdrawal by Subject|8|||
156858742|NCT00435409|566238581|FG001|Overall Study|Withdrawal by Subject|7|||
156858743|NCT00435409|566238582|FG002|Overall Study|Withdrawal by Subject|1|||
156858744|NCT00435409|566238580|FG000|Overall Study|Other|45|||
156858745|NCT00435409|566238581|FG001|Overall Study|Other|30|||
156858746|NCT00435409|566238582|FG002|Overall Study|Other|1|||
156858747|NCT00435409|566238580|FG000|Overall Study|Adverse Event|0|||
156858748|NCT00435409|566238581|FG001|Overall Study|Adverse Event|0|||
156858749|NCT00435409|566238582|FG002|Overall Study|Adverse Event|8|||
156858750|NCT00435409|566238580|FG000|Overall Study|Sponsor decision|0|||
156858751|NCT00435409|566238581|FG001|Overall Study|Sponsor decision|3|||
156542238|NCT03002155|565079292|FG001|Overall Study|Withdrawal by Subject|0|||
156858752|NCT00435409|566238582|FG002|Overall Study|Sponsor decision|0|||
156858753|NCT05635461|566238585|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858754|NCT05635461|566238586|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858755|NCT05635461|566238587|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858756|NCT05635461|566238588|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858757|NCT05635461|566238589|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
156858758|NCT05635461|566238590|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858759|NCT05635461|566238585|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156858760|NCT05635461|566238586|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
156858761|NCT05635461|566238587|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156858762|NCT05635461|566238588|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156858763|NCT05635461|566238589|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156342675|NCT02380677|564354381|FG011|Overall Study|Lack of Efficacy|1|||
156858764|NCT05635461|566238590|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156858765|NCT05635461|566238585|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156858766|NCT05635461|566238586|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156473345|NCT03057600|564827565|FG003|Overall Study|Other, Not Specified|1|||
156473346|NCT01968967|564827566|FG000|Treatment Period|Other|22|||
156473347|NCT01968967|564827567|FG001|Treatment Period|Other|22|||
156473348|NCT01968967|564827568|FG002|Treatment Period|Other|0|||
156473349|NCT01968967|564827569|FG003|Treatment Period|Other|0|||
156473350|NCT01968967|564827570|FG004|Treatment Period|Other|0|||
156473351|NCT01968967|564827566|FG000|Treatment Period|Withdrawal by Subject|71|||
156473352|NCT01968967|564827567|FG001|Treatment Period|Withdrawal by Subject|61|||
156473353|NCT01968967|564827568|FG002|Treatment Period|Withdrawal by Subject|0|||
156342676|NCT02380677|564354370|FG000|Overall Study|Withdrawal by Subject|0|||
156473354|NCT01968967|564827569|FG003|Treatment Period|Withdrawal by Subject|0|||
156473355|NCT01968967|564827570|FG004|Treatment Period|Withdrawal by Subject|0|||
156473356|NCT01968967|564827566|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
156473357|NCT01968967|564827567|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
156473358|NCT01968967|564827568|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
156473359|NCT01968967|564827569|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
156473360|NCT01968967|564827570|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
156473361|NCT01968967|564827566|FG000|Treatment Period|Lost to Follow-up|26|||
156473362|NCT01968967|564827567|FG001|Treatment Period|Lost to Follow-up|31|||
156473363|NCT01968967|564827568|FG002|Treatment Period|Lost to Follow-up|0|||
156473364|NCT01968967|564827569|FG003|Treatment Period|Lost to Follow-up|0|||
156473365|NCT01968967|564827570|FG004|Treatment Period|Lost to Follow-up|0|||
156473366|NCT01968967|564827566|FG000|Treatment Period|Protocol Violation|1|||
156473367|NCT01968967|564827567|FG001|Treatment Period|Protocol Violation|2|||
156473368|NCT01968967|564827568|FG002|Treatment Period|Protocol Violation|0|||
156342677|NCT02380677|564354371|FG001|Overall Study|Withdrawal by Subject|0|||
156342678|NCT02380677|564354372|FG002|Overall Study|Withdrawal by Subject|0|||
156342679|NCT02380677|564354373|FG003|Overall Study|Withdrawal by Subject|0|||
156342680|NCT02380677|564354374|FG004|Overall Study|Withdrawal by Subject|0|||
156342681|NCT02380677|564354375|FG005|Overall Study|Withdrawal by Subject|0|||
156342682|NCT02380677|564354376|FG006|Overall Study|Withdrawal by Subject|0|||
156342683|NCT02380677|564354377|FG007|Overall Study|Withdrawal by Subject|0|||
156342684|NCT02380677|564354378|FG008|Overall Study|Withdrawal by Subject|0|||
156342685|NCT02380677|564354379|FG009|Overall Study|Withdrawal by Subject|1|||
156342686|NCT02380677|564354380|FG010|Overall Study|Withdrawal by Subject|0|||
156473369|NCT01968967|564827569|FG003|Treatment Period|Protocol Violation|0|||
156473370|NCT01968967|564827570|FG004|Treatment Period|Protocol Violation|0|||
156473371|NCT01968967|564827566|FG000|Treatment Period|Adverse Event|9|||
156473372|NCT01968967|564827567|FG001|Treatment Period|Adverse Event|8|||
156473373|NCT01968967|564827568|FG002|Treatment Period|Adverse Event|0|||
156473374|NCT01968967|564827569|FG003|Treatment Period|Adverse Event|0|||
156473375|NCT01968967|564827570|FG004|Treatment Period|Adverse Event|0|||
156473376|NCT01968967|564827566|FG000|Treatment Period|Death|9|||
156858767|NCT05635461|566238587|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156858768|NCT05635461|566238588|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
156858769|NCT05635461|566238589|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156858770|NCT05635461|566238590|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156858771|NCT04750824|566238594|FG000|Overall Study|Toxicity/intolerability|3|||
156858772|NCT04750824|566238595|FG001|Overall Study|Toxicity/intolerability|1|||
156858773|NCT04750824|566238594|FG000|Overall Study|Death|1|||
156858774|NCT04750824|566238595|FG001|Overall Study|Death|3|||
156858775|NCT04750824|566238594|FG000|Overall Study|Scheduled duration of therapy complete|1|||
156858776|NCT04750824|566238595|FG001|Overall Study|Scheduled duration of therapy complete|9|||
156858777|NCT04750824|566238594|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
156858778|NCT04750824|566238595|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
156858779|NCT03192176|566238600|FG000|Overall Study|Adverse Event|1|||
156858780|NCT03192176|566238601|FG001|Overall Study|Adverse Event|0|||
156858781|NCT03192176|566238602|FG002|Overall Study|Adverse Event|4|||
156858782|NCT03192176|566238603|FG003|Overall Study|Adverse Event|5|||
156858783|NCT03192176|566238604|FG004|Overall Study|Adverse Event|3|||
156858784|NCT03192176|566238605|FG005|Overall Study|Adverse Event|2|||
156858785|NCT03192176|566238606|FG006|Overall Study|Adverse Event|3|||
156858786|NCT03192176|566238607|FG007|Overall Study|Adverse Event|3|||
156858787|NCT03192176|566238600|FG000|Overall Study|Lost to Follow-up|0|||
156858788|NCT03192176|566238601|FG001|Overall Study|Lost to Follow-up|0|||
156858789|NCT03192176|566238602|FG002|Overall Study|Lost to Follow-up|1|||
156858790|NCT03192176|566238603|FG003|Overall Study|Lost to Follow-up|2|||
156858791|NCT03192176|566238604|FG004|Overall Study|Lost to Follow-up|3|||
156858792|NCT03192176|566238605|FG005|Overall Study|Lost to Follow-up|1|||
156858793|NCT03192176|566238606|FG006|Overall Study|Lost to Follow-up|1|||
156858794|NCT03192176|566238607|FG007|Overall Study|Lost to Follow-up|1|||
156858795|NCT03192176|566238600|FG000|Overall Study|Physician Decision|1|||
156858796|NCT03192176|566238601|FG001|Overall Study|Physician Decision|0|||
156858797|NCT03192176|566238602|FG002|Overall Study|Physician Decision|0|||
156858798|NCT03192176|566238603|FG003|Overall Study|Physician Decision|0|||
156858799|NCT03192176|566238604|FG004|Overall Study|Physician Decision|0|||
156858800|NCT03192176|566238605|FG005|Overall Study|Physician Decision|2|||
156858801|NCT03192176|566238606|FG006|Overall Study|Physician Decision|1|||
156858802|NCT03192176|566238607|FG007|Overall Study|Physician Decision|0|||
156858803|NCT03192176|566238600|FG000|Overall Study|Protocol Deviation|1|||
156858804|NCT03192176|566238601|FG001|Overall Study|Protocol Deviation|1|||
156858805|NCT03192176|566238602|FG002|Overall Study|Protocol Deviation|0|||
156858806|NCT03192176|566238603|FG003|Overall Study|Protocol Deviation|0|||
156858807|NCT03192176|566238604|FG004|Overall Study|Protocol Deviation|2|||
156858808|NCT03192176|566238605|FG005|Overall Study|Protocol Deviation|0|||
156858809|NCT03192176|566238606|FG006|Overall Study|Protocol Deviation|0|||
156858810|NCT03192176|566238607|FG007|Overall Study|Protocol Deviation|0|||
156858811|NCT03192176|566238600|FG000|Overall Study|Withdrawal by Subject|3|||
156858812|NCT03192176|566238601|FG001|Overall Study|Withdrawal by Subject|4|||
156858813|NCT03192176|566238602|FG002|Overall Study|Withdrawal by Subject|0|||
156858814|NCT03192176|566238603|FG003|Overall Study|Withdrawal by Subject|4|||
156858815|NCT03192176|566238604|FG004|Overall Study|Withdrawal by Subject|3|||
156858816|NCT03192176|566238605|FG005|Overall Study|Withdrawal by Subject|4|||
156858817|NCT03192176|566238606|FG006|Overall Study|Withdrawal by Subject|4|||
156858818|NCT03192176|566238607|FG007|Overall Study|Withdrawal by Subject|2|||
156858819|NCT03192176|566238600|FG000|Overall Study|Miscellaneous|1|||
156858820|NCT03192176|566238601|FG001|Overall Study|Miscellaneous|0|||
156473377|NCT01968967|564827567|FG001|Treatment Period|Death|2|||
156473378|NCT01968967|564827568|FG002|Treatment Period|Death|0|||
156473379|NCT01968967|564827569|FG003|Treatment Period|Death|0|||
156473380|NCT01968967|564827570|FG004|Treatment Period|Death|0|||
156858821|NCT03192176|566238602|FG002|Overall Study|Miscellaneous|1|||
156858822|NCT03192176|566238603|FG003|Overall Study|Miscellaneous|1|||
156858823|NCT03192176|566238604|FG004|Overall Study|Miscellaneous|1|||
156858824|NCT03192176|566238605|FG005|Overall Study|Miscellaneous|2|||
156858825|NCT03192176|566238606|FG006|Overall Study|Miscellaneous|0|||
156858826|NCT03192176|566238607|FG007|Overall Study|Miscellaneous|1|||
156858827|NCT03532542|566238610|FG000|Overall Study|Death|1|||
156858828|NCT03532542|566238611|FG001|Overall Study|Death|0|||
156858829|NCT03532542|566238610|FG000|Overall Study|Study Terminated by Sponsor|41|||
156858830|NCT03532542|566238611|FG001|Overall Study|Study Terminated by Sponsor|65|||
156858831|NCT03532542|566238610|FG000|Overall Study|Withdrawal by Subject|6|||
156858832|NCT03532542|566238611|FG001|Overall Study|Withdrawal by Subject|5|||
156858833|NCT00117637|566238612|FG000|First Intervention (Period 1)|Adverse Event|11|||
156342687|NCT02380677|564354381|FG011|Overall Study|Withdrawal by Subject|3|||
156342688|NCT02380677|564354370|FG000|Overall Study|Other|0|||
156342689|NCT02380677|564354371|FG001|Overall Study|Other|0|||
156342690|NCT02380677|564354372|FG002|Overall Study|Other|0|||
156858834|NCT00117637|566238613|FG001|First Intervention (Period 1)|Adverse Event|16|||
156858835|NCT00117637|566238612|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
156858836|NCT00117637|566238613|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
156858837|NCT00117637|566238612|FG000|First Intervention (Period 1)|Protocol Violation|1|||
156858838|NCT00117637|566238613|FG001|First Intervention (Period 1)|Protocol Violation|0|||
156858839|NCT00117637|566238612|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
156858840|NCT00117637|566238613|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
156858841|NCT00117637|566238612|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
156858842|NCT00117637|566238613|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
156858843|NCT00117637|566238612|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
156858844|NCT00117637|566238613|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
156858845|NCT00117637|566238612|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
156858846|NCT00117637|566238613|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
156858847|NCT00117637|566238612|FG000|First Intervention (Period 1)|reason not reported|0|||
156858848|NCT00117637|566238613|FG001|First Intervention (Period 1)|reason not reported|1|||
156858849|NCT00117637|566238612|FG000|Second Intervention (Period 2)|Adverse Event|0|||
156858850|NCT00117637|566238613|FG001|Second Intervention (Period 2)|Adverse Event|9|||
156858851|NCT00117637|566238612|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
156858852|NCT00117637|566238613|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
156858853|NCT00117637|566238612|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
156858854|NCT00117637|566238613|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
156858855|NCT00117637|566238612|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
156858856|NCT00117637|566238613|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
156858857|NCT00117637|566238612|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
156858858|NCT00117637|566238613|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
156858859|NCT00117637|566238612|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
156858860|NCT00117637|566238613|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
156858861|NCT00117637|566238612|FG000|Second Intervention (Period 2)|reason not reported|1|||
156858862|NCT00117637|566238613|FG001|Second Intervention (Period 2)|reason not reported|0|||
156858863|NCT02914639|566238621|FG000|Overall Study|Withdrawal by Subject|0|||
156858864|NCT02914639|566238622|FG001|Overall Study|Withdrawal by Subject|2|||
156858865|NCT00189540|566238623|FG000|Overall Study|Withdrawal by Subject|3|||
156858866|NCT00189540|566238624|FG001|Overall Study|Withdrawal by Subject|0|||
156858867|NCT00189540|566238623|FG000|Overall Study|Death|4|||
156858868|NCT00189540|566238624|FG001|Overall Study|Death|1|||
156858869|NCT01924845|566238625|FG000|Overall Study|Adverse Event|3|||
156858870|NCT01924845|566238625|FG000|Overall Study|Withdrawal by Subject|2|||
156858871|NCT01924845|566238625|FG000|Overall Study|Protocol Violation|1|||
156858872|NCT00062439|566238626|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
156858873|NCT00062439|566238626|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
156858874|NCT00062439|566238626|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
156858875|NCT00062439|566238626|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
156858876|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Death|1|||
156858877|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Disease progression|2|||
156858878|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
156858879|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
156858880|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
156858881|NCT00062439|566238626|FG000|Surgery|Physician Decision|4|||
156858882|NCT00062439|566238626|FG000|Surgery|Death|1|||
156858883|NCT00062439|566238626|FG000|Surgery|Adverse Event|2|||
156858884|NCT00062439|566238626|FG000|Consolidation Chemotherapy|Adverse Event|2|||
156858885|NCT01903356|566238627|FG000|Overall Study|Lost to Follow-up|7|||
156858886|NCT01903356|566238627|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
156858887|NCT01903356|566238627|FG000|Overall Study|Violated the dosage and administration|3|||
156858888|NCT00286442|566238628|FG000|Overall Study|Hyperglycemic Rescue|19|||
156858889|NCT00286442|566238629|FG001|Overall Study|Hyperglycemic Rescue|17|||
156858890|NCT00286442|566238630|FG002|Overall Study|Hyperglycemic Rescue|25|||
156858891|NCT00286442|566238628|FG000|Overall Study|Adverse Event|7|||
156858892|NCT00286442|566238629|FG001|Overall Study|Adverse Event|6|||
156858893|NCT00286442|566238630|FG002|Overall Study|Adverse Event|1|||
156858894|NCT00286442|566238628|FG000|Overall Study|Protocol Violation|2|||
156858895|NCT00286442|566238629|FG001|Overall Study|Protocol Violation|4|||
156858896|NCT00286442|566238630|FG002|Overall Study|Protocol Violation|2|||
156858897|NCT00286442|566238628|FG000|Overall Study|Lost to Follow-up|5|||
156858898|NCT00286442|566238629|FG001|Overall Study|Lost to Follow-up|2|||
156858899|NCT00286442|566238630|FG002|Overall Study|Lost to Follow-up|1|||
156342691|NCT02380677|564354373|FG003|Overall Study|Other|1|||
156473381|NCT01968967|564827566|FG000|Treatment Period|Randomized Not Treated|6|||
156858900|NCT00286442|566238628|FG000|Overall Study|Physician Decision|1|||
156858901|NCT00286442|566238629|FG001|Overall Study|Physician Decision|1|||
156858902|NCT00286442|566238630|FG002|Overall Study|Physician Decision|1|||
156858903|NCT00286442|566238628|FG000|Overall Study|Administrative Error|1|||
156858904|NCT00286442|566238629|FG001|Overall Study|Administrative Error|1|||
156858905|NCT00286442|566238630|FG002|Overall Study|Administrative Error|0|||
156858906|NCT00286442|566238628|FG000|Overall Study|Withdrawal by Subject|2|||
156858907|NCT00286442|566238629|FG001|Overall Study|Withdrawal by Subject|14|||
156858908|NCT00286442|566238630|FG002|Overall Study|Withdrawal by Subject|2|||
156858909|NCT00079040|566238631|FG000|Overall Study|Withdrew before treatment|1|||
156858910|NCT00079040|566238631|FG000|Overall Study|Ineligible|1|||
156858911|NCT01919229|566238632|FG000|Overall Study|Subject/guardian decision|0|||
156858912|NCT01919229|566238633|FG001|Overall Study|Subject/guardian decision|0|||
156858913|NCT01919229|566238634|FG002|Overall Study|Subject/guardian decision|1|||
156858914|NCT01632020|566238635|FG000|Overall Study|Withdrawal by Subject|1|||
156858915|NCT01632020|566238636|FG001|Overall Study|Withdrawal by Subject|0|||
156858916|NCT01632020|566238635|FG000|Overall Study|Adverse Event|1|||
156858917|NCT01632020|566238636|FG001|Overall Study|Adverse Event|0|||
156858918|NCT00549640|566238638|FG000|Overall Study|Withdrawal by Subject|6|||
156858919|NCT00549640|566238639|FG001|Overall Study|Withdrawal by Subject|12|||
156858920|NCT00549640|566238638|FG000|Overall Study|Adverse Event|5|||
156858921|NCT00549640|566238639|FG001|Overall Study|Adverse Event|0|||
156858922|NCT00549640|566238638|FG000|Overall Study|Lost to Follow-up|7|||
156858923|NCT00549640|566238639|FG001|Overall Study|Lost to Follow-up|4|||
156858924|NCT04999839|566238644|FG000|Overall Study|Adverse Event|1|||
156858925|NCT04999839|566238645|FG001|Overall Study|Adverse Event|1|||
156858926|NCT04999839|566238646|FG002|Overall Study|Adverse Event|1|||
156858927|NCT04999839|566238647|FG003|Overall Study|Adverse Event|1|||
156858928|NCT04999839|566238648|FG004|Overall Study|Adverse Event|1|||
156858929|NCT04999839|566238644|FG000|Overall Study|Lost to Follow-up|2|||
156858930|NCT04999839|566238645|FG001|Overall Study|Lost to Follow-up|0|||
156858931|NCT04999839|566238646|FG002|Overall Study|Lost to Follow-up|2|||
156858932|NCT04999839|566238647|FG003|Overall Study|Lost to Follow-up|4|||
156858933|NCT04999839|566238648|FG004|Overall Study|Lost to Follow-up|1|||
156858934|NCT04999839|566238644|FG000|Overall Study|Withdrawal by Subject|6|||
156858935|NCT04999839|566238645|FG001|Overall Study|Withdrawal by Subject|5|||
156858936|NCT04999839|566238646|FG002|Overall Study|Withdrawal by Subject|3|||
156858937|NCT04999839|566238647|FG003|Overall Study|Withdrawal by Subject|2|||
156858938|NCT04999839|566238648|FG004|Overall Study|Withdrawal by Subject|2|||
156858939|NCT04999839|566238644|FG000|Overall Study|Lack of Efficacy|0|||
156858940|NCT04999839|566238645|FG001|Overall Study|Lack of Efficacy|1|||
156858941|NCT04999839|566238646|FG002|Overall Study|Lack of Efficacy|0|||
156858942|NCT04999839|566238647|FG003|Overall Study|Lack of Efficacy|0|||
156858943|NCT04999839|566238648|FG004|Overall Study|Lack of Efficacy|0|||
156858944|NCT04999839|566238644|FG000|Overall Study|Physician Decision|0|||
156858945|NCT04999839|566238645|FG001|Overall Study|Physician Decision|0|||
156858946|NCT04999839|566238646|FG002|Overall Study|Physician Decision|0|||
156858947|NCT04999839|566238647|FG003|Overall Study|Physician Decision|0|||
156858948|NCT04999839|566238648|FG004|Overall Study|Physician Decision|1|||
156858949|NCT04999839|566238644|FG000|Overall Study|Sponsor request|0|||
156858950|NCT04999839|566238645|FG001|Overall Study|Sponsor request|1|||
156858951|NCT04999839|566238646|FG002|Overall Study|Sponsor request|0|||
156858952|NCT04999839|566238647|FG003|Overall Study|Sponsor request|0|||
156858953|NCT04999839|566238648|FG004|Overall Study|Sponsor request|0|||
156858954|NCT04999839|566238644|FG000|Overall Study|Other|0|||
156858955|NCT04999839|566238645|FG001|Overall Study|Other|0|||
156858956|NCT04999839|566238646|FG002|Overall Study|Other|1|||
156858957|NCT04999839|566238647|FG003|Overall Study|Other|0|||
156858958|NCT04999839|566238648|FG004|Overall Study|Other|0|||
156858959|NCT02734693|566238649|FG000|Overall Study|Adverse Event|1|||
156858960|NCT02734693|566238650|FG001|Overall Study|Adverse Event|3|||
156858961|NCT02734693|566238651|FG002|Overall Study|Adverse Event|3|||
156473382|NCT01968967|564827567|FG001|Treatment Period|Randomized Not Treated|5|||
156473383|NCT01968967|564827568|FG002|Treatment Period|Randomized Not Treated|0|||
156473384|NCT01968967|564827569|FG003|Treatment Period|Randomized Not Treated|0|||
156858962|NCT02734693|566238649|FG000|Overall Study|Lack of Efficacy|1|||
156858963|NCT02734693|566238650|FG001|Overall Study|Lack of Efficacy|0|||
156858964|NCT02734693|566238651|FG002|Overall Study|Lack of Efficacy|0|||
156858965|NCT02734693|566238649|FG000|Overall Study|Lost to Follow-up|2|||
156858966|NCT02734693|566238650|FG001|Overall Study|Lost to Follow-up|0|||
156858967|NCT02734693|566238651|FG002|Overall Study|Lost to Follow-up|0|||
156858968|NCT02734693|566238649|FG000|Overall Study|Protocol Violation|1|||
156858969|NCT02734693|566238650|FG001|Overall Study|Protocol Violation|0|||
156858970|NCT02734693|566238651|FG002|Overall Study|Protocol Violation|0|||
156858971|NCT02734693|566238649|FG000|Overall Study|Withdrawal by Subject|1|||
156858972|NCT02734693|566238650|FG001|Overall Study|Withdrawal by Subject|0|||
156858973|NCT02734693|566238651|FG002|Overall Study|Withdrawal by Subject|0|||
156858974|NCT03740048|566238652|FG000|Overall Study|Withdrawal by Subject|1|||
156473385|NCT01968967|564827570|FG004|Treatment Period|Randomized Not Treated|0|||
156473386|NCT01968967|564827566|FG000|Extension Period|Withdrew Consent|0|||
156473387|NCT01968967|564827567|FG001|Extension Period|Withdrew Consent|0|||
156473388|NCT01968967|564827568|FG002|Extension Period|Withdrew Consent|2|||
156473389|NCT01968967|564827569|FG003|Extension Period|Withdrew Consent|0|||
156473390|NCT01968967|564827570|FG004|Extension Period|Withdrew Consent|5|||
156473391|NCT00701415|564827577|FG000|Overall Study|Adverse Event|0|||
156473392|NCT00701415|564827578|FG001|Overall Study|Adverse Event|1|||
156473393|NCT00701415|564827577|FG000|Overall Study|Social/family issues and needle phobia|1|||
156473394|NCT00701415|564827578|FG001|Overall Study|Social/family issues and needle phobia|0|||
156473395|NCT00109031|564827579|FG000|Overall Study|Adverse Event|0|||
156858975|NCT03740048|566238653|FG001|Overall Study|Withdrawal by Subject|1|||
156858976|NCT03740048|566238652|FG000|Overall Study|Death|1|||
156858977|NCT03740048|566238653|FG001|Overall Study|Death|6|||
156858978|NCT03740048|566238652|FG000|Overall Study|Switched to thrice-weekly HD|2|||
156858979|NCT03740048|566238653|FG001|Overall Study|Switched to thrice-weekly HD|0|||
156858980|NCT03740048|566238652|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
156858981|NCT03740048|566238653|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
156858982|NCT03740048|566238652|FG000|Overall Study|Lost to Follow-up|0|||
156858983|NCT03740048|566238653|FG001|Overall Study|Lost to Follow-up|1|||
156858984|NCT03740048|566238652|FG000|Overall Study|Non-compliance with HD|0|||
156858985|NCT03740048|566238653|FG001|Overall Study|Non-compliance with HD|1|||
156858986|NCT03261336|566238654|FG000|Overall Study|Adverse Event|1|||
156858987|NCT01069484|566238656|FG000|Overall Study|Death-in-near-family|1|||
156858988|NCT01069484|566238657|FG001|Overall Study|Death-in-near-family|0|||
156858989|NCT01069484|566238656|FG000|Overall Study|No specific reason|8|||
156858990|NCT01069484|566238657|FG001|Overall Study|No specific reason|2|||
156858991|NCT01069484|566238656|FG000|Overall Study|Illness mother or child|3|||
156858992|NCT01069484|566238657|FG001|Overall Study|Illness mother or child|1|||
156858993|NCT00292942|566238658|FG000|Overall Study|Withdrawal by Subject|0|||
156858994|NCT00292942|566238659|FG001|Overall Study|Withdrawal by Subject|0|||
156858995|NCT00292942|566238660|FG002|Overall Study|Withdrawal by Subject|1|||
156858996|NCT00292942|566238661|FG003|Overall Study|Withdrawal by Subject|0|||
156858997|NCT00292942|566238658|FG000|Overall Study|Adverse Event|0|||
156858998|NCT00292942|566238659|FG001|Overall Study|Adverse Event|0|||
156858999|NCT00292942|566238660|FG002|Overall Study|Adverse Event|0|||
156859000|NCT00292942|566238661|FG003|Overall Study|Adverse Event|1|||
156859001|NCT00644358|566238662|FG000|Overall Study|Adverse Event|124|||
156859002|NCT00644358|566238662|FG000|Overall Study|Lost to Follow-up|105|||
156859003|NCT00644358|566238662|FG000|Overall Study|Consent Withdrawal|64|||
156859004|NCT00644358|566238662|FG000|Overall Study|Lack of Effectiveness|39|||
156859005|NCT00644358|566238662|FG000|Overall Study|Protocol Violation|5|||
156859006|NCT00644358|566238662|FG000|Overall Study|Noncompliance|14|||
156859007|NCT00644358|566238662|FG000|Overall Study|Other Unspecified|11|||
156859008|NCT00651924|566238667|FG000|Overall Study|Withdrawal by PI|0|||
156859009|NCT00651924|566238668|FG001|Overall Study|Withdrawal by PI|2|||
156859010|NCT00651924|566238667|FG000|Overall Study|Withdrawal by Subject|0|||
156859011|NCT00651924|566238668|FG001|Overall Study|Withdrawal by Subject|5|||
156859012|NCT00758771|566238669|FG000|Overall Study|Withdrawal by Subject|1|||
156859013|NCT00758771|566238670|FG001|Overall Study|Withdrawal by Subject|1|||
156859014|NCT00758771|566238669|FG000|Overall Study|Did not meet eligibility criteria|2|||
156859015|NCT00758771|566238670|FG001|Overall Study|Did not meet eligibility criteria|4|||
156859016|NCT00960063|566238671|FG000|Overall Study|Adverse Event|1|||
156859017|NCT00960063|566238672|FG001|Overall Study|Adverse Event|0|||
156859018|NCT00960063|566238673|FG002|Overall Study|Adverse Event|0|||
156859019|NCT00960063|566238671|FG000|Overall Study|Progression of Disease|0|||
156859020|NCT00960063|566238672|FG001|Overall Study|Progression of Disease|0|||
156859021|NCT00960063|566238673|FG002|Overall Study|Progression of Disease|3|||
156859022|NCT05083351|566238678|FG000|Overall Study|Adverse Event|3|||
156859023|NCT05083351|566238678|FG000|Overall Study|Did not meet data inclusion criteria|8|||
156859024|NCT05083351|566238678|FG000|Overall Study|Did not meet eligibility criteria|19|||
156859025|NCT05083351|566238678|FG000|Overall Study|Study Staff Decision|19|||
156859026|NCT01611792|566238679|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
156859027|NCT01611792|566238680|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
156859028|NCT01611792|566238679|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
156859029|NCT01611792|566238680|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
156859030|NCT00083889|566238686|FG000|Overall Study|Adverse Event|76|||
156859031|NCT00083889|566238687|FG001|Overall Study|Adverse Event|86|||
156473396|NCT00109031|564827580|FG001|Overall Study|Adverse Event|0|||
156859032|NCT00083889|566238686|FG000|Overall Study|Protocol Violation|2|||
156859033|NCT00083889|566238687|FG001|Overall Study|Protocol Violation|2|||
156859034|NCT00083889|566238686|FG000|Overall Study|Withdrawal by Subject|22|||
156859035|NCT00083889|566238687|FG001|Overall Study|Withdrawal by Subject|24|||
156859036|NCT00083889|566238686|FG000|Overall Study|Lack of Efficacy|240|||
156859037|NCT00083889|566238687|FG001|Overall Study|Lack of Efficacy|219|||
156859038|NCT00083889|566238686|FG000|Overall Study|Decision of sponsor|32|||
156859039|NCT00083889|566238687|FG001|Overall Study|Decision of sponsor|4|||
156473397|NCT00109031|564827581|FG002|Overall Study|Adverse Event|1|||
156473398|NCT00109031|564827582|FG003|Overall Study|Adverse Event|0|||
156473399|NCT00109031|564827579|FG000|Overall Study|Withdrawal by Subject|0|||
156473400|NCT00109031|564827580|FG001|Overall Study|Withdrawal by Subject|1|||
156473401|NCT00109031|564827581|FG002|Overall Study|Withdrawal by Subject|0|||
156473402|NCT00109031|564827582|FG003|Overall Study|Withdrawal by Subject|0|||
156473403|NCT00109031|564827579|FG000|Overall Study|Physician Decision|0|||
156473404|NCT00109031|564827580|FG001|Overall Study|Physician Decision|1|||
156473405|NCT00109031|564827581|FG002|Overall Study|Physician Decision|0|||
156473406|NCT00109031|564827582|FG003|Overall Study|Physician Decision|0|||
156473407|NCT00109031|564827579|FG000|Overall Study|Protocol Violation|0|||
156473408|NCT00109031|564827580|FG001|Overall Study|Protocol Violation|0|||
156473409|NCT00109031|564827581|FG002|Overall Study|Protocol Violation|1|||
156473410|NCT00109031|564827582|FG003|Overall Study|Protocol Violation|0|||
156473411|NCT04029090|564827583|FG000|Overall Study|Protocol Violation|1|||
156473412|NCT04029090|564827584|FG001|Overall Study|Protocol Violation|0|||
156473413|NCT04029090|564827585|FG002|Overall Study|Protocol Violation|0|||
156473414|NCT04029090|564827583|FG000|Overall Study|Withdrawal by Subject|0|||
156473415|NCT04029090|564827584|FG001|Overall Study|Withdrawal by Subject|1|||
156473416|NCT04029090|564827585|FG002|Overall Study|Withdrawal by Subject|0|||
156473417|NCT01065779|564827586|FG000|Overall Study|Duplicate Investigation|1|||
156473418|NCT01065779|564827586|FG000|Overall Study|Investigation Before Contract Date|37|||
156473419|NCT01065779|564827586|FG000|Overall Study|Non-enrollment Period Administration|10|||
156473420|NCT01065779|564827586|FG000|Overall Study|Not Administered With Study Drug|17|||
156342692|NCT02380677|564354374|FG004|Overall Study|Other|1|||
156342693|NCT02380677|564354375|FG005|Overall Study|Other|1|||
156342694|NCT02380677|564354376|FG006|Overall Study|Other|0|||
156342695|NCT02380677|564354377|FG007|Overall Study|Other|0|||
156342696|NCT02380677|564354378|FG008|Overall Study|Other|0|||
156342697|NCT02380677|564354379|FG009|Overall Study|Other|0|||
156542239|NCT03002155|565079291|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
156342698|NCT02380677|564354380|FG010|Overall Study|Other|0|||
156342699|NCT02380677|564354381|FG011|Overall Study|Other|0|||
156473421|NCT01065779|564827586|FG000|Overall Study|Failed to Follow-up|10|||
156473422|NCT01065779|564827586|FG000|Overall Study|Inclusion Criteria Violation|7|||
156473423|NCT02157948|564827587|FG000|Overall Study|Withdrawal by Subject|4|||
156473424|NCT02157948|564827588|FG001|Overall Study|Withdrawal by Subject|5|||
156473425|NCT02157948|564827587|FG000|Overall Study|Lost to Follow-up|3|||
156473426|NCT02157948|564827588|FG001|Overall Study|Lost to Follow-up|2|||
156473427|NCT02157948|564827587|FG000|Overall Study|Protocol Specified Criteria|2|||
156473428|NCT02157948|564827588|FG001|Overall Study|Protocol Specified Criteria|1|||
156473429|NCT02157948|564827587|FG000|Overall Study|Decision by Sponsor|0|||
156473430|NCT02157948|564827588|FG001|Overall Study|Decision by Sponsor|1|||
156473431|NCT01604824|564827590|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
156473432|NCT01604824|564827591|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
156473433|NCT01604824|564827592|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
156473434|NCT01604824|564827593|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
156473435|NCT01604824|564827594|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
156473436|NCT01604824|564827595|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
156473437|NCT01604824|564827590|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
156473438|NCT01604824|564827591|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
156473439|NCT01604824|564827592|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
156473440|NCT01604824|564827593|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
156473441|NCT01604824|564827594|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
156473442|NCT01604824|564827595|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
156473443|NCT03822832|564827596|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
156473444|NCT03822832|564827597|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
156473445|NCT03822832|564827596|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
156473446|NCT03822832|564827597|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
156473447|NCT03822832|564827596|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
156473448|NCT03822832|564827597|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
156473449|NCT03822832|564827596|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
156473450|NCT03822832|564827597|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
156473451|NCT03822832|564827596|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
156473452|NCT03822832|564827597|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
156473453|NCT03822832|564827596|FG000|Re-allocation|Not re-allocated to open label period|2|||
156473454|NCT03822832|564827597|FG001|Re-allocation|Not re-allocated to open label period|6|||
156473455|NCT03822832|564827596|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
156473456|NCT03822832|564827597|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
156473457|NCT03822832|564827596|FG000|Period 2 - Open Label Period|Adverse Event|0|||
156473458|NCT03822832|564827597|FG001|Period 2 - Open Label Period|Adverse Event|3|||
156473459|NCT04218864|564827602|FG000|Overall Study|Lost to Follow-up|8|||
156473460|NCT04218864|564827603|FG001|Overall Study|Lost to Follow-up|4|||
156473461|NCT04218864|564827602|FG000|Overall Study|Withdrawal by Subject|1|||
156473462|NCT04218864|564827603|FG001|Overall Study|Withdrawal by Subject|3|||
156473463|NCT00933270|564827604|FG000|Overall Study|Withdrawal by Subject|26|||
156473464|NCT00933270|564827604|FG000|Overall Study|Insufficient Follow-up|10|||
156473465|NCT00933270|564827604|FG000|Overall Study|Lost to Follow-up|14|||
156473466|NCT00933270|564827604|FG000|Overall Study|Adverse Event|1|||
156473467|NCT00933270|564827604|FG000|Overall Study|Missed Visit|2|||
156342700|NCT00617123|564354386|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
156342701|NCT00617123|564354387|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
156342702|NCT00617123|564354386|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
156342703|NCT00617123|564354387|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
156473468|NCT00933270|564827604|FG000|Overall Study|Death|24|||
156473469|NCT00933270|564827604|FG000|Overall Study|Moved or would not return|10|||
156473470|NCT02409680|564827605|FG000|Overall Study|Lost to Follow-up|15|||
156473471|NCT02409680|564827606|FG001|Overall Study|Lost to Follow-up|30|||
156342704|NCT00617123|564354386|FG000|Referral Screening Period|Adverse Event|0|||
156473472|NCT05366751|564827607|FG000|Overall Study|Adverse Event|25|||
156342705|NCT00617123|564354387|FG001|Referral Screening Period|Adverse Event|1|||
156342706|NCT00617123|564354386|FG000|Study Treatment Period|Withdrawal by Subject|8|||
156342707|NCT00617123|564354387|FG001|Study Treatment Period|Withdrawal by Subject|12|||
156473473|NCT05366751|564827607|FG000|Overall Study|Physician Decision|3|||
156473474|NCT05366751|564827607|FG000|Overall Study|Lost to Follow-up|2|||
156473475|NCT05366751|564827607|FG000|Overall Study|Withdrawal by Subject|14|||
156473476|NCT05366751|564827607|FG000|Overall Study|Study Terminated by Sponsor|50|||
156473477|NCT05366751|564827607|FG000|Overall Study|Site Terminated by Sponsor|3|||
156473478|NCT00647387|564827611|FG000|Overall Study|Lost to Follow-up|6|||
156473479|NCT00647387|564827611|FG000|Overall Study|Unsuccessful implant|5|||
156473480|NCT00647387|564827611|FG000|Overall Study|Device explanted|3|||
156473481|NCT00647387|564827611|FG000|Overall Study|Other Reason|3|||
156473482|NCT00647387|564827611|FG000|Overall Study|Death|2|||
156473483|NCT00108355|564829258|FG000|Overall Study|Peritonitis at index paracentesis|1|||
156473484|NCT00108355|564829259|FG001|Overall Study|Peritonitis at index paracentesis|1|||
156473485|NCT00108355|564829258|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
156342708|NCT00617123|564354386|FG000|Study Treatment Period|Adverse Event|7|||
156342709|NCT00617123|564354387|FG001|Study Treatment Period|Adverse Event|3|||
156342710|NCT00617123|564354386|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
156342711|NCT00617123|564354387|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
156342712|NCT00617123|564354386|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
156342713|NCT00617123|564354387|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
156342714|NCT00133952|564354389|FG000|Overall Study|Adverse Event|1|||
156342715|NCT00133952|564354390|FG001|Overall Study|Adverse Event|2|||
156342716|NCT00133952|564354389|FG000|Overall Study|Death|3|||
156342717|NCT00133952|564354390|FG001|Overall Study|Death|2|||
156342718|NCT00133952|564354389|FG000|Overall Study|Lost to Follow-up|9|||
156342719|NCT00133952|564354390|FG001|Overall Study|Lost to Follow-up|14|||
156342720|NCT00133952|564354389|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
156342721|NCT00133952|564354390|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
156342722|NCT00133952|564354389|FG000|Overall Study|Protocol Violation|1|||
156342723|NCT00133952|564354390|FG001|Overall Study|Protocol Violation|1|||
156342724|NCT00133952|564354389|FG000|Overall Study|Withdrawal by Subject|20|||
156342725|NCT00133952|564354390|FG001|Overall Study|Withdrawal by Subject|4|||
156342726|NCT00133952|564354389|FG000|Overall Study|Physician Decision|4|||
156342727|NCT00133952|564354390|FG001|Overall Study|Physician Decision|3|||
156342728|NCT00133952|564354389|FG000|Overall Study|Sponsor Decision|0|||
156342729|NCT00133952|564354390|FG001|Overall Study|Sponsor Decision|1|||
156342730|NCT02170298|564354393|FG000|Overall Study|Withdrawal by Subject|0|||
156342731|NCT02170298|564354394|FG001|Overall Study|Withdrawal by Subject|1|||
156342732|NCT02170298|564354393|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
156342733|NCT02170298|564354394|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
156342734|NCT00777608|564354399|FG000|Overall Study|Lost to Follow-up|1|||
156342735|NCT00777608|564354400|FG001|Overall Study|Lost to Follow-up|1|||
156342736|NCT00777608|564354399|FG000|Overall Study|Withdrawal by Subject|1|||
156342737|NCT00777608|564354400|FG001|Overall Study|Withdrawal by Subject|3|||
156342738|NCT00777608|564354399|FG000|Overall Study|Protocol Violation|1|||
156342739|NCT00777608|564354400|FG001|Overall Study|Protocol Violation|0|||
156342740|NCT00777608|564354399|FG000|Overall Study|Investigator Decision|1|||
156342741|NCT00777608|564354400|FG001|Overall Study|Investigator Decision|2|||
156342742|NCT02853604|564354401|FG000|Overall Study|Withdrawal by Subject|12|||
156342743|NCT02853604|564354402|FG001|Overall Study|Withdrawal by Subject|35|||
156342744|NCT02853604|564354401|FG000|Overall Study|Lost to Follow-up|4|||
156342745|NCT02853604|564354402|FG001|Overall Study|Lost to Follow-up|8|||
156342746|NCT02853604|564354401|FG000|Overall Study|Death|1|||
156342747|NCT02853604|564354402|FG001|Overall Study|Death|5|||
156342748|NCT02853604|564354401|FG000|Overall Study|Miscellaneous|11|||
156342749|NCT02853604|564354402|FG001|Overall Study|Miscellaneous|2|||
156342750|NCT02853604|564354401|FG000|Overall Study|Progressive Disease|0|||
156342751|NCT02853604|564354402|FG001|Overall Study|Progressive Disease|2|||
156342752|NCT00982878|564354417|FG000|Overall Study|Physician Decision|1|||
156342753|NCT01854710|564354418|FG000|Overall Study|Withdrawal by Subject|2|||
156342754|NCT01854710|564354419|FG001|Overall Study|Withdrawal by Subject|1|||
156342755|NCT01854710|564354420|FG002|Overall Study|Withdrawal by Subject|0|||
156342756|NCT01854710|564354421|FG003|Overall Study|Withdrawal by Subject|0|||
156542240|NCT03002155|565079292|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
156542241|NCT01087775|565079293|FG000|Overall Study|failed inclusion criteria|2|||
156473486|NCT00108355|564829259|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
156473487|NCT03214081|564829260|FG000|Overall Study|Case Report Forms Uncollected|9|||
156473488|NCT03214081|564829260|FG000|Overall Study|Protocol Deviation|54|||
156473489|NCT02962284|564829261|FG000|Overall Study|Death|2|||
156473490|NCT02962284|564829262|FG001|Overall Study|Death|0|||
156473491|NCT02962284|564829261|FG000|Overall Study|Progressive disease|2|||
156342757|NCT01854710|564354422|FG004|Overall Study|Withdrawal by Subject|0|||
156342758|NCT01854710|564354423|FG005|Overall Study|Withdrawal by Subject|0|||
156342759|NCT01854710|564354418|FG000|Overall Study|CRI procedural error|2|||
156342760|NCT01854710|564354419|FG001|Overall Study|CRI procedural error|2|||
156342761|NCT01854710|564354420|FG002|Overall Study|CRI procedural error|2|||
156342762|NCT01854710|564354421|FG003|Overall Study|CRI procedural error|2|||
156342763|NCT01854710|564354422|FG004|Overall Study|CRI procedural error|2|||
156342764|NCT01854710|564354423|FG005|Overall Study|CRI procedural error|2|||
156342765|NCT02573311|564354428|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
156342766|NCT02573311|564354429|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
156342767|NCT02573311|564354428|FG000|Disposition for Part 2|Physician Decision|25|||
156342768|NCT02573311|564354429|FG001|Disposition for Part 2|Physician Decision|7|||
156342769|NCT02573311|564354428|FG000|Disposition for Part 2|Adverse Event|36|||
156342770|NCT02573311|564354429|FG001|Disposition for Part 2|Adverse Event|5|||
156342771|NCT02573311|564354428|FG000|Disposition for Part 2|Lost to Follow-up|76|||
156342772|NCT02573311|564354429|FG001|Disposition for Part 2|Lost to Follow-up|7|||
156342773|NCT02573311|564354428|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
156342774|NCT02573311|564354429|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
156342775|NCT02573311|564354428|FG000|Disposition for Part 2|Investigator decision|0|||
156342776|NCT02573311|564354429|FG001|Disposition for Part 2|Investigator decision|1|||
156342777|NCT02573311|564354428|FG000|Disposition for Part 2|Other than specified above|13|||
156342778|NCT02573311|564354429|FG001|Disposition for Part 2|Other than specified above|3|||
156342779|NCT04862585|564354431|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
156342780|NCT04862585|564354432|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
156342781|NCT04862585|564354431|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
156342782|NCT04862585|564354432|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
156342783|NCT04862585|564354431|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
156342784|NCT04862585|564354432|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
156342785|NCT04862585|564354431|FG000|Overall Study|one withdrew without providing a reason|0|||
156473492|NCT02962284|564829262|FG001|Overall Study|Progressive disease|3|||
156473493|NCT02962284|564829261|FG000|Overall Study|Withdrawal by Subject|1|||
156473494|NCT02962284|564829262|FG001|Overall Study|Withdrawal by Subject|0|||
156473495|NCT02637063|564829263|FG000|Overall Study|Lost to Follow-up|3|||
156473496|NCT02637063|564829264|FG001|Overall Study|Lost to Follow-up|2|||
156542242|NCT00974675|565079296|FG000|Overall Study|Adverse Event|2|||
156473497|NCT02637063|564829265|FG002|Overall Study|Lost to Follow-up|3|||
156473498|NCT02637063|564829263|FG000|Overall Study|Withdrawal by Subject|2|||
156473499|NCT02637063|564829264|FG001|Overall Study|Withdrawal by Subject|2|||
156473500|NCT02637063|564829265|FG002|Overall Study|Withdrawal by Subject|3|||
156473501|NCT02634307|564829266|FG000|Overall Study|Adverse Event|50|||
156473502|NCT02634307|564829267|FG001|Overall Study|Adverse Event|24|||
156473503|NCT02634307|564829268|FG002|Overall Study|Adverse Event|14|||
156473504|NCT02634307|564829266|FG000|Overall Study|Lost to Follow-up|21|||
156473505|NCT02634307|564829267|FG001|Overall Study|Lost to Follow-up|5|||
156473506|NCT02634307|564829268|FG002|Overall Study|Lost to Follow-up|6|||
156342786|NCT04862585|564354432|FG001|Overall Study|one withdrew without providing a reason|1|||
156342787|NCT05229406|564354435|FG000|Overall Study|Withdrawal by Subject|1|||
156342788|NCT05229406|564354436|FG001|Overall Study|Withdrawal by Subject|2|||
156342789|NCT00702923|564354439|FG000|Overall Study|Adverse Event|1|||
156342790|NCT01233258|564354440|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
156342791|NCT01233258|564354441|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
156342792|NCT01233258|564354442|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
156342793|NCT01233258|564354443|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
156342794|NCT01233258|564354444|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
156342795|NCT01233258|564354445|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
156342796|NCT01233258|564354440|FG000|First Intervention (6 Months)|Protocol Violation|0|||
156342797|NCT01233258|564354441|FG001|First Intervention (6 Months)|Protocol Violation|0|||
156342798|NCT01233258|564354442|FG002|First Intervention (6 Months)|Protocol Violation|1|||
156342799|NCT01233258|564354443|FG003|First Intervention (6 Months)|Protocol Violation|0|||
156342800|NCT01233258|564354444|FG004|First Intervention (6 Months)|Protocol Violation|0|||
156342801|NCT01233258|564354445|FG005|First Intervention (6 Months)|Protocol Violation|0|||
156342802|NCT01233258|564354440|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
156342803|NCT01233258|564354441|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
156342804|NCT01233258|564354442|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
156473507|NCT02634307|564829266|FG000|Overall Study|Pregnancy|5|||
156473508|NCT02634307|564829267|FG001|Overall Study|Pregnancy|1|||
156542243|NCT00974675|565079297|FG001|Overall Study|Adverse Event|1|||
156859040|NCT00083889|566238686|FG000|Overall Study|Randomized: did not take study drug|0|||
156859041|NCT00083889|566238687|FG001|Overall Study|Randomized: did not take study drug|15|||
156859042|NCT00083889|566238686|FG000|Overall Study|Completed on marketed sunitinub|3|||
156859043|NCT00083889|566238687|FG001|Overall Study|Completed on marketed sunitinub|0|||
156859044|NCT00083889|566238686|FG000|Overall Study|Crossover to SU011248|0|||
156859045|NCT00083889|566238687|FG001|Overall Study|Crossover to SU011248|25|||
156859046|NCT03473236|566238688|FG000|Overall Study|Withdrawal by Subject|0|||
156859047|NCT03473236|566238689|FG001|Overall Study|Withdrawal by Subject|0|||
156859048|NCT03473236|566238690|FG002|Overall Study|Withdrawal by Subject|0|||
156859049|NCT03473236|566238691|FG003|Overall Study|Withdrawal by Subject|0|||
156859050|NCT03473236|566238692|FG004|Overall Study|Withdrawal by Subject|0|||
156859051|NCT03473236|566238693|FG005|Overall Study|Withdrawal by Subject|1|||
156859052|NCT03473236|566238694|FG006|Overall Study|Withdrawal by Subject|0|||
156859053|NCT03473236|566238695|FG007|Overall Study|Withdrawal by Subject|0|||
156859054|NCT03473236|566238696|FG008|Overall Study|Withdrawal by Subject|1|||
156473509|NCT02634307|564829268|FG002|Overall Study|Pregnancy|3|||
156542244|NCT00974675|565079298|FG002|Overall Study|Adverse Event|1|||
156342805|NCT01233258|564354443|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
156342806|NCT01233258|564354444|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
156342807|NCT01233258|564354445|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
156342808|NCT02795832|564354449|FG000|Overall Study|Adverse Event|0|||
156342809|NCT02795832|564354450|FG001|Overall Study|Adverse Event|0|||
156342810|NCT02795832|564354451|FG002|Overall Study|Adverse Event|0|||
156342811|NCT02795832|564354452|FG003|Overall Study|Adverse Event|0|||
156342812|NCT02795832|564354453|FG004|Overall Study|Adverse Event|0|||
156342813|NCT02795832|564354454|FG005|Overall Study|Adverse Event|3|||
156342814|NCT00221403|564354455|FG000|Overall Study|Protocol Violation|1|||
156342815|NCT00221403|564354456|FG001|Overall Study|Protocol Violation|0|||
156342816|NCT00221403|564354457|FG002|Overall Study|Protocol Violation|0|||
156342817|NCT00221403|564354455|FG000|Overall Study|Physician Decision|1|||
156342818|NCT00221403|564354456|FG001|Overall Study|Physician Decision|0|||
156342819|NCT00221403|564354457|FG002|Overall Study|Physician Decision|0|||
156342820|NCT00221403|564354455|FG000|Overall Study|Withdrawal by Subject|0|||
156342821|NCT00221403|564354456|FG001|Overall Study|Withdrawal by Subject|3|||
156342822|NCT00221403|564354457|FG002|Overall Study|Withdrawal by Subject|0|||
156342823|NCT00221403|564354455|FG000|Overall Study|Lack of Efficacy|0|||
156342824|NCT00221403|564354456|FG001|Overall Study|Lack of Efficacy|1|||
156342825|NCT00221403|564354457|FG002|Overall Study|Lack of Efficacy|0|||
156342826|NCT00221403|564354455|FG000|Overall Study|Adverse Event|0|||
156342827|NCT00221403|564354456|FG001|Overall Study|Adverse Event|1|||
156342828|NCT00221403|564354457|FG002|Overall Study|Adverse Event|0|||
156342829|NCT00256750|564354459|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
156342830|NCT00256750|564354460|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
156342831|NCT00256750|564354461|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
156342832|NCT00256750|564354459|FG000|Transplanted Pre-Treatment|Other|2|||
156342833|NCT00256750|564354460|FG001|Transplanted Pre-Treatment|Other|0|||
156342834|NCT00256750|564354461|FG002|Transplanted Pre-Treatment|Other|0|||
156342835|NCT00256750|564354459|FG000|Transplanted Pre-Treatment|Death|1|||
156542245|NCT00974675|565079299|FG003|Overall Study|Adverse Event|1|||
156542246|NCT00974675|565079296|FG000|Overall Study|Physician Decision|0|||
156859055|NCT03473236|566238697|FG009|Overall Study|Withdrawal by Subject|0|||
156859056|NCT04264442|566238698|FG000|Overall Study|Lack of Efficacy|6|||
156859057|NCT04264442|566238698|FG000|Overall Study|Lost to Follow-up|2|||
156859058|NCT04264442|566238698|FG000|Overall Study|Sponsor Decision|23|||
156859059|NCT04264442|566238698|FG000|Overall Study|Withdrawal by Subject|11|||
156859060|NCT04264442|566238698|FG000|Overall Study|Study Termination|5|||
156859061|NCT01290523|566238703|FG000|Overall Study|Death|3|||
156859062|NCT00584415|566238705|FG000|Overall Study|Adverse Event|7|||
156859063|NCT00556894|566238706|FG000|Overall Study|Adverse Event|2|||
156859064|NCT00556894|566238707|FG001|Overall Study|Adverse Event|3|||
156859065|NCT00556894|566238708|FG002|Overall Study|Adverse Event|3|||
156859066|NCT00556894|566238706|FG000|Overall Study|Death|1|||
156859067|NCT00556894|566238707|FG001|Overall Study|Death|0|||
156859068|NCT00556894|566238708|FG002|Overall Study|Death|0|||
156859069|NCT00556894|566238706|FG000|Overall Study|regulatory decision in Bulgaria|10|||
156859070|NCT00556894|566238707|FG001|Overall Study|regulatory decision in Bulgaria|14|||
156859071|NCT00556894|566238708|FG002|Overall Study|regulatory decision in Bulgaria|13|||
156859072|NCT00556894|566238706|FG000|Overall Study|Change in therapy|2|||
156859073|NCT00556894|566238707|FG001|Overall Study|Change in therapy|1|||
156859074|NCT00556894|566238708|FG002|Overall Study|Change in therapy|2|||
156859075|NCT00556894|566238706|FG000|Overall Study|Withdrawal by Subject|1|||
156859076|NCT00556894|566238707|FG001|Overall Study|Withdrawal by Subject|1|||
156859077|NCT00556894|566238708|FG002|Overall Study|Withdrawal by Subject|1|||
156859078|NCT03883581|566238709|FG000|Overall Study|Withdrawal by Subject|4|||
156859079|NCT01602224|566241119|FG000|Overall Study|Adverse Event|0|||
156859080|NCT01602224|566241120|FG001|Overall Study|Adverse Event|1|||
156859081|NCT01602224|566241121|FG002|Overall Study|Adverse Event|0|||
156859082|NCT01602224|566241119|FG000|Overall Study|Investigator Decison|1|||
156859083|NCT01602224|566241120|FG001|Overall Study|Investigator Decison|0|||
156859084|NCT01602224|566241121|FG002|Overall Study|Investigator Decison|0|||
156859085|NCT01602224|566241119|FG000|Overall Study|Lost to Follow-up|0|||
156859086|NCT01602224|566241120|FG001|Overall Study|Lost to Follow-up|0|||
156859087|NCT01602224|566241121|FG002|Overall Study|Lost to Follow-up|1|||
156859088|NCT01602224|566241119|FG000|Overall Study|Protocol Violation|0|||
156342836|NCT00256750|564354460|FG001|Transplanted Pre-Treatment|Death|0|||
156342837|NCT00256750|564354461|FG002|Transplanted Pre-Treatment|Death|0|||
156342838|NCT00256750|564354459|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
156342839|NCT00256750|564354460|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
156859089|NCT01602224|566241120|FG001|Overall Study|Protocol Violation|1|||
156859090|NCT01602224|566241121|FG002|Overall Study|Protocol Violation|0|||
156542247|NCT00974675|565079297|FG001|Overall Study|Physician Decision|0|||
156473510|NCT02634307|564829266|FG000|Overall Study|Withdrawal by Subject|38|||
156473511|NCT02634307|564829267|FG001|Overall Study|Withdrawal by Subject|24|||
156473512|NCT02634307|564829268|FG002|Overall Study|Withdrawal by Subject|18|||
156473513|NCT02634307|564829266|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156473514|NCT02634307|564829267|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156473515|NCT02634307|564829268|FG002|Overall Study|Non-Compliance with Study Drug|2|||
156473516|NCT02634307|564829266|FG000|Overall Study|Lack of Efficacy|1|||
156473517|NCT02634307|564829267|FG001|Overall Study|Lack of Efficacy|5|||
156473518|NCT02634307|564829268|FG002|Overall Study|Lack of Efficacy|3|||
156473519|NCT02634307|564829266|FG000|Overall Study|Physician Decision|7|||
156473520|NCT02634307|564829267|FG001|Overall Study|Physician Decision|5|||
156473521|NCT02634307|564829268|FG002|Overall Study|Physician Decision|5|||
156473522|NCT02634307|564829266|FG000|Overall Study|Reason not Specified|3|||
156473523|NCT02634307|564829267|FG001|Overall Study|Reason not Specified|5|||
156473524|NCT02634307|564829268|FG002|Overall Study|Reason not Specified|10|||
156473525|NCT01532648|564829274|FG000|Overall Study|Lost to Follow-up|3|||
156342840|NCT00256750|564354461|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
156342841|NCT00256750|564354459|FG000|Post-Transplant Treated (12 Months)|Death|3|||
156342842|NCT00256750|564354460|FG001|Post-Transplant Treated (12 Months)|Death|2|||
156473526|NCT01532648|564829275|FG001|Overall Study|Lost to Follow-up|4|||
156473527|NCT01532648|564829274|FG000|Overall Study|Lack of Efficacy|4|||
156473528|NCT01532648|564829275|FG001|Overall Study|Lack of Efficacy|1|||
156473529|NCT01532648|564829274|FG000|Overall Study|Protocol Violation|1|||
156473530|NCT01532648|564829275|FG001|Overall Study|Protocol Violation|1|||
156473531|NCT01532648|564829274|FG000|Overall Study|Adverse Event|12|||
156473532|NCT01532648|564829275|FG001|Overall Study|Adverse Event|9|||
156473533|NCT01532648|564829274|FG000|Overall Study|Withdrawal by Subject|16|||
156473534|NCT01532648|564829275|FG001|Overall Study|Withdrawal by Subject|2|||
156473535|NCT02824198|564829276|FG000|Overall Study|Non-compliance with the protocol|5|||
156473536|NCT02824198|564829277|FG001|Overall Study|Non-compliance with the protocol|1|||
156473537|NCT02824198|564829276|FG000|Overall Study|Lost to Follow-up|5|||
156473538|NCT02824198|564829277|FG001|Overall Study|Lost to Follow-up|2|||
156473539|NCT02824198|564829276|FG000|Overall Study|Withdrawal by Subject|5|||
156473540|NCT02824198|564829277|FG001|Overall Study|Withdrawal by Subject|0|||
156473541|NCT01256359|564829278|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
156473542|NCT01256359|564829279|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
156473543|NCT01256359|564829278|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
156473544|NCT01256359|564829279|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
156473545|NCT03292406|564829280|FG000|Overall Study|Progressive Disease|6|||
156473546|NCT03292406|564829281|FG001|Overall Study|Progressive Disease|3|||
156473547|NCT03292406|564829282|FG002|Overall Study|Progressive Disease|4|||
156473548|NCT03292406|564829280|FG000|Overall Study|Adverse Event|7|||
156473549|NCT03292406|564829281|FG001|Overall Study|Adverse Event|1|||
156473550|NCT03292406|564829282|FG002|Overall Study|Adverse Event|4|||
156473551|NCT03292406|564829280|FG000|Overall Study|Withdrawal by Subject|0|||
156473552|NCT03292406|564829281|FG001|Overall Study|Withdrawal by Subject|7|||
156473553|NCT03292406|564829282|FG002|Overall Study|Withdrawal by Subject|2|||
156473554|NCT03292406|564829280|FG000|Overall Study|Protocol Violation|0|||
156473555|NCT03292406|564829281|FG001|Overall Study|Protocol Violation|1|||
156473556|NCT03292406|564829282|FG002|Overall Study|Protocol Violation|1|||
156473557|NCT03292406|564829280|FG000|Overall Study|Other|0|||
156473558|NCT03292406|564829281|FG001|Overall Study|Other|1|||
156342843|NCT00256750|564354461|FG002|Post-Transplant Treated (12 Months)|Death|4|||
156473559|NCT03292406|564829282|FG002|Overall Study|Other|2|||
156473560|NCT02575365|564829283|FG000|Overall Study|Lost to Follow-up|4|||
156473561|NCT00487240|564829285|FG000|Overall Study|Withdrawal by Subject|12|||
156473562|NCT00487240|564829286|FG001|Overall Study|Withdrawal by Subject|6|||
156473563|NCT00487240|564829285|FG000|Overall Study|Lost to Follow-up|7|||
156473564|NCT00487240|564829286|FG001|Overall Study|Lost to Follow-up|6|||
156342844|NCT00256750|564354459|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
156342845|NCT00256750|564354460|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
156342846|NCT00256750|564354461|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
156473565|NCT00487240|564829285|FG000|Overall Study|Adverse Event|0|||
156473566|NCT00487240|564829286|FG001|Overall Study|Adverse Event|4|||
156473567|NCT00487240|564829285|FG000|Overall Study|Protocol Violation|5|||
156473568|NCT00487240|564829286|FG001|Overall Study|Protocol Violation|5|||
156473569|NCT00487240|564829285|FG000|Overall Study|Entry Criteria Not Met|3|||
156473570|NCT00487240|564829286|FG001|Overall Study|Entry Criteria Not Met|4|||
156473571|NCT00487240|564829285|FG000|Overall Study|Sponsor Decision|2|||
156473572|NCT00487240|564829286|FG001|Overall Study|Sponsor Decision|1|||
156473573|NCT00487240|564829285|FG000|Overall Study|Physician Decision|2|||
156473574|NCT00487240|564829286|FG001|Overall Study|Physician Decision|0|||
156473575|NCT01698918|564829287|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
156473576|NCT01698918|564829287|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
156473577|NCT01698918|564829287|FG000|First Line Treatment (Core+Extension)|Death|2|||
156473578|NCT01698918|564829287|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
156473579|NCT01698918|564829287|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
156473580|NCT01698918|564829287|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
156473581|NCT01698918|564829287|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
156473582|NCT01698918|564829287|FG000|Second Line Treatment (Core+Extension)|Death|1|||
156473583|NCT01698918|564829287|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
156473584|NCT01698918|564829287|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
156473585|NCT03176407|564829288|FG000|Overall Study|Protocol Violation|1|||
156473586|NCT03176407|564829288|FG000|Overall Study|human failure|1|||
156473587|NCT03176407|564829288|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
156473588|NCT00768755|564829289|FG000|Phase 1|Death|6|||
156473589|NCT00768755|564829290|FG001|Phase 1|Death|0|||
156473590|NCT00768755|564829291|FG002|Phase 1|Death|0|||
156473591|NCT00768755|564829292|FG003|Phase 1|Death|0|||
156473592|NCT00768755|564829289|FG000|Phase 1|Other|4|||
156473593|NCT00768755|564829290|FG001|Phase 1|Other|0|||
156473594|NCT00768755|564829291|FG002|Phase 1|Other|0|||
156473595|NCT00768755|564829292|FG003|Phase 1|Other|0|||
156473596|NCT00768755|564829289|FG000|Phase 2|Death|0|||
156473597|NCT00768755|564829290|FG001|Phase 2|Death|37|||
156473598|NCT00768755|564829291|FG002|Phase 2|Death|48|||
156473599|NCT00768755|564829292|FG003|Phase 2|Death|31|||
156473600|NCT00768755|564829289|FG000|Phase 2|Protocol Violation|0|||
156473601|NCT00768755|564829290|FG001|Phase 2|Protocol Violation|2|||
156473602|NCT00768755|564829291|FG002|Phase 2|Protocol Violation|0|||
156473603|NCT00768755|564829292|FG003|Phase 2|Protocol Violation|1|||
156473604|NCT00768755|564829289|FG000|Phase 2|Lost to Follow-up|0|||
156473605|NCT00768755|564829290|FG001|Phase 2|Lost to Follow-up|1|||
156473606|NCT00768755|564829291|FG002|Phase 2|Lost to Follow-up|1|||
156473607|NCT00768755|564829292|FG003|Phase 2|Lost to Follow-up|4|||
156473608|NCT00768755|564829289|FG000|Phase 2|Withdrawal by Subject|0|||
156473609|NCT00768755|564829290|FG001|Phase 2|Withdrawal by Subject|1|||
156473610|NCT00768755|564829291|FG002|Phase 2|Withdrawal by Subject|0|||
156473611|NCT00768755|564829292|FG003|Phase 2|Withdrawal by Subject|1|||
156473612|NCT00768755|564829289|FG000|Phase 2|Other|0|||
156473613|NCT00768755|564829290|FG001|Phase 2|Other|1|||
156473614|NCT00768755|564829291|FG002|Phase 2|Other|2|||
156473615|NCT00768755|564829292|FG003|Phase 2|Other|4|||
156473616|NCT00768755|564829289|FG000|Phase 2|Study Terminated by Sponsor|0|||
156473617|NCT00768755|564829290|FG001|Phase 2|Study Terminated by Sponsor|13|||
156473618|NCT00768755|564829291|FG002|Phase 2|Study Terminated by Sponsor|7|||
156473619|NCT00768755|564829292|FG003|Phase 2|Study Terminated by Sponsor|14|||
156473620|NCT00768755|564829289|FG000|Phase 2|Randomized but not treated|0|||
156473621|NCT00768755|564829290|FG001|Phase 2|Randomized but not treated|0|||
156473622|NCT00768755|564829291|FG002|Phase 2|Randomized but not treated|0|||
156473623|NCT00768755|564829292|FG003|Phase 2|Randomized but not treated|2|||
156473624|NCT00670488|564829293|FG000|Overall Study|Adverse Event|0|||
156473625|NCT00670488|564829294|FG001|Overall Study|Adverse Event|7|||
156473626|NCT00670488|564829295|FG002|Overall Study|Adverse Event|0|||
156473627|NCT00670488|564829296|FG003|Overall Study|Adverse Event|3|||
156473628|NCT00670488|564829297|FG004|Overall Study|Adverse Event|1|||
156473629|NCT00670488|564829298|FG005|Overall Study|Adverse Event|1|||
156473630|NCT00670488|564829299|FG006|Overall Study|Adverse Event|5|||
156473631|NCT00670488|564829300|FG007|Overall Study|Adverse Event|1|||
156473632|NCT00670488|564829301|FG008|Overall Study|Adverse Event|0|||
156473633|NCT00670488|564829302|FG009|Overall Study|Adverse Event|1|||
156473634|NCT00670488|564829293|FG000|Overall Study|Physician Decision|1|||
156473635|NCT00670488|564829294|FG001|Overall Study|Physician Decision|9|||
156473636|NCT00670488|564829295|FG002|Overall Study|Physician Decision|0|||
156473637|NCT00670488|564829296|FG003|Overall Study|Physician Decision|1|||
156342847|NCT00256750|564354459|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
156342848|NCT00256750|564354460|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
156342849|NCT00256750|564354461|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
156342850|NCT00256750|564354459|FG000|Post-Transplant Treated (12 Months)|Other|5|||
156342851|NCT00256750|564354460|FG001|Post-Transplant Treated (12 Months)|Other|4|||
156473638|NCT00670488|564829297|FG004|Overall Study|Physician Decision|0|||
156342852|NCT00256750|564354461|FG002|Post-Transplant Treated (12 Months)|Other|2|||
156473639|NCT00670488|564829298|FG005|Overall Study|Physician Decision|0|||
156473640|NCT00670488|564829299|FG006|Overall Study|Physician Decision|0|||
156473641|NCT00670488|564829300|FG007|Overall Study|Physician Decision|0|||
156473642|NCT00670488|564829301|FG008|Overall Study|Physician Decision|0|||
156473643|NCT00670488|564829302|FG009|Overall Study|Physician Decision|0|||
156473644|NCT00670488|564829293|FG000|Overall Study|Progressive Disease|2|||
156473645|NCT00670488|564829294|FG001|Overall Study|Progressive Disease|41|||
156473646|NCT00670488|564829295|FG002|Overall Study|Progressive Disease|3|||
156473647|NCT00670488|564829296|FG003|Overall Study|Progressive Disease|2|||
156473648|NCT00670488|564829297|FG004|Overall Study|Progressive Disease|2|||
156473649|NCT00670488|564829298|FG005|Overall Study|Progressive Disease|4|||
156473650|NCT00670488|564829299|FG006|Overall Study|Progressive Disease|11|||
156473651|NCT00670488|564829300|FG007|Overall Study|Progressive Disease|2|||
156473652|NCT00670488|564829301|FG008|Overall Study|Progressive Disease|2|||
156473653|NCT00670488|564829302|FG009|Overall Study|Progressive Disease|1|||
156473654|NCT00670488|564829293|FG000|Overall Study|Withdrawal by Subject|0|||
156473655|NCT00670488|564829294|FG001|Overall Study|Withdrawal by Subject|1|||
156473656|NCT00670488|564829295|FG002|Overall Study|Withdrawal by Subject|0|||
156473657|NCT00670488|564829296|FG003|Overall Study|Withdrawal by Subject|1|||
156342853|NCT00256750|564354459|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
156342854|NCT00256750|564354460|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
156473658|NCT00670488|564829297|FG004|Overall Study|Withdrawal by Subject|0|||
156473659|NCT00670488|564829298|FG005|Overall Study|Withdrawal by Subject|0|||
156473660|NCT00670488|564829299|FG006|Overall Study|Withdrawal by Subject|1|||
156473661|NCT00670488|564829300|FG007|Overall Study|Withdrawal by Subject|0|||
156473662|NCT00670488|564829301|FG008|Overall Study|Withdrawal by Subject|1|||
156473663|NCT00670488|564829302|FG009|Overall Study|Withdrawal by Subject|0|||
156473664|NCT04237792|564829303|FG000|Treatment (Day 1)|Adverse Event|1|||
156473665|NCT04237792|564829304|FG001|Treatment (Day 1)|Adverse Event|0|||
156473666|NCT04237792|564829305|FG002|Treatment (Day 1)|Adverse Event|0|||
156473667|NCT04237792|564829306|FG003|Treatment (Day 1)|Adverse Event|0|||
156473668|NCT04237792|564829307|FG004|Treatment (Day 1)|Adverse Event|1|||
156473669|NCT04237792|564829308|FG005|Treatment (Day 1)|Adverse Event|1|||
156473670|NCT04237792|564829303|FG000|Treatment (Day 1)|Other|0|||
156473671|NCT04237792|564829304|FG001|Treatment (Day 1)|Other|0|||
156473672|NCT04237792|564829305|FG002|Treatment (Day 1)|Other|1|||
156473673|NCT04237792|564829306|FG003|Treatment (Day 1)|Other|0|||
156473674|NCT04237792|564829307|FG004|Treatment (Day 1)|Other|0|||
156473675|NCT04237792|564829308|FG005|Treatment (Day 1)|Other|1|||
156473676|NCT04237792|564829303|FG000|Treatment (Day 1)|Not treated|1|||
156473677|NCT04237792|564829304|FG001|Treatment (Day 1)|Not treated|1|||
156473678|NCT04237792|564829305|FG002|Treatment (Day 1)|Not treated|2|||
156473679|NCT04237792|564829306|FG003|Treatment (Day 1)|Not treated|1|||
156473680|NCT04237792|564829307|FG004|Treatment (Day 1)|Not treated|0|||
156473681|NCT04237792|564829308|FG005|Treatment (Day 1)|Not treated|1|||
156473682|NCT04693637|564829309|FG000|Overall Study|Death|4|||
156473683|NCT04693637|564829309|FG000|Overall Study|Withdrawal by Subject|3|||
156473684|NCT04693637|564829309|FG000|Overall Study|Physician Decision|2|||
156473685|NCT04693637|564829309|FG000|Overall Study|Lost to Follow-up|1|||
156473686|NCT04885998|564829310|FG000|Overall Study|Withdrawal by Subject|0|||
156473687|NCT04885998|564829311|FG001|Overall Study|Withdrawal by Subject|2|||
156473688|NCT04885998|564829312|FG002|Overall Study|Withdrawal by Subject|0|||
156473689|NCT04885998|564829313|FG003|Overall Study|Withdrawal by Subject|3|||
156473690|NCT04885998|564829310|FG000|Overall Study|Lost to Follow-up|1|||
156473691|NCT04885998|564829311|FG001|Overall Study|Lost to Follow-up|1|||
156473692|NCT04885998|564829312|FG002|Overall Study|Lost to Follow-up|0|||
156473693|NCT04885998|564829313|FG003|Overall Study|Lost to Follow-up|0|||
156473694|NCT04885998|564829310|FG000|Overall Study|Death|2|||
156473695|NCT04885998|564829311|FG001|Overall Study|Death|1|||
156473696|NCT04885998|564829312|FG002|Overall Study|Death|2|||
156473697|NCT04885998|564829313|FG003|Overall Study|Death|2|||
156859091|NCT01602224|566241119|FG000|Overall Study|Sponsor Decision|2|||
156859092|NCT01602224|566241120|FG001|Overall Study|Sponsor Decision|3|||
156859093|NCT01602224|566241121|FG002|Overall Study|Sponsor Decision|2|||
156859094|NCT01602224|566241119|FG000|Overall Study|Withdrawal by Subject|5|||
156859095|NCT01602224|566241120|FG001|Overall Study|Withdrawal by Subject|3|||
156859096|NCT01602224|566241121|FG002|Overall Study|Withdrawal by Subject|3|||
156859097|NCT03346434|566241122|FG000|Overall Study|Randomized in Error|0|||
156859098|NCT03346434|566241123|FG001|Overall Study|Randomized in Error|0|||
156859099|NCT03346434|566241124|FG002|Overall Study|Randomized in Error|0|||
156859100|NCT03346434|566241125|FG003|Overall Study|Randomized in Error|0|||
156859101|NCT03346434|566241126|FG004|Overall Study|Randomized in Error|1|||
156859102|NCT03346434|566241127|FG005|Overall Study|Randomized in Error|0|||
156859103|NCT03346434|566241122|FG000|Overall Study|Withdrawal by Subject|0|||
156859104|NCT03346434|566241123|FG001|Overall Study|Withdrawal by Subject|0|||
156859105|NCT03346434|566241124|FG002|Overall Study|Withdrawal by Subject|1|||
156859106|NCT03346434|566241125|FG003|Overall Study|Withdrawal by Subject|0|||
156859107|NCT03346434|566241126|FG004|Overall Study|Withdrawal by Subject|1|||
156859108|NCT03346434|566241127|FG005|Overall Study|Withdrawal by Subject|0|||
156859109|NCT03346434|566241122|FG000|Overall Study|Lost to Follow-up|0|||
156859110|NCT03346434|566241123|FG001|Overall Study|Lost to Follow-up|0|||
156859111|NCT03346434|566241124|FG002|Overall Study|Lost to Follow-up|0|||
156859112|NCT03346434|566241125|FG003|Overall Study|Lost to Follow-up|0|||
156859113|NCT03346434|566241126|FG004|Overall Study|Lost to Follow-up|1|||
156859114|NCT03346434|566241127|FG005|Overall Study|Lost to Follow-up|1|||
156859115|NCT03346434|566241122|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
156859116|NCT03346434|566241123|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
156859117|NCT03346434|566241124|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
156859118|NCT03346434|566241125|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
156859119|NCT03346434|566241126|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
156859120|NCT03346434|566241127|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
156859121|NCT02741128|566241129|FG000|Overall Study|Protocol Violation|4|||
156859122|NCT02741128|566241130|FG001|Overall Study|Protocol Violation|1|||
156859123|NCT02741128|566241129|FG000|Overall Study|Withdrawal by Subject|2|||
156859124|NCT02741128|566241130|FG001|Overall Study|Withdrawal by Subject|0|||
156859125|NCT02741128|566241129|FG000|Overall Study|Lost to Follow-up|1|||
156859126|NCT02741128|566241130|FG001|Overall Study|Lost to Follow-up|0|||
156859127|NCT02081677|566241131|FG000|Overall Study|Adverse Event|0|||
156859128|NCT02081677|566241132|FG001|Overall Study|Adverse Event|0|||
156859129|NCT02081677|566241133|FG002|Overall Study|Adverse Event|1|||
156473698|NCT04885998|564829310|FG000|Overall Study|Decision by sponsor|1|||
156473699|NCT04885998|564829311|FG001|Overall Study|Decision by sponsor|1|||
156473700|NCT04885998|564829312|FG002|Overall Study|Decision by sponsor|0|||
156859130|NCT02081677|566241134|FG003|Overall Study|Adverse Event|0|||
156859131|NCT02081677|566241131|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156859132|NCT02081677|566241132|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156859133|NCT02081677|566241133|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
156473701|NCT04885998|564829313|FG003|Overall Study|Decision by sponsor|0|||
156473702|NCT05260437|564829314|FG000|Overall Study|Lost to Follow-up|5|||
156473703|NCT05260437|564829315|FG001|Overall Study|Lost to Follow-up|2|||
156473704|NCT05260437|564829316|FG002|Overall Study|Lost to Follow-up|1|||
156473705|NCT05260437|564829317|FG003|Overall Study|Lost to Follow-up|2|||
156473706|NCT05260437|564829318|FG004|Overall Study|Lost to Follow-up|2|||
156473707|NCT05260437|564829314|FG000|Overall Study|Withdrawal by Subject|3|||
156473708|NCT05260437|564829315|FG001|Overall Study|Withdrawal by Subject|0|||
156473709|NCT05260437|564829316|FG002|Overall Study|Withdrawal by Subject|4|||
156473710|NCT05260437|564829317|FG003|Overall Study|Withdrawal by Subject|5|||
156473711|NCT05260437|564829318|FG004|Overall Study|Withdrawal by Subject|0|||
156473712|NCT05260437|564829314|FG000|Overall Study|Vaccine Not Administered|0|||
156473713|NCT05260437|564829315|FG001|Overall Study|Vaccine Not Administered|1|||
156473714|NCT05260437|564829316|FG002|Overall Study|Vaccine Not Administered|0|||
156473715|NCT05260437|564829317|FG003|Overall Study|Vaccine Not Administered|0|||
156473716|NCT05260437|564829318|FG004|Overall Study|Vaccine Not Administered|0|||
156473717|NCT00910962|564829319|FG000|Overall Study|Adverse Event|5|||
156473718|NCT00910962|564829320|FG001|Overall Study|Adverse Event|20|||
156473719|NCT00910962|564829321|FG002|Overall Study|Adverse Event|17|||
156473720|NCT00910962|564829319|FG000|Overall Study|Protocol Violation|1|||
156473721|NCT00910962|564829320|FG001|Overall Study|Protocol Violation|3|||
156859134|NCT02081677|566241134|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156859135|NCT02081677|566241131|FG000|Overall Study|Not comfortable with lens care system|1|||
156859136|NCT02081677|566241132|FG001|Overall Study|Not comfortable with lens care system|0|||
156859137|NCT02081677|566241133|FG002|Overall Study|Not comfortable with lens care system|0|||
156859138|NCT02081677|566241134|FG003|Overall Study|Not comfortable with lens care system|0|||
156859139|NCT02081677|566241131|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
156859140|NCT02081677|566241132|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
156859141|NCT02081677|566241133|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
156859142|NCT02081677|566241134|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
156859143|NCT01419769|566241135|FG000|Overall Study|Did not receive the AXIOS stent|3|||
156859144|NCT01419769|566241135|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
156859145|NCT00812708|566241138|FG000|Overall Study|Device could not be implanted|2|||
156859146|NCT00812708|566241138|FG000|Overall Study|Lack of medical insurance|1|||
156859147|NCT00812708|566241138|FG000|Overall Study|Switched to another study|1|||
156859148|NCT00812708|566241138|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
156859149|NCT00812708|566241138|FG000|Overall Study|Signed consent but later withdrew|3|||
156859150|NCT03598036|566241144|FG000|Overall Study|Withdrawal by Subject|1|||
156859151|NCT03598036|566241145|FG001|Overall Study|Withdrawal by Subject|0|||
156859152|NCT04235140|566241146|FG000|Overall Study|Adverse Event|2|||
156859153|NCT04235140|566241146|FG000|Overall Study|Lost to Follow-up|1|||
156859154|NCT04235140|566241146|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
156859155|NCT04235140|566241146|FG000|Overall Study|Commercial drug is available for participants|7|||
156859156|NCT02587520|566241147|FG000|Overall Study|Protocol Violation|2|||
156859157|NCT02587520|566241148|FG001|Overall Study|Protocol Violation|0|||
156859158|NCT02587520|566241149|FG002|Overall Study|Protocol Violation|0|||
156859159|NCT02587520|566241150|FG003|Overall Study|Protocol Violation|2|||
156859160|NCT02587520|566241151|FG004|Overall Study|Protocol Violation|0|||
156859161|NCT02587520|566241152|FG005|Overall Study|Protocol Violation|1|||
156859162|NCT02587520|566241153|FG006|Overall Study|Protocol Violation|1|||
156859163|NCT02587520|566241154|FG007|Overall Study|Protocol Violation|1|||
156859164|NCT02587520|566241155|FG008|Overall Study|Protocol Violation|3|||
156859165|NCT02587520|566241156|FG009|Overall Study|Protocol Violation|3|||
156859166|NCT02587520|566241157|FG010|Overall Study|Protocol Violation|1|||
156859167|NCT02587520|566241158|FG011|Overall Study|Protocol Violation|2|||
156859168|NCT02587520|566241159|FG012|Overall Study|Protocol Violation|0|||
156859169|NCT02587520|566241160|FG013|Overall Study|Protocol Violation|0|||
156859170|NCT02587520|566241161|FG014|Overall Study|Protocol Violation|0|||
156859171|NCT02587520|566241162|FG015|Overall Study|Protocol Violation|0|||
156859172|NCT02587520|566241163|FG016|Overall Study|Protocol Violation|0|||
156859173|NCT02587520|566241164|FG017|Overall Study|Protocol Violation|0|||
156859174|NCT02587520|566241147|FG000|Overall Study|Adverse Event|0|||
156859175|NCT02587520|566241148|FG001|Overall Study|Adverse Event|0|||
156859176|NCT02587520|566241149|FG002|Overall Study|Adverse Event|0|||
156859177|NCT02587520|566241150|FG003|Overall Study|Adverse Event|0|||
156342855|NCT00256750|564354461|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
156342856|NCT00256750|564354459|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
156473722|NCT00910962|564829321|FG002|Overall Study|Protocol Violation|3|||
156473723|NCT00910962|564829319|FG000|Overall Study|Lost to Follow-up|0|||
156473724|NCT00910962|564829320|FG001|Overall Study|Lost to Follow-up|3|||
156473725|NCT00910962|564829321|FG002|Overall Study|Lost to Follow-up|1|||
156473726|NCT00910962|564829319|FG000|Overall Study|Physician Decision|0|||
156473727|NCT00910962|564829320|FG001|Overall Study|Physician Decision|6|||
156473728|NCT00910962|564829321|FG002|Overall Study|Physician Decision|6|||
156473729|NCT00910962|564829319|FG000|Overall Study|Withdrawal by Subject|25|||
156473730|NCT00910962|564829320|FG001|Overall Study|Withdrawal by Subject|32|||
156342857|NCT00256750|564354460|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
156342858|NCT00256750|564354461|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
156342859|NCT00256750|564354459|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
156342860|NCT00256750|564354460|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
156342861|NCT00256750|564354461|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
156473731|NCT00910962|564829321|FG002|Overall Study|Withdrawal by Subject|32|||
156342862|NCT00256750|564354459|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
156342863|NCT00256750|564354460|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
156342864|NCT00256750|564354461|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
156473732|NCT00910962|564829319|FG000|Overall Study|Reached defined stopping criteria|12|||
156473733|NCT00910962|564829320|FG001|Overall Study|Reached defined stopping criteria|14|||
156473734|NCT00910962|564829321|FG002|Overall Study|Reached defined stopping criteria|17|||
156473735|NCT00195819|564829322|FG000|Double-Blind|Withdrawal by Subject|1|||
156473736|NCT00195819|564829323|FG001|Double-Blind|Withdrawal by Subject|0|||
156473737|NCT00195819|564829322|FG000|Double-Blind|Moved|1|||
156473738|NCT00195819|564829323|FG001|Double-Blind|Moved|0|||
156342865|NCT00256750|564354459|FG000|Post-Transplant Treated (24 Months)|Death|3|||
156342866|NCT00256750|564354460|FG001|Post-Transplant Treated (24 Months)|Death|0|||
156342867|NCT00256750|564354461|FG002|Post-Transplant Treated (24 Months)|Death|0|||
156342868|NCT00256750|564354459|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
156342869|NCT00256750|564354460|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
156342870|NCT00256750|564354461|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
156342871|NCT00256750|564354459|FG000|Post-Transplant Treated (24 Months)|Other|2|||
156342872|NCT00256750|564354460|FG001|Post-Transplant Treated (24 Months)|Other|0|||
156342873|NCT00256750|564354461|FG002|Post-Transplant Treated (24 Months)|Other|1|||
156342874|NCT00256750|564354459|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
156342875|NCT00256750|564354460|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
156473739|NCT00195819|564829322|FG000|Open-label|Adverse Event|0|||
156473740|NCT00195819|564829323|FG001|Open-label|Adverse Event|9|||
156473741|NCT00195819|564829322|FG000|Open-label|Lack of Efficacy|0|||
156473742|NCT00195819|564829323|FG001|Open-label|Lack of Efficacy|2|||
156473743|NCT00195819|564829322|FG000|Open-label|Pregnancy|0|||
156473744|NCT00195819|564829323|FG001|Open-label|Pregnancy|1|||
156473745|NCT00195819|564829322|FG000|Open-label|Protocol Violation|0|||
156473746|NCT00195819|564829323|FG001|Open-label|Protocol Violation|2|||
156473747|NCT00195819|564829322|FG000|Open-label|Moved|0|||
156473748|NCT00195819|564829323|FG001|Open-label|Moved|1|||
156473749|NCT00195819|564829322|FG000|Open-label|Withdrawal by Subject|0|||
156473750|NCT00195819|564829323|FG001|Open-label|Withdrawal by Subject|5|||
156473751|NCT00787176|564829324|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
156473752|NCT00787176|564829325|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
156473753|NCT00787176|564829326|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
156473754|NCT00787176|564829327|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
156473755|NCT03298087|564829329|FG000|Overall Study|Withdrawal by Subject|4|||
156473756|NCT01303510|564829330|FG000|Overall Study|Lost to Follow-up|1|||
156473757|NCT01303510|564829331|FG001|Overall Study|Lost to Follow-up|0|||
156473758|NCT02022670|564829334|FG000|Overall Study|Adverse Event|1|||
156473759|NCT02022670|564829335|FG001|Overall Study|Adverse Event|0|||
156473760|NCT02022670|564829336|FG002|Overall Study|Adverse Event|1|||
156473761|NCT02113449|564829337|FG000|Overall Study|Adverse Event|4|||
156473762|NCT04638816|564829338|FG000|Overall Study|Withdrawal by Subject|0|||
156473763|NCT04638816|564829339|FG001|Overall Study|Withdrawal by Subject|1|||
156473764|NCT04638816|564829338|FG000|Overall Study|Lost to Follow-up|0|||
156473765|NCT04638816|564829339|FG001|Overall Study|Lost to Follow-up|1|||
156473766|NCT01328496|564829342|FG000|Overall Study|Significant Change in Health Status|1|||
156473767|NCT01328496|564829343|FG001|Overall Study|Significant Change in Health Status|0|||
156473768|NCT02208843|564829346|FG000|Overall Study|Clinical symptoms of progression|2|||
156473769|NCT02208843|564829346|FG000|Overall Study|Progression disease according to RECIST|24|||
156473770|NCT02208843|564829346|FG000|Overall Study|Adverse Event|12|||
156473771|NCT02208843|564829346|FG000|Overall Study|Protocol Violation|1|||
156473772|NCT02208843|564829346|FG000|Overall Study|Withdrawal by Subject|1|||
156473773|NCT02208843|564829346|FG000|Overall Study|Switched to commercial afatinib|20|||
156473774|NCT04248803|564829351|FG000|Overall Study|Lost to Follow-up|7|||
156473775|NCT04248803|564829352|FG001|Overall Study|Lost to Follow-up|7|||
156473776|NCT04248803|564829353|FG002|Overall Study|Lost to Follow-up|7|||
156473777|NCT04248803|564829354|FG003|Overall Study|Lost to Follow-up|7|||
156473778|NCT04248803|564829355|FG004|Overall Study|Lost to Follow-up|7|||
156473779|NCT04248803|564829356|FG005|Overall Study|Lost to Follow-up|7|||
156473780|NCT05352230|564829357|FG000|First Intervention (3 Months)|study terminated|2|||
156473781|NCT05352230|564829358|FG001|First Intervention (3 Months)|study terminated|2|||
156473782|NCT04399837|564829359|FG000|Overall Study|Other than listed|0|||
156473783|NCT04399837|564829360|FG001|Overall Study|Other than listed|2|||
156342876|NCT00256750|564354461|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
156342877|NCT00256750|564354459|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
156342878|NCT00256750|564354460|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
156473784|NCT04399837|564829361|FG002|Overall Study|Other than listed|2|||
156473785|NCT04399837|564829362|FG003|Overall Study|Other than listed|3|||
156473786|NCT04399837|564829359|FG000|Overall Study|Withdrawal by Subject|1|||
156473787|NCT04399837|564829360|FG001|Overall Study|Withdrawal by Subject|2|||
156473788|NCT04399837|564829361|FG002|Overall Study|Withdrawal by Subject|1|||
156473789|NCT04399837|564829362|FG003|Overall Study|Withdrawal by Subject|1|||
156473790|NCT02060487|564829363|FG000|Overall Study|Other|1|||
156473791|NCT02060487|564829364|FG001|Overall Study|Other|2|||
156473792|NCT02060487|564829365|FG002|Overall Study|Other|1|||
156473793|NCT02060487|564829363|FG000|Overall Study|Lack of Efficacy|0|||
156473794|NCT02060487|564829364|FG001|Overall Study|Lack of Efficacy|1|||
156473795|NCT02060487|564829365|FG002|Overall Study|Lack of Efficacy|0|||
156473796|NCT02060487|564829363|FG000|Overall Study|Withdrawal by Subject|3|||
156473797|NCT02060487|564829364|FG001|Overall Study|Withdrawal by Subject|10|||
156473798|NCT02060487|564829365|FG002|Overall Study|Withdrawal by Subject|4|||
156473799|NCT02060487|564829363|FG000|Overall Study|Study Terminated By Sponsor|87|||
156473800|NCT02060487|564829364|FG001|Overall Study|Study Terminated By Sponsor|89|||
156542248|NCT00974675|565079298|FG002|Overall Study|Physician Decision|1|||
156473801|NCT02060487|564829365|FG002|Overall Study|Study Terminated By Sponsor|100|||
156473802|NCT02060487|564829363|FG000|Overall Study|Randomized in error|1|||
156473803|NCT02060487|564829364|FG001|Overall Study|Randomized in error|0|||
156473804|NCT02060487|564829365|FG002|Overall Study|Randomized in error|0|||
156342879|NCT00256750|564354461|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
156342880|NCT00256750|564354459|FG000|Post-Transplant Treated (36 Months)|Death|0|||
156473805|NCT02060487|564829363|FG000|Overall Study|Protocol Violation|0|||
156473806|NCT02060487|564829364|FG001|Overall Study|Protocol Violation|1|||
156473807|NCT02060487|564829365|FG002|Overall Study|Protocol Violation|1|||
156473808|NCT02060487|564829363|FG000|Overall Study|Lost to Follow-up|3|||
156473809|NCT02060487|564829364|FG001|Overall Study|Lost to Follow-up|0|||
156473810|NCT02060487|564829365|FG002|Overall Study|Lost to Follow-up|2|||
156473811|NCT02060487|564829363|FG000|Overall Study|Death|34|||
156473812|NCT02060487|564829364|FG001|Overall Study|Death|25|||
156473813|NCT02060487|564829365|FG002|Overall Study|Death|19|||
156342881|NCT00256750|564354460|FG001|Post-Transplant Treated (36 Months)|Death|2|||
156342882|NCT00256750|564354461|FG002|Post-Transplant Treated (36 Months)|Death|1|||
156342883|NCT00256750|564354459|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
156342884|NCT00256750|564354460|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
156342885|NCT00256750|564354461|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
156342886|NCT00256750|564354459|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
156342887|NCT00256750|564354460|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
156342888|NCT00256750|564354461|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
156342889|NCT00256750|564354459|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
156342890|NCT00256750|564354460|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
156342891|NCT00256750|564354461|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
156342892|NCT00256750|564354459|FG000|Post-Transplant Treated (36 Months)|Other|0|||
156342893|NCT00256750|564354460|FG001|Post-Transplant Treated (36 Months)|Other|1|||
156342894|NCT00256750|564354461|FG002|Post-Transplant Treated (36 Months)|Other|1|||
156342895|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
156342896|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
156342897|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
156342898|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
156342899|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
156342900|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
156342901|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
156542249|NCT00974675|565079299|FG003|Overall Study|Physician Decision|0|||
156542250|NCT00974675|565079296|FG000|Overall Study|Participant on holiday; unable to attend|0|||
156542251|NCT00974675|565079297|FG001|Overall Study|Participant on holiday; unable to attend|0|||
156342902|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
156342903|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
156342904|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
156342905|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
156342906|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
156342907|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
156342908|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
156342909|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
156342910|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
156342911|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
156342912|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
156342913|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
156342914|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
156342915|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
156342916|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
156342917|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
156342918|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
156342919|NCT00256750|564354459|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
156342920|NCT00256750|564354460|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
156342921|NCT00256750|564354461|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
156342922|NCT01348165|564354462|FG000|Overall Study|Adverse Event|0|||
156342923|NCT01348165|564354463|FG001|Overall Study|Adverse Event|0|||
156342924|NCT01348165|564354464|FG002|Overall Study|Adverse Event|0|||
156342925|NCT01348165|564354465|FG003|Overall Study|Adverse Event|0|||
156342926|NCT01348165|564354466|FG004|Overall Study|Adverse Event|0|||
156342927|NCT01348165|564354467|FG005|Overall Study|Adverse Event|0|||
156342928|NCT01348165|564354468|FG006|Overall Study|Adverse Event|1|||
156342929|NCT03648983|564354473|FG000|Overall Study|Study was terminated due to PI departure|95|||
156342930|NCT01269463|564354474|FG000|First Intervention|Withdrawal by Subject|1|||
156342931|NCT01269463|564354475|FG001|First Intervention|Withdrawal by Subject|0|||
156342932|NCT01269463|564354474|FG000|First Intervention|Adverse Event|1|||
156342933|NCT01269463|564354475|FG001|First Intervention|Adverse Event|0|||
156342934|NCT01269463|564354474|FG000|First Intervention|Lack of Efficacy|0|||
156342935|NCT01269463|564354475|FG001|First Intervention|Lack of Efficacy|1|||
156342936|NCT01269463|564354474|FG000|First Intervention|Physician Decision|0|||
156342937|NCT01269463|564354475|FG001|First Intervention|Physician Decision|1|||
156342938|NCT00279305|564354478|FG000|Overall Study|Pregnancy|1|||
156342939|NCT00279305|564354479|FG001|Overall Study|Pregnancy|0|||
156342940|NCT00279305|564354478|FG000|Overall Study|Withdrawal by Subject|2|||
156342941|NCT00279305|564354479|FG001|Overall Study|Withdrawal by Subject|0|||
156342942|NCT00279305|564354478|FG000|Overall Study|Dificulting establishing IV|1|||
156342943|NCT00279305|564354479|FG001|Overall Study|Dificulting establishing IV|0|||
156342944|NCT00279305|564354478|FG000|Overall Study|FDA Safety Alert|4|||
156342945|NCT00279305|564354479|FG001|Overall Study|FDA Safety Alert|1|||
156342946|NCT04404361|564354480|FG000|Overall Study|Death|12|||
156342947|NCT04404361|564354481|FG001|Overall Study|Death|12|||
156342948|NCT04404361|564354480|FG000|Overall Study|Withdrawal by Subject|13|||
156342949|NCT04404361|564354481|FG001|Overall Study|Withdrawal by Subject|5|||
156342950|NCT04404361|564354480|FG000|Overall Study|Lost to Follow-up|6|||
156342951|NCT04404361|564354481|FG001|Overall Study|Lost to Follow-up|3|||
156342952|NCT04404361|564354480|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
156342953|NCT04404361|564354481|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
156342954|NCT00558558|564354482|FG000|Overall Study|Unable to swallow|1|||
156342955|NCT00558558|564354482|FG000|Overall Study|Withdrawal by Subject|1|||
156342956|NCT00558558|564354482|FG000|Overall Study|Lack of Efficacy|4|||
156342957|NCT02549937|564354484|FG000|Overall Study|Death|0|||
156342958|NCT02549937|564354485|FG001|Overall Study|Death|1|||
156342959|NCT02549937|564354486|FG002|Overall Study|Death|0|||
156342960|NCT02549937|564354487|FG003|Overall Study|Death|1|||
156342961|NCT02549937|564354488|FG004|Overall Study|Death|0|||
156342962|NCT02549937|564354489|FG005|Overall Study|Death|8|||
156342963|NCT02549937|564354490|FG006|Overall Study|Death|0|||
156342964|NCT02549937|564354491|FG007|Overall Study|Death|0|||
156342965|NCT02549937|564354492|FG008|Overall Study|Death|19|||
156342966|NCT02549937|564354484|FG000|Overall Study|No follow up required|3|||
156342967|NCT02549937|564354485|FG001|Overall Study|No follow up required|6|||
156473814|NCT02060487|564829363|FG000|Overall Study|Adverse Event|0|||
156473815|NCT02060487|564829364|FG001|Overall Study|Adverse Event|0|||
156473816|NCT02060487|564829365|FG002|Overall Study|Adverse Event|1|||
156473817|NCT03697603|564829366|FG000|Overall Study|Adverse Event|3|||
156342968|NCT02549937|564354486|FG002|Overall Study|No follow up required|3|||
156342969|NCT02549937|564354487|FG003|Overall Study|No follow up required|8|||
156342970|NCT02549937|564354488|FG004|Overall Study|No follow up required|12|||
156342971|NCT02549937|564354489|FG005|Overall Study|No follow up required|21|||
156473818|NCT03697603|564829367|FG001|Overall Study|Adverse Event|18|||
156473819|NCT03697603|564829368|FG002|Overall Study|Adverse Event|3|||
156473820|NCT03697603|564829366|FG000|Overall Study|Physician Decision|1|||
156473821|NCT03697603|564829367|FG001|Overall Study|Physician Decision|0|||
156342972|NCT02549937|564354490|FG006|Overall Study|No follow up required|9|||
156342973|NCT02549937|564354491|FG007|Overall Study|No follow up required|11|||
156342974|NCT02549937|564354492|FG008|Overall Study|No follow up required|0|||
156473822|NCT03697603|564829368|FG002|Overall Study|Physician Decision|2|||
156473823|NCT03697603|564829366|FG000|Overall Study|Protocol Violation|3|||
156473824|NCT03697603|564829367|FG001|Overall Study|Protocol Violation|8|||
156473825|NCT03697603|564829368|FG002|Overall Study|Protocol Violation|5|||
156473826|NCT03697603|564829366|FG000|Overall Study|Withdrawal by Subject|5|||
156473827|NCT03697603|564829367|FG001|Overall Study|Withdrawal by Subject|1|||
156473828|NCT03697603|564829368|FG002|Overall Study|Withdrawal by Subject|1|||
156473829|NCT03697603|564829366|FG000|Overall Study|Protocol Violation|0|||
156473830|NCT03697603|564829367|FG001|Overall Study|Protocol Violation|0|||
156473831|NCT03697603|564829368|FG002|Overall Study|Protocol Violation|1|||
156473832|NCT05182606|564829369|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
156473833|NCT02309294|564829370|FG000|Overall Study|Withdrawal by Subject|2|||
156473834|NCT03683030|564829373|FG000|Overall Study|Enrolled but screen failures|12|||
156473835|NCT03683030|564829374|FG001|Overall Study|Enrolled but screen failures|7|||
156473836|NCT03683030|564829373|FG000|Overall Study|Enrolled but no catheter inserted|11|||
156473837|NCT03683030|564829374|FG001|Overall Study|Enrolled but no catheter inserted|13|||
156473838|NCT03683030|564829373|FG000|Overall Study|Withdrawal by Subject|0|||
156473839|NCT03683030|564829374|FG001|Overall Study|Withdrawal by Subject|2|||
156473840|NCT03683030|564829373|FG000|Overall Study|Early termination by subject|1|||
156473841|NCT03683030|564829374|FG001|Overall Study|Early termination by subject|0|||
156473842|NCT03683030|564829373|FG000|Overall Study|Lost to Follow-up|0|||
156473843|NCT03683030|564829374|FG001|Overall Study|Lost to Follow-up|6|||
156473844|NCT03683030|564829373|FG000|Overall Study|Death|0|||
156473845|NCT03683030|564829374|FG001|Overall Study|Death|2|||
156473846|NCT03683030|564829373|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
156473847|NCT03683030|564829374|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
156473848|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
156473849|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
156473850|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
156473851|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
156473852|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
156473853|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
156473854|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
156473855|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
156859178|NCT02587520|566241151|FG004|Overall Study|Adverse Event|0|||
156859179|NCT02587520|566241152|FG005|Overall Study|Adverse Event|0|||
156859180|NCT02587520|566241153|FG006|Overall Study|Adverse Event|0|||
156859181|NCT02587520|566241154|FG007|Overall Study|Adverse Event|0|||
156859182|NCT02587520|566241155|FG008|Overall Study|Adverse Event|0|||
156859183|NCT02587520|566241156|FG009|Overall Study|Adverse Event|0|||
156859184|NCT02587520|566241157|FG010|Overall Study|Adverse Event|0|||
156859185|NCT02587520|566241158|FG011|Overall Study|Adverse Event|1|||
156859186|NCT02587520|566241159|FG012|Overall Study|Adverse Event|0|||
156859187|NCT02587520|566241160|FG013|Overall Study|Adverse Event|0|||
156859188|NCT02587520|566241161|FG014|Overall Study|Adverse Event|0|||
156859189|NCT02587520|566241162|FG015|Overall Study|Adverse Event|0|||
156859190|NCT02587520|566241163|FG016|Overall Study|Adverse Event|0|||
156859191|NCT02587520|566241164|FG017|Overall Study|Adverse Event|0|||
156859192|NCT02587520|566241147|FG000|Overall Study|Withdrawal by Subject|0|||
156859193|NCT02587520|566241148|FG001|Overall Study|Withdrawal by Subject|0|||
156859194|NCT02587520|566241149|FG002|Overall Study|Withdrawal by Subject|1|||
156859195|NCT02587520|566241150|FG003|Overall Study|Withdrawal by Subject|1|||
156859196|NCT02587520|566241151|FG004|Overall Study|Withdrawal by Subject|0|||
156859197|NCT02587520|566241152|FG005|Overall Study|Withdrawal by Subject|1|||
156859198|NCT02587520|566241153|FG006|Overall Study|Withdrawal by Subject|1|||
156859199|NCT02587520|566241154|FG007|Overall Study|Withdrawal by Subject|0|||
156859200|NCT02587520|566241155|FG008|Overall Study|Withdrawal by Subject|0|||
156859201|NCT02587520|566241156|FG009|Overall Study|Withdrawal by Subject|0|||
156859202|NCT02587520|566241157|FG010|Overall Study|Withdrawal by Subject|0|||
156859203|NCT02587520|566241158|FG011|Overall Study|Withdrawal by Subject|0|||
156859204|NCT02587520|566241159|FG012|Overall Study|Withdrawal by Subject|0|||
156859205|NCT02587520|566241160|FG013|Overall Study|Withdrawal by Subject|1|||
156859206|NCT02587520|566241161|FG014|Overall Study|Withdrawal by Subject|0|||
156859207|NCT02587520|566241162|FG015|Overall Study|Withdrawal by Subject|0|||
156859208|NCT02587520|566241163|FG016|Overall Study|Withdrawal by Subject|0|||
156859209|NCT02587520|566241164|FG017|Overall Study|Withdrawal by Subject|0|||
156859210|NCT02587520|566241147|FG000|Overall Study|Lost to Follow-up|0|||
156859211|NCT02587520|566241148|FG001|Overall Study|Lost to Follow-up|2|||
156859212|NCT02587520|566241149|FG002|Overall Study|Lost to Follow-up|0|||
156859213|NCT02587520|566241150|FG003|Overall Study|Lost to Follow-up|2|||
156859214|NCT02587520|566241151|FG004|Overall Study|Lost to Follow-up|0|||
156859215|NCT02587520|566241152|FG005|Overall Study|Lost to Follow-up|1|||
156859216|NCT02587520|566241153|FG006|Overall Study|Lost to Follow-up|1|||
156859217|NCT02587520|566241154|FG007|Overall Study|Lost to Follow-up|1|||
156859218|NCT02587520|566241155|FG008|Overall Study|Lost to Follow-up|0|||
156542252|NCT00974675|565079298|FG002|Overall Study|Participant on holiday; unable to attend|0|||
156342975|NCT02549937|564354484|FG000|Overall Study|Other|0|||
156342976|NCT02549937|564354485|FG001|Overall Study|Other|0|||
156342977|NCT02549937|564354486|FG002|Overall Study|Other|0|||
156542253|NCT00974675|565079299|FG003|Overall Study|Participant on holiday; unable to attend|1|||
156542254|NCT04744207|565079301|FG000|Treatment|Withdrawal by Subject|2|||
156342978|NCT02549937|564354487|FG003|Overall Study|Other|0|||
156342979|NCT02549937|564354488|FG004|Overall Study|Other|1|||
156859219|NCT02587520|566241156|FG009|Overall Study|Lost to Follow-up|2|||
156859220|NCT02587520|566241157|FG010|Overall Study|Lost to Follow-up|2|||
156859221|NCT02587520|566241158|FG011|Overall Study|Lost to Follow-up|1|||
156859222|NCT02587520|566241159|FG012|Overall Study|Lost to Follow-up|0|||
156859223|NCT02587520|566241160|FG013|Overall Study|Lost to Follow-up|0|||
156859224|NCT02587520|566241161|FG014|Overall Study|Lost to Follow-up|0|||
156859225|NCT02587520|566241162|FG015|Overall Study|Lost to Follow-up|0|||
156859226|NCT02587520|566241163|FG016|Overall Study|Lost to Follow-up|0|||
156859227|NCT02587520|566241164|FG017|Overall Study|Lost to Follow-up|0|||
156859228|NCT00672555|566241165|FG000|Overall Study|Lost to Follow-up|4|||
156859229|NCT00672555|566241165|FG000|Overall Study|Did not want to answer questionnaire|2|||
156859230|NCT04516746|566241168|FG000|Overall Study|Randomized but not Treated|51|||
156859231|NCT04516746|566241169|FG001|Overall Study|Randomized but not Treated|19|||
156859232|NCT04516746|566241168|FG000|Overall Study|Adverse Event|0|||
156859233|NCT04516746|566241169|FG001|Overall Study|Adverse Event|1|||
156859234|NCT04516746|566241168|FG000|Overall Study|Death|62|||
156859235|NCT04516746|566241169|FG001|Overall Study|Death|32|||
156859236|NCT04516746|566241168|FG000|Overall Study|Lost to Follow-up|3431|||
156859237|NCT04516746|566241169|FG001|Overall Study|Lost to Follow-up|1831|||
156859238|NCT04516746|566241168|FG000|Overall Study|Withdrawal by Subject|1946|||
156859239|NCT04516746|566241169|FG001|Overall Study|Withdrawal by Subject|1696|||
156859240|NCT04516746|566241168|FG000|Overall Study|Physician Decision|10|||
156859241|NCT04516746|566241169|FG001|Overall Study|Physician Decision|8|||
156859242|NCT04516746|566241168|FG000|Overall Study|Other|35|||
156859243|NCT04516746|566241169|FG001|Overall Study|Other|16|||
156859244|NCT00446849|566241171|FG000|Acute Phase|Lack of Efficacy|64|||
156859245|NCT00446849|566241171|FG000|Acute Phase|Protocol Violation|10|||
156859246|NCT00446849|566241171|FG000|Acute Phase|Consent withdrawn|4|||
156859247|NCT00446849|566241171|FG000|Acute Phase|Lost to Follow-up|2|||
156859248|NCT00446849|566241171|FG000|Acute Phase|Physician Decision|1|||
156859249|NCT00446849|566241171|FG000|Acute Phase|noncompliance|1|||
156859250|NCT00446849|566241171|FG000|Maintenance Phase|Lack of Efficacy|40|||
156859251|NCT00446849|566241171|FG000|Maintenance Phase|Protocol Violation|7|||
156859252|NCT00446849|566241171|FG000|Maintenance Phase|Adverse Event|6|||
156859253|NCT00446849|566241171|FG000|Maintenance Phase|Consent withdrawn|5|||
156859254|NCT00446849|566241171|FG000|Maintenance Phase|Lost to Follow-up|3|||
156859255|NCT00446849|566241171|FG000|Maintenance Phase|Pregnancy|1|||
156859256|NCT00446849|566241171|FG000|Maintenance Phase|noncompliance|2|||
156859257|NCT00446849|566241171|FG000|Maintenance Phase|prohibited medication use|2|||
156859258|NCT00446849|566241171|FG000|Maintenance Phase|antibiotic use|1|||
156859259|NCT00446849|566241171|FG000|Maintenance Phase|study closure|1|||
156859260|NCT00446849|566241171|FG000|Maintenance Phase|hydrocodone use|1|||
156859261|NCT00446849|566241171|FG000|Maintenance Phase|concomitant medication use|1|||
156859262|NCT05546476|566241175|FG000|Period 1: Part A|Adverse Event|2|||
156859263|NCT05546476|566241176|FG001|Period 1: Part A|Adverse Event|0|||
156859264|NCT05546476|566241177|FG002|Period 1: Part A|Adverse Event|0|||
156859265|NCT05546476|566241178|FG003|Period 1: Part A|Adverse Event|1|||
156859266|NCT05546476|566241175|FG000|Period 1: Part A|Death|4|||
156473856|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
156473857|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
156473858|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
156473859|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
156473860|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
156473861|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
156473862|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
156473863|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
156473864|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
156473865|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
156473866|NCT02222493|564829377|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
156473867|NCT02222493|564829378|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
156473868|NCT02222493|564829377|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
156473869|NCT02222493|564829378|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
156473870|NCT02222493|564829377|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
156473871|NCT02222493|564829378|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
156473872|NCT02222493|564829377|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
156473873|NCT02222493|564829378|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
156473874|NCT02222493|564829377|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
156473875|NCT02222493|564829378|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
156473876|NCT02222493|564829377|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
156473877|NCT02222493|564829378|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
156473878|NCT02222493|564829377|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
156473879|NCT02222493|564829378|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
156473880|NCT02222493|564829377|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
156473881|NCT02222493|564829378|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
156473882|NCT02222493|564829377|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
156473883|NCT02222493|564829378|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
156473884|NCT02222493|564829377|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
156473885|NCT02222493|564829378|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
156473886|NCT02222493|564829377|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
156473887|NCT02222493|564829378|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
156473888|NCT02222493|564829377|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
156473889|NCT02222493|564829378|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
156473890|NCT02222493|564829377|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
156473891|NCT02222493|564829378|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
156473892|NCT02542943|564829381|FG000|Overall Study|Lost to Follow-up|1|||
156473893|NCT02542943|564829382|FG001|Overall Study|Lost to Follow-up|0|||
156473894|NCT02542943|564829383|FG002|Overall Study|Lost to Follow-up|0|||
156473895|NCT02542943|564829381|FG000|Overall Study|Withdrawal by Subject|0|||
156473896|NCT02542943|564829382|FG001|Overall Study|Withdrawal by Subject|1|||
156473897|NCT02542943|564829383|FG002|Overall Study|Withdrawal by Subject|0|||
156473898|NCT03476798|564829387|FG000|Overall Study|Death|1|||
156473899|NCT03476798|564829387|FG000|Overall Study|Withdrawal by Subject|2|||
156473900|NCT03476798|564829387|FG000|Overall Study|Protocol Violation|2|||
156473901|NCT06269003|564829388|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
156473902|NCT06269003|564829389|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
156473903|NCT06269003|564829390|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
156473904|NCT06269003|564829391|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
156342980|NCT02549937|564354489|FG005|Overall Study|Other|0|||
156342981|NCT02549937|564354490|FG006|Overall Study|Other|3|||
156473905|NCT00985088|564830908|FG000|Overall Study|Serious Adverse Event|1|||
156473906|NCT00985088|564830909|FG001|Overall Study|Serious Adverse Event|1|||
156473907|NCT00985088|564830910|FG002|Overall Study|Serious Adverse Event|0|||
156473908|NCT00985088|564830911|FG003|Overall Study|Serious Adverse Event|0|||
156473909|NCT00985088|564830912|FG004|Overall Study|Serious Adverse Event|0|||
156473910|NCT00985088|564830913|FG005|Overall Study|Serious Adverse Event|0|||
156473911|NCT00985088|564830914|FG006|Overall Study|Serious Adverse Event|0|||
156473912|NCT00985088|564830915|FG007|Overall Study|Serious Adverse Event|1|||
156473913|NCT00985088|564830908|FG000|Overall Study|Adverse Event|0|||
156473914|NCT00985088|564830909|FG001|Overall Study|Adverse Event|0|||
156473915|NCT00985088|564830910|FG002|Overall Study|Adverse Event|1|||
156473916|NCT00985088|564830911|FG003|Overall Study|Adverse Event|0|||
156473917|NCT00985088|564830912|FG004|Overall Study|Adverse Event|0|||
156473918|NCT00985088|564830913|FG005|Overall Study|Adverse Event|0|||
156473919|NCT00985088|564830914|FG006|Overall Study|Adverse Event|0|||
156473920|NCT00985088|564830915|FG007|Overall Study|Adverse Event|0|||
156473921|NCT00985088|564830908|FG000|Overall Study|Withdrawal by Subject|4|||
156473922|NCT00985088|564830909|FG001|Overall Study|Withdrawal by Subject|0|||
156473923|NCT00985088|564830910|FG002|Overall Study|Withdrawal by Subject|0|||
156473924|NCT00985088|564830911|FG003|Overall Study|Withdrawal by Subject|1|||
156542255|NCT04744207|565079302|FG001|Treatment|Withdrawal by Subject|0|||
156542256|NCT04744207|565079301|FG000|Treatment|Adverse Event|1|||
156342982|NCT02549937|564354491|FG007|Overall Study|Other|2|||
156473925|NCT00985088|564830912|FG004|Overall Study|Withdrawal by Subject|3|||
156473926|NCT00985088|564830913|FG005|Overall Study|Withdrawal by Subject|2|||
156342983|NCT02549937|564354492|FG008|Overall Study|Other|3|||
156542257|NCT04744207|565079302|FG001|Treatment|Adverse Event|2|||
156542258|NCT00942175|565079308|FG000|Overall Study|Adverse Event|2|||
156542259|NCT00942175|565079309|FG001|Overall Study|Adverse Event|1|||
156542260|NCT00942175|565079310|FG002|Overall Study|Adverse Event|0|||
156542261|NCT00942175|565079311|FG003|Overall Study|Adverse Event|0|||
156542262|NCT00942175|565079308|FG000|Overall Study|Protocol Violation|0|||
156542263|NCT00942175|565079309|FG001|Overall Study|Protocol Violation|1|||
156542264|NCT00942175|565079310|FG002|Overall Study|Protocol Violation|2|||
156542265|NCT00942175|565079311|FG003|Overall Study|Protocol Violation|0|||
156542266|NCT00942175|565079308|FG000|Overall Study|Pregnancy|0|||
156542267|NCT00942175|565079309|FG001|Overall Study|Pregnancy|0|||
156542268|NCT00942175|565079310|FG002|Overall Study|Pregnancy|0|||
156542269|NCT00942175|565079311|FG003|Overall Study|Pregnancy|1|||
156542270|NCT00942175|565079308|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
156542271|NCT00942175|565079309|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
156542272|NCT00942175|565079310|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
156542273|NCT00942175|565079311|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
156542274|NCT00942175|565079308|FG000|Overall Study|Low Platelet Count|0|||
156542275|NCT00942175|565079309|FG001|Overall Study|Low Platelet Count|2|||
156542276|NCT00942175|565079310|FG002|Overall Study|Low Platelet Count|0|||
156542277|NCT00942175|565079311|FG003|Overall Study|Low Platelet Count|0|||
156542278|NCT03710486|565079312|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
156542279|NCT03710486|565079313|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
156542280|NCT03710486|565079312|FG000|Overall Study|Missing|0|||
156542281|NCT03710486|565079313|FG001|Overall Study|Missing|2|||
156542282|NCT01279850|565079318|FG000|Overall Study|Protocol Violation|50|||
156542283|NCT01279850|565079318|FG000|Overall Study|No Drug Administration Information|7|||
156542284|NCT01279850|565079318|FG000|Overall Study|No Visit After Treatment|34|||
156542285|NCT01147744|565079319|FG000|Overall Study|Protocol Violation|1|||
156542286|NCT01147744|565079320|FG001|Overall Study|Protocol Violation|0|||
156542287|NCT01147744|565079321|FG002|Overall Study|Protocol Violation|1|||
156542288|NCT01147744|565079322|FG003|Overall Study|Protocol Violation|0|||
156542289|NCT01147744|565079323|FG004|Overall Study|Protocol Violation|1|||
156542290|NCT01147744|565079324|FG005|Overall Study|Protocol Violation|3|||
156542291|NCT01147744|565079325|FG006|Overall Study|Protocol Violation|1|||
156542292|NCT01147744|565079319|FG000|Overall Study|Physician Decision|0|||
156542293|NCT01147744|565079320|FG001|Overall Study|Physician Decision|1|||
156542294|NCT01147744|565079321|FG002|Overall Study|Physician Decision|1|||
156542295|NCT01147744|565079322|FG003|Overall Study|Physician Decision|0|||
156542296|NCT01147744|565079323|FG004|Overall Study|Physician Decision|0|||
156542297|NCT01147744|565079324|FG005|Overall Study|Physician Decision|0|||
156542298|NCT01147744|565079325|FG006|Overall Study|Physician Decision|1|||
156542299|NCT01147744|565079319|FG000|Overall Study|Lack of Efficacy|11|||
156542300|NCT01147744|565079320|FG001|Overall Study|Lack of Efficacy|11|||
156542301|NCT01147744|565079321|FG002|Overall Study|Lack of Efficacy|9|||
156342984|NCT02549937|564354484|FG000|Overall Study|Lost to Follow-up|0|||
156342985|NCT02549937|564354485|FG001|Overall Study|Lost to Follow-up|0|||
156342986|NCT02549937|564354486|FG002|Overall Study|Lost to Follow-up|0|||
156342987|NCT02549937|564354487|FG003|Overall Study|Lost to Follow-up|0|||
156342988|NCT02549937|564354488|FG004|Overall Study|Lost to Follow-up|0|||
156342989|NCT02549937|564354489|FG005|Overall Study|Lost to Follow-up|0|||
156342990|NCT02549937|564354490|FG006|Overall Study|Lost to Follow-up|0|||
156342991|NCT02549937|564354491|FG007|Overall Study|Lost to Follow-up|0|||
156342992|NCT02549937|564354492|FG008|Overall Study|Lost to Follow-up|3|||
156342993|NCT02549937|564354484|FG000|Overall Study|Withdrawal by Subject|0|||
156342994|NCT02549937|564354485|FG001|Overall Study|Withdrawal by Subject|0|||
156342995|NCT02549937|564354486|FG002|Overall Study|Withdrawal by Subject|0|||
156342996|NCT02549937|564354487|FG003|Overall Study|Withdrawal by Subject|0|||
156342997|NCT02549937|564354488|FG004|Overall Study|Withdrawal by Subject|0|||
156342998|NCT02549937|564354489|FG005|Overall Study|Withdrawal by Subject|1|||
156342999|NCT02549937|564354490|FG006|Overall Study|Withdrawal by Subject|4|||
156343000|NCT02549937|564354491|FG007|Overall Study|Withdrawal by Subject|3|||
156343001|NCT02549937|564354492|FG008|Overall Study|Withdrawal by Subject|2|||
156343002|NCT02549937|564354484|FG000|Overall Study|Sponsor Decision|0|||
156343003|NCT02549937|564354485|FG001|Overall Study|Sponsor Decision|0|||
156343004|NCT02549937|564354486|FG002|Overall Study|Sponsor Decision|0|||
156343005|NCT02549937|564354487|FG003|Overall Study|Sponsor Decision|0|||
156343006|NCT02549937|564354488|FG004|Overall Study|Sponsor Decision|0|||
156343007|NCT02549937|564354489|FG005|Overall Study|Sponsor Decision|0|||
156343008|NCT02549937|564354490|FG006|Overall Study|Sponsor Decision|0|||
156343009|NCT02549937|564354491|FG007|Overall Study|Sponsor Decision|0|||
156343010|NCT02549937|564354492|FG008|Overall Study|Sponsor Decision|6|||
156343011|NCT01638546|564354504|FG000|Overall Study|Adverse Event|1|||
156343012|NCT01638546|564354505|FG001|Overall Study|Adverse Event|3|||
156343013|NCT04292743|564354508|FG000|Overall Study|Physician Decision|1|||
156343014|NCT04292743|564354509|FG001|Overall Study|Physician Decision|3|||
156343015|NCT04292743|564354510|FG002|Overall Study|Physician Decision|0|||
156343016|NCT04292743|564354511|FG003|Overall Study|Physician Decision|0|||
156343017|NCT04292743|564354508|FG000|Overall Study|Withdrawal by Subject|0|||
156343018|NCT04292743|564354509|FG001|Overall Study|Withdrawal by Subject|5|||
156343019|NCT04292743|564354510|FG002|Overall Study|Withdrawal by Subject|0|||
156343020|NCT04292743|564354511|FG003|Overall Study|Withdrawal by Subject|0|||
156343021|NCT04292743|564354508|FG000|Overall Study|Death|0|||
156343022|NCT04292743|564354509|FG001|Overall Study|Death|1|||
156343023|NCT04292743|564354510|FG002|Overall Study|Death|0|||
156343024|NCT04292743|564354511|FG003|Overall Study|Death|0|||
156343025|NCT04292743|564354508|FG000|Overall Study|Progression of Disease|2|||
156343026|NCT04292743|564354509|FG001|Overall Study|Progression of Disease|5|||
156343027|NCT04292743|564354510|FG002|Overall Study|Progression of Disease|0|||
156343028|NCT04292743|564354511|FG003|Overall Study|Progression of Disease|0|||
156343029|NCT04292743|564354508|FG000|Overall Study|No Treatment per protocol|0|||
156343030|NCT04292743|564354509|FG001|Overall Study|No Treatment per protocol|2|||
156473927|NCT00985088|564830914|FG006|Overall Study|Withdrawal by Subject|1|||
156473928|NCT00985088|564830915|FG007|Overall Study|Withdrawal by Subject|2|||
156473929|NCT00985088|564830908|FG000|Overall Study|Migrated/moved from study area|0|||
156473930|NCT00985088|564830909|FG001|Overall Study|Migrated/moved from study area|0|||
156473931|NCT00985088|564830910|FG002|Overall Study|Migrated/moved from study area|1|||
156473932|NCT00985088|564830911|FG003|Overall Study|Migrated/moved from study area|0|||
156473933|NCT00985088|564830912|FG004|Overall Study|Migrated/moved from study area|0|||
156473934|NCT00985088|564830913|FG005|Overall Study|Migrated/moved from study area|0|||
156473935|NCT00985088|564830914|FG006|Overall Study|Migrated/moved from study area|0|||
156473936|NCT00985088|564830915|FG007|Overall Study|Migrated/moved from study area|1|||
156473937|NCT00985088|564830908|FG000|Overall Study|Lost to Follow-up|6|||
156473938|NCT00985088|564830909|FG001|Overall Study|Lost to Follow-up|1|||
156473939|NCT00985088|564830910|FG002|Overall Study|Lost to Follow-up|2|||
156473940|NCT00985088|564830911|FG003|Overall Study|Lost to Follow-up|6|||
156473941|NCT00985088|564830912|FG004|Overall Study|Lost to Follow-up|6|||
156473942|NCT00985088|564830913|FG005|Overall Study|Lost to Follow-up|5|||
156473943|NCT00985088|564830914|FG006|Overall Study|Lost to Follow-up|3|||
156473944|NCT00985088|564830915|FG007|Overall Study|Lost to Follow-up|2|||
156343031|NCT04292743|564354510|FG002|Overall Study|No Treatment per protocol|0|||
156343032|NCT04292743|564354511|FG003|Overall Study|No Treatment per protocol|0|||
156343033|NCT05330702|564354512|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
156343034|NCT05330702|564354513|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
156343035|NCT05330702|564354514|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
156343036|NCT02881554|564354515|FG000|Overall Study|Withdrawal by Subject|2|||
156343037|NCT02881554|564354516|FG001|Overall Study|Withdrawal by Subject|0|||
156343038|NCT01411774|564356200|FG000|Overall Study|Withdrawal by Subject|0|||
156343039|NCT01411774|564356201|FG001|Overall Study|Withdrawal by Subject|3|||
156343040|NCT00056316|564356202|FG000|Overall Study|Withdrawal by Subject|2|||
156343041|NCT00056316|564356203|FG001|Overall Study|Withdrawal by Subject|2|||
156343042|NCT00056316|564356202|FG000|Overall Study|Death/NH placement of pt|1|||
156343043|NCT00056316|564356203|FG001|Overall Study|Death/NH placement of pt|1|||
156343044|NCT01315678|564356206|FG000|Overall Study|Withdrawal by Subject|7|||
156343045|NCT01315678|564356207|FG001|Overall Study|Withdrawal by Subject|3|||
156343046|NCT01315678|564356206|FG000|Overall Study|Adverse Event|3|||
156343047|NCT01315678|564356207|FG001|Overall Study|Adverse Event|1|||
156343048|NCT01315678|564356206|FG000|Overall Study|Lost to Follow-up|1|||
156343049|NCT01315678|564356207|FG001|Overall Study|Lost to Follow-up|0|||
156343050|NCT01315678|564356206|FG000|Overall Study|similar reason to those listed above|3|||
156343051|NCT01315678|564356207|FG001|Overall Study|similar reason to those listed above|2|||
156343052|NCT01104493|564356220|FG000|Overall Study|Lost to Follow-up|0|||
156343053|NCT01104493|564356221|FG001|Overall Study|Lost to Follow-up|2|||
156343054|NCT02511184|564356222|FG000|Overall Study|Death|1|||
156343055|NCT02511184|564356223|FG001|Overall Study|Death|0|||
156343056|NCT02511184|564356222|FG000|Overall Study|Lost to Follow-up|0|||
156343057|NCT02511184|564356223|FG001|Overall Study|Lost to Follow-up|1|||
156343058|NCT02511184|564356222|FG000|Overall Study|Study terminated by sponsor|1|||
156343059|NCT02511184|564356223|FG001|Overall Study|Study terminated by sponsor|5|||
156343060|NCT02511184|564356222|FG000|Overall Study|Withdrawal by Subject|0|||
156343061|NCT02511184|564356223|FG001|Overall Study|Withdrawal by Subject|1|||
156343062|NCT03902574|564356224|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
156343063|NCT03902574|564356225|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
156343064|NCT03902574|564356226|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
156343065|NCT05048784|564356235|FG000|Period 1|Adverse Event|3|||
156343066|NCT05048784|564356236|FG001|Period 1|Adverse Event|1|||
156343067|NCT05048784|564356237|FG002|Period 1|Adverse Event|0|||
156343068|NCT05048784|564356238|FG003|Period 1|Adverse Event|0|||
156343069|NCT05048784|564356235|FG000|Period 2|Lost to Follow-up|0|||
156343070|NCT05048784|564356236|FG001|Period 2|Lost to Follow-up|1|||
156343071|NCT05048784|564356237|FG002|Period 2|Lost to Follow-up|0|||
156343072|NCT05048784|564356238|FG003|Period 2|Lost to Follow-up|0|||
156343073|NCT00727025|564356241|FG000|Overall Study|Physician Decision|23|||
156343074|NCT02101060|564356242|FG000|Overall Study|Adverse Event|1|||
156343075|NCT02101060|564356243|FG001|Overall Study|Adverse Event|0|||
156343076|NCT02101060|564356242|FG000|Overall Study|Withdrawal by Subject|1|||
156343077|NCT02101060|564356243|FG001|Overall Study|Withdrawal by Subject|1|||
156343078|NCT02101060|564356242|FG000|Overall Study|Lost to Follow-up|3|||
156473945|NCT01970878|564830917|FG000|Overall Study|Withdrawal by Subject|11|||
156473946|NCT01970878|564830918|FG001|Overall Study|Withdrawal by Subject|10|||
156473947|NCT01970878|564830919|FG002|Overall Study|Withdrawal by Subject|14|||
156473948|NCT01970878|564830920|FG003|Overall Study|Withdrawal by Subject|7|||
156343079|NCT02101060|564356243|FG001|Overall Study|Lost to Follow-up|3|||
156343080|NCT02269241|564356244|FG000|Overall Study|Lost to Follow-up|269|||
156343081|NCT02269241|564356244|FG000|Overall Study|Withdrawal by Subject|155|||
156343082|NCT02269241|564356244|FG000|Overall Study|Protocol Violation|1|||
156343083|NCT02269241|564356244|FG000|Overall Study|Physician Decision|7|||
156343084|NCT02269241|564356244|FG000|Overall Study|Pregnancy|15|||
156473949|NCT01970878|564830917|FG000|Overall Study|Lost to Follow-up|1|||
156473950|NCT01970878|564830918|FG001|Overall Study|Lost to Follow-up|3|||
156473951|NCT01970878|564830919|FG002|Overall Study|Lost to Follow-up|2|||
156473952|NCT01970878|564830920|FG003|Overall Study|Lost to Follow-up|4|||
156859267|NCT05546476|566241176|FG001|Period 1: Part A|Death|4|||
156859268|NCT05546476|566241177|FG002|Period 1: Part A|Death|5|||
156859269|NCT05546476|566241178|FG003|Period 1: Part A|Death|6|||
156859270|NCT05546476|566241175|FG000|Period 1: Part A|Lack of Efficacy|0|||
156859271|NCT05546476|566241176|FG001|Period 1: Part A|Lack of Efficacy|0|||
156859272|NCT05546476|566241177|FG002|Period 1: Part A|Lack of Efficacy|0|||
156859273|NCT05546476|566241178|FG003|Period 1: Part A|Lack of Efficacy|1|||
156859274|NCT05546476|566241175|FG000|Period 1: Part A|Lost to Follow-up|0|||
156859275|NCT05546476|566241176|FG001|Period 1: Part A|Lost to Follow-up|0|||
156859276|NCT05546476|566241177|FG002|Period 1: Part A|Lost to Follow-up|0|||
156859277|NCT05546476|566241178|FG003|Period 1: Part A|Lost to Follow-up|1|||
156859278|NCT05546476|566241175|FG000|Period 1: Part A|Physician Decision|1|||
156859279|NCT05546476|566241176|FG001|Period 1: Part A|Physician Decision|0|||
156859280|NCT05546476|566241177|FG002|Period 1: Part A|Physician Decision|0|||
156859281|NCT05546476|566241178|FG003|Period 1: Part A|Physician Decision|0|||
156859282|NCT05546476|566241175|FG000|Period 1: Part A|Progressive disease|3|||
156859283|NCT05546476|566241176|FG001|Period 1: Part A|Progressive disease|5|||
156859284|NCT05546476|566241177|FG002|Period 1: Part A|Progressive disease|0|||
156859285|NCT05546476|566241178|FG003|Period 1: Part A|Progressive disease|1|||
156859286|NCT05546476|566241175|FG000|Period 1: Part A|Withdrawal by Subject|1|||
156859287|NCT05546476|566241176|FG001|Period 1: Part A|Withdrawal by Subject|1|||
156859288|NCT05546476|566241177|FG002|Period 1: Part A|Withdrawal by Subject|1|||
156859289|NCT05546476|566241178|FG003|Period 1: Part A|Withdrawal by Subject|2|||
156859290|NCT05546476|566241175|FG000|Period 1: Part A|Global deterioration of health status|2|||
156859291|NCT05546476|566241176|FG001|Period 1: Part A|Global deterioration of health status|2|||
156859292|NCT05546476|566241177|FG002|Period 1: Part A|Global deterioration of health status|1|||
156859293|NCT05546476|566241178|FG003|Period 1: Part A|Global deterioration of health status|4|||
156859294|NCT05546476|566241175|FG000|Period 1: Part A|Other: Unspecified|0|||
156859295|NCT05546476|566241176|FG001|Period 1: Part A|Other: Unspecified|2|||
156859296|NCT05546476|566241177|FG002|Period 1: Part A|Other: Unspecified|0|||
156859297|NCT05546476|566241178|FG003|Period 1: Part A|Other: Unspecified|0|||
156859298|NCT05546476|566241175|FG000|Period 2: Part B|Ongoing|26|||
156859299|NCT05546476|566241176|FG001|Period 2: Part B|Ongoing|27|||
156859300|NCT05546476|566241177|FG002|Period 2: Part B|Ongoing|35|||
156859301|NCT05546476|566241178|FG003|Period 2: Part B|Ongoing|29|||
156859302|NCT03585660|566241184|FG000|Overall Study|operator error|1|||
156859303|NCT03585660|566241184|FG000|Overall Study|technical error|2|||
156859304|NCT03585660|566241184|FG000|Overall Study|hip prosthesis|2|||
156859305|NCT03585660|566241184|FG000|Overall Study|did not undergo biopsy|8|||
156859306|NCT03585660|566241184|FG000|Overall Study|scanner problem|2|||
156859307|NCT03661723|566241187|FG000|Overall Study|Disease Progression|4|||
156859308|NCT03661723|566241188|FG001|Overall Study|Disease Progression|24|||
156859309|NCT03661723|566241189|FG002|Overall Study|Disease Progression|4|||
156859310|NCT03661723|566241190|FG003|Overall Study|Disease Progression|19|||
156859311|NCT03661723|566241187|FG000|Overall Study|Withdrawal by Subject|1|||
156859312|NCT03661723|566241188|FG001|Overall Study|Withdrawal by Subject|0|||
156859313|NCT03661723|566241189|FG002|Overall Study|Withdrawal by Subject|2|||
156859314|NCT03661723|566241190|FG003|Overall Study|Withdrawal by Subject|4|||
156859315|NCT03661723|566241187|FG000|Overall Study|Physician Decision|1|||
156859316|NCT03661723|566241188|FG001|Overall Study|Physician Decision|0|||
156859317|NCT03661723|566241189|FG002|Overall Study|Physician Decision|0|||
156859318|NCT03661723|566241190|FG003|Overall Study|Physician Decision|0|||
156859319|NCT03661723|566241187|FG000|Overall Study|Clinical Deterioration|0|||
156859320|NCT03661723|566241188|FG001|Overall Study|Clinical Deterioration|0|||
156859321|NCT03661723|566241189|FG002|Overall Study|Clinical Deterioration|0|||
156859322|NCT03661723|566241190|FG003|Overall Study|Clinical Deterioration|1|||
156859323|NCT03760029|566241191|FG000|Overall Study|Death|1|||
156859324|NCT03760029|566241192|FG001|Overall Study|Death|0|||
156859325|NCT03760029|566241193|FG002|Overall Study|Death|0|||
156859326|NCT03760029|566241191|FG000|Overall Study|Lost to Follow-up|0|||
156859327|NCT03760029|566241192|FG001|Overall Study|Lost to Follow-up|2|||
156859328|NCT03760029|566241193|FG002|Overall Study|Lost to Follow-up|1|||
156859329|NCT03760029|566241191|FG000|Overall Study|Withdrawal by Subject|1|||
156859330|NCT03760029|566241192|FG001|Overall Study|Withdrawal by Subject|4|||
156859331|NCT03760029|566241193|FG002|Overall Study|Withdrawal by Subject|1|||
156859332|NCT03760029|566241191|FG000|Overall Study|Withdrawal by parent/guardian|4|||
156859333|NCT03760029|566241192|FG001|Overall Study|Withdrawal by parent/guardian|4|||
156859334|NCT03760029|566241193|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156859335|NCT03760029|566241191|FG000|Overall Study|Other|2|||
156859336|NCT03760029|566241192|FG001|Overall Study|Other|1|||
156473953|NCT01970878|564830917|FG000|Overall Study|Administrative Reasons|1|||
156859337|NCT03760029|566241193|FG002|Overall Study|Other|0|||
156859338|NCT04890652|566241201|FG000|Overall Study|Withdrawal by Subject|2|||
156859339|NCT00807911|566241202|FG000|Overall Study|Withdrawal by Subject|12|||
156542302|NCT01147744|565079322|FG003|Overall Study|Lack of Efficacy|11|||
156473954|NCT01970878|564830918|FG001|Overall Study|Administrative Reasons|0|||
156473955|NCT01970878|564830919|FG002|Overall Study|Administrative Reasons|0|||
156473956|NCT01970878|564830920|FG003|Overall Study|Administrative Reasons|4|||
156473957|NCT01970878|564830917|FG000|Overall Study|Lack of Efficacy|2|||
156473958|NCT01970878|564830918|FG001|Overall Study|Lack of Efficacy|1|||
156473959|NCT01970878|564830919|FG002|Overall Study|Lack of Efficacy|2|||
156473960|NCT01970878|564830920|FG003|Overall Study|Lack of Efficacy|0|||
156473961|NCT01970878|564830917|FG000|Overall Study|Adverse Event|12|||
156473962|NCT01970878|564830918|FG001|Overall Study|Adverse Event|7|||
156473963|NCT01970878|564830919|FG002|Overall Study|Adverse Event|4|||
156473964|NCT01970878|564830920|FG003|Overall Study|Adverse Event|3|||
156473965|NCT01970878|564830917|FG000|Overall Study|Protocol Specified Criteria|10|||
156473966|NCT01970878|564830918|FG001|Overall Study|Protocol Specified Criteria|4|||
156473967|NCT01970878|564830919|FG002|Overall Study|Protocol Specified Criteria|3|||
156473968|NCT01970878|564830920|FG003|Overall Study|Protocol Specified Criteria|6|||
156473969|NCT01970878|564830917|FG000|Overall Study|Physician Decision|0|||
156473970|NCT01970878|564830918|FG001|Overall Study|Physician Decision|1|||
156473971|NCT01970878|564830919|FG002|Overall Study|Physician Decision|1|||
156473972|NCT01970878|564830920|FG003|Overall Study|Physician Decision|0|||
156473973|NCT01970878|564830917|FG000|Overall Study|No Completion Status|0|||
156473974|NCT01970878|564830918|FG001|Overall Study|No Completion Status|1|||
156473975|NCT01970878|564830919|FG002|Overall Study|No Completion Status|0|||
156473976|NCT01970878|564830920|FG003|Overall Study|No Completion Status|0|||
156473977|NCT06571695|564830921|FG000|Overall Study|Lost to Follow-up|1|||
156473978|NCT06571695|564830922|FG001|Overall Study|Lost to Follow-up|6|||
156473979|NCT00491400|564830923|FG000|Overall Study|Withdrawal by Subject|5|||
156473980|NCT00491400|564830924|FG001|Overall Study|Withdrawal by Subject|4|||
156473981|NCT00597376|564830925|FG000|Overall Study|Withdrawal by Subject|4|||
156473982|NCT00597376|564830926|FG001|Overall Study|Withdrawal by Subject|3|||
156473983|NCT00597376|564830925|FG000|Overall Study|Adverse Event|4|||
156473984|NCT00597376|564830926|FG001|Overall Study|Adverse Event|1|||
156473985|NCT02698475|564830927|FG000|Main Study Period|Lack of Efficacy|1|||
156473986|NCT02698475|564830927|FG000|Main Study Period|Protocol Violation|2|||
156473987|NCT02698475|564830927|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
156473988|NCT02698475|564830927|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
156473989|NCT02698475|564830927|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
156473990|NCT02698475|564830927|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
156473991|NCT02698475|564830927|FG000|Long-Term Extension Period|Other|1|||
156473992|NCT01214200|564830932|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
156473993|NCT01214200|564830932|FG000|Overall Study|Withdrawal by Subject|2|||
156473994|NCT00587171|564830933|FG000|Overall Study|Lost to Follow-up|1|||
156473995|NCT00587171|564830934|FG001|Overall Study|Lost to Follow-up|1|||
156473996|NCT02148705|564830938|FG000|Overall Study|Death|2|||
156473997|NCT02148705|564830939|FG001|Overall Study|Death|0|||
156473998|NCT02148705|564830940|FG002|Overall Study|Death|0|||
156473999|NCT02148705|564830938|FG000|Overall Study|Lost to Follow-up|13|||
156474000|NCT02148705|564830939|FG001|Overall Study|Lost to Follow-up|4|||
156474001|NCT02148705|564830940|FG002|Overall Study|Lost to Follow-up|10|||
156474002|NCT02148705|564830938|FG000|Overall Study|Withdrawal by Subject|3|||
156474003|NCT02148705|564830939|FG001|Overall Study|Withdrawal by Subject|0|||
156474004|NCT02148705|564830940|FG002|Overall Study|Withdrawal by Subject|2|||
156474005|NCT02148705|564830938|FG000|Overall Study|Not Treated|0|||
156474006|NCT02148705|564830939|FG001|Overall Study|Not Treated|1|||
156474007|NCT02148705|564830940|FG002|Overall Study|Not Treated|5|||
156474008|NCT01737021|564830943|FG000|Overall Study|Lost to Follow-up|5|||
156474009|NCT01737021|564830944|FG001|Overall Study|Lost to Follow-up|3|||
156474010|NCT01673594|564830945|FG000|Overall Study|Adverse Event|3|||
156474011|NCT01673594|564830946|FG001|Overall Study|Adverse Event|1|||
156474012|NCT01673594|564830945|FG000|Overall Study|Lost to Follow-up|1|||
156474013|NCT01673594|564830946|FG001|Overall Study|Lost to Follow-up|0|||
156474014|NCT01673594|564830945|FG000|Overall Study|Physician Decision|2|||
156474015|NCT01673594|564830946|FG001|Overall Study|Physician Decision|4|||
156474016|NCT01673594|564830945|FG000|Overall Study|Withdrawal by Subject|0|||
156474017|NCT01673594|564830946|FG001|Overall Study|Withdrawal by Subject|1|||
156474018|NCT02605174|564830947|FG000|Overall Study|Adverse Event|0|||
156474019|NCT02605174|564830948|FG001|Overall Study|Adverse Event|0|||
156474020|NCT02605174|564830949|FG002|Overall Study|Adverse Event|1|||
156474021|NCT02605174|564830950|FG003|Overall Study|Adverse Event|0|||
156474022|NCT02605174|564830951|FG004|Overall Study|Adverse Event|4|||
156474023|NCT02605174|564830952|FG005|Overall Study|Adverse Event|0|||
156474024|NCT02605174|564830953|FG006|Overall Study|Adverse Event|0|||
156474025|NCT02605174|564830947|FG000|Overall Study|Lost to Follow-up|20|||
156474026|NCT02605174|564830948|FG001|Overall Study|Lost to Follow-up|7|||
156474027|NCT02605174|564830949|FG002|Overall Study|Lost to Follow-up|27|||
156343085|NCT02269241|564356244|FG000|Overall Study|Wish for pregnancy|5|||
156343086|NCT02269241|564356244|FG000|Overall Study|Development of an exclusion criteria|16|||
156343087|NCT02269241|564356244|FG000|Overall Study|Adverse Event|113|||
156343088|NCT02269241|564356244|FG000|Overall Study|At the specific request of the sponsor|20|||
156542303|NCT01147744|565079323|FG004|Overall Study|Lack of Efficacy|13|||
156343089|NCT02269241|564356244|FG000|Overall Study|Several reasons not classified|53|||
156343090|NCT02269241|564356244|FG000|Overall Study|Screening failures|546|||
156343091|NCT03020160|564356245|FG000|Overall Study|Withdrawal by Subject|1|||
156343092|NCT03020160|564356246|FG001|Overall Study|Withdrawal by Subject|0|||
156343093|NCT02270957|564356247|FG000|Overall Study|Lack of Efficacy|2|||
156542304|NCT01147744|565079324|FG005|Overall Study|Lack of Efficacy|8|||
156343094|NCT02270957|564356248|FG001|Overall Study|Lack of Efficacy|4|||
156343095|NCT02270957|564356247|FG000|Overall Study|Adverse Event|2|||
156343096|NCT02270957|564356248|FG001|Overall Study|Adverse Event|0|||
156542305|NCT01147744|565079325|FG006|Overall Study|Lack of Efficacy|7|||
156542306|NCT01147744|565079319|FG000|Overall Study|Adverse Event|1|||
156474028|NCT02605174|564830950|FG003|Overall Study|Lost to Follow-up|10|||
156474029|NCT02605174|564830951|FG004|Overall Study|Lost to Follow-up|20|||
156474030|NCT02605174|564830952|FG005|Overall Study|Lost to Follow-up|10|||
156474031|NCT02605174|564830953|FG006|Overall Study|Lost to Follow-up|29|||
156474032|NCT02605174|564830947|FG000|Overall Study|Protocol Violation|10|||
156474033|NCT02605174|564830948|FG001|Overall Study|Protocol Violation|4|||
156474034|NCT02605174|564830949|FG002|Overall Study|Protocol Violation|14|||
156474035|NCT02605174|564830950|FG003|Overall Study|Protocol Violation|6|||
156474036|NCT02605174|564830951|FG004|Overall Study|Protocol Violation|7|||
156474037|NCT02605174|564830952|FG005|Overall Study|Protocol Violation|7|||
156474038|NCT02605174|564830953|FG006|Overall Study|Protocol Violation|12|||
156474039|NCT02605174|564830947|FG000|Overall Study|Pregnancy|1|||
156474040|NCT02605174|564830948|FG001|Overall Study|Pregnancy|0|||
156474041|NCT02605174|564830949|FG002|Overall Study|Pregnancy|0|||
156474042|NCT02605174|564830950|FG003|Overall Study|Pregnancy|2|||
156474043|NCT02605174|564830951|FG004|Overall Study|Pregnancy|0|||
156474044|NCT02605174|564830952|FG005|Overall Study|Pregnancy|0|||
156474045|NCT02605174|564830953|FG006|Overall Study|Pregnancy|0|||
156474046|NCT02605174|564830947|FG000|Overall Study|Withdrawal by Subject|9|||
156474047|NCT02605174|564830948|FG001|Overall Study|Withdrawal by Subject|6|||
156474048|NCT02605174|564830949|FG002|Overall Study|Withdrawal by Subject|14|||
156474049|NCT02605174|564830950|FG003|Overall Study|Withdrawal by Subject|11|||
156474050|NCT02605174|564830951|FG004|Overall Study|Withdrawal by Subject|6|||
156474051|NCT02605174|564830952|FG005|Overall Study|Withdrawal by Subject|4|||
156474052|NCT02605174|564830953|FG006|Overall Study|Withdrawal by Subject|15|||
156474053|NCT02605174|564830947|FG000|Overall Study|Physician Decision|2|||
156474054|NCT02605174|564830948|FG001|Overall Study|Physician Decision|0|||
156474055|NCT02605174|564830949|FG002|Overall Study|Physician Decision|0|||
156474056|NCT02605174|564830950|FG003|Overall Study|Physician Decision|0|||
156474057|NCT02605174|564830951|FG004|Overall Study|Physician Decision|0|||
156474058|NCT02605174|564830952|FG005|Overall Study|Physician Decision|0|||
156474059|NCT02605174|564830953|FG006|Overall Study|Physician Decision|3|||
156474060|NCT02605174|564830947|FG000|Overall Study|Randomization Failure|22|||
156474061|NCT02605174|564830948|FG001|Overall Study|Randomization Failure|6|||
156474062|NCT02605174|564830949|FG002|Overall Study|Randomization Failure|20|||
156474063|NCT02605174|564830950|FG003|Overall Study|Randomization Failure|7|||
156474064|NCT02605174|564830951|FG004|Overall Study|Randomization Failure|16|||
156474065|NCT02605174|564830952|FG005|Overall Study|Randomization Failure|11|||
156474066|NCT02605174|564830953|FG006|Overall Study|Randomization Failure|30|||
156474067|NCT02736188|564830961|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
156474068|NCT02736188|564830961|FG000|Overall Study|Adverse Event|1|||
156474069|NCT02736188|564830961|FG000|Overall Study|Withdrawal by Subject|1|||
156474070|NCT02736188|564830961|FG000|Overall Study|Other|6|||
156474071|NCT02708498|564830962|FG000|Overall Study|Death|20|||
156474072|NCT02708498|564830963|FG001|Overall Study|Death|19|||
156474073|NCT02708498|564830964|FG002|Overall Study|Death|0|||
156474074|NCT02708498|564830965|FG003|Overall Study|Death|0|||
156474075|NCT02708498|564830966|FG004|Overall Study|Death|1|||
156474076|NCT02708498|564830967|FG005|Overall Study|Death|0|||
156474077|NCT02708498|564830968|FG006|Overall Study|Death|0|||
156474078|NCT02708498|564830969|FG007|Overall Study|Death|0|||
156474079|NCT02708498|564830962|FG000|Overall Study|Unknown reason, missing data|0|||
156474080|NCT02708498|564830963|FG001|Overall Study|Unknown reason, missing data|0|||
156474081|NCT02708498|564830964|FG002|Overall Study|Unknown reason, missing data|62|||
156474082|NCT02708498|564830965|FG003|Overall Study|Unknown reason, missing data|51|||
156474083|NCT02708498|564830966|FG004|Overall Study|Unknown reason, missing data|195|||
156474084|NCT02708498|564830967|FG005|Overall Study|Unknown reason, missing data|132|||
156474085|NCT02708498|564830968|FG006|Overall Study|Unknown reason, missing data|0|||
156474086|NCT02708498|564830969|FG007|Overall Study|Unknown reason, missing data|0|||
156474087|NCT03052517|564830970|FG000|Overall Study|Study Terminated By Sponsor|928|||
156474088|NCT03052517|564830971|FG001|Overall Study|Study Terminated By Sponsor|938|||
156542307|NCT01147744|565079320|FG001|Overall Study|Adverse Event|2|||
156542308|NCT01147744|565079321|FG002|Overall Study|Adverse Event|3|||
156474089|NCT03052517|564830972|FG002|Overall Study|Study Terminated By Sponsor|296|||
156859340|NCT00807911|566241203|FG001|Overall Study|Withdrawal by Subject|10|||
156859341|NCT00807911|566241202|FG000|Overall Study|Ineligible|0|||
156859342|NCT00807911|566241203|FG001|Overall Study|Ineligible|4|||
156859343|NCT03562195|566241206|FG000|Overall Study|Adverse Event|0|||
156859344|NCT03562195|566241207|FG001|Overall Study|Adverse Event|6|||
156859345|NCT03562195|566241206|FG000|Overall Study|Lack of Efficacy|0|||
156859346|NCT03562195|566241207|FG001|Overall Study|Lack of Efficacy|5|||
156859347|NCT03562195|566241206|FG000|Overall Study|Protocol Violation|0|||
156859348|NCT03562195|566241207|FG001|Overall Study|Protocol Violation|1|||
156859349|NCT03562195|566241206|FG000|Overall Study|Lost to Follow-up|0|||
156859350|NCT03562195|566241207|FG001|Overall Study|Lost to Follow-up|1|||
156859351|NCT03562195|566241206|FG000|Overall Study|Physician Decision|1|||
156859352|NCT03562195|566241207|FG001|Overall Study|Physician Decision|0|||
156859353|NCT03562195|566241206|FG000|Overall Study|Withdrawal by Subject|3|||
156859354|NCT03562195|566241207|FG001|Overall Study|Withdrawal by Subject|0|||
156859355|NCT00836589|566241208|FG000|Overall Study|Lost to Follow-up|246|||
156859356|NCT00836589|566241208|FG000|Overall Study|Death|429|||
156859357|NCT00836589|566241208|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
156859358|NCT00614575|566241209|FG000|Overall Study|Adverse Event|106|||
156859359|NCT00614575|566241209|FG000|Overall Study|Lost to Follow-up|55|||
156859360|NCT00614575|566241209|FG000|Overall Study|Lack of Efficacy|14|||
156859361|NCT00614575|566241209|FG000|Overall Study|Withdrawal by Subject|6|||
156859362|NCT00614575|566241209|FG000|Overall Study|Death|3|||
156859363|NCT00614575|566241209|FG000|Overall Study|Physician Decision|2|||
156859364|NCT00614575|566241209|FG000|Overall Study|No data were collected.|18|||
156859365|NCT00614575|566241209|FG000|Overall Study|Irregularly enrolled patients|23|||
156859366|NCT00614575|566241209|FG000|Overall Study|No treatment|1|||
156859367|NCT01018030|566241210|FG000|Overall Study|Adverse Event|10|||
156859368|NCT01018030|566241211|FG001|Overall Study|Adverse Event|5|||
156859369|NCT01018030|566241212|FG002|Overall Study|Adverse Event|5|||
156859370|NCT01018030|566241210|FG000|Overall Study|Withdrawal by Subject|2|||
156859371|NCT01018030|566241211|FG001|Overall Study|Withdrawal by Subject|2|||
156859372|NCT01018030|566241212|FG002|Overall Study|Withdrawal by Subject|4|||
156859373|NCT01018030|566241210|FG000|Overall Study|Lost to Follow-up|2|||
156859374|NCT01018030|566241211|FG001|Overall Study|Lost to Follow-up|0|||
156859375|NCT01018030|566241212|FG002|Overall Study|Lost to Follow-up|3|||
156859376|NCT01018030|566241210|FG000|Overall Study|Protocol Violation|2|||
156859377|NCT01018030|566241211|FG001|Overall Study|Protocol Violation|1|||
156859378|NCT01018030|566241212|FG002|Overall Study|Protocol Violation|0|||
156859379|NCT01018030|566241210|FG000|Overall Study|Physician Decision|1|||
156859380|NCT01018030|566241211|FG001|Overall Study|Physician Decision|0|||
156859381|NCT01018030|566241212|FG002|Overall Study|Physician Decision|1|||
156859382|NCT01018030|566241210|FG000|Overall Study|Lack of Efficacy|1|||
156859383|NCT01018030|566241211|FG001|Overall Study|Lack of Efficacy|0|||
156859384|NCT01018030|566241212|FG002|Overall Study|Lack of Efficacy|0|||
156859385|NCT01018030|566241210|FG000|Overall Study|Did Not Receive Study Drug|1|||
156859386|NCT01018030|566241211|FG001|Overall Study|Did Not Receive Study Drug|3|||
156859387|NCT01018030|566241212|FG002|Overall Study|Did Not Receive Study Drug|0|||
156859388|NCT00436332|566241216|FG000|Overall Study|Adverse Event|9|||
156859389|NCT00436332|566241216|FG000|Overall Study|Withdrawal by Subject|2|||
156859390|NCT00436332|566241216|FG000|Overall Study|Progression|59|||
156859391|NCT00436332|566241216|FG000|Overall Study|Death|2|||
156859392|NCT00436332|566241216|FG000|Overall Study|Not Protocol Specified|6|||
156859393|NCT00436332|566241216|FG000|Overall Study|Ineligible|2|||
156859394|NCT00436332|566241216|FG000|Overall Study|Never Received Treatment|3|||
156859395|NCT00472108|566241217|FG000|Overall Study|Lost to Follow-up|0|||
156859396|NCT00472108|566241218|FG001|Overall Study|Lost to Follow-up|1|||
156859397|NCT00265564|566241223|FG000|Overall Study|Lost to Follow-up|5|||
156859398|NCT00265564|566241224|FG001|Overall Study|Lost to Follow-up|7|||
156859399|NCT00265564|566241223|FG000|Overall Study|met exclusion criteria|5|||
156859400|NCT00265564|566241224|FG001|Overall Study|met exclusion criteria|2|||
156859401|NCT01553084|566241227|FG000|Overall Study|Withdrawal by Subject|15|||
156859402|NCT01553084|566241228|FG001|Overall Study|Withdrawal by Subject|13|||
156859403|NCT01553084|566241229|FG002|Overall Study|Withdrawal by Subject|35|||
156859404|NCT04698343|566241230|FG000|Overall Study|Withdrawal by Subject|6|||
156859405|NCT04698343|566241230|FG000|Overall Study|Physician Decision|2|||
156474090|NCT03052517|564830970|FG000|Overall Study|Subject/Guardian Decision|50|||
156474091|NCT03052517|564830971|FG001|Overall Study|Subject/Guardian Decision|45|||
156474092|NCT03052517|564830972|FG002|Overall Study|Subject/Guardian Decision|22|||
156474093|NCT03052517|564830970|FG000|Overall Study|Lack of Efficacy|23|||
156474094|NCT03052517|564830971|FG001|Overall Study|Lack of Efficacy|14|||
156474095|NCT03052517|564830972|FG002|Overall Study|Lack of Efficacy|7|||
156474096|NCT03052517|564830970|FG000|Overall Study|Adverse Event|6|||
156474097|NCT03052517|564830971|FG001|Overall Study|Adverse Event|5|||
156474098|NCT03052517|564830972|FG002|Overall Study|Adverse Event|0|||
156474099|NCT03052517|564830970|FG000|Overall Study|Physician Decision|4|||
156474100|NCT03052517|564830971|FG001|Overall Study|Physician Decision|5|||
156474101|NCT03052517|564830972|FG002|Overall Study|Physician Decision|1|||
156474102|NCT03052517|564830970|FG000|Overall Study|Death|3|||
156474103|NCT03052517|564830971|FG001|Overall Study|Death|0|||
156474104|NCT03052517|564830972|FG002|Overall Study|Death|1|||
156474105|NCT03052517|564830970|FG000|Overall Study|Lost to Follow-up|2|||
156859406|NCT04698343|566241230|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
156859407|NCT04698343|566241230|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
156859408|NCT04698343|566241230|FG000|Overall Study|Personal reasons|3|||
156859409|NCT04698343|566241230|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
156859410|NCT02756338|566241234|FG000|Overall Study|Withdrawn by Investigator|1|||
156859411|NCT02756338|566241234|FG000|Overall Study|Device Replaced with Pacemaker|4|||
156859412|NCT01339689|566241237|FG000|Overall Study|Adverse Event|1|||
156859413|NCT01339689|566241238|FG001|Overall Study|Adverse Event|2|||
156859414|NCT01339689|566241237|FG000|Overall Study|Lost to Follow-up|9|||
156859415|NCT01339689|566241238|FG001|Overall Study|Lost to Follow-up|3|||
156859416|NCT01339689|566241237|FG000|Overall Study|Withdrawal by Subject|3|||
156859417|NCT01339689|566241238|FG001|Overall Study|Withdrawal by Subject|0|||
156859418|NCT01339689|566241237|FG000|Overall Study|Noncompliance|1|||
156859419|NCT01339689|566241238|FG001|Overall Study|Noncompliance|0|||
156859420|NCT01339689|566241237|FG000|Overall Study|Relocated out of area|0|||
156859421|NCT01339689|566241238|FG001|Overall Study|Relocated out of area|1|||
156859422|NCT01339689|566241237|FG000|Overall Study|Other|2|||
156859423|NCT01339689|566241238|FG001|Overall Study|Other|2|||
156859424|NCT01339689|566241237|FG000|Overall Study|multiple reasons|1|||
156859425|NCT01339689|566241238|FG001|Overall Study|multiple reasons|1|||
156859426|NCT03582215|566241239|FG000|Overall Study|Adverse Event|1|||
156859427|NCT03582215|566241240|FG001|Overall Study|Adverse Event|0|||
156859428|NCT03582215|566241241|FG002|Overall Study|Adverse Event|0|||
156859429|NCT03582215|566241242|FG003|Overall Study|Adverse Event|0|||
156859430|NCT03582215|566241243|FG004|Overall Study|Adverse Event|0|||
156859431|NCT03582215|566241244|FG005|Overall Study|Adverse Event|0|||
156859432|NCT03582215|566241245|FG006|Overall Study|Adverse Event|2|||
156859433|NCT03582215|566241246|FG007|Overall Study|Adverse Event|2|||
156859434|NCT01791244|566241247|FG000|Overall Study|Adverse Event|5|||
156859435|NCT01791244|566241248|FG001|Overall Study|Adverse Event|7|||
156859436|NCT01791244|566241247|FG000|Overall Study|Insufficient clinical response|10|||
156859437|NCT01791244|566241248|FG001|Overall Study|Insufficient clinical response|10|||
156859438|NCT01791244|566241247|FG000|Overall Study|Laboratory Abnormality|0|||
156859439|NCT01791244|566241248|FG001|Overall Study|Laboratory Abnormality|1|||
156859440|NCT00703014|566241251|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
156859441|NCT00703014|566241252|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
156859442|NCT00703014|566241253|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
156859443|NCT00703014|566241254|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
156859444|NCT00703014|566241251|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
156859445|NCT00703014|566241252|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
156859446|NCT00703014|566241253|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
156859447|NCT00703014|566241254|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
156859448|NCT04949191|566241255|FG000|Overall Study|Non-compliance with Study Drug|1|||
156859449|NCT04949191|566241256|FG001|Overall Study|Non-compliance with Study Drug|0|||
156859450|NCT04949191|566241257|FG002|Overall Study|Non-compliance with Study Drug|0|||
156859451|NCT04949191|566241258|FG003|Overall Study|Non-compliance with Study Drug|0|||
156859452|NCT04949191|566241255|FG000|Overall Study|Progressive Disease|0|||
156859453|NCT04949191|566241256|FG001|Overall Study|Progressive Disease|1|||
156859454|NCT04949191|566241257|FG002|Overall Study|Progressive Disease|0|||
156859455|NCT04949191|566241258|FG003|Overall Study|Progressive Disease|0|||
156859456|NCT04949191|566241255|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
156859457|NCT04949191|566241256|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
156859458|NCT04949191|566241257|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
156859459|NCT04949191|566241258|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
156859460|NCT04949191|566241255|FG000|Overall Study|Sponsor Terminated Study|0|||
156859461|NCT04949191|566241256|FG001|Overall Study|Sponsor Terminated Study|0|||
156859462|NCT04949191|566241257|FG002|Overall Study|Sponsor Terminated Study|1|||
156343097|NCT00166114|564356249|FG000|Overall Study|Protocol Violation|2|||
156343098|NCT00166114|564356250|FG001|Overall Study|Protocol Violation|1|||
156343099|NCT00166114|564356249|FG000|Overall Study|Withdrawal by Subject|10|||
156343100|NCT00166114|564356250|FG001|Overall Study|Withdrawal by Subject|4|||
156343101|NCT00166114|564356249|FG000|Overall Study|Adverse Event|2|||
156343102|NCT00166114|564356250|FG001|Overall Study|Adverse Event|1|||
156343103|NCT01218204|564356257|FG000|Part B Washout|Adverse Event|0|||
156343104|NCT01218204|564356258|FG001|Part B Washout|Adverse Event|1|||
156343105|NCT01218204|564356259|FG002|Part B Washout|Adverse Event|0|||
156474106|NCT03052517|564830971|FG001|Overall Study|Lost to Follow-up|4|||
156474107|NCT03052517|564830972|FG002|Overall Study|Lost to Follow-up|0|||
156474108|NCT03052517|564830970|FG000|Overall Study|Pregnancy|1|||
156474109|NCT03052517|564830971|FG001|Overall Study|Pregnancy|0|||
156859463|NCT04949191|566241258|FG003|Overall Study|Sponsor Terminated Study|1|||
156859464|NCT05121766|566241259|FG000|Overall Study|Covid reinfection|3|||
156859465|NCT05121766|566241260|FG001|Overall Study|Covid reinfection|0|||
156859466|NCT05121766|566241259|FG000|Overall Study|Withdrawal by Subject|3|||
156859467|NCT05121766|566241260|FG001|Overall Study|Withdrawal by Subject|1|||
156859468|NCT05121766|566241259|FG000|Overall Study|Adverse Event|2|||
156859469|NCT05121766|566241260|FG001|Overall Study|Adverse Event|4|||
156859470|NCT05121766|566241259|FG000|Overall Study|Lost to Follow-up|0|||
156859471|NCT05121766|566241260|FG001|Overall Study|Lost to Follow-up|1|||
156859472|NCT00730158|566241261|FG000|Overall Study|Withdrawal by Subject|1|||
156859473|NCT00730158|566241262|FG001|Overall Study|Withdrawal by Subject|1|||
156859474|NCT03535974|566241264|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
156859475|NCT03535974|566241265|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
156859476|NCT03535974|566241266|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
156859477|NCT03535974|566241264|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
156859478|NCT03535974|566241265|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
156859479|NCT03535974|566241266|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
156859480|NCT04059549|566241267|FG000|Overall Study|Withdrawal by Subject|2|||
156859481|NCT04059549|566241268|FG001|Overall Study|Withdrawal by Subject|0|||
156859482|NCT03259230|566241270|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
156859483|NCT03259230|566241271|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
156859484|NCT02678351|566241272|FG000|Overall Study|Withdrawal by Subject|1|||
156859485|NCT01033240|566241273|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
156859486|NCT01033240|566241274|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
156859487|NCT01033240|566241275|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
156859488|NCT01033240|566241273|FG000|Overall Study|Death|2|||
156859489|NCT01033240|566241274|FG001|Overall Study|Death|0|||
156859490|NCT01033240|566241275|FG002|Overall Study|Death|0|||
156859491|NCT01033240|566241273|FG000|Overall Study|Withdrew Consent|2|||
156859492|NCT01033240|566241274|FG001|Overall Study|Withdrew Consent|9|||
156859493|NCT01033240|566241275|FG002|Overall Study|Withdrew Consent|2|||
156859494|NCT01033240|566241273|FG000|Overall Study|Disease Progression|35|||
156859495|NCT01033240|566241274|FG001|Overall Study|Disease Progression|32|||
156859496|NCT01033240|566241275|FG002|Overall Study|Disease Progression|41|||
156859497|NCT01033240|566241273|FG000|Overall Study|Investigator Discretion|0|||
156859498|NCT01033240|566241274|FG001|Overall Study|Investigator Discretion|0|||
156859499|NCT01033240|566241275|FG002|Overall Study|Investigator Discretion|2|||
156859500|NCT01033240|566241273|FG000|Overall Study|Other|0|||
156859501|NCT01033240|566241274|FG001|Overall Study|Other|1|||
156859502|NCT01033240|566241275|FG002|Overall Study|Other|2|||
156859503|NCT02913482|566241276|FG000|Overall Study|Death|0|||
156859504|NCT02913482|566241277|FG001|Overall Study|Death|2|||
156859505|NCT02913482|566241278|FG002|Overall Study|Death|2|||
156859506|NCT02913482|566241276|FG000|Overall Study|Progressive Disease|1|||
156859507|NCT02913482|566241277|FG001|Overall Study|Progressive Disease|1|||
156859508|NCT02913482|566241278|FG002|Overall Study|Progressive Disease|1|||
156859509|NCT02913482|566241276|FG000|Overall Study|Reason not specified|0|||
156859510|NCT02913482|566241277|FG001|Overall Study|Reason not specified|0|||
156859511|NCT02913482|566241278|FG002|Overall Study|Reason not specified|1|||
156859512|NCT02913482|566241276|FG000|Overall Study|Withdrawal by Subject|0|||
156474110|NCT03052517|564830972|FG002|Overall Study|Pregnancy|1|||
156474111|NCT03052517|564830970|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
156474112|NCT03052517|564830971|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
156474113|NCT03052517|564830972|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
156474114|NCT03052517|564830970|FG000|Overall Study|Technical Problems|0|||
156474115|NCT03052517|564830971|FG001|Overall Study|Technical Problems|1|||
156474116|NCT03052517|564830972|FG002|Overall Study|Technical Problems|0|||
156474117|NCT01858688|564830973|FG000|Overall Study|Withdrawal by Subject|8|||
156474118|NCT01858688|564830973|FG000|Overall Study|Participant began another therapy|3|||
156474119|NCT01858688|564830973|FG000|Overall Study|Physician Decision|2|||
156474120|NCT01858688|564830973|FG000|Overall Study|Progressive Disease|2|||
156474121|NCT01858688|564830973|FG000|Overall Study|Reason not reproted|5|||
156474122|NCT00822900|564830979|FG000|Overall Study|Withdrawal by Subject|14|||
156474123|NCT00822900|564830980|FG001|Overall Study|Withdrawal by Subject|14|||
156474124|NCT00822900|564830979|FG000|Overall Study|Lost to Follow-up|9|||
156474125|NCT00822900|564830980|FG001|Overall Study|Lost to Follow-up|9|||
156474126|NCT00822900|564830979|FG000|Overall Study|Death|83|||
156474127|NCT00822900|564830980|FG001|Overall Study|Death|69|||
156474128|NCT00822900|564830979|FG000|Overall Study|Became a ward of the state|2|||
156474129|NCT00822900|564830980|FG001|Overall Study|Became a ward of the state|1|||
156474130|NCT00659373|564830992|FG000|Overall Study|Withdrawal by Subject|3|||
156474131|NCT00659373|564830993|FG001|Overall Study|Withdrawal by Subject|5|||
156474132|NCT00659373|564830992|FG000|Overall Study|Assessment Missed|2|||
156474133|NCT00659373|564830993|FG001|Overall Study|Assessment Missed|2|||
156542309|NCT01147744|565079322|FG003|Overall Study|Adverse Event|0|||
156474134|NCT03042767|564830996|FG000|Overall Study|Lost to Follow-up|1|||
156474135|NCT03042767|564830997|FG001|Overall Study|Lost to Follow-up|2|||
156474136|NCT02686658|564831004|FG000|Overall Study|Adverse Event|0|||
156474137|NCT02686658|564831005|FG001|Overall Study|Adverse Event|0|||
156474138|NCT02686658|564831006|FG002|Overall Study|Adverse Event|1|||
156474139|NCT02686658|564831007|FG003|Overall Study|Adverse Event|1|||
156343106|NCT01218204|564356260|FG003|Part B Washout|Adverse Event|0|||
156474140|NCT02686658|564831008|FG004|Overall Study|Adverse Event|2|||
156474141|NCT02686658|564831009|FG005|Overall Study|Adverse Event|1|||
156474142|NCT02686658|564831004|FG000|Overall Study|Investigator decision|0|||
156474143|NCT02686658|564831005|FG001|Overall Study|Investigator decision|0|||
156474144|NCT02686658|564831006|FG002|Overall Study|Investigator decision|0|||
156474145|NCT02686658|564831007|FG003|Overall Study|Investigator decision|1|||
156474146|NCT02686658|564831008|FG004|Overall Study|Investigator decision|2|||
156474147|NCT02686658|564831009|FG005|Overall Study|Investigator decision|1|||
156474148|NCT02686658|564831004|FG000|Overall Study|Sponsor decision|1|||
156474149|NCT02686658|564831005|FG001|Overall Study|Sponsor decision|2|||
156474150|NCT02686658|564831006|FG002|Overall Study|Sponsor decision|1|||
156474151|NCT02686658|564831007|FG003|Overall Study|Sponsor decision|5|||
156474152|NCT02686658|564831008|FG004|Overall Study|Sponsor decision|13|||
156474153|NCT02686658|564831009|FG005|Overall Study|Sponsor decision|2|||
156474154|NCT02686658|564831004|FG000|Overall Study|Lost to Follow-up|0|||
156474155|NCT02686658|564831005|FG001|Overall Study|Lost to Follow-up|0|||
156474156|NCT02686658|564831006|FG002|Overall Study|Lost to Follow-up|2|||
156474157|NCT02686658|564831007|FG003|Overall Study|Lost to Follow-up|0|||
156474158|NCT02686658|564831008|FG004|Overall Study|Lost to Follow-up|0|||
156474159|NCT02686658|564831009|FG005|Overall Study|Lost to Follow-up|1|||
156474160|NCT02686658|564831004|FG000|Overall Study|Death|1|||
156474161|NCT02686658|564831005|FG001|Overall Study|Death|0|||
156474162|NCT02686658|564831006|FG002|Overall Study|Death|0|||
156474163|NCT02686658|564831007|FG003|Overall Study|Death|1|||
156474164|NCT02686658|564831008|FG004|Overall Study|Death|1|||
156474165|NCT02686658|564831009|FG005|Overall Study|Death|1|||
156474166|NCT02686658|564831004|FG000|Overall Study|Withdrawal by Subject|2|||
156474167|NCT02686658|564831005|FG001|Overall Study|Withdrawal by Subject|5|||
156474168|NCT02686658|564831006|FG002|Overall Study|Withdrawal by Subject|4|||
156474169|NCT02686658|564831007|FG003|Overall Study|Withdrawal by Subject|4|||
156474170|NCT02686658|564831008|FG004|Overall Study|Withdrawal by Subject|17|||
156474171|NCT02686658|564831009|FG005|Overall Study|Withdrawal by Subject|8|||
156474172|NCT02686658|564831004|FG000|Overall Study|Placed in hospice care|0|||
156474173|NCT02686658|564831005|FG001|Overall Study|Placed in hospice care|0|||
156474174|NCT02686658|564831006|FG002|Overall Study|Placed in hospice care|1|||
156474175|NCT02686658|564831007|FG003|Overall Study|Placed in hospice care|0|||
156474176|NCT02686658|564831008|FG004|Overall Study|Placed in hospice care|0|||
156474177|NCT02686658|564831009|FG005|Overall Study|Placed in hospice care|0|||
156474178|NCT02686658|564831004|FG000|Overall Study|Participant non-compliance|0|||
156474179|NCT02686658|564831005|FG001|Overall Study|Participant non-compliance|0|||
156474180|NCT02686658|564831006|FG002|Overall Study|Participant non-compliance|0|||
156474181|NCT02686658|564831007|FG003|Overall Study|Participant non-compliance|0|||
156474182|NCT02686658|564831008|FG004|Overall Study|Participant non-compliance|0|||
156474183|NCT02686658|564831009|FG005|Overall Study|Participant non-compliance|1|||
156474184|NCT02686658|564831004|FG000|Overall Study|Concern over coronavirus disease care|0|||
156474185|NCT02686658|564831005|FG001|Overall Study|Concern over coronavirus disease care|0|||
156474186|NCT02686658|564831006|FG002|Overall Study|Concern over coronavirus disease care|0|||
156474187|NCT02686658|564831007|FG003|Overall Study|Concern over coronavirus disease care|0|||
156474188|NCT02686658|564831008|FG004|Overall Study|Concern over coronavirus disease care|2|||
156474189|NCT02686658|564831009|FG005|Overall Study|Concern over coronavirus disease care|1|||
156474190|NCT01227421|564831012|FG000|Overall Study|Lost to Follow-up|6|||
156474191|NCT01227421|564831013|FG001|Overall Study|Lost to Follow-up|7|||
156474192|NCT01227421|564831014|FG002|Overall Study|Lost to Follow-up|5|||
156474193|NCT01227421|564831012|FG000|Overall Study|Adverse Event|2|||
156474194|NCT01227421|564831013|FG001|Overall Study|Adverse Event|7|||
156474195|NCT01227421|564831014|FG002|Overall Study|Adverse Event|2|||
156474196|NCT01227421|564831012|FG000|Overall Study|Withdrawal by Subject|1|||
156474197|NCT01227421|564831013|FG001|Overall Study|Withdrawal by Subject|2|||
156474198|NCT01227421|564831014|FG002|Overall Study|Withdrawal by Subject|1|||
156474199|NCT01227421|564831012|FG000|Overall Study|Protocol Violation|1|||
156474200|NCT01227421|564831013|FG001|Overall Study|Protocol Violation|1|||
156474201|NCT01227421|564831014|FG002|Overall Study|Protocol Violation|2|||
156474202|NCT01227421|564831012|FG000|Overall Study|Randomized in error|1|||
156474203|NCT01227421|564831013|FG001|Overall Study|Randomized in error|1|||
156474204|NCT01227421|564831014|FG002|Overall Study|Randomized in error|0|||
156474205|NCT01827839|564831017|FG000|Overall Study|Adverse Event|1|||
156474206|NCT01827839|564831017|FG000|Overall Study|Consent Withdrawal|2|||
156474207|NCT00614614|564831018|FG000|Primary Vaccination Phase|Adverse Event|6|||
156474208|NCT00614614|564831019|FG001|Primary Vaccination Phase|Adverse Event|0|||
156474209|NCT00614614|564831020|FG002|Primary Vaccination Phase|Adverse Event|0|||
156474210|NCT00614614|564831021|FG003|Primary Vaccination Phase|Adverse Event|0|||
156474211|NCT00614614|564831022|FG004|Primary Vaccination Phase|Adverse Event|0|||
156474212|NCT00614614|564831018|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
156542310|NCT01147744|565079323|FG004|Overall Study|Adverse Event|2|||
156542311|NCT01147744|565079324|FG005|Overall Study|Adverse Event|1|||
156542312|NCT01147744|565079325|FG006|Overall Study|Adverse Event|2|||
156343107|NCT01218204|564356257|FG000|Part B Washout|Lost to Follow-up|0|||
156474213|NCT00614614|564831019|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
156474214|NCT00614614|564831020|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
156474215|NCT00614614|564831021|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
156474216|NCT00614614|564831022|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
156343108|NCT01218204|564356258|FG001|Part B Washout|Lost to Follow-up|2|||
156343109|NCT01218204|564356259|FG002|Part B Washout|Lost to Follow-up|0|||
156542313|NCT01147744|565079319|FG000|Overall Study|Withdrawal by Subject|8|||
156542314|NCT01147744|565079320|FG001|Overall Study|Withdrawal by Subject|4|||
156343110|NCT01218204|564356260|FG003|Part B Washout|Lost to Follow-up|0|||
156343111|NCT01218204|564356257|FG000|Part B Washout|Physician Decision|0|||
156343112|NCT01218204|564356258|FG001|Part B Washout|Physician Decision|14|||
156343113|NCT01218204|564356259|FG002|Part B Washout|Physician Decision|0|||
156343114|NCT01218204|564356260|FG003|Part B Washout|Physician Decision|0|||
156343115|NCT01218204|564356257|FG000|Part B Washout|Withdrawal by Subject|0|||
156343116|NCT01218204|564356258|FG001|Part B Washout|Withdrawal by Subject|14|||
156542315|NCT01147744|565079321|FG002|Overall Study|Withdrawal by Subject|2|||
156343117|NCT01218204|564356259|FG002|Part B Washout|Withdrawal by Subject|0|||
156542316|NCT01147744|565079322|FG003|Overall Study|Withdrawal by Subject|2|||
156343118|NCT01218204|564356260|FG003|Part B Washout|Withdrawal by Subject|0|||
156542317|NCT01147744|565079323|FG004|Overall Study|Withdrawal by Subject|2|||
156343119|NCT01218204|564356257|FG000|Part B Washout|Reached defined stopping criteria|0|||
156859513|NCT02913482|566241277|FG001|Overall Study|Withdrawal by Subject|1|||
156859514|NCT02913482|566241278|FG002|Overall Study|Withdrawal by Subject|1|||
156859515|NCT01011673|566241279|FG000|Randomized|Secondary headache|2|||
156859516|NCT01011673|566241280|FG001|Randomized|Secondary headache|1|||
156859517|NCT01011673|566241279|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
156859518|NCT01011673|566241280|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
156859519|NCT04716426|566241281|FG000|Overall Study|Vaccination|1|||
156859520|NCT04716426|566241282|FG001|Overall Study|Vaccination|1|||
156859521|NCT04716426|566241281|FG000|Overall Study|Contamination|1|||
156859522|NCT04716426|566241282|FG001|Overall Study|Contamination|0|||
156859523|NCT01046565|566241283|FG000|Overall Study|Adverse Event|2|||
156859524|NCT01046565|566241283|FG000|Overall Study|Withdrawal by Subject|7|||
156859525|NCT05190120|566241286|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
156859526|NCT05190120|566241287|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
156859527|NCT05190120|566241288|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
156859528|NCT05190120|566241289|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
156859529|NCT05190120|566241286|FG000|Overall Study|Lost to Follow-up|5|||
156859530|NCT05190120|566241287|FG001|Overall Study|Lost to Follow-up|0|||
156859531|NCT05190120|566241288|FG002|Overall Study|Lost to Follow-up|2|||
156859532|NCT05190120|566241289|FG003|Overall Study|Lost to Follow-up|3|||
156859533|NCT03062358|566241290|FG000|Overall Study|Death|269|||
156859534|NCT03062358|566241291|FG001|Overall Study|Death|145|||
156859535|NCT03062358|566241290|FG000|Overall Study|Withdrawal by Subject|2|||
156859536|NCT03062358|566241291|FG001|Overall Study|Withdrawal by Subject|1|||
156859537|NCT03062358|566241290|FG000|Overall Study|Sponsor Decision|29|||
156859538|NCT03062358|566241291|FG001|Overall Study|Sponsor Decision|7|||
156859539|NCT05893862|566241292|FG000|Overall Study|Physician Decision|0|||
156859540|NCT05893862|566241293|FG001|Overall Study|Physician Decision|1|||
156859541|NCT05893862|566241294|FG002|Overall Study|Physician Decision|0|||
156859542|NCT05893862|566241295|FG003|Overall Study|Physician Decision|0|||
156859543|NCT05893862|566241296|FG004|Overall Study|Physician Decision|1|||
156859544|NCT05893862|566241297|FG005|Overall Study|Physician Decision|0|||
156859545|NCT05893862|566241292|FG000|Overall Study|Withdrawal by Subject|1|||
156859546|NCT05893862|566241293|FG001|Overall Study|Withdrawal by Subject|7|||
156859547|NCT05893862|566241294|FG002|Overall Study|Withdrawal by Subject|1|||
156859548|NCT05893862|566241295|FG003|Overall Study|Withdrawal by Subject|3|||
156859549|NCT05893862|566241296|FG004|Overall Study|Withdrawal by Subject|3|||
156859550|NCT05893862|566241297|FG005|Overall Study|Withdrawal by Subject|2|||
156859551|NCT05893862|566241292|FG000|Overall Study|Adverse Event|1|||
156859552|NCT05893862|566241293|FG001|Overall Study|Adverse Event|4|||
156859553|NCT05893862|566241294|FG002|Overall Study|Adverse Event|2|||
156859554|NCT05893862|566241295|FG003|Overall Study|Adverse Event|2|||
156859555|NCT05893862|566241296|FG004|Overall Study|Adverse Event|1|||
156859556|NCT05893862|566241297|FG005|Overall Study|Adverse Event|0|||
156859557|NCT01400698|566241298|FG000|Overall Study|Lost to Follow-up|2|||
156859558|NCT01400698|566241299|FG001|Overall Study|Lost to Follow-up|5|||
156859559|NCT01400698|566241300|FG002|Overall Study|Lost to Follow-up|2|||
156859560|NCT01400698|566241301|FG003|Overall Study|Lost to Follow-up|1|||
156859561|NCT01400698|566241302|FG004|Overall Study|Lost to Follow-up|4|||
156859562|NCT01400698|566241303|FG005|Overall Study|Lost to Follow-up|3|||
156859563|NCT01400698|566241298|FG000|Overall Study|Withdrawal by Subject|8|||
156859564|NCT01400698|566241299|FG001|Overall Study|Withdrawal by Subject|2|||
156859565|NCT01400698|566241300|FG002|Overall Study|Withdrawal by Subject|0|||
156859566|NCT01400698|566241301|FG003|Overall Study|Withdrawal by Subject|4|||
156859567|NCT01400698|566241302|FG004|Overall Study|Withdrawal by Subject|1|||
156859568|NCT01400698|566241303|FG005|Overall Study|Withdrawal by Subject|3|||
156859569|NCT01400698|566241298|FG000|Overall Study|Protocol Violation|0|||
156859570|NCT01400698|566241299|FG001|Overall Study|Protocol Violation|1|||
156859571|NCT01400698|566241300|FG002|Overall Study|Protocol Violation|0|||
156859572|NCT01400698|566241301|FG003|Overall Study|Protocol Violation|0|||
156859573|NCT01400698|566241302|FG004|Overall Study|Protocol Violation|1|||
156859574|NCT01400698|566241303|FG005|Overall Study|Protocol Violation|0|||
156859575|NCT01400698|566241298|FG000|Overall Study|Non-compliance|0|||
156859576|NCT01400698|566241299|FG001|Overall Study|Non-compliance|1|||
156859577|NCT01400698|566241300|FG002|Overall Study|Non-compliance|0|||
156474217|NCT00614614|564831018|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
156474218|NCT00614614|564831019|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
156474219|NCT00614614|564831020|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
156474220|NCT00614614|564831021|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
156474221|NCT00614614|564831022|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
156474222|NCT00614614|564831018|FG000|Primary Vaccination Phase|Protocol Violation|9|||
156474223|NCT00614614|564831019|FG001|Primary Vaccination Phase|Protocol Violation|3|||
156343120|NCT01218204|564356258|FG001|Part B Washout|Reached defined stopping criteria|2|||
156343121|NCT01218204|564356259|FG002|Part B Washout|Reached defined stopping criteria|0|||
156474224|NCT00614614|564831020|FG002|Primary Vaccination Phase|Protocol Violation|0|||
156474225|NCT00614614|564831021|FG003|Primary Vaccination Phase|Protocol Violation|0|||
156474226|NCT00614614|564831022|FG004|Primary Vaccination Phase|Protocol Violation|0|||
156474227|NCT00614614|564831018|FG000|Primary Vaccination Phase|Other|4|||
156474228|NCT00614614|564831019|FG001|Primary Vaccination Phase|Other|0|||
156474229|NCT00614614|564831020|FG002|Primary Vaccination Phase|Other|0|||
156474230|NCT00614614|564831021|FG003|Primary Vaccination Phase|Other|0|||
156474231|NCT00614614|564831022|FG004|Primary Vaccination Phase|Other|0|||
156474232|NCT00614614|564831018|FG000|Booster Vaccination Phase|Adverse Event|0|||
156474233|NCT00614614|564831019|FG001|Booster Vaccination Phase|Adverse Event|0|||
156859578|NCT01400698|566241301|FG003|Overall Study|Non-compliance|1|||
156859579|NCT01400698|566241302|FG004|Overall Study|Non-compliance|0|||
156859580|NCT01400698|566241303|FG005|Overall Study|Non-compliance|0|||
156859581|NCT01400698|566241298|FG000|Overall Study|Adverse Event|1|||
156859582|NCT01400698|566241299|FG001|Overall Study|Adverse Event|0|||
156859583|NCT01400698|566241300|FG002|Overall Study|Adverse Event|0|||
156859584|NCT01400698|566241301|FG003|Overall Study|Adverse Event|0|||
156859585|NCT01400698|566241302|FG004|Overall Study|Adverse Event|0|||
156859586|NCT01400698|566241303|FG005|Overall Study|Adverse Event|0|||
156859587|NCT01400698|566241298|FG000|Overall Study|Other|4|||
156859588|NCT01400698|566241299|FG001|Overall Study|Other|2|||
156859589|NCT01400698|566241300|FG002|Overall Study|Other|0|||
156859590|NCT01400698|566241301|FG003|Overall Study|Other|2|||
156859591|NCT01400698|566241302|FG004|Overall Study|Other|1|||
156859592|NCT01400698|566241303|FG005|Overall Study|Other|0|||
156859593|NCT01352117|566243115|FG000|Overall Study|Death|15|||
156859594|NCT01352117|566243116|FG001|Overall Study|Death|16|||
156859595|NCT01352117|566243115|FG000|Overall Study|Withdrawal by Subject|1|||
156859596|NCT01352117|566243116|FG001|Overall Study|Withdrawal by Subject|0|||
156859597|NCT01352117|566243115|FG000|Overall Study|Lost to Follow-up|2|||
156859598|NCT01352117|566243116|FG001|Overall Study|Lost to Follow-up|7|||
156859599|NCT01352117|566243115|FG000|Overall Study|Non-adherent to study requirements|1|||
156859600|NCT01352117|566243116|FG001|Overall Study|Non-adherent to study requirements|1|||
156859601|NCT01352117|566243115|FG000|Overall Study|Did not initiate study treatment|1|||
156859602|NCT01352117|566243116|FG001|Overall Study|Did not initiate study treatment|0|||
156859603|NCT01352117|566243115|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
156859604|NCT01352117|566243116|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
156859605|NCT01766050|566243117|FG000|Overall Study|Adverse Event|1|||
156859606|NCT01766050|566243117|FG000|Overall Study|Lost to Follow-up|1|||
156859607|NCT01766050|566243117|FG000|Overall Study|Withdrawal by Subject|2|||
156859608|NCT01021020|566243118|FG000|Period I|Protocol Violation|1|||
156859609|NCT01021020|566243118|FG000|Period I|Withdrawal by Subject|1|||
156859610|NCT01021020|566243118|FG000|14 Day Washout Period A|Physician Decision|1|||
156859611|NCT01706458|566243120|FG000|Overall Study|Physician Decision|3|||
156859612|NCT01706458|566243121|FG001|Overall Study|Physician Decision|4|||
156859613|NCT02766023|566243123|FG000|Overall Study|Lost to Follow-up|23|||
156859614|NCT02766023|566243124|FG001|Overall Study|Lost to Follow-up|11|||
156859615|NCT02766023|566243123|FG000|Overall Study|Pregnancy|1|||
156859616|NCT02766023|566243124|FG001|Overall Study|Pregnancy|0|||
156859617|NCT02766023|566243123|FG000|Overall Study|Adverse Event|1|||
156859618|NCT02766023|566243124|FG001|Overall Study|Adverse Event|0|||
156859619|NCT02766023|566243123|FG000|Overall Study|Withdrawal by Subject|4|||
156859620|NCT02766023|566243124|FG001|Overall Study|Withdrawal by Subject|5|||
156859621|NCT02766023|566243123|FG000|Overall Study|Physician Decision|1|||
156859622|NCT02766023|566243124|FG001|Overall Study|Physician Decision|0|||
156859623|NCT02766023|566243123|FG000|Overall Study|Not Eligible at Enrollment|0|||
156859624|NCT02766023|566243124|FG001|Overall Study|Not Eligible at Enrollment|1|||
156859625|NCT02384551|566243128|FG000|Overall Study|Lost to Follow-up|13|||
156859626|NCT02384551|566243129|FG001|Overall Study|Lost to Follow-up|14|||
156859627|NCT02384551|566243130|FG002|Overall Study|Lost to Follow-up|14|||
156859628|NCT02384551|566243131|FG003|Overall Study|Lost to Follow-up|14|||
156859629|NCT04349891|566243132|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
156859630|NCT04349891|566243133|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
156859631|NCT04349891|566243132|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
156859632|NCT04349891|566243133|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
156859633|NCT04349891|566243132|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
156859634|NCT04349891|566243133|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
156859635|NCT04349891|566243132|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
156859636|NCT04349891|566243133|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
156859637|NCT02923726|566243138|FG000|Overall Study|Death|196|||
156859638|NCT02923726|566243139|FG001|Overall Study|Death|175|||
156859639|NCT02923726|566243138|FG000|Overall Study|Withdrawal by Subject|337|||
156859640|NCT02923726|566243139|FG001|Overall Study|Withdrawal by Subject|307|||
156859641|NCT02399215|566243153|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
156859642|NCT02399215|566243153|FG000|Overall Study|Withdrawal by Subject|1|||
156859643|NCT00772538|566243154|FG000|Overall Study|Adverse Event|6|||
156859644|NCT00772538|566243155|FG001|Overall Study|Adverse Event|6|||
156474234|NCT00614614|564831020|FG002|Booster Vaccination Phase|Adverse Event|1|||
156343122|NCT01218204|564356260|FG003|Part B Washout|Reached defined stopping criteria|0|||
156542318|NCT01147744|565079324|FG005|Overall Study|Withdrawal by Subject|5|||
156474235|NCT00614614|564831021|FG003|Booster Vaccination Phase|Adverse Event|1|||
156474236|NCT00614614|564831022|FG004|Booster Vaccination Phase|Adverse Event|0|||
156474237|NCT00614614|564831018|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
156474238|NCT00614614|564831019|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
156474239|NCT00614614|564831020|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
156474240|NCT00614614|564831021|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
156474241|NCT00614614|564831022|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
156474242|NCT00614614|564831018|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
156474243|NCT00614614|564831019|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
156474244|NCT00614614|564831020|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
156474245|NCT00614614|564831021|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
156474246|NCT00614614|564831022|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
156474247|NCT00614614|564831018|FG000|Booster Vaccination Phase|Protocol Violation|0|||
156474248|NCT00614614|564831019|FG001|Booster Vaccination Phase|Protocol Violation|0|||
156474249|NCT00614614|564831020|FG002|Booster Vaccination Phase|Protocol Violation|2|||
156474250|NCT00614614|564831021|FG003|Booster Vaccination Phase|Protocol Violation|3|||
156474251|NCT00614614|564831022|FG004|Booster Vaccination Phase|Protocol Violation|0|||
156474252|NCT00614614|564831018|FG000|Booster Vaccination Phase|Other|0|||
156474253|NCT00614614|564831019|FG001|Booster Vaccination Phase|Other|1|||
156474254|NCT00614614|564831020|FG002|Booster Vaccination Phase|Other|3|||
156343123|NCT01218204|564356257|FG000|Part B Washout|Did not meet continuation criteria|0|||
156474255|NCT00614614|564831021|FG003|Booster Vaccination Phase|Other|2|||
156343124|NCT01218204|564356258|FG001|Part B Washout|Did not meet continuation criteria|112|||
156343125|NCT01218204|564356259|FG002|Part B Washout|Did not meet continuation criteria|0|||
156343126|NCT01218204|564356260|FG003|Part B Washout|Did not meet continuation criteria|0|||
156343127|NCT01218204|564356257|FG000|Part B Run-in|Adverse Event|0|||
156343128|NCT01218204|564356258|FG001|Part B Run-in|Adverse Event|0|||
156343129|NCT01218204|564356259|FG002|Part B Run-in|Adverse Event|1|||
156343130|NCT01218204|564356260|FG003|Part B Run-in|Adverse Event|0|||
156343131|NCT01218204|564356257|FG000|Part B Run-in|Protocol Violation|0|||
156343132|NCT01218204|564356258|FG001|Part B Run-in|Protocol Violation|0|||
156343133|NCT01218204|564356259|FG002|Part B Run-in|Protocol Violation|2|||
156343134|NCT01218204|564356260|FG003|Part B Run-in|Protocol Violation|0|||
156343135|NCT01218204|564356257|FG000|Part B Run-in|Withdrawal by Subject|0|||
156343136|NCT01218204|564356258|FG001|Part B Run-in|Withdrawal by Subject|0|||
156343137|NCT01218204|564356259|FG002|Part B Run-in|Withdrawal by Subject|3|||
156474256|NCT00614614|564831022|FG004|Booster Vaccination Phase|Other|1|||
156474257|NCT05426109|564831023|FG000|Overall Study|Withdrawal by Subject|0|||
156474258|NCT05426109|564831024|FG001|Overall Study|Withdrawal by Subject|1|||
156474259|NCT05212285|564831025|FG000|Overall Study|Lack of Efficacy|12|||
156474260|NCT05212285|564831026|FG001|Overall Study|Lack of Efficacy|8|||
156474261|NCT05212285|564831025|FG000|Overall Study|Withdrawal by Subject|8|||
156474262|NCT05212285|564831026|FG001|Overall Study|Withdrawal by Subject|1|||
156474263|NCT05212285|564831025|FG000|Overall Study|Lost to Follow-up|13|||
156474264|NCT05212285|564831026|FG001|Overall Study|Lost to Follow-up|1|||
156474265|NCT05212285|564831025|FG000|Overall Study|miss data|21|||
156474266|NCT05212285|564831026|FG001|Overall Study|miss data|2|||
156474267|NCT01000805|564831028|FG000|Overall Study|Adverse Event|21|||
156474268|NCT01000805|564831029|FG001|Overall Study|Adverse Event|9|||
156474269|NCT01000805|564831028|FG000|Overall Study|Lack of Efficacy|5|||
156474270|NCT01000805|564831029|FG001|Overall Study|Lack of Efficacy|16|||
156343138|NCT01218204|564356260|FG003|Part B Run-in|Withdrawal by Subject|0|||
156343139|NCT01218204|564356257|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
156343140|NCT01218204|564356258|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
156343141|NCT01218204|564356259|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
156343142|NCT01218204|564356260|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
156343143|NCT01218204|564356257|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
156343144|NCT01218204|564356258|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
156343145|NCT01218204|564356259|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
156343146|NCT01218204|564356260|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
156343147|NCT00545168|564356261|FG000|Overall Study|Lost to Follow-up|5|||
156343148|NCT00545168|564356262|FG001|Overall Study|Lost to Follow-up|5|||
156343149|NCT00545168|564356263|FG002|Overall Study|Lost to Follow-up|5|||
156343150|NCT00545168|564356261|FG000|Overall Study|Withdrawal by Subject|9|||
156343151|NCT00545168|564356262|FG001|Overall Study|Withdrawal by Subject|0|||
156343152|NCT00545168|564356263|FG002|Overall Study|Withdrawal by Subject|13|||
156343153|NCT00545168|564356261|FG000|Overall Study|Protocol Violation|1|||
156343154|NCT00545168|564356262|FG001|Overall Study|Protocol Violation|0|||
156474271|NCT01000805|564831028|FG000|Overall Study|Lost to Follow-up|16|||
156542319|NCT01147744|565079325|FG006|Overall Study|Withdrawal by Subject|2|||
156474272|NCT01000805|564831029|FG001|Overall Study|Lost to Follow-up|21|||
156542320|NCT01147744|565079319|FG000|Overall Study|Lost to Follow-up|0|||
156474273|NCT01000805|564831028|FG000|Overall Study|Physician Decision|0|||
156343155|NCT00545168|564356263|FG002|Overall Study|Protocol Violation|1|||
156542321|NCT01147744|565079320|FG001|Overall Study|Lost to Follow-up|1|||
156542322|NCT01147744|565079321|FG002|Overall Study|Lost to Follow-up|0|||
156474274|NCT01000805|564831029|FG001|Overall Study|Physician Decision|1|||
156474275|NCT01000805|564831028|FG000|Overall Study|Protocol Violation|12|||
156474276|NCT01000805|564831029|FG001|Overall Study|Protocol Violation|8|||
156474277|NCT01000805|564831028|FG000|Overall Study|Withdrawal by Subject|16|||
156474278|NCT01000805|564831029|FG001|Overall Study|Withdrawal by Subject|6|||
156474279|NCT01000805|564831028|FG000|Overall Study|Sponsor Decision|0|||
156474280|NCT01000805|564831029|FG001|Overall Study|Sponsor Decision|1|||
156474281|NCT03343704|564831032|FG000|Overall Study|Refused to complete follow up|0|||
156343156|NCT00545168|564356261|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
156343157|NCT00545168|564356262|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
156343158|NCT00545168|564356263|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
156343159|NCT04390191|564356276|FG000|Overall Study|Withdrawal by Subject|1|||
156343160|NCT04390191|564356277|FG001|Overall Study|Withdrawal by Subject|0|||
156343161|NCT03978832|564356280|FG000|Overall Study|Adverse Event|1|||
156343162|NCT03978832|564356280|FG000|Overall Study|Lost to Follow-up|1|||
156343163|NCT03978832|564356280|FG000|Overall Study|Withdrawal by Subject|6|||
156343164|NCT03978832|564356280|FG000|Overall Study|Physician Decision|2|||
156343165|NCT03978832|564356280|FG000|Overall Study|did not pass screening criteria|44|||
156343166|NCT00003499|564356281|FG000|Overall Study|Not evaluable|8|||
156343167|NCT01256008|564356282|FG000|Overall Study|Lost to Follow-up|6|||
156343168|NCT01256008|564356283|FG001|Overall Study|Lost to Follow-up|4|||
156343169|NCT01256008|564356284|FG002|Overall Study|Lost to Follow-up|11|||
156343170|NCT01256008|564356282|FG000|Overall Study|Withdrawal by Subject|2|||
156343171|NCT01256008|564356283|FG001|Overall Study|Withdrawal by Subject|3|||
156343172|NCT01256008|564356284|FG002|Overall Study|Withdrawal by Subject|10|||
156343173|NCT02244606|564356285|FG000|Overall Study|Adverse Event|0|||
156343174|NCT02244606|564356286|FG001|Overall Study|Adverse Event|1|||
156343175|NCT02244606|564356287|FG002|Overall Study|Adverse Event|1|||
156343176|NCT02244606|564356288|FG003|Overall Study|Adverse Event|0|||
156343177|NCT02244606|564356285|FG000|Overall Study|Lost to Follow-up|2|||
156343178|NCT02244606|564356286|FG001|Overall Study|Lost to Follow-up|2|||
156343179|NCT02244606|564356287|FG002|Overall Study|Lost to Follow-up|1|||
156343180|NCT02244606|564356288|FG003|Overall Study|Lost to Follow-up|0|||
156343181|NCT02244606|564356285|FG000|Overall Study|Protocol Violation|0|||
156343182|NCT02244606|564356286|FG001|Overall Study|Protocol Violation|0|||
156343183|NCT02244606|564356287|FG002|Overall Study|Protocol Violation|0|||
156343184|NCT02244606|564356288|FG003|Overall Study|Protocol Violation|1|||
156343185|NCT02244606|564356285|FG000|Overall Study|Withdrawal by Subject|1|||
156343186|NCT02244606|564356286|FG001|Overall Study|Withdrawal by Subject|1|||
156343187|NCT02244606|564356287|FG002|Overall Study|Withdrawal by Subject|0|||
156343188|NCT02244606|564356288|FG003|Overall Study|Withdrawal by Subject|0|||
156343189|NCT02244606|564356285|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
156343190|NCT02244606|564356286|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
156343191|NCT02244606|564356287|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
156343192|NCT02244606|564356288|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
156343193|NCT01402492|564356295|FG000|Overall Study|Withdrawal by Subject|17|||
156343194|NCT01402492|564356296|FG001|Overall Study|Withdrawal by Subject|11|||
156343195|NCT01402492|564356297|FG002|Overall Study|Withdrawal by Subject|11|||
156343196|NCT01402492|564356295|FG000|Overall Study|Adverse Event|2|||
156343197|NCT01402492|564356296|FG001|Overall Study|Adverse Event|3|||
156343198|NCT01402492|564356297|FG002|Overall Study|Adverse Event|4|||
156542323|NCT01147744|565079322|FG003|Overall Study|Lost to Follow-up|0|||
156343199|NCT01402492|564356295|FG000|Overall Study|Physician Decision|0|||
156343200|NCT01402492|564356296|FG001|Overall Study|Physician Decision|3|||
156343201|NCT01402492|564356297|FG002|Overall Study|Physician Decision|0|||
156343202|NCT01402492|564356295|FG000|Overall Study|Incarcerated (N=3)|2|||
156343203|NCT01402492|564356296|FG001|Overall Study|Incarcerated (N=3)|0|||
156343204|NCT01402492|564356297|FG002|Overall Study|Incarcerated (N=3)|1|||
156343205|NCT05537883|564356300|FG000|Overall Study|revisional surgery|4|||
156343206|NCT05537883|564356301|FG001|Overall Study|revisional surgery|2|||
156474282|NCT03343704|564831033|FG001|Overall Study|Refused to complete follow up|1|||
156474283|NCT03343704|564831032|FG000|Overall Study|Death|0|||
156474284|NCT03343704|564831033|FG001|Overall Study|Death|1|||
156343207|NCT05537883|564356300|FG000|Overall Study|surgeries were cancelled|0|||
156474285|NCT03343704|564831032|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
156474286|NCT03343704|564831033|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
156474287|NCT05432986|564831036|FG000|Overall Study|Withdrawal by Subject|2|||
156474288|NCT05432986|564831036|FG000|Overall Study|incomplete measurement|7|||
156474289|NCT00949117|564832348|FG000|Overall Study|Lack of Efficacy|2|||
156474290|NCT00949117|564832349|FG001|Overall Study|Lack of Efficacy|3|||
156474291|NCT00949117|564832348|FG000|Overall Study|Protocol Violation|1|||
156474292|NCT00949117|564832349|FG001|Overall Study|Protocol Violation|1|||
156474293|NCT00949117|564832348|FG000|Overall Study|Adverse Event|0|||
156474294|NCT00949117|564832349|FG001|Overall Study|Adverse Event|1|||
156474295|NCT03964974|564832350|FG000|Overall Study|Lost to Follow-up|3|||
156474296|NCT03964974|564832351|FG001|Overall Study|Lost to Follow-up|2|||
156474297|NCT03964974|564832350|FG000|Overall Study|Withdrawal by Subject|0|||
156474298|NCT03964974|564832351|FG001|Overall Study|Withdrawal by Subject|3|||
156474299|NCT02014402|564832352|FG000|Overall Study|Adverse Event|1|||
156474300|NCT02014402|564832353|FG001|Overall Study|Adverse Event|0|||
156474301|NCT02014402|564832354|FG002|Overall Study|Adverse Event|0|||
156474302|NCT02014402|564832355|FG003|Overall Study|Adverse Event|0|||
156474303|NCT02014402|564832352|FG000|Overall Study|Withdrawal by Subject|1|||
156474304|NCT02014402|564832353|FG001|Overall Study|Withdrawal by Subject|2|||
156474305|NCT02014402|564832354|FG002|Overall Study|Withdrawal by Subject|2|||
156474306|NCT02014402|564832355|FG003|Overall Study|Withdrawal by Subject|1|||
156474307|NCT02014402|564832352|FG000|Overall Study|Subject did not have transportation|0|||
156474308|NCT02014402|564832353|FG001|Overall Study|Subject did not have transportation|1|||
156474309|NCT02014402|564832354|FG002|Overall Study|Subject did not have transportation|0|||
156474310|NCT02014402|564832355|FG003|Overall Study|Subject did not have transportation|0|||
156474311|NCT02014402|564832352|FG000|Overall Study|Lost to Follow-up|0|||
156474312|NCT02014402|564832353|FG001|Overall Study|Lost to Follow-up|0|||
156474313|NCT02014402|564832354|FG002|Overall Study|Lost to Follow-up|1|||
156474314|NCT02014402|564832355|FG003|Overall Study|Lost to Follow-up|2|||
156859645|NCT00772538|566243154|FG000|Overall Study|Protocol Violation|3|||
156859646|NCT00772538|566243155|FG001|Overall Study|Protocol Violation|3|||
156859647|NCT00772538|566243154|FG000|Overall Study|Lost to Follow-up|1|||
156859648|NCT00772538|566243155|FG001|Overall Study|Lost to Follow-up|1|||
156859649|NCT00772538|566243154|FG000|Overall Study|Withdrawal by Subject|3|||
156859650|NCT00772538|566243155|FG001|Overall Study|Withdrawal by Subject|8|||
156859651|NCT00772538|566243154|FG000|Overall Study|Lack of Efficacy|0|||
156859652|NCT00772538|566243155|FG001|Overall Study|Lack of Efficacy|1|||
156859653|NCT00772538|566243154|FG000|Overall Study|Other|7|||
156859654|NCT00772538|566243155|FG001|Overall Study|Other|7|||
156859655|NCT00001832|566243158|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
156859656|NCT00001832|566243159|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
156859657|NCT00001832|566243160|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
156859658|NCT00001832|566243161|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
156859659|NCT00001832|566243162|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
156859660|NCT00001832|566243163|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
156859661|NCT00001832|566243164|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
156859662|NCT00001832|566243165|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
156859663|NCT00001832|566243166|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
156859664|NCT00001832|566243167|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
156859665|NCT00001832|566243168|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
156859666|NCT00001832|566243169|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
156859667|NCT00001832|566243170|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
156859668|NCT00001832|566243171|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
156859669|NCT00001832|566243172|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
156859670|NCT00001832|566243158|FG000|Treatment Period|Death during treatment|0|||
156859671|NCT00001832|566243159|FG001|Treatment Period|Death during treatment|0|||
156859672|NCT00001832|566243160|FG002|Treatment Period|Death during treatment|0|||
156859673|NCT00001832|566243161|FG003|Treatment Period|Death during treatment|0|||
156859674|NCT00001832|566243162|FG004|Treatment Period|Death during treatment|0|||
156859675|NCT00001832|566243163|FG005|Treatment Period|Death during treatment|1|||
156859676|NCT00001832|566243164|FG006|Treatment Period|Death during treatment|0|||
156859677|NCT00001832|566243165|FG007|Treatment Period|Death during treatment|0|||
156859678|NCT00001832|566243166|FG008|Treatment Period|Death during treatment|0|||
156859679|NCT00001832|566243167|FG009|Treatment Period|Death during treatment|0|||
156859680|NCT00001832|566243168|FG010|Treatment Period|Death during treatment|0|||
156859681|NCT00001832|566243169|FG011|Treatment Period|Death during treatment|0|||
156859682|NCT00001832|566243170|FG012|Treatment Period|Death during treatment|0|||
156859683|NCT00001832|566243171|FG013|Treatment Period|Death during treatment|0|||
156859684|NCT00001832|566243172|FG014|Treatment Period|Death during treatment|0|||
156859685|NCT00001832|566243158|FG000|Treatment Period|Not treated|0|||
156859686|NCT00001832|566243159|FG001|Treatment Period|Not treated|0|||
156859687|NCT00001832|566243160|FG002|Treatment Period|Not treated|0|||
156859688|NCT00001832|566243161|FG003|Treatment Period|Not treated|0|||
156474315|NCT04992273|564832359|FG000|Overall Study|Lost to Follow-up|0|||
156474316|NCT04992273|564832360|FG001|Overall Study|Lost to Follow-up|1|||
156474317|NCT01364597|564832361|FG000|Overall Study|Adverse Event|4|||
156474318|NCT01364597|564832362|FG001|Overall Study|Adverse Event|5|||
156474319|NCT01364597|564832363|FG002|Overall Study|Adverse Event|16|||
156474320|NCT01364597|564832364|FG003|Overall Study|Adverse Event|7|||
156474321|NCT01364597|564832361|FG000|Overall Study|Lack of Efficacy|4|||
156474322|NCT01364597|564832362|FG001|Overall Study|Lack of Efficacy|4|||
156474323|NCT01364597|564832363|FG002|Overall Study|Lack of Efficacy|23|||
156474324|NCT01364597|564832364|FG003|Overall Study|Lack of Efficacy|8|||
156343208|NCT05537883|564356301|FG001|Overall Study|surgeries were cancelled|2|||
156343209|NCT05537883|564356300|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
156343210|NCT05537883|564356301|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
156474325|NCT01364597|564832361|FG000|Overall Study|Protocol Violation|0|||
156474326|NCT01364597|564832362|FG001|Overall Study|Protocol Violation|0|||
156474327|NCT01364597|564832363|FG002|Overall Study|Protocol Violation|2|||
156474328|NCT01364597|564832364|FG003|Overall Study|Protocol Violation|0|||
156474329|NCT01364597|564832361|FG000|Overall Study|Lost to Follow-up|0|||
156474330|NCT01364597|564832362|FG001|Overall Study|Lost to Follow-up|0|||
156474331|NCT01364597|564832363|FG002|Overall Study|Lost to Follow-up|5|||
156474332|NCT01364597|564832364|FG003|Overall Study|Lost to Follow-up|3|||
156474333|NCT01364597|564832361|FG000|Overall Study|Withdrawal by Subject|4|||
156474334|NCT01364597|564832362|FG001|Overall Study|Withdrawal by Subject|1|||
156474335|NCT01364597|564832363|FG002|Overall Study|Withdrawal by Subject|18|||
156474336|NCT01364597|564832364|FG003|Overall Study|Withdrawal by Subject|6|||
156474337|NCT01364597|564832361|FG000|Overall Study|Non compliance|1|||
156343211|NCT02296320|564356303|FG000|Overall Study|Withdrawal by Subject|4|||
156474338|NCT01364597|564832362|FG001|Overall Study|Non compliance|0|||
156474339|NCT01364597|564832363|FG002|Overall Study|Non compliance|1|||
156474340|NCT01364597|564832364|FG003|Overall Study|Non compliance|0|||
156474341|NCT01364597|564832361|FG000|Overall Study|Lack of compliance|1|||
156474342|NCT01364597|564832362|FG001|Overall Study|Lack of compliance|0|||
156343212|NCT02296320|564356304|FG001|Overall Study|Withdrawal by Subject|0|||
156474343|NCT01364597|564832363|FG002|Overall Study|Lack of compliance|0|||
156474344|NCT01364597|564832364|FG003|Overall Study|Lack of compliance|0|||
156474345|NCT01364597|564832361|FG000|Overall Study|End of treatment epilepsy|1|||
156343213|NCT02296320|564356305|FG002|Overall Study|Withdrawal by Subject|2|||
156343214|NCT02296320|564356303|FG000|Overall Study|Death|24|||
156343215|NCT02296320|564356304|FG001|Overall Study|Death|3|||
156343216|NCT02296320|564356305|FG002|Overall Study|Death|27|||
156343217|NCT02296320|564356303|FG000|Overall Study|Lost to Follow-up|5|||
156343218|NCT02296320|564356304|FG001|Overall Study|Lost to Follow-up|2|||
156343219|NCT02296320|564356305|FG002|Overall Study|Lost to Follow-up|7|||
156343220|NCT02296320|564356303|FG000|Overall Study|Not treated|2|||
156343221|NCT02296320|564356304|FG001|Overall Study|Not treated|0|||
156343222|NCT02296320|564356305|FG002|Overall Study|Not treated|0|||
156343223|NCT02296320|564356303|FG000|Overall Study|Not - specified|0|||
156343224|NCT02296320|564356304|FG001|Overall Study|Not - specified|0|||
156343225|NCT02296320|564356305|FG002|Overall Study|Not - specified|1|||
156343226|NCT03953820|564356307|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
156343227|NCT03953820|564356308|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
156343228|NCT03953820|564356309|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
156343229|NCT03953820|564356307|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
156343230|NCT03953820|564356308|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
156343231|NCT03953820|564356309|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
156343232|NCT00880009|564356310|FG000|Overall Study|Study terminated by sponsor|14|||
156343233|NCT00880009|564356310|FG000|Overall Study|Withdrawal by Subject|1|||
156343234|NCT00880009|564356310|FG000|Overall Study|Protocol Violation|1|||
156343235|NCT01049308|564356312|FG000|Pill Counts|Withdrawal by Subject|83|||
156343236|NCT03845985|564356317|FG000|Overall Study|Lost to Follow-up|2|||
156343237|NCT03845985|564356318|FG001|Overall Study|Lost to Follow-up|1|||
156343238|NCT03845985|564356317|FG000|Overall Study|Physician Decision|1|||
156343239|NCT03845985|564356318|FG001|Overall Study|Physician Decision|0|||
156343240|NCT03845985|564356317|FG000|Overall Study|Withdrawal by Subject|4|||
156343241|NCT03845985|564356318|FG001|Overall Study|Withdrawal by Subject|1|||
156343242|NCT01318993|564356319|FG000|Overall Study|Adverse Event|53|||
156343243|NCT01318993|564356319|FG000|Overall Study|Lack of Efficacy|121|||
156343244|NCT01318993|564356319|FG000|Overall Study|Protocol Violation|3|||
156542324|NCT01147744|565079323|FG004|Overall Study|Lost to Follow-up|0|||
156474346|NCT01364597|564832362|FG001|Overall Study|End of treatment epilepsy|0|||
156474347|NCT01364597|564832363|FG002|Overall Study|End of treatment epilepsy|0|||
156474348|NCT01364597|564832364|FG003|Overall Study|End of treatment epilepsy|0|||
156474349|NCT01364597|564832361|FG000|Overall Study|No Seizures|1|||
156474350|NCT01364597|564832362|FG001|Overall Study|No Seizures|0|||
156474351|NCT01364597|564832363|FG002|Overall Study|No Seizures|0|||
156474352|NCT01364597|564832364|FG003|Overall Study|No Seizures|0|||
156474353|NCT01364597|564832361|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
156474354|NCT01364597|564832362|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
156474355|NCT01364597|564832363|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
156474356|NCT01364597|564832364|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
156474357|NCT01364597|564832361|FG000|Overall Study|Cure|1|||
156474358|NCT01364597|564832362|FG001|Overall Study|Cure|0|||
156474359|NCT01364597|564832363|FG002|Overall Study|Cure|0|||
156474360|NCT01364597|564832364|FG003|Overall Study|Cure|0|||
156474361|NCT01364597|564832361|FG000|Overall Study|Patient was moving|0|||
156474362|NCT01364597|564832362|FG001|Overall Study|Patient was moving|1|||
156474363|NCT01364597|564832363|FG002|Overall Study|Patient was moving|0|||
156474364|NCT01364597|564832364|FG003|Overall Study|Patient was moving|0|||
156474365|NCT01364597|564832361|FG000|Overall Study|Seizures resolved|0|||
156474366|NCT01364597|564832362|FG001|Overall Study|Seizures resolved|0|||
156474367|NCT01364597|564832363|FG002|Overall Study|Seizures resolved|1|||
156474368|NCT01364597|564832364|FG003|Overall Study|Seizures resolved|0|||
156474369|NCT01364597|564832361|FG000|Overall Study|Patient became seizure-free after surgery|0|||
156474370|NCT01364597|564832362|FG001|Overall Study|Patient became seizure-free after surgery|0|||
156474371|NCT01364597|564832363|FG002|Overall Study|Patient became seizure-free after surgery|1|||
156474372|NCT01364597|564832364|FG003|Overall Study|Patient became seizure-free after surgery|0|||
156474373|NCT01364597|564832361|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
156859689|NCT00001832|566243162|FG004|Treatment Period|Not treated|0|||
156859690|NCT00001832|566243163|FG005|Treatment Period|Not treated|0|||
156859691|NCT00001832|566243164|FG006|Treatment Period|Not treated|0|||
156859692|NCT00001832|566243165|FG007|Treatment Period|Not treated|1|||
156859693|NCT00001832|566243166|FG008|Treatment Period|Not treated|0|||
156859694|NCT00001832|566243167|FG009|Treatment Period|Not treated|0|||
156859695|NCT00001832|566243168|FG010|Treatment Period|Not treated|0|||
156859696|NCT00001832|566243169|FG011|Treatment Period|Not treated|0|||
156859697|NCT00001832|566243170|FG012|Treatment Period|Not treated|0|||
156859698|NCT00001832|566243171|FG013|Treatment Period|Not treated|0|||
156859699|NCT00001832|566243172|FG014|Treatment Period|Not treated|0|||
156859700|NCT00713609|566243173|FG000|Overall Study|Adverse Event|2|||
156859701|NCT00713609|566243174|FG001|Overall Study|Adverse Event|0|||
156859702|NCT00713609|566243175|FG002|Overall Study|Adverse Event|2|||
156859703|NCT00713609|566243176|FG003|Overall Study|Adverse Event|2|||
156859704|NCT00713609|566243177|FG004|Overall Study|Adverse Event|3|||
156859705|NCT00713609|566243178|FG005|Overall Study|Adverse Event|1|||
156859706|NCT00713609|566243173|FG000|Overall Study|Lost to Follow-up|5|||
156859707|NCT00713609|566243174|FG001|Overall Study|Lost to Follow-up|7|||
156859708|NCT00713609|566243175|FG002|Overall Study|Lost to Follow-up|5|||
156859709|NCT00713609|566243176|FG003|Overall Study|Lost to Follow-up|5|||
156859710|NCT00713609|566243177|FG004|Overall Study|Lost to Follow-up|7|||
156859711|NCT00713609|566243178|FG005|Overall Study|Lost to Follow-up|0|||
156859712|NCT00713609|566243173|FG000|Overall Study|Lack of Efficacy|1|||
156859713|NCT00713609|566243174|FG001|Overall Study|Lack of Efficacy|3|||
156859714|NCT00713609|566243175|FG002|Overall Study|Lack of Efficacy|0|||
156859715|NCT00713609|566243176|FG003|Overall Study|Lack of Efficacy|0|||
156859716|NCT00713609|566243177|FG004|Overall Study|Lack of Efficacy|1|||
156859717|NCT00713609|566243178|FG005|Overall Study|Lack of Efficacy|0|||
156859718|NCT00713609|566243173|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
156859719|NCT00713609|566243174|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
156859720|NCT00713609|566243175|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
156859721|NCT00713609|566243176|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
156859722|NCT00713609|566243177|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
156859723|NCT00713609|566243178|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
156859724|NCT00713609|566243173|FG000|Overall Study|Withdrawal by Subject|6|||
156859725|NCT00713609|566243174|FG001|Overall Study|Withdrawal by Subject|1|||
156859726|NCT00713609|566243175|FG002|Overall Study|Withdrawal by Subject|5|||
156859727|NCT00713609|566243176|FG003|Overall Study|Withdrawal by Subject|1|||
156859728|NCT00713609|566243177|FG004|Overall Study|Withdrawal by Subject|5|||
156859729|NCT00713609|566243178|FG005|Overall Study|Withdrawal by Subject|7|||
156859730|NCT00713609|566243173|FG000|Overall Study|Protocol Violation|6|||
156859731|NCT00713609|566243174|FG001|Overall Study|Protocol Violation|3|||
156859732|NCT00713609|566243175|FG002|Overall Study|Protocol Violation|1|||
156859733|NCT00713609|566243176|FG003|Overall Study|Protocol Violation|1|||
156859734|NCT00713609|566243177|FG004|Overall Study|Protocol Violation|2|||
156859735|NCT00713609|566243178|FG005|Overall Study|Protocol Violation|0|||
156474374|NCT01364597|564832362|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
156859736|NCT04529083|566243179|FG000|Overall Study|Withdrawal by Subject|3|||
156474375|NCT01364597|564832363|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
156474376|NCT01364597|564832364|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
156474377|NCT01364597|564832361|FG000|Overall Study|Patient cured from Epilepsy|0|||
156474378|NCT01364597|564832362|FG001|Overall Study|Patient cured from Epilepsy|0|||
156474379|NCT01364597|564832363|FG002|Overall Study|Patient cured from Epilepsy|1|||
156474380|NCT01364597|564832364|FG003|Overall Study|Patient cured from Epilepsy|0|||
156474381|NCT01364597|564832361|FG000|Overall Study|Investigator decision|0|||
156474382|NCT01364597|564832362|FG001|Overall Study|Investigator decision|0|||
156474383|NCT01364597|564832363|FG002|Overall Study|Investigator decision|1|||
156474384|NCT01364597|564832364|FG003|Overall Study|Investigator decision|0|||
156474385|NCT01364597|564832361|FG000|Overall Study|Sponsor recommended discontinuation|0|||
156474386|NCT01364597|564832362|FG001|Overall Study|Sponsor recommended discontinuation|0|||
156474387|NCT01364597|564832363|FG002|Overall Study|Sponsor recommended discontinuation|0|||
156474388|NCT01364597|564832364|FG003|Overall Study|Sponsor recommended discontinuation|1|||
156474389|NCT01364597|564832361|FG000|Overall Study|Parents went abroad with the patient|0|||
156474390|NCT01364597|564832362|FG001|Overall Study|Parents went abroad with the patient|0|||
156474391|NCT01364597|564832363|FG002|Overall Study|Parents went abroad with the patient|1|||
156474392|NCT01364597|564832364|FG003|Overall Study|Parents went abroad with the patient|0|||
156474393|NCT01364597|564832361|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
156474394|NCT01364597|564832362|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
156474395|NCT01364597|564832363|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
156474396|NCT01364597|564832364|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
156474397|NCT01364597|564832361|FG000|Overall Study|BRV administration dropout|0|||
156474398|NCT01364597|564832362|FG001|Overall Study|BRV administration dropout|0|||
156474399|NCT01364597|564832363|FG002|Overall Study|BRV administration dropout|1|||
156474400|NCT01364597|564832364|FG003|Overall Study|BRV administration dropout|0|||
156474401|NCT01364597|564832361|FG000|Overall Study|Dropout|0|||
156474402|NCT01364597|564832362|FG001|Overall Study|Dropout|0|||
156474403|NCT01364597|564832363|FG002|Overall Study|Dropout|3|||
156474404|NCT01364597|564832364|FG003|Overall Study|Dropout|1|||
156474405|NCT01364597|564832361|FG000|Overall Study|Unreliable subject|0|||
156474406|NCT01364597|564832362|FG001|Overall Study|Unreliable subject|0|||
156474407|NCT01364597|564832363|FG002|Overall Study|Unreliable subject|0|||
156474408|NCT01364597|564832364|FG003|Overall Study|Unreliable subject|1|||
156474409|NCT01364597|564832361|FG000|Overall Study|Other|0|||
156474410|NCT01364597|564832362|FG001|Overall Study|Other|0|||
156474411|NCT01364597|564832363|FG002|Overall Study|Other|0|||
156474412|NCT01364597|564832364|FG003|Overall Study|Other|1|||
156474413|NCT03493282|564832368|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
156474414|NCT03493282|564832369|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
156474415|NCT03493282|564832370|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
156474416|NCT03493282|564832368|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
156474417|NCT03493282|564832369|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
156474418|NCT03493282|564832370|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
156474419|NCT01380145|564832371|FG000|Overall Study|Progressive disease|4|||
156474420|NCT02038049|564832372|FG000|Overall Study|Lost to Follow-up|1|||
156474421|NCT02038049|564832373|FG001|Overall Study|Lost to Follow-up|0|||
156474422|NCT02660086|564832375|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
156474423|NCT02660086|564832376|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
156859737|NCT03305666|566243184|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
156859738|NCT03305666|566243185|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
156859739|NCT04196686|566243186|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
156859740|NCT04196686|566243187|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
156859741|NCT03780452|566243191|FG000|Overall Study|Screening failure|2|||
156859742|NCT00914849|566243192|FG000|Overall Study|Withdrawal by Subject|1|||
156859743|NCT00914849|566243193|FG001|Overall Study|Withdrawal by Subject|0|||
156859744|NCT00914849|566243192|FG000|Overall Study|Not eligible|0|||
156859745|NCT00914849|566243193|FG001|Overall Study|Not eligible|1|||
156859746|NCT01001221|566243196|FG000|Overall Study|Adverse Event|1|||
156859747|NCT01001221|566243197|FG001|Overall Study|Adverse Event|2|||
156859748|NCT01001221|566243198|FG002|Overall Study|Adverse Event|0|||
156859749|NCT01001221|566243199|FG003|Overall Study|Adverse Event|2|||
156859750|NCT01001221|566243200|FG004|Overall Study|Adverse Event|0|||
156859751|NCT01001221|566243196|FG000|Overall Study|Disease progression|3|||
156859752|NCT01001221|566243197|FG001|Overall Study|Disease progression|2|||
156859753|NCT01001221|566243198|FG002|Overall Study|Disease progression|2|||
156859754|NCT01001221|566243199|FG003|Overall Study|Disease progression|4|||
156859755|NCT01001221|566243200|FG004|Overall Study|Disease progression|0|||
156474424|NCT02660086|564832375|FG000|Overall Study- 12-month|Left full-time employment|12|||
156474425|NCT02660086|564832376|FG001|Overall Study- 12-month|Left full-time employment|20|||
156474426|NCT02660086|564832375|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
156474427|NCT02660086|564832376|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
156474428|NCT02660086|564832375|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
156474429|NCT02660086|564832376|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
156474430|NCT02660086|564832375|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
156474431|NCT02660086|564832376|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
156474432|NCT02660086|564832375|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
156474433|NCT02660086|564832376|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
156474434|NCT04250636|564832382|FG000|Overall Study|Lost to Follow-up|2|||
156474435|NCT05005247|564832384|FG000|Overall Study|Withdrawal by Subject|0|||
156474436|NCT05005247|564832385|FG001|Overall Study|Withdrawal by Subject|1|||
156474437|NCT05005247|564832386|FG002|Overall Study|Withdrawal by Subject|0|||
156474438|NCT02827201|564832393|FG000|Overall Study|Death|1|||
156474439|NCT02827201|564832394|FG001|Overall Study|Death|2|||
156474440|NCT02827201|564832393|FG000|Overall Study|Patients not treated|1|||
156474441|NCT02827201|564832394|FG001|Overall Study|Patients not treated|1|||
156474442|NCT02630186|564832395|FG000|Overall Study|Withdrawal by Subject|1|||
156474443|NCT00439218|564832396|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
156474444|NCT02128269|564832399|FG000|Treatment Period|Adverse Event|1|||
156474445|NCT02128269|564832399|FG000|Treatment Period|Physician Decision|1|||
156474446|NCT01021748|564832400|FG000|Overall Study|Adverse Event|2|||
156474447|NCT01021748|564832401|FG001|Overall Study|Adverse Event|1|||
156474448|NCT01021748|564832402|FG002|Overall Study|Adverse Event|2|||
156474449|NCT01021748|564832403|FG003|Overall Study|Adverse Event|0|||
156474450|NCT01021748|564832404|FG004|Overall Study|Adverse Event|2|||
156474451|NCT01021748|564832405|FG005|Overall Study|Adverse Event|0|||
156474452|NCT01021748|564832406|FG006|Overall Study|Adverse Event|1|||
156474453|NCT01021748|564832407|FG007|Overall Study|Adverse Event|0|||
156474454|NCT01021748|564832408|FG008|Overall Study|Adverse Event|7|||
156474455|NCT01021748|564832400|FG000|Overall Study|Physician Decision|1|||
156474456|NCT01021748|564832401|FG001|Overall Study|Physician Decision|0|||
156474457|NCT01021748|564832402|FG002|Overall Study|Physician Decision|1|||
156474458|NCT01021748|564832403|FG003|Overall Study|Physician Decision|1|||
156474459|NCT01021748|564832404|FG004|Overall Study|Physician Decision|0|||
156474460|NCT01021748|564832405|FG005|Overall Study|Physician Decision|0|||
156474461|NCT01021748|564832406|FG006|Overall Study|Physician Decision|1|||
156474462|NCT01021748|564832407|FG007|Overall Study|Physician Decision|1|||
156474463|NCT01021748|564832408|FG008|Overall Study|Physician Decision|2|||
156474464|NCT01021748|564832400|FG000|Overall Study|Progressive Disease|3|||
156474465|NCT01021748|564832401|FG001|Overall Study|Progressive Disease|3|||
156474466|NCT01021748|564832402|FG002|Overall Study|Progressive Disease|4|||
156474467|NCT01021748|564832403|FG003|Overall Study|Progressive Disease|6|||
156859756|NCT01001221|566243196|FG000|Overall Study|Other|1|||
156859757|NCT01001221|566243197|FG001|Overall Study|Other|1|||
156859758|NCT01001221|566243198|FG002|Overall Study|Other|0|||
156859759|NCT01001221|566243199|FG003|Overall Study|Other|0|||
156859760|NCT01001221|566243200|FG004|Overall Study|Other|0|||
156859761|NCT01001221|566243196|FG000|Overall Study|Not treated; protocol exclusion|0|||
156859762|NCT01001221|566243197|FG001|Overall Study|Not treated; protocol exclusion|0|||
156859763|NCT01001221|566243198|FG002|Overall Study|Not treated; protocol exclusion|1|||
156859764|NCT01001221|566243199|FG003|Overall Study|Not treated; protocol exclusion|0|||
156859765|NCT01001221|566243200|FG004|Overall Study|Not treated; protocol exclusion|0|||
156859766|NCT02388269|566243201|FG000|Overall Study|Adverse Event|2|||
156859767|NCT02388269|566243202|FG001|Overall Study|Adverse Event|0|||
156859768|NCT02388269|566243203|FG002|Overall Study|Adverse Event|0|||
156859769|NCT02388269|566243201|FG000|Overall Study|Withdrawal by Subject|1|||
156859770|NCT02388269|566243202|FG001|Overall Study|Withdrawal by Subject|2|||
156859771|NCT02388269|566243203|FG002|Overall Study|Withdrawal by Subject|0|||
156859772|NCT02388269|566243201|FG000|Overall Study|less than 50% stimulations|1|||
156859773|NCT02388269|566243202|FG001|Overall Study|less than 50% stimulations|0|||
156859774|NCT02388269|566243203|FG002|Overall Study|less than 50% stimulations|0|||
156859775|NCT02388269|566243201|FG000|Overall Study|no diary data|3|||
156859776|NCT02388269|566243202|FG001|Overall Study|no diary data|0|||
156859777|NCT02388269|566243203|FG002|Overall Study|no diary data|0|||
156859778|NCT02388269|566243201|FG000|Overall Study|Protocol Violation|2|||
156859779|NCT02388269|566243202|FG001|Overall Study|Protocol Violation|0|||
156859780|NCT02388269|566243203|FG002|Overall Study|Protocol Violation|0|||
156859781|NCT02388269|566243201|FG000|Overall Study|Screen Failure|0|||
156859782|NCT02388269|566243202|FG001|Overall Study|Screen Failure|0|||
156859783|NCT02388269|566243203|FG002|Overall Study|Screen Failure|10|||
156859784|NCT05106959|566243204|FG000|Overall Study|Lost to Follow-up|1|||
156859785|NCT00087152|566243205|FG000|Overall Study|Ineligible|6|||
156859786|NCT01292486|566243206|FG000|Overall Study|Protocol Violation|2|||
156859787|NCT01292486|566243206|FG000|Overall Study|Did not meet screening criteria|2|||
156859788|NCT01292486|566243206|FG000|Overall Study|Adverse Event|1|||
156859789|NCT01292486|566243206|FG000|Overall Study|Physician Decision|1|||
156859790|NCT03882021|566243213|FG000|Enrollment|Procedure aborted/cancelled|2|||
156859791|NCT03882021|566243213|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
156859792|NCT03882021|566243213|FG000|Enrollment to 3-Month|Death|1|||
156859793|NCT03882021|566243213|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
156859794|NCT03882021|566243213|FG000|Enrollment to 3-Month|Missed Visit|4|||
156859795|NCT03882021|566243213|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
156859796|NCT03882021|566243213|FG000|6-Month to 12-Month Visit|Death|1|||
156474468|NCT01021748|564832404|FG004|Overall Study|Progressive Disease|7|||
156474469|NCT01021748|564832405|FG005|Overall Study|Progressive Disease|3|||
156859797|NCT03882021|566243213|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
156859798|NCT01546857|566243215|FG000|Overall Study|Withdrawal by Subject|2|||
156859799|NCT01546857|566243216|FG001|Overall Study|Withdrawal by Subject|3|||
156474470|NCT01021748|564832406|FG006|Overall Study|Progressive Disease|0|||
156474471|NCT01021748|564832407|FG007|Overall Study|Progressive Disease|5|||
156474472|NCT01021748|564832408|FG008|Overall Study|Progressive Disease|6|||
156474473|NCT01021748|564832400|FG000|Overall Study|Withdrawal by Subject|0|||
156474474|NCT01021748|564832401|FG001|Overall Study|Withdrawal by Subject|0|||
156474475|NCT01021748|564832402|FG002|Overall Study|Withdrawal by Subject|0|||
156474476|NCT01021748|564832403|FG003|Overall Study|Withdrawal by Subject|0|||
156474477|NCT01021748|564832404|FG004|Overall Study|Withdrawal by Subject|0|||
156474478|NCT01021748|564832405|FG005|Overall Study|Withdrawal by Subject|0|||
156474479|NCT01021748|564832406|FG006|Overall Study|Withdrawal by Subject|1|||
156474480|NCT01021748|564832407|FG007|Overall Study|Withdrawal by Subject|0|||
156474481|NCT01021748|564832408|FG008|Overall Study|Withdrawal by Subject|1|||
156474482|NCT01021748|564832400|FG000|Overall Study|Not Treated|0|||
156343245|NCT01318993|564356319|FG000|Overall Study|Protocol based stopping criteria|6|||
156343246|NCT01318993|564356319|FG000|Overall Study|Study closed or terminated|174|||
156474483|NCT01021748|564832401|FG001|Overall Study|Not Treated|1|||
156474484|NCT01021748|564832402|FG002|Overall Study|Not Treated|0|||
156474485|NCT01021748|564832403|FG003|Overall Study|Not Treated|0|||
156474486|NCT01021748|564832404|FG004|Overall Study|Not Treated|0|||
156474487|NCT01021748|564832405|FG005|Overall Study|Not Treated|0|||
156474488|NCT01021748|564832406|FG006|Overall Study|Not Treated|0|||
156474489|NCT01021748|564832407|FG007|Overall Study|Not Treated|0|||
156474490|NCT01021748|564832408|FG008|Overall Study|Not Treated|0|||
156474491|NCT01829711|564832409|FG000|Overall Study|Lost to Follow-up|2|||
156474492|NCT01829711|564832409|FG000|Overall Study|Withdrawal by Subject|3|||
156474493|NCT01829711|564832409|FG000|Overall Study|Death|4|||
156474494|NCT01829711|564832409|FG000|Overall Study|Started new therapies|17|||
156474495|NCT01829711|564832409|FG000|Overall Study|Adverse Event|3|||
156474496|NCT01829711|564832409|FG000|Overall Study|Due to progression of disease|13|||
156474497|NCT01829711|564832409|FG000|Overall Study|Due to lack of response|1|||
156474498|NCT01480258|564832410|FG000|Infant Series|Protocol Violation|2|||
156474499|NCT01480258|564832411|FG001|Infant Series|Protocol Violation|0|||
156542325|NCT01147744|565079324|FG005|Overall Study|Lost to Follow-up|0|||
156474500|NCT01480258|564832410|FG000|Infant Series|Physician Decision|0|||
156474501|NCT01480258|564832411|FG001|Infant Series|Physician Decision|1|||
156474502|NCT01480258|564832410|FG000|Infant Series|Not Vaccinated|3|||
156474503|NCT01480258|564832411|FG001|Infant Series|Not Vaccinated|0|||
156474504|NCT01480258|564832410|FG000|Infant Series|Adverse Event|1|||
156343247|NCT01318993|564356319|FG000|Overall Study|Lost to Follow-up|4|||
156343248|NCT01318993|564356319|FG000|Overall Study|Physician Decision|13|||
156343249|NCT01318993|564356319|FG000|Overall Study|Withdrawal by Subject|24|||
156343250|NCT01845831|564356321|FG000|Inpatient Phase|Withdrawal by Subject|1|||
156343251|NCT01845831|564356322|FG001|Inpatient Phase|Withdrawal by Subject|1|||
156343252|NCT01845831|564356323|FG002|Inpatient Phase|Withdrawal by Subject|0|||
156343253|NCT01845831|564356324|FG003|Inpatient Phase|Withdrawal by Subject|0|||
156343254|NCT01845831|564356325|FG004|Inpatient Phase|Withdrawal by Subject|0|||
156343255|NCT04659161|564356327|FG000|Overall Study|Adverse Event|10|||
156343256|NCT04659161|564356328|FG001|Overall Study|Adverse Event|6|||
156343257|NCT04659161|564356327|FG000|Overall Study|Withdrawal by Subject|13|||
156343258|NCT04659161|564356328|FG001|Overall Study|Withdrawal by Subject|12|||
156343259|NCT04659161|564356327|FG000|Overall Study|Other|9|||
156343260|NCT04659161|564356328|FG001|Overall Study|Other|8|||
156343261|NCT01929343|564356329|FG000|Overall Study|Physician Decision|0|||
156343262|NCT01929343|564356330|FG001|Overall Study|Physician Decision|2|||
156343263|NCT01929343|564356331|FG002|Overall Study|Physician Decision|0|||
156343264|NCT01929343|564356329|FG000|Overall Study|Withdrawal by Subject|1|||
156343265|NCT01929343|564356330|FG001|Overall Study|Withdrawal by Subject|0|||
156343266|NCT01929343|564356331|FG002|Overall Study|Withdrawal by Subject|0|||
156343267|NCT02197130|564356334|FG000|Overall Study|Adverse Event|13|||
156474505|NCT01480258|564832411|FG001|Infant Series|Adverse Event|1|||
156474506|NCT01480258|564832410|FG000|Infant Series|Withdrawal by Subject|1|||
156474507|NCT01480258|564832411|FG001|Infant Series|Withdrawal by Subject|6|||
156859800|NCT02542865|566243217|FG000|Overall Study|Identified as screen failure|1|||
156859801|NCT02542865|566243218|FG001|Overall Study|Identified as screen failure|0|||
156859802|NCT02542865|566243217|FG000|Overall Study|Withdrawal by Subject|16|||
156859803|NCT02542865|566243218|FG001|Overall Study|Withdrawal by Subject|0|||
156859804|NCT01469221|566243219|FG000|Double Blind Phase|Protocol Violation|1|||
156859805|NCT01469221|566243220|FG001|Double Blind Phase|Protocol Violation|0|||
156859806|NCT01469221|566243221|FG002|Double Blind Phase|Protocol Violation|0|||
156859807|NCT01469221|566243219|FG000|Double Blind Phase|Physician Decision|1|||
156859808|NCT01469221|566243220|FG001|Double Blind Phase|Physician Decision|1|||
156859809|NCT01469221|566243221|FG002|Double Blind Phase|Physician Decision|0|||
156474508|NCT01480258|564832410|FG000|Interim Period|Lost to Follow-up|0|||
156474509|NCT01480258|564832411|FG001|Interim Period|Lost to Follow-up|2|||
156474510|NCT01480258|564832410|FG000|Interim Period|Physician Decision|1|||
156474511|NCT01480258|564832411|FG001|Interim Period|Physician Decision|0|||
156474512|NCT01480258|564832410|FG000|Interim Period|Protocol Violation|0|||
156474513|NCT01480258|564832411|FG001|Interim Period|Protocol Violation|1|||
156474514|NCT01480258|564832410|FG000|Interim Period|Withdrawal by Subject|9|||
156474515|NCT01480258|564832411|FG001|Interim Period|Withdrawal by Subject|6|||
156542326|NCT01147744|565079325|FG006|Overall Study|Lost to Follow-up|0|||
156474516|NCT01640288|564832414|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
156474517|NCT01640288|564832415|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
156474518|NCT01640288|564832414|FG000|Overall Study|Screen Failure|20|||
156474519|NCT01640288|564832415|FG001|Overall Study|Screen Failure|18|||
156474520|NCT01640288|564832414|FG000|Overall Study|Withdrawn by PI|5|||
156474521|NCT01640288|564832415|FG001|Overall Study|Withdrawn by PI|0|||
156474522|NCT01640288|564832414|FG000|Overall Study|Withdrawal by Subject|1|||
156474523|NCT01640288|564832415|FG001|Overall Study|Withdrawal by Subject|0|||
156474524|NCT01485887|564832419|FG000|Overall Study|Withdrawal by Subject|2|||
156474525|NCT01485887|564832419|FG000|Overall Study|Adverse Event|8|||
156474526|NCT01485887|564832419|FG000|Overall Study|Deterioration of primary disease|1|||
156474527|NCT01485887|564832419|FG000|Overall Study|Primary disease markedly improved|1|||
156474528|NCT02234141|564832420|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
156474529|NCT02234141|564832421|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
156474530|NCT02234141|564832422|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
156474531|NCT02234141|564832423|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
156474532|NCT02234141|564832424|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
156474533|NCT02234141|564832425|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
156474534|NCT02234141|564832426|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
156474535|NCT02234141|564832420|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
156474536|NCT02234141|564832421|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
156474537|NCT02234141|564832422|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
156474538|NCT02234141|564832423|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
156474539|NCT02234141|564832424|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
156474540|NCT02234141|564832425|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
156474541|NCT02234141|564832426|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
156343268|NCT02197130|564356335|FG001|Overall Study|Adverse Event|4|||
156474542|NCT02234141|564832420|FG000|Treatment Period (24 Weeks)|Death|1|||
156474543|NCT02234141|564832421|FG001|Treatment Period (24 Weeks)|Death|2|||
156474544|NCT02234141|564832422|FG002|Treatment Period (24 Weeks)|Death|0|||
156474545|NCT02234141|564832423|FG003|Treatment Period (24 Weeks)|Death|1|||
156474546|NCT02234141|564832424|FG004|Treatment Period (24 Weeks)|Death|0|||
156474547|NCT02234141|564832425|FG005|Treatment Period (24 Weeks)|Death|0|||
156474548|NCT02234141|564832426|FG006|Treatment Period (24 Weeks)|Death|0|||
156474549|NCT02234141|564832420|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
156474550|NCT02234141|564832421|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
156474551|NCT02234141|564832422|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
156474552|NCT02234141|564832423|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
156474553|NCT02234141|564832424|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
156474554|NCT02234141|564832425|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
156474555|NCT02234141|564832426|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
156474556|NCT02234141|564832420|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
156474557|NCT02234141|564832421|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
156474558|NCT02234141|564832422|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
156474559|NCT02234141|564832423|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
156474560|NCT02234141|564832424|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
156474561|NCT02234141|564832425|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
156474562|NCT02234141|564832426|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
156474563|NCT02234141|564832420|FG000|Long-Term Treatment Period|Death|0|||
156474564|NCT02234141|564832421|FG001|Long-Term Treatment Period|Death|0|||
156474565|NCT02234141|564832422|FG002|Long-Term Treatment Period|Death|0|||
156474566|NCT02234141|564832423|FG003|Long-Term Treatment Period|Death|0|||
156474567|NCT02234141|564832424|FG004|Long-Term Treatment Period|Death|0|||
156474568|NCT02234141|564832425|FG005|Long-Term Treatment Period|Death|1|||
156474569|NCT02234141|564832426|FG006|Long-Term Treatment Period|Death|0|||
156474570|NCT02234141|564832420|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
156343269|NCT02197130|564356336|FG002|Overall Study|Adverse Event|23|||
156474571|NCT02234141|564832421|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
156474572|NCT02234141|564832422|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
156474573|NCT02234141|564832423|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
156474574|NCT02234141|564832424|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
156474575|NCT02234141|564832425|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
156474576|NCT02234141|564832426|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
156474577|NCT02234141|564832420|FG000|Long-Term Treatment Period|Adverse Event|4|||
156474578|NCT02234141|564832421|FG001|Long-Term Treatment Period|Adverse Event|0|||
156474579|NCT02234141|564832422|FG002|Long-Term Treatment Period|Adverse Event|5|||
156474580|NCT02234141|564832423|FG003|Long-Term Treatment Period|Adverse Event|0|||
156474581|NCT02234141|564832424|FG004|Long-Term Treatment Period|Adverse Event|1|||
156474582|NCT02234141|564832425|FG005|Long-Term Treatment Period|Adverse Event|1|||
156474583|NCT02234141|564832426|FG006|Long-Term Treatment Period|Adverse Event|1|||
156474584|NCT02234141|564832420|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
156474585|NCT02234141|564832421|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
156474586|NCT02234141|564832422|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
156474587|NCT02234141|564832423|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
156474588|NCT02234141|564832424|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
156474589|NCT02234141|564832425|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
156474590|NCT02234141|564832426|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
156474591|NCT02234141|564832420|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
156474592|NCT02234141|564832421|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
156474593|NCT02234141|564832422|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
156474594|NCT02234141|564832423|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
156474595|NCT02234141|564832424|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
156474596|NCT02234141|564832425|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
156474597|NCT02234141|564832426|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
156474598|NCT00895245|564832427|FG000|Overall Study|Lack of Efficacy|6|||
156474599|NCT02095678|564832428|FG000|Overall Study|Withdrawal by Subject|0|||
156474600|NCT02095678|564832429|FG001|Overall Study|Withdrawal by Subject|1|||
156474601|NCT02095678|564832428|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
156474602|NCT02095678|564832429|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
156474603|NCT02095678|564832428|FG000|Overall Study|lesion impacted by previous treatment|1|||
156474604|NCT02095678|564832429|FG001|Overall Study|lesion impacted by previous treatment|1|||
156474605|NCT02095678|564832428|FG000|Overall Study|No Confirmed Diagnosis|0|||
156474606|NCT02095678|564832429|FG001|Overall Study|No Confirmed Diagnosis|3|||
156474607|NCT02095678|564832428|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
156474608|NCT02095678|564832429|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
156474609|NCT02095678|564832428|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
156474610|NCT02095678|564832429|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
156474611|NCT03418545|564832430|FG000|Overall Study|Withdrawal by Participant|2|||
156474612|NCT03418545|564832431|FG001|Overall Study|Withdrawal by Participant|4|||
156474613|NCT03418545|564832430|FG000|Overall Study|Lost to Follow-up|3|||
156474614|NCT03418545|564832431|FG001|Overall Study|Lost to Follow-up|5|||
156474615|NCT03418545|564832430|FG000|Overall Study|Reason Not Specified|0|||
156859810|NCT01469221|566243219|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
156859811|NCT01469221|566243220|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
156859812|NCT01469221|566243221|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
156859813|NCT00475670|566243222|FG000|Overall Study|Death|0|||
156859814|NCT00475670|566243223|FG001|Overall Study|Death|1|||
156859815|NCT00475670|566243222|FG000|Overall Study|Lack of Efficacy|3|||
156859816|NCT00475670|566243223|FG001|Overall Study|Lack of Efficacy|34|||
156859817|NCT00475670|566243222|FG000|Overall Study|Refused treatment|0|||
156859818|NCT00475670|566243223|FG001|Overall Study|Refused treatment|2|||
156859819|NCT00475670|566243222|FG000|Overall Study|Failure to Return|0|||
156859820|NCT00475670|566243223|FG001|Overall Study|Failure to Return|1|||
156859821|NCT00475670|566243222|FG000|Overall Study|Other|0|||
156859822|NCT00475670|566243223|FG001|Overall Study|Other|3|||
156859823|NCT01168349|566243224|FG000|Overall Study|Death|157|||
156859824|NCT01168349|566243224|FG000|Overall Study|Lost to Follow-up|34|||
156859825|NCT01168349|566243224|FG000|Overall Study|Withdrawal by Subject|9|||
156859826|NCT01168349|566243224|FG000|Overall Study|Kidney transplantation|3|||
156859827|NCT01168349|566243224|FG000|Overall Study|Other|22|||
156859828|NCT01168349|566243224|FG000|Overall Study|Protocol Violation|76|||
156859829|NCT05468814|566243225|FG000|Overall Study|Lost to Follow-up|5|||
156859830|NCT05468814|566243226|FG001|Overall Study|Lost to Follow-up|6|||
156859831|NCT01650558|566243232|FG000|Overall Study|Migration out of study area|61|||
156859832|NCT01650558|566243233|FG001|Overall Study|Migration out of study area|71|||
156859833|NCT01650558|566243234|FG002|Overall Study|Migration out of study area|56|||
156859834|NCT01650558|566243232|FG000|Overall Study|Lost to Follow-up|10|||
156474616|NCT03418545|564832431|FG001|Overall Study|Reason Not Specified|1|||
156474617|NCT03418545|564832430|FG000|Overall Study|Missing Completion Status|0|||
156474618|NCT03418545|564832431|FG001|Overall Study|Missing Completion Status|1|||
156474619|NCT01220999|564832434|FG000|Overall Study|Progressive disease|0|||
156474620|NCT01220999|564832435|FG001|Overall Study|Progressive disease|0|||
156474621|NCT01220999|564832436|FG002|Overall Study|Progressive disease|1|||
156474622|NCT01220999|564832437|FG003|Overall Study|Progressive disease|0|||
156474623|NCT01220999|564832438|FG004|Overall Study|Progressive disease|0|||
156474624|NCT01560429|564832440|FG000|Overall Study|Protocol Violation|3|||
156474625|NCT01560429|564832441|FG001|Overall Study|Protocol Violation|6|||
156474626|NCT02449902|564832442|FG000|Overall Study|Adverse Event|0|||
156474627|NCT02449902|564832443|FG001|Overall Study|Adverse Event|1|||
156474628|NCT02449902|564832442|FG000|Overall Study|Withdrawal by Subject|0|||
156474629|NCT02449902|564832443|FG001|Overall Study|Withdrawal by Subject|1|||
156474630|NCT01365546|564832444|FG000|Overall Study|Withdrawal by Subject|1|||
156343270|NCT02197130|564356334|FG000|Overall Study|Death|0|||
156474631|NCT01365546|564832444|FG000|Overall Study|Screen failure|9|||
156474632|NCT01365546|564832444|FG000|Overall Study|Study termination|1|||
156474633|NCT03326856|564832445|FG000|Overall Study|Lost to Follow-up|1|||
156474634|NCT03326856|564832446|FG001|Overall Study|Lost to Follow-up|1|||
156474635|NCT03326856|564832447|FG002|Overall Study|Lost to Follow-up|0|||
156474636|NCT03326856|564832448|FG003|Overall Study|Lost to Follow-up|0|||
156474637|NCT03326856|564832449|FG004|Overall Study|Lost to Follow-up|0|||
156474638|NCT02037568|564832450|FG000|Overall Study|Withdrawal by Subject|17|||
156474639|NCT02037568|564832451|FG001|Overall Study|Withdrawal by Subject|24|||
156474640|NCT02037568|564832450|FG000|Overall Study|Lost to Follow-up|16|||
156474641|NCT02037568|564832451|FG001|Overall Study|Lost to Follow-up|13|||
156474642|NCT02037568|564832450|FG000|Overall Study|Screen Failure|3|||
156474643|NCT02037568|564832451|FG001|Overall Study|Screen Failure|1|||
156474644|NCT02037568|564832450|FG000|Overall Study|Patient did not receive transplant|0|||
156474645|NCT02037568|564832451|FG001|Overall Study|Patient did not receive transplant|1|||
156474646|NCT04447027|564832454|FG000|Dose Escalation|Withdrawal by Subject|1|||
156474647|NCT04447027|564832455|FG001|Dose Escalation|Withdrawal by Subject|4|||
156474648|NCT04447027|564832456|FG002|Dose Escalation|Withdrawal by Subject|3|||
156474649|NCT04447027|564832457|FG003|Dose Escalation|Withdrawal by Subject|3|||
156474650|NCT04447027|564832458|FG004|Dose Escalation|Withdrawal by Subject|1|||
156474651|NCT04447027|564832459|FG005|Dose Escalation|Withdrawal by Subject|0|||
156859835|NCT01650558|566243233|FG001|Overall Study|Lost to Follow-up|13|||
156859836|NCT01650558|566243234|FG002|Overall Study|Lost to Follow-up|6|||
156859837|NCT01650558|566243232|FG000|Overall Study|Death|10|||
156859838|NCT01650558|566243233|FG001|Overall Study|Death|6|||
156859839|NCT01650558|566243234|FG002|Overall Study|Death|8|||
156859840|NCT01650558|566243232|FG000|Overall Study|Withdrawal by Subject|1|||
156859841|NCT01650558|566243233|FG001|Overall Study|Withdrawal by Subject|1|||
156859842|NCT01650558|566243234|FG002|Overall Study|Withdrawal by Subject|3|||
156859843|NCT01650558|566243232|FG000|Overall Study|Non-compliant participant|1|||
156859844|NCT01650558|566243233|FG001|Overall Study|Non-compliant participant|0|||
156859845|NCT01650558|566243234|FG002|Overall Study|Non-compliant participant|2|||
156859846|NCT01650558|566243232|FG000|Overall Study|Physician Decision|0|||
156859847|NCT01650558|566243233|FG001|Overall Study|Physician Decision|1|||
156859848|NCT01650558|566243234|FG002|Overall Study|Physician Decision|0|||
156859849|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
156859850|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
156859851|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
156859852|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
156859853|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
156859854|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
156859855|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
156859856|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
156859857|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
156859858|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
156859859|NCT02960217|566243235|FG000|Open-Label Extension Phase|Adverse Event|1|||
156859860|NCT02960217|566243236|FG001|Open-Label Extension Phase|Adverse Event|0|||
156859861|NCT02960217|566243235|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
156859862|NCT02960217|566243236|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
156859863|NCT02960217|566243235|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
156859864|NCT02960217|566243236|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
156859865|NCT02960217|566243235|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
156859866|NCT02960217|566243236|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
156859867|NCT00918385|566243237|FG000|Monotherapy|Adverse Event|1|||
156859868|NCT00918385|566243238|FG001|Monotherapy|Adverse Event|6|||
156859869|NCT00918385|566243237|FG000|Monotherapy|Complicating illness|1|||
156859870|NCT00918385|566243238|FG001|Monotherapy|Complicating illness|0|||
156859871|NCT00918385|566243237|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
156859872|NCT00918385|566243238|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
156859873|NCT00918385|566243237|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
156859874|NCT00918385|566243238|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
156859875|NCT00918385|566243237|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
156859876|NCT00918385|566243238|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
156859877|NCT00918385|566243237|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
156859878|NCT00918385|566243238|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
156859879|NCT00528957|566243240|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
156859880|NCT00528957|566243241|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
156859881|NCT00528957|566243240|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
156859882|NCT00528957|566243241|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
156859883|NCT00528957|566243240|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
156474652|NCT04447027|564832460|FG006|Dose Escalation|Withdrawal by Subject|0|||
156474653|NCT04447027|564832461|FG007|Dose Escalation|Withdrawal by Subject|0|||
156474654|NCT04447027|564832462|FG008|Dose Escalation|Withdrawal by Subject|0|||
156474655|NCT04447027|564832454|FG000|Dose Escalation|Refused further treatment|0|||
156474656|NCT04447027|564832455|FG001|Dose Escalation|Refused further treatment|1|||
156474657|NCT04447027|564832456|FG002|Dose Escalation|Refused further treatment|1|||
156474658|NCT04447027|564832457|FG003|Dose Escalation|Refused further treatment|0|||
156474659|NCT04447027|564832458|FG004|Dose Escalation|Refused further treatment|0|||
156474660|NCT04447027|564832459|FG005|Dose Escalation|Refused further treatment|0|||
156474661|NCT04447027|564832460|FG006|Dose Escalation|Refused further treatment|0|||
156474662|NCT04447027|564832461|FG007|Dose Escalation|Refused further treatment|0|||
156474663|NCT04447027|564832462|FG008|Dose Escalation|Refused further treatment|0|||
156474664|NCT04447027|564832454|FG000|Dose Expansion|Withdrawal by Subject|0|||
156474665|NCT04447027|564832455|FG001|Dose Expansion|Withdrawal by Subject|0|||
156474666|NCT04447027|564832456|FG002|Dose Expansion|Withdrawal by Subject|0|||
156474667|NCT04447027|564832457|FG003|Dose Expansion|Withdrawal by Subject|0|||
156343271|NCT02197130|564356335|FG001|Overall Study|Death|1|||
156343272|NCT02197130|564356336|FG002|Overall Study|Death|0|||
156343273|NCT02197130|564356334|FG000|Overall Study|Lost to Follow-up|2|||
156343274|NCT02197130|564356335|FG001|Overall Study|Lost to Follow-up|0|||
156343275|NCT02197130|564356336|FG002|Overall Study|Lost to Follow-up|1|||
156343276|NCT02197130|564356334|FG000|Overall Study|Does not meet entrance criteria|0|||
156343277|NCT02197130|564356335|FG001|Overall Study|Does not meet entrance criteria|0|||
156343278|NCT02197130|564356336|FG002|Overall Study|Does not meet entrance criteria|1|||
156343279|NCT02197130|564356334|FG000|Overall Study|Withdrawal by Subject|0|||
156343280|NCT02197130|564356335|FG001|Overall Study|Withdrawal by Subject|3|||
156343281|NCT02197130|564356336|FG002|Overall Study|Withdrawal by Subject|4|||
156343282|NCT02197130|564356334|FG000|Overall Study|Other|1|||
156343283|NCT02197130|564356335|FG001|Overall Study|Other|0|||
156343284|NCT02197130|564356336|FG002|Overall Study|Other|3|||
156343285|NCT02615145|564356337|FG000|Overall Study|Did Not Start Treatment|0|||
156343286|NCT02615145|564356338|FG001|Overall Study|Did Not Start Treatment|0|||
156343287|NCT02615145|564356339|FG002|Overall Study|Did Not Start Treatment|1|||
156343288|NCT02615145|564356340|FG003|Overall Study|Did Not Start Treatment|1|||
156343289|NCT02615145|564356337|FG000|Overall Study|Failure to Return|20|||
156343290|NCT02615145|564356338|FG001|Overall Study|Failure to Return|10|||
156343291|NCT02615145|564356339|FG002|Overall Study|Failure to Return|7|||
156343292|NCT02615145|564356340|FG003|Overall Study|Failure to Return|0|||
156343293|NCT02615145|564356337|FG000|Overall Study|Death|2|||
156343294|NCT02615145|564356338|FG001|Overall Study|Death|3|||
156343295|NCT02615145|564356339|FG002|Overall Study|Death|0|||
156343296|NCT02615145|564356340|FG003|Overall Study|Death|0|||
156343297|NCT02615145|564356337|FG000|Overall Study|Other, Not Specified|5|||
156343298|NCT02615145|564356338|FG001|Overall Study|Other, Not Specified|2|||
156343299|NCT02615145|564356339|FG002|Overall Study|Other, Not Specified|0|||
156343300|NCT02615145|564356340|FG003|Overall Study|Other, Not Specified|0|||
156343301|NCT00006237|564356343|FG000|Overall Study|Adverse Event|39|||
156343302|NCT00006237|564356344|FG001|Overall Study|Adverse Event|29|||
156343303|NCT00006237|564356343|FG000|Overall Study|Death|1|||
156343304|NCT00006237|564356344|FG001|Overall Study|Death|0|||
156343305|NCT00006237|564356343|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
156343306|NCT00006237|564356344|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
156343307|NCT00006237|564356343|FG000|Overall Study|Progression/relapse|54|||
156343308|NCT00006237|564356344|FG001|Overall Study|Progression/relapse|2|||
156343309|NCT00006237|564356343|FG000|Overall Study|Not eligible|9|||
156343310|NCT00006237|564356344|FG001|Overall Study|Not eligible|20|||
156343311|NCT00006237|564356343|FG000|Overall Study|Withdrawal by Subject|0|||
156343312|NCT00006237|564356344|FG001|Overall Study|Withdrawal by Subject|1|||
156343313|NCT00006237|564356343|FG000|Overall Study|Not protocol specified|14|||
156343314|NCT00006237|564356344|FG001|Overall Study|Not protocol specified|5|||
156343315|NCT03727347|564356345|FG000|Overall Study|Withdrawal by Subject|2|||
156343316|NCT03727347|564356345|FG000|Overall Study|Lost to Follow-up|1|||
156343317|NCT01846416|564356350|FG000|Treatment Phase|Death|2|||
156343318|NCT01846416|564356351|FG001|Treatment Phase|Death|9|||
156343319|NCT01846416|564356352|FG002|Treatment Phase|Death|1|||
156343320|NCT01846416|564356350|FG000|Treatment Phase|Withdrawal by Subject|2|||
156343321|NCT01846416|564356351|FG001|Treatment Phase|Withdrawal by Subject|4|||
156343322|NCT01846416|564356352|FG002|Treatment Phase|Withdrawal by Subject|2|||
156343323|NCT01846416|564356350|FG000|Treatment Phase|Other|1|||
156343324|NCT01846416|564356351|FG001|Treatment Phase|Other|5|||
156343325|NCT01846416|564356352|FG002|Treatment Phase|Other|1|||
156343326|NCT01846416|564356350|FG000|Treatment Phase|Physician Decision|1|||
156343327|NCT01846416|564356351|FG001|Treatment Phase|Physician Decision|2|||
156343328|NCT01846416|564356352|FG002|Treatment Phase|Physician Decision|0|||
156343329|NCT01846416|564356350|FG000|Treatment Phase|Adverse Event|3|||
156343330|NCT01846416|564356351|FG001|Treatment Phase|Adverse Event|4|||
156474668|NCT04447027|564832458|FG004|Dose Expansion|Withdrawal by Subject|0|||
156343331|NCT01846416|564356352|FG002|Treatment Phase|Adverse Event|0|||
156343332|NCT01846416|564356350|FG000|Treatment Phase|Non-compliance|0|||
156343333|NCT01846416|564356351|FG001|Treatment Phase|Non-compliance|2|||
156343334|NCT01846416|564356352|FG002|Treatment Phase|Non-compliance|0|||
156343335|NCT01846416|564356350|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
156343336|NCT01846416|564356351|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
156343337|NCT01846416|564356352|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
156343338|NCT01846416|564356350|FG000|Treatment Phase|Progressive Disease|21|||
156343339|NCT01846416|564356351|FG001|Treatment Phase|Progressive Disease|63|||
156343340|NCT01846416|564356352|FG002|Treatment Phase|Progressive Disease|9|||
156343341|NCT01846416|564356350|FG000|Survival Follow-up|Death|21|||
156343342|NCT01846416|564356351|FG001|Survival Follow-up|Death|62|||
156343343|NCT01846416|564356352|FG002|Survival Follow-up|Death|9|||
156343344|NCT01846416|564356350|FG000|Survival Follow-up|Lost to Follow-up|0|||
156343345|NCT01846416|564356351|FG001|Survival Follow-up|Lost to Follow-up|2|||
156343346|NCT01846416|564356352|FG002|Survival Follow-up|Lost to Follow-up|2|||
156343347|NCT01846416|564356350|FG000|Survival Follow-up|Withdrawal by Subject|2|||
156343348|NCT01846416|564356351|FG001|Survival Follow-up|Withdrawal by Subject|7|||
156343349|NCT01846416|564356352|FG002|Survival Follow-up|Withdrawal by Subject|0|||
156343350|NCT01846416|564356350|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
156343351|NCT01846416|564356351|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
156343352|NCT01846416|564356352|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
156343353|NCT01846416|564356350|FG000|Survival Follow-up|Other|3|||
156343354|NCT01846416|564356351|FG001|Survival Follow-up|Other|1|||
156343355|NCT01846416|564356352|FG002|Survival Follow-up|Other|1|||
156343356|NCT02521870|564356353|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343357|NCT02521870|564356354|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
156343358|NCT02521870|564356355|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343359|NCT02521870|564356356|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343360|NCT02521870|564356357|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343361|NCT02521870|564356358|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343362|NCT02521870|564356359|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343363|NCT02521870|564356360|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343364|NCT02521870|564356361|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343365|NCT02521870|564356362|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343366|NCT02521870|564356363|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343367|NCT02521870|564356364|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156343368|NCT02521870|564356353|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
156343369|NCT02521870|564356354|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
156343370|NCT02521870|564356355|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
156343371|NCT02521870|564356356|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
156343372|NCT02521870|564356357|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
156343373|NCT02521870|564356358|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
156343374|NCT02521870|564356359|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
156343375|NCT02521870|564356360|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
156343376|NCT02521870|564356361|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
156343377|NCT02521870|564356362|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
156343378|NCT02521870|564356363|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
156343379|NCT02521870|564356364|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
156343380|NCT02521870|564356353|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
156343381|NCT02521870|564356354|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
156343382|NCT02521870|564356355|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
156343383|NCT02521870|564356356|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
156343384|NCT02521870|564356357|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
156343385|NCT02521870|564356358|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
156343386|NCT02521870|564356359|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
156343387|NCT02521870|564356360|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
156343388|NCT02521870|564356361|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
156343389|NCT02521870|564356362|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
156343390|NCT02521870|564356363|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
156343391|NCT02521870|564356364|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
156343392|NCT02521870|564356353|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156343393|NCT02521870|564356354|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156343394|NCT02521870|564356355|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156343395|NCT02521870|564356356|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156343396|NCT02521870|564356357|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
156343397|NCT02521870|564356358|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
156343398|NCT02521870|564356359|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
156343399|NCT02521870|564356360|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156474669|NCT04447027|564832459|FG005|Dose Expansion|Withdrawal by Subject|2|||
156474670|NCT04447027|564832460|FG006|Dose Expansion|Withdrawal by Subject|0|||
156474671|NCT04447027|564832461|FG007|Dose Expansion|Withdrawal by Subject|2|||
156474672|NCT04447027|564832462|FG008|Dose Expansion|Withdrawal by Subject|0|||
156343400|NCT02521870|564356361|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
156343401|NCT02521870|564356362|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
156343402|NCT02521870|564356363|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
156343403|NCT02521870|564356364|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156343404|NCT02521870|564356353|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
156343405|NCT02521870|564356354|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
156343406|NCT02521870|564356355|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
156343407|NCT02521870|564356356|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
156343408|NCT02521870|564356357|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
156343409|NCT02521870|564356358|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
156343410|NCT02521870|564356359|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
156343411|NCT02521870|564356360|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
156343412|NCT02521870|564356361|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
156343413|NCT02521870|564356362|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
156343414|NCT02521870|564356363|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
156343415|NCT02521870|564356364|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
156343416|NCT02521870|564356353|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
156343417|NCT02521870|564356354|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
156343418|NCT02521870|564356355|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
156343419|NCT02521870|564356356|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
156343420|NCT02521870|564356357|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
156343421|NCT02521870|564356358|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
156343422|NCT02521870|564356359|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
156343423|NCT02521870|564356360|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
156343424|NCT02521870|564356361|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
156343425|NCT02521870|564356362|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
156343426|NCT02521870|564356363|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
156343427|NCT02521870|564356364|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
156343428|NCT02521870|564356353|FG000|Phase 2: Dose Expansion|Death|0|||
156343429|NCT02521870|564356354|FG001|Phase 2: Dose Expansion|Death|0|||
156343430|NCT02521870|564356355|FG002|Phase 2: Dose Expansion|Death|0|||
156343431|NCT02521870|564356356|FG003|Phase 2: Dose Expansion|Death|0|||
156343432|NCT02521870|564356357|FG004|Phase 2: Dose Expansion|Death|1|||
156343433|NCT02521870|564356358|FG005|Phase 2: Dose Expansion|Death|1|||
156343434|NCT02521870|564356359|FG006|Phase 2: Dose Expansion|Death|3|||
156343435|NCT02521870|564356360|FG007|Phase 2: Dose Expansion|Death|1|||
156343436|NCT02521870|564356361|FG008|Phase 2: Dose Expansion|Death|1|||
156343437|NCT02521870|564356362|FG009|Phase 2: Dose Expansion|Death|5|||
156343438|NCT02521870|564356363|FG010|Phase 2: Dose Expansion|Death|2|||
156343439|NCT02521870|564356364|FG011|Phase 2: Dose Expansion|Death|2|||
156343440|NCT02521870|564356353|FG000|Phase 2: Dose Expansion|Other|0|||
156343441|NCT02521870|564356354|FG001|Phase 2: Dose Expansion|Other|0|||
156343442|NCT02521870|564356355|FG002|Phase 2: Dose Expansion|Other|0|||
156343443|NCT02521870|564356356|FG003|Phase 2: Dose Expansion|Other|0|||
156343444|NCT02521870|564356357|FG004|Phase 2: Dose Expansion|Other|10|||
156343445|NCT02521870|564356358|FG005|Phase 2: Dose Expansion|Other|3|||
156343446|NCT02521870|564356359|FG006|Phase 2: Dose Expansion|Other|2|||
156343447|NCT02521870|564356360|FG007|Phase 2: Dose Expansion|Other|0|||
156343448|NCT02521870|564356361|FG008|Phase 2: Dose Expansion|Other|10|||
156343449|NCT02521870|564356362|FG009|Phase 2: Dose Expansion|Other|5|||
156343450|NCT02521870|564356363|FG010|Phase 2: Dose Expansion|Other|1|||
156343451|NCT02521870|564356364|FG011|Phase 2: Dose Expansion|Other|7|||
156343452|NCT02521870|564356353|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343453|NCT02521870|564356354|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343454|NCT02521870|564356355|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343455|NCT02521870|564356356|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343456|NCT02521870|564356357|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
156343457|NCT02521870|564356358|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343458|NCT02521870|564356359|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343459|NCT02521870|564356360|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343460|NCT02521870|564356361|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343461|NCT02521870|564356362|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343462|NCT02521870|564356363|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343463|NCT02521870|564356364|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156343464|NCT02521870|564356353|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343465|NCT02521870|564356354|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343466|NCT02521870|564356355|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343467|NCT02521870|564356356|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343468|NCT02521870|564356357|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
156343469|NCT02521870|564356358|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343470|NCT02521870|564356359|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343471|NCT02521870|564356360|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343472|NCT02521870|564356361|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343473|NCT02521870|564356362|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343474|NCT02521870|564356363|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343475|NCT02521870|564356364|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156343476|NCT00331682|564358399|FG000|Overall Study|Adverse Event|1|||
156343477|NCT03292588|564358400|FG000|Overall Study|Death|1|||
156343478|NCT03292588|564358401|FG001|Overall Study|Death|0|||
156343479|NCT03292588|564358400|FG000|Overall Study|Lost to Follow-up|12|||
156343480|NCT03292588|564358401|FG001|Overall Study|Lost to Follow-up|16|||
156343481|NCT03292588|564358400|FG000|Overall Study|Physician Decision|0|||
156343482|NCT03292588|564358401|FG001|Overall Study|Physician Decision|1|||
156343483|NCT03292588|564358400|FG000|Overall Study|Withdrawal by Subject|4|||
156343484|NCT03292588|564358401|FG001|Overall Study|Withdrawal by Subject|4|||
156343485|NCT03292588|564358400|FG000|Overall Study|Move out of town|1|||
156343486|NCT03292588|564358401|FG001|Overall Study|Move out of town|0|||
156343487|NCT03292588|564358400|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
156343488|NCT03292588|564358401|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
156343489|NCT00187486|564358402|FG000|Overall Study|Protocol Violation|1|||
156343490|NCT00684307|564358403|FG000|Overall Study|Adverse Event|11|||
156343491|NCT00684307|564358404|FG001|Overall Study|Adverse Event|6|||
156343492|NCT00684307|564358405|FG002|Overall Study|Adverse Event|15|||
156343493|NCT00684307|564358406|FG003|Overall Study|Adverse Event|16|||
156343494|NCT00684307|564358407|FG004|Overall Study|Adverse Event|8|||
156343495|NCT00684307|564358403|FG000|Overall Study|Development of increasing Liver Function|0|||
156343496|NCT00684307|564358404|FG001|Overall Study|Development of increasing Liver Function|2|||
156343497|NCT00684307|564358405|FG002|Overall Study|Development of increasing Liver Function|0|||
156343498|NCT00684307|564358406|FG003|Overall Study|Development of increasing Liver Function|1|||
156343499|NCT00684307|564358407|FG004|Overall Study|Development of increasing Liver Function|0|||
156343500|NCT00684307|564358403|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
156343501|NCT00684307|564358404|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
156343502|NCT00684307|564358405|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
156343503|NCT00684307|564358406|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
156343504|NCT00684307|564358407|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
156343505|NCT00684307|564358403|FG000|Overall Study|Incorrect enrolment or randomization|4|||
156343506|NCT00684307|564358404|FG001|Overall Study|Incorrect enrolment or randomization|0|||
156343507|NCT00684307|564358405|FG002|Overall Study|Incorrect enrolment or randomization|0|||
156343508|NCT00684307|564358406|FG003|Overall Study|Incorrect enrolment or randomization|0|||
156343509|NCT00684307|564358407|FG004|Overall Study|Incorrect enrolment or randomization|0|||
156343510|NCT00684307|564358403|FG000|Overall Study|Interupted IP for more than 7 days|0|||
156343511|NCT00684307|564358404|FG001|Overall Study|Interupted IP for more than 7 days|4|||
156343512|NCT00684307|564358405|FG002|Overall Study|Interupted IP for more than 7 days|1|||
156343513|NCT00684307|564358406|FG003|Overall Study|Interupted IP for more than 7 days|3|||
156343514|NCT00684307|564358407|FG004|Overall Study|Interupted IP for more than 7 days|3|||
156343515|NCT00684307|564358403|FG000|Overall Study|Severe non compliance to protocol|1|||
156343516|NCT00684307|564358404|FG001|Overall Study|Severe non compliance to protocol|0|||
156343517|NCT00684307|564358405|FG002|Overall Study|Severe non compliance to protocol|0|||
156343518|NCT00684307|564358406|FG003|Overall Study|Severe non compliance to protocol|1|||
156343519|NCT00684307|564358407|FG004|Overall Study|Severe non compliance to protocol|2|||
156343520|NCT00684307|564358403|FG000|Overall Study|Participant not willing to continue|7|||
156474673|NCT04224272|564832463|FG000|Part 1 - Dose Finding|Death|4|||
156343521|NCT00684307|564358404|FG001|Overall Study|Participant not willing to continue|10|||
156343522|NCT00684307|564358405|FG002|Overall Study|Participant not willing to continue|11|||
156343523|NCT00684307|564358406|FG003|Overall Study|Participant not willing to continue|5|||
156343524|NCT00684307|564358407|FG004|Overall Study|Participant not willing to continue|8|||
156343525|NCT00684307|564358403|FG000|Overall Study|Criteria from the CSR|0|||
156343526|NCT00684307|564358404|FG001|Overall Study|Criteria from the CSR|0|||
156343527|NCT00684307|564358405|FG002|Overall Study|Criteria from the CSR|1|||
156343528|NCT00684307|564358406|FG003|Overall Study|Criteria from the CSR|3|||
156343529|NCT00684307|564358407|FG004|Overall Study|Criteria from the CSR|3|||
156343530|NCT00759031|564358408|FG000|First Intervention (1 Day)|Physician Decision|1|||
156343531|NCT00759031|564358409|FG001|First Intervention (1 Day)|Physician Decision|0|||
156343532|NCT00759031|564358408|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
156343533|NCT00759031|564358409|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
156343534|NCT00759031|564358408|FG000|First Intervention (1 Day)|Screening failure|1|||
156343535|NCT00759031|564358409|FG001|First Intervention (1 Day)|Screening failure|0|||
156343536|NCT00543140|564358410|FG000|Overall Study|Lost to Follow-up|33|||
156343537|NCT00543140|564358410|FG000|Overall Study|Withdrawal by Subject|13|||
156343538|NCT00543140|564358410|FG000|Overall Study|Protocol Violation|10|||
156343539|NCT00543140|564358410|FG000|Overall Study|Insufficient weight loss|10|||
156474674|NCT04224272|564832463|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
156474675|NCT04224272|564832463|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
156474676|NCT04224272|564832463|FG000|Part 2 - Dose Expansion|Death|10|||
156474677|NCT04224272|564832463|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
156474678|NCT02609048|564832464|FG000|Overall Study|Adverse Event|3|||
156474679|NCT02609048|564832465|FG001|Overall Study|Adverse Event|0|||
156474680|NCT02609048|564832466|FG002|Overall Study|Adverse Event|0|||
156474681|NCT02609048|564832464|FG000|Overall Study|Randomized but never treated|1|||
156474682|NCT02609048|564832465|FG001|Overall Study|Randomized but never treated|1|||
156474683|NCT02609048|564832466|FG002|Overall Study|Randomized but never treated|1|||
156859884|NCT00528957|566243241|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
156859885|NCT00528957|566243240|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
156859886|NCT00528957|566243241|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
156859887|NCT00528957|566243240|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
156859888|NCT00528957|566243241|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
156859889|NCT00528957|566243240|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
156859890|NCT00528957|566243241|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
156859891|NCT00528957|566243240|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
156859892|NCT00528957|566243241|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
156859893|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
156859894|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
156859895|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
156859896|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
156859897|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
156859898|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
156859899|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
156859900|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
156859901|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
156859902|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
156859903|NCT00528957|566243240|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
156859904|NCT00528957|566243241|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
156859905|NCT00528957|566243240|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
156343540|NCT00543140|564358410|FG000|Overall Study|SAE leading to explant of SAGB|3|||
156343541|NCT00543140|564358410|FG000|Overall Study|Death|1|||
156343542|NCT00543140|564358410|FG000|Overall Study|Subject moved|1|||
156343543|NCT00543140|564358410|FG000|Overall Study|Conversion to different procedure|1|||
156343544|NCT02483520|564358411|FG000|Overall Study|Lost to Follow-up|3|||
156343545|NCT02483520|564358412|FG001|Overall Study|Lost to Follow-up|4|||
156343546|NCT02483520|564358411|FG000|Overall Study|Withdrawal by Subject|4|||
156343547|NCT02483520|564358412|FG001|Overall Study|Withdrawal by Subject|14|||
156343548|NCT02483520|564358411|FG000|Overall Study|Hospitalized|2|||
156343549|NCT02483520|564358412|FG001|Overall Study|Hospitalized|3|||
156343550|NCT02483520|564358411|FG000|Overall Study|Moved to LTC|2|||
156343551|NCT02483520|564358412|FG001|Overall Study|Moved to LTC|3|||
156343552|NCT03489720|564358415|FG000|Overall Study|Withdrawal by Subject|2|||
156343553|NCT03489720|564358416|FG001|Overall Study|Withdrawal by Subject|0|||
156343554|NCT01806545|564358417|FG000|Overall Study|Adverse Event|2|||
156343555|NCT01806545|564358418|FG001|Overall Study|Adverse Event|3|||
156343556|NCT01806545|564358417|FG000|Overall Study|Lost to Follow-up|1|||
156343557|NCT01806545|564358418|FG001|Overall Study|Lost to Follow-up|0|||
156343558|NCT01806545|564358417|FG000|Overall Study|Withdrawal by Subject|3|||
156343559|NCT01806545|564358418|FG001|Overall Study|Withdrawal by Subject|2|||
156343560|NCT00884312|564358419|FG000|Overall Study|Non-fatal Progressive Disease|0|||
156343561|NCT00884312|564358420|FG001|Overall Study|Non-fatal Progressive Disease|8|||
156343562|NCT00884312|564358419|FG000|Overall Study|Fatal Progressive Disease|0|||
156343563|NCT00884312|564358420|FG001|Overall Study|Fatal Progressive Disease|1|||
156343564|NCT00884312|564358419|FG000|Overall Study|Non-fatal Adverse Event|1|||
156343565|NCT00884312|564358420|FG001|Overall Study|Non-fatal Adverse Event|0|||
156343566|NCT00884312|564358419|FG000|Overall Study|Fatal Adverse Event|1|||
156343567|NCT00884312|564358420|FG001|Overall Study|Fatal Adverse Event|4|||
156343568|NCT00884312|564358419|FG000|Overall Study|Withdrawal by Subject|0|||
156343569|NCT00884312|564358420|FG001|Overall Study|Withdrawal by Subject|6|||
156343570|NCT00884312|564358419|FG000|Overall Study|Physician Decision|0|||
156343571|NCT00884312|564358420|FG001|Overall Study|Physician Decision|1|||
156343572|NCT00884312|564358419|FG000|Overall Study|Other|0|||
156343573|NCT00884312|564358420|FG001|Overall Study|Other|4|||
156343574|NCT00884312|564358419|FG000|Overall Study|Did Not Receive Study Drug|0|||
156343575|NCT00884312|564358420|FG001|Overall Study|Did Not Receive Study Drug|1|||
156343576|NCT03521934|564358424|FG000|Overall Study|Death|65|||
156343577|NCT03521934|564358425|FG001|Overall Study|Death|73|||
156343578|NCT03521934|564358424|FG000|Overall Study|Withdrawal by Subject|18|||
156343579|NCT03521934|564358425|FG001|Overall Study|Withdrawal by Subject|23|||
156343580|NCT03521934|564358424|FG000|Overall Study|Site Terminated by Sponsor|39|||
156343581|NCT03521934|564358425|FG001|Overall Study|Site Terminated by Sponsor|35|||
156343582|NCT03521934|564358424|FG000|Overall Study|Study Terminated by Sponsor|483|||
156343583|NCT03521934|564358425|FG001|Overall Study|Study Terminated by Sponsor|477|||
156343584|NCT03521934|564358424|FG000|Overall Study|Reason not Specified|3|||
156343585|NCT03521934|564358425|FG001|Overall Study|Reason not Specified|6|||
156343586|NCT00284050|564358429|FG000|Overall Study|Adverse Event|1|||
156343587|NCT00284050|564358430|FG001|Overall Study|Adverse Event|1|||
156343588|NCT00284050|564358431|FG002|Overall Study|Adverse Event|1|||
156343589|NCT00284050|564358429|FG000|Overall Study|Lack of Efficacy|0|||
156343590|NCT00284050|564358430|FG001|Overall Study|Lack of Efficacy|1|||
156474684|NCT02609048|564832464|FG000|Overall Study|Withdrawal of informed consent|1|||
156474685|NCT02609048|564832465|FG001|Overall Study|Withdrawal of informed consent|0|||
156474686|NCT02609048|564832466|FG002|Overall Study|Withdrawal of informed consent|0|||
156474687|NCT02609048|564832464|FG000|Overall Study|Reason not specified|6|||
156474688|NCT02609048|564832465|FG001|Overall Study|Reason not specified|9|||
156474689|NCT02609048|564832466|FG002|Overall Study|Reason not specified|9|||
156474690|NCT04118894|564832472|FG000|Overall Study|Lost to Follow-up|21|||
156474691|NCT04118894|564832472|FG000|Overall Study|Withdrawal by Subject|10|||
156474692|NCT04118894|564832472|FG000|Overall Study|Adverse Event|4|||
156474693|NCT00670449|564834117|FG000|Overall Study|Adverse Event|6|||
156474694|NCT00670449|564834118|FG001|Overall Study|Adverse Event|2|||
156474695|NCT00670449|564834119|FG002|Overall Study|Adverse Event|8|||
156474696|NCT00670449|564834120|FG003|Overall Study|Adverse Event|5|||
156474697|NCT00670449|564834117|FG000|Overall Study|Protocol Deviation|1|||
156474698|NCT00670449|564834118|FG001|Overall Study|Protocol Deviation|2|||
156474699|NCT00670449|564834119|FG002|Overall Study|Protocol Deviation|0|||
156474700|NCT00670449|564834120|FG003|Overall Study|Protocol Deviation|1|||
156474701|NCT00670449|564834117|FG000|Overall Study|Administrative Problems|0|||
156474702|NCT00670449|564834118|FG001|Overall Study|Administrative Problems|2|||
156474703|NCT00670449|564834119|FG002|Overall Study|Administrative Problems|0|||
156474704|NCT00670449|564834120|FG003|Overall Study|Administrative Problems|1|||
156474705|NCT00670449|564834117|FG000|Overall Study|Subject Withdrew Consent|0|||
156474706|NCT00670449|564834118|FG001|Overall Study|Subject Withdrew Consent|2|||
156474707|NCT00670449|564834119|FG002|Overall Study|Subject Withdrew Consent|0|||
156474708|NCT00670449|564834120|FG003|Overall Study|Subject Withdrew Consent|1|||
156474709|NCT00670449|564834117|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
156474710|NCT00670449|564834118|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156474711|NCT00670449|564834119|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
156474712|NCT00670449|564834120|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156474713|NCT00670449|564834117|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
156474714|NCT00670449|564834118|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
156474715|NCT00670449|564834119|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
156474716|NCT00670449|564834120|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
156474717|NCT00413283|564834121|FG000|Overall Study|Withdrawal by Subject|1|||
156474718|NCT00413283|564834122|FG001|Overall Study|Withdrawal by Subject|0|||
156474719|NCT00413283|564834123|FG002|Overall Study|Withdrawal by Subject|0|||
156474720|NCT00413283|564834124|FG003|Overall Study|Withdrawal by Subject|1|||
156474721|NCT00413283|564834121|FG000|Overall Study|Death|0|||
156474722|NCT00413283|564834122|FG001|Overall Study|Death|0|||
156474723|NCT00413283|564834123|FG002|Overall Study|Death|1|||
156474724|NCT00413283|564834124|FG003|Overall Study|Death|1|||
156474725|NCT00413283|564834121|FG000|Overall Study|Adverse Event|0|||
156474726|NCT00413283|564834122|FG001|Overall Study|Adverse Event|0|||
156474727|NCT00413283|564834123|FG002|Overall Study|Adverse Event|0|||
156474728|NCT00413283|564834124|FG003|Overall Study|Adverse Event|1|||
156474729|NCT00413283|564834121|FG000|Overall Study|Ineligibility determined|0|||
156474730|NCT00413283|564834122|FG001|Overall Study|Ineligibility determined|0|||
156474731|NCT00413283|564834123|FG002|Overall Study|Ineligibility determined|0|||
156474732|NCT00413283|564834124|FG003|Overall Study|Ineligibility determined|1|||
156474733|NCT00413283|564834121|FG000|Overall Study|Protocol deviation|0|||
156474734|NCT00413283|564834122|FG001|Overall Study|Protocol deviation|1|||
156474735|NCT00413283|564834123|FG002|Overall Study|Protocol deviation|0|||
156474736|NCT00413283|564834124|FG003|Overall Study|Protocol deviation|0|||
156474737|NCT00413283|564834121|FG000|Overall Study|Requirement for alternative therapy|0|||
156474738|NCT00413283|564834122|FG001|Overall Study|Requirement for alternative therapy|2|||
156474739|NCT00413283|564834123|FG002|Overall Study|Requirement for alternative therapy|0|||
156474740|NCT00413283|564834124|FG003|Overall Study|Requirement for alternative therapy|0|||
156474741|NCT00413283|564834121|FG000|Overall Study|Other|0|||
156474742|NCT00413283|564834122|FG001|Overall Study|Other|0|||
156474743|NCT00413283|564834123|FG002|Overall Study|Other|1|||
156474744|NCT00413283|564834124|FG003|Overall Study|Other|0|||
156474745|NCT02771366|564834125|FG000|Period 1|Withdrawal by Subject|0|||
156474746|NCT02771366|564834126|FG001|Period 1|Withdrawal by Subject|2|||
156474747|NCT02771366|564834125|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
156474748|NCT02771366|564834126|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
156474749|NCT01823224|564834127|FG000|Overall Study|Lost to Follow-up|5|||
156474750|NCT01823224|564834128|FG001|Overall Study|Lost to Follow-up|6|||
156474751|NCT01823224|564834127|FG000|Overall Study|didn't qualify|1|||
156474752|NCT01823224|564834128|FG001|Overall Study|didn't qualify|2|||
156474753|NCT01823224|564834127|FG000|Overall Study|pharmacy error|0|||
156343591|NCT00284050|564358431|FG002|Overall Study|Lack of Efficacy|3|||
156859906|NCT00528957|566243241|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
156859907|NCT00528957|566243240|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
156859908|NCT00528957|566243241|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
156859909|NCT00528957|566243240|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
156859910|NCT00528957|566243241|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
156859911|NCT01323582|566243242|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
156859912|NCT01323582|566243243|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
156859913|NCT01323582|566243242|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
156859914|NCT01323582|566243243|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
156859915|NCT01323582|566243242|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
156859916|NCT01323582|566243243|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
156859917|NCT00960375|566243244|FG000|Overall Study|Lost to Follow-up|20|||
156859918|NCT00960375|566243245|FG001|Overall Study|Lost to Follow-up|22|||
156859919|NCT03353675|566243248|FG000|Overall Study|Adverse Event|4|||
156859920|NCT00402168|566243249|FG000|Randomized|Lost to Follow-up|1|||
156859921|NCT00402168|566243250|FG001|Randomized|Lost to Follow-up|0|||
156859922|NCT00402168|566243249|FG000|Randomized|Withdrawal by Subject|0|||
156859923|NCT00402168|566243250|FG001|Randomized|Withdrawal by Subject|1|||
156859924|NCT00402168|566243249|FG000|Treatment (up to 12 Months)|Death|0|||
156859925|NCT00402168|566243250|FG001|Treatment (up to 12 Months)|Death|1|||
156859926|NCT00402168|566243249|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
156859927|NCT00402168|566243250|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
156859928|NCT00402168|566243249|FG000|Treatment (up to 12 Months)|non-specified|0|||
156859929|NCT00402168|566243250|FG001|Treatment (up to 12 Months)|non-specified|1|||
156859930|NCT00402168|566243249|FG000|Long Term (LT)|Adverse Event|1|||
156859931|NCT00402168|566243250|FG001|Long Term (LT)|Adverse Event|5|||
156859932|NCT00402168|566243249|FG000|Long Term (LT)|Withdrawal by Subject|4|||
156859933|NCT00402168|566243250|FG001|Long Term (LT)|Withdrawal by Subject|7|||
156859934|NCT00402168|566243249|FG000|Long Term (LT)|Pregnancy|0|||
156859935|NCT00402168|566243250|FG001|Long Term (LT)|Pregnancy|1|||
156859936|NCT00402168|566243249|FG000|Long Term (LT)|Lost to Follow-up|1|||
156859937|NCT00402168|566243250|FG001|Long Term (LT)|Lost to Follow-up|0|||
156859938|NCT00402168|566243249|FG000|Long Term (LT)|Death|4|||
156859939|NCT00402168|566243250|FG001|Long Term (LT)|Death|0|||
156859940|NCT00402168|566243249|FG000|Long Term (LT)|Lack of Efficacy|0|||
156859941|NCT00402168|566243250|FG001|Long Term (LT)|Lack of Efficacy|2|||
156859942|NCT00402168|566243249|FG000|Long Term (LT)|non-specified|1|||
156859943|NCT00402168|566243250|FG001|Long Term (LT)|non-specified|2|||
156859944|NCT00402168|566243249|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
156859945|NCT00402168|566243250|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
156859946|NCT00402168|566243249|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
156859947|NCT00402168|566243250|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
156859948|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
156859949|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
156859950|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
156859951|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
156859952|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
156859953|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
156859954|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
156859955|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
156859956|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
156859957|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
156859958|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
156859959|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
156859960|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
156859961|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
156859962|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
156859963|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
156859964|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
156859965|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
156859966|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
156859967|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
156859968|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
156859969|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
156859970|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
156859971|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
156859972|NCT00550407|566243251|FG000|26-Week Randomized Phase|Adverse Event|0|||
156859973|NCT00550407|566243252|FG001|26-Week Randomized Phase|Adverse Event|5|||
156859974|NCT00550407|566243253|FG002|26-Week Randomized Phase|Adverse Event|2|||
156474754|NCT01823224|564834128|FG001|Overall Study|pharmacy error|1|||
156343592|NCT00284050|564358429|FG000|Overall Study|Protocol Violation|0|||
156474755|NCT01823224|564834127|FG000|Overall Study|missed med dose|0|||
156474756|NCT01823224|564834128|FG001|Overall Study|missed med dose|1|||
156474757|NCT01823224|564834127|FG000|Overall Study|Withdrawal by Subject|0|||
156474758|NCT01823224|564834128|FG001|Overall Study|Withdrawal by Subject|1|||
156474759|NCT01779050|564834129|FG000|Overall Study|Withdrawal by Subject|1|||
156474760|NCT01779050|564834130|FG001|Overall Study|Withdrawal by Subject|0|||
156474761|NCT01409837|564834133|FG000|Overall Study|Withdrawal by Subject|2|||
156474762|NCT01409837|564834134|FG001|Overall Study|Withdrawal by Subject|1|||
156474763|NCT01409837|564834133|FG000|Overall Study|Lost to Follow-up|1|||
156474764|NCT01409837|564834134|FG001|Overall Study|Lost to Follow-up|0|||
156542327|NCT01147744|565079319|FG000|Overall Study|Sponsor decision to amend protocol|7|||
156343593|NCT00284050|564358430|FG001|Overall Study|Protocol Violation|1|||
156343594|NCT00284050|564358431|FG002|Overall Study|Protocol Violation|2|||
156343595|NCT00284050|564358429|FG000|Overall Study|Withdrawal by Subject|2|||
156343596|NCT00284050|564358430|FG001|Overall Study|Withdrawal by Subject|2|||
156343597|NCT00284050|564358431|FG002|Overall Study|Withdrawal by Subject|2|||
156343598|NCT00284050|564358429|FG000|Overall Study|Lost to Follow-up|1|||
156343599|NCT00284050|564358430|FG001|Overall Study|Lost to Follow-up|0|||
156343600|NCT00284050|564358431|FG002|Overall Study|Lost to Follow-up|1|||
156343601|NCT00284050|564358429|FG000|Overall Study|Death|1|||
156343602|NCT00284050|564358430|FG001|Overall Study|Death|0|||
156343603|NCT00284050|564358431|FG002|Overall Study|Death|0|||
156343604|NCT00489541|564358441|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
156343605|NCT00489541|564358442|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
156343606|NCT00489541|564358441|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
156474765|NCT01409837|564834133|FG000|Overall Study|Physician Decision|0|||
156474766|NCT01409837|564834134|FG001|Overall Study|Physician Decision|1|||
156343607|NCT00489541|564358442|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
156343608|NCT00489541|564358441|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
156343609|NCT00489541|564358442|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
156343610|NCT00489541|564358441|FG000|12-Month Clinical Follow-up|Death|3|||
156474767|NCT00022672|564834136|FG000|Main Phase: 24 Months|Adverse Event|6|||
156474768|NCT00022672|564834137|FG001|Main Phase: 24 Months|Adverse Event|0|||
156474769|NCT00022672|564834136|FG000|Main Phase: 24 Months|Death|0|||
156474770|NCT00022672|564834137|FG001|Main Phase: 24 Months|Death|3|||
156474771|NCT00022672|564834136|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
156474772|NCT00022672|564834137|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
156474773|NCT00022672|564834136|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
156474774|NCT00022672|564834137|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
156474775|NCT00022672|564834136|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
156343611|NCT00489541|564358442|FG001|12-Month Clinical Follow-up|Death|2|||
156343612|NCT00489541|564358441|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
156343613|NCT00489541|564358442|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
156343614|NCT00489541|564358441|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
156474776|NCT00022672|564834137|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
156474777|NCT00022672|564834136|FG000|Main Phase: 24 Months|Refused Treatment|3|||
156474778|NCT00022672|564834137|FG001|Main Phase: 24 Months|Refused Treatment|4|||
156474779|NCT00022672|564834136|FG000|Main Phase: 24 Months|Failure to Return|1|||
156343615|NCT00489541|564358442|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
156343616|NCT00299104|564358448|FG000|Treatment Period|Adverse Event|14|||
156343617|NCT00299104|564358449|FG001|Treatment Period|Adverse Event|9|||
156343618|NCT00299104|564358450|FG002|Treatment Period|Adverse Event|7|||
156343619|NCT00299104|564358448|FG000|Treatment Period|Death|1|||
156343620|NCT00299104|564358449|FG001|Treatment Period|Death|1|||
156343621|NCT00299104|564358450|FG002|Treatment Period|Death|1|||
156343622|NCT00299104|564358448|FG000|Treatment Period|Insufficient therapeutic response|34|||
156343623|NCT00299104|564358449|FG001|Treatment Period|Insufficient therapeutic response|13|||
156343624|NCT00299104|564358450|FG002|Treatment Period|Insufficient therapeutic response|8|||
156343625|NCT00299104|564358448|FG000|Treatment Period|Failure to return|9|||
156474780|NCT00022672|564834137|FG001|Main Phase: 24 Months|Failure to Return|1|||
156474781|NCT00022672|564834136|FG000|Main Phase: 24 Months|Other|1|||
156343626|NCT00299104|564358449|FG001|Treatment Period|Failure to return|8|||
156474782|NCT00022672|564834137|FG001|Main Phase: 24 Months|Other|0|||
156343627|NCT00299104|564358450|FG002|Treatment Period|Failure to return|8|||
156343628|NCT00299104|564358448|FG000|Treatment Period|Violation of selection criteria|1|||
156343629|NCT00299104|564358449|FG001|Treatment Period|Violation of selection criteria|2|||
156343630|NCT00299104|564358450|FG002|Treatment Period|Violation of selection criteria|0|||
156343631|NCT00299104|564358448|FG000|Treatment Period|Protocol Violation|1|||
156343632|NCT00299104|564358449|FG001|Treatment Period|Protocol Violation|1|||
156343633|NCT00299104|564358450|FG002|Treatment Period|Protocol Violation|0|||
156343634|NCT00299104|564358448|FG000|Treatment Period|Refused treatment|9|||
156343635|NCT00299104|564358449|FG001|Treatment Period|Refused treatment|2|||
156343636|NCT00299104|564358450|FG002|Treatment Period|Refused treatment|2|||
156343637|NCT00299104|564358448|FG000|Treatment Period|Withdrew consent|14|||
156343638|NCT00299104|564358449|FG001|Treatment Period|Withdrew consent|19|||
156343639|NCT00299104|564358450|FG002|Treatment Period|Withdrew consent|9|||
156343640|NCT00299104|564358448|FG000|Treatment Period|Administrative reasons|106|||
156343641|NCT00299104|564358449|FG001|Treatment Period|Administrative reasons|120|||
156343642|NCT00299104|564358450|FG002|Treatment Period|Administrative reasons|137|||
156343643|NCT00299104|564358448|FG000|Safety Follow-Up (SFU) Period|Death|3|||
156343644|NCT00299104|564358449|FG001|Safety Follow-Up (SFU) Period|Death|2|||
156343645|NCT00299104|564358450|FG002|Safety Follow-Up (SFU) Period|Death|1|||
156343646|NCT00299104|564358448|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
156474783|NCT00022672|564834136|FG000|Extension Phase|Adverse Event|1|||
156474784|NCT00022672|564834137|FG001|Extension Phase|Adverse Event|3|||
156474785|NCT00022672|564834136|FG000|Extension Phase|Death|0|||
156474786|NCT00022672|564834137|FG001|Extension Phase|Death|1|||
156474787|NCT00022672|564834136|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
156474788|NCT00022672|564834137|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
156474789|NCT00022672|564834136|FG000|Extension Phase|Refused Treatment|0|||
156474790|NCT00022672|564834137|FG001|Extension Phase|Refused Treatment|2|||
156474791|NCT00022672|564834136|FG000|Extension Phase|Other|1|||
156474792|NCT00022672|564834137|FG001|Extension Phase|Other|1|||
156474793|NCT00403494|564834138|FG000|Overall Study|Adverse Event|10|||
156474794|NCT00403494|564834139|FG001|Overall Study|Adverse Event|8|||
156474795|NCT00403494|564834138|FG000|Overall Study|Withdrew Consent|3|||
156474796|NCT00403494|564834139|FG001|Overall Study|Withdrew Consent|2|||
156474797|NCT00403494|564834138|FG000|Overall Study|Inappropriately enrolled|0|||
156474798|NCT00403494|564834139|FG001|Overall Study|Inappropriately enrolled|1|||
156474799|NCT00403494|564834138|FG000|Overall Study|Lost to Follow-up|0|||
156474800|NCT00403494|564834139|FG001|Overall Study|Lost to Follow-up|2|||
156474801|NCT00403494|564834138|FG000|Overall Study|Protocol noncompliance|0|||
156474802|NCT00403494|564834139|FG001|Overall Study|Protocol noncompliance|1|||
156474803|NCT00403494|564834138|FG000|Overall Study|Death|1|||
156474804|NCT00403494|564834139|FG001|Overall Study|Death|0|||
156474805|NCT00403494|564834138|FG000|Overall Study|Sponsor Request|1|||
156474806|NCT00403494|564834139|FG001|Overall Study|Sponsor Request|0|||
156474807|NCT03648541|564834141|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
156474808|NCT03648541|564834142|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
156474809|NCT03648541|564834141|FG000|Re-induction Period Only|Lack of Efficacy|7|||
156474810|NCT03648541|564834142|FG001|Re-induction Period Only|Lack of Efficacy|0|||
156474811|NCT03648541|564834141|FG000|Maintenance Period Only|Missing|0|||
156474812|NCT03648541|564834142|FG001|Maintenance Period Only|Missing|1|||
156474813|NCT03648541|564834141|FG000|Maintenance Period Only|Other not listed below|0|||
156474814|NCT03648541|564834142|FG001|Maintenance Period Only|Other not listed below|4|||
156474815|NCT03648541|564834141|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
156474816|NCT03648541|564834142|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
156474817|NCT03648541|564834141|FG000|Maintenance Period Only|Protocol Violation|0|||
156474818|NCT03648541|564834142|FG001|Maintenance Period Only|Protocol Violation|1|||
156474819|NCT03648541|564834141|FG000|Maintenance Period Only|Lack of Efficacy|0|||
156474820|NCT03648541|564834142|FG001|Maintenance Period Only|Lack of Efficacy|18|||
156474821|NCT03648541|564834141|FG000|Maintenance Period Only|Adverse Event|0|||
156474822|NCT03648541|564834142|FG001|Maintenance Period Only|Adverse Event|4|||
156474823|NCT03648541|564834141|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
156474824|NCT03648541|564834142|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
156474825|NCT03490032|564834143|FG000|Overall Study|family issue (child custody)|1|||
156474826|NCT03490032|564834144|FG001|Overall Study|family issue (child custody)|0|||
156474827|NCT03490032|564834145|FG002|Overall Study|family issue (child custody)|0|||
156474828|NCT00308308|564834146|FG000|Overall Study|Adverse Event|17|||
156474829|NCT00308308|564834147|FG001|Overall Study|Adverse Event|2|||
156474830|NCT00308308|564834146|FG000|Overall Study|Lost to Follow-up|5|||
156474831|NCT00308308|564834147|FG001|Overall Study|Lost to Follow-up|5|||
156474832|NCT00308308|564834146|FG000|Overall Study|Physician Decision|15|||
156474833|NCT00308308|564834147|FG001|Overall Study|Physician Decision|7|||
156474834|NCT00308308|564834146|FG000|Overall Study|Protocol Violation|3|||
156474835|NCT00308308|564834147|FG001|Overall Study|Protocol Violation|14|||
156474836|NCT00308308|564834146|FG000|Overall Study|Withdrawal by Subject|47|||
156474837|NCT00308308|564834147|FG001|Overall Study|Withdrawal by Subject|19|||
156474838|NCT00308308|564834146|FG000|Overall Study|Various|7|||
156474839|NCT00308308|564834147|FG001|Overall Study|Various|5|||
156474840|NCT00308308|564834146|FG000|Overall Study|Randomized but not dosed|8|||
156474841|NCT00308308|564834147|FG001|Overall Study|Randomized but not dosed|16|||
156474842|NCT00308308|564834146|FG000|Overall Study|Other|1|||
156474843|NCT00308308|564834147|FG001|Overall Study|Other|0|||
156474844|NCT00273052|564834150|FG000|Overall Study|Withdrawal by Subject|16|||
156474845|NCT00273052|564834151|FG001|Overall Study|Withdrawal by Subject|19|||
156474846|NCT00273052|564834150|FG000|Overall Study|Adverse Event|21|||
156474847|NCT00273052|564834151|FG001|Overall Study|Adverse Event|19|||
156474848|NCT00273052|564834150|FG000|Overall Study|Protocol Violation|14|||
156474849|NCT00273052|564834151|FG001|Overall Study|Protocol Violation|18|||
156474850|NCT00273052|564834150|FG000|Overall Study|Lost to Follow-up|7|||
156474851|NCT00273052|564834151|FG001|Overall Study|Lost to Follow-up|25|||
156474852|NCT00273052|564834150|FG000|Overall Study|Lack of Efficacy|6|||
156474853|NCT00273052|564834151|FG001|Overall Study|Lack of Efficacy|4|||
156474854|NCT00273052|564834150|FG000|Overall Study|Non-Compliance|3|||
156474855|NCT00273052|564834151|FG001|Overall Study|Non-Compliance|1|||
156474856|NCT00273052|564834150|FG000|Overall Study|Other|2|||
156474857|NCT00273052|564834151|FG001|Overall Study|Other|0|||
156474858|NCT00273052|564834150|FG000|Overall Study|Worsening serum lipid levels|0|||
156474859|NCT00273052|564834151|FG001|Overall Study|Worsening serum lipid levels|2|||
156474860|NCT01852045|564834152|FG000|Overall Study|Adverse Event|1|||
156474861|NCT01852045|564834153|FG001|Overall Study|Adverse Event|0|||
156474862|NCT01852045|564834154|FG002|Overall Study|Adverse Event|0|||
156474863|NCT01852045|564834152|FG000|Overall Study|Lack of Efficacy|3|||
156474864|NCT01852045|564834153|FG001|Overall Study|Lack of Efficacy|0|||
156474865|NCT01852045|564834154|FG002|Overall Study|Lack of Efficacy|0|||
156474866|NCT01852045|564834152|FG000|Overall Study|Lost to Follow-up|0|||
156474867|NCT01852045|564834153|FG001|Overall Study|Lost to Follow-up|1|||
156474868|NCT01852045|564834154|FG002|Overall Study|Lost to Follow-up|1|||
156474869|NCT01852045|564834152|FG000|Overall Study|Withdrawal by Subject|1|||
156474870|NCT01852045|564834153|FG001|Overall Study|Withdrawal by Subject|0|||
156474871|NCT01852045|564834154|FG002|Overall Study|Withdrawal by Subject|1|||
156474872|NCT01852045|564834152|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156474873|NCT01852045|564834153|FG001|Overall Study|Other Miscellaneous Reasons|3|||
156474874|NCT01852045|564834154|FG002|Overall Study|Other Miscellaneous Reasons|2|||
156474875|NCT00240994|564834155|FG000|Overall Study|Lost to Follow-up|1|||
156474876|NCT00240994|564834155|FG000|Overall Study|Protocol Violation|1|||
156474877|NCT00240994|564834155|FG000|Overall Study|Graft failure|1|||
156474878|NCT03142932|564834157|FG000|Overall Study|Lost to Follow-up|2|||
156474879|NCT03142932|564834158|FG001|Overall Study|Lost to Follow-up|11|||
156474880|NCT00703092|564834159|FG000|Overall Study|Withdrawal by Subject|2|||
156474881|NCT00681109|564834160|FG000|Overall Study|Lost to Follow-up|2|||
156474882|NCT00681109|564834161|FG001|Overall Study|Lost to Follow-up|6|||
156474883|NCT00681109|564834162|FG002|Overall Study|Lost to Follow-up|0|||
156474884|NCT02706483|564834163|FG000|Overall Study|Adverse Event|97|||
156474885|NCT02706483|564834163|FG000|Overall Study|Death|1|||
156474886|NCT02706483|564834163|FG000|Overall Study|Lack of Efficacy|39|||
156474887|NCT02706483|564834163|FG000|Overall Study|Lost to Follow-up|101|||
156474888|NCT02706483|564834163|FG000|Overall Study|Non-compliance with study drug|15|||
156474889|NCT02706483|564834163|FG000|Overall Study|Physician Decision|6|||
156474890|NCT02706483|564834163|FG000|Overall Study|Pregnancy|6|||
156474891|NCT02706483|564834163|FG000|Overall Study|Protocol Violation|18|||
156474892|NCT02706483|564834163|FG000|Overall Study|Withdrawal by Subject|136|||
156474893|NCT02706483|564834163|FG000|Overall Study|Non-compliance with visits|6|||
156474894|NCT02706483|564834163|FG000|Overall Study|Site closure|4|||
156474895|NCT02706483|564834163|FG000|Overall Study|Subject moved|1|||
156474896|NCT04248868|564834164|FG000|Overall Study|Death|1|||
156474897|NCT04248868|564834164|FG000|Overall Study|Lost to Follow-up|3|||
156474898|NCT04248868|564834164|FG000|Overall Study|Protocol Violation|2|||
156474899|NCT04660799|564834165|FG000|Overall Study|Progressive Disease|1|||
156474900|NCT04660799|564834166|FG001|Overall Study|Progressive Disease|1|||
156859975|NCT00550407|566243251|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
156859976|NCT00550407|566243252|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
156859977|NCT00550407|566243253|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
156859978|NCT00550407|566243251|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
156859979|NCT00550407|566243252|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
156859980|NCT00550407|566243253|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
156859981|NCT00550407|566243251|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
156859982|NCT00550407|566243252|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
156859983|NCT00550407|566243253|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
156859984|NCT02370420|566243254|FG000|Overall Study|Physician Decision|3|||
156859985|NCT02370420|566243255|FG001|Overall Study|Physician Decision|3|||
156859986|NCT02370420|566243254|FG000|Overall Study|Lost to Follow-up|11|||
156859987|NCT02370420|566243255|FG001|Overall Study|Lost to Follow-up|9|||
156859988|NCT02919761|566243260|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
156859989|NCT02919761|566243261|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
156859990|NCT02919761|566243262|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
156859991|NCT02919761|566243260|FG000|Part 1: Open Label|Adverse Event|1|||
156859992|NCT02919761|566243261|FG001|Part 1: Open Label|Adverse Event|0|||
156859993|NCT02919761|566243262|FG002|Part 1: Open Label|Adverse Event|0|||
156859994|NCT02919761|566243260|FG000|Part 1: Open Label|Lost to Follow-up|1|||
156859995|NCT02919761|566243261|FG001|Part 1: Open Label|Lost to Follow-up|0|||
156859996|NCT02919761|566243262|FG002|Part 1: Open Label|Lost to Follow-up|0|||
156859997|NCT02919761|566243260|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
156859998|NCT02919761|566243261|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
156859999|NCT02919761|566243262|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
156860000|NCT02919761|566243260|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
156860001|NCT02919761|566243261|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
156860002|NCT02919761|566243262|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
156860003|NCT02919761|566243260|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
156860004|NCT02919761|566243261|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
156860005|NCT02919761|566243262|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
156860006|NCT02919761|566243260|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
156860007|NCT02919761|566243261|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
156860008|NCT02919761|566243262|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
156860009|NCT02919761|566243260|FG000|Part 1: Open Label|Termination by Sponsor|1|||
156860010|NCT02919761|566243261|FG001|Part 1: Open Label|Termination by Sponsor|0|||
156860011|NCT02919761|566243262|FG002|Part 1: Open Label|Termination by Sponsor|0|||
156860012|NCT02919761|566243260|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
156860013|NCT02919761|566243261|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
156860014|NCT02919761|566243262|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
156860015|NCT02919761|566243260|FG000|Part 2: Double-blind|Adverse Event|0|||
156860016|NCT02919761|566243261|FG001|Part 2: Double-blind|Adverse Event|1|||
156860017|NCT02919761|566243262|FG002|Part 2: Double-blind|Adverse Event|0|||
156860018|NCT02919761|566243260|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
156860019|NCT02919761|566243261|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
156860020|NCT02919761|566243262|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
156860021|NCT02919761|566243260|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
156860022|NCT02919761|566243261|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
156860023|NCT02919761|566243262|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
156860024|NCT02919761|566243260|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
156860025|NCT02919761|566243261|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
156860026|NCT02919761|566243262|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
156860027|NCT02919761|566243260|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
156860028|NCT02919761|566243261|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
156860029|NCT02919761|566243262|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
156860030|NCT02919761|566243260|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
156860031|NCT02919761|566243261|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
156860032|NCT02919761|566243262|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
156860033|NCT02919761|566243260|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
156860034|NCT02919761|566243261|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
156860035|NCT02919761|566243262|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
156860036|NCT00410956|566243263|FG000|Overall Study|Adverse Event|1|||
156860037|NCT00410956|566243263|FG000|Overall Study|Death|2|||
156860038|NCT00410956|566243263|FG000|Overall Study|Lack of Efficacy|10|||
156860039|NCT00410956|566243263|FG000|Overall Study|Physician Decision|6|||
156860040|NCT00755183|566244643|FG000|Overall Study|Adverse Event|5|||
156860041|NCT00755183|566244644|FG001|Overall Study|Adverse Event|2|||
156860042|NCT00755183|566244643|FG000|Overall Study|Protocol Violation|0|||
156860043|NCT00755183|566244644|FG001|Overall Study|Protocol Violation|1|||
156860044|NCT00755183|566244643|FG000|Overall Study|Withdrawal by Subject|0|||
156860045|NCT00755183|566244644|FG001|Overall Study|Withdrawal by Subject|2|||
156860046|NCT00755183|566244643|FG000|Overall Study|Administrative|2|||
156860047|NCT00755183|566244644|FG001|Overall Study|Administrative|1|||
156343647|NCT00299104|564358449|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
156343648|NCT00299104|564358450|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
156343649|NCT00299104|564358448|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
156343650|NCT00299104|564358449|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
156343651|NCT00299104|564358450|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
156343652|NCT00299104|564358448|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
156343653|NCT00299104|564358449|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
156343654|NCT00299104|564358450|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
156474901|NCT04660799|564834165|FG000|Overall Study|Death|2|||
156474902|NCT04660799|564834166|FG001|Overall Study|Death|1|||
156474903|NCT04660799|564834165|FG000|Overall Study|Adverse Event|2|||
156474904|NCT04660799|564834166|FG001|Overall Study|Adverse Event|1|||
156474905|NCT04660799|564834165|FG000|Overall Study|Withdrawal by Subject|2|||
156474906|NCT04660799|564834166|FG001|Overall Study|Withdrawal by Subject|5|||
156474907|NCT03131713|564834167|FG000|Overall Study|Lost to Follow-up|5|||
156474908|NCT03131713|564834168|FG001|Overall Study|Lost to Follow-up|0|||
156474909|NCT01972776|564834171|FG000|Part 1|Withdrawal by Subject|0|||
156474910|NCT01972776|564834172|FG001|Part 1|Withdrawal by Subject|0|||
156474911|NCT01972776|564834173|FG002|Part 1|Withdrawal by Subject|1|||
156474912|NCT01972776|564834174|FG003|Part 1|Withdrawal by Subject|0|||
156474913|NCT01972776|564834175|FG004|Part 1|Withdrawal by Subject|0|||
156474914|NCT01972776|564834176|FG005|Part 1|Withdrawal by Subject|0|||
156474915|NCT01972776|564834171|FG000|Part 1|Adverse Event|0|||
156474916|NCT01972776|564834172|FG001|Part 1|Adverse Event|0|||
156343655|NCT00299104|564358448|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
156343656|NCT00299104|564358449|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
156343657|NCT00299104|564358450|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
156343658|NCT00299104|564358448|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
156343659|NCT00299104|564358449|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
156343660|NCT00299104|564358450|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
156343661|NCT00299104|564358448|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
156343662|NCT00299104|564358449|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
156343663|NCT00299104|564358450|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
156474917|NCT01972776|564834173|FG002|Part 1|Adverse Event|1|||
156474918|NCT01972776|564834174|FG003|Part 1|Adverse Event|1|||
156343664|NCT00299104|564358448|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
156343665|NCT00299104|564358449|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
156474919|NCT01972776|564834175|FG004|Part 1|Adverse Event|0|||
156860048|NCT04199351|566244647|FG000|Overall Study|Decision by sponsor|0|||
156860049|NCT04199351|566244648|FG001|Overall Study|Decision by sponsor|0|||
156860050|NCT04199351|566244649|FG002|Overall Study|Decision by sponsor|0|||
156860051|NCT04199351|566244650|FG003|Overall Study|Decision by sponsor|2|||
156860052|NCT04199351|566244651|FG004|Overall Study|Decision by sponsor|0|||
156860053|NCT04199351|566244652|FG005|Overall Study|Decision by sponsor|0|||
156860054|NCT04199351|566244653|FG006|Overall Study|Decision by sponsor|0|||
156860055|NCT04199351|566244654|FG007|Overall Study|Decision by sponsor|0|||
156860056|NCT04199351|566244655|FG008|Overall Study|Decision by sponsor|0|||
156860057|NCT04199351|566244656|FG009|Overall Study|Decision by sponsor|6|||
156860058|NCT04199351|566244647|FG000|Overall Study|Lost to Follow-up|0|||
156860059|NCT04199351|566244648|FG001|Overall Study|Lost to Follow-up|0|||
156860060|NCT04199351|566244649|FG002|Overall Study|Lost to Follow-up|1|||
156860061|NCT04199351|566244650|FG003|Overall Study|Lost to Follow-up|0|||
156860062|NCT04199351|566244651|FG004|Overall Study|Lost to Follow-up|0|||
156860063|NCT04199351|566244652|FG005|Overall Study|Lost to Follow-up|1|||
156860064|NCT04199351|566244653|FG006|Overall Study|Lost to Follow-up|0|||
156860065|NCT04199351|566244654|FG007|Overall Study|Lost to Follow-up|0|||
156860066|NCT04199351|566244655|FG008|Overall Study|Lost to Follow-up|0|||
156860067|NCT04199351|566244656|FG009|Overall Study|Lost to Follow-up|0|||
156860068|NCT04199351|566244647|FG000|Overall Study|Withdrawal by Subject|0|||
156860069|NCT04199351|566244648|FG001|Overall Study|Withdrawal by Subject|1|||
156860070|NCT04199351|566244649|FG002|Overall Study|Withdrawal by Subject|0|||
156860071|NCT04199351|566244650|FG003|Overall Study|Withdrawal by Subject|0|||
156860072|NCT04199351|566244651|FG004|Overall Study|Withdrawal by Subject|1|||
156860073|NCT04199351|566244652|FG005|Overall Study|Withdrawal by Subject|4|||
156860074|NCT04199351|566244653|FG006|Overall Study|Withdrawal by Subject|2|||
156860075|NCT04199351|566244654|FG007|Overall Study|Withdrawal by Subject|0|||
156860076|NCT04199351|566244655|FG008|Overall Study|Withdrawal by Subject|3|||
156860077|NCT04199351|566244656|FG009|Overall Study|Withdrawal by Subject|0|||
156860078|NCT04742556|566244657|FG000|Overall Study|Withdrawal by Subject|0|||
156860079|NCT04742556|566244658|FG001|Overall Study|Withdrawal by Subject|1|||
156860080|NCT04742556|566244659|FG002|Overall Study|Withdrawal by Subject|0|||
156860081|NCT04742556|566244657|FG000|Overall Study|Adverse Event|0|||
156860082|NCT04742556|566244658|FG001|Overall Study|Adverse Event|0|||
156860083|NCT04742556|566244659|FG002|Overall Study|Adverse Event|2|||
156860084|NCT04742556|566244657|FG000|Overall Study|Clinical disease progression|0|||
156860085|NCT04742556|566244658|FG001|Overall Study|Clinical disease progression|1|||
156860086|NCT04742556|566244659|FG002|Overall Study|Clinical disease progression|2|||
156860087|NCT04742556|566244657|FG000|Overall Study|Objective disease progression|3|||
156860088|NCT04742556|566244658|FG001|Overall Study|Objective disease progression|2|||
156860089|NCT04742556|566244659|FG002|Overall Study|Objective disease progression|4|||
156860090|NCT04247347|566244660|FG000|Overall Study|Withdrawal by Subject|2|||
156860091|NCT04247347|566244661|FG001|Overall Study|Withdrawal by Subject|3|||
156860092|NCT04247347|566244662|FG002|Overall Study|Withdrawal by Subject|3|||
156860093|NCT04247347|566244660|FG000|Overall Study|Lost to Follow-up|1|||
156860094|NCT04247347|566244661|FG001|Overall Study|Lost to Follow-up|1|||
156860095|NCT04247347|566244662|FG002|Overall Study|Lost to Follow-up|1|||
156860096|NCT03035032|566244663|FG000|Overall Study|Adverse Event|2|||
156860097|NCT03035032|566244663|FG000|Overall Study|Death|9|||
156860098|NCT03035032|566244663|FG000|Overall Study|Lost to Follow-up|1|||
156860099|NCT03035032|566244663|FG000|Overall Study|Progressive Disease|22|||
156860100|NCT03035032|566244663|FG000|Overall Study|Protocol Violation|2|||
156860101|NCT03035032|566244663|FG000|Overall Study|Withdrawal by Subject|2|||
156860102|NCT03035032|566244663|FG000|Overall Study|Physician Decision|5|||
156860103|NCT01089504|566244669|FG000|Overall Study|Lost to Follow-up|1|||
156860104|NCT01089504|566244670|FG001|Overall Study|Lost to Follow-up|1|||
156860105|NCT01089504|566244669|FG000|Overall Study|Withdrawal by Subject|2|||
156860106|NCT01089504|566244670|FG001|Overall Study|Withdrawal by Subject|0|||
156860107|NCT03448406|566244671|FG000|Overall Study|Noncompliance of scheduled visits|1|||
156860108|NCT03448406|566244672|FG001|Overall Study|Noncompliance of scheduled visits|2|||
156343666|NCT00299104|564358450|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
156343667|NCT02042183|564358452|FG000|Overall Study|Physician Decision|7|||
156343668|NCT02042183|564358453|FG001|Overall Study|Physician Decision|2|||
156343669|NCT02042183|564358452|FG000|Overall Study|Lack of Efficacy|4|||
156343670|NCT02042183|564358453|FG001|Overall Study|Lack of Efficacy|3|||
156343671|NCT02042183|564358452|FG000|Overall Study|Non-compliance with Study Drug|2|||
156343672|NCT02042183|564358453|FG001|Overall Study|Non-compliance with Study Drug|3|||
156343673|NCT02042183|564358452|FG000|Overall Study|Adverse Event|17|||
156343674|NCT02042183|564358453|FG001|Overall Study|Adverse Event|6|||
156343675|NCT02042183|564358452|FG000|Overall Study|Other|3|||
156343676|NCT02042183|564358453|FG001|Overall Study|Other|3|||
156343677|NCT02042183|564358452|FG000|Overall Study|Withdrawal by Subject|21|||
156343678|NCT02042183|564358453|FG001|Overall Study|Withdrawal by Subject|16|||
156343679|NCT02042183|564358452|FG000|Overall Study|Site Terminated by Sponsor|2|||
156343680|NCT02042183|564358453|FG001|Overall Study|Site Terminated by Sponsor|1|||
156343681|NCT02042183|564358452|FG000|Overall Study|Lost to Follow-up|9|||
156474920|NCT01972776|564834176|FG005|Part 1|Adverse Event|0|||
156474921|NCT01972776|564834171|FG000|Part 2|Adverse Event|0|||
156474922|NCT01972776|564834172|FG001|Part 2|Adverse Event|0|||
156474923|NCT01972776|564834173|FG002|Part 2|Adverse Event|0|||
156474924|NCT01972776|564834174|FG003|Part 2|Adverse Event|0|||
156474925|NCT01972776|564834175|FG004|Part 2|Adverse Event|3|||
156474926|NCT01972776|564834176|FG005|Part 2|Adverse Event|0|||
156474927|NCT01972776|564834171|FG000|Part 2|Administrative problems|0|||
156343682|NCT02042183|564358453|FG001|Overall Study|Lost to Follow-up|2|||
156343683|NCT02321800|564358454|FG000|Overall Study|Withdrawal by Subject|3|||
156343684|NCT02321800|564358455|FG001|Overall Study|Withdrawal by Subject|3|||
156343685|NCT02321800|564358454|FG000|Overall Study|Death|1|||
156343686|NCT02321800|564358455|FG001|Overall Study|Death|0|||
156343687|NCT02321800|564358454|FG000|Overall Study|Protocol Violation|1|||
156474928|NCT01972776|564834172|FG001|Part 2|Administrative problems|0|||
156474929|NCT01972776|564834173|FG002|Part 2|Administrative problems|0|||
156343688|NCT02321800|564358455|FG001|Overall Study|Protocol Violation|0|||
156474930|NCT01972776|564834174|FG003|Part 2|Administrative problems|0|||
156474931|NCT01972776|564834175|FG004|Part 2|Administrative problems|10|||
156474932|NCT01972776|564834176|FG005|Part 2|Administrative problems|7|||
156474933|NCT01228734|564834180|FG000|Overall Study|Randomized, but not treated|0|||
156474934|NCT01228734|564834181|FG001|Overall Study|Randomized, but not treated|4|||
156474935|NCT02382640|564834187|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
156474936|NCT02382640|564834188|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
156474937|NCT02382640|564834189|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
156474938|NCT02382640|564834190|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
156474939|NCT01543204|564834191|FG000|Overall Study|Non-compliance|1|||
156474940|NCT01543204|564834191|FG000|Overall Study|Adverse Event|1|||
156474941|NCT01543204|564834191|FG000|Overall Study|Withdrawal by Subject|4|||
156474942|NCT01543204|564834191|FG000|Overall Study|Requirement for Alternative Therapy|1|||
156474943|NCT01543204|564834191|FG000|Overall Study|Lost to Follow-up|1|||
156343689|NCT02321800|564358454|FG000|Overall Study|Lost to Follow-up|10|||
156474944|NCT00721734|564834194|FG000|Overall Study|Progressive Disease|3|||
156474945|NCT00721734|564834195|FG001|Overall Study|Progressive Disease|10|||
156474946|NCT00721734|564834196|FG002|Overall Study|Progressive Disease|4|||
156343690|NCT02321800|564358455|FG001|Overall Study|Lost to Follow-up|4|||
156474947|NCT00721734|564834197|FG003|Overall Study|Progressive Disease|5|||
156474948|NCT00721734|564834198|FG004|Overall Study|Progressive Disease|2|||
156474949|NCT00721734|564834194|FG000|Overall Study|Adverse Event|3|||
156474950|NCT00721734|564834195|FG001|Overall Study|Adverse Event|1|||
156474951|NCT00721734|564834196|FG002|Overall Study|Adverse Event|4|||
156474952|NCT00721734|564834197|FG003|Overall Study|Adverse Event|0|||
156474953|NCT00721734|564834198|FG004|Overall Study|Adverse Event|3|||
156474954|NCT00721734|564834194|FG000|Overall Study|Withdrawal by Subject|2|||
156474955|NCT00721734|564834195|FG001|Overall Study|Withdrawal by Subject|1|||
156474956|NCT00721734|564834196|FG002|Overall Study|Withdrawal by Subject|0|||
156474957|NCT00721734|564834197|FG003|Overall Study|Withdrawal by Subject|0|||
156474958|NCT00721734|564834198|FG004|Overall Study|Withdrawal by Subject|1|||
156474959|NCT00721734|564834194|FG000|Overall Study|Other|0|||
156474960|NCT00721734|564834195|FG001|Overall Study|Other|0|||
156474961|NCT00721734|564834196|FG002|Overall Study|Other|0|||
156474962|NCT00721734|564834197|FG003|Overall Study|Other|1|||
156474963|NCT00721734|564834198|FG004|Overall Study|Other|0|||
156474964|NCT03162614|564834199|FG000|Overall Study|Lost to Follow-up|2|||
156474965|NCT03162614|564834200|FG001|Overall Study|Lost to Follow-up|1|||
156474966|NCT03162614|564834201|FG002|Overall Study|Lost to Follow-up|1|||
156474967|NCT03162614|564834202|FG003|Overall Study|Lost to Follow-up|1|||
156474968|NCT03162614|564834203|FG004|Overall Study|Lost to Follow-up|2|||
156474969|NCT03162614|564834204|FG005|Overall Study|Lost to Follow-up|0|||
156474970|NCT03162614|564834199|FG000|Overall Study|Protocol Violation|0|||
156474971|NCT03162614|564834200|FG001|Overall Study|Protocol Violation|1|||
156474972|NCT03162614|564834201|FG002|Overall Study|Protocol Violation|0|||
156474973|NCT03162614|564834202|FG003|Overall Study|Protocol Violation|1|||
156474974|NCT03162614|564834203|FG004|Overall Study|Protocol Violation|0|||
156474975|NCT03162614|564834204|FG005|Overall Study|Protocol Violation|0|||
156474976|NCT03162614|564834199|FG000|Overall Study|Withdrawal by Subject|2|||
156474977|NCT03162614|564834200|FG001|Overall Study|Withdrawal by Subject|1|||
156474978|NCT03162614|564834201|FG002|Overall Study|Withdrawal by Subject|1|||
156474979|NCT03162614|564834202|FG003|Overall Study|Withdrawal by Subject|1|||
156474980|NCT03162614|564834203|FG004|Overall Study|Withdrawal by Subject|0|||
156474981|NCT03162614|564834204|FG005|Overall Study|Withdrawal by Subject|0|||
156474982|NCT03162614|564834199|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
156474983|NCT03162614|564834200|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
156474984|NCT03162614|564834201|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
156474985|NCT03162614|564834202|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
156474986|NCT03162614|564834203|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
156474987|NCT03162614|564834204|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
156474988|NCT03861234|564834205|FG000|Overall Study|Not treated|0|||
156474989|NCT03861234|564834206|FG001|Overall Study|Not treated|0|||
156474990|NCT03861234|564834207|FG002|Overall Study|Not treated|0|||
156474991|NCT03861234|564834208|FG003|Overall Study|Not treated|0|||
156474992|NCT03861234|564834209|FG004|Overall Study|Not treated|0|||
156474993|NCT03861234|564834210|FG005|Overall Study|Not treated|1|||
156474994|NCT03861234|564834211|FG006|Overall Study|Not treated|0|||
156474995|NCT03861234|564834212|FG007|Overall Study|Not treated|0|||
156474996|NCT03861234|564834205|FG000|Overall Study|Adverse Event|0|||
156474997|NCT03861234|564834206|FG001|Overall Study|Adverse Event|0|||
156474998|NCT03861234|564834207|FG002|Overall Study|Adverse Event|0|||
156474999|NCT03861234|564834208|FG003|Overall Study|Adverse Event|0|||
156475000|NCT03861234|564834209|FG004|Overall Study|Adverse Event|0|||
156475001|NCT03861234|564834210|FG005|Overall Study|Adverse Event|1|||
156475002|NCT03861234|564834211|FG006|Overall Study|Adverse Event|0|||
156475003|NCT03861234|564834212|FG007|Overall Study|Adverse Event|0|||
156475004|NCT03861234|564834205|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
156475005|NCT03861234|564834206|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
156475006|NCT03861234|564834207|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
156475007|NCT03861234|564834208|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
156475008|NCT03861234|564834209|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
156475009|NCT03861234|564834210|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
156475010|NCT03861234|564834211|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
156475011|NCT03861234|564834212|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
156475012|NCT03861234|564834205|FG000|Overall Study|As per sponsor decision|0|||
156475013|NCT03861234|564834206|FG001|Overall Study|As per sponsor decision|0|||
156475014|NCT03861234|564834207|FG002|Overall Study|As per sponsor decision|0|||
156475015|NCT03861234|564834208|FG003|Overall Study|As per sponsor decision|0|||
156475016|NCT03861234|564834209|FG004|Overall Study|As per sponsor decision|0|||
156475017|NCT03861234|564834210|FG005|Overall Study|As per sponsor decision|0|||
156475018|NCT03861234|564834211|FG006|Overall Study|As per sponsor decision|1|||
156475019|NCT03861234|564834212|FG007|Overall Study|As per sponsor decision|0|||
156475020|NCT03861234|564834205|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
156475021|NCT03861234|564834206|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
156475022|NCT03861234|564834207|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
156475023|NCT03861234|564834208|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
156475024|NCT03861234|564834209|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
156475025|NCT03861234|564834210|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
156475026|NCT03861234|564834211|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
156475027|NCT03861234|564834212|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
156475028|NCT00621842|564834213|FG000|Overall Study|Adverse Event|6|||
156475029|NCT00621842|564834213|FG000|Overall Study|Withdrawal by Subject|7|||
156475030|NCT00621842|564834213|FG000|Overall Study|Protocol Violation|4|||
156475031|NCT00621842|564834213|FG000|Overall Study|Lack of Efficacy|2|||
156475032|NCT02251652|564834216|FG000|Overall Study|Withdrawal by Subject|1|||
156475033|NCT01074242|564834219|FG000|Overall Study|Case report before date of contract|40|||
156475034|NCT01074242|564834219|FG000|Overall Study|Lost to Follow-up|1|||
156475035|NCT01074242|564834219|FG000|Overall Study|Case report unclear|6|||
156475036|NCT01074242|564834219|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
156475037|NCT01074242|564834219|FG000|Overall Study|Duplicate Case Report Form|5|||
156475038|NCT01957163|564834220|FG000|Overall Study|Adverse Event|5|||
156475039|NCT01957163|564834221|FG001|Overall Study|Adverse Event|2|||
156475040|NCT01957163|564834222|FG002|Overall Study|Adverse Event|4|||
156475041|NCT01957163|564834220|FG000|Overall Study|Lack of Efficacy|5|||
156475042|NCT01957163|564834221|FG001|Overall Study|Lack of Efficacy|4|||
156475043|NCT01957163|564834222|FG002|Overall Study|Lack of Efficacy|9|||
156475044|NCT01957163|564834220|FG000|Overall Study|Protocol Violation|1|||
156475045|NCT01957163|564834221|FG001|Overall Study|Protocol Violation|2|||
156475046|NCT01957163|564834222|FG002|Overall Study|Protocol Violation|0|||
156475047|NCT01957163|564834220|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
156475048|NCT01957163|564834221|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
156475049|NCT01957163|564834222|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
156475050|NCT01957163|564834220|FG000|Overall Study|Lost to Follow-up|0|||
156475051|NCT01957163|564834221|FG001|Overall Study|Lost to Follow-up|1|||
156475052|NCT01957163|564834222|FG002|Overall Study|Lost to Follow-up|0|||
156475053|NCT01957163|564834220|FG000|Overall Study|Withdrawal by Subject|4|||
156475054|NCT01957163|564834221|FG001|Overall Study|Withdrawal by Subject|2|||
156475055|NCT01957163|564834222|FG002|Overall Study|Withdrawal by Subject|4|||
156475056|NCT05169684|564834223|FG000|Overall Study|Adverse Event|1|||
156475057|NCT05169684|564834224|FG001|Overall Study|Adverse Event|3|||
156475058|NCT05169684|564834223|FG000|Overall Study|Physician Decision|0|||
156475059|NCT05169684|564834224|FG001|Overall Study|Physician Decision|1|||
156475060|NCT05169684|564834223|FG000|Overall Study|Progressive Disease|1|||
156475061|NCT05169684|564834224|FG001|Overall Study|Progressive Disease|1|||
156475062|NCT05169684|564834223|FG000|Overall Study|Participant request to discontinue treatment|0|||
156475063|NCT05169684|564834224|FG001|Overall Study|Participant request to discontinue treatment|1|||
156475064|NCT05169684|564834223|FG000|Overall Study|Other Reason|0|||
156475065|NCT05169684|564834224|FG001|Overall Study|Other Reason|1|||
156475066|NCT01668719|564834225|FG000|Phase I|On treatment|1|||
156475067|NCT01668719|564834226|FG001|Phase I|On treatment|0|||
156475068|NCT01668719|564834227|FG002|Phase I|On treatment|0|||
156475069|NCT01668719|564834225|FG000|Phase I|Adverse Event|2|||
156475070|NCT01668719|564834226|FG001|Phase I|Adverse Event|0|||
156475071|NCT01668719|564834227|FG002|Phase I|Adverse Event|0|||
156343691|NCT02321800|564358454|FG000|Overall Study|Adverse Event|2|||
156475072|NCT01668719|564834225|FG000|Phase I|Progression/relapse|1|||
156343692|NCT02321800|564358455|FG001|Overall Study|Adverse Event|3|||
156343693|NCT02321800|564358454|FG000|Overall Study|Other, Miscellaneous|3|||
156475073|NCT01668719|564834226|FG001|Phase I|Progression/relapse|0|||
156475074|NCT01668719|564834227|FG002|Phase I|Progression/relapse|0|||
156475075|NCT01668719|564834225|FG000|Phase I|not protocol specified|2|||
156475076|NCT01668719|564834226|FG001|Phase I|not protocol specified|0|||
156475077|NCT01668719|564834227|FG002|Phase I|not protocol specified|0|||
156475078|NCT01668719|564834225|FG000|Phase II|On treatment|0|||
156475079|NCT01668719|564834226|FG001|Phase II|On treatment|4|||
156475080|NCT01668719|564834227|FG002|Phase II|On treatment|3|||
156475081|NCT01668719|564834225|FG000|Phase II|Adverse Event|0|||
156475082|NCT01668719|564834226|FG001|Phase II|Adverse Event|18|||
156475083|NCT01668719|564834227|FG002|Phase II|Adverse Event|18|||
156475084|NCT01668719|564834225|FG000|Phase II|Refusal unrelated to adverse event|0|||
156475085|NCT01668719|564834226|FG001|Phase II|Refusal unrelated to adverse event|4|||
156475086|NCT01668719|564834227|FG002|Phase II|Refusal unrelated to adverse event|1|||
156475087|NCT01668719|564834225|FG000|Phase II|Progression/relapse|0|||
156475088|NCT01668719|564834226|FG001|Phase II|Progression/relapse|13|||
156475089|NCT01668719|564834227|FG002|Phase II|Progression/relapse|17|||
156475090|NCT01668719|564834225|FG000|Phase II|Death|0|||
156475091|NCT01668719|564834226|FG001|Phase II|Death|0|||
156475092|NCT01668719|564834227|FG002|Phase II|Death|2|||
156475093|NCT01668719|564834225|FG000|Phase II|not protocol specified|0|||
156475094|NCT01668719|564834226|FG001|Phase II|not protocol specified|13|||
156475095|NCT01668719|564834227|FG002|Phase II|not protocol specified|7|||
156475096|NCT03539055|564834228|FG000|Overall Study|Death|4|||
156475097|NCT03539055|564834228|FG000|Overall Study|Lost to Follow-up|1|||
156475098|NCT03539055|564834228|FG000|Overall Study|Withdrawal by Subject|2|||
156475099|NCT03539055|564834228|FG000|Overall Study|Screen Fail|7|||
156475100|NCT03539055|564834228|FG000|Overall Study|Drug Intolerance|2|||
156475101|NCT01321073|564834229|FG000|Overall Study|Did not attempt implant|4|||
156475102|NCT01321073|564834229|FG000|Overall Study|Death|3|||
156343694|NCT02321800|564358455|FG001|Overall Study|Other, Miscellaneous|1|||
156343695|NCT01051323|564358456|FG000|Overall Study|Discontinuation of treatment|103|||
156475103|NCT01638000|564834232|FG000|Overall Study|Randomized but Never Received Drug|7|||
156475104|NCT01638000|564834233|FG001|Overall Study|Randomized but Never Received Drug|10|||
156475105|NCT01638000|564834232|FG000|Overall Study|Adverse Event|14|||
156475106|NCT01638000|564834233|FG001|Overall Study|Adverse Event|16|||
156475107|NCT01638000|564834232|FG000|Overall Study|Lack of Efficacy|5|||
156542328|NCT01147744|565079320|FG001|Overall Study|Sponsor decision to amend protocol|4|||
156343696|NCT01051323|564358456|FG000|Overall Study|Transplantation|28|||
156475108|NCT01638000|564834233|FG001|Overall Study|Lack of Efficacy|6|||
156475109|NCT01638000|564834232|FG000|Overall Study|Protocol Violation|11|||
156475110|NCT01638000|564834233|FG001|Overall Study|Protocol Violation|13|||
156475111|NCT01638000|564834232|FG000|Overall Study|Withdrawal by Subject|21|||
156475112|NCT01638000|564834233|FG001|Overall Study|Withdrawal by Subject|24|||
156475113|NCT01638000|564834232|FG000|Overall Study|Miscellaneous|2|||
156475114|NCT01638000|564834233|FG001|Overall Study|Miscellaneous|2|||
156475115|NCT05484661|564834234|FG000|Overall Study|Withdrawal by Subject|1|||
156475116|NCT05484661|564834235|FG001|Overall Study|Withdrawal by Subject|0|||
156475117|NCT00875706|564834236|FG000|Overall Study|Withdrawal by Subject|1|||
156475118|NCT00875706|564834237|FG001|Overall Study|Withdrawal by Subject|0|||
156475119|NCT00875706|564834238|FG002|Overall Study|Withdrawal by Subject|0|||
156475120|NCT03652610|564834239|FG000|Overall Study|Lost to Follow-up|1|||
156475121|NCT03652610|564834240|FG001|Overall Study|Lost to Follow-up|0|||
156475122|NCT03652610|564834239|FG000|Overall Study|Withdrawal by Subject|3|||
156475123|NCT03652610|564834240|FG001|Overall Study|Withdrawal by Subject|5|||
156343697|NCT01051323|564358456|FG000|Overall Study|Dialysis dependency|22|||
156475124|NCT03775213|564834241|FG000|Overall Study|Withdrawal by Subject|51|||
156475125|NCT03775213|564834242|FG001|Overall Study|Withdrawal by Subject|53|||
156475126|NCT03775213|564834241|FG000|Overall Study|Incomplete Survey|7|||
156475127|NCT03775213|564834242|FG001|Overall Study|Incomplete Survey|7|||
156343698|NCT01051323|564358456|FG000|Overall Study|Withdrawal by Subject|13|||
156343699|NCT01051323|564358456|FG000|Overall Study|Lost to Follow-up|31|||
156343700|NCT01051323|564358456|FG000|Overall Study|Death|129|||
156343701|NCT01051323|564358456|FG000|Overall Study|Hospitalization|28|||
156343702|NCT01051323|564358456|FG000|Overall Study|Other|148|||
156343703|NCT01051323|564358456|FG000|Overall Study|Missing|37|||
156343704|NCT04171531|564358460|FG000|Overall Study|Lost to Follow-up|4|||
156343705|NCT04171531|564358461|FG001|Overall Study|Lost to Follow-up|5|||
156343706|NCT04171531|564358460|FG000|Overall Study|Consent only through 6 months|1|||
156343707|NCT04171531|564358461|FG001|Overall Study|Consent only through 6 months|1|||
156343708|NCT04171531|564358460|FG000|Overall Study|Insurance did not cover procedure|0|||
156475128|NCT00786188|564834243|FG000|Overall Study|Adverse Event|3|||
156475129|NCT00786188|564834244|FG001|Overall Study|Adverse Event|1|||
156475130|NCT00786188|564834243|FG000|Overall Study|Withdrawal by Subject|2|||
156475131|NCT00786188|564834244|FG001|Overall Study|Withdrawal by Subject|0|||
156475132|NCT00326183|564834245|FG000|Overall Study|Lost to Follow-up|104|||
156475133|NCT00326183|564834246|FG001|Overall Study|Lost to Follow-up|56|||
156475134|NCT00326183|564834245|FG000|Overall Study|Protocol Violation|6|||
156475135|NCT00326183|564834246|FG001|Overall Study|Protocol Violation|3|||
156475136|NCT00326183|564834245|FG000|Overall Study|Withdrawal by Subject|35|||
156475137|NCT00326183|564834246|FG001|Overall Study|Withdrawal by Subject|7|||
156475138|NCT00326183|564834245|FG000|Overall Study|Subject Moved|7|||
156475139|NCT00326183|564834246|FG001|Overall Study|Subject Moved|4|||
156475140|NCT00326183|564834245|FG000|Overall Study|Other|47|||
156475141|NCT00326183|564834246|FG001|Overall Study|Other|13|||
156475142|NCT00326183|564834245|FG000|Overall Study|Adverse Event|1|||
156475143|NCT00326183|564834246|FG001|Overall Study|Adverse Event|0|||
156475144|NCT00570505|564834251|FG000|Overall Study|Adverse Event|7|||
156343709|NCT04171531|564358461|FG001|Overall Study|Insurance did not cover procedure|1|||
156343710|NCT04171531|564358460|FG000|Overall Study|Physician Decision|0|||
156343711|NCT04171531|564358461|FG001|Overall Study|Physician Decision|3|||
156343712|NCT04171531|564358460|FG000|Overall Study|Withdrawal by Subject|1|||
156343713|NCT04171531|564358461|FG001|Overall Study|Withdrawal by Subject|5|||
156343714|NCT02099708|564358463|FG000|Overall Study|Data Not Available|30|||
156343715|NCT02099708|564358463|FG000|Overall Study|Lost to Follow-up|141|||
156343716|NCT02099708|564358463|FG000|Overall Study|Other|29|||
156475145|NCT00570505|564834251|FG000|Overall Study|Withdrawal by Subject|7|||
156475146|NCT00570505|564834251|FG000|Overall Study|Lost to Follow-up|23|||
156475147|NCT00570505|564834251|FG000|Overall Study|Other loss to follow-up|4|||
156475148|NCT02334215|564834254|FG000|Overall Study|Death|1|||
156475149|NCT02334215|564834255|FG001|Overall Study|Death|1|||
156475150|NCT02334215|564834256|FG002|Overall Study|Death|0|||
156475151|NCT02334215|564834254|FG000|Overall Study|Lost to Follow-up|1|||
156475152|NCT02334215|564834255|FG001|Overall Study|Lost to Follow-up|0|||
156475153|NCT02334215|564834256|FG002|Overall Study|Lost to Follow-up|4|||
156475154|NCT02334215|564834254|FG000|Overall Study|Withdrawal by Subject|2|||
156475155|NCT02334215|564834255|FG001|Overall Study|Withdrawal by Subject|2|||
156343717|NCT01658072|564358471|FG000|Overall Study|Protocol Violation|4|||
156475156|NCT02334215|564834256|FG002|Overall Study|Withdrawal by Subject|1|||
156475157|NCT02334215|564834254|FG000|Overall Study|Not released from incarceration on time|3|||
156475158|NCT02334215|564834255|FG001|Overall Study|Not released from incarceration on time|3|||
156475159|NCT02334215|564834256|FG002|Overall Study|Not released from incarceration on time|3|||
156475160|NCT02334215|564834254|FG000|Overall Study|Incarcerated|0|||
156475161|NCT02334215|564834255|FG001|Overall Study|Incarcerated|0|||
156475162|NCT02334215|564834256|FG002|Overall Study|Incarcerated|7|||
156475163|NCT05865392|564834259|FG000|Overall Study|Withdrawal by Subject|4|||
156343718|NCT01658072|564358472|FG001|Overall Study|Protocol Violation|2|||
156343719|NCT00040664|564358473|FG000|Overall Study|Adverse Event|12|||
156343720|NCT00040664|564358474|FG001|Overall Study|Adverse Event|3|||
156343721|NCT00040664|564358475|FG002|Overall Study|Adverse Event|2|||
156343722|NCT00040664|564358476|FG003|Overall Study|Adverse Event|7|||
156343723|NCT00040664|564358473|FG000|Overall Study|Lack of Efficacy|9|||
156343724|NCT00040664|564358474|FG001|Overall Study|Lack of Efficacy|2|||
156343725|NCT00040664|564358475|FG002|Overall Study|Lack of Efficacy|3|||
156343726|NCT00040664|564358476|FG003|Overall Study|Lack of Efficacy|4|||
156343727|NCT00040664|564358473|FG000|Overall Study|Insufficient CD4 response|1|||
156343728|NCT00040664|564358474|FG001|Overall Study|Insufficient CD4 response|0|||
156343729|NCT00040664|564358475|FG002|Overall Study|Insufficient CD4 response|1|||
156343730|NCT00040664|564358476|FG003|Overall Study|Insufficient CD4 response|0|||
156343731|NCT00040664|564358473|FG000|Overall Study|Lost to Follow-up|4|||
156343732|NCT00040664|564358474|FG001|Overall Study|Lost to Follow-up|2|||
156343733|NCT00040664|564358475|FG002|Overall Study|Lost to Follow-up|0|||
156343734|NCT00040664|564358476|FG003|Overall Study|Lost to Follow-up|2|||
156343735|NCT00040664|564358473|FG000|Overall Study|Protocol Violation|2|||
156343736|NCT00040664|564358474|FG001|Overall Study|Protocol Violation|1|||
156343737|NCT00040664|564358475|FG002|Overall Study|Protocol Violation|0|||
156343738|NCT00040664|564358476|FG003|Overall Study|Protocol Violation|1|||
156343739|NCT00040664|564358473|FG000|Overall Study|Withdrawal by Subject|7|||
156343740|NCT00040664|564358474|FG001|Overall Study|Withdrawal by Subject|0|||
156343741|NCT00040664|564358475|FG002|Overall Study|Withdrawal by Subject|3|||
156343742|NCT00040664|564358476|FG003|Overall Study|Withdrawal by Subject|4|||
156343743|NCT00040664|564358473|FG000|Overall Study|Pregnancy|3|||
156343744|NCT00040664|564358474|FG001|Overall Study|Pregnancy|0|||
156343745|NCT00040664|564358475|FG002|Overall Study|Pregnancy|0|||
156343746|NCT00040664|564358476|FG003|Overall Study|Pregnancy|3|||
156343747|NCT00040664|564358473|FG000|Overall Study|Medication adherence/compliance problems|8|||
156343748|NCT00040664|564358474|FG001|Overall Study|Medication adherence/compliance problems|2|||
156343749|NCT00040664|564358475|FG002|Overall Study|Medication adherence/compliance problems|1|||
156343750|NCT00040664|564358476|FG003|Overall Study|Medication adherence/compliance problems|5|||
156343751|NCT00040664|564358473|FG000|Overall Study|Poor taste|2|||
156343752|NCT00040664|564358474|FG001|Overall Study|Poor taste|0|||
156343753|NCT00040664|564358475|FG002|Overall Study|Poor taste|2|||
156343754|NCT00040664|564358476|FG003|Overall Study|Poor taste|0|||
156343755|NCT00040664|564358473|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
156343756|NCT00040664|564358474|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
156343757|NCT00040664|564358475|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
156343758|NCT00040664|564358476|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
156343759|NCT00040664|564358473|FG000|Overall Study|Change of formulation|2|||
156343760|NCT00040664|564358474|FG001|Overall Study|Change of formulation|2|||
156343761|NCT00040664|564358475|FG002|Overall Study|Change of formulation|0|||
156343762|NCT00040664|564358476|FG003|Overall Study|Change of formulation|0|||
156343763|NCT00040664|564358473|FG000|Overall Study|Non-viability of oral suspension|1|||
156343764|NCT00040664|564358474|FG001|Overall Study|Non-viability of oral suspension|0|||
156343765|NCT00040664|564358475|FG002|Overall Study|Non-viability of oral suspension|1|||
156343766|NCT00040664|564358476|FG003|Overall Study|Non-viability of oral suspension|0|||
156343767|NCT01709162|564358477|FG000|Overall Study|Disease progression|3|||
156343768|NCT01709162|564358478|FG001|Overall Study|Disease progression|3|||
156343769|NCT01709162|564358477|FG000|Overall Study|Study drug toxicity|2|||
156343770|NCT01709162|564358478|FG001|Overall Study|Study drug toxicity|0|||
156343771|NCT01709162|564358477|FG000|Overall Study|Administrative reason by sponsor|0|||
156343772|NCT01709162|564358478|FG001|Overall Study|Administrative reason by sponsor|1|||
156343773|NCT01709162|564358477|FG000|Overall Study|Other|1|||
156343774|NCT01709162|564358478|FG001|Overall Study|Other|0|||
156343775|NCT01709162|564358477|FG000|Overall Study|Withdrawal by Subject|0|||
156343776|NCT01709162|564358478|FG001|Overall Study|Withdrawal by Subject|1|||
156343777|NCT00799422|564358483|FG000|First Week of Wear|Lost to Follow-up|0|||
156343778|NCT00799422|564358484|FG001|First Week of Wear|Lost to Follow-up|0|||
156475164|NCT05865392|564834260|FG001|Overall Study|Withdrawal by Subject|0|||
156475165|NCT05865392|564834259|FG000|Overall Study|Didn't meet inclusion criteria|4|||
156475166|NCT05865392|564834260|FG001|Overall Study|Didn't meet inclusion criteria|0|||
156475167|NCT02159989|564834261|FG000|Overall Study|Adverse Event|1|||
156475168|NCT02159989|564834262|FG001|Overall Study|Adverse Event|0|||
156475169|NCT02159989|564834263|FG002|Overall Study|Adverse Event|0|||
156475170|NCT02159989|564834264|FG003|Overall Study|Adverse Event|0|||
156475171|NCT02159989|564834265|FG004|Overall Study|Adverse Event|1|||
156475172|NCT02159989|564834266|FG005|Overall Study|Adverse Event|0|||
156475173|NCT02159989|564834267|FG006|Overall Study|Adverse Event|1|||
156475174|NCT02159989|564834268|FG007|Overall Study|Adverse Event|2|||
156475175|NCT02159989|564834269|FG008|Overall Study|Adverse Event|0|||
156475176|NCT02159989|564834270|FG009|Overall Study|Adverse Event|2|||
156475177|NCT02159989|564834271|FG010|Overall Study|Adverse Event|1|||
156475178|NCT02159989|564834261|FG000|Overall Study|Death|0|||
156475179|NCT02159989|564834262|FG001|Overall Study|Death|0|||
156475180|NCT02159989|564834263|FG002|Overall Study|Death|0|||
156475181|NCT02159989|564834264|FG003|Overall Study|Death|0|||
156475182|NCT02159989|564834265|FG004|Overall Study|Death|0|||
156475183|NCT02159989|564834266|FG005|Overall Study|Death|0|||
156475184|NCT02159989|564834267|FG006|Overall Study|Death|0|||
156475185|NCT02159989|564834268|FG007|Overall Study|Death|0|||
156475186|NCT02159989|564834269|FG008|Overall Study|Death|0|||
156475187|NCT02159989|564834270|FG009|Overall Study|Death|0|||
156475188|NCT02159989|564834271|FG010|Overall Study|Death|1|||
156475189|NCT02159989|564834261|FG000|Overall Study|Lack of Efficacy|2|||
156475190|NCT02159989|564834262|FG001|Overall Study|Lack of Efficacy|3|||
156475191|NCT02159989|564834263|FG002|Overall Study|Lack of Efficacy|3|||
156475192|NCT02159989|564834264|FG003|Overall Study|Lack of Efficacy|0|||
156475193|NCT02159989|564834265|FG004|Overall Study|Lack of Efficacy|2|||
156475194|NCT02159989|564834266|FG005|Overall Study|Lack of Efficacy|3|||
156475195|NCT02159989|564834267|FG006|Overall Study|Lack of Efficacy|3|||
156475196|NCT02159989|564834268|FG007|Overall Study|Lack of Efficacy|1|||
156343779|NCT00799422|564358485|FG002|First Week of Wear|Lost to Follow-up|1|||
156475197|NCT02159989|564834269|FG008|Overall Study|Lack of Efficacy|3|||
156475198|NCT02159989|564834270|FG009|Overall Study|Lack of Efficacy|6|||
156475199|NCT02159989|564834271|FG010|Overall Study|Lack of Efficacy|7|||
156475200|NCT02159989|564834261|FG000|Overall Study|Lost to Follow-up|0|||
156475201|NCT02159989|564834262|FG001|Overall Study|Lost to Follow-up|0|||
156475202|NCT02159989|564834263|FG002|Overall Study|Lost to Follow-up|0|||
156475203|NCT02159989|564834264|FG003|Overall Study|Lost to Follow-up|1|||
156343780|NCT00799422|564358486|FG003|First Week of Wear|Lost to Follow-up|0|||
156475204|NCT02159989|564834265|FG004|Overall Study|Lost to Follow-up|0|||
156475205|NCT02159989|564834266|FG005|Overall Study|Lost to Follow-up|0|||
156475206|NCT02159989|564834267|FG006|Overall Study|Lost to Follow-up|0|||
156475207|NCT02159989|564834268|FG007|Overall Study|Lost to Follow-up|0|||
156475208|NCT02159989|564834269|FG008|Overall Study|Lost to Follow-up|0|||
156475209|NCT02159989|564834270|FG009|Overall Study|Lost to Follow-up|0|||
156475210|NCT02159989|564834271|FG010|Overall Study|Lost to Follow-up|1|||
156475211|NCT02159989|564834261|FG000|Overall Study|Withdrawal by Subject|2|||
156475212|NCT02159989|564834262|FG001|Overall Study|Withdrawal by Subject|0|||
156475213|NCT02159989|564834263|FG002|Overall Study|Withdrawal by Subject|0|||
156475214|NCT02159989|564834264|FG003|Overall Study|Withdrawal by Subject|2|||
156475215|NCT02159989|564834265|FG004|Overall Study|Withdrawal by Subject|1|||
156475216|NCT02159989|564834266|FG005|Overall Study|Withdrawal by Subject|0|||
156475217|NCT02159989|564834267|FG006|Overall Study|Withdrawal by Subject|3|||
156475218|NCT02159989|564834268|FG007|Overall Study|Withdrawal by Subject|1|||
156475219|NCT02159989|564834269|FG008|Overall Study|Withdrawal by Subject|0|||
156475220|NCT02159989|564834270|FG009|Overall Study|Withdrawal by Subject|0|||
156475221|NCT02159989|564834271|FG010|Overall Study|Withdrawal by Subject|0|||
156475222|NCT02159989|564834261|FG000|Overall Study|New treatment|0|||
156475223|NCT02159989|564834262|FG001|Overall Study|New treatment|1|||
156475224|NCT02159989|564834263|FG002|Overall Study|New treatment|0|||
156475225|NCT02159989|564834264|FG003|Overall Study|New treatment|0|||
156475226|NCT02159989|564834265|FG004|Overall Study|New treatment|0|||
156475227|NCT02159989|564834266|FG005|Overall Study|New treatment|0|||
156475228|NCT02159989|564834267|FG006|Overall Study|New treatment|0|||
156475229|NCT02159989|564834268|FG007|Overall Study|New treatment|0|||
156475230|NCT02159989|564834269|FG008|Overall Study|New treatment|0|||
156475231|NCT02159989|564834270|FG009|Overall Study|New treatment|0|||
156475232|NCT02159989|564834271|FG010|Overall Study|New treatment|0|||
156475233|NCT02159989|564834261|FG000|Overall Study|Insurance Issues|0|||
156475234|NCT02159989|564834262|FG001|Overall Study|Insurance Issues|0|||
156475235|NCT02159989|564834263|FG002|Overall Study|Insurance Issues|0|||
156475236|NCT02159989|564834264|FG003|Overall Study|Insurance Issues|0|||
156475237|NCT02159989|564834265|FG004|Overall Study|Insurance Issues|0|||
156475238|NCT02159989|564834266|FG005|Overall Study|Insurance Issues|0|||
156475239|NCT02159989|564834267|FG006|Overall Study|Insurance Issues|0|||
156475240|NCT02159989|564834268|FG007|Overall Study|Insurance Issues|0|||
156475241|NCT02159989|564834269|FG008|Overall Study|Insurance Issues|0|||
156475242|NCT02159989|564834270|FG009|Overall Study|Insurance Issues|1|||
156475243|NCT02159989|564834271|FG010|Overall Study|Insurance Issues|0|||
156475244|NCT02485925|564834279|FG000|Overall Study|Withdrawal by Subject|3|||
156475245|NCT02485925|564834279|FG000|Overall Study|Death|1|||
156475246|NCT02485925|564834279|FG000|Overall Study|Lost to Follow-up|11|||
156475247|NCT02969356|564834280|FG000|Overall Study|Adverse Event|7|||
156542329|NCT01147744|565079321|FG002|Overall Study|Sponsor decision to amend protocol|2|||
156343781|NCT00799422|564358487|FG004|First Week of Wear|Lost to Follow-up|0|||
156343782|NCT00799422|564358488|FG005|First Week of Wear|Lost to Follow-up|0|||
156343783|NCT00799422|564358483|FG000|First Week of Wear|Adverse Event|0|||
156343784|NCT00799422|564358484|FG001|First Week of Wear|Adverse Event|0|||
156343785|NCT00799422|564358485|FG002|First Week of Wear|Adverse Event|0|||
156343786|NCT00799422|564358486|FG003|First Week of Wear|Adverse Event|1|||
156343787|NCT00799422|564358487|FG004|First Week of Wear|Adverse Event|0|||
156343788|NCT00799422|564358488|FG005|First Week of Wear|Adverse Event|0|||
156343789|NCT04584645|564358489|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
156475248|NCT02969356|564834280|FG000|Overall Study|Consent withdrawn|2|||
156475249|NCT02969356|564834280|FG000|Overall Study|Lost to Follow-up|3|||
156475250|NCT02969356|564834280|FG000|Overall Study|Did not need to be reinjected|6|||
156475251|NCT02969356|564834280|FG000|Overall Study|Personal reasons|5|||
156475252|NCT04924608|564835515|FG000|Overall Study|Adverse Event|10|||
156475253|NCT04924608|564835516|FG001|Overall Study|Adverse Event|6|||
156475254|NCT04924608|564835515|FG000|Overall Study|Lost to Follow-up|1|||
156475255|NCT04924608|564835516|FG001|Overall Study|Lost to Follow-up|1|||
156475256|NCT04924608|564835515|FG000|Overall Study|Ongoing at the data cut-off date|54|||
156475257|NCT04924608|564835516|FG001|Overall Study|Ongoing at the data cut-off date|60|||
156475258|NCT04924608|564835515|FG000|Overall Study|Progressive Disease|2|||
156475259|NCT04924608|564835516|FG001|Overall Study|Progressive Disease|0|||
156475260|NCT04924608|564835515|FG000|Overall Study|Withdrawal by Subject|3|||
156475261|NCT04924608|564835516|FG001|Overall Study|Withdrawal by Subject|6|||
156475262|NCT04924608|564835515|FG000|Overall Study|Other reason|1|||
156475263|NCT04924608|564835516|FG001|Overall Study|Other reason|1|||
156475264|NCT01276509|564835517|FG000|Overall Study|Adverse Event|9|||
156475265|NCT01276509|564835518|FG001|Overall Study|Adverse Event|8|||
156475266|NCT01276509|564835519|FG002|Overall Study|Adverse Event|4|||
156475267|NCT01276509|564835520|FG003|Overall Study|Adverse Event|3|||
156475268|NCT01276509|564835517|FG000|Overall Study|Lack of Efficacy|2|||
156475269|NCT01276509|564835518|FG001|Overall Study|Lack of Efficacy|1|||
156475270|NCT01276509|564835519|FG002|Overall Study|Lack of Efficacy|1|||
156475271|NCT01276509|564835520|FG003|Overall Study|Lack of Efficacy|2|||
156475272|NCT01276509|564835517|FG000|Overall Study|Pregnancy|1|||
156475273|NCT01276509|564835518|FG001|Overall Study|Pregnancy|0|||
156475274|NCT01276509|564835519|FG002|Overall Study|Pregnancy|0|||
156475275|NCT01276509|564835520|FG003|Overall Study|Pregnancy|0|||
156475276|NCT01276509|564835517|FG000|Overall Study|Withdrawal by Subject|1|||
156475277|NCT01276509|564835518|FG001|Overall Study|Withdrawal by Subject|2|||
156475278|NCT01276509|564835519|FG002|Overall Study|Withdrawal by Subject|0|||
156475279|NCT01276509|564835520|FG003|Overall Study|Withdrawal by Subject|0|||
156475280|NCT01276509|564835517|FG000|Overall Study|Other|0|||
156475281|NCT01276509|564835518|FG001|Overall Study|Other|1|||
156475282|NCT01276509|564835519|FG002|Overall Study|Other|0|||
156475283|NCT01276509|564835520|FG003|Overall Study|Other|0|||
156475284|NCT04493424|564835522|FG000|Overall Study|Termination of the trial by the sponsor|89|||
156475285|NCT04493424|564835522|FG000|Overall Study|Withdrawal by Subject|9|||
156475286|NCT04493424|564835522|FG000|Overall Study|Lost to Follow-up|2|||
156475287|NCT04493424|564835522|FG000|Overall Study|Lack of Efficacy|3|||
156475288|NCT04493424|564835522|FG000|Overall Study|Adverse Event|5|||
156475289|NCT03769090|564835523|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
156475290|NCT03769090|564835524|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
156475291|NCT03769090|564835525|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
156475292|NCT03769090|564835523|FG000|Overall Study|Withdrawal by Subject|52|||
156475293|NCT03769090|564835524|FG001|Overall Study|Withdrawal by Subject|62|||
156475294|NCT03769090|564835525|FG002|Overall Study|Withdrawal by Subject|74|||
156475295|NCT03769090|564835523|FG000|Overall Study|Death|4|||
156475296|NCT03769090|564835524|FG001|Overall Study|Death|2|||
156475297|NCT03769090|564835525|FG002|Overall Study|Death|2|||
156475298|NCT03769090|564835523|FG000|Overall Study|Adverse Event|7|||
156343790|NCT04584645|564358490|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
156343791|NCT03334539|564358493|FG000|Overall Study|Adverse Event|3|||
156343792|NCT03334539|564358494|FG001|Overall Study|Adverse Event|5|||
156343793|NCT03334539|564358495|FG002|Overall Study|Adverse Event|0|||
156343794|NCT03334539|564358493|FG000|Overall Study|Withdrawal by Subject|0|||
156343795|NCT03334539|564358494|FG001|Overall Study|Withdrawal by Subject|1|||
156475299|NCT03769090|564835524|FG001|Overall Study|Adverse Event|7|||
156343796|NCT03334539|564358495|FG002|Overall Study|Withdrawal by Subject|1|||
156343797|NCT03334539|564358493|FG000|Overall Study|Administrative Reasons|1|||
156475300|NCT03769090|564835525|FG002|Overall Study|Adverse Event|8|||
156475301|NCT03769090|564835523|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
156475302|NCT03769090|564835524|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
156475303|NCT03769090|564835525|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
156475304|NCT03769090|564835523|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
156475305|NCT03769090|564835524|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
156343798|NCT03334539|564358494|FG001|Overall Study|Administrative Reasons|0|||
156343799|NCT03334539|564358495|FG002|Overall Study|Administrative Reasons|0|||
156343800|NCT03334539|564358493|FG000|Overall Study|Hypertension Not Controlled|0|||
156475306|NCT03769090|564835525|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
156475307|NCT03769090|564835523|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
156343801|NCT03334539|564358494|FG001|Overall Study|Hypertension Not Controlled|1|||
156343802|NCT03334539|564358495|FG002|Overall Study|Hypertension Not Controlled|0|||
156343803|NCT04974697|564358501|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
156343804|NCT04974697|564358501|FG000|Overall Study|Lens discomfort|1|||
156475308|NCT03769090|564835524|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
156475309|NCT03769090|564835525|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
156475310|NCT03769090|564835523|FG000|Overall Study|Protocol Violation|5|||
156475311|NCT03769090|564835524|FG001|Overall Study|Protocol Violation|6|||
156475312|NCT03769090|564835525|FG002|Overall Study|Protocol Violation|8|||
156475313|NCT03769090|564835523|FG000|Overall Study|Pregnancy|1|||
156475314|NCT03769090|564835524|FG001|Overall Study|Pregnancy|0|||
156475315|NCT03769090|564835525|FG002|Overall Study|Pregnancy|3|||
156475316|NCT03769090|564835523|FG000|Overall Study|Lost to Follow-up|19|||
156475317|NCT03769090|564835524|FG001|Overall Study|Lost to Follow-up|25|||
156475318|NCT03769090|564835525|FG002|Overall Study|Lost to Follow-up|21|||
156475319|NCT03769090|564835523|FG000|Overall Study|Condition under investigation worsened|2|||
156475320|NCT03769090|564835524|FG001|Overall Study|Condition under investigation worsened|0|||
156475321|NCT03769090|564835525|FG002|Overall Study|Condition under investigation worsened|1|||
156475322|NCT03769090|564835523|FG000|Overall Study|Lack of Efficacy|1|||
156475323|NCT03769090|564835524|FG001|Overall Study|Lack of Efficacy|2|||
156475324|NCT03769090|564835525|FG002|Overall Study|Lack of Efficacy|2|||
156475325|NCT03769090|564835523|FG000|Overall Study|Other reasons|8|||
156475326|NCT03769090|564835524|FG001|Overall Study|Other reasons|12|||
156475327|NCT03769090|564835525|FG002|Overall Study|Other reasons|15|||
156475328|NCT01190124|564835532|FG000|Overall Study|Death|3|||
156475329|NCT01190124|564835533|FG001|Overall Study|Death|0|||
156475330|NCT01190124|564835534|FG002|Overall Study|Death|0|||
156475331|NCT01190124|564835532|FG000|Overall Study|Therapeutic Failure|12|||
156475332|NCT01190124|564835533|FG001|Overall Study|Therapeutic Failure|0|||
156475333|NCT01190124|564835534|FG002|Overall Study|Therapeutic Failure|1|||
156475334|NCT01190124|564835532|FG000|Overall Study|Lost to Follow-up|2|||
156475335|NCT01190124|564835533|FG001|Overall Study|Lost to Follow-up|0|||
156475336|NCT01190124|564835534|FG002|Overall Study|Lost to Follow-up|0|||
156475337|NCT02713594|564835535|FG000|Overall Study|Withdrawal by Subject|32|||
156475338|NCT02713594|564835536|FG001|Overall Study|Withdrawal by Subject|22|||
156475339|NCT02713594|564835535|FG000|Overall Study|Lost to Follow-up|358|||
156475340|NCT02713594|564835536|FG001|Overall Study|Lost to Follow-up|374|||
156475341|NCT00671853|564835538|FG000|Overall Study|Lack of Efficacy|3|||
156475342|NCT00671853|564835539|FG001|Overall Study|Lack of Efficacy|7|||
156475343|NCT00671853|564835538|FG000|Overall Study|Adverse Event|7|||
156475344|NCT00671853|564835539|FG001|Overall Study|Adverse Event|1|||
156475345|NCT00671853|564835538|FG000|Overall Study|Withdrawal by Subject|1|||
156475346|NCT00671853|564835539|FG001|Overall Study|Withdrawal by Subject|5|||
156475347|NCT00671853|564835538|FG000|Overall Study|Lost to Follow-up|8|||
156475348|NCT00671853|564835539|FG001|Overall Study|Lost to Follow-up|8|||
156475349|NCT00671853|564835538|FG000|Overall Study|Physician Decision|0|||
156475350|NCT00671853|564835539|FG001|Overall Study|Physician Decision|2|||
156475351|NCT00671853|564835538|FG000|Overall Study|Non-adherence with study procedures|1|||
156475352|NCT00671853|564835539|FG001|Overall Study|Non-adherence with study procedures|4|||
156475353|NCT01377844|564835540|FG000|Overall Study|Withdrawal by Subject|25|||
156475354|NCT01377844|564835541|FG001|Overall Study|Withdrawal by Subject|28|||
156475355|NCT01377844|564835540|FG000|Overall Study|Protocol Violation|2|||
156475356|NCT01377844|564835541|FG001|Overall Study|Protocol Violation|3|||
156475357|NCT01377844|564835540|FG000|Overall Study|Adverse Event|3|||
156475358|NCT01377844|564835541|FG001|Overall Study|Adverse Event|0|||
156475359|NCT01377844|564835540|FG000|Overall Study|Physician Decision|6|||
156475360|NCT01377844|564835541|FG001|Overall Study|Physician Decision|3|||
156475361|NCT01377844|564835540|FG000|Overall Study|Study terminated by Sponsor|0|||
156475362|NCT01377844|564835541|FG001|Overall Study|Study terminated by Sponsor|1|||
156475363|NCT01185340|564835545|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
156475364|NCT01185340|564835546|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156475365|NCT01185340|564835547|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156475366|NCT01185340|564835548|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156475367|NCT01185340|564835545|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
156475368|NCT01185340|564835546|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156475369|NCT01185340|564835547|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156475370|NCT01185340|564835548|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156475371|NCT01185340|564835545|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
156475372|NCT01185340|564835546|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156475373|NCT01185340|564835547|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156475374|NCT01185340|564835548|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156475375|NCT01185340|564835545|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
156475376|NCT01185340|564835546|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156475377|NCT01185340|564835547|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156475378|NCT01185340|564835548|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156475379|NCT01185340|564835545|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
156475380|NCT01185340|564835546|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156475381|NCT01185340|564835547|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156475382|NCT01185340|564835548|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156475383|NCT01185340|564835545|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
156475384|NCT01185340|564835546|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156475385|NCT01185340|564835547|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156475386|NCT01185340|564835548|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156475387|NCT01185340|564835545|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
156475388|NCT01185340|564835546|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156475389|NCT01185340|564835547|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156475390|NCT01185340|564835548|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156475391|NCT01185340|564835545|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
156475392|NCT01185340|564835546|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
156475393|NCT01185340|564835547|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
156475394|NCT01185340|564835548|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
156475395|NCT01185340|564835545|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
156475396|NCT01185340|564835546|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
156542330|NCT01147744|565079322|FG003|Overall Study|Sponsor decision to amend protocol|5|||
156542331|NCT01147744|565079323|FG004|Overall Study|Sponsor decision to amend protocol|7|||
156542332|NCT01147744|565079324|FG005|Overall Study|Sponsor decision to amend protocol|2|||
156542333|NCT01147744|565079325|FG006|Overall Study|Sponsor decision to amend protocol|6|||
156542334|NCT01147744|565079319|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156542335|NCT01147744|565079320|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
156542336|NCT01147744|565079321|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
156542337|NCT01147744|565079322|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
156542338|NCT01147744|565079323|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
156542339|NCT01147744|565079324|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156860109|NCT03448406|566244671|FG000|Overall Study|Withdrawal by Subject|1|||
156860110|NCT03448406|566244672|FG001|Overall Study|Withdrawal by Subject|2|||
156860111|NCT03448406|566244671|FG000|Overall Study|Protocol Violation|1|||
156860112|NCT03448406|566244672|FG001|Overall Study|Protocol Violation|0|||
156860113|NCT03448406|566244671|FG000|Overall Study|Adverse Event|8|||
156860114|NCT03448406|566244672|FG001|Overall Study|Adverse Event|9|||
156860115|NCT04602390|566244673|FG000|Overall Study|Withdrawal by Subject|0|||
156860116|NCT04602390|566244674|FG001|Overall Study|Withdrawal by Subject|0|||
156860117|NCT04602390|566244675|FG002|Overall Study|Withdrawal by Subject|0|||
156860118|NCT04602390|566244676|FG003|Overall Study|Withdrawal by Subject|0|||
156860119|NCT04602390|566244677|FG004|Overall Study|Withdrawal by Subject|1|||
156860120|NCT04602390|566244678|FG005|Overall Study|Withdrawal by Subject|0|||
156860121|NCT04602390|566244673|FG000|Overall Study|Adverse Event|0|||
156860122|NCT04602390|566244674|FG001|Overall Study|Adverse Event|0|||
156860123|NCT04602390|566244675|FG002|Overall Study|Adverse Event|0|||
156860124|NCT04602390|566244676|FG003|Overall Study|Adverse Event|0|||
156860125|NCT04602390|566244677|FG004|Overall Study|Adverse Event|0|||
156860126|NCT04602390|566244678|FG005|Overall Study|Adverse Event|1|||
156860127|NCT01176032|566244679|FG000|Overall Study|Adverse Event|1|||
156860128|NCT01176032|566244680|FG001|Overall Study|Adverse Event|0|||
156860129|NCT01176032|566244679|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156860130|NCT01176032|566244680|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156860131|NCT01176032|566244679|FG000|Overall Study|Protocol Violation|1|||
156860132|NCT01176032|566244680|FG001|Overall Study|Protocol Violation|0|||
156860133|NCT01176032|566244679|FG000|Overall Study|Informed consent withdrawn|3|||
156860134|NCT01176032|566244680|FG001|Overall Study|Informed consent withdrawn|0|||
156860135|NCT01176032|566244679|FG000|Overall Study|Other|1|||
156860136|NCT01176032|566244680|FG001|Overall Study|Other|0|||
156860137|NCT00659061|566244682|FG000|Overall Study|Migration due to political unrest|21|||
156860138|NCT00659061|566244683|FG001|Overall Study|Migration due to political unrest|15|||
156860139|NCT01277744|566244692|FG000|Overall Study|Physician Decision|2|||
156860140|NCT02358473|566244700|FG000|Overall Study|Disease Progession|6|||
156860141|NCT02358473|566244700|FG000|Overall Study|Adverse Event|3|||
156860142|NCT02358473|566244700|FG000|Overall Study|Withdrawal by Subject|2|||
156860143|NCT02358473|566244700|FG000|Overall Study|Physician Decision|2|||
156860144|NCT04038359|566244718|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
156860145|NCT04038359|566244719|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
156860146|NCT04038359|566244718|FG000|Overall Study|Death|8|||
156860147|NCT04038359|566244719|FG001|Overall Study|Death|7|||
156860148|NCT04038359|566244718|FG000|Overall Study|Lost to Follow-up|3|||
156860149|NCT04038359|566244719|FG001|Overall Study|Lost to Follow-up|0|||
156860150|NCT04038359|566244718|FG000|Overall Study|Participant Moved|1|||
156860151|NCT04038359|566244719|FG001|Overall Study|Participant Moved|0|||
156860152|NCT04038359|566244718|FG000|Overall Study|Withdrawal by Subject|4|||
156860153|NCT04038359|566244719|FG001|Overall Study|Withdrawal by Subject|3|||
156860154|NCT04038359|566244718|FG000|Overall Study|Physician Decision|3|||
156860155|NCT04038359|566244719|FG001|Overall Study|Physician Decision|2|||
156860156|NCT04038359|566244718|FG000|Overall Study|Adverse Event|0|||
156860157|NCT04038359|566244719|FG001|Overall Study|Adverse Event|2|||
156860158|NCT04038359|566244718|FG000|Overall Study|Progressive Disease|0|||
156860159|NCT04038359|566244719|FG001|Overall Study|Progressive Disease|1|||
156860160|NCT02004236|566244720|FG000|Overall Study|Lack of Efficacy|0|||
156860161|NCT02004236|566244721|FG001|Overall Study|Lack of Efficacy|0|||
156860162|NCT02004236|566244722|FG002|Overall Study|Lack of Efficacy|16|||
156475397|NCT01185340|564835547|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
156860163|NCT01476722|566244724|FG000|Overall Study|Adverse Event|1|||
156860164|NCT00625131|566244730|FG000|Overall Study|Lost to Follow-up|3|||
156860165|NCT00625131|566244731|FG001|Overall Study|Lost to Follow-up|2|||
156860166|NCT00625131|566244732|FG002|Overall Study|Lost to Follow-up|0|||
156860167|NCT00625131|566244730|FG000|Overall Study|Withdrawal by Subject|1|||
156860168|NCT00625131|566244731|FG001|Overall Study|Withdrawal by Subject|0|||
156860169|NCT00625131|566244732|FG002|Overall Study|Withdrawal by Subject|5|||
156860170|NCT00918281|566244736|FG000|Overall Study|Physician Decision|29|||
156860171|NCT02978417|566244739|FG000|Overall Study|Lost to Follow-up|2|||
156475398|NCT01185340|564835548|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
156475399|NCT01185340|564835545|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
156860172|NCT02978417|566244740|FG001|Overall Study|Lost to Follow-up|2|||
156860173|NCT02675907|566244743|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
156860174|NCT02675907|566244744|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
156860175|NCT02675907|566244743|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
156860176|NCT02675907|566244744|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
156860177|NCT02675907|566244743|FG000|Study Overall|Lack of Efficacy|1|||
156860178|NCT02675907|566244744|FG001|Study Overall|Lack of Efficacy|0|||
156860179|NCT02675907|566244743|FG000|Study Overall|Withdrawal by Subject|2|||
156860180|NCT02675907|566244744|FG001|Study Overall|Withdrawal by Subject|2|||
156860181|NCT02675907|566244743|FG000|Study Overall|Lost to Follow-up|0|||
156860182|NCT02675907|566244744|FG001|Study Overall|Lost to Follow-up|2|||
156860183|NCT03416868|566244748|FG000|Overall Study|Withdrawal by Subject|2|||
156860184|NCT03416868|566244748|FG000|Overall Study|Lost to Follow-up|1|||
156860185|NCT03624881|566244749|FG000|Overall Study|Screen Failure|14|||
156860186|NCT03624881|566244750|FG001|Overall Study|Screen Failure|0|||
156860187|NCT03624881|566244749|FG000|Overall Study|No Catheter Inserted|6|||
156860188|NCT03624881|566244750|FG001|Overall Study|No Catheter Inserted|1|||
156860189|NCT03624881|566244749|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
156860190|NCT03624881|566244750|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
156860191|NCT03624881|566244749|FG000|Overall Study|Death|2|||
156860192|NCT03624881|566244750|FG001|Overall Study|Death|0|||
156860193|NCT03624881|566244749|FG000|Overall Study|Lost to Follow-up|10|||
156860194|NCT03624881|566244750|FG001|Overall Study|Lost to Follow-up|4|||
156860195|NCT03624881|566244749|FG000|Overall Study|Withdrawal by Subject|12|||
156860196|NCT03624881|566244750|FG001|Overall Study|Withdrawal by Subject|1|||
156860197|NCT00168844|566244751|FG000|Overall Study|Adverse Event|31|||
156860198|NCT00168844|566244752|FG001|Overall Study|Adverse Event|32|||
156860199|NCT00168844|566244753|FG002|Overall Study|Adverse Event|48|||
156860200|NCT00168844|566244751|FG000|Overall Study|Lost to Follow-up|4|||
156860201|NCT00168844|566244752|FG001|Overall Study|Lost to Follow-up|5|||
156860202|NCT00168844|566244753|FG002|Overall Study|Lost to Follow-up|11|||
156860203|NCT00168844|566244751|FG000|Overall Study|Withdrawal by Subject|12|||
156860204|NCT00168844|566244752|FG001|Overall Study|Withdrawal by Subject|9|||
156860205|NCT00168844|566244753|FG002|Overall Study|Withdrawal by Subject|19|||
156860206|NCT00168844|566244751|FG000|Overall Study|Protocol Violation|2|||
156860207|NCT00168844|566244752|FG001|Overall Study|Protocol Violation|2|||
156860208|NCT00168844|566244753|FG002|Overall Study|Protocol Violation|4|||
156860209|NCT00168844|566244751|FG000|Overall Study|Other|6|||
156343805|NCT03706456|564358502|FG000|Overall Study|Adverse Event|1|||
156860210|NCT00168844|566244752|FG001|Overall Study|Other|7|||
156860211|NCT00168844|566244753|FG002|Overall Study|Other|9|||
156860212|NCT00112736|566244758|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
156860213|NCT00112736|566244759|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
156860214|NCT00004563|566244767|FG000|Overall Study|Withdrawal by Subject|20|||
156860215|NCT00004563|566244768|FG001|Overall Study|Withdrawal by Subject|16|||
156860216|NCT00004563|566244767|FG000|Overall Study|Lack of Efficacy|3|||
156860217|NCT00004563|566244768|FG001|Overall Study|Lack of Efficacy|5|||
156860218|NCT00004563|566244767|FG000|Overall Study|Death|2|||
156860219|NCT00004563|566244768|FG001|Overall Study|Death|3|||
156860220|NCT00849940|566244776|FG000|Overall Study|Physician Decision|4|||
156860221|NCT04258423|566244777|FG000|Overall Study|Study Closure|2|||
156860222|NCT04258423|566244778|FG001|Overall Study|Study Closure|2|||
156860223|NCT02994108|566246678|FG000|Intervention Messages|Withdrawal by Subject|2|||
156860224|NCT02994108|566246679|FG001|Intervention Messages|Withdrawal by Subject|0|||
156860225|NCT02994108|566246678|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
156343806|NCT03706456|564358502|FG000|Overall Study|Lack of Efficacy|2|||
156343807|NCT03708328|564358503|FG000|Overall Study|Death|3|||
156860226|NCT02994108|566246679|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
156860227|NCT02994108|566246678|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
156860228|NCT02994108|566246679|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
156860229|NCT02994108|566246678|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
156860230|NCT02994108|566246679|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
156860231|NCT00089297|566246680|FG000|Overall Study|Adverse Event|9|||
156860232|NCT00089297|566246680|FG000|Overall Study|Death|1|||
156860233|NCT00089297|566246680|FG000|Overall Study|Withdrawal by Subject|12|||
156860234|NCT00089297|566246680|FG000|Overall Study|Disease progression|2|||
156860235|NCT00089297|566246680|FG000|Overall Study|Ineligible|11|||
156860236|NCT00089297|566246680|FG000|Overall Study|Secondary malignancy|1|||
156860237|NCT00089297|566246680|FG000|Overall Study|IRB approval not ready|1|||
156860238|NCT00089297|566246680|FG000|Overall Study|Non-compliance|1|||
156860239|NCT00904969|566246681|FG000|Overall Study|Lost to Follow-up|4|||
156860240|NCT00904969|566246681|FG000|Overall Study|Withdrawal by Subject|3|||
156860241|NCT00904969|566246681|FG000|Overall Study|Additional Treatments|11|||
156860242|NCT00904969|566246681|FG000|Overall Study|Case Aborted; Subject Exited|1|||
156860243|NCT01097668|566246682|FG000|Overall Study|Withdrawal by Subject|1|||
156860244|NCT01097668|566246683|FG001|Overall Study|Withdrawal by Subject|2|||
156860245|NCT01097668|566246682|FG000|Overall Study|Lost to Follow-up|1|||
156860246|NCT01097668|566246683|FG001|Overall Study|Lost to Follow-up|0|||
156860247|NCT00385671|566246684|FG000|Overall Study|Adverse Event|14|||
156860248|NCT00385671|566246685|FG001|Overall Study|Adverse Event|27|||
156860249|NCT00385671|566246686|FG002|Overall Study|Adverse Event|18|||
156860250|NCT00385671|566246684|FG000|Overall Study|Lack of Efficacy|5|||
156860251|NCT00385671|566246685|FG001|Overall Study|Lack of Efficacy|9|||
156860252|NCT00385671|566246686|FG002|Overall Study|Lack of Efficacy|5|||
156860253|NCT00385671|566246684|FG000|Overall Study|Lost to Follow-up|6|||
156475400|NCT01185340|564835546|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
156860254|NCT00385671|566246685|FG001|Overall Study|Lost to Follow-up|6|||
156475401|NCT01185340|564835547|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
156475402|NCT01185340|564835548|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
156475403|NCT01185340|564835545|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156475404|NCT01185340|564835546|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
156475405|NCT01185340|564835547|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156475406|NCT01185340|564835548|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
156475407|NCT01185340|564835545|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
156475408|NCT01185340|564835546|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
156475409|NCT01185340|564835547|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
156475410|NCT01185340|564835548|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
156475411|NCT01185340|564835545|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
156475412|NCT01185340|564835546|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
156475413|NCT01185340|564835547|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
156860255|NCT00385671|566246686|FG002|Overall Study|Lost to Follow-up|5|||
156860256|NCT00385671|566246684|FG000|Overall Study|Physician Decision|2|||
156860257|NCT00385671|566246685|FG001|Overall Study|Physician Decision|1|||
156860258|NCT00385671|566246686|FG002|Overall Study|Physician Decision|2|||
156475414|NCT01185340|564835548|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
156475415|NCT01185340|564835545|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156475416|NCT01185340|564835546|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156860259|NCT00385671|566246684|FG000|Overall Study|Protocol Violation|5|||
156860260|NCT00385671|566246685|FG001|Overall Study|Protocol Violation|2|||
156860261|NCT00385671|566246686|FG002|Overall Study|Protocol Violation|1|||
156860262|NCT00385671|566246684|FG000|Overall Study|Sponsor Decision|2|||
156860263|NCT00385671|566246685|FG001|Overall Study|Sponsor Decision|2|||
156860264|NCT00385671|566246686|FG002|Overall Study|Sponsor Decision|1|||
156860265|NCT00385671|566246684|FG000|Overall Study|Withdrawal by Subject|4|||
156860266|NCT00385671|566246685|FG001|Overall Study|Withdrawal by Subject|4|||
156860267|NCT00385671|566246686|FG002|Overall Study|Withdrawal by Subject|4|||
156860268|NCT01295814|566246687|FG000|Overall Study|Lack of Efficacy|0|||
156860269|NCT01295814|566246688|FG001|Overall Study|Lack of Efficacy|2|||
156860270|NCT01295814|566246687|FG000|Overall Study|Withdrawal by Subject|2|||
156860271|NCT01295814|566246688|FG001|Overall Study|Withdrawal by Subject|0|||
156860272|NCT04515771|566246689|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
156475417|NCT01185340|564835547|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
156860273|NCT04515771|566246690|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
156343808|NCT03708328|564358504|FG001|Overall Study|Death|3|||
156343809|NCT03708328|564358505|FG002|Overall Study|Death|4|||
156343810|NCT03708328|564358506|FG003|Overall Study|Death|2|||
156475418|NCT01185340|564835548|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
156860274|NCT04515771|566246689|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
156860275|NCT04515771|566246690|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
156860276|NCT04515771|566246689|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
156860277|NCT04515771|566246690|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
156860278|NCT00948246|566246694|FG000|Overall Study|Lost to Follow-up|11|||
156860279|NCT00948246|566246694|FG000|Overall Study|Adverse Event|11|||
156860280|NCT00948246|566246694|FG000|Overall Study|Death|1|||
156860281|NCT00948246|566246694|FG000|Overall Study|Withdrawal by Subject|1|||
156860282|NCT00148317|566246695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
156860283|NCT00148317|566246695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
156475419|NCT00667017|564835549|FG000|Overall Study|Withdrawal by Subject|1|||
156475420|NCT01848483|564835550|FG000|Overall Study|Death|2|||
156475421|NCT01848483|564835551|FG001|Overall Study|Death|1|||
156475422|NCT01848483|564835550|FG000|Overall Study|Lost to Follow-up|6|||
156475423|NCT01848483|564835551|FG001|Overall Study|Lost to Follow-up|8|||
156475424|NCT01848483|564835550|FG000|Overall Study|Withdrawal by Subject|1|||
156475425|NCT01848483|564835551|FG001|Overall Study|Withdrawal by Subject|0|||
156860284|NCT00148317|566246695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
156860285|NCT03623243|566246698|FG000|Overall Study|Adverse Event|15|||
156860286|NCT03623243|566246698|FG000|Overall Study|Guardian Decision|1|||
156860287|NCT03623243|566246698|FG000|Overall Study|New Therapy for Study Indication|1|||
156860288|NCT03623243|566246698|FG000|Overall Study|Protocol Deviation|3|||
156860289|NCT03623243|566246698|FG000|Overall Study|Physician Decision|4|||
156860290|NCT03623243|566246698|FG000|Overall Study|Patient Decision|15|||
156860291|NCT00979901|566246702|FG000|Overall Study|Adverse Event|1|||
156860292|NCT00979901|566246703|FG001|Overall Study|Adverse Event|3|||
156860293|NCT00979901|566246704|FG002|Overall Study|Adverse Event|9|||
156860294|NCT00979901|566246705|FG003|Overall Study|Adverse Event|2|||
156860295|NCT00979901|566246702|FG000|Overall Study|Lack of Efficacy|8|||
156860296|NCT00979901|566246703|FG001|Overall Study|Lack of Efficacy|4|||
156860297|NCT00979901|566246704|FG002|Overall Study|Lack of Efficacy|9|||
156860298|NCT00979901|566246705|FG003|Overall Study|Lack of Efficacy|0|||
156860299|NCT00979901|566246702|FG000|Overall Study|Lost to Follow-up|1|||
156860300|NCT00979901|566246703|FG001|Overall Study|Lost to Follow-up|1|||
156860301|NCT00979901|566246704|FG002|Overall Study|Lost to Follow-up|2|||
156860302|NCT00979901|566246705|FG003|Overall Study|Lost to Follow-up|0|||
156860303|NCT00979901|566246702|FG000|Overall Study|Protocol Violation|2|||
156860304|NCT00979901|566246703|FG001|Overall Study|Protocol Violation|2|||
156860305|NCT00979901|566246704|FG002|Overall Study|Protocol Violation|7|||
156860306|NCT00979901|566246705|FG003|Overall Study|Protocol Violation|1|||
156860307|NCT00979901|566246702|FG000|Overall Study|Withdrawal by Subject|2|||
156860308|NCT00979901|566246703|FG001|Overall Study|Withdrawal by Subject|1|||
156860309|NCT00979901|566246704|FG002|Overall Study|Withdrawal by Subject|1|||
156860310|NCT00979901|566246705|FG003|Overall Study|Withdrawal by Subject|1|||
156860311|NCT00979901|566246702|FG000|Overall Study|Noncompliance|1|||
156860312|NCT00979901|566246703|FG001|Overall Study|Noncompliance|0|||
156860313|NCT00979901|566246704|FG002|Overall Study|Noncompliance|0|||
156860314|NCT00979901|566246705|FG003|Overall Study|Noncompliance|0|||
156860315|NCT00979901|566246702|FG000|Overall Study|out-of-state|1|||
156860316|NCT00979901|566246703|FG001|Overall Study|out-of-state|0|||
156860317|NCT00979901|566246704|FG002|Overall Study|out-of-state|0|||
156860318|NCT00979901|566246705|FG003|Overall Study|out-of-state|0|||
156860319|NCT00979901|566246702|FG000|Overall Study|vacation|1|||
156860320|NCT00979901|566246703|FG001|Overall Study|vacation|0|||
156860321|NCT00979901|566246704|FG002|Overall Study|vacation|0|||
156860322|NCT00979901|566246705|FG003|Overall Study|vacation|0|||
156860323|NCT00979901|566246702|FG000|Overall Study|elevated lab values pre-randomization|1|||
156860324|NCT00979901|566246703|FG001|Overall Study|elevated lab values pre-randomization|0|||
156860325|NCT00979901|566246704|FG002|Overall Study|elevated lab values pre-randomization|0|||
156860326|NCT00979901|566246705|FG003|Overall Study|elevated lab values pre-randomization|0|||
156860327|NCT00979901|566246702|FG000|Overall Study|Discontinued in Error|0|||
156860328|NCT00979901|566246703|FG001|Overall Study|Discontinued in Error|1|||
156860329|NCT00979901|566246704|FG002|Overall Study|Discontinued in Error|0|||
156860330|NCT00979901|566246705|FG003|Overall Study|Discontinued in Error|0|||
156860331|NCT00979901|566246702|FG000|Overall Study|Left Country|0|||
156860332|NCT00979901|566246703|FG001|Overall Study|Left Country|0|||
156860333|NCT00979901|566246704|FG002|Overall Study|Left Country|1|||
156860334|NCT00979901|566246705|FG003|Overall Study|Left Country|0|||
156860335|NCT00979901|566246702|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
156860336|NCT00979901|566246703|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
156860337|NCT00979901|566246704|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
156860338|NCT00979901|566246705|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
156860339|NCT03924622|566246706|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
156860340|NCT03924622|566246707|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
156343811|NCT03708328|564358507|FG004|Overall Study|Death|2|||
156475426|NCT01848483|564835550|FG000|Overall Study|Incarceration|2|||
156475427|NCT01848483|564835551|FG001|Overall Study|Incarceration|2|||
156475428|NCT00246129|564835556|FG000|Overall Study|Lost to Follow-up|1|||
156860341|NCT03924622|566246708|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
156343812|NCT03708328|564358508|FG005|Overall Study|Death|13|||
156475429|NCT00246129|564835557|FG001|Overall Study|Lost to Follow-up|0|||
156475430|NCT00246129|564835556|FG000|Overall Study|Death|2|||
156475431|NCT00246129|564835557|FG001|Overall Study|Death|1|||
156475432|NCT00246129|564835556|FG000|Overall Study|suffered primary non-function|1|||
156860342|NCT03924622|566246709|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
156860343|NCT03924622|566246710|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
156860344|NCT03924622|566246711|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
156860345|NCT00248625|566246712|FG000|Overall Study|Withdrawal by Subject|0|||
156860346|NCT00248625|566246713|FG001|Overall Study|Withdrawal by Subject|2|||
156860347|NCT03284710|566246718|FG000|Overall Study|Withdrawal by Subject|1|||
156860348|NCT03284710|566246719|FG001|Overall Study|Withdrawal by Subject|0|||
156860349|NCT03284710|566246720|FG002|Overall Study|Withdrawal by Subject|1|||
156860350|NCT03284710|566246721|FG003|Overall Study|Withdrawal by Subject|6|||
156860351|NCT03284710|566246718|FG000|Overall Study|Lost to Follow-up|3|||
156860352|NCT03284710|566246719|FG001|Overall Study|Lost to Follow-up|3|||
156860353|NCT03284710|566246720|FG002|Overall Study|Lost to Follow-up|1|||
156860354|NCT03284710|566246721|FG003|Overall Study|Lost to Follow-up|0|||
156860355|NCT03284710|566246718|FG000|Overall Study|Physician Decision|1|||
156860356|NCT03284710|566246719|FG001|Overall Study|Physician Decision|0|||
156860357|NCT03284710|566246720|FG002|Overall Study|Physician Decision|0|||
156860358|NCT03284710|566246721|FG003|Overall Study|Physician Decision|0|||
156860359|NCT03284710|566246718|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
156860360|NCT03284710|566246719|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
156860361|NCT03284710|566246720|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
156860362|NCT03284710|566246721|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
156860363|NCT03284710|566246718|FG000|Overall Study|HIV Infection|0|||
156860364|NCT03284710|566246719|FG001|Overall Study|HIV Infection|2|||
156860365|NCT03284710|566246720|FG002|Overall Study|HIV Infection|2|||
156860366|NCT03284710|566246721|FG003|Overall Study|HIV Infection|1|||
156860367|NCT02814916|566246725|FG000|Overall Study|Withdrawal of consent|0|||
156860368|NCT02814916|566246726|FG001|Overall Study|Withdrawal of consent|2|||
156860369|NCT02814916|566246727|FG002|Overall Study|Withdrawal of consent|0|||
156860370|NCT02814916|566246725|FG000|Overall Study|Lost to Follow-up|0|||
156860371|NCT02814916|566246726|FG001|Overall Study|Lost to Follow-up|1|||
156860372|NCT02814916|566246727|FG002|Overall Study|Lost to Follow-up|0|||
156860373|NCT02814916|566246725|FG000|Overall Study|Other, not specified|0|||
156860374|NCT02814916|566246726|FG001|Overall Study|Other, not specified|1|||
156860375|NCT02814916|566246727|FG002|Overall Study|Other, not specified|0|||
156860376|NCT03547518|566246732|FG000|Overall Study|Lost to Follow-up|2|||
156860377|NCT03547518|566246733|FG001|Overall Study|Lost to Follow-up|0|||
156860378|NCT00286468|566246739|FG000|Overall Study|Hyperglycemic Rescue|28|||
156860379|NCT00286468|566246740|FG001|Overall Study|Hyperglycemic Rescue|30|||
156860380|NCT00286468|566246741|FG002|Overall Study|Hyperglycemic Rescue|31|||
156860381|NCT00286468|566246739|FG000|Overall Study|Adverse Event|2|||
156860382|NCT00286468|566246740|FG001|Overall Study|Adverse Event|6|||
156860383|NCT00286468|566246741|FG002|Overall Study|Adverse Event|4|||
156860384|NCT00286468|566246739|FG000|Overall Study|Protocol Violation|0|||
156860385|NCT00286468|566246740|FG001|Overall Study|Protocol Violation|3|||
156860386|NCT00286468|566246741|FG002|Overall Study|Protocol Violation|1|||
156860387|NCT00286468|566246739|FG000|Overall Study|Lost to Follow-up|1|||
156860388|NCT00286468|566246740|FG001|Overall Study|Lost to Follow-up|1|||
156860389|NCT00286468|566246741|FG002|Overall Study|Lost to Follow-up|2|||
156860390|NCT00286468|566246739|FG000|Overall Study|Withdrawal by Subject|3|||
156860391|NCT00286468|566246740|FG001|Overall Study|Withdrawal by Subject|8|||
156860392|NCT00286468|566246741|FG002|Overall Study|Withdrawal by Subject|11|||
156860393|NCT00286468|566246739|FG000|Overall Study|Physician Decision|3|||
156860394|NCT00286468|566246740|FG001|Overall Study|Physician Decision|2|||
156860395|NCT00286468|566246741|FG002|Overall Study|Physician Decision|1|||
156860396|NCT02953652|566246742|FG000|Overall Study|Adverse Event|18|||
156860397|NCT02953652|566246742|FG000|Overall Study|Withdrawal by Subject|6|||
156860398|NCT02953652|566246742|FG000|Overall Study|Protocol Violation|1|||
156860399|NCT02953652|566246742|FG000|Overall Study|Disease Progression|27|||
156860400|NCT00671658|566246746|FG000|Overall Study|Physician Decision|5|||
156860401|NCT03617172|566246755|FG000|Overall Study|Lost to Follow-up|1|||
156860402|NCT03617172|566246756|FG001|Overall Study|Lost to Follow-up|0|||
156860403|NCT03557970|566246757|FG000|Overall Study|Study closure|1|||
156860404|NCT03557970|566246758|FG001|Overall Study|Study closure|0|||
156860405|NCT03557970|566246757|FG000|Overall Study|Physician Decision|0|||
156860406|NCT03557970|566246758|FG001|Overall Study|Physician Decision|1|||
156860407|NCT03557970|566246757|FG000|Overall Study|Death|0|||
156860408|NCT03557970|566246758|FG001|Overall Study|Death|1|||
156860409|NCT02138890|566246761|FG000|Overall Study|Adverse Event|1|||
156860410|NCT02138890|566246762|FG001|Overall Study|Adverse Event|0|||
156860411|NCT03019406|566246763|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
156860412|NCT03019406|566246764|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
156860413|NCT03019406|566246765|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
156860414|NCT03019406|566246766|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
156860415|NCT01446159|566246767|FG000|Overall Study|Withdrawal by Subject|1|||
156860416|NCT01446159|566246768|FG001|Overall Study|Withdrawal by Subject|0|||
156860417|NCT01446159|566246769|FG002|Overall Study|Withdrawal by Subject|14|||
156860418|NCT01446159|566246770|FG003|Overall Study|Withdrawal by Subject|11|||
156860419|NCT01446159|566246767|FG000|Overall Study|Lost to Follow-up|0|||
156860420|NCT01446159|566246768|FG001|Overall Study|Lost to Follow-up|0|||
156860421|NCT01446159|566246769|FG002|Overall Study|Lost to Follow-up|1|||
156475433|NCT00246129|564835557|FG001|Overall Study|suffered primary non-function|0|||
156475434|NCT00246129|564835556|FG000|Overall Study|grafts failed|3|||
156475435|NCT00246129|564835557|FG001|Overall Study|grafts failed|1|||
156860422|NCT01446159|566246770|FG003|Overall Study|Lost to Follow-up|2|||
156860423|NCT01446159|566246767|FG000|Overall Study|Death|2|||
156860424|NCT01446159|566246768|FG001|Overall Study|Death|3|||
156860425|NCT01446159|566246769|FG002|Overall Study|Death|43|||
156860426|NCT01446159|566246770|FG003|Overall Study|Death|36|||
156860427|NCT01446159|566246767|FG000|Overall Study|Other|0|||
156860428|NCT01446159|566246768|FG001|Overall Study|Other|0|||
156860429|NCT01446159|566246769|FG002|Overall Study|Other|13|||
156860430|NCT01446159|566246770|FG003|Overall Study|Other|13|||
156860431|NCT03668873|566246771|FG000|Overall Study|Lost to Follow-up|6|||
156860432|NCT03668873|566246772|FG001|Overall Study|Lost to Follow-up|3|||
156860433|NCT03155724|566246777|FG000|Overall Study|Death|3|||
156860434|NCT03155724|566246777|FG000|Overall Study|Physician Decision|1|||
156860435|NCT03155724|566246777|FG000|Overall Study|Study closure|7|||
156860436|NCT05135871|566246779|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
156860437|NCT05135871|566246780|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
156860438|NCT05135871|566246781|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
156860439|NCT05135871|566246782|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
156860440|NCT00525512|566246783|FG000|Double-Blind Phase|Adverse Event|48|||
156860441|NCT00525512|566246784|FG001|Double-Blind Phase|Adverse Event|28|||
156860442|NCT00525512|566246785|FG002|Double-Blind Phase|Adverse Event|0|||
156860443|NCT00525512|566246786|FG003|Double-Blind Phase|Adverse Event|0|||
156860444|NCT00525512|566246783|FG000|Double-Blind Phase|Protocol Violation|3|||
156860445|NCT00525512|566246784|FG001|Double-Blind Phase|Protocol Violation|1|||
156860446|NCT00525512|566246785|FG002|Double-Blind Phase|Protocol Violation|0|||
156860447|NCT00525512|566246786|FG003|Double-Blind Phase|Protocol Violation|0|||
156860448|NCT00525512|566246783|FG000|Double-Blind Phase|Lost to Follow-up|3|||
156860449|NCT00525512|566246784|FG001|Double-Blind Phase|Lost to Follow-up|7|||
156860450|NCT00525512|566246785|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156860451|NCT00525512|566246786|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156860452|NCT00525512|566246783|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
156860453|NCT00525512|566246784|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
156860454|NCT00525512|566246785|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156860455|NCT00525512|566246786|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156860456|NCT00525512|566246783|FG000|Double-Blind Phase|Lack of Efficacy|13|||
156860457|NCT00525512|566246784|FG001|Double-Blind Phase|Lack of Efficacy|5|||
156860458|NCT00525512|566246785|FG002|Double-Blind Phase|Lack of Efficacy|0|||
156860459|NCT00525512|566246786|FG003|Double-Blind Phase|Lack of Efficacy|0|||
156860460|NCT00525512|566246783|FG000|Double-Blind Phase|Other reason (not specified)|12|||
156860461|NCT00525512|566246784|FG001|Double-Blind Phase|Other reason (not specified)|13|||
156860462|NCT00525512|566246785|FG002|Double-Blind Phase|Other reason (not specified)|0|||
156860463|NCT00525512|566246786|FG003|Double-Blind Phase|Other reason (not specified)|0|||
156860464|NCT00525512|566246783|FG000|Open-Label Phase|Adverse Event|0|||
156860465|NCT00525512|566246784|FG001|Open-Label Phase|Adverse Event|0|||
156860466|NCT00525512|566246785|FG002|Open-Label Phase|Adverse Event|1|||
156860467|NCT00525512|566246786|FG003|Open-Label Phase|Adverse Event|0|||
156860468|NCT00525512|566246783|FG000|Open-Label Phase|Lost to Follow-up|0|||
156860469|NCT00525512|566246784|FG001|Open-Label Phase|Lost to Follow-up|0|||
156860470|NCT00525512|566246785|FG002|Open-Label Phase|Lost to Follow-up|1|||
156860471|NCT00525512|566246786|FG003|Open-Label Phase|Lost to Follow-up|0|||
156860472|NCT00525512|566246783|FG000|Open-Label Phase|Other reason (not specified)|0|||
156860473|NCT00525512|566246784|FG001|Open-Label Phase|Other reason (not specified)|0|||
156860474|NCT00525512|566246785|FG002|Open-Label Phase|Other reason (not specified)|4|||
156860475|NCT00525512|566246786|FG003|Open-Label Phase|Other reason (not specified)|5|||
156860476|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
156860477|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
156860478|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
156860479|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
156860480|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
156475436|NCT03469258|564835558|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
156860481|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
156860482|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
156860483|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
156343813|NCT03708328|564358509|FG006|Overall Study|Death|26|||
156475437|NCT03041090|564835564|FG000|Overall Study|technical error|0|||
156475438|NCT03041090|564835565|FG001|Overall Study|technical error|3|||
156860484|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
156860485|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
156860486|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
156860487|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
156860488|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
156860489|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
156860490|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
156860491|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
156860492|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Death|2|||
156860493|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Death|1|||
156860494|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
156860495|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
156860496|NCT03309020|566246795|FG000|Overall Study|Death|1|||
156860497|NCT03309020|566246796|FG001|Overall Study|Death|0|||
156860498|NCT03309020|566246795|FG000|Overall Study|Did not undergo surgery|2|||
156860499|NCT03309020|566246796|FG001|Overall Study|Did not undergo surgery|1|||
156860500|NCT02025179|566246805|FG000|Overall Study|Lost to Follow-up|0|||
156860501|NCT02025179|566246806|FG001|Overall Study|Lost to Follow-up|0|||
156860502|NCT02025179|566246807|FG002|Overall Study|Lost to Follow-up|1|||
156860503|NCT02362724|566246808|FG000|Overall Study|Withdrawal by Subject|3|||
156860504|NCT02362724|566246809|FG001|Overall Study|Withdrawal by Subject|1|||
156860505|NCT02362724|566246808|FG000|Overall Study|Adverse Event|3|||
156860506|NCT02362724|566246809|FG001|Overall Study|Adverse Event|0|||
156860507|NCT00601835|566246815|FG000|Overall Study|Withdrawal by Subject|9|||
156860508|NCT00601835|566246816|FG001|Overall Study|Withdrawal by Subject|6|||
156860509|NCT00601835|566246815|FG000|Overall Study|Physician Decision|1|||
156860510|NCT00601835|566246816|FG001|Overall Study|Physician Decision|0|||
156860511|NCT00601835|566246815|FG000|Overall Study|Lost to Follow-up|37|||
156860512|NCT00601835|566246816|FG001|Overall Study|Lost to Follow-up|5|||
156860513|NCT00601835|566246815|FG000|Overall Study|Adverse Event|1|||
156860514|NCT00601835|566246816|FG001|Overall Study|Adverse Event|1|||
156860515|NCT00601835|566246815|FG000|Overall Study|Relocate|12|||
156860516|NCT00601835|566246816|FG001|Overall Study|Relocate|2|||
156860517|NCT00880620|566246817|FG000|Overall Study|Adverse Event|4|||
156860518|NCT00880620|566246818|FG001|Overall Study|Adverse Event|5|||
156860519|NCT00880620|566246819|FG002|Overall Study|Adverse Event|15|||
156860520|NCT00880620|566246820|FG003|Overall Study|Adverse Event|15|||
156860521|NCT00880620|566246817|FG000|Overall Study|Death|0|||
156860522|NCT00880620|566246818|FG001|Overall Study|Death|0|||
156860523|NCT00880620|566246819|FG002|Overall Study|Death|1|||
156860524|NCT00880620|566246820|FG003|Overall Study|Death|0|||
156860525|NCT00880620|566246817|FG000|Overall Study|Lack of Efficacy|12|||
156860526|NCT00880620|566246818|FG001|Overall Study|Lack of Efficacy|4|||
156860527|NCT00880620|566246819|FG002|Overall Study|Lack of Efficacy|0|||
156860528|NCT00880620|566246820|FG003|Overall Study|Lack of Efficacy|1|||
156860529|NCT00880620|566246817|FG000|Overall Study|Lost to Follow-up|0|||
156860530|NCT00880620|566246818|FG001|Overall Study|Lost to Follow-up|1|||
156860531|NCT00880620|566246819|FG002|Overall Study|Lost to Follow-up|1|||
156860532|NCT00880620|566246820|FG003|Overall Study|Lost to Follow-up|0|||
156860533|NCT00880620|566246817|FG000|Overall Study|Protocol Violation|0|||
156860534|NCT00880620|566246818|FG001|Overall Study|Protocol Violation|1|||
156860535|NCT00880620|566246819|FG002|Overall Study|Protocol Violation|0|||
156860536|NCT00880620|566246820|FG003|Overall Study|Protocol Violation|2|||
156860537|NCT00880620|566246817|FG000|Overall Study|Withdrawal by Subject|4|||
156860538|NCT00880620|566246818|FG001|Overall Study|Withdrawal by Subject|3|||
156860539|NCT00880620|566246819|FG002|Overall Study|Withdrawal by Subject|1|||
156860540|NCT00880620|566246820|FG003|Overall Study|Withdrawal by Subject|3|||
156860541|NCT00880620|566246817|FG000|Overall Study|Noncompliance|0|||
156860542|NCT00880620|566246818|FG001|Overall Study|Noncompliance|0|||
156860543|NCT00880620|566246819|FG002|Overall Study|Noncompliance|1|||
156860544|NCT00880620|566246820|FG003|Overall Study|Noncompliance|1|||
156860545|NCT00880620|566246817|FG000|Overall Study|Other|1|||
156860546|NCT00880620|566246818|FG001|Overall Study|Other|1|||
156860547|NCT00880620|566246819|FG002|Overall Study|Other|2|||
156860548|NCT00880620|566246820|FG003|Overall Study|Other|2|||
156860549|NCT00880698|566246823|FG000|Overall Study|Death|0|||
156860550|NCT00880698|566246824|FG001|Overall Study|Death|0|||
156860551|NCT00880698|566246825|FG002|Overall Study|Death|1|||
156860552|NCT00880698|566246826|FG003|Overall Study|Death|2|||
156860553|NCT00880698|566246823|FG000|Overall Study|Lost to Follow-up|1|||
156860554|NCT00880698|566246824|FG001|Overall Study|Lost to Follow-up|3|||
156860555|NCT00880698|566246825|FG002|Overall Study|Lost to Follow-up|0|||
156860556|NCT00880698|566246826|FG003|Overall Study|Lost to Follow-up|1|||
156860557|NCT04972162|566246829|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
156860558|NCT04972162|566246830|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
156860559|NCT03414983|566248943|FG000|Pre-Treatment|Other reasons|1|||
156860560|NCT03414983|566248944|FG001|Pre-Treatment|Other reasons|0|||
156860561|NCT03414983|566248943|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
156860562|NCT03414983|566248944|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
156860563|NCT03414983|566248943|FG000|Pre-Treatment|Participant withdrew consent|1|||
156860564|NCT03414983|566248944|FG001|Pre-Treatment|Participant withdrew consent|3|||
156860565|NCT03414983|566248943|FG000|Treatment|Participant withdrew consent|4|||
156860566|NCT03414983|566248944|FG001|Treatment|Participant withdrew consent|3|||
156860567|NCT03414983|566248943|FG000|Treatment|Participant request to discontinue study treatment|8|||
156860568|NCT03414983|566248944|FG001|Treatment|Participant request to discontinue study treatment|10|||
156860569|NCT03414983|566248943|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
156860570|NCT03414983|566248944|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
156860571|NCT03414983|566248943|FG000|Treatment|Death|0|||
156860572|NCT03414983|566248944|FG001|Treatment|Death|1|||
156860573|NCT03414983|566248943|FG000|Treatment|Study Drug Toxicity|10|||
156860574|NCT03414983|566248944|FG001|Treatment|Study Drug Toxicity|5|||
156860575|NCT03414983|566248943|FG000|Treatment|Disease Progression|75|||
156860576|NCT03414983|566248944|FG001|Treatment|Disease Progression|29|||
156860577|NCT03414983|566248943|FG000|Treatment|Not reported|1|||
156860578|NCT03414983|566248944|FG001|Treatment|Not reported|0|||
156860579|NCT03414983|566248943|FG000|Treatment|Other reasons|3|||
156860580|NCT03414983|566248944|FG001|Treatment|Other reasons|2|||
156860581|NCT03414983|566248943|FG000|Treatment|Poor/non-compliance|2|||
156860582|NCT03414983|566248944|FG001|Treatment|Poor/non-compliance|0|||
156860583|NCT03414983|566248943|FG000|Treatment|Maximum clinical benefit|5|||
156860584|NCT03414983|566248944|FG001|Treatment|Maximum clinical benefit|9|||
156860585|NCT03414983|566248943|FG000|Treatment|Lost to Follow-up|0|||
156860586|NCT03414983|566248944|FG001|Treatment|Lost to Follow-up|1|||
156860587|NCT03414983|566248943|FG000|Treatment|Administrative reasons by sponsor|1|||
156860588|NCT03414983|566248944|FG001|Treatment|Administrative reasons by sponsor|0|||
156860589|NCT02608684|566248945|FG000|Overall Study|Physician Decision|2|||
156860590|NCT02608684|566248945|FG000|Overall Study|Withdrawal by Subject|1|||
156860591|NCT01910298|566248946|FG000|Overall Study|Adverse Event|1|||
156860592|NCT01910298|566248947|FG001|Overall Study|Adverse Event|0|||
156860593|NCT01910298|566248946|FG000|Overall Study|Withdrawal by Subject|2|||
156860594|NCT01910298|566248947|FG001|Overall Study|Withdrawal by Subject|7|||
156860595|NCT01910298|566248946|FG000|Overall Study|Protocol Deviation|0|||
156860596|NCT01910298|566248947|FG001|Overall Study|Protocol Deviation|5|||
156860597|NCT01910298|566248946|FG000|Overall Study|Lost to Follow-up|1|||
156860598|NCT01910298|566248947|FG001|Overall Study|Lost to Follow-up|1|||
156860599|NCT01910298|566248946|FG000|Overall Study|Study Terminated by Sponsor|1|||
156860600|NCT01910298|566248947|FG001|Overall Study|Study Terminated by Sponsor|17|||
156860601|NCT01910298|566248946|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156860602|NCT01910298|566248947|FG001|Overall Study|Other Miscellaneous Reasons|2|||
156860603|NCT01775501|566248948|FG000|Overall Study|Discontinued prior to treatment|1|||
156860604|NCT03037385|566248949|FG000|Overall Study|Adverse Event|0|||
156860605|NCT03037385|566248950|FG001|Overall Study|Adverse Event|0|||
156860606|NCT03037385|566248951|FG002|Overall Study|Adverse Event|1|||
156860607|NCT03037385|566248952|FG003|Overall Study|Adverse Event|0|||
156860608|NCT03037385|566248953|FG004|Overall Study|Adverse Event|0|||
156860609|NCT03037385|566248954|FG005|Overall Study|Adverse Event|0|||
156860610|NCT03037385|566248955|FG006|Overall Study|Adverse Event|0|||
156860611|NCT03037385|566248956|FG007|Overall Study|Adverse Event|0|||
156860612|NCT03037385|566248957|FG008|Overall Study|Adverse Event|0|||
156860613|NCT03037385|566248958|FG009|Overall Study|Adverse Event|6|||
156860614|NCT03037385|566248949|FG000|Overall Study|Death|1|||
156860615|NCT03037385|566248950|FG001|Overall Study|Death|4|||
156860616|NCT03037385|566248951|FG002|Overall Study|Death|2|||
156860617|NCT03037385|566248952|FG003|Overall Study|Death|2|||
156860618|NCT03037385|566248953|FG004|Overall Study|Death|5|||
156860619|NCT03037385|566248954|FG005|Overall Study|Death|2|||
156860620|NCT03037385|566248955|FG006|Overall Study|Death|1|||
156860621|NCT03037385|566248956|FG007|Overall Study|Death|4|||
156860622|NCT03037385|566248957|FG008|Overall Study|Death|3|||
156860623|NCT03037385|566248958|FG009|Overall Study|Death|240|||
156860624|NCT03037385|566248949|FG000|Overall Study|Initiation of Another Therapy|1|||
156475439|NCT02202317|564835566|FG000|Overall Study|Lost to Follow-up|1|||
156475440|NCT03403036|564835567|FG000|Overall Study|Lack of Efficacy|5|||
156475441|NCT01353274|564835568|FG000|Overall Study|No case report form (CRF) collected|28|||
156475442|NCT01128959|564835569|FG000|Lead in Period|Adverse Event|3|||
156860625|NCT03037385|566248950|FG001|Overall Study|Initiation of Another Therapy|0|||
156860626|NCT03037385|566248951|FG002|Overall Study|Initiation of Another Therapy|0|||
156860627|NCT03037385|566248952|FG003|Overall Study|Initiation of Another Therapy|0|||
156860628|NCT03037385|566248953|FG004|Overall Study|Initiation of Another Therapy|0|||
156860629|NCT03037385|566248954|FG005|Overall Study|Initiation of Another Therapy|0|||
156860630|NCT03037385|566248955|FG006|Overall Study|Initiation of Another Therapy|0|||
156860631|NCT03037385|566248956|FG007|Overall Study|Initiation of Another Therapy|1|||
156860632|NCT03037385|566248957|FG008|Overall Study|Initiation of Another Therapy|0|||
156475443|NCT01128959|564835569|FG000|Treatment Period|Adverse Event|3|||
156860633|NCT03037385|566248958|FG009|Overall Study|Initiation of Another Therapy|2|||
156860634|NCT03037385|566248949|FG000|Overall Study|Lost to Follow-up|0|||
156860635|NCT03037385|566248950|FG001|Overall Study|Lost to Follow-up|0|||
156860636|NCT03037385|566248951|FG002|Overall Study|Lost to Follow-up|0|||
156860637|NCT03037385|566248952|FG003|Overall Study|Lost to Follow-up|0|||
156860638|NCT03037385|566248953|FG004|Overall Study|Lost to Follow-up|0|||
156860639|NCT03037385|566248954|FG005|Overall Study|Lost to Follow-up|1|||
156860640|NCT03037385|566248955|FG006|Overall Study|Lost to Follow-up|0|||
156860641|NCT03037385|566248956|FG007|Overall Study|Lost to Follow-up|0|||
156860642|NCT03037385|566248957|FG008|Overall Study|Lost to Follow-up|0|||
156860643|NCT03037385|566248958|FG009|Overall Study|Lost to Follow-up|16|||
156860644|NCT03037385|566248949|FG000|Overall Study|Physician Decision|0|||
156860645|NCT03037385|566248950|FG001|Overall Study|Physician Decision|0|||
156860646|NCT03037385|566248951|FG002|Overall Study|Physician Decision|0|||
156860647|NCT03037385|566248952|FG003|Overall Study|Physician Decision|0|||
156860648|NCT03037385|566248953|FG004|Overall Study|Physician Decision|0|||
156860649|NCT03037385|566248954|FG005|Overall Study|Physician Decision|0|||
156860650|NCT03037385|566248955|FG006|Overall Study|Physician Decision|0|||
156860651|NCT03037385|566248956|FG007|Overall Study|Physician Decision|0|||
156860652|NCT03037385|566248957|FG008|Overall Study|Physician Decision|0|||
156860653|NCT03037385|566248958|FG009|Overall Study|Physician Decision|1|||
156860654|NCT03037385|566248949|FG000|Overall Study|Progressive Disease|0|||
156860655|NCT03037385|566248950|FG001|Overall Study|Progressive Disease|1|||
156860656|NCT03037385|566248951|FG002|Overall Study|Progressive Disease|1|||
156860657|NCT03037385|566248952|FG003|Overall Study|Progressive Disease|5|||
156860658|NCT03037385|566248953|FG004|Overall Study|Progressive Disease|2|||
156860659|NCT03037385|566248954|FG005|Overall Study|Progressive Disease|0|||
156860660|NCT03037385|566248955|FG006|Overall Study|Progressive Disease|1|||
156860661|NCT03037385|566248956|FG007|Overall Study|Progressive Disease|0|||
156860662|NCT03037385|566248957|FG008|Overall Study|Progressive Disease|0|||
156860663|NCT03037385|566248958|FG009|Overall Study|Progressive Disease|30|||
156860664|NCT03037385|566248949|FG000|Overall Study|Withdrawal by Subject|0|||
156860665|NCT03037385|566248950|FG001|Overall Study|Withdrawal by Subject|0|||
156860666|NCT03037385|566248951|FG002|Overall Study|Withdrawal by Subject|1|||
156860667|NCT03037385|566248952|FG003|Overall Study|Withdrawal by Subject|2|||
156860668|NCT03037385|566248953|FG004|Overall Study|Withdrawal by Subject|1|||
156860669|NCT03037385|566248954|FG005|Overall Study|Withdrawal by Subject|3|||
156860670|NCT03037385|566248955|FG006|Overall Study|Withdrawal by Subject|0|||
156860671|NCT03037385|566248956|FG007|Overall Study|Withdrawal by Subject|0|||
156860672|NCT03037385|566248957|FG008|Overall Study|Withdrawal by Subject|0|||
156860673|NCT03037385|566248958|FG009|Overall Study|Withdrawal by Subject|52|||
156860674|NCT03037385|566248949|FG000|Overall Study|Reason Not Specified|0|||
156860675|NCT03037385|566248950|FG001|Overall Study|Reason Not Specified|1|||
156860676|NCT03037385|566248951|FG002|Overall Study|Reason Not Specified|0|||
156860677|NCT03037385|566248952|FG003|Overall Study|Reason Not Specified|4|||
156860678|NCT03037385|566248953|FG004|Overall Study|Reason Not Specified|3|||
156860679|NCT03037385|566248954|FG005|Overall Study|Reason Not Specified|6|||
156860680|NCT03037385|566248955|FG006|Overall Study|Reason Not Specified|2|||
156860681|NCT03037385|566248956|FG007|Overall Study|Reason Not Specified|0|||
156860682|NCT03037385|566248957|FG008|Overall Study|Reason Not Specified|1|||
156343814|NCT03708328|564358510|FG007|Overall Study|Death|18|||
156343815|NCT03708328|564358511|FG008|Overall Study|Death|13|||
156343816|NCT03708328|564358512|FG009|Overall Study|Death|8|||
156343817|NCT03708328|564358503|FG000|Overall Study|Lost to Follow-up|0|||
156343818|NCT03708328|564358504|FG001|Overall Study|Lost to Follow-up|1|||
156343819|NCT03708328|564358505|FG002|Overall Study|Lost to Follow-up|0|||
156343820|NCT03708328|564358506|FG003|Overall Study|Lost to Follow-up|1|||
156343821|NCT03708328|564358507|FG004|Overall Study|Lost to Follow-up|0|||
156343822|NCT03708328|564358508|FG005|Overall Study|Lost to Follow-up|3|||
156343823|NCT03708328|564358509|FG006|Overall Study|Lost to Follow-up|3|||
156343824|NCT03708328|564358510|FG007|Overall Study|Lost to Follow-up|0|||
156343825|NCT03708328|564358511|FG008|Overall Study|Lost to Follow-up|0|||
156343826|NCT03708328|564358512|FG009|Overall Study|Lost to Follow-up|1|||
156343827|NCT03708328|564358503|FG000|Overall Study|Physician Decision|0|||
156343828|NCT03708328|564358504|FG001|Overall Study|Physician Decision|0|||
156343829|NCT03708328|564358505|FG002|Overall Study|Physician Decision|0|||
156343830|NCT03708328|564358506|FG003|Overall Study|Physician Decision|0|||
156343831|NCT03708328|564358507|FG004|Overall Study|Physician Decision|0|||
156343832|NCT03708328|564358508|FG005|Overall Study|Physician Decision|1|||
156343833|NCT03708328|564358509|FG006|Overall Study|Physician Decision|0|||
156343834|NCT03708328|564358510|FG007|Overall Study|Physician Decision|0|||
156343835|NCT03708328|564358511|FG008|Overall Study|Physician Decision|0|||
156343836|NCT03708328|564358512|FG009|Overall Study|Physician Decision|0|||
156860683|NCT03037385|566248958|FG009|Overall Study|Reason Not Specified|181|||
156860684|NCT03007966|566248962|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
156860685|NCT03007966|566248963|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
156860686|NCT00419393|566248964|FG000|Overall Study|Adverse Event|5|||
156860687|NCT00419393|566248964|FG000|Overall Study|Protocol Violation|5|||
156860688|NCT00419393|566248964|FG000|Overall Study|Withdrawal by Subject|7|||
156860689|NCT00419393|566248964|FG000|Overall Study|Other: Sponsor request|3|||
156343837|NCT03708328|564358503|FG000|Overall Study|Withdrawal by Subject|0|||
156343838|NCT03708328|564358504|FG001|Overall Study|Withdrawal by Subject|0|||
156860690|NCT00419393|566248964|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
156860691|NCT00419393|566248964|FG000|Overall Study|Other: Site closure|1|||
156860692|NCT00419393|566248964|FG000|Overall Study|Other: Other health problems|1|||
156475444|NCT01128959|564835569|FG000|Treatment Period|Withdrawal by Subject|1|||
156475445|NCT02338999|564835570|FG000|First Intervention|Withdrawal by Subject|3|||
156475446|NCT02338999|564835571|FG001|First Intervention|Withdrawal by Subject|1|||
156860693|NCT00419393|566248964|FG000|Overall Study|Other: Investigator decision|1|||
156860694|NCT02587221|566248968|FG000|Overall Study|Adverse Event|3|||
156860695|NCT02587221|566248969|FG001|Overall Study|Adverse Event|3|||
156860696|NCT02587221|566248968|FG000|Overall Study|Death|33|||
156860697|NCT02587221|566248969|FG001|Overall Study|Death|34|||
156860698|NCT02587221|566248968|FG000|Overall Study|Withdrawal by Subject|66|||
156860699|NCT02587221|566248969|FG001|Overall Study|Withdrawal by Subject|61|||
156860700|NCT02587221|566248968|FG000|Overall Study|Lost to Follow-up|21|||
156860701|NCT02587221|566248969|FG001|Overall Study|Lost to Follow-up|19|||
156860702|NCT02587221|566248968|FG000|Overall Study|Protocol Violation|6|||
156860703|NCT02587221|566248969|FG001|Overall Study|Protocol Violation|5|||
156860704|NCT02587221|566248968|FG000|Overall Study|Other Reason or Unspecified|2|||
156860705|NCT02587221|566248969|FG001|Overall Study|Other Reason or Unspecified|1|||
156860706|NCT02546609|566248970|FG000|Overall Study|Withdrawal by Subject|0|||
156860707|NCT02546609|566248971|FG001|Overall Study|Withdrawal by Subject|1|||
156860708|NCT02546609|566248972|FG002|Overall Study|Withdrawal by Subject|2|||
156860709|NCT02546609|566248970|FG000|Overall Study|Adverse Event|0|||
156860710|NCT02546609|566248971|FG001|Overall Study|Adverse Event|6|||
156860711|NCT02546609|566248972|FG002|Overall Study|Adverse Event|1|||
156860712|NCT02546609|566248970|FG000|Overall Study|Protocol Violation|0|||
156860713|NCT02546609|566248971|FG001|Overall Study|Protocol Violation|1|||
156860714|NCT02546609|566248972|FG002|Overall Study|Protocol Violation|1|||
156860715|NCT02546609|566248970|FG000|Overall Study|Lost to Follow-up|2|||
156860716|NCT02546609|566248971|FG001|Overall Study|Lost to Follow-up|3|||
156860717|NCT02546609|566248972|FG002|Overall Study|Lost to Follow-up|1|||
156860718|NCT02546609|566248970|FG000|Overall Study|travel or work schedule restriction|0|||
156860719|NCT02546609|566248971|FG001|Overall Study|travel or work schedule restriction|0|||
156860720|NCT02546609|566248972|FG002|Overall Study|travel or work schedule restriction|2|||
156860721|NCT03988400|566248974|FG000|Overall Study|Adverse Event|1|||
156860722|NCT03988400|566248975|FG001|Overall Study|Adverse Event|0|||
156860723|NCT03988400|566248974|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
156860724|NCT03988400|566248975|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
156860725|NCT03988400|566248974|FG000|Overall Study|Lost to Follow-up|0|||
156860726|NCT03988400|566248975|FG001|Overall Study|Lost to Follow-up|1|||
156860727|NCT04913610|566248976|FG000|Randomized Participants|Did Not Receive Treatment|0|||
156860728|NCT04913610|566248977|FG001|Randomized Participants|Did Not Receive Treatment|0|||
156860729|NCT04913610|566248978|FG002|Randomized Participants|Did Not Receive Treatment|1|||
156860730|NCT04913610|566248979|FG003|Randomized Participants|Did Not Receive Treatment|1|||
156860731|NCT04913610|566248980|FG004|Randomized Participants|Did Not Receive Treatment|0|||
156860732|NCT04913610|566248976|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
156860733|NCT04913610|566248977|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
156860734|NCT04913610|566248978|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
156860735|NCT04913610|566248979|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
156860736|NCT04913610|566248980|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
156860737|NCT03186209|566248981|FG000|Overall Study|Withdrawal by Subject|11|||
156860738|NCT03186209|566248982|FG001|Overall Study|Withdrawal by Subject|22|||
156860739|NCT03186209|566248981|FG000|Overall Study|Pregnancy|1|||
156860740|NCT03186209|566248982|FG001|Overall Study|Pregnancy|0|||
156860741|NCT03186209|566248981|FG000|Overall Study|Adverse Event|4|||
156860742|NCT03186209|566248982|FG001|Overall Study|Adverse Event|0|||
156860743|NCT03186209|566248981|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
156860744|NCT03186209|566248982|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
156860745|NCT03186209|566248981|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
156860746|NCT03186209|566248982|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
156860747|NCT03186209|566248981|FG000|Overall Study|Fail to meet randomization criteria|0|||
156860748|NCT03186209|566248982|FG001|Overall Study|Fail to meet randomization criteria|1|||
156860749|NCT03186209|566248981|FG000|Overall Study|Lost to Follow-up|0|||
156860750|NCT03186209|566248982|FG001|Overall Study|Lost to Follow-up|1|||
156475447|NCT02338999|564835570|FG000|Washout Period|Withdrawal by Subject|0|||
156475448|NCT02338999|564835571|FG001|Washout Period|Withdrawal by Subject|2|||
156860751|NCT00953667|566248983|FG000|Overall Study|Lost to Follow-up|11|||
156475449|NCT02338999|564835570|FG000|Second Intervention|Withdrawal by Subject|0|||
156475450|NCT02338999|564835571|FG001|Second Intervention|Withdrawal by Subject|2|||
156860752|NCT00953667|566248983|FG000|Overall Study|Physician Decision|35|||
156860753|NCT00953667|566248983|FG000|Overall Study|Withdrawal by Subject|63|||
156860754|NCT00953667|566248983|FG000|Overall Study|Adverse Event|10|||
156475451|NCT02701296|564835572|FG000|Overall Study|Incomplete Data|0|||
156860755|NCT00953667|566248983|FG000|Overall Study|poor venous access,unable to draw blood|4|||
156860756|NCT00322881|566248985|FG000|Overall Study|Death|2|||
156860757|NCT00322881|566248985|FG000|Overall Study|Adverse Event|1|||
156860758|NCT00322881|566248985|FG000|Overall Study|Disease Progression|2|||
156860759|NCT05435339|566248993|FG000|Overall Study|Death|1|||
156860760|NCT05435339|566248994|FG001|Overall Study|Death|0|||
156860761|NCT05435339|566248995|FG002|Overall Study|Death|3|||
156475452|NCT02701296|564835573|FG001|Overall Study|Incomplete Data|2|||
156475453|NCT03851094|564835574|FG000|Overall Study|Withdrawal by Subject|0|||
156860762|NCT05435339|566248996|FG003|Overall Study|Death|1|||
156860763|NCT05435339|566248997|FG004|Overall Study|Death|3|||
156860764|NCT05435339|566248998|FG005|Overall Study|Death|2|||
156860765|NCT05435339|566248999|FG006|Overall Study|Death|4|||
156860766|NCT05435339|566249000|FG007|Overall Study|Death|6|||
156860767|NCT05435339|566248993|FG000|Overall Study|Sponsor Decision|0|||
156860768|NCT05435339|566248994|FG001|Overall Study|Sponsor Decision|1|||
156860769|NCT05435339|566248995|FG002|Overall Study|Sponsor Decision|0|||
156860770|NCT05435339|566248996|FG003|Overall Study|Sponsor Decision|0|||
156860771|NCT05435339|566248997|FG004|Overall Study|Sponsor Decision|2|||
156860772|NCT05435339|566248998|FG005|Overall Study|Sponsor Decision|1|||
156860773|NCT05435339|566248999|FG006|Overall Study|Sponsor Decision|2|||
156860774|NCT05435339|566249000|FG007|Overall Study|Sponsor Decision|2|||
156860775|NCT05435339|566248993|FG000|Overall Study|Withdrawal by Subject|0|||
156860776|NCT05435339|566248994|FG001|Overall Study|Withdrawal by Subject|0|||
156860777|NCT05435339|566248995|FG002|Overall Study|Withdrawal by Subject|0|||
156860778|NCT05435339|566248996|FG003|Overall Study|Withdrawal by Subject|0|||
156860779|NCT05435339|566248997|FG004|Overall Study|Withdrawal by Subject|1|||
156860780|NCT05435339|566248998|FG005|Overall Study|Withdrawal by Subject|0|||
156860781|NCT05435339|566248999|FG006|Overall Study|Withdrawal by Subject|1|||
156860782|NCT05435339|566249000|FG007|Overall Study|Withdrawal by Subject|1|||
156860783|NCT00537394|566249001|FG000|First Year of Follow-up|Death|7|||
156860784|NCT00537394|566249002|FG001|First Year of Follow-up|Death|0|||
156860785|NCT00537394|566249003|FG002|First Year of Follow-up|Death|0|||
156860786|NCT00537394|566249001|FG000|First Year of Follow-up|Severe debilitation|1|||
156860787|NCT00537394|566249002|FG001|First Year of Follow-up|Severe debilitation|0|||
156860788|NCT00537394|566249003|FG002|First Year of Follow-up|Severe debilitation|1|||
156860789|NCT00537394|566249001|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
156860790|NCT00537394|566249002|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
156860791|NCT00537394|566249003|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
156860792|NCT00537394|566249001|FG000|First Year of Follow-up|Lost to Follow-up|1|||
156860793|NCT00537394|566249002|FG001|First Year of Follow-up|Lost to Follow-up|5|||
156860794|NCT00537394|566249003|FG002|First Year of Follow-up|Lost to Follow-up|1|||
156860795|NCT00537394|566249001|FG000|2nd Year of Follow-up|Death|4|||
156860796|NCT00537394|566249002|FG001|2nd Year of Follow-up|Death|1|||
156860797|NCT00537394|566249003|FG002|2nd Year of Follow-up|Death|2|||
156860798|NCT00537394|566249001|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
156860799|NCT00537394|566249002|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
156860800|NCT00537394|566249003|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
156860801|NCT00537394|566249001|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
156860802|NCT00537394|566249002|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
156860803|NCT00537394|566249003|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
156860804|NCT00537394|566249001|FG000|2nd Year of Follow-up|Clinic site closure|1|||
156860805|NCT00537394|566249002|FG001|2nd Year of Follow-up|Clinic site closure|0|||
156860806|NCT00537394|566249003|FG002|2nd Year of Follow-up|Clinic site closure|0|||
156860807|NCT01283139|566249004|FG000|Overall Study|Lost to Follow-up|5|||
156860808|NCT01283139|566249005|FG001|Overall Study|Lost to Follow-up|2|||
156860809|NCT01283139|566249006|FG002|Overall Study|Lost to Follow-up|3|||
156860810|NCT01283139|566249007|FG003|Overall Study|Lost to Follow-up|1|||
156860811|NCT01283139|566249004|FG000|Overall Study|Withdrawal by Subject|8|||
156860812|NCT01283139|566249005|FG001|Overall Study|Withdrawal by Subject|8|||
156860813|NCT01283139|566249006|FG002|Overall Study|Withdrawal by Subject|6|||
156860814|NCT01283139|566249007|FG003|Overall Study|Withdrawal by Subject|8|||
156860815|NCT01283139|566249004|FG000|Overall Study|Death|2|||
156860816|NCT01283139|566249005|FG001|Overall Study|Death|0|||
156860817|NCT01283139|566249006|FG002|Overall Study|Death|2|||
156860818|NCT01283139|566249007|FG003|Overall Study|Death|2|||
156860819|NCT01283139|566249004|FG000|Overall Study|Lack of Efficacy|1|||
156860820|NCT01283139|566249005|FG001|Overall Study|Lack of Efficacy|2|||
156860821|NCT01283139|566249006|FG002|Overall Study|Lack of Efficacy|2|||
156860822|NCT01283139|566249007|FG003|Overall Study|Lack of Efficacy|1|||
156860823|NCT01283139|566249004|FG000|Overall Study|Early termination due to AE/SAE|1|||
156860824|NCT01283139|566249005|FG001|Overall Study|Early termination due to AE/SAE|1|||
156860825|NCT01283139|566249006|FG002|Overall Study|Early termination due to AE/SAE|0|||
156860826|NCT01283139|566249007|FG003|Overall Study|Early termination due to AE/SAE|0|||
156860827|NCT01283139|566249004|FG000|Overall Study|Participant's refusal to continue|0|||
156860828|NCT01283139|566249005|FG001|Overall Study|Participant's refusal to continue|3|||
156860829|NCT01283139|566249006|FG002|Overall Study|Participant's refusal to continue|1|||
156475454|NCT03851094|564835575|FG001|Overall Study|Withdrawal by Subject|1|||
156475455|NCT03851094|564835574|FG000|Overall Study|Participant lost device|0|||
156475456|NCT03851094|564835575|FG001|Overall Study|Participant lost device|1|||
156860830|NCT01283139|566249007|FG003|Overall Study|Participant's refusal to continue|1|||
156860831|NCT01283139|566249004|FG000|Overall Study|Pregnancy|0|||
156860832|NCT01283139|566249005|FG001|Overall Study|Pregnancy|1|||
156475457|NCT03851094|564835574|FG000|Overall Study|Participant returned device|0|||
156475458|NCT03851094|564835575|FG001|Overall Study|Participant returned device|2|||
156475459|NCT04658784|564835576|FG000|6-month Follow-up|Lost to Follow-up|2|||
156475460|NCT04658784|564835577|FG001|6-month Follow-up|Lost to Follow-up|5|||
156475461|NCT02958553|564835578|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
156475462|NCT02958553|564835578|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
156475463|NCT02392507|564835586|FG000|Induction Regimen|Death|3|||
156475464|NCT02392507|564835586|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
156475465|NCT02392507|564835586|FG000|Induction Regimen|Physician Decision|1|||
156860833|NCT01283139|566249006|FG002|Overall Study|Pregnancy|1|||
156860834|NCT01283139|566249007|FG003|Overall Study|Pregnancy|0|||
156860835|NCT01283139|566249004|FG000|Overall Study|Missed follow-up visit|0|||
156860836|NCT01283139|566249005|FG001|Overall Study|Missed follow-up visit|1|||
156860837|NCT01283139|566249006|FG002|Overall Study|Missed follow-up visit|2|||
156860838|NCT01283139|566249007|FG003|Overall Study|Missed follow-up visit|2|||
156860839|NCT01283139|566249004|FG000|Overall Study|Participant randomized in error|0|||
156860840|NCT01283139|566249005|FG001|Overall Study|Participant randomized in error|0|||
156860841|NCT01283139|566249006|FG002|Overall Study|Participant randomized in error|1|||
156860842|NCT01283139|566249007|FG003|Overall Study|Participant randomized in error|0|||
156860843|NCT02183675|566249008|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860844|NCT02183675|566249009|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860845|NCT02183675|566249010|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860846|NCT02183675|566249011|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860847|NCT02183675|566249012|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860848|NCT02183675|566249013|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
156860849|NCT01521117|566249014|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
156860850|NCT01521117|566249015|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
156860851|NCT01521117|566249014|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
156860852|NCT01521117|566249015|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
156860853|NCT01521117|566249014|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
156860854|NCT01521117|566249015|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
156860855|NCT01056822|566249016|FG000|Overall Study|Adverse Event|0|||
156860856|NCT01056822|566249017|FG001|Overall Study|Adverse Event|1|||
156860857|NCT01056822|566249016|FG000|Overall Study|Protocol Violation|6|||
156860858|NCT01056822|566249017|FG001|Overall Study|Protocol Violation|5|||
156860859|NCT01056822|566249016|FG000|Overall Study|Withdrawal by Subject|1|||
156860860|NCT01056822|566249017|FG001|Overall Study|Withdrawal by Subject|1|||
156860861|NCT01056822|566249016|FG000|Overall Study|Lost to Follow-up|1|||
156475466|NCT02392507|564835586|FG000|Induction Regimen|Withdrawal by Subject|2|||
156475467|NCT02392507|564835586|FG000|Maintenance Regimen|Death|1|||
156475468|NCT02392507|564835586|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
156475469|NCT01802333|564835587|FG000|Overall Study|Ineligible|2|||
156475470|NCT01802333|564835588|FG001|Overall Study|Ineligible|6|||
156475471|NCT01802333|564835589|FG002|Overall Study|Ineligible|8|||
156475472|NCT01802333|564835587|FG000|Overall Study|Adverse Event|1|||
156475473|NCT01802333|564835588|FG001|Overall Study|Adverse Event|8|||
156475474|NCT01802333|564835589|FG002|Overall Study|Adverse Event|8|||
156475475|NCT01802333|564835587|FG000|Overall Study|Withdrawal by Subject|6|||
156475476|NCT01802333|564835588|FG001|Overall Study|Withdrawal by Subject|6|||
156475477|NCT01802333|564835589|FG002|Overall Study|Withdrawal by Subject|5|||
156475478|NCT01802333|564835587|FG000|Overall Study|Progression/relapse|1|||
156475479|NCT01802333|564835588|FG001|Overall Study|Progression/relapse|3|||
156475480|NCT01802333|564835589|FG002|Overall Study|Progression/relapse|0|||
156475481|NCT01802333|564835587|FG000|Overall Study|Death|7|||
156475482|NCT01802333|564835588|FG001|Overall Study|Death|14|||
156475483|NCT01802333|564835589|FG002|Overall Study|Death|13|||
156475484|NCT01802333|564835587|FG000|Overall Study|Other - not protocol specified|32|||
156860862|NCT01056822|566249017|FG001|Overall Study|Lost to Follow-up|0|||
156475485|NCT01802333|564835588|FG001|Overall Study|Other - not protocol specified|22|||
156475486|NCT01802333|564835589|FG002|Overall Study|Other - not protocol specified|24|||
156475487|NCT01802333|564835587|FG000|Overall Study|Did not start treatment|0|||
156860863|NCT01601535|566249030|FG000|Phase 1|Adverse Event|1|||
156860864|NCT01601535|566249031|FG001|Phase 1|Adverse Event|0|||
156860865|NCT01601535|566249032|FG002|Phase 1|Adverse Event|2|||
156860866|NCT01601535|566249033|FG003|Phase 1|Adverse Event|1|||
156475488|NCT01802333|564835588|FG001|Overall Study|Did not start treatment|2|||
156475489|NCT01802333|564835589|FG002|Overall Study|Did not start treatment|5|||
156475490|NCT02224755|564835592|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
156475491|NCT02224755|564835593|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
156475492|NCT02224755|564835592|FG000|Two Year Follow up Post-implant|Death|103|||
156475493|NCT02224755|564835593|FG001|Two Year Follow up Post-implant|Death|98|||
156475494|NCT02224755|564835592|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
156860867|NCT01601535|566249034|FG004|Phase 1|Adverse Event|0|||
156860868|NCT01601535|566249035|FG005|Phase 1|Adverse Event|0|||
156860869|NCT01601535|566249030|FG000|Phase 1|Withdrawal by Subject|2|||
156860870|NCT01601535|566249031|FG001|Phase 1|Withdrawal by Subject|1|||
156860871|NCT01601535|566249032|FG002|Phase 1|Withdrawal by Subject|1|||
156860872|NCT01601535|566249033|FG003|Phase 1|Withdrawal by Subject|2|||
156860873|NCT01601535|566249034|FG004|Phase 1|Withdrawal by Subject|0|||
156860874|NCT01601535|566249035|FG005|Phase 1|Withdrawal by Subject|0|||
156860875|NCT01601535|566249030|FG000|Phase 1|Progressive Disease|2|||
156860876|NCT01601535|566249031|FG001|Phase 1|Progressive Disease|3|||
156860877|NCT01601535|566249032|FG002|Phase 1|Progressive Disease|2|||
156860878|NCT01601535|566249033|FG003|Phase 1|Progressive Disease|1|||
156860879|NCT01601535|566249034|FG004|Phase 1|Progressive Disease|0|||
156860880|NCT01601535|566249035|FG005|Phase 1|Progressive Disease|0|||
156860881|NCT01601535|566249030|FG000|Phase 1|Started Another Treatment|1|||
156860882|NCT01601535|566249031|FG001|Phase 1|Started Another Treatment|2|||
156860883|NCT01601535|566249032|FG002|Phase 1|Started Another Treatment|0|||
156860884|NCT01601535|566249033|FG003|Phase 1|Started Another Treatment|0|||
156860885|NCT01601535|566249034|FG004|Phase 1|Started Another Treatment|0|||
156860886|NCT01601535|566249035|FG005|Phase 1|Started Another Treatment|0|||
156860887|NCT01601535|566249030|FG000|Phase 2|Adverse Event|0|||
156860888|NCT01601535|566249031|FG001|Phase 2|Adverse Event|0|||
156860889|NCT01601535|566249032|FG002|Phase 2|Adverse Event|0|||
156860890|NCT01601535|566249033|FG003|Phase 2|Adverse Event|0|||
156860891|NCT01601535|566249034|FG004|Phase 2|Adverse Event|5|||
156860892|NCT01601535|566249035|FG005|Phase 2|Adverse Event|1|||
156860893|NCT01601535|566249030|FG000|Phase 2|Withdrawal by Subject|0|||
156860894|NCT01601535|566249031|FG001|Phase 2|Withdrawal by Subject|0|||
156860895|NCT01601535|566249032|FG002|Phase 2|Withdrawal by Subject|0|||
156860896|NCT01601535|566249033|FG003|Phase 2|Withdrawal by Subject|0|||
156860897|NCT01601535|566249034|FG004|Phase 2|Withdrawal by Subject|8|||
156860898|NCT01601535|566249035|FG005|Phase 2|Withdrawal by Subject|2|||
156860899|NCT01601535|566249030|FG000|Phase 2|Progressive Disease|0|||
156860900|NCT01601535|566249031|FG001|Phase 2|Progressive Disease|0|||
156860901|NCT01601535|566249032|FG002|Phase 2|Progressive Disease|0|||
156860902|NCT01601535|566249033|FG003|Phase 2|Progressive Disease|0|||
156860903|NCT01601535|566249034|FG004|Phase 2|Progressive Disease|5|||
156860904|NCT01601535|566249035|FG005|Phase 2|Progressive Disease|7|||
156860905|NCT01601535|566249030|FG000|Phase 2|Started Another Treatment|0|||
156860906|NCT01601535|566249031|FG001|Phase 2|Started Another Treatment|0|||
156860907|NCT01601535|566249032|FG002|Phase 2|Started Another Treatment|0|||
156860908|NCT01601535|566249033|FG003|Phase 2|Started Another Treatment|0|||
156860909|NCT01601535|566249034|FG004|Phase 2|Started Another Treatment|1|||
156860910|NCT01601535|566249035|FG005|Phase 2|Started Another Treatment|2|||
156860911|NCT01576341|566249038|FG000|Overall Study|Withdrawal by Subject|24|||
156860912|NCT01576341|566249038|FG000|Overall Study|Adverse Event|10|||
156860913|NCT01576341|566249038|FG000|Overall Study|Death|21|||
156860914|NCT01576341|566249038|FG000|Overall Study|Physician Decision|2|||
156860915|NCT01576341|566249038|FG000|Overall Study|Lost to Follow-up|2|||
156860916|NCT01576341|566249038|FG000|Overall Study|Kidney transplantation|10|||
156860917|NCT01576341|566249038|FG000|Overall Study|Protocol Violation|12|||
156860918|NCT01576341|566249038|FG000|Overall Study|Other|12|||
156860919|NCT00556075|566249039|FG000|Overall Study|Lost to Follow-up|3|||
156860920|NCT00556075|566249040|FG001|Overall Study|Lost to Follow-up|0|||
156860921|NCT00556075|566249041|FG002|Overall Study|Lost to Follow-up|3|||
156860922|NCT00556075|566249039|FG000|Overall Study|Withdrawal by Subject|3|||
156860923|NCT00556075|566249040|FG001|Overall Study|Withdrawal by Subject|3|||
156475495|NCT02224755|564835593|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
156475496|NCT02224755|564835592|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
156475497|NCT02224755|564835593|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
156475498|NCT02224755|564835592|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
156475499|NCT02224755|564835593|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
156475500|NCT01951703|564835594|FG000|First Intervention|Withdrawal by Subject|1|||
156475501|NCT01951703|564835595|FG001|First Intervention|Withdrawal by Subject|0|||
156860924|NCT00556075|566249041|FG002|Overall Study|Withdrawal by Subject|0|||
156860925|NCT00556075|566249039|FG000|Overall Study|Protocol Violation|1|||
156860926|NCT00556075|566249040|FG001|Overall Study|Protocol Violation|1|||
156860927|NCT00556075|566249041|FG002|Overall Study|Protocol Violation|3|||
156860928|NCT00556075|566249039|FG000|Overall Study|Not eligible|1|||
156860929|NCT00556075|566249040|FG001|Overall Study|Not eligible|1|||
156860930|NCT00556075|566249041|FG002|Overall Study|Not eligible|2|||
156860931|NCT00556075|566249039|FG000|Overall Study|Adverse Event|1|||
156860932|NCT00556075|566249040|FG001|Overall Study|Adverse Event|2|||
156860933|NCT00556075|566249041|FG002|Overall Study|Adverse Event|0|||
156860934|NCT00556075|566249039|FG000|Overall Study|Personal issues|4|||
156860935|NCT00556075|566249040|FG001|Overall Study|Personal issues|1|||
156860936|NCT00556075|566249041|FG002|Overall Study|Personal issues|0|||
156860937|NCT00556075|566249039|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
156860938|NCT00556075|566249040|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
156860939|NCT00556075|566249041|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
156860940|NCT01927497|566249042|FG000|Overall Study|Death|0|||
156860941|NCT01927497|566249043|FG001|Overall Study|Death|1|||
156860942|NCT01927497|566249042|FG000|Overall Study|Protocol Violation|2|||
156860943|NCT01927497|566249043|FG001|Overall Study|Protocol Violation|0|||
156860944|NCT00395746|566249044|FG000|Overall Study|Adverse Event|5|||
156860945|NCT00395746|566249045|FG001|Overall Study|Adverse Event|2|||
156860946|NCT00395746|566249046|FG002|Overall Study|Adverse Event|2|||
156860947|NCT00395746|566249044|FG000|Overall Study|Protocol Violation|0|||
156860948|NCT00395746|566249045|FG001|Overall Study|Protocol Violation|1|||
156860949|NCT00395746|566249046|FG002|Overall Study|Protocol Violation|0|||
156860950|NCT00395746|566249044|FG000|Overall Study|Lack of Efficacy|2|||
156860951|NCT00395746|566249045|FG001|Overall Study|Lack of Efficacy|0|||
156860952|NCT00395746|566249046|FG002|Overall Study|Lack of Efficacy|17|||
156860953|NCT00395746|566249044|FG000|Overall Study|Hypoglycaemia|2|||
156860954|NCT00395746|566249045|FG001|Overall Study|Hypoglycaemia|1|||
156860955|NCT00395746|566249046|FG002|Overall Study|Hypoglycaemia|0|||
156860956|NCT00395746|566249044|FG000|Overall Study|Subject decision|0|||
156860957|NCT00395746|566249045|FG001|Overall Study|Subject decision|0|||
156860958|NCT00395746|566249046|FG002|Overall Study|Subject decision|1|||
156542340|NCT01147744|565079325|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
156542341|NCT01342484|565079330|FG000|Overall Study|Other Reasons|1|||
156860959|NCT00395746|566249044|FG000|Overall Study|Withdrawal of consent|0|||
156860960|NCT00395746|566249045|FG001|Overall Study|Withdrawal of consent|0|||
156860961|NCT00395746|566249046|FG002|Overall Study|Withdrawal of consent|1|||
156860962|NCT00395746|566249044|FG000|Overall Study|Difficultulty in use of device|0|||
156860963|NCT00395746|566249045|FG001|Overall Study|Difficultulty in use of device|0|||
156860964|NCT00395746|566249046|FG002|Overall Study|Difficultulty in use of device|1|||
156860965|NCT00395746|566249044|FG000|Overall Study|Unable to visit site on schedule|1|||
156860966|NCT00395746|566249045|FG001|Overall Study|Unable to visit site on schedule|0|||
156860967|NCT00395746|566249046|FG002|Overall Study|Unable to visit site on schedule|0|||
156860968|NCT04528641|566249047|FG000|Overall Study|Withdrawal by Subject|0|||
156860969|NCT04528641|566249048|FG001|Overall Study|Withdrawal by Subject|0|||
156860970|NCT04528641|566249049|FG002|Overall Study|Withdrawal by Subject|0|||
156860971|NCT04528641|566249050|FG003|Overall Study|Withdrawal by Subject|1|||
156860972|NCT04528641|566249051|FG004|Overall Study|Withdrawal by Subject|0|||
156860973|NCT04528641|566249052|FG005|Overall Study|Withdrawal by Subject|1|||
156860974|NCT00517296|566249055|FG000|Overall Study|Withdrawal by Subject|1|||
156860975|NCT00517296|566249056|FG001|Overall Study|Withdrawal by Subject|0|||
156860976|NCT04764162|566249057|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
156860977|NCT04764162|566249058|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
156860978|NCT03361137|566249059|FG000|Overall Study|Reason not specified|1|||
156860979|NCT03361137|566249060|FG001|Overall Study|Reason not specified|0|||
156860980|NCT03361137|566249061|FG002|Overall Study|Reason not specified|0|||
156860981|NCT03361137|566249062|FG003|Overall Study|Reason not specified|0|||
156860982|NCT03361137|566249063|FG004|Overall Study|Reason not specified|0|||
156860983|NCT03009058|566249066|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
156860984|NCT05556265|566249067|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
156860985|NCT05556265|566249068|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
156860986|NCT05556265|566249069|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
156860987|NCT05556265|566249070|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
156860988|NCT05556265|566249071|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
156860989|NCT05556265|566249067|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
156860990|NCT05556265|566249068|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
156860991|NCT05556265|566249069|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
156860992|NCT05556265|566249070|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
156860993|NCT05556265|566249071|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
156860994|NCT05556265|566249067|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
156860995|NCT05556265|566249068|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
156860996|NCT05556265|566249069|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
156860997|NCT05556265|566249070|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
156860998|NCT05556265|566249071|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
156860999|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
156861000|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
156861001|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
156861002|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
156861003|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
156861004|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
156861005|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
156861006|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
156861007|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
156861008|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
156861009|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
156861010|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
156861011|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
156861012|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
156861013|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
156861014|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
156861015|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
156861016|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
156861017|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
156861018|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
156475502|NCT01951703|564835594|FG000|First Intervention|Subject was not compliant|1|||
156475503|NCT01951703|564835595|FG001|First Intervention|Subject was not compliant|1|||
156475504|NCT01951703|564835594|FG000|First Intervention|Physician Decision|1|||
156475505|NCT01951703|564835595|FG001|First Intervention|Physician Decision|0|||
156861019|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
156861020|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
156861021|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
156861022|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
156861023|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
156861024|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
156861025|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
156861026|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
156861027|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
156861028|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
156861029|NCT03077542|566249074|FG000|Overall Study|Death|4|||
156861030|NCT03077542|566249075|FG001|Overall Study|Death|0|||
156861031|NCT03077542|566249074|FG000|Overall Study|Physician Decision|6|||
156861032|NCT03077542|566249075|FG001|Overall Study|Physician Decision|1|||
156861033|NCT03077542|566249074|FG000|Overall Study|Withdrawal by Subject|0|||
156861034|NCT03077542|566249075|FG001|Overall Study|Withdrawal by Subject|1|||
156861035|NCT00795704|566249076|FG000|Overall Study|Withdrawal by Subject|3|||
156861036|NCT00795704|566249077|FG001|Overall Study|Withdrawal by Subject|2|||
156861037|NCT00795704|566249076|FG000|Overall Study|Adverse Event|1|||
156861038|NCT00795704|566249077|FG001|Overall Study|Adverse Event|1|||
156861039|NCT03980730|566249078|FG000|Overall Study|Study Terminated by Sponsor|0|||
156861040|NCT03980730|566249079|FG001|Overall Study|Study Terminated by Sponsor|3|||
156861041|NCT03980730|566249078|FG000|Overall Study|Adverse Event|2|||
156861042|NCT03980730|566249079|FG001|Overall Study|Adverse Event|0|||
156861043|NCT03980730|566249078|FG000|Overall Study|Sponsor Request|0|||
156861044|NCT03980730|566249079|FG001|Overall Study|Sponsor Request|1|||
156861045|NCT01300728|566249080|FG000|Overall Study|Withdrawal by Subject|1|||
156861046|NCT01300728|566249081|FG001|Overall Study|Withdrawal by Subject|1|||
156861047|NCT01300728|566249080|FG000|Overall Study|Physician Decision|1|||
156861048|NCT01300728|566249081|FG001|Overall Study|Physician Decision|0|||
156861049|NCT03474588|566249089|FG000|Overall Study|Withdrawal by Subject|4|||
156861050|NCT03474588|566249090|FG001|Overall Study|Withdrawal by Subject|3|||
156861051|NCT03474588|566249089|FG000|Overall Study|Death|0|||
156861052|NCT03474588|566249090|FG001|Overall Study|Death|1|||
156861053|NCT00945009|566249094|FG000|Overall Study|Lack of Efficacy|10|||
156861054|NCT00945009|566249095|FG001|Overall Study|Lack of Efficacy|0|||
156861055|NCT00945009|566249096|FG002|Overall Study|Lack of Efficacy|0|||
156861056|NCT00945009|566249094|FG000|Overall Study|Physician Decision|21|||
156861057|NCT00945009|566249095|FG001|Overall Study|Physician Decision|4|||
156861058|NCT00945009|566249096|FG002|Overall Study|Physician Decision|3|||
156861059|NCT00945009|566249094|FG000|Overall Study|Protocol Violation|6|||
156861060|NCT00945009|566249095|FG001|Overall Study|Protocol Violation|1|||
156861061|NCT00945009|566249096|FG002|Overall Study|Protocol Violation|0|||
156861062|NCT00945009|566249094|FG000|Overall Study|Withdrawal by Subject|1|||
156861063|NCT00945009|566249095|FG001|Overall Study|Withdrawal by Subject|0|||
156861064|NCT00945009|566249096|FG002|Overall Study|Withdrawal by Subject|0|||
156861065|NCT00945009|566249094|FG000|Overall Study|Ineligible|6|||
156861066|NCT00945009|566249095|FG001|Overall Study|Ineligible|1|||
156861067|NCT00945009|566249096|FG002|Overall Study|Ineligible|0|||
156861068|NCT00945009|566249094|FG000|Overall Study|Inevaluable|0|||
156861069|NCT00945009|566249095|FG001|Overall Study|Inevaluable|1|||
156861070|NCT00945009|566249096|FG002|Overall Study|Inevaluable|0|||
156861071|NCT00945009|566249094|FG000|Overall Study|Refusal of further protocol|1|||
156861072|NCT00945009|566249095|FG001|Overall Study|Refusal of further protocol|0|||
156861073|NCT00945009|566249096|FG002|Overall Study|Refusal of further protocol|0|||
156861074|NCT03724942|566249097|FG000|Overall Study|Adverse Event|20|||
156861075|NCT03724942|566249098|FG001|Overall Study|Adverse Event|14|||
156861076|NCT03724942|566249097|FG000|Overall Study|Lack of Efficacy|0|||
156861077|NCT03724942|566249098|FG001|Overall Study|Lack of Efficacy|1|||
156861078|NCT03724942|566249097|FG000|Overall Study|Physician Decision|5|||
156861079|NCT03724942|566249098|FG001|Overall Study|Physician Decision|2|||
156475506|NCT01951703|564835594|FG000|Second Intervention|Protocol Violation|0|||
156475507|NCT01951703|564835595|FG001|Second Intervention|Protocol Violation|1|||
156475508|NCT01951703|564835594|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
156861080|NCT03724942|566249097|FG000|Overall Study|Protocol Violation|1|||
156861081|NCT03724942|566249098|FG001|Overall Study|Protocol Violation|0|||
156861082|NCT03724942|566249097|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
156475509|NCT01951703|564835595|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
156475510|NCT01019135|564835601|FG000|Overall Study|Did not receive allocated intervention|12|||
156861083|NCT03724942|566249098|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
156861084|NCT03724942|566249097|FG000|Overall Study|Withdrawal by Legal Representative|3|||
156861085|NCT03724942|566249098|FG001|Overall Study|Withdrawal by Legal Representative|0|||
156861086|NCT04875975|566249099|FG000|Overall Study|Adverse Event|1|||
156861087|NCT04875975|566249100|FG001|Overall Study|Adverse Event|2|||
156861088|NCT04875975|566249099|FG000|Overall Study|Lack of Efficacy|2|||
156861089|NCT04875975|566249100|FG001|Overall Study|Lack of Efficacy|2|||
156861090|NCT04875975|566249099|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
156861091|NCT04875975|566249100|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
156861092|NCT04875975|566249099|FG000|Overall Study|Relapse With Insults|0|||
156861093|NCT04875975|566249100|FG001|Overall Study|Relapse With Insults|1|||
156861094|NCT04875975|566249099|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
156861095|NCT04875975|566249100|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
156861096|NCT02429830|566249101|FG000|Overall Study|Lost to Follow-up|1|||
156861097|NCT02429830|566249101|FG000|Overall Study|Device Explant|2|||
156861098|NCT00474487|566250678|FG000|Overall Study|Withdrawal by Subject|6|||
156861099|NCT00474487|566250679|FG001|Overall Study|Withdrawal by Subject|0|||
156861100|NCT00474487|566250680|FG002|Overall Study|Withdrawal by Subject|0|||
156861101|NCT00474487|566250681|FG003|Overall Study|Withdrawal by Subject|0|||
156861102|NCT00474487|566250678|FG000|Overall Study|Lost to Follow-up|20|||
156861103|NCT00474487|566250679|FG001|Overall Study|Lost to Follow-up|1|||
156861104|NCT00474487|566250680|FG002|Overall Study|Lost to Follow-up|7|||
156861105|NCT00474487|566250681|FG003|Overall Study|Lost to Follow-up|0|||
156861106|NCT00474487|566250678|FG000|Overall Study|Inappropriate enrollment|4|||
156861107|NCT00474487|566250679|FG001|Overall Study|Inappropriate enrollment|0|||
156861108|NCT00474487|566250680|FG002|Overall Study|Inappropriate enrollment|7|||
156861109|NCT00474487|566250681|FG003|Overall Study|Inappropriate enrollment|0|||
156861110|NCT00474487|566250678|FG000|Overall Study|Death|0|||
156861111|NCT00474487|566250679|FG001|Overall Study|Death|1|||
156861112|NCT00474487|566250680|FG002|Overall Study|Death|0|||
156861113|NCT00474487|566250681|FG003|Overall Study|Death|0|||
156861114|NCT02220920|566250682|FG000|Overall Study|Adverse Event|1|||
156861115|NCT02220920|566250683|FG001|Overall Study|Adverse Event|0|||
156861116|NCT02220920|566250682|FG000|Overall Study|Lack of Efficacy|0|||
156861117|NCT02220920|566250683|FG001|Overall Study|Lack of Efficacy|1|||
156861118|NCT02220920|566250682|FG000|Overall Study|Withdrawal by Subject|1|||
156861119|NCT02220920|566250683|FG001|Overall Study|Withdrawal by Subject|0|||
156861120|NCT02220920|566250682|FG000|Overall Study|Conflict with the stopping criteria|1|||
156861121|NCT02220920|566250683|FG001|Overall Study|Conflict with the stopping criteria|2|||
156861122|NCT05176314|566250686|FG000|Overall Study|Lost to Follow-up|2|||
156861123|NCT05176314|566250686|FG000|Overall Study|Physician Decision|1|||
156861124|NCT05176314|566250686|FG000|Overall Study|Adverse Event|1|||
156861125|NCT05543265|566250689|FG000|Overall Study|Lost to Follow-up|3|||
156861126|NCT05543265|566250690|FG001|Overall Study|Lost to Follow-up|3|||
156861127|NCT05543265|566250689|FG000|Overall Study|Withdrawal by Subject|0|||
156861128|NCT05543265|566250690|FG001|Overall Study|Withdrawal by Subject|1|||
156861129|NCT05316597|566250691|FG000|First Session|Withdrawal by Subject|0|||
156861130|NCT05316597|566250692|FG001|First Session|Withdrawal by Subject|1|||
156861131|NCT05316597|566250691|FG000|Washout Period|Lost to Follow-up|1|||
156861132|NCT05316597|566250692|FG001|Washout Period|Lost to Follow-up|2|||
156861133|NCT05316597|566250691|FG000|Washout Period|Physician Decision|1|||
156475511|NCT01019135|564835602|FG001|Overall Study|Did not receive allocated intervention|6|||
156475512|NCT01019135|564835603|FG002|Overall Study|Did not receive allocated intervention|25|||
156475513|NCT01019135|564835601|FG000|Overall Study|Did not attend CR|8|||
156475514|NCT01019135|564835602|FG001|Overall Study|Did not attend CR|13|||
156475515|NCT01019135|564835603|FG002|Overall Study|Did not attend CR|6|||
156475516|NCT05124210|564835604|FG000|Overall Study|Lost to Follow-up|1|||
156475517|NCT05124210|564835605|FG001|Overall Study|Lost to Follow-up|0|||
156475518|NCT05124210|564835604|FG000|Overall Study|Withdrawal by Subject|1|||
156542342|NCT01342484|565079331|FG001|Overall Study|Other Reasons|0|||
156542343|NCT01342484|565079332|FG002|Overall Study|Other Reasons|0|||
156542344|NCT01342484|565079330|FG000|Overall Study|Protocol Violation|0|||
156475519|NCT05124210|564835605|FG001|Overall Study|Withdrawal by Subject|0|||
156861134|NCT05316597|566250692|FG001|Washout Period|Physician Decision|1|||
156861135|NCT05316597|566250691|FG000|Washout Period|Excluded before second session|1|||
156475520|NCT00638456|564835606|FG000|Overall Study|Withdrawal by Subject|6|||
156542345|NCT01342484|565079331|FG001|Overall Study|Protocol Violation|0|||
156861136|NCT05316597|566250692|FG001|Washout Period|Excluded before second session|1|||
156861137|NCT05316597|566250691|FG000|Washout Period|Withdrawal by Subject|0|||
156861138|NCT05316597|566250692|FG001|Washout Period|Withdrawal by Subject|4|||
156861139|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
156861140|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
156861141|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
156861142|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Death|9|||
156861143|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Death|0|||
156861144|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Death|0|||
156861145|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
156861146|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
156861147|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
156475521|NCT00638456|564835607|FG001|Overall Study|Withdrawal by Subject|2|||
156475522|NCT02007070|564835608|FG000|Overall Study|Adverse Event|4|||
156475523|NCT02007070|564835608|FG000|Overall Study|Clinical Progression|4|||
156861148|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
156861149|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
156861150|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
156861151|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Other|135|||
156861152|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Other|0|||
156861153|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Other|0|||
156861154|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
156861155|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
156861156|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
156861157|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
156861158|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
156861159|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
156861160|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
156861161|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
156861162|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
156861163|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Other|3|||
156861164|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Other|0|||
156861165|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Other|0|||
156861166|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
156861167|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
156475524|NCT02007070|564835608|FG000|Overall Study|Death|1|||
156475525|NCT02007070|564835608|FG000|Overall Study|Protocol Violation|2|||
156475526|NCT02007070|564835608|FG000|Overall Study|Physician Decision|1|||
156861168|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
156861169|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
156861170|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
156861171|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
156861172|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
156861173|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
156861174|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
156861175|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
156861176|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
156861177|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
156861178|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
156861179|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
156861180|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
156861181|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
156861182|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
156861183|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
156861184|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
156861185|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
156861186|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
156861187|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
156861188|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
156861189|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
156861190|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
156861191|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
156861192|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
156861193|NCT02182895|566250698|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
156475527|NCT02007070|564835608|FG000|Overall Study|Progressive Disease|21|||
156475528|NCT03128099|564835611|FG000|Overall Study|High dose task was too long|0|||
156475529|NCT03128099|564835612|FG001|Overall Study|High dose task was too long|4|||
156861194|NCT02182895|566250699|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
156861195|NCT03103542|566250700|FG000|Overall Study|Physician Decision|2|||
156861196|NCT03103542|566250700|FG000|Overall Study|Adverse Event|2|||
156861197|NCT03103542|566250700|FG000|Overall Study|Other|2|||
156861198|NCT03103542|566250700|FG000|Overall Study|Withdrawal by Subject|1|||
156861199|NCT03566511|566250701|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
156475530|NCT03128099|564835613|FG002|Overall Study|High dose task was too long|0|||
156475531|NCT03128099|564835611|FG000|Overall Study|Participant got a full time job.|1|||
156475532|NCT03128099|564835612|FG001|Overall Study|Participant got a full time job.|0|||
156475533|NCT03128099|564835613|FG002|Overall Study|Participant got a full time job.|0|||
156475534|NCT03128099|564835611|FG000|Overall Study|Became homeless and lost contact|1|||
156475535|NCT03128099|564835612|FG001|Overall Study|Became homeless and lost contact|0|||
156475536|NCT03128099|564835613|FG002|Overall Study|Became homeless and lost contact|0|||
156475537|NCT03128099|564835611|FG000|Overall Study|Did not complete all the assessments|0|||
156475538|NCT03128099|564835612|FG001|Overall Study|Did not complete all the assessments|0|||
156475539|NCT03128099|564835613|FG002|Overall Study|Did not complete all the assessments|1|||
156542346|NCT01342484|565079332|FG002|Overall Study|Protocol Violation|1|||
156542347|NCT01342484|565079330|FG000|Overall Study|Withdrawal by Subject|1|||
156542348|NCT01342484|565079331|FG001|Overall Study|Withdrawal by Subject|0|||
156542349|NCT01342484|565079332|FG002|Overall Study|Withdrawal by Subject|0|||
156542350|NCT01840579|565079333|FG000|Overall Study|Status not recorded|0|||
156542351|NCT01840579|565079334|FG001|Overall Study|Status not recorded|0|||
156542352|NCT01840579|565079335|FG002|Overall Study|Status not recorded|2|||
156542353|NCT01840579|565079336|FG003|Overall Study|Status not recorded|3|||
156542354|NCT01840579|565079337|FG004|Overall Study|Status not recorded|4|||
156542355|NCT01840579|565079338|FG005|Overall Study|Status not recorded|3|||
156542356|NCT01840579|565079339|FG006|Overall Study|Status not recorded|0|||
156542357|NCT01840579|565079340|FG007|Overall Study|Status not recorded|3|||
156542358|NCT01840579|565079341|FG008|Overall Study|Status not recorded|3|||
156542359|NCT01840579|565079342|FG009|Overall Study|Status not recorded|3|||
156542360|NCT01840579|565079333|FG000|Overall Study|Progressive disease|3|||
156542361|NCT01840579|565079334|FG001|Overall Study|Progressive disease|5|||
156542362|NCT01840579|565079335|FG002|Overall Study|Progressive disease|0|||
156542363|NCT01840579|565079336|FG003|Overall Study|Progressive disease|0|||
156542364|NCT01840579|565079337|FG004|Overall Study|Progressive disease|0|||
156542365|NCT01840579|565079338|FG005|Overall Study|Progressive disease|0|||
156542366|NCT01840579|565079339|FG006|Overall Study|Progressive disease|0|||
156542367|NCT01840579|565079340|FG007|Overall Study|Progressive disease|0|||
156542368|NCT01840579|565079341|FG008|Overall Study|Progressive disease|0|||
156542369|NCT01840579|565079342|FG009|Overall Study|Progressive disease|0|||
156542370|NCT01840579|565079333|FG000|Overall Study|Ongoing in study|0|||
156861200|NCT03566511|566250702|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
156861201|NCT02939287|566250706|FG000|Overall Study|met exclusion criteria|1|||
156861202|NCT02939287|566250707|FG001|Overall Study|met exclusion criteria|1|||
156861203|NCT02939287|566250708|FG002|Overall Study|met exclusion criteria|1|||
156861204|NCT02939287|566250706|FG000|Overall Study|Did not complete survey|2|||
156861205|NCT02939287|566250707|FG001|Overall Study|Did not complete survey|2|||
156861206|NCT02939287|566250708|FG002|Overall Study|Did not complete survey|0|||
156542371|NCT01840579|565079334|FG001|Overall Study|Ongoing in study|1|||
156861207|NCT02939287|566250706|FG000|Overall Study|Withdrawal by Subject|1|||
156861208|NCT02939287|566250707|FG001|Overall Study|Withdrawal by Subject|1|||
156861209|NCT02939287|566250708|FG002|Overall Study|Withdrawal by Subject|0|||
156861210|NCT02927301|566250709|FG000|Overall Study|Death|39|||
156861211|NCT02927301|566250709|FG000|Overall Study|Lost to Follow-up|8|||
156861212|NCT02927301|566250709|FG000|Overall Study|Physician Decision|2|||
156861213|NCT02927301|566250709|FG000|Overall Study|Withdrawal by Subject|12|||
156861214|NCT02927301|566250709|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
156861215|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
156861216|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861217|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861218|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861219|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861220|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861221|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
156861222|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
156861223|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
156861224|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
156475540|NCT02362789|564835621|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
156861225|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
156542372|NCT01840579|565079335|FG002|Overall Study|Ongoing in study|0|||
156542373|NCT01840579|565079336|FG003|Overall Study|Ongoing in study|0|||
156542374|NCT01840579|565079337|FG004|Overall Study|Ongoing in study|0|||
156861226|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
156861227|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
156542375|NCT01840579|565079338|FG005|Overall Study|Ongoing in study|0|||
156542376|NCT01840579|565079339|FG006|Overall Study|Ongoing in study|0|||
156542377|NCT01840579|565079340|FG007|Overall Study|Ongoing in study|0|||
156542378|NCT01840579|565079341|FG008|Overall Study|Ongoing in study|0|||
156542379|NCT01840579|565079342|FG009|Overall Study|Ongoing in study|0|||
156542380|NCT01840579|565079333|FG000|Overall Study|Death|0|||
156542381|NCT01840579|565079334|FG001|Overall Study|Death|0|||
156861228|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
156861229|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861230|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861231|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
156861232|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861233|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861234|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
156861235|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861236|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861237|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861238|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861239|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861240|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
156861241|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861242|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861243|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861244|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861245|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861246|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861247|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861248|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
156475541|NCT02362789|564835622|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
156475542|NCT02362789|564835623|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
156475543|NCT02362789|564835621|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
156475544|NCT02362789|564835622|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
156475545|NCT02362789|564835623|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
156475546|NCT02362789|564835621|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
156475547|NCT02362789|564835622|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
156475548|NCT02362789|564835623|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
156475549|NCT02362789|564835621|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
156475550|NCT02362789|564835622|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
156475551|NCT02362789|564835623|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
156475552|NCT02362789|564835621|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
156475553|NCT02362789|564835622|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
156475554|NCT02362789|564835623|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
156475555|NCT05074433|564835626|FG000|Overall Study|Adverse Event|0|||
156475556|NCT05074433|564835627|FG001|Overall Study|Adverse Event|2|||
156475557|NCT05074433|564835628|FG002|Overall Study|Adverse Event|0|||
156475558|NCT05074433|564835629|FG003|Overall Study|Adverse Event|1|||
156475559|NCT05074433|564835626|FG000|Overall Study|Sponsor Request|0|||
156475560|NCT05074433|564835627|FG001|Overall Study|Sponsor Request|1|||
156475561|NCT05074433|564835628|FG002|Overall Study|Sponsor Request|1|||
156475562|NCT05074433|564835629|FG003|Overall Study|Sponsor Request|0|||
156475563|NCT05074433|564835626|FG000|Overall Study|Death|1|||
156475564|NCT05074433|564835627|FG001|Overall Study|Death|0|||
156475565|NCT05074433|564835628|FG002|Overall Study|Death|0|||
156475566|NCT05074433|564835629|FG003|Overall Study|Death|0|||
156475567|NCT05074433|564835626|FG000|Overall Study|Lost to Follow-up|0|||
156475568|NCT05074433|564835627|FG001|Overall Study|Lost to Follow-up|0|||
156475569|NCT05074433|564835628|FG002|Overall Study|Lost to Follow-up|2|||
156475570|NCT05074433|564835629|FG003|Overall Study|Lost to Follow-up|0|||
156475571|NCT05074433|564835626|FG000|Overall Study|Subject Decision|8|||
156475572|NCT05074433|564835627|FG001|Overall Study|Subject Decision|6|||
156475573|NCT05074433|564835628|FG002|Overall Study|Subject Decision|4|||
156475574|NCT05074433|564835629|FG003|Overall Study|Subject Decision|5|||
156475575|NCT04397263|564835630|FG000|Overall Study|Withdrawal by Subject|2|||
156475576|NCT05270460|564835631|FG000|Overall Study|Adverse Event|0|||
156475577|NCT05270460|564835632|FG001|Overall Study|Adverse Event|1|||
156475578|NCT05270460|564835633|FG002|Overall Study|Adverse Event|0|||
156861249|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861250|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156343839|NCT03708328|564358505|FG002|Overall Study|Withdrawal by Subject|0|||
156343840|NCT03708328|564358506|FG003|Overall Study|Withdrawal by Subject|0|||
156475579|NCT05270460|564835631|FG000|Overall Study|Early Termination|0|||
156475580|NCT05270460|564835632|FG001|Overall Study|Early Termination|1|||
156475581|NCT05270460|564835633|FG002|Overall Study|Early Termination|0|||
156475582|NCT00680771|564835636|FG000|Overall Study|Withdrawal by Subject|1|||
156475583|NCT00680771|564835637|FG001|Overall Study|Withdrawal by Subject|0|||
156475584|NCT00680771|564835636|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
156475585|NCT00680771|564835637|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
156475586|NCT00680771|564835636|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
156475587|NCT00680771|564835637|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
156861251|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861252|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861253|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861254|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
156861255|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861256|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861257|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861258|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861259|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861260|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861261|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
156861262|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861263|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861264|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861265|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861266|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861267|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861268|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
156861269|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861270|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861271|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861272|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861273|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861274|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861275|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
156861276|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861277|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861278|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861279|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861280|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861281|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861282|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
156861283|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861284|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861285|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861286|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861287|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861288|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861289|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
156861290|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861291|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861292|NCT02218372|566250717|FG000|Overall Study|Adverse Event|1|||
156861293|NCT02218372|566250718|FG001|Overall Study|Adverse Event|1|||
156861294|NCT02218372|566250717|FG000|Overall Study|Miscellaneous|2|||
156861295|NCT02218372|566250718|FG001|Overall Study|Miscellaneous|1|||
156861296|NCT02218372|566250717|FG000|Overall Study|Randomized but did not receive treatment|2|||
156861297|NCT02218372|566250718|FG001|Overall Study|Randomized but did not receive treatment|3|||
156861298|NCT02218372|566250717|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156861299|NCT02218372|566250718|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156861300|NCT03406780|566250723|FG000|Overall Study|Withdrawal by Subject|1|||
156861301|NCT03406780|566250724|FG001|Overall Study|Withdrawal by Subject|1|||
156861302|NCT03406780|566250723|FG000|Overall Study|Other|0|||
156861303|NCT03406780|566250724|FG001|Overall Study|Other|2|||
156861304|NCT01488045|566250729|FG000|Overall Study|Withdrawal by Subject|6|||
156861305|NCT01488045|566250730|FG001|Overall Study|Withdrawal by Subject|11|||
156861306|NCT01488045|566250729|FG000|Overall Study|Failure to present for colonoscopy|3|||
156861307|NCT01488045|566250730|FG001|Overall Study|Failure to present for colonoscopy|6|||
156861308|NCT01488045|566250729|FG000|Overall Study|Failure to report exclusion criteria|0|||
156861309|NCT01488045|566250730|FG001|Overall Study|Failure to report exclusion criteria|1|||
156861310|NCT05365217|566250732|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156861311|NCT05365217|566250733|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156861312|NCT01680341|566250736|FG000|Overall Study|Adverse Event|3|||
156861313|NCT01680341|566250737|FG001|Overall Study|Adverse Event|2|||
156861314|NCT01680341|566250736|FG000|Overall Study|Unclassified|18|||
156861315|NCT01680341|566250737|FG001|Overall Study|Unclassified|15|||
156861316|NCT03796728|566250739|FG000|Overall Study|Lost to Follow-up|8|||
156861317|NCT03796728|566250739|FG000|Overall Study|Reason not Specified|16|||
156861318|NCT00333775|566250740|FG000|Overall Study|Death|144|||
156861319|NCT00333775|566250741|FG001|Overall Study|Death|149|||
156861320|NCT00333775|566250742|FG002|Overall Study|Death|143|||
156861321|NCT00333775|566250740|FG000|Overall Study|In Follow-up When Study Stopped|87|||
156861322|NCT00333775|566250741|FG001|Overall Study|In Follow-up When Study Stopped|92|||
156861323|NCT00333775|566250742|FG002|Overall Study|In Follow-up When Study Stopped|96|||
156861324|NCT00333775|566250740|FG000|Overall Study|Lost to Follow-up|10|||
156861325|NCT00333775|566250741|FG001|Overall Study|Lost to Follow-up|7|||
156861326|NCT00333775|566250742|FG002|Overall Study|Lost to Follow-up|8|||
156861327|NCT02476617|566250743|FG000|Overall Study|Adverse Event|1|||
156861328|NCT02476617|566250743|FG000|Overall Study|Lost to Follow-up|1|||
156861329|NCT01383928|566250744|FG000|Overall Study|Initiation of ASCT|2|||
156861330|NCT01383928|566250745|FG001|Overall Study|Initiation of ASCT|1|||
156861331|NCT01383928|566250746|FG002|Overall Study|Initiation of ASCT|18|||
156861332|NCT01383928|566250744|FG000|Overall Study|Adverse Event|1|||
156861333|NCT01383928|566250745|FG001|Overall Study|Adverse Event|2|||
156861334|NCT01383928|566250746|FG002|Overall Study|Adverse Event|8|||
156861335|NCT01383928|566250744|FG000|Overall Study|Other|1|||
156861336|NCT01383928|566250745|FG001|Overall Study|Other|3|||
156861337|NCT01383928|566250746|FG002|Overall Study|Other|4|||
156861338|NCT01383928|566250744|FG000|Overall Study|Progressive Disease|1|||
156861339|NCT01383928|566250745|FG001|Overall Study|Progressive Disease|1|||
156861340|NCT01383928|566250746|FG002|Overall Study|Progressive Disease|5|||
156861341|NCT01383928|566250744|FG000|Overall Study|Withdrawal by Subject|0|||
156861342|NCT01383928|566250745|FG001|Overall Study|Withdrawal by Subject|0|||
156861343|NCT01383928|566250746|FG002|Overall Study|Withdrawal by Subject|4|||
156861344|NCT01383928|566250744|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
156861345|NCT01383928|566250745|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
156861346|NCT01383928|566250746|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
156861347|NCT02491684|566250747|FG000|Treatment Phase|Adverse Event|2|||
156861348|NCT02491684|566250748|FG001|Treatment Phase|Adverse Event|2|||
156861349|NCT02491684|566250747|FG000|Treatment Phase|Incorrect randomisation|1|||
156861350|NCT02491684|566250748|FG001|Treatment Phase|Incorrect randomisation|0|||
156861351|NCT02491684|566250747|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
156861352|NCT02491684|566250748|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
156861353|NCT01149096|566250749|FG000|Overall Study|Lost to Follow-up|0|||
156861354|NCT01149096|566250750|FG001|Overall Study|Lost to Follow-up|1|||
156861355|NCT04739982|566250752|FG000|Overall Study|Lost to Follow-up|176|||
156861356|NCT04739982|566250753|FG001|Overall Study|Lost to Follow-up|65|||
156861357|NCT04739982|566250752|FG000|Overall Study|Withdrawal by Subject|19|||
156861358|NCT04739982|566250753|FG001|Overall Study|Withdrawal by Subject|0|||
156861359|NCT04739982|566250752|FG000|Overall Study|Protocol Violation|0|||
156861360|NCT04739982|566250753|FG001|Overall Study|Protocol Violation|5|||
156861361|NCT03651765|566250754|FG000|Overall Study|Adverse Event|6|||
156861362|NCT03651765|566250754|FG000|Overall Study|Lack of Efficacy|18|||
156861363|NCT03651765|566250754|FG000|Overall Study|Lost to Follow-up|5|||
156861364|NCT03651765|566250754|FG000|Overall Study|Non-Compliance with Study Drug|4|||
156861365|NCT03651765|566250754|FG000|Overall Study|Physician Decision|6|||
156861366|NCT03651765|566250754|FG000|Overall Study|Pregnancy|1|||
156861367|NCT03651765|566250754|FG000|Overall Study|Discontinued by Sponsor|40|||
156861368|NCT03651765|566250754|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
156861369|NCT03651765|566250754|FG000|Overall Study|Withdrawal by Subject|24|||
156861370|NCT03651765|566250754|FG000|Overall Study|Miscellaneous|6|||
156475588|NCT03205488|564835647|FG000|Overall Study|Adverse Event|1|||
156475589|NCT03205488|564835648|FG001|Overall Study|Adverse Event|2|||
156475590|NCT03205488|564835649|FG002|Overall Study|Adverse Event|4|||
156475591|NCT03205488|564835647|FG000|Overall Study|Protocol Violation|0|||
156861371|NCT04914364|566250755|FG000|Overall Study|No longer eligible for study|1|||
156861372|NCT04914364|566250755|FG000|Overall Study|Lost to Follow-up|2|||
156861373|NCT01263769|566250756|FG000|Overall Study|Non-Compliant with treatment|1|||
156861374|NCT03267277|566250757|FG000|Overall Study|Withdrawal by Subject|1|||
156861375|NCT00702702|566250762|FG000|Overall Study|Study prematurely terminated|56|||
156861376|NCT03521570|566250765|FG000|Overall Study|Not eligible|11|||
156861377|NCT01667900|566250766|FG000|Part B|Death|0|||
156861378|NCT01667900|566250767|FG001|Part B|Death|0|||
156861379|NCT01667900|566250768|FG002|Part B|Death|0|||
156861380|NCT01667900|566250769|FG003|Part B|Death|0|||
156861381|NCT01667900|566250770|FG004|Part B|Death|0|||
156861382|NCT01667900|566250771|FG005|Part B|Death|0|||
156861383|NCT01667900|566250772|FG006|Part B|Death|0|||
156861384|NCT01667900|566250773|FG007|Part B|Death|0|||
156861385|NCT01667900|566250774|FG008|Part B|Death|0|||
156861386|NCT01667900|566250775|FG009|Part B|Death|0|||
156861387|NCT01667900|566250776|FG010|Part B|Death|0|||
156861388|NCT01667900|566250777|FG011|Part B|Death|0|||
156861389|NCT01667900|566250778|FG012|Part B|Death|0|||
156861390|NCT01667900|566250779|FG013|Part B|Death|0|||
156861391|NCT01667900|566250780|FG014|Part B|Death|0|||
156861392|NCT01667900|566250781|FG015|Part B|Death|0|||
156861393|NCT01667900|566250782|FG016|Part B|Death|1|||
156861394|NCT01667900|566250783|FG017|Part B|Death|0|||
156861395|NCT01667900|566250784|FG018|Part B|Death|0|||
156861396|NCT01667900|566250785|FG019|Part B|Death|0|||
156861397|NCT00468169|566250788|FG000|Overall Study|Withdrawal by Subject|1|||
156861398|NCT00468169|566250789|FG001|Overall Study|Withdrawal by Subject|0|||
156861399|NCT00784563|566250790|FG000|Years 1 & 2|Withdrawal by Subject|3|||
156861400|NCT00784563|566250791|FG001|Years 1 & 2|Withdrawal by Subject|2|||
156861401|NCT00784563|566250792|FG002|Years 1 & 2|Withdrawal by Subject|0|||
156861402|NCT00784563|566250790|FG000|Years 1 & 2|Adverse Event|0|||
156861403|NCT00784563|566250791|FG001|Years 1 & 2|Adverse Event|3|||
156861404|NCT00784563|566250792|FG002|Years 1 & 2|Adverse Event|0|||
156861405|NCT00784563|566250790|FG000|Year 3|Withdrawal by Subject|0|||
156861406|NCT00784563|566250791|FG001|Year 3|Withdrawal by Subject|0|||
156861407|NCT00784563|566250792|FG002|Year 3|Withdrawal by Subject|2|||
156861408|NCT00784563|566250790|FG000|Year 3|Adverse Event|0|||
156861409|NCT00784563|566250791|FG001|Year 3|Adverse Event|0|||
156861410|NCT00784563|566250792|FG002|Year 3|Adverse Event|1|||
156861411|NCT00762164|566250793|FG000|Overall Study|Lost to Follow-up|1|||
156861412|NCT00762164|566250794|FG001|Overall Study|Lost to Follow-up|1|||
156861413|NCT00762164|566250793|FG000|Overall Study|Discontinued medication|2|||
156861414|NCT00762164|566250794|FG001|Overall Study|Discontinued medication|0|||
156861415|NCT00762164|566250793|FG000|Overall Study|Withdrawal by Subject|0|||
156861416|NCT00762164|566250794|FG001|Overall Study|Withdrawal by Subject|1|||
156861417|NCT03600909|566250795|FG000|Overall Study|Not treated|0|||
156861418|NCT03600909|566250796|FG001|Overall Study|Not treated|3|||
156861419|NCT03600909|566250797|FG002|Overall Study|Not treated|0|||
156861420|NCT01607957|566250805|FG000|Overall Study|Not treated|1|||
156861421|NCT01607957|566250806|FG001|Overall Study|Not treated|1|||
156861422|NCT01607957|566250805|FG000|Overall Study|Death|367|||
156861423|NCT01607957|566250806|FG001|Overall Study|Death|211|||
156861424|NCT01607957|566250805|FG000|Overall Study|Lost to Follow-up|3|||
156861425|NCT01607957|566250806|FG001|Overall Study|Lost to Follow-up|3|||
156861426|NCT01607957|566250805|FG000|Overall Study|Participant refusal|1|||
156861427|NCT01607957|566250806|FG001|Overall Study|Participant refusal|0|||
156861428|NCT01691794|566250807|FG000|Overall Study|Poor/Non-Compliance|1|||
156861429|NCT01691794|566250808|FG001|Overall Study|Poor/Non-Compliance|4|||
156861430|NCT01691794|566250809|FG002|Overall Study|Poor/Non-Compliance|1|||
156861431|NCT01691794|566250807|FG000|Overall Study|Death|0|||
156861432|NCT01691794|566250808|FG001|Overall Study|Death|0|||
156861433|NCT01691794|566250809|FG002|Overall Study|Death|1|||
156861434|NCT01691794|566250807|FG000|Overall Study|Lack of Efficacy|0|||
156861435|NCT01691794|566250808|FG001|Overall Study|Lack of Efficacy|7|||
156861436|NCT01691794|566250809|FG002|Overall Study|Lack of Efficacy|1|||
156861437|NCT01691794|566250807|FG000|Overall Study|Participant request to discontinue|0|||
156861438|NCT01691794|566250808|FG001|Overall Study|Participant request to discontinue|1|||
156861439|NCT01691794|566250809|FG002|Overall Study|Participant request to discontinue|0|||
156861440|NCT01691794|566250807|FG000|Overall Study|Adverse Event|0|||
156861441|NCT01691794|566250808|FG001|Overall Study|Adverse Event|1|||
156861442|NCT01691794|566250809|FG002|Overall Study|Adverse Event|1|||
156861443|NCT01691794|566250807|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
156861444|NCT01691794|566250808|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
156861445|NCT01691794|566250809|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
156861446|NCT01691794|566250807|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
156861447|NCT01691794|566250808|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
156475592|NCT03205488|564835648|FG001|Overall Study|Protocol Violation|0|||
156475593|NCT03205488|564835649|FG002|Overall Study|Protocol Violation|1|||
156475594|NCT04748341|564835651|FG000|Overall Study|Lost to Follow-up|1|||
156475595|NCT04748341|564835652|FG001|Overall Study|Lost to Follow-up|1|||
156475596|NCT05615363|564835653|FG000|Overall Study|Adverse Event|0|||
156861448|NCT01691794|566250809|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
156861449|NCT00844844|566250810|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
156861450|NCT00844844|566250810|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
156861451|NCT00844844|566250810|FG000|Extension Treatment Period|Adverse Event|2|||
156861452|NCT00844844|566250810|FG000|Post Treatment Period|Withdrawal by Subject|1|||
156861453|NCT03905096|566250811|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
156861454|NCT03905096|566250812|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
156861455|NCT02016781|566250813|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
156861456|NCT02016781|566250814|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
156861457|NCT02016781|566250813|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
156861458|NCT02016781|566250814|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
156861459|NCT02016781|566250813|FG000|Final Database Lock|Withdrawal by Subject|2|||
156475597|NCT05615363|564835654|FG001|Overall Study|Adverse Event|4|||
156475598|NCT05615363|564835655|FG002|Overall Study|Adverse Event|4|||
156475599|NCT05615363|564835656|FG003|Overall Study|Adverse Event|3|||
156475600|NCT05615363|564835657|FG004|Overall Study|Adverse Event|1|||
156475601|NCT05615363|564835653|FG000|Overall Study|Physician Decision|2|||
156475602|NCT05615363|564835654|FG001|Overall Study|Physician Decision|0|||
156475603|NCT05615363|564835655|FG002|Overall Study|Physician Decision|4|||
156475604|NCT05615363|564835656|FG003|Overall Study|Physician Decision|1|||
156475605|NCT05615363|564835657|FG004|Overall Study|Physician Decision|3|||
156475606|NCT05615363|564835653|FG000|Overall Study|Protocol Violation|2|||
156475607|NCT05615363|564835654|FG001|Overall Study|Protocol Violation|0|||
156475608|NCT05615363|564835655|FG002|Overall Study|Protocol Violation|0|||
156475609|NCT05615363|564835656|FG003|Overall Study|Protocol Violation|0|||
156475610|NCT05615363|564835657|FG004|Overall Study|Protocol Violation|1|||
156475611|NCT05615363|564835653|FG000|Overall Study|Withdrawal by Subject|0|||
156475612|NCT05615363|564835654|FG001|Overall Study|Withdrawal by Subject|0|||
156475613|NCT05615363|564835655|FG002|Overall Study|Withdrawal by Subject|1|||
156475614|NCT05615363|564835656|FG003|Overall Study|Withdrawal by Subject|0|||
156475615|NCT05615363|564835657|FG004|Overall Study|Withdrawal by Subject|0|||
156475616|NCT02092285|564837417|FG000|Induction Phase|Adverse Event|7|||
156475617|NCT02092285|564837417|FG000|Induction Phase|Physician Decision|4|||
156475618|NCT02092285|564837417|FG000|Induction Phase|Pregnancy|1|||
156475619|NCT02092285|564837417|FG000|Induction Phase|Relapse/Recurrence|7|||
156475620|NCT02092285|564837417|FG000|Induction Phase|Withdrawal by Subject|2|||
156475621|NCT02092285|564837417|FG000|Induction Phase|Lack of Efficacy|14|||
156475622|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
156475623|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
156475624|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
156475625|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
156475626|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
156475627|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
156475628|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
156475629|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
156475630|NCT02092285|564837417|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
156475631|NCT00087516|564837418|FG000|Overall Study|Adverse Event|10|||
156475632|NCT00087516|564837419|FG001|Overall Study|Adverse Event|10|||
156475633|NCT00087516|564837420|FG002|Overall Study|Adverse Event|3|||
156475634|NCT00087516|564837421|FG003|Overall Study|Adverse Event|6|||
156475635|NCT00087516|564837418|FG000|Overall Study|Lack of Efficacy|82|||
156861460|NCT02016781|566250814|FG001|Final Database Lock|Withdrawal by Subject|1|||
156861461|NCT02016781|566250813|FG000|Final Database Lock|Lost to Follow-up|11|||
156861462|NCT02016781|566250814|FG001|Final Database Lock|Lost to Follow-up|4|||
156861463|NCT02016781|566250813|FG000|Final Database Lock|Missing data|0|||
156861464|NCT02016781|566250814|FG001|Final Database Lock|Missing data|3|||
156861465|NCT04886154|566250817|FG000|Overall Study|Adverse Event|0|||
156861466|NCT04886154|566250818|FG001|Overall Study|Adverse Event|0|||
156861467|NCT04886154|566250819|FG002|Overall Study|Adverse Event|0|||
156861468|NCT04886154|566250820|FG003|Overall Study|Adverse Event|0|||
156861469|NCT04886154|566250821|FG004|Overall Study|Adverse Event|1|||
156861470|NCT04886154|566250822|FG005|Overall Study|Adverse Event|0|||
156861471|NCT04886154|566250823|FG006|Overall Study|Adverse Event|0|||
156861472|NCT04886154|566250824|FG007|Overall Study|Adverse Event|1|||
156861473|NCT04886154|566250825|FG008|Overall Study|Adverse Event|1|||
156861474|NCT04886154|566250826|FG009|Overall Study|Adverse Event|0|||
156861475|NCT04886154|566250827|FG010|Overall Study|Adverse Event|0|||
156861476|NCT04886154|566250828|FG011|Overall Study|Adverse Event|1|||
156861477|NCT04886154|566250829|FG012|Overall Study|Adverse Event|0|||
156861478|NCT04886154|566250830|FG013|Overall Study|Adverse Event|0|||
156861479|NCT04886154|566250831|FG014|Overall Study|Adverse Event|3|||
156861480|NCT04886154|566250817|FG000|Overall Study|Lost to Follow-up|1|||
156861481|NCT04886154|566250818|FG001|Overall Study|Lost to Follow-up|0|||
156861482|NCT04886154|566250819|FG002|Overall Study|Lost to Follow-up|2|||
156861483|NCT04886154|566250820|FG003|Overall Study|Lost to Follow-up|0|||
156475636|NCT00087516|564837419|FG001|Overall Study|Lack of Efficacy|80|||
156475637|NCT00087516|564837420|FG002|Overall Study|Lack of Efficacy|39|||
156475638|NCT00087516|564837421|FG003|Overall Study|Lack of Efficacy|29|||
156475639|NCT00087516|564837418|FG000|Overall Study|Lost to Follow-up|8|||
156475640|NCT00087516|564837419|FG001|Overall Study|Lost to Follow-up|6|||
156475641|NCT00087516|564837420|FG002|Overall Study|Lost to Follow-up|5|||
156475642|NCT00087516|564837421|FG003|Overall Study|Lost to Follow-up|5|||
156861484|NCT04886154|566250821|FG004|Overall Study|Lost to Follow-up|17|||
156861485|NCT04886154|566250822|FG005|Overall Study|Lost to Follow-up|7|||
156861486|NCT04886154|566250823|FG006|Overall Study|Lost to Follow-up|8|||
156861487|NCT04886154|566250824|FG007|Overall Study|Lost to Follow-up|7|||
156861488|NCT04886154|566250825|FG008|Overall Study|Lost to Follow-up|8|||
156861489|NCT04886154|566250826|FG009|Overall Study|Lost to Follow-up|0|||
156861490|NCT04886154|566250827|FG010|Overall Study|Lost to Follow-up|2|||
156861491|NCT04886154|566250828|FG011|Overall Study|Lost to Follow-up|0|||
156861492|NCT04886154|566250829|FG012|Overall Study|Lost to Follow-up|0|||
156343841|NCT03708328|564358507|FG004|Overall Study|Withdrawal by Subject|1|||
156475643|NCT00087516|564837418|FG000|Overall Study|Protocol Violation|4|||
156475644|NCT00087516|564837419|FG001|Overall Study|Protocol Violation|8|||
156475645|NCT00087516|564837420|FG002|Overall Study|Protocol Violation|3|||
156475646|NCT00087516|564837421|FG003|Overall Study|Protocol Violation|6|||
156861493|NCT04886154|566250830|FG013|Overall Study|Lost to Follow-up|0|||
156861494|NCT04886154|566250831|FG014|Overall Study|Lost to Follow-up|0|||
156861495|NCT04886154|566250817|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861496|NCT04886154|566250818|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861497|NCT04886154|566250819|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861498|NCT04886154|566250820|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861499|NCT04886154|566250821|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861500|NCT04886154|566250822|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861501|NCT04886154|566250823|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
156861502|NCT04886154|566250824|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861503|NCT04886154|566250825|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861504|NCT04886154|566250826|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861505|NCT04886154|566250827|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861506|NCT04886154|566250828|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861507|NCT04886154|566250829|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861508|NCT04886154|566250830|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861509|NCT04886154|566250831|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861510|NCT04886154|566250817|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861511|NCT04886154|566250818|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861512|NCT04886154|566250819|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861513|NCT04886154|566250820|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861514|NCT04886154|566250821|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156475647|NCT00087516|564837418|FG000|Overall Study|Withdrawal by Subject|16|||
156861515|NCT04886154|566250822|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861516|NCT04886154|566250823|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156861517|NCT04886154|566250824|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156861518|NCT04886154|566250825|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861519|NCT04886154|566250826|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861520|NCT04886154|566250827|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861521|NCT04886154|566250828|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861522|NCT04886154|566250829|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861523|NCT04886154|566250830|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861524|NCT04886154|566250831|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156861525|NCT04886154|566250817|FG000|Overall Study|Other, Not Specified|0|||
156861526|NCT04886154|566250818|FG001|Overall Study|Other, Not Specified|0|||
156861527|NCT04886154|566250819|FG002|Overall Study|Other, Not Specified|0|||
156861528|NCT04886154|566250820|FG003|Overall Study|Other, Not Specified|0|||
156861529|NCT04886154|566250821|FG004|Overall Study|Other, Not Specified|11|||
156861530|NCT04886154|566250822|FG005|Overall Study|Other, Not Specified|8|||
156861531|NCT04886154|566250823|FG006|Overall Study|Other, Not Specified|9|||
156861532|NCT04886154|566250824|FG007|Overall Study|Other, Not Specified|10|||
156475648|NCT00087516|564837419|FG001|Overall Study|Withdrawal by Subject|27|||
156475649|NCT00087516|564837420|FG002|Overall Study|Withdrawal by Subject|11|||
156861533|NCT04886154|566250825|FG008|Overall Study|Other, Not Specified|6|||
156861534|NCT04886154|566250826|FG009|Overall Study|Other, Not Specified|1|||
156861535|NCT04886154|566250827|FG010|Overall Study|Other, Not Specified|1|||
156861536|NCT04886154|566250828|FG011|Overall Study|Other, Not Specified|2|||
156861537|NCT04886154|566250829|FG012|Overall Study|Other, Not Specified|1|||
156861538|NCT04886154|566250830|FG013|Overall Study|Other, Not Specified|2|||
156475650|NCT00087516|564837421|FG003|Overall Study|Withdrawal by Subject|12|||
156475651|NCT00087516|564837418|FG000|Overall Study|Site terminated|0|||
156861539|NCT04886154|566250831|FG014|Overall Study|Other, Not Specified|3|||
156861540|NCT03919773|566250840|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
156861541|NCT03919773|566250841|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
156861542|NCT03919773|566250840|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
156861543|NCT03919773|566250841|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
156861544|NCT04659044|566250844|FG000|Induction|Physician Decision|1|||
156861545|NCT04659044|566250844|FG000|Induction|Adverse Event|2|||
156861546|NCT04966013|566250846|FG000|Overall Study|Withdrawal by Subject|0|||
156861547|NCT04966013|566250847|FG001|Overall Study|Withdrawal by Subject|2|||
156861548|NCT04966013|566250848|FG002|Overall Study|Withdrawal by Subject|1|||
156861549|NCT04966013|566250846|FG000|Overall Study|Adverse Event|2|||
156861550|NCT04966013|566250847|FG001|Overall Study|Adverse Event|1|||
156861551|NCT04966013|566250848|FG002|Overall Study|Adverse Event|1|||
156861552|NCT02458313|566253122|FG000|Overall Study|Withdrawal by Subject|6|||
156861553|NCT02458313|566253123|FG001|Overall Study|Withdrawal by Subject|8|||
156861554|NCT02458313|566253122|FG000|Overall Study|Excluded for motion during MRI|1|||
156861555|NCT02458313|566253123|FG001|Overall Study|Excluded for motion during MRI|2|||
156861556|NCT03714672|566253126|FG000|Overall Study|Adverse Event|0|||
156861557|NCT03714672|566253127|FG001|Overall Study|Adverse Event|0|||
156861558|NCT03714672|566253128|FG002|Overall Study|Adverse Event|3|||
156861559|NCT03714672|566253129|FG003|Overall Study|Adverse Event|0|||
156861560|NCT03714672|566253126|FG000|Overall Study|Physician Decision|0|||
156861561|NCT03714672|566253127|FG001|Overall Study|Physician Decision|1|||
156861562|NCT03714672|566253128|FG002|Overall Study|Physician Decision|0|||
156861563|NCT03714672|566253129|FG003|Overall Study|Physician Decision|0|||
156861564|NCT03714672|566253126|FG000|Overall Study|Other Reason|1|||
156861565|NCT03714672|566253127|FG001|Overall Study|Other Reason|2|||
156861566|NCT03714672|566253128|FG002|Overall Study|Other Reason|1|||
156861567|NCT03714672|566253129|FG003|Overall Study|Other Reason|1|||
156861568|NCT03714672|566253126|FG000|Overall Study|Lost to Follow-up|1|||
156861569|NCT03714672|566253127|FG001|Overall Study|Lost to Follow-up|1|||
156861570|NCT03714672|566253128|FG002|Overall Study|Lost to Follow-up|0|||
156861571|NCT03714672|566253129|FG003|Overall Study|Lost to Follow-up|0|||
156861572|NCT01428258|566253135|FG000|Intervention 1|Withdrawal by Subject|2|||
156861573|NCT01428258|566253136|FG001|Intervention 1|Withdrawal by Subject|0|||
156861574|NCT03085095|566253141|FG000|Overall Study|Adverse Event|23|||
156861575|NCT03085095|566253142|FG001|Overall Study|Adverse Event|8|||
156861576|NCT03085095|566253141|FG000|Overall Study|Protocol Violation|0|||
156861577|NCT03085095|566253142|FG001|Overall Study|Protocol Violation|1|||
156861578|NCT03085095|566253141|FG000|Overall Study|Lost to Follow-up|2|||
156861579|NCT03085095|566253142|FG001|Overall Study|Lost to Follow-up|1|||
156861580|NCT03085095|566253141|FG000|Overall Study|Withdrawal by Subject|17|||
156861581|NCT03085095|566253142|FG001|Overall Study|Withdrawal by Subject|6|||
156861582|NCT03085095|566253141|FG000|Overall Study|Physician Decision|9|||
156861583|NCT03085095|566253142|FG001|Overall Study|Physician Decision|3|||
156861584|NCT03085095|566253141|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
156861585|NCT03085095|566253142|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
156861586|NCT03085095|566253141|FG000|Overall Study|Did not Receive Study Drug|2|||
156861587|NCT03085095|566253142|FG001|Overall Study|Did not Receive Study Drug|2|||
156861588|NCT03085095|566253141|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
156475652|NCT00087516|564837419|FG001|Overall Study|Site terminated|2|||
156475653|NCT00087516|564837420|FG002|Overall Study|Site terminated|1|||
156475654|NCT00087516|564837421|FG003|Overall Study|Site terminated|0|||
156475655|NCT00087516|564837418|FG000|Overall Study|Protocol specified discontinuation|35|||
156475656|NCT00087516|564837419|FG001|Overall Study|Protocol specified discontinuation|33|||
156475657|NCT00087516|564837420|FG002|Overall Study|Protocol specified discontinuation|33|||
156475658|NCT00087516|564837421|FG003|Overall Study|Protocol specified discontinuation|26|||
156861589|NCT03085095|566253142|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
156861590|NCT01074502|566253143|FG000|Overall Study|Withdrawal by Subject|1|||
156861591|NCT00674817|566253151|FG000|Period 1|Withdrawal by Subject|2|||
156861592|NCT00674817|566253151|FG000|Period 1|Protocol Violation|1|||
156861593|NCT00674817|566253151|FG000|Period 3|Adverse Event|1|||
156861594|NCT00674817|566253151|FG000|Period 3|Protocol Violation|1|||
156861595|NCT00674817|566253151|FG000|Period 4|Adverse Event|1|||
156861596|NCT00726063|566253152|FG000|Overall Study|Adverse Event|9|||
156861597|NCT00726063|566253153|FG001|Overall Study|Adverse Event|7|||
156475659|NCT00087516|564837418|FG000|Overall Study|Patient moved|3|||
156475660|NCT00087516|564837419|FG001|Overall Study|Patient moved|2|||
156542382|NCT01840579|565079335|FG002|Overall Study|Death|0|||
156475661|NCT00087516|564837420|FG002|Overall Study|Patient moved|1|||
156861598|NCT01231984|566253154|FG000|Study Period 1|Withdrawal by Subject|0|||
156861599|NCT01231984|566253155|FG001|Study Period 1|Withdrawal by Subject|0|||
156861600|NCT01231984|566253156|FG002|Study Period 1|Withdrawal by Subject|0|||
156861601|NCT01231984|566253157|FG003|Study Period 1|Withdrawal by Subject|1|||
156861602|NCT01231984|566253154|FG000|Study Period 1|Lost to Follow-up|1|||
156861603|NCT01231984|566253155|FG001|Study Period 1|Lost to Follow-up|1|||
156861604|NCT01231984|566253156|FG002|Study Period 1|Lost to Follow-up|1|||
156861605|NCT01231984|566253157|FG003|Study Period 1|Lost to Follow-up|0|||
156861606|NCT01231984|566253154|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
156861607|NCT01231984|566253155|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
156475662|NCT00087516|564837421|FG003|Overall Study|Patient moved|0|||
156475663|NCT00087516|564837418|FG000|Overall Study|Patient was non-compliant|3|||
156475664|NCT00087516|564837419|FG001|Overall Study|Patient was non-compliant|1|||
156475665|NCT00087516|564837420|FG002|Overall Study|Patient was non-compliant|0|||
156475666|NCT00087516|564837421|FG003|Overall Study|Patient was non-compliant|0|||
156475667|NCT00087516|564837418|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
156475668|NCT00087516|564837419|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
156475669|NCT00087516|564837420|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
156475670|NCT00087516|564837421|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
156475671|NCT00087516|564837418|FG000|Overall Study|Other|0|||
156475672|NCT00087516|564837419|FG001|Overall Study|Other|0|||
156475673|NCT00087516|564837420|FG002|Overall Study|Other|1|||
156475674|NCT00087516|564837421|FG003|Overall Study|Other|0|||
156861608|NCT01231984|566253156|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
156861609|NCT01231984|566253157|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
156861610|NCT01231984|566253154|FG000|Study Period 1|Screen Failure|0|||
156475675|NCT01719172|564837422|FG000|Overall Study|Lost to Follow-up|1|||
156475676|NCT01719172|564837422|FG000|Overall Study|Death|1|||
156861611|NCT01231984|566253155|FG001|Study Period 1|Screen Failure|0|||
156861612|NCT01231984|566253156|FG002|Study Period 1|Screen Failure|0|||
156861613|NCT01231984|566253157|FG003|Study Period 1|Screen Failure|1|||
156861614|NCT01231984|566253154|FG000|Study Period 1|Non-compliance with study requirements|5|||
156861615|NCT01231984|566253155|FG001|Study Period 1|Non-compliance with study requirements|0|||
156861616|NCT01231984|566253156|FG002|Study Period 1|Non-compliance with study requirements|2|||
156861617|NCT01231984|566253157|FG003|Study Period 1|Non-compliance with study requirements|1|||
156475677|NCT02236611|564837423|FG000|Overall Study|Adverse Event|10|||
156861618|NCT01231984|566253154|FG000|Study Period 1|Protocol Violation|3|||
156861619|NCT01231984|566253155|FG001|Study Period 1|Protocol Violation|4|||
156861620|NCT01231984|566253156|FG002|Study Period 1|Protocol Violation|2|||
156861621|NCT01231984|566253157|FG003|Study Period 1|Protocol Violation|3|||
156861622|NCT01231984|566253154|FG000|Study Period 1|Adverse Event|1|||
156861623|NCT01231984|566253155|FG001|Study Period 1|Adverse Event|0|||
156861624|NCT01231984|566253156|FG002|Study Period 1|Adverse Event|0|||
156861625|NCT01231984|566253157|FG003|Study Period 1|Adverse Event|0|||
156861626|NCT01231984|566253154|FG000|Study Period 1|Other|0|||
156861627|NCT01231984|566253155|FG001|Study Period 1|Other|0|||
156861628|NCT01231984|566253156|FG002|Study Period 1|Other|0|||
156861629|NCT01231984|566253157|FG003|Study Period 1|Other|1|||
156861630|NCT01231984|566253154|FG000|Study Period 2|Withdrawal by Subject|1|||
156861631|NCT01231984|566253155|FG001|Study Period 2|Withdrawal by Subject|1|||
156861632|NCT01231984|566253156|FG002|Study Period 2|Withdrawal by Subject|0|||
156861633|NCT01231984|566253157|FG003|Study Period 2|Withdrawal by Subject|0|||
156861634|NCT01231984|566253154|FG000|Study Period 2|Lost to Follow-up|1|||
156861635|NCT01231984|566253155|FG001|Study Period 2|Lost to Follow-up|0|||
156861636|NCT01231984|566253156|FG002|Study Period 2|Lost to Follow-up|0|||
156861637|NCT01231984|566253157|FG003|Study Period 2|Lost to Follow-up|3|||
156861638|NCT01231984|566253154|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
156861639|NCT01231984|566253155|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
156861640|NCT01231984|566253156|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
156861641|NCT01231984|566253157|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
156861642|NCT00981656|566253160|FG000|Overall Study|Protocol Violation|1|||
156861643|NCT00981656|566253160|FG000|Overall Study|Did not start protocol treatment|2|||
156861644|NCT05236270|566253164|FG000|Overall Study|Lost to Follow-up|3|||
156861645|NCT05236270|566253165|FG001|Overall Study|Lost to Follow-up|2|||
156861646|NCT05236270|566253166|FG002|Overall Study|Lost to Follow-up|0|||
156861647|NCT05236270|566253167|FG003|Overall Study|Lost to Follow-up|0|||
156861648|NCT05236270|566253168|FG004|Overall Study|Lost to Follow-up|2|||
156861649|NCT05236270|566253169|FG005|Overall Study|Lost to Follow-up|0|||
156861650|NCT05236270|566253170|FG006|Overall Study|Lost to Follow-up|1|||
156861651|NCT05236270|566253171|FG007|Overall Study|Lost to Follow-up|3|||
156861652|NCT03486912|566253173|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
156861653|NCT03486912|566253174|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
156861654|NCT03486912|566253175|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
156861655|NCT03486912|566253176|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
156861656|NCT03486912|566253173|FG000|Treatment Period|Withdrawal by Subject|3|||
156861657|NCT03486912|566253174|FG001|Treatment Period|Withdrawal by Subject|3|||
156861658|NCT03486912|566253175|FG002|Treatment Period|Withdrawal by Subject|3|||
156861659|NCT03486912|566253176|FG003|Treatment Period|Withdrawal by Subject|2|||
156475678|NCT02236611|564837424|FG001|Overall Study|Adverse Event|16|||
156475679|NCT02236611|564837423|FG000|Overall Study|Lack of Efficacy|4|||
156861660|NCT03486912|566253173|FG000|Treatment Period|Other Reasons|0|||
156861661|NCT03486912|566253174|FG001|Treatment Period|Other Reasons|2|||
156861662|NCT03486912|566253175|FG002|Treatment Period|Other Reasons|1|||
156861663|NCT03486912|566253176|FG003|Treatment Period|Other Reasons|1|||
156861664|NCT03486912|566253173|FG000|Treatment Period|Adverse Event|0|||
156861665|NCT03486912|566253174|FG001|Treatment Period|Adverse Event|1|||
156861666|NCT03486912|566253175|FG002|Treatment Period|Adverse Event|1|||
156861667|NCT03486912|566253176|FG003|Treatment Period|Adverse Event|0|||
156861668|NCT03486912|566253173|FG000|Treatment Period|Lost to Follow-up|1|||
156861669|NCT03486912|566253174|FG001|Treatment Period|Lost to Follow-up|0|||
156861670|NCT03486912|566253175|FG002|Treatment Period|Lost to Follow-up|0|||
156861671|NCT03486912|566253176|FG003|Treatment Period|Lost to Follow-up|2|||
156861672|NCT01499940|566253177|FG000|Overall Study|Study was withdrawn before completion.|9|||
156861673|NCT01346358|566253181|FG000|Overall Study|Withdrawal by Subject|1|||
156861674|NCT01346358|566253182|FG001|Overall Study|Withdrawal by Subject|0|||
156861675|NCT01346358|566253183|FG002|Overall Study|Withdrawal by Subject|1|||
156861676|NCT01346358|566253184|FG003|Overall Study|Withdrawal by Subject|1|||
156861677|NCT01346358|566253185|FG004|Overall Study|Withdrawal by Subject|0|||
156861678|NCT01346358|566253186|FG005|Overall Study|Withdrawal by Subject|2|||
156861679|NCT01346358|566253187|FG006|Overall Study|Withdrawal by Subject|1|||
156861680|NCT01346358|566253188|FG007|Overall Study|Withdrawal by Subject|1|||
156861681|NCT01346358|566253189|FG008|Overall Study|Withdrawal by Subject|1|||
156861682|NCT01346358|566253181|FG000|Overall Study|Adverse Event|1|||
156861683|NCT01346358|566253182|FG001|Overall Study|Adverse Event|0|||
156861684|NCT01346358|566253183|FG002|Overall Study|Adverse Event|0|||
156861685|NCT01346358|566253184|FG003|Overall Study|Adverse Event|0|||
156861686|NCT01346358|566253185|FG004|Overall Study|Adverse Event|1|||
156861687|NCT01346358|566253186|FG005|Overall Study|Adverse Event|0|||
156861688|NCT01346358|566253187|FG006|Overall Study|Adverse Event|0|||
156861689|NCT01346358|566253188|FG007|Overall Study|Adverse Event|0|||
156861690|NCT01346358|566253189|FG008|Overall Study|Adverse Event|1|||
156861691|NCT01346358|566253181|FG000|Overall Study|Non-Compliance|0|||
156861692|NCT01346358|566253182|FG001|Overall Study|Non-Compliance|0|||
156861693|NCT01346358|566253183|FG002|Overall Study|Non-Compliance|0|||
156861694|NCT01346358|566253184|FG003|Overall Study|Non-Compliance|0|||
156861695|NCT01346358|566253185|FG004|Overall Study|Non-Compliance|0|||
156861696|NCT01346358|566253186|FG005|Overall Study|Non-Compliance|0|||
156861697|NCT01346358|566253187|FG006|Overall Study|Non-Compliance|0|||
156861698|NCT01346358|566253188|FG007|Overall Study|Non-Compliance|2|||
156861699|NCT01346358|566253189|FG008|Overall Study|Non-Compliance|0|||
156861700|NCT01346358|566253181|FG000|Overall Study|Physician Decision|0|||
156861701|NCT01346358|566253182|FG001|Overall Study|Physician Decision|1|||
156861702|NCT01346358|566253183|FG002|Overall Study|Physician Decision|0|||
156861703|NCT01346358|566253184|FG003|Overall Study|Physician Decision|0|||
156861704|NCT01346358|566253185|FG004|Overall Study|Physician Decision|0|||
156861705|NCT01346358|566253186|FG005|Overall Study|Physician Decision|0|||
156861706|NCT01346358|566253187|FG006|Overall Study|Physician Decision|0|||
156861707|NCT01346358|566253188|FG007|Overall Study|Physician Decision|1|||
156861708|NCT01346358|566253189|FG008|Overall Study|Physician Decision|1|||
156861709|NCT05058365|566253190|FG000|Overall Study|Migration|1|||
156861710|NCT05058365|566253191|FG001|Overall Study|Migration|1|||
156861711|NCT04819945|566253192|FG000|Overall Study|Lost to Follow-up|1|||
156861712|NCT00551759|566253194|FG000|Overall Study|Adverse Event|7|||
156861713|NCT00551759|566253194|FG000|Overall Study|Death|5|||
156861714|NCT00551759|566253194|FG000|Overall Study|Ineligible|1|||
156861715|NCT04531176|566253195|FG000|Overall Study|Study was stopped early|24|||
156861716|NCT04531176|566253196|FG001|Overall Study|Study was stopped early|26|||
156861717|NCT04531176|566253197|FG002|Overall Study|Study was stopped early|24|||
156861718|NCT00561652|566253200|FG000|Overall Study|Withdrawal by Subject|0|||
156861719|NCT00561652|566253201|FG001|Overall Study|Withdrawal by Subject|1|||
156475680|NCT02236611|564837424|FG001|Overall Study|Lack of Efficacy|7|||
156475681|NCT02236611|564837423|FG000|Overall Study|Lost to Follow-up|0|||
156475682|NCT02236611|564837424|FG001|Overall Study|Lost to Follow-up|2|||
156475683|NCT02236611|564837423|FG000|Overall Study|Protocol deviation|3|||
156475684|NCT02236611|564837424|FG001|Overall Study|Protocol deviation|5|||
156475685|NCT02236611|564837423|FG000|Overall Study|Withdrew consent|9|||
156475686|NCT02236611|564837424|FG001|Overall Study|Withdrew consent|4|||
156475687|NCT01450007|564837426|FG000|Overall Study|Late exclusion before treatment|2|||
156475688|NCT01450007|564837427|FG001|Overall Study|Late exclusion before treatment|3|||
156861720|NCT01345240|566253207|FG000|Overall Study|Adverse Event|3|||
156861721|NCT01345240|566253208|FG001|Overall Study|Adverse Event|5|||
156861722|NCT01345240|566253209|FG002|Overall Study|Adverse Event|4|||
156861723|NCT01345240|566253210|FG003|Overall Study|Adverse Event|2|||
156861724|NCT01345240|566253211|FG004|Overall Study|Adverse Event|1|||
156861725|NCT01345240|566253207|FG000|Overall Study|Lost to Follow-up|8|||
156861726|NCT01345240|566253208|FG001|Overall Study|Lost to Follow-up|9|||
156542383|NCT01840579|565079336|FG003|Overall Study|Death|0|||
156542384|NCT01840579|565079337|FG004|Overall Study|Death|0|||
156861727|NCT01345240|566253209|FG002|Overall Study|Lost to Follow-up|14|||
156861728|NCT01345240|566253210|FG003|Overall Study|Lost to Follow-up|7|||
156861729|NCT01345240|566253211|FG004|Overall Study|Lost to Follow-up|9|||
156861730|NCT00774046|566253212|FG000|Screening|Not eligible|56|||
156861731|NCT00774046|566253212|FG000|Enrollment|Desired other therapy/refused|28|||
156861732|NCT00774046|566253212|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
156861733|NCT05498649|566253219|FG000|Overall Study|Lost to Follow-up|1|||
156861734|NCT03094416|566253223|FG000|Run-in|Screening failure|8|||
156861735|NCT03094416|566253223|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
156861736|NCT03094416|566253223|FG000|Run-in|Withdrawal by Subject|3|||
156861737|NCT03094416|566253223|FG000|Treatment Period|Withdrawal by Subject|2|||
156861738|NCT00685165|566253224|FG000|Washout Period of 14 Days|Adverse Event|1|||
156861739|NCT00685165|566253225|FG001|Washout Period of 14 Days|Adverse Event|0|||
156861740|NCT00321789|566253226|FG000|Overall Study|Lost to Follow-up|4|||
156861741|NCT00321789|566253227|FG001|Overall Study|Lost to Follow-up|7|||
156861742|NCT00321789|566253226|FG000|Overall Study|Withdrawal by Subject|6|||
156861743|NCT00321789|566253227|FG001|Overall Study|Withdrawal by Subject|6|||
156861744|NCT00321789|566253226|FG000|Overall Study|Protocol Violation|5|||
156861745|NCT00321789|566253227|FG001|Overall Study|Protocol Violation|3|||
156861746|NCT03050801|566253228|FG000|Experiment 1|Lost to Follow-up|0|||
156861747|NCT03050801|566253229|FG001|Experiment 1|Lost to Follow-up|1|||
156861748|NCT03050801|566253230|FG002|Experiment 1|Lost to Follow-up|0|||
156861749|NCT03050801|566253231|FG003|Experiment 1|Lost to Follow-up|0|||
156861750|NCT03050801|566253232|FG004|Experiment 1|Lost to Follow-up|0|||
156861751|NCT03050801|566253233|FG005|Experiment 1|Lost to Follow-up|0|||
156861752|NCT03050801|566253228|FG000|Experiment 1|Physician Decision|0|||
156861753|NCT03050801|566253229|FG001|Experiment 1|Physician Decision|3|||
156861754|NCT03050801|566253230|FG002|Experiment 1|Physician Decision|0|||
156861755|NCT03050801|566253231|FG003|Experiment 1|Physician Decision|0|||
156861756|NCT03050801|566253232|FG004|Experiment 1|Physician Decision|0|||
156861757|NCT03050801|566253233|FG005|Experiment 1|Physician Decision|0|||
156861758|NCT03050801|566253228|FG000|Experiment 1|Change of experimental design|0|||
156861759|NCT03050801|566253229|FG001|Experiment 1|Change of experimental design|3|||
156861760|NCT03050801|566253230|FG002|Experiment 1|Change of experimental design|0|||
156861761|NCT03050801|566253231|FG003|Experiment 1|Change of experimental design|0|||
156861762|NCT03050801|566253232|FG004|Experiment 1|Change of experimental design|0|||
156861763|NCT03050801|566253233|FG005|Experiment 1|Change of experimental design|0|||
156861764|NCT03050801|566253228|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861765|NCT03050801|566253229|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861766|NCT03050801|566253230|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
156861767|NCT03050801|566253231|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861768|NCT03050801|566253232|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861769|NCT03050801|566253233|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861770|NCT03050801|566253228|FG000|Experiment 2|Lost to Follow-up|0|||
156861771|NCT03050801|566253229|FG001|Experiment 2|Lost to Follow-up|0|||
156861772|NCT03050801|566253230|FG002|Experiment 2|Lost to Follow-up|0|||
156861773|NCT03050801|566253231|FG003|Experiment 2|Lost to Follow-up|1|||
156861774|NCT03050801|566253232|FG004|Experiment 2|Lost to Follow-up|1|||
156861775|NCT03050801|566253233|FG005|Experiment 2|Lost to Follow-up|0|||
156861776|NCT03050801|566253228|FG000|Experiment 2|Physician Decision|0|||
156861777|NCT03050801|566253229|FG001|Experiment 2|Physician Decision|0|||
156861778|NCT03050801|566253230|FG002|Experiment 2|Physician Decision|0|||
156861779|NCT03050801|566253231|FG003|Experiment 2|Physician Decision|0|||
156861780|NCT03050801|566253232|FG004|Experiment 2|Physician Decision|1|||
156861781|NCT03050801|566253233|FG005|Experiment 2|Physician Decision|0|||
156861782|NCT03050801|566253228|FG000|Experiment 2|Pregnancy|0|||
156861783|NCT03050801|566253229|FG001|Experiment 2|Pregnancy|0|||
156861784|NCT03050801|566253230|FG002|Experiment 2|Pregnancy|0|||
156861785|NCT03050801|566253231|FG003|Experiment 2|Pregnancy|0|||
156861786|NCT03050801|566253232|FG004|Experiment 2|Pregnancy|1|||
156861787|NCT03050801|566253233|FG005|Experiment 2|Pregnancy|0|||
156861788|NCT03050801|566253228|FG000|Experiment 2|Withdrawal by Subject|0|||
156861789|NCT03050801|566253229|FG001|Experiment 2|Withdrawal by Subject|0|||
156861790|NCT03050801|566253230|FG002|Experiment 2|Withdrawal by Subject|0|||
156861791|NCT03050801|566253231|FG003|Experiment 2|Withdrawal by Subject|1|||
156861792|NCT03050801|566253232|FG004|Experiment 2|Withdrawal by Subject|0|||
156861793|NCT03050801|566253233|FG005|Experiment 2|Withdrawal by Subject|0|||
156861794|NCT03050801|566253228|FG000|Experiment 2|Poor data quality|0|||
156861795|NCT03050801|566253229|FG001|Experiment 2|Poor data quality|0|||
156861796|NCT03050801|566253230|FG002|Experiment 2|Poor data quality|0|||
156861797|NCT03050801|566253231|FG003|Experiment 2|Poor data quality|4|||
156861798|NCT03050801|566253232|FG004|Experiment 2|Poor data quality|1|||
156861799|NCT03050801|566253233|FG005|Experiment 2|Poor data quality|0|||
156861800|NCT03050801|566253228|FG000|Experiment 2|Discomfort during stimulation|0|||
156861801|NCT03050801|566253229|FG001|Experiment 2|Discomfort during stimulation|0|||
156861802|NCT03050801|566253230|FG002|Experiment 2|Discomfort during stimulation|0|||
156861803|NCT03050801|566253231|FG003|Experiment 2|Discomfort during stimulation|0|||
156861804|NCT03050801|566253232|FG004|Experiment 2|Discomfort during stimulation|0|||
156861805|NCT03050801|566253233|FG005|Experiment 2|Discomfort during stimulation|2|||
156861806|NCT01844765|566253234|FG000|Overall Study|Adverse Event|6|||
156861807|NCT01844765|566253235|FG001|Overall Study|Adverse Event|8|||
156861808|NCT01844765|566253234|FG000|Overall Study|Withdrawal by Subject|2|||
156861809|NCT01844765|566253235|FG001|Overall Study|Withdrawal by Subject|3|||
156861810|NCT01844765|566253234|FG000|Overall Study|Disease progression|1|||
156861811|NCT01844765|566253235|FG001|Overall Study|Disease progression|0|||
156861812|NCT01844765|566253234|FG000|Overall Study|Administrative problems|3|||
156861813|NCT01844765|566253235|FG001|Overall Study|Administrative problems|4|||
156861814|NCT01844765|566253234|FG000|Overall Study|Protocol deviation|2|||
156861815|NCT01844765|566253235|FG001|Overall Study|Protocol deviation|0|||
156861816|NCT01844765|566253234|FG000|Overall Study|Untreated|1|||
156861817|NCT01844765|566253235|FG001|Overall Study|Untreated|0|||
156861818|NCT00617734|566253236|FG000|Overall Study|Withdrew Consent|2|||
156861819|NCT00617734|566253237|FG001|Overall Study|Withdrew Consent|0|||
156861820|NCT00617734|566253236|FG000|Overall Study|Adverse Event|4|||
156861821|NCT00617734|566253237|FG001|Overall Study|Adverse Event|1|||
156861822|NCT00617734|566253236|FG000|Overall Study|Protocol Violation|1|||
156861823|NCT00617734|566253237|FG001|Overall Study|Protocol Violation|0|||
156861824|NCT00617734|566253236|FG000|Overall Study|Found Ineligible After Randomization|1|||
156861825|NCT00617734|566253237|FG001|Overall Study|Found Ineligible After Randomization|4|||
156861826|NCT00617734|566253236|FG000|Overall Study|Lost to Follow-up|0|||
156861827|NCT00617734|566253237|FG001|Overall Study|Lost to Follow-up|1|||
156861828|NCT02485691|566253238|FG000|Overall Study|Adverse Event|25|||
156861829|NCT02485691|566253239|FG001|Overall Study|Adverse Event|11|||
156861830|NCT02485691|566253238|FG000|Overall Study|Poor compliance to protocol|0|||
156861831|NCT02485691|566253239|FG001|Overall Study|Poor compliance to protocol|1|||
156861832|NCT02485691|566253238|FG000|Overall Study|Disease progression|57|||
156861833|NCT02485691|566253239|FG001|Overall Study|Disease progression|92|||
156861834|NCT02485691|566253238|FG000|Overall Study|Investigator's decision|23|||
156861835|NCT02485691|566253239|FG001|Overall Study|Investigator's decision|5|||
156861836|NCT02485691|566253238|FG000|Overall Study|Participant's request|13|||
156861837|NCT02485691|566253239|FG001|Overall Study|Participant's request|6|||
156861838|NCT02485691|566253238|FG000|Overall Study|Other reason|8|||
156861839|NCT02485691|566253239|FG001|Overall Study|Other reason|9|||
156861840|NCT02485691|566253238|FG000|Overall Study|Randomized and not treated|3|||
156861841|NCT02485691|566253239|FG001|Overall Study|Randomized and not treated|2|||
156861842|NCT04292535|566253240|FG000|Overall Study|Withdrawal by Subject|0|||
156861843|NCT04292535|566253241|FG001|Overall Study|Withdrawal by Subject|0|||
156861844|NCT04292535|566253242|FG002|Overall Study|Withdrawal by Subject|0|||
156861845|NCT04292535|566253243|FG003|Overall Study|Withdrawal by Subject|0|||
156861846|NCT04292535|566253244|FG004|Overall Study|Withdrawal by Subject|0|||
156861847|NCT04292535|566253245|FG005|Overall Study|Withdrawal by Subject|0|||
156861848|NCT04292535|566253246|FG006|Overall Study|Withdrawal by Subject|0|||
156861849|NCT04292535|566253247|FG007|Overall Study|Withdrawal by Subject|1|||
156861850|NCT04292535|566253248|FG008|Overall Study|Withdrawal by Subject|0|||
156861851|NCT04292535|566253249|FG009|Overall Study|Withdrawal by Subject|0|||
156861852|NCT04292535|566253250|FG010|Overall Study|Withdrawal by Subject|0|||
156861853|NCT04292535|566253251|FG011|Overall Study|Withdrawal by Subject|0|||
156861854|NCT04292535|566253252|FG012|Overall Study|Withdrawal by Subject|0|||
156861855|NCT04292535|566253253|FG013|Overall Study|Withdrawal by Subject|0|||
156861856|NCT04292535|566253240|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861857|NCT04292535|566253241|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861858|NCT04292535|566253242|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861859|NCT04292535|566253243|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861860|NCT04292535|566253244|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861861|NCT04292535|566253245|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861862|NCT04292535|566253246|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861863|NCT04292535|566253247|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
156861864|NCT04292535|566253248|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861865|NCT04292535|566253249|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861866|NCT04292535|566253250|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861867|NCT04292535|566253251|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861868|NCT04292535|566253252|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
156861869|NCT04292535|566253253|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
156861870|NCT04292535|566253240|FG000|Overall Study|Report of Dizziness|0|||
156861871|NCT04292535|566253241|FG001|Overall Study|Report of Dizziness|0|||
156861872|NCT04292535|566253242|FG002|Overall Study|Report of Dizziness|0|||
156861873|NCT04292535|566253243|FG003|Overall Study|Report of Dizziness|0|||
156861874|NCT04292535|566253244|FG004|Overall Study|Report of Dizziness|0|||
156861875|NCT04292535|566253245|FG005|Overall Study|Report of Dizziness|0|||
156861876|NCT04292535|566253246|FG006|Overall Study|Report of Dizziness|0|||
156861877|NCT04292535|566253247|FG007|Overall Study|Report of Dizziness|0|||
156861878|NCT04292535|566253248|FG008|Overall Study|Report of Dizziness|0|||
156861879|NCT04292535|566253249|FG009|Overall Study|Report of Dizziness|0|||
156861880|NCT04292535|566253250|FG010|Overall Study|Report of Dizziness|0|||
156861881|NCT04292535|566253251|FG011|Overall Study|Report of Dizziness|0|||
156861882|NCT04292535|566253252|FG012|Overall Study|Report of Dizziness|0|||
156861883|NCT04292535|566253253|FG013|Overall Study|Report of Dizziness|1|||
156861884|NCT04292535|566253240|FG000|Overall Study|Equipment Failure|0|||
156861885|NCT04292535|566253241|FG001|Overall Study|Equipment Failure|0|||
156861886|NCT04292535|566253242|FG002|Overall Study|Equipment Failure|0|||
156861887|NCT04292535|566253243|FG003|Overall Study|Equipment Failure|0|||
156861888|NCT04292535|566253244|FG004|Overall Study|Equipment Failure|0|||
156861889|NCT04292535|566253245|FG005|Overall Study|Equipment Failure|0|||
156861890|NCT04292535|566253246|FG006|Overall Study|Equipment Failure|0|||
156861891|NCT04292535|566253247|FG007|Overall Study|Equipment Failure|0|||
156861892|NCT04292535|566253248|FG008|Overall Study|Equipment Failure|0|||
156861893|NCT04292535|566253249|FG009|Overall Study|Equipment Failure|0|||
156861894|NCT04292535|566253250|FG010|Overall Study|Equipment Failure|0|||
156861895|NCT04292535|566253251|FG011|Overall Study|Equipment Failure|1|||
156861896|NCT04292535|566253252|FG012|Overall Study|Equipment Failure|0|||
156861897|NCT04292535|566253253|FG013|Overall Study|Equipment Failure|0|||
156861898|NCT03914417|566253254|FG000|Overall Study|Withdrawal by Subject|2|||
156861899|NCT03836625|566253255|FG000|Overall Study|Lost to Follow-up|9|||
156861900|NCT03836625|566253256|FG001|Overall Study|Lost to Follow-up|9|||
156861901|NCT03836625|566253255|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
156861902|NCT03836625|566253256|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
156861903|NCT03836625|566253255|FG000|Overall Study|Death|0|||
156861904|NCT03836625|566253256|FG001|Overall Study|Death|1|||
156861905|NCT03836625|566253255|FG000|Overall Study|Refused follow-up|0|||
156861906|NCT03836625|566253256|FG001|Overall Study|Refused follow-up|1|||
156861907|NCT01420861|566253257|FG000|Overall Study|Adverse Event|2|||
156861908|NCT01420861|566253257|FG000|Overall Study|Study terminated by Sponsor|7|||
156861909|NCT01420861|566253257|FG000|Overall Study|Screen failure|7|||
156861910|NCT01420861|566253257|FG000|Overall Study|Randomized not Treated|2|||
156861911|NCT00791934|566253258|FG000|Overall Study|Withdrawal by Subject|2|||
156861912|NCT00791934|566253258|FG000|Overall Study|Did not consent for extended follow-up|13|||
156861913|NCT03413891|566253260|FG000|Overall Study|Lost to Follow-up|2|||
156861914|NCT03413891|566253261|FG001|Overall Study|Lost to Follow-up|1|||
156861915|NCT03413891|566253260|FG000|Overall Study|Protocol Violation|0|||
156861916|NCT03413891|566253261|FG001|Overall Study|Protocol Violation|1|||
156861917|NCT04905134|566253262|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
156861918|NCT04905134|566253262|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
156861919|NCT03137992|566253263|FG000|Washout Period 1|Adverse Event|1|||
156861920|NCT03137992|566253264|FG001|Washout Period 1|Adverse Event|1|||
156861921|NCT03137992|566253265|FG002|Washout Period 1|Adverse Event|0|||
156861922|NCT03137992|566253266|FG003|Washout Period 1|Adverse Event|0|||
156861923|NCT03137992|566253267|FG004|Washout Period 1|Adverse Event|0|||
156861924|NCT03137992|566253268|FG005|Washout Period 1|Adverse Event|1|||
156861925|NCT03137992|566253263|FG000|Washout Period 1|Withdrawal by Subject|0|||
156861926|NCT03137992|566253264|FG001|Washout Period 1|Withdrawal by Subject|1|||
156861927|NCT03137992|566253265|FG002|Washout Period 1|Withdrawal by Subject|1|||
156861928|NCT03137992|566253266|FG003|Washout Period 1|Withdrawal by Subject|0|||
156861929|NCT03137992|566253267|FG004|Washout Period 1|Withdrawal by Subject|0|||
156861930|NCT03137992|566253268|FG005|Washout Period 1|Withdrawal by Subject|0|||
156861931|NCT03137992|566253263|FG000|Washout Period 1|Principal Investigator Discretion|0|||
156861932|NCT03137992|566253264|FG001|Washout Period 1|Principal Investigator Discretion|1|||
156861933|NCT03137992|566253265|FG002|Washout Period 1|Principal Investigator Discretion|0|||
156861934|NCT03137992|566253266|FG003|Washout Period 1|Principal Investigator Discretion|0|||
156861935|NCT03137992|566253267|FG004|Washout Period 1|Principal Investigator Discretion|0|||
156861936|NCT03137992|566253268|FG005|Washout Period 1|Principal Investigator Discretion|0|||
156861937|NCT03137992|566253263|FG000|Washout Period 1|COPD Exacerbation|1|||
156861938|NCT03137992|566253264|FG001|Washout Period 1|COPD Exacerbation|1|||
156861939|NCT03137992|566253265|FG002|Washout Period 1|COPD Exacerbation|1|||
156861940|NCT03137992|566253266|FG003|Washout Period 1|COPD Exacerbation|0|||
156861941|NCT03137992|566253267|FG004|Washout Period 1|COPD Exacerbation|1|||
156861942|NCT03137992|566253268|FG005|Washout Period 1|COPD Exacerbation|1|||
156861943|NCT03137992|566253263|FG000|Washout Period 1|Subject Noncompliance|1|||
156861944|NCT03137992|566253264|FG001|Washout Period 1|Subject Noncompliance|0|||
156861945|NCT03137992|566253265|FG002|Washout Period 1|Subject Noncompliance|0|||
156861946|NCT03137992|566253266|FG003|Washout Period 1|Subject Noncompliance|0|||
156861947|NCT03137992|566253267|FG004|Washout Period 1|Subject Noncompliance|1|||
156861948|NCT03137992|566253268|FG005|Washout Period 1|Subject Noncompliance|0|||
156861949|NCT03137992|566253263|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
156861950|NCT03137992|566253264|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
156861951|NCT03137992|566253265|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
156861952|NCT03137992|566253266|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
156861953|NCT03137992|566253267|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
156861954|NCT03137992|566253268|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
156861955|NCT03137992|566253263|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
156861956|NCT03137992|566253264|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
156861957|NCT03137992|566253265|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
156861958|NCT03137992|566253266|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
156861959|NCT03137992|566253267|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
156861960|NCT03137992|566253268|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
156861961|NCT03137992|566253263|FG000|Period 2 (Visit 3)|Adverse Event|0|||
156861962|NCT03137992|566253264|FG001|Period 2 (Visit 3)|Adverse Event|1|||
156861963|NCT03137992|566253265|FG002|Period 2 (Visit 3)|Adverse Event|0|||
156861964|NCT03137992|566253266|FG003|Period 2 (Visit 3)|Adverse Event|0|||
156861965|NCT03137992|566253267|FG004|Period 2 (Visit 3)|Adverse Event|0|||
156861966|NCT03137992|566253268|FG005|Period 2 (Visit 3)|Adverse Event|0|||
156861967|NCT03137992|566253263|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861968|NCT03137992|566253264|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861969|NCT03137992|566253265|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861970|NCT03137992|566253266|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
156861971|NCT03137992|566253267|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861972|NCT03137992|566253268|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861973|NCT03137992|566253263|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
156861974|NCT03137992|566253264|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
156861975|NCT03137992|566253265|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
156861976|NCT03137992|566253266|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
156861977|NCT03137992|566253267|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
156861978|NCT03137992|566253268|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
156861979|NCT03137992|566253263|FG000|Washout Period 2|COPD Exacerbation|1|||
156861980|NCT03137992|566253264|FG001|Washout Period 2|COPD Exacerbation|1|||
156861981|NCT03137992|566253265|FG002|Washout Period 2|COPD Exacerbation|0|||
156861982|NCT03137992|566253266|FG003|Washout Period 2|COPD Exacerbation|0|||
156861983|NCT03137992|566253267|FG004|Washout Period 2|COPD Exacerbation|1|||
156542385|NCT01840579|565079338|FG005|Overall Study|Death|1|||
156861984|NCT03137992|566253268|FG005|Washout Period 2|COPD Exacerbation|0|||
156861985|NCT03137992|566253263|FG000|Washout Period 2|Subject Non-compliance|0|||
156861986|NCT03137992|566253264|FG001|Washout Period 2|Subject Non-compliance|1|||
156861987|NCT03137992|566253265|FG002|Washout Period 2|Subject Non-compliance|0|||
156861988|NCT03137992|566253266|FG003|Washout Period 2|Subject Non-compliance|0|||
156542386|NCT01840579|565079339|FG006|Overall Study|Death|0|||
156542387|NCT01840579|565079340|FG007|Overall Study|Death|0|||
156861989|NCT03137992|566253267|FG004|Washout Period 2|Subject Non-compliance|0|||
156861990|NCT03137992|566253268|FG005|Washout Period 2|Subject Non-compliance|0|||
156861991|NCT03137992|566253263|FG000|Washout Period 2|Adverse Event|0|||
156861992|NCT03137992|566253264|FG001|Washout Period 2|Adverse Event|0|||
156861993|NCT03137992|566253265|FG002|Washout Period 2|Adverse Event|0|||
156861994|NCT03137992|566253266|FG003|Washout Period 2|Adverse Event|1|||
156861995|NCT03137992|566253267|FG004|Washout Period 2|Adverse Event|1|||
156861996|NCT03137992|566253268|FG005|Washout Period 2|Adverse Event|0|||
156861997|NCT03137992|566253263|FG000|Washout Period 2|Withdrawal by Subject|1|||
156861998|NCT03137992|566253264|FG001|Washout Period 2|Withdrawal by Subject|0|||
156861999|NCT03137992|566253265|FG002|Washout Period 2|Withdrawal by Subject|0|||
156862000|NCT03137992|566253266|FG003|Washout Period 2|Withdrawal by Subject|0|||
156862001|NCT03137992|566253267|FG004|Washout Period 2|Withdrawal by Subject|1|||
156862002|NCT03137992|566253268|FG005|Washout Period 2|Withdrawal by Subject|0|||
156862003|NCT03137992|566253263|FG000|Washout Period 2|Sponsor Decision|0|||
156862004|NCT03137992|566253264|FG001|Washout Period 2|Sponsor Decision|0|||
156862005|NCT03137992|566253265|FG002|Washout Period 2|Sponsor Decision|0|||
156862006|NCT03137992|566253266|FG003|Washout Period 2|Sponsor Decision|0|||
156862007|NCT03137992|566253267|FG004|Washout Period 2|Sponsor Decision|0|||
156862008|NCT03137992|566253268|FG005|Washout Period 2|Sponsor Decision|1|||
156475689|NCT01450007|564837428|FG002|Overall Study|Late exclusion before treatment|2|||
156475690|NCT01450007|564837426|FG000|Overall Study|Protocol Violation|0|||
156475691|NCT01450007|564837427|FG001|Overall Study|Protocol Violation|1|||
156475692|NCT01450007|564837428|FG002|Overall Study|Protocol Violation|1|||
156475693|NCT01450007|564837426|FG000|Overall Study|Adverse Event|0|||
156475694|NCT01450007|564837427|FG001|Overall Study|Adverse Event|1|||
156475695|NCT01450007|564837428|FG002|Overall Study|Adverse Event|0|||
156475696|NCT00484198|564837429|FG000|Overall Study|Participant Withdrew Consent|12|||
156475697|NCT00484198|564837430|FG001|Overall Study|Participant Withdrew Consent|21|||
156475698|NCT00484198|564837431|FG002|Overall Study|Participant Withdrew Consent|47|||
156475699|NCT00484198|564837432|FG003|Overall Study|Participant Withdrew Consent|59|||
156475700|NCT00484198|564837429|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
156475701|NCT00484198|564837430|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
156475702|NCT00484198|564837431|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
156475703|NCT00484198|564837432|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
156475704|NCT00484198|564837429|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
156475705|NCT00484198|564837430|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
156475706|NCT00484198|564837431|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
156475707|NCT00484198|564837432|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
156475708|NCT00484198|564837429|FG000|Overall Study|Adverse Event|3|||
156475709|NCT00484198|564837430|FG001|Overall Study|Adverse Event|11|||
156475710|NCT00484198|564837431|FG002|Overall Study|Adverse Event|32|||
156475711|NCT00484198|564837432|FG003|Overall Study|Adverse Event|31|||
156475712|NCT00484198|564837429|FG000|Overall Study|Protocol Violation|0|||
156475713|NCT00484198|564837430|FG001|Overall Study|Protocol Violation|5|||
156475714|NCT00484198|564837431|FG002|Overall Study|Protocol Violation|6|||
156475715|NCT00484198|564837432|FG003|Overall Study|Protocol Violation|8|||
156475716|NCT00484198|564837429|FG000|Overall Study|Other|7|||
156475717|NCT00484198|564837430|FG001|Overall Study|Other|10|||
156475718|NCT00484198|564837431|FG002|Overall Study|Other|31|||
156475719|NCT00484198|564837432|FG003|Overall Study|Other|28|||
156475720|NCT01332266|564837433|FG000|Phase 1b|Death|3|||
156475721|NCT01332266|564837434|FG001|Phase 1b|Death|3|||
156475722|NCT01332266|564837435|FG002|Phase 1b|Death|2|||
156475723|NCT01332266|564837436|FG003|Phase 1b|Death|0|||
156475724|NCT01332266|564837437|FG004|Phase 1b|Death|0|||
156475725|NCT01332266|564837433|FG000|Phase 1b|Lost to Follow-up|0|||
156475726|NCT01332266|564837434|FG001|Phase 1b|Lost to Follow-up|1|||
156475727|NCT01332266|564837435|FG002|Phase 1b|Lost to Follow-up|0|||
156475728|NCT01332266|564837436|FG003|Phase 1b|Lost to Follow-up|0|||
156475729|NCT01332266|564837437|FG004|Phase 1b|Lost to Follow-up|0|||
156475730|NCT01332266|564837433|FG000|Phase 1b|Withdrawal by Subject|1|||
156475731|NCT01332266|564837434|FG001|Phase 1b|Withdrawal by Subject|1|||
156475732|NCT01332266|564837435|FG002|Phase 1b|Withdrawal by Subject|1|||
156475733|NCT01332266|564837436|FG003|Phase 1b|Withdrawal by Subject|0|||
156542388|NCT01840579|565079341|FG008|Overall Study|Death|0|||
156542389|NCT01840579|565079342|FG009|Overall Study|Death|0|||
156862009|NCT03137992|566253263|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
156862010|NCT03137992|566253264|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
156862011|NCT03137992|566253265|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
156862012|NCT03137992|566253266|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
156475734|NCT01332266|564837437|FG004|Phase 1b|Withdrawal by Subject|0|||
156475735|NCT01332266|564837433|FG000|Phase 2|Death|0|||
156475736|NCT01332266|564837434|FG001|Phase 2|Death|0|||
156475737|NCT01332266|564837435|FG002|Phase 2|Death|0|||
156475738|NCT01332266|564837436|FG003|Phase 2|Death|33|||
156475739|NCT01332266|564837437|FG004|Phase 2|Death|36|||
156475740|NCT01332266|564837433|FG000|Phase 2|Lost to Follow-up|0|||
156475741|NCT01332266|564837434|FG001|Phase 2|Lost to Follow-up|0|||
156475742|NCT01332266|564837435|FG002|Phase 2|Lost to Follow-up|0|||
156475743|NCT01332266|564837436|FG003|Phase 2|Lost to Follow-up|2|||
156862013|NCT03137992|566253267|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
156862014|NCT03137992|566253268|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
156862015|NCT03137992|566253263|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
156862016|NCT03137992|566253264|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
156862017|NCT03137992|566253265|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
156862018|NCT03137992|566253266|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
156862019|NCT03137992|566253267|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
156862020|NCT03137992|566253268|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
156862021|NCT03137992|566253263|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
156862022|NCT03137992|566253264|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
156862023|NCT03137992|566253265|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
156862024|NCT03137992|566253266|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
156862025|NCT03137992|566253267|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
156862026|NCT03137992|566253268|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
156862027|NCT03137992|566253263|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862028|NCT03137992|566253264|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862029|NCT03137992|566253265|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862030|NCT03137992|566253266|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
156862031|NCT03137992|566253267|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862032|NCT03137992|566253268|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862033|NCT03137992|566253263|FG000|Part 2 (Open-label Extension)|Per study team|1|||
156862034|NCT03137992|566253264|FG001|Part 2 (Open-label Extension)|Per study team|0|||
156862035|NCT03137992|566253265|FG002|Part 2 (Open-label Extension)|Per study team|0|||
156862036|NCT03137992|566253266|FG003|Part 2 (Open-label Extension)|Per study team|0|||
156862037|NCT03137992|566253267|FG004|Part 2 (Open-label Extension)|Per study team|0|||
156862038|NCT03137992|566253268|FG005|Part 2 (Open-label Extension)|Per study team|0|||
156862039|NCT03137992|566253263|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862040|NCT03137992|566253264|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862041|NCT03137992|566253265|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862042|NCT03137992|566253266|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862043|NCT03137992|566253267|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862044|NCT03137992|566253268|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
156862045|NCT04609319|566253269|FG000|Overall Study|Death|64|||
156862046|NCT04609319|566253270|FG001|Overall Study|Death|49|||
156862047|NCT04609319|566253271|FG002|Overall Study|Death|1|||
156862048|NCT04609319|566253269|FG000|Overall Study|Withdrawal of consent|15|||
156862049|NCT04609319|566253270|FG001|Overall Study|Withdrawal of consent|3|||
156862050|NCT04609319|566253271|FG002|Overall Study|Withdrawal of consent|0|||
156862051|NCT04609319|566253269|FG000|Overall Study|Lost to Follow-up|20|||
156862052|NCT04609319|566253270|FG001|Overall Study|Lost to Follow-up|33|||
156862053|NCT04609319|566253271|FG002|Overall Study|Lost to Follow-up|0|||
156862054|NCT04609319|566253269|FG000|Overall Study|Alive until end of follow-up|60|||
156862055|NCT04609319|566253270|FG001|Overall Study|Alive until end of follow-up|53|||
156862056|NCT04609319|566253271|FG002|Overall Study|Alive until end of follow-up|1|||
156862057|NCT03221556|566253274|FG000|Allocation|post-randomization exclusion|0|||
156862058|NCT03221556|566253275|FG001|Allocation|post-randomization exclusion|1|||
156862059|NCT03221556|566253274|FG000|Follow-Up|Withdrawal by Subject|0|||
156862060|NCT03221556|566253275|FG001|Follow-Up|Withdrawal by Subject|1|||
156862061|NCT01247324|566253278|FG000|Overall Study|Death|6|||
156862062|NCT01247324|566253279|FG001|Overall Study|Death|10|||
156862063|NCT01247324|566253278|FG000|Overall Study|Physician Decision|2|||
156862064|NCT01247324|566253279|FG001|Overall Study|Physician Decision|3|||
156862065|NCT01247324|566253278|FG000|Overall Study|Non-compliance with study drug|3|||
156862066|NCT01247324|566253279|FG001|Overall Study|Non-compliance with study drug|0|||
156862067|NCT01247324|566253278|FG000|Overall Study|Lack of Efficacy|24|||
156862068|NCT01247324|566253279|FG001|Overall Study|Lack of Efficacy|14|||
156862069|NCT01247324|566253278|FG000|Overall Study|Non-compliance|3|||
156862070|NCT01247324|566253279|FG001|Overall Study|Non-compliance|2|||
156862071|NCT01247324|566253278|FG000|Overall Study|Pregnancy|5|||
156862072|NCT01247324|566253279|FG001|Overall Study|Pregnancy|10|||
156862073|NCT01247324|566253278|FG000|Overall Study|Protocol Violation|1|||
156862074|NCT01247324|566253279|FG001|Overall Study|Protocol Violation|1|||
156862075|NCT01247324|566253278|FG000|Overall Study|Reason not specified|42|||
156862076|NCT01247324|566253279|FG001|Overall Study|Reason not specified|32|||
156862077|NCT01247324|566253278|FG000|Overall Study|Consent withdrawn by participant|41|||
156862078|NCT01247324|566253279|FG001|Overall Study|Consent withdrawn by participant|56|||
156862079|NCT01247324|566253278|FG000|Overall Study|Adverse Event|49|||
156862080|NCT01247324|566253279|FG001|Overall Study|Adverse Event|35|||
156862081|NCT01247324|566253278|FG000|Overall Study|Lost to Follow-up|3|||
156862082|NCT01247324|566253279|FG001|Overall Study|Lost to Follow-up|6|||
156862083|NCT01247324|566253278|FG000|Overall Study|Study Terminated by Sponsor|4|||
156862084|NCT01247324|566253279|FG001|Overall Study|Study Terminated by Sponsor|1|||
156862085|NCT01247324|566253278|FG000|Overall Study|Missing|2|||
156862086|NCT01247324|566253279|FG001|Overall Study|Missing|1|||
156862087|NCT01486966|566253280|FG000|Overall Study|Adverse Event|0|||
156475744|NCT01332266|564837437|FG004|Phase 2|Lost to Follow-up|0|||
156475745|NCT01332266|564837433|FG000|Phase 2|Physician Decision|0|||
156475746|NCT01332266|564837434|FG001|Phase 2|Physician Decision|0|||
156475747|NCT01332266|564837435|FG002|Phase 2|Physician Decision|0|||
156475748|NCT01332266|564837436|FG003|Phase 2|Physician Decision|3|||
156475749|NCT01332266|564837437|FG004|Phase 2|Physician Decision|1|||
156475750|NCT01332266|564837433|FG000|Phase 2|Symptomatic deterioration|0|||
156475751|NCT01332266|564837434|FG001|Phase 2|Symptomatic deterioration|0|||
156475752|NCT01332266|564837435|FG002|Phase 2|Symptomatic deterioration|0|||
156475753|NCT01332266|564837436|FG003|Phase 2|Symptomatic deterioration|0|||
156475754|NCT01332266|564837437|FG004|Phase 2|Symptomatic deterioration|1|||
156475755|NCT01332266|564837433|FG000|Phase 2|Progression Disease|0|||
156475756|NCT01332266|564837434|FG001|Phase 2|Progression Disease|0|||
156475757|NCT01332266|564837435|FG002|Phase 2|Progression Disease|0|||
156475758|NCT01332266|564837436|FG003|Phase 2|Progression Disease|2|||
156475759|NCT01332266|564837437|FG004|Phase 2|Progression Disease|1|||
156475760|NCT01332266|564837433|FG000|Phase 2|Withdrawal by Subject|0|||
156475761|NCT01332266|564837434|FG001|Phase 2|Withdrawal by Subject|0|||
156475762|NCT01332266|564837435|FG002|Phase 2|Withdrawal by Subject|0|||
156475763|NCT01332266|564837436|FG003|Phase 2|Withdrawal by Subject|2|||
156475764|NCT01332266|564837437|FG004|Phase 2|Withdrawal by Subject|2|||
156475765|NCT01536704|564837438|FG000|Washout Period 1|Withdrawal by Subject|1|||
156475766|NCT01536704|564837439|FG001|Washout Period 1|Withdrawal by Subject|2|||
156475767|NCT01536704|564837440|FG002|Washout Period 1|Withdrawal by Subject|0|||
156475768|NCT01536704|564837441|FG003|Washout Period 1|Withdrawal by Subject|0|||
156475769|NCT01536704|564837438|FG000|Washout Period 2|Adverse Event|1|||
156475770|NCT01536704|564837439|FG001|Washout Period 2|Adverse Event|0|||
156475771|NCT01536704|564837440|FG002|Washout Period 2|Adverse Event|0|||
156475772|NCT01536704|564837441|FG003|Washout Period 2|Adverse Event|0|||
156475773|NCT01536704|564837438|FG000|Washout Period 2|Withdrawal by Subject|0|||
156475774|NCT01536704|564837439|FG001|Washout Period 2|Withdrawal by Subject|0|||
156475775|NCT01536704|564837440|FG002|Washout Period 2|Withdrawal by Subject|0|||
156475776|NCT01536704|564837441|FG003|Washout Period 2|Withdrawal by Subject|1|||
156475777|NCT01536704|564837438|FG000|Period 3|Adverse Event|0|||
156862088|NCT01486966|566253281|FG001|Overall Study|Adverse Event|1|||
156475778|NCT01536704|564837439|FG001|Period 3|Adverse Event|0|||
156475779|NCT01536704|564837440|FG002|Period 3|Adverse Event|0|||
156475780|NCT01536704|564837441|FG003|Period 3|Adverse Event|1|||
156475781|NCT01536704|564837438|FG000|Washout Period 3|Adverse Event|0|||
156475782|NCT01536704|564837439|FG001|Washout Period 3|Adverse Event|0|||
156475783|NCT01536704|564837440|FG002|Washout Period 3|Adverse Event|1|||
156475784|NCT01536704|564837441|FG003|Washout Period 3|Adverse Event|0|||
156475785|NCT01947491|564837442|FG000|Overall Study|Lost to Follow-up|5|||
156475786|NCT01947491|564837443|FG001|Overall Study|Lost to Follow-up|3|||
156862089|NCT01486966|566253280|FG000|Overall Study|Withdrawal by Subject|0|||
156862090|NCT01486966|566253281|FG001|Overall Study|Withdrawal by Subject|1|||
156862091|NCT00301808|566253284|FG000|Overall Study|Adverse Event|5|||
156475787|NCT01947491|564837444|FG002|Overall Study|Lost to Follow-up|1|||
156475788|NCT01947491|564837445|FG003|Overall Study|Lost to Follow-up|2|||
156862092|NCT00301808|566253284|FG000|Overall Study|Death|3|||
156862093|NCT00301808|566253284|FG000|Overall Study|Lack of Efficacy|4|||
156862094|NCT00506350|566253285|FG000|Overall Study|Serious Adverse Event|1|||
156862095|NCT00506350|566253286|FG001|Overall Study|Serious Adverse Event|0|||
156862096|NCT00506350|566253287|FG002|Overall Study|Serious Adverse Event|0|||
156862097|NCT00506350|566253288|FG003|Overall Study|Serious Adverse Event|0|||
156862098|NCT00506350|566253289|FG004|Overall Study|Serious Adverse Event|0|||
156862099|NCT00506350|566253290|FG005|Overall Study|Serious Adverse Event|0|||
156862100|NCT00506350|566253291|FG006|Overall Study|Serious Adverse Event|0|||
156862101|NCT00506350|566253292|FG007|Overall Study|Serious Adverse Event|0|||
156862102|NCT00506350|566253293|FG008|Overall Study|Serious Adverse Event|0|||
156862103|NCT00506350|566253285|FG000|Overall Study|Adverse Event|0|||
156862104|NCT00506350|566253286|FG001|Overall Study|Adverse Event|0|||
156862105|NCT00506350|566253287|FG002|Overall Study|Adverse Event|0|||
156862106|NCT00506350|566253288|FG003|Overall Study|Adverse Event|0|||
156862107|NCT00506350|566253289|FG004|Overall Study|Adverse Event|0|||
156862108|NCT00506350|566253290|FG005|Overall Study|Adverse Event|0|||
156862109|NCT00506350|566253291|FG006|Overall Study|Adverse Event|0|||
156862110|NCT00506350|566253292|FG007|Overall Study|Adverse Event|1|||
156862111|NCT00506350|566253293|FG008|Overall Study|Adverse Event|1|||
156862112|NCT00506350|566253285|FG000|Overall Study|Protocol Violation|0|||
156862113|NCT00506350|566253286|FG001|Overall Study|Protocol Violation|0|||
156862114|NCT00506350|566253287|FG002|Overall Study|Protocol Violation|1|||
156862115|NCT00506350|566253288|FG003|Overall Study|Protocol Violation|0|||
156862116|NCT00506350|566253289|FG004|Overall Study|Protocol Violation|0|||
156862117|NCT00506350|566253290|FG005|Overall Study|Protocol Violation|0|||
156862118|NCT00506350|566253291|FG006|Overall Study|Protocol Violation|1|||
156862119|NCT00506350|566253292|FG007|Overall Study|Protocol Violation|0|||
156862120|NCT00506350|566253293|FG008|Overall Study|Protocol Violation|0|||
156862121|NCT00506350|566253285|FG000|Overall Study|Withdrawal by Subject|0|||
156862122|NCT00506350|566253286|FG001|Overall Study|Withdrawal by Subject|1|||
156862123|NCT00506350|566253287|FG002|Overall Study|Withdrawal by Subject|1|||
156862124|NCT00506350|566253288|FG003|Overall Study|Withdrawal by Subject|1|||
156862125|NCT00506350|566253289|FG004|Overall Study|Withdrawal by Subject|4|||
156862126|NCT00506350|566253290|FG005|Overall Study|Withdrawal by Subject|1|||
156862127|NCT00506350|566253291|FG006|Overall Study|Withdrawal by Subject|1|||
156862128|NCT00506350|566253292|FG007|Overall Study|Withdrawal by Subject|2|||
156862129|NCT00506350|566253293|FG008|Overall Study|Withdrawal by Subject|0|||
156862130|NCT00506350|566253285|FG000|Overall Study|Lost to Follow-up|1|||
156862131|NCT00506350|566253286|FG001|Overall Study|Lost to Follow-up|1|||
156862132|NCT00506350|566253287|FG002|Overall Study|Lost to Follow-up|1|||
156862133|NCT00506350|566253288|FG003|Overall Study|Lost to Follow-up|1|||
156862134|NCT00506350|566253289|FG004|Overall Study|Lost to Follow-up|2|||
156862135|NCT00506350|566253290|FG005|Overall Study|Lost to Follow-up|1|||
156862136|NCT00506350|566253291|FG006|Overall Study|Lost to Follow-up|0|||
156862137|NCT00506350|566253292|FG007|Overall Study|Lost to Follow-up|0|||
156862138|NCT00506350|566253293|FG008|Overall Study|Lost to Follow-up|2|||
156862139|NCT00506350|566253285|FG000|Overall Study|Medical Reason|0|||
156862140|NCT00506350|566253286|FG001|Overall Study|Medical Reason|0|||
156862141|NCT00506350|566253287|FG002|Overall Study|Medical Reason|0|||
156862142|NCT00506350|566253288|FG003|Overall Study|Medical Reason|0|||
156862143|NCT00506350|566253289|FG004|Overall Study|Medical Reason|1|||
156862144|NCT00506350|566253290|FG005|Overall Study|Medical Reason|0|||
156862145|NCT00506350|566253291|FG006|Overall Study|Medical Reason|0|||
156862146|NCT00506350|566253292|FG007|Overall Study|Medical Reason|0|||
156862147|NCT00506350|566253293|FG008|Overall Study|Medical Reason|0|||
156862148|NCT00506350|566253285|FG000|Overall Study|Other|1|||
156862149|NCT00506350|566253286|FG001|Overall Study|Other|1|||
156862150|NCT00506350|566253287|FG002|Overall Study|Other|3|||
156862151|NCT00506350|566253288|FG003|Overall Study|Other|0|||
156862152|NCT00506350|566253289|FG004|Overall Study|Other|3|||
156862153|NCT00506350|566253290|FG005|Overall Study|Other|0|||
156475789|NCT01947491|564837442|FG000|Overall Study|Lack of Efficacy|1|||
156475790|NCT01947491|564837443|FG001|Overall Study|Lack of Efficacy|0|||
156862154|NCT00506350|566253291|FG006|Overall Study|Other|0|||
156862155|NCT00506350|566253292|FG007|Overall Study|Other|2|||
156862156|NCT00506350|566253293|FG008|Overall Study|Other|2|||
156343842|NCT03708328|564358508|FG005|Overall Study|Withdrawal by Subject|0|||
156343843|NCT03708328|564358509|FG006|Overall Study|Withdrawal by Subject|2|||
156343844|NCT03708328|564358510|FG007|Overall Study|Withdrawal by Subject|4|||
156343845|NCT03708328|564358511|FG008|Overall Study|Withdrawal by Subject|1|||
156343846|NCT03708328|564358512|FG009|Overall Study|Withdrawal by Subject|5|||
156343847|NCT03708328|564358503|FG000|Overall Study|Study Closed Locally|0|||
156343848|NCT03708328|564358504|FG001|Overall Study|Study Closed Locally|0|||
156343849|NCT03708328|564358505|FG002|Overall Study|Study Closed Locally|0|||
156343850|NCT03708328|564358506|FG003|Overall Study|Study Closed Locally|0|||
156343851|NCT03708328|564358507|FG004|Overall Study|Study Closed Locally|0|||
156343852|NCT03708328|564358508|FG005|Overall Study|Study Closed Locally|0|||
156343853|NCT03708328|564358509|FG006|Overall Study|Study Closed Locally|0|||
156862157|NCT04972786|566253294|FG000|First Intervention (1 Day)|Adverse Event|1|||
156862158|NCT04972786|566253295|FG001|First Intervention (1 Day)|Adverse Event|0|||
156862159|NCT03518086|566253297|FG000|Overall Study|Adverse Event|23|||
156862160|NCT03518086|566253298|FG001|Overall Study|Adverse Event|15|||
156862161|NCT03518086|566253299|FG002|Overall Study|Adverse Event|3|||
156862162|NCT03518086|566253300|FG003|Overall Study|Adverse Event|2|||
156862163|NCT03518086|566253297|FG000|Overall Study|Withdrawal by Subject|8|||
156862164|NCT03518086|566253298|FG001|Overall Study|Withdrawal by Subject|5|||
156862165|NCT03518086|566253299|FG002|Overall Study|Withdrawal by Subject|1|||
156862166|NCT03518086|566253300|FG003|Overall Study|Withdrawal by Subject|0|||
156862167|NCT03518086|566253297|FG000|Overall Study|Lack of Efficacy|5|||
156862168|NCT03518086|566253298|FG001|Overall Study|Lack of Efficacy|5|||
156862169|NCT03518086|566253299|FG002|Overall Study|Lack of Efficacy|0|||
156862170|NCT03518086|566253300|FG003|Overall Study|Lack of Efficacy|2|||
156862171|NCT03518086|566253297|FG000|Overall Study|Protocol Violation|1|||
156862172|NCT03518086|566253298|FG001|Overall Study|Protocol Violation|5|||
156862173|NCT03518086|566253299|FG002|Overall Study|Protocol Violation|1|||
156862174|NCT03518086|566253300|FG003|Overall Study|Protocol Violation|3|||
156862175|NCT03518086|566253297|FG000|Overall Study|Lost to Follow-up|0|||
156862176|NCT03518086|566253298|FG001|Overall Study|Lost to Follow-up|3|||
156862177|NCT03518086|566253299|FG002|Overall Study|Lost to Follow-up|0|||
156862178|NCT03518086|566253300|FG003|Overall Study|Lost to Follow-up|0|||
156862179|NCT03518086|566253297|FG000|Overall Study|Insufficient Diary Data|0|||
156862180|NCT03518086|566253298|FG001|Overall Study|Insufficient Diary Data|2|||
156862181|NCT03518086|566253299|FG002|Overall Study|Insufficient Diary Data|0|||
156862182|NCT03518086|566253300|FG003|Overall Study|Insufficient Diary Data|0|||
156862183|NCT03518086|566253297|FG000|Overall Study|Non- compliance to Protocol|0|||
156862184|NCT03518086|566253298|FG001|Overall Study|Non- compliance to Protocol|1|||
156862185|NCT03518086|566253299|FG002|Overall Study|Non- compliance to Protocol|0|||
156862186|NCT03518086|566253300|FG003|Overall Study|Non- compliance to Protocol|0|||
156862187|NCT03518086|566253297|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
156862188|NCT03518086|566253298|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
156862189|NCT03518086|566253299|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
156862190|NCT03518086|566253300|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
156862191|NCT03518086|566253297|FG000|Overall Study|Site Terminated by Sponsor|0|||
156862192|NCT03518086|566253298|FG001|Overall Study|Site Terminated by Sponsor|1|||
156862193|NCT03518086|566253299|FG002|Overall Study|Site Terminated by Sponsor|0|||
156862194|NCT03518086|566253300|FG003|Overall Study|Site Terminated by Sponsor|0|||
156862195|NCT03518086|566253297|FG000|Overall Study|Pregnancy|0|||
156862196|NCT03518086|566253298|FG001|Overall Study|Pregnancy|0|||
156862197|NCT03518086|566253299|FG002|Overall Study|Pregnancy|0|||
156862198|NCT03518086|566253300|FG003|Overall Study|Pregnancy|2|||
156862199|NCT02336282|566253304|FG000|Overall Study|Unrelated illness|1|||
156862200|NCT02336282|566253304|FG000|Overall Study|Uncomfortable with technology|1|||
156862201|NCT02336282|566253304|FG000|Overall Study|Lost to Follow-up|1|||
156343854|NCT03708328|564358510|FG007|Overall Study|Study Closed Locally|1|||
156343855|NCT03708328|564358511|FG008|Overall Study|Study Closed Locally|0|||
156343856|NCT03708328|564358512|FG009|Overall Study|Study Closed Locally|0|||
156343857|NCT03708328|564358503|FG000|Overall Study|Study Ended By Sponsor|0|||
156343858|NCT03708328|564358504|FG001|Overall Study|Study Ended By Sponsor|0|||
156343859|NCT03708328|564358505|FG002|Overall Study|Study Ended By Sponsor|0|||
156343860|NCT03708328|564358506|FG003|Overall Study|Study Ended By Sponsor|0|||
156343861|NCT03708328|564358507|FG004|Overall Study|Study Ended By Sponsor|0|||
156343862|NCT03708328|564358508|FG005|Overall Study|Study Ended By Sponsor|1|||
156343863|NCT03708328|564358509|FG006|Overall Study|Study Ended By Sponsor|0|||
156343864|NCT03708328|564358510|FG007|Overall Study|Study Ended By Sponsor|1|||
156343865|NCT03708328|564358511|FG008|Overall Study|Study Ended By Sponsor|0|||
156475791|NCT01947491|564837444|FG002|Overall Study|Lack of Efficacy|0|||
156862202|NCT02336282|566253304|FG000|Overall Study|Not enough time to complete sessions|2|||
156862203|NCT00668148|566253320|FG000|Overall Study|Adverse Event|5|||
156862204|NCT00668148|566253320|FG000|Overall Study|Subject Non-compliance|1|||
156862205|NCT00668148|566253320|FG000|Overall Study|Progressive Disease Before Treatment|2|||
156862206|NCT00668148|566253320|FG000|Overall Study|Withdrawal of Consent|2|||
156862207|NCT02702492|566253321|FG000|Overall Study|Disease progression|3|||
156862208|NCT02702492|566253322|FG001|Overall Study|Disease progression|3|||
156862209|NCT02702492|566253323|FG002|Overall Study|Disease progression|2|||
156862210|NCT02702492|566253324|FG003|Overall Study|Disease progression|4|||
156862211|NCT02702492|566253325|FG004|Overall Study|Disease progression|4|||
156862212|NCT02702492|566253326|FG005|Overall Study|Disease progression|1|||
156862213|NCT02702492|566253327|FG006|Overall Study|Disease progression|2|||
156862214|NCT02702492|566253328|FG007|Overall Study|Disease progression|8|||
156862215|NCT02702492|566253329|FG008|Overall Study|Disease progression|5|||
156862216|NCT02702492|566253330|FG009|Overall Study|Disease progression|1|||
156862217|NCT02702492|566253331|FG010|Overall Study|Disease progression|0|||
156862218|NCT02702492|566253332|FG011|Overall Study|Disease progression|3|||
156862219|NCT02702492|566253333|FG012|Overall Study|Disease progression|2|||
156862220|NCT02702492|566253321|FG000|Overall Study|Clinical progression|0|||
156862221|NCT02702492|566253322|FG001|Overall Study|Clinical progression|0|||
156862222|NCT02702492|566253323|FG002|Overall Study|Clinical progression|2|||
156862223|NCT02702492|566253324|FG003|Overall Study|Clinical progression|1|||
156862224|NCT02702492|566253325|FG004|Overall Study|Clinical progression|0|||
156862225|NCT02702492|566253326|FG005|Overall Study|Clinical progression|2|||
156862226|NCT02702492|566253327|FG006|Overall Study|Clinical progression|1|||
156862227|NCT02702492|566253328|FG007|Overall Study|Clinical progression|4|||
156862228|NCT02702492|566253329|FG008|Overall Study|Clinical progression|0|||
156862229|NCT02702492|566253330|FG009|Overall Study|Clinical progression|0|||
156862230|NCT02702492|566253331|FG010|Overall Study|Clinical progression|1|||
156862231|NCT02702492|566253332|FG011|Overall Study|Clinical progression|2|||
156862232|NCT02702492|566253333|FG012|Overall Study|Clinical progression|0|||
156862233|NCT02702492|566253321|FG000|Overall Study|Adverse Event|0|||
156862234|NCT02702492|566253322|FG001|Overall Study|Adverse Event|0|||
156862235|NCT02702492|566253323|FG002|Overall Study|Adverse Event|1|||
156862236|NCT02702492|566253324|FG003|Overall Study|Adverse Event|2|||
156862237|NCT02702492|566253325|FG004|Overall Study|Adverse Event|1|||
156862238|NCT02702492|566253326|FG005|Overall Study|Adverse Event|0|||
156862239|NCT02702492|566253327|FG006|Overall Study|Adverse Event|1|||
156862240|NCT02702492|566253328|FG007|Overall Study|Adverse Event|0|||
156862241|NCT02702492|566253329|FG008|Overall Study|Adverse Event|2|||
156862242|NCT02702492|566253330|FG009|Overall Study|Adverse Event|0|||
156862243|NCT02702492|566253331|FG010|Overall Study|Adverse Event|0|||
156862244|NCT02702492|566253332|FG011|Overall Study|Adverse Event|0|||
156862245|NCT02702492|566253333|FG012|Overall Study|Adverse Event|1|||
156862246|NCT02702492|566253321|FG000|Overall Study|Other|0|||
156862247|NCT02702492|566253322|FG001|Overall Study|Other|0|||
156862248|NCT02702492|566253323|FG002|Overall Study|Other|0|||
156862249|NCT02702492|566253324|FG003|Overall Study|Other|0|||
156862250|NCT02702492|566253325|FG004|Overall Study|Other|0|||
156862251|NCT02702492|566253326|FG005|Overall Study|Other|0|||
156862252|NCT02702492|566253327|FG006|Overall Study|Other|0|||
156862253|NCT02702492|566253328|FG007|Overall Study|Other|0|||
156862254|NCT02702492|566253329|FG008|Overall Study|Other|0|||
156862255|NCT02702492|566253330|FG009|Overall Study|Other|0|||
156862256|NCT02702492|566253331|FG010|Overall Study|Other|0|||
156862257|NCT02702492|566253332|FG011|Overall Study|Other|0|||
156862258|NCT02702492|566253333|FG012|Overall Study|Other|1|||
156862259|NCT00781768|566254713|FG000|Overall Study|Not transplanted.|0|||
156862260|NCT00781768|566254714|FG001|Overall Study|Not transplanted.|2|||
156862261|NCT00199381|566254717|FG000|Overall Study|Withdrawal by Subject|38|||
156862262|NCT00199381|566254717|FG000|Overall Study|Adverse Event|73|||
156862263|NCT00199381|566254717|FG000|Overall Study|Protocol Violation|6|||
156862264|NCT00199381|566254717|FG000|Overall Study|Lack of Efficacy|27|||
156862265|NCT00199381|566254717|FG000|Overall Study|Not including due to early termination|37|||
156862266|NCT00199381|566254717|FG000|Overall Study|Study termination by Sponsor|323|||
156862267|NCT02892344|566254718|FG000|Overall Study|Protocol deviation|3|||
156862268|NCT02892344|566254719|FG001|Overall Study|Protocol deviation|4|||
156862269|NCT02892344|566254718|FG000|Overall Study|Adverse Event|1|||
156862270|NCT02892344|566254719|FG001|Overall Study|Adverse Event|8|||
156862271|NCT02892344|566254718|FG000|Overall Study|Lost to Follow-up|0|||
156862272|NCT02892344|566254719|FG001|Overall Study|Lost to Follow-up|1|||
156542390|NCT01840579|565079333|FG000|Overall Study|Adverse Event|0|||
156862273|NCT02892344|566254718|FG000|Overall Study|Non-compliance with study treatment|0|||
156862274|NCT02892344|566254719|FG001|Overall Study|Non-compliance with study treatment|1|||
156862275|NCT02892344|566254718|FG000|Overall Study|Physician Decision|0|||
156862276|NCT02892344|566254719|FG001|Overall Study|Physician Decision|2|||
156862277|NCT02892344|566254718|FG000|Overall Study|Subject/guardian decision|0|||
156862278|NCT02892344|566254719|FG001|Overall Study|Subject/guardian decision|4|||
156862279|NCT02892344|566254718|FG000|Overall Study|Technical problems|0|||
156862280|NCT02892344|566254719|FG001|Overall Study|Technical problems|1|||
156862281|NCT00751296|566254720|FG000|Overall Study|Adverse Event|2|||
156862282|NCT02318706|566254723|FG000|Double-blind Phase|Adverse Event|7|||
156862283|NCT02318706|566254724|FG001|Double-blind Phase|Adverse Event|4|||
156862284|NCT02318706|566254725|FG002|Double-blind Phase|Adverse Event|3|||
156862285|NCT02318706|566254726|FG003|Double-blind Phase|Adverse Event|10|||
156862286|NCT02318706|566254727|FG004|Double-blind Phase|Adverse Event|0|||
156862287|NCT02318706|566254723|FG000|Double-blind Phase|Lost to Follow-up|1|||
156862288|NCT02318706|566254724|FG001|Double-blind Phase|Lost to Follow-up|0|||
156862289|NCT02318706|566254725|FG002|Double-blind Phase|Lost to Follow-up|0|||
156862290|NCT02318706|566254726|FG003|Double-blind Phase|Lost to Follow-up|0|||
156862291|NCT02318706|566254727|FG004|Double-blind Phase|Lost to Follow-up|0|||
156862292|NCT02318706|566254723|FG000|Double-blind Phase|Protocol Violation|4|||
156862293|NCT02318706|566254724|FG001|Double-blind Phase|Protocol Violation|2|||
156862294|NCT02318706|566254725|FG002|Double-blind Phase|Protocol Violation|4|||
156862295|NCT02318706|566254726|FG003|Double-blind Phase|Protocol Violation|3|||
156862296|NCT02318706|566254727|FG004|Double-blind Phase|Protocol Violation|0|||
156862297|NCT02318706|566254723|FG000|Double-blind Phase|Withdrawal by Subject|9|||
156862298|NCT02318706|566254724|FG001|Double-blind Phase|Withdrawal by Subject|5|||
156862299|NCT02318706|566254725|FG002|Double-blind Phase|Withdrawal by Subject|7|||
156862300|NCT02318706|566254726|FG003|Double-blind Phase|Withdrawal by Subject|10|||
156862301|NCT02318706|566254727|FG004|Double-blind Phase|Withdrawal by Subject|0|||
156862302|NCT02318706|566254723|FG000|Double-blind Phase|Other|4|||
156862303|NCT02318706|566254724|FG001|Double-blind Phase|Other|1|||
156862304|NCT02318706|566254725|FG002|Double-blind Phase|Other|2|||
156862305|NCT02318706|566254726|FG003|Double-blind Phase|Other|1|||
156862306|NCT02318706|566254727|FG004|Double-blind Phase|Other|0|||
156862307|NCT02318706|566254723|FG000|Double-blind Phase|Death|0|||
156862308|NCT02318706|566254724|FG001|Double-blind Phase|Death|0|||
156862309|NCT02318706|566254725|FG002|Double-blind Phase|Death|2|||
156862310|NCT02318706|566254726|FG003|Double-blind Phase|Death|0|||
156862311|NCT02318706|566254727|FG004|Double-blind Phase|Death|0|||
156862312|NCT02318706|566254723|FG000|Open-label Extension Phase|Adverse Event|0|||
156862313|NCT02318706|566254724|FG001|Open-label Extension Phase|Adverse Event|0|||
156862314|NCT02318706|566254725|FG002|Open-label Extension Phase|Adverse Event|0|||
156862315|NCT02318706|566254726|FG003|Open-label Extension Phase|Adverse Event|0|||
156862316|NCT02318706|566254727|FG004|Open-label Extension Phase|Adverse Event|21|||
156862317|NCT02318706|566254723|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
156862318|NCT02318706|566254724|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
156862319|NCT02318706|566254725|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
156862320|NCT02318706|566254726|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
156862321|NCT02318706|566254727|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
156862322|NCT02318706|566254723|FG000|Open-label Extension Phase|Death|0|||
156862323|NCT02318706|566254724|FG001|Open-label Extension Phase|Death|0|||
156862324|NCT02318706|566254725|FG002|Open-label Extension Phase|Death|0|||
156862325|NCT02318706|566254726|FG003|Open-label Extension Phase|Death|0|||
156862326|NCT02318706|566254727|FG004|Open-label Extension Phase|Death|1|||
156862327|NCT02318706|566254723|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
156862328|NCT02318706|566254724|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
156862329|NCT02318706|566254725|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
156862330|NCT02318706|566254726|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
156862331|NCT02318706|566254727|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
156862332|NCT04328077|566254728|FG000|Overall Study|Lost to Follow-up|0|||
156862333|NCT04328077|566254729|FG001|Overall Study|Lost to Follow-up|1|||
156862334|NCT04328077|566254730|FG002|Overall Study|Lost to Follow-up|0|||
156862335|NCT04328077|566254731|FG003|Overall Study|Lost to Follow-up|0|||
156862336|NCT04328077|566254728|FG000|Overall Study|Withdrawal by Subject|0|||
156862337|NCT04328077|566254729|FG001|Overall Study|Withdrawal by Subject|1|||
156862338|NCT04328077|566254730|FG002|Overall Study|Withdrawal by Subject|1|||
156862339|NCT04328077|566254731|FG003|Overall Study|Withdrawal by Subject|3|||
156862340|NCT01702311|566254732|FG000|Overall Study|Withdrawal by Subject|3|||
156862341|NCT01702311|566254733|FG001|Overall Study|Withdrawal by Subject|2|||
156862342|NCT01702311|566254732|FG000|Overall Study|Discharge less than 24 hours|10|||
156862343|NCT01702311|566254733|FG001|Overall Study|Discharge less than 24 hours|7|||
156542391|NCT01840579|565079334|FG001|Overall Study|Adverse Event|1|||
156862344|NCT01702311|566254732|FG000|Overall Study|Physician Decision|3|||
156862345|NCT01702311|566254733|FG001|Overall Study|Physician Decision|4|||
156862346|NCT00804908|566254734|FG000|Overall Study|Other|115|||
156862347|NCT00804908|566254735|FG001|Overall Study|Other|116|||
156862348|NCT00804908|566254736|FG002|Overall Study|Other|114|||
156862349|NCT04945733|566254740|FG000|Overall Study|Physician Decision|1|||
156862350|NCT04945733|566254741|FG001|Overall Study|Physician Decision|3|||
156862351|NCT04945733|566254742|FG002|Overall Study|Physician Decision|0|||
156862352|NCT04945733|566254740|FG000|Overall Study|Withdrawal by Subject|3|||
156862353|NCT04945733|566254741|FG001|Overall Study|Withdrawal by Subject|3|||
156862354|NCT04945733|566254742|FG002|Overall Study|Withdrawal by Subject|0|||
156862355|NCT02007096|566254743|FG000|Overall Study|medication not available|2|||
156862356|NCT02007096|566254744|FG001|Overall Study|medication not available|0|||
156862357|NCT02007096|566254743|FG000|Overall Study|did not inject saline|0|||
156862358|NCT02007096|566254744|FG001|Overall Study|did not inject saline|3|||
156862359|NCT02007096|566254743|FG000|Overall Study|did not follow postoperative protocol|8|||
156862360|NCT02007096|566254744|FG001|Overall Study|did not follow postoperative protocol|11|||
156862361|NCT02007096|566254743|FG000|Overall Study|converted to open surgery|1|||
156862362|NCT02007096|566254744|FG001|Overall Study|converted to open surgery|1|||
156862363|NCT02007096|566254743|FG000|Overall Study|no mesh placed|0|||
156862364|NCT02007096|566254744|FG001|Overall Study|no mesh placed|1|||
156862365|NCT05660577|566254745|FG000|Overall Study|Discontinued|9|||
156862366|NCT03363841|566254751|FG000|Overall Study|Adverse Event|1|||
156862367|NCT03363841|566254751|FG000|Overall Study|Withdrawal by Subject|1|||
156862368|NCT03363841|566254751|FG000|Overall Study|Death|7|||
156862369|NCT03363841|566254751|FG000|Overall Study|Physician Decision|1|||
156862370|NCT02156076|566254754|FG000|Treatment Period|no longer meets study criteria|0|||
156862371|NCT02156076|566254755|FG001|Treatment Period|no longer meets study criteria|0|||
156862372|NCT02156076|566254756|FG002|Treatment Period|no longer meets study criteria|1|||
156862373|NCT02156076|566254757|FG003|Treatment Period|no longer meets study criteria|0|||
156862374|NCT02156076|566254754|FG000|Treatment Period|Poor/non-compliance|0|||
156862375|NCT02156076|566254755|FG001|Treatment Period|Poor/non-compliance|1|||
156862376|NCT02156076|566254756|FG002|Treatment Period|Poor/non-compliance|0|||
156862377|NCT02156076|566254757|FG003|Treatment Period|Poor/non-compliance|0|||
156862378|NCT02156076|566254754|FG000|Treatment Period|Lost to Follow-up|0|||
156862379|NCT02156076|566254755|FG001|Treatment Period|Lost to Follow-up|0|||
156862380|NCT02156076|566254756|FG002|Treatment Period|Lost to Follow-up|0|||
156862381|NCT02156076|566254757|FG003|Treatment Period|Lost to Follow-up|1|||
156862382|NCT02156076|566254754|FG000|Treatment Period|Withdrawal by Subject|0|||
156862383|NCT02156076|566254755|FG001|Treatment Period|Withdrawal by Subject|0|||
156862384|NCT02156076|566254756|FG002|Treatment Period|Withdrawal by Subject|1|||
156862385|NCT02156076|566254757|FG003|Treatment Period|Withdrawal by Subject|0|||
156862386|NCT02156076|566254754|FG000|Treatment Period|Subject request to discontinue treatment|0|||
156862387|NCT02156076|566254755|FG001|Treatment Period|Subject request to discontinue treatment|1|||
156862388|NCT02156076|566254756|FG002|Treatment Period|Subject request to discontinue treatment|0|||
156862389|NCT02156076|566254757|FG003|Treatment Period|Subject request to discontinue treatment|0|||
156862390|NCT02156076|566254754|FG000|Treatment Period|Adverse Event|0|||
156862391|NCT02156076|566254755|FG001|Treatment Period|Adverse Event|0|||
156862392|NCT02156076|566254756|FG002|Treatment Period|Adverse Event|0|||
156862393|NCT02156076|566254757|FG003|Treatment Period|Adverse Event|1|||
156862394|NCT02156076|566254754|FG000|Follow-up Period|Withdrawal by Subject|1|||
156862395|NCT02156076|566254755|FG001|Follow-up Period|Withdrawal by Subject|0|||
156862396|NCT02156076|566254756|FG002|Follow-up Period|Withdrawal by Subject|0|||
156862397|NCT02156076|566254757|FG003|Follow-up Period|Withdrawal by Subject|0|||
156862398|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
156862399|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
156862400|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
156862401|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
156862402|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
156862403|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
156862404|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
156862405|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
156862406|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
156862407|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156862408|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156862409|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156862410|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
156862411|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
156862412|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
156475792|NCT01947491|564837445|FG003|Overall Study|Lack of Efficacy|1|||
156475793|NCT01947491|564837442|FG000|Overall Study|Protocol Violation|1|||
156475794|NCT01947491|564837443|FG001|Overall Study|Protocol Violation|0|||
156475795|NCT01947491|564837444|FG002|Overall Study|Protocol Violation|0|||
156475796|NCT01947491|564837445|FG003|Overall Study|Protocol Violation|0|||
156475797|NCT01947491|564837442|FG000|Overall Study|Withdrawal by Subject|1|||
156475798|NCT01947491|564837443|FG001|Overall Study|Withdrawal by Subject|1|||
156475799|NCT01947491|564837444|FG002|Overall Study|Withdrawal by Subject|1|||
156542392|NCT01840579|565079335|FG002|Overall Study|Adverse Event|0|||
156862413|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
156862414|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
156862415|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
156475800|NCT01947491|564837445|FG003|Overall Study|Withdrawal by Subject|0|||
156475801|NCT01947491|564837442|FG000|Overall Study|Worsening of condition|0|||
156542393|NCT01840579|565079336|FG003|Overall Study|Adverse Event|0|||
156343866|NCT03708328|564358512|FG009|Overall Study|Study Ended By Sponsor|0|||
156475802|NCT01947491|564837443|FG001|Overall Study|Worsening of condition|1|||
156862416|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
156862417|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
156862418|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
156862419|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
156862420|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156862421|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156862422|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
156862423|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
156862424|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
156862425|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
156862426|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156862427|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
156862428|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156862429|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156862430|NCT04026113|566254760|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
156862431|NCT04026113|566254761|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
156862432|NCT04026113|566254762|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
156862433|NCT04026113|566254763|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
156862434|NCT00687596|566254764|FG000|Overall Study|Adverse Event (AE)|10|||
156862435|NCT00687596|566254765|FG001|Overall Study|Adverse Event (AE)|3|||
156862436|NCT00687596|566254764|FG000|Overall Study|Radiological Disease Progression|6|||
156862437|NCT00687596|566254765|FG001|Overall Study|Radiological Disease Progression|2|||
156862438|NCT00687596|566254764|FG000|Overall Study|Clinical Disease Progression|1|||
156862439|NCT00687596|566254765|FG001|Overall Study|Clinical Disease Progression|3|||
156862440|NCT00687596|566254764|FG000|Overall Study|Investigator Discretion|3|||
156862441|NCT00687596|566254765|FG001|Overall Study|Investigator Discretion|1|||
156862442|NCT00687596|566254764|FG000|Overall Study|Sponsor Terminated Study|6|||
156862443|NCT00687596|566254765|FG001|Overall Study|Sponsor Terminated Study|17|||
156862444|NCT01527149|566254767|FG000|Overall Study|Death|2|||
156862445|NCT00499486|566254770|FG000|Overall Study|Withdrawal by Subject|16|||
156862446|NCT01867671|566254776|FG000|Overall Study|Adverse Event|5|||
156862447|NCT01867671|566254777|FG001|Overall Study|Adverse Event|3|||
156862448|NCT01867671|566254776|FG000|Overall Study|Anaphylaxis|0|||
156862449|NCT01867671|566254777|FG001|Overall Study|Anaphylaxis|1|||
156862450|NCT01867671|566254776|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
156862451|NCT01867671|566254777|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
156862452|NCT01867671|566254776|FG000|Overall Study|Lost to Follow-up|0|||
156862453|NCT01867671|566254777|FG001|Overall Study|Lost to Follow-up|1|||
156862454|NCT01867671|566254776|FG000|Overall Study|Non-compliance with Study Drug|1|||
156862455|NCT01867671|566254777|FG001|Overall Study|Non-compliance with Study Drug|2|||
156862456|NCT01867671|566254776|FG000|Overall Study|Withdrawal by Subject|21|||
156862457|NCT01867671|566254777|FG001|Overall Study|Withdrawal by Subject|21|||
156862458|NCT01451606|566254783|FG000|Overall Study|Withdrawal by Subject|4|||
156862459|NCT01451606|566254784|FG001|Overall Study|Withdrawal by Subject|3|||
156862460|NCT02163538|566254785|FG000|Overall Study|Protocol Violation|1|||
156862461|NCT02163538|566254786|FG001|Overall Study|Protocol Violation|0|||
156862462|NCT02163538|566254785|FG000|Overall Study|Physician Decision|0|||
156862463|NCT02163538|566254786|FG001|Overall Study|Physician Decision|1|||
156862464|NCT04484961|566254787|FG000|Overall Study|Lost to Follow-up|9|||
156862465|NCT04484961|566254788|FG001|Overall Study|Lost to Follow-up|9|||
156862466|NCT00388349|566254789|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
156862467|NCT00388349|566254790|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
156343867|NCT03708328|564358503|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156475803|NCT01947491|564837444|FG002|Overall Study|Worsening of condition|0|||
156475804|NCT01947491|564837445|FG003|Overall Study|Worsening of condition|0|||
156475805|NCT01947491|564837442|FG000|Overall Study|Adverse Event|0|||
156475806|NCT01947491|564837443|FG001|Overall Study|Adverse Event|1|||
156475807|NCT01947491|564837444|FG002|Overall Study|Adverse Event|0|||
156475808|NCT01947491|564837445|FG003|Overall Study|Adverse Event|2|||
156475809|NCT02067663|564837447|FG000|Overall Study|Lost to Follow-up|13|||
156475810|NCT02067663|564837448|FG001|Overall Study|Lost to Follow-up|14|||
156475811|NCT00704340|564837449|FG000|Overall Study|Lost to Follow-up|2|||
156862468|NCT01126749|566254793|FG000|Phase 1b|Other|0|||
156862469|NCT01126749|566254794|FG001|Phase 1b|Other|1|||
156862470|NCT01126749|566254795|FG002|Phase 1b|Other|0|||
156862471|NCT01126749|566254796|FG003|Phase 1b|Other|0|||
156475812|NCT00704340|564837450|FG001|Overall Study|Lost to Follow-up|1|||
156475813|NCT00704340|564837449|FG000|Overall Study|Death|0|||
156862472|NCT01126749|566254793|FG000|Phase 1b|Withdrawal by Subject|0|||
156475814|NCT00704340|564837450|FG001|Overall Study|Death|1|||
156475815|NCT03236779|564837454|FG000|Overall Study|Lost to Follow-up|13|||
156475816|NCT03236779|564837455|FG001|Overall Study|Lost to Follow-up|21|||
156862473|NCT01126749|566254794|FG001|Phase 1b|Withdrawal by Subject|1|||
156862474|NCT01126749|566254795|FG002|Phase 1b|Withdrawal by Subject|0|||
156862475|NCT01126749|566254796|FG003|Phase 1b|Withdrawal by Subject|0|||
156862476|NCT01126749|566254793|FG000|Phase 1b|Death|3|||
156862477|NCT01126749|566254794|FG001|Phase 1b|Death|4|||
156862478|NCT01126749|566254795|FG002|Phase 1b|Death|0|||
156862479|NCT01126749|566254796|FG003|Phase 1b|Death|0|||
156862480|NCT01126749|566254793|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
156862481|NCT01126749|566254794|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
156862482|NCT01126749|566254795|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
156862483|NCT01126749|566254796|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
156862484|NCT01126749|566254793|FG000|Phase 2|Study Termination by Sponsor|0|||
156862485|NCT01126749|566254794|FG001|Phase 2|Study Termination by Sponsor|0|||
156862486|NCT01126749|566254795|FG002|Phase 2|Study Termination by Sponsor|12|||
156862487|NCT01126749|566254796|FG003|Phase 2|Study Termination by Sponsor|6|||
156862488|NCT01126749|566254793|FG000|Phase 2|Other|0|||
156862489|NCT01126749|566254794|FG001|Phase 2|Other|0|||
156862490|NCT01126749|566254795|FG002|Phase 2|Other|4|||
156862491|NCT01126749|566254796|FG003|Phase 2|Other|2|||
156862492|NCT01126749|566254793|FG000|Phase 2|Withdrawal by Subject|0|||
156862493|NCT01126749|566254794|FG001|Phase 2|Withdrawal by Subject|0|||
156862494|NCT01126749|566254795|FG002|Phase 2|Withdrawal by Subject|0|||
156862495|NCT01126749|566254796|FG003|Phase 2|Withdrawal by Subject|2|||
156862496|NCT01126749|566254793|FG000|Phase 2|Lost to Follow-up|0|||
156862497|NCT01126749|566254794|FG001|Phase 2|Lost to Follow-up|0|||
156862498|NCT01126749|566254795|FG002|Phase 2|Lost to Follow-up|0|||
156862499|NCT01126749|566254796|FG003|Phase 2|Lost to Follow-up|1|||
156862500|NCT01126749|566254793|FG000|Phase 2|Death|0|||
156862501|NCT01126749|566254794|FG001|Phase 2|Death|0|||
156862502|NCT01126749|566254795|FG002|Phase 2|Death|22|||
156862503|NCT01126749|566254796|FG003|Phase 2|Death|22|||
156862504|NCT01126749|566254793|FG000|Phase 2|Adverse Event|0|||
156862505|NCT01126749|566254794|FG001|Phase 2|Adverse Event|0|||
156862506|NCT01126749|566254795|FG002|Phase 2|Adverse Event|0|||
156862507|NCT01126749|566254796|FG003|Phase 2|Adverse Event|1|||
156862508|NCT00976274|566254797|FG000|Overall Study|Lost to Follow-up|5|||
156862509|NCT00976274|566254798|FG001|Overall Study|Lost to Follow-up|5|||
156862510|NCT00976274|566254797|FG000|Overall Study|Withdrawal by Subject|1|||
156862511|NCT00976274|566254798|FG001|Overall Study|Withdrawal by Subject|1|||
156862512|NCT00976274|566254797|FG000|Overall Study|Physician Decision|1|||
156862513|NCT00976274|566254798|FG001|Overall Study|Physician Decision|2|||
156862514|NCT01614249|566254800|FG000|Overall Study|Lost to Follow-up|11|||
156862515|NCT01614249|566254801|FG001|Overall Study|Lost to Follow-up|23|||
156862516|NCT02954536|566254802|FG000|Overall Study|Adverse Event|2|||
156862517|NCT02954536|566254802|FG000|Overall Study|Death|12|||
156343868|NCT03708328|564358504|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156343869|NCT03708328|564358505|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156343870|NCT03708328|564358506|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156343871|NCT03708328|564358507|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156343872|NCT03708328|564358508|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156343873|NCT03708328|564358509|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156343874|NCT03708328|564358510|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156343875|NCT03708328|564358511|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
156343876|NCT03708328|564358512|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156343877|NCT04523220|564358513|FG000|Main Treatment Period|Physician Decision|1|||
156343878|NCT04523220|564358514|FG001|Main Treatment Period|Physician Decision|1|||
156343879|NCT04523220|564358515|FG002|Main Treatment Period|Physician Decision|0|||
156343880|NCT04523220|564358513|FG000|Main Treatment Period|Other|5|||
156343881|NCT04523220|564358514|FG001|Main Treatment Period|Other|2|||
156343882|NCT04523220|564358515|FG002|Main Treatment Period|Other|4|||
156862518|NCT02946580|566254803|FG000|Overall Study|Withdrawal by Subject|1|||
156862519|NCT02946580|566254804|FG001|Overall Study|Withdrawal by Subject|2|||
156862520|NCT02946580|566254803|FG000|Overall Study|Adverse Event|0|||
156343883|NCT04523220|564358513|FG000|Main Treatment Period|Subject Decision|5|||
156343884|NCT04523220|564358514|FG001|Main Treatment Period|Subject Decision|7|||
156343885|NCT04523220|564358515|FG002|Main Treatment Period|Subject Decision|3|||
156343886|NCT04523220|564358513|FG000|Main Treatment Period|Death|5|||
156862521|NCT02946580|566254804|FG001|Overall Study|Adverse Event|2|||
156862522|NCT02946580|566254803|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
156862523|NCT02946580|566254804|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
156862524|NCT02158442|566254805|FG000|Overall Study|Withdrawal by Subject|1|||
156862525|NCT02158442|566254806|FG001|Overall Study|Withdrawal by Subject|0|||
156862526|NCT02158442|566254805|FG000|Overall Study|Perfusion staff not available|1|||
156862527|NCT02158442|566254806|FG001|Overall Study|Perfusion staff not available|0|||
156862528|NCT02657889|566254809|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
156862529|NCT02657889|566254810|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
156862530|NCT02657889|566254811|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
156862531|NCT02657889|566254812|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
156862532|NCT02657889|566254809|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
156862533|NCT02657889|566254810|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
156862534|NCT02657889|566254811|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
156862535|NCT02657889|566254812|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
156862536|NCT02657889|566254809|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
156862537|NCT02657889|566254810|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
156862538|NCT02657889|566254811|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
156862539|NCT02657889|566254812|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
156862540|NCT02657889|566254809|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
156862541|NCT02657889|566254810|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
156862542|NCT02657889|566254811|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
156862543|NCT02657889|566254812|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
156862544|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
156862545|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
156862546|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
156862547|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
156862548|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
156862549|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
156862550|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
156862551|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
156862552|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
156862553|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
156862554|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
156343887|NCT04523220|564358514|FG001|Main Treatment Period|Death|11|||
156343888|NCT04523220|564358515|FG002|Main Treatment Period|Death|4|||
156475817|NCT00403845|564837460|FG000|Treatment Period 1|Subject withdrew consent|1|||
156475818|NCT00403845|564837461|FG001|Treatment Period 1|Subject withdrew consent|0|||
156475819|NCT00403845|564837462|FG002|Treatment Period 1|Subject withdrew consent|0|||
156475820|NCT00403845|564837463|FG003|Treatment Period 1|Subject withdrew consent|0|||
156475821|NCT00403845|564837460|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
156475822|NCT00403845|564837461|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
156475823|NCT00403845|564837462|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
156475824|NCT00403845|564837463|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
156475825|NCT00403845|564837460|FG000|Treatment Period 2|Subject withdrew consent|1|||
156475826|NCT00403845|564837461|FG001|Treatment Period 2|Subject withdrew consent|0|||
156475827|NCT00403845|564837462|FG002|Treatment Period 2|Subject withdrew consent|0|||
156475828|NCT00403845|564837463|FG003|Treatment Period 2|Subject withdrew consent|0|||
156475829|NCT00403845|564837460|FG000|Treatment Period 3|Subject withdrew consent|0|||
156475830|NCT00403845|564837461|FG001|Treatment Period 3|Subject withdrew consent|0|||
156475831|NCT00403845|564837462|FG002|Treatment Period 3|Subject withdrew consent|0|||
156475832|NCT00403845|564837463|FG003|Treatment Period 3|Subject withdrew consent|1|||
156475833|NCT00403845|564837460|FG000|Treatment Period 3|Adverse Event|0|||
156475834|NCT00403845|564837461|FG001|Treatment Period 3|Adverse Event|0|||
156475835|NCT00403845|564837462|FG002|Treatment Period 3|Adverse Event|0|||
156475836|NCT00403845|564837463|FG003|Treatment Period 3|Adverse Event|1|||
156475837|NCT01836523|564837464|FG000|Overall Study|Adverse Event|15|||
156475838|NCT01836523|564837465|FG001|Overall Study|Adverse Event|41|||
156475839|NCT01836523|564837466|FG002|Overall Study|Adverse Event|49|||
156475840|NCT01836523|564837467|FG003|Overall Study|Adverse Event|14|||
156475841|NCT01836523|564837464|FG000|Overall Study|Protocol Violation|6|||
156475842|NCT01836523|564837465|FG001|Overall Study|Protocol Violation|3|||
156475843|NCT01836523|564837466|FG002|Overall Study|Protocol Violation|2|||
156475844|NCT01836523|564837467|FG003|Overall Study|Protocol Violation|4|||
156475845|NCT01836523|564837464|FG000|Overall Study|Met Withdrawal Criteria|13|||
156475846|NCT01836523|564837465|FG001|Overall Study|Met Withdrawal Criteria|13|||
156475847|NCT01836523|564837466|FG002|Overall Study|Met Withdrawal Criteria|21|||
156475848|NCT01836523|564837467|FG003|Overall Study|Met Withdrawal Criteria|27|||
156862555|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
156862556|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
156862557|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
156862558|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
156862559|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
156862560|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
156863430|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
156343889|NCT04523220|564358513|FG000|Main Treatment Period|Adverse Event|11|||
156475849|NCT01836523|564837464|FG000|Overall Study|Unclassified|17|||
156475850|NCT01836523|564837465|FG001|Overall Study|Unclassified|28|||
156475851|NCT01836523|564837466|FG002|Overall Study|Unclassified|19|||
156475852|NCT01836523|564837467|FG003|Overall Study|Unclassified|29|||
156475853|NCT00624377|564837470|FG000|Overall Study|Lost to Follow-up|355|||
156343890|NCT04523220|564358514|FG001|Main Treatment Period|Adverse Event|9|||
156343891|NCT04523220|564358515|FG002|Main Treatment Period|Adverse Event|9|||
156343892|NCT04523220|564358513|FG000|Main Treatment Period|Withdrawal by Subject|3|||
156343893|NCT04523220|564358514|FG001|Main Treatment Period|Withdrawal by Subject|3|||
156343894|NCT04523220|564358515|FG002|Main Treatment Period|Withdrawal by Subject|4|||
156343895|NCT04523220|564358513|FG000|Main Treatment Period|Study drug never adminstered|10|||
156343896|NCT04523220|564358514|FG001|Main Treatment Period|Study drug never adminstered|3|||
156862561|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
156862562|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
156862563|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
156862564|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
156862565|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
156862566|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
156862567|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
156862568|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
156862569|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
156862570|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
156862571|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
156862572|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
156862573|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
156862574|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
156862575|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
156862576|NCT02234843|566254815|FG000|Overall Study|Death|1|||
156862577|NCT02234843|566254816|FG001|Overall Study|Death|0|||
156862578|NCT02234843|566254817|FG002|Overall Study|Death|0|||
156862579|NCT02234843|566254818|FG003|Overall Study|Death|0|||
156862580|NCT02234843|566254819|FG004|Overall Study|Death|0|||
156862581|NCT02234843|566254820|FG005|Overall Study|Death|0|||
156862582|NCT02234843|566254821|FG006|Overall Study|Death|0|||
156862583|NCT02234843|566254822|FG007|Overall Study|Death|0|||
156862584|NCT02234843|566254823|FG008|Overall Study|Death|0|||
156862585|NCT02234843|566254824|FG009|Overall Study|Death|0|||
156862586|NCT02234843|566254815|FG000|Overall Study|Protocol Violation|1|||
156862587|NCT02234843|566254816|FG001|Overall Study|Protocol Violation|0|||
156862588|NCT02234843|566254817|FG002|Overall Study|Protocol Violation|1|||
156862589|NCT02234843|566254818|FG003|Overall Study|Protocol Violation|0|||
156862590|NCT02234843|566254819|FG004|Overall Study|Protocol Violation|0|||
156862591|NCT02234843|566254820|FG005|Overall Study|Protocol Violation|0|||
156862592|NCT02234843|566254821|FG006|Overall Study|Protocol Violation|0|||
156862593|NCT02234843|566254822|FG007|Overall Study|Protocol Violation|0|||
156862594|NCT02234843|566254823|FG008|Overall Study|Protocol Violation|0|||
156862595|NCT02234843|566254824|FG009|Overall Study|Protocol Violation|0|||
156862596|NCT02234843|566254815|FG000|Overall Study|Efficacy outcome reached|2|||
156862597|NCT02234843|566254816|FG001|Overall Study|Efficacy outcome reached|0|||
156862598|NCT02234843|566254817|FG002|Overall Study|Efficacy outcome reached|0|||
156862599|NCT02234843|566254818|FG003|Overall Study|Efficacy outcome reached|0|||
156862600|NCT02234843|566254819|FG004|Overall Study|Efficacy outcome reached|0|||
156862601|NCT02234843|566254820|FG005|Overall Study|Efficacy outcome reached|2|||
156862602|NCT02234843|566254821|FG006|Overall Study|Efficacy outcome reached|0|||
156862603|NCT02234843|566254822|FG007|Overall Study|Efficacy outcome reached|0|||
156862604|NCT02234843|566254823|FG008|Overall Study|Efficacy outcome reached|0|||
156862605|NCT02234843|566254824|FG009|Overall Study|Efficacy outcome reached|0|||
156862606|NCT02234843|566254815|FG000|Overall Study|Patient convenience|2|||
156862607|NCT02234843|566254816|FG001|Overall Study|Patient convenience|0|||
156862608|NCT02234843|566254817|FG002|Overall Study|Patient convenience|0|||
156862609|NCT02234843|566254818|FG003|Overall Study|Patient convenience|0|||
156343897|NCT04523220|564358515|FG002|Main Treatment Period|Study drug never adminstered|5|||
156343898|NCT04523220|564358513|FG000|Extension Treatment Period|Physician Decision|1|||
156343899|NCT04523220|564358514|FG001|Extension Treatment Period|Physician Decision|0|||
156343900|NCT04523220|564358515|FG002|Extension Treatment Period|Physician Decision|3|||
156343901|NCT04523220|564358513|FG000|Extension Treatment Period|Other|2|||
156343902|NCT04523220|564358514|FG001|Extension Treatment Period|Other|6|||
156475854|NCT00624377|564837470|FG000|Overall Study|Withdrawal by Subject|100|||
156862610|NCT02234843|566254819|FG004|Overall Study|Patient convenience|0|||
156862611|NCT02234843|566254820|FG005|Overall Study|Patient convenience|1|||
156862612|NCT02234843|566254821|FG006|Overall Study|Patient convenience|0|||
156862613|NCT02234843|566254822|FG007|Overall Study|Patient convenience|0|||
156862614|NCT02234843|566254823|FG008|Overall Study|Patient convenience|0|||
156862615|NCT02234843|566254824|FG009|Overall Study|Patient convenience|0|||
156862616|NCT02234843|566254815|FG000|Overall Study|Withdrawal by Subject|5|||
156862617|NCT02234843|566254816|FG001|Overall Study|Withdrawal by Subject|1|||
156475855|NCT00624377|564837470|FG000|Overall Study|Adverse Event|14|||
156343903|NCT04523220|564358515|FG002|Extension Treatment Period|Other|6|||
156542394|NCT01840579|565079337|FG004|Overall Study|Adverse Event|0|||
156542395|NCT01840579|565079338|FG005|Overall Study|Adverse Event|0|||
156542396|NCT01840579|565079339|FG006|Overall Study|Adverse Event|0|||
156542397|NCT01840579|565079340|FG007|Overall Study|Adverse Event|0|||
156542398|NCT01840579|565079341|FG008|Overall Study|Adverse Event|0|||
156542399|NCT01840579|565079342|FG009|Overall Study|Adverse Event|0|||
156542400|NCT01840579|565079333|FG000|Overall Study|Follow-up ended by Sponsor|0|||
156542401|NCT01840579|565079334|FG001|Overall Study|Follow-up ended by Sponsor|0|||
156542402|NCT01840579|565079335|FG002|Overall Study|Follow-up ended by Sponsor|0|||
156542403|NCT01840579|565079336|FG003|Overall Study|Follow-up ended by Sponsor|0|||
156542404|NCT01840579|565079337|FG004|Overall Study|Follow-up ended by Sponsor|0|||
156542405|NCT01840579|565079338|FG005|Overall Study|Follow-up ended by Sponsor|0|||
156542406|NCT01840579|565079339|FG006|Overall Study|Follow-up ended by Sponsor|2|||
156542407|NCT01840579|565079340|FG007|Overall Study|Follow-up ended by Sponsor|0|||
156542408|NCT01840579|565079341|FG008|Overall Study|Follow-up ended by Sponsor|0|||
156542409|NCT01840579|565079342|FG009|Overall Study|Follow-up ended by Sponsor|0|||
156862618|NCT02234843|566254817|FG002|Overall Study|Withdrawal by Subject|1|||
156862619|NCT02234843|566254818|FG003|Overall Study|Withdrawal by Subject|0|||
156862620|NCT02234843|566254819|FG004|Overall Study|Withdrawal by Subject|0|||
156862621|NCT02234843|566254820|FG005|Overall Study|Withdrawal by Subject|7|||
156862622|NCT02234843|566254821|FG006|Overall Study|Withdrawal by Subject|0|||
156862623|NCT02234843|566254822|FG007|Overall Study|Withdrawal by Subject|0|||
156862624|NCT02234843|566254823|FG008|Overall Study|Withdrawal by Subject|0|||
156862625|NCT02234843|566254824|FG009|Overall Study|Withdrawal by Subject|0|||
156862626|NCT02234843|566254815|FG000|Overall Study|Recovery|1|||
156862627|NCT02234843|566254816|FG001|Overall Study|Recovery|0|||
156862628|NCT02234843|566254817|FG002|Overall Study|Recovery|0|||
156862629|NCT02234843|566254818|FG003|Overall Study|Recovery|0|||
156862630|NCT02234843|566254819|FG004|Overall Study|Recovery|0|||
156862631|NCT02234843|566254820|FG005|Overall Study|Recovery|0|||
156862632|NCT02234843|566254821|FG006|Overall Study|Recovery|0|||
156862633|NCT02234843|566254822|FG007|Overall Study|Recovery|0|||
156862634|NCT02234843|566254823|FG008|Overall Study|Recovery|0|||
156862635|NCT02234843|566254824|FG009|Overall Study|Recovery|0|||
156862636|NCT02234843|566254815|FG000|Overall Study|Other|0|||
156862637|NCT02234843|566254816|FG001|Overall Study|Other|2|||
156475856|NCT00624377|564837470|FG000|Overall Study|Other|91|||
156475857|NCT00624377|564837470|FG000|Overall Study|Non-evaluable population|84|||
156475858|NCT00089791|564837472|FG000|Overall Study|Physician Decision|6|||
156475859|NCT00089791|564837473|FG001|Overall Study|Physician Decision|3|||
156475860|NCT00089791|564837472|FG000|Overall Study|Adverse Event|81|||
156475861|NCT00089791|564837473|FG001|Overall Study|Adverse Event|93|||
156475862|NCT00089791|564837472|FG000|Overall Study|Withdrawal by Subject|403|||
156475863|NCT00089791|564837473|FG001|Overall Study|Withdrawal by Subject|344|||
156475864|NCT00089791|564837472|FG000|Overall Study|Death|78|||
156475865|NCT00089791|564837473|FG001|Overall Study|Death|62|||
156475866|NCT00089791|564837472|FG000|Overall Study|Disease progression|7|||
156475867|NCT00089791|564837473|FG001|Overall Study|Disease progression|3|||
156475868|NCT00089791|564837472|FG000|Overall Study|Ineligibility determined|12|||
156475869|NCT00089791|564837473|FG001|Overall Study|Ineligibility determined|9|||
156475870|NCT00089791|564837472|FG000|Overall Study|Lost to Follow-up|57|||
156475871|NCT00089791|564837473|FG001|Overall Study|Lost to Follow-up|57|||
156475872|NCT00089791|564837472|FG000|Overall Study|Noncompliance|17|||
156475873|NCT00089791|564837473|FG001|Overall Study|Noncompliance|13|||
156475874|NCT00089791|564837472|FG000|Overall Study|Other|20|||
156475875|NCT00089791|564837473|FG001|Overall Study|Other|32|||
156475876|NCT00089791|564837472|FG000|Overall Study|Protocol deviation|12|||
156475877|NCT00089791|564837473|FG001|Overall Study|Protocol deviation|10|||
156475878|NCT00089791|564837472|FG000|Overall Study|Requirement for alternative therapy|7|||
156475879|NCT00089791|564837473|FG001|Overall Study|Requirement for alternative therapy|4|||
156475880|NCT00148122|564837474|FG000|Overall Study|Withdrawal by Subject|2|||
156542410|NCT03803059|565079343|FG000|Overall Study|Protocol Violation|2|||
156542411|NCT03803059|565079343|FG000|Overall Study|Lost to Follow-up|1|||
156542412|NCT02090413|565079348|FG000|Overall Study|Adverse Event|11|||
156862638|NCT02234843|566254817|FG002|Overall Study|Other|0|||
156862639|NCT02234843|566254818|FG003|Overall Study|Other|1|||
156862640|NCT02234843|566254819|FG004|Overall Study|Other|0|||
156862641|NCT02234843|566254820|FG005|Overall Study|Other|1|||
156475881|NCT01989689|564837475|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
156475882|NCT01989689|564837476|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
156475883|NCT01989689|564837475|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
156475884|NCT01989689|564837476|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
156542413|NCT02090413|565079349|FG001|Overall Study|Adverse Event|15|||
156862642|NCT02234843|566254821|FG006|Overall Study|Other|0|||
156862643|NCT02234843|566254822|FG007|Overall Study|Other|1|||
156862644|NCT02234843|566254823|FG008|Overall Study|Other|0|||
156862645|NCT02234843|566254824|FG009|Overall Study|Other|0|||
156862646|NCT02234843|566254815|FG000|Overall Study|Physician Decision|4|||
156862647|NCT02234843|566254816|FG001|Overall Study|Physician Decision|1|||
156862648|NCT02234843|566254817|FG002|Overall Study|Physician Decision|0|||
156862649|NCT02234843|566254818|FG003|Overall Study|Physician Decision|1|||
156862650|NCT02234843|566254819|FG004|Overall Study|Physician Decision|0|||
156862651|NCT02234843|566254820|FG005|Overall Study|Physician Decision|0|||
156862652|NCT02234843|566254821|FG006|Overall Study|Physician Decision|0|||
156862653|NCT02234843|566254822|FG007|Overall Study|Physician Decision|1|||
156862654|NCT02234843|566254823|FG008|Overall Study|Physician Decision|0|||
156862655|NCT02234843|566254824|FG009|Overall Study|Physician Decision|0|||
156862656|NCT02234843|566254815|FG000|Overall Study|Adverse Event|5|||
156862657|NCT02234843|566254816|FG001|Overall Study|Adverse Event|1|||
156862658|NCT02234843|566254817|FG002|Overall Study|Adverse Event|1|||
156862659|NCT02234843|566254818|FG003|Overall Study|Adverse Event|3|||
156862660|NCT02234843|566254819|FG004|Overall Study|Adverse Event|2|||
156862661|NCT02234843|566254820|FG005|Overall Study|Adverse Event|1|||
156862662|NCT02234843|566254821|FG006|Overall Study|Adverse Event|0|||
156862663|NCT02234843|566254822|FG007|Overall Study|Adverse Event|0|||
156862664|NCT02234843|566254823|FG008|Overall Study|Adverse Event|1|||
156862665|NCT02234843|566254824|FG009|Overall Study|Adverse Event|0|||
156862666|NCT02234843|566254815|FG000|Overall Study|Non-compliance with study drug|1|||
156862667|NCT02234843|566254816|FG001|Overall Study|Non-compliance with study drug|0|||
156862668|NCT02234843|566254817|FG002|Overall Study|Non-compliance with study drug|0|||
156862669|NCT02234843|566254818|FG003|Overall Study|Non-compliance with study drug|0|||
156862670|NCT02234843|566254819|FG004|Overall Study|Non-compliance with study drug|0|||
156862671|NCT02234843|566254820|FG005|Overall Study|Non-compliance with study drug|1|||
156862672|NCT02234843|566254821|FG006|Overall Study|Non-compliance with study drug|1|||
156862673|NCT02234843|566254822|FG007|Overall Study|Non-compliance with study drug|0|||
156862674|NCT02234843|566254823|FG008|Overall Study|Non-compliance with study drug|0|||
156862675|NCT02234843|566254824|FG009|Overall Study|Non-compliance with study drug|0|||
156862676|NCT02234843|566254815|FG000|Overall Study|Lost to Follow-up|0|||
156862677|NCT02234843|566254816|FG001|Overall Study|Lost to Follow-up|1|||
156862678|NCT02234843|566254817|FG002|Overall Study|Lost to Follow-up|0|||
156862679|NCT02234843|566254818|FG003|Overall Study|Lost to Follow-up|0|||
156862680|NCT02234843|566254819|FG004|Overall Study|Lost to Follow-up|0|||
156862681|NCT02234843|566254820|FG005|Overall Study|Lost to Follow-up|0|||
156862682|NCT02234843|566254821|FG006|Overall Study|Lost to Follow-up|1|||
156862683|NCT02234843|566254822|FG007|Overall Study|Lost to Follow-up|0|||
156862684|NCT02234843|566254823|FG008|Overall Study|Lost to Follow-up|0|||
156862685|NCT02234843|566254824|FG009|Overall Study|Lost to Follow-up|0|||
156862686|NCT05472090|566254833|FG000|Overall Study|Adverse Event|2|||
156862687|NCT05472090|566254834|FG001|Overall Study|Adverse Event|3|||
156862688|NCT05472090|566254833|FG000|Overall Study|Lack of Efficacy|1|||
156862689|NCT05472090|566254834|FG001|Overall Study|Lack of Efficacy|0|||
156862690|NCT05472090|566254833|FG000|Overall Study|Physician Decision|1|||
156862691|NCT05472090|566254834|FG001|Overall Study|Physician Decision|0|||
156862692|NCT05472090|566254833|FG000|Overall Study|Withdrawal by Subject|2|||
156862693|NCT05472090|566254834|FG001|Overall Study|Withdrawal by Subject|0|||
156862694|NCT05472090|566254833|FG000|Overall Study|Lost to Follow-up|0|||
156862695|NCT05472090|566254834|FG001|Overall Study|Lost to Follow-up|3|||
156862696|NCT00079417|566256524|FG000|Overall Study|Physician Decision|2|||
156862697|NCT00079417|566256524|FG000|Overall Study|Ineligible|7|||
156862698|NCT01456039|566256525|FG000|Phase 1 (First Step)|Disease Progression|1|||
156862699|NCT01456039|566256526|FG001|Phase 1 (First Step)|Disease Progression|1|||
156862700|NCT01456039|566256527|FG002|Phase 1 (First Step)|Disease Progression|0|||
156862701|NCT01456039|566256525|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
156862702|NCT01456039|566256526|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
156862703|NCT01456039|566256527|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
156862704|NCT01456039|566256525|FG000|Phase 1 (First Step)|Adverse Event|0|||
156862705|NCT01456039|566256526|FG001|Phase 1 (First Step)|Adverse Event|3|||
156862706|NCT01456039|566256527|FG002|Phase 1 (First Step)|Adverse Event|0|||
156862707|NCT01456039|566256525|FG000|Phase 1 (First Step)|Other|0|||
156862708|NCT01456039|566256526|FG001|Phase 1 (First Step)|Other|1|||
156862709|NCT01456039|566256527|FG002|Phase 1 (First Step)|Other|0|||
156862710|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Disease Progression|0|||
156862711|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Disease Progression|0|||
156862712|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Disease Progression|17|||
156862713|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Adverse Event|0|||
156862714|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Adverse Event|0|||
156862715|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Adverse Event|10|||
156862716|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
156862717|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
156862718|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
156862719|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
156542414|NCT02090413|565079350|FG002|Overall Study|Adverse Event|20|||
156542415|NCT02090413|565079348|FG000|Overall Study|Flushing event|2|||
156542416|NCT02090413|565079349|FG001|Overall Study|Flushing event|0|||
156542417|NCT02090413|565079350|FG002|Overall Study|Flushing event|1|||
156542418|NCT02090413|565079348|FG000|Overall Study|Withdrawal by Subject|2|||
156542419|NCT02090413|565079349|FG001|Overall Study|Withdrawal by Subject|2|||
156542420|NCT02090413|565079350|FG002|Overall Study|Withdrawal by Subject|2|||
156542421|NCT02090413|565079348|FG000|Overall Study|Investigator Decision|1|||
156542422|NCT02090413|565079349|FG001|Overall Study|Investigator Decision|1|||
156542423|NCT02090413|565079350|FG002|Overall Study|Investigator Decision|0|||
156542424|NCT02090413|565079348|FG000|Overall Study|Other|2|||
156542425|NCT02090413|565079349|FG001|Overall Study|Other|1|||
156542426|NCT02090413|565079350|FG002|Overall Study|Other|0|||
156542427|NCT02090413|565079348|FG000|Overall Study|Lost to Follow-up|1|||
156542428|NCT02090413|565079349|FG001|Overall Study|Lost to Follow-up|1|||
156542429|NCT02090413|565079350|FG002|Overall Study|Lost to Follow-up|0|||
156542430|NCT05419128|565079351|FG000|Overall Study|Withdrawal by Subject|1|||
156542431|NCT05419128|565079352|FG001|Overall Study|Withdrawal by Subject|1|||
156542432|NCT05419128|565079353|FG002|Overall Study|Withdrawal by Subject|0|||
156542433|NCT05419128|565079354|FG003|Overall Study|Withdrawal by Subject|1|||
156542434|NCT05419128|565079355|FG004|Overall Study|Withdrawal by Subject|1|||
156542435|NCT05419128|565079356|FG005|Overall Study|Withdrawal by Subject|0|||
156542436|NCT05419128|565079351|FG000|Overall Study|Lost to Follow-up|0|||
156542437|NCT05419128|565079352|FG001|Overall Study|Lost to Follow-up|0|||
156542438|NCT05419128|565079353|FG002|Overall Study|Lost to Follow-up|1|||
156542439|NCT05419128|565079354|FG003|Overall Study|Lost to Follow-up|0|||
156542440|NCT05419128|565079355|FG004|Overall Study|Lost to Follow-up|0|||
156542441|NCT05419128|565079356|FG005|Overall Study|Lost to Follow-up|1|||
156542442|NCT05248295|565079357|FG000|Overall Study|found ineligible|4|||
156542443|NCT05248295|565079358|FG001|Overall Study|found ineligible|1|||
156542444|NCT05248295|565079357|FG000|Overall Study|Withdrawal by Subject|0|||
156542445|NCT05248295|565079358|FG001|Overall Study|Withdrawal by Subject|1|||
156542446|NCT05248295|565079357|FG000|Overall Study|Data loss: audio recording error|1|||
156542447|NCT05248295|565079358|FG001|Overall Study|Data loss: audio recording error|1|||
156542448|NCT04066491|565079359|FG000|Overall Study|Randomized, not treated|0|||
156542449|NCT04066491|565079360|FG001|Overall Study|Randomized, not treated|0|||
156542450|NCT04066491|565079361|FG002|Overall Study|Randomized, not treated|2|||
156542451|NCT04506086|565079362|FG000|Overall Study|Withdrawal by Subject|2|||
156542452|NCT04490018|565079363|FG000|Overall Study|Protocol Violation|0|||
156542453|NCT04490018|565079364|FG001|Overall Study|Protocol Violation|2|||
156542454|NCT04490018|565079365|FG002|Overall Study|Protocol Violation|1|||
156542455|NCT04490018|565079363|FG000|Overall Study|Lost to Follow-up|2|||
156542456|NCT04490018|565079364|FG001|Overall Study|Lost to Follow-up|2|||
156542457|NCT04490018|565079365|FG002|Overall Study|Lost to Follow-up|0|||
156542458|NCT04490018|565079363|FG000|Overall Study|Withdrawal by Subject|2|||
156542459|NCT04490018|565079364|FG001|Overall Study|Withdrawal by Subject|1|||
156542460|NCT04490018|565079365|FG002|Overall Study|Withdrawal by Subject|0|||
156542461|NCT04490018|565079363|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156862720|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
156862721|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
156862722|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Other|0|||
156862723|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Other|0|||
156862724|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Other|1|||
156862725|NCT04106557|566256536|FG000|Overall Study|Physician Decision|0|||
156542462|NCT04490018|565079364|FG001|Overall Study|Withdrawal by parent/guardian|3|||
156542463|NCT04490018|565079365|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156542464|NCT02321930|565079368|FG000|Overall Study|Lost to Follow-up|1|||
156542465|NCT01293968|565079369|FG000|Overall Study|non-cooperation|3|||
156542466|NCT01293968|565079370|FG001|Overall Study|non-cooperation|3|||
156862726|NCT04106557|566256537|FG001|Overall Study|Physician Decision|1|||
156862727|NCT04106557|566256538|FG002|Overall Study|Physician Decision|0|||
156862728|NCT04106557|566256536|FG000|Overall Study|Protocol Violation|0|||
156862729|NCT04106557|566256537|FG001|Overall Study|Protocol Violation|1|||
156862730|NCT04106557|566256538|FG002|Overall Study|Protocol Violation|0|||
156862731|NCT02326155|566256539|FG000|Overall Study|Adverse Event|21|||
156862732|NCT02326155|566256540|FG001|Overall Study|Adverse Event|5|||
156542467|NCT01484977|565079371|FG000|Overall Study|Adverse Event|8|||
156542468|NCT01484977|565079371|FG000|Overall Study|Lack of Efficacy|4|||
156542469|NCT01484977|565079371|FG000|Overall Study|Protocol Violation|6|||
156542470|NCT01484977|565079371|FG000|Overall Study|Lost to Follow-up|1|||
156542471|NCT01484977|565079371|FG000|Overall Study|Withdrawal by Subject|4|||
156542472|NCT01484977|565079371|FG000|Overall Study|Subject Protocol Non-compliant|1|||
156542473|NCT01484977|565079371|FG000|Overall Study|Moving Overseas|1|||
156862733|NCT02326155|566256539|FG000|Overall Study|Death|3|||
156862734|NCT02326155|566256540|FG001|Overall Study|Death|0|||
156862735|NCT02326155|566256539|FG000|Overall Study|Lack of Efficacy|49|||
156862736|NCT02326155|566256540|FG001|Overall Study|Lack of Efficacy|5|||
156862737|NCT02326155|566256539|FG000|Overall Study|Lost to Follow-up|14|||
156862738|NCT02326155|566256540|FG001|Overall Study|Lost to Follow-up|3|||
156862739|NCT02326155|566256539|FG000|Overall Study|Protocol Violation|2|||
156862740|NCT02326155|566256540|FG001|Overall Study|Protocol Violation|0|||
156862741|NCT02326155|566256539|FG000|Overall Study|Withdrawal by Subject|34|||
156862742|NCT02326155|566256540|FG001|Overall Study|Withdrawal by Subject|11|||
156862743|NCT02326155|566256539|FG000|Overall Study|Disease progression|37|||
156862744|NCT02326155|566256540|FG001|Overall Study|Disease progression|4|||
156862745|NCT02326155|566256539|FG000|Overall Study|Study close|188|||
156862746|NCT02326155|566256540|FG001|Overall Study|Study close|21|||
156862747|NCT02326155|566256539|FG000|Overall Study|except for study close|46|||
156862748|NCT02326155|566256540|FG001|Overall Study|except for study close|13|||
156862749|NCT00939393|566256541|FG000|Overall Study|Withdrawal by Subject|1|||
156862750|NCT00939393|566256542|FG001|Overall Study|Withdrawal by Subject|0|||
156862751|NCT00939393|566256541|FG000|Overall Study|Lost to Follow-up|3|||
156862752|NCT00939393|566256542|FG001|Overall Study|Lost to Follow-up|0|||
156862753|NCT00313014|566256543|FG000|Overall Study|Withdrawal by Subject|11|||
156862754|NCT00313014|566256544|FG001|Overall Study|Withdrawal by Subject|7|||
156862755|NCT00313014|566256545|FG002|Overall Study|Withdrawal by Subject|5|||
156862756|NCT00313014|566256543|FG000|Overall Study|Adverse Event|14|||
156862757|NCT00313014|566256544|FG001|Overall Study|Adverse Event|29|||
156862758|NCT00313014|566256545|FG002|Overall Study|Adverse Event|16|||
156862759|NCT00313014|566256543|FG000|Overall Study|Lost to Follow-up|7|||
156862760|NCT00313014|566256544|FG001|Overall Study|Lost to Follow-up|6|||
156862761|NCT00313014|566256545|FG002|Overall Study|Lost to Follow-up|10|||
156862762|NCT00313014|566256543|FG000|Overall Study|Administrative|9|||
156862763|NCT00313014|566256544|FG001|Overall Study|Administrative|6|||
156862764|NCT00313014|566256545|FG002|Overall Study|Administrative|14|||
156862765|NCT00313014|566256543|FG000|Overall Study|Lack of Efficacy|52|||
156862766|NCT00313014|566256544|FG001|Overall Study|Lack of Efficacy|25|||
156862767|NCT00313014|566256545|FG002|Overall Study|Lack of Efficacy|16|||
156862768|NCT01280903|566256546|FG000|Overall Study|Lost to Follow-up|23|||
156862769|NCT01280903|566256547|FG001|Overall Study|Lost to Follow-up|16|||
156862770|NCT03453164|566256548|FG000|Overall Study|Lack of Efficacy|16|||
156862771|NCT03453164|566256548|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
156862772|NCT03829228|566256549|FG000|Overall Study|Protocol Violation|1|||
156862773|NCT02177695|566256550|FG000|ITT Analysis|Ineligible|5|||
156862774|NCT02177695|566256551|FG001|ITT Analysis|Ineligible|5|||
156862775|NCT02177695|566256550|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
156862776|NCT02177695|566256551|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
156862777|NCT02177695|566256550|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
156862778|NCT02177695|566256551|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
156862779|NCT02177695|566256550|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
156862780|NCT02177695|566256551|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
156862781|NCT02443688|566256554|FG000|Overall Study|Adverse Event|2|||
156862782|NCT02443688|566256555|FG001|Overall Study|Adverse Event|3|||
156862783|NCT02443688|566256556|FG002|Overall Study|Adverse Event|2|||
156862784|NCT02443688|566256554|FG000|Overall Study|Lost to Follow-up|1|||
156862785|NCT02443688|566256555|FG001|Overall Study|Lost to Follow-up|0|||
156862786|NCT02443688|566256556|FG002|Overall Study|Lost to Follow-up|0|||
156862787|NCT02443688|566256554|FG000|Overall Study|Physician Decision|3|||
156862788|NCT02443688|566256555|FG001|Overall Study|Physician Decision|0|||
156862789|NCT02443688|566256556|FG002|Overall Study|Physician Decision|1|||
156862790|NCT02443688|566256554|FG000|Overall Study|Pregnancy|0|||
156862791|NCT02443688|566256555|FG001|Overall Study|Pregnancy|0|||
156862792|NCT02443688|566256556|FG002|Overall Study|Pregnancy|1|||
156862793|NCT02443688|566256554|FG000|Overall Study|Withdrawal by Subject|3|||
156862794|NCT02443688|566256555|FG001|Overall Study|Withdrawal by Subject|3|||
156862795|NCT02443688|566256556|FG002|Overall Study|Withdrawal by Subject|4|||
156862796|NCT02443688|566256554|FG000|Overall Study|Non-compliance with study drug|1|||
156862797|NCT02443688|566256555|FG001|Overall Study|Non-compliance with study drug|2|||
156862798|NCT02443688|566256556|FG002|Overall Study|Non-compliance with study drug|4|||
156862799|NCT02443688|566256554|FG000|Overall Study|Sponsor Request|2|||
156862800|NCT02443688|566256555|FG001|Overall Study|Sponsor Request|1|||
156862801|NCT02443688|566256556|FG002|Overall Study|Sponsor Request|0|||
156862802|NCT03459079|566256558|FG000|Overall Study|Adverse Event|4|||
156862803|NCT03459079|566256559|FG001|Overall Study|Adverse Event|2|||
156862804|NCT03459079|566256560|FG002|Overall Study|Adverse Event|0|||
156862805|NCT03459079|566256558|FG000|Overall Study|Withdrawal by Subject|2|||
156862806|NCT03459079|566256559|FG001|Overall Study|Withdrawal by Subject|2|||
156862807|NCT03459079|566256560|FG002|Overall Study|Withdrawal by Subject|0|||
156862808|NCT02379728|566256561|FG000|Overall Study|Lost to Follow-up|1|||
156862809|NCT02379728|566256562|FG001|Overall Study|Lost to Follow-up|0|||
156343904|NCT04523220|564358513|FG000|Extension Treatment Period|Subject Decision|5|||
156343905|NCT04523220|564358514|FG001|Extension Treatment Period|Subject Decision|2|||
156343906|NCT04523220|564358515|FG002|Extension Treatment Period|Subject Decision|4|||
156343907|NCT04523220|564358513|FG000|Extension Treatment Period|Death|6|||
156343908|NCT04523220|564358514|FG001|Extension Treatment Period|Death|4|||
156343909|NCT04523220|564358515|FG002|Extension Treatment Period|Death|7|||
156343910|NCT04523220|564358513|FG000|Extension Treatment Period|Adverse Event|6|||
156343911|NCT04523220|564358514|FG001|Extension Treatment Period|Adverse Event|7|||
156343912|NCT04523220|564358515|FG002|Extension Treatment Period|Adverse Event|9|||
156343913|NCT04523220|564358513|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
156343914|NCT04523220|564358514|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
156343915|NCT04523220|564358515|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
156343916|NCT04523220|564358513|FG000|Extension Treatment Period|Study drug never administered|0|||
156343917|NCT04523220|564358514|FG001|Extension Treatment Period|Study drug never administered|1|||
156343918|NCT04523220|564358515|FG002|Extension Treatment Period|Study drug never administered|0|||
156343919|NCT02010775|564358516|FG000|Overall Study|Adverse Event|0|||
156343920|NCT02010775|564358517|FG001|Overall Study|Adverse Event|0|||
156343921|NCT02010775|564358518|FG002|Overall Study|Adverse Event|0|||
156343922|NCT02010775|564358519|FG003|Overall Study|Adverse Event|0|||
156343923|NCT02010775|564358520|FG004|Overall Study|Adverse Event|1|||
156343924|NCT02010775|564358516|FG000|Overall Study|Pregnancy|0|||
156343925|NCT02010775|564358517|FG001|Overall Study|Pregnancy|0|||
156343926|NCT02010775|564358518|FG002|Overall Study|Pregnancy|2|||
156343927|NCT02010775|564358519|FG003|Overall Study|Pregnancy|0|||
156343928|NCT02010775|564358520|FG004|Overall Study|Pregnancy|0|||
156343929|NCT02010775|564358516|FG000|Overall Study|Lost to Follow-up|2|||
156343930|NCT02010775|564358517|FG001|Overall Study|Lost to Follow-up|0|||
156343931|NCT02010775|564358518|FG002|Overall Study|Lost to Follow-up|0|||
156343932|NCT02010775|564358519|FG003|Overall Study|Lost to Follow-up|1|||
156343933|NCT02010775|564358520|FG004|Overall Study|Lost to Follow-up|1|||
156343934|NCT02010775|564358516|FG000|Overall Study|Personal Reasons|3|||
156343935|NCT02010775|564358517|FG001|Overall Study|Personal Reasons|3|||
156343936|NCT02010775|564358518|FG002|Overall Study|Personal Reasons|1|||
156343937|NCT02010775|564358519|FG003|Overall Study|Personal Reasons|2|||
156475885|NCT04492475|564837477|FG000|Overall Study|Enrolled but not treated|8|||
156475886|NCT04492475|564837478|FG001|Overall Study|Enrolled but not treated|8|||
156475887|NCT04492475|564837477|FG000|Overall Study|Withdrawal by Subject|4|||
156475888|NCT04492475|564837478|FG001|Overall Study|Withdrawal by Subject|0|||
156475889|NCT04492475|564837477|FG000|Overall Study|Became ineligible after enrollment|2|||
156475890|NCT04492475|564837478|FG001|Overall Study|Became ineligible after enrollment|0|||
156475891|NCT02066636|564837479|FG000|Overall Study|Disease progression|51|||
156475892|NCT02066636|564837480|FG001|Overall Study|Disease progression|60|||
156475893|NCT02066636|564837481|FG002|Overall Study|Disease progression|700|||
156475894|NCT02066636|564837479|FG000|Overall Study|Study drug toxicity|13|||
156475895|NCT02066636|564837480|FG001|Overall Study|Study drug toxicity|2|||
156475896|NCT02066636|564837481|FG002|Overall Study|Study drug toxicity|58|||
156475897|NCT02066636|564837479|FG000|Overall Study|Death|4|||
156475898|NCT02066636|564837480|FG001|Overall Study|Death|2|||
156343938|NCT02010775|564358520|FG004|Overall Study|Personal Reasons|4|||
156475899|NCT02066636|564837481|FG002|Overall Study|Death|158|||
156475900|NCT02066636|564837479|FG000|Overall Study|Adverse event unrelated to study drug|6|||
156343939|NCT02006719|564358521|FG000|Overall Study|Withdrawal by Subject|10|||
156343940|NCT02006719|564358522|FG001|Overall Study|Withdrawal by Subject|2|||
156343941|NCT02006719|564358521|FG000|Overall Study|Lost to Follow-up|5|||
156343942|NCT02006719|564358522|FG001|Overall Study|Lost to Follow-up|1|||
156343943|NCT02006719|564358521|FG000|Overall Study|Protocol Violation|2|||
156343944|NCT02006719|564358522|FG001|Overall Study|Protocol Violation|0|||
156475901|NCT02066636|564837480|FG001|Overall Study|Adverse event unrelated to study drug|4|||
156343945|NCT02006719|564358521|FG000|Overall Study|Adverse Event|1|||
156475902|NCT02066636|564837481|FG002|Overall Study|Adverse event unrelated to study drug|45|||
156475903|NCT02066636|564837479|FG000|Overall Study|Participant request to discontinue treatment|12|||
156475904|NCT02066636|564837480|FG001|Overall Study|Participant request to discontinue treatment|12|||
156475905|NCT02066636|564837481|FG002|Overall Study|Participant request to discontinue treatment|70|||
156475906|NCT02066636|564837479|FG000|Overall Study|Participant withdrew consent|10|||
156475907|NCT02066636|564837480|FG001|Overall Study|Participant withdrew consent|18|||
156475908|NCT02066636|564837481|FG002|Overall Study|Participant withdrew consent|61|||
156475909|NCT02066636|564837479|FG000|Overall Study|Lost to Follow-up|0|||
156475910|NCT02066636|564837480|FG001|Overall Study|Lost to Follow-up|2|||
156475911|NCT02066636|564837481|FG002|Overall Study|Lost to Follow-up|2|||
156475912|NCT02066636|564837479|FG000|Overall Study|Maximum clinical benefit|2|||
156475913|NCT02066636|564837480|FG001|Overall Study|Maximum clinical benefit|2|||
156475914|NCT02066636|564837481|FG002|Overall Study|Maximum clinical benefit|3|||
156475915|NCT02066636|564837479|FG000|Overall Study|Poor/non-compliance|2|||
156475916|NCT02066636|564837480|FG001|Overall Study|Poor/non-compliance|1|||
156475917|NCT02066636|564837481|FG002|Overall Study|Poor/non-compliance|1|||
156475918|NCT02066636|564837479|FG000|Overall Study|Participant no loner meets study criteria|3|||
156475919|NCT02066636|564837480|FG001|Overall Study|Participant no loner meets study criteria|2|||
156475920|NCT02066636|564837481|FG002|Overall Study|Participant no loner meets study criteria|28|||
156475921|NCT02066636|564837479|FG000|Overall Study|Administrative reasons by sponsor|8|||
156475922|NCT02066636|564837480|FG001|Overall Study|Administrative reasons by sponsor|5|||
156475923|NCT02066636|564837481|FG002|Overall Study|Administrative reasons by sponsor|0|||
156475924|NCT02066636|564837479|FG000|Overall Study|Other reasons|16|||
156475925|NCT02066636|564837480|FG001|Overall Study|Other reasons|15|||
156475926|NCT02066636|564837481|FG002|Overall Study|Other reasons|50|||
156475927|NCT00391170|564837484|FG000|Overall Study|Withdrawal by Subject|1|||
156475928|NCT00391170|564837485|FG001|Overall Study|Withdrawal by Subject|0|||
156475929|NCT00391170|564837484|FG000|Overall Study|Adverse Event|3|||
156475930|NCT00391170|564837485|FG001|Overall Study|Adverse Event|2|||
156475931|NCT00391170|564837484|FG000|Overall Study|Physician Decision|2|||
156475932|NCT00391170|564837485|FG001|Overall Study|Physician Decision|2|||
156475933|NCT03567616|564837488|FG000|Overall Study|Disease progression|4|||
156475934|NCT03567616|564837488|FG000|Overall Study|Withdrawal by Subject|1|||
156475935|NCT03567616|564837488|FG000|Overall Study|Physician Decision|1|||
156475936|NCT03567616|564837488|FG000|Overall Study|Death|1|||
156475937|NCT03567616|564837488|FG000|Overall Study|Adverse Event|1|||
156475938|NCT03200574|564837501|FG000|Overall Study|Death|4|||
156475939|NCT03200574|564837501|FG000|Overall Study|Withdrawal by Subject|8|||
156475940|NCT03200574|564837501|FG000|Overall Study|Long-Term need for anticoagulation|1|||
156475941|NCT03200574|564837501|FG000|Overall Study|Relocation|2|||
156475942|NCT03200574|564837501|FG000|Overall Study|Lost to Follow-up|2|||
156475943|NCT00705159|564837502|FG000|Overall Study|Withdrawal by Subject|0|||
156475944|NCT00705159|564837503|FG001|Overall Study|Withdrawal by Subject|1|||
156475945|NCT00705159|564837504|FG002|Overall Study|Withdrawal by Subject|1|||
156475946|NCT00705159|564837505|FG003|Overall Study|Withdrawal by Subject|1|||
156475947|NCT00705159|564837502|FG000|Overall Study|Protocol Violation|0|||
156475948|NCT00705159|564837503|FG001|Overall Study|Protocol Violation|1|||
156475949|NCT00705159|564837504|FG002|Overall Study|Protocol Violation|0|||
156475950|NCT00705159|564837505|FG003|Overall Study|Protocol Violation|0|||
156475951|NCT00705159|564837502|FG000|Overall Study|Adverse Event|0|||
156475952|NCT00705159|564837503|FG001|Overall Study|Adverse Event|0|||
156475953|NCT00705159|564837504|FG002|Overall Study|Adverse Event|1|||
156475954|NCT00705159|564837505|FG003|Overall Study|Adverse Event|0|||
156475955|NCT00705159|564837502|FG000|Overall Study|Lost to Follow-up|0|||
156475956|NCT00705159|564837503|FG001|Overall Study|Lost to Follow-up|0|||
156475957|NCT00705159|564837504|FG002|Overall Study|Lost to Follow-up|3|||
156475958|NCT00705159|564837505|FG003|Overall Study|Lost to Follow-up|2|||
156475959|NCT00705159|564837502|FG000|Overall Study|Screen Failure|0|||
156475960|NCT00705159|564837503|FG001|Overall Study|Screen Failure|0|||
156542474|NCT01484977|565079371|FG000|Overall Study|Low White Blood Cell Count|1|||
156542475|NCT01484977|565079371|FG000|Overall Study|Lack of Compliance|1|||
156475961|NCT00705159|564837504|FG002|Overall Study|Screen Failure|0|||
156475962|NCT00705159|564837505|FG003|Overall Study|Screen Failure|1|||
156475963|NCT00526994|564837506|FG000|Overall Study|Lost to Follow-up|98|||
156475964|NCT00526994|564837507|FG001|Overall Study|Lost to Follow-up|108|||
156343946|NCT02006719|564358522|FG001|Overall Study|Adverse Event|1|||
156475965|NCT00526994|564837508|FG002|Overall Study|Lost to Follow-up|96|||
156475966|NCT00526994|564837506|FG000|Overall Study|Death|4|||
156475967|NCT00526994|564837507|FG001|Overall Study|Death|3|||
156475968|NCT00526994|564837508|FG002|Overall Study|Death|3|||
156475969|NCT00526994|564837506|FG000|Overall Study|Withdrawal by Subject|2|||
156475970|NCT00526994|564837507|FG001|Overall Study|Withdrawal by Subject|7|||
156475971|NCT00526994|564837508|FG002|Overall Study|Withdrawal by Subject|5|||
156542476|NCT01133379|565079372|FG000|Overall Study|Withdrawal by Subject|0|||
156542477|NCT01133379|565079373|FG001|Overall Study|Withdrawal by Subject|1|||
156542478|NCT01133379|565079374|FG002|Overall Study|Withdrawal by Subject|1|||
156542479|NCT01133379|565079372|FG000|Overall Study|Lost to Follow-up|1|||
156542480|NCT01133379|565079373|FG001|Overall Study|Lost to Follow-up|1|||
156542481|NCT01133379|565079374|FG002|Overall Study|Lost to Follow-up|1|||
156542482|NCT00591214|565079375|FG000|Overall Study|Physician Decision|7|||
156542483|NCT00591214|565079375|FG000|Overall Study|Withdrawal by Subject|1|||
156542484|NCT00121108|565079378|FG000|Overall Study|Lost to Follow-up|10|||
156542485|NCT00121108|565079379|FG001|Overall Study|Lost to Follow-up|22|||
156542486|NCT00121108|565079378|FG000|Overall Study|Withdrawal by Subject|106|||
156542487|NCT00121108|565079379|FG001|Overall Study|Withdrawal by Subject|195|||
156542488|NCT00121108|565079378|FG000|Overall Study|Death|5|||
156542489|NCT00121108|565079379|FG001|Overall Study|Death|8|||
156542490|NCT03996876|565079380|FG000|Overall Study|Incomplete Data|2|||
156542491|NCT03996876|565079381|FG001|Overall Study|Incomplete Data|4|||
156542492|NCT00597753|565079386|FG000|Overall Study|Adverse Event|6|||
156542493|NCT00597753|565079387|FG001|Overall Study|Adverse Event|2|||
156542494|NCT00597753|565079386|FG000|Overall Study|Death|55|||
156542495|NCT00597753|565079387|FG001|Overall Study|Death|29|||
156475972|NCT00526994|564837506|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
156475973|NCT00526994|564837507|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
156475974|NCT00526994|564837508|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
156475975|NCT03026166|564837509|FG000|Overall Study|Death|22|||
156475976|NCT03026166|564837510|FG001|Overall Study|Death|7|||
156475977|NCT03026166|564837509|FG000|Overall Study|Physician Decision|2|||
156475978|NCT03026166|564837510|FG001|Overall Study|Physician Decision|0|||
156475979|NCT03026166|564837509|FG000|Overall Study|Withdrawal by Subject|1|||
156475980|NCT03026166|564837510|FG001|Overall Study|Withdrawal by Subject|2|||
156475981|NCT03026166|564837509|FG000|Overall Study|Lost to Follow-up|1|||
156475982|NCT03026166|564837510|FG001|Overall Study|Lost to Follow-up|0|||
156475983|NCT03026166|564837509|FG000|Overall Study|Study Terminated by Sponsor|3|||
156475984|NCT03026166|564837510|FG001|Overall Study|Study Terminated by Sponsor|3|||
156475985|NCT03026166|564837509|FG000|Overall Study|Other|1|||
156475986|NCT03026166|564837510|FG001|Overall Study|Other|0|||
156475987|NCT03035942|564837511|FG000|Overall Study|Adverse Event|8|||
156475988|NCT03035942|564837512|FG001|Overall Study|Adverse Event|4|||
156475989|NCT03035942|564837513|FG002|Overall Study|Adverse Event|5|||
156475990|NCT00380250|564837514|FG000|Overall Study|Withdrawal by Subject|39|||
156475991|NCT00380250|564837515|FG001|Overall Study|Withdrawal by Subject|28|||
156475992|NCT00380250|564837514|FG000|Overall Study|Adverse Event|20|||
156475993|NCT00380250|564837515|FG001|Overall Study|Adverse Event|9|||
156475994|NCT00380250|564837514|FG000|Overall Study|Lack of Efficacy|10|||
156475995|NCT00380250|564837515|FG001|Overall Study|Lack of Efficacy|8|||
156475996|NCT00380250|564837514|FG000|Overall Study|Protocol Violation|15|||
156475997|NCT00380250|564837515|FG001|Overall Study|Protocol Violation|5|||
156475998|NCT00380250|564837514|FG000|Overall Study|Lost to Follow-up|14|||
156475999|NCT00380250|564837515|FG001|Overall Study|Lost to Follow-up|5|||
156476000|NCT00380250|564837514|FG000|Overall Study|Physician Decision|1|||
156476001|NCT00380250|564837515|FG001|Overall Study|Physician Decision|0|||
156476002|NCT01989104|564837516|FG000|Overall Study|Withdrawal by Subject|3|||
156476003|NCT01989104|564837517|FG001|Overall Study|Withdrawal by Subject|0|||
156476004|NCT01989104|564837518|FG002|Overall Study|Withdrawal by Subject|0|||
156542496|NCT00597753|565079386|FG000|Overall Study|Lack of Efficacy|2|||
156542497|NCT00597753|565079387|FG001|Overall Study|Lack of Efficacy|0|||
156343947|NCT02006719|564358521|FG000|Overall Study|Other/Unknown|0|||
156476005|NCT01989104|564837519|FG003|Overall Study|Withdrawal by Subject|0|||
156476006|NCT01989104|564837520|FG004|Overall Study|Withdrawal by Subject|0|||
156476007|NCT02833948|564837521|FG000|Overall Study|Death|2|||
156542498|NCT00597753|565079386|FG000|Overall Study|Lost to Follow-up|10|||
156476008|NCT02833948|564837522|FG001|Overall Study|Death|3|||
156476009|NCT02833948|564837521|FG000|Overall Study|were not scanned|8|||
156476010|NCT02833948|564837522|FG001|Overall Study|were not scanned|13|||
156542499|NCT00597753|565079387|FG001|Overall Study|Lost to Follow-up|3|||
156542500|NCT00597753|565079386|FG000|Overall Study|Physician Decision|5|||
156542501|NCT00597753|565079387|FG001|Overall Study|Physician Decision|1|||
156542502|NCT00597753|565079386|FG000|Overall Study|Pregnancy|1|||
156542503|NCT00597753|565079387|FG001|Overall Study|Pregnancy|0|||
156542504|NCT00597753|565079386|FG000|Overall Study|Withdrawal by Subject|35|||
156542505|NCT00597753|565079387|FG001|Overall Study|Withdrawal by Subject|12|||
156542506|NCT00597753|565079386|FG000|Overall Study|Discontinued Dialysis|0|||
156542507|NCT00597753|565079387|FG001|Overall Study|Discontinued Dialysis|1|||
156542508|NCT00597753|565079386|FG000|Overall Study|Never dosed|2|||
156542509|NCT00597753|565079387|FG001|Overall Study|Never dosed|0|||
156542510|NCT00597753|565079386|FG000|Overall Study|Noncompliance|2|||
156542511|NCT00597753|565079387|FG001|Overall Study|Noncompliance|1|||
156542512|NCT00597753|565079386|FG000|Overall Study|Relocation|17|||
156542513|NCT00597753|565079387|FG001|Overall Study|Relocation|6|||
156542514|NCT00597753|565079386|FG000|Overall Study|Renal transplant|10|||
156542515|NCT00597753|565079387|FG001|Overall Study|Renal transplant|3|||
156542516|NCT00597753|565079386|FG000|Overall Study|Site closed by sponsor|19|||
156542517|NCT00597753|565079387|FG001|Overall Study|Site closed by sponsor|7|||
156542518|NCT00597753|565079386|FG000|Overall Study|Site elected to close|2|||
156542519|NCT00597753|565079387|FG001|Overall Study|Site elected to close|4|||
156542520|NCT03080883|565079388|FG000|Overall Study|Withdrawal by Subject|11|||
156542521|NCT03080883|565079389|FG001|Overall Study|Withdrawal by Subject|15|||
156542522|NCT03080883|565079388|FG000|Overall Study|Adverse Event|22|||
156542523|NCT03080883|565079389|FG001|Overall Study|Adverse Event|22|||
156542524|NCT03080883|565079388|FG000|Overall Study|Alternative Therapy|0|||
156542525|NCT03080883|565079389|FG001|Overall Study|Alternative Therapy|3|||
156542526|NCT03080883|565079388|FG000|Overall Study|Other Complicating Disease|9|||
156542527|NCT03080883|565079389|FG001|Overall Study|Other Complicating Disease|5|||
156542528|NCT03080883|565079388|FG000|Overall Study|Death|21|||
156542529|NCT03080883|565079389|FG001|Overall Study|Death|16|||
156542530|NCT03080883|565079388|FG000|Overall Study|Physician Decision|2|||
156542531|NCT03080883|565079389|FG001|Overall Study|Physician Decision|2|||
156542532|NCT03080883|565079388|FG000|Overall Study|Disease Progression|2|||
156542533|NCT03080883|565079389|FG001|Overall Study|Disease Progression|8|||
156542534|NCT03080883|565079388|FG000|Overall Study|Lost to Follow-up|1|||
156542535|NCT03080883|565079389|FG001|Overall Study|Lost to Follow-up|1|||
156542536|NCT03723707|565081195|FG000|Overall Study|Death|32|||
156542537|NCT03723707|565081196|FG001|Overall Study|Death|32|||
156542538|NCT03723707|565081195|FG000|Overall Study|Admitted to long term care|12|||
156542539|NCT03723707|565081196|FG001|Overall Study|Admitted to long term care|12|||
156542540|NCT03723707|565081195|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
156542541|NCT03723707|565081196|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
156542542|NCT03723707|565081195|FG000|Overall Study|Lost to Follow-up|40|||
156542543|NCT03723707|565081196|FG001|Overall Study|Lost to Follow-up|22|||
156542544|NCT03723707|565081195|FG000|Overall Study|Discontinued after study closure|24|||
156542545|NCT03723707|565081196|FG001|Overall Study|Discontinued after study closure|12|||
156542546|NCT00750698|565081197|FG000|Overall Study|Withdrawal by Subject|1|||
156542547|NCT00750698|565081198|FG001|Overall Study|Withdrawal by Subject|0|||
156542548|NCT00750698|565081197|FG000|Overall Study|Progressive disease|5|||
156542549|NCT00750698|565081198|FG001|Overall Study|Progressive disease|2|||
156542550|NCT01999465|565081199|FG000|Overall Study|Lost to Follow-up|0|||
156542551|NCT01999465|565081200|FG001|Overall Study|Lost to Follow-up|2|||
156542552|NCT01999465|565081199|FG000|Overall Study|Protocol Violation|0|||
156542553|NCT01999465|565081200|FG001|Overall Study|Protocol Violation|1|||
156542554|NCT00390546|565081201|FG000|Overall Study|Renal impairment|1|||
156542555|NCT00390546|565081202|FG001|Overall Study|Renal impairment|0|||
156542556|NCT00390546|565081201|FG000|Overall Study|Physician Decision|5|||
156542557|NCT00390546|565081202|FG001|Overall Study|Physician Decision|5|||
156542558|NCT01308008|565081203|FG000|4 Weeks|Illness, disinterest, time|9|||
156542559|NCT01308008|565081204|FG001|4 Weeks|Illness, disinterest, time|2|||
156542560|NCT02325219|565081205|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
156542561|NCT02325219|565081206|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
156542562|NCT02325219|565081207|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
156542563|NCT02325219|565081208|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
156542564|NCT02325219|565081209|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
156542565|NCT02325219|565081205|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
156542566|NCT02325219|565081206|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
156862810|NCT02379728|566256563|FG002|Overall Study|Lost to Follow-up|3|||
156862811|NCT02379728|566256564|FG003|Overall Study|Lost to Follow-up|0|||
156862812|NCT02379728|566256561|FG000|Overall Study|Withdrawal by Subject|5|||
156862813|NCT02379728|566256562|FG001|Overall Study|Withdrawal by Subject|0|||
156862814|NCT02379728|566256563|FG002|Overall Study|Withdrawal by Subject|5|||
156862815|NCT02379728|566256564|FG003|Overall Study|Withdrawal by Subject|3|||
156862816|NCT02379728|566256561|FG000|Overall Study|Protocol Violation|0|||
156862817|NCT02379728|566256562|FG001|Overall Study|Protocol Violation|0|||
156862818|NCT02379728|566256563|FG002|Overall Study|Protocol Violation|2|||
156862819|NCT02379728|566256564|FG003|Overall Study|Protocol Violation|0|||
156343948|NCT02006719|564358522|FG001|Overall Study|Other/Unknown|1|||
156343949|NCT02439138|564358524|FG000|Overall Study|Adverse Event|1|||
156343950|NCT02439138|564358524|FG000|Overall Study|PI decision to terminate the study|2|||
156343951|NCT00833794|564358529|FG000|Open-label Phase|Adverse Event|225|||
156343952|NCT00833794|564358530|FG001|Open-label Phase|Adverse Event|0|||
156343953|NCT00833794|564358529|FG000|Open-label Phase|Lack of Efficacy|28|||
156343954|NCT00833794|564358530|FG001|Open-label Phase|Lack of Efficacy|0|||
156343955|NCT00833794|564358529|FG000|Open-label Phase|Withdrawal by Subject|48|||
156343956|NCT00833794|564358530|FG001|Open-label Phase|Withdrawal by Subject|0|||
156343957|NCT00833794|564358529|FG000|Open-label Phase|Physician Decision|20|||
156343958|NCT00833794|564358530|FG001|Open-label Phase|Physician Decision|0|||
156343959|NCT00833794|564358529|FG000|Open-label Phase|Administrative reason|1|||
156343960|NCT00833794|564358530|FG001|Open-label Phase|Administrative reason|0|||
156343961|NCT00833794|564358529|FG000|Open-label Phase|Protocol Violation|47|||
156343962|NCT00833794|564358530|FG001|Open-label Phase|Protocol Violation|0|||
156343963|NCT00833794|564358529|FG000|Open-label Phase|Did not complete wash-out period|12|||
156343964|NCT00833794|564358530|FG001|Open-label Phase|Did not complete wash-out period|0|||
156343965|NCT00833794|564358529|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
156343966|NCT00833794|564358530|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
156343967|NCT00833794|564358529|FG000|Double-blind Phase|Adverse Event|44|||
156343968|NCT00833794|564358530|FG001|Double-blind Phase|Adverse Event|11|||
156343969|NCT00833794|564358529|FG000|Double-blind Phase|Lack of Efficacy|34|||
156343970|NCT00833794|564358530|FG001|Double-blind Phase|Lack of Efficacy|22|||
156343971|NCT00833794|564358529|FG000|Double-blind Phase|Withdrawal by Subject|23|||
156343972|NCT00833794|564358530|FG001|Double-blind Phase|Withdrawal by Subject|6|||
156343973|NCT00833794|564358529|FG000|Double-blind Phase|Physician Decision|4|||
156343974|NCT00833794|564358530|FG001|Double-blind Phase|Physician Decision|7|||
156343975|NCT00833794|564358529|FG000|Double-blind Phase|Administrative reason|1|||
156343976|NCT00833794|564358530|FG001|Double-blind Phase|Administrative reason|3|||
156343977|NCT01866930|564358531|FG000|Treatment Period|Other|1|||
156343978|NCT01866930|564358532|FG001|Treatment Period|Other|0|||
156343979|NCT01866930|564358531|FG000|Treatment Period|Death|0|||
156343980|NCT01866930|564358532|FG001|Treatment Period|Death|2|||
156343981|NCT01866930|564358531|FG000|Treatment Period|Poor/non compliance|0|||
156343982|NCT01866930|564358532|FG001|Treatment Period|Poor/non compliance|2|||
156343983|NCT01866930|564358531|FG000|Treatment Period|No longer meets study criteria|0|||
156343984|NCT01866930|564358532|FG001|Treatment Period|No longer meets study criteria|1|||
156343985|NCT01866930|564358531|FG000|Treatment Period|Withdrawal by Subject|2|||
156343986|NCT01866930|564358532|FG001|Treatment Period|Withdrawal by Subject|8|||
156343987|NCT01866930|564358531|FG000|Treatment Period|Lack of Efficacy|1|||
156343988|NCT01866930|564358532|FG001|Treatment Period|Lack of Efficacy|9|||
156343989|NCT01866930|564358531|FG000|Treatment Period|Adverse Event|4|||
156343990|NCT01866930|564358532|FG001|Treatment Period|Adverse Event|12|||
156343991|NCT01866930|564358531|FG000|Treatment Period|Lost to Follow-up|1|||
156343992|NCT01866930|564358532|FG001|Treatment Period|Lost to Follow-up|1|||
156343993|NCT01866930|564358531|FG000|Follow-up Period|Lost to Follow-up|1|||
156343994|NCT01866930|564358532|FG001|Follow-up Period|Lost to Follow-up|1|||
156343995|NCT01866930|564358531|FG000|Follow-up Period|Other|1|||
156343996|NCT01866930|564358532|FG001|Follow-up Period|Other|5|||
156343997|NCT01866930|564358531|FG000|Follow-up Period|No longer required per protocol|1|||
156343998|NCT01866930|564358532|FG001|Follow-up Period|No longer required per protocol|0|||
156343999|NCT01866930|564358531|FG000|Follow-up Period|Withdrawal by Subject|3|||
156344000|NCT01866930|564358532|FG001|Follow-up Period|Withdrawal by Subject|3|||
156862820|NCT01112917|566256566|FG000|Overall Study|Death|2|||
156862821|NCT01112917|566256567|FG001|Overall Study|Death|11|||
156862822|NCT01112917|566256566|FG000|Overall Study|Lost to Follow-up|1|||
156862823|NCT01112917|566256567|FG001|Overall Study|Lost to Follow-up|1|||
156862824|NCT01112917|566256566|FG000|Overall Study|Withdrawal by Subject|1|||
156862825|NCT01112917|566256567|FG001|Overall Study|Withdrawal by Subject|3|||
156862826|NCT01112917|566256566|FG000|Overall Study|Unable to Convert Filter|3|||
156862827|NCT01112917|566256567|FG001|Overall Study|Unable to Convert Filter|0|||
156862828|NCT05101122|566256568|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
156862829|NCT05101122|566256568|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
156862830|NCT05101122|566256568|FG000|AD313 80/5|Withdrawal by Subject|1|||
156862831|NCT05101122|566256568|FG000|AD313 80/10|Physician Decision|1|||
156862832|NCT00837434|566256580|FG000|Overall Study|Physician Decision|3|||
156862833|NCT00837434|566256581|FG001|Overall Study|Physician Decision|0|||
156862834|NCT00837434|566256580|FG000|Overall Study|Lost to Follow-up|1|||
156862835|NCT00837434|566256581|FG001|Overall Study|Lost to Follow-up|1|||
156862836|NCT00837434|566256580|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
156862837|NCT00837434|566256581|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
156862838|NCT00837434|566256580|FG000|Overall Study|Noncompliant|2|||
156862839|NCT00837434|566256581|FG001|Overall Study|Noncompliant|0|||
156862840|NCT00837434|566256580|FG000|Overall Study|Baseline assessments not done in time|1|||
156862841|NCT00837434|566256581|FG001|Overall Study|Baseline assessments not done in time|0|||
156862842|NCT00837434|566256580|FG000|Overall Study|Unable to obtain study drug|1|||
156862843|NCT00837434|566256581|FG001|Overall Study|Unable to obtain study drug|0|||
156862844|NCT01709721|566256582|FG000|Open Label Phase|Withdrawal by Subject|0|||
156862845|NCT01709721|566256583|FG001|Open Label Phase|Withdrawal by Subject|0|||
156862846|NCT01709721|566256584|FG002|Open Label Phase|Withdrawal by Subject|5|||
156476011|NCT02833948|564837521|FG000|Overall Study|scans could not be evaluated|5|||
156476012|NCT02833948|564837522|FG001|Overall Study|scans could not be evaluated|2|||
156476013|NCT02691702|564837526|FG000|Overall Study|Adverse Event|1|||
156476014|NCT02691702|564837527|FG001|Overall Study|Adverse Event|0|||
156476015|NCT02691702|564837528|FG002|Overall Study|Adverse Event|0|||
156476016|NCT02691702|564837529|FG003|Overall Study|Adverse Event|0|||
156476017|NCT02691702|564837530|FG004|Overall Study|Adverse Event|0|||
156476018|NCT02691702|564837531|FG005|Overall Study|Adverse Event|0|||
156476019|NCT02691702|564837532|FG006|Overall Study|Adverse Event|0|||
156476020|NCT02691702|564837533|FG007|Overall Study|Adverse Event|0|||
156476021|NCT02691702|564837534|FG008|Overall Study|Adverse Event|1|||
156476022|NCT02691702|564837535|FG009|Overall Study|Adverse Event|0|||
156476023|NCT02691702|564837536|FG010|Overall Study|Adverse Event|1|||
156476024|NCT02691702|564837526|FG000|Overall Study|Lost to Follow-up|0|||
156476025|NCT02691702|564837527|FG001|Overall Study|Lost to Follow-up|0|||
156476026|NCT02691702|564837528|FG002|Overall Study|Lost to Follow-up|1|||
156476027|NCT02691702|564837529|FG003|Overall Study|Lost to Follow-up|0|||
156476028|NCT02691702|564837530|FG004|Overall Study|Lost to Follow-up|0|||
156476029|NCT02691702|564837531|FG005|Overall Study|Lost to Follow-up|2|||
156476030|NCT02691702|564837532|FG006|Overall Study|Lost to Follow-up|0|||
156476031|NCT02691702|564837533|FG007|Overall Study|Lost to Follow-up|0|||
156476032|NCT02691702|564837534|FG008|Overall Study|Lost to Follow-up|0|||
156476033|NCT02691702|564837535|FG009|Overall Study|Lost to Follow-up|0|||
156476034|NCT02691702|564837536|FG010|Overall Study|Lost to Follow-up|1|||
156476035|NCT02691702|564837526|FG000|Overall Study|Withdrawal by Subject|1|||
156476036|NCT02691702|564837527|FG001|Overall Study|Withdrawal by Subject|1|||
156476037|NCT02691702|564837528|FG002|Overall Study|Withdrawal by Subject|0|||
156476038|NCT02691702|564837529|FG003|Overall Study|Withdrawal by Subject|0|||
156476039|NCT02691702|564837530|FG004|Overall Study|Withdrawal by Subject|0|||
156476040|NCT02691702|564837531|FG005|Overall Study|Withdrawal by Subject|1|||
156476041|NCT02691702|564837532|FG006|Overall Study|Withdrawal by Subject|2|||
156476042|NCT02691702|564837533|FG007|Overall Study|Withdrawal by Subject|0|||
156476043|NCT02691702|564837534|FG008|Overall Study|Withdrawal by Subject|0|||
156476044|NCT02691702|564837535|FG009|Overall Study|Withdrawal by Subject|0|||
156476045|NCT02691702|564837536|FG010|Overall Study|Withdrawal by Subject|0|||
156476046|NCT02691702|564837526|FG000|Overall Study|Other|0|||
156476047|NCT02691702|564837527|FG001|Overall Study|Other|0|||
156476048|NCT02691702|564837528|FG002|Overall Study|Other|0|||
156476049|NCT02691702|564837529|FG003|Overall Study|Other|0|||
156476050|NCT02691702|564837530|FG004|Overall Study|Other|0|||
156476051|NCT02691702|564837531|FG005|Overall Study|Other|0|||
156476052|NCT02691702|564837532|FG006|Overall Study|Other|1|||
156476053|NCT02691702|564837533|FG007|Overall Study|Other|0|||
156476054|NCT02691702|564837534|FG008|Overall Study|Other|1|||
156476055|NCT02691702|564837535|FG009|Overall Study|Other|0|||
156476056|NCT02691702|564837536|FG010|Overall Study|Other|0|||
156476057|NCT02691702|564837526|FG000|Overall Study|Protocol Violation|0|||
156862847|NCT01709721|566256582|FG000|Open Label Phase|Adverse Event|0|||
156862848|NCT01709721|566256583|FG001|Open Label Phase|Adverse Event|0|||
156862849|NCT01709721|566256584|FG002|Open Label Phase|Adverse Event|8|||
156476058|NCT02691702|564837527|FG001|Overall Study|Protocol Violation|0|||
156476059|NCT02691702|564837528|FG002|Overall Study|Protocol Violation|0|||
156542567|NCT02325219|565081207|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156542568|NCT02325219|565081208|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156542569|NCT02325219|565081209|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156542570|NCT02325219|565081205|FG000|Controlled Period (Week 0 - 16)|Other|0|||
156542571|NCT02325219|565081206|FG001|Controlled Period (Week 0 - 16)|Other|0|||
156542572|NCT02325219|565081207|FG002|Controlled Period (Week 0 - 16)|Other|1|||
156476060|NCT02691702|564837529|FG003|Overall Study|Protocol Violation|0|||
156476061|NCT02691702|564837530|FG004|Overall Study|Protocol Violation|0|||
156476062|NCT02691702|564837531|FG005|Overall Study|Protocol Violation|0|||
156476063|NCT02691702|564837532|FG006|Overall Study|Protocol Violation|0|||
156476064|NCT02691702|564837533|FG007|Overall Study|Protocol Violation|0|||
156476065|NCT02691702|564837534|FG008|Overall Study|Protocol Violation|0|||
156476066|NCT02691702|564837535|FG009|Overall Study|Protocol Violation|2|||
156476067|NCT02691702|564837536|FG010|Overall Study|Protocol Violation|0|||
156476068|NCT05613088|564837537|FG000|Treatment|Ongoing Study Treatment|9|||
156476069|NCT05613088|564837538|FG001|Treatment|Ongoing Study Treatment|2|||
156476070|NCT05613088|564837537|FG000|Treatment|Adverse Event|3|||
156476071|NCT05613088|564837538|FG001|Treatment|Adverse Event|1|||
156476072|NCT05613088|564837537|FG000|Treatment|Other Reasons|0|||
156476073|NCT05613088|564837538|FG001|Treatment|Other Reasons|1|||
156476074|NCT05613088|564837537|FG000|Treatment|Progressive Disease|58|||
156476075|NCT05613088|564837538|FG001|Treatment|Progressive Disease|26|||
156476076|NCT05613088|564837537|FG000|Treatment|Withdrawal by Subject|0|||
156476077|NCT05613088|564837538|FG001|Treatment|Withdrawal by Subject|4|||
156476078|NCT05163353|564837541|FG000|Overall Study|Adverse Event|1|||
156476079|NCT05163353|564837542|FG001|Overall Study|Adverse Event|0|||
156476080|NCT05163353|564837541|FG000|Overall Study|Withdrawal by Subject|21|||
156476081|NCT05163353|564837542|FG001|Overall Study|Withdrawal by Subject|6|||
156476082|NCT05163353|564837541|FG000|Overall Study|Protocol Violation|0|||
156476083|NCT05163353|564837542|FG001|Overall Study|Protocol Violation|1|||
156476084|NCT05163353|564837541|FG000|Overall Study|Lost to Follow-up|13|||
156476085|NCT05163353|564837542|FG001|Overall Study|Lost to Follow-up|2|||
156476086|NCT06086028|564837544|FG000|Overall Study|Withdrawal by Subject|1|||
156476087|NCT06086028|564837545|FG001|Overall Study|Withdrawal by Subject|1|||
156476088|NCT06086028|564837544|FG000|Overall Study|Lost to Follow-up|2|||
156476089|NCT06086028|564837545|FG001|Overall Study|Lost to Follow-up|3|||
156476090|NCT00824408|564837546|FG000|Run-in Phase|Progressive disease|4|||
156476091|NCT00824408|564837547|FG001|Run-in Phase|Progressive disease|4|||
156476092|NCT00824408|564837548|FG002|Run-in Phase|Progressive disease|0|||
156476093|NCT00824408|564837549|FG003|Run-in Phase|Progressive disease|0|||
156476094|NCT00824408|564837550|FG004|Run-in Phase|Progressive disease|0|||
156476095|NCT00824408|564837546|FG000|Run-in Phase|Adverse Event|1|||
156476096|NCT00824408|564837547|FG001|Run-in Phase|Adverse Event|1|||
156476097|NCT00824408|564837548|FG002|Run-in Phase|Adverse Event|0|||
156476098|NCT00824408|564837549|FG003|Run-in Phase|Adverse Event|0|||
156476099|NCT00824408|564837550|FG004|Run-in Phase|Adverse Event|0|||
156476100|NCT00824408|564837546|FG000|Run-in Phase|Refused to continue medication|1|||
156476101|NCT00824408|564837547|FG001|Run-in Phase|Refused to continue medication|0|||
156476102|NCT00824408|564837548|FG002|Run-in Phase|Refused to continue medication|0|||
156476103|NCT00824408|564837549|FG003|Run-in Phase|Refused to continue medication|0|||
156476104|NCT00824408|564837550|FG004|Run-in Phase|Refused to continue medication|0|||
156476105|NCT00824408|564837546|FG000|Run-in Phase|Other reason not defined above|0|||
156476106|NCT00824408|564837547|FG001|Run-in Phase|Other reason not defined above|1|||
156476107|NCT00824408|564837548|FG002|Run-in Phase|Other reason not defined above|0|||
156476108|NCT00824408|564837549|FG003|Run-in Phase|Other reason not defined above|0|||
156476109|NCT00824408|564837550|FG004|Run-in Phase|Other reason not defined above|0|||
156476110|NCT00824408|564837546|FG000|Randomized Phase|Not treated|0|||
156476111|NCT00824408|564837547|FG001|Randomized Phase|Not treated|0|||
156476112|NCT00824408|564837548|FG002|Randomized Phase|Not treated|1|||
156476113|NCT00824408|564837549|FG003|Randomized Phase|Not treated|1|||
156476114|NCT00824408|564837550|FG004|Randomized Phase|Not treated|1|||
156476115|NCT00824408|564837546|FG000|Randomized Phase|Progressive disease|0|||
156476116|NCT00824408|564837547|FG001|Randomized Phase|Progressive disease|0|||
156476117|NCT00824408|564837548|FG002|Randomized Phase|Progressive disease|25|||
156476118|NCT00824408|564837549|FG003|Randomized Phase|Progressive disease|36|||
156476119|NCT00824408|564837550|FG004|Randomized Phase|Progressive disease|34|||
156476120|NCT00824408|564837546|FG000|Randomized Phase|Adverse Event|0|||
156476121|NCT00824408|564837547|FG001|Randomized Phase|Adverse Event|0|||
156476122|NCT00824408|564837548|FG002|Randomized Phase|Adverse Event|4|||
156476123|NCT00824408|564837549|FG003|Randomized Phase|Adverse Event|5|||
156476124|NCT00824408|564837550|FG004|Randomized Phase|Adverse Event|5|||
156476125|NCT00824408|564837546|FG000|Randomized Phase|Refused to continue medication|0|||
156476126|NCT00824408|564837547|FG001|Randomized Phase|Refused to continue medication|0|||
156476127|NCT00824408|564837548|FG002|Randomized Phase|Refused to continue medication|2|||
156476128|NCT00824408|564837549|FG003|Randomized Phase|Refused to continue medication|2|||
156476129|NCT00824408|564837550|FG004|Randomized Phase|Refused to continue medication|2|||
156476130|NCT00824408|564837546|FG000|Randomized Phase|Other reason not defined above|0|||
156344001|NCT00519831|564358535|FG000|Overall Study|Adverse Event|3|||
156862850|NCT01709721|566256582|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
156862851|NCT01709721|566256583|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
156862852|NCT01709721|566256584|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
156862853|NCT01709721|566256582|FG000|Open Label Phase|Investigator Decision|0|||
156862854|NCT01709721|566256583|FG001|Open Label Phase|Investigator Decision|0|||
156862855|NCT01709721|566256584|FG002|Open Label Phase|Investigator Decision|1|||
156862856|NCT01709721|566256582|FG000|Open Label Phase|Sponsor Decision|0|||
156862857|NCT01709721|566256583|FG001|Open Label Phase|Sponsor Decision|0|||
156862858|NCT01709721|566256584|FG002|Open Label Phase|Sponsor Decision|2|||
156862859|NCT01709721|566256582|FG000|Open Label Phase|Protocol Violation|0|||
156862860|NCT01709721|566256583|FG001|Open Label Phase|Protocol Violation|0|||
156862861|NCT01709721|566256584|FG002|Open Label Phase|Protocol Violation|1|||
156862862|NCT01709721|566256582|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
156862863|NCT01709721|566256583|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
156862864|NCT01709721|566256584|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
156862865|NCT01709721|566256582|FG000|Open Label Phase|Inadequate Pain Control|0|||
156862866|NCT01709721|566256583|FG001|Open Label Phase|Inadequate Pain Control|0|||
156862867|NCT01709721|566256584|FG002|Open Label Phase|Inadequate Pain Control|37|||
156862868|NCT01709721|566256582|FG000|Open Label Phase|Other, Specify in text field in database|0|||
156862869|NCT01709721|566256583|FG001|Open Label Phase|Other, Specify in text field in database|0|||
156862870|NCT01709721|566256584|FG002|Open Label Phase|Other, Specify in text field in database|14|||
156862871|NCT01709721|566256582|FG000|Randomized Phase|Adverse Event|0|||
156862872|NCT01709721|566256583|FG001|Randomized Phase|Adverse Event|1|||
156862873|NCT01709721|566256584|FG002|Randomized Phase|Adverse Event|0|||
156862874|NCT01709721|566256582|FG000|Randomized Phase|Lost to Follow-up|1|||
156862875|NCT01709721|566256583|FG001|Randomized Phase|Lost to Follow-up|0|||
156862876|NCT01709721|566256584|FG002|Randomized Phase|Lost to Follow-up|0|||
156862877|NCT01709721|566256582|FG000|Randomized Phase|Inadequate Pain Control|1|||
156862878|NCT01709721|566256583|FG001|Randomized Phase|Inadequate Pain Control|2|||
156862879|NCT01709721|566256584|FG002|Randomized Phase|Inadequate Pain Control|0|||
156862880|NCT01709721|566256582|FG000|Randomized Phase|Other, Specify text field in database|1|||
156862881|NCT01709721|566256583|FG001|Randomized Phase|Other, Specify text field in database|3|||
156862882|NCT01709721|566256584|FG002|Randomized Phase|Other, Specify text field in database|0|||
156862883|NCT02230410|566256585|FG000|Overall Study|Screen Failure|3|||
156862884|NCT02558894|566256591|FG000|Overall Study|Death; any cause, entire study duration|28|||
156862885|NCT02558894|566256592|FG001|Overall Study|Death; any cause, entire study duration|31|||
156344002|NCT02854631|564358536|FG000|Overall Study|Adverse Event|1|||
156344003|NCT02854631|564358537|FG001|Overall Study|Adverse Event|2|||
156476131|NCT00824408|564837547|FG001|Randomized Phase|Other reason not defined above|0|||
156344004|NCT02854631|564358536|FG000|Overall Study|Withdrew Consent|3|||
156344005|NCT02854631|564358537|FG001|Overall Study|Withdrew Consent|2|||
156862886|NCT02558894|566256591|FG000|Overall Study|Withdrawal by Subject|2|||
156862887|NCT02558894|566256592|FG001|Overall Study|Withdrawal by Subject|1|||
156862888|NCT02558894|566256591|FG000|Overall Study|Closure of Part A|2|||
156862889|NCT02558894|566256592|FG001|Overall Study|Closure of Part A|1|||
156862890|NCT02992288|566256593|FG000|Overall Study|Adverse Event|8|||
156862891|NCT02992288|566256594|FG001|Overall Study|Adverse Event|2|||
156862892|NCT02992288|566256595|FG002|Overall Study|Adverse Event|2|||
156862893|NCT02992288|566256596|FG003|Overall Study|Adverse Event|2|||
156862894|NCT02992288|566256597|FG004|Overall Study|Adverse Event|2|||
156862895|NCT02992288|566256598|FG005|Overall Study|Adverse Event|7|||
156862896|NCT02992288|566256593|FG000|Overall Study|Non-compliance with study drug|0|||
156862897|NCT02992288|566256594|FG001|Overall Study|Non-compliance with study drug|1|||
156862898|NCT02992288|566256595|FG002|Overall Study|Non-compliance with study drug|1|||
156862899|NCT02992288|566256596|FG003|Overall Study|Non-compliance with study drug|0|||
156862900|NCT02992288|566256597|FG004|Overall Study|Non-compliance with study drug|1|||
156862901|NCT02992288|566256598|FG005|Overall Study|Non-compliance with study drug|0|||
156862902|NCT02992288|566256593|FG000|Overall Study|Physician Decision|3|||
156862903|NCT02992288|566256594|FG001|Overall Study|Physician Decision|0|||
156862904|NCT02992288|566256595|FG002|Overall Study|Physician Decision|1|||
156862905|NCT02992288|566256596|FG003|Overall Study|Physician Decision|0|||
156862906|NCT02992288|566256597|FG004|Overall Study|Physician Decision|0|||
156862907|NCT02992288|566256598|FG005|Overall Study|Physician Decision|1|||
156862908|NCT02992288|566256593|FG000|Overall Study|Death|2|||
156862909|NCT02992288|566256594|FG001|Overall Study|Death|0|||
156862910|NCT02992288|566256595|FG002|Overall Study|Death|2|||
156862911|NCT02992288|566256596|FG003|Overall Study|Death|1|||
156862912|NCT02992288|566256597|FG004|Overall Study|Death|2|||
156862913|NCT02992288|566256598|FG005|Overall Study|Death|0|||
156862914|NCT02992288|566256593|FG000|Overall Study|Lost to Follow-up|0|||
156862915|NCT02992288|566256594|FG001|Overall Study|Lost to Follow-up|0|||
156862916|NCT02992288|566256595|FG002|Overall Study|Lost to Follow-up|0|||
156862917|NCT02992288|566256596|FG003|Overall Study|Lost to Follow-up|1|||
156862918|NCT02992288|566256597|FG004|Overall Study|Lost to Follow-up|0|||
156862919|NCT02992288|566256598|FG005|Overall Study|Lost to Follow-up|0|||
156862920|NCT02992288|566256593|FG000|Overall Study|Protocol Violation|0|||
156862921|NCT02992288|566256594|FG001|Overall Study|Protocol Violation|0|||
156862922|NCT02992288|566256595|FG002|Overall Study|Protocol Violation|0|||
156862923|NCT02992288|566256596|FG003|Overall Study|Protocol Violation|0|||
156862924|NCT02992288|566256597|FG004|Overall Study|Protocol Violation|0|||
156862925|NCT02992288|566256598|FG005|Overall Study|Protocol Violation|1|||
156862926|NCT02992288|566256593|FG000|Overall Study|Withdrawal by Subject|4|||
156862927|NCT02992288|566256594|FG001|Overall Study|Withdrawal by Subject|2|||
156862928|NCT02992288|566256595|FG002|Overall Study|Withdrawal by Subject|1|||
156862929|NCT02992288|566256596|FG003|Overall Study|Withdrawal by Subject|5|||
156862930|NCT02992288|566256597|FG004|Overall Study|Withdrawal by Subject|3|||
156862931|NCT02992288|566256598|FG005|Overall Study|Withdrawal by Subject|4|||
156862932|NCT00656513|566256599|FG000|Overall Study|Protocol Violation|1|||
156862933|NCT00656513|566256600|FG001|Overall Study|Protocol Violation|0|||
156862934|NCT00656513|566256601|FG002|Overall Study|Protocol Violation|2|||
156862935|NCT00656513|566256599|FG000|Overall Study|Withdrawal by Subject|0|||
156862936|NCT00656513|566256600|FG001|Overall Study|Withdrawal by Subject|11|||
156862937|NCT00656513|566256601|FG002|Overall Study|Withdrawal by Subject|4|||
156862938|NCT00656513|566256599|FG000|Overall Study|Death|0|||
156862939|NCT00656513|566256600|FG001|Overall Study|Death|0|||
156862940|NCT00656513|566256601|FG002|Overall Study|Death|1|||
156862941|NCT00656513|566256599|FG000|Overall Study|Missing data|0|||
156862942|NCT00656513|566256600|FG001|Overall Study|Missing data|11|||
156862943|NCT00656513|566256601|FG002|Overall Study|Missing data|9|||
156862944|NCT00656513|566256599|FG000|Overall Study|Incomplete treatment|3|||
156862945|NCT00656513|566256600|FG001|Overall Study|Incomplete treatment|0|||
156862946|NCT00656513|566256601|FG002|Overall Study|Incomplete treatment|0|||
156862947|NCT00656513|566256599|FG000|Overall Study|Treatment completed outside of timeframe|0|||
156344006|NCT02854631|564358536|FG000|Overall Study|Investigator's Discretion|2|||
156862948|NCT00656513|566256600|FG001|Overall Study|Treatment completed outside of timeframe|3|||
156862949|NCT00656513|566256601|FG002|Overall Study|Treatment completed outside of timeframe|1|||
156862950|NCT00656513|566256599|FG000|Overall Study|Missing baseline form|0|||
156862951|NCT00656513|566256600|FG001|Overall Study|Missing baseline form|5|||
156862952|NCT00656513|566256601|FG002|Overall Study|Missing baseline form|5|||
156862953|NCT04558125|566256602|FG000|Overall Study|Death|1|||
156862954|NCT01748292|566256603|FG000|Overall Study|Adverse Event|2|||
156862955|NCT01748292|566256604|FG001|Overall Study|Adverse Event|4|||
156862956|NCT01748292|566256603|FG000|Overall Study|Lost to Follow-up|0|||
156862957|NCT01748292|566256604|FG001|Overall Study|Lost to Follow-up|3|||
156862958|NCT01748292|566256603|FG000|Overall Study|Death|0|||
156862959|NCT01748292|566256604|FG001|Overall Study|Death|3|||
156862960|NCT01748292|566256603|FG000|Overall Study|Withdrawal by Subject|0|||
156862961|NCT01748292|566256604|FG001|Overall Study|Withdrawal by Subject|2|||
156862962|NCT03199976|566256606|FG000|Overall Study|Lack of Efficacy|3|||
156862963|NCT03199976|566256607|FG001|Overall Study|Lack of Efficacy|6|||
156862964|NCT03199976|566256608|FG002|Overall Study|Lack of Efficacy|13|||
156862965|NCT03199976|566256606|FG000|Overall Study|Withdrawal by Subject|1|||
156862966|NCT03199976|566256607|FG001|Overall Study|Withdrawal by Subject|0|||
156862967|NCT03199976|566256608|FG002|Overall Study|Withdrawal by Subject|0|||
156862968|NCT03199976|566256606|FG000|Overall Study|Lost to Follow-up|0|||
156862969|NCT03199976|566256607|FG001|Overall Study|Lost to Follow-up|1|||
156862970|NCT03199976|566256608|FG002|Overall Study|Lost to Follow-up|1|||
156862971|NCT01761877|566256609|FG000|Overall Study|Adverse Event|7|||
156862972|NCT01761877|566256610|FG001|Overall Study|Adverse Event|0|||
156862973|NCT01761877|566256609|FG000|Overall Study|Withdrawal by Subject|6|||
156862974|NCT01761877|566256610|FG001|Overall Study|Withdrawal by Subject|4|||
156862975|NCT01761877|566256609|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
156862976|NCT01761877|566256610|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
156862977|NCT01761877|566256609|FG000|Overall Study|Death|0|||
156862978|NCT01761877|566256610|FG001|Overall Study|Death|1|||
156862979|NCT01761877|566256609|FG000|Overall Study|MRI intolerant|1|||
156862980|NCT01761877|566256610|FG001|Overall Study|MRI intolerant|6|||
156862981|NCT00003475|566256612|FG000|Overall Study|Not evaluable|13|||
156862982|NCT03962491|566256613|FG000|Overall Study|Lost to Follow-up|4|||
156862983|NCT03962491|566256614|FG001|Overall Study|Lost to Follow-up|5|||
156862984|NCT03697252|566256621|FG000|Overall Study|Adverse Event|3|||
156862985|NCT03697252|566256622|FG001|Overall Study|Adverse Event|2|||
156862986|NCT03697252|566256621|FG000|Overall Study|Withdrawal by Subject|14|||
156862987|NCT03697252|566256622|FG001|Overall Study|Withdrawal by Subject|14|||
156862988|NCT03697252|566256621|FG000|Overall Study|Lost to Follow-up|0|||
156862989|NCT03697252|566256622|FG001|Overall Study|Lost to Follow-up|1|||
156862990|NCT03697252|566256621|FG000|Overall Study|Physician Decision|1|||
156862991|NCT03697252|566256622|FG001|Overall Study|Physician Decision|1|||
156862992|NCT03697252|566256621|FG000|Overall Study|Other|0|||
156862993|NCT03697252|566256622|FG001|Overall Study|Other|1|||
156862994|NCT00106704|566256623|FG000|Overall Study|Adverse Event|10|||
156862995|NCT00106704|566256624|FG001|Overall Study|Adverse Event|7|||
156862996|NCT00106704|566256623|FG000|Overall Study|Death|2|||
156862997|NCT00106704|566256624|FG001|Overall Study|Death|1|||
156862998|NCT00106704|566256623|FG000|Overall Study|Lack of Efficacy|67|||
156862999|NCT00106704|566256624|FG001|Overall Study|Lack of Efficacy|69|||
156863000|NCT00106704|566256623|FG000|Overall Study|Lost to Follow-up|7|||
156863001|NCT00106704|566256624|FG001|Overall Study|Lost to Follow-up|3|||
156863002|NCT00106704|566256623|FG000|Overall Study|Pregnancy|1|||
156863003|NCT00106704|566256624|FG001|Overall Study|Pregnancy|0|||
156863004|NCT00106704|566256623|FG000|Overall Study|Protocol Violation|4|||
156863005|NCT00106704|566256624|FG001|Overall Study|Protocol Violation|7|||
156863006|NCT00106704|566256623|FG000|Overall Study|Withdrawal by Subject|14|||
156863007|NCT00106704|566256624|FG001|Overall Study|Withdrawal by Subject|21|||
156863008|NCT00106704|566256623|FG000|Overall Study|Patient moved|1|||
156863009|NCT00106704|566256624|FG001|Overall Study|Patient moved|0|||
156863010|NCT00106704|566256623|FG000|Overall Study|Site terminated|0|||
156863011|NCT00106704|566256624|FG001|Overall Study|Site terminated|1|||
156863012|NCT00106704|566256623|FG000|Overall Study|Planned major surgery|1|||
156863013|NCT00106704|566256624|FG001|Overall Study|Planned major surgery|0|||
156863014|NCT00106704|566256623|FG000|Overall Study|Patient Received Glycemic Medication|22|||
156863015|NCT00106704|566256624|FG001|Overall Study|Patient Received Glycemic Medication|41|||
156863016|NCT00106704|566256623|FG000|Overall Study|Unable to re-enter US|1|||
156863017|NCT00106704|566256624|FG001|Overall Study|Unable to re-enter US|0|||
156863018|NCT00106704|566256623|FG000|Overall Study|Laboratory test|1|||
156863019|NCT00106704|566256624|FG001|Overall Study|Laboratory test|1|||
156863020|NCT01780506|566256625|FG000|Double-Blind Phase|Randomized but not Treated|3|||
156863021|NCT01780506|566256626|FG001|Double-Blind Phase|Randomized but not Treated|2|||
156863022|NCT01780506|566256625|FG000|Double-Blind Phase|Adverse Event|4|||
156863023|NCT01780506|566256626|FG001|Double-Blind Phase|Adverse Event|14|||
156863024|NCT01780506|566256625|FG000|Double-Blind Phase|Death|1|||
156863025|NCT01780506|566256626|FG001|Double-Blind Phase|Death|2|||
156542573|NCT02325219|565081208|FG003|Controlled Period (Week 0 - 16)|Other|0|||
156863026|NCT01780506|566256625|FG000|Double-Blind Phase|Pregnancy|2|||
156863027|NCT01780506|566256626|FG001|Double-Blind Phase|Pregnancy|1|||
156863028|NCT01780506|566256625|FG000|Double-Blind Phase|Lack of Efficacy|1|||
156863029|NCT01780506|566256626|FG001|Double-Blind Phase|Lack of Efficacy|1|||
156863030|NCT01780506|566256625|FG000|Double-Blind Phase|Investigator's Discretion|5|||
156863031|NCT01780506|566256626|FG001|Double-Blind Phase|Investigator's Discretion|2|||
156863032|NCT01780506|566256625|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
156863033|NCT01780506|566256626|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
156863034|NCT01780506|566256625|FG000|Double-Blind Phase|Protocol Violation|4|||
156863035|NCT01780506|566256626|FG001|Double-Blind Phase|Protocol Violation|3|||
156863036|NCT01780506|566256625|FG000|Double-Blind Phase|Withdrew Consent|23|||
156863037|NCT01780506|566256626|FG001|Double-Blind Phase|Withdrew Consent|24|||
156863038|NCT01780506|566256625|FG000|Double-Blind Phase|Lost to Follow-up|23|||
156863039|NCT01780506|566256626|FG001|Double-Blind Phase|Lost to Follow-up|26|||
156863040|NCT01780506|566256625|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
156863041|NCT01780506|566256626|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
156863042|NCT00412984|566256631|FG000|Overall Study|Death|331|||
156863043|NCT00412984|566256632|FG001|Overall Study|Death|349|||
156863044|NCT00412984|566256631|FG000|Overall Study|Adverse Event|679|||
156476132|NCT00824408|564837548|FG002|Randomized Phase|Other reason not defined above|4|||
156476133|NCT00824408|564837549|FG003|Randomized Phase|Other reason not defined above|2|||
156476134|NCT00824408|564837550|FG004|Randomized Phase|Other reason not defined above|4|||
156476135|NCT01218594|564837553|FG000|Overall Study|Death|1|||
156863045|NCT00412984|566256632|FG001|Overall Study|Adverse Event|738|||
156863046|NCT00412984|566256631|FG000|Overall Study|Withdrawal by Subject|921|||
156863047|NCT00412984|566256632|FG001|Overall Study|Withdrawal by Subject|989|||
156863048|NCT00412984|566256631|FG000|Overall Study|Lost to Follow-up|51|||
156476136|NCT01218594|564837553|FG000|Overall Study|Withdrawal by Subject|3|||
156476137|NCT01218594|564837553|FG000|Overall Study|Adverse Event|2|||
156476138|NCT01218594|564837553|FG000|Overall Study|Physician Decision|6|||
156476139|NCT04602728|564837556|FG000|Overall Study|Lost to Follow-up|4|||
156476140|NCT04602728|564837557|FG001|Overall Study|Lost to Follow-up|4|||
156476141|NCT04181788|564837558|FG000|TREATMENT|Adverse Event|0|||
156476142|NCT04181788|564837559|FG001|TREATMENT|Adverse Event|2|||
156476143|NCT04181788|564837560|FG002|TREATMENT|Adverse Event|1|||
156476144|NCT04181788|564837561|FG003|TREATMENT|Adverse Event|0|||
156476145|NCT04181788|564837562|FG004|TREATMENT|Adverse Event|1|||
156476146|NCT04181788|564837563|FG005|TREATMENT|Adverse Event|3|||
156476147|NCT04181788|564837558|FG000|TREATMENT|Death|0|||
156476148|NCT04181788|564837559|FG001|TREATMENT|Death|0|||
156476149|NCT04181788|564837560|FG002|TREATMENT|Death|0|||
156476150|NCT04181788|564837561|FG003|TREATMENT|Death|0|||
156476151|NCT04181788|564837562|FG004|TREATMENT|Death|8|||
156476152|NCT04181788|564837563|FG005|TREATMENT|Death|8|||
156476153|NCT04181788|564837558|FG000|TREATMENT|Physician Decision|0|||
156476154|NCT04181788|564837559|FG001|TREATMENT|Physician Decision|0|||
156476155|NCT04181788|564837560|FG002|TREATMENT|Physician Decision|0|||
156476156|NCT04181788|564837561|FG003|TREATMENT|Physician Decision|0|||
156476157|NCT04181788|564837562|FG004|TREATMENT|Physician Decision|0|||
156476158|NCT04181788|564837563|FG005|TREATMENT|Physician Decision|1|||
156476159|NCT04181788|564837558|FG000|TREATMENT|Progressive disease|3|||
156476160|NCT04181788|564837559|FG001|TREATMENT|Progressive disease|3|||
156476161|NCT04181788|564837560|FG002|TREATMENT|Progressive disease|5|||
156476162|NCT04181788|564837561|FG003|TREATMENT|Progressive disease|7|||
156863049|NCT00412984|566256632|FG001|Overall Study|Lost to Follow-up|39|||
156863050|NCT00412984|566256631|FG000|Overall Study|Poor/Noncompliance|57|||
156863051|NCT00412984|566256632|FG001|Overall Study|Poor/Noncompliance|77|||
156863052|NCT00412984|566256631|FG000|Overall Study|Pregnancy|1|||
156863053|NCT00412984|566256632|FG001|Overall Study|Pregnancy|0|||
156863054|NCT00412984|566256631|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
156344007|NCT02854631|564358537|FG001|Overall Study|Investigator's Discretion|0|||
156344008|NCT02854631|564358536|FG000|Overall Study|Death|12|||
156344009|NCT02854631|564358537|FG001|Overall Study|Death|8|||
156476163|NCT04181788|564837562|FG004|TREATMENT|Progressive disease|20|||
156542574|NCT02325219|565081209|FG004|Controlled Period (Week 0 - 16)|Other|0|||
156863055|NCT00412984|566256632|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
156863056|NCT00412984|566256631|FG000|Overall Study|Administrative Reason by Sponsor|11|||
156863057|NCT00412984|566256632|FG001|Overall Study|Administrative Reason by Sponsor|8|||
156863058|NCT00412984|566256631|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
156863059|NCT00412984|566256632|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
156863060|NCT00412984|566256631|FG000|Overall Study|Other Reason|80|||
156863061|NCT00412984|566256632|FG001|Overall Study|Other Reason|92|||
156863062|NCT00412984|566256631|FG000|Overall Study|Not Reported|11|||
156863063|NCT00412984|566256632|FG001|Overall Study|Not Reported|12|||
156863064|NCT04097678|566256633|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
156863065|NCT04097678|566256634|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
156863066|NCT03694678|566256635|FG000|Overall Study|Withdrawal by Subject|2|||
156863067|NCT03694678|566256636|FG001|Overall Study|Withdrawal by Subject|0|||
156863068|NCT03694678|566256635|FG000|Overall Study|Lost to Follow-up|2|||
156863069|NCT03694678|566256636|FG001|Overall Study|Lost to Follow-up|3|||
156476164|NCT04181788|564837563|FG005|TREATMENT|Progressive disease|38|||
156476165|NCT04181788|564837558|FG000|TREATMENT|Global deterioration of health status|0|||
156476166|NCT04181788|564837559|FG001|TREATMENT|Global deterioration of health status|2|||
156476167|NCT04181788|564837560|FG002|TREATMENT|Global deterioration of health status|0|||
156542575|NCT02325219|565081205|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
156863070|NCT02435212|566256637|FG000|Core Phase|Adverse Event|8|||
156863071|NCT02435212|566256638|FG001|Core Phase|Adverse Event|5|||
156863072|NCT02435212|566256637|FG000|Core Phase|Withdrawal by Subject|3|||
156344010|NCT02854631|564358536|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
156476168|NCT04181788|564837561|FG003|TREATMENT|Global deterioration of health status|0|||
156476169|NCT04181788|564837562|FG004|TREATMENT|Global deterioration of health status|2|||
156863073|NCT02435212|566256638|FG001|Core Phase|Withdrawal by Subject|0|||
156863074|NCT02435212|566256637|FG000|Core Phase|Withdrawal by parent/guardian|9|||
156863075|NCT02435212|566256638|FG001|Core Phase|Withdrawal by parent/guardian|4|||
156863076|NCT02435212|566256637|FG000|Core Phase|Protocol Violation|1|||
156863077|NCT02435212|566256638|FG001|Core Phase|Protocol Violation|2|||
156863078|NCT02435212|566256637|FG000|Core Phase|Physician Decision|3|||
156863079|NCT02435212|566256638|FG001|Core Phase|Physician Decision|0|||
156863080|NCT02435212|566256637|FG000|Core Phase|Lost to Follow-up|0|||
156863081|NCT02435212|566256638|FG001|Core Phase|Lost to Follow-up|1|||
156863082|NCT02435212|566256637|FG000|Core Phase|Lack of Efficacy|0|||
156863083|NCT02435212|566256638|FG001|Core Phase|Lack of Efficacy|1|||
156863084|NCT02435212|566256637|FG000|Core Phase|Recovery|1|||
156863085|NCT02435212|566256638|FG001|Core Phase|Recovery|0|||
156863086|NCT02435212|566256637|FG000|Optional Extension Phase|Adverse Event|3|||
156863087|NCT02435212|566256638|FG001|Optional Extension Phase|Adverse Event|9|||
156863088|NCT02435212|566256637|FG000|Optional Extension Phase|Physician Decision|6|||
156863089|NCT02435212|566256638|FG001|Optional Extension Phase|Physician Decision|8|||
156863090|NCT02435212|566256637|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
156863091|NCT02435212|566256638|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
156863092|NCT02435212|566256637|FG000|Optional Extension Phase|Lack of Efficacy|2|||
156863093|NCT02435212|566256638|FG001|Optional Extension Phase|Lack of Efficacy|3|||
156863094|NCT02435212|566256637|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
156863095|NCT02435212|566256638|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
156863096|NCT02435212|566256637|FG000|Optional Extension Phase|Protocol Violation|0|||
156863097|NCT02435212|566256638|FG001|Optional Extension Phase|Protocol Violation|1|||
156863098|NCT02435212|566256637|FG000|Optional Extension Phase|Recovery|1|||
156863099|NCT02435212|566256638|FG001|Optional Extension Phase|Recovery|1|||
156863100|NCT02435212|566256637|FG000|Optional Extension Phase|Death|1|||
156863101|NCT02435212|566256638|FG001|Optional Extension Phase|Death|0|||
156863102|NCT02435212|566256637|FG000|Optional Extension Phase|Technical problems|2|||
156863103|NCT02435212|566256638|FG001|Optional Extension Phase|Technical problems|0|||
156863104|NCT04852302|566256639|FG000|Overall Study|Withdrawal by Subject|2|||
156863105|NCT04852302|566256639|FG000|Overall Study|Did not complete CALM therapy.|2|||
156863106|NCT04711850|566256640|FG000|Overall Study|Graft loss|2|||
156863107|NCT04711850|566256641|FG001|Overall Study|Graft loss|1|||
156863108|NCT04711850|566256640|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
156863109|NCT04711850|566256641|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
156863110|NCT04711850|566256640|FG000|Overall Study|Study terminated by sponsor|5|||
156863111|NCT04711850|566256641|FG001|Overall Study|Study terminated by sponsor|3|||
156863112|NCT04711850|566256640|FG000|Overall Study|Sponsor decision|0|||
156863113|NCT04711850|566256641|FG001|Overall Study|Sponsor decision|2|||
156863114|NCT05249582|566256642|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
156863115|NCT05249582|566256643|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
156863116|NCT05249582|566256642|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
156863117|NCT05249582|566256643|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
156863118|NCT05249582|566256642|FG000|Overall Study|Declined to use virtual reality headset|1|||
156863119|NCT05249582|566256643|FG001|Overall Study|Declined to use virtual reality headset|0|||
156863120|NCT02718898|566256647|FG000|Blinded Treatment Period|Adverse Event|5|||
156863121|NCT02718898|566256648|FG001|Blinded Treatment Period|Adverse Event|1|||
156863122|NCT02718898|566256649|FG002|Blinded Treatment Period|Adverse Event|0|||
156863123|NCT02718898|566256650|FG003|Blinded Treatment Period|Adverse Event|0|||
156863124|NCT02718898|566256651|FG004|Blinded Treatment Period|Adverse Event|0|||
156863125|NCT02718898|566256652|FG005|Blinded Treatment Period|Adverse Event|0|||
156863126|NCT02718898|566256653|FG006|Blinded Treatment Period|Adverse Event|0|||
156863127|NCT02718898|566256647|FG000|Blinded Treatment Period|Physician Decision|1|||
156863128|NCT02718898|566256648|FG001|Blinded Treatment Period|Physician Decision|0|||
156863129|NCT02718898|566256649|FG002|Blinded Treatment Period|Physician Decision|0|||
156863130|NCT02718898|566256650|FG003|Blinded Treatment Period|Physician Decision|0|||
156863131|NCT02718898|566256651|FG004|Blinded Treatment Period|Physician Decision|0|||
156863132|NCT02718898|566256652|FG005|Blinded Treatment Period|Physician Decision|0|||
156863133|NCT02718898|566256653|FG006|Blinded Treatment Period|Physician Decision|0|||
156863134|NCT02718898|566256647|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
156863135|NCT02718898|566256648|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
156863136|NCT02718898|566256649|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
156863137|NCT02718898|566256650|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
156863138|NCT02718898|566256651|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
156863139|NCT02718898|566256652|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
156863140|NCT02718898|566256653|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
156863141|NCT02718898|566256647|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
156863142|NCT02718898|566256648|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
156863143|NCT02718898|566256649|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
156863144|NCT02718898|566256650|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
156863145|NCT02718898|566256651|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
156863146|NCT02718898|566256652|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
156542576|NCT02325219|565081206|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
156542577|NCT02325219|565081207|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
156542578|NCT02325219|565081208|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
156542579|NCT02325219|565081209|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
156542580|NCT02325219|565081205|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
156542581|NCT02325219|565081206|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
156542582|NCT02325219|565081207|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
156863147|NCT02718898|566256653|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
156863148|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863149|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863150|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
156863151|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
156863152|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863153|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863154|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863155|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156863156|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156476170|NCT04181788|564837563|FG005|TREATMENT|Global deterioration of health status|8|||
156476171|NCT04181788|564837558|FG000|TREATMENT|Withdrawal by Subject|1|||
156476172|NCT04181788|564837559|FG001|TREATMENT|Withdrawal by Subject|2|||
156476173|NCT04181788|564837560|FG002|TREATMENT|Withdrawal by Subject|0|||
156476174|NCT04181788|564837561|FG003|TREATMENT|Withdrawal by Subject|0|||
156476175|NCT04181788|564837562|FG004|TREATMENT|Withdrawal by Subject|3|||
156476176|NCT04181788|564837563|FG005|TREATMENT|Withdrawal by Subject|5|||
156476177|NCT04181788|564837558|FG000|TREATMENT|Other unspecified|0|||
156476178|NCT04181788|564837559|FG001|TREATMENT|Other unspecified|0|||
156476179|NCT04181788|564837560|FG002|TREATMENT|Other unspecified|0|||
156476180|NCT04181788|564837561|FG003|TREATMENT|Other unspecified|0|||
156476181|NCT04181788|564837562|FG004|TREATMENT|Other unspecified|0|||
156476182|NCT04181788|564837563|FG005|TREATMENT|Other unspecified|2|||
156476183|NCT04181788|564837558|FG000|TREATMENT|Ongoing|0|||
156476184|NCT04181788|564837559|FG001|TREATMENT|Ongoing|3|||
156476185|NCT04181788|564837560|FG002|TREATMENT|Ongoing|0|||
156476186|NCT04181788|564837561|FG003|TREATMENT|Ongoing|5|||
156476187|NCT04181788|564837562|FG004|TREATMENT|Ongoing|7|||
156476188|NCT04181788|564837563|FG005|TREATMENT|Ongoing|15|||
156476189|NCT04181788|564837558|FG000|FOLLOW-UP|Death|0|||
156476190|NCT04181788|564837559|FG001|FOLLOW-UP|Death|0|||
156476191|NCT04181788|564837560|FG002|FOLLOW-UP|Death|1|||
156476192|NCT04181788|564837561|FG003|FOLLOW-UP|Death|2|||
156476193|NCT04181788|564837562|FG004|FOLLOW-UP|Death|8|||
156476194|NCT04181788|564837563|FG005|FOLLOW-UP|Death|20|||
156476195|NCT04181788|564837558|FG000|FOLLOW-UP|Lost to Follow-up|0|||
156476196|NCT04181788|564837559|FG001|FOLLOW-UP|Lost to Follow-up|0|||
156476197|NCT04181788|564837560|FG002|FOLLOW-UP|Lost to Follow-up|0|||
156476198|NCT04181788|564837561|FG003|FOLLOW-UP|Lost to Follow-up|0|||
156476199|NCT04181788|564837562|FG004|FOLLOW-UP|Lost to Follow-up|0|||
156476200|NCT04181788|564837563|FG005|FOLLOW-UP|Lost to Follow-up|2|||
156476201|NCT04181788|564837558|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
156476202|NCT04181788|564837559|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
156476203|NCT04181788|564837560|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
156476204|NCT04181788|564837561|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
156476205|NCT04181788|564837562|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
156476206|NCT04181788|564837563|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
156476207|NCT04181788|564837558|FG000|FOLLOW-UP|Other unspecified|0|||
156476208|NCT04181788|564837559|FG001|FOLLOW-UP|Other unspecified|1|||
156476209|NCT04181788|564837560|FG002|FOLLOW-UP|Other unspecified|0|||
156476210|NCT04181788|564837561|FG003|FOLLOW-UP|Other unspecified|0|||
156476211|NCT04181788|564837562|FG004|FOLLOW-UP|Other unspecified|0|||
156476212|NCT04181788|564837563|FG005|FOLLOW-UP|Other unspecified|3|||
156476213|NCT04181788|564837558|FG000|FOLLOW-UP|Ongoing|0|||
156476214|NCT04181788|564837559|FG001|FOLLOW-UP|Ongoing|0|||
156476215|NCT04181788|564837560|FG002|FOLLOW-UP|Ongoing|1|||
156476216|NCT04181788|564837561|FG003|FOLLOW-UP|Ongoing|3|||
156476217|NCT04181788|564837562|FG004|FOLLOW-UP|Ongoing|2|||
156863157|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156476218|NCT04181788|564837563|FG005|FOLLOW-UP|Ongoing|2|||
156476219|NCT04937504|564837564|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
156476220|NCT04937504|564837565|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
156476221|NCT04937504|564837564|FG000|9 Months Assessment|Lost to Follow-up|3|||
156476222|NCT04937504|564837565|FG001|9 Months Assessment|Lost to Follow-up|2|||
156476223|NCT04535414|564837566|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
156476224|NCT04535414|564837567|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
156476225|NCT04535414|564837566|FG000|Overall Study|Cancelled appointment|1|||
156476226|NCT04535414|564837567|FG001|Overall Study|Cancelled appointment|0|||
156476227|NCT04535414|564837566|FG000|Overall Study|cancelled - food in stomach|2|||
156476228|NCT04535414|564837567|FG001|Overall Study|cancelled - food in stomach|0|||
156476229|NCT04535414|564837566|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
156542583|NCT02325219|565081208|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
156542584|NCT02325219|565081209|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
156542585|NCT02325219|565081205|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
156542586|NCT02325219|565081206|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
156542587|NCT02325219|565081207|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
156542588|NCT02325219|565081208|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
156542589|NCT02325219|565081209|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
156542590|NCT02257372|565081210|FG000|Overall Study|Adverse Event|3|||
156542591|NCT02257372|565081211|FG001|Overall Study|Adverse Event|7|||
156542592|NCT02257372|565081210|FG000|Overall Study|Lack of Efficacy|2|||
156542593|NCT02257372|565081211|FG001|Overall Study|Lack of Efficacy|1|||
156542594|NCT02257372|565081210|FG000|Overall Study|Protocol Violation|1|||
156542595|NCT02257372|565081211|FG001|Overall Study|Protocol Violation|1|||
156542596|NCT02257372|565081210|FG000|Overall Study|Lost to Follow-up|0|||
156542597|NCT02257372|565081211|FG001|Overall Study|Lost to Follow-up|1|||
156542598|NCT02257372|565081210|FG000|Overall Study|Withdrew consent|1|||
156542599|NCT02257372|565081211|FG001|Overall Study|Withdrew consent|0|||
156542600|NCT02187172|565081214|FG000|Overall Study|Lost to Follow-up|1|||
156542601|NCT02187172|565081215|FG001|Overall Study|Lost to Follow-up|2|||
156542602|NCT02187172|565081214|FG000|Overall Study|Lack of Efficacy|1|||
156542603|NCT02187172|565081215|FG001|Overall Study|Lack of Efficacy|2|||
156542604|NCT02187172|565081214|FG000|Overall Study|Adverse Event|0|||
156542605|NCT02187172|565081215|FG001|Overall Study|Adverse Event|1|||
156542606|NCT02187172|565081214|FG000|Overall Study|Physician Decision|1|||
156542607|NCT02187172|565081215|FG001|Overall Study|Physician Decision|1|||
156542608|NCT00880399|565081216|FG000|Overall Study|Adverse Event|4|||
156542609|NCT00880399|565081217|FG001|Overall Study|Adverse Event|6|||
156542610|NCT00880399|565081218|FG002|Overall Study|Adverse Event|5|||
156542611|NCT00880399|565081216|FG000|Overall Study|Lack of Efficacy|1|||
156542612|NCT00880399|565081217|FG001|Overall Study|Lack of Efficacy|4|||
156542613|NCT00880399|565081218|FG002|Overall Study|Lack of Efficacy|2|||
156542614|NCT00880399|565081216|FG000|Overall Study|Protocol Violation|4|||
156476230|NCT04535414|564837567|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
156476231|NCT04535414|564837566|FG000|Overall Study|Withdrawal by Subject|0|||
156476232|NCT04535414|564837567|FG001|Overall Study|Withdrawal by Subject|1|||
156476233|NCT04186247|564837568|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
156476234|NCT04186247|564837569|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
156476235|NCT04186247|564837570|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
156476236|NCT04186247|564837571|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
156476237|NCT04186247|564837572|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
156476238|NCT03662659|564837573|FG000|Pre-treatment|Participant no longer met study criteria|1|||
156476239|NCT03662659|564837574|FG001|Pre-treatment|Participant no longer met study criteria|1|||
156476240|NCT03662659|564837573|FG000|Pre-treatment|Other reasons|1|||
156476241|NCT03662659|564837574|FG001|Pre-treatment|Other reasons|0|||
156476242|NCT03662659|564837573|FG000|Treatment|Completed Treatment|0|||
156476243|NCT03662659|564837574|FG001|Treatment|Completed Treatment|2|||
156476244|NCT03662659|564837573|FG000|Treatment|Disease Progression|85|||
156476245|NCT03662659|564837574|FG001|Treatment|Disease Progression|97|||
156476246|NCT03662659|564837573|FG000|Treatment|Study Drug Toxicity|19|||
156476247|NCT03662659|564837574|FG001|Treatment|Study Drug Toxicity|9|||
156476248|NCT03662659|564837573|FG000|Treatment|Death|11|||
156476249|NCT03662659|564837574|FG001|Treatment|Death|9|||
156476250|NCT03662659|564837573|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
156476251|NCT03662659|564837574|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
156476252|NCT03662659|564837573|FG000|Treatment|Withdrawal by Subject|1|||
156476253|NCT03662659|564837574|FG001|Treatment|Withdrawal by Subject|1|||
156476254|NCT03662659|564837573|FG000|Treatment|Poor/Non-compliance|1|||
156476255|NCT03662659|564837574|FG001|Treatment|Poor/Non-compliance|0|||
156476256|NCT03662659|564837573|FG000|Treatment|Participant no longer meets study criteria|1|||
156476257|NCT03662659|564837574|FG001|Treatment|Participant no longer meets study criteria|0|||
156476258|NCT03662659|564837573|FG000|Treatment|Other reasons|10|||
156476259|NCT03662659|564837574|FG001|Treatment|Other reasons|8|||
156542615|NCT00880399|565081217|FG001|Overall Study|Protocol Violation|4|||
156542616|NCT00880399|565081218|FG002|Overall Study|Protocol Violation|6|||
156542617|NCT00880399|565081216|FG000|Overall Study|Study closed/terminated|3|||
156542618|NCT00880399|565081217|FG001|Overall Study|Study closed/terminated|7|||
156863158|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
156863159|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156476260|NCT03662659|564837573|FG000|Treatment|Administrative reasons by sponsor|1|||
156476261|NCT03662659|564837574|FG001|Treatment|Administrative reasons by sponsor|0|||
156863160|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156476262|NCT03662659|564837573|FG000|Treatment|maximum clinical benefit|0|||
156542619|NCT00880399|565081218|FG002|Overall Study|Study closed/terminated|4|||
156542620|NCT00880399|565081216|FG000|Overall Study|Lost to Follow-up|8|||
156542621|NCT00880399|565081217|FG001|Overall Study|Lost to Follow-up|5|||
156542622|NCT00880399|565081218|FG002|Overall Study|Lost to Follow-up|3|||
156863161|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156863162|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863163|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863164|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
156863165|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
156863166|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863167|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863168|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863169|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863170|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863171|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
156863172|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
156863173|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863174|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863175|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863176|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863177|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863178|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863179|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
156863180|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863181|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863182|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863183|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863184|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863185|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863186|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
156863187|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863188|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863189|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863190|NCT02718898|566256647|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
156344011|NCT02854631|564358537|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
156344012|NCT02854631|564358536|FG000|Overall Study|Protocol Violation|0|||
156344013|NCT02854631|564358537|FG001|Overall Study|Protocol Violation|1|||
156344014|NCT02854631|564358536|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
156344015|NCT02854631|564358537|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
156344016|NCT02854631|564358536|FG000|Overall Study|Lost to Follow-up|4|||
156344017|NCT02854631|564358537|FG001|Overall Study|Lost to Follow-up|2|||
156344018|NCT02862171|564358538|FG000|Overall Study|Death|1|||
156344019|NCT02862171|564358538|FG000|Overall Study|Lost to Follow-up|13|||
156344020|NCT02862171|564358538|FG000|Overall Study|Withdrawal by Subject|57|||
156344021|NCT02862171|564358538|FG000|Overall Study|Non-compliance|4|||
156344022|NCT02862171|564358538|FG000|Overall Study|HIV-1 seroconversion|18|||
156344023|NCT03930797|564358539|FG000|Overall Study|Lost to Follow-up|3|||
156344024|NCT03930797|564358540|FG001|Overall Study|Lost to Follow-up|10|||
156344025|NCT00662012|564358541|FG000|Overall Study|Lost to Follow-up|85|||
156344026|NCT00662012|564358541|FG000|Overall Study|Death|1|||
156344027|NCT00662012|564358541|FG000|Overall Study|Withdrawal by Subject|1|||
156344028|NCT02144012|564358544|FG000|Overall Study|Adverse Event|1|||
156344029|NCT02144012|564358545|FG001|Overall Study|Adverse Event|0|||
156344030|NCT02144012|564358544|FG000|Overall Study|Death|1|||
156344031|NCT02144012|564358545|FG001|Overall Study|Death|0|||
156344032|NCT02144012|564358544|FG000|Overall Study|Withdrawal by Subject|11|||
156344033|NCT02144012|564358545|FG001|Overall Study|Withdrawal by Subject|3|||
156344034|NCT02144012|564358544|FG000|Overall Study|Study Terminated by Sponsor|18|||
156344035|NCT02144012|564358545|FG001|Overall Study|Study Terminated by Sponsor|12|||
156344036|NCT02144012|564358544|FG000|Overall Study|Other|3|||
156344037|NCT02144012|564358545|FG001|Overall Study|Other|0|||
156344038|NCT00317356|564358546|FG000|Overall Study|Adverse Event|0|||
156344039|NCT00317356|564358547|FG001|Overall Study|Adverse Event|0|||
156344040|NCT00317356|564358548|FG002|Overall Study|Adverse Event|1|||
156476263|NCT03662659|564837574|FG001|Treatment|maximum clinical benefit|2|||
156476264|NCT04369664|564840133|FG000|Overall Study|Physician Decision|1|||
156344041|NCT00317356|564358549|FG003|Overall Study|Adverse Event|0|||
156344042|NCT00317356|564358546|FG000|Overall Study|Lack of Efficacy|1|||
156344043|NCT00317356|564358547|FG001|Overall Study|Lack of Efficacy|1|||
156344044|NCT00317356|564358548|FG002|Overall Study|Lack of Efficacy|0|||
156344045|NCT00317356|564358549|FG003|Overall Study|Lack of Efficacy|3|||
156344046|NCT00317356|564358546|FG000|Overall Study|Physician Decision|0|||
156344047|NCT00317356|564358547|FG001|Overall Study|Physician Decision|1|||
156344048|NCT00317356|564358548|FG002|Overall Study|Physician Decision|0|||
156344049|NCT00317356|564358549|FG003|Overall Study|Physician Decision|0|||
156476265|NCT04369664|564840134|FG001|Overall Study|Physician Decision|0|||
156476266|NCT01668355|564840137|FG000|Overall Study|Death|3|||
156476267|NCT01668355|564840138|FG001|Overall Study|Death|1|||
156476268|NCT01668355|564840137|FG000|Overall Study|Withdrawal by Subject|6|||
156476269|NCT01668355|564840138|FG001|Overall Study|Withdrawal by Subject|1|||
156476270|NCT00535626|564840139|FG000|Overall Study|Death|15|||
156863191|NCT02718898|566256648|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
156863192|NCT02718898|566256649|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
156863193|NCT02718898|566256650|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
156863194|NCT02718898|566256651|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
156863195|NCT02718898|566256652|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
156863196|NCT02718898|566256653|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
156863197|NCT02718898|566256647|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
156863198|NCT02718898|566256648|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
156863199|NCT02718898|566256649|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
156344050|NCT00753415|564358550|FG000|Part A|Disease progression|1|||
156344051|NCT00753415|564358551|FG001|Part A|Disease progression|0|||
156344052|NCT00753415|564358552|FG002|Part A|Disease progression|1|||
156344053|NCT00753415|564358553|FG003|Part A|Disease progression|2|||
156344054|NCT00753415|564358554|FG004|Part A|Disease progression|0|||
156344055|NCT00753415|564358555|FG005|Part A|Disease progression|0|||
156344056|NCT00753415|564358556|FG006|Part A|Disease progression|0|||
156344057|NCT00753415|564358557|FG007|Part A|Disease progression|0|||
156344058|NCT00753415|564358558|FG008|Part A|Disease progression|0|||
156344059|NCT00753415|564358559|FG009|Part A|Disease progression|0|||
156344060|NCT00753415|564358550|FG000|Part A|Withdrawal by Subject|0|||
156344061|NCT00753415|564358551|FG001|Part A|Withdrawal by Subject|0|||
156344062|NCT00753415|564358552|FG002|Part A|Withdrawal by Subject|1|||
156344063|NCT00753415|564358553|FG003|Part A|Withdrawal by Subject|0|||
156344064|NCT00753415|564358554|FG004|Part A|Withdrawal by Subject|0|||
156344065|NCT00753415|564358555|FG005|Part A|Withdrawal by Subject|0|||
156344066|NCT00753415|564358556|FG006|Part A|Withdrawal by Subject|0|||
156344067|NCT00753415|564358557|FG007|Part A|Withdrawal by Subject|0|||
156344068|NCT00753415|564358558|FG008|Part A|Withdrawal by Subject|0|||
156344069|NCT00753415|564358559|FG009|Part A|Withdrawal by Subject|0|||
156344070|NCT00753415|564358550|FG000|Part B|Lost to Follow-up|0|||
156344071|NCT00753415|564358551|FG001|Part B|Lost to Follow-up|0|||
156344072|NCT00753415|564358552|FG002|Part B|Lost to Follow-up|0|||
156344073|NCT00753415|564358553|FG003|Part B|Lost to Follow-up|0|||
156344074|NCT00753415|564358554|FG004|Part B|Lost to Follow-up|0|||
156344075|NCT00753415|564358555|FG005|Part B|Lost to Follow-up|0|||
156344076|NCT00753415|564358556|FG006|Part B|Lost to Follow-up|0|||
156344077|NCT00753415|564358557|FG007|Part B|Lost to Follow-up|1|||
156344078|NCT00753415|564358558|FG008|Part B|Lost to Follow-up|1|||
156344079|NCT00753415|564358559|FG009|Part B|Lost to Follow-up|0|||
156344080|NCT00753415|564358550|FG000|Part B|Disease progression|0|||
156344081|NCT00753415|564358551|FG001|Part B|Disease progression|0|||
156344082|NCT00753415|564358552|FG002|Part B|Disease progression|0|||
156344083|NCT00753415|564358553|FG003|Part B|Disease progression|0|||
156344084|NCT00753415|564358554|FG004|Part B|Disease progression|0|||
156344085|NCT00753415|564358555|FG005|Part B|Disease progression|0|||
156344086|NCT00753415|564358556|FG006|Part B|Disease progression|0|||
156344087|NCT00753415|564358557|FG007|Part B|Disease progression|0|||
156344088|NCT00753415|564358558|FG008|Part B|Disease progression|2|||
156344089|NCT00753415|564358559|FG009|Part B|Disease progression|1|||
156344090|NCT00598832|564358560|FG000|Overall Study|Lack of Efficacy|3|||
156476271|NCT00535626|564840139|FG000|Overall Study|Lost to Follow-up|29|||
156476272|NCT00535626|564840139|FG000|Overall Study|Withdrawal by Subject|20|||
156476273|NCT00535626|564840139|FG000|Overall Study|Removal/revision of study component|8|||
156476274|NCT00535626|564840139|FG000|Overall Study|Subject terminated|31|||
156476275|NCT00535626|564840139|FG000|Overall Study|Unable to return|2|||
156476276|NCT02830893|564840140|FG000|Overall Study|Relocation to out of the country|1|||
156476277|NCT02830893|564840141|FG001|Overall Study|Relocation to out of the country|0|||
156476278|NCT02830893|564840140|FG000|Overall Study|Lost to Follow-up|0|||
156476279|NCT02830893|564840141|FG001|Overall Study|Lost to Follow-up|2|||
156476280|NCT02830893|564840140|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
156476281|NCT02830893|564840141|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
156344091|NCT00598832|564358561|FG001|Overall Study|Lack of Efficacy|7|||
156344092|NCT00598832|564358560|FG000|Overall Study|Adverse Event|6|||
156344093|NCT00598832|564358561|FG001|Overall Study|Adverse Event|2|||
156344094|NCT00598832|564358560|FG000|Overall Study|Withdrawal by Subject|25|||
156344095|NCT00598832|564358561|FG001|Overall Study|Withdrawal by Subject|36|||
156344096|NCT00598832|564358560|FG000|Overall Study|Protocol Violation|0|||
156344097|NCT00598832|564358561|FG001|Overall Study|Protocol Violation|2|||
156344098|NCT00598832|564358560|FG000|Overall Study|Lost to Follow-up|24|||
156344099|NCT00598832|564358561|FG001|Overall Study|Lost to Follow-up|29|||
156344100|NCT00598832|564358560|FG000|Overall Study|Pregnancy|2|||
156344101|NCT00598832|564358561|FG001|Overall Study|Pregnancy|2|||
156863200|NCT02718898|566256650|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
156863201|NCT02718898|566256651|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
156863202|NCT02718898|566256652|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
156863203|NCT02718898|566256653|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
156863204|NCT02718898|566256647|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863205|NCT02718898|566256648|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863206|NCT02718898|566256649|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863207|NCT02718898|566256650|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863208|NCT02718898|566256651|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863209|NCT02718898|566256652|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
156863210|NCT02718898|566256653|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
156863211|NCT04011540|566256654|FG000|Overall Study|Lost to Follow-up|9|||
156863212|NCT04011540|566256655|FG001|Overall Study|Lost to Follow-up|6|||
156863213|NCT01339832|566256656|FG000|Overall Study|Lost to Follow-up|3|||
156863214|NCT01339832|566256656|FG000|Overall Study|Death|11|||
156863215|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
156863216|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
156863217|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
156863218|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
156863219|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
156863220|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
156863221|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
156863222|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
156863223|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
156863224|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
156863225|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
156863226|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
156863227|NCT01668784|566256671|FG000|Treatment Period|Disease Progression|316|||
156863228|NCT01668784|566256672|FG001|Treatment Period|Disease Progression|293|||
156863229|NCT01668784|566256671|FG000|Treatment Period|Study Drug Toxicity|46|||
156863230|NCT01668784|566256672|FG001|Treatment Period|Study Drug Toxicity|53|||
156863231|NCT01668784|566256671|FG000|Treatment Period|Death|1|||
156863232|NCT01668784|566256672|FG001|Treatment Period|Death|1|||
156863233|NCT01668784|566256671|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
156863234|NCT01668784|566256672|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
156863235|NCT01668784|566256671|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
156863236|NCT01668784|566256672|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
156863237|NCT01668784|566256671|FG000|Treatment Period|Withdrawal by Subject|5|||
156863238|NCT01668784|566256672|FG001|Treatment Period|Withdrawal by Subject|3|||
156863239|NCT01668784|566256671|FG000|Treatment Period|Maximal Clinical Benefit|3|||
156863240|NCT01668784|566256672|FG001|Treatment Period|Maximal Clinical Benefit|3|||
156863241|NCT01668784|566256671|FG000|Treatment Period|Other|2|||
156863242|NCT01668784|566256672|FG001|Treatment Period|Other|8|||
156863243|NCT01668784|566256671|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
156863244|NCT01668784|566256672|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
156863245|NCT02761330|566256673|FG000|Treatment Week 1|Withdrawal by Subject|0|||
156863246|NCT02761330|566256674|FG001|Treatment Week 1|Withdrawal by Subject|0|||
156863247|NCT02761330|566256675|FG002|Treatment Week 1|Withdrawal by Subject|0|||
156863248|NCT02761330|566256676|FG003|Treatment Week 1|Withdrawal by Subject|1|||
156863249|NCT02761330|566256677|FG004|Treatment Week 1|Withdrawal by Subject|0|||
156863250|NCT02761330|566256678|FG005|Treatment Week 1|Withdrawal by Subject|1|||
156863251|NCT05386329|566256679|FG000|Overall Study|Lost to Follow-up|3|||
156863252|NCT03341299|566256682|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
156863253|NCT03341299|566256683|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
156863254|NCT03341299|566256684|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
156863255|NCT03341299|566256685|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
156863256|NCT05967260|566256686|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
156863257|NCT05967260|566256687|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
156863258|NCT05565742|566256688|FG000|Overall Study|Withdrawal by Subject|0|||
156863259|NCT05565742|566256689|FG001|Overall Study|Withdrawal by Subject|0|||
156863260|NCT05565742|566256690|FG002|Overall Study|Withdrawal by Subject|2|||
156863261|NCT05565742|566256691|FG003|Overall Study|Withdrawal by Subject|2|||
156863262|NCT05565742|566256692|FG004|Overall Study|Withdrawal by Subject|2|||
156542623|NCT00880399|565081216|FG000|Overall Study|Physician Decision|5|||
156542624|NCT00880399|565081217|FG001|Overall Study|Physician Decision|0|||
156542625|NCT00880399|565081218|FG002|Overall Study|Physician Decision|3|||
156542626|NCT00880399|565081216|FG000|Overall Study|Withdrawal by Subject|6|||
156542627|NCT00880399|565081217|FG001|Overall Study|Withdrawal by Subject|3|||
156542628|NCT00880399|565081218|FG002|Overall Study|Withdrawal by Subject|3|||
156542629|NCT03709654|565081224|FG000|Overall Study|Lost to Follow-up|1|||
156542630|NCT03709654|565081225|FG001|Overall Study|Lost to Follow-up|1|||
156542631|NCT03709654|565081224|FG000|Overall Study|Withdrawal by Subject|1|||
156542632|NCT03709654|565081225|FG001|Overall Study|Withdrawal by Subject|1|||
156542633|NCT03709654|565081224|FG000|Overall Study|Adverse Event|1|||
156542634|NCT03709654|565081225|FG001|Overall Study|Adverse Event|0|||
156542635|NCT01902966|565081226|FG000|Overall Study|Death|1|||
156542636|NCT01902966|565081226|FG000|Overall Study|Physician Decision|1|||
156542637|NCT01902966|565081226|FG000|Overall Study|Withdrawal by Subject|1|||
156542638|NCT01549275|565081227|FG000|Overall Study|Lost to Follow-up|1|||
156542639|NCT01549275|565081228|FG001|Overall Study|Lost to Follow-up|0|||
156863263|NCT05565742|566256688|FG000|Overall Study|Death|1|||
156863264|NCT05565742|566256689|FG001|Overall Study|Death|0|||
156863265|NCT05565742|566256690|FG002|Overall Study|Death|0|||
156863266|NCT05565742|566256691|FG003|Overall Study|Death|0|||
156863267|NCT05565742|566256692|FG004|Overall Study|Death|0|||
156863268|NCT05565742|566256688|FG000|Overall Study|Participant Travelled Abroad|0|||
156863269|NCT05565742|566256689|FG001|Overall Study|Participant Travelled Abroad|0|||
156863270|NCT05565742|566256690|FG002|Overall Study|Participant Travelled Abroad|0|||
156863271|NCT05565742|566256691|FG003|Overall Study|Participant Travelled Abroad|0|||
156863272|NCT05565742|566256692|FG004|Overall Study|Participant Travelled Abroad|1|||
156863273|NCT04163341|566256693|FG000|Overall Study|Withdrawal by Subject|2|||
156863274|NCT04163341|566256694|FG001|Overall Study|Withdrawal by Subject|0|||
156863275|NCT04163341|566256693|FG000|Overall Study|Lost to Follow-up|3|||
156863276|NCT04163341|566256694|FG001|Overall Study|Lost to Follow-up|4|||
156863277|NCT01615939|566258593|FG000|Overall Study|Lost to Follow-up|5|||
156863278|NCT01615939|566258594|FG001|Overall Study|Lost to Follow-up|0|||
156863279|NCT01586364|566258598|FG000|Overall Study|Withdrawal by Subject|40|||
156863280|NCT01586364|566258598|FG000|Overall Study|Adverse Event|37|||
156863281|NCT01586364|566258598|FG000|Overall Study|Lost to Follow-up|17|||
156863282|NCT01586364|566258598|FG000|Overall Study|Protocol Violation|16|||
156863283|NCT01586364|566258598|FG000|Overall Study|Lack of Efficacy|1|||
156863284|NCT01586364|566258598|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
156863285|NCT01586364|566258598|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
156863286|NCT01586364|566258598|FG000|Overall Study|Other-Site closure due to PI illness|1|||
156863287|NCT01586364|566258598|FG000|Overall Study|Other-PI discretion, site closing|2|||
156863288|NCT01586364|566258598|FG000|Overall Study|Other-Not specified|1|||
156863289|NCT02121535|566258599|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
156863290|NCT02121535|566258600|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
156863291|NCT02121535|566258599|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
156863292|NCT02121535|566258600|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
156863293|NCT04944992|566258601|FG000|Overall Study|Lost to Follow-up|1|||
156863294|NCT04944992|566258602|FG001|Overall Study|Lost to Follow-up|1|||
156863295|NCT04944992|566258601|FG000|Overall Study|Physician Decision|1|||
156863296|NCT04944992|566258602|FG001|Overall Study|Physician Decision|0|||
156863297|NCT04944992|566258601|FG000|Overall Study|Withdrawal by Subject|6|||
156863298|NCT04944992|566258602|FG001|Overall Study|Withdrawal by Subject|1|||
156863299|NCT00091949|566258603|FG000|Overall Study|Withdrawal by Subject|117|||
156863300|NCT00091949|566258604|FG001|Overall Study|Withdrawal by Subject|110|||
156863301|NCT00091949|566258603|FG000|Overall Study|Lost to Follow-up|58|||
156863302|NCT00091949|566258604|FG001|Overall Study|Lost to Follow-up|41|||
156863303|NCT05366738|566258606|FG000|Overall Study|Adverse Event|0|||
156863304|NCT05366738|566258607|FG001|Overall Study|Adverse Event|1|||
156863305|NCT05366738|566258608|FG002|Overall Study|Adverse Event|0|||
156863306|NCT00335777|566258609|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
156863307|NCT00335777|566258609|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
156863308|NCT00335777|566258609|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
156863309|NCT00335777|566258609|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
156863310|NCT00335777|566258609|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
156863311|NCT00535496|566258616|FG000|Overall Study|Lost to Follow-up|0|||
156863312|NCT00535496|566258617|FG001|Overall Study|Lost to Follow-up|1|||
156863313|NCT00535496|566258618|FG002|Overall Study|Lost to Follow-up|0|||
156863314|NCT00535496|566258619|FG003|Overall Study|Lost to Follow-up|0|||
156863315|NCT00535496|566258616|FG000|Overall Study|Not treated with sugammadex|0|||
156542640|NCT01040351|565081229|FG000|Overall Study|poor ovarian response|1|||
156542641|NCT01040351|565081230|FG001|Overall Study|poor ovarian response|2|||
156542642|NCT02969187|565081240|FG000|Overall Study|Physician Decision|12|||
156542643|NCT02969187|565081241|FG001|Overall Study|Physician Decision|13|||
156542644|NCT04329702|565081242|FG000|Overall Study|illness|3|||
156542645|NCT04329702|565081243|FG001|Overall Study|illness|4|||
156863316|NCT00535496|566258617|FG001|Overall Study|Not treated with sugammadex|1|||
156863317|NCT00535496|566258618|FG002|Overall Study|Not treated with sugammadex|0|||
156863318|NCT00535496|566258619|FG003|Overall Study|Not treated with sugammadex|0|||
156863319|NCT05024032|566258622|FG000|Overall Study|Withdrawal by Subject|0|||
156863320|NCT05024032|566258623|FG001|Overall Study|Withdrawal by Subject|3|||
156863321|NCT05024032|566258624|FG002|Overall Study|Withdrawal by Subject|4|||
156476282|NCT01277302|564840142|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
156476283|NCT01277302|564840143|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
156476284|NCT01277302|564840144|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
156476285|NCT01277302|564840142|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
156476286|NCT01277302|564840143|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
156476287|NCT01277302|564840144|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
156476288|NCT01277302|564840142|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
156476289|NCT01277302|564840143|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
156476290|NCT01277302|564840144|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
156476291|NCT01277302|564840142|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
156476292|NCT01277302|564840143|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
156476293|NCT01277302|564840144|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
156476294|NCT01277302|564840142|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
156476295|NCT01277302|564840143|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
156476296|NCT01277302|564840144|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
156476297|NCT01277302|564840142|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
156476298|NCT01277302|564840143|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
156476299|NCT01277302|564840144|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
156476300|NCT01277302|564840142|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
156476301|NCT01277302|564840143|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
156476302|NCT01277302|564840144|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
156476303|NCT01277302|564840142|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
156476304|NCT01277302|564840143|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
156476305|NCT01277302|564840144|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
156476306|NCT01277302|564840142|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
156476307|NCT01277302|564840143|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
156476308|NCT01277302|564840144|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
156476309|NCT02710669|564840147|FG000|Overall Study|Physician Decision|2|||
156863322|NCT05024032|566258622|FG000|Overall Study|Adverse Event|0|||
156863323|NCT05024032|566258623|FG001|Overall Study|Adverse Event|1|||
156863324|NCT05024032|566258624|FG002|Overall Study|Adverse Event|0|||
156863325|NCT05024032|566258622|FG000|Overall Study|Protocol Deviation|1|||
156863326|NCT05024032|566258623|FG001|Overall Study|Protocol Deviation|0|||
156863327|NCT05024032|566258624|FG002|Overall Study|Protocol Deviation|0|||
156863328|NCT01209689|566258625|FG000|Overall Study|Insufficient Therapeutic Response|7|||
156863329|NCT01209689|566258626|FG001|Overall Study|Insufficient Therapeutic Response|2|||
156863330|NCT01209689|566258625|FG000|Overall Study|Refused Treatment|8|||
156863331|NCT01209689|566258626|FG001|Overall Study|Refused Treatment|3|||
156863332|NCT01209689|566258625|FG000|Overall Study|Adverse Event|4|||
156863333|NCT01209689|566258626|FG001|Overall Study|Adverse Event|0|||
156863334|NCT01209689|566258625|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
156863335|NCT01209689|566258626|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
156863336|NCT01209689|566258625|FG000|Overall Study|Failure to Return|3|||
156476310|NCT02710669|564840148|FG001|Overall Study|Physician Decision|1|||
156476311|NCT02710669|564840149|FG002|Overall Study|Physician Decision|0|||
156476312|NCT02710669|564840147|FG000|Overall Study|Institutional delays (including COVID)|2|||
156476313|NCT02710669|564840148|FG001|Overall Study|Institutional delays (including COVID)|2|||
156476314|NCT02710669|564840149|FG002|Overall Study|Institutional delays (including COVID)|0|||
156476315|NCT02710669|564840147|FG000|Overall Study|arrived in afib/aflutter|10|||
156476316|NCT02710669|564840148|FG001|Overall Study|arrived in afib/aflutter|8|||
156476317|NCT02710669|564840149|FG002|Overall Study|arrived in afib/aflutter|2|||
156476318|NCT01567852|564840150|FG000|Overall Study|Withdrawal by Subject|3|||
156476319|NCT01567852|564840151|FG001|Overall Study|Withdrawal by Subject|6|||
156476320|NCT01567852|564840150|FG000|Overall Study|ECT discontinued|1|||
156476321|NCT01567852|564840151|FG001|Overall Study|ECT discontinued|1|||
156476322|NCT03332589|564840152|FG000|Overall Study|Lack of Efficacy|2|||
156476323|NCT03332589|564840153|FG001|Overall Study|Lack of Efficacy|0|||
156476324|NCT03332589|564840154|FG002|Overall Study|Lack of Efficacy|0|||
156476325|NCT03332589|564840152|FG000|Overall Study|Adverse Event|1|||
156476326|NCT03332589|564840153|FG001|Overall Study|Adverse Event|0|||
156476327|NCT03332589|564840154|FG002|Overall Study|Adverse Event|0|||
156476328|NCT03332589|564840152|FG000|Overall Study|Death|1|||
156476329|NCT03332589|564840153|FG001|Overall Study|Death|0|||
156476330|NCT03332589|564840154|FG002|Overall Study|Death|0|||
156863337|NCT01209689|566258626|FG001|Overall Study|Failure to Return|0|||
156863338|NCT01209689|566258625|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
156476331|NCT04633200|564840155|FG000|Overall Study|Lost to Follow-up|3|||
156476332|NCT04633200|564840156|FG001|Overall Study|Lost to Follow-up|5|||
156476333|NCT03690219|564840157|FG000|Overall Study|no injuries|9|||
156476334|NCT03690219|564840158|FG001|Overall Study|no injuries|20|||
156476335|NCT03690219|564840157|FG000|Overall Study|missing information|7|||
156476336|NCT03690219|564840158|FG001|Overall Study|missing information|7|||
156476337|NCT01523392|564840159|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156476338|NCT01523392|564840160|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156476339|NCT01523392|564840159|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
156476340|NCT01523392|564840160|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
156476341|NCT01523392|564840159|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
156476342|NCT01523392|564840160|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
156476343|NCT04809623|564840161|FG000|Overall Study|Study Terminated by Sponsor|1|||
156476344|NCT04809623|564840162|FG001|Overall Study|Study Terminated by Sponsor|0|||
156476345|NCT02002689|564840163|FG000|Overall Study|Disease Progression|7|||
156476346|NCT02002689|564840163|FG000|Overall Study|Adverse Event|3|||
156344102|NCT00598832|564358560|FG000|Overall Study|Physician Decision|1|||
156344103|NCT00598832|564358561|FG001|Overall Study|Physician Decision|4|||
156344104|NCT00598832|564358560|FG000|Overall Study|Non compliance|1|||
156476347|NCT02354417|564840164|FG000|Overall Study|Physician Decision|1|||
156476348|NCT00486954|564840167|FG000|Pilot Part|Adverse Event|4|||
156476349|NCT00486954|564840168|FG001|Pilot Part|Adverse Event|0|||
156476350|NCT00486954|564840169|FG002|Pilot Part|Adverse Event|5|||
156476351|NCT00486954|564840170|FG003|Pilot Part|Adverse Event|0|||
156476352|NCT00486954|564840171|FG004|Pilot Part|Adverse Event|0|||
156476353|NCT00486954|564840167|FG000|Pilot Part|Disease Progression|2|||
156476354|NCT00486954|564840168|FG001|Pilot Part|Disease Progression|0|||
156476355|NCT00486954|564840169|FG002|Pilot Part|Disease Progression|1|||
156476356|NCT00486954|564840170|FG003|Pilot Part|Disease Progression|0|||
156476357|NCT00486954|564840171|FG004|Pilot Part|Disease Progression|0|||
156476358|NCT00486954|564840167|FG000|Randomized Part|Lost to Follow-up|0|||
156344105|NCT00598832|564358561|FG001|Overall Study|Non compliance|0|||
156476359|NCT00486954|564840168|FG001|Randomized Part|Lost to Follow-up|0|||
156476360|NCT00486954|564840169|FG002|Randomized Part|Lost to Follow-up|0|||
156476361|NCT00486954|564840170|FG003|Randomized Part|Lost to Follow-up|0|||
156476362|NCT00486954|564840171|FG004|Randomized Part|Lost to Follow-up|1|||
156476363|NCT00486954|564840167|FG000|Randomized Part|Withdrawal by Subject|0|||
156476364|NCT00486954|564840168|FG001|Randomized Part|Withdrawal by Subject|0|||
156476365|NCT00486954|564840169|FG002|Randomized Part|Withdrawal by Subject|0|||
156476366|NCT00486954|564840170|FG003|Randomized Part|Withdrawal by Subject|1|||
156476367|NCT00486954|564840171|FG004|Randomized Part|Withdrawal by Subject|0|||
156476368|NCT00486954|564840167|FG000|Randomized Part|Sponsor Terminated Study|0|||
156476369|NCT00486954|564840168|FG001|Randomized Part|Sponsor Terminated Study|0|||
156476370|NCT00486954|564840169|FG002|Randomized Part|Sponsor Terminated Study|0|||
156476371|NCT00486954|564840170|FG003|Randomized Part|Sponsor Terminated Study|19|||
156476372|NCT00486954|564840171|FG004|Randomized Part|Sponsor Terminated Study|13|||
156476373|NCT03316170|564840172|FG000|Overall Study|Death|1|||
156476374|NCT03316170|564840173|FG001|Overall Study|Death|0|||
156476375|NCT03316170|564840172|FG000|Overall Study|Lost to Follow-up|6|||
156476376|NCT03316170|564840173|FG001|Overall Study|Lost to Follow-up|7|||
156476377|NCT02935673|564840174|FG000|Overall Study|Adverse Event|0|||
156476378|NCT02935673|564840175|FG001|Overall Study|Adverse Event|1|||
156476379|NCT02935673|564840176|FG002|Overall Study|Adverse Event|0|||
156476380|NCT02935673|564840174|FG000|Overall Study|Withdrawal by Subject|1|||
156476381|NCT02935673|564840175|FG001|Overall Study|Withdrawal by Subject|2|||
156476382|NCT02935673|564840176|FG002|Overall Study|Withdrawal by Subject|0|||
156476383|NCT00749944|564840177|FG000|Overall Study|Lost to Follow-up|2|||
156476384|NCT00749944|564840178|FG001|Overall Study|Lost to Follow-up|1|||
156476385|NCT00749944|564840177|FG000|Overall Study|Other|1|||
156476386|NCT00749944|564840178|FG001|Overall Study|Other|0|||
156476387|NCT00749944|564840177|FG000|Overall Study|Withdrawal by Subject|2|||
156476388|NCT00749944|564840178|FG001|Overall Study|Withdrawal by Subject|0|||
156476389|NCT02547974|564840179|FG000|Overall Study|Withdrawal by Subject|1|||
156476390|NCT02547974|564840180|FG001|Overall Study|Withdrawal by Subject|0|||
156476391|NCT02547974|564840181|FG002|Overall Study|Withdrawal by Subject|0|||
156476392|NCT02547974|564840182|FG003|Overall Study|Withdrawal by Subject|0|||
156476393|NCT00923078|564840189|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
156476394|NCT00923078|564840190|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
156476395|NCT00923078|564840191|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
156476396|NCT00923078|564840189|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
156476397|NCT00923078|564840190|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
156476398|NCT00923078|564840191|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
156476399|NCT01102426|564840192|FG000|Overall Study|Randomized but not treated|4|||
156476400|NCT01102426|564840193|FG001|Overall Study|Randomized but not treated|1|||
156476401|NCT01102426|564840192|FG000|Overall Study|Adverse Events (treatment-related)|15|||
156476402|NCT01102426|564840193|FG001|Overall Study|Adverse Events (treatment-related)|8|||
156476403|NCT01102426|564840192|FG000|Overall Study|Physician Decision|9|||
156476404|NCT01102426|564840193|FG001|Overall Study|Physician Decision|6|||
156476405|NCT01102426|564840192|FG000|Overall Study|Progressive Disease|85|||
156476406|NCT01102426|564840193|FG001|Overall Study|Progressive Disease|44|||
156542646|NCT04329702|565081244|FG002|Overall Study|illness|0|||
156476407|NCT01102426|564840192|FG000|Overall Study|Adverse Events (unrelated to|9|||
156476408|NCT01102426|564840193|FG001|Overall Study|Adverse Events (unrelated to|1|||
156476409|NCT01102426|564840192|FG000|Overall Study|Patient Refusal|24|||
156476410|NCT01102426|564840193|FG001|Overall Study|Patient Refusal|12|||
156476411|NCT01102426|564840192|FG000|Overall Study|Death (due to adverse events|0|||
156476412|NCT01102426|564840193|FG001|Overall Study|Death (due to adverse events|1|||
156476413|NCT01102426|564840192|FG000|Overall Study|Death (non-related to the study|19|||
156476414|NCT01102426|564840193|FG001|Overall Study|Death (non-related to the study|8|||
156476415|NCT03265132|564840194|FG000|Overall Study|Adverse Event|0|||
156476416|NCT03265132|564840195|FG001|Overall Study|Adverse Event|1|||
156476417|NCT03265132|564840194|FG000|Overall Study|Lack of Efficacy|0|||
156476418|NCT03265132|564840195|FG001|Overall Study|Lack of Efficacy|2|||
156476419|NCT03265132|564840194|FG000|Overall Study|Progressive disease|0|||
156476420|NCT03265132|564840195|FG001|Overall Study|Progressive disease|2|||
156476421|NCT03265132|564840194|FG000|Overall Study|Withdrawal by Subject|0|||
156476422|NCT03265132|564840195|FG001|Overall Study|Withdrawal by Subject|1|||
156476423|NCT00666705|564840201|FG000|Overall Study|Withdrawal by Subject|1|||
156476424|NCT03259568|564840204|FG000|Overall Study|Participant performance was low|3|||
156476425|NCT01976507|564840205|FG000|Overall Study|Adverse Event|6|||
156476426|NCT01976507|564840205|FG000|Overall Study|ablation not done, drug not given|1|||
156476427|NCT02161458|564840208|FG000|Overall Study|Withdrawal by Subject|0|||
156476428|NCT02161458|564840209|FG001|Overall Study|Withdrawal by Subject|4|||
156476429|NCT02161458|564840210|FG002|Overall Study|Withdrawal by Subject|4|||
156476430|NCT02161458|564840211|FG003|Overall Study|Withdrawal by Subject|0|||
156476431|NCT02161458|564840208|FG000|Overall Study|Lost to Follow-up|0|||
156476432|NCT02161458|564840209|FG001|Overall Study|Lost to Follow-up|2|||
156476433|NCT02161458|564840210|FG002|Overall Study|Lost to Follow-up|1|||
156476434|NCT02161458|564840211|FG003|Overall Study|Lost to Follow-up|0|||
156476435|NCT01262456|564840222|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
156476436|NCT01262456|564840223|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
156476437|NCT01262456|564840224|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
156476438|NCT01262456|564840222|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
156476439|NCT01262456|564840223|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
156476440|NCT01262456|564840224|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
156476441|NCT01262456|564840222|FG000|3-Month Double-Blind Period|Adverse Event|6|||
156476442|NCT01262456|564840223|FG001|3-Month Double-Blind Period|Adverse Event|4|||
156476443|NCT01262456|564840224|FG002|3-Month Double-Blind Period|Adverse Event|8|||
156476444|NCT01262456|564840222|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
156476445|NCT01262456|564840223|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
156476446|NCT01262456|564840224|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
156476447|NCT01262456|564840222|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
156476448|NCT01262456|564840223|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
156476449|NCT01262456|564840224|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
156476450|NCT01262456|564840222|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
156476451|NCT01262456|564840223|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
156476452|NCT01262456|564840224|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
156476453|NCT01262456|564840222|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
156476454|NCT01262456|564840223|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
156476455|NCT01262456|564840224|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
156476456|NCT01262456|564840222|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
156476457|NCT01262456|564840223|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
156476458|NCT01262456|564840224|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
156542647|NCT04329702|565081242|FG000|Overall Study|Lost to Follow-up|0|||
156542648|NCT04329702|565081243|FG001|Overall Study|Lost to Follow-up|0|||
156476459|NCT01262456|564840222|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
156476460|NCT01262456|564840223|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
156476461|NCT01262456|564840224|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
156476462|NCT03938272|564840225|FG000|Overall Study|Withdrawal by Subject|1|||
156476463|NCT03938272|564840226|FG001|Overall Study|Withdrawal by Subject|0|||
156476464|NCT03938272|564840225|FG000|Overall Study|Physician Decision|0|||
156476465|NCT03938272|564840226|FG001|Overall Study|Physician Decision|2|||
156476466|NCT03938272|564840225|FG000|Overall Study|Study termination by sponsor|10|||
156476467|NCT03938272|564840226|FG001|Overall Study|Study termination by sponsor|8|||
156542649|NCT04329702|565081244|FG002|Overall Study|Lost to Follow-up|2|||
156542650|NCT04329702|565081242|FG000|Overall Study|Death|0|||
156476468|NCT04821271|564840234|FG000|Period 1|Withdrawal by Subject|2|||
156476469|NCT04821271|564840235|FG001|Period 1|Withdrawal by Subject|0|||
156476470|NCT02521493|564840239|FG000|Overall Study|Death|3|||
156476471|NCT02521493|564840240|FG001|Overall Study|Death|4|||
156476472|NCT02521493|564840241|FG002|Overall Study|Death|1|||
156476473|NCT02521493|564840239|FG000|Overall Study|Physician Decision|19|||
156476474|NCT02521493|564840240|FG001|Overall Study|Physician Decision|1|||
156476475|NCT02521493|564840241|FG002|Overall Study|Physician Decision|2|||
156542651|NCT04329702|565081243|FG001|Overall Study|Death|2|||
156542652|NCT04329702|565081244|FG002|Overall Study|Death|0|||
156476476|NCT02521493|564840239|FG000|Overall Study|Withdrawal by Subject|3|||
156476477|NCT02521493|564840240|FG001|Overall Study|Withdrawal by Subject|0|||
156476478|NCT02521493|564840241|FG002|Overall Study|Withdrawal by Subject|0|||
156476479|NCT02521493|564840239|FG000|Overall Study|Ineligible|0|||
156476480|NCT02521493|564840240|FG001|Overall Study|Ineligible|1|||
156476481|NCT02521493|564840241|FG002|Overall Study|Ineligible|0|||
156476482|NCT02521493|564840239|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
156863339|NCT01209689|566258626|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
156863340|NCT03780244|566258627|FG000|Overall Study|Lost to Follow-up|1|||
156863341|NCT03780244|566258628|FG001|Overall Study|Lost to Follow-up|0|||
156863342|NCT02345070|566258629|FG000|Overall Study|Adverse Event|12|||
156863343|NCT02345070|566258630|FG001|Overall Study|Adverse Event|8|||
156863344|NCT02345070|566258631|FG002|Overall Study|Adverse Event|16|||
156863345|NCT02345070|566258629|FG000|Overall Study|Poor compliance to protocol|2|||
156863346|NCT02345070|566258630|FG001|Overall Study|Poor compliance to protocol|0|||
156863347|NCT02345070|566258631|FG002|Overall Study|Poor compliance to protocol|0|||
156863348|NCT02345070|566258629|FG000|Overall Study|Other than specified above|6|||
156863349|NCT02345070|566258630|FG001|Overall Study|Other than specified above|3|||
156476483|NCT02521493|564840240|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
156542653|NCT00766532|565081245|FG000|Overall Study|Protocol Violation|2|||
156542654|NCT01438489|565081246|FG000|Overall Study|Lost to Follow-up|4|||
156542655|NCT01438489|565081247|FG001|Overall Study|Lost to Follow-up|2|||
156542656|NCT01438489|565081248|FG002|Overall Study|Lost to Follow-up|2|||
156542657|NCT01438489|565081246|FG000|Overall Study|Withdrawal by Subject|11|||
156542658|NCT01438489|565081247|FG001|Overall Study|Withdrawal by Subject|3|||
156542659|NCT01438489|565081248|FG002|Overall Study|Withdrawal by Subject|8|||
156542660|NCT01438489|565081246|FG000|Overall Study|Death|0|||
156542661|NCT01438489|565081247|FG001|Overall Study|Death|0|||
156542662|NCT01438489|565081248|FG002|Overall Study|Death|1|||
156542663|NCT01438489|565081246|FG000|Overall Study|Sponsor decision|4|||
156542664|NCT01438489|565081247|FG001|Overall Study|Sponsor decision|1|||
156542665|NCT01438489|565081248|FG002|Overall Study|Sponsor decision|4|||
156542666|NCT01438489|565081246|FG000|Overall Study|Subject choice/Subject moved|2|||
156542667|NCT01438489|565081247|FG001|Overall Study|Subject choice/Subject moved|1|||
156542668|NCT01438489|565081248|FG002|Overall Study|Subject choice/Subject moved|1|||
156542669|NCT01438489|565081246|FG000|Overall Study|Investigator decision|0|||
156542670|NCT01438489|565081247|FG001|Overall Study|Investigator decision|1|||
156542671|NCT01438489|565081248|FG002|Overall Study|Investigator decision|0|||
156542672|NCT01438489|565081246|FG000|Overall Study|AE/SAEs|2|||
156542673|NCT01438489|565081247|FG001|Overall Study|AE/SAEs|1|||
156542674|NCT01438489|565081248|FG002|Overall Study|AE/SAEs|1|||
156542675|NCT01438489|565081246|FG000|Overall Study|Received prohibited medication|1|||
156542676|NCT01438489|565081247|FG001|Overall Study|Received prohibited medication|0|||
156542677|NCT01438489|565081248|FG002|Overall Study|Received prohibited medication|0|||
156542678|NCT01438489|565081246|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
156542679|NCT01438489|565081247|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
156542680|NCT01438489|565081248|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
156542681|NCT01438489|565081246|FG000|Overall Study|Inadequate venous access|0|||
156542682|NCT01438489|565081247|FG001|Overall Study|Inadequate venous access|2|||
156542683|NCT01438489|565081248|FG002|Overall Study|Inadequate venous access|0|||
156542684|NCT03719690|565081252|FG000|Overall Study|Withdrawal by Subject|5|||
156542685|NCT03719690|565081253|FG001|Overall Study|Withdrawal by Subject|10|||
156542686|NCT03719690|565081252|FG000|Overall Study|Death|40|||
156542687|NCT03719690|565081253|FG001|Overall Study|Death|149|||
156344106|NCT02142959|564358562|FG000|Overall Study|Adverse Event|1|||
156344107|NCT02142959|564358563|FG001|Overall Study|Adverse Event|0|||
156476484|NCT02521493|564840241|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
156476485|NCT02521493|564840239|FG000|Overall Study|No MRD result|0|||
156476486|NCT02521493|564840240|FG001|Overall Study|No MRD result|0|||
156476487|NCT02521493|564840241|FG002|Overall Study|No MRD result|4|||
156476488|NCT04083781|564840242|FG000|Main Part|Physician Decision|0|||
156476489|NCT04083781|564840243|FG001|Main Part|Physician Decision|1|||
156476490|NCT04083781|564840244|FG002|Main Part|Physician Decision|2|||
156476491|NCT04083781|564840245|FG003|Main Part|Physician Decision|0|||
156476492|NCT04083781|564840242|FG000|Main Part|Death|1|||
156476493|NCT04083781|564840243|FG001|Main Part|Death|3|||
156476494|NCT04083781|564840244|FG002|Main Part|Death|1|||
156476495|NCT04083781|564840245|FG003|Main Part|Death|0|||
156476496|NCT04083781|564840242|FG000|Main Part|Withdrawal by Subject|5|||
156344108|NCT02142959|564358564|FG002|Overall Study|Adverse Event|0|||
156344109|NCT02142959|564358562|FG000|Overall Study|Death|0|||
156476497|NCT04083781|564840243|FG001|Main Part|Withdrawal by Subject|2|||
156476498|NCT04083781|564840244|FG002|Main Part|Withdrawal by Subject|3|||
156476499|NCT04083781|564840245|FG003|Main Part|Withdrawal by Subject|7|||
156476500|NCT04083781|564840242|FG000|Extension Part|Physician Decision|0|||
156863350|NCT02345070|566258631|FG002|Overall Study|Other than specified above|7|||
156344110|NCT02142959|564358563|FG001|Overall Study|Death|1|||
156344111|NCT02142959|564358564|FG002|Overall Study|Death|0|||
156476501|NCT04083781|564840243|FG001|Extension Part|Physician Decision|0|||
156476502|NCT04083781|564840244|FG002|Extension Part|Physician Decision|0|||
156863351|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
156863352|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863353|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863354|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863355|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863356|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863357|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863358|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
156863359|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863360|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863361|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863362|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863363|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863364|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863365|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
156863366|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863367|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863368|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863369|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863370|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863371|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863372|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
156863373|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863374|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863375|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863376|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863377|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863378|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863379|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
156863380|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863381|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863382|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863383|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863384|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863385|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863386|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
156863387|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863388|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863389|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863390|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863391|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863392|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863393|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
156863394|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
156863395|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
156542688|NCT03719690|565081252|FG000|Overall Study|Miscellaneous|12|||
156476503|NCT04083781|564840245|FG003|Extension Part|Physician Decision|1|||
156476504|NCT04083781|564840242|FG000|Extension Part|Death|0|||
156476505|NCT04083781|564840243|FG001|Extension Part|Death|1|||
156476506|NCT04083781|564840244|FG002|Extension Part|Death|0|||
156476507|NCT04083781|564840245|FG003|Extension Part|Death|1|||
156476508|NCT04083781|564840242|FG000|Extension Part|Withdrawal by Subject|0|||
156476509|NCT04083781|564840243|FG001|Extension Part|Withdrawal by Subject|1|||
156476510|NCT04083781|564840244|FG002|Extension Part|Withdrawal by Subject|0|||
156476511|NCT04083781|564840245|FG003|Extension Part|Withdrawal by Subject|0|||
156476512|NCT04083781|564840242|FG000|Extension Part|Ongoing|13|||
156476513|NCT04083781|564840243|FG001|Extension Part|Ongoing|25|||
156476514|NCT04083781|564840244|FG002|Extension Part|Ongoing|15|||
156476515|NCT04083781|564840245|FG003|Extension Part|Ongoing|51|||
156476516|NCT01263496|564840246|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
156476517|NCT01263496|564840247|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
156476518|NCT01263496|564840248|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
156476519|NCT01263496|564840249|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
156476520|NCT01263496|564840250|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
156476521|NCT01263496|564840251|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
156476522|NCT01263496|564840252|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
156476523|NCT01263496|564840253|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
156476524|NCT01263496|564840254|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
156476525|NCT01263496|564840246|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156476526|NCT01263496|564840247|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156476527|NCT01263496|564840248|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156476528|NCT01263496|564840249|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
156476529|NCT01263496|564840250|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
156476530|NCT01263496|564840251|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156476531|NCT01263496|564840252|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156476532|NCT01263496|564840253|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156476533|NCT01263496|564840254|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156476534|NCT01263496|564840246|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
156476535|NCT01263496|564840247|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
156476536|NCT01263496|564840248|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
156476537|NCT01263496|564840249|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
156476538|NCT01263496|564840250|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
156476539|NCT01263496|564840251|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
156476540|NCT01263496|564840252|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
156476541|NCT01263496|564840253|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
156476542|NCT01263496|564840254|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
156476543|NCT01263496|564840246|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156476544|NCT01263496|564840247|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
156476545|NCT01263496|564840248|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156476546|NCT01263496|564840249|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156476547|NCT01263496|564840250|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156476548|NCT01263496|564840251|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156476549|NCT01263496|564840252|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156476550|NCT01263496|564840253|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156476551|NCT01263496|564840254|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156476552|NCT01263496|564840246|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156476553|NCT01263496|564840247|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156476554|NCT01263496|564840248|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156476555|NCT01263496|564840249|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156476556|NCT01263496|564840250|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
156476557|NCT01263496|564840251|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156476558|NCT01263496|564840252|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156476559|NCT01263496|564840253|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156542689|NCT03719690|565081253|FG001|Overall Study|Miscellaneous|56|||
156476560|NCT01263496|564840254|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156476561|NCT01263496|564840246|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
156476562|NCT01263496|564840247|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
156476563|NCT01263496|564840248|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
156476564|NCT01263496|564840249|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
156476565|NCT01263496|564840250|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
156476566|NCT01263496|564840251|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
156476567|NCT01263496|564840252|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
156476568|NCT01263496|564840253|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
156476569|NCT01263496|564840254|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
156476570|NCT01263496|564840246|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156476571|NCT01263496|564840247|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156476572|NCT01263496|564840248|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156476573|NCT01263496|564840249|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156476574|NCT01263496|564840250|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156476575|NCT01263496|564840251|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156476576|NCT01263496|564840252|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156476577|NCT01263496|564840253|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
156476578|NCT01263496|564840254|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156476579|NCT02203032|564840256|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
156542690|NCT03719690|565081252|FG000|Overall Study|Lost to Follow-up|2|||
156542691|NCT03719690|565081253|FG001|Overall Study|Lost to Follow-up|18|||
156542692|NCT03719690|565081252|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
156476580|NCT02203032|564840257|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
156476581|NCT02203032|564840258|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
156476582|NCT02203032|564840259|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
156476583|NCT02203032|564840256|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
156476584|NCT02203032|564840257|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
156476585|NCT02203032|564840258|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
156476586|NCT02203032|564840259|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
156476587|NCT02203032|564840256|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
156476588|NCT02203032|564840257|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
156476589|NCT02203032|564840258|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
156476590|NCT02203032|564840259|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
156476591|NCT02203032|564840256|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
156476592|NCT02203032|564840257|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
156476593|NCT02203032|564840258|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
156476594|NCT02203032|564840259|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
156476595|NCT02203032|564840256|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
156476596|NCT02203032|564840257|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
156476597|NCT02203032|564840258|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
156476598|NCT02203032|564840259|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
156476599|NCT02203032|564840256|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
156476600|NCT02203032|564840257|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
156476601|NCT02203032|564840258|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
156476602|NCT02203032|564840259|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
156476603|NCT02203032|564840256|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
156476604|NCT02203032|564840257|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
156476605|NCT02203032|564840258|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
156476606|NCT02203032|564840259|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
156476607|NCT02203032|564840256|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
156476608|NCT02203032|564840257|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
156476609|NCT02203032|564840258|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
156476610|NCT02203032|564840259|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
156476611|NCT02203032|564840256|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
156476612|NCT02203032|564840257|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
156476613|NCT02203032|564840258|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
156476614|NCT02203032|564840259|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
156476615|NCT02203032|564840256|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
156476616|NCT02203032|564840257|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
156476617|NCT02203032|564840258|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
156476618|NCT02203032|564840259|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
156476619|NCT02203032|564840256|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
156476620|NCT02203032|564840257|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
156476621|NCT02203032|564840258|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
156476622|NCT02203032|564840259|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
156476623|NCT02203032|564840256|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
156476624|NCT02203032|564840257|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
156476625|NCT02203032|564840258|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
156476626|NCT02203032|564840259|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
156476627|NCT02241785|564840260|FG000|Overall Study|Sponsor Termination|43|||
156476628|NCT02241785|564840260|FG000|Overall Study|Withdrawal by Subject|1|||
156476629|NCT02241785|564840260|FG000|Overall Study|Lost to Follow-up|2|||
156476630|NCT02241785|564840260|FG000|Overall Study|Adverse Event|1|||
156476631|NCT03905642|564840263|FG000|Overall Study|Withdrawal by Subject|3|||
156476632|NCT03905642|564840263|FG000|Overall Study|Pregnancy|1|||
156476633|NCT03905642|564840263|FG000|Overall Study|Adverse Event|1|||
156476634|NCT03905642|564840263|FG000|Overall Study|Lack of Efficacy|1|||
156476635|NCT03905642|564840263|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
156476636|NCT05289037|564840266|FG000|Overall Study|Withdrawal by Subject|7|||
156476637|NCT05289037|564840267|FG001|Overall Study|Withdrawal by Subject|0|||
156476638|NCT05289037|564840268|FG002|Overall Study|Withdrawal by Subject|3|||
156476639|NCT05289037|564840269|FG003|Overall Study|Withdrawal by Subject|3|||
156476640|NCT05289037|564840270|FG004|Overall Study|Withdrawal by Subject|1|||
156863396|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
156863397|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
156863398|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
156863399|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
156476641|NCT05289037|564840271|FG005|Overall Study|Withdrawal by Subject|5|||
156476642|NCT05289037|564840272|FG006|Overall Study|Withdrawal by Subject|2|||
156476643|NCT05289037|564840273|FG007|Overall Study|Withdrawal by Subject|1|||
156476644|NCT05289037|564840274|FG008|Overall Study|Withdrawal by Subject|2|||
156542693|NCT03719690|565081253|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
156542694|NCT01372384|565081254|FG000|Overall Study|Progression of disease|3|||
156542695|NCT02576444|565081261|FG000|Overall Study|Death|1|||
156542696|NCT02576444|565081262|FG001|Overall Study|Death|1|||
156542697|NCT02576444|565081263|FG002|Overall Study|Death|0|||
156542698|NCT02576444|565081264|FG003|Overall Study|Death|0|||
156542699|NCT02576444|565081261|FG000|Overall Study|Withdrawal by Subject|0|||
156542700|NCT02576444|565081262|FG001|Overall Study|Withdrawal by Subject|0|||
156542701|NCT02576444|565081263|FG002|Overall Study|Withdrawal by Subject|2|||
156542702|NCT02576444|565081264|FG003|Overall Study|Withdrawal by Subject|0|||
156542703|NCT02576444|565081261|FG000|Overall Study|Adverse Event|0|||
156542704|NCT02576444|565081262|FG001|Overall Study|Adverse Event|0|||
156542705|NCT02576444|565081263|FG002|Overall Study|Adverse Event|1|||
156542706|NCT02576444|565081264|FG003|Overall Study|Adverse Event|0|||
156542707|NCT02576444|565081261|FG000|Overall Study|Physician Decision|0|||
156542708|NCT02576444|565081262|FG001|Overall Study|Physician Decision|0|||
156542709|NCT02576444|565081263|FG002|Overall Study|Physician Decision|1|||
156542710|NCT02576444|565081264|FG003|Overall Study|Physician Decision|0|||
156542711|NCT02700412|565081272|FG000|Overall Study|Adverse Event|6|||
156542712|NCT02700412|565081272|FG000|Overall Study|Death|1|||
156542713|NCT02700412|565081272|FG000|Overall Study|Lack of Efficacy|19|||
156542714|NCT02700412|565081272|FG000|Overall Study|Protocol Violation|5|||
156542715|NCT02700412|565081272|FG000|Overall Study|Withdrawal by Subject|2|||
156542716|NCT00530270|565081277|FG000|Overall Study|Protocol Violation|1|||
156542717|NCT00530270|565081278|FG001|Overall Study|Protocol Violation|0|||
156542718|NCT01923285|565081287|FG000|Overall Study|Withdrawal by Subject|7|||
156542719|NCT01923285|565081288|FG001|Overall Study|Withdrawal by Subject|6|||
156542720|NCT02375724|565081290|FG000|Overall Study|Lack of Efficacy|1|||
156542721|NCT02375724|565081291|FG001|Overall Study|Lack of Efficacy|1|||
156542722|NCT02375724|565081290|FG000|Overall Study|Withdrawal by Subject|1|||
156542723|NCT02375724|565081291|FG001|Overall Study|Withdrawal by Subject|1|||
156542724|NCT02375724|565081290|FG000|Overall Study|Lost to Follow-up|1|||
156542725|NCT02375724|565081291|FG001|Overall Study|Lost to Follow-up|0|||
156542726|NCT02375724|565081290|FG000|Overall Study|Protocol Violation|1|||
156542727|NCT02375724|565081291|FG001|Overall Study|Protocol Violation|0|||
156542728|NCT02375724|565081290|FG000|Overall Study|Adverse Event|2|||
156542729|NCT02375724|565081291|FG001|Overall Study|Adverse Event|4|||
156542730|NCT04712110|565081294|FG000|Overall Study|Lost to Follow-up|0|||
156542731|NCT04712110|565081295|FG001|Overall Study|Lost to Follow-up|1|||
156542732|NCT04712110|565081294|FG000|Overall Study|Withdrawal by Subject|0|||
156542733|NCT04712110|565081295|FG001|Overall Study|Withdrawal by Subject|4|||
156542734|NCT04712110|565081294|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
156542735|NCT04712110|565081295|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
156542736|NCT01197521|565081296|FG000|Overall Study|Not reported|24|||
156542737|NCT01197521|565081297|FG001|Overall Study|Not reported|25|||
156542738|NCT01197521|565081298|FG002|Overall Study|Not reported|21|||
156542739|NCT01197521|565081296|FG000|Overall Study|Enrolment in long term extension|42|||
156542740|NCT01197521|565081297|FG001|Overall Study|Enrolment in long term extension|36|||
156542741|NCT01197521|565081298|FG002|Overall Study|Enrolment in long term extension|87|||
156542742|NCT01197521|565081296|FG000|Overall Study|Severe non-compliance to protocol|1|||
156542743|NCT01197521|565081297|FG001|Overall Study|Severe non-compliance to protocol|3|||
156542744|NCT01197521|565081298|FG002|Overall Study|Severe non-compliance to protocol|3|||
156542745|NCT01197521|565081296|FG000|Overall Study|Lack of therapeutic response|2|||
156542746|NCT01197521|565081297|FG001|Overall Study|Lack of therapeutic response|3|||
156542747|NCT01197521|565081298|FG002|Overall Study|Lack of therapeutic response|4|||
156542748|NCT01197521|565081296|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
156542749|NCT01197521|565081297|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
156542750|NCT01197521|565081298|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
156542751|NCT01197521|565081296|FG000|Overall Study|Lost to Follow-up|3|||
156542752|NCT01197521|565081297|FG001|Overall Study|Lost to Follow-up|2|||
156542753|NCT01197521|565081298|FG002|Overall Study|Lost to Follow-up|2|||
156542754|NCT01197521|565081296|FG000|Overall Study|Adverse Event|25|||
156542755|NCT01197521|565081297|FG001|Overall Study|Adverse Event|28|||
156542756|NCT01197521|565081298|FG002|Overall Study|Adverse Event|24|||
156542757|NCT01309659|565081299|FG000|Overall Study|Protocol Violation|0|||
156542758|NCT01309659|565081300|FG001|Overall Study|Protocol Violation|1|||
156542759|NCT02285777|565081301|FG000|Overall Study|Withdrawal by Subject|1|||
156542760|NCT02285777|565081302|FG001|Overall Study|Withdrawal by Subject|1|||
156542761|NCT02285777|565081301|FG000|Overall Study|Lost to Follow-up|4|||
156542762|NCT02285777|565081302|FG001|Overall Study|Lost to Follow-up|2|||
156542763|NCT02184195|565081304|FG000|Overall Study|Patient decision|5|||
156542764|NCT02184195|565081305|FG001|Overall Study|Patient decision|2|||
156542765|NCT02184195|565081304|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156344112|NCT02142959|564358562|FG000|Overall Study|Withdrawal by Subject|3|||
156344113|NCT02142959|564358563|FG001|Overall Study|Withdrawal by Subject|1|||
156344114|NCT02142959|564358564|FG002|Overall Study|Withdrawal by Subject|3|||
156344115|NCT02142959|564358562|FG000|Overall Study|Administrative Reasons|1|||
156344116|NCT02142959|564358563|FG001|Overall Study|Administrative Reasons|0|||
156344117|NCT02142959|564358564|FG002|Overall Study|Administrative Reasons|1|||
156344118|NCT02142959|564358562|FG000|Overall Study|Missing|0|||
156344119|NCT02142959|564358563|FG001|Overall Study|Missing|1|||
156344120|NCT02142959|564358564|FG002|Overall Study|Missing|0|||
156344121|NCT02142959|564358562|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
156344122|NCT02142959|564358563|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
156344123|NCT02142959|564358564|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
156344124|NCT02142959|564358562|FG000|Overall Study|Patient didn't complete end of study visit|0|||
156344125|NCT02142959|564358563|FG001|Overall Study|Patient didn't complete end of study visit|0|||
156344126|NCT02142959|564358564|FG002|Overall Study|Patient didn't complete end of study visit|1|||
156344127|NCT02700815|564360122|FG000|Overall Study|Adverse Event|0|||
156344128|NCT02700815|564360123|FG001|Overall Study|Adverse Event|6|||
156344129|NCT02700815|564360124|FG002|Overall Study|Adverse Event|2|||
156344130|NCT02700815|564360125|FG003|Overall Study|Adverse Event|3|||
156344131|NCT02700815|564360122|FG000|Overall Study|Lack of Efficacy|0|||
156344132|NCT02700815|564360123|FG001|Overall Study|Lack of Efficacy|0|||
156344133|NCT02700815|564360124|FG002|Overall Study|Lack of Efficacy|1|||
156344134|NCT02700815|564360125|FG003|Overall Study|Lack of Efficacy|2|||
156344135|NCT02700815|564360122|FG000|Overall Study|Lost to Follow-up|1|||
156344136|NCT02700815|564360123|FG001|Overall Study|Lost to Follow-up|0|||
156344137|NCT02700815|564360124|FG002|Overall Study|Lost to Follow-up|0|||
156344138|NCT02700815|564360125|FG003|Overall Study|Lost to Follow-up|1|||
156344139|NCT02700815|564360122|FG000|Overall Study|Refusal to continue medication|0|||
156344140|NCT02700815|564360123|FG001|Overall Study|Refusal to continue medication|1|||
156344141|NCT02700815|564360124|FG002|Overall Study|Refusal to continue medication|0|||
156344142|NCT02700815|564360125|FG003|Overall Study|Refusal to continue medication|1|||
156344143|NCT02700815|564360122|FG000|Overall Study|Withdrawal by Subject|0|||
156344144|NCT02700815|564360123|FG001|Overall Study|Withdrawal by Subject|0|||
156344145|NCT02700815|564360124|FG002|Overall Study|Withdrawal by Subject|1|||
156344146|NCT02700815|564360125|FG003|Overall Study|Withdrawal by Subject|0|||
156344147|NCT01943292|564360134|FG000|Overall Study|Withdrawal by Subject|1|||
156344148|NCT01943292|564360135|FG001|Overall Study|Withdrawal by Subject|0|||
156344149|NCT01943292|564360136|FG002|Overall Study|Withdrawal by Subject|0|||
156344150|NCT00911820|564360137|FG000|Overall Study|RECIST progression|12|||
156344151|NCT00911820|564360138|FG001|Overall Study|RECIST progression|8|||
156344152|NCT00911820|564360137|FG000|Overall Study|Adverse Event|8|||
156344153|NCT00911820|564360138|FG001|Overall Study|Adverse Event|8|||
156344154|NCT00911820|564360137|FG000|Overall Study|Clinical Progression|7|||
156344155|NCT00911820|564360138|FG001|Overall Study|Clinical Progression|5|||
156344156|NCT00911820|564360137|FG000|Overall Study|Physician Decision|5|||
156344157|NCT00911820|564360138|FG001|Overall Study|Physician Decision|9|||
156344158|NCT00911820|564360137|FG000|Overall Study|Decline in Performance Status|4|||
156344159|NCT00911820|564360138|FG001|Overall Study|Decline in Performance Status|2|||
156344160|NCT00911820|564360137|FG000|Overall Study|Withdrawal by Subject|3|||
156344161|NCT00911820|564360138|FG001|Overall Study|Withdrawal by Subject|4|||
156344162|NCT00911820|564360137|FG000|Overall Study|Death|1|||
156344163|NCT00911820|564360138|FG001|Overall Study|Death|2|||
156344164|NCT00911820|564360137|FG000|Overall Study|Pursue surgery|1|||
156476645|NCT05289037|564840275|FG009|Overall Study|Withdrawal by Subject|2|||
156344165|NCT00911820|564360138|FG001|Overall Study|Pursue surgery|1|||
156344166|NCT00911820|564360137|FG000|Overall Study|Pursue Radiation|1|||
156344167|NCT00911820|564360138|FG001|Overall Study|Pursue Radiation|0|||
156344168|NCT00911820|564360137|FG000|Overall Study|Still on Therapy|2|||
156344169|NCT00911820|564360138|FG001|Overall Study|Still on Therapy|2|||
156344170|NCT00911820|564360137|FG000|Overall Study|Pathology Not Confirmed|1|||
156344171|NCT00911820|564360138|FG001|Overall Study|Pathology Not Confirmed|0|||
156344172|NCT00911820|564360137|FG000|Overall Study|Withdraw before Receive Treatment|0|||
156344173|NCT00911820|564360138|FG001|Overall Study|Withdraw before Receive Treatment|2|||
156344174|NCT00996216|564360139|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
156344175|NCT00996216|564360139|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
156476646|NCT05289037|564840276|FG010|Overall Study|Withdrawal by Subject|1|||
156344176|NCT00996216|564360139|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
156344177|NCT00963547|564360148|FG000|Overall Study|Adverse Event|0|||
156344178|NCT00963547|564360149|FG001|Overall Study|Adverse Event|1|||
156344179|NCT00963547|564360150|FG002|Overall Study|Adverse Event|0|||
156344180|NCT00963547|564360151|FG003|Overall Study|Adverse Event|1|||
156344181|NCT00963547|564360152|FG004|Overall Study|Adverse Event|0|||
156344182|NCT00963547|564360153|FG005|Overall Study|Adverse Event|0|||
156344183|NCT00963547|564360154|FG006|Overall Study|Adverse Event|0|||
156344184|NCT00963547|564360148|FG000|Overall Study|Physician Decision|1|||
156476647|NCT05289037|564840277|FG011|Overall Study|Withdrawal by Subject|0|||
156476648|NCT05289037|564840278|FG012|Overall Study|Withdrawal by Subject|1|||
156476649|NCT05289037|564840279|FG013|Overall Study|Withdrawal by Subject|2|||
156476650|NCT05289037|564840280|FG014|Overall Study|Withdrawal by Subject|0|||
156476651|NCT05289037|564840281|FG015|Overall Study|Withdrawal by Subject|3|||
156476652|NCT05289037|564840282|FG016|Overall Study|Withdrawal by Subject|3|||
156476653|NCT05289037|564840266|FG000|Overall Study|Lost to Follow-up|1|||
156476654|NCT05289037|564840267|FG001|Overall Study|Lost to Follow-up|4|||
156476655|NCT05289037|564840268|FG002|Overall Study|Lost to Follow-up|3|||
156476656|NCT05289037|564840269|FG003|Overall Study|Lost to Follow-up|3|||
156476657|NCT05289037|564840270|FG004|Overall Study|Lost to Follow-up|3|||
156476658|NCT05289037|564840271|FG005|Overall Study|Lost to Follow-up|2|||
156476659|NCT05289037|564840272|FG006|Overall Study|Lost to Follow-up|3|||
156476660|NCT05289037|564840273|FG007|Overall Study|Lost to Follow-up|2|||
156476661|NCT05289037|564840274|FG008|Overall Study|Lost to Follow-up|2|||
156476662|NCT05289037|564840275|FG009|Overall Study|Lost to Follow-up|1|||
156476663|NCT05289037|564840276|FG010|Overall Study|Lost to Follow-up|3|||
156476664|NCT05289037|564840277|FG011|Overall Study|Lost to Follow-up|4|||
156476665|NCT05289037|564840278|FG012|Overall Study|Lost to Follow-up|2|||
156476666|NCT05289037|564840279|FG013|Overall Study|Lost to Follow-up|7|||
156476667|NCT05289037|564840280|FG014|Overall Study|Lost to Follow-up|4|||
156476668|NCT05289037|564840281|FG015|Overall Study|Lost to Follow-up|6|||
156476669|NCT05289037|564840282|FG016|Overall Study|Lost to Follow-up|4|||
156476670|NCT05289037|564840266|FG000|Overall Study|Death|0|||
156476671|NCT05289037|564840267|FG001|Overall Study|Death|0|||
156476672|NCT05289037|564840268|FG002|Overall Study|Death|0|||
156476673|NCT05289037|564840269|FG003|Overall Study|Death|0|||
156476674|NCT05289037|564840270|FG004|Overall Study|Death|0|||
156476675|NCT05289037|564840271|FG005|Overall Study|Death|1|||
156476676|NCT05289037|564840272|FG006|Overall Study|Death|0|||
156476677|NCT05289037|564840273|FG007|Overall Study|Death|0|||
156476678|NCT05289037|564840274|FG008|Overall Study|Death|0|||
156476679|NCT05289037|564840275|FG009|Overall Study|Death|0|||
156476680|NCT05289037|564840276|FG010|Overall Study|Death|0|||
156476681|NCT05289037|564840277|FG011|Overall Study|Death|0|||
156476682|NCT05289037|564840278|FG012|Overall Study|Death|0|||
156476683|NCT05289037|564840279|FG013|Overall Study|Death|0|||
156476684|NCT05289037|564840280|FG014|Overall Study|Death|1|||
156476685|NCT05289037|564840281|FG015|Overall Study|Death|0|||
156476686|NCT05289037|564840282|FG016|Overall Study|Death|0|||
156476687|NCT05289037|564840266|FG000|Overall Study|Did not receive vaccine|0|||
156476688|NCT05289037|564840267|FG001|Overall Study|Did not receive vaccine|3|||
156476689|NCT05289037|564840268|FG002|Overall Study|Did not receive vaccine|0|||
156476690|NCT05289037|564840269|FG003|Overall Study|Did not receive vaccine|0|||
156476691|NCT05289037|564840270|FG004|Overall Study|Did not receive vaccine|1|||
156476692|NCT05289037|564840271|FG005|Overall Study|Did not receive vaccine|1|||
156476693|NCT05289037|564840272|FG006|Overall Study|Did not receive vaccine|1|||
156476694|NCT05289037|564840273|FG007|Overall Study|Did not receive vaccine|0|||
156476695|NCT05289037|564840274|FG008|Overall Study|Did not receive vaccine|0|||
156476696|NCT05289037|564840275|FG009|Overall Study|Did not receive vaccine|0|||
156476697|NCT05289037|564840276|FG010|Overall Study|Did not receive vaccine|0|||
156476698|NCT05289037|564840277|FG011|Overall Study|Did not receive vaccine|0|||
156476699|NCT05289037|564840278|FG012|Overall Study|Did not receive vaccine|0|||
156476700|NCT05289037|564840279|FG013|Overall Study|Did not receive vaccine|0|||
156476701|NCT05289037|564840280|FG014|Overall Study|Did not receive vaccine|1|||
156476702|NCT05289037|564840281|FG015|Overall Study|Did not receive vaccine|0|||
156476703|NCT05289037|564840282|FG016|Overall Study|Did not receive vaccine|0|||
156476704|NCT05289037|564840266|FG000|Overall Study|Unable to make last visit|0|||
156476705|NCT05289037|564840267|FG001|Overall Study|Unable to make last visit|0|||
156476706|NCT05289037|564840268|FG002|Overall Study|Unable to make last visit|1|||
156476707|NCT05289037|564840269|FG003|Overall Study|Unable to make last visit|0|||
156476708|NCT05289037|564840270|FG004|Overall Study|Unable to make last visit|0|||
156476709|NCT05289037|564840271|FG005|Overall Study|Unable to make last visit|0|||
156476710|NCT05289037|564840272|FG006|Overall Study|Unable to make last visit|0|||
156476711|NCT05289037|564840273|FG007|Overall Study|Unable to make last visit|0|||
156476712|NCT05289037|564840274|FG008|Overall Study|Unable to make last visit|0|||
156476713|NCT05289037|564840275|FG009|Overall Study|Unable to make last visit|0|||
156476714|NCT05289037|564840276|FG010|Overall Study|Unable to make last visit|0|||
156542766|NCT02184195|565081305|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156476715|NCT05289037|564840277|FG011|Overall Study|Unable to make last visit|0|||
156476716|NCT05289037|564840278|FG012|Overall Study|Unable to make last visit|0|||
156476717|NCT05289037|564840279|FG013|Overall Study|Unable to make last visit|0|||
156476718|NCT05289037|564840280|FG014|Overall Study|Unable to make last visit|0|||
156476719|NCT05289037|564840281|FG015|Overall Study|Unable to make last visit|0|||
156476720|NCT05289037|564840282|FG016|Overall Study|Unable to make last visit|0|||
156542767|NCT02184195|565081304|FG000|Overall Study|Death|67|||
156542768|NCT02184195|565081305|FG001|Overall Study|Death|44|||
156476721|NCT05289037|564840266|FG000|Overall Study|Protocol deviation|0|||
156476722|NCT05289037|564840267|FG001|Overall Study|Protocol deviation|0|||
156476723|NCT05289037|564840268|FG002|Overall Study|Protocol deviation|0|||
156476724|NCT05289037|564840269|FG003|Overall Study|Protocol deviation|0|||
156476725|NCT05289037|564840270|FG004|Overall Study|Protocol deviation|0|||
156476726|NCT05289037|564840271|FG005|Overall Study|Protocol deviation|0|||
156476727|NCT05289037|564840272|FG006|Overall Study|Protocol deviation|0|||
156476728|NCT05289037|564840273|FG007|Overall Study|Protocol deviation|0|||
156476729|NCT05289037|564840274|FG008|Overall Study|Protocol deviation|0|||
156476730|NCT05289037|564840275|FG009|Overall Study|Protocol deviation|0|||
156476731|NCT05289037|564840276|FG010|Overall Study|Protocol deviation|0|||
156476732|NCT05289037|564840277|FG011|Overall Study|Protocol deviation|0|||
156476733|NCT05289037|564840278|FG012|Overall Study|Protocol deviation|0|||
156476734|NCT05289037|564840279|FG013|Overall Study|Protocol deviation|0|||
156476735|NCT05289037|564840280|FG014|Overall Study|Protocol deviation|0|||
156476736|NCT05289037|564840281|FG015|Overall Study|Protocol deviation|1|||
156476737|NCT05289037|564840282|FG016|Overall Study|Protocol deviation|0|||
156476738|NCT05995977|564840283|FG000|Overall Study|Withdrawal by Subject|1|||
156476739|NCT05995977|564840284|FG001|Overall Study|Withdrawal by Subject|4|||
156476740|NCT05995977|564840283|FG000|Overall Study|Lost to Follow-up|2|||
156476741|NCT05995977|564840284|FG001|Overall Study|Lost to Follow-up|0|||
156476742|NCT04852978|564840287|FG000|Overall Study|Physician Decision|0|||
156476743|NCT04852978|564840288|FG001|Overall Study|Physician Decision|1|||
156476744|NCT04852978|564840289|FG002|Overall Study|Physician Decision|0|||
156476745|NCT04852978|564840290|FG003|Overall Study|Physician Decision|0|||
156476746|NCT04852978|564840291|FG004|Overall Study|Physician Decision|0|||
156476747|NCT04852978|564840292|FG005|Overall Study|Physician Decision|0|||
156476748|NCT04852978|564840293|FG006|Overall Study|Physician Decision|0|||
156476749|NCT04852978|564840294|FG007|Overall Study|Physician Decision|2|||
156476750|NCT04852978|564840295|FG008|Overall Study|Physician Decision|0|||
156476751|NCT04852978|564840287|FG000|Overall Study|Sponsor request|0|||
156476752|NCT04852978|564840288|FG001|Overall Study|Sponsor request|0|||
156476753|NCT04852978|564840289|FG002|Overall Study|Sponsor request|1|||
156476754|NCT04852978|564840290|FG003|Overall Study|Sponsor request|0|||
156476755|NCT04852978|564840291|FG004|Overall Study|Sponsor request|0|||
156476756|NCT04852978|564840292|FG005|Overall Study|Sponsor request|0|||
156476757|NCT04852978|564840293|FG006|Overall Study|Sponsor request|0|||
156476758|NCT04852978|564840294|FG007|Overall Study|Sponsor request|0|||
156476759|NCT04852978|564840295|FG008|Overall Study|Sponsor request|0|||
156476760|NCT04852978|564840287|FG000|Overall Study|Death|0|||
156476761|NCT04852978|564840288|FG001|Overall Study|Death|0|||
156476762|NCT04852978|564840289|FG002|Overall Study|Death|0|||
156476763|NCT04852978|564840290|FG003|Overall Study|Death|0|||
156344185|NCT00963547|564360149|FG001|Overall Study|Physician Decision|1|||
156476764|NCT04852978|564840291|FG004|Overall Study|Death|0|||
156476765|NCT04852978|564840292|FG005|Overall Study|Death|0|||
156476766|NCT04852978|564840293|FG006|Overall Study|Death|1|||
156476767|NCT04852978|564840294|FG007|Overall Study|Death|0|||
156476768|NCT04852978|564840295|FG008|Overall Study|Death|0|||
156476769|NCT04852978|564840287|FG000|Overall Study|Lost to Follow-up|3|||
156476770|NCT04852978|564840288|FG001|Overall Study|Lost to Follow-up|2|||
156476771|NCT04852978|564840289|FG002|Overall Study|Lost to Follow-up|2|||
156476772|NCT04852978|564840290|FG003|Overall Study|Lost to Follow-up|0|||
156476773|NCT04852978|564840291|FG004|Overall Study|Lost to Follow-up|2|||
156476774|NCT04852978|564840292|FG005|Overall Study|Lost to Follow-up|4|||
156476775|NCT04852978|564840293|FG006|Overall Study|Lost to Follow-up|1|||
156476776|NCT04852978|564840294|FG007|Overall Study|Lost to Follow-up|2|||
156476777|NCT04852978|564840295|FG008|Overall Study|Lost to Follow-up|2|||
156476778|NCT04852978|564840287|FG000|Overall Study|Withdrawal by Subject|4|||
156476779|NCT04852978|564840288|FG001|Overall Study|Withdrawal by Subject|2|||
156476780|NCT04852978|564840289|FG002|Overall Study|Withdrawal by Subject|2|||
156476781|NCT04852978|564840290|FG003|Overall Study|Withdrawal by Subject|1|||
156476782|NCT04852978|564840291|FG004|Overall Study|Withdrawal by Subject|5|||
156476783|NCT04852978|564840292|FG005|Overall Study|Withdrawal by Subject|3|||
156476784|NCT04852978|564840293|FG006|Overall Study|Withdrawal by Subject|2|||
156476785|NCT04852978|564840294|FG007|Overall Study|Withdrawal by Subject|2|||
156476786|NCT04852978|564840295|FG008|Overall Study|Withdrawal by Subject|1|||
156476787|NCT03840200|564841928|FG000|Overall Study|Death|6|||
156476788|NCT03840200|564841929|FG001|Overall Study|Death|3|||
156476789|NCT03840200|564841930|FG002|Overall Study|Death|6|||
156476790|NCT03840200|564841931|FG003|Overall Study|Death|10|||
156476791|NCT03840200|564841928|FG000|Overall Study|Reason Not Specified|2|||
156476792|NCT03840200|564841929|FG001|Overall Study|Reason Not Specified|2|||
156476793|NCT03840200|564841930|FG002|Overall Study|Reason Not Specified|1|||
156476794|NCT03840200|564841931|FG003|Overall Study|Reason Not Specified|15|||
156476795|NCT03840200|564841928|FG000|Overall Study|Physician Decision|0|||
156476796|NCT03840200|564841929|FG001|Overall Study|Physician Decision|0|||
156476797|NCT03840200|564841930|FG002|Overall Study|Physician Decision|0|||
156476798|NCT03840200|564841931|FG003|Overall Study|Physician Decision|2|||
156476799|NCT03840200|564841928|FG000|Overall Study|Progressive Disease|0|||
156476800|NCT03840200|564841929|FG001|Overall Study|Progressive Disease|0|||
156476801|NCT03840200|564841930|FG002|Overall Study|Progressive Disease|0|||
156476802|NCT03840200|564841931|FG003|Overall Study|Progressive Disease|1|||
156476803|NCT03840200|564841928|FG000|Overall Study|Withdrawal by Subject|0|||
156476804|NCT03840200|564841929|FG001|Overall Study|Withdrawal by Subject|1|||
156476805|NCT03840200|564841930|FG002|Overall Study|Withdrawal by Subject|0|||
156476806|NCT03840200|564841931|FG003|Overall Study|Withdrawal by Subject|2|||
156476807|NCT02196259|564841934|FG000|Overall Study|Researcher choice|0|||
156476808|NCT02196259|564841935|FG001|Overall Study|Researcher choice|0|||
156476809|NCT02196259|564841936|FG002|Overall Study|Researcher choice|1|||
156476810|NCT02196259|564841934|FG000|Overall Study|Partial data analysis|0|||
156476811|NCT02196259|564841935|FG001|Overall Study|Partial data analysis|3|||
156476812|NCT02196259|564841936|FG002|Overall Study|Partial data analysis|0|||
156476813|NCT00070707|564841937|FG000|Overall Study|Adverse Event|1|||
156476814|NCT00070707|564841938|FG001|Overall Study|Adverse Event|2|||
156476815|NCT00070707|564841937|FG000|Overall Study|Lack of Efficacy|4|||
156476816|NCT00070707|564841938|FG001|Overall Study|Lack of Efficacy|1|||
156476817|NCT00070707|564841937|FG000|Overall Study|Protocol Violation|8|||
156476818|NCT00070707|564841938|FG001|Overall Study|Protocol Violation|4|||
156476819|NCT00070707|564841937|FG000|Overall Study|Unrelated to Study Medication|1|||
156476820|NCT00070707|564841938|FG001|Overall Study|Unrelated to Study Medication|0|||
156476821|NCT01808534|564841943|FG000|Overall Study|Disease progression|3|||
156476822|NCT01808534|564841943|FG000|Overall Study|Physician Decision|1|||
156476823|NCT00278395|564841946|FG000|Overall Study|Adverse Event|2|||
156476824|NCT00278395|564841946|FG000|Overall Study|Nonevaluable|1|||
156476825|NCT01148017|564841947|FG000|Overall Study|Withdrawal by Subject|31|||
156476826|NCT01148017|564841948|FG001|Overall Study|Withdrawal by Subject|14|||
156476827|NCT01148017|564841949|FG002|Overall Study|Withdrawal by Subject|0|||
156476828|NCT01148017|564841950|FG003|Overall Study|Withdrawal by Subject|0|||
156476829|NCT01148017|564841947|FG000|Overall Study|Lost to Follow-up|23|||
156476830|NCT01148017|564841948|FG001|Overall Study|Lost to Follow-up|10|||
156476831|NCT01148017|564841949|FG002|Overall Study|Lost to Follow-up|0|||
156476832|NCT01148017|564841950|FG003|Overall Study|Lost to Follow-up|0|||
156476833|NCT01148017|564841947|FG000|Overall Study|Inappropriate enrollment|1|||
156476834|NCT01148017|564841948|FG001|Overall Study|Inappropriate enrollment|0|||
156476835|NCT01148017|564841949|FG002|Overall Study|Inappropriate enrollment|0|||
156476836|NCT01148017|564841950|FG003|Overall Study|Inappropriate enrollment|0|||
156476837|NCT01148017|564841947|FG000|Overall Study|Administrative reason|22|||
156476838|NCT01148017|564841948|FG001|Overall Study|Administrative reason|9|||
156476839|NCT01148017|564841949|FG002|Overall Study|Administrative reason|0|||
156476840|NCT01148017|564841950|FG003|Overall Study|Administrative reason|0|||
156476841|NCT01148017|564841947|FG000|Overall Study|Unable to classify|3|||
156476842|NCT01148017|564841948|FG001|Overall Study|Unable to classify|1|||
156476843|NCT01148017|564841949|FG002|Overall Study|Unable to classify|0|||
156476844|NCT01148017|564841950|FG003|Overall Study|Unable to classify|0|||
156476845|NCT03740737|564841951|FG000|Overall Study|Protocol deviation|13|||
156476846|NCT03740737|564841952|FG001|Overall Study|Protocol deviation|0|||
156476847|NCT03740737|564841951|FG000|Overall Study|Adverse Event|2|||
156476848|NCT03740737|564841952|FG001|Overall Study|Adverse Event|0|||
156476849|NCT03740737|564841951|FG000|Overall Study|Lost to Follow-up|1|||
156476850|NCT03740737|564841952|FG001|Overall Study|Lost to Follow-up|0|||
156476851|NCT03740737|564841951|FG000|Overall Study|Randomization failure|1|||
156476852|NCT03740737|564841952|FG001|Overall Study|Randomization failure|0|||
156542769|NCT02184195|565081304|FG000|Overall Study|Lost to Follow-up|1|||
156476853|NCT03740737|564841951|FG000|Overall Study|Participant withdrew consent|1|||
156476854|NCT03740737|564841952|FG001|Overall Study|Participant withdrew consent|0|||
156476855|NCT03740737|564841951|FG000|Overall Study|Participant withdrew from trial|2|||
156476856|NCT03740737|564841952|FG001|Overall Study|Participant withdrew from trial|1|||
156476857|NCT00569166|564841954|FG000|Overall Study|Withdrawal by Subject|7|||
156476858|NCT00569166|564841955|FG001|Overall Study|Withdrawal by Subject|5|||
156476859|NCT00569166|564841956|FG002|Overall Study|Withdrawal by Subject|3|||
156476860|NCT00569166|564841954|FG000|Overall Study|Lost to Follow-up|2|||
156476861|NCT00569166|564841955|FG001|Overall Study|Lost to Follow-up|1|||
156476862|NCT00569166|564841956|FG002|Overall Study|Lost to Follow-up|1|||
156476863|NCT01686152|564841957|FG000|Overall Study|Withdrawal by Subject|11|||
156476864|NCT01686152|564841958|FG001|Overall Study|Withdrawal by Subject|11|||
156476865|NCT01686152|564841959|FG002|Overall Study|Withdrawal by Subject|3|||
156476866|NCT01686152|564841957|FG000|Overall Study|Drug Code Unblinded|0|||
156476867|NCT01686152|564841958|FG001|Overall Study|Drug Code Unblinded|1|||
156476868|NCT01686152|564841959|FG002|Overall Study|Drug Code Unblinded|0|||
156476869|NCT01686152|564841957|FG000|Overall Study|Protocol Violation|6|||
156476870|NCT01686152|564841958|FG001|Overall Study|Protocol Violation|1|||
156476871|NCT01686152|564841959|FG002|Overall Study|Protocol Violation|0|||
156476872|NCT01686152|564841957|FG000|Overall Study|Adverse Event|12|||
156476873|NCT01686152|564841958|FG001|Overall Study|Adverse Event|11|||
156476874|NCT01686152|564841959|FG002|Overall Study|Adverse Event|0|||
156476875|NCT01686152|564841957|FG000|Overall Study|Lack of Efficacy|0|||
156476876|NCT01686152|564841958|FG001|Overall Study|Lack of Efficacy|0|||
156476877|NCT01686152|564841959|FG002|Overall Study|Lack of Efficacy|1|||
156476878|NCT01686152|564841957|FG000|Overall Study|IP Non-compliance|5|||
156476879|NCT01686152|564841958|FG001|Overall Study|IP Non-compliance|5|||
156476880|NCT01686152|564841959|FG002|Overall Study|IP Non-compliance|0|||
156476881|NCT01686152|564841957|FG000|Overall Study|Lost to Follow-up|7|||
156476882|NCT01686152|564841958|FG001|Overall Study|Lost to Follow-up|6|||
156476883|NCT01686152|564841959|FG002|Overall Study|Lost to Follow-up|5|||
156476884|NCT01853384|564841960|FG000|Randomized|Adverse Event|5|||
156476885|NCT01853384|564841961|FG001|Randomized|Adverse Event|3|||
156476886|NCT01853384|564841960|FG000|Randomized|Death|1|||
156542770|NCT02184195|565081305|FG001|Overall Study|Lost to Follow-up|5|||
156542771|NCT02184195|565081304|FG000|Overall Study|Other|0|||
156542772|NCT02184195|565081305|FG001|Overall Study|Other|3|||
156542773|NCT00916149|565081306|FG000|Overall Study|Lost to Follow-up|3|||
156476887|NCT01853384|564841961|FG001|Randomized|Death|2|||
156542774|NCT00916149|565081307|FG001|Overall Study|Lost to Follow-up|2|||
156542775|NCT00916149|565081308|FG002|Overall Study|Lost to Follow-up|0|||
156542776|NCT00916149|565081306|FG000|Overall Study|Unable to place scalp EEG leads|1|||
156476888|NCT01853384|564841960|FG000|Randomized|Lost to Follow-up|1|||
156344186|NCT00963547|564360150|FG002|Overall Study|Physician Decision|0|||
156476889|NCT01853384|564841961|FG001|Randomized|Lost to Follow-up|1|||
156476890|NCT01853384|564841960|FG000|Randomized|Withdrawal by Subject|5|||
156476891|NCT01853384|564841961|FG001|Randomized|Withdrawal by Subject|3|||
156476892|NCT01853384|564841960|FG000|Randomized|Sponsor Decision|47|||
156476893|NCT01853384|564841961|FG001|Randomized|Sponsor Decision|34|||
156476894|NCT01853384|564841960|FG000|Randomized|Other|3|||
156476895|NCT01853384|564841961|FG001|Randomized|Other|3|||
156476896|NCT01853384|564841960|FG000|Completed Follow up Visit 1|Early Termination|13|||
156476897|NCT01853384|564841961|FG001|Completed Follow up Visit 1|Early Termination|9|||
156476898|NCT01853384|564841960|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
156476899|NCT01853384|564841961|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
156476900|NCT01853384|564841960|FG000|Completed Follow up Visit 2|Adverse Event|1|||
156344187|NCT00963547|564360151|FG003|Overall Study|Physician Decision|0|||
156476901|NCT01853384|564841961|FG001|Completed Follow up Visit 2|Adverse Event|0|||
156476902|NCT01853384|564841960|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
156476903|NCT01853384|564841961|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
156476904|NCT01853384|564841960|FG000|Completed Follow up Visit 2|Death|1|||
156476905|NCT01853384|564841961|FG001|Completed Follow up Visit 2|Death|0|||
156476906|NCT01853384|564841960|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
156476907|NCT01853384|564841961|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
156476908|NCT04311983|564841962|FG000|Overall Study|Lost to Follow-up|421|||
156476909|NCT04311983|564841963|FG001|Overall Study|Lost to Follow-up|456|||
156476910|NCT04311983|564841962|FG000|Overall Study|Incomplete survey|7|||
156476911|NCT04311983|564841963|FG001|Overall Study|Incomplete survey|9|||
156476912|NCT04311983|564841962|FG000|Overall Study|Death|1|||
156476913|NCT04311983|564841963|FG001|Overall Study|Death|0|||
156476914|NCT01205126|564841964|FG000|Titration Phase|Adverse Event|5|||
156476915|NCT01205126|564841965|FG001|Titration Phase|Adverse Event|3|||
156476916|NCT01205126|564841964|FG000|Titration Phase|Withdrawal by Subject|5|||
156476917|NCT01205126|564841965|FG001|Titration Phase|Withdrawal by Subject|5|||
156476918|NCT01205126|564841964|FG000|Titration Phase|Lost to Follow-up|2|||
156476919|NCT01205126|564841965|FG001|Titration Phase|Lost to Follow-up|2|||
156476920|NCT01205126|564841964|FG000|Titration Phase|No stable titration dose|1|||
156476921|NCT01205126|564841965|FG001|Titration Phase|No stable titration dose|0|||
156476922|NCT01205126|564841964|FG000|Titration Phase|More than maximum dosage required|2|||
156476923|NCT01205126|564841965|FG001|Titration Phase|More than maximum dosage required|3|||
156476924|NCT01205126|564841964|FG000|Titration Phase|Other|8|||
156476925|NCT01205126|564841965|FG001|Titration Phase|Other|6|||
156476926|NCT01205126|564841964|FG000|Between Titration & Maintenance Phase|Other|0|||
156476927|NCT01205126|564841965|FG001|Between Titration & Maintenance Phase|Other|4|||
156476928|NCT01205126|564841964|FG000|Maintenance Phase|Adverse Event|3|||
156476929|NCT01205126|564841965|FG001|Maintenance Phase|Adverse Event|7|||
156476930|NCT01205126|564841964|FG000|Maintenance Phase|Death|4|||
156476931|NCT01205126|564841965|FG001|Maintenance Phase|Death|4|||
156476932|NCT01205126|564841964|FG000|Maintenance Phase|More than the maximum dosage required|5|||
156476933|NCT01205126|564841965|FG001|Maintenance Phase|More than the maximum dosage required|5|||
156476934|NCT01205126|564841964|FG000|Maintenance Phase|Prohibited drugs used|1|||
156476935|NCT01205126|564841965|FG001|Maintenance Phase|Prohibited drugs used|0|||
156476936|NCT01205126|564841964|FG000|Maintenance Phase|Other|11|||
156476937|NCT01205126|564841965|FG001|Maintenance Phase|Other|8|||
156476938|NCT01205126|564841964|FG000|Maintenance Phase|Lost to Follow-up|5|||
156476939|NCT01205126|564841965|FG001|Maintenance Phase|Lost to Follow-up|5|||
156476940|NCT01205126|564841964|FG000|Maintenance Phase|Withdrawal by Subject|8|||
156476941|NCT01205126|564841965|FG001|Maintenance Phase|Withdrawal by Subject|11|||
156476942|NCT00929526|564841966|FG000|Overall Study|Withdrawal by Subject|1|||
156476943|NCT00929526|564841967|FG001|Overall Study|Withdrawal by Subject|11|||
156476944|NCT00929526|564841966|FG000|Overall Study|Lost to Follow-up|8|||
156476945|NCT00929526|564841967|FG001|Overall Study|Lost to Follow-up|12|||
156476946|NCT00929526|564841966|FG000|Overall Study|Other|8|||
156476947|NCT00929526|564841967|FG001|Overall Study|Other|6|||
156476948|NCT02169414|564841970|FG000|Overall Study|Withdrawal by Subject|1|||
156476949|NCT02169414|564841971|FG001|Overall Study|Withdrawal by Subject|0|||
156476950|NCT02169414|564841972|FG002|Overall Study|Withdrawal by Subject|0|||
156476951|NCT02169414|564841973|FG003|Overall Study|Withdrawal by Subject|0|||
156476952|NCT02169414|564841970|FG000|Overall Study|Adverse Event|0|||
156476953|NCT02169414|564841971|FG001|Overall Study|Adverse Event|1|||
156476954|NCT02169414|564841972|FG002|Overall Study|Adverse Event|0|||
156476955|NCT02169414|564841973|FG003|Overall Study|Adverse Event|0|||
156476956|NCT00578344|564841974|FG000|Overall Study|Insurance problems|1|||
156476957|NCT00578344|564841974|FG000|Overall Study|Graft failure|1|||
156476958|NCT03374254|564841977|FG000|Overall Study|Death|5|||
156476959|NCT03374254|564841978|FG001|Overall Study|Death|16|||
156476960|NCT03374254|564841979|FG002|Overall Study|Death|13|||
156476961|NCT03374254|564841980|FG003|Overall Study|Death|11|||
156476962|NCT03374254|564841981|FG004|Overall Study|Death|9|||
156476963|NCT03374254|564841982|FG005|Overall Study|Death|12|||
156476964|NCT03374254|564841983|FG006|Overall Study|Death|11|||
156476965|NCT03374254|564841984|FG007|Overall Study|Death|6|||
156476966|NCT03374254|564841985|FG008|Overall Study|Death|7|||
156476967|NCT03374254|564841977|FG000|Overall Study|Lost to Follow-up|0|||
156476968|NCT03374254|564841978|FG001|Overall Study|Lost to Follow-up|0|||
156476969|NCT03374254|564841979|FG002|Overall Study|Lost to Follow-up|0|||
156476970|NCT03374254|564841980|FG003|Overall Study|Lost to Follow-up|0|||
156476971|NCT03374254|564841981|FG004|Overall Study|Lost to Follow-up|0|||
156476972|NCT03374254|564841982|FG005|Overall Study|Lost to Follow-up|0|||
156476973|NCT03374254|564841983|FG006|Overall Study|Lost to Follow-up|2|||
156476974|NCT03374254|564841984|FG007|Overall Study|Lost to Follow-up|0|||
156476975|NCT03374254|564841985|FG008|Overall Study|Lost to Follow-up|0|||
156476976|NCT03374254|564841977|FG000|Overall Study|Sponsor Decision|1|||
156476977|NCT03374254|564841978|FG001|Overall Study|Sponsor Decision|0|||
156476978|NCT03374254|564841979|FG002|Overall Study|Sponsor Decision|2|||
156476979|NCT03374254|564841980|FG003|Overall Study|Sponsor Decision|3|||
156476980|NCT03374254|564841981|FG004|Overall Study|Sponsor Decision|2|||
156476981|NCT03374254|564841982|FG005|Overall Study|Sponsor Decision|3|||
156476982|NCT03374254|564841983|FG006|Overall Study|Sponsor Decision|3|||
156476983|NCT03374254|564841984|FG007|Overall Study|Sponsor Decision|3|||
156476984|NCT03374254|564841985|FG008|Overall Study|Sponsor Decision|4|||
156476985|NCT03374254|564841977|FG000|Overall Study|Withdrawal by Subject|0|||
156476986|NCT03374254|564841978|FG001|Overall Study|Withdrawal by Subject|0|||
156476987|NCT03374254|564841979|FG002|Overall Study|Withdrawal by Subject|0|||
156476988|NCT03374254|564841980|FG003|Overall Study|Withdrawal by Subject|2|||
156476989|NCT03374254|564841981|FG004|Overall Study|Withdrawal by Subject|0|||
156476990|NCT03374254|564841982|FG005|Overall Study|Withdrawal by Subject|1|||
156476991|NCT03374254|564841983|FG006|Overall Study|Withdrawal by Subject|0|||
156476992|NCT03374254|564841984|FG007|Overall Study|Withdrawal by Subject|0|||
156476993|NCT03374254|564841985|FG008|Overall Study|Withdrawal by Subject|0|||
156476994|NCT02309515|564841987|FG000|Overall Study|Withdrawal by Subject|0|||
156476995|NCT02309515|564841988|FG001|Overall Study|Withdrawal by Subject|1|||
156476996|NCT04070105|564841989|FG000|Overall Study|Lost to Follow-up|0|||
156476997|NCT04070105|564841990|FG001|Overall Study|Lost to Follow-up|0|||
156476998|NCT04070105|564841991|FG002|Overall Study|Lost to Follow-up|0|||
156476999|NCT04070105|564841992|FG003|Overall Study|Lost to Follow-up|0|||
156477000|NCT04070105|564841993|FG004|Overall Study|Lost to Follow-up|0|||
156477001|NCT04070105|564841994|FG005|Overall Study|Lost to Follow-up|1|||
156477002|NCT01072149|564841997|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477003|NCT01072149|564841998|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477004|NCT01072149|564841999|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
156477005|NCT01072149|564842000|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477006|NCT01072149|564842001|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477007|NCT01072149|564842002|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477008|NCT01072149|564842003|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477009|NCT01072149|564842004|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477010|NCT01072149|564842005|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477011|NCT01072149|564842006|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477012|NCT01072149|564842007|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477013|NCT01072149|564842008|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477014|NCT01072149|564842009|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477015|NCT01072149|564842010|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477016|NCT01072149|564842011|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477017|NCT01072149|564842012|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477018|NCT01072149|564842013|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477019|NCT01072149|564842014|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156477020|NCT01072149|564841997|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477021|NCT01072149|564841998|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477022|NCT01072149|564841999|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477023|NCT01072149|564842000|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156863400|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156863401|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156863402|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
156863403|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
156863404|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156863405|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
156863406|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156863407|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
156863408|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
156477024|NCT01072149|564842001|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477025|NCT01072149|564842002|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477026|NCT01072149|564842003|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477027|NCT01072149|564842004|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477028|NCT01072149|564842005|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477029|NCT01072149|564842006|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477030|NCT01072149|564842007|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477031|NCT01072149|564842008|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477032|NCT01072149|564842009|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477033|NCT01072149|564842010|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477034|NCT01072149|564842011|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477035|NCT01072149|564842012|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477036|NCT01072149|564842013|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
156477037|NCT01072149|564842014|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
156477038|NCT01072149|564841997|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477039|NCT01072149|564841998|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477040|NCT01072149|564841999|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477041|NCT01072149|564842000|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477042|NCT01072149|564842001|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477043|NCT01072149|564842002|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477044|NCT01072149|564842003|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477045|NCT01072149|564842004|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477046|NCT01072149|564842005|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477047|NCT01072149|564842006|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477048|NCT01072149|564842007|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
156477049|NCT01072149|564842008|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477050|NCT01072149|564842009|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477051|NCT01072149|564842010|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477052|NCT01072149|564842011|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477053|NCT01072149|564842012|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477054|NCT01072149|564842013|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477055|NCT01072149|564842014|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
156477056|NCT01072149|564841997|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477057|NCT01072149|564841998|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
156477058|NCT01072149|564841999|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477059|NCT01072149|564842000|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477060|NCT01072149|564842001|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477061|NCT01072149|564842002|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477062|NCT01072149|564842003|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477063|NCT01072149|564842004|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477064|NCT01072149|564842005|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477065|NCT01072149|564842006|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477066|NCT01072149|564842007|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477067|NCT01072149|564842008|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477068|NCT01072149|564842009|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477069|NCT01072149|564842010|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477070|NCT01072149|564842011|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477071|NCT01072149|564842012|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477072|NCT01072149|564842013|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477073|NCT01072149|564842014|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
156477074|NCT01072149|564841997|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477075|NCT01072149|564841998|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477076|NCT01072149|564841999|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
156477077|NCT01072149|564842000|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477078|NCT01072149|564842001|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477079|NCT01072149|564842002|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477080|NCT01072149|564842003|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477081|NCT01072149|564842004|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477082|NCT01072149|564842005|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477083|NCT01072149|564842006|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477084|NCT01072149|564842007|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477085|NCT01072149|564842008|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477086|NCT01072149|564842009|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477087|NCT01072149|564842010|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477088|NCT01072149|564842011|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477089|NCT01072149|564842012|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477090|NCT01072149|564842013|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477091|NCT01072149|564842014|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
156477092|NCT01072149|564841997|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477093|NCT01072149|564841998|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477094|NCT01072149|564841999|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477095|NCT01072149|564842000|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
156542777|NCT00916149|565081307|FG001|Overall Study|Unable to place scalp EEG leads|0|||
156542778|NCT00916149|565081308|FG002|Overall Study|Unable to place scalp EEG leads|0|||
156542779|NCT00912028|565081311|FG000|Overall Study|Lost to Follow-up|2|||
156542780|NCT00912028|565081312|FG001|Overall Study|Lost to Follow-up|3|||
156477096|NCT01072149|564842001|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
156542781|NCT00912028|565081313|FG002|Overall Study|Lost to Follow-up|0|||
156542782|NCT00912028|565081314|FG003|Overall Study|Lost to Follow-up|1|||
156542783|NCT00912028|565081315|FG004|Overall Study|Lost to Follow-up|3|||
156344188|NCT00963547|564360152|FG004|Overall Study|Physician Decision|0|||
156344189|NCT00963547|564360153|FG005|Overall Study|Physician Decision|0|||
156344190|NCT00963547|564360154|FG006|Overall Study|Physician Decision|0|||
156344191|NCT00963547|564360148|FG000|Overall Study|Progressive Disease|3|||
156344192|NCT00963547|564360149|FG001|Overall Study|Progressive Disease|8|||
156344193|NCT00963547|564360150|FG002|Overall Study|Progressive Disease|9|||
156344194|NCT00963547|564360151|FG003|Overall Study|Progressive Disease|5|||
156344195|NCT00963547|564360152|FG004|Overall Study|Progressive Disease|0|||
156344196|NCT00963547|564360153|FG005|Overall Study|Progressive Disease|0|||
156344197|NCT00963547|564360154|FG006|Overall Study|Progressive Disease|0|||
156344198|NCT00963547|564360148|FG000|Overall Study|Withdrawal by Subject|0|||
156344199|NCT00963547|564360149|FG001|Overall Study|Withdrawal by Subject|0|||
156344200|NCT00963547|564360150|FG002|Overall Study|Withdrawal by Subject|3|||
156344201|NCT00963547|564360151|FG003|Overall Study|Withdrawal by Subject|0|||
156344202|NCT00963547|564360152|FG004|Overall Study|Withdrawal by Subject|0|||
156344203|NCT00963547|564360153|FG005|Overall Study|Withdrawal by Subject|0|||
156344204|NCT00963547|564360154|FG006|Overall Study|Withdrawal by Subject|0|||
156344205|NCT00963547|564360148|FG000|Overall Study|Reason Unknown|0|||
156344206|NCT00963547|564360149|FG001|Overall Study|Reason Unknown|1|||
156344207|NCT00963547|564360150|FG002|Overall Study|Reason Unknown|0|||
156344208|NCT00963547|564360151|FG003|Overall Study|Reason Unknown|0|||
156344209|NCT00963547|564360152|FG004|Overall Study|Reason Unknown|0|||
156344210|NCT00963547|564360153|FG005|Overall Study|Reason Unknown|0|||
156344211|NCT00963547|564360154|FG006|Overall Study|Reason Unknown|0|||
156344212|NCT03761277|564360158|FG000|Enrollment to Implant|Screen Failure|17|||
156344213|NCT03761277|564360158|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
156344214|NCT03761277|564360158|FG000|Enrollment to Implant|Physician Decision|2|||
156344215|NCT03761277|564360158|FG000|Enrollment to Implant|Site Closure|3|||
156344216|NCT03761277|564360158|FG000|Enrollment to Implant|Sponsor Request|2|||
156344217|NCT03761277|564360158|FG000|Post-Implant to 6 Months|Adverse Event|2|||
156344218|NCT03761277|564360158|FG000|Post-Implant to 6 Months|Death|1|||
156344219|NCT03761277|564360158|FG000|Post-Implant to 6 Months|Site Closure|2|||
156344220|NCT03761277|564360158|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
156344221|NCT03761277|564360158|FG000|6 Months to 12 Months|Physician Decision|2|||
156344222|NCT03761277|564360158|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
156344223|NCT04532164|564360159|FG000|Overall Study|Adverse Event|1|||
156344224|NCT04532164|564360159|FG000|Overall Study|Protocol Violation|5|||
156344225|NCT04532164|564360159|FG000|Overall Study|Lost to Follow-up|1|||
156344226|NCT04532164|564360159|FG000|Overall Study|Found to be Ineligible|3|||
156344227|NCT04532164|564360159|FG000|Overall Study|Withdrawal by Subject|14|||
156344228|NCT04492618|564360162|FG000|Overall Study|Withdrawal by Subject|1|||
156344229|NCT02041286|564360165|FG000|Overall Study|Adverse Event|1|||
156344230|NCT04166435|564360170|FG000|Overall Study|2 patients ineligible for response|2|||
156344231|NCT00127660|564360171|FG000|Overall Study|Protocol Violation|3|||
156344232|NCT00127660|564360172|FG001|Overall Study|Protocol Violation|3|||
156344233|NCT00127660|564360173|FG002|Overall Study|Protocol Violation|5|||
156344234|NCT00127660|564360174|FG003|Overall Study|Protocol Violation|0|||
156477097|NCT01072149|564842002|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477098|NCT01072149|564842003|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477099|NCT01072149|564842004|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
156477100|NCT01072149|564842005|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477101|NCT01072149|564842006|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477102|NCT01072149|564842007|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477103|NCT01072149|564842008|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477104|NCT01072149|564842009|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477105|NCT01072149|564842010|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477106|NCT01072149|564842011|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477107|NCT01072149|564842012|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477108|NCT01072149|564842013|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
156344235|NCT01425281|564360175|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
156344236|NCT01425281|564360176|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
156344237|NCT01425281|564360175|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
156344238|NCT01425281|564360176|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
156344239|NCT01425281|564360175|FG000|At 180-day Clinical Follow-up|Death|0|||
156344240|NCT01425281|564360176|FG001|At 180-day Clinical Follow-up|Death|1|||
156344241|NCT01425281|564360175|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
156344242|NCT01425281|564360176|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
156344243|NCT01425281|564360175|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
156344244|NCT01425281|564360176|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
156344245|NCT01425281|564360175|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
156344246|NCT01425281|564360176|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
156344247|NCT01425281|564360175|FG000|At 2-year Clinical Follow-up|Death|2|||
156344248|NCT01425281|564360176|FG001|At 2-year Clinical Follow-up|Death|0|||
156344249|NCT01425281|564360175|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
156477109|NCT01072149|564842014|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
156477110|NCT01072149|564841997|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
156477111|NCT01072149|564841998|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
156477112|NCT01072149|564841999|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
156477113|NCT01072149|564842000|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
156477114|NCT01072149|564842001|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
156477115|NCT01072149|564842002|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
156477116|NCT01072149|564842003|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
156477117|NCT01072149|564842004|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
156477118|NCT01072149|564842005|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
156477119|NCT01072149|564842006|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
156477120|NCT01072149|564842007|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
156477121|NCT01072149|564842008|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
156477122|NCT01072149|564842009|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
156477123|NCT01072149|564842010|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
156477124|NCT01072149|564842011|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
156477125|NCT01072149|564842012|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
156477126|NCT01072149|564842013|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
156477127|NCT01072149|564842014|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
156477128|NCT01072149|564841997|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477129|NCT01072149|564841998|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477130|NCT01072149|564841999|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477131|NCT01072149|564842000|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477132|NCT01072149|564842001|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477133|NCT01072149|564842002|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477134|NCT01072149|564842003|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477135|NCT01072149|564842004|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477136|NCT01072149|564842005|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477137|NCT01072149|564842006|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477138|NCT01072149|564842007|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477139|NCT01072149|564842008|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477140|NCT01072149|564842009|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477141|NCT01072149|564842010|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477142|NCT01072149|564842011|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477143|NCT01072149|564842012|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
156477144|NCT01072149|564842013|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477145|NCT01072149|564842014|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
156477146|NCT01072149|564841997|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
156477147|NCT01072149|564841998|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
156477148|NCT01072149|564841999|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
156477149|NCT01072149|564842000|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
156477150|NCT01072149|564842001|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
156477151|NCT01072149|564842002|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
156477152|NCT01072149|564842003|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
156477153|NCT01072149|564842004|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
156477154|NCT01072149|564842005|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
156477155|NCT01072149|564842006|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
156477156|NCT01072149|564842007|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
156477157|NCT01072149|564842008|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
156477158|NCT01072149|564842009|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
156477159|NCT01072149|564842010|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
156477160|NCT01072149|564842011|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
156477161|NCT01072149|564842012|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
156477162|NCT01072149|564842013|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
156477163|NCT01072149|564842014|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
156477164|NCT01072149|564841997|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477165|NCT01072149|564841998|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477166|NCT01072149|564841999|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477167|NCT01072149|564842000|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477168|NCT01072149|564842001|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477169|NCT01072149|564842002|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477170|NCT01072149|564842003|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477171|NCT01072149|564842004|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477172|NCT01072149|564842005|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477173|NCT01072149|564842006|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477174|NCT01072149|564842007|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477175|NCT01072149|564842008|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477176|NCT01072149|564842009|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
156477177|NCT01072149|564842010|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477178|NCT01072149|564842011|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477179|NCT01072149|564842012|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477180|NCT01072149|564842013|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477181|NCT01072149|564842014|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
156477182|NCT01072149|564841997|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477183|NCT01072149|564841998|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477184|NCT01072149|564841999|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
156477185|NCT01072149|564842000|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477186|NCT01072149|564842001|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477187|NCT01072149|564842002|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477188|NCT01072149|564842003|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477189|NCT01072149|564842004|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477190|NCT01072149|564842005|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477191|NCT01072149|564842006|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477192|NCT01072149|564842007|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477193|NCT01072149|564842008|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477194|NCT01072149|564842009|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477195|NCT01072149|564842010|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
156477196|NCT01072149|564842011|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477197|NCT01072149|564842012|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477198|NCT01072149|564842013|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477199|NCT01072149|564842014|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
156477200|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
156542784|NCT00912028|565081311|FG000|Overall Study|Withdrawal by Subject|3|||
156344250|NCT01425281|564360176|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
156344251|NCT01425281|564360175|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
156344252|NCT01425281|564360176|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
156344253|NCT01425281|564360175|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
156344254|NCT01425281|564360176|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
156344255|NCT01425281|564360175|FG000|At 3-year Clinical Follow-up|Death|2|||
156344256|NCT01425281|564360176|FG001|At 3-year Clinical Follow-up|Death|3|||
156344257|NCT01425281|564360175|FG000|At 4-year Clinical Follow-up|Death|7|||
156344258|NCT01425281|564360176|FG001|At 4-year Clinical Follow-up|Death|3|||
156344259|NCT01425281|564360175|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
156344260|NCT01425281|564360176|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
156344261|NCT01425281|564360175|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
156344262|NCT01425281|564360176|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
156344263|NCT01425281|564360175|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
156344264|NCT01425281|564360176|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
156344265|NCT01425281|564360175|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
156344266|NCT01425281|564360176|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
156344267|NCT01425281|564360175|FG000|At 5-year Clinical Follow-up|Death|2|||
156344268|NCT01425281|564360176|FG001|At 5-year Clinical Follow-up|Death|0|||
156344269|NCT01425281|564360175|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
156344270|NCT01425281|564360176|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
156344271|NCT01425281|564360175|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
156344272|NCT01425281|564360176|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
156344273|NCT01425281|564360175|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
156344274|NCT01425281|564360176|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
156344275|NCT01833520|564360177|FG000|Overall Study|Lack of Efficacy|3|||
156344276|NCT01833520|564360178|FG001|Overall Study|Lack of Efficacy|3|||
156344277|NCT01833520|564360179|FG002|Overall Study|Lack of Efficacy|8|||
156344278|NCT01833520|564360180|FG003|Overall Study|Lack of Efficacy|3|||
156344279|NCT05131646|564360181|FG000|Overall Study|Withdrawal by Subject|1|||
156344280|NCT05131646|564360182|FG001|Overall Study|Withdrawal by Subject|0|||
156344281|NCT05131646|564360183|FG002|Overall Study|Withdrawal by Subject|0|||
156344282|NCT03266107|564360184|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
156344283|NCT03266107|564360184|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
156344284|NCT03266107|564360184|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
156344285|NCT03266107|564360184|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
156344286|NCT02548650|564360187|FG000|Triple Therapy|Adverse Event|1|||
156344287|NCT02548650|564360188|FG001|Triple Therapy|Adverse Event|0|||
156344288|NCT02548650|564360187|FG000|Triple Therapy|Withdrawal by Subject|0|||
156344289|NCT02548650|564360188|FG001|Triple Therapy|Withdrawal by Subject|4|||
156344290|NCT02548650|564360187|FG000|Double Therapy|Adverse Event|1|||
156344291|NCT02548650|564360188|FG001|Double Therapy|Adverse Event|1|||
156344292|NCT02548650|564360187|FG000|Double Therapy|Withdrawal by Subject|0|||
156344293|NCT02548650|564360188|FG001|Double Therapy|Withdrawal by Subject|1|||
156344294|NCT01191801|564360189|FG000|Overall Study|Death|36|||
156344295|NCT01191801|564360190|FG001|Overall Study|Death|12|||
156344296|NCT01191801|564360189|FG000|Overall Study|Lack of Efficacy|176|||
156344297|NCT01191801|564360190|FG001|Overall Study|Lack of Efficacy|258|||
156344298|NCT01191801|564360189|FG000|Overall Study|Adverse Event|9|||
156344299|NCT01191801|564360190|FG001|Overall Study|Adverse Event|8|||
156344300|NCT01191801|564360189|FG000|Overall Study|Protocol Violation|2|||
156344301|NCT01191801|564360190|FG001|Overall Study|Protocol Violation|4|||
156344302|NCT01191801|564360189|FG000|Overall Study|Physician Decision|47|||
156344303|NCT01191801|564360190|FG001|Overall Study|Physician Decision|24|||
156344304|NCT01191801|564360189|FG000|Overall Study|Withdrawal by Subject|1|||
156344305|NCT01191801|564360190|FG001|Overall Study|Withdrawal by Subject|4|||
156344306|NCT01191801|564360189|FG000|Overall Study|Not Provided|45|||
156344307|NCT01191801|564360190|FG001|Overall Study|Not Provided|27|||
156344308|NCT00003479|564360191|FG000|Overall Study|Not evaluable|3|||
156344309|NCT02128113|564360192|FG000|Overall Study|Withdrawal by Subject|3|||
156344310|NCT02128113|564360193|FG001|Overall Study|Withdrawal by Subject|1|||
156344311|NCT02128113|564360194|FG002|Overall Study|Withdrawal by Subject|0|||
156344312|NCT02128113|564360192|FG000|Overall Study|Protocol Violation|0|||
156344313|NCT02128113|564360193|FG001|Overall Study|Protocol Violation|1|||
156344314|NCT02128113|564360194|FG002|Overall Study|Protocol Violation|0|||
156344315|NCT02128113|564360192|FG000|Overall Study|Surgery cancelled|0|||
156344316|NCT02128113|564360193|FG001|Overall Study|Surgery cancelled|1|||
156344317|NCT02128113|564360194|FG002|Overall Study|Surgery cancelled|0|||
156344318|NCT02128113|564360192|FG000|Overall Study|Adverse Event|0|||
156344319|NCT02128113|564360193|FG001|Overall Study|Adverse Event|0|||
156344320|NCT02128113|564360194|FG002|Overall Study|Adverse Event|1|||
156344321|NCT02969369|564360195|FG000|Study|Adverse Event|1|||
156344322|NCT02969369|564360196|FG001|Study|Adverse Event|6|||
156344323|NCT02969369|564360195|FG000|Study|Lack of Efficacy|0|||
156477201|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
156477202|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
156477203|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
156477204|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Adverse Event|7|||
156477205|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Adverse Event|8|||
156477206|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Adverse Event|8|||
156477207|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Adverse Event|9|||
156477208|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
156477209|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
156477210|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
156477211|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
156477212|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
156477213|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
156477214|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
156477215|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
156477216|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Pregnancy|0|||
156477217|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Pregnancy|2|||
156477218|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Pregnancy|2|||
156477219|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Pregnancy|0|||
156477220|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Non-compliance|1|||
156477221|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Non-compliance|0|||
156477222|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Non-compliance|0|||
156477223|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Non-compliance|3|||
156477224|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Other|3|||
156477225|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Other|0|||
156477226|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Other|3|||
156477227|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Other|2|||
156477228|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
156477229|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
156477230|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
156477231|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
156477232|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
156477233|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
156477234|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
156477235|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
156477236|NCT02143713|564842015|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
156477237|NCT02143713|564842016|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
156477238|NCT02143713|564842017|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
156477239|NCT02143713|564842018|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
156477240|NCT02143713|564842015|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
156477241|NCT02143713|564842016|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
156477242|NCT02143713|564842017|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
156477243|NCT02143713|564842018|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
156477244|NCT02143713|564842015|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
156477245|NCT02143713|564842016|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
156477246|NCT02143713|564842017|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
156477247|NCT02143713|564842018|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
156477248|NCT02143713|564842015|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
156477249|NCT02143713|564842016|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
156477250|NCT02143713|564842017|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
156477251|NCT02143713|564842018|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
156477252|NCT02143713|564842015|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
156542785|NCT00912028|565081312|FG001|Overall Study|Withdrawal by Subject|0|||
156542786|NCT00912028|565081313|FG002|Overall Study|Withdrawal by Subject|0|||
156542787|NCT00912028|565081314|FG003|Overall Study|Withdrawal by Subject|0|||
156542788|NCT00912028|565081315|FG004|Overall Study|Withdrawal by Subject|0|||
156542789|NCT00978029|565081316|FG000|Overall Study|Adverse Event|1|||
156477253|NCT02143713|564842016|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
156477254|NCT02143713|564842017|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
156477255|NCT02143713|564842018|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
156477256|NCT02143713|564842015|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
156477257|NCT02143713|564842016|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
156477258|NCT02143713|564842017|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
156477259|NCT02143713|564842018|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
156477260|NCT02143713|564842015|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
156477261|NCT02143713|564842016|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
156477262|NCT02143713|564842017|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
156542790|NCT00978029|565081317|FG001|Overall Study|Adverse Event|2|||
156477263|NCT02143713|564842018|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
156477264|NCT02245620|564842021|FG000|Overall Study|Physician Decision|1|||
156477265|NCT02245620|564842022|FG001|Overall Study|Physician Decision|1|||
156477266|NCT01768572|564842023|FG000|Overall Study|Adverse Event|7|||
156477267|NCT01768572|564842024|FG001|Overall Study|Adverse Event|8|||
156477268|NCT01768572|564842025|FG002|Overall Study|Adverse Event|4|||
156477269|NCT01768572|564842023|FG000|Overall Study|Lack of Efficacy|1|||
156477270|NCT01768572|564842024|FG001|Overall Study|Lack of Efficacy|3|||
156477271|NCT01768572|564842025|FG002|Overall Study|Lack of Efficacy|1|||
156477272|NCT01768572|564842023|FG000|Overall Study|Other, Not due to an adverse event|1|||
156477273|NCT01768572|564842024|FG001|Overall Study|Other, Not due to an adverse event|1|||
156477274|NCT01768572|564842025|FG002|Overall Study|Other, Not due to an adverse event|1|||
156477275|NCT01999335|564842026|FG000|Overall Study|Discontinued before receiving treatment|0|||
156477276|NCT01999335|564842027|FG001|Overall Study|Discontinued before receiving treatment|0|||
156477277|NCT01999335|564842028|FG002|Overall Study|Discontinued before receiving treatment|0|||
156477278|NCT01999335|564842029|FG003|Overall Study|Discontinued before receiving treatment|0|||
156477279|NCT01999335|564842030|FG004|Overall Study|Discontinued before receiving treatment|2|||
156477280|NCT00080119|564842031|FG000|Overall Study|Discontinued because of study closure|0|||
156477281|NCT00080119|564842032|FG001|Overall Study|Discontinued because of study closure|0|||
156477282|NCT00080119|564842033|FG002|Overall Study|Discontinued because of study closure|130|||
156477283|NCT00080119|564842034|FG003|Overall Study|Discontinued because of study closure|141|||
156477284|NCT00080119|564842031|FG000|Overall Study|Unable to get to clinic|24|||
156477285|NCT00080119|564842032|FG001|Overall Study|Unable to get to clinic|24|||
156477286|NCT00080119|564842033|FG002|Overall Study|Unable to get to clinic|7|||
156477287|NCT00080119|564842034|FG003|Overall Study|Unable to get to clinic|1|||
156477288|NCT00080119|564842031|FG000|Overall Study|Consent withdrawn|13|||
156477289|NCT00080119|564842032|FG001|Overall Study|Consent withdrawn|17|||
156477290|NCT00080119|564842033|FG002|Overall Study|Consent withdrawn|4|||
156477291|NCT00080119|564842034|FG003|Overall Study|Consent withdrawn|6|||
156477292|NCT00080119|564842031|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
156477293|NCT00080119|564842032|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
156477294|NCT00080119|564842033|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
156477295|NCT00080119|564842034|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
156477296|NCT00080119|564842031|FG000|Overall Study|Lost to Follow-up|16|||
156477297|NCT00080119|564842032|FG001|Overall Study|Lost to Follow-up|19|||
156477298|NCT00080119|564842033|FG002|Overall Study|Lost to Follow-up|19|||
156477299|NCT00080119|564842034|FG003|Overall Study|Lost to Follow-up|14|||
156477300|NCT04766996|564842035|FG000|Overall Study|Withdrawal by Subject|1|||
156477301|NCT04766996|564842036|FG001|Overall Study|Withdrawal by Subject|0|||
156477302|NCT04766996|564842037|FG002|Overall Study|Withdrawal by Subject|13|||
156477303|NCT01322386|564842038|FG000|Overall Study|Protocol Violation|0|||
156477304|NCT01322386|564842039|FG001|Overall Study|Protocol Violation|1|||
156477305|NCT01322386|564842038|FG000|Overall Study|Physician Decision|0|||
156477306|NCT01322386|564842039|FG001|Overall Study|Physician Decision|1|||
156477307|NCT00871494|564842050|FG000|Overall Study|Protocol Violation|5|||
156477308|NCT00871494|564842050|FG000|Overall Study|Lack of Efficacy|4|||
156477309|NCT00871494|564842050|FG000|Overall Study|Adverse Event|4|||
156477310|NCT00871494|564842050|FG000|Overall Study|Lost to Follow-up|1|||
156477311|NCT00889863|564842054|FG000|Part I: Open Label|Death|1|||
156477312|NCT00889863|564842055|FG001|Part I: Open Label|Death|0|||
156477313|NCT00889863|564842054|FG000|Part I: Open Label|Adverse Event|4|||
156477314|NCT00889863|564842055|FG001|Part I: Open Label|Adverse Event|0|||
156477315|NCT00889863|564842054|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
156477316|NCT00889863|564842055|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
156477317|NCT00889863|564842054|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
156477318|NCT00889863|564842055|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
156477319|NCT00889863|564842054|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
156477320|NCT00889863|564842055|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
156477321|NCT00889863|564842054|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
156477322|NCT00889863|564842055|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
156477323|NCT00889863|564842054|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
156477324|NCT00889863|564842055|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
156477325|NCT04410445|564842064|FG000|Overall Study|Lost to Follow-up|3|||
156477326|NCT04410445|564842065|FG001|Overall Study|Lost to Follow-up|9|||
156477327|NCT04410445|564842064|FG000|Overall Study|Withdrawal by Subject|27|||
156477328|NCT04410445|564842065|FG001|Overall Study|Withdrawal by Subject|15|||
156477329|NCT03547154|564842071|FG000|Overall Study|Disease Progression/Recurrence|6|||
156477330|NCT03547154|564842072|FG001|Overall Study|Disease Progression/Recurrence|14|||
156477331|NCT03547154|564842071|FG000|Overall Study|Adverse Event|26|||
156542791|NCT00978029|565081318|FG002|Overall Study|Adverse Event|5|||
156477332|NCT03547154|564842072|FG001|Overall Study|Adverse Event|31|||
156477333|NCT03547154|564842071|FG000|Overall Study|Protocol Violation|6|||
156477334|NCT03547154|564842072|FG001|Overall Study|Protocol Violation|1|||
156344324|NCT02969369|564360196|FG001|Study|Lack of Efficacy|1|||
156542792|NCT00978029|565081316|FG000|Overall Study|Withdrawal by Subject|0|||
156542793|NCT00978029|565081317|FG001|Overall Study|Withdrawal by Subject|0|||
156542794|NCT00978029|565081318|FG002|Overall Study|Withdrawal by Subject|1|||
156542795|NCT00978029|565081316|FG000|Overall Study|Protocol Violation|0|||
156542796|NCT00978029|565081317|FG001|Overall Study|Protocol Violation|1|||
156542797|NCT00978029|565081318|FG002|Overall Study|Protocol Violation|0|||
156542798|NCT00545298|565081319|FG000|Overall Study|Issues with Standard of Care|2|||
156542799|NCT00545298|565081320|FG001|Overall Study|Issues with Standard of Care|0|||
156542800|NCT00545298|565081321|FG002|Overall Study|Issues with Standard of Care|1|||
156542801|NCT01793142|565081322|FG000|Overall Study|Randomized not treated|7|||
156542802|NCT01820364|565081323|FG000|Part I: LGX818|Death|1|||
156542803|NCT01820364|565081324|FG001|Part I: LGX818|Death|0|||
156542804|NCT01820364|565081323|FG000|Part I: LGX818|Administrative Problems|3|||
156542805|NCT01820364|565081324|FG001|Part I: LGX818|Administrative Problems|0|||
156542806|NCT01820364|565081323|FG000|Part I: LGX818|Adverse Event|6|||
156542807|NCT01820364|565081324|FG001|Part I: LGX818|Adverse Event|0|||
156542808|NCT01820364|565081323|FG000|Part I: LGX818|Disease Progression|4|||
156542809|NCT01820364|565081324|FG001|Part I: LGX818|Disease Progression|0|||
156542810|NCT01820364|565081323|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
156542811|NCT01820364|565081324|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
156542812|NCT00808236|565081326|FG000|Overall Study|Was not resuscitated|50|||
156542813|NCT00808236|565081327|FG001|Overall Study|Was not resuscitated|56|||
156542814|NCT00808236|565081326|FG000|Overall Study|Pre-defined exclusion|13|||
156542815|NCT00808236|565081327|FG001|Overall Study|Pre-defined exclusion|3|||
156542816|NCT00808236|565081326|FG000|Overall Study|Lost to Follow-up|1|||
156542817|NCT00808236|565081327|FG001|Overall Study|Lost to Follow-up|1|||
156542818|NCT00808236|565081326|FG000|Overall Study|Physician Decision|0|||
156542819|NCT00808236|565081327|FG001|Overall Study|Physician Decision|1|||
156542820|NCT00808236|565081326|FG000|Overall Study|Death|18|||
156542821|NCT00808236|565081327|FG001|Overall Study|Death|30|||
156542822|NCT02230384|565081328|FG000|Phase 1|Lost to Follow-up|1|||
156542823|NCT02230384|565081329|FG001|Phase 1|Lost to Follow-up|0|||
156542824|NCT02230384|565081328|FG000|Phase 1|Physician Decision|0|||
156542825|NCT02230384|565081329|FG001|Phase 1|Physician Decision|1|||
156542826|NCT02230384|565081328|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
156542827|NCT02230384|565081329|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
156344325|NCT02969369|564360195|FG000|Study|Lost to Follow-up|0|||
156344326|NCT02969369|564360196|FG001|Study|Lost to Follow-up|1|||
156344327|NCT02969369|564360195|FG000|Study|Withdrawal by Subject|3|||
156344328|NCT02969369|564360196|FG001|Study|Withdrawal by Subject|5|||
156344329|NCT02969369|564360195|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
156344330|NCT02969369|564360196|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
156344331|NCT02969369|564360195|FG000|Double-blind Period|Adverse Event|1|||
156344332|NCT02969369|564360196|FG001|Double-blind Period|Adverse Event|5|||
156344333|NCT02969369|564360195|FG000|Double-blind Period|Lost to Follow-up|0|||
156344334|NCT02969369|564360196|FG001|Double-blind Period|Lost to Follow-up|1|||
156344335|NCT02969369|564360195|FG000|Double-blind Period|Withdrawal by Subject|2|||
156344336|NCT02969369|564360196|FG001|Double-blind Period|Withdrawal by Subject|3|||
156344337|NCT02969369|564360195|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
156344338|NCT02969369|564360196|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
156344339|NCT02969369|564360195|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
156344340|NCT02969369|564360196|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
156344341|NCT02969369|564360195|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
156344342|NCT02969369|564360196|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
156344343|NCT02969369|564360195|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
156344344|NCT02969369|564360196|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
156344345|NCT01484197|564360204|FG000|Treatment Period 1|Adverse Event|1|||
156344346|NCT01484197|564360205|FG001|Treatment Period 1|Adverse Event|0|||
156344347|NCT01484197|564360206|FG002|Treatment Period 1|Adverse Event|0|||
156344348|NCT01484197|564360207|FG003|Treatment Period 1|Adverse Event|0|||
156344349|NCT01484197|564360204|FG000|Treatment Period 2|Subject withdrew consent|0|||
156344350|NCT01484197|564360205|FG001|Treatment Period 2|Subject withdrew consent|0|||
156344351|NCT01484197|564360206|FG002|Treatment Period 2|Subject withdrew consent|0|||
156344352|NCT01484197|564360207|FG003|Treatment Period 2|Subject withdrew consent|1|||
156344353|NCT01727297|564360208|FG000|Overall Study|Death|13|||
156344354|NCT01727297|564360209|FG001|Overall Study|Death|0|||
156344355|NCT01727297|564360208|FG000|Overall Study|Protocol Violation|1|||
156344356|NCT01727297|564360209|FG001|Overall Study|Protocol Violation|10|||
156344357|NCT01727297|564360208|FG000|Overall Study|Adverse Event|3|||
156344358|NCT01727297|564360209|FG001|Overall Study|Adverse Event|1|||
156344359|NCT01727297|564360208|FG000|Overall Study|Lost to Follow-up|11|||
156344360|NCT01727297|564360209|FG001|Overall Study|Lost to Follow-up|0|||
156344361|NCT01727297|564360208|FG000|Overall Study|Withdrawal by Subject|26|||
156344362|NCT01727297|564360209|FG001|Overall Study|Withdrawal by Subject|27|||
156344363|NCT01727297|564360208|FG000|Overall Study|Physician Decision|19|||
156344364|NCT01727297|564360209|FG001|Overall Study|Physician Decision|5|||
156344365|NCT01727297|564360208|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
156344366|NCT01727297|564360209|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
156344367|NCT01192516|564360210|FG000|Overall Study|Lost to Follow-up|7|||
156344368|NCT01192516|564360211|FG001|Overall Study|Lost to Follow-up|10|||
156344369|NCT01192516|564360212|FG002|Overall Study|Lost to Follow-up|7|||
156344370|NCT01192516|564360210|FG000|Overall Study|Withdrawal by Subject|4|||
156344371|NCT01192516|564360211|FG001|Overall Study|Withdrawal by Subject|4|||
156344372|NCT01192516|564360212|FG002|Overall Study|Withdrawal by Subject|1|||
156344373|NCT01192516|564360210|FG000|Overall Study|started new treatment|5|||
156344374|NCT01192516|564360211|FG001|Overall Study|started new treatment|1|||
156344375|NCT01192516|564360212|FG002|Overall Study|started new treatment|0|||
156344376|NCT01192516|564360210|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
156477335|NCT03547154|564842071|FG000|Overall Study|Physician Decision|4|||
156477336|NCT03547154|564842072|FG001|Overall Study|Physician Decision|3|||
156477337|NCT03547154|564842071|FG000|Overall Study|Insufficient Therapeutic Response|13|||
156477338|NCT03547154|564842072|FG001|Overall Study|Insufficient Therapeutic Response|10|||
156477339|NCT03547154|564842071|FG000|Overall Study|Withdrawal by Subject|10|||
156477340|NCT03547154|564842072|FG001|Overall Study|Withdrawal by Subject|6|||
156477341|NCT03547154|564842071|FG000|Overall Study|Not Selected|0|||
156477342|NCT03547154|564842072|FG001|Overall Study|Not Selected|1|||
156477343|NCT03547154|564842071|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
156344377|NCT01192516|564360211|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
156344378|NCT01192516|564360212|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
156344379|NCT01980992|564360220|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
156344380|NCT01980992|564360221|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
156344381|NCT01980992|564360220|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
156344382|NCT01980992|564360221|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
156344383|NCT01980992|564360220|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
156344384|NCT01980992|564360221|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
156344385|NCT01980992|564360220|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
156344386|NCT01980992|564360221|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
156344387|NCT01980992|564360220|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
156477344|NCT03547154|564842072|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
156477345|NCT02988713|564842073|FG000|Overall Study|Withdrawal by Subject|1|||
156477346|NCT02988713|564842073|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
156477347|NCT02404441|564842074|FG000|Phase 1 Part|Adverse Event|1|||
156477348|NCT02404441|564842075|FG001|Phase 1 Part|Adverse Event|0|||
156477349|NCT02404441|564842076|FG002|Phase 1 Part|Adverse Event|0|||
156477350|NCT02404441|564842077|FG003|Phase 1 Part|Adverse Event|0|||
156477351|NCT02404441|564842078|FG004|Phase 1 Part|Adverse Event|0|||
156477352|NCT02404441|564842079|FG005|Phase 1 Part|Adverse Event|0|||
156477353|NCT02404441|564842080|FG006|Phase 1 Part|Adverse Event|0|||
156477354|NCT02404441|564842081|FG007|Phase 1 Part|Adverse Event|0|||
156477355|NCT02404441|564842082|FG008|Phase 1 Part|Adverse Event|0|||
156477356|NCT02404441|564842083|FG009|Phase 1 Part|Adverse Event|0|||
156477357|NCT02404441|564842074|FG000|Phase 1 Part|Physician Decision|0|||
156477358|NCT02404441|564842075|FG001|Phase 1 Part|Physician Decision|1|||
156477359|NCT02404441|564842076|FG002|Phase 1 Part|Physician Decision|0|||
156477360|NCT02404441|564842077|FG003|Phase 1 Part|Physician Decision|0|||
156477361|NCT02404441|564842078|FG004|Phase 1 Part|Physician Decision|0|||
156477362|NCT02404441|564842079|FG005|Phase 1 Part|Physician Decision|0|||
156477363|NCT02404441|564842080|FG006|Phase 1 Part|Physician Decision|0|||
156477364|NCT02404441|564842081|FG007|Phase 1 Part|Physician Decision|0|||
156477365|NCT02404441|564842082|FG008|Phase 1 Part|Physician Decision|0|||
156477366|NCT02404441|564842083|FG009|Phase 1 Part|Physician Decision|0|||
156542828|NCT02230384|565081328|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
156542829|NCT02230384|565081329|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
156477367|NCT02404441|564842074|FG000|Phase 1 Part|Progressive Disease|14|||
156477368|NCT02404441|564842075|FG001|Phase 1 Part|Progressive Disease|11|||
156477369|NCT02404441|564842076|FG002|Phase 1 Part|Progressive Disease|7|||
156477370|NCT02404441|564842077|FG003|Phase 1 Part|Progressive Disease|6|||
156477371|NCT02404441|564842078|FG004|Phase 1 Part|Progressive Disease|9|||
156477372|NCT02404441|564842079|FG005|Phase 1 Part|Progressive Disease|0|||
156477373|NCT02404441|564842080|FG006|Phase 1 Part|Progressive Disease|0|||
156477374|NCT02404441|564842081|FG007|Phase 1 Part|Progressive Disease|0|||
156477375|NCT02404441|564842082|FG008|Phase 1 Part|Progressive Disease|0|||
156477376|NCT02404441|564842083|FG009|Phase 1 Part|Progressive Disease|0|||
156477377|NCT02404441|564842074|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
156477378|NCT02404441|564842075|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
156477379|NCT02404441|564842076|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
156477380|NCT02404441|564842077|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
156477381|NCT02404441|564842078|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
156477382|NCT02404441|564842079|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
156477383|NCT02404441|564842080|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
156477384|NCT02404441|564842081|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
156477385|NCT02404441|564842082|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
156477386|NCT02404441|564842083|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
156477387|NCT02404441|564842074|FG000|Phase 1 Part|Death|1|||
156477388|NCT02404441|564842075|FG001|Phase 1 Part|Death|1|||
156477389|NCT02404441|564842076|FG002|Phase 1 Part|Death|1|||
156477390|NCT02404441|564842077|FG003|Phase 1 Part|Death|0|||
156477391|NCT02404441|564842078|FG004|Phase 1 Part|Death|1|||
156477392|NCT02404441|564842079|FG005|Phase 1 Part|Death|0|||
156477393|NCT02404441|564842080|FG006|Phase 1 Part|Death|0|||
156477394|NCT02404441|564842081|FG007|Phase 1 Part|Death|0|||
156477395|NCT02404441|564842082|FG008|Phase 1 Part|Death|0|||
156477396|NCT02404441|564842083|FG009|Phase 1 Part|Death|0|||
156477397|NCT02404441|564842074|FG000|Phase 2 Part|Adverse Event|0|||
156477398|NCT02404441|564842075|FG001|Phase 2 Part|Adverse Event|0|||
156477399|NCT02404441|564842076|FG002|Phase 2 Part|Adverse Event|0|||
156477400|NCT02404441|564842077|FG003|Phase 2 Part|Adverse Event|0|||
156477401|NCT02404441|564842078|FG004|Phase 2 Part|Adverse Event|0|||
156477402|NCT02404441|564842079|FG005|Phase 2 Part|Adverse Event|2|||
156542830|NCT02230384|565081328|FG000|Phase 2 - Switch|Adverse Event|2|||
156542831|NCT02230384|565081329|FG001|Phase 2 - Switch|Adverse Event|0|||
156542832|NCT00961220|565081330|FG000|Overall Study|Adverse Event|3|||
156542833|NCT00961220|565081330|FG000|Overall Study|Lack of Efficacy|1|||
156542834|NCT00961220|565081330|FG000|Overall Study|No IV access for O6BG|1|||
156542835|NCT00961220|565081330|FG000|Overall Study|O6BG no longer supplied|1|||
156542836|NCT00961220|565081330|FG000|Overall Study|Complete Response prior to 12 courses|1|||
156542837|NCT00825162|565081333|FG000|Overall Study|Withdrawal by Subject|11|||
156542838|NCT00825162|565081334|FG001|Overall Study|Withdrawal by Subject|13|||
156542839|NCT00825162|565081335|FG002|Overall Study|Withdrawal by Subject|3|||
156542840|NCT00825162|565081333|FG000|Overall Study|Lost to Follow-up|9|||
156542841|NCT00825162|565081334|FG001|Overall Study|Lost to Follow-up|6|||
156542842|NCT00825162|565081335|FG002|Overall Study|Lost to Follow-up|3|||
156542843|NCT00825162|565081333|FG000|Overall Study|Physician Decision|2|||
156542844|NCT00825162|565081334|FG001|Overall Study|Physician Decision|0|||
156542845|NCT00825162|565081335|FG002|Overall Study|Physician Decision|0|||
156542846|NCT00825162|565081333|FG000|Overall Study|Move away from the study area|1|||
156542847|NCT00825162|565081334|FG001|Overall Study|Move away from the study area|0|||
156542848|NCT00825162|565081335|FG002|Overall Study|Move away from the study area|0|||
156542849|NCT00825162|565081333|FG000|Overall Study|Unable to attend the study visit|5|||
156542850|NCT00825162|565081334|FG001|Overall Study|Unable to attend the study visit|2|||
156542851|NCT00825162|565081335|FG002|Overall Study|Unable to attend the study visit|0|||
156542852|NCT00258674|565081342|FG000|Overall Study|Death|32|||
156542853|NCT00258674|565081343|FG001|Overall Study|Death|53|||
156542854|NCT00258674|565081344|FG002|Overall Study|Death|34|||
156542855|NCT00432042|565081349|FG000|Overall Study|Protocol Violation|2|||
156542856|NCT00432042|565081350|FG001|Overall Study|Protocol Violation|0|||
156542857|NCT00432042|565081351|FG002|Overall Study|Protocol Violation|0|||
156542858|NCT00432042|565081349|FG000|Overall Study|Withdrawal by Subject|0|||
156542859|NCT00432042|565081350|FG001|Overall Study|Withdrawal by Subject|0|||
156542860|NCT00432042|565081351|FG002|Overall Study|Withdrawal by Subject|2|||
156542861|NCT00432042|565081349|FG000|Overall Study|Lost to Follow-up|5|||
156542862|NCT00432042|565081350|FG001|Overall Study|Lost to Follow-up|1|||
156542863|NCT00432042|565081351|FG002|Overall Study|Lost to Follow-up|0|||
156542864|NCT00747643|565082584|FG000|Overall Study|Withdrawal by Subject|36|||
156542865|NCT00747643|565082585|FG001|Overall Study|Withdrawal by Subject|27|||
156542866|NCT01417195|565082588|FG000|Overall Study|Stimulation failure|1|||
156542867|NCT01417195|565082589|FG001|Overall Study|Stimulation failure|0|||
156542868|NCT01417195|565082588|FG000|Overall Study|No embryos for transfer|0|||
156542869|NCT01417195|565082589|FG001|Overall Study|No embryos for transfer|1|||
156542870|NCT01417195|565082588|FG000|Overall Study|No transfer due to risk of OHSS|1|||
156542871|NCT01417195|565082589|FG001|Overall Study|No transfer due to risk of OHSS|0|||
156542872|NCT01417195|565082588|FG000|Overall Study|No transfer due to elevated progesterone|1|||
156542873|NCT01417195|565082589|FG001|Overall Study|No transfer due to elevated progesterone|0|||
156542874|NCT01239342|565082590|FG000|Overall Study|Adverse Event|1|||
156542875|NCT01239342|565082591|FG001|Overall Study|Adverse Event|0|||
156542876|NCT01239342|565082590|FG000|Overall Study|Withdrawal by Subject|1|||
156542877|NCT01239342|565082591|FG001|Overall Study|Withdrawal by Subject|5|||
156542878|NCT01239342|565082590|FG000|Overall Study|Reason Unknown|1|||
156542879|NCT01239342|565082591|FG001|Overall Study|Reason Unknown|1|||
156542880|NCT02918864|565082592|FG000|Overall Study|Withdrawal by Subject|1|||
156542881|NCT02918864|565082593|FG001|Overall Study|Withdrawal by Subject|1|||
156542882|NCT02918864|565082592|FG000|Overall Study|Lost to Follow-up|3|||
156542883|NCT02918864|565082593|FG001|Overall Study|Lost to Follow-up|2|||
156542884|NCT04766021|565082594|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
156542885|NCT04766021|565082594|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
156542886|NCT01849874|565082601|FG000|Overall Study|Death|89|||
156542887|NCT01849874|565082602|FG001|Overall Study|Death|42|||
156542888|NCT01849874|565082601|FG000|Overall Study|Withdrawal by Subject|17|||
156542889|NCT01849874|565082602|FG001|Overall Study|Withdrawal by Subject|16|||
156542890|NCT01849874|565082601|FG000|Overall Study|Lost to Follow-up|3|||
156542891|NCT01849874|565082602|FG001|Overall Study|Lost to Follow-up|2|||
156542892|NCT01849874|565082601|FG000|Overall Study|Study Termination By Sponsor|93|||
156542893|NCT01849874|565082602|FG001|Overall Study|Study Termination By Sponsor|48|||
156542894|NCT01849874|565082601|FG000|Overall Study|Completed as per protocol amendment 6|3|||
156542895|NCT01849874|565082602|FG001|Overall Study|Completed as per protocol amendment 6|0|||
156542896|NCT01849874|565082601|FG000|Overall Study|Physician Decision|7|||
156477403|NCT02404441|564842080|FG006|Phase 2 Part|Adverse Event|3|||
156477404|NCT02404441|564842081|FG007|Phase 2 Part|Adverse Event|3|||
156477405|NCT02404441|564842082|FG008|Phase 2 Part|Adverse Event|6|||
156477406|NCT02404441|564842083|FG009|Phase 2 Part|Adverse Event|1|||
156477407|NCT02404441|564842074|FG000|Phase 2 Part|Physician Decision|0|||
156477408|NCT02404441|564842075|FG001|Phase 2 Part|Physician Decision|0|||
156477409|NCT02404441|564842076|FG002|Phase 2 Part|Physician Decision|0|||
156477410|NCT02404441|564842077|FG003|Phase 2 Part|Physician Decision|0|||
156477411|NCT02404441|564842078|FG004|Phase 2 Part|Physician Decision|0|||
156477412|NCT02404441|564842079|FG005|Phase 2 Part|Physician Decision|7|||
156477413|NCT02404441|564842080|FG006|Phase 2 Part|Physician Decision|9|||
156477414|NCT02404441|564842081|FG007|Phase 2 Part|Physician Decision|2|||
156477415|NCT02404441|564842082|FG008|Phase 2 Part|Physician Decision|1|||
156477416|NCT02404441|564842083|FG009|Phase 2 Part|Physician Decision|3|||
156477417|NCT02404441|564842074|FG000|Phase 2 Part|Progressive disease|0|||
156477418|NCT02404441|564842075|FG001|Phase 2 Part|Progressive disease|0|||
156477419|NCT02404441|564842076|FG002|Phase 2 Part|Progressive disease|0|||
156477420|NCT02404441|564842077|FG003|Phase 2 Part|Progressive disease|0|||
156477421|NCT02404441|564842078|FG004|Phase 2 Part|Progressive disease|0|||
156477422|NCT02404441|564842079|FG005|Phase 2 Part|Progressive disease|43|||
156477423|NCT02404441|564842080|FG006|Phase 2 Part|Progressive disease|32|||
156477424|NCT02404441|564842081|FG007|Phase 2 Part|Progressive disease|31|||
156477425|NCT02404441|564842082|FG008|Phase 2 Part|Progressive disease|39|||
156477426|NCT02404441|564842083|FG009|Phase 2 Part|Progressive disease|27|||
156477427|NCT02404441|564842074|FG000|Phase 2 Part|Subject/guardian decision|0|||
156477428|NCT02404441|564842075|FG001|Phase 2 Part|Subject/guardian decision|0|||
156477429|NCT02404441|564842076|FG002|Phase 2 Part|Subject/guardian decision|0|||
156477430|NCT02404441|564842077|FG003|Phase 2 Part|Subject/guardian decision|0|||
156477431|NCT02404441|564842078|FG004|Phase 2 Part|Subject/guardian decision|0|||
156477432|NCT02404441|564842079|FG005|Phase 2 Part|Subject/guardian decision|3|||
156477433|NCT02404441|564842080|FG006|Phase 2 Part|Subject/guardian decision|9|||
156477434|NCT02404441|564842081|FG007|Phase 2 Part|Subject/guardian decision|0|||
156477435|NCT02404441|564842082|FG008|Phase 2 Part|Subject/guardian decision|3|||
156477436|NCT02404441|564842083|FG009|Phase 2 Part|Subject/guardian decision|2|||
156477437|NCT02404441|564842074|FG000|Phase 2 Part|Death|0|||
156477438|NCT02404441|564842075|FG001|Phase 2 Part|Death|0|||
156477439|NCT02404441|564842076|FG002|Phase 2 Part|Death|0|||
156477440|NCT02404441|564842077|FG003|Phase 2 Part|Death|0|||
156477441|NCT02404441|564842078|FG004|Phase 2 Part|Death|0|||
156477442|NCT02404441|564842079|FG005|Phase 2 Part|Death|4|||
156477443|NCT02404441|564842080|FG006|Phase 2 Part|Death|8|||
156477444|NCT02404441|564842081|FG007|Phase 2 Part|Death|4|||
156477445|NCT02404441|564842082|FG008|Phase 2 Part|Death|10|||
156477446|NCT02404441|564842083|FG009|Phase 2 Part|Death|9|||
156477447|NCT00088166|564842084|FG000|Overall Study|Adverse Event|11|||
156477448|NCT00088166|564842085|FG001|Overall Study|Adverse Event|9|||
156477449|NCT00088166|564842084|FG000|Overall Study|Death|3|||
156477450|NCT00088166|564842085|FG001|Overall Study|Death|1|||
156477451|NCT00088166|564842084|FG000|Overall Study|Lost to Follow-up|0|||
156477452|NCT00088166|564842085|FG001|Overall Study|Lost to Follow-up|1|||
156477453|NCT00088166|564842084|FG000|Overall Study|Physician Decision|4|||
156477454|NCT00088166|564842085|FG001|Overall Study|Physician Decision|1|||
156477455|NCT00088166|564842084|FG000|Overall Study|Protocol Violation|1|||
156477456|NCT00088166|564842085|FG001|Overall Study|Protocol Violation|5|||
156477457|NCT00088166|564842084|FG000|Overall Study|Patient deterioration|29|||
156477458|NCT00088166|564842085|FG001|Overall Study|Patient deterioration|39|||
156477459|NCT00088166|564842084|FG000|Overall Study|Withdrawal by Subject|5|||
156477460|NCT00088166|564842085|FG001|Overall Study|Withdrawal by Subject|5|||
156477461|NCT02671266|564842086|FG000|Overall Study|Withdrawal by Subject|1|||
156477462|NCT02671266|564842087|FG001|Overall Study|Withdrawal by Subject|1|||
156477463|NCT01029704|564842088|FG000|Overall Study|Adverse Event|0|||
156477464|NCT01029704|564842089|FG001|Overall Study|Adverse Event|0|||
156477465|NCT01029704|564842090|FG002|Overall Study|Adverse Event|0|||
156477466|NCT01029704|564842091|FG003|Overall Study|Adverse Event|0|||
156477467|NCT01029704|564842092|FG004|Overall Study|Adverse Event|0|||
156477468|NCT01029704|564842093|FG005|Overall Study|Adverse Event|0|||
156477469|NCT01029704|564842094|FG006|Overall Study|Adverse Event|1|||
156477470|NCT01029704|564842095|FG007|Overall Study|Adverse Event|1|||
156477471|NCT01029704|564842096|FG008|Overall Study|Adverse Event|0|||
156477472|NCT01029704|564842088|FG000|Overall Study|Withdrawal by Subject|0|||
156477473|NCT01029704|564842089|FG001|Overall Study|Withdrawal by Subject|0|||
156477474|NCT01029704|564842090|FG002|Overall Study|Withdrawal by Subject|0|||
156477475|NCT01029704|564842091|FG003|Overall Study|Withdrawal by Subject|0|||
156477476|NCT01029704|564842092|FG004|Overall Study|Withdrawal by Subject|2|||
156344388|NCT01980992|564360221|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
156477477|NCT01029704|564842093|FG005|Overall Study|Withdrawal by Subject|1|||
156477478|NCT01029704|564842094|FG006|Overall Study|Withdrawal by Subject|1|||
156477479|NCT01029704|564842095|FG007|Overall Study|Withdrawal by Subject|1|||
156477480|NCT01029704|564842096|FG008|Overall Study|Withdrawal by Subject|0|||
156477481|NCT01029704|564842088|FG000|Overall Study|Lost to Follow-up|0|||
156477482|NCT01029704|564842089|FG001|Overall Study|Lost to Follow-up|0|||
156477483|NCT01029704|564842090|FG002|Overall Study|Lost to Follow-up|0|||
156477484|NCT01029704|564842091|FG003|Overall Study|Lost to Follow-up|0|||
156477485|NCT01029704|564842092|FG004|Overall Study|Lost to Follow-up|0|||
156477486|NCT01029704|564842093|FG005|Overall Study|Lost to Follow-up|0|||
156477487|NCT01029704|564842094|FG006|Overall Study|Lost to Follow-up|1|||
156477488|NCT01029704|564842095|FG007|Overall Study|Lost to Follow-up|1|||
156477489|NCT01029704|564842096|FG008|Overall Study|Lost to Follow-up|1|||
156477490|NCT01029704|564842088|FG000|Overall Study|Lack of Efficacy|0|||
156477491|NCT01029704|564842089|FG001|Overall Study|Lack of Efficacy|0|||
156477492|NCT01029704|564842090|FG002|Overall Study|Lack of Efficacy|0|||
156344389|NCT01980992|564360220|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
156344390|NCT01980992|564360221|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
156344391|NCT05228132|564360227|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
156477493|NCT01029704|564842091|FG003|Overall Study|Lack of Efficacy|0|||
156477494|NCT01029704|564842092|FG004|Overall Study|Lack of Efficacy|2|||
156477495|NCT01029704|564842093|FG005|Overall Study|Lack of Efficacy|3|||
156477496|NCT01029704|564842094|FG006|Overall Study|Lack of Efficacy|1|||
156477497|NCT01029704|564842095|FG007|Overall Study|Lack of Efficacy|2|||
156477498|NCT01029704|564842096|FG008|Overall Study|Lack of Efficacy|0|||
156477499|NCT01029704|564842088|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
156477500|NCT01029704|564842089|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
156344392|NCT05228132|564360227|FG000|Overall Study|Adverse Event|3|||
156477501|NCT01029704|564842090|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
156477502|NCT01029704|564842091|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
156477503|NCT01029704|564842092|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
156477504|NCT01029704|564842093|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
156477505|NCT01029704|564842094|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
156477506|NCT01029704|564842095|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
156477507|NCT01029704|564842096|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
156477508|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
156477509|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
156477510|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
156344393|NCT05228132|564360227|FG000|Overall Study|Lost to Follow-up|1|||
156344394|NCT05228132|564360227|FG000|Overall Study|Arteriovenous-fistula mature|1|||
156344395|NCT02627144|564360228|FG000|Overall Study|Serious adverse event|32|||
156344396|NCT02627144|564360228|FG000|Overall Study|Cancer progression|171|||
156344397|NCT02627144|564360228|FG000|Overall Study|Death from cancer|20|||
156344398|NCT02627144|564360228|FG000|Overall Study|Death from other cause|8|||
156344399|NCT02627144|564360228|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
156344400|NCT02627144|564360228|FG000|Overall Study|Administrative reasons|65|||
156344401|NCT02627144|564360228|FG000|Overall Study|Lost to Follow-up|8|||
156344402|NCT02627144|564360228|FG000|Overall Study|Enrolled, not treated|6|||
156344403|NCT02627144|564360228|FG000|Overall Study|Other|17|||
156344404|NCT04605484|564360236|FG000|Overall Study|Lost to Follow-up|0|||
156344405|NCT04605484|564360237|FG001|Overall Study|Lost to Follow-up|1|||
156344406|NCT04605484|564360238|FG002|Overall Study|Lost to Follow-up|1|||
156344407|NCT04605484|564360236|FG000|Overall Study|Other|0|||
156344408|NCT04605484|564360237|FG001|Overall Study|Other|1|||
156344409|NCT04605484|564360238|FG002|Overall Study|Other|0|||
156344410|NCT03366337|564360239|FG000|Overall Study|Lost to Follow-up|1|||
156344411|NCT03366337|564360240|FG001|Overall Study|Lost to Follow-up|0|||
156344412|NCT03366337|564360241|FG002|Overall Study|Lost to Follow-up|1|||
156344413|NCT03366337|564360242|FG003|Overall Study|Lost to Follow-up|0|||
156344414|NCT03366337|564360239|FG000|Overall Study|Withdrawal by Subject|2|||
156344415|NCT03366337|564360240|FG001|Overall Study|Withdrawal by Subject|0|||
156344416|NCT03366337|564360241|FG002|Overall Study|Withdrawal by Subject|1|||
156344417|NCT03366337|564360242|FG003|Overall Study|Withdrawal by Subject|1|||
156344418|NCT05288062|564360243|FG000|Overall Study|Ineligible|0|||
156344419|NCT05288062|564360244|FG001|Overall Study|Ineligible|0|||
156344420|NCT05288062|564360245|FG002|Overall Study|Ineligible|1|||
156344421|NCT05288062|564360246|FG003|Overall Study|Ineligible|0|||
156344422|NCT05288062|564360243|FG000|Overall Study|Withdrawal by Subject|0|||
156344423|NCT05288062|564360244|FG001|Overall Study|Withdrawal by Subject|0|||
156344424|NCT05288062|564360245|FG002|Overall Study|Withdrawal by Subject|1|||
156344425|NCT05288062|564360246|FG003|Overall Study|Withdrawal by Subject|0|||
156344426|NCT00729651|564360253|FG000|Overall Study|Withdrawal by Subject|5|||
156344427|NCT00729651|564360254|FG001|Overall Study|Withdrawal by Subject|6|||
156344428|NCT00729651|564360253|FG000|Overall Study|Lost to Follow-up|5|||
156344429|NCT00729651|564360254|FG001|Overall Study|Lost to Follow-up|4|||
156344430|NCT00729651|564360253|FG000|Overall Study|Protocol Violation|0|||
156344431|NCT00729651|564360254|FG001|Overall Study|Protocol Violation|1|||
156344432|NCT00729651|564360253|FG000|Overall Study|Adverse Event|7|||
156344433|NCT00729651|564360254|FG001|Overall Study|Adverse Event|3|||
156344434|NCT00729651|564360253|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
156344435|NCT00729651|564360254|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
156344436|NCT00729651|564360253|FG000|Overall Study|Subject's private reason|2|||
156344437|NCT00729651|564360254|FG001|Overall Study|Subject's private reason|0|||
156344438|NCT01874054|564360255|FG000|Overall Study|Withdrawal by Subject|3|||
156344439|NCT01874054|564360255|FG000|Overall Study|Study Termination by Sponsor|42|||
156344440|NCT01874054|564360255|FG000|Overall Study|Lost to Follow-up|5|||
156344441|NCT01874054|564360255|FG000|Overall Study|Death|5|||
156344442|NCT01844518|564360259|FG000|Overall Study|Adverse Event|7|||
156344443|NCT01844518|564360260|FG001|Overall Study|Adverse Event|1|||
156344444|NCT01844518|564360259|FG000|Overall Study|Lack of Efficacy|17|||
156344445|NCT01844518|564360260|FG001|Overall Study|Lack of Efficacy|5|||
156344446|NCT01844518|564360259|FG000|Overall Study|Participant's request to discontinue|4|||
156344447|NCT01844518|564360260|FG001|Overall Study|Participant's request to discontinue|1|||
156344448|NCT01844518|564360259|FG000|Overall Study|Poor/Non-compliance|1|||
156344449|NCT01844518|564360260|FG001|Overall Study|Poor/Non-compliance|0|||
156344450|NCT01844518|564360259|FG000|Overall Study|No Longer Met Study Criteria|2|||
156344451|NCT01844518|564360260|FG001|Overall Study|No Longer Met Study Criteria|0|||
156477511|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
156477512|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Death|0|||
156477513|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Death|0|||
156477514|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Death|1|||
156477515|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Death|0|||
156477516|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
156477517|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
156477518|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
156477519|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
156477520|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
156477521|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
156477522|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
156477523|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
156477524|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
156477525|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
156477526|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
156477527|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
156542897|NCT01849874|565082602|FG001|Overall Study|Physician Decision|1|||
156477528|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
156477529|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
156477530|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
156477531|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
156477532|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
156477533|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
156477534|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
156477535|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
156477536|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Other|2|||
156477537|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Other|0|||
156477538|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Other|0|||
156477539|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Other|0|||
156477540|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
156477541|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
156477542|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
156477543|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
156477544|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
156477545|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
156477546|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
156477547|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
156477548|NCT03845517|564842097|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
156477549|NCT03845517|564842098|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
156477550|NCT03845517|564842099|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
156477551|NCT03845517|564842100|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
156477552|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
156477553|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
156542898|NCT01849874|565082601|FG000|Overall Study|Other|16|||
156542899|NCT01849874|565082602|FG001|Overall Study|Other|4|||
156542900|NCT02104583|565082603|FG000|Overall Study|New ICD or CRT-D implanted|2|||
156344452|NCT01844518|564360259|FG000|Overall Study|Withdrawal by Subject|9|||
156344453|NCT01844518|564360260|FG001|Overall Study|Withdrawal by Subject|0|||
156344454|NCT01844518|564360259|FG000|Overall Study|Pregnancy|1|||
156344455|NCT01844518|564360260|FG001|Overall Study|Pregnancy|0|||
156344456|NCT01217801|564360261|FG000|Period 1|Protocol Violation|1|||
156344457|NCT01217801|564360262|FG001|Period 1|Protocol Violation|1|||
156344458|NCT01217801|564360261|FG000|Period 1|Withdrawal by Subject|0|||
156344459|NCT01217801|564360262|FG001|Period 1|Withdrawal by Subject|1|||
156344460|NCT03926169|564360263|FG000|Period A|Adverse Event|2|||
156344461|NCT03926169|564360264|FG001|Period A|Adverse Event|2|||
156344462|NCT03926169|564360265|FG002|Period A|Adverse Event|1|||
156344463|NCT03926169|564360263|FG000|Period A|Withdrawal by Subject|2|||
156344464|NCT03926169|564360264|FG001|Period A|Withdrawal by Subject|2|||
156344465|NCT03926169|564360265|FG002|Period A|Withdrawal by Subject|2|||
156344466|NCT03926169|564360263|FG000|Period A|Lost to Follow-up|3|||
156344467|NCT03926169|564360264|FG001|Period A|Lost to Follow-up|1|||
156344468|NCT03926169|564360265|FG002|Period A|Lost to Follow-up|0|||
156344469|NCT03926169|564360263|FG000|Period A|Lack of Efficacy|0|||
156344470|NCT03926169|564360264|FG001|Period A|Lack of Efficacy|2|||
156344471|NCT03926169|564360265|FG002|Period A|Lack of Efficacy|2|||
156344472|NCT03926169|564360263|FG000|Period A|COVID-19 Infection|0|||
156344473|NCT03926169|564360264|FG001|Period A|COVID-19 Infection|1|||
156344474|NCT03926169|564360265|FG002|Period A|COVID-19 Infection|0|||
156477554|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
156477555|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
156477556|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Death|0|||
156477557|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Death|0|||
156477558|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Death|1|||
156344475|NCT03926169|564360263|FG000|Period A|COVID-19 Logistical Restrictions|0|||
156344476|NCT03926169|564360264|FG001|Period A|COVID-19 Logistical Restrictions|2|||
156344477|NCT03926169|564360265|FG002|Period A|COVID-19 Logistical Restrictions|1|||
156344478|NCT03926169|564360263|FG000|Period A|Other, Not Specified|1|||
156344479|NCT03926169|564360264|FG001|Period A|Other, Not Specified|0|||
156477559|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Death|1|||
156344480|NCT03926169|564360265|FG002|Period A|Other, Not Specified|0|||
156344481|NCT03926169|564360263|FG000|Period B|Adverse Event|3|||
156477560|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
156477561|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
156477562|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
156344482|NCT03926169|564360264|FG001|Period B|Adverse Event|1|||
156477563|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
156477564|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
156477565|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
156477566|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
156477567|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
156477568|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
156477569|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
156477570|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
156477571|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
156344483|NCT03926169|564360265|FG002|Period B|Adverse Event|1|||
156477572|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Other|1|||
156477573|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Other|0|||
156477574|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Other|1|||
156344484|NCT03926169|564360263|FG000|Period B|Withdrawal by Subject|1|||
156477575|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Other|0|||
156477576|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
156477577|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
156477578|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
156477579|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
156477580|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
156477581|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
156477582|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
156477583|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
156477584|NCT03845517|564842097|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
156477585|NCT03845517|564842098|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
156477586|NCT03845517|564842099|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
156477587|NCT03845517|564842100|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
156477588|NCT01109979|564842101|FG000|Overall Study|Physician Decision|2|||
156477589|NCT01109979|564842102|FG001|Overall Study|Physician Decision|0|||
156477590|NCT01109979|564842101|FG000|Overall Study|Withdrawal by Subject|0|||
156477591|NCT01109979|564842102|FG001|Overall Study|Withdrawal by Subject|1|||
156477592|NCT03136861|564842104|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
156477593|NCT03136861|564842105|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
156477594|NCT03136861|564842106|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
156477595|NCT03136861|564842107|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
156477596|NCT03136861|564842108|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
156477597|NCT03136861|564842109|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
156477598|NCT03136861|564842110|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
156344485|NCT03926169|564360264|FG001|Period B|Withdrawal by Subject|3|||
156477599|NCT03136861|564842104|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
156477600|NCT03136861|564842105|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
156477601|NCT03136861|564842106|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
156477602|NCT03136861|564842107|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
156477603|NCT03136861|564842108|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
156542901|NCT02104583|565082604|FG001|Overall Study|New ICD or CRT-D implanted|0|||
156542902|NCT02104583|565082605|FG002|Overall Study|New ICD or CRT-D implanted|1|||
156542903|NCT02104583|565082606|FG003|Overall Study|New ICD or CRT-D implanted|0|||
156542904|NCT02104583|565082607|FG004|Overall Study|New ICD or CRT-D implanted|0|||
156542905|NCT02104583|565082603|FG000|Overall Study|Death|2|||
156542906|NCT02104583|565082604|FG001|Overall Study|Death|1|||
156542907|NCT02104583|565082605|FG002|Overall Study|Death|3|||
156542908|NCT02104583|565082606|FG003|Overall Study|Death|3|||
156542909|NCT02104583|565082607|FG004|Overall Study|Death|5|||
156542910|NCT02104583|565082603|FG000|Overall Study|Subject required cardiac ablation|6|||
156542911|NCT02104583|565082604|FG001|Overall Study|Subject required cardiac ablation|4|||
156542912|NCT02104583|565082605|FG002|Overall Study|Subject required cardiac ablation|4|||
156542913|NCT02104583|565082606|FG003|Overall Study|Subject required cardiac ablation|5|||
156542914|NCT02104583|565082607|FG004|Overall Study|Subject required cardiac ablation|4|||
156542915|NCT02104583|565082603|FG000|Overall Study|Subject required prohibited medication|0|||
156542916|NCT02104583|565082604|FG001|Overall Study|Subject required prohibited medication|1|||
156542917|NCT02104583|565082605|FG002|Overall Study|Subject required prohibited medication|1|||
156542918|NCT02104583|565082606|FG003|Overall Study|Subject required prohibited medication|0|||
156542919|NCT02104583|565082607|FG004|Overall Study|Subject required prohibited medication|1|||
156542920|NCT02104583|565082603|FG000|Overall Study|Withdrew Consent|3|||
156542921|NCT02104583|565082604|FG001|Overall Study|Withdrew Consent|2|||
156542922|NCT02104583|565082605|FG002|Overall Study|Withdrew Consent|0|||
156542923|NCT02104583|565082606|FG003|Overall Study|Withdrew Consent|2|||
156542924|NCT02104583|565082607|FG004|Overall Study|Withdrew Consent|1|||
156542925|NCT02104583|565082603|FG000|Overall Study|Investigator's Discretion|1|||
156542926|NCT02104583|565082604|FG001|Overall Study|Investigator's Discretion|0|||
156344486|NCT03926169|564360265|FG002|Period B|Withdrawal by Subject|0|||
156344487|NCT03926169|564360263|FG000|Period B|Lack of Efficacy|3|||
156344488|NCT03926169|564360264|FG001|Period B|Lack of Efficacy|1|||
156344489|NCT03926169|564360265|FG002|Period B|Lack of Efficacy|1|||
156344490|NCT03926169|564360263|FG000|Period B|Lost to Follow-up|1|||
156477604|NCT03136861|564842109|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
156344491|NCT03926169|564360264|FG001|Period B|Lost to Follow-up|1|||
156344492|NCT03926169|564360265|FG002|Period B|Lost to Follow-up|4|||
156477605|NCT03136861|564842110|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
156477606|NCT03136861|564842104|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
156477607|NCT03136861|564842105|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
156477608|NCT03136861|564842106|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
156477609|NCT03136861|564842107|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
156477610|NCT03136861|564842108|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
156477611|NCT03136861|564842109|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
156477612|NCT03136861|564842110|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
156477613|NCT03136861|564842104|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
156477614|NCT03136861|564842105|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
156477615|NCT03136861|564842106|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
156542927|NCT02104583|565082605|FG002|Overall Study|Investigator's Discretion|0|||
156542928|NCT02104583|565082606|FG003|Overall Study|Investigator's Discretion|0|||
156542929|NCT02104583|565082607|FG004|Overall Study|Investigator's Discretion|0|||
156542930|NCT02104583|565082603|FG000|Overall Study|Protocol Violation|0|||
156542931|NCT02104583|565082604|FG001|Overall Study|Protocol Violation|0|||
156542932|NCT02104583|565082605|FG002|Overall Study|Protocol Violation|1|||
156542933|NCT02104583|565082606|FG003|Overall Study|Protocol Violation|0|||
156542934|NCT02104583|565082607|FG004|Overall Study|Protocol Violation|0|||
156542935|NCT02104583|565082603|FG000|Overall Study|Adverse Event|3|||
156542936|NCT02104583|565082604|FG001|Overall Study|Adverse Event|3|||
156542937|NCT02104583|565082605|FG002|Overall Study|Adverse Event|6|||
156542938|NCT02104583|565082606|FG003|Overall Study|Adverse Event|6|||
156542939|NCT02104583|565082607|FG004|Overall Study|Adverse Event|1|||
156542940|NCT02104583|565082603|FG000|Overall Study|Lost to Follow-up|1|||
156542941|NCT02104583|565082604|FG001|Overall Study|Lost to Follow-up|0|||
156542942|NCT02104583|565082605|FG002|Overall Study|Lost to Follow-up|0|||
156542943|NCT02104583|565082606|FG003|Overall Study|Lost to Follow-up|0|||
156542944|NCT02104583|565082607|FG004|Overall Study|Lost to Follow-up|0|||
156542945|NCT02104583|565082603|FG000|Overall Study|Randomized but Never Treated|0|||
156542946|NCT02104583|565082604|FG001|Overall Study|Randomized but Never Treated|0|||
156542947|NCT02104583|565082605|FG002|Overall Study|Randomized but Never Treated|0|||
156542948|NCT02104583|565082606|FG003|Overall Study|Randomized but Never Treated|1|||
156542949|NCT02104583|565082607|FG004|Overall Study|Randomized but Never Treated|0|||
156542950|NCT04640272|565082608|FG000|Overall Study|Subject moved out of area|1|||
156542951|NCT02535715|565082612|FG000|Overall Study|Withdrawal by Subject|0|||
156542952|NCT02535715|565082613|FG001|Overall Study|Withdrawal by Subject|0|||
156542953|NCT02535715|565082614|FG002|Overall Study|Withdrawal by Subject|1|||
156344493|NCT03926169|564360263|FG000|Period B|Other, Not Specified|62|||
156477616|NCT03136861|564842107|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
156477617|NCT03136861|564842108|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
156477618|NCT03136861|564842109|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
156477619|NCT03136861|564842110|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
156477620|NCT03136861|564842104|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
156477621|NCT03136861|564842105|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
156477622|NCT03136861|564842106|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
156477623|NCT03136861|564842107|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
156477624|NCT03136861|564842108|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
156477625|NCT03136861|564842109|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
156477626|NCT03136861|564842110|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
156477627|NCT03136861|564842104|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
156477628|NCT03136861|564842105|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
156477629|NCT03136861|564842106|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
156477630|NCT03136861|564842107|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
156477631|NCT03136861|564842108|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
156477632|NCT03136861|564842109|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
156477633|NCT03136861|564842110|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
156477634|NCT03136861|564842104|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
156477635|NCT03136861|564842105|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
156477636|NCT03136861|564842106|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
156477637|NCT03136861|564842107|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
156477638|NCT03136861|564842108|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
156477639|NCT03136861|564842109|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
156477640|NCT03136861|564842110|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
156477641|NCT03136861|564842104|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
156477642|NCT03136861|564842105|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
156542954|NCT04353284|565082615|FG000|Overall Study|Adverse Event|1|||
156344494|NCT03926169|564360264|FG001|Period B|Other, Not Specified|57|||
156344495|NCT03926169|564360265|FG002|Period B|Other, Not Specified|65|||
156344496|NCT03302234|564360266|FG000|Overall Study|Death|191|||
156344497|NCT03302234|564360267|FG001|Overall Study|Death|192|||
156344498|NCT03302234|564360266|FG000|Overall Study|Withdrawal by Subject|2|||
156344499|NCT03302234|564360267|FG001|Overall Study|Withdrawal by Subject|2|||
156344500|NCT03302234|564360266|FG000|Overall Study|Sponsor Decision|90|||
156344501|NCT03302234|564360267|FG001|Overall Study|Sponsor Decision|89|||
156344502|NCT03302234|564360266|FG000|Overall Study|Laryngeal carcinoma|0|||
156344503|NCT03302234|564360267|FG001|Overall Study|Laryngeal carcinoma|1|||
156344504|NCT03302234|564360266|FG000|Overall Study|Not Reported|1|||
156344505|NCT03302234|564360267|FG001|Overall Study|Not Reported|0|||
156344506|NCT04112784|564360268|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
156344507|NCT04112784|564360268|FG000|Overall Study|Screen Failures|4|||
156344508|NCT01753856|564360274|FG000|Overall Study|Adverse Event|1|||
156344509|NCT01753856|564360275|FG001|Overall Study|Adverse Event|0|||
156344510|NCT01753856|564360274|FG000|Overall Study|Withdrawal by Subject|0|||
156344511|NCT01753856|564360275|FG001|Overall Study|Withdrawal by Subject|2|||
156344512|NCT01753856|564360274|FG000|Overall Study|Sponsor Decision|2|||
156344513|NCT01753856|564360275|FG001|Overall Study|Sponsor Decision|0|||
156344514|NCT05980182|564360276|FG000|Overall Study|Lost to Follow-up|10|||
156344515|NCT02239978|564362275|FG000|Overall Study|Withdrawal by Subject|2|||
156344516|NCT02239978|564362276|FG001|Overall Study|Withdrawal by Subject|0|||
156344517|NCT02324569|564362280|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156344518|NCT02324569|564362281|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
156344519|NCT02324569|564362280|FG000|Overall Study|Voluntary Withdrawal|3|||
156344520|NCT02324569|564362281|FG001|Overall Study|Voluntary Withdrawal|6|||
156344521|NCT02324569|564362280|FG000|Overall Study|Lack of Efficacy|2|||
156344522|NCT02324569|564362281|FG001|Overall Study|Lack of Efficacy|3|||
156344523|NCT02324569|564362280|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
156344524|NCT02324569|564362281|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
156344525|NCT02324569|564362280|FG000|Overall Study|Inconvenient Schedule|2|||
156344526|NCT02324569|564362281|FG001|Overall Study|Inconvenient Schedule|0|||
156344527|NCT00903695|564362287|FG000|Overall Study|medical exclusion after 1st testing|1|||
156344528|NCT00903695|564362288|FG001|Overall Study|medical exclusion after 1st testing|0|||
156344529|NCT00903695|564362287|FG000|Overall Study|lung cancer|1|||
156344530|NCT00903695|564362288|FG001|Overall Study|lung cancer|0|||
156344531|NCT01549860|564362289|FG000|Overall Study|Withdrawal by Subject|1|||
156344532|NCT01549860|564362290|FG001|Overall Study|Withdrawal by Subject|0|||
156344533|NCT01549860|564362289|FG000|Overall Study|Physician Decision|1|||
156344534|NCT01549860|564362290|FG001|Overall Study|Physician Decision|1|||
156344535|NCT02430311|564362292|FG000|Part A|Adverse Event|0|||
156344536|NCT02430311|564362293|FG001|Part A|Adverse Event|1|||
156344537|NCT02430311|564362292|FG000|Part A|Withdrawal by Subject|1|||
156344538|NCT02430311|564362293|FG001|Part A|Withdrawal by Subject|0|||
156344539|NCT02430311|564362292|FG000|Part B|Meet study-specific withdrawal criteria|6|||
156344540|NCT02430311|564362293|FG001|Part B|Meet study-specific withdrawal criteria|6|||
156344541|NCT02430311|564362292|FG000|Part B|Withdrawal by Subject|2|||
156344542|NCT02430311|564362293|FG001|Part B|Withdrawal by Subject|2|||
156344543|NCT02430311|564362292|FG000|Part B|Adverse Event|1|||
156344544|NCT02430311|564362293|FG001|Part B|Adverse Event|0|||
156344545|NCT02430311|564362292|FG000|Part B|Death|1|||
156344546|NCT02430311|564362293|FG001|Part B|Death|0|||
156344547|NCT00578812|564362294|FG000|Overall Study|Not treated|6|||
156344548|NCT00578812|564362295|FG001|Overall Study|Not treated|7|||
156542955|NCT04353284|565082616|FG001|Overall Study|Adverse Event|1|||
156542956|NCT04353284|565082615|FG000|Overall Study|Lost to Follow-up|1|||
156477643|NCT03136861|564842106|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
156477644|NCT03136861|564842107|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
156477645|NCT03136861|564842108|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
156477646|NCT03136861|564842109|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
156477647|NCT03136861|564842110|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
156477648|NCT03390166|564842111|FG000|Overall Study|Death|0|||
156542957|NCT04353284|565082616|FG001|Overall Study|Lost to Follow-up|0|||
156542958|NCT01230307|565082621|FG000|Overall Study|LVAD Placement|0|||
156542959|NCT01230307|565082622|FG001|Overall Study|LVAD Placement|2|||
156542960|NCT04773106|565082623|FG000|Overall Study|Withdrawal by Subject|3|||
156542961|NCT04773106|565082623|FG000|Overall Study|Death|1|||
156542962|NCT00530894|565082627|FG000|Overall Study|Death|84|||
156542963|NCT00530894|565082628|FG001|Overall Study|Death|89|||
156542964|NCT00530894|565082629|FG002|Overall Study|Death|55|||
156542965|NCT00530894|565082630|FG003|Overall Study|Death|89|||
156542966|NCT00530894|565082627|FG000|Overall Study|Lost to Follow-up|1|||
156542967|NCT00530894|565082628|FG001|Overall Study|Lost to Follow-up|3|||
156542968|NCT00530894|565082629|FG002|Overall Study|Lost to Follow-up|0|||
156542969|NCT00530894|565082630|FG003|Overall Study|Lost to Follow-up|0|||
156542970|NCT00530894|565082627|FG000|Overall Study|Withdrawal by Subject|1|||
156542971|NCT00530894|565082628|FG001|Overall Study|Withdrawal by Subject|23|||
156542972|NCT00530894|565082629|FG002|Overall Study|Withdrawal by Subject|0|||
156542973|NCT00530894|565082630|FG003|Overall Study|Withdrawal by Subject|5|||
156542974|NCT00530894|565082627|FG000|Overall Study|Alive and censored prior to 1 year|2|||
156542975|NCT00530894|565082628|FG001|Overall Study|Alive and censored prior to 1 year|0|||
156542976|NCT00530894|565082629|FG002|Overall Study|Alive and censored prior to 1 year|0|||
156542977|NCT00530894|565082630|FG003|Overall Study|Alive and censored prior to 1 year|0|||
156542978|NCT01349465|565082631|FG000|Overall Study|Adverse Event|1|||
156542979|NCT01349465|565082632|FG001|Overall Study|Adverse Event|0|||
156542980|NCT01349465|565082631|FG000|Overall Study|Death|3|||
156542981|NCT01349465|565082632|FG001|Overall Study|Death|0|||
156542982|NCT01349465|565082631|FG000|Overall Study|Lost to Follow-up|10|||
156542983|NCT01349465|565082632|FG001|Overall Study|Lost to Follow-up|1|||
156542984|NCT01349465|565082631|FG000|Overall Study|Withdrawal by Subject|4|||
156542985|NCT01349465|565082632|FG001|Overall Study|Withdrawal by Subject|2|||
156542986|NCT01349465|565082631|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
156542987|NCT01349465|565082632|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
156542988|NCT02256540|565082633|FG000|Overall Study|Withdrawal by Subject|0|||
156542989|NCT02256540|565082634|FG001|Overall Study|Withdrawal by Subject|1|||
156542990|NCT02256540|565082635|FG002|Overall Study|Withdrawal by Subject|1|||
156542991|NCT02256540|565082633|FG000|Overall Study|Back pain preventing exercise|0|||
156542992|NCT02256540|565082634|FG001|Overall Study|Back pain preventing exercise|0|||
156542993|NCT02256540|565082635|FG002|Overall Study|Back pain preventing exercise|1|||
156542994|NCT01230242|565082636|FG000|Overall Study|Physician Decision|2|||
156542995|NCT01230242|565082636|FG000|Overall Study|Withdrawal by Subject|1|||
156542996|NCT03923426|565082639|FG000|Overall Study|Other|19|||
156542997|NCT03923426|565082639|FG000|Overall Study|Lost to Follow-up|16|||
156542998|NCT03923426|565082639|FG000|Overall Study|Death|107|||
156542999|NCT03923426|565082639|FG000|Overall Study|Incomplete response to question|13|||
156543000|NCT00751400|565082640|FG000|Overall Study|Lost to Follow-up|10|||
156543001|NCT01918007|565082644|FG000|Overall Study|Baseline oximetry not acceptable|11|||
156543002|NCT01918007|565082645|FG001|Overall Study|Baseline oximetry not acceptable|7|||
156543003|NCT01918007|565082644|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
156543004|NCT01918007|565082645|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
156543005|NCT01918007|565082644|FG000|Overall Study|Lost to Follow-up|4|||
156543006|NCT01918007|565082645|FG001|Overall Study|Lost to Follow-up|7|||
156543007|NCT03370120|565082649|FG000|Overall Study|Adverse event, non-fatal|24|||
156543008|NCT03370120|565082649|FG000|Overall Study|Withdrawal by Subject|6|||
156543009|NCT03370120|565082649|FG000|Overall Study|Lost to Follow-up|1|||
156543010|NCT03370120|565082649|FG000|Overall Study|Lack of Efficacy|37|||
156543011|NCT03370120|565082649|FG000|Overall Study|Per sponsor's instructions|1|||
156543012|NCT03370120|565082649|FG000|Overall Study|Study was terminated by parent company UCB|2|||
156543013|NCT03370120|565082649|FG000|Overall Study|The study was ended by the promoter|3|||
156543014|NCT03370120|565082649|FG000|Overall Study|Discontinuation of drug development|3|||
156543015|NCT03370120|565082649|FG000|Overall Study|End of project|2|||
156543016|NCT03370120|565082649|FG000|Overall Study|Premature study closure|2|||
156543017|NCT03370120|565082649|FG000|Overall Study|Premature program termination|1|||
156543018|NCT03370120|565082649|FG000|Overall Study|Premature study termination|7|||
156543019|NCT03370120|565082649|FG000|Overall Study|Trial terminated by sponsor|2|||
156543020|NCT03370120|565082649|FG000|Overall Study|Trial discontinued by sponsor|2|||
156543021|NCT03370120|565082649|FG000|Overall Study|Study ended|15|||
156543022|NCT03370120|565082649|FG000|Overall Study|Clinical trial has been cancelled|1|||
156543023|NCT03370120|565082649|FG000|Overall Study|End of study per sponsor decision|2|||
156543024|NCT03370120|565082649|FG000|Overall Study|Promoter's decision|2|||
156543025|NCT03370120|565082649|FG000|Overall Study|The trial has been suspended|3|||
156543026|NCT03370120|565082649|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
156543027|NCT03370120|565082649|FG000|Overall Study|Early termination by order of sponsor|2|||
156543028|NCT03370120|565082649|FG000|Overall Study|Discontinuation of the study|5|||
156543029|NCT03370120|565082649|FG000|Overall Study|End of clinical trial discontinuation|1|||
156543030|NCT03370120|565082649|FG000|Overall Study|Because the clinical trial ended halfway|4|||
156344549|NCT00309387|564362297|FG000|Overall Study|Death|72|||
156344550|NCT00309387|564362298|FG001|Overall Study|Death|73|||
156344551|NCT00309387|564362297|FG000|Overall Study|Lost to Follow-up|70|||
156344552|NCT00309387|564362298|FG001|Overall Study|Lost to Follow-up|86|||
156344553|NCT01599234|564362300|FG000|Overall Study|Adverse Event|9|||
156477649|NCT03390166|564842112|FG001|Overall Study|Death|1|||
156344554|NCT01599234|564362301|FG001|Overall Study|Adverse Event|5|||
156543031|NCT03370120|565082649|FG000|Overall Study|Development discontinued|5|||
156543032|NCT03370120|565082649|FG000|Overall Study|Padsenovil program closed|3|||
156543033|NCT03370120|565082649|FG000|Overall Study|End of project|2|||
156543034|NCT03370120|565082649|FG000|Overall Study|Termination of project|1|||
156543035|NCT03370120|565082649|FG000|Overall Study|The study was interrupted by sponsor|4|||
156543036|NCT03370120|565082649|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
156543037|NCT03370120|565082649|FG000|Overall Study|End of sponsor decision|1|||
156543038|NCT03370120|565082649|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
156543039|NCT03370120|565082649|FG000|Overall Study|Early termination of studies|5|||
156543040|NCT03370120|565082649|FG000|Overall Study|This study is ended early|1|||
156543041|NCT03370120|565082649|FG000|Overall Study|End of padsevonil program|2|||
156543042|NCT03370120|565082649|FG000|Overall Study|Decision of sponsor|6|||
156543043|NCT03370120|565082649|FG000|Overall Study|Asked by the sponsor|3|||
156543044|NCT03370120|565082649|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
156543045|NCT03370120|565082649|FG000|Overall Study|PI decision poor compliance from participant|1|||
156543046|NCT03370120|565082649|FG000|Overall Study|Promoter ended the study|3|||
156543047|NCT03370120|565082649|FG000|Overall Study|Premature study close by sponsor's decision|4|||
156543048|NCT03370120|565082649|FG000|Overall Study|Study terminated by sponsor|33|||
156543049|NCT03370120|565082649|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
156543050|NCT03370120|565082649|FG000|Overall Study|Sponsor decision to terminate study|63|||
156543051|NCT03370120|565082649|FG000|Overall Study|Program closure|3|||
156543052|NCT03370120|565082649|FG000|Overall Study|Study ended prematurely|1|||
156543053|NCT03370120|565082649|FG000|Overall Study|Study stopped by sponsor|2|||
156543054|NCT03370120|565082649|FG000|Overall Study|Program termination|55|||
156543055|NCT03370120|565082649|FG000|Overall Study|Sponsor decision|62|||
156543056|NCT03370120|565082649|FG000|Overall Study|Sponsor study closure|10|||
156543057|NCT04206020|565082650|FG000|Overall Study|Adverse Event|1|||
156543058|NCT04206020|565082651|FG001|Overall Study|Adverse Event|4|||
156543059|NCT04206020|565082650|FG000|Overall Study|Protocol Violation|2|||
156543060|NCT04206020|565082651|FG001|Overall Study|Protocol Violation|0|||
156543061|NCT04206020|565082650|FG000|Overall Study|Withdrawal by Subject|2|||
156543062|NCT04206020|565082651|FG001|Overall Study|Withdrawal by Subject|0|||
156543063|NCT04206020|565082650|FG000|Overall Study|Lost to Follow-up|2|||
156543064|NCT04206020|565082651|FG001|Overall Study|Lost to Follow-up|0|||
156543065|NCT04206020|565082650|FG000|Overall Study|Pregnancy|0|||
156543066|NCT04206020|565082651|FG001|Overall Study|Pregnancy|1|||
156543067|NCT04206020|565082650|FG000|Overall Study|Unable to attend visits|1|||
156543068|NCT04206020|565082651|FG001|Overall Study|Unable to attend visits|2|||
156543069|NCT00928889|565082652|FG000|Overall Study|Lost to Follow-up|3|||
156543070|NCT00928889|565082653|FG001|Overall Study|Lost to Follow-up|1|||
156543071|NCT00928889|565082652|FG000|Overall Study|Protocol Violation|0|||
156543072|NCT00928889|565082653|FG001|Overall Study|Protocol Violation|1|||
156543073|NCT00928889|565082652|FG000|Overall Study|Adverse Event|1|||
156344555|NCT01599234|564362300|FG000|Overall Study|Withdrawal by Subject|2|||
156344556|NCT01599234|564362301|FG001|Overall Study|Withdrawal by Subject|1|||
156543074|NCT00928889|565082653|FG001|Overall Study|Adverse Event|0|||
156543075|NCT00928889|565082652|FG000|Overall Study|Other|1|||
156543076|NCT00928889|565082653|FG001|Overall Study|Other|0|||
156543077|NCT04416555|565082655|FG000|Overall Study|Withdrawal by Subject|0|||
156543078|NCT04416555|565082656|FG001|Overall Study|Withdrawal by Subject|3|||
156543079|NCT01356407|565082657|FG000|Overall Study|Lost to Follow-up|2|||
156543080|NCT01356407|565082658|FG001|Overall Study|Lost to Follow-up|0|||
156344557|NCT01599234|564362300|FG000|Overall Study|Lost to Follow-up|1|||
156344558|NCT01599234|564362301|FG001|Overall Study|Lost to Follow-up|2|||
156344559|NCT01599234|564362300|FG000|Overall Study|Lack of Efficacy|2|||
156344560|NCT01599234|564362301|FG001|Overall Study|Lack of Efficacy|4|||
156344561|NCT01599234|564362300|FG000|Overall Study|Unable to operate spray|1|||
156344562|NCT01599234|564362301|FG001|Overall Study|Unable to operate spray|0|||
156344563|NCT01599234|564362300|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
156344564|NCT01599234|564362301|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
156344565|NCT01599234|564362300|FG000|Overall Study|Death|1|||
156344566|NCT01599234|564362301|FG001|Overall Study|Death|0|||
156344567|NCT01599234|564362300|FG000|Overall Study|Patient would not stop driving|1|||
156344568|NCT01599234|564362301|FG001|Overall Study|Patient would not stop driving|0|||
156344569|NCT01599234|564362300|FG000|Overall Study|Contra-indication discovered|0|||
156344570|NCT01599234|564362301|FG001|Overall Study|Contra-indication discovered|1|||
156344571|NCT01599234|564362300|FG000|Overall Study|Pregnancy|0|||
156344572|NCT01599234|564362301|FG001|Overall Study|Pregnancy|1|||
156344573|NCT00085631|564362313|FG000|Overall Study|Missing Data|4|||
156344574|NCT00085631|564362314|FG001|Overall Study|Missing Data|11|||
156344575|NCT00085631|564362315|FG002|Overall Study|Missing Data|7|||
156344576|NCT01349790|564362316|FG000|Overall Study|Investigator Judgement|3|||
156344577|NCT01349790|564362316|FG000|Overall Study|Death|2|||
156344578|NCT01349790|564362316|FG000|Overall Study|Withdrawal by Patient|2|||
156344579|NCT01349790|564362316|FG000|Overall Study|Adverse Event|1|||
156344580|NCT01349790|564362316|FG000|Overall Study|Lost to Follow-up|1|||
156344581|NCT02495168|564362317|FG000|Overall Study|Other than Specified|18|||
156344582|NCT02495168|564362318|FG001|Overall Study|Other than Specified|22|||
156344583|NCT02495168|564362319|FG002|Overall Study|Other than Specified|5|||
156344584|NCT02495168|564362317|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
156477650|NCT03390166|564842111|FG000|Overall Study|Lost to Follow-up|6|||
156477651|NCT03390166|564842112|FG001|Overall Study|Lost to Follow-up|4|||
156477652|NCT03390166|564842111|FG000|Overall Study|Physician Decision|2|||
156477653|NCT03390166|564842112|FG001|Overall Study|Physician Decision|1|||
156477654|NCT03390166|564842111|FG000|Overall Study|Move from study area|3|||
156477655|NCT03390166|564842112|FG001|Overall Study|Move from study area|2|||
156477656|NCT03390166|564842111|FG000|Overall Study|To militarycamp for conscript|1|||
156477657|NCT03390166|564842112|FG001|Overall Study|To militarycamp for conscript|0|||
156477658|NCT03390166|564842111|FG000|Overall Study|To drug therapy course|0|||
156477659|NCT03390166|564842112|FG001|Overall Study|To drug therapy course|1|||
156477660|NCT03390166|564842111|FG000|Overall Study|Move to work oversea|0|||
156477661|NCT03390166|564842112|FG001|Overall Study|Move to work oversea|1|||
156477662|NCT00274287|564842115|FG000|Overall Study|Withdrawal by Subject|1|||
156477663|NCT00274287|564842115|FG000|Overall Study|subject non-compliance|1|||
156477664|NCT01880736|564842119|FG000|Overall Study|Adverse Event|0|||
156477665|NCT01880736|564842120|FG001|Overall Study|Adverse Event|0|||
156477666|NCT01880736|564842121|FG002|Overall Study|Adverse Event|0|||
156477667|NCT01880736|564842122|FG003|Overall Study|Adverse Event|1|||
156477668|NCT01880736|564842119|FG000|Overall Study|Withdrawal Criteria|1|||
156477669|NCT01880736|564842120|FG001|Overall Study|Withdrawal Criteria|2|||
156477670|NCT01880736|564842121|FG002|Overall Study|Withdrawal Criteria|1|||
156477671|NCT01880736|564842122|FG003|Overall Study|Withdrawal Criteria|5|||
156477672|NCT02831049|564842126|FG000|Overall Study|Lost to Follow-up|0|||
156477673|NCT02831049|564842127|FG001|Overall Study|Lost to Follow-up|0|||
156477674|NCT02831049|564842128|FG002|Overall Study|Lost to Follow-up|1|||
156477675|NCT02831049|564842126|FG000|Overall Study|Withdrawal by Subject|0|||
156477676|NCT02831049|564842127|FG001|Overall Study|Withdrawal by Subject|1|||
156477677|NCT02831049|564842128|FG002|Overall Study|Withdrawal by Subject|1|||
156477678|NCT02831049|564842126|FG000|Overall Study|Pandemic shutdown|1|||
156477679|NCT02831049|564842127|FG001|Overall Study|Pandemic shutdown|0|||
156477680|NCT02831049|564842128|FG002|Overall Study|Pandemic shutdown|0|||
156477681|NCT00747149|564843312|FG000|Overall Study|Adverse Event|0|||
156477682|NCT00747149|564843313|FG001|Overall Study|Adverse Event|15|||
156477683|NCT00747149|564843312|FG000|Overall Study|Lost to Follow-up|0|||
156477684|NCT00747149|564843313|FG001|Overall Study|Lost to Follow-up|10|||
156477685|NCT00747149|564843312|FG000|Overall Study|Withdrawal by Subject|0|||
156477686|NCT00747149|564843313|FG001|Overall Study|Withdrawal by Subject|6|||
156477687|NCT00747149|564843312|FG000|Overall Study|Did not receive treatment|0|||
156477688|NCT00747149|564843313|FG001|Overall Study|Did not receive treatment|1|||
156477689|NCT00747149|564843312|FG000|Overall Study|Incorrect enrollment|0|||
156477690|NCT00747149|564843313|FG001|Overall Study|Incorrect enrollment|6|||
156477691|NCT00747149|564843312|FG000|Overall Study|Severe non-compliance to protocol|0|||
156477692|NCT00747149|564843313|FG001|Overall Study|Severe non-compliance to protocol|1|||
156477693|NCT00747149|564843312|FG000|Overall Study|Not reported|1|||
156477694|NCT00747149|564843313|FG001|Overall Study|Not reported|4|||
156477695|NCT00443820|564843314|FG000|Overall Study|Adverse Event|1|||
156477696|NCT00443820|564843315|FG001|Overall Study|Adverse Event|1|||
156477697|NCT00443820|564843316|FG002|Overall Study|Adverse Event|0|||
156477698|NCT00443820|564843317|FG003|Overall Study|Adverse Event|0|||
156477699|NCT00443820|564843314|FG000|Overall Study|Lack of Efficacy|3|||
156477700|NCT00443820|564843315|FG001|Overall Study|Lack of Efficacy|2|||
156477701|NCT00443820|564843316|FG002|Overall Study|Lack of Efficacy|1|||
156477702|NCT00443820|564843317|FG003|Overall Study|Lack of Efficacy|1|||
156477703|NCT00443820|564843314|FG000|Overall Study|Protocol Violation|2|||
156477704|NCT00443820|564843315|FG001|Overall Study|Protocol Violation|1|||
156477705|NCT00443820|564843316|FG002|Overall Study|Protocol Violation|2|||
156477706|NCT00443820|564843317|FG003|Overall Study|Protocol Violation|1|||
156477707|NCT00443820|564843314|FG000|Overall Study|Withdrawal by Subject|6|||
156477708|NCT00443820|564843315|FG001|Overall Study|Withdrawal by Subject|7|||
156477709|NCT00443820|564843316|FG002|Overall Study|Withdrawal by Subject|8|||
156477710|NCT00443820|564843317|FG003|Overall Study|Withdrawal by Subject|9|||
156477711|NCT00443820|564843314|FG000|Overall Study|Lost to Follow-up|9|||
156477712|NCT00443820|564843315|FG001|Overall Study|Lost to Follow-up|8|||
156477713|NCT00443820|564843316|FG002|Overall Study|Lost to Follow-up|6|||
156344585|NCT02495168|564362318|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
156344586|NCT02495168|564362319|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
156344587|NCT02495168|564362317|FG000|Overall Study|Physician Decision|1|||
156344588|NCT02495168|564362318|FG001|Overall Study|Physician Decision|1|||
156344589|NCT02495168|564362319|FG002|Overall Study|Physician Decision|0|||
156344590|NCT02495168|564362317|FG000|Overall Study|Lost to Follow-up|10|||
156344591|NCT02495168|564362318|FG001|Overall Study|Lost to Follow-up|6|||
156344592|NCT02495168|564362319|FG002|Overall Study|Lost to Follow-up|1|||
156344593|NCT02495168|564362317|FG000|Overall Study|Withdrawal by Subject|1|||
156344594|NCT02495168|564362318|FG001|Overall Study|Withdrawal by Subject|4|||
156344595|NCT02495168|564362319|FG002|Overall Study|Withdrawal by Subject|2|||
156344596|NCT02495168|564362317|FG000|Overall Study|Protocol Violation|0|||
156344597|NCT02495168|564362318|FG001|Overall Study|Protocol Violation|10|||
156344598|NCT02495168|564362319|FG002|Overall Study|Protocol Violation|1|||
156344599|NCT02495168|564362317|FG000|Overall Study|Adverse Event|4|||
156344600|NCT02495168|564362318|FG001|Overall Study|Adverse Event|8|||
156344601|NCT02495168|564362319|FG002|Overall Study|Adverse Event|3|||
156344602|NCT02495168|564362317|FG000|Overall Study|Lack of Efficacy|0|||
156344603|NCT02495168|564362318|FG001|Overall Study|Lack of Efficacy|0|||
156344604|NCT02495168|564362319|FG002|Overall Study|Lack of Efficacy|3|||
156344605|NCT01513473|564362322|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
156344606|NCT01513473|564362323|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
156344607|NCT01513473|564362322|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
156344608|NCT01513473|564362323|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
156344609|NCT01513473|564362322|FG000|Main Trial (26 Weeks)|Unclassified|0|||
156344610|NCT01513473|564362323|FG001|Main Trial (26 Weeks)|Unclassified|2|||
156344611|NCT01513473|564362322|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
156344612|NCT01513473|564362323|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
156344613|NCT01513473|564362322|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
156344614|NCT01513473|564362323|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
156344615|NCT03462082|564362324|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156344616|NCT03462082|564362325|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156543081|NCT01356407|565082657|FG000|Overall Study|Patient Withdrew Consent|2|||
156543082|NCT01356407|565082658|FG001|Overall Study|Patient Withdrew Consent|1|||
156543083|NCT01356407|565082657|FG000|Overall Study|Could not afford IMP administration|0|||
156543084|NCT01356407|565082658|FG001|Overall Study|Could not afford IMP administration|1|||
156543085|NCT01356407|565082657|FG000|Overall Study|Not complete Endoscopy|2|||
156543086|NCT01356407|565082658|FG001|Overall Study|Not complete Endoscopy|2|||
156543087|NCT02716987|565082663|FG000|Overall Study|Ligand synthesis failure|0|||
156543088|NCT02716987|565082664|FG001|Overall Study|Ligand synthesis failure|0|||
156543089|NCT02716987|565082665|FG002|Overall Study|Ligand synthesis failure|1|||
156543090|NCT02716987|565082666|FG003|Overall Study|Ligand synthesis failure|0|||
156543091|NCT02716987|565082667|FG004|Overall Study|Ligand synthesis failure|0|||
156543092|NCT02716987|565082668|FG005|Overall Study|Ligand synthesis failure|0|||
156543093|NCT02716987|565082663|FG000|Overall Study|Withdrawal by Subject|0|||
156543094|NCT02716987|565082664|FG001|Overall Study|Withdrawal by Subject|0|||
156543095|NCT02716987|565082665|FG002|Overall Study|Withdrawal by Subject|0|||
156543096|NCT02716987|565082666|FG003|Overall Study|Withdrawal by Subject|0|||
156543097|NCT02716987|565082667|FG004|Overall Study|Withdrawal by Subject|1|||
156543098|NCT02716987|565082668|FG005|Overall Study|Withdrawal by Subject|1|||
156543099|NCT02829138|565082669|FG000|Overall Study|Withdrawal by Subject|1|||
156543100|NCT02829138|565082670|FG001|Overall Study|Withdrawal by Subject|0|||
156543101|NCT01394627|565082671|FG000|First Intervention (1 Day)|poor intravenous access|0|||
156543102|NCT01394627|565082672|FG001|First Intervention (1 Day)|poor intravenous access|1|||
156543103|NCT01394627|565082671|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
156543104|NCT01394627|565082672|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
156543105|NCT03223428|565082673|FG000|Overall Study|No longer taking Xermelo|27|||
156543106|NCT03223428|565082673|FG000|Overall Study|Declined Consent|1|||
156543107|NCT03223428|565082673|FG000|Overall Study|Non-responders|56|||
156543108|NCT03223428|565082673|FG000|Overall Study|Withdrawal by Subject|14|||
156543109|NCT01301950|565082676|FG000|Overall Study|Surgery was cancelled by patient|0|||
156543110|NCT01301950|565082677|FG001|Overall Study|Surgery was cancelled by patient|1|||
156543111|NCT04041284|565082678|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
156543112|NCT04041284|565082679|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
156543113|NCT04041284|565082678|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
156543114|NCT04041284|565082679|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
156543115|NCT04041284|565082678|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
156543116|NCT04041284|565082679|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
156543117|NCT04041284|565082678|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
156543118|NCT04041284|565082679|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
156543119|NCT04041284|565082678|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
156477714|NCT00443820|564843317|FG003|Overall Study|Lost to Follow-up|5|||
156477715|NCT00443820|564843314|FG000|Overall Study|Administrative problems|0|||
156477716|NCT00443820|564843315|FG001|Overall Study|Administrative problems|0|||
156477717|NCT00443820|564843316|FG002|Overall Study|Administrative problems|0|||
156477718|NCT00443820|564843317|FG003|Overall Study|Administrative problems|1|||
156477719|NCT00443820|564843314|FG000|Overall Study|Death|0|||
156543120|NCT04041284|565082679|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
156543121|NCT04041284|565082678|FG000|DB Phase (12 Weeks)|Other than specified|1|||
156543122|NCT04041284|565082679|FG001|DB Phase (12 Weeks)|Other than specified|0|||
156543123|NCT04041284|565082678|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
156543124|NCT04041284|565082679|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
156543125|NCT04041284|565082678|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
156543126|NCT04041284|565082679|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
156543127|NCT04041284|565082678|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
156543128|NCT04041284|565082679|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
156543129|NCT04041284|565082678|FG000|OL Phase (12 Weeks)|Other than specified|6|||
156543130|NCT04041284|565082679|FG001|OL Phase (12 Weeks)|Other than specified|2|||
156543131|NCT01744665|565082682|FG000|Monitoring Phase|Adverse Event|4|||
156543132|NCT01744665|565082682|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
156543133|NCT01744665|565082682|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
156543134|NCT01744665|565082682|FG000|Monitoring Phase|Withdrawal by Subject|5|||
156543135|NCT01744665|565082682|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
156543136|NCT01744665|565082682|FG000|Consolidation Phase|Adverse Event|2|||
156543137|NCT01744665|565082682|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
156344617|NCT03462082|564362326|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156543138|NCT01744665|565082682|FG000|Consolidation Phase|Withdrawal by Subject|4|||
156543139|NCT01744665|565082682|FG000|Consolidation Phase|Administrative problems|9|||
156543140|NCT01744665|565082682|FG000|Re-initiation Phase|Administrative problems|10|||
156543141|NCT01744665|565082682|FG000|Re-initiation Phase|Adverse Event|1|||
156543142|NCT01744665|565082682|FG000|Re-initiation Phase|No longer required treatment|1|||
156543143|NCT01744665|565082682|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
156543144|NCT00492752|565082683|FG000|Double Blind Treatment|Death|13|||
156543145|NCT00492752|565082684|FG001|Double Blind Treatment|Death|0|||
156543146|NCT00492752|565082685|FG002|Double Blind Treatment|Death|2|||
156543147|NCT00492752|565082686|FG003|Double Blind Treatment|Death|0|||
156543148|NCT00492752|565082683|FG000|Double Blind Treatment|Adverse Event|1|||
156477720|NCT00443820|564843315|FG001|Overall Study|Death|0|||
156477721|NCT00443820|564843316|FG002|Overall Study|Death|1|||
156477722|NCT00443820|564843317|FG003|Overall Study|Death|0|||
156477723|NCT02507297|564843318|FG000|Overall Study|Withdrawal by Subject|1|||
156477724|NCT02507297|564843319|FG001|Overall Study|Withdrawal by Subject|0|||
156477725|NCT02507297|564843318|FG000|Overall Study|Lost to Follow-up|0|||
156477726|NCT02507297|564843319|FG001|Overall Study|Lost to Follow-up|1|||
156477727|NCT02489799|564843320|FG000|Overall Study|Lost to Follow-up|4|||
156344618|NCT03462082|564362327|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156344619|NCT03462082|564362328|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156344620|NCT03462082|564362329|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156344621|NCT03462082|564362330|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
156344622|NCT03462082|564362331|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
156344623|NCT00743340|564362338|FG000|Overall Study|Study medication non-compliance|1|||
156477728|NCT02489799|564843321|FG001|Overall Study|Lost to Follow-up|1|||
156477729|NCT02489799|564843320|FG000|Overall Study|Failure to Maintain Eligibility|4|||
156477730|NCT02489799|564843321|FG001|Overall Study|Failure to Maintain Eligibility|6|||
156477731|NCT02489799|564843320|FG000|Overall Study|Withdrawal by Subject|1|||
156477732|NCT02489799|564843321|FG001|Overall Study|Withdrawal by Subject|1|||
156477733|NCT02489799|564843320|FG000|Overall Study|Death|0|||
156477734|NCT02489799|564843321|FG001|Overall Study|Death|1|||
156477735|NCT01304940|564843327|FG000|Overall Study|not meet symptom severity requirement|3|||
156477736|NCT01304940|564843328|FG001|Overall Study|not meet symptom severity requirement|0|||
156477737|NCT04803734|564843332|FG000|Overall Study|Withdrawal by Subject|0|||
156477738|NCT04803734|564843333|FG001|Overall Study|Withdrawal by Subject|1|||
156477739|NCT04803734|564843332|FG000|Overall Study|Protocol Violation|0|||
156477740|NCT04803734|564843333|FG001|Overall Study|Protocol Violation|1|||
156477741|NCT02753075|564843345|FG000|Overall Study|Adverse Event|2|||
156477742|NCT02753075|564843346|FG001|Overall Study|Adverse Event|1|||
156477743|NCT02753075|564843347|FG002|Overall Study|Adverse Event|0|||
156477744|NCT02753075|564843345|FG000|Overall Study|Lost to Follow-up|2|||
156477745|NCT02753075|564843346|FG001|Overall Study|Lost to Follow-up|0|||
156477746|NCT02753075|564843347|FG002|Overall Study|Lost to Follow-up|0|||
156477747|NCT02753075|564843345|FG000|Overall Study|Withdrawal of Consent|1|||
156477748|NCT02753075|564843346|FG001|Overall Study|Withdrawal of Consent|1|||
156477749|NCT02753075|564843347|FG002|Overall Study|Withdrawal of Consent|3|||
156477750|NCT02753075|564843345|FG000|Overall Study|Physician Decision|3|||
156477751|NCT02753075|564843346|FG001|Overall Study|Physician Decision|1|||
156477752|NCT02753075|564843347|FG002|Overall Study|Physician Decision|0|||
156477753|NCT02784834|564843349|FG000|Overall Study|Lack of Efficacy|1|||
156477754|NCT01090739|564843354|FG000|Enrollment|Withdrawal by Subject|24|||
156477755|NCT01090739|564843354|FG000|Enrollment|Protocol Violation|14|||
156477756|NCT01090739|564843354|FG000|Enrollment|Lost to Follow-up|5|||
156477757|NCT01090739|564843354|FG000|Enrollment|Physician Decision|5|||
156477758|NCT01090739|564843354|FG000|Enrollment|Sponsor termination of site|4|||
156477759|NCT01090739|564843354|FG000|Enrollment|Study implant limit reached|2|||
156477760|NCT01090739|564843354|FG000|Enrollment|Adverse Event|1|||
156477761|NCT01090739|564843354|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
156477762|NCT01090739|564843354|FG000|12 Month Follow-up|Lost to Follow-up|1|||
156477763|NCT01090739|564843354|FG000|12 Month Follow-up|Physician Decision|1|||
156477764|NCT01090739|564843354|FG000|12 Month Follow-up|Death|1|||
156477765|NCT01090739|564843354|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
156477766|NCT01090739|564843354|FG000|24 Month Follow-up|Lost to Follow-up|1|||
156477767|NCT01090739|564843354|FG000|24 Month Follow-up|Death|1|||
156477768|NCT01090739|564843354|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
156477769|NCT01090739|564843354|FG000|36 Month Follow-up|Visit still pending|17|||
156477770|NCT00441168|564843355|FG000|Treatment Period|Death|3|||
156477771|NCT00441168|564843356|FG001|Treatment Period|Death|0|||
156477772|NCT00441168|564843355|FG000|Treatment Period|Adverse Event|1|||
156477773|NCT00441168|564843356|FG001|Treatment Period|Adverse Event|2|||
156477774|NCT00441168|564843355|FG000|Treatment Period|Progressive Disease|0|||
156477775|NCT00441168|564843356|FG001|Treatment Period|Progressive Disease|2|||
156477776|NCT00441168|564843355|FG000|Treatment Period|Protocol Violation|0|||
156477777|NCT00441168|564843356|FG001|Treatment Period|Protocol Violation|1|||
156477778|NCT00441168|564843355|FG000|Treatment Period|Lost to Follow-up|0|||
156477779|NCT00441168|564843356|FG001|Treatment Period|Lost to Follow-up|1|||
156477780|NCT00441168|564843355|FG000|Treatment Period|Withdrawal by Subject|3|||
156477781|NCT00441168|564843356|FG001|Treatment Period|Withdrawal by Subject|0|||
156477782|NCT00441168|564843355|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
156477783|NCT00441168|564843356|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
156477784|NCT00441168|564843355|FG000|Treatment Period|refractory disease|1|||
156477785|NCT00441168|564843356|FG001|Treatment Period|refractory disease|0|||
156477786|NCT00441168|564843355|FG000|Follow-up Period|Death|3|||
156477787|NCT00441168|564843356|FG001|Follow-up Period|Death|0|||
156477788|NCT00441168|564843355|FG000|Follow-up Period|Lost to Follow-up|5|||
156477789|NCT00441168|564843356|FG001|Follow-up Period|Lost to Follow-up|6|||
156477790|NCT00441168|564843355|FG000|Follow-up Period|Withdrawal by Subject|3|||
156477791|NCT00441168|564843356|FG001|Follow-up Period|Withdrawal by Subject|0|||
156477792|NCT00441168|564843355|FG000|Follow-up Period|Other|1|||
156477793|NCT00441168|564843356|FG001|Follow-up Period|Other|3|||
156344624|NCT00743340|564362338|FG000|Overall Study|Lost to Follow-up|1|||
156344625|NCT00743340|564362338|FG000|Overall Study|Withdrawal from the Study|5|||
156344626|NCT00743340|564362338|FG000|Overall Study|Protocol Violation|1|||
156344627|NCT00743340|564362338|FG000|Overall Study|Virologic failure|8|||
156344628|NCT00743340|564362338|FG000|Overall Study|Pregnancy|1|||
156344629|NCT00743340|564362338|FG000|Overall Study|Rolled over to other Gilead Study|23|||
156344630|NCT00743340|564362338|FG000|Overall Study|Participant Relocated|1|||
156344631|NCT02708121|564362339|FG000|Overall Study|Withdrawn by Study Team|1|||
156344632|NCT02708121|564362340|FG001|Overall Study|Withdrawn by Study Team|1|||
156344633|NCT02708121|564362339|FG000|Overall Study|Withdrawal by Subject|0|||
156344634|NCT02708121|564362340|FG001|Overall Study|Withdrawal by Subject|4|||
156344635|NCT01749514|564362343|FG000|Overall Study|Lost to Follow-up|0|||
156344636|NCT01749514|564362344|FG001|Overall Study|Lost to Follow-up|0|||
156344637|NCT01749514|564362345|FG002|Overall Study|Lost to Follow-up|0|||
156344638|NCT01749514|564362346|FG003|Overall Study|Lost to Follow-up|0|||
156344639|NCT01749514|564362347|FG004|Overall Study|Lost to Follow-up|0|||
156344640|NCT01749514|564362348|FG005|Overall Study|Lost to Follow-up|0|||
156344641|NCT01749514|564362349|FG006|Overall Study|Lost to Follow-up|0|||
156344642|NCT01749514|564362350|FG007|Overall Study|Lost to Follow-up|1|||
156344643|NCT01749514|564362343|FG000|Overall Study|Withdrawal by Subject|0|||
156344644|NCT01749514|564362344|FG001|Overall Study|Withdrawal by Subject|0|||
156344645|NCT01749514|564362345|FG002|Overall Study|Withdrawal by Subject|0|||
156344646|NCT01749514|564362346|FG003|Overall Study|Withdrawal by Subject|0|||
156344647|NCT01749514|564362347|FG004|Overall Study|Withdrawal by Subject|0|||
156344648|NCT01749514|564362348|FG005|Overall Study|Withdrawal by Subject|1|||
156344649|NCT01749514|564362349|FG006|Overall Study|Withdrawal by Subject|0|||
156344650|NCT01749514|564362350|FG007|Overall Study|Withdrawal by Subject|1|||
156344651|NCT01749514|564362343|FG000|Overall Study|Not Reported|0|||
156344652|NCT01749514|564362344|FG001|Overall Study|Not Reported|0|||
156344653|NCT01749514|564362345|FG002|Overall Study|Not Reported|0|||
156344654|NCT01749514|564362346|FG003|Overall Study|Not Reported|0|||
156344655|NCT01749514|564362347|FG004|Overall Study|Not Reported|0|||
156344656|NCT01749514|564362348|FG005|Overall Study|Not Reported|0|||
156344657|NCT01749514|564362349|FG006|Overall Study|Not Reported|0|||
156344658|NCT01749514|564362350|FG007|Overall Study|Not Reported|5|||
156344659|NCT02551731|564362351|FG000|Overall Study|Withdrawal by Subject|2|||
156344660|NCT01750242|564362352|FG000|Overall Study|Unreadable Images|3|||
156344661|NCT03765918|564362353|FG000|Overall Study|Death|109|||
156344662|NCT03765918|564362354|FG001|Overall Study|Death|127|||
156344663|NCT03765918|564362353|FG000|Overall Study|Lost to Follow-up|2|||
156344664|NCT03765918|564362354|FG001|Overall Study|Lost to Follow-up|3|||
156344665|NCT03765918|564362353|FG000|Overall Study|Withdrawal by Subject|12|||
156344666|NCT03765918|564362354|FG001|Overall Study|Withdrawal by Subject|16|||
156344667|NCT03765918|564362353|FG000|Overall Study|Participants Ongoing|240|||
156344668|NCT03765918|564362354|FG001|Overall Study|Participants Ongoing|205|||
156344669|NCT00814164|564362355|FG000|Overall Study|Progression|7|||
156344670|NCT00814164|564362355|FG000|Overall Study|not stated|7|||
156344671|NCT00814164|564362355|FG000|Overall Study|Death|5|||
156344672|NCT01169493|564362358|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
156344673|NCT01169493|564362359|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
156344674|NCT01169493|564362360|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
156344675|NCT01169493|564362361|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
156344676|NCT01169493|564362362|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
156344677|NCT01169493|564362363|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
156344678|NCT01169493|564362358|FG000|Period 3 (6 Months)|Adverse Event|0|||
156344679|NCT01169493|564362359|FG001|Period 3 (6 Months)|Adverse Event|1|||
156344680|NCT01169493|564362360|FG002|Period 3 (6 Months)|Adverse Event|0|||
156344681|NCT01169493|564362361|FG003|Period 3 (6 Months)|Adverse Event|0|||
156344682|NCT01169493|564362362|FG004|Period 3 (6 Months)|Adverse Event|0|||
156344683|NCT01169493|564362363|FG005|Period 3 (6 Months)|Adverse Event|0|||
156344684|NCT01169493|564362358|FG000|Period 3 (6 Months)|Physician Decision|0|||
156344685|NCT01169493|564362359|FG001|Period 3 (6 Months)|Physician Decision|1|||
156344686|NCT01169493|564362360|FG002|Period 3 (6 Months)|Physician Decision|1|||
156344687|NCT01169493|564362361|FG003|Period 3 (6 Months)|Physician Decision|0|||
156344688|NCT01169493|564362362|FG004|Period 3 (6 Months)|Physician Decision|0|||
156477794|NCT01918033|564843360|FG000|Overall Study|Adverse Event|1|||
156477795|NCT01918033|564843361|FG001|Overall Study|Adverse Event|0|||
156477796|NCT01918033|564843362|FG002|Overall Study|Adverse Event|2|||
156477797|NCT01918033|564843360|FG000|Overall Study|Lost to Follow-up|0|||
156477798|NCT01918033|564843361|FG001|Overall Study|Lost to Follow-up|1|||
156477799|NCT01918033|564843362|FG002|Overall Study|Lost to Follow-up|0|||
156477800|NCT01918033|564843360|FG000|Overall Study|Protocol Violation|2|||
156477801|NCT01918033|564843361|FG001|Overall Study|Protocol Violation|0|||
156477802|NCT01918033|564843362|FG002|Overall Study|Protocol Violation|1|||
156477803|NCT01918033|564843360|FG000|Overall Study|Withdrawal by Subject|2|||
156477804|NCT01918033|564843361|FG001|Overall Study|Withdrawal by Subject|1|||
156477805|NCT01918033|564843362|FG002|Overall Study|Withdrawal by Subject|0|||
156477806|NCT03909100|564843369|FG000|Overall Study|Protocol Deviation|2|||
156477807|NCT03909100|564843369|FG000|Overall Study|Technical Problems|4|||
156477808|NCT03909100|564843369|FG000|Overall Study|Withdrawal by Subject|4|||
156477809|NCT03909100|564843369|FG000|Overall Study|Lost to Follow-up|1|||
156477810|NCT03909100|564843369|FG000|Overall Study|Reason not Specified|4|||
156477811|NCT01794299|564843370|FG000|Overall Study|ATIR manufacturing not possible|1|||
156477812|NCT01794299|564843370|FG000|Overall Study|Death|14|||
156477813|NCT01794299|564843370|FG000|Overall Study|Graft failure|1|||
156477814|NCT01794299|564843370|FG000|Overall Study|ATIR batch rejected|2|||
156477815|NCT01794299|564843370|FG000|Overall Study|Relapse|2|||
156477816|NCT01794299|564843370|FG000|Overall Study|Discontinued from active follow-up|1|||
156477817|NCT01794299|564843370|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
156477818|NCT02538094|564843373|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
156477819|NCT02538094|564843374|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
156477820|NCT02538094|564843373|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
156477821|NCT02538094|564843374|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
156477822|NCT04867382|564843375|FG000|Overall Study|Did not complete the survey|2|||
156477823|NCT04867382|564843376|FG001|Overall Study|Did not complete the survey|1|||
156477824|NCT03803475|564843377|FG000|Overall Study|Physician Decision|1|||
156477825|NCT00266656|564843378|FG000|Overall Study|Death|1|||
156477826|NCT00266656|564843379|FG001|Overall Study|Death|0|||
156477827|NCT00266656|564843378|FG000|Overall Study|Lost to Follow-up|4|||
156477828|NCT00266656|564843379|FG001|Overall Study|Lost to Follow-up|1|||
156477829|NCT00266656|564843378|FG000|Overall Study|Withdrawal by Subject|4|||
156477830|NCT00266656|564843379|FG001|Overall Study|Withdrawal by Subject|2|||
156477831|NCT00266656|564843378|FG000|Overall Study|Did Not Reach Final Height|4|||
156477832|NCT00266656|564843379|FG001|Overall Study|Did Not Reach Final Height|8|||
156477833|NCT00266656|564843378|FG000|Overall Study|Parent/Caregiver Decision|1|||
156477834|NCT00266656|564843379|FG001|Overall Study|Parent/Caregiver Decision|2|||
156477835|NCT00428714|564843382|FG000|Overall Study|Progressive Disease|28|||
156477836|NCT00428714|564843383|FG001|Overall Study|Progressive Disease|36|||
156477837|NCT00428714|564843382|FG000|Overall Study|Withdrawal by Subject|0|||
156477838|NCT00428714|564843383|FG001|Overall Study|Withdrawal by Subject|3|||
156477839|NCT00428714|564843382|FG000|Overall Study|Adverse Event|0|||
156477840|NCT00428714|564843383|FG001|Overall Study|Adverse Event|2|||
156477841|NCT00428714|564843382|FG000|Overall Study|Physician Decision|1|||
156477842|NCT00428714|564843383|FG001|Overall Study|Physician Decision|1|||
156477843|NCT00428714|564843382|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
156477844|NCT00428714|564843383|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
156477845|NCT00428714|564843382|FG000|Overall Study|Death due to other then PD|1|||
156477846|NCT00428714|564843383|FG001|Overall Study|Death due to other then PD|0|||
156477847|NCT02807857|564843386|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
156477848|NCT02807857|564843386|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
156477849|NCT02807857|564843386|FG000|Follow-Up Set|Withdrawal by Subject|8|||
156477850|NCT02807857|564843386|FG000|Follow-Up Set|Lost to Follow-up|7|||
156477851|NCT02807857|564843386|FG000|Follow-Up Set|Physician Decision|6|||
156477852|NCT02807857|564843386|FG000|Follow-Up Set|Adverse Event|3|||
156477853|NCT02807857|564843386|FG000|Follow-Up Set|Death|27|||
156477854|NCT02807857|564843386|FG000|Follow-Up Set|Relocation|2|||
156477855|NCT00513071|564843388|FG000|Overall Study|Adverse Event|1|||
156477856|NCT00513071|564843388|FG000|Overall Study|Withdrawal by Subject|1|||
156477857|NCT00513071|564843388|FG000|Overall Study|Physician Decision|3|||
156477858|NCT00667732|564843390|FG000|Run -In (8 Weeks)|Adverse Event|4|||
156477859|NCT00667732|564843391|FG001|Run -In (8 Weeks)|Adverse Event|0|||
156477860|NCT00667732|564843392|FG002|Run -In (8 Weeks)|Adverse Event|0|||
156477861|NCT00667732|564843390|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
156477862|NCT00667732|564843391|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
156477863|NCT00667732|564843392|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
156477864|NCT00667732|564843390|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
156477865|NCT00667732|564843391|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
156477866|NCT00667732|564843392|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
156477867|NCT02106325|564843395|FG000|Phase 1|Lost to Follow-up|2|||
156477868|NCT02106325|564843396|FG001|Phase 1|Lost to Follow-up|2|||
156477869|NCT02106325|564843395|FG000|Phase 2|Lost to Follow-up|2|||
156477870|NCT02106325|564843396|FG001|Phase 2|Lost to Follow-up|3|||
156477871|NCT02106325|564843395|FG000|Phase 3|Lost to Follow-up|2|||
156477872|NCT02106325|564843396|FG001|Phase 3|Lost to Follow-up|1|||
156477873|NCT00452114|564843398|FG000|Overall Study|Physician Decision|3|||
156477874|NCT00452114|564843399|FG001|Overall Study|Physician Decision|3|||
156477875|NCT04197713|564843400|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
156477876|NCT04197713|564843401|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
156477877|NCT03242863|564843402|FG000|Study Week 1|Withdrawal by Subject|0|||
156477878|NCT03242863|564843403|FG001|Study Week 1|Withdrawal by Subject|1|||
156477879|NCT03242863|564843404|FG002|Study Week 1|Withdrawal by Subject|0|||
156477880|NCT03242863|564843405|FG003|Study Week 1|Withdrawal by Subject|0|||
156477881|NCT03242863|564843406|FG004|Study Week 1|Withdrawal by Subject|3|||
156477882|NCT03242863|564843407|FG005|Study Week 1|Withdrawal by Subject|0|||
156477883|NCT05338476|564843420|FG000|Period 2|Adverse Event|0|||
156477884|NCT05338476|564843421|FG001|Period 2|Adverse Event|1|||
156477885|NCT03786471|564843424|FG000|Overall Study|Death|254|||
156477886|NCT03786471|564843425|FG001|Overall Study|Death|223|||
156477887|NCT03786471|564843426|FG002|Overall Study|Death|37|||
156477888|NCT03786471|564843424|FG000|Overall Study|Lost to Follow-up|63|||
156477889|NCT03786471|564843425|FG001|Overall Study|Lost to Follow-up|50|||
156477890|NCT03786471|564843426|FG002|Overall Study|Lost to Follow-up|15|||
156344689|NCT01169493|564362363|FG005|Period 3 (6 Months)|Physician Decision|0|||
156477891|NCT03786471|564843424|FG000|Overall Study|Withdrawal by Subject|99|||
156477892|NCT03786471|564843425|FG001|Overall Study|Withdrawal by Subject|81|||
156477893|NCT03786471|564843426|FG002|Overall Study|Withdrawal by Subject|11|||
156477894|NCT00215943|564844880|FG000|Overall Study|Disease Progression|3|||
156477895|NCT00215943|564844881|FG001|Overall Study|Disease Progression|5|||
156477896|NCT00215943|564844880|FG000|Overall Study|Alternate therapy|0|||
156477897|NCT00215943|564844881|FG001|Overall Study|Alternate therapy|1|||
156477898|NCT00215943|564844880|FG000|Overall Study|Adverse Event|3|||
156543149|NCT00492752|565082684|FG001|Double Blind Treatment|Adverse Event|0|||
156543150|NCT00492752|565082685|FG002|Double Blind Treatment|Adverse Event|0|||
156543151|NCT00492752|565082686|FG003|Double Blind Treatment|Adverse Event|0|||
156543152|NCT00492752|565082683|FG000|Double Blind Treatment|Protocol Violation|0|||
156543153|NCT00492752|565082684|FG001|Double Blind Treatment|Protocol Violation|0|||
156543154|NCT00492752|565082685|FG002|Double Blind Treatment|Protocol Violation|1|||
156543155|NCT00492752|565082686|FG003|Double Blind Treatment|Protocol Violation|0|||
156543156|NCT00492752|565082683|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
156543157|NCT00492752|565082684|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
156543158|NCT00492752|565082685|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
156543159|NCT00492752|565082686|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
156543160|NCT00492752|565082683|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
156543161|NCT00492752|565082684|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
156543162|NCT00492752|565082685|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
156543163|NCT00492752|565082686|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
156543164|NCT00492752|565082683|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
156543165|NCT00492752|565082684|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
156543166|NCT00492752|565082685|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
156543167|NCT00492752|565082686|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
156543168|NCT00492752|565082683|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
156543169|NCT00492752|565082684|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
156543170|NCT00492752|565082685|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
156543171|NCT00492752|565082686|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
156543172|NCT00492752|565082683|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
156543173|NCT00492752|565082684|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
156543174|NCT00492752|565082685|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
156543175|NCT00492752|565082686|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
156543176|NCT00492752|565082683|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
156543177|NCT00492752|565082684|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
156543178|NCT00492752|565082685|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
156543179|NCT00492752|565082686|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
156543180|NCT00492752|565082683|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
156543181|NCT00492752|565082684|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
156543182|NCT00492752|565082685|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
156543183|NCT00492752|565082686|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
156543184|NCT00492752|565082683|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
156543185|NCT00492752|565082684|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
156543186|NCT00492752|565082685|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
156543187|NCT00492752|565082686|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
156543188|NCT02581202|565082690|FG000|Overall Study|Lack of Efficacy|2|||
156543189|NCT02581202|565082690|FG000|Overall Study|Withdrawal by Subject|4|||
156543190|NCT02581202|565082690|FG000|Overall Study|Lost to Follow-up|5|||
156543191|NCT02581202|565082690|FG000|Overall Study|Pregnancy|3|||
156543192|NCT04050982|565082691|FG000|Overall Study|Did not meet eligibility criteria|0|||
156543193|NCT04050982|565082692|FG001|Overall Study|Did not meet eligibility criteria|1|||
156543194|NCT04050982|565082693|FG002|Overall Study|Did not meet eligibility criteria|0|||
156543195|NCT04050982|565082691|FG000|Overall Study|Withdrawal by Subject|1|||
156543196|NCT04050982|565082692|FG001|Overall Study|Withdrawal by Subject|0|||
156543197|NCT04050982|565082693|FG002|Overall Study|Withdrawal by Subject|0|||
156543198|NCT04050982|565082691|FG000|Overall Study|Unable to enroll on platform|1|||
156543199|NCT04050982|565082692|FG001|Overall Study|Unable to enroll on platform|0|||
156543200|NCT04050982|565082693|FG002|Overall Study|Unable to enroll on platform|0|||
156543201|NCT04218201|565084531|FG000|Overall Study|Death|0|||
156543202|NCT04218201|565084532|FG001|Overall Study|Death|0|||
156543203|NCT04218201|565084533|FG002|Overall Study|Death|2|||
156543204|NCT04218201|565084534|FG003|Overall Study|Death|0|||
156543205|NCT04218201|565084531|FG000|Overall Study|Unable to contact participant|4|||
156543206|NCT04218201|565084532|FG001|Overall Study|Unable to contact participant|0|||
156543207|NCT04218201|565084533|FG002|Overall Study|Unable to contact participant|3|||
156543208|NCT04218201|565084534|FG003|Overall Study|Unable to contact participant|0|||
156543209|NCT04218201|565084531|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
156543210|NCT04218201|565084532|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
156543211|NCT04218201|565084533|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
156543212|NCT04218201|565084534|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
156543213|NCT04218201|565084531|FG000|Overall Study|Withdrawal by Subject|2|||
156543214|NCT04218201|565084532|FG001|Overall Study|Withdrawal by Subject|0|||
156543215|NCT04218201|565084533|FG002|Overall Study|Withdrawal by Subject|0|||
156543216|NCT04218201|565084534|FG003|Overall Study|Withdrawal by Subject|0|||
156543217|NCT04218201|565084531|FG000|Overall Study|PCP plans to leave practice|0|||
156543218|NCT04218201|565084532|FG001|Overall Study|PCP plans to leave practice|8|||
156543219|NCT04218201|565084533|FG002|Overall Study|PCP plans to leave practice|0|||
156543220|NCT04218201|565084534|FG003|Overall Study|PCP plans to leave practice|5|||
156543221|NCT04218201|565084531|FG000|Overall Study|Reduced panel|0|||
156543222|NCT04218201|565084532|FG001|Overall Study|Reduced panel|0|||
156543223|NCT04218201|565084533|FG002|Overall Study|Reduced panel|0|||
156543224|NCT04218201|565084534|FG003|Overall Study|Reduced panel|1|||
156543225|NCT04218201|565084531|FG000|Overall Study|No longer interested in participating|0|||
156543226|NCT04218201|565084532|FG001|Overall Study|No longer interested in participating|1|||
156543227|NCT04218201|565084533|FG002|Overall Study|No longer interested in participating|0|||
156543228|NCT04218201|565084534|FG003|Overall Study|No longer interested in participating|0|||
156543229|NCT04649255|565084535|FG000|Overall Study|Death|9|||
156344690|NCT00642460|564362366|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
156344691|NCT00642460|564362367|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
156344692|NCT00642460|564362368|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
156477899|NCT00215943|564844881|FG001|Overall Study|Adverse Event|6|||
156477900|NCT00215943|564844880|FG000|Overall Study|Other disease|0|||
156477901|NCT00215943|564844881|FG001|Overall Study|Other disease|1|||
156477902|NCT00215943|564844880|FG000|Overall Study|Other complications|3|||
156477903|NCT00215943|564844881|FG001|Overall Study|Other complications|1|||
156477904|NCT04909593|564844882|FG000|Overall Study|Withdrawal by Subject|1|||
156477905|NCT01018992|564844883|FG000|Overall Study|Adverse Event|8|||
156477906|NCT01018992|564844884|FG001|Overall Study|Adverse Event|3|||
156477907|NCT01018992|564844883|FG000|Overall Study|Withdrawal by Subject|3|||
156477908|NCT01018992|564844884|FG001|Overall Study|Withdrawal by Subject|8|||
156477909|NCT01018992|564844883|FG000|Overall Study|Protocol Violation|0|||
156477910|NCT01018992|564844884|FG001|Overall Study|Protocol Violation|4|||
156477911|NCT01018992|564844883|FG000|Overall Study|Lost to Follow-up|5|||
156477912|NCT01018992|564844884|FG001|Overall Study|Lost to Follow-up|1|||
156477913|NCT01241448|564844885|FG000|Overall Study|Adverse Event|1|||
156477914|NCT01241448|564844886|FG001|Overall Study|Adverse Event|0|||
156477915|NCT01241448|564844887|FG002|Overall Study|Adverse Event|2|||
156477916|NCT01241448|564844888|FG003|Overall Study|Adverse Event|2|||
156477917|NCT01241448|564844885|FG000|Overall Study|Lost to Follow-up|2|||
156477918|NCT01241448|564844886|FG001|Overall Study|Lost to Follow-up|1|||
156477919|NCT01241448|564844887|FG002|Overall Study|Lost to Follow-up|1|||
156477920|NCT01241448|564844888|FG003|Overall Study|Lost to Follow-up|1|||
156477921|NCT01241448|564844885|FG000|Overall Study|Physician Decision|0|||
156477922|NCT01241448|564844886|FG001|Overall Study|Physician Decision|2|||
156477923|NCT01241448|564844887|FG002|Overall Study|Physician Decision|0|||
156477924|NCT01241448|564844888|FG003|Overall Study|Physician Decision|0|||
156477925|NCT01241448|564844885|FG000|Overall Study|Protocol Violation|10|||
156477926|NCT01241448|564844886|FG001|Overall Study|Protocol Violation|5|||
156477927|NCT01241448|564844887|FG002|Overall Study|Protocol Violation|3|||
156477928|NCT01241448|564844888|FG003|Overall Study|Protocol Violation|6|||
156477929|NCT01241448|564844885|FG000|Overall Study|Sponsor Decision|17|||
156477930|NCT01241448|564844886|FG001|Overall Study|Sponsor Decision|14|||
156477931|NCT01241448|564844887|FG002|Overall Study|Sponsor Decision|12|||
156477932|NCT01241448|564844888|FG003|Overall Study|Sponsor Decision|6|||
156477933|NCT01241448|564844885|FG000|Overall Study|Withdrawal by Subject|4|||
156477934|NCT01241448|564844886|FG001|Overall Study|Withdrawal by Subject|5|||
156477935|NCT01241448|564844887|FG002|Overall Study|Withdrawal by Subject|3|||
156477936|NCT01241448|564844888|FG003|Overall Study|Withdrawal by Subject|6|||
156477937|NCT01241448|564844885|FG000|Overall Study|Excluded due to data integrity issues|3|||
156477938|NCT01241448|564844886|FG001|Overall Study|Excluded due to data integrity issues|2|||
156477939|NCT01241448|564844887|FG002|Overall Study|Excluded due to data integrity issues|2|||
156477940|NCT01241448|564844888|FG003|Overall Study|Excluded due to data integrity issues|2|||
156477941|NCT04425252|564844889|FG000|Overall Study|Withdrawal by Subject|2|||
156477942|NCT04425252|564844890|FG001|Overall Study|Withdrawal by Subject|1|||
156477943|NCT04425252|564844889|FG000|Overall Study|Lost to Follow-up|1|||
156477944|NCT04425252|564844890|FG001|Overall Study|Lost to Follow-up|0|||
156477945|NCT04425252|564844889|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
156543230|NCT04649255|565084535|FG000|Overall Study|Withdrawal by Subject|1|||
156543231|NCT02222207|565084536|FG000|Overall Study|Death|1|||
156543232|NCT02222207|565084536|FG000|Overall Study|Other reasons|2|||
156543233|NCT02222207|565084536|FG000|Overall Study|Adverse Event|1|||
156543234|NCT04682405|565084537|FG000|Overall Study|Adverse Event|0|||
156543235|NCT04682405|565084538|FG001|Overall Study|Adverse Event|1|||
156543236|NCT03557281|565084539|FG000|Overall Study|Investigator discretion|0|||
156477946|NCT04425252|564844890|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
156477947|NCT00304278|564844892|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
156477948|NCT00304278|564844892|FG000|Overall Study|PT had medical condition preventing TX|1|||
156477949|NCT02065895|564844893|FG000|Overall Study|Protocol Violation|1|||
156543237|NCT03557281|565084540|FG001|Overall Study|Investigator discretion|0|||
156543238|NCT03557281|565084541|FG002|Overall Study|Investigator discretion|1|||
156344693|NCT00642460|564362369|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
156477950|NCT02065895|564844894|FG001|Overall Study|Protocol Violation|0|||
156477951|NCT02065895|564844895|FG002|Overall Study|Protocol Violation|0|||
156477952|NCT02065895|564844896|FG003|Overall Study|Protocol Violation|1|||
156477953|NCT02065895|564844897|FG004|Overall Study|Protocol Violation|0|||
156477954|NCT02065895|564844898|FG005|Overall Study|Protocol Violation|0|||
156477955|NCT02065895|564844893|FG000|Overall Study|Scheduling conflicts|0|||
156477956|NCT02065895|564844894|FG001|Overall Study|Scheduling conflicts|1|||
156477957|NCT02065895|564844895|FG002|Overall Study|Scheduling conflicts|0|||
156477958|NCT02065895|564844896|FG003|Overall Study|Scheduling conflicts|0|||
156477959|NCT02065895|564844897|FG004|Overall Study|Scheduling conflicts|0|||
156477960|NCT02065895|564844898|FG005|Overall Study|Scheduling conflicts|0|||
156477961|NCT03137784|564844902|FG000|Overall Study|Adverse Event|1|||
156477962|NCT03137784|564844903|FG001|Overall Study|Adverse Event|1|||
156477963|NCT03137784|564844904|FG002|Overall Study|Adverse Event|0|||
156477964|NCT03137784|564844905|FG003|Overall Study|Adverse Event|0|||
156477965|NCT03137784|564844906|FG004|Overall Study|Adverse Event|0|||
156477966|NCT03137784|564844907|FG005|Overall Study|Adverse Event|0|||
156477967|NCT03137784|564844902|FG000|Overall Study|Subject/guardian decision|1|||
156477968|NCT03137784|564844903|FG001|Overall Study|Subject/guardian decision|0|||
156477969|NCT03137784|564844904|FG002|Overall Study|Subject/guardian decision|0|||
156477970|NCT03137784|564844905|FG003|Overall Study|Subject/guardian decision|0|||
156477971|NCT03137784|564844906|FG004|Overall Study|Subject/guardian decision|0|||
156477972|NCT03137784|564844907|FG005|Overall Study|Subject/guardian decision|0|||
156543239|NCT03557281|565084542|FG003|Overall Study|Investigator discretion|0|||
156543240|NCT03557281|565084543|FG004|Overall Study|Investigator discretion|0|||
156543241|NCT03557281|565084539|FG000|Overall Study|Withdrawal by Subject|0|||
156543242|NCT03557281|565084540|FG001|Overall Study|Withdrawal by Subject|1|||
156543243|NCT03557281|565084541|FG002|Overall Study|Withdrawal by Subject|1|||
156543244|NCT03557281|565084542|FG003|Overall Study|Withdrawal by Subject|1|||
156543245|NCT03557281|565084543|FG004|Overall Study|Withdrawal by Subject|2|||
156543246|NCT03557281|565084539|FG000|Overall Study|Randomized, but did not receive treatment|0|||
156543247|NCT03557281|565084540|FG001|Overall Study|Randomized, but did not receive treatment|0|||
156543248|NCT03557281|565084541|FG002|Overall Study|Randomized, but did not receive treatment|0|||
156543249|NCT03557281|565084542|FG003|Overall Study|Randomized, but did not receive treatment|0|||
156543250|NCT03557281|565084543|FG004|Overall Study|Randomized, but did not receive treatment|1|||
156543251|NCT01199042|565084544|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
156543252|NCT01199042|565084544|FG000|At Home (3 Months)|Lost to Follow-up|1|||
156543253|NCT03357731|565084547|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
156543254|NCT03357731|565084548|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
156543255|NCT03357731|565084549|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
156543256|NCT03357731|565084550|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
156543257|NCT03357731|565084551|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
156543258|NCT03357731|565084552|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
156543259|NCT03357731|565084547|FG000|Overall Study|Acute bradycardia and hypotension|0|||
156543260|NCT03357731|565084548|FG001|Overall Study|Acute bradycardia and hypotension|0|||
156543261|NCT03357731|565084549|FG002|Overall Study|Acute bradycardia and hypotension|0|||
156543262|NCT03357731|565084550|FG003|Overall Study|Acute bradycardia and hypotension|1|||
156543263|NCT03357731|565084551|FG004|Overall Study|Acute bradycardia and hypotension|0|||
156543264|NCT03357731|565084552|FG005|Overall Study|Acute bradycardia and hypotension|0|||
156543265|NCT03357731|565084547|FG000|Overall Study|Adverse Event|0|||
156543266|NCT03357731|565084548|FG001|Overall Study|Adverse Event|0|||
156543267|NCT03357731|565084549|FG002|Overall Study|Adverse Event|0|||
156543268|NCT03357731|565084550|FG003|Overall Study|Adverse Event|0|||
156543269|NCT03357731|565084551|FG004|Overall Study|Adverse Event|0|||
156543270|NCT03357731|565084552|FG005|Overall Study|Adverse Event|1|||
156543271|NCT03357731|565084547|FG000|Overall Study|Hypotension|0|||
156543272|NCT03357731|565084548|FG001|Overall Study|Hypotension|0|||
156543273|NCT03357731|565084549|FG002|Overall Study|Hypotension|1|||
156543274|NCT03357731|565084550|FG003|Overall Study|Hypotension|1|||
156543275|NCT03357731|565084551|FG004|Overall Study|Hypotension|0|||
156543276|NCT03357731|565084552|FG005|Overall Study|Hypotension|0|||
156543277|NCT03357731|565084547|FG000|Overall Study|Lost to Follow-up|0|||
156543278|NCT03357731|565084548|FG001|Overall Study|Lost to Follow-up|0|||
156543279|NCT03357731|565084549|FG002|Overall Study|Lost to Follow-up|0|||
156543280|NCT03357731|565084550|FG003|Overall Study|Lost to Follow-up|1|||
156543281|NCT03357731|565084551|FG004|Overall Study|Lost to Follow-up|0|||
156543282|NCT03357731|565084552|FG005|Overall Study|Lost to Follow-up|0|||
156543283|NCT01773109|565084553|FG000|Overall Study|Symptomatic Progression|2|||
156543284|NCT01773109|565084553|FG000|Overall Study|Death|1|||
156543285|NCT04036708|565084556|FG000|Overall Study|Lost to Follow-up|14|||
156543286|NCT04036708|565084557|FG001|Overall Study|Lost to Follow-up|4|||
156344694|NCT00642460|564362370|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
156344695|NCT00642460|564362371|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
156344696|NCT00642460|564362366|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
156344697|NCT00642460|564362367|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156344698|NCT00642460|564362368|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156344699|NCT00642460|564362369|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156344700|NCT00642460|564362370|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156344701|NCT00642460|564362371|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156477973|NCT03137784|564844902|FG000|Overall Study|Non-compliance with study treatment|0|||
156477974|NCT03137784|564844903|FG001|Overall Study|Non-compliance with study treatment|0|||
156477975|NCT03137784|564844904|FG002|Overall Study|Non-compliance with study treatment|0|||
156477976|NCT03137784|564844905|FG003|Overall Study|Non-compliance with study treatment|0|||
156477977|NCT03137784|564844906|FG004|Overall Study|Non-compliance with study treatment|1|||
156477978|NCT03137784|564844907|FG005|Overall Study|Non-compliance with study treatment|0|||
156477979|NCT00805792|564844908|FG000|Overall Study|Death|3|||
156477980|NCT00805792|564844908|FG000|Overall Study|Lost to Follow-up|2|||
156477981|NCT02165202|564844910|FG000|Oral Phase|Refused further participation|5|||
156477982|NCT02165202|564844911|FG001|Oral Phase|Refused further participation|1|||
156477983|NCT02165202|564844910|FG000|Oral Phase|Study product Related Toxicity|1|||
156477984|NCT02165202|564844911|FG001|Oral Phase|Study product Related Toxicity|0|||
156477985|NCT02165202|564844910|FG000|Oral Phase|Unable to contact Participant|1|||
156477986|NCT02165202|564844911|FG001|Oral Phase|Unable to contact Participant|1|||
156477987|NCT02165202|564844910|FG000|Oral Phase|Clinical reasons|1|||
156477988|NCT02165202|564844911|FG001|Oral Phase|Clinical reasons|0|||
156477989|NCT02165202|564844910|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
156477990|NCT02165202|564844911|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
156477991|NCT02165202|564844910|FG000|Oral Phase|CMC advised termination|1|||
156477992|NCT02165202|564844911|FG001|Oral Phase|CMC advised termination|0|||
156477993|NCT02165202|564844910|FG000|Oral Phase|Relocated, no follow-up planned|1|||
156477994|NCT02165202|564844911|FG001|Oral Phase|Relocated, no follow-up planned|0|||
156477995|NCT02165202|564844910|FG000|Oral Phase|Abnormal EKG|0|||
156477996|NCT02165202|564844911|FG001|Oral Phase|Abnormal EKG|1|||
156477997|NCT02165202|564844910|FG000|Injection Phase|Abnormal Lab Value|5|||
156477998|NCT02165202|564844911|FG001|Injection Phase|Abnormal Lab Value|1|||
156477999|NCT02165202|564844910|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
156478000|NCT02165202|564844911|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
156478001|NCT02165202|564844910|FG000|Injection Phase|Unable to attend within Visit Window|1|||
156478002|NCT02165202|564844911|FG001|Injection Phase|Unable to attend within Visit Window|0|||
156478003|NCT02165202|564844910|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
156478004|NCT02165202|564844911|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
156478005|NCT02165202|564844910|FG000|Injection Phase|End of Study|2|||
156344702|NCT00642460|564362366|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
156344703|NCT00642460|564362367|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
156344704|NCT00642460|564362368|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
156344705|NCT00642460|564362369|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
156344706|NCT00642460|564362370|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
156344707|NCT00642460|564362371|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
156344708|NCT00642460|564362366|FG000|Part II: Open-Label Up to Week 92|Death|0|||
156478006|NCT02165202|564844911|FG001|Injection Phase|End of Study|1|||
156478007|NCT02165202|564844910|FG000|Injection Phase|Study Product related Toxicity|1|||
156478008|NCT02165202|564844911|FG001|Injection Phase|Study Product related Toxicity|0|||
156478009|NCT02165202|564844910|FG000|Injection Phase|No longer interested|0|||
156478010|NCT02165202|564844911|FG001|Injection Phase|No longer interested|1|||
156543287|NCT04036708|565084558|FG002|Overall Study|Lost to Follow-up|14|||
156543288|NCT04036708|565084559|FG003|Overall Study|Lost to Follow-up|4|||
156543289|NCT01471015|565084566|FG000|Overall Study|Death|0|||
156543290|NCT01471015|565084567|FG001|Overall Study|Death|1|||
156543291|NCT01471015|565084568|FG002|Overall Study|Death|1|||
156543292|NCT04962022|565084569|FG000|Period 1|Withdrawal by Subject|1|||
156543293|NCT04962022|565084570|FG001|Period 1|Withdrawal by Subject|0|||
156543294|NCT02055820|565084573|FG000|Phase I: Dose-Finding|Death|1|||
156543295|NCT02055820|565084574|FG001|Phase I: Dose-Finding|Death|0|||
156543296|NCT02055820|565084575|FG002|Phase I: Dose-Finding|Death|1|||
156543297|NCT02055820|565084576|FG003|Phase I: Dose-Finding|Death|2|||
156543298|NCT02055820|565084577|FG004|Phase I: Dose-Finding|Death|0|||
156478011|NCT02165202|564844910|FG000|Injection Phase|Participant unwilling to comply|1|||
156478012|NCT02165202|564844911|FG001|Injection Phase|Participant unwilling to comply|0|||
156478013|NCT00990184|564844919|FG000|Overall Study|Physician Decision|1|||
156478014|NCT02152384|564844922|FG000|Period 1|Withdrawal by Subject|0|||
156478015|NCT02152384|564844923|FG001|Period 1|Withdrawal by Subject|1|||
156478016|NCT02152384|564844922|FG000|Period 1|Adverse Event|1|||
156478017|NCT02152384|564844923|FG001|Period 1|Adverse Event|1|||
156478018|NCT01215253|564844927|FG000|Overall Study|Withdrawal by Subject|57|||
156478019|NCT01215253|564844928|FG001|Overall Study|Withdrawal by Subject|35|||
156478020|NCT01215253|564844927|FG000|Overall Study|Physician Decision|9|||
156478021|NCT01215253|564844928|FG001|Overall Study|Physician Decision|12|||
156478022|NCT01215253|564844927|FG000|Overall Study|Lost to Follow-up|6|||
156478023|NCT01215253|564844928|FG001|Overall Study|Lost to Follow-up|4|||
156478024|NCT01215253|564844927|FG000|Overall Study|Other|14|||
156478025|NCT01215253|564844928|FG001|Overall Study|Other|12|||
156478026|NCT01320683|564844929|FG000|Overall Study|Positive antibody response|1|||
156478027|NCT02291861|564844930|FG000|Overall Study|Adverse Event|2|||
156478028|NCT02291861|564844931|FG001|Overall Study|Adverse Event|4|||
156478029|NCT02291861|564844932|FG002|Overall Study|Adverse Event|1|||
156478030|NCT02291861|564844933|FG003|Overall Study|Adverse Event|2|||
156478031|NCT02291861|564844930|FG000|Overall Study|Death|0|||
156478032|NCT02291861|564844931|FG001|Overall Study|Death|0|||
156478033|NCT02291861|564844932|FG002|Overall Study|Death|1|||
156478034|NCT02291861|564844933|FG003|Overall Study|Death|1|||
156478035|NCT02291861|564844930|FG000|Overall Study|Protocol Violation|1|||
156478036|NCT02291861|564844931|FG001|Overall Study|Protocol Violation|0|||
156478037|NCT02291861|564844932|FG002|Overall Study|Protocol Violation|0|||
156478038|NCT02291861|564844933|FG003|Overall Study|Protocol Violation|1|||
156478039|NCT02291861|564844930|FG000|Overall Study|Withdrawal by Subject|1|||
156478040|NCT02291861|564844931|FG001|Overall Study|Withdrawal by Subject|2|||
156478041|NCT02291861|564844932|FG002|Overall Study|Withdrawal by Subject|1|||
156478042|NCT02291861|564844933|FG003|Overall Study|Withdrawal by Subject|4|||
156478043|NCT02291861|564844930|FG000|Overall Study|Noncompliance|1|||
156478044|NCT02291861|564844931|FG001|Overall Study|Noncompliance|1|||
156344709|NCT00642460|564362367|FG001|Part II: Open-Label Up to Week 92|Death|1|||
156344710|NCT00642460|564362368|FG002|Part II: Open-Label Up to Week 92|Death|0|||
156344711|NCT00642460|564362369|FG003|Part II: Open-Label Up to Week 92|Death|2|||
156344712|NCT00642460|564362370|FG004|Part II: Open-Label Up to Week 92|Death|0|||
156344713|NCT00642460|564362371|FG005|Part II: Open-Label Up to Week 92|Death|0|||
156344714|NCT00642460|564362366|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
156344715|NCT00642460|564362367|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
156344716|NCT00642460|564362368|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
156344717|NCT00642460|564362369|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
156344718|NCT00642460|564362370|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
156344719|NCT00642460|564362371|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
156344720|NCT00642460|564362366|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
156344721|NCT00642460|564362367|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
156344722|NCT00642460|564362368|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
156344723|NCT00642460|564362369|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
156344724|NCT00642460|564362370|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
156344725|NCT00642460|564362371|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
156344726|NCT00642460|564362366|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
156344727|NCT00642460|564362367|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
156344728|NCT00642460|564362368|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
156478045|NCT02291861|564844932|FG002|Overall Study|Noncompliance|2|||
156478046|NCT02291861|564844933|FG003|Overall Study|Noncompliance|1|||
156478047|NCT02291861|564844930|FG000|Overall Study|Lost to Follow-up|2|||
156344729|NCT00642460|564362369|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
156344730|NCT00642460|564362370|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
156344731|NCT00642460|564362371|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
156344732|NCT00642460|564362366|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156344733|NCT00642460|564362367|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156478048|NCT02291861|564844931|FG001|Overall Study|Lost to Follow-up|1|||
156478049|NCT02291861|564844932|FG002|Overall Study|Lost to Follow-up|4|||
156478050|NCT02291861|564844933|FG003|Overall Study|Lost to Follow-up|0|||
156478051|NCT02291861|564844930|FG000|Overall Study|Other|0|||
156478052|NCT02291861|564844931|FG001|Overall Study|Other|0|||
156478053|NCT02291861|564844932|FG002|Overall Study|Other|0|||
156478054|NCT02291861|564844933|FG003|Overall Study|Other|1|||
156478055|NCT00267956|564844936|FG000|Controlled Period|Adverse Event|4|||
156478056|NCT00267956|564844937|FG001|Controlled Period|Adverse Event|1|||
156478057|NCT00267956|564844938|FG002|Controlled Period|Adverse Event|0|||
156478058|NCT00267956|564844939|FG003|Controlled Period|Adverse Event|0|||
156478059|NCT00267956|564844936|FG000|Controlled Period|Lack of Efficacy|4|||
156478060|NCT00267956|564844937|FG001|Controlled Period|Lack of Efficacy|2|||
156344734|NCT00642460|564362368|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156344735|NCT00642460|564362369|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
156344736|NCT00642460|564362370|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156344737|NCT00642460|564362371|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156478061|NCT00267956|564844938|FG002|Controlled Period|Lack of Efficacy|0|||
156478062|NCT00267956|564844939|FG003|Controlled Period|Lack of Efficacy|0|||
156478063|NCT00267956|564844936|FG000|Controlled Period|Lost to Follow-up|2|||
156478064|NCT00267956|564844937|FG001|Controlled Period|Lost to Follow-up|0|||
156478065|NCT00267956|564844938|FG002|Controlled Period|Lost to Follow-up|0|||
156478066|NCT00267956|564844939|FG003|Controlled Period|Lost to Follow-up|0|||
156478067|NCT00267956|564844936|FG000|Controlled Period|Withdrew consent|3|||
156478068|NCT00267956|564844937|FG001|Controlled Period|Withdrew consent|1|||
156478069|NCT00267956|564844938|FG002|Controlled Period|Withdrew consent|0|||
156478070|NCT00267956|564844939|FG003|Controlled Period|Withdrew consent|0|||
156478071|NCT00267956|564844936|FG000|After Controlled Period|Adverse Event|0|||
156478072|NCT00267956|564844937|FG001|After Controlled Period|Adverse Event|0|||
156478073|NCT00267956|564844938|FG002|After Controlled Period|Adverse Event|2|||
156478074|NCT00267956|564844939|FG003|After Controlled Period|Adverse Event|1|||
156478075|NCT00267956|564844936|FG000|After Controlled Period|Lack of Efficacy|0|||
156478076|NCT00267956|564844937|FG001|After Controlled Period|Lack of Efficacy|0|||
156478077|NCT00267956|564844938|FG002|After Controlled Period|Lack of Efficacy|1|||
156478078|NCT00267956|564844939|FG003|After Controlled Period|Lack of Efficacy|1|||
156478079|NCT00267956|564844936|FG000|After Controlled Period|Lost to Follow-up|0|||
156478080|NCT00267956|564844937|FG001|After Controlled Period|Lost to Follow-up|0|||
156478081|NCT00267956|564844938|FG002|After Controlled Period|Lost to Follow-up|1|||
156478082|NCT00267956|564844939|FG003|After Controlled Period|Lost to Follow-up|0|||
156478083|NCT00267956|564844936|FG000|After Controlled Period|Withdrew consent|0|||
156478084|NCT00267956|564844937|FG001|After Controlled Period|Withdrew consent|0|||
156478085|NCT00267956|564844938|FG002|After Controlled Period|Withdrew consent|1|||
156478086|NCT00267956|564844939|FG003|After Controlled Period|Withdrew consent|0|||
156478087|NCT01263223|564844942|FG000|Period 2|Withdrawal by Subject|0|||
156478088|NCT01263223|564844943|FG001|Period 2|Withdrawal by Subject|1|||
156478089|NCT01263223|564844942|FG000|7-day Follow-up|Withdrawal by Subject|0|||
156478090|NCT01263223|564844943|FG001|7-day Follow-up|Withdrawal by Subject|1|||
156478091|NCT01263223|564844942|FG000|7-day Follow-up|Lost to Follow-up|1|||
156478092|NCT01263223|564844943|FG001|7-day Follow-up|Lost to Follow-up|0|||
156478093|NCT02005484|564844944|FG000|Overall Study|Death|1|||
156478094|NCT02005484|564844944|FG000|Overall Study|Disease progression|1|||
156478095|NCT02005484|564844944|FG000|Overall Study|Changed to a Different Study|1|||
156344738|NCT00642460|564362366|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
156344739|NCT00642460|564362367|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
156344740|NCT00642460|564362368|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
156344741|NCT00642460|564362369|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
156344742|NCT00642460|564362370|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
156344743|NCT00642460|564362371|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
156344744|NCT00642460|564362366|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
156344745|NCT00642460|564362367|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
156344746|NCT00642460|564362368|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
156344747|NCT00642460|564362369|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
156344748|NCT00642460|564362370|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
156344749|NCT00642460|564362371|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
156344750|NCT00642460|564362366|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
156344751|NCT00642460|564362367|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
156344752|NCT00642460|564362368|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
156344753|NCT00642460|564362369|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
156344754|NCT00642460|564362370|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
156344755|NCT00642460|564362371|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
156344756|NCT00642460|564362366|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
156344757|NCT00642460|564362367|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
156344758|NCT00642460|564362368|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
156344759|NCT00642460|564362369|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
156344760|NCT00642460|564362370|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
156344761|NCT00642460|564362371|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
156344762|NCT00642460|564362366|FG000|Part III: Open-Label Up to Week 260|Other|0|||
156344763|NCT00642460|564362367|FG001|Part III: Open-Label Up to Week 260|Other|0|||
156344764|NCT00642460|564362368|FG002|Part III: Open-Label Up to Week 260|Other|0|||
156344765|NCT00642460|564362369|FG003|Part III: Open-Label Up to Week 260|Other|0|||
156344766|NCT00642460|564362370|FG004|Part III: Open-Label Up to Week 260|Other|2|||
156344767|NCT00642460|564362371|FG005|Part III: Open-Label Up to Week 260|Other|2|||
156344768|NCT00642460|564362366|FG000|Part III: Open-Label Up to Week 260|Death|0|||
156344769|NCT00642460|564362367|FG001|Part III: Open-Label Up to Week 260|Death|0|||
156344770|NCT00642460|564362368|FG002|Part III: Open-Label Up to Week 260|Death|0|||
156344771|NCT00642460|564362369|FG003|Part III: Open-Label Up to Week 260|Death|0|||
156344772|NCT00642460|564362370|FG004|Part III: Open-Label Up to Week 260|Death|0|||
156344773|NCT00642460|564362371|FG005|Part III: Open-Label Up to Week 260|Death|3|||
156344774|NCT00642460|564362366|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156344775|NCT00642460|564362367|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156344776|NCT00642460|564362368|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156344777|NCT00642460|564362369|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156344778|NCT00642460|564362370|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156344779|NCT00642460|564362371|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
156344780|NCT00642460|564362366|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
156344781|NCT00642460|564362367|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
156344782|NCT00642460|564362368|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
156344783|NCT00642460|564362369|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
156344784|NCT00642460|564362370|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
156344785|NCT00642460|564362371|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
156344786|NCT02516163|564362376|FG000|Overall Study|Withdrawal by Subject|1|||
156344787|NCT02516163|564362376|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
156344788|NCT02516163|564362376|FG000|Overall Study|Unfit/delay in surgery|3|||
156344789|NCT02516163|564362376|FG000|Overall Study|Use of incorrect measurement technique|5|||
156344790|NCT02516163|564362376|FG000|Overall Study|Data not recorded|2|||
156344791|NCT02516163|564362376|FG000|Overall Study|MRI contraindication exclusion|6|||
156344792|NCT01637272|564362378|FG000|Overall Study|Adverse Event|6|||
156478096|NCT02005484|564844944|FG000|Overall Study|Sponsor decision|1|||
156344793|NCT01637272|564362378|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156344794|NCT01637272|564362378|FG000|Overall Study|Withdrawal by Subject|3|||
156344795|NCT01637272|564362378|FG000|Overall Study|Lost to Follow-up|2|||
156344796|NCT01637272|564362378|FG000|Overall Study|completed core, did not enter ext. phase|4|||
156478097|NCT02246647|564844945|FG000|Overall Study|Withdrawal by Subject|1|||
156478098|NCT02246647|564844946|FG001|Overall Study|Withdrawal by Subject|1|||
156478099|NCT01393964|564844947|FG000|Overall Study|Disease Progression|4|||
156478100|NCT01393964|564844948|FG001|Overall Study|Disease Progression|3|||
156478101|NCT01393964|564844949|FG002|Overall Study|Disease Progression|5|||
156478102|NCT01393964|564844947|FG000|Overall Study|Study drug toxicity|1|||
156478103|NCT01393964|564844948|FG001|Overall Study|Study drug toxicity|0|||
156478104|NCT01393964|564844949|FG002|Overall Study|Study drug toxicity|0|||
156478105|NCT01393964|564844947|FG000|Overall Study|Withdrawal by Subject|0|||
156478106|NCT01393964|564844948|FG001|Overall Study|Withdrawal by Subject|0|||
156478107|NCT01393964|564844949|FG002|Overall Study|Withdrawal by Subject|1|||
156478108|NCT01393964|564844947|FG000|Overall Study|Adverse event unrelated to study drug|0|||
156478109|NCT01393964|564844948|FG001|Overall Study|Adverse event unrelated to study drug|3|||
156478110|NCT01393964|564844949|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156478111|NCT01393964|564844947|FG000|Overall Study|Subject request stop study treatment|0|||
156478112|NCT01393964|564844948|FG001|Overall Study|Subject request stop study treatment|1|||
156478113|NCT01393964|564844949|FG002|Overall Study|Subject request stop study treatment|0|||
156478114|NCT01393964|564844947|FG000|Overall Study|Subject decided to move to transplant|1|||
156478115|NCT01393964|564844948|FG001|Overall Study|Subject decided to move to transplant|0|||
156478116|NCT01393964|564844949|FG002|Overall Study|Subject decided to move to transplant|0|||
156478117|NCT01393964|564844947|FG000|Overall Study|Subject switched to commercial supply|1|||
156478118|NCT01393964|564844948|FG001|Overall Study|Subject switched to commercial supply|0|||
156478119|NCT01393964|564844949|FG002|Overall Study|Subject switched to commercial supply|2|||
156478120|NCT01393964|564844947|FG000|Overall Study|Subject plateaued in terms of effect|1|||
156478121|NCT01393964|564844948|FG001|Overall Study|Subject plateaued in terms of effect|0|||
156478122|NCT01393964|564844949|FG002|Overall Study|Subject plateaued in terms of effect|0|||
156478123|NCT01393964|564844947|FG000|Overall Study|Investigator removed subject from study|0|||
156478124|NCT01393964|564844948|FG001|Overall Study|Investigator removed subject from study|1|||
156478125|NCT01393964|564844949|FG002|Overall Study|Investigator removed subject from study|0|||
156478126|NCT01393964|564844947|FG000|Overall Study|Subject converted to roll-over study|0|||
156478127|NCT01393964|564844948|FG001|Overall Study|Subject converted to roll-over study|1|||
156478128|NCT01393964|564844949|FG002|Overall Study|Subject converted to roll-over study|0|||
156478129|NCT01393964|564844947|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
156478130|NCT01393964|564844948|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
156478131|NCT01393964|564844949|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
156478132|NCT01113541|564844950|FG000|Overall Study|Withdrawal by Subject|1|||
156478133|NCT01113541|564844950|FG000|Overall Study|Protocol Violation|1|||
156478134|NCT01113541|564844950|FG000|Overall Study|Study Terminated by Sponsor|7|||
156478135|NCT01113541|564844950|FG000|Overall Study|Adverse Event|4|||
156478136|NCT04679675|564844951|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
156478137|NCT04679675|564844952|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
156478138|NCT04679675|564844953|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
156478139|NCT04679675|564844954|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
156478140|NCT04679675|564844951|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
156543299|NCT02055820|565084578|FG005|Phase I: Dose-Finding|Death|1|||
156543300|NCT02055820|565084579|FG006|Phase I: Dose-Finding|Death|1|||
156543301|NCT02055820|565084580|FG007|Phase I: Dose-Finding|Death|0|||
156543302|NCT02055820|565084581|FG008|Phase I: Dose-Finding|Death|0|||
156543303|NCT02055820|565084582|FG009|Phase I: Dose-Finding|Death|0|||
156543304|NCT02055820|565084573|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543305|NCT02055820|565084574|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543306|NCT02055820|565084575|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543307|NCT02055820|565084576|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543308|NCT02055820|565084577|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543309|NCT02055820|565084578|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
156543310|NCT02055820|565084579|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543311|NCT02055820|565084580|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543312|NCT02055820|565084581|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543313|NCT02055820|565084582|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
156543314|NCT02055820|565084573|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
156543315|NCT02055820|565084574|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
156543316|NCT02055820|565084575|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
156543317|NCT02055820|565084576|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
156543318|NCT02055820|565084577|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
156543319|NCT02055820|565084578|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
156543320|NCT02055820|565084579|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
156543321|NCT02055820|565084580|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
156543322|NCT02055820|565084581|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
156543323|NCT02055820|565084582|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
156543324|NCT02055820|565084573|FG000|Phase II: Expansion|Death|0|||
156543325|NCT02055820|565084574|FG001|Phase II: Expansion|Death|0|||
156543326|NCT02055820|565084575|FG002|Phase II: Expansion|Death|0|||
156543327|NCT02055820|565084576|FG003|Phase II: Expansion|Death|0|||
156543328|NCT02055820|565084577|FG004|Phase II: Expansion|Death|33|||
156543329|NCT02055820|565084578|FG005|Phase II: Expansion|Death|0|||
156543330|NCT02055820|565084579|FG006|Phase II: Expansion|Death|0|||
156543331|NCT02055820|565084580|FG007|Phase II: Expansion|Death|0|||
156543332|NCT02055820|565084581|FG008|Phase II: Expansion|Death|0|||
156543333|NCT02055820|565084582|FG009|Phase II: Expansion|Death|0|||
156543334|NCT02055820|565084573|FG000|Phase II: Expansion|Lost to Follow-up|0|||
156543335|NCT02055820|565084574|FG001|Phase II: Expansion|Lost to Follow-up|0|||
156543336|NCT02055820|565084575|FG002|Phase II: Expansion|Lost to Follow-up|0|||
156543337|NCT02055820|565084576|FG003|Phase II: Expansion|Lost to Follow-up|0|||
156543338|NCT02055820|565084577|FG004|Phase II: Expansion|Lost to Follow-up|4|||
156543339|NCT02055820|565084578|FG005|Phase II: Expansion|Lost to Follow-up|0|||
156543340|NCT02055820|565084579|FG006|Phase II: Expansion|Lost to Follow-up|0|||
156543341|NCT02055820|565084580|FG007|Phase II: Expansion|Lost to Follow-up|0|||
156543342|NCT02055820|565084581|FG008|Phase II: Expansion|Lost to Follow-up|0|||
156543343|NCT02055820|565084582|FG009|Phase II: Expansion|Lost to Follow-up|0|||
156543344|NCT02055820|565084573|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
156543345|NCT02055820|565084574|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
156543346|NCT02055820|565084575|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
156543347|NCT02055820|565084576|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
156543348|NCT02055820|565084577|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
156543349|NCT02055820|565084578|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
156543350|NCT02055820|565084579|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
156543351|NCT02055820|565084580|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
156543352|NCT02055820|565084581|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
156543353|NCT02055820|565084582|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
156543354|NCT00552175|565084583|FG000|Overall Study|Lack of Efficacy|2|||
156543355|NCT00552175|565084584|FG001|Overall Study|Lack of Efficacy|0|||
156543356|NCT00552175|565084585|FG002|Overall Study|Lack of Efficacy|1|||
156543357|NCT00552175|565084583|FG000|Overall Study|Adverse Event|9|||
156344797|NCT01637272|564362378|FG000|Overall Study|Administrative problems|1|||
156344798|NCT01637272|564362378|FG000|Overall Study|Protocol Violation|2|||
156344799|NCT01496612|564362379|FG000|1st Intervention|Adverse Event|1|||
156543358|NCT00552175|565084584|FG001|Overall Study|Adverse Event|9|||
156543359|NCT00552175|565084585|FG002|Overall Study|Adverse Event|10|||
156543360|NCT00552175|565084583|FG000|Overall Study|Withdrawal by Subject|2|||
156344800|NCT01496612|564362380|FG001|1st Intervention|Adverse Event|0|||
156344801|NCT01496612|564362379|FG000|1st Intervention|Withdrawal by Subject|1|||
156344802|NCT01496612|564362380|FG001|1st Intervention|Withdrawal by Subject|0|||
156543361|NCT00552175|565084584|FG001|Overall Study|Withdrawal by Subject|2|||
156543362|NCT00552175|565084585|FG002|Overall Study|Withdrawal by Subject|1|||
156543363|NCT00552175|565084583|FG000|Overall Study|Lost to Follow-up|0|||
156543364|NCT00552175|565084584|FG001|Overall Study|Lost to Follow-up|0|||
156543365|NCT00552175|565084585|FG002|Overall Study|Lost to Follow-up|1|||
156543366|NCT00552175|565084583|FG000|Overall Study|Entry Criteria Not Met|1|||
156543367|NCT00552175|565084584|FG001|Overall Study|Entry Criteria Not Met|1|||
156543368|NCT00552175|565084585|FG002|Overall Study|Entry Criteria Not Met|0|||
156543369|NCT00552175|565084583|FG000|Overall Study|Reason Not Specified|3|||
156543370|NCT00552175|565084584|FG001|Overall Study|Reason Not Specified|1|||
156543371|NCT00552175|565084585|FG002|Overall Study|Reason Not Specified|1|||
156543372|NCT03962101|565084586|FG000|Overall Study|Adverse Event|1|||
156344803|NCT00291577|564362381|FG000|Overall Study|Adverse Event|1|||
156344804|NCT00291577|564362381|FG000|Overall Study|Other|4|||
156344805|NCT00291577|564362381|FG000|Overall Study|Withdrawal by Subject|2|||
156344806|NCT00291577|564362381|FG000|Overall Study|Lack of Efficacy|14|||
156344807|NCT03129100|564362386|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
156344808|NCT03129100|564362387|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
156344809|NCT03129100|564362388|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
156344810|NCT03129100|564362389|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
156344811|NCT03129100|564362390|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
156344812|NCT03129100|564362391|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
156344813|NCT03129100|564362392|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
156344814|NCT03129100|564362393|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
156344815|NCT03129100|564362394|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
156344816|NCT03129100|564362395|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
156344817|NCT03129100|564362396|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
156344818|NCT03129100|564362397|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
156344819|NCT03129100|564362398|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
156344820|NCT03129100|564362399|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
156344821|NCT03129100|564362400|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
156344822|NCT03129100|564362401|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
156344823|NCT03129100|564362402|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
156344824|NCT03129100|564362403|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
156344825|NCT03129100|564362404|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
156344826|NCT03129100|564362405|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
156344827|NCT03129100|564362406|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
156344828|NCT03129100|564362407|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
156344829|NCT03129100|564362408|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
156344830|NCT03129100|564362409|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
156344831|NCT03129100|564362410|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
156344832|NCT03129100|564362411|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
156344833|NCT03129100|564362386|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
156344834|NCT03129100|564362387|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344835|NCT03129100|564362388|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344836|NCT03129100|564362389|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344837|NCT03129100|564362390|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344838|NCT03129100|564362391|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344839|NCT03129100|564362392|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344840|NCT03129100|564362393|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344841|NCT03129100|564362394|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344842|NCT03129100|564362395|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344843|NCT03129100|564362396|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344844|NCT03129100|564362397|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344845|NCT03129100|564362398|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344846|NCT03129100|564362399|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344847|NCT03129100|564362400|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344848|NCT03129100|564362401|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344849|NCT03129100|564362402|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344850|NCT03129100|564362403|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344851|NCT03129100|564362404|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344852|NCT03129100|564362405|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344853|NCT03129100|564362406|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344854|NCT03129100|564362407|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344855|NCT03129100|564362408|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344856|NCT03129100|564362409|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344857|NCT03129100|564362410|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344858|NCT03129100|564362411|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156344859|NCT03129100|564362386|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
156344860|NCT03129100|564362387|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
156344861|NCT03129100|564362388|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344862|NCT03129100|564362389|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344863|NCT03129100|564362390|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344864|NCT03129100|564362391|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344865|NCT03129100|564362392|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344866|NCT03129100|564362393|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344867|NCT03129100|564362394|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344868|NCT03129100|564362395|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344869|NCT03129100|564362396|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344870|NCT03129100|564362397|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344871|NCT03129100|564362398|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344872|NCT03129100|564362399|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344873|NCT03129100|564362400|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156478141|NCT04679675|564844952|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
156344874|NCT03129100|564362401|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344875|NCT03129100|564362402|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344876|NCT03129100|564362403|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344877|NCT03129100|564362404|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344878|NCT03129100|564362405|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344879|NCT03129100|564362406|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344880|NCT03129100|564362407|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344881|NCT03129100|564362408|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344882|NCT03129100|564362409|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344883|NCT03129100|564362410|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344884|NCT03129100|564362411|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156344885|NCT03129100|564362386|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
156344886|NCT03129100|564362387|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
156344887|NCT03129100|564362388|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344888|NCT03129100|564362389|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344889|NCT03129100|564362390|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344890|NCT03129100|564362391|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344891|NCT03129100|564362392|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344892|NCT03129100|564362393|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344893|NCT03129100|564362394|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344894|NCT03129100|564362395|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344895|NCT03129100|564362396|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344896|NCT03129100|564362397|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344897|NCT03129100|564362398|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344898|NCT03129100|564362399|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344899|NCT03129100|564362400|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344900|NCT03129100|564362401|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344901|NCT03129100|564362402|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344902|NCT03129100|564362403|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344903|NCT03129100|564362404|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344904|NCT03129100|564362405|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344905|NCT03129100|564362406|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344906|NCT03129100|564362407|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344907|NCT03129100|564362408|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344908|NCT03129100|564362409|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344909|NCT03129100|564362410|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344910|NCT03129100|564362411|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156344911|NCT03129100|564362386|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344912|NCT03129100|564362387|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
156344913|NCT03129100|564362388|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344914|NCT03129100|564362389|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344915|NCT03129100|564362390|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344916|NCT03129100|564362391|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344917|NCT03129100|564362392|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344918|NCT03129100|564362393|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344919|NCT03129100|564362394|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344920|NCT03129100|564362395|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344921|NCT03129100|564362396|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344922|NCT03129100|564362397|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344923|NCT03129100|564362398|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344924|NCT03129100|564362399|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344925|NCT03129100|564362400|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344926|NCT03129100|564362401|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344927|NCT03129100|564362402|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344928|NCT03129100|564362403|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344929|NCT03129100|564362404|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344930|NCT03129100|564362405|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344931|NCT03129100|564362406|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344932|NCT03129100|564362407|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344933|NCT03129100|564362408|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
156478142|NCT04679675|564844953|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
156344934|NCT03129100|564362409|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344935|NCT03129100|564362410|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
156344936|NCT03129100|564362411|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
156543373|NCT03962101|565084586|FG000|Overall Study|Physician Decision|2|||
156543374|NCT03962101|565084586|FG000|Overall Study|Not related to medical events|1|||
156543375|NCT03548935|565084588|FG000|Overall Study|Withdrawal by Subject|26|||
156543376|NCT03548935|565084589|FG001|Overall Study|Withdrawal by Subject|17|||
156543377|NCT03548935|565084588|FG000|Overall Study|Lost to Follow-up|39|||
156543378|NCT03548935|565084589|FG001|Overall Study|Lost to Follow-up|28|||
156543379|NCT03548935|565084588|FG000|Overall Study|Death|1|||
156543380|NCT03548935|565084589|FG001|Overall Study|Death|1|||
156543381|NCT03972969|565084590|FG000|3-month Follow-up|Death|1|||
156543382|NCT03972969|565084591|FG001|3-month Follow-up|Death|1|||
156543383|NCT03972969|565084592|FG002|3-month Follow-up|Death|0|||
156543384|NCT03972969|565084590|FG000|6-month Follow-up|Death|1|||
156543385|NCT03972969|565084591|FG001|6-month Follow-up|Death|1|||
156543386|NCT03972969|565084592|FG002|6-month Follow-up|Death|1|||
156543387|NCT03972969|565084590|FG000|6-month Follow-up|Lost to Follow-up|2|||
156543388|NCT03972969|565084591|FG001|6-month Follow-up|Lost to Follow-up|2|||
156543389|NCT03972969|565084592|FG002|6-month Follow-up|Lost to Follow-up|2|||
156543390|NCT04677959|565084593|FG000|Overall Study|Adverse Event|1|||
156543391|NCT04677959|565084594|FG001|Overall Study|Adverse Event|9|||
156543392|NCT04677959|565084593|FG000|Overall Study|Withdrawal by Subject|2|||
156543393|NCT04677959|565084594|FG001|Overall Study|Withdrawal by Subject|15|||
156543394|NCT04677959|565084593|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156543395|NCT04677959|565084594|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156543396|NCT04677959|565084593|FG000|Overall Study|Non-compliance with study drug|0|||
156543397|NCT04677959|565084594|FG001|Overall Study|Non-compliance with study drug|2|||
156478143|NCT04679675|564844954|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
156478144|NCT03006393|564844958|FG000|Overall Study|Withdrawal by Subject|1|||
156478145|NCT03006393|564844959|FG001|Overall Study|Withdrawal by Subject|1|||
156478146|NCT03006393|564844958|FG000|Overall Study|Pregnancy|0|||
156478147|NCT03006393|564844959|FG001|Overall Study|Pregnancy|1|||
156478148|NCT03006393|564844958|FG000|Overall Study|Lost to Follow-up|0|||
156478149|NCT03006393|564844959|FG001|Overall Study|Lost to Follow-up|1|||
156478150|NCT00807599|564844960|FG000|Overall Study|Not treated on protocol study|0|||
156478151|NCT00807599|564844961|FG001|Overall Study|Not treated on protocol study|0|||
156478152|NCT00807599|564844962|FG002|Overall Study|Not treated on protocol study|2|||
156478153|NCT00807599|564844960|FG000|Overall Study|Adverse Event|0|||
156478154|NCT00807599|564844961|FG001|Overall Study|Adverse Event|0|||
156478155|NCT00807599|564844962|FG002|Overall Study|Adverse Event|5|||
156478156|NCT00807599|564844960|FG000|Overall Study|Inadequate response to induction|0|||
156478157|NCT00807599|564844961|FG001|Overall Study|Inadequate response to induction|0|||
156478158|NCT00807599|564844962|FG002|Overall Study|Inadequate response to induction|9|||
156478159|NCT00807599|564844960|FG000|Overall Study|Withdrawal by Subject|0|||
156543398|NCT04677959|565084593|FG000|Overall Study|Protocol deviation|0|||
156543399|NCT04677959|565084594|FG001|Overall Study|Protocol deviation|11|||
156543400|NCT04677959|565084593|FG000|Overall Study|Lost to Follow-up|9|||
156543401|NCT04677959|565084594|FG001|Overall Study|Lost to Follow-up|13|||
156478160|NCT00807599|564844961|FG001|Overall Study|Withdrawal by Subject|0|||
156478161|NCT00807599|564844962|FG002|Overall Study|Withdrawal by Subject|1|||
156478162|NCT03695185|564844963|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
156478163|NCT03695185|564844963|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
156478164|NCT03695185|564844963|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
156478165|NCT03695185|564844963|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
156478166|NCT03695185|564844963|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
156478167|NCT03695185|564844963|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
156478168|NCT01328756|564844967|FG000|Overall Study|Protocol Violation|4|||
156478169|NCT01328756|564844967|FG000|Overall Study|Adverse Event|39|||
156478170|NCT01328756|564844967|FG000|Overall Study|Lack of Efficacy|5|||
156478171|NCT01328756|564844967|FG000|Overall Study|Withdrawal by Subject|41|||
156478172|NCT01328756|564844967|FG000|Overall Study|Lost to Follow-up|5|||
156478173|NCT01328756|564844967|FG000|Overall Study|Other|29|||
156478174|NCT04183491|564844973|FG000|Overall Study|Withdrawal by Subject|0|||
156478175|NCT04183491|564844974|FG001|Overall Study|Withdrawal by Subject|0|||
156478176|NCT04183491|564844975|FG002|Overall Study|Withdrawal by Subject|1|||
156478177|NCT04183491|564844976|FG003|Overall Study|Withdrawal by Subject|0|||
156478178|NCT04183491|564844977|FG004|Overall Study|Withdrawal by Subject|0|||
156478179|NCT04183491|564844978|FG005|Overall Study|Withdrawal by Subject|1|||
156478180|NCT04183491|564844979|FG006|Overall Study|Withdrawal by Subject|0|||
156478181|NCT03288506|564844980|FG000|Overall Study|Withdrawal by Subject|52|||
156478182|NCT03692871|564844981|FG000|Overall Study|Death|1|||
156478183|NCT03692871|564844982|FG001|Overall Study|Death|1|||
156478184|NCT03692871|564844981|FG000|Overall Study|Lost to Follow-up|24|||
156478185|NCT03692871|564844982|FG001|Overall Study|Lost to Follow-up|9|||
156478186|NCT03692871|564844981|FG000|Overall Study|Physician Decision|22|||
156478187|NCT03692871|564844982|FG001|Overall Study|Physician Decision|7|||
156478188|NCT03692871|564844981|FG000|Overall Study|Protocol Deviation|1|||
156478189|NCT03692871|564844982|FG001|Overall Study|Protocol Deviation|0|||
156478190|NCT03692871|564844981|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
156478191|NCT03692871|564844982|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
156478192|NCT02852824|564844985|FG000|Overall Study|Withdrawal by Subject|1|||
156478193|NCT02852824|564844986|FG001|Overall Study|Withdrawal by Subject|0|||
156478194|NCT02852824|564844987|FG002|Overall Study|Withdrawal by Subject|0|||
156478195|NCT02852824|564844988|FG003|Overall Study|Withdrawal by Subject|0|||
156478196|NCT02852824|564844989|FG004|Overall Study|Withdrawal by Subject|0|||
156478197|NCT02852824|564844990|FG005|Overall Study|Withdrawal by Subject|0|||
156478198|NCT02852824|564844991|FG006|Overall Study|Withdrawal by Subject|0|||
156478199|NCT02852824|564844985|FG000|Overall Study|Adverse Event|0|||
156478200|NCT02852824|564844986|FG001|Overall Study|Adverse Event|0|||
156478201|NCT02852824|564844987|FG002|Overall Study|Adverse Event|0|||
156478202|NCT02852824|564844988|FG003|Overall Study|Adverse Event|0|||
156478203|NCT02852824|564844989|FG004|Overall Study|Adverse Event|2|||
156478204|NCT02852824|564844990|FG005|Overall Study|Adverse Event|0|||
156478205|NCT02852824|564844991|FG006|Overall Study|Adverse Event|0|||
156478206|NCT01316913|564844992|FG000|Overall Study|Adverse Event|17|||
156478207|NCT01316913|564844993|FG001|Overall Study|Adverse Event|20|||
156478208|NCT01316913|564844994|FG002|Overall Study|Adverse Event|15|||
156478209|NCT01316913|564844995|FG003|Overall Study|Adverse Event|11|||
156478210|NCT01316913|564844992|FG000|Overall Study|Lack of Efficacy|22|||
156478211|NCT01316913|564844993|FG001|Overall Study|Lack of Efficacy|12|||
156478212|NCT01316913|564844994|FG002|Overall Study|Lack of Efficacy|9|||
156478213|NCT01316913|564844995|FG003|Overall Study|Lack of Efficacy|13|||
156478214|NCT01316913|564844992|FG000|Overall Study|Protocol Violation|1|||
156478215|NCT01316913|564844993|FG001|Overall Study|Protocol Violation|4|||
156478216|NCT01316913|564844994|FG002|Overall Study|Protocol Violation|4|||
156478217|NCT01316913|564844995|FG003|Overall Study|Protocol Violation|1|||
156478218|NCT01316913|564844992|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
156478219|NCT01316913|564844993|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
156478220|NCT01316913|564844994|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
156478221|NCT01316913|564844995|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
156478222|NCT01316913|564844992|FG000|Overall Study|Lost to Follow-up|0|||
156478223|NCT01316913|564844993|FG001|Overall Study|Lost to Follow-up|1|||
156478224|NCT01316913|564844994|FG002|Overall Study|Lost to Follow-up|0|||
156478225|NCT01316913|564844995|FG003|Overall Study|Lost to Follow-up|2|||
156478226|NCT01316913|564844992|FG000|Overall Study|Withdrawal by Subject|10|||
156478227|NCT01316913|564844993|FG001|Overall Study|Withdrawal by Subject|9|||
156478228|NCT01316913|564844994|FG002|Overall Study|Withdrawal by Subject|10|||
156478229|NCT01316913|564844995|FG003|Overall Study|Withdrawal by Subject|6|||
156478230|NCT01860079|564844996|FG000|Overall Study|Physician Decision|14|||
156344937|NCT03129100|564362386|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344938|NCT03129100|564362387|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344939|NCT03129100|564362388|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
156344940|NCT03129100|564362389|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
156344941|NCT03129100|564362390|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344942|NCT03129100|564362391|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
156344943|NCT03129100|564362392|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344944|NCT03129100|564362393|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478231|NCT01860079|564844997|FG001|Overall Study|Physician Decision|22|||
156478232|NCT02102724|564844998|FG000|Overall Study|Lost to Follow-up|1|||
156478233|NCT02102724|564844999|FG001|Overall Study|Lost to Follow-up|0|||
156478234|NCT02102724|564844998|FG000|Overall Study|surgery for brain aneurysm|1|||
156478235|NCT02102724|564844999|FG001|Overall Study|surgery for brain aneurysm|1|||
156478236|NCT05445557|564845000|FG000|Double Blind Part|Lost to Follow-up|1|||
156478237|NCT02008916|564845001|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
156478238|NCT02008916|564845002|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
156478239|NCT02008916|564845003|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
156478240|NCT02008916|564845001|FG000|Week 16 - 156|Adverse Event|4|||
156478241|NCT02008916|564845002|FG001|Week 16 - 156|Adverse Event|2|||
156478242|NCT02008916|564845003|FG002|Week 16 - 156|Adverse Event|3|||
156478243|NCT02008916|564845001|FG000|Week 16 - 156|Withdrawal by Subject|7|||
156478244|NCT02008916|564845002|FG001|Week 16 - 156|Withdrawal by Subject|3|||
156478245|NCT02008916|564845003|FG002|Week 16 - 156|Withdrawal by Subject|5|||
156478246|NCT02008916|564845001|FG000|Week 16 - 156|No longer requires treatment|0|||
156478247|NCT02008916|564845002|FG001|Week 16 - 156|No longer requires treatment|1|||
156478248|NCT02008916|564845003|FG002|Week 16 - 156|No longer requires treatment|0|||
156478249|NCT02008916|564845001|FG000|Week 16 - 156|Lost to Follow-up|5|||
156478250|NCT02008916|564845002|FG001|Week 16 - 156|Lost to Follow-up|0|||
156478251|NCT02008916|564845003|FG002|Week 16 - 156|Lost to Follow-up|0|||
156478252|NCT02008916|564845001|FG000|Week 16 - 156|Lack of Efficacy|3|||
156478253|NCT02008916|564845002|FG001|Week 16 - 156|Lack of Efficacy|5|||
156478254|NCT02008916|564845003|FG002|Week 16 - 156|Lack of Efficacy|2|||
156478255|NCT02008916|564845001|FG000|Week 16 - 156|Pregnancy|0|||
156478256|NCT02008916|564845002|FG001|Week 16 - 156|Pregnancy|1|||
156478257|NCT02008916|564845003|FG002|Week 16 - 156|Pregnancy|0|||
156478258|NCT02008916|564845001|FG000|Week 16 - 156|Physician Decision|0|||
156478259|NCT02008916|564845002|FG001|Week 16 - 156|Physician Decision|1|||
156478260|NCT02008916|564845003|FG002|Week 16 - 156|Physician Decision|0|||
156478261|NCT01323790|564845004|FG000|Overall Study|Other|3|||
156478262|NCT01323790|564845005|FG001|Overall Study|Other|2|||
156478263|NCT01323790|564845006|FG002|Overall Study|Other|1|||
156478264|NCT01323790|564845004|FG000|Overall Study|Lost to Follow-up|11|||
156478265|NCT01323790|564845005|FG001|Overall Study|Lost to Follow-up|9|||
156478266|NCT01323790|564845006|FG002|Overall Study|Lost to Follow-up|9|||
156478267|NCT01323790|564845004|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
156478268|NCT01323790|564845005|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
156478269|NCT01323790|564845006|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
156478270|NCT01323790|564845004|FG000|Overall Study|Lack of Efficacy|3|||
156478271|NCT01323790|564845005|FG001|Overall Study|Lack of Efficacy|0|||
156478272|NCT01323790|564845006|FG002|Overall Study|Lack of Efficacy|3|||
156478273|NCT01323790|564845004|FG000|Overall Study|Adverse Event|11|||
156478274|NCT01323790|564845005|FG001|Overall Study|Adverse Event|24|||
156478275|NCT01323790|564845006|FG002|Overall Study|Adverse Event|12|||
156478276|NCT01323790|564845004|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156478277|NCT01323790|564845005|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156478278|NCT01323790|564845006|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
156478279|NCT01323790|564845004|FG000|Overall Study|Withdrawal by Subject|23|||
156478280|NCT01323790|564845005|FG001|Overall Study|Withdrawal by Subject|20|||
156478281|NCT01323790|564845006|FG002|Overall Study|Withdrawal by Subject|13|||
156478282|NCT01323790|564845004|FG000|Overall Study|Did Not Receive Treatment|2|||
156478283|NCT01323790|564845005|FG001|Overall Study|Did Not Receive Treatment|0|||
156478284|NCT01323790|564845006|FG002|Overall Study|Did Not Receive Treatment|1|||
156478285|NCT01323790|564845004|FG000|Overall Study|Severe non-compliance with protocol|2|||
156478286|NCT01323790|564845005|FG001|Overall Study|Severe non-compliance with protocol|2|||
156478287|NCT01323790|564845006|FG002|Overall Study|Severe non-compliance with protocol|2|||
156478288|NCT02915783|564845013|FG000|Overall Study|Death|21|||
156478289|NCT02915783|564845013|FG000|Overall Study|Lost to Follow-up|1|||
156478290|NCT02915783|564845013|FG000|Overall Study|Withdrawal by Subject|2|||
156478291|NCT02950961|564845015|FG000|Overall Study|Study had to stop due to COVID.|7|||
156478292|NCT01915914|564845016|FG000|Acute Phase|Withdrawal by Subject|4|||
156478293|NCT01915914|564845017|FG001|Acute Phase|Withdrawal by Subject|0|||
156478294|NCT01915914|564845018|FG002|Acute Phase|Withdrawal by Subject|0|||
156478295|NCT01915914|564845019|FG003|Acute Phase|Withdrawal by Subject|0|||
156478296|NCT01915914|564845016|FG000|Acute Phase|Lost to Follow-up|4|||
156478297|NCT01915914|564845017|FG001|Acute Phase|Lost to Follow-up|0|||
156478298|NCT01915914|564845018|FG002|Acute Phase|Lost to Follow-up|0|||
156478299|NCT01915914|564845019|FG003|Acute Phase|Lost to Follow-up|0|||
156478300|NCT01915914|564845016|FG000|Acute Phase|Physician Decision|1|||
156478301|NCT01915914|564845017|FG001|Acute Phase|Physician Decision|0|||
156478302|NCT01915914|564845018|FG002|Acute Phase|Physician Decision|0|||
156344945|NCT03129100|564362394|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478303|NCT01915914|564845019|FG003|Acute Phase|Physician Decision|0|||
156478304|NCT01915914|564845016|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
156478305|NCT01915914|564845017|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
156478306|NCT01915914|564845018|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
156478307|NCT01915914|564845019|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
156478308|NCT01915914|564845016|FG000|Acute Phase|"Not Achieved treatment success"|1|||
156478309|NCT01915914|564845017|FG001|Acute Phase|"Not Achieved treatment success"|0|||
156478310|NCT01915914|564845018|FG002|Acute Phase|"Not Achieved treatment success"|0|||
156478311|NCT01915914|564845019|FG003|Acute Phase|"Not Achieved treatment success"|0|||
156478312|NCT01915914|564845016|FG000|Acute Phase|Missing|1|||
156478313|NCT01915914|564845017|FG001|Acute Phase|Missing|0|||
156478314|NCT01915914|564845018|FG002|Acute Phase|Missing|0|||
156478315|NCT01915914|564845019|FG003|Acute Phase|Missing|0|||
156478316|NCT01915914|564845016|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156478317|NCT01915914|564845017|FG001|Maintenance Phase|Withdrawal by Subject|1|||
156478318|NCT01915914|564845018|FG002|Maintenance Phase|Withdrawal by Subject|1|||
156478319|NCT01915914|564845019|FG003|Maintenance Phase|Withdrawal by Subject|0|||
156478320|NCT01915914|564845016|FG000|Maintenance Phase|Lost to Follow-up|0|||
156478321|NCT01915914|564845017|FG001|Maintenance Phase|Lost to Follow-up|4|||
156478322|NCT01915914|564845018|FG002|Maintenance Phase|Lost to Follow-up|1|||
156478323|NCT01915914|564845019|FG003|Maintenance Phase|Lost to Follow-up|0|||
156478324|NCT01915914|564845016|FG000|Maintenance Phase|Missing|0|||
156478325|NCT01915914|564845017|FG001|Maintenance Phase|Missing|1|||
156478326|NCT01915914|564845018|FG002|Maintenance Phase|Missing|0|||
156478327|NCT01915914|564845019|FG003|Maintenance Phase|Missing|0|||
156478328|NCT01915914|564845016|FG000|Follow-up Phase|Withdrawal by Subject|0|||
156478329|NCT01915914|564845017|FG001|Follow-up Phase|Withdrawal by Subject|0|||
156478330|NCT01915914|564845018|FG002|Follow-up Phase|Withdrawal by Subject|0|||
156478331|NCT01915914|564845019|FG003|Follow-up Phase|Withdrawal by Subject|1|||
156478332|NCT01915914|564845016|FG000|Follow-up Phase|Physician Decision|0|||
156478333|NCT01915914|564845017|FG001|Follow-up Phase|Physician Decision|0|||
156478334|NCT01915914|564845018|FG002|Follow-up Phase|Physician Decision|0|||
156478335|NCT01915914|564845019|FG003|Follow-up Phase|Physician Decision|1|||
156478336|NCT02432274|564845021|FG000|Overall Study|Death|2|||
156478337|NCT02432274|564845022|FG001|Overall Study|Death|6|||
156478338|NCT02432274|564845023|FG002|Overall Study|Death|7|||
156478339|NCT02432274|564845024|FG003|Overall Study|Death|0|||
156478340|NCT02432274|564845025|FG004|Overall Study|Death|27|||
156478341|NCT02432274|564845026|FG005|Overall Study|Death|7|||
156478342|NCT02432274|564845027|FG006|Overall Study|Death|9|||
156478343|NCT02432274|564845028|FG007|Overall Study|Death|14|||
156478344|NCT02432274|564845021|FG000|Overall Study|Withdrawal of Consent|0|||
156478345|NCT02432274|564845022|FG001|Overall Study|Withdrawal of Consent|0|||
156478346|NCT02432274|564845023|FG002|Overall Study|Withdrawal of Consent|0|||
156478347|NCT02432274|564845024|FG003|Overall Study|Withdrawal of Consent|0|||
156478348|NCT02432274|564845025|FG004|Overall Study|Withdrawal of Consent|2|||
156478349|NCT02432274|564845026|FG005|Overall Study|Withdrawal of Consent|0|||
156478350|NCT02432274|564845027|FG006|Overall Study|Withdrawal of Consent|1|||
156478351|NCT02432274|564845028|FG007|Overall Study|Withdrawal of Consent|2|||
156478352|NCT01736475|564845029|FG000|Overall Study|Adverse Event|4|||
156478353|NCT01736475|564845030|FG001|Overall Study|Adverse Event|0|||
156478354|NCT01736475|564845029|FG000|Overall Study|Withdrawal by Subject|2|||
156478355|NCT01736475|564845030|FG001|Overall Study|Withdrawal by Subject|0|||
156478356|NCT01736475|564845029|FG000|Overall Study|Protocol Violation|4|||
156478357|NCT01736475|564845030|FG001|Overall Study|Protocol Violation|0|||
156478358|NCT01736475|564845029|FG000|Overall Study|Other - Screen failure|1|||
156478359|NCT01736475|564845030|FG001|Overall Study|Other - Screen failure|0|||
156478360|NCT01736475|564845029|FG000|Overall Study|Other - Surgical procedure|1|||
156478361|NCT01736475|564845030|FG001|Overall Study|Other - Surgical procedure|0|||
156478362|NCT02114515|564845032|FG000|Overall Study|Lost to Follow-up|52|||
156478363|NCT02114515|564845033|FG001|Overall Study|Lost to Follow-up|55|||
156478364|NCT02114515|564845032|FG000|Overall Study|Death|12|||
156478365|NCT02114515|564845033|FG001|Overall Study|Death|12|||
156478366|NCT02114515|564845032|FG000|Overall Study|Withdrawal by Subject|4|||
156478367|NCT02114515|564845033|FG001|Overall Study|Withdrawal by Subject|22|||
156478368|NCT02114515|564845032|FG000|Overall Study|Other|65|||
156478369|NCT02114515|564845033|FG001|Overall Study|Other|61|||
156478370|NCT05522777|564846687|FG000|Overall Study|Lack of Efficacy|1|||
156478371|NCT05522777|564846687|FG000|Overall Study|Withdrawal by Subject|1|||
156478372|NCT05487300|564846690|FG000|Overall Study|Withdrawal by Subject|1|||
156478373|NCT05487300|564846691|FG001|Overall Study|Withdrawal by Subject|0|||
156478374|NCT03141177|564846692|FG000|Overall Study|Death|62|||
156478375|NCT03141177|564846693|FG001|Overall Study|Death|13|||
156478376|NCT03141177|564846694|FG002|Overall Study|Death|84|||
156478377|NCT03141177|564846692|FG000|Overall Study|Participant withdrew consent|9|||
156478378|NCT03141177|564846693|FG001|Overall Study|Participant withdrew consent|2|||
156478379|NCT03141177|564846694|FG002|Overall Study|Participant withdrew consent|13|||
156478380|NCT03141177|564846692|FG000|Overall Study|Not reported|1|||
156478381|NCT03141177|564846693|FG001|Overall Study|Not reported|0|||
156478382|NCT03141177|564846694|FG002|Overall Study|Not reported|1|||
156478383|NCT03141177|564846692|FG000|Overall Study|Lost to Follow-up|2|||
156478384|NCT03141177|564846693|FG001|Overall Study|Lost to Follow-up|1|||
156478385|NCT03141177|564846694|FG002|Overall Study|Lost to Follow-up|1|||
156478386|NCT03141177|564846692|FG000|Overall Study|Other reasons|4|||
156478387|NCT03141177|564846693|FG001|Overall Study|Other reasons|0|||
156478388|NCT03141177|564846694|FG002|Overall Study|Other reasons|11|||
156478389|NCT03141177|564846692|FG000|Overall Study|Participants did not start treatment period|3|||
156478390|NCT03141177|564846693|FG001|Overall Study|Participants did not start treatment period|0|||
156478391|NCT03141177|564846694|FG002|Overall Study|Participants did not start treatment period|8|||
156478392|NCT05006703|564846695|FG000|Overall Study|Withdrawal by Subject|1|||
156344946|NCT03129100|564362395|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344947|NCT03129100|564362396|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344948|NCT03129100|564362397|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478393|NCT05006703|564846696|FG001|Overall Study|Withdrawal by Subject|0|||
156478394|NCT05006703|564846695|FG000|Overall Study|Lost to Follow-up|13|||
156478395|NCT05006703|564846696|FG001|Overall Study|Lost to Follow-up|5|||
156478396|NCT00264576|564846701|FG000|Overall Study|Lost to Follow-up|1|||
156344949|NCT03129100|564362398|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478397|NCT00264576|564846702|FG001|Overall Study|Lost to Follow-up|1|||
156344950|NCT03129100|564362399|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478398|NCT02659059|564846703|FG000|Overall Study|Other reasons|6|||
156478399|NCT02659059|564846704|FG001|Overall Study|Other reasons|1|||
156478400|NCT02659059|564846703|FG000|Overall Study|Disease Progression|143|||
156478401|NCT02659059|564846704|FG001|Overall Study|Disease Progression|16|||
156478402|NCT02659059|564846703|FG000|Overall Study|Study Drug toxicity|56|||
156478403|NCT02659059|564846704|FG001|Overall Study|Study Drug toxicity|9|||
156478404|NCT02659059|564846703|FG000|Overall Study|Death|3|||
156478405|NCT02659059|564846704|FG001|Overall Study|Death|1|||
156478406|NCT02659059|564846703|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
156478407|NCT02659059|564846704|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
156478408|NCT02659059|564846703|FG000|Overall Study|Participant request to discontinue study treatment|5|||
156478409|NCT02659059|564846704|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156478410|NCT02659059|564846703|FG000|Overall Study|Participant withdrew consent|6|||
156478411|NCT02659059|564846704|FG001|Overall Study|Participant withdrew consent|1|||
156478412|NCT00092456|564846707|FG000|Overall Study|Adverse Event|0|||
156478413|NCT00092456|564846708|FG001|Overall Study|Adverse Event|0|||
156478414|NCT00092456|564846709|FG002|Overall Study|Adverse Event|1|||
156478415|NCT00092456|564846710|FG003|Overall Study|Adverse Event|1|||
156478416|NCT00092456|564846707|FG000|Overall Study|Lost to Follow-up|2|||
156478417|NCT00092456|564846708|FG001|Overall Study|Lost to Follow-up|2|||
156478418|NCT00092456|564846709|FG002|Overall Study|Lost to Follow-up|1|||
156478419|NCT00092456|564846710|FG003|Overall Study|Lost to Follow-up|2|||
156478420|NCT00092456|564846707|FG000|Overall Study|Protocol Violation|5|||
156478421|NCT00092456|564846708|FG001|Overall Study|Protocol Violation|7|||
156478422|NCT00092456|564846709|FG002|Overall Study|Protocol Violation|8|||
156478423|NCT00092456|564846710|FG003|Overall Study|Protocol Violation|6|||
156478424|NCT00092456|564846707|FG000|Overall Study|Withdrawal by Subject|13|||
156478425|NCT00092456|564846708|FG001|Overall Study|Withdrawal by Subject|5|||
156478426|NCT00092456|564846709|FG002|Overall Study|Withdrawal by Subject|16|||
156478427|NCT00092456|564846710|FG003|Overall Study|Withdrawal by Subject|6|||
156478428|NCT00092456|564846707|FG000|Overall Study|Moved|1|||
156478429|NCT00092456|564846708|FG001|Overall Study|Moved|1|||
156478430|NCT00092456|564846709|FG002|Overall Study|Moved|0|||
156478431|NCT00092456|564846710|FG003|Overall Study|Moved|1|||
156478432|NCT00092456|564846707|FG000|Overall Study|Other|4|||
156478433|NCT00092456|564846708|FG001|Overall Study|Other|2|||
156478434|NCT00092456|564846709|FG002|Overall Study|Other|3|||
156478435|NCT00092456|564846710|FG003|Overall Study|Other|0|||
156478436|NCT04783389|564846711|FG000|Overall Study|Withdrawal by Subject|2|||
156478437|NCT04783389|564846712|FG001|Overall Study|Withdrawal by Subject|0|||
156478438|NCT04783389|564846713|FG002|Overall Study|Withdrawal by Subject|0|||
156478439|NCT04783389|564846711|FG000|Overall Study|Termination of Study by Sponsor|10|||
156478440|NCT04783389|564846712|FG001|Overall Study|Termination of Study by Sponsor|12|||
156478441|NCT04783389|564846713|FG002|Overall Study|Termination of Study by Sponsor|14|||
156478442|NCT02121808|564846714|FG000|Overall Study|Technical problem|3|||
156478443|NCT03924193|564846715|FG000|Overall Study|Adverse Event|10|||
156478444|NCT03924193|564846716|FG001|Overall Study|Adverse Event|0|||
156478445|NCT03924193|564846717|FG002|Overall Study|Adverse Event|10|||
156478446|NCT03924193|564846715|FG000|Overall Study|Withdrawal by Subject|5|||
156478447|NCT03924193|564846716|FG001|Overall Study|Withdrawal by Subject|10|||
156478448|NCT03924193|564846717|FG002|Overall Study|Withdrawal by Subject|2|||
156478449|NCT01562275|564846718|FG000|Stage 1|Adverse Event|0|||
156478450|NCT01562275|564846719|FG001|Stage 1|Adverse Event|0|||
156478451|NCT01562275|564846720|FG002|Stage 1|Adverse Event|0|||
156478452|NCT01562275|564846721|FG003|Stage 1|Adverse Event|1|||
156478453|NCT01562275|564846722|FG004|Stage 1|Adverse Event|1|||
156478454|NCT01562275|564846723|FG005|Stage 1|Adverse Event|0|||
156478455|NCT01562275|564846724|FG006|Stage 1|Adverse Event|0|||
156478456|NCT01562275|564846725|FG007|Stage 1|Adverse Event|0|||
156478457|NCT01562275|564846726|FG008|Stage 1|Adverse Event|0|||
156478458|NCT01562275|564846727|FG009|Stage 1|Adverse Event|1|||
156478459|NCT01562275|564846728|FG010|Stage 1|Adverse Event|0|||
156478460|NCT01562275|564846729|FG011|Stage 1|Adverse Event|0|||
156478461|NCT01562275|564846730|FG012|Stage 1|Adverse Event|0|||
156478462|NCT01562275|564846718|FG000|Stage 1|Death|1|||
156478463|NCT01562275|564846719|FG001|Stage 1|Death|0|||
156478464|NCT01562275|564846720|FG002|Stage 1|Death|0|||
156478465|NCT01562275|564846721|FG003|Stage 1|Death|0|||
156478466|NCT01562275|564846722|FG004|Stage 1|Death|0|||
156478467|NCT01562275|564846723|FG005|Stage 1|Death|0|||
156478468|NCT01562275|564846724|FG006|Stage 1|Death|0|||
156478469|NCT01562275|564846725|FG007|Stage 1|Death|0|||
156478470|NCT01562275|564846726|FG008|Stage 1|Death|0|||
156478471|NCT01562275|564846727|FG009|Stage 1|Death|0|||
156543402|NCT04677959|565084593|FG000|Overall Study|Other than specified|0|||
156478472|NCT01562275|564846728|FG010|Stage 1|Death|0|||
156478473|NCT01562275|564846729|FG011|Stage 1|Death|0|||
156478474|NCT01562275|564846730|FG012|Stage 1|Death|0|||
156478475|NCT01562275|564846718|FG000|Stage 1|Non Compliance|0|||
156478476|NCT01562275|564846719|FG001|Stage 1|Non Compliance|0|||
156478477|NCT01562275|564846720|FG002|Stage 1|Non Compliance|1|||
156478478|NCT01562275|564846721|FG003|Stage 1|Non Compliance|0|||
156543403|NCT04677959|565084594|FG001|Overall Study|Other than specified|8|||
156543404|NCT00732303|565084595|FG000|Overall Study|Study Terminated|2|||
156543405|NCT01074190|565084602|FG000|Overall Study|Emergency Cesarean Delivery|1|||
156543406|NCT01074190|565084603|FG001|Overall Study|Emergency Cesarean Delivery|2|||
156543407|NCT01074190|565084604|FG002|Overall Study|Emergency Cesarean Delivery|1|||
156543408|NCT01074190|565084602|FG000|Overall Study|Protocol Violation|2|||
156543409|NCT01074190|565084603|FG001|Overall Study|Protocol Violation|1|||
156543410|NCT01074190|565084604|FG002|Overall Study|Protocol Violation|0|||
156543411|NCT01074190|565084602|FG000|Overall Study|Delivered in under 90 minutes|0|||
156543412|NCT01074190|565084603|FG001|Overall Study|Delivered in under 90 minutes|2|||
156543413|NCT01074190|565084604|FG002|Overall Study|Delivered in under 90 minutes|1|||
156543414|NCT01074190|565084602|FG000|Overall Study|Subject withdrew consent|1|||
156543415|NCT01074190|565084603|FG001|Overall Study|Subject withdrew consent|1|||
156543416|NCT01074190|565084604|FG002|Overall Study|Subject withdrew consent|1|||
156543417|NCT02919436|565084607|FG000|Overall Study|Did not undergo surgery|16|||
156543418|NCT02919436|565084608|FG001|Overall Study|Did not undergo surgery|20|||
156543419|NCT02919436|565084607|FG000|Overall Study|Enrolled before trial registration|44|||
156543420|NCT02919436|565084608|FG001|Overall Study|Enrolled before trial registration|33|||
156543421|NCT00283595|565084609|FG000|Overall Study|Withdrawal by Subject|1|||
156543422|NCT00283595|565084610|FG001|Overall Study|Withdrawal by Subject|2|||
156543423|NCT02409290|565084621|FG000|Overall Study|Protocol Violation|3|||
156543424|NCT02409290|565084622|FG001|Overall Study|Protocol Violation|6|||
156543425|NCT02409290|565084623|FG002|Overall Study|Protocol Violation|9|||
156543426|NCT02409290|565084624|FG003|Overall Study|Protocol Violation|4|||
156543427|NCT02409290|565084621|FG000|Overall Study|No positive culture/no baseline sample|3|||
156543428|NCT02409290|565084622|FG001|Overall Study|No positive culture/no baseline sample|9|||
156543429|NCT02409290|565084623|FG002|Overall Study|No positive culture/no baseline sample|6|||
156543430|NCT02409290|565084624|FG003|Overall Study|No positive culture/no baseline sample|5|||
156543431|NCT02409290|565084621|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
156543432|NCT02409290|565084622|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
156543433|NCT02409290|565084623|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
156543434|NCT02409290|565084624|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
156543435|NCT04607148|565084625|FG000|Overall Study|Withdrawal by Subject|0|||
156543436|NCT04607148|565084626|FG001|Overall Study|Withdrawal by Subject|4|||
156543437|NCT04607148|565084627|FG002|Overall Study|Withdrawal by Subject|2|||
156543438|NCT04607148|565084628|FG003|Overall Study|Withdrawal by Subject|8|||
156543439|NCT04607148|565084625|FG000|Overall Study|Study Terminated by Sponsor|14|||
156543440|NCT04607148|565084626|FG001|Overall Study|Study Terminated by Sponsor|59|||
156478479|NCT01562275|564846722|FG004|Stage 1|Non Compliance|0|||
156478480|NCT01562275|564846723|FG005|Stage 1|Non Compliance|0|||
156478481|NCT01562275|564846724|FG006|Stage 1|Non Compliance|0|||
156478482|NCT01562275|564846725|FG007|Stage 1|Non Compliance|0|||
156478483|NCT01562275|564846726|FG008|Stage 1|Non Compliance|0|||
156478484|NCT01562275|564846727|FG009|Stage 1|Non Compliance|0|||
156478485|NCT01562275|564846728|FG010|Stage 1|Non Compliance|0|||
156478486|NCT01562275|564846729|FG011|Stage 1|Non Compliance|0|||
156478487|NCT01562275|564846730|FG012|Stage 1|Non Compliance|0|||
156478488|NCT01562275|564846718|FG000|Stage 1|Physician Decision|0|||
156478489|NCT01562275|564846719|FG001|Stage 1|Physician Decision|0|||
156478490|NCT01562275|564846720|FG002|Stage 1|Physician Decision|0|||
156478491|NCT01562275|564846721|FG003|Stage 1|Physician Decision|0|||
156478492|NCT01562275|564846722|FG004|Stage 1|Physician Decision|1|||
156478493|NCT01562275|564846723|FG005|Stage 1|Physician Decision|0|||
156478494|NCT01562275|564846724|FG006|Stage 1|Physician Decision|1|||
156478495|NCT01562275|564846725|FG007|Stage 1|Physician Decision|0|||
156478496|NCT01562275|564846726|FG008|Stage 1|Physician Decision|1|||
156478497|NCT01562275|564846727|FG009|Stage 1|Physician Decision|0|||
156478498|NCT01562275|564846728|FG010|Stage 1|Physician Decision|0|||
156478499|NCT01562275|564846729|FG011|Stage 1|Physician Decision|0|||
156478500|NCT01562275|564846730|FG012|Stage 1|Physician Decision|0|||
156478501|NCT01562275|564846718|FG000|Stage 1|Progression of Disease|2|||
156478502|NCT01562275|564846719|FG001|Stage 1|Progression of Disease|6|||
156478503|NCT01562275|564846720|FG002|Stage 1|Progression of Disease|2|||
156478504|NCT01562275|564846721|FG003|Stage 1|Progression of Disease|1|||
156478505|NCT01562275|564846722|FG004|Stage 1|Progression of Disease|2|||
156478506|NCT01562275|564846723|FG005|Stage 1|Progression of Disease|4|||
156478507|NCT01562275|564846724|FG006|Stage 1|Progression of Disease|1|||
156478508|NCT01562275|564846725|FG007|Stage 1|Progression of Disease|7|||
156478509|NCT01562275|564846726|FG008|Stage 1|Progression of Disease|2|||
156478510|NCT01562275|564846727|FG009|Stage 1|Progression of Disease|5|||
156478511|NCT01562275|564846728|FG010|Stage 1|Progression of Disease|3|||
156478512|NCT01562275|564846729|FG011|Stage 1|Progression of Disease|0|||
156478513|NCT01562275|564846730|FG012|Stage 1|Progression of Disease|0|||
156478514|NCT01562275|564846718|FG000|Stage 1|Withdrawal by Subject|0|||
156478515|NCT01562275|564846719|FG001|Stage 1|Withdrawal by Subject|1|||
156478516|NCT01562275|564846720|FG002|Stage 1|Withdrawal by Subject|0|||
156478517|NCT01562275|564846721|FG003|Stage 1|Withdrawal by Subject|2|||
156478518|NCT01562275|564846722|FG004|Stage 1|Withdrawal by Subject|0|||
156478519|NCT01562275|564846723|FG005|Stage 1|Withdrawal by Subject|0|||
156478520|NCT01562275|564846724|FG006|Stage 1|Withdrawal by Subject|1|||
156478521|NCT01562275|564846725|FG007|Stage 1|Withdrawal by Subject|0|||
156478522|NCT01562275|564846726|FG008|Stage 1|Withdrawal by Subject|0|||
156478523|NCT01562275|564846727|FG009|Stage 1|Withdrawal by Subject|1|||
156478524|NCT01562275|564846728|FG010|Stage 1|Withdrawal by Subject|0|||
156478525|NCT01562275|564846729|FG011|Stage 1|Withdrawal by Subject|0|||
156478526|NCT01562275|564846730|FG012|Stage 1|Withdrawal by Subject|0|||
156478527|NCT01562275|564846718|FG000|Stage 2|Death|0|||
156478528|NCT01562275|564846719|FG001|Stage 2|Death|0|||
156478529|NCT01562275|564846720|FG002|Stage 2|Death|0|||
156478530|NCT01562275|564846721|FG003|Stage 2|Death|0|||
156478531|NCT01562275|564846722|FG004|Stage 2|Death|0|||
156478532|NCT01562275|564846723|FG005|Stage 2|Death|0|||
156478533|NCT01562275|564846724|FG006|Stage 2|Death|0|||
156478534|NCT01562275|564846725|FG007|Stage 2|Death|0|||
156478535|NCT01562275|564846726|FG008|Stage 2|Death|0|||
156478536|NCT01562275|564846727|FG009|Stage 2|Death|0|||
156478537|NCT01562275|564846728|FG010|Stage 2|Death|0|||
156478538|NCT01562275|564846729|FG011|Stage 2|Death|2|||
156478539|NCT01562275|564846730|FG012|Stage 2|Death|1|||
156478540|NCT01562275|564846718|FG000|Stage 2|Progression of Disease|0|||
156478541|NCT01562275|564846719|FG001|Stage 2|Progression of Disease|0|||
156478542|NCT01562275|564846720|FG002|Stage 2|Progression of Disease|0|||
156478543|NCT01562275|564846721|FG003|Stage 2|Progression of Disease|0|||
156478544|NCT01562275|564846722|FG004|Stage 2|Progression of Disease|0|||
156478545|NCT01562275|564846723|FG005|Stage 2|Progression of Disease|0|||
156478546|NCT01562275|564846724|FG006|Stage 2|Progression of Disease|0|||
156478547|NCT01562275|564846725|FG007|Stage 2|Progression of Disease|0|||
156478548|NCT01562275|564846726|FG008|Stage 2|Progression of Disease|0|||
156478549|NCT01562275|564846727|FG009|Stage 2|Progression of Disease|0|||
156478550|NCT01562275|564846728|FG010|Stage 2|Progression of Disease|0|||
156478551|NCT01562275|564846729|FG011|Stage 2|Progression of Disease|12|||
156478552|NCT01562275|564846730|FG012|Stage 2|Progression of Disease|4|||
156478553|NCT01863368|564846731|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
156478554|NCT01863368|564846732|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
156478555|NCT01863368|564846731|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
156478556|NCT01863368|564846732|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
156478557|NCT01863368|564846731|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
156478558|NCT01863368|564846732|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
156478559|NCT01863368|564846731|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
156478560|NCT01863368|564846732|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
156478561|NCT01863368|564846731|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
156478562|NCT01863368|564846732|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
156478563|NCT01863368|564846731|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
156478564|NCT01863368|564846732|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
156478565|NCT00647699|564846733|FG000|Overall Study|Lost to Follow-up|5|||
156478566|NCT00647699|564846734|FG001|Overall Study|Lost to Follow-up|4|||
156478567|NCT00647699|564846733|FG000|Overall Study|Withdrawal by Subject|3|||
156478568|NCT00647699|564846734|FG001|Overall Study|Withdrawal by Subject|8|||
156478569|NCT00515112|564846736|FG000|Overall Study|Death|0|||
156478570|NCT00515112|564846737|FG001|Overall Study|Death|1|||
156478571|NCT00515112|564846736|FG000|Overall Study|The study was terminated|3|||
156478572|NCT00515112|564846737|FG001|Overall Study|The study was terminated|2|||
156478573|NCT01825785|564846738|FG000|Overall Study|Adverse Event|0|||
156478574|NCT01825785|564846739|FG001|Overall Study|Adverse Event|0|||
156478575|NCT01825785|564846740|FG002|Overall Study|Adverse Event|0|||
156478576|NCT01825785|564846741|FG003|Overall Study|Adverse Event|0|||
156478577|NCT01825785|564846742|FG004|Overall Study|Adverse Event|1|||
156478578|NCT01825785|564846743|FG005|Overall Study|Adverse Event|0|||
156478579|NCT01825785|564846744|FG006|Overall Study|Adverse Event|0|||
156478580|NCT01825785|564846738|FG000|Overall Study|Withdrawal by Subject|0|||
156478581|NCT01825785|564846739|FG001|Overall Study|Withdrawal by Subject|0|||
156478582|NCT01825785|564846740|FG002|Overall Study|Withdrawal by Subject|0|||
156478583|NCT01825785|564846741|FG003|Overall Study|Withdrawal by Subject|0|||
156478584|NCT01825785|564846742|FG004|Overall Study|Withdrawal by Subject|1|||
156478585|NCT01825785|564846743|FG005|Overall Study|Withdrawal by Subject|1|||
156478586|NCT01825785|564846744|FG006|Overall Study|Withdrawal by Subject|0|||
156478587|NCT00307489|564846745|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
156478588|NCT00307489|564846746|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
156478589|NCT00307489|564846745|FG000|Baseline Through Week 48|Physician Decision|1|||
156478590|NCT00307489|564846746|FG001|Baseline Through Week 48|Physician Decision|0|||
156478591|NCT00307489|564846745|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
156478592|NCT00307489|564846746|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
156478593|NCT00307489|564846745|FG000|Week 48 Through Week 168|Adverse Event|1|||
156478594|NCT00307489|564846746|FG001|Week 48 Through Week 168|Adverse Event|0|||
156478595|NCT00307489|564846745|FG000|Week 48 Through Week 168|Physician Decision|1|||
156478596|NCT00307489|564846746|FG001|Week 48 Through Week 168|Physician Decision|0|||
156478597|NCT00307489|564846745|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
156478598|NCT00307489|564846746|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
156478599|NCT00307489|564846745|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
156478600|NCT00307489|564846746|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
156478601|NCT00307489|564846745|FG000|Week 48 Through Week 168|Death|0|||
156478602|NCT00307489|564846746|FG001|Week 48 Through Week 168|Death|1|||
156478603|NCT00307489|564846745|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
156478604|NCT00307489|564846746|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
156478605|NCT00307489|564846745|FG000|Week 48 Through Week 168|Seroconversion|1|||
156478606|NCT00307489|564846746|FG001|Week 48 Through Week 168|Seroconversion|0|||
156478607|NCT01381549|564846752|FG000|Overall Study|Ineligible: No organisms isolated|0|||
156478608|NCT01381549|564846753|FG001|Overall Study|Ineligible: No organisms isolated|0|||
156478609|NCT01381549|564846754|FG002|Overall Study|Ineligible: No organisms isolated|1|||
156478610|NCT02981953|564846755|FG000|Overall Study|Death|9|||
156478611|NCT02981953|564846755|FG000|Overall Study|Withdrawal by Subject|1|||
156478612|NCT02981953|564846755|FG000|Overall Study|Withdrawal to non-compliance|1|||
156478613|NCT01655498|564846764|FG000|Overall Study|Unrelated health issue|2|||
156478614|NCT01655498|564846764|FG000|Overall Study|Protocol Violation|2|||
156478615|NCT01655498|564846764|FG000|Overall Study|Withdrawal by Subject|1|||
156478616|NCT00603798|564846765|FG000|Overall Study|Adverse Event|4|||
156478617|NCT00603798|564846766|FG001|Overall Study|Adverse Event|2|||
156478618|NCT00603798|564846767|FG002|Overall Study|Adverse Event|1|||
156478619|NCT00603798|564846765|FG000|Overall Study|Withdrawal by Subject|4|||
156344951|NCT03129100|564362400|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344952|NCT03129100|564362401|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344953|NCT03129100|564362402|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478620|NCT00603798|564846766|FG001|Overall Study|Withdrawal by Subject|3|||
156478621|NCT00603798|564846767|FG002|Overall Study|Withdrawal by Subject|4|||
156478622|NCT00603798|564846765|FG000|Overall Study|Lost to Follow-up|1|||
156478623|NCT00603798|564846766|FG001|Overall Study|Lost to Follow-up|0|||
156478624|NCT00603798|564846767|FG002|Overall Study|Lost to Follow-up|1|||
156478625|NCT00603798|564846765|FG000|Overall Study|Non-compliance with study procedures|0|||
156478626|NCT00603798|564846766|FG001|Overall Study|Non-compliance with study procedures|1|||
156478627|NCT00603798|564846767|FG002|Overall Study|Non-compliance with study procedures|0|||
156478628|NCT00603798|564846765|FG000|Overall Study|Not due to AE|1|||
156478629|NCT00603798|564846766|FG001|Overall Study|Not due to AE|1|||
156478630|NCT00603798|564846767|FG002|Overall Study|Not due to AE|4|||
156478631|NCT00988429|564846768|FG000|Overall Study|Adverse Event|9|||
156478632|NCT00988429|564846769|FG001|Overall Study|Adverse Event|21|||
156478633|NCT00988429|564846770|FG002|Overall Study|Adverse Event|45|||
156478634|NCT00988429|564846768|FG000|Overall Study|Lack of Efficacy|0|||
156478635|NCT00988429|564846769|FG001|Overall Study|Lack of Efficacy|0|||
156478636|NCT00988429|564846770|FG002|Overall Study|Lack of Efficacy|1|||
156478637|NCT00988429|564846768|FG000|Overall Study|Non-Compliance with Study Drug|5|||
156478638|NCT00988429|564846769|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156478639|NCT00988429|564846770|FG002|Overall Study|Non-Compliance with Study Drug|3|||
156478640|NCT00988429|564846768|FG000|Overall Study|Physician Decision|1|||
156478641|NCT00988429|564846769|FG001|Overall Study|Physician Decision|0|||
156478642|NCT00988429|564846770|FG002|Overall Study|Physician Decision|3|||
156543441|NCT04607148|565084627|FG002|Overall Study|Study Terminated by Sponsor|9|||
156478643|NCT00988429|564846768|FG000|Overall Study|Pregnancy|2|||
156478644|NCT00988429|564846769|FG001|Overall Study|Pregnancy|1|||
156478645|NCT00988429|564846770|FG002|Overall Study|Pregnancy|0|||
156478646|NCT00988429|564846768|FG000|Overall Study|Protocol Violation|4|||
156478647|NCT00988429|564846769|FG001|Overall Study|Protocol Violation|3|||
156478648|NCT00988429|564846770|FG002|Overall Study|Protocol Violation|3|||
156478649|NCT00988429|564846768|FG000|Overall Study|Withdrawal by Subject|7|||
156478650|NCT00988429|564846769|FG001|Overall Study|Withdrawal by Subject|7|||
156478651|NCT00988429|564846770|FG002|Overall Study|Withdrawal by Subject|12|||
156478652|NCT00988429|564846768|FG000|Overall Study|Administrative Reasons|1|||
156478653|NCT00988429|564846769|FG001|Overall Study|Administrative Reasons|2|||
156478654|NCT00988429|564846770|FG002|Overall Study|Administrative Reasons|1|||
156478655|NCT00988429|564846768|FG000|Overall Study|other reasons|8|||
156478656|NCT00988429|564846769|FG001|Overall Study|other reasons|8|||
156478657|NCT00988429|564846770|FG002|Overall Study|other reasons|1|||
156478658|NCT02964234|564846771|FG000|Overall Study|Lost to Follow-up|22|||
156478659|NCT02964234|564846772|FG001|Overall Study|Lost to Follow-up|13|||
156478660|NCT01799993|564846773|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
156478661|NCT01799993|564846774|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
156478662|NCT01799993|564846773|FG000|Overall Study|Death|61|||
156478663|NCT01799993|564846774|FG001|Overall Study|Death|45|||
156478664|NCT01799993|564846773|FG000|Overall Study|Withdrawal by Subject|23|||
156478665|NCT01799993|564846774|FG001|Overall Study|Withdrawal by Subject|24|||
156478666|NCT01799993|564846773|FG000|Overall Study|Lost to Follow-up|5|||
156478667|NCT01799993|564846774|FG001|Overall Study|Lost to Follow-up|8|||
156478668|NCT01799993|564846773|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
156478669|NCT01799993|564846774|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
156478670|NCT01799993|564846773|FG000|Overall Study|Protocol driven decision point|0|||
156478671|NCT01799993|564846774|FG001|Overall Study|Protocol driven decision point|3|||
156478672|NCT01799993|564846773|FG000|Overall Study|Protocol Violation|1|||
156478673|NCT01799993|564846774|FG001|Overall Study|Protocol Violation|1|||
156478674|NCT01799993|564846773|FG000|Overall Study|Deterioration of general conditions|2|||
156478675|NCT01799993|564846774|FG001|Overall Study|Deterioration of general conditions|0|||
156478676|NCT01799993|564846773|FG000|Overall Study|Screen failure|0|||
156478677|NCT01799993|564846774|FG001|Overall Study|Screen failure|1|||
156478678|NCT01799993|564846773|FG000|Overall Study|Adverse Event|1|||
156478679|NCT01799993|564846774|FG001|Overall Study|Adverse Event|0|||
156478680|NCT01799993|564846773|FG000|Overall Study|Lack of Efficacy|1|||
156478681|NCT01799993|564846774|FG001|Overall Study|Lack of Efficacy|0|||
156478682|NCT01799993|564846773|FG000|Overall Study|Recovery|0|||
156478683|NCT01799993|564846774|FG001|Overall Study|Recovery|1|||
156478684|NCT01799993|564846773|FG000|Overall Study|Logistical difficulties|1|||
156478685|NCT01799993|564846774|FG001|Overall Study|Logistical difficulties|0|||
156478686|NCT01799993|564846773|FG000|Overall Study|Protocol deviation|1|||
156478687|NCT01799993|564846774|FG001|Overall Study|Protocol deviation|0|||
156478688|NCT01799993|564846773|FG000|Overall Study|Non-compliance with medical device|1|||
156478689|NCT01799993|564846774|FG001|Overall Study|Non-compliance with medical device|0|||
156478690|NCT01799993|564846773|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156478691|NCT01799993|564846774|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156478692|NCT01799993|564846773|FG000|Overall Study|Other|1|||
156478693|NCT01799993|564846774|FG001|Overall Study|Other|0|||
156478694|NCT01799993|564846773|FG000|Overall Study|Subject didn't return for follow-up|0|||
156478695|NCT01799993|564846774|FG001|Overall Study|Subject didn't return for follow-up|1|||
156478696|NCT04361617|564846775|FG000|Overall Study|Withdrawal by Subject|0|||
156478697|NCT04361617|564846776|FG001|Overall Study|Withdrawal by Subject|1|||
156478698|NCT00687297|564846782|FG000|Randomization|Withdrawal by Subject|2|||
156478699|NCT00687297|564846783|FG001|Randomization|Withdrawal by Subject|0|||
156478700|NCT00687297|564846782|FG000|Randomization|Withdrew before treatment, ineligible|1|||
156478701|NCT00687297|564846783|FG001|Randomization|Withdrew before treatment, ineligible|1|||
156478702|NCT00687297|564846782|FG000|Induction|Withdrawal by Subject|4|||
156478703|NCT00687297|564846783|FG001|Induction|Withdrawal by Subject|4|||
156478704|NCT00687297|564846782|FG000|Induction|Adverse Event|16|||
156478705|NCT00687297|564846783|FG001|Induction|Adverse Event|15|||
156478706|NCT00687297|564846782|FG000|Induction|Death|7|||
156478707|NCT00687297|564846783|FG001|Induction|Death|11|||
156478708|NCT00687297|564846782|FG000|Induction|Lack of Efficacy|17|||
156478709|NCT00687297|564846783|FG001|Induction|Lack of Efficacy|21|||
156478710|NCT00687297|564846782|FG000|Induction|Ineligible|0|||
156478711|NCT00687297|564846783|FG001|Induction|Ineligible|1|||
156478712|NCT00687297|564846782|FG000|Induction|Patient Noncompliance|1|||
156478713|NCT00687297|564846783|FG001|Induction|Patient Noncompliance|0|||
156478714|NCT00687297|564846782|FG000|Induction|Physician Decision|0|||
156478715|NCT00687297|564846783|FG001|Induction|Physician Decision|2|||
156478716|NCT00687297|564846782|FG000|Induction|Other|0|||
156478717|NCT00687297|564846783|FG001|Induction|Other|1|||
156478718|NCT02525744|564846786|FG000|Period 1|Physician Decision|0|||
156478719|NCT02525744|564846787|FG001|Period 1|Physician Decision|0|||
156478720|NCT02525744|564846788|FG002|Period 1|Physician Decision|1|||
156478721|NCT02525744|564846789|FG003|Period 1|Physician Decision|0|||
156478722|NCT02525744|564846786|FG000|Period 3|Adverse Event|0|||
156478723|NCT02525744|564846787|FG001|Period 3|Adverse Event|1|||
156478724|NCT02525744|564846788|FG002|Period 3|Adverse Event|0|||
156478725|NCT02525744|564846789|FG003|Period 3|Adverse Event|0|||
156478726|NCT02525744|564846786|FG000|Period 4|Withdrawal by Subject|1|||
156478727|NCT02525744|564846787|FG001|Period 4|Withdrawal by Subject|0|||
156478728|NCT02525744|564846788|FG002|Period 4|Withdrawal by Subject|0|||
156478729|NCT02525744|564846789|FG003|Period 4|Withdrawal by Subject|0|||
156478730|NCT02525744|564846786|FG000|Period 5|Physician Decision|1|||
156478731|NCT02525744|564846787|FG001|Period 5|Physician Decision|0|||
156478732|NCT02525744|564846788|FG002|Period 5|Physician Decision|0|||
156478733|NCT02525744|564846789|FG003|Period 5|Physician Decision|0|||
156478734|NCT01182285|564846790|FG000|First Intervention Week 1-10|Disease progression|1|||
156478735|NCT01182285|564846791|FG001|First Intervention Week 1-10|Disease progression|0|||
156478736|NCT01182285|564846792|FG002|First Intervention Week 1-10|Disease progression|0|||
156478737|NCT01182285|564846790|FG000|First Intervention Week 1-10|Adverse Event|1|||
156478738|NCT01182285|564846791|FG001|First Intervention Week 1-10|Adverse Event|0|||
156478739|NCT01182285|564846792|FG002|First Intervention Week 1-10|Adverse Event|0|||
156478740|NCT01182285|564846790|FG000|First Intervention Week 1-10|Non-compliance|1|||
156478741|NCT01182285|564846791|FG001|First Intervention Week 1-10|Non-compliance|0|||
156478742|NCT01182285|564846792|FG002|First Intervention Week 1-10|Non-compliance|0|||
156478743|NCT01182285|564846790|FG000|Third Intervention Week 11-52|Disease Progression|0|||
156478744|NCT01182285|564846791|FG001|Third Intervention Week 11-52|Disease Progression|0|||
156478745|NCT01182285|564846792|FG002|Third Intervention Week 11-52|Disease Progression|6|||
156478746|NCT01182285|564846790|FG000|Third Intervention Week 11-52|Other|0|||
156478747|NCT01182285|564846791|FG001|Third Intervention Week 11-52|Other|0|||
156478748|NCT01182285|564846792|FG002|Third Intervention Week 11-52|Other|2|||
156478749|NCT00472082|564846793|FG000|Overall Study|Study prematurely terminated|5|||
156478750|NCT02069379|564846794|FG000|Baseline Measurements|Lost to Follow-up|1|||
156344954|NCT03129100|564362403|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344955|NCT03129100|564362404|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344956|NCT03129100|564362405|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478751|NCT02069379|564846795|FG001|Baseline Measurements|Lost to Follow-up|0|||
156478752|NCT02069379|564846796|FG002|Baseline Measurements|Lost to Follow-up|0|||
156543442|NCT04607148|565084628|FG003|Overall Study|Study Terminated by Sponsor|39|||
156478753|NCT02069379|564846797|FG003|Baseline Measurements|Lost to Follow-up|0|||
156478754|NCT02069379|564846794|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
156478755|NCT02069379|564846795|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
156344957|NCT03129100|564362406|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478756|NCT02069379|564846796|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
156344958|NCT03129100|564362407|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344959|NCT03129100|564362408|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344960|NCT03129100|564362409|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156478757|NCT02069379|564846797|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
156478758|NCT02069379|564846794|FG000|First Treatment Arm|Lost to Follow-up|0|||
156478759|NCT02069379|564846795|FG001|First Treatment Arm|Lost to Follow-up|1|||
156478760|NCT02069379|564846796|FG002|First Treatment Arm|Lost to Follow-up|1|||
156478761|NCT02069379|564846797|FG003|First Treatment Arm|Lost to Follow-up|0|||
156478762|NCT02069379|564846794|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
156543443|NCT04607148|565084625|FG000|Overall Study|Sponsor Decision|0|||
156478763|NCT02069379|564846795|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
156478764|NCT02069379|564846796|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
156478765|NCT02069379|564846797|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
156543444|NCT04607148|565084626|FG001|Overall Study|Sponsor Decision|0|||
156543445|NCT04607148|565084627|FG002|Overall Study|Sponsor Decision|1|||
156543446|NCT04607148|565084628|FG003|Overall Study|Sponsor Decision|0|||
156543447|NCT04607148|565084625|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156543448|NCT04607148|565084626|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156543449|NCT04607148|565084627|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156543450|NCT04607148|565084628|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156543451|NCT04607148|565084625|FG000|Overall Study|Lost to Follow-up|0|||
156543452|NCT04607148|565084626|FG001|Overall Study|Lost to Follow-up|2|||
156543453|NCT04607148|565084627|FG002|Overall Study|Lost to Follow-up|0|||
156543454|NCT04607148|565084628|FG003|Overall Study|Lost to Follow-up|0|||
156543455|NCT04607148|565084625|FG000|Overall Study|Death|0|||
156543456|NCT04607148|565084626|FG001|Overall Study|Death|3|||
156543457|NCT04607148|565084627|FG002|Overall Study|Death|0|||
156543458|NCT04607148|565084628|FG003|Overall Study|Death|1|||
156543459|NCT04607148|565084625|FG000|Overall Study|Adverse Event|0|||
156543460|NCT04607148|565084626|FG001|Overall Study|Adverse Event|1|||
156543461|NCT04607148|565084627|FG002|Overall Study|Adverse Event|0|||
156543462|NCT04607148|565084628|FG003|Overall Study|Adverse Event|0|||
156543463|NCT00804570|565084629|FG000|Overall Study|Adverse Event|14|||
156543464|NCT00804570|565084630|FG001|Overall Study|Adverse Event|7|||
156543465|NCT00804570|565084629|FG000|Overall Study|Lack of Efficacy|0|||
156543466|NCT00804570|565084630|FG001|Overall Study|Lack of Efficacy|1|||
156543467|NCT00804570|565084629|FG000|Overall Study|Lost to Follow-up|18|||
156543468|NCT00804570|565084630|FG001|Overall Study|Lost to Follow-up|21|||
156543469|NCT00804570|565084629|FG000|Overall Study|Entry criteria not met|5|||
156543470|NCT00804570|565084630|FG001|Overall Study|Entry criteria not met|5|||
156543471|NCT00804570|565084629|FG000|Overall Study|Protocol Violation|12|||
156543472|NCT00804570|565084630|FG001|Overall Study|Protocol Violation|16|||
156543473|NCT00804570|565084629|FG000|Overall Study|Physician Decision|1|||
156543474|NCT00804570|565084630|FG001|Overall Study|Physician Decision|2|||
156543475|NCT00804570|565084629|FG000|Overall Study|Sponsor decision|1|||
156543476|NCT00804570|565084630|FG001|Overall Study|Sponsor decision|4|||
156543477|NCT00804570|565084629|FG000|Overall Study|Withdrawal by Subject|21|||
156543478|NCT00804570|565084630|FG001|Overall Study|Withdrawal by Subject|38|||
156543479|NCT00290342|565084631|FG000|Overall Study|Other|0|||
156543480|NCT00290342|565084632|FG001|Overall Study|Other|1|||
156543481|NCT00290342|565084631|FG000|Overall Study|Withdrawal by Subject|6|||
156543482|NCT00290342|565084632|FG001|Overall Study|Withdrawal by Subject|4|||
156543483|NCT00290342|565084631|FG000|Overall Study|Lost to Follow-up|1|||
156543484|NCT00290342|565084632|FG001|Overall Study|Lost to Follow-up|0|||
156543485|NCT01056510|565084635|FG000|Overall Study|Dropout Before Start of Treatment|1|||
156543486|NCT01056510|565084636|FG001|Overall Study|Dropout Before Start of Treatment|1|||
156543487|NCT01056510|565084635|FG000|Overall Study|Withdrawal by Subject|4|||
156543488|NCT01056510|565084636|FG001|Overall Study|Withdrawal by Subject|2|||
156543489|NCT01056510|565084635|FG000|Overall Study|Death|29|||
156543490|NCT01056510|565084636|FG001|Overall Study|Death|34|||
156543491|NCT01056510|565084635|FG000|Overall Study|Noncompliance|1|||
156478766|NCT02069379|564846794|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
156478767|NCT02069379|564846795|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
156478768|NCT02069379|564846796|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
156478769|NCT02069379|564846797|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
156478770|NCT02069379|564846794|FG000|Second Treatment Arm|Lost to Follow-up|0|||
156478771|NCT02069379|564846795|FG001|Second Treatment Arm|Lost to Follow-up|0|||
156478772|NCT02069379|564846796|FG002|Second Treatment Arm|Lost to Follow-up|1|||
156478773|NCT02069379|564846797|FG003|Second Treatment Arm|Lost to Follow-up|0|||
156478774|NCT04617847|564846800|FG000|Overall Study|Withdrawal by Subject|1|||
156478775|NCT04617847|564846801|FG001|Overall Study|Withdrawal by Subject|0|||
156478776|NCT04617847|564846800|FG000|Overall Study|Adverse Event|0|||
156543492|NCT01056510|565084636|FG001|Overall Study|Noncompliance|3|||
156543493|NCT01056510|565084635|FG000|Overall Study|Physician Decision|4|||
156478777|NCT04617847|564846801|FG001|Overall Study|Adverse Event|2|||
156478778|NCT04617847|564846800|FG000|Overall Study|Death|0|||
156478779|NCT04617847|564846801|FG001|Overall Study|Death|1|||
156478780|NCT04617847|564846800|FG000|Overall Study|Termination of Study by Sponsor|2|||
156543494|NCT01056510|565084636|FG001|Overall Study|Physician Decision|5|||
156543495|NCT01056510|565084635|FG000|Overall Study|Lost to Follow-up|5|||
156543496|NCT01056510|565084636|FG001|Overall Study|Lost to Follow-up|6|||
156543497|NCT01056510|565084635|FG000|Overall Study|Other|10|||
156543498|NCT01056510|565084636|FG001|Overall Study|Other|12|||
156543499|NCT01056510|565084635|FG000|Overall Study|Missing|0|||
156543500|NCT01056510|565084636|FG001|Overall Study|Missing|1|||
156543501|NCT02285998|565084637|FG000|Overall Study|Adverse Event|9|||
156543502|NCT02285998|565084638|FG001|Overall Study|Adverse Event|8|||
156543503|NCT02285998|565084637|FG000|Overall Study|Physician Decision|1|||
156543504|NCT02285998|565084638|FG001|Overall Study|Physician Decision|2|||
156543505|NCT02285998|565084637|FG000|Overall Study|Lost to Follow-up|176|||
156543506|NCT02285998|565084638|FG001|Overall Study|Lost to Follow-up|172|||
156543507|NCT02285998|565084637|FG000|Overall Study|Withdrawal by Subject|53|||
156543508|NCT02285998|565084638|FG001|Overall Study|Withdrawal by Subject|61|||
156478781|NCT04617847|564846801|FG001|Overall Study|Termination of Study by Sponsor|21|||
156478782|NCT01525875|564846802|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
156478783|NCT01525875|564846803|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
156478784|NCT01525875|564846802|FG000|Open-label Period|Lost to Follow-up|0|||
156478785|NCT01525875|564846803|FG001|Open-label Period|Lost to Follow-up|2|||
156478786|NCT00700999|564846804|FG000|Overall Study|Lost to Follow-up|7|||
156478787|NCT00700999|564846805|FG001|Overall Study|Lost to Follow-up|7|||
156478788|NCT00700999|564846804|FG000|Overall Study|Excluded - did not meet study criteria|0|||
156478789|NCT00700999|564846805|FG001|Overall Study|Excluded - did not meet study criteria|1|||
156478790|NCT00700999|564846804|FG000|Overall Study|Withdrawal by Subject|8|||
156478791|NCT00700999|564846805|FG001|Overall Study|Withdrawal by Subject|1|||
156478792|NCT00244751|564846806|FG000|Overall Study|Adverse Event|7|||
156478793|NCT00244751|564846807|FG001|Overall Study|Adverse Event|7|||
156478794|NCT00244751|564846808|FG002|Overall Study|Adverse Event|5|||
156478795|NCT00244751|564846806|FG000|Overall Study|Lost to Follow-up|0|||
156478796|NCT00244751|564846807|FG001|Overall Study|Lost to Follow-up|1|||
156478797|NCT00244751|564846808|FG002|Overall Study|Lost to Follow-up|0|||
156478798|NCT00244751|564846806|FG000|Overall Study|Protocol Violation|1|||
156478799|NCT00244751|564846807|FG001|Overall Study|Protocol Violation|0|||
156478800|NCT00244751|564846808|FG002|Overall Study|Protocol Violation|1|||
156478801|NCT00244751|564846806|FG000|Overall Study|Withdrawal by Subject|7|||
156478802|NCT00244751|564846807|FG001|Overall Study|Withdrawal by Subject|5|||
156478803|NCT00244751|564846808|FG002|Overall Study|Withdrawal by Subject|3|||
156478804|NCT00244751|564846806|FG000|Overall Study|Elevated liver enzymes|1|||
156478805|NCT00244751|564846807|FG001|Overall Study|Elevated liver enzymes|0|||
156478806|NCT00244751|564846808|FG002|Overall Study|Elevated liver enzymes|0|||
156478807|NCT00244751|564846806|FG000|Overall Study|Lack of compliance with protocol|0|||
156478808|NCT00244751|564846807|FG001|Overall Study|Lack of compliance with protocol|1|||
156478809|NCT00244751|564846808|FG002|Overall Study|Lack of compliance with protocol|0|||
156478810|NCT00244751|564846806|FG000|Overall Study|Safety reasons|0|||
156478811|NCT00244751|564846807|FG001|Overall Study|Safety reasons|1|||
156478812|NCT00244751|564846808|FG002|Overall Study|Safety reasons|0|||
156478813|NCT00244751|564846806|FG000|Overall Study|Participant randomized by mistake|0|||
156478814|NCT00244751|564846807|FG001|Overall Study|Participant randomized by mistake|0|||
156478815|NCT00244751|564846808|FG002|Overall Study|Participant randomized by mistake|1|||
156478816|NCT03031782|564846811|FG000|Treatment Period 1|Lack of Efficacy|3|||
156478817|NCT03031782|564846812|FG001|Treatment Period 1|Lack of Efficacy|0|||
156478818|NCT03031782|564846813|FG002|Treatment Period 1|Lack of Efficacy|0|||
156478819|NCT03031782|564846814|FG003|Treatment Period 1|Lack of Efficacy|0|||
156478820|NCT03031782|564846815|FG004|Treatment Period 1|Lack of Efficacy|0|||
156478821|NCT03031782|564846811|FG000|Treatment Period 2|Physician Decision|0|||
156478822|NCT03031782|564846812|FG001|Treatment Period 2|Physician Decision|1|||
156478823|NCT03031782|564846813|FG002|Treatment Period 2|Physician Decision|0|||
156478824|NCT03031782|564846814|FG003|Treatment Period 2|Physician Decision|0|||
156478825|NCT03031782|564846815|FG004|Treatment Period 2|Physician Decision|3|||
156478826|NCT03031782|564846811|FG000|Treatment Period 2|Lack of Efficacy|0|||
156478827|NCT03031782|564846812|FG001|Treatment Period 2|Lack of Efficacy|1|||
156478828|NCT03031782|564846813|FG002|Treatment Period 2|Lack of Efficacy|0|||
156478829|NCT03031782|564846814|FG003|Treatment Period 2|Lack of Efficacy|0|||
156478830|NCT03031782|564846815|FG004|Treatment Period 2|Lack of Efficacy|1|||
156478831|NCT03031782|564846811|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156478832|NCT03031782|564846812|FG001|Treatment Period 2|Withdrawal by Subject|3|||
156478833|NCT03031782|564846813|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156478834|NCT03031782|564846814|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156478835|NCT03031782|564846815|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156478836|NCT03031782|564846811|FG000|Treatment Period 2|Adverse Event|0|||
156478837|NCT03031782|564846812|FG001|Treatment Period 2|Adverse Event|1|||
156478838|NCT03031782|564846813|FG002|Treatment Period 2|Adverse Event|2|||
156478839|NCT03031782|564846814|FG003|Treatment Period 2|Adverse Event|0|||
156478840|NCT03031782|564846815|FG004|Treatment Period 2|Adverse Event|0|||
156478841|NCT03031782|564846811|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156478842|NCT03031782|564846812|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156478843|NCT03031782|564846813|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156478844|NCT03031782|564846814|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156478845|NCT03031782|564846815|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156478846|NCT03122860|564846816|FG000|Overall Study|Discontinued Before Treatment|1|||
156478847|NCT03122860|564846817|FG001|Overall Study|Discontinued Before Treatment|1|||
156478848|NCT03122860|564846818|FG002|Overall Study|Discontinued Before Treatment|2|||
156478849|NCT03122860|564846819|FG003|Overall Study|Discontinued Before Treatment|0|||
156478850|NCT03122860|564846820|FG004|Overall Study|Discontinued Before Treatment|1|||
156478851|NCT03122860|564846821|FG005|Overall Study|Discontinued Before Treatment|0|||
156478852|NCT03122860|564846816|FG000|Overall Study|Adverse Event|1|||
156478853|NCT03122860|564846817|FG001|Overall Study|Adverse Event|0|||
156478854|NCT03122860|564846818|FG002|Overall Study|Adverse Event|1|||
156478855|NCT03122860|564846819|FG003|Overall Study|Adverse Event|1|||
156478856|NCT03122860|564846820|FG004|Overall Study|Adverse Event|0|||
156478857|NCT03122860|564846821|FG005|Overall Study|Adverse Event|0|||
156478858|NCT03122860|564846816|FG000|Overall Study|Lost to Follow-up|5|||
156478859|NCT03122860|564846817|FG001|Overall Study|Lost to Follow-up|2|||
156478860|NCT03122860|564846818|FG002|Overall Study|Lost to Follow-up|3|||
156478861|NCT03122860|564846819|FG003|Overall Study|Lost to Follow-up|3|||
156478862|NCT03122860|564846820|FG004|Overall Study|Lost to Follow-up|5|||
156478863|NCT03122860|564846821|FG005|Overall Study|Lost to Follow-up|4|||
156478864|NCT03122860|564846816|FG000|Overall Study|Subject Non-Compliance|0|||
156478865|NCT03122860|564846817|FG001|Overall Study|Subject Non-Compliance|0|||
156478866|NCT03122860|564846818|FG002|Overall Study|Subject Non-Compliance|1|||
156478867|NCT03122860|564846819|FG003|Overall Study|Subject Non-Compliance|0|||
156478868|NCT03122860|564846820|FG004|Overall Study|Subject Non-Compliance|0|||
156478869|NCT03122860|564846821|FG005|Overall Study|Subject Non-Compliance|0|||
156478870|NCT03122860|564846816|FG000|Overall Study|Withdrawal by Subject|3|||
156478871|NCT03122860|564846817|FG001|Overall Study|Withdrawal by Subject|2|||
156478872|NCT03122860|564846818|FG002|Overall Study|Withdrawal by Subject|5|||
156478873|NCT03122860|564846819|FG003|Overall Study|Withdrawal by Subject|7|||
156478874|NCT03122860|564846820|FG004|Overall Study|Withdrawal by Subject|9|||
156478875|NCT03122860|564846821|FG005|Overall Study|Withdrawal by Subject|8|||
156478876|NCT01138657|564846822|FG000|Overall Study|Adverse Event|3|||
156478877|NCT01138657|564846823|FG001|Overall Study|Adverse Event|10|||
156478878|NCT01138657|564846822|FG000|Overall Study|Lack of Efficacy|2|||
156478879|NCT01138657|564846823|FG001|Overall Study|Lack of Efficacy|1|||
156478880|NCT01138657|564846822|FG000|Overall Study|Lost to Follow-up|0|||
156478881|NCT01138657|564846823|FG001|Overall Study|Lost to Follow-up|3|||
156478882|NCT01138657|564846822|FG000|Overall Study|Miscellaneous Reasons|3|||
156478883|NCT01138657|564846823|FG001|Overall Study|Miscellaneous Reasons|4|||
156478884|NCT02699099|564846824|FG000|Overall Study|Adverse Event|1|||
156478885|NCT02699099|564846825|FG001|Overall Study|Adverse Event|0|||
156478886|NCT02699099|564846826|FG002|Overall Study|Adverse Event|2|||
156478887|NCT02699099|564846824|FG000|Overall Study|Lost to Follow-up|0|||
156478888|NCT02699099|564846825|FG001|Overall Study|Lost to Follow-up|1|||
156478889|NCT02699099|564846826|FG002|Overall Study|Lost to Follow-up|0|||
156478890|NCT02699099|564846824|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
156478891|NCT02699099|564846825|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
156478892|NCT02699099|564846826|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
156478893|NCT01240590|564846829|FG000|Phase I|Refused further treatment|0|||
156478894|NCT01240590|564846830|FG001|Phase I|Refused further treatment|0|||
156478895|NCT01240590|564846831|FG002|Phase I|Refused further treatment|3|||
156478896|NCT01240590|564846832|FG003|Phase I|Refused further treatment|0|||
156478897|NCT01240590|564846833|FG004|Phase I|Refused further treatment|0|||
156478898|NCT01240590|564846829|FG000|Phase II|Refused further treatment|0|||
156478899|NCT01240590|564846830|FG001|Phase II|Refused further treatment|0|||
156543509|NCT02285998|565084637|FG000|Overall Study|Other Reasons|7|||
156478900|NCT01240590|564846831|FG002|Phase II|Refused further treatment|0|||
156478901|NCT01240590|564846832|FG003|Phase II|Refused further treatment|2|||
156478902|NCT01240590|564846833|FG004|Phase II|Refused further treatment|1|||
156478903|NCT02144285|564846838|FG000|Overall Study|Withdrawal by Subject|0|||
156478904|NCT02144285|564846839|FG001|Overall Study|Withdrawal by Subject|0|||
156478905|NCT02144285|564846840|FG002|Overall Study|Withdrawal by Subject|0|||
156478906|NCT02144285|564846841|FG003|Overall Study|Withdrawal by Subject|0|||
156478907|NCT02144285|564846842|FG004|Overall Study|Withdrawal by Subject|1|||
156478908|NCT02144285|564846843|FG005|Overall Study|Withdrawal by Subject|0|||
156478909|NCT02144285|564846844|FG006|Overall Study|Withdrawal by Subject|0|||
156478910|NCT02144285|564846845|FG007|Overall Study|Withdrawal by Subject|0|||
156478911|NCT02144285|564846846|FG008|Overall Study|Withdrawal by Subject|0|||
156478912|NCT02144285|564846847|FG009|Overall Study|Withdrawal by Subject|0|||
156478913|NCT05184062|564846848|FG000|Overall Study|Lost to Follow-up|5|||
156478914|NCT05184062|564846849|FG001|Overall Study|Lost to Follow-up|1|||
156478915|NCT05184062|564846848|FG000|Overall Study|Withdrawal by Subject|1|||
156478916|NCT05184062|564846849|FG001|Overall Study|Withdrawal by Subject|0|||
156478917|NCT04620733|564848305|FG000|Overall Study|Adverse Event|4|||
156478918|NCT04620733|564848306|FG001|Overall Study|Adverse Event|3|||
156478919|NCT04620733|564848305|FG000|Overall Study|Withdrawal by Subject|2|||
156478920|NCT04620733|564848306|FG001|Overall Study|Withdrawal by Subject|5|||
156478921|NCT04620733|564848305|FG000|Overall Study|Lost to Follow-up|1|||
156478922|NCT04620733|564848306|FG001|Overall Study|Lost to Follow-up|1|||
156478923|NCT04620733|564848305|FG000|Overall Study|Protocol Deviation|1|||
156478924|NCT04620733|564848306|FG001|Overall Study|Protocol Deviation|1|||
156478925|NCT04620733|564848305|FG000|Overall Study|Reason Not Specified|0|||
156478926|NCT04620733|564848306|FG001|Overall Study|Reason Not Specified|1|||
156478927|NCT03976102|564848307|FG000|Overall Study|Withdrawal by Subject|4|||
156478928|NCT03976102|564848308|FG001|Overall Study|Withdrawal by Subject|4|||
156478929|NCT03976102|564848307|FG000|Overall Study|Adverse Event|2|||
156478930|NCT03976102|564848308|FG001|Overall Study|Adverse Event|4|||
156478931|NCT03976102|564848307|FG000|Overall Study|Not related to Covid-19|9|||
156478932|NCT03976102|564848308|FG001|Overall Study|Not related to Covid-19|13|||
156478933|NCT03976102|564848307|FG000|Overall Study|Lost to Follow-up|0|||
156478934|NCT03976102|564848308|FG001|Overall Study|Lost to Follow-up|2|||
156478935|NCT03976102|564848307|FG000|Overall Study|Death|3|||
156478936|NCT03976102|564848308|FG001|Overall Study|Death|2|||
156478937|NCT03976102|564848307|FG000|Overall Study|Physician Decision|1|||
156478938|NCT03976102|564848308|FG001|Overall Study|Physician Decision|1|||
156478939|NCT02164578|564848318|FG000|Treatment Period|Withdrawal by Subject|3|||
156478940|NCT02164578|564848319|FG001|Treatment Period|Withdrawal by Subject|3|||
156478941|NCT02164578|564848318|FG000|Treatment Period|Adverse Event|13|||
156478942|NCT02164578|564848319|FG001|Treatment Period|Adverse Event|6|||
156478943|NCT02164578|564848318|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
156478944|NCT02164578|564848319|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
156478945|NCT02164578|564848318|FG000|Treatment Period|Protocol Violation|0|||
156478946|NCT02164578|564848319|FG001|Treatment Period|Protocol Violation|2|||
156478947|NCT02164578|564848318|FG000|Extension Period|Withdrawal by Subject|2|||
156478948|NCT02164578|564848319|FG001|Extension Period|Withdrawal by Subject|0|||
156478949|NCT02164578|564848318|FG000|Extension Period|Adverse Event|4|||
156478950|NCT02164578|564848319|FG001|Extension Period|Adverse Event|0|||
156478951|NCT02164578|564848318|FG000|Extension Period|Expiry of study medication|1|||
156478952|NCT02164578|564848319|FG001|Extension Period|Expiry of study medication|0|||
156478953|NCT02164578|564848318|FG000|Extension Period|Protocol Violation|0|||
156478954|NCT02164578|564848319|FG001|Extension Period|Protocol Violation|1|||
156478955|NCT03029585|564848327|FG000|Overall Study|Death|1|||
156478956|NCT03029585|564848328|FG001|Overall Study|Death|1|||
156478957|NCT03029585|564848327|FG000|Overall Study|Withdrawal by Subject|1|||
156478958|NCT03029585|564848328|FG001|Overall Study|Withdrawal by Subject|0|||
156478959|NCT04025762|564848331|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
156478960|NCT04025762|564848332|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
156478961|NCT03340961|564848334|FG000|Overall Study|Adverse Event|1|||
156478962|NCT03340961|564848335|FG001|Overall Study|Adverse Event|3|||
156478963|NCT03340961|564848336|FG002|Overall Study|Adverse Event|2|||
156478964|NCT03340961|564848337|FG003|Overall Study|Adverse Event|4|||
156478965|NCT03340961|564848334|FG000|Overall Study|Lost to Follow-up|0|||
156478966|NCT03340961|564848335|FG001|Overall Study|Lost to Follow-up|1|||
156478967|NCT03340961|564848336|FG002|Overall Study|Lost to Follow-up|0|||
156478968|NCT03340961|564848337|FG003|Overall Study|Lost to Follow-up|1|||
156478969|NCT03340961|564848334|FG000|Overall Study|Withdrawal by Subject|3|||
156478970|NCT03340961|564848335|FG001|Overall Study|Withdrawal by Subject|2|||
156478971|NCT03340961|564848336|FG002|Overall Study|Withdrawal by Subject|4|||
156478972|NCT03340961|564848337|FG003|Overall Study|Withdrawal by Subject|7|||
156478973|NCT03340961|564848334|FG000|Overall Study|Use of prohibited treatment|0|||
156478974|NCT03340961|564848335|FG001|Overall Study|Use of prohibited treatment|3|||
156478975|NCT03340961|564848336|FG002|Overall Study|Use of prohibited treatment|2|||
156478976|NCT03340961|564848337|FG003|Overall Study|Use of prohibited treatment|4|||
156478977|NCT03340961|564848334|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
156478978|NCT03340961|564848335|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
156478979|NCT03340961|564848336|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
156478980|NCT03340961|564848337|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
156478981|NCT03340961|564848334|FG000|Overall Study|Subject developed an exclusion criterion|0|||
156478982|NCT03340961|564848335|FG001|Overall Study|Subject developed an exclusion criterion|1|||
156478983|NCT03340961|564848336|FG002|Overall Study|Subject developed an exclusion criterion|0|||
156478984|NCT03340961|564848337|FG003|Overall Study|Subject developed an exclusion criterion|0|||
156478985|NCT03340961|564848334|FG000|Overall Study|Protocol Violation|1|||
156478986|NCT03340961|564848335|FG001|Overall Study|Protocol Violation|0|||
156478987|NCT03340961|564848336|FG002|Overall Study|Protocol Violation|1|||
156478988|NCT03340961|564848337|FG003|Overall Study|Protocol Violation|0|||
156478989|NCT03340961|564848334|FG000|Overall Study|Adverse Event|1|||
156478990|NCT03340961|564848335|FG001|Overall Study|Adverse Event|1|||
156478991|NCT03340961|564848336|FG002|Overall Study|Adverse Event|0|||
156478992|NCT03340961|564848337|FG003|Overall Study|Adverse Event|0|||
156478993|NCT03340961|564848334|FG000|Overall Study|Lack of Efficacy|0|||
156478994|NCT03340961|564848335|FG001|Overall Study|Lack of Efficacy|0|||
156478995|NCT03340961|564848336|FG002|Overall Study|Lack of Efficacy|0|||
156478996|NCT03340961|564848337|FG003|Overall Study|Lack of Efficacy|1|||
156478997|NCT01286311|564848338|FG000|Overall Study|Physician did not want outreach sent|14|||
156478998|NCT01286311|564848339|FG001|Overall Study|Physician did not want outreach sent|0|||
156478999|NCT01437540|564848340|FG000|Overall Study|Not listed below|7|||
156479000|NCT01437540|564848341|FG001|Overall Study|Not listed below|6|||
156479001|NCT01437540|564848340|FG000|Overall Study|COPD exacerbation|13|||
156479002|NCT01437540|564848341|FG001|Overall Study|COPD exacerbation|3|||
156479003|NCT01437540|564848340|FG000|Overall Study|Lost to Follow-up|3|||
156479004|NCT01437540|564848341|FG001|Overall Study|Lost to Follow-up|5|||
156479005|NCT01437540|564848340|FG000|Overall Study|Lack of Efficacy|23|||
156479006|NCT01437540|564848341|FG001|Overall Study|Lack of Efficacy|11|||
156479007|NCT01437540|564848340|FG000|Overall Study|Protocol Violation|24|||
156479008|NCT01437540|564848341|FG001|Overall Study|Protocol Violation|12|||
156479009|NCT01437540|564848340|FG000|Overall Study|Adverse Event|26|||
156479010|NCT01437540|564848341|FG001|Overall Study|Adverse Event|13|||
156479011|NCT01437540|564848340|FG000|Overall Study|Withdrawal by Subject|31|||
156479012|NCT01437540|564848341|FG001|Overall Study|Withdrawal by Subject|15|||
156479013|NCT04328467|564848346|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
156479014|NCT04328467|564848347|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
156479015|NCT04328467|564848348|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
156479016|NCT01975701|564848349|FG000|Overall Study|Lost to Follow-up|1|||
156479017|NCT01975701|564848349|FG000|Overall Study|Death|23|||
156479018|NCT01975701|564848349|FG000|Overall Study|Physician Decision|1|||
156479019|NCT02446015|564848352|FG000|Overall Study|Adverse Event|0|||
156479020|NCT02446015|564848353|FG001|Overall Study|Adverse Event|1|||
156479021|NCT02446015|564848352|FG000|Overall Study|Withdrawal by Subject|1|||
156479022|NCT02446015|564848353|FG001|Overall Study|Withdrawal by Subject|0|||
156479023|NCT01393600|564848354|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
156479024|NCT01393600|564848355|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
156479025|NCT01393600|564848356|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
156479026|NCT01393600|564848357|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
156479027|NCT01393600|564848354|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
156479028|NCT01393600|564848355|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
156479029|NCT01393600|564848356|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
156479030|NCT01393600|564848357|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
156479031|NCT01393600|564848354|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
156479032|NCT01393600|564848355|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
156479033|NCT01393600|564848356|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
156479034|NCT01393600|564848357|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
156479035|NCT01393600|564848354|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
156479036|NCT01393600|564848355|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
156479037|NCT01393600|564848356|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
156479038|NCT01393600|564848357|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
156479039|NCT01393600|564848354|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
156479040|NCT01393600|564848355|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
156479041|NCT01393600|564848356|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
156479042|NCT01393600|564848357|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
156479043|NCT01393600|564848354|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
156479044|NCT01393600|564848355|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
156479045|NCT01393600|564848356|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
156479046|NCT01393600|564848357|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
156479047|NCT01393600|564848354|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
156479048|NCT01393600|564848355|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
156479049|NCT01393600|564848356|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
156479050|NCT01393600|564848357|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
156479051|NCT02410278|564848358|FG000|Run-in Period|Adverse Event|5|||
156479052|NCT02410278|564848359|FG001|Run-in Period|Adverse Event|0|||
156479053|NCT02410278|564848360|FG002|Run-in Period|Adverse Event|0|||
156479054|NCT02410278|564848358|FG000|Run-in Period|GSRS Threshold Not Met|30|||
156479055|NCT02410278|564848359|FG001|Run-in Period|GSRS Threshold Not Met|0|||
156479056|NCT02410278|564848360|FG002|Run-in Period|GSRS Threshold Not Met|0|||
156479057|NCT02410278|564848358|FG000|Run-in Period|Lost to Follow-up|1|||
156479058|NCT02410278|564848359|FG001|Run-in Period|Lost to Follow-up|0|||
156479059|NCT02410278|564848360|FG002|Run-in Period|Lost to Follow-up|0|||
156479060|NCT02410278|564848358|FG000|Run-in Period|Withdrawal by Subject|1|||
156479061|NCT02410278|564848359|FG001|Run-in Period|Withdrawal by Subject|0|||
156479062|NCT02410278|564848360|FG002|Run-in Period|Withdrawal by Subject|0|||
156479063|NCT02410278|564848358|FG000|Run-in Period|Pregnancy|1|||
156479064|NCT02410278|564848359|FG001|Run-in Period|Pregnancy|0|||
156479065|NCT02410278|564848360|FG002|Run-in Period|Pregnancy|0|||
156479066|NCT02410278|564848358|FG000|Study Treatment Period|Adverse Event|0|||
156479067|NCT02410278|564848359|FG001|Study Treatment Period|Adverse Event|6|||
156479068|NCT02410278|564848360|FG002|Study Treatment Period|Adverse Event|3|||
156479069|NCT02410278|564848358|FG000|Study Treatment Period|Physician Decision|0|||
156479070|NCT02410278|564848359|FG001|Study Treatment Period|Physician Decision|0|||
156479071|NCT02410278|564848360|FG002|Study Treatment Period|Physician Decision|1|||
156479072|NCT02410278|564848358|FG000|Study Treatment Period|Withdrawal by Subject|0|||
156479073|NCT02410278|564848359|FG001|Study Treatment Period|Withdrawal by Subject|1|||
156479074|NCT02410278|564848360|FG002|Study Treatment Period|Withdrawal by Subject|0|||
156479075|NCT02410278|564848358|FG000|Study Treatment Period|Other|0|||
156344961|NCT03129100|564362410|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156344962|NCT03129100|564362411|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156479076|NCT02410278|564848359|FG001|Study Treatment Period|Other|3|||
156479077|NCT02410278|564848360|FG002|Study Treatment Period|Other|0|||
156479078|NCT02410278|564848358|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
156479079|NCT02410278|564848359|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
156479080|NCT02410278|564848360|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
156479081|NCT01670877|564848361|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
156479082|NCT01670877|564848362|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
156479083|NCT01670877|564848363|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
156479084|NCT01670877|564848364|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
156479085|NCT01670877|564848365|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
156479086|NCT01670877|564848366|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
156479087|NCT01670877|564848361|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
156479088|NCT01670877|564848362|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
156479089|NCT01670877|564848363|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
156479090|NCT01670877|564848364|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
156479091|NCT01670877|564848365|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
156479092|NCT01670877|564848366|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
156479093|NCT01670877|564848361|FG000|Part I and Part 2|Grade 2 vomiting|0|||
156479094|NCT01670877|564848362|FG001|Part I and Part 2|Grade 2 vomiting|0|||
156479095|NCT01670877|564848363|FG002|Part I and Part 2|Grade 2 vomiting|0|||
156479096|NCT01670877|564848364|FG003|Part I and Part 2|Grade 2 vomiting|1|||
156479097|NCT01670877|564848365|FG004|Part I and Part 2|Grade 2 vomiting|0|||
156479098|NCT01670877|564848366|FG005|Part I and Part 2|Grade 2 vomiting|0|||
156479099|NCT01670877|564848361|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
156479100|NCT01670877|564848362|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
156479101|NCT01670877|564848363|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
156479102|NCT01670877|564848364|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
156479103|NCT01670877|564848365|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
156479104|NCT01670877|564848366|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
156479105|NCT01670877|564848361|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
156479106|NCT01670877|564848362|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
156479107|NCT01670877|564848363|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
156479108|NCT01670877|564848364|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
156479109|NCT01670877|564848365|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
156479110|NCT01670877|564848366|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
156479111|NCT01137682|564848370|FG000|Overall Study|Adverse Event-CORE|2|||
156479112|NCT01137682|564848371|FG001|Overall Study|Adverse Event-CORE|4|||
156479113|NCT01137682|564848372|FG002|Overall Study|Adverse Event-CORE|0|||
156479114|NCT01137682|564848370|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
156479115|NCT01137682|564848371|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
156479116|NCT01137682|564848372|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
156479117|NCT01137682|564848370|FG000|Overall Study|Administrative problems-CORE|2|||
156479118|NCT01137682|564848371|FG001|Overall Study|Administrative problems-CORE|1|||
156479119|NCT01137682|564848372|FG002|Overall Study|Administrative problems-CORE|0|||
156479120|NCT01137682|564848370|FG000|Overall Study|Protocol Violation-CORE|0|||
156543510|NCT02285998|565084638|FG001|Overall Study|Other Reasons|10|||
156543511|NCT02830776|565084639|FG000|Overall Study|Lost to Follow-up|1|||
156543512|NCT03451084|565084643|FG000|Overall Study|Withdrawal by Subject|2|||
156543513|NCT03451084|565084644|FG001|Overall Study|Withdrawal by Subject|1|||
156543514|NCT03451084|565084645|FG002|Overall Study|Withdrawal by Subject|2|||
156543515|NCT03451084|565084646|FG003|Overall Study|Withdrawal by Subject|1|||
156543516|NCT03451084|565084643|FG000|Overall Study|Disease recurrence|0|||
156543517|NCT03451084|565084644|FG001|Overall Study|Disease recurrence|2|||
156543518|NCT03451084|565084645|FG002|Overall Study|Disease recurrence|0|||
156543519|NCT03451084|565084646|FG003|Overall Study|Disease recurrence|0|||
156543520|NCT03451084|565084643|FG000|Overall Study|Lack of Efficacy|0|||
156543521|NCT03451084|565084644|FG001|Overall Study|Lack of Efficacy|3|||
156543522|NCT03451084|565084645|FG002|Overall Study|Lack of Efficacy|0|||
156543523|NCT03451084|565084646|FG003|Overall Study|Lack of Efficacy|1|||
156543524|NCT03451084|565084643|FG000|Overall Study|Death|1|||
156543525|NCT03451084|565084644|FG001|Overall Study|Death|0|||
156543526|NCT03451084|565084645|FG002|Overall Study|Death|2|||
156543527|NCT03451084|565084646|FG003|Overall Study|Death|0|||
156543528|NCT03451084|565084643|FG000|Overall Study|Physician Decision|0|||
156543529|NCT03451084|565084644|FG001|Overall Study|Physician Decision|0|||
156543530|NCT03451084|565084645|FG002|Overall Study|Physician Decision|2|||
156543531|NCT03451084|565084646|FG003|Overall Study|Physician Decision|2|||
156543532|NCT03451084|565084643|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
156543533|NCT03451084|565084644|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
156543534|NCT03451084|565084645|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
156543535|NCT03451084|565084646|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
156543536|NCT03029143|565084647|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
156543537|NCT03029143|565084648|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
156543538|NCT03029143|565084649|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
156543539|NCT03029143|565084647|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
156543540|NCT03029143|565084648|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
156543541|NCT03029143|565084649|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
156543542|NCT03029143|565084647|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
156543543|NCT03029143|565084648|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
156543544|NCT03029143|565084649|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
156543545|NCT03029143|565084647|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
156543546|NCT03029143|565084648|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
156543547|NCT03029143|565084649|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
156543548|NCT03029143|565084647|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
156543549|NCT03029143|565084648|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
156543550|NCT03029143|565084649|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
156543551|NCT03029143|565084647|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
156543552|NCT03029143|565084648|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
156543553|NCT03029143|565084649|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
156543554|NCT03029143|565084647|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
156543555|NCT03029143|565084648|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
156543556|NCT03029143|565084649|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
156543557|NCT03029143|565084647|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156543558|NCT03029143|565084648|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156543559|NCT03029143|565084649|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
156543560|NCT03029143|565084647|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
156543561|NCT03029143|565084648|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
156543562|NCT03029143|565084649|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
156543563|NCT03029143|565084647|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
156543564|NCT03029143|565084648|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
156543565|NCT03029143|565084649|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
156543566|NCT03029143|565084647|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
156543567|NCT03029143|565084648|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
156543568|NCT03029143|565084649|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
156543569|NCT02121262|565084650|FG000|Overall Study|Adverse Event|6|||
156543570|NCT02121262|565084651|FG001|Overall Study|Adverse Event|3|||
156543571|NCT02121262|565084650|FG000|Overall Study|Lack of Efficacy|3|||
156543572|NCT02121262|565084651|FG001|Overall Study|Lack of Efficacy|0|||
156543573|NCT02121262|565084650|FG000|Overall Study|Personal Reasons|19|||
156543574|NCT02121262|565084651|FG001|Overall Study|Personal Reasons|5|||
156543575|NCT02121262|565084650|FG000|Overall Study|Protocol Violation|1|||
156344963|NCT03129100|564362386|FG000|Period2 Extension Period (Group A and B)|Death|0|||
156543576|NCT02121262|565084651|FG001|Overall Study|Protocol Violation|1|||
156543577|NCT02121262|565084650|FG000|Overall Study|Participant Dropped-out|0|||
156543578|NCT02121262|565084651|FG001|Overall Study|Participant Dropped-out|1|||
156479121|NCT01137682|564848371|FG001|Overall Study|Protocol Violation-CORE|1|||
156479122|NCT01137682|564848372|FG002|Overall Study|Protocol Violation-CORE|1|||
156479123|NCT01137682|564848370|FG000|Overall Study|Adverse Event-Extension|4|||
156479124|NCT01137682|564848371|FG001|Overall Study|Adverse Event-Extension|8|||
156479125|NCT01137682|564848372|FG002|Overall Study|Adverse Event-Extension|7|||
156479126|NCT01137682|564848370|FG000|Overall Study|Lack of Efficacy-Extension|15|||
156479127|NCT01137682|564848371|FG001|Overall Study|Lack of Efficacy-Extension|9|||
156479128|NCT01137682|564848372|FG002|Overall Study|Lack of Efficacy-Extension|13|||
156479129|NCT01137682|564848370|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
156479130|NCT01137682|564848371|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
156479131|NCT01137682|564848372|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
156479132|NCT01137682|564848370|FG000|Overall Study|Lost to Follow Up-Extension|0|||
156479133|NCT01137682|564848371|FG001|Overall Study|Lost to Follow Up-Extension|1|||
156479134|NCT01137682|564848372|FG002|Overall Study|Lost to Follow Up-Extension|0|||
156479135|NCT01137682|564848370|FG000|Overall Study|Administrative problems-Extension|0|||
156479136|NCT01137682|564848371|FG001|Overall Study|Administrative problems-Extension|2|||
156479137|NCT01137682|564848372|FG002|Overall Study|Administrative problems-Extension|0|||
156479138|NCT01137682|564848370|FG000|Overall Study|Death-Extension|2|||
156479139|NCT01137682|564848371|FG001|Overall Study|Death-Extension|0|||
156479140|NCT01137682|564848372|FG002|Overall Study|Death-Extension|0|||
156479141|NCT01137682|564848370|FG000|Overall Study|Protocol Violation-Extension|2|||
156479142|NCT01137682|564848371|FG001|Overall Study|Protocol Violation-Extension|1|||
156479143|NCT01137682|564848372|FG002|Overall Study|Protocol Violation-Extension|0|||
156479144|NCT01137682|564848370|FG000|Overall Study|Did not enter extension|2|||
156479145|NCT01137682|564848371|FG001|Overall Study|Did not enter extension|3|||
156479146|NCT01137682|564848372|FG002|Overall Study|Did not enter extension|2|||
156479147|NCT01137682|564848370|FG000|Overall Study|Did not receive treatment in extension|0|||
156479148|NCT01137682|564848371|FG001|Overall Study|Did not receive treatment in extension|0|||
156479149|NCT01137682|564848372|FG002|Overall Study|Did not receive treatment in extension|1|||
156479150|NCT00042939|564848377|FG000|Overall Study|Adverse Event|6|||
156479151|NCT00042939|564848378|FG001|Overall Study|Adverse Event|7|||
156479152|NCT00042939|564848377|FG000|Overall Study|Death|3|||
156479153|NCT00042939|564848378|FG001|Overall Study|Death|2|||
156344964|NCT03129100|564362387|FG001|Period2 Extension Period (Group A and B)|Death|0|||
156344965|NCT03129100|564362388|FG002|Period2 Extension Period (Group A and B)|Death|1|||
156479154|NCT00042939|564848377|FG000|Overall Study|Withdrawal by Subject|3|||
156479155|NCT00042939|564848378|FG001|Overall Study|Withdrawal by Subject|4|||
156344966|NCT03129100|564362389|FG003|Period2 Extension Period (Group A and B)|Death|0|||
156479156|NCT00042939|564848377|FG000|Overall Study|Other disease|1|||
156479157|NCT00042939|564848378|FG001|Overall Study|Other disease|0|||
156479158|NCT00042939|564848377|FG000|Overall Study|Ineligible|2|||
156479159|NCT00042939|564848378|FG001|Overall Study|Ineligible|2|||
156479160|NCT00042939|564848377|FG000|Overall Study|Deterioration of health|3|||
156479161|NCT00042939|564848378|FG001|Overall Study|Deterioration of health|4|||
156479162|NCT00042939|564848377|FG000|Overall Study|QOL diminished|1|||
156479163|NCT00042939|564848378|FG001|Overall Study|QOL diminished|0|||
156479164|NCT00042939|564848377|FG000|Overall Study|Rising ca 19-9|1|||
156479165|NCT00042939|564848378|FG001|Overall Study|Rising ca 19-9|0|||
156479166|NCT00042939|564848377|FG000|Overall Study|Patient non-compliance|1|||
156479167|NCT00042939|564848378|FG001|Overall Study|Patient non-compliance|0|||
156479168|NCT00042939|564848377|FG000|Overall Study|Still on treatment|1|||
156479169|NCT00042939|564848378|FG001|Overall Study|Still on treatment|0|||
156479170|NCT00042939|564848377|FG000|Overall Study|Treatment break > 4 weeks|0|||
156479171|NCT00042939|564848378|FG001|Overall Study|Treatment break > 4 weeks|1|||
156479172|NCT00042939|564848377|FG000|Overall Study|Did not start treatment|2|||
156479173|NCT00042939|564848378|FG001|Overall Study|Did not start treatment|1|||
156479174|NCT00795639|564848379|FG000|Overall Study|Death|1|||
156479175|NCT00795639|564848380|FG001|Overall Study|Death|6|||
156479176|NCT00795639|564848379|FG000|Overall Study|Withdrawal by Subject|1|||
156479177|NCT00795639|564848380|FG001|Overall Study|Withdrawal by Subject|3|||
156479178|NCT00795639|564848379|FG000|Overall Study|Pregnancy|1|||
156479179|NCT00795639|564848380|FG001|Overall Study|Pregnancy|0|||
156479180|NCT00795639|564848379|FG000|Overall Study|Adverse Event|5|||
156479181|NCT00795639|564848380|FG001|Overall Study|Adverse Event|2|||
156479182|NCT00795639|564848379|FG000|Overall Study|Other|0|||
156479183|NCT00795639|564848380|FG001|Overall Study|Other|2|||
156479184|NCT00795639|564848379|FG000|Overall Study|Terminated by sponsor|13|||
156479185|NCT00795639|564848380|FG001|Overall Study|Terminated by sponsor|12|||
156479186|NCT00795639|564848379|FG000|Overall Study|Randomized and not treated|0|||
156479187|NCT00795639|564848380|FG001|Overall Study|Randomized and not treated|1|||
156479188|NCT03349476|564848381|FG000|Overall Study|Physician Decision|3|||
156479189|NCT03449979|564848382|FG000|Overall Study|Technical difficulty|0|||
156479190|NCT03449979|564848383|FG001|Overall Study|Technical difficulty|0|||
156479191|NCT03449979|564848384|FG002|Overall Study|Technical difficulty|0|||
156479192|NCT03449979|564848385|FG003|Overall Study|Technical difficulty|1|||
156479193|NCT01762345|564848386|FG000|Overall Study|Adverse Event|5|||
156479194|NCT01762345|564848386|FG000|Overall Study|Protocol Violation|2|||
156479195|NCT02379078|564848387|FG000|Overall Study|Lost to Follow-up|33|||
156479196|NCT02379078|564848388|FG001|Overall Study|Lost to Follow-up|30|||
156479197|NCT02379078|564848387|FG000|Overall Study|Withdrawal by Subject|6|||
156479198|NCT02379078|564848388|FG001|Overall Study|Withdrawal by Subject|5|||
156479199|NCT02206607|564848391|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
156479200|NCT02206607|564848392|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
156479201|NCT02206607|564848393|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
156479202|NCT02206607|564848394|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
156479203|NCT02206607|564848395|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
156479204|NCT02206607|564848391|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
156479205|NCT02206607|564848392|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
156479206|NCT02206607|564848393|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
156479207|NCT02206607|564848394|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
156479208|NCT02206607|564848395|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
156479209|NCT00761267|564848396|FG000|Overall Study|Death|1|||
156479210|NCT00761267|564848397|FG001|Overall Study|Death|2|||
156479211|NCT00761267|564848398|FG002|Overall Study|Death|5|||
156479212|NCT00761267|564848396|FG000|Overall Study|Lost to Follow-up|0|||
156479213|NCT00761267|564848397|FG001|Overall Study|Lost to Follow-up|0|||
156479214|NCT00761267|564848398|FG002|Overall Study|Lost to Follow-up|1|||
156479215|NCT00761267|564848396|FG000|Overall Study|Randomized but not treated|1|||
156479216|NCT00761267|564848397|FG001|Overall Study|Randomized but not treated|1|||
156479217|NCT00761267|564848398|FG002|Overall Study|Randomized but not treated|0|||
156479218|NCT00761267|564848396|FG000|Overall Study|Withdrawal by Subject|0|||
156479219|NCT00761267|564848397|FG001|Overall Study|Withdrawal by Subject|1|||
156479220|NCT00761267|564848398|FG002|Overall Study|Withdrawal by Subject|0|||
156479221|NCT01777932|564848403|FG000|Overall Study|Disease progression|136|||
156479222|NCT01777932|564848403|FG000|Overall Study|Death|3|||
156479223|NCT01777932|564848403|FG000|Overall Study|Adverse Event|34|||
156479224|NCT01777932|564848403|FG000|Overall Study|Lost to Follow-up|3|||
156479225|NCT01777932|564848403|FG000|Overall Study|Investigator decision|10|||
156479226|NCT01777932|564848403|FG000|Overall Study|Reimbursement limit|9|||
156479227|NCT01777932|564848403|FG000|Overall Study|Patient refused further treatment|10|||
156479228|NCT00068107|564848409|FG000|Overall Study|end-stage renal disease|6|||
156479229|NCT00068107|564848409|FG000|Overall Study|Death|2|||
156479230|NCT00068107|564848409|FG000|Overall Study|Withdrawal by Subject|1|||
156479231|NCT01419184|564848410|FG000|Overall Study|Site data not available|3|||
156479232|NCT01419184|564848411|FG001|Overall Study|Site data not available|2|||
156479233|NCT01419184|564848410|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
156479234|NCT01419184|564848411|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
156479235|NCT01419184|564848410|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
156543579|NCT02121262|565084650|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
156479236|NCT01419184|564848411|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
156479237|NCT01419184|564848410|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
156479238|NCT01419184|564848411|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
156479239|NCT01419184|564848410|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
156479240|NCT01419184|564848411|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
156479241|NCT01419184|564848410|FG000|Overall Study|Participant randomized, not treated|1|||
156479242|NCT01419184|564848411|FG001|Overall Study|Participant randomized, not treated|0|||
156479243|NCT03989232|564848418|FG000|Overall Study|Lost to Follow-up|3|||
156479244|NCT03989232|564848419|FG001|Overall Study|Lost to Follow-up|10|||
156479245|NCT03989232|564848418|FG000|Overall Study|Withdrawal by Subject|6|||
156479246|NCT03989232|564848419|FG001|Overall Study|Withdrawal by Subject|6|||
156479247|NCT03989232|564848418|FG000|Overall Study|Death|1|||
156479248|NCT03989232|564848419|FG001|Overall Study|Death|2|||
156479249|NCT02644122|564848423|FG000|Overall Study|Withdrawal by Subject|1|||
156479250|NCT01930188|564848424|FG000|Overall Study|unclassified|4|||
156543580|NCT02121262|565084651|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
156543581|NCT02121262|565084650|FG000|Overall Study|Consent Withdrawn|1|||
156479251|NCT01930188|564848425|FG001|Overall Study|unclassified|5|||
156479252|NCT01930188|564848426|FG002|Overall Study|unclassified|3|||
156344967|NCT03129100|564362390|FG004|Period2 Extension Period (Group A and B)|Death|0|||
156344968|NCT03129100|564362391|FG005|Period2 Extension Period (Group A and B)|Death|0|||
156344969|NCT03129100|564362392|FG006|Period2 Extension Period (Group A and B)|Death|0|||
156344970|NCT03129100|564362393|FG007|Period2 Extension Period (Group A and B)|Death|0|||
156344971|NCT03129100|564362394|FG008|Period2 Extension Period (Group A and B)|Death|0|||
156344972|NCT03129100|564362395|FG009|Period2 Extension Period (Group A and B)|Death|0|||
156344973|NCT03129100|564362396|FG010|Period2 Extension Period (Group A and B)|Death|0|||
156479253|NCT01930188|564848424|FG000|Overall Study|Missing follow-up information|2|||
156479254|NCT01930188|564848425|FG001|Overall Study|Missing follow-up information|2|||
156479255|NCT01930188|564848426|FG002|Overall Study|Missing follow-up information|3|||
156479256|NCT01930188|564848424|FG000|Overall Study|Lost to Follow-up|5|||
156479257|NCT01930188|564848425|FG001|Overall Study|Lost to Follow-up|2|||
156479258|NCT01930188|564848426|FG002|Overall Study|Lost to Follow-up|2|||
156479259|NCT01930188|564848424|FG000|Overall Study|Death|2|||
156479260|NCT01930188|564848425|FG001|Overall Study|Death|1|||
156479261|NCT01930188|564848426|FG002|Overall Study|Death|3|||
156479262|NCT01930188|564848424|FG000|Overall Study|Withdrawal by Subject|9|||
156479263|NCT01930188|564848425|FG001|Overall Study|Withdrawal by Subject|11|||
156479264|NCT01930188|564848426|FG002|Overall Study|Withdrawal by Subject|8|||
156479265|NCT02514824|564848427|FG000|Overall Study|Withdrawal by Subject|1|||
156479266|NCT02514824|564848428|FG001|Overall Study|Withdrawal by Subject|0|||
156479267|NCT02514824|564848429|FG002|Overall Study|Withdrawal by Subject|0|||
156479268|NCT02514824|564848430|FG003|Overall Study|Withdrawal by Subject|0|||
156479269|NCT02514824|564848427|FG000|Overall Study|Dose-Limiting Toxicity|0|||
156479270|NCT02514824|564848428|FG001|Overall Study|Dose-Limiting Toxicity|1|||
156479271|NCT02514824|564848429|FG002|Overall Study|Dose-Limiting Toxicity|0|||
156479272|NCT02514824|564848430|FG003|Overall Study|Dose-Limiting Toxicity|0|||
156479273|NCT02170207|564848433|FG000|Overall Study|Case report forms unavailable|5|||
156479274|NCT02399449|564848436|FG000|Overall Study|Withdrawal by Subject|3|||
156344974|NCT03129100|564362397|FG011|Period2 Extension Period (Group A and B)|Death|0|||
156344975|NCT03129100|564362398|FG012|Period2 Extension Period (Group A and B)|Death|0|||
156344976|NCT03129100|564362399|FG013|Period2 Extension Period (Group A and B)|Death|0|||
156344977|NCT03129100|564362400|FG014|Period2 Extension Period (Group A and B)|Death|0|||
156344978|NCT03129100|564362401|FG015|Period2 Extension Period (Group A and B)|Death|0|||
156344979|NCT03129100|564362402|FG016|Period2 Extension Period (Group A and B)|Death|0|||
156344980|NCT03129100|564362403|FG017|Period2 Extension Period (Group A and B)|Death|0|||
156344981|NCT03129100|564362404|FG018|Period2 Extension Period (Group A and B)|Death|0|||
156344982|NCT03129100|564362405|FG019|Period2 Extension Period (Group A and B)|Death|0|||
156344983|NCT03129100|564362406|FG020|Period2 Extension Period (Group A and B)|Death|0|||
156344984|NCT03129100|564362407|FG021|Period2 Extension Period (Group A and B)|Death|0|||
156344985|NCT03129100|564362408|FG022|Period2 Extension Period (Group A and B)|Death|0|||
156344986|NCT03129100|564362409|FG023|Period2 Extension Period (Group A and B)|Death|0|||
156344987|NCT03129100|564362410|FG024|Period2 Extension Period (Group A and B)|Death|0|||
156344988|NCT03129100|564362411|FG025|Period2 Extension Period (Group A and B)|Death|0|||
156344989|NCT03129100|564362386|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156344990|NCT03129100|564362387|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156344991|NCT03129100|564362388|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
156344992|NCT03129100|564362389|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
156344993|NCT03129100|564362390|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
156344994|NCT03129100|564362391|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
156344995|NCT03129100|564362392|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
156344996|NCT03129100|564362393|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156344997|NCT03129100|564362394|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156344998|NCT03129100|564362395|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156344999|NCT03129100|564362396|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345000|NCT03129100|564362397|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345001|NCT03129100|564362398|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345002|NCT03129100|564362399|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345003|NCT03129100|564362400|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345004|NCT03129100|564362401|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345005|NCT03129100|564362402|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345006|NCT03129100|564362403|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345007|NCT03129100|564362404|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345008|NCT03129100|564362405|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345009|NCT03129100|564362406|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345010|NCT03129100|564362407|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345011|NCT03129100|564362408|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345012|NCT03129100|564362409|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345013|NCT03129100|564362410|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156345014|NCT03129100|564362411|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156543582|NCT02121262|565084651|FG001|Overall Study|Consent Withdrawn|0|||
156543583|NCT05289570|565084655|FG000|Overall Study|Physician Decision|1|||
156543584|NCT01617070|565084656|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
156543585|NCT00777101|565084662|FG000|Overall Study|Death|48|||
156543586|NCT00777101|565084663|FG001|Overall Study|Death|43|||
156543587|NCT00777101|565084662|FG000|Overall Study|Withdrawal by Subject|11|||
156543588|NCT00777101|565084663|FG001|Overall Study|Withdrawal by Subject|6|||
156543589|NCT00777101|565084662|FG000|Overall Study|Lost to Follow-up|2|||
156543590|NCT00777101|565084663|FG001|Overall Study|Lost to Follow-up|1|||
156543591|NCT00777101|565084662|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
156543592|NCT00777101|565084663|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
156479275|NCT02399449|564848437|FG001|Overall Study|Withdrawal by Subject|9|||
156479276|NCT02399449|564848436|FG000|Overall Study|Physician Decision|0|||
156479277|NCT02399449|564848437|FG001|Overall Study|Physician Decision|1|||
156543593|NCT00777101|565084662|FG000|Overall Study|Failed to Return|0|||
156543594|NCT00777101|565084663|FG001|Overall Study|Failed to Return|1|||
156479278|NCT01020435|564848438|FG000|Overall Study|Lost to Follow-up|0|||
156479279|NCT01020435|564848439|FG001|Overall Study|Lost to Follow-up|1|||
156479280|NCT00337610|564848440|FG000|Overall Study|Adverse Event|2|||
156479281|NCT00337610|564848441|FG001|Overall Study|Adverse Event|2|||
156479282|NCT00337610|564848440|FG000|Overall Study|Death|0|||
156479283|NCT00337610|564848441|FG001|Overall Study|Death|1|||
156479284|NCT00337610|564848440|FG000|Overall Study|Lack of Efficacy|6|||
156479285|NCT00337610|564848441|FG001|Overall Study|Lack of Efficacy|3|||
156479286|NCT00337610|564848440|FG000|Overall Study|Lost to Follow-up|3|||
156479287|NCT00337610|564848441|FG001|Overall Study|Lost to Follow-up|3|||
156479288|NCT00337610|564848440|FG000|Overall Study|Withdrawal by Subject|6|||
156345015|NCT03129100|564362386|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345016|NCT03129100|564362387|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345017|NCT03129100|564362388|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
156345018|NCT03129100|564362389|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345019|NCT03129100|564362390|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345020|NCT03129100|564362391|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345021|NCT03129100|564362392|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345022|NCT03129100|564362393|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345023|NCT03129100|564362394|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156479289|NCT00337610|564848441|FG001|Overall Study|Withdrawal by Subject|5|||
156345024|NCT03129100|564362395|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156479290|NCT00346398|564848442|FG000|Overall Study|Lost to Follow-up|3|||
156479291|NCT00346398|564848443|FG001|Overall Study|Lost to Follow-up|0|||
156543595|NCT05376215|565084664|FG000|Overall Study|Withdrawal by Subject|2|||
156543596|NCT05376215|565084665|FG001|Overall Study|Withdrawal by Subject|1|||
156543597|NCT05376215|565084664|FG000|Overall Study|Lost to Follow-up|0|||
156543598|NCT05376215|565084665|FG001|Overall Study|Lost to Follow-up|1|||
156543599|NCT00282334|565084666|FG000|Overall Study|Withdrawal by Subject|8|||
156543600|NCT00282334|565084667|FG001|Overall Study|Withdrawal by Subject|5|||
156543601|NCT01066585|565084672|FG000|Overall Study|Protocol Violation|1|||
156543602|NCT01066585|565084673|FG001|Overall Study|Protocol Violation|0|||
156543603|NCT01066585|565084672|FG000|Overall Study|Withdrawal by Subject|0|||
156543604|NCT01066585|565084673|FG001|Overall Study|Withdrawal by Subject|3|||
156543605|NCT00964743|565084675|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
156543606|NCT03317795|565084678|FG000|Overall Study|IUD Expulsion|1|||
156543607|NCT03317795|565084679|FG001|Overall Study|IUD Expulsion|0|||
156543608|NCT03317795|565084678|FG000|Overall Study|Lost to Follow-up|1|||
156543609|NCT03317795|565084679|FG001|Overall Study|Lost to Follow-up|3|||
156543610|NCT03317795|565084678|FG000|Overall Study|Treatment change|0|||
156543611|NCT03317795|565084679|FG001|Overall Study|Treatment change|3|||
156479292|NCT00346398|564848442|FG000|Overall Study|Withdrawal by Subject|0|||
156479293|NCT00346398|564848443|FG001|Overall Study|Withdrawal by Subject|2|||
156479294|NCT03979040|564848444|FG000|Overall Study|Withdrawal by Subject|24|||
156479295|NCT03979040|564848445|FG001|Overall Study|Withdrawal by Subject|32|||
156543612|NCT03317795|565084678|FG000|Overall Study|Intolerance of medication|0|||
156543613|NCT03317795|565084679|FG001|Overall Study|Intolerance of medication|1|||
156543614|NCT00886600|565084680|FG000|Double-blind Monotherapy|Adverse Event|1|||
156543615|NCT00886600|565084681|FG001|Double-blind Monotherapy|Adverse Event|1|||
156543616|NCT00886600|565084682|FG002|Double-blind Monotherapy|Adverse Event|1|||
156543617|NCT00886600|565084683|FG003|Double-blind Monotherapy|Adverse Event|1|||
156345025|NCT03129100|564362396|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345026|NCT03129100|564362397|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345027|NCT03129100|564362398|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345028|NCT03129100|564362399|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345029|NCT03129100|564362400|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345030|NCT03129100|564362401|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345031|NCT03129100|564362402|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345032|NCT03129100|564362403|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345033|NCT03129100|564362404|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345034|NCT03129100|564362405|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345035|NCT03129100|564362406|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345036|NCT03129100|564362407|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345037|NCT03129100|564362408|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345038|NCT03129100|564362409|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345039|NCT03129100|564362410|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345040|NCT03129100|564362411|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156345041|NCT03129100|564362386|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345042|NCT03129100|564362387|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345043|NCT03129100|564362388|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
156345044|NCT03129100|564362389|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345045|NCT03129100|564362390|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345046|NCT03129100|564362391|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345047|NCT03129100|564362392|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345048|NCT03129100|564362393|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345049|NCT03129100|564362394|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345050|NCT03129100|564362395|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345051|NCT03129100|564362396|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156479296|NCT03979040|564848444|FG000|Overall Study|randomized but never started treatment|32|||
156479297|NCT03979040|564848445|FG001|Overall Study|randomized but never started treatment|39|||
156479298|NCT03979040|564848444|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
156479299|NCT03979040|564848445|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
156479300|NCT02607956|564848446|FG000|Double-Blinded Phase|Withdrew Consent|17|||
156479301|NCT02607956|564848447|FG001|Double-Blinded Phase|Withdrew Consent|19|||
156479302|NCT02607956|564848448|FG002|Double-Blinded Phase|Withdrew Consent|0|||
156479303|NCT02607956|564848449|FG003|Double-Blinded Phase|Withdrew Consent|0|||
156479304|NCT02607956|564848446|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
156479305|NCT02607956|564848447|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
156479306|NCT02607956|564848448|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
156543618|NCT00886600|565084680|FG000|Double-blind Monotherapy|Protocol Violation|0|||
156543619|NCT00886600|565084681|FG001|Double-blind Monotherapy|Protocol Violation|0|||
156345052|NCT03129100|564362397|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345053|NCT03129100|564362398|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345054|NCT03129100|564362399|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345055|NCT03129100|564362400|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345056|NCT03129100|564362401|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345057|NCT03129100|564362402|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345058|NCT03129100|564362403|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345059|NCT03129100|564362404|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345060|NCT03129100|564362405|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345061|NCT03129100|564362406|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345062|NCT03129100|564362407|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345063|NCT03129100|564362408|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345064|NCT03129100|564362409|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345065|NCT03129100|564362410|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345066|NCT03129100|564362411|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156345067|NCT03129100|564362386|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345068|NCT03129100|564362387|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345069|NCT03129100|564362388|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
156345070|NCT03129100|564362389|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345071|NCT03129100|564362390|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345072|NCT03129100|564362391|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345073|NCT03129100|564362392|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345074|NCT03129100|564362393|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345075|NCT03129100|564362394|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345076|NCT03129100|564362395|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345077|NCT03129100|564362396|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345078|NCT03129100|564362397|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345079|NCT03129100|564362398|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345080|NCT03129100|564362399|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345081|NCT03129100|564362400|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345082|NCT03129100|564362401|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345083|NCT03129100|564362402|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345084|NCT03129100|564362403|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345085|NCT03129100|564362404|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345086|NCT03129100|564362405|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345087|NCT03129100|564362406|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345088|NCT03129100|564362407|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345089|NCT03129100|564362408|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345090|NCT03129100|564362409|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345091|NCT03129100|564362410|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345092|NCT03129100|564362411|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156345093|NCT03129100|564362386|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345094|NCT03129100|564362387|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345095|NCT03129100|564362388|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345096|NCT03129100|564362389|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345097|NCT03129100|564362390|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
156345098|NCT03129100|564362391|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
156345099|NCT03129100|564362392|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
156345100|NCT03129100|564362393|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345101|NCT03129100|564362394|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345102|NCT03129100|564362395|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345103|NCT03129100|564362396|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345104|NCT03129100|564362397|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345105|NCT03129100|564362398|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345106|NCT03129100|564362399|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345107|NCT03129100|564362400|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345108|NCT03129100|564362401|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345109|NCT03129100|564362402|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345110|NCT03129100|564362403|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345111|NCT03129100|564362404|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345112|NCT03129100|564362405|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345113|NCT03129100|564362406|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345114|NCT03129100|564362407|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345115|NCT03129100|564362408|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345116|NCT03129100|564362409|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345117|NCT03129100|564362410|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345118|NCT03129100|564362411|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156345119|NCT03129100|564362386|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345120|NCT03129100|564362387|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345121|NCT03129100|564362388|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345122|NCT03129100|564362389|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345123|NCT03129100|564362390|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345124|NCT03129100|564362391|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345125|NCT03129100|564362392|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345126|NCT03129100|564362393|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345127|NCT03129100|564362394|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345128|NCT03129100|564362395|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
156345129|NCT03129100|564362396|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345130|NCT03129100|564362397|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345131|NCT03129100|564362398|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345132|NCT03129100|564362399|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345133|NCT03129100|564362400|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345134|NCT03129100|564362401|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345135|NCT03129100|564362402|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345136|NCT03129100|564362403|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345137|NCT03129100|564362404|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345138|NCT03129100|564362405|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345139|NCT03129100|564362406|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345140|NCT03129100|564362407|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345141|NCT03129100|564362408|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345142|NCT03129100|564362409|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345143|NCT03129100|564362410|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345144|NCT03129100|564362411|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156345145|NCT03129100|564362386|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345146|NCT03129100|564362387|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345147|NCT03129100|564362388|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345148|NCT03129100|564362389|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345149|NCT03129100|564362390|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345150|NCT03129100|564362391|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345151|NCT03129100|564362392|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345152|NCT03129100|564362393|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345153|NCT03129100|564362394|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345154|NCT03129100|564362395|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345155|NCT03129100|564362396|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345156|NCT03129100|564362397|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
156345157|NCT03129100|564362398|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345158|NCT03129100|564362399|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345159|NCT03129100|564362400|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345160|NCT03129100|564362401|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345161|NCT03129100|564362402|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345162|NCT03129100|564362403|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345163|NCT03129100|564362404|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345164|NCT03129100|564362405|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345165|NCT03129100|564362406|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345166|NCT03129100|564362407|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156479307|NCT02607956|564848449|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
156479308|NCT02607956|564848446|FG000|Double-Blinded Phase|Randomized but never treated|7|||
156479309|NCT02607956|564848447|FG001|Double-Blinded Phase|Randomized but never treated|5|||
156479310|NCT02607956|564848448|FG002|Double-Blinded Phase|Randomized but never treated|0|||
156479311|NCT02607956|564848449|FG003|Double-Blinded Phase|Randomized but never treated|0|||
156479312|NCT02607956|564848446|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
156479313|NCT02607956|564848447|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
156479314|NCT02607956|564848448|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
156543620|NCT00886600|565084682|FG002|Double-blind Monotherapy|Protocol Violation|0|||
156543621|NCT00886600|565084683|FG003|Double-blind Monotherapy|Protocol Violation|1|||
156543622|NCT00886600|565084680|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
156543623|NCT00886600|565084681|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
156543624|NCT00886600|565084682|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
156543625|NCT00886600|565084683|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
156543626|NCT00886600|565084680|FG000|Combination Therapy Period|Adverse Event|0|||
156543627|NCT00886600|565084681|FG001|Combination Therapy Period|Adverse Event|0|||
156543628|NCT00886600|565084682|FG002|Combination Therapy Period|Adverse Event|1|||
156543629|NCT00886600|565084683|FG003|Combination Therapy Period|Adverse Event|0|||
156543630|NCT00886600|565084680|FG000|Combination Therapy Period|Protocol Violation|0|||
156543631|NCT00886600|565084681|FG001|Combination Therapy Period|Protocol Violation|0|||
156543632|NCT00886600|565084682|FG002|Combination Therapy Period|Protocol Violation|1|||
156543633|NCT00886600|565084683|FG003|Combination Therapy Period|Protocol Violation|0|||
156543634|NCT00501007|565084684|FG000|Overall Study|Inclusion criteria not met.|29|||
156543635|NCT00501007|565084685|FG001|Overall Study|Inclusion criteria not met.|25|||
156543636|NCT03917823|565084687|FG000|Overall Study|Lost to Follow-up|1|||
156543637|NCT03917823|565084688|FG001|Overall Study|Lost to Follow-up|1|||
156543638|NCT03917823|565084687|FG000|Overall Study|Withdrawal by Subject|0|||
156543639|NCT03917823|565084688|FG001|Overall Study|Withdrawal by Subject|1|||
156543640|NCT02016820|565084689|FG000|Overall Study|Lost to Follow-up|2|||
156543641|NCT02016820|565084690|FG001|Overall Study|Lost to Follow-up|4|||
156543642|NCT02424253|565084693|FG000|Overall Study|Other, unspecified|1|||
156543643|NCT02424253|565084694|FG001|Overall Study|Other, unspecified|0|||
156345167|NCT03129100|564362408|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345168|NCT03129100|564362409|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345169|NCT03129100|564362410|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345170|NCT03129100|564362411|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156345171|NCT03129100|564362386|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345172|NCT03129100|564362387|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156543644|NCT02424253|565084693|FG000|Overall Study|Compliance problems|1|||
156543645|NCT02424253|565084694|FG001|Overall Study|Compliance problems|0|||
156543646|NCT02424253|565084693|FG000|Overall Study|Physician Decision|2|||
156543647|NCT02424253|565084694|FG001|Overall Study|Physician Decision|0|||
156543648|NCT02424253|565084693|FG000|Overall Study|Lack of Efficacy|0|||
156543649|NCT02424253|565084694|FG001|Overall Study|Lack of Efficacy|7|||
156543650|NCT02424253|565084693|FG000|Overall Study|Adverse Event|2|||
156543651|NCT02424253|565084694|FG001|Overall Study|Adverse Event|0|||
156543652|NCT02424253|565084693|FG000|Overall Study|Consent withdrawn by subject|4|||
156543653|NCT02424253|565084694|FG001|Overall Study|Consent withdrawn by subject|1|||
156543654|NCT02424253|565084693|FG000|Overall Study|Lost to Follow-up|1|||
156543655|NCT02424253|565084694|FG001|Overall Study|Lost to Follow-up|1|||
156543656|NCT00884273|565084695|FG000|Overall Study|Adverse Event|0|||
156543657|NCT00884273|565084696|FG001|Overall Study|Adverse Event|2|||
156543658|NCT00884273|565084695|FG000|Overall Study|Protocol Violation|1|||
156543659|NCT00884273|565084696|FG001|Overall Study|Protocol Violation|3|||
156543660|NCT00884273|565084695|FG000|Overall Study|Practical reasons|1|||
156543661|NCT00884273|565084696|FG001|Overall Study|Practical reasons|0|||
156543662|NCT00473343|565084697|FG000|Overall Study|Adverse Event|9|||
156543663|NCT00473343|565084697|FG000|Overall Study|Lost to Follow-up|8|||
156543664|NCT00473343|565084697|FG000|Overall Study|Treatment failure|27|||
156543665|NCT00473343|565084697|FG000|Overall Study|Withdrew consent|3|||
156543666|NCT00473343|565084697|FG000|Overall Study|Other un-specified reason|3|||
156479315|NCT02607956|564848449|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
156479316|NCT02607956|564848446|FG000|Double-Blinded Phase|Death|4|||
156479317|NCT02607956|564848447|FG001|Double-Blinded Phase|Death|4|||
156479318|NCT02607956|564848448|FG002|Double-Blinded Phase|Death|0|||
156479319|NCT02607956|564848449|FG003|Double-Blinded Phase|Death|0|||
156479320|NCT02607956|564848446|FG000|Double-Blinded Phase|Adverse Event|4|||
156479321|NCT02607956|564848447|FG001|Double-Blinded Phase|Adverse Event|3|||
156479322|NCT02607956|564848448|FG002|Double-Blinded Phase|Adverse Event|0|||
156479323|NCT02607956|564848449|FG003|Double-Blinded Phase|Adverse Event|0|||
156479324|NCT02607956|564848446|FG000|Double-Blinded Phase|Protocol Violation|3|||
156479325|NCT02607956|564848447|FG001|Double-Blinded Phase|Protocol Violation|1|||
156479326|NCT02607956|564848448|FG002|Double-Blinded Phase|Protocol Violation|0|||
156479327|NCT02607956|564848449|FG003|Double-Blinded Phase|Protocol Violation|0|||
156479328|NCT02607956|564848446|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
156479329|NCT02607956|564848447|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
156479330|NCT02607956|564848448|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
156479331|NCT02607956|564848449|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
156479332|NCT02607956|564848446|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
156479333|NCT02607956|564848447|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
156479334|NCT02607956|564848448|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
156479335|NCT02607956|564848449|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
156479336|NCT02607956|564848446|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
156479337|NCT02607956|564848447|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
156479338|NCT02607956|564848448|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
156479339|NCT02607956|564848449|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
156479340|NCT02607956|564848446|FG000|Open-Label Extension Phase|Death|0|||
156479341|NCT02607956|564848447|FG001|Open-Label Extension Phase|Death|0|||
156479342|NCT02607956|564848448|FG002|Open-Label Extension Phase|Death|1|||
156479343|NCT02607956|564848449|FG003|Open-Label Extension Phase|Death|3|||
156479344|NCT02607956|564848446|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
156479345|NCT02607956|564848447|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
156479346|NCT02607956|564848448|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
156543667|NCT02290873|565084698|FG000|Overall Study|Withdrawal by Subject|0|||
156543668|NCT02290873|565084699|FG001|Overall Study|Withdrawal by Subject|1|||
156543669|NCT02290873|565084700|FG002|Overall Study|Withdrawal by Subject|1|||
156479347|NCT02607956|564848449|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
156479348|NCT02607956|564848446|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
156479349|NCT02607956|564848447|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
156479350|NCT02607956|564848448|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
156543670|NCT02290873|565084698|FG000|Overall Study|Nellcor device error|1|||
156543671|NCT02290873|565084699|FG001|Overall Study|Nellcor device error|0|||
156543672|NCT02290873|565084700|FG002|Overall Study|Nellcor device error|0|||
156543673|NCT02290873|565084698|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
156543674|NCT02290873|565084699|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
156543675|NCT02290873|565084700|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
156543676|NCT02290873|565084698|FG000|Overall Study|Protocol Violation|0|||
156543677|NCT02290873|565084699|FG001|Overall Study|Protocol Violation|0|||
156543678|NCT02290873|565084700|FG002|Overall Study|Protocol Violation|1|||
156543679|NCT03715153|565084701|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
156479351|NCT02607956|564848449|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
156479352|NCT02607956|564848446|FG000|Open-Label Extension Phase|Protocol Violation|0|||
156479353|NCT02607956|564848447|FG001|Open-Label Extension Phase|Protocol Violation|0|||
156479354|NCT02607956|564848448|FG002|Open-Label Extension Phase|Protocol Violation|0|||
156345173|NCT03129100|564362388|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345174|NCT03129100|564362389|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345175|NCT03129100|564362390|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345176|NCT03129100|564362391|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345177|NCT03129100|564362392|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345178|NCT03129100|564362393|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345179|NCT03129100|564362394|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345180|NCT03129100|564362395|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345181|NCT03129100|564362396|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345182|NCT03129100|564362397|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
156345183|NCT03129100|564362398|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
156479355|NCT02607956|564848449|FG003|Open-Label Extension Phase|Protocol Violation|2|||
156479356|NCT02607956|564848446|FG000|Open-Label Extension Phase|Pregnancy|0|||
156479357|NCT02607956|564848447|FG001|Open-Label Extension Phase|Pregnancy|0|||
156479358|NCT02607956|564848448|FG002|Open-Label Extension Phase|Pregnancy|0|||
156479359|NCT02607956|564848449|FG003|Open-Label Extension Phase|Pregnancy|1|||
156479360|NCT02326220|564848463|FG000|Double-blind Treatment Period|Adverse Event|1|||
156479361|NCT02326220|564848464|FG001|Double-blind Treatment Period|Adverse Event|2|||
156479362|NCT02326220|564848465|FG002|Double-blind Treatment Period|Adverse Event|0|||
156479363|NCT02326220|564848463|FG000|Double-blind Treatment Period|Protocol Violation|0|||
156479364|NCT02326220|564848464|FG001|Double-blind Treatment Period|Protocol Violation|1|||
156479365|NCT02326220|564848465|FG002|Double-blind Treatment Period|Protocol Violation|0|||
156479366|NCT02326220|564848463|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
156479367|NCT02326220|564848464|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
156479368|NCT02326220|564848465|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156479369|NCT02326220|564848463|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
156479370|NCT02326220|564848464|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156479371|NCT02326220|564848465|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
156479372|NCT02326220|564848463|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
156479373|NCT02326220|564848464|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
156479374|NCT02326220|564848465|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
156479375|NCT00824850|564848466|FG000|Overall Study|Withdrawal by Subject|0|||
156479376|NCT00824850|564848467|FG001|Overall Study|Withdrawal by Subject|1|||
156479377|NCT01075152|564848469|FG000|Overall Study|Withdrawal by Subject|1|||
156479378|NCT01075152|564848470|FG001|Overall Study|Withdrawal by Subject|0|||
156479379|NCT04820491|564848471|FG000|Overall Study|Withdrawal by Subject|1|||
156479380|NCT04820491|564848472|FG001|Overall Study|Withdrawal by Subject|0|||
156479381|NCT01079949|564848475|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
156479382|NCT01079949|564848476|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
156479383|NCT01079949|564848475|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
156479384|NCT01079949|564848476|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
156479385|NCT01079949|564848475|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
156479386|NCT01079949|564848476|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
156479387|NCT01079949|564848475|FG000|Overall Study|Randomized but not treated|1|||
156479388|NCT01079949|564848476|FG001|Overall Study|Randomized but not treated|0|||
156479389|NCT01529632|564848477|FG000|Overall Study|Administrative problem|2|||
156479390|NCT01529632|564848478|FG001|Overall Study|Administrative problem|1|||
156479391|NCT01529632|564848477|FG000|Overall Study|Protocol Violation|0|||
156479392|NCT01529632|564848478|FG001|Overall Study|Protocol Violation|1|||
156479393|NCT01529632|564848477|FG000|Overall Study|Adverse Event|1|||
156479394|NCT01529632|564848478|FG001|Overall Study|Adverse Event|1|||
156479395|NCT03659136|564848484|FG000|Overall Study|Not treated|2|||
156479396|NCT03659136|564848485|FG001|Overall Study|Not treated|0|||
156479397|NCT03659136|564848484|FG000|Overall Study|Covid-19 related|1|||
156479398|NCT03659136|564848485|FG001|Overall Study|Covid-19 related|1|||
156479399|NCT03659136|564848484|FG000|Overall Study|Withdrawal by Subject|1|||
156479400|NCT03659136|564848485|FG001|Overall Study|Withdrawal by Subject|6|||
156479401|NCT03659136|564848484|FG000|Overall Study|Adverse Event|4|||
156479402|NCT03659136|564848485|FG001|Overall Study|Adverse Event|6|||
156479403|NCT03659136|564848484|FG000|Overall Study|Progressive disease|37|||
156479404|NCT03659136|564848485|FG001|Overall Study|Progressive disease|31|||
156479405|NCT03659136|564848484|FG000|Overall Study|Study closure|2|||
156479406|NCT03659136|564848485|FG001|Overall Study|Study closure|2|||
156479407|NCT03659136|564848484|FG000|Overall Study|Sponsor decision/recommendation|3|||
156479408|NCT03659136|564848485|FG001|Overall Study|Sponsor decision/recommendation|2|||
156479409|NCT03659136|564848484|FG000|Overall Study|Switched to other drug/therapy|2|||
156479410|NCT03659136|564848485|FG001|Overall Study|Switched to other drug/therapy|2|||
156479411|NCT03659136|564848484|FG000|Overall Study|Lack of clinical benefit|0|||
156479412|NCT03659136|564848485|FG001|Overall Study|Lack of clinical benefit|1|||
156479413|NCT04914897|564850579|FG000|Overall Study|Withdrawal by Subject|3|||
156479414|NCT04914897|564850580|FG001|Overall Study|Withdrawal by Subject|1|||
156479415|NCT04914897|564850581|FG002|Overall Study|Withdrawal by Subject|1|||
156479416|NCT04914897|564850582|FG003|Overall Study|Withdrawal by Subject|1|||
156479417|NCT04914897|564850579|FG000|Overall Study|Poor compliance to protocol|0|||
156479418|NCT04914897|564850580|FG001|Overall Study|Poor compliance to protocol|0|||
156479419|NCT04914897|564850581|FG002|Overall Study|Poor compliance to protocol|1|||
156479420|NCT04914897|564850582|FG003|Overall Study|Poor compliance to protocol|0|||
156479421|NCT04914897|564850579|FG000|Overall Study|Progressive disease|5|||
156479422|NCT04914897|564850580|FG001|Overall Study|Progressive disease|14|||
156479423|NCT04914897|564850581|FG002|Overall Study|Progressive disease|30|||
156479424|NCT04914897|564850582|FG003|Overall Study|Progressive disease|21|||
156479425|NCT04914897|564850579|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
156479426|NCT04914897|564850580|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
156479427|NCT04914897|564850581|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
156479428|NCT04914897|564850582|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
156479429|NCT04914897|564850579|FG000|Overall Study|Other|1|||
156479430|NCT04914897|564850580|FG001|Overall Study|Other|0|||
156479431|NCT04914897|564850581|FG002|Overall Study|Other|0|||
156479432|NCT04914897|564850582|FG003|Overall Study|Other|1|||
156479433|NCT03020914|564850583|FG000|Overall Study|Surgery Cancelled|1|||
156479434|NCT03020914|564850584|FG001|Overall Study|Surgery Cancelled|0|||
156479435|NCT00451906|564850593|FG000|Overall Study|Adverse Event|515|||
156479436|NCT00451906|564850593|FG000|Overall Study|Lost to Follow-up|31|||
156479437|NCT00451906|564850593|FG000|Overall Study|Withdrawal by Subject|111|||
156479438|NCT00451906|564850593|FG000|Overall Study|Protocol Violation|21|||
156479439|NCT00451906|564850593|FG000|Overall Study|Progressive disease|1328|||
156479440|NCT00451906|564850593|FG000|Overall Study|Termination of the study|108|||
156479441|NCT00451906|564850593|FG000|Overall Study|Other Reasons|121|||
156479442|NCT00451906|564850593|FG000|Overall Study|Did not complete final visit|4|||
156479443|NCT05066230|564850595|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
156479444|NCT05066230|564850596|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
156479445|NCT05066230|564850595|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
156479446|NCT05066230|564850596|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
156479447|NCT05066230|564850595|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
156479448|NCT05066230|564850596|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
156479449|NCT05066230|564850595|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
156479450|NCT05066230|564850596|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
156479451|NCT05066230|564850595|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
156479452|NCT05066230|564850596|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
156479453|NCT05066230|564850595|FG000|After Week 48|Adverse Event|1|||
156479454|NCT05066230|564850596|FG001|After Week 48|Adverse Event|0|||
156479455|NCT05066230|564850595|FG000|After Week 48|Non-compliance with study schedule|1|||
156479456|NCT05066230|564850596|FG001|After Week 48|Non-compliance with study schedule|0|||
156479457|NCT05066230|564850595|FG000|After Week 48|Withdrawal by Subject|0|||
156479458|NCT05066230|564850596|FG001|After Week 48|Withdrawal by Subject|1|||
156479459|NCT05066230|564850595|FG000|After Week 48|Lost to Follow-up|3|||
156479460|NCT05066230|564850596|FG001|After Week 48|Lost to Follow-up|3|||
156479461|NCT05066230|564850595|FG000|After Week 48|Sponsor Request|115|||
156479462|NCT05066230|564850596|FG001|After Week 48|Sponsor Request|111|||
156479463|NCT03072238|564850597|FG000|Overall Study|Withdrawal by Subject|44|||
156479464|NCT03072238|564850598|FG001|Overall Study|Withdrawal by Subject|64|||
156479465|NCT03072238|564850597|FG000|Overall Study|Lost to Follow-up|14|||
156479466|NCT03072238|564850598|FG001|Overall Study|Lost to Follow-up|5|||
156479467|NCT03072238|564850597|FG000|Overall Study|Physician Decision|4|||
156479468|NCT03072238|564850598|FG001|Overall Study|Physician Decision|6|||
156479469|NCT03072238|564850597|FG000|Overall Study|Death|351|||
156479470|NCT03072238|564850598|FG001|Overall Study|Death|318|||
156479471|NCT03072238|564850597|FG000|Overall Study|Progressive Disease|3|||
156479472|NCT03072238|564850598|FG001|Overall Study|Progressive Disease|4|||
156479473|NCT03072238|564850597|FG000|Overall Study|Reason Not Specified|138|||
156479474|NCT03072238|564850598|FG001|Overall Study|Reason Not Specified|150|||
156479475|NCT02400749|564850599|FG000|Week 0 -16|Withdrawal by Subject|5|||
156479476|NCT02400749|564850600|FG001|Week 0 -16|Withdrawal by Subject|5|||
156479477|NCT02400749|564850599|FG000|Week 0 -16|Adverse Event|3|||
156479478|NCT02400749|564850600|FG001|Week 0 -16|Adverse Event|1|||
156479479|NCT02400749|564850599|FG000|Week 0 -16|Lost to Follow-up|2|||
156479480|NCT02400749|564850600|FG001|Week 0 -16|Lost to Follow-up|0|||
156479481|NCT02400749|564850599|FG000|Week 0 -16|Protocol Violation|1|||
156479482|NCT02400749|564850600|FG001|Week 0 -16|Protocol Violation|0|||
156479483|NCT02400749|564850599|FG000|Week 17 - 32|Withdrawal by Subject|3|||
156479484|NCT02400749|564850600|FG001|Week 17 - 32|Withdrawal by Subject|2|||
156479485|NCT02400749|564850599|FG000|Week 17 - 32|Adverse Event|2|||
156479486|NCT02400749|564850600|FG001|Week 17 - 32|Adverse Event|1|||
156479487|NCT00507429|564850601|FG000|Treatment Phase|Disease Progression|12|||
156479488|NCT00507429|564850602|FG001|Treatment Phase|Disease Progression|5|||
156479489|NCT00507429|564850601|FG000|Treatment Phase|Adverse Event|12|||
156479490|NCT00507429|564850602|FG001|Treatment Phase|Adverse Event|5|||
156479491|NCT00507429|564850601|FG000|Treatment Phase|Withdrawal by Subject|3|||
156479492|NCT00507429|564850602|FG001|Treatment Phase|Withdrawal by Subject|3|||
156479493|NCT00507429|564850601|FG000|Treatment Phase|Physician Decision|4|||
156479494|NCT00507429|564850602|FG001|Treatment Phase|Physician Decision|2|||
156479495|NCT00507429|564850601|FG000|Treatment Phase|Other|6|||
156479496|NCT00507429|564850602|FG001|Treatment Phase|Other|3|||
156479497|NCT00507429|564850601|FG000|Maintenance Phase|Progressive Disease|14|||
156479498|NCT00507429|564850602|FG001|Maintenance Phase|Progressive Disease|0|||
156479499|NCT02889900|564850603|FG000|Overall Study|Adverse Event|11|||
156479500|NCT02889900|564850603|FG000|Overall Study|Condition under investigation worsened|32|||
156479501|NCT02889900|564850603|FG000|Overall Study|Other|5|||
156479502|NCT02889900|564850603|FG000|Overall Study|Withdrawal by Subject|7|||
156479503|NCT02889900|564850603|FG000|Overall Study|Not treated|2|||
156479504|NCT00813709|564850604|FG000|Double Blind Period|Adverse Event|4|||
156479505|NCT00813709|564850605|FG001|Double Blind Period|Adverse Event|1|||
156479506|NCT00813709|564850606|FG002|Double Blind Period|Adverse Event|4|||
156479507|NCT00813709|564850607|FG003|Double Blind Period|Adverse Event|0|||
156479508|NCT00813709|564850608|FG004|Double Blind Period|Adverse Event|0|||
156479509|NCT00813709|564850609|FG005|Double Blind Period|Adverse Event|0|||
156479510|NCT00813709|564850604|FG000|Double Blind Period|Lost to Follow-up|3|||
156479511|NCT00813709|564850605|FG001|Double Blind Period|Lost to Follow-up|2|||
156479512|NCT00813709|564850606|FG002|Double Blind Period|Lost to Follow-up|2|||
156479513|NCT00813709|564850607|FG003|Double Blind Period|Lost to Follow-up|0|||
156479514|NCT00813709|564850608|FG004|Double Blind Period|Lost to Follow-up|0|||
156479515|NCT00813709|564850609|FG005|Double Blind Period|Lost to Follow-up|0|||
156479516|NCT00813709|564850604|FG000|Double Blind Period|Switched to open label phase|9|||
156479517|NCT00813709|564850605|FG001|Double Blind Period|Switched to open label phase|26|||
156479518|NCT00813709|564850606|FG002|Double Blind Period|Switched to open label phase|18|||
156479519|NCT00813709|564850607|FG003|Double Blind Period|Switched to open label phase|0|||
156479520|NCT00813709|564850608|FG004|Double Blind Period|Switched to open label phase|0|||
156479521|NCT00813709|564850609|FG005|Double Blind Period|Switched to open label phase|0|||
156479522|NCT00813709|564850604|FG000|Double Blind Period|Randomized but not treated|1|||
156479523|NCT00813709|564850605|FG001|Double Blind Period|Randomized but not treated|3|||
156479524|NCT00813709|564850606|FG002|Double Blind Period|Randomized but not treated|1|||
156479525|NCT00813709|564850607|FG003|Double Blind Period|Randomized but not treated|0|||
156479526|NCT00813709|564850608|FG004|Double Blind Period|Randomized but not treated|0|||
156479527|NCT00813709|564850609|FG005|Double Blind Period|Randomized but not treated|0|||
156479528|NCT00813709|564850604|FG000|Double Blind Period|Other|14|||
156479529|NCT00813709|564850605|FG001|Double Blind Period|Other|9|||
156479530|NCT00813709|564850606|FG002|Double Blind Period|Other|6|||
156479531|NCT00813709|564850607|FG003|Double Blind Period|Other|0|||
156479532|NCT00813709|564850608|FG004|Double Blind Period|Other|0|||
156479533|NCT00813709|564850609|FG005|Double Blind Period|Other|0|||
156479534|NCT00813709|564850604|FG000|Open Label Period|Adverse Event|0|||
156479535|NCT00813709|564850605|FG001|Open Label Period|Adverse Event|0|||
156479536|NCT00813709|564850606|FG002|Open Label Period|Adverse Event|0|||
156479537|NCT00813709|564850607|FG003|Open Label Period|Adverse Event|5|||
156479538|NCT00813709|564850608|FG004|Open Label Period|Adverse Event|4|||
156479539|NCT00813709|564850609|FG005|Open Label Period|Adverse Event|3|||
156479540|NCT00813709|564850604|FG000|Open Label Period|Lack of Efficacy|0|||
156479541|NCT00813709|564850605|FG001|Open Label Period|Lack of Efficacy|0|||
156479542|NCT00813709|564850606|FG002|Open Label Period|Lack of Efficacy|0|||
156479543|NCT00813709|564850607|FG003|Open Label Period|Lack of Efficacy|3|||
156479544|NCT00813709|564850608|FG004|Open Label Period|Lack of Efficacy|1|||
156479545|NCT00813709|564850609|FG005|Open Label Period|Lack of Efficacy|1|||
156479546|NCT00813709|564850604|FG000|Open Label Period|Randomized but not treated|0|||
156479547|NCT00813709|564850605|FG001|Open Label Period|Randomized but not treated|0|||
156479548|NCT00813709|564850606|FG002|Open Label Period|Randomized but not treated|0|||
156479549|NCT00813709|564850607|FG003|Open Label Period|Randomized but not treated|1|||
156479550|NCT00813709|564850608|FG004|Open Label Period|Randomized but not treated|0|||
156479551|NCT00813709|564850609|FG005|Open Label Period|Randomized but not treated|1|||
156479552|NCT00813709|564850604|FG000|Open Label Period|Other|0|||
156479553|NCT00813709|564850605|FG001|Open Label Period|Other|0|||
156479554|NCT00813709|564850606|FG002|Open Label Period|Other|0|||
156479555|NCT00813709|564850607|FG003|Open Label Period|Other|11|||
156479556|NCT00813709|564850608|FG004|Open Label Period|Other|5|||
156479557|NCT00813709|564850609|FG005|Open Label Period|Other|6|||
156479558|NCT01919489|564850612|FG000|Overall Study|Rejected the need of injections|4|||
156479559|NCT01919489|564850613|FG001|Overall Study|Rejected the need of injections|7|||
156479560|NCT01919489|564850612|FG000|Overall Study|Adverse Event|10|||
156479561|NCT01919489|564850613|FG001|Overall Study|Adverse Event|0|||
156479562|NCT01919489|564850612|FG000|Overall Study|Hospital readmission|2|||
156479563|NCT01919489|564850613|FG001|Overall Study|Hospital readmission|9|||
156479564|NCT01919489|564850612|FG000|Overall Study|Death|2|||
156479565|NCT01919489|564850613|FG001|Overall Study|Death|1|||
156479566|NCT01919489|564850612|FG000|Overall Study|Lost to Follow-up|38|||
156479567|NCT01919489|564850613|FG001|Overall Study|Lost to Follow-up|27|||
156479568|NCT03761849|564850614|FG000|Overall Study|transferred to OpenLabelExtension|35|||
156479569|NCT03761849|564850615|FG001|Overall Study|transferred to OpenLabelExtension|34|||
156479570|NCT03761849|564850616|FG002|Overall Study|transferred to OpenLabelExtension|36|||
156479571|NCT03761849|564850617|FG003|Overall Study|transferred to OpenLabelExtension|0|||
156479572|NCT03761849|564850618|FG004|Overall Study|transferred to OpenLabelExtension|0|||
156479573|NCT03761849|564850619|FG005|Overall Study|transferred to OpenLabelExtension|0|||
156479574|NCT03761849|564850614|FG000|Overall Study|Adverse Event|1|||
156479575|NCT03761849|564850615|FG001|Overall Study|Adverse Event|0|||
156479576|NCT03761849|564850616|FG002|Overall Study|Adverse Event|0|||
156543680|NCT03715153|565084702|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
156543681|NCT03715153|565084701|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
156543682|NCT03715153|565084702|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
156543683|NCT03715153|565084701|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
156543684|NCT03715153|565084702|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
156543685|NCT03715153|565084701|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
156543686|NCT03715153|565084702|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
156543687|NCT03715153|565084701|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
156543688|NCT03715153|565084702|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
156543689|NCT03715153|565084701|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
156543690|NCT03715153|565084702|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
156543691|NCT01519765|565084707|FG000|Overall Study|Adverse Event|0|||
156543692|NCT01519765|565084708|FG001|Overall Study|Adverse Event|1|||
156543693|NCT01519765|565084707|FG000|Overall Study|Lack of Efficacy|2|||
156543694|NCT01519765|565084708|FG001|Overall Study|Lack of Efficacy|0|||
156543695|NCT01519765|565084707|FG000|Overall Study|Protocol Violation|1|||
156543696|NCT01519765|565084708|FG001|Overall Study|Protocol Violation|0|||
156543697|NCT01519765|565084707|FG000|Overall Study|Withdrawal by Subject|0|||
156543698|NCT01519765|565084708|FG001|Overall Study|Withdrawal by Subject|1|||
156543699|NCT00578136|565084709|FG000|Overall Study|Not given intervention|1|||
156543700|NCT00578136|565084710|FG001|Overall Study|Not given intervention|1|||
156543701|NCT02437864|565084717|FG000|Overall Study|Protocol Violation|4|||
156543702|NCT02437864|565084718|FG001|Overall Study|Protocol Violation|0|||
156543703|NCT00645593|565084720|FG000|Overall Study|Later found to be ineligible|1|||
156543704|NCT00645593|565084721|FG001|Overall Study|Later found to be ineligible|0|||
156543705|NCT01585272|565084722|FG000|Overall Study|Adverse Event|22|||
156543706|NCT01585272|565084722|FG000|Overall Study|Protocol Violation|7|||
156543707|NCT01585272|565084722|FG000|Overall Study|Withdrawal by Subject|10|||
156543708|NCT00781911|565084723|FG000|Overall Study|Adverse Event|4|||
156543709|NCT00781911|565084724|FG001|Overall Study|Adverse Event|4|||
156543710|NCT00781911|565084723|FG000|Overall Study|Withdrawal by Subject|1|||
156543711|NCT00781911|565084724|FG001|Overall Study|Withdrawal by Subject|2|||
156543712|NCT00781911|565084723|FG000|Overall Study|Physician Decision|0|||
156543713|NCT00781911|565084724|FG001|Overall Study|Physician Decision|2|||
156543714|NCT00781911|565084723|FG000|Overall Study|Sponsor Decision|1|||
156543715|NCT00781911|565084724|FG001|Overall Study|Sponsor Decision|0|||
156543716|NCT03021499|565084731|FG000|Overall Study|Adverse Event|1|||
156543717|NCT03021499|565084732|FG001|Overall Study|Adverse Event|0|||
156543718|NCT03021499|565084731|FG000|Overall Study|Death|1|||
156543719|NCT03021499|565084732|FG001|Overall Study|Death|5|||
156543720|NCT03021499|565084731|FG000|Overall Study|Lack of Efficacy|0|||
156543721|NCT03021499|565084732|FG001|Overall Study|Lack of Efficacy|1|||
156543722|NCT03021499|565084731|FG000|Overall Study|Lost to Follow-up|1|||
156543723|NCT03021499|565084732|FG001|Overall Study|Lost to Follow-up|3|||
156543724|NCT03021499|565084731|FG000|Overall Study|Physician Decision|2|||
156543725|NCT03021499|565084732|FG001|Overall Study|Physician Decision|3|||
156543726|NCT03021499|565084731|FG000|Overall Study|Pregnancy|1|||
156543727|NCT03021499|565084732|FG001|Overall Study|Pregnancy|0|||
156479577|NCT03761849|564850617|FG003|Overall Study|Adverse Event|0|||
156479578|NCT03761849|564850618|FG004|Overall Study|Adverse Event|2|||
156479579|NCT03761849|564850619|FG005|Overall Study|Adverse Event|3|||
156479580|NCT03761849|564850614|FG000|Overall Study|Withdrawal by Subject|0|||
156479581|NCT03761849|564850615|FG001|Overall Study|Withdrawal by Subject|0|||
156479582|NCT03761849|564850616|FG002|Overall Study|Withdrawal by Subject|0|||
156479583|NCT03761849|564850617|FG003|Overall Study|Withdrawal by Subject|41|||
156479584|NCT03761849|564850618|FG004|Overall Study|Withdrawal by Subject|43|||
156479585|NCT03761849|564850619|FG005|Overall Study|Withdrawal by Subject|35|||
156543728|NCT03021499|565084731|FG000|Overall Study|Withdrawal by Subject|7|||
156543729|NCT03021499|565084732|FG001|Overall Study|Withdrawal by Subject|14|||
156543730|NCT03021499|565084731|FG000|Overall Study|Prohibited medication required|1|||
156543731|NCT03021499|565084732|FG001|Overall Study|Prohibited medication required|0|||
156543732|NCT03021499|565084731|FG000|Overall Study|Protocol non-compliance|1|||
156479586|NCT03761849|564850614|FG000|Overall Study|Lost to Follow-up|0|||
156479587|NCT03761849|564850615|FG001|Overall Study|Lost to Follow-up|1|||
156543733|NCT03021499|565084732|FG001|Overall Study|Protocol non-compliance|1|||
156543734|NCT03021499|565084731|FG000|Overall Study|None of the above|0|||
156479588|NCT03761849|564850616|FG002|Overall Study|Lost to Follow-up|0|||
156479589|NCT03761849|564850617|FG003|Overall Study|Lost to Follow-up|2|||
156479590|NCT03761849|564850618|FG004|Overall Study|Lost to Follow-up|4|||
156479591|NCT03761849|564850619|FG005|Overall Study|Lost to Follow-up|5|||
156543735|NCT03021499|565084732|FG001|Overall Study|None of the above|4|||
156543736|NCT03021499|565084731|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
156543737|NCT03021499|565084732|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
156543738|NCT00609791|565086177|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
156479592|NCT03761849|564850614|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
156479593|NCT03761849|564850615|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
156479594|NCT03761849|564850616|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
156479595|NCT03761849|564850617|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
156479596|NCT03761849|564850618|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
156479597|NCT03761849|564850619|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
156479598|NCT03761849|564850614|FG000|Overall Study|Physician Decision|0|||
156479599|NCT03761849|564850615|FG001|Overall Study|Physician Decision|0|||
156479600|NCT03761849|564850616|FG002|Overall Study|Physician Decision|0|||
156479601|NCT03761849|564850617|FG003|Overall Study|Physician Decision|1|||
156479602|NCT03761849|564850618|FG004|Overall Study|Physician Decision|4|||
156479603|NCT03761849|564850619|FG005|Overall Study|Physician Decision|4|||
156479604|NCT03761849|564850614|FG000|Overall Study|Death|0|||
156479605|NCT03761849|564850615|FG001|Overall Study|Death|0|||
156479606|NCT03761849|564850616|FG002|Overall Study|Death|0|||
156479607|NCT03761849|564850617|FG003|Overall Study|Death|1|||
156479608|NCT03761849|564850618|FG004|Overall Study|Death|1|||
156479609|NCT03761849|564850619|FG005|Overall Study|Death|3|||
156479610|NCT03761849|564850614|FG000|Overall Study|Protocol Violation|0|||
156479611|NCT03761849|564850615|FG001|Overall Study|Protocol Violation|0|||
156479612|NCT03761849|564850616|FG002|Overall Study|Protocol Violation|0|||
156479613|NCT03761849|564850617|FG003|Overall Study|Protocol Violation|2|||
156479614|NCT03761849|564850618|FG004|Overall Study|Protocol Violation|2|||
156479615|NCT03761849|564850619|FG005|Overall Study|Protocol Violation|1|||
156479616|NCT03761849|564850614|FG000|Overall Study|Participant could not come to site|0|||
156479617|NCT03761849|564850615|FG001|Overall Study|Participant could not come to site|0|||
156479618|NCT03761849|564850616|FG002|Overall Study|Participant could not come to site|0|||
156479619|NCT03761849|564850617|FG003|Overall Study|Participant could not come to site|0|||
156479620|NCT03761849|564850618|FG004|Overall Study|Participant could not come to site|1|||
156479621|NCT03761849|564850619|FG005|Overall Study|Participant could not come to site|0|||
156479622|NCT03761849|564850614|FG000|Overall Study|SF- safety Finding|0|||
156479623|NCT03761849|564850615|FG001|Overall Study|SF- safety Finding|0|||
156479624|NCT03761849|564850616|FG002|Overall Study|SF- safety Finding|0|||
156479625|NCT03761849|564850617|FG003|Overall Study|SF- safety Finding|0|||
156479626|NCT03761849|564850618|FG004|Overall Study|SF- safety Finding|0|||
156479627|NCT03761849|564850619|FG005|Overall Study|SF- safety Finding|1|||
156479628|NCT03761849|564850614|FG000|Overall Study|Patient did not attend visit|0|||
156479629|NCT03761849|564850615|FG001|Overall Study|Patient did not attend visit|0|||
156479630|NCT03761849|564850616|FG002|Overall Study|Patient did not attend visit|0|||
156479631|NCT03761849|564850617|FG003|Overall Study|Patient did not attend visit|0|||
156479632|NCT03761849|564850618|FG004|Overall Study|Patient did not attend visit|0|||
156479633|NCT03761849|564850619|FG005|Overall Study|Patient did not attend visit|1|||
156479634|NCT03884478|564850620|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
156479635|NCT03884478|564850621|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
156479636|NCT03884478|564850622|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
156479637|NCT03884478|564850620|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
156479638|NCT03884478|564850621|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
156479639|NCT03884478|564850622|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
156479640|NCT03884478|564850620|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
156479641|NCT03884478|564850621|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
156479642|NCT03884478|564850622|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
156479643|NCT03884478|564850620|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
156479644|NCT03884478|564850621|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
156479645|NCT03884478|564850622|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
156479646|NCT01540474|564850623|FG000|Vaccination Period|Lost to Follow-up|0|||
156479647|NCT01540474|564850624|FG001|Vaccination Period|Lost to Follow-up|1|||
156479648|NCT01540474|564850625|FG002|Vaccination Period|Lost to Follow-up|0|||
156479649|NCT01540474|564850626|FG003|Vaccination Period|Lost to Follow-up|0|||
156479650|NCT00857311|564850627|FG000|Overall Study|Lost to Follow-up|1|||
156479651|NCT00857311|564850628|FG001|Overall Study|Lost to Follow-up|0|||
156479652|NCT00857311|564850629|FG002|Overall Study|Lost to Follow-up|0|||
156479653|NCT00857311|564850630|FG003|Overall Study|Lost to Follow-up|0|||
156479654|NCT01587703|564850631|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
156479655|NCT01587703|564850632|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479656|NCT01587703|564850633|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479657|NCT01587703|564850634|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156543739|NCT00129766|565086179|FG000|Overall Study|Death|3|||
156543740|NCT00129766|565086180|FG001|Overall Study|Death|8|||
156543741|NCT00129766|565086179|FG000|Overall Study|Withdrawal of consent|31|||
156543742|NCT00129766|565086180|FG001|Overall Study|Withdrawal of consent|30|||
156543743|NCT00129766|565086179|FG000|Overall Study|Lost to Follow-up|26|||
156543744|NCT00129766|565086180|FG001|Overall Study|Lost to Follow-up|21|||
156543745|NCT00122681|565086188|FG000|Overall Study|Adverse Event|20|||
156543746|NCT00122681|565086189|FG001|Overall Study|Adverse Event|16|||
156479658|NCT01587703|564850635|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479659|NCT01587703|564850636|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479660|NCT01587703|564850637|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479661|NCT01587703|564850638|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479662|NCT01587703|564850639|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479663|NCT01587703|564850640|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479664|NCT01587703|564850641|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479665|NCT01587703|564850642|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479666|NCT01587703|564850643|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479667|NCT01587703|564850644|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479668|NCT01587703|564850645|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479669|NCT01587703|564850646|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479670|NCT01587703|564850647|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479671|NCT01587703|564850648|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479672|NCT01587703|564850649|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
156479673|NCT01587703|564850631|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479674|NCT01587703|564850632|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479675|NCT01587703|564850633|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479676|NCT01587703|564850634|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479677|NCT01587703|564850635|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479678|NCT01587703|564850636|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
156479679|NCT01587703|564850637|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479680|NCT01587703|564850638|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
156479681|NCT01587703|564850639|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479682|NCT01587703|564850640|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479683|NCT01587703|564850641|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156543747|NCT00122681|565086188|FG000|Overall Study|Lost to Follow-up|1080|||
156543748|NCT00122681|565086189|FG001|Overall Study|Lost to Follow-up|1097|||
156479684|NCT01587703|564850642|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479685|NCT01587703|564850643|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479686|NCT01587703|564850644|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479687|NCT01587703|564850645|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479688|NCT01587703|564850646|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156543749|NCT00122681|565086188|FG000|Overall Study|Protocol Violation|7|||
156543750|NCT00122681|565086189|FG001|Overall Study|Protocol Violation|10|||
156543751|NCT00122681|565086188|FG000|Overall Study|Withdrawal by Subject|257|||
156543752|NCT00122681|565086189|FG001|Overall Study|Withdrawal by Subject|251|||
156543753|NCT00122681|565086188|FG000|Overall Study|Personal reasons|150|||
156543754|NCT00122681|565086189|FG001|Overall Study|Personal reasons|147|||
156543755|NCT02819635|565086190|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
156543756|NCT02819635|565086191|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
156543757|NCT02819635|565086192|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
156543758|NCT02819635|565086193|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
156543759|NCT02819635|565086194|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
156543760|NCT02819635|565086195|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
156543761|NCT02819635|565086196|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
156543762|NCT02819635|565086197|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
156543763|NCT02819635|565086198|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
156543764|NCT02819635|565086199|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
156543765|NCT02819635|565086200|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
156543766|NCT02819635|565086201|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
156543767|NCT02819635|565086190|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543768|NCT02819635|565086191|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543769|NCT02819635|565086192|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543770|NCT02819635|565086193|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543771|NCT02819635|565086194|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
156543772|NCT02819635|565086195|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
156543773|NCT02819635|565086196|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
156543774|NCT02819635|565086197|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543775|NCT02819635|565086198|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543776|NCT02819635|565086199|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543777|NCT02819635|565086200|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543778|NCT02819635|565086201|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
156543779|NCT02819635|565086190|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543780|NCT02819635|565086191|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543781|NCT02819635|565086192|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543782|NCT02819635|565086193|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543783|NCT02819635|565086194|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543784|NCT02819635|565086195|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
156543785|NCT02819635|565086196|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
156543786|NCT02819635|565086197|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543787|NCT02819635|565086198|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543788|NCT02819635|565086199|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543789|NCT02819635|565086200|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543790|NCT02819635|565086201|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
156543791|NCT02819635|565086190|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156345184|NCT03129100|564362399|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
156479689|NCT01587703|564850647|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479690|NCT01587703|564850648|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479691|NCT01587703|564850649|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
156479692|NCT01587703|564850631|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479693|NCT01587703|564850632|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479694|NCT01587703|564850633|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479695|NCT01587703|564850634|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479696|NCT01587703|564850635|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479697|NCT01587703|564850636|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479698|NCT01587703|564850637|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
156479699|NCT01587703|564850638|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479700|NCT01587703|564850639|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479701|NCT01587703|564850640|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479702|NCT01587703|564850641|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479703|NCT01587703|564850642|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479704|NCT01587703|564850643|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479705|NCT01587703|564850644|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479706|NCT01587703|564850645|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479707|NCT01587703|564850646|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479708|NCT01587703|564850647|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479709|NCT01587703|564850648|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479710|NCT01587703|564850649|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
156479711|NCT01587703|564850631|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
156479712|NCT01587703|564850632|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
156479713|NCT01587703|564850633|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
156479714|NCT01587703|564850634|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
156479715|NCT01587703|564850635|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
156479716|NCT01587703|564850636|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
156479717|NCT01587703|564850637|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
156479718|NCT01587703|564850638|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
156479719|NCT01587703|564850639|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479720|NCT01587703|564850640|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479721|NCT01587703|564850641|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479722|NCT01587703|564850642|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479723|NCT01587703|564850643|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479724|NCT01587703|564850644|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479725|NCT01587703|564850645|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479726|NCT01587703|564850646|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479727|NCT01587703|564850647|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479728|NCT01587703|564850648|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479729|NCT01587703|564850649|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
156479730|NCT01587703|564850631|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479731|NCT01587703|564850632|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479732|NCT01587703|564850633|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479733|NCT01587703|564850634|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479734|NCT01587703|564850635|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479735|NCT01587703|564850636|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479736|NCT01587703|564850637|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479737|NCT01587703|564850638|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156345185|NCT03129100|564362400|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
156345186|NCT03129100|564362401|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345187|NCT03129100|564362402|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345188|NCT03129100|564362403|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345189|NCT03129100|564362404|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345190|NCT03129100|564362405|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345191|NCT03129100|564362406|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345192|NCT03129100|564362407|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345193|NCT03129100|564362408|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345194|NCT03129100|564362409|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345195|NCT03129100|564362410|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156479738|NCT01587703|564850639|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
156479739|NCT01587703|564850640|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
156479740|NCT01587703|564850641|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
156479741|NCT01587703|564850642|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479742|NCT01587703|564850643|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156345196|NCT03129100|564362411|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156345197|NCT03129100|564362386|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345198|NCT03129100|564362387|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345199|NCT03129100|564362388|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345200|NCT03129100|564362389|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345201|NCT03129100|564362390|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345202|NCT03129100|564362391|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345203|NCT03129100|564362392|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345204|NCT03129100|564362393|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345205|NCT03129100|564362394|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345206|NCT03129100|564362395|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345207|NCT03129100|564362396|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345208|NCT03129100|564362397|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
156543792|NCT02819635|565086191|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543793|NCT02819635|565086192|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156565215|NCT03263806|565157644|FG001|Overall Study|Withdrawal by Subject|1|||
156345209|NCT03129100|564362398|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156479743|NCT01587703|564850644|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479744|NCT01587703|564850645|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479745|NCT01587703|564850646|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479746|NCT01587703|564850647|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479747|NCT01587703|564850648|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479748|NCT01587703|564850649|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
156479749|NCT01587703|564850631|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479750|NCT01587703|564850632|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479751|NCT01587703|564850633|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479752|NCT01587703|564850634|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479753|NCT01587703|564850635|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479754|NCT01587703|564850636|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479755|NCT01587703|564850637|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479756|NCT01587703|564850638|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479757|NCT01587703|564850639|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
156479758|NCT01587703|564850640|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479759|NCT01587703|564850641|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
156479760|NCT01587703|564850642|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479761|NCT01587703|564850643|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479762|NCT01587703|564850644|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479763|NCT01587703|564850645|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479764|NCT01587703|564850646|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479765|NCT01587703|564850647|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479766|NCT01587703|564850648|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479767|NCT01587703|564850649|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
156479768|NCT01587703|564850631|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479769|NCT01587703|564850632|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479770|NCT01587703|564850633|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479771|NCT01587703|564850634|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479772|NCT01587703|564850635|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479773|NCT01587703|564850636|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479774|NCT01587703|564850637|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479775|NCT01587703|564850638|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479776|NCT01587703|564850639|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479777|NCT01587703|564850640|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
156479778|NCT01587703|564850641|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
156479779|NCT01587703|564850642|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479780|NCT01587703|564850643|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479781|NCT01587703|564850644|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479782|NCT01587703|564850645|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479783|NCT01587703|564850646|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479784|NCT01587703|564850647|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479785|NCT01587703|564850648|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479786|NCT01587703|564850649|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
156479787|NCT01587703|564850631|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479788|NCT01587703|564850632|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479789|NCT01587703|564850633|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479790|NCT01587703|564850634|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156543794|NCT02819635|565086193|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543795|NCT02819635|565086194|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543796|NCT02819635|565086195|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543797|NCT02819635|565086196|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
156479791|NCT01587703|564850635|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156345210|NCT03129100|564362399|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
156479792|NCT01587703|564850636|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479793|NCT01587703|564850637|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479794|NCT01587703|564850638|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479795|NCT01587703|564850639|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
156479796|NCT01587703|564850640|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479797|NCT01587703|564850641|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479798|NCT01587703|564850642|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479799|NCT01587703|564850643|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479800|NCT01587703|564850644|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479801|NCT01587703|564850645|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479802|NCT01587703|564850646|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479803|NCT01587703|564850647|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479804|NCT01587703|564850648|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479805|NCT01587703|564850649|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
156479806|NCT01587703|564850631|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479807|NCT01587703|564850632|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479808|NCT01587703|564850633|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479809|NCT01587703|564850634|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479810|NCT01587703|564850635|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479811|NCT01587703|564850636|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479812|NCT01587703|564850637|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479813|NCT01587703|564850638|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479814|NCT01587703|564850639|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479815|NCT01587703|564850640|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479816|NCT01587703|564850641|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479817|NCT01587703|564850642|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479818|NCT01587703|564850643|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479819|NCT01587703|564850644|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479820|NCT01587703|564850645|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479821|NCT01587703|564850646|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479822|NCT01587703|564850647|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479823|NCT01587703|564850648|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
156479824|NCT01587703|564850649|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
156479825|NCT01587703|564850631|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479826|NCT01587703|564850632|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479827|NCT01587703|564850633|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479828|NCT01587703|564850634|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479829|NCT01587703|564850635|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479830|NCT01587703|564850636|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479831|NCT01587703|564850637|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479832|NCT01587703|564850638|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479833|NCT01587703|564850639|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479834|NCT01587703|564850640|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479835|NCT01587703|564850641|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479836|NCT01587703|564850642|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479837|NCT01587703|564850643|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479838|NCT01587703|564850644|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479839|NCT01587703|564850645|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479840|NCT01587703|564850646|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156543798|NCT02819635|565086197|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543799|NCT02819635|565086198|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543800|NCT02819635|565086199|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543801|NCT02819635|565086200|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543802|NCT02819635|565086201|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
156543803|NCT02819635|565086190|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
156543804|NCT02819635|565086191|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
156543805|NCT02819635|565086192|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
156479841|NCT01587703|564850647|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
156479842|NCT01587703|564850648|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
156479843|NCT01587703|564850649|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
156479844|NCT01587703|564850631|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156543806|NCT02819635|565086193|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
156479845|NCT01587703|564850632|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156543807|NCT02819635|565086194|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
156479846|NCT01587703|564850633|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479847|NCT01587703|564850634|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479848|NCT01587703|564850635|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479849|NCT01587703|564850636|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479850|NCT01587703|564850637|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156345211|NCT03129100|564362400|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
156345212|NCT03129100|564362401|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345213|NCT03129100|564362402|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156479851|NCT01587703|564850638|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156345214|NCT03129100|564362403|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156479852|NCT01587703|564850639|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479853|NCT01587703|564850640|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479854|NCT01587703|564850641|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479855|NCT01587703|564850642|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479856|NCT01587703|564850643|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479857|NCT01587703|564850644|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479858|NCT01587703|564850645|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479859|NCT01587703|564850646|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
156479860|NCT01587703|564850647|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479861|NCT01587703|564850648|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479862|NCT01587703|564850649|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
156479863|NCT01587703|564850631|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479864|NCT01587703|564850632|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479865|NCT01587703|564850633|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479866|NCT01587703|564850634|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479867|NCT01587703|564850635|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479868|NCT01587703|564850636|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479869|NCT01587703|564850637|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479870|NCT01587703|564850638|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479871|NCT01587703|564850639|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479872|NCT01587703|564850640|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479873|NCT01587703|564850641|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479874|NCT01587703|564850642|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
156479875|NCT01587703|564850643|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479876|NCT01587703|564850644|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479877|NCT01587703|564850645|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
156479878|NCT01587703|564850646|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479879|NCT01587703|564850647|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479880|NCT01587703|564850648|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479881|NCT01587703|564850649|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
156479882|NCT01587703|564850631|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479883|NCT01587703|564850632|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479884|NCT01587703|564850633|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479885|NCT01587703|564850634|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479886|NCT01587703|564850635|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479887|NCT01587703|564850636|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479888|NCT01587703|564850637|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479889|NCT01587703|564850638|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479890|NCT01587703|564850639|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479891|NCT01587703|564850640|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479892|NCT01587703|564850641|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479893|NCT01587703|564850642|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
156479894|NCT01587703|564850643|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
156479895|NCT01587703|564850644|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
156479896|NCT01587703|564850645|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
156479897|NCT01587703|564850646|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
156479898|NCT01587703|564850647|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
156345215|NCT03129100|564362404|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156479899|NCT01587703|564850648|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479900|NCT01587703|564850649|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
156479901|NCT01587703|564850631|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
156345216|NCT03129100|564362405|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156479902|NCT01587703|564850632|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479903|NCT01587703|564850633|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479904|NCT01587703|564850634|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479905|NCT01587703|564850635|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479906|NCT01587703|564850636|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479907|NCT01587703|564850637|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479908|NCT01587703|564850638|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479909|NCT01587703|564850639|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479910|NCT01587703|564850640|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479911|NCT01587703|564850641|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479912|NCT01587703|564850642|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
156479913|NCT01587703|564850643|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
156479914|NCT01587703|564850644|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
156479915|NCT01587703|564850645|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
156479916|NCT01587703|564850646|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
156479917|NCT01587703|564850647|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
156479918|NCT01587703|564850648|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479919|NCT01587703|564850649|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
156479920|NCT01587703|564850631|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479921|NCT01587703|564850632|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479922|NCT01587703|564850633|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479923|NCT01587703|564850634|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479924|NCT01587703|564850635|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479925|NCT01587703|564850636|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479926|NCT01587703|564850637|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479927|NCT01587703|564850638|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479928|NCT01587703|564850639|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479929|NCT01587703|564850640|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479930|NCT01587703|564850641|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479931|NCT01587703|564850642|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
156479932|NCT01587703|564850643|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479933|NCT01587703|564850644|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479934|NCT01587703|564850645|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479935|NCT01587703|564850646|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479936|NCT01587703|564850647|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479937|NCT01587703|564850648|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479938|NCT01587703|564850649|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
156479939|NCT00828139|564850650|FG000|Overall Study|Adverse Event|8|||
156479940|NCT00828139|564850651|FG001|Overall Study|Adverse Event|1|||
156479941|NCT00828139|564850652|FG002|Overall Study|Adverse Event|10|||
156479942|NCT00828139|564850653|FG003|Overall Study|Adverse Event|5|||
156479943|NCT00828139|564850650|FG000|Overall Study|Death|2|||
156479944|NCT00828139|564850651|FG001|Overall Study|Death|1|||
156479945|NCT00828139|564850652|FG002|Overall Study|Death|0|||
156479946|NCT00828139|564850653|FG003|Overall Study|Death|2|||
156479947|NCT00828139|564850650|FG000|Overall Study|Refusal unrelated to toxicity|3|||
156479948|NCT00828139|564850651|FG001|Overall Study|Refusal unrelated to toxicity|4|||
156479949|NCT00828139|564850652|FG002|Overall Study|Refusal unrelated to toxicity|5|||
156479950|NCT00828139|564850653|FG003|Overall Study|Refusal unrelated to toxicity|3|||
156479951|NCT00828139|564850650|FG000|Overall Study|Disease Progression|24|||
156479952|NCT00828139|564850651|FG001|Overall Study|Disease Progression|33|||
156479953|NCT00828139|564850652|FG002|Overall Study|Disease Progression|35|||
156479954|NCT00828139|564850653|FG003|Overall Study|Disease Progression|39|||
156479955|NCT00828139|564850650|FG000|Overall Study|Other|4|||
156479956|NCT00828139|564850651|FG001|Overall Study|Other|2|||
156479957|NCT00828139|564850652|FG002|Overall Study|Other|5|||
156479958|NCT00828139|564850653|FG003|Overall Study|Other|2|||
156479959|NCT01714947|564850654|FG000|Part B|Progressive Disease|3|||
156479960|NCT04271254|564850658|FG000|Overall Study|Withdrawal by Subject|3|||
156479961|NCT04751929|564850659|FG000|Overall Study|Withdrawal by Subject|2|||
156479962|NCT04751929|564850660|FG001|Overall Study|Withdrawal by Subject|0|||
156479963|NCT04751929|564850661|FG002|Overall Study|Withdrawal by Subject|0|||
156479964|NCT04751929|564850662|FG003|Overall Study|Withdrawal by Subject|0|||
156479965|NCT04751929|564850659|FG000|Overall Study|Rising PSA|0|||
156479966|NCT04751929|564850660|FG001|Overall Study|Rising PSA|1|||
156479967|NCT04751929|564850661|FG002|Overall Study|Rising PSA|0|||
156479968|NCT04751929|564850662|FG003|Overall Study|Rising PSA|0|||
156479969|NCT04751929|564850659|FG000|Overall Study|Adverse Event|1|||
156479970|NCT04751929|564850660|FG001|Overall Study|Adverse Event|2|||
156479971|NCT04751929|564850661|FG002|Overall Study|Adverse Event|0|||
156479972|NCT04751929|564850662|FG003|Overall Study|Adverse Event|0|||
156479973|NCT04751929|564850659|FG000|Overall Study|Progressive Disease|3|||
156479974|NCT04751929|564850660|FG001|Overall Study|Progressive Disease|4|||
156479975|NCT04751929|564850661|FG002|Overall Study|Progressive Disease|4|||
156479976|NCT04751929|564850662|FG003|Overall Study|Progressive Disease|0|||
156345217|NCT03129100|564362406|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345218|NCT03129100|564362407|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345219|NCT03129100|564362408|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345220|NCT03129100|564362409|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345221|NCT03129100|564362410|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156479977|NCT04751929|564850659|FG000|Overall Study|Death|1|||
156479978|NCT04751929|564850660|FG001|Overall Study|Death|1|||
156479979|NCT04751929|564850661|FG002|Overall Study|Death|0|||
156479980|NCT04751929|564850662|FG003|Overall Study|Death|0|||
156479981|NCT01123356|564850663|FG000|Overall Study|Adverse Event|2|||
156479982|NCT01123356|564850663|FG000|Overall Study|Lack of Efficacy|4|||
156479983|NCT01123356|564850663|FG000|Overall Study|Withdrawal by Subject|1|||
156479984|NCT00376259|564850666|FG000|Overall Study|Sponsor request - study termination|21|||
156479985|NCT00376259|564850667|FG001|Overall Study|Sponsor request - study termination|21|||
156479986|NCT00376259|564850666|FG000|Overall Study|Patient request|1|||
156479987|NCT00376259|564850667|FG001|Overall Study|Patient request|0|||
156479988|NCT00759681|564850669|FG000|Overall Study|Death|2|||
156479989|NCT00759681|564850670|FG001|Overall Study|Death|5|||
156479990|NCT00759681|564850669|FG000|Overall Study|Lost to Follow-up|8|||
156479991|NCT00759681|564850670|FG001|Overall Study|Lost to Follow-up|5|||
156479992|NCT00930644|564850671|FG000|Overall Study|Withdrawal by Subject|4|||
156479993|NCT00930644|564850671|FG000|Overall Study|Physician Decision|2|||
156479994|NCT00930644|564850671|FG000|Overall Study|Death|1|||
156479995|NCT00930644|564850671|FG000|Overall Study|Adverse Event|16|||
156479996|NCT01877720|564850672|FG000|Overall Study|Adverse Event|1|||
156479997|NCT01877720|564850673|FG001|Overall Study|Adverse Event|0|||
156479998|NCT00473512|564850676|FG000|Period 1 (Phase 1)|Adverse Event|0|||
156479999|NCT00473512|564850677|FG001|Period 1 (Phase 1)|Adverse Event|0|||
156480000|NCT00473512|564850678|FG002|Period 1 (Phase 1)|Adverse Event|0|||
156480001|NCT00473512|564850679|FG003|Period 1 (Phase 1)|Adverse Event|5|||
156480002|NCT00473512|564850680|FG004|Period 1 (Phase 1)|Adverse Event|0|||
156480003|NCT00473512|564850676|FG000|Period 1 (Phase 1)|Death|0|||
156480004|NCT00473512|564850677|FG001|Period 1 (Phase 1)|Death|0|||
156480005|NCT00473512|564850678|FG002|Period 1 (Phase 1)|Death|0|||
156480006|NCT00473512|564850679|FG003|Period 1 (Phase 1)|Death|1|||
156480007|NCT00473512|564850680|FG004|Period 1 (Phase 1)|Death|0|||
156480008|NCT00473512|564850676|FG000|Period 1 (Phase 1)|Disease Progression|1|||
156480009|NCT00473512|564850677|FG001|Period 1 (Phase 1)|Disease Progression|1|||
156480010|NCT00473512|564850678|FG002|Period 1 (Phase 1)|Disease Progression|0|||
156480011|NCT00473512|564850679|FG003|Period 1 (Phase 1)|Disease Progression|10|||
156480012|NCT00473512|564850680|FG004|Period 1 (Phase 1)|Disease Progression|1|||
156480013|NCT00473512|564850676|FG000|Period 1 (Phase 1)|Other|0|||
156480014|NCT00473512|564850677|FG001|Period 1 (Phase 1)|Other|0|||
156480015|NCT00473512|564850678|FG002|Period 1 (Phase 1)|Other|0|||
156480016|NCT00473512|564850679|FG003|Period 1 (Phase 1)|Other|1|||
156480017|NCT00473512|564850680|FG004|Period 1 (Phase 1)|Other|0|||
156480018|NCT00473512|564850676|FG000|Period 2 (Phase 2)|Adverse Event|0|||
156480019|NCT00473512|564850677|FG001|Period 2 (Phase 2)|Adverse Event|0|||
156480020|NCT00473512|564850678|FG002|Period 2 (Phase 2)|Adverse Event|0|||
156480021|NCT00473512|564850679|FG003|Period 2 (Phase 2)|Adverse Event|1|||
156480022|NCT00473512|564850680|FG004|Period 2 (Phase 2)|Adverse Event|0|||
156480023|NCT00473512|564850676|FG000|Period 2 (Phase 2)|Death|0|||
156480024|NCT00473512|564850677|FG001|Period 2 (Phase 2)|Death|0|||
156480025|NCT00473512|564850678|FG002|Period 2 (Phase 2)|Death|0|||
156480026|NCT00473512|564850679|FG003|Period 2 (Phase 2)|Death|1|||
156480027|NCT00473512|564850680|FG004|Period 2 (Phase 2)|Death|1|||
156480028|NCT00473512|564850676|FG000|Period 2 (Phase 2)|Disease Progression|0|||
156480029|NCT00473512|564850677|FG001|Period 2 (Phase 2)|Disease Progression|2|||
156480030|NCT00473512|564850678|FG002|Period 2 (Phase 2)|Disease Progression|2|||
156480031|NCT00473512|564850679|FG003|Period 2 (Phase 2)|Disease Progression|17|||
156480032|NCT00473512|564850680|FG004|Period 2 (Phase 2)|Disease Progression|1|||
156543808|NCT02819635|565086195|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
156543809|NCT02819635|565086196|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
156543810|NCT02819635|565086197|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
156480033|NCT00473512|564850676|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
156480034|NCT00473512|564850677|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
156480035|NCT00473512|564850678|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
156480036|NCT00473512|564850679|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
156480037|NCT00473512|564850680|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
156480038|NCT00473512|564850676|FG000|Period 2 (Phase 2)|Other|1|||
156480039|NCT00473512|564850677|FG001|Period 2 (Phase 2)|Other|0|||
156480040|NCT00473512|564850678|FG002|Period 2 (Phase 2)|Other|0|||
156480041|NCT00473512|564850679|FG003|Period 2 (Phase 2)|Other|3|||
156480042|NCT00473512|564850680|FG004|Period 2 (Phase 2)|Other|0|||
156480043|NCT01129011|564850681|FG000|Overall Study|Adverse Event|20|||
156480044|NCT01129011|564850682|FG001|Overall Study|Adverse Event|30|||
156480045|NCT01129011|564850681|FG000|Overall Study|Withdrawal by Subject|24|||
156480046|NCT01129011|564850682|FG001|Overall Study|Withdrawal by Subject|8|||
156480047|NCT01129011|564850681|FG000|Overall Study|Lost to Follow-up|6|||
156480048|NCT01129011|564850682|FG001|Overall Study|Lost to Follow-up|7|||
156480049|NCT01129011|564850681|FG000|Overall Study|Duodenal Ulcer|2|||
156480050|NCT01129011|564850682|FG001|Overall Study|Duodenal Ulcer|8|||
156480051|NCT01129011|564850681|FG000|Overall Study|misc|7|||
156480052|NCT01129011|564850682|FG001|Overall Study|misc|4|||
156480053|NCT01012999|564850688|FG000|Overall Study|Protocol Violation|1|||
156480054|NCT01369147|564850689|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
156480055|NCT01369147|564850690|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
156480056|NCT01369147|564850691|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
156480057|NCT01494467|564850696|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
156480058|NCT01494467|564850697|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
156480059|NCT01494467|564850696|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
156480060|NCT01494467|564850697|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
156480061|NCT01494467|564850696|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
156480062|NCT01494467|564850697|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
156480063|NCT01494467|564850696|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
156480064|NCT01494467|564850697|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
156480065|NCT01494467|564850696|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
156480066|NCT01494467|564850697|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
156480067|NCT01494467|564850696|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
156480068|NCT01494467|564850697|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
156480069|NCT01494467|564850696|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
156480070|NCT01494467|564850697|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
156480071|NCT01494467|564850696|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
156480072|NCT01494467|564850697|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
156480073|NCT01494467|564850696|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
156480074|NCT01494467|564850697|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
156480075|NCT01494467|564850696|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
156480076|NCT01494467|564850697|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
156480077|NCT01494467|564850696|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
156480078|NCT01494467|564850697|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
156480079|NCT01494467|564850696|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
156480080|NCT01494467|564850697|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
156480081|NCT01494467|564850696|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
156480082|NCT01494467|564850697|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
156480083|NCT01494467|564850696|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
156480084|NCT01494467|564850697|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
156480085|NCT02584257|564850700|FG000|Period 1|Withdrawal by Subject|0|||
156480086|NCT02584257|564850701|FG001|Period 1|Withdrawal by Subject|0|||
156480087|NCT02584257|564850702|FG002|Period 1|Withdrawal by Subject|0|||
156480088|NCT02584257|564850703|FG003|Period 1|Withdrawal by Subject|0|||
156480089|NCT02584257|564850704|FG004|Period 1|Withdrawal by Subject|0|||
156480090|NCT02584257|564850705|FG005|Period 1|Withdrawal by Subject|0|||
156480091|NCT02584257|564850706|FG006|Period 1|Withdrawal by Subject|1|||
156480092|NCT02584257|564850707|FG007|Period 1|Withdrawal by Subject|0|||
156480093|NCT02584257|564850708|FG008|Period 1|Withdrawal by Subject|0|||
156480094|NCT02584257|564850700|FG000|Period 2|Physician Decision|1|||
156480095|NCT02584257|564850701|FG001|Period 2|Physician Decision|0|||
156480096|NCT02584257|564850702|FG002|Period 2|Physician Decision|0|||
156480097|NCT02584257|564850703|FG003|Period 2|Physician Decision|0|||
156480098|NCT02584257|564850704|FG004|Period 2|Physician Decision|0|||
156480099|NCT02584257|564850705|FG005|Period 2|Physician Decision|0|||
156480100|NCT02584257|564850706|FG006|Period 2|Physician Decision|0|||
156480101|NCT02584257|564850707|FG007|Period 2|Physician Decision|0|||
156480102|NCT02584257|564850708|FG008|Period 2|Physician Decision|0|||
156480103|NCT02584257|564850700|FG000|Period 2|Adverse Event|0|||
156480104|NCT02584257|564850701|FG001|Period 2|Adverse Event|1|||
156480105|NCT02584257|564850702|FG002|Period 2|Adverse Event|0|||
156480106|NCT02584257|564850703|FG003|Period 2|Adverse Event|0|||
156480107|NCT02584257|564850704|FG004|Period 2|Adverse Event|0|||
156480108|NCT02584257|564850705|FG005|Period 2|Adverse Event|0|||
156480109|NCT02584257|564850706|FG006|Period 2|Adverse Event|0|||
156480110|NCT02584257|564850707|FG007|Period 2|Adverse Event|0|||
156480111|NCT02584257|564850708|FG008|Period 2|Adverse Event|0|||
156480112|NCT02309892|564850709|FG000|Overall Study|Physician Decision|1|||
156480113|NCT02309892|564850710|FG001|Overall Study|Physician Decision|0|||
156480114|NCT02309892|564850711|FG002|Overall Study|Physician Decision|0|||
156480115|NCT02309892|564850712|FG003|Overall Study|Physician Decision|0|||
156480116|NCT02309892|564850713|FG004|Overall Study|Physician Decision|0|||
156480117|NCT02309892|564850714|FG005|Overall Study|Physician Decision|0|||
156480118|NCT02309892|564850715|FG006|Overall Study|Physician Decision|0|||
156480119|NCT02309892|564850709|FG000|Overall Study|Adverse Event|1|||
156480120|NCT02309892|564850710|FG001|Overall Study|Adverse Event|0|||
156480121|NCT02309892|564850711|FG002|Overall Study|Adverse Event|1|||
156480122|NCT02309892|564850712|FG003|Overall Study|Adverse Event|0|||
156480123|NCT02309892|564850713|FG004|Overall Study|Adverse Event|0|||
156480124|NCT02309892|564850714|FG005|Overall Study|Adverse Event|0|||
156480125|NCT02309892|564850715|FG006|Overall Study|Adverse Event|0|||
156480126|NCT02309892|564850709|FG000|Overall Study|Progressive Disease|0|||
156480127|NCT02309892|564850710|FG001|Overall Study|Progressive Disease|1|||
156480128|NCT02309892|564850711|FG002|Overall Study|Progressive Disease|0|||
156480129|NCT02309892|564850712|FG003|Overall Study|Progressive Disease|0|||
156480130|NCT02309892|564850713|FG004|Overall Study|Progressive Disease|1|||
156480131|NCT02309892|564850714|FG005|Overall Study|Progressive Disease|0|||
156480132|NCT02309892|564850715|FG006|Overall Study|Progressive Disease|0|||
156480133|NCT02309892|564850709|FG000|Overall Study|Death|0|||
156480134|NCT02309892|564850710|FG001|Overall Study|Death|0|||
156480135|NCT02309892|564850711|FG002|Overall Study|Death|0|||
156480136|NCT02309892|564850712|FG003|Overall Study|Death|0|||
156345222|NCT03129100|564362411|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156345223|NCT03129100|564362386|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156480137|NCT02309892|564850713|FG004|Overall Study|Death|0|||
156480138|NCT02309892|564850714|FG005|Overall Study|Death|1|||
156480139|NCT02309892|564850715|FG006|Overall Study|Death|0|||
156480140|NCT05376397|564850716|FG000|Overall Study|Lost to Follow-up|1|||
156480141|NCT02721147|564850717|FG000|Overall Study|Lost to Follow-up|2|||
156480142|NCT02721147|564850718|FG001|Overall Study|Lost to Follow-up|0|||
156480143|NCT02721147|564850719|FG002|Overall Study|Lost to Follow-up|0|||
156480144|NCT01722097|564850720|FG000|Overall Study|Patient sheets not returned|6|||
156480145|NCT01722097|564850721|FG001|Overall Study|Patient sheets not returned|5|||
156480146|NCT01535261|564850722|FG000|Overall Study|Physician Decision|8|||
156480147|NCT01535261|564850722|FG000|Overall Study|Protocol Violation|3|||
156480148|NCT01535261|564850722|FG000|Overall Study|Death|5|||
156480149|NCT01535261|564850722|FG000|Overall Study|Lost to Follow-up|8|||
156480150|NCT01535261|564850722|FG000|Overall Study|Withdrawal by Subject|14|||
156480151|NCT01535261|564850722|FG000|Overall Study|Adverse Event|12|||
156543811|NCT02819635|565086198|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
156480152|NCT02009332|564850725|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
156480153|NCT02009332|564850726|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
156480154|NCT02009332|564850727|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
156480155|NCT02009332|564850728|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
156480156|NCT02009332|564850729|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
156480157|NCT02009332|564850730|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
156480158|NCT02009332|564850725|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
156480159|NCT02009332|564850726|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
156480160|NCT02009332|564850727|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
156480161|NCT02009332|564850728|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
156480162|NCT02009332|564850729|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
156480163|NCT02009332|564850730|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
156480164|NCT02009332|564850725|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
156480165|NCT02009332|564850726|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
156480166|NCT02009332|564850727|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
156480167|NCT02009332|564850728|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
156480168|NCT02009332|564850729|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
156480169|NCT02009332|564850730|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
156480170|NCT01912599|564850731|FG000|Overall Study|Withdrawal by Subject|0|||
156480171|NCT01912599|564850732|FG001|Overall Study|Withdrawal by Subject|1|||
156480172|NCT01280721|564850733|FG000|Overall Study|Adverse Event|4|||
156480173|NCT01280721|564850733|FG000|Overall Study|Physician Decision|3|||
156480174|NCT01280721|564850733|FG000|Overall Study|Withdrawal by Subject|6|||
156480175|NCT01280721|564850733|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
156480176|NCT01280721|564850733|FG000|Overall Study|No tolerability for the lowest dose|2|||
156480177|NCT01180400|564850734|FG000|Overall Study|Withdrawal by Subject|5|||
156480178|NCT01180400|564850735|FG001|Overall Study|Withdrawal by Subject|6|||
156480179|NCT01180400|564850734|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156480180|NCT01180400|564850735|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
156480181|NCT01180400|564850734|FG000|Overall Study|Adverse Event|12|||
156480182|NCT01180400|564850735|FG001|Overall Study|Adverse Event|10|||
156480183|NCT01180400|564850734|FG000|Overall Study|Severe non-compliance to protocol|1|||
156480184|NCT01180400|564850735|FG001|Overall Study|Severe non-compliance to protocol|2|||
156480185|NCT01180400|564850734|FG000|Overall Study|Condition under investigation worsened|2|||
156480186|NCT01180400|564850735|FG001|Overall Study|Condition under investigation worsened|1|||
156480187|NCT01180400|564850734|FG000|Overall Study|Lack of Efficacy|2|||
156480188|NCT01180400|564850735|FG001|Overall Study|Lack of Efficacy|0|||
156480189|NCT01180400|564850734|FG000|Overall Study|Study-specific withdrawal criteria|1|||
156480190|NCT01180400|564850735|FG001|Overall Study|Study-specific withdrawal criteria|2|||
156480191|NCT01180400|564850734|FG000|Overall Study|Lost to Follow-up|2|||
156480192|NCT01180400|564850735|FG001|Overall Study|Lost to Follow-up|3|||
156480193|NCT01180400|564850734|FG000|Overall Study|Other|0|||
156480194|NCT01180400|564850735|FG001|Overall Study|Other|1|||
156543812|NCT02819635|565086199|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
156480195|NCT03481725|564850736|FG000|Overall Study|Withdrawal by Subject|1|||
156480196|NCT03481725|564850737|FG001|Overall Study|Withdrawal by Subject|0|||
156480197|NCT00424476|564850744|FG000|Overall Study|Withdrawal by Subject|7|||
156480198|NCT00424476|564850745|FG001|Overall Study|Withdrawal by Subject|6|||
156480199|NCT00424476|564850746|FG002|Overall Study|Withdrawal by Subject|3|||
156480200|NCT00424476|564850744|FG000|Overall Study|Adverse Event|19|||
156480201|NCT00424476|564850745|FG001|Overall Study|Adverse Event|16|||
156480202|NCT00424476|564850746|FG002|Overall Study|Adverse Event|15|||
156480203|NCT00424476|564850744|FG000|Overall Study|Lack of Efficacy|16|||
156480204|NCT00424476|564850745|FG001|Overall Study|Lack of Efficacy|12|||
156345224|NCT03129100|564362387|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345225|NCT03129100|564362388|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345226|NCT03129100|564362389|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345227|NCT03129100|564362390|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345228|NCT03129100|564362391|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345229|NCT03129100|564362392|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345230|NCT03129100|564362393|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156480205|NCT00424476|564850746|FG002|Overall Study|Lack of Efficacy|12|||
156480206|NCT00424476|564850744|FG000|Overall Study|Lack of Compliance|1|||
156480207|NCT00424476|564850745|FG001|Overall Study|Lack of Compliance|1|||
156480208|NCT00424476|564850746|FG002|Overall Study|Lack of Compliance|1|||
156480209|NCT00424476|564850744|FG000|Overall Study|Lost to Follow-up|4|||
156480210|NCT00424476|564850745|FG001|Overall Study|Lost to Follow-up|6|||
156480211|NCT00424476|564850746|FG002|Overall Study|Lost to Follow-up|3|||
156480212|NCT00424476|564850744|FG000|Overall Study|Protocol Violation|7|||
156480213|NCT00424476|564850745|FG001|Overall Study|Protocol Violation|2|||
156480214|NCT00424476|564850746|FG002|Overall Study|Protocol Violation|3|||
156480215|NCT00424476|564850744|FG000|Overall Study|Physician Decision|3|||
156480216|NCT00424476|564850745|FG001|Overall Study|Physician Decision|2|||
156480217|NCT00424476|564850746|FG002|Overall Study|Physician Decision|3|||
156480218|NCT00424476|564850744|FG000|Overall Study|Other|4|||
156480219|NCT00424476|564850745|FG001|Overall Study|Other|3|||
156480220|NCT00424476|564850746|FG002|Overall Study|Other|9|||
156480221|NCT00657709|564850747|FG000|Overall Study|AE or Death|7|||
156480222|NCT00657709|564850748|FG001|Overall Study|AE or Death|7|||
156480223|NCT00657709|564850749|FG002|Overall Study|AE or Death|6|||
156480224|NCT00657709|564850750|FG003|Overall Study|AE or Death|7|||
156480225|NCT00657709|564850751|FG004|Overall Study|AE or Death|1|||
156480226|NCT00657709|564850747|FG000|Overall Study|Withdrawal by Subject|7|||
156480227|NCT00657709|564850748|FG001|Overall Study|Withdrawal by Subject|15|||
156480228|NCT00657709|564850749|FG002|Overall Study|Withdrawal by Subject|15|||
156480229|NCT00657709|564850750|FG003|Overall Study|Withdrawal by Subject|5|||
156480230|NCT00657709|564850751|FG004|Overall Study|Withdrawal by Subject|9|||
156480231|NCT00657709|564850747|FG000|Overall Study|Lost to Follow-up|9|||
156480232|NCT00657709|564850748|FG001|Overall Study|Lost to Follow-up|9|||
156480233|NCT00657709|564850749|FG002|Overall Study|Lost to Follow-up|7|||
156480234|NCT00657709|564850750|FG003|Overall Study|Lost to Follow-up|1|||
156480235|NCT00657709|564850751|FG004|Overall Study|Lost to Follow-up|21|||
156480236|NCT00657709|564850747|FG000|Overall Study|Protocol Violation|0|||
156480237|NCT00657709|564850748|FG001|Overall Study|Protocol Violation|2|||
156480238|NCT00657709|564850749|FG002|Overall Study|Protocol Violation|0|||
156480239|NCT00657709|564850750|FG003|Overall Study|Protocol Violation|1|||
156480240|NCT00657709|564850751|FG004|Overall Study|Protocol Violation|2|||
156480241|NCT01441596|564850752|FG000|Overall Study|Other reason not defined below|0|||
156480242|NCT01441596|564850753|FG001|Overall Study|Other reason not defined below|2|||
156480243|NCT01441596|564850754|FG002|Overall Study|Other reason not defined below|1|||
156480244|NCT01441596|564850752|FG000|Overall Study|Withdrawal by Subject|4|||
156480245|NCT01441596|564850753|FG001|Overall Study|Withdrawal by Subject|0|||
156480246|NCT01441596|564850754|FG002|Overall Study|Withdrawal by Subject|2|||
156480247|NCT01441596|564850752|FG000|Overall Study|Not treated|0|||
156480248|NCT01441596|564850753|FG001|Overall Study|Not treated|1|||
156480249|NCT01441596|564850754|FG002|Overall Study|Not treated|1|||
156480250|NCT03055988|564850755|FG000|Period 1|Adverse Event|0|||
156480251|NCT03055988|564850756|FG001|Period 1|Adverse Event|1|||
156480252|NCT03055988|564850755|FG000|Period 1|Lost to Follow-up|1|||
156480253|NCT03055988|564850756|FG001|Period 1|Lost to Follow-up|0|||
156480254|NCT03055988|564850755|FG000|Period 1|Withdrawal by Subject|0|||
156480255|NCT03055988|564850756|FG001|Period 1|Withdrawal by Subject|4|||
156480256|NCT03055988|564850755|FG000|Period 2|Adverse Event|0|||
156480257|NCT03055988|564850756|FG001|Period 2|Adverse Event|1|||
156480258|NCT03055988|564850755|FG000|Period 2|Other than listed|1|||
156480259|NCT03055988|564850756|FG001|Period 2|Other than listed|1|||
156480260|NCT01528605|564850757|FG000|Overall Study|Lost to Follow-up|1|||
156480261|NCT01528605|564850758|FG001|Overall Study|Lost to Follow-up|0|||
156480262|NCT01528605|564850759|FG002|Overall Study|Lost to Follow-up|1|||
156480263|NCT01528605|564850760|FG003|Overall Study|Lost to Follow-up|1|||
156480264|NCT01528605|564850761|FG004|Overall Study|Lost to Follow-up|0|||
156480265|NCT01528605|564850762|FG005|Overall Study|Lost to Follow-up|0|||
156480266|NCT01528605|564850757|FG000|Overall Study|Death|1|||
156480267|NCT01528605|564850758|FG001|Overall Study|Death|0|||
156480268|NCT01528605|564850759|FG002|Overall Study|Death|0|||
156480269|NCT01528605|564850760|FG003|Overall Study|Death|0|||
156480270|NCT01528605|564850761|FG004|Overall Study|Death|0|||
156480271|NCT01528605|564850762|FG005|Overall Study|Death|0|||
156480272|NCT01681511|564850763|FG000|Overall Study|No Treatment Received|1|||
156480273|NCT01681511|564850764|FG001|Overall Study|No Treatment Received|3|||
156480274|NCT01681511|564850763|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
156480275|NCT01681511|564850764|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
156480276|NCT01681511|564850763|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
156480277|NCT01681511|564850764|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
156480278|NCT01681511|564850763|FG000|Overall Study|No Daily Urine Sample Collected|0|||
156480279|NCT01681511|564850764|FG001|Overall Study|No Daily Urine Sample Collected|1|||
156480280|NCT01681511|564850763|FG000|Overall Study|No post-catheter sample collected|11|||
156480281|NCT01681511|564850764|FG001|Overall Study|No post-catheter sample collected|4|||
156480282|NCT01156675|564850765|FG000|Overall Study|Death|5|||
156480283|NCT01156675|564850766|FG001|Overall Study|Death|3|||
156480284|NCT01156675|564850767|FG002|Overall Study|Death|0|||
156480285|NCT01156675|564850765|FG000|Overall Study|No data|29|||
156480286|NCT01156675|564850766|FG001|Overall Study|No data|22|||
156480287|NCT01156675|564850767|FG002|Overall Study|No data|2|||
156480288|NCT00090519|564850781|FG000|Overall Study|Adverse Event|5|||
156480289|NCT00090519|564850782|FG001|Overall Study|Adverse Event|4|||
156480290|NCT00090519|564850781|FG000|Overall Study|Death|9|||
156480291|NCT00090519|564850782|FG001|Overall Study|Death|9|||
156480292|NCT00090519|564850781|FG000|Overall Study|Lost to Follow-up|26|||
156480293|NCT00090519|564850782|FG001|Overall Study|Lost to Follow-up|29|||
156480294|NCT00090519|564850781|FG000|Overall Study|Withdrawal by Subject|28|||
156480295|NCT00090519|564850782|FG001|Overall Study|Withdrawal by Subject|29|||
156480296|NCT00090519|564850781|FG000|Overall Study|Physician Decision|2|||
156480297|NCT00090519|564850782|FG001|Overall Study|Physician Decision|3|||
156480298|NCT00090519|564850781|FG000|Overall Study|Sponsor Decision|3|||
156480299|NCT00090519|564850782|FG001|Overall Study|Sponsor Decision|1|||
156480300|NCT00116649|564850783|FG000|Overall Study|Adverse Event|20|||
156480301|NCT00116649|564850783|FG000|Overall Study|Lack of Efficacy|1|||
156480302|NCT00116649|564850783|FG000|Overall Study|Lost to Follow-up|32|||
156480303|NCT00116649|564850783|FG000|Overall Study|Withdrawal by Subject|68|||
156480304|NCT00116649|564850783|FG000|Overall Study|Local Skin Reaction|9|||
156480305|NCT00116649|564850783|FG000|Overall Study|Various Reasons|18|||
156480306|NCT00116649|564850783|FG000|Overall Study|Protocol Specified|7|||
156480307|NCT02161146|564850784|FG000|Overall Study|Adverse Event|1|||
156480308|NCT02161146|564850785|FG001|Overall Study|Adverse Event|1|||
156480309|NCT02161146|564850786|FG002|Overall Study|Adverse Event|0|||
156480310|NCT02161146|564850787|FG003|Overall Study|Adverse Event|1|||
156480311|NCT02161146|564850788|FG004|Overall Study|Adverse Event|0|||
156480312|NCT02161146|564850784|FG000|Overall Study|Lost to Follow-up|0|||
156480313|NCT02161146|564850785|FG001|Overall Study|Lost to Follow-up|1|||
156480314|NCT02161146|564850786|FG002|Overall Study|Lost to Follow-up|0|||
156480315|NCT02161146|564850787|FG003|Overall Study|Lost to Follow-up|0|||
156480316|NCT02161146|564850788|FG004|Overall Study|Lost to Follow-up|0|||
156480317|NCT02161146|564850784|FG000|Overall Study|Personal Reasons|0|||
156480318|NCT02161146|564850785|FG001|Overall Study|Personal Reasons|1|||
156480319|NCT02161146|564850786|FG002|Overall Study|Personal Reasons|0|||
156480320|NCT02161146|564850787|FG003|Overall Study|Personal Reasons|2|||
156480321|NCT02161146|564850788|FG004|Overall Study|Personal Reasons|1|||
156480322|NCT02161146|564850784|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156480323|NCT02161146|564850785|FG001|Overall Study|Other Miscellaneous Reasons|1|||
156480324|NCT02161146|564850786|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156480325|NCT02161146|564850787|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156480326|NCT02161146|564850788|FG004|Overall Study|Other Miscellaneous Reasons|0|||
156345231|NCT03129100|564362394|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156480327|NCT00845520|564850789|FG000|Overall Study|Death|1|||
156480328|NCT00845520|564850790|FG001|Overall Study|Death|2|||
156480329|NCT00845520|564850791|FG002|Overall Study|Death|0|||
156480330|NCT00845520|564850789|FG000|Overall Study|Lost to Follow-up|1|||
156480331|NCT00845520|564850790|FG001|Overall Study|Lost to Follow-up|0|||
156480332|NCT00845520|564850791|FG002|Overall Study|Lost to Follow-up|0|||
156480333|NCT00845520|564850789|FG000|Overall Study|Adverse Event|0|||
156480334|NCT00845520|564850790|FG001|Overall Study|Adverse Event|0|||
156480335|NCT00845520|564850791|FG002|Overall Study|Adverse Event|1|||
156480336|NCT02613403|564850792|FG000|Overall Study|Lost to Follow-up|0|||
156480337|NCT02613403|564850793|FG001|Overall Study|Lost to Follow-up|1|||
156480338|NCT02613403|564850794|FG002|Overall Study|Lost to Follow-up|0|||
156480339|NCT02613403|564850795|FG003|Overall Study|Lost to Follow-up|0|||
156480340|NCT02613403|564850796|FG004|Overall Study|Lost to Follow-up|0|||
156480341|NCT02613403|564850792|FG000|Overall Study|Withdrawal by Subject|2|||
156480342|NCT02613403|564850793|FG001|Overall Study|Withdrawal by Subject|0|||
156480343|NCT02613403|564850794|FG002|Overall Study|Withdrawal by Subject|0|||
156480344|NCT02613403|564850795|FG003|Overall Study|Withdrawal by Subject|0|||
156480345|NCT02613403|564850796|FG004|Overall Study|Withdrawal by Subject|0|||
156480346|NCT00800176|564850797|FG000|Overall Study|Adverse Event|2|||
156480347|NCT00800176|564850798|FG001|Overall Study|Adverse Event|1|||
156480348|NCT00800176|564850799|FG002|Overall Study|Adverse Event|0|||
156480349|NCT00800176|564850800|FG003|Overall Study|Adverse Event|2|||
156480350|NCT00800176|564850801|FG004|Overall Study|Adverse Event|1|||
156480351|NCT00800176|564850802|FG005|Overall Study|Adverse Event|1|||
156480352|NCT00800176|564850797|FG000|Overall Study|Refused treatment|3|||
156345232|NCT03129100|564362395|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345233|NCT03129100|564362396|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345234|NCT03129100|564362397|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345235|NCT03129100|564362398|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345236|NCT03129100|564362399|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156480353|NCT00800176|564850798|FG001|Overall Study|Refused treatment|2|||
156480354|NCT00800176|564850799|FG002|Overall Study|Refused treatment|0|||
156480355|NCT00800176|564850800|FG003|Overall Study|Refused treatment|0|||
156480356|NCT00800176|564850801|FG004|Overall Study|Refused treatment|1|||
156480357|NCT00800176|564850802|FG005|Overall Study|Refused treatment|4|||
156480358|NCT00800176|564850797|FG000|Overall Study|Failure to return|3|||
156480359|NCT00800176|564850798|FG001|Overall Study|Failure to return|3|||
156480360|NCT00800176|564850799|FG002|Overall Study|Failure to return|0|||
156480361|NCT00800176|564850800|FG003|Overall Study|Failure to return|2|||
156480362|NCT00800176|564850801|FG004|Overall Study|Failure to return|0|||
156480363|NCT00800176|564850802|FG005|Overall Study|Failure to return|0|||
156480364|NCT00800176|564850797|FG000|Overall Study|Other|1|||
156480365|NCT00800176|564850798|FG001|Overall Study|Other|0|||
156480366|NCT00800176|564850799|FG002|Overall Study|Other|0|||
156480367|NCT00800176|564850800|FG003|Overall Study|Other|0|||
156480368|NCT00800176|564850801|FG004|Overall Study|Other|2|||
156480369|NCT00800176|564850802|FG005|Overall Study|Other|0|||
156480370|NCT02659540|564850805|FG000|Overall Study|Adverse Event|3|||
156480371|NCT02659540|564850806|FG001|Overall Study|Adverse Event|2|||
156480372|NCT02659540|564850805|FG000|Overall Study|Death|1|||
156480373|NCT02659540|564850806|FG001|Overall Study|Death|0|||
156480374|NCT02659540|564850805|FG000|Overall Study|Progressive disease|2|||
156480375|NCT02659540|564850806|FG001|Overall Study|Progressive disease|6|||
156480376|NCT00608959|564852474|FG000|Part 1|Did not meet eligibility criteria|1|||
156480377|NCT01416285|564852475|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
156480378|NCT01416285|564852476|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
156480379|NCT01005602|564852477|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
156480380|NCT01005602|564852478|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
156480381|NCT01248715|564852479|FG000|Overall Study|Not influenza positive|501|||
156480382|NCT01248715|564852480|FG001|Overall Study|Not influenza positive|510|||
156480383|NCT01131325|564852481|FG000|Overall Study|Adverse Event|1|||
156480384|NCT01131325|564852481|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
156480385|NCT01807234|564852482|FG000|Overall Study|Lost to Follow-up|2|||
156480386|NCT01807234|564852483|FG001|Overall Study|Lost to Follow-up|5|||
156480387|NCT01807234|564852484|FG002|Overall Study|Lost to Follow-up|1|||
156480388|NCT01807234|564852485|FG003|Overall Study|Lost to Follow-up|1|||
156480389|NCT01807234|564852486|FG004|Overall Study|Lost to Follow-up|1|||
156480390|NCT01807234|564852487|FG005|Overall Study|Lost to Follow-up|2|||
156480391|NCT01807234|564852482|FG000|Overall Study|Withdrawal by Subject|3|||
156480392|NCT01807234|564852483|FG001|Overall Study|Withdrawal by Subject|1|||
156480393|NCT01807234|564852484|FG002|Overall Study|Withdrawal by Subject|1|||
156480394|NCT01807234|564852485|FG003|Overall Study|Withdrawal by Subject|1|||
156480395|NCT01807234|564852486|FG004|Overall Study|Withdrawal by Subject|2|||
156480396|NCT01807234|564852487|FG005|Overall Study|Withdrawal by Subject|1|||
156480397|NCT01807234|564852482|FG000|Overall Study|Lack of Efficacy|0|||
156480398|NCT01807234|564852483|FG001|Overall Study|Lack of Efficacy|0|||
156480399|NCT01807234|564852484|FG002|Overall Study|Lack of Efficacy|0|||
156480400|NCT01807234|564852485|FG003|Overall Study|Lack of Efficacy|0|||
156480401|NCT01807234|564852486|FG004|Overall Study|Lack of Efficacy|1|||
156480402|NCT01807234|564852487|FG005|Overall Study|Lack of Efficacy|1|||
156480403|NCT01345253|564852488|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
156480404|NCT01345253|564852489|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
156480405|NCT01345253|564852488|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
156480406|NCT01345253|564852489|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
156480407|NCT01345253|564852488|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
156480408|NCT01345253|564852489|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
156480409|NCT01345253|564852488|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
156480410|NCT01345253|564852489|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
156480411|NCT01345253|564852488|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
156480412|NCT01345253|564852489|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
156480413|NCT01345253|564852488|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
156480414|NCT01345253|564852489|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
156480415|NCT01345253|564852488|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
156345237|NCT03129100|564362400|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345238|NCT03129100|564362401|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
156480416|NCT01345253|564852489|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
156480417|NCT01345253|564852488|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
156480418|NCT01345253|564852489|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
156480419|NCT01345253|564852488|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
156480420|NCT01345253|564852489|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
156480421|NCT01345253|564852488|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
156480422|NCT01345253|564852489|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
156480423|NCT01345253|564852488|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
156565216|NCT03263806|565157643|FG000|Overall Study|Study Termination|5|||
156543813|NCT02819635|565086200|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
156543814|NCT02819635|565086201|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
156543815|NCT02819635|565086190|FG000|Substudy 2, Part 2|Adverse Event|0|||
156480424|NCT01345253|564852489|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
156480425|NCT01345253|564852488|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
156480426|NCT01345253|564852489|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
156480427|NCT01345253|564852488|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
156345239|NCT03129100|564362402|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345240|NCT03129100|564362403|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156480428|NCT01345253|564852489|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
156480429|NCT01345253|564852488|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
156345241|NCT03129100|564362404|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345242|NCT03129100|564362405|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345243|NCT03129100|564362406|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345244|NCT03129100|564362407|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345245|NCT03129100|564362408|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345246|NCT03129100|564362409|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345247|NCT03129100|564362410|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345248|NCT03129100|564362411|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156345249|NCT03129100|564362386|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345250|NCT03129100|564362387|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345251|NCT03129100|564362388|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345252|NCT03129100|564362389|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345253|NCT03129100|564362390|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345254|NCT03129100|564362391|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345255|NCT03129100|564362392|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345256|NCT03129100|564362393|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345257|NCT03129100|564362394|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345258|NCT03129100|564362395|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345259|NCT03129100|564362396|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345260|NCT03129100|564362397|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345261|NCT03129100|564362398|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
156345262|NCT03129100|564362399|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345263|NCT03129100|564362400|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
156345264|NCT03129100|564362401|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
156345265|NCT03129100|564362402|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156480430|NCT01345253|564852489|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
156480431|NCT01345253|564852488|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
156480432|NCT01345253|564852489|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
156480433|NCT02137785|564852492|FG000|Overall Study|Lost to Follow-up|1|||
156480434|NCT02137785|564852493|FG001|Overall Study|Lost to Follow-up|0|||
156480435|NCT02137785|564852492|FG000|Overall Study|Withdrawal by Subject|1|||
156480436|NCT02137785|564852493|FG001|Overall Study|Withdrawal by Subject|4|||
156480437|NCT02137785|564852492|FG000|Overall Study|subject moved out of state|1|||
156480438|NCT02137785|564852493|FG001|Overall Study|subject moved out of state|0|||
156480439|NCT00417885|564852494|FG000|Overall Study|Adverse Event|1|||
156480440|NCT00417885|564852494|FG000|Overall Study|Objective Progression or Relapse|3|||
156480441|NCT00417885|564852494|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
156480442|NCT01584648|564852495|FG000|Overall Study|Death|136|||
156480443|NCT01584648|564852496|FG001|Overall Study|Death|146|||
156480444|NCT01584648|564852495|FG000|Overall Study|Lost to Follow-up|9|||
156480445|NCT01584648|564852496|FG001|Overall Study|Lost to Follow-up|9|||
156480446|NCT01584648|564852495|FG000|Overall Study|Investigator discretion|3|||
156480447|NCT01584648|564852496|FG001|Overall Study|Investigator discretion|2|||
156480448|NCT01584648|564852495|FG000|Overall Study|Withdrew consent|13|||
156480449|NCT01584648|564852496|FG001|Overall Study|Withdrew consent|4|||
156480450|NCT01584648|564852495|FG000|Overall Study|Study closed/terminated|50|||
156480451|NCT01584648|564852496|FG001|Overall Study|Study closed/terminated|23|||
156480452|NCT01584648|564852495|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
156480453|NCT01584648|564852496|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
156480454|NCT01190436|564852497|FG000|Overall Study|Lost to Follow-up|35|||
156480455|NCT01190436|564852497|FG000|Overall Study|Other|4|||
156480456|NCT03146845|564852498|FG000|Overall Study|Reference ulcer healed|1|||
156480457|NCT03146845|564852499|FG001|Overall Study|Reference ulcer healed|0|||
156480458|NCT03146845|564852498|FG000|Overall Study|Physician Decision|1|||
156345266|NCT03129100|564362403|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345267|NCT03129100|564362404|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345268|NCT03129100|564362405|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345269|NCT03129100|564362406|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345270|NCT03129100|564362407|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345271|NCT03129100|564362408|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345272|NCT03129100|564362409|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345273|NCT03129100|564362410|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345274|NCT03129100|564362411|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156345275|NCT03129100|564362386|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345276|NCT03129100|564362387|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345277|NCT03129100|564362388|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345278|NCT03129100|564362389|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345279|NCT03129100|564362390|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345280|NCT03129100|564362391|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345281|NCT03129100|564362392|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345282|NCT03129100|564362393|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345283|NCT03129100|564362394|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156480459|NCT03146845|564852499|FG001|Overall Study|Physician Decision|0|||
156480460|NCT03146845|564852498|FG000|Overall Study|Adverse Event|1|||
156480461|NCT03146845|564852499|FG001|Overall Study|Adverse Event|0|||
156480462|NCT03146845|564852498|FG000|Overall Study|Withdrawal by Subject|2|||
156480463|NCT03146845|564852499|FG001|Overall Study|Withdrawal by Subject|0|||
156480464|NCT03146845|564852498|FG000|Overall Study|Noncompliance|0|||
156480465|NCT03146845|564852499|FG001|Overall Study|Noncompliance|1|||
156480466|NCT03146845|564852498|FG000|Overall Study|Protocol Violation|0|||
156480467|NCT03146845|564852499|FG001|Overall Study|Protocol Violation|2|||
156480468|NCT03146845|564852498|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
156480469|NCT03146845|564852499|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
156480470|NCT00113529|564852503|FG000|Overall Study|Adverse Event|4|||
156480471|NCT00113529|564852503|FG000|Overall Study|Lack of Efficacy|20|||
156480472|NCT00113529|564852503|FG000|Overall Study|Decision of sponsor|6|||
156480473|NCT00113529|564852503|FG000|Overall Study|Withdrawal by Subject|4|||
156480474|NCT01757288|564852509|FG000|Overall Study|Consent withdrawal|0|||
156480475|NCT01757288|564852510|FG001|Overall Study|Consent withdrawal|4|||
156480476|NCT01757288|564852511|FG002|Overall Study|Consent withdrawal|4|||
156480477|NCT01757288|564852509|FG000|Overall Study|Patient off study, IRB hold.|0|||
156480478|NCT01757288|564852510|FG001|Overall Study|Patient off study, IRB hold.|0|||
156480479|NCT01757288|564852511|FG002|Overall Study|Patient off study, IRB hold.|1|||
156480480|NCT01757288|564852509|FG000|Overall Study|Patient death prior to starting treatment|0|||
156480481|NCT01757288|564852510|FG001|Overall Study|Patient death prior to starting treatment|0|||
156480482|NCT01757288|564852511|FG002|Overall Study|Patient death prior to starting treatment|1|||
156480483|NCT01757288|564852509|FG000|Overall Study|Wrong medication administered|0|||
156480484|NCT01757288|564852510|FG001|Overall Study|Wrong medication administered|1|||
156480485|NCT01757288|564852511|FG002|Overall Study|Wrong medication administered|0|||
156480486|NCT01757288|564852509|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
156480487|NCT01757288|564852510|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
156480488|NCT01757288|564852511|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
156480489|NCT01757288|564852509|FG000|Overall Study|Not meeting protocol constraints|0|||
156480490|NCT01757288|564852510|FG001|Overall Study|Not meeting protocol constraints|1|||
156480491|NCT01757288|564852511|FG002|Overall Study|Not meeting protocol constraints|1|||
156480492|NCT01757288|564852509|FG000|Overall Study|Multiple missed appointments|0|||
156480493|NCT01757288|564852510|FG001|Overall Study|Multiple missed appointments|1|||
156480494|NCT01757288|564852511|FG002|Overall Study|Multiple missed appointments|0|||
156480495|NCT01757288|564852509|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
156480496|NCT01757288|564852510|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
156480497|NCT01757288|564852511|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
156480498|NCT01757288|564852509|FG000|Overall Study|>2 weeks treatment break|0|||
156480499|NCT01757288|564852510|FG001|Overall Study|>2 weeks treatment break|0|||
156480500|NCT01757288|564852511|FG002|Overall Study|>2 weeks treatment break|1|||
156480501|NCT02825550|564852513|FG000|Overall Study|Physician Decision|1|||
156480502|NCT03386344|564852514|FG000|Overall Study|Adverse Event|6|||
156480503|NCT03386344|564852515|FG001|Overall Study|Adverse Event|3|||
156480504|NCT03386344|564852516|FG002|Overall Study|Adverse Event|1|||
156480505|NCT03386344|564852514|FG000|Overall Study|Poor Compliance to Protocol|0|||
156480506|NCT03386344|564852515|FG001|Overall Study|Poor Compliance to Protocol|1|||
156480507|NCT03386344|564852516|FG002|Overall Study|Poor Compliance to Protocol|0|||
156480508|NCT03386344|564852514|FG000|Overall Study|Study Terminated by Sponsor|101|||
156480509|NCT03386344|564852515|FG001|Overall Study|Study Terminated by Sponsor|102|||
156480510|NCT03386344|564852516|FG002|Overall Study|Study Terminated by Sponsor|106|||
156543816|NCT02819635|565086191|FG001|Substudy 2, Part 2|Adverse Event|0|||
156480511|NCT03386344|564852514|FG000|Overall Study|Lost to Follow-up|3|||
156480512|NCT03386344|564852515|FG001|Overall Study|Lost to Follow-up|2|||
156480513|NCT03386344|564852516|FG002|Overall Study|Lost to Follow-up|1|||
156543817|NCT02819635|565086192|FG002|Substudy 2, Part 2|Adverse Event|0|||
156480514|NCT03386344|564852514|FG000|Overall Study|At the Participant's own Request|7|||
156480515|NCT03386344|564852515|FG001|Overall Study|At the Participant's own Request|7|||
156480516|NCT03386344|564852516|FG002|Overall Study|At the Participant's own Request|8|||
156480517|NCT03386344|564852514|FG000|Overall Study|Reason not Specified|0|||
156480518|NCT03386344|564852515|FG001|Overall Study|Reason not Specified|1|||
156480519|NCT03386344|564852516|FG002|Overall Study|Reason not Specified|0|||
156480520|NCT00248794|564852525|FG000|Overall Study|Lost to Follow-up|6|||
156480521|NCT00248794|564852526|FG001|Overall Study|Lost to Follow-up|8|||
156480522|NCT00248794|564852527|FG002|Overall Study|Lost to Follow-up|3|||
156480523|NCT04421456|564852528|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
156480524|NCT04421456|564852529|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
156480525|NCT04421456|564852530|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
156480526|NCT04421456|564852528|FG000|Randomized Treatment Period|Adverse Event|0|||
156480527|NCT04421456|564852529|FG001|Randomized Treatment Period|Adverse Event|1|||
156480528|NCT04421456|564852530|FG002|Randomized Treatment Period|Adverse Event|0|||
156480529|NCT04421456|564852528|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
156480530|NCT04421456|564852529|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
156480531|NCT04421456|564852530|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
156480532|NCT04421456|564852528|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
156480533|NCT04421456|564852529|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
156480534|NCT04421456|564852530|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
156480535|NCT04421456|564852528|FG000|Randomized Treatment Period|Participant non-compliance|1|||
156480536|NCT04421456|564852529|FG001|Randomized Treatment Period|Participant non-compliance|1|||
156480537|NCT04421456|564852530|FG002|Randomized Treatment Period|Participant non-compliance|2|||
156480538|NCT04421456|564852528|FG000|Randomized Treatment Period|Other|0|||
156480539|NCT04421456|564852529|FG001|Randomized Treatment Period|Other|1|||
156480540|NCT04421456|564852530|FG002|Randomized Treatment Period|Other|3|||
156480541|NCT03209492|564852531|FG000|Overall Study|Case Report Forms Uncollected|5|||
156480542|NCT03444155|564852534|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
156480543|NCT03444155|564852535|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
156480544|NCT01894620|564852540|FG000|Overall Study|Withdrawal by Subject|0|||
156480545|NCT01894620|564852541|FG001|Overall Study|Withdrawal by Subject|1|||
156480546|NCT02877680|564852542|FG000|Overall Study|Lost to Follow-up|1|||
156480547|NCT02877680|564852543|FG001|Overall Study|Lost to Follow-up|1|||
156480548|NCT01133678|564852544|FG000|Overall Study|Death|1|||
156480549|NCT01133678|564852545|FG001|Overall Study|Death|1|||
156480550|NCT01124916|564852546|FG000|Overall Study|Lost to Follow-up|3|||
156480551|NCT01124916|564852547|FG001|Overall Study|Lost to Follow-up|2|||
156480552|NCT00879710|564852548|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
156480553|NCT00879710|564852549|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
156480554|NCT00879710|564852550|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
156480555|NCT00879710|564852551|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
156480556|NCT00879710|564852548|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
156480557|NCT00879710|564852549|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
156480558|NCT00879710|564852550|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
156480559|NCT00879710|564852551|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
156543818|NCT02819635|565086193|FG003|Substudy 2, Part 2|Adverse Event|0|||
156480560|NCT01864200|564852552|FG000|Overall Study|Lost to Follow-up|1|||
156480561|NCT01864200|564852553|FG001|Overall Study|Lost to Follow-up|3|||
156480562|NCT01864200|564852552|FG000|Overall Study|Protocol Violation|1|||
156480563|NCT01864200|564852553|FG001|Overall Study|Protocol Violation|0|||
156480564|NCT02077374|564852556|FG000|Overall Study|Withdrawal by Subject|0|||
156480565|NCT02077374|564852557|FG001|Overall Study|Withdrawal by Subject|1|||
156480566|NCT02077374|564852556|FG000|Overall Study|Protocol Violation|0|||
156480567|NCT02077374|564852557|FG001|Overall Study|Protocol Violation|1|||
156480568|NCT00446095|564852558|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
156480569|NCT00446095|564852559|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
156480570|NCT00446095|564852560|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
156480571|NCT00446095|564852561|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
156480572|NCT00446095|564852562|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
156480573|NCT00446095|564852558|FG000|Phase II (8 Weeks)|Adverse Event|0|||
156345284|NCT03129100|564362395|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345285|NCT03129100|564362396|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345286|NCT03129100|564362397|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345287|NCT03129100|564362398|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345288|NCT03129100|564362399|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345289|NCT03129100|564362400|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345290|NCT03129100|564362401|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345291|NCT03129100|564362402|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345292|NCT03129100|564362403|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
156345293|NCT03129100|564362404|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345294|NCT03129100|564362405|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
156345295|NCT03129100|564362406|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345296|NCT03129100|564362407|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345297|NCT03129100|564362408|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345298|NCT03129100|564362409|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345299|NCT03129100|564362410|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345300|NCT03129100|564362411|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156345301|NCT03129100|564362386|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345302|NCT03129100|564362387|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345303|NCT03129100|564362388|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345304|NCT03129100|564362389|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345305|NCT03129100|564362390|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345306|NCT03129100|564362391|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345307|NCT03129100|564362392|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345308|NCT03129100|564362393|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345309|NCT03129100|564362394|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345310|NCT03129100|564362395|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345311|NCT03129100|564362396|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345312|NCT03129100|564362397|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345313|NCT03129100|564362398|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345314|NCT03129100|564362399|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345315|NCT03129100|564362400|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345316|NCT03129100|564362401|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345317|NCT03129100|564362402|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345318|NCT03129100|564362403|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345319|NCT03129100|564362404|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345320|NCT03129100|564362405|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345321|NCT03129100|564362406|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
156345322|NCT03129100|564362407|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345323|NCT03129100|564362408|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345324|NCT03129100|564362409|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345325|NCT03129100|564362410|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156480574|NCT00446095|564852559|FG001|Phase II (8 Weeks)|Adverse Event|1|||
156345326|NCT03129100|564362411|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156345327|NCT03129100|564362386|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
156345328|NCT03129100|564362387|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
156345329|NCT03129100|564362388|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
156345330|NCT03129100|564362389|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
156480575|NCT00446095|564852560|FG002|Phase II (8 Weeks)|Adverse Event|1|||
156480576|NCT00446095|564852561|FG003|Phase II (8 Weeks)|Adverse Event|0|||
156480577|NCT00446095|564852562|FG004|Phase II (8 Weeks)|Adverse Event|0|||
156480578|NCT00446095|564852558|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
156345331|NCT03129100|564362390|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
156480579|NCT00446095|564852559|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
156480580|NCT00446095|564852560|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
156480581|NCT00446095|564852561|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
156480582|NCT00446095|564852562|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
156480583|NCT00446095|564852558|FG000|Phase II (8 Weeks)|Physician Decision|1|||
156480584|NCT00446095|564852559|FG001|Phase II (8 Weeks)|Physician Decision|0|||
156480585|NCT00446095|564852560|FG002|Phase II (8 Weeks)|Physician Decision|0|||
156480586|NCT00446095|564852561|FG003|Phase II (8 Weeks)|Physician Decision|0|||
156480587|NCT00446095|564852562|FG004|Phase II (8 Weeks)|Physician Decision|0|||
156480588|NCT00446095|564852558|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
156480589|NCT00446095|564852559|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
156480590|NCT00446095|564852560|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
156480591|NCT00446095|564852561|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
156480592|NCT00446095|564852562|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
156480593|NCT00446095|564852558|FG000|Phase II (8 Weeks)|Ongoing|0|||
156480594|NCT00446095|564852559|FG001|Phase II (8 Weeks)|Ongoing|0|||
156480595|NCT00446095|564852560|FG002|Phase II (8 Weeks)|Ongoing|1|||
156480596|NCT00446095|564852561|FG003|Phase II (8 Weeks)|Ongoing|0|||
156480597|NCT00446095|564852562|FG004|Phase II (8 Weeks)|Ongoing|0|||
156480598|NCT00446095|564852558|FG000|Phase I (28 Days)|Adverse Event|0|||
156480599|NCT00446095|564852559|FG001|Phase I (28 Days)|Adverse Event|0|||
156480600|NCT00446095|564852560|FG002|Phase I (28 Days)|Adverse Event|0|||
156480601|NCT00446095|564852561|FG003|Phase I (28 Days)|Adverse Event|1|||
156480602|NCT00446095|564852562|FG004|Phase I (28 Days)|Adverse Event|0|||
156480603|NCT00446095|564852558|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
156480604|NCT00446095|564852559|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
156480605|NCT00446095|564852560|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
156480606|NCT00446095|564852561|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
156480607|NCT00446095|564852562|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
156480608|NCT00886834|564852563|FG000|Overall Study|Protocol Violation|0|||
156480609|NCT00886834|564852564|FG001|Overall Study|Protocol Violation|3|||
156480610|NCT02574286|564852565|FG000|Overall Study|Adverse Event|3|||
156480611|NCT02574286|564852565|FG000|Overall Study|Withdrawal by Subject|2|||
156480612|NCT01029925|564852568|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
156480613|NCT01029925|564852568|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
156480614|NCT01029925|564852568|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
156480615|NCT02159352|564852569|FG000|Overall Study|Adverse Event|3|||
156480616|NCT02159352|564852570|FG001|Overall Study|Adverse Event|1|||
156480617|NCT02159352|564852569|FG000|Overall Study|Withdrawal by Subject|0|||
156480618|NCT02159352|564852570|FG001|Overall Study|Withdrawal by Subject|1|||
156480619|NCT00529529|564852571|FG000|Overall Study|Adverse Event|12|||
156480620|NCT00529529|564852572|FG001|Overall Study|Adverse Event|17|||
156480621|NCT00529529|564852573|FG002|Overall Study|Adverse Event|8|||
156480622|NCT00529529|564852571|FG000|Overall Study|Subject withdrew consent|12|||
156480623|NCT00529529|564852572|FG001|Overall Study|Subject withdrew consent|9|||
156480624|NCT00529529|564852573|FG002|Overall Study|Subject withdrew consent|12|||
156480625|NCT00529529|564852571|FG000|Overall Study|Protocol deviation|8|||
156480626|NCT00529529|564852572|FG001|Overall Study|Protocol deviation|12|||
156480627|NCT00529529|564852573|FG002|Overall Study|Protocol deviation|5|||
156480628|NCT00529529|564852571|FG000|Overall Study|Lost to Follow-up|5|||
156480629|NCT00529529|564852572|FG001|Overall Study|Lost to Follow-up|3|||
156480630|NCT00529529|564852573|FG002|Overall Study|Lost to Follow-up|1|||
156480631|NCT00529529|564852571|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156480632|NCT00529529|564852572|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156480633|NCT00529529|564852573|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156480634|NCT00529529|564852571|FG000|Overall Study|Death|2|||
156480635|NCT00529529|564852572|FG001|Overall Study|Death|0|||
156480636|NCT00529529|564852573|FG002|Overall Study|Death|0|||
156480637|NCT00529529|564852571|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156480638|NCT00529529|564852572|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156480639|NCT00529529|564852573|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156480640|NCT00529529|564852571|FG000|Overall Study|Administrative problems|1|||
156480641|NCT00529529|564852572|FG001|Overall Study|Administrative problems|0|||
156480642|NCT00529529|564852573|FG002|Overall Study|Administrative problems|3|||
156480643|NCT02279732|564852574|FG000|Overall Study|Death|23|||
156480644|NCT02279732|564852575|FG001|Overall Study|Death|20|||
156480645|NCT02279732|564852574|FG000|Overall Study|Disease Progression|13|||
156480646|NCT02279732|564852575|FG001|Overall Study|Disease Progression|3|||
156480647|NCT02279732|564852574|FG000|Overall Study|Withdrawal by Subject|2|||
156480648|NCT02279732|564852575|FG001|Overall Study|Withdrawal by Subject|7|||
156480649|NCT02279732|564852574|FG000|Overall Study|Adverse Event|1|||
156345332|NCT03129100|564362391|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
156345333|NCT03129100|564362392|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
156345334|NCT03129100|564362393|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
156345335|NCT03129100|564362394|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
156345336|NCT03129100|564362395|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
156345337|NCT03129100|564362396|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
156480650|NCT02279732|564852575|FG001|Overall Study|Adverse Event|2|||
156480651|NCT02279732|564852574|FG000|Overall Study|Administrative Reason By Sponsor|0|||
156480652|NCT02279732|564852575|FG001|Overall Study|Administrative Reason By Sponsor|2|||
156480653|NCT02279732|564852574|FG000|Overall Study|Study Drug Toxicity|2|||
156480654|NCT02279732|564852575|FG001|Overall Study|Study Drug Toxicity|0|||
156480655|NCT02279732|564852574|FG000|Overall Study|Lost to Follow-up|0|||
156480656|NCT02279732|564852575|FG001|Overall Study|Lost to Follow-up|1|||
156480657|NCT02279732|564852574|FG000|Overall Study|Maximum Clinical Benefit|1|||
156480658|NCT02279732|564852575|FG001|Overall Study|Maximum Clinical Benefit|0|||
156480659|NCT02279732|564852574|FG000|Overall Study|Subject Requested to Discontinue|0|||
156480660|NCT02279732|564852575|FG001|Overall Study|Subject Requested to Discontinue|1|||
156480661|NCT02279732|564852574|FG000|Overall Study|Other|53|||
156480662|NCT02279732|564852575|FG001|Overall Study|Other|67|||
156480663|NCT02279732|564852574|FG000|Overall Study|Other|3|||
156480664|NCT02279732|564852575|FG001|Overall Study|Other|3|||
156480665|NCT02203513|564852576|FG000|Overall Study|Refused further treatment|2|||
156480666|NCT02203513|564852577|FG001|Overall Study|Refused further treatment|0|||
156480667|NCT02203513|564852578|FG002|Overall Study|Refused further treatment|1|||
156480668|NCT02203513|564852579|FG003|Overall Study|Refused further treatment|0|||
156480669|NCT02203513|564852580|FG004|Overall Study|Refused further treatment|0|||
156480670|NCT02203513|564852576|FG000|Overall Study|Switched to alternative treatment|3|||
156480671|NCT02203513|564852577|FG001|Overall Study|Switched to alternative treatment|4|||
156480672|NCT02203513|564852578|FG002|Overall Study|Switched to alternative treatment|0|||
156480673|NCT02203513|564852579|FG003|Overall Study|Switched to alternative treatment|0|||
156345338|NCT03129100|564362397|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
156345339|NCT03129100|564362398|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
156480674|NCT02203513|564852580|FG004|Overall Study|Switched to alternative treatment|4|||
156480675|NCT02203513|564852576|FG000|Overall Study|Did not receive investigational product (IP)|0|||
156480676|NCT02203513|564852577|FG001|Overall Study|Did not receive investigational product (IP)|1|||
156480677|NCT02203513|564852578|FG002|Overall Study|Did not receive investigational product (IP)|0|||
156480678|NCT02203513|564852579|FG003|Overall Study|Did not receive investigational product (IP)|0|||
156345340|NCT03129100|564362399|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
156480679|NCT02203513|564852580|FG004|Overall Study|Did not receive investigational product (IP)|0|||
156480680|NCT02203513|564852576|FG000|Overall Study|Death (unrelated to study therapy)|1|||
156480681|NCT02203513|564852577|FG001|Overall Study|Death (unrelated to study therapy)|3|||
156480682|NCT02203513|564852578|FG002|Overall Study|Death (unrelated to study therapy)|1|||
156480683|NCT02203513|564852579|FG003|Overall Study|Death (unrelated to study therapy)|0|||
156543819|NCT02819635|565086194|FG004|Substudy 2, Part 2|Adverse Event|0|||
156480684|NCT02203513|564852580|FG004|Overall Study|Death (unrelated to study therapy)|2|||
156480685|NCT02203513|564852576|FG000|Overall Study|Lost to Follow-up|0|||
156480686|NCT02203513|564852577|FG001|Overall Study|Lost to Follow-up|0|||
156480687|NCT02203513|564852578|FG002|Overall Study|Lost to Follow-up|1|||
156480688|NCT02203513|564852579|FG003|Overall Study|Lost to Follow-up|1|||
156480689|NCT02203513|564852580|FG004|Overall Study|Lost to Follow-up|0|||
156480690|NCT03060525|564852582|FG000|Overall Study|moved out of state|1|||
156480691|NCT03060525|564852583|FG001|Overall Study|moved out of state|1|||
156480692|NCT03060525|564852584|FG002|Overall Study|moved out of state|1|||
156480693|NCT03060525|564852585|FG003|Overall Study|moved out of state|1|||
156480694|NCT03060525|564852582|FG000|Overall Study|unable to meet time commitment required of study|2|||
156480695|NCT03060525|564852583|FG001|Overall Study|unable to meet time commitment required of study|3|||
156480696|NCT03060525|564852584|FG002|Overall Study|unable to meet time commitment required of study|3|||
156480697|NCT03060525|564852585|FG003|Overall Study|unable to meet time commitment required of study|1|||
156480698|NCT03060525|564852582|FG000|Overall Study|no longer interested in doing intervention|0|||
156480699|NCT03060525|564852583|FG001|Overall Study|no longer interested in doing intervention|0|||
156480700|NCT03060525|564852584|FG002|Overall Study|no longer interested in doing intervention|0|||
156480701|NCT03060525|564852585|FG003|Overall Study|no longer interested in doing intervention|1|||
156480702|NCT02978716|564852586|FG000|Overall Study|Death|25|||
156480703|NCT02978716|564852587|FG001|Overall Study|Death|13|||
156480704|NCT02978716|564852588|FG002|Overall Study|Death|20|||
156480705|NCT02978716|564852586|FG000|Overall Study|Lost to Follow-up|0|||
156480706|NCT02978716|564852587|FG001|Overall Study|Lost to Follow-up|0|||
156480707|NCT02978716|564852588|FG002|Overall Study|Lost to Follow-up|1|||
156480708|NCT02978716|564852586|FG000|Overall Study|Withdrawal by Subject|6|||
156480709|NCT02978716|564852587|FG001|Overall Study|Withdrawal by Subject|4|||
156480710|NCT02978716|564852588|FG002|Overall Study|Withdrawal by Subject|5|||
156480711|NCT02978716|564852586|FG000|Overall Study|Sponsor terminated|2|||
156480712|NCT02978716|564852587|FG001|Overall Study|Sponsor terminated|13|||
156480713|NCT02978716|564852588|FG002|Overall Study|Sponsor terminated|9|||
156480714|NCT02978716|564852586|FG000|Overall Study|Other|1|||
156480715|NCT02978716|564852587|FG001|Overall Study|Other|3|||
156345341|NCT03129100|564362400|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
156345342|NCT03129100|564362401|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
156345343|NCT03129100|564362402|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
156345344|NCT03129100|564362403|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
156345345|NCT03129100|564362404|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
156480716|NCT02978716|564852588|FG002|Overall Study|Other|0|||
156480717|NCT00960206|564852589|FG000|Overall Study|Death|7|||
156480718|NCT00960206|564852590|FG001|Overall Study|Death|4|||
156480719|NCT00960206|564852591|FG002|Overall Study|Death|1|||
156480720|NCT00960206|564852589|FG000|Overall Study|Unwilling/Unable to return|1|||
156480721|NCT00960206|564852590|FG001|Overall Study|Unwilling/Unable to return|2|||
156480722|NCT00960206|564852591|FG002|Overall Study|Unwilling/Unable to return|0|||
156480723|NCT00960206|564852589|FG000|Overall Study|Lost to Follow-up|8|||
156480724|NCT00960206|564852590|FG001|Overall Study|Lost to Follow-up|14|||
156480725|NCT00960206|564852591|FG002|Overall Study|Lost to Follow-up|8|||
156480726|NCT00960206|564852589|FG000|Overall Study|Withdrawal by Subject|2|||
156480727|NCT00960206|564852590|FG001|Overall Study|Withdrawal by Subject|4|||
156480728|NCT00960206|564852591|FG002|Overall Study|Withdrawal by Subject|0|||
156480729|NCT00960206|564852589|FG000|Overall Study|Revision of study component|2|||
156480730|NCT00960206|564852590|FG001|Overall Study|Revision of study component|2|||
156480731|NCT00960206|564852591|FG002|Overall Study|Revision of study component|2|||
156480732|NCT00960206|564852589|FG000|Overall Study|Missing 10 year data|20|||
156480733|NCT00960206|564852590|FG001|Overall Study|Missing 10 year data|1|||
156480734|NCT00960206|564852591|FG002|Overall Study|Missing 10 year data|1|||
156480735|NCT02548585|564852604|FG000|Overall Study|Withdrawal by Subject|0|||
156480736|NCT02548585|564852605|FG001|Overall Study|Withdrawal by Subject|0|||
156480737|NCT02548585|564852606|FG002|Overall Study|Withdrawal by Subject|0|||
156480738|NCT02548585|564852607|FG003|Overall Study|Withdrawal by Subject|0|||
156480739|NCT02548585|564852608|FG004|Overall Study|Withdrawal by Subject|0|||
156345346|NCT03129100|564362405|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
156345347|NCT03129100|564362406|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
156345348|NCT03129100|564362407|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
156345349|NCT03129100|564362408|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
156345350|NCT03129100|564362409|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
156345351|NCT03129100|564362410|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
156345352|NCT03129100|564362411|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
156345353|NCT03129100|564362386|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345354|NCT03129100|564362387|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156480740|NCT02548585|564852609|FG005|Overall Study|Withdrawal by Subject|1|||
156345355|NCT03129100|564362388|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345356|NCT03129100|564362389|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345357|NCT03129100|564362390|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345358|NCT03129100|564362391|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345359|NCT03129100|564362392|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345360|NCT03129100|564362393|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156480741|NCT02548585|564852610|FG006|Overall Study|Withdrawal by Subject|0|||
156480742|NCT02548585|564852604|FG000|Overall Study|Lost to Follow-up|1|||
156480743|NCT02548585|564852605|FG001|Overall Study|Lost to Follow-up|0|||
156480744|NCT02548585|564852606|FG002|Overall Study|Lost to Follow-up|0|||
156543820|NCT02819635|565086195|FG005|Substudy 2, Part 2|Adverse Event|4|||
156543821|NCT02819635|565086196|FG006|Substudy 2, Part 2|Adverse Event|0|||
156345361|NCT03129100|564362394|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156480745|NCT02548585|564852607|FG003|Overall Study|Lost to Follow-up|0|||
156480746|NCT02548585|564852608|FG004|Overall Study|Lost to Follow-up|0|||
156543822|NCT02819635|565086197|FG007|Substudy 2, Part 2|Adverse Event|0|||
156345362|NCT03129100|564362395|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345363|NCT03129100|564362396|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345364|NCT03129100|564362397|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345365|NCT03129100|564362398|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345366|NCT03129100|564362399|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345367|NCT03129100|564362400|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345368|NCT03129100|564362401|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345369|NCT03129100|564362402|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345370|NCT03129100|564362403|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345371|NCT03129100|564362404|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345372|NCT03129100|564362405|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345373|NCT03129100|564362406|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
156345374|NCT03129100|564362407|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345375|NCT03129100|564362408|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345376|NCT03129100|564362409|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345377|NCT03129100|564362410|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345378|NCT03129100|564362411|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156345379|NCT03129100|564362386|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
156345380|NCT03129100|564362387|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
156345381|NCT03129100|564362388|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
156345382|NCT03129100|564362389|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
156345383|NCT03129100|564362390|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
156345384|NCT03129100|564362391|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
156345385|NCT03129100|564362392|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
156345386|NCT03129100|564362393|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
156345387|NCT03129100|564362394|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
156345388|NCT03129100|564362395|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
156345389|NCT03129100|564362396|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
156345390|NCT03129100|564362397|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
156480747|NCT02548585|564852609|FG005|Overall Study|Lost to Follow-up|0|||
156480748|NCT02548585|564852610|FG006|Overall Study|Lost to Follow-up|0|||
156345391|NCT03129100|564362398|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
156345392|NCT03129100|564362399|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
156345393|NCT03129100|564362400|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
156345394|NCT03129100|564362401|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
156345395|NCT03129100|564362402|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
156345396|NCT03129100|564362403|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
156345397|NCT03129100|564362404|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
156345398|NCT03129100|564362405|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
156345399|NCT03129100|564362406|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
156345400|NCT03129100|564362407|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
156345401|NCT03129100|564362408|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
156345402|NCT03129100|564362409|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
156345403|NCT03129100|564362410|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
156345404|NCT03129100|564362411|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
156345405|NCT03129100|564362386|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345406|NCT03129100|564362387|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345407|NCT03129100|564362388|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345408|NCT03129100|564362389|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345409|NCT03129100|564362390|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345410|NCT03129100|564362391|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345411|NCT03129100|564362392|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345412|NCT03129100|564362393|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345413|NCT03129100|564362394|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345414|NCT03129100|564362395|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345415|NCT03129100|564362396|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345416|NCT03129100|564362397|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345417|NCT03129100|564362398|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345418|NCT03129100|564362399|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345419|NCT03129100|564362400|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345420|NCT03129100|564362401|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345421|NCT03129100|564362402|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345422|NCT03129100|564362403|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345423|NCT03129100|564362404|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345424|NCT03129100|564362405|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345425|NCT03129100|564362406|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345426|NCT03129100|564362407|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156480749|NCT02548585|564852604|FG000|Overall Study|Other|1|||
156480750|NCT02548585|564852605|FG001|Overall Study|Other|0|||
156345427|NCT03129100|564362408|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345428|NCT03129100|564362409|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156345429|NCT03129100|564362410|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
156345430|NCT03129100|564362411|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
156345431|NCT03129100|564362386|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345432|NCT03129100|564362387|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345433|NCT03129100|564362388|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345434|NCT03129100|564362389|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156480751|NCT02548585|564852606|FG002|Overall Study|Other|0|||
156480752|NCT02548585|564852607|FG003|Overall Study|Other|2|||
156480753|NCT02548585|564852608|FG004|Overall Study|Other|3|||
156480754|NCT02548585|564852609|FG005|Overall Study|Other|0|||
156480755|NCT02548585|564852610|FG006|Overall Study|Other|1|||
156480756|NCT02548585|564852604|FG000|Overall Study|Randomized but not treated|0|||
156480757|NCT02548585|564852605|FG001|Overall Study|Randomized but not treated|0|||
156480758|NCT02548585|564852606|FG002|Overall Study|Randomized but not treated|0|||
156480759|NCT02548585|564852607|FG003|Overall Study|Randomized but not treated|0|||
156480760|NCT02548585|564852608|FG004|Overall Study|Randomized but not treated|0|||
156480761|NCT02548585|564852609|FG005|Overall Study|Randomized but not treated|1|||
156480762|NCT02548585|564852610|FG006|Overall Study|Randomized but not treated|0|||
156480763|NCT02612285|564852611|FG000|Overall Study|Withdrawal by Subject|1|||
156480764|NCT00452452|564852614|FG000|Overall Study|Protocol Violation|0|||
156480765|NCT00452452|564852615|FG001|Overall Study|Protocol Violation|0|||
156480766|NCT00452452|564852616|FG002|Overall Study|Protocol Violation|1|||
156480767|NCT00452452|564852614|FG000|Overall Study|Withdrawal by Subject|1|||
156480768|NCT00452452|564852615|FG001|Overall Study|Withdrawal by Subject|0|||
156480769|NCT00452452|564852616|FG002|Overall Study|Withdrawal by Subject|0|||
156480770|NCT00452452|564852614|FG000|Overall Study|Lost to Follow-up|1|||
156480771|NCT00452452|564852615|FG001|Overall Study|Lost to Follow-up|0|||
156480772|NCT00452452|564852616|FG002|Overall Study|Lost to Follow-up|0|||
156480773|NCT00711555|564854217|FG000|Overall Study|Adverse Event|3|||
156480774|NCT00476151|564854223|FG000|Overall Study|Adverse Event|0|||
156480775|NCT00476151|564854224|FG001|Overall Study|Adverse Event|2|||
156480776|NCT00476151|564854223|FG000|Overall Study|Protocol Violation|1|||
156480777|NCT00476151|564854224|FG001|Overall Study|Protocol Violation|3|||
156480778|NCT00476151|564854223|FG000|Overall Study|Withdrawal by Subject|2|||
156480779|NCT00476151|564854224|FG001|Overall Study|Withdrawal by Subject|0|||
156480780|NCT00476151|564854223|FG000|Overall Study|Physician Decision|0|||
156480781|NCT00476151|564854224|FG001|Overall Study|Physician Decision|2|||
156480782|NCT02068352|564854225|FG000|Overall Study|Lost to Follow-up|0|||
156480783|NCT02068352|564854226|FG001|Overall Study|Lost to Follow-up|2|||
156345435|NCT03129100|564362390|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156480784|NCT02068352|564854227|FG002|Overall Study|Lost to Follow-up|0|||
156480785|NCT02068352|564854225|FG000|Overall Study|Adverse Event|4|||
156480786|NCT02068352|564854226|FG001|Overall Study|Adverse Event|2|||
156480787|NCT02068352|564854227|FG002|Overall Study|Adverse Event|7|||
156480788|NCT02068352|564854225|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
156480789|NCT02068352|564854226|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
156480790|NCT02068352|564854227|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
156480791|NCT02068352|564854225|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
156480792|NCT02068352|564854226|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
156480793|NCT02068352|564854227|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
156480794|NCT02068352|564854225|FG000|Overall Study|Protocol Deviation|0|||
156480795|NCT02068352|564854226|FG001|Overall Study|Protocol Deviation|0|||
156480796|NCT02068352|564854227|FG002|Overall Study|Protocol Deviation|1|||
156480797|NCT03557307|564854233|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
156480798|NCT03557307|564854233|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
156480799|NCT03557307|564854233|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
156480800|NCT03557307|564854233|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
156480801|NCT03557307|564854233|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
156480802|NCT03557307|564854233|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
156480803|NCT03557307|564854233|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
156480804|NCT03557307|564854233|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
156480805|NCT03557307|564854233|FG000|Period 2: Maintenance Phase|Death|3|||
156480806|NCT03557307|564854233|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
156480807|NCT03557307|564854233|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
156480808|NCT03557307|564854233|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
156480809|NCT03557307|564854233|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
156480810|NCT03557307|564854233|FG000|Period 2: Maintenance Phase|other|3|||
156480811|NCT03745651|564854234|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
156480812|NCT03745651|564854235|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
156480813|NCT03745651|564854236|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156480814|NCT03745651|564854237|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156480815|NCT03745651|564854238|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156480816|NCT03745651|564854239|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156480817|NCT03745651|564854240|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156480818|NCT03745651|564854234|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
156480819|NCT03745651|564854235|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
156480820|NCT03745651|564854236|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
156480821|NCT03745651|564854237|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156480822|NCT03745651|564854238|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156480823|NCT03745651|564854239|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156480824|NCT03745651|564854240|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156480825|NCT03745651|564854234|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
156480826|NCT03745651|564854235|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156480827|NCT03745651|564854236|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
156543823|NCT02819635|565086198|FG008|Substudy 2, Part 2|Adverse Event|0|||
156543824|NCT02819635|565086199|FG009|Substudy 2, Part 2|Adverse Event|0|||
156480828|NCT03745651|564854237|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156480829|NCT03745651|564854238|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156480830|NCT03745651|564854239|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156480831|NCT03745651|564854240|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156480832|NCT03745651|564854234|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156480833|NCT03745651|564854235|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
156480834|NCT03745651|564854236|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156480835|NCT03745651|564854237|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156480836|NCT03745651|564854238|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156480837|NCT03745651|564854239|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156480838|NCT03745651|564854240|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156480839|NCT03745651|564854234|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
156480840|NCT03745651|564854235|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
156480841|NCT03745651|564854236|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
156480842|NCT03745651|564854237|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156480843|NCT03745651|564854238|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156480844|NCT03745651|564854239|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156480845|NCT03745651|564854240|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156480846|NCT03745651|564854234|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
156480847|NCT03745651|564854235|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
156480848|NCT03745651|564854236|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
156480849|NCT03745651|564854237|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
156480850|NCT03745651|564854238|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
156480851|NCT03745651|564854239|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
156480852|NCT03745651|564854240|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
156480853|NCT03745651|564854234|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156480854|NCT03745651|564854235|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156480855|NCT03745651|564854236|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156480856|NCT03745651|564854237|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156480857|NCT03745651|564854238|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156480858|NCT03745651|564854239|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
156480859|NCT03745651|564854240|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156345436|NCT03129100|564362391|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345437|NCT03129100|564362392|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345438|NCT03129100|564362393|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345439|NCT03129100|564362394|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345440|NCT03129100|564362395|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345441|NCT03129100|564362396|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345442|NCT03129100|564362397|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345443|NCT03129100|564362398|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345444|NCT03129100|564362399|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345445|NCT03129100|564362400|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345446|NCT03129100|564362401|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345447|NCT03129100|564362402|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345448|NCT03129100|564362403|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345449|NCT03129100|564362404|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156480860|NCT03745651|564854234|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156480861|NCT03745651|564854235|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156480862|NCT03745651|564854236|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156480863|NCT03745651|564854237|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
156480864|NCT03745651|564854238|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156480865|NCT03745651|564854239|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
156480866|NCT03745651|564854240|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
156480867|NCT03745651|564854234|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156480868|NCT03745651|564854235|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156480869|NCT03745651|564854236|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156480870|NCT03745651|564854237|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
156480871|NCT03745651|564854238|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
156480872|NCT03745651|564854239|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
156480873|NCT03745651|564854240|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
156480874|NCT03745651|564854234|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156480875|NCT03745651|564854235|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156480876|NCT03745651|564854236|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156480877|NCT03745651|564854237|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
156480878|NCT03745651|564854238|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156543825|NCT02819635|565086200|FG010|Substudy 2, Part 2|Adverse Event|0|||
156480879|NCT03745651|564854239|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
156480880|NCT03745651|564854240|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
156480881|NCT03745651|564854234|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
156480882|NCT03745651|564854235|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
156480883|NCT03745651|564854236|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
156480884|NCT03745651|564854237|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
156480885|NCT03745651|564854238|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
156480886|NCT03745651|564854239|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
156480887|NCT03745651|564854240|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
156480888|NCT03745651|564854234|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156480889|NCT03745651|564854235|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156480890|NCT03745651|564854236|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156480891|NCT03745651|564854237|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156480892|NCT03745651|564854238|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156480893|NCT03745651|564854239|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
156480894|NCT03745651|564854240|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156480895|NCT03745651|564854234|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156480896|NCT03745651|564854235|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156480897|NCT03745651|564854236|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156480898|NCT03745651|564854237|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
156480899|NCT03745651|564854238|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
156480900|NCT03745651|564854239|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
156480901|NCT03745651|564854240|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
156480902|NCT03745651|564854234|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
156480903|NCT03745651|564854235|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
156480904|NCT03745651|564854236|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
156480905|NCT03745651|564854237|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
156480906|NCT03745651|564854238|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
156480907|NCT03745651|564854239|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
156480908|NCT03745651|564854240|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
156480909|NCT04175834|564854241|FG000|Overall Study|Withdrawal by Subject|1|||
156480910|NCT04175834|564854242|FG001|Overall Study|Withdrawal by Subject|0|||
156480911|NCT04239911|564854246|FG000|Overall Study|Lost to Follow-up|2|||
156480912|NCT04239911|564854247|FG001|Overall Study|Lost to Follow-up|1|||
156480913|NCT03456856|564854248|FG000|Overall Study|Lost to Follow-up|2|||
156480914|NCT03456856|564854248|FG000|Overall Study|Withdrawal by Subject|1|||
156480915|NCT01077284|564854249|FG000|Overall Study|Adverse Event|2|||
156480916|NCT01077284|564854250|FG001|Overall Study|Adverse Event|0|||
156480917|NCT01077284|564854251|FG002|Overall Study|Adverse Event|1|||
156480918|NCT01077284|564854249|FG000|Overall Study|Lost to Follow-up|1|||
156543826|NCT02819635|565086201|FG011|Substudy 2, Part 2|Adverse Event|0|||
156543827|NCT02819635|565086190|FG000|Substudy 2, Part 2|Withdrew consent|0|||
156480919|NCT01077284|564854250|FG001|Overall Study|Lost to Follow-up|2|||
156480920|NCT01077284|564854251|FG002|Overall Study|Lost to Follow-up|0|||
156480921|NCT01077284|564854249|FG000|Overall Study|Withdrawal by Subject|2|||
156480922|NCT01077284|564854250|FG001|Overall Study|Withdrawal by Subject|3|||
156480923|NCT01077284|564854251|FG002|Overall Study|Withdrawal by Subject|1|||
156480924|NCT01077284|564854249|FG000|Overall Study|Other|0|||
156480925|NCT01077284|564854250|FG001|Overall Study|Other|0|||
156480926|NCT01077284|564854251|FG002|Overall Study|Other|1|||
156480927|NCT04626128|564854252|FG000|Overall Study|Withdrawal by Subject|0|||
156480928|NCT04626128|564854253|FG001|Overall Study|Withdrawal by Subject|1|||
156480929|NCT04626128|564854254|FG002|Overall Study|Withdrawal by Subject|0|||
156480930|NCT04626128|564854255|FG003|Overall Study|Withdrawal by Subject|0|||
156480931|NCT00841321|564854256|FG000|Overall Study|Lost to Follow-up|1|||
156480932|NCT00841321|564854257|FG001|Overall Study|Lost to Follow-up|1|||
156480933|NCT00841321|564854256|FG000|Overall Study|Adverse Event|0|||
156480934|NCT00841321|564854257|FG001|Overall Study|Adverse Event|2|||
156480935|NCT02632747|564854258|FG000|Wash-out Period|Adverse Event|1|||
156480936|NCT02632747|564854259|FG001|Wash-out Period|Adverse Event|0|||
156480937|NCT04908488|564854260|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
156480938|NCT04908488|564854261|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
156480939|NCT04908488|564854260|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
156480940|NCT04908488|564854261|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
156480941|NCT01107912|564854262|FG000|Period 1|Adverse Event|0|||
156480942|NCT01107912|564854263|FG001|Period 1|Adverse Event|0|||
156480943|NCT01107912|564854264|FG002|Period 1|Adverse Event|0|||
156480944|NCT01107912|564854265|FG003|Period 1|Adverse Event|0|||
156480945|NCT01107912|564854266|FG004|Period 1|Adverse Event|2|||
156480946|NCT01107912|564854267|FG005|Period 1|Adverse Event|0|||
156480947|NCT01107912|564854262|FG000|Period 1|Physician Decision|0|||
156480948|NCT01107912|564854263|FG001|Period 1|Physician Decision|0|||
156345450|NCT03129100|564362405|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345451|NCT03129100|564362406|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345452|NCT03129100|564362407|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345453|NCT03129100|564362408|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156345454|NCT03129100|564362409|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
156345455|NCT03129100|564362410|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
156345456|NCT03129100|564362411|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
156345457|NCT03129100|564362386|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345458|NCT03129100|564362387|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345459|NCT03129100|564362388|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345460|NCT03129100|564362389|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345461|NCT03129100|564362390|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345462|NCT03129100|564362391|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345463|NCT03129100|564362392|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345464|NCT03129100|564362393|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345465|NCT03129100|564362394|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345466|NCT03129100|564362395|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345467|NCT03129100|564362396|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345468|NCT03129100|564362397|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345469|NCT03129100|564362398|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345470|NCT03129100|564362399|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345471|NCT03129100|564362400|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345472|NCT03129100|564362401|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345473|NCT03129100|564362402|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345474|NCT03129100|564362403|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345475|NCT03129100|564362404|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345476|NCT03129100|564362405|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345477|NCT03129100|564362406|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345478|NCT03129100|564362407|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345479|NCT03129100|564362408|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345480|NCT03129100|564362409|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345481|NCT03129100|564362410|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
156345482|NCT03129100|564362411|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156345483|NCT03129100|564362386|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345484|NCT03129100|564362387|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345485|NCT03129100|564362388|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345486|NCT03129100|564362389|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345487|NCT03129100|564362390|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345488|NCT03129100|564362391|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345489|NCT03129100|564362392|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345490|NCT03129100|564362393|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345491|NCT03129100|564362394|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345492|NCT03129100|564362395|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345493|NCT03129100|564362396|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345494|NCT03129100|564362397|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345495|NCT03129100|564362398|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345496|NCT03129100|564362399|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345497|NCT03129100|564362400|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345498|NCT03129100|564362401|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345499|NCT03129100|564362402|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345500|NCT03129100|564362403|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345501|NCT03129100|564362404|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345502|NCT03129100|564362405|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345503|NCT03129100|564362406|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345504|NCT03129100|564362407|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345505|NCT03129100|564362408|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345506|NCT03129100|564362409|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345507|NCT03129100|564362410|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156345508|NCT03129100|564362411|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
156345509|NCT03129100|564362386|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
156345510|NCT03129100|564362387|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
156345511|NCT03129100|564362388|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
156345512|NCT03129100|564362389|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
156345513|NCT03129100|564362390|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
156345514|NCT03129100|564362391|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
156345515|NCT03129100|564362392|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
156345516|NCT03129100|564362393|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
156345517|NCT03129100|564362394|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
156345518|NCT03129100|564362395|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
156345519|NCT03129100|564362396|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
156345520|NCT03129100|564362397|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
156345521|NCT03129100|564362398|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
156480949|NCT01107912|564854264|FG002|Period 1|Physician Decision|0|||
156480950|NCT01107912|564854265|FG003|Period 1|Physician Decision|0|||
156480951|NCT01107912|564854266|FG004|Period 1|Physician Decision|1|||
156480952|NCT01107912|564854267|FG005|Period 1|Physician Decision|0|||
156480953|NCT01107912|564854262|FG000|Period 1|Withdrawal by Subject|1|||
156480954|NCT01107912|564854263|FG001|Period 1|Withdrawal by Subject|0|||
156480955|NCT01107912|564854264|FG002|Period 1|Withdrawal by Subject|0|||
156480956|NCT01107912|564854265|FG003|Period 1|Withdrawal by Subject|0|||
156480957|NCT01107912|564854266|FG004|Period 1|Withdrawal by Subject|0|||
156480958|NCT01107912|564854267|FG005|Period 1|Withdrawal by Subject|0|||
156480959|NCT01107912|564854262|FG000|Period 2|Physician Decision|0|||
156480960|NCT01107912|564854263|FG001|Period 2|Physician Decision|0|||
156480961|NCT01107912|564854264|FG002|Period 2|Physician Decision|1|||
156480962|NCT01107912|564854265|FG003|Period 2|Physician Decision|0|||
156480963|NCT01107912|564854266|FG004|Period 2|Physician Decision|0|||
156480964|NCT01107912|564854267|FG005|Period 2|Physician Decision|0|||
156480965|NCT01107912|564854262|FG000|Period 3|Adverse Event|0|||
156480966|NCT01107912|564854263|FG001|Period 3|Adverse Event|1|||
156480967|NCT01107912|564854264|FG002|Period 3|Adverse Event|1|||
156480968|NCT01107912|564854265|FG003|Period 3|Adverse Event|0|||
156480969|NCT01107912|564854266|FG004|Period 3|Adverse Event|0|||
156480970|NCT01107912|564854267|FG005|Period 3|Adverse Event|0|||
156480971|NCT01107912|564854262|FG000|Period 3|Withdrawal by Subject|0|||
156480972|NCT01107912|564854263|FG001|Period 3|Withdrawal by Subject|0|||
156480973|NCT01107912|564854264|FG002|Period 3|Withdrawal by Subject|0|||
156480974|NCT01107912|564854265|FG003|Period 3|Withdrawal by Subject|1|||
156480975|NCT01107912|564854266|FG004|Period 3|Withdrawal by Subject|0|||
156480976|NCT01107912|564854267|FG005|Period 3|Withdrawal by Subject|0|||
156480977|NCT00595959|564854268|FG000|Overall Study|Withdrawal by Subject|1|||
156480978|NCT00595959|564854268|FG000|Overall Study|Lost to Follow-up|1|||
156480979|NCT00963924|564854269|FG000|Overall Study|Adverse Event|1|||
156480980|NCT00963924|564854270|FG001|Overall Study|Adverse Event|0|||
156480981|NCT00963924|564854269|FG000|Overall Study|Withdrawal by Subject|0|||
156480982|NCT00963924|564854270|FG001|Overall Study|Withdrawal by Subject|1|||
156480983|NCT00963924|564854269|FG000|Overall Study|Changed antipsychotic|0|||
156480984|NCT00963924|564854270|FG001|Overall Study|Changed antipsychotic|1|||
156480985|NCT00963924|564854269|FG000|Overall Study|Lost to Follow-up|0|||
156480986|NCT00963924|564854270|FG001|Overall Study|Lost to Follow-up|1|||
156480987|NCT03875729|564854272|FG000|Overall Study|Adverse Event|0|||
156480988|NCT03875729|564854273|FG001|Overall Study|Adverse Event|5|||
156480989|NCT03875729|564854272|FG000|Overall Study|Withdrawal by Subject|8|||
156480990|NCT03875729|564854273|FG001|Overall Study|Withdrawal by Subject|11|||
156480991|NCT03875729|564854272|FG000|Overall Study|Pregnancy|0|||
156480992|NCT03875729|564854273|FG001|Overall Study|Pregnancy|1|||
156345522|NCT03129100|564362399|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
156345523|NCT03129100|564362400|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
156345524|NCT03129100|564362401|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
156345525|NCT03129100|564362402|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
156345526|NCT03129100|564362403|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
156345527|NCT03129100|564362404|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
156480993|NCT03875729|564854272|FG000|Overall Study|Lost to Follow-up|0|||
156480994|NCT03875729|564854273|FG001|Overall Study|Lost to Follow-up|5|||
156480995|NCT03875729|564854272|FG000|Overall Study|Personal reasons|2|||
156480996|NCT03875729|564854273|FG001|Overall Study|Personal reasons|0|||
156480997|NCT00753896|564854274|FG000|Overall Study|Adverse Event|4|||
156480998|NCT00753896|564854274|FG000|Overall Study|Death|1|||
156480999|NCT00753896|564854274|FG000|Overall Study|Lost to Follow-up|2|||
156481000|NCT00753896|564854274|FG000|Overall Study|Protocol Violation|1|||
156481001|NCT00753896|564854274|FG000|Overall Study|Withdrawal by Subject|4|||
156481002|NCT00753896|564854274|FG000|Overall Study|Entry Criteria Not Met|4|||
156481003|NCT01280656|564854275|FG000|Overall Study|Adverse Event|1|||
156481004|NCT01280656|564854276|FG001|Overall Study|Adverse Event|14|||
156481005|NCT01280656|564854277|FG002|Overall Study|Adverse Event|13|||
156481006|NCT01280656|564854275|FG000|Overall Study|Lack of Efficacy|1|||
156481007|NCT01280656|564854276|FG001|Overall Study|Lack of Efficacy|22|||
156481008|NCT01280656|564854277|FG002|Overall Study|Lack of Efficacy|38|||
156481009|NCT01280656|564854275|FG000|Overall Study|Treatment shortening (RGT)|0|||
156481010|NCT01280656|564854276|FG001|Overall Study|Treatment shortening (RGT)|4|||
156481011|NCT01280656|564854277|FG002|Overall Study|Treatment shortening (RGT)|5|||
156481012|NCT01280656|564854275|FG000|Overall Study|Other|1|||
156481013|NCT01280656|564854276|FG001|Overall Study|Other|7|||
156481014|NCT01280656|564854277|FG002|Overall Study|Other|7|||
156481015|NCT00952523|564854278|FG000|Overall Study|Withdrawal by Subject|7|||
156481016|NCT05265247|564854279|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
156481017|NCT05265247|564854280|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
156565217|NCT03263806|565157644|FG001|Overall Study|Study Termination|6|||
156481018|NCT05265247|564854279|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
156481019|NCT05265247|564854280|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
156481020|NCT05265247|564854279|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
156481021|NCT05265247|564854280|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
156481022|NCT01856569|564854287|FG000|Overall Study|Other|1|||
156481023|NCT01856569|564854287|FG000|Overall Study|Changed Site/Structure|1|||
156481024|NCT01856569|564854287|FG000|Overall Study|Lost to Follow-up|3|||
156481025|NCT01856569|564854287|FG000|Overall Study|Did not met inclusion criteria|8|||
156481026|NCT02707952|564854288|FG000|Overall Study|Adverse Event|1|||
156481027|NCT02707952|564854289|FG001|Overall Study|Adverse Event|0|||
156481028|NCT02707952|564854290|FG002|Overall Study|Adverse Event|0|||
156481029|NCT02707952|564854291|FG003|Overall Study|Adverse Event|0|||
156481030|NCT02707952|564854288|FG000|Overall Study|Lost to Follow-up|1|||
156481031|NCT02707952|564854289|FG001|Overall Study|Lost to Follow-up|0|||
156481032|NCT02707952|564854290|FG002|Overall Study|Lost to Follow-up|0|||
156481033|NCT02707952|564854291|FG003|Overall Study|Lost to Follow-up|0|||
156481034|NCT02707952|564854288|FG000|Overall Study|Withdrawal by Subject|0|||
156481035|NCT02707952|564854289|FG001|Overall Study|Withdrawal by Subject|1|||
156481036|NCT02707952|564854290|FG002|Overall Study|Withdrawal by Subject|2|||
156481037|NCT02707952|564854291|FG003|Overall Study|Withdrawal by Subject|0|||
156481038|NCT01287832|564854293|FG000|Overall Study|Adverse Event|1|||
156481039|NCT01287832|564854294|FG001|Overall Study|Adverse Event|0|||
156481040|NCT01287832|564854293|FG000|Overall Study|Death|0|||
156481041|NCT01287832|564854294|FG001|Overall Study|Death|1|||
156481042|NCT03065400|564854298|FG000|Overall Study|Adverse Event|1|||
156481043|NCT03065400|564854298|FG000|Overall Study|Physician Decision|3|||
156481044|NCT03065400|564854298|FG000|Overall Study|Withdrawal by Subject|1|||
156481045|NCT03065400|564854298|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
156481046|NCT04749797|564854299|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
156481047|NCT04749797|564854300|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
156481048|NCT04749797|564854301|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
156481049|NCT03072862|564854302|FG000|Overall Study|Withdrawal by Subject|4|||
156481050|NCT03072862|564854302|FG000|Overall Study|Lost to Follow-up|6|||
156481051|NCT03072862|564854302|FG000|Overall Study|Protocol Violation|4|||
156481052|NCT03072862|564854302|FG000|Overall Study|Physician Decision|2|||
156481053|NCT03072862|564854302|FG000|Overall Study|Death|1|||
156481054|NCT03072862|564854302|FG000|Overall Study|Adverse Event|1|||
156481055|NCT00632736|564854303|FG000|Overall Study|Adverse Event|104|||
156481056|NCT00632736|564854303|FG000|Overall Study|Lost to Follow-up|15|||
156481057|NCT00632736|564854303|FG000|Overall Study|Protocol Violation|14|||
156481058|NCT00632736|564854303|FG000|Overall Study|Withdrawal by Subject|99|||
156481059|NCT00632736|564854303|FG000|Overall Study|Lack of Efficacy|5|||
156481060|NCT00632736|564854303|FG000|Overall Study|Sponsor terminated study|5|||
156481061|NCT00632736|564854303|FG000|Overall Study|Non-compliance|10|||
156481062|NCT00632736|564854303|FG000|Overall Study|Other|16|||
156481063|NCT03347396|564854304|FG000|Part A (26 Weeks)|Adverse Event|1|||
156481064|NCT03347396|564854305|FG001|Part A (26 Weeks)|Adverse Event|0|||
156481065|NCT03347396|564854304|FG000|Part A (26 Weeks)|Death|0|||
156481066|NCT03347396|564854305|FG001|Part A (26 Weeks)|Death|1|||
156481067|NCT03347396|564854304|FG000|Part B (149 Weeks)|Adverse Event|1|||
156481068|NCT03347396|564854305|FG001|Part B (149 Weeks)|Adverse Event|1|||
156481069|NCT03347396|564854304|FG000|Part B (149 Weeks)|Death|1|||
156481070|NCT03347396|564854305|FG001|Part B (149 Weeks)|Death|0|||
156481071|NCT00871715|564854310|FG000|Overall Study|Withdrawal by Subject|6|||
156481072|NCT00871715|564854311|FG001|Overall Study|Withdrawal by Subject|10|||
156481073|NCT00871715|564854312|FG002|Overall Study|Withdrawal by Subject|15|||
156481074|NCT00871715|564854310|FG000|Overall Study|Physician Decision|6|||
156481075|NCT00871715|564854311|FG001|Overall Study|Physician Decision|0|||
156481076|NCT00871715|564854312|FG002|Overall Study|Physician Decision|2|||
156481077|NCT00871715|564854310|FG000|Overall Study|Lost to Follow-up|3|||
156481078|NCT00871715|564854311|FG001|Overall Study|Lost to Follow-up|6|||
156481079|NCT00871715|564854312|FG002|Overall Study|Lost to Follow-up|9|||
156481080|NCT03015220|564854315|FG000|Overall Study|Withdrawal by Subject|3|||
156481081|NCT03015220|564854316|FG001|Overall Study|Withdrawal by Subject|2|||
156481082|NCT03015220|564854317|FG002|Overall Study|Withdrawal by Subject|2|||
156481083|NCT03015220|564854318|FG003|Overall Study|Withdrawal by Subject|2|||
156481084|NCT03015220|564854315|FG000|Overall Study|Lost to Follow-up|0|||
156481085|NCT03015220|564854316|FG001|Overall Study|Lost to Follow-up|0|||
156481086|NCT03015220|564854317|FG002|Overall Study|Lost to Follow-up|1|||
156481087|NCT03015220|564854318|FG003|Overall Study|Lost to Follow-up|0|||
156481088|NCT01670526|564854319|FG000|Overall Study|Withdrawal by Subject|3|||
156481089|NCT01670526|564854320|FG001|Overall Study|Withdrawal by Subject|1|||
156481090|NCT01670526|564854319|FG000|Overall Study|Lost to Follow-up|9|||
156481091|NCT01670526|564854320|FG001|Overall Study|Lost to Follow-up|5|||
156345528|NCT03129100|564362405|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
156345529|NCT03129100|564362406|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
156481092|NCT00392197|564854321|FG000|Overall Study|Adverse Event|4|||
156481093|NCT00392197|564854322|FG001|Overall Study|Adverse Event|12|||
156481094|NCT00392197|564854321|FG000|Overall Study|Lack of Efficacy|3|||
156481095|NCT00392197|564854322|FG001|Overall Study|Lack of Efficacy|4|||
156481096|NCT00392197|564854321|FG000|Overall Study|Lost to Follow-up|0|||
156481097|NCT00392197|564854322|FG001|Overall Study|Lost to Follow-up|1|||
156481098|NCT00392197|564854321|FG000|Overall Study|Physician Decision|3|||
156481099|NCT00392197|564854322|FG001|Overall Study|Physician Decision|2|||
156481100|NCT00392197|564854321|FG000|Overall Study|Protocol Violation|7|||
156481101|NCT00392197|564854322|FG001|Overall Study|Protocol Violation|5|||
156481102|NCT00392197|564854321|FG000|Overall Study|Withdrawal by Subject|4|||
156481103|NCT00392197|564854322|FG001|Overall Study|Withdrawal by Subject|6|||
156481104|NCT01794689|564854323|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
156481105|NCT01794689|564854324|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
156481106|NCT01794689|564854325|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
156481107|NCT01794689|564854326|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
156481108|NCT01794689|564854323|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
156481109|NCT01794689|564854324|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
156481110|NCT01794689|564854325|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
156481111|NCT01794689|564854326|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
156481112|NCT01794689|564854323|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
156345530|NCT03129100|564362407|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
156345531|NCT03129100|564362408|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
156345532|NCT03129100|564362409|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
156345533|NCT03129100|564362410|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
156345534|NCT03129100|564362411|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
156345535|NCT02030041|564362412|FG000|Overall Study|Withdrawal by Subject|2|||
156345536|NCT02030041|564362413|FG001|Overall Study|Withdrawal by Subject|2|||
156345537|NCT02030041|564362414|FG002|Overall Study|Withdrawal by Subject|1|||
156345538|NCT01032837|564362416|FG000|Overall Study|Adverse event/internal illness|0|||
156345539|NCT01032837|564362417|FG001|Overall Study|Adverse event/internal illness|1|||
156345540|NCT01032837|564362418|FG002|Overall Study|Adverse event/internal illness|0|||
156345541|NCT01032837|564362419|FG003|Overall Study|Adverse event/internal illness|1|||
156345542|NCT01032837|564362416|FG000|Overall Study|Withdrew consent|0|||
156345543|NCT01032837|564362417|FG001|Overall Study|Withdrew consent|2|||
156345544|NCT01032837|564362418|FG002|Overall Study|Withdrew consent|0|||
156345545|NCT01032837|564362419|FG003|Overall Study|Withdrew consent|1|||
156345546|NCT01032837|564362416|FG000|Overall Study|Failed to return|0|||
156345547|NCT01032837|564362417|FG001|Overall Study|Failed to return|0|||
156345548|NCT01032837|564362418|FG002|Overall Study|Failed to return|1|||
156345549|NCT01032837|564362419|FG003|Overall Study|Failed to return|0|||
156345550|NCT01032837|564362416|FG000|Overall Study|Refused treatment|0|||
156345551|NCT01032837|564362417|FG001|Overall Study|Refused treatment|0|||
156345552|NCT01032837|564362418|FG002|Overall Study|Refused treatment|0|||
156345553|NCT01032837|564362419|FG003|Overall Study|Refused treatment|1|||
156345554|NCT01197560|564362420|FG000|Overall Study|Adverse Event|6|||
156345555|NCT01197560|564362421|FG001|Overall Study|Adverse Event|8|||
156345556|NCT01197560|564362420|FG000|Overall Study|Death|3|||
156345557|NCT01197560|564362421|FG001|Overall Study|Death|5|||
156345558|NCT01197560|564362420|FG000|Overall Study|Withdrawal by Subject|1|||
156345559|NCT01197560|564362421|FG001|Overall Study|Withdrawal by Subject|1|||
156345560|NCT01197560|564362420|FG000|Overall Study|Disease progression|40|||
156345561|NCT01197560|564362421|FG001|Overall Study|Disease progression|35|||
156345562|NCT01197560|564362420|FG000|Overall Study|Miscellaneous|4|||
156345563|NCT01197560|564362421|FG001|Overall Study|Miscellaneous|3|||
156345564|NCT01197560|564362420|FG000|Overall Study|Missing|0|||
156481113|NCT01794689|564854324|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
156565218|NCT00023322|565157651|FG000|Overall Study|Lost to Follow-up|1|||
156481114|NCT01794689|564854325|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
156481115|NCT01794689|564854326|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
156481116|NCT01794689|564854323|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
156481117|NCT01794689|564854324|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
156481118|NCT01794689|564854325|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
156481119|NCT01794689|564854326|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
156481120|NCT02312258|564854327|FG000|Overall Study|Lost to Follow-up|8|||
156481121|NCT02312258|564854328|FG001|Overall Study|Lost to Follow-up|8|||
156481122|NCT02312258|564854327|FG000|Overall Study|Withdrawal by Patient|49|||
156481123|NCT02312258|564854328|FG001|Overall Study|Withdrawal by Patient|76|||
156481124|NCT02312258|564854327|FG000|Overall Study|Reason not Specified|107|||
156481125|NCT02312258|564854328|FG001|Overall Study|Reason not Specified|159|||
156481126|NCT02312258|564854327|FG000|Overall Study|Missing|2|||
156481127|NCT02312258|564854328|FG001|Overall Study|Missing|1|||
156481128|NCT02312258|564854327|FG000|Overall Study|Death|115|||
156481129|NCT02312258|564854328|FG001|Overall Study|Death|181|||
156481130|NCT01970527|564854329|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
156481131|NCT01970527|564854330|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
156481132|NCT01970527|564854329|FG000|Treatment|Disease progression|0|||
156481133|NCT01970527|564854330|FG001|Treatment|Disease progression|1|||
156481134|NCT01970527|564854329|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
156481135|NCT01970527|564854330|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
156481136|NCT01970527|564854329|FG000|Treatment|Death|0|||
156481137|NCT01970527|564854330|FG001|Treatment|Death|1|||
156481138|NCT01970527|564854329|FG000|Follow-up Clinic Visit|Disease progression|1|||
156481139|NCT01970527|564854330|FG001|Follow-up Clinic Visit|Disease progression|1|||
156481140|NCT01970527|564854329|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
156481141|NCT01970527|564854330|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
156481142|NCT01970527|564854329|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
156481143|NCT01970527|564854330|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
156481144|NCT01964547|564854331|FG000|Overall Study|Adverse Event|8|||
156481145|NCT01964547|564854332|FG001|Overall Study|Adverse Event|2|||
156481146|NCT01964547|564854331|FG000|Overall Study|Withdrawal by Subject|4|||
156481147|NCT01964547|564854332|FG001|Overall Study|Withdrawal by Subject|7|||
156481148|NCT01964547|564854331|FG000|Overall Study|Lost to Follow-up|0|||
156481149|NCT01964547|564854332|FG001|Overall Study|Lost to Follow-up|1|||
156481150|NCT01964547|564854331|FG000|Overall Study|Withdrawal by Investigator|0|||
156481151|NCT01964547|564854332|FG001|Overall Study|Withdrawal by Investigator|1|||
156481152|NCT04447287|564854333|FG000|Period 1: Run-in Period|Adverse Event|3|||
156481153|NCT04447287|564854334|FG001|Period 1: Run-in Period|Adverse Event|0|||
156481154|NCT04447287|564854335|FG002|Period 1: Run-in Period|Adverse Event|0|||
156481155|NCT04447287|564854333|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
156481156|NCT04447287|564854334|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
156481157|NCT04447287|564854335|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
156481158|NCT04447287|564854333|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
156481159|NCT04447287|564854334|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
156481160|NCT04447287|564854335|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
156481161|NCT05700851|564854336|FG000|Overall Study|Received a kidney transplant|1|||
156481162|NCT05700851|564854336|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
156481163|NCT05700851|564854336|FG000|Overall Study|Withdrawal by Subject|1|||
156481164|NCT02147093|564854339|FG000|Period 1|Lost to Follow-up|0|||
156481165|NCT02147093|564854340|FG001|Period 1|Lost to Follow-up|1|||
156345565|NCT01197560|564362421|FG001|Overall Study|Missing|1|||
156481166|NCT02147093|564854339|FG000|Period 2|Protocol Violation|2|||
156481167|NCT02147093|564854340|FG001|Period 2|Protocol Violation|0|||
156481168|NCT03246724|564854341|FG000|Overall Study|Withdrawal by Subject|5|||
156481169|NCT03246724|564854342|FG001|Overall Study|Withdrawal by Subject|2|||
156481170|NCT03246724|564854343|FG002|Overall Study|Withdrawal by Subject|4|||
156481171|NCT03246724|564854344|FG003|Overall Study|Withdrawal by Subject|2|||
156481172|NCT03246724|564854341|FG000|Overall Study|Ineligible on day of surgery|7|||
156481173|NCT03246724|564854342|FG001|Overall Study|Ineligible on day of surgery|2|||
156481174|NCT03246724|564854343|FG002|Overall Study|Ineligible on day of surgery|0|||
156481175|NCT03246724|564854344|FG003|Overall Study|Ineligible on day of surgery|3|||
156481176|NCT03246724|564854341|FG000|Overall Study|Study completed before surgical date|2|||
156481177|NCT03246724|564854342|FG001|Overall Study|Study completed before surgical date|1|||
156481178|NCT03246724|564854343|FG002|Overall Study|Study completed before surgical date|8|||
156481179|NCT03246724|564854344|FG003|Overall Study|Study completed before surgical date|1|||
156481180|NCT03246724|564854341|FG000|Overall Study|Transferred to other arm|0|||
156481181|NCT03246724|564854342|FG001|Overall Study|Transferred to other arm|0|||
156481182|NCT03246724|564854343|FG002|Overall Study|Transferred to other arm|1|||
156481183|NCT03246724|564854344|FG003|Overall Study|Transferred to other arm|0|||
156481184|NCT03246724|564854341|FG000|Overall Study|Unable to obtain medication timely|0|||
156481185|NCT03246724|564854342|FG001|Overall Study|Unable to obtain medication timely|2|||
156481186|NCT03246724|564854343|FG002|Overall Study|Unable to obtain medication timely|2|||
156481187|NCT03246724|564854344|FG003|Overall Study|Unable to obtain medication timely|1|||
156481188|NCT03246724|564854341|FG000|Overall Study|Re-consented to participate|0|||
156481189|NCT03246724|564854342|FG001|Overall Study|Re-consented to participate|0|||
156481190|NCT03246724|564854343|FG002|Overall Study|Re-consented to participate|0|||
156481191|NCT03246724|564854344|FG003|Overall Study|Re-consented to participate|1|||
156481192|NCT01229176|564854347|FG000|Overall Study|Withdrawal by Subject|0|||
156481193|NCT01229176|564854348|FG001|Overall Study|Withdrawal by Subject|0|||
156481194|NCT01229176|564854349|FG002|Overall Study|Withdrawal by Subject|0|||
156481195|NCT01229176|564854350|FG003|Overall Study|Withdrawal by Subject|1|||
156481196|NCT01229176|564854351|FG004|Overall Study|Withdrawal by Subject|1|||
156481197|NCT01229176|564854352|FG005|Overall Study|Withdrawal by Subject|1|||
156481198|NCT01229176|564854353|FG006|Overall Study|Withdrawal by Subject|0|||
156481199|NCT01229176|564854354|FG007|Overall Study|Withdrawal by Subject|1|||
156481200|NCT01229176|564854347|FG000|Overall Study|Lost to Follow-up|0|||
156481201|NCT01229176|564854348|FG001|Overall Study|Lost to Follow-up|3|||
156481202|NCT01229176|564854349|FG002|Overall Study|Lost to Follow-up|0|||
156481203|NCT01229176|564854350|FG003|Overall Study|Lost to Follow-up|0|||
156481204|NCT01229176|564854351|FG004|Overall Study|Lost to Follow-up|1|||
156481205|NCT01229176|564854352|FG005|Overall Study|Lost to Follow-up|1|||
156481206|NCT01229176|564854353|FG006|Overall Study|Lost to Follow-up|0|||
156481207|NCT01229176|564854354|FG007|Overall Study|Lost to Follow-up|2|||
156481208|NCT03890484|564854355|FG000|Overall Study|Lost to Follow-up|1|||
156481209|NCT03890484|564854356|FG001|Overall Study|Lost to Follow-up|1|||
156481210|NCT00518206|564854357|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
156481211|NCT00518206|564854358|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
156481212|NCT00518206|564854357|FG000|Overall Study|Withdrawal by Subject|2|||
156481213|NCT00518206|564854358|FG001|Overall Study|Withdrawal by Subject|0|||
156481214|NCT00518206|564854357|FG000|Overall Study|Drug Supply Issue|1|||
156481215|NCT00518206|564854358|FG001|Overall Study|Drug Supply Issue|0|||
156481216|NCT00518206|564854357|FG000|Overall Study|Reason Unknown|1|||
156543828|NCT02819635|565086191|FG001|Substudy 2, Part 2|Withdrew consent|0|||
156481217|NCT00518206|564854358|FG001|Overall Study|Reason Unknown|0|||
156481218|NCT00518206|564854357|FG000|Overall Study|Completion Status Unknown|1|||
156481219|NCT00518206|564854358|FG001|Overall Study|Completion Status Unknown|0|||
156481220|NCT03075878|564854359|FG000|Overall Study|Physician Decision|1|||
156481221|NCT02188459|564854360|FG000|Overall Study|Lost to Follow-up|3|||
156481222|NCT02188459|564854361|FG001|Overall Study|Lost to Follow-up|4|||
156481223|NCT02188459|564854360|FG000|Overall Study|Early Termination|0|||
156481224|NCT02188459|564854361|FG001|Overall Study|Early Termination|3|||
156481225|NCT00882050|564854366|FG000|Overall Study|Physician Decision|1|||
156481226|NCT00882050|564854367|FG001|Overall Study|Physician Decision|0|||
156481227|NCT00882050|564854368|FG002|Overall Study|Physician Decision|0|||
156481228|NCT00805441|564854369|FG000|Overall Study|Adverse Event|5|||
156481229|NCT00805441|564854370|FG001|Overall Study|Adverse Event|2|||
156481230|NCT00805441|564854369|FG000|Overall Study|Lack of Efficacy|0|||
156481231|NCT00805441|564854370|FG001|Overall Study|Lack of Efficacy|2|||
156481232|NCT00805441|564854369|FG000|Overall Study|Protocol Violation|4|||
156481233|NCT00805441|564854370|FG001|Overall Study|Protocol Violation|8|||
156481234|NCT00805441|564854369|FG000|Overall Study|Lost to Follow-up|10|||
156481235|NCT00805441|564854370|FG001|Overall Study|Lost to Follow-up|13|||
156481236|NCT00805441|564854369|FG000|Overall Study|Withdrawal by Subject|15|||
156481237|NCT00805441|564854370|FG001|Overall Study|Withdrawal by Subject|9|||
156481238|NCT00805441|564854369|FG000|Overall Study|Physician Decision|0|||
156481239|NCT00805441|564854370|FG001|Overall Study|Physician Decision|1|||
156481240|NCT00805441|564854369|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
156481241|NCT00805441|564854370|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
156481242|NCT02935894|564854375|FG000|Overall Study|Subject dismissed|1|||
156481243|NCT00853957|564854376|FG000|Overall Study|Adverse Event|9|||
156481244|NCT00853957|564854377|FG001|Overall Study|Adverse Event|3|||
156481245|NCT00853957|564854376|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156481246|NCT00853957|564854377|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156481247|NCT00853957|564854376|FG000|Overall Study|Subject withdrew consent|4|||
156481248|NCT00853957|564854377|FG001|Overall Study|Subject withdrew consent|5|||
156481249|NCT00853957|564854376|FG000|Overall Study|Lost to Follow-up|1|||
156481250|NCT00853957|564854377|FG001|Overall Study|Lost to Follow-up|6|||
156481251|NCT00853957|564854376|FG000|Overall Study|Protocol deviation|0|||
156481252|NCT00853957|564854377|FG001|Overall Study|Protocol deviation|3|||
156481253|NCT02942771|564854378|FG000|Overall Study|Adverse Event|1|||
156481254|NCT02942771|564854379|FG001|Overall Study|Adverse Event|0|||
156481255|NCT02942771|564854380|FG002|Overall Study|Adverse Event|0|||
156481256|NCT02942771|564854381|FG003|Overall Study|Adverse Event|0|||
156481257|NCT02942771|564854382|FG004|Overall Study|Adverse Event|2|||
156481258|NCT02942771|564854378|FG000|Overall Study|Lost to Follow-up|1|||
156481259|NCT02942771|564854379|FG001|Overall Study|Lost to Follow-up|0|||
156481260|NCT02942771|564854380|FG002|Overall Study|Lost to Follow-up|0|||
156345566|NCT01950741|564362424|FG000|Overall Study|Lost to Follow-up|1|||
156481261|NCT02942771|564854381|FG003|Overall Study|Lost to Follow-up|0|||
156481262|NCT02942771|564854382|FG004|Overall Study|Lost to Follow-up|0|||
156481263|NCT02942771|564854378|FG000|Overall Study|Withdrawal by Subject|1|||
156481264|NCT02942771|564854379|FG001|Overall Study|Withdrawal by Subject|0|||
156481265|NCT02942771|564854380|FG002|Overall Study|Withdrawal by Subject|0|||
156481266|NCT02942771|564854381|FG003|Overall Study|Withdrawal by Subject|0|||
156481267|NCT02942771|564854382|FG004|Overall Study|Withdrawal by Subject|2|||
156481268|NCT01186809|564854383|FG000|Overall Study|Death|30|||
156481269|NCT04895085|564854384|FG000|Overall Study|Death|1|||
156481270|NCT04895085|564854384|FG000|Overall Study|Withdrawal by Subject|1|||
156481271|NCT04895085|564854384|FG000|Overall Study|No longer eligible: Moved from area|1|||
156481272|NCT04919499|564854389|FG000|Overall Study|Adverse Event|0|||
156481273|NCT04919499|564854390|FG001|Overall Study|Adverse Event|0|||
156481274|NCT04919499|564854391|FG002|Overall Study|Adverse Event|0|||
156481275|NCT04919499|564854392|FG003|Overall Study|Adverse Event|0|||
156481276|NCT04919499|564854393|FG004|Overall Study|Adverse Event|2|||
156481277|NCT04919499|564854389|FG000|Overall Study|Not treated|0|||
156481278|NCT04919499|564854390|FG001|Overall Study|Not treated|0|||
156543829|NCT02819635|565086192|FG002|Substudy 2, Part 2|Withdrew consent|0|||
156543830|NCT02819635|565086193|FG003|Substudy 2, Part 2|Withdrew consent|0|||
156481279|NCT04919499|564854391|FG002|Overall Study|Not treated|0|||
156481280|NCT04919499|564854392|FG003|Overall Study|Not treated|1|||
156481281|NCT04919499|564854393|FG004|Overall Study|Not treated|0|||
156481282|NCT00946998|564856262|FG000|Overall Study|Exited prior to first outcome assessment|5|||
156481283|NCT00946998|564856263|FG001|Overall Study|Exited prior to first outcome assessment|3|||
156481284|NCT01945593|564856266|FG000|Overall Study|Adverse Event|0|||
156481285|NCT01945593|564856267|FG001|Overall Study|Adverse Event|0|||
156481286|NCT01945593|564856268|FG002|Overall Study|Adverse Event|0|||
156481287|NCT01945593|564856269|FG003|Overall Study|Adverse Event|5|||
156481288|NCT01945593|564856266|FG000|Overall Study|Physician Decision|0|||
156481289|NCT01945593|564856267|FG001|Overall Study|Physician Decision|0|||
156481290|NCT01945593|564856268|FG002|Overall Study|Physician Decision|1|||
156481291|NCT01945593|564856269|FG003|Overall Study|Physician Decision|1|||
156481292|NCT01945593|564856266|FG000|Overall Study|Withdrawal by Subject|0|||
156481293|NCT01945593|564856267|FG001|Overall Study|Withdrawal by Subject|2|||
156481294|NCT01945593|564856268|FG002|Overall Study|Withdrawal by Subject|0|||
156481295|NCT01945593|564856269|FG003|Overall Study|Withdrawal by Subject|4|||
156481296|NCT01945593|564856266|FG000|Overall Study|Protocol Violation|0|||
156481297|NCT01945593|564856267|FG001|Overall Study|Protocol Violation|2|||
156481298|NCT01945593|564856268|FG002|Overall Study|Protocol Violation|1|||
156481299|NCT01945593|564856269|FG003|Overall Study|Protocol Violation|3|||
156481300|NCT01945593|564856266|FG000|Overall Study|Death|0|||
156481301|NCT01945593|564856267|FG001|Overall Study|Death|0|||
156481302|NCT01945593|564856268|FG002|Overall Study|Death|1|||
156481303|NCT01945593|564856269|FG003|Overall Study|Death|0|||
156481304|NCT01945593|564856266|FG000|Overall Study|Other: Terminated|0|||
156481305|NCT01945593|564856267|FG001|Overall Study|Other: Terminated|0|||
156481306|NCT01945593|564856268|FG002|Overall Study|Other: Terminated|0|||
156481307|NCT01945593|564856269|FG003|Overall Study|Other: Terminated|1|||
156345567|NCT01950741|564362424|FG000|Overall Study|Death|1|||
156481308|NCT01945593|564856266|FG000|Overall Study|Other: Surgical Procedure|0|||
156481309|NCT01945593|564856267|FG001|Overall Study|Other: Surgical Procedure|2|||
156481310|NCT01945593|564856268|FG002|Overall Study|Other: Surgical Procedure|0|||
156481311|NCT01945593|564856269|FG003|Overall Study|Other: Surgical Procedure|6|||
156481312|NCT01945593|564856266|FG000|Overall Study|Other: Screen Failure|0|||
156481313|NCT01945593|564856267|FG001|Overall Study|Other: Screen Failure|2|||
156481314|NCT01945593|564856268|FG002|Overall Study|Other: Screen Failure|0|||
156481315|NCT01945593|564856269|FG003|Overall Study|Other: Screen Failure|0|||
156481316|NCT01767376|564856270|FG000|Overall Study|Lost to Follow-up|3|||
156481317|NCT01767376|564856271|FG001|Overall Study|Lost to Follow-up|2|||
156481318|NCT01767376|564856272|FG002|Overall Study|Lost to Follow-up|0|||
156481319|NCT01767376|564856270|FG000|Overall Study|Withdrawal by Subject|1|||
156481320|NCT01767376|564856271|FG001|Overall Study|Withdrawal by Subject|1|||
156481321|NCT01767376|564856272|FG002|Overall Study|Withdrawal by Subject|0|||
156481322|NCT00946088|564856273|FG000|Overall Study|Withdrawal by Subject|0|||
156481323|NCT00946088|564856274|FG001|Overall Study|Withdrawal by Subject|1|||
156481324|NCT01322347|564856275|FG000|Overall Study|Adverse Event|7|||
156481325|NCT01322347|564856276|FG001|Overall Study|Adverse Event|2|||
156481326|NCT01322347|564856275|FG000|Overall Study|Death|5|||
156481327|NCT01322347|564856276|FG001|Overall Study|Death|3|||
156481328|NCT01322347|564856275|FG000|Overall Study|Physician Decision|2|||
156481329|NCT01322347|564856276|FG001|Overall Study|Physician Decision|1|||
156481330|NCT01322347|564856275|FG000|Overall Study|Protocol Violation|5|||
156481331|NCT01322347|564856276|FG001|Overall Study|Protocol Violation|2|||
156481332|NCT01322347|564856275|FG000|Overall Study|Withdrawal by Subject|1|||
156481333|NCT01322347|564856276|FG001|Overall Study|Withdrawal by Subject|4|||
156481334|NCT01322347|564856275|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
156481335|NCT01322347|564856276|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
156481336|NCT01322347|564856275|FG000|Overall Study|blood transfusion|5|||
156481337|NCT01322347|564856276|FG001|Overall Study|blood transfusion|5|||
156481338|NCT01322347|564856275|FG000|Overall Study|sponsor decision|1|||
156481339|NCT01322347|564856276|FG001|Overall Study|sponsor decision|3|||
156481340|NCT01322347|564856275|FG000|Overall Study|ineligible|6|||
156481341|NCT01322347|564856276|FG001|Overall Study|ineligible|3|||
156481342|NCT01322347|564856275|FG000|Overall Study|kidney transplant|3|||
156481343|NCT01322347|564856276|FG001|Overall Study|kidney transplant|1|||
156481344|NCT01322347|564856275|FG000|Overall Study|study drug withheld > 12 wks|0|||
156481345|NCT01322347|564856276|FG001|Overall Study|study drug withheld > 12 wks|1|||
156481346|NCT01322347|564856275|FG000|Overall Study|moved/changed dialysis|2|||
156481347|NCT01322347|564856276|FG001|Overall Study|moved/changed dialysis|4|||
156481348|NCT01193283|564856277|FG000|Overall Study|Death|1|||
156481349|NCT04883541|564856278|FG000|Overall Study|Not attending regular yoga class|16|||
156481350|NCT04883541|564856279|FG001|Overall Study|Not attending regular yoga class|0|||
156481351|NCT04883541|564856278|FG000|Overall Study|Not attending the pregnancy school|0|||
156481352|NCT04883541|564856279|FG001|Overall Study|Not attending the pregnancy school|9|||
156481353|NCT03693989|564856281|FG000|Overall Study|Protocol Violation|3|||
156481354|NCT03693989|564856282|FG001|Overall Study|Protocol Violation|4|||
156481355|NCT01052272|564856283|FG000|Overall Study|Death|0|||
156481356|NCT01052272|564856284|FG001|Overall Study|Death|0|||
156481357|NCT01052272|564856285|FG002|Overall Study|Death|1|||
156481358|NCT01052272|564856286|FG003|Overall Study|Death|1|||
156481359|NCT01052272|564856283|FG000|Overall Study|Physician Decision|0|||
156481360|NCT01052272|564856284|FG001|Overall Study|Physician Decision|1|||
156481361|NCT01052272|564856285|FG002|Overall Study|Physician Decision|0|||
156481362|NCT01052272|564856286|FG003|Overall Study|Physician Decision|0|||
156481363|NCT01052272|564856283|FG000|Overall Study|patient refuses follow-up|5|||
156481364|NCT01052272|564856284|FG001|Overall Study|patient refuses follow-up|4|||
156481365|NCT01052272|564856285|FG002|Overall Study|patient refuses follow-up|2|||
156481366|NCT01052272|564856286|FG003|Overall Study|patient refuses follow-up|4|||
156481367|NCT01052272|564856283|FG000|Overall Study|Withdrawal by Subject|0|||
156345568|NCT01950741|564362424|FG000|Overall Study|Withdrawal by Subject|1|||
156345569|NCT04051008|564362429|FG000|Overall Study|Withdrawal by Subject|2|||
156345570|NCT04051008|564362430|FG001|Overall Study|Withdrawal by Subject|0|||
156481368|NCT01052272|564856284|FG001|Overall Study|Withdrawal by Subject|2|||
156481369|NCT01052272|564856285|FG002|Overall Study|Withdrawal by Subject|3|||
156481370|NCT01052272|564856286|FG003|Overall Study|Withdrawal by Subject|2|||
156481371|NCT01052272|564856283|FG000|Overall Study|placed in long-term care|0|||
156481372|NCT01052272|564856284|FG001|Overall Study|placed in long-term care|0|||
156481373|NCT01052272|564856285|FG002|Overall Study|placed in long-term care|1|||
156481374|NCT01052272|564856286|FG003|Overall Study|placed in long-term care|0|||
156481375|NCT01052272|564856283|FG000|Overall Study|decline in health|0|||
156481376|NCT01052272|564856284|FG001|Overall Study|decline in health|0|||
156481377|NCT01052272|564856285|FG002|Overall Study|decline in health|1|||
156481378|NCT01052272|564856286|FG003|Overall Study|decline in health|0|||
156481379|NCT00648895|564856287|FG000|Overall Study|Lack of Efficacy|0|||
156481380|NCT00648895|564856288|FG001|Overall Study|Lack of Efficacy|1|||
156481381|NCT00096278|564856291|FG000|Overall Study|No follow-up data|15|||
156481382|NCT00096278|564856292|FG001|Overall Study|No follow-up data|18|||
156481383|NCT00096278|564856291|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
156481384|NCT00096278|564856292|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
156481385|NCT00379210|564856295|FG000|Overall Study|Withdrawal by Subject|10|||
156481386|NCT00379210|564856296|FG001|Overall Study|Withdrawal by Subject|7|||
156481387|NCT01358175|564856297|FG000|Overall Study|Death|1|||
156345571|NCT04051008|564362431|FG002|Overall Study|Withdrawal by Subject|1|||
156345572|NCT04342897|564362432|FG000|Overall Study|Death|7|||
156345573|NCT04342897|564362433|FG001|Overall Study|Death|4|||
156481388|NCT01358175|564856298|FG001|Overall Study|Death|0|||
156481389|NCT01358175|564856299|FG002|Overall Study|Death|1|||
156481390|NCT01358175|564856297|FG000|Overall Study|Withdrawal by Subject|9|||
156481391|NCT01358175|564856298|FG001|Overall Study|Withdrawal by Subject|5|||
156481392|NCT01358175|564856299|FG002|Overall Study|Withdrawal by Subject|10|||
156481393|NCT01358175|564856297|FG000|Overall Study|Technical issues|0|||
156481394|NCT01358175|564856298|FG001|Overall Study|Technical issues|1|||
156481395|NCT01358175|564856299|FG002|Overall Study|Technical issues|0|||
156481396|NCT01358175|564856297|FG000|Overall Study|Pregnancy|0|||
156481397|NCT01358175|564856298|FG001|Overall Study|Pregnancy|1|||
156481398|NCT01358175|564856299|FG002|Overall Study|Pregnancy|0|||
156481399|NCT01358175|564856297|FG000|Overall Study|Physician Decision|1|||
156481400|NCT01358175|564856298|FG001|Overall Study|Physician Decision|0|||
156481401|NCT01358175|564856299|FG002|Overall Study|Physician Decision|0|||
156481402|NCT01358175|564856297|FG000|Overall Study|Non Compliance with Study Treatment|0|||
156481403|NCT01358175|564856298|FG001|Overall Study|Non Compliance with Study Treatment|1|||
156481404|NCT01358175|564856299|FG002|Overall Study|Non Compliance with Study Treatment|1|||
156481405|NCT01358175|564856297|FG000|Overall Study|Lost to Follow-up|1|||
156481406|NCT01358175|564856298|FG001|Overall Study|Lost to Follow-up|1|||
156481407|NCT01358175|564856299|FG002|Overall Study|Lost to Follow-up|3|||
156481408|NCT01358175|564856297|FG000|Overall Study|Lack of Efficacy|3|||
156481409|NCT01358175|564856298|FG001|Overall Study|Lack of Efficacy|8|||
156345574|NCT04342897|564362432|FG000|Overall Study|Lost to Follow-up|6|||
156345575|NCT04342897|564362433|FG001|Overall Study|Lost to Follow-up|6|||
156481410|NCT01358175|564856299|FG002|Overall Study|Lack of Efficacy|6|||
156481411|NCT01358175|564856297|FG000|Overall Study|Adverse Event|6|||
156481412|NCT01358175|564856298|FG001|Overall Study|Adverse Event|11|||
156345576|NCT04342897|564362432|FG000|Overall Study|Withdrawal by Subject|1|||
156345577|NCT04342897|564362433|FG001|Overall Study|Withdrawal by Subject|2|||
156481413|NCT01358175|564856299|FG002|Overall Study|Adverse Event|11|||
156481414|NCT02991118|564856302|FG000|Overall Study|Death|3|||
156481415|NCT02991118|564856303|FG001|Overall Study|Death|8|||
156481416|NCT02991118|564856302|FG000|Overall Study|Protocol Violation|0|||
156481417|NCT02991118|564856303|FG001|Overall Study|Protocol Violation|3|||
156481418|NCT02991118|564856302|FG000|Overall Study|Physician Decision|0|||
156481419|NCT02991118|564856303|FG001|Overall Study|Physician Decision|1|||
156481420|NCT02991118|564856302|FG000|Overall Study|Moved out of the country|0|||
156481421|NCT02991118|564856303|FG001|Overall Study|Moved out of the country|1|||
156481422|NCT02991118|564856302|FG000|Overall Study|Adverse Event|2|||
156481423|NCT02991118|564856303|FG001|Overall Study|Adverse Event|2|||
156481424|NCT02991118|564856302|FG000|Overall Study|Withdrawal by Subject|1|||
156481425|NCT02991118|564856303|FG001|Overall Study|Withdrawal by Subject|7|||
156481426|NCT02991118|564856302|FG000|Overall Study|Could not attend study visits|0|||
156481427|NCT02991118|564856303|FG001|Overall Study|Could not attend study visits|1|||
156481428|NCT02991118|564856302|FG000|Overall Study|Lost to Follow-up|1|||
156481429|NCT02991118|564856303|FG001|Overall Study|Lost to Follow-up|9|||
156481430|NCT02764320|564856310|FG000|Overall Study|Withdrawal by Subject|35|||
156481431|NCT02764320|564856311|FG001|Overall Study|Withdrawal by Subject|38|||
156481432|NCT02764320|564856310|FG000|Overall Study|Protocol Violation|11|||
156481433|NCT02764320|564856311|FG001|Overall Study|Protocol Violation|6|||
156481434|NCT02764320|564856310|FG000|Overall Study|Adverse Event|2|||
156481435|NCT02764320|564856311|FG001|Overall Study|Adverse Event|0|||
156481436|NCT02764320|564856310|FG000|Overall Study|Health Issues unable to continue|2|||
156481437|NCT02764320|564856311|FG001|Overall Study|Health Issues unable to continue|0|||
156481438|NCT02764320|564856310|FG000|Overall Study|Did not meet inclusion criteria|1|||
156481439|NCT02764320|564856311|FG001|Overall Study|Did not meet inclusion criteria|0|||
156481440|NCT02764320|564856310|FG000|Overall Study|Subject moved|0|||
156481441|NCT02764320|564856311|FG001|Overall Study|Subject moved|2|||
156481442|NCT02764320|564856310|FG000|Overall Study|Overused medication unavailable|0|||
156481443|NCT02764320|564856311|FG001|Overall Study|Overused medication unavailable|1|||
156481444|NCT02764320|564856310|FG000|Overall Study|Seeking care outside site|0|||
156481445|NCT02764320|564856311|FG001|Overall Study|Seeking care outside site|1|||
156481446|NCT02764320|564856310|FG000|Overall Study|Technology barriers|0|||
156481447|NCT02764320|564856311|FG001|Overall Study|Technology barriers|1|||
156481448|NCT04085614|564856312|FG000|Overall Study|Protocol Violation|9|||
156481449|NCT04085614|564856313|FG001|Overall Study|Protocol Violation|6|||
156481450|NCT03529942|564856314|FG000|Overall Study|Withdrawal by Subject|13|||
156481451|NCT03529942|564856314|FG000|Overall Study|Physician Decision|1|||
156481452|NCT03529942|564856314|FG000|Overall Study|Lost to Follow-up|7|||
156481453|NCT03529942|564856314|FG000|Overall Study|Needle inserted but no drug administered|1|||
156481454|NCT03529942|564856314|FG000|Overall Study|Personal reasons|1|||
156481455|NCT00476957|564856319|FG000|Overall Study|Lost to Follow-up|176|||
156481456|NCT00476957|564856320|FG001|Overall Study|Lost to Follow-up|193|||
156481457|NCT02516202|564856321|FG000|Overall Study|Withdrawal by Subject|1|||
156481458|NCT02516202|564856322|FG001|Overall Study|Withdrawal by Subject|0|||
156481459|NCT02516202|564856323|FG002|Overall Study|Withdrawal by Subject|1|||
156481460|NCT02516202|564856321|FG000|Overall Study|Lost to Follow-up|1|||
156543831|NCT02819635|565086194|FG004|Substudy 2, Part 2|Withdrew consent|0|||
156543832|NCT02819635|565086195|FG005|Substudy 2, Part 2|Withdrew consent|3|||
156345578|NCT00621153|564362435|FG000|Overall Study|Safety Reason|8|||
156345579|NCT00621153|564362436|FG001|Overall Study|Safety Reason|7|||
156543833|NCT02819635|565086196|FG006|Substudy 2, Part 2|Withdrew consent|1|||
156345580|NCT00621153|564362435|FG000|Overall Study|Adverse Event|3|||
156481461|NCT02516202|564856322|FG001|Overall Study|Lost to Follow-up|1|||
156481462|NCT02516202|564856323|FG002|Overall Study|Lost to Follow-up|1|||
156481463|NCT02516202|564856321|FG000|Overall Study|Stopped Follow-up|0|||
156481464|NCT02516202|564856322|FG001|Overall Study|Stopped Follow-up|0|||
156481465|NCT02516202|564856323|FG002|Overall Study|Stopped Follow-up|1|||
156481466|NCT00409747|564856328|FG000|Overall Study|Withdrawal by Subject|1|||
156481467|NCT01000649|564856329|FG000|Overall Study|Adverse Event|5|||
156481468|NCT01000649|564856330|FG001|Overall Study|Adverse Event|1|||
156481469|NCT01000649|564856331|FG002|Overall Study|Adverse Event|2|||
156481470|NCT01000649|564856332|FG003|Overall Study|Adverse Event|4|||
156481471|NCT01000649|564856329|FG000|Overall Study|Lost to Follow-up|0|||
156481472|NCT01000649|564856330|FG001|Overall Study|Lost to Follow-up|2|||
156481473|NCT01000649|564856331|FG002|Overall Study|Lost to Follow-up|0|||
156481474|NCT01000649|564856332|FG003|Overall Study|Lost to Follow-up|2|||
156481475|NCT01989156|564856335|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
156481476|NCT01989156|564856336|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
156481477|NCT01989156|564856337|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
156481478|NCT01989156|564856335|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
156481479|NCT01989156|564856336|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
156481480|NCT01989156|564856337|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
156481481|NCT01989156|564856335|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
156481482|NCT01989156|564856336|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
156481483|NCT01989156|564856337|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
156481484|NCT01989156|564856335|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
156481485|NCT01989156|564856336|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
156481486|NCT01989156|564856337|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
156481487|NCT01989156|564856335|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
156481488|NCT01989156|564856336|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
156481489|NCT01989156|564856337|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
156481490|NCT01989156|564856335|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
156481491|NCT01989156|564856336|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
156481492|NCT01989156|564856337|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
156481493|NCT01989156|564856335|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
156481494|NCT01989156|564856336|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
156481495|NCT01989156|564856337|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
156481496|NCT01989156|564856335|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
156481497|NCT01989156|564856336|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
156481498|NCT01989156|564856337|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
156481499|NCT03839355|564856338|FG000|Overall Study|Withdrawal by Subject|1|||
156481500|NCT03839355|564856339|FG001|Overall Study|Withdrawal by Subject|0|||
156481501|NCT01916109|564856340|FG000|Overall Study|Withdrawal by Subject|1|||
156481502|NCT00103857|564856341|FG000|54-Week Base Study|Adverse Event|12|||
156481503|NCT00103857|564856342|FG001|54-Week Base Study|Adverse Event|9|||
156481504|NCT00103857|564856343|FG002|54-Week Base Study|Adverse Event|11|||
156481505|NCT00103857|564856344|FG003|54-Week Base Study|Adverse Event|6|||
156481506|NCT00103857|564856345|FG004|54-Week Base Study|Adverse Event|5|||
156481507|NCT00103857|564856346|FG005|54-Week Base Study|Adverse Event|11|||
156481508|NCT00103857|564856347|FG006|54-Week Base Study|Adverse Event|3|||
156481509|NCT00103857|564856341|FG000|54-Week Base Study|Death|0|||
156481510|NCT00103857|564856342|FG001|54-Week Base Study|Death|0|||
156481511|NCT00103857|564856343|FG002|54-Week Base Study|Death|0|||
156481512|NCT00103857|564856344|FG003|54-Week Base Study|Death|0|||
156481513|NCT00103857|564856345|FG004|54-Week Base Study|Death|1|||
156481514|NCT00103857|564856346|FG005|54-Week Base Study|Death|1|||
156481515|NCT00103857|564856347|FG006|54-Week Base Study|Death|0|||
156481516|NCT00103857|564856341|FG000|54-Week Base Study|Lack of Efficacy|11|||
156481517|NCT00103857|564856342|FG001|54-Week Base Study|Lack of Efficacy|14|||
156481518|NCT00103857|564856343|FG002|54-Week Base Study|Lack of Efficacy|8|||
156481519|NCT00103857|564856344|FG003|54-Week Base Study|Lack of Efficacy|4|||
156481520|NCT00103857|564856345|FG004|54-Week Base Study|Lack of Efficacy|3|||
156481521|NCT00103857|564856346|FG005|54-Week Base Study|Lack of Efficacy|14|||
156481522|NCT00103857|564856347|FG006|54-Week Base Study|Lack of Efficacy|19|||
156481523|NCT00103857|564856341|FG000|54-Week Base Study|Lost to Follow-up|5|||
156481524|NCT00103857|564856342|FG001|54-Week Base Study|Lost to Follow-up|4|||
156481525|NCT00103857|564856343|FG002|54-Week Base Study|Lost to Follow-up|7|||
156481526|NCT00103857|564856344|FG003|54-Week Base Study|Lost to Follow-up|5|||
156481527|NCT00103857|564856345|FG004|54-Week Base Study|Lost to Follow-up|10|||
156481528|NCT00103857|564856346|FG005|54-Week Base Study|Lost to Follow-up|9|||
156481529|NCT00103857|564856347|FG006|54-Week Base Study|Lost to Follow-up|3|||
156345581|NCT00621153|564362436|FG001|Overall Study|Adverse Event|2|||
156345582|NCT00621153|564362435|FG000|Overall Study|Lost to Follow-up|5|||
156345583|NCT00621153|564362436|FG001|Overall Study|Lost to Follow-up|1|||
156345584|NCT00621153|564362435|FG000|Overall Study|Withdrawal by Subject|4|||
156481530|NCT00103857|564856341|FG000|54-Week Base Study|Physician Decision|1|||
156345585|NCT00621153|564362436|FG001|Overall Study|Withdrawal by Subject|5|||
156481531|NCT00103857|564856342|FG001|54-Week Base Study|Physician Decision|1|||
156481532|NCT00103857|564856343|FG002|54-Week Base Study|Physician Decision|0|||
156481533|NCT00103857|564856344|FG003|54-Week Base Study|Physician Decision|0|||
156481534|NCT00103857|564856345|FG004|54-Week Base Study|Physician Decision|1|||
156481535|NCT00103857|564856346|FG005|54-Week Base Study|Physician Decision|0|||
156481536|NCT00103857|564856347|FG006|54-Week Base Study|Physician Decision|0|||
156481537|NCT00103857|564856341|FG000|54-Week Base Study|Pregnancy|1|||
156481538|NCT00103857|564856342|FG001|54-Week Base Study|Pregnancy|0|||
156481539|NCT00103857|564856343|FG002|54-Week Base Study|Pregnancy|0|||
156481540|NCT00103857|564856344|FG003|54-Week Base Study|Pregnancy|0|||
156481541|NCT00103857|564856345|FG004|54-Week Base Study|Pregnancy|1|||
156481542|NCT00103857|564856346|FG005|54-Week Base Study|Pregnancy|0|||
156481543|NCT00103857|564856347|FG006|54-Week Base Study|Pregnancy|1|||
156481544|NCT00103857|564856341|FG000|54-Week Base Study|Protocol Violation|6|||
156481545|NCT00103857|564856342|FG001|54-Week Base Study|Protocol Violation|4|||
156481546|NCT00103857|564856343|FG002|54-Week Base Study|Protocol Violation|2|||
156481547|NCT00103857|564856344|FG003|54-Week Base Study|Protocol Violation|4|||
156481548|NCT00103857|564856345|FG004|54-Week Base Study|Protocol Violation|0|||
156481549|NCT00103857|564856346|FG005|54-Week Base Study|Protocol Violation|3|||
156481550|NCT00103857|564856347|FG006|54-Week Base Study|Protocol Violation|3|||
156481551|NCT00103857|564856341|FG000|54-Week Base Study|Withdrawal by Subject|17|||
156481552|NCT00103857|564856342|FG001|54-Week Base Study|Withdrawal by Subject|16|||
156481553|NCT00103857|564856343|FG002|54-Week Base Study|Withdrawal by Subject|16|||
156481554|NCT00103857|564856344|FG003|54-Week Base Study|Withdrawal by Subject|15|||
156481555|NCT00103857|564856345|FG004|54-Week Base Study|Withdrawal by Subject|10|||
156481556|NCT00103857|564856346|FG005|54-Week Base Study|Withdrawal by Subject|15|||
156481557|NCT00103857|564856347|FG006|54-Week Base Study|Withdrawal by Subject|4|||
156481558|NCT00103857|564856341|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
156481559|NCT00103857|564856342|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
156481560|NCT00103857|564856343|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
156481561|NCT00103857|564856344|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
156481562|NCT00103857|564856345|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
156481563|NCT00103857|564856346|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
156481564|NCT00103857|564856347|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
156481565|NCT00103857|564856341|FG000|54-Week Base Study|patient moved|0|||
156481566|NCT00103857|564856342|FG001|54-Week Base Study|patient moved|1|||
156481567|NCT00103857|564856343|FG002|54-Week Base Study|patient moved|1|||
156481568|NCT00103857|564856344|FG003|54-Week Base Study|patient moved|2|||
156481569|NCT00103857|564856345|FG004|54-Week Base Study|patient moved|3|||
156481570|NCT00103857|564856346|FG005|54-Week Base Study|patient moved|1|||
156481571|NCT00103857|564856347|FG006|54-Week Base Study|patient moved|0|||
156481572|NCT00103857|564856341|FG000|54-Week Base Study|non-compliance with study procedures|1|||
156481573|NCT00103857|564856342|FG001|54-Week Base Study|non-compliance with study procedures|2|||
156481574|NCT00103857|564856343|FG002|54-Week Base Study|non-compliance with study procedures|0|||
156481575|NCT00103857|564856344|FG003|54-Week Base Study|non-compliance with study procedures|0|||
156481576|NCT00103857|564856345|FG004|54-Week Base Study|non-compliance with study procedures|0|||
156481577|NCT00103857|564856346|FG005|54-Week Base Study|non-compliance with study procedures|2|||
156481578|NCT00103857|564856347|FG006|54-Week Base Study|non-compliance with study procedures|0|||
156481579|NCT00103857|564856341|FG000|54-Week Base Study|patient incarcerated|0|||
156481580|NCT00103857|564856342|FG001|54-Week Base Study|patient incarcerated|0|||
156481581|NCT00103857|564856343|FG002|54-Week Base Study|patient incarcerated|0|||
156481582|NCT00103857|564856344|FG003|54-Week Base Study|patient incarcerated|0|||
156481583|NCT00103857|564856345|FG004|54-Week Base Study|patient incarcerated|1|||
156481584|NCT00103857|564856346|FG005|54-Week Base Study|patient incarcerated|1|||
156481585|NCT00103857|564856347|FG006|54-Week Base Study|patient incarcerated|0|||
156481586|NCT00103857|564856341|FG000|54-Week Base Study|laboratory reporting error|0|||
156481587|NCT00103857|564856342|FG001|54-Week Base Study|laboratory reporting error|0|||
156481588|NCT00103857|564856343|FG002|54-Week Base Study|laboratory reporting error|0|||
156481589|NCT00103857|564856344|FG003|54-Week Base Study|laboratory reporting error|0|||
156345586|NCT04212650|564362437|FG000|Overall Study|Withdrawal by Subject|1|||
156345587|NCT04212650|564362438|FG001|Overall Study|Withdrawal by Subject|0|||
156481590|NCT00103857|564856345|FG004|54-Week Base Study|laboratory reporting error|1|||
156481591|NCT00103857|564856346|FG005|54-Week Base Study|laboratory reporting error|0|||
156481592|NCT00103857|564856347|FG006|54-Week Base Study|laboratory reporting error|0|||
156481593|NCT00103857|564856341|FG000|54-Week Base Study|site error|0|||
156481594|NCT00103857|564856342|FG001|54-Week Base Study|site error|0|||
156481595|NCT00103857|564856343|FG002|54-Week Base Study|site error|0|||
156481596|NCT00103857|564856344|FG003|54-Week Base Study|site error|0|||
156481597|NCT00103857|564856345|FG004|54-Week Base Study|site error|0|||
156481598|NCT00103857|564856346|FG005|54-Week Base Study|site error|1|||
156481599|NCT00103857|564856347|FG006|54-Week Base Study|site error|0|||
156481600|NCT00103857|564856341|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
156481601|NCT00103857|564856342|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
156481602|NCT00103857|564856343|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
156481603|NCT00103857|564856344|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
156481604|NCT00103857|564856345|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
156481605|NCT00103857|564856346|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
156481606|NCT00103857|564856347|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
156481607|NCT00103857|564856341|FG000|50-Week Extension Study|Adverse Event|2|||
156481608|NCT00103857|564856342|FG001|50-Week Extension Study|Adverse Event|3|||
156481609|NCT00103857|564856343|FG002|50-Week Extension Study|Adverse Event|2|||
156481610|NCT00103857|564856344|FG003|50-Week Extension Study|Adverse Event|0|||
156481611|NCT00103857|564856345|FG004|50-Week Extension Study|Adverse Event|1|||
156481612|NCT00103857|564856346|FG005|50-Week Extension Study|Adverse Event|1|||
156481613|NCT00103857|564856347|FG006|50-Week Extension Study|Adverse Event|0|||
156481614|NCT00103857|564856341|FG000|50-Week Extension Study|Death|0|||
156481615|NCT00103857|564856342|FG001|50-Week Extension Study|Death|0|||
156481616|NCT00103857|564856343|FG002|50-Week Extension Study|Death|0|||
156481617|NCT00103857|564856344|FG003|50-Week Extension Study|Death|1|||
156481618|NCT00103857|564856345|FG004|50-Week Extension Study|Death|0|||
156481619|NCT00103857|564856346|FG005|50-Week Extension Study|Death|1|||
156481620|NCT00103857|564856347|FG006|50-Week Extension Study|Death|0|||
156481621|NCT00103857|564856341|FG000|50-Week Extension Study|Lack of Efficacy|26|||
156481622|NCT00103857|564856342|FG001|50-Week Extension Study|Lack of Efficacy|15|||
156481623|NCT00103857|564856343|FG002|50-Week Extension Study|Lack of Efficacy|13|||
156481624|NCT00103857|564856344|FG003|50-Week Extension Study|Lack of Efficacy|16|||
156481625|NCT00103857|564856345|FG004|50-Week Extension Study|Lack of Efficacy|8|||
156481626|NCT00103857|564856346|FG005|50-Week Extension Study|Lack of Efficacy|8|||
156481627|NCT00103857|564856347|FG006|50-Week Extension Study|Lack of Efficacy|0|||
156481628|NCT00103857|564856341|FG000|50-Week Extension Study|Lost to Follow-up|4|||
156481629|NCT00103857|564856342|FG001|50-Week Extension Study|Lost to Follow-up|0|||
156481630|NCT00103857|564856343|FG002|50-Week Extension Study|Lost to Follow-up|1|||
156543834|NCT02819635|565086197|FG007|Substudy 2, Part 2|Withdrew consent|0|||
156481631|NCT00103857|564856344|FG003|50-Week Extension Study|Lost to Follow-up|4|||
156481632|NCT00103857|564856345|FG004|50-Week Extension Study|Lost to Follow-up|3|||
156481633|NCT00103857|564856346|FG005|50-Week Extension Study|Lost to Follow-up|3|||
156481634|NCT00103857|564856347|FG006|50-Week Extension Study|Lost to Follow-up|0|||
156481635|NCT00103857|564856341|FG000|50-Week Extension Study|Physician Decision|0|||
156481636|NCT00103857|564856342|FG001|50-Week Extension Study|Physician Decision|1|||
156481637|NCT00103857|564856343|FG002|50-Week Extension Study|Physician Decision|1|||
156481638|NCT00103857|564856344|FG003|50-Week Extension Study|Physician Decision|0|||
156481639|NCT00103857|564856345|FG004|50-Week Extension Study|Physician Decision|0|||
156481640|NCT00103857|564856346|FG005|50-Week Extension Study|Physician Decision|0|||
156481641|NCT00103857|564856347|FG006|50-Week Extension Study|Physician Decision|0|||
156345588|NCT00357968|564362443|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
156481642|NCT00103857|564856341|FG000|50-Week Extension Study|Pregnancy|0|||
156481643|NCT00103857|564856342|FG001|50-Week Extension Study|Pregnancy|0|||
156481644|NCT00103857|564856343|FG002|50-Week Extension Study|Pregnancy|1|||
156481645|NCT00103857|564856344|FG003|50-Week Extension Study|Pregnancy|0|||
156481646|NCT00103857|564856345|FG004|50-Week Extension Study|Pregnancy|1|||
156481647|NCT00103857|564856346|FG005|50-Week Extension Study|Pregnancy|0|||
156481648|NCT00103857|564856347|FG006|50-Week Extension Study|Pregnancy|0|||
156481649|NCT00103857|564856341|FG000|50-Week Extension Study|Protocol Violation|1|||
156543835|NCT02819635|565086198|FG008|Substudy 2, Part 2|Withdrew consent|0|||
156543836|NCT02819635|565086199|FG009|Substudy 2, Part 2|Withdrew consent|0|||
156345589|NCT00357968|564362444|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
156481650|NCT00103857|564856342|FG001|50-Week Extension Study|Protocol Violation|1|||
156481651|NCT00103857|564856343|FG002|50-Week Extension Study|Protocol Violation|1|||
156481652|NCT00103857|564856344|FG003|50-Week Extension Study|Protocol Violation|2|||
156481653|NCT00103857|564856345|FG004|50-Week Extension Study|Protocol Violation|0|||
156481654|NCT00103857|564856346|FG005|50-Week Extension Study|Protocol Violation|1|||
156481655|NCT00103857|564856347|FG006|50-Week Extension Study|Protocol Violation|0|||
156481656|NCT00103857|564856341|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
156481657|NCT00103857|564856342|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
156481658|NCT00103857|564856343|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
156481659|NCT00103857|564856344|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
156481660|NCT00103857|564856345|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
156481661|NCT00103857|564856346|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
156481662|NCT00103857|564856347|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
156481663|NCT00103857|564856341|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
156481664|NCT00103857|564856342|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
156481665|NCT00103857|564856343|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
156345590|NCT00357968|564362443|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
156345591|NCT00357968|564362444|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
156345592|NCT00679302|564362446|FG000|Overall Study|Lost to Follow-up|8|||
156481666|NCT00103857|564856344|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
156481667|NCT00103857|564856345|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
156543837|NCT02819635|565086200|FG010|Substudy 2, Part 2|Withdrew consent|0|||
156543838|NCT02819635|565086201|FG011|Substudy 2, Part 2|Withdrew consent|0|||
156543839|NCT02819635|565086190|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
156543840|NCT02819635|565086191|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
156543841|NCT02819635|565086192|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
156543842|NCT02819635|565086193|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
156543843|NCT02819635|565086194|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
156543844|NCT02819635|565086195|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
156543845|NCT02819635|565086196|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
156543846|NCT02819635|565086197|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
156543847|NCT02819635|565086198|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
156543848|NCT02819635|565086199|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
156543849|NCT02819635|565086200|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
156481668|NCT00103857|564856346|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
156481669|NCT00103857|564856347|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
156345593|NCT00679302|564362447|FG001|Overall Study|Lost to Follow-up|4|||
156345594|NCT03547687|564362448|FG000|Overall Study|Withdrawal by Subject|1|||
156345595|NCT03547687|564362448|FG000|Overall Study|Death|1|||
156345596|NCT04656691|564362451|FG000|Overall Study|Adverse Event|1|||
156345597|NCT02846779|564362454|FG000|Overall Study|Lost Enrollment|83|||
156345598|NCT02846779|564362455|FG001|Overall Study|Lost Enrollment|82|||
156345599|NCT02846779|564362456|FG002|Overall Study|Lost Enrollment|86|||
156345600|NCT02846779|564362454|FG000|Overall Study|Less than 31 days of follow-up|56|||
156345601|NCT02846779|564362455|FG001|Overall Study|Less than 31 days of follow-up|45|||
156345602|NCT02846779|564362456|FG002|Overall Study|Less than 31 days of follow-up|52|||
156345603|NCT00887978|564362457|FG000|Overall Study|Adverse Event|18|||
156345604|NCT00887978|564362458|FG001|Overall Study|Adverse Event|5|||
156345605|NCT00887978|564362457|FG000|Overall Study|Clinical Worsening|4|||
156345606|NCT00887978|564362458|FG001|Overall Study|Clinical Worsening|4|||
156345607|NCT00887978|564362457|FG000|Overall Study|Death|2|||
156345608|NCT00887978|564362458|FG001|Overall Study|Death|3|||
156345609|NCT00887978|564362457|FG000|Overall Study|Withdrawal by Subject|1|||
156345610|NCT00887978|564362458|FG001|Overall Study|Withdrawal by Subject|2|||
156345611|NCT00887978|564362457|FG000|Overall Study|Lost to Follow-up|0|||
156345612|NCT00887978|564362458|FG001|Overall Study|Lost to Follow-up|1|||
156345613|NCT04600921|564362459|FG000|Overall Study|Withdrawal by Subject|3|||
156345614|NCT04600921|564362460|FG001|Overall Study|Withdrawal by Subject|5|||
156345615|NCT04600921|564362459|FG000|Overall Study|Death|0|||
156345616|NCT04600921|564362460|FG001|Overall Study|Death|1|||
156345617|NCT01366521|564364157|FG000|Overall Study|Adverse Event|1|||
156345618|NCT01366521|564364158|FG001|Overall Study|Adverse Event|0|||
156345619|NCT01366521|564364159|FG002|Overall Study|Adverse Event|0|||
156345620|NCT01366521|564364160|FG003|Overall Study|Adverse Event|0|||
156345621|NCT01366521|564364157|FG000|Overall Study|Protocol Violation|0|||
156345622|NCT01366521|564364158|FG001|Overall Study|Protocol Violation|0|||
156345623|NCT01366521|564364159|FG002|Overall Study|Protocol Violation|1|||
156345624|NCT01366521|564364160|FG003|Overall Study|Protocol Violation|0|||
156345625|NCT01366521|564364157|FG000|Overall Study|Physician Decision|0|||
156345626|NCT01366521|564364158|FG001|Overall Study|Physician Decision|0|||
156345627|NCT01366521|564364159|FG002|Overall Study|Physician Decision|1|||
156345628|NCT01366521|564364160|FG003|Overall Study|Physician Decision|0|||
156481670|NCT00103857|564856341|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
156481671|NCT00103857|564856342|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
156481672|NCT00103857|564856343|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
156481673|NCT00103857|564856344|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
156345629|NCT01366521|564364157|FG000|Overall Study|Withdrawal by Subject|0|||
156345630|NCT01366521|564364158|FG001|Overall Study|Withdrawal by Subject|1|||
156481674|NCT00103857|564856345|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
156481675|NCT00103857|564856346|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
156481676|NCT00103857|564856347|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
156481677|NCT00103857|564856341|FG000|50-Week Extension Study|patient moved|0|||
156481678|NCT00103857|564856342|FG001|50-Week Extension Study|patient moved|0|||
156481679|NCT00103857|564856343|FG002|50-Week Extension Study|patient moved|1|||
156481680|NCT00103857|564856344|FG003|50-Week Extension Study|patient moved|2|||
156481681|NCT00103857|564856345|FG004|50-Week Extension Study|patient moved|0|||
156481682|NCT00103857|564856346|FG005|50-Week Extension Study|patient moved|0|||
156481683|NCT00103857|564856347|FG006|50-Week Extension Study|patient moved|0|||
156481684|NCT00103857|564856341|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
156481685|NCT00103857|564856342|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
156543850|NCT02819635|565086201|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
156543851|NCT02819635|565086190|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156345631|NCT01366521|564364159|FG002|Overall Study|Withdrawal by Subject|0|||
156345632|NCT01366521|564364160|FG003|Overall Study|Withdrawal by Subject|0|||
156345633|NCT02899988|564364163|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
156345634|NCT02899988|564364164|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
156345635|NCT02899988|564364165|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156481686|NCT00103857|564856343|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
156481687|NCT00103857|564856344|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
156345636|NCT02899988|564364166|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156345637|NCT02899988|564364167|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156345638|NCT02899988|564364168|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156345639|NCT02899988|564364169|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156345640|NCT02899988|564364170|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156345641|NCT02899988|564364171|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156481688|NCT00103857|564856345|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
156481689|NCT00103857|564856346|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
156481690|NCT00103857|564856347|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
156481691|NCT00103857|564856341|FG000|50-Week Extension Study|reason unspecified|0|||
156481692|NCT00103857|564856342|FG001|50-Week Extension Study|reason unspecified|0|||
156481693|NCT00103857|564856343|FG002|50-Week Extension Study|reason unspecified|0|||
156481694|NCT00103857|564856344|FG003|50-Week Extension Study|reason unspecified|0|||
156481695|NCT00103857|564856345|FG004|50-Week Extension Study|reason unspecified|1|||
156481696|NCT00103857|564856346|FG005|50-Week Extension Study|reason unspecified|0|||
156481697|NCT00103857|564856347|FG006|50-Week Extension Study|reason unspecified|0|||
156481698|NCT00636168|564856350|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
156481699|NCT00636168|564856351|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
156481700|NCT00636168|564856350|FG000|Randomized to Study Drug|Adverse Event|1|||
156481701|NCT00636168|564856351|FG001|Randomized to Study Drug|Adverse Event|0|||
156481702|NCT00636168|564856350|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
156481703|NCT00636168|564856351|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
156481704|NCT00636168|564856350|FG000|Treated With Study Drug|Recurrence of disease|135|||
156481705|NCT00636168|564856351|FG001|Treated With Study Drug|Recurrence of disease|282|||
156481706|NCT00636168|564856350|FG000|Treated With Study Drug|Adverse Event|250|||
156481707|NCT00636168|564856351|FG001|Treated With Study Drug|Adverse Event|22|||
156481708|NCT00636168|564856350|FG000|Treated With Study Drug|Participant withdrew consent|16|||
156481709|NCT00636168|564856351|FG001|Treated With Study Drug|Participant withdrew consent|21|||
156481710|NCT00636168|564856350|FG000|Treated With Study Drug|Poor/non-compliance|1|||
156481711|NCT00636168|564856351|FG001|Treated With Study Drug|Poor/non-compliance|3|||
156481712|NCT00636168|564856350|FG000|Treated With Study Drug|Death|3|||
156481713|NCT00636168|564856351|FG001|Treated With Study Drug|Death|0|||
156481714|NCT00636168|564856350|FG000|Treated With Study Drug|Pregnancy|1|||
156481715|NCT00636168|564856351|FG001|Treated With Study Drug|Pregnancy|0|||
156481716|NCT00636168|564856350|FG000|Treated With Study Drug|No longer meets study criteria|1|||
156481717|NCT00636168|564856351|FG001|Treated With Study Drug|No longer meets study criteria|0|||
156481718|NCT00636168|564856350|FG000|Treated With Study Drug|Other reason|1|||
156481719|NCT00636168|564856351|FG001|Treated With Study Drug|Other reason|3|||
156481720|NCT00636168|564856350|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
156481721|NCT00636168|564856351|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
156481722|NCT00636168|564856350|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
156481723|NCT00636168|564856351|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
156481724|NCT00636168|564856350|FG000|Long Term Follow-Up|Death|8|||
156481725|NCT00636168|564856351|FG001|Long Term Follow-Up|Death|9|||
156481726|NCT03541369|564856355|FG000|Overall Study|Death|0|||
156481727|NCT03541369|564856356|FG001|Overall Study|Death|0|||
156481728|NCT03541369|564856357|FG002|Overall Study|Death|0|||
156481729|NCT03541369|564856358|FG003|Overall Study|Death|0|||
156481730|NCT03541369|564856359|FG004|Overall Study|Death|1|||
156481731|NCT03541369|564856360|FG005|Overall Study|Death|1|||
156481732|NCT03541369|564856361|FG006|Overall Study|Death|0|||
156481733|NCT03541369|564856362|FG007|Overall Study|Death|2|||
156481734|NCT03541369|564856363|FG008|Overall Study|Death|1|||
156481735|NCT03541369|564856364|FG009|Overall Study|Death|2|||
156481736|NCT03541369|564856365|FG010|Overall Study|Death|1|||
156481737|NCT03541369|564856366|FG011|Overall Study|Death|0|||
156481738|NCT03541369|564856367|FG012|Overall Study|Death|2|||
156481739|NCT03541369|564856368|FG013|Overall Study|Death|1|||
156481740|NCT03541369|564856369|FG014|Overall Study|Death|1|||
156481741|NCT03541369|564856370|FG015|Overall Study|Death|1|||
156481742|NCT03541369|564856371|FG016|Overall Study|Death|0|||
156481743|NCT03541369|564856372|FG017|Overall Study|Death|1|||
156481744|NCT03541369|564856355|FG000|Overall Study|Decision by sponsor|0|||
156481745|NCT03541369|564856356|FG001|Overall Study|Decision by sponsor|0|||
156481746|NCT03541369|564856357|FG002|Overall Study|Decision by sponsor|0|||
156481747|NCT03541369|564856358|FG003|Overall Study|Decision by sponsor|1|||
156481748|NCT03541369|564856359|FG004|Overall Study|Decision by sponsor|0|||
156481749|NCT03541369|564856360|FG005|Overall Study|Decision by sponsor|2|||
156481750|NCT03541369|564856361|FG006|Overall Study|Decision by sponsor|0|||
156481751|NCT03541369|564856362|FG007|Overall Study|Decision by sponsor|1|||
156481752|NCT03541369|564856363|FG008|Overall Study|Decision by sponsor|2|||
156481753|NCT03541369|564856364|FG009|Overall Study|Decision by sponsor|0|||
156481754|NCT03541369|564856365|FG010|Overall Study|Decision by sponsor|0|||
156481755|NCT03541369|564856366|FG011|Overall Study|Decision by sponsor|0|||
156481756|NCT03541369|564856367|FG012|Overall Study|Decision by sponsor|2|||
156481757|NCT03541369|564856368|FG013|Overall Study|Decision by sponsor|2|||
156481758|NCT03541369|564856369|FG014|Overall Study|Decision by sponsor|0|||
156481759|NCT03541369|564856370|FG015|Overall Study|Decision by sponsor|1|||
156481760|NCT03541369|564856371|FG016|Overall Study|Decision by sponsor|1|||
156481761|NCT03541369|564856372|FG017|Overall Study|Decision by sponsor|1|||
156481762|NCT03541369|564856355|FG000|Overall Study|Withdrawal by Subject|0|||
156481763|NCT03541369|564856356|FG001|Overall Study|Withdrawal by Subject|0|||
156481764|NCT03541369|564856357|FG002|Overall Study|Withdrawal by Subject|0|||
156481765|NCT03541369|564856358|FG003|Overall Study|Withdrawal by Subject|0|||
156481766|NCT03541369|564856359|FG004|Overall Study|Withdrawal by Subject|0|||
156481767|NCT03541369|564856360|FG005|Overall Study|Withdrawal by Subject|0|||
156481768|NCT03541369|564856361|FG006|Overall Study|Withdrawal by Subject|1|||
156481769|NCT03541369|564856362|FG007|Overall Study|Withdrawal by Subject|0|||
156481770|NCT03541369|564856363|FG008|Overall Study|Withdrawal by Subject|0|||
156481771|NCT03541369|564856364|FG009|Overall Study|Withdrawal by Subject|0|||
156481772|NCT03541369|564856365|FG010|Overall Study|Withdrawal by Subject|0|||
156481773|NCT03541369|564856366|FG011|Overall Study|Withdrawal by Subject|1|||
156481774|NCT03541369|564856367|FG012|Overall Study|Withdrawal by Subject|0|||
156481775|NCT03541369|564856368|FG013|Overall Study|Withdrawal by Subject|0|||
156481776|NCT03541369|564856369|FG014|Overall Study|Withdrawal by Subject|3|||
156481777|NCT03541369|564856370|FG015|Overall Study|Withdrawal by Subject|0|||
156481778|NCT03541369|564856371|FG016|Overall Study|Withdrawal by Subject|4|||
156481779|NCT03541369|564856372|FG017|Overall Study|Withdrawal by Subject|2|||
156481780|NCT03541369|564856355|FG000|Overall Study|Lost to Follow-up|0|||
156481781|NCT03541369|564856356|FG001|Overall Study|Lost to Follow-up|0|||
156481782|NCT03541369|564856357|FG002|Overall Study|Lost to Follow-up|0|||
156481783|NCT03541369|564856358|FG003|Overall Study|Lost to Follow-up|0|||
156481784|NCT03541369|564856359|FG004|Overall Study|Lost to Follow-up|1|||
156481785|NCT03541369|564856360|FG005|Overall Study|Lost to Follow-up|0|||
156481786|NCT03541369|564856361|FG006|Overall Study|Lost to Follow-up|0|||
156481787|NCT03541369|564856362|FG007|Overall Study|Lost to Follow-up|0|||
156481788|NCT03541369|564856363|FG008|Overall Study|Lost to Follow-up|1|||
156481789|NCT03541369|564856364|FG009|Overall Study|Lost to Follow-up|0|||
156481790|NCT03541369|564856365|FG010|Overall Study|Lost to Follow-up|0|||
156481791|NCT03541369|564856366|FG011|Overall Study|Lost to Follow-up|0|||
156481792|NCT03541369|564856367|FG012|Overall Study|Lost to Follow-up|1|||
156481793|NCT03541369|564856368|FG013|Overall Study|Lost to Follow-up|0|||
156481794|NCT03541369|564856369|FG014|Overall Study|Lost to Follow-up|0|||
156481795|NCT03541369|564856370|FG015|Overall Study|Lost to Follow-up|0|||
156481796|NCT03541369|564856371|FG016|Overall Study|Lost to Follow-up|0|||
156481797|NCT03541369|564856372|FG017|Overall Study|Lost to Follow-up|0|||
156481798|NCT00696241|564856373|FG000|Overall Study|Adverse Event|11|||
156481799|NCT00696241|564856374|FG001|Overall Study|Adverse Event|3|||
156481800|NCT00696241|564856375|FG002|Overall Study|Adverse Event|6|||
156481801|NCT00696241|564856376|FG003|Overall Study|Adverse Event|4|||
156481802|NCT00696241|564856377|FG004|Overall Study|Adverse Event|5|||
156481803|NCT00696241|564856373|FG000|Overall Study|Protocol Violation|1|||
156481804|NCT00696241|564856374|FG001|Overall Study|Protocol Violation|1|||
156481805|NCT00696241|564856375|FG002|Overall Study|Protocol Violation|2|||
156481806|NCT00696241|564856376|FG003|Overall Study|Protocol Violation|0|||
156481807|NCT00696241|564856377|FG004|Overall Study|Protocol Violation|3|||
156481808|NCT00696241|564856373|FG000|Overall Study|Lost to Follow-up|1|||
156481809|NCT00696241|564856374|FG001|Overall Study|Lost to Follow-up|4|||
156481810|NCT00696241|564856375|FG002|Overall Study|Lost to Follow-up|1|||
156481811|NCT00696241|564856376|FG003|Overall Study|Lost to Follow-up|2|||
156481812|NCT00696241|564856377|FG004|Overall Study|Lost to Follow-up|0|||
156481813|NCT00696241|564856373|FG000|Overall Study|Withdrawal by Subject|4|||
156345642|NCT02899988|564364172|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156481814|NCT00696241|564856374|FG001|Overall Study|Withdrawal by Subject|8|||
156481815|NCT00696241|564856375|FG002|Overall Study|Withdrawal by Subject|6|||
156481816|NCT00696241|564856376|FG003|Overall Study|Withdrawal by Subject|1|||
156481817|NCT00696241|564856377|FG004|Overall Study|Withdrawal by Subject|0|||
156481818|NCT00696241|564856373|FG000|Overall Study|Lack of Efficacy|1|||
156481819|NCT00696241|564856374|FG001|Overall Study|Lack of Efficacy|5|||
156481820|NCT00696241|564856375|FG002|Overall Study|Lack of Efficacy|4|||
156481821|NCT00696241|564856376|FG003|Overall Study|Lack of Efficacy|5|||
156481822|NCT00696241|564856377|FG004|Overall Study|Lack of Efficacy|3|||
156481823|NCT00696241|564856373|FG000|Overall Study|Other|6|||
156481824|NCT00696241|564856374|FG001|Overall Study|Other|1|||
156481825|NCT00696241|564856375|FG002|Overall Study|Other|5|||
156481826|NCT00696241|564856376|FG003|Overall Study|Other|2|||
156481827|NCT00696241|564856377|FG004|Overall Study|Other|1|||
156481828|NCT02513667|564856378|FG000|Overall Study|Withdrawal by Subject|0|||
156481829|NCT02513667|564856379|FG001|Overall Study|Withdrawal by Subject|1|||
156481830|NCT02291549|564856380|FG000|Overall Study|Lost to Follow-up|1|||
156481831|NCT02291549|564856381|FG001|Overall Study|Lost to Follow-up|0|||
156481832|NCT02291549|564856380|FG000|Overall Study|Withdrawal by Subject|0|||
156481833|NCT02291549|564856381|FG001|Overall Study|Withdrawal by Subject|1|||
156481834|NCT00537914|564856382|FG000|Overall Study|Death|1|||
156481835|NCT00537914|564856382|FG000|Overall Study|Adverse Event|7|||
156345643|NCT02899988|564364173|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156345644|NCT02899988|564364163|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
156345645|NCT02899988|564364164|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
156345646|NCT02899988|564364165|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
156481836|NCT00537914|564856382|FG000|Overall Study|Treatment failure|10|||
156481837|NCT00537914|564856382|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
156481838|NCT00537914|564856382|FG000|Overall Study|Lost to Follow-up|19|||
156481839|NCT00537914|564856382|FG000|Overall Study|Withdrawal of informed consent|59|||
156481840|NCT01697956|564856384|FG000|Overall Study|Protocol Violation|1|||
156481841|NCT01697956|564856385|FG001|Overall Study|Protocol Violation|1|||
156481842|NCT01115309|564856386|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
156481843|NCT01115309|564856386|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
156481844|NCT01115309|564856386|FG000|Long-term Follow-up|Lost to Follow-up|6|||
156481845|NCT00655824|564856387|FG000|Overall Study|Adverse Event|3|||
156481846|NCT00655824|564856387|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
156481847|NCT00655824|564856387|FG000|Overall Study|Protocol Violation|1|||
156481848|NCT00655824|564856387|FG000|Overall Study|Withdrawal by Subject|4|||
156481849|NCT00655824|564856387|FG000|Overall Study|Deterioration of Trial Disease|2|||
156481850|NCT00589628|564856388|FG000|Overall Study|Lost to Follow-up|0|||
156481851|NCT00589628|564856389|FG001|Overall Study|Lost to Follow-up|1|||
156481852|NCT02189759|564856397|FG000|Overall Study|Lost to Follow-up|0|||
156481853|NCT02189759|564856398|FG001|Overall Study|Lost to Follow-up|0|||
156481854|NCT02189759|564856399|FG002|Overall Study|Lost to Follow-up|2|||
156481855|NCT02189759|564856400|FG003|Overall Study|Lost to Follow-up|5|||
156481856|NCT02470806|564856401|FG000|Overall Study|Lost to Follow-up|1|||
156481857|NCT02470806|564856402|FG001|Overall Study|Lost to Follow-up|1|||
156345647|NCT02899988|564364166|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
156481858|NCT02470806|564856401|FG000|Overall Study|Adverse Event|5|||
156481859|NCT02470806|564856402|FG001|Overall Study|Adverse Event|2|||
156481860|NCT02470806|564856401|FG000|Overall Study|Protocol Violation|4|||
156481861|NCT02470806|564856402|FG001|Overall Study|Protocol Violation|11|||
156481862|NCT02470806|564856401|FG000|Overall Study|Physician Decision|0|||
156481863|NCT02470806|564856402|FG001|Overall Study|Physician Decision|3|||
156481864|NCT02470806|564856401|FG000|Overall Study|Withdrawal by Subject|3|||
156481865|NCT02470806|564856402|FG001|Overall Study|Withdrawal by Subject|10|||
156481866|NCT02470806|564856401|FG000|Overall Study|Lack of Efficacy|5|||
156481867|NCT02470806|564856402|FG001|Overall Study|Lack of Efficacy|15|||
156481868|NCT03032198|564856403|FG000|Overall Study|Screen Fail|1|||
156481869|NCT01147471|564856404|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
156481870|NCT01147471|564856405|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
156481871|NCT01147471|564856404|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
156481872|NCT01147471|564856405|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
156481873|NCT01147471|564856404|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
156481874|NCT01147471|564856405|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
156481875|NCT01147471|564856404|FG000|3 Month Follow Up|Lost to Follow-up|1|||
156481876|NCT01147471|564856405|FG001|3 Month Follow Up|Lost to Follow-up|1|||
156481877|NCT01147471|564856404|FG000|3 Month Follow Up|Physician Decision|0|||
156481878|NCT01147471|564856405|FG001|3 Month Follow Up|Physician Decision|1|||
156481879|NCT01147471|564856404|FG000|6 Month Follow Up|Lost to Follow-up|4|||
156481880|NCT01147471|564856405|FG001|6 Month Follow Up|Lost to Follow-up|2|||
156481881|NCT00866619|564856406|FG000|Overall Study|Adverse Event|112|||
156481882|NCT00866619|564856407|FG001|Overall Study|Adverse Event|106|||
156481883|NCT00866619|564856408|FG002|Overall Study|Adverse Event|47|||
156481884|NCT00866619|564856409|FG003|Overall Study|Adverse Event|44|||
156481885|NCT00866619|564856406|FG000|Overall Study|Protocol Violation|2|||
156481886|NCT00866619|564856407|FG001|Overall Study|Protocol Violation|39|||
156481887|NCT00866619|564856408|FG002|Overall Study|Protocol Violation|2|||
156481888|NCT00866619|564856409|FG003|Overall Study|Protocol Violation|17|||
156481889|NCT00866619|564856406|FG000|Overall Study|Withdrawal by Subject|587|||
156481890|NCT00866619|564856407|FG001|Overall Study|Withdrawal by Subject|295|||
156481891|NCT00866619|564856408|FG002|Overall Study|Withdrawal by Subject|272|||
156481892|NCT00866619|564856409|FG003|Overall Study|Withdrawal by Subject|144|||
156481893|NCT00866619|564856406|FG000|Overall Study|Lost to Follow-up|1145|||
156481894|NCT00866619|564856407|FG001|Overall Study|Lost to Follow-up|830|||
156481895|NCT00866619|564856408|FG002|Overall Study|Lost to Follow-up|568|||
156481896|NCT00866619|564856409|FG003|Overall Study|Lost to Follow-up|425|||
156481897|NCT02892019|564856412|FG000|Overall Study|randomized but not treated|0|||
156481898|NCT02892019|564856413|FG001|Overall Study|randomized but not treated|1|||
156481899|NCT02892019|564856412|FG000|Overall Study|Withdrawal by Subject|0|||
156481900|NCT02892019|564856413|FG001|Overall Study|Withdrawal by Subject|1|||
156481901|NCT02892019|564856412|FG000|Overall Study|Adverse Event|1|||
156481902|NCT02892019|564856413|FG001|Overall Study|Adverse Event|1|||
156481903|NCT01020487|564857891|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
156481904|NCT01020487|564857892|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
156481905|NCT01020487|564857893|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
156481906|NCT01020487|564857891|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
156481907|NCT01020487|564857892|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
156481908|NCT01020487|564857893|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
156481909|NCT01020487|564857891|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
156481910|NCT01020487|564857892|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
156481911|NCT01020487|564857893|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
156481912|NCT01020487|564857891|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
156481913|NCT01020487|564857892|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
156481914|NCT01020487|564857893|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
156481915|NCT01020487|564857891|FG000|Part 2 Open-label Period|Adverse Event|0|||
156481916|NCT01020487|564857892|FG001|Part 2 Open-label Period|Adverse Event|4|||
156481917|NCT01020487|564857893|FG002|Part 2 Open-label Period|Adverse Event|1|||
156481918|NCT00228813|564857894|FG000|Overall Study|Death|4|||
156481919|NCT01279447|564857900|FG000|Overall Study|Lost to Follow-up|3|||
156481920|NCT01279447|564857901|FG001|Overall Study|Lost to Follow-up|1|||
156481921|NCT01074229|564857907|FG000|Overall Study|Lost to Follow-up|1|||
156481922|NCT01074229|564857908|FG001|Overall Study|Lost to Follow-up|0|||
156481923|NCT01074229|564857909|FG002|Overall Study|Lost to Follow-up|0|||
156481924|NCT01074229|564857907|FG000|Overall Study|Change to open surgical procedure|1|||
156481925|NCT01074229|564857908|FG001|Overall Study|Change to open surgical procedure|3|||
156481926|NCT01074229|564857909|FG002|Overall Study|Change to open surgical procedure|4|||
156481927|NCT02163499|564857910|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
156481928|NCT02163499|564857910|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
156481929|NCT02163499|564857910|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
156481930|NCT02163499|564857910|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
156481931|NCT02163499|564857910|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
156481932|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
156481933|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
156481934|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
156481935|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
156481936|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
156481937|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
156481938|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
156481939|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
156481940|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
156481941|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Death|8|||
156481942|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
156481943|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
156481944|NCT02163499|564857910|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
156481945|NCT01922102|564857912|FG000|Overall Study|Withdrawal by Subject|7|||
156481946|NCT01922102|564857913|FG001|Overall Study|Withdrawal by Subject|3|||
156481947|NCT01922102|564857914|FG002|Overall Study|Withdrawal by Subject|7|||
156481948|NCT01922102|564857912|FG000|Overall Study|Physician Decision|0|||
156481949|NCT01922102|564857913|FG001|Overall Study|Physician Decision|2|||
156345648|NCT02899988|564364167|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
156345649|NCT02899988|564364168|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
156345650|NCT02899988|564364169|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
156345651|NCT02899988|564364170|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
156345652|NCT02899988|564364171|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
156345653|NCT02899988|564364172|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
156345654|NCT02899988|564364173|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
156345655|NCT02899988|564364163|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
156345656|NCT02899988|564364164|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
156345657|NCT02899988|564364165|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
156345658|NCT02899988|564364166|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
156345659|NCT02899988|564364167|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
156345660|NCT02899988|564364168|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
156345661|NCT02899988|564364169|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
156345662|NCT02899988|564364170|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
156345663|NCT02899988|564364171|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
156345664|NCT02899988|564364172|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
156345665|NCT02899988|564364173|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
156345666|NCT02899988|564364163|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
156345667|NCT02899988|564364164|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
156345668|NCT02899988|564364165|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
156345669|NCT02899988|564364166|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
156345670|NCT02899988|564364167|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
156345671|NCT02899988|564364168|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
156345672|NCT02899988|564364169|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
156345673|NCT02899988|564364170|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
156345674|NCT02899988|564364171|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
156345675|NCT02899988|564364172|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
156345676|NCT02899988|564364173|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
156345677|NCT02899988|564364163|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345678|NCT02899988|564364164|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345679|NCT02899988|564364165|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345680|NCT02899988|564364166|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345681|NCT02899988|564364167|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345682|NCT02899988|564364168|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
156345683|NCT02899988|564364169|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345684|NCT02899988|564364170|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
156345685|NCT02899988|564364171|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345686|NCT02899988|564364172|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345687|NCT02899988|564364173|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156345688|NCT02899988|564364163|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156345689|NCT02899988|564364164|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156345690|NCT02899988|564364165|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156345691|NCT02899988|564364166|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156345692|NCT02899988|564364167|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
156345693|NCT02899988|564364168|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156345694|NCT02899988|564364169|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
156345695|NCT02899988|564364170|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
156345696|NCT02899988|564364171|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
156345697|NCT02899988|564364172|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156345698|NCT02899988|564364173|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
156345699|NCT04202965|564364178|FG000|Overall Study|Adverse Event|3|||
156345700|NCT04202965|564364178|FG000|Overall Study|Did not meet inclusion criteria|1|||
156345701|NCT00299975|564364179|FG000|Overall Study|Adverse Event|1|||
156345702|NCT00299975|564364180|FG001|Overall Study|Adverse Event|0|||
156345703|NCT00299975|564364181|FG002|Overall Study|Adverse Event|2|||
156345704|NCT00299975|564364179|FG000|Overall Study|Pregnancy|0|||
156345705|NCT00299975|564364180|FG001|Overall Study|Pregnancy|0|||
156345706|NCT00299975|564364181|FG002|Overall Study|Pregnancy|1|||
156345707|NCT00299975|564364179|FG000|Overall Study|Lack of Efficacy|1|||
156345708|NCT00299975|564364180|FG001|Overall Study|Lack of Efficacy|0|||
156345709|NCT00299975|564364181|FG002|Overall Study|Lack of Efficacy|1|||
156345710|NCT00299975|564364179|FG000|Overall Study|Lost to Follow-up|1|||
156345711|NCT00299975|564364180|FG001|Overall Study|Lost to Follow-up|0|||
156345712|NCT00299975|564364181|FG002|Overall Study|Lost to Follow-up|0|||
156345713|NCT00299975|564364179|FG000|Overall Study|Withdrawal by Subject|0|||
156345714|NCT00299975|564364180|FG001|Overall Study|Withdrawal by Subject|1|||
156345715|NCT00299975|564364181|FG002|Overall Study|Withdrawal by Subject|3|||
156345716|NCT00299975|564364179|FG000|Overall Study|Physician Decision|0|||
156345717|NCT00299975|564364180|FG001|Overall Study|Physician Decision|0|||
156345718|NCT00299975|564364181|FG002|Overall Study|Physician Decision|1|||
156345719|NCT02651922|564364183|FG000|Overall Study|due to exclusion criteria|2|||
156345720|NCT01053221|564364184|FG000|Overall Study|The study was closed prematurely|5|||
156345721|NCT01053221|564364185|FG001|Overall Study|The study was closed prematurely|9|||
156345722|NCT03018704|564364186|FG000|Overall Study|Lost to Follow-up|1|||
156345723|NCT03018704|564364187|FG001|Overall Study|Lost to Follow-up|1|||
156345724|NCT04448171|564364188|FG000|Overall Study|Procedure Cancelled|1|||
156345725|NCT04448171|564364189|FG001|Overall Study|Procedure Cancelled|0|||
156345726|NCT04448171|564364188|FG000|Overall Study|Protocol Violation|1|||
156345727|NCT04448171|564364189|FG001|Overall Study|Protocol Violation|0|||
156345728|NCT02088047|564364190|FG000|Overall Study|Withdrawal by Subject|1|||
156345729|NCT02088047|564364191|FG001|Overall Study|Withdrawal by Subject|0|||
156345730|NCT01025752|564364196|FG000|Overall Study|Lost to Follow-up|7|||
156345731|NCT01025752|564364197|FG001|Overall Study|Lost to Follow-up|10|||
156345732|NCT01025752|564364196|FG000|Overall Study|Physician Decision|1|||
156345733|NCT01025752|564364197|FG001|Overall Study|Physician Decision|3|||
156345734|NCT00211809|564364198|FG000|Overall Study|Lack of Efficacy|1|||
156481950|NCT01922102|564857914|FG002|Overall Study|Physician Decision|1|||
156481951|NCT01922102|564857912|FG000|Overall Study|Adverse Event|1|||
156481952|NCT01922102|564857913|FG001|Overall Study|Adverse Event|2|||
156481953|NCT01922102|564857914|FG002|Overall Study|Adverse Event|0|||
156481954|NCT01922102|564857912|FG000|Overall Study|Lost to Follow-up|1|||
156481955|NCT01922102|564857913|FG001|Overall Study|Lost to Follow-up|0|||
156481956|NCT01922102|564857914|FG002|Overall Study|Lost to Follow-up|0|||
156481957|NCT01922102|564857912|FG000|Overall Study|Administrative problems|0|||
156481958|NCT01922102|564857913|FG001|Overall Study|Administrative problems|2|||
156481959|NCT01922102|564857914|FG002|Overall Study|Administrative problems|0|||
156481960|NCT05361304|564857917|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
156481961|NCT05361304|564857918|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
156481962|NCT05361304|564857917|FG000|Overall Study|COVID-19 Related|1|||
156481963|NCT05361304|564857918|FG001|Overall Study|COVID-19 Related|2|||
156481964|NCT05361304|564857917|FG000|Overall Study|Withdrawal by Subject|1|||
156481965|NCT05361304|564857918|FG001|Overall Study|Withdrawal by Subject|0|||
156345735|NCT00211809|564364198|FG000|Overall Study|Lost to Follow-up|2|||
156345736|NCT00211809|564364198|FG000|Overall Study|Pregnancy|1|||
156345737|NCT00211809|564364198|FG000|Overall Study|side effects|2|||
156345738|NCT00023764|564364199|FG000|Overall Study|Other|1|||
156345739|NCT00023764|564364199|FG000|Overall Study|Adverse Event|4|||
156345740|NCT00023764|564364199|FG000|Overall Study|Withdrawal by Subject|1|||
156345741|NCT00023764|564364199|FG000|Overall Study|Progression of disease|6|||
156345742|NCT00023764|564364199|FG000|Overall Study|patient received other treatment|1|||
156345743|NCT00023764|564364199|FG000|Overall Study|delay in obtaining staging images|1|||
156345744|NCT01537393|564364200|FG000|Overall Study|Exclude prior to study|32|||
156345745|NCT01537393|564364201|FG001|Overall Study|Exclude prior to study|44|||
156345746|NCT01537393|564364200|FG000|Overall Study|Death|20|||
156345747|NCT01537393|564364201|FG001|Overall Study|Death|32|||
156345748|NCT01537393|564364200|FG000|Overall Study|Withdrawal by Subject|18|||
156345749|NCT01537393|564364201|FG001|Overall Study|Withdrawal by Subject|17|||
156345750|NCT01537393|564364200|FG000|Overall Study|Lost to Follow-up|53|||
156345751|NCT01537393|564364201|FG001|Overall Study|Lost to Follow-up|48|||
156345752|NCT01537393|564364200|FG000|Overall Study|Failure - Regrafted|28|||
156345753|NCT01537393|564364201|FG001|Overall Study|Failure - Regrafted|43|||
156345754|NCT01537393|564364200|FG000|Overall Study|Failure - Not regrafted|2|||
156345755|NCT01537393|564364201|FG001|Overall Study|Failure - Not regrafted|6|||
156345756|NCT01537393|564364200|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
156345757|NCT01537393|564364201|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
156345758|NCT01697566|564364205|FG000|Overall Study|Withdrawal by Subject|0|||
156345759|NCT01697566|564364206|FG001|Overall Study|Withdrawal by Subject|0|||
156345760|NCT01697566|564364207|FG002|Overall Study|Withdrawal by Subject|1|||
156345761|NCT01697566|564364208|FG003|Overall Study|Withdrawal by Subject|1|||
156345762|NCT01697566|564364205|FG000|Overall Study|Final biopsy not obtained|0|||
156345763|NCT01697566|564364206|FG001|Overall Study|Final biopsy not obtained|0|||
156345764|NCT01697566|564364207|FG002|Overall Study|Final biopsy not obtained|1|||
156345765|NCT01697566|564364208|FG003|Overall Study|Final biopsy not obtained|0|||
156345766|NCT00459953|564364210|FG000|Overall Study|not analyzed-household member in study|1|||
156345767|NCT00459953|564364211|FG001|Overall Study|not analyzed-household member in study|1|||
156345768|NCT01447433|564364212|FG000|Overall Study|Lost to Follow-up|0|||
156345769|NCT01447433|564364213|FG001|Overall Study|Lost to Follow-up|2|||
156345770|NCT01447433|564364212|FG000|Overall Study|Withdrawal by Subject|3|||
156345771|NCT01447433|564364213|FG001|Overall Study|Withdrawal by Subject|3|||
156345772|NCT01447433|564364212|FG000|Overall Study|Protocol Violation|1|||
156345773|NCT01447433|564364213|FG001|Overall Study|Protocol Violation|1|||
156345774|NCT00036270|564364214|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
156345775|NCT00036270|564364215|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
156345776|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
156345777|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
156345778|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
156345779|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
156345780|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
156345781|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
156345782|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Other|277|||
156345783|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Other|288|||
156345784|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
156345785|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
156345786|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
156345787|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
156345788|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
156345789|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
156345790|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
156345791|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
156345792|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
156345793|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
156345794|NCT00036270|564364214|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
156345795|NCT00036270|564364215|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
156345796|NCT01578187|564364216|FG000|Usability Phase|Withdrawal by Subject|1|||
156345797|NCT00496470|564364217|FG000|Overall Study|Adverse Event|8|||
156345798|NCT00496470|564364218|FG001|Overall Study|Adverse Event|10|||
156481966|NCT03320941|564857919|FG000|Overall Study|subject/guardian decision|0|||
156481967|NCT03320941|564857920|FG001|Overall Study|subject/guardian decision|0|||
156481968|NCT03320941|564857921|FG002|Overall Study|subject/guardian decision|0|||
156481969|NCT03320941|564857922|FG003|Overall Study|subject/guardian decision|1|||
156481970|NCT03320941|564857923|FG004|Overall Study|subject/guardian decision|0|||
156481971|NCT00447499|564857924|FG000|Overall Study|Adverse Event|1|||
156481972|NCT00447499|564857924|FG000|Overall Study|Patient Decision|4|||
156481973|NCT00447499|564857924|FG000|Overall Study|Sponsor Decision|1|||
156345799|NCT00496470|564364217|FG000|Overall Study|Withdrawal by Subject|5|||
156345800|NCT00496470|564364218|FG001|Overall Study|Withdrawal by Subject|12|||
156345801|NCT00496470|564364217|FG000|Overall Study|Incorrectly enrolled|13|||
156345802|NCT00496470|564364218|FG001|Overall Study|Incorrectly enrolled|5|||
156345803|NCT00496470|564364217|FG000|Overall Study|Other reason|0|||
156481974|NCT00447499|564857924|FG000|Overall Study|Physician Decision|1|||
156481975|NCT03360071|564857927|FG000|Overall Study|Lost to Follow-up|1|||
156481976|NCT03360071|564857928|FG001|Overall Study|Lost to Follow-up|0|||
156481977|NCT02823574|564857934|FG000|Randomization|Disease Progression|0|||
156481978|NCT02823574|564857935|FG001|Randomization|Disease Progression|0|||
156345804|NCT00496470|564364218|FG001|Overall Study|Other reason|2|||
156345805|NCT01217814|564364219|FG000|Overall Study|Adverse Event|1|||
156345806|NCT01217814|564364220|FG001|Overall Study|Adverse Event|1|||
156345807|NCT01217814|564364221|FG002|Overall Study|Adverse Event|0|||
156345808|NCT01217814|564364219|FG000|Overall Study|Lack of Efficacy|0|||
156345809|NCT01217814|564364220|FG001|Overall Study|Lack of Efficacy|0|||
156345810|NCT01217814|564364221|FG002|Overall Study|Lack of Efficacy|1|||
156345811|NCT01370356|564364222|FG000|Overall Study|Death|1|||
156345812|NCT01370356|564364223|FG001|Overall Study|Death|0|||
156345813|NCT01370356|564364222|FG000|Overall Study|Lack of Efficacy|6|||
156345814|NCT01370356|564364223|FG001|Overall Study|Lack of Efficacy|28|||
156345815|NCT01370356|564364222|FG000|Overall Study|Lost to Follow-up|76|||
156345816|NCT01370356|564364223|FG001|Overall Study|Lost to Follow-up|81|||
156345817|NCT01370356|564364222|FG000|Overall Study|Withdrawal by Subject|54|||
156345818|NCT01370356|564364223|FG001|Overall Study|Withdrawal by Subject|59|||
156345819|NCT01370356|564364222|FG000|Overall Study|Reason not specified|39|||
156345820|NCT01370356|564364223|FG001|Overall Study|Reason not specified|43|||
156345821|NCT01370356|564364222|FG000|Overall Study|Protocol Violation|3|||
156345822|NCT01370356|564364223|FG001|Overall Study|Protocol Violation|3|||
156481979|NCT02823574|564857936|FG002|Randomization|Disease Progression|1|||
156481980|NCT02823574|564857937|FG003|Randomization|Disease Progression|0|||
156345823|NCT01370356|564364222|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
156345824|NCT01370356|564364223|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
156345825|NCT01370356|564364222|FG000|Overall Study|AE Not Related to Study Drug|1|||
156345826|NCT01370356|564364223|FG001|Overall Study|AE Not Related to Study Drug|4|||
156345827|NCT01218243|564364224|FG000|Overall Study|Lack of Efficacy|1|||
156345828|NCT01218243|564364225|FG001|Overall Study|Lack of Efficacy|1|||
156345829|NCT01218243|564364224|FG000|Overall Study|Lost to Follow-up|3|||
156345830|NCT01218243|564364225|FG001|Overall Study|Lost to Follow-up|3|||
156345831|NCT01218243|564364224|FG000|Overall Study|Protocol Violation|5|||
156345832|NCT01218243|564364225|FG001|Overall Study|Protocol Violation|10|||
156345833|NCT02756013|564364226|FG000|Overall Study|Adverse Event|1|||
156345834|NCT02756013|564364226|FG000|Overall Study|Hypersensitivity|1|||
156345835|NCT00571948|564364227|FG000|Overall Study|Lost to Follow-up|2|||
156345836|NCT00571948|564364228|FG001|Overall Study|Lost to Follow-up|0|||
156345837|NCT00571948|564364227|FG000|Overall Study|Withdrawal by Subject|1|||
156481981|NCT02823574|564857934|FG000|Randomization|AE unrelated to Study Drug|1|||
156481982|NCT02823574|564857935|FG001|Randomization|AE unrelated to Study Drug|0|||
156481983|NCT02823574|564857936|FG002|Randomization|AE unrelated to Study Drug|0|||
156481984|NCT02823574|564857937|FG003|Randomization|AE unrelated to Study Drug|0|||
156345838|NCT00571948|564364228|FG001|Overall Study|Withdrawal by Subject|2|||
156481985|NCT02823574|564857934|FG000|Treatment Period|Poor/Non Compliance|1|||
156481986|NCT02823574|564857935|FG001|Treatment Period|Poor/Non Compliance|0|||
156543852|NCT02819635|565086191|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156481987|NCT02823574|564857936|FG002|Treatment Period|Poor/Non Compliance|0|||
156481988|NCT02823574|564857937|FG003|Treatment Period|Poor/Non Compliance|1|||
156481989|NCT02823574|564857934|FG000|Treatment Period|Maximum Clinical Benefit|8|||
156481990|NCT02823574|564857935|FG001|Treatment Period|Maximum Clinical Benefit|4|||
156481991|NCT02823574|564857936|FG002|Treatment Period|Maximum Clinical Benefit|7|||
156481992|NCT02823574|564857937|FG003|Treatment Period|Maximum Clinical Benefit|1|||
156481993|NCT02823574|564857934|FG000|Treatment Period|Lost to Follow-up|1|||
156481994|NCT02823574|564857935|FG001|Treatment Period|Lost to Follow-up|1|||
156481995|NCT02823574|564857936|FG002|Treatment Period|Lost to Follow-up|0|||
156481996|NCT02823574|564857937|FG003|Treatment Period|Lost to Follow-up|0|||
156481997|NCT02823574|564857934|FG000|Treatment Period|Participant withdrew consent|4|||
156481998|NCT02823574|564857935|FG001|Treatment Period|Participant withdrew consent|0|||
156481999|NCT02823574|564857936|FG002|Treatment Period|Participant withdrew consent|0|||
156482000|NCT02823574|564857937|FG003|Treatment Period|Participant withdrew consent|1|||
156482001|NCT02823574|564857934|FG000|Treatment Period|Participant request to discontinue|5|||
156482002|NCT02823574|564857935|FG001|Treatment Period|Participant request to discontinue|0|||
156482003|NCT02823574|564857936|FG002|Treatment Period|Participant request to discontinue|3|||
156482004|NCT02823574|564857937|FG003|Treatment Period|Participant request to discontinue|2|||
156482005|NCT02823574|564857934|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
156482006|NCT02823574|564857935|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
156482007|NCT02823574|564857936|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
156482008|NCT02823574|564857937|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
156482009|NCT02823574|564857934|FG000|Treatment Period|Study Drug Toxicity|11|||
156482010|NCT02823574|564857935|FG001|Treatment Period|Study Drug Toxicity|2|||
156482011|NCT02823574|564857936|FG002|Treatment Period|Study Drug Toxicity|14|||
156482012|NCT02823574|564857937|FG003|Treatment Period|Study Drug Toxicity|4|||
156482013|NCT02823574|564857934|FG000|Treatment Period|Disease Progression|113|||
156482014|NCT02823574|564857935|FG001|Treatment Period|Disease Progression|64|||
156482015|NCT02823574|564857936|FG002|Treatment Period|Disease Progression|82|||
156345839|NCT00571948|564364227|FG000|Overall Study|Protocol Violation|3|||
156345840|NCT00571948|564364228|FG001|Overall Study|Protocol Violation|3|||
156345841|NCT00571948|564364227|FG000|Overall Study|infant refused study meal|3|||
156345842|NCT00571948|564364228|FG001|Overall Study|infant refused study meal|4|||
156345843|NCT00571948|564364227|FG000|Overall Study|Parent were afraid of blood colection|2|||
156345844|NCT00571948|564364228|FG001|Overall Study|Parent were afraid of blood colection|5|||
156345845|NCT00843024|564364229|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
156345846|NCT00843024|564364230|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
156345847|NCT00843024|564364231|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
156345848|NCT00843024|564364232|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
156345849|NCT00843024|564364233|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
156345850|NCT00843024|564364234|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
156345851|NCT00843024|564364229|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
156345852|NCT00843024|564364230|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
156345853|NCT00843024|564364231|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
156345854|NCT00843024|564364232|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
156345855|NCT00843024|564364233|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
156345856|NCT00843024|564364234|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
156345857|NCT00843024|564364229|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
156345858|NCT00843024|564364230|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
156345859|NCT00843024|564364231|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
156345860|NCT00843024|564364232|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
156345861|NCT00843024|564364233|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
156345862|NCT00843024|564364234|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
156345863|NCT00843024|564364229|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
156345864|NCT00843024|564364230|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
156345865|NCT00843024|564364231|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
156345866|NCT00843024|564364232|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
156345867|NCT00843024|564364233|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
156345868|NCT00843024|564364234|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
156345869|NCT00843024|564364229|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
156345870|NCT00843024|564364230|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
156345871|NCT00843024|564364231|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
156345872|NCT00843024|564364232|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
156345873|NCT00843024|564364233|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
156345874|NCT00843024|564364234|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
156345875|NCT00843024|564364229|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156345876|NCT00843024|564364230|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
156345877|NCT00843024|564364231|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156345878|NCT00843024|564364232|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156345879|NCT00843024|564364233|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156345880|NCT00843024|564364234|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156345881|NCT00843024|564364229|FG000|Single-blind Placebo Run-In Phase|Other|0|||
156345882|NCT00843024|564364230|FG001|Single-blind Placebo Run-In Phase|Other|1|||
156345883|NCT00843024|564364231|FG002|Single-blind Placebo Run-In Phase|Other|0|||
156345884|NCT00843024|564364232|FG003|Single-blind Placebo Run-In Phase|Other|0|||
156345885|NCT00843024|564364233|FG004|Single-blind Placebo Run-In Phase|Other|0|||
156345886|NCT00843024|564364234|FG005|Single-blind Placebo Run-In Phase|Other|0|||
156345887|NCT00843024|564364229|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
156345888|NCT00843024|564364230|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
156345889|NCT00843024|564364231|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
156345890|NCT00843024|564364232|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
156345891|NCT00843024|564364233|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
156345892|NCT00843024|564364234|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
156345893|NCT00843024|564364229|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156345894|NCT00843024|564364230|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
156345895|NCT00843024|564364231|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
156345896|NCT00843024|564364232|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
156345897|NCT00843024|564364233|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
156345898|NCT00843024|564364234|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
156345899|NCT00843024|564364229|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156345900|NCT00843024|564364230|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156345901|NCT00843024|564364231|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156345902|NCT00843024|564364232|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
156345903|NCT00843024|564364233|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156345904|NCT00843024|564364234|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
156345905|NCT00843024|564364229|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
156345906|NCT00843024|564364230|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
156345907|NCT00843024|564364231|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
156482016|NCT02823574|564857937|FG003|Treatment Period|Disease Progression|43|||
156345908|NCT00843024|564364232|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
156345909|NCT00843024|564364233|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
156345910|NCT00843024|564364234|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
156345911|NCT00843024|564364229|FG000|Double-blind Treatment Phase|Physician Decision|0|||
156345912|NCT00843024|564364230|FG001|Double-blind Treatment Phase|Physician Decision|0|||
156345913|NCT00843024|564364231|FG002|Double-blind Treatment Phase|Physician Decision|0|||
156345914|NCT00843024|564364232|FG003|Double-blind Treatment Phase|Physician Decision|3|||
156345915|NCT00843024|564364233|FG004|Double-blind Treatment Phase|Physician Decision|1|||
156345916|NCT00843024|564364234|FG005|Double-blind Treatment Phase|Physician Decision|1|||
156345917|NCT00843024|564364229|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156345918|NCT00843024|564364230|FG001|Double-blind Treatment Phase|Adverse Event|0|||
156345919|NCT00843024|564364231|FG002|Double-blind Treatment Phase|Adverse Event|0|||
156345920|NCT00843024|564364232|FG003|Double-blind Treatment Phase|Adverse Event|0|||
156345921|NCT00843024|564364233|FG004|Double-blind Treatment Phase|Adverse Event|1|||
156345922|NCT00843024|564364234|FG005|Double-blind Treatment Phase|Adverse Event|1|||
156345923|NCT00843024|564364229|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
156345924|NCT00843024|564364230|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
156345925|NCT00843024|564364231|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
156345926|NCT00843024|564364232|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
156345927|NCT00843024|564364233|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
156345928|NCT00843024|564364234|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
156345929|NCT05201703|564364235|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
156345930|NCT05201703|564364236|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
156345931|NCT05201703|564364235|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
156345932|NCT05201703|564364236|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
156345933|NCT00211510|564364237|FG000|Overall Study|Physician Decision|3|||
156345934|NCT00211510|564364238|FG001|Overall Study|Physician Decision|1|||
156345935|NCT00211510|564364237|FG000|Overall Study|Withdrawal by Subject|3|||
156345936|NCT00211510|564364238|FG001|Overall Study|Withdrawal by Subject|1|||
156345937|NCT01487200|564364239|FG000|Overall Study|Withdrawal by Subject|0|||
156345938|NCT01487200|564364240|FG001|Overall Study|Withdrawal by Subject|1|||
156345939|NCT01487200|564364241|FG002|Overall Study|Withdrawal by Subject|0|||
156345940|NCT01487200|564364242|FG003|Overall Study|Withdrawal by Subject|0|||
156345941|NCT00496054|564364247|FG000|Overall Study|Adverse Event|1|||
156345942|NCT00496054|564364247|FG000|Overall Study|Lost to Follow-up|7|||
156345943|NCT01737697|564364248|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345944|NCT01737697|564364249|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
156345945|NCT01737697|564364250|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345946|NCT01737697|564364251|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
156345947|NCT01737697|564364252|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
156345948|NCT01737697|564364253|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345949|NCT01737697|564364254|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345950|NCT01737697|564364255|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345951|NCT01737697|564364256|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345952|NCT01737697|564364257|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345953|NCT01737697|564364258|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345954|NCT01737697|564364259|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345955|NCT01737697|564364260|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345956|NCT01737697|564364261|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345957|NCT01737697|564364262|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156345958|NCT01737697|564364248|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
156345959|NCT01737697|564364249|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
156345960|NCT01737697|564364250|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
156345961|NCT01737697|564364251|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345962|NCT01737697|564364252|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345963|NCT01737697|564364253|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345964|NCT01737697|564364254|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345965|NCT01737697|564364255|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345966|NCT01737697|564364256|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345967|NCT01737697|564364257|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345968|NCT01737697|564364258|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345969|NCT01737697|564364259|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345970|NCT01737697|564364260|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345971|NCT01737697|564364261|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345972|NCT01737697|564364262|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156345973|NCT01737697|564364248|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
156482017|NCT02823574|564857934|FG000|Treatment Period|Other reasons|5|||
156345974|NCT01737697|564364249|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345975|NCT01737697|564364250|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
156482018|NCT02823574|564857935|FG001|Treatment Period|Other reasons|9|||
156482019|NCT02823574|564857936|FG002|Treatment Period|Other reasons|3|||
156482020|NCT02823574|564857937|FG003|Treatment Period|Other reasons|6|||
156482021|NCT02823574|564857934|FG000|Treatment Period|Participant no longer meets study criteria|0|||
156345976|NCT01737697|564364251|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
156345977|NCT01737697|564364252|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345978|NCT01737697|564364253|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345979|NCT01737697|564364254|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345980|NCT01737697|564364255|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345981|NCT01737697|564364256|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345982|NCT01737697|564364257|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345983|NCT01737697|564364258|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345984|NCT01737697|564364259|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345985|NCT01737697|564364260|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345986|NCT01737697|564364261|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345987|NCT01737697|564364262|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
156345988|NCT01737697|564364248|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345989|NCT01737697|564364249|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
156345990|NCT01737697|564364250|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345991|NCT01737697|564364251|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345992|NCT01737697|564364252|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345993|NCT01737697|564364253|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345994|NCT01737697|564364254|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345995|NCT01737697|564364255|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345996|NCT01737697|564364256|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345997|NCT01737697|564364257|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345998|NCT01737697|564364258|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156345999|NCT01737697|564364259|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156346000|NCT01737697|564364260|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156346001|NCT01737697|564364261|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156346002|NCT01737697|564364262|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156346003|NCT01737697|564364248|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346004|NCT01737697|564364249|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346005|NCT01737697|564364250|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346006|NCT01737697|564364251|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346007|NCT01737697|564364252|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
156482022|NCT02823574|564857935|FG001|Treatment Period|Participant no longer meets study criteria|0|||
156482023|NCT02823574|564857936|FG002|Treatment Period|Participant no longer meets study criteria|1|||
156346008|NCT01737697|564364253|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346009|NCT01737697|564364254|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346010|NCT01737697|564364255|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346011|NCT01737697|564364256|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346012|NCT01737697|564364257|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346013|NCT01737697|564364258|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346014|NCT01737697|564364259|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346015|NCT01737697|564364260|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346016|NCT01737697|564364261|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156346017|NCT01737697|564364262|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156482024|NCT02823574|564857937|FG003|Treatment Period|Participant no longer meets study criteria|0|||
156482025|NCT02823574|564857934|FG000|Treatment Period|Death|0|||
156482026|NCT02823574|564857935|FG001|Treatment Period|Death|0|||
156482027|NCT02823574|564857936|FG002|Treatment Period|Death|3|||
156482028|NCT02823574|564857937|FG003|Treatment Period|Death|1|||
156482029|NCT00590759|564857938|FG000|Overall Study|Death|52|||
156482030|NCT00590759|564857938|FG000|Overall Study|Lost to Follow-up|28|||
156482031|NCT02542696|564857944|FG000|Overall Study|Adverse Event|167|||
156482032|NCT02542696|564857944|FG000|Overall Study|Lack of Efficacy|26|||
156482033|NCT02542696|564857944|FG000|Overall Study|Lost to Follow-up|6|||
156482034|NCT02542696|564857944|FG000|Overall Study|Withdrawal by Subject|104|||
156482035|NCT02542696|564857944|FG000|Overall Study|Protocol Violation|5|||
156482036|NCT02542696|564857944|FG000|Overall Study|Death|8|||
156482037|NCT02542696|564857944|FG000|Overall Study|DECREASED OFF TIME|1|||
156482038|NCT02542696|564857944|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
156482039|NCT02542696|564857944|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
156482040|NCT02542696|564857944|FG000|Overall Study|MEDICAL HISTORY|1|||
156482041|NCT02542696|564857944|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
156482042|NCT02542696|564857944|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
156346018|NCT01737697|564364248|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156482043|NCT02542696|564857944|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
156482044|NCT02542696|564857944|FG000|Overall Study|SPONSOR DECISION|3|||
156482045|NCT02542696|564857944|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
156482046|NCT02542696|564857944|FG000|Overall Study|SUBJECT DECISION|2|||
156482047|NCT03345407|564857945|FG000|Overall Study|Withdrawal by Subject|11|||
156482048|NCT03345407|564857946|FG001|Overall Study|Withdrawal by Subject|1|||
156346019|NCT01737697|564364249|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
156346020|NCT01737697|564364250|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
156346021|NCT01737697|564364251|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
156482049|NCT03345407|564857947|FG002|Overall Study|Withdrawal by Subject|5|||
156482050|NCT03345407|564857948|FG003|Overall Study|Withdrawal by Subject|6|||
156482051|NCT03345407|564857949|FG004|Overall Study|Withdrawal by Subject|3|||
156482052|NCT03345407|564857950|FG005|Overall Study|Withdrawal by Subject|6|||
156482053|NCT03345407|564857951|FG006|Overall Study|Withdrawal by Subject|16|||
156482054|NCT03345407|564857945|FG000|Overall Study|Physician Decision|3|||
156482055|NCT03345407|564857946|FG001|Overall Study|Physician Decision|1|||
156482056|NCT03345407|564857947|FG002|Overall Study|Physician Decision|0|||
156482057|NCT03345407|564857948|FG003|Overall Study|Physician Decision|0|||
156346022|NCT01737697|564364252|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
156346023|NCT01737697|564364253|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346024|NCT01737697|564364254|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346025|NCT01737697|564364255|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346026|NCT01737697|564364256|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346027|NCT01737697|564364257|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346028|NCT01737697|564364258|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346029|NCT01737697|564364259|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346030|NCT01737697|564364260|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346031|NCT01737697|564364261|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346032|NCT01737697|564364262|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156346033|NCT01737697|564364248|FG000|Subacute Phase|Adverse Event|0|||
156346034|NCT01737697|564364249|FG001|Subacute Phase|Adverse Event|0|||
156346035|NCT01737697|564364250|FG002|Subacute Phase|Adverse Event|0|||
156346036|NCT01737697|564364251|FG003|Subacute Phase|Adverse Event|0|||
156346037|NCT01737697|564364252|FG004|Subacute Phase|Adverse Event|0|||
156346038|NCT01737697|564364253|FG005|Subacute Phase|Adverse Event|1|||
156346039|NCT01737697|564364254|FG006|Subacute Phase|Adverse Event|1|||
156346040|NCT01737697|564364255|FG007|Subacute Phase|Adverse Event|1|||
156346041|NCT01737697|564364256|FG008|Subacute Phase|Adverse Event|1|||
156346042|NCT01737697|564364257|FG009|Subacute Phase|Adverse Event|1|||
156346043|NCT01737697|564364258|FG010|Subacute Phase|Adverse Event|4|||
156346044|NCT01737697|564364259|FG011|Subacute Phase|Adverse Event|1|||
156346045|NCT01737697|564364260|FG012|Subacute Phase|Adverse Event|1|||
156346046|NCT01737697|564364261|FG013|Subacute Phase|Adverse Event|0|||
156346047|NCT01737697|564364262|FG014|Subacute Phase|Adverse Event|0|||
156346048|NCT01737697|564364248|FG000|Subacute Phase|Withdrawal by Subject|0|||
156346049|NCT01737697|564364249|FG001|Subacute Phase|Withdrawal by Subject|0|||
156346050|NCT01737697|564364250|FG002|Subacute Phase|Withdrawal by Subject|0|||
156346051|NCT01737697|564364251|FG003|Subacute Phase|Withdrawal by Subject|0|||
156346052|NCT01737697|564364252|FG004|Subacute Phase|Withdrawal by Subject|0|||
156346053|NCT01737697|564364253|FG005|Subacute Phase|Withdrawal by Subject|1|||
156346054|NCT01737697|564364254|FG006|Subacute Phase|Withdrawal by Subject|0|||
156346055|NCT01737697|564364255|FG007|Subacute Phase|Withdrawal by Subject|2|||
156346056|NCT01737697|564364256|FG008|Subacute Phase|Withdrawal by Subject|0|||
156346057|NCT01737697|564364257|FG009|Subacute Phase|Withdrawal by Subject|1|||
156346058|NCT01737697|564364258|FG010|Subacute Phase|Withdrawal by Subject|0|||
156346059|NCT01737697|564364259|FG011|Subacute Phase|Withdrawal by Subject|1|||
156346060|NCT01737697|564364260|FG012|Subacute Phase|Withdrawal by Subject|1|||
156346061|NCT01737697|564364261|FG013|Subacute Phase|Withdrawal by Subject|1|||
156346062|NCT01737697|564364262|FG014|Subacute Phase|Withdrawal by Subject|0|||
156346063|NCT01737697|564364248|FG000|Subacute Phase|Lost to Follow-up|0|||
156346064|NCT01737697|564364249|FG001|Subacute Phase|Lost to Follow-up|0|||
156346065|NCT01737697|564364250|FG002|Subacute Phase|Lost to Follow-up|0|||
156346066|NCT01737697|564364251|FG003|Subacute Phase|Lost to Follow-up|0|||
156346067|NCT01737697|564364252|FG004|Subacute Phase|Lost to Follow-up|0|||
156346068|NCT01737697|564364253|FG005|Subacute Phase|Lost to Follow-up|0|||
156346069|NCT01737697|564364254|FG006|Subacute Phase|Lost to Follow-up|0|||
156346070|NCT01737697|564364255|FG007|Subacute Phase|Lost to Follow-up|0|||
156346071|NCT01737697|564364256|FG008|Subacute Phase|Lost to Follow-up|0|||
156482058|NCT03345407|564857949|FG004|Overall Study|Physician Decision|1|||
156346072|NCT01737697|564364257|FG009|Subacute Phase|Lost to Follow-up|0|||
156346073|NCT01737697|564364258|FG010|Subacute Phase|Lost to Follow-up|0|||
156346074|NCT01737697|564364259|FG011|Subacute Phase|Lost to Follow-up|0|||
156346075|NCT01737697|564364260|FG012|Subacute Phase|Lost to Follow-up|0|||
156346076|NCT01737697|564364261|FG013|Subacute Phase|Lost to Follow-up|0|||
156346077|NCT01737697|564364262|FG014|Subacute Phase|Lost to Follow-up|1|||
156346078|NCT01737697|564364248|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
156482059|NCT03345407|564857950|FG005|Overall Study|Physician Decision|2|||
156482060|NCT03345407|564857951|FG006|Overall Study|Physician Decision|3|||
156346079|NCT01737697|564364249|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
156346080|NCT01737697|564364250|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
156346081|NCT01737697|564364251|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
156346082|NCT01737697|564364252|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
156346083|NCT01737697|564364253|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
156346084|NCT01737697|564364254|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
156346085|NCT01737697|564364255|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
156346086|NCT01737697|564364256|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
156346087|NCT01737697|564364257|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
156346088|NCT01737697|564364258|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
156346089|NCT01737697|564364259|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
156346090|NCT01737697|564364260|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
156346091|NCT01737697|564364261|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
156346092|NCT01737697|564364262|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
156346093|NCT01737697|564364248|FG000|Subacute Phase|Protocol Violation|0|||
156346094|NCT01737697|564364249|FG001|Subacute Phase|Protocol Violation|0|||
156346095|NCT01737697|564364250|FG002|Subacute Phase|Protocol Violation|0|||
156346096|NCT01737697|564364251|FG003|Subacute Phase|Protocol Violation|0|||
156346097|NCT01737697|564364252|FG004|Subacute Phase|Protocol Violation|0|||
156346098|NCT01737697|564364253|FG005|Subacute Phase|Protocol Violation|1|||
156346099|NCT01737697|564364254|FG006|Subacute Phase|Protocol Violation|0|||
156346100|NCT01737697|564364255|FG007|Subacute Phase|Protocol Violation|0|||
156346101|NCT01737697|564364256|FG008|Subacute Phase|Protocol Violation|0|||
156346102|NCT01737697|564364257|FG009|Subacute Phase|Protocol Violation|0|||
156346103|NCT01737697|564364258|FG010|Subacute Phase|Protocol Violation|1|||
156346104|NCT01737697|564364259|FG011|Subacute Phase|Protocol Violation|0|||
156346105|NCT01737697|564364260|FG012|Subacute Phase|Protocol Violation|0|||
156346106|NCT01737697|564364261|FG013|Subacute Phase|Protocol Violation|0|||
156346107|NCT01737697|564364262|FG014|Subacute Phase|Protocol Violation|0|||
156346108|NCT01737697|564364248|FG000|Subacute Phase|Physician Decision|0|||
156346109|NCT01737697|564364249|FG001|Subacute Phase|Physician Decision|0|||
156346110|NCT01737697|564364250|FG002|Subacute Phase|Physician Decision|0|||
156346111|NCT01737697|564364251|FG003|Subacute Phase|Physician Decision|0|||
156346112|NCT01737697|564364252|FG004|Subacute Phase|Physician Decision|0|||
156346113|NCT01737697|564364253|FG005|Subacute Phase|Physician Decision|0|||
156346114|NCT01737697|564364254|FG006|Subacute Phase|Physician Decision|0|||
156346115|NCT01737697|564364255|FG007|Subacute Phase|Physician Decision|0|||
156346116|NCT01737697|564364256|FG008|Subacute Phase|Physician Decision|1|||
156346117|NCT01737697|564364257|FG009|Subacute Phase|Physician Decision|0|||
156346118|NCT01737697|564364258|FG010|Subacute Phase|Physician Decision|0|||
156346119|NCT01737697|564364259|FG011|Subacute Phase|Physician Decision|0|||
156346120|NCT01737697|564364260|FG012|Subacute Phase|Physician Decision|0|||
156346121|NCT01737697|564364261|FG013|Subacute Phase|Physician Decision|0|||
156346122|NCT01737697|564364262|FG014|Subacute Phase|Physician Decision|0|||
156346123|NCT01737697|564364248|FG000|Subacute Phase|Death|0|||
156346124|NCT01737697|564364249|FG001|Subacute Phase|Death|0|||
156346125|NCT01737697|564364250|FG002|Subacute Phase|Death|0|||
156346126|NCT01737697|564364251|FG003|Subacute Phase|Death|0|||
156346127|NCT01737697|564364252|FG004|Subacute Phase|Death|0|||
156346128|NCT01737697|564364253|FG005|Subacute Phase|Death|0|||
156346129|NCT01737697|564364254|FG006|Subacute Phase|Death|0|||
156346130|NCT01737697|564364255|FG007|Subacute Phase|Death|0|||
156346131|NCT01737697|564364256|FG008|Subacute Phase|Death|0|||
156346132|NCT01737697|564364257|FG009|Subacute Phase|Death|0|||
156346133|NCT01737697|564364258|FG010|Subacute Phase|Death|1|||
156346134|NCT01737697|564364259|FG011|Subacute Phase|Death|0|||
156346135|NCT01737697|564364260|FG012|Subacute Phase|Death|0|||
156346136|NCT01737697|564364261|FG013|Subacute Phase|Death|0|||
156346137|NCT01737697|564364262|FG014|Subacute Phase|Death|0|||
156346138|NCT02207244|564364265|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
156346139|NCT02207244|564364266|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
156346140|NCT02207244|564364267|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
156346141|NCT02207244|564364268|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156346142|NCT02207244|564364269|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156346143|NCT02207244|564364270|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156346144|NCT02207244|564364271|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156346145|NCT02207244|564364272|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156346146|NCT02207244|564364273|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156346147|NCT02207244|564364274|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156346148|NCT02207244|564364275|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156346149|NCT02207244|564364265|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
156346150|NCT02207244|564364266|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346151|NCT02207244|564364267|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
156346152|NCT02207244|564364268|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346153|NCT02207244|564364269|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346154|NCT02207244|564364270|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346155|NCT02207244|564364271|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346156|NCT02207244|564364272|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346157|NCT02207244|564364273|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346158|NCT02207244|564364274|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346159|NCT02207244|564364275|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156346160|NCT02207244|564364265|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
156346161|NCT02207244|564364266|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
156346162|NCT02207244|564364267|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
156346163|NCT02207244|564364268|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156346164|NCT02207244|564364269|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156346165|NCT02207244|564364270|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156346166|NCT02207244|564364271|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156346167|NCT02207244|564364272|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156346168|NCT02207244|564364273|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156346169|NCT02207244|564364274|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156346170|NCT02207244|564364275|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156346171|NCT02207244|564364265|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
156346172|NCT02207244|564364266|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
156346173|NCT02207244|564364267|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346174|NCT02207244|564364268|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346175|NCT02207244|564364269|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346176|NCT02207244|564364270|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346177|NCT02207244|564364271|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346178|NCT02207244|564364272|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346179|NCT02207244|564364273|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346180|NCT02207244|564364274|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346181|NCT02207244|564364275|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156346182|NCT02207244|564364265|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
156346183|NCT02207244|564364266|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
156346184|NCT02207244|564364267|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
156346185|NCT02207244|564364268|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156346186|NCT02207244|564364269|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156346187|NCT02207244|564364270|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156346188|NCT02207244|564364271|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156346189|NCT02207244|564364272|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156346190|NCT02207244|564364273|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156346191|NCT02207244|564364274|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156346192|NCT02207244|564364275|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156346193|NCT02207244|564364265|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346194|NCT02207244|564364266|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
156346195|NCT02207244|564364267|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
156346196|NCT02207244|564364268|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346197|NCT02207244|564364269|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346198|NCT02207244|564364270|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346199|NCT02207244|564364271|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346200|NCT02207244|564364272|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346201|NCT02207244|564364273|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346202|NCT02207244|564364274|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346203|NCT02207244|564364275|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156346204|NCT02207244|564364265|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346205|NCT02207244|564364266|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
156346206|NCT02207244|564364267|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346207|NCT02207244|564364268|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346208|NCT02207244|564364269|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346209|NCT02207244|564364270|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346210|NCT02207244|564364271|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346211|NCT02207244|564364272|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346212|NCT02207244|564364273|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346213|NCT02207244|564364274|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346214|NCT02207244|564364275|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
156346215|NCT02207244|564364265|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346216|NCT02207244|564364266|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346217|NCT02207244|564364267|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346218|NCT02207244|564364268|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346219|NCT02207244|564364269|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
156346220|NCT02207244|564364270|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
156482061|NCT03345407|564857945|FG000|Overall Study|Lost to Follow-up|2|||
156346221|NCT02207244|564364271|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346222|NCT02207244|564364272|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346223|NCT02207244|564364273|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346224|NCT02207244|564364274|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346225|NCT02207244|564364275|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156346226|NCT02207244|564364265|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346227|NCT02207244|564364266|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346228|NCT02207244|564364267|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346229|NCT02207244|564364268|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346230|NCT02207244|564364269|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346231|NCT02207244|564364270|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
156346232|NCT02207244|564364271|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346233|NCT02207244|564364272|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346234|NCT02207244|564364273|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346235|NCT02207244|564364274|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346236|NCT02207244|564364275|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156346237|NCT02207244|564364265|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156346238|NCT02207244|564364266|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156346239|NCT02207244|564364267|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156346240|NCT02207244|564364268|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
156346241|NCT02207244|564364269|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
156346242|NCT02207244|564364270|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
156346243|NCT02207244|564364271|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156346244|NCT02207244|564364272|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156346245|NCT02207244|564364273|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156346246|NCT02207244|564364274|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156346247|NCT02207244|564364275|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156346248|NCT02207244|564364265|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156346249|NCT02207244|564364266|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156346250|NCT02207244|564364267|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156346251|NCT02207244|564364268|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
156346252|NCT02207244|564364269|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
156346253|NCT02207244|564364270|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
156346254|NCT02207244|564364271|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156346255|NCT02207244|564364272|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156346256|NCT02207244|564364273|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156346257|NCT02207244|564364274|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156346258|NCT02207244|564364275|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156346259|NCT02207244|564364265|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346260|NCT02207244|564364266|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346261|NCT02207244|564364267|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346262|NCT02207244|564364268|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
156346263|NCT02207244|564364269|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346264|NCT02207244|564364270|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
156346265|NCT02207244|564364271|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346266|NCT02207244|564364272|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346267|NCT02207244|564364273|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346268|NCT02207244|564364274|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346269|NCT02207244|564364275|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156346270|NCT02207244|564364265|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346271|NCT02207244|564364266|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346272|NCT02207244|564364267|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346273|NCT02207244|564364268|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
156346274|NCT02207244|564364269|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346275|NCT02207244|564364270|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346276|NCT02207244|564364271|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346277|NCT02207244|564364272|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346278|NCT02207244|564364273|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346279|NCT02207244|564364274|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
156482062|NCT03345407|564857946|FG001|Overall Study|Lost to Follow-up|0|||
156482063|NCT03345407|564857947|FG002|Overall Study|Lost to Follow-up|1|||
156482064|NCT03345407|564857948|FG003|Overall Study|Lost to Follow-up|0|||
156482065|NCT03345407|564857949|FG004|Overall Study|Lost to Follow-up|1|||
156482066|NCT03345407|564857950|FG005|Overall Study|Lost to Follow-up|2|||
156482067|NCT03345407|564857951|FG006|Overall Study|Lost to Follow-up|3|||
156482068|NCT03345407|564857945|FG000|Overall Study|Protocol-defined stopping criteria|9|||
156482069|NCT03345407|564857946|FG001|Overall Study|Protocol-defined stopping criteria|0|||
156482070|NCT03345407|564857947|FG002|Overall Study|Protocol-defined stopping criteria|0|||
156482071|NCT03345407|564857948|FG003|Overall Study|Protocol-defined stopping criteria|0|||
156346280|NCT02207244|564364275|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
156346281|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156346282|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156346283|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156346284|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156346285|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156346286|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156346287|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
156346288|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
156346289|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
156346290|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
156346291|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156346292|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346293|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346294|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346295|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346296|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346297|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346298|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346299|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
156346300|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346301|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346302|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156346303|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156346304|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156346305|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156346306|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156346307|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156346308|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156346309|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
156346310|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
156346311|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
156346312|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
156346313|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156346314|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156346315|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156346316|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156346317|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156346318|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156346319|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156346320|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
156346321|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
156346322|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156346323|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
156346324|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156346325|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156346326|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156346327|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156346328|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156346329|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156346330|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156346331|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
156346332|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
156346333|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
156346334|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
156346335|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156346336|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346337|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346338|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346339|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346340|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346341|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346342|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346343|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
156346344|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
156346345|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346346|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156346347|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346348|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346349|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346350|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346351|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346352|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346353|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346354|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346355|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
156346356|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346357|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156346358|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346359|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346360|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346361|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346362|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346363|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346364|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346365|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
156346366|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346367|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346368|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156346369|NCT02207244|564364265|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346370|NCT02207244|564364266|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346371|NCT02207244|564364267|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346372|NCT02207244|564364268|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346373|NCT02207244|564364269|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346374|NCT02207244|564364270|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346375|NCT02207244|564364271|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
156346376|NCT02207244|564364272|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346377|NCT02207244|564364273|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346378|NCT02207244|564364274|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346379|NCT02207244|564364275|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156346380|NCT02207244|564364265|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346381|NCT02207244|564364266|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346382|NCT02207244|564364267|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346383|NCT02207244|564364268|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346384|NCT02207244|564364269|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346385|NCT02207244|564364270|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346386|NCT02207244|564364271|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346387|NCT02207244|564364272|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346388|NCT02207244|564364273|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
156346389|NCT02207244|564364274|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156346390|NCT02207244|564364275|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
156346391|NCT02207244|564364265|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156346392|NCT02207244|564364266|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156346393|NCT02207244|564364267|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156346394|NCT02207244|564364268|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156346395|NCT02207244|564364269|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156346396|NCT02207244|564364270|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156346397|NCT02207244|564364271|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156482072|NCT03345407|564857949|FG004|Overall Study|Protocol-defined stopping criteria|2|||
156482073|NCT03345407|564857950|FG005|Overall Study|Protocol-defined stopping criteria|1|||
156482074|NCT03345407|564857951|FG006|Overall Study|Protocol-defined stopping criteria|1|||
156482075|NCT03345407|564857945|FG000|Overall Study|Protocol Violation|2|||
156482076|NCT03345407|564857946|FG001|Overall Study|Protocol Violation|0|||
156482077|NCT03345407|564857947|FG002|Overall Study|Protocol Violation|0|||
156482078|NCT03345407|564857948|FG003|Overall Study|Protocol Violation|0|||
156482079|NCT03345407|564857949|FG004|Overall Study|Protocol Violation|1|||
156482080|NCT03345407|564857950|FG005|Overall Study|Protocol Violation|0|||
156543853|NCT02819635|565086192|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156482081|NCT03345407|564857951|FG006|Overall Study|Protocol Violation|3|||
156543854|NCT02819635|565086193|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156543855|NCT02819635|565086194|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156543856|NCT02819635|565086195|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156543857|NCT02819635|565086196|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
156543858|NCT02819635|565086197|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156543859|NCT02819635|565086198|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156346398|NCT02207244|564364272|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156346399|NCT02207244|564364273|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
156543860|NCT02819635|565086199|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156346400|NCT02207244|564364274|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156346401|NCT02207244|564364275|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
156346402|NCT02207244|564364265|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346403|NCT02207244|564364266|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346404|NCT02207244|564364267|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346405|NCT02207244|564364268|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346406|NCT02207244|564364269|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346407|NCT02207244|564364270|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346408|NCT02207244|564364271|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346409|NCT02207244|564364272|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346410|NCT02207244|564364273|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
156346411|NCT02207244|564364274|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156346412|NCT02207244|564364275|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
156482082|NCT03345407|564857945|FG000|Overall Study|Lack of Efficacy|1|||
156482083|NCT03345407|564857946|FG001|Overall Study|Lack of Efficacy|1|||
156482084|NCT03345407|564857947|FG002|Overall Study|Lack of Efficacy|1|||
156482085|NCT03345407|564857948|FG003|Overall Study|Lack of Efficacy|1|||
156482086|NCT03345407|564857949|FG004|Overall Study|Lack of Efficacy|1|||
156346413|NCT02207244|564364265|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156482087|NCT03345407|564857950|FG005|Overall Study|Lack of Efficacy|0|||
156346414|NCT02207244|564364266|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156346415|NCT02207244|564364267|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156346416|NCT02207244|564364268|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156346417|NCT02207244|564364269|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156346418|NCT02207244|564364270|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156346419|NCT02207244|564364271|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156346420|NCT02207244|564364272|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156346421|NCT02207244|564364273|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
156346422|NCT02207244|564364274|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156346423|NCT02207244|564364275|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
156346424|NCT02207244|564364265|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
156346425|NCT02207244|564364266|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
156346426|NCT02207244|564364267|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
156346427|NCT02207244|564364268|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
156346428|NCT02207244|564364269|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
156346429|NCT02207244|564364270|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
156346430|NCT02207244|564364271|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
156346431|NCT02207244|564364272|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
156346432|NCT02207244|564364273|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
156346433|NCT02207244|564364274|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
156346434|NCT02207244|564364275|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
156346435|NCT02207244|564364265|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
156346436|NCT02207244|564364266|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
156346437|NCT02207244|564364267|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
156346438|NCT02207244|564364268|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
156346439|NCT02207244|564364269|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
156346440|NCT02207244|564364270|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
156346441|NCT02207244|564364271|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
156346442|NCT02207244|564364272|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
156482088|NCT03345407|564857951|FG006|Overall Study|Lack of Efficacy|3|||
156482089|NCT03345407|564857945|FG000|Overall Study|Adverse Event|4|||
156482090|NCT03345407|564857946|FG001|Overall Study|Adverse Event|0|||
156482091|NCT03345407|564857947|FG002|Overall Study|Adverse Event|5|||
156346443|NCT02207244|564364273|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
156346444|NCT02207244|564364274|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
156482092|NCT03345407|564857948|FG003|Overall Study|Adverse Event|4|||
156482093|NCT03345407|564857949|FG004|Overall Study|Adverse Event|6|||
156482094|NCT03345407|564857950|FG005|Overall Study|Adverse Event|5|||
156482095|NCT03345407|564857951|FG006|Overall Study|Adverse Event|16|||
156482096|NCT03262389|564857954|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
156482097|NCT03262389|564857954|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
156346445|NCT02207244|564364275|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
156346446|NCT02207244|564364265|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346447|NCT02207244|564364266|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346448|NCT02207244|564364267|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346449|NCT02207244|564364268|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346450|NCT02207244|564364269|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346451|NCT02207244|564364270|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346452|NCT02207244|564364271|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346453|NCT02207244|564364272|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346454|NCT02207244|564364273|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346455|NCT02207244|564364274|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156346456|NCT02207244|564364275|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
156346457|NCT02216591|564364276|FG000|Overall Study|Lost to Follow-up|0|||
156346458|NCT02216591|564364277|FG001|Overall Study|Lost to Follow-up|1|||
156346459|NCT00471328|564364281|FG000|Core Phase|Adverse Event|18|||
156346460|NCT00471328|564364282|FG001|Core Phase|Adverse Event|6|||
156346461|NCT00471328|564364281|FG000|Core Phase|Death|8|||
156346462|NCT00471328|564364282|FG001|Core Phase|Death|4|||
156346463|NCT00471328|564364281|FG000|Core Phase|Withdrawal by Subject|2|||
156346464|NCT00471328|564364282|FG001|Core Phase|Withdrawal by Subject|2|||
156346465|NCT00471328|564364281|FG000|Core Phase|Abnormal laboratory value|1|||
156346466|NCT00471328|564364282|FG001|Core Phase|Abnormal laboratory value|0|||
156346467|NCT00471328|564364281|FG000|Core Phase|Disease Progression|78|||
156346468|NCT00471328|564364282|FG001|Core Phase|Disease Progression|53|||
156346469|NCT00471328|564364281|FG000|Core Phase|Administrative Problem|0|||
156346470|NCT00471328|564364282|FG001|Core Phase|Administrative Problem|1|||
156346471|NCT00471328|564364281|FG000|Core Phase|Protocol Deviation|0|||
156346472|NCT00471328|564364282|FG001|Core Phase|Protocol Deviation|1|||
156346473|NCT00471328|564364281|FG000|Extension Phase|Adverse Event|3|||
156346474|NCT00471328|564364282|FG001|Extension Phase|Adverse Event|12|||
156346475|NCT00471328|564364281|FG000|Extension Phase|Withdrawal by Subject|0|||
156346476|NCT00471328|564364282|FG001|Extension Phase|Withdrawal by Subject|2|||
156482098|NCT03262389|564857954|FG000|Overall Study|opted out of PET/MR|1|||
156482099|NCT02256553|564857956|FG000|Period I|Adverse Event|5|||
156346477|NCT00471328|564364281|FG000|Extension Phase|Death|1|||
156346478|NCT00471328|564364282|FG001|Extension Phase|Death|7|||
156346479|NCT00471328|564364281|FG000|Extension Phase|Protocol Deviation|3|||
156346480|NCT00471328|564364282|FG001|Extension Phase|Protocol Deviation|1|||
156346481|NCT00471328|564364281|FG000|Extension Phase|Treatment duration as per protocol|0|||
156346482|NCT00471328|564364282|FG001|Extension Phase|Treatment duration as per protocol|1|||
156346483|NCT00471328|564364281|FG000|Extension Phase|Disease Progression|32|||
156346484|NCT00471328|564364282|FG001|Extension Phase|Disease Progression|44|||
156346485|NCT00471328|564364281|FG000|Extension Phase|New cancer Therapy|1|||
156346486|NCT00471328|564364282|FG001|Extension Phase|New cancer Therapy|0|||
156482100|NCT02256553|564857956|FG000|Period I|Protocol Violation|1|||
156482101|NCT02256553|564857956|FG000|Period II|Adverse Event|1|||
156346487|NCT00471328|564364281|FG000|Extension Phase|Administrative Problem|1|||
156346488|NCT00471328|564364282|FG001|Extension Phase|Administrative Problem|0|||
156346489|NCT02837783|564364283|FG000|Overall Study|Adverse Event|1|||
156482102|NCT02256553|564857956|FG000|Period II|Subject Moved|1|||
156482103|NCT02256553|564857956|FG000|Period III|Adverse Event|3|||
156482104|NCT02865083|564857957|FG000|Overall Study|Early Termination|3|||
156482105|NCT02865083|564857958|FG001|Overall Study|Early Termination|1|||
156482106|NCT03651271|564857959|FG000|Overall Study|Death|4|||
156482107|NCT03651271|564857960|FG001|Overall Study|Death|37|||
156482108|NCT03651271|564857961|FG002|Overall Study|Death|0|||
156482109|NCT03651271|564857962|FG003|Overall Study|Death|2|||
156482110|NCT03651271|564857963|FG004|Overall Study|Death|6|||
156482111|NCT03651271|564857959|FG000|Overall Study|Lost to Follow-up|1|||
156482112|NCT03651271|564857960|FG001|Overall Study|Lost to Follow-up|5|||
156482113|NCT03651271|564857961|FG002|Overall Study|Lost to Follow-up|0|||
156346490|NCT02837783|564364284|FG001|Overall Study|Adverse Event|0|||
156346491|NCT02837783|564364283|FG000|Overall Study|Other, Not Specified|1|||
156346492|NCT02837783|564364284|FG001|Overall Study|Other, Not Specified|2|||
156346493|NCT01962896|564364285|FG000|Overall Study|Lack of Efficacy|4|||
156346494|NCT03200860|564364286|FG000|Overall Study|Withdrawal by Subject|1|||
156346495|NCT03200860|564364287|FG001|Overall Study|Withdrawal by Subject|0|||
156346496|NCT00844896|564364288|FG000|Overall Study|Lost to Follow-up|12|||
156346497|NCT00844896|564364289|FG001|Overall Study|Lost to Follow-up|16|||
156346498|NCT00844896|564364288|FG000|Overall Study|Parents did not have time to complete|0|||
156346499|NCT00844896|564364289|FG001|Overall Study|Parents did not have time to complete|1|||
156346500|NCT02233647|564364293|FG000|Overall Study|Adverse Event|1|||
156346501|NCT00458211|564364294|FG000|Overall Study|Lack of Efficacy|12|||
156346502|NCT00458211|564364294|FG000|Overall Study|Withdrawal by Subject|2|||
156346503|NCT00458211|564364294|FG000|Overall Study|Protocol Violation|2|||
156346504|NCT02634320|564364297|FG000|Overall Study|Adverse Event|2|||
156346505|NCT02634320|564364297|FG000|Overall Study|Lost to Follow-up|3|||
156346506|NCT02634320|564364297|FG000|Overall Study|Moved out of area|2|||
156346507|NCT02634320|564364297|FG000|Overall Study|Out of window for study visits|1|||
156346508|NCT02634320|564364297|FG000|Overall Study|Protocol Violation|1|||
156346509|NCT02634320|564364297|FG000|Overall Study|Withdrawal by Subject|5|||
156346510|NCT02634320|564364297|FG000|Overall Study|Lack of Efficacy|2|||
156346511|NCT00838578|564364298|FG000|Overall Study|Protocol Violation|2|||
156346512|NCT03919799|564364306|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
156346513|NCT03919799|564364307|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
156346514|NCT03919799|564364308|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
156346515|NCT03919799|564364309|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
156346516|NCT03919799|564364310|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
156346517|NCT03919799|564364306|FG000|DB Period (28 Weeks)|Adverse Event|1|||
156346518|NCT03919799|564364307|FG001|DB Period (28 Weeks)|Adverse Event|1|||
156346519|NCT03919799|564364308|FG002|DB Period (28 Weeks)|Adverse Event|1|||
156346520|NCT03919799|564364309|FG003|DB Period (28 Weeks)|Adverse Event|0|||
156346521|NCT03919799|564364310|FG004|DB Period (28 Weeks)|Adverse Event|0|||
156346522|NCT03919799|564364306|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
156346523|NCT03919799|564364307|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
156346524|NCT03919799|564364308|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
156346525|NCT03919799|564364309|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
156346526|NCT03919799|564364310|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
156346527|NCT03919799|564364306|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
156346528|NCT03919799|564364307|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
156346529|NCT03919799|564364308|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
156346530|NCT03919799|564364309|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
156346531|NCT03919799|564364310|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
156346532|NCT03919799|564364306|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
156346533|NCT03919799|564364307|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
156346534|NCT03919799|564364308|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
156346535|NCT03919799|564364309|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
156346536|NCT03919799|564364310|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
156543861|NCT02819635|565086200|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156543862|NCT02819635|565086201|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156346537|NCT00646776|564364313|FG000|Overall Study|Adverse Event|1|||
156346538|NCT00646776|564364314|FG001|Overall Study|Adverse Event|9|||
156346539|NCT00646776|564364313|FG000|Overall Study|Investigator discretion|0|||
156346540|NCT00646776|564364314|FG001|Overall Study|Investigator discretion|4|||
156346541|NCT05425745|564364317|FG000|Overall Study|Withdrawal of Consent|3|||
156346542|NCT05425745|564364318|FG001|Overall Study|Withdrawal of Consent|3|||
156346543|NCT05425745|564364317|FG000|Overall Study|Death|2|||
156346544|NCT05425745|564364318|FG001|Overall Study|Death|3|||
156346545|NCT05425745|564364317|FG000|Overall Study|Lost to Follow-up|1|||
156346546|NCT05425745|564364318|FG001|Overall Study|Lost to Follow-up|2|||
156346547|NCT05425745|564364317|FG000|Overall Study|Adverse Event|0|||
156346548|NCT05425745|564364318|FG001|Overall Study|Adverse Event|1|||
156346549|NCT05425745|564364317|FG000|Overall Study|Did not return for end of study visit|0|||
156543863|NCT02819635|565086190|FG000|Substudy 2, Part 2|Other, not specified|0|||
156543864|NCT02819635|565086191|FG001|Substudy 2, Part 2|Other, not specified|0|||
156543865|NCT02819635|565086192|FG002|Substudy 2, Part 2|Other, not specified|0|||
156346550|NCT05425745|564364318|FG001|Overall Study|Did not return for end of study visit|1|||
156346551|NCT05425745|564364317|FG000|Overall Study|End of study visit completed by phone|1|||
156346552|NCT05425745|564364318|FG001|Overall Study|End of study visit completed by phone|0|||
156346553|NCT05425745|564364317|FG000|Overall Study|Subject decision|1|||
156346554|NCT05425745|564364318|FG001|Overall Study|Subject decision|0|||
156346555|NCT00524368|564366122|FG000|Overall Study|Adverse Event|10|||
156346556|NCT00524368|564366123|FG001|Overall Study|Adverse Event|12|||
156346557|NCT00524368|564366122|FG000|Overall Study|Lost to Follow-up|9|||
156346558|NCT00524368|564366123|FG001|Overall Study|Lost to Follow-up|13|||
156346559|NCT00524368|564366122|FG000|Overall Study|Withdrawal by Subject|4|||
156346560|NCT00524368|564366123|FG001|Overall Study|Withdrawal by Subject|5|||
156346561|NCT00524368|564366122|FG000|Overall Study|Non-compliant|8|||
156346562|NCT00524368|564366123|FG001|Overall Study|Non-compliant|9|||
156346563|NCT00524368|564366122|FG000|Overall Study|Reached a Virologic Endpoint|3|||
156346564|NCT00524368|564366123|FG001|Overall Study|Reached a Virologic Endpoint|2|||
156346565|NCT00524368|564366122|FG000|Overall Study|Sponsor's Decision|2|||
156346566|NCT00524368|564366123|FG001|Overall Study|Sponsor's Decision|0|||
156346567|NCT00524368|564366122|FG000|Overall Study|Ineligible to Continue the study|2|||
156346568|NCT00524368|564366123|FG001|Overall Study|Ineligible to Continue the study|5|||
156346569|NCT00524368|564366122|FG000|Overall Study|Other|3|||
156346570|NCT00524368|564366123|FG001|Overall Study|Other|2|||
156346571|NCT04023526|564366124|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
156346572|NCT04023526|564366125|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
156346573|NCT04023526|564366124|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
156346574|NCT04023526|564366125|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
156346575|NCT01955733|564366129|FG000|Period 1|Lost to Follow-up|1|||
156346576|NCT01955733|564366130|FG001|Period 1|Lost to Follow-up|0|||
156346577|NCT01955733|564366131|FG002|Period 1|Lost to Follow-up|0|||
156346578|NCT01955733|564366129|FG000|Period 2|Adverse Event|1|||
156346579|NCT01955733|564366130|FG001|Period 2|Adverse Event|0|||
156346580|NCT01955733|564366131|FG002|Period 2|Adverse Event|0|||
156346581|NCT01955733|564366129|FG000|Period 2|Physician Decision|0|||
156346582|NCT01955733|564366130|FG001|Period 2|Physician Decision|0|||
156346583|NCT01955733|564366131|FG002|Period 2|Physician Decision|1|||
156346584|NCT01955733|564366129|FG000|Period 2|Withdrawal by Subject|1|||
156346585|NCT01955733|564366130|FG001|Period 2|Withdrawal by Subject|3|||
156346586|NCT01955733|564366131|FG002|Period 2|Withdrawal by Subject|2|||
156346587|NCT01955733|564366129|FG000|Period 2|Study terminated by sponsor|8|||
156346588|NCT01955733|564366130|FG001|Period 2|Study terminated by sponsor|14|||
156346589|NCT01955733|564366131|FG002|Period 2|Study terminated by sponsor|16|||
156346590|NCT01955733|564366129|FG000|Period 2|Lost to Follow-up|2|||
156346591|NCT01955733|564366130|FG001|Period 2|Lost to Follow-up|0|||
156346592|NCT01955733|564366131|FG002|Period 2|Lost to Follow-up|0|||
156346593|NCT01955733|564366129|FG000|Period 2|Other not defined above|0|||
156346594|NCT01955733|564366130|FG001|Period 2|Other not defined above|2|||
156346595|NCT01955733|564366131|FG002|Period 2|Other not defined above|2|||
156346596|NCT01852110|564366139|FG000|Overall Study|Adverse Event|12|||
156346597|NCT01852110|564366140|FG001|Overall Study|Adverse Event|5|||
156346598|NCT01852110|564366141|FG002|Overall Study|Adverse Event|0|||
156346599|NCT01852110|564366142|FG003|Overall Study|Adverse Event|0|||
156346600|NCT01852110|564366143|FG004|Overall Study|Adverse Event|0|||
156346601|NCT01852110|564366144|FG005|Overall Study|Adverse Event|0|||
156346602|NCT01852110|564366139|FG000|Overall Study|Lost to Follow-up|1|||
156346603|NCT01852110|564366140|FG001|Overall Study|Lost to Follow-up|3|||
156346604|NCT01852110|564366141|FG002|Overall Study|Lost to Follow-up|0|||
156346605|NCT01852110|564366142|FG003|Overall Study|Lost to Follow-up|0|||
156346606|NCT01852110|564366143|FG004|Overall Study|Lost to Follow-up|0|||
156346607|NCT01852110|564366144|FG005|Overall Study|Lost to Follow-up|0|||
156346608|NCT01852110|564366139|FG000|Overall Study|Non-compliance with Study Drug|2|||
156346609|NCT01852110|564366140|FG001|Overall Study|Non-compliance with Study Drug|1|||
156346610|NCT01852110|564366141|FG002|Overall Study|Non-compliance with Study Drug|0|||
156346611|NCT01852110|564366142|FG003|Overall Study|Non-compliance with Study Drug|0|||
156346612|NCT01852110|564366143|FG004|Overall Study|Non-compliance with Study Drug|0|||
156346613|NCT01852110|564366144|FG005|Overall Study|Non-compliance with Study Drug|0|||
156346614|NCT01852110|564366139|FG000|Overall Study|Physician Decision|1|||
156346615|NCT01852110|564366140|FG001|Overall Study|Physician Decision|0|||
156346616|NCT01852110|564366141|FG002|Overall Study|Physician Decision|0|||
156346617|NCT01852110|564366142|FG003|Overall Study|Physician Decision|0|||
156346618|NCT01852110|564366143|FG004|Overall Study|Physician Decision|0|||
156346619|NCT01852110|564366144|FG005|Overall Study|Physician Decision|0|||
156346620|NCT01852110|564366139|FG000|Overall Study|Protocol Violation|0|||
156346621|NCT01852110|564366140|FG001|Overall Study|Protocol Violation|1|||
156346622|NCT01852110|564366141|FG002|Overall Study|Protocol Violation|0|||
156346623|NCT01852110|564366142|FG003|Overall Study|Protocol Violation|0|||
156346624|NCT01852110|564366143|FG004|Overall Study|Protocol Violation|0|||
156346625|NCT01852110|564366144|FG005|Overall Study|Protocol Violation|0|||
156346626|NCT01852110|564366139|FG000|Overall Study|Study Terminated by Sponsor|30|||
156346627|NCT01852110|564366140|FG001|Overall Study|Study Terminated by Sponsor|32|||
156346628|NCT01852110|564366141|FG002|Overall Study|Study Terminated by Sponsor|0|||
156346629|NCT01852110|564366142|FG003|Overall Study|Study Terminated by Sponsor|0|||
156346630|NCT01852110|564366143|FG004|Overall Study|Study Terminated by Sponsor|0|||
156346631|NCT01852110|564366144|FG005|Overall Study|Study Terminated by Sponsor|0|||
156346632|NCT01852110|564366139|FG000|Overall Study|Withdrawal by Subject|4|||
156346633|NCT01852110|564366140|FG001|Overall Study|Withdrawal by Subject|4|||
156346634|NCT01852110|564366141|FG002|Overall Study|Withdrawal by Subject|0|||
156346635|NCT01852110|564366142|FG003|Overall Study|Withdrawal by Subject|0|||
156346636|NCT01852110|564366143|FG004|Overall Study|Withdrawal by Subject|0|||
156346637|NCT01852110|564366144|FG005|Overall Study|Withdrawal by Subject|0|||
156346638|NCT00793403|564366145|FG000|Overall Study|Other|73|||
156346639|NCT02961751|564366156|FG000|Overall Study|Lost to Follow-up|11|||
156346640|NCT02961751|564366156|FG000|Overall Study|Physician Decision|2|||
156346641|NCT02961751|564366156|FG000|Overall Study|Not Eligible at Enrollment|1|||
156346642|NCT02961751|564366156|FG000|Overall Study|Protocol Violation|1|||
156346643|NCT00842712|564366157|FG000|Safety Run-in Part|Adverse Event|0|||
156346644|NCT00842712|564366158|FG001|Safety Run-in Part|Adverse Event|1|||
156346645|NCT00842712|564366159|FG002|Safety Run-in Part|Adverse Event|0|||
156346646|NCT00842712|564366160|FG003|Safety Run-in Part|Adverse Event|0|||
156346647|NCT00842712|564366161|FG004|Safety Run-in Part|Adverse Event|0|||
156346648|NCT00842712|564366162|FG005|Safety Run-in Part|Adverse Event|0|||
156346649|NCT00842712|564366163|FG006|Safety Run-in Part|Adverse Event|0|||
156346650|NCT00842712|564366157|FG000|Safety Run-in Part|Progressive disease|3|||
156346651|NCT00842712|564366158|FG001|Safety Run-in Part|Progressive disease|1|||
156346652|NCT00842712|564366159|FG002|Safety Run-in Part|Progressive disease|0|||
156346653|NCT00842712|564366160|FG003|Safety Run-in Part|Progressive disease|1|||
156346654|NCT00842712|564366161|FG004|Safety Run-in Part|Progressive disease|0|||
156346655|NCT00842712|564366162|FG005|Safety Run-in Part|Progressive disease|0|||
156346656|NCT00842712|564366163|FG006|Safety Run-in Part|Progressive disease|0|||
156346657|NCT00842712|564366157|FG000|Randomized Part|Randomized but not treated|0|||
156346658|NCT00842712|564366158|FG001|Randomized Part|Randomized but not treated|0|||
156346659|NCT00842712|564366159|FG002|Randomized Part|Randomized but not treated|0|||
156346660|NCT00842712|564366160|FG003|Randomized Part|Randomized but not treated|0|||
156346661|NCT00842712|564366161|FG004|Randomized Part|Randomized but not treated|0|||
156346662|NCT00842712|564366162|FG005|Randomized Part|Randomized but not treated|1|||
156346663|NCT00842712|564366163|FG006|Randomized Part|Randomized but not treated|4|||
156346664|NCT00842712|564366157|FG000|Randomized Part|Ongoing at cut-off date|0|||
156346665|NCT00842712|564366158|FG001|Randomized Part|Ongoing at cut-off date|0|||
156346666|NCT00842712|564366159|FG002|Randomized Part|Ongoing at cut-off date|0|||
156346667|NCT00842712|564366160|FG003|Randomized Part|Ongoing at cut-off date|0|||
156346668|NCT00842712|564366161|FG004|Randomized Part|Ongoing at cut-off date|0|||
156482114|NCT03651271|564857962|FG003|Overall Study|Lost to Follow-up|1|||
156482115|NCT03651271|564857963|FG004|Overall Study|Lost to Follow-up|0|||
156482116|NCT03651271|564857959|FG000|Overall Study|Physician Decision|0|||
156482117|NCT03651271|564857960|FG001|Overall Study|Physician Decision|2|||
156482118|NCT03651271|564857961|FG002|Overall Study|Physician Decision|0|||
156482119|NCT03651271|564857962|FG003|Overall Study|Physician Decision|0|||
156482120|NCT03651271|564857963|FG004|Overall Study|Physician Decision|0|||
156482121|NCT03651271|564857959|FG000|Overall Study|Withdrawal by Subject|1|||
156482122|NCT03651271|564857960|FG001|Overall Study|Withdrawal by Subject|15|||
156482123|NCT03651271|564857961|FG002|Overall Study|Withdrawal by Subject|0|||
156482124|NCT03651271|564857962|FG003|Overall Study|Withdrawal by Subject|0|||
156482125|NCT03651271|564857963|FG004|Overall Study|Withdrawal by Subject|1|||
156482126|NCT03651271|564857959|FG000|Overall Study|Patient medically unable to continue|0|||
156482127|NCT03651271|564857960|FG001|Overall Study|Patient medically unable to continue|0|||
156482128|NCT03651271|564857961|FG002|Overall Study|Patient medically unable to continue|0|||
156543866|NCT02819635|565086193|FG003|Substudy 2, Part 2|Other, not specified|0|||
156482129|NCT03651271|564857962|FG003|Overall Study|Patient medically unable to continue|1|||
156543867|NCT02819635|565086194|FG004|Substudy 2, Part 2|Other, not specified|0|||
156482130|NCT03651271|564857963|FG004|Overall Study|Patient medically unable to continue|0|||
156543868|NCT02819635|565086195|FG005|Substudy 2, Part 2|Other, not specified|4|||
156482131|NCT00821093|564857965|FG000|Overall Study|Adverse Event|20|||
156482132|NCT00821093|564857966|FG001|Overall Study|Adverse Event|12|||
156346669|NCT00842712|564366162|FG005|Randomized Part|Ongoing at cut-off date|0|||
156346670|NCT00842712|564366163|FG006|Randomized Part|Ongoing at cut-off date|2|||
156346671|NCT02373202|564366165|FG000|Overall Study|Adverse Event|2|||
156346672|NCT02373202|564366166|FG001|Overall Study|Adverse Event|5|||
156346673|NCT02373202|564366167|FG002|Overall Study|Adverse Event|2|||
156346674|NCT02373202|564366168|FG003|Overall Study|Adverse Event|1|||
156346675|NCT02373202|564366165|FG000|Overall Study|Lack of Efficacy|0|||
156346676|NCT02373202|564366166|FG001|Overall Study|Lack of Efficacy|0|||
156346677|NCT02373202|564366167|FG002|Overall Study|Lack of Efficacy|1|||
156346678|NCT02373202|564366168|FG003|Overall Study|Lack of Efficacy|0|||
156346679|NCT02373202|564366165|FG000|Overall Study|Other|0|||
156346680|NCT02373202|564366166|FG001|Overall Study|Other|1|||
156346681|NCT02373202|564366167|FG002|Overall Study|Other|0|||
156346682|NCT02373202|564366168|FG003|Overall Study|Other|0|||
156346683|NCT00410046|564366169|FG000|Overall Study|Adverse Event|3|||
156346684|NCT00410046|564366169|FG000|Overall Study|Withdrawal by Subject|1|||
156346685|NCT00410046|564366169|FG000|Overall Study|Lost to Follow-up|1|||
156346686|NCT03010254|564366170|FG000|Overall Study|Adverse Event|0|||
156346687|NCT03010254|564366171|FG001|Overall Study|Adverse Event|1|||
156346688|NCT03010254|564366170|FG000|Overall Study|Lost to Follow-up|4|||
156346689|NCT03010254|564366171|FG001|Overall Study|Lost to Follow-up|0|||
156346690|NCT03010254|564366170|FG000|Overall Study|Withdrawal by Subject|1|||
156346691|NCT03010254|564366171|FG001|Overall Study|Withdrawal by Subject|1|||
156346692|NCT03010254|564366170|FG000|Overall Study|Other|2|||
156346693|NCT03010254|564366171|FG001|Overall Study|Other|3|||
156346694|NCT02141282|564366179|FG000|Overall Study|Adverse event, not related to progression|8|||
156346695|NCT02141282|564366180|FG001|Overall Study|Adverse event, not related to progression|1|||
156346696|NCT02141282|564366181|FG002|Overall Study|Adverse event, not related to progression|3|||
156346697|NCT02141282|564366182|FG003|Overall Study|Adverse event, not related to progression|1|||
156482133|NCT00821093|564857965|FG000|Overall Study|Withdrawal by Subject|9|||
156482134|NCT00821093|564857966|FG001|Overall Study|Withdrawal by Subject|13|||
156482135|NCT00821093|564857965|FG000|Overall Study|Lost to Follow-up|9|||
156346698|NCT02141282|564366179|FG000|Overall Study|Adverse event, related to progression|1|||
156346699|NCT02141282|564366180|FG001|Overall Study|Adverse event, related to progression|0|||
156346700|NCT02141282|564366181|FG002|Overall Study|Adverse event, related to progression|2|||
156346701|NCT02141282|564366182|FG003|Overall Study|Adverse event, related to progression|0|||
156346702|NCT02141282|564366179|FG000|Overall Study|COVID-19 infection|1|||
156346703|NCT02141282|564366180|FG001|Overall Study|COVID-19 infection|0|||
156346704|NCT02141282|564366181|FG002|Overall Study|COVID-19 infection|0|||
156346705|NCT02141282|564366182|FG003|Overall Study|COVID-19 infection|0|||
156346706|NCT02141282|564366179|FG000|Overall Study|Lost to Follow-up|0|||
156543869|NCT02819635|565086196|FG006|Substudy 2, Part 2|Other, not specified|8|||
156543870|NCT02819635|565086197|FG007|Substudy 2, Part 2|Other, not specified|0|||
156543871|NCT02819635|565086198|FG008|Substudy 2, Part 2|Other, not specified|0|||
156543872|NCT02819635|565086199|FG009|Substudy 2, Part 2|Other, not specified|0|||
156543873|NCT02819635|565086200|FG010|Substudy 2, Part 2|Other, not specified|0|||
156543874|NCT02819635|565086201|FG011|Substudy 2, Part 2|Other, not specified|0|||
156543875|NCT02819635|565086190|FG000|Substudy 3|Adverse Event|0|||
156543876|NCT02819635|565086191|FG001|Substudy 3|Adverse Event|0|||
156482136|NCT00821093|564857966|FG001|Overall Study|Lost to Follow-up|3|||
156482137|NCT00821093|564857965|FG000|Overall Study|Protocol deviation|3|||
156482138|NCT00821093|564857966|FG001|Overall Study|Protocol deviation|6|||
156482139|NCT00821093|564857965|FG000|Overall Study|Abnormal laboratory value(s)|2|||
156482140|NCT00821093|564857966|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156482141|NCT00821093|564857965|FG000|Overall Study|Lack of Efficacy|2|||
156482142|NCT00821093|564857966|FG001|Overall Study|Lack of Efficacy|2|||
156346707|NCT02141282|564366180|FG001|Overall Study|Lost to Follow-up|0|||
156482143|NCT00821093|564857965|FG000|Overall Study|Death|2|||
156482144|NCT00821093|564857966|FG001|Overall Study|Death|1|||
156482145|NCT00821093|564857965|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156543877|NCT02819635|565086192|FG002|Substudy 3|Adverse Event|0|||
156543878|NCT02819635|565086193|FG003|Substudy 3|Adverse Event|0|||
156543879|NCT02819635|565086194|FG004|Substudy 3|Adverse Event|0|||
156346708|NCT02141282|564366181|FG002|Overall Study|Lost to Follow-up|4|||
156346709|NCT02141282|564366182|FG003|Overall Study|Lost to Follow-up|2|||
156482146|NCT00821093|564857966|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156482147|NCT00821093|564857965|FG000|Overall Study|Administrative problems|1|||
156482148|NCT00821093|564857966|FG001|Overall Study|Administrative problems|2|||
156482149|NCT05104242|564857969|FG000|Overall Study|Withdrawal by Subject|1|||
156482150|NCT05104242|564857970|FG001|Overall Study|Withdrawal by Subject|5|||
156482151|NCT05104242|564857969|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
156482152|NCT05104242|564857970|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
156482153|NCT02469155|564857975|FG000|Overall Study|Adverse Event|6|||
156543880|NCT02819635|565086195|FG005|Substudy 3|Adverse Event|0|||
156543881|NCT02819635|565086196|FG006|Substudy 3|Adverse Event|0|||
156543882|NCT02819635|565086197|FG007|Substudy 3|Adverse Event|0|||
156346710|NCT02141282|564366179|FG000|Overall Study|Other, not specified|14|||
156346711|NCT02141282|564366180|FG001|Overall Study|Other, not specified|11|||
156346712|NCT02141282|564366181|FG002|Overall Study|Other, not specified|23|||
156346713|NCT02141282|564366182|FG003|Overall Study|Other, not specified|9|||
156482154|NCT02469155|564857976|FG001|Overall Study|Adverse Event|0|||
156482155|NCT02469155|564857977|FG002|Overall Study|Adverse Event|1|||
156346714|NCT02141282|564366179|FG000|Overall Study|Progressive disease, Richter's|4|||
156346715|NCT02141282|564366180|FG001|Overall Study|Progressive disease, Richter's|1|||
156346716|NCT02141282|564366181|FG002|Overall Study|Progressive disease, Richter's|1|||
156346717|NCT02141282|564366182|FG003|Overall Study|Progressive disease, Richter's|1|||
156346718|NCT02141282|564366179|FG000|Overall Study|Progressive disease per protocol|12|||
156346719|NCT02141282|564366180|FG001|Overall Study|Progressive disease per protocol|7|||
156346720|NCT02141282|564366181|FG002|Overall Study|Progressive disease per protocol|9|||
156346721|NCT02141282|564366182|FG003|Overall Study|Progressive disease per protocol|2|||
156346722|NCT02141282|564366179|FG000|Overall Study|Stem cell transplant|1|||
156346723|NCT02141282|564366180|FG001|Overall Study|Stem cell transplant|0|||
156543883|NCT02819635|565086198|FG008|Substudy 3|Adverse Event|32|||
156543884|NCT02819635|565086199|FG009|Substudy 3|Adverse Event|3|||
156543885|NCT02819635|565086200|FG010|Substudy 3|Adverse Event|12|||
156346724|NCT02141282|564366181|FG002|Overall Study|Stem cell transplant|1|||
156346725|NCT02141282|564366182|FG003|Overall Study|Stem cell transplant|0|||
156543886|NCT02819635|565086201|FG011|Substudy 3|Adverse Event|18|||
156543887|NCT02819635|565086190|FG000|Substudy 3|Withdrew consent|0|||
156346726|NCT02141282|564366179|FG000|Overall Study|Study terminated by Sponsor|0|||
156346727|NCT02141282|564366180|FG001|Overall Study|Study terminated by Sponsor|1|||
156346728|NCT02141282|564366181|FG002|Overall Study|Study terminated by Sponsor|0|||
156346729|NCT02141282|564366182|FG003|Overall Study|Study terminated by Sponsor|0|||
156346730|NCT02141282|564366179|FG000|Overall Study|Subject non-compliance|0|||
156346731|NCT02141282|564366180|FG001|Overall Study|Subject non-compliance|0|||
156346732|NCT02141282|564366181|FG002|Overall Study|Subject non-compliance|1|||
156346733|NCT02141282|564366182|FG003|Overall Study|Subject non-compliance|0|||
156346734|NCT02141282|564366179|FG000|Overall Study|Withdrew consent|2|||
156346735|NCT02141282|564366180|FG001|Overall Study|Withdrew consent|0|||
156346736|NCT02141282|564366181|FG002|Overall Study|Withdrew consent|4|||
156346737|NCT02141282|564366182|FG003|Overall Study|Withdrew consent|0|||
156346738|NCT03312933|564366183|FG000|Overall Study|Protocol Violation|15|||
156346739|NCT03312933|564366183|FG000|Overall Study|Lost to Follow-up|36|||
156346740|NCT03312933|564366183|FG000|Overall Study|Withdrawal by Subject|3|||
156346741|NCT01752907|564366185|FG000|Overall Study|Withdrawal by Subject|4|||
156346742|NCT01752907|564366186|FG001|Overall Study|Withdrawal by Subject|10|||
156346743|NCT01752907|564366185|FG000|Overall Study|Lost to Follow-up|2|||
156346744|NCT01752907|564366186|FG001|Overall Study|Lost to Follow-up|1|||
156346745|NCT01752907|564366185|FG000|Overall Study|Decision by Sponsor|6|||
156346746|NCT01752907|564366186|FG001|Overall Study|Decision by Sponsor|9|||
156346747|NCT03098550|564366187|FG000|Overall Study|Disease Progression|30|||
156346748|NCT03098550|564366188|FG001|Overall Study|Disease Progression|19|||
156346749|NCT03098550|564366189|FG002|Overall Study|Disease Progression|41|||
156346750|NCT03098550|564366187|FG000|Overall Study|Study Drug Toxicity|2|||
156346751|NCT03098550|564366188|FG001|Overall Study|Study Drug Toxicity|1|||
156346752|NCT03098550|564366189|FG002|Overall Study|Study Drug Toxicity|0|||
156346753|NCT03098550|564366187|FG000|Overall Study|Death|1|||
156346754|NCT03098550|564366188|FG001|Overall Study|Death|0|||
156346755|NCT03098550|564366189|FG002|Overall Study|Death|0|||
156346756|NCT03098550|564366187|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
156346757|NCT03098550|564366188|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
156346758|NCT03098550|564366189|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
156346759|NCT03098550|564366187|FG000|Overall Study|Administrative reason by sponsor|0|||
156346760|NCT03098550|564366188|FG001|Overall Study|Administrative reason by sponsor|0|||
156346761|NCT03098550|564366189|FG002|Overall Study|Administrative reason by sponsor|1|||
156346762|NCT03098550|564366187|FG000|Overall Study|Other reasons|2|||
156346763|NCT03098550|564366188|FG001|Overall Study|Other reasons|0|||
156346764|NCT03098550|564366189|FG002|Overall Study|Other reasons|0|||
156346765|NCT01384760|564366190|FG000|Overall Study|Lost to Follow-up|0|||
156346766|NCT01384760|564366191|FG001|Overall Study|Lost to Follow-up|6|||
156346767|NCT01384760|564366190|FG000|Overall Study|Protocol Violation|16|||
156346768|NCT01384760|564366191|FG001|Overall Study|Protocol Violation|0|||
156346769|NCT00630396|564366192|FG000|Overall Study|Death|4|||
156346770|NCT00630396|564366192|FG000|Overall Study|Lost to Follow-up|3|||
156346771|NCT02990910|564366198|FG000|Overall Study|Lack of Efficacy|6|||
156346772|NCT02990910|564366199|FG001|Overall Study|Lack of Efficacy|10|||
156346773|NCT00381095|564366210|FG000|Overall Study|Death|3|||
156346774|NCT00381095|564366211|FG001|Overall Study|Death|4|||
156346775|NCT00381095|564366210|FG000|Overall Study|Lack of Efficacy|2|||
156346776|NCT00381095|564366211|FG001|Overall Study|Lack of Efficacy|4|||
156346777|NCT00381095|564366210|FG000|Overall Study|Other|2|||
156346778|NCT00381095|564366211|FG001|Overall Study|Other|2|||
156543888|NCT02819635|565086191|FG001|Substudy 3|Withdrew consent|0|||
156543889|NCT02819635|565086192|FG002|Substudy 3|Withdrew consent|0|||
156543890|NCT02819635|565086193|FG003|Substudy 3|Withdrew consent|0|||
156543891|NCT02819635|565086194|FG004|Substudy 3|Withdrew consent|0|||
156543892|NCT02819635|565086195|FG005|Substudy 3|Withdrew consent|0|||
156543893|NCT02819635|565086196|FG006|Substudy 3|Withdrew consent|0|||
156543894|NCT02819635|565086197|FG007|Substudy 3|Withdrew consent|0|||
156543895|NCT02819635|565086198|FG008|Substudy 3|Withdrew consent|11|||
156543896|NCT02819635|565086199|FG009|Substudy 3|Withdrew consent|1|||
156543897|NCT02819635|565086200|FG010|Substudy 3|Withdrew consent|4|||
156346779|NCT00381095|564366210|FG000|Overall Study|Protocol Violation|1|||
156346780|NCT00381095|564366211|FG001|Overall Study|Protocol Violation|1|||
156346781|NCT00381095|564366210|FG000|Overall Study|Withdrawal by Subject|3|||
156346782|NCT00381095|564366211|FG001|Overall Study|Withdrawal by Subject|3|||
156346783|NCT00381095|564366210|FG000|Overall Study|Adverse Event|2|||
156346784|NCT00381095|564366211|FG001|Overall Study|Adverse Event|7|||
156346785|NCT00856284|564366216|FG000|Overall Study|Hyperglycemic rescue|231|||
156346786|NCT00856284|564366217|FG001|Overall Study|Hyperglycemic rescue|201|||
156346787|NCT00856284|564366218|FG002|Overall Study|Hyperglycemic rescue|235|||
156346788|NCT00856284|564366216|FG000|Overall Study|Adverse Event|60|||
156346789|NCT00856284|564366217|FG001|Overall Study|Adverse Event|74|||
156346790|NCT00856284|564366218|FG002|Overall Study|Adverse Event|82|||
156346791|NCT00856284|564366216|FG000|Overall Study|Major protocol deviation|24|||
156346792|NCT00856284|564366217|FG001|Overall Study|Major protocol deviation|16|||
156346793|NCT00856284|564366218|FG002|Overall Study|Major protocol deviation|15|||
156346794|NCT00856284|564366216|FG000|Overall Study|Lost to Follow-up|20|||
156346795|NCT00856284|564366217|FG001|Overall Study|Lost to Follow-up|22|||
156346796|NCT00856284|564366218|FG002|Overall Study|Lost to Follow-up|28|||
156346797|NCT00856284|564366216|FG000|Overall Study|Voluntary withdrawal|48|||
156346798|NCT00856284|564366217|FG001|Overall Study|Voluntary withdrawal|52|||
156346799|NCT00856284|564366218|FG002|Overall Study|Voluntary withdrawal|62|||
156346800|NCT00856284|564366216|FG000|Overall Study|Pregnancy|1|||
156346801|NCT00856284|564366217|FG001|Overall Study|Pregnancy|2|||
156346802|NCT00856284|564366218|FG002|Overall Study|Pregnancy|0|||
156346803|NCT00856284|564366216|FG000|Overall Study|Investigator discretion|9|||
156346804|NCT00856284|564366217|FG001|Overall Study|Investigator discretion|8|||
156346805|NCT00856284|564366218|FG002|Overall Study|Investigator discretion|10|||
156346806|NCT00856284|564366216|FG000|Overall Study|Other|15|||
156346807|NCT00856284|564366217|FG001|Overall Study|Other|17|||
156346808|NCT00856284|564366218|FG002|Overall Study|Other|14|||
156346809|NCT00856284|564366216|FG000|Overall Study|Randomized in error|0|||
156346810|NCT00856284|564366217|FG001|Overall Study|Randomized in error|0|||
156346811|NCT00856284|564366218|FG002|Overall Study|Randomized in error|1|||
156346812|NCT01327885|564366223|FG000|Overall Study|Disease progression-according to RECIST|173|||
156346813|NCT01327885|564366224|FG001|Overall Study|Disease progression-according to RECIST|165|||
156346814|NCT01327885|564366223|FG000|Overall Study|Clinical progression|24|||
156346815|NCT01327885|564366224|FG001|Overall Study|Clinical progression|27|||
156346816|NCT01327885|564366223|FG000|Overall Study|Adverse Event|14|||
156346817|NCT01327885|564366224|FG001|Overall Study|Adverse Event|10|||
156346818|NCT01327885|564366223|FG000|Overall Study|Subject choice|5|||
156346819|NCT01327885|564366224|FG001|Overall Study|Subject choice|10|||
156346820|NCT01327885|564366223|FG000|Overall Study|Other|8|||
156346821|NCT01327885|564366224|FG001|Overall Study|Other|6|||
156346822|NCT01327885|564366223|FG000|Overall Study|Withdrawal of consent from study|3|||
156346823|NCT01327885|564366224|FG001|Overall Study|Withdrawal of consent from study|4|||
156346824|NCT01327885|564366223|FG000|Overall Study|Not treated|1|||
156346825|NCT01327885|564366224|FG001|Overall Study|Not treated|1|||
156346826|NCT01327885|564366223|FG000|Overall Study|Administrative decision|0|||
156346827|NCT01327885|564366224|FG001|Overall Study|Administrative decision|1|||
156346828|NCT04271605|564366227|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
156346829|NCT02485301|564366228|FG000|Overall Study|Serious Adverse Events|2|||
156346830|NCT02485301|564366229|FG001|Overall Study|Serious Adverse Events|1|||
156346831|NCT02485301|564366228|FG000|Overall Study|Protocol Violation|0|||
156346832|NCT02485301|564366229|FG001|Overall Study|Protocol Violation|1|||
156346833|NCT02485301|564366228|FG000|Overall Study|Withdrawal by Subject|6|||
156346834|NCT02485301|564366229|FG001|Overall Study|Withdrawal by Subject|7|||
156346835|NCT02485301|564366228|FG000|Overall Study|Migrated/moved from study area|10|||
156346836|NCT02485301|564366229|FG001|Overall Study|Migrated/moved from study area|19|||
156346837|NCT02485301|564366228|FG000|Overall Study|Lost to Follow-up|17|||
156346838|NCT02485301|564366229|FG001|Overall Study|Lost to Follow-up|17|||
156346839|NCT02485301|564366228|FG000|Overall Study|Other|3|||
156346840|NCT02485301|564366229|FG001|Overall Study|Other|4|||
156346841|NCT01059825|564366230|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156346842|NCT01059825|564366231|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156346843|NCT01059825|564366232|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156346844|NCT01059825|564366233|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156346845|NCT01059825|564366234|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156346846|NCT01059825|564366235|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156346847|NCT01059825|564366236|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
156346848|NCT01059825|564366230|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156346849|NCT01059825|564366231|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156346850|NCT01059825|564366232|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156346851|NCT01059825|564366233|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156346852|NCT01059825|564366234|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156346853|NCT01059825|564366235|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156346854|NCT01059825|564366236|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
156346855|NCT01059825|564366230|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
156346856|NCT01059825|564366231|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
156346857|NCT01059825|564366232|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
156346858|NCT01059825|564366233|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
156346859|NCT01059825|564366234|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
156346860|NCT01059825|564366235|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
156346861|NCT01059825|564366236|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
156346862|NCT01059825|564366230|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156346863|NCT01059825|564366231|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156346864|NCT01059825|564366232|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156346865|NCT01059825|564366233|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156346866|NCT01059825|564366234|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156346867|NCT01059825|564366235|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156346868|NCT01059825|564366236|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
156346869|NCT01059825|564366230|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
156346870|NCT01059825|564366231|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
156346871|NCT01059825|564366232|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
156346872|NCT01059825|564366233|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
156346873|NCT01059825|564366234|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
156346874|NCT01059825|564366235|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
156346875|NCT01059825|564366236|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
156346876|NCT01059825|564366230|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
156346877|NCT01059825|564366231|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
156346878|NCT01059825|564366232|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
156346879|NCT01059825|564366233|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
156346880|NCT01059825|564366234|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
156346881|NCT01059825|564366235|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
156346882|NCT01059825|564366236|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
156346883|NCT01059825|564366230|FG000|Treatment Period|Lost to Follow-up|2|||
156346884|NCT01059825|564366231|FG001|Treatment Period|Lost to Follow-up|1|||
156346885|NCT01059825|564366232|FG002|Treatment Period|Lost to Follow-up|0|||
156346886|NCT01059825|564366233|FG003|Treatment Period|Lost to Follow-up|1|||
156346887|NCT01059825|564366234|FG004|Treatment Period|Lost to Follow-up|2|||
156346888|NCT01059825|564366235|FG005|Treatment Period|Lost to Follow-up|0|||
156346889|NCT01059825|564366236|FG006|Treatment Period|Lost to Follow-up|0|||
156346890|NCT01059825|564366230|FG000|Treatment Period|Withdrawal by Subject|3|||
156346891|NCT01059825|564366231|FG001|Treatment Period|Withdrawal by Subject|0|||
156346892|NCT01059825|564366232|FG002|Treatment Period|Withdrawal by Subject|1|||
156346893|NCT01059825|564366233|FG003|Treatment Period|Withdrawal by Subject|5|||
156346894|NCT01059825|564366234|FG004|Treatment Period|Withdrawal by Subject|4|||
156346895|NCT01059825|564366235|FG005|Treatment Period|Withdrawal by Subject|1|||
156346896|NCT01059825|564366236|FG006|Treatment Period|Withdrawal by Subject|0|||
156346897|NCT01059825|564366230|FG000|Treatment Period|Other reason not specified|1|||
156346898|NCT01059825|564366231|FG001|Treatment Period|Other reason not specified|2|||
156346899|NCT01059825|564366232|FG002|Treatment Period|Other reason not specified|1|||
156346900|NCT01059825|564366233|FG003|Treatment Period|Other reason not specified|2|||
156346901|NCT01059825|564366234|FG004|Treatment Period|Other reason not specified|0|||
156346902|NCT01059825|564366235|FG005|Treatment Period|Other reason not specified|0|||
156346903|NCT01059825|564366236|FG006|Treatment Period|Other reason not specified|0|||
156346904|NCT01059825|564366230|FG000|Treatment Period|Protocol Violation|0|||
156346905|NCT01059825|564366231|FG001|Treatment Period|Protocol Violation|0|||
156346906|NCT01059825|564366232|FG002|Treatment Period|Protocol Violation|1|||
156346907|NCT01059825|564366233|FG003|Treatment Period|Protocol Violation|1|||
156346908|NCT01059825|564366234|FG004|Treatment Period|Protocol Violation|1|||
156346909|NCT01059825|564366235|FG005|Treatment Period|Protocol Violation|1|||
156346910|NCT01059825|564366236|FG006|Treatment Period|Protocol Violation|0|||
156346911|NCT01059825|564366230|FG000|Treatment Period|Adverse event related to study drug|1|||
156346912|NCT01059825|564366231|FG001|Treatment Period|Adverse event related to study drug|0|||
156346913|NCT01059825|564366232|FG002|Treatment Period|Adverse event related to study drug|1|||
156346914|NCT01059825|564366233|FG003|Treatment Period|Adverse event related to study drug|1|||
156346915|NCT01059825|564366234|FG004|Treatment Period|Adverse event related to study drug|0|||
156346916|NCT01059825|564366235|FG005|Treatment Period|Adverse event related to study drug|0|||
156346917|NCT01059825|564366236|FG006|Treatment Period|Adverse event related to study drug|0|||
156346918|NCT01059825|564366230|FG000|Treatment Period|Insufficient clinical response|3|||
156346919|NCT01059825|564366231|FG001|Treatment Period|Insufficient clinical response|0|||
156346920|NCT01059825|564366232|FG002|Treatment Period|Insufficient clinical response|0|||
156346921|NCT01059825|564366233|FG003|Treatment Period|Insufficient clinical response|0|||
156346922|NCT01059825|564366234|FG004|Treatment Period|Insufficient clinical response|0|||
156346923|NCT01059825|564366235|FG005|Treatment Period|Insufficient clinical response|0|||
156346924|NCT01059825|564366236|FG006|Treatment Period|Insufficient clinical response|0|||
156346925|NCT01059825|564366230|FG000|Treatment Period|Adverse event not related to study drug|0|||
156346926|NCT01059825|564366231|FG001|Treatment Period|Adverse event not related to study drug|1|||
156346927|NCT01059825|564366232|FG002|Treatment Period|Adverse event not related to study drug|2|||
156346928|NCT01059825|564366233|FG003|Treatment Period|Adverse event not related to study drug|1|||
156346929|NCT01059825|564366234|FG004|Treatment Period|Adverse event not related to study drug|1|||
156346930|NCT01059825|564366235|FG005|Treatment Period|Adverse event not related to study drug|1|||
156346931|NCT01059825|564366236|FG006|Treatment Period|Adverse event not related to study drug|0|||
156346932|NCT03138889|564366237|FG000|Overall Study|Withdrawal by Subject|5|||
156346933|NCT03138889|564366238|FG001|Overall Study|Withdrawal by Subject|5|||
156346934|NCT03138889|564366239|FG002|Overall Study|Withdrawal by Subject|0|||
156346935|NCT03138889|564366240|FG003|Overall Study|Withdrawal by Subject|2|||
156346936|NCT03138889|564366241|FG004|Overall Study|Withdrawal by Subject|1|||
156346937|NCT03138889|564366242|FG005|Overall Study|Withdrawal by Subject|3|||
156346938|NCT03138889|564366243|FG006|Overall Study|Withdrawal by Subject|0|||
156346939|NCT03138889|564366244|FG007|Overall Study|Withdrawal by Subject|1|||
156346940|NCT00105482|564366245|FG000|Overall Study|Adverse Event|1|||
156346941|NCT00105482|564366246|FG001|Overall Study|Adverse Event|1|||
156346942|NCT00105482|564366245|FG000|Overall Study|Lost to Follow-up|26|||
156346943|NCT00105482|564366246|FG001|Overall Study|Lost to Follow-up|17|||
156346944|NCT00105482|564366245|FG000|Overall Study|Withdrawal by Subject|0|||
156482156|NCT02469155|564857978|FG003|Overall Study|Adverse Event|10|||
156482157|NCT02469155|564857975|FG000|Overall Study|Lack of Efficacy|13|||
156482158|NCT02469155|564857976|FG001|Overall Study|Lack of Efficacy|10|||
156346945|NCT00105482|564366246|FG001|Overall Study|Withdrawal by Subject|1|||
156482159|NCT02469155|564857977|FG002|Overall Study|Lack of Efficacy|10|||
156482160|NCT02469155|564857978|FG003|Overall Study|Lack of Efficacy|8|||
156482161|NCT02469155|564857975|FG000|Overall Study|Death|0|||
156482162|NCT02469155|564857976|FG001|Overall Study|Death|0|||
156346946|NCT00105482|564366245|FG000|Overall Study|Lost Interest|29|||
156346947|NCT00105482|564366246|FG001|Overall Study|Lost Interest|32|||
156346948|NCT00105482|564366245|FG000|Overall Study|Scheduling Conflict|2|||
156346949|NCT00105482|564366246|FG001|Overall Study|Scheduling Conflict|3|||
156346950|NCT00105482|564366245|FG000|Overall Study|Withdrawn by PI|1|||
156346951|NCT00105482|564366246|FG001|Overall Study|Withdrawn by PI|1|||
156346952|NCT00411645|564366247|FG000|Overall Study|Consent Withdrawn|13|||
156346953|NCT00411645|564366248|FG001|Overall Study|Consent Withdrawn|22|||
156346954|NCT00411645|564366247|FG000|Overall Study|Death|56|||
156346955|NCT00411645|564366248|FG001|Overall Study|Death|135|||
156346956|NCT00411645|564366247|FG000|Overall Study|Investigator/Sponsor Decision|10|||
156346957|NCT00411645|564366248|FG001|Overall Study|Investigator/Sponsor Decision|7|||
156346958|NCT00411645|564366247|FG000|Overall Study|Lost to Follow-up|2|||
156346959|NCT00411645|564366248|FG001|Overall Study|Lost to Follow-up|0|||
156346960|NCT04016285|564366249|FG000|Overall Study|Did not progress to surgery|2|||
156346961|NCT04016285|564366250|FG001|Overall Study|Did not progress to surgery|5|||
156346962|NCT04016285|564366249|FG000|Overall Study|Failed to collect outcome data|5|||
156346963|NCT04016285|564366250|FG001|Overall Study|Failed to collect outcome data|3|||
156346964|NCT01987505|564366251|FG000|Overall Study|Other|9|||
156346965|NCT01987505|564366251|FG000|Overall Study|Withdrawal by Subject|2|||
156346966|NCT01987505|564366251|FG000|Overall Study|Other Reason|2|||
156346967|NCT01987505|564366251|FG000|Overall Study|Lost to Follow-up|15|||
156346968|NCT01987505|564366251|FG000|Overall Study|Investigator Decision|2|||
156346969|NCT01987505|564366251|FG000|Overall Study|Death|4|||
156346970|NCT02509156|564366253|FG000|Randomized Phase|Death|1|||
156346971|NCT02509156|564366254|FG001|Randomized Phase|Death|0|||
156346972|NCT02509156|564366253|FG000|Randomized Phase|Withdrawal by Subject|1|||
156346973|NCT02509156|564366254|FG001|Randomized Phase|Withdrawal by Subject|1|||
156346974|NCT03042533|564366255|FG000|Overall Study|MD left program|1|||
156346975|NCT03042533|564366256|FG001|Overall Study|MD left program|4|||
156346976|NCT03042533|564366257|FG002|Overall Study|MD left program|1|||
156346977|NCT01111149|564366259|FG000|Overall Study|Protocol Violation|1|||
156346978|NCT01111149|564366260|FG001|Overall Study|Protocol Violation|1|||
156346979|NCT01111149|564366261|FG002|Overall Study|Protocol Violation|2|||
156346980|NCT01111149|564366259|FG000|Overall Study|Withdrawal by Subject|1|||
156346981|NCT01111149|564366260|FG001|Overall Study|Withdrawal by Subject|0|||
156346982|NCT01111149|564366261|FG002|Overall Study|Withdrawal by Subject|2|||
156346983|NCT01909674|564366271|FG000|Overall Study|Withdrawal by Subject|5|||
156346984|NCT01909674|564366272|FG001|Overall Study|Withdrawal by Subject|2|||
156346985|NCT02794883|564366273|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
156346986|NCT02794883|564366274|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
156346987|NCT02794883|564366275|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
156346988|NCT02794883|564366273|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
156346989|NCT02794883|564366274|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
156346990|NCT02794883|564366275|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
156346991|NCT02794883|564366273|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
156346992|NCT02794883|564366274|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
156346993|NCT02794883|564366275|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
156346994|NCT02794883|564366273|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
156346995|NCT02794883|564366274|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
156346996|NCT02794883|564366275|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
156346997|NCT02794883|564366273|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
156346998|NCT02794883|564366274|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
156346999|NCT02794883|564366275|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
156347000|NCT02794883|564366273|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
156347001|NCT02794883|564366274|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
156347002|NCT02794883|564366275|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
156347003|NCT02794883|564366273|FG000|Follow-up Period (up to 2 Years)|Death|12|||
156347004|NCT02794883|564366274|FG001|Follow-up Period (up to 2 Years)|Death|10|||
156347005|NCT02794883|564366275|FG002|Follow-up Period (up to 2 Years)|Death|10|||
156347006|NCT03167411|564366278|FG000|Overall Study|Adverse Event|0|||
156347007|NCT03167411|564366279|FG001|Overall Study|Adverse Event|1|||
156347008|NCT01366209|564366282|FG000|Overall Study|Adverse Event|6|||
156347009|NCT01366209|564366283|FG001|Overall Study|Adverse Event|7|||
156347010|NCT01366209|564366282|FG000|Overall Study|Withdrawal by Subject|4|||
156347011|NCT01366209|564366283|FG001|Overall Study|Withdrawal by Subject|4|||
156347012|NCT01366209|564366282|FG000|Overall Study|Death|12|||
156347013|NCT01366209|564366283|FG001|Overall Study|Death|19|||
156347014|NCT01366209|564366282|FG000|Overall Study|Lung transplantation|6|||
156347015|NCT01366209|564366283|FG001|Overall Study|Lung transplantation|1|||
156347016|NCT01366209|564366282|FG000|Overall Study|Lost to Follow-up|2|||
156347017|NCT01366209|564366283|FG001|Overall Study|Lost to Follow-up|1|||
156347018|NCT01366209|564366282|FG000|Overall Study|Physician Decision|1|||
156347019|NCT01366209|564366283|FG001|Overall Study|Physician Decision|0|||
156347020|NCT01366209|564366282|FG000|Overall Study|Sponsors decision|0|||
156347021|NCT01366209|564366283|FG001|Overall Study|Sponsors decision|1|||
156347022|NCT01366209|564366282|FG000|Overall Study|Withdrew consent|4|||
156347023|NCT01366209|564366283|FG001|Overall Study|Withdrew consent|3|||
156347024|NCT02266225|564366284|FG000|Overall Study|Lost to Follow-up|2|||
156347025|NCT02266225|564366284|FG000|Overall Study|Death|1|||
156347026|NCT02266225|564366284|FG000|Overall Study|Withdrawal by Subject|13|||
156347027|NCT00420927|564366285|FG000|Period 1|Adverse Event|19|||
156347028|NCT00420927|564366286|FG001|Period 1|Adverse Event|15|||
156347029|NCT00420927|564366287|FG002|Period 1|Adverse Event|0|||
156347030|NCT00420927|564366288|FG003|Period 1|Adverse Event|0|||
156347031|NCT00420927|564366289|FG004|Period 1|Adverse Event|0|||
156347032|NCT00420927|564366290|FG005|Period 1|Adverse Event|0|||
156347033|NCT00420927|564366291|FG006|Period 1|Adverse Event|0|||
156347034|NCT00420927|564366285|FG000|Period 1|Withdrawal by Subject|7|||
156347035|NCT00420927|564366286|FG001|Period 1|Withdrawal by Subject|12|||
156347036|NCT00420927|564366287|FG002|Period 1|Withdrawal by Subject|0|||
156347037|NCT00420927|564366288|FG003|Period 1|Withdrawal by Subject|0|||
156347038|NCT00420927|564366289|FG004|Period 1|Withdrawal by Subject|0|||
156347039|NCT00420927|564366290|FG005|Period 1|Withdrawal by Subject|0|||
156347040|NCT00420927|564366291|FG006|Period 1|Withdrawal by Subject|0|||
156347041|NCT00420927|564366285|FG000|Period 1|Lost to Follow-up|8|||
156347042|NCT00420927|564366286|FG001|Period 1|Lost to Follow-up|6|||
156347043|NCT00420927|564366287|FG002|Period 1|Lost to Follow-up|0|||
156347044|NCT00420927|564366288|FG003|Period 1|Lost to Follow-up|0|||
156347045|NCT00420927|564366289|FG004|Period 1|Lost to Follow-up|0|||
156347046|NCT00420927|564366290|FG005|Period 1|Lost to Follow-up|0|||
156347047|NCT00420927|564366291|FG006|Period 1|Lost to Follow-up|0|||
156347048|NCT00420927|564366285|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
156347049|NCT00420927|564366286|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
156347050|NCT00420927|564366287|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
156347051|NCT00420927|564366288|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
156347052|NCT00420927|564366289|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
156347053|NCT00420927|564366290|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
156347054|NCT00420927|564366291|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
156347055|NCT00420927|564366285|FG000|Period 1|Death|2|||
156347056|NCT00420927|564366286|FG001|Period 1|Death|0|||
156347057|NCT00420927|564366287|FG002|Period 1|Death|0|||
156347058|NCT00420927|564366288|FG003|Period 1|Death|0|||
156347059|NCT00420927|564366289|FG004|Period 1|Death|0|||
156347060|NCT00420927|564366290|FG005|Period 1|Death|0|||
156347061|NCT00420927|564366291|FG006|Period 1|Death|0|||
156347062|NCT00420927|564366285|FG000|Period 1|Subject moved/relocated|0|||
156347063|NCT00420927|564366286|FG001|Period 1|Subject moved/relocated|2|||
156347064|NCT00420927|564366287|FG002|Period 1|Subject moved/relocated|0|||
156347065|NCT00420927|564366288|FG003|Period 1|Subject moved/relocated|0|||
156347066|NCT00420927|564366289|FG004|Period 1|Subject moved/relocated|0|||
156347067|NCT00420927|564366290|FG005|Period 1|Subject moved/relocated|0|||
156347068|NCT00420927|564366291|FG006|Period 1|Subject moved/relocated|0|||
156347069|NCT00420927|564366285|FG000|Period 1|Noncompliant with study drug|1|||
156347070|NCT00420927|564366286|FG001|Period 1|Noncompliant with study drug|1|||
156347071|NCT00420927|564366287|FG002|Period 1|Noncompliant with study drug|0|||
156347072|NCT00420927|564366288|FG003|Period 1|Noncompliant with study drug|0|||
156482163|NCT02469155|564857977|FG002|Overall Study|Death|0|||
156347073|NCT00420927|564366289|FG004|Period 1|Noncompliant with study drug|0|||
156347074|NCT00420927|564366290|FG005|Period 1|Noncompliant with study drug|0|||
156347075|NCT00420927|564366291|FG006|Period 1|Noncompliant with study drug|0|||
156347076|NCT00420927|564366285|FG000|Period 1|Randomization error|1|||
156482164|NCT02469155|564857978|FG003|Overall Study|Death|1|||
156347077|NCT00420927|564366286|FG001|Period 1|Randomization error|0|||
156347078|NCT00420927|564366287|FG002|Period 1|Randomization error|0|||
156347079|NCT00420927|564366288|FG003|Period 1|Randomization error|0|||
156347080|NCT00420927|564366289|FG004|Period 1|Randomization error|0|||
156347081|NCT00420927|564366290|FG005|Period 1|Randomization error|0|||
156347082|NCT00420927|564366291|FG006|Period 1|Randomization error|0|||
156347083|NCT00420927|564366285|FG000|Period 1|Suspected tuberculosis/positive test|1|||
156347084|NCT00420927|564366286|FG001|Period 1|Suspected tuberculosis/positive test|1|||
156347085|NCT00420927|564366287|FG002|Period 1|Suspected tuberculosis/positive test|0|||
156347086|NCT00420927|564366288|FG003|Period 1|Suspected tuberculosis/positive test|0|||
156347087|NCT00420927|564366289|FG004|Period 1|Suspected tuberculosis/positive test|0|||
156347088|NCT00420927|564366290|FG005|Period 1|Suspected tuberculosis/positive test|0|||
156347089|NCT00420927|564366291|FG006|Period 1|Suspected tuberculosis/positive test|0|||
156347090|NCT00420927|564366285|FG000|Period 1|Study site closure|0|||
156347091|NCT00420927|564366286|FG001|Period 1|Study site closure|1|||
156347092|NCT00420927|564366287|FG002|Period 1|Study site closure|0|||
156347093|NCT00420927|564366288|FG003|Period 1|Study site closure|0|||
156347094|NCT00420927|564366289|FG004|Period 1|Study site closure|0|||
156347095|NCT00420927|564366290|FG005|Period 1|Study site closure|0|||
156347096|NCT00420927|564366291|FG006|Period 1|Study site closure|0|||
156347097|NCT00420927|564366285|FG000|Period 1|Subject received new diagnosis|0|||
156347098|NCT00420927|564366286|FG001|Period 1|Subject received new diagnosis|2|||
156347099|NCT00420927|564366287|FG002|Period 1|Subject received new diagnosis|0|||
156347100|NCT00420927|564366288|FG003|Period 1|Subject received new diagnosis|0|||
156347101|NCT00420927|564366289|FG004|Period 1|Subject received new diagnosis|0|||
156347102|NCT00420927|564366290|FG005|Period 1|Subject received new diagnosis|0|||
156347103|NCT00420927|564366291|FG006|Period 1|Subject received new diagnosis|0|||
156347104|NCT00420927|564366285|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
156347105|NCT00420927|564366286|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
156347106|NCT00420927|564366287|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
156347107|NCT00420927|564366288|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
156347108|NCT00420927|564366289|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
156347109|NCT00420927|564366290|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
156347110|NCT00420927|564366291|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
156347111|NCT00420927|564366285|FG000|Period 1|Failed to meet entry criteria|8|||
156347112|NCT00420927|564366286|FG001|Period 1|Failed to meet entry criteria|7|||
156347113|NCT00420927|564366287|FG002|Period 1|Failed to meet entry criteria|0|||
156347114|NCT00420927|564366288|FG003|Period 1|Failed to meet entry criteria|0|||
156347115|NCT00420927|564366289|FG004|Period 1|Failed to meet entry criteria|0|||
156347116|NCT00420927|564366290|FG005|Period 1|Failed to meet entry criteria|0|||
156347117|NCT00420927|564366291|FG006|Period 1|Failed to meet entry criteria|0|||
156347118|NCT00420927|564366285|FG000|Period 1|Took prohibited medication|1|||
156347119|NCT00420927|564366286|FG001|Period 1|Took prohibited medication|3|||
156347120|NCT00420927|564366287|FG002|Period 1|Took prohibited medication|0|||
156347121|NCT00420927|564366288|FG003|Period 1|Took prohibited medication|0|||
156347122|NCT00420927|564366289|FG004|Period 1|Took prohibited medication|0|||
156347123|NCT00420927|564366290|FG005|Period 1|Took prohibited medication|0|||
156347124|NCT00420927|564366291|FG006|Period 1|Took prohibited medication|0|||
156347125|NCT00420927|564366285|FG000|Period 2|Adverse Event|0|||
156347126|NCT00420927|564366286|FG001|Period 2|Adverse Event|0|||
156347127|NCT00420927|564366287|FG002|Period 2|Adverse Event|7|||
156347128|NCT00420927|564366288|FG003|Period 2|Adverse Event|3|||
156347129|NCT00420927|564366289|FG004|Period 2|Adverse Event|17|||
156347130|NCT00420927|564366290|FG005|Period 2|Adverse Event|6|||
156347131|NCT00420927|564366291|FG006|Period 2|Adverse Event|20|||
156347132|NCT00420927|564366285|FG000|Period 2|Withdrawal by Subject|0|||
156347133|NCT00420927|564366286|FG001|Period 2|Withdrawal by Subject|0|||
156482165|NCT02469155|564857975|FG000|Overall Study|Lost to Follow-up|5|||
156482166|NCT02469155|564857976|FG001|Overall Study|Lost to Follow-up|2|||
156482167|NCT02469155|564857977|FG002|Overall Study|Lost to Follow-up|7|||
156482168|NCT02469155|564857978|FG003|Overall Study|Lost to Follow-up|2|||
156482169|NCT02469155|564857975|FG000|Overall Study|Physician Decision|0|||
156482170|NCT02469155|564857976|FG001|Overall Study|Physician Decision|0|||
156482171|NCT02469155|564857977|FG002|Overall Study|Physician Decision|1|||
156482172|NCT02469155|564857978|FG003|Overall Study|Physician Decision|0|||
156482173|NCT02469155|564857975|FG000|Overall Study|Withdrawal by Subject|34|||
156482174|NCT02469155|564857976|FG001|Overall Study|Withdrawal by Subject|30|||
156482175|NCT02469155|564857977|FG002|Overall Study|Withdrawal by Subject|20|||
156482176|NCT02469155|564857978|FG003|Overall Study|Withdrawal by Subject|37|||
156482177|NCT02469155|564857975|FG000|Overall Study|Other|3|||
156482178|NCT02469155|564857976|FG001|Overall Study|Other|3|||
156482179|NCT02469155|564857977|FG002|Overall Study|Other|2|||
156482180|NCT02469155|564857978|FG003|Overall Study|Other|10|||
156482181|NCT02469155|564857975|FG000|Overall Study|Protocol Violation|0|||
156482182|NCT02469155|564857976|FG001|Overall Study|Protocol Violation|1|||
156482183|NCT02469155|564857977|FG002|Overall Study|Protocol Violation|0|||
156482184|NCT02469155|564857978|FG003|Overall Study|Protocol Violation|1|||
156482185|NCT03150589|564857981|FG000|Overall Study|Withdrawal by Subject|16|||
156482186|NCT03150589|564857982|FG001|Overall Study|Withdrawal by Subject|9|||
156482187|NCT03150589|564857981|FG000|Overall Study|Adverse Event|7|||
156347134|NCT00420927|564366287|FG002|Period 2|Withdrawal by Subject|1|||
156347135|NCT00420927|564366288|FG003|Period 2|Withdrawal by Subject|3|||
156347136|NCT00420927|564366289|FG004|Period 2|Withdrawal by Subject|11|||
156347137|NCT00420927|564366290|FG005|Period 2|Withdrawal by Subject|2|||
156347138|NCT00420927|564366291|FG006|Period 2|Withdrawal by Subject|12|||
156482188|NCT03150589|564857982|FG001|Overall Study|Adverse Event|6|||
156347139|NCT00420927|564366285|FG000|Period 2|Lost to Follow-up|0|||
156347140|NCT00420927|564366286|FG001|Period 2|Lost to Follow-up|0|||
156347141|NCT00420927|564366287|FG002|Period 2|Lost to Follow-up|2|||
156347142|NCT00420927|564366288|FG003|Period 2|Lost to Follow-up|2|||
156347143|NCT00420927|564366289|FG004|Period 2|Lost to Follow-up|6|||
156347144|NCT00420927|564366290|FG005|Period 2|Lost to Follow-up|3|||
156347145|NCT00420927|564366291|FG006|Period 2|Lost to Follow-up|9|||
156347146|NCT00420927|564366285|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
156347147|NCT00420927|564366286|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
156347148|NCT00420927|564366287|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
156347149|NCT00420927|564366288|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
156482189|NCT03150589|564857981|FG000|Overall Study|Protocol Violation|4|||
156482190|NCT03150589|564857982|FG001|Overall Study|Protocol Violation|3|||
156482191|NCT03150589|564857981|FG000|Overall Study|Lost to Follow-up|3|||
156482192|NCT03150589|564857982|FG001|Overall Study|Lost to Follow-up|3|||
156482193|NCT03150589|564857981|FG000|Overall Study|Death|2|||
156482194|NCT03150589|564857982|FG001|Overall Study|Death|3|||
156482195|NCT03150589|564857981|FG000|Overall Study|IP non-compliance and other reasons|12|||
156482196|NCT03150589|564857982|FG001|Overall Study|IP non-compliance and other reasons|3|||
156482197|NCT01405508|564857983|FG000|Overall Study|AE, non-serious non-fatal|1|||
156482198|NCT01405508|564857984|FG001|Overall Study|AE, non-serious non-fatal|1|||
156482199|NCT01405508|564857985|FG002|Overall Study|AE, non-serious non-fatal|0|||
156482200|NCT01405508|564857986|FG003|Overall Study|AE, non-serious non-fatal|0|||
156482201|NCT00689351|564857989|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
156482202|NCT00689351|564857990|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
156482203|NCT00689351|564857989|FG000|Infant Series of Dosing|Adverse Event|1|||
156482204|NCT00689351|564857990|FG001|Infant Series of Dosing|Adverse Event|0|||
156482205|NCT00689351|564857989|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
156482206|NCT00689351|564857990|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
156482207|NCT00689351|564857989|FG000|After Infant Series|Parent/legal guardian request|1|||
156482208|NCT00689351|564857990|FG001|After Infant Series|Parent/legal guardian request|0|||
156482209|NCT01766206|564857991|FG000|Overall Study|Withdrawal by Subject|22|||
156482210|NCT01766206|564857991|FG000|Overall Study|Lost to Follow-up|10|||
156482211|NCT01766206|564857991|FG000|Overall Study|Inappropriate enrollment|18|||
156543898|NCT02819635|565086201|FG011|Substudy 3|Withdrew consent|9|||
156347150|NCT00420927|564366289|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
156347151|NCT00420927|564366290|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
156347152|NCT00420927|564366291|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
156347153|NCT00420927|564366285|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
156347154|NCT00420927|564366286|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
156347155|NCT00420927|564366287|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
156347156|NCT00420927|564366288|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
156347157|NCT00420927|564366289|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
156347158|NCT00420927|564366290|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
156347159|NCT00420927|564366291|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
156347160|NCT00420927|564366285|FG000|Period 2|Subject unable to find transportation|0|||
156347161|NCT00420927|564366286|FG001|Period 2|Subject unable to find transportation|0|||
156347162|NCT00420927|564366287|FG002|Period 2|Subject unable to find transportation|0|||
156347163|NCT00420927|564366288|FG003|Period 2|Subject unable to find transportation|0|||
156347164|NCT00420927|564366289|FG004|Period 2|Subject unable to find transportation|0|||
156347165|NCT00420927|564366290|FG005|Period 2|Subject unable to find transportation|0|||
156347166|NCT00420927|564366291|FG006|Period 2|Subject unable to find transportation|1|||
156347167|NCT00420927|564366285|FG000|Period 2|Physician Decision|0|||
156347168|NCT00420927|564366286|FG001|Period 2|Physician Decision|0|||
156347169|NCT00420927|564366287|FG002|Period 2|Physician Decision|0|||
156347170|NCT00420927|564366288|FG003|Period 2|Physician Decision|0|||
156347171|NCT00420927|564366289|FG004|Period 2|Physician Decision|1|||
156347172|NCT00420927|564366290|FG005|Period 2|Physician Decision|1|||
156347173|NCT00420927|564366291|FG006|Period 2|Physician Decision|0|||
156347174|NCT00420927|564366285|FG000|Period 2|Sponsor decision|0|||
156347175|NCT00420927|564366286|FG001|Period 2|Sponsor decision|0|||
156347176|NCT00420927|564366287|FG002|Period 2|Sponsor decision|1|||
156347177|NCT00420927|564366288|FG003|Period 2|Sponsor decision|0|||
156347178|NCT00420927|564366289|FG004|Period 2|Sponsor decision|0|||
156347179|NCT00420927|564366290|FG005|Period 2|Sponsor decision|0|||
156347180|NCT00420927|564366291|FG006|Period 2|Sponsor decision|1|||
156347181|NCT00420927|564366285|FG000|Period 2|Randomization error|0|||
156347182|NCT00420927|564366286|FG001|Period 2|Randomization error|0|||
156347183|NCT00420927|564366287|FG002|Period 2|Randomization error|0|||
156347184|NCT00420927|564366288|FG003|Period 2|Randomization error|0|||
156347185|NCT00420927|564366289|FG004|Period 2|Randomization error|1|||
156347186|NCT00420927|564366290|FG005|Period 2|Randomization error|1|||
156347187|NCT00420927|564366291|FG006|Period 2|Randomization error|0|||
156347188|NCT00420927|564366285|FG000|Period 2|Noncompliant with study drug|0|||
156347189|NCT00420927|564366286|FG001|Period 2|Noncompliant with study drug|0|||
156347190|NCT00420927|564366287|FG002|Period 2|Noncompliant with study drug|0|||
156347191|NCT00420927|564366288|FG003|Period 2|Noncompliant with study drug|1|||
156347192|NCT00420927|564366289|FG004|Period 2|Noncompliant with study drug|0|||
156347193|NCT00420927|564366290|FG005|Period 2|Noncompliant with study drug|0|||
156347194|NCT00420927|564366291|FG006|Period 2|Noncompliant with study drug|2|||
156347195|NCT00420927|564366285|FG000|Period 2|Methotrexate intolerance|0|||
156347196|NCT00420927|564366286|FG001|Period 2|Methotrexate intolerance|0|||
156347197|NCT00420927|564366287|FG002|Period 2|Methotrexate intolerance|0|||
156347198|NCT00420927|564366288|FG003|Period 2|Methotrexate intolerance|0|||
156347199|NCT00420927|564366289|FG004|Period 2|Methotrexate intolerance|0|||
156347200|NCT00420927|564366290|FG005|Period 2|Methotrexate intolerance|0|||
156347201|NCT00420927|564366291|FG006|Period 2|Methotrexate intolerance|1|||
156347202|NCT00420927|564366285|FG000|Period 2|Took prohibited medication|0|||
156347203|NCT00420927|564366286|FG001|Period 2|Took prohibited medication|0|||
156347204|NCT00420927|564366287|FG002|Period 2|Took prohibited medication|0|||
156347205|NCT00420927|564366288|FG003|Period 2|Took prohibited medication|0|||
156347206|NCT00420927|564366289|FG004|Period 2|Took prohibited medication|1|||
156347207|NCT00420927|564366290|FG005|Period 2|Took prohibited medication|0|||
156347208|NCT00420927|564366291|FG006|Period 2|Took prohibited medication|0|||
156347209|NCT00320411|564366292|FG000|Overall Study|No investigational product admin.|4|||
156347210|NCT01417234|564366295|FG000|Overall Study|Subject non-compliant|3|||
156347211|NCT02268084|564366297|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
156347212|NCT02268084|564366298|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
156347213|NCT02268084|564366297|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
156347214|NCT02268084|564366298|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
156347215|NCT05227027|564366299|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
156347216|NCT05227027|564366300|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
156347217|NCT00855920|564366301|FG000|Overall Study|Protocol Violation|0|||
156347218|NCT00855920|564366302|FG001|Overall Study|Protocol Violation|0|||
156347219|NCT00855920|564366303|FG002|Overall Study|Protocol Violation|2|||
156347220|NCT00855920|564366301|FG000|Overall Study|Adverse Event|2|||
156347221|NCT00855920|564366302|FG001|Overall Study|Adverse Event|1|||
156347222|NCT00855920|564366303|FG002|Overall Study|Adverse Event|1|||
156347223|NCT00855920|564366301|FG000|Overall Study|Lack of Efficacy|2|||
156347224|NCT00855920|564366302|FG001|Overall Study|Lack of Efficacy|2|||
156347225|NCT00855920|564366303|FG002|Overall Study|Lack of Efficacy|2|||
156347226|NCT00855920|564366301|FG000|Overall Study|Withdrawal by Subject|2|||
156347227|NCT00855920|564366302|FG001|Overall Study|Withdrawal by Subject|3|||
156347228|NCT00855920|564366303|FG002|Overall Study|Withdrawal by Subject|2|||
156347229|NCT00855920|564366301|FG000|Overall Study|Lost to Follow-up|1|||
156347230|NCT00855920|564366302|FG001|Overall Study|Lost to Follow-up|0|||
156347231|NCT00855920|564366303|FG002|Overall Study|Lost to Follow-up|2|||
156347232|NCT00855920|564366301|FG000|Overall Study|Death|0|||
156347233|NCT00855920|564366302|FG001|Overall Study|Death|1|||
156347234|NCT00855920|564366303|FG002|Overall Study|Death|0|||
156347235|NCT00855920|564366301|FG000|Overall Study|Decision by the sponsor|0|||
156347236|NCT00855920|564366302|FG001|Overall Study|Decision by the sponsor|1|||
156347237|NCT00855920|564366303|FG002|Overall Study|Decision by the sponsor|1|||
156347238|NCT00855920|564366301|FG000|Overall Study|Other than specified above|1|||
156347239|NCT00855920|564366302|FG001|Overall Study|Other than specified above|1|||
156347240|NCT00855920|564366303|FG002|Overall Study|Other than specified above|1|||
156347241|NCT01587001|564366306|FG000|Overall Study|Lost to Follow-up|2|||
156347242|NCT01587001|564366307|FG001|Overall Study|Lost to Follow-up|0|||
156347243|NCT01587001|564366306|FG000|Overall Study|Insufficient samples to complete testing|4|||
156347244|NCT01587001|564366307|FG001|Overall Study|Insufficient samples to complete testing|1|||
156482212|NCT01766206|564857991|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
156482213|NCT01662505|564857992|FG000|Overall Study|Progressive disease|6|||
156482214|NCT01662505|564857993|FG001|Overall Study|Progressive disease|1|||
156482215|NCT01662505|564857994|FG002|Overall Study|Progressive disease|5|||
156347245|NCT00687323|564366308|FG000|Overall Study|Death|25|||
156347246|NCT00687323|564366308|FG000|Overall Study|Withdrawal by Subject|1|||
156347247|NCT00687323|564366308|FG000|Overall Study|Excluded from efficacy evaluations|6|||
156347248|NCT00687323|564366308|FG000|Overall Study|Screen failure|148|||
156347249|NCT02762266|564367706|FG000|Overall Study|Physician Decision|2|||
156347250|NCT02762266|564367707|FG001|Overall Study|Physician Decision|0|||
156347251|NCT02310568|564367710|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
156347252|NCT02310568|564367711|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
156347253|NCT02310568|564367712|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
156347254|NCT02310568|564367713|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
156347255|NCT02310568|564367714|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
156347256|NCT02310568|564367710|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
156347257|NCT02310568|564367711|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
156347258|NCT02310568|564367712|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
156347259|NCT02310568|564367713|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
156347260|NCT02310568|564367714|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
156347261|NCT02310568|564367710|FG000|Stage 1 ( 4 Weeks)|Other|1|||
156347262|NCT02310568|564367711|FG001|Stage 1 ( 4 Weeks)|Other|1|||
156347263|NCT02310568|564367712|FG002|Stage 1 ( 4 Weeks)|Other|0|||
156347264|NCT02310568|564367713|FG003|Stage 1 ( 4 Weeks)|Other|0|||
156347265|NCT02310568|564367714|FG004|Stage 1 ( 4 Weeks)|Other|0|||
156347266|NCT02310568|564367710|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
156347267|NCT02310568|564367711|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
156347268|NCT02310568|564367712|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
156347269|NCT02310568|564367713|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
156347270|NCT02310568|564367714|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
156347271|NCT02310568|564367710|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
156347272|NCT02310568|564367711|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
156347273|NCT02310568|564367712|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
156347274|NCT02310568|564367713|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
156347275|NCT02310568|564367714|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
156347276|NCT02310568|564367710|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
156347277|NCT02310568|564367711|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
156347278|NCT02310568|564367712|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
156347279|NCT02310568|564367713|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
156347280|NCT02310568|564367714|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
156347281|NCT02310568|564367710|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
156347282|NCT02310568|564367711|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
156347283|NCT02310568|564367712|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
156347284|NCT02310568|564367713|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
156347285|NCT02310568|564367714|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
156543899|NCT02819635|565086190|FG000|Substudy 3|Lost to Follow-up|0|||
156543900|NCT02819635|565086191|FG001|Substudy 3|Lost to Follow-up|0|||
156543901|NCT02819635|565086192|FG002|Substudy 3|Lost to Follow-up|0|||
156543902|NCT02819635|565086193|FG003|Substudy 3|Lost to Follow-up|0|||
156543903|NCT02819635|565086194|FG004|Substudy 3|Lost to Follow-up|0|||
156543904|NCT02819635|565086195|FG005|Substudy 3|Lost to Follow-up|0|||
156543905|NCT02819635|565086196|FG006|Substudy 3|Lost to Follow-up|0|||
156543906|NCT02819635|565086197|FG007|Substudy 3|Lost to Follow-up|0|||
156543907|NCT02819635|565086198|FG008|Substudy 3|Lost to Follow-up|1|||
156543908|NCT02819635|565086199|FG009|Substudy 3|Lost to Follow-up|0|||
156347286|NCT02310568|564367710|FG000|Stage 2 (4 Weeks)|Other|0|||
156347287|NCT02310568|564367711|FG001|Stage 2 (4 Weeks)|Other|1|||
156347288|NCT02310568|564367712|FG002|Stage 2 (4 Weeks)|Other|1|||
156347289|NCT02310568|564367713|FG003|Stage 2 (4 Weeks)|Other|0|||
156347290|NCT02310568|564367714|FG004|Stage 2 (4 Weeks)|Other|0|||
156347291|NCT02310568|564367710|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
156347292|NCT02310568|564367711|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
156347293|NCT02310568|564367712|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
156347294|NCT02310568|564367713|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
156347295|NCT02310568|564367714|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
156347296|NCT02310568|564367710|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
156543909|NCT02819635|565086200|FG010|Substudy 3|Lost to Follow-up|1|||
156347297|NCT02310568|564367711|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
156347298|NCT02310568|564367712|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
156347299|NCT02310568|564367713|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
156347300|NCT02310568|564367714|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
156347301|NCT02310568|564367710|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
156347302|NCT02310568|564367711|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
156347303|NCT02310568|564367712|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
156347304|NCT02310568|564367713|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
156347305|NCT02310568|564367714|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
156347306|NCT02989194|564367715|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
156543910|NCT02819635|565086201|FG011|Substudy 3|Lost to Follow-up|1|||
156543911|NCT02819635|565086190|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
156543912|NCT02819635|565086191|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
156543913|NCT02819635|565086192|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
156482216|NCT01662505|564857992|FG000|Overall Study|Refused cont. medication|0|||
156482217|NCT01662505|564857993|FG001|Overall Study|Refused cont. medication|0|||
156482218|NCT01662505|564857994|FG002|Overall Study|Refused cont. medication|1|||
156482219|NCT01662505|564857992|FG000|Overall Study|Not specified above|1|||
156482220|NCT01662505|564857993|FG001|Overall Study|Not specified above|3|||
156347307|NCT02989194|564367716|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
156347308|NCT02989194|564367717|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
156347309|NCT02989194|564367715|FG000|Overall Study|Lost to Follow-up|0|||
156347310|NCT02989194|564367716|FG001|Overall Study|Lost to Follow-up|1|||
156347311|NCT02989194|564367717|FG002|Overall Study|Lost to Follow-up|0|||
156347312|NCT02989194|564367715|FG000|Overall Study|Withdrawal by Subject|0|||
156347313|NCT02989194|564367716|FG001|Overall Study|Withdrawal by Subject|1|||
156347314|NCT02989194|564367717|FG002|Overall Study|Withdrawal by Subject|0|||
156347315|NCT00482612|564367718|FG000|In-treatment Period|No study medication administered|0|||
156347316|NCT00482612|564367719|FG001|In-treatment Period|No study medication administered|0|||
156347317|NCT00482612|564367720|FG002|In-treatment Period|No study medication administered|1|||
156347318|NCT00482612|564367721|FG003|In-treatment Period|No study medication administered|0|||
156347319|NCT00482612|564367718|FG000|Follow-up Period|Other|4|||
156347320|NCT00482612|564367719|FG001|Follow-up Period|Other|2|||
156347321|NCT00482612|564367720|FG002|Follow-up Period|Other|1|||
156347322|NCT00482612|564367721|FG003|Follow-up Period|Other|2|||
156347323|NCT00482612|564367718|FG000|Follow-up Period|Lack of compliance|0|||
156347324|NCT00482612|564367719|FG001|Follow-up Period|Lack of compliance|0|||
156347325|NCT00482612|564367720|FG002|Follow-up Period|Lack of compliance|1|||
156347326|NCT00482612|564367721|FG003|Follow-up Period|Lack of compliance|0|||
156347327|NCT00482612|564367718|FG000|Follow-up Period|Lost to Follow-up|0|||
156347328|NCT00482612|564367719|FG001|Follow-up Period|Lost to Follow-up|4|||
156347329|NCT00482612|564367720|FG002|Follow-up Period|Lost to Follow-up|2|||
156347330|NCT00482612|564367721|FG003|Follow-up Period|Lost to Follow-up|1|||
156347331|NCT00482612|564367718|FG000|Follow-up Period|Adverse Event|4|||
156347332|NCT00482612|564367719|FG001|Follow-up Period|Adverse Event|7|||
156347333|NCT00482612|564367720|FG002|Follow-up Period|Adverse Event|9|||
156347334|NCT00482612|564367721|FG003|Follow-up Period|Adverse Event|0|||
156347335|NCT00482612|564367718|FG000|Follow-up Period|Lack of Efficacy|2|||
156347336|NCT00482612|564367719|FG001|Follow-up Period|Lack of Efficacy|0|||
156347337|NCT00482612|564367720|FG002|Follow-up Period|Lack of Efficacy|1|||
156347338|NCT00482612|564367721|FG003|Follow-up Period|Lack of Efficacy|0|||
156347339|NCT00482612|564367718|FG000|Follow-up Period|Withdrawal by Subject|3|||
156347340|NCT00482612|564367719|FG001|Follow-up Period|Withdrawal by Subject|5|||
156347341|NCT00482612|564367720|FG002|Follow-up Period|Withdrawal by Subject|7|||
156347342|NCT00482612|564367721|FG003|Follow-up Period|Withdrawal by Subject|2|||
156347343|NCT00482612|564367718|FG000|Follow-up Period|Reasons not related to trial|1|||
156347344|NCT00482612|564367719|FG001|Follow-up Period|Reasons not related to trial|0|||
156347345|NCT00482612|564367720|FG002|Follow-up Period|Reasons not related to trial|1|||
156347346|NCT00482612|564367721|FG003|Follow-up Period|Reasons not related to trial|3|||
156347347|NCT03506815|564367722|FG000|Overall Study|Adverse Event|8|||
156347348|NCT03506815|564367723|FG001|Overall Study|Adverse Event|0|||
156347349|NCT03506815|564367722|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
156347350|NCT03506815|564367723|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
156347351|NCT03506815|564367722|FG000|Overall Study|Protocol Violation|1|||
156347352|NCT03506815|564367723|FG001|Overall Study|Protocol Violation|0|||
156347353|NCT03506815|564367722|FG000|Overall Study|Elective Surgery|1|||
156347354|NCT03506815|564367723|FG001|Overall Study|Elective Surgery|0|||
156347355|NCT04160091|564367724|FG000|Overall Study|Terminated by Sponsor|7|||
156347356|NCT04160091|564367725|FG001|Overall Study|Terminated by Sponsor|3|||
156347357|NCT04160091|564367726|FG002|Overall Study|Terminated by Sponsor|5|||
156347358|NCT04160091|564367727|FG003|Overall Study|Terminated by Sponsor|2|||
156347359|NCT04160091|564367724|FG000|Overall Study|Noncompliance|0|||
156347360|NCT04160091|564367725|FG001|Overall Study|Noncompliance|0|||
156347361|NCT04160091|564367726|FG002|Overall Study|Noncompliance|0|||
156347362|NCT04160091|564367727|FG003|Overall Study|Noncompliance|1|||
156347363|NCT04160091|564367724|FG000|Overall Study|Withdrawal by Subject|0|||
156347364|NCT04160091|564367725|FG001|Overall Study|Withdrawal by Subject|0|||
156347365|NCT04160091|564367726|FG002|Overall Study|Withdrawal by Subject|0|||
156347366|NCT04160091|564367727|FG003|Overall Study|Withdrawal by Subject|1|||
156347367|NCT02692716|564367728|FG000|Overall Study|Lost to Follow-up|2|||
156347368|NCT02692716|564367729|FG001|Overall Study|Lost to Follow-up|5|||
156347369|NCT02692716|564367728|FG000|Overall Study|Withdrawal by Subject|3|||
156347370|NCT02692716|564367729|FG001|Overall Study|Withdrawal by Subject|1|||
156347371|NCT03342690|564367743|FG000|Overall Study|Missing Information|9|||
156347372|NCT03342690|564367743|FG000|Overall Study|Protocol Violation|16|||
156347373|NCT02289690|564367744|FG000|Overall Study|Adverse Event Related to Progression|0|||
156347374|NCT02289690|564367745|FG001|Overall Study|Adverse Event Related to Progression|1|||
156347375|NCT02289690|564367746|FG002|Overall Study|Adverse Event Related to Progression|1|||
156347376|NCT02289690|564367747|FG003|Overall Study|Adverse Event Related to Progression|0|||
156347377|NCT02289690|564367748|FG004|Overall Study|Adverse Event Related to Progression|1|||
156347378|NCT02289690|564367749|FG005|Overall Study|Adverse Event Related to Progression|0|||
156347379|NCT02289690|564367750|FG006|Overall Study|Adverse Event Related to Progression|1|||
156347380|NCT02289690|564367751|FG007|Overall Study|Adverse Event Related to Progression|0|||
156347381|NCT02289690|564367752|FG008|Overall Study|Adverse Event Related to Progression|0|||
156347382|NCT02289690|564367753|FG009|Overall Study|Adverse Event Related to Progression|0|||
156543914|NCT02819635|565086193|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
156347383|NCT02289690|564367744|FG000|Overall Study|Withdrawal by Subject|1|||
156482221|NCT01662505|564857994|FG002|Overall Study|Not specified above|2|||
156347384|NCT02289690|564367745|FG001|Overall Study|Withdrawal by Subject|0|||
156347385|NCT02289690|564367746|FG002|Overall Study|Withdrawal by Subject|0|||
156347386|NCT02289690|564367747|FG003|Overall Study|Withdrawal by Subject|0|||
156347387|NCT02289690|564367748|FG004|Overall Study|Withdrawal by Subject|1|||
156347388|NCT02289690|564367749|FG005|Overall Study|Withdrawal by Subject|1|||
156347389|NCT02289690|564367750|FG006|Overall Study|Withdrawal by Subject|0|||
156347390|NCT02289690|564367751|FG007|Overall Study|Withdrawal by Subject|0|||
156347391|NCT02289690|564367752|FG008|Overall Study|Withdrawal by Subject|4|||
156347392|NCT02289690|564367753|FG009|Overall Study|Withdrawal by Subject|2|||
156347393|NCT02289690|564367744|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
156347394|NCT02289690|564367745|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
156347395|NCT02289690|564367746|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
156347396|NCT02289690|564367747|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
156347397|NCT02289690|564367748|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
156347398|NCT02289690|564367749|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
156347399|NCT02289690|564367750|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
156347400|NCT02289690|564367751|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
156347401|NCT02289690|564367752|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
156347402|NCT02289690|564367753|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
156347403|NCT02289690|564367744|FG000|Overall Study|Lost to Follow-up|0|||
156347404|NCT02289690|564367745|FG001|Overall Study|Lost to Follow-up|0|||
156347405|NCT02289690|564367746|FG002|Overall Study|Lost to Follow-up|0|||
156347406|NCT02289690|564367747|FG003|Overall Study|Lost to Follow-up|0|||
156347407|NCT02289690|564367748|FG004|Overall Study|Lost to Follow-up|0|||
156347408|NCT02289690|564367749|FG005|Overall Study|Lost to Follow-up|0|||
156347409|NCT02289690|564367750|FG006|Overall Study|Lost to Follow-up|0|||
156347410|NCT02289690|564367751|FG007|Overall Study|Lost to Follow-up|1|||
156347411|NCT02289690|564367752|FG008|Overall Study|Lost to Follow-up|0|||
156347412|NCT02289690|564367753|FG009|Overall Study|Lost to Follow-up|2|||
156347413|NCT02289690|564367744|FG000|Overall Study|Death|0|||
156347414|NCT02289690|564367745|FG001|Overall Study|Death|0|||
156347415|NCT02289690|564367746|FG002|Overall Study|Death|0|||
156347416|NCT02289690|564367747|FG003|Overall Study|Death|0|||
156347417|NCT02289690|564367748|FG004|Overall Study|Death|0|||
156347418|NCT02289690|564367749|FG005|Overall Study|Death|0|||
156347419|NCT02289690|564367750|FG006|Overall Study|Death|0|||
156347420|NCT02289690|564367751|FG007|Overall Study|Death|49|||
156347421|NCT02289690|564367752|FG008|Overall Study|Death|45|||
156347422|NCT02289690|564367753|FG009|Overall Study|Death|41|||
156347423|NCT02289690|564367744|FG000|Overall Study|Sponsor Discontinued Study|0|||
156347424|NCT02289690|564367745|FG001|Overall Study|Sponsor Discontinued Study|0|||
156347425|NCT02289690|564367746|FG002|Overall Study|Sponsor Discontinued Study|0|||
156347426|NCT02289690|564367747|FG003|Overall Study|Sponsor Discontinued Study|0|||
156347427|NCT02289690|564367748|FG004|Overall Study|Sponsor Discontinued Study|0|||
156347428|NCT02289690|564367749|FG005|Overall Study|Sponsor Discontinued Study|0|||
156347429|NCT02289690|564367750|FG006|Overall Study|Sponsor Discontinued Study|0|||
156347430|NCT02289690|564367751|FG007|Overall Study|Sponsor Discontinued Study|9|||
156347431|NCT02289690|564367752|FG008|Overall Study|Sponsor Discontinued Study|7|||
156347432|NCT02289690|564367753|FG009|Overall Study|Sponsor Discontinued Study|15|||
156347433|NCT02289690|564367744|FG000|Overall Study|Other|0|||
156347434|NCT02289690|564367745|FG001|Overall Study|Other|0|||
156347435|NCT02289690|564367746|FG002|Overall Study|Other|0|||
156347436|NCT02289690|564367747|FG003|Overall Study|Other|1|||
156347437|NCT02289690|564367748|FG004|Overall Study|Other|1|||
156347438|NCT02289690|564367749|FG005|Overall Study|Other|0|||
156347439|NCT02289690|564367750|FG006|Overall Study|Other|1|||
156347440|NCT02289690|564367751|FG007|Overall Study|Other|2|||
156347441|NCT02289690|564367752|FG008|Overall Study|Other|3|||
156347442|NCT02289690|564367753|FG009|Overall Study|Other|1|||
156347443|NCT02085785|564367756|FG000|Overall Study|Withdrawal by Subject|2|||
156347444|NCT02085785|564367757|FG001|Overall Study|Withdrawal by Subject|1|||
156347445|NCT02085785|564367756|FG000|Overall Study|Lost to Follow-up|0|||
156347446|NCT02085785|564367757|FG001|Overall Study|Lost to Follow-up|1|||
156347447|NCT02547649|564367760|FG000|Overall Study|Lost to Follow-up|3|||
156347448|NCT02547649|564367761|FG001|Overall Study|Lost to Follow-up|1|||
156347449|NCT02547649|564367762|FG002|Overall Study|Lost to Follow-up|1|||
156347450|NCT02547649|564367760|FG000|Overall Study|Not vaccinated|0|||
156347451|NCT02547649|564367761|FG001|Overall Study|Not vaccinated|0|||
156347452|NCT02547649|564367762|FG002|Overall Study|Not vaccinated|1|||
156347453|NCT02547649|564367760|FG000|Overall Study|Withdrawal by Subject|0|||
156347454|NCT02547649|564367761|FG001|Overall Study|Withdrawal by Subject|4|||
156347455|NCT02547649|564367762|FG002|Overall Study|Withdrawal by Subject|2|||
156347456|NCT03454997|564367763|FG000|Overall Study|Staff Coach - Left Oranization|1|||
156347457|NCT03454997|564367764|FG001|Overall Study|Staff Coach - Left Oranization|1|||
156347458|NCT03454997|564367763|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
156347459|NCT03454997|564367764|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
156347460|NCT03454997|564367763|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
156347461|NCT03454997|564367764|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
156347462|NCT03454997|564367763|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
156347463|NCT03454997|564367764|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
156347464|NCT03454997|564367763|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
156347465|NCT03454997|564367764|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
156347466|NCT03454997|564367763|FG000|Overall Study|Client with SMI - Left organization|0|||
156347467|NCT03454997|564367764|FG001|Overall Study|Client with SMI - Left organization|1|||
156347468|NCT03454997|564367763|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
156347469|NCT03454997|564367764|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
156347470|NCT00006903|564367769|FG000|Overall Study|Still receiving treatment|0|||
156347471|NCT00006903|564367770|FG001|Overall Study|Still receiving treatment|0|||
156347472|NCT00006903|564367771|FG002|Overall Study|Still receiving treatment|1|||
156347473|NCT00006903|564367769|FG000|Overall Study|Refused further treatment|0|||
156347474|NCT00006903|564367770|FG001|Overall Study|Refused further treatment|2|||
156347475|NCT00006903|564367771|FG002|Overall Study|Refused further treatment|1|||
156347476|NCT00006903|564367769|FG000|Overall Study|Adverse Event|0|||
156347477|NCT00006903|564367770|FG001|Overall Study|Adverse Event|0|||
156347478|NCT00006903|564367771|FG002|Overall Study|Adverse Event|1|||
156347479|NCT00006903|564367769|FG000|Overall Study|Death|0|||
156347480|NCT00006903|564367770|FG001|Overall Study|Death|1|||
156347481|NCT00006903|564367771|FG002|Overall Study|Death|0|||
156347482|NCT00006903|564367769|FG000|Overall Study|Patient never treated|0|||
156347483|NCT00006903|564367770|FG001|Overall Study|Patient never treated|0|||
156347484|NCT00006903|564367771|FG002|Overall Study|Patient never treated|1|||
156347485|NCT00006903|564367769|FG000|Overall Study|Ineligible|10|||
156347486|NCT00006903|564367770|FG001|Overall Study|Ineligible|1|||
156347487|NCT00006903|564367771|FG002|Overall Study|Ineligible|2|||
156347488|NCT01906008|564367776|FG000|Overall Study|Lost to Follow-up|2|||
156347489|NCT01906008|564367777|FG001|Overall Study|Lost to Follow-up|0|||
156347490|NCT01906008|564367776|FG000|Overall Study|Oxaliplatin toxicity|2|||
156347491|NCT01906008|564367777|FG001|Overall Study|Oxaliplatin toxicity|0|||
156347492|NCT01906008|564367776|FG000|Overall Study|Protocol Violation|0|||
156347493|NCT01906008|564367777|FG001|Overall Study|Protocol Violation|1|||
156347494|NCT01906008|564367776|FG000|Overall Study|Withdrawal by Subject|1|||
156347495|NCT01906008|564367777|FG001|Overall Study|Withdrawal by Subject|5|||
156347496|NCT01906008|564367776|FG000|Overall Study|Did not start study med|3|||
156347497|NCT01906008|564367777|FG001|Overall Study|Did not start study med|4|||
156347498|NCT01906008|564367776|FG000|Overall Study|Oxaliplatin stops|10|||
156347499|NCT01906008|564367777|FG001|Overall Study|Oxaliplatin stops|8|||
156347500|NCT01906008|564367776|FG000|Overall Study|Hospice|1|||
156347501|NCT01906008|564367777|FG001|Overall Study|Hospice|0|||
156347502|NCT01906008|564367776|FG000|Overall Study|Physician Decision|3|||
156347503|NCT01906008|564367777|FG001|Overall Study|Physician Decision|3|||
156347504|NCT01906008|564367776|FG000|Overall Study|Lack of compliance of study med|5|||
156347505|NCT01906008|564367777|FG001|Overall Study|Lack of compliance of study med|3|||
156347506|NCT01906008|564367776|FG000|Overall Study|Adverse Event|0|||
156347507|NCT01906008|564367777|FG001|Overall Study|Adverse Event|3|||
156347508|NCT02117648|564367778|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
156347509|NCT02117648|564367778|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
156347510|NCT02117648|564367778|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
156347511|NCT02117648|564367778|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
156347512|NCT02117648|564367778|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
156347513|NCT02117648|564367778|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
156347514|NCT02117648|564367778|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
156347515|NCT02117648|564367778|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
156347516|NCT02117648|564367778|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
156347517|NCT02117648|564367778|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
156347518|NCT02117648|564367778|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
156347519|NCT01465997|564367779|FG000|Overall Study|Adverse Event|12|||
156347520|NCT01465997|564367780|FG001|Overall Study|Adverse Event|22|||
156347521|NCT01465997|564367779|FG000|Overall Study|Lack of Efficacy|13|||
156347522|NCT01465997|564367780|FG001|Overall Study|Lack of Efficacy|1|||
156347523|NCT01465997|564367779|FG000|Overall Study|Protocol Violation|1|||
156347524|NCT01465997|564367780|FG001|Overall Study|Protocol Violation|4|||
156543915|NCT02819635|565086194|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
156347525|NCT01465997|564367779|FG000|Overall Study|Lost to Follow-up|6|||
156347526|NCT01465997|564367780|FG001|Overall Study|Lost to Follow-up|9|||
156347527|NCT01465997|564367779|FG000|Overall Study|Withdrawal by Subject|32|||
156347528|NCT01465997|564367780|FG001|Overall Study|Withdrawal by Subject|35|||
156347529|NCT01465997|564367779|FG000|Overall Study|investigator's decision|1|||
156347530|NCT01465997|564367780|FG001|Overall Study|investigator's decision|1|||
156347531|NCT01465997|564367779|FG000|Overall Study|Death|0|||
156347532|NCT01465997|564367780|FG001|Overall Study|Death|1|||
156347533|NCT01465997|564367779|FG000|Overall Study|sponsor's decision|1|||
156347534|NCT01465997|564367780|FG001|Overall Study|sponsor's decision|1|||
156347535|NCT01465997|564367779|FG000|Overall Study|subject withdrew consent|1|||
156347536|NCT01465997|564367780|FG001|Overall Study|subject withdrew consent|0|||
156347537|NCT01465997|564367779|FG000|Overall Study|local lab unblinded site|1|||
156347538|NCT01465997|564367780|FG001|Overall Study|local lab unblinded site|0|||
156347539|NCT01465997|564367779|FG000|Overall Study|withdrew before follow-up|0|||
156347540|NCT01465997|564367780|FG001|Overall Study|withdrew before follow-up|13|||
156347541|NCT01465997|564367779|FG000|Overall Study|decision by site staff|0|||
156347542|NCT01465997|564367780|FG001|Overall Study|decision by site staff|1|||
156347543|NCT01465997|564367779|FG000|Overall Study|subject left participation SP0993|0|||
156347544|NCT01465997|564367780|FG001|Overall Study|subject left participation SP0993|1|||
156347545|NCT06149247|564367785|FG000|Overall Study|Adverse Event|0|||
156347546|NCT06149247|564367786|FG001|Overall Study|Adverse Event|1|||
156347547|NCT01666782|564367794|FG000|Overall Study|Received 2 doses of vaccine|0|||
156347548|NCT01666782|564367795|FG001|Overall Study|Received 2 doses of vaccine|1|||
156347549|NCT01666782|564367794|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
156347550|NCT01666782|564367795|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
156347551|NCT04786990|564367796|FG000|Overall Study|Withdrawal by Subject|1|||
156347552|NCT04786990|564367796|FG000|Overall Study|Adverse Event|1|||
156347553|NCT04786990|564367796|FG000|Overall Study|Lost to Follow-up|1|||
156347554|NCT04786990|564367796|FG000|Overall Study|Noncompliance|1|||
156347555|NCT04786990|564367796|FG000|Overall Study|Unable to complete site visits|1|||
156347556|NCT04786990|564367796|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
156347557|NCT02007109|564367797|FG000|Overall Study|Diary not returned or excluded|102|||
156347558|NCT02007109|564367797|FG000|Overall Study|Excluded - Age<7yo|9|||
156347559|NCT02132130|564367804|FG000|Overall Study|Lost to Follow-up|0|||
156347560|NCT02132130|564367805|FG001|Overall Study|Lost to Follow-up|2|||
156347561|NCT02132130|564367806|FG002|Overall Study|Lost to Follow-up|0|||
156347562|NCT02132130|564367807|FG003|Overall Study|Lost to Follow-up|0|||
156347563|NCT02132130|564367804|FG000|Overall Study|Withdrawal by Subject|0|||
156347564|NCT02132130|564367805|FG001|Overall Study|Withdrawal by Subject|0|||
156347565|NCT02132130|564367806|FG002|Overall Study|Withdrawal by Subject|0|||
156347566|NCT02132130|564367807|FG003|Overall Study|Withdrawal by Subject|1|||
156347567|NCT02760069|564367808|FG000|Overall Study|Withdrawal by Subject|0|||
156347568|NCT02760069|564367809|FG001|Overall Study|Withdrawal by Subject|1|||
156347569|NCT02760069|564367810|FG002|Overall Study|Withdrawal by Subject|1|||
156347570|NCT03031678|564367813|FG000|Overall Study|Study closed prior to completion|1|||
156347571|NCT00439244|564367814|FG000|Overall Study|Adverse Event|5|||
156347572|NCT00439244|564367815|FG001|Overall Study|Adverse Event|2|||
156347573|NCT00439244|564367816|FG002|Overall Study|Adverse Event|3|||
156347574|NCT00439244|564367814|FG000|Overall Study|Withdrawal by Subject|3|||
156347575|NCT00439244|564367815|FG001|Overall Study|Withdrawal by Subject|1|||
156347576|NCT00439244|564367816|FG002|Overall Study|Withdrawal by Subject|2|||
156347577|NCT00439244|564367814|FG000|Overall Study|Lost to Follow-up|2|||
156347578|NCT00439244|564367815|FG001|Overall Study|Lost to Follow-up|1|||
156347579|NCT00439244|564367816|FG002|Overall Study|Lost to Follow-up|2|||
156347580|NCT00439244|564367814|FG000|Overall Study|Death|0|||
156347581|NCT00439244|564367815|FG001|Overall Study|Death|1|||
156543916|NCT02819635|565086195|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
156543917|NCT02819635|565086196|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
156543918|NCT02819635|565086197|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
156543919|NCT02819635|565086198|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
156347582|NCT00439244|564367816|FG002|Overall Study|Death|0|||
156347583|NCT00439244|564367814|FG000|Overall Study|Protocol Violation|0|||
156347584|NCT00439244|564367815|FG001|Overall Study|Protocol Violation|1|||
156347585|NCT00439244|564367816|FG002|Overall Study|Protocol Violation|0|||
156347586|NCT00439244|564367814|FG000|Overall Study|Administrative problems|1|||
156347587|NCT00439244|564367815|FG001|Overall Study|Administrative problems|0|||
156347588|NCT00439244|564367816|FG002|Overall Study|Administrative problems|0|||
156347589|NCT04557371|564367819|FG000|Overall Study|Covid-19-related|0|||
156347590|NCT04557371|564367820|FG001|Overall Study|Covid-19-related|1|||
156347591|NCT04557371|564367821|FG002|Overall Study|Covid-19-related|0|||
156347592|NCT04557371|564367819|FG000|Overall Study|Withdrawal by Subject|0|||
156347593|NCT04557371|564367820|FG001|Overall Study|Withdrawal by Subject|1|||
156347594|NCT04557371|564367821|FG002|Overall Study|Withdrawal by Subject|0|||
156347595|NCT04557371|564367819|FG000|Overall Study|Adverse Event|1|||
156347596|NCT04557371|564367820|FG001|Overall Study|Adverse Event|0|||
156347597|NCT04557371|564367821|FG002|Overall Study|Adverse Event|0|||
156347598|NCT01482884|564367824|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
156347599|NCT01482884|564367825|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
156347600|NCT01482884|564367824|FG000|Overall Study|Protocol Violation|1|||
156347601|NCT01482884|564367825|FG001|Overall Study|Protocol Violation|0|||
156347602|NCT01482884|564367824|FG000|Overall Study|Lost to Follow-up|2|||
156347603|NCT01482884|564367825|FG001|Overall Study|Lost to Follow-up|2|||
156347604|NCT01482884|564367824|FG000|Overall Study|Lack of Efficacy|0|||
156347605|NCT01482884|564367825|FG001|Overall Study|Lack of Efficacy|1|||
156347606|NCT01482884|564367824|FG000|Overall Study|Adverse Event|2|||
156347607|NCT01482884|564367825|FG001|Overall Study|Adverse Event|1|||
156347608|NCT01482884|564367824|FG000|Overall Study|Withdrawal by Subject|8|||
156347609|NCT01482884|564367825|FG001|Overall Study|Withdrawal by Subject|13|||
156347610|NCT05353985|564367832|FG000|Overall Study|Adverse Event|5|||
156347611|NCT05353985|564367833|FG001|Overall Study|Adverse Event|7|||
156347612|NCT05353985|564367832|FG000|Overall Study|Lost to Follow-up|1|||
156347613|NCT05353985|564367833|FG001|Overall Study|Lost to Follow-up|1|||
156347614|NCT05353985|564367832|FG000|Overall Study|Protocol Violation|1|||
156347615|NCT05353985|564367833|FG001|Overall Study|Protocol Violation|0|||
156347616|NCT05353985|564367832|FG000|Overall Study|Withdrawal by Subject|13|||
156347617|NCT05353985|564367833|FG001|Overall Study|Withdrawal by Subject|17|||
156347618|NCT05353985|564367832|FG000|Overall Study|Reason Not Specified|1|||
156347619|NCT05353985|564367833|FG001|Overall Study|Reason Not Specified|0|||
156347620|NCT05353985|564367832|FG000|Overall Study|Randomized in Error & Not Treated|0|||
156347621|NCT05353985|564367833|FG001|Overall Study|Randomized in Error & Not Treated|1|||
156347622|NCT04419714|564367834|FG000|Overall Study|Technical Fault|5|||
156347623|NCT04419714|564367834|FG000|Overall Study|Protocol Deviation|2|||
156347624|NCT04419714|564367834|FG000|Overall Study|Withdrawal by Subject|1|||
156347625|NCT03909295|564370033|FG000|Overall Study|Adverse Event|2|||
156347626|NCT03909295|564370033|FG000|Overall Study|Study terminated by sponsor|50|||
156347627|NCT00848081|564370037|FG000|Overall Study|Adverse Event|6|||
156347628|NCT00848081|564370038|FG001|Overall Study|Adverse Event|7|||
156347629|NCT00848081|564370037|FG000|Overall Study|Protocol Violation|8|||
156347630|NCT00848081|564370038|FG001|Overall Study|Protocol Violation|5|||
156347631|NCT00848081|564370037|FG000|Overall Study|Lost to Follow-up|1|||
156347632|NCT00848081|564370038|FG001|Overall Study|Lost to Follow-up|0|||
156347633|NCT00848081|564370037|FG000|Overall Study|Physician Decision|0|||
156347634|NCT00848081|564370038|FG001|Overall Study|Physician Decision|3|||
156347635|NCT00848081|564370037|FG000|Overall Study|Withdrawal by Subject|5|||
156347636|NCT00848081|564370038|FG001|Overall Study|Withdrawal by Subject|3|||
156482222|NCT01313663|564857995|FG000|Overall Study|Study Closed/Terminated|2|||
156482223|NCT01313663|564857996|FG001|Overall Study|Study Closed/Terminated|4|||
156482224|NCT01313663|564857995|FG000|Overall Study|Lost to Follow-up|0|||
156482225|NCT01313663|564857996|FG001|Overall Study|Lost to Follow-up|1|||
156482226|NCT01313663|564857995|FG000|Overall Study|Physician Decision|0|||
156482227|NCT01313663|564857996|FG001|Overall Study|Physician Decision|2|||
156482228|NCT01313663|564857995|FG000|Overall Study|Withdrawal by Subject|2|||
156482229|NCT01313663|564857996|FG001|Overall Study|Withdrawal by Subject|1|||
156482230|NCT01661972|564857997|FG000|Overall Study|Adverse Event|1|||
156482231|NCT01661972|564857998|FG001|Overall Study|Adverse Event|2|||
156482232|NCT01661972|564857997|FG000|Overall Study|Death during Treatment period|1|||
156482233|NCT01661972|564857998|FG001|Overall Study|Death during Treatment period|1|||
156482234|NCT01661972|564857997|FG000|Overall Study|Withdrawal by Subject|0|||
156482235|NCT01661972|564857998|FG001|Overall Study|Withdrawal by Subject|1|||
156482236|NCT02138838|564858004|FG000|Overall Study|Study Closure|7|||
156482237|NCT02138838|564858005|FG001|Overall Study|Study Closure|6|||
156482238|NCT02138838|564858004|FG000|Overall Study|Withdrawal by Subject|1|||
156347637|NCT02064868|564370045|FG000|Overall Study|Lost to Follow-up|14|||
156482239|NCT02138838|564858005|FG001|Overall Study|Withdrawal by Subject|5|||
156482240|NCT01294644|564858007|FG000|Overall Study|Adverse Event|2|||
156482241|NCT01294644|564858008|FG001|Overall Study|Adverse Event|0|||
156482242|NCT01294644|564858009|FG002|Overall Study|Adverse Event|1|||
156482243|NCT01294644|564858007|FG000|Overall Study|Withdrawal by Subject|3|||
156347638|NCT02064868|564370046|FG001|Overall Study|Lost to Follow-up|8|||
156347639|NCT02064868|564370045|FG000|Overall Study|Physician Decision|1|||
156347640|NCT02064868|564370046|FG001|Overall Study|Physician Decision|0|||
156347641|NCT02064868|564370045|FG000|Overall Study|Withdrawal by Subject|14|||
156347642|NCT02064868|564370046|FG001|Overall Study|Withdrawal by Subject|3|||
156347643|NCT02064868|564370045|FG000|Overall Study|Technical Problems or Missing|5|||
156347644|NCT02064868|564370046|FG001|Overall Study|Technical Problems or Missing|2|||
156347645|NCT01224431|564370051|FG000|Overall Study|not randomized|0|||
156347646|NCT01224431|564370052|FG001|Overall Study|not randomized|4|||
156347647|NCT01224431|564370051|FG000|Overall Study|no video record|0|||
156347648|NCT01224431|564370052|FG001|Overall Study|no video record|1|||
156347649|NCT02057406|564370053|FG000|Overall Study|Physician Decision|0|||
156347650|NCT02057406|564370054|FG001|Overall Study|Physician Decision|0|||
156347651|NCT02057406|564370055|FG002|Overall Study|Physician Decision|2|||
156347652|NCT02057406|564370053|FG000|Overall Study|Withdrawal by Subject|0|||
156347653|NCT02057406|564370054|FG001|Overall Study|Withdrawal by Subject|2|||
156347654|NCT02057406|564370055|FG002|Overall Study|Withdrawal by Subject|0|||
156347655|NCT02057406|564370053|FG000|Overall Study|Lost to Follow-up|0|||
156347656|NCT02057406|564370054|FG001|Overall Study|Lost to Follow-up|0|||
156347657|NCT02057406|564370055|FG002|Overall Study|Lost to Follow-up|1|||
156347658|NCT02057406|564370053|FG000|Overall Study|Death|1|||
156347659|NCT02057406|564370054|FG001|Overall Study|Death|0|||
156347660|NCT02057406|564370055|FG002|Overall Study|Death|0|||
156347661|NCT02057406|564370053|FG000|Overall Study|Protocol Violation|0|||
156347662|NCT02057406|564370054|FG001|Overall Study|Protocol Violation|1|||
156347663|NCT02057406|564370055|FG002|Overall Study|Protocol Violation|0|||
156347664|NCT02057406|564370053|FG000|Overall Study|Patient transportation issues|0|||
156347665|NCT02057406|564370054|FG001|Overall Study|Patient transportation issues|0|||
156347666|NCT02057406|564370055|FG002|Overall Study|Patient transportation issues|1|||
156347667|NCT03562481|564370056|FG000|First Intervention|Lost to Follow-up|1|||
156347668|NCT03562481|564370057|FG001|First Intervention|Lost to Follow-up|0|||
156347669|NCT03654651|564370059|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
156347670|NCT03654651|564370060|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
156347671|NCT01401283|564370061|FG000|Overall Study|surgery cancelled|5|||
156347672|NCT01401283|564370062|FG001|Overall Study|surgery cancelled|8|||
156347673|NCT01401283|564370061|FG000|Overall Study|preoperative arrhythmia|5|||
156347674|NCT01401283|564370062|FG001|Overall Study|preoperative arrhythmia|0|||
156347675|NCT01401283|564370061|FG000|Overall Study|no central venous access|0|||
156347676|NCT01401283|564370062|FG001|Overall Study|no central venous access|1|||
156347677|NCT01401283|564370061|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
156347678|NCT01401283|564370062|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
156347679|NCT02433483|564370063|FG000|Overall Study|Unacceptable toxicity|1|||
156347680|NCT02433483|564370063|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
156347681|NCT03824912|564370064|FG000|Overall Study|Lost to Follow-up|18|||
156347682|NCT03824912|564370065|FG001|Overall Study|Lost to Follow-up|15|||
156347683|NCT03824912|564370066|FG002|Overall Study|Lost to Follow-up|8|||
156347684|NCT03824912|564370064|FG000|Overall Study|Negative Baseline Culture Result|118|||
156347685|NCT03824912|564370065|FG001|Overall Study|Negative Baseline Culture Result|112|||
156347686|NCT03824912|564370066|FG002|Overall Study|Negative Baseline Culture Result|57|||
156347687|NCT03824912|564370064|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156347688|NCT03824912|564370065|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156347689|NCT03824912|564370066|FG002|Overall Study|Non-Compliance with Study Drug|1|||
156347690|NCT03824912|564370064|FG000|Overall Study|Protocol Violation|1|||
156347691|NCT03824912|564370065|FG001|Overall Study|Protocol Violation|4|||
156347692|NCT03824912|564370066|FG002|Overall Study|Protocol Violation|1|||
156347693|NCT03824912|564370064|FG000|Overall Study|Withdrawal by Subject|3|||
156347694|NCT03824912|564370065|FG001|Overall Study|Withdrawal by Subject|2|||
156347695|NCT03824912|564370066|FG002|Overall Study|Withdrawal by Subject|1|||
156347696|NCT03824912|564370064|FG000|Overall Study|Participation in another study|0|||
156347697|NCT03824912|564370065|FG001|Overall Study|Participation in another study|1|||
156347698|NCT03824912|564370066|FG002|Overall Study|Participation in another study|0|||
156347699|NCT00549302|564370074|FG000|Double-Blind|Death|2|||
156347700|NCT00549302|564370075|FG001|Double-Blind|Death|9|||
156347701|NCT00549302|564370076|FG002|Double-Blind|Death|0|||
156347702|NCT00549302|564370074|FG000|Double-Blind|Adverse Event|3|||
156347703|NCT00549302|564370075|FG001|Double-Blind|Adverse Event|16|||
156347704|NCT00549302|564370076|FG002|Double-Blind|Adverse Event|0|||
156347705|NCT00549302|564370074|FG000|Double-Blind|Withdrawal by Subject|3|||
156347706|NCT00549302|564370075|FG001|Double-Blind|Withdrawal by Subject|8|||
156347707|NCT00549302|564370076|FG002|Double-Blind|Withdrawal by Subject|0|||
156347708|NCT00549302|564370074|FG000|Double-Blind|Investigator Decision|1|||
156347709|NCT00549302|564370075|FG001|Double-Blind|Investigator Decision|5|||
156347710|NCT00549302|564370076|FG002|Double-Blind|Investigator Decision|0|||
156482244|NCT01294644|564858008|FG001|Overall Study|Withdrawal by Subject|7|||
156482245|NCT01294644|564858009|FG002|Overall Study|Withdrawal by Subject|4|||
156482246|NCT01294644|564858007|FG000|Overall Study|Lost to Follow-up|3|||
156482247|NCT01294644|564858008|FG001|Overall Study|Lost to Follow-up|2|||
156347711|NCT00549302|564370074|FG000|Double-Blind|Sponsor Decision|0|||
156347712|NCT00549302|564370075|FG001|Double-Blind|Sponsor Decision|1|||
156347713|NCT00549302|564370076|FG002|Double-Blind|Sponsor Decision|0|||
156347714|NCT00549302|564370074|FG000|Double-Blind|Lost to Follow-up|1|||
156482248|NCT01294644|564858009|FG002|Overall Study|Lost to Follow-up|5|||
156347715|NCT00549302|564370075|FG001|Double-Blind|Lost to Follow-up|2|||
156347716|NCT00549302|564370076|FG002|Double-Blind|Lost to Follow-up|0|||
156347717|NCT00549302|564370074|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
156347718|NCT00549302|564370075|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
156347719|NCT00549302|564370076|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
156347720|NCT00549302|564370074|FG000|Double-Blind|New condition or starts new therapy|0|||
156482249|NCT01294644|564858007|FG000|Overall Study|Miscellaneous Reason|2|||
156347721|NCT00549302|564370075|FG001|Double-Blind|New condition or starts new therapy|2|||
156347722|NCT00549302|564370076|FG002|Double-Blind|New condition or starts new therapy|0|||
156347723|NCT00549302|564370074|FG000|Open-Label|Adverse Event|0|||
156482250|NCT01294644|564858008|FG001|Overall Study|Miscellaneous Reason|1|||
156482251|NCT01294644|564858009|FG002|Overall Study|Miscellaneous Reason|4|||
156482252|NCT02367794|564858010|FG000|Overall Study|Death|252|||
156347724|NCT00549302|564370075|FG001|Open-Label|Adverse Event|0|||
156482253|NCT02367794|564858011|FG001|Overall Study|Death|245|||
156482254|NCT02367794|564858012|FG002|Overall Study|Death|243|||
156347725|NCT00549302|564370076|FG002|Open-Label|Adverse Event|11|||
156347726|NCT00549302|564370074|FG000|Open-Label|Death|0|||
156347727|NCT00549302|564370075|FG001|Open-Label|Death|0|||
156347728|NCT00549302|564370076|FG002|Open-Label|Death|40|||
156347729|NCT00549302|564370074|FG000|Open-Label|Investigator Decision|0|||
156347730|NCT00549302|564370075|FG001|Open-Label|Investigator Decision|0|||
156347731|NCT00549302|564370076|FG002|Open-Label|Investigator Decision|5|||
156347732|NCT00549302|564370074|FG000|Open-Label|Lost to Follow-up|0|||
156347733|NCT00549302|564370075|FG001|Open-Label|Lost to Follow-up|0|||
156347734|NCT00549302|564370076|FG002|Open-Label|Lost to Follow-up|2|||
156347735|NCT00549302|564370074|FG000|Open-Label|Other|0|||
156347736|NCT00549302|564370075|FG001|Open-Label|Other|0|||
156347737|NCT00549302|564370076|FG002|Open-Label|Other|3|||
156347738|NCT00549302|564370074|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
156347739|NCT00549302|564370075|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
156347740|NCT00549302|564370076|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
156347741|NCT00549302|564370074|FG000|Open-Label|Withdrawal by Subject|0|||
156347742|NCT00549302|564370075|FG001|Open-Label|Withdrawal by Subject|0|||
156347743|NCT00549302|564370076|FG002|Open-Label|Withdrawal by Subject|6|||
156347744|NCT01414114|564370077|FG000|Overall Study|Adverse Event|2|||
156347745|NCT01414114|564370077|FG000|Overall Study|Withdrawal by Subject|1|||
156347746|NCT01414114|564370077|FG000|Overall Study|Other|2|||
156347747|NCT05620563|564370082|FG000|Overall Study|Adverse Event|3|||
156347748|NCT05620563|564370083|FG001|Overall Study|Adverse Event|1|||
156482255|NCT02367794|564858010|FG000|Overall Study|Lost to Follow-up|1|||
156482256|NCT02367794|564858011|FG001|Overall Study|Lost to Follow-up|2|||
156347749|NCT05620563|564370082|FG000|Overall Study|Lost to Follow-up|0|||
156347750|NCT05620563|564370083|FG001|Overall Study|Lost to Follow-up|2|||
156347751|NCT05620563|564370082|FG000|Overall Study|Protocol Deviation|1|||
156347752|NCT05620563|564370083|FG001|Overall Study|Protocol Deviation|2|||
156347753|NCT05620563|564370082|FG000|Overall Study|Withdrawal by Subject|3|||
156482257|NCT02367794|564858012|FG002|Overall Study|Lost to Follow-up|2|||
156347754|NCT05620563|564370083|FG001|Overall Study|Withdrawal by Subject|3|||
156347755|NCT05620563|564370082|FG000|Overall Study|Physician Decision|0|||
156347756|NCT05620563|564370083|FG001|Overall Study|Physician Decision|1|||
156347757|NCT00779467|564370089|FG000|Overall Study|Lack of Efficacy|11|||
156347758|NCT00779467|564370090|FG001|Overall Study|Lack of Efficacy|2|||
156347759|NCT00779467|564370091|FG002|Overall Study|Lack of Efficacy|6|||
156347760|NCT00779467|564370092|FG003|Overall Study|Lack of Efficacy|11|||
156347761|NCT00779467|564370089|FG000|Overall Study|failed inclusion criteria|3|||
156347762|NCT00779467|564370090|FG001|Overall Study|failed inclusion criteria|3|||
156347763|NCT00779467|564370091|FG002|Overall Study|failed inclusion criteria|1|||
156347764|NCT00779467|564370092|FG003|Overall Study|failed inclusion criteria|2|||
156347765|NCT00779467|564370089|FG000|Overall Study|missing data|1|||
156347766|NCT00779467|564370090|FG001|Overall Study|missing data|0|||
156347767|NCT00779467|564370091|FG002|Overall Study|missing data|1|||
156347768|NCT00779467|564370092|FG003|Overall Study|missing data|4|||
156347769|NCT00779467|564370089|FG000|Overall Study|technical issue|0|||
156347770|NCT00779467|564370090|FG001|Overall Study|technical issue|0|||
156347771|NCT00779467|564370091|FG002|Overall Study|technical issue|2|||
156347772|NCT00779467|564370092|FG003|Overall Study|technical issue|1|||
156347773|NCT00779467|564370089|FG000|Overall Study|unavailable research staff|0|||
156347774|NCT00779467|564370090|FG001|Overall Study|unavailable research staff|0|||
156347775|NCT00779467|564370091|FG002|Overall Study|unavailable research staff|0|||
156347776|NCT00779467|564370092|FG003|Overall Study|unavailable research staff|1|||
156347777|NCT02692703|564370093|FG000|Overall Study|Lost to Follow-up|1|||
156347778|NCT02692703|564370093|FG000|Overall Study|Other|1|||
156347779|NCT00644995|564370094|FG000|Overall Study|Lost to Follow-up|1|||
156347780|NCT00644995|564370095|FG001|Overall Study|Lost to Follow-up|4|||
156347781|NCT00644995|564370094|FG000|Overall Study|Refused|1|||
156347782|NCT00644995|564370095|FG001|Overall Study|Refused|0|||
156347783|NCT00865124|564370102|FG000|Overall Study|Physician Decision|2|||
156347784|NCT00865124|564370103|FG001|Overall Study|Physician Decision|1|||
156347785|NCT00865124|564370104|FG002|Overall Study|Physician Decision|0|||
156347786|NCT00865124|564370102|FG000|Overall Study|Withdrawn consent|2|||
156347787|NCT00865124|564370103|FG001|Overall Study|Withdrawn consent|0|||
156347788|NCT00865124|564370104|FG002|Overall Study|Withdrawn consent|0|||
156347789|NCT02573350|564370105|FG000|Overall Study|Lost to Follow-up|2|||
156543920|NCT02819635|565086199|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
156543921|NCT02819635|565086200|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
156543922|NCT02819635|565086201|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
156543923|NCT02819635|565086190|FG000|Substudy 3|Other, not specified|0|||
156543924|NCT02819635|565086191|FG001|Substudy 3|Other, not specified|0|||
156543925|NCT02819635|565086192|FG002|Substudy 3|Other, not specified|0|||
156543926|NCT02819635|565086193|FG003|Substudy 3|Other, not specified|0|||
156543927|NCT02819635|565086194|FG004|Substudy 3|Other, not specified|0|||
156543928|NCT02819635|565086195|FG005|Substudy 3|Other, not specified|0|||
156543929|NCT02819635|565086196|FG006|Substudy 3|Other, not specified|0|||
156543930|NCT02819635|565086197|FG007|Substudy 3|Other, not specified|0|||
156543931|NCT02819635|565086198|FG008|Substudy 3|Other, not specified|202|||
156543932|NCT02819635|565086199|FG009|Substudy 3|Other, not specified|5|||
156347790|NCT02573350|564370106|FG001|Overall Study|Lost to Follow-up|1|||
156347791|NCT02573350|564370105|FG000|Overall Study|Adverse Event|3|||
156347792|NCT02573350|564370106|FG001|Overall Study|Adverse Event|4|||
156543933|NCT02819635|565086200|FG010|Substudy 3|Other, not specified|89|||
156543934|NCT02819635|565086201|FG011|Substudy 3|Other, not specified|39|||
156543935|NCT01476475|565086202|FG000|Overall Study|Adverse Event|6|||
156543936|NCT01476475|565086203|FG001|Overall Study|Adverse Event|0|||
156543937|NCT01476475|565086202|FG000|Overall Study|Poor compliance to protocol|1|||
156543938|NCT01476475|565086203|FG001|Overall Study|Poor compliance to protocol|1|||
156543939|NCT01476475|565086202|FG000|Overall Study|Other reasons|4|||
156543940|NCT01476475|565086203|FG001|Overall Study|Other reasons|2|||
156543941|NCT00441974|565086204|FG000|Overall Study|Adverse Event|6|||
156543942|NCT00441974|565086204|FG000|Overall Study|Consent Withdrawn|35|||
156543943|NCT00441974|565086204|FG000|Overall Study|Lost to Follow-up|80|||
156543944|NCT00441974|565086204|FG000|Overall Study|Protocol Violation|7|||
156543945|NCT01146873|565086212|FG000|Overall Study|Transfer out|0|||
156543946|NCT01146873|565086213|FG001|Overall Study|Transfer out|6|||
156543947|NCT00631020|565086219|FG000|Overall Study|Lost to Follow-up|7|||
156543948|NCT00631020|565086219|FG000|Overall Study|Incarcerated|1|||
156347793|NCT02573350|564370105|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
156347794|NCT02573350|564370106|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
156347795|NCT02573350|564370105|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
156347796|NCT02573350|564370106|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
156347797|NCT02573350|564370105|FG000|Overall Study|Subject withdrew consent to participate|6|||
156347798|NCT02573350|564370106|FG001|Overall Study|Subject withdrew consent to participate|1|||
156347799|NCT02573350|564370105|FG000|Overall Study|Protocol Deviation|1|||
156347800|NCT02573350|564370106|FG001|Overall Study|Protocol Deviation|1|||
156347801|NCT02743520|564370107|FG000|Overall Study|Withdrawal by Subject|1|||
156347802|NCT03247530|564370108|FG000|Overall Study|Withdrawal by caregiver|19|||
156347803|NCT03247530|564370109|FG001|Overall Study|Withdrawal by caregiver|8|||
156347804|NCT03247530|564370110|FG002|Overall Study|Withdrawal by caregiver|10|||
156347805|NCT03247530|564370108|FG000|Overall Study|Lost to Follow-up|3|||
156347806|NCT03247530|564370109|FG001|Overall Study|Lost to Follow-up|9|||
156347807|NCT03247530|564370110|FG002|Overall Study|Lost to Follow-up|6|||
156347808|NCT03247530|564370108|FG000|Overall Study|Adverse Event|2|||
156347809|NCT03247530|564370109|FG001|Overall Study|Adverse Event|5|||
156347810|NCT03247530|564370110|FG002|Overall Study|Adverse Event|2|||
156347811|NCT03247530|564370108|FG000|Overall Study|Failure to follow procedure|1|||
156347812|NCT03247530|564370109|FG001|Overall Study|Failure to follow procedure|1|||
156347813|NCT03247530|564370110|FG002|Overall Study|Failure to follow procedure|1|||
156347814|NCT03247530|564370108|FG000|Overall Study|Withdrawal by Subject|1|||
156347815|NCT03247530|564370109|FG001|Overall Study|Withdrawal by Subject|1|||
156347816|NCT03247530|564370110|FG002|Overall Study|Withdrawal by Subject|0|||
156347817|NCT03247530|564370108|FG000|Overall Study|Study medication misuse|0|||
156347818|NCT03247530|564370109|FG001|Overall Study|Study medication misuse|1|||
156347819|NCT03247530|564370110|FG002|Overall Study|Study medication misuse|0|||
156347820|NCT03247530|564370108|FG000|Overall Study|Other, multiple categories|1|||
156347821|NCT03247530|564370109|FG001|Overall Study|Other, multiple categories|3|||
156347822|NCT03247530|564370110|FG002|Overall Study|Other, multiple categories|1|||
156347823|NCT01678911|564370111|FG000|Second Intervention|Lost to Follow-up|2|||
156347824|NCT01678911|564370112|FG001|Second Intervention|Lost to Follow-up|0|||
156347825|NCT04649060|564370113|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
156347826|NCT04649060|564370114|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
156347827|NCT04649060|564370113|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
156347828|NCT04649060|564370114|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
156347829|NCT04649060|564370113|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
156347830|NCT04649060|564370114|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
156347831|NCT04649060|564370113|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
156347832|NCT04649060|564370114|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
156347833|NCT04649060|564370113|FG000|Arm A/Arm B Treatment|Patient Request|1|||
156347834|NCT04649060|564370114|FG001|Arm A/Arm B Treatment|Patient Request|0|||
156347835|NCT04649060|564370113|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
156347836|NCT04649060|564370114|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
156347837|NCT04649060|564370113|FG000|Arm A/Arm B Treatment|Other|1|||
156347838|NCT04649060|564370114|FG001|Arm A/Arm B Treatment|Other|0|||
156347839|NCT04649060|564370113|FG000|Crossover (Arm B)|Adverse Event|0|||
156347840|NCT04649060|564370114|FG001|Crossover (Arm B)|Adverse Event|1|||
156347841|NCT04649060|564370113|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
156347842|NCT04649060|564370114|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
156347843|NCT00171730|564370116|FG000|Overall Study|Adverse Event|3|||
156347844|NCT00171730|564370116|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
156347845|NCT00171730|564370116|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
156347846|NCT00171730|564370116|FG000|Overall Study|Withdrawal by Subject|3|||
156347847|NCT05025241|564370117|FG000|Screening|Failed Screening|5|||
156347848|NCT05025241|564370117|FG000|Treatment and Follow Up|Adverse Event|3|||
156347849|NCT02670837|564370118|FG000|Overall Study|Death|2|||
156347850|NCT02670837|564370119|FG001|Overall Study|Death|0|||
156347851|NCT02670837|564370120|FG002|Overall Study|Death|0|||
156543949|NCT02614859|565086221|FG000|Overall Study|Physician Decision|0|||
156543950|NCT02614859|565086222|FG001|Overall Study|Physician Decision|1|||
156543951|NCT01399788|565086223|FG000|First Intervention Period|Adverse Event|1|||
156543952|NCT01399788|565086224|FG001|First Intervention Period|Adverse Event|0|||
156347852|NCT01985867|564370121|FG000|Overall Study|Lost to Follow-up|3|||
156347853|NCT01985867|564370122|FG001|Overall Study|Lost to Follow-up|4|||
156347854|NCT01985867|564370121|FG000|Overall Study|Adverse Event|3|||
156347855|NCT01985867|564370122|FG001|Overall Study|Adverse Event|2|||
156347856|NCT01985867|564370121|FG000|Overall Study|Lack of Efficacy|1|||
156347857|NCT01985867|564370122|FG001|Overall Study|Lack of Efficacy|0|||
156347858|NCT02220205|564370123|FG000|Overall Study|Withdrawal by Subject|1|||
156347859|NCT02220205|564370124|FG001|Overall Study|Withdrawal by Subject|0|||
156347860|NCT02557646|564370127|FG000|Overall Study|Adverse Event|40|||
156347861|NCT02557646|564370127|FG000|Overall Study|Death|1|||
156347862|NCT02557646|564370127|FG000|Overall Study|Lack of Efficacy|186|||
156347863|NCT02557646|564370127|FG000|Overall Study|Withdrawal by Subject|18|||
156347864|NCT02557646|564370127|FG000|Overall Study|Lost to Follow-up|17|||
156347865|NCT02557646|564370127|FG000|Overall Study|Other|14|||
156347866|NCT00660309|564370128|FG000|Overall Study|Adverse Event|2|||
156347867|NCT00660309|564370129|FG001|Overall Study|Adverse Event|0|||
156347868|NCT00660309|564370128|FG000|Overall Study|Withdrawal by Subject|0|||
156543953|NCT03699007|565086228|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
156543954|NCT03699007|565086229|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
156347869|NCT00660309|564370129|FG001|Overall Study|Withdrawal by Subject|3|||
156347870|NCT00137046|564370130|FG000|Overall Study|Death|2|||
156347871|NCT00137046|564370131|FG001|Overall Study|Death|1|||
156482258|NCT02367794|564858010|FG000|Overall Study|Physician Decision|0|||
156482259|NCT02367794|564858011|FG001|Overall Study|Physician Decision|5|||
156347872|NCT00137046|564370130|FG000|Overall Study|Adverse Event|16|||
156347873|NCT00137046|564370131|FG001|Overall Study|Adverse Event|5|||
156347874|NCT00137046|564370130|FG000|Overall Study|Laboratory Abnormality|2|||
156482260|NCT02367794|564858012|FG002|Overall Study|Physician Decision|3|||
156482261|NCT02367794|564858010|FG000|Overall Study|Protocol Violation|1|||
156482262|NCT02367794|564858011|FG001|Overall Study|Protocol Violation|0|||
156482263|NCT02367794|564858012|FG002|Overall Study|Protocol Violation|1|||
156482264|NCT02367794|564858010|FG000|Overall Study|Withdrawal by Subject|25|||
156482265|NCT02367794|564858011|FG001|Overall Study|Withdrawal by Subject|12|||
156347875|NCT00137046|564370131|FG001|Overall Study|Laboratory Abnormality|0|||
156347876|NCT00137046|564370130|FG000|Overall Study|Lack of Efficacy|13|||
156347877|NCT00137046|564370131|FG001|Overall Study|Lack of Efficacy|1|||
156347878|NCT00137046|564370130|FG000|Overall Study|Lost to Follow-up|8|||
156347879|NCT00137046|564370131|FG001|Overall Study|Lost to Follow-up|24|||
156347880|NCT00137046|564370130|FG000|Overall Study|Other|23|||
156347881|NCT00137046|564370131|FG001|Overall Study|Other|19|||
156347882|NCT00137046|564370130|FG000|Overall Study|Withdrawal by Subject|33|||
156347883|NCT00137046|564370131|FG001|Overall Study|Withdrawal by Subject|42|||
156543955|NCT03699007|565086228|FG000|6-month Follow Up|Lost to Follow-up|2|||
156543956|NCT03699007|565086229|FG001|6-month Follow Up|Lost to Follow-up|3|||
156543957|NCT04718974|565086230|FG000|Overall Study|Death|0|||
156543958|NCT04718974|565086231|FG001|Overall Study|Death|2|||
156543959|NCT04718974|565086230|FG000|Overall Study|Lost to Follow-up|10|||
156543960|NCT04718974|565086231|FG001|Overall Study|Lost to Follow-up|20|||
156543961|NCT04718974|565086230|FG000|Overall Study|Transferred out|2|||
156543962|NCT04718974|565086231|FG001|Overall Study|Transferred out|4|||
156543963|NCT00845728|565086232|FG000|Overall Study|Abnormal laboratory value (s)|2|||
156543964|NCT00845728|565086233|FG001|Overall Study|Abnormal laboratory value (s)|2|||
156543965|NCT00845728|565086232|FG000|Overall Study|Patient's inability to use the device|4|||
156543966|NCT00845728|565086233|FG001|Overall Study|Patient's inability to use the device|6|||
156543967|NCT00845728|565086232|FG000|Overall Study|Abnormal test procedure result (s)|7|||
156543968|NCT00845728|565086233|FG001|Overall Study|Abnormal test procedure result (s)|2|||
156543969|NCT00845728|565086232|FG000|Overall Study|Lost to Follow-up|22|||
156543970|NCT00845728|565086233|FG001|Overall Study|Lost to Follow-up|13|||
156543971|NCT00845728|565086232|FG000|Overall Study|Death|24|||
156543972|NCT00845728|565086233|FG001|Overall Study|Death|26|||
156543973|NCT00845728|565086232|FG000|Overall Study|Administrative Problems|34|||
156543974|NCT00845728|565086233|FG001|Overall Study|Administrative Problems|26|||
156543975|NCT00845728|565086232|FG000|Overall Study|Protocol Violation|36|||
156543976|NCT00845728|565086233|FG001|Overall Study|Protocol Violation|24|||
156347884|NCT00137046|564370130|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
156347885|NCT00137046|564370131|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
156347886|NCT00137046|564370130|FG000|Overall Study|Withdrew prior to study treatment|1|||
156347887|NCT00137046|564370131|FG001|Overall Study|Withdrew prior to study treatment|1|||
156347888|NCT02532972|564370132|FG000|Overall Study|Withdrawal by Subject|1|||
156347889|NCT00110149|564370133|FG000|Overall Study|Physician Decision|3|||
156347890|NCT00748033|564370136|FG000|Overall Study|Adverse Event|0|||
156347891|NCT00748033|564370137|FG001|Overall Study|Adverse Event|1|||
156347892|NCT01018186|564370138|FG000|2-week Run-in Period|Protocol Violation|1|||
156347893|NCT01018186|564370139|FG001|2-week Run-in Period|Protocol Violation|0|||
156347894|NCT01018186|564370140|FG002|2-week Run-in Period|Protocol Violation|0|||
156347895|NCT01018186|564370141|FG003|2-week Run-in Period|Protocol Violation|0|||
156347896|NCT01018186|564370138|FG000|2-week Run-in Period|Lost to Follow-up|2|||
156347897|NCT01018186|564370139|FG001|2-week Run-in Period|Lost to Follow-up|0|||
156347898|NCT01018186|564370140|FG002|2-week Run-in Period|Lost to Follow-up|0|||
156347899|NCT01018186|564370141|FG003|2-week Run-in Period|Lost to Follow-up|0|||
156347900|NCT01018186|564370138|FG000|2-week Run-in Period|Physician Decision|3|||
156347901|NCT01018186|564370139|FG001|2-week Run-in Period|Physician Decision|0|||
156347902|NCT01018186|564370140|FG002|2-week Run-in Period|Physician Decision|0|||
156347903|NCT01018186|564370141|FG003|2-week Run-in Period|Physician Decision|0|||
156347904|NCT01018186|564370138|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
156347905|NCT01018186|564370139|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156347906|NCT01018186|564370140|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156347907|NCT01018186|564370141|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
156347908|NCT01018186|564370138|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
156347909|NCT01018186|564370139|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156347910|NCT01018186|564370140|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156347911|NCT01018186|564370141|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156347912|NCT01018186|564370138|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
156347913|NCT01018186|564370139|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
156347914|NCT01018186|564370140|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
156347915|NCT01018186|564370141|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
156347916|NCT01018186|564370138|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
156347917|NCT01018186|564370139|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
156347918|NCT01018186|564370140|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
156347919|NCT01018186|564370141|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
156347920|NCT01018186|564370138|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
156347921|NCT01018186|564370139|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
156347922|NCT01018186|564370140|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
156347923|NCT01018186|564370141|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
156347924|NCT01018186|564370138|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
156347925|NCT01018186|564370139|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
156347926|NCT01018186|564370140|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
156347927|NCT01018186|564370141|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
156347928|NCT01018186|564370138|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
156347929|NCT01018186|564370139|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
156347930|NCT01018186|564370140|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
156347931|NCT01018186|564370141|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
156347932|NCT01018186|564370138|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
156347933|NCT01018186|564370139|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
156347934|NCT01018186|564370140|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
156347935|NCT01018186|564370141|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
156347936|NCT01018186|564370138|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156347937|NCT01018186|564370139|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
156347938|NCT01018186|564370140|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
156347939|NCT01018186|564370141|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
156347940|NCT02603419|564370142|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156347941|NCT02603419|564370143|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
156347942|NCT02603419|564370144|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156347943|NCT02603419|564370145|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156347944|NCT02603419|564370146|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156347945|NCT02603419|564370147|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156543977|NCT00845728|565086232|FG000|Overall Study|Lack of Efficacy|51|||
156543978|NCT00845728|565086233|FG001|Overall Study|Lack of Efficacy|39|||
156482266|NCT02367794|564858012|FG002|Overall Study|Withdrawal by Subject|20|||
156482267|NCT02367794|564858010|FG000|Overall Study|Brain metastasis|1|||
156482268|NCT02367794|564858011|FG001|Overall Study|Brain metastasis|0|||
156482269|NCT02367794|564858012|FG002|Overall Study|Brain metastasis|0|||
156482270|NCT02367794|564858010|FG000|Overall Study|Randomized in error|0|||
156482271|NCT02367794|564858011|FG001|Overall Study|Randomized in error|0|||
156482272|NCT02367794|564858012|FG002|Overall Study|Randomized in error|1|||
156482273|NCT02367794|564858010|FG000|Overall Study|Patient unable to receive carboplatin|0|||
156482274|NCT02367794|564858011|FG001|Overall Study|Patient unable to receive carboplatin|0|||
156482275|NCT02367794|564858012|FG002|Overall Study|Patient unable to receive carboplatin|1|||
156482276|NCT02367794|564858010|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
156482277|NCT02367794|564858011|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
156482278|NCT02367794|564858012|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
156482279|NCT02367794|564858010|FG000|Overall Study|Adverse Event|0|||
156482280|NCT02367794|564858011|FG001|Overall Study|Adverse Event|0|||
156482281|NCT02367794|564858012|FG002|Overall Study|Adverse Event|2|||
156482282|NCT02367794|564858010|FG000|Overall Study|Study Terminated By Sponsor|0|||
156482283|NCT02367794|564858011|FG001|Overall Study|Study Terminated By Sponsor|1|||
156482284|NCT02367794|564858012|FG002|Overall Study|Study Terminated By Sponsor|1|||
156482285|NCT02367794|564858010|FG000|Overall Study|Moved to Roll-Over Study|0|||
156482286|NCT02367794|564858011|FG001|Overall Study|Moved to Roll-Over Study|15|||
156482287|NCT02367794|564858012|FG002|Overall Study|Moved to Roll-Over Study|13|||
156482288|NCT02367794|564858010|FG000|Overall Study|Sponsor Request|60|||
156482289|NCT02367794|564858011|FG001|Overall Study|Sponsor Request|57|||
156347946|NCT02603419|564370142|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
156347947|NCT02603419|564370143|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
156347948|NCT02603419|564370144|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
156347949|NCT02603419|564370145|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
156347950|NCT02603419|564370146|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
156347951|NCT02603419|564370147|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
156347952|NCT02603419|564370142|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
156347953|NCT02603419|564370143|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
156347954|NCT02603419|564370144|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
156347955|NCT02603419|564370145|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
156347956|NCT02603419|564370146|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
156347957|NCT02603419|564370147|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
156347958|NCT02603419|564370142|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156347959|NCT02603419|564370143|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156347960|NCT02603419|564370144|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156347961|NCT02603419|564370145|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156347962|NCT02603419|564370146|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
156347963|NCT02603419|564370147|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156347964|NCT02603419|564370142|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156347965|NCT02603419|564370143|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
156347966|NCT02603419|564370144|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156347967|NCT02603419|564370145|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156347968|NCT02603419|564370146|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156347969|NCT02603419|564370147|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156347970|NCT02603419|564370142|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
156347971|NCT02603419|564370143|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
156347972|NCT02603419|564370144|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
156347973|NCT02603419|564370145|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
156347974|NCT02603419|564370146|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
156347975|NCT02603419|564370147|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
156347976|NCT02603419|564370142|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156347977|NCT02603419|564370143|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156347978|NCT02603419|564370144|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156347979|NCT02603419|564370145|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
156347980|NCT02603419|564370146|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156347981|NCT02603419|564370147|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156347982|NCT02603419|564370142|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156347983|NCT02603419|564370143|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156347984|NCT02603419|564370144|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156347985|NCT02603419|564370145|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156347986|NCT02603419|564370146|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156347987|NCT02603419|564370147|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
156347988|NCT02603419|564370142|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156347989|NCT02603419|564370143|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156347990|NCT02603419|564370144|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156347991|NCT02603419|564370145|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156347992|NCT02603419|564370146|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156347993|NCT02603419|564370147|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
156347994|NCT02603419|564370142|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156347995|NCT02603419|564370143|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156347996|NCT02603419|564370144|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156347997|NCT02603419|564370145|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156347998|NCT02603419|564370146|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156347999|NCT02603419|564370147|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
156348000|NCT03552198|564370148|FG000|Overall Study|Lost to Follow-up|42|||
156348001|NCT03552198|564370149|FG001|Overall Study|Lost to Follow-up|48|||
156348002|NCT03552198|564370150|FG002|Overall Study|Lost to Follow-up|15|||
156348003|NCT03552198|564370151|FG003|Overall Study|Lost to Follow-up|19|||
156348004|NCT03552198|564370148|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
156482290|NCT02367794|564858012|FG002|Overall Study|Sponsor Request|45|||
156348005|NCT03552198|564370149|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
156348006|NCT03552198|564370150|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
156348007|NCT03552198|564370151|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
156482291|NCT02367794|564858010|FG000|Overall Study|Moved into PTAP Study|0|||
156482292|NCT02367794|564858011|FG001|Overall Study|Moved into PTAP Study|2|||
156482293|NCT02367794|564858012|FG002|Overall Study|Moved into PTAP Study|3|||
156482294|NCT02367794|564858010|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
156482295|NCT02367794|564858011|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
156482296|NCT02367794|564858012|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
156482297|NCT02367794|564858010|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
156482298|NCT02367794|564858011|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
156543979|NCT00845728|565086232|FG000|Overall Study|Adverse Event|101|||
156348008|NCT03552198|564370148|FG000|Overall Study|Did not receive air alerts|1|||
156543980|NCT00845728|565086233|FG001|Overall Study|Adverse Event|96|||
156543981|NCT00845728|565086232|FG000|Overall Study|Withdrawal by Subject|105|||
156482299|NCT02367794|564858012|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
156482300|NCT02367794|564858010|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
156482301|NCT02367794|564858011|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
156482302|NCT02367794|564858012|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
156482303|NCT02367794|564858010|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
156482304|NCT02367794|564858011|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
156543982|NCT00845728|565086233|FG001|Overall Study|Withdrawal by Subject|108|||
156543983|NCT01389752|565086234|FG000|Study Period 1|Sponsor decision|0|||
156543984|NCT01389752|565086235|FG001|Study Period 1|Sponsor decision|2|||
156543985|NCT01389752|565086234|FG000|Study Period 2|Sponsor decision|1|||
156543986|NCT01389752|565086235|FG001|Study Period 2|Sponsor decision|0|||
156543987|NCT03259074|565086236|FG000|Overall Study|Adverse Event|9|||
156543988|NCT03259074|565086237|FG001|Overall Study|Adverse Event|12|||
156348009|NCT03552198|564370149|FG001|Overall Study|Did not receive air alerts|0|||
156348010|NCT03552198|564370150|FG002|Overall Study|Did not receive air alerts|0|||
156348011|NCT03552198|564370151|FG003|Overall Study|Did not receive air alerts|1|||
156348012|NCT02925494|564370152|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
156348013|NCT02925494|564370153|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
156348014|NCT02925494|564370154|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
156348015|NCT02925494|564370155|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
156348016|NCT02925494|564370152|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
156348017|NCT02925494|564370153|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
156348018|NCT02925494|564370154|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
156348019|NCT02925494|564370155|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
156348020|NCT02925494|564370152|FG000|Post-Treatment Follow-Up Period|Other|1|||
156348021|NCT02925494|564370153|FG001|Post-Treatment Follow-Up Period|Other|4|||
156348022|NCT02925494|564370154|FG002|Post-Treatment Follow-Up Period|Other|3|||
156348023|NCT02925494|564370155|FG003|Post-Treatment Follow-Up Period|Other|6|||
156348024|NCT02925494|564370152|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
156348025|NCT02925494|564370153|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
156348026|NCT02925494|564370154|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
156348027|NCT02925494|564370155|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
156348028|NCT02925494|564370152|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
156348029|NCT02925494|564370153|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
156348030|NCT02925494|564370154|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
156348031|NCT02925494|564370155|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
156348032|NCT02925494|564370152|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156348033|NCT02925494|564370153|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156348034|NCT02925494|564370154|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
156348035|NCT02925494|564370155|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
156348036|NCT02925494|564370152|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
156348037|NCT02925494|564370153|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
156348038|NCT02925494|564370154|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
156348039|NCT02925494|564370155|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
156348040|NCT03334448|564370161|FG000|Washout|Personal Reason|0|||
156348041|NCT03334448|564370162|FG001|Washout|Personal Reason|1|||
156348042|NCT03334448|564370163|FG002|Washout|Personal Reason|0|||
156348043|NCT03334448|564370164|FG003|Washout|Personal Reason|0|||
156482305|NCT02367794|564858012|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
156482306|NCT01986348|564858013|FG000|Overall Study|Death|8|||
156482307|NCT01986348|564858014|FG001|Overall Study|Death|22|||
156482308|NCT01986348|564858015|FG002|Overall Study|Death|10|||
156482309|NCT01986348|564858016|FG003|Overall Study|Death|21|||
156482310|NCT01986348|564858013|FG000|Overall Study|Lost to Follow-up|0|||
156482311|NCT01986348|564858014|FG001|Overall Study|Lost to Follow-up|0|||
156482312|NCT01986348|564858015|FG002|Overall Study|Lost to Follow-up|0|||
156482313|NCT01986348|564858016|FG003|Overall Study|Lost to Follow-up|2|||
156348044|NCT03334448|564370161|FG000|Washout|Protocol Violation|0|||
156348045|NCT03334448|564370162|FG001|Washout|Protocol Violation|0|||
156348046|NCT03334448|564370163|FG002|Washout|Protocol Violation|0|||
156482314|NCT01986348|564858013|FG000|Overall Study|Physician Decision|0|||
156482315|NCT01986348|564858014|FG001|Overall Study|Physician Decision|0|||
156482316|NCT01986348|564858015|FG002|Overall Study|Physician Decision|0|||
156348047|NCT03334448|564370164|FG003|Washout|Protocol Violation|1|||
156348048|NCT01365910|564370165|FG000|Overall Study|Withdrawal by Subject|7|||
156348049|NCT01365910|564370165|FG000|Overall Study|disease progression|18|||
156348050|NCT01365910|564370165|FG000|Overall Study|Adverse Event|3|||
156348051|NCT01365910|564370165|FG000|Overall Study|other complicating disease|1|||
156482317|NCT01986348|564858016|FG003|Overall Study|Physician Decision|1|||
156482318|NCT01986348|564858013|FG000|Overall Study|Progressive Disease|0|||
156482319|NCT01986348|564858014|FG001|Overall Study|Progressive Disease|0|||
156482320|NCT01986348|564858015|FG002|Overall Study|Progressive Disease|2|||
156482321|NCT01986348|564858016|FG003|Overall Study|Progressive Disease|0|||
156482322|NCT01986348|564858013|FG000|Overall Study|Withdrawal by Participant|0|||
156348052|NCT01365910|564370165|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
156348053|NCT00371137|564370166|FG000|Overall Study|Adverse Event|20|||
156348054|NCT00371137|564370167|FG001|Overall Study|Adverse Event|35|||
156348055|NCT00371137|564370168|FG002|Overall Study|Adverse Event|42|||
156348056|NCT00371137|564370166|FG000|Overall Study|Withdrawal by Subject|11|||
156348057|NCT00371137|564370167|FG001|Overall Study|Withdrawal by Subject|10|||
156348058|NCT00371137|564370168|FG002|Overall Study|Withdrawal by Subject|15|||
156348059|NCT00371137|564370166|FG000|Overall Study|Lost to Follow-up|6|||
156348060|NCT00371137|564370167|FG001|Overall Study|Lost to Follow-up|3|||
156348061|NCT00371137|564370168|FG002|Overall Study|Lost to Follow-up|5|||
156348062|NCT00371137|564370166|FG000|Overall Study|Lack of Efficacy|30|||
156348063|NCT00371137|564370167|FG001|Overall Study|Lack of Efficacy|12|||
156348064|NCT00371137|564370168|FG002|Overall Study|Lack of Efficacy|13|||
156348065|NCT00371137|564370166|FG000|Overall Study|Sponsor Decision|2|||
156348066|NCT00371137|564370167|FG001|Overall Study|Sponsor Decision|1|||
156348067|NCT00371137|564370168|FG002|Overall Study|Sponsor Decision|2|||
156348068|NCT00371137|564370166|FG000|Overall Study|Physician Decision|1|||
156348069|NCT00371137|564370167|FG001|Overall Study|Physician Decision|1|||
156348070|NCT00371137|564370168|FG002|Overall Study|Physician Decision|1|||
156348071|NCT00371137|564370166|FG000|Overall Study|Protocol Violation|2|||
156348072|NCT00371137|564370167|FG001|Overall Study|Protocol Violation|1|||
156348073|NCT00371137|564370168|FG002|Overall Study|Protocol Violation|1|||
156348074|NCT02013791|564370169|FG000|Period 1|Lost to Follow-up|0|||
156348075|NCT02013791|564370170|FG001|Period 1|Lost to Follow-up|0|||
156348076|NCT02013791|564370171|FG002|Period 1|Lost to Follow-up|0|||
156348077|NCT02013791|564370172|FG003|Period 1|Lost to Follow-up|1|||
156348078|NCT02013791|564370173|FG004|Period 1|Lost to Follow-up|0|||
156348079|NCT02013791|564370174|FG005|Period 1|Lost to Follow-up|0|||
156348080|NCT02013791|564370175|FG006|Period 1|Lost to Follow-up|1|||
156348081|NCT02013791|564370176|FG007|Period 1|Lost to Follow-up|1|||
156348082|NCT02013791|564370177|FG008|Period 1|Lost to Follow-up|0|||
156348083|NCT02013791|564370169|FG000|Period 1|Other Miscellaneous Reasons|0|||
156348084|NCT02013791|564370170|FG001|Period 1|Other Miscellaneous Reasons|2|||
156348085|NCT02013791|564370171|FG002|Period 1|Other Miscellaneous Reasons|0|||
156348086|NCT02013791|564370172|FG003|Period 1|Other Miscellaneous Reasons|0|||
156348087|NCT02013791|564370173|FG004|Period 1|Other Miscellaneous Reasons|0|||
156348088|NCT02013791|564370174|FG005|Period 1|Other Miscellaneous Reasons|0|||
156348089|NCT02013791|564370175|FG006|Period 1|Other Miscellaneous Reasons|0|||
156348090|NCT02013791|564370176|FG007|Period 1|Other Miscellaneous Reasons|0|||
156348091|NCT02013791|564370177|FG008|Period 1|Other Miscellaneous Reasons|0|||
156348092|NCT01782222|564370191|FG000|Overall Study|Adverse Event|4|||
156348093|NCT01782222|564370192|FG001|Overall Study|Adverse Event|5|||
156348094|NCT01782222|564370193|FG002|Overall Study|Adverse Event|3|||
156348095|NCT01782222|564370191|FG000|Overall Study|Lack of Efficacy|2|||
156348096|NCT01782222|564370192|FG001|Overall Study|Lack of Efficacy|1|||
156348097|NCT01782222|564370193|FG002|Overall Study|Lack of Efficacy|0|||
156348098|NCT01782222|564370191|FG000|Overall Study|Protocol Violation|1|||
156348099|NCT01782222|564370192|FG001|Overall Study|Protocol Violation|0|||
156348100|NCT01782222|564370193|FG002|Overall Study|Protocol Violation|0|||
156348101|NCT01782222|564370191|FG000|Overall Study|Withdrawal by Subject|1|||
156348102|NCT01782222|564370192|FG001|Overall Study|Withdrawal by Subject|4|||
156348103|NCT01782222|564370193|FG002|Overall Study|Withdrawal by Subject|1|||
156348104|NCT01782222|564370191|FG000|Overall Study|Moved to other state|0|||
156348105|NCT01782222|564370192|FG001|Overall Study|Moved to other state|1|||
156348106|NCT01782222|564370193|FG002|Overall Study|Moved to other state|0|||
156482323|NCT01986348|564858014|FG001|Overall Study|Withdrawal by Participant|1|||
156348107|NCT01756898|564370197|FG000|Overall Study|Adverse Event|7|||
156348108|NCT01756898|564370198|FG001|Overall Study|Adverse Event|1|||
156348109|NCT01756898|564370199|FG002|Overall Study|Adverse Event|0|||
156348110|NCT01756898|564370200|FG003|Overall Study|Adverse Event|0|||
156348111|NCT01756898|564370197|FG000|Overall Study|Lack of Efficacy|4|||
156348112|NCT01756898|564370198|FG001|Overall Study|Lack of Efficacy|7|||
156348113|NCT01756898|564370199|FG002|Overall Study|Lack of Efficacy|6|||
156348114|NCT01756898|564370200|FG003|Overall Study|Lack of Efficacy|6|||
156348115|NCT01756898|564370197|FG000|Overall Study|Lost to Follow-up|2|||
156348116|NCT01756898|564370198|FG001|Overall Study|Lost to Follow-up|4|||
156543989|NCT03259074|565086238|FG002|Overall Study|Adverse Event|8|||
156543990|NCT03259074|565086236|FG000|Overall Study|Death|1|||
156348117|NCT01756898|564370199|FG002|Overall Study|Lost to Follow-up|2|||
156543991|NCT03259074|565086237|FG001|Overall Study|Death|1|||
156482324|NCT01986348|564858015|FG002|Overall Study|Withdrawal by Participant|2|||
156482325|NCT01986348|564858016|FG003|Overall Study|Withdrawal by Participant|1|||
156482326|NCT01986348|564858013|FG000|Overall Study|Study Terminated by Sponsor|0|||
156482327|NCT01986348|564858014|FG001|Overall Study|Study Terminated by Sponsor|0|||
156482328|NCT01986348|564858015|FG002|Overall Study|Study Terminated by Sponsor|0|||
156482329|NCT01986348|564858016|FG003|Overall Study|Study Terminated by Sponsor|3|||
156482330|NCT01986348|564858013|FG000|Overall Study|Other-unspecified|0|||
156482331|NCT01986348|564858014|FG001|Overall Study|Other-unspecified|1|||
156482332|NCT01986348|564858015|FG002|Overall Study|Other-unspecified|0|||
156482333|NCT01986348|564858016|FG003|Overall Study|Other-unspecified|2|||
156482334|NCT02010684|564858017|FG000|Overall Study|Lost to Follow-up|8|||
156482335|NCT02010684|564858018|FG001|Overall Study|Lost to Follow-up|18|||
156482336|NCT02010684|564858017|FG000|Overall Study|Withdrawal by Subject|4|||
156482337|NCT02010684|564858018|FG001|Overall Study|Withdrawal by Subject|5|||
156482338|NCT01884571|564858023|FG000|Overall Study|Adverse Event|1|||
156482339|NCT01884571|564858023|FG000|Overall Study|Death|2|||
156482340|NCT01884571|564858023|FG000|Overall Study|Withdrawal by Subject|2|||
156482341|NCT01884571|564858023|FG000|Overall Study|Disease progression|3|||
156482342|NCT02158806|564858028|FG000|Overall Study|Death|2|||
156482343|NCT02158806|564858029|FG001|Overall Study|Death|0|||
156348118|NCT01756898|564370200|FG003|Overall Study|Lost to Follow-up|3|||
156348119|NCT01756898|564370197|FG000|Overall Study|Protocol Violation|1|||
156348120|NCT01756898|564370198|FG001|Overall Study|Protocol Violation|2|||
156348121|NCT01756898|564370199|FG002|Overall Study|Protocol Violation|2|||
156348122|NCT01756898|564370200|FG003|Overall Study|Protocol Violation|1|||
156348123|NCT01756898|564370197|FG000|Overall Study|Withdrew Consent|5|||
156348124|NCT01756898|564370198|FG001|Overall Study|Withdrew Consent|3|||
156482344|NCT02158806|564858028|FG000|Overall Study|Withdrawal by Subject|2|||
156482345|NCT02158806|564858029|FG001|Overall Study|Withdrawal by Subject|0|||
156482346|NCT02158806|564858028|FG000|Overall Study|Lost to Follow-up|0|||
156482347|NCT02158806|564858029|FG001|Overall Study|Lost to Follow-up|3|||
156348125|NCT01756898|564370199|FG002|Overall Study|Withdrew Consent|5|||
156348126|NCT01756898|564370200|FG003|Overall Study|Withdrew Consent|6|||
156348127|NCT01756898|564370197|FG000|Overall Study|Other|0|||
156348128|NCT01756898|564370198|FG001|Overall Study|Other|2|||
156482348|NCT02158806|564858028|FG000|Overall Study|Moved out of area|0|||
156348129|NCT01756898|564370199|FG002|Overall Study|Other|2|||
156348130|NCT01756898|564370200|FG003|Overall Study|Other|0|||
156543992|NCT03259074|565086238|FG002|Overall Study|Death|3|||
156543993|NCT03259074|565086236|FG000|Overall Study|Lost to Follow-up|2|||
156543994|NCT03259074|565086237|FG001|Overall Study|Lost to Follow-up|4|||
156482349|NCT02158806|564858029|FG001|Overall Study|Moved out of area|1|||
156482350|NCT02158806|564858028|FG000|Overall Study|Transferred to palliative care|0|||
156482351|NCT02158806|564858029|FG001|Overall Study|Transferred to palliative care|1|||
156482352|NCT01898299|564858033|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
156482353|NCT01898299|564858034|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
156482354|NCT02340806|564858035|FG000|Overall Study|Protocol Violation|2|||
156482355|NCT02340806|564858036|FG001|Overall Study|Protocol Violation|0|||
156482356|NCT02340806|564858035|FG000|Overall Study|epidural catheter replaced|2|||
156482357|NCT02340806|564858036|FG001|Overall Study|epidural catheter replaced|1|||
156482358|NCT02340806|564858035|FG000|Overall Study|history of chronic pain medication|1|||
156348131|NCT01500694|564370201|FG000|Overall Study|Adverse Event|4|||
156348132|NCT01500694|564370202|FG001|Overall Study|Adverse Event|3|||
156348133|NCT01500694|564370201|FG000|Overall Study|Protocol Violation|0|||
156348134|NCT01500694|564370202|FG001|Overall Study|Protocol Violation|1|||
156348135|NCT01500694|564370201|FG000|Overall Study|Withdrawal by Subject|23|||
156348136|NCT01500694|564370202|FG001|Overall Study|Withdrawal by Subject|14|||
156348137|NCT01500694|564370201|FG000|Overall Study|Lost to Follow-up|2|||
156348138|NCT01500694|564370202|FG001|Overall Study|Lost to Follow-up|3|||
156348139|NCT01500694|564370201|FG000|Overall Study|Lack of Efficacy|14|||
156348140|NCT01500694|564370202|FG001|Overall Study|Lack of Efficacy|5|||
156348141|NCT01500694|564370201|FG000|Overall Study|Other|9|||
156348142|NCT01500694|564370202|FG001|Overall Study|Other|3|||
156348143|NCT01691781|564370203|FG000|Overall Study|Withdrawal by Subject|4|||
156348144|NCT01691781|564370204|FG001|Overall Study|Withdrawal by Subject|3|||
156348145|NCT01691781|564370203|FG000|Overall Study|Physician Decision|1|||
156348146|NCT01691781|564370204|FG001|Overall Study|Physician Decision|1|||
156348147|NCT01691781|564370203|FG000|Overall Study|Protocol Violation|2|||
156348148|NCT01691781|564370204|FG001|Overall Study|Protocol Violation|2|||
156348149|NCT01691781|564370203|FG000|Overall Study|Adverse Event|0|||
156348150|NCT01691781|564370204|FG001|Overall Study|Adverse Event|1|||
156348151|NCT03978520|564370205|FG000|Overall Study|Adverse Event|2|||
156348152|NCT03978520|564370206|FG001|Overall Study|Adverse Event|5|||
156348153|NCT03978520|564370207|FG002|Overall Study|Adverse Event|3|||
156348154|NCT03978520|564370208|FG003|Overall Study|Adverse Event|5|||
156348155|NCT03978520|564370209|FG004|Overall Study|Adverse Event|6|||
156348156|NCT03978520|564370205|FG000|Overall Study|Withdrawal by Subject|10|||
156348157|NCT03978520|564370206|FG001|Overall Study|Withdrawal by Subject|4|||
156348158|NCT03978520|564370207|FG002|Overall Study|Withdrawal by Subject|5|||
156348159|NCT03978520|564370208|FG003|Overall Study|Withdrawal by Subject|6|||
156348160|NCT03978520|564370209|FG004|Overall Study|Withdrawal by Subject|5|||
156348161|NCT03978520|564370205|FG000|Overall Study|Lost to Follow-up|2|||
156348162|NCT03978520|564370206|FG001|Overall Study|Lost to Follow-up|2|||
156348163|NCT03978520|564370207|FG002|Overall Study|Lost to Follow-up|2|||
156348164|NCT03978520|564370208|FG003|Overall Study|Lost to Follow-up|0|||
156348165|NCT03978520|564370209|FG004|Overall Study|Lost to Follow-up|1|||
156348166|NCT03978520|564370205|FG000|Overall Study|COVID-19 infection|0|||
156348167|NCT03978520|564370206|FG001|Overall Study|COVID-19 infection|1|||
156348168|NCT03978520|564370207|FG002|Overall Study|COVID-19 infection|0|||
156348169|NCT03978520|564370208|FG003|Overall Study|COVID-19 infection|0|||
156348170|NCT03978520|564370209|FG004|Overall Study|COVID-19 infection|0|||
156348171|NCT03978520|564370205|FG000|Overall Study|Other, not specified|9|||
156348172|NCT03978520|564370206|FG001|Overall Study|Other, not specified|4|||
156348173|NCT03978520|564370207|FG002|Overall Study|Other, not specified|1|||
156348174|NCT03978520|564370208|FG003|Overall Study|Other, not specified|1|||
156348175|NCT03978520|564370209|FG004|Overall Study|Other, not specified|2|||
156348176|NCT03978520|564370205|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
156348177|NCT03978520|564370206|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
156348178|NCT03978520|564370207|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
156348179|NCT03978520|564370208|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
156348180|NCT03978520|564370209|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
156348181|NCT01918085|564370212|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
156348182|NCT01918085|564370213|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
156348183|NCT04102020|564370218|FG000|Overall Study|Adverse Event|1|||
156348184|NCT04102020|564370219|FG001|Overall Study|Adverse Event|0|||
156348185|NCT04102020|564370220|FG002|Overall Study|Adverse Event|0|||
156348186|NCT04102020|564370221|FG003|Overall Study|Adverse Event|1|||
156348187|NCT04102020|564370222|FG004|Overall Study|Adverse Event|0|||
156348188|NCT04102020|564370218|FG000|Overall Study|Withdrawal by Subject|0|||
156348189|NCT04102020|564370219|FG001|Overall Study|Withdrawal by Subject|1|||
156348190|NCT04102020|564370220|FG002|Overall Study|Withdrawal by Subject|1|||
156348191|NCT04102020|564370221|FG003|Overall Study|Withdrawal by Subject|1|||
156348192|NCT04102020|564370222|FG004|Overall Study|Withdrawal by Subject|1|||
156348193|NCT04102020|564370218|FG000|Overall Study|Death|1|||
156348194|NCT04102020|564370219|FG001|Overall Study|Death|4|||
156348195|NCT04102020|564370220|FG002|Overall Study|Death|1|||
156348196|NCT04102020|564370221|FG003|Overall Study|Death|1|||
156348197|NCT04102020|564370222|FG004|Overall Study|Death|0|||
156348198|NCT04102020|564370218|FG000|Overall Study|Physician Decision|1|||
156348199|NCT04102020|564370219|FG001|Overall Study|Physician Decision|2|||
156348200|NCT04102020|564370220|FG002|Overall Study|Physician Decision|2|||
156348201|NCT04102020|564370221|FG003|Overall Study|Physician Decision|0|||
156348202|NCT04102020|564370222|FG004|Overall Study|Physician Decision|1|||
156348203|NCT04102020|564370218|FG000|Overall Study|COVID-19 Infection|1|||
156348204|NCT04102020|564370219|FG001|Overall Study|COVID-19 Infection|0|||
156543995|NCT03259074|565086238|FG002|Overall Study|Lost to Follow-up|3|||
156348205|NCT04102020|564370220|FG002|Overall Study|COVID-19 Infection|0|||
156348206|NCT04102020|564370221|FG003|Overall Study|COVID-19 Infection|0|||
156348207|NCT04102020|564370222|FG004|Overall Study|COVID-19 Infection|0|||
156348208|NCT04102020|564370218|FG000|Overall Study|Not disclosed|5|||
156348209|NCT04102020|564370219|FG001|Overall Study|Not disclosed|3|||
156348210|NCT04102020|564370220|FG002|Overall Study|Not disclosed|8|||
156348211|NCT04102020|564370221|FG003|Overall Study|Not disclosed|0|||
156348212|NCT04102020|564370222|FG004|Overall Study|Not disclosed|1|||
156348213|NCT04102020|564370218|FG000|Overall Study|MIssing|1|||
156348214|NCT04102020|564370219|FG001|Overall Study|MIssing|0|||
156348215|NCT04102020|564370220|FG002|Overall Study|MIssing|1|||
156348216|NCT04102020|564370221|FG003|Overall Study|MIssing|1|||
156348217|NCT04102020|564370222|FG004|Overall Study|MIssing|1|||
156348218|NCT04102020|564370218|FG000|Overall Study|Continuing in ongoing study|13|||
156348219|NCT04102020|564370219|FG001|Overall Study|Continuing in ongoing study|13|||
156348220|NCT04102020|564370220|FG002|Overall Study|Continuing in ongoing study|7|||
156348221|NCT04102020|564370221|FG003|Overall Study|Continuing in ongoing study|26|||
156348222|NCT04102020|564370222|FG004|Overall Study|Continuing in ongoing study|12|||
156348223|NCT05109442|564370223|FG000|Overall Study|Withdrawal by Subject|0|||
156348224|NCT05109442|564370224|FG001|Overall Study|Withdrawal by Subject|0|||
156348225|NCT05109442|564370225|FG002|Overall Study|Withdrawal by Subject|1|||
156348226|NCT05109442|564370226|FG003|Overall Study|Withdrawal by Subject|0|||
156348227|NCT05109442|564370227|FG004|Overall Study|Withdrawal by Subject|0|||
156348228|NCT05109442|564370228|FG005|Overall Study|Withdrawal by Subject|0|||
156348229|NCT05109442|564370223|FG000|Overall Study|Adverse Event|0|||
156348230|NCT05109442|564370224|FG001|Overall Study|Adverse Event|1|||
156348231|NCT05109442|564370225|FG002|Overall Study|Adverse Event|5|||
156348232|NCT05109442|564370226|FG003|Overall Study|Adverse Event|0|||
156348233|NCT05109442|564370227|FG004|Overall Study|Adverse Event|0|||
156348234|NCT05109442|564370228|FG005|Overall Study|Adverse Event|2|||
156348235|NCT05109442|564370223|FG000|Overall Study|Death|0|||
156348236|NCT05109442|564370224|FG001|Overall Study|Death|0|||
156348237|NCT05109442|564370225|FG002|Overall Study|Death|4|||
156348238|NCT05109442|564370226|FG003|Overall Study|Death|0|||
156348239|NCT05109442|564370227|FG004|Overall Study|Death|0|||
156348240|NCT05109442|564370228|FG005|Overall Study|Death|1|||
156348241|NCT05109442|564370223|FG000|Overall Study|Physician Decision|1|||
156348242|NCT05109442|564370224|FG001|Overall Study|Physician Decision|0|||
156348243|NCT05109442|564370225|FG002|Overall Study|Physician Decision|1|||
156348244|NCT05109442|564370226|FG003|Overall Study|Physician Decision|0|||
156348245|NCT05109442|564370227|FG004|Overall Study|Physician Decision|0|||
156348246|NCT05109442|564370228|FG005|Overall Study|Physician Decision|2|||
156348247|NCT05109442|564370223|FG000|Overall Study|Other than listed|0|||
156348248|NCT05109442|564370224|FG001|Overall Study|Other than listed|0|||
156348249|NCT05109442|564370225|FG002|Overall Study|Other than listed|9|||
156348250|NCT05109442|564370226|FG003|Overall Study|Other than listed|2|||
156348251|NCT05109442|564370227|FG004|Overall Study|Other than listed|0|||
156348252|NCT05109442|564370228|FG005|Overall Study|Other than listed|8|||
156348253|NCT05109442|564370223|FG000|Overall Study|Lack of Efficacy|3|||
156348254|NCT05109442|564370224|FG001|Overall Study|Lack of Efficacy|5|||
156348255|NCT05109442|564370225|FG002|Overall Study|Lack of Efficacy|29|||
156348256|NCT05109442|564370226|FG003|Overall Study|Lack of Efficacy|10|||
156348257|NCT05109442|564370227|FG004|Overall Study|Lack of Efficacy|11|||
156348258|NCT05109442|564370228|FG005|Overall Study|Lack of Efficacy|17|||
156348259|NCT04853225|564370233|FG000|Overall Study|Withdrawal by Subject|81|||
156348260|NCT04853225|564370234|FG001|Overall Study|Withdrawal by Subject|4|||
156348261|NCT04853225|564370235|FG002|Overall Study|Withdrawal by Subject|1|||
156348262|NCT04853225|564370233|FG000|Overall Study|Physician Decision|12|||
156348263|NCT04853225|564370234|FG001|Overall Study|Physician Decision|4|||
156348264|NCT04853225|564370235|FG002|Overall Study|Physician Decision|1|||
156348265|NCT04853225|564370233|FG000|Overall Study|Lost to Follow-up|50|||
156348266|NCT04853225|564370234|FG001|Overall Study|Lost to Follow-up|0|||
156348267|NCT04853225|564370235|FG002|Overall Study|Lost to Follow-up|0|||
156348268|NCT04853225|564370233|FG000|Overall Study|Other|102|||
156482359|NCT02340806|564858036|FG001|Overall Study|history of chronic pain medication|0|||
156348269|NCT04853225|564370234|FG001|Overall Study|Other|11|||
156348270|NCT04853225|564370235|FG002|Overall Study|Other|5|||
156348271|NCT04853225|564370233|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
156348272|NCT04853225|564370234|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
156348273|NCT04853225|564370235|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
156348274|NCT04853225|564370233|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
156348275|NCT04853225|564370234|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
156348276|NCT04853225|564370235|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
156348277|NCT03918447|564370236|FG000|Overall Study|Death|1|||
156348278|NCT03918447|564370237|FG001|Overall Study|Death|0|||
156348279|NCT03918447|564370236|FG000|Overall Study|Lost to Follow-up|13|||
156348280|NCT03918447|564370237|FG001|Overall Study|Lost to Follow-up|6|||
156348281|NCT03918447|564370236|FG000|Overall Study|Withdrawal by Subject|19|||
156348282|NCT03918447|564370237|FG001|Overall Study|Withdrawal by Subject|17|||
156348283|NCT03918447|564370236|FG000|Overall Study|Study Terminated by Sponsor|195|||
156348284|NCT03918447|564370237|FG001|Overall Study|Study Terminated by Sponsor|197|||
156348285|NCT03918447|564370236|FG000|Overall Study|Reason not Specified|0|||
156348286|NCT03918447|564370237|FG001|Overall Study|Reason not Specified|1|||
156348287|NCT03278613|564370238|FG000|Overall Study|Lost to Follow-up|3|||
156482360|NCT02340806|564858035|FG000|Overall Study|re-dose < 90 min of CSE|1|||
156482361|NCT02340806|564858036|FG001|Overall Study|re-dose < 90 min of CSE|3|||
156482362|NCT01159600|564858038|FG000|Overall Study|Not treated|0|||
156482363|NCT01159600|564858039|FG001|Overall Study|Not treated|0|||
156482364|NCT01159600|564858040|FG002|Overall Study|Not treated|1|||
156482365|NCT01159600|564858041|FG003|Overall Study|Not treated|0|||
156348288|NCT03278613|564370239|FG001|Overall Study|Lost to Follow-up|1|||
156348289|NCT01405456|564370240|FG000|Overall Study|Lost to Follow-up|2|||
156348290|NCT01405456|564370241|FG001|Overall Study|Lost to Follow-up|1|||
156348291|NCT01405456|564370240|FG000|Overall Study|Physician Decision|1|||
156543996|NCT03259074|565086236|FG000|Overall Study|New Therapy For Study Indication|1|||
156543997|NCT03259074|565086237|FG001|Overall Study|New Therapy For Study Indication|2|||
156348292|NCT01405456|564370241|FG001|Overall Study|Physician Decision|0|||
156348293|NCT05475236|564370242|FG000|Overall Study|Withdrawal by Subject|0|||
156348294|NCT05475236|564370243|FG001|Overall Study|Withdrawal by Subject|1|||
156348295|NCT01774968|564370244|FG000|Overall Study|Adverse Event|4|||
156348296|NCT01774968|564370245|FG001|Overall Study|Adverse Event|4|||
156348297|NCT01774968|564370244|FG000|Overall Study|Death|0|||
156348298|NCT01774968|564370245|FG001|Overall Study|Death|1|||
156348299|NCT01774968|564370244|FG000|Overall Study|Lost to Follow-up|1|||
156348300|NCT01774968|564370245|FG001|Overall Study|Lost to Follow-up|3|||
156348301|NCT01774968|564370244|FG000|Overall Study|Physician Decision|5|||
156348302|NCT01774968|564370245|FG001|Overall Study|Physician Decision|1|||
156348303|NCT01774968|564370244|FG000|Overall Study|Protocol Violation|14|||
156348304|NCT01774968|564370245|FG001|Overall Study|Protocol Violation|13|||
156348305|NCT01774968|564370244|FG000|Overall Study|Sponsor Decision|0|||
156348306|NCT01774968|564370245|FG001|Overall Study|Sponsor Decision|2|||
156348307|NCT01774968|564370244|FG000|Overall Study|Withdrawal by Subject|6|||
156348308|NCT01774968|564370245|FG001|Overall Study|Withdrawal by Subject|11|||
156348309|NCT04221009|564372021|FG000|Overall Study|Withdrawal by Subject|4|||
156348310|NCT00793598|564372022|FG000|Overall Study|Patient Request|0|||
156348311|NCT00793598|564372023|FG001|Overall Study|Patient Request|1|||
156348312|NCT00793598|564372024|FG002|Overall Study|Patient Request|0|||
156348313|NCT00793598|564372025|FG003|Overall Study|Patient Request|0|||
156348314|NCT00793598|564372026|FG004|Overall Study|Patient Request|0|||
156348315|NCT00793598|564372027|FG005|Overall Study|Patient Request|0|||
156348316|NCT00793598|564372028|FG006|Overall Study|Patient Request|0|||
156348317|NCT00793598|564372029|FG007|Overall Study|Patient Request|0|||
156348318|NCT00793598|564372022|FG000|Overall Study|Protocol Violation|0|||
156348319|NCT00793598|564372023|FG001|Overall Study|Protocol Violation|0|||
156348320|NCT00793598|564372024|FG002|Overall Study|Protocol Violation|0|||
156348321|NCT00793598|564372025|FG003|Overall Study|Protocol Violation|0|||
156348322|NCT00793598|564372026|FG004|Overall Study|Protocol Violation|0|||
156348323|NCT00793598|564372027|FG005|Overall Study|Protocol Violation|0|||
156348324|NCT00793598|564372028|FG006|Overall Study|Protocol Violation|0|||
156348325|NCT00793598|564372029|FG007|Overall Study|Protocol Violation|1|||
156348326|NCT00793598|564372022|FG000|Overall Study|Subject not dosed|0|||
156348327|NCT00793598|564372023|FG001|Overall Study|Subject not dosed|0|||
156348328|NCT00793598|564372024|FG002|Overall Study|Subject not dosed|0|||
156348329|NCT00793598|564372025|FG003|Overall Study|Subject not dosed|0|||
156348330|NCT00793598|564372026|FG004|Overall Study|Subject not dosed|0|||
156348331|NCT00793598|564372027|FG005|Overall Study|Subject not dosed|1|||
156348332|NCT00793598|564372028|FG006|Overall Study|Subject not dosed|0|||
156348333|NCT00793598|564372029|FG007|Overall Study|Subject not dosed|0|||
156348334|NCT02154490|564372030|FG000|Overall Study|No tissue submitted|23|||
156348335|NCT02154490|564372030|FG000|Overall Study|No biomarker results|167|||
156348336|NCT02154490|564372030|FG000|Overall Study|Not assigned to a sub-study|270|||
156348337|NCT02154490|564372030|FG000|Overall Study|Did not register to a sub-study|749|||
156482366|NCT01159600|564858042|FG004|Overall Study|Not treated|0|||
156482367|NCT01159600|564858043|FG005|Overall Study|Not treated|1|||
156348338|NCT01404325|564372031|FG000|Overall Study|Lost to Follow-up|1|||
156482368|NCT01159600|564858044|FG006|Overall Study|Not treated|2|||
156482369|NCT01159600|564858045|FG007|Overall Study|Not treated|2|||
156482370|NCT01159600|564858038|FG000|Overall Study|Adverse Event|7|||
156482371|NCT01159600|564858039|FG001|Overall Study|Adverse Event|2|||
156482372|NCT01159600|564858040|FG002|Overall Study|Adverse Event|5|||
156482373|NCT01159600|564858041|FG003|Overall Study|Adverse Event|1|||
156482374|NCT01159600|564858042|FG004|Overall Study|Adverse Event|8|||
156482375|NCT01159600|564858043|FG005|Overall Study|Adverse Event|6|||
156482376|NCT01159600|564858044|FG006|Overall Study|Adverse Event|7|||
156348339|NCT01404325|564372032|FG001|Overall Study|Lost to Follow-up|0|||
156348340|NCT01404325|564372031|FG000|Overall Study|Death|2|||
156348341|NCT01404325|564372032|FG001|Overall Study|Death|0|||
156348342|NCT01404325|564372031|FG000|Overall Study|Graft loss/Retransplantation|1|||
156348343|NCT01404325|564372032|FG001|Overall Study|Graft loss/Retransplantation|0|||
156348344|NCT01404325|564372031|FG000|Overall Study|non-specified reason|0|||
156348345|NCT01404325|564372032|FG001|Overall Study|non-specified reason|2|||
156348346|NCT00660023|564372037|FG000|Overall Study|Adverse Event|2|||
156348347|NCT00660023|564372037|FG000|Overall Study|Death|8|||
156348348|NCT00660023|564372037|FG000|Overall Study|Blood Transfusion|5|||
156348349|NCT00660023|564372037|FG000|Overall Study|Renal Transplantation|3|||
156348350|NCT00660023|564372037|FG000|Overall Study|Withdrawal by Subject|1|||
156348351|NCT00660023|564372037|FG000|Overall Study|Missed Pregnancy Test|1|||
156348352|NCT00660023|564372037|FG000|Overall Study|Other Screening Failure|9|||
156348353|NCT04180488|564372039|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
156348354|NCT04180488|564372040|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
156348355|NCT04180488|564372041|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
156348356|NCT04180488|564372042|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
156348357|NCT04180488|564372043|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
156348358|NCT04180488|564372044|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
156348359|NCT04180488|564372039|FG000|Overall Study|Withdrawal by Subject|8|||
156348360|NCT04180488|564372040|FG001|Overall Study|Withdrawal by Subject|4|||
156348361|NCT04180488|564372041|FG002|Overall Study|Withdrawal by Subject|5|||
156348362|NCT04180488|564372042|FG003|Overall Study|Withdrawal by Subject|2|||
156348363|NCT04180488|564372043|FG004|Overall Study|Withdrawal by Subject|8|||
156348364|NCT04180488|564372044|FG005|Overall Study|Withdrawal by Subject|6|||
156348365|NCT04180488|564372039|FG000|Overall Study|Adverse Event|3|||
156348366|NCT04180488|564372040|FG001|Overall Study|Adverse Event|2|||
156348367|NCT04180488|564372041|FG002|Overall Study|Adverse Event|0|||
156348368|NCT04180488|564372042|FG003|Overall Study|Adverse Event|0|||
156348369|NCT04180488|564372043|FG004|Overall Study|Adverse Event|0|||
156348370|NCT04180488|564372044|FG005|Overall Study|Adverse Event|0|||
156348371|NCT04180488|564372039|FG000|Overall Study|Poor compliance to protocol|0|||
156348372|NCT04180488|564372040|FG001|Overall Study|Poor compliance to protocol|0|||
156348373|NCT04180488|564372041|FG002|Overall Study|Poor compliance to protocol|1|||
156348374|NCT04180488|564372042|FG003|Overall Study|Poor compliance to protocol|0|||
156348375|NCT04180488|564372043|FG004|Overall Study|Poor compliance to protocol|0|||
156348376|NCT04180488|564372044|FG005|Overall Study|Poor compliance to protocol|0|||
156348377|NCT00609492|564372048|FG000|Overall Study|Withdrawal by Subject|0|||
156348378|NCT00609492|564372049|FG001|Overall Study|Withdrawal by Subject|2|||
156348379|NCT00609492|564372050|FG002|Overall Study|Withdrawal by Subject|3|||
156348380|NCT00609492|564372048|FG000|Overall Study|Lost to Follow-up|1|||
156348381|NCT00609492|564372049|FG001|Overall Study|Lost to Follow-up|1|||
156348382|NCT00609492|564372050|FG002|Overall Study|Lost to Follow-up|4|||
156348383|NCT03585504|564372055|FG000|Overall Study|Lost to Follow-up|26|||
156348384|NCT03585504|564372056|FG001|Overall Study|Lost to Follow-up|29|||
156482377|NCT01159600|564858045|FG007|Overall Study|Adverse Event|5|||
156482378|NCT01159600|564858038|FG000|Overall Study|Lack of Efficacy|0|||
156482379|NCT01159600|564858039|FG001|Overall Study|Lack of Efficacy|0|||
156482380|NCT01159600|564858040|FG002|Overall Study|Lack of Efficacy|0|||
156482381|NCT01159600|564858041|FG003|Overall Study|Lack of Efficacy|0|||
156482382|NCT01159600|564858042|FG004|Overall Study|Lack of Efficacy|2|||
156482383|NCT01159600|564858043|FG005|Overall Study|Lack of Efficacy|0|||
156482384|NCT01159600|564858044|FG006|Overall Study|Lack of Efficacy|0|||
156348385|NCT04626297|564372057|FG000|Overall Study|Adverse Event|5|||
156348386|NCT04626297|564372058|FG001|Overall Study|Adverse Event|3|||
156348387|NCT04626297|564372057|FG000|Overall Study|Lost to Follow-up|7|||
156348388|NCT04626297|564372058|FG001|Overall Study|Lost to Follow-up|3|||
156348389|NCT04626297|564372057|FG000|Overall Study|Protocol Violation|5|||
156348390|NCT04626297|564372058|FG001|Overall Study|Protocol Violation|1|||
156348391|NCT04626297|564372057|FG000|Overall Study|Withdrawal by Subject|20|||
156348392|NCT04626297|564372058|FG001|Overall Study|Withdrawal by Subject|6|||
156348393|NCT04626297|564372057|FG000|Overall Study|Sponsor decision|2|||
156348394|NCT04626297|564372058|FG001|Overall Study|Sponsor decision|1|||
156348395|NCT04118166|564372059|FG000|Overall Study|Adverse Event|1|||
156348396|NCT01979016|564372065|FG000|Overall Study|Withdrawal by Subject|2|||
156348397|NCT01979016|564372066|FG001|Overall Study|Withdrawal by Subject|0|||
156348398|NCT01979016|564372065|FG000|Overall Study|Adverse Event|0|||
156348399|NCT01979016|564372066|FG001|Overall Study|Adverse Event|1|||
156348400|NCT03303079|564372069|FG000|Overall Study|Adverse Event|0|||
156348401|NCT03303079|564372070|FG001|Overall Study|Adverse Event|1|||
156348402|NCT03303079|564372071|FG002|Overall Study|Adverse Event|3|||
156348403|NCT03303079|564372069|FG000|Overall Study|Protocol Violation|5|||
156348404|NCT03303079|564372070|FG001|Overall Study|Protocol Violation|4|||
156348405|NCT03303079|564372071|FG002|Overall Study|Protocol Violation|7|||
156348406|NCT03303079|564372069|FG000|Overall Study|Withdrawal by Subject|2|||
156348407|NCT03303079|564372070|FG001|Overall Study|Withdrawal by Subject|4|||
156348408|NCT03303079|564372071|FG002|Overall Study|Withdrawal by Subject|2|||
156348409|NCT03303079|564372069|FG000|Overall Study|Other than specified|0|||
156348410|NCT03303079|564372070|FG001|Overall Study|Other than specified|2|||
156348411|NCT03303079|564372071|FG002|Overall Study|Other than specified|0|||
156348412|NCT02706691|564372075|FG000|Overall Study|Adverse Event|1|||
156348413|NCT02927431|564372076|FG000|Overall Study|Withdrawal by Subject|0|||
156348414|NCT02927431|564372077|FG001|Overall Study|Withdrawal by Subject|0|||
156348415|NCT02927431|564372078|FG002|Overall Study|Withdrawal by Subject|1|||
156348416|NCT01830972|564372079|FG000|Part II|Withdrawal by Subject|2|||
156348417|NCT01830972|564372080|FG001|Part II|Withdrawal by Subject|2|||
156348418|NCT01830972|564372079|FG000|Part III|Withdrawal by Subject|1|||
156348419|NCT01830972|564372080|FG001|Part III|Withdrawal by Subject|0|||
156348420|NCT01830972|564372079|FG000|Part III|Noncompliance|1|||
156348421|NCT01830972|564372080|FG001|Part III|Noncompliance|0|||
156348422|NCT01830972|564372079|FG000|Part IV|Withdrawal by Subject|2|||
156348423|NCT01830972|564372080|FG001|Part IV|Withdrawal by Subject|1|||
156348424|NCT01830972|564372079|FG000|Part IV|Non-Compliance|1|||
156348425|NCT01830972|564372080|FG001|Part IV|Non-Compliance|0|||
156348426|NCT01829191|564372081|FG000|Overall Study|Relocation|0|||
156348427|NCT01829191|564372082|FG001|Overall Study|Relocation|1|||
156348428|NCT01829191|564372081|FG000|Overall Study|Lens discomfort|0|||
156348429|NCT01829191|564372082|FG001|Overall Study|Lens discomfort|3|||
156348430|NCT01829191|564372081|FG000|Overall Study|Lens handling difficulty|1|||
156348431|NCT01829191|564372082|FG001|Overall Study|Lens handling difficulty|4|||
156348432|NCT01829191|564372081|FG000|Overall Study|Protocol Violation|4|||
156348433|NCT01829191|564372082|FG001|Overall Study|Protocol Violation|1|||
156348434|NCT01829191|564372081|FG000|Overall Study|Withdrawal by Subject|2|||
156348435|NCT01829191|564372082|FG001|Overall Study|Withdrawal by Subject|3|||
156348436|NCT01829191|564372081|FG000|Overall Study|Lost to Follow-up|0|||
156348437|NCT01829191|564372082|FG001|Overall Study|Lost to Follow-up|1|||
156348438|NCT01829191|564372081|FG000|Overall Study|Subject was fit for ortho - k|0|||
156348439|NCT01829191|564372082|FG001|Overall Study|Subject was fit for ortho - k|1|||
156348440|NCT01276353|564372085|FG000|Double-blind|Adverse Event|2|||
156348441|NCT01276353|564372086|FG001|Double-blind|Adverse Event|0|||
156348442|NCT01276353|564372085|FG000|Double-blind|Withdrawal by Subject|1|||
156348443|NCT01276353|564372086|FG001|Double-blind|Withdrawal by Subject|0|||
156348444|NCT01276353|564372085|FG000|Extension|Adverse Event|2|||
156348445|NCT01276353|564372086|FG001|Extension|Adverse Event|5|||
156348446|NCT01276353|564372085|FG000|Extension|Withdrawal by Subject|1|||
156348447|NCT01276353|564372086|FG001|Extension|Withdrawal by Subject|2|||
156482385|NCT01159600|564858045|FG007|Overall Study|Lack of Efficacy|1|||
156348448|NCT01276353|564372085|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
156348449|NCT01276353|564372086|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
156348450|NCT01276353|564372085|FG000|Extension|Physician Decision|1|||
156348451|NCT01276353|564372086|FG001|Extension|Physician Decision|0|||
156348452|NCT01276353|564372085|FG000|Extension|Prohibited concomitant medications|0|||
156348453|NCT01276353|564372086|FG001|Extension|Prohibited concomitant medications|1|||
156348454|NCT00553514|564372089|FG000|Overall Study|Protocol deviation|0|||
156482386|NCT01159600|564858038|FG000|Overall Study|Non compliant with protocol|2|||
156482387|NCT01159600|564858039|FG001|Overall Study|Non compliant with protocol|1|||
156482388|NCT01159600|564858040|FG002|Overall Study|Non compliant with protocol|0|||
156482389|NCT01159600|564858041|FG003|Overall Study|Non compliant with protocol|0|||
156482390|NCT01159600|564858042|FG004|Overall Study|Non compliant with protocol|2|||
156482391|NCT01159600|564858043|FG005|Overall Study|Non compliant with protocol|0|||
156482392|NCT01159600|564858044|FG006|Overall Study|Non compliant with protocol|2|||
156482393|NCT01159600|564858045|FG007|Overall Study|Non compliant with protocol|0|||
156482394|NCT01159600|564858038|FG000|Overall Study|Lost to Follow-up|2|||
156543998|NCT03259074|565086238|FG002|Overall Study|New Therapy For Study Indication|2|||
156482395|NCT01159600|564858039|FG001|Overall Study|Lost to Follow-up|3|||
156482396|NCT01159600|564858040|FG002|Overall Study|Lost to Follow-up|4|||
156482397|NCT01159600|564858041|FG003|Overall Study|Lost to Follow-up|3|||
156482398|NCT01159600|564858042|FG004|Overall Study|Lost to Follow-up|3|||
156543999|NCT03259074|565086236|FG000|Overall Study|Physician Decision|4|||
156544000|NCT03259074|565086237|FG001|Overall Study|Physician Decision|12|||
156482399|NCT01159600|564858043|FG005|Overall Study|Lost to Follow-up|0|||
156482400|NCT01159600|564858044|FG006|Overall Study|Lost to Follow-up|3|||
156482401|NCT01159600|564858045|FG007|Overall Study|Lost to Follow-up|2|||
156482402|NCT01159600|564858038|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
156482403|NCT01159600|564858039|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
156482404|NCT01159600|564858040|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
156482405|NCT01159600|564858041|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
156482406|NCT01159600|564858042|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
156482407|NCT01159600|564858043|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
156348455|NCT00553514|564372090|FG001|Overall Study|Protocol deviation|0|||
156348456|NCT00553514|564372091|FG002|Overall Study|Protocol deviation|0|||
156544001|NCT03259074|565086238|FG002|Overall Study|Physician Decision|10|||
156544002|NCT03259074|565086236|FG000|Overall Study|Pregnancy|1|||
156544003|NCT03259074|565086237|FG001|Overall Study|Pregnancy|1|||
156544004|NCT03259074|565086238|FG002|Overall Study|Pregnancy|0|||
156544005|NCT03259074|565086236|FG000|Overall Study|Progressive Disease|1|||
156544006|NCT03259074|565086237|FG001|Overall Study|Progressive Disease|0|||
156544007|NCT03259074|565086238|FG002|Overall Study|Progressive Disease|0|||
156544008|NCT03259074|565086236|FG000|Overall Study|Protocol Deviation|1|||
156544009|NCT03259074|565086237|FG001|Overall Study|Protocol Deviation|1|||
156544010|NCT03259074|565086238|FG002|Overall Study|Protocol Deviation|3|||
156544011|NCT03259074|565086236|FG000|Overall Study|Subject/Guardian Decision|13|||
156544012|NCT03259074|565086237|FG001|Overall Study|Subject/Guardian Decision|16|||
156544013|NCT03259074|565086238|FG002|Overall Study|Subject/Guardian Decision|14|||
156544014|NCT00053417|565086239|FG000|Overall Study|Adverse Event|1|||
156544015|NCT00053417|565086240|FG001|Overall Study|Adverse Event|0|||
156544016|NCT00053417|565086241|FG002|Overall Study|Adverse Event|1|||
156544017|NCT00053417|565086242|FG003|Overall Study|Adverse Event|5|||
156544018|NCT00053417|565086239|FG000|Overall Study|Non-Compliance|0|||
156544019|NCT00053417|565086240|FG001|Overall Study|Non-Compliance|0|||
156544020|NCT00053417|565086241|FG002|Overall Study|Non-Compliance|0|||
156544021|NCT00053417|565086242|FG003|Overall Study|Non-Compliance|1|||
156544022|NCT00053417|565086239|FG000|Overall Study|Withdrawal by Subject|0|||
156544023|NCT00053417|565086240|FG001|Overall Study|Withdrawal by Subject|1|||
156544024|NCT00053417|565086241|FG002|Overall Study|Withdrawal by Subject|0|||
156544025|NCT00053417|565086242|FG003|Overall Study|Withdrawal by Subject|0|||
156544026|NCT00053417|565086239|FG000|Overall Study|Lost to Follow-up|1|||
156544027|NCT00053417|565086240|FG001|Overall Study|Lost to Follow-up|1|||
156544028|NCT00053417|565086241|FG002|Overall Study|Lost to Follow-up|0|||
156544029|NCT00053417|565086242|FG003|Overall Study|Lost to Follow-up|0|||
156348457|NCT00553514|564372092|FG003|Overall Study|Protocol deviation|1|||
156544030|NCT04251910|565086248|FG000|Overall Study|Covid 19 lockdown|0|||
156544031|NCT04251910|565086249|FG001|Overall Study|Covid 19 lockdown|5|||
156544032|NCT04251910|565086250|FG002|Overall Study|Covid 19 lockdown|0|||
156544033|NCT04251910|565086251|FG003|Overall Study|Covid 19 lockdown|4|||
156544034|NCT04251910|565086252|FG004|Overall Study|Covid 19 lockdown|0|||
156544035|NCT04251910|565086253|FG005|Overall Study|Covid 19 lockdown|0|||
156544036|NCT04251910|565086248|FG000|Overall Study|Assisted living facility was closed|0|||
156544037|NCT04251910|565086249|FG001|Overall Study|Assisted living facility was closed|0|||
156544038|NCT04251910|565086250|FG002|Overall Study|Assisted living facility was closed|0|||
156348458|NCT00553514|564372093|FG004|Overall Study|Protocol deviation|0|||
156348459|NCT00553514|564372089|FG000|Overall Study|Lack of ovarian response|4|||
156348460|NCT00553514|564372090|FG001|Overall Study|Lack of ovarian response|5|||
156482408|NCT01159600|564858044|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
156544039|NCT04251910|565086251|FG003|Overall Study|Assisted living facility was closed|0|||
156544040|NCT04251910|565086252|FG004|Overall Study|Assisted living facility was closed|1|||
156544041|NCT04251910|565086253|FG005|Overall Study|Assisted living facility was closed|0|||
156544042|NCT01553188|565086260|FG000|Overall Study|Patient choice|1|||
156544043|NCT01553188|565086261|FG001|Overall Study|Patient choice|0|||
156544044|NCT01553188|565086262|FG002|Overall Study|Patient choice|0|||
156544045|NCT01553188|565086263|FG003|Overall Study|Patient choice|0|||
156544046|NCT01553188|565086260|FG000|Overall Study|Intercurrent illness and adverse event|0|||
156544047|NCT01553188|565086261|FG001|Overall Study|Intercurrent illness and adverse event|1|||
156544048|NCT01553188|565086262|FG002|Overall Study|Intercurrent illness and adverse event|2|||
156544049|NCT01553188|565086263|FG003|Overall Study|Intercurrent illness and adverse event|0|||
156544050|NCT04544475|565086264|FG000|Overall Study|Withdrawal by Subject|1|||
156544051|NCT04544475|565086265|FG001|Overall Study|Withdrawal by Subject|3|||
156544052|NCT00135668|565086270|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
156544053|NCT00135668|565086271|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
156544054|NCT00135668|565086272|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
156544055|NCT00135668|565086273|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
156544056|NCT04126083|565086274|FG000|Overall Study|Withdrawal by Subject|1|||
156544057|NCT00932360|565086275|FG000|Washout (One Week)|Withdrawal by Subject|0|||
156544058|NCT00932360|565086276|FG001|Washout (One Week)|Withdrawal by Subject|0|||
156544059|NCT00932360|565086277|FG002|Washout (One Week)|Withdrawal by Subject|0|||
156544060|NCT00932360|565086278|FG003|Washout (One Week)|Withdrawal by Subject|0|||
156544061|NCT00932360|565086279|FG004|Washout (One Week)|Withdrawal by Subject|2|||
156544062|NCT00932360|565086280|FG005|Washout (One Week)|Withdrawal by Subject|0|||
156544063|NCT01892163|565086283|FG000|Overall Study|Death|1|||
156544064|NCT01892163|565086284|FG001|Overall Study|Death|1|||
156544065|NCT01892163|565086283|FG000|Overall Study|Lost to Follow-up|1|||
156544066|NCT01892163|565086284|FG001|Overall Study|Lost to Follow-up|0|||
156544067|NCT04143009|565086286|FG000|Pilot Trial|Lost to Follow-up|0|||
156544068|NCT04143009|565086287|FG001|Pilot Trial|Lost to Follow-up|1|||
156544069|NCT04143009|565086288|FG002|Pilot Trial|Lost to Follow-up|1|||
156544070|NCT02577146|565086293|FG000|Overall Study|Lost to Follow-up|8|||
156544071|NCT02577146|565086293|FG000|Overall Study|Physician Decision|3|||
156544072|NCT02577146|565086293|FG000|Overall Study|Screen Failure|17|||
156544073|NCT01357655|565086294|FG000|Overall Study|Administrative Reason by Sponsor|45|||
156544074|NCT01357655|565086295|FG001|Overall Study|Administrative Reason by Sponsor|0|||
156544075|NCT01357655|565086294|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
156544076|NCT01357655|565086295|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156544077|NCT01357655|565086294|FG000|Overall Study|Disease Progression|1|||
156544078|NCT01357655|565086295|FG001|Overall Study|Disease Progression|0|||
156544079|NCT01357655|565086294|FG000|Overall Study|Lost to Follow-up|2|||
156348461|NCT00553514|564372091|FG002|Overall Study|Lack of ovarian response|5|||
156348462|NCT00553514|564372092|FG003|Overall Study|Lack of ovarian response|5|||
156482409|NCT01159600|564858045|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
156482410|NCT01159600|564858038|FG000|Overall Study|Other reason not defined above|3|||
156544080|NCT01357655|565086295|FG001|Overall Study|Lost to Follow-up|0|||
156348463|NCT00553514|564372093|FG004|Overall Study|Lack of ovarian response|6|||
156348464|NCT00553514|564372089|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
156348465|NCT00553514|564372090|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
156348466|NCT00553514|564372091|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
156348467|NCT00553514|564372092|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
156348468|NCT00553514|564372093|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
156348469|NCT00553514|564372089|FG000|Overall Study|Risk of multiple pregnancy|0|||
156348470|NCT00553514|564372090|FG001|Overall Study|Risk of multiple pregnancy|2|||
156348471|NCT00553514|564372091|FG002|Overall Study|Risk of multiple pregnancy|0|||
156348472|NCT00553514|564372092|FG003|Overall Study|Risk of multiple pregnancy|1|||
156348473|NCT00553514|564372093|FG004|Overall Study|Risk of multiple pregnancy|0|||
156348474|NCT00553514|564372089|FG000|Overall Study|Other|1|||
156348475|NCT00553514|564372090|FG001|Overall Study|Other|1|||
156348476|NCT00553514|564372091|FG002|Overall Study|Other|0|||
156348477|NCT00553514|564372092|FG003|Overall Study|Other|0|||
156348478|NCT00553514|564372093|FG004|Overall Study|Other|1|||
156348479|NCT02205814|564372095|FG000|Overall Study|Lost to Follow-up|0|||
156348480|NCT02205814|564372096|FG001|Overall Study|Lost to Follow-up|0|||
156348481|NCT02205814|564372097|FG002|Overall Study|Lost to Follow-up|0|||
156348482|NCT02205814|564372098|FG003|Overall Study|Lost to Follow-up|1|||
156348483|NCT02205814|564372095|FG000|Overall Study|Lack of Efficacy|1|||
156348484|NCT02205814|564372096|FG001|Overall Study|Lack of Efficacy|0|||
156348485|NCT02205814|564372097|FG002|Overall Study|Lack of Efficacy|1|||
156348486|NCT02205814|564372098|FG003|Overall Study|Lack of Efficacy|1|||
156482411|NCT01159600|564858039|FG001|Overall Study|Other reason not defined above|0|||
156482412|NCT01159600|564858040|FG002|Overall Study|Other reason not defined above|4|||
156348487|NCT02205814|564372095|FG000|Overall Study|Physician Decision|0|||
156482413|NCT01159600|564858041|FG003|Overall Study|Other reason not defined above|2|||
156482414|NCT01159600|564858042|FG004|Overall Study|Other reason not defined above|5|||
156482415|NCT01159600|564858043|FG005|Overall Study|Other reason not defined above|7|||
156482416|NCT01159600|564858044|FG006|Overall Study|Other reason not defined above|3|||
156482417|NCT01159600|564858045|FG007|Overall Study|Other reason not defined above|3|||
156482418|NCT00760877|564859029|FG000|Overall Study|Protocol Violation|1|||
156482419|NCT00760877|564859030|FG001|Overall Study|Protocol Violation|0|||
156482420|NCT00760877|564859029|FG000|Overall Study|Non-compliance with protocol treatment|2|||
156482421|NCT00760877|564859030|FG001|Overall Study|Non-compliance with protocol treatment|1|||
156482422|NCT00760877|564859029|FG000|Overall Study|Pregnancy|1|||
156482423|NCT00760877|564859030|FG001|Overall Study|Pregnancy|4|||
156482424|NCT00760877|564859029|FG000|Overall Study|Death|2|||
156482425|NCT00760877|564859030|FG001|Overall Study|Death|1|||
156482426|NCT00760877|564859029|FG000|Overall Study|Withdrawal by Subject|7|||
156482427|NCT00760877|564859030|FG001|Overall Study|Withdrawal by Subject|3|||
156482428|NCT00760877|564859029|FG000|Overall Study|Adverse Event|19|||
156482429|NCT00760877|564859030|FG001|Overall Study|Adverse Event|12|||
156482430|NCT00760877|564859029|FG000|Overall Study|Participant diagnosed with AML|0|||
156482431|NCT00760877|564859030|FG001|Overall Study|Participant diagnosed with AML|1|||
156482432|NCT00760877|564859029|FG000|Overall Study|Participant not eligible to cross-over|0|||
156482433|NCT00760877|564859030|FG001|Overall Study|Participant not eligible to cross-over|1|||
156482434|NCT00760877|564859029|FG000|Overall Study|Physician Decision|1|||
156482435|NCT00760877|564859030|FG001|Overall Study|Physician Decision|2|||
156482436|NCT00760877|564859029|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
156482437|NCT00760877|564859030|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
156482438|NCT00760877|564859029|FG000|Overall Study|Treatment failure|1|||
156482439|NCT00760877|564859030|FG001|Overall Study|Treatment failure|0|||
156482440|NCT01730118|564859031|FG000|Dose Escalation|Death on study|5|||
156482441|NCT01730118|564859032|FG001|Dose Escalation|Death on study|7|||
156482442|NCT01730118|564859033|FG002|Dose Escalation|Death on study|2|||
156482443|NCT01730118|564859034|FG003|Dose Escalation|Death on study|6|||
156482444|NCT01730118|564859035|FG004|Dose Escalation|Death on study|0|||
156482445|NCT01730118|564859036|FG005|Dose Escalation|Death on study|0|||
156482446|NCT01730118|564859037|FG006|Dose Escalation|Death on study|0|||
156544081|NCT01357655|565086294|FG000|Overall Study|Maximum Clinical Benefit|2|||
156348488|NCT02205814|564372096|FG001|Overall Study|Physician Decision|0|||
156482447|NCT01730118|564859031|FG000|Dose Escalation|Died before treatment|0|||
156482448|NCT01730118|564859032|FG001|Dose Escalation|Died before treatment|0|||
156482449|NCT01730118|564859033|FG002|Dose Escalation|Died before treatment|0|||
156482450|NCT01730118|564859034|FG003|Dose Escalation|Died before treatment|0|||
156482451|NCT01730118|564859035|FG004|Dose Escalation|Died before treatment|0|||
156544082|NCT01357655|565086295|FG001|Overall Study|Maximum Clinical Benefit|0|||
156544083|NCT01357655|565086294|FG000|Overall Study|Reason Unspecified|1|||
156544084|NCT01357655|565086295|FG001|Overall Study|Reason Unspecified|0|||
156544085|NCT01357655|565086294|FG000|Overall Study|Study Drug Toxicity|11|||
156544086|NCT01357655|565086295|FG001|Overall Study|Study Drug Toxicity|0|||
156544087|NCT01357655|565086294|FG000|Overall Study|Subject Withdrew Consent|1|||
156544088|NCT01357655|565086295|FG001|Overall Study|Subject Withdrew Consent|0|||
156544089|NCT05003622|565086296|FG000|Overall Study|Progressive disease|2|||
156544090|NCT05003622|565086296|FG000|Overall Study|Withdrawal by Subject|1|||
156544091|NCT01624662|565086301|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
156544092|NCT01624662|565086302|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
156544093|NCT01624662|565086303|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
156544094|NCT01624662|565086304|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
156544095|NCT01624662|565086301|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
156544096|NCT01624662|565086302|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
156348489|NCT02205814|564372097|FG002|Overall Study|Physician Decision|1|||
156348490|NCT02205814|564372098|FG003|Overall Study|Physician Decision|0|||
156544097|NCT01624662|565086303|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
156348491|NCT02205814|564372095|FG000|Overall Study|Protocol Violation|1|||
156544098|NCT01624662|565086304|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
156348492|NCT02205814|564372096|FG001|Overall Study|Protocol Violation|0|||
156348493|NCT02205814|564372097|FG002|Overall Study|Protocol Violation|0|||
156348494|NCT02205814|564372098|FG003|Overall Study|Protocol Violation|1|||
156348495|NCT02205814|564372095|FG000|Overall Study|Withdrawal by Subject|0|||
156348496|NCT02205814|564372096|FG001|Overall Study|Withdrawal by Subject|1|||
156348497|NCT02205814|564372097|FG002|Overall Study|Withdrawal by Subject|2|||
156348498|NCT02205814|564372098|FG003|Overall Study|Withdrawal by Subject|1|||
156348499|NCT02205814|564372095|FG000|Overall Study|not compliant with study procedures|0|||
156348500|NCT02205814|564372096|FG001|Overall Study|not compliant with study procedures|0|||
156348501|NCT02205814|564372097|FG002|Overall Study|not compliant with study procedures|1|||
156348502|NCT02205814|564372098|FG003|Overall Study|not compliant with study procedures|0|||
156348503|NCT01426373|564372099|FG000|Overall Study|Adverse Event|6|||
156348504|NCT01426373|564372099|FG000|Overall Study|Lost to Follow-up|14|||
156348505|NCT01426373|564372099|FG000|Overall Study|Participant Convenience|10|||
156348506|NCT01426373|564372099|FG000|Overall Study|Miscellaneous Reasons|4|||
156348507|NCT02246660|564372100|FG000|Overall Study|Withdrawal by Subject|0|||
156348508|NCT02246660|564372101|FG001|Overall Study|Withdrawal by Subject|1|||
156348509|NCT02246660|564372102|FG002|Overall Study|Withdrawal by Subject|0|||
156348510|NCT02246660|564372100|FG000|Overall Study|Death|0|||
156348511|NCT02246660|564372101|FG001|Overall Study|Death|0|||
156348512|NCT02246660|564372102|FG002|Overall Study|Death|1|||
156348513|NCT00726661|564372103|FG000|Overall Study|Lost to Follow-up|36|||
156348514|NCT00726661|564372104|FG001|Overall Study|Lost to Follow-up|11|||
156348515|NCT00726661|564372103|FG000|Overall Study|Withdrawal by Subject|17|||
156348516|NCT00726661|564372104|FG001|Overall Study|Withdrawal by Subject|13|||
156348517|NCT00726661|564372103|FG000|Overall Study|Trial terminated by sponsor|214|||
156348518|NCT00726661|564372104|FG001|Overall Study|Trial terminated by sponsor|187|||
156348519|NCT00726661|564372103|FG000|Overall Study|Death|475|||
156348520|NCT00726661|564372104|FG001|Overall Study|Death|159|||
156348521|NCT00726661|564372103|FG000|Overall Study|Physician Decision|25|||
156348522|NCT00726661|564372104|FG001|Overall Study|Physician Decision|13|||
156348523|NCT00726661|564372103|FG000|Overall Study|Other|47|||
156348524|NCT00726661|564372104|FG001|Overall Study|Other|35|||
156348525|NCT00587639|564372105|FG000|Overall Study|Withdrawal by Subject|1|||
156348526|NCT01574326|564372108|FG000|Overall Study|Randomized but not treated|0|||
156348527|NCT01574326|564372109|FG001|Overall Study|Randomized but not treated|1|||
156348528|NCT01574326|564372108|FG000|Overall Study|Withdrawal by Participant|2|||
156348529|NCT01574326|564372109|FG001|Overall Study|Withdrawal by Participant|4|||
156348530|NCT01574326|564372108|FG000|Overall Study|Physician Decision|5|||
156348531|NCT01574326|564372109|FG001|Overall Study|Physician Decision|3|||
156348532|NCT01574326|564372108|FG000|Overall Study|Adverse Event|1|||
156348533|NCT01574326|564372109|FG001|Overall Study|Adverse Event|3|||
156348534|NCT01574326|564372108|FG000|Overall Study|Other: Mainly kidney transplant|8|||
156348535|NCT01574326|564372109|FG001|Overall Study|Other: Mainly kidney transplant|8|||
156348536|NCT00005937|564372116|FG000|Overall Study|Lack of Efficacy|5|||
156482452|NCT01730118|564859036|FG005|Dose Escalation|Died before treatment|0|||
156482453|NCT01730118|564859037|FG006|Dose Escalation|Died before treatment|1|||
156482454|NCT01730118|564859031|FG000|Dose Escalation|Chose to start a different treatment|1|||
156482455|NCT01730118|564859032|FG001|Dose Escalation|Chose to start a different treatment|0|||
156482456|NCT01730118|564859033|FG002|Dose Escalation|Chose to start a different treatment|0|||
156482457|NCT01730118|564859034|FG003|Dose Escalation|Chose to start a different treatment|0|||
156482458|NCT01730118|564859035|FG004|Dose Escalation|Chose to start a different treatment|0|||
156482459|NCT01730118|564859036|FG005|Dose Escalation|Chose to start a different treatment|0|||
156482460|NCT01730118|564859037|FG006|Dose Escalation|Chose to start a different treatment|0|||
156482461|NCT01730118|564859031|FG000|Dose Escalation|Withdrawal by Subject|0|||
156482462|NCT01730118|564859032|FG001|Dose Escalation|Withdrawal by Subject|0|||
156482463|NCT01730118|564859033|FG002|Dose Escalation|Withdrawal by Subject|1|||
156482464|NCT01730118|564859034|FG003|Dose Escalation|Withdrawal by Subject|0|||
156544099|NCT01624662|565086301|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
156348537|NCT01288469|564372117|FG000|Overall Study|Adverse Event|4|||
156348538|NCT01288469|564372118|FG001|Overall Study|Adverse Event|1|||
156348539|NCT01288469|564372119|FG002|Overall Study|Adverse Event|1|||
156348540|NCT01288469|564372117|FG000|Overall Study|Poor compliance to protocol|0|||
156348541|NCT01288469|564372118|FG001|Overall Study|Poor compliance to protocol|1|||
156348542|NCT01288469|564372119|FG002|Overall Study|Poor compliance to protocol|0|||
156348543|NCT01288469|564372117|FG000|Overall Study|Participant Moved|1|||
156544100|NCT01624662|565086302|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
156348544|NCT01288469|564372118|FG001|Overall Study|Participant Moved|0|||
156348545|NCT01288469|564372119|FG002|Overall Study|Participant Moved|0|||
156348546|NCT01288469|564372117|FG000|Overall Study|Consent withdrawn by subject|1|||
156482465|NCT01730118|564859035|FG004|Dose Escalation|Withdrawal by Subject|0|||
156482466|NCT01730118|564859036|FG005|Dose Escalation|Withdrawal by Subject|0|||
156348547|NCT01288469|564372118|FG001|Overall Study|Consent withdrawn by subject|1|||
156348548|NCT01288469|564372119|FG002|Overall Study|Consent withdrawn by subject|1|||
156348549|NCT01288469|564372117|FG000|Overall Study|Exclusion criteria finally met|1|||
156348550|NCT01288469|564372118|FG001|Overall Study|Exclusion criteria finally met|0|||
156348551|NCT01288469|564372119|FG002|Overall Study|Exclusion criteria finally met|0|||
156348552|NCT00582166|564372122|FG000|Overall Study|Death|1|||
156348553|NCT00582166|564372122|FG000|Overall Study|Ineligible pathology|1|||
156348554|NCT04294472|564372123|FG000|Overall Study|Adverse Event|0|||
156348555|NCT04294472|564372124|FG001|Overall Study|Adverse Event|1|||
156348556|NCT04294472|564372125|FG002|Overall Study|Adverse Event|1|||
156348557|NCT04294472|564372123|FG000|Overall Study|Randomized but not treated|0|||
156348558|NCT04294472|564372124|FG001|Overall Study|Randomized but not treated|1|||
156348559|NCT04294472|564372125|FG002|Overall Study|Randomized but not treated|1|||
156348560|NCT02452398|564372128|FG000|Overall Study|Adverse Event|1|||
156348561|NCT02452398|564372128|FG000|Overall Study|Lost to Follow-up|28|||
156348562|NCT02452398|564372128|FG000|Overall Study|Physician Decision|2|||
156348563|NCT02452398|564372128|FG000|Overall Study|Withdrawal by Subject|6|||
156348564|NCT02452398|564372128|FG000|Overall Study|Moved away|4|||
156348565|NCT03944954|564372129|FG000|Overall Study|Withdrawal by Subject|22|||
156348566|NCT03944954|564372130|FG001|Overall Study|Withdrawal by Subject|4|||
156348567|NCT03944954|564372129|FG000|Overall Study|Lost to Follow-up|18|||
156348568|NCT03944954|564372130|FG001|Overall Study|Lost to Follow-up|0|||
156348569|NCT03944954|564372129|FG000|Overall Study|Failed Medical Screening|7|||
156348570|NCT03944954|564372130|FG001|Overall Study|Failed Medical Screening|0|||
156348571|NCT03798483|564372131|FG000|Overall Study|Lost to Follow-up|2|||
156348572|NCT02289417|564372132|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
156348573|NCT02289417|564372133|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156348574|NCT02289417|564372134|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
156348575|NCT02289417|564372135|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156348576|NCT02289417|564372136|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156482467|NCT01730118|564859037|FG006|Dose Escalation|Withdrawal by Subject|0|||
156348577|NCT02289417|564372137|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156348578|NCT02289417|564372138|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156348579|NCT02289417|564372139|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156348580|NCT02289417|564372140|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156482468|NCT01730118|564859031|FG000|Dose Escalation|Disease progression prior to treatment|0|||
156482469|NCT01730118|564859032|FG001|Dose Escalation|Disease progression prior to treatment|0|||
156482470|NCT01730118|564859033|FG002|Dose Escalation|Disease progression prior to treatment|0|||
156482471|NCT01730118|564859034|FG003|Dose Escalation|Disease progression prior to treatment|0|||
156482472|NCT01730118|564859035|FG004|Dose Escalation|Disease progression prior to treatment|0|||
156482473|NCT01730118|564859036|FG005|Dose Escalation|Disease progression prior to treatment|0|||
156544101|NCT01624662|565086303|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
156544102|NCT01624662|565086304|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
156348581|NCT02289417|564372132|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
156348582|NCT02289417|564372133|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
156348583|NCT02289417|564372134|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
156348584|NCT02289417|564372135|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156348585|NCT02289417|564372136|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156348586|NCT02289417|564372137|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156348587|NCT02289417|564372138|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156348588|NCT02289417|564372139|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156348589|NCT02289417|564372140|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156348590|NCT02289417|564372132|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156348591|NCT02289417|564372133|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
156348592|NCT02289417|564372134|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156348593|NCT02289417|564372135|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156348594|NCT02289417|564372136|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156348595|NCT02289417|564372137|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156348596|NCT02289417|564372138|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156348597|NCT02289417|564372139|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156348598|NCT02289417|564372140|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156348599|NCT02289417|564372132|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
156348600|NCT02289417|564372133|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156482474|NCT01730118|564859037|FG006|Dose Escalation|Disease progression prior to treatment|1|||
156482475|NCT01730118|564859031|FG000|Dose Expansion|Death|0|||
156348601|NCT02289417|564372134|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156348602|NCT02289417|564372135|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156348603|NCT02289417|564372136|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156348604|NCT02289417|564372137|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156348605|NCT02289417|564372138|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156348606|NCT02289417|564372139|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156482476|NCT01730118|564859032|FG001|Dose Expansion|Death|0|||
156482477|NCT01730118|564859033|FG002|Dose Expansion|Death|0|||
156482478|NCT01730118|564859034|FG003|Dose Expansion|Death|0|||
156482479|NCT01730118|564859035|FG004|Dose Expansion|Death|1|||
156348607|NCT02289417|564372140|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156348608|NCT02289417|564372132|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
156482480|NCT01730118|564859036|FG005|Dose Expansion|Death|0|||
156348609|NCT02289417|564372133|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
156348610|NCT02289417|564372134|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
156348611|NCT02289417|564372135|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
156348612|NCT02289417|564372136|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
156348613|NCT02289417|564372137|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
156348614|NCT02289417|564372138|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
156348615|NCT02289417|564372139|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
156348616|NCT02289417|564372140|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
156348617|NCT02289417|564372132|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156348618|NCT02289417|564372133|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156348619|NCT02289417|564372134|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
156348620|NCT02289417|564372135|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156348621|NCT02289417|564372136|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156348622|NCT02289417|564372137|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156348623|NCT02289417|564372138|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156348624|NCT02289417|564372139|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156348625|NCT02289417|564372140|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156348626|NCT02289417|564372132|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
156348627|NCT02289417|564372133|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
156348628|NCT02289417|564372134|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
156348629|NCT02289417|564372135|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
156348630|NCT02289417|564372136|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
156348631|NCT02289417|564372137|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
156348632|NCT02289417|564372138|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
156348633|NCT02289417|564372139|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
156348634|NCT02289417|564372140|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
156348635|NCT02289417|564372132|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156348636|NCT02289417|564372133|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156348637|NCT02289417|564372134|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
156348638|NCT02289417|564372135|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156348639|NCT02289417|564372136|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
156348640|NCT02289417|564372137|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
156348641|NCT02289417|564372138|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156348642|NCT02289417|564372139|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156348643|NCT02289417|564372140|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156348644|NCT02289417|564372132|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156348645|NCT02289417|564372133|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156348646|NCT02289417|564372134|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156348647|NCT02289417|564372135|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156348648|NCT02289417|564372136|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156348649|NCT02289417|564372137|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156348650|NCT02289417|564372138|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
156348651|NCT02289417|564372139|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156348652|NCT02289417|564372140|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156348653|NCT02289417|564372132|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156348654|NCT02289417|564372133|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156348655|NCT02289417|564372134|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156348656|NCT02289417|564372135|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
156482481|NCT01730118|564859037|FG006|Dose Expansion|Death|0|||
156482482|NCT01730118|564859031|FG000|Dose Expansion|Other medical condition|0|||
156482483|NCT01730118|564859032|FG001|Dose Expansion|Other medical condition|0|||
156482484|NCT01730118|564859033|FG002|Dose Expansion|Other medical condition|0|||
156482485|NCT01730118|564859034|FG003|Dose Expansion|Other medical condition|0|||
156482486|NCT01730118|564859035|FG004|Dose Expansion|Other medical condition|1|||
156482487|NCT01730118|564859036|FG005|Dose Expansion|Other medical condition|0|||
156482488|NCT01730118|564859037|FG006|Dose Expansion|Other medical condition|0|||
156482489|NCT01730118|564859031|FG000|Dose Expansion|Withdrawal by Subject|0|||
156482490|NCT01730118|564859032|FG001|Dose Expansion|Withdrawal by Subject|0|||
156482491|NCT01730118|564859033|FG002|Dose Expansion|Withdrawal by Subject|0|||
156348657|NCT02289417|564372136|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156482492|NCT01730118|564859034|FG003|Dose Expansion|Withdrawal by Subject|0|||
156482493|NCT01730118|564859035|FG004|Dose Expansion|Withdrawal by Subject|1|||
156348658|NCT02289417|564372137|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156348659|NCT02289417|564372138|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
156348660|NCT02289417|564372139|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156348661|NCT02289417|564372140|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156348662|NCT02289417|564372132|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
156348663|NCT02289417|564372133|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
156348664|NCT02289417|564372134|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
156544103|NCT01624662|565086301|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
156482494|NCT01730118|564859036|FG005|Dose Expansion|Withdrawal by Subject|0|||
156482495|NCT01730118|564859037|FG006|Dose Expansion|Withdrawal by Subject|0|||
156482496|NCT01730118|564859031|FG000|Dose Expansion|Disease progression|0|||
156348665|NCT02289417|564372135|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
156348666|NCT02289417|564372136|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
156482497|NCT01730118|564859032|FG001|Dose Expansion|Disease progression|0|||
156482498|NCT01730118|564859033|FG002|Dose Expansion|Disease progression|0|||
156482499|NCT01730118|564859034|FG003|Dose Expansion|Disease progression|0|||
156482500|NCT01730118|564859035|FG004|Dose Expansion|Disease progression|0|||
156482501|NCT01730118|564859036|FG005|Dose Expansion|Disease progression|1|||
156482502|NCT01730118|564859037|FG006|Dose Expansion|Disease progression|0|||
156482503|NCT01730118|564859031|FG000|Dose Expansion|Inability to return|0|||
156482504|NCT01730118|564859032|FG001|Dose Expansion|Inability to return|0|||
156482505|NCT01730118|564859033|FG002|Dose Expansion|Inability to return|0|||
156348667|NCT02289417|564372137|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
156348668|NCT02289417|564372138|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
156348669|NCT02289417|564372139|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
156348670|NCT02289417|564372140|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
156348671|NCT02289417|564372132|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156348672|NCT02289417|564372133|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156348673|NCT02289417|564372134|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156348674|NCT02289417|564372135|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156348675|NCT02289417|564372136|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156348676|NCT02289417|564372137|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156348677|NCT02289417|564372138|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156348678|NCT02289417|564372139|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
156348679|NCT02289417|564372140|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
156348680|NCT02289417|564372132|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156348681|NCT02289417|564372133|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156348682|NCT02289417|564372134|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156348683|NCT02289417|564372135|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156348684|NCT02289417|564372136|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156348685|NCT02289417|564372137|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156348686|NCT02289417|564372138|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156348687|NCT02289417|564372139|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
156348688|NCT02289417|564372140|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
156348689|NCT02289417|564372132|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
156348690|NCT02289417|564372133|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
156348691|NCT02289417|564372134|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
156348692|NCT02289417|564372135|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
156348693|NCT02289417|564372136|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
156348694|NCT02289417|564372137|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
156348695|NCT02289417|564372138|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
156348696|NCT02289417|564372139|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
156348697|NCT02289417|564372140|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
156348698|NCT02725710|564372141|FG000|Overall Study|Lost to Follow-up|1|||
156348699|NCT02725710|564372142|FG001|Overall Study|Lost to Follow-up|0|||
156348700|NCT01858389|564372143|FG000|Overall Study|Death|1|||
156348701|NCT01858389|564372144|FG001|Overall Study|Death|3|||
156348702|NCT01858389|564372143|FG000|Overall Study|Study terminated by sponsor|0|||
156348703|NCT01858389|564372144|FG001|Overall Study|Study terminated by sponsor|2|||
156348704|NCT01858389|564372143|FG000|Overall Study|Withdrawal by Subject|0|||
156348705|NCT01858389|564372144|FG001|Overall Study|Withdrawal by Subject|1|||
156348706|NCT01858389|564372143|FG000|Overall Study|Progressive disease|10|||
156348707|NCT01858389|564372144|FG001|Overall Study|Progressive disease|11|||
156348708|NCT01858389|564372143|FG000|Overall Study|Other|2|||
156348709|NCT01858389|564372144|FG001|Overall Study|Other|4|||
156348710|NCT01858389|564372143|FG000|Overall Study|Adverse Event|3|||
156348711|NCT01858389|564372144|FG001|Overall Study|Adverse Event|1|||
156348712|NCT01858389|564372143|FG000|Overall Study|Did not receive treatment|0|||
156348713|NCT01858389|564372144|FG001|Overall Study|Did not receive treatment|3|||
156348714|NCT03572062|564372145|FG000|Overall Study|Adverse Event|0|||
156348715|NCT03572062|564372146|FG001|Overall Study|Adverse Event|0|||
156348716|NCT03572062|564372147|FG002|Overall Study|Adverse Event|0|||
156348717|NCT03572062|564372148|FG003|Overall Study|Adverse Event|0|||
156348718|NCT03572062|564372149|FG004|Overall Study|Adverse Event|0|||
156348719|NCT03572062|564372150|FG005|Overall Study|Adverse Event|0|||
156348720|NCT03572062|564372151|FG006|Overall Study|Adverse Event|0|||
156348721|NCT03572062|564372152|FG007|Overall Study|Adverse Event|0|||
156348722|NCT03572062|564372153|FG008|Overall Study|Adverse Event|1|||
156348723|NCT03572062|564372154|FG009|Overall Study|Adverse Event|3|||
156348724|NCT03572062|564372145|FG000|Overall Study|Death|0|||
156348725|NCT03572062|564372146|FG001|Overall Study|Death|0|||
156348726|NCT03572062|564372147|FG002|Overall Study|Death|0|||
156348727|NCT03572062|564372148|FG003|Overall Study|Death|0|||
156348728|NCT03572062|564372149|FG004|Overall Study|Death|0|||
156348729|NCT03572062|564372150|FG005|Overall Study|Death|1|||
156348730|NCT03572062|564372151|FG006|Overall Study|Death|0|||
156348731|NCT03572062|564372152|FG007|Overall Study|Death|0|||
156348732|NCT03572062|564372153|FG008|Overall Study|Death|0|||
156348733|NCT03572062|564372154|FG009|Overall Study|Death|0|||
156348734|NCT03572062|564372145|FG000|Overall Study|Lost to Follow-up|0|||
156348735|NCT03572062|564372146|FG001|Overall Study|Lost to Follow-up|0|||
156348736|NCT03572062|564372147|FG002|Overall Study|Lost to Follow-up|0|||
156348737|NCT03572062|564372148|FG003|Overall Study|Lost to Follow-up|0|||
156348738|NCT03572062|564372149|FG004|Overall Study|Lost to Follow-up|0|||
156348739|NCT03572062|564372150|FG005|Overall Study|Lost to Follow-up|1|||
156348740|NCT03572062|564372151|FG006|Overall Study|Lost to Follow-up|1|||
156348741|NCT03572062|564372152|FG007|Overall Study|Lost to Follow-up|0|||
156348742|NCT03572062|564372153|FG008|Overall Study|Lost to Follow-up|0|||
156348743|NCT03572062|564372154|FG009|Overall Study|Lost to Follow-up|0|||
156348744|NCT03572062|564372145|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348745|NCT03572062|564372146|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348746|NCT03572062|564372147|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348747|NCT03572062|564372148|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348748|NCT03572062|564372149|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348749|NCT03572062|564372150|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348750|NCT03572062|564372151|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348751|NCT03572062|564372152|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348752|NCT03572062|564372153|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
156348753|NCT03572062|564372154|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
156348754|NCT03572062|564372145|FG000|Overall Study|Study Terminated By Sponsor|0|||
156348755|NCT03572062|564372146|FG001|Overall Study|Study Terminated By Sponsor|0|||
156348756|NCT03572062|564372147|FG002|Overall Study|Study Terminated By Sponsor|0|||
156348757|NCT03572062|564372148|FG003|Overall Study|Study Terminated By Sponsor|0|||
156544104|NCT01624662|565086302|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
156348758|NCT03572062|564372149|FG004|Overall Study|Study Terminated By Sponsor|0|||
156348759|NCT03572062|564372150|FG005|Overall Study|Study Terminated By Sponsor|0|||
156348760|NCT03572062|564372151|FG006|Overall Study|Study Terminated By Sponsor|0|||
156348761|NCT03572062|564372152|FG007|Overall Study|Study Terminated By Sponsor|0|||
156348762|NCT03572062|564372153|FG008|Overall Study|Study Terminated By Sponsor|29|||
156348763|NCT03572062|564372154|FG009|Overall Study|Study Terminated By Sponsor|27|||
156348764|NCT03572062|564372145|FG000|Overall Study|Physician Decision|0|||
156348765|NCT03572062|564372146|FG001|Overall Study|Physician Decision|0|||
156348766|NCT03572062|564372147|FG002|Overall Study|Physician Decision|0|||
156348767|NCT03572062|564372148|FG003|Overall Study|Physician Decision|0|||
156348768|NCT03572062|564372149|FG004|Overall Study|Physician Decision|0|||
156482506|NCT01730118|564859034|FG003|Dose Expansion|Inability to return|0|||
156482507|NCT01730118|564859035|FG004|Dose Expansion|Inability to return|0|||
156482508|NCT01730118|564859036|FG005|Dose Expansion|Inability to return|1|||
156482509|NCT01730118|564859037|FG006|Dose Expansion|Inability to return|0|||
156348769|NCT03572062|564372150|FG005|Overall Study|Physician Decision|0|||
156348770|NCT03572062|564372151|FG006|Overall Study|Physician Decision|0|||
156348771|NCT03572062|564372152|FG007|Overall Study|Physician Decision|0|||
156348772|NCT03572062|564372153|FG008|Overall Study|Physician Decision|1|||
156348773|NCT03572062|564372154|FG009|Overall Study|Physician Decision|0|||
156482510|NCT01730118|564859031|FG000|Dose Expansion|Physician Decision|0|||
156482511|NCT01730118|564859032|FG001|Dose Expansion|Physician Decision|0|||
156482512|NCT01730118|564859033|FG002|Dose Expansion|Physician Decision|0|||
156348774|NCT03572062|564372145|FG000|Overall Study|Withdrawal by Subject|0|||
156348775|NCT03572062|564372146|FG001|Overall Study|Withdrawal by Subject|0|||
156348776|NCT03572062|564372147|FG002|Overall Study|Withdrawal by Subject|0|||
156348777|NCT03572062|564372148|FG003|Overall Study|Withdrawal by Subject|0|||
156348778|NCT03572062|564372149|FG004|Overall Study|Withdrawal by Subject|0|||
156348779|NCT03572062|564372150|FG005|Overall Study|Withdrawal by Subject|0|||
156348780|NCT03572062|564372151|FG006|Overall Study|Withdrawal by Subject|0|||
156348781|NCT03572062|564372152|FG007|Overall Study|Withdrawal by Subject|0|||
156348782|NCT03572062|564372153|FG008|Overall Study|Withdrawal by Subject|0|||
156348783|NCT03572062|564372154|FG009|Overall Study|Withdrawal by Subject|1|||
156348784|NCT03572062|564372145|FG000|Overall Study|Randomized But Not Treated|0|||
156348785|NCT03572062|564372146|FG001|Overall Study|Randomized But Not Treated|0|||
156348786|NCT03572062|564372147|FG002|Overall Study|Randomized But Not Treated|0|||
156348787|NCT03572062|564372148|FG003|Overall Study|Randomized But Not Treated|0|||
156482513|NCT01730118|564859034|FG003|Dose Expansion|Physician Decision|0|||
156348788|NCT03572062|564372149|FG004|Overall Study|Randomized But Not Treated|1|||
156348789|NCT03572062|564372150|FG005|Overall Study|Randomized But Not Treated|2|||
156348790|NCT03572062|564372151|FG006|Overall Study|Randomized But Not Treated|0|||
156348791|NCT03572062|564372152|FG007|Overall Study|Randomized But Not Treated|1|||
156482514|NCT01730118|564859035|FG004|Dose Expansion|Physician Decision|0|||
156348792|NCT03572062|564372153|FG008|Overall Study|Randomized But Not Treated|0|||
156348793|NCT03572062|564372154|FG009|Overall Study|Randomized But Not Treated|0|||
156348794|NCT00600483|564372157|FG000|Overall Study|Lost to Follow-up|26|||
156482515|NCT01730118|564859036|FG005|Dose Expansion|Physician Decision|1|||
156348795|NCT00600483|564372158|FG001|Overall Study|Lost to Follow-up|47|||
156482516|NCT01730118|564859037|FG006|Dose Expansion|Physician Decision|0|||
156348796|NCT00600483|564372157|FG000|Overall Study|Randomized but not treated|10|||
156348797|NCT00600483|564372158|FG001|Overall Study|Randomized but not treated|0|||
156348798|NCT02547454|564372167|FG000|Overall Study|Due to hemodialysis|53|||
156348799|NCT02547454|564372167|FG000|Overall Study|Due to transplantation|1|||
156348800|NCT02547454|564372167|FG000|Overall Study|Due to no further need to treat|4|||
156348801|NCT02547454|564372167|FG000|Overall Study|Death|38|||
156348802|NCT02547454|564372167|FG000|Overall Study|Lost to Follow-up|26|||
156348803|NCT02547454|564372167|FG000|Overall Study|Other|39|||
156348804|NCT02547454|564372167|FG000|Overall Study|No data|11|||
156348805|NCT03655691|564372170|FG000|Overall Study|Adverse Event|0|||
156348806|NCT03655691|564372171|FG001|Overall Study|Adverse Event|0|||
156348807|NCT03655691|564372172|FG002|Overall Study|Adverse Event|1|||
156348808|NCT03655691|564372170|FG000|Overall Study|Lost to Follow-up|1|||
156348809|NCT03655691|564372171|FG001|Overall Study|Lost to Follow-up|1|||
156348810|NCT03655691|564372172|FG002|Overall Study|Lost to Follow-up|2|||
156348811|NCT03655691|564372170|FG000|Overall Study|Protocol Violation|0|||
156348812|NCT03655691|564372171|FG001|Overall Study|Protocol Violation|1|||
156348813|NCT03655691|564372172|FG002|Overall Study|Protocol Violation|0|||
156348814|NCT03655691|564372170|FG000|Overall Study|Withdrawal by Subject|1|||
156348815|NCT03655691|564372171|FG001|Overall Study|Withdrawal by Subject|1|||
156348816|NCT03655691|564372172|FG002|Overall Study|Withdrawal by Subject|0|||
156348817|NCT03694821|564372173|FG000|Overall Study|Study terminated|4|||
156348818|NCT03694821|564372174|FG001|Overall Study|Study terminated|8|||
156348819|NCT03694821|564372175|FG002|Overall Study|Study terminated|4|||
156348820|NCT05355805|564372178|FG000|Overall Study|Lost to Follow-up|6|||
156348821|NCT05355805|564372179|FG001|Overall Study|Lost to Follow-up|11|||
156348822|NCT05355805|564372180|FG002|Overall Study|Lost to Follow-up|10|||
156348823|NCT05355805|564372181|FG003|Overall Study|Lost to Follow-up|6|||
156348824|NCT05355805|564372178|FG000|Overall Study|Decision by Sponsor|0|||
156348825|NCT05355805|564372179|FG001|Overall Study|Decision by Sponsor|0|||
156348826|NCT05355805|564372180|FG002|Overall Study|Decision by Sponsor|1|||
156348827|NCT05355805|564372181|FG003|Overall Study|Decision by Sponsor|0|||
156348828|NCT05355805|564372178|FG000|Overall Study|Withdrawal by Subject|7|||
156348829|NCT05355805|564372179|FG001|Overall Study|Withdrawal by Subject|14|||
156348830|NCT05355805|564372180|FG002|Overall Study|Withdrawal by Subject|15|||
156348831|NCT05355805|564372181|FG003|Overall Study|Withdrawal by Subject|13|||
156348832|NCT04847557|564372182|FG000|Overall Study|Adverse Event|1|||
156348833|NCT04847557|564372183|FG001|Overall Study|Adverse Event|0|||
156348834|NCT04847557|564372182|FG000|Overall Study|Death|19|||
156348835|NCT04847557|564372183|FG001|Overall Study|Death|15|||
156348836|NCT04847557|564372182|FG000|Overall Study|Lost to Follow-up|3|||
156348837|NCT04847557|564372183|FG001|Overall Study|Lost to Follow-up|6|||
156348838|NCT04847557|564372182|FG000|Overall Study|Physician Decision|1|||
156348839|NCT04847557|564372183|FG001|Overall Study|Physician Decision|0|||
156348840|NCT04847557|564372182|FG000|Overall Study|Protocol Violation|0|||
156348841|NCT04847557|564372183|FG001|Overall Study|Protocol Violation|1|||
156348842|NCT04847557|564372182|FG000|Overall Study|Withdrawal by Subject|8|||
156348843|NCT04847557|564372183|FG001|Overall Study|Withdrawal by Subject|14|||
156348844|NCT01325584|564372184|FG000|Overall Study|Death|1|||
156348845|NCT01411228|564373574|FG000|Overall Study|Lost to Follow-up|0|||
156348846|NCT01411228|564373575|FG001|Overall Study|Lost to Follow-up|0|||
156348847|NCT01411228|564373576|FG002|Overall Study|Lost to Follow-up|1|||
156348848|NCT01411228|564373574|FG000|Overall Study|Withdrawal by Subject|1|||
156348849|NCT01411228|564373575|FG001|Overall Study|Withdrawal by Subject|0|||
156348850|NCT01411228|564373576|FG002|Overall Study|Withdrawal by Subject|0|||
156348851|NCT00664742|564373577|FG000|Overall Study|Withdrawn due to adverse events|3|||
156348852|NCT00664742|564373577|FG000|Overall Study|Withdrawal by Subject|31|||
156348853|NCT00664742|564373577|FG000|Overall Study|Lost to Follow-up|92|||
156348854|NCT01986855|564373578|FG000|Overall Study|Adverse Event|1|||
156348855|NCT01986855|564373579|FG001|Overall Study|Adverse Event|0|||
156348856|NCT01986855|564373580|FG002|Overall Study|Adverse Event|0|||
156348857|NCT01986855|564373578|FG000|Overall Study|Death|3|||
156348858|NCT01986855|564373579|FG001|Overall Study|Death|4|||
156348859|NCT01986855|564373580|FG002|Overall Study|Death|4|||
156348860|NCT01986855|564373578|FG000|Overall Study|Lost to Follow-up|2|||
156348861|NCT01986855|564373579|FG001|Overall Study|Lost to Follow-up|1|||
156348862|NCT01986855|564373580|FG002|Overall Study|Lost to Follow-up|0|||
156348863|NCT01986855|564373578|FG000|Overall Study|Screen Failure|0|||
156348864|NCT01986855|564373579|FG001|Overall Study|Screen Failure|1|||
156348865|NCT01986855|564373580|FG002|Overall Study|Screen Failure|0|||
156348866|NCT01986855|564373578|FG000|Overall Study|Participant Moved|0|||
156348867|NCT01986855|564373579|FG001|Overall Study|Participant Moved|0|||
156348868|NCT01986855|564373580|FG002|Overall Study|Participant Moved|2|||
156348869|NCT01986855|564373578|FG000|Overall Study|Withdrawal by Subject|7|||
156348870|NCT01986855|564373579|FG001|Overall Study|Withdrawal by Subject|8|||
156348871|NCT01986855|564373580|FG002|Overall Study|Withdrawal by Subject|5|||
156348872|NCT04317066|564373581|FG000|Overall Study|Sponsor decision|5|||
156348873|NCT04317066|564373581|FG000|Overall Study|Death|2|||
156348874|NCT02670083|564373585|FG000|Overall Study|Adverse Event|16|||
156348875|NCT02670083|564373586|FG001|Overall Study|Adverse Event|13|||
156348876|NCT02670083|564373585|FG000|Overall Study|Death|4|||
156348877|NCT02670083|564373586|FG001|Overall Study|Death|6|||
156348878|NCT02670083|564373585|FG000|Overall Study|Lost to Follow-up|2|||
156348879|NCT02670083|564373586|FG001|Overall Study|Lost to Follow-up|2|||
156348880|NCT02670083|564373585|FG000|Overall Study|Multiple Reasons|9|||
156348881|NCT02670083|564373586|FG001|Overall Study|Multiple Reasons|9|||
156348882|NCT02670083|564373585|FG000|Overall Study|Physician Decision|0|||
156348883|NCT02670083|564373586|FG001|Overall Study|Physician Decision|2|||
156348884|NCT02670083|564373585|FG000|Overall Study|Study Terminated By Sponsor|257|||
156348885|NCT02670083|564373586|FG001|Overall Study|Study Terminated By Sponsor|254|||
156348886|NCT02670083|564373585|FG000|Overall Study|Symptomatic Deterioration|0|||
156348887|NCT02670083|564373586|FG001|Overall Study|Symptomatic Deterioration|2|||
156348888|NCT02670083|564373585|FG000|Overall Study|Withdrawal by Subject|32|||
156348889|NCT02670083|564373586|FG001|Overall Study|Withdrawal by Subject|31|||
156348890|NCT02670083|564373585|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156348891|NCT02670083|564373586|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156348892|NCT02825992|564373587|FG000|Overall Study|Withdrawal by Subject|4|||
156348893|NCT02825992|564373587|FG000|Overall Study|Lost to Follow-up|2|||
156348894|NCT02825992|564373587|FG000|Overall Study|Procedure terminated|2|||
156348895|NCT02279173|564373589|FG000|Overall Study|Protocol-specified Criteria|67|||
156348896|NCT02279173|564373589|FG000|Overall Study|Withdrawal by Subject|20|||
156348897|NCT02279173|564373589|FG000|Overall Study|Decision by Sponsor|4|||
156348898|NCT02279173|564373589|FG000|Overall Study|Lost to Follow-up|3|||
156348899|NCT00464087|564373591|FG000|Overall Study|No PCI per inclusion criteria|0|||
156348900|NCT00464087|564373592|FG001|Overall Study|No PCI per inclusion criteria|0|||
156348901|NCT00464087|564373593|FG002|Overall Study|No PCI per inclusion criteria|29|||
156348902|NCT01164956|564373594|FG000|Overall Study|Side Effects|1|||
156348903|NCT01164956|564373595|FG001|Overall Study|Side Effects|0|||
156348904|NCT01164956|564373596|FG002|Overall Study|Side Effects|1|||
156348905|NCT00720434|564373597|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
156348906|NCT00720434|564373598|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
156348907|NCT00720434|564373599|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
156348908|NCT00720434|564373600|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
156348909|NCT00720434|564373597|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
156348910|NCT00720434|564373598|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
156348911|NCT00720434|564373599|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
156348912|NCT00720434|564373600|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
156348913|NCT00720434|564373597|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
156348914|NCT00720434|564373598|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
156348915|NCT00720434|564373599|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
156348916|NCT00720434|564373600|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
156348917|NCT00720434|564373597|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
156348918|NCT00720434|564373598|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
156348919|NCT00720434|564373599|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
156348920|NCT00720434|564373600|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
156348921|NCT00720434|564373597|FG000|Open-Label Period (Week 5-72)|Other|4|||
156348922|NCT00720434|564373598|FG001|Open-Label Period (Week 5-72)|Other|3|||
156348923|NCT00720434|564373599|FG002|Open-Label Period (Week 5-72)|Other|3|||
156348924|NCT00720434|564373600|FG003|Open-Label Period (Week 5-72)|Other|2|||
156348925|NCT00418314|564373601|FG000|Overall Study|Withdrawal by Subject|1|||
156348926|NCT00418314|564373602|FG001|Overall Study|Withdrawal by Subject|2|||
156348927|NCT02425046|564373603|FG000|Overall Study|Lost to Follow-up|52|||
156348928|NCT02425046|564373604|FG001|Overall Study|Lost to Follow-up|50|||
156348929|NCT02425046|564373605|FG002|Overall Study|Lost to Follow-up|56|||
156348930|NCT02425046|564373603|FG000|Overall Study|Withdrawal by Subject|16|||
156348931|NCT02425046|564373604|FG001|Overall Study|Withdrawal by Subject|12|||
156348932|NCT02425046|564373605|FG002|Overall Study|Withdrawal by Subject|0|||
156348933|NCT02782780|564373606|FG000|Overall Study|dropped out after randomization.|7|||
156348934|NCT02782780|564373607|FG001|Overall Study|dropped out after randomization.|5|||
156482517|NCT05379400|564859041|FG000|Overall Study|Lost to Follow-up|1|||
156544105|NCT01624662|565086303|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
156544106|NCT01624662|565086304|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
156544107|NCT01624662|565086301|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
156544108|NCT01624662|565086302|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
156348935|NCT02782780|564373606|FG000|Overall Study|Protocol Violation|0|||
156348936|NCT02782780|564373607|FG001|Overall Study|Protocol Violation|2|||
156348937|NCT01413191|564373608|FG000|Overall Study|Lost to Follow-up|5|||
156348938|NCT01413191|564373608|FG000|Overall Study|Disease Progression|5|||
156348939|NCT01413191|564373608|FG000|Overall Study|Death|1|||
156348940|NCT02904512|564373611|FG000|Overall Study|Withdrawal by Subject|1|||
156348941|NCT02904512|564373612|FG001|Overall Study|Withdrawal by Subject|0|||
156348942|NCT02904512|564373611|FG000|Overall Study|Transferred to ICU|1|||
156348943|NCT02904512|564373612|FG001|Overall Study|Transferred to ICU|0|||
156348944|NCT02904512|564373611|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
156348945|NCT02904512|564373612|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
156348946|NCT01963403|564373621|FG000|Overall Study|Lost to Follow-up|2|||
156348947|NCT01963403|564373622|FG001|Overall Study|Lost to Follow-up|3|||
156348948|NCT01963403|564373621|FG000|Overall Study|Implant removal|0|||
156348949|NCT01963403|564373622|FG001|Overall Study|Implant removal|1|||
156348950|NCT00589914|564373625|FG000|Overall Study|Adverse Event|19|||
156348951|NCT00589914|564373626|FG001|Overall Study|Adverse Event|10|||
156348952|NCT00589914|564373625|FG000|Overall Study|Death|2|||
156348953|NCT00589914|564373626|FG001|Overall Study|Death|0|||
156348954|NCT00589914|564373625|FG000|Overall Study|Lack of Efficacy|40|||
156348955|NCT00589914|564373626|FG001|Overall Study|Lack of Efficacy|43|||
156348956|NCT00589914|564373625|FG000|Overall Study|Lost to Follow-up|11|||
156348957|NCT00589914|564373626|FG001|Overall Study|Lost to Follow-up|18|||
156348958|NCT00589914|564373625|FG000|Overall Study|Pregnancy|1|||
156348959|NCT00589914|564373626|FG001|Overall Study|Pregnancy|0|||
156348960|NCT00589914|564373625|FG000|Overall Study|Withdrawal by Subject|55|||
156348961|NCT00589914|564373626|FG001|Overall Study|Withdrawal by Subject|49|||
156348962|NCT00589914|564373625|FG000|Overall Study|Other|22|||
156348963|NCT00589914|564373626|FG001|Overall Study|Other|17|||
156348964|NCT02743806|564373627|FG000|Overall Study|Adverse Event|9|||
156348965|NCT02743806|564373627|FG000|Overall Study|Lost to Follow-up|8|||
156348966|NCT02743806|564373627|FG000|Overall Study|Voluntary Withdrawal|54|||
156348967|NCT02743806|564373627|FG000|Overall Study|Study Termination|65|||
156348968|NCT02743806|564373627|FG000|Overall Study|Pregnancy|6|||
156348969|NCT02743806|564373627|FG000|Overall Study|No Longer Clinically Benefiting|27|||
156348970|NCT02743806|564373627|FG000|Overall Study|Reason Not Specified|12|||
156348971|NCT03590041|564373631|FG000|Overall Study|Protocol Violation|4|||
156348972|NCT03590041|564373632|FG001|Overall Study|Protocol Violation|3|||
156348973|NCT03590041|564373631|FG000|Overall Study|No session data recorded|14|||
156348974|NCT03590041|564373632|FG001|Overall Study|No session data recorded|2|||
156348975|NCT02289898|564373633|FG000|Overall Study|Death|5|||
156348976|NCT02289898|564373634|FG001|Overall Study|Death|4|||
156348977|NCT02289898|564373635|FG002|Overall Study|Death|3|||
156348978|NCT02289898|564373633|FG000|Overall Study|Physician Decision|2|||
156348979|NCT02289898|564373634|FG001|Overall Study|Physician Decision|5|||
156348980|NCT02289898|564373635|FG002|Overall Study|Physician Decision|2|||
156348981|NCT02289898|564373633|FG000|Overall Study|Withdrawal by Subject|0|||
156348982|NCT02289898|564373634|FG001|Overall Study|Withdrawal by Subject|4|||
156348983|NCT02289898|564373635|FG002|Overall Study|Withdrawal by Subject|1|||
156348984|NCT02289898|564373633|FG000|Overall Study|Adverse Event|3|||
156348985|NCT02289898|564373634|FG001|Overall Study|Adverse Event|5|||
156348986|NCT02289898|564373635|FG002|Overall Study|Adverse Event|5|||
156348987|NCT02289898|564373633|FG000|Overall Study|Disease progression|34|||
156348988|NCT02289898|564373634|FG001|Overall Study|Disease progression|28|||
156348989|NCT02289898|564373635|FG002|Overall Study|Disease progression|34|||
156348990|NCT02289898|564373633|FG000|Overall Study|Use of another anticancer therapy|0|||
156348991|NCT02289898|564373634|FG001|Overall Study|Use of another anticancer therapy|0|||
156348992|NCT02289898|564373635|FG002|Overall Study|Use of another anticancer therapy|1|||
156348993|NCT02289898|564373633|FG000|Overall Study|Other|8|||
156348994|NCT02289898|564373634|FG001|Overall Study|Other|7|||
156348995|NCT02289898|564373635|FG002|Overall Study|Other|10|||
156348996|NCT00460408|564373636|FG000|Overall Study|Adverse Event|1|||
156348997|NCT00460408|564373637|FG001|Overall Study|Adverse Event|0|||
156348998|NCT00460408|564373638|FG002|Overall Study|Adverse Event|0|||
156348999|NCT00460408|564373639|FG003|Overall Study|Adverse Event|0|||
156349000|NCT00460408|564373636|FG000|Overall Study|Death|7|||
156349001|NCT00460408|564373637|FG001|Overall Study|Death|0|||
156349002|NCT00460408|564373638|FG002|Overall Study|Death|0|||
156349003|NCT00460408|564373639|FG003|Overall Study|Death|0|||
156349004|NCT00460408|564373636|FG000|Overall Study|Lost to Follow-up|11|||
156349005|NCT00460408|564373637|FG001|Overall Study|Lost to Follow-up|0|||
156349006|NCT00460408|564373638|FG002|Overall Study|Lost to Follow-up|1|||
156349007|NCT00460408|564373639|FG003|Overall Study|Lost to Follow-up|0|||
156349008|NCT00460408|564373636|FG000|Overall Study|Withdrawal by Subject|31|||
156349009|NCT00460408|564373637|FG001|Overall Study|Withdrawal by Subject|0|||
156349010|NCT00460408|564373638|FG002|Overall Study|Withdrawal by Subject|0|||
156349011|NCT00460408|564373639|FG003|Overall Study|Withdrawal by Subject|0|||
156349012|NCT00460408|564373636|FG000|Overall Study|Insufficient clinical response|5|||
156349013|NCT00460408|564373637|FG001|Overall Study|Insufficient clinical response|1|||
156349014|NCT00460408|564373638|FG002|Overall Study|Insufficient clinical response|5|||
156349015|NCT00460408|564373639|FG003|Overall Study|Insufficient clinical response|0|||
156349016|NCT00460408|564373636|FG000|Overall Study|Other|12|||
156349017|NCT00460408|564373637|FG001|Overall Study|Other|2|||
156349018|NCT00460408|564373638|FG002|Overall Study|Other|0|||
156349019|NCT00460408|564373639|FG003|Overall Study|Other|0|||
156349020|NCT00103142|564373640|FG000|Overall Study|Adverse Event|1|||
156349021|NCT00103142|564373641|FG001|Overall Study|Adverse Event|0|||
156349022|NCT00103142|564373640|FG000|Overall Study|Progression of disease|2|||
156349023|NCT00103142|564373641|FG001|Overall Study|Progression of disease|1|||
156349024|NCT01442493|564373645|FG000|Overall Study|withdrawn from study|3|||
156349025|NCT01442493|564373646|FG001|Overall Study|withdrawn from study|2|||
156349026|NCT00938639|564373647|FG000|Overall Study|Moved away from study area|0|||
156349027|NCT00938639|564373648|FG001|Overall Study|Moved away from study area|1|||
156349028|NCT00938639|564373647|FG000|Overall Study|Lost to Follow-up|1|||
156349029|NCT00938639|564373648|FG001|Overall Study|Lost to Follow-up|2|||
156482518|NCT05379400|564859042|FG001|Overall Study|Lost to Follow-up|1|||
156482519|NCT05356130|564859044|FG000|Overall Study|Withdrawal by Subject|0|||
156482520|NCT05356130|564859045|FG001|Overall Study|Withdrawal by Subject|0|||
156349030|NCT00938639|564373647|FG000|Overall Study|Family issues|1|||
156349031|NCT00938639|564373648|FG001|Overall Study|Family issues|1|||
156544109|NCT01624662|565086303|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
156544110|NCT01624662|565086304|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
156482521|NCT05356130|564859046|FG002|Overall Study|Withdrawal by Subject|3|||
156482522|NCT04851587|564859047|FG000|Overall Study|Lost to Follow-up|18|||
156482523|NCT02101554|564859052|FG000|Overall Study|Protocol Violation|0|||
156482524|NCT02101554|564859053|FG001|Overall Study|Protocol Violation|1|||
156482525|NCT02101554|564859054|FG002|Overall Study|Protocol Violation|0|||
156482526|NCT02101554|564859052|FG000|Overall Study|Insufficient Clinical Response|0|||
156482527|NCT02101554|564859053|FG001|Overall Study|Insufficient Clinical Response|2|||
156482528|NCT02101554|564859054|FG002|Overall Study|Insufficient Clinical Response|0|||
156482529|NCT02101554|564859052|FG000|Overall Study|Adverse Event|2|||
156349032|NCT00938639|564373647|FG000|Overall Study|Participant noncompliance|1|||
156349033|NCT00938639|564373648|FG001|Overall Study|Participant noncompliance|0|||
156349034|NCT04326231|564373650|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
156349035|NCT00759954|564373651|FG000|Overall Study|Personal reason|1|||
156349036|NCT00759954|564373652|FG001|Overall Study|Personal reason|0|||
156349037|NCT00759954|564373651|FG000|Overall Study|Adverse Event|1|||
156349038|NCT00759954|564373652|FG001|Overall Study|Adverse Event|2|||
156349039|NCT01741701|564373654|FG000|Overall Study|Adverse Event|5|||
156349040|NCT01741701|564373655|FG001|Overall Study|Adverse Event|1|||
156349041|NCT01741701|564373654|FG000|Overall Study|Withdrawal by Subject|0|||
156349042|NCT01741701|564373655|FG001|Overall Study|Withdrawal by Subject|1|||
156544111|NCT01624662|565086301|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
156544112|NCT01624662|565086302|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
156544113|NCT01624662|565086303|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
156349043|NCT00372112|564373656|FG000|Overall Study|Adverse Event|0|||
156349044|NCT00372112|564373657|FG001|Overall Study|Adverse Event|1|||
156349045|NCT00372112|564373658|FG002|Overall Study|Adverse Event|1|||
156349046|NCT00372112|564373659|FG003|Overall Study|Adverse Event|1|||
156349047|NCT00372112|564373656|FG000|Overall Study|Withdrawal by Subject|0|||
156349048|NCT00372112|564373657|FG001|Overall Study|Withdrawal by Subject|0|||
156349049|NCT00372112|564373658|FG002|Overall Study|Withdrawal by Subject|2|||
156349050|NCT00372112|564373659|FG003|Overall Study|Withdrawal by Subject|1|||
156349051|NCT00372112|564373656|FG000|Overall Study|Exacerbation|0|||
156482530|NCT02101554|564859053|FG001|Overall Study|Adverse Event|1|||
156482531|NCT02101554|564859054|FG002|Overall Study|Adverse Event|1|||
156482532|NCT02101554|564859052|FG000|Overall Study|Lost to Follow-up|0|||
156482533|NCT02101554|564859053|FG001|Overall Study|Lost to Follow-up|1|||
156482534|NCT02101554|564859054|FG002|Overall Study|Lost to Follow-up|0|||
156482535|NCT02101554|564859052|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
156482536|NCT02101554|564859053|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
156482537|NCT02101554|564859054|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
156482538|NCT04820023|564859055|FG000|Overall Study|Death|0|||
156482539|NCT04820023|564859056|FG001|Overall Study|Death|0|||
156482540|NCT04820023|564859057|FG002|Overall Study|Death|0|||
156349052|NCT00372112|564373657|FG001|Overall Study|Exacerbation|0|||
156482541|NCT04820023|564859058|FG003|Overall Study|Death|0|||
156482542|NCT04820023|564859059|FG004|Overall Study|Death|0|||
156349053|NCT00372112|564373658|FG002|Overall Study|Exacerbation|0|||
156482543|NCT04820023|564859060|FG005|Overall Study|Death|0|||
156482544|NCT04820023|564859061|FG006|Overall Study|Death|1|||
156482545|NCT04820023|564859062|FG007|Overall Study|Death|0|||
156482546|NCT04820023|564859063|FG008|Overall Study|Death|1|||
156482547|NCT04820023|564859055|FG000|Overall Study|Withdrawal by Subject|1|||
156482548|NCT04820023|564859056|FG001|Overall Study|Withdrawal by Subject|2|||
156349054|NCT00372112|564373659|FG003|Overall Study|Exacerbation|1|||
156544114|NCT01624662|565086304|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
156482549|NCT04820023|564859057|FG002|Overall Study|Withdrawal by Subject|2|||
156349055|NCT00372112|564373656|FG000|Overall Study|PR >240 at Visit 3|0|||
156349056|NCT00372112|564373657|FG001|Overall Study|PR >240 at Visit 3|0|||
156349057|NCT00372112|564373658|FG002|Overall Study|PR >240 at Visit 3|0|||
156349058|NCT00372112|564373659|FG003|Overall Study|PR >240 at Visit 3|1|||
156349059|NCT00372112|564373656|FG000|Overall Study|Hepatitis B|1|||
156349060|NCT00372112|564373657|FG001|Overall Study|Hepatitis B|0|||
156349061|NCT00372112|564373658|FG002|Overall Study|Hepatitis B|0|||
156482550|NCT04820023|564859058|FG003|Overall Study|Withdrawal by Subject|1|||
156482551|NCT04820023|564859059|FG004|Overall Study|Withdrawal by Subject|4|||
156482552|NCT04820023|564859060|FG005|Overall Study|Withdrawal by Subject|3|||
156482553|NCT04820023|564859061|FG006|Overall Study|Withdrawal by Subject|3|||
156482554|NCT04820023|564859062|FG007|Overall Study|Withdrawal by Subject|6|||
156482555|NCT04820023|564859063|FG008|Overall Study|Withdrawal by Subject|5|||
156482556|NCT04820023|564859055|FG000|Overall Study|Progressive Disease|3|||
156482557|NCT04820023|564859056|FG001|Overall Study|Progressive Disease|0|||
156482558|NCT04820023|564859057|FG002|Overall Study|Progressive Disease|2|||
156482559|NCT04820023|564859058|FG003|Overall Study|Progressive Disease|2|||
156482560|NCT04820023|564859059|FG004|Overall Study|Progressive Disease|2|||
156349062|NCT00372112|564373659|FG003|Overall Study|Hepatitis B|0|||
156349063|NCT00372112|564373656|FG000|Overall Study|Other-protocol violation|0|||
156349064|NCT00372112|564373657|FG001|Overall Study|Other-protocol violation|0|||
156349065|NCT00372112|564373658|FG002|Overall Study|Other-protocol violation|1|||
156349066|NCT00372112|564373659|FG003|Overall Study|Other-protocol violation|0|||
156349067|NCT01606436|564373666|FG000|Overall Study|Withdrawal by Subject|0|||
156349068|NCT01606436|564373667|FG001|Overall Study|Withdrawal by Subject|0|||
156349069|NCT01606436|564373668|FG002|Overall Study|Withdrawal by Subject|1|||
156349070|NCT01606436|564373669|FG003|Overall Study|Withdrawal by Subject|1|||
156349071|NCT01606436|564373670|FG004|Overall Study|Withdrawal by Subject|1|||
156482561|NCT04820023|564859060|FG005|Overall Study|Progressive Disease|0|||
156349072|NCT01606436|564373671|FG005|Overall Study|Withdrawal by Subject|0|||
156482562|NCT04820023|564859061|FG006|Overall Study|Progressive Disease|1|||
156482563|NCT04820023|564859062|FG007|Overall Study|Progressive Disease|1|||
156349073|NCT01606436|564373666|FG000|Overall Study|Adverse Event|0|||
156349074|NCT01606436|564373667|FG001|Overall Study|Adverse Event|0|||
156482564|NCT04820023|564859063|FG008|Overall Study|Progressive Disease|0|||
156482565|NCT04820023|564859055|FG000|Overall Study|New anti-cancer therapy|0|||
156482566|NCT04820023|564859056|FG001|Overall Study|New anti-cancer therapy|0|||
156482567|NCT04820023|564859057|FG002|Overall Study|New anti-cancer therapy|0|||
156482568|NCT04820023|564859058|FG003|Overall Study|New anti-cancer therapy|0|||
156482569|NCT04820023|564859059|FG004|Overall Study|New anti-cancer therapy|2|||
156482570|NCT04820023|564859060|FG005|Overall Study|New anti-cancer therapy|0|||
156482571|NCT04820023|564859061|FG006|Overall Study|New anti-cancer therapy|0|||
156482572|NCT04820023|564859062|FG007|Overall Study|New anti-cancer therapy|0|||
156482573|NCT04820023|564859063|FG008|Overall Study|New anti-cancer therapy|0|||
156482574|NCT04820023|564859055|FG000|Overall Study|Other|0|||
156482575|NCT04820023|564859056|FG001|Overall Study|Other|1|||
156349075|NCT01606436|564373668|FG002|Overall Study|Adverse Event|1|||
156482576|NCT04820023|564859057|FG002|Overall Study|Other|0|||
156482577|NCT04820023|564859058|FG003|Overall Study|Other|0|||
156482578|NCT04820023|564859059|FG004|Overall Study|Other|0|||
156482579|NCT04820023|564859060|FG005|Overall Study|Other|0|||
156482580|NCT04820023|564859061|FG006|Overall Study|Other|0|||
156482581|NCT04820023|564859062|FG007|Overall Study|Other|2|||
156482582|NCT04820023|564859063|FG008|Overall Study|Other|0|||
156482583|NCT04049578|564859065|FG000|Overall Study|Physician Decision|1|||
156482584|NCT02109172|564859071|FG000|Overall Study|Withdrawal by Subject|1|||
156482585|NCT02109172|564859072|FG001|Overall Study|Withdrawal by Subject|0|||
156482586|NCT02109172|564859073|FG002|Overall Study|Withdrawal by Subject|0|||
156482587|NCT02109172|564859074|FG003|Overall Study|Withdrawal by Subject|1|||
156349076|NCT01606436|564373669|FG003|Overall Study|Adverse Event|0|||
156349077|NCT01606436|564373670|FG004|Overall Study|Adverse Event|0|||
156349078|NCT01606436|564373671|FG005|Overall Study|Adverse Event|0|||
156349079|NCT01606436|564373666|FG000|Overall Study|Sponsor Decision|0|||
156482588|NCT02109172|564859075|FG004|Overall Study|Withdrawal by Subject|0|||
156482589|NCT02109172|564859076|FG005|Overall Study|Withdrawal by Subject|0|||
156482590|NCT02109172|564859071|FG000|Overall Study|Adverse Event|0|||
156482591|NCT02109172|564859072|FG001|Overall Study|Adverse Event|0|||
156482592|NCT02109172|564859073|FG002|Overall Study|Adverse Event|1|||
156349080|NCT01606436|564373667|FG001|Overall Study|Sponsor Decision|0|||
156349081|NCT01606436|564373668|FG002|Overall Study|Sponsor Decision|0|||
156349082|NCT01606436|564373669|FG003|Overall Study|Sponsor Decision|1|||
156482593|NCT02109172|564859074|FG003|Overall Study|Adverse Event|0|||
156482594|NCT02109172|564859075|FG004|Overall Study|Adverse Event|0|||
156349083|NCT01606436|564373670|FG004|Overall Study|Sponsor Decision|0|||
156349084|NCT01606436|564373671|FG005|Overall Study|Sponsor Decision|0|||
156349085|NCT02859454|564373674|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
156349086|NCT01605877|564373677|FG000|Overall Study|Withdrawal by Subject|1|||
156349087|NCT03310775|564373680|FG000|Overall Study|Lost to Follow-up|2|||
156349088|NCT03310775|564373681|FG001|Overall Study|Lost to Follow-up|3|||
156349089|NCT03310775|564373680|FG000|Overall Study|aggravation of depression|0|||
156349090|NCT03310775|564373681|FG001|Overall Study|aggravation of depression|1|||
156349091|NCT00580606|564373691|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
156349092|NCT00580606|564373692|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
156349093|NCT00580606|564373691|FG000|Open Label (OL)|Withdrawal by Subject|4|||
156349094|NCT00580606|564373692|FG001|Open Label (OL)|Withdrawal by Subject|6|||
156349095|NCT00580606|564373691|FG000|Open Label (OL)|Dosing Symptoms|0|||
156349096|NCT00580606|564373692|FG001|Open Label (OL)|Dosing Symptoms|1|||
156349097|NCT00580606|564373691|FG000|Open Label (OL)|Lost to Follow-up|0|||
156349098|NCT00580606|564373692|FG001|Open Label (OL)|Lost to Follow-up|1|||
156349099|NCT00580606|564373691|FG000|Open Label (OL)|Pregnancy|0|||
156349100|NCT00580606|564373692|FG001|Open Label (OL)|Pregnancy|1|||
156349101|NCT00580606|564373691|FG000|Open Label (OL)|Non-compliance|2|||
156349102|NCT00580606|564373692|FG001|Open Label (OL)|Non-compliance|0|||
156349103|NCT00580606|564373691|FG000|Open Label (OL)|Physician Decision|1|||
156482595|NCT02109172|564859076|FG005|Overall Study|Adverse Event|1|||
156482596|NCT02109172|564859071|FG000|Overall Study|Death|0|||
156482597|NCT02109172|564859072|FG001|Overall Study|Death|0|||
156482598|NCT02109172|564859073|FG002|Overall Study|Death|0|||
156482599|NCT02109172|564859074|FG003|Overall Study|Death|0|||
156349104|NCT00580606|564373692|FG001|Open Label (OL)|Physician Decision|1|||
156349105|NCT00580606|564373691|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
156349106|NCT00580606|564373692|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
156349107|NCT03064451|564373694|FG000|Overall Study|Lost to Follow-up|1|||
156349108|NCT03064451|564373694|FG000|Overall Study|Mapping Failure|4|||
156349109|NCT03064451|564373694|FG000|Overall Study|Exited prior to procedure|8|||
156349110|NCT03064451|564373694|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
156349111|NCT00750204|564373697|FG000|Overall Study|study halted prematurely|1|||
156349112|NCT00750204|564373698|FG001|Overall Study|study halted prematurely|1|||
156349113|NCT02167893|564373699|FG000|Overall Study|Investigator transferred|85|||
156349114|NCT02167893|564373699|FG000|Overall Study|Investigator health reasons|10|||
156349115|NCT02167893|564373699|FG000|Overall Study|Case report forms not collected|68|||
156349116|NCT01438424|564374896|FG000|Overall Study|Continuing treatment|29|||
156349117|NCT01438424|564374896|FG000|Overall Study|Minimal virologic response|95|||
156349118|NCT01438424|564374896|FG000|Overall Study|Not identified|55|||
156349119|NCT01438424|564374896|FG000|Overall Study|Withdrawal by Subject|104|||
156349120|NCT01438424|564374896|FG000|Overall Study|Progression of chronic hepatitis B|22|||
156349121|NCT01438424|564374896|FG000|Overall Study|Death|22|||
156349122|NCT01438424|564374896|FG000|Overall Study|Adverse Event|17|||
156349123|NCT01438424|564374896|FG000|Overall Study|Lost to Follow-up|17|||
156349124|NCT01438424|564374896|FG000|Overall Study|Abnormal laboratory test result|14|||
156349125|NCT01438424|564374896|FG000|Overall Study|Need for drug prohibited by protocol|14|||
156349126|NCT01438424|564374896|FG000|Overall Study|Pregnancy|7|||
156349127|NCT01438424|564374896|FG000|Overall Study|No longer met inclusion criteria|1|||
156349128|NCT01438424|564374896|FG000|Overall Study|Participant noncompliance|20|||
156349129|NCT02927080|564374897|FG000|Overall Study|Withdrawal by Subject|0|||
156349130|NCT02927080|564374898|FG001|Overall Study|Withdrawal by Subject|0|||
156349131|NCT02927080|564374899|FG002|Overall Study|Withdrawal by Subject|0|||
156349132|NCT02927080|564374900|FG003|Overall Study|Withdrawal by Subject|0|||
156349133|NCT02927080|564374901|FG004|Overall Study|Withdrawal by Subject|1|||
156349134|NCT02927080|564374902|FG005|Overall Study|Withdrawal by Subject|0|||
156349135|NCT02927080|564374903|FG006|Overall Study|Withdrawal by Subject|1|||
156349136|NCT02927080|564374904|FG007|Overall Study|Withdrawal by Subject|1|||
156349137|NCT02927080|564374905|FG008|Overall Study|Withdrawal by Subject|0|||
156349138|NCT02927080|564374906|FG009|Overall Study|Withdrawal by Subject|2|||
156349139|NCT02927080|564374897|FG000|Overall Study|Willingness to comply with protocol|0|||
156349140|NCT02927080|564374898|FG001|Overall Study|Willingness to comply with protocol|0|||
156349141|NCT02927080|564374899|FG002|Overall Study|Willingness to comply with protocol|0|||
156349142|NCT02927080|564374900|FG003|Overall Study|Willingness to comply with protocol|0|||
156349143|NCT02927080|564374901|FG004|Overall Study|Willingness to comply with protocol|0|||
156349144|NCT02927080|564374902|FG005|Overall Study|Willingness to comply with protocol|0|||
156349145|NCT02927080|564374903|FG006|Overall Study|Willingness to comply with protocol|0|||
156349146|NCT02927080|564374904|FG007|Overall Study|Willingness to comply with protocol|0|||
156349147|NCT02927080|564374905|FG008|Overall Study|Willingness to comply with protocol|0|||
156349148|NCT02927080|564374906|FG009|Overall Study|Willingness to comply with protocol|1|||
156349149|NCT02927080|564374897|FG000|Overall Study|Study terminated by Sponsor|0|||
156349150|NCT02927080|564374898|FG001|Overall Study|Study terminated by Sponsor|0|||
156349151|NCT02927080|564374899|FG002|Overall Study|Study terminated by Sponsor|0|||
156349152|NCT02927080|564374900|FG003|Overall Study|Study terminated by Sponsor|0|||
156349153|NCT02927080|564374901|FG004|Overall Study|Study terminated by Sponsor|0|||
156349154|NCT02927080|564374902|FG005|Overall Study|Study terminated by Sponsor|0|||
156349155|NCT02927080|564374903|FG006|Overall Study|Study terminated by Sponsor|6|||
156349156|NCT02927080|564374904|FG007|Overall Study|Study terminated by Sponsor|7|||
156349157|NCT02927080|564374905|FG008|Overall Study|Study terminated by Sponsor|2|||
156482600|NCT02109172|564859075|FG004|Overall Study|Death|1|||
156482601|NCT02109172|564859076|FG005|Overall Study|Death|0|||
156482602|NCT03605745|564859077|FG000|Overall Study|Study was terminated for business reasons|47|||
156482603|NCT02213094|564859079|FG000|Overall Study|Adverse Event|1|||
156482604|NCT02213094|564859080|FG001|Overall Study|Adverse Event|0|||
156482605|NCT00538629|564859081|FG000|Overall Study|At subject's request|1|||
156482606|NCT00538629|564859081|FG000|Overall Study|Adverse Event|2|||
156482607|NCT00538629|564859081|FG000|Overall Study|Lack of Efficacy|12|||
156482608|NCT00538629|564859081|FG000|Overall Study|Lost to Follow-up|6|||
156482609|NCT00538629|564859081|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
156482610|NCT04454125|564859086|FG000|Overall Study|Lost to Follow-up|0|||
156482611|NCT04454125|564859087|FG001|Overall Study|Lost to Follow-up|1|||
156482612|NCT00555620|564859088|FG000|Overall Study|Death|0|||
156482613|NCT00555620|564859089|FG001|Overall Study|Death|1|||
156482614|NCT00555620|564859090|FG002|Overall Study|Death|0|||
156482615|NCT00555620|564859091|FG003|Overall Study|Death|0|||
156349158|NCT02927080|564374906|FG009|Overall Study|Study terminated by Sponsor|3|||
156349159|NCT02927080|564374897|FG000|Overall Study|Adverse Event|0|||
156349160|NCT02927080|564374898|FG001|Overall Study|Adverse Event|1|||
156349161|NCT02927080|564374899|FG002|Overall Study|Adverse Event|0|||
156349162|NCT02927080|564374900|FG003|Overall Study|Adverse Event|0|||
156349163|NCT02927080|564374901|FG004|Overall Study|Adverse Event|0|||
156349164|NCT02927080|564374902|FG005|Overall Study|Adverse Event|0|||
156349165|NCT02927080|564374903|FG006|Overall Study|Adverse Event|0|||
156349166|NCT02927080|564374904|FG007|Overall Study|Adverse Event|1|||
156349167|NCT02927080|564374905|FG008|Overall Study|Adverse Event|0|||
156544115|NCT01624662|565086301|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
156482616|NCT00555620|564859092|FG004|Overall Study|Death|0|||
156482617|NCT00555620|564859093|FG005|Overall Study|Death|1|||
156482618|NCT00555620|564859088|FG000|Overall Study|Study terminated by sponsor|0|||
156349168|NCT02927080|564374906|FG009|Overall Study|Adverse Event|1|||
156349169|NCT02927080|564374897|FG000|Overall Study|Other|0|||
156349170|NCT02927080|564374898|FG001|Overall Study|Other|0|||
156349171|NCT02927080|564374899|FG002|Overall Study|Other|0|||
156349172|NCT02927080|564374900|FG003|Overall Study|Other|0|||
156349173|NCT02927080|564374901|FG004|Overall Study|Other|0|||
156349174|NCT02927080|564374902|FG005|Overall Study|Other|0|||
156349175|NCT02927080|564374903|FG006|Overall Study|Other|1|||
156349176|NCT02927080|564374904|FG007|Overall Study|Other|0|||
156349177|NCT02927080|564374905|FG008|Overall Study|Other|1|||
156349178|NCT02927080|564374906|FG009|Overall Study|Other|0|||
156349179|NCT01356966|564374907|FG000|Overall Study|Withdrawal by Subject|1|||
156349180|NCT01356966|564374908|FG001|Overall Study|Withdrawal by Subject|2|||
156349181|NCT01356966|564374907|FG000|Overall Study|Physician Decision|1|||
156349182|NCT01356966|564374908|FG001|Overall Study|Physician Decision|0|||
156482619|NCT00555620|564859089|FG001|Overall Study|Study terminated by sponsor|0|||
156482620|NCT00555620|564859090|FG002|Overall Study|Study terminated by sponsor|1|||
156482621|NCT00555620|564859091|FG003|Overall Study|Study terminated by sponsor|0|||
156482622|NCT00555620|564859092|FG004|Overall Study|Study terminated by sponsor|0|||
156349183|NCT00849381|564374909|FG000|Overall Study|Adverse Event|1|||
156349184|NCT00849381|564374909|FG000|Overall Study|Lost to Follow-up|129|||
156349185|NCT00849381|564374909|FG000|Overall Study|Protocol Violation|5|||
156349186|NCT00849381|564374909|FG000|Overall Study|Withdrawal by Subject|6|||
156349187|NCT00849381|564374909|FG000|Overall Study|Other|4|||
156349188|NCT04429061|564374911|FG000|Overall Study|Lost to Follow-up|62|||
156349189|NCT04429061|564374912|FG001|Overall Study|Lost to Follow-up|87|||
156349190|NCT04429061|564374911|FG000|Overall Study|Withdrawal by Subject|3|||
156349191|NCT04429061|564374912|FG001|Overall Study|Withdrawal by Subject|4|||
156349192|NCT02618434|564374917|FG000|Overall Study|Withdrawal by Subject|0|||
156349193|NCT02618434|564374918|FG001|Overall Study|Withdrawal by Subject|2|||
156349194|NCT02618434|564374919|FG002|Overall Study|Withdrawal by Subject|3|||
156349195|NCT02618434|564374917|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
156349196|NCT02618434|564374918|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
156349197|NCT02618434|564374919|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
156349198|NCT02618434|564374917|FG000|Overall Study|Lost to Follow-up|3|||
156349199|NCT02618434|564374918|FG001|Overall Study|Lost to Follow-up|1|||
156349200|NCT02618434|564374919|FG002|Overall Study|Lost to Follow-up|3|||
156349201|NCT02618434|564374917|FG000|Overall Study|Adverse Event|1|||
156482623|NCT00555620|564859093|FG005|Overall Study|Study terminated by sponsor|0|||
156482624|NCT00555620|564859088|FG000|Overall Study|Adverse Event|0|||
156482625|NCT00555620|564859089|FG001|Overall Study|Adverse Event|0|||
156482626|NCT00555620|564859090|FG002|Overall Study|Adverse Event|1|||
156482627|NCT00555620|564859091|FG003|Overall Study|Adverse Event|5|||
156349202|NCT02618434|564374918|FG001|Overall Study|Adverse Event|0|||
156349203|NCT02618434|564374919|FG002|Overall Study|Adverse Event|12|||
156349204|NCT02618434|564374917|FG000|Overall Study|Physician Decision|0|||
156349205|NCT02618434|564374918|FG001|Overall Study|Physician Decision|1|||
156349206|NCT02618434|564374919|FG002|Overall Study|Physician Decision|0|||
156349207|NCT02618434|564374917|FG000|Overall Study|Protocol Violation|0|||
156482628|NCT00555620|564859092|FG004|Overall Study|Adverse Event|0|||
156482629|NCT00555620|564859093|FG005|Overall Study|Adverse Event|1|||
156349208|NCT02618434|564374918|FG001|Overall Study|Protocol Violation|0|||
156349209|NCT02618434|564374919|FG002|Overall Study|Protocol Violation|1|||
156349210|NCT02618434|564374917|FG000|Overall Study|Other, Multiple categories|1|||
156482630|NCT00555620|564859088|FG000|Overall Study|Objective progression or relapse|6|||
156482631|NCT00555620|564859089|FG001|Overall Study|Objective progression or relapse|5|||
156482632|NCT00555620|564859090|FG002|Overall Study|Objective progression or relapse|12|||
156482633|NCT00555620|564859091|FG003|Overall Study|Objective progression or relapse|17|||
156482634|NCT00555620|564859092|FG004|Overall Study|Objective progression or relapse|3|||
156482635|NCT00555620|564859093|FG005|Overall Study|Objective progression or relapse|16|||
156482636|NCT00555620|564859088|FG000|Overall Study|Participant refused treatment|0|||
156349211|NCT02618434|564374918|FG001|Overall Study|Other, Multiple categories|1|||
156349212|NCT02618434|564374919|FG002|Overall Study|Other, Multiple categories|1|||
156349213|NCT00885105|564374925|FG000|Overall Study|Withdrawal by Subject|0|||
156349214|NCT00885105|564374926|FG001|Overall Study|Withdrawal by Subject|8|||
156349215|NCT00885105|564374925|FG000|Overall Study|Adverse Event|1|||
156349216|NCT00885105|564374926|FG001|Overall Study|Adverse Event|0|||
156349217|NCT00885105|564374925|FG000|Overall Study|Protocol Violation|0|||
156349218|NCT00885105|564374926|FG001|Overall Study|Protocol Violation|2|||
156349219|NCT03519932|564374927|FG000|First Intervention|Adverse Event|1|||
156349220|NCT03519932|564374928|FG001|First Intervention|Adverse Event|3|||
156349221|NCT02254486|564374929|FG000|Overall Study|Adverse Event|1|||
156349222|NCT02254486|564374930|FG001|Overall Study|Adverse Event|1|||
156349223|NCT02254486|564374929|FG000|Overall Study|Lack of Efficacy|1|||
156349224|NCT02254486|564374930|FG001|Overall Study|Lack of Efficacy|0|||
156349225|NCT02254486|564374929|FG000|Overall Study|Lost to Follow-up|2|||
156349226|NCT02254486|564374930|FG001|Overall Study|Lost to Follow-up|4|||
156349227|NCT02254486|564374929|FG000|Overall Study|Protocol Violation|1|||
156349228|NCT02254486|564374930|FG001|Overall Study|Protocol Violation|2|||
156349229|NCT02254486|564374929|FG000|Overall Study|Withdrawal by Subject|17|||
156349230|NCT02254486|564374930|FG001|Overall Study|Withdrawal by Subject|15|||
156349231|NCT02254486|564374929|FG000|Overall Study|GFR<60mL/min|16|||
156349232|NCT02254486|564374930|FG001|Overall Study|GFR<60mL/min|21|||
156349233|NCT02254486|564374929|FG000|Overall Study|Various|12|||
156349234|NCT02254486|564374930|FG001|Overall Study|Various|12|||
156349235|NCT01350414|564374931|FG000|Overall Study|Lost to Follow-up|13|||
156349236|NCT01350414|564374931|FG000|Overall Study|Withdrawal by Subject|4|||
156349237|NCT01350414|564374931|FG000|Overall Study|Physician Decision|2|||
156349238|NCT00267046|564374937|FG000|Overall Study|Disease progression|4|||
156349239|NCT00267046|564374938|FG001|Overall Study|Disease progression|2|||
156349240|NCT00267046|564374937|FG000|Overall Study|Chemotoxicity|2|||
156349241|NCT00267046|564374938|FG001|Overall Study|Chemotoxicity|0|||
156349242|NCT00267046|564374937|FG000|Overall Study|Open-label palifermin|2|||
156349243|NCT00267046|564374938|FG001|Overall Study|Open-label palifermin|7|||
156349244|NCT00267046|564374937|FG000|Overall Study|Surgery|3|||
156349245|NCT00267046|564374938|FG001|Overall Study|Surgery|1|||
156349246|NCT00267046|564374937|FG000|Overall Study|Withdrawal by Subject|1|||
156349247|NCT00267046|564374938|FG001|Overall Study|Withdrawal by Subject|0|||
156349248|NCT00267046|564374937|FG000|Overall Study|Radiation|0|||
156349249|NCT00267046|564374938|FG001|Overall Study|Radiation|1|||
156349250|NCT02066233|564374939|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
156349251|NCT02066233|564374940|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
156349252|NCT02772081|564374941|FG000|Overall Study|Physician Decision|1|||
156349253|NCT02772081|564374942|FG001|Overall Study|Physician Decision|1|||
156544116|NCT01624662|565086302|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
156349254|NCT02772081|564374941|FG000|Overall Study|Death|1|||
156349255|NCT02772081|564374942|FG001|Overall Study|Death|1|||
156349256|NCT02598076|564374946|FG000|Overall Study|Lost to Follow-up|2|||
156349257|NCT02598076|564374947|FG001|Overall Study|Lost to Follow-up|3|||
156349258|NCT04983264|564374948|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
156349259|NCT04983264|564374949|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
156349260|NCT04983264|564374950|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
156349261|NCT04983264|564374948|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
156349262|NCT04983264|564374949|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
156349263|NCT04983264|564374950|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
156349264|NCT00010374|564374955|FG000|Overall Study|False positive phrenic nerve test|1|||
156349265|NCT03315208|564374956|FG000|Overall Study|Lost to Follow-up|11|||
156349266|NCT03315208|564374957|FG001|Overall Study|Lost to Follow-up|6|||
156349267|NCT03315208|564374956|FG000|Overall Study|Withdrawal by Subject|2|||
156349268|NCT03315208|564374957|FG001|Overall Study|Withdrawal by Subject|0|||
156349269|NCT02875860|564374961|FG000|Overall Study|Withdrawal by Subject|0|||
156349270|NCT02875860|564374962|FG001|Overall Study|Withdrawal by Subject|1|||
156349271|NCT03033394|564374971|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
156349272|NCT03033394|564374971|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
156349273|NCT03033394|564374971|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
156349274|NCT03033394|564374971|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
156349275|NCT03033394|564374971|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
156349276|NCT00356369|564374972|FG000|Active Phase|Withdrawal by Subject|2|||
156349277|NCT00356369|564374973|FG001|Active Phase|Withdrawal by Subject|1|||
156349278|NCT00673465|564374977|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
156349279|NCT00673465|564374978|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
156349280|NCT00673465|564374979|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
156349281|NCT00673465|564374980|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
156349282|NCT00673465|564374981|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
156349283|NCT00673465|564374982|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
156349284|NCT00673465|564374983|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
156349285|NCT00673465|564374984|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
156349286|NCT00673465|564374985|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
156482637|NCT00555620|564859089|FG001|Overall Study|Participant refused treatment|1|||
156482638|NCT00555620|564859090|FG002|Overall Study|Participant refused treatment|1|||
156482639|NCT00555620|564859091|FG003|Overall Study|Participant refused treatment|0|||
156482640|NCT00555620|564859092|FG004|Overall Study|Participant refused treatment|0|||
156482641|NCT00555620|564859093|FG005|Overall Study|Participant refused treatment|1|||
156482642|NCT00555620|564859088|FG000|Overall Study|Other|0|||
156544117|NCT01624662|565086303|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
156349287|NCT00673465|564374986|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
156349288|NCT00673465|564374987|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
156482643|NCT00555620|564859089|FG001|Overall Study|Other|0|||
156482644|NCT00555620|564859090|FG002|Overall Study|Other|0|||
156544118|NCT01624662|565086304|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
156482645|NCT00555620|564859091|FG003|Overall Study|Other|1|||
156349289|NCT00673465|564374988|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
156349290|NCT00673465|564374977|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349291|NCT00673465|564374978|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349292|NCT00673465|564374979|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349293|NCT00673465|564374980|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349294|NCT00673465|564374981|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
156349295|NCT00673465|564374982|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349296|NCT00673465|564374983|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349297|NCT00673465|564374984|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349298|NCT00673465|564374985|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349299|NCT00673465|564374986|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349300|NCT00673465|564374987|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349301|NCT00673465|564374988|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
156349302|NCT00143403|564374989|FG000|Overall Study|Adverse Event|3|||
156349303|NCT00143403|564374990|FG001|Overall Study|Adverse Event|8|||
156349304|NCT00143403|564374989|FG000|Overall Study|Death|1|||
156349305|NCT00143403|564374990|FG001|Overall Study|Death|0|||
156349306|NCT00143403|564374989|FG000|Overall Study|Withdrawal by Subject|3|||
156349307|NCT00143403|564374990|FG001|Overall Study|Withdrawal by Subject|12|||
156349308|NCT00143403|564374989|FG000|Overall Study|Relapse|15|||
156349309|NCT00143403|564374990|FG001|Overall Study|Relapse|7|||
156349310|NCT00143403|564374989|FG000|Overall Study|Protocol Violation|2|||
156349311|NCT00143403|564374990|FG001|Overall Study|Protocol Violation|2|||
156349312|NCT00143403|564374989|FG000|Overall Study|specified by site|4|||
156349313|NCT00143403|564374990|FG001|Overall Study|specified by site|9|||
156349314|NCT00143403|564374989|FG000|Overall Study|Randomized Not Treated|7|||
156349315|NCT00143403|564374990|FG001|Overall Study|Randomized Not Treated|8|||
156349316|NCT01919723|564374991|FG000|Overall Study|Blood Samples Hemolyzed|2|||
156349317|NCT01919723|564374992|FG001|Overall Study|Blood Samples Hemolyzed|2|||
156349318|NCT04502589|564374993|FG000|Overall Study|Physician Decision|1|||
156349319|NCT04502589|564374994|FG001|Overall Study|Physician Decision|0|||
156349320|NCT00160251|564374995|FG000|Prior to Amendment 2|Adverse Event|2|||
156349321|NCT00160251|564374996|FG001|Prior to Amendment 2|Adverse Event|1|||
156349322|NCT00160251|564374997|FG002|Prior to Amendment 2|Adverse Event|3|||
156349323|NCT00160251|564374998|FG003|Prior to Amendment 2|Adverse Event|1|||
156349324|NCT00160251|564374999|FG004|Prior to Amendment 2|Adverse Event|1|||
156349325|NCT00160251|564375000|FG005|Prior to Amendment 2|Adverse Event|1|||
156349326|NCT00160251|564375001|FG006|Prior to Amendment 2|Adverse Event|1|||
156349327|NCT00160251|564375002|FG007|Prior to Amendment 2|Adverse Event|0|||
156349328|NCT00160251|564374995|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
156349329|NCT00160251|564374996|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
156349330|NCT00160251|564374997|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
156349331|NCT00160251|564374998|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
156349332|NCT00160251|564374999|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
156349333|NCT00160251|564375000|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
156349334|NCT00160251|564375001|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
156349335|NCT00160251|564375002|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
156349336|NCT00160251|564374995|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
156349337|NCT00160251|564374996|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
156349338|NCT00160251|564374997|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
156349339|NCT00160251|564374998|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
156349340|NCT00160251|564374999|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
156349341|NCT00160251|564375000|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
156349342|NCT00160251|564375001|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
156482646|NCT00555620|564859092|FG004|Overall Study|Other|0|||
156482647|NCT00555620|564859093|FG005|Overall Study|Other|3|||
156482648|NCT05203822|564859094|FG000|Overall Study|Adverse Event|1|||
156482649|NCT05203822|564859094|FG000|Overall Study|Withdrawal by Subject|1|||
156349343|NCT00160251|564375002|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
156349344|NCT00160251|564374995|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
156349345|NCT00160251|564374996|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
156349346|NCT00160251|564374997|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
156349347|NCT00160251|564374998|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
156349348|NCT00160251|564374999|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
156349349|NCT00160251|564375000|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
156349350|NCT00160251|564375001|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
156349351|NCT00160251|564375002|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
156349352|NCT00160251|564374995|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
156349353|NCT00160251|564374996|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
156349354|NCT00160251|564374997|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
156349355|NCT00160251|564374998|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
156349356|NCT00160251|564374999|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
156482650|NCT03184519|564859103|FG000|Overall Study|Lost to Follow-up|6|||
156482651|NCT03184519|564859103|FG000|Overall Study|Physician Decision|21|||
156349357|NCT00160251|564375000|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
156349358|NCT00160251|564375001|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
156349359|NCT00160251|564375002|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
156349360|NCT00160251|564374995|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
156349361|NCT00160251|564374996|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
156482652|NCT00901459|564859108|FG000|Overall Study|Withdrawal by Subject|6|||
156482653|NCT04765046|564859109|FG000|Overall Study|Screen Failure|2|||
156349362|NCT00160251|564374997|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
156349363|NCT00160251|564374998|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
156349364|NCT00160251|564374999|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
156349365|NCT00160251|564375000|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
156349366|NCT00160251|564375001|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
156349367|NCT00160251|564375002|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
156349368|NCT00160251|564374995|FG000|Post-amendment 2|Adverse Event|0|||
156349369|NCT00160251|564374996|FG001|Post-amendment 2|Adverse Event|0|||
156349370|NCT00160251|564374997|FG002|Post-amendment 2|Adverse Event|0|||
156349371|NCT00160251|564374998|FG003|Post-amendment 2|Adverse Event|0|||
156349372|NCT00160251|564374999|FG004|Post-amendment 2|Adverse Event|0|||
156349373|NCT00160251|564375000|FG005|Post-amendment 2|Adverse Event|0|||
156349374|NCT00160251|564375001|FG006|Post-amendment 2|Adverse Event|0|||
156349375|NCT00160251|564375002|FG007|Post-amendment 2|Adverse Event|20|||
156349376|NCT00160251|564374995|FG000|Post-amendment 2|Lack of Efficacy|0|||
156349377|NCT00160251|564374996|FG001|Post-amendment 2|Lack of Efficacy|0|||
156349378|NCT00160251|564374997|FG002|Post-amendment 2|Lack of Efficacy|0|||
156349379|NCT00160251|564374998|FG003|Post-amendment 2|Lack of Efficacy|0|||
156349380|NCT00160251|564374999|FG004|Post-amendment 2|Lack of Efficacy|0|||
156349381|NCT00160251|564375000|FG005|Post-amendment 2|Lack of Efficacy|0|||
156349382|NCT00160251|564375001|FG006|Post-amendment 2|Lack of Efficacy|0|||
156349383|NCT00160251|564375002|FG007|Post-amendment 2|Lack of Efficacy|24|||
156349384|NCT00160251|564374995|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156349385|NCT00160251|564374996|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156349386|NCT00160251|564374997|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156349387|NCT00160251|564374998|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156349388|NCT00160251|564374999|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156349389|NCT00160251|564375000|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156349390|NCT00160251|564375001|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156349391|NCT00160251|564375002|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
156349392|NCT01574612|564375003|FG000|Overall Study|Adverse Event|3|||
156349393|NCT01574612|564375003|FG000|Overall Study|non compliant with drug|2|||
156349394|NCT01574612|564375003|FG000|Overall Study|Withdrawal by Subject|1|||
156349395|NCT01574612|564375003|FG000|Overall Study|Lost to Follow-up|2|||
156349396|NCT03235154|564375004|FG000|Overall Study|Withdrawal by Subject|1|||
156349397|NCT03235154|564375004|FG000|Overall Study|Adverse Event|1|||
156349398|NCT03235154|564375004|FG000|Overall Study|Lost to Follow-up|2|||
156349399|NCT01683383|564375009|FG000|Overall Study|Infant was not transported|1|||
156349400|NCT01683383|564375010|FG001|Overall Study|Infant was not transported|0|||
156349401|NCT02496611|564375011|FG000|Overall Study|Lost to Follow-up|2|||
156349402|NCT02496611|564375012|FG001|Overall Study|Lost to Follow-up|1|||
156349403|NCT02496611|564375011|FG000|Overall Study|Withdrawal by Subject|5|||
156349404|NCT02496611|564375012|FG001|Overall Study|Withdrawal by Subject|2|||
156349405|NCT02850965|564375013|FG000|Overall Study|Other than listed|3|||
156349406|NCT02850965|564375014|FG001|Overall Study|Other than listed|4|||
156349407|NCT02850965|564375013|FG000|Overall Study|Protocol Violation|0|||
156349408|NCT02850965|564375014|FG001|Overall Study|Protocol Violation|2|||
156349409|NCT02850965|564375013|FG000|Overall Study|Lost to Follow-up|5|||
156349410|NCT02850965|564375014|FG001|Overall Study|Lost to Follow-up|3|||
156349411|NCT02850965|564375013|FG000|Overall Study|Lack of Efficacy|4|||
156349412|NCT02850965|564375014|FG001|Overall Study|Lack of Efficacy|8|||
156349413|NCT02850965|564375013|FG000|Overall Study|Adverse Event|3|||
156349414|NCT02850965|564375014|FG001|Overall Study|Adverse Event|2|||
156349415|NCT02850965|564375013|FG000|Overall Study|Withdrawal by Subject|3|||
156349416|NCT02850965|564375014|FG001|Overall Study|Withdrawal by Subject|4|||
156349417|NCT02850965|564375013|FG000|Overall Study|Physician Decision|0|||
156349418|NCT02850965|564375014|FG001|Overall Study|Physician Decision|1|||
156349419|NCT02850965|564375013|FG000|Overall Study|Randomized but not treated|0|||
156349420|NCT02850965|564375014|FG001|Overall Study|Randomized but not treated|1|||
156349421|NCT02326025|564375015|FG000|Overall Study|Adverse Event|3|||
156349422|NCT02326025|564375016|FG001|Overall Study|Adverse Event|0|||
156349423|NCT02326025|564375015|FG000|Overall Study|Physician Decision|1|||
156349424|NCT02326025|564375016|FG001|Overall Study|Physician Decision|2|||
156349425|NCT02326025|564375015|FG000|Overall Study|Physician and Participant Decision|1|||
156349426|NCT02326025|564375016|FG001|Overall Study|Physician and Participant Decision|0|||
156349427|NCT02326025|564375015|FG000|Overall Study|Withdrawal by Subject|0|||
156349428|NCT02326025|564375016|FG001|Overall Study|Withdrawal by Subject|2|||
156544119|NCT00361270|565086305|FG000|Overall Study|Death|0|||
156349429|NCT02326025|564375015|FG000|Overall Study|Protocol Violation|0|||
156349430|NCT02326025|564375016|FG001|Overall Study|Protocol Violation|1|||
156349431|NCT00536198|564375017|FG000|Overall Study|Lost to Follow-up|15|||
156349432|NCT00536198|564375018|FG001|Overall Study|Lost to Follow-up|14|||
156349433|NCT00536198|564375017|FG000|Overall Study|Withdrawal by Subject|16|||
156349434|NCT00536198|564375018|FG001|Overall Study|Withdrawal by Subject|12|||
156349435|NCT00536198|564375017|FG000|Overall Study|Adverse Event|2|||
156349436|NCT00536198|564375018|FG001|Overall Study|Adverse Event|2|||
156349437|NCT00536198|564375017|FG000|Overall Study|Rescue|3|||
156349438|NCT00536198|564375018|FG001|Overall Study|Rescue|9|||
156482654|NCT04765046|564859109|FG000|Overall Study|Withdrawal by Subject|4|||
156482655|NCT04765046|564859109|FG000|Overall Study|Physician Decision|4|||
156482656|NCT04765046|564859109|FG000|Overall Study|Surgery Cancelled|8|||
156482657|NCT02959866|564859113|FG000|Overall Study|Withdrawal by Subject|1|||
156482658|NCT04529941|564859117|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
156482659|NCT04529941|564859118|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
156482660|NCT01005914|564859119|FG000|Overall Study|Adverse Event|4|||
156482661|NCT01005914|564859119|FG000|Overall Study|Death|4|||
156482662|NCT01005914|564859119|FG000|Overall Study|Lack of Efficacy|1|||
156482663|NCT01005914|564859119|FG000|Overall Study|Withdrawal by Subject|1|||
156482664|NCT01240785|564859120|FG000|Overall Study|Lost to Follow-up|1|||
156482665|NCT01240785|564859121|FG001|Overall Study|Lost to Follow-up|0|||
156544120|NCT00361270|565086306|FG001|Overall Study|Death|0|||
156544121|NCT00361270|565086307|FG002|Overall Study|Death|0|||
156544122|NCT00361270|565086308|FG003|Overall Study|Death|2|||
156544123|NCT00361270|565086305|FG000|Overall Study|Lost to Follow-up|4|||
156544124|NCT00361270|565086306|FG001|Overall Study|Lost to Follow-up|1|||
156544125|NCT00361270|565086307|FG002|Overall Study|Lost to Follow-up|0|||
156544126|NCT00361270|565086308|FG003|Overall Study|Lost to Follow-up|0|||
156544127|NCT00361270|565086305|FG000|Overall Study|Physician Decision|0|||
156544128|NCT00361270|565086306|FG001|Overall Study|Physician Decision|0|||
156544129|NCT00361270|565086307|FG002|Overall Study|Physician Decision|1|||
156544130|NCT00361270|565086308|FG003|Overall Study|Physician Decision|0|||
156544131|NCT00361270|565086305|FG000|Overall Study|Protocol Violation|9|||
156544132|NCT00361270|565086306|FG001|Overall Study|Protocol Violation|4|||
156544133|NCT00361270|565086307|FG002|Overall Study|Protocol Violation|5|||
156544134|NCT00361270|565086308|FG003|Overall Study|Protocol Violation|4|||
156544135|NCT00361270|565086305|FG000|Overall Study|Withdrawal by Subject|6|||
156544136|NCT00361270|565086306|FG001|Overall Study|Withdrawal by Subject|6|||
156544137|NCT00361270|565086307|FG002|Overall Study|Withdrawal by Subject|3|||
156544138|NCT00361270|565086308|FG003|Overall Study|Withdrawal by Subject|7|||
156349439|NCT00536198|564375017|FG000|Overall Study|Pregnancy|1|||
156349440|NCT00536198|564375018|FG001|Overall Study|Pregnancy|1|||
156349441|NCT00536198|564375017|FG000|Overall Study|Protocol Violation|0|||
156349442|NCT00536198|564375018|FG001|Overall Study|Protocol Violation|1|||
156349443|NCT02643082|564375019|FG000|Period 1|Adverse Event|1|||
156349444|NCT02643082|564375020|FG001|Period 1|Adverse Event|0|||
156349445|NCT00881712|564375021|FG000|Overall Study|Death|1|||
156349446|NCT00881712|564375022|FG001|Overall Study|Death|0|||
156349447|NCT00881712|564375023|FG002|Overall Study|Death|0|||
156349448|NCT00881712|564375021|FG000|Overall Study|Withdrawal by Subject|1|||
156349449|NCT00881712|564375022|FG001|Overall Study|Withdrawal by Subject|0|||
156349450|NCT00881712|564375023|FG002|Overall Study|Withdrawal by Subject|0|||
156349451|NCT00276744|564375024|FG000|PART A|Reason unknown|98|||
156349452|NCT02505867|564375025|FG000|Overall Study|Lack of Efficacy|6|||
156349453|NCT02505867|564375026|FG001|Overall Study|Lack of Efficacy|6|||
156349454|NCT01428453|564375029|FG000|Overall Study|Adverse Event|2|||
156349455|NCT01428453|564375030|FG001|Overall Study|Adverse Event|7|||
156349456|NCT01428453|564375029|FG000|Overall Study|Protocol Violation|1|||
156349457|NCT01428453|564375030|FG001|Overall Study|Protocol Violation|0|||
156349458|NCT01428453|564375029|FG000|Overall Study|Lost to Follow-up|0|||
156349459|NCT01428453|564375030|FG001|Overall Study|Lost to Follow-up|1|||
156349460|NCT01428453|564375029|FG000|Overall Study|Withdrawal by Subject|3|||
156349461|NCT01428453|564375030|FG001|Overall Study|Withdrawal by Subject|1|||
156349462|NCT01996709|564375031|FG000|Overall Study|Withdrawal by Subject|1|||
156349463|NCT01996709|564375032|FG001|Overall Study|Withdrawal by Subject|0|||
156349464|NCT01996709|564375031|FG000|Overall Study|Lost to Follow-up|3|||
156349465|NCT01996709|564375032|FG001|Overall Study|Lost to Follow-up|0|||
156349466|NCT01996709|564375031|FG000|Overall Study|Subject Non-Compliant|1|||
156349467|NCT01996709|564375032|FG001|Overall Study|Subject Non-Compliant|0|||
156349468|NCT01996709|564375031|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
156349469|NCT01996709|564375032|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
156349470|NCT00477971|564375033|FG000|Overall Study|Disease progression|6|||
156349471|NCT00477971|564375034|FG001|Overall Study|Disease progression|0|||
156349472|NCT00477971|564375033|FG000|Overall Study|Withdrawal by Subject|3|||
156349473|NCT00477971|564375034|FG001|Overall Study|Withdrawal by Subject|1|||
156349474|NCT00477971|564375033|FG000|Overall Study|Adverse Event|3|||
156349475|NCT00477971|564375034|FG001|Overall Study|Adverse Event|0|||
156349476|NCT00477971|564375033|FG000|Overall Study|Death|2|||
156349477|NCT00477971|564375034|FG001|Overall Study|Death|4|||
156349478|NCT00477971|564375033|FG000|Overall Study|Alternative treatment|3|||
156349479|NCT00477971|564375034|FG001|Overall Study|Alternative treatment|1|||
156349480|NCT00531232|564377904|FG000|Overall Study|Investigator decision|0|||
156349481|NCT00531232|564377905|FG001|Overall Study|Investigator decision|0|||
156349482|NCT00531232|564377906|FG002|Overall Study|Investigator decision|4|||
156349483|NCT00531232|564377904|FG000|Overall Study|Participants refused further treatment|0|||
156349484|NCT00531232|564377905|FG001|Overall Study|Participants refused further treatment|1|||
156349485|NCT00531232|564377906|FG002|Overall Study|Participants refused further treatment|2|||
156349486|NCT00531232|564377904|FG000|Overall Study|Adverse events (AEs)|1|||
156349487|NCT00531232|564377905|FG001|Overall Study|Adverse events (AEs)|2|||
156349488|NCT00531232|564377906|FG002|Overall Study|Adverse events (AEs)|2|||
156349489|NCT00531232|564377904|FG000|Overall Study|Treatment failure|1|||
156349490|NCT00531232|564377905|FG001|Overall Study|Treatment failure|3|||
156349491|NCT00531232|564377906|FG002|Overall Study|Treatment failure|7|||
156349492|NCT00531232|564377904|FG000|Overall Study|Disease recurrence|0|||
156349493|NCT00531232|564377905|FG001|Overall Study|Disease recurrence|0|||
156349494|NCT00531232|564377906|FG002|Overall Study|Disease recurrence|1|||
156349495|NCT00531232|564377904|FG000|Overall Study|Deceased|2|||
156349496|NCT00531232|564377905|FG001|Overall Study|Deceased|2|||
156349497|NCT00531232|564377906|FG002|Overall Study|Deceased|2|||
156349498|NCT00531232|564377904|FG000|Overall Study|Withdrawal by Subject|0|||
156349499|NCT00531232|564377905|FG001|Overall Study|Withdrawal by Subject|1|||
156349500|NCT00531232|564377906|FG002|Overall Study|Withdrawal by Subject|2|||
156349501|NCT00531232|564377904|FG000|Overall Study|Other|0|||
156349502|NCT00531232|564377905|FG001|Overall Study|Other|0|||
156349503|NCT00531232|564377906|FG002|Overall Study|Other|5|||
156349504|NCT00397982|564377907|FG000|Overall Study|Withdrawal by Subject|1|||
156349505|NCT00397982|564377907|FG000|Overall Study|Adverse Event|1|||
156349506|NCT00397982|564377907|FG000|Overall Study|noncompliance|1|||
156482666|NCT01240785|564859120|FG000|Overall Study|Protocol Violation|0|||
156349507|NCT00397982|564377907|FG000|Overall Study|Unrelated health issues|1|||
156349508|NCT04232124|564377908|FG000|Overall Study|Lost to Follow-up|3|||
156349509|NCT00754624|564377912|FG000|Overall Study|Adverse Event|16|||
156544139|NCT00361270|565086305|FG000|Overall Study|Afraid of Hypnosis|1|||
156482667|NCT01240785|564859121|FG001|Overall Study|Protocol Violation|3|||
156482668|NCT00321555|564859125|FG000|Overall Study|Developed antibodies|1|||
156482669|NCT00321555|564859125|FG000|Overall Study|Switched to alternative treatment|3|||
156544140|NCT00361270|565086306|FG001|Overall Study|Afraid of Hypnosis|2|||
156482670|NCT00321555|564859125|FG000|Overall Study|Physician Decision|1|||
156349510|NCT00754624|564377912|FG000|Overall Study|Death|1|||
156349511|NCT00754624|564377912|FG000|Overall Study|Physician Decision|8|||
156349512|NCT00754624|564377912|FG000|Overall Study|Protocol Violation|1|||
156482671|NCT00321555|564859125|FG000|Overall Study|Disease progression on study|1|||
156482672|NCT04520256|564859129|FG000|Overall Study|Lost to Follow-up|6|||
156349513|NCT00754624|564377912|FG000|Overall Study|Withdrawal by Subject|28|||
156482673|NCT04520256|564859130|FG001|Overall Study|Lost to Follow-up|4|||
156482674|NCT04520256|564859131|FG002|Overall Study|Lost to Follow-up|2|||
156482675|NCT04520256|564859132|FG003|Overall Study|Lost to Follow-up|3|||
156482676|NCT04520256|564859133|FG004|Overall Study|Lost to Follow-up|6|||
156482677|NCT04520256|564859134|FG005|Overall Study|Lost to Follow-up|6|||
156482678|NCT04520256|564859135|FG006|Overall Study|Lost to Follow-up|4|||
156482679|NCT04520256|564859136|FG007|Overall Study|Lost to Follow-up|6|||
156349514|NCT00754624|564377912|FG000|Overall Study|Various|12|||
156349515|NCT00754624|564377912|FG000|Overall Study|Lost to Follow-up|3|||
156349516|NCT04067544|564377913|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
156349517|NCT00967798|564377914|FG000|Overall Study|Withdrawal by Subject|5|||
156349518|NCT00967798|564377915|FG001|Overall Study|Withdrawal by Subject|2|||
156349519|NCT00967798|564377914|FG000|Overall Study|Lost to Follow-up|4|||
156349520|NCT00967798|564377915|FG001|Overall Study|Lost to Follow-up|1|||
156349521|NCT03045328|564377921|FG000|Overall Study|Withdrawal by Subject|2|||
156349522|NCT00592839|564377926|FG000|Overall Study|Withdrawal by Subject|1|||
156349523|NCT00592839|564377927|FG001|Overall Study|Withdrawal by Subject|1|||
156349524|NCT00592839|564377928|FG002|Overall Study|Withdrawal by Subject|3|||
156349525|NCT00592839|564377926|FG000|Overall Study|Protocol Violation|1|||
156349526|NCT00592839|564377927|FG001|Overall Study|Protocol Violation|1|||
156349527|NCT00592839|564377928|FG002|Overall Study|Protocol Violation|2|||
156349528|NCT00592839|564377926|FG000|Overall Study|Adverse Event|0|||
156349529|NCT00592839|564377927|FG001|Overall Study|Adverse Event|1|||
156349530|NCT00592839|564377928|FG002|Overall Study|Adverse Event|0|||
156349531|NCT00592839|564377926|FG000|Overall Study|Lost to Follow-up|0|||
156349532|NCT00592839|564377927|FG001|Overall Study|Lost to Follow-up|1|||
156349533|NCT00592839|564377928|FG002|Overall Study|Lost to Follow-up|1|||
156349534|NCT02564042|564377929|FG000|Overall Study|Adverse Event|4|||
156349535|NCT02564042|564377930|FG001|Overall Study|Adverse Event|4|||
156349536|NCT02564042|564377931|FG002|Overall Study|Adverse Event|3|||
156349537|NCT02564042|564377932|FG003|Overall Study|Adverse Event|0|||
156349538|NCT02564042|564377933|FG004|Overall Study|Adverse Event|0|||
156349539|NCT02564042|564377934|FG005|Overall Study|Adverse Event|1|||
156349540|NCT02564042|564377929|FG000|Overall Study|Lost to Follow-up|1|||
156349541|NCT02564042|564377930|FG001|Overall Study|Lost to Follow-up|1|||
156349542|NCT02564042|564377931|FG002|Overall Study|Lost to Follow-up|1|||
156349543|NCT02564042|564377932|FG003|Overall Study|Lost to Follow-up|0|||
156349544|NCT02564042|564377933|FG004|Overall Study|Lost to Follow-up|1|||
156349545|NCT02564042|564377934|FG005|Overall Study|Lost to Follow-up|1|||
156349546|NCT02564042|564377929|FG000|Overall Study|Physician Decision|1|||
156349547|NCT02564042|564377930|FG001|Overall Study|Physician Decision|0|||
156349548|NCT02564042|564377931|FG002|Overall Study|Physician Decision|0|||
156349549|NCT02564042|564377932|FG003|Overall Study|Physician Decision|1|||
156349550|NCT02564042|564377933|FG004|Overall Study|Physician Decision|0|||
156349551|NCT02564042|564377934|FG005|Overall Study|Physician Decision|0|||
156349552|NCT02564042|564377929|FG000|Overall Study|Withdrawal by Subject|5|||
156349553|NCT02564042|564377930|FG001|Overall Study|Withdrawal by Subject|3|||
156349554|NCT02564042|564377931|FG002|Overall Study|Withdrawal by Subject|2|||
156349555|NCT02564042|564377932|FG003|Overall Study|Withdrawal by Subject|2|||
156349556|NCT02564042|564377933|FG004|Overall Study|Withdrawal by Subject|10|||
156349557|NCT02564042|564377934|FG005|Overall Study|Withdrawal by Subject|12|||
156349558|NCT01124422|564377935|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
156349559|NCT01124422|564377936|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
156349560|NCT01124422|564377937|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
156349561|NCT01124422|564377935|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
156349562|NCT01124422|564377936|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
156349563|NCT01124422|564377937|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
156349564|NCT01124422|564377935|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
156349565|NCT01124422|564377936|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
156349566|NCT01124422|564377937|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
156349567|NCT01124422|564377935|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
156349568|NCT01124422|564377936|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
156349569|NCT01124422|564377937|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
156349570|NCT01124422|564377935|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
156349571|NCT01124422|564377936|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
156349572|NCT01124422|564377937|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
156349573|NCT01124422|564377935|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
156349574|NCT01124422|564377936|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
156349575|NCT01124422|564377937|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
156349576|NCT01124422|564377935|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
156349577|NCT01124422|564377936|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
156349578|NCT01124422|564377937|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
156349579|NCT01124422|564377935|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
156349580|NCT01124422|564377936|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
156349581|NCT01124422|564377937|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
156349582|NCT01124422|564377935|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
156349583|NCT01124422|564377936|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
156349584|NCT01124422|564377937|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
156349585|NCT01124422|564377935|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
156349586|NCT01124422|564377936|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
156349587|NCT01124422|564377937|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
156349588|NCT01828281|564377938|FG000|Overall Study|Withdrawal by Subject|1|||
156349589|NCT01828281|564377939|FG001|Overall Study|Withdrawal by Subject|0|||
156349590|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Death|3|||
156349591|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Death|3|||
156349592|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Death|0|||
156349593|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Death|0|||
156349594|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
156349595|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
156349596|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
156349597|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
156349598|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
156349599|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
156349600|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
156349601|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
156349602|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
156349603|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
156349604|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
156349605|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
156349606|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
156349607|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
156349608|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
156349609|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
156349610|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
156349611|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
156349612|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
156349613|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
156349614|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
156349615|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
156349616|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
156349617|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
156349618|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Other|6|||
156349619|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Other|3|||
156349620|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Other|0|||
156349621|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Other|0|||
156349622|NCT02051608|564377940|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
156349623|NCT02051608|564377941|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
156349624|NCT02051608|564377942|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
156349625|NCT02051608|564377943|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
156349626|NCT02051608|564377940|FG000|Part 2: Open-label Extension|Adverse Event|0|||
156349627|NCT02051608|564377941|FG001|Part 2: Open-label Extension|Adverse Event|0|||
156349628|NCT02051608|564377942|FG002|Part 2: Open-label Extension|Adverse Event|6|||
156349629|NCT02051608|564377943|FG003|Part 2: Open-label Extension|Adverse Event|8|||
156349630|NCT02051608|564377940|FG000|Part 2: Open-label Extension|Death|0|||
156349631|NCT02051608|564377941|FG001|Part 2: Open-label Extension|Death|0|||
156349632|NCT02051608|564377942|FG002|Part 2: Open-label Extension|Death|7|||
156349633|NCT02051608|564377943|FG003|Part 2: Open-label Extension|Death|4|||
156349634|NCT02051608|564377940|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
156349635|NCT02051608|564377941|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
156349636|NCT02051608|564377942|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
156482680|NCT04520256|564859137|FG008|Overall Study|Lost to Follow-up|1|||
156482681|NCT04520256|564859138|FG009|Overall Study|Lost to Follow-up|3|||
156482682|NCT04520256|564859139|FG010|Overall Study|Lost to Follow-up|3|||
156349637|NCT02051608|564377943|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
156349638|NCT02051608|564377940|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
156349639|NCT02051608|564377941|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
156349640|NCT02051608|564377942|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
156349641|NCT02051608|564377943|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
156349642|NCT02051608|564377940|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
156349643|NCT02051608|564377941|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
156349644|NCT02051608|564377942|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
156349645|NCT02051608|564377943|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
156349646|NCT02051608|564377940|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
156482683|NCT04520256|564859140|FG011|Overall Study|Lost to Follow-up|2|||
156349647|NCT02051608|564377941|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
156349648|NCT02051608|564377942|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
156349649|NCT02051608|564377943|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
156349650|NCT02051608|564377940|FG000|Part 2: Open-label Extension|Physician Decision|0|||
156349651|NCT02051608|564377941|FG001|Part 2: Open-label Extension|Physician Decision|0|||
156349652|NCT02051608|564377942|FG002|Part 2: Open-label Extension|Physician Decision|8|||
156349653|NCT02051608|564377943|FG003|Part 2: Open-label Extension|Physician Decision|5|||
156349654|NCT02051608|564377940|FG000|Part 2: Open-label Extension|Other|0|||
156349655|NCT02051608|564377941|FG001|Part 2: Open-label Extension|Other|0|||
156349656|NCT02051608|564377942|FG002|Part 2: Open-label Extension|Other|9|||
156349657|NCT02051608|564377943|FG003|Part 2: Open-label Extension|Other|9|||
156349658|NCT00142584|564377946|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
156349659|NCT00142584|564377947|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
156349660|NCT00142584|564377946|FG000|Overall Study|Withdrawal by Subject|30|||
156349661|NCT00142584|564377947|FG001|Overall Study|Withdrawal by Subject|16|||
156349662|NCT00142584|564377946|FG000|Overall Study|Lost to Follow-up|22|||
156349663|NCT00142584|564377947|FG001|Overall Study|Lost to Follow-up|12|||
156349664|NCT00142584|564377946|FG000|Overall Study|Adverse Event|14|||
156349665|NCT00142584|564377947|FG001|Overall Study|Adverse Event|5|||
156349666|NCT00142584|564377946|FG000|Overall Study|Protocol Violation|4|||
156349667|NCT00142584|564377947|FG001|Overall Study|Protocol Violation|7|||
156349668|NCT00142584|564377946|FG000|Overall Study|Treatment Failure|2|||
156349669|NCT00142584|564377947|FG001|Overall Study|Treatment Failure|0|||
156349670|NCT03070782|564377948|FG000|Overall Study|Adverse Event|3|||
156349671|NCT03070782|564377949|FG001|Overall Study|Adverse Event|0|||
156349672|NCT03070782|564377950|FG002|Overall Study|Adverse Event|3|||
156349673|NCT03070782|564377951|FG003|Overall Study|Adverse Event|1|||
156349674|NCT03070782|564377952|FG004|Overall Study|Adverse Event|6|||
156349675|NCT03070782|564377953|FG005|Overall Study|Adverse Event|2|||
156349676|NCT03070782|564377948|FG000|Overall Study|Withdrawal by Subject|2|||
156349677|NCT03070782|564377949|FG001|Overall Study|Withdrawal by Subject|1|||
156349678|NCT03070782|564377950|FG002|Overall Study|Withdrawal by Subject|1|||
156349679|NCT03070782|564377951|FG003|Overall Study|Withdrawal by Subject|0|||
156349680|NCT03070782|564377952|FG004|Overall Study|Withdrawal by Subject|4|||
156349681|NCT03070782|564377953|FG005|Overall Study|Withdrawal by Subject|3|||
156349682|NCT03070782|564377948|FG000|Overall Study|Reason Not Specified|2|||
156349683|NCT03070782|564377949|FG001|Overall Study|Reason Not Specified|0|||
156349684|NCT03070782|564377950|FG002|Overall Study|Reason Not Specified|0|||
156349685|NCT03070782|564377951|FG003|Overall Study|Reason Not Specified|1|||
156349686|NCT03070782|564377952|FG004|Overall Study|Reason Not Specified|2|||
156349687|NCT03070782|564377953|FG005|Overall Study|Reason Not Specified|1|||
156349688|NCT03070782|564377948|FG000|Overall Study|Ineligibility|0|||
156349689|NCT03070782|564377949|FG001|Overall Study|Ineligibility|0|||
156349690|NCT03070782|564377950|FG002|Overall Study|Ineligibility|0|||
156349691|NCT03070782|564377951|FG003|Overall Study|Ineligibility|1|||
156349692|NCT03070782|564377952|FG004|Overall Study|Ineligibility|0|||
156349693|NCT03070782|564377953|FG005|Overall Study|Ineligibility|1|||
156349694|NCT03070782|564377948|FG000|Overall Study|Pregnancy|0|||
156349695|NCT03070782|564377949|FG001|Overall Study|Pregnancy|0|||
156349696|NCT03070782|564377950|FG002|Overall Study|Pregnancy|0|||
156349697|NCT03070782|564377951|FG003|Overall Study|Pregnancy|1|||
156349698|NCT03070782|564377952|FG004|Overall Study|Pregnancy|0|||
156349699|NCT03070782|564377953|FG005|Overall Study|Pregnancy|0|||
156349700|NCT03070782|564377948|FG000|Overall Study|Investigator Judgement|0|||
156544141|NCT00361270|565086307|FG002|Overall Study|Afraid of Hypnosis|0|||
156349701|NCT03070782|564377949|FG001|Overall Study|Investigator Judgement|0|||
156349702|NCT03070782|564377950|FG002|Overall Study|Investigator Judgement|0|||
156349703|NCT03070782|564377951|FG003|Overall Study|Investigator Judgement|1|||
156349704|NCT03070782|564377952|FG004|Overall Study|Investigator Judgement|0|||
156349705|NCT03070782|564377953|FG005|Overall Study|Investigator Judgement|0|||
156349706|NCT00449540|564377956|FG000|Pretreatment Phase|No migraine experienced|66|||
156349707|NCT00449540|564377957|FG001|Pretreatment Phase|No migraine experienced|0|||
156349708|NCT00449540|564377958|FG002|Pretreatment Phase|No migraine experienced|0|||
156349709|NCT00449540|564377956|FG000|Treatment Phase|did not experience or treat migraine|0|||
156349710|NCT00449540|564377957|FG001|Treatment Phase|did not experience or treat migraine|20|||
156349711|NCT00449540|564377958|FG002|Treatment Phase|did not experience or treat migraine|17|||
156349712|NCT02709785|564377959|FG000|Overall Study|Withdrawal by Subject|1|||
156349713|NCT02709785|564377960|FG001|Overall Study|Withdrawal by Subject|2|||
156349714|NCT02709785|564377961|FG002|Overall Study|Withdrawal by Subject|1|||
156349715|NCT01961323|564377962|FG000|Overall Study|Withdrawal by Subject|7|||
156349716|NCT01961323|564377962|FG000|Overall Study|Lost to Follow-up|8|||
156349717|NCT01961323|564377962|FG000|Overall Study|screen failure|34|||
156349718|NCT01881776|564377963|FG000|Overall Study|Lost to Follow-up|1|||
156349719|NCT01881776|564377964|FG001|Overall Study|Lost to Follow-up|2|||
156349720|NCT01881776|564377965|FG002|Overall Study|Lost to Follow-up|1|||
156349721|NCT01881776|564377963|FG000|Overall Study|Protocol Violation|0|||
156349722|NCT01881776|564377964|FG001|Overall Study|Protocol Violation|2|||
156349723|NCT01881776|564377965|FG002|Overall Study|Protocol Violation|1|||
156349724|NCT02320149|564377966|FG000|Overall Study|Adverse Event|3|||
156349725|NCT02320149|564377967|FG001|Overall Study|Adverse Event|7|||
156349726|NCT02320149|564377966|FG000|Overall Study|Withdrawal of Consent|28|||
156349727|NCT02320149|564377967|FG001|Overall Study|Withdrawal of Consent|32|||
156349728|NCT02320149|564377966|FG000|Overall Study|Lost to Follow-up|21|||
156349729|NCT02320149|564377967|FG001|Overall Study|Lost to Follow-up|34|||
156349730|NCT02320149|564377966|FG000|Overall Study|Protocol Violation|2|||
156349731|NCT02320149|564377967|FG001|Overall Study|Protocol Violation|1|||
156349732|NCT02320149|564377966|FG000|Overall Study|Noncompliance with Study Treatment|7|||
156349733|NCT02320149|564377967|FG001|Overall Study|Noncompliance with Study Treatment|2|||
156349734|NCT02320149|564377966|FG000|Overall Study|Lack of Efficacy|0|||
156349735|NCT02320149|564377967|FG001|Overall Study|Lack of Efficacy|1|||
156349736|NCT02320149|564377966|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156349737|NCT02320149|564377967|FG001|Overall Study|Other Miscellaneous Reasons|3|||
156349738|NCT01156311|564377971|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
156349739|NCT01156311|564377972|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
156349740|NCT01156311|564377973|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
156349741|NCT01156311|564377974|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
156544142|NCT00361270|565086308|FG003|Overall Study|Afraid of Hypnosis|0|||
156349742|NCT01156311|564377971|FG000|2-Month Monotherapy Period|Physician Decision|0|||
156349743|NCT01156311|564377972|FG001|2-Month Monotherapy Period|Physician Decision|1|||
156349744|NCT01156311|564377973|FG002|2-Month Monotherapy Period|Physician Decision|0|||
156544143|NCT00361270|565086305|FG000|Overall Study|Problems with Transportation|4|||
156349745|NCT01156311|564377974|FG003|2-Month Monotherapy Period|Physician Decision|0|||
156349746|NCT01156311|564377971|FG000|2-Month Monotherapy Period|Other|1|||
156349747|NCT01156311|564377972|FG001|2-Month Monotherapy Period|Other|0|||
156349748|NCT01156311|564377973|FG002|2-Month Monotherapy Period|Other|0|||
156349749|NCT01156311|564377974|FG003|2-Month Monotherapy Period|Other|0|||
156349750|NCT01156311|564377971|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
156349751|NCT01156311|564377972|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
156349752|NCT01156311|564377973|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
156349753|NCT01156311|564377974|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
156349754|NCT01156311|564377971|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
156349755|NCT01156311|564377972|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
156349756|NCT01156311|564377973|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
156349757|NCT01156311|564377974|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
156349758|NCT01156311|564377971|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
156349759|NCT01156311|564377972|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
156349760|NCT01156311|564377973|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
156349761|NCT01156311|564377974|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
156349762|NCT01156311|564377971|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
156349763|NCT01156311|564377972|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
156349764|NCT01156311|564377973|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
156349765|NCT01156311|564377974|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
156349766|NCT01156311|564377971|FG000|6-month Add-on Therapy Period|Other|0|||
156349767|NCT01156311|564377972|FG001|6-month Add-on Therapy Period|Other|0|||
156349768|NCT01156311|564377973|FG002|6-month Add-on Therapy Period|Other|1|||
156349769|NCT01156311|564377974|FG003|6-month Add-on Therapy Period|Other|2|||
156349770|NCT00022633|564377977|FG000|Overall Study|Adverse Event|11|||
156349771|NCT00022633|564377978|FG001|Overall Study|Adverse Event|1|||
156349772|NCT00022633|564377977|FG000|Overall Study|Refusal unrelated to adverse event|1|||
156349773|NCT00022633|564377978|FG001|Overall Study|Refusal unrelated to adverse event|0|||
156349774|NCT00022633|564377977|FG000|Overall Study|Progression/relapse|9|||
156349775|NCT00022633|564377978|FG001|Overall Study|Progression/relapse|2|||
156349776|NCT00022633|564377977|FG000|Overall Study|Death|4|||
156349777|NCT00022633|564377978|FG001|Overall Study|Death|0|||
156349778|NCT00022633|564377977|FG000|Overall Study|Other - not protocol specified|3|||
156349779|NCT00022633|564377978|FG001|Overall Study|Other - not protocol specified|2|||
156349780|NCT00022633|564377977|FG000|Overall Study|Ineligible|4|||
156349781|NCT00022633|564377978|FG001|Overall Study|Ineligible|0|||
156349782|NCT06133348|564377981|FG000|Overall Study|Death|3|||
156349783|NCT06133348|564377981|FG000|Overall Study|Lost to Follow-up|1|||
156349784|NCT06133348|564377981|FG000|Overall Study|Physician Decision|1|||
156349785|NCT06133348|564377981|FG000|Overall Study|Withdrawal by Subject|5|||
156349786|NCT02036294|564377986|FG000|Overall Study|Death|7|||
156349787|NCT02036294|564377987|FG001|Overall Study|Death|8|||
156349788|NCT02036294|564377986|FG000|Overall Study|Withdrawal by Subject|2|||
156349789|NCT02036294|564377987|FG001|Overall Study|Withdrawal by Subject|3|||
156349790|NCT04952402|564377988|FG000|Overall Study|Lost to Follow-up|1|||
156349791|NCT04952402|564377989|FG001|Overall Study|Lost to Follow-up|3|||
156349792|NCT04952402|564377988|FG000|Overall Study|Lack Of Venous Access|0|||
156349793|NCT04952402|564377989|FG001|Overall Study|Lack Of Venous Access|1|||
156349794|NCT01285310|564377992|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
156349795|NCT01285310|564377993|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
156349796|NCT01285310|564377994|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
156482684|NCT04520256|564859141|FG012|Overall Study|Lost to Follow-up|5|||
156482685|NCT04520256|564859142|FG013|Overall Study|Lost to Follow-up|3|||
156482686|NCT04520256|564859143|FG014|Overall Study|Lost to Follow-up|3|||
156482687|NCT04520256|564859144|FG015|Overall Study|Lost to Follow-up|6|||
156482688|NCT04520256|564859145|FG016|Overall Study|Lost to Follow-up|6|||
156349797|NCT01285310|564377995|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
156349798|NCT01285310|564377996|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
156349799|NCT01285310|564377992|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
156349800|NCT01285310|564377993|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
156349801|NCT01285310|564377994|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
156482689|NCT04520256|564859146|FG017|Overall Study|Lost to Follow-up|4|||
156482690|NCT04520256|564859147|FG018|Overall Study|Lost to Follow-up|3|||
156349802|NCT01285310|564377995|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
156349803|NCT01285310|564377996|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
156349804|NCT01285310|564377992|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
156482691|NCT04520256|564859148|FG019|Overall Study|Lost to Follow-up|3|||
156349805|NCT01285310|564377993|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
156349806|NCT01285310|564377994|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
156349807|NCT01285310|564377995|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
156349808|NCT01285310|564377996|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
156349809|NCT01285310|564377992|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
156349810|NCT01285310|564377993|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
156349811|NCT01285310|564377994|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
156349812|NCT01285310|564377995|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
156349813|NCT01285310|564377996|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
156349814|NCT01285310|564377992|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
156349815|NCT01285310|564377993|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
156349816|NCT01285310|564377994|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
156349817|NCT01285310|564377995|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
156349818|NCT01285310|564377996|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
156349819|NCT01285310|564377992|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
156482692|NCT04520256|564859149|FG020|Overall Study|Lost to Follow-up|7|||
156482693|NCT04520256|564859150|FG021|Overall Study|Lost to Follow-up|3|||
156482694|NCT04520256|564859151|FG022|Overall Study|Lost to Follow-up|3|||
156482695|NCT04520256|564859152|FG023|Overall Study|Lost to Follow-up|8|||
156482696|NCT04520256|564859153|FG024|Overall Study|Lost to Follow-up|5|||
156349820|NCT01285310|564377993|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
156349821|NCT01285310|564377994|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
156482697|NCT04520256|564859154|FG025|Overall Study|Lost to Follow-up|4|||
156482698|NCT04520256|564859155|FG026|Overall Study|Lost to Follow-up|3|||
156482699|NCT04520256|564859156|FG027|Overall Study|Lost to Follow-up|4|||
156482700|NCT04520256|564859157|FG028|Overall Study|Lost to Follow-up|3|||
156482701|NCT04520256|564859158|FG029|Overall Study|Lost to Follow-up|4|||
156482702|NCT04520256|564859159|FG030|Overall Study|Lost to Follow-up|4|||
156482703|NCT04520256|564859160|FG031|Overall Study|Lost to Follow-up|4|||
156482704|NCT01816165|564860562|FG000|Overall Study|Adverse Event|1|||
156482705|NCT01816165|564860563|FG001|Overall Study|Adverse Event|0|||
156482706|NCT01816165|564860564|FG002|Overall Study|Adverse Event|0|||
156482707|NCT01816165|564860565|FG003|Overall Study|Adverse Event|0|||
156482708|NCT01183013|564860568|FG000|Overall Study|Adverse Event|6|||
156482709|NCT01183013|564860569|FG001|Overall Study|Adverse Event|8|||
156482710|NCT01183013|564860570|FG002|Overall Study|Adverse Event|5|||
156482711|NCT01183013|564860571|FG003|Overall Study|Adverse Event|5|||
156482712|NCT01183013|564860572|FG004|Overall Study|Adverse Event|10|||
156349822|NCT01285310|564377995|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
156349823|NCT01285310|564377996|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
156349824|NCT01285310|564377992|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
156349825|NCT01285310|564377993|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
156349826|NCT01285310|564377994|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
156349827|NCT01285310|564377995|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
156349828|NCT01285310|564377996|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
156349829|NCT01285310|564377992|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
156349830|NCT01285310|564377993|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
156349831|NCT01285310|564377994|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
156349832|NCT01285310|564377995|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
156349833|NCT01285310|564377996|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
156349834|NCT01285310|564377992|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
156349835|NCT01285310|564377993|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
156349836|NCT01285310|564377994|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
156349837|NCT01285310|564377995|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
156349838|NCT01285310|564377996|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
156349839|NCT01285310|564377992|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
156349840|NCT01285310|564377993|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
156349841|NCT01285310|564377994|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
156349842|NCT01285310|564377995|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
156349843|NCT01285310|564377996|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
156349844|NCT01285310|564377992|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
156349845|NCT01285310|564377993|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
156349846|NCT01285310|564377994|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
156349847|NCT01285310|564377995|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
156349848|NCT01285310|564377996|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
156349849|NCT01285310|564377992|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
156349850|NCT01285310|564377993|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
156349851|NCT01285310|564377994|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
156349852|NCT01285310|564377995|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
156349853|NCT01285310|564377996|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
156349854|NCT01996982|564377997|FG000|Overall Study|PI/team left institution|7|||
156349855|NCT01195415|564378018|FG000|Overall Study|No repeat biopsy due to progression|2|||
156349856|NCT00533845|564378019|FG000|Overall Study|Physician Decision|1|||
156349857|NCT00533845|564378020|FG001|Overall Study|Physician Decision|0|||
156349858|NCT01442675|564378025|FG000|Overall Study|Protocol Violation|6|||
156349859|NCT01442675|564378025|FG000|Overall Study|Lost to Follow-up|2|||
156349860|NCT01442675|564378025|FG000|Overall Study|Withdrawal by Subject|4|||
156349861|NCT00555321|564378026|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
156349862|NCT00555321|564378027|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
156349863|NCT00555321|564378028|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
156349864|NCT00555321|564378029|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
156349865|NCT00555321|564378030|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
156349866|NCT00555321|564378026|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
156349867|NCT00555321|564378027|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
156482713|NCT01183013|564860573|FG005|Overall Study|Adverse Event|10|||
156482714|NCT01183013|564860574|FG006|Overall Study|Adverse Event|6|||
156482715|NCT01183013|564860568|FG000|Overall Study|Lack of Efficacy|3|||
156482716|NCT01183013|564860569|FG001|Overall Study|Lack of Efficacy|2|||
156349868|NCT00555321|564378028|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
156349869|NCT00555321|564378029|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
156349870|NCT00555321|564378030|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
156349871|NCT00555321|564378026|FG000|Treatment Phase up to 12-months|Death|2|||
156349872|NCT00555321|564378027|FG001|Treatment Phase up to 12-months|Death|1|||
156349873|NCT00555321|564378028|FG002|Treatment Phase up to 12-months|Death|4|||
156349874|NCT00555321|564378029|FG003|Treatment Phase up to 12-months|Death|0|||
156349875|NCT00555321|564378030|FG004|Treatment Phase up to 12-months|Death|0|||
156349876|NCT00555321|564378026|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
156349877|NCT00555321|564378027|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
156482717|NCT01183013|564860570|FG002|Overall Study|Lack of Efficacy|1|||
156482718|NCT01183013|564860571|FG003|Overall Study|Lack of Efficacy|2|||
156482719|NCT01183013|564860572|FG004|Overall Study|Lack of Efficacy|1|||
156482720|NCT01183013|564860573|FG005|Overall Study|Lack of Efficacy|2|||
156349878|NCT00555321|564378028|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
156482721|NCT01183013|564860574|FG006|Overall Study|Lack of Efficacy|0|||
156482722|NCT01183013|564860568|FG000|Overall Study|Protocol Violation|5|||
156482723|NCT01183013|564860569|FG001|Overall Study|Protocol Violation|2|||
156482724|NCT01183013|564860570|FG002|Overall Study|Protocol Violation|4|||
156349879|NCT00555321|564378029|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
156349880|NCT00555321|564378030|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
156482725|NCT01183013|564860571|FG003|Overall Study|Protocol Violation|0|||
156482726|NCT01183013|564860572|FG004|Overall Study|Protocol Violation|4|||
156482727|NCT01183013|564860573|FG005|Overall Study|Protocol Violation|3|||
156482728|NCT01183013|564860574|FG006|Overall Study|Protocol Violation|3|||
156482729|NCT01183013|564860568|FG000|Overall Study|Lost to Follow-up|7|||
156482730|NCT01183013|564860569|FG001|Overall Study|Lost to Follow-up|3|||
156482731|NCT01183013|564860570|FG002|Overall Study|Lost to Follow-up|4|||
156482732|NCT01183013|564860571|FG003|Overall Study|Lost to Follow-up|3|||
156482733|NCT01183013|564860572|FG004|Overall Study|Lost to Follow-up|2|||
156482734|NCT01183013|564860573|FG005|Overall Study|Lost to Follow-up|6|||
156482735|NCT01183013|564860574|FG006|Overall Study|Lost to Follow-up|5|||
156349881|NCT00555321|564378026|FG000|Treatment Phase up to 12-months|Other Reason|1|||
156349882|NCT00555321|564378027|FG001|Treatment Phase up to 12-months|Other Reason|3|||
156349883|NCT00555321|564378028|FG002|Treatment Phase up to 12-months|Other Reason|2|||
156349884|NCT00555321|564378029|FG003|Treatment Phase up to 12-months|Other Reason|0|||
156349885|NCT00555321|564378030|FG004|Treatment Phase up to 12-months|Other Reason|0|||
156349886|NCT00555321|564378026|FG000|Treatment Phase up to 12-months|Never treated|2|||
156349887|NCT00555321|564378027|FG001|Treatment Phase up to 12-months|Never treated|3|||
156349888|NCT00555321|564378028|FG002|Treatment Phase up to 12-months|Never treated|1|||
156349889|NCT00555321|564378029|FG003|Treatment Phase up to 12-months|Never treated|0|||
156349890|NCT00555321|564378030|FG004|Treatment Phase up to 12-months|Never treated|4|||
156349891|NCT00555321|564378026|FG000|Long-term Extension Phase|Adverse Event|2|||
156349892|NCT00555321|564378027|FG001|Long-term Extension Phase|Adverse Event|5|||
156349893|NCT00555321|564378028|FG002|Long-term Extension Phase|Adverse Event|2|||
156349894|NCT00555321|564378029|FG003|Long-term Extension Phase|Adverse Event|1|||
156349895|NCT00555321|564378030|FG004|Long-term Extension Phase|Adverse Event|0|||
156349896|NCT00555321|564378026|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
156349897|NCT00555321|564378027|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
156349898|NCT00555321|564378028|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
156349899|NCT00555321|564378029|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
156349900|NCT00555321|564378030|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
156349901|NCT00555321|564378026|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
156349902|NCT00555321|564378027|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
156349903|NCT00555321|564378028|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
156349904|NCT00555321|564378029|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
156349905|NCT00555321|564378030|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
156349906|NCT00555321|564378026|FG000|Long-term Extension Phase|Death|2|||
156349907|NCT00555321|564378027|FG001|Long-term Extension Phase|Death|0|||
156349908|NCT00555321|564378028|FG002|Long-term Extension Phase|Death|0|||
156349909|NCT00555321|564378029|FG003|Long-term Extension Phase|Death|3|||
156349910|NCT00555321|564378030|FG004|Long-term Extension Phase|Death|0|||
156349911|NCT00555321|564378026|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
156349912|NCT00555321|564378027|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
156482736|NCT01183013|564860568|FG000|Overall Study|Withdrawal by Subject|9|||
156482737|NCT01183013|564860569|FG001|Overall Study|Withdrawal by Subject|13|||
156482738|NCT01183013|564860570|FG002|Overall Study|Withdrawal by Subject|10|||
156482739|NCT01183013|564860571|FG003|Overall Study|Withdrawal by Subject|8|||
156482740|NCT01183013|564860572|FG004|Overall Study|Withdrawal by Subject|7|||
156482741|NCT01183013|564860573|FG005|Overall Study|Withdrawal by Subject|9|||
156482742|NCT01183013|564860574|FG006|Overall Study|Withdrawal by Subject|10|||
156349913|NCT00555321|564378028|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
156349914|NCT00555321|564378029|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
156349915|NCT00555321|564378030|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
156349916|NCT00555321|564378026|FG000|Long-term Extension Phase|Other Reason|1|||
156349917|NCT00555321|564378027|FG001|Long-term Extension Phase|Other Reason|0|||
156349918|NCT00555321|564378028|FG002|Long-term Extension Phase|Other Reason|2|||
156349919|NCT00555321|564378029|FG003|Long-term Extension Phase|Other Reason|0|||
156349920|NCT00555321|564378030|FG004|Long-term Extension Phase|Other Reason|0|||
156349921|NCT00563381|564378039|FG000|Overall Study|Adverse Event|264|||
156349922|NCT00563381|564378040|FG001|Overall Study|Adverse Event|292|||
156349923|NCT00563381|564378039|FG000|Overall Study|Protocol Violation|66|||
156349924|NCT00563381|564378040|FG001|Overall Study|Protocol Violation|74|||
156349925|NCT00563381|564378039|FG000|Overall Study|Lost to Follow-up|7|||
156349926|NCT00563381|564378040|FG001|Overall Study|Lost to Follow-up|15|||
156349927|NCT00563381|564378039|FG000|Overall Study|Withdrawal by Subject|192|||
156349928|NCT00563381|564378040|FG001|Overall Study|Withdrawal by Subject|209|||
156349929|NCT00563381|564378039|FG000|Overall Study|Lack of Efficacy|32|||
156349930|NCT00563381|564378040|FG001|Overall Study|Lack of Efficacy|24|||
156349931|NCT00563381|564378039|FG000|Overall Study|Individual different reasons|24|||
156349932|NCT00563381|564378040|FG001|Overall Study|Individual different reasons|34|||
156349933|NCT02407704|564378043|FG000|Overall Study|Lost to Follow-up|0|||
156482743|NCT01183013|564860568|FG000|Overall Study|Reasons other than stated above|15|||
156482744|NCT01183013|564860569|FG001|Overall Study|Reasons other than stated above|11|||
156482745|NCT01183013|564860570|FG002|Overall Study|Reasons other than stated above|17|||
156349934|NCT02407704|564378044|FG001|Overall Study|Lost to Follow-up|0|||
156349935|NCT02407704|564378045|FG002|Overall Study|Lost to Follow-up|0|||
156349936|NCT02407704|564378046|FG003|Overall Study|Lost to Follow-up|2|||
156349937|NCT02407704|564378043|FG000|Overall Study|Protocol Violation|0|||
156349938|NCT02407704|564378044|FG001|Overall Study|Protocol Violation|0|||
156349939|NCT02407704|564378045|FG002|Overall Study|Protocol Violation|0|||
156349940|NCT02407704|564378046|FG003|Overall Study|Protocol Violation|1|||
156349941|NCT02407704|564378043|FG000|Overall Study|Withdrawal by Subject|0|||
156349942|NCT02407704|564378044|FG001|Overall Study|Withdrawal by Subject|0|||
156349943|NCT02407704|564378045|FG002|Overall Study|Withdrawal by Subject|1|||
156349944|NCT02407704|564378046|FG003|Overall Study|Withdrawal by Subject|0|||
156349945|NCT01957644|564378047|FG000|Overall Study|Adverse Event|4|||
156349946|NCT01957644|564378048|FG001|Overall Study|Adverse Event|2|||
156349947|NCT01957644|564378049|FG002|Overall Study|Adverse Event|0|||
156349948|NCT01957644|564378050|FG003|Overall Study|Adverse Event|0|||
156349949|NCT01957644|564378051|FG004|Overall Study|Adverse Event|1|||
156349950|NCT01957644|564378047|FG000|Overall Study|Progressive disease / relapse|0|||
156349951|NCT01957644|564378048|FG001|Overall Study|Progressive disease / relapse|1|||
156349952|NCT01957644|564378049|FG002|Overall Study|Progressive disease / relapse|0|||
156349953|NCT01957644|564378050|FG003|Overall Study|Progressive disease / relapse|1|||
156349954|NCT01957644|564378051|FG004|Overall Study|Progressive disease / relapse|0|||
156349955|NCT01957644|564378047|FG000|Overall Study|Other reason|1|||
156349956|NCT01957644|564378048|FG001|Overall Study|Other reason|2|||
156349957|NCT01957644|564378049|FG002|Overall Study|Other reason|1|||
156349958|NCT01957644|564378050|FG003|Overall Study|Other reason|1|||
156349959|NCT01957644|564378051|FG004|Overall Study|Other reason|0|||
156349960|NCT01957644|564378047|FG000|Overall Study|Withdrawal by Subject|1|||
156349961|NCT01957644|564378048|FG001|Overall Study|Withdrawal by Subject|0|||
156349962|NCT01957644|564378049|FG002|Overall Study|Withdrawal by Subject|0|||
156349963|NCT01957644|564378050|FG003|Overall Study|Withdrawal by Subject|0|||
156349964|NCT01957644|564378051|FG004|Overall Study|Withdrawal by Subject|0|||
156349965|NCT01957644|564378047|FG000|Overall Study|Protocol Violation|0|||
156349966|NCT01957644|564378048|FG001|Overall Study|Protocol Violation|1|||
156349967|NCT01957644|564378049|FG002|Overall Study|Protocol Violation|0|||
156349968|NCT01957644|564378050|FG003|Overall Study|Protocol Violation|0|||
156349969|NCT01957644|564378051|FG004|Overall Study|Protocol Violation|0|||
156349970|NCT01129960|564378054|FG000|Overall Study|Withdrawal by Subject|3|||
156349971|NCT01129960|564378055|FG001|Overall Study|Withdrawal by Subject|0|||
156349972|NCT01129960|564378056|FG002|Overall Study|Withdrawal by Subject|3|||
156349973|NCT01129960|564378057|FG003|Overall Study|Withdrawal by Subject|2|||
156349974|NCT01129960|564378054|FG000|Overall Study|Lack of Efficacy|1|||
156349975|NCT01129960|564378055|FG001|Overall Study|Lack of Efficacy|1|||
156349976|NCT01129960|564378056|FG002|Overall Study|Lack of Efficacy|1|||
156349977|NCT01129960|564378057|FG003|Overall Study|Lack of Efficacy|1|||
156349978|NCT01129960|564378054|FG000|Overall Study|Adverse Event|23|||
156349979|NCT01129960|564378055|FG001|Overall Study|Adverse Event|16|||
156349980|NCT01129960|564378056|FG002|Overall Study|Adverse Event|16|||
156349981|NCT01129960|564378057|FG003|Overall Study|Adverse Event|7|||
156349982|NCT01129960|564378054|FG000|Overall Study|Protocol Violation|1|||
156349983|NCT01129960|564378055|FG001|Overall Study|Protocol Violation|2|||
156349984|NCT01129960|564378056|FG002|Overall Study|Protocol Violation|3|||
156349985|NCT01129960|564378057|FG003|Overall Study|Protocol Violation|0|||
156349986|NCT01129960|564378054|FG000|Overall Study|Lost to Follow-up|0|||
156349987|NCT01129960|564378055|FG001|Overall Study|Lost to Follow-up|2|||
156349988|NCT01129960|564378056|FG002|Overall Study|Lost to Follow-up|3|||
156349989|NCT01129960|564378057|FG003|Overall Study|Lost to Follow-up|3|||
156349990|NCT01129960|564378054|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
156482746|NCT01183013|564860571|FG003|Overall Study|Reasons other than stated above|12|||
156482747|NCT01183013|564860572|FG004|Overall Study|Reasons other than stated above|12|||
156349991|NCT01129960|564378055|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
156349992|NCT01129960|564378056|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
156349993|NCT01129960|564378057|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
156349994|NCT01129960|564378054|FG000|Overall Study|Physician Decision|1|||
156349995|NCT01129960|564378055|FG001|Overall Study|Physician Decision|0|||
156349996|NCT01129960|564378056|FG002|Overall Study|Physician Decision|0|||
156349997|NCT01129960|564378057|FG003|Overall Study|Physician Decision|0|||
156349998|NCT01129960|564378054|FG000|Overall Study|Pregnancy|1|||
156349999|NCT01129960|564378055|FG001|Overall Study|Pregnancy|0|||
156350000|NCT01129960|564378056|FG002|Overall Study|Pregnancy|0|||
156350001|NCT01129960|564378057|FG003|Overall Study|Pregnancy|0|||
156350002|NCT00230607|564378058|FG000|Overall Study|Other|3|||
156350003|NCT02860169|564378059|FG000|Part A|Withdrawal by Subject|1|||
156350004|NCT02860169|564378059|FG000|Part A|Other (Screening failure)|6|||
156350005|NCT02860169|564378059|FG000|Part A|Other (Survey not completed)|3|||
156350006|NCT02860169|564378059|FG000|Part A|Other (did not completed consent)|1|||
156350007|NCT02860169|564378059|FG000|Part B|Other (Screening failure)|10|||
156350008|NCT02860169|564378059|FG000|Part B|Withdrawal by Subject|1|||
156350009|NCT02860169|564378059|FG000|Part C|Other (Screening failure)|1|||
156350010|NCT03672747|564378060|FG000|Overall Study|Lost to Follow-up|1|||
156350011|NCT03672747|564378061|FG001|Overall Study|Lost to Follow-up|1|||
156350012|NCT03672747|564378062|FG002|Overall Study|Lost to Follow-up|2|||
156350013|NCT03672747|564378063|FG003|Overall Study|Lost to Follow-up|2|||
156350014|NCT03672747|564378064|FG004|Overall Study|Lost to Follow-up|2|||
156350015|NCT03672747|564378065|FG005|Overall Study|Lost to Follow-up|1|||
156350016|NCT00165776|564378066|FG000|Overall Study|Lack of Efficacy|0|||
156350017|NCT00165776|564378067|FG001|Overall Study|Lack of Efficacy|0|||
156350018|NCT00165776|564378068|FG002|Overall Study|Lack of Efficacy|0|||
156350019|NCT00165776|564378069|FG003|Overall Study|Lack of Efficacy|1|||
156350020|NCT00165776|564378066|FG000|Overall Study|Withdrawal by Subject|4|||
156350021|NCT00165776|564378067|FG001|Overall Study|Withdrawal by Subject|1|||
156350022|NCT00165776|564378068|FG002|Overall Study|Withdrawal by Subject|2|||
156350023|NCT00165776|564378069|FG003|Overall Study|Withdrawal by Subject|0|||
156350024|NCT00165776|564378066|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
156350025|NCT00165776|564378067|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
156350026|NCT00165776|564378068|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
156350027|NCT00165776|564378069|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
156350028|NCT01835587|564378073|FG000|Overall Study|Disease Recurrence or Relapse|0|||
156350029|NCT01835587|564378074|FG001|Overall Study|Disease Recurrence or Relapse|3|||
156350030|NCT01835587|564378075|FG002|Overall Study|Disease Recurrence or Relapse|0|||
156350031|NCT01835587|564378076|FG003|Overall Study|Disease Recurrence or Relapse|3|||
156350032|NCT01835587|564378073|FG000|Overall Study|Withdrawal by Subject|2|||
156350033|NCT01835587|564378074|FG001|Overall Study|Withdrawal by Subject|0|||
156350034|NCT01835587|564378075|FG002|Overall Study|Withdrawal by Subject|0|||
156350035|NCT01835587|564378076|FG003|Overall Study|Withdrawal by Subject|3|||
156350036|NCT01835587|564378073|FG000|Overall Study|Adverse Event|0|||
156350037|NCT01835587|564378074|FG001|Overall Study|Adverse Event|0|||
156350038|NCT01835587|564378075|FG002|Overall Study|Adverse Event|2|||
156350039|NCT01835587|564378076|FG003|Overall Study|Adverse Event|2|||
156350040|NCT01835587|564378073|FG000|Overall Study|Death|0|||
156350041|NCT01835587|564378074|FG001|Overall Study|Death|0|||
156350042|NCT01835587|564378075|FG002|Overall Study|Death|0|||
156350043|NCT01835587|564378076|FG003|Overall Study|Death|1|||
156350044|NCT01835587|564378073|FG000|Overall Study|Miscellaneous|0|||
156350045|NCT01835587|564378074|FG001|Overall Study|Miscellaneous|1|||
156350046|NCT01835587|564378075|FG002|Overall Study|Miscellaneous|0|||
156350047|NCT01835587|564378076|FG003|Overall Study|Miscellaneous|0|||
156350048|NCT00126568|564378081|FG000|Overall Study|Death|2|||
156350049|NCT03358290|564378082|FG000|Overall Study|Study discontinued by Sponsor|0|||
156350050|NCT03358290|564378083|FG001|Overall Study|Study discontinued by Sponsor|1|||
156350051|NCT03358290|564378084|FG002|Overall Study|Study discontinued by Sponsor|1|||
156350052|NCT03358290|564378085|FG003|Overall Study|Study discontinued by Sponsor|0|||
156350053|NCT03358290|564378086|FG004|Overall Study|Study discontinued by Sponsor|0|||
156350054|NCT03358290|564378082|FG000|Overall Study|Adverse Event|0|||
156350055|NCT03358290|564378083|FG001|Overall Study|Adverse Event|0|||
156350056|NCT03358290|564378084|FG002|Overall Study|Adverse Event|1|||
156350057|NCT03358290|564378085|FG003|Overall Study|Adverse Event|2|||
156350058|NCT03358290|564378086|FG004|Overall Study|Adverse Event|0|||
156350059|NCT03358290|564378082|FG000|Overall Study|Withdrawal by Subject|0|||
156350060|NCT03358290|564378083|FG001|Overall Study|Withdrawal by Subject|0|||
156350061|NCT03358290|564378084|FG002|Overall Study|Withdrawal by Subject|0|||
156350062|NCT03358290|564378085|FG003|Overall Study|Withdrawal by Subject|0|||
156350063|NCT03358290|564378086|FG004|Overall Study|Withdrawal by Subject|1|||
156350064|NCT00203996|564378087|FG000|Overall Study|Lost to Follow-up|0|||
156350065|NCT00203996|564378088|FG001|Overall Study|Lost to Follow-up|0|||
156350066|NCT00203996|564378089|FG002|Overall Study|Lost to Follow-up|0|||
156350067|NCT00203996|564378090|FG003|Overall Study|Lost to Follow-up|1|||
156350068|NCT00203996|564378091|FG004|Overall Study|Lost to Follow-up|0|||
156350069|NCT00203996|564378092|FG005|Overall Study|Lost to Follow-up|0|||
156350070|NCT00203996|564378093|FG006|Overall Study|Lost to Follow-up|0|||
156350071|NCT00203996|564378094|FG007|Overall Study|Lost to Follow-up|0|||
156350072|NCT00203996|564378095|FG008|Overall Study|Lost to Follow-up|0|||
156350073|NCT00203996|564378096|FG009|Overall Study|Lost to Follow-up|0|||
156350074|NCT00203996|564378087|FG000|Overall Study|Protocol Violation|0|||
156350075|NCT00203996|564378088|FG001|Overall Study|Protocol Violation|0|||
156350076|NCT00203996|564378089|FG002|Overall Study|Protocol Violation|0|||
156350077|NCT00203996|564378090|FG003|Overall Study|Protocol Violation|6|||
156350078|NCT00203996|564378091|FG004|Overall Study|Protocol Violation|1|||
156350079|NCT00203996|564378092|FG005|Overall Study|Protocol Violation|0|||
156350080|NCT00203996|564378093|FG006|Overall Study|Protocol Violation|0|||
156350081|NCT00203996|564378094|FG007|Overall Study|Protocol Violation|0|||
156350082|NCT00203996|564378095|FG008|Overall Study|Protocol Violation|0|||
156350083|NCT00203996|564378096|FG009|Overall Study|Protocol Violation|0|||
156350084|NCT00203996|564378087|FG000|Overall Study|Physician Decision|0|||
156350085|NCT00203996|564378088|FG001|Overall Study|Physician Decision|0|||
156350086|NCT00203996|564378089|FG002|Overall Study|Physician Decision|0|||
156350087|NCT00203996|564378090|FG003|Overall Study|Physician Decision|2|||
156350088|NCT00203996|564378091|FG004|Overall Study|Physician Decision|0|||
156350089|NCT00203996|564378092|FG005|Overall Study|Physician Decision|0|||
156350090|NCT00203996|564378093|FG006|Overall Study|Physician Decision|0|||
156350091|NCT00203996|564378094|FG007|Overall Study|Physician Decision|0|||
156350092|NCT00203996|564378095|FG008|Overall Study|Physician Decision|0|||
156350093|NCT00203996|564378096|FG009|Overall Study|Physician Decision|1|||
156350094|NCT00203996|564378087|FG000|Overall Study|CPAP machine malfunction|0|||
156350095|NCT00203996|564378088|FG001|Overall Study|CPAP machine malfunction|0|||
156350096|NCT00203996|564378089|FG002|Overall Study|CPAP machine malfunction|0|||
156350097|NCT00203996|564378090|FG003|Overall Study|CPAP machine malfunction|1|||
156350098|NCT00203996|564378091|FG004|Overall Study|CPAP machine malfunction|0|||
156350099|NCT00203996|564378092|FG005|Overall Study|CPAP machine malfunction|0|||
156350100|NCT00203996|564378093|FG006|Overall Study|CPAP machine malfunction|0|||
156350101|NCT00203996|564378094|FG007|Overall Study|CPAP machine malfunction|0|||
156350102|NCT00203996|564378095|FG008|Overall Study|CPAP machine malfunction|0|||
156350103|NCT00203996|564378096|FG009|Overall Study|CPAP machine malfunction|0|||
156350104|NCT00203996|564378087|FG000|Overall Study|Scheduling issue|0|||
156350105|NCT00203996|564378088|FG001|Overall Study|Scheduling issue|0|||
156350106|NCT00203996|564378089|FG002|Overall Study|Scheduling issue|0|||
156350107|NCT00203996|564378090|FG003|Overall Study|Scheduling issue|0|||
156350108|NCT00203996|564378091|FG004|Overall Study|Scheduling issue|0|||
156350109|NCT00203996|564378092|FG005|Overall Study|Scheduling issue|0|||
156350110|NCT00203996|564378093|FG006|Overall Study|Scheduling issue|0|||
156350111|NCT00203996|564378094|FG007|Overall Study|Scheduling issue|2|||
156350112|NCT00203996|564378095|FG008|Overall Study|Scheduling issue|0|||
156350113|NCT00203996|564378096|FG009|Overall Study|Scheduling issue|0|||
156350114|NCT00897104|564378097|FG000|Overall Study|Lost to Follow-up|12|||
156350115|NCT00897104|564378098|FG001|Overall Study|Lost to Follow-up|17|||
156350116|NCT00897104|564378099|FG002|Overall Study|Lost to Follow-up|2|||
156350117|NCT00897104|564378097|FG000|Overall Study|Pregnancy|0|||
156350118|NCT00897104|564378098|FG001|Overall Study|Pregnancy|1|||
156350119|NCT00897104|564378099|FG002|Overall Study|Pregnancy|0|||
156350120|NCT00897104|564378097|FG000|Overall Study|Protocol Violation|0|||
156350121|NCT00897104|564378098|FG001|Overall Study|Protocol Violation|1|||
156350122|NCT00897104|564378099|FG002|Overall Study|Protocol Violation|0|||
156350123|NCT00897104|564378097|FG000|Overall Study|Withdrawal by Subject|23|||
156350124|NCT00897104|564378098|FG001|Overall Study|Withdrawal by Subject|27|||
156350125|NCT00897104|564378099|FG002|Overall Study|Withdrawal by Subject|3|||
156350126|NCT00897104|564378097|FG000|Overall Study|Abnormal Prestudy Labs|2|||
156350127|NCT00897104|564378098|FG001|Overall Study|Abnormal Prestudy Labs|0|||
156350128|NCT00897104|564378099|FG002|Overall Study|Abnormal Prestudy Labs|0|||
156350129|NCT00897104|564378097|FG000|Overall Study|Abnormal Baseline ECG|2|||
156350130|NCT00897104|564378098|FG001|Overall Study|Abnormal Baseline ECG|2|||
156482748|NCT01183013|564860573|FG005|Overall Study|Reasons other than stated above|15|||
156350131|NCT00897104|564378099|FG002|Overall Study|Abnormal Baseline ECG|0|||
156350132|NCT00897104|564378097|FG000|Overall Study|Need for Concom. Med.|0|||
156350133|NCT00897104|564378098|FG001|Overall Study|Need for Concom. Med.|1|||
156350134|NCT00897104|564378099|FG002|Overall Study|Need for Concom. Med.|1|||
156350135|NCT00897104|564378097|FG000|Overall Study|Lack of Migraine Attack|20|||
156350136|NCT00897104|564378098|FG001|Overall Study|Lack of Migraine Attack|22|||
156350137|NCT00897104|564378099|FG002|Overall Study|Lack of Migraine Attack|1|||
156350138|NCT00897104|564378097|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
156350139|NCT00897104|564378098|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156350140|NCT00897104|564378099|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156350141|NCT00897104|564378097|FG000|Overall Study|Other|3|||
156350142|NCT00897104|564378098|FG001|Overall Study|Other|0|||
156350143|NCT00897104|564378099|FG002|Overall Study|Other|0|||
156350144|NCT00897104|564378097|FG000|Overall Study|Protocol Violation|1|||
156350145|NCT00897104|564378098|FG001|Overall Study|Protocol Violation|0|||
156350146|NCT00897104|564378099|FG002|Overall Study|Protocol Violation|0|||
156350147|NCT00897104|564378097|FG000|Overall Study|Withdrawal by Subject|0|||
156350148|NCT00897104|564378098|FG001|Overall Study|Withdrawal by Subject|0|||
156350149|NCT00897104|564378099|FG002|Overall Study|Withdrawal by Subject|1|||
156350150|NCT00434330|564378102|FG000|Overall Study|Adverse Event|0|||
156350151|NCT00434330|564378103|FG001|Overall Study|Adverse Event|0|||
156350152|NCT00434330|564378104|FG002|Overall Study|Adverse Event|1|||
156350153|NCT00434330|564378105|FG003|Overall Study|Adverse Event|0|||
156350154|NCT00434330|564378106|FG004|Overall Study|Adverse Event|0|||
156350155|NCT00434330|564378107|FG005|Overall Study|Adverse Event|0|||
156350156|NCT00434330|564378102|FG000|Overall Study|Death|1|||
156350157|NCT00434330|564378103|FG001|Overall Study|Death|0|||
156350158|NCT00434330|564378104|FG002|Overall Study|Death|0|||
156350159|NCT00434330|564378105|FG003|Overall Study|Death|0|||
156350160|NCT00434330|564378106|FG004|Overall Study|Death|1|||
156350161|NCT00434330|564378107|FG005|Overall Study|Death|1|||
156350162|NCT00434330|564378102|FG000|Overall Study|Withdrawal by Subject|0|||
156350163|NCT00434330|564378103|FG001|Overall Study|Withdrawal by Subject|0|||
156350164|NCT00434330|564378104|FG002|Overall Study|Withdrawal by Subject|1|||
156350165|NCT00434330|564378105|FG003|Overall Study|Withdrawal by Subject|1|||
156350166|NCT00434330|564378106|FG004|Overall Study|Withdrawal by Subject|0|||
156350167|NCT00434330|564378107|FG005|Overall Study|Withdrawal by Subject|0|||
156350168|NCT00434330|564378102|FG000|Overall Study|Renal transplant|0|||
156350169|NCT00434330|564378103|FG001|Overall Study|Renal transplant|0|||
156350170|NCT00434330|564378104|FG002|Overall Study|Renal transplant|0|||
156350171|NCT00434330|564378105|FG003|Overall Study|Renal transplant|1|||
156350172|NCT00434330|564378106|FG004|Overall Study|Renal transplant|0|||
156350173|NCT00434330|564378107|FG005|Overall Study|Renal transplant|0|||
156350174|NCT00434330|564378102|FG000|Overall Study|Subject Not Compliant With Study|0|||
156350175|NCT00434330|564378103|FG001|Overall Study|Subject Not Compliant With Study|0|||
156350176|NCT00434330|564378104|FG002|Overall Study|Subject Not Compliant With Study|1|||
156350177|NCT00434330|564378105|FG003|Overall Study|Subject Not Compliant With Study|0|||
156350178|NCT00434330|564378106|FG004|Overall Study|Subject Not Compliant With Study|0|||
156350179|NCT00434330|564378107|FG005|Overall Study|Subject Not Compliant With Study|0|||
156350180|NCT03789318|564378108|FG000|Overall Study|Adverse Event|0|||
156350181|NCT03789318|564378109|FG001|Overall Study|Adverse Event|0|||
156350182|NCT03789318|564378110|FG002|Overall Study|Adverse Event|1|||
156350183|NCT03789318|564378111|FG003|Overall Study|Adverse Event|1|||
156350184|NCT03789318|564378112|FG004|Overall Study|Adverse Event|0|||
156350185|NCT03789318|564378108|FG000|Overall Study|Lost to Follow-up|0|||
156350186|NCT03789318|564378109|FG001|Overall Study|Lost to Follow-up|0|||
156350187|NCT03789318|564378110|FG002|Overall Study|Lost to Follow-up|1|||
156350188|NCT03789318|564378111|FG003|Overall Study|Lost to Follow-up|0|||
156350189|NCT03789318|564378112|FG004|Overall Study|Lost to Follow-up|0|||
156482749|NCT01183013|564860574|FG006|Overall Study|Reasons other than stated above|13|||
156482750|NCT00584909|564860575|FG000|Overall Study|Adverse Event|4|||
156482751|NCT02092909|564860576|FG000|Overall Study|Adverse Event|0|||
156482752|NCT02092909|564860577|FG001|Overall Study|Adverse Event|0|||
156482753|NCT02092909|564860578|FG002|Overall Study|Adverse Event|4|||
156482754|NCT02092909|564860579|FG003|Overall Study|Adverse Event|2|||
156482755|NCT02092909|564860576|FG000|Overall Study|Lack of Efficacy|0|||
156482756|NCT02092909|564860577|FG001|Overall Study|Lack of Efficacy|2|||
156350190|NCT03789318|564378108|FG000|Overall Study|Withdrawal by Subject|0|||
156350191|NCT03789318|564378109|FG001|Overall Study|Withdrawal by Subject|0|||
156350192|NCT03789318|564378110|FG002|Overall Study|Withdrawal by Subject|1|||
156482757|NCT02092909|564860578|FG002|Overall Study|Lack of Efficacy|1|||
156482758|NCT02092909|564860579|FG003|Overall Study|Lack of Efficacy|0|||
156350193|NCT03789318|564378111|FG003|Overall Study|Withdrawal by Subject|0|||
156350194|NCT03789318|564378112|FG004|Overall Study|Withdrawal by Subject|0|||
156350195|NCT00850564|564378113|FG000|Overall Study|Withdrawal by Subject|2|||
156482759|NCT02092909|564860576|FG000|Overall Study|Withdrawal by Subject|0|||
156482760|NCT02092909|564860577|FG001|Overall Study|Withdrawal by Subject|0|||
156482761|NCT02092909|564860578|FG002|Overall Study|Withdrawal by Subject|2|||
156482762|NCT02092909|564860579|FG003|Overall Study|Withdrawal by Subject|1|||
156350196|NCT02345850|564379877|FG000|Overall Study|Not transplanted|10|||
156350197|NCT02345850|564379878|FG001|Overall Study|Not transplanted|5|||
156350198|NCT02345850|564379879|FG002|Overall Study|Not transplanted|4|||
156350199|NCT02345850|564379877|FG000|Overall Study|Lost to Follow-up|2|||
156350200|NCT02345850|564379878|FG001|Overall Study|Lost to Follow-up|3|||
156350201|NCT02345850|564379879|FG002|Overall Study|Lost to Follow-up|2|||
156350202|NCT02345850|564379877|FG000|Overall Study|Withdrawal by Subject|1|||
156350203|NCT02345850|564379878|FG001|Overall Study|Withdrawal by Subject|0|||
156350204|NCT02345850|564379879|FG002|Overall Study|Withdrawal by Subject|0|||
156350205|NCT02392247|564379882|FG000|Overall Study|Withdrawal by Subject|1|||
156350206|NCT02392247|564379882|FG000|Overall Study|Surgery cancelled; no data|1|||
156350207|NCT02014597|564379883|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
156350208|NCT02014597|564379884|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
156350209|NCT01409564|564379885|FG000|Overall Study|low medication compliance|4|||
156350210|NCT01409564|564379886|FG001|Overall Study|low medication compliance|3|||
156350211|NCT01409564|564379885|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
156350212|NCT01409564|564379886|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
156350213|NCT00715078|564379887|FG000|Overall Study|Death|29|||
156350214|NCT00715078|564379888|FG001|Overall Study|Death|36|||
156350215|NCT00715078|564379889|FG002|Overall Study|Death|36|||
156350216|NCT00715078|564379887|FG000|Overall Study|Withdrawal by Subject|1|||
156350217|NCT00715078|564379888|FG001|Overall Study|Withdrawal by Subject|0|||
156350218|NCT00715078|564379889|FG002|Overall Study|Withdrawal by Subject|1|||
156350219|NCT00715078|564379887|FG000|Overall Study|Unable to start due to disease prog.|0|||
156350220|NCT00715078|564379888|FG001|Overall Study|Unable to start due to disease prog.|0|||
156350221|NCT00715078|564379889|FG002|Overall Study|Unable to start due to disease prog.|1|||
156350222|NCT01500629|564379890|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
156350223|NCT01500629|564379891|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
156350224|NCT03998189|564379892|FG000|Overall Study|Lack of Efficacy|0|||
156350225|NCT03998189|564379893|FG001|Overall Study|Lack of Efficacy|1|||
156350226|NCT03454893|564379898|FG000|Overall Study|Study Terminated by the Sponsor|5|||
156350227|NCT03454893|564379898|FG000|Overall Study|Did not pass screening|4|||
156350228|NCT01986985|564379899|FG000|Overall Study|Withdrawal by Subject|4|||
156350229|NCT01986985|564379899|FG000|Overall Study|Scan not completed due to malfunction|3|||
156350230|NCT02288559|564379900|FG000|Overall Study|Adverse Event|1|||
156350231|NCT02288559|564379901|FG001|Overall Study|Adverse Event|1|||
156350232|NCT02288559|564379902|FG002|Overall Study|Adverse Event|5|||
156350233|NCT02288559|564379903|FG003|Overall Study|Adverse Event|0|||
156350234|NCT02288559|564379900|FG000|Overall Study|Death|0|||
156350235|NCT02288559|564379901|FG001|Overall Study|Death|0|||
156350236|NCT02288559|564379902|FG002|Overall Study|Death|1|||
156350237|NCT02288559|564379903|FG003|Overall Study|Death|0|||
156350238|NCT02288559|564379900|FG000|Overall Study|Lost to Follow-up|0|||
156350239|NCT02288559|564379901|FG001|Overall Study|Lost to Follow-up|0|||
156350240|NCT02288559|564379902|FG002|Overall Study|Lost to Follow-up|0|||
156350241|NCT02288559|564379903|FG003|Overall Study|Lost to Follow-up|1|||
156350242|NCT02288559|564379900|FG000|Overall Study|Withdrawal by Subject|0|||
156350243|NCT02288559|564379901|FG001|Overall Study|Withdrawal by Subject|0|||
156350244|NCT02288559|564379902|FG002|Overall Study|Withdrawal by Subject|2|||
156350245|NCT02288559|564379903|FG003|Overall Study|Withdrawal by Subject|1|||
156350246|NCT02288559|564379900|FG000|Overall Study|Reason Not Specified|0|||
156544144|NCT00361270|565086306|FG001|Overall Study|Problems with Transportation|0|||
156544145|NCT00361270|565086307|FG002|Overall Study|Problems with Transportation|0|||
156350247|NCT02288559|564379901|FG001|Overall Study|Reason Not Specified|0|||
156350248|NCT02288559|564379902|FG002|Overall Study|Reason Not Specified|3|||
156350249|NCT02288559|564379903|FG003|Overall Study|Reason Not Specified|0|||
156350250|NCT00558025|564379904|FG000|Overall Study|Adverse Event|1|||
156350251|NCT00558025|564379905|FG001|Overall Study|Adverse Event|1|||
156350252|NCT00558025|564379904|FG000|Overall Study|Withdrawal by Subject|2|||
156350253|NCT00558025|564379905|FG001|Overall Study|Withdrawal by Subject|2|||
156350254|NCT00558025|564379904|FG000|Overall Study|Protocol Violation|1|||
156350255|NCT00558025|564379905|FG001|Overall Study|Protocol Violation|0|||
156350256|NCT00752232|564379929|FG000|Overall Study|Protocol Violation|0|||
156350257|NCT00752232|564379930|FG001|Overall Study|Protocol Violation|0|||
156350258|NCT00752232|564379931|FG002|Overall Study|Protocol Violation|0|||
156350259|NCT00752232|564379932|FG003|Overall Study|Protocol Violation|0|||
156350260|NCT00752232|564379933|FG004|Overall Study|Protocol Violation|0|||
156350261|NCT00752232|564379934|FG005|Overall Study|Protocol Violation|1|||
156350262|NCT00752232|564379935|FG006|Overall Study|Protocol Violation|0|||
156350263|NCT00752232|564379929|FG000|Overall Study|Caregiver request|2|||
156350264|NCT00752232|564379930|FG001|Overall Study|Caregiver request|0|||
156350265|NCT00752232|564379931|FG002|Overall Study|Caregiver request|0|||
156350266|NCT00752232|564379932|FG003|Overall Study|Caregiver request|0|||
156350267|NCT00752232|564379933|FG004|Overall Study|Caregiver request|1|||
156350268|NCT00752232|564379934|FG005|Overall Study|Caregiver request|0|||
156350269|NCT00752232|564379935|FG006|Overall Study|Caregiver request|0|||
156350270|NCT00752232|564379929|FG000|Overall Study|Investigator request|0|||
156350271|NCT00752232|564379930|FG001|Overall Study|Investigator request|0|||
156350272|NCT00752232|564379931|FG002|Overall Study|Investigator request|0|||
156350273|NCT00752232|564379932|FG003|Overall Study|Investigator request|0|||
156350274|NCT00752232|564379933|FG004|Overall Study|Investigator request|1|||
156350275|NCT00752232|564379934|FG005|Overall Study|Investigator request|0|||
156350276|NCT00752232|564379935|FG006|Overall Study|Investigator request|0|||
156350277|NCT00752232|564379929|FG000|Overall Study|Subject request|0|||
156350278|NCT00752232|564379930|FG001|Overall Study|Subject request|0|||
156350279|NCT00752232|564379931|FG002|Overall Study|Subject request|1|||
156350280|NCT00752232|564379932|FG003|Overall Study|Subject request|0|||
156350281|NCT00752232|564379933|FG004|Overall Study|Subject request|0|||
156350282|NCT00752232|564379934|FG005|Overall Study|Subject request|0|||
156350283|NCT00752232|564379935|FG006|Overall Study|Subject request|0|||
156350284|NCT00752232|564379929|FG000|Overall Study|Group home admission|0|||
156350285|NCT00752232|564379930|FG001|Overall Study|Group home admission|0|||
156350286|NCT00752232|564379931|FG002|Overall Study|Group home admission|0|||
156350287|NCT00752232|564379932|FG003|Overall Study|Group home admission|1|||
156350288|NCT00752232|564379933|FG004|Overall Study|Group home admission|0|||
156350289|NCT00752232|564379934|FG005|Overall Study|Group home admission|0|||
156350290|NCT00752232|564379935|FG006|Overall Study|Group home admission|0|||
156350291|NCT00752232|564379929|FG000|Overall Study|Caregiver could not attend the subject|0|||
156350292|NCT00752232|564379930|FG001|Overall Study|Caregiver could not attend the subject|0|||
156350293|NCT00752232|564379931|FG002|Overall Study|Caregiver could not attend the subject|0|||
156350294|NCT00752232|564379932|FG003|Overall Study|Caregiver could not attend the subject|0|||
156350295|NCT00752232|564379933|FG004|Overall Study|Caregiver could not attend the subject|1|||
156350296|NCT00752232|564379934|FG005|Overall Study|Caregiver could not attend the subject|0|||
156350297|NCT00752232|564379935|FG006|Overall Study|Caregiver could not attend the subject|0|||
156350298|NCT00667368|564379936|FG000|Overall Study|Lost to Follow-up|176|||
156350299|NCT00667368|564379937|FG001|Overall Study|Lost to Follow-up|155|||
156350300|NCT00667368|564379936|FG000|Overall Study|Discontinued early|24|||
156350301|NCT00667368|564379937|FG001|Overall Study|Discontinued early|17|||
156350302|NCT04044716|564379938|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
156350303|NCT04044716|564379939|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
156350304|NCT04044716|564379940|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
156350305|NCT04044716|564379938|FG000|Overall Study|Lost to Follow-up|2|||
156350306|NCT04044716|564379939|FG001|Overall Study|Lost to Follow-up|3|||
156350307|NCT04044716|564379940|FG002|Overall Study|Lost to Follow-up|0|||
156350308|NCT01957553|564379941|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
156350309|NCT01957553|564379942|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
156350310|NCT01957553|564379941|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
156350311|NCT01957553|564379942|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
156350312|NCT01957553|564379941|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
156350313|NCT01957553|564379942|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
156350314|NCT01957553|564379941|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
156350315|NCT01957553|564379942|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
156350316|NCT01957553|564379941|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
156350317|NCT01957553|564379942|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
156350318|NCT01957553|564379941|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
156350319|NCT01957553|564379942|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
156350320|NCT01957553|564379941|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
156350321|NCT01957553|564379942|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
156350322|NCT01957553|564379941|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
156350323|NCT01957553|564379942|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
156350324|NCT01957553|564379941|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
156350325|NCT01957553|564379942|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
156350326|NCT02733367|564379943|FG000|Overall Study|Withdrawal by Subject|6|||
156350327|NCT01348347|564379944|FG000|Overall Study|Withdrawal by Subject|1|||
156350328|NCT01348347|564379945|FG001|Overall Study|Withdrawal by Subject|1|||
156350329|NCT01348347|564379946|FG002|Overall Study|Withdrawal by Subject|1|||
156350330|NCT01348347|564379944|FG000|Overall Study|Progressive disease|2|||
156350331|NCT01348347|564379945|FG001|Overall Study|Progressive disease|5|||
156350332|NCT01348347|564379946|FG002|Overall Study|Progressive disease|5|||
156350333|NCT01922089|564379949|FG000|Overall Study|Adverse Event|18|||
156350334|NCT01922089|564379950|FG001|Overall Study|Adverse Event|13|||
156350335|NCT01922089|564379949|FG000|Overall Study|Protocol Deviation|10|||
156350336|NCT01922089|564379950|FG001|Overall Study|Protocol Deviation|7|||
156350337|NCT01922089|564379949|FG000|Overall Study|Withdrawal by Subject|3|||
156350338|NCT01922089|564379950|FG001|Overall Study|Withdrawal by Subject|4|||
156350339|NCT01922089|564379949|FG000|Overall Study|administrative problems|4|||
156350340|NCT01922089|564379950|FG001|Overall Study|administrative problems|1|||
156350341|NCT01922089|564379949|FG000|Overall Study|Physician Decision|2|||
156350342|NCT01922089|564379950|FG001|Overall Study|Physician Decision|3|||
156350343|NCT01922089|564379949|FG000|Overall Study|Death|2|||
156350344|NCT01922089|564379950|FG001|Overall Study|Death|1|||
156482763|NCT02092909|564860576|FG000|Overall Study|Study terminated by Sponsor|0|||
156482764|NCT02092909|564860577|FG001|Overall Study|Study terminated by Sponsor|0|||
156482765|NCT02092909|564860578|FG002|Overall Study|Study terminated by Sponsor|0|||
156482766|NCT02092909|564860579|FG003|Overall Study|Study terminated by Sponsor|2|||
156350345|NCT01922089|564379949|FG000|Overall Study|Lost to Follow-up|0|||
156350346|NCT01922089|564379950|FG001|Overall Study|Lost to Follow-up|1|||
156350347|NCT02788357|564379952|FG000|Overall Study|Lost to Follow-up|3|||
156350348|NCT02788357|564379953|FG001|Overall Study|Lost to Follow-up|0|||
156350349|NCT02170051|564379954|FG000|Overall Study|Withdrawal by Subject|10|||
156350350|NCT02170051|564379955|FG001|Overall Study|Withdrawal by Subject|10|||
156350351|NCT02170051|564379954|FG000|Overall Study|Lost to Follow-up|1|||
156350352|NCT02170051|564379955|FG001|Overall Study|Lost to Follow-up|3|||
156350353|NCT01324999|564379956|FG000|Overall Study|Adverse Event|3|||
156350354|NCT01324999|564379956|FG000|Overall Study|Withdrawal by Subject|2|||
156350355|NCT00640601|564379962|FG000|Overall Study|Adverse Event|43|||
156482767|NCT02092909|564860576|FG000|Overall Study|Miscellaneous|1|||
156482768|NCT02092909|564860577|FG001|Overall Study|Miscellaneous|1|||
156482769|NCT02092909|564860578|FG002|Overall Study|Miscellaneous|2|||
156482770|NCT02092909|564860579|FG003|Overall Study|Miscellaneous|1|||
156482771|NCT04175392|564860580|FG000|Overall Study|Withdrawal by Subject|3|||
156482772|NCT04175392|564860581|FG001|Overall Study|Withdrawal by Subject|2|||
156482773|NCT02727998|564860582|FG000|Overall Study|Lost to Follow-up|3|||
156482774|NCT02727998|564860583|FG001|Overall Study|Lost to Follow-up|3|||
156482775|NCT02727998|564860582|FG000|Overall Study|Withdrawal by Subject|0|||
156482776|NCT02727998|564860583|FG001|Overall Study|Withdrawal by Subject|1|||
156482777|NCT02105688|564860584|FG000|Part A: Double-Blind|Adverse Event|1|||
156482778|NCT02105688|564860585|FG001|Part A: Double-Blind|Adverse Event|0|||
156482779|NCT02105688|564860584|FG000|Part A: Double-Blind|Death|0|||
156482780|NCT02105688|564860585|FG001|Part A: Double-Blind|Death|1|||
156482781|NCT02105688|564860584|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
156482782|NCT02105688|564860585|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
156482783|NCT02105688|564860584|FG000|Part A: Double-Blind|Physician Decision|0|||
156482784|NCT02105688|564860585|FG001|Part A: Double-Blind|Physician Decision|1|||
156482785|NCT02105688|564860584|FG000|Part A: Double-Blind|Status Unknown|0|||
156482786|NCT02105688|564860585|FG001|Part A: Double-Blind|Status Unknown|2|||
156350356|NCT00640601|564379962|FG000|Overall Study|Withdrawal by Subject|20|||
156482787|NCT02105688|564860584|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
156482788|NCT02105688|564860585|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
156482789|NCT02105688|564860584|FG000|Part B: Observational Follow-up|Death|2|||
156482790|NCT02105688|564860585|FG001|Part B: Observational Follow-up|Death|1|||
156482791|NCT02105688|564860584|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
156482792|NCT02105688|564860585|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
156482793|NCT02105688|564860584|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
156482794|NCT02105688|564860585|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
156482795|NCT02105688|564860584|FG000|Part B: Observational Follow-up|Physician Decision|3|||
156350357|NCT00640601|564379962|FG000|Overall Study|Protocol Violation|6|||
156350358|NCT00640601|564379962|FG000|Overall Study|Lack of Efficacy|16|||
156350359|NCT00640601|564379962|FG000|Overall Study|Lost to Follow-up|9|||
156350360|NCT00640601|564379962|FG000|Overall Study|Physician Decision|8|||
156350361|NCT00640601|564379962|FG000|Overall Study|treatment naive, combination therapy|10|||
156350362|NCT03681405|564379963|FG000|Overall Study|Found to be ineligible after randomized|1|||
156350363|NCT03681405|564379964|FG001|Overall Study|Found to be ineligible after randomized|0|||
156350364|NCT01714635|564379970|FG000|Overall Study|Discontinued|1|||
156350365|NCT01714635|564379971|FG001|Overall Study|Discontinued|0|||
156350366|NCT01714635|564379972|FG002|Overall Study|Discontinued|2|||
156350367|NCT01714635|564379970|FG000|Overall Study|Missed 6-month exam|1|||
156350368|NCT01714635|564379971|FG001|Overall Study|Missed 6-month exam|0|||
156350369|NCT01714635|564379972|FG002|Overall Study|Missed 6-month exam|0|||
156350370|NCT03198234|564379973|FG000|Overall Study|Relapse of primary disease|0|||
156350371|NCT03198234|564379974|FG001|Overall Study|Relapse of primary disease|1|||
156350372|NCT03198234|564379975|FG002|Overall Study|Relapse of primary disease|0|||
156350373|NCT04285879|564379976|FG000|Overall Study|Lost to Follow-up|1|||
156350374|NCT04285879|564379977|FG001|Overall Study|Lost to Follow-up|8|||
156350375|NCT04285879|564379976|FG000|Overall Study|medical/surgical exclusion|16|||
156350376|NCT04285879|564379977|FG001|Overall Study|medical/surgical exclusion|0|||
156350377|NCT03228537|564379982|FG000|Neoadjuvant|Adverse Event|2|||
156350378|NCT03228537|564379982|FG000|Neoadjuvant|Progression/Relapse|4|||
156350379|NCT03228537|564379982|FG000|Neoadjuvant|Death|1|||
156350380|NCT03228537|564379982|FG000|Surgery|Death|1|||
156350381|NCT03228537|564379982|FG000|Surgery|Other - Not Protocol Specified|2|||
156350382|NCT03228537|564379982|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
156350383|NCT03228537|564379982|FG000|Maintenance|Progression/Relapse|10|||
156350384|NCT01927367|564379983|FG000|Overall Study|Withdrawal by Subject|7|||
156350385|NCT01927367|564379984|FG001|Overall Study|Withdrawal by Subject|4|||
156350386|NCT01927367|564379983|FG000|Overall Study|No baseline data|0|||
156350387|NCT01927367|564379984|FG001|Overall Study|No baseline data|1|||
156482796|NCT02105688|564860585|FG001|Part B: Observational Follow-up|Physician Decision|1|||
156482797|NCT01103141|564860586|FG000|Overall Study|Death|0|||
156350388|NCT00071513|564379987|FG000|Intervention Component|Withdrawal by Subject|2|||
156350389|NCT00071513|564379988|FG001|Intervention Component|Withdrawal by Subject|3|||
156350390|NCT00071513|564379987|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
156350391|NCT00071513|564379988|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
156350392|NCT01648205|564379989|FG000|Placebo|Pregnancy|1|||
156350393|NCT01648205|564379989|FG000|Placebo|Withdrawal by Subject|1|||
156350394|NCT01648205|564379989|FG000|Placebo|Protocol Violation|2|||
156350395|NCT01648205|564379989|FG000|Ranolazine|Death|1|||
156350396|NCT01648205|564379989|FG000|Ranolazine|Withdrawal by Subject|1|||
156350397|NCT01648205|564379989|FG000|Ranolazine|Protocol Violation|3|||
156350398|NCT02622321|564379990|FG000|Overall Study|Withdrawal by Subject|2|||
156350399|NCT02622321|564379991|FG001|Overall Study|Withdrawal by Subject|0|||
156350400|NCT02622321|564379992|FG002|Overall Study|Withdrawal by Subject|0|||
156350401|NCT02622321|564379993|FG003|Overall Study|Withdrawal by Subject|0|||
156350402|NCT02622321|564379990|FG000|Overall Study|Death|0|||
156350403|NCT02622321|564379991|FG001|Overall Study|Death|0|||
156350404|NCT02622321|564379992|FG002|Overall Study|Death|1|||
156350405|NCT02622321|564379993|FG003|Overall Study|Death|0|||
156482798|NCT01103141|564860587|FG001|Overall Study|Death|1|||
156482799|NCT01103141|564860586|FG000|Overall Study|Lost to Follow-up|2|||
156482800|NCT01103141|564860587|FG001|Overall Study|Lost to Follow-up|1|||
156482801|NCT05072795|564860588|FG000|Overall Study|Lost to Follow-up|5|||
156482802|NCT00910871|564860597|FG000|Overall Study|Adverse Event|5|||
156482803|NCT00910871|564860597|FG000|Overall Study|Death|12|||
156482804|NCT00910871|564860597|FG000|Overall Study|Lost to Follow-up|8|||
156350406|NCT02622321|564379990|FG000|Overall Study|Physician Decision|1|||
156350407|NCT02622321|564379991|FG001|Overall Study|Physician Decision|0|||
156350408|NCT02622321|564379992|FG002|Overall Study|Physician Decision|0|||
156350409|NCT02622321|564379993|FG003|Overall Study|Physician Decision|0|||
156350410|NCT00965718|564379997|FG000|Overall Study|Withdrawal by Subject|4|||
156350411|NCT01958008|564379998|FG000|Overall Study|Worsening of disease under study|0|||
156350412|NCT01958008|564379999|FG001|Overall Study|Worsening of disease under study|0|||
156350413|NCT01958008|564380000|FG002|Overall Study|Worsening of disease under study|1|||
156350414|NCT01958008|564380001|FG003|Overall Study|Worsening of disease under study|0|||
156482805|NCT00910871|564860597|FG000|Overall Study|Protocol Violation|11|||
156350415|NCT01958008|564379998|FG000|Overall Study|Other adverse event|1|||
156350416|NCT01958008|564379999|FG001|Overall Study|Other adverse event|0|||
156350417|NCT01958008|564380000|FG002|Overall Study|Other adverse event|0|||
156350418|NCT01958008|564380001|FG003|Overall Study|Other adverse event|0|||
156350419|NCT01634360|564380002|FG000|Overall Study|Adverse Event|10|||
156350420|NCT01634360|564380003|FG001|Overall Study|Adverse Event|34|||
156350421|NCT01634360|564380002|FG000|Overall Study|subject withdrew consent|13|||
156350422|NCT01634360|564380003|FG001|Overall Study|subject withdrew consent|23|||
156350423|NCT01634360|564380002|FG000|Overall Study|Protocol Violation|1|||
156350424|NCT01634360|564380003|FG001|Overall Study|Protocol Violation|1|||
156482806|NCT00910871|564860597|FG000|Overall Study|Withdrawal by Subject|12|||
156544146|NCT00361270|565086308|FG003|Overall Study|Problems with Transportation|0|||
156544147|NCT00361270|565086305|FG000|Overall Study|Adverse Event|0|||
156544148|NCT00361270|565086306|FG001|Overall Study|Adverse Event|1|||
156544149|NCT00361270|565086307|FG002|Overall Study|Adverse Event|1|||
156544150|NCT00361270|565086308|FG003|Overall Study|Adverse Event|0|||
156350425|NCT01634360|564380002|FG000|Overall Study|Lack of Efficacy|4|||
156350426|NCT01634360|564380003|FG001|Overall Study|Lack of Efficacy|14|||
156350427|NCT01634360|564380002|FG000|Overall Study|Other|3|||
156350428|NCT01634360|564380003|FG001|Overall Study|Other|20|||
156350429|NCT01634360|564380002|FG000|Overall Study|Study termination by sponsor|18|||
156350430|NCT01634360|564380003|FG001|Overall Study|Study termination by sponsor|44|||
156350431|NCT01414855|564380004|FG000|Overall Study|Death|17|||
156350432|NCT01414855|564380004|FG000|Overall Study|Lost to Follow-up|5|||
156350433|NCT01414855|564380004|FG000|Overall Study|Withdrawal by Subject|7|||
156350434|NCT03667924|564380005|FG000|Baseline Completed|Lost to Follow-up|0|||
156350435|NCT03667924|564380006|FG001|Baseline Completed|Lost to Follow-up|2|||
156350436|NCT03667924|564380007|FG002|Baseline Completed|Lost to Follow-up|0|||
156350437|NCT03667924|564380005|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
156350438|NCT03667924|564380006|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
156350439|NCT03667924|564380007|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
156350440|NCT03667924|564380005|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
156350441|NCT03667924|564380006|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
156350442|NCT03667924|564380007|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
156350443|NCT03667924|564380005|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
156350444|NCT03667924|564380006|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
156350445|NCT03667924|564380007|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
156350446|NCT03667924|564380005|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
156350447|NCT03667924|564380006|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
156350448|NCT03667924|564380007|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
156350449|NCT03667924|564380005|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
156350450|NCT03667924|564380006|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
156350451|NCT03667924|564380007|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
156350452|NCT03667924|564380005|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
156350453|NCT03667924|564380006|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
156350454|NCT03667924|564380007|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
156350455|NCT02260921|564380014|FG000|Overall Study|Adverse Event|1|||
156350456|NCT02260921|564380015|FG001|Overall Study|Adverse Event|0|||
156350457|NCT02260921|564380014|FG000|Overall Study|Lost to Follow-up|4|||
156350458|NCT02260921|564380015|FG001|Overall Study|Lost to Follow-up|3|||
156350459|NCT02260921|564380014|FG000|Overall Study|Withdraw Consent|4|||
156350460|NCT02260921|564380015|FG001|Overall Study|Withdraw Consent|1|||
156350461|NCT02260921|564380014|FG000|Overall Study|Death|1|||
156350462|NCT02260921|564380015|FG001|Overall Study|Death|0|||
156350463|NCT02260921|564380014|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
156350464|NCT02260921|564380015|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
156350465|NCT01244425|564380016|FG000|Overall Study|Withdrawal by Subject|2|||
156350466|NCT01244425|564380017|FG001|Overall Study|Withdrawal by Subject|2|||
156350467|NCT01244425|564380016|FG000|Overall Study|Adverse Event|1|||
156350468|NCT01244425|564380017|FG001|Overall Study|Adverse Event|1|||
156350469|NCT02743871|564380018|FG000|Overall Study|Lost to Follow-up|0|||
156350470|NCT02743871|564380019|FG001|Overall Study|Lost to Follow-up|0|||
156350471|NCT02743871|564380020|FG002|Overall Study|Lost to Follow-up|0|||
156350472|NCT02743871|564380021|FG003|Overall Study|Lost to Follow-up|1|||
156350473|NCT02743871|564380022|FG004|Overall Study|Lost to Follow-up|0|||
156350474|NCT02743871|564380023|FG005|Overall Study|Lost to Follow-up|0|||
156350475|NCT02743871|564380024|FG006|Overall Study|Lost to Follow-up|1|||
156350476|NCT02743871|564380025|FG007|Overall Study|Lost to Follow-up|0|||
156350477|NCT02743871|564380026|FG008|Overall Study|Lost to Follow-up|0|||
156350478|NCT02743871|564380027|FG009|Overall Study|Lost to Follow-up|0|||
156350479|NCT02743871|564380028|FG010|Overall Study|Lost to Follow-up|0|||
156350480|NCT02743871|564380029|FG011|Overall Study|Lost to Follow-up|2|||
156350481|NCT02743871|564380030|FG012|Overall Study|Lost to Follow-up|0|||
156350482|NCT02743871|564380031|FG013|Overall Study|Lost to Follow-up|0|||
156350483|NCT02743871|564380018|FG000|Overall Study|Withdrawal by Subject|0|||
156350484|NCT02743871|564380019|FG001|Overall Study|Withdrawal by Subject|0|||
156350485|NCT02743871|564380020|FG002|Overall Study|Withdrawal by Subject|0|||
156482807|NCT00910871|564860597|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
156482808|NCT00910871|564860597|FG000|Overall Study|Undefined|1|||
156482809|NCT00850993|564860598|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
156350486|NCT02743871|564380021|FG003|Overall Study|Withdrawal by Subject|0|||
156350487|NCT02743871|564380022|FG004|Overall Study|Withdrawal by Subject|0|||
156482810|NCT00850993|564860599|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
156482811|NCT00850993|564860600|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
156482812|NCT00850993|564860601|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
156482813|NCT04501614|564860606|FG000|Overall Study|Study Terminated by Sponsor|6|||
156482814|NCT04501614|564860607|FG001|Overall Study|Study Terminated by Sponsor|3|||
156350488|NCT02743871|564380023|FG005|Overall Study|Withdrawal by Subject|0|||
156350489|NCT02743871|564380024|FG006|Overall Study|Withdrawal by Subject|0|||
156350490|NCT02743871|564380025|FG007|Overall Study|Withdrawal by Subject|0|||
156350491|NCT02743871|564380026|FG008|Overall Study|Withdrawal by Subject|0|||
156350492|NCT02743871|564380027|FG009|Overall Study|Withdrawal by Subject|0|||
156350493|NCT02743871|564380028|FG010|Overall Study|Withdrawal by Subject|1|||
156350494|NCT02743871|564380029|FG011|Overall Study|Withdrawal by Subject|0|||
156350495|NCT02743871|564380030|FG012|Overall Study|Withdrawal by Subject|12|||
156350496|NCT02743871|564380031|FG013|Overall Study|Withdrawal by Subject|6|||
156350497|NCT02743871|564380018|FG000|Overall Study|Adverse Event|1|||
156350498|NCT02743871|564380019|FG001|Overall Study|Adverse Event|0|||
156350499|NCT02743871|564380020|FG002|Overall Study|Adverse Event|0|||
156350500|NCT02743871|564380021|FG003|Overall Study|Adverse Event|0|||
156350501|NCT02743871|564380022|FG004|Overall Study|Adverse Event|0|||
156350502|NCT02743871|564380023|FG005|Overall Study|Adverse Event|0|||
156350503|NCT02743871|564380024|FG006|Overall Study|Adverse Event|0|||
156350504|NCT02743871|564380025|FG007|Overall Study|Adverse Event|0|||
156350505|NCT02743871|564380026|FG008|Overall Study|Adverse Event|0|||
156350506|NCT02743871|564380027|FG009|Overall Study|Adverse Event|0|||
156350507|NCT02743871|564380028|FG010|Overall Study|Adverse Event|0|||
156350508|NCT02743871|564380029|FG011|Overall Study|Adverse Event|0|||
156350509|NCT02743871|564380030|FG012|Overall Study|Adverse Event|0|||
156350510|NCT02743871|564380031|FG013|Overall Study|Adverse Event|0|||
156350511|NCT02743871|564380018|FG000|Overall Study|Other|0|||
156350512|NCT02743871|564380019|FG001|Overall Study|Other|0|||
156350513|NCT02743871|564380020|FG002|Overall Study|Other|0|||
156350514|NCT02743871|564380021|FG003|Overall Study|Other|0|||
156350515|NCT02743871|564380022|FG004|Overall Study|Other|0|||
156350516|NCT02743871|564380023|FG005|Overall Study|Other|0|||
156350517|NCT02743871|564380024|FG006|Overall Study|Other|0|||
156350518|NCT02743871|564380025|FG007|Overall Study|Other|0|||
156350519|NCT02743871|564380026|FG008|Overall Study|Other|0|||
156350520|NCT02743871|564380027|FG009|Overall Study|Other|0|||
156350521|NCT02743871|564380028|FG010|Overall Study|Other|0|||
156350522|NCT02743871|564380029|FG011|Overall Study|Other|1|||
156350523|NCT02743871|564380030|FG012|Overall Study|Other|1|||
156350524|NCT02743871|564380031|FG013|Overall Study|Other|1|||
156350525|NCT02743871|564380018|FG000|Overall Study|Protocol Violation|0|||
156350526|NCT02743871|564380019|FG001|Overall Study|Protocol Violation|0|||
156350527|NCT02743871|564380020|FG002|Overall Study|Protocol Violation|0|||
156350528|NCT02743871|564380021|FG003|Overall Study|Protocol Violation|0|||
156350529|NCT02743871|564380022|FG004|Overall Study|Protocol Violation|0|||
156350530|NCT02743871|564380023|FG005|Overall Study|Protocol Violation|0|||
156350531|NCT02743871|564380024|FG006|Overall Study|Protocol Violation|0|||
156350532|NCT02743871|564380025|FG007|Overall Study|Protocol Violation|0|||
156350533|NCT02743871|564380026|FG008|Overall Study|Protocol Violation|0|||
156350534|NCT02743871|564380027|FG009|Overall Study|Protocol Violation|0|||
156350535|NCT02743871|564380028|FG010|Overall Study|Protocol Violation|0|||
156350536|NCT02743871|564380029|FG011|Overall Study|Protocol Violation|0|||
156350537|NCT02743871|564380030|FG012|Overall Study|Protocol Violation|2|||
156350538|NCT02743871|564380031|FG013|Overall Study|Protocol Violation|0|||
156350539|NCT02999854|564380032|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
156350540|NCT02999854|564380033|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
156350541|NCT02999854|564380032|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
156350542|NCT02999854|564380033|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
156350543|NCT02999854|564380032|FG000|Active Study Phase (up to 18 Months)|Death|7|||
156350544|NCT02999854|564380033|FG001|Active Study Phase (up to 18 Months)|Death|5|||
156350545|NCT02999854|564380032|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
156350546|NCT02999854|564380033|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
156482815|NCT04501614|564860606|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
156482816|NCT04501614|564860607|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
156482817|NCT02555397|564860611|FG000|Overall Study|Withdrawal by Subject|1|||
156350547|NCT02999854|564380032|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
156350548|NCT02999854|564380033|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
156350549|NCT02999854|564380032|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
156350550|NCT02999854|564380033|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
156350551|NCT02999854|564380032|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
156350552|NCT02999854|564380033|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
156350553|NCT02999854|564380032|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
156350554|NCT02999854|564380033|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
156350555|NCT03032705|564380034|FG000|Overall Study|Lost to Follow-up|16|||
156350556|NCT03032705|564380035|FG001|Overall Study|Lost to Follow-up|17|||
156350557|NCT03032705|564380034|FG000|Overall Study|did not quality|6|||
156350558|NCT03032705|564380035|FG001|Overall Study|did not quality|6|||
156350559|NCT01937559|564380038|FG000|Overall Study|Physician Decision|3|||
156350560|NCT01937559|564380039|FG001|Overall Study|Physician Decision|3|||
156482818|NCT02555397|564860612|FG001|Overall Study|Withdrawal by Subject|0|||
156482819|NCT02555397|564860613|FG002|Overall Study|Withdrawal by Subject|0|||
156482820|NCT02555397|564860614|FG003|Overall Study|Withdrawal by Subject|0|||
156482821|NCT02555397|564860615|FG004|Overall Study|Withdrawal by Subject|0|||
156482822|NCT00237809|564860621|FG000|Overall Study|Lost to Follow-up|11|||
156482823|NCT00237809|564860622|FG001|Overall Study|Lost to Follow-up|10|||
156482824|NCT00237809|564860623|FG002|Overall Study|Lost to Follow-up|9|||
156482825|NCT00237809|564860624|FG003|Overall Study|Lost to Follow-up|9|||
156482826|NCT02006641|564860625|FG000|Overall Study|Withdrawal before treatment|2|||
156544151|NCT04013529|565086312|FG000|Overall Study|Withdrawal by Subject|1|||
156482827|NCT02006641|564860626|FG001|Overall Study|Withdrawal before treatment|5|||
156482828|NCT02006641|564860627|FG002|Overall Study|Withdrawal before treatment|3|||
156482829|NCT02006641|564860625|FG000|Overall Study|Adverse Event|15|||
156482830|NCT02006641|564860626|FG001|Overall Study|Adverse Event|11|||
156482831|NCT02006641|564860627|FG002|Overall Study|Adverse Event|15|||
156482832|NCT02006641|564860625|FG000|Overall Study|Protocol Violation|0|||
156350561|NCT01937559|564380040|FG002|Overall Study|Physician Decision|0|||
156350562|NCT01937559|564380038|FG000|Overall Study|Withdrawal by Subject|6|||
156350563|NCT01937559|564380039|FG001|Overall Study|Withdrawal by Subject|4|||
156350564|NCT01937559|564380040|FG002|Overall Study|Withdrawal by Subject|0|||
156350565|NCT01937559|564380038|FG000|Overall Study|screen fail|2|||
156350566|NCT01937559|564380039|FG001|Overall Study|screen fail|4|||
156350567|NCT01937559|564380040|FG002|Overall Study|screen fail|0|||
156350568|NCT04818840|564380041|FG000|Overall Study|Lost to Follow-up|0|||
156350569|NCT04818840|564380042|FG001|Overall Study|Lost to Follow-up|5|||
156350570|NCT04818840|564380041|FG000|Overall Study|Physician Decision|1|||
156350571|NCT04818840|564380042|FG001|Overall Study|Physician Decision|0|||
156350572|NCT04818840|564380041|FG000|Overall Study|Site Terminated by Sponsor|0|||
156350573|NCT04818840|564380042|FG001|Overall Study|Site Terminated by Sponsor|3|||
156350574|NCT04818840|564380041|FG000|Overall Study|Study Terminated by Sponsor|43|||
156350575|NCT04818840|564380042|FG001|Overall Study|Study Terminated by Sponsor|7|||
156350576|NCT04818840|564380041|FG000|Overall Study|Withdrawal by Subject|0|||
156350577|NCT04818840|564380042|FG001|Overall Study|Withdrawal by Subject|1|||
156350578|NCT00733408|564382089|FG000|Overall Study|Adverse Event|4|||
156350579|NCT01134783|564382090|FG000|Overall Study|Pregnancy|16|||
156482833|NCT02006641|564860626|FG001|Overall Study|Protocol Violation|2|||
156482834|NCT02006641|564860627|FG002|Overall Study|Protocol Violation|2|||
156482835|NCT02006641|564860625|FG000|Overall Study|Lost to Follow-up|0|||
156482836|NCT02006641|564860626|FG001|Overall Study|Lost to Follow-up|1|||
156350580|NCT01134783|564382091|FG001|Overall Study|Pregnancy|8|||
156350581|NCT01134783|564382090|FG000|Overall Study|Withdrawal by Subject|15|||
156350582|NCT01134783|564382091|FG001|Overall Study|Withdrawal by Subject|9|||
156350583|NCT01134783|564382090|FG000|Overall Study|Lost to Follow-up|5|||
156350584|NCT01134783|564382091|FG001|Overall Study|Lost to Follow-up|20|||
156350585|NCT02329730|564382099|FG000|Overall Study|Protocol Violation|0|||
156482837|NCT02006641|564860627|FG002|Overall Study|Lost to Follow-up|0|||
156482838|NCT02006641|564860625|FG000|Overall Study|Withdrawal by Subject|7|||
156482839|NCT02006641|564860626|FG001|Overall Study|Withdrawal by Subject|12|||
156482840|NCT02006641|564860627|FG002|Overall Study|Withdrawal by Subject|11|||
156482841|NCT02006641|564860625|FG000|Overall Study|Other reason: patient didn't show up|1|||
156482842|NCT02006641|564860626|FG001|Overall Study|Other reason: patient didn't show up|0|||
156482843|NCT02006641|564860627|FG002|Overall Study|Other reason: patient didn't show up|0|||
156482844|NCT02006641|564860625|FG000|Overall Study|Other reason:patient didn't want to come|0|||
156482845|NCT02006641|564860626|FG001|Overall Study|Other reason:patient didn't want to come|0|||
156482846|NCT02006641|564860627|FG002|Overall Study|Other reason:patient didn't want to come|1|||
156482847|NCT02006641|564860625|FG000|Overall Study|Other reason: patient has moved|1|||
156482848|NCT02006641|564860626|FG001|Overall Study|Other reason: patient has moved|0|||
156482849|NCT02006641|564860627|FG002|Overall Study|Other reason: patient has moved|1|||
156482850|NCT02006641|564860625|FG000|Overall Study|Other reason: caregiver in hospital|0|||
156482851|NCT02006641|564860626|FG001|Overall Study|Other reason: caregiver in hospital|1|||
156482852|NCT02006641|564860627|FG002|Overall Study|Other reason: caregiver in hospital|0|||
156482853|NCT02006641|564860625|FG000|Overall Study|Other reason: patient's wife has died|0|||
156482854|NCT02006641|564860626|FG001|Overall Study|Other reason: patient's wife has died|0|||
156482855|NCT02006641|564860627|FG002|Overall Study|Other reason: patient's wife has died|1|||
156482856|NCT02006641|564860625|FG000|Overall Study|Other reason: hospitalisation|0|||
156482857|NCT02006641|564860626|FG001|Overall Study|Other reason: hospitalisation|1|||
156482858|NCT02006641|564860627|FG002|Overall Study|Other reason: hospitalisation|0|||
156482859|NCT02006641|564860625|FG000|Overall Study|Other reason: caregiver impossibility|0|||
156482860|NCT02006641|564860626|FG001|Overall Study|Other reason: caregiver impossibility|0|||
156482861|NCT02006641|564860627|FG002|Overall Study|Other reason: caregiver impossibility|1|||
156482862|NCT02006641|564860625|FG000|Overall Study|Other reason: protocol non-compliance|0|||
156482863|NCT02006641|564860626|FG001|Overall Study|Other reason: protocol non-compliance|0|||
156482864|NCT02006641|564860627|FG002|Overall Study|Other reason: protocol non-compliance|1|||
156482865|NCT01613599|564860628|FG000|Overall Study|Death|9|||
156482866|NCT01613599|564860628|FG000|Overall Study|Lost to Follow-up|5|||
156482867|NCT01613599|564860628|FG000|Overall Study|Withdrawal by Subject|8|||
156482868|NCT01613599|564860628|FG000|Overall Study|Reason not specified|3|||
156482869|NCT02132195|564860631|FG000|Initial Assignment|Relapsed|14|||
156482870|NCT02132195|564860632|FG001|Initial Assignment|Relapsed|0|||
156482871|NCT02132195|564860633|FG002|Initial Assignment|Relapsed|0|||
156482872|NCT02132195|564860631|FG000|Rescue Therapy|Relapsed|0|||
156482873|NCT02132195|564860632|FG001|Rescue Therapy|Relapsed|0|||
156482874|NCT02132195|564860633|FG002|Rescue Therapy|Relapsed|7|||
156482875|NCT02132195|564860631|FG000|Rescue Therapy|Physician Decision|0|||
156482876|NCT02132195|564860632|FG001|Rescue Therapy|Physician Decision|0|||
156482877|NCT02132195|564860633|FG002|Rescue Therapy|Physician Decision|1|||
156482878|NCT02132195|564860631|FG000|Rescue Therapy|Withdrawal by Subject|0|||
156482879|NCT02132195|564860632|FG001|Rescue Therapy|Withdrawal by Subject|0|||
156482880|NCT02132195|564860633|FG002|Rescue Therapy|Withdrawal by Subject|1|||
156482881|NCT02132195|564860631|FG000|Rescue Therapy|Adverse Event|0|||
156482882|NCT02132195|564860632|FG001|Rescue Therapy|Adverse Event|0|||
156482883|NCT02132195|564860633|FG002|Rescue Therapy|Adverse Event|2|||
156482884|NCT02066389|564860635|FG000|Overall Study|Adverse Event|1|||
156482885|NCT02066389|564860636|FG001|Overall Study|Adverse Event|1|||
156482886|NCT02066389|564860637|FG002|Overall Study|Adverse Event|1|||
156482887|NCT02066389|564860638|FG003|Overall Study|Adverse Event|1|||
156482888|NCT02066389|564860639|FG004|Overall Study|Adverse Event|5|||
156544152|NCT04013529|565086313|FG001|Overall Study|Withdrawal by Subject|1|||
156350586|NCT02329730|564382100|FG001|Overall Study|Protocol Violation|0|||
156482889|NCT02066389|564860640|FG005|Overall Study|Adverse Event|1|||
156482890|NCT02066389|564860635|FG000|Overall Study|Withdrawal by Subject|4|||
156482891|NCT02066389|564860636|FG001|Overall Study|Withdrawal by Subject|0|||
156482892|NCT02066389|564860637|FG002|Overall Study|Withdrawal by Subject|5|||
156482893|NCT02066389|564860638|FG003|Overall Study|Withdrawal by Subject|1|||
156482894|NCT02066389|564860639|FG004|Overall Study|Withdrawal by Subject|1|||
156482895|NCT02066389|564860640|FG005|Overall Study|Withdrawal by Subject|2|||
156482896|NCT02066389|564860635|FG000|Overall Study|Lost to Follow-up|0|||
156482897|NCT02066389|564860636|FG001|Overall Study|Lost to Follow-up|0|||
156350587|NCT02329730|564382101|FG002|Overall Study|Protocol Violation|0|||
156350588|NCT02329730|564382102|FG003|Overall Study|Protocol Violation|0|||
156350589|NCT02329730|564382103|FG004|Overall Study|Protocol Violation|2|||
156350590|NCT02329730|564382104|FG005|Overall Study|Protocol Violation|2|||
156350591|NCT02329730|564382105|FG006|Overall Study|Protocol Violation|0|||
156350592|NCT02329730|564382106|FG007|Overall Study|Protocol Violation|0|||
156350593|NCT02329730|564382107|FG008|Overall Study|Protocol Violation|0|||
156350594|NCT02329730|564382108|FG009|Overall Study|Protocol Violation|0|||
156350595|NCT02329730|564382109|FG010|Overall Study|Protocol Violation|0|||
156350596|NCT02329730|564382110|FG011|Overall Study|Protocol Violation|0|||
156350597|NCT02329730|564382099|FG000|Overall Study|Withdrawal by Subject|0|||
156350598|NCT02329730|564382100|FG001|Overall Study|Withdrawal by Subject|0|||
156350599|NCT02329730|564382101|FG002|Overall Study|Withdrawal by Subject|0|||
156350600|NCT02329730|564382102|FG003|Overall Study|Withdrawal by Subject|0|||
156350601|NCT02329730|564382103|FG004|Overall Study|Withdrawal by Subject|1|||
156350602|NCT02329730|564382104|FG005|Overall Study|Withdrawal by Subject|0|||
156350603|NCT02329730|564382105|FG006|Overall Study|Withdrawal by Subject|1|||
156350604|NCT02329730|564382106|FG007|Overall Study|Withdrawal by Subject|1|||
156350605|NCT02329730|564382107|FG008|Overall Study|Withdrawal by Subject|1|||
156350606|NCT02329730|564382108|FG009|Overall Study|Withdrawal by Subject|1|||
156350607|NCT02329730|564382109|FG010|Overall Study|Withdrawal by Subject|0|||
156350608|NCT02329730|564382110|FG011|Overall Study|Withdrawal by Subject|0|||
156350609|NCT00463346|564382111|FG000|Overall Study|Withdrawal by Subject|3|||
156350610|NCT00463346|564382112|FG001|Overall Study|Withdrawal by Subject|3|||
156350611|NCT03641651|564382114|FG000|Overall Study|organizational issues at one study site|1|||
156350612|NCT01991067|564382116|FG000|Overall Study|Lost to Follow-up|6|||
156350613|NCT01991067|564382117|FG001|Overall Study|Lost to Follow-up|5|||
156350614|NCT00951665|564382119|FG000|Phase 1b|Adverse Event|2|||
156350615|NCT00951665|564382120|FG001|Phase 1b|Adverse Event|1|||
156350616|NCT00951665|564382121|FG002|Phase 1b|Adverse Event|0|||
156350617|NCT00951665|564382122|FG003|Phase 1b|Adverse Event|1|||
156350618|NCT00951665|564382123|FG004|Phase 1b|Adverse Event|0|||
156350619|NCT00951665|564382124|FG005|Phase 1b|Adverse Event|0|||
156350620|NCT00951665|564382119|FG000|Phase 1b|Death|1|||
156350621|NCT00951665|564382120|FG001|Phase 1b|Death|0|||
156350622|NCT00951665|564382121|FG002|Phase 1b|Death|2|||
156350623|NCT00951665|564382122|FG003|Phase 1b|Death|0|||
156350624|NCT00951665|564382123|FG004|Phase 1b|Death|0|||
156350625|NCT00951665|564382124|FG005|Phase 1b|Death|0|||
156350626|NCT00951665|564382119|FG000|Phase 1b|Physician Decision|4|||
156350627|NCT00951665|564382120|FG001|Phase 1b|Physician Decision|0|||
156350628|NCT00951665|564382121|FG002|Phase 1b|Physician Decision|1|||
156350629|NCT00951665|564382122|FG003|Phase 1b|Physician Decision|0|||
156350630|NCT00951665|564382123|FG004|Phase 1b|Physician Decision|0|||
156350631|NCT00951665|564382124|FG005|Phase 1b|Physician Decision|0|||
156350632|NCT00951665|564382119|FG000|Phase 1b|Withdrawal by Subject|0|||
156350633|NCT00951665|564382120|FG001|Phase 1b|Withdrawal by Subject|1|||
156350634|NCT00951665|564382121|FG002|Phase 1b|Withdrawal by Subject|0|||
156350635|NCT00951665|564382122|FG003|Phase 1b|Withdrawal by Subject|0|||
156350636|NCT00951665|564382123|FG004|Phase 1b|Withdrawal by Subject|0|||
156350637|NCT00951665|564382124|FG005|Phase 1b|Withdrawal by Subject|0|||
156350638|NCT00951665|564382119|FG000|Phase 1b|Disease Progression|13|||
156350639|NCT00951665|564382120|FG001|Phase 1b|Disease Progression|2|||
156350640|NCT00951665|564382121|FG002|Phase 1b|Disease Progression|14|||
156482898|NCT02066389|564860637|FG002|Overall Study|Lost to Follow-up|0|||
156482899|NCT02066389|564860638|FG003|Overall Study|Lost to Follow-up|1|||
156482900|NCT02066389|564860639|FG004|Overall Study|Lost to Follow-up|1|||
156482901|NCT02066389|564860640|FG005|Overall Study|Lost to Follow-up|1|||
156482902|NCT02066389|564860635|FG000|Overall Study|Randomized in Error|0|||
156350641|NCT00951665|564382122|FG003|Phase 1b|Disease Progression|0|||
156350642|NCT00951665|564382123|FG004|Phase 1b|Disease Progression|0|||
156350643|NCT00951665|564382124|FG005|Phase 1b|Disease Progression|0|||
156482903|NCT02066389|564860636|FG001|Overall Study|Randomized in Error|0|||
156482904|NCT02066389|564860637|FG002|Overall Study|Randomized in Error|0|||
156482905|NCT02066389|564860638|FG003|Overall Study|Randomized in Error|0|||
156350644|NCT00951665|564382119|FG000|Phase 1b|Protocol Violation|2|||
156350645|NCT00951665|564382120|FG001|Phase 1b|Protocol Violation|0|||
156350646|NCT00951665|564382121|FG002|Phase 1b|Protocol Violation|0|||
156350647|NCT00951665|564382122|FG003|Phase 1b|Protocol Violation|0|||
156350648|NCT00951665|564382123|FG004|Phase 1b|Protocol Violation|0|||
156350649|NCT00951665|564382124|FG005|Phase 1b|Protocol Violation|0|||
156350650|NCT00951665|564382119|FG000|Phase 2a|Adverse Event|0|||
156350651|NCT00951665|564382120|FG001|Phase 2a|Adverse Event|0|||
156482906|NCT02066389|564860639|FG004|Overall Study|Randomized in Error|0|||
156482907|NCT02066389|564860640|FG005|Overall Study|Randomized in Error|1|||
156350652|NCT00951665|564382121|FG002|Phase 2a|Adverse Event|0|||
156350653|NCT00951665|564382122|FG003|Phase 2a|Adverse Event|0|||
156350654|NCT00951665|564382123|FG004|Phase 2a|Adverse Event|2|||
156350655|NCT00951665|564382124|FG005|Phase 2a|Adverse Event|0|||
156350656|NCT00951665|564382119|FG000|Phase 2a|Death|0|||
156350657|NCT00951665|564382120|FG001|Phase 2a|Death|0|||
156350658|NCT00951665|564382121|FG002|Phase 2a|Death|0|||
156482908|NCT01468597|564860649|FG000|Overall Study|Found ineligible|17|||
156482909|NCT01468597|564860649|FG000|Overall Study|concomitant valves|12|||
156350659|NCT00951665|564382122|FG003|Phase 2a|Death|0|||
156350660|NCT00951665|564382123|FG004|Phase 2a|Death|1|||
156350661|NCT00951665|564382124|FG005|Phase 2a|Death|1|||
156350662|NCT00951665|564382119|FG000|Phase 2a|Lost to Follow-up|0|||
156350663|NCT00951665|564382120|FG001|Phase 2a|Lost to Follow-up|0|||
156350664|NCT00951665|564382121|FG002|Phase 2a|Lost to Follow-up|0|||
156350665|NCT00951665|564382122|FG003|Phase 2a|Lost to Follow-up|0|||
156350666|NCT00951665|564382123|FG004|Phase 2a|Lost to Follow-up|1|||
156350667|NCT00951665|564382124|FG005|Phase 2a|Lost to Follow-up|0|||
156350668|NCT00951665|564382119|FG000|Phase 2a|Physician Decision|0|||
156350669|NCT00951665|564382120|FG001|Phase 2a|Physician Decision|0|||
156350670|NCT00951665|564382121|FG002|Phase 2a|Physician Decision|0|||
156350671|NCT00951665|564382122|FG003|Phase 2a|Physician Decision|0|||
156350672|NCT00951665|564382123|FG004|Phase 2a|Physician Decision|0|||
156350673|NCT00951665|564382124|FG005|Phase 2a|Physician Decision|1|||
156350674|NCT00951665|564382119|FG000|Phase 2a|Withdrawal by Subject|0|||
156350675|NCT00951665|564382120|FG001|Phase 2a|Withdrawal by Subject|0|||
156350676|NCT00951665|564382121|FG002|Phase 2a|Withdrawal by Subject|0|||
156350677|NCT00951665|564382122|FG003|Phase 2a|Withdrawal by Subject|0|||
156350678|NCT00951665|564382123|FG004|Phase 2a|Withdrawal by Subject|2|||
156350679|NCT00951665|564382124|FG005|Phase 2a|Withdrawal by Subject|0|||
156350680|NCT00951665|564382119|FG000|Phase 2a|Disease Progression|0|||
156350681|NCT00951665|564382120|FG001|Phase 2a|Disease Progression|0|||
156350682|NCT00951665|564382121|FG002|Phase 2a|Disease Progression|0|||
156350683|NCT00951665|564382122|FG003|Phase 2a|Disease Progression|0|||
156350684|NCT00951665|564382123|FG004|Phase 2a|Disease Progression|6|||
156350685|NCT00951665|564382124|FG005|Phase 2a|Disease Progression|5|||
156350686|NCT00224055|564382125|FG000|Overall Study|Adverse Event|9|||
156350687|NCT00224055|564382126|FG001|Overall Study|Adverse Event|3|||
156350688|NCT00224055|564382125|FG000|Overall Study|Lost to Follow-up|1|||
156350689|NCT00224055|564382126|FG001|Overall Study|Lost to Follow-up|2|||
156350690|NCT00224055|564382125|FG000|Overall Study|Protocol Violation|1|||
156350691|NCT00224055|564382126|FG001|Overall Study|Protocol Violation|1|||
156350692|NCT00224055|564382125|FG000|Overall Study|Inclusion Violation|3|||
156350693|NCT00224055|564382126|FG001|Overall Study|Inclusion Violation|6|||
156350694|NCT00224055|564382125|FG000|Overall Study|Withdrawal by Subject|0|||
156350695|NCT00224055|564382126|FG001|Overall Study|Withdrawal by Subject|2|||
156350696|NCT00224055|564382125|FG000|Overall Study|Other|1|||
156350697|NCT00224055|564382126|FG001|Overall Study|Other|0|||
156350698|NCT02068443|564382127|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156350699|NCT02068443|564382128|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
156350700|NCT02068443|564382129|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
156350701|NCT02068443|564382127|FG000|Overall Study|Voluntary Withdrawal|4|||
156350702|NCT02068443|564382128|FG001|Overall Study|Voluntary Withdrawal|0|||
156350703|NCT02068443|564382129|FG002|Overall Study|Voluntary Withdrawal|1|||
156350704|NCT02068443|564382127|FG000|Overall Study|Lack of Efficacy|2|||
156350705|NCT02068443|564382128|FG001|Overall Study|Lack of Efficacy|1|||
156350706|NCT02068443|564382129|FG002|Overall Study|Lack of Efficacy|0|||
156350707|NCT02068443|564382127|FG000|Overall Study|Other Reason Not Specified|1|||
156350708|NCT02068443|564382128|FG001|Overall Study|Other Reason Not Specified|0|||
156350709|NCT02068443|564382129|FG002|Overall Study|Other Reason Not Specified|0|||
156350710|NCT00127712|564382132|FG000|Overall Study|Adverse Event|3|||
156350711|NCT00127712|564382133|FG001|Overall Study|Adverse Event|0|||
156350712|NCT00127712|564382132|FG000|Overall Study|Lack of GI access to continue|2|||
156350713|NCT00127712|564382133|FG001|Overall Study|Lack of GI access to continue|0|||
156350714|NCT00407563|564382136|FG000|Overall Study|Patient continues on treatment|1|||
156350715|NCT02450903|564382137|FG000|Overall Study|Adverse Event|3|||
156350716|NCT02450903|564382137|FG000|Overall Study|Progressive disease|15|||
156350717|NCT02450903|564382137|FG000|Overall Study|Switched to commercial drug|1|||
156350718|NCT02450903|564382137|FG000|Overall Study|Subject/guardian decision|1|||
156350719|NCT05126901|564382138|FG000|Overall Study|Withdrawal by Subject|1|||
156350720|NCT05126901|564382139|FG001|Overall Study|Withdrawal by Subject|1|||
156350721|NCT05126901|564382140|FG002|Overall Study|Withdrawal by Subject|4|||
156350722|NCT05126901|564382138|FG000|Overall Study|Adverse Event|0|||
156350723|NCT05126901|564382139|FG001|Overall Study|Adverse Event|0|||
156350724|NCT05126901|564382140|FG002|Overall Study|Adverse Event|1|||
156350725|NCT05126901|564382138|FG000|Overall Study|Lost to Follow-up|0|||
156350726|NCT05126901|564382139|FG001|Overall Study|Lost to Follow-up|2|||
156350727|NCT05126901|564382140|FG002|Overall Study|Lost to Follow-up|0|||
156350728|NCT01320085|564382141|FG000|Overall Study|Disease Progression|26|||
156350729|NCT01320085|564382142|FG001|Overall Study|Disease Progression|93|||
156350730|NCT01320085|564382143|FG002|Overall Study|Disease Progression|17|||
156350731|NCT01320085|564382141|FG000|Overall Study|Adverse Event|12|||
156350732|NCT01320085|564382142|FG001|Overall Study|Adverse Event|20|||
156350733|NCT01320085|564382143|FG002|Overall Study|Adverse Event|5|||
156350734|NCT01320085|564382141|FG000|Overall Study|Withdrawal by Subject|2|||
156350735|NCT01320085|564382142|FG001|Overall Study|Withdrawal by Subject|4|||
156350736|NCT01320085|564382143|FG002|Overall Study|Withdrawal by Subject|1|||
156350737|NCT01320085|564382141|FG000|Overall Study|Protocol Deviation|1|||
156350738|NCT01320085|564382142|FG001|Overall Study|Protocol Deviation|0|||
156350739|NCT01320085|564382143|FG002|Overall Study|Protocol Deviation|1|||
156350740|NCT01320085|564382141|FG000|Overall Study|Administrative problems|0|||
156350741|NCT01320085|564382142|FG001|Overall Study|Administrative problems|0|||
156350742|NCT01320085|564382143|FG002|Overall Study|Administrative problems|1|||
156350743|NCT05040386|564382144|FG000|Overall Study|Withdrawal by Subject|1|||
156350744|NCT05040386|564382145|FG001|Overall Study|Withdrawal by Subject|0|||
156350745|NCT05040386|564382146|FG002|Overall Study|Withdrawal by Subject|1|||
156350746|NCT05040386|564382147|FG003|Overall Study|Withdrawal by Subject|0|||
156350747|NCT05040386|564382144|FG000|Overall Study|Lost to Follow-up|0|||
156350748|NCT05040386|564382145|FG001|Overall Study|Lost to Follow-up|0|||
156350749|NCT05040386|564382146|FG002|Overall Study|Lost to Follow-up|1|||
156350750|NCT05040386|564382147|FG003|Overall Study|Lost to Follow-up|0|||
156350751|NCT01702454|564382148|FG000|Overall Study|Consent withdrawal|0|||
156350752|NCT01702454|564382149|FG001|Overall Study|Consent withdrawal|1|||
156350753|NCT01702454|564382148|FG000|Overall Study|Migrated/moved from study area|0|||
156350754|NCT01702454|564382149|FG001|Overall Study|Migrated/moved from study area|1|||
156350755|NCT01702454|564382148|FG000|Overall Study|Lost to Follow-up|3|||
156350756|NCT01702454|564382149|FG001|Overall Study|Lost to Follow-up|6|||
156350757|NCT02282020|564382150|FG000|Overall Study|Objective Disease Progression|128|||
156350758|NCT02282020|564382151|FG001|Overall Study|Objective Disease Progression|30|||
156350759|NCT02282020|564382150|FG000|Overall Study|Adverse Event|18|||
156350760|NCT02282020|564382151|FG001|Overall Study|Adverse Event|15|||
156350761|NCT02282020|564382150|FG000|Overall Study|Withdrawal by Subject|7|||
156350762|NCT02282020|564382151|FG001|Overall Study|Withdrawal by Subject|10|||
156350763|NCT02282020|564382150|FG000|Overall Study|Miscellaneous|5|||
156350764|NCT02282020|564382151|FG001|Overall Study|Miscellaneous|19|||
156482910|NCT01468597|564860649|FG000|Overall Study|off-pump CABG|1|||
156482911|NCT01468597|564860649|FG000|Overall Study|no platelet function data|5|||
156482912|NCT02561195|564860651|FG000|Vaccination 1 to 3|Adverse Event|4|||
156482913|NCT02561195|564860652|FG001|Vaccination 1 to 3|Adverse Event|5|||
156482914|NCT02561195|564860653|FG002|Vaccination 1 to 3|Adverse Event|0|||
156482915|NCT02561195|564860654|FG003|Vaccination 1 to 3|Adverse Event|3|||
156482916|NCT02561195|564860655|FG004|Vaccination 1 to 3|Adverse Event|4|||
156350765|NCT02282020|564382150|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
156350766|NCT02282020|564382151|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
156350767|NCT02282020|564382150|FG000|Overall Study|Developed Discontinuation Criteria|0|||
156350768|NCT02282020|564382151|FG001|Overall Study|Developed Discontinuation Criteria|2|||
156350769|NCT02282020|564382150|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
156350770|NCT02282020|564382151|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
156350771|NCT00249444|564382152|FG000|Overall Study|Lost to Follow-up|2|||
156350772|NCT00249444|564382153|FG001|Overall Study|Lost to Follow-up|2|||
156350773|NCT00249444|564382152|FG000|Overall Study|non-compliant|9|||
156350774|NCT00249444|564382153|FG001|Overall Study|non-compliant|11|||
156350775|NCT00249444|564382152|FG000|Overall Study|Adverse Event|1|||
156350776|NCT00249444|564382153|FG001|Overall Study|Adverse Event|1|||
156350777|NCT00249444|564382152|FG000|Overall Study|life event|0|||
156350778|NCT00249444|564382153|FG001|Overall Study|life event|1|||
156350779|NCT01499667|564382154|FG000|Overall Study|administrative problems|4|||
156350780|NCT01499667|564382155|FG001|Overall Study|administrative problems|5|||
156350781|NCT01499667|564382156|FG002|Overall Study|administrative problems|5|||
156350782|NCT01499667|564382154|FG000|Overall Study|Protocol Violation|1|||
156350783|NCT01499667|564382155|FG001|Overall Study|Protocol Violation|3|||
156350784|NCT01499667|564382156|FG002|Overall Study|Protocol Violation|2|||
156350785|NCT01499667|564382154|FG000|Overall Study|Adverse Event|0|||
156350786|NCT01499667|564382155|FG001|Overall Study|Adverse Event|2|||
156350787|NCT01499667|564382156|FG002|Overall Study|Adverse Event|2|||
156350788|NCT01499667|564382154|FG000|Overall Study|Withdrawal by Subject|2|||
156350789|NCT01499667|564382155|FG001|Overall Study|Withdrawal by Subject|1|||
156350790|NCT01499667|564382156|FG002|Overall Study|Withdrawal by Subject|1|||
156350791|NCT01499667|564382154|FG000|Overall Study|Lack of Efficacy|2|||
156350792|NCT01499667|564382155|FG001|Overall Study|Lack of Efficacy|0|||
156350793|NCT01499667|564382156|FG002|Overall Study|Lack of Efficacy|0|||
156350794|NCT00759863|564382157|FG000|Overall Study|Death, moved, or lost contact|20|||
156350795|NCT00759863|564382158|FG001|Overall Study|Death, moved, or lost contact|18|||
156350796|NCT04273217|564382159|FG000|Overall Study|Lost to Follow-up|0|||
156350797|NCT04273217|564382160|FG001|Overall Study|Lost to Follow-up|0|||
156350798|NCT04273217|564382161|FG002|Overall Study|Lost to Follow-up|0|||
156350799|NCT04273217|564382162|FG003|Overall Study|Lost to Follow-up|0|||
156350800|NCT04273217|564382163|FG004|Overall Study|Lost to Follow-up|0|||
156350801|NCT04273217|564382164|FG005|Overall Study|Lost to Follow-up|1|||
156350802|NCT04273217|564382159|FG000|Overall Study|Participant non-compliance|0|||
156350803|NCT04273217|564382160|FG001|Overall Study|Participant non-compliance|0|||
156350804|NCT04273217|564382161|FG002|Overall Study|Participant non-compliance|0|||
156350805|NCT04273217|564382162|FG003|Overall Study|Participant non-compliance|0|||
156350806|NCT04273217|564382163|FG004|Overall Study|Participant non-compliance|1|||
156350807|NCT04273217|564382164|FG005|Overall Study|Participant non-compliance|0|||
156350808|NCT04273217|564382159|FG000|Overall Study|Positive urine drug screen|1|||
156350809|NCT04273217|564382160|FG001|Overall Study|Positive urine drug screen|0|||
156350810|NCT04273217|564382161|FG002|Overall Study|Positive urine drug screen|1|||
156482917|NCT02561195|564860656|FG005|Vaccination 1 to 3|Adverse Event|0|||
156482918|NCT02561195|564860657|FG006|Vaccination 1 to 3|Adverse Event|0|||
156482919|NCT02561195|564860658|FG007|Vaccination 1 to 3|Adverse Event|0|||
156350811|NCT04273217|564382162|FG003|Overall Study|Positive urine drug screen|0|||
156482920|NCT02561195|564860659|FG008|Vaccination 1 to 3|Adverse Event|0|||
156482921|NCT02561195|564860660|FG009|Vaccination 1 to 3|Adverse Event|0|||
156482922|NCT02561195|564860661|FG010|Vaccination 1 to 3|Adverse Event|0|||
156482923|NCT02561195|564860662|FG011|Vaccination 1 to 3|Adverse Event|0|||
156482924|NCT02561195|564860663|FG012|Vaccination 1 to 3|Adverse Event|0|||
156482925|NCT02561195|564860664|FG013|Vaccination 1 to 3|Adverse Event|0|||
156482926|NCT02561195|564860651|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
156482927|NCT02561195|564860652|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
156482928|NCT02561195|564860653|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
156482929|NCT02561195|564860654|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
156482930|NCT02561195|564860655|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
156482931|NCT02561195|564860656|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
156482932|NCT02561195|564860657|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
156482933|NCT02561195|564860658|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
156482934|NCT02561195|564860659|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
156482935|NCT02561195|564860660|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
156482936|NCT02561195|564860661|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
156482937|NCT02561195|564860662|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
156482938|NCT02561195|564860663|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
156482939|NCT02561195|564860664|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
156482940|NCT02561195|564860651|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482941|NCT02561195|564860652|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
156482942|NCT02561195|564860653|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482943|NCT02561195|564860654|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
156482944|NCT02561195|564860655|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
156482945|NCT02561195|564860656|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
156482946|NCT02561195|564860657|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482947|NCT02561195|564860658|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482948|NCT02561195|564860659|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482949|NCT02561195|564860660|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482950|NCT02561195|564860661|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482951|NCT02561195|564860662|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482952|NCT02561195|564860663|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482953|NCT02561195|564860664|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
156482954|NCT02561195|564860651|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
156482955|NCT02561195|564860652|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
156482956|NCT02561195|564860653|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
156482957|NCT02561195|564860654|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
156482958|NCT02561195|564860655|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
156482959|NCT02561195|564860656|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
156482960|NCT02561195|564860657|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
156482961|NCT02561195|564860658|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
156482962|NCT02561195|564860659|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
156482963|NCT02561195|564860660|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
156482964|NCT02561195|564860661|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
156482965|NCT02561195|564860662|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
156482966|NCT02561195|564860663|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
156482967|NCT02561195|564860664|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
156482968|NCT02561195|564860651|FG000|Vaccination 1 to 3|Other|7|||
156482969|NCT02561195|564860652|FG001|Vaccination 1 to 3|Other|3|||
156482970|NCT02561195|564860653|FG002|Vaccination 1 to 3|Other|1|||
156482971|NCT02561195|564860654|FG003|Vaccination 1 to 3|Other|7|||
156482972|NCT02561195|564860655|FG004|Vaccination 1 to 3|Other|5|||
156482973|NCT02561195|564860656|FG005|Vaccination 1 to 3|Other|1|||
156482974|NCT02561195|564860657|FG006|Vaccination 1 to 3|Other|0|||
156482975|NCT02561195|564860658|FG007|Vaccination 1 to 3|Other|0|||
156482976|NCT02561195|564860659|FG008|Vaccination 1 to 3|Other|0|||
156482977|NCT02561195|564860660|FG009|Vaccination 1 to 3|Other|0|||
156482978|NCT02561195|564860661|FG010|Vaccination 1 to 3|Other|0|||
156482979|NCT02561195|564860662|FG011|Vaccination 1 to 3|Other|0|||
156482980|NCT02561195|564860663|FG012|Vaccination 1 to 3|Other|0|||
156482981|NCT02561195|564860664|FG013|Vaccination 1 to 3|Other|0|||
156482982|NCT02561195|564860651|FG000|Vaccination 1 to 3|Protocol Violation|1|||
156482983|NCT02561195|564860652|FG001|Vaccination 1 to 3|Protocol Violation|0|||
156482984|NCT02561195|564860653|FG002|Vaccination 1 to 3|Protocol Violation|1|||
156482985|NCT02561195|564860654|FG003|Vaccination 1 to 3|Protocol Violation|2|||
156544153|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
156482986|NCT02561195|564860655|FG004|Vaccination 1 to 3|Protocol Violation|5|||
156482987|NCT02561195|564860656|FG005|Vaccination 1 to 3|Protocol Violation|2|||
156482988|NCT02561195|564860657|FG006|Vaccination 1 to 3|Protocol Violation|0|||
156482989|NCT02561195|564860658|FG007|Vaccination 1 to 3|Protocol Violation|0|||
156482990|NCT02561195|564860659|FG008|Vaccination 1 to 3|Protocol Violation|0|||
156350812|NCT04273217|564382163|FG004|Overall Study|Positive urine drug screen|0|||
156350813|NCT04273217|564382164|FG005|Overall Study|Positive urine drug screen|1|||
156482991|NCT02561195|564860660|FG009|Vaccination 1 to 3|Protocol Violation|0|||
156482992|NCT02561195|564860661|FG010|Vaccination 1 to 3|Protocol Violation|0|||
156350814|NCT04532099|564382165|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
156350815|NCT04532099|564382166|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
156544154|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
156544155|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
156544156|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
156350816|NCT04532099|564382167|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
156350817|NCT05492942|564382168|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
156350818|NCT05492942|564382169|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
156350819|NCT05492942|564382170|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
156350820|NCT05492942|564382171|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
156350821|NCT03103919|564382174|FG000|Overall Study|Adverse Event|2|||
156350822|NCT03103919|564382175|FG001|Overall Study|Adverse Event|2|||
156350823|NCT04876274|564382176|FG000|Overall Study|Lost to Follow-up|9|||
156350824|NCT04876274|564382177|FG001|Overall Study|Lost to Follow-up|12|||
156565219|NCT02660580|565157656|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
156482993|NCT02561195|564860662|FG011|Vaccination 1 to 3|Protocol Violation|0|||
156482994|NCT02561195|564860663|FG012|Vaccination 1 to 3|Protocol Violation|0|||
156350825|NCT03527966|564382178|FG000|Overall Study|Lost to Follow-up|3|||
156350826|NCT03527966|564382179|FG001|Overall Study|Lost to Follow-up|0|||
156350827|NCT01948050|564382180|FG000|Overall Study|Withdrawal by Subject|0|||
156350828|NCT01948050|564382181|FG001|Overall Study|Withdrawal by Subject|1|||
156350829|NCT02005445|564382182|FG000|Overall Study|Dual study enrollment|0|||
156350830|NCT02005445|564382183|FG001|Overall Study|Dual study enrollment|1|||
156350831|NCT00333866|564382186|FG000|Overall Study|Adverse Event|23|||
156350832|NCT00333866|564382187|FG001|Overall Study|Adverse Event|37|||
156350833|NCT00333866|564382188|FG002|Overall Study|Adverse Event|38|||
156350834|NCT00333866|564382189|FG003|Overall Study|Adverse Event|47|||
156350835|NCT00333866|564382186|FG000|Overall Study|Other|3|||
156350836|NCT00333866|564382187|FG001|Overall Study|Other|2|||
156350837|NCT00333866|564382188|FG002|Overall Study|Other|2|||
156350838|NCT00333866|564382189|FG003|Overall Study|Other|2|||
156350839|NCT00333866|564382186|FG000|Overall Study|Lack of Efficacy|8|||
156350840|NCT00333866|564382187|FG001|Overall Study|Lack of Efficacy|6|||
156350841|NCT00333866|564382188|FG002|Overall Study|Lack of Efficacy|3|||
156350842|NCT00333866|564382189|FG003|Overall Study|Lack of Efficacy|5|||
156350843|NCT00333866|564382186|FG000|Overall Study|Lost to Follow-up|1|||
156350844|NCT00333866|564382187|FG001|Overall Study|Lost to Follow-up|2|||
156350845|NCT00333866|564382188|FG002|Overall Study|Lost to Follow-up|2|||
156350846|NCT00333866|564382189|FG003|Overall Study|Lost to Follow-up|2|||
156350847|NCT00333866|564382186|FG000|Overall Study|Withdrawal by Subject|8|||
156350848|NCT00333866|564382187|FG001|Overall Study|Withdrawal by Subject|14|||
156350849|NCT00333866|564382188|FG002|Overall Study|Withdrawal by Subject|4|||
156350850|NCT00333866|564382189|FG003|Overall Study|Withdrawal by Subject|9|||
156350851|NCT00333866|564382186|FG000|Overall Study|Randomized but not Treated|5|||
156350852|NCT00333866|564382187|FG001|Overall Study|Randomized but not Treated|3|||
156350853|NCT00333866|564382188|FG002|Overall Study|Randomized but not Treated|2|||
156350854|NCT00333866|564382189|FG003|Overall Study|Randomized but not Treated|1|||
156350855|NCT06073119|564382190|FG000|Overall Study|Adverse Event|1|||
156350856|NCT06073119|564382191|FG001|Overall Study|Adverse Event|3|||
156350857|NCT06073119|564382192|FG002|Overall Study|Adverse Event|0|||
156350858|NCT06073119|564382193|FG003|Overall Study|Adverse Event|0|||
156350859|NCT06073119|564382194|FG004|Overall Study|Adverse Event|1|||
156350860|NCT06073119|564382195|FG005|Overall Study|Adverse Event|0|||
156350861|NCT06073119|564382190|FG000|Overall Study|Non-compliance with study schedule|1|||
156350862|NCT06073119|564382191|FG001|Overall Study|Non-compliance with study schedule|0|||
156350863|NCT06073119|564382192|FG002|Overall Study|Non-compliance with study schedule|0|||
156350864|NCT06073119|564382193|FG003|Overall Study|Non-compliance with study schedule|0|||
156350865|NCT06073119|564382194|FG004|Overall Study|Non-compliance with study schedule|1|||
156350866|NCT06073119|564382195|FG005|Overall Study|Non-compliance with study schedule|0|||
156350867|NCT06073119|564382190|FG000|Overall Study|Withdrawal by Subject|4|||
156350868|NCT06073119|564382191|FG001|Overall Study|Withdrawal by Subject|4|||
156350869|NCT06073119|564382192|FG002|Overall Study|Withdrawal by Subject|3|||
156350870|NCT06073119|564382193|FG003|Overall Study|Withdrawal by Subject|5|||
156350871|NCT06073119|564382194|FG004|Overall Study|Withdrawal by Subject|3|||
156350872|NCT06073119|564382195|FG005|Overall Study|Withdrawal by Subject|1|||
156350873|NCT06073119|564382190|FG000|Overall Study|Other|2|||
156350874|NCT06073119|564382191|FG001|Overall Study|Other|4|||
156350875|NCT06073119|564382192|FG002|Overall Study|Other|1|||
156350876|NCT06073119|564382193|FG003|Overall Study|Other|0|||
156350877|NCT06073119|564382194|FG004|Overall Study|Other|1|||
156350878|NCT06073119|564382195|FG005|Overall Study|Other|0|||
156350879|NCT02393547|564382196|FG000|Overall Study|Adverse Event|2|||
156350880|NCT02393547|564382196|FG000|Overall Study|Withdrawal by Subject|3|||
156350881|NCT02393547|564382196|FG000|Overall Study|Lost to Follow-up|1|||
156350882|NCT01907815|564382197|FG000|Overall Study|Withdrawal by Subject|1|||
156350883|NCT01907815|564382198|FG001|Overall Study|Withdrawal by Subject|0|||
156350884|NCT00514540|564382199|FG000|First-Line Chemo|Withdrawal by Subject|1|||
156350885|NCT00514540|564382199|FG000|First-Line Chemo|Protocol Violation|7|||
156350886|NCT00514540|564382199|FG000|Second-Line|Physician/Patient Decision|31|||
156350887|NCT05185089|564382200|FG000|First Intervention (4 weeks)|Adverse Event|0|||
156350888|NCT05185089|564382201|FG001|First Intervention (4 weeks)|Adverse Event|0|||
156350889|NCT05185089|564382202|FG002|First Intervention (4 weeks)|Adverse Event|0|||
156350890|NCT05185089|564382203|FG003|First Intervention (4 weeks)|Adverse Event|1|||
156350891|NCT05185089|564382200|FG000|Second Intervention (4 weeks)|Death|0|||
156350892|NCT05185089|564382201|FG001|Second Intervention (4 weeks)|Death|1|||
156350893|NCT05185089|564382202|FG002|Second Intervention (4 weeks)|Death|0|||
156350894|NCT05185089|564382203|FG003|Second Intervention (4 weeks)|Death|0|||
156350895|NCT05185089|564382200|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
156350896|NCT05185089|564382201|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
156350897|NCT05185089|564382202|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
156350898|NCT05185089|564382203|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
156350899|NCT04997161|564382211|FG000|Overall Study|Study terminated by sponsor|3|||
156350900|NCT02730455|564382212|FG000|Overall Study|Death|5|||
156350901|NCT02730455|564382213|FG001|Overall Study|Death|6|||
156350902|NCT02730455|564382214|FG002|Overall Study|Death|4|||
156482995|NCT02561195|564860664|FG013|Vaccination 1 to 3|Protocol Violation|0|||
156482996|NCT02561195|564860651|FG000|Vaccination 1 to 3|Death|2|||
156482997|NCT02561195|564860652|FG001|Vaccination 1 to 3|Death|1|||
156482998|NCT02561195|564860653|FG002|Vaccination 1 to 3|Death|0|||
156482999|NCT02561195|564860654|FG003|Vaccination 1 to 3|Death|2|||
156483000|NCT02561195|564860655|FG004|Vaccination 1 to 3|Death|0|||
156483001|NCT02561195|564860656|FG005|Vaccination 1 to 3|Death|0|||
156483002|NCT02561195|564860657|FG006|Vaccination 1 to 3|Death|0|||
156483003|NCT02561195|564860658|FG007|Vaccination 1 to 3|Death|0|||
156483004|NCT02561195|564860659|FG008|Vaccination 1 to 3|Death|0|||
156483005|NCT02561195|564860660|FG009|Vaccination 1 to 3|Death|0|||
156483006|NCT02561195|564860661|FG010|Vaccination 1 to 3|Death|0|||
156483007|NCT02561195|564860662|FG011|Vaccination 1 to 3|Death|0|||
156483008|NCT02561195|564860663|FG012|Vaccination 1 to 3|Death|0|||
156483009|NCT02561195|564860664|FG013|Vaccination 1 to 3|Death|0|||
156483010|NCT02561195|564860651|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
156483011|NCT02561195|564860652|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
156483012|NCT02561195|564860653|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
156483013|NCT02561195|564860654|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
156483014|NCT02561195|564860655|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
156483015|NCT02561195|564860656|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483016|NCT02561195|564860657|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483017|NCT02561195|564860658|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483018|NCT02561195|564860659|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483019|NCT02561195|564860660|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483020|NCT02561195|564860661|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483021|NCT02561195|564860662|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483022|NCT02561195|564860663|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483023|NCT02561195|564860664|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
156483024|NCT02561195|564860651|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
156483025|NCT02561195|564860652|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
156483026|NCT02561195|564860653|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
156483027|NCT02561195|564860654|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
156483028|NCT02561195|564860655|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
156483029|NCT02561195|564860656|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
156483030|NCT02561195|564860657|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
156483031|NCT02561195|564860658|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
156483032|NCT02561195|564860659|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
156483033|NCT02561195|564860660|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
156483034|NCT02561195|564860661|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
156483035|NCT02561195|564860662|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
156483036|NCT02561195|564860663|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
156483037|NCT02561195|564860664|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
156483038|NCT02561195|564860651|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483039|NCT02561195|564860652|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483040|NCT02561195|564860653|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483041|NCT02561195|564860654|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483042|NCT02561195|564860655|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483043|NCT02561195|564860656|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483044|NCT02561195|564860657|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483045|NCT02561195|564860658|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483046|NCT02561195|564860659|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
156483047|NCT02561195|564860660|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
156483048|NCT02561195|564860661|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
156483049|NCT02561195|564860662|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
156483050|NCT02561195|564860663|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
156483051|NCT02561195|564860664|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
156483052|NCT02561195|564860651|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
156483053|NCT02561195|564860652|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
156483054|NCT02561195|564860653|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
156544157|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
156544158|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
156483055|NCT02561195|564860654|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
156483056|NCT02561195|564860655|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
156483057|NCT02561195|564860656|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
156350903|NCT02730455|564382212|FG000|Overall Study|Consent withdrawn|2|||
156350904|NCT02730455|564382213|FG001|Overall Study|Consent withdrawn|4|||
156350905|NCT02730455|564382214|FG002|Overall Study|Consent withdrawn|1|||
156350906|NCT02730455|564382212|FG000|Overall Study|Lost to Follow-up|3|||
156350907|NCT02730455|564382213|FG001|Overall Study|Lost to Follow-up|1|||
156350908|NCT02730455|564382214|FG002|Overall Study|Lost to Follow-up|4|||
156350909|NCT02730455|564382212|FG000|Overall Study|Other|1|||
156350910|NCT02730455|564382213|FG001|Overall Study|Other|1|||
156350911|NCT02730455|564382214|FG002|Overall Study|Other|2|||
156350912|NCT02730455|564382212|FG000|Overall Study|Other|2|||
156350913|NCT02730455|564382213|FG001|Overall Study|Other|2|||
156350914|NCT02730455|564382214|FG002|Overall Study|Other|0|||
156350915|NCT00996307|564382223|FG000|Overall Study|Adverse Event|0|||
156350916|NCT00996307|564382224|FG001|Overall Study|Adverse Event|1|||
156350917|NCT00996307|564382225|FG002|Overall Study|Adverse Event|0|||
156350918|NCT00996307|564382226|FG003|Overall Study|Adverse Event|0|||
156350919|NCT00996307|564382223|FG000|Overall Study|Withdrawal by Subject|3|||
156350920|NCT00996307|564382224|FG001|Overall Study|Withdrawal by Subject|2|||
156350921|NCT00996307|564382225|FG002|Overall Study|Withdrawal by Subject|5|||
156350922|NCT00996307|564382226|FG003|Overall Study|Withdrawal by Subject|5|||
156350923|NCT00996307|564382223|FG000|Overall Study|Lost to Follow-up|13|||
156350924|NCT00996307|564382224|FG001|Overall Study|Lost to Follow-up|13|||
156350925|NCT00996307|564382225|FG002|Overall Study|Lost to Follow-up|7|||
156350926|NCT00996307|564382226|FG003|Overall Study|Lost to Follow-up|15|||
156350927|NCT00996307|564382223|FG000|Overall Study|Administrative reason|0|||
156350928|NCT00996307|564382224|FG001|Overall Study|Administrative reason|1|||
156350929|NCT00996307|564382225|FG002|Overall Study|Administrative reason|0|||
156350930|NCT00996307|564382226|FG003|Overall Study|Administrative reason|0|||
156350931|NCT00996307|564382223|FG000|Overall Study|Unable to classify|4|||
156350932|NCT00996307|564382224|FG001|Overall Study|Unable to classify|0|||
156350933|NCT00996307|564382225|FG002|Overall Study|Unable to classify|2|||
156350934|NCT00996307|564382226|FG003|Overall Study|Unable to classify|1|||
156350935|NCT00001723|564382227|FG000|Overall Study|Lack of Efficacy|6|||
156350936|NCT00001723|564382228|FG001|Overall Study|Lack of Efficacy|7|||
156350937|NCT00001723|564382227|FG000|Overall Study|Lack of family interest|4|||
156350938|NCT00001723|564382228|FG001|Overall Study|Lack of family interest|5|||
156350939|NCT00001723|564382227|FG000|Overall Study|Lost to Follow-up|2|||
156350940|NCT00001723|564382228|FG001|Overall Study|Lost to Follow-up|2|||
156350941|NCT00001723|564382227|FG000|Overall Study|medication intolerance|1|||
156350942|NCT00001723|564382228|FG001|Overall Study|medication intolerance|2|||
156350943|NCT01867021|564382229|FG000|Overall Study|Adverse Event|0|||
156350944|NCT01867021|564382230|FG001|Overall Study|Adverse Event|1|||
156350945|NCT01867021|564382229|FG000|Overall Study|Not Eligible|0|||
156350946|NCT01867021|564382230|FG001|Overall Study|Not Eligible|1|||
156350947|NCT01867021|564382229|FG000|Overall Study|Death|1|||
156350948|NCT01867021|564382230|FG001|Overall Study|Death|0|||
156350949|NCT01867021|564382229|FG000|Overall Study|Lost to Follow-up|0|||
156350950|NCT01867021|564382230|FG001|Overall Study|Lost to Follow-up|2|||
156350951|NCT01867021|564382229|FG000|Overall Study|Withdrawal by Subject|1|||
156350952|NCT01867021|564382230|FG001|Overall Study|Withdrawal by Subject|6|||
156350953|NCT01712490|564382231|FG000|Overall Study|Ongoing|601|||
156350954|NCT01712490|564382232|FG001|Overall Study|Ongoing|586|||
156350955|NCT01712490|564382231|FG000|Overall Study|Other|11|||
156350956|NCT01712490|564382232|FG001|Overall Study|Other|11|||
156350957|NCT01712490|564382231|FG000|Overall Study|Withdrawal by Subject|36|||
156350958|NCT01712490|564382232|FG001|Overall Study|Withdrawal by Subject|44|||
156350959|NCT01712490|564382231|FG000|Overall Study|Lost to Follow-up|16|||
156350960|NCT01712490|564382232|FG001|Overall Study|Lost to Follow-up|29|||
156350961|NCT01862874|564382235|FG000|Overall Study|Randomized not treated|1|||
156350962|NCT01862874|564382236|FG001|Overall Study|Randomized not treated|0|||
156350963|NCT01862874|564382235|FG000|Overall Study|Adverse Event|0|||
156350964|NCT01862874|564382236|FG001|Overall Study|Adverse Event|3|||
156350965|NCT01862874|564382235|FG000|Overall Study|Lost to Follow-up|26|||
156350966|NCT01862874|564382236|FG001|Overall Study|Lost to Follow-up|29|||
156350967|NCT01862874|564382235|FG000|Overall Study|Physician Decision|5|||
156350968|NCT01862874|564382236|FG001|Overall Study|Physician Decision|3|||
156350969|NCT01862874|564382235|FG000|Overall Study|Withdrawn by parent/guardian|1|||
156350970|NCT01862874|564382236|FG001|Overall Study|Withdrawn by parent/guardian|1|||
156483058|NCT02561195|564860657|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
156350971|NCT01862874|564382235|FG000|Overall Study|Withdrawal by Subject|46|||
156350972|NCT01862874|564382236|FG001|Overall Study|Withdrawal by Subject|40|||
156350973|NCT01862874|564382235|FG000|Overall Study|Death|0|||
156350974|NCT01862874|564382236|FG001|Overall Study|Death|1|||
156350975|NCT01782495|564382242|FG000|Overall Study|Adverse Event|0|||
156350976|NCT01782495|564382243|FG001|Overall Study|Adverse Event|0|||
156350977|NCT01782495|564382244|FG002|Overall Study|Adverse Event|0|||
156350978|NCT01782495|564382245|FG003|Overall Study|Adverse Event|0|||
156350979|NCT01782495|564382246|FG004|Overall Study|Adverse Event|0|||
156350980|NCT01782495|564382247|FG005|Overall Study|Adverse Event|0|||
156350981|NCT01782495|564382248|FG006|Overall Study|Adverse Event|0|||
156483059|NCT02561195|564860658|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
156483060|NCT02561195|564860659|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
156483061|NCT02561195|564860660|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
156483062|NCT02561195|564860661|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
156350982|NCT01782495|564382249|FG007|Overall Study|Adverse Event|2|||
156350983|NCT01782495|564382250|FG008|Overall Study|Adverse Event|0|||
156350984|NCT01782495|564382251|FG009|Overall Study|Adverse Event|0|||
156350985|NCT01782495|564382252|FG010|Overall Study|Adverse Event|0|||
156350986|NCT01782495|564382242|FG000|Overall Study|Withdrew Consent|0|||
156350987|NCT01782495|564382243|FG001|Overall Study|Withdrew Consent|1|||
156350988|NCT01782495|564382244|FG002|Overall Study|Withdrew Consent|0|||
156350989|NCT01782495|564382245|FG003|Overall Study|Withdrew Consent|0|||
156350990|NCT01782495|564382246|FG004|Overall Study|Withdrew Consent|0|||
156350991|NCT01782495|564382247|FG005|Overall Study|Withdrew Consent|0|||
156350992|NCT01782495|564382248|FG006|Overall Study|Withdrew Consent|0|||
156350993|NCT01782495|564382249|FG007|Overall Study|Withdrew Consent|1|||
156483063|NCT02561195|564860662|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
156350994|NCT01782495|564382250|FG008|Overall Study|Withdrew Consent|0|||
156483064|NCT02561195|564860663|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
156483065|NCT02561195|564860664|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
156483066|NCT02561195|564860651|FG000|Extension Stage (Vaccination 4)|Death|0|||
156483067|NCT02561195|564860652|FG001|Extension Stage (Vaccination 4)|Death|0|||
156483068|NCT02561195|564860653|FG002|Extension Stage (Vaccination 4)|Death|0|||
156483069|NCT02561195|564860654|FG003|Extension Stage (Vaccination 4)|Death|0|||
156483070|NCT02561195|564860655|FG004|Extension Stage (Vaccination 4)|Death|0|||
156483071|NCT02561195|564860656|FG005|Extension Stage (Vaccination 4)|Death|0|||
156483072|NCT02561195|564860657|FG006|Extension Stage (Vaccination 4)|Death|0|||
156483073|NCT02561195|564860658|FG007|Extension Stage (Vaccination 4)|Death|0|||
156483074|NCT02561195|564860659|FG008|Extension Stage (Vaccination 4)|Death|0|||
156483075|NCT02561195|564860660|FG009|Extension Stage (Vaccination 4)|Death|1|||
156483076|NCT02561195|564860661|FG010|Extension Stage (Vaccination 4)|Death|0|||
156483077|NCT02561195|564860662|FG011|Extension Stage (Vaccination 4)|Death|0|||
156483078|NCT02561195|564860663|FG012|Extension Stage (Vaccination 4)|Death|0|||
156483079|NCT02561195|564860664|FG013|Extension Stage (Vaccination 4)|Death|0|||
156483080|NCT02561195|564860651|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
156483081|NCT02561195|564860652|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
156483082|NCT02561195|564860653|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
156483083|NCT02561195|564860654|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
156483084|NCT02561195|564860655|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
156483085|NCT02561195|564860656|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
156483086|NCT02561195|564860657|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
156483087|NCT02561195|564860658|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
156483088|NCT02561195|564860659|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
156483089|NCT02561195|564860660|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
156483090|NCT02561195|564860661|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
156483091|NCT02561195|564860662|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
156483092|NCT02561195|564860663|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
156483093|NCT02561195|564860664|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
156483094|NCT02561195|564860651|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483095|NCT02561195|564860652|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483096|NCT02561195|564860653|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483097|NCT02561195|564860654|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483098|NCT02561195|564860655|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483099|NCT02561195|564860656|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483100|NCT02561195|564860657|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483101|NCT02561195|564860658|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483102|NCT02561195|564860659|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483103|NCT02561195|564860660|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483104|NCT02561195|564860661|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
156483105|NCT02561195|564860662|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
156483106|NCT02561195|564860663|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
156483107|NCT02561195|564860664|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
156483108|NCT02561195|564860651|FG000|Extension Stage (Vaccination 4)|Other|0|||
156483109|NCT02561195|564860652|FG001|Extension Stage (Vaccination 4)|Other|0|||
156483110|NCT02561195|564860653|FG002|Extension Stage (Vaccination 4)|Other|0|||
156483111|NCT02561195|564860654|FG003|Extension Stage (Vaccination 4)|Other|0|||
156483112|NCT02561195|564860655|FG004|Extension Stage (Vaccination 4)|Other|0|||
156483113|NCT02561195|564860656|FG005|Extension Stage (Vaccination 4)|Other|0|||
156483114|NCT02561195|564860657|FG006|Extension Stage (Vaccination 4)|Other|0|||
156483115|NCT02561195|564860658|FG007|Extension Stage (Vaccination 4)|Other|0|||
156483116|NCT02561195|564860659|FG008|Extension Stage (Vaccination 4)|Other|0|||
156483117|NCT02561195|564860660|FG009|Extension Stage (Vaccination 4)|Other|0|||
156483118|NCT02561195|564860661|FG010|Extension Stage (Vaccination 4)|Other|2|||
156483119|NCT02561195|564860662|FG011|Extension Stage (Vaccination 4)|Other|2|||
156483120|NCT02561195|564860663|FG012|Extension Stage (Vaccination 4)|Other|1|||
156483121|NCT02561195|564860664|FG013|Extension Stage (Vaccination 4)|Other|0|||
156483122|NCT02561195|564860651|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483123|NCT02561195|564860652|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483124|NCT02561195|564860653|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483125|NCT02561195|564860654|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483126|NCT02561195|564860655|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483127|NCT02561195|564860656|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483128|NCT02561195|564860657|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
156483129|NCT02561195|564860658|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483130|NCT02561195|564860659|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483131|NCT02561195|564860660|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483132|NCT02561195|564860661|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
156483133|NCT02561195|564860662|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
156483134|NCT02561195|564860663|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
156483135|NCT02561195|564860664|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
156483136|NCT03905512|564860665|FG000|Overall Study|Withdrawal by Subject|9|||
156483137|NCT03905512|564860666|FG001|Overall Study|Withdrawal by Subject|8|||
156350995|NCT01782495|564382251|FG009|Overall Study|Withdrew Consent|0|||
156350996|NCT01782495|564382252|FG010|Overall Study|Withdrew Consent|0|||
156350997|NCT02848651|564382254|FG000|Overall Study|Death|85|||
156350998|NCT02848651|564382254|FG000|Overall Study|Lost to Follow-up|1|||
156350999|NCT02848651|564382254|FG000|Overall Study|Non-Compliance|1|||
156351000|NCT02848651|564382254|FG000|Overall Study|Symptomatic Deterioration|1|||
156351001|NCT02848651|564382254|FG000|Overall Study|Physician Decision|4|||
156351002|NCT02848651|564382254|FG000|Overall Study|Withdrawal by Subject|14|||
156351003|NCT02480114|564382259|FG000|Overall Study|Not completing surveys|3|||
156351004|NCT02480114|564382260|FG001|Overall Study|Not completing surveys|2|||
156351005|NCT02480114|564382259|FG000|Overall Study|Withdrawal by Subject|2|||
156351006|NCT02480114|564382260|FG001|Overall Study|Withdrawal by Subject|4|||
156351007|NCT02480114|564382259|FG000|Overall Study|Disease progression|3|||
156351008|NCT02480114|564382260|FG001|Overall Study|Disease progression|0|||
156351009|NCT02480114|564382259|FG000|Overall Study|Improper completion of survey|1|||
156351010|NCT02480114|564382260|FG001|Overall Study|Improper completion of survey|1|||
156351011|NCT02480114|564382259|FG000|Overall Study|Not eligible|0|||
156351012|NCT02480114|564382260|FG001|Overall Study|Not eligible|1|||
156351013|NCT01535053|564382261|FG000|Overall Study|Ineligible|1|||
156351014|NCT01535053|564382262|FG001|Overall Study|Ineligible|2|||
156351015|NCT01031069|564382263|FG000|Overall Study|Serious Adverse Event|0|||
156351016|NCT01031069|564382264|FG001|Overall Study|Serious Adverse Event|1|||
156351017|NCT01031069|564382265|FG002|Overall Study|Serious Adverse Event|0|||
156351018|NCT01031069|564382266|FG003|Overall Study|Serious Adverse Event|0|||
156351019|NCT01031069|564382263|FG000|Overall Study|Withdrawal by Subject|2|||
156351020|NCT01031069|564382264|FG001|Overall Study|Withdrawal by Subject|3|||
156351021|NCT01031069|564382265|FG002|Overall Study|Withdrawal by Subject|18|||
156351022|NCT01031069|564382266|FG003|Overall Study|Withdrawal by Subject|18|||
156351023|NCT01031069|564382263|FG000|Overall Study|Migrated/moved from study area|1|||
156351024|NCT01031069|564382264|FG001|Overall Study|Migrated/moved from study area|2|||
156351025|NCT01031069|564382265|FG002|Overall Study|Migrated/moved from study area|1|||
156351026|NCT01031069|564382266|FG003|Overall Study|Migrated/moved from study area|1|||
156351027|NCT01031069|564382263|FG000|Overall Study|Lost to Follow-up|9|||
156351028|NCT01031069|564382264|FG001|Overall Study|Lost to Follow-up|5|||
156351029|NCT01031069|564382265|FG002|Overall Study|Lost to Follow-up|21|||
156351030|NCT01031069|564382266|FG003|Overall Study|Lost to Follow-up|15|||
156351031|NCT01031069|564382263|FG000|Overall Study|Other|0|||
156351032|NCT01031069|564382264|FG001|Overall Study|Other|0|||
156351033|NCT01031069|564382265|FG002|Overall Study|Other|1|||
156351034|NCT01031069|564382266|FG003|Overall Study|Other|0|||
156351035|NCT00512707|564382267|FG000|Overall Study|Lost to Follow-up|5|||
156351036|NCT00512707|564382268|FG001|Overall Study|Lost to Follow-up|11|||
156351037|NCT00512707|564382267|FG000|Overall Study|Developed skin irritation|2|||
156351038|NCT00512707|564382268|FG001|Overall Study|Developed skin irritation|1|||
156351039|NCT00512707|564382267|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
156351040|NCT00512707|564382268|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
156351041|NCT00512707|564382267|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
156351042|NCT00512707|564382268|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
156351043|NCT01317160|564382269|FG000|Overall Study|Incorrect inclusion|1|||
156351044|NCT01317160|564382270|FG001|Overall Study|Incorrect inclusion|1|||
156351045|NCT01317160|564382269|FG000|Overall Study|Lost to Follow-up|3|||
156351046|NCT01317160|564382270|FG001|Overall Study|Lost to Follow-up|3|||
156351047|NCT01317160|564382269|FG000|Overall Study|Withdrawal by Subject|0|||
156351048|NCT01317160|564382270|FG001|Overall Study|Withdrawal by Subject|2|||
156351049|NCT01853826|564384157|FG000|Overall Study|Patients who switched to commercial drug|11|||
156351050|NCT01853826|564384157|FG000|Overall Study|Patient refused to continue medication|21|||
156351051|NCT01853826|564384157|FG000|Overall Study|Lost to Follow-up|2|||
156351052|NCT01853826|564384157|FG000|Overall Study|Non-compliant with protocol|4|||
156351053|NCT01853826|564384157|FG000|Overall Study|Other adverse events (AE)|62|||
156351054|NCT01853826|564384157|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
156351055|NCT01853826|564384157|FG000|Overall Study|Progressive disease|342|||
156351056|NCT01853826|564384157|FG000|Overall Study|Other than listed|13|||
156351057|NCT01853826|564384157|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
156351058|NCT03653637|564384158|FG000|Overall Study|Death|1|||
156351059|NCT03653637|564384159|FG001|Overall Study|Death|3|||
156351060|NCT03653637|564384158|FG000|Overall Study|Lost to Follow-up|29|||
156351061|NCT03653637|564384159|FG001|Overall Study|Lost to Follow-up|30|||
156351062|NCT03653637|564384158|FG000|Overall Study|Physician Decision|1|||
156351063|NCT03653637|564384159|FG001|Overall Study|Physician Decision|1|||
156351064|NCT03653637|564384158|FG000|Overall Study|Withdrawal by Subject|7|||
156351065|NCT03653637|564384159|FG001|Overall Study|Withdrawal by Subject|4|||
156351066|NCT05661942|564384160|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
156351067|NCT05661942|564384161|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
156351068|NCT01572909|564384178|FG000|Overall Study|Adverse Event|7|||
156351069|NCT01572909|564384179|FG001|Overall Study|Adverse Event|2|||
156351070|NCT01572909|564384178|FG000|Overall Study|Death|3|||
156351071|NCT01572909|564384179|FG001|Overall Study|Death|1|||
156351072|NCT01572909|564384178|FG000|Overall Study|Lost to Follow-up|8|||
156351073|NCT01572909|564384179|FG001|Overall Study|Lost to Follow-up|7|||
156351074|NCT01572909|564384178|FG000|Overall Study|Physician Decision|1|||
156351075|NCT01572909|564384179|FG001|Overall Study|Physician Decision|1|||
156351076|NCT01572909|564384178|FG000|Overall Study|Technical Issues|1|||
156351077|NCT01572909|564384179|FG001|Overall Study|Technical Issues|0|||
156351078|NCT01572909|564384178|FG000|Overall Study|Withdrawal by Subject|12|||
156351079|NCT01572909|564384179|FG001|Overall Study|Withdrawal by Subject|11|||
156351080|NCT01572909|564384178|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
156351081|NCT01572909|564384179|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
156351082|NCT04779489|564384180|FG000|Overall Study|Physician Decision|1|||
156351083|NCT02723084|564384182|FG000|Overall Study|Withdrawal by Subject|1|||
156351084|NCT02723084|564384183|FG001|Overall Study|Withdrawal by Subject|1|||
156351085|NCT02723084|564384182|FG000|Overall Study|Lost to Follow-up|3|||
156351086|NCT02723084|564384183|FG001|Overall Study|Lost to Follow-up|0|||
156351087|NCT05024058|564384186|FG000|Treatment|Study terminated by sponsor|5|||
156351088|NCT05024058|564384187|FG001|Treatment|Study terminated by sponsor|6|||
156351089|NCT05024058|564384188|FG002|Treatment|Study terminated by sponsor|4|||
156351090|NCT05024058|564384189|FG003|Treatment|Study terminated by sponsor|2|||
156351091|NCT05024058|564384190|FG004|Treatment|Study terminated by sponsor|3|||
156351092|NCT05024058|564384191|FG005|Treatment|Study terminated by sponsor|3|||
156351093|NCT05024058|564384192|FG006|Treatment|Study terminated by sponsor|1|||
156351094|NCT05024058|564384193|FG007|Treatment|Study terminated by sponsor|3|||
156351095|NCT05024058|564384194|FG008|Treatment|Study terminated by sponsor|6|||
156351096|NCT05024058|564384195|FG009|Treatment|Study terminated by sponsor|6|||
156351097|NCT05024058|564384186|FG000|Follow-up|Withdrawal by Subject|1|||
156351098|NCT05024058|564384187|FG001|Follow-up|Withdrawal by Subject|0|||
156351099|NCT05024058|564384188|FG002|Follow-up|Withdrawal by Subject|1|||
156351100|NCT05024058|564384189|FG003|Follow-up|Withdrawal by Subject|0|||
156351101|NCT05024058|564384190|FG004|Follow-up|Withdrawal by Subject|0|||
156351102|NCT05024058|564384191|FG005|Follow-up|Withdrawal by Subject|0|||
156351103|NCT05024058|564384192|FG006|Follow-up|Withdrawal by Subject|0|||
156351104|NCT05024058|564384193|FG007|Follow-up|Withdrawal by Subject|1|||
156351105|NCT05024058|564384194|FG008|Follow-up|Withdrawal by Subject|0|||
156351106|NCT05024058|564384195|FG009|Follow-up|Withdrawal by Subject|1|||
156351107|NCT03055260|564384199|FG000|Overall Study|Withdrawal by Subject|1|||
156351108|NCT03055260|564384200|FG001|Overall Study|Withdrawal by Subject|0|||
156351109|NCT00931762|564384201|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
156351110|NCT00931762|564384201|FG000|Overall Study|Administrative Problems|5|||
156351111|NCT00931762|564384201|FG000|Overall Study|Death|1|||
156351112|NCT00931762|564384201|FG000|Overall Study|Disease Progression|3|||
156351113|NCT00931762|564384201|FG000|Overall Study|Adverse Event (s)|11|||
156351114|NCT00931762|564384201|FG000|Overall Study|Subject withdrew consent|13|||
156351115|NCT00225251|564384204|FG000|Overall Study|Withdrawal by Subject|1|||
156351116|NCT00225251|564384205|FG001|Overall Study|Withdrawal by Subject|1|||
156351117|NCT02664441|564384206|FG000|Randomization|Withdrawal by Subject|0|||
156351118|NCT02664441|564384207|FG001|Randomization|Withdrawal by Subject|1|||
156351119|NCT02664441|564384206|FG000|36-week Randomized Trial|Adverse Event|2|||
156351120|NCT02664441|564384207|FG001|36-week Randomized Trial|Adverse Event|0|||
156351121|NCT02664441|564384206|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
156351122|NCT02664441|564384207|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
156351123|NCT02664441|564384206|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
156351124|NCT02664441|564384207|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
156351125|NCT02664441|564384206|FG000|18-week Open Label Extension|Adverse Event|1|||
156351126|NCT02664441|564384207|FG001|18-week Open Label Extension|Adverse Event|0|||
156351127|NCT02664441|564384206|FG000|18-week Open Label Extension|Physician Decision|1|||
156351128|NCT02664441|564384207|FG001|18-week Open Label Extension|Physician Decision|0|||
156351129|NCT02664441|564384206|FG000|18-week Open Label Extension|Death|1|||
156351130|NCT02664441|564384207|FG001|18-week Open Label Extension|Death|0|||
156351131|NCT02664441|564384206|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
156351132|NCT02664441|564384207|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
156351133|NCT00710710|564384208|FG000|Overall Study|Consent withdrawn|2|||
156351134|NCT00710710|564384209|FG001|Overall Study|Consent withdrawn|2|||
156351135|NCT00710710|564384208|FG000|Overall Study|Protocol Violation|0|||
156351136|NCT00710710|564384209|FG001|Overall Study|Protocol Violation|1|||
156351137|NCT00710710|564384208|FG000|Overall Study|Adverse Event|3|||
156351138|NCT00710710|564384209|FG001|Overall Study|Adverse Event|3|||
156351139|NCT00710710|564384208|FG000|Overall Study|Progressive disease|40|||
156351140|NCT00710710|564384209|FG001|Overall Study|Progressive disease|38|||
156351141|NCT03510884|564384210|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
156351142|NCT03510884|564384211|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
156351143|NCT03510884|564384212|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
156351144|NCT03510884|564384213|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
156351145|NCT03510884|564384210|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
156351146|NCT03510884|564384211|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
156351147|NCT03510884|564384212|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
156351148|NCT03510884|564384213|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
156351149|NCT03510884|564384210|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
156483138|NCT03905512|564860665|FG000|Overall Study|Adverse Event|1|||
156483139|NCT03905512|564860666|FG001|Overall Study|Adverse Event|2|||
156483140|NCT03905512|564860665|FG000|Overall Study|Lost to Follow-up|4|||
156483141|NCT03905512|564860666|FG001|Overall Study|Lost to Follow-up|3|||
156483142|NCT03905512|564860665|FG000|Overall Study|Other than Specified|7|||
156483143|NCT03905512|564860666|FG001|Overall Study|Other than Specified|4|||
156483144|NCT00736502|564860673|FG000|Overall Study|Adverse Event|22|||
156483145|NCT00736502|564860673|FG000|Overall Study|Lack of Efficacy|16|||
156483146|NCT00736502|564860673|FG000|Overall Study|Lost to Follow-up|27|||
156483147|NCT03987074|564860675|FG000|Overall Study|Withdrew Consent|1|||
156483148|NCT03987074|564860676|FG001|Overall Study|Withdrew Consent|1|||
156483149|NCT03987074|564860677|FG002|Overall Study|Withdrew Consent|0|||
156483150|NCT03987074|564860678|FG003|Overall Study|Withdrew Consent|2|||
156483151|NCT03987074|564860679|FG004|Overall Study|Withdrew Consent|1|||
156483152|NCT03987074|564860675|FG000|Overall Study|Adverse Event|2|||
156483153|NCT03987074|564860676|FG001|Overall Study|Adverse Event|1|||
156483154|NCT03987074|564860677|FG002|Overall Study|Adverse Event|0|||
156483155|NCT03987074|564860678|FG003|Overall Study|Adverse Event|0|||
156483156|NCT03987074|564860679|FG004|Overall Study|Adverse Event|1|||
156483157|NCT03987074|564860675|FG000|Overall Study|Lost to Follow-up|0|||
156483158|NCT03987074|564860676|FG001|Overall Study|Lost to Follow-up|0|||
156483159|NCT03987074|564860677|FG002|Overall Study|Lost to Follow-up|1|||
156483160|NCT03987074|564860678|FG003|Overall Study|Lost to Follow-up|1|||
156483161|NCT03987074|564860679|FG004|Overall Study|Lost to Follow-up|0|||
156483162|NCT03987074|564860675|FG000|Overall Study|Investigator's Discretion|0|||
156483163|NCT03987074|564860676|FG001|Overall Study|Investigator's Discretion|0|||
156483164|NCT03987074|564860677|FG002|Overall Study|Investigator's Discretion|0|||
156351150|NCT03510884|564384211|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
156351151|NCT03510884|564384212|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
156351152|NCT03510884|564384213|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
156483165|NCT03987074|564860678|FG003|Overall Study|Investigator's Discretion|1|||
156483166|NCT03987074|564860679|FG004|Overall Study|Investigator's Discretion|0|||
156483167|NCT01307800|564860680|FG000|Overall Study|Adverse Event|9|||
156483168|NCT01307800|564860681|FG001|Overall Study|Adverse Event|8|||
156483169|NCT01307800|564860682|FG002|Overall Study|Adverse Event|10|||
156483170|NCT01307800|564860683|FG003|Overall Study|Adverse Event|14|||
156483171|NCT01307800|564860680|FG000|Overall Study|Entry Criteria Not Met|0|||
156483172|NCT01307800|564860681|FG001|Overall Study|Entry Criteria Not Met|0|||
156483173|NCT01307800|564860682|FG002|Overall Study|Entry Criteria Not Met|0|||
156483174|NCT01307800|564860683|FG003|Overall Study|Entry Criteria Not Met|2|||
156483175|NCT01307800|564860680|FG000|Overall Study|Lost to Follow-up|5|||
156483176|NCT01307800|564860681|FG001|Overall Study|Lost to Follow-up|6|||
156483177|NCT01307800|564860682|FG002|Overall Study|Lost to Follow-up|2|||
156483178|NCT01307800|564860683|FG003|Overall Study|Lost to Follow-up|8|||
156483179|NCT01307800|564860680|FG000|Overall Study|Perceived Lack of Efficacy|24|||
156483180|NCT01307800|564860681|FG001|Overall Study|Perceived Lack of Efficacy|23|||
156483181|NCT01307800|564860682|FG002|Overall Study|Perceived Lack of Efficacy|20|||
156483182|NCT01307800|564860683|FG003|Overall Study|Perceived Lack of Efficacy|33|||
156483183|NCT01307800|564860680|FG000|Overall Study|Protocol Violation|0|||
156483184|NCT01307800|564860681|FG001|Overall Study|Protocol Violation|3|||
156483185|NCT01307800|564860682|FG002|Overall Study|Protocol Violation|4|||
156483186|NCT01307800|564860683|FG003|Overall Study|Protocol Violation|5|||
156483187|NCT01307800|564860680|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
156483188|NCT01307800|564860681|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
156483189|NCT01307800|564860682|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
156483190|NCT01307800|564860683|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
156483191|NCT01307800|564860680|FG000|Overall Study|Sponsor Decision|6|||
156483192|NCT01307800|564860681|FG001|Overall Study|Sponsor Decision|9|||
156483193|NCT01307800|564860682|FG002|Overall Study|Sponsor Decision|12|||
156483194|NCT01307800|564860683|FG003|Overall Study|Sponsor Decision|28|||
156483195|NCT01307800|564860680|FG000|Overall Study|Withdrawal by Subject|10|||
156483196|NCT01307800|564860681|FG001|Overall Study|Withdrawal by Subject|11|||
156483197|NCT01307800|564860682|FG002|Overall Study|Withdrawal by Subject|8|||
156483198|NCT01307800|564860683|FG003|Overall Study|Withdrawal by Subject|15|||
156483199|NCT01307800|564860680|FG000|Overall Study|Participant Moved|0|||
156483200|NCT01307800|564860681|FG001|Overall Study|Participant Moved|2|||
156483201|NCT01307800|564860682|FG002|Overall Study|Participant Moved|1|||
156483202|NCT01307800|564860683|FG003|Overall Study|Participant Moved|3|||
156483203|NCT00508144|564860686|FG000|Overall Study|Not eligible|6|||
156483204|NCT00508144|564860686|FG000|Overall Study|Death|5|||
156483205|NCT01084772|564860690|FG000|Baseline|Withdrawal by Subject|7|||
156483206|NCT01084772|564860691|FG001|Baseline|Withdrawal by Subject|6|||
156483207|NCT01084772|564860690|FG000|3 Months|Death|1|||
156483208|NCT01084772|564860691|FG001|3 Months|Death|0|||
156483209|NCT01084772|564860690|FG000|3 Months|Study Termination|2|||
156483210|NCT01084772|564860691|FG001|3 Months|Study Termination|2|||
156483211|NCT01084772|564860690|FG000|1 Year|Withdrawal by Subject|0|||
156483212|NCT01084772|564860691|FG001|1 Year|Withdrawal by Subject|1|||
156483213|NCT01084772|564860690|FG000|1 Year|Lost to Follow-up|3|||
156483214|NCT01084772|564860691|FG001|1 Year|Lost to Follow-up|0|||
156483215|NCT01084772|564860690|FG000|1 Year|Study Termination|0|||
156483216|NCT01084772|564860691|FG001|1 Year|Study Termination|7|||
156483217|NCT01084772|564860690|FG000|2 Years|Withdrawal by Subject|1|||
156483218|NCT01084772|564860691|FG001|2 Years|Withdrawal by Subject|0|||
156483219|NCT01084772|564860690|FG000|2 Years|Lost to Follow-up|5|||
156483220|NCT01084772|564860691|FG001|2 Years|Lost to Follow-up|2|||
156483221|NCT01084772|564860690|FG000|2 Years|Study Termination|3|||
156483222|NCT01084772|564860691|FG001|2 Years|Study Termination|2|||
156483223|NCT01517282|564860692|FG000|Overall Study|Consent withdrawn|0|||
156483224|NCT01517282|564860693|FG001|Overall Study|Consent withdrawn|1|||
156483225|NCT01517282|564860694|FG002|Overall Study|Consent withdrawn|1|||
156483226|NCT01517282|564860695|FG003|Overall Study|Consent withdrawn|1|||
156483227|NCT01517282|564860692|FG000|Overall Study|Physician Decision|1|||
156483228|NCT01517282|564860693|FG001|Overall Study|Physician Decision|0|||
156483229|NCT01517282|564860694|FG002|Overall Study|Physician Decision|0|||
156483230|NCT01517282|564860695|FG003|Overall Study|Physician Decision|0|||
156483231|NCT01199302|564860702|FG000|Overall Study|Adverse Event|1|||
156483232|NCT01199302|564860703|FG001|Overall Study|Adverse Event|1|||
156483233|NCT01199302|564860704|FG002|Overall Study|Adverse Event|2|||
156483234|NCT01199302|564860705|FG003|Overall Study|Adverse Event|0|||
156483235|NCT01199302|564860702|FG000|Overall Study|Withdrawal by Subject|2|||
156483236|NCT01199302|564860703|FG001|Overall Study|Withdrawal by Subject|2|||
156483237|NCT01199302|564860704|FG002|Overall Study|Withdrawal by Subject|3|||
156483238|NCT01199302|564860705|FG003|Overall Study|Withdrawal by Subject|0|||
156483239|NCT01199302|564860702|FG000|Overall Study|Disease Progression|3|||
156483240|NCT01199302|564860703|FG001|Overall Study|Disease Progression|4|||
156483241|NCT01199302|564860704|FG002|Overall Study|Disease Progression|4|||
156483242|NCT01199302|564860705|FG003|Overall Study|Disease Progression|2|||
156483243|NCT01199302|564860702|FG000|Overall Study|Study Termination|13|||
156483244|NCT01199302|564860703|FG001|Overall Study|Study Termination|8|||
156483245|NCT01199302|564860704|FG002|Overall Study|Study Termination|11|||
156483246|NCT01199302|564860705|FG003|Overall Study|Study Termination|9|||
156483247|NCT01199302|564860702|FG000|Overall Study|Lost to Follow-up|0|||
156483248|NCT01199302|564860703|FG001|Overall Study|Lost to Follow-up|1|||
156483249|NCT01199302|564860704|FG002|Overall Study|Lost to Follow-up|0|||
156483250|NCT01199302|564860705|FG003|Overall Study|Lost to Follow-up|0|||
156483251|NCT01199302|564860702|FG000|Overall Study|Other|1|||
156483252|NCT01199302|564860703|FG001|Overall Study|Other|0|||
156483253|NCT01199302|564860704|FG002|Overall Study|Other|0|||
156483254|NCT01199302|564860705|FG003|Overall Study|Other|0|||
156483255|NCT04433091|564860706|FG000|Overall Study|Lost to Follow-up|1|||
156483256|NCT04433091|564860707|FG001|Overall Study|Lost to Follow-up|0|||
156483257|NCT04433091|564860706|FG000|Overall Study|Withdrawn .|2|||
156483258|NCT04433091|564860707|FG001|Overall Study|Withdrawn .|4|||
156483259|NCT03820024|564860708|FG000|Overall Study|Physician Decision|1|||
156483260|NCT03820024|564860709|FG001|Overall Study|Physician Decision|2|||
156483261|NCT04413149|564862010|FG000|Overall Study|Death|10|||
156483262|NCT04413149|564862011|FG001|Overall Study|Death|5|||
156483263|NCT04413149|564862010|FG000|Overall Study|Lung transplantation|1|||
156483264|NCT04413149|564862011|FG001|Overall Study|Lung transplantation|0|||
156483265|NCT02878590|564862012|FG000|Overall Study|Withdrawal by Subject|2|||
156351153|NCT03510884|564384210|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
156351154|NCT03510884|564384211|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
156351155|NCT03510884|564384212|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
156351156|NCT03510884|564384213|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
156351157|NCT03510884|564384210|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
156351158|NCT03510884|564384211|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
156351159|NCT03510884|564384212|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
156351160|NCT03510884|564384213|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
156351161|NCT03510884|564384210|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
156351162|NCT03510884|564384211|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
156351163|NCT03510884|564384212|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
156351164|NCT03510884|564384213|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
156351165|NCT03510884|564384210|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
156351166|NCT03510884|564384211|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
156351167|NCT03510884|564384212|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
156351168|NCT03510884|564384213|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
156351169|NCT03510884|564384210|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
156351170|NCT03510884|564384211|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
156351171|NCT03510884|564384212|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
156351172|NCT03510884|564384213|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
156351173|NCT03510884|564384210|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
156351174|NCT03510884|564384211|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
156351175|NCT03510884|564384212|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
156351176|NCT03510884|564384213|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
156351177|NCT03510884|564384210|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
156351178|NCT03510884|564384211|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
156351179|NCT03510884|564384212|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
156351180|NCT03510884|564384213|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
156351181|NCT01313767|564384215|FG000|Overall Study|Adverse Event|1|||
156351182|NCT01313767|564384216|FG001|Overall Study|Adverse Event|0|||
156351183|NCT01313767|564384215|FG000|Overall Study|Lost to Follow-up|1|||
156351184|NCT01313767|564384216|FG001|Overall Study|Lost to Follow-up|0|||
156351185|NCT01313767|564384215|FG000|Overall Study|Withdrawal by Subject|2|||
156351186|NCT01313767|564384216|FG001|Overall Study|Withdrawal by Subject|1|||
156351187|NCT01313767|564384215|FG000|Overall Study|Protocol Violation|3|||
156351188|NCT01313767|564384216|FG001|Overall Study|Protocol Violation|1|||
156351189|NCT00157950|564384217|FG000|Overall Study|Death|1|||
156351190|NCT00157950|564384218|FG001|Overall Study|Death|0|||
156351191|NCT01529346|564384219|FG000|Overall Study|Lost to Follow-up|2|||
156351192|NCT01529346|564384220|FG001|Overall Study|Lost to Follow-up|0|||
156351193|NCT01529346|564384221|FG002|Overall Study|Lost to Follow-up|1|||
156351194|NCT01529346|564384222|FG003|Overall Study|Lost to Follow-up|0|||
156351195|NCT01529346|564384223|FG004|Overall Study|Lost to Follow-up|0|||
156351196|NCT01529346|564384219|FG000|Overall Study|Other|0|||
156351197|NCT01529346|564384220|FG001|Overall Study|Other|1|||
156351198|NCT01529346|564384221|FG002|Overall Study|Other|1|||
156351199|NCT01529346|564384222|FG003|Overall Study|Other|0|||
156351200|NCT01529346|564384223|FG004|Overall Study|Other|0|||
156351201|NCT02892760|564384227|FG000|Overall Study|Withdrawal by Subject|3|||
156351202|NCT00386776|564384234|FG000|Overall Study|Withdrawal by Subject|8|||
156351203|NCT02673489|564384235|FG000|Treatment Period|Lost to Follow-up|3|||
156351204|NCT02673489|564384236|FG001|Treatment Period|Lost to Follow-up|0|||
156351205|NCT02673489|564384235|FG000|Treatment Period|Participant request to discontinue|1|||
156351206|NCT02673489|564384236|FG001|Treatment Period|Participant request to discontinue|1|||
156351207|NCT02673489|564384235|FG000|Treatment Period|Participant moved to another province|1|||
156351208|NCT02673489|564384236|FG001|Treatment Period|Participant moved to another province|0|||
156351209|NCT02673489|564384235|FG000|Treatment Period|Participant was incarcerated|0|||
156351210|NCT02673489|564384236|FG001|Treatment Period|Participant was incarcerated|1|||
156351211|NCT02673489|564384235|FG000|Treatment Period|Adverse Event|0|||
156351212|NCT02673489|564384236|FG001|Treatment Period|Adverse Event|1|||
156351213|NCT02673489|564384235|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
156351214|NCT02673489|564384236|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
156351215|NCT02673489|564384235|FG000|Follow Up Period|Unable to return for follow-up|0|||
156351216|NCT02673489|564384236|FG001|Follow Up Period|Unable to return for follow-up|1|||
156351217|NCT00531050|564384238|FG000|Part 1: Period 1|Adverse Event|0|||
156351218|NCT00531050|564384239|FG001|Part 1: Period 1|Adverse Event|1|||
156351219|NCT00531050|564384240|FG002|Part 1: Period 1|Adverse Event|0|||
156351220|NCT00531050|564384241|FG003|Part 1: Period 1|Adverse Event|0|||
156351221|NCT00531050|564384242|FG004|Part 1: Period 1|Adverse Event|0|||
156351222|NCT00531050|564384243|FG005|Part 1: Period 1|Adverse Event|0|||
156351223|NCT00531050|564384238|FG000|Part 1: Period 1|Protocol Deviation|0|||
156351224|NCT00531050|564384239|FG001|Part 1: Period 1|Protocol Deviation|0|||
156351225|NCT00531050|564384240|FG002|Part 1: Period 1|Protocol Deviation|0|||
156351226|NCT00531050|564384241|FG003|Part 1: Period 1|Protocol Deviation|1|||
156351227|NCT00531050|564384242|FG004|Part 1: Period 1|Protocol Deviation|0|||
156351228|NCT00531050|564384243|FG005|Part 1: Period 1|Protocol Deviation|0|||
156351229|NCT00531050|564384238|FG000|Part 1: Period 3|Adverse Event|1|||
156351230|NCT00531050|564384239|FG001|Part 1: Period 3|Adverse Event|0|||
156351231|NCT00531050|564384240|FG002|Part 1: Period 3|Adverse Event|0|||
156483266|NCT00814632|564862013|FG000|Overall Study|Lack of Efficacy|2|||
156483267|NCT04198428|564862014|FG000|Overall Study|Withdrawal by Subject|150|||
156483268|NCT04198428|564862015|FG001|Overall Study|Withdrawal by Subject|156|||
156483269|NCT05878990|564862017|FG000|Overall Study|Lost to Follow-up|7|||
156483270|NCT05878990|564862017|FG000|Overall Study|Withdrawal by Subject|1|||
156351232|NCT00531050|564384241|FG003|Part 1: Period 3|Adverse Event|0|||
156351233|NCT00531050|564384242|FG004|Part 1: Period 3|Adverse Event|0|||
156351234|NCT00531050|564384243|FG005|Part 1: Period 3|Adverse Event|0|||
156351235|NCT00531050|564384238|FG000|Part 2: Period 1|Adverse Event|0|||
156351236|NCT00531050|564384239|FG001|Part 2: Period 1|Adverse Event|0|||
156351237|NCT00531050|564384240|FG002|Part 2: Period 1|Adverse Event|0|||
156351238|NCT00531050|564384241|FG003|Part 2: Period 1|Adverse Event|0|||
156351239|NCT00531050|564384242|FG004|Part 2: Period 1|Adverse Event|0|||
156351240|NCT00531050|564384243|FG005|Part 2: Period 1|Adverse Event|1|||
156351241|NCT00531050|564384238|FG000|Part 2: Period 3|Abnormal test procedure|1|||
156351242|NCT00531050|564384239|FG001|Part 2: Period 3|Abnormal test procedure|0|||
156351243|NCT00531050|564384240|FG002|Part 2: Period 3|Abnormal test procedure|0|||
156351244|NCT00531050|564384241|FG003|Part 2: Period 3|Abnormal test procedure|0|||
156483271|NCT00668746|564862018|FG000|Overall Study|Lost to Follow-up|2|||
156483272|NCT00668746|564862019|FG001|Overall Study|Lost to Follow-up|1|||
156351245|NCT00531050|564384242|FG004|Part 2: Period 3|Abnormal test procedure|0|||
156351246|NCT00531050|564384243|FG005|Part 2: Period 3|Abnormal test procedure|1|||
156351247|NCT02233309|564384248|FG000|Overall Study|Physician Decision|5|||
156351248|NCT00232817|564384251|FG000|Overall Study|Protocol Violation|2|||
156351249|NCT00232817|564384252|FG001|Overall Study|Protocol Violation|1|||
156351250|NCT00799487|564384253|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
156351251|NCT00799487|564384254|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
156351252|NCT00799487|564384255|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
156483273|NCT03409276|564862020|FG000|Overall Study|Withdrawal by Subject|0|||
156483274|NCT03409276|564862021|FG001|Overall Study|Withdrawal by Subject|0|||
156483275|NCT03409276|564862022|FG002|Overall Study|Withdrawal by Subject|0|||
156483276|NCT03409276|564862023|FG003|Overall Study|Withdrawal by Subject|0|||
156483277|NCT03409276|564862024|FG004|Overall Study|Withdrawal by Subject|1|||
156483278|NCT03409276|564862020|FG000|Overall Study|Lost to Follow-up|0|||
156483279|NCT03409276|564862021|FG001|Overall Study|Lost to Follow-up|0|||
156483280|NCT03409276|564862022|FG002|Overall Study|Lost to Follow-up|0|||
156483281|NCT03409276|564862023|FG003|Overall Study|Lost to Follow-up|2|||
156351253|NCT00799487|564384253|FG000|Dose Adjustment Period|Adverse Event|2|||
156351254|NCT00799487|564384254|FG001|Dose Adjustment Period|Adverse Event|0|||
156351255|NCT00799487|564384255|FG002|Dose Adjustment Period|Adverse Event|0|||
156351256|NCT00799487|564384253|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
156483282|NCT03409276|564862024|FG004|Overall Study|Lost to Follow-up|2|||
156483283|NCT03960437|564862030|FG000|Overall Study|Removed by PI|4|||
156483284|NCT03960437|564862030|FG000|Overall Study|Lost to Follow-up|2|||
156483285|NCT03960437|564862030|FG000|Overall Study|Withdrawal by Subject|1|||
156483286|NCT03960437|564862030|FG000|Overall Study|Death|2|||
156483287|NCT02368691|564862031|FG000|Overall Study|Death|13|||
156483288|NCT02368691|564862031|FG000|Overall Study|Lack of Efficacy|15|||
156483289|NCT02368691|564862031|FG000|Overall Study|Physician Decision|4|||
156483290|NCT01838447|564862032|FG000|Overall Study|Change in surgical plan|1|||
156483291|NCT01838447|564862033|FG001|Overall Study|Change in surgical plan|2|||
156351257|NCT00799487|564384254|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
156351258|NCT00799487|564384255|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
156351259|NCT00799487|564384253|FG000|Dose Adjustment Period|Investigator Discretion|2|||
156351260|NCT00799487|564384254|FG001|Dose Adjustment Period|Investigator Discretion|0|||
156351261|NCT00799487|564384255|FG002|Dose Adjustment Period|Investigator Discretion|0|||
156351262|NCT00799487|564384253|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
156351263|NCT00799487|564384254|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
156351264|NCT00799487|564384255|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
156351265|NCT00799487|564384253|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
156351266|NCT00799487|564384254|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
156351267|NCT00799487|564384255|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
156351268|NCT00799487|564384253|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
156351269|NCT00799487|564384254|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
156351270|NCT00799487|564384255|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
156351271|NCT00799487|564384253|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
156351272|NCT00799487|564384254|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
156351273|NCT00799487|564384255|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
156351274|NCT00799487|564384253|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
156351275|NCT00799487|564384254|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
156351276|NCT00799487|564384255|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
156351277|NCT00799487|564384253|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
156351278|NCT00799487|564384254|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
156351279|NCT00799487|564384255|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
156351280|NCT00799487|564384253|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
156351281|NCT00799487|564384254|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
156351282|NCT00799487|564384255|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
156351283|NCT00799487|564384253|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
156351284|NCT00799487|564384254|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
156351285|NCT00799487|564384255|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
156351286|NCT01484873|564384256|FG000|Overall Study|Withdrawal by Subject|2|||
156351287|NCT01549392|564384257|FG000|Overall Study|Withdrawal by Subject|1|||
156351288|NCT01549392|564384258|FG001|Overall Study|Withdrawal by Subject|0|||
156351289|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
156351290|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
156351291|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
156351292|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
156351293|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
156351294|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
156351295|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
156351296|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
156351297|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
156351298|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
156351299|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
156351300|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
156351301|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
156351302|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
156351303|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
156351304|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
156351305|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
156351306|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
156351307|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
156351308|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
156351309|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
156351310|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
156351311|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
156351312|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
156351313|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
156351314|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
156351315|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
156351316|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
156351317|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
156351318|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
156351319|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
156351320|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
156351321|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
156351322|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
156483292|NCT01838447|564862032|FG000|Overall Study|Withdrawal by Subject|1|||
156483293|NCT01838447|564862033|FG001|Overall Study|Withdrawal by Subject|1|||
156483294|NCT01114217|564862034|FG000|Overall Study|Adverse Event|5|||
156483295|NCT01114217|564862035|FG001|Overall Study|Adverse Event|3|||
156483296|NCT01114217|564862034|FG000|Overall Study|Lost to Follow-up|17|||
156351323|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
156351324|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
156351325|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
156351326|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
156351327|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
156351328|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
156351329|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
156351330|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
156351331|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
156351332|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
156544159|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
156544160|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
156544161|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to death|4|||
156544162|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to death|3|||
156351333|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
156351334|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
156351335|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
156351336|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
156351337|NCT03720470|564384261|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156351338|NCT03720470|564384262|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156351339|NCT03720470|564384263|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156351340|NCT03720470|564384264|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156351341|NCT03720470|564384265|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156351342|NCT03720470|564384266|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
156351343|NCT03720470|564384261|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
156351344|NCT03720470|564384262|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
156351345|NCT03720470|564384263|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
156351346|NCT03720470|564384264|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
156351347|NCT03720470|564384265|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
156351348|NCT03720470|564384266|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
156351349|NCT03720470|564384261|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156351350|NCT03720470|564384262|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156351351|NCT03720470|564384263|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
156351352|NCT03720470|564384264|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156351353|NCT03720470|564384265|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156351354|NCT03720470|564384266|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156351355|NCT03720470|564384261|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
156351356|NCT03720470|564384262|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
156351357|NCT03720470|564384263|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
156351358|NCT03720470|564384264|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
156351359|NCT03720470|564384265|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
156351360|NCT03720470|564384266|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
156351361|NCT03720470|564384261|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156351362|NCT03720470|564384262|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156351363|NCT03720470|564384263|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156351364|NCT03720470|564384264|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156351365|NCT03720470|564384265|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156351366|NCT03720470|564384266|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
156351367|NCT03720470|564384261|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156351368|NCT03720470|564384262|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156351369|NCT03720470|564384263|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
156351370|NCT03720470|564384264|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156351371|NCT03720470|564384265|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156351372|NCT03720470|564384266|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156351373|NCT03720470|564384261|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
156351374|NCT03720470|564384262|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
156351375|NCT03720470|564384263|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
156351376|NCT03720470|564384264|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
156483297|NCT01114217|564862035|FG001|Overall Study|Lost to Follow-up|33|||
156483298|NCT01114217|564862034|FG000|Overall Study|Withdrawal by Subject|21|||
156483299|NCT01114217|564862035|FG001|Overall Study|Withdrawal by Subject|28|||
156483300|NCT01114217|564862034|FG000|Overall Study|Other-Clerical Error|3|||
156483301|NCT01114217|564862035|FG001|Overall Study|Other-Clerical Error|0|||
156483302|NCT01114217|564862034|FG000|Overall Study|Other-Early termination|6|||
156483303|NCT01114217|564862035|FG001|Overall Study|Other-Early termination|10|||
156483304|NCT01114217|564862034|FG000|Overall Study|Other-Procedure|1|||
156483305|NCT01114217|564862035|FG001|Overall Study|Other-Procedure|1|||
156483306|NCT01114217|564862034|FG000|Overall Study|Other-Pregnancy|2|||
156483307|NCT01114217|564862035|FG001|Overall Study|Other-Pregnancy|4|||
156483308|NCT01114217|564862034|FG000|Overall Study|Other-Protocol Violation|1|||
156483309|NCT01114217|564862035|FG001|Overall Study|Other-Protocol Violation|3|||
156483310|NCT01114217|564862034|FG000|Overall Study|Other-Lack of Efficacy|1|||
156483311|NCT01114217|564862035|FG001|Overall Study|Other-Lack of Efficacy|0|||
156483312|NCT01114217|564862034|FG000|Overall Study|Other-Non Compliance|2|||
156483313|NCT01114217|564862035|FG001|Overall Study|Other-Non Compliance|0|||
156483314|NCT01114217|564862034|FG000|Overall Study|Other-Physician Decision|1|||
156483315|NCT01114217|564862035|FG001|Overall Study|Other-Physician Decision|1|||
156544163|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
156544164|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
156351377|NCT03720470|564384265|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
156351378|NCT03720470|564384266|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
156351379|NCT03720470|564384261|FG000|Treatment Period: Final 4 Weeks|Other|0|||
156351380|NCT03720470|564384262|FG001|Treatment Period: Final 4 Weeks|Other|1|||
156351381|NCT03720470|564384263|FG002|Treatment Period: Final 4 Weeks|Other|0|||
156351382|NCT03720470|564384264|FG003|Treatment Period: Final 4 Weeks|Other|2|||
156351383|NCT03720470|564384265|FG004|Treatment Period: Final 4 Weeks|Other|1|||
156351384|NCT03720470|564384266|FG005|Treatment Period: Final 4 Weeks|Other|0|||
156351385|NCT01988103|564384271|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
156351386|NCT01988103|564384272|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
156351387|NCT01988103|564384273|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
156351388|NCT01988103|564384274|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
156351389|NCT01988103|564384275|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
156351390|NCT01988103|564384271|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
156351391|NCT01988103|564384272|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
156351392|NCT01988103|564384273|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
156351393|NCT01988103|564384274|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
156351394|NCT01988103|564384275|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
156351395|NCT01988103|564384271|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
156351396|NCT01988103|564384272|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
156351397|NCT01988103|564384273|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
156351398|NCT01988103|564384274|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
156351399|NCT01988103|564384275|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
156351400|NCT01988103|564384271|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
156351401|NCT01988103|564384272|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
156351402|NCT01988103|564384273|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
156351403|NCT01988103|564384274|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
156351404|NCT01988103|564384275|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
156351405|NCT01988103|564384271|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
156351406|NCT01988103|564384272|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
156351407|NCT01988103|564384273|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
156351408|NCT01988103|564384274|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
156351409|NCT01988103|564384275|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
156351410|NCT01988103|564384271|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
156351411|NCT01988103|564384272|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
156483316|NCT01114217|564862034|FG000|Overall Study|Other-Sponsor Decision|10|||
156483317|NCT01114217|564862035|FG001|Overall Study|Other-Sponsor Decision|12|||
156483318|NCT01114217|564862034|FG000|Overall Study|Other-Study Termination|0|||
156483319|NCT01114217|564862035|FG001|Overall Study|Other-Study Termination|1|||
156483320|NCT01114217|564862034|FG000|Overall Study|Other-Study Withdrawn|1|||
156483321|NCT01114217|564862035|FG001|Overall Study|Other-Study Withdrawn|1|||
156483322|NCT01114217|564862034|FG000|Overall Study|Other-Site Stopped Communicating|2|||
156483323|NCT01114217|564862035|FG001|Overall Study|Other-Site Stopped Communicating|0|||
156483324|NCT01114217|564862034|FG000|Overall Study|Other-Lost to Follow-up|1|||
156483325|NCT01114217|564862035|FG001|Overall Study|Other-Lost to Follow-up|0|||
156483326|NCT01114217|564862034|FG000|Overall Study|Other-Withdrawal by Subject|1|||
156483327|NCT01114217|564862035|FG001|Overall Study|Other-Withdrawal by Subject|1|||
156483328|NCT06247488|564862036|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
156483329|NCT06247488|564862037|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
156483330|NCT06247488|564862038|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
156483331|NCT06247488|564862039|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
156483332|NCT06247488|564862040|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
156483333|NCT06247488|564862041|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
156483334|NCT06247488|564862036|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
156483335|NCT06247488|564862037|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
156483336|NCT06247488|564862038|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
156483337|NCT06247488|564862039|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
156483338|NCT06247488|564862040|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
156483339|NCT06247488|564862041|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
156483340|NCT06247488|564862036|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
156483341|NCT06247488|564862037|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
156483342|NCT06247488|564862038|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
156483343|NCT06247488|564862039|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
156483344|NCT06247488|564862040|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
156483345|NCT06247488|564862041|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
156483346|NCT06247488|564862036|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
156483347|NCT06247488|564862037|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
156483348|NCT06247488|564862038|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
156483349|NCT06247488|564862039|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
156483350|NCT06247488|564862040|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
156483351|NCT06247488|564862041|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
156483352|NCT06247488|564862036|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
156483353|NCT06247488|564862037|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
156483354|NCT06247488|564862038|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
156483355|NCT06247488|564862039|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
156483356|NCT06247488|564862040|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
156483357|NCT06247488|564862041|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
156351412|NCT01988103|564384273|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
156483358|NCT06247488|564862036|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
156483359|NCT06247488|564862037|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
156483360|NCT06247488|564862038|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
156483361|NCT06247488|564862039|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
156483362|NCT06247488|564862040|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
156483363|NCT06247488|564862041|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
156483364|NCT06247488|564862036|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
156483365|NCT06247488|564862037|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
156483366|NCT06247488|564862038|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
156483367|NCT06247488|564862039|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
156483368|NCT06247488|564862040|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
156483369|NCT06247488|564862041|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
156483370|NCT03436797|564862045|FG000|Main Study|Withdrawal by Subject|2|||
156351413|NCT01988103|564384274|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
156351414|NCT01988103|564384275|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
156351415|NCT01988103|564384271|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
156351416|NCT01988103|564384272|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
156351417|NCT01988103|564384273|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
156351418|NCT01988103|564384274|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
156351419|NCT01988103|564384275|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
156351420|NCT02506153|564384276|FG000|Overall Study|Adverse Event|359|||
156351421|NCT02506153|564384277|FG001|Overall Study|Adverse Event|114|||
156351422|NCT02506153|564384276|FG000|Overall Study|Refused unrelated to adverse event|127|||
156351423|NCT02506153|564384277|FG001|Overall Study|Refused unrelated to adverse event|18|||
156351424|NCT02506153|564384276|FG000|Overall Study|Progression/relapse|91|||
156351425|NCT02506153|564384277|FG001|Overall Study|Progression/relapse|136|||
156351426|NCT02506153|564384276|FG000|Overall Study|Death|2|||
156351427|NCT02506153|564384277|FG001|Overall Study|Death|1|||
156351428|NCT02506153|564384276|FG000|Overall Study|Other - not protocol specified|23|||
156351429|NCT02506153|564384277|FG001|Overall Study|Other - not protocol specified|12|||
156351430|NCT00311623|564384278|FG000|Overall Study|Physician Decision|0|||
156351431|NCT00311623|564384279|FG001|Overall Study|Physician Decision|0|||
156351432|NCT00311623|564384280|FG002|Overall Study|Physician Decision|2|||
156351433|NCT01402544|564384281|FG000|Overall Study|Withdrawal by Subject|6|||
156351434|NCT01083576|564384282|FG000|Overall Study|Treatment Failure|6|||
156351435|NCT01083576|564384283|FG001|Overall Study|Treatment Failure|1|||
156351436|NCT04577118|564384284|FG000|Overall Study|Withdrawal by Subject|4|||
156351437|NCT00276159|564384285|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
156351438|NCT01359449|564384288|FG000|Overall Study|Lost to Follow-up|1|||
156351439|NCT01359449|564384289|FG001|Overall Study|Lost to Follow-up|0|||
156351440|NCT01359449|564384288|FG000|Overall Study|Protocol Violation|0|||
156351441|NCT01359449|564384289|FG001|Overall Study|Protocol Violation|2|||
156351442|NCT01359449|564384288|FG000|Overall Study|Withdrawal by Subject|3|||
156351443|NCT01359449|564384289|FG001|Overall Study|Withdrawal by Subject|2|||
156351444|NCT00191789|564384294|FG000|Overall Study|Adverse Event|5|||
156351445|NCT00191789|564384294|FG000|Overall Study|Patient: Satisfactory Response|5|||
156351446|NCT00191789|564384294|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
156351447|NCT00191789|564384294|FG000|Overall Study|Withdrawal by Subject|4|||
156351448|NCT00191789|564384294|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
156351449|NCT00191789|564384294|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
156483371|NCT03436797|564862045|FG000|Main Study|Adverse Event|4|||
156483372|NCT03436797|564862045|FG000|Main Study|Lost to Follow-up|1|||
156483373|NCT03436797|564862045|FG000|Main Study|Death|1|||
156483374|NCT03436797|564862045|FG000|Main Study|Non-Specific|2|||
156483375|NCT03436797|564862045|FG000|Extended Dosing|Patient decision|1|||
156483376|NCT04739306|564862046|FG000|Main Study Period|Adverse Event|6|||
156483377|NCT04739306|564862047|FG001|Main Study Period|Adverse Event|7|||
156483378|NCT04739306|564862046|FG000|Main Study Period|Lost to Follow-up|4|||
156483379|NCT04739306|564862047|FG001|Main Study Period|Lost to Follow-up|6|||
156483380|NCT04739306|564862046|FG000|Main Study Period|Physician Decision|1|||
156483381|NCT04739306|564862047|FG001|Main Study Period|Physician Decision|1|||
156483382|NCT04739306|564862046|FG000|Main Study Period|Withdrawal by Subject|8|||
156544165|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
156544166|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
156544167|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
156544168|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
156544169|NCT02258451|565086314|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
156351450|NCT00191789|564384294|FG000|Overall Study|Death - Not Study-Drug Related|1|||
156351451|NCT03049280|564384295|FG000|Overall Study|Physician Decision|1|||
156351452|NCT05582889|564384296|FG000|Overall Study|Health event|3|||
156544170|NCT02258451|565086315|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
156351453|NCT05582889|564384297|FG001|Overall Study|Health event|2|||
156351454|NCT05582889|564384296|FG000|Overall Study|Lost to Follow-up|2|||
156351455|NCT05582889|564384297|FG001|Overall Study|Lost to Follow-up|4|||
156351456|NCT06112756|564384298|FG000|Overall Study|Withdrawal by Subject|0|||
156351457|NCT06112756|564384299|FG001|Overall Study|Withdrawal by Subject|2|||
156351458|NCT06112756|564384298|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
156351459|NCT06112756|564384299|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
156351460|NCT06112756|564384298|FG000|Overall Study|Adverse Event|2|||
156351461|NCT06112756|564384299|FG001|Overall Study|Adverse Event|2|||
156351462|NCT04551092|564384300|FG000|Overall Study|Lost to Follow-up|7|||
156351463|NCT04551092|564384300|FG000|Overall Study|Withdrawal by Subject|4|||
156483383|NCT04739306|564862047|FG001|Main Study Period|Withdrawal by Subject|6|||
156483384|NCT04739306|564862046|FG000|Main Study Period|Protocol Violation|0|||
156483385|NCT04739306|564862047|FG001|Main Study Period|Protocol Violation|1|||
156351464|NCT03060629|564384303|FG000|Overall Study|Death|4|||
156351465|NCT03060629|564384304|FG001|Overall Study|Death|5|||
156351466|NCT03060629|564384303|FG000|Overall Study|Withdrawal by Subject|50|||
156351467|NCT03060629|564384304|FG001|Overall Study|Withdrawal by Subject|35|||
156351468|NCT03060629|564384303|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
156351469|NCT03060629|564384304|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
156351470|NCT03060629|564384303|FG000|Overall Study|Participant Relocate|15|||
156351471|NCT03060629|564384304|FG001|Overall Study|Participant Relocate|15|||
156351472|NCT03060629|564384303|FG000|Overall Study|Unable to Contact Participant|34|||
156351473|NCT03060629|564384304|FG001|Overall Study|Unable to Contact Participant|23|||
156351474|NCT03060629|564384303|FG000|Overall Study|Investigator Decision|7|||
156351475|NCT03060629|564384304|FG001|Overall Study|Investigator Decision|7|||
156351476|NCT03060629|564384303|FG000|Overall Study|Study Terminated by Sponsor|1100|||
156351477|NCT03060629|564384304|FG001|Overall Study|Study Terminated by Sponsor|1123|||
156351478|NCT03060629|564384303|FG000|Overall Study|Other|4|||
156351479|NCT03060629|564384304|FG001|Overall Study|Other|4|||
156351480|NCT02056340|564384305|FG000|Overall Study|Lost to Follow-up|5|||
156351481|NCT02056340|564384306|FG001|Overall Study|Lost to Follow-up|5|||
156351482|NCT02056340|564384305|FG000|Overall Study|Withdrawal by Subject|2|||
156351483|NCT02056340|564384306|FG001|Overall Study|Withdrawal by Subject|6|||
156351484|NCT00241280|564384310|FG000|Overall Study|Adverse Event|2|||
156351485|NCT00241280|564384311|FG001|Overall Study|Adverse Event|6|||
156351486|NCT00241280|564384310|FG000|Overall Study|Discomfort|11|||
156351487|NCT00241280|564384311|FG001|Overall Study|Discomfort|16|||
156351488|NCT00241280|564384310|FG000|Overall Study|Pregnancy|1|||
156351489|NCT00241280|564384311|FG001|Overall Study|Pregnancy|5|||
156351490|NCT00241280|564384310|FG000|Overall Study|Lost to Follow-up|5|||
156351491|NCT00241280|564384311|FG001|Overall Study|Lost to Follow-up|8|||
156351492|NCT00241280|564384310|FG000|Overall Study|Withdrawal by Subject|7|||
156351493|NCT00241280|564384311|FG001|Overall Study|Withdrawal by Subject|4|||
156351494|NCT00241280|564384310|FG000|Overall Study|Protocol Violation|4|||
156351495|NCT00241280|564384311|FG001|Overall Study|Protocol Violation|10|||
156351496|NCT00241280|564384310|FG000|Overall Study|Relocation|4|||
156351497|NCT00241280|564384311|FG001|Overall Study|Relocation|4|||
156351498|NCT00241280|564384310|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
156351499|NCT00241280|564384311|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
156351500|NCT00241280|564384310|FG000|Overall Study|Unsatisfactory Visual Response|1|||
156351501|NCT00241280|564384311|FG001|Overall Study|Unsatisfactory Visual Response|1|||
156351502|NCT00241280|564384310|FG000|Overall Study|Diabetic|1|||
156351503|NCT00241280|564384311|FG001|Overall Study|Diabetic|0|||
156351504|NCT00241280|564384310|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
156351505|NCT00241280|564384311|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
156351506|NCT00241280|564384310|FG000|Overall Study|Dispensed incorrect test article|1|||
156351507|NCT00241280|564384311|FG001|Overall Study|Dispensed incorrect test article|2|||
156351508|NCT00241280|564384310|FG000|Overall Study|Unacceptable Fit|0|||
156351509|NCT00241280|564384311|FG001|Overall Study|Unacceptable Fit|1|||
156351510|NCT00241280|564384310|FG000|Overall Study|Scheduling Conflict|0|||
156351511|NCT00241280|564384311|FG001|Overall Study|Scheduling Conflict|2|||
156351512|NCT00241280|564384310|FG000|Overall Study|History of Ocular Surgery|0|||
156351513|NCT00241280|564384311|FG001|Overall Study|History of Ocular Surgery|1|||
156351514|NCT00241280|564384310|FG000|Overall Study|Coating on Lens|1|||
156351515|NCT00241280|564384311|FG001|Overall Study|Coating on Lens|0|||
156351516|NCT00241280|564384310|FG000|Overall Study|Excessive Dryness|0|||
156351517|NCT00241280|564384311|FG001|Overall Study|Excessive Dryness|1|||
156351518|NCT04140292|564384318|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
156351519|NCT04140292|564384319|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
156351520|NCT00396591|564384320|FG000|Overall Study|Disease Progression|13|||
156351521|NCT00396591|564384320|FG000|Overall Study|Adverse Event|2|||
156351522|NCT00396591|564384320|FG000|Overall Study|Participant request|1|||
156351523|NCT04405037|564384321|FG000|Overall Study|Withdrawal by Subject|1|||
156351524|NCT04405037|564384322|FG001|Overall Study|Withdrawal by Subject|0|||
156351525|NCT04405037|564384321|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
156351526|NCT04405037|564384322|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
156351527|NCT01287897|564385907|FG000|Overall Study|Adverse Event|5|||
156351528|NCT01287897|564385908|FG001|Overall Study|Adverse Event|3|||
156351529|NCT01287897|564385909|FG002|Overall Study|Adverse Event|6|||
156351530|NCT01287897|564385910|FG003|Overall Study|Adverse Event|4|||
156351531|NCT01287897|564385907|FG000|Overall Study|Lack of Efficacy|2|||
156351532|NCT01287897|564385908|FG001|Overall Study|Lack of Efficacy|0|||
156351533|NCT01287897|564385909|FG002|Overall Study|Lack of Efficacy|0|||
156351534|NCT01287897|564385910|FG003|Overall Study|Lack of Efficacy|0|||
156351535|NCT01287897|564385907|FG000|Overall Study|Protocol Violation|1|||
156351536|NCT01287897|564385908|FG001|Overall Study|Protocol Violation|1|||
156351537|NCT01287897|564385909|FG002|Overall Study|Protocol Violation|0|||
156351538|NCT01287897|564385910|FG003|Overall Study|Protocol Violation|1|||
156351539|NCT01287897|564385907|FG000|Overall Study|Lost to Follow-up|0|||
156351540|NCT01287897|564385908|FG001|Overall Study|Lost to Follow-up|0|||
156351541|NCT01287897|564385909|FG002|Overall Study|Lost to Follow-up|2|||
156351542|NCT01287897|564385910|FG003|Overall Study|Lost to Follow-up|0|||
156351543|NCT01287897|564385907|FG000|Overall Study|Withdrawal by Subject|1|||
156351544|NCT01287897|564385908|FG001|Overall Study|Withdrawal by Subject|5|||
156351545|NCT01287897|564385909|FG002|Overall Study|Withdrawal by Subject|3|||
156351546|NCT01287897|564385910|FG003|Overall Study|Withdrawal by Subject|2|||
156351547|NCT01287897|564385907|FG000|Overall Study|Not consented properly|0|||
156351548|NCT01287897|564385908|FG001|Overall Study|Not consented properly|1|||
156351549|NCT01287897|564385909|FG002|Overall Study|Not consented properly|0|||
156351550|NCT01287897|564385910|FG003|Overall Study|Not consented properly|0|||
156351551|NCT01287897|564385907|FG000|Overall Study|Not meeting entrance criteria|1|||
156351552|NCT01287897|564385908|FG001|Overall Study|Not meeting entrance criteria|1|||
156351553|NCT01287897|564385909|FG002|Overall Study|Not meeting entrance criteria|0|||
156351554|NCT01287897|564385910|FG003|Overall Study|Not meeting entrance criteria|0|||
156351555|NCT01287897|564385907|FG000|Overall Study|Other|1|||
156351556|NCT01287897|564385908|FG001|Overall Study|Other|0|||
156351557|NCT01287897|564385909|FG002|Overall Study|Other|1|||
156351558|NCT01287897|564385910|FG003|Overall Study|Other|0|||
156351559|NCT00588848|564385911|FG000|Overall Study|Physician Decision|0|||
156351560|NCT00588848|564385912|FG001|Overall Study|Physician Decision|3|||
156351561|NCT02902965|564385913|FG000|Overall Study|Withdrawal by Subject|10|||
156351562|NCT00082355|564385914|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
156351563|NCT00082355|564385914|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
156351564|NCT00082355|564385914|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
156351565|NCT02335489|564385915|FG000|Overall Study|Sponsor terminated study|4|||
156351566|NCT02335489|564385915|FG000|Overall Study|Lost to Follow-up|1|||
156351567|NCT02335489|564385915|FG000|Overall Study|Withdrawal by Subject|2|||
156351568|NCT02335489|564385915|FG000|Overall Study|Physician Decision|2|||
156351569|NCT02335489|564385915|FG000|Overall Study|Lack of Efficacy|1|||
156351570|NCT00412854|564385922|FG000|Overall Study|Withdrawn due to adverse events|1|||
156351571|NCT00412854|564385923|FG001|Overall Study|Withdrawn due to adverse events|5|||
156351572|NCT00412854|564385922|FG000|Overall Study|Withdrawn for other reasons|13|||
156351573|NCT00412854|564385923|FG001|Overall Study|Withdrawn for other reasons|11|||
156351574|NCT03263442|564385924|FG000|Inpatient Phase|Death|1|||
156351575|NCT03263442|564385925|FG001|Inpatient Phase|Death|0|||
156351576|NCT03263442|564385924|FG000|Inpatient Phase|Withdrawal by Subject|1|||
156351577|NCT03263442|564385925|FG001|Inpatient Phase|Withdrawal by Subject|0|||
156351578|NCT03263442|564385924|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
156351579|NCT03263442|564385925|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
156351580|NCT03263442|564385924|FG000|1-month Follow-Up|Lost to Follow-up|1|||
156351581|NCT03263442|564385925|FG001|1-month Follow-Up|Lost to Follow-up|0|||
156351582|NCT03263442|564385924|FG000|3-month Follow-Up|Lost to Follow-up|1|||
156351583|NCT03263442|564385925|FG001|3-month Follow-Up|Lost to Follow-up|3|||
156351584|NCT03263442|564385924|FG000|6-month Follow-Up|Lost to Follow-up|2|||
156351585|NCT03263442|564385925|FG001|6-month Follow-Up|Lost to Follow-up|2|||
156351586|NCT02436889|564385926|FG000|Overall Study|No improvement in symptoms|1|||
156351587|NCT02436889|564385927|FG001|Overall Study|No improvement in symptoms|0|||
156351588|NCT02436889|564385926|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
156351589|NCT02436889|564385927|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
156351590|NCT01084174|564385928|FG000|Overall Study|gastrointestinal symptoms|1|||
156351591|NCT01084174|564385929|FG001|Overall Study|gastrointestinal symptoms|1|||
156351592|NCT01084174|564385928|FG000|Overall Study|Eosinophilic esophagitis|0|||
156351593|NCT01084174|564385929|FG001|Overall Study|Eosinophilic esophagitis|1|||
156351594|NCT01084174|564385928|FG000|Overall Study|Anaphylaxis|0|||
156351595|NCT01084174|564385929|FG001|Overall Study|Anaphylaxis|1|||
156351596|NCT01084174|564385928|FG000|Overall Study|Participant noncompliance|0|||
156351597|NCT01084174|564385929|FG001|Overall Study|Participant noncompliance|1|||
156351598|NCT00708643|564385930|FG000|Overall Study|Adverse Event|0|||
156351599|NCT00708643|564385931|FG001|Overall Study|Adverse Event|1|||
156351600|NCT00227903|564385932|FG000|Overall Study|Withdrawal by Subject|2|||
156351601|NCT00227903|564385933|FG001|Overall Study|Withdrawal by Subject|5|||
156351602|NCT00227903|564385932|FG000|Overall Study|Subject moved out of area|1|||
156351603|NCT00227903|564385933|FG001|Overall Study|Subject moved out of area|2|||
156351604|NCT00227903|564385932|FG000|Overall Study|Lost to Follow-up|1|||
156351605|NCT00227903|564385933|FG001|Overall Study|Lost to Follow-up|3|||
156351606|NCT00227903|564385932|FG000|Overall Study|Miscarriage|1|||
156351607|NCT00227903|564385933|FG001|Overall Study|Miscarriage|0|||
156351608|NCT00460031|564385936|FG000|Overall Study|Adverse Event|5|||
156351609|NCT00460031|564385936|FG000|Overall Study|Withdrawal by Subject|5|||
156351610|NCT00460031|564385936|FG000|Overall Study|Death|1|||
156351611|NCT01946425|564385938|FG000|Overall Study|Protocol Violation|1|||
156351612|NCT01946425|564385939|FG001|Overall Study|Protocol Violation|0|||
156351613|NCT01946425|564385938|FG000|Overall Study|Withdrawal by Subject|1|||
156351614|NCT01946425|564385939|FG001|Overall Study|Withdrawal by Subject|0|||
156351615|NCT05682326|564385945|FG000|Overall Study|Withdrawal by Subject|1|||
156351616|NCT05682326|564385946|FG001|Overall Study|Withdrawal by Subject|0|||
156483386|NCT04739306|564862046|FG000|Main Study Period|War in Ukraine|1|||
156483387|NCT04739306|564862047|FG001|Main Study Period|War in Ukraine|1|||
156483388|NCT01951105|564862052|FG000|Overall Study|Adverse Event|0|||
156483389|NCT01951105|564862053|FG001|Overall Study|Adverse Event|5|||
156483390|NCT01951105|564862054|FG002|Overall Study|Adverse Event|0|||
156483391|NCT01951105|564862052|FG000|Overall Study|Lost to Follow-up|0|||
156483392|NCT01951105|564862053|FG001|Overall Study|Lost to Follow-up|1|||
156483393|NCT01951105|564862054|FG002|Overall Study|Lost to Follow-up|0|||
156483394|NCT01951105|564862052|FG000|Overall Study|Protocol Violation|1|||
156483395|NCT01951105|564862053|FG001|Overall Study|Protocol Violation|1|||
156483396|NCT01951105|564862054|FG002|Overall Study|Protocol Violation|1|||
156483397|NCT01951105|564862052|FG000|Overall Study|Withdrawal by Subject|0|||
156483398|NCT01951105|564862053|FG001|Overall Study|Withdrawal by Subject|3|||
156483399|NCT01951105|564862054|FG002|Overall Study|Withdrawal by Subject|1|||
156483400|NCT00561678|564862055|FG000|Overall Study|Withdrawal by Subject|4|||
156544171|NCT02258451|565086314|FG000|Overall Study|Other reason|1|||
156483401|NCT00561678|564862056|FG001|Overall Study|Withdrawal by Subject|3|||
156483402|NCT00561678|564862055|FG000|Overall Study|surgery cancelled|1|||
156483403|NCT00561678|564862056|FG001|Overall Study|surgery cancelled|1|||
156544172|NCT02258451|565086315|FG001|Overall Study|Other reason|1|||
156351617|NCT03414424|564385947|FG000|Overall Study|Screened out after consent|0|||
156351618|NCT03414424|564385948|FG001|Overall Study|Screened out after consent|2|||
156351619|NCT03414424|564385947|FG000|Overall Study|Lost to Follow-up|0|||
156351620|NCT03414424|564385948|FG001|Overall Study|Lost to Follow-up|1|||
156351621|NCT01506479|564385953|FG000|Overall Study|Lost to Follow-up|1|||
156351622|NCT01506479|564385954|FG001|Overall Study|Lost to Follow-up|2|||
156351623|NCT01506479|564385955|FG002|Overall Study|Lost to Follow-up|2|||
156351624|NCT01506479|564385953|FG000|Overall Study|Withdrawal by Subject|1|||
156351625|NCT01506479|564385954|FG001|Overall Study|Withdrawal by Subject|2|||
156544173|NCT02258451|565086314|FG000|Overall Study|Never treated|2|||
156544174|NCT02258451|565086315|FG001|Overall Study|Never treated|3|||
156544175|NCT00517751|565086321|FG000|Overall Study|Death|3|||
156544176|NCT00517751|565086321|FG000|Overall Study|Withdrawal by Subject|37|||
156544177|NCT00517751|565086321|FG000|Overall Study|Lost to Follow-up|4|||
156544178|NCT00517751|565086321|FG000|Overall Study|patient not over due|6|||
156544179|NCT00517751|565086321|FG000|Overall Study|Patient not due for visit|76|||
156544180|NCT00517751|565086321|FG000|Overall Study|Missing|3|||
156544181|NCT00495820|565086324|FG000|Overall Study|Adverse Event|1|||
156544182|NCT00495820|565086325|FG001|Overall Study|Adverse Event|1|||
156544183|NCT00820950|565086326|FG000|Overall Study|Scheduling Conflict|0|||
156544184|NCT00820950|565086327|FG001|Overall Study|Scheduling Conflict|0|||
156544185|NCT00820950|565086328|FG002|Overall Study|Scheduling Conflict|0|||
156544186|NCT00820950|565086329|FG003|Overall Study|Scheduling Conflict|0|||
156544187|NCT00820950|565086330|FG004|Overall Study|Scheduling Conflict|0|||
156544188|NCT00820950|565086331|FG005|Overall Study|Scheduling Conflict|0|||
156544189|NCT00820950|565086332|FG006|Overall Study|Scheduling Conflict|1|||
156544190|NCT00820950|565086333|FG007|Overall Study|Scheduling Conflict|1|||
156544191|NCT00820950|565086334|FG008|Overall Study|Scheduling Conflict|0|||
156544192|NCT00820950|565086335|FG009|Overall Study|Scheduling Conflict|0|||
156544193|NCT00820950|565086326|FG000|Overall Study|Protocol Violation|1|||
156544194|NCT00820950|565086327|FG001|Overall Study|Protocol Violation|1|||
156544195|NCT00820950|565086328|FG002|Overall Study|Protocol Violation|0|||
156544196|NCT00820950|565086329|FG003|Overall Study|Protocol Violation|0|||
156544197|NCT00820950|565086330|FG004|Overall Study|Protocol Violation|0|||
156544198|NCT00820950|565086331|FG005|Overall Study|Protocol Violation|0|||
156351626|NCT01506479|564385955|FG002|Overall Study|Withdrawal by Subject|1|||
156351627|NCT01506479|564385953|FG000|Overall Study|Missing assessment|1|||
156351628|NCT01506479|564385954|FG001|Overall Study|Missing assessment|0|||
156351629|NCT01506479|564385955|FG002|Overall Study|Missing assessment|0|||
156351630|NCT01506479|564385953|FG000|Overall Study|Adverse Event|0|||
156544199|NCT00820950|565086332|FG006|Overall Study|Protocol Violation|0|||
156544200|NCT00820950|565086333|FG007|Overall Study|Protocol Violation|0|||
156544201|NCT00820950|565086334|FG008|Overall Study|Protocol Violation|0|||
156544202|NCT00820950|565086335|FG009|Overall Study|Protocol Violation|0|||
156544203|NCT02484911|565087711|FG000|Overall Study|Withdrawal by Subject|2|||
156544204|NCT02484911|565087712|FG001|Overall Study|Withdrawal by Subject|1|||
156544205|NCT02484911|565087711|FG000|Overall Study|Protocol Violation|2|||
156544206|NCT02484911|565087712|FG001|Overall Study|Protocol Violation|1|||
156544207|NCT04129528|565087713|FG000|Overall Study|Adverse Event|1|||
156483404|NCT00561678|564862055|FG000|Overall Study|surgery rescheduled to different site|2|||
156483405|NCT00561678|564862056|FG001|Overall Study|surgery rescheduled to different site|2|||
156483406|NCT00561678|564862055|FG000|Overall Study|anesthesia provider refusal|1|||
156483407|NCT00561678|564862056|FG001|Overall Study|anesthesia provider refusal|0|||
156483408|NCT00422162|564862064|FG000|Overall Study|Adverse Event|11|||
156483409|NCT00422162|564862065|FG001|Overall Study|Adverse Event|9|||
156483410|NCT00422162|564862064|FG000|Overall Study|Lack of Efficacy|4|||
156483411|NCT00422162|564862065|FG001|Overall Study|Lack of Efficacy|10|||
156483412|NCT00422162|564862064|FG000|Overall Study|Withdrawal by Subject|7|||
156483413|NCT00422162|564862065|FG001|Overall Study|Withdrawal by Subject|6|||
156483414|NCT00422162|564862064|FG000|Overall Study|Lost to Follow-up|1|||
156483415|NCT00422162|564862065|FG001|Overall Study|Lost to Follow-up|2|||
156483416|NCT00422162|564862064|FG000|Overall Study|Non-Compliant with Protocol|1|||
156483417|NCT00422162|564862065|FG001|Overall Study|Non-Compliant with Protocol|1|||
156483418|NCT00422162|564862064|FG000|Overall Study|Other|0|||
156483419|NCT00422162|564862065|FG001|Overall Study|Other|1|||
156483420|NCT00422162|564862064|FG000|Overall Study|Didn't Receive Treatment|0|||
156483421|NCT00422162|564862065|FG001|Overall Study|Didn't Receive Treatment|1|||
156483422|NCT05274906|564862066|FG000|Overall Study|Withdrawal by Subject|2|||
156483423|NCT05274906|564862067|FG001|Overall Study|Withdrawal by Subject|1|||
156483424|NCT00848198|564862068|FG000|Overall Study|Incomplete Case Report Forms|15|||
156483425|NCT02062827|564862069|FG000|Overall Study|Death|1|||
156483426|NCT02062827|564862070|FG001|Overall Study|Death|0|||
156483427|NCT02062827|564862071|FG002|Overall Study|Death|0|||
156483428|NCT02062827|564862072|FG003|Overall Study|Death|0|||
156351631|NCT01506479|564385954|FG001|Overall Study|Adverse Event|1|||
156351632|NCT01506479|564385955|FG002|Overall Study|Adverse Event|0|||
156351633|NCT01846507|564385956|FG000|Overall Study|Lost to Follow-up|4|||
156351634|NCT01846507|564385956|FG000|Overall Study|Protocol Violation|1|||
156351635|NCT01846507|564385956|FG000|Overall Study|Missing data|2|||
156351636|NCT01314443|564385957|FG000|Overall Study|Withdrawal by Subject|2|||
156351637|NCT01314443|564385958|FG001|Overall Study|Withdrawal by Subject|1|||
156351638|NCT01314443|564385959|FG002|Overall Study|Withdrawal by Subject|1|||
156351639|NCT01314443|564385960|FG003|Overall Study|Withdrawal by Subject|1|||
156544208|NCT04129528|565087714|FG001|Overall Study|Adverse Event|0|||
156351640|NCT01314443|564385957|FG000|Overall Study|Protocol Violation|2|||
156351641|NCT01314443|564385958|FG001|Overall Study|Protocol Violation|2|||
156351642|NCT01314443|564385959|FG002|Overall Study|Protocol Violation|1|||
156351643|NCT01314443|564385960|FG003|Overall Study|Protocol Violation|1|||
156351644|NCT04545866|564385962|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
156351645|NCT04545866|564385963|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
156351646|NCT04545866|564385962|FG000|Overall Study|Withdrawal by Physician|1|||
156351647|NCT04545866|564385963|FG001|Overall Study|Withdrawal by Physician|0|||
156351648|NCT05247866|564385964|FG000|Overall Study|Adverse Event|2|||
156351649|NCT05247866|564385964|FG000|Overall Study|Lack of Efficacy|1|||
156351650|NCT05247866|564385964|FG000|Overall Study|Protocol Violation|1|||
156351651|NCT05247866|564385964|FG000|Overall Study|Withdrawal by Subject|3|||
156351652|NCT04463719|564385969|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
156351653|NCT04463719|564385970|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
156351654|NCT04463719|564385971|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
156351655|NCT02436356|564385972|FG000|Overall Study|Excluded by MRI Screening|0|||
156351656|NCT02436356|564385973|FG001|Overall Study|Excluded by MRI Screening|0|||
156351657|NCT02436356|564385974|FG002|Overall Study|Excluded by MRI Screening|2|||
156351658|NCT02436356|564385972|FG000|Overall Study|Lost to Follow-up|0|||
156351659|NCT02436356|564385973|FG001|Overall Study|Lost to Follow-up|1|||
156351660|NCT02436356|564385974|FG002|Overall Study|Lost to Follow-up|0|||
156351661|NCT02436356|564385972|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
156351662|NCT02436356|564385973|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
156351663|NCT02436356|564385974|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
156351664|NCT02436356|564385972|FG000|Overall Study|Excluded due to other medical conditions|3|||
156351665|NCT02436356|564385973|FG001|Overall Study|Excluded due to other medical conditions|0|||
156351666|NCT02436356|564385974|FG002|Overall Study|Excluded due to other medical conditions|0|||
156351667|NCT02436356|564385972|FG000|Overall Study|Withdrawal by Subject|1|||
156351668|NCT02436356|564385973|FG001|Overall Study|Withdrawal by Subject|0|||
156351669|NCT02436356|564385974|FG002|Overall Study|Withdrawal by Subject|0|||
156351670|NCT00810407|564385975|FG000|Overall Study|Protocol Violation|3|||
156351671|NCT00810407|564385975|FG000|Overall Study|No Visit After First Day of Treatment|3|||
156351672|NCT02746874|564385976|FG000|Overall Study|Withdrawal by Subject|0|||
156351673|NCT02746874|564385977|FG001|Overall Study|Withdrawal by Subject|1|||
156351674|NCT02746874|564385976|FG000|Overall Study|Surgery Date Changed|0|||
156483429|NCT02062827|564862073|FG004|Overall Study|Death|0|||
156483430|NCT02062827|564862074|FG005|Overall Study|Death|0|||
156483431|NCT02062827|564862075|FG006|Overall Study|Death|0|||
156483432|NCT02062827|564862076|FG007|Overall Study|Death|0|||
156483433|NCT02062827|564862069|FG000|Overall Study|Withdrawal by Subject|3|||
156483434|NCT02062827|564862070|FG001|Overall Study|Withdrawal by Subject|1|||
156483435|NCT02062827|564862071|FG002|Overall Study|Withdrawal by Subject|1|||
156544209|NCT04129528|565087713|FG000|Overall Study|Physician Decision|1|||
156544210|NCT04129528|565087714|FG001|Overall Study|Physician Decision|1|||
156483436|NCT02062827|564862072|FG003|Overall Study|Withdrawal by Subject|2|||
156483437|NCT02062827|564862073|FG004|Overall Study|Withdrawal by Subject|6|||
156483438|NCT02062827|564862074|FG005|Overall Study|Withdrawal by Subject|0|||
156483439|NCT02062827|564862075|FG006|Overall Study|Withdrawal by Subject|5|||
156544211|NCT04129528|565087713|FG000|Overall Study|Withdrawal by Subject|1|||
156544212|NCT04129528|565087714|FG001|Overall Study|Withdrawal by Subject|1|||
156544213|NCT00490568|565087723|FG000|Overall Study|Adverse Event|116|||
156544214|NCT00490568|565087723|FG000|Overall Study|Lost to Follow-up|13|||
156544215|NCT00490568|565087723|FG000|Overall Study|Protocol Violation|45|||
156351675|NCT02746874|564385977|FG001|Overall Study|Surgery Date Changed|2|||
156351676|NCT00487747|564385978|FG000|Overall Study|Adverse Event|1|||
156351677|NCT00487747|564385978|FG000|Overall Study|Lost to Follow-up|9|||
156351678|NCT00487747|564385978|FG000|Overall Study|Lack of Efficacy|1|||
156351679|NCT02979522|564385982|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
156351680|NCT02979522|564385983|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
156351681|NCT02979522|564385982|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
156351682|NCT02979522|564385983|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
156351683|NCT01896531|564385986|FG000|Overall Study|Death|57|||
156351684|NCT01896531|564385987|FG001|Overall Study|Death|59|||
156351685|NCT01896531|564385986|FG000|Overall Study|Lost to Follow-up|3|||
156351686|NCT01896531|564385987|FG001|Overall Study|Lost to Follow-up|0|||
156351687|NCT01896531|564385986|FG000|Overall Study|Non-compliance|0|||
156351688|NCT01896531|564385987|FG001|Overall Study|Non-compliance|1|||
156351689|NCT01896531|564385986|FG000|Overall Study|Study Ended by Sponsor|7|||
156351690|NCT01896531|564385987|FG001|Overall Study|Study Ended by Sponsor|20|||
156351691|NCT01896531|564385986|FG000|Overall Study|Withdrawal by Subject|3|||
156351692|NCT01896531|564385987|FG001|Overall Study|Withdrawal by Subject|2|||
156351693|NCT01896531|564385986|FG000|Overall Study|Death Prior to Treatment|1|||
156351694|NCT01896531|564385987|FG001|Overall Study|Death Prior to Treatment|0|||
156351695|NCT02956486|564385988|FG000|Core Phase|Adverse Event|51|||
156351696|NCT02956486|564385989|FG001|Core Phase|Adverse Event|88|||
156351697|NCT02956486|564385990|FG002|Core Phase|Adverse Event|0|||
156351698|NCT02956486|564385988|FG000|Core Phase|Lost to Follow-up|8|||
156351699|NCT02956486|564385989|FG001|Core Phase|Lost to Follow-up|6|||
156351700|NCT02956486|564385990|FG002|Core Phase|Lost to Follow-up|0|||
156351701|NCT02956486|564385988|FG000|Core Phase|Inadequate therapeutic effect|4|||
156351702|NCT02956486|564385989|FG001|Core Phase|Inadequate therapeutic effect|5|||
156351703|NCT02956486|564385990|FG002|Core Phase|Inadequate therapeutic effect|0|||
156351704|NCT02956486|564385988|FG000|Core Phase|Withdrawal by Subject|101|||
156351705|NCT02956486|564385989|FG001|Core Phase|Withdrawal by Subject|104|||
156351706|NCT02956486|564385990|FG002|Core Phase|Withdrawal by Subject|0|||
156351707|NCT02956486|564385988|FG000|Core Phase|Study terminated by sponsor|888|||
156351708|NCT02956486|564385989|FG001|Core Phase|Study terminated by sponsor|848|||
156351709|NCT02956486|564385990|FG002|Core Phase|Study terminated by sponsor|0|||
156351710|NCT02956486|564385988|FG000|Core Phase|Other|27|||
156351711|NCT02956486|564385989|FG001|Core Phase|Other|18|||
156351712|NCT02956486|564385990|FG002|Core Phase|Other|0|||
156351713|NCT02956486|564385988|FG000|Core Phase|Not treated|0|||
156351714|NCT02956486|564385989|FG001|Core Phase|Not treated|3|||
156351715|NCT02956486|564385990|FG002|Core Phase|Not treated|0|||
156351716|NCT02956486|564385988|FG000|Extension Phase|Adverse Event|0|||
156351717|NCT02956486|564385989|FG001|Extension Phase|Adverse Event|0|||
156351718|NCT02956486|564385990|FG002|Extension Phase|Adverse Event|2|||
156351719|NCT02956486|564385988|FG000|Extension Phase|Study terminated by sponsor|0|||
156351720|NCT02956486|564385989|FG001|Extension Phase|Study terminated by sponsor|0|||
156351721|NCT02956486|564385990|FG002|Extension Phase|Study terminated by sponsor|16|||
156351722|NCT02956486|564385988|FG000|Extension Phase|Not Treated|0|||
156351723|NCT02956486|564385989|FG001|Extension Phase|Not Treated|0|||
156351724|NCT02956486|564385990|FG002|Extension Phase|Not Treated|1|||
156351725|NCT00680745|564385991|FG000|Overall Study|Withdrawal by Subject|8|||
156351726|NCT00680745|564385992|FG001|Overall Study|Withdrawal by Subject|3|||
156351727|NCT00680745|564385993|FG002|Overall Study|Withdrawal by Subject|2|||
156351728|NCT00680745|564385994|FG003|Overall Study|Withdrawal by Subject|8|||
156351729|NCT00680745|564385991|FG000|Overall Study|Lost to Follow-up|0|||
156351730|NCT00680745|564385992|FG001|Overall Study|Lost to Follow-up|1|||
156351731|NCT00680745|564385993|FG002|Overall Study|Lost to Follow-up|1|||
156351732|NCT00680745|564385994|FG003|Overall Study|Lost to Follow-up|0|||
156351733|NCT00680745|564385991|FG000|Overall Study|Death|1|||
156351734|NCT00680745|564385992|FG001|Overall Study|Death|0|||
156351735|NCT00680745|564385993|FG002|Overall Study|Death|1|||
156351736|NCT00680745|564385994|FG003|Overall Study|Death|0|||
156351737|NCT00680745|564385991|FG000|Overall Study|Adverse Event|5|||
156351738|NCT00680745|564385992|FG001|Overall Study|Adverse Event|3|||
156351739|NCT00680745|564385993|FG002|Overall Study|Adverse Event|3|||
156351740|NCT00680745|564385994|FG003|Overall Study|Adverse Event|3|||
156351741|NCT00680745|564385991|FG000|Overall Study|Poor/Non-compliance|0|||
156351742|NCT00680745|564385992|FG001|Overall Study|Poor/Non-compliance|3|||
156351743|NCT00680745|564385993|FG002|Overall Study|Poor/Non-compliance|0|||
156351744|NCT00680745|564385994|FG003|Overall Study|Poor/Non-compliance|0|||
156351745|NCT00680745|564385991|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
156351746|NCT00680745|564385992|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
156351747|NCT00680745|564385993|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
156544216|NCT00490568|565087723|FG000|Overall Study|Withdrawal by Subject|135|||
156351748|NCT00680745|564385994|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
156351749|NCT00680745|564385991|FG000|Overall Study|False Treatment|0|||
156351750|NCT00680745|564385992|FG001|Overall Study|False Treatment|1|||
156351751|NCT00680745|564385993|FG002|Overall Study|False Treatment|3|||
156483440|NCT02062827|564862076|FG007|Overall Study|Withdrawal by Subject|0|||
156483441|NCT02062827|564862069|FG000|Overall Study|Screen Fail|0|||
156483442|NCT02062827|564862070|FG001|Overall Study|Screen Fail|0|||
156483443|NCT02062827|564862071|FG002|Overall Study|Screen Fail|0|||
156351752|NCT00680745|564385994|FG003|Overall Study|False Treatment|0|||
156351753|NCT02485574|564385999|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
156351754|NCT01408914|564386001|FG000|Overall Study|Could not complete tx in protocol period|5|||
156351755|NCT01408914|564386002|FG001|Overall Study|Could not complete tx in protocol period|5|||
156351756|NCT01408914|564386003|FG002|Overall Study|Could not complete tx in protocol period|6|||
156351757|NCT01408914|564386001|FG000|Overall Study|Lost to Follow-up|4|||
156351758|NCT01408914|564386002|FG001|Overall Study|Lost to Follow-up|1|||
156351759|NCT01408914|564386003|FG002|Overall Study|Lost to Follow-up|2|||
156351760|NCT01408914|564386001|FG000|Overall Study|Physician Decision|1|||
156351761|NCT01408914|564386002|FG001|Overall Study|Physician Decision|1|||
156351762|NCT01408914|564386003|FG002|Overall Study|Physician Decision|0|||
156351763|NCT01408914|564386001|FG000|Overall Study|Withdrawal by Subject|1|||
156351764|NCT01408914|564386002|FG001|Overall Study|Withdrawal by Subject|0|||
156351765|NCT01408914|564386003|FG002|Overall Study|Withdrawal by Subject|1|||
156351766|NCT01408914|564386001|FG000|Overall Study|Moved out of study jurisdiction|1|||
156351767|NCT01408914|564386002|FG001|Overall Study|Moved out of study jurisdiction|1|||
156351768|NCT01408914|564386003|FG002|Overall Study|Moved out of study jurisdiction|0|||
156351769|NCT01408914|564386001|FG000|Overall Study|Late exclusion|0|||
156351770|NCT01408914|564386002|FG001|Overall Study|Late exclusion|3|||
156351771|NCT01408914|564386003|FG002|Overall Study|Late exclusion|3|||
156351772|NCT01408914|564386001|FG000|Overall Study|Change in local TB/HIV norms|0|||
156351773|NCT01408914|564386002|FG001|Overall Study|Change in local TB/HIV norms|1|||
156351774|NCT01408914|564386003|FG002|Overall Study|Change in local TB/HIV norms|1|||
156351775|NCT04851314|564386004|FG000|Overall Study|Unable to complete research set-up procedures|0|||
156351776|NCT04851314|564386005|FG001|Overall Study|Unable to complete research set-up procedures|2|||
156351777|NCT04851314|564386004|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
156544217|NCT00490568|565087723|FG000|Overall Study|Still in the study at termination|974|||
156544218|NCT00490568|565087723|FG000|Overall Study|Other|1|||
156351778|NCT04851314|564386005|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
156351779|NCT00541034|564386010|FG000|Overall Study|Non-Compliance|3|||
156351780|NCT00847704|564386012|FG000|Overall Study|Withdrawal by Subject|1|||
156351781|NCT01962207|564386013|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
156483444|NCT02062827|564862072|FG003|Overall Study|Screen Fail|0|||
156483445|NCT02062827|564862073|FG004|Overall Study|Screen Fail|0|||
156483446|NCT02062827|564862074|FG005|Overall Study|Screen Fail|0|||
156351782|NCT01962207|564386014|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
156483447|NCT02062827|564862075|FG006|Overall Study|Screen Fail|0|||
156483448|NCT02062827|564862076|FG007|Overall Study|Screen Fail|8|||
156483449|NCT04930263|564862077|FG000|Overall Study|Withdrawal by Subject|3|||
156483450|NCT04930263|564862078|FG001|Overall Study|Withdrawal by Subject|5|||
156483451|NCT02812706|564862079|FG000|Phase 1|Adverse Event|0|||
156483452|NCT02812706|564862080|FG001|Phase 1|Adverse Event|2|||
156483453|NCT02812706|564862081|FG002|Phase 1|Adverse Event|0|||
156483454|NCT02812706|564862079|FG000|Phase 1|Progressive disease|3|||
156483455|NCT02812706|564862080|FG001|Phase 1|Progressive disease|3|||
156483456|NCT02812706|564862081|FG002|Phase 1|Progressive disease|0|||
156483457|NCT02812706|564862079|FG000|Phase 2|Adverse Event|0|||
156483458|NCT02812706|564862080|FG001|Phase 2|Adverse Event|0|||
156483459|NCT02812706|564862081|FG002|Phase 2|Adverse Event|2|||
156483460|NCT02812706|564862079|FG000|Phase 2|Progressive disease|0|||
156544219|NCT00490568|565087723|FG000|Overall Study|Exclusion criteria met|1|||
156544220|NCT00490568|565087723|FG000|Overall Study|Caregiver related|20|||
156351783|NCT01962207|564386015|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
156351784|NCT01962207|564386016|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
156351785|NCT01962207|564386013|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
156351786|NCT01962207|564386014|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
156351787|NCT01962207|564386015|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
156351788|NCT01962207|564386016|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
156351789|NCT01962207|564386013|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
156351790|NCT01962207|564386014|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
156351791|NCT01962207|564386015|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
156351792|NCT01962207|564386016|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
156351793|NCT01962207|564386013|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
156351794|NCT01962207|564386014|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
156351795|NCT01962207|564386015|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
156351796|NCT01962207|564386016|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
156351797|NCT01962207|564386013|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
156351798|NCT01962207|564386014|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
156351799|NCT01962207|564386015|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
156351800|NCT01962207|564386016|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
156483461|NCT02812706|564862080|FG001|Phase 2|Progressive disease|0|||
156483462|NCT02812706|564862081|FG002|Phase 2|Progressive disease|22|||
156483463|NCT02812706|564862079|FG000|Phase 2|Other-Unspecified|0|||
156483464|NCT02812706|564862080|FG001|Phase 2|Other-Unspecified|0|||
156483465|NCT02812706|564862081|FG002|Phase 2|Other-Unspecified|4|||
156483466|NCT04362176|564862083|FG000|Overall Study|Lost to Follow-up|5|||
156483467|NCT04362176|564862084|FG001|Overall Study|Lost to Follow-up|8|||
156483468|NCT04362176|564862083|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
156483469|NCT04362176|564862084|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
156483470|NCT06312566|564862085|FG000|Overall Study|Protocol Violation|0|||
156483471|NCT06312566|564862086|FG001|Overall Study|Protocol Violation|1|||
156483472|NCT02971683|564862087|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
156483473|NCT02971683|564862088|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
156483474|NCT02971683|564862087|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
156483475|NCT02971683|564862088|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
156483476|NCT02971683|564862087|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
156483477|NCT02971683|564862088|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
156483478|NCT02971683|564862087|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
156351801|NCT01962207|564386013|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
156483479|NCT02971683|564862088|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
156483480|NCT02971683|564862087|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
156483481|NCT02971683|564862088|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
156351802|NCT01962207|564386014|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
156483482|NCT02971683|564862087|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
156483483|NCT02971683|564862088|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
156483484|NCT02971683|564862087|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
156483485|NCT02971683|564862088|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
156483486|NCT02971683|564862087|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
156483487|NCT02971683|564862088|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
156483488|NCT02971683|564862087|FG000|Open-Label|Lost to Follow-up|1|||
156483489|NCT02971683|564862088|FG001|Open-Label|Lost to Follow-up|0|||
156483490|NCT02971683|564862087|FG000|Open-Label|Participants withdrew consent|0|||
156483491|NCT02971683|564862088|FG001|Open-Label|Participants withdrew consent|2|||
156483492|NCT02971683|564862087|FG000|Open-Label|Participant request to discontinue study treatment|1|||
156483493|NCT02971683|564862088|FG001|Open-Label|Participant request to discontinue study treatment|0|||
156483494|NCT02971683|564862087|FG000|Open-Label|Lack of Efficacy|2|||
156483495|NCT02971683|564862088|FG001|Open-Label|Lack of Efficacy|0|||
156483496|NCT02971683|564862087|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
156483497|NCT02971683|564862088|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
156483498|NCT02971683|564862087|FG000|Long-Term Open Label|Participant withdrew consent|1|||
156483499|NCT02971683|564862088|FG001|Long-Term Open Label|Participant withdrew consent|0|||
156483500|NCT02971683|564862087|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
156483501|NCT02971683|564862088|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
156483502|NCT02971683|564862087|FG000|Long-Term Open Label|Adverse Event|1|||
156483503|NCT02971683|564862088|FG001|Long-Term Open Label|Adverse Event|2|||
156483504|NCT02971683|564862087|FG000|Long-Term Open Label|Lack of Efficacy|1|||
156483505|NCT02971683|564862088|FG001|Long-Term Open Label|Lack of Efficacy|1|||
156483506|NCT01699178|564862089|FG000|Overall Study|Adverse Event|1|||
156483507|NCT01699178|564862090|FG001|Overall Study|Adverse Event|5|||
156483508|NCT01699178|564862089|FG000|Overall Study|Lost to Follow-up|1|||
156483509|NCT01699178|564862090|FG001|Overall Study|Lost to Follow-up|6|||
156483510|NCT01699178|564862089|FG000|Overall Study|Non-compliance with Study Drug|3|||
156483511|NCT01699178|564862090|FG001|Overall Study|Non-compliance with Study Drug|1|||
156483512|NCT01699178|564862089|FG000|Overall Study|Physician Decision|1|||
156483513|NCT01699178|564862090|FG001|Overall Study|Physician Decision|0|||
156483514|NCT01699178|564862089|FG000|Overall Study|Withdrawal by Subject|4|||
156483515|NCT01699178|564862090|FG001|Overall Study|Withdrawal by Subject|12|||
156483516|NCT01699178|564862089|FG000|Overall Study|Hematocrit >54%|1|||
156483517|NCT01699178|564862090|FG001|Overall Study|Hematocrit >54%|1|||
156483518|NCT01699178|564862089|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
156483519|NCT01699178|564862090|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
156483520|NCT01699178|564862089|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
156483521|NCT01699178|564862090|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
156483522|NCT04016415|564862093|FG000|Overall Study|Adverse Event|2|||
156483523|NCT04016415|564862094|FG001|Overall Study|Adverse Event|1|||
156483524|NCT04016415|564862093|FG000|Overall Study|Lost to Follow-up|6|||
156483525|NCT04016415|564862094|FG001|Overall Study|Lost to Follow-up|2|||
156483526|NCT04016415|564862093|FG000|Overall Study|Physician Decision|5|||
156483527|NCT04016415|564862094|FG001|Overall Study|Physician Decision|1|||
156483528|NCT04016415|564862093|FG000|Overall Study|Pregnancy|0|||
156483529|NCT04016415|564862094|FG001|Overall Study|Pregnancy|1|||
156483530|NCT04016415|564862093|FG000|Overall Study|Withdrawal by Subject|24|||
156483531|NCT04016415|564862094|FG001|Overall Study|Withdrawal by Subject|27|||
156483532|NCT04016415|564862093|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
156483533|NCT04016415|564862094|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
156483534|NCT00912964|564862097|FG000|Overall Study|Eligibility criterion not met|1|||
156483535|NCT00912964|564862098|FG001|Overall Study|Eligibility criterion not met|1|||
156483536|NCT00912964|564862099|FG002|Overall Study|Eligibility criterion not met|0|||
156483537|NCT00912964|564862097|FG000|Overall Study|Adverse Event|15|||
156483538|NCT00912964|564862098|FG001|Overall Study|Adverse Event|18|||
156483539|NCT00912964|564862099|FG002|Overall Study|Adverse Event|12|||
156483540|NCT00912964|564862097|FG000|Overall Study|Lack of Efficacy|11|||
156483541|NCT00912964|564862098|FG001|Overall Study|Lack of Efficacy|4|||
156483542|NCT00912964|564862099|FG002|Overall Study|Lack of Efficacy|3|||
156483543|NCT00912964|564862097|FG000|Overall Study|Withdrawal by Subject|20|||
156483544|NCT00912964|564862098|FG001|Overall Study|Withdrawal by Subject|12|||
156483545|NCT00912964|564862099|FG002|Overall Study|Withdrawal by Subject|18|||
156483546|NCT00912964|564862097|FG000|Overall Study|Lost to Follow-up|4|||
156483547|NCT00912964|564862098|FG001|Overall Study|Lost to Follow-up|3|||
156483548|NCT00912964|564862099|FG002|Overall Study|Lost to Follow-up|3|||
156544221|NCT00490568|565087723|FG000|Overall Study|Abnormal ECG|25|||
156483549|NCT00912964|564862097|FG000|Overall Study|Protocol Violation|5|||
156544222|NCT00490568|565087723|FG000|Overall Study|Participant refused follow-up|9|||
156483550|NCT00912964|564862098|FG001|Overall Study|Protocol Violation|3|||
156544223|NCT00490568|565087723|FG000|Overall Study|Legal representative withdrew consent|1|||
156544224|NCT00490568|565087723|FG000|Overall Study|Disease progression|4|||
156544225|NCT00490568|565087723|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
156544226|NCT00490568|565087723|FG000|Overall Study|Investigator decision|3|||
156544227|NCT00490568|565087723|FG000|Overall Study|Non-Compliance|7|||
156544228|NCT00490568|565087723|FG000|Overall Study|Efficacy related|3|||
156544229|NCT00490568|565087723|FG000|Overall Study|Participant died|1|||
156544230|NCT00490568|565087723|FG000|Overall Study|Participant withdrawal due to surgery|1|||
156544231|NCT03927105|565087726|FG000|Overall Study|Death|1|||
156544232|NCT03927105|565087726|FG000|Overall Study|In observation for potential re-treatment|2|||
156544233|NCT03927105|565087726|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
156544234|NCT01351389|565087728|FG000|Overall Study|Withdrawal by Subject|7|||
156544235|NCT01351389|565087729|FG001|Overall Study|Withdrawal by Subject|0|||
156544236|NCT01351389|565087728|FG000|Overall Study|did not complete intervention|23|||
156544237|NCT01351389|565087729|FG001|Overall Study|did not complete intervention|15|||
156544238|NCT01081912|565087730|FG000|Conversion/Titration|Adverse Event|47|||
156544239|NCT01081912|565087731|FG001|Conversion/Titration|Adverse Event|0|||
156544240|NCT01081912|565087732|FG002|Conversion/Titration|Adverse Event|0|||
156544241|NCT01081912|565087730|FG000|Conversion/Titration|Lack of Efficacy|17|||
156544242|NCT01081912|565087731|FG001|Conversion/Titration|Lack of Efficacy|0|||
156544243|NCT01081912|565087732|FG002|Conversion/Titration|Lack of Efficacy|0|||
156544244|NCT01081912|565087730|FG000|Conversion/Titration|Lost to Follow-up|5|||
156544245|NCT01081912|565087731|FG001|Conversion/Titration|Lost to Follow-up|0|||
156544246|NCT01081912|565087732|FG002|Conversion/Titration|Lost to Follow-up|0|||
156544247|NCT01081912|565087730|FG000|Conversion/Titration|Physician Decision|2|||
156544248|NCT01081912|565087731|FG001|Conversion/Titration|Physician Decision|0|||
156544249|NCT01081912|565087732|FG002|Conversion/Titration|Physician Decision|0|||
156544250|NCT01081912|565087730|FG000|Conversion/Titration|Protocol Violation|67|||
156544251|NCT01081912|565087731|FG001|Conversion/Titration|Protocol Violation|0|||
156544252|NCT01081912|565087732|FG002|Conversion/Titration|Protocol Violation|0|||
156544253|NCT01081912|565087730|FG000|Conversion/Titration|Withdrawal by Subject|23|||
156544254|NCT01081912|565087731|FG001|Conversion/Titration|Withdrawal by Subject|0|||
156544255|NCT01081912|565087732|FG002|Conversion/Titration|Withdrawal by Subject|0|||
156544256|NCT01081912|565087730|FG000|Conversion/Titration|Non-Compliance|47|||
156544257|NCT01081912|565087731|FG001|Conversion/Titration|Non-Compliance|0|||
156544258|NCT01081912|565087732|FG002|Conversion/Titration|Non-Compliance|0|||
156544259|NCT01081912|565087730|FG000|Maintenance Treatment|Adverse Event|0|||
156544260|NCT01081912|565087731|FG001|Maintenance Treatment|Adverse Event|2|||
156544261|NCT01081912|565087732|FG002|Maintenance Treatment|Adverse Event|12|||
156544262|NCT01081912|565087730|FG000|Maintenance Treatment|Lack of Efficacy|0|||
156544263|NCT01081912|565087731|FG001|Maintenance Treatment|Lack of Efficacy|14|||
156544264|NCT01081912|565087732|FG002|Maintenance Treatment|Lack of Efficacy|64|||
156544265|NCT01081912|565087730|FG000|Maintenance Treatment|Lost to Follow-up|0|||
156544266|NCT01081912|565087731|FG001|Maintenance Treatment|Lost to Follow-up|1|||
156544267|NCT01081912|565087732|FG002|Maintenance Treatment|Lost to Follow-up|0|||
156544268|NCT01081912|565087730|FG000|Maintenance Treatment|Physician Decision|0|||
156544269|NCT01081912|565087731|FG001|Maintenance Treatment|Physician Decision|0|||
156544270|NCT01081912|565087732|FG002|Maintenance Treatment|Physician Decision|1|||
156544271|NCT01081912|565087730|FG000|Maintenance Treatment|Protocol Violation|0|||
156544272|NCT01081912|565087731|FG001|Maintenance Treatment|Protocol Violation|1|||
156544273|NCT01081912|565087732|FG002|Maintenance Treatment|Protocol Violation|2|||
156483551|NCT00912964|564862099|FG002|Overall Study|Protocol Violation|8|||
156483552|NCT00912964|564862097|FG000|Overall Study|Taking exclusionary medications|7|||
156483553|NCT00912964|564862098|FG001|Overall Study|Taking exclusionary medications|4|||
156483554|NCT00912964|564862099|FG002|Overall Study|Taking exclusionary medications|8|||
156483555|NCT00912964|564862097|FG000|Overall Study|Medical History|1|||
156483556|NCT00912964|564862098|FG001|Overall Study|Medical History|0|||
156483557|NCT00912964|564862099|FG002|Overall Study|Medical History|0|||
156483558|NCT00912964|564862097|FG000|Overall Study|Non-compliance with study procedures|2|||
156483559|NCT00912964|564862098|FG001|Overall Study|Non-compliance with study procedures|0|||
156544274|NCT01081912|565087730|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
156544275|NCT01081912|565087731|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
156544276|NCT01081912|565087732|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
156544277|NCT01081912|565087730|FG000|Maintenance Treatment|Non-Compliance|0|||
156544278|NCT01081912|565087731|FG001|Maintenance Treatment|Non-Compliance|4|||
156544279|NCT01081912|565087732|FG002|Maintenance Treatment|Non-Compliance|7|||
156544280|NCT01081912|565087730|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
156544281|NCT01081912|565087731|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
156544282|NCT01081912|565087732|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
156483560|NCT00912964|564862099|FG002|Overall Study|Non-compliance with study procedures|0|||
156483561|NCT00912964|564862097|FG000|Overall Study|Violation of exclusion criterion|0|||
156483562|NCT00912964|564862098|FG001|Overall Study|Violation of exclusion criterion|0|||
156483563|NCT00912964|564862099|FG002|Overall Study|Violation of exclusion criterion|2|||
156483564|NCT00912964|564862097|FG000|Overall Study|Randomized but never received study drug|0|||
156483565|NCT00912964|564862098|FG001|Overall Study|Randomized but never received study drug|1|||
156483566|NCT00912964|564862099|FG002|Overall Study|Randomized but never received study drug|0|||
156483567|NCT02260154|564862100|FG000|Overall Study|Screening failure|2|||
156483568|NCT03547167|564862103|FG000|Overall Study|Withdrawal by Subject|34|||
156483569|NCT03547167|564862104|FG001|Overall Study|Withdrawal by Subject|12|||
156483570|NCT03547167|564862103|FG000|Overall Study|Screen Failure|0|||
156483571|NCT03547167|564862104|FG001|Overall Study|Screen Failure|1|||
156483572|NCT03547167|564862103|FG000|Overall Study|Lost to Follow-up|59|||
156483573|NCT03547167|564862104|FG001|Overall Study|Lost to Follow-up|15|||
156483574|NCT03547167|564862103|FG000|Overall Study|Death|4|||
156483575|NCT03547167|564862104|FG001|Overall Study|Death|2|||
156483576|NCT00070317|564862105|FG000|Overall Study|Inevaluable (Never Treated)|1|||
156483577|NCT00070317|564862105|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
156483578|NCT00070317|564862105|FG000|Overall Study|Ineligible required test not done|1|||
156483579|NCT00070317|564862105|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
156483580|NCT00070317|564862105|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
156483581|NCT01885559|564862106|FG000|Overall Study|Lost to Follow-up|15|||
156483582|NCT01885559|564862107|FG001|Overall Study|Lost to Follow-up|16|||
156483583|NCT01885559|564862106|FG000|Overall Study|Less than full participation|9|||
156483584|NCT01885559|564862107|FG001|Overall Study|Less than full participation|19|||
156483585|NCT01885559|564862106|FG000|Overall Study|Protocol Violation|0|||
156483586|NCT01885559|564862107|FG001|Overall Study|Protocol Violation|1|||
156483587|NCT00645411|564862108|FG000|Overall Study|Adverse Event|0|||
156483588|NCT00645411|564862109|FG001|Overall Study|Adverse Event|0|||
156483589|NCT00645411|564862110|FG002|Overall Study|Adverse Event|0|||
156483590|NCT00645411|564862111|FG003|Overall Study|Adverse Event|2|||
156483591|NCT00645411|564862108|FG000|Overall Study|Withdrawal by Subject|2|||
156483592|NCT00645411|564862109|FG001|Overall Study|Withdrawal by Subject|1|||
156483593|NCT00645411|564862110|FG002|Overall Study|Withdrawal by Subject|19|||
156483594|NCT00645411|564862111|FG003|Overall Study|Withdrawal by Subject|21|||
156483595|NCT00645411|564862108|FG000|Overall Study|Lost to Follow-up|10|||
156483596|NCT00645411|564862109|FG001|Overall Study|Lost to Follow-up|5|||
156483597|NCT00645411|564862110|FG002|Overall Study|Lost to Follow-up|124|||
156483598|NCT00645411|564862111|FG003|Overall Study|Lost to Follow-up|75|||
156483599|NCT00645411|564862108|FG000|Overall Study|Protocol Violation|1|||
156483600|NCT00645411|564862109|FG001|Overall Study|Protocol Violation|0|||
156483601|NCT00645411|564862110|FG002|Overall Study|Protocol Violation|1|||
156483602|NCT00645411|564862111|FG003|Overall Study|Protocol Violation|0|||
156483603|NCT00645411|564862108|FG000|Overall Study|Inappropriate enrollment|0|||
156483604|NCT00645411|564862109|FG001|Overall Study|Inappropriate enrollment|0|||
156483605|NCT00645411|564862110|FG002|Overall Study|Inappropriate enrollment|4|||
156483606|NCT00645411|564862111|FG003|Overall Study|Inappropriate enrollment|1|||
156483607|NCT00645411|564862108|FG000|Overall Study|Unable to classify|0|||
156483608|NCT00645411|564862109|FG001|Overall Study|Unable to classify|0|||
156483609|NCT00645411|564862110|FG002|Overall Study|Unable to classify|3|||
156483610|NCT00645411|564862111|FG003|Overall Study|Unable to classify|4|||
156483611|NCT03560206|564862112|FG000|Overall Study|Lost to Follow-up|19|||
156483612|NCT03560206|564862113|FG001|Overall Study|Lost to Follow-up|11|||
156483613|NCT03560206|564862112|FG000|Overall Study|Withdrawal by Subject|2|||
156483614|NCT03560206|564862113|FG001|Overall Study|Withdrawal by Subject|4|||
156483615|NCT03560206|564862112|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
156483616|NCT03560206|564862113|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
156483617|NCT03560206|564862112|FG000|Overall Study|Busy schedule|14|||
156483618|NCT03560206|564862113|FG001|Overall Study|Busy schedule|2|||
156483619|NCT03560206|564862112|FG000|Overall Study|patients' new health condition such as cancer|10|||
156483620|NCT03560206|564862113|FG001|Overall Study|patients' new health condition such as cancer|1|||
156483621|NCT03100370|564862114|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156483622|NCT03100370|564862115|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156483623|NCT03100370|564862116|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156483624|NCT03100370|564862117|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156483625|NCT03100370|564862118|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156483626|NCT03100370|564862119|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156483627|NCT00738400|564862120|FG000|Overall Study|Adverse Event|3|||
156483628|NCT00738400|564862121|FG001|Overall Study|Adverse Event|1|||
156483629|NCT00738400|564862120|FG000|Overall Study|Withdrawal by Subject|0|||
156483630|NCT00738400|564862121|FG001|Overall Study|Withdrawal by Subject|1|||
156483631|NCT00738400|564862120|FG000|Overall Study|Lack of Efficacy|0|||
156483632|NCT00738400|564862121|FG001|Overall Study|Lack of Efficacy|1|||
156483633|NCT00738400|564862120|FG000|Overall Study|Lost to Follow-up|0|||
156483634|NCT00738400|564862121|FG001|Overall Study|Lost to Follow-up|3|||
156483635|NCT00738400|564862120|FG000|Overall Study|Protocol Violation|1|||
156483636|NCT00738400|564862121|FG001|Overall Study|Protocol Violation|0|||
156483637|NCT00738400|564862120|FG000|Overall Study|Non-compliant with study medication|0|||
156483638|NCT00738400|564862121|FG001|Overall Study|Non-compliant with study medication|1|||
156483639|NCT02674399|564862122|FG000|Overall Study|Lost to Follow-up|2|||
156483640|NCT02674399|564862123|FG001|Overall Study|Lost to Follow-up|0|||
156483641|NCT00091572|564862137|FG000|Overall Study|Lost to Follow-up|1|||
156483642|NCT00091572|564862138|FG001|Overall Study|Lost to Follow-up|1|||
156483643|NCT00091572|564862137|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
156483644|NCT00091572|564862138|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
156483645|NCT00091572|564862137|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
156483646|NCT00091572|564862138|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
156483647|NCT00091572|564862137|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
156483648|NCT00091572|564862138|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
156483649|NCT00091572|564862137|FG000|Overall Study|Other Reason|6|||
156483650|NCT00091572|564862138|FG001|Overall Study|Other Reason|13|||
156483651|NCT00091572|564862137|FG000|Overall Study|Ongoing (still on treatment)|8|||
156483652|NCT00091572|564862138|FG001|Overall Study|Ongoing (still on treatment)|12|||
156483653|NCT00091572|564862137|FG000|Overall Study|Major Protocol Violation|2|||
156483654|NCT00091572|564862138|FG001|Overall Study|Major Protocol Violation|0|||
156483655|NCT00091572|564862137|FG000|Overall Study|Toxicity (Related AE)|53|||
156483656|NCT00091572|564862138|FG001|Overall Study|Toxicity (Related AE)|9|||
156483657|NCT04097535|564862139|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
156483658|NCT03070301|564862140|FG000|Overall Study|Progression of disease|16|||
156483659|NCT03070301|564862140|FG000|Overall Study|Physician Decision|3|||
156483660|NCT03070301|564862140|FG000|Overall Study|Withdrawal by Subject|1|||
156483661|NCT02514577|564863353|FG000|Overall Study|Lost to Follow-up|6|||
156483662|NCT02514577|564863354|FG001|Overall Study|Lost to Follow-up|6|||
156483663|NCT02514577|564863353|FG000|Overall Study|Protocol Violation|1|||
156483664|NCT02514577|564863354|FG001|Overall Study|Protocol Violation|0|||
156483665|NCT02514577|564863353|FG000|Overall Study|Withdrawal by Subject|6|||
156483666|NCT02514577|564863354|FG001|Overall Study|Withdrawal by Subject|6|||
156483667|NCT02514577|564863353|FG000|Overall Study|Adverse Event|1|||
156483668|NCT02514577|564863354|FG001|Overall Study|Adverse Event|1|||
156483669|NCT00489489|564863355|FG000|Overall Study|Not treated due to protocol violation|0|||
156483670|NCT00489489|564863356|FG001|Overall Study|Not treated due to protocol violation|1|||
156483671|NCT00489489|564863357|FG002|Overall Study|Not treated due to protocol violation|1|||
156483672|NCT00489489|564863355|FG000|Overall Study|Adverse Event|1|||
156483673|NCT00489489|564863356|FG001|Overall Study|Adverse Event|1|||
156483674|NCT00489489|564863357|FG002|Overall Study|Adverse Event|1|||
156483675|NCT00489489|564863355|FG000|Overall Study|Protocol Violation|1|||
156483676|NCT00489489|564863356|FG001|Overall Study|Protocol Violation|0|||
156483677|NCT00489489|564863357|FG002|Overall Study|Protocol Violation|1|||
156483678|NCT00489489|564863355|FG000|Overall Study|Progressive disease|0|||
156483679|NCT00489489|564863356|FG001|Overall Study|Progressive disease|1|||
156483680|NCT00489489|564863357|FG002|Overall Study|Progressive disease|0|||
156483681|NCT00489489|564863355|FG000|Overall Study|Participant did not wish to continue|1|||
156483682|NCT00489489|564863356|FG001|Overall Study|Participant did not wish to continue|1|||
156483683|NCT00489489|564863357|FG002|Overall Study|Participant did not wish to continue|0|||
156483684|NCT00489489|564863355|FG000|Overall Study|Other than above|0|||
156483685|NCT00489489|564863356|FG001|Overall Study|Other than above|1|||
156483686|NCT00489489|564863357|FG002|Overall Study|Other than above|0|||
156483687|NCT03978130|564863362|FG000|Overall Study|Lost to Follow-up|13|||
156483688|NCT03978130|564863363|FG001|Overall Study|Lost to Follow-up|14|||
156483689|NCT03978130|564863362|FG000|Overall Study|Withdrawal by Subject|12|||
156483690|NCT03978130|564863363|FG001|Overall Study|Withdrawal by Subject|2|||
156483691|NCT03978130|564863362|FG000|Overall Study|Adverse Event|2|||
156483692|NCT03978130|564863363|FG001|Overall Study|Adverse Event|1|||
156483693|NCT02880293|564863364|FG000|Overall Study|Inevaluable|5|||
156483694|NCT01038128|564863367|FG000|Overall Study|Lack of Efficacy|1|||
156483695|NCT01038128|564863367|FG000|Overall Study|Lost to Follow-up|1|||
156483696|NCT01038128|564863367|FG000|Overall Study|Withdrawal by Subject|2|||
156483697|NCT04203199|564863374|FG000|First Intervention Period|Lost to Follow-up|0|||
156483698|NCT04203199|564863375|FG001|First Intervention Period|Lost to Follow-up|1|||
156483699|NCT04203199|564863374|FG000|Second Intervention Period|Medication change|1|||
156483700|NCT04203199|564863375|FG001|Second Intervention Period|Medication change|0|||
156483701|NCT01838499|564863379|FG000|Overall Study|Protocol Violation|0|||
156483702|NCT01838499|564863380|FG001|Overall Study|Protocol Violation|1|||
156483703|NCT01838499|564863379|FG000|Overall Study|Lost to Follow-up|2|||
156483704|NCT01838499|564863380|FG001|Overall Study|Lost to Follow-up|4|||
156483705|NCT01838499|564863379|FG000|Overall Study|Lack of Efficacy|1|||
156483706|NCT01838499|564863380|FG001|Overall Study|Lack of Efficacy|2|||
156483707|NCT01838499|564863379|FG000|Overall Study|Adverse Event|2|||
156483708|NCT01838499|564863380|FG001|Overall Study|Adverse Event|1|||
156351803|NCT01962207|564386015|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
156351804|NCT01962207|564386016|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
156351805|NCT03036072|564386020|FG000|Overall Study|Death|0|||
156351806|NCT03036072|564386021|FG001|Overall Study|Death|1|||
156351807|NCT03036072|564386020|FG000|Overall Study|Withdrawal by Subject|0|||
156351808|NCT03036072|564386021|FG001|Overall Study|Withdrawal by Subject|1|||
156351809|NCT03036072|564386020|FG000|Overall Study|Physician Decision|0|||
156351810|NCT03036072|564386021|FG001|Overall Study|Physician Decision|1|||
156483709|NCT01838499|564863379|FG000|Overall Study|Withdrawal by Subject|19|||
156483710|NCT01838499|564863380|FG001|Overall Study|Withdrawal by Subject|9|||
156483711|NCT03614923|564863381|FG000|Overall Study|Withdrawal by Subject|2|||
156351811|NCT00680043|564386022|FG000|Overall Study|Withdrawal by Subject|1|||
156483712|NCT03614923|564863382|FG001|Overall Study|Withdrawal by Subject|1|||
156483713|NCT03614923|564863383|FG002|Overall Study|Withdrawal by Subject|1|||
156483714|NCT03614923|564863381|FG000|Overall Study|Adverse Event|0|||
156483715|NCT03614923|564863382|FG001|Overall Study|Adverse Event|2|||
156483716|NCT03614923|564863383|FG002|Overall Study|Adverse Event|1|||
156483717|NCT03614923|564863381|FG000|Overall Study|Lost to Follow-up|1|||
156483718|NCT03614923|564863382|FG001|Overall Study|Lost to Follow-up|0|||
156483719|NCT03614923|564863383|FG002|Overall Study|Lost to Follow-up|1|||
156483720|NCT03614923|564863381|FG000|Overall Study|Lack of Efficacy|2|||
156483721|NCT03614923|564863382|FG001|Overall Study|Lack of Efficacy|0|||
156483722|NCT03614923|564863383|FG002|Overall Study|Lack of Efficacy|1|||
156483723|NCT03614923|564863381|FG000|Overall Study|Non-compliance|0|||
156483724|NCT03614923|564863382|FG001|Overall Study|Non-compliance|1|||
156483725|NCT03614923|564863383|FG002|Overall Study|Non-compliance|0|||
156483726|NCT03614923|564863381|FG000|Overall Study|Other|0|||
156483727|NCT03614923|564863382|FG001|Overall Study|Other|1|||
156483728|NCT03614923|564863383|FG002|Overall Study|Other|1|||
156483729|NCT01136733|564863384|FG000|Phase 1b|Adverse Event|0|||
156483730|NCT01136733|564863385|FG001|Phase 1b|Adverse Event|3|||
156483731|NCT01136733|564863386|FG002|Phase 1b|Adverse Event|1|||
156483732|NCT01136733|564863387|FG003|Phase 1b|Adverse Event|0|||
156483733|NCT01136733|564863388|FG004|Phase 1b|Adverse Event|0|||
156483734|NCT01136733|564863389|FG005|Phase 1b|Adverse Event|0|||
156483735|NCT01136733|564863390|FG006|Phase 1b|Adverse Event|0|||
156483736|NCT01136733|564863384|FG000|Phase 1b|Participant Choice|0|||
156483737|NCT01136733|564863385|FG001|Phase 1b|Participant Choice|0|||
156483738|NCT01136733|564863386|FG002|Phase 1b|Participant Choice|1|||
156483739|NCT01136733|564863387|FG003|Phase 1b|Participant Choice|0|||
156483740|NCT01136733|564863388|FG004|Phase 1b|Participant Choice|0|||
156483741|NCT01136733|564863389|FG005|Phase 1b|Participant Choice|0|||
156483742|NCT01136733|564863390|FG006|Phase 1b|Participant Choice|0|||
156483743|NCT01136733|564863384|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
156483744|NCT01136733|564863385|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
156483745|NCT01136733|564863386|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
156483746|NCT01136733|564863387|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
156483747|NCT01136733|564863388|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
156483748|NCT01136733|564863389|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
156483749|NCT01136733|564863390|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
156483750|NCT01136733|564863384|FG000|Phase 1b|Clinical Progression|1|||
156483751|NCT01136733|564863385|FG001|Phase 1b|Clinical Progression|1|||
156483752|NCT01136733|564863386|FG002|Phase 1b|Clinical Progression|0|||
156483753|NCT01136733|564863387|FG003|Phase 1b|Clinical Progression|0|||
156483754|NCT01136733|564863388|FG004|Phase 1b|Clinical Progression|0|||
156483755|NCT01136733|564863389|FG005|Phase 1b|Clinical Progression|0|||
156483756|NCT01136733|564863390|FG006|Phase 1b|Clinical Progression|0|||
156351812|NCT00680043|564386023|FG001|Overall Study|Withdrawal by Subject|0|||
156483757|NCT01136733|564863384|FG000|Phase 2|Disease Progression|0|||
156483758|NCT01136733|564863385|FG001|Phase 2|Disease Progression|0|||
156483759|NCT01136733|564863386|FG002|Phase 2|Disease Progression|0|||
156483760|NCT01136733|564863387|FG003|Phase 2|Disease Progression|0|||
156483761|NCT01136733|564863388|FG004|Phase 2|Disease Progression|30|||
156483762|NCT01136733|564863389|FG005|Phase 2|Disease Progression|32|||
156483763|NCT01136733|564863390|FG006|Phase 2|Disease Progression|38|||
156483764|NCT01136733|564863384|FG000|Phase 2|Adverse Event|0|||
156483765|NCT01136733|564863385|FG001|Phase 2|Adverse Event|0|||
156483766|NCT01136733|564863386|FG002|Phase 2|Adverse Event|0|||
156483767|NCT01136733|564863387|FG003|Phase 2|Adverse Event|0|||
156483768|NCT01136733|564863388|FG004|Phase 2|Adverse Event|11|||
156483769|NCT01136733|564863389|FG005|Phase 2|Adverse Event|13|||
156483770|NCT01136733|564863390|FG006|Phase 2|Adverse Event|5|||
156483771|NCT01136733|564863384|FG000|Phase 2|Participant Choice|0|||
156483772|NCT01136733|564863385|FG001|Phase 2|Participant Choice|0|||
156483773|NCT01136733|564863386|FG002|Phase 2|Participant Choice|0|||
156483774|NCT01136733|564863387|FG003|Phase 2|Participant Choice|0|||
156351813|NCT00680043|564386024|FG002|Overall Study|Withdrawal by Subject|0|||
156483775|NCT01136733|564863388|FG004|Phase 2|Participant Choice|3|||
156483776|NCT01136733|564863389|FG005|Phase 2|Participant Choice|0|||
156483777|NCT01136733|564863390|FG006|Phase 2|Participant Choice|1|||
156351814|NCT00680043|564386022|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
156351815|NCT00680043|564386023|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
156351816|NCT00680043|564386024|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
156351817|NCT00680043|564386022|FG000|Overall Study|Renal Transplant|1|||
156351818|NCT00680043|564386023|FG001|Overall Study|Renal Transplant|0|||
156351819|NCT00680043|564386024|FG002|Overall Study|Renal Transplant|4|||
156351820|NCT02484729|564386025|FG000|Overall Study|Failure of IntelliCap Error|0|||
156351821|NCT02484729|564386026|FG001|Overall Study|Failure of IntelliCap Error|0|||
156351822|NCT02484729|564386027|FG002|Overall Study|Failure of IntelliCap Error|0|||
156351823|NCT02484729|564386028|FG003|Overall Study|Failure of IntelliCap Error|0|||
156351824|NCT02484729|564386029|FG004|Overall Study|Failure of IntelliCap Error|0|||
156351825|NCT02484729|564386030|FG005|Overall Study|Failure of IntelliCap Error|0|||
156351826|NCT02484729|564386031|FG006|Overall Study|Failure of IntelliCap Error|0|||
156351827|NCT02484729|564386032|FG007|Overall Study|Failure of IntelliCap Error|0|||
156351828|NCT02484729|564386033|FG008|Overall Study|Failure of IntelliCap Error|0|||
156351829|NCT02484729|564386034|FG009|Overall Study|Failure of IntelliCap Error|1|||
156351830|NCT03334903|564386035|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
156351831|NCT03334903|564386036|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
156351832|NCT03334903|564386035|FG000|Overall Study|Protocol Violation|1|||
156351833|NCT03334903|564386036|FG001|Overall Study|Protocol Violation|3|||
156351834|NCT03334903|564386035|FG000|Overall Study|Surgery postponed|1|||
156351835|NCT03334903|564386036|FG001|Overall Study|Surgery postponed|0|||
156351836|NCT03334903|564386035|FG000|Overall Study|Adverse Event|1|||
156351837|NCT03334903|564386036|FG001|Overall Study|Adverse Event|1|||
156351838|NCT03334903|564386035|FG000|Overall Study|Withdrawal by Subject|0|||
156351839|NCT03334903|564386036|FG001|Overall Study|Withdrawal by Subject|1|||
156351840|NCT02081690|564387461|FG000|Overall Study|Death|3|||
156351841|NCT02081690|564387461|FG000|Overall Study|Physician Decision|3|||
156351842|NCT02081690|564387461|FG000|Overall Study|Withdrawal by Subject|1|||
156351843|NCT02734810|564387462|FG000|Overall Study|Adverse Event|1|||
156351844|NCT02734810|564387463|FG001|Overall Study|Adverse Event|0|||
156351845|NCT02734810|564387462|FG000|Overall Study|Lack of Efficacy|1|||
156351846|NCT02734810|564387463|FG001|Overall Study|Lack of Efficacy|0|||
156351847|NCT02507505|564387465|FG000|Overall Study|Withdrawal by Subject|13|||
156351848|NCT02507505|564387466|FG001|Overall Study|Withdrawal by Subject|11|||
156351849|NCT02507505|564387465|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
156351850|NCT02507505|564387466|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
156351851|NCT02507505|564387465|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
156351852|NCT02507505|564387466|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
156351853|NCT02507505|564387465|FG000|Overall Study|Death before receipt of anesthesia|0|||
156351854|NCT02507505|564387466|FG001|Overall Study|Death before receipt of anesthesia|1|||
156351855|NCT00254540|564387467|FG000|Overall Study|Adverse Event|6|||
156351856|NCT00254540|564387468|FG001|Overall Study|Adverse Event|7|||
156351857|NCT00254540|564387467|FG000|Overall Study|Lack of Efficacy|13|||
156483778|NCT01136733|564863384|FG000|Phase 2|Administrative-Withdrew Consent|0|||
156483779|NCT01136733|564863385|FG001|Phase 2|Administrative-Withdrew Consent|0|||
156483780|NCT01136733|564863386|FG002|Phase 2|Administrative-Withdrew Consent|0|||
156483781|NCT01136733|564863387|FG003|Phase 2|Administrative-Withdrew Consent|0|||
156483782|NCT01136733|564863388|FG004|Phase 2|Administrative-Withdrew Consent|1|||
156483783|NCT01136733|564863389|FG005|Phase 2|Administrative-Withdrew Consent|0|||
156483784|NCT01136733|564863390|FG006|Phase 2|Administrative-Withdrew Consent|0|||
156483785|NCT01136733|564863384|FG000|Phase 2|Other|0|||
156483786|NCT01136733|564863385|FG001|Phase 2|Other|0|||
156483787|NCT01136733|564863386|FG002|Phase 2|Other|0|||
156483788|NCT01136733|564863387|FG003|Phase 2|Other|0|||
156483789|NCT01136733|564863388|FG004|Phase 2|Other|6|||
156483790|NCT01136733|564863389|FG005|Phase 2|Other|7|||
156483791|NCT01136733|564863390|FG006|Phase 2|Other|6|||
156351858|NCT00254540|564387468|FG001|Overall Study|Lack of Efficacy|13|||
156351859|NCT00254540|564387467|FG000|Overall Study|Death|0|||
156351860|NCT00254540|564387468|FG001|Overall Study|Death|1|||
156351861|NCT00254540|564387467|FG000|Overall Study|Laboratory Test Abnormality|0|||
156351862|NCT00254540|564387468|FG001|Overall Study|Laboratory Test Abnormality|1|||
156483792|NCT01882088|564863392|FG000|Overall Study|Intolerance of esophageal manometry|1|||
156483793|NCT01882088|564863392|FG000|Overall Study|no possibility to place the catheter|1|||
156483794|NCT01882088|564863392|FG000|Overall Study|Protocol Violation|1|||
156483795|NCT01882088|564863392|FG000|Overall Study|inadequate pH-impedance tracings|2|||
156483796|NCT02186015|564863393|FG000|Overall Study|Physician Decision|1|||
156483797|NCT02186015|564863394|FG001|Overall Study|Physician Decision|0|||
156483798|NCT02069366|564863397|FG000|Overall Study|Lost to Follow-up|0|||
156483799|NCT02069366|564863398|FG001|Overall Study|Lost to Follow-up|0|||
156483800|NCT02069366|564863399|FG002|Overall Study|Lost to Follow-up|1|||
156483801|NCT02069366|564863400|FG003|Overall Study|Lost to Follow-up|0|||
156351863|NCT00293254|564387469|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
156351864|NCT00293254|564387470|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
156483802|NCT02069366|564863401|FG004|Overall Study|Lost to Follow-up|0|||
156544283|NCT02037295|565087733|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
156544284|NCT02037295|565087734|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
156544285|NCT02037295|565087735|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
156544286|NCT02037295|565087736|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
156544287|NCT01140451|565087738|FG000|Overall Study|Withdrawal by Subject|26|||
156544288|NCT01140451|565087739|FG001|Overall Study|Withdrawal by Subject|33|||
156544289|NCT01140451|565087738|FG000|Overall Study|Adverse Event|2|||
156544290|NCT01140451|565087739|FG001|Overall Study|Adverse Event|6|||
156544291|NCT01140451|565087738|FG000|Overall Study|Physician Decision|5|||
156544292|NCT01140451|565087739|FG001|Overall Study|Physician Decision|3|||
156544293|NCT01140451|565087738|FG000|Overall Study|Lost to Follow-up|2|||
156544294|NCT01140451|565087739|FG001|Overall Study|Lost to Follow-up|0|||
156544295|NCT01140451|565087738|FG000|Overall Study|Participants Planning Pregnancy|3|||
156544296|NCT01140451|565087739|FG001|Overall Study|Participants Planning Pregnancy|0|||
156544297|NCT00661531|565087745|FG000|Overall Study|Withdrawal by Subject|3|||
156544298|NCT03134599|565087746|FG000|Week 1|Lost to Follow-up|0|||
156544299|NCT03134599|565087747|FG001|Week 1|Lost to Follow-up|0|||
156544300|NCT03134599|565087748|FG002|Week 1|Lost to Follow-up|0|||
156544301|NCT03134599|565087749|FG003|Week 1|Lost to Follow-up|0|||
156544302|NCT03134599|565087750|FG004|Week 1|Lost to Follow-up|1|||
156544303|NCT03134599|565087751|FG005|Week 1|Lost to Follow-up|0|||
156544304|NCT03134599|565087746|FG000|Week 2|Lost to Follow-up|1|||
156544305|NCT03134599|565087747|FG001|Week 2|Lost to Follow-up|0|||
156544306|NCT03134599|565087748|FG002|Week 2|Lost to Follow-up|0|||
156544307|NCT03134599|565087749|FG003|Week 2|Lost to Follow-up|1|||
156544308|NCT03134599|565087750|FG004|Week 2|Lost to Follow-up|1|||
156544309|NCT03134599|565087751|FG005|Week 2|Lost to Follow-up|0|||
156544310|NCT03134599|565087746|FG000|Week 3|Lost to Follow-up|0|||
156351865|NCT00293254|564387469|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
156351866|NCT00293254|564387470|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
156351867|NCT00293254|564387469|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
156351868|NCT00293254|564387470|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
156351869|NCT00293254|564387469|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
156351870|NCT00293254|564387470|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
156351871|NCT00293254|564387469|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
156351872|NCT00293254|564387470|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
156351873|NCT00293254|564387469|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
156351874|NCT00293254|564387470|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
156351875|NCT00293254|564387469|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
156351876|NCT00293254|564387470|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
156351877|NCT00293254|564387469|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
156351878|NCT00293254|564387470|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
156351879|NCT00293254|564387469|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
156351880|NCT00293254|564387470|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
156483803|NCT02069366|564863402|FG005|Overall Study|Lost to Follow-up|2|||
156483804|NCT02069366|564863397|FG000|Overall Study|Protocol Violation|0|||
156351881|NCT00293254|564387469|FG000|Extension - Double-Blind Week 49-156|Death|4|||
156351882|NCT00293254|564387470|FG001|Extension - Double-Blind Week 49-156|Death|1|||
156351883|NCT00293254|564387469|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
156351884|NCT00293254|564387470|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
156351885|NCT00293254|564387469|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
156351886|NCT00293254|564387470|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
156351887|NCT00293254|564387469|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
156351888|NCT00293254|564387470|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
156483805|NCT02069366|564863398|FG001|Overall Study|Protocol Violation|0|||
156483806|NCT02069366|564863399|FG002|Overall Study|Protocol Violation|1|||
156483807|NCT02069366|564863400|FG003|Overall Study|Protocol Violation|0|||
156483808|NCT02069366|564863401|FG004|Overall Study|Protocol Violation|0|||
156483809|NCT02069366|564863402|FG005|Overall Study|Protocol Violation|0|||
156483810|NCT02069366|564863397|FG000|Overall Study|Withdrawal by Subject|1|||
156483811|NCT02069366|564863398|FG001|Overall Study|Withdrawal by Subject|0|||
156483812|NCT02069366|564863399|FG002|Overall Study|Withdrawal by Subject|1|||
156483813|NCT02069366|564863400|FG003|Overall Study|Withdrawal by Subject|2|||
156483814|NCT02069366|564863401|FG004|Overall Study|Withdrawal by Subject|0|||
156483815|NCT02069366|564863402|FG005|Overall Study|Withdrawal by Subject|0|||
156483816|NCT00168805|564863405|FG000|Overall Study|Adverse Event|7|||
156483817|NCT00168805|564863406|FG001|Overall Study|Adverse Event|11|||
156483818|NCT00168805|564863407|FG002|Overall Study|Adverse Event|16|||
156483819|NCT00168805|564863405|FG000|Overall Study|Protocol Violation|12|||
156483820|NCT00168805|564863406|FG001|Overall Study|Protocol Violation|11|||
156351889|NCT00293254|564387469|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
156351890|NCT00293254|564387470|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
156351891|NCT00293254|564387469|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
156351892|NCT00293254|564387470|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
156351893|NCT00293254|564387469|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
156351894|NCT00293254|564387470|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
156351895|NCT00293254|564387469|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
156351896|NCT00293254|564387470|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
156483821|NCT00168805|564863407|FG002|Overall Study|Protocol Violation|8|||
156351897|NCT00293254|564387469|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
156351898|NCT00293254|564387470|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
156351899|NCT00293254|564387469|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
156351900|NCT00293254|564387470|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
156351901|NCT00293254|564387469|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
156351902|NCT00293254|564387470|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
156351903|NCT00293254|564387469|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
156351904|NCT00293254|564387470|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
156351905|NCT00293254|564387469|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
156351906|NCT00293254|564387470|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
156351907|NCT00293254|564387469|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
156351908|NCT00293254|564387470|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
156351909|NCT00293254|564387469|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
156351910|NCT00293254|564387470|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
156351911|NCT00293254|564387469|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
156544311|NCT03134599|565087747|FG001|Week 3|Lost to Follow-up|0|||
156544312|NCT03134599|565087748|FG002|Week 3|Lost to Follow-up|0|||
156544313|NCT03134599|565087749|FG003|Week 3|Lost to Follow-up|1|||
156483822|NCT00168805|564863405|FG000|Overall Study|Lost to Follow-up|12|||
156483823|NCT00168805|564863406|FG001|Overall Study|Lost to Follow-up|17|||
156483824|NCT00168805|564863407|FG002|Overall Study|Lost to Follow-up|11|||
156483825|NCT00168805|564863405|FG000|Overall Study|Withdrawal by Subject|16|||
156483826|NCT00168805|564863406|FG001|Overall Study|Withdrawal by Subject|18|||
156483827|NCT00168805|564863407|FG002|Overall Study|Withdrawal by Subject|21|||
156483828|NCT00168805|564863405|FG000|Overall Study|Other|24|||
156483829|NCT00168805|564863406|FG001|Overall Study|Other|21|||
156483830|NCT00168805|564863407|FG002|Overall Study|Other|22|||
156483831|NCT00168805|564863405|FG000|Treatment|Adverse Event|25|||
156483832|NCT00168805|564863406|FG001|Treatment|Adverse Event|26|||
156483833|NCT00168805|564863407|FG002|Treatment|Adverse Event|32|||
156483834|NCT00168805|564863405|FG000|Treatment|Protocol Violation|3|||
156483835|NCT00168805|564863406|FG001|Treatment|Protocol Violation|5|||
156483836|NCT00168805|564863407|FG002|Treatment|Protocol Violation|5|||
156483837|NCT00168805|564863405|FG000|Treatment|Withdrawal by Subject|3|||
156483838|NCT00168805|564863406|FG001|Treatment|Withdrawal by Subject|7|||
156483839|NCT00168805|564863407|FG002|Treatment|Withdrawal by Subject|8|||
156483840|NCT00168805|564863405|FG000|Treatment|Other|18|||
156483841|NCT00168805|564863406|FG001|Treatment|Other|18|||
156483842|NCT00168805|564863407|FG002|Treatment|Other|17|||
156483843|NCT01837719|564863408|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
156483844|NCT01837719|564863408|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
156483845|NCT02023099|564863409|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
156483846|NCT02023099|564863410|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
156483847|NCT02023099|564863411|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
156483848|NCT02023099|564863409|FG000|Overall Study|Withdrawn Consent|3|||
156483849|NCT02023099|564863410|FG001|Overall Study|Withdrawn Consent|0|||
156483850|NCT02023099|564863411|FG002|Overall Study|Withdrawn Consent|1|||
156483851|NCT02023099|564863409|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
156483852|NCT02023099|564863410|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
156483853|NCT02023099|564863411|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
156483854|NCT03708744|564863412|FG000|Overall Study|Withdrawal by Subject|0|||
156483855|NCT03708744|564863413|FG001|Overall Study|Withdrawal by Subject|0|||
156483856|NCT03708744|564863414|FG002|Overall Study|Withdrawal by Subject|1|||
156483857|NCT03708744|564863415|FG003|Overall Study|Withdrawal by Subject|0|||
156483858|NCT02604199|564863417|FG000|Overall Study|Pregnancy|0|||
156483859|NCT02604199|564863418|FG001|Overall Study|Pregnancy|0|||
156483860|NCT02604199|564863419|FG002|Overall Study|Pregnancy|0|||
156483861|NCT02604199|564863420|FG003|Overall Study|Pregnancy|1|||
156483862|NCT02604199|564863417|FG000|Overall Study|Study terminated by sponsor|0|||
156483863|NCT02604199|564863418|FG001|Overall Study|Study terminated by sponsor|2|||
156483864|NCT02604199|564863419|FG002|Overall Study|Study terminated by sponsor|0|||
156483865|NCT02604199|564863420|FG003|Overall Study|Study terminated by sponsor|2|||
156483866|NCT02604199|564863417|FG000|Overall Study|Withdrawal by Subject|0|||
156483867|NCT02604199|564863418|FG001|Overall Study|Withdrawal by Subject|1|||
156483868|NCT02604199|564863419|FG002|Overall Study|Withdrawal by Subject|0|||
156483869|NCT02604199|564863420|FG003|Overall Study|Withdrawal by Subject|0|||
156483870|NCT00460577|564863424|FG000|Overall Study|Protocol Violation|2|||
156483871|NCT00460577|564863425|FG001|Overall Study|Protocol Violation|6|||
156483872|NCT02213458|564863426|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
156483873|NCT02213458|564863427|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
156483874|NCT02213458|564863426|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
156483875|NCT02213458|564863427|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
156483876|NCT02213458|564863426|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
156483877|NCT02213458|564863427|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
156544314|NCT03134599|565087750|FG004|Week 3|Lost to Follow-up|0|||
156351912|NCT00293254|564387470|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
156351913|NCT00293254|564387469|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
156351914|NCT00293254|564387470|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
156351915|NCT00293254|564387469|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
156351916|NCT00293254|564387470|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
156351917|NCT00503308|564387471|FG000|Overall Study|Protocol Violation|2|||
156351918|NCT00503308|564387472|FG001|Overall Study|Protocol Violation|1|||
156351919|NCT04481750|564387473|FG000|Period 1 (Fasted)|Adverse Event|0|||
156351920|NCT04481750|564387474|FG001|Period 1 (Fasted)|Adverse Event|0|||
156351921|NCT04481750|564387475|FG002|Period 1 (Fasted)|Adverse Event|1|||
156351922|NCT04481750|564387476|FG003|Period 1 (Fasted)|Adverse Event|0|||
156351923|NCT04481750|564387477|FG004|Period 1 (Fasted)|Adverse Event|0|||
156351924|NCT04481750|564387478|FG005|Period 1 (Fasted)|Adverse Event|0|||
156351925|NCT04481750|564387479|FG006|Period 1 (Fasted)|Adverse Event|0|||
156351926|NCT04481750|564387480|FG007|Period 1 (Fasted)|Adverse Event|0|||
156351927|NCT04481750|564387481|FG008|Period 1 (Fasted)|Adverse Event|0|||
156351928|NCT04481750|564387482|FG009|Period 1 (Fasted)|Adverse Event|0|||
156351929|NCT04481750|564387483|FG010|Period 1 (Fasted)|Adverse Event|0|||
156351930|NCT00475176|564387484|FG000|Overall Study|Adverse Event|2|||
156351931|NCT00475176|564387484|FG000|Overall Study|Withdrawal by Subject|1|||
156351932|NCT00475176|564387484|FG000|Overall Study|Protocol Violation|1|||
156351933|NCT01463878|564387488|FG000|Overall Study|no longer met criteria for tube feed|2|||
156351934|NCT01463878|564387489|FG001|Overall Study|no longer met criteria for tube feed|2|||
156351935|NCT01034462|564387490|FG000|Overall Study|Adverse Event|7|||
156351936|NCT01034462|564387491|FG001|Overall Study|Adverse Event|17|||
156351937|NCT01034462|564387490|FG000|Overall Study|Lack of Efficacy|4|||
156351938|NCT01034462|564387491|FG001|Overall Study|Lack of Efficacy|4|||
156351939|NCT01034462|564387490|FG000|Overall Study|Protocol Violation|10|||
156351940|NCT01034462|564387491|FG001|Overall Study|Protocol Violation|7|||
156351941|NCT01034462|564387490|FG000|Overall Study|Withdrawal by Subject|9|||
156351942|NCT01034462|564387491|FG001|Overall Study|Withdrawal by Subject|8|||
156483878|NCT02213458|564863426|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
156483879|NCT02213458|564863427|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
156483880|NCT02213458|564863426|FG000|Overall Study|Refused re-consent|6|||
156483881|NCT02213458|564863427|FG001|Overall Study|Refused re-consent|0|||
156483882|NCT02213458|564863426|FG000|Overall Study|Lost to Follow-up|2|||
156483883|NCT02213458|564863427|FG001|Overall Study|Lost to Follow-up|2|||
156483884|NCT02213458|564863426|FG000|Overall Study|Withdrawal by Subject|26|||
156483885|NCT02213458|564863427|FG001|Overall Study|Withdrawal by Subject|8|||
156483886|NCT04043806|564863428|FG000|Overall Study|Commercial drug is available for participants|13|||
156483887|NCT04043806|564863428|FG000|Overall Study|Physician Decision|2|||
156483888|NCT04043806|564863428|FG000|Overall Study|Other|12|||
156483889|NCT04043806|564863428|FG000|Overall Study|Adverse Event|2|||
156483890|NCT04043806|564863428|FG000|Overall Study|Lost to Follow-up|6|||
156483891|NCT04043806|564863428|FG000|Overall Study|Other non-compliance|2|||
156483892|NCT04043806|564863428|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
156483893|NCT04043806|564863428|FG000|Overall Study|Never Dosed|1|||
156483894|NCT01622088|564863429|FG000|Overall Study|Adverse Event|20|||
156483895|NCT01622088|564863429|FG000|Overall Study|Lost to Follow-up|1|||
156483896|NCT01622088|564863429|FG000|Overall Study|Withdrawal by Subject|20|||
156483897|NCT01622088|564863429|FG000|Overall Study|Investigator Decision|1|||
156483898|NCT01622088|564863429|FG000|Overall Study|Death|53|||
156483899|NCT01622088|564863429|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
156483900|NCT02255474|564863437|FG000|Overall Study|Lost to Follow-up|1|||
156483901|NCT02255474|564863438|FG001|Overall Study|Lost to Follow-up|1|||
156483902|NCT02255474|564863439|FG002|Overall Study|Lost to Follow-up|3|||
156351943|NCT01034462|564387490|FG000|Overall Study|Lost to Follow-up|14|||
156483903|NCT02255474|564863437|FG000|Overall Study|Withdrawal by Subject|1|||
156483904|NCT02255474|564863438|FG001|Overall Study|Withdrawal by Subject|1|||
156483905|NCT02255474|564863439|FG002|Overall Study|Withdrawal by Subject|0|||
156483906|NCT02993926|564863440|FG000|Enantone Treatment Phase|Adverse Event|1|||
156483907|NCT02993926|564863441|FG001|Enantone Treatment Phase|Adverse Event|0|||
156483908|NCT02993926|564863442|FG002|Enantone Treatment Phase|Adverse Event|0|||
156483909|NCT02993926|564863440|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
156483910|NCT02993926|564863441|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
156483911|NCT02993926|564863442|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
156483912|NCT02993926|564863440|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
156483913|NCT02993926|564863441|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
156483914|NCT02993926|564863442|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
156483915|NCT02993926|564863440|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
156483916|NCT02993926|564863441|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
156483917|NCT02993926|564863442|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
156483918|NCT01867307|564863443|FG000|Overall Study|Protocol Violation|2|||
156351944|NCT01034462|564387491|FG001|Overall Study|Lost to Follow-up|16|||
156483919|NCT01867307|564863444|FG001|Overall Study|Protocol Violation|0|||
156483920|NCT01867307|564863443|FG000|Overall Study|Other Adverse Event|1|||
156483921|NCT01867307|564863444|FG001|Overall Study|Other Adverse Event|3|||
156483922|NCT02009865|564863448|FG000|Overall Study|Adverse Event|0|||
156483923|NCT02009865|564863449|FG001|Overall Study|Adverse Event|2|||
156483924|NCT02009865|564863448|FG000|Overall Study|Protocol Violation|0|||
156483925|NCT02009865|564863449|FG001|Overall Study|Protocol Violation|2|||
156483926|NCT02009865|564863448|FG000|Overall Study|Withdrawal by Subject|1|||
156483927|NCT02009865|564863449|FG001|Overall Study|Withdrawal by Subject|1|||
156483928|NCT01760876|564863450|FG000|Overall Study|Non-cardiac death (head injury)|1|||
156483929|NCT01760876|564863450|FG000|Overall Study|Carcinoma of prostate|1|||
156483930|NCT01760876|564863450|FG000|Overall Study|Impaired renal function|1|||
156483931|NCT01760876|564863450|FG000|Overall Study|Major depression|1|||
156483932|NCT01760876|564863450|FG000|Overall Study|Very poor baseline OCT quality|2|||
156483933|NCT00525915|564863454|FG000|Overall Study|Non-Compliance|0|||
156483934|NCT00525915|564863455|FG001|Overall Study|Non-Compliance|1|||
156351945|NCT01034462|564387490|FG000|Overall Study|Other reasons|1|||
156351946|NCT01034462|564387491|FG001|Overall Study|Other reasons|2|||
156483935|NCT00525915|564863454|FG000|Overall Study|Disease Progression|5|||
156483936|NCT00525915|564863455|FG001|Overall Study|Disease Progression|6|||
156483937|NCT00525915|564863454|FG000|Overall Study|Withdrawal by Subject|1|||
156483938|NCT00525915|564863455|FG001|Overall Study|Withdrawal by Subject|0|||
156483939|NCT00525915|564863454|FG000|Overall Study|Refused Surgery|1|||
156483940|NCT00525915|564863455|FG001|Overall Study|Refused Surgery|2|||
156351947|NCT01594125|564387492|FG000|Overall Study|Withdrawal by Subject|1|||
156483941|NCT00525915|564863454|FG000|Overall Study|Unrelated illness|1|||
156351948|NCT01594125|564387493|FG001|Overall Study|Withdrawal by Subject|0|||
156351949|NCT01594125|564387494|FG002|Overall Study|Withdrawal by Subject|0|||
156351950|NCT01594125|564387495|FG003|Overall Study|Withdrawal by Subject|1|||
156351951|NCT01594125|564387496|FG004|Overall Study|Withdrawal by Subject|0|||
156351952|NCT01594125|564387492|FG000|Overall Study|Progressive Disease|3|||
156351953|NCT01594125|564387493|FG001|Overall Study|Progressive Disease|12|||
156351954|NCT01594125|564387494|FG002|Overall Study|Progressive Disease|3|||
156351955|NCT01594125|564387495|FG003|Overall Study|Progressive Disease|3|||
156351956|NCT01594125|564387496|FG004|Overall Study|Progressive Disease|7|||
156351957|NCT01475331|564387499|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
156351958|NCT01475331|564387500|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
156351959|NCT01475331|564387499|FG000|Overall Study|excessive main duct communication|1|||
156351960|NCT01475331|564387500|FG001|Overall Study|excessive main duct communication|1|||
156351961|NCT01475331|564387499|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
156351962|NCT01475331|564387500|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
156351963|NCT01475331|564387499|FG000|Overall Study|Sign of malignancy during the procedure|2|||
156351964|NCT01475331|564387500|FG001|Overall Study|Sign of malignancy during the procedure|0|||
156351965|NCT01475331|564387499|FG000|Overall Study|cyst found to be prohibitively small|0|||
156351966|NCT01475331|564387500|FG001|Overall Study|cyst found to be prohibitively small|1|||
156351967|NCT00462761|564387501|FG000|Overall Study|Adverse Event|6|||
156351968|NCT00462761|564387501|FG000|Overall Study|Withdrawal by Subject|9|||
156351969|NCT00462761|564387501|FG000|Overall Study|Physician Decision|5|||
156351970|NCT00462761|564387501|FG000|Overall Study|Disease progression|43|||
156351971|NCT00462761|564387501|FG000|Overall Study|Death|12|||
156351972|NCT00462761|564387501|FG000|Overall Study|Other|1|||
156351973|NCT02877082|564387502|FG000|Overall Study|Trial was closed early|5|||
156351974|NCT01113801|564387503|FG000|Overall Study|Adverse Event|4|||
156351975|NCT01113801|564387504|FG001|Overall Study|Adverse Event|0|||
156351976|NCT01113801|564387505|FG002|Overall Study|Adverse Event|2|||
156351977|NCT01113801|564387506|FG003|Overall Study|Adverse Event|6|||
156351978|NCT01113801|564387503|FG000|Overall Study|Death|4|||
156351979|NCT01113801|564387504|FG001|Overall Study|Death|5|||
156351980|NCT01113801|564387505|FG002|Overall Study|Death|3|||
156351981|NCT01113801|564387506|FG003|Overall Study|Death|4|||
156351982|NCT01113801|564387503|FG000|Overall Study|Protocol Violation|0|||
156351983|NCT01113801|564387504|FG001|Overall Study|Protocol Violation|1|||
156351984|NCT01113801|564387505|FG002|Overall Study|Protocol Violation|0|||
156351985|NCT01113801|564387506|FG003|Overall Study|Protocol Violation|0|||
156351986|NCT01113801|564387503|FG000|Overall Study|Withdrawal by Subject|9|||
156351987|NCT01113801|564387504|FG001|Overall Study|Withdrawal by Subject|7|||
156351988|NCT01113801|564387505|FG002|Overall Study|Withdrawal by Subject|7|||
156351989|NCT01113801|564387506|FG003|Overall Study|Withdrawal by Subject|8|||
156351990|NCT01113801|564387503|FG000|Overall Study|Physician Decision|2|||
156351991|NCT01113801|564387504|FG001|Overall Study|Physician Decision|2|||
156351992|NCT01113801|564387505|FG002|Overall Study|Physician Decision|3|||
156351993|NCT01113801|564387506|FG003|Overall Study|Physician Decision|3|||
156351994|NCT01113801|564387503|FG000|Overall Study|Sponsor Decision|15|||
156351995|NCT01113801|564387504|FG001|Overall Study|Sponsor Decision|21|||
156351996|NCT01113801|564387505|FG002|Overall Study|Sponsor Decision|20|||
156351997|NCT01113801|564387506|FG003|Overall Study|Sponsor Decision|15|||
156351998|NCT01113801|564387503|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
156351999|NCT01113801|564387504|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
156352000|NCT01113801|564387505|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
156352001|NCT01113801|564387506|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
156352002|NCT01949051|564387507|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
156352003|NCT01949051|564387508|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
156352004|NCT01949051|564387509|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
156352005|NCT01949051|564387510|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
156352006|NCT01949051|564387511|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
156352007|NCT01949051|564387512|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
156352008|NCT01949051|564387507|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
156352009|NCT01949051|564387508|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156352010|NCT01949051|564387509|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156352011|NCT01949051|564387510|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156352012|NCT01949051|564387511|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156352013|NCT01949051|564387512|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156483942|NCT00525915|564863455|FG001|Overall Study|Unrelated illness|0|||
156483943|NCT00732498|564863456|FG000|Overall Study|Ineligible|1|||
156352014|NCT01949051|564387507|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156483944|NCT00732498|564863456|FG000|Overall Study|Adverse Event|2|||
156483945|NCT00732498|564863456|FG000|Overall Study|Physician Decision|3|||
156483946|NCT03394508|564863457|FG000|Overall Study|Protocol Violation|0|||
156483947|NCT03394508|564863458|FG001|Overall Study|Protocol Violation|3|||
156483948|NCT03394508|564863457|FG000|Overall Study|Lost to Follow-up|1|||
156352015|NCT01949051|564387508|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156352016|NCT01949051|564387509|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156544315|NCT03134599|565087751|FG005|Week 3|Lost to Follow-up|1|||
156544316|NCT01732796|565087752|FG000|Overall Study|Adverse Event|16|||
156483949|NCT03394508|564863458|FG001|Overall Study|Lost to Follow-up|0|||
156483950|NCT00267865|564863459|FG000|Induction Treatment|Died before completing.|2|||
156483951|NCT00267865|564863459|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
156352017|NCT01949051|564387510|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156352018|NCT01949051|564387511|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156352019|NCT01949051|564387512|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
156352020|NCT01949051|564387507|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156352021|NCT01949051|564387508|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
156352022|NCT01949051|564387509|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156352023|NCT01949051|564387510|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156483952|NCT04295499|564863463|FG000|Overall Study|moving out of state|1|||
156483953|NCT04295499|564863464|FG001|Overall Study|moving out of state|0|||
156483954|NCT04295499|564863463|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
156352024|NCT01949051|564387511|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156352025|NCT01949051|564387512|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156352026|NCT01949051|564387507|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156483955|NCT04295499|564863464|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
156483956|NCT01755598|564863465|FG000|Overall Study|Other|109|||
156483957|NCT01755598|564863466|FG001|Overall Study|Other|109|||
156352027|NCT01949051|564387508|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156352028|NCT01949051|564387509|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
156352029|NCT01949051|564387510|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156352030|NCT01949051|564387511|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156352031|NCT01949051|564387512|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156352032|NCT01782859|564387513|FG000|Overall Study|Protocol Violation|6|||
156352033|NCT01782859|564387514|FG001|Overall Study|Protocol Violation|6|||
156352034|NCT01782859|564387513|FG000|Overall Study|Withdrawal by Subject|0|||
156352035|NCT01782859|564387514|FG001|Overall Study|Withdrawal by Subject|1|||
156352036|NCT04483011|564387517|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
156352037|NCT04483011|564387518|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
156352038|NCT00429104|564387529|FG000|Overall Study|Protocol Violation|1|||
156352039|NCT00770289|564387530|FG000|Overall Study|Other|6|||
156352040|NCT01187043|564387543|FG000|Overall Study|Adverse Event|0|||
156352041|NCT01187043|564387544|FG001|Overall Study|Adverse Event|0|||
156352042|NCT01187043|564387545|FG002|Overall Study|Adverse Event|0|||
156352043|NCT01187043|564387546|FG003|Overall Study|Adverse Event|0|||
156352044|NCT01187043|564387547|FG004|Overall Study|Adverse Event|1|||
156352045|NCT01187043|564387543|FG000|Overall Study|Unable to make scheduled visits|1|||
156483958|NCT01755598|564863465|FG000|Overall Study|Lost to Follow-up|32|||
156483959|NCT01755598|564863466|FG001|Overall Study|Lost to Follow-up|43|||
156483960|NCT01755598|564863465|FG000|Overall Study|Migrated/moved from study area|76|||
156483961|NCT01755598|564863466|FG001|Overall Study|Migrated/moved from study area|65|||
156483962|NCT01755598|564863465|FG000|Overall Study|Withdrawal by Subject|22|||
156483963|NCT01755598|564863466|FG001|Overall Study|Withdrawal by Subject|31|||
156483964|NCT01755598|564863465|FG000|Overall Study|Protocol Violation|7|||
156483965|NCT01755598|564863466|FG001|Overall Study|Protocol Violation|7|||
156483966|NCT01755598|564863465|FG000|Overall Study|Adverse Event|19|||
156483967|NCT01755598|564863466|FG001|Overall Study|Adverse Event|28|||
156483968|NCT03122548|564863467|FG000|Overall Study|Death|2|||
156483969|NCT03122548|564863467|FG000|Overall Study|Progression - subject went into hospice|1|||
156483970|NCT03122548|564863467|FG000|Overall Study|Study Terminated by Sponsor|2|||
156483971|NCT02332889|564863470|FG000|Overall Study|Physician Decision|1|||
156483972|NCT00308113|564863471|FG000|Overall Study|Protocol closure|0|||
156483973|NCT00308113|564863472|FG001|Overall Study|Protocol closure|0|||
156483974|NCT00308113|564863473|FG002|Overall Study|Protocol closure|0|||
156483975|NCT00308113|564863474|FG003|Overall Study|Protocol closure|1|||
156483976|NCT01634165|564863475|FG000|Period 2|Adverse Event|0|||
156483977|NCT01634165|564863476|FG001|Period 2|Adverse Event|1|||
156483978|NCT01634165|564863477|FG002|Period 2|Adverse Event|0|||
156483979|NCT01634165|564863478|FG003|Period 2|Adverse Event|0|||
156483980|NCT02135445|564863479|FG000|Overall Study|Lost to Follow-up|1|||
156483981|NCT02135445|564863480|FG001|Overall Study|Lost to Follow-up|0|||
156483982|NCT02135445|564863479|FG000|Overall Study|Withdrawal by Subject|1|||
156483983|NCT02135445|564863480|FG001|Overall Study|Withdrawal by Subject|0|||
156483984|NCT00676195|564864865|FG000|Overall Study|Lost to Follow-up|1|||
156483985|NCT00676195|564864865|FG000|Overall Study|Adverse Event|1|||
156483986|NCT00676195|564864865|FG000|Overall Study|Physician Decision|1|||
156483987|NCT03322514|564864866|FG000|Overall Study|Withdrawal by Subject|1|||
156483988|NCT03322514|564864867|FG001|Overall Study|Withdrawal by Subject|1|||
156483989|NCT02136797|564864868|FG000|Overall Study|Not Treated|8|||
156483990|NCT04523571|564864869|FG000|Received 2 Doses|Withdrawal by Subject|0|||
156483991|NCT04523571|564864870|FG001|Received 2 Doses|Withdrawal by Subject|0|||
156483992|NCT04523571|564864871|FG002|Received 2 Doses|Withdrawal by Subject|0|||
156483993|NCT04523571|564864872|FG003|Received 2 Doses|Withdrawal by Subject|1|||
156352046|NCT01187043|564387544|FG001|Overall Study|Unable to make scheduled visits|0|||
156352047|NCT01187043|564387545|FG002|Overall Study|Unable to make scheduled visits|4|||
156352048|NCT01187043|564387546|FG003|Overall Study|Unable to make scheduled visits|0|||
156352049|NCT01187043|564387547|FG004|Overall Study|Unable to make scheduled visits|1|||
156352050|NCT04903626|564387548|FG000|Overall Study|Lost to Follow-up|6|||
156483994|NCT04523571|564864873|FG004|Received 2 Doses|Withdrawal by Subject|1|||
156483995|NCT04523571|564864874|FG005|Received 2 Doses|Withdrawal by Subject|0|||
156352051|NCT04903626|564387548|FG000|Overall Study|Withdrawal by Subject|1|||
156352052|NCT04903626|564387548|FG000|Overall Study|Other, Not Specified|1|||
156352053|NCT00573534|564387549|FG000|Overall Study|oppositional behavior|3|||
156483996|NCT04523571|564864869|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
156483997|NCT04523571|564864870|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
156483998|NCT04523571|564864871|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
156483999|NCT04523571|564864872|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
156484000|NCT04523571|564864873|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
156484001|NCT04523571|564864874|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
156484002|NCT04523571|564864869|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
156484003|NCT04523571|564864870|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
156484004|NCT04523571|564864871|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
156484005|NCT04523571|564864872|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
156484006|NCT04523571|564864873|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
156484007|NCT04523571|564864874|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
156352054|NCT03035409|564387550|FG000|Overall Study|Adverse Event|5|||
156352055|NCT03035409|564387550|FG000|Overall Study|Death|2|||
156352056|NCT03035409|564387550|FG000|Overall Study|Withdrawal by Subject|2|||
156352057|NCT03035409|564387550|FG000|Overall Study|Non compliance|4|||
156352058|NCT03035409|564387550|FG000|Overall Study|Patient was jittery|1|||
156352059|NCT03035409|564387550|FG000|Overall Study|Did not like Questionnaire|1|||
156352060|NCT03035409|564387550|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
156352061|NCT03035409|564387550|FG000|Overall Study|Did not like taking drugs|1|||
156352062|NCT00927784|564387555|FG000|Overall Study|Death|1|||
156352063|NCT00927784|564387556|FG001|Overall Study|Death|0|||
156352064|NCT00927784|564387555|FG000|Overall Study|Withdrawal by Subject|1|||
156352065|NCT00927784|564387556|FG001|Overall Study|Withdrawal by Subject|0|||
156352066|NCT02457910|564387557|FG000|Overall Study|Withdrawal by Subject|0|||
156352067|NCT02457910|564387558|FG001|Overall Study|Withdrawal by Subject|0|||
156352068|NCT02457910|564387559|FG002|Overall Study|Withdrawal by Subject|0|||
156352069|NCT02457910|564387560|FG003|Overall Study|Withdrawal by Subject|0|||
156352070|NCT02457910|564387561|FG004|Overall Study|Withdrawal by Subject|0|||
156352071|NCT02457910|564387562|FG005|Overall Study|Withdrawal by Subject|1|||
156352072|NCT02457910|564387557|FG000|Overall Study|Adverse Event|0|||
156352073|NCT02457910|564387558|FG001|Overall Study|Adverse Event|2|||
156352074|NCT02457910|564387559|FG002|Overall Study|Adverse Event|1|||
156352075|NCT02457910|564387560|FG003|Overall Study|Adverse Event|1|||
156352076|NCT02457910|564387561|FG004|Overall Study|Adverse Event|1|||
156352077|NCT02457910|564387562|FG005|Overall Study|Adverse Event|3|||
156352078|NCT02457910|564387557|FG000|Overall Study|Disease progression|3|||
156352079|NCT02457910|564387558|FG001|Overall Study|Disease progression|3|||
156352080|NCT02457910|564387559|FG002|Overall Study|Disease progression|1|||
156352081|NCT02457910|564387560|FG003|Overall Study|Disease progression|1|||
156352082|NCT02457910|564387561|FG004|Overall Study|Disease progression|4|||
156352083|NCT02457910|564387562|FG005|Overall Study|Disease progression|6|||
156352084|NCT02457910|564387557|FG000|Overall Study|Other complicating illness|0|||
156352085|NCT02457910|564387558|FG001|Overall Study|Other complicating illness|0|||
156352086|NCT02457910|564387559|FG002|Overall Study|Other complicating illness|0|||
156352087|NCT02457910|564387560|FG003|Overall Study|Other complicating illness|0|||
156352088|NCT02457910|564387561|FG004|Overall Study|Other complicating illness|0|||
156352089|NCT02457910|564387562|FG005|Overall Study|Other complicating illness|1|||
156352090|NCT02457910|564387557|FG000|Overall Study|Death|0|||
156352091|NCT02457910|564387558|FG001|Overall Study|Death|0|||
156352092|NCT02457910|564387559|FG002|Overall Study|Death|1|||
156352093|NCT02457910|564387560|FG003|Overall Study|Death|0|||
156352094|NCT02457910|564387561|FG004|Overall Study|Death|0|||
156352095|NCT02457910|564387562|FG005|Overall Study|Death|0|||
156352096|NCT00467259|564387563|FG000|Overall Study|Adverse Event|24|||
156352097|NCT00467259|564387564|FG001|Overall Study|Adverse Event|90|||
156352098|NCT00467259|564387563|FG000|Overall Study|Protocol Violation|1|||
156352099|NCT00467259|564387564|FG001|Overall Study|Protocol Violation|7|||
156352100|NCT00467259|564387563|FG000|Overall Study|Withdrawal by Subject|34|||
156352101|NCT00467259|564387564|FG001|Overall Study|Withdrawal by Subject|108|||
156352102|NCT00467259|564387563|FG000|Overall Study|Physician Decision|0|||
156352103|NCT00467259|564387564|FG001|Overall Study|Physician Decision|2|||
156352104|NCT00467259|564387563|FG000|Overall Study|Lost to Follow-up|14|||
156352105|NCT00467259|564387564|FG001|Overall Study|Lost to Follow-up|34|||
156352106|NCT00467259|564387563|FG000|Overall Study|Site Closed|2|||
156352107|NCT00467259|564387564|FG001|Overall Study|Site Closed|1|||
156352108|NCT00867009|564387570|FG000|Induction Period|Nonserious Adverse Event|5|||
156352109|NCT00867009|564387570|FG000|Induction Period|Serious Adverse Event|10|||
156352110|NCT00867009|564387570|FG000|Induction Period|Death due to serious adverse event|6|||
156352111|NCT00867009|564387570|FG000|Induction Period|Death due to Study Disease|4|||
156352112|NCT00867009|564387570|FG000|Induction Period|Protocol Violation|1|||
156352113|NCT00867009|564387570|FG000|Induction Period|Withdrawal by Subject|8|||
156352114|NCT00867009|564387570|FG000|Induction Period|Physician Decision|3|||
156352115|NCT00867009|564387570|FG000|Induction Period|Progressive Disease (PD)|25|||
156352116|NCT00867009|564387570|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
156352117|NCT03266094|564387571|FG000|Overall Study|Lost to Follow-up|1|||
156352118|NCT03266094|564387571|FG000|Overall Study|Withdrawal by Subject|1|||
156352119|NCT03171415|564387572|FG000|Overall Study|Lost to Follow-up|0|||
156352120|NCT03171415|564387573|FG001|Overall Study|Lost to Follow-up|0|||
156352121|NCT03171415|564387574|FG002|Overall Study|Lost to Follow-up|0|||
156352122|NCT03171415|564387575|FG003|Overall Study|Lost to Follow-up|0|||
156352123|NCT03171415|564387576|FG004|Overall Study|Lost to Follow-up|2|||
156352124|NCT03241342|564387581|FG000|Overall Study|Adverse Event|5|||
156352125|NCT03241342|564387582|FG001|Overall Study|Adverse Event|8|||
156352126|NCT03241342|564387583|FG002|Overall Study|Adverse Event|4|||
156352127|NCT03241342|564387581|FG000|Overall Study|Lack of Efficacy|0|||
156352128|NCT03241342|564387582|FG001|Overall Study|Lack of Efficacy|0|||
156352129|NCT03241342|564387583|FG002|Overall Study|Lack of Efficacy|1|||
156352130|NCT03241342|564387581|FG000|Overall Study|noncompliance with study drug|2|||
156352131|NCT03241342|564387582|FG001|Overall Study|noncompliance with study drug|1|||
156352132|NCT03241342|564387583|FG002|Overall Study|noncompliance with study drug|1|||
156352133|NCT03241342|564387581|FG000|Overall Study|sponsor decision|0|||
156352134|NCT03241342|564387582|FG001|Overall Study|sponsor decision|1|||
156352135|NCT03241342|564387583|FG002|Overall Study|sponsor decision|2|||
156352136|NCT03241342|564387581|FG000|Overall Study|not reported|15|||
156352137|NCT03241342|564387582|FG001|Overall Study|not reported|21|||
156352138|NCT03241342|564387583|FG002|Overall Study|not reported|19|||
156352139|NCT01846611|564387590|FG000|Overall Study|Lost to Follow-up|4|||
156352140|NCT01846611|564387591|FG001|Overall Study|Lost to Follow-up|6|||
156352141|NCT01846611|564387590|FG000|Overall Study|Withdrawal by Subject|15|||
156484008|NCT04523571|564864869|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
156484009|NCT04523571|564864870|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
156484010|NCT04523571|564864871|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
156484011|NCT04523571|564864872|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
156484012|NCT04523571|564864873|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
156484013|NCT04523571|564864874|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
156484014|NCT00627523|564864875|FG000|Overall Study|Lack of Efficacy|1|||
156484015|NCT00627523|564864876|FG001|Overall Study|Lack of Efficacy|0|||
156484016|NCT00627523|564864875|FG000|Overall Study|Withdrawal by Subject|0|||
156484017|NCT00627523|564864876|FG001|Overall Study|Withdrawal by Subject|2|||
156484018|NCT00627523|564864875|FG000|Overall Study|Other|1|||
156484019|NCT00627523|564864876|FG001|Overall Study|Other|0|||
156484020|NCT02011568|564864881|FG000|Overall Study|Withdrawal by Subject|8|||
156484021|NCT02011568|564864882|FG001|Overall Study|Withdrawal by Subject|10|||
156484022|NCT02011568|564864881|FG000|Overall Study|Physician Decision|1|||
156484023|NCT02011568|564864882|FG001|Overall Study|Physician Decision|3|||
156484024|NCT03344458|564864883|FG000|Overall Study|Physician Decision|1|||
156484025|NCT03344458|564864883|FG000|Overall Study|Withdrawal by Subject|16|||
156484026|NCT03344458|564864883|FG000|Overall Study|Other reasons|10|||
156484027|NCT03344458|564864883|FG000|Overall Study|Lost to Follow-up|9|||
156544317|NCT01732796|565087753|FG001|Overall Study|Adverse Event|16|||
156544318|NCT01732796|565087754|FG002|Overall Study|Adverse Event|4|||
156484028|NCT03344458|564864883|FG000|Overall Study|Protocol Violation|3|||
156544319|NCT01732796|565087752|FG000|Overall Study|Lack of Efficacy|21|||
156544320|NCT01732796|565087753|FG001|Overall Study|Lack of Efficacy|18|||
156544321|NCT01732796|565087754|FG002|Overall Study|Lack of Efficacy|5|||
156544322|NCT01732796|565087752|FG000|Overall Study|Lost to Follow-up|2|||
156484029|NCT00396409|564864889|FG000|Period 1 - 2007|Adverse Event|0|||
156484030|NCT00396409|564864890|FG001|Period 1 - 2007|Adverse Event|1|||
156484031|NCT00396409|564864889|FG000|Period 1 - 2007|Lack of Efficacy|0|||
156484032|NCT00396409|564864890|FG001|Period 1 - 2007|Lack of Efficacy|1|||
156544323|NCT01732796|565087753|FG001|Overall Study|Lost to Follow-up|0|||
156544324|NCT01732796|565087754|FG002|Overall Study|Lost to Follow-up|0|||
156484033|NCT00396409|564864889|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
156484034|NCT00396409|564864890|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
156484035|NCT00396409|564864889|FG000|Period 1 - 2007|Lost to Follow-up|2|||
156484036|NCT00396409|564864890|FG001|Period 1 - 2007|Lost to Follow-up|3|||
156484037|NCT00396409|564864889|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
156544325|NCT01732796|565087752|FG000|Overall Study|Withdrawal by Subject|6|||
156544326|NCT01732796|565087753|FG001|Overall Study|Withdrawal by Subject|8|||
156544327|NCT01732796|565087754|FG002|Overall Study|Withdrawal by Subject|2|||
156544328|NCT01732796|565087752|FG000|Overall Study|Other reason not defined above|1|||
156544329|NCT01732796|565087753|FG001|Overall Study|Other reason not defined above|0|||
156544330|NCT01732796|565087754|FG002|Overall Study|Other reason not defined above|2|||
156544331|NCT00876187|565087756|FG000|Overall Study|Adverse Event|14|||
156544332|NCT00876187|565087757|FG001|Overall Study|Adverse Event|12|||
156544333|NCT00876187|565087758|FG002|Overall Study|Adverse Event|19|||
156544334|NCT00876187|565087759|FG003|Overall Study|Adverse Event|29|||
156544335|NCT00876187|565087760|FG004|Overall Study|Adverse Event|10|||
156544336|NCT00876187|565087756|FG000|Overall Study|Lack of Efficacy|59|||
156544337|NCT00876187|565087757|FG001|Overall Study|Lack of Efficacy|34|||
156544338|NCT00876187|565087758|FG002|Overall Study|Lack of Efficacy|45|||
156544339|NCT00876187|565087759|FG003|Overall Study|Lack of Efficacy|34|||
156544340|NCT00876187|565087760|FG004|Overall Study|Lack of Efficacy|59|||
156544341|NCT00876187|565087756|FG000|Overall Study|Lost to Follow-up|9|||
156544342|NCT00876187|565087757|FG001|Overall Study|Lost to Follow-up|10|||
156544343|NCT00876187|565087758|FG002|Overall Study|Lost to Follow-up|8|||
156544344|NCT00876187|565087759|FG003|Overall Study|Lost to Follow-up|8|||
156544345|NCT00876187|565087760|FG004|Overall Study|Lost to Follow-up|11|||
156544346|NCT00876187|565087756|FG000|Overall Study|Protocol Violation|6|||
156544347|NCT00876187|565087757|FG001|Overall Study|Protocol Violation|7|||
156544348|NCT00876187|565087758|FG002|Overall Study|Protocol Violation|7|||
156544349|NCT00876187|565087759|FG003|Overall Study|Protocol Violation|6|||
156544350|NCT00876187|565087760|FG004|Overall Study|Protocol Violation|3|||
156544351|NCT00876187|565087756|FG000|Overall Study|Withdrawal by Subject|16|||
156544352|NCT00876187|565087757|FG001|Overall Study|Withdrawal by Subject|26|||
156544353|NCT00876187|565087758|FG002|Overall Study|Withdrawal by Subject|32|||
156544354|NCT00876187|565087759|FG003|Overall Study|Withdrawal by Subject|38|||
156544355|NCT00876187|565087760|FG004|Overall Study|Withdrawal by Subject|37|||
156544356|NCT00876187|565087756|FG000|Overall Study|Entered extension study|101|||
156352142|NCT01846611|564387591|FG001|Overall Study|Withdrawal by Subject|19|||
156352143|NCT01846611|564387590|FG000|Overall Study|Other|19|||
156352144|NCT01846611|564387591|FG001|Overall Study|Other|18|||
156352145|NCT02289079|564387592|FG000|Overall Study|Physician Decision|2|||
156352146|NCT02289079|564387593|FG001|Overall Study|Physician Decision|0|||
156352147|NCT02289079|564387592|FG000|Overall Study|Lost to Follow-up|0|||
156352148|NCT02289079|564387593|FG001|Overall Study|Lost to Follow-up|1|||
156352149|NCT02671422|564387594|FG000|Overall Study|Lost to Follow-up|1|||
156352150|NCT02671422|564387594|FG000|Overall Study|Adverse Event|68|||
156544357|NCT00876187|565087757|FG001|Overall Study|Entered extension study|120|||
156544358|NCT00876187|565087758|FG002|Overall Study|Entered extension study|156|||
156544359|NCT00876187|565087759|FG003|Overall Study|Entered extension study|151|||
156544360|NCT00876187|565087760|FG004|Overall Study|Entered extension study|144|||
156544361|NCT00876187|565087756|FG000|Overall Study|Randomized but not treated|3|||
156544362|NCT00876187|565087757|FG001|Overall Study|Randomized but not treated|1|||
156544363|NCT00876187|565087758|FG002|Overall Study|Randomized but not treated|3|||
156352151|NCT02671422|564387594|FG000|Overall Study|Lack of Efficacy|1|||
156352152|NCT02671422|564387594|FG000|Overall Study|Lost to Follow-up|4|||
156352153|NCT02671422|564387594|FG000|Overall Study|Withdrawal by Subject|7|||
156484038|NCT00396409|564864890|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
156484039|NCT00396409|564864889|FG000|Period 2 - 2008|Protocol Violation|1|||
156484040|NCT00396409|564864890|FG001|Period 2 - 2008|Protocol Violation|0|||
156484041|NCT00396409|564864889|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
156484042|NCT00396409|564864890|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
156484043|NCT00396409|564864889|FG000|Period 2 - 2008|Lost to Follow-up|3|||
156484044|NCT00396409|564864890|FG001|Period 2 - 2008|Lost to Follow-up|1|||
156484045|NCT00331799|564864891|FG000|Overall Study|Withdrawal by Subject|2|||
156484046|NCT00331799|564864891|FG000|Overall Study|Sedation|1|||
156484047|NCT02889809|564864892|FG000|Overall Study|Withdrawal by Subject|30|||
156484048|NCT02889809|564864893|FG001|Overall Study|Withdrawal by Subject|21|||
156484049|NCT02889809|564864892|FG000|Overall Study|Lost to Follow-up|1|||
156484050|NCT02889809|564864893|FG001|Overall Study|Lost to Follow-up|1|||
156484051|NCT02889809|564864892|FG000|Overall Study|Site Closed|12|||
156484052|NCT02889809|564864893|FG001|Overall Study|Site Closed|11|||
156484053|NCT03696342|564864894|FG000|Overall Study|Lost to Follow-up|1|||
156484054|NCT03696342|564864895|FG001|Overall Study|Lost to Follow-up|0|||
156484055|NCT02409732|564864896|FG000|Overall Study|Withdrawal by Subject|4|||
156484056|NCT02409732|564864896|FG000|Overall Study|Lost to Follow-up|2|||
156484057|NCT03314233|564864903|FG000|Overall Study|No longer eligible at time of delivery|1|||
156484058|NCT01797705|564864904|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
156484059|NCT01797705|564864904|FG000|Overall Study|Withdrawal by Subject|1|||
156484060|NCT01533181|564864905|FG000|Overall Study|Disease progression pre-active treatment|0|||
156484061|NCT01533181|564864906|FG001|Overall Study|Disease progression pre-active treatment|1|||
156484062|NCT01533181|564864905|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
156484063|NCT01533181|564864906|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
156484064|NCT02030847|564864907|FG000|Overall Study|Death|10|||
156484065|NCT02030847|564864907|FG000|Overall Study|Disease Progression|15|||
156484066|NCT02030847|564864907|FG000|Overall Study|New Cancer Therapy|8|||
156484067|NCT02030847|564864907|FG000|Overall Study|Physician Decision|3|||
156484068|NCT02030847|564864907|FG000|Overall Study|Withdrawal by Subject|1|||
156484069|NCT01703988|564864908|FG000|Overall Study|Investigator Judgment|0|||
156484070|NCT01703988|564864909|FG001|Overall Study|Investigator Judgment|0|||
156484071|NCT01703988|564864910|FG002|Overall Study|Investigator Judgment|0|||
156484072|NCT01703988|564864911|FG003|Overall Study|Investigator Judgment|1|||
156484073|NCT03785210|564864914|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
156484074|NCT03785210|564864915|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
156484075|NCT04468633|564864918|FG000|Overall Study|Withdrawal by Subject|4|||
156484076|NCT04468633|564864919|FG001|Overall Study|Withdrawal by Subject|0|||
156484077|NCT00460434|564864920|FG000|Overall Study|Lost to Follow-up|3|||
156484078|NCT00460434|564864921|FG001|Overall Study|Lost to Follow-up|7|||
156484079|NCT01498445|564864922|FG000|Overall Study|Lack of Efficacy|0|||
156352154|NCT02671422|564387594|FG000|Overall Study|Progressive Disease|156|||
156352155|NCT02671422|564387594|FG000|Overall Study|Worsening of Disease|4|||
156352156|NCT02671422|564387594|FG000|Overall Study|Sponsor decision|5|||
156352157|NCT02671422|564387594|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
156352158|NCT02671422|564387594|FG000|Overall Study|Not treated with Vargatef®|3|||
156352159|NCT02671422|564387594|FG000|Overall Study|Other not defined above|3|||
156352160|NCT02111850|564387595|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352161|NCT02111850|564387596|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352162|NCT02111850|564387597|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352163|NCT02111850|564387598|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352164|NCT02111850|564387599|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
156352165|NCT02111850|564387600|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352166|NCT02111850|564387601|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352167|NCT02111850|564387602|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352168|NCT02111850|564387603|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352169|NCT02111850|564387604|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352170|NCT02111850|564387605|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156352171|NCT00513474|564387606|FG000|Overall Study|Death|6|||
156352172|NCT00513474|564387607|FG001|Overall Study|Death|9|||
156352173|NCT00513474|564387606|FG000|Overall Study|Participant Withdrew Consent|1|||
156352174|NCT00513474|564387607|FG001|Overall Study|Participant Withdrew Consent|0|||
156352175|NCT00662363|564387608|FG000|Overall Study|Withdrawal by Subject|6|||
156352176|NCT00662363|564387609|FG001|Overall Study|Withdrawal by Subject|5|||
156352177|NCT00662363|564387608|FG000|Overall Study|Adverse Event|0|||
156352178|NCT00662363|564387609|FG001|Overall Study|Adverse Event|3|||
156352179|NCT00662363|564387608|FG000|Overall Study|Discharged early from rehab|4|||
156352180|NCT00662363|564387609|FG001|Overall Study|Discharged early from rehab|1|||
156352181|NCT00662363|564387608|FG000|Overall Study|Protocol Violation|1|||
156352182|NCT00662363|564387609|FG001|Overall Study|Protocol Violation|1|||
156352183|NCT00195676|564387610|FG000|Period O - Open-label Treatment|Adverse Event|82|||
156352184|NCT00195676|564387610|FG000|Period O - Open-label Treatment|Death|6|||
156352185|NCT00195676|564387610|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
156352186|NCT00195676|564387610|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
156352187|NCT00195676|564387610|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
156352188|NCT00195676|564387610|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
156352189|NCT00195676|564387610|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
156352190|NCT00195676|564387610|FG000|Period O - Open-label Treatment|Other reasons|68|||
156352191|NCT00195676|564387610|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
156352192|NCT00195676|564387610|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
156352193|NCT00195676|564387610|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
156352194|NCT00195676|564387610|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
156352195|NCT00195676|564387610|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
156352196|NCT00195676|564387610|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
156352197|NCT00195676|564387610|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
156352198|NCT00195676|564387610|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
156352199|NCT00195676|564387610|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
156352200|NCT00195676|564387610|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
156352201|NCT00195676|564387610|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
156352202|NCT00195676|564387610|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
156352203|NCT00195676|564387610|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
156352204|NCT01189812|564387611|FG000|Overall Study|Withdrawal by Subject|2|||
156352205|NCT01189812|564387612|FG001|Overall Study|Withdrawal by Subject|3|||
156352206|NCT01189812|564387611|FG000|Overall Study|Adverse Event|1|||
156484080|NCT01498445|564864923|FG001|Overall Study|Lack of Efficacy|0|||
156484081|NCT01498445|564864924|FG002|Overall Study|Lack of Efficacy|1|||
156484082|NCT01498445|564864925|FG003|Overall Study|Lack of Efficacy|2|||
156352207|NCT01189812|564387612|FG001|Overall Study|Adverse Event|0|||
156352208|NCT01189812|564387611|FG000|Overall Study|Out of Window|4|||
156352209|NCT01189812|564387612|FG001|Overall Study|Out of Window|3|||
156352210|NCT01189812|564387611|FG000|Overall Study|Moved out of State|1|||
156352211|NCT01189812|564387612|FG001|Overall Study|Moved out of State|2|||
156352212|NCT01905657|564387613|FG000|Overall Study|Adverse Event|23|||
156352213|NCT01905657|564387614|FG001|Overall Study|Adverse Event|17|||
156352214|NCT01905657|564387615|FG002|Overall Study|Adverse Event|18|||
156352215|NCT01905657|564387613|FG000|Overall Study|Clinical Progression|103|||
156352216|NCT01905657|564387614|FG001|Overall Study|Clinical Progression|78|||
156484083|NCT01498445|564864926|FG004|Overall Study|Lack of Efficacy|0|||
156484084|NCT01498445|564864927|FG005|Overall Study|Lack of Efficacy|0|||
156352217|NCT01905657|564387615|FG002|Overall Study|Clinical Progression|59|||
156484085|NCT01498445|564864922|FG000|Overall Study|Screen Failure|0|||
156484086|NCT01498445|564864923|FG001|Overall Study|Screen Failure|0|||
156484087|NCT01498445|564864924|FG002|Overall Study|Screen Failure|0|||
156484088|NCT01498445|564864925|FG003|Overall Study|Screen Failure|0|||
156484089|NCT01498445|564864926|FG004|Overall Study|Screen Failure|1|||
156484090|NCT01498445|564864927|FG005|Overall Study|Screen Failure|1|||
156352218|NCT01905657|564387613|FG000|Overall Study|Death|40|||
156352219|NCT01905657|564387614|FG001|Overall Study|Death|43|||
156352220|NCT01905657|564387615|FG002|Overall Study|Death|47|||
156352221|NCT01905657|564387613|FG000|Overall Study|Excluded Medication|13|||
156352222|NCT01905657|564387614|FG001|Overall Study|Excluded Medication|16|||
156352223|NCT01905657|564387615|FG002|Overall Study|Excluded Medication|9|||
156352224|NCT01905657|564387613|FG000|Overall Study|Lost to Follow-up|1|||
156352225|NCT01905657|564387614|FG001|Overall Study|Lost to Follow-up|2|||
156352226|NCT01905657|564387615|FG002|Overall Study|Lost to Follow-up|1|||
156352227|NCT01905657|564387613|FG000|Overall Study|Physician Decision|5|||
156352228|NCT01905657|564387614|FG001|Overall Study|Physician Decision|8|||
156352229|NCT01905657|564387615|FG002|Overall Study|Physician Decision|12|||
156352230|NCT01905657|564387613|FG000|Overall Study|Protocol Violation|2|||
156352231|NCT01905657|564387614|FG001|Overall Study|Protocol Violation|1|||
156352232|NCT01905657|564387615|FG002|Overall Study|Protocol Violation|1|||
156352233|NCT01905657|564387613|FG000|Overall Study|Screen Failure|0|||
156352234|NCT01905657|564387614|FG001|Overall Study|Screen Failure|1|||
156484091|NCT02722278|564864928|FG000|Overall Study|Withdrawal by Subject|5|||
156484092|NCT02722278|564864929|FG001|Overall Study|Withdrawal by Subject|3|||
156484093|NCT02722278|564864928|FG000|Overall Study|Adverse Event|4|||
156484094|NCT02722278|564864929|FG001|Overall Study|Adverse Event|1|||
156484095|NCT02722278|564864928|FG000|Overall Study|Lost to Follow-up|2|||
156484096|NCT02722278|564864929|FG001|Overall Study|Lost to Follow-up|0|||
156484097|NCT02722278|564864928|FG000|Overall Study|Protocol Violation|1|||
156484098|NCT02722278|564864929|FG001|Overall Study|Protocol Violation|0|||
156484099|NCT02722278|564864928|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
156484100|NCT02722278|564864929|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
156484101|NCT02722278|564864928|FG000|Overall Study|Subject declined after tx assignment|0|||
156484102|NCT02722278|564864929|FG001|Overall Study|Subject declined after tx assignment|1|||
156484103|NCT02722278|564864928|FG000|Overall Study|Site closure not study related|0|||
156484104|NCT02722278|564864929|FG001|Overall Study|Site closure not study related|1|||
156484105|NCT02465866|564864930|FG000|Period 3|Withdrawal by Subject|0|||
156484106|NCT02465866|564864931|FG001|Period 3|Withdrawal by Subject|1|||
156484107|NCT02465866|564864932|FG002|Period 3|Withdrawal by Subject|0|||
156484108|NCT02465866|564864933|FG003|Period 3|Withdrawal by Subject|0|||
156484109|NCT00203502|564864934|FG000|Overall Study|Death|1|||
156484110|NCT01469819|564864935|FG000|Overall Study|Withdrawal by Subject|1|||
156484111|NCT01469819|564864935|FG000|Overall Study|Did not meet inclusionary criteria|2|||
156484112|NCT01469819|564864935|FG000|Overall Study|Could not swallow SmartPill|2|||
156484113|NCT01469819|564864935|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
156484114|NCT01403805|564864938|FG000|Overall Study|Withdrawal by Subject|0|||
156484115|NCT01403805|564864939|FG001|Overall Study|Withdrawal by Subject|4|||
156484116|NCT01403805|564864938|FG000|Overall Study|Lost to Follow-up|0|||
156484117|NCT01403805|564864939|FG001|Overall Study|Lost to Follow-up|2|||
156484118|NCT01403805|564864938|FG000|Overall Study|Death|0|||
156484119|NCT01403805|564864939|FG001|Overall Study|Death|1|||
156484120|NCT01695993|564864940|FG000|Overall Study|Lost to Follow-up|2|||
156484121|NCT01695993|564864941|FG001|Overall Study|Lost to Follow-up|1|||
156484122|NCT01695993|564864942|FG002|Overall Study|Lost to Follow-up|3|||
156484123|NCT01695993|564864940|FG000|Overall Study|Withdrawal by Subject|2|||
156484124|NCT01695993|564864941|FG001|Overall Study|Withdrawal by Subject|2|||
156484125|NCT01695993|564864942|FG002|Overall Study|Withdrawal by Subject|2|||
156484126|NCT01695993|564864940|FG000|Overall Study|To ill to continue|1|||
156484127|NCT01695993|564864941|FG001|Overall Study|To ill to continue|2|||
156484128|NCT01695993|564864942|FG002|Overall Study|To ill to continue|0|||
156484129|NCT01695993|564864940|FG000|Overall Study|Changed Medical Facility|0|||
156484130|NCT01695993|564864941|FG001|Overall Study|Changed Medical Facility|0|||
156484131|NCT01695993|564864942|FG002|Overall Study|Changed Medical Facility|1|||
156484132|NCT01601821|564864943|FG000|Overall Study|Death|2|||
156484133|NCT01601821|564864944|FG001|Overall Study|Death|5|||
156484134|NCT01601821|564864943|FG000|Overall Study|Protocol Violation|2|||
156484135|NCT01601821|564864944|FG001|Overall Study|Protocol Violation|2|||
156352235|NCT01905657|564387615|FG002|Overall Study|Screen Failure|0|||
156484136|NCT01601821|564864943|FG000|Overall Study|Lost to Follow-up|6|||
156484137|NCT01601821|564864944|FG001|Overall Study|Lost to Follow-up|14|||
156484138|NCT01601821|564864943|FG000|Overall Study|Withdrawal by Subject|1|||
156484139|NCT01601821|564864944|FG001|Overall Study|Withdrawal by Subject|0|||
156352236|NCT01905657|564387613|FG000|Overall Study|Withdrawal by Subject|15|||
156484140|NCT01601821|564864943|FG000|Overall Study|Graft Loss|6|||
156484141|NCT01601821|564864944|FG001|Overall Study|Graft Loss|6|||
156352237|NCT01905657|564387614|FG001|Overall Study|Withdrawal by Subject|21|||
156484142|NCT01601821|564864943|FG000|Overall Study|Study Events|7|||
156484143|NCT01601821|564864944|FG001|Overall Study|Study Events|1|||
156484144|NCT01601821|564864943|FG000|Overall Study|Other|5|||
156484145|NCT01601821|564864944|FG001|Overall Study|Other|1|||
156484146|NCT00147745|564864945|FG000|Overall Study|Withdrawal by Subject|1|||
156484147|NCT00147745|564864946|FG001|Overall Study|Withdrawal by Subject|0|||
156484148|NCT00147745|564864947|FG002|Overall Study|Withdrawal by Subject|0|||
156484149|NCT01901302|564864948|FG000|Overall Study|Adverse Event|2|||
156484150|NCT01901302|564864949|FG001|Overall Study|Adverse Event|1|||
156484151|NCT01901302|564864948|FG000|Overall Study|Lack of Efficacy|0|||
156484152|NCT01901302|564864949|FG001|Overall Study|Lack of Efficacy|2|||
156484153|NCT01901302|564864948|FG000|Overall Study|Study Terminated by Sponsor|23|||
156484154|NCT01901302|564864949|FG001|Overall Study|Study Terminated by Sponsor|20|||
156484155|NCT01901302|564864948|FG000|Overall Study|Withdrawal by Subject|2|||
156484156|NCT01901302|564864949|FG001|Overall Study|Withdrawal by Subject|0|||
156484157|NCT00510783|564864951|FG000|Overall Study|Lost to Follow-up|29|||
156352238|NCT01905657|564387615|FG002|Overall Study|Withdrawal by Subject|53|||
156352239|NCT01905657|564387613|FG000|Overall Study|Sponsor Decision|1|||
156352240|NCT01905657|564387614|FG001|Overall Study|Sponsor Decision|0|||
156352241|NCT01905657|564387615|FG002|Overall Study|Sponsor Decision|0|||
156352242|NCT05119569|564387616|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
156352243|NCT05119569|564387617|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
156352244|NCT05119569|564387618|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
156352245|NCT05119569|564387619|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
156352246|NCT05119569|564387616|FG000|Double Blind Treatment Phase|Adverse Event|6|||
156352247|NCT05119569|564387617|FG001|Double Blind Treatment Phase|Adverse Event|0|||
156352248|NCT05119569|564387618|FG002|Double Blind Treatment Phase|Adverse Event|0|||
156352249|NCT05119569|564387619|FG003|Double Blind Treatment Phase|Adverse Event|0|||
156352250|NCT05119569|564387616|FG000|Open Label Extension Phase|Ongoing in the study|0|||
156352251|NCT05119569|564387617|FG001|Open Label Extension Phase|Ongoing in the study|0|||
156352252|NCT05119569|564387618|FG002|Open Label Extension Phase|Ongoing in the study|65|||
156352253|NCT05119569|564387619|FG003|Open Label Extension Phase|Ongoing in the study|34|||
156352254|NCT02623439|564387622|FG000|Overall Study|Withdrawal by Subject|1|||
156352255|NCT02623439|564387622|FG000|Overall Study|Screen Failure|1|||
156352256|NCT02200445|564387626|FG000|Overall Study|Lack of Efficacy|1|||
156352257|NCT02200445|564387627|FG001|Overall Study|Lack of Efficacy|2|||
156352258|NCT02200445|564387628|FG002|Overall Study|Lack of Efficacy|2|||
156352259|NCT02200445|564387626|FG000|Overall Study|Adverse Event|0|||
156352260|NCT02200445|564387627|FG001|Overall Study|Adverse Event|2|||
156352261|NCT02200445|564387628|FG002|Overall Study|Adverse Event|0|||
156352262|NCT04484142|564387629|FG000|Overall Study|Adverse Event|13|||
156352263|NCT04484142|564387629|FG000|Overall Study|Progressive Disease|87|||
156352264|NCT04484142|564387629|FG000|Overall Study|Clinical Progression|10|||
156352265|NCT04484142|564387629|FG000|Overall Study|Withdrawal by Subject|6|||
156352266|NCT04484142|564387629|FG000|Overall Study|Physician Decision|1|||
156352267|NCT03700671|564387630|FG000|Overall Study|Lack of Efficacy|1|||
156352268|NCT03700671|564387631|FG001|Overall Study|Lack of Efficacy|2|||
156352269|NCT05371509|564387632|FG000|Overall Study|Physician Decision|1|||
156352270|NCT05371509|564387633|FG001|Overall Study|Physician Decision|0|||
156352271|NCT03851302|564387638|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
156484158|NCT00510783|564864952|FG001|Overall Study|Lost to Follow-up|25|||
156484159|NCT00510783|564864951|FG000|Overall Study|Withdrawal by Subject|2|||
156352272|NCT03851302|564387639|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
156352273|NCT03851302|564387640|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
156484160|NCT00510783|564864952|FG001|Overall Study|Withdrawal by Subject|3|||
156352274|NCT03851302|564387641|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
156352275|NCT03851302|564387642|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
156352276|NCT03851302|564387643|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
156352277|NCT03851302|564387638|FG000|Screening (1 Day)|Screened out|0|||
156352278|NCT03851302|564387639|FG001|Screening (1 Day)|Screened out|0|||
156352279|NCT03851302|564387640|FG002|Screening (1 Day)|Screened out|1|||
156352280|NCT03851302|564387641|FG003|Screening (1 Day)|Screened out|1|||
156352281|NCT03851302|564387642|FG004|Screening (1 Day)|Screened out|0|||
156484161|NCT00510783|564864951|FG000|Overall Study|Protocol Violation|0|||
156484162|NCT00510783|564864952|FG001|Overall Study|Protocol Violation|1|||
156484163|NCT00316121|564864953|FG000|Overall Study|Death|1|||
156484164|NCT00316121|564864954|FG001|Overall Study|Death|0|||
156484165|NCT00316121|564864953|FG000|Overall Study|Lost to Follow-up|14|||
156484166|NCT00316121|564864954|FG001|Overall Study|Lost to Follow-up|8|||
156484167|NCT00316121|564864953|FG000|Overall Study|Withdrawal by Subject|2|||
156484168|NCT00316121|564864954|FG001|Overall Study|Withdrawal by Subject|0|||
156484169|NCT00316121|564864953|FG000|Overall Study|Reason is missing|1|||
156484170|NCT00316121|564864954|FG001|Overall Study|Reason is missing|0|||
156352282|NCT03851302|564387643|FG005|Screening (1 Day)|Screened out|0|||
156352283|NCT03851302|564387638|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
156352284|NCT03851302|564387639|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
156484171|NCT00316121|564864953|FG000|Overall Study|Subject relocated|1|||
156484172|NCT00316121|564864954|FG001|Overall Study|Subject relocated|1|||
156484173|NCT00316121|564864953|FG000|Overall Study|Subject refused to return|1|||
156484174|NCT00316121|564864954|FG001|Overall Study|Subject refused to return|0|||
156484175|NCT00316121|564864953|FG000|Overall Study|Subject no show for visit x 3|1|||
156484176|NCT00316121|564864954|FG001|Overall Study|Subject no show for visit x 3|0|||
156484177|NCT00316121|564864953|FG000|Overall Study|Subject did not have 24 month visit|1|||
156484178|NCT00316121|564864954|FG001|Overall Study|Subject did not have 24 month visit|0|||
156484179|NCT01721109|564864963|FG000|Overall Study|Lack of Efficacy|1|||
156484180|NCT01721109|564864963|FG000|Overall Study|Non- Compliance with Study Drug|3|||
156484181|NCT01721109|564864963|FG000|Overall Study|Withdrew Consent|1|||
156484182|NCT01721109|564864963|FG000|Overall Study|Lost to Follow-up|2|||
156484183|NCT03166215|564864964|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
156484184|NCT03166215|564864965|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
156484185|NCT03166215|564864966|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
156484186|NCT03166215|564864964|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
156484187|NCT03166215|564864965|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
156484188|NCT03166215|564864966|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
156484189|NCT04985604|564864968|FG000|Overall Study|Death|4|||
156484190|NCT04985604|564864969|FG001|Overall Study|Death|6|||
156484191|NCT04985604|564864968|FG000|Overall Study|Withdrawal by Subject|0|||
156484192|NCT04985604|564864969|FG001|Overall Study|Withdrawal by Subject|1|||
156484193|NCT04598776|564864970|FG000|Overall Study|Protocol Violation|5|||
156484194|NCT04598776|564864970|FG000|Overall Study|Physician Decision|4|||
156484195|NCT00348283|564864971|FG000|Induction|Adverse Event|0|||
156484196|NCT00348283|564864972|FG001|Induction|Adverse Event|2|||
156484197|NCT00348283|564864971|FG000|Induction|Protocol Violation|0|||
156484198|NCT00348283|564864972|FG001|Induction|Protocol Violation|4|||
156484199|NCT00348283|564864971|FG000|Double Blind|Adverse Event|2|||
156484200|NCT00348283|564864972|FG001|Double Blind|Adverse Event|5|||
156484201|NCT00348283|564864971|FG000|Double Blind|Withdrawal by Subject|1|||
156484202|NCT00348283|564864972|FG001|Double Blind|Withdrawal by Subject|1|||
156484203|NCT00348283|564864971|FG000|Double Blind|Protocol Violation|0|||
156484204|NCT00348283|564864972|FG001|Double Blind|Protocol Violation|1|||
156484205|NCT00348283|564864971|FG000|Double Blind|Lack of Efficacy|2|||
156484206|NCT00348283|564864972|FG001|Double Blind|Lack of Efficacy|2|||
156484207|NCT00348283|564864971|FG000|Double Blind|Pregnancy|0|||
156484208|NCT00348283|564864972|FG001|Double Blind|Pregnancy|1|||
156352285|NCT03851302|564387640|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
156352286|NCT03851302|564387641|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
156352287|NCT03851302|564387642|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
156352288|NCT03851302|564387643|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
156352289|NCT03578367|564387644|FG000|Overall Study|Adverse Event|0|||
156352290|NCT03578367|564387645|FG001|Overall Study|Adverse Event|3|||
156352291|NCT03578367|564387646|FG002|Overall Study|Adverse Event|0|||
156352292|NCT03578367|564387647|FG003|Overall Study|Adverse Event|5|||
156352293|NCT03578367|564387644|FG000|Overall Study|Withdrawal by Subject|2|||
156352294|NCT03578367|564387645|FG001|Overall Study|Withdrawal by Subject|2|||
156352295|NCT03578367|564387646|FG002|Overall Study|Withdrawal by Subject|1|||
156352296|NCT03578367|564387647|FG003|Overall Study|Withdrawal by Subject|3|||
156352297|NCT03578367|564387644|FG000|Overall Study|Physician Decision|0|||
156352298|NCT03578367|564387645|FG001|Overall Study|Physician Decision|0|||
156352299|NCT03578367|564387646|FG002|Overall Study|Physician Decision|14|||
156352300|NCT03578367|564387647|FG003|Overall Study|Physician Decision|0|||
156352301|NCT03578367|564387644|FG000|Overall Study|Death|1|||
156352302|NCT03578367|564387645|FG001|Overall Study|Death|0|||
156352303|NCT03578367|564387646|FG002|Overall Study|Death|0|||
156352304|NCT03578367|564387647|FG003|Overall Study|Death|0|||
156352305|NCT03578367|564387644|FG000|Overall Study|Not treated|0|||
156352306|NCT03578367|564387645|FG001|Overall Study|Not treated|0|||
156352307|NCT03578367|564387646|FG002|Overall Study|Not treated|1|||
156352308|NCT03578367|564387647|FG003|Overall Study|Not treated|0|||
156352309|NCT00587561|564389624|FG000|Overall Study|Lost to Follow-up|6|||
156352310|NCT00587561|564389625|FG001|Overall Study|Lost to Follow-up|4|||
156352311|NCT00982488|564389627|FG000|Overall Study|Administrative reason by sponsor|81|||
156352312|NCT00982488|564389628|FG001|Overall Study|Administrative reason by sponsor|3|||
156352313|NCT00982488|564389629|FG002|Overall Study|Administrative reason by sponsor|11|||
156352314|NCT00982488|564389630|FG003|Overall Study|Administrative reason by sponsor|0|||
156484209|NCT00348283|564864971|FG000|Open Label|Adverse Event|0|||
156352315|NCT00982488|564389631|FG004|Overall Study|Administrative reason by sponsor|0|||
156352316|NCT00982488|564389627|FG000|Overall Study|Adverse event unrelated to study drug|5|||
156352317|NCT00982488|564389628|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156352318|NCT00982488|564389629|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156484210|NCT00348283|564864972|FG001|Open Label|Adverse Event|8|||
156484211|NCT00348283|564864971|FG000|Open Label|Withdrawal by Subject|0|||
156484212|NCT00348283|564864972|FG001|Open Label|Withdrawal by Subject|4|||
156484213|NCT00348283|564864971|FG000|Open Label|Lost to Follow-up|0|||
156484214|NCT00348283|564864972|FG001|Open Label|Lost to Follow-up|1|||
156484215|NCT00348283|564864971|FG000|Open Label|Lack of Efficacy|0|||
156484216|NCT00348283|564864972|FG001|Open Label|Lack of Efficacy|13|||
156484217|NCT00348283|564864971|FG000|Open Label|Administrative reasons|0|||
156484218|NCT00348283|564864972|FG001|Open Label|Administrative reasons|5|||
156484219|NCT00348283|564864971|FG000|Open Label|Subject moved to the United States|0|||
156484220|NCT00348283|564864972|FG001|Open Label|Subject moved to the United States|1|||
156484221|NCT00348283|564864971|FG000|Open Label|Pregnancy|0|||
156484222|NCT00348283|564864972|FG001|Open Label|Pregnancy|1|||
156484223|NCT00348283|564864971|FG000|Open Label|Sponsor decision|0|||
156484224|NCT00348283|564864972|FG001|Open Label|Sponsor decision|1|||
156484225|NCT02282761|564864975|FG000|Overall Study|Death|0|||
156484226|NCT02282761|564864976|FG001|Overall Study|Death|0|||
156484227|NCT02282761|564864977|FG002|Overall Study|Death|1|||
156484228|NCT02282761|564864975|FG000|Overall Study|Adverse Event|6|||
156484229|NCT02282761|564864976|FG001|Overall Study|Adverse Event|2|||
156484230|NCT02282761|564864977|FG002|Overall Study|Adverse Event|0|||
156352319|NCT00982488|564389630|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156352320|NCT00982488|564389631|FG004|Overall Study|Adverse event unrelated to study drug|0|||
156352321|NCT00982488|564389627|FG000|Overall Study|Death|11|||
156352322|NCT00982488|564389628|FG001|Overall Study|Death|0|||
156352323|NCT00982488|564389629|FG002|Overall Study|Death|2|||
156352324|NCT00982488|564389630|FG003|Overall Study|Death|0|||
156352325|NCT00982488|564389631|FG004|Overall Study|Death|0|||
156352326|NCT00982488|564389627|FG000|Overall Study|Disease progression|30|||
156352327|NCT00982488|564389628|FG001|Overall Study|Disease progression|5|||
156352328|NCT00982488|564389629|FG002|Overall Study|Disease progression|10|||
156352329|NCT00982488|564389630|FG003|Overall Study|Disease progression|1|||
156352330|NCT00982488|564389631|FG004|Overall Study|Disease progression|1|||
156352331|NCT00982488|564389627|FG000|Overall Study|Lost to Follow-up|1|||
156352332|NCT00982488|564389628|FG001|Overall Study|Lost to Follow-up|0|||
156352333|NCT00982488|564389629|FG002|Overall Study|Lost to Follow-up|0|||
156352334|NCT00982488|564389630|FG003|Overall Study|Lost to Follow-up|0|||
156352335|NCT00982488|564389631|FG004|Overall Study|Lost to Follow-up|0|||
156352336|NCT00982488|564389627|FG000|Overall Study|Maximum clinical benefit|1|||
156352337|NCT00982488|564389628|FG001|Overall Study|Maximum clinical benefit|1|||
156352338|NCT00982488|564389629|FG002|Overall Study|Maximum clinical benefit|1|||
156352339|NCT00982488|564389630|FG003|Overall Study|Maximum clinical benefit|0|||
156352340|NCT00982488|564389631|FG004|Overall Study|Maximum clinical benefit|0|||
156352341|NCT00982488|564389627|FG000|Overall Study|Other|15|||
156484231|NCT02282761|564864975|FG000|Overall Study|Lack of Efficacy|11|||
156484232|NCT02282761|564864976|FG001|Overall Study|Lack of Efficacy|6|||
156484233|NCT02282761|564864977|FG002|Overall Study|Lack of Efficacy|17|||
156484234|NCT02282761|564864975|FG000|Overall Study|Lost to Follow-up|2|||
156484235|NCT02282761|564864976|FG001|Overall Study|Lost to Follow-up|2|||
156484236|NCT02282761|564864977|FG002|Overall Study|Lost to Follow-up|1|||
156484237|NCT02282761|564864975|FG000|Overall Study|Physician Decision|0|||
156484238|NCT02282761|564864976|FG001|Overall Study|Physician Decision|0|||
156484239|NCT02282761|564864977|FG002|Overall Study|Physician Decision|2|||
156484240|NCT02282761|564864975|FG000|Overall Study|Withdrawal by Subject|8|||
156484241|NCT02282761|564864976|FG001|Overall Study|Withdrawal by Subject|10|||
156484242|NCT02282761|564864977|FG002|Overall Study|Withdrawal by Subject|16|||
156484243|NCT02282761|564864975|FG000|Overall Study|Other|3|||
156484244|NCT02282761|564864976|FG001|Overall Study|Other|2|||
156484245|NCT02282761|564864977|FG002|Overall Study|Other|1|||
156484246|NCT00658632|564864980|FG000|Overall Study|Adverse Event|13|||
156484247|NCT00658632|564864981|FG001|Overall Study|Adverse Event|11|||
156484248|NCT00658632|564864980|FG000|Overall Study|Lost to Follow-up|25|||
156484249|NCT00658632|564864981|FG001|Overall Study|Lost to Follow-up|23|||
156484250|NCT00658632|564864980|FG000|Overall Study|Withdrawal by Subject|10|||
156484251|NCT00658632|564864981|FG001|Overall Study|Withdrawal by Subject|7|||
156484252|NCT00658632|564864980|FG000|Overall Study|Lack of Efficacy|0|||
156484253|NCT00658632|564864981|FG001|Overall Study|Lack of Efficacy|1|||
156484254|NCT00658632|564864980|FG000|Overall Study|Withdrawal of consent|8|||
156484255|NCT00658632|564864981|FG001|Overall Study|Withdrawal of consent|14|||
156484256|NCT00658632|564864980|FG000|Overall Study|Pregnancy|1|||
156484257|NCT00658632|564864981|FG001|Overall Study|Pregnancy|1|||
156484258|NCT00658632|564864980|FG000|Overall Study|Other|7|||
156484259|NCT00658632|564864981|FG001|Overall Study|Other|8|||
156484260|NCT02632045|564864983|FG000|Overall Study|Withdrawal by Subject|1|||
156484261|NCT02632045|564864984|FG001|Overall Study|Withdrawal by Subject|2|||
156484262|NCT05878522|564864985|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484263|NCT05878522|564864986|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484264|NCT05878522|564864987|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484265|NCT05878522|564864988|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484266|NCT05878522|564864989|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484267|NCT05878522|564864990|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484268|NCT05878522|564864991|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484269|NCT05878522|564864992|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484270|NCT05878522|564864993|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
156484271|NCT05878522|564864994|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484272|NCT05878522|564864995|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484273|NCT05878522|564864996|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
156484274|NCT05878522|564864985|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
156484275|NCT05878522|564864986|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484276|NCT05878522|564864987|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484277|NCT05878522|564864988|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156352342|NCT00982488|564389628|FG001|Overall Study|Other|1|||
156352343|NCT00982488|564389629|FG002|Overall Study|Other|3|||
156484278|NCT05878522|564864989|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484279|NCT05878522|564864990|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484280|NCT05878522|564864991|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484281|NCT05878522|564864992|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484282|NCT05878522|564864993|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484283|NCT05878522|564864994|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
156484284|NCT05878522|564864995|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484285|NCT05878522|564864996|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
156484286|NCT05878522|564864985|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484287|NCT05878522|564864986|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
156484288|NCT05878522|564864987|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484289|NCT05878522|564864988|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
156484290|NCT05878522|564864989|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484291|NCT05878522|564864990|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484292|NCT05878522|564864991|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484293|NCT05878522|564864992|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484294|NCT05878522|564864993|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484295|NCT05878522|564864994|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484296|NCT05878522|564864995|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484297|NCT05878522|564864996|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
156484298|NCT05878522|564864985|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484299|NCT05878522|564864986|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484300|NCT05878522|564864987|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484301|NCT05878522|564864988|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484302|NCT05878522|564864989|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
156484303|NCT05878522|564864990|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484304|NCT05878522|564864991|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484305|NCT05878522|564864992|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484306|NCT05878522|564864993|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484307|NCT05878522|564864994|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484308|NCT05878522|564864995|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484309|NCT05878522|564864996|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
156484310|NCT05263492|564864997|FG000|Overall Study|Adverse Event|1|||
156484311|NCT05263492|564864997|FG000|Overall Study|Disease progression during active treatment|3|||
156484312|NCT05216835|564865000|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
156484313|NCT05216835|564865001|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
156484314|NCT05216835|564865002|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
156484315|NCT05216835|564865003|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
156484316|NCT05216835|564865004|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
156484317|NCT05216835|564865005|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
156484318|NCT05216835|564865006|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
156484319|NCT05216835|564865007|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
156544364|NCT00876187|565087759|FG003|Overall Study|Randomized but not treated|2|||
156352344|NCT00982488|564389630|FG003|Overall Study|Other|1|||
156484320|NCT05216835|564865000|FG000|Overall Study|Death|0|||
156484321|NCT05216835|564865001|FG001|Overall Study|Death|0|||
156484322|NCT05216835|564865002|FG002|Overall Study|Death|0|||
156484323|NCT05216835|564865003|FG003|Overall Study|Death|1|||
156484324|NCT05216835|564865004|FG004|Overall Study|Death|1|||
156352345|NCT00982488|564389631|FG004|Overall Study|Other|0|||
156484325|NCT05216835|564865005|FG005|Overall Study|Death|1|||
156352346|NCT00982488|564389627|FG000|Overall Study|Poor compliance/noncompliance|0|||
156484326|NCT05216835|564865006|FG006|Overall Study|Death|1|||
156484327|NCT05216835|564865007|FG007|Overall Study|Death|1|||
156352347|NCT00982488|564389628|FG001|Overall Study|Poor compliance/noncompliance|1|||
156484328|NCT05216835|564865000|FG000|Overall Study|Physician Decision|0|||
156484329|NCT05216835|564865001|FG001|Overall Study|Physician Decision|0|||
156484330|NCT05216835|564865002|FG002|Overall Study|Physician Decision|0|||
156484331|NCT05216835|564865003|FG003|Overall Study|Physician Decision|0|||
156484332|NCT05216835|564865004|FG004|Overall Study|Physician Decision|0|||
156484333|NCT05216835|564865005|FG005|Overall Study|Physician Decision|1|||
156484334|NCT05216835|564865006|FG006|Overall Study|Physician Decision|1|||
156484335|NCT05216835|564865007|FG007|Overall Study|Physician Decision|0|||
156484336|NCT05216835|564865000|FG000|Overall Study|Study terminated by Sponsor|0|||
156484337|NCT05216835|564865001|FG001|Overall Study|Study terminated by Sponsor|0|||
156484338|NCT05216835|564865002|FG002|Overall Study|Study terminated by Sponsor|0|||
156484339|NCT05216835|564865003|FG003|Overall Study|Study terminated by Sponsor|0|||
156484340|NCT05216835|564865004|FG004|Overall Study|Study terminated by Sponsor|0|||
156544365|NCT00876187|565087760|FG004|Overall Study|Randomized but not treated|3|||
156544366|NCT00876187|565087756|FG000|Overall Study|Other|2|||
156544367|NCT00876187|565087757|FG001|Overall Study|Other|5|||
156352348|NCT00982488|564389629|FG002|Overall Study|Poor compliance/noncompliance|0|||
156352349|NCT00982488|564389630|FG003|Overall Study|Poor compliance/noncompliance|0|||
156352350|NCT00982488|564389631|FG004|Overall Study|Poor compliance/noncompliance|0|||
156352351|NCT00982488|564389627|FG000|Overall Study|Stem cell transplant|2|||
156352352|NCT00982488|564389628|FG001|Overall Study|Stem cell transplant|0|||
156352353|NCT00982488|564389629|FG002|Overall Study|Stem cell transplant|0|||
156352354|NCT00982488|564389630|FG003|Overall Study|Stem cell transplant|1|||
156352355|NCT00982488|564389631|FG004|Overall Study|Stem cell transplant|0|||
156352356|NCT00982488|564389627|FG000|Overall Study|Study drug toxicity|34|||
156352357|NCT00982488|564389628|FG001|Overall Study|Study drug toxicity|1|||
156352358|NCT00982488|564389629|FG002|Overall Study|Study drug toxicity|6|||
156352359|NCT00982488|564389630|FG003|Overall Study|Study drug toxicity|0|||
156352360|NCT00982488|564389631|FG004|Overall Study|Study drug toxicity|0|||
156352361|NCT00982488|564389627|FG000|Overall Study|Withdrawal by Subject|5|||
156352362|NCT00982488|564389628|FG001|Overall Study|Withdrawal by Subject|1|||
156352363|NCT00982488|564389629|FG002|Overall Study|Withdrawal by Subject|1|||
156352364|NCT00982488|564389630|FG003|Overall Study|Withdrawal by Subject|0|||
156352365|NCT00982488|564389631|FG004|Overall Study|Withdrawal by Subject|0|||
156352366|NCT03204981|564389632|FG000|Overall Study|Physician Decision|2|||
156352367|NCT03204981|564389632|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
156352368|NCT04203238|564389633|FG000|Overall Study|Withdrawal by Subject|1|||
156352369|NCT04203238|564389634|FG001|Overall Study|Withdrawal by Subject|1|||
156352370|NCT04203238|564389633|FG000|Overall Study|Covid-19|3|||
156352371|NCT04203238|564389634|FG001|Overall Study|Covid-19|0|||
156352372|NCT04244786|564389637|FG000|Overall Study|Adverse Event|0|||
156352373|NCT04244786|564389638|FG001|Overall Study|Adverse Event|0|||
156352374|NCT04244786|564389639|FG002|Overall Study|Adverse Event|2|||
156352375|NCT04244786|564389637|FG000|Overall Study|Withdrawal by Subject|0|||
156352376|NCT04244786|564389638|FG001|Overall Study|Withdrawal by Subject|0|||
156352377|NCT04244786|564389639|FG002|Overall Study|Withdrawal by Subject|5|||
156352378|NCT00001596|564389640|FG000|Overall Study|Death|1|||
156352379|NCT00001596|564389641|FG001|Overall Study|Death|0|||
156352380|NCT00001596|564389640|FG000|Overall Study|Withdrawal by Subject|3|||
156352381|NCT00001596|564389641|FG001|Overall Study|Withdrawal by Subject|1|||
156352382|NCT00001596|564389640|FG000|Overall Study|Study Termination|12|||
156352383|NCT00001596|564389641|FG001|Overall Study|Study Termination|9|||
156352384|NCT00001596|564389640|FG000|Overall Study|Adverse Event|1|||
156352385|NCT00001596|564389641|FG001|Overall Study|Adverse Event|0|||
156352386|NCT03274687|564389642|FG000|Overall Study|Protocol Violation|1|||
156352387|NCT03274687|564389643|FG001|Overall Study|Protocol Violation|1|||
156352388|NCT01199289|564389645|FG000|Overall Study|Ineligibility determined|2|||
156352389|NCT01199289|564389646|FG001|Overall Study|Ineligibility determined|1|||
156352390|NCT01199289|564389647|FG002|Overall Study|Ineligibility determined|0|||
156352391|NCT01199289|564389648|FG003|Overall Study|Ineligibility determined|0|||
156352392|NCT01199289|564389645|FG000|Overall Study|Protocol Violation|1|||
156352393|NCT01199289|564389646|FG001|Overall Study|Protocol Violation|0|||
156352394|NCT01199289|564389647|FG002|Overall Study|Protocol Violation|0|||
156352395|NCT01199289|564389648|FG003|Overall Study|Protocol Violation|1|||
156352396|NCT01199289|564389645|FG000|Overall Study|Noncompliance|1|||
156352397|NCT01199289|564389646|FG001|Overall Study|Noncompliance|0|||
156352398|NCT01199289|564389647|FG002|Overall Study|Noncompliance|2|||
156352399|NCT01199289|564389648|FG003|Overall Study|Noncompliance|0|||
156352400|NCT01199289|564389645|FG000|Overall Study|Adverse Event|0|||
156484341|NCT05216835|564865005|FG005|Overall Study|Study terminated by Sponsor|0|||
156484342|NCT05216835|564865006|FG006|Overall Study|Study terminated by Sponsor|0|||
156484343|NCT05216835|564865007|FG007|Overall Study|Study terminated by Sponsor|1|||
156484344|NCT05216835|564865000|FG000|Overall Study|Withdrawal by Subject|1|||
156484345|NCT05216835|564865001|FG001|Overall Study|Withdrawal by Subject|0|||
156484346|NCT05216835|564865002|FG002|Overall Study|Withdrawal by Subject|1|||
156484347|NCT05216835|564865003|FG003|Overall Study|Withdrawal by Subject|0|||
156484348|NCT05216835|564865004|FG004|Overall Study|Withdrawal by Subject|1|||
156484349|NCT05216835|564865005|FG005|Overall Study|Withdrawal by Subject|0|||
156352401|NCT01199289|564389646|FG001|Overall Study|Adverse Event|3|||
156352402|NCT01199289|564389647|FG002|Overall Study|Adverse Event|1|||
156352403|NCT01199289|564389648|FG003|Overall Study|Adverse Event|4|||
156352404|NCT01199289|564389645|FG000|Overall Study|Full consent withdrawn|2|||
156352405|NCT01199289|564389646|FG001|Overall Study|Full consent withdrawn|2|||
156484350|NCT05216835|564865006|FG006|Overall Study|Withdrawal by Subject|0|||
156352406|NCT01199289|564389647|FG002|Overall Study|Full consent withdrawn|2|||
156352407|NCT01199289|564389648|FG003|Overall Study|Full consent withdrawn|3|||
156352408|NCT01199289|564389645|FG000|Overall Study|Administrative decision|0|||
156352409|NCT01199289|564389646|FG001|Overall Study|Administrative decision|0|||
156352410|NCT01199289|564389647|FG002|Overall Study|Administrative decision|0|||
156352411|NCT01199289|564389648|FG003|Overall Study|Administrative decision|1|||
156352412|NCT01199289|564389645|FG000|Overall Study|Lost to Follow-up|0|||
156352413|NCT01199289|564389646|FG001|Overall Study|Lost to Follow-up|0|||
156484351|NCT05216835|564865007|FG007|Overall Study|Withdrawal by Subject|1|||
156484352|NCT05216835|564865000|FG000|Overall Study|Other|0|||
156484353|NCT05216835|564865001|FG001|Overall Study|Other|1|||
156484354|NCT05216835|564865002|FG002|Overall Study|Other|0|||
156484355|NCT05216835|564865003|FG003|Overall Study|Other|0|||
156484356|NCT05216835|564865004|FG004|Overall Study|Other|0|||
156484357|NCT05216835|564865005|FG005|Overall Study|Other|0|||
156484358|NCT05216835|564865006|FG006|Overall Study|Other|0|||
156484359|NCT05216835|564865007|FG007|Overall Study|Other|0|||
156484360|NCT04551053|564865008|FG000|Overall Study|Death|10|||
156484361|NCT04551053|564865009|FG001|Overall Study|Death|9|||
156484362|NCT04551053|564865008|FG000|Overall Study|Lost to Follow-up|0|||
156484363|NCT04551053|564865009|FG001|Overall Study|Lost to Follow-up|2|||
156484364|NCT04551053|564865008|FG000|Overall Study|Study Terminated by Sponsor|57|||
156484365|NCT04551053|564865009|FG001|Overall Study|Study Terminated by Sponsor|65|||
156484366|NCT04551053|564865008|FG000|Overall Study|Withdrawal by Subject|12|||
156484367|NCT04551053|564865009|FG001|Overall Study|Withdrawal by Subject|5|||
156484368|NCT04551053|564865008|FG000|Overall Study|Adverse Event|2|||
156352414|NCT01199289|564389647|FG002|Overall Study|Lost to Follow-up|0|||
156484369|NCT04551053|564865009|FG001|Overall Study|Adverse Event|0|||
156352415|NCT01199289|564389648|FG003|Overall Study|Lost to Follow-up|1|||
156352416|NCT01199289|564389645|FG000|Overall Study|Protocol-specified criteria|3|||
156352417|NCT01199289|564389646|FG001|Overall Study|Protocol-specified criteria|0|||
156352418|NCT01199289|564389647|FG002|Overall Study|Protocol-specified criteria|0|||
156352419|NCT01199289|564389648|FG003|Overall Study|Protocol-specified criteria|1|||
156352420|NCT01199289|564389645|FG000|Overall Study|Pregnancy|0|||
156352421|NCT01199289|564389646|FG001|Overall Study|Pregnancy|1|||
156352422|NCT01199289|564389647|FG002|Overall Study|Pregnancy|0|||
156352423|NCT01199289|564389648|FG003|Overall Study|Pregnancy|1|||
156352424|NCT02636868|564389649|FG000|Overall Study|Death|0|||
156352425|NCT02636868|564389650|FG001|Overall Study|Death|1|||
156352426|NCT02636868|564389651|FG002|Overall Study|Death|2|||
156352427|NCT00415909|564389653|FG000|Overall Study|Withdrawal by Subject|2|||
156352428|NCT00415909|564389653|FG000|Overall Study|Death|1|||
156352429|NCT00903617|564389656|FG000|Overall Study|Adverse Event|0|||
156352430|NCT00903617|564389657|FG001|Overall Study|Adverse Event|1|||
156352431|NCT00903617|564389658|FG002|Overall Study|Adverse Event|1|||
156352432|NCT00903617|564389659|FG003|Overall Study|Adverse Event|0|||
156352433|NCT00903617|564389656|FG000|Overall Study|Protocol-defined stopping criteria|0|||
156352434|NCT00903617|564389657|FG001|Overall Study|Protocol-defined stopping criteria|2|||
156352435|NCT00903617|564389658|FG002|Overall Study|Protocol-defined stopping criteria|0|||
156352436|NCT00903617|564389659|FG003|Overall Study|Protocol-defined stopping criteria|0|||
156352437|NCT00903617|564389656|FG000|Overall Study|Lost to Follow-up|2|||
156352438|NCT00903617|564389657|FG001|Overall Study|Lost to Follow-up|0|||
156352439|NCT00903617|564389658|FG002|Overall Study|Lost to Follow-up|1|||
156352440|NCT00903617|564389659|FG003|Overall Study|Lost to Follow-up|1|||
156352441|NCT00903617|564389656|FG000|Overall Study|Withdrawal by Subject|1|||
156352442|NCT00903617|564389657|FG001|Overall Study|Withdrawal by Subject|2|||
156352443|NCT00903617|564389658|FG002|Overall Study|Withdrawal by Subject|3|||
156352444|NCT00903617|564389659|FG003|Overall Study|Withdrawal by Subject|0|||
156352445|NCT01104636|564389660|FG000|Overall Study|Lack of Efficacy|43|||
156352446|NCT01104636|564389660|FG000|Overall Study|Lost to Follow-up|24|||
156352447|NCT01104636|564389660|FG000|Overall Study|Withdrawal by Subject|4|||
156352448|NCT01104636|564389660|FG000|Overall Study|Other|43|||
156352449|NCT01104636|564389660|FG000|Overall Study|Study terminated by sponsor|1|||
156352450|NCT01104636|564389660|FG000|Overall Study|Pregnancy|2|||
156352451|NCT01104636|564389660|FG000|Overall Study|Adverse Event|40|||
156352452|NCT01104636|564389660|FG000|Overall Study|Ongoing|21|||
156352453|NCT01706003|564389661|FG000|Overall Study|Withdrawal by Subject|2|||
156352454|NCT01706003|564389662|FG001|Overall Study|Withdrawal by Subject|0|||
156352455|NCT01706003|564389661|FG000|Overall Study|Not scheduled|3|||
156352456|NCT01706003|564389662|FG001|Overall Study|Not scheduled|0|||
156352457|NCT01706003|564389661|FG000|Overall Study|Lost to Follow-up|6|||
156352458|NCT01706003|564389662|FG001|Overall Study|Lost to Follow-up|4|||
156352459|NCT03182829|564389665|FG000|Overall Study|Protocol Violation|12|||
156352460|NCT03182829|564389666|FG001|Overall Study|Protocol Violation|12|||
156352461|NCT03182829|564389665|FG000|Overall Study|Other|4|||
156352462|NCT03182829|564389666|FG001|Overall Study|Other|3|||
156352463|NCT03316131|564389667|FG000|Treatment Period 2|Protocol deviation|1|||
156352464|NCT03316131|564389668|FG001|Treatment Period 2|Protocol deviation|0|||
156352465|NCT05608005|564389669|FG000|Overall Study|Adverse Event|2|||
156352466|NCT05608005|564389670|FG001|Overall Study|Adverse Event|1|||
156352467|NCT05608005|564389671|FG002|Overall Study|Adverse Event|3|||
156352468|NCT05608005|564389669|FG000|Overall Study|Protocol Violation|2|||
156352469|NCT05608005|564389670|FG001|Overall Study|Protocol Violation|3|||
156352470|NCT05608005|564389671|FG002|Overall Study|Protocol Violation|0|||
156352471|NCT05608005|564389669|FG000|Overall Study|Withdrawal by Subject|10|||
156352472|NCT05608005|564389670|FG001|Overall Study|Withdrawal by Subject|12|||
156352473|NCT05608005|564389671|FG002|Overall Study|Withdrawal by Subject|4|||
156352474|NCT05608005|564389669|FG000|Overall Study|Lost to Follow-up|25|||
156484370|NCT04551053|564865008|FG000|Overall Study|Lack of Efficacy|2|||
156484371|NCT04551053|564865009|FG001|Overall Study|Lack of Efficacy|1|||
156484372|NCT04551053|564865008|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
156484373|NCT04551053|564865009|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
156484374|NCT04551053|564865008|FG000|Overall Study|Splenapendectomi|1|||
156352475|NCT05608005|564389670|FG001|Overall Study|Lost to Follow-up|27|||
156352476|NCT05608005|564389671|FG002|Overall Study|Lost to Follow-up|15|||
156352477|NCT05608005|564389669|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
156352478|NCT05608005|564389670|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
156352479|NCT05608005|564389671|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
156352480|NCT02259582|564389678|FG000|Overall Study|Physician Decision|0|||
156352481|NCT02259582|564389679|FG001|Overall Study|Physician Decision|1|||
156352482|NCT02259582|564389680|FG002|Overall Study|Physician Decision|0|||
156352483|NCT02259582|564389678|FG000|Overall Study|Death|0|||
156352484|NCT02259582|564389679|FG001|Overall Study|Death|0|||
156352485|NCT02259582|564389680|FG002|Overall Study|Death|1|||
156352486|NCT02259582|564389678|FG000|Overall Study|Adverse Event|1|||
156352487|NCT02259582|564389679|FG001|Overall Study|Adverse Event|0|||
156352488|NCT02259582|564389680|FG002|Overall Study|Adverse Event|1|||
156484375|NCT04551053|564865009|FG001|Overall Study|Splenapendectomi|0|||
156352489|NCT02259582|564389678|FG000|Overall Study|Withdrawal by Subject|0|||
156352490|NCT02259582|564389679|FG001|Overall Study|Withdrawal by Subject|0|||
156352491|NCT02259582|564389680|FG002|Overall Study|Withdrawal by Subject|1|||
156352492|NCT02259582|564389678|FG000|Overall Study|Disease progression|14|||
156352493|NCT02259582|564389679|FG001|Overall Study|Disease progression|15|||
156352494|NCT02259582|564389680|FG002|Overall Study|Disease progression|17|||
156352495|NCT02259582|564389678|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
156352496|NCT02259582|564389679|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
156352497|NCT02259582|564389680|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
156352498|NCT03518073|564389681|FG000|Overall Study|Adverse Event|2|||
156352499|NCT03518073|564389682|FG001|Overall Study|Adverse Event|4|||
156352500|NCT03518073|564389683|FG002|Overall Study|Adverse Event|2|||
156352501|NCT03518073|564389681|FG000|Overall Study|Death|2|||
156352502|NCT03518073|564389682|FG001|Overall Study|Death|1|||
156352503|NCT03518073|564389683|FG002|Overall Study|Death|3|||
156352504|NCT03518073|564389681|FG000|Overall Study|Lost to Follow-up|1|||
156352505|NCT03518073|564389682|FG001|Overall Study|Lost to Follow-up|0|||
156352506|NCT03518073|564389683|FG002|Overall Study|Lost to Follow-up|1|||
156352507|NCT03518073|564389681|FG000|Overall Study|Physician Decision|5|||
156352508|NCT03518073|564389682|FG001|Overall Study|Physician Decision|0|||
156352509|NCT03518073|564389683|FG002|Overall Study|Physician Decision|2|||
156352510|NCT03518073|564389681|FG000|Overall Study|Progressive disease|1|||
156352511|NCT03518073|564389682|FG001|Overall Study|Progressive disease|1|||
156352512|NCT03518073|564389683|FG002|Overall Study|Progressive disease|1|||
156352513|NCT03518073|564389681|FG000|Overall Study|Protocol Violation|1|||
156352514|NCT03518073|564389682|FG001|Overall Study|Protocol Violation|0|||
156352515|NCT03518073|564389683|FG002|Overall Study|Protocol Violation|0|||
156352516|NCT03518073|564389681|FG000|Overall Study|Withdrawal by Subject|30|||
156352517|NCT03518073|564389682|FG001|Overall Study|Withdrawal by Subject|34|||
156352518|NCT03518073|564389683|FG002|Overall Study|Withdrawal by Subject|29|||
156352519|NCT03518073|564389681|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
156352520|NCT03518073|564389682|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
156352521|NCT03518073|564389683|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
156352522|NCT03518073|564389681|FG000|Overall Study|Covid-19|1|||
156352523|NCT03518073|564389682|FG001|Overall Study|Covid-19|2|||
156352524|NCT03518073|564389683|FG002|Overall Study|Covid-19|1|||
156352525|NCT03045081|564389684|FG000|Overall Study|Withdrawal by Subject|6|||
156352526|NCT03045081|564389685|FG001|Overall Study|Withdrawal by Subject|11|||
156352527|NCT03804879|564389686|FG000|Overall Study|Adverse Event|3|||
156352528|NCT03804879|564389687|FG001|Overall Study|Adverse Event|0|||
156352529|NCT03804879|564389686|FG000|Overall Study|Study Terminated By Sponsor|10|||
156352530|NCT03804879|564389687|FG001|Overall Study|Study Terminated By Sponsor|12|||
156352531|NCT03804879|564389686|FG000|Overall Study|Withdrawal by Subject|3|||
156352532|NCT03804879|564389687|FG001|Overall Study|Withdrawal by Subject|1|||
156352533|NCT02169739|564389689|FG000|Overall Study|Lost to Follow-up|0|||
156352534|NCT02169739|564389690|FG001|Overall Study|Lost to Follow-up|4|||
156352535|NCT03635957|564389691|FG000|Run-In Period|Lost to Follow-up|1|||
156352536|NCT03635957|564389691|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
156352537|NCT01710033|564389692|FG000|Stage 2|Adverse Event|0|||
156352538|NCT01710033|564389693|FG001|Stage 2|Adverse Event|0|||
156352539|NCT01710033|564389694|FG002|Stage 2|Adverse Event|0|||
156352540|NCT01710033|564389695|FG003|Stage 2|Adverse Event|0|||
156352541|NCT01710033|564389696|FG004|Stage 2|Adverse Event|1|||
156352542|NCT00100815|564389697|FG000|Overall Study|Progression|24|||
156352543|NCT00100815|564389697|FG000|Overall Study|Adverse Event|18|||
156352544|NCT00100815|564389697|FG000|Overall Study|Death|4|||
156352545|NCT00100815|564389697|FG000|Overall Study|Other|3|||
156352546|NCT01525550|564389704|FG000|Overall Study|Lost to Follow-up|8|||
156352547|NCT01525550|564389705|FG001|Overall Study|Lost to Follow-up|2|||
156352548|NCT01525550|564389704|FG000|Overall Study|Death|19|||
156352549|NCT01525550|564389705|FG001|Overall Study|Death|28|||
156352550|NCT01525550|564389704|FG000|Overall Study|Other|0|||
156352551|NCT01525550|564389705|FG001|Overall Study|Other|4|||
156352552|NCT01525550|564389704|FG000|Overall Study|Sponsor's Decision|30|||
156352553|NCT01525550|564389705|FG001|Overall Study|Sponsor's Decision|11|||
156352554|NCT01525550|564389704|FG000|Overall Study|Withdrawal by Subject|4|||
156352555|NCT01525550|564389705|FG001|Overall Study|Withdrawal by Subject|0|||
156352556|NCT03287804|564389708|FG000|Overall Study|Death|1|||
156352557|NCT03287804|564389708|FG000|Overall Study|Physician Decision|2|||
156352558|NCT03287804|564389708|FG000|Overall Study|Progressive disease|8|||
156352559|NCT02426892|564389709|FG000|Overall Study|Adverse Event|2|||
156352560|NCT02426892|564389709|FG000|Overall Study|Lack of Efficacy|17|||
156352561|NCT02426892|564389709|FG000|Overall Study|Withdrawal by Subject|1|||
156352562|NCT03178773|564389710|FG000|Overall Study|Death|0|||
156352563|NCT03178773|564389711|FG001|Overall Study|Death|1|||
156352564|NCT03178773|564389710|FG000|Overall Study|Lost to Follow-up|29|||
156352565|NCT03178773|564389711|FG001|Overall Study|Lost to Follow-up|25|||
156352566|NCT03178773|564389710|FG000|Overall Study|Withdrawal by Subject|10|||
156352567|NCT03178773|564389711|FG001|Overall Study|Withdrawal by Subject|14|||
156352568|NCT03402386|564389712|FG000|Overall Study|Adverse Event|3|||
156484376|NCT04551053|564865008|FG000|Overall Study|Medical Decision|1|||
156484377|NCT04551053|564865009|FG001|Overall Study|Medical Decision|1|||
156484378|NCT03861078|564865010|FG000|Overall Study|COVID-19 shut down|4|||
156484379|NCT03861078|564865010|FG000|Overall Study|Lost to Follow-up|1|||
156484380|NCT03861078|564865010|FG000|Overall Study|Protocol Violation|2|||
156484381|NCT03861078|564865010|FG000|Overall Study|lack of venous access|1|||
156484382|NCT00596960|564865012|FG000|Overall Study|Death|1|||
156484383|NCT00596960|564865013|FG001|Overall Study|Death|2|||
156484384|NCT00596960|564865012|FG000|Overall Study|Lost to Follow-up|6|||
156484385|NCT00596960|564865013|FG001|Overall Study|Lost to Follow-up|5|||
156484386|NCT00596960|564865012|FG000|Overall Study|Withdrawal by Subject|1|||
156484387|NCT00596960|564865013|FG001|Overall Study|Withdrawal by Subject|0|||
156484388|NCT00596960|564865012|FG000|Overall Study|Incarcerated|2|||
156484389|NCT00596960|564865013|FG001|Overall Study|Incarcerated|0|||
156544368|NCT00876187|565087758|FG002|Overall Study|Other|9|||
156544369|NCT00876187|565087759|FG003|Overall Study|Other|7|||
156484390|NCT00596960|564865012|FG000|Overall Study|Physician Decision|1|||
156484391|NCT00596960|564865013|FG001|Overall Study|Physician Decision|0|||
156484392|NCT00596960|564865012|FG000|Overall Study|Protocol Violation|0|||
156544370|NCT00876187|565087760|FG004|Overall Study|Other|4|||
156352569|NCT03402386|564389712|FG000|Overall Study|Physician Decision|1|||
156352570|NCT03402386|564389712|FG000|Overall Study|Difficult to control Hb|2|||
156352571|NCT02733991|564389713|FG000|Overall Study|Adverse Event|1|||
156352572|NCT02733991|564389714|FG001|Overall Study|Adverse Event|0|||
156352573|NCT02733991|564389713|FG000|Overall Study|Withdrawal by Subject|0|||
156352574|NCT02733991|564389714|FG001|Overall Study|Withdrawal by Subject|5|||
156352575|NCT02617511|564389717|FG000|Overall Study|Withdrawal by Subject|1|||
156352576|NCT02617511|564389718|FG001|Overall Study|Withdrawal by Subject|0|||
156352577|NCT00255047|564389719|FG000|Overall Study|Serious Adverse Events|2|||
156352578|NCT00255047|564389720|FG001|Overall Study|Serious Adverse Events|1|||
156352579|NCT00255047|564389721|FG002|Overall Study|Serious Adverse Events|2|||
156352580|NCT00255047|564389722|FG003|Overall Study|Serious Adverse Events|1|||
156352581|NCT00255047|564389719|FG000|Overall Study|Adverse Event|0|||
156484393|NCT00596960|564865013|FG001|Overall Study|Protocol Violation|1|||
156484394|NCT00596960|564865012|FG000|Overall Study|No alcohol use data|0|||
156484395|NCT00596960|564865013|FG001|Overall Study|No alcohol use data|1|||
156484396|NCT03503188|564865014|FG000|Overall Study|Non eligible in the sub study|0|||
156484397|NCT03503188|564865015|FG001|Overall Study|Non eligible in the sub study|1|||
156484398|NCT03556891|564865025|FG000|Initial Pivotal Study|Adverse Event|4|||
156352582|NCT00255047|564389720|FG001|Overall Study|Adverse Event|3|||
156352583|NCT00255047|564389721|FG002|Overall Study|Adverse Event|2|||
156352584|NCT00255047|564389722|FG003|Overall Study|Adverse Event|1|||
156352585|NCT00255047|564389719|FG000|Overall Study|Protocol Violation|13|||
156352586|NCT00255047|564389720|FG001|Overall Study|Protocol Violation|13|||
156352587|NCT00255047|564389721|FG002|Overall Study|Protocol Violation|16|||
156352588|NCT00255047|564389722|FG003|Overall Study|Protocol Violation|20|||
156352589|NCT00255047|564389719|FG000|Overall Study|Lost to Follow-up|9|||
156352590|NCT00255047|564389720|FG001|Overall Study|Lost to Follow-up|8|||
156352591|NCT00255047|564389721|FG002|Overall Study|Lost to Follow-up|5|||
156352592|NCT00255047|564389722|FG003|Overall Study|Lost to Follow-up|6|||
156352593|NCT00255047|564389719|FG000|Overall Study|Withdrawal by Subject|24|||
156352594|NCT00255047|564389720|FG001|Overall Study|Withdrawal by Subject|23|||
156352595|NCT00255047|564389721|FG002|Overall Study|Withdrawal by Subject|25|||
156352596|NCT00255047|564389722|FG003|Overall Study|Withdrawal by Subject|18|||
156352597|NCT00811473|564389723|FG000|Overall Study|Adverse Event|3|||
156352598|NCT00811473|564389724|FG001|Overall Study|Adverse Event|12|||
156352599|NCT00811473|564389723|FG000|Overall Study|Lost to Follow-up|5|||
156352600|NCT00811473|564389724|FG001|Overall Study|Lost to Follow-up|1|||
156352601|NCT00811473|564389723|FG000|Overall Study|Withdrawal by Subject|2|||
156352602|NCT00811473|564389724|FG001|Overall Study|Withdrawal by Subject|4|||
156352603|NCT00811473|564389723|FG000|Overall Study|Severe non-compliance to protocol|2|||
156352604|NCT00811473|564389724|FG001|Overall Study|Severe non-compliance to protocol|4|||
156352605|NCT00811473|564389723|FG000|Overall Study|Lack of therapeutic response|4|||
156352606|NCT00811473|564389724|FG001|Overall Study|Lack of therapeutic response|1|||
156352607|NCT00811473|564389723|FG000|Overall Study|Condition under investigation worsened|1|||
156352608|NCT00811473|564389724|FG001|Overall Study|Condition under investigation worsened|3|||
156352609|NCT00811473|564389723|FG000|Overall Study|Other 2|4|||
156352610|NCT00811473|564389724|FG001|Overall Study|Other 2|1|||
156352611|NCT00811473|564389723|FG000|Overall Study|Incorrect Enrollment|1|||
156352612|NCT00811473|564389724|FG001|Overall Study|Incorrect Enrollment|0|||
156352613|NCT00811473|564389723|FG000|Overall Study|Safety Reasons|1|||
156352614|NCT00811473|564389724|FG001|Overall Study|Safety Reasons|0|||
156352615|NCT01585194|564389730|FG000|Overall Study|Withdrawal by Subject|1|||
156352616|NCT01585194|564389730|FG000|Overall Study|Physician Decision|2|||
156352617|NCT01585194|564389730|FG000|Overall Study|Lack of insurance|1|||
156352618|NCT01119131|564389731|FG000|Overall Study|Adverse Event|1|||
156352619|NCT01119131|564389732|FG001|Overall Study|Adverse Event|1|||
156352620|NCT01119131|564389733|FG002|Overall Study|Adverse Event|1|||
156352621|NCT01119131|564389731|FG000|Overall Study|Non-Compliance|1|||
156352622|NCT01119131|564389732|FG001|Overall Study|Non-Compliance|0|||
156352623|NCT01119131|564389733|FG002|Overall Study|Non-Compliance|4|||
156352624|NCT01119131|564389731|FG000|Overall Study|Physician Decision|0|||
156352625|NCT01119131|564389732|FG001|Overall Study|Physician Decision|0|||
156484399|NCT03556891|564865025|FG000|Initial Pivotal Study|MRI Need|3|||
156484400|NCT03556891|564865025|FG000|Initial Pivotal Study|Device Failure|1|||
156484401|NCT03556891|564865025|FG000|Initial Pivotal Study|Death|1|||
156484402|NCT03556891|564865025|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
156484403|NCT03556891|564865025|FG000|Initial Pivotal Study|Missing at random|1|||
156352626|NCT01119131|564389733|FG002|Overall Study|Physician Decision|1|||
156352627|NCT00732615|564389734|FG000|Overall Study|Withdrawal by Subject|3|||
156352628|NCT00732615|564389735|FG001|Overall Study|Withdrawal by Subject|1|||
156352629|NCT00732615|564389734|FG000|Overall Study|Lost to Follow-up|0|||
156352630|NCT00732615|564389735|FG001|Overall Study|Lost to Follow-up|1|||
156352631|NCT00732615|564389734|FG000|Overall Study|Adverse Event|0|||
156352632|NCT00732615|564389735|FG001|Overall Study|Adverse Event|2|||
156352633|NCT00732615|564389734|FG000|Overall Study|Physician Decision|3|||
156352634|NCT00732615|564389735|FG001|Overall Study|Physician Decision|0|||
156352635|NCT00732615|564389734|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
156352636|NCT00732615|564389735|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
156352637|NCT00993291|564389736|FG000|Overall Study|Withdrawal by Subject|1|||
156352638|NCT00003492|564389737|FG000|Overall Study|Not evaluable|6|||
156352639|NCT01333059|564389738|FG000|Overall Study|Physician Decision|3|||
156352640|NCT01333059|564389739|FG001|Overall Study|Physician Decision|3|||
156352641|NCT01333059|564389738|FG000|Overall Study|Protocol Violation|3|||
156352642|NCT01333059|564389739|FG001|Overall Study|Protocol Violation|0|||
156352643|NCT03566823|564389740|FG000|Overall Study|Lack of Efficacy|0|||
156352644|NCT03566823|564389741|FG001|Overall Study|Lack of Efficacy|1|||
156352645|NCT03566823|564389742|FG002|Overall Study|Lack of Efficacy|0|||
156352646|NCT03566823|564389740|FG000|Overall Study|Withdrawal by Subject|1|||
156352647|NCT03566823|564389741|FG001|Overall Study|Withdrawal by Subject|2|||
156352648|NCT03566823|564389742|FG002|Overall Study|Withdrawal by Subject|0|||
156352649|NCT03566823|564389740|FG000|Overall Study|Adverse Event|1|||
156484404|NCT03556891|564865025|FG000|Initial Pivotal Study|Missing due to COVID|1|||
156484405|NCT03556891|564865025|FG000|Initial Pivotal Study|Protocol Violation|1|||
156484406|NCT02661490|564867438|FG000|Overall Study|Lost to Follow-up|0|||
156484407|NCT02661490|564867439|FG001|Overall Study|Lost to Follow-up|1|||
156484408|NCT02661490|564867440|FG002|Overall Study|Lost to Follow-up|0|||
156484409|NCT02661490|564867441|FG003|Overall Study|Lost to Follow-up|0|||
156484410|NCT02661490|564867442|FG004|Overall Study|Lost to Follow-up|2|||
156352650|NCT03566823|564389741|FG001|Overall Study|Adverse Event|0|||
156352651|NCT03566823|564389742|FG002|Overall Study|Adverse Event|2|||
156352652|NCT04446377|564389743|FG000|Overall Study|Withdrawal by Subject|6|||
156352653|NCT04446377|564389744|FG001|Overall Study|Withdrawal by Subject|1|||
156352654|NCT04446377|564389743|FG000|Overall Study|Physician Decision|1|||
156352655|NCT04446377|564389744|FG001|Overall Study|Physician Decision|1|||
156352656|NCT04446377|564389743|FG000|Overall Study|Lost to Follow-up|0|||
156352657|NCT04446377|564389744|FG001|Overall Study|Lost to Follow-up|2|||
156352658|NCT04446377|564389743|FG000|Overall Study|Not eligible|0|||
156352659|NCT04446377|564389744|FG001|Overall Study|Not eligible|1|||
156352660|NCT01414075|564389752|FG000|Overall Study|Adverse Event|1|||
156352661|NCT01414075|564389753|FG001|Overall Study|Adverse Event|0|||
156352662|NCT01414075|564389754|FG002|Overall Study|Adverse Event|1|||
156352663|NCT01414075|564389755|FG003|Overall Study|Adverse Event|0|||
156352664|NCT01414075|564389752|FG000|Overall Study|Death|1|||
156352665|NCT01414075|564389753|FG001|Overall Study|Death|0|||
156352666|NCT01414075|564389754|FG002|Overall Study|Death|0|||
156352667|NCT01414075|564389755|FG003|Overall Study|Death|1|||
156352668|NCT01414075|564389752|FG000|Overall Study|Withdrawal by Subject|0|||
156352669|NCT01414075|564389753|FG001|Overall Study|Withdrawal by Subject|0|||
156352670|NCT01414075|564389754|FG002|Overall Study|Withdrawal by Subject|0|||
156352671|NCT01414075|564389755|FG003|Overall Study|Withdrawal by Subject|1|||
156352672|NCT01414075|564389752|FG000|Overall Study|Other than specified|1|||
156352673|NCT01414075|564389753|FG001|Overall Study|Other than specified|0|||
156352674|NCT01414075|564389754|FG002|Overall Study|Other than specified|1|||
156352675|NCT01414075|564389755|FG003|Overall Study|Other than specified|0|||
156352676|NCT06079320|564389756|FG000|Follow up Phase|Lost to Follow-up|1|||
156352677|NCT06079320|564389757|FG001|Follow up Phase|Lost to Follow-up|0|||
156352678|NCT01405742|564389758|FG000|Overall Study|Lost to Follow-up|1|||
156352679|NCT01405742|564389759|FG001|Overall Study|Lost to Follow-up|0|||
156352680|NCT03473808|564389760|FG000|Overall Study|Withdrawal by Subject|1|||
156352681|NCT04059094|564389763|FG000|Overall Study|Adverse Event|0|||
156352682|NCT04059094|564389764|FG001|Overall Study|Adverse Event|0|||
156352683|NCT04059094|564389765|FG002|Overall Study|Adverse Event|0|||
156352684|NCT04059094|564389766|FG003|Overall Study|Adverse Event|0|||
156352685|NCT04059094|564389767|FG004|Overall Study|Adverse Event|1|||
156352686|NCT04059094|564389763|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
156352687|NCT04059094|564389764|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
156352688|NCT04059094|564389765|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
156352689|NCT04059094|564389766|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
156352690|NCT04059094|564389767|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
156352691|NCT01339429|564389770|FG000|Overall Study|Withdrawal by Subject|1|||
156484411|NCT02661490|564867438|FG000|Overall Study|Withdrawal by Subject|2|||
156484412|NCT02661490|564867439|FG001|Overall Study|Withdrawal by Subject|0|||
156484413|NCT02661490|564867440|FG002|Overall Study|Withdrawal by Subject|2|||
156544371|NCT01379274|565087761|FG000|Overall Study|funding withdrawn|1|||
156352692|NCT01339429|564389770|FG000|Overall Study|Physician Decision|3|||
156352693|NCT01085591|564389771|FG000|Overall Study|Adverse Event|0|||
156352694|NCT01085591|564389772|FG001|Overall Study|Adverse Event|1|||
156352695|NCT01085591|564389773|FG002|Overall Study|Adverse Event|3|||
156352696|NCT01085591|564389771|FG000|Overall Study|Physician Decision|1|||
156352697|NCT01085591|564389772|FG001|Overall Study|Physician Decision|0|||
156352698|NCT01085591|564389773|FG002|Overall Study|Physician Decision|1|||
156352699|NCT01085591|564389771|FG000|Overall Study|Withdrawal by Subject|0|||
156484414|NCT02661490|564867441|FG003|Overall Study|Withdrawal by Subject|0|||
156484415|NCT02661490|564867442|FG004|Overall Study|Withdrawal by Subject|0|||
156484416|NCT02661490|564867438|FG000|Overall Study|Death|1|||
156352700|NCT01085591|564389772|FG001|Overall Study|Withdrawal by Subject|2|||
156352701|NCT01085591|564389773|FG002|Overall Study|Withdrawal by Subject|1|||
156352702|NCT01085591|564389771|FG000|Overall Study|Lost to Follow-up|0|||
156352703|NCT01085591|564389772|FG001|Overall Study|Lost to Follow-up|1|||
156352704|NCT01085591|564389773|FG002|Overall Study|Lost to Follow-up|1|||
156352705|NCT01085591|564389771|FG000|Overall Study|Protocol Violation|1|||
156352706|NCT01085591|564389772|FG001|Overall Study|Protocol Violation|1|||
156352707|NCT01085591|564389773|FG002|Overall Study|Protocol Violation|1|||
156352708|NCT01085591|564389771|FG000|Overall Study|Other|0|||
156352709|NCT01085591|564389772|FG001|Overall Study|Other|1|||
156352710|NCT01085591|564389773|FG002|Overall Study|Other|0|||
156352711|NCT01085591|564389771|FG000|Overall Study|Not Properly Consented|1|||
156352712|NCT01085591|564389772|FG001|Overall Study|Not Properly Consented|0|||
156352713|NCT01085591|564389773|FG002|Overall Study|Not Properly Consented|0|||
156352714|NCT00883116|564389776|FG000|Overall Study|Adverse event unrelated to study drug|5|||
156352715|NCT00883116|564389777|FG001|Overall Study|Adverse event unrelated to study drug|10|||
156352716|NCT00883116|564389776|FG000|Overall Study|Death|6|||
156352717|NCT00883116|564389777|FG001|Overall Study|Death|2|||
156352718|NCT00883116|564389776|FG000|Overall Study|Disease progression|130|||
156352719|NCT00883116|564389777|FG001|Overall Study|Disease progression|128|||
156352720|NCT00883116|564389776|FG000|Overall Study|Lost to Follow-up|0|||
156352721|NCT00883116|564389777|FG001|Overall Study|Lost to Follow-up|1|||
156352722|NCT00883116|564389776|FG000|Overall Study|Maximum clinical benefit|13|||
156352723|NCT00883116|564389777|FG001|Overall Study|Maximum clinical benefit|46|||
156352724|NCT00883116|564389776|FG000|Overall Study|Not identified|3|||
156352725|NCT00883116|564389777|FG001|Overall Study|Not identified|6|||
156352726|NCT00883116|564389776|FG000|Overall Study|Study drug toxicity|36|||
156352727|NCT00883116|564389777|FG001|Overall Study|Study drug toxicity|16|||
156352728|NCT00883116|564389776|FG000|Overall Study|Withdrawal by Subject|14|||
156352729|NCT00883116|564389777|FG001|Overall Study|Withdrawal by Subject|8|||
156352730|NCT00883116|564389776|FG000|Overall Study|No longer meets study criteria|2|||
156352731|NCT00883116|564389777|FG001|Overall Study|No longer meets study criteria|2|||
156352732|NCT00459667|564389778|FG000|Overall Study|Adverse Event|9|||
156352733|NCT00459667|564389779|FG001|Overall Study|Adverse Event|12|||
156352734|NCT00459667|564389780|FG002|Overall Study|Adverse Event|8|||
156352735|NCT00459667|564389778|FG000|Overall Study|Lost to Follow-up|5|||
156352736|NCT00459667|564389779|FG001|Overall Study|Lost to Follow-up|9|||
156352737|NCT00459667|564389780|FG002|Overall Study|Lost to Follow-up|3|||
156352738|NCT00459667|564389778|FG000|Overall Study|Pregnancy|1|||
156352739|NCT00459667|564389779|FG001|Overall Study|Pregnancy|1|||
156352740|NCT00459667|564389780|FG002|Overall Study|Pregnancy|1|||
156352741|NCT00459667|564389778|FG000|Overall Study|Protocol Violation|1|||
156352742|NCT00459667|564389779|FG001|Overall Study|Protocol Violation|0|||
156352743|NCT00459667|564389780|FG002|Overall Study|Protocol Violation|0|||
156352744|NCT00459667|564389778|FG000|Overall Study|Withdrawal by Subject|3|||
156352745|NCT00459667|564389779|FG001|Overall Study|Withdrawal by Subject|5|||
156352746|NCT00459667|564389780|FG002|Overall Study|Withdrawal by Subject|5|||
156352747|NCT00459667|564389778|FG000|Overall Study|Other disease modifying treatment|1|||
156352748|NCT00459667|564389779|FG001|Overall Study|Other disease modifying treatment|2|||
156352749|NCT00459667|564389780|FG002|Overall Study|Other disease modifying treatment|1|||
156352750|NCT00459667|564389778|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
156352751|NCT00459667|564389779|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
156352752|NCT00459667|564389780|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
156352753|NCT00459667|564389778|FG000|Overall Study|No treatment administered|6|||
156352754|NCT00459667|564389779|FG001|Overall Study|No treatment administered|3|||
156352755|NCT00459667|564389780|FG002|Overall Study|No treatment administered|1|||
156352756|NCT01013701|564389781|FG000|Overall Study|study prematurely terminated|7|||
156352757|NCT00556712|564389782|FG000|Overall Study|Adverse Event|7|||
156352758|NCT00556712|564389783|FG001|Overall Study|Adverse Event|19|||
156352759|NCT00556712|564389782|FG000|Overall Study|Death|5|||
156352760|NCT00556712|564389783|FG001|Overall Study|Death|10|||
156352761|NCT00556712|564389782|FG000|Overall Study|Progressive Disease|383|||
156544372|NCT03200366|565087762|FG000|Patient Navigation Intervention Given|Death|0|||
156352762|NCT00556712|564389783|FG001|Overall Study|Progressive Disease|320|||
156352763|NCT00556712|564389782|FG000|Overall Study|Protocol Violation|3|||
156352764|NCT00556712|564389783|FG001|Overall Study|Protocol Violation|2|||
156352765|NCT00556712|564389782|FG000|Overall Study|Refused Treatment|17|||
156352766|NCT00556712|564389783|FG001|Overall Study|Refused Treatment|16|||
156352767|NCT00556712|564389782|FG000|Overall Study|Failure to Return|2|||
156352768|NCT00556712|564389783|FG001|Overall Study|Failure to Return|3|||
156352769|NCT00556712|564389782|FG000|Overall Study|Other|2|||
156352770|NCT00556712|564389783|FG001|Overall Study|Other|2|||
156352771|NCT00556712|564389782|FG000|Overall Study|Ongoing at Data Cutoff|32|||
156352772|NCT00556712|564389783|FG001|Overall Study|Ongoing at Data Cutoff|66|||
156352773|NCT01059799|564389784|FG000|Overall Study|Adverse Event|2|||
156352774|NCT01059799|564389785|FG001|Overall Study|Adverse Event|3|||
156352775|NCT01059799|564389784|FG000|Overall Study|Lack of Efficacy|1|||
156544373|NCT03200366|565087763|FG001|Patient Navigation Intervention Given|Death|2|||
156352776|NCT01059799|564389785|FG001|Overall Study|Lack of Efficacy|0|||
156352777|NCT01059799|564389784|FG000|Overall Study|Protocol Violation|3|||
156352778|NCT01059799|564389785|FG001|Overall Study|Protocol Violation|2|||
156352779|NCT01059799|564389784|FG000|Overall Study|Withdrawal criteria|13|||
156352780|NCT01059799|564389785|FG001|Overall Study|Withdrawal criteria|2|||
156352781|NCT01059799|564389784|FG000|Overall Study|Other|12|||
156352782|NCT01059799|564389785|FG001|Overall Study|Other|3|||
156352783|NCT03061331|564389786|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
156352784|NCT03061331|564389787|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
156352785|NCT01980875|564389788|FG000|Overall Study|Withdrew Consent|1|||
156352786|NCT01980875|564389789|FG001|Overall Study|Withdrew Consent|1|||
156352787|NCT01980875|564389790|FG002|Overall Study|Withdrew Consent|1|||
156352788|NCT01980875|564389788|FG000|Overall Study|Study Terminated by Sponsor|7|||
156352789|NCT01980875|564389789|FG001|Overall Study|Study Terminated by Sponsor|24|||
156352790|NCT01980875|564389790|FG002|Overall Study|Study Terminated by Sponsor|22|||
156352791|NCT01980875|564389788|FG000|Overall Study|Lost to Follow-up|0|||
156352792|NCT01980875|564389789|FG001|Overall Study|Lost to Follow-up|0|||
156352793|NCT01980875|564389790|FG002|Overall Study|Lost to Follow-up|1|||
156352794|NCT02625259|564389791|FG000|First Intervention (Day 1)|Other|0|||
156352795|NCT02625259|564389792|FG001|First Intervention (Day 1)|Other|0|||
156352796|NCT02625259|564389793|FG002|First Intervention (Day 1)|Other|1|||
156352797|NCT02625259|564389794|FG003|First Intervention (Day 1)|Other|0|||
156352798|NCT02625259|564389795|FG004|First Intervention (Day 1)|Other|0|||
156352799|NCT02625259|564389791|FG000|First Intervention (Day 1)|Adverse Event|2|||
156352800|NCT02625259|564389792|FG001|First Intervention (Day 1)|Adverse Event|1|||
156352801|NCT02625259|564389793|FG002|First Intervention (Day 1)|Adverse Event|0|||
156352802|NCT02625259|564389794|FG003|First Intervention (Day 1)|Adverse Event|0|||
156352803|NCT02625259|564389795|FG004|First Intervention (Day 1)|Adverse Event|0|||
156352804|NCT02625259|564389791|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
156352805|NCT02625259|564389792|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
156352806|NCT02625259|564389793|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
156352807|NCT02625259|564389794|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
156352808|NCT02625259|564389795|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
156352809|NCT04772755|564389796|FG000|Overall Study|Withdrawal by Subject|1|||
156352810|NCT04772755|564389797|FG001|Overall Study|Withdrawal by Subject|0|||
156352811|NCT04772755|564389796|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
156352812|NCT04772755|564389797|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
156352813|NCT04080297|564389799|FG000|Overall Study|Adverse Event|1|||
156352814|NCT04080297|564389800|FG001|Overall Study|Adverse Event|3|||
156352815|NCT04080297|564389799|FG000|Overall Study|concurrent illness|1|||
156352816|NCT04080297|564389800|FG001|Overall Study|concurrent illness|0|||
156352817|NCT05838742|564389802|FG000|Overall Study|Adverse Event|2|||
156352818|NCT05838742|564389803|FG001|Overall Study|Adverse Event|0|||
156352819|NCT05838742|564389804|FG002|Overall Study|Adverse Event|1|||
156352820|NCT05838742|564389805|FG003|Overall Study|Adverse Event|0|||
156352821|NCT05838742|564389806|FG004|Overall Study|Adverse Event|1|||
156352822|NCT05838742|564389802|FG000|Overall Study|Lost to Follow-up|1|||
156352823|NCT05838742|564389803|FG001|Overall Study|Lost to Follow-up|1|||
156352824|NCT05838742|564389804|FG002|Overall Study|Lost to Follow-up|1|||
156352825|NCT05838742|564389805|FG003|Overall Study|Lost to Follow-up|0|||
156352826|NCT05838742|564389806|FG004|Overall Study|Lost to Follow-up|0|||
156352827|NCT05838742|564389802|FG000|Overall Study|Physician Decision|0|||
156352828|NCT05838742|564389803|FG001|Overall Study|Physician Decision|0|||
156352829|NCT05838742|564389804|FG002|Overall Study|Physician Decision|0|||
156352830|NCT05838742|564389805|FG003|Overall Study|Physician Decision|0|||
156352831|NCT05838742|564389806|FG004|Overall Study|Physician Decision|1|||
156352832|NCT05838742|564389802|FG000|Overall Study|Withdrawal by Subject|8|||
156352833|NCT05838742|564389803|FG001|Overall Study|Withdrawal by Subject|3|||
156352834|NCT05838742|564389804|FG002|Overall Study|Withdrawal by Subject|3|||
156352835|NCT05838742|564389805|FG003|Overall Study|Withdrawal by Subject|1|||
156352836|NCT05838742|564389806|FG004|Overall Study|Withdrawal by Subject|4|||
156352837|NCT05838742|564389802|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
156352838|NCT05838742|564389803|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
156352839|NCT05838742|564389804|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
156352840|NCT05838742|564389805|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
156352841|NCT05838742|564389806|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
156352842|NCT05838742|564389802|FG000|Overall Study|Lack of Efficacy|0|||
156352843|NCT05838742|564389803|FG001|Overall Study|Lack of Efficacy|0|||
156352844|NCT05838742|564389804|FG002|Overall Study|Lack of Efficacy|0|||
156352845|NCT05838742|564389805|FG003|Overall Study|Lack of Efficacy|1|||
156352846|NCT05838742|564389806|FG004|Overall Study|Lack of Efficacy|0|||
156352847|NCT05838742|564389802|FG000|Overall Study|Randomized, not treated|2|||
156352848|NCT05838742|564389803|FG001|Overall Study|Randomized, not treated|1|||
156352849|NCT05838742|564389804|FG002|Overall Study|Randomized, not treated|0|||
156352850|NCT05838742|564389805|FG003|Overall Study|Randomized, not treated|1|||
156352851|NCT05838742|564389806|FG004|Overall Study|Randomized, not treated|0|||
156352852|NCT00180414|564392060|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
156352853|NCT00180414|564392061|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
156352854|NCT00613938|564392066|FG000|Overall Study|Withdrawal by Subject|2|||
156352855|NCT00613938|564392067|FG001|Overall Study|Withdrawal by Subject|4|||
156352856|NCT00613938|564392068|FG002|Overall Study|Withdrawal by Subject|9|||
156352857|NCT00613938|564392069|FG003|Overall Study|Withdrawal by Subject|9|||
156352858|NCT00613938|564392066|FG000|Overall Study|Adverse Event|1|||
156352859|NCT00613938|564392067|FG001|Overall Study|Adverse Event|4|||
156352860|NCT00613938|564392068|FG002|Overall Study|Adverse Event|8|||
156352861|NCT00613938|564392069|FG003|Overall Study|Adverse Event|5|||
156352862|NCT00613938|564392066|FG000|Overall Study|Lack of Efficacy|16|||
156352863|NCT00613938|564392067|FG001|Overall Study|Lack of Efficacy|18|||
156352864|NCT00613938|564392068|FG002|Overall Study|Lack of Efficacy|5|||
156352865|NCT00613938|564392069|FG003|Overall Study|Lack of Efficacy|9|||
156352866|NCT00613938|564392066|FG000|Overall Study|Other|1|||
156352867|NCT00613938|564392067|FG001|Overall Study|Other|2|||
156352868|NCT00613938|564392068|FG002|Overall Study|Other|1|||
156352869|NCT00613938|564392069|FG003|Overall Study|Other|3|||
156352870|NCT00623727|564392070|FG000|Double Blind (DB)|Adverse Event|1|||
156352871|NCT00623727|564392071|FG001|Double Blind (DB)|Adverse Event|3|||
156352872|NCT00623727|564392070|FG000|Double Blind (DB)|Physician Decision|0|||
156352873|NCT00623727|564392071|FG001|Double Blind (DB)|Physician Decision|1|||
156352874|NCT00623727|564392070|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
156352875|NCT00623727|564392071|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
156352876|NCT00623727|564392070|FG000|Double Blind (DB)|Lack of Efficacy|2|||
156352877|NCT00623727|564392071|FG001|Double Blind (DB)|Lack of Efficacy|2|||
156352878|NCT00623727|564392070|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
156352879|NCT00623727|564392071|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
156352880|NCT00623727|564392070|FG000|Double Blind (DB)|Lost to Follow-up|1|||
156352881|NCT00623727|564392071|FG001|Double Blind (DB)|Lost to Follow-up|1|||
156352882|NCT00623727|564392070|FG000|Double Blind (DB)|Protocol Violation|2|||
156352883|NCT00623727|564392071|FG001|Double Blind (DB)|Protocol Violation|2|||
156352884|NCT00623727|564392070|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
156352885|NCT00623727|564392071|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
156352886|NCT00623727|564392070|FG000|Open Label Follow-up|Study termination|0|||
156352887|NCT00623727|564392071|FG001|Open Label Follow-up|Study termination|6|||
156352888|NCT00623727|564392070|FG000|Open Label Follow-up|Participant convenience|0|||
156352889|NCT00623727|564392071|FG001|Open Label Follow-up|Participant convenience|1|||
156352890|NCT03220217|564392072|FG000|Overall Study|Withdrawal by Subject|0|||
156352891|NCT03220217|564392073|FG001|Overall Study|Withdrawal by Subject|1|||
156352892|NCT03220217|564392074|FG002|Overall Study|Withdrawal by Subject|0|||
156352893|NCT03220217|564392072|FG000|Overall Study|Subject Missed Procedure|0|||
156352894|NCT03220217|564392073|FG001|Overall Study|Subject Missed Procedure|0|||
156352895|NCT03220217|564392074|FG002|Overall Study|Subject Missed Procedure|1|||
156352896|NCT03025542|564392075|FG000|Overall Study|Adverse Event|0|||
156352897|NCT03025542|564392076|FG001|Overall Study|Adverse Event|2|||
156352898|NCT03025542|564392075|FG000|Overall Study|Lost to Follow-up|1|||
156352899|NCT03025542|564392076|FG001|Overall Study|Lost to Follow-up|0|||
156352900|NCT03025542|564392075|FG000|Overall Study|Withdrawal by Subject|1|||
156352901|NCT03025542|564392076|FG001|Overall Study|Withdrawal by Subject|0|||
156352902|NCT03745937|564392077|FG000|Overall Study|Withdrawal by Subject|0|||
156352903|NCT03745937|564392078|FG001|Overall Study|Withdrawal by Subject|0|||
156352904|NCT03745937|564392079|FG002|Overall Study|Withdrawal by Subject|0|||
156352905|NCT03745937|564392080|FG003|Overall Study|Withdrawal by Subject|1|||
156352906|NCT03745937|564392077|FG000|Overall Study|Not-specifed|0|||
156352907|NCT03745937|564392078|FG001|Overall Study|Not-specifed|1|||
156352908|NCT03745937|564392079|FG002|Overall Study|Not-specifed|0|||
156352909|NCT03745937|564392080|FG003|Overall Study|Not-specifed|1|||
156352910|NCT00501293|564392081|FG000|Optimization Period|Enrolled in error|1|||
156352911|NCT00501293|564392082|FG001|Optimization Period|Enrolled in error|0|||
156352912|NCT00501293|564392081|FG000|Maintenance Period|Withdrawal by Subject|14|||
156352913|NCT00501293|564392082|FG001|Maintenance Period|Withdrawal by Subject|13|||
156352914|NCT00501293|564392081|FG000|Maintenance Period|Lost to Follow-up|12|||
156352915|NCT00501293|564392082|FG001|Maintenance Period|Lost to Follow-up|7|||
156352916|NCT00501293|564392081|FG000|Maintenance Period|Adverse Event|6|||
156484417|NCT02661490|564867439|FG001|Overall Study|Death|1|||
156484418|NCT02661490|564867440|FG002|Overall Study|Death|0|||
156484419|NCT02661490|564867441|FG003|Overall Study|Death|1|||
156484420|NCT02661490|564867442|FG004|Overall Study|Death|0|||
156352917|NCT00501293|564392082|FG001|Maintenance Period|Adverse Event|6|||
156352918|NCT00501293|564392081|FG000|Maintenance Period|Protocol Violation|2|||
156352919|NCT00501293|564392082|FG001|Maintenance Period|Protocol Violation|1|||
156352920|NCT00501293|564392081|FG000|Maintenance Period|Lack of Efficacy|4|||
156352921|NCT00501293|564392082|FG001|Maintenance Period|Lack of Efficacy|1|||
156352922|NCT00501293|564392081|FG000|Maintenance Period|Noncompliant with study medication|5|||
156352923|NCT00501293|564392082|FG001|Maintenance Period|Noncompliant with study medication|0|||
156352924|NCT00501293|564392081|FG000|Maintenance Period|Went into rehabilitation|1|||
156484421|NCT02661490|564867438|FG000|Overall Study|Reason not Specified|0|||
156352925|NCT00501293|564392082|FG001|Maintenance Period|Went into rehabilitation|0|||
156352926|NCT00501293|564392081|FG000|Maintenance Period|Would not wear patch|1|||
156352927|NCT00501293|564392082|FG001|Maintenance Period|Would not wear patch|0|||
156352928|NCT00501293|564392081|FG000|Maintenance Period|Application site reaction|1|||
156352929|NCT00501293|564392082|FG001|Maintenance Period|Application site reaction|0|||
156352930|NCT00488345|564392083|FG000|Overall Study|Adverse Event|0|||
156352931|NCT00488345|564392084|FG001|Overall Study|Adverse Event|1|||
156352932|NCT00488345|564392085|FG002|Overall Study|Adverse Event|1|||
156352933|NCT00488345|564392083|FG000|Overall Study|Unable to administer antibiotics at home|0|||
156352934|NCT00488345|564392084|FG001|Overall Study|Unable to administer antibiotics at home|1|||
156352935|NCT00488345|564392085|FG002|Overall Study|Unable to administer antibiotics at home|0|||
156352936|NCT00488345|564392083|FG000|Overall Study|Institutional Review Board review|0|||
156352937|NCT00488345|564392084|FG001|Overall Study|Institutional Review Board review|0|||
156352938|NCT00488345|564392085|FG002|Overall Study|Institutional Review Board review|1|||
156352939|NCT00488345|564392083|FG000|Overall Study|Surgical team recommendation|0|||
156352940|NCT00488345|564392084|FG001|Overall Study|Surgical team recommendation|1|||
156352941|NCT00488345|564392085|FG002|Overall Study|Surgical team recommendation|0|||
156352942|NCT00488345|564392083|FG000|Overall Study|Parent/legal guardian request|0|||
156352943|NCT00488345|564392084|FG001|Overall Study|Parent/legal guardian request|1|||
156352944|NCT00488345|564392085|FG002|Overall Study|Parent/legal guardian request|1|||
156352945|NCT01853046|564392086|FG000|Overall Study|Withdrawal by Subject|1|||
156352946|NCT01853046|564392087|FG001|Overall Study|Withdrawal by Subject|1|||
156352947|NCT01853046|564392086|FG000|Overall Study|Adverse Event|4|||
156352948|NCT01853046|564392087|FG001|Overall Study|Adverse Event|2|||
156352949|NCT01853046|564392086|FG000|Overall Study|Disease progression|13|||
156352950|NCT01853046|564392087|FG001|Overall Study|Disease progression|3|||
156352951|NCT01585428|564392088|FG000|Overall Study|Death during treatment|1|||
156352952|NCT01585428|564392089|FG001|Overall Study|Death during treatment|0|||
156352953|NCT00708162|564392090|FG000|Randomized Phase|Randomized but Not Treated|7|||
156352954|NCT00708162|564392091|FG001|Randomized Phase|Randomized but Not Treated|5|||
156352955|NCT00708162|564392090|FG000|Randomized Phase|Participant Noncompliance|40|||
156352956|NCT00708162|564392091|FG001|Randomized Phase|Participant Noncompliance|32|||
156352957|NCT00708162|564392090|FG000|Randomized Phase|Lost to Follow-up|34|||
156352958|NCT00708162|564392091|FG001|Randomized Phase|Lost to Follow-up|34|||
156352959|NCT00708162|564392090|FG000|Randomized Phase|Withdrew Consent|31|||
156352960|NCT00708162|564392091|FG001|Randomized Phase|Withdrew Consent|22|||
156352961|NCT00708162|564392090|FG000|Randomized Phase|Lack of Efficacy|14|||
156352962|NCT00708162|564392091|FG001|Randomized Phase|Lack of Efficacy|19|||
156352963|NCT00708162|564392090|FG000|Randomized Phase|Protocol Violation|10|||
156352964|NCT00708162|564392091|FG001|Randomized Phase|Protocol Violation|11|||
156352965|NCT00708162|564392090|FG000|Randomized Phase|Adverse Event|8|||
156352966|NCT00708162|564392091|FG001|Randomized Phase|Adverse Event|12|||
156352967|NCT00708162|564392090|FG000|Randomized Phase|Investigator's Discretion|7|||
156352968|NCT00708162|564392091|FG001|Randomized Phase|Investigator's Discretion|10|||
156352969|NCT00708162|564392090|FG000|Randomized Phase|Death|2|||
156352970|NCT00708162|564392091|FG001|Randomized Phase|Death|9|||
156352971|NCT00708162|564392090|FG000|Randomized Phase|Pregnancy|3|||
156352972|NCT00708162|564392091|FG001|Randomized Phase|Pregnancy|0|||
156352973|NCT00708162|564392090|FG000|Open-Label Phase|Lost to Follow-up|10|||
156352974|NCT00708162|564392091|FG001|Open-Label Phase|Lost to Follow-up|8|||
156352975|NCT00708162|564392090|FG000|Open-Label Phase|Withdrew Consent|12|||
156352976|NCT00708162|564392091|FG001|Open-Label Phase|Withdrew Consent|6|||
156352977|NCT00708162|564392090|FG000|Open-Label Phase|Participant Noncompliance|7|||
156352978|NCT00708162|564392091|FG001|Open-Label Phase|Participant Noncompliance|7|||
156352979|NCT00708162|564392090|FG000|Open-Label Phase|Lack of Efficacy|7|||
156352980|NCT00708162|564392091|FG001|Open-Label Phase|Lack of Efficacy|4|||
156352981|NCT00708162|564392090|FG000|Open-Label Phase|Investigator's Discretion|3|||
156352982|NCT00708162|564392091|FG001|Open-Label Phase|Investigator's Discretion|2|||
156352983|NCT00708162|564392090|FG000|Open-Label Phase|Death|3|||
156352984|NCT00708162|564392091|FG001|Open-Label Phase|Death|1|||
156352985|NCT00708162|564392090|FG000|Open-Label Phase|Adverse Event|1|||
156352986|NCT00708162|564392091|FG001|Open-Label Phase|Adverse Event|2|||
156352987|NCT00708162|564392090|FG000|Open-Label Phase|Other|1|||
156352988|NCT00708162|564392091|FG001|Open-Label Phase|Other|0|||
156352989|NCT02699554|564392092|FG000|Overall Study|Lost to Follow-up|9|||
156352990|NCT00788151|564392093|FG000|Overall Study|Other adverse event|0|||
156352991|NCT00788151|564392094|FG001|Overall Study|Other adverse event|2|||
156352992|NCT00788151|564392093|FG000|Overall Study|Protocol Violation|0|||
156352993|NCT00788151|564392094|FG001|Overall Study|Protocol Violation|1|||
156352994|NCT00788151|564392093|FG000|Overall Study|Withdrawal by Subject|13|||
156352995|NCT00788151|564392094|FG001|Overall Study|Withdrawal by Subject|6|||
156352996|NCT00788151|564392093|FG000|Overall Study|Enrolled but not treated|1|||
156352997|NCT00788151|564392094|FG001|Overall Study|Enrolled but not treated|1|||
156352998|NCT00503009|564392097|FG000|Overall Study|Protocol Violation|1|||
156352999|NCT00503009|564392098|FG001|Overall Study|Protocol Violation|0|||
156353000|NCT00503009|564392099|FG002|Overall Study|Protocol Violation|1|||
156353001|NCT00503009|564392097|FG000|Overall Study|Withdrawal by Subject|0|||
156353002|NCT00503009|564392098|FG001|Overall Study|Withdrawal by Subject|1|||
156353003|NCT00503009|564392099|FG002|Overall Study|Withdrawal by Subject|1|||
156353004|NCT00503009|564392097|FG000|Overall Study|Physician Decision|0|||
156353005|NCT00503009|564392098|FG001|Overall Study|Physician Decision|1|||
156353006|NCT00503009|564392099|FG002|Overall Study|Physician Decision|1|||
156353007|NCT01244906|564392101|FG000|Overall Study|Death|2|||
156353008|NCT01244906|564392101|FG000|Overall Study|Progression of disease post treatment|6|||
156353009|NCT02522286|564392102|FG000|Overall Study|Withdrawal by Subject|3|||
156353010|NCT02522286|564392103|FG001|Overall Study|Withdrawal by Subject|0|||
156353011|NCT02522286|564392104|FG002|Overall Study|Withdrawal by Subject|0|||
156353012|NCT02522286|564392105|FG003|Overall Study|Withdrawal by Subject|3|||
156353013|NCT03480750|564392106|FG000|Overall Study|Withdrawal by Subject|0|||
156353014|NCT03480750|564392107|FG001|Overall Study|Withdrawal by Subject|1|||
156353015|NCT03480750|564392108|FG002|Overall Study|Withdrawal by Subject|0|||
156353016|NCT03480750|564392109|FG003|Overall Study|Withdrawal by Subject|0|||
156353017|NCT03480750|564392110|FG004|Overall Study|Withdrawal by Subject|0|||
156353018|NCT03480750|564392111|FG005|Overall Study|Withdrawal by Subject|0|||
156353019|NCT03480750|564392106|FG000|Overall Study|The interruption in Trientine shippment|0|||
156353020|NCT03480750|564392107|FG001|Overall Study|The interruption in Trientine shippment|0|||
156353021|NCT03480750|564392108|FG002|Overall Study|The interruption in Trientine shippment|0|||
156353022|NCT03480750|564392109|FG003|Overall Study|The interruption in Trientine shippment|0|||
156353023|NCT03480750|564392110|FG004|Overall Study|The interruption in Trientine shippment|0|||
156353024|NCT03480750|564392111|FG005|Overall Study|The interruption in Trientine shippment|1|||
156353025|NCT03683758|564392116|FG000|Overall Study|Non-study commitment conflict|1|||
156353026|NCT03683758|564392117|FG001|Overall Study|Non-study commitment conflict|3|||
156353027|NCT03683758|564392116|FG000|Overall Study|Illness preventing participation|1|||
156353028|NCT03683758|564392117|FG001|Overall Study|Illness preventing participation|0|||
156353029|NCT03683758|564392116|FG000|Overall Study|Adverse Event|1|||
156353030|NCT03683758|564392117|FG001|Overall Study|Adverse Event|0|||
156353031|NCT00723892|564392118|FG000|Overall Study|Participant not tracked|33|||
156353032|NCT00723892|564392119|FG001|Overall Study|Participant not tracked|35|||
156353033|NCT00723892|564392118|FG000|Overall Study|Virological criterion|24|||
156353034|NCT00723892|564392119|FG001|Overall Study|Virological criterion|9|||
156353035|NCT00723892|564392118|FG000|Overall Study|Withdrawal by Subject|6|||
156484422|NCT02661490|564867439|FG001|Overall Study|Reason not Specified|0|||
156353036|NCT00723892|564392119|FG001|Overall Study|Withdrawal by Subject|9|||
156353037|NCT00723892|564392118|FG000|Overall Study|End planned|11|||
156353038|NCT00723892|564392119|FG001|Overall Study|End planned|7|||
156353039|NCT00723892|564392118|FG000|Overall Study|Bad tolerance|5|||
156353040|NCT00723892|564392119|FG001|Overall Study|Bad tolerance|5|||
156353041|NCT00723892|564392118|FG000|Overall Study|Multiple reasons|17|||
156353042|NCT00723892|564392119|FG001|Overall Study|Multiple reasons|12|||
156353043|NCT00723892|564392118|FG000|Overall Study|Other|6|||
156353044|NCT00723892|564392119|FG001|Overall Study|Other|3|||
156353045|NCT00723892|564392118|FG000|Overall Study|Study end|1|||
156353046|NCT00723892|564392119|FG001|Overall Study|Study end|3|||
156353047|NCT00723892|564392118|FG000|Overall Study|Weight loss|1|||
156353048|NCT00723892|564392119|FG001|Overall Study|Weight loss|3|||
156353049|NCT00723892|564392118|FG000|Overall Study|Alcohol abuse|0|||
156353050|NCT00723892|564392119|FG001|Overall Study|Alcohol abuse|1|||
156353051|NCT00723892|564392118|FG000|Overall Study|Intercurrent infection|2|||
156353052|NCT00723892|564392119|FG001|Overall Study|Intercurrent infection|0|||
156353053|NCT00723892|564392118|FG000|Overall Study|Drug addiction|1|||
156353054|NCT00723892|564392119|FG001|Overall Study|Drug addiction|0|||
156353055|NCT02411292|564392122|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
156353056|NCT02411292|564392122|FG000|Overall Study|Death|2|||
156353057|NCT02411292|564392122|FG000|Overall Study|Lost to Follow-up|3|||
156353058|NCT00453921|564392123|FG000|Overall Study|Withdrawal by Subject|1|||
156353059|NCT00453921|564392124|FG001|Overall Study|Withdrawal by Subject|1|||
156353060|NCT00453921|564392125|FG002|Overall Study|Withdrawal by Subject|1|||
156353061|NCT00453921|564392126|FG003|Overall Study|Withdrawal by Subject|1|||
156484423|NCT02661490|564867440|FG002|Overall Study|Reason not Specified|0|||
156484424|NCT02661490|564867441|FG003|Overall Study|Reason not Specified|0|||
156353062|NCT00453921|564392123|FG000|Overall Study|Lost to Follow-up|0|||
156353063|NCT00453921|564392124|FG001|Overall Study|Lost to Follow-up|0|||
156353064|NCT00453921|564392125|FG002|Overall Study|Lost to Follow-up|1|||
156484425|NCT02661490|564867442|FG004|Overall Study|Reason not Specified|1|||
156353065|NCT00453921|564392126|FG003|Overall Study|Lost to Follow-up|0|||
156353066|NCT00303498|564392127|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
156353067|NCT00303498|564392128|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
156353068|NCT00303498|564392127|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
156353069|NCT00303498|564392128|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
156353070|NCT00303498|564392127|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
156353071|NCT00303498|564392128|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
156484426|NCT00961298|564867443|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
156353072|NCT00303498|564392127|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
156353073|NCT00303498|564392128|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
156353074|NCT00303498|564392127|FG000|Run-In-Phase (10 Weeks)|Other|4|||
156353075|NCT00303498|564392128|FG001|Run-In-Phase (10 Weeks)|Other|1|||
156353076|NCT00303498|564392127|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
156353077|NCT00303498|564392128|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
156353078|NCT00303498|564392127|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
156353079|NCT00303498|564392128|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
156353080|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
156353081|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
156353082|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Death|1|||
156353083|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Death|0|||
156353084|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
156353085|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
156353086|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
156353087|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
156353088|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
156353089|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
156353090|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
156353091|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
156353092|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Other|1|||
156353093|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Other|0|||
156353094|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
156353095|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
156353096|NCT00303498|564392127|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
156353097|NCT00303498|564392128|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
156353098|NCT00174915|564392129|FG000|Overall Study|Lost to Follow-up|19|||
156353099|NCT00174915|564392130|FG001|Overall Study|Lost to Follow-up|17|||
156353100|NCT00174915|564392131|FG002|Overall Study|Lost to Follow-up|9|||
156353101|NCT00174915|564392132|FG003|Overall Study|Lost to Follow-up|17|||
156353102|NCT00174915|564392133|FG004|Overall Study|Lost to Follow-up|10|||
156353103|NCT00174915|564392129|FG000|Overall Study|Adverse Event|18|||
156353104|NCT00174915|564392130|FG001|Overall Study|Adverse Event|16|||
156353105|NCT00174915|564392131|FG002|Overall Study|Adverse Event|11|||
156353106|NCT00174915|564392132|FG003|Overall Study|Adverse Event|18|||
156353107|NCT00174915|564392133|FG004|Overall Study|Adverse Event|5|||
156353108|NCT00174915|564392129|FG000|Overall Study|Personal Reason(s)|16|||
156353109|NCT00174915|564392130|FG001|Overall Study|Personal Reason(s)|16|||
156353110|NCT00174915|564392131|FG002|Overall Study|Personal Reason(s)|9|||
156353111|NCT00174915|564392132|FG003|Overall Study|Personal Reason(s)|9|||
156353112|NCT00174915|564392133|FG004|Overall Study|Personal Reason(s)|9|||
156353113|NCT00174915|564392129|FG000|Overall Study|Other|15|||
156353114|NCT00174915|564392130|FG001|Overall Study|Other|8|||
156353115|NCT00174915|564392131|FG002|Overall Study|Other|6|||
156353116|NCT00174915|564392132|FG003|Overall Study|Other|5|||
156353117|NCT00174915|564392133|FG004|Overall Study|Other|3|||
156353118|NCT00174915|564392129|FG000|Overall Study|Gout Flare|13|||
156353119|NCT00174915|564392130|FG001|Overall Study|Gout Flare|6|||
156353120|NCT00174915|564392131|FG002|Overall Study|Gout Flare|8|||
156353121|NCT00174915|564392132|FG003|Overall Study|Gout Flare|1|||
156353122|NCT00174915|564392133|FG004|Overall Study|Gout Flare|0|||
156353123|NCT00174915|564392129|FG000|Overall Study|Protocol Violation|6|||
156353124|NCT00174915|564392130|FG001|Overall Study|Protocol Violation|3|||
156353125|NCT00174915|564392131|FG002|Overall Study|Protocol Violation|3|||
156353126|NCT00174915|564392132|FG003|Overall Study|Protocol Violation|6|||
156353127|NCT00174915|564392133|FG004|Overall Study|Protocol Violation|3|||
156353128|NCT00174915|564392129|FG000|Overall Study|Therapeutic Failure|6|||
156353129|NCT00174915|564392130|FG001|Overall Study|Therapeutic Failure|3|||
156353130|NCT00174915|564392131|FG002|Overall Study|Therapeutic Failure|2|||
156353131|NCT00174915|564392132|FG003|Overall Study|Therapeutic Failure|1|||
156353132|NCT00174915|564392133|FG004|Overall Study|Therapeutic Failure|3|||
156353133|NCT02232425|564392134|FG000|Overall Study|Lost to Follow-up|6|||
156353134|NCT02232425|564392135|FG001|Overall Study|Lost to Follow-up|2|||
156353135|NCT02232425|564392134|FG000|Overall Study|Adverse Event|2|||
156544374|NCT03200366|565087764|FG002|Patient Navigation Intervention Given|Death|0|||
156544375|NCT03200366|565087762|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
156353136|NCT02232425|564392135|FG001|Overall Study|Adverse Event|0|||
156353137|NCT02232425|564392134|FG000|Overall Study|Withdrawal by Subject|5|||
156353138|NCT02232425|564392135|FG001|Overall Study|Withdrawal by Subject|6|||
156353139|NCT02232425|564392134|FG000|Overall Study|Lack of Efficacy|1|||
156353140|NCT02232425|564392135|FG001|Overall Study|Lack of Efficacy|0|||
156353141|NCT03060447|564392136|FG000|Overall Study|Withdrawal by Subject|2|||
156353142|NCT03060447|564392137|FG001|Overall Study|Withdrawal by Subject|0|||
156353143|NCT01601626|564392140|FG000|Overall Study|Death|1|||
156353144|NCT01601626|564392141|FG001|Overall Study|Death|1|||
156353145|NCT01601626|564392142|FG002|Overall Study|Death|1|||
156353146|NCT01601626|564392140|FG000|Overall Study|Lost to Follow-up|1|||
156353147|NCT01601626|564392141|FG001|Overall Study|Lost to Follow-up|2|||
156353148|NCT01601626|564392142|FG002|Overall Study|Lost to Follow-up|0|||
156353149|NCT01601626|564392140|FG000|Overall Study|Unable to Get to Clinic|0|||
156353150|NCT01601626|564392141|FG001|Overall Study|Unable to Get to Clinic|1|||
156353151|NCT01601626|564392142|FG002|Overall Study|Unable to Get to Clinic|0|||
156353152|NCT01601626|564392140|FG000|Overall Study|Withdrawal by Subject|0|||
156353153|NCT01601626|564392141|FG001|Overall Study|Withdrawal by Subject|1|||
156353154|NCT01601626|564392142|FG002|Overall Study|Withdrawal by Subject|1|||
156353155|NCT01601626|564392140|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
156353156|NCT01601626|564392141|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
156353157|NCT01601626|564392142|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
156353158|NCT00498602|564392143|FG000|Overall Study|Death|0|||
156353159|NCT00498602|564392144|FG001|Overall Study|Death|0|||
156353160|NCT00498602|564392145|FG002|Overall Study|Death|0|||
156353161|NCT00498602|564392146|FG003|Overall Study|Death|0|||
156353162|NCT00498602|564392147|FG004|Overall Study|Death|0|||
156353163|NCT00498602|564392148|FG005|Overall Study|Death|1|||
156353164|NCT00498602|564392149|FG006|Overall Study|Death|0|||
156353165|NCT00498602|564392143|FG000|Overall Study|Lack of Efficacy|1|||
156353166|NCT00498602|564392144|FG001|Overall Study|Lack of Efficacy|0|||
156353167|NCT00498602|564392145|FG002|Overall Study|Lack of Efficacy|0|||
156353168|NCT00498602|564392146|FG003|Overall Study|Lack of Efficacy|0|||
156353169|NCT00498602|564392147|FG004|Overall Study|Lack of Efficacy|0|||
156353170|NCT00498602|564392148|FG005|Overall Study|Lack of Efficacy|0|||
156353171|NCT00498602|564392149|FG006|Overall Study|Lack of Efficacy|0|||
156353172|NCT00498602|564392143|FG000|Overall Study|Lost to Follow-up|0|||
156353173|NCT00498602|564392144|FG001|Overall Study|Lost to Follow-up|2|||
156353174|NCT00498602|564392145|FG002|Overall Study|Lost to Follow-up|0|||
156353175|NCT00498602|564392146|FG003|Overall Study|Lost to Follow-up|2|||
156353176|NCT00498602|564392147|FG004|Overall Study|Lost to Follow-up|0|||
156353177|NCT00498602|564392148|FG005|Overall Study|Lost to Follow-up|0|||
156484427|NCT00961298|564867443|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
156484428|NCT00961298|564867443|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
156484429|NCT02388932|564867450|FG000|Overall Study|Death|1|||
156484430|NCT05927753|564867453|FG000|Overall Study|Withdrawal by Subject|0|||
156484431|NCT05927753|564867454|FG001|Overall Study|Withdrawal by Subject|2|||
156484432|NCT05927753|564867453|FG000|Overall Study|Physician Decision|0|||
156484433|NCT05927753|564867454|FG001|Overall Study|Physician Decision|1|||
156484434|NCT00409006|564867457|FG000|Overall Study|Death|15|||
156484435|NCT00409006|564867458|FG001|Overall Study|Death|6|||
156484436|NCT00409006|564867457|FG000|Overall Study|Lost to Follow-up|1|||
156484437|NCT00409006|564867458|FG001|Overall Study|Lost to Follow-up|2|||
156484438|NCT00409006|564867457|FG000|Overall Study|Withdrawal by Subject|3|||
156484439|NCT00409006|564867458|FG001|Overall Study|Withdrawal by Subject|2|||
156484440|NCT00409006|564867457|FG000|Overall Study|Physician Decision|1|||
156484441|NCT00409006|564867458|FG001|Overall Study|Physician Decision|2|||
156484442|NCT02123797|564867459|FG000|Baseline Intervention|Death|9|||
156484443|NCT02123797|564867460|FG001|Baseline Intervention|Death|16|||
156484444|NCT02123797|564867461|FG002|Baseline Intervention|Death|0|||
156484445|NCT02123797|564867462|FG003|Baseline Intervention|Death|0|||
156484446|NCT02123797|564867463|FG004|Baseline Intervention|Death|0|||
156484447|NCT02123797|564867459|FG000|Baseline Intervention|Withdrawal by Subject|2|||
156484448|NCT02123797|564867460|FG001|Baseline Intervention|Withdrawal by Subject|8|||
156484449|NCT02123797|564867461|FG002|Baseline Intervention|Withdrawal by Subject|0|||
156484450|NCT02123797|564867462|FG003|Baseline Intervention|Withdrawal by Subject|0|||
156484451|NCT02123797|564867463|FG004|Baseline Intervention|Withdrawal by Subject|0|||
156484452|NCT02123797|564867459|FG000|Baseline Intervention|Relocation|2|||
156484453|NCT02123797|564867460|FG001|Baseline Intervention|Relocation|0|||
156484454|NCT02123797|564867461|FG002|Baseline Intervention|Relocation|0|||
156484455|NCT02123797|564867462|FG003|Baseline Intervention|Relocation|0|||
156484456|NCT02123797|564867463|FG004|Baseline Intervention|Relocation|0|||
156484457|NCT02123797|564867459|FG000|Baseline Intervention|Out of window for initial survey|6|||
156484458|NCT02123797|564867460|FG001|Baseline Intervention|Out of window for initial survey|13|||
156484459|NCT02123797|564867461|FG002|Baseline Intervention|Out of window for initial survey|0|||
156484460|NCT02123797|564867462|FG003|Baseline Intervention|Out of window for initial survey|0|||
156484461|NCT02123797|564867463|FG004|Baseline Intervention|Out of window for initial survey|0|||
156484462|NCT02123797|564867459|FG000|Baseline Intervention|Lost to Follow-up|0|||
156484463|NCT02123797|564867460|FG001|Baseline Intervention|Lost to Follow-up|5|||
156484464|NCT02123797|564867461|FG002|Baseline Intervention|Lost to Follow-up|0|||
156484465|NCT02123797|564867462|FG003|Baseline Intervention|Lost to Follow-up|0|||
156484466|NCT02123797|564867463|FG004|Baseline Intervention|Lost to Follow-up|0|||
156353178|NCT00498602|564392149|FG006|Overall Study|Lost to Follow-up|0|||
156353179|NCT00498602|564392143|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
156353180|NCT00498602|564392144|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156353181|NCT00498602|564392145|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
156353182|NCT00498602|564392146|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
156353183|NCT00498602|564392147|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156353184|NCT00498602|564392148|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
156353185|NCT00498602|564392149|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156353186|NCT00498602|564392143|FG000|Overall Study|AE not related to Study Drug|1|||
156353187|NCT00498602|564392144|FG001|Overall Study|AE not related to Study Drug|3|||
156353188|NCT00498602|564392145|FG002|Overall Study|AE not related to Study Drug|0|||
156353189|NCT00498602|564392146|FG003|Overall Study|AE not related to Study Drug|0|||
156353190|NCT00498602|564392147|FG004|Overall Study|AE not related to Study Drug|2|||
156353191|NCT00498602|564392148|FG005|Overall Study|AE not related to Study Drug|2|||
156353192|NCT00498602|564392149|FG006|Overall Study|AE not related to Study Drug|1|||
156353193|NCT00498602|564392143|FG000|Overall Study|Caregiver Request|2|||
156353194|NCT00498602|564392144|FG001|Overall Study|Caregiver Request|2|||
156353195|NCT00498602|564392145|FG002|Overall Study|Caregiver Request|2|||
156353196|NCT00498602|564392146|FG003|Overall Study|Caregiver Request|0|||
156353197|NCT00498602|564392147|FG004|Overall Study|Caregiver Request|1|||
156353198|NCT00498602|564392148|FG005|Overall Study|Caregiver Request|2|||
156353199|NCT00498602|564392149|FG006|Overall Study|Caregiver Request|0|||
156353200|NCT00498602|564392143|FG000|Overall Study|Investigator Request|0|||
156353201|NCT00498602|564392144|FG001|Overall Study|Investigator Request|0|||
156353202|NCT00498602|564392145|FG002|Overall Study|Investigator Request|1|||
156353203|NCT00498602|564392146|FG003|Overall Study|Investigator Request|0|||
156353204|NCT00498602|564392147|FG004|Overall Study|Investigator Request|0|||
156353205|NCT00498602|564392148|FG005|Overall Study|Investigator Request|0|||
156353206|NCT00498602|564392149|FG006|Overall Study|Investigator Request|0|||
156353207|NCT00498602|564392143|FG000|Overall Study|Subject Request|3|||
156353208|NCT00498602|564392144|FG001|Overall Study|Subject Request|0|||
156353209|NCT00498602|564392145|FG002|Overall Study|Subject Request|1|||
156353210|NCT00498602|564392146|FG003|Overall Study|Subject Request|1|||
156353211|NCT00498602|564392147|FG004|Overall Study|Subject Request|1|||
156353212|NCT00498602|564392148|FG005|Overall Study|Subject Request|4|||
156353213|NCT00498602|564392149|FG006|Overall Study|Subject Request|1|||
156353214|NCT00498602|564392143|FG000|Overall Study|Other|2|||
156353215|NCT00498602|564392144|FG001|Overall Study|Other|3|||
156353216|NCT00498602|564392145|FG002|Overall Study|Other|1|||
156353217|NCT00498602|564392146|FG003|Overall Study|Other|0|||
156353218|NCT00498602|564392147|FG004|Overall Study|Other|0|||
156353219|NCT00498602|564392148|FG005|Overall Study|Other|3|||
156353220|NCT00498602|564392149|FG006|Overall Study|Other|0|||
156353221|NCT03045887|564392150|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
156353222|NCT03045887|564392151|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353223|NCT03045887|564392152|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353224|NCT03045887|564392153|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353225|NCT03045887|564392154|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353226|NCT03045887|564392155|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353227|NCT03045887|564392156|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353228|NCT03045887|564392157|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353229|NCT03045887|564392158|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353230|NCT03045887|564392159|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156353231|NCT03045887|564392150|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156353232|NCT03045887|564392151|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156353233|NCT03045887|564392152|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156353234|NCT03045887|564392153|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
156353235|NCT03045887|564392154|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156353236|NCT03045887|564392155|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156353237|NCT03045887|564392156|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156353238|NCT03045887|564392157|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156353239|NCT03045887|564392158|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156484467|NCT02123797|564867459|FG000|Baseline Intervention|Other Disease|3|||
156484468|NCT02123797|564867460|FG001|Baseline Intervention|Other Disease|0|||
156353240|NCT03045887|564392159|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156353241|NCT03045887|564392150|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
156353242|NCT03045887|564392151|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
156353243|NCT03045887|564392152|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
156484469|NCT02123797|564867461|FG002|Baseline Intervention|Other Disease|0|||
156484470|NCT02123797|564867462|FG003|Baseline Intervention|Other Disease|0|||
156353244|NCT03045887|564392153|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
156353245|NCT03045887|564392154|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
156353246|NCT03045887|564392155|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
156353247|NCT03045887|564392156|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
156353248|NCT03045887|564392157|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
156353249|NCT03045887|564392158|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
156484471|NCT02123797|564867463|FG004|Baseline Intervention|Other Disease|0|||
156484472|NCT02123797|564867459|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
156353250|NCT03045887|564392159|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
156353251|NCT03045887|564392150|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156353252|NCT03045887|564392151|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156353253|NCT03045887|564392152|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
156353254|NCT03045887|564392153|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
156353255|NCT03045887|564392154|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156353256|NCT03045887|564392155|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156353257|NCT03045887|564392156|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156353258|NCT03045887|564392157|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156353259|NCT03045887|564392158|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156353260|NCT03045887|564392159|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156353261|NCT03045887|564392150|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353262|NCT03045887|564392151|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353263|NCT03045887|564392152|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353264|NCT03045887|564392153|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
156353265|NCT03045887|564392154|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353266|NCT03045887|564392155|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353267|NCT03045887|564392156|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353268|NCT03045887|564392157|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353269|NCT03045887|564392158|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353270|NCT03045887|564392159|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156353271|NCT01382446|564392160|FG000|Overall Study|Withdrawal by Subject|0|||
156353272|NCT01382446|564392161|FG001|Overall Study|Withdrawal by Subject|1|||
156353273|NCT01382446|564392160|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
156353274|NCT01382446|564392161|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
156353275|NCT04900220|564392166|FG000|Overall Study|Lost to Follow-up|1|||
156353276|NCT04900220|564392167|FG001|Overall Study|Lost to Follow-up|1|||
156353277|NCT02196558|564392168|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
156353278|NCT02196558|564392169|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
156353279|NCT02196558|564392170|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
156353280|NCT02196558|564392168|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
156353281|NCT02196558|564392169|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
156353282|NCT02196558|564392170|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
156353283|NCT02196558|564392168|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
156353284|NCT02196558|564392169|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
156353285|NCT02196558|564392170|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
156353286|NCT02196558|564392168|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
156353287|NCT02196558|564392169|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
156353288|NCT02196558|564392170|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
156353289|NCT02196558|564392168|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
156353290|NCT02196558|564392169|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
156353291|NCT02196558|564392170|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
156353292|NCT03428360|564392171|FG000|Overall Study|Informed consent withdrawn|5|||
156353293|NCT03428360|564392171|FG000|Overall Study|Withdrawal by Subject|4|||
156353294|NCT03428360|564392171|FG000|Overall Study|Lost to Follow-up|5|||
156353295|NCT03428360|564392171|FG000|Overall Study|Physician Decision|2|||
156353296|NCT03428360|564392171|FG000|Overall Study|Informed consent withdrawn|5|||
156353297|NCT03428360|564392171|FG000|Overall Study|Study terminated by sponsor|10|||
156353298|NCT03428360|564392171|FG000|Overall Study|Non-compliant with study|1|||
156353299|NCT03428360|564392171|FG000|Overall Study|Non-compliant with study drug|3|||
156353300|NCT03428360|564392171|FG000|Overall Study|Death|3|||
156353301|NCT03428360|564392171|FG000|Overall Study|Adverse Event|1|||
156353302|NCT03428360|564392171|FG000|Overall Study|Not on antiepileptic drug|1|||
156353303|NCT02107482|564392175|FG000|Overall Study|inconveinence|2|||
156353304|NCT02107482|564392175|FG000|Overall Study|Lost to Follow-up|1|||
156353305|NCT02107482|564392175|FG000|Overall Study|Lack of Efficacy|1|||
156353306|NCT02669433|564392178|FG000|Overall Study|Protocol Violation|0|||
156353307|NCT02669433|564392179|FG001|Overall Study|Protocol Violation|4|||
156353308|NCT02669433|564392180|FG002|Overall Study|Protocol Violation|1|||
156353309|NCT02669433|564392178|FG000|Overall Study|Disease Progression|1|||
156353310|NCT02669433|564392179|FG001|Overall Study|Disease Progression|0|||
156353311|NCT02669433|564392180|FG002|Overall Study|Disease Progression|0|||
156353312|NCT02669433|564392178|FG000|Overall Study|Physician Decision|1|||
156353313|NCT02669433|564392179|FG001|Overall Study|Physician Decision|1|||
156353314|NCT02669433|564392180|FG002|Overall Study|Physician Decision|0|||
156353315|NCT02669433|564392178|FG000|Overall Study|Adverse Event|6|||
156353316|NCT02669433|564392179|FG001|Overall Study|Adverse Event|7|||
156353317|NCT02669433|564392180|FG002|Overall Study|Adverse Event|10|||
156353318|NCT02669433|564392178|FG000|Overall Study|Sponsor Termination|1|||
156353319|NCT02669433|564392179|FG001|Overall Study|Sponsor Termination|0|||
156353320|NCT02669433|564392180|FG002|Overall Study|Sponsor Termination|1|||
156353321|NCT02669433|564392178|FG000|Overall Study|Withdrawal by Subject|5|||
156353322|NCT02669433|564392179|FG001|Overall Study|Withdrawal by Subject|1|||
156353323|NCT02669433|564392180|FG002|Overall Study|Withdrawal by Subject|0|||
156353324|NCT02669433|564392178|FG000|Overall Study|Withdrawal by Caregiver|1|||
156353325|NCT02669433|564392179|FG001|Overall Study|Withdrawal by Caregiver|0|||
156353326|NCT02669433|564392180|FG002|Overall Study|Withdrawal by Caregiver|2|||
156353327|NCT02669433|564392178|FG000|Overall Study|Death|0|||
156353328|NCT02669433|564392179|FG001|Overall Study|Death|1|||
156353329|NCT02669433|564392180|FG002|Overall Study|Death|1|||
156353330|NCT00576927|564392181|FG000|Clinical Assessment|Lack of Efficacy|24|||
156353331|NCT00576927|564392181|FG000|Clinical Assessment|Death|1|||
156353332|NCT00576927|564392181|FG000|Clinical Assessment|Withdrawal by Subject|10|||
156353333|NCT00576927|564392181|FG000|Clinical Assessment|Physician Decision|1|||
156353334|NCT00576927|564392181|FG000|Baseline|Physician Decision|9|||
156353335|NCT00576927|564392181|FG000|Baseline|Medication Change by PCP of subject|1|||
156353336|NCT00576927|564392181|FG000|Baseline|Withdrawal by Subject|3|||
156353337|NCT00576927|564392181|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
156353338|NCT00576927|564392181|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
156353339|NCT00576927|564392181|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
156353340|NCT00576927|564392181|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
156353341|NCT00576927|564392181|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
156353342|NCT03128892|564392182|FG000|Overall Study|Withdrawal by Subject|2|||
156353343|NCT03128892|564392182|FG000|Overall Study|Physician Decision|1|||
156353344|NCT01850524|564392185|FG000|Overall Study|Lost to Follow-up|5|||
156353345|NCT01850524|564392186|FG001|Overall Study|Lost to Follow-up|10|||
156353346|NCT01850524|564392185|FG000|Overall Study|Withdrawal by Subject|24|||
156353347|NCT01850524|564392186|FG001|Overall Study|Withdrawal by Subject|22|||
156353348|NCT01850524|564392185|FG000|Overall Study|Reason not Specified|142|||
156353349|NCT01850524|564392186|FG001|Overall Study|Reason not Specified|141|||
156353350|NCT00368355|564392187|FG000|Overall Study|Adverse Event|1|||
156353351|NCT00368355|564392188|FG001|Overall Study|Adverse Event|0|||
156353352|NCT00368355|564392187|FG000|Overall Study|Death|2|||
156353353|NCT00368355|564392188|FG001|Overall Study|Death|4|||
156353354|NCT00368355|564392187|FG000|Overall Study|Relapse|6|||
156353355|NCT00368355|564392188|FG001|Overall Study|Relapse|10|||
156353356|NCT00368355|564392187|FG000|Overall Study|Subsequent transplant|0|||
156353357|NCT00368355|564392188|FG001|Overall Study|Subsequent transplant|3|||
156353358|NCT00368355|564392187|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
156353359|NCT00368355|564392188|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
156353360|NCT03761147|564392198|FG000|Overall Study|Withdrawal by Subject|6|||
156353361|NCT03761147|564392199|FG001|Overall Study|Withdrawal by Subject|1|||
156353362|NCT03761147|564392198|FG000|Overall Study|Adverse Event|1|||
156353363|NCT03761147|564392199|FG001|Overall Study|Adverse Event|3|||
156353364|NCT02744391|564392200|FG000|Overall Study|Lost to Follow-up|9|||
156353365|NCT02744391|564392200|FG000|Overall Study|Physician Decision|2|||
156353366|NCT02744391|564392200|FG000|Overall Study|Withdrawal by Subject|3|||
156353367|NCT02045797|564392201|FG000|Overall Study|Adverse Event|3|||
156353368|NCT02045797|564392202|FG001|Overall Study|Adverse Event|1|||
156353369|NCT02045797|564392203|FG002|Overall Study|Adverse Event|0|||
156353370|NCT02045797|564392201|FG000|Overall Study|Lack of Efficacy|1|||
156353371|NCT02045797|564392202|FG001|Overall Study|Lack of Efficacy|0|||
156353372|NCT02045797|564392203|FG002|Overall Study|Lack of Efficacy|0|||
156353373|NCT02045797|564392201|FG000|Overall Study|Lost to Follow-up|2|||
156353374|NCT02045797|564392202|FG001|Overall Study|Lost to Follow-up|3|||
156353375|NCT02045797|564392203|FG002|Overall Study|Lost to Follow-up|1|||
156353376|NCT02045797|564392201|FG000|Overall Study|Physician Decision|0|||
156353377|NCT02045797|564392202|FG001|Overall Study|Physician Decision|1|||
156353378|NCT02045797|564392203|FG002|Overall Study|Physician Decision|0|||
156353379|NCT02045797|564392201|FG000|Overall Study|Withdrawal by Subject|1|||
156353380|NCT02045797|564392202|FG001|Overall Study|Withdrawal by Subject|2|||
156353381|NCT02045797|564392203|FG002|Overall Study|Withdrawal by Subject|0|||
156353382|NCT04434092|564392204|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
156353383|NCT04434092|564392205|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
156353384|NCT04434092|564392206|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
156484473|NCT02123797|564867460|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
156353385|NCT04434092|564392204|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
156353386|NCT04434092|564392205|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
156353387|NCT04434092|564392206|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
156353388|NCT04434092|564392204|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
156353389|NCT04434092|564392205|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
156353390|NCT04434092|564392206|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
156484474|NCT02123797|564867461|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
156353391|NCT04434092|564392204|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
156353392|NCT04434092|564392205|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
156484475|NCT02123797|564867462|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
156484476|NCT02123797|564867463|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
156484477|NCT02123797|564867459|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
156484478|NCT02123797|564867460|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
156484479|NCT02123797|564867461|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
156484480|NCT02123797|564867462|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
156484481|NCT02123797|564867463|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
156484482|NCT02123797|564867459|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
156484483|NCT02123797|564867460|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
156484484|NCT02123797|564867461|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
156484485|NCT02123797|564867462|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
156484486|NCT02123797|564867463|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
156484487|NCT02123797|564867459|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
156484488|NCT02123797|564867460|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
156353393|NCT04434092|564392206|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
156353394|NCT04434092|564392204|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
156353395|NCT04434092|564392205|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
156353396|NCT04434092|564392206|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
156353397|NCT04434092|564392204|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
156353398|NCT04434092|564392205|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
156353399|NCT04434092|564392206|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
156353400|NCT04434092|564392204|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
156353401|NCT04434092|564392205|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
156353402|NCT04434092|564392206|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
156353403|NCT02554812|564392207|FG000|Overall Study|Adverse Event|2|||
156353404|NCT02554812|564392208|FG001|Overall Study|Adverse Event|5|||
156353405|NCT02554812|564392209|FG002|Overall Study|Adverse Event|3|||
156353406|NCT02554812|564392210|FG003|Overall Study|Adverse Event|0|||
156484489|NCT02123797|564867461|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
156544376|NCT03200366|565087763|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
156353407|NCT02554812|564392211|FG004|Overall Study|Adverse Event|5|||
156353408|NCT02554812|564392212|FG005|Overall Study|Adverse Event|0|||
156353409|NCT02554812|564392213|FG006|Overall Study|Adverse Event|1|||
156353410|NCT02554812|564392214|FG007|Overall Study|Adverse Event|6|||
156353411|NCT02554812|564392215|FG008|Overall Study|Adverse Event|2|||
156353412|NCT02554812|564392216|FG009|Overall Study|Adverse Event|2|||
156353413|NCT02554812|564392217|FG010|Overall Study|Adverse Event|1|||
156353414|NCT02554812|564392218|FG011|Overall Study|Adverse Event|2|||
156353415|NCT02554812|564392219|FG012|Overall Study|Adverse Event|0|||
156353416|NCT02554812|564392220|FG013|Overall Study|Adverse Event|3|||
156353417|NCT02554812|564392221|FG014|Overall Study|Adverse Event|2|||
156353418|NCT02554812|564392222|FG015|Overall Study|Adverse Event|1|||
156353419|NCT02554812|564392223|FG016|Overall Study|Adverse Event|0|||
156353420|NCT02554812|564392224|FG017|Overall Study|Adverse Event|1|||
156353421|NCT02554812|564392225|FG018|Overall Study|Adverse Event|0|||
156353422|NCT02554812|564392226|FG019|Overall Study|Adverse Event|0|||
156484490|NCT02123797|564867462|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
156484491|NCT02123797|564867463|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
156484492|NCT02123797|564867459|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
156484493|NCT02123797|564867460|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
156484494|NCT02123797|564867461|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
156484495|NCT02123797|564867462|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
156484496|NCT02123797|564867463|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
156484497|NCT02123797|564867459|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
156484498|NCT02123797|564867460|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
156484499|NCT02123797|564867461|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
156484500|NCT02123797|564867462|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
156484501|NCT02123797|564867463|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
156484502|NCT02123797|564867459|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
156484503|NCT02123797|564867460|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
156484504|NCT02123797|564867461|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
156484505|NCT02123797|564867462|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
156484506|NCT02123797|564867463|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
156484507|NCT02123797|564867459|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
156484508|NCT02123797|564867460|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
156484509|NCT02123797|564867461|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
156484510|NCT02123797|564867462|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
156484511|NCT02123797|564867463|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
156484512|NCT02123797|564867459|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
156484513|NCT02123797|564867460|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
156484514|NCT02123797|564867461|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
156484515|NCT02123797|564867462|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
156484516|NCT02123797|564867463|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
156484517|NCT04385849|564867467|FG000|Overall Study|Lost to Follow-up|1|||
156353423|NCT02554812|564392227|FG020|Overall Study|Adverse Event|0|||
156353424|NCT02554812|564392228|FG021|Overall Study|Adverse Event|2|||
156484518|NCT04385849|564867468|FG001|Overall Study|Lost to Follow-up|0|||
156484519|NCT01375777|564867469|FG000|Overall Study|Withdrawal by Subject|0|||
156484520|NCT01375777|564867470|FG001|Overall Study|Withdrawal by Subject|2|||
156353425|NCT02554812|564392229|FG022|Overall Study|Adverse Event|1|||
156353426|NCT02554812|564392230|FG023|Overall Study|Adverse Event|1|||
156353427|NCT02554812|564392231|FG024|Overall Study|Adverse Event|1|||
156353428|NCT02554812|564392232|FG025|Overall Study|Adverse Event|2|||
156353429|NCT02554812|564392233|FG026|Overall Study|Adverse Event|1|||
156484521|NCT01375777|564867471|FG002|Overall Study|Withdrawal by Subject|1|||
156484522|NCT01375777|564867472|FG003|Overall Study|Withdrawal by Subject|0|||
156484523|NCT01375777|564867473|FG004|Overall Study|Withdrawal by Subject|1|||
156484524|NCT01375777|564867474|FG005|Overall Study|Withdrawal by Subject|1|||
156484525|NCT01375777|564867475|FG006|Overall Study|Withdrawal by Subject|1|||
156484526|NCT01375777|564867476|FG007|Overall Study|Withdrawal by Subject|2|||
156484527|NCT01375777|564867477|FG008|Overall Study|Withdrawal by Subject|1|||
156484528|NCT01375777|564867469|FG000|Overall Study|Lost to Follow-up|1|||
156484529|NCT01375777|564867470|FG001|Overall Study|Lost to Follow-up|0|||
156484530|NCT01375777|564867471|FG002|Overall Study|Lost to Follow-up|0|||
156484531|NCT01375777|564867472|FG003|Overall Study|Lost to Follow-up|0|||
156484532|NCT01375777|564867473|FG004|Overall Study|Lost to Follow-up|0|||
156484533|NCT01375777|564867474|FG005|Overall Study|Lost to Follow-up|0|||
156484534|NCT01375777|564867475|FG006|Overall Study|Lost to Follow-up|1|||
156484535|NCT01375777|564867476|FG007|Overall Study|Lost to Follow-up|0|||
156484536|NCT01375777|564867477|FG008|Overall Study|Lost to Follow-up|0|||
156484537|NCT01375777|564867469|FG000|Overall Study|Other|1|||
156544377|NCT03200366|565087764|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
156544378|NCT03200366|565087762|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
156544379|NCT03200366|565087763|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
156544380|NCT03200366|565087764|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
156484538|NCT01375777|564867470|FG001|Overall Study|Other|1|||
156484539|NCT01375777|564867471|FG002|Overall Study|Other|0|||
156484540|NCT01375777|564867472|FG003|Overall Study|Other|0|||
156484541|NCT01375777|564867473|FG004|Overall Study|Other|0|||
156484542|NCT01375777|564867474|FG005|Overall Study|Other|0|||
156484543|NCT01375777|564867475|FG006|Overall Study|Other|0|||
156484544|NCT01375777|564867476|FG007|Overall Study|Other|0|||
156484545|NCT01375777|564867477|FG008|Overall Study|Other|1|||
156484546|NCT00355784|564867478|FG000|Overall Study|Withdrawal by Subject|0|||
156484547|NCT00355784|564867479|FG001|Overall Study|Withdrawal by Subject|0|||
156484548|NCT00355784|564867480|FG002|Overall Study|Withdrawal by Subject|2|||
156484549|NCT03602053|564867487|FG000|Overall Study|Withdrawal by Subject|7|||
156484550|NCT03602053|564867488|FG001|Overall Study|Withdrawal by Subject|9|||
156484551|NCT03602053|564867489|FG002|Overall Study|Withdrawal by Subject|7|||
156484552|NCT03602053|564867487|FG000|Overall Study|Lost to Follow-up|5|||
156484553|NCT03602053|564867488|FG001|Overall Study|Lost to Follow-up|6|||
156484554|NCT03602053|564867489|FG002|Overall Study|Lost to Follow-up|0|||
156484555|NCT03602053|564867487|FG000|Overall Study|Protocol Violation|3|||
156484556|NCT03602053|564867488|FG001|Overall Study|Protocol Violation|0|||
156484557|NCT03602053|564867489|FG002|Overall Study|Protocol Violation|4|||
156484558|NCT03602053|564867487|FG000|Overall Study|Physician Decision|1|||
156484559|NCT03602053|564867488|FG001|Overall Study|Physician Decision|0|||
156484560|NCT03602053|564867489|FG002|Overall Study|Physician Decision|0|||
156484561|NCT03602053|564867487|FG000|Overall Study|migration|2|||
156484562|NCT03602053|564867488|FG001|Overall Study|migration|3|||
156484563|NCT03602053|564867489|FG002|Overall Study|migration|0|||
156484564|NCT03602053|564867487|FG000|Overall Study|Other|1|||
156484565|NCT03602053|564867488|FG001|Overall Study|Other|0|||
156484566|NCT03602053|564867489|FG002|Overall Study|Other|0|||
156484567|NCT03672188|564867500|FG000|Overall Study|Withdrawal by Subject|0|||
156484568|NCT03672188|564867501|FG001|Overall Study|Withdrawal by Subject|0|||
156484569|NCT03672188|564867502|FG002|Overall Study|Withdrawal by Subject|0|||
156484570|NCT03672188|564867503|FG003|Overall Study|Withdrawal by Subject|3|||
156484571|NCT03672188|564867504|FG004|Overall Study|Withdrawal by Subject|0|||
156484572|NCT03672188|564867505|FG005|Overall Study|Withdrawal by Subject|0|||
156484573|NCT03672188|564867506|FG006|Overall Study|Withdrawal by Subject|0|||
156484574|NCT03672188|564867507|FG007|Overall Study|Withdrawal by Subject|0|||
156484575|NCT03672188|564867508|FG008|Overall Study|Withdrawal by Subject|0|||
156484576|NCT03672188|564867509|FG009|Overall Study|Withdrawal by Subject|0|||
156484577|NCT03672188|564867510|FG010|Overall Study|Withdrawal by Subject|0|||
156484578|NCT03672188|564867511|FG011|Overall Study|Withdrawal by Subject|0|||
156484579|NCT03672188|564867512|FG012|Overall Study|Withdrawal by Subject|0|||
156484580|NCT03672188|564867513|FG013|Overall Study|Withdrawal by Subject|0|||
156484581|NCT03672188|564867514|FG014|Overall Study|Withdrawal by Subject|0|||
156484582|NCT03672188|564867500|FG000|Overall Study|Death|0|||
156484583|NCT03672188|564867501|FG001|Overall Study|Death|0|||
156484584|NCT03672188|564867502|FG002|Overall Study|Death|0|||
156484585|NCT03672188|564867503|FG003|Overall Study|Death|0|||
156484586|NCT03672188|564867504|FG004|Overall Study|Death|0|||
156484587|NCT03672188|564867505|FG005|Overall Study|Death|0|||
156484588|NCT03672188|564867506|FG006|Overall Study|Death|0|||
156484589|NCT03672188|564867507|FG007|Overall Study|Death|0|||
156484590|NCT03672188|564867508|FG008|Overall Study|Death|0|||
156484591|NCT03672188|564867509|FG009|Overall Study|Death|0|||
156484592|NCT03672188|564867510|FG010|Overall Study|Death|0|||
156484593|NCT03672188|564867511|FG011|Overall Study|Death|0|||
156484594|NCT03672188|564867512|FG012|Overall Study|Death|1|||
156484595|NCT03672188|564867513|FG013|Overall Study|Death|0|||
156484596|NCT03672188|564867514|FG014|Overall Study|Death|0|||
156484597|NCT03672188|564867500|FG000|Overall Study|Lost to Follow-up|0|||
156484598|NCT03672188|564867501|FG001|Overall Study|Lost to Follow-up|0|||
156484599|NCT03672188|564867502|FG002|Overall Study|Lost to Follow-up|1|||
156484600|NCT03672188|564867503|FG003|Overall Study|Lost to Follow-up|0|||
156484601|NCT03672188|564867504|FG004|Overall Study|Lost to Follow-up|0|||
156484602|NCT03672188|564867505|FG005|Overall Study|Lost to Follow-up|0|||
156484603|NCT03672188|564867506|FG006|Overall Study|Lost to Follow-up|0|||
156484604|NCT03672188|564867507|FG007|Overall Study|Lost to Follow-up|0|||
156484605|NCT03672188|564867508|FG008|Overall Study|Lost to Follow-up|0|||
156484606|NCT03672188|564867509|FG009|Overall Study|Lost to Follow-up|0|||
156484607|NCT03672188|564867510|FG010|Overall Study|Lost to Follow-up|0|||
156484608|NCT03672188|564867511|FG011|Overall Study|Lost to Follow-up|0|||
156484609|NCT03672188|564867512|FG012|Overall Study|Lost to Follow-up|0|||
156484610|NCT03672188|564867513|FG013|Overall Study|Lost to Follow-up|0|||
156484611|NCT03672188|564867514|FG014|Overall Study|Lost to Follow-up|0|||
156484612|NCT01234675|564867515|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
156484613|NCT01234675|564867516|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
156484614|NCT01234675|564867515|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
156484615|NCT01234675|564867516|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
156353430|NCT02554812|564392207|FG000|Overall Study|Death|1|||
156353431|NCT02554812|564392208|FG001|Overall Study|Death|2|||
156353432|NCT02554812|564392209|FG002|Overall Study|Death|2|||
156353433|NCT02554812|564392210|FG003|Overall Study|Death|2|||
156353434|NCT02554812|564392211|FG004|Overall Study|Death|0|||
156353435|NCT02554812|564392212|FG005|Overall Study|Death|1|||
156353436|NCT02554812|564392213|FG006|Overall Study|Death|1|||
156353437|NCT02554812|564392214|FG007|Overall Study|Death|1|||
156353438|NCT02554812|564392215|FG008|Overall Study|Death|0|||
156353439|NCT02554812|564392216|FG009|Overall Study|Death|0|||
156353440|NCT02554812|564392217|FG010|Overall Study|Death|0|||
156353441|NCT02554812|564392218|FG011|Overall Study|Death|0|||
156353442|NCT02554812|564392219|FG012|Overall Study|Death|0|||
156353443|NCT02554812|564392220|FG013|Overall Study|Death|0|||
156353444|NCT02554812|564392221|FG014|Overall Study|Death|1|||
156353445|NCT02554812|564392222|FG015|Overall Study|Death|1|||
156353446|NCT02554812|564392223|FG016|Overall Study|Death|1|||
156353447|NCT02554812|564392224|FG017|Overall Study|Death|0|||
156353448|NCT02554812|564392225|FG018|Overall Study|Death|1|||
156353449|NCT02554812|564392226|FG019|Overall Study|Death|2|||
156353450|NCT02554812|564392227|FG020|Overall Study|Death|0|||
156353451|NCT02554812|564392228|FG021|Overall Study|Death|1|||
156353452|NCT02554812|564392229|FG022|Overall Study|Death|1|||
156353453|NCT02554812|564392230|FG023|Overall Study|Death|0|||
156353454|NCT02554812|564392231|FG024|Overall Study|Death|0|||
156353455|NCT02554812|564392232|FG025|Overall Study|Death|0|||
156353456|NCT02554812|564392233|FG026|Overall Study|Death|0|||
156353457|NCT02554812|564392207|FG000|Overall Study|Lost to Follow-up|0|||
156353458|NCT02554812|564392208|FG001|Overall Study|Lost to Follow-up|1|||
156353459|NCT02554812|564392209|FG002|Overall Study|Lost to Follow-up|0|||
156353460|NCT02554812|564392210|FG003|Overall Study|Lost to Follow-up|0|||
156353461|NCT02554812|564392211|FG004|Overall Study|Lost to Follow-up|0|||
156353462|NCT02554812|564392212|FG005|Overall Study|Lost to Follow-up|0|||
156353463|NCT02554812|564392213|FG006|Overall Study|Lost to Follow-up|0|||
156353464|NCT02554812|564392214|FG007|Overall Study|Lost to Follow-up|0|||
156353465|NCT02554812|564392215|FG008|Overall Study|Lost to Follow-up|0|||
156353466|NCT02554812|564392216|FG009|Overall Study|Lost to Follow-up|0|||
156353467|NCT02554812|564392217|FG010|Overall Study|Lost to Follow-up|0|||
156353468|NCT02554812|564392218|FG011|Overall Study|Lost to Follow-up|0|||
156353469|NCT02554812|564392219|FG012|Overall Study|Lost to Follow-up|0|||
156353470|NCT02554812|564392220|FG013|Overall Study|Lost to Follow-up|0|||
156353471|NCT02554812|564392221|FG014|Overall Study|Lost to Follow-up|0|||
156353472|NCT02554812|564392222|FG015|Overall Study|Lost to Follow-up|0|||
156353473|NCT02554812|564392223|FG016|Overall Study|Lost to Follow-up|0|||
156353474|NCT02554812|564392224|FG017|Overall Study|Lost to Follow-up|0|||
156353475|NCT02554812|564392225|FG018|Overall Study|Lost to Follow-up|0|||
156353476|NCT02554812|564392226|FG019|Overall Study|Lost to Follow-up|0|||
156353477|NCT02554812|564392227|FG020|Overall Study|Lost to Follow-up|0|||
156353478|NCT02554812|564392228|FG021|Overall Study|Lost to Follow-up|0|||
156353479|NCT02554812|564392229|FG022|Overall Study|Lost to Follow-up|0|||
156353480|NCT02554812|564392230|FG023|Overall Study|Lost to Follow-up|0|||
156353481|NCT02554812|564392231|FG024|Overall Study|Lost to Follow-up|0|||
156353482|NCT02554812|564392232|FG025|Overall Study|Lost to Follow-up|0|||
156353483|NCT02554812|564392233|FG026|Overall Study|Lost to Follow-up|0|||
156353484|NCT02554812|564392207|FG000|Overall Study|Global deterioration of health status|4|||
156353485|NCT02554812|564392208|FG001|Overall Study|Global deterioration of health status|3|||
156353486|NCT02554812|564392209|FG002|Overall Study|Global deterioration of health status|3|||
156353487|NCT02554812|564392210|FG003|Overall Study|Global deterioration of health status|2|||
156484616|NCT03997409|564867517|FG000|Overall Study|Protocol Violation|1|||
156484617|NCT03997409|564867518|FG001|Overall Study|Protocol Violation|1|||
156484618|NCT03997409|564867519|FG002|Overall Study|Protocol Violation|0|||
156484619|NCT03997409|564867517|FG000|Overall Study|Withdrawal by Subject|3|||
156484620|NCT03997409|564867518|FG001|Overall Study|Withdrawal by Subject|0|||
156484621|NCT03997409|564867519|FG002|Overall Study|Withdrawal by Subject|0|||
156484622|NCT03997409|564867517|FG000|Overall Study|Lost to Follow-up|0|||
156353488|NCT02554812|564392211|FG004|Overall Study|Global deterioration of health status|5|||
156353489|NCT02554812|564392212|FG005|Overall Study|Global deterioration of health status|0|||
156353490|NCT02554812|564392213|FG006|Overall Study|Global deterioration of health status|2|||
156353491|NCT02554812|564392214|FG007|Overall Study|Global deterioration of health status|1|||
156353492|NCT02554812|564392215|FG008|Overall Study|Global deterioration of health status|1|||
156484623|NCT03997409|564867518|FG001|Overall Study|Lost to Follow-up|0|||
156484624|NCT03997409|564867519|FG002|Overall Study|Lost to Follow-up|1|||
156353493|NCT02554812|564392216|FG009|Overall Study|Global deterioration of health status|1|||
156353494|NCT02554812|564392217|FG010|Overall Study|Global deterioration of health status|2|||
156353495|NCT02554812|564392218|FG011|Overall Study|Global deterioration of health status|1|||
156353496|NCT02554812|564392219|FG012|Overall Study|Global deterioration of health status|0|||
156353497|NCT02554812|564392220|FG013|Overall Study|Global deterioration of health status|0|||
156353498|NCT02554812|564392221|FG014|Overall Study|Global deterioration of health status|0|||
156353499|NCT02554812|564392222|FG015|Overall Study|Global deterioration of health status|1|||
156484625|NCT01753323|564867520|FG000|Overall Study|Lack of Efficacy|0|||
156484626|NCT01753323|564867521|FG001|Overall Study|Lack of Efficacy|0|||
156484627|NCT01753323|564867522|FG002|Overall Study|Lack of Efficacy|8|||
156484628|NCT01753323|564867520|FG000|Overall Study|Protocol deviation|1|||
156484629|NCT01753323|564867521|FG001|Overall Study|Protocol deviation|0|||
156484630|NCT01753323|564867522|FG002|Overall Study|Protocol deviation|0|||
156484631|NCT01753323|564867520|FG000|Overall Study|Adverse Event|0|||
156484632|NCT01753323|564867521|FG001|Overall Study|Adverse Event|0|||
156484633|NCT01753323|564867522|FG002|Overall Study|Adverse Event|1|||
156484634|NCT01870999|564867523|FG000|Overall Study|Adverse Event|0|||
156484635|NCT01870999|564867524|FG001|Overall Study|Adverse Event|4|||
156484636|NCT01870999|564867525|FG002|Overall Study|Adverse Event|1|||
156484637|NCT01870999|564867523|FG000|Overall Study|Subject met withdrawal criteria|3|||
156484638|NCT01870999|564867524|FG001|Overall Study|Subject met withdrawal criteria|2|||
156484639|NCT01870999|564867525|FG002|Overall Study|Subject met withdrawal criteria|0|||
156484640|NCT01870999|564867523|FG000|Overall Study|Subject withdrawn by Investigator|1|||
156484641|NCT01870999|564867524|FG001|Overall Study|Subject withdrawn by Investigator|0|||
156484642|NCT01870999|564867525|FG002|Overall Study|Subject withdrawn by Investigator|0|||
156484643|NCT01870999|564867523|FG000|Overall Study|Withdrawal by Subject|0|||
156484644|NCT01870999|564867524|FG001|Overall Study|Withdrawal by Subject|2|||
156484645|NCT01870999|564867525|FG002|Overall Study|Withdrawal by Subject|5|||
156484646|NCT01870999|564867523|FG000|Overall Study|Protocol Violation|0|||
156544381|NCT03200366|565087762|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
156565220|NCT02660580|565157657|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
156484647|NCT01870999|564867524|FG001|Overall Study|Protocol Violation|0|||
156484648|NCT01870999|564867525|FG002|Overall Study|Protocol Violation|1|||
156484649|NCT03034772|564867536|FG000|Overall Study|Adverse Event|0|||
156484650|NCT03034772|564867537|FG001|Overall Study|Adverse Event|1|||
156353500|NCT02554812|564392223|FG016|Overall Study|Global deterioration of health status|0|||
156353501|NCT02554812|564392224|FG017|Overall Study|Global deterioration of health status|0|||
156353502|NCT02554812|564392225|FG018|Overall Study|Global deterioration of health status|0|||
156353503|NCT02554812|564392226|FG019|Overall Study|Global deterioration of health status|0|||
156353504|NCT02554812|564392227|FG020|Overall Study|Global deterioration of health status|0|||
156353505|NCT02554812|564392228|FG021|Overall Study|Global deterioration of health status|0|||
156353506|NCT02554812|564392229|FG022|Overall Study|Global deterioration of health status|0|||
156353507|NCT02554812|564392230|FG023|Overall Study|Global deterioration of health status|0|||
156353508|NCT02554812|564392231|FG024|Overall Study|Global deterioration of health status|0|||
156353509|NCT02554812|564392232|FG025|Overall Study|Global deterioration of health status|0|||
156353510|NCT02554812|564392233|FG026|Overall Study|Global deterioration of health status|0|||
156353511|NCT02554812|564392207|FG000|Overall Study|Progressive disease|20|||
156353512|NCT02554812|564392208|FG001|Overall Study|Progressive disease|16|||
156353513|NCT02554812|564392209|FG002|Overall Study|Progressive disease|19|||
156353514|NCT02554812|564392210|FG003|Overall Study|Progressive disease|18|||
156353515|NCT02554812|564392211|FG004|Overall Study|Progressive disease|21|||
156353516|NCT02554812|564392212|FG005|Overall Study|Progressive disease|15|||
156353517|NCT02554812|564392213|FG006|Overall Study|Progressive disease|6|||
156353518|NCT02554812|564392214|FG007|Overall Study|Progressive disease|13|||
156353519|NCT02554812|564392215|FG008|Overall Study|Progressive disease|6|||
156353520|NCT02554812|564392216|FG009|Overall Study|Progressive disease|6|||
156353521|NCT02554812|564392217|FG010|Overall Study|Progressive disease|8|||
156353522|NCT02554812|564392218|FG011|Overall Study|Progressive disease|8|||
156353523|NCT02554812|564392219|FG012|Overall Study|Progressive disease|6|||
156353524|NCT02554812|564392220|FG013|Overall Study|Progressive disease|10|||
156353525|NCT02554812|564392221|FG014|Overall Study|Progressive disease|20|||
156484651|NCT03034772|564867536|FG000|Overall Study|Withdrawal by Subject|0|||
156484652|NCT03034772|564867537|FG001|Overall Study|Withdrawal by Subject|1|||
156484653|NCT00116584|564867538|FG000|Overall Study|Withdrawal by Subject|1|||
156484654|NCT00116584|564867539|FG001|Overall Study|Withdrawal by Subject|0|||
156484655|NCT00116584|564867538|FG000|Overall Study|Protocol Violation|1|||
156353526|NCT02554812|564392222|FG015|Overall Study|Progressive disease|6|||
156353527|NCT02554812|564392223|FG016|Overall Study|Progressive disease|3|||
156353528|NCT02554812|564392224|FG017|Overall Study|Progressive disease|3|||
156353529|NCT02554812|564392225|FG018|Overall Study|Progressive disease|11|||
156484656|NCT00116584|564867539|FG001|Overall Study|Protocol Violation|1|||
156484657|NCT01745380|564867540|FG000|Overall Study|Lost to Follow-up|1|||
156484658|NCT01745380|564867541|FG001|Overall Study|Lost to Follow-up|0|||
156484659|NCT01745380|564867540|FG000|Overall Study|Lack of Efficacy|0|||
156484660|NCT01745380|564867541|FG001|Overall Study|Lack of Efficacy|1|||
156484661|NCT02660034|564867542|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
156484662|NCT02660034|564867543|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
156484663|NCT02660034|564867544|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
156484664|NCT02660034|564867545|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
156484665|NCT02660034|564867546|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
156484666|NCT02660034|564867547|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
156484667|NCT02660034|564867548|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
156484668|NCT02660034|564867549|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
156484669|NCT02660034|564867550|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
156484670|NCT02660034|564867551|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
156484671|NCT02660034|564867552|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
156484672|NCT02660034|564867553|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
156484673|NCT02660034|564867554|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
156484674|NCT02660034|564867555|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
156484675|NCT02660034|564867542|FG000|Overall Study|Progressive Disease (Clinical)|7|||
156484676|NCT02660034|564867543|FG001|Overall Study|Progressive Disease (Clinical)|8|||
156484677|NCT02660034|564867544|FG002|Overall Study|Progressive Disease (Clinical)|3|||
156484678|NCT02660034|564867545|FG003|Overall Study|Progressive Disease (Clinical)|9|||
156484679|NCT02660034|564867546|FG004|Overall Study|Progressive Disease (Clinical)|3|||
156484680|NCT02660034|564867547|FG005|Overall Study|Progressive Disease (Clinical)|0|||
156484681|NCT02660034|564867548|FG006|Overall Study|Progressive Disease (Clinical)|0|||
156484682|NCT02660034|564867549|FG007|Overall Study|Progressive Disease (Clinical)|0|||
156484683|NCT02660034|564867550|FG008|Overall Study|Progressive Disease (Clinical)|0|||
156484684|NCT02660034|564867551|FG009|Overall Study|Progressive Disease (Clinical)|0|||
156484685|NCT02660034|564867552|FG010|Overall Study|Progressive Disease (Clinical)|0|||
156484686|NCT02660034|564867553|FG011|Overall Study|Progressive Disease (Clinical)|0|||
156484687|NCT02660034|564867554|FG012|Overall Study|Progressive Disease (Clinical)|0|||
156484688|NCT02660034|564867555|FG013|Overall Study|Progressive Disease (Clinical)|0|||
156484689|NCT02660034|564867542|FG000|Overall Study|Lost to Follow-up|0|||
156353530|NCT02554812|564392226|FG019|Overall Study|Progressive disease|7|||
156353531|NCT02554812|564392227|FG020|Overall Study|Progressive disease|11|||
156353532|NCT02554812|564392228|FG021|Overall Study|Progressive disease|6|||
156353533|NCT02554812|564392229|FG022|Overall Study|Progressive disease|9|||
156353534|NCT02554812|564392230|FG023|Overall Study|Progressive disease|9|||
156353535|NCT02554812|564392231|FG024|Overall Study|Progressive disease|4|||
156353536|NCT02554812|564392232|FG025|Overall Study|Progressive disease|5|||
156353537|NCT02554812|564392233|FG026|Overall Study|Progressive disease|5|||
156353538|NCT02554812|564392207|FG000|Overall Study|Other|0|||
156353539|NCT02554812|564392208|FG001|Overall Study|Other|0|||
156353540|NCT02554812|564392209|FG002|Overall Study|Other|2|||
156353541|NCT02554812|564392210|FG003|Overall Study|Other|3|||
156353542|NCT02554812|564392211|FG004|Overall Study|Other|2|||
156353543|NCT02554812|564392212|FG005|Overall Study|Other|1|||
156353544|NCT02554812|564392213|FG006|Overall Study|Other|0|||
156353545|NCT02554812|564392214|FG007|Overall Study|Other|0|||
156353546|NCT02554812|564392215|FG008|Overall Study|Other|1|||
156353547|NCT02554812|564392216|FG009|Overall Study|Other|1|||
156353548|NCT02554812|564392217|FG010|Overall Study|Other|0|||
156353549|NCT02554812|564392218|FG011|Overall Study|Other|0|||
156353550|NCT02554812|564392219|FG012|Overall Study|Other|1|||
156353551|NCT02554812|564392220|FG013|Overall Study|Other|0|||
156353552|NCT02554812|564392221|FG014|Overall Study|Other|1|||
156353553|NCT02554812|564392222|FG015|Overall Study|Other|0|||
156353554|NCT02554812|564392223|FG016|Overall Study|Other|0|||
156353555|NCT02554812|564392224|FG017|Overall Study|Other|0|||
156353556|NCT02554812|564392225|FG018|Overall Study|Other|0|||
156353557|NCT02554812|564392226|FG019|Overall Study|Other|0|||
156353558|NCT02554812|564392227|FG020|Overall Study|Other|0|||
156353559|NCT02554812|564392228|FG021|Overall Study|Other|2|||
156353560|NCT02554812|564392229|FG022|Overall Study|Other|0|||
156353561|NCT02554812|564392230|FG023|Overall Study|Other|0|||
156353562|NCT02554812|564392231|FG024|Overall Study|Other|0|||
156353563|NCT02554812|564392232|FG025|Overall Study|Other|0|||
156353564|NCT02554812|564392233|FG026|Overall Study|Other|0|||
156353565|NCT02554812|564392207|FG000|Overall Study|Withdrawal by Subject|1|||
156484690|NCT02660034|564867543|FG001|Overall Study|Lost to Follow-up|0|||
156353566|NCT02554812|564392208|FG001|Overall Study|Withdrawal by Subject|0|||
156353567|NCT02554812|564392209|FG002|Overall Study|Withdrawal by Subject|0|||
156353568|NCT02554812|564392210|FG003|Overall Study|Withdrawal by Subject|2|||
156353569|NCT02554812|564392211|FG004|Overall Study|Withdrawal by Subject|2|||
156353570|NCT02554812|564392212|FG005|Overall Study|Withdrawal by Subject|3|||
156353571|NCT02554812|564392213|FG006|Overall Study|Withdrawal by Subject|0|||
156353572|NCT02554812|564392214|FG007|Overall Study|Withdrawal by Subject|0|||
156353573|NCT02554812|564392215|FG008|Overall Study|Withdrawal by Subject|1|||
156353574|NCT02554812|564392216|FG009|Overall Study|Withdrawal by Subject|1|||
156353575|NCT02554812|564392217|FG010|Overall Study|Withdrawal by Subject|0|||
156353576|NCT02554812|564392218|FG011|Overall Study|Withdrawal by Subject|1|||
156353577|NCT02554812|564392219|FG012|Overall Study|Withdrawal by Subject|1|||
156353578|NCT02554812|564392220|FG013|Overall Study|Withdrawal by Subject|1|||
156353579|NCT02554812|564392221|FG014|Overall Study|Withdrawal by Subject|1|||
156353580|NCT02554812|564392222|FG015|Overall Study|Withdrawal by Subject|1|||
156353581|NCT02554812|564392223|FG016|Overall Study|Withdrawal by Subject|3|||
156353582|NCT02554812|564392224|FG017|Overall Study|Withdrawal by Subject|1|||
156353583|NCT02554812|564392225|FG018|Overall Study|Withdrawal by Subject|0|||
156353584|NCT02554812|564392226|FG019|Overall Study|Withdrawal by Subject|2|||
156353585|NCT02554812|564392227|FG020|Overall Study|Withdrawal by Subject|0|||
156353586|NCT02554812|564392228|FG021|Overall Study|Withdrawal by Subject|1|||
156353587|NCT02554812|564392229|FG022|Overall Study|Withdrawal by Subject|0|||
156353588|NCT02554812|564392230|FG023|Overall Study|Withdrawal by Subject|1|||
156353589|NCT02554812|564392231|FG024|Overall Study|Withdrawal by Subject|0|||
156353590|NCT02554812|564392232|FG025|Overall Study|Withdrawal by Subject|0|||
156353591|NCT02554812|564392233|FG026|Overall Study|Withdrawal by Subject|1|||
156353592|NCT02554812|564392207|FG000|Overall Study|Physician Decision|1|||
156353593|NCT02554812|564392208|FG001|Overall Study|Physician Decision|0|||
156353594|NCT02554812|564392209|FG002|Overall Study|Physician Decision|0|||
156353595|NCT02554812|564392210|FG003|Overall Study|Physician Decision|1|||
156353596|NCT02554812|564392211|FG004|Overall Study|Physician Decision|0|||
156353597|NCT02554812|564392212|FG005|Overall Study|Physician Decision|1|||
156353598|NCT02554812|564392213|FG006|Overall Study|Physician Decision|0|||
156353599|NCT02554812|564392214|FG007|Overall Study|Physician Decision|0|||
156353600|NCT02554812|564392215|FG008|Overall Study|Physician Decision|0|||
156353601|NCT02554812|564392216|FG009|Overall Study|Physician Decision|0|||
156353602|NCT02554812|564392217|FG010|Overall Study|Physician Decision|1|||
156353603|NCT02554812|564392218|FG011|Overall Study|Physician Decision|0|||
156353604|NCT02554812|564392219|FG012|Overall Study|Physician Decision|0|||
156353605|NCT02554812|564392220|FG013|Overall Study|Physician Decision|0|||
156353606|NCT02554812|564392221|FG014|Overall Study|Physician Decision|0|||
156353607|NCT02554812|564392222|FG015|Overall Study|Physician Decision|0|||
156353608|NCT02554812|564392223|FG016|Overall Study|Physician Decision|1|||
156353609|NCT02554812|564392224|FG017|Overall Study|Physician Decision|1|||
156353610|NCT02554812|564392225|FG018|Overall Study|Physician Decision|0|||
156353611|NCT02554812|564392226|FG019|Overall Study|Physician Decision|1|||
156353612|NCT02554812|564392227|FG020|Overall Study|Physician Decision|1|||
156353613|NCT02554812|564392228|FG021|Overall Study|Physician Decision|0|||
156353614|NCT02554812|564392229|FG022|Overall Study|Physician Decision|1|||
156353615|NCT02554812|564392230|FG023|Overall Study|Physician Decision|0|||
156353616|NCT02554812|564392231|FG024|Overall Study|Physician Decision|0|||
156353617|NCT02554812|564392232|FG025|Overall Study|Physician Decision|0|||
156353618|NCT02554812|564392233|FG026|Overall Study|Physician Decision|0|||
156353619|NCT02554812|564392207|FG000|Overall Study|Study terminated by sponsor|0|||
156353620|NCT02554812|564392208|FG001|Overall Study|Study terminated by sponsor|0|||
156353621|NCT02554812|564392209|FG002|Overall Study|Study terminated by sponsor|0|||
156353622|NCT02554812|564392210|FG003|Overall Study|Study terminated by sponsor|0|||
156353623|NCT02554812|564392211|FG004|Overall Study|Study terminated by sponsor|0|||
156353624|NCT02554812|564392212|FG005|Overall Study|Study terminated by sponsor|0|||
156353625|NCT02554812|564392213|FG006|Overall Study|Study terminated by sponsor|0|||
156353626|NCT02554812|564392214|FG007|Overall Study|Study terminated by sponsor|0|||
156353627|NCT02554812|564392215|FG008|Overall Study|Study terminated by sponsor|0|||
156353628|NCT02554812|564392216|FG009|Overall Study|Study terminated by sponsor|0|||
156353629|NCT02554812|564392217|FG010|Overall Study|Study terminated by sponsor|0|||
156353630|NCT02554812|564392218|FG011|Overall Study|Study terminated by sponsor|0|||
156353631|NCT02554812|564392219|FG012|Overall Study|Study terminated by sponsor|0|||
156353632|NCT02554812|564392220|FG013|Overall Study|Study terminated by sponsor|0|||
156353633|NCT02554812|564392221|FG014|Overall Study|Study terminated by sponsor|0|||
156353634|NCT02554812|564392222|FG015|Overall Study|Study terminated by sponsor|0|||
156353635|NCT02554812|564392223|FG016|Overall Study|Study terminated by sponsor|0|||
156353636|NCT02554812|564392224|FG017|Overall Study|Study terminated by sponsor|0|||
156353637|NCT02554812|564392225|FG018|Overall Study|Study terminated by sponsor|0|||
156484691|NCT02660034|564867544|FG002|Overall Study|Lost to Follow-up|1|||
156484692|NCT02660034|564867545|FG003|Overall Study|Lost to Follow-up|1|||
156353638|NCT02554812|564392226|FG019|Overall Study|Study terminated by sponsor|0|||
156353639|NCT02554812|564392227|FG020|Overall Study|Study terminated by sponsor|0|||
156353640|NCT02554812|564392228|FG021|Overall Study|Study terminated by sponsor|0|||
156353641|NCT02554812|564392229|FG022|Overall Study|Study terminated by sponsor|0|||
156353642|NCT02554812|564392230|FG023|Overall Study|Study terminated by sponsor|0|||
156484693|NCT02660034|564867546|FG004|Overall Study|Lost to Follow-up|0|||
156353643|NCT02554812|564392231|FG024|Overall Study|Study terminated by sponsor|1|||
156353644|NCT02554812|564392232|FG025|Overall Study|Study terminated by sponsor|0|||
156353645|NCT02554812|564392233|FG026|Overall Study|Study terminated by sponsor|0|||
156353646|NCT02554812|564392207|FG000|Overall Study|No longer meets eligibility criteria|0|||
156484694|NCT02660034|564867547|FG005|Overall Study|Lost to Follow-up|0|||
156484695|NCT02660034|564867548|FG006|Overall Study|Lost to Follow-up|0|||
156484696|NCT02660034|564867549|FG007|Overall Study|Lost to Follow-up|0|||
156353647|NCT02554812|564392208|FG001|Overall Study|No longer meets eligibility criteria|1|||
156353648|NCT02554812|564392209|FG002|Overall Study|No longer meets eligibility criteria|0|||
156353649|NCT02554812|564392210|FG003|Overall Study|No longer meets eligibility criteria|0|||
156353650|NCT02554812|564392211|FG004|Overall Study|No longer meets eligibility criteria|0|||
156353651|NCT02554812|564392212|FG005|Overall Study|No longer meets eligibility criteria|0|||
156353652|NCT02554812|564392213|FG006|Overall Study|No longer meets eligibility criteria|0|||
156353653|NCT02554812|564392214|FG007|Overall Study|No longer meets eligibility criteria|0|||
156353654|NCT02554812|564392215|FG008|Overall Study|No longer meets eligibility criteria|0|||
156353655|NCT02554812|564392216|FG009|Overall Study|No longer meets eligibility criteria|0|||
156353656|NCT02554812|564392217|FG010|Overall Study|No longer meets eligibility criteria|0|||
156353657|NCT02554812|564392218|FG011|Overall Study|No longer meets eligibility criteria|0|||
156353658|NCT02554812|564392219|FG012|Overall Study|No longer meets eligibility criteria|0|||
156353659|NCT02554812|564392220|FG013|Overall Study|No longer meets eligibility criteria|0|||
156353660|NCT02554812|564392221|FG014|Overall Study|No longer meets eligibility criteria|0|||
156353661|NCT02554812|564392222|FG015|Overall Study|No longer meets eligibility criteria|0|||
156353662|NCT02554812|564392223|FG016|Overall Study|No longer meets eligibility criteria|0|||
156353663|NCT02554812|564392224|FG017|Overall Study|No longer meets eligibility criteria|0|||
156353664|NCT02554812|564392225|FG018|Overall Study|No longer meets eligibility criteria|0|||
156353665|NCT02554812|564392226|FG019|Overall Study|No longer meets eligibility criteria|0|||
156353666|NCT02554812|564392227|FG020|Overall Study|No longer meets eligibility criteria|0|||
156353667|NCT02554812|564392228|FG021|Overall Study|No longer meets eligibility criteria|0|||
156353668|NCT02554812|564392229|FG022|Overall Study|No longer meets eligibility criteria|0|||
156353669|NCT02554812|564392230|FG023|Overall Study|No longer meets eligibility criteria|0|||
156353670|NCT02554812|564392231|FG024|Overall Study|No longer meets eligibility criteria|0|||
156353671|NCT02554812|564392232|FG025|Overall Study|No longer meets eligibility criteria|0|||
156353672|NCT02554812|564392233|FG026|Overall Study|No longer meets eligibility criteria|0|||
156353673|NCT02879305|564392234|FG000|Overall Study|Investigator Site Closed|55|||
156353674|NCT02879305|564392235|FG001|Overall Study|Investigator Site Closed|57|||
156353675|NCT02879305|564392234|FG000|Overall Study|Withdrawal by Subject|44|||
156353676|NCT02879305|564392235|FG001|Overall Study|Withdrawal by Subject|42|||
156353677|NCT02879305|564392234|FG000|Overall Study|Lost to Follow-up|17|||
156353678|NCT02879305|564392235|FG001|Overall Study|Lost to Follow-up|12|||
156353679|NCT02879305|564392234|FG000|Overall Study|Other|1|||
156353680|NCT02879305|564392235|FG001|Overall Study|Other|0|||
156353681|NCT00670800|564393912|FG000|Overall Study|2 controls were insulin resistant|0|||
156353682|NCT00670800|564393913|FG001|Overall Study|2 controls were insulin resistant|2|||
156353683|NCT00936910|564393919|FG000|Overall Study|Lack of Efficacy|3|||
156353684|NCT03020407|564393921|FG000|Overall Study|Withdrawal by Subject|2|||
156353685|NCT03020407|564393922|FG001|Overall Study|Withdrawal by Subject|1|||
156353686|NCT03020407|564393921|FG000|Overall Study|Lost to Follow-up|2|||
156353687|NCT03020407|564393922|FG001|Overall Study|Lost to Follow-up|3|||
156353688|NCT03020407|564393921|FG000|Overall Study|Protocol Violation|0|||
156353689|NCT03020407|564393922|FG001|Overall Study|Protocol Violation|1|||
156353690|NCT02057198|564393923|FG000|Overall Study|Death|0|||
156353691|NCT02057198|564393924|FG001|Overall Study|Death|0|||
156353692|NCT02057198|564393925|FG002|Overall Study|Death|1|||
156353693|NCT02057198|564393923|FG000|Overall Study|Discharged early; lost to followup|0|||
156353694|NCT02057198|564393924|FG001|Overall Study|Discharged early; lost to followup|1|||
156353695|NCT02057198|564393925|FG002|Overall Study|Discharged early; lost to followup|0|||
156353696|NCT00065507|564393926|FG000|Overall Study|Death|16|||
156353697|NCT00065507|564393927|FG001|Overall Study|Death|17|||
156353698|NCT00065507|564393926|FG000|Overall Study|Adverse Event|4|||
156353699|NCT00065507|564393927|FG001|Overall Study|Adverse Event|3|||
156353700|NCT00065507|564393926|FG000|Overall Study|Lack of Efficacy|0|||
156353701|NCT00065507|564393927|FG001|Overall Study|Lack of Efficacy|6|||
156353702|NCT00065507|564393926|FG000|Overall Study|Poor/Non-compliance|3|||
156353703|NCT00065507|564393927|FG001|Overall Study|Poor/Non-compliance|2|||
156353704|NCT00065507|564393926|FG000|Overall Study|Lost to Follow-up|3|||
156353705|NCT00065507|564393927|FG001|Overall Study|Lost to Follow-up|0|||
156353706|NCT00065507|564393926|FG000|Overall Study|Subject Withdrew Consent|2|||
156353707|NCT00065507|564393927|FG001|Overall Study|Subject Withdrew Consent|1|||
156353708|NCT00065507|564393926|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
156353709|NCT00065507|564393927|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
156353710|NCT00350636|564393928|FG000|Overall Study|Adverse Event|19|||
156353711|NCT00350636|564393929|FG001|Overall Study|Adverse Event|13|||
156484697|NCT02660034|564867550|FG008|Overall Study|Lost to Follow-up|0|||
156484698|NCT02660034|564867551|FG009|Overall Study|Lost to Follow-up|1|||
156484699|NCT02660034|564867552|FG010|Overall Study|Lost to Follow-up|1|||
156353712|NCT00350636|564393928|FG000|Overall Study|Protocol Violation|1|||
156484700|NCT02660034|564867553|FG011|Overall Study|Lost to Follow-up|1|||
156353713|NCT00350636|564393929|FG001|Overall Study|Protocol Violation|3|||
156353714|NCT00350636|564393928|FG000|Overall Study|Withdrawal by Subject|13|||
156484701|NCT02660034|564867554|FG012|Overall Study|Lost to Follow-up|0|||
156484702|NCT02660034|564867555|FG013|Overall Study|Lost to Follow-up|0|||
156353715|NCT00350636|564393929|FG001|Overall Study|Withdrawal by Subject|17|||
156353716|NCT00350636|564393928|FG000|Overall Study|Lost to Follow-up|9|||
156353717|NCT00350636|564393929|FG001|Overall Study|Lost to Follow-up|8|||
156353718|NCT00350636|564393928|FG000|Overall Study|Physician Decision|0|||
156353719|NCT00350636|564393929|FG001|Overall Study|Physician Decision|2|||
156353720|NCT00350636|564393928|FG000|Overall Study|Other|1|||
156353721|NCT00350636|564393929|FG001|Overall Study|Other|2|||
156353722|NCT01647282|564393932|FG000|Overall Study|Physician Decision|7|||
156353723|NCT01647282|564393933|FG001|Overall Study|Physician Decision|5|||
156353724|NCT01042236|564393934|FG000|Treatment Period 1|Adverse Event|0|||
156353725|NCT01042236|564393935|FG001|Treatment Period 1|Adverse Event|1|||
156353726|NCT01042236|564393936|FG002|Treatment Period 1|Adverse Event|0|||
156353727|NCT01042236|564393937|FG003|Treatment Period 1|Adverse Event|0|||
156353728|NCT01042236|564393938|FG004|Treatment Period 1|Adverse Event|1|||
156353729|NCT01042236|564393939|FG005|Treatment Period 1|Adverse Event|0|||
156353730|NCT01042236|564393934|FG000|Treatment Period 3|Adverse Event|0|||
156353731|NCT01042236|564393935|FG001|Treatment Period 3|Adverse Event|0|||
156353732|NCT01042236|564393936|FG002|Treatment Period 3|Adverse Event|0|||
156353733|NCT01042236|564393937|FG003|Treatment Period 3|Adverse Event|1|||
156353734|NCT01042236|564393938|FG004|Treatment Period 3|Adverse Event|0|||
156353735|NCT01042236|564393939|FG005|Treatment Period 3|Adverse Event|0|||
156353736|NCT01042236|564393934|FG000|Treatment Period 3|Protocol Violation|0|||
156353737|NCT01042236|564393935|FG001|Treatment Period 3|Protocol Violation|0|||
156353738|NCT01042236|564393936|FG002|Treatment Period 3|Protocol Violation|0|||
156353739|NCT01042236|564393937|FG003|Treatment Period 3|Protocol Violation|1|||
156353740|NCT01042236|564393938|FG004|Treatment Period 3|Protocol Violation|0|||
156353741|NCT01042236|564393939|FG005|Treatment Period 3|Protocol Violation|0|||
156353742|NCT02632552|564393940|FG000|Overall Study|Lost to Follow-up|14|||
156353743|NCT02632552|564393941|FG001|Overall Study|Lost to Follow-up|8|||
156353744|NCT02632552|564393940|FG000|Overall Study|Withdrawal by Subject|2|||
156353745|NCT02632552|564393941|FG001|Overall Study|Withdrawal by Subject|0|||
156353746|NCT02632552|564393940|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
156353747|NCT02632552|564393941|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
156353748|NCT00546637|564393944|FG000|Overall Study|Adverse Event|46|||
156353749|NCT00546637|564393945|FG001|Overall Study|Adverse Event|20|||
156353750|NCT00546637|564393944|FG000|Overall Study|Lack of Efficacy|5|||
156353751|NCT00546637|564393945|FG001|Overall Study|Lack of Efficacy|5|||
156353752|NCT00546637|564393944|FG000|Overall Study|Lost to Follow-up|2|||
156353753|NCT00546637|564393945|FG001|Overall Study|Lost to Follow-up|2|||
156353754|NCT00546637|564393944|FG000|Overall Study|Other|10|||
156353755|NCT00546637|564393945|FG001|Overall Study|Other|12|||
156353756|NCT00546637|564393944|FG000|Overall Study|Withdrawal by Subject|7|||
156353757|NCT00546637|564393945|FG001|Overall Study|Withdrawal by Subject|9|||
156353758|NCT00546637|564393944|FG000|Overall Study|Randomized, but not treated|3|||
156353759|NCT00546637|564393945|FG001|Overall Study|Randomized, but not treated|1|||
156353760|NCT02611778|564393949|FG000|Overall Study|Withdrawal by Subject|2|||
156353761|NCT02611778|564393950|FG001|Overall Study|Withdrawal by Subject|8|||
156353762|NCT02611778|564393949|FG000|Overall Study|Adverse Event|1|||
156353763|NCT02611778|564393950|FG001|Overall Study|Adverse Event|2|||
156353764|NCT02611778|564393949|FG000|Overall Study|Death|2|||
156353765|NCT02611778|564393950|FG001|Overall Study|Death|1|||
156353766|NCT02611778|564393949|FG000|Overall Study|Protocol Violation|1|||
156353767|NCT02611778|564393950|FG001|Overall Study|Protocol Violation|0|||
156353768|NCT02611778|564393949|FG000|Overall Study|Lost to Follow-up|3|||
156353769|NCT02611778|564393950|FG001|Overall Study|Lost to Follow-up|1|||
156353770|NCT02611778|564393949|FG000|Overall Study|Need for alternative treatment|1|||
156353771|NCT02611778|564393950|FG001|Overall Study|Need for alternative treatment|0|||
156353772|NCT02611778|564393949|FG000|Overall Study|Other Reason|2|||
156353773|NCT02611778|564393950|FG001|Overall Study|Other Reason|1|||
156353774|NCT02968563|564393951|FG000|Overall Study|Adverse Event|0|||
156353775|NCT02968563|564393952|FG001|Overall Study|Adverse Event|6|||
156353776|NCT02968563|564393951|FG000|Overall Study|Death|1|||
156353777|NCT02968563|564393952|FG001|Overall Study|Death|1|||
156353778|NCT02968563|564393951|FG000|Overall Study|Lost to Follow-up|0|||
156353779|NCT02968563|564393952|FG001|Overall Study|Lost to Follow-up|1|||
156353780|NCT03108027|564393961|FG000|Period 1|Subject/Guardian Decision|0|||
156353781|NCT03108027|564393962|FG001|Period 1|Subject/Guardian Decision|0|||
156353782|NCT03108027|564393963|FG002|Period 1|Subject/Guardian Decision|0|||
156353783|NCT03108027|564393964|FG003|Period 1|Subject/Guardian Decision|2|||
156353784|NCT03108027|564393965|FG004|Period 1|Subject/Guardian Decision|0|||
156353785|NCT03108027|564393966|FG005|Period 1|Subject/Guardian Decision|0|||
156353786|NCT03108027|564393961|FG000|Period 3|Adverse Event|0|||
156353787|NCT03108027|564393962|FG001|Period 3|Adverse Event|1|||
156353788|NCT03108027|564393963|FG002|Period 3|Adverse Event|0|||
156353789|NCT03108027|564393964|FG003|Period 3|Adverse Event|0|||
156353790|NCT03108027|564393965|FG004|Period 3|Adverse Event|0|||
156353791|NCT03108027|564393966|FG005|Period 3|Adverse Event|0|||
156353792|NCT00003901|564393967|FG000|Overall Study|Adverse Event|1|||
156353793|NCT00003901|564393967|FG000|Overall Study|Withdrawal by Subject|1|||
156353794|NCT00003901|564393967|FG000|Overall Study|Ineligible|6|||
156353795|NCT00003901|564393967|FG000|Overall Study|CT Scan not within protocol requirement|2|||
156353796|NCT00003901|564393967|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
156353797|NCT00003901|564393967|FG000|Overall Study|Medical problems|6|||
156353798|NCT00268996|564393970|FG000|Overall Study|Adverse Event|11|||
156353799|NCT00268996|564393971|FG001|Overall Study|Adverse Event|7|||
156353800|NCT00268996|564393970|FG000|Overall Study|Lost to Follow-up|3|||
156353801|NCT00268996|564393971|FG001|Overall Study|Lost to Follow-up|1|||
156353802|NCT00268996|564393970|FG000|Overall Study|Withdrawal by Subject|5|||
156353803|NCT00268996|564393971|FG001|Overall Study|Withdrawal by Subject|11|||
156353804|NCT00268996|564393970|FG000|Overall Study|Non-compliance|1|||
156353805|NCT00268996|564393971|FG001|Overall Study|Non-compliance|0|||
156353806|NCT00268996|564393970|FG000|Overall Study|Other|1|||
156353807|NCT00268996|564393971|FG001|Overall Study|Other|1|||
156353808|NCT03325075|564393973|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
156353809|NCT03325075|564393974|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
156353810|NCT03325075|564393975|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
156353811|NCT03325075|564393976|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
156353812|NCT03325075|564393973|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
156353813|NCT03325075|564393974|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
156353814|NCT03325075|564393975|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
156353815|NCT03325075|564393976|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
156353816|NCT03325075|564393973|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
156353817|NCT03325075|564393974|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
156353818|NCT03325075|564393975|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
156353819|NCT03325075|564393976|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
156353820|NCT00422591|564393977|FG000|Overall Study|Physician Decision|4|||
156353821|NCT00422591|564393977|FG000|Overall Study|Withdrawal by Subject|2|||
156353822|NCT00495170|564393980|FG000|Overall Study|Lost to Follow-up|9|||
156353823|NCT00495170|564393980|FG000|Overall Study|Withdrawal by Subject|3|||
156353824|NCT00495170|564393980|FG000|Overall Study|Inappropriate staging|8|||
156353825|NCT04210310|564393981|FG000|Overall Study|Lost to Follow-up|32|||
156353826|NCT04210310|564393982|FG001|Overall Study|Lost to Follow-up|1|||
156353827|NCT04191499|564393983|FG000|Overall Study|Adverse Event|1|||
156353828|NCT04191499|564393984|FG001|Overall Study|Adverse Event|0|||
156353829|NCT04191499|564393983|FG000|Overall Study|Death|42|||
156353830|NCT04191499|564393984|FG001|Overall Study|Death|55|||
156353831|NCT04191499|564393983|FG000|Overall Study|Lost to Follow-up|4|||
156353832|NCT04191499|564393984|FG001|Overall Study|Lost to Follow-up|1|||
156353833|NCT04191499|564393983|FG000|Overall Study|Physician Decision|1|||
156353834|NCT04191499|564393984|FG001|Overall Study|Physician Decision|0|||
156353835|NCT04191499|564393983|FG000|Overall Study|Progressive Disease|1|||
156353836|NCT04191499|564393984|FG001|Overall Study|Progressive Disease|0|||
156353837|NCT04191499|564393983|FG000|Overall Study|Symptomatic Deterioration|1|||
156353838|NCT04191499|564393984|FG001|Overall Study|Symptomatic Deterioration|0|||
156353839|NCT04191499|564393983|FG000|Overall Study|Withdrawal by Subject|7|||
156484703|NCT02660034|564867542|FG000|Overall Study|Participant moved into special access scheme|1|||
156484704|NCT02660034|564867543|FG001|Overall Study|Participant moved into special access scheme|2|||
156353840|NCT04191499|564393984|FG001|Overall Study|Withdrawal by Subject|11|||
156353841|NCT04191499|564393983|FG000|Overall Study|Ongoing in the study|104|||
156353842|NCT04191499|564393984|FG001|Overall Study|Ongoing in the study|97|||
156353843|NCT01928329|564393985|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
156353844|NCT01928329|564393986|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
156353845|NCT01928329|564393985|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
156353846|NCT01928329|564393986|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
156484705|NCT02660034|564867544|FG002|Overall Study|Participant moved into special access scheme|0|||
156353847|NCT01928329|564393985|FG000|Overall Study|Adverse Event|5|||
156353848|NCT01928329|564393986|FG001|Overall Study|Adverse Event|3|||
156353849|NCT01928329|564393985|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
156353850|NCT01928329|564393986|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
156353851|NCT01928329|564393985|FG000|Overall Study|Withdrawal by Subject|1|||
156353852|NCT01928329|564393986|FG001|Overall Study|Withdrawal by Subject|5|||
156484706|NCT02660034|564867545|FG003|Overall Study|Participant moved into special access scheme|0|||
156484707|NCT02660034|564867546|FG004|Overall Study|Participant moved into special access scheme|0|||
156353853|NCT01928329|564393985|FG000|Overall Study|Physician Decision|1|||
156353854|NCT01928329|564393986|FG001|Overall Study|Physician Decision|1|||
156353855|NCT00330616|564393987|FG000|Overall Study|Adverse Event|13|||
156353856|NCT00330616|564393987|FG000|Overall Study|Lack of Efficacy|1|||
156353857|NCT00330616|564393987|FG000|Overall Study|Lost to Follow-up|2|||
156353858|NCT00330616|564393987|FG000|Overall Study|Withdrawal by Subject|4|||
156353859|NCT00330616|564393987|FG000|Overall Study|Other|1|||
156353860|NCT02141997|564393992|FG000|Overall Study|Adverse Event|0|||
156353861|NCT02141997|564393993|FG001|Overall Study|Adverse Event|2|||
156353862|NCT02141997|564393994|FG002|Overall Study|Adverse Event|0|||
156353863|NCT02141997|564393995|FG003|Overall Study|Adverse Event|1|||
156353864|NCT02141997|564393992|FG000|Overall Study|Participant noncompliance|1|||
156353865|NCT02141997|564393993|FG001|Overall Study|Participant noncompliance|0|||
156353866|NCT02141997|564393994|FG002|Overall Study|Participant noncompliance|0|||
156353867|NCT02141997|564393995|FG003|Overall Study|Participant noncompliance|0|||
156353868|NCT02141997|564393992|FG000|Overall Study|Withdrew consent|1|||
156353869|NCT02141997|564393993|FG001|Overall Study|Withdrew consent|0|||
156353870|NCT02141997|564393994|FG002|Overall Study|Withdrew consent|3|||
156353871|NCT02141997|564393995|FG003|Overall Study|Withdrew consent|0|||
156353872|NCT02141997|564393992|FG000|Overall Study|Other|1|||
156353873|NCT02141997|564393993|FG001|Overall Study|Other|4|||
156353874|NCT02141997|564393994|FG002|Overall Study|Other|0|||
156353875|NCT02141997|564393995|FG003|Overall Study|Other|0|||
156353876|NCT00597766|564394001|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
156353877|NCT00597766|564394002|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
156353878|NCT00597766|564394003|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
156353879|NCT00597766|564394001|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
156353880|NCT00597766|564394002|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
156353881|NCT00597766|564394003|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
156353882|NCT01166763|564394004|FG000|Overall Study|Withdrawal by Subject|3|||
156353883|NCT01528254|564394005|FG000|Overall Study|Administrative problems|96|||
156353884|NCT01528254|564394006|FG001|Overall Study|Administrative problems|94|||
156353885|NCT01528254|564394005|FG000|Overall Study|Adverse Event|28|||
156353886|NCT01528254|564394006|FG001|Overall Study|Adverse Event|44|||
156353887|NCT01528254|564394005|FG000|Overall Study|Lost to Follow-up|17|||
156353888|NCT01528254|564394006|FG001|Overall Study|Lost to Follow-up|24|||
156353889|NCT01528254|564394005|FG000|Overall Study|Death|13|||
156353890|NCT01528254|564394006|FG001|Overall Study|Death|9|||
156353891|NCT01528254|564394005|FG000|Overall Study|Protocol deviation|9|||
156353892|NCT01528254|564394006|FG001|Overall Study|Protocol deviation|19|||
156353893|NCT01528254|564394005|FG000|Overall Study|New therapy for study indication|8|||
156353894|NCT01528254|564394006|FG001|Overall Study|New therapy for study indication|6|||
156353895|NCT01528254|564394005|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
156353896|NCT01528254|564394006|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
156353897|NCT01528254|564394005|FG000|Overall Study|Withdrawal by Subject|5|||
156353898|NCT01528254|564394006|FG001|Overall Study|Withdrawal by Subject|4|||
156353899|NCT01528254|564394005|FG000|Overall Study|Abnormal laboratory value(s)|3|||
156353900|NCT01528254|564394006|FG001|Overall Study|Abnormal laboratory value(s)|7|||
156353901|NCT01528254|564394005|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156353902|NCT01528254|564394006|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156353903|NCT01528254|564394005|FG000|Overall Study|No longer requires study drug|1|||
156353904|NCT01528254|564394006|FG001|Overall Study|No longer requires study drug|1|||
156353905|NCT01909479|564394007|FG000|From Baseline to Week 26|Adverse Event|3|||
156353906|NCT01909479|564394008|FG001|From Baseline to Week 26|Adverse Event|2|||
156353907|NCT01909479|564394007|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
156353908|NCT01909479|564394008|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
156353909|NCT01909479|564394007|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
156353910|NCT01909479|564394008|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
156353911|NCT01909479|564394007|FG000|26 - 52 Weeks|Adverse Event|0|||
156353912|NCT01909479|564394008|FG001|26 - 52 Weeks|Adverse Event|1|||
156353913|NCT01909479|564394007|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
156353914|NCT01909479|564394008|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
156353915|NCT01909479|564394007|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
156353916|NCT01909479|564394008|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
156353917|NCT01909479|564394007|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
156353918|NCT01909479|564394008|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
156353919|NCT01909479|564394007|FG000|52 Weeks to End of Study|Adverse Event|2|||
156353920|NCT01909479|564394008|FG001|52 Weeks to End of Study|Adverse Event|1|||
156353921|NCT01909479|564394007|FG000|52 Weeks to End of Study|Death|0|||
156353922|NCT01909479|564394008|FG001|52 Weeks to End of Study|Death|1|||
156353923|NCT01909479|564394007|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
156353924|NCT01909479|564394008|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
156353925|NCT01909479|564394007|FG000|52 Weeks to End of Study|Protocol Violation|1|||
156353926|NCT01909479|564394008|FG001|52 Weeks to End of Study|Protocol Violation|0|||
156353927|NCT01909479|564394007|FG000|52 Weeks to End of Study|Progressive disease|1|||
156353928|NCT01909479|564394008|FG001|52 Weeks to End of Study|Progressive disease|1|||
156353929|NCT01909479|564394007|FG000|52 Weeks to End of Study|Personal reasons|2|||
156353930|NCT01909479|564394008|FG001|52 Weeks to End of Study|Personal reasons|1|||
156353931|NCT01909479|564394007|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
156353932|NCT01909479|564394008|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
156353933|NCT01909479|564394007|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
156353934|NCT01909479|564394008|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
156353935|NCT01909479|564394007|FG000|52 Weeks to End of Study|Lack of contact|1|||
156353936|NCT01909479|564394008|FG001|52 Weeks to End of Study|Lack of contact|0|||
156353937|NCT01909479|564394007|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
156353938|NCT01909479|564394008|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
156353939|NCT01909479|564394007|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
156353940|NCT01909479|564394008|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
156353941|NCT02049957|564394013|FG000|Overall Study|Progressive Disease|5|||
156544382|NCT03200366|565087763|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
156544383|NCT03200366|565087764|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
156544384|NCT03200366|565087762|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
156544385|NCT03200366|565087763|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
156544386|NCT03200366|565087764|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
156544387|NCT03200366|565087762|FG000|6 Month Post-Baseline Interview|Death|1|||
156544388|NCT03200366|565087763|FG001|6 Month Post-Baseline Interview|Death|1|||
156544389|NCT03200366|565087764|FG002|6 Month Post-Baseline Interview|Death|1|||
156544390|NCT03200366|565087762|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
156544391|NCT03200366|565087763|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
156544392|NCT03200366|565087764|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
156544393|NCT03200366|565087762|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
156544394|NCT03200366|565087763|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
156544395|NCT03200366|565087764|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
156544396|NCT03200366|565087762|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
156544397|NCT03200366|565087763|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
156544398|NCT03200366|565087764|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
156544399|NCT03200366|565087762|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
156544400|NCT03200366|565087763|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
156544401|NCT03200366|565087764|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
156544402|NCT03200366|565087762|FG000|9 Month Post-Baseline Interview|Death|1|||
156544403|NCT03200366|565087763|FG001|9 Month Post-Baseline Interview|Death|1|||
156353942|NCT02049957|564394014|FG001|Overall Study|Progressive Disease|4|||
156353943|NCT02049957|564394015|FG002|Overall Study|Progressive Disease|2|||
156353944|NCT02049957|564394016|FG003|Overall Study|Progressive Disease|2|||
156353945|NCT02049957|564394017|FG004|Overall Study|Progressive Disease|6|||
156353946|NCT02049957|564394018|FG005|Overall Study|Progressive Disease|35|||
156353947|NCT02049957|564394019|FG006|Overall Study|Progressive Disease|7|||
156353948|NCT02049957|564394020|FG007|Overall Study|Progressive Disease|26|||
156353949|NCT02049957|564394021|FG008|Overall Study|Progressive Disease|6|||
156353950|NCT02049957|564394013|FG000|Overall Study|Adverse Event|1|||
156353951|NCT02049957|564394014|FG001|Overall Study|Adverse Event|1|||
156353952|NCT02049957|564394015|FG002|Overall Study|Adverse Event|1|||
156353953|NCT02049957|564394016|FG003|Overall Study|Adverse Event|0|||
156353954|NCT02049957|564394017|FG004|Overall Study|Adverse Event|0|||
156353955|NCT02049957|564394018|FG005|Overall Study|Adverse Event|5|||
156353956|NCT02049957|564394019|FG006|Overall Study|Adverse Event|0|||
156353957|NCT02049957|564394020|FG007|Overall Study|Adverse Event|6|||
156353958|NCT02049957|564394021|FG008|Overall Study|Adverse Event|1|||
156353959|NCT02049957|564394013|FG000|Overall Study|Study Terminated by Sponsor|0|||
156353960|NCT02049957|564394014|FG001|Overall Study|Study Terminated by Sponsor|1|||
156353961|NCT02049957|564394015|FG002|Overall Study|Study Terminated by Sponsor|0|||
156353962|NCT02049957|564394016|FG003|Overall Study|Study Terminated by Sponsor|0|||
156353963|NCT02049957|564394017|FG004|Overall Study|Study Terminated by Sponsor|0|||
156353964|NCT02049957|564394018|FG005|Overall Study|Study Terminated by Sponsor|0|||
156353965|NCT02049957|564394019|FG006|Overall Study|Study Terminated by Sponsor|1|||
156353966|NCT02049957|564394020|FG007|Overall Study|Study Terminated by Sponsor|0|||
156353967|NCT02049957|564394021|FG008|Overall Study|Study Terminated by Sponsor|0|||
156353968|NCT02049957|564394013|FG000|Overall Study|Withdrawal by Subject|0|||
156353969|NCT02049957|564394014|FG001|Overall Study|Withdrawal by Subject|0|||
156353970|NCT02049957|564394015|FG002|Overall Study|Withdrawal by Subject|0|||
156353971|NCT02049957|564394016|FG003|Overall Study|Withdrawal by Subject|1|||
156353972|NCT02049957|564394017|FG004|Overall Study|Withdrawal by Subject|0|||
156353973|NCT02049957|564394018|FG005|Overall Study|Withdrawal by Subject|2|||
156353974|NCT02049957|564394019|FG006|Overall Study|Withdrawal by Subject|0|||
156353975|NCT02049957|564394020|FG007|Overall Study|Withdrawal by Subject|3|||
156353976|NCT02049957|564394021|FG008|Overall Study|Withdrawal by Subject|1|||
156353977|NCT02049957|564394013|FG000|Overall Study|Physician Decision|0|||
156353978|NCT02049957|564394014|FG001|Overall Study|Physician Decision|0|||
156353979|NCT02049957|564394015|FG002|Overall Study|Physician Decision|0|||
156353980|NCT02049957|564394016|FG003|Overall Study|Physician Decision|0|||
156353981|NCT02049957|564394017|FG004|Overall Study|Physician Decision|0|||
156484708|NCT02660034|564867547|FG005|Overall Study|Participant moved into special access scheme|0|||
156484709|NCT02660034|564867548|FG006|Overall Study|Participant moved into special access scheme|0|||
156484710|NCT02660034|564867549|FG007|Overall Study|Participant moved into special access scheme|0|||
156484711|NCT02660034|564867550|FG008|Overall Study|Participant moved into special access scheme|0|||
156484712|NCT02660034|564867551|FG009|Overall Study|Participant moved into special access scheme|0|||
156484713|NCT02660034|564867552|FG010|Overall Study|Participant moved into special access scheme|0|||
156484714|NCT02660034|564867553|FG011|Overall Study|Participant moved into special access scheme|0|||
156484715|NCT02660034|564867554|FG012|Overall Study|Participant moved into special access scheme|0|||
156484716|NCT02660034|564867555|FG013|Overall Study|Participant moved into special access scheme|0|||
156484717|NCT02660034|564867542|FG000|Overall Study|Adverse Event|1|||
156484718|NCT02660034|564867543|FG001|Overall Study|Adverse Event|0|||
156484719|NCT02660034|564867544|FG002|Overall Study|Adverse Event|0|||
156484720|NCT02660034|564867545|FG003|Overall Study|Adverse Event|0|||
156484721|NCT02660034|564867546|FG004|Overall Study|Adverse Event|0|||
156484722|NCT02660034|564867547|FG005|Overall Study|Adverse Event|0|||
156484723|NCT02660034|564867548|FG006|Overall Study|Adverse Event|0|||
156484724|NCT02660034|564867549|FG007|Overall Study|Adverse Event|0|||
156484725|NCT02660034|564867550|FG008|Overall Study|Adverse Event|0|||
156484726|NCT02660034|564867551|FG009|Overall Study|Adverse Event|0|||
156484727|NCT02660034|564867552|FG010|Overall Study|Adverse Event|0|||
156484728|NCT02660034|564867553|FG011|Overall Study|Adverse Event|0|||
156484729|NCT02660034|564867554|FG012|Overall Study|Adverse Event|0|||
156484730|NCT02660034|564867555|FG013|Overall Study|Adverse Event|0|||
156484731|NCT02660034|564867542|FG000|Overall Study|Sponsor Decision|0|||
156484732|NCT02660034|564867543|FG001|Overall Study|Sponsor Decision|1|||
156484733|NCT02660034|564867544|FG002|Overall Study|Sponsor Decision|2|||
156484734|NCT02660034|564867545|FG003|Overall Study|Sponsor Decision|2|||
156484735|NCT02660034|564867546|FG004|Overall Study|Sponsor Decision|3|||
156484736|NCT02660034|564867547|FG005|Overall Study|Sponsor Decision|0|||
156353982|NCT02049957|564394018|FG005|Overall Study|Physician Decision|1|||
156353983|NCT02049957|564394019|FG006|Overall Study|Physician Decision|0|||
156353984|NCT02049957|564394020|FG007|Overall Study|Physician Decision|0|||
156353985|NCT02049957|564394021|FG008|Overall Study|Physician Decision|0|||
156353986|NCT03557151|564394022|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
156353987|NCT03557151|564394023|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
156484737|NCT02660034|564867548|FG006|Overall Study|Sponsor Decision|0|||
156484738|NCT02660034|564867549|FG007|Overall Study|Sponsor Decision|0|||
156484739|NCT02660034|564867550|FG008|Overall Study|Sponsor Decision|0|||
156484740|NCT02660034|564867551|FG009|Overall Study|Sponsor Decision|0|||
156484741|NCT02660034|564867552|FG010|Overall Study|Sponsor Decision|0|||
156484742|NCT02660034|564867553|FG011|Overall Study|Sponsor Decision|0|||
156484743|NCT02660034|564867554|FG012|Overall Study|Sponsor Decision|0|||
156484744|NCT02660034|564867555|FG013|Overall Study|Sponsor Decision|1|||
156484745|NCT02660034|564867542|FG000|Overall Study|Withdrawal by Subject|0|||
156484746|NCT02660034|564867543|FG001|Overall Study|Withdrawal by Subject|0|||
156484747|NCT02660034|564867544|FG002|Overall Study|Withdrawal by Subject|0|||
156484748|NCT02660034|564867545|FG003|Overall Study|Withdrawal by Subject|0|||
156484749|NCT02660034|564867546|FG004|Overall Study|Withdrawal by Subject|0|||
156484750|NCT02660034|564867547|FG005|Overall Study|Withdrawal by Subject|0|||
156484751|NCT02660034|564867548|FG006|Overall Study|Withdrawal by Subject|1|||
156484752|NCT02660034|564867549|FG007|Overall Study|Withdrawal by Subject|1|||
156484753|NCT02660034|564867550|FG008|Overall Study|Withdrawal by Subject|1|||
156484754|NCT02660034|564867551|FG009|Overall Study|Withdrawal by Subject|0|||
156484755|NCT02660034|564867552|FG010|Overall Study|Withdrawal by Subject|0|||
156484756|NCT02660034|564867553|FG011|Overall Study|Withdrawal by Subject|1|||
156484757|NCT02660034|564867554|FG012|Overall Study|Withdrawal by Subject|2|||
156484758|NCT02660034|564867555|FG013|Overall Study|Withdrawal by Subject|0|||
156484759|NCT02660034|564867542|FG000|Overall Study|Death|0|||
156484760|NCT02660034|564867543|FG001|Overall Study|Death|0|||
156484761|NCT02660034|564867544|FG002|Overall Study|Death|0|||
156484762|NCT02660034|564867545|FG003|Overall Study|Death|0|||
156484763|NCT02660034|564867546|FG004|Overall Study|Death|0|||
156484764|NCT02660034|564867547|FG005|Overall Study|Death|13|||
156484765|NCT02660034|564867548|FG006|Overall Study|Death|14|||
156484766|NCT02660034|564867549|FG007|Overall Study|Death|10|||
156484767|NCT02660034|564867550|FG008|Overall Study|Death|9|||
156484768|NCT02660034|564867551|FG009|Overall Study|Death|21|||
156484769|NCT02660034|564867552|FG010|Overall Study|Death|17|||
156484770|NCT02660034|564867553|FG011|Overall Study|Death|15|||
156484771|NCT02660034|564867554|FG012|Overall Study|Death|18|||
156484772|NCT02660034|564867555|FG013|Overall Study|Death|7|||
156484773|NCT02660034|564867542|FG000|Overall Study|Physician Decision|0|||
156484774|NCT02660034|564867543|FG001|Overall Study|Physician Decision|0|||
156484775|NCT02660034|564867544|FG002|Overall Study|Physician Decision|0|||
156484776|NCT02660034|564867545|FG003|Overall Study|Physician Decision|0|||
156484777|NCT02660034|564867546|FG004|Overall Study|Physician Decision|0|||
156484778|NCT02660034|564867547|FG005|Overall Study|Physician Decision|0|||
156484779|NCT02660034|564867548|FG006|Overall Study|Physician Decision|0|||
156484780|NCT02660034|564867549|FG007|Overall Study|Physician Decision|0|||
156484781|NCT02660034|564867550|FG008|Overall Study|Physician Decision|0|||
156484782|NCT02660034|564867551|FG009|Overall Study|Physician Decision|0|||
156484783|NCT02660034|564867552|FG010|Overall Study|Physician Decision|0|||
156484784|NCT02660034|564867553|FG011|Overall Study|Physician Decision|0|||
156484785|NCT02660034|564867554|FG012|Overall Study|Physician Decision|0|||
156484786|NCT02660034|564867555|FG013|Overall Study|Physician Decision|1|||
156484787|NCT02660034|564867542|FG000|Overall Study|Participants transferred to LTE|0|||
156484788|NCT02660034|564867543|FG001|Overall Study|Participants transferred to LTE|0|||
156484789|NCT02660034|564867544|FG002|Overall Study|Participants transferred to LTE|0|||
156484790|NCT02660034|564867545|FG003|Overall Study|Participants transferred to LTE|0|||
156484791|NCT02660034|564867546|FG004|Overall Study|Participants transferred to LTE|0|||
156484792|NCT02660034|564867547|FG005|Overall Study|Participants transferred to LTE|10|||
156484793|NCT02660034|564867548|FG006|Overall Study|Participants transferred to LTE|8|||
156484794|NCT02660034|564867549|FG007|Overall Study|Participants transferred to LTE|8|||
156484795|NCT02660034|564867550|FG008|Overall Study|Participants transferred to LTE|10|||
156484796|NCT02660034|564867551|FG009|Overall Study|Participants transferred to LTE|1|||
156484797|NCT02660034|564867552|FG010|Overall Study|Participants transferred to LTE|2|||
156484798|NCT02660034|564867553|FG011|Overall Study|Participants transferred to LTE|4|||
156484799|NCT02660034|564867554|FG012|Overall Study|Participants transferred to LTE|1|||
156484800|NCT02660034|564867555|FG013|Overall Study|Participants transferred to LTE|1|||
156484801|NCT02995733|564867558|FG000|Overall Study|Study site closed|9|||
156484802|NCT02995733|564867559|FG001|Overall Study|Study site closed|10|||
156484803|NCT02995733|564867558|FG000|Overall Study|Death|3|||
156484804|NCT02995733|564867559|FG001|Overall Study|Death|4|||
156484805|NCT02995733|564867558|FG000|Overall Study|Withdrawal by Subject|6|||
156484806|NCT02995733|564867559|FG001|Overall Study|Withdrawal by Subject|2|||
156484807|NCT02995733|564867558|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
156484808|NCT02995733|564867559|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
156484809|NCT02995733|564867558|FG000|Overall Study|Lost to Follow-up|48|||
156484810|NCT02995733|564867559|FG001|Overall Study|Lost to Follow-up|37|||
156484811|NCT02995733|564867558|FG000|Overall Study|Other|0|||
156484812|NCT02995733|564867559|FG001|Overall Study|Other|1|||
156484813|NCT02720198|564867560|FG000|Overall Study|Withdrawal by Subject|0|||
156484814|NCT02720198|564867561|FG001|Overall Study|Withdrawal by Subject|1|||
156484815|NCT04879823|564867562|FG000|Overall Study|Physician Decision|3|||
156484816|NCT04879823|564867563|FG001|Overall Study|Physician Decision|1|||
156484817|NCT04879823|564867562|FG000|Overall Study|Protocol Violation|2|||
156484818|NCT04879823|564867563|FG001|Overall Study|Protocol Violation|3|||
156484819|NCT04879823|564867562|FG000|Overall Study|Lost to Follow-up|43|||
156484820|NCT04879823|564867563|FG001|Overall Study|Lost to Follow-up|35|||
156484821|NCT02592434|564867564|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
156484822|NCT02592434|564867565|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
156484823|NCT02592434|564867566|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
156484824|NCT02592434|564867564|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
156484825|NCT02592434|564867565|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
156484826|NCT02592434|564867566|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
156484827|NCT02592434|564867564|FG000|Open-Label Phase (18 Weeks)|Other|3|||
156484828|NCT02592434|564867565|FG001|Open-Label Phase (18 Weeks)|Other|0|||
156484829|NCT02592434|564867566|FG002|Open-Label Phase (18 Weeks)|Other|0|||
156484830|NCT02592434|564867564|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
156484831|NCT02592434|564867565|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
156484832|NCT02592434|564867566|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
156484833|NCT02592434|564867564|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
156484834|NCT02592434|564867565|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
156484835|NCT02592434|564867566|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
156484836|NCT02592434|564867564|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
156484837|NCT02592434|564867565|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
156484838|NCT02592434|564867566|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
156484839|NCT02592434|564867564|FG000|Double Blind Phase (26 Weeks)|Other|0|||
156484840|NCT02592434|564867565|FG001|Double Blind Phase (26 Weeks)|Other|1|||
156484841|NCT02592434|564867566|FG002|Double Blind Phase (26 Weeks)|Other|0|||
156484842|NCT02592434|564867564|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
156484843|NCT02592434|564867565|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
156484844|NCT02592434|564867566|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
156484845|NCT02592434|564867564|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
156484846|NCT02592434|564867565|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
156484847|NCT02592434|564867566|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
156484848|NCT02592434|564867564|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
156484849|NCT02592434|564867565|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
156484850|NCT02592434|564867566|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
156484851|NCT00472199|564867567|FG000|Overall Study|Adverse Event|19|||
156484852|NCT00472199|564867568|FG001|Overall Study|Adverse Event|23|||
156484853|NCT00472199|564867567|FG000|Overall Study|Lack of Efficacy|4|||
156484854|NCT00472199|564867568|FG001|Overall Study|Lack of Efficacy|25|||
156484855|NCT00472199|564867567|FG000|Overall Study|Lost to Follow-up|2|||
156484856|NCT00472199|564867568|FG001|Overall Study|Lost to Follow-up|4|||
156484857|NCT00472199|564867567|FG000|Overall Study|Protocol Violation|3|||
156484858|NCT00472199|564867568|FG001|Overall Study|Protocol Violation|2|||
156484859|NCT00472199|564867567|FG000|Overall Study|Withdrawal by Subject|6|||
156484860|NCT00472199|564867568|FG001|Overall Study|Withdrawal by Subject|5|||
156484861|NCT00472199|564867567|FG000|Overall Study|personal reason|0|||
156484862|NCT00472199|564867568|FG001|Overall Study|personal reason|1|||
156484863|NCT00472199|564867567|FG000|Overall Study|patient was asymptomatic|1|||
156484864|NCT00472199|564867568|FG001|Overall Study|patient was asymptomatic|0|||
156484865|NCT01106586|564867570|FG000|Overall Study|Adverse Event|9|||
156484866|NCT01106586|564867571|FG001|Overall Study|Adverse Event|15|||
156484867|NCT01106586|564867570|FG000|Overall Study|Death|1|||
156484868|NCT01106586|564867571|FG001|Overall Study|Death|3|||
156484869|NCT01106586|564867570|FG000|Overall Study|Pregnancy|2|||
156484870|NCT01106586|564867571|FG001|Overall Study|Pregnancy|2|||
156484871|NCT01106586|564867570|FG000|Overall Study|Lack of Efficacy|1|||
156484872|NCT01106586|564867571|FG001|Overall Study|Lack of Efficacy|0|||
156484873|NCT01106586|564867570|FG000|Overall Study|Investigator's Discretion|5|||
156484874|NCT01106586|564867571|FG001|Overall Study|Investigator's Discretion|8|||
156484875|NCT01106586|564867570|FG000|Overall Study|Withdrew Consent|18|||
156484876|NCT01106586|564867571|FG001|Overall Study|Withdrew Consent|30|||
156484877|NCT01106586|564867570|FG000|Overall Study|Lost to Follow-up|24|||
156484878|NCT01106586|564867571|FG001|Overall Study|Lost to Follow-up|20|||
156484879|NCT01106586|564867570|FG000|Overall Study|Participant Noncompliance|12|||
156484880|NCT01106586|564867571|FG001|Overall Study|Participant Noncompliance|10|||
156484881|NCT01106586|564867570|FG000|Overall Study|Protocol Violation|1|||
156484882|NCT01106586|564867571|FG001|Overall Study|Protocol Violation|0|||
156484883|NCT01106586|564867570|FG000|Overall Study|Participant Transferred to Another Study|212|||
156484884|NCT01106586|564867571|FG001|Overall Study|Participant Transferred to Another Study|197|||
156484885|NCT00105521|564867572|FG000|Overall Study|Other|1|||
156484886|NCT00105521|564867573|FG001|Overall Study|Other|1|||
156484887|NCT00105521|564867574|FG002|Overall Study|Other|2|||
156484888|NCT00105521|564867575|FG003|Overall Study|Other|0|||
156484889|NCT00105521|564867572|FG000|Overall Study|Adverse Event|10|||
156484890|NCT00105521|564867573|FG001|Overall Study|Adverse Event|4|||
156484891|NCT00105521|564867574|FG002|Overall Study|Adverse Event|10|||
156484892|NCT00105521|564867575|FG003|Overall Study|Adverse Event|8|||
156484893|NCT00105521|564867572|FG000|Overall Study|Withdrawal by Subject|1|||
156484894|NCT00105521|564867573|FG001|Overall Study|Withdrawal by Subject|0|||
156484895|NCT00105521|564867574|FG002|Overall Study|Withdrawal by Subject|1|||
156484896|NCT00105521|564867575|FG003|Overall Study|Withdrawal by Subject|4|||
156484897|NCT00105521|564867572|FG000|Overall Study|Lack of Efficacy|0|||
156484898|NCT00105521|564867573|FG001|Overall Study|Lack of Efficacy|0|||
156484899|NCT00105521|564867574|FG002|Overall Study|Lack of Efficacy|0|||
156353988|NCT03557151|564394022|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
156484900|NCT00105521|564867575|FG003|Overall Study|Lack of Efficacy|1|||
156484901|NCT00105521|564867572|FG000|Overall Study|Protocol Violation|3|||
156484902|NCT00105521|564867573|FG001|Overall Study|Protocol Violation|5|||
156484903|NCT00105521|564867574|FG002|Overall Study|Protocol Violation|4|||
156484904|NCT00105521|564867575|FG003|Overall Study|Protocol Violation|4|||
156484905|NCT00105521|564867572|FG000|Overall Study|Lost to Follow-up|0|||
156484906|NCT00105521|564867573|FG001|Overall Study|Lost to Follow-up|1|||
156484907|NCT00105521|564867574|FG002|Overall Study|Lost to Follow-up|0|||
156484908|NCT00105521|564867575|FG003|Overall Study|Lost to Follow-up|0|||
156484909|NCT03045302|564867581|FG000|Overall Study|Pre-treatment adverse event|1|||
156484910|NCT00134056|564867582|FG000|Randomization|Not eligible for assigned treatment|22|||
156484911|NCT00134056|564867583|FG001|Randomization|Not eligible for assigned treatment|20|||
156484912|NCT00134056|564867582|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
156484913|NCT00134056|564867583|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
156484914|NCT00134056|564867582|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
156484915|NCT00134056|564867583|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
156484916|NCT00134056|564867582|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
156484917|NCT00134056|564867583|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
156484918|NCT00134056|564867582|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
156484919|NCT00134056|564867583|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
156484920|NCT00742560|564867585|FG000|Overall Study|Adverse Event|0|||
156484921|NCT00742560|564867586|FG001|Overall Study|Adverse Event|0|||
156484922|NCT00742560|564867587|FG002|Overall Study|Adverse Event|1|||
156484923|NCT00742560|564867588|FG003|Overall Study|Adverse Event|1|||
156484924|NCT00742560|564867589|FG004|Overall Study|Adverse Event|1|||
156484925|NCT00742560|564867585|FG000|Overall Study|Death|0|||
156484926|NCT00742560|564867586|FG001|Overall Study|Death|2|||
156484927|NCT00742560|564867587|FG002|Overall Study|Death|0|||
156484928|NCT00742560|564867588|FG003|Overall Study|Death|2|||
156484929|NCT00742560|564867589|FG004|Overall Study|Death|3|||
156484930|NCT00742560|564867585|FG000|Overall Study|Subject's Decision|1|||
156484931|NCT00742560|564867586|FG001|Overall Study|Subject's Decision|0|||
156484932|NCT00742560|564867587|FG002|Overall Study|Subject's Decision|2|||
156484933|NCT00742560|564867588|FG003|Overall Study|Subject's Decision|3|||
156484934|NCT00742560|564867589|FG004|Overall Study|Subject's Decision|3|||
156484935|NCT00742560|564867585|FG000|Overall Study|Investigator's Decision|0|||
156484936|NCT00742560|564867586|FG001|Overall Study|Investigator's Decision|0|||
156484937|NCT00742560|564867587|FG002|Overall Study|Investigator's Decision|4|||
156484938|NCT00742560|564867588|FG003|Overall Study|Investigator's Decision|1|||
156484939|NCT00742560|564867589|FG004|Overall Study|Investigator's Decision|0|||
156484940|NCT00742560|564867585|FG000|Overall Study|Disease Progression|1|||
156484941|NCT00742560|564867586|FG001|Overall Study|Disease Progression|0|||
156484942|NCT00742560|564867587|FG002|Overall Study|Disease Progression|5|||
156484943|NCT00742560|564867588|FG003|Overall Study|Disease Progression|17|||
156484944|NCT00742560|564867589|FG004|Overall Study|Disease Progression|16|||
156484945|NCT00742560|564867585|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
156484946|NCT00742560|564867586|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
156484947|NCT00742560|564867587|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
156484948|NCT00742560|564867588|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
156484949|NCT00742560|564867589|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
156484950|NCT00742560|564867585|FG000|Overall Study|Other|0|||
156484951|NCT00742560|564867586|FG001|Overall Study|Other|1|||
156484952|NCT00742560|564867587|FG002|Overall Study|Other|8|||
156484953|NCT00742560|564867588|FG003|Overall Study|Other|9|||
156484954|NCT00742560|564867589|FG004|Overall Study|Other|9|||
156484955|NCT00742560|564867585|FG000|Overall Study|MIssing|0|||
156484956|NCT00742560|564867586|FG001|Overall Study|MIssing|0|||
156484957|NCT00742560|564867587|FG002|Overall Study|MIssing|0|||
156484958|NCT00742560|564867588|FG003|Overall Study|MIssing|0|||
156484959|NCT00742560|564867589|FG004|Overall Study|MIssing|1|||
156484960|NCT01536795|564867590|FG000|Overall Study|Lost to Follow-up|0|||
156484961|NCT01536795|564867591|FG001|Overall Study|Lost to Follow-up|2|||
156484962|NCT01536795|564867590|FG000|Overall Study|Lack of Efficacy|1|||
156484963|NCT01536795|564867591|FG001|Overall Study|Lack of Efficacy|0|||
156484964|NCT01812837|564867592|FG000|Overall Study|Lost to Follow-up|1|||
156484965|NCT01812837|564867593|FG001|Overall Study|Lost to Follow-up|1|||
156484966|NCT01812837|564867594|FG002|Overall Study|Lost to Follow-up|0|||
156484967|NCT01812837|564867592|FG000|Overall Study|Protocol Violation|1|||
156484968|NCT01812837|564867593|FG001|Overall Study|Protocol Violation|0|||
156484969|NCT01812837|564867594|FG002|Overall Study|Protocol Violation|0|||
156484970|NCT05008224|564867595|FG000|Overall Study|Death|3|||
156484971|NCT05008224|564867595|FG000|Overall Study|Lost to Follow-up|2|||
156484972|NCT05008224|564867595|FG000|Overall Study|Did Not Continue on Extension Study|39|||
156484973|NCT05008224|564867595|FG000|Overall Study|Transferred to Extension Study|100|||
156484974|NCT05008224|564867595|FG000|Overall Study|Withdrawal by Subject|2|||
156484975|NCT00617708|564867596|FG000|Overall Study|Adverse Event|0|||
156484976|NCT00617708|564867597|FG001|Overall Study|Adverse Event|6|||
156484977|NCT00617708|564867598|FG002|Overall Study|Adverse Event|9|||
156484978|NCT00617708|564867596|FG000|Overall Study|Withdrawal by Subject|1|||
156484979|NCT00617708|564867597|FG001|Overall Study|Withdrawal by Subject|1|||
156484980|NCT00617708|564867598|FG002|Overall Study|Withdrawal by Subject|7|||
156484981|NCT00617708|564867596|FG000|Overall Study|Death|0|||
156484982|NCT00617708|564867597|FG001|Overall Study|Death|6|||
156484983|NCT00617708|564867598|FG002|Overall Study|Death|5|||
156484984|NCT00617708|564867596|FG000|Overall Study|Progression/Relapse|7|||
156544404|NCT03200366|565087764|FG002|9 Month Post-Baseline Interview|Death|1|||
156484985|NCT00617708|564867597|FG001|Overall Study|Progression/Relapse|40|||
156484986|NCT00617708|564867598|FG002|Overall Study|Progression/Relapse|36|||
156484987|NCT00617708|564867596|FG000|Overall Study|Not protocol specified|1|||
156484988|NCT00617708|564867597|FG001|Overall Study|Not protocol specified|4|||
156484989|NCT00617708|564867598|FG002|Overall Study|Not protocol specified|2|||
156484990|NCT00617708|564867596|FG000|Overall Study|Not eligible|1|||
156484991|NCT00617708|564867597|FG001|Overall Study|Not eligible|3|||
156484992|NCT00617708|564867598|FG002|Overall Study|Not eligible|5|||
156484993|NCT01075815|564867599|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
156484994|NCT01075815|564867600|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
156484995|NCT01075815|564867599|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
156484996|NCT01075815|564867600|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
156484997|NCT01075815|564867599|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
156484998|NCT01075815|564867600|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
156484999|NCT02058992|564867601|FG000|Overall Study|Lost to Follow-up|4|||
156485000|NCT02058992|564867601|FG000|Overall Study|Protocol Violation|92|||
156485001|NCT02058992|564867601|FG000|Overall Study|CRF Uncollected|20|||
156485002|NCT02991456|564867602|FG000|Overall Study|Adverse Event|2|||
156485003|NCT02991456|564867603|FG001|Overall Study|Adverse Event|0|||
156485004|NCT02991456|564867602|FG000|Overall Study|Lost to Follow-up|0|||
156485005|NCT02991456|564867603|FG001|Overall Study|Lost to Follow-up|2|||
156485006|NCT02991456|564867602|FG000|Overall Study|Withdrawal by Subject|1|||
156353989|NCT03557151|564394023|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
156353990|NCT03557151|564394022|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
156485007|NCT02991456|564867603|FG001|Overall Study|Withdrawal by Subject|0|||
156485008|NCT03747575|564867604|FG000|Overall Study|Withdrawal by Subject|6|||
156485009|NCT03747575|564867605|FG001|Overall Study|Withdrawal by Subject|3|||
156485010|NCT03747575|564867604|FG000|Overall Study|Lost to Follow-up|3|||
156485011|NCT03747575|564867605|FG001|Overall Study|Lost to Follow-up|3|||
156485012|NCT03747575|564867604|FG000|Overall Study|Adverse Event|0|||
156485013|NCT03747575|564867605|FG001|Overall Study|Adverse Event|1|||
156544405|NCT03200366|565087762|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
156544406|NCT03200366|565087763|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
156544407|NCT03200366|565087764|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
156544408|NCT03200366|565087762|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
156544409|NCT03200366|565087763|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
156544410|NCT03200366|565087764|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
156544411|NCT03200366|565087762|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
156544412|NCT03200366|565087763|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
156544413|NCT03200366|565087764|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
156544414|NCT00405067|565087765|FG000|Overall Study|Adverse Event|4|||
156544415|NCT00405067|565087766|FG001|Overall Study|Adverse Event|9|||
156544416|NCT00405067|565087767|FG002|Overall Study|Adverse Event|4|||
156544417|NCT00405067|565087765|FG000|Overall Study|Lost to Follow-up|0|||
156544418|NCT00405067|565087766|FG001|Overall Study|Lost to Follow-up|0|||
156544419|NCT00405067|565087767|FG002|Overall Study|Lost to Follow-up|1|||
156544420|NCT03287219|565087768|FG000|Overall Study|Protocol Violation|0|||
156544421|NCT03287219|565087769|FG001|Overall Study|Protocol Violation|2|||
156544422|NCT00930761|565087770|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
156544423|NCT00930761|565087771|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
156544424|NCT00930761|565087770|FG000|Overall Study|less than 3 music therapy sessions|0|||
156544425|NCT00930761|565087771|FG001|Overall Study|less than 3 music therapy sessions|3|||
156544426|NCT03571646|565087772|FG000|Overall Study|Adverse Event|1|||
156544427|NCT03571646|565087773|FG001|Overall Study|Adverse Event|0|||
156544428|NCT03571646|565087772|FG000|Overall Study|Withdrawal by Subject|1|||
156544429|NCT03571646|565087773|FG001|Overall Study|Withdrawal by Subject|1|||
156544430|NCT01576549|565087774|FG000|Overall Study|Sponsor Decision|2|||
156544431|NCT04081363|565087775|FG000|Overall Study|Withdrawal by Subject|1|||
156544432|NCT04081363|565087776|FG001|Overall Study|Withdrawal by Subject|0|||
156544433|NCT00705783|565087777|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
156544434|NCT00705783|565087778|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
156544435|NCT00705783|565087779|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
156544436|NCT00705783|565087777|FG000|Conversion Phase|Lost to Follow-up|13|||
156544437|NCT00705783|565087778|FG001|Conversion Phase|Lost to Follow-up|0|||
156544438|NCT00705783|565087779|FG002|Conversion Phase|Lost to Follow-up|0|||
156544439|NCT00705783|565087777|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
156544440|NCT00705783|565087778|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
156544441|NCT00705783|565087779|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
156544442|NCT00705783|565087777|FG000|Conversion Phase|Withdrawn by Investigator|4|||
156544443|NCT00705783|565087778|FG001|Conversion Phase|Withdrawn by Investigator|0|||
156544444|NCT00705783|565087779|FG002|Conversion Phase|Withdrawn by Investigator|0|||
156544445|NCT00705783|565087777|FG000|Conversion Phase|Withdrew Consent|24|||
156544446|NCT00705783|565087778|FG001|Conversion Phase|Withdrew Consent|0|||
156544447|NCT00705783|565087779|FG002|Conversion Phase|Withdrew Consent|0|||
156544448|NCT00705783|565087777|FG000|Conversion Phase|Protocol Deviation|2|||
156544449|NCT00705783|565087778|FG001|Conversion Phase|Protocol Deviation|0|||
156544450|NCT00705783|565087779|FG002|Conversion Phase|Protocol Deviation|0|||
156544451|NCT00705783|565087777|FG000|Conversion Phase|Adverse Event|11|||
156544452|NCT00705783|565087778|FG001|Conversion Phase|Adverse Event|0|||
156544453|NCT00705783|565087779|FG002|Conversion Phase|Adverse Event|0|||
156544454|NCT00705783|565087777|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
156544455|NCT00705783|565087778|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
156544456|NCT00705783|565087779|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
156544457|NCT00705783|565087777|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
156544458|NCT00705783|565087778|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
156544459|NCT00705783|565087779|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
156544460|NCT00705783|565087777|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
156544461|NCT00705783|565087778|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
156485014|NCT00936065|564867610|FG000|Overall Study|Adverse Event|1|||
156485015|NCT00936065|564867611|FG001|Overall Study|Adverse Event|0|||
156485016|NCT00936065|564867612|FG002|Overall Study|Adverse Event|1|||
156485017|NCT00936065|564867610|FG000|Overall Study|Lack of Efficacy|1|||
156544462|NCT00705783|565087779|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
156544463|NCT00705783|565087777|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
156544464|NCT00705783|565087778|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
156485018|NCT00936065|564867611|FG001|Overall Study|Lack of Efficacy|0|||
156485019|NCT00936065|564867612|FG002|Overall Study|Lack of Efficacy|1|||
156485020|NCT00936065|564867610|FG000|Overall Study|Lost to Follow-up|1|||
156485021|NCT00936065|564867611|FG001|Overall Study|Lost to Follow-up|0|||
156485022|NCT00936065|564867612|FG002|Overall Study|Lost to Follow-up|0|||
156485023|NCT00936065|564867610|FG000|Overall Study|Protocol Violation|1|||
156485024|NCT00936065|564867611|FG001|Overall Study|Protocol Violation|2|||
156485025|NCT00936065|564867612|FG002|Overall Study|Protocol Violation|1|||
156485026|NCT00936065|564867610|FG000|Overall Study|Withdrawal by Subject|0|||
156485027|NCT00936065|564867611|FG001|Overall Study|Withdrawal by Subject|2|||
156485028|NCT00936065|564867612|FG002|Overall Study|Withdrawal by Subject|4|||
156485029|NCT01549951|564867615|FG000|Overall Study|Adverse Event|15|||
156485030|NCT01549951|564867615|FG000|Overall Study|Withdrawal by Subject|2|||
156485031|NCT01549951|564867615|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
156485032|NCT01549951|564867615|FG000|Overall Study|Progressive disease|29|||
156485033|NCT01549951|564867615|FG000|Overall Study|Symptomatic deterioration|1|||
156485034|NCT01549951|564867615|FG000|Overall Study|Other|2|||
156485035|NCT00990314|564867616|FG000|Overall Study|Death|2|||
156485036|NCT00990314|564867616|FG000|Overall Study|Adverse Event|2|||
156485037|NCT00990314|564867616|FG000|Overall Study|Withdrawal by Subject|3|||
156485038|NCT00990314|564867616|FG000|Overall Study|Non-Compliance|1|||
156485039|NCT00990314|564867616|FG000|Overall Study|Physician Decision|3|||
156485040|NCT00990314|564867616|FG000|Overall Study|Lack of Efficacy|1|||
156485041|NCT03689452|564867617|FG000|Overall Study|Lost to Follow-up|1|||
156485042|NCT03689452|564867618|FG001|Overall Study|Lost to Follow-up|1|||
156485043|NCT02676778|564867619|FG000|Overall Study|Disease Progression|7|||
156485044|NCT02676778|564867620|FG001|Overall Study|Disease Progression|3|||
156485045|NCT02676778|564867621|FG002|Overall Study|Disease Progression|1|||
156485046|NCT02676778|564867619|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
156485047|NCT02676778|564867620|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
156485048|NCT02676778|564867621|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
156485049|NCT02676778|564867619|FG000|Overall Study|Withdrawal by Subject|3|||
156485050|NCT02676778|564867620|FG001|Overall Study|Withdrawal by Subject|2|||
156485051|NCT02676778|564867621|FG002|Overall Study|Withdrawal by Subject|0|||
156485052|NCT02676778|564867619|FG000|Overall Study|Other|4|||
156485053|NCT02676778|564867620|FG001|Overall Study|Other|3|||
156485054|NCT02676778|564867621|FG002|Overall Study|Other|0|||
156485055|NCT02676778|564867619|FG000|Overall Study|Adverse Event|2|||
156485056|NCT02676778|564867620|FG001|Overall Study|Adverse Event|3|||
156485057|NCT02676778|564867621|FG002|Overall Study|Adverse Event|0|||
156485058|NCT03686176|564867628|FG000|Overall Study|Procedure cancelled|1|||
156485059|NCT03686176|564867629|FG001|Overall Study|Procedure cancelled|0|||
156485060|NCT03686176|564867630|FG002|Overall Study|Procedure cancelled|0|||
156485061|NCT03686176|564867628|FG000|Overall Study|VR Malfunction|1|||
156485062|NCT03686176|564867629|FG001|Overall Study|VR Malfunction|0|||
156485063|NCT03686176|564867630|FG002|Overall Study|VR Malfunction|0|||
156485064|NCT02819141|564867635|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
156485065|NCT02819141|564867636|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
156485066|NCT00705614|564868779|FG000|Initial Intervention|Adverse Event|40|||
156485067|NCT00705614|564868780|FG001|Initial Intervention|Adverse Event|21|||
156485068|NCT00705614|564868779|FG000|Initial Intervention|Lost to Follow-up|310|||
156485069|NCT00705614|564868780|FG001|Initial Intervention|Lost to Follow-up|191|||
156485070|NCT00705614|564868779|FG000|Initial Intervention|Withdrawal by Subject|114|||
156485071|NCT00705614|564868780|FG001|Initial Intervention|Withdrawal by Subject|71|||
156485072|NCT00705614|564868779|FG000|Initial Intervention|Administrative Reason|51|||
156485073|NCT00705614|564868780|FG001|Initial Intervention|Administrative Reason|38|||
156485074|NCT00705614|564868779|FG000|Initial Intervention|Status completion unknown|3|||
156485075|NCT00705614|564868780|FG001|Initial Intervention|Status completion unknown|0|||
156485076|NCT00705614|564868779|FG000|Switch to Remicade|Adverse Event|0|||
156485077|NCT00705614|564868780|FG001|Switch to Remicade|Adverse Event|5|||
156485078|NCT00705614|564868779|FG000|Switch to Remicade|Lost to Follow-up|0|||
156485079|NCT00705614|564868780|FG001|Switch to Remicade|Lost to Follow-up|23|||
156485080|NCT00705614|564868779|FG000|Switch to Remicade|Withdrawal by Subject|0|||
156485081|NCT00705614|564868780|FG001|Switch to Remicade|Withdrawal by Subject|12|||
156485082|NCT00705614|564868779|FG000|Switch to Remicade|Administrative Reason|0|||
156485083|NCT00705614|564868780|FG001|Switch to Remicade|Administrative Reason|9|||
156485084|NCT00088452|564868784|FG000|Overall Study|Did not receive intervention|1|||
156485085|NCT00088452|564868785|FG001|Overall Study|Did not receive intervention|0|||
156485086|NCT00088452|564868786|FG002|Overall Study|Did not receive intervention|1|||
156485087|NCT01184859|564868787|FG000|Period 1: Single Dose|Insufficient urine production|0|||
156485088|NCT01184859|564868788|FG001|Period 1: Single Dose|Insufficient urine production|1|||
156485089|NCT01184859|564868789|FG002|Period 1: Single Dose|Insufficient urine production|0|||
156485090|NCT01184859|564868790|FG003|Period 1: Single Dose|Insufficient urine production|0|||
156485091|NCT01184859|564868791|FG004|Period 1: Single Dose|Insufficient urine production|0|||
156485092|NCT01184859|564868787|FG000|Period 1: Single Dose|Protocol Violation|0|||
156485093|NCT01184859|564868788|FG001|Period 1: Single Dose|Protocol Violation|1|||
156485094|NCT01184859|564868789|FG002|Period 1: Single Dose|Protocol Violation|0|||
156485095|NCT01184859|564868790|FG003|Period 1: Single Dose|Protocol Violation|0|||
156485096|NCT01184859|564868791|FG004|Period 1: Single Dose|Protocol Violation|0|||
156485097|NCT01184859|564868787|FG000|Period 1: Single Dose|Adverse Event|0|||
156485098|NCT01184859|564868788|FG001|Period 1: Single Dose|Adverse Event|0|||
156485099|NCT01184859|564868789|FG002|Period 1: Single Dose|Adverse Event|0|||
156485100|NCT01184859|564868790|FG003|Period 1: Single Dose|Adverse Event|0|||
156485101|NCT01184859|564868791|FG004|Period 1: Single Dose|Adverse Event|1|||
156485102|NCT01184859|564868787|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
156485103|NCT01184859|564868788|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
156485104|NCT01184859|564868789|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
156485105|NCT01184859|564868790|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
156485106|NCT01184859|564868791|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
156485107|NCT01184859|564868787|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
156485108|NCT01184859|564868788|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
156485109|NCT01184859|564868789|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
156485110|NCT01184859|564868790|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
156485111|NCT01184859|564868791|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
156485112|NCT02081196|564868793|FG000|Overall Study|Lost to Follow-up|1|||
156485113|NCT05335005|564868799|FG000|Overall Study|Lost to Follow-up|1|||
156485114|NCT01636258|564868805|FG000|Overall Study|Lost to Follow-up|1|||
156485115|NCT01636258|564868806|FG001|Overall Study|Lost to Follow-up|0|||
156485116|NCT02798861|564868809|FG000|Overall Study|Lost to Follow-up|22|||
156485117|NCT02798861|564868809|FG000|Overall Study|Withdrawal by Subject|1|||
156485118|NCT00730925|564868819|FG000|Overall Study|Progressive Disease|21|||
156485119|NCT00730925|564868819|FG000|Overall Study|Dose reducing Event|2|||
156485120|NCT00730925|564868819|FG000|Overall Study|Other Averse Event|7|||
156485121|NCT00730925|564868819|FG000|Overall Study|Protocol Violation|1|||
156485122|NCT00730925|564868819|FG000|Overall Study|Withdrawal by Subject|1|||
156485123|NCT00730925|564868819|FG000|Overall Study|Switch to combination therapy|8|||
156485124|NCT00730925|564868819|FG000|Overall Study|Other|1|||
156485125|NCT02137239|564868820|FG000|Overall Study|Discontinued Study Treatment|0|||
156485126|NCT02137239|564868821|FG001|Overall Study|Discontinued Study Treatment|3|||
156485127|NCT02137239|564868820|FG000|Overall Study|Withdrew Consent|1|||
156485128|NCT02137239|564868821|FG001|Overall Study|Withdrew Consent|1|||
156485129|NCT02137239|564868820|FG000|Overall Study|Adverse Event|2|||
156485130|NCT02137239|564868821|FG001|Overall Study|Adverse Event|2|||
156485131|NCT04057937|564868822|FG000|Placebo-controlled Phase|Adverse Event|3|||
156485132|NCT04057937|564868823|FG001|Placebo-controlled Phase|Adverse Event|0|||
156485133|NCT04057937|564868822|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
156485134|NCT04057937|564868823|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
156485135|NCT04057937|564868822|FG000|Active-treatment Phase|Pregnancy|0|||
156485136|NCT04057937|564868823|FG001|Active-treatment Phase|Pregnancy|1|||
156485137|NCT04057937|564868822|FG000|Active-treatment Phase|Physician Decision|0|||
156485138|NCT04057937|564868823|FG001|Active-treatment Phase|Physician Decision|1|||
156485139|NCT02446912|564868824|FG000|Overall Study|Adverse Event|3|||
156485140|NCT02446912|564868825|FG001|Overall Study|Adverse Event|13|||
156485141|NCT02446912|564868826|FG002|Overall Study|Adverse Event|5|||
156485142|NCT02446912|564868824|FG000|Overall Study|Condition under investigation worsened|0|||
156485143|NCT02446912|564868825|FG001|Overall Study|Condition under investigation worsened|1|||
156485144|NCT02446912|564868826|FG002|Overall Study|Condition under investigation worsened|1|||
156485145|NCT02446912|564868824|FG000|Overall Study|Study-specific withdrawal criteria|1|||
156485146|NCT02446912|564868825|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156485147|NCT02446912|564868826|FG002|Overall Study|Study-specific withdrawal criteria|0|||
156485148|NCT02446912|564868824|FG000|Overall Study|Lack of Efficacy|1|||
156485149|NCT02446912|564868825|FG001|Overall Study|Lack of Efficacy|4|||
156485150|NCT02446912|564868826|FG002|Overall Study|Lack of Efficacy|7|||
156485151|NCT02446912|564868824|FG000|Overall Study|Lost to Follow-up|0|||
156485152|NCT02446912|564868825|FG001|Overall Study|Lost to Follow-up|0|||
156485153|NCT02446912|564868826|FG002|Overall Study|Lost to Follow-up|2|||
156485154|NCT02446912|564868824|FG000|Overall Study|Severe non-compliance to protocol|1|||
156485155|NCT02446912|564868825|FG001|Overall Study|Severe non-compliance to protocol|0|||
156485156|NCT02446912|564868826|FG002|Overall Study|Severe non-compliance to protocol|1|||
156485157|NCT02446912|564868824|FG000|Overall Study|Withdrawal by Subject|10|||
156485158|NCT02446912|564868825|FG001|Overall Study|Withdrawal by Subject|15|||
156485159|NCT02446912|564868826|FG002|Overall Study|Withdrawal by Subject|15|||
156485160|NCT02446912|564868824|FG000|Overall Study|Miscellaneous|2|||
156485161|NCT02446912|564868825|FG001|Overall Study|Miscellaneous|2|||
156485162|NCT02446912|564868826|FG002|Overall Study|Miscellaneous|4|||
156485163|NCT01757171|564868829|FG000|Overall Study|Adverse Event|5|||
156485164|NCT01757171|564868830|FG001|Overall Study|Adverse Event|1|||
156485165|NCT01757171|564868829|FG000|Overall Study|Disease Progression|1|||
156485166|NCT01757171|564868830|FG001|Overall Study|Disease Progression|0|||
156485167|NCT01757171|564868829|FG000|Overall Study|Hospitalization|1|||
156485168|NCT01757171|564868830|FG001|Overall Study|Hospitalization|0|||
156485169|NCT01757171|564868829|FG000|Overall Study|ECOG decline|1|||
156485170|NCT01757171|564868830|FG001|Overall Study|ECOG decline|0|||
156485171|NCT00385697|564868835|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
156485172|NCT00385697|564868836|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
156485173|NCT00385697|564868837|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
156485174|NCT00385697|564868838|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
156485175|NCT00385697|564868839|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
156485176|NCT00385697|564868835|FG000|Open-label Segment 1|Lost to Follow-up|1|||
156485177|NCT00385697|564868836|FG001|Open-label Segment 1|Lost to Follow-up|0|||
156485178|NCT00385697|564868837|FG002|Open-label Segment 1|Lost to Follow-up|0|||
156485179|NCT00385697|564868838|FG003|Open-label Segment 1|Lost to Follow-up|0|||
156485180|NCT00385697|564868839|FG004|Open-label Segment 1|Lost to Follow-up|0|||
156485181|NCT00385697|564868835|FG000|Double-blind Segment 2|Adverse Event|0|||
156485182|NCT00385697|564868836|FG001|Double-blind Segment 2|Adverse Event|3|||
156485183|NCT00385697|564868837|FG002|Double-blind Segment 2|Adverse Event|1|||
156485184|NCT00385697|564868838|FG003|Double-blind Segment 2|Adverse Event|0|||
156485185|NCT00385697|564868839|FG004|Double-blind Segment 2|Adverse Event|0|||
156485186|NCT00385697|564868835|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
156485187|NCT00385697|564868836|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
156485188|NCT00385697|564868837|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
156485189|NCT00385697|564868838|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
156485190|NCT00385697|564868839|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
156485191|NCT00385697|564868835|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
156485192|NCT00385697|564868836|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
156485193|NCT00385697|564868837|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
156485194|NCT00385697|564868838|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
156485195|NCT00385697|564868839|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
156485196|NCT00385697|564868835|FG000|Double-blind Segment 2|Other|0|||
156485197|NCT00385697|564868836|FG001|Double-blind Segment 2|Other|2|||
156485198|NCT00385697|564868837|FG002|Double-blind Segment 2|Other|0|||
156485199|NCT00385697|564868838|FG003|Double-blind Segment 2|Other|0|||
156485200|NCT00385697|564868839|FG004|Double-blind Segment 2|Other|0|||
156485201|NCT00442559|564868842|FG000|Overall Study|Lost to Follow-up|32|||
156485202|NCT00442559|564868843|FG001|Overall Study|Lost to Follow-up|34|||
156485203|NCT00442559|564868842|FG000|Overall Study|Protocol Violation|1|||
156485204|NCT00442559|564868843|FG001|Overall Study|Protocol Violation|1|||
156485205|NCT00442559|564868842|FG000|Overall Study|Withdrawal by Subject|1|||
156485206|NCT00442559|564868843|FG001|Overall Study|Withdrawal by Subject|0|||
156485207|NCT02305797|564868844|FG000|Overall Study|Adverse Event|11|||
156485208|NCT02305797|564868845|FG001|Overall Study|Adverse Event|2|||
156485209|NCT02305797|564868844|FG000|Overall Study|Withdrawal by Subject|9|||
156485210|NCT02305797|564868845|FG001|Overall Study|Withdrawal by Subject|10|||
156485211|NCT02305797|564868844|FG000|Overall Study|Lack of Efficacy|6|||
156485212|NCT02305797|564868845|FG001|Overall Study|Lack of Efficacy|0|||
156485213|NCT02305797|564868844|FG000|Overall Study|Lost to Follow-up|5|||
156485214|NCT02305797|564868845|FG001|Overall Study|Lost to Follow-up|11|||
156485215|NCT02305797|564868844|FG000|Overall Study|Pregnancy|0|||
156485216|NCT02305797|564868845|FG001|Overall Study|Pregnancy|2|||
156485217|NCT02305797|564868844|FG000|Overall Study|Noncompliance|14|||
156485218|NCT02305797|564868845|FG001|Overall Study|Noncompliance|12|||
156485219|NCT02305797|564868844|FG000|Overall Study|Reason not collected|0|||
156485220|NCT02305797|564868845|FG001|Overall Study|Reason not collected|1|||
156485221|NCT03906240|564868846|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
156485222|NCT03906240|564868847|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
156485223|NCT03906240|564868846|FG000|Overall Study|Lost to Follow-up|1|||
156485224|NCT03906240|564868847|FG001|Overall Study|Lost to Follow-up|0|||
156544465|NCT00705783|565087779|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
156485225|NCT03906240|564868846|FG000|Overall Study|Withdrawal by Subject|0|||
156485226|NCT03906240|564868847|FG001|Overall Study|Withdrawal by Subject|1|||
156485227|NCT05287178|564868849|FG000|Overall Study|Lost to Follow-up|2|||
156485228|NCT01426217|564868850|FG000|Overall Study|lost sample|8|||
156544466|NCT00705783|565087777|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
156485229|NCT01426217|564868851|FG001|Overall Study|lost sample|14|||
156485230|NCT02267746|564868852|FG000|Overall Study|Adverse Event|0|||
156485231|NCT02267746|564868853|FG001|Overall Study|Adverse Event|2|||
156485232|NCT02267746|564868854|FG002|Overall Study|Adverse Event|1|||
156485233|NCT02267746|564868852|FG000|Overall Study|Protocol Violation|8|||
156485234|NCT02267746|564868853|FG001|Overall Study|Protocol Violation|7|||
156485235|NCT02267746|564868854|FG002|Overall Study|Protocol Violation|3|||
156485236|NCT02267746|564868852|FG000|Overall Study|Lack of Efficacy|11|||
156485237|NCT02267746|564868853|FG001|Overall Study|Lack of Efficacy|11|||
156485238|NCT02267746|564868854|FG002|Overall Study|Lack of Efficacy|15|||
156485239|NCT02267746|564868852|FG000|Overall Study|Protocol Violation|1|||
156485240|NCT02267746|564868853|FG001|Overall Study|Protocol Violation|2|||
156485241|NCT02267746|564868854|FG002|Overall Study|Protocol Violation|1|||
156485242|NCT02267746|564868852|FG000|Overall Study|Miscellaneous|1|||
156485243|NCT02267746|564868853|FG001|Overall Study|Miscellaneous|0|||
156544467|NCT00705783|565087778|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
156485244|NCT02267746|564868854|FG002|Overall Study|Miscellaneous|1|||
156485245|NCT05234632|564868859|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
156544468|NCT00705783|565087779|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
156485246|NCT05234632|564868860|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
156485247|NCT05234632|564868859|FG000|Overall Study|Withdrawal by Subject|2|||
156485248|NCT05234632|564868860|FG001|Overall Study|Withdrawal by Subject|0|||
156485249|NCT05234632|564868859|FG000|Overall Study|Adverse Event|0|||
156485250|NCT05234632|564868860|FG001|Overall Study|Adverse Event|4|||
156485251|NCT05234632|564868859|FG000|Overall Study|Physician Decision|1|||
156485252|NCT05234632|564868860|FG001|Overall Study|Physician Decision|1|||
156485253|NCT05234632|564868859|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
156485254|NCT05234632|564868860|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
156485255|NCT05234632|564868859|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
156485256|NCT05234632|564868860|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
156485257|NCT02849509|564868862|FG000|Overall Study|Worsening of disease under study|1|||
156485258|NCT02849509|564868863|FG001|Overall Study|Worsening of disease under study|1|||
156485259|NCT02849509|564868864|FG002|Overall Study|Worsening of disease under study|1|||
156485260|NCT02849509|564868862|FG000|Overall Study|Worsening of other pre-existing disease|0|||
156485261|NCT02849509|564868863|FG001|Overall Study|Worsening of other pre-existing disease|1|||
156485262|NCT02849509|564868864|FG002|Overall Study|Worsening of other pre-existing disease|2|||
156485263|NCT02849509|564868862|FG000|Overall Study|Other adverse event|36|||
156485264|NCT02849509|564868863|FG001|Overall Study|Other adverse event|41|||
156485265|NCT02849509|564868864|FG002|Overall Study|Other adverse event|8|||
156485266|NCT02849509|564868862|FG000|Overall Study|Withdrawal by Subject|6|||
156485267|NCT02849509|564868863|FG001|Overall Study|Withdrawal by Subject|17|||
156485268|NCT02849509|564868864|FG002|Overall Study|Withdrawal by Subject|12|||
156485269|NCT02849509|564868862|FG000|Overall Study|Lost to Follow-up|27|||
156544469|NCT00705783|565087777|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
156544470|NCT00705783|565087778|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
156544471|NCT00705783|565087779|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
156544472|NCT00705783|565087777|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
156544473|NCT00705783|565087778|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
156544474|NCT00705783|565087779|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
156544475|NCT00705783|565087777|FG000|Oral Stabilization Phase|Adverse Event|14|||
156544476|NCT00705783|565087778|FG001|Oral Stabilization Phase|Adverse Event|0|||
156544477|NCT00705783|565087779|FG002|Oral Stabilization Phase|Adverse Event|0|||
156544478|NCT00705783|565087777|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
156544479|NCT00705783|565087778|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
156544480|NCT00705783|565087779|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
156544481|NCT00705783|565087777|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
156544482|NCT00705783|565087778|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
156544483|NCT00705783|565087779|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
156544484|NCT00705783|565087777|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
156544485|NCT00705783|565087778|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
156544486|NCT00705783|565087779|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
156544487|NCT00705783|565087777|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
156544488|NCT00705783|565087778|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
156485270|NCT02849509|564868863|FG001|Overall Study|Lost to Follow-up|67|||
156485271|NCT02849509|564868864|FG002|Overall Study|Lost to Follow-up|36|||
156485272|NCT02849509|564868862|FG000|Overall Study|Other, reason not specified|14|||
156544489|NCT00705783|565087779|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
156544490|NCT00705783|565087777|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
156544491|NCT00705783|565087778|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
156485273|NCT02849509|564868863|FG001|Overall Study|Other, reason not specified|29|||
156485274|NCT02849509|564868864|FG002|Overall Study|Other, reason not specified|25|||
156485275|NCT02849509|564868862|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
156485276|NCT02849509|564868863|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
156485277|NCT02849509|564868864|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
156485278|NCT02924051|564868871|FG000|Overall Study|Withdrawal by Subject|1|||
156485279|NCT02924051|564868872|FG001|Overall Study|Withdrawal by Subject|9|||
156485280|NCT05615870|564868873|FG000|Overall Study|Lost to Follow-up|10|||
156485281|NCT05615870|564868874|FG001|Overall Study|Lost to Follow-up|13|||
156485282|NCT05615870|564868873|FG000|Overall Study|Physician Decision|2|||
156485283|NCT05615870|564868874|FG001|Overall Study|Physician Decision|0|||
156485284|NCT05615870|564868873|FG000|Overall Study|Withdrawal by Subject|0|||
156485285|NCT05615870|564868874|FG001|Overall Study|Withdrawal by Subject|2|||
156485286|NCT05615870|564868873|FG000|Overall Study|Protocol Violation|0|||
156485287|NCT05615870|564868874|FG001|Overall Study|Protocol Violation|3|||
156485288|NCT05615870|564868873|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
156485289|NCT05615870|564868874|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
156485290|NCT05615870|564868873|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
156485291|NCT05615870|564868874|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
156485292|NCT05615870|564868873|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
156485293|NCT05615870|564868874|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
156485294|NCT02130401|564868875|FG000|Overall Study|Poor enrollment|6|||
156485295|NCT03019289|564868876|FG000|Overall Study|Adverse Event|1|||
156485296|NCT03019289|564868877|FG001|Overall Study|Adverse Event|0|||
156485297|NCT03019289|564868878|FG002|Overall Study|Adverse Event|0|||
156485298|NCT03019289|564868879|FG003|Overall Study|Adverse Event|0|||
156485299|NCT03019289|564868880|FG004|Overall Study|Adverse Event|0|||
156485300|NCT03019289|564868881|FG005|Overall Study|Adverse Event|0|||
156485301|NCT03019289|564868882|FG006|Overall Study|Adverse Event|0|||
156485302|NCT03019289|564868883|FG007|Overall Study|Adverse Event|0|||
156485303|NCT03019289|564868884|FG008|Overall Study|Adverse Event|1|||
156485304|NCT03019289|564868876|FG000|Overall Study|Other|1|||
156485305|NCT03019289|564868877|FG001|Overall Study|Other|0|||
156485306|NCT03019289|564868878|FG002|Overall Study|Other|0|||
156485307|NCT03019289|564868879|FG003|Overall Study|Other|0|||
156485308|NCT03019289|564868880|FG004|Overall Study|Other|0|||
156485309|NCT03019289|564868881|FG005|Overall Study|Other|0|||
156485310|NCT03019289|564868882|FG006|Overall Study|Other|0|||
156485311|NCT03019289|564868883|FG007|Overall Study|Other|0|||
156485312|NCT03019289|564868884|FG008|Overall Study|Other|0|||
156485313|NCT00145496|564868885|FG000|Overall Study|Adverse Event|42|||
156485314|NCT00145496|564868886|FG001|Overall Study|Adverse Event|30|||
156485315|NCT00145496|564868885|FG000|Overall Study|Lack of Efficacy|12|||
156485316|NCT00145496|564868886|FG001|Overall Study|Lack of Efficacy|7|||
156485317|NCT00145496|564868885|FG000|Overall Study|Withdrawal by Subject|32|||
156485318|NCT00145496|564868886|FG001|Overall Study|Withdrawal by Subject|26|||
156485319|NCT00145496|564868885|FG000|Overall Study|Lost to Follow-up|12|||
156485320|NCT00145496|564868886|FG001|Overall Study|Lost to Follow-up|5|||
156485321|NCT00145496|564868885|FG000|Overall Study|Other|25|||
156485322|NCT00145496|564868886|FG001|Overall Study|Other|13|||
156485323|NCT01334606|564868891|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
156485324|NCT02312245|564868892|FG000|Overall Study|Death|0|||
156485325|NCT02312245|564868893|FG001|Overall Study|Death|0|||
156485326|NCT02312245|564868894|FG002|Overall Study|Death|0|||
156485327|NCT02312245|564868895|FG003|Overall Study|Death|1|||
156485328|NCT02312245|564868892|FG000|Overall Study|Withdrawal by Subject|1|||
156485329|NCT02312245|564868893|FG001|Overall Study|Withdrawal by Subject|1|||
156485330|NCT02312245|564868894|FG002|Overall Study|Withdrawal by Subject|0|||
156485331|NCT02312245|564868895|FG003|Overall Study|Withdrawal by Subject|2|||
156485332|NCT02312245|564868892|FG000|Overall Study|Alternative Therapy|1|||
156485333|NCT02312245|564868893|FG001|Overall Study|Alternative Therapy|0|||
156485334|NCT02312245|564868894|FG002|Overall Study|Alternative Therapy|0|||
156485335|NCT02312245|564868895|FG003|Overall Study|Alternative Therapy|0|||
156485336|NCT02312245|564868892|FG000|Overall Study|Progression|0|||
156485337|NCT02312245|564868893|FG001|Overall Study|Progression|0|||
156485338|NCT02312245|564868894|FG002|Overall Study|Progression|0|||
156485339|NCT02312245|564868895|FG003|Overall Study|Progression|5|||
156485340|NCT02312245|564868892|FG000|Overall Study|Patient went to hospice|0|||
156485341|NCT02312245|564868893|FG001|Overall Study|Patient went to hospice|0|||
156485342|NCT02312245|564868894|FG002|Overall Study|Patient went to hospice|0|||
156485343|NCT02312245|564868895|FG003|Overall Study|Patient went to hospice|1|||
156485344|NCT02312245|564868892|FG000|Overall Study|Ineligible|1|||
156485345|NCT02312245|564868893|FG001|Overall Study|Ineligible|0|||
156485346|NCT02312245|564868894|FG002|Overall Study|Ineligible|0|||
156485347|NCT02312245|564868895|FG003|Overall Study|Ineligible|0|||
156485348|NCT01232569|564870674|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
156485349|NCT01232569|564870675|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
156485350|NCT01232569|564870676|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156485351|NCT01232569|564870677|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
156485352|NCT01232569|564870674|FG000|Double-blind Treatment Period|Escape|2|||
156485353|NCT01232569|564870675|FG001|Double-blind Treatment Period|Escape|2|||
156485354|NCT01232569|564870676|FG002|Double-blind Treatment Period|Escape|0|||
156485355|NCT01232569|564870677|FG003|Double-blind Treatment Period|Escape|0|||
156485356|NCT01232569|564870674|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
156485357|NCT01232569|564870675|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
156485358|NCT01232569|564870676|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
156485359|NCT01232569|564870677|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
156485360|NCT01232569|564870674|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
156485361|NCT01232569|564870675|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
156485362|NCT01232569|564870676|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
156485363|NCT01232569|564870677|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
156485364|NCT01232569|564870674|FG000|Double-blind Treatment Period|Physician Decision|1|||
156485365|NCT01232569|564870675|FG001|Double-blind Treatment Period|Physician Decision|0|||
156485366|NCT01232569|564870676|FG002|Double-blind Treatment Period|Physician Decision|0|||
156485367|NCT01232569|564870677|FG003|Double-blind Treatment Period|Physician Decision|0|||
156485368|NCT01232569|564870674|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
156485369|NCT01232569|564870675|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
156485370|NCT01232569|564870676|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
156485371|NCT01232569|564870677|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
156485372|NCT01232569|564870674|FG000|Double-blind Treatment Period|Death|2|||
156485373|NCT01232569|564870675|FG001|Double-blind Treatment Period|Death|0|||
156485374|NCT01232569|564870676|FG002|Double-blind Treatment Period|Death|0|||
156485375|NCT01232569|564870677|FG003|Double-blind Treatment Period|Death|0|||
156485376|NCT04044352|564870678|FG000|Overall Study|Lost to Follow-up|9|||
156485377|NCT04044352|564870678|FG000|Overall Study|Withdrawal by Subject|2|||
156485378|NCT02176356|564870684|FG000|Overall Study|Screen Failure|14|||
156485379|NCT02176356|564870684|FG000|Overall Study|Lost to Follow-up|4|||
156485380|NCT02176356|564870684|FG000|Overall Study|Personal Reasons|3|||
156485381|NCT02176356|564870684|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156485382|NCT00958711|564870686|FG000|Overall Study|Withdrawal by Subject|0|||
156485383|NCT00958711|564870687|FG001|Overall Study|Withdrawal by Subject|4|||
156485384|NCT00958711|564870686|FG000|Overall Study|Physician Decision|5|||
156485385|NCT00958711|564870687|FG001|Overall Study|Physician Decision|7|||
156485386|NCT00958711|564870686|FG000|Overall Study|Lost to Follow-up|4|||
156485387|NCT00958711|564870687|FG001|Overall Study|Lost to Follow-up|1|||
156485388|NCT00958711|564870686|FG000|Overall Study|Other|2|||
156485389|NCT00958711|564870687|FG001|Overall Study|Other|5|||
156485390|NCT00958711|564870686|FG000|Overall Study|Death|1|||
156485391|NCT00958711|564870687|FG001|Overall Study|Death|2|||
156485392|NCT00958711|564870686|FG000|Overall Study|Adverse Event|1|||
156485393|NCT00958711|564870687|FG001|Overall Study|Adverse Event|2|||
156485394|NCT03722485|564870688|FG000|Overall Study|Withdrawal by Subject|1|||
156485395|NCT03722485|564870689|FG001|Overall Study|Withdrawal by Subject|0|||
156485396|NCT03722485|564870688|FG000|Overall Study|Adverse Event|0|||
156485397|NCT03722485|564870689|FG001|Overall Study|Adverse Event|2|||
156485398|NCT03722485|564870688|FG000|Overall Study|subject discharged prior to study completion|1|||
156485399|NCT03722485|564870689|FG001|Overall Study|subject discharged prior to study completion|5|||
156485400|NCT03722485|564870688|FG000|Overall Study|eligibility criteria not met|2|||
156485401|NCT03722485|564870689|FG001|Overall Study|eligibility criteria not met|0|||
156485402|NCT02151643|564870692|FG000|Overall Study|Adverse Event|2|||
156485403|NCT02151643|564870693|FG001|Overall Study|Adverse Event|0|||
156485404|NCT02151643|564870694|FG002|Overall Study|Adverse Event|1|||
156485405|NCT02151643|564870695|FG003|Overall Study|Adverse Event|4|||
156485406|NCT02151643|564870696|FG004|Overall Study|Adverse Event|0|||
156485407|NCT02151643|564870692|FG000|Overall Study|Withdrawal by Subject|0|||
156485408|NCT02151643|564870693|FG001|Overall Study|Withdrawal by Subject|1|||
156485409|NCT02151643|564870694|FG002|Overall Study|Withdrawal by Subject|1|||
156485410|NCT02151643|564870695|FG003|Overall Study|Withdrawal by Subject|1|||
156485411|NCT02151643|564870696|FG004|Overall Study|Withdrawal by Subject|1|||
156485412|NCT02151643|564870692|FG000|Overall Study|Hyperphosphataemia|1|||
156485413|NCT02151643|564870693|FG001|Overall Study|Hyperphosphataemia|0|||
156485414|NCT02151643|564870694|FG002|Overall Study|Hyperphosphataemia|0|||
156485415|NCT02151643|564870695|FG003|Overall Study|Hyperphosphataemia|0|||
156485416|NCT02151643|564870696|FG004|Overall Study|Hyperphosphataemia|1|||
156485417|NCT02151643|564870692|FG000|Overall Study|High Ferritin levels|3|||
156485418|NCT02151643|564870693|FG001|Overall Study|High Ferritin levels|3|||
156485419|NCT02151643|564870694|FG002|Overall Study|High Ferritin levels|2|||
156485420|NCT02151643|564870695|FG003|Overall Study|High Ferritin levels|2|||
156485421|NCT02151643|564870696|FG004|Overall Study|High Ferritin levels|1|||
156485422|NCT03087851|564870698|FG000|Overall Study|Withdraw on medical grounds|0|||
156485423|NCT03087851|564870699|FG001|Overall Study|Withdraw on medical grounds|1|||
156485424|NCT03087851|564870700|FG002|Overall Study|Withdraw on medical grounds|2|||
156485425|NCT00644332|564870701|FG000|Overall Study|Adverse Event|11|||
156485426|NCT00644332|564870701|FG000|Overall Study|Withdrawal by Subject|6|||
156485427|NCT00644332|564870701|FG000|Overall Study|Completion Status Unknown|2|||
156485428|NCT00644332|564870701|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
156485429|NCT00644332|564870701|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
156485430|NCT03694210|564870702|FG000|Overall Study|Death|1|||
156485431|NCT03694210|564870702|FG000|Overall Study|Screen Failure|7|||
156485432|NCT03050372|564870705|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
156485433|NCT03050372|564870706|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
156485434|NCT03050372|564870705|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
156485435|NCT03050372|564870706|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
156485436|NCT00443755|564870709|FG000|Overall Study|Withdrawal by Subject|2|||
156485437|NCT00443755|564870710|FG001|Overall Study|Withdrawal by Subject|1|||
156485438|NCT02775214|564870711|FG000|Overall Study|Withdrawal by Subject|2|||
156485439|NCT02775214|564870712|FG001|Overall Study|Withdrawal by Subject|0|||
156485440|NCT02706834|564870714|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156485441|NCT02706834|564870715|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
156485442|NCT02706834|564870716|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156485443|NCT02706834|564870717|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
156485444|NCT02706834|564870718|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
156485445|NCT02706834|564870719|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
156485446|NCT02706834|564870720|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
156485447|NCT02706834|564870721|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
156485448|NCT02706834|564870722|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
156485449|NCT02706834|564870723|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
156485450|NCT02706834|564870724|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
156485451|NCT02706834|564870714|FG000|Overall Study|Lost to Follow-up|0|||
156485452|NCT02706834|564870715|FG001|Overall Study|Lost to Follow-up|0|||
156485453|NCT02706834|564870716|FG002|Overall Study|Lost to Follow-up|1|||
156485454|NCT02706834|564870717|FG003|Overall Study|Lost to Follow-up|0|||
156485455|NCT02706834|564870718|FG004|Overall Study|Lost to Follow-up|0|||
156485456|NCT02706834|564870719|FG005|Overall Study|Lost to Follow-up|0|||
156485457|NCT02706834|564870720|FG006|Overall Study|Lost to Follow-up|0|||
156485458|NCT02706834|564870721|FG007|Overall Study|Lost to Follow-up|0|||
156485459|NCT02706834|564870722|FG008|Overall Study|Lost to Follow-up|0|||
156485460|NCT02706834|564870723|FG009|Overall Study|Lost to Follow-up|0|||
156485461|NCT02706834|564870724|FG010|Overall Study|Lost to Follow-up|0|||
156485462|NCT02706834|564870714|FG000|Overall Study|Voluntary Withdrawal|1|||
156485463|NCT02706834|564870715|FG001|Overall Study|Voluntary Withdrawal|0|||
156485464|NCT02706834|564870716|FG002|Overall Study|Voluntary Withdrawal|0|||
156485465|NCT02706834|564870717|FG003|Overall Study|Voluntary Withdrawal|0|||
156485466|NCT02706834|564870718|FG004|Overall Study|Voluntary Withdrawal|0|||
156485467|NCT02706834|564870719|FG005|Overall Study|Voluntary Withdrawal|0|||
156485468|NCT02706834|564870720|FG006|Overall Study|Voluntary Withdrawal|0|||
156485469|NCT02706834|564870721|FG007|Overall Study|Voluntary Withdrawal|0|||
156485470|NCT02706834|564870722|FG008|Overall Study|Voluntary Withdrawal|0|||
156485471|NCT02706834|564870723|FG009|Overall Study|Voluntary Withdrawal|1|||
156485472|NCT02706834|564870724|FG010|Overall Study|Voluntary Withdrawal|0|||
156485473|NCT02706834|564870714|FG000|Overall Study|Other Reason Not Specified|1|||
156485474|NCT02706834|564870715|FG001|Overall Study|Other Reason Not Specified|0|||
156485475|NCT02706834|564870716|FG002|Overall Study|Other Reason Not Specified|0|||
156485476|NCT02706834|564870717|FG003|Overall Study|Other Reason Not Specified|0|||
156485477|NCT02706834|564870718|FG004|Overall Study|Other Reason Not Specified|1|||
156485478|NCT02706834|564870719|FG005|Overall Study|Other Reason Not Specified|0|||
156485479|NCT02706834|564870720|FG006|Overall Study|Other Reason Not Specified|0|||
156485480|NCT02706834|564870721|FG007|Overall Study|Other Reason Not Specified|0|||
156485481|NCT02706834|564870722|FG008|Overall Study|Other Reason Not Specified|0|||
156485482|NCT02706834|564870723|FG009|Overall Study|Other Reason Not Specified|0|||
156485483|NCT02706834|564870724|FG010|Overall Study|Other Reason Not Specified|0|||
156485484|NCT00678899|564870725|FG000|Overall Study|Adverse Event|1|||
156485485|NCT02543294|564870726|FG000|Overall Study|Lost to Follow-up|3|||
156485486|NCT02543294|564870726|FG000|Overall Study|Physician Decision|2|||
156485487|NCT02543294|564870726|FG000|Overall Study|Withdrawal by Subject|7|||
156485488|NCT01107353|564870729|FG000|Overall Study|Positive Drug Screen|1|||
156485489|NCT01107353|564870730|FG001|Overall Study|Positive Drug Screen|0|||
156485490|NCT00907517|564870731|FG000|Overall Study|Progressive Disease|3|||
156485491|NCT00907517|564870732|FG001|Overall Study|Progressive Disease|3|||
156485492|NCT00907517|564870733|FG002|Overall Study|Progressive Disease|4|||
156485493|NCT00907517|564870734|FG003|Overall Study|Progressive Disease|4|||
156485494|NCT00907517|564870735|FG004|Overall Study|Progressive Disease|4|||
156485495|NCT00907517|564870731|FG000|Overall Study|Symptomatic Deterioration|0|||
156485496|NCT00907517|564870732|FG001|Overall Study|Symptomatic Deterioration|0|||
156485497|NCT00907517|564870733|FG002|Overall Study|Symptomatic Deterioration|0|||
156485498|NCT00907517|564870734|FG003|Overall Study|Symptomatic Deterioration|0|||
156485499|NCT00907517|564870735|FG004|Overall Study|Symptomatic Deterioration|1|||
156485500|NCT02029521|564870758|FG000|Overall Study|Protocol Violation|1|||
156485501|NCT02029521|564870759|FG001|Overall Study|Protocol Violation|0|||
156485502|NCT02029521|564870758|FG000|Overall Study|Withdrawal by Subject|1|||
156485503|NCT02029521|564870759|FG001|Overall Study|Withdrawal by Subject|1|||
156485504|NCT01072396|564870760|FG000|Period One|Adverse Event|1|||
156485505|NCT01072396|564870761|FG001|Period One|Adverse Event|1|||
156485506|NCT01072396|564870760|FG000|Period One|Protocol Violation|2|||
156485507|NCT01072396|564870761|FG001|Period One|Protocol Violation|1|||
156485508|NCT01072396|564870760|FG000|Period One|Withdrawal by Subject|2|||
156485509|NCT01072396|564870761|FG001|Period One|Withdrawal by Subject|0|||
156485510|NCT01072396|564870760|FG000|Washout Period|Missing termination information|0|||
156485511|NCT01072396|564870761|FG001|Washout Period|Missing termination information|1|||
156485512|NCT01072396|564870760|FG000|Period Two|Adverse Event|0|||
156485513|NCT01072396|564870761|FG001|Period Two|Adverse Event|3|||
156485514|NCT01072396|564870760|FG000|Period Two|Lost to Follow-up|1|||
156485515|NCT01072396|564870761|FG001|Period Two|Lost to Follow-up|0|||
156485516|NCT01268488|564870762|FG000|Overall Study|Adverse Event|3|||
156485517|NCT01268488|564870762|FG000|Overall Study|Physician Decision|2|||
156485518|NCT02131155|564870764|FG000|Overall Study|Adverse Event|1|||
156485519|NCT02131155|564870765|FG001|Overall Study|Adverse Event|0|||
156485520|NCT02131155|564870764|FG000|Overall Study|Treatment completed|1|||
156485521|NCT02131155|564870765|FG001|Overall Study|Treatment completed|0|||
156485522|NCT02131155|564870764|FG000|Overall Study|Primary tumour recurrence|2|||
156485523|NCT02131155|564870765|FG001|Overall Study|Primary tumour recurrence|1|||
156485524|NCT02131155|564870764|FG000|Overall Study|Refused to continue study medication|1|||
156485525|NCT02131155|564870765|FG001|Overall Study|Refused to continue study medication|0|||
156485526|NCT02131155|564870764|FG000|Overall Study|Study early termination|20|||
156485527|NCT02131155|564870765|FG001|Overall Study|Study early termination|10|||
156485528|NCT01014013|564870768|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
156485529|NCT01014013|564870769|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
156485530|NCT01014013|564870768|FG000|Overall Study|Clinical adverse experience|4|||
156485531|NCT01014013|564870769|FG001|Overall Study|Clinical adverse experience|2|||
156485532|NCT01014013|564870768|FG000|Overall Study|Laboratory adverse experience|1|||
156485533|NCT01014013|564870769|FG001|Overall Study|Laboratory adverse experience|1|||
156485534|NCT01014013|564870768|FG000|Overall Study|Protocol Violation|1|||
156485535|NCT01014013|564870769|FG001|Overall Study|Protocol Violation|3|||
156485536|NCT01014013|564870768|FG000|Overall Study|Withdrawal by Subject|7|||
156485537|NCT01014013|564870769|FG001|Overall Study|Withdrawal by Subject|4|||
156485538|NCT01014013|564870768|FG000|Overall Study|Clinical/microbiologic failure|1|||
156485539|NCT01014013|564870769|FG001|Overall Study|Clinical/microbiologic failure|2|||
156485540|NCT01014013|564870768|FG000|Overall Study|Pathogen culture = no growth|26|||
156485541|NCT01014013|564870769|FG001|Overall Study|Pathogen culture = no growth|34|||
156485542|NCT01014013|564870768|FG000|Overall Study|Negative urine culture|2|||
156485543|NCT01014013|564870769|FG001|Overall Study|Negative urine culture|0|||
156485544|NCT01014013|564870768|FG000|Overall Study|Pathogen resistant|7|||
156485545|NCT01014013|564870769|FG001|Overall Study|Pathogen resistant|4|||
156485546|NCT01014013|564870768|FG000|Overall Study|Physician Decision|0|||
156485547|NCT01014013|564870769|FG001|Overall Study|Physician Decision|1|||
156485548|NCT01014013|564870768|FG000|Overall Study|Another antibiotic therapy required|0|||
156485549|NCT01014013|564870769|FG001|Overall Study|Another antibiotic therapy required|1|||
156485550|NCT01014013|564870768|FG000|Overall Study|Appendectomy|1|||
156485551|NCT01014013|564870769|FG001|Overall Study|Appendectomy|0|||
156485552|NCT01014013|564870768|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
156485553|NCT01014013|564870769|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
156485554|NCT03575572|564870770|FG000|Overall Study|Withdrawal by Subject|2|||
156485555|NCT03575572|564870770|FG000|Overall Study|Physician Decision|2|||
156485556|NCT04908800|564870771|FG000|Overall Study|Adverse Event|0|||
156485557|NCT04908800|564870772|FG001|Overall Study|Adverse Event|0|||
156485558|NCT04908800|564870773|FG002|Overall Study|Adverse Event|0|||
156485559|NCT04908800|564870774|FG003|Overall Study|Adverse Event|0|||
156485560|NCT04908800|564870775|FG004|Overall Study|Adverse Event|0|||
156485561|NCT04908800|564870776|FG005|Overall Study|Adverse Event|0|||
156485562|NCT04908800|564870777|FG006|Overall Study|Adverse Event|0|||
156485563|NCT04908800|564870778|FG007|Overall Study|Adverse Event|0|||
156485564|NCT04908800|564870779|FG008|Overall Study|Adverse Event|0|||
156485565|NCT04908800|564870780|FG009|Overall Study|Adverse Event|0|||
156485566|NCT04908800|564870781|FG010|Overall Study|Adverse Event|1|||
156485567|NCT04908800|564870782|FG011|Overall Study|Adverse Event|0|||
156485568|NCT04908800|564870783|FG012|Overall Study|Adverse Event|0|||
156485569|NCT03751280|564870784|FG000|Overall Study|Adverse Event|0|||
156485570|NCT03751280|564870785|FG001|Overall Study|Adverse Event|1|||
156485571|NCT03751280|564870784|FG000|Overall Study|Lost to Follow-up|3|||
156485572|NCT03751280|564870785|FG001|Overall Study|Lost to Follow-up|5|||
156485573|NCT03751280|564870784|FG000|Overall Study|Physician Decision|0|||
156485574|NCT03751280|564870785|FG001|Overall Study|Physician Decision|2|||
156485575|NCT03751280|564870784|FG000|Overall Study|Protocol Violation|0|||
156485576|NCT03751280|564870785|FG001|Overall Study|Protocol Violation|2|||
156485577|NCT03751280|564870784|FG000|Overall Study|Withdrawal by Subject|5|||
156485578|NCT03751280|564870785|FG001|Overall Study|Withdrawal by Subject|2|||
156485579|NCT03647709|564870787|FG000|Overall Study|Lost to Follow-up|5|||
156485580|NCT03647709|564870787|FG000|Overall Study|Physician Decision|6|||
156485581|NCT03647709|564870787|FG000|Overall Study|Withdrawal by Subject|3|||
156485582|NCT01648699|564870788|FG000|Overall Study|Death|1|||
156485583|NCT01648699|564870788|FG000|Overall Study|Lost to Follow-up|2|||
156485584|NCT01648699|564870788|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
156485585|NCT01920178|564870789|FG000|Overall Study|Lost to Follow-up|2|||
156485586|NCT01920178|564870790|FG001|Overall Study|Lost to Follow-up|1|||
156485587|NCT03023878|564870791|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
156485588|NCT03023878|564870791|FG000|Pre-Study Run-In Period|Death|1|||
156485589|NCT03023878|564870791|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
156485590|NCT03023878|564870791|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
156485591|NCT03023878|564870791|FG000|Treatment Period|Disease Progression|1|||
156485592|NCT03023878|564870791|FG000|Treatment Period|Withdrawal by Subject|1|||
156485593|NCT03023878|564870791|FG000|Treatment Period|Adverse Event|1|||
156485594|NCT03023878|564870791|FG000|Long Term Follow-Up Period|Death|2|||
156485595|NCT00288353|564870792|FG000|Overall Study|Lack of Efficacy|2|||
156485596|NCT00288353|564870793|FG001|Overall Study|Lack of Efficacy|2|||
156485597|NCT00288353|564870792|FG000|Overall Study|Withdrawal by Subject|5|||
156485598|NCT00288353|564870793|FG001|Overall Study|Withdrawal by Subject|5|||
156485599|NCT04799587|564870794|FG000|Overall Study|Withdrawal by Subject|0|||
156485600|NCT04799587|564870795|FG001|Overall Study|Withdrawal by Subject|1|||
156485601|NCT00728884|564870796|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
156485602|NCT00728884|564870796|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
156485603|NCT02374476|564870805|FG000|VT Induced Ablation|Screening Failures|36|||
156485604|NCT02374476|564870806|FG001|VT Induced Ablation|Screening Failures|0|||
156485605|NCT02374476|564870807|FG002|VT Induced Ablation|Screening Failures|0|||
156485606|NCT02374476|564870805|FG000|Arm Assignment|Withdrawal by Subject|0|||
156485607|NCT02374476|564870806|FG001|Arm Assignment|Withdrawal by Subject|0|||
156485608|NCT02374476|564870807|FG002|Arm Assignment|Withdrawal by Subject|1|||
156485609|NCT05431543|564870808|FG000|Overall Study|Medical History|1|||
156485610|NCT05431543|564870809|FG001|Overall Study|Medical History|0|||
156485611|NCT05431543|564870810|FG002|Overall Study|Medical History|0|||
156485612|NCT02784535|564870811|FG000|Overall Study|Adverse Event|1|||
156544492|NCT00705783|565087779|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
156485613|NCT02784535|564870812|FG001|Overall Study|Adverse Event|0|||
156485614|NCT02784535|564870811|FG000|Overall Study|Withdrawal by Subject|0|||
156485615|NCT02784535|564870812|FG001|Overall Study|Withdrawal by Subject|1|||
156485616|NCT02784535|564870811|FG000|Overall Study|Physician Decision|0|||
156485617|NCT02784535|564870812|FG001|Overall Study|Physician Decision|1|||
156485618|NCT00914732|564870813|FG000|Overall Study|Lost to Follow-up|6|||
156485619|NCT00914732|564870814|FG001|Overall Study|Lost to Follow-up|7|||
156485620|NCT00914732|564870815|FG002|Overall Study|Lost to Follow-up|9|||
156485621|NCT00914732|564870813|FG000|Overall Study|Withdrawal by Subject|3|||
156485622|NCT00914732|564870814|FG001|Overall Study|Withdrawal by Subject|0|||
156485623|NCT00914732|564870815|FG002|Overall Study|Withdrawal by Subject|2|||
156485624|NCT00914732|564870813|FG000|Overall Study|Adverse Event|1|||
156485625|NCT00914732|564870814|FG001|Overall Study|Adverse Event|0|||
156485626|NCT00914732|564870815|FG002|Overall Study|Adverse Event|0|||
156485627|NCT03005106|564870818|FG000|Overall Study|Lost to Follow-up|16|||
156485628|NCT03005106|564870818|FG000|Overall Study|Adverse Event|1|||
156485629|NCT03005106|564870818|FG000|Overall Study|Physician Decision|1|||
156485630|NCT03005106|564870818|FG000|Overall Study|Death|2|||
156485631|NCT00321672|564870821|FG000|Overall Study|Withdrawal by Subject|5|||
156485632|NCT00321672|564870822|FG001|Overall Study|Withdrawal by Subject|1|||
156485633|NCT00321672|564870823|FG002|Overall Study|Withdrawal by Subject|2|||
156485634|NCT00321672|564870824|FG003|Overall Study|Withdrawal by Subject|0|||
156485635|NCT00321672|564870821|FG000|Overall Study|Noncompliance|1|||
156485636|NCT00321672|564870822|FG001|Overall Study|Noncompliance|2|||
156485637|NCT00321672|564870823|FG002|Overall Study|Noncompliance|1|||
156485638|NCT00321672|564870824|FG003|Overall Study|Noncompliance|0|||
156485639|NCT00321672|564870821|FG000|Overall Study|Adverse Event|1|||
156485640|NCT00321672|564870822|FG001|Overall Study|Adverse Event|1|||
156485641|NCT00321672|564870823|FG002|Overall Study|Adverse Event|0|||
156485642|NCT00321672|564870824|FG003|Overall Study|Adverse Event|0|||
156485643|NCT00321672|564870821|FG000|Overall Study|Lack of Efficacy|1|||
156485644|NCT00321672|564870822|FG001|Overall Study|Lack of Efficacy|1|||
156485645|NCT00321672|564870823|FG002|Overall Study|Lack of Efficacy|0|||
156485646|NCT00321672|564870824|FG003|Overall Study|Lack of Efficacy|0|||
156485647|NCT00321672|564870821|FG000|Overall Study|Lost to Follow-up|2|||
156485648|NCT00321672|564870822|FG001|Overall Study|Lost to Follow-up|0|||
156485649|NCT00321672|564870823|FG002|Overall Study|Lost to Follow-up|4|||
156485650|NCT00321672|564870824|FG003|Overall Study|Lost to Follow-up|2|||
156485651|NCT00321672|564870821|FG000|Overall Study|Death|1|||
156485652|NCT00321672|564870822|FG001|Overall Study|Death|0|||
156485653|NCT00321672|564870823|FG002|Overall Study|Death|0|||
156485654|NCT00321672|564870824|FG003|Overall Study|Death|0|||
156485655|NCT00321672|564870821|FG000|Overall Study|Too far to travel for visits|1|||
156485656|NCT00321672|564870822|FG001|Overall Study|Too far to travel for visits|0|||
156485657|NCT00321672|564870823|FG002|Overall Study|Too far to travel for visits|0|||
156485658|NCT00321672|564870824|FG003|Overall Study|Too far to travel for visits|0|||
156485659|NCT00321672|564870821|FG000|Overall Study|Incarcerated|0|||
156485660|NCT00321672|564870822|FG001|Overall Study|Incarcerated|0|||
156485661|NCT00321672|564870823|FG002|Overall Study|Incarcerated|2|||
156485662|NCT00321672|564870824|FG003|Overall Study|Incarcerated|0|||
156485663|NCT00321672|564870821|FG000|Overall Study|Moved out of state|0|||
156485664|NCT00321672|564870822|FG001|Overall Study|Moved out of state|1|||
156485665|NCT00321672|564870823|FG002|Overall Study|Moved out of state|1|||
156485666|NCT00321672|564870824|FG003|Overall Study|Moved out of state|0|||
156485667|NCT00321672|564870821|FG000|Overall Study|Protocol Violation|0|||
156485668|NCT00321672|564870822|FG001|Overall Study|Protocol Violation|0|||
156485669|NCT00321672|564870823|FG002|Overall Study|Protocol Violation|1|||
156485670|NCT00321672|564870824|FG003|Overall Study|Protocol Violation|0|||
156485671|NCT00321672|564870821|FG000|Overall Study|Diagnosis of testicular cancer|0|||
156485672|NCT00321672|564870822|FG001|Overall Study|Diagnosis of testicular cancer|1|||
156485673|NCT00321672|564870823|FG002|Overall Study|Diagnosis of testicular cancer|0|||
156485674|NCT00321672|564870824|FG003|Overall Study|Diagnosis of testicular cancer|0|||
156485675|NCT00321672|564870821|FG000|Overall Study|Extensive travel required for new job|0|||
156485676|NCT00321672|564870822|FG001|Overall Study|Extensive travel required for new job|1|||
156485677|NCT00321672|564870823|FG002|Overall Study|Extensive travel required for new job|0|||
156485678|NCT00321672|564870824|FG003|Overall Study|Extensive travel required for new job|0|||
156485679|NCT03953079|564870825|FG000|Core Study|Withdrawal by Subject|1|||
156485680|NCT03953079|564870826|FG001|Core Study|Withdrawal by Subject|2|||
156485681|NCT03953079|564870827|FG002|Core Study|Withdrawal by Subject|1|||
156485682|NCT03953079|564870825|FG000|Core Study|COVID-19|0|||
156485683|NCT03953079|564870826|FG001|Core Study|COVID-19|1|||
156485684|NCT03953079|564870827|FG002|Core Study|COVID-19|0|||
156485685|NCT03953079|564870825|FG000|Core Study|Difficulties leaving the house|0|||
156485686|NCT03953079|564870826|FG001|Core Study|Difficulties leaving the house|1|||
156485687|NCT03953079|564870827|FG002|Core Study|Difficulties leaving the house|0|||
156544493|NCT00705783|565087777|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
156485688|NCT03953079|564870825|FG000|Extension Study|Withdrawal by Subject|1|||
156485689|NCT03953079|564870826|FG001|Extension Study|Withdrawal by Subject|0|||
156485690|NCT03953079|564870827|FG002|Extension Study|Withdrawal by Subject|0|||
156485691|NCT03953079|564870825|FG000|Extension Study|Received Rescue Treatment|5|||
156485692|NCT03953079|564870826|FG001|Extension Study|Received Rescue Treatment|6|||
156485693|NCT03953079|564870827|FG002|Extension Study|Received Rescue Treatment|5|||
156485694|NCT02389894|564870829|FG000|Overall Study|Death|4|||
156485695|NCT02389894|564870830|FG001|Overall Study|Death|5|||
156485696|NCT02389894|564870831|FG002|Overall Study|Death|3|||
156485697|NCT02389894|564870829|FG000|Overall Study|Withdrawal by Subject|2|||
156485698|NCT02389894|564870830|FG001|Overall Study|Withdrawal by Subject|4|||
156485699|NCT02389894|564870831|FG002|Overall Study|Withdrawal by Subject|5|||
156485700|NCT02389894|564870829|FG000|Overall Study|Lost to Follow-up|2|||
156485701|NCT02389894|564870830|FG001|Overall Study|Lost to Follow-up|1|||
156485702|NCT02389894|564870831|FG002|Overall Study|Lost to Follow-up|1|||
156485703|NCT01429285|564870833|FG000|Overall Study|Protocol Violation|9|||
156485704|NCT01429285|564870834|FG001|Overall Study|Protocol Violation|4|||
156485705|NCT01429285|564870833|FG000|Overall Study|Missing Data|5|||
156485706|NCT01429285|564870834|FG001|Overall Study|Missing Data|3|||
156485707|NCT01429285|564870833|FG000|Overall Study|Erroneously Enrolled Twice|8|||
156485708|NCT01429285|564870834|FG001|Overall Study|Erroneously Enrolled Twice|2|||
156485709|NCT01288729|564870835|FG000|Overall Study|Withdrawal by Subject|1|||
156485710|NCT01288729|564870836|FG001|Overall Study|Withdrawal by Subject|0|||
156485711|NCT03214198|564870837|FG000|Overall Study|Case Report Forms Uncollected|18|||
156485712|NCT03214198|564870837|FG000|Overall Study|Protocol Deviation|18|||
156485713|NCT02442622|564870838|FG000|Overall Study|Withdrawal by Subject|3|||
156485714|NCT02442622|564870839|FG001|Overall Study|Withdrawal by Subject|1|||
156485715|NCT04448561|564870840|FG000|Overall Study|Noncompliance|1|||
156485716|NCT04448561|564870841|FG001|Overall Study|Noncompliance|0|||
156485717|NCT01002547|564872653|FG000|Overall Study|Withdrawal by Subject|4|||
156485718|NCT01002547|564872654|FG001|Overall Study|Withdrawal by Subject|0|||
156485719|NCT01002547|564872655|FG002|Overall Study|Withdrawal by Subject|5|||
156485720|NCT01002547|564872653|FG000|Overall Study|Lost to Follow-up|2|||
156485721|NCT01002547|564872654|FG001|Overall Study|Lost to Follow-up|1|||
156485722|NCT01002547|564872655|FG002|Overall Study|Lost to Follow-up|1|||
156544494|NCT00705783|565087778|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
156544495|NCT00705783|565087779|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
156485723|NCT01002547|564872653|FG000|Overall Study|Physician Decision|1|||
156485724|NCT01002547|564872654|FG001|Overall Study|Physician Decision|0|||
156485725|NCT01002547|564872655|FG002|Overall Study|Physician Decision|0|||
156485726|NCT01002547|564872653|FG000|Overall Study|Death|0|||
156485727|NCT01002547|564872654|FG001|Overall Study|Death|2|||
156485728|NCT01002547|564872655|FG002|Overall Study|Death|2|||
156485729|NCT01002547|564872653|FG000|Overall Study|Adverse Event|1|||
156485730|NCT01002547|564872654|FG001|Overall Study|Adverse Event|0|||
156485731|NCT01002547|564872655|FG002|Overall Study|Adverse Event|0|||
156485732|NCT00925288|564872658|FG000|Overall Study|Lost to Follow-up|9|||
156485733|NCT00925288|564872659|FG001|Overall Study|Lost to Follow-up|7|||
156485734|NCT00434577|564872660|FG000|Months 0-3|Serious Adverse Event|0|||
156485735|NCT00434577|564872661|FG001|Months 0-3|Serious Adverse Event|0|||
156485736|NCT00434577|564872662|FG002|Months 0-3|Serious Adverse Event|1|||
156485737|NCT00434577|564872663|FG003|Months 0-3|Serious Adverse Event|0|||
156485738|NCT00434577|564872664|FG004|Months 0-3|Serious Adverse Event|0|||
156485739|NCT00434577|564872660|FG000|Months 0-3|Adverse Event|0|||
156485740|NCT00434577|564872661|FG001|Months 0-3|Adverse Event|1|||
156485741|NCT00434577|564872662|FG002|Months 0-3|Adverse Event|1|||
156485742|NCT00434577|564872663|FG003|Months 0-3|Adverse Event|0|||
156485743|NCT00434577|564872664|FG004|Months 0-3|Adverse Event|0|||
156485744|NCT00434577|564872660|FG000|Months 0-3|Lost to Follow-up|0|||
156485745|NCT00434577|564872661|FG001|Months 0-3|Lost to Follow-up|0|||
156485746|NCT00434577|564872662|FG002|Months 0-3|Lost to Follow-up|0|||
156485747|NCT00434577|564872663|FG003|Months 0-3|Lost to Follow-up|0|||
156485748|NCT00434577|564872664|FG004|Months 0-3|Lost to Follow-up|2|||
156485749|NCT00434577|564872660|FG000|Months 0-3|Protocol Violation|1|||
156485750|NCT00434577|564872661|FG001|Months 0-3|Protocol Violation|0|||
156485751|NCT00434577|564872662|FG002|Months 0-3|Protocol Violation|1|||
156485752|NCT00434577|564872663|FG003|Months 0-3|Protocol Violation|0|||
156485753|NCT00434577|564872664|FG004|Months 0-3|Protocol Violation|0|||
156485754|NCT00434577|564872660|FG000|Months 0-3|Withdrawal by Subject|2|||
156485755|NCT00434577|564872661|FG001|Months 0-3|Withdrawal by Subject|1|||
156485756|NCT00434577|564872662|FG002|Months 0-3|Withdrawal by Subject|1|||
156485757|NCT00434577|564872663|FG003|Months 0-3|Withdrawal by Subject|1|||
156485758|NCT00434577|564872664|FG004|Months 0-3|Withdrawal by Subject|1|||
156485759|NCT00651937|564872665|FG000|Overall Study|Withdrawal by Subject|4|||
156485760|NCT00651937|564872666|FG001|Overall Study|Withdrawal by Subject|1|||
156485761|NCT01904019|564872669|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
156485762|NCT01904019|564872669|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
156485763|NCT01904019|564872669|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
156485764|NCT01904019|564872669|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
156485765|NCT01904019|564872669|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
156485766|NCT01904019|564872669|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
156485767|NCT00381888|564872670|FG000|Overall Study|Death|1|||
156485768|NCT00381888|564872670|FG000|Overall Study|Withdrawal by Subject|1|||
156485769|NCT00381888|564872670|FG000|Overall Study|Physician Decision|1|||
156485770|NCT00381888|564872670|FG000|Overall Study|Protocol Violation|9|||
156485771|NCT00381888|564872670|FG000|Overall Study|Had laparoscopic surgery|2|||
156485772|NCT00381888|564872670|FG000|Overall Study|Surgery was cancelled|2|||
156485773|NCT00381888|564872670|FG000|Overall Study|Adverse Event|1|||
156485774|NCT01537120|564872674|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
156485775|NCT01537120|564872674|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
156485776|NCT04816708|564872679|FG000|Overall Study|Lost to Follow-up|10|||
156485777|NCT04816708|564872680|FG001|Overall Study|Lost to Follow-up|4|||
156485778|NCT01732627|564872681|FG000|Overall Study|Withdrawal by Subject|1|||
156485779|NCT01732627|564872682|FG001|Overall Study|Withdrawal by Subject|0|||
156485780|NCT02475733|564872685|FG000|Overall Study|Withdrawal by Subject|1|||
156485781|NCT02475733|564872686|FG001|Overall Study|Withdrawal by Subject|0|||
156485782|NCT02475733|564872685|FG000|Overall Study|Physician Decision|1|||
156485783|NCT02475733|564872686|FG001|Overall Study|Physician Decision|0|||
156485784|NCT01887418|564872687|FG000|Overall Study|Travelling difficulties|0|||
156485785|NCT01887418|564872688|FG001|Overall Study|Travelling difficulties|0|||
156485786|NCT01887418|564872689|FG002|Overall Study|Travelling difficulties|1|||
156485787|NCT02744898|564872690|FG000|Overall Study|Progressive Disease|2|||
156485788|NCT02744898|564872690|FG000|Overall Study|Physician Decision|1|||
156485789|NCT02744898|564872690|FG000|Overall Study|Toxicity|1|||
156485790|NCT03508830|564872697|FG000|Overall Study|Withdrawal by Subject|3|||
156485791|NCT03508830|564872698|FG001|Overall Study|Withdrawal by Subject|4|||
156485792|NCT03508830|564872697|FG000|Overall Study|Physician Decision|2|||
156485793|NCT03508830|564872698|FG001|Overall Study|Physician Decision|2|||
156485794|NCT02522299|564872699|FG000|Overall Study|Adverse Event|2|||
156485795|NCT02522299|564872700|FG001|Overall Study|Adverse Event|0|||
156485796|NCT02522299|564872699|FG000|Overall Study|Physician Decision|0|||
156485797|NCT02522299|564872700|FG001|Overall Study|Physician Decision|1|||
156485798|NCT02522299|564872699|FG000|Overall Study|Withdrawal by Subject|2|||
156485799|NCT02522299|564872700|FG001|Overall Study|Withdrawal by Subject|0|||
156485800|NCT02097056|564872703|FG000|Overall Study|Protocol Violation|2|||
156485801|NCT02097056|564872703|FG000|Overall Study|Withdrawal by Subject|15|||
156485802|NCT02097056|564872703|FG000|Overall Study|Lost to Follow-up|2|||
156485803|NCT02097056|564872703|FG000|Overall Study|Adverse Event|37|||
156485804|NCT02097056|564872703|FG000|Overall Study|Other|2|||
156485805|NCT01446042|564872704|FG000|Overall Study|Withdrawal by Subject|12|||
156485806|NCT01446042|564872705|FG001|Overall Study|Withdrawal by Subject|2|||
156485807|NCT01446042|564872706|FG002|Overall Study|Withdrawal by Subject|4|||
156485808|NCT01446042|564872704|FG000|Overall Study|Adverse Event|1|||
156485809|NCT01446042|564872705|FG001|Overall Study|Adverse Event|0|||
156485810|NCT01446042|564872706|FG002|Overall Study|Adverse Event|4|||
156485811|NCT01446042|564872704|FG000|Overall Study|Lost to Follow-up|5|||
156485812|NCT01446042|564872705|FG001|Overall Study|Lost to Follow-up|0|||
156485813|NCT01446042|564872706|FG002|Overall Study|Lost to Follow-up|0|||
156485814|NCT01446042|564872704|FG000|Overall Study|Other reasons|2|||
156485815|NCT01446042|564872705|FG001|Overall Study|Other reasons|1|||
156485816|NCT01446042|564872706|FG002|Overall Study|Other reasons|1|||
156485817|NCT00296504|564872714|FG000|Interim Analysis|Withdrawal by Subject|8|||
156485818|NCT00296504|564872715|FG001|Interim Analysis|Withdrawal by Subject|0|||
156485819|NCT00296504|564872716|FG002|Interim Analysis|Withdrawal by Subject|12|||
156485820|NCT00296504|564872717|FG003|Interim Analysis|Withdrawal by Subject|0|||
156485821|NCT00296504|564872718|FG004|Interim Analysis|Withdrawal by Subject|5|||
156485822|NCT00296504|564872719|FG005|Interim Analysis|Withdrawal by Subject|5|||
156485823|NCT00296504|564872720|FG006|Interim Analysis|Withdrawal by Subject|9|||
156485824|NCT00296504|564872721|FG007|Interim Analysis|Withdrawal by Subject|3|||
156485825|NCT00296504|564872722|FG008|Interim Analysis|Withdrawal by Subject|0|||
156485826|NCT00296504|564872714|FG000|Interim Analysis|Lost to Follow-up|13|||
156485827|NCT00296504|564872715|FG001|Interim Analysis|Lost to Follow-up|3|||
156485828|NCT00296504|564872716|FG002|Interim Analysis|Lost to Follow-up|26|||
156485829|NCT00296504|564872717|FG003|Interim Analysis|Lost to Follow-up|8|||
156485830|NCT00296504|564872718|FG004|Interim Analysis|Lost to Follow-up|14|||
156485831|NCT00296504|564872719|FG005|Interim Analysis|Lost to Follow-up|4|||
156485832|NCT00296504|564872720|FG006|Interim Analysis|Lost to Follow-up|11|||
156544496|NCT00705783|565087777|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
156485833|NCT00296504|564872721|FG007|Interim Analysis|Lost to Follow-up|4|||
156485834|NCT00296504|564872722|FG008|Interim Analysis|Lost to Follow-up|0|||
156485835|NCT00296504|564872714|FG000|Interim Analysis|Clinical Progression|1|||
156485836|NCT00296504|564872715|FG001|Interim Analysis|Clinical Progression|0|||
156485837|NCT00296504|564872716|FG002|Interim Analysis|Clinical Progression|1|||
156485838|NCT00296504|564872717|FG003|Interim Analysis|Clinical Progression|1|||
156485839|NCT00296504|564872718|FG004|Interim Analysis|Clinical Progression|0|||
156485840|NCT00296504|564872719|FG005|Interim Analysis|Clinical Progression|2|||
156485841|NCT00296504|564872720|FG006|Interim Analysis|Clinical Progression|1|||
156485842|NCT00296504|564872721|FG007|Interim Analysis|Clinical Progression|2|||
156485843|NCT00296504|564872722|FG008|Interim Analysis|Clinical Progression|0|||
156485844|NCT00296504|564872714|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
156485845|NCT00296504|564872715|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
156485846|NCT00296504|564872716|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
156485847|NCT00296504|564872717|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
156485848|NCT00296504|564872718|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
156485849|NCT00296504|564872719|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
156485850|NCT00296504|564872720|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
156485851|NCT00296504|564872721|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
156485852|NCT00296504|564872722|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
156485853|NCT00296504|564872714|FG000|Interim Analysis|Adverse Event|0|||
156485854|NCT00296504|564872715|FG001|Interim Analysis|Adverse Event|0|||
156485855|NCT00296504|564872716|FG002|Interim Analysis|Adverse Event|13|||
156485856|NCT00296504|564872717|FG003|Interim Analysis|Adverse Event|4|||
156485857|NCT00296504|564872718|FG004|Interim Analysis|Adverse Event|6|||
156485858|NCT00296504|564872719|FG005|Interim Analysis|Adverse Event|3|||
156485859|NCT00296504|564872720|FG006|Interim Analysis|Adverse Event|4|||
156485860|NCT00296504|564872721|FG007|Interim Analysis|Adverse Event|5|||
156485861|NCT00296504|564872722|FG008|Interim Analysis|Adverse Event|0|||
156485862|NCT00296504|564872714|FG000|Interim Analysis|Protocol Violation|0|||
156485863|NCT00296504|564872715|FG001|Interim Analysis|Protocol Violation|0|||
156485864|NCT00296504|564872716|FG002|Interim Analysis|Protocol Violation|2|||
156485865|NCT00296504|564872717|FG003|Interim Analysis|Protocol Violation|0|||
156485866|NCT00296504|564872718|FG004|Interim Analysis|Protocol Violation|1|||
156485867|NCT00296504|564872719|FG005|Interim Analysis|Protocol Violation|0|||
156485868|NCT00296504|564872720|FG006|Interim Analysis|Protocol Violation|0|||
156485869|NCT00296504|564872721|FG007|Interim Analysis|Protocol Violation|1|||
156485870|NCT00296504|564872722|FG008|Interim Analysis|Protocol Violation|0|||
156485871|NCT00296504|564872714|FG000|Interim Analysis|Insufficient CD4 Response|0|||
156544497|NCT00705783|565087778|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
156485872|NCT00296504|564872715|FG001|Interim Analysis|Insufficient CD4 Response|0|||
156485873|NCT00296504|564872716|FG002|Interim Analysis|Insufficient CD4 Response|0|||
156485874|NCT00296504|564872717|FG003|Interim Analysis|Insufficient CD4 Response|0|||
156485875|NCT00296504|564872718|FG004|Interim Analysis|Insufficient CD4 Response|1|||
156485876|NCT00296504|564872719|FG005|Interim Analysis|Insufficient CD4 Response|1|||
156485877|NCT00296504|564872720|FG006|Interim Analysis|Insufficient CD4 Response|0|||
156485878|NCT00296504|564872721|FG007|Interim Analysis|Insufficient CD4 Response|0|||
156485879|NCT00296504|564872722|FG008|Interim Analysis|Insufficient CD4 Response|0|||
156485880|NCT00296504|564872714|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
156485881|NCT00296504|564872715|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
156485882|NCT00296504|564872716|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
156485883|NCT00296504|564872717|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
156485884|NCT00296504|564872718|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
156485885|NCT00296504|564872719|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
156485886|NCT00296504|564872720|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
156485887|NCT00296504|564872721|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
156485888|NCT00296504|564872722|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
156485889|NCT00296504|564872714|FG000|Interim Analysis|Pregnancy|4|||
156485890|NCT00296504|564872715|FG001|Interim Analysis|Pregnancy|1|||
156485891|NCT00296504|564872716|FG002|Interim Analysis|Pregnancy|4|||
156485892|NCT00296504|564872717|FG003|Interim Analysis|Pregnancy|2|||
156485893|NCT00296504|564872718|FG004|Interim Analysis|Pregnancy|0|||
156485894|NCT00296504|564872719|FG005|Interim Analysis|Pregnancy|1|||
156485895|NCT00296504|564872720|FG006|Interim Analysis|Pregnancy|1|||
156485896|NCT00296504|564872721|FG007|Interim Analysis|Pregnancy|1|||
156485897|NCT00296504|564872722|FG008|Interim Analysis|Pregnancy|0|||
156485898|NCT00296504|564872714|FG000|Interim Analysis|Death|1|||
156485899|NCT00296504|564872715|FG001|Interim Analysis|Death|0|||
156485900|NCT00296504|564872716|FG002|Interim Analysis|Death|3|||
156485901|NCT00296504|564872717|FG003|Interim Analysis|Death|0|||
156485902|NCT00296504|564872718|FG004|Interim Analysis|Death|0|||
156485903|NCT00296504|564872719|FG005|Interim Analysis|Death|0|||
156485904|NCT00296504|564872720|FG006|Interim Analysis|Death|0|||
156485905|NCT00296504|564872721|FG007|Interim Analysis|Death|0|||
156485906|NCT00296504|564872722|FG008|Interim Analysis|Death|0|||
156485907|NCT00296504|564872714|FG000|Interim Analysis|Participant Non-compliant|0|||
156485908|NCT00296504|564872715|FG001|Interim Analysis|Participant Non-compliant|1|||
156485909|NCT00296504|564872716|FG002|Interim Analysis|Participant Non-compliant|2|||
156485910|NCT00296504|564872717|FG003|Interim Analysis|Participant Non-compliant|1|||
156485911|NCT00296504|564872718|FG004|Interim Analysis|Participant Non-compliant|1|||
156485912|NCT00296504|564872719|FG005|Interim Analysis|Participant Non-compliant|3|||
156485913|NCT00296504|564872720|FG006|Interim Analysis|Participant Non-compliant|6|||
156485914|NCT00296504|564872721|FG007|Interim Analysis|Participant Non-compliant|2|||
156485915|NCT00296504|564872722|FG008|Interim Analysis|Participant Non-compliant|0|||
156485916|NCT00296504|564872714|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
156485917|NCT00296504|564872715|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
156485918|NCT00296504|564872716|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
156485919|NCT00296504|564872717|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
156485920|NCT00296504|564872718|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
156485921|NCT00296504|564872719|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
156485922|NCT00296504|564872720|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
156485923|NCT00296504|564872721|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
156485924|NCT00296504|564872722|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
156485925|NCT00296504|564872714|FG000|Interim Analysis|To Simplify Treatment|0|||
156485926|NCT00296504|564872715|FG001|Interim Analysis|To Simplify Treatment|0|||
156485927|NCT00296504|564872716|FG002|Interim Analysis|To Simplify Treatment|1|||
156485928|NCT00296504|564872717|FG003|Interim Analysis|To Simplify Treatment|0|||
156485929|NCT00296504|564872718|FG004|Interim Analysis|To Simplify Treatment|0|||
156485930|NCT00296504|564872719|FG005|Interim Analysis|To Simplify Treatment|0|||
156485931|NCT00296504|564872720|FG006|Interim Analysis|To Simplify Treatment|2|||
156485932|NCT00296504|564872721|FG007|Interim Analysis|To Simplify Treatment|0|||
156485933|NCT00296504|564872722|FG008|Interim Analysis|To Simplify Treatment|0|||
156485934|NCT00296504|564872714|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
156485935|NCT00296504|564872715|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
156485936|NCT00296504|564872716|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
156485937|NCT00296504|564872717|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
156485938|NCT00296504|564872718|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
156485939|NCT00296504|564872719|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
156485940|NCT00296504|564872720|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
156485941|NCT00296504|564872721|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
156485942|NCT00296504|564872722|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
156485943|NCT00296504|564872714|FG000|Interim Analysis|Participant Moved|1|||
156485944|NCT00296504|564872715|FG001|Interim Analysis|Participant Moved|0|||
156485945|NCT00296504|564872716|FG002|Interim Analysis|Participant Moved|1|||
156485946|NCT00296504|564872717|FG003|Interim Analysis|Participant Moved|0|||
156485947|NCT00296504|564872718|FG004|Interim Analysis|Participant Moved|0|||
156485948|NCT00296504|564872719|FG005|Interim Analysis|Participant Moved|1|||
156485949|NCT00296504|564872720|FG006|Interim Analysis|Participant Moved|1|||
156485950|NCT00296504|564872721|FG007|Interim Analysis|Participant Moved|0|||
156485951|NCT00296504|564872722|FG008|Interim Analysis|Participant Moved|0|||
156485952|NCT00296504|564872714|FG000|Interim Analysis|Participant Was Incarcerated|2|||
156485953|NCT00296504|564872715|FG001|Interim Analysis|Participant Was Incarcerated|0|||
156485954|NCT00296504|564872716|FG002|Interim Analysis|Participant Was Incarcerated|1|||
156485955|NCT00296504|564872717|FG003|Interim Analysis|Participant Was Incarcerated|0|||
156485956|NCT00296504|564872718|FG004|Interim Analysis|Participant Was Incarcerated|0|||
156485957|NCT00296504|564872719|FG005|Interim Analysis|Participant Was Incarcerated|0|||
156485958|NCT00296504|564872720|FG006|Interim Analysis|Participant Was Incarcerated|0|||
156485959|NCT00296504|564872721|FG007|Interim Analysis|Participant Was Incarcerated|0|||
156485960|NCT00296504|564872722|FG008|Interim Analysis|Participant Was Incarcerated|0|||
156485961|NCT00296504|564872714|FG000|Interim Analysis|Resistance to FPV|0|||
156485962|NCT00296504|564872715|FG001|Interim Analysis|Resistance to FPV|0|||
156485963|NCT00296504|564872716|FG002|Interim Analysis|Resistance to FPV|1|||
156485964|NCT00296504|564872717|FG003|Interim Analysis|Resistance to FPV|0|||
156485965|NCT00296504|564872718|FG004|Interim Analysis|Resistance to FPV|0|||
156485966|NCT00296504|564872719|FG005|Interim Analysis|Resistance to FPV|0|||
156485967|NCT00296504|564872720|FG006|Interim Analysis|Resistance to FPV|0|||
156485968|NCT00296504|564872721|FG007|Interim Analysis|Resistance to FPV|0|||
156485969|NCT00296504|564872722|FG008|Interim Analysis|Resistance to FPV|0|||
156485970|NCT00296504|564872714|FG000|Interim Analysis|Physician Decision|0|||
156485971|NCT00296504|564872715|FG001|Interim Analysis|Physician Decision|0|||
156485972|NCT00296504|564872716|FG002|Interim Analysis|Physician Decision|1|||
156485973|NCT00296504|564872717|FG003|Interim Analysis|Physician Decision|0|||
156544498|NCT00705783|565087779|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
156544499|NCT00705783|565087777|FG000|Depot Stabilization Phase|Adverse Event|17|||
156544500|NCT00705783|565087778|FG001|Depot Stabilization Phase|Adverse Event|0|||
156544501|NCT00705783|565087779|FG002|Depot Stabilization Phase|Adverse Event|0|||
156544502|NCT00705783|565087777|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
156544503|NCT00705783|565087778|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
156544504|NCT00705783|565087779|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
156544505|NCT00705783|565087777|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
156544506|NCT00705783|565087778|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
156544507|NCT00705783|565087779|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
156544508|NCT00705783|565087777|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
156544509|NCT00705783|565087778|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
156544510|NCT00705783|565087779|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
156544511|NCT00705783|565087777|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
156544512|NCT00705783|565087778|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
156544513|NCT00705783|565087779|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
156544514|NCT00705783|565087777|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
156544515|NCT00705783|565087778|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
156544516|NCT00705783|565087779|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
156544517|NCT00705783|565087777|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
156544518|NCT00705783|565087778|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
156544519|NCT00705783|565087779|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
156544520|NCT00705783|565087777|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
156544521|NCT00705783|565087778|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
156544522|NCT00705783|565087779|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
156544523|NCT00705783|565087777|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
156544524|NCT00705783|565087778|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
156544525|NCT00705783|565087779|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
156544526|NCT00705783|565087777|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
156544527|NCT00705783|565087778|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
156544528|NCT00705783|565087779|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
156544529|NCT00705783|565087777|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
156544530|NCT00705783|565087778|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
156544531|NCT00705783|565087779|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
156544532|NCT00705783|565087777|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
156544533|NCT00705783|565087778|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
156544534|NCT00705783|565087779|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
156544535|NCT02182687|565087780|FG000|Overall Study|Withdrawal by Subject|4|||
156544536|NCT02182687|565087781|FG001|Overall Study|Withdrawal by Subject|0|||
156544537|NCT02182687|565087780|FG000|Overall Study|Adverse Event|1|||
156544538|NCT02182687|565087781|FG001|Overall Study|Adverse Event|0|||
156544539|NCT02182687|565087780|FG000|Overall Study|Lost to Follow-up|0|||
156544540|NCT02182687|565087781|FG001|Overall Study|Lost to Follow-up|1|||
156544541|NCT01765920|565087787|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
156544542|NCT01765920|565087788|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
156544543|NCT01765920|565087787|FG000|Overall Study|Patient code disclosure|0|||
156544544|NCT01765920|565087788|FG001|Overall Study|Patient code disclosure|1|||
156544545|NCT02025907|565087789|FG000|Overall Study|Lack of Efficacy|1|||
156544546|NCT02025907|565087790|FG001|Overall Study|Lack of Efficacy|0|||
156544547|NCT02025907|565087789|FG000|Overall Study|Withdrawal by Subject|15|||
156485974|NCT00296504|564872718|FG004|Interim Analysis|Physician Decision|0|||
156544548|NCT02025907|565087790|FG001|Overall Study|Withdrawal by Subject|8|||
156544549|NCT02025907|565087789|FG000|Overall Study|Protocol Violation|2|||
156485975|NCT00296504|564872719|FG005|Interim Analysis|Physician Decision|0|||
156485976|NCT00296504|564872720|FG006|Interim Analysis|Physician Decision|0|||
156485977|NCT00296504|564872721|FG007|Interim Analysis|Physician Decision|0|||
156485978|NCT00296504|564872722|FG008|Interim Analysis|Physician Decision|0|||
156485979|NCT00296504|564872714|FG000|Interim Analysis|Principle Investigator Discretion|2|||
156485980|NCT00296504|564872715|FG001|Interim Analysis|Principle Investigator Discretion|0|||
156485981|NCT00296504|564872716|FG002|Interim Analysis|Principle Investigator Discretion|1|||
156485982|NCT00296504|564872717|FG003|Interim Analysis|Principle Investigator Discretion|1|||
156485983|NCT00296504|564872718|FG004|Interim Analysis|Principle Investigator Discretion|0|||
156485984|NCT00296504|564872719|FG005|Interim Analysis|Principle Investigator Discretion|0|||
156353991|NCT03557151|564394023|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
156485985|NCT00296504|564872720|FG006|Interim Analysis|Principle Investigator Discretion|0|||
156544550|NCT02025907|565087790|FG001|Overall Study|Protocol Violation|0|||
156485986|NCT00296504|564872721|FG007|Interim Analysis|Principle Investigator Discretion|0|||
156485987|NCT00296504|564872722|FG008|Interim Analysis|Principle Investigator Discretion|0|||
156353992|NCT02810392|564394024|FG000|Overall Study|Subject too ill to continue|1|||
156353993|NCT02810392|564394025|FG001|Overall Study|Subject too ill to continue|0|||
156353994|NCT02810392|564394024|FG000|Overall Study|COVID 19 research restrictions|0|||
156353995|NCT02810392|564394025|FG001|Overall Study|COVID 19 research restrictions|1|||
156353996|NCT00840294|564394026|FG000|Overall Study|Withdrawal by Subject|2|||
156353997|NCT00840294|564394027|FG001|Overall Study|Withdrawal by Subject|1|||
156353998|NCT00840294|564394026|FG000|Overall Study|Protocol Violation|1|||
156353999|NCT00840294|564394027|FG001|Overall Study|Protocol Violation|3|||
156354000|NCT00840294|564394026|FG000|Overall Study|Illness|0|||
156354001|NCT00840294|564394027|FG001|Overall Study|Illness|1|||
156354002|NCT02028065|564394032|FG000|Randomization Through Start Treatment|Not treated|1|||
156354003|NCT02028065|564394033|FG001|Randomization Through Start Treatment|Not treated|3|||
156354004|NCT02028065|564394034|FG002|Randomization Through Start Treatment|Not treated|3|||
156354005|NCT02028065|564394032|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
156354006|NCT02028065|564394033|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
156354007|NCT02028065|564394034|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
156354008|NCT02028065|564394032|FG000|Treatment Through Study Completion|Physician Decision|1|||
156354009|NCT02028065|564394033|FG001|Treatment Through Study Completion|Physician Decision|0|||
156354010|NCT02028065|564394034|FG002|Treatment Through Study Completion|Physician Decision|0|||
156354011|NCT02028065|564394032|FG000|Treatment Through Study Completion|Protocol Violation|1|||
156354012|NCT02028065|564394033|FG001|Treatment Through Study Completion|Protocol Violation|4|||
156354013|NCT02028065|564394034|FG002|Treatment Through Study Completion|Protocol Violation|0|||
156354014|NCT02028065|564394032|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
156354015|NCT02028065|564394033|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
156354016|NCT02028065|564394034|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
156354017|NCT02028065|564394032|FG000|Treatment Through Study Completion|Adverse Event|3|||
156354018|NCT02028065|564394033|FG001|Treatment Through Study Completion|Adverse Event|3|||
156354019|NCT02028065|564394034|FG002|Treatment Through Study Completion|Adverse Event|5|||
156354020|NCT04868890|564394035|FG000|Overall Study|Death|2|||
156354021|NCT04868890|564394036|FG001|Overall Study|Death|1|||
156354022|NCT04868890|564394035|FG000|Overall Study|Withdrawal by Subject|1|||
156354023|NCT04868890|564394036|FG001|Overall Study|Withdrawal by Subject|5|||
156354024|NCT02157298|564394044|FG000|Overall Study|Adverse Event|1|||
156354025|NCT02157298|564394045|FG001|Overall Study|Adverse Event|0|||
156354026|NCT02157298|564394044|FG000|Overall Study|Subject no longer meets study criteria|1|||
156354027|NCT02157298|564394045|FG001|Overall Study|Subject no longer meets study criteria|2|||
156354028|NCT02157298|564394044|FG000|Overall Study|Poor/Non-compliance|1|||
156354029|NCT02157298|564394045|FG001|Overall Study|Poor/Non-compliance|0|||
156354030|NCT02157298|564394044|FG000|Overall Study|Withdrawal by Subject|1|||
156354031|NCT02157298|564394045|FG001|Overall Study|Withdrawal by Subject|0|||
156354032|NCT03715764|564394046|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
156354033|NCT03715764|564394047|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
156354034|NCT03715764|564394046|FG000|3 Month Follow-up|Lost to Follow-up|2|||
156354035|NCT03715764|564394047|FG001|3 Month Follow-up|Lost to Follow-up|2|||
156354036|NCT03715764|564394046|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
156354037|NCT03715764|564394047|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
156354038|NCT03715764|564394046|FG000|6 Month Follow-up|Lost to Follow-up|3|||
156354039|NCT03715764|564394047|FG001|6 Month Follow-up|Lost to Follow-up|0|||
156354040|NCT03715764|564394046|FG000|12 Month Follow-up|Lost to Follow-up|2|||
156354041|NCT03715764|564394047|FG001|12 Month Follow-up|Lost to Follow-up|3|||
156354042|NCT03715764|564394046|FG000|12 Month Follow-up|Pregnancy|0|||
156354043|NCT03715764|564394047|FG001|12 Month Follow-up|Pregnancy|1|||
156354044|NCT03715764|564394046|FG000|12 Month Follow-up|Surgery|2|||
156354045|NCT03715764|564394047|FG001|12 Month Follow-up|Surgery|0|||
156354046|NCT03715764|564394046|FG000|12 Month Follow-up|Wrong address|1|||
156354047|NCT03715764|564394047|FG001|12 Month Follow-up|Wrong address|0|||
156354048|NCT03715764|564394046|FG000|12 Month Follow-up|No symptoms|1|||
156354049|NCT03715764|564394047|FG001|12 Month Follow-up|No symptoms|0|||
156354050|NCT03715764|564394046|FG000|12 Month Follow-up|Changed primary care centre|0|||
156354051|NCT03715764|564394047|FG001|12 Month Follow-up|Changed primary care centre|1|||
156354052|NCT01722071|564394051|FG000|Overall Study|Protocol Violation|1|||
156354053|NCT01722071|564394052|FG001|Overall Study|Protocol Violation|0|||
156354054|NCT03021265|564394053|FG000|Overall Study|Adverse Event|29|||
156354055|NCT03021265|564394053|FG000|Overall Study|Lack of Efficacy|3|||
156354056|NCT03021265|564394053|FG000|Overall Study|Improved|17|||
156354057|NCT03021265|564394053|FG000|Overall Study|Lost to Follow-up|67|||
156354058|NCT03021265|564394053|FG000|Overall Study|No reason given|2|||
156354059|NCT03021265|564394053|FG000|Overall Study|No visit since the first visit|4|||
156354060|NCT00818662|564394054|FG000|Overall Study|Adverse Event|5|||
156354061|NCT00818662|564394055|FG001|Overall Study|Adverse Event|14|||
156354062|NCT00818662|564394056|FG002|Overall Study|Adverse Event|4|||
156354063|NCT00818662|564394057|FG003|Overall Study|Adverse Event|3|||
156354064|NCT00818662|564394054|FG000|Overall Study|Withdrawal by Subject|5|||
156354065|NCT00818662|564394055|FG001|Overall Study|Withdrawal by Subject|4|||
156354066|NCT00818662|564394056|FG002|Overall Study|Withdrawal by Subject|2|||
156354067|NCT00818662|564394057|FG003|Overall Study|Withdrawal by Subject|2|||
156354068|NCT00818662|564394054|FG000|Overall Study|Death|1|||
156354069|NCT00818662|564394055|FG001|Overall Study|Death|3|||
156354070|NCT00818662|564394056|FG002|Overall Study|Death|0|||
156354071|NCT00818662|564394057|FG003|Overall Study|Death|0|||
156354072|NCT00818662|564394054|FG000|Overall Study|Physician Decision|1|||
156354073|NCT00818662|564394055|FG001|Overall Study|Physician Decision|0|||
156354074|NCT00818662|564394056|FG002|Overall Study|Physician Decision|0|||
156354075|NCT00818662|564394057|FG003|Overall Study|Physician Decision|0|||
156354076|NCT00818662|564394054|FG000|Overall Study|Lost to Follow-up|0|||
156354077|NCT00818662|564394055|FG001|Overall Study|Lost to Follow-up|0|||
156354078|NCT00818662|564394056|FG002|Overall Study|Lost to Follow-up|0|||
156354079|NCT00818662|564394057|FG003|Overall Study|Lost to Follow-up|1|||
156354080|NCT00818662|564394054|FG000|Overall Study|Unwilling or Unable to Participate|4|||
156354081|NCT00818662|564394055|FG001|Overall Study|Unwilling or Unable to Participate|6|||
156354082|NCT00818662|564394056|FG002|Overall Study|Unwilling or Unable to Participate|2|||
156354083|NCT00818662|564394057|FG003|Overall Study|Unwilling or Unable to Participate|4|||
156354084|NCT00818662|564394054|FG000|Overall Study|Protocol Violation|1|||
156354085|NCT00818662|564394055|FG001|Overall Study|Protocol Violation|1|||
156354086|NCT00818662|564394056|FG002|Overall Study|Protocol Violation|0|||
156354087|NCT00818662|564394057|FG003|Overall Study|Protocol Violation|0|||
156354088|NCT00818662|564394054|FG000|Overall Study|Requires a Prohibited Medication|1|||
156354089|NCT00818662|564394055|FG001|Overall Study|Requires a Prohibited Medication|0|||
156354090|NCT00818662|564394056|FG002|Overall Study|Requires a Prohibited Medication|0|||
156354091|NCT00818662|564394057|FG003|Overall Study|Requires a Prohibited Medication|0|||
156354092|NCT00818662|564394054|FG000|Overall Study|Safety Risk|1|||
156354093|NCT00818662|564394055|FG001|Overall Study|Safety Risk|1|||
156354094|NCT00818662|564394056|FG002|Overall Study|Safety Risk|0|||
156354095|NCT00818662|564394057|FG003|Overall Study|Safety Risk|1|||
156354096|NCT00818662|564394054|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
156354097|NCT00818662|564394055|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
156354098|NCT00818662|564394056|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
156354099|NCT00818662|564394057|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
156354100|NCT00818662|564394054|FG000|Overall Study|Participant's health declined|0|||
156354101|NCT00818662|564394055|FG001|Overall Study|Participant's health declined|0|||
156354102|NCT00818662|564394056|FG002|Overall Study|Participant's health declined|0|||
156354103|NCT00818662|564394057|FG003|Overall Study|Participant's health declined|1|||
156354104|NCT00818662|564394054|FG000|Overall Study|Caregiver to pursue other treatment|0|||
156354105|NCT00818662|564394055|FG001|Overall Study|Caregiver to pursue other treatment|1|||
156354106|NCT00818662|564394056|FG002|Overall Study|Caregiver to pursue other treatment|0|||
156354107|NCT00818662|564394057|FG003|Overall Study|Caregiver to pursue other treatment|0|||
156354108|NCT00818662|564394054|FG000|Overall Study|Moving out of state|0|||
156354109|NCT00818662|564394055|FG001|Overall Study|Moving out of state|0|||
156354110|NCT00818662|564394056|FG002|Overall Study|Moving out of state|0|||
156354111|NCT00818662|564394057|FG003|Overall Study|Moving out of state|1|||
156354112|NCT00818662|564394054|FG000|Overall Study|Declined move to another study site|1|||
156354113|NCT00818662|564394055|FG001|Overall Study|Declined move to another study site|0|||
156354114|NCT00818662|564394056|FG002|Overall Study|Declined move to another study site|0|||
156354115|NCT00818662|564394057|FG003|Overall Study|Declined move to another study site|0|||
156354116|NCT00818662|564394054|FG000|Overall Study|Change in living situation|0|||
156354117|NCT00818662|564394055|FG001|Overall Study|Change in living situation|0|||
156354118|NCT00818662|564394056|FG002|Overall Study|Change in living situation|0|||
156354119|NCT00818662|564394057|FG003|Overall Study|Change in living situation|1|||
156354120|NCT00818662|564394054|FG000|Overall Study|Study partner decision|0|||
156354121|NCT00818662|564394055|FG001|Overall Study|Study partner decision|0|||
156354122|NCT00818662|564394056|FG002|Overall Study|Study partner decision|0|||
156354123|NCT00818662|564394057|FG003|Overall Study|Study partner decision|1|||
156354124|NCT00818662|564394054|FG000|Overall Study|Admitted to long term nursing care|0|||
156354125|NCT00818662|564394055|FG001|Overall Study|Admitted to long term nursing care|1|||
156354126|NCT00818662|564394056|FG002|Overall Study|Admitted to long term nursing care|0|||
156354127|NCT00818662|564394057|FG003|Overall Study|Admitted to long term nursing care|0|||
156354128|NCT01338493|564394058|FG000|Enrolled|Withdrawal by Subject|1|||
156354129|NCT01338493|564394058|FG000|Enrolled|Patient not implanted|4|||
156354130|NCT01338493|564394058|FG000|Discharge|Death|1|||
156354131|NCT01338493|564394058|FG000|Discharge|Missed visit|1|||
156354132|NCT01338493|564394058|FG000|6 Months Follow up|Lost to Follow-up|11|||
156354133|NCT01338493|564394058|FG000|6 Months Follow up|Missed visit|8|||
156354134|NCT01338493|564394058|FG000|12 Months Follow up|Lost to Follow-up|9|||
156354135|NCT01698801|564394059|FG000|Treatment Phase|Adverse Event|4|||
156354136|NCT01698801|564394059|FG000|Treatment Phase|Protocol Violation|1|||
156354137|NCT01698801|564394059|FG000|Treatment Phase|Other|4|||
156354138|NCT01698801|564394059|FG000|Treatment Phase|Withdrawal by Subject|1|||
156354139|NCT01698801|564394059|FG000|Treatment Phase|Disease progression|1|||
156485988|NCT00296504|564872714|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
156485989|NCT00296504|564872715|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
156485990|NCT00296504|564872716|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
156485991|NCT00296504|564872717|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
156354140|NCT01698801|564394059|FG000|Follow Up Phase|Withdrawal by Subject|1|||
156354141|NCT01698801|564394059|FG000|Follow Up Phase|Death|4|||
156354142|NCT01705652|564394060|FG000|Overall Study|Adverse Event|1|||
156354143|NCT01705652|564394061|FG001|Overall Study|Adverse Event|0|||
156485992|NCT00296504|564872718|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
156485993|NCT00296504|564872719|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
156485994|NCT00296504|564872720|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
156485995|NCT00296504|564872721|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
156485996|NCT00296504|564872722|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
156485997|NCT00296504|564872714|FG000|Interim Analysis|Non-adherence|2|||
156485998|NCT00296504|564872715|FG001|Interim Analysis|Non-adherence|0|||
156485999|NCT00296504|564872716|FG002|Interim Analysis|Non-adherence|0|||
156486000|NCT00296504|564872717|FG003|Interim Analysis|Non-adherence|0|||
156486001|NCT00296504|564872718|FG004|Interim Analysis|Non-adherence|1|||
156486002|NCT00296504|564872719|FG005|Interim Analysis|Non-adherence|0|||
156486003|NCT00296504|564872720|FG006|Interim Analysis|Non-adherence|0|||
156486004|NCT00296504|564872721|FG007|Interim Analysis|Non-adherence|1|||
156486005|NCT00296504|564872722|FG008|Interim Analysis|Non-adherence|0|||
156486006|NCT00296504|564872714|FG000|Interim Analysis|Site Closing|1|||
156486007|NCT00296504|564872715|FG001|Interim Analysis|Site Closing|0|||
156486008|NCT00296504|564872716|FG002|Interim Analysis|Site Closing|0|||
156486009|NCT00296504|564872717|FG003|Interim Analysis|Site Closing|0|||
156354144|NCT01705652|564394060|FG000|Overall Study|Withdrawal by Subject|1|||
156354145|NCT01705652|564394061|FG001|Overall Study|Withdrawal by Subject|2|||
156354146|NCT01705652|564394060|FG000|Overall Study|non-compliance|1|||
156354147|NCT01705652|564394061|FG001|Overall Study|non-compliance|1|||
156354148|NCT00656474|564394062|FG000|Overall Study|Other Reason|1|||
156354149|NCT01614067|564394063|FG000|Overall Study|Pregnancy|1|||
156354150|NCT01614067|564394064|FG001|Overall Study|Pregnancy|0|||
156354151|NCT01614067|564394063|FG000|Overall Study|Physician Decision|6|||
156354152|NCT01614067|564394064|FG001|Overall Study|Physician Decision|5|||
156354153|NCT01614067|564394063|FG000|Overall Study|Withdrawal by Subject|0|||
156486010|NCT00296504|564872718|FG004|Interim Analysis|Site Closing|0|||
156486011|NCT00296504|564872719|FG005|Interim Analysis|Site Closing|1|||
156486012|NCT00296504|564872720|FG006|Interim Analysis|Site Closing|2|||
156486013|NCT00296504|564872721|FG007|Interim Analysis|Site Closing|0|||
156486014|NCT00296504|564872722|FG008|Interim Analysis|Site Closing|0|||
156486015|NCT00296504|564872714|FG000|Interim Analysis|Lack of Personnel at Site|1|||
156354154|NCT01614067|564394064|FG001|Overall Study|Withdrawal by Subject|1|||
156354155|NCT01614067|564394063|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
156354156|NCT01614067|564394064|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
156354157|NCT02062879|564394065|FG000|Overall Study|Withdrawal by Subject|4|||
156354158|NCT02062879|564394066|FG001|Overall Study|Withdrawal by Subject|1|||
156354159|NCT02998840|564394072|FG000|Overall Study|Lost to Follow-up|1|||
156354160|NCT02998840|564394073|FG001|Overall Study|Lost to Follow-up|1|||
156354161|NCT02998840|564394074|FG002|Overall Study|Lost to Follow-up|2|||
156354162|NCT02998840|564394075|FG003|Overall Study|Lost to Follow-up|3|||
156354163|NCT02998840|564394072|FG000|Overall Study|Withdrawal by Subject|1|||
156354164|NCT02998840|564394073|FG001|Overall Study|Withdrawal by Subject|1|||
156354165|NCT02998840|564394074|FG002|Overall Study|Withdrawal by Subject|0|||
156354166|NCT02998840|564394075|FG003|Overall Study|Withdrawal by Subject|1|||
156354167|NCT02998840|564394072|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
156354168|NCT02998840|564394073|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
156354169|NCT02998840|564394074|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
156354170|NCT02998840|564394075|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
156354171|NCT00665847|564394076|FG000|Overall Study|Adverse Event|8|||
156354172|NCT00665847|564394076|FG000|Overall Study|Withdrawal by Subject|2|||
156354173|NCT00665847|564394076|FG000|Overall Study|Subject non-compliant|8|||
156354174|NCT00665847|564394076|FG000|Overall Study|Subject reached a virologic endpoint|4|||
156354175|NCT00665847|564394076|FG000|Overall Study|Resistance to TMC125|1|||
156354176|NCT00665847|564394076|FG000|Overall Study|Subject ineligible to continue the trial|1|||
156354177|NCT00665847|564394076|FG000|Overall Study|Switch to Commercial Medication|1|||
156354178|NCT00511667|564394082|FG000|Overall Study|Adverse Event|1|||
156354179|NCT00511667|564394083|FG001|Overall Study|Adverse Event|0|||
156354180|NCT00511667|564394082|FG000|Overall Study|Protocol Violation|1|||
156354181|NCT00511667|564394083|FG001|Overall Study|Protocol Violation|1|||
156354182|NCT00511667|564394082|FG000|Overall Study|Withdrawal by Subject|2|||
156354183|NCT00511667|564394083|FG001|Overall Study|Withdrawal by Subject|0|||
156354184|NCT00511667|564394082|FG000|Overall Study|Site terminated|6|||
156354185|NCT00511667|564394083|FG001|Overall Study|Site terminated|1|||
156354186|NCT00511667|564394082|FG000|Overall Study|Other|2|||
156354187|NCT00511667|564394083|FG001|Overall Study|Other|1|||
156354188|NCT03564145|564394084|FG000|Overall Study|Adverse Event|4|||
156354189|NCT03564145|564394084|FG000|Overall Study|Lost to Follow-up|21|||
156354190|NCT03564145|564394084|FG000|Overall Study|Protocol Violation|2|||
156354191|NCT03564145|564394084|FG000|Overall Study|Withdrawal by Subject|48|||
156354192|NCT03564145|564394084|FG000|Overall Study|Study Terminated by Sponsor|146|||
156354193|NCT03564145|564394084|FG000|Overall Study|Physician Decision|1|||
156354194|NCT03564145|564394084|FG000|Overall Study|Other Than Specified|1|||
156354195|NCT03564145|564394084|FG000|Overall Study|Pregnancy|1|||
156354196|NCT02355691|564395672|FG000|Overall Study|Loss of Research Personnel|7|||
156354197|NCT02355691|564395673|FG001|Overall Study|Loss of Research Personnel|9|||
156354198|NCT02345811|564395674|FG000|First Intervention|Withdrawal by Subject|1|||
156354199|NCT02345811|564395675|FG001|First Intervention|Withdrawal by Subject|1|||
156354200|NCT01172847|564395676|FG000|Overall Study|Withdrawal by Subject|3|||
156354201|NCT01163279|564395677|FG000|Overall Study|Withdrawal by Subject|2|||
156354202|NCT01163279|564395678|FG001|Overall Study|Withdrawal by Subject|0|||
156354203|NCT02132767|564395679|FG000|Overall Study|Death|3|||
156354204|NCT02132767|564395680|FG001|Overall Study|Death|2|||
156354205|NCT02132767|564395679|FG000|Overall Study|Withdrawal by Subject|10|||
156354206|NCT02132767|564395680|FG001|Overall Study|Withdrawal by Subject|9|||
156354207|NCT02132767|564395679|FG000|Overall Study|Lost to Follow-up|4|||
156354208|NCT02132767|564395680|FG001|Overall Study|Lost to Follow-up|4|||
156354209|NCT00390858|564395681|FG000|Overall Study|Adverse Event|6|||
156354210|NCT00390858|564395682|FG001|Overall Study|Adverse Event|2|||
156354211|NCT00390858|564395681|FG000|Overall Study|Lack of Efficacy|0|||
156354212|NCT00390858|564395682|FG001|Overall Study|Lack of Efficacy|1|||
156354213|NCT00390858|564395681|FG000|Overall Study|Withdrawal by Subject|3|||
156354214|NCT00390858|564395682|FG001|Overall Study|Withdrawal by Subject|4|||
156354215|NCT00450450|564395689|FG000|Overall Study|Death|1|||
156354216|NCT00450450|564395690|FG001|Overall Study|Death|3|||
156354217|NCT00450450|564395689|FG000|Overall Study|Relapse|2|||
156354218|NCT00450450|564395690|FG001|Overall Study|Relapse|0|||
156354219|NCT00450450|564395689|FG000|Overall Study|Missing Data|2|||
156354220|NCT00450450|564395690|FG001|Overall Study|Missing Data|0|||
156354221|NCT04984993|564395691|FG000|Overall Study|Withdrawal by Subject|8|||
156354222|NCT04984993|564395692|FG001|Overall Study|Withdrawal by Subject|2|||
156354223|NCT04984993|564395691|FG000|Overall Study|Lost to Follow-up|2|||
156354224|NCT04984993|564395692|FG001|Overall Study|Lost to Follow-up|2|||
156354225|NCT04984993|564395691|FG000|Overall Study|Both patients moved to another country|4|||
156354226|NCT04984993|564395692|FG001|Overall Study|Both patients moved to another country|0|||
156354227|NCT01110707|564395693|FG000|Overall Study|Protocol Violation|0|||
156354228|NCT01110707|564395694|FG001|Overall Study|Protocol Violation|3|||
156354229|NCT03318315|564395695|FG000|Overall Study|Lost to Follow-up|3|||
156354230|NCT03318315|564395696|FG001|Overall Study|Lost to Follow-up|2|||
156354231|NCT03318315|564395697|FG002|Overall Study|Lost to Follow-up|1|||
156354232|NCT03318315|564395695|FG000|Overall Study|Protocol Violation|1|||
156544551|NCT02025907|565087789|FG000|Overall Study|Physician Decision|2|||
156544552|NCT02025907|565087790|FG001|Overall Study|Physician Decision|0|||
156544553|NCT02025907|565087789|FG000|Overall Study|Lost to Follow-up|2|||
156354233|NCT03318315|564395696|FG001|Overall Study|Protocol Violation|1|||
156354234|NCT03318315|564395697|FG002|Overall Study|Protocol Violation|1|||
156354235|NCT03318315|564395695|FG000|Overall Study|Withdrawal by Subject|0|||
156354236|NCT03318315|564395696|FG001|Overall Study|Withdrawal by Subject|0|||
156354237|NCT03318315|564395697|FG002|Overall Study|Withdrawal by Subject|2|||
156354238|NCT04008030|564395705|FG000|Pre-Treatment|Withdrawal by Subject|0|||
156354239|NCT04008030|564395706|FG001|Pre-Treatment|Withdrawal by Subject|0|||
156354240|NCT04008030|564395707|FG002|Pre-Treatment|Withdrawal by Subject|9|||
156354241|NCT04008030|564395705|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
156354242|NCT04008030|564395706|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
156354243|NCT04008030|564395707|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
156354244|NCT04008030|564395705|FG000|Pre-Treatment|Other reasons|0|||
156354245|NCT04008030|564395706|FG001|Pre-Treatment|Other reasons|1|||
156354246|NCT04008030|564395707|FG002|Pre-Treatment|Other reasons|6|||
156354247|NCT04008030|564395705|FG000|Treatment|Withdrawal by Subject|1|||
156354248|NCT04008030|564395706|FG001|Treatment|Withdrawal by Subject|1|||
156354249|NCT04008030|564395707|FG002|Treatment|Withdrawal by Subject|1|||
156354250|NCT04008030|564395705|FG000|Treatment|Death|2|||
156354251|NCT04008030|564395706|FG001|Treatment|Death|4|||
156354252|NCT04008030|564395707|FG002|Treatment|Death|0|||
156354253|NCT04008030|564395705|FG000|Treatment|Pregnancy|0|||
156354254|NCT04008030|564395706|FG001|Treatment|Pregnancy|1|||
156354255|NCT04008030|564395707|FG002|Treatment|Pregnancy|0|||
156354256|NCT04008030|564395705|FG000|Treatment|Participant no longer meets study criteria|0|||
156354257|NCT04008030|564395706|FG001|Treatment|Participant no longer meets study criteria|1|||
156354258|NCT04008030|564395707|FG002|Treatment|Participant no longer meets study criteria|0|||
156354259|NCT04008030|564395705|FG000|Treatment|Other reasons|5|||
156354260|NCT04008030|564395706|FG001|Treatment|Other reasons|13|||
156354261|NCT04008030|564395707|FG002|Treatment|Other reasons|6|||
156354262|NCT04008030|564395705|FG000|Treatment|Disease Progression|137|||
156354263|NCT04008030|564395706|FG001|Treatment|Disease Progression|82|||
156354264|NCT04008030|564395707|FG002|Treatment|Disease Progression|85|||
156354265|NCT04008030|564395705|FG000|Treatment|Study drug toxicity|28|||
156354266|NCT04008030|564395706|FG001|Treatment|Study drug toxicity|48|||
156354267|NCT04008030|564395707|FG002|Treatment|Study drug toxicity|8|||
156354268|NCT04008030|564395705|FG000|Treatment|Adverse Event unrelated to study drug|28|||
156354269|NCT04008030|564395706|FG001|Treatment|Adverse Event unrelated to study drug|22|||
156354270|NCT04008030|564395707|FG002|Treatment|Adverse Event unrelated to study drug|6|||
156354271|NCT04008030|564395705|FG000|Treatment|Maximum Clinical Benefit|0|||
156354272|NCT04008030|564395706|FG001|Treatment|Maximum Clinical Benefit|1|||
156354273|NCT04008030|564395707|FG002|Treatment|Maximum Clinical Benefit|9|||
156354274|NCT04008030|564395705|FG000|Treatment|On-going treatment|13|||
156354275|NCT04008030|564395706|FG001|Treatment|On-going treatment|20|||
156354276|NCT04008030|564395707|FG002|Treatment|On-going treatment|0|||
156354277|NCT00674661|564395708|FG000|Overall Study|Other|5|||
156354278|NCT00674661|564395709|FG001|Overall Study|Other|7|||
156354279|NCT00674661|564395708|FG000|Overall Study|Lost to Follow-up|6|||
156354280|NCT00674661|564395709|FG001|Overall Study|Lost to Follow-up|3|||
156354281|NCT00674661|564395708|FG000|Overall Study|Withdrawal by Subject|0|||
156354282|NCT00674661|564395709|FG001|Overall Study|Withdrawal by Subject|5|||
156354283|NCT02574247|564395712|FG000|Overall Study|Withdrawal by Subject|1|||
156354284|NCT02574247|564395713|FG001|Overall Study|Withdrawal by Subject|0|||
156354285|NCT02574247|564395714|FG002|Overall Study|Withdrawal by Subject|0|||
156354286|NCT02574247|564395712|FG000|Overall Study|Did not meet inclusion criteria|4|||
156354287|NCT02574247|564395713|FG001|Overall Study|Did not meet inclusion criteria|3|||
156354288|NCT02574247|564395714|FG002|Overall Study|Did not meet inclusion criteria|5|||
156354289|NCT02659631|564395717|FG000|Overall Study|Lost to Follow-up|0|||
156354290|NCT02659631|564395718|FG001|Overall Study|Lost to Follow-up|0|||
156354291|NCT02659631|564395719|FG002|Overall Study|Lost to Follow-up|2|||
156354292|NCT02659631|564395720|FG003|Overall Study|Lost to Follow-up|0|||
156354293|NCT02659631|564395721|FG004|Overall Study|Lost to Follow-up|0|||
156354294|NCT02659631|564395722|FG005|Overall Study|Lost to Follow-up|1|||
156354295|NCT02659631|564395723|FG006|Overall Study|Lost to Follow-up|0|||
156354296|NCT02659631|564395724|FG007|Overall Study|Lost to Follow-up|0|||
156354297|NCT02659631|564395725|FG008|Overall Study|Lost to Follow-up|0|||
156354298|NCT02659631|564395726|FG009|Overall Study|Lost to Follow-up|0|||
156354299|NCT02659631|564395717|FG000|Overall Study|Withdrawal prior to treatment|0|||
156354300|NCT02659631|564395718|FG001|Overall Study|Withdrawal prior to treatment|0|||
156354301|NCT02659631|564395719|FG002|Overall Study|Withdrawal prior to treatment|0|||
156354302|NCT02659631|564395720|FG003|Overall Study|Withdrawal prior to treatment|0|||
156354303|NCT02659631|564395721|FG004|Overall Study|Withdrawal prior to treatment|1|||
156544554|NCT02025907|565087790|FG001|Overall Study|Lost to Follow-up|2|||
156354304|NCT02659631|564395722|FG005|Overall Study|Withdrawal prior to treatment|0|||
156354305|NCT02659631|564395723|FG006|Overall Study|Withdrawal prior to treatment|0|||
156354306|NCT02659631|564395724|FG007|Overall Study|Withdrawal prior to treatment|0|||
156354307|NCT02659631|564395725|FG008|Overall Study|Withdrawal prior to treatment|0|||
156354308|NCT02659631|564395726|FG009|Overall Study|Withdrawal prior to treatment|0|||
156354309|NCT02659631|564395717|FG000|Overall Study|Participant refused further follow-up|0|||
156354310|NCT02659631|564395718|FG001|Overall Study|Participant refused further follow-up|0|||
156354311|NCT02659631|564395719|FG002|Overall Study|Participant refused further follow-up|0|||
156354312|NCT02659631|564395720|FG003|Overall Study|Participant refused further follow-up|1|||
156354313|NCT02659631|564395721|FG004|Overall Study|Participant refused further follow-up|0|||
156354314|NCT02659631|564395722|FG005|Overall Study|Participant refused further follow-up|0|||
156354315|NCT02659631|564395723|FG006|Overall Study|Participant refused further follow-up|0|||
156354316|NCT02659631|564395724|FG007|Overall Study|Participant refused further follow-up|0|||
156354317|NCT02659631|564395725|FG008|Overall Study|Participant refused further follow-up|1|||
156354318|NCT02659631|564395726|FG009|Overall Study|Participant refused further follow-up|0|||
156354319|NCT02659631|564395717|FG000|Overall Study|Death (follow-up phase)|1|||
156354320|NCT02659631|564395718|FG001|Overall Study|Death (follow-up phase)|2|||
156354321|NCT02659631|564395719|FG002|Overall Study|Death (follow-up phase)|1|||
156354322|NCT02659631|564395720|FG003|Overall Study|Death (follow-up phase)|1|||
156354323|NCT02659631|564395721|FG004|Overall Study|Death (follow-up phase)|3|||
156354324|NCT02659631|564395722|FG005|Overall Study|Death (follow-up phase)|2|||
156354325|NCT02659631|564395723|FG006|Overall Study|Death (follow-up phase)|0|||
156354326|NCT02659631|564395724|FG007|Overall Study|Death (follow-up phase)|3|||
156354327|NCT02659631|564395725|FG008|Overall Study|Death (follow-up phase)|1|||
156354328|NCT02659631|564395726|FG009|Overall Study|Death (follow-up phase)|0|||
156354329|NCT02659631|564395717|FG000|Overall Study|Death (treatment phase)|0|||
156354330|NCT02659631|564395718|FG001|Overall Study|Death (treatment phase)|0|||
156354331|NCT02659631|564395719|FG002|Overall Study|Death (treatment phase)|0|||
156354332|NCT02659631|564395720|FG003|Overall Study|Death (treatment phase)|0|||
156354333|NCT02659631|564395721|FG004|Overall Study|Death (treatment phase)|1|||
156354334|NCT02659631|564395722|FG005|Overall Study|Death (treatment phase)|0|||
156354335|NCT02659631|564395723|FG006|Overall Study|Death (treatment phase)|1|||
156354336|NCT02659631|564395724|FG007|Overall Study|Death (treatment phase)|0|||
156354337|NCT02659631|564395725|FG008|Overall Study|Death (treatment phase)|0|||
156354338|NCT02659631|564395726|FG009|Overall Study|Death (treatment phase)|0|||
156354339|NCT02377466|564395727|FG000|Overall Study|Other: Randomized and not treated|0|||
156354340|NCT02377466|564395728|FG001|Overall Study|Other: Randomized and not treated|2|||
156354341|NCT02612428|564395729|FG000|VTL-308|Death|14|||
156354342|NCT02612428|564395730|FG001|VTL-308|Death|16|||
156354343|NCT02612428|564395729|FG000|VTL-308|Withdrawal by Subject|0|||
156354344|NCT02612428|564395730|FG001|VTL-308|Withdrawal by Subject|1|||
156354345|NCT02612428|564395729|FG000|VTL-308E|Death|9|||
156354346|NCT02612428|564395730|FG001|VTL-308E|Death|7|||
156354347|NCT02612428|564395729|FG000|VTL-308E|Lost to Follow-up|2|||
156354348|NCT02612428|564395730|FG001|VTL-308E|Lost to Follow-up|0|||
156354349|NCT00742001|564395733|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
156354350|NCT00742001|564395734|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
156354351|NCT00742001|564395735|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
156354352|NCT00137423|564395736|FG000|Overall Study|Adverse Event|7|||
156354353|NCT00137423|564395737|FG001|Overall Study|Adverse Event|9|||
156354354|NCT00137423|564395736|FG000|Overall Study|consent withdrawn|1|||
156354355|NCT00137423|564395737|FG001|Overall Study|consent withdrawn|1|||
156354356|NCT00137423|564395736|FG000|Overall Study|Lack of Efficacy|31|||
156354357|NCT00137423|564395737|FG001|Overall Study|Lack of Efficacy|33|||
156354358|NCT00137423|564395736|FG000|Overall Study|Death|0|||
156354359|NCT00137423|564395737|FG001|Overall Study|Death|1|||
156354360|NCT03187262|564395739|FG000|Induction|Lack of Efficacy|2|||
156354361|NCT03187262|564395739|FG000|Induction|Progressive Disease|4|||
156354362|NCT03187262|564395739|FG000|Consolidation|Progressive Disease|5|||
156354363|NCT01496313|564395740|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
156354364|NCT01496313|564395741|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
156354365|NCT01496313|564395742|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
156354366|NCT01496313|564395743|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
156354367|NCT01496313|564395744|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
156354368|NCT01496313|564395745|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
156354369|NCT01496313|564395740|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
156354370|NCT01496313|564395741|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
156354371|NCT01496313|564395742|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
156354372|NCT01496313|564395743|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
156354373|NCT01496313|564395744|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
156354374|NCT01496313|564395745|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
156486016|NCT00296504|564872715|FG001|Interim Analysis|Lack of Personnel at Site|0|||
156354375|NCT01496313|564395740|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156354376|NCT01496313|564395741|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
156354377|NCT01496313|564395742|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156354378|NCT01496313|564395743|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156354379|NCT01496313|564395744|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156354380|NCT01496313|564395745|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156354381|NCT01496313|564395740|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
156354382|NCT01496313|564395741|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
156354383|NCT01496313|564395742|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
156354384|NCT01496313|564395743|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
156354385|NCT01496313|564395744|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
156354386|NCT01496313|564395745|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
156354387|NCT01496313|564395740|FG000|Randomized Period (up to 14 Months)|Other|1|||
156354388|NCT01496313|564395741|FG001|Randomized Period (up to 14 Months)|Other|2|||
156354389|NCT01496313|564395742|FG002|Randomized Period (up to 14 Months)|Other|0|||
156354390|NCT01496313|564395743|FG003|Randomized Period (up to 14 Months)|Other|0|||
156354391|NCT01496313|564395744|FG004|Randomized Period (up to 14 Months)|Other|0|||
156354392|NCT01496313|564395745|FG005|Randomized Period (up to 14 Months)|Other|0|||
156354393|NCT01496313|564395740|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156354394|NCT01496313|564395741|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156354395|NCT01496313|564395742|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156354396|NCT01496313|564395743|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156354397|NCT01496313|564395744|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156354398|NCT01496313|564395745|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
156354399|NCT01496313|564395740|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156354400|NCT01496313|564395741|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156354401|NCT01496313|564395742|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156354402|NCT01496313|564395743|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156354403|NCT01496313|564395744|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156354404|NCT01496313|564395745|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
156354405|NCT01496313|564395740|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
156354406|NCT01496313|564395741|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
156354407|NCT01496313|564395742|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
156354408|NCT01496313|564395743|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
156354409|NCT01496313|564395744|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
156354410|NCT01496313|564395745|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
156354411|NCT00451321|564395750|FG000|Overall Study|Lost to Follow-up|3|||
156354412|NCT00451321|564395751|FG001|Overall Study|Lost to Follow-up|3|||
156354413|NCT00451321|564395752|FG002|Overall Study|Lost to Follow-up|1|||
156354414|NCT00451321|564395753|FG003|Overall Study|Lost to Follow-up|3|||
156354415|NCT00451321|564395754|FG004|Overall Study|Lost to Follow-up|0|||
156354416|NCT00451321|564395755|FG005|Overall Study|Lost to Follow-up|1|||
156354417|NCT00451321|564395756|FG006|Overall Study|Lost to Follow-up|0|||
156354418|NCT00451321|564395757|FG007|Overall Study|Lost to Follow-up|0|||
156354419|NCT00451321|564395750|FG000|Overall Study|Withdrawal by Subject|3|||
156354420|NCT00451321|564395751|FG001|Overall Study|Withdrawal by Subject|1|||
156354421|NCT00451321|564395752|FG002|Overall Study|Withdrawal by Subject|0|||
156354422|NCT00451321|564395753|FG003|Overall Study|Withdrawal by Subject|4|||
156354423|NCT00451321|564395754|FG004|Overall Study|Withdrawal by Subject|0|||
156354424|NCT00451321|564395755|FG005|Overall Study|Withdrawal by Subject|0|||
156354425|NCT00451321|564395756|FG006|Overall Study|Withdrawal by Subject|0|||
156354426|NCT00451321|564395757|FG007|Overall Study|Withdrawal by Subject|0|||
156354427|NCT00451321|564395750|FG000|Overall Study|Study closed/terminated|1|||
156354428|NCT00451321|564395751|FG001|Overall Study|Study closed/terminated|1|||
156354429|NCT00451321|564395752|FG002|Overall Study|Study closed/terminated|17|||
156354430|NCT00451321|564395753|FG003|Overall Study|Study closed/terminated|5|||
156354431|NCT00451321|564395754|FG004|Overall Study|Study closed/terminated|7|||
156354432|NCT00451321|564395755|FG005|Overall Study|Study closed/terminated|7|||
156354433|NCT00451321|564395756|FG006|Overall Study|Study closed/terminated|5|||
156354434|NCT00451321|564395757|FG007|Overall Study|Study closed/terminated|3|||
156354435|NCT00451321|564395750|FG000|Overall Study|Sponsor decision to amend protocol|0|||
156354436|NCT00451321|564395751|FG001|Overall Study|Sponsor decision to amend protocol|0|||
156354437|NCT00451321|564395752|FG002|Overall Study|Sponsor decision to amend protocol|0|||
156354438|NCT00451321|564395753|FG003|Overall Study|Sponsor decision to amend protocol|0|||
156354439|NCT00451321|564395754|FG004|Overall Study|Sponsor decision to amend protocol|0|||
156354440|NCT00451321|564395755|FG005|Overall Study|Sponsor decision to amend protocol|1|||
156354441|NCT00451321|564395756|FG006|Overall Study|Sponsor decision to amend protocol|1|||
156354442|NCT00451321|564395757|FG007|Overall Study|Sponsor decision to amend protocol|3|||
156486017|NCT00296504|564872716|FG002|Interim Analysis|Lack of Personnel at Site|0|||
156486018|NCT00296504|564872717|FG003|Interim Analysis|Lack of Personnel at Site|0|||
156486019|NCT00296504|564872718|FG004|Interim Analysis|Lack of Personnel at Site|0|||
156486020|NCT00296504|564872719|FG005|Interim Analysis|Lack of Personnel at Site|0|||
156486021|NCT00296504|564872720|FG006|Interim Analysis|Lack of Personnel at Site|0|||
156486022|NCT00296504|564872721|FG007|Interim Analysis|Lack of Personnel at Site|0|||
156354443|NCT00909389|564395763|FG000|Overall Study|Adverse Event|6|||
156354444|NCT00909389|564395763|FG000|Overall Study|Death|4|||
156354445|NCT00909389|564395763|FG000|Overall Study|Poor Compliance|16|||
156354446|NCT00909389|564395763|FG000|Overall Study|Lost to Follow-up|4|||
156354447|NCT00909389|564395763|FG000|Overall Study|No Information|103|||
156354448|NCT00737282|564395768|FG000|Overall Study|Study prematurely terminated|175|||
156354449|NCT02763189|564395769|FG000|Overall Study|Device failure|0|||
156354450|NCT02763189|564395770|FG001|Overall Study|Device failure|2|||
156354451|NCT01361464|564395771|FG000|Overall Study|Death|1|||
156354452|NCT01361464|564395771|FG000|Overall Study|Withdrawal by Subject|2|||
156354453|NCT01106898|564395772|FG000|Overall Study|Adverse Event|6|||
156354454|NCT01686633|564395773|FG000|Overall Study|Lack of Efficacy|33|||
156354455|NCT01686633|564395774|FG001|Overall Study|Lack of Efficacy|13|||
156354456|NCT01686633|564395775|FG002|Overall Study|Lack of Efficacy|11|||
156354457|NCT01686633|564395773|FG000|Overall Study|Withdrawal by Subject|8|||
156354458|NCT01686633|564395774|FG001|Overall Study|Withdrawal by Subject|8|||
156354459|NCT01686633|564395775|FG002|Overall Study|Withdrawal by Subject|5|||
156354460|NCT01686633|564395773|FG000|Overall Study|Physician Decision|3|||
156354461|NCT01686633|564395774|FG001|Overall Study|Physician Decision|4|||
156354462|NCT01686633|564395775|FG002|Overall Study|Physician Decision|4|||
156354463|NCT01686633|564395773|FG000|Overall Study|Adverse Event|4|||
156354464|NCT01686633|564395774|FG001|Overall Study|Adverse Event|3|||
156354465|NCT01686633|564395775|FG002|Overall Study|Adverse Event|3|||
156354466|NCT01686633|564395773|FG000|Overall Study|Protocol Violation|2|||
156354467|NCT01686633|564395774|FG001|Overall Study|Protocol Violation|3|||
156354468|NCT01686633|564395775|FG002|Overall Study|Protocol Violation|0|||
156354469|NCT01686633|564395773|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
156354470|NCT01686633|564395774|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
156354471|NCT01686633|564395775|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
156354472|NCT01686633|564395773|FG000|Overall Study|Lost to Follow-up|0|||
156354473|NCT01686633|564395774|FG001|Overall Study|Lost to Follow-up|1|||
156354474|NCT01686633|564395775|FG002|Overall Study|Lost to Follow-up|1|||
156354475|NCT00056407|564395776|FG000|Overall Study|Adverse Event|282|||
156354476|NCT00056407|564395777|FG001|Overall Study|Adverse Event|364|||
156354477|NCT00056407|564395776|FG000|Overall Study|Withdrawal by Subject|377|||
156354478|NCT00056407|564395777|FG001|Overall Study|Withdrawal by Subject|361|||
156354479|NCT00056407|564395776|FG000|Overall Study|Lost to Follow-up|123|||
156354480|NCT00056407|564395777|FG001|Overall Study|Lost to Follow-up|113|||
156354481|NCT00056407|564395776|FG000|Overall Study|Protocol Violation|104|||
156354482|NCT00056407|564395777|FG001|Overall Study|Protocol Violation|95|||
156354483|NCT00056407|564395776|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
156354484|NCT00056407|564395777|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
156354485|NCT00056407|564395776|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
156354486|NCT00056407|564395777|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
156354487|NCT00056407|564395776|FG000|Overall Study|Missing|25|||
156354488|NCT00056407|564395777|FG001|Overall Study|Missing|34|||
156354489|NCT00616655|564395778|FG000|Overall Study|Adverse Event|10|||
156354490|NCT00616655|564395779|FG001|Overall Study|Adverse Event|7|||
156354491|NCT00616655|564395780|FG002|Overall Study|Adverse Event|12|||
156354492|NCT00616655|564395778|FG000|Overall Study|Lack of Efficacy|5|||
156354493|NCT00616655|564395779|FG001|Overall Study|Lack of Efficacy|5|||
156486023|NCT00296504|564872722|FG008|Interim Analysis|Lack of Personnel at Site|0|||
156486024|NCT00296504|564872714|FG000|Interim Analysis|Missed Schedule Date|1|||
156486025|NCT00296504|564872715|FG001|Interim Analysis|Missed Schedule Date|0|||
156486026|NCT00296504|564872716|FG002|Interim Analysis|Missed Schedule Date|0|||
156486027|NCT00296504|564872717|FG003|Interim Analysis|Missed Schedule Date|0|||
156486028|NCT00296504|564872718|FG004|Interim Analysis|Missed Schedule Date|0|||
156486029|NCT00296504|564872719|FG005|Interim Analysis|Missed Schedule Date|0|||
156486030|NCT00296504|564872720|FG006|Interim Analysis|Missed Schedule Date|0|||
156486031|NCT00296504|564872721|FG007|Interim Analysis|Missed Schedule Date|0|||
156486032|NCT00296504|564872722|FG008|Interim Analysis|Missed Schedule Date|0|||
156354494|NCT00616655|564395780|FG002|Overall Study|Lack of Efficacy|5|||
156354495|NCT00616655|564395778|FG000|Overall Study|Lost to Follow-up|3|||
156354496|NCT00616655|564395779|FG001|Overall Study|Lost to Follow-up|12|||
156354497|NCT00616655|564395780|FG002|Overall Study|Lost to Follow-up|10|||
156354498|NCT00616655|564395778|FG000|Overall Study|Protocol Violation|2|||
156354499|NCT00616655|564395779|FG001|Overall Study|Protocol Violation|4|||
156486033|NCT00296504|564872714|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
156354500|NCT00616655|564395780|FG002|Overall Study|Protocol Violation|3|||
156354501|NCT00616655|564395778|FG000|Overall Study|Withdrawal by Subject|9|||
156354502|NCT00616655|564395779|FG001|Overall Study|Withdrawal by Subject|7|||
156544555|NCT02025907|565087789|FG000|Overall Study|Adverse Event|3|||
156486034|NCT00296504|564872715|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
156486035|NCT00296504|564872716|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
156486036|NCT00296504|564872717|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
156486037|NCT00296504|564872718|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
156486038|NCT00296504|564872719|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
156486039|NCT00296504|564872720|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
156486040|NCT00296504|564872721|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
156486041|NCT00296504|564872722|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
156486042|NCT00296504|564872714|FG000|Interim Analysis|Participant Stopped|0|||
156486043|NCT00296504|564872715|FG001|Interim Analysis|Participant Stopped|0|||
156486044|NCT00296504|564872716|FG002|Interim Analysis|Participant Stopped|0|||
156486045|NCT00296504|564872717|FG003|Interim Analysis|Participant Stopped|0|||
156486046|NCT00296504|564872718|FG004|Interim Analysis|Participant Stopped|1|||
156486047|NCT00296504|564872719|FG005|Interim Analysis|Participant Stopped|0|||
156486048|NCT00296504|564872720|FG006|Interim Analysis|Participant Stopped|0|||
156486049|NCT00296504|564872721|FG007|Interim Analysis|Participant Stopped|0|||
156486050|NCT00296504|564872722|FG008|Interim Analysis|Participant Stopped|0|||
156486051|NCT00296504|564872714|FG000|Interim Analysis|Physician and Participant Decision|0|||
156486052|NCT00296504|564872715|FG001|Interim Analysis|Physician and Participant Decision|0|||
156486053|NCT00296504|564872716|FG002|Interim Analysis|Physician and Participant Decision|0|||
156486054|NCT00296504|564872717|FG003|Interim Analysis|Physician and Participant Decision|0|||
156486055|NCT00296504|564872718|FG004|Interim Analysis|Physician and Participant Decision|0|||
156486056|NCT00296504|564872719|FG005|Interim Analysis|Physician and Participant Decision|1|||
156486057|NCT00296504|564872720|FG006|Interim Analysis|Physician and Participant Decision|0|||
156486058|NCT00296504|564872721|FG007|Interim Analysis|Physician and Participant Decision|0|||
156486059|NCT00296504|564872722|FG008|Interim Analysis|Physician and Participant Decision|0|||
156486060|NCT00296504|564872714|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
156486061|NCT00296504|564872715|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
156486062|NCT00296504|564872716|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
156486063|NCT00296504|564872717|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
156486064|NCT00296504|564872718|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
156486065|NCT00296504|564872719|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
156486066|NCT00296504|564872720|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
156486067|NCT00296504|564872721|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
156486068|NCT00296504|564872722|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
156486069|NCT00296504|564872714|FG000|Interim Analysis|Study Ended|0|||
156486070|NCT00296504|564872715|FG001|Interim Analysis|Study Ended|0|||
156486071|NCT00296504|564872716|FG002|Interim Analysis|Study Ended|0|||
156486072|NCT00296504|564872717|FG003|Interim Analysis|Study Ended|0|||
156486073|NCT00296504|564872718|FG004|Interim Analysis|Study Ended|0|||
156486074|NCT00296504|564872719|FG005|Interim Analysis|Study Ended|0|||
156486075|NCT00296504|564872720|FG006|Interim Analysis|Study Ended|1|||
156486076|NCT00296504|564872721|FG007|Interim Analysis|Study Ended|0|||
156486077|NCT00296504|564872722|FG008|Interim Analysis|Study Ended|0|||
156486078|NCT00296504|564872714|FG000|Interim Analysis|Participant Needed Interferon|0|||
156486079|NCT00296504|564872715|FG001|Interim Analysis|Participant Needed Interferon|0|||
156486080|NCT00296504|564872716|FG002|Interim Analysis|Participant Needed Interferon|0|||
156486081|NCT00296504|564872717|FG003|Interim Analysis|Participant Needed Interferon|0|||
156486082|NCT00296504|564872718|FG004|Interim Analysis|Participant Needed Interferon|0|||
156486083|NCT00296504|564872719|FG005|Interim Analysis|Participant Needed Interferon|0|||
156486084|NCT00296504|564872720|FG006|Interim Analysis|Participant Needed Interferon|0|||
156486085|NCT00296504|564872721|FG007|Interim Analysis|Participant Needed Interferon|1|||
156486086|NCT00296504|564872722|FG008|Interim Analysis|Participant Needed Interferon|0|||
156486087|NCT00296504|564872714|FG000|Interim Analysis|Ongoing|32|||
156486088|NCT00296504|564872715|FG001|Interim Analysis|Ongoing|12|||
156486089|NCT00296504|564872716|FG002|Interim Analysis|Ongoing|16|||
156486090|NCT00296504|564872717|FG003|Interim Analysis|Ongoing|22|||
156486091|NCT00296504|564872718|FG004|Interim Analysis|Ongoing|0|||
156486092|NCT00296504|564872719|FG005|Interim Analysis|Ongoing|0|||
156486093|NCT00296504|564872720|FG006|Interim Analysis|Ongoing|30|||
156486094|NCT00296504|564872721|FG007|Interim Analysis|Ongoing|1|||
156544556|NCT02025907|565087790|FG001|Overall Study|Adverse Event|1|||
156544557|NCT02025907|565087789|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
156486095|NCT00296504|564872722|FG008|Interim Analysis|Ongoing|0|||
156486096|NCT00296504|564872714|FG000|Final Analysis|Withdrawal by Subject|0|||
156354503|NCT00616655|564395780|FG002|Overall Study|Withdrawal by Subject|11|||
156354504|NCT00616655|564395778|FG000|Overall Study|Does not meet in/ex criteria|0|||
156354505|NCT00616655|564395779|FG001|Overall Study|Does not meet in/ex criteria|0|||
156354506|NCT00616655|564395780|FG002|Overall Study|Does not meet in/ex criteria|2|||
156354507|NCT00616655|564395778|FG000|Overall Study|Other|6|||
156354508|NCT00616655|564395779|FG001|Overall Study|Other|6|||
156354509|NCT00616655|564395780|FG002|Overall Study|Other|5|||
156354510|NCT03605303|564395781|FG000|Period 1|Study Terminated|2|||
156354511|NCT03605303|564395782|FG001|Period 1|Study Terminated|1|||
156354512|NCT01026792|564395785|FG000|Overall Study|Protocol Violation|1|||
156354513|NCT00309842|564395786|FG000|Overall Study|Lost to Follow-up|1|||
156354514|NCT01472081|564395791|FG000|Overall Study|Continuing treatment at time of analysis|1|||
156354515|NCT01472081|564395792|FG001|Overall Study|Continuing treatment at time of analysis|4|||
156354516|NCT01472081|564395793|FG002|Overall Study|Continuing treatment at time of analysis|1|||
156354517|NCT01472081|564395794|FG003|Overall Study|Continuing treatment at time of analysis|8|||
156354518|NCT01472081|564395795|FG004|Overall Study|Continuing treatment at time of analysis|9|||
156486097|NCT00296504|564872715|FG001|Final Analysis|Withdrawal by Subject|0|||
156486098|NCT00296504|564872716|FG002|Final Analysis|Withdrawal by Subject|0|||
156486099|NCT00296504|564872717|FG003|Final Analysis|Withdrawal by Subject|0|||
156354519|NCT01472081|564395796|FG005|Overall Study|Continuing treatment at time of analysis|0|||
156354520|NCT01472081|564395791|FG000|Overall Study|Disease Progression|4|||
156354521|NCT01472081|564395792|FG001|Overall Study|Disease Progression|10|||
156354522|NCT01472081|564395793|FG002|Overall Study|Disease Progression|12|||
156354523|NCT01472081|564395794|FG003|Overall Study|Disease Progression|31|||
156354524|NCT01472081|564395795|FG004|Overall Study|Disease Progression|22|||
156354525|NCT01472081|564395796|FG005|Overall Study|Disease Progression|3|||
156354526|NCT01472081|564395791|FG000|Overall Study|Study drug toxicity|2|||
156354527|NCT01472081|564395792|FG001|Overall Study|Study drug toxicity|9|||
156354528|NCT01472081|564395793|FG002|Overall Study|Study drug toxicity|4|||
156354529|NCT01472081|564395794|FG003|Overall Study|Study drug toxicity|6|||
156354530|NCT01472081|564395795|FG004|Overall Study|Study drug toxicity|13|||
156354531|NCT01472081|564395796|FG005|Overall Study|Study drug toxicity|2|||
156354532|NCT01472081|564395791|FG000|Overall Study|Death|0|||
156354533|NCT01472081|564395792|FG001|Overall Study|Death|0|||
156354534|NCT01472081|564395793|FG002|Overall Study|Death|0|||
156354535|NCT01472081|564395794|FG003|Overall Study|Death|0|||
156354536|NCT01472081|564395795|FG004|Overall Study|Death|1|||
156354537|NCT01472081|564395796|FG005|Overall Study|Death|0|||
156354538|NCT01472081|564395791|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
156354539|NCT01472081|564395792|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
156354540|NCT01472081|564395793|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
156354541|NCT01472081|564395794|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
156354542|NCT01472081|564395795|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
156354543|NCT01472081|564395796|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
156354544|NCT01472081|564395791|FG000|Overall Study|Withdrawal by Subject|0|||
156354545|NCT01472081|564395792|FG001|Overall Study|Withdrawal by Subject|0|||
156354546|NCT01472081|564395793|FG002|Overall Study|Withdrawal by Subject|0|||
156354547|NCT01472081|564395794|FG003|Overall Study|Withdrawal by Subject|0|||
156354548|NCT01472081|564395795|FG004|Overall Study|Withdrawal by Subject|0|||
156354549|NCT01472081|564395796|FG005|Overall Study|Withdrawal by Subject|1|||
156354550|NCT01472081|564395791|FG000|Overall Study|Poor/non-compliance|0|||
156354551|NCT01472081|564395792|FG001|Overall Study|Poor/non-compliance|0|||
156354552|NCT01472081|564395793|FG002|Overall Study|Poor/non-compliance|1|||
156354553|NCT01472081|564395794|FG003|Overall Study|Poor/non-compliance|0|||
156354554|NCT01472081|564395795|FG004|Overall Study|Poor/non-compliance|1|||
156354555|NCT01472081|564395796|FG005|Overall Study|Poor/non-compliance|0|||
156354556|NCT01472081|564395791|FG000|Overall Study|No longer meets study criteria|0|||
156354557|NCT01472081|564395792|FG001|Overall Study|No longer meets study criteria|0|||
156486100|NCT00296504|564872718|FG004|Final Analysis|Withdrawal by Subject|0|||
156486101|NCT00296504|564872719|FG005|Final Analysis|Withdrawal by Subject|0|||
156486102|NCT00296504|564872720|FG006|Final Analysis|Withdrawal by Subject|0|||
156486103|NCT00296504|564872721|FG007|Final Analysis|Withdrawal by Subject|0|||
156354558|NCT01472081|564395793|FG002|Overall Study|No longer meets study criteria|1|||
156354559|NCT01472081|564395794|FG003|Overall Study|No longer meets study criteria|0|||
156354560|NCT01472081|564395795|FG004|Overall Study|No longer meets study criteria|0|||
156354561|NCT01472081|564395796|FG005|Overall Study|No longer meets study criteria|0|||
156354562|NCT01472081|564395791|FG000|Overall Study|Subject request to discontinue treatment|0|||
156354563|NCT01472081|564395792|FG001|Overall Study|Subject request to discontinue treatment|3|||
156354564|NCT01472081|564395793|FG002|Overall Study|Subject request to discontinue treatment|1|||
156354565|NCT01472081|564395794|FG003|Overall Study|Subject request to discontinue treatment|1|||
156354566|NCT01472081|564395795|FG004|Overall Study|Subject request to discontinue treatment|0|||
156354567|NCT01472081|564395796|FG005|Overall Study|Subject request to discontinue treatment|0|||
156486104|NCT00296504|564872722|FG008|Final Analysis|Withdrawal by Subject|1|||
156486105|NCT00296504|564872714|FG000|Final Analysis|Lost to Follow-up|0|||
156486106|NCT00296504|564872715|FG001|Final Analysis|Lost to Follow-up|0|||
156354568|NCT04702997|564395797|FG000|Overall Study|Withdrawal by Subject|1|||
156354569|NCT04702997|564395798|FG001|Overall Study|Withdrawal by Subject|1|||
156354570|NCT01386554|564395801|FG000|Overall Study|Lost to Follow-up|0|||
156354571|NCT01386554|564395802|FG001|Overall Study|Lost to Follow-up|0|||
156354572|NCT01386554|564395803|FG002|Overall Study|Lost to Follow-up|1|||
156354573|NCT01386554|564395801|FG000|Overall Study|Adverse Event|2|||
156354574|NCT01386554|564395802|FG001|Overall Study|Adverse Event|5|||
156354575|NCT01386554|564395803|FG002|Overall Study|Adverse Event|2|||
156354576|NCT01386554|564395801|FG000|Overall Study|Progressive disease|1|||
156354577|NCT01386554|564395802|FG001|Overall Study|Progressive disease|2|||
156354578|NCT01386554|564395803|FG002|Overall Study|Progressive disease|2|||
156354579|NCT01386554|564395801|FG000|Overall Study|Administration of live vaccines|0|||
156354580|NCT01386554|564395802|FG001|Overall Study|Administration of live vaccines|1|||
156354581|NCT01386554|564395803|FG002|Overall Study|Administration of live vaccines|0|||
156354582|NCT01386554|564395801|FG000|Overall Study|Investigator discretion|0|||
156354583|NCT01386554|564395802|FG001|Overall Study|Investigator discretion|0|||
156354584|NCT01386554|564395803|FG002|Overall Study|Investigator discretion|1|||
156354585|NCT01386554|564395801|FG000|Overall Study|Reason not collected|0|||
156354586|NCT01386554|564395802|FG001|Overall Study|Reason not collected|1|||
156354587|NCT01386554|564395803|FG002|Overall Study|Reason not collected|0|||
156354588|NCT00353262|564395804|FG000|Overall Study|Adverse Event|8|||
156354589|NCT00353262|564395804|FG000|Overall Study|Withdrawal by Subject|2|||
156354590|NCT00353262|564395804|FG000|Overall Study|Insufficient Therapeutic Response|13|||
156354591|NCT00353262|564395804|FG000|Overall Study|Progression|1|||
156354592|NCT00353262|564395804|FG000|Overall Study|Surgery|4|||
156354593|NCT00353262|564395804|FG000|Overall Study|Break from Chemotherapy|1|||
156486107|NCT00296504|564872716|FG002|Final Analysis|Lost to Follow-up|0|||
156486108|NCT00296504|564872717|FG003|Final Analysis|Lost to Follow-up|0|||
156486109|NCT00296504|564872718|FG004|Final Analysis|Lost to Follow-up|0|||
156486110|NCT00296504|564872719|FG005|Final Analysis|Lost to Follow-up|0|||
156486111|NCT00296504|564872720|FG006|Final Analysis|Lost to Follow-up|0|||
156486112|NCT00296504|564872721|FG007|Final Analysis|Lost to Follow-up|0|||
156486113|NCT00296504|564872722|FG008|Final Analysis|Lost to Follow-up|5|||
156486114|NCT00296504|564872714|FG000|Final Analysis|Insufficient Viral Load Response|0|||
156486115|NCT00296504|564872715|FG001|Final Analysis|Insufficient Viral Load Response|0|||
156486116|NCT00296504|564872716|FG002|Final Analysis|Insufficient Viral Load Response|0|||
156486117|NCT00296504|564872717|FG003|Final Analysis|Insufficient Viral Load Response|0|||
156486118|NCT00296504|564872718|FG004|Final Analysis|Insufficient Viral Load Response|0|||
156486119|NCT00296504|564872719|FG005|Final Analysis|Insufficient Viral Load Response|0|||
156486120|NCT00296504|564872720|FG006|Final Analysis|Insufficient Viral Load Response|0|||
156486121|NCT00296504|564872721|FG007|Final Analysis|Insufficient Viral Load Response|0|||
156486122|NCT00296504|564872722|FG008|Final Analysis|Insufficient Viral Load Response|6|||
156486123|NCT00296504|564872714|FG000|Final Analysis|Adverse Event|0|||
156486124|NCT00296504|564872715|FG001|Final Analysis|Adverse Event|0|||
156486125|NCT00296504|564872716|FG002|Final Analysis|Adverse Event|0|||
156486126|NCT00296504|564872717|FG003|Final Analysis|Adverse Event|0|||
156486127|NCT00296504|564872718|FG004|Final Analysis|Adverse Event|0|||
156486128|NCT00296504|564872719|FG005|Final Analysis|Adverse Event|0|||
156486129|NCT00296504|564872720|FG006|Final Analysis|Adverse Event|0|||
156486130|NCT00296504|564872721|FG007|Final Analysis|Adverse Event|0|||
156486131|NCT00296504|564872722|FG008|Final Analysis|Adverse Event|2|||
156486132|NCT00296504|564872714|FG000|Final Analysis|Pregnancy|0|||
156486133|NCT00296504|564872715|FG001|Final Analysis|Pregnancy|0|||
156486134|NCT00296504|564872716|FG002|Final Analysis|Pregnancy|0|||
156486135|NCT00296504|564872717|FG003|Final Analysis|Pregnancy|0|||
156486136|NCT00296504|564872718|FG004|Final Analysis|Pregnancy|0|||
156486137|NCT00296504|564872719|FG005|Final Analysis|Pregnancy|0|||
156486138|NCT00296504|564872720|FG006|Final Analysis|Pregnancy|0|||
156486139|NCT00296504|564872721|FG007|Final Analysis|Pregnancy|0|||
156486140|NCT00296504|564872722|FG008|Final Analysis|Pregnancy|4|||
156486141|NCT00296504|564872714|FG000|Final Analysis|Tuberculosis|0|||
156486142|NCT00296504|564872715|FG001|Final Analysis|Tuberculosis|0|||
156354594|NCT04166513|564395805|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
156354595|NCT04166513|564395806|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
156486143|NCT00296504|564872716|FG002|Final Analysis|Tuberculosis|0|||
156486144|NCT00296504|564872717|FG003|Final Analysis|Tuberculosis|0|||
156486145|NCT00296504|564872718|FG004|Final Analysis|Tuberculosis|0|||
156486146|NCT00296504|564872719|FG005|Final Analysis|Tuberculosis|0|||
156486147|NCT00296504|564872720|FG006|Final Analysis|Tuberculosis|0|||
156486148|NCT00296504|564872721|FG007|Final Analysis|Tuberculosis|0|||
156486149|NCT00296504|564872722|FG008|Final Analysis|Tuberculosis|1|||
156486150|NCT00296504|564872714|FG000|Final Analysis|Participant Moved to Another Country|0|||
156486151|NCT00296504|564872715|FG001|Final Analysis|Participant Moved to Another Country|0|||
156354596|NCT04166513|564395807|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
156354597|NCT04166513|564395808|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
156354598|NCT04166513|564395805|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
156486152|NCT00296504|564872716|FG002|Final Analysis|Participant Moved to Another Country|0|||
156486153|NCT00296504|564872717|FG003|Final Analysis|Participant Moved to Another Country|0|||
156486154|NCT00296504|564872718|FG004|Final Analysis|Participant Moved to Another Country|0|||
156486155|NCT00296504|564872719|FG005|Final Analysis|Participant Moved to Another Country|0|||
156486156|NCT00296504|564872720|FG006|Final Analysis|Participant Moved to Another Country|0|||
156486157|NCT00296504|564872721|FG007|Final Analysis|Participant Moved to Another Country|0|||
156486158|NCT00296504|564872722|FG008|Final Analysis|Participant Moved to Another Country|1|||
156354599|NCT04166513|564395806|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
156486159|NCT00296504|564872714|FG000|Final Analysis|Poor Adherence|0|||
156486160|NCT00296504|564872715|FG001|Final Analysis|Poor Adherence|0|||
156486161|NCT00296504|564872716|FG002|Final Analysis|Poor Adherence|0|||
156486162|NCT00296504|564872717|FG003|Final Analysis|Poor Adherence|0|||
156486163|NCT00296504|564872718|FG004|Final Analysis|Poor Adherence|0|||
156486164|NCT00296504|564872719|FG005|Final Analysis|Poor Adherence|0|||
156486165|NCT00296504|564872720|FG006|Final Analysis|Poor Adherence|0|||
156486166|NCT00296504|564872721|FG007|Final Analysis|Poor Adherence|0|||
156486167|NCT00296504|564872722|FG008|Final Analysis|Poor Adherence|1|||
156486168|NCT01323309|564872728|FG000|Overall Study|Death|9|||
156486169|NCT01323309|564872729|FG001|Overall Study|Death|15|||
156486170|NCT01323309|564872730|FG002|Overall Study|Death|5|||
156486171|NCT01323309|564872728|FG000|Overall Study|Lost to Follow-up|11|||
156486172|NCT01323309|564872729|FG001|Overall Study|Lost to Follow-up|14|||
156486173|NCT01323309|564872730|FG002|Overall Study|Lost to Follow-up|24|||
156486174|NCT01323309|564872728|FG000|Overall Study|Withdrawal by Subject|14|||
156486175|NCT01323309|564872729|FG001|Overall Study|Withdrawal by Subject|14|||
156486176|NCT01323309|564872730|FG002|Overall Study|Withdrawal by Subject|18|||
156486177|NCT01323309|564872728|FG000|Overall Study|Disease progression|5|||
156486178|NCT01323309|564872729|FG001|Overall Study|Disease progression|11|||
156486179|NCT01323309|564872730|FG002|Overall Study|Disease progression|4|||
156486180|NCT02162771|564872731|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
156486181|NCT02162771|564872732|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
156486182|NCT02162771|564872731|FG000|Core Study Period (Part 2)|Adverse Event|4|||
156486183|NCT02162771|564872732|FG001|Core Study Period (Part 2)|Adverse Event|1|||
156486184|NCT02162771|564872731|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
156486185|NCT02162771|564872732|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
156486186|NCT02162771|564872731|FG000|Core Study Period (Part 2)|Physician Decision|0|||
156486187|NCT02162771|564872732|FG001|Core Study Period (Part 2)|Physician Decision|2|||
156486188|NCT02162771|564872731|FG000|Core Study Period (Part 2)|Death|1|||
156486189|NCT02162771|564872732|FG001|Core Study Period (Part 2)|Death|0|||
156486190|NCT02162771|564872731|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
156486191|NCT02162771|564872732|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
156486192|NCT02162771|564872731|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
156486193|NCT02162771|564872732|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
156486194|NCT02162771|564872731|FG000|Maintenance Study Period (Part 2)|Death|2|||
156486195|NCT02162771|564872732|FG001|Maintenance Study Period (Part 2)|Death|1|||
156486196|NCT02162771|564872731|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
156486197|NCT02162771|564872732|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
156486198|NCT02162771|564872731|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
156486199|NCT02162771|564872732|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
156486200|NCT02162771|564872731|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
156486201|NCT02162771|564872732|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
156486202|NCT01348763|564872733|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
156486203|NCT01348763|564872733|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
156486204|NCT01078571|564872737|FG000|Overall Study|Adverse Event|36|||
156486205|NCT01078571|564872737|FG000|Overall Study|Lack of effectiveness|36|||
156486206|NCT01078571|564872737|FG000|Overall Study|Reason not reported|21|||
156486207|NCT01078571|564872737|FG000|Overall Study|Withdrawal by Subject|12|||
156486208|NCT01078571|564872737|FG000|Overall Study|Lost to Follow-up|8|||
156486209|NCT01078571|564872737|FG000|Overall Study|Protocol Violation|2|||
156486210|NCT01047306|564872750|FG000|Overall Study|Withdrawal by Subject|2|||
156486211|NCT01047306|564872751|FG001|Overall Study|Withdrawal by Subject|0|||
156486212|NCT01047306|564872750|FG000|Overall Study|Lost to Follow-up|1|||
156486213|NCT01047306|564872751|FG001|Overall Study|Lost to Follow-up|0|||
156486214|NCT01878253|564872752|FG000|Overall Study|Death|1|||
156486215|NCT01878253|564872752|FG000|Overall Study|SIdus System Removal|3|||
156486216|NCT01878253|564872752|FG000|Overall Study|Withdrawal by Subject|1|||
156486217|NCT01878253|564872752|FG000|Overall Study|Lost to Follow-up|2|||
156486218|NCT01878253|564872752|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
156486219|NCT00449033|564872757|FG000|Treatment Period|Adverse Event|117|||
156544558|NCT02025907|565087790|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
156486220|NCT00449033|564872758|FG001|Treatment Period|Adverse Event|83|||
156486221|NCT00449033|564872757|FG000|Treatment Period|Death|21|||
156486222|NCT00449033|564872758|FG001|Treatment Period|Death|12|||
156486223|NCT00449033|564872757|FG000|Treatment Period|Lost to Follow-up|0|||
156486224|NCT00449033|564872758|FG001|Treatment Period|Lost to Follow-up|2|||
156486225|NCT00449033|564872757|FG000|Treatment Period|Physician Decision|4|||
156486226|NCT00449033|564872758|FG001|Treatment Period|Physician Decision|5|||
156486227|NCT00449033|564872757|FG000|Treatment Period|Protocol Violation|8|||
156486228|NCT00449033|564872758|FG001|Treatment Period|Protocol Violation|7|||
156486229|NCT00449033|564872757|FG000|Treatment Period|Disease Progression|231|||
156544559|NCT01549002|565087799|FG000|Overall Study|Excessive pain|0|||
156354600|NCT04166513|564395807|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
156354601|NCT04166513|564395808|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
156354602|NCT04166513|564395805|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
156354603|NCT04166513|564395806|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
156486230|NCT00449033|564872758|FG001|Treatment Period|Disease Progression|288|||
156486231|NCT00449033|564872757|FG000|Treatment Period|Consent Withdrawn|36|||
156486232|NCT00449033|564872758|FG001|Treatment Period|Consent Withdrawn|20|||
156486233|NCT00449033|564872757|FG000|Treatment Period|Amended Protocol Criteria|22|||
156486234|NCT00449033|564872758|FG001|Treatment Period|Amended Protocol Criteria|18|||
156486235|NCT00449033|564872757|FG000|Treatment Period|Non-compliance|7|||
156486236|NCT00449033|564872758|FG001|Treatment Period|Non-compliance|8|||
156486237|NCT00449033|564872757|FG000|Treatment Period|Second Malignancy|0|||
156486238|NCT00449033|564872758|FG001|Treatment Period|Second Malignancy|1|||
156486239|NCT00449033|564872757|FG000|Treatment Period|Reason Missing|0|||
156486240|NCT00449033|564872758|FG001|Treatment Period|Reason Missing|4|||
156486241|NCT00449033|564872757|FG000|Treatment Period|Treatment Ongoing|6|||
156486242|NCT00449033|564872758|FG001|Treatment Period|Treatment Ongoing|4|||
156486243|NCT00449033|564872757|FG000|Follow-up Period|Death|299|||
156486244|NCT00449033|564872758|FG001|Follow-up Period|Death|311|||
156486245|NCT00449033|564872757|FG000|Follow-up Period|Lost to Follow-up|6|||
156486246|NCT00449033|564872758|FG001|Follow-up Period|Lost to Follow-up|10|||
156486247|NCT00449033|564872757|FG000|Follow-up Period|Reason Missing|120|||
156486248|NCT00449033|564872758|FG001|Follow-up Period|Reason Missing|113|||
156486249|NCT04393779|564872761|FG000|Overall Study|Death|1|||
156486250|NCT04393779|564872761|FG000|Overall Study|Device reintervention or explant|4|||
156486251|NCT03802513|564872762|FG000|Overall Study|Lost to Follow-up|1|||
156486252|NCT01190228|564872766|FG000|Overall Study|Protocol Violation|4|||
156486253|NCT01190228|564872767|FG001|Overall Study|Protocol Violation|0|||
156486254|NCT01190228|564872768|FG002|Overall Study|Protocol Violation|0|||
156486255|NCT01190228|564872766|FG000|Overall Study|Withdrawal by Subject|1|||
156486256|NCT01190228|564872767|FG001|Overall Study|Withdrawal by Subject|0|||
156486257|NCT01190228|564872768|FG002|Overall Study|Withdrawal by Subject|0|||
156486258|NCT02268526|564872769|FG000|Overall Study|Adverse Event|0|||
156486259|NCT02268526|564872770|FG001|Overall Study|Adverse Event|2|||
156486260|NCT02268526|564872771|FG002|Overall Study|Adverse Event|1|||
156486261|NCT02268526|564872769|FG000|Overall Study|Death|1|||
156486262|NCT02268526|564872770|FG001|Overall Study|Death|11|||
156486263|NCT02268526|564872771|FG002|Overall Study|Death|0|||
156486264|NCT02268526|564872769|FG000|Overall Study|protocol deviation|0|||
156486265|NCT02268526|564872770|FG001|Overall Study|protocol deviation|1|||
156486266|NCT02268526|564872771|FG002|Overall Study|protocol deviation|0|||
156486267|NCT02268526|564872769|FG000|Overall Study|Physician Decision|0|||
156486268|NCT02268526|564872770|FG001|Overall Study|Physician Decision|0|||
156486269|NCT02268526|564872771|FG002|Overall Study|Physician Decision|1|||
156486270|NCT02268526|564872769|FG000|Overall Study|Subject/guardian decision|0|||
156486271|NCT02268526|564872770|FG001|Overall Study|Subject/guardian decision|7|||
156486272|NCT02268526|564872771|FG002|Overall Study|Subject/guardian decision|3|||
156486273|NCT01261793|564872772|FG000|Overall Study|Lack of Efficacy|44|||
156486274|NCT01261793|564872773|FG001|Overall Study|Lack of Efficacy|37|||
156486275|NCT01261793|564872774|FG002|Overall Study|Lack of Efficacy|32|||
156486276|NCT01261793|564872772|FG000|Overall Study|Protocol Violation|3|||
156486277|NCT01261793|564872773|FG001|Overall Study|Protocol Violation|5|||
156486278|NCT01261793|564872774|FG002|Overall Study|Protocol Violation|6|||
156486279|NCT01261793|564872772|FG000|Overall Study|Lost to Follow-up|10|||
156486280|NCT01261793|564872773|FG001|Overall Study|Lost to Follow-up|3|||
156486281|NCT01261793|564872774|FG002|Overall Study|Lost to Follow-up|7|||
156486282|NCT01261793|564872772|FG000|Overall Study|Withdrawal by Subject|12|||
156486283|NCT01261793|564872773|FG001|Overall Study|Withdrawal by Subject|14|||
156486284|NCT01261793|564872774|FG002|Overall Study|Withdrawal by Subject|14|||
156486285|NCT01261793|564872772|FG000|Overall Study|Death|3|||
156486286|NCT01261793|564872773|FG001|Overall Study|Death|1|||
156486287|NCT01261793|564872774|FG002|Overall Study|Death|0|||
156486288|NCT01261793|564872772|FG000|Overall Study|Adverse Event|9|||
156354604|NCT04166513|564395807|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
156486289|NCT01261793|564872773|FG001|Overall Study|Adverse Event|24|||
156544560|NCT01549002|565087800|FG001|Overall Study|Excessive pain|2|||
156354605|NCT04166513|564395808|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
156354606|NCT04166513|564395805|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
156354607|NCT04166513|564395806|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
156354608|NCT04166513|564395807|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
156354609|NCT04166513|564395808|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
156354610|NCT04166513|564395805|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
156354611|NCT04166513|564395806|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
156354612|NCT04166513|564395807|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
156354613|NCT04166513|564395808|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
156354614|NCT05286307|564395809|FG000|Overall Study|Incomplete outcome assessments|2|||
156354615|NCT05286307|564395810|FG001|Overall Study|Incomplete outcome assessments|1|||
156354616|NCT05286307|564395809|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
156354617|NCT05286307|564395810|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
156354618|NCT05286307|564395809|FG000|Overall Study|Lost to follow up at 6 months|25|||
156354619|NCT05286307|564395810|FG001|Overall Study|Lost to follow up at 6 months|35|||
156354620|NCT05286307|564395809|FG000|Overall Study|Study medication not available|1|||
156354621|NCT05286307|564395810|FG001|Overall Study|Study medication not available|1|||
156354622|NCT02759471|564395812|FG000|Overall Study|discomfort|2|||
156354623|NCT01103284|564395815|FG000|Overall Study|Death|2|||
156354624|NCT01103284|564395816|FG001|Overall Study|Death|0|||
156354625|NCT01103284|564395815|FG000|Overall Study|Lost to Follow-up|9|||
156354626|NCT01103284|564395816|FG001|Overall Study|Lost to Follow-up|10|||
156354627|NCT01103284|564395815|FG000|Overall Study|Pregnancy|3|||
156354628|NCT01103284|564395816|FG001|Overall Study|Pregnancy|1|||
156354629|NCT01103284|564395815|FG000|Overall Study|Protocol Violation|12|||
156354630|NCT01103284|564395816|FG001|Overall Study|Protocol Violation|5|||
156354631|NCT01103284|564395815|FG000|Overall Study|Adverse Event|0|||
156354632|NCT01103284|564395816|FG001|Overall Study|Adverse Event|5|||
156354633|NCT01103284|564395815|FG000|Overall Study|Withdrawal by Subject|14|||
156354634|NCT01103284|564395816|FG001|Overall Study|Withdrawal by Subject|18|||
156354635|NCT01103284|564395815|FG000|Overall Study|Dermal Hypersensitivity|0|||
156354636|NCT01103284|564395816|FG001|Overall Study|Dermal Hypersensitivity|1|||
156354637|NCT01103284|564395815|FG000|Overall Study|Termination by the Sponsor|0|||
156354638|NCT01103284|564395816|FG001|Overall Study|Termination by the Sponsor|1|||
156354639|NCT01103284|564395815|FG000|Overall Study|Not described|2|||
156354640|NCT01103284|564395816|FG001|Overall Study|Not described|1|||
156354641|NCT01103284|564395815|FG000|Overall Study|Missing CRF entries for study completion|0|||
156354642|NCT01103284|564395816|FG001|Overall Study|Missing CRF entries for study completion|2|||
156354643|NCT01786629|564397249|FG000|Overall Study|Lack of Efficacy|0|||
156354644|NCT01786629|564397250|FG001|Overall Study|Lack of Efficacy|4|||
156354645|NCT01786629|564397249|FG000|Overall Study|Adverse Event|0|||
156354646|NCT01786629|564397250|FG001|Overall Study|Adverse Event|1|||
156354647|NCT00410761|564397251|FG000|Randomized Treatment Period|Adverse Event|34|||
156354648|NCT00410761|564397252|FG001|Randomized Treatment Period|Adverse Event|3|||
156354649|NCT00410761|564397251|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
156354650|NCT00410761|564397252|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
156354651|NCT00410761|564397251|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
156354652|NCT00410761|564397252|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
156354653|NCT00410761|564397251|FG000|Randomized Treatment Period|Other|69|||
156354654|NCT00410761|564397252|FG001|Randomized Treatment Period|Other|21|||
156354655|NCT00410761|564397251|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
156354656|NCT00410761|564397252|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
156354657|NCT00410761|564397251|FG000|Open-Label Treatment Period|Adverse Event|13|||
156354658|NCT00410761|564397252|FG001|Open-Label Treatment Period|Adverse Event|15|||
156354659|NCT00410761|564397251|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
156354660|NCT00410761|564397252|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
156354661|NCT00410761|564397251|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
156354662|NCT00410761|564397252|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
156486290|NCT01261793|564872774|FG002|Overall Study|Adverse Event|19|||
156486291|NCT01261793|564872772|FG000|Overall Study|Patient non-availability|1|||
156486292|NCT01261793|564872773|FG001|Overall Study|Patient non-availability|1|||
156486293|NCT01261793|564872774|FG002|Overall Study|Patient non-availability|1|||
156486294|NCT01261793|564872772|FG000|Overall Study|Suspected pregnancy|1|||
156486295|NCT01261793|564872773|FG001|Overall Study|Suspected pregnancy|1|||
156486296|NCT01261793|564872774|FG002|Overall Study|Suspected pregnancy|0|||
156486297|NCT01261793|564872772|FG000|Overall Study|Patient non-compliance|1|||
156486298|NCT01261793|564872773|FG001|Overall Study|Patient non-compliance|0|||
156354663|NCT00410761|564397251|FG000|Open-Label Treatment Period|Other|18|||
156486299|NCT01261793|564872774|FG002|Overall Study|Patient non-compliance|1|||
156354664|NCT00410761|564397252|FG001|Open-Label Treatment Period|Other|9|||
156354665|NCT00312494|564397253|FG000|Overall Study|Randomized; not treated with study drug|9|||
156486300|NCT01261793|564872772|FG000|Overall Study|Patient pregnant|1|||
156486301|NCT01261793|564872773|FG001|Overall Study|Patient pregnant|0|||
156486302|NCT01261793|564872774|FG002|Overall Study|Patient pregnant|0|||
156486303|NCT01261793|564872772|FG000|Overall Study|Outside the study area|0|||
156486304|NCT01261793|564872773|FG001|Overall Study|Outside the study area|2|||
156486305|NCT01261793|564872774|FG002|Overall Study|Outside the study area|1|||
156486306|NCT01261793|564872772|FG000|Overall Study|Lack of efficacy & patient not available|0|||
156486307|NCT01261793|564872773|FG001|Overall Study|Lack of efficacy & patient not available|1|||
156354666|NCT00312494|564397254|FG001|Overall Study|Randomized; not treated with study drug|10|||
156486308|NCT01261793|564872774|FG002|Overall Study|Lack of efficacy & patient not available|0|||
156486309|NCT01261793|564872772|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
156486310|NCT01261793|564872773|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
156486311|NCT01261793|564872774|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
156486312|NCT01261793|564872772|FG000|Overall Study|Randomization error|0|||
156486313|NCT01261793|564872773|FG001|Overall Study|Randomization error|1|||
156486314|NCT01261793|564872774|FG002|Overall Study|Randomization error|0|||
156486315|NCT01261793|564872772|FG000|Overall Study|Patient unable to start IV line|0|||
156486316|NCT01261793|564872773|FG001|Overall Study|Patient unable to start IV line|0|||
156486317|NCT01261793|564872774|FG002|Overall Study|Patient unable to start IV line|1|||
156486318|NCT03219216|564872775|FG000|Overall Study|Lost to Follow-up|0|||
156486319|NCT03219216|564872776|FG001|Overall Study|Lost to Follow-up|1|||
156486320|NCT01855399|564872777|FG000|6 Month|Lost to Follow-up|12|||
156486321|NCT01855399|564872778|FG001|6 Month|Lost to Follow-up|9|||
156486322|NCT01855399|564872777|FG000|6 Month|Withdrawal by Subject|8|||
156486323|NCT01855399|564872778|FG001|6 Month|Withdrawal by Subject|6|||
156486324|NCT01855399|564872777|FG000|12 Month|Lost to Follow-up|7|||
156486325|NCT01855399|564872778|FG001|12 Month|Lost to Follow-up|11|||
156486326|NCT00512902|564872779|FG000|Overall Study|Adverse Event|7|||
156486327|NCT00512902|564872779|FG000|Overall Study|Lost to Follow-up|1|||
156486328|NCT01123200|564872780|FG000|Overall Study|Withdrawal by Subject|1|||
156486329|NCT02577315|564872786|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
156486330|NCT02577315|564872787|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
156486331|NCT01636778|564872790|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
156486332|NCT01636778|564872791|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
156486333|NCT01636778|564872792|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
156486334|NCT01636778|564872790|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
156486335|NCT01636778|564872791|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
156486336|NCT01636778|564872792|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
156486337|NCT01636778|564872790|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
156486338|NCT01636778|564872791|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
156486339|NCT01636778|564872792|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
156486340|NCT01636778|564872790|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
156486341|NCT01636778|564872791|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
156486342|NCT01636778|564872792|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
156486343|NCT01636778|564872790|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
156486344|NCT01636778|564872791|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
156486345|NCT01636778|564872792|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
156486346|NCT01636778|564872790|FG000|Follow-up Period After Part 2|Other|0|||
156486347|NCT01636778|564872791|FG001|Follow-up Period After Part 2|Other|0|||
156486348|NCT01636778|564872792|FG002|Follow-up Period After Part 2|Other|1|||
156486349|NCT01636778|564872790|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
156486350|NCT01636778|564872791|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
156486351|NCT01636778|564872792|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
156486352|NCT01636778|564872790|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
156486353|NCT01636778|564872791|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
156486354|NCT01636778|564872792|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
156486355|NCT03530345|564872798|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
156486356|NCT03530345|564872799|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
156486357|NCT03530345|564872798|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
156486358|NCT03530345|564872799|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
156486359|NCT03530345|564872798|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
156486360|NCT03530345|564872799|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
156486361|NCT03530345|564872798|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
156486362|NCT03530345|564872799|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
156486363|NCT00170950|564872802|FG000|Overall Study|Death|236|||
156486364|NCT00170950|564872803|FG001|Overall Study|Death|274|||
156486365|NCT00170950|564872802|FG000|Overall Study|Withdrawal by Subject|496|||
156486366|NCT00170950|564872803|FG001|Overall Study|Withdrawal by Subject|498|||
156486367|NCT00170950|564872802|FG000|Overall Study|Lost to Follow-up|134|||
156486368|NCT00170950|564872803|FG001|Overall Study|Lost to Follow-up|115|||
156486369|NCT00170950|564872802|FG000|Overall Study|Missing|2|||
156486370|NCT00170950|564872803|FG001|Overall Study|Missing|1|||
156486371|NCT00170950|564872802|FG000|Overall Study|Termination Data Not Recorded|17|||
156486372|NCT00170950|564872803|FG001|Overall Study|Termination Data Not Recorded|22|||
156486373|NCT00748098|564872804|FG000|First Treatment Intervention Period|Adverse Event|1|||
156486374|NCT00748098|564872805|FG001|First Treatment Intervention Period|Adverse Event|1|||
156486375|NCT00748098|564872804|FG000|First Treatment Intervention Period|Protocol Violation|1|||
156486376|NCT00748098|564872805|FG001|First Treatment Intervention Period|Protocol Violation|0|||
156486377|NCT00748098|564872804|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
156486378|NCT00748098|564872805|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
156486379|NCT00748098|564872804|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
156486380|NCT00748098|564872805|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
156486381|NCT00748098|564872804|FG000|First Taper Period|Protocol Violation|1|||
156486382|NCT00748098|564872805|FG001|First Taper Period|Protocol Violation|0|||
156486383|NCT00748098|564872804|FG000|First Taper Period|Withdrawal by Subject|2|||
156486384|NCT00748098|564872805|FG001|First Taper Period|Withdrawal by Subject|0|||
156354667|NCT00312494|564397255|FG002|Overall Study|Randomized; not treated with study drug|5|||
156486385|NCT00748098|564872804|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
156486386|NCT00748098|564872805|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
156486387|NCT00748098|564872804|FG000|1-Week Washout Period|Adverse Event|0|||
156354668|NCT00312494|564397253|FG000|Overall Study|Adverse Event|33|||
156354669|NCT00312494|564397254|FG001|Overall Study|Adverse Event|15|||
156486388|NCT00748098|564872805|FG001|1-Week Washout Period|Adverse Event|1|||
156486389|NCT00748098|564872804|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
156486390|NCT00748098|564872805|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
156486391|NCT00748098|564872804|FG000|Second Treatment Intervention Period|Adverse Event|4|||
156486392|NCT00748098|564872805|FG001|Second Treatment Intervention Period|Adverse Event|1|||
156486393|NCT00748098|564872804|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
156544561|NCT01549002|565087799|FG000|Overall Study|Moderate sedation required|0|||
156544562|NCT01549002|565087800|FG001|Overall Study|Moderate sedation required|2|||
156544563|NCT01251367|565087801|FG000|Overall Study|Protocol Violation|1|||
156544564|NCT01251367|565087801|FG000|Overall Study|Lack of Efficacy|2|||
156354670|NCT00312494|564397255|FG002|Overall Study|Adverse Event|11|||
156354671|NCT00312494|564397253|FG000|Overall Study|Lack of Efficacy|4|||
156544565|NCT01251367|565087801|FG000|Overall Study|Adverse Event|19|||
156486394|NCT00748098|564872805|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
156486395|NCT00748098|564872804|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
156486396|NCT00748098|564872805|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
156486397|NCT00635570|564874325|FG000|Overall Study|Lost to Follow-up|8|||
156486398|NCT00635570|564874326|FG001|Overall Study|Lost to Follow-up|8|||
156486399|NCT00635570|564874325|FG000|Overall Study|Withdrawal by Subject|1|||
156486400|NCT00635570|564874326|FG001|Overall Study|Withdrawal by Subject|1|||
156486401|NCT00635570|564874325|FG000|Overall Study|Adverse Event|2|||
156486402|NCT00635570|564874326|FG001|Overall Study|Adverse Event|0|||
156486403|NCT00635570|564874325|FG000|Overall Study|Physician Decision|1|||
156486404|NCT00635570|564874326|FG001|Overall Study|Physician Decision|0|||
156486405|NCT00635570|564874325|FG000|Overall Study|Did not complete survey|2|||
156486406|NCT00635570|564874326|FG001|Overall Study|Did not complete survey|1|||
156486407|NCT00635570|564874325|FG000|Overall Study|Early termination(No sexual activity)|1|||
156486408|NCT00635570|564874326|FG001|Overall Study|Early termination(No sexual activity)|1|||
156486409|NCT01816685|564874329|FG000|Overall Study|Lost to Follow-up|7|||
156486410|NCT01816685|564874330|FG001|Overall Study|Lost to Follow-up|9|||
156486411|NCT01816685|564874329|FG000|Overall Study|Surgery Cancelled|3|||
156486412|NCT01816685|564874330|FG001|Overall Study|Surgery Cancelled|2|||
156486413|NCT03721978|564874332|FG000|Overall Study|Withdrawal by Subject|6|||
156486414|NCT03721978|564874333|FG001|Overall Study|Withdrawal by Subject|1|||
156486415|NCT03721978|564874332|FG000|Overall Study|Adverse Event|1|||
156486416|NCT03721978|564874333|FG001|Overall Study|Adverse Event|1|||
156486417|NCT03721978|564874332|FG000|Overall Study|Progressive Disease|1|||
156486418|NCT03721978|564874333|FG001|Overall Study|Progressive Disease|0|||
156486419|NCT03721978|564874332|FG000|Overall Study|Lost to Follow-up|5|||
156486420|NCT03721978|564874333|FG001|Overall Study|Lost to Follow-up|1|||
156544566|NCT01251367|565087801|FG000|Overall Study|Withdrawal by Subject|36|||
156544567|NCT01251367|565087801|FG000|Overall Study|Lost to Follow-up|5|||
156486421|NCT03721978|564874332|FG000|Overall Study|Reason not Specified|0|||
156486422|NCT03721978|564874333|FG001|Overall Study|Reason not Specified|2|||
156486423|NCT00197106|564874334|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
156486424|NCT00197106|564874335|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
156486425|NCT00197106|564874336|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
156486426|NCT00197106|564874334|FG000|Overall Treatment Period|Lack of Efficacy|0|||
156486427|NCT00197106|564874335|FG001|Overall Treatment Period|Lack of Efficacy|1|||
156486428|NCT00197106|564874336|FG002|Overall Treatment Period|Lack of Efficacy|0|||
156486429|NCT00197106|564874334|FG000|Overall Treatment Period|Lost to Follow-up|0|||
156486430|NCT00197106|564874335|FG001|Overall Treatment Period|Lost to Follow-up|0|||
156486431|NCT00197106|564874336|FG002|Overall Treatment Period|Lost to Follow-up|2|||
156486432|NCT00197106|564874334|FG000|Overall Treatment Period|Protocol Violation|0|||
156486433|NCT00197106|564874335|FG001|Overall Treatment Period|Protocol Violation|0|||
156486434|NCT00197106|564874336|FG002|Overall Treatment Period|Protocol Violation|2|||
156486435|NCT00197106|564874334|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
156486436|NCT00197106|564874335|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
156486437|NCT00197106|564874336|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
156486438|NCT00762723|564874337|FG000|Overall Study|Study Terminated slow enrollement|5|||
156486439|NCT00762723|564874338|FG001|Overall Study|Study Terminated slow enrollement|5|||
156486440|NCT00762723|564874339|FG002|Overall Study|Study Terminated slow enrollement|3|||
156486441|NCT00382408|564874340|FG000|Overall Study|Did not meet protocol requirement|3|||
156486442|NCT00382408|564874341|FG001|Overall Study|Did not meet protocol requirement|3|||
156486443|NCT00382408|564874340|FG000|Overall Study|Protocol Violation|2|||
156486444|NCT00382408|564874341|FG001|Overall Study|Protocol Violation|2|||
156486445|NCT00382408|564874340|FG000|Overall Study|Physician Decision|1|||
156486446|NCT00382408|564874341|FG001|Overall Study|Physician Decision|0|||
156486447|NCT00382408|564874340|FG000|Overall Study|Withdrawal by Subject|17|||
156486448|NCT00382408|564874341|FG001|Overall Study|Withdrawal by Subject|6|||
156486449|NCT00382408|564874340|FG000|Overall Study|Pregnancy|2|||
156486450|NCT00382408|564874341|FG001|Overall Study|Pregnancy|0|||
156486451|NCT00382408|564874340|FG000|Overall Study|Lost to Follow-up|19|||
156544568|NCT01251367|565087801|FG000|Overall Study|Subject Required Alternative Treatment|7|||
156486452|NCT00382408|564874341|FG001|Overall Study|Lost to Follow-up|8|||
156486453|NCT00382408|564874340|FG000|Overall Study|Other|100|||
156486454|NCT00382408|564874341|FG001|Overall Study|Other|35|||
156486455|NCT01572493|564874342|FG000|Overall Study|Physician Decision|1|||
156486456|NCT01572493|564874343|FG001|Overall Study|Physician Decision|0|||
156486457|NCT01572493|564874344|FG002|Overall Study|Physician Decision|0|||
156544569|NCT01251367|565087801|FG000|Overall Study|No Study Drug Available|1|||
156486458|NCT01572493|564874345|FG003|Overall Study|Physician Decision|0|||
156486459|NCT01572493|564874346|FG004|Overall Study|Physician Decision|0|||
156486460|NCT01572493|564874347|FG005|Overall Study|Physician Decision|0|||
156486461|NCT01572493|564874348|FG006|Overall Study|Physician Decision|0|||
156486462|NCT01572493|564874349|FG007|Overall Study|Physician Decision|0|||
156486463|NCT01572493|564874350|FG008|Overall Study|Physician Decision|0|||
156486464|NCT01572493|564874342|FG000|Overall Study|Switched to alternative treatment|0|||
156486465|NCT01572493|564874343|FG001|Overall Study|Switched to alternative treatment|1|||
156486466|NCT01572493|564874344|FG002|Overall Study|Switched to alternative treatment|2|||
156486467|NCT01572493|564874345|FG003|Overall Study|Switched to alternative treatment|1|||
156486468|NCT01572493|564874346|FG004|Overall Study|Switched to alternative treatment|2|||
156486469|NCT01572493|564874347|FG005|Overall Study|Switched to alternative treatment|0|||
156486470|NCT01572493|564874348|FG006|Overall Study|Switched to alternative treatment|2|||
156486471|NCT01572493|564874349|FG007|Overall Study|Switched to alternative treatment|0|||
156486472|NCT01572493|564874350|FG008|Overall Study|Switched to alternative treatment|2|||
156486473|NCT01572493|564874342|FG000|Overall Study|Death|0|||
156486474|NCT01572493|564874343|FG001|Overall Study|Death|0|||
156486475|NCT01572493|564874344|FG002|Overall Study|Death|0|||
156486476|NCT01572493|564874345|FG003|Overall Study|Death|1|||
156486477|NCT01572493|564874346|FG004|Overall Study|Death|0|||
156486478|NCT01572493|564874347|FG005|Overall Study|Death|1|||
156354672|NCT00312494|564397254|FG001|Overall Study|Lack of Efficacy|6|||
156354673|NCT00312494|564397255|FG002|Overall Study|Lack of Efficacy|8|||
156486479|NCT01572493|564874348|FG006|Overall Study|Death|0|||
156486480|NCT01572493|564874349|FG007|Overall Study|Death|0|||
156486481|NCT01572493|564874350|FG008|Overall Study|Death|0|||
156354674|NCT00312494|564397253|FG000|Overall Study|Laboratory abnormality|1|||
156354675|NCT00312494|564397254|FG001|Overall Study|Laboratory abnormality|0|||
156354676|NCT00312494|564397255|FG002|Overall Study|Laboratory abnormality|0|||
156354677|NCT00312494|564397253|FG000|Overall Study|Lost to Follow-up|8|||
156354678|NCT00312494|564397254|FG001|Overall Study|Lost to Follow-up|8|||
156354679|NCT00312494|564397255|FG002|Overall Study|Lost to Follow-up|8|||
156354680|NCT00312494|564397253|FG000|Overall Study|Withdrawal by Subject|6|||
156354681|NCT00312494|564397254|FG001|Overall Study|Withdrawal by Subject|9|||
156354682|NCT00312494|564397255|FG002|Overall Study|Withdrawal by Subject|10|||
156354683|NCT00312494|564397253|FG000|Overall Study|Other|10|||
156354684|NCT00312494|564397254|FG001|Overall Study|Other|10|||
156354685|NCT00312494|564397255|FG002|Overall Study|Other|1|||
156354686|NCT00696696|564397256|FG000|Overall Study|Adverse Event|5|||
156354687|NCT00696696|564397256|FG000|Overall Study|Withdrawal by Subject|8|||
156354688|NCT00696696|564397256|FG000|Overall Study|Physician Decision|2|||
156354689|NCT00696696|564397256|FG000|Overall Study|Death|3|||
156354690|NCT01349803|564397258|FG000|Overall Study|Adverse Event|0|||
156354691|NCT01349803|564397259|FG001|Overall Study|Adverse Event|0|||
156354692|NCT01349803|564397260|FG002|Overall Study|Adverse Event|0|||
156354693|NCT01349803|564397261|FG003|Overall Study|Adverse Event|2|||
156354694|NCT01349803|564397258|FG000|Overall Study|Withdrawal by Subject|1|||
156354695|NCT01349803|564397259|FG001|Overall Study|Withdrawal by Subject|0|||
156354696|NCT01349803|564397260|FG002|Overall Study|Withdrawal by Subject|0|||
156354697|NCT01349803|564397261|FG003|Overall Study|Withdrawal by Subject|0|||
156354698|NCT01349803|564397258|FG000|Overall Study|Protocol-specified criteria|0|||
156354699|NCT01349803|564397259|FG001|Overall Study|Protocol-specified criteria|1|||
156354700|NCT01349803|564397260|FG002|Overall Study|Protocol-specified criteria|3|||
156354701|NCT01349803|564397261|FG003|Overall Study|Protocol-specified criteria|0|||
156354702|NCT00605813|564397263|FG000|Overall Study|Protocol Violation|25|||
156354703|NCT00665353|564397268|FG000|Study Step 1|Adverse Event|1|||
156354704|NCT00665353|564397268|FG000|Study Step 1|Withdrawal by Subject|2|||
156354705|NCT00665353|564397268|FG000|Study Step 2|Lost to Follow-up|2|||
156354706|NCT00665353|564397268|FG000|Study Step 2|Lack of Efficacy|12|||
156354707|NCT00573755|564397269|FG000|Overall Study|Still receiving treatment|1|||
156354708|NCT00573755|564397270|FG001|Overall Study|Still receiving treatment|0|||
156486482|NCT01572493|564874342|FG000|Overall Study|Adverse Event|0|||
156486483|NCT01572493|564874343|FG001|Overall Study|Adverse Event|0|||
156354709|NCT03724812|564397271|FG000|Overall Study|Missed Visit|1|||
156354710|NCT03724812|564397271|FG000|Overall Study|Death|2|||
156354711|NCT03724812|564397271|FG000|Overall Study|Withdrawal by Subject|1|||
156354712|NCT01851720|564397272|FG000|Overall Study|Lost to Follow-up|0|||
156354713|NCT01851720|564397273|FG001|Overall Study|Lost to Follow-up|1|||
156354714|NCT01870583|564397278|FG000|Overall Study|Protocol Violation|0|||
156354715|NCT01870583|564397279|FG001|Overall Study|Protocol Violation|5|||
156354716|NCT01870583|564397280|FG002|Overall Study|Protocol Violation|3|||
156486484|NCT01572493|564874344|FG002|Overall Study|Adverse Event|0|||
156486485|NCT01572493|564874345|FG003|Overall Study|Adverse Event|0|||
156486486|NCT01572493|564874346|FG004|Overall Study|Adverse Event|0|||
156486487|NCT01572493|564874347|FG005|Overall Study|Adverse Event|0|||
156486488|NCT01572493|564874348|FG006|Overall Study|Adverse Event|1|||
156486489|NCT01572493|564874349|FG007|Overall Study|Adverse Event|0|||
156486490|NCT01572493|564874350|FG008|Overall Study|Adverse Event|0|||
156486491|NCT01090076|564874351|FG000|Overall Study|Death|1|||
156486492|NCT01090076|564874352|FG001|Overall Study|Death|1|||
156486493|NCT01090076|564874351|FG000|Overall Study|Withdrawal by Subject|0|||
156486494|NCT01090076|564874352|FG001|Overall Study|Withdrawal by Subject|1|||
156486495|NCT02402465|564874357|FG000|Overall Study|Withdrawal by Subject|0|||
156486496|NCT02402465|564874358|FG001|Overall Study|Withdrawal by Subject|0|||
156486497|NCT02402465|564874359|FG002|Overall Study|Withdrawal by Subject|0|||
156486498|NCT02402465|564874360|FG003|Overall Study|Withdrawal by Subject|0|||
156486499|NCT02402465|564874361|FG004|Overall Study|Withdrawal by Subject|0|||
156486500|NCT02402465|564874362|FG005|Overall Study|Withdrawal by Subject|1|||
156486501|NCT02402465|564874357|FG000|Overall Study|Lost to Follow-up|0|||
156486502|NCT02402465|564874358|FG001|Overall Study|Lost to Follow-up|1|||
156486503|NCT02402465|564874359|FG002|Overall Study|Lost to Follow-up|0|||
156486504|NCT02402465|564874360|FG003|Overall Study|Lost to Follow-up|0|||
156486505|NCT02402465|564874361|FG004|Overall Study|Lost to Follow-up|1|||
156486506|NCT02402465|564874362|FG005|Overall Study|Lost to Follow-up|0|||
156486507|NCT01284634|564874363|FG000|Overall Study|Adverse Event|1|||
156486508|NCT01284634|564874364|FG001|Overall Study|Adverse Event|0|||
156486509|NCT01284634|564874365|FG002|Overall Study|Adverse Event|2|||
156486510|NCT01284634|564874366|FG003|Overall Study|Adverse Event|1|||
156486511|NCT02236598|564874367|FG000|Overall Study|Adverse Event|0|||
156486512|NCT02236598|564874368|FG001|Overall Study|Adverse Event|1|||
156486513|NCT02236598|564874367|FG000|Overall Study|Withdrawal by Subject|0|||
156486514|NCT02236598|564874368|FG001|Overall Study|Withdrawal by Subject|1|||
156486515|NCT00428441|564874380|FG000|Overall Study|Lost to Follow-up|1|||
156486516|NCT03132753|564874381|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
156486517|NCT03132753|564874382|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
156486518|NCT03132753|564874381|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
156486519|NCT03132753|564874382|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
156486520|NCT00084747|564874383|FG000|Overall Study|Relapsed|8|||
156486521|NCT00084747|564874383|FG000|Overall Study|Death|3|||
156486522|NCT00084747|564874383|FG000|Overall Study|Withdrawal by Subject|2|||
156486523|NCT00679549|564874385|FG000|Overall Study|dropout|2|||
156486524|NCT00679549|564874386|FG001|Overall Study|dropout|4|||
156486525|NCT00679549|564874385|FG000|Overall Study|missing outcome echocardiograms|4|||
156486526|NCT00679549|564874386|FG001|Overall Study|missing outcome echocardiograms|5|||
156486527|NCT00125853|564874387|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
156486528|NCT00125853|564874388|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
156486529|NCT00157209|564874395|FG000|Overall Study|Ongoing at data cut-off|10|||
156486530|NCT00157209|564874396|FG001|Overall Study|Ongoing at data cut-off|0|||
156486531|NCT04474691|564874397|FG000|Overall Study|Withdrawal by Subject|9|||
156486532|NCT03048058|564874399|FG000|Overall Study|Lost to Follow-up|4|||
156486533|NCT03048058|564874400|FG001|Overall Study|Lost to Follow-up|0|||
156486534|NCT03048058|564874399|FG000|Overall Study|Withdrawal by Subject|0|||
156486535|NCT03048058|564874400|FG001|Overall Study|Withdrawal by Subject|4|||
156486536|NCT01257698|564874401|FG000|Overall Study|Protocol Violation|4|||
156486537|NCT01257698|564874402|FG001|Overall Study|Protocol Violation|0|||
156486538|NCT00274846|564874405|FG000|Overall Study|Did not receive adequate NK cells|1|||
156486539|NCT01395914|564874414|FG000|Overall Study|Unrelated to study drug AE|6|||
156486540|NCT01395914|564874415|FG001|Overall Study|Unrelated to study drug AE|1|||
156486541|NCT01395914|564874414|FG000|Overall Study|Death|23|||
156486542|NCT01395914|564874415|FG001|Overall Study|Death|17|||
156486543|NCT01395914|564874414|FG000|Overall Study|Other|9|||
156486544|NCT01395914|564874415|FG001|Overall Study|Other|3|||
156486545|NCT01395914|564874414|FG000|Overall Study|Withdrawal by patient|27|||
156486546|NCT01395914|564874415|FG001|Overall Study|Withdrawal by patient|14|||
156486547|NCT01395914|564874414|FG000|Overall Study|Study drug-related AE|1|||
156486548|NCT01395914|564874415|FG001|Overall Study|Study drug-related AE|0|||
156486549|NCT01395914|564874414|FG000|Overall Study|Lost to Follow-up|6|||
156486550|NCT01395914|564874415|FG001|Overall Study|Lost to Follow-up|2|||
156486551|NCT02256488|564874418|FG000|Overall Study|Lost to Follow-up|6|||
156486552|NCT02256488|564874419|FG001|Overall Study|Lost to Follow-up|6|||
156486553|NCT02256488|564874420|FG002|Overall Study|Lost to Follow-up|9|||
156486554|NCT02256488|564874421|FG003|Overall Study|Lost to Follow-up|3|||
156486555|NCT02256488|564874418|FG000|Overall Study|OTHER|1|||
156486556|NCT02256488|564874419|FG001|Overall Study|OTHER|0|||
156486557|NCT02256488|564874420|FG002|Overall Study|OTHER|1|||
156486558|NCT02256488|564874421|FG003|Overall Study|OTHER|1|||
156486559|NCT02256488|564874418|FG000|Overall Study|Withdrawal by Subject|1|||
156486560|NCT02256488|564874419|FG001|Overall Study|Withdrawal by Subject|0|||
156486561|NCT02256488|564874420|FG002|Overall Study|Withdrawal by Subject|0|||
156486562|NCT02256488|564874421|FG003|Overall Study|Withdrawal by Subject|2|||
156486563|NCT00975130|564874422|FG000|Study Part 1|Adverse Event|150|||
156486564|NCT00975130|564874423|FG001|Study Part 1|Adverse Event|0|||
156486565|NCT00975130|564874424|FG002|Study Part 1|Adverse Event|0|||
156486566|NCT00975130|564874422|FG000|Study Part 1|Lost to Follow-up|19|||
156486567|NCT00975130|564874423|FG001|Study Part 1|Lost to Follow-up|0|||
156486568|NCT00975130|564874424|FG002|Study Part 1|Lost to Follow-up|0|||
156486569|NCT00975130|564874422|FG000|Study Part 1|Withdrawal by Subject|61|||
156486570|NCT00975130|564874423|FG001|Study Part 1|Withdrawal by Subject|0|||
156486571|NCT00975130|564874424|FG002|Study Part 1|Withdrawal by Subject|0|||
156486572|NCT00975130|564874422|FG000|Study Part 1|Protocol Violation|13|||
156486573|NCT00975130|564874423|FG001|Study Part 1|Protocol Violation|0|||
156486574|NCT00975130|564874424|FG002|Study Part 1|Protocol Violation|0|||
156486575|NCT00975130|564874422|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
156544570|NCT01251367|565087801|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
156544571|NCT01251367|565087801|FG000|Overall Study|End of Study Visit Performed in Error|1|||
156486576|NCT00975130|564874423|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
156486577|NCT00975130|564874424|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
156486578|NCT00975130|564874422|FG000|Study Part 1|Administrative|4|||
156486579|NCT00975130|564874423|FG001|Study Part 1|Administrative|0|||
156486580|NCT00975130|564874424|FG002|Study Part 1|Administrative|0|||
156354717|NCT01870583|564397278|FG000|Overall Study|Lost to Follow-up|11|||
156354718|NCT01870583|564397279|FG001|Overall Study|Lost to Follow-up|13|||
156354719|NCT01870583|564397280|FG002|Overall Study|Lost to Follow-up|5|||
156354720|NCT01394523|564397281|FG000|Overall Study|Unable to place block|1|||
156354721|NCT01394523|564397282|FG001|Overall Study|Unable to place block|0|||
156354722|NCT01394523|564397283|FG002|Overall Study|Unable to place block|0|||
156354723|NCT02389998|564397287|FG000|Overall Study|car accident|1|||
156354724|NCT02389998|564397288|FG001|Overall Study|car accident|0|||
156354725|NCT01770379|564397292|FG000|Overall Study|Technical issues|1|||
156354726|NCT01770379|564397293|FG001|Overall Study|Technical issues|0|||
156354727|NCT01770379|564397294|FG002|Overall Study|Technical issues|0|||
156354728|NCT01770379|564397292|FG000|Overall Study|Withdrawal by Subject|7|||
156354729|NCT01770379|564397293|FG001|Overall Study|Withdrawal by Subject|10|||
156354730|NCT01770379|564397294|FG002|Overall Study|Withdrawal by Subject|7|||
156354731|NCT01770379|564397292|FG000|Overall Study|study terminated by sponsor|22|||
156354732|NCT01770379|564397293|FG001|Overall Study|study terminated by sponsor|23|||
156354733|NCT01770379|564397294|FG002|Overall Study|study terminated by sponsor|22|||
156354734|NCT01770379|564397292|FG000|Overall Study|Protocol Violation|0|||
156354735|NCT01770379|564397293|FG001|Overall Study|Protocol Violation|1|||
156354736|NCT01770379|564397294|FG002|Overall Study|Protocol Violation|1|||
156354737|NCT01770379|564397292|FG000|Overall Study|Physician Decision|0|||
156354738|NCT01770379|564397293|FG001|Overall Study|Physician Decision|1|||
156354739|NCT01770379|564397294|FG002|Overall Study|Physician Decision|2|||
156354740|NCT01770379|564397292|FG000|Overall Study|Lost to Follow-up|0|||
156354741|NCT01770379|564397293|FG001|Overall Study|Lost to Follow-up|0|||
156354742|NCT01770379|564397294|FG002|Overall Study|Lost to Follow-up|2|||
156354743|NCT01770379|564397292|FG000|Overall Study|Lack of Efficacy|8|||
156354744|NCT01770379|564397293|FG001|Overall Study|Lack of Efficacy|6|||
156354745|NCT01770379|564397294|FG002|Overall Study|Lack of Efficacy|6|||
156354746|NCT01770379|564397292|FG000|Overall Study|Adverse Event|1|||
156354747|NCT01770379|564397293|FG001|Overall Study|Adverse Event|3|||
156354748|NCT01770379|564397294|FG002|Overall Study|Adverse Event|2|||
156354749|NCT00778700|564397301|FG000|Overall Study|Adverse Event|6|||
156354750|NCT00778700|564397302|FG001|Overall Study|Adverse Event|1|||
156354751|NCT00778700|564397303|FG002|Overall Study|Adverse Event|3|||
156354752|NCT00778700|564397304|FG003|Overall Study|Adverse Event|5|||
156354753|NCT00778700|564397301|FG000|Overall Study|Protocol Violation|1|||
156354754|NCT00778700|564397302|FG001|Overall Study|Protocol Violation|1|||
156354755|NCT00778700|564397303|FG002|Overall Study|Protocol Violation|0|||
156354756|NCT00778700|564397304|FG003|Overall Study|Protocol Violation|0|||
156354757|NCT00778700|564397301|FG000|Overall Study|Subject Withdrew Consent|6|||
156354758|NCT00778700|564397302|FG001|Overall Study|Subject Withdrew Consent|4|||
156354759|NCT00778700|564397303|FG002|Overall Study|Subject Withdrew Consent|1|||
156354760|NCT00778700|564397304|FG003|Overall Study|Subject Withdrew Consent|4|||
156354761|NCT00778700|564397301|FG000|Overall Study|Lost to Follow-up|3|||
156354762|NCT00778700|564397302|FG001|Overall Study|Lost to Follow-up|1|||
156354763|NCT00778700|564397303|FG002|Overall Study|Lost to Follow-up|0|||
156354764|NCT00778700|564397304|FG003|Overall Study|Lost to Follow-up|1|||
156354765|NCT00778700|564397301|FG000|Overall Study|Reason not Specified|2|||
156354766|NCT00778700|564397302|FG001|Overall Study|Reason not Specified|0|||
156354767|NCT00778700|564397303|FG002|Overall Study|Reason not Specified|1|||
156354768|NCT00778700|564397304|FG003|Overall Study|Reason not Specified|3|||
156354769|NCT00778700|564397301|FG000|Overall Study|Other|0|||
156354770|NCT00778700|564397302|FG001|Overall Study|Other|0|||
156354771|NCT00778700|564397303|FG002|Overall Study|Other|1|||
156354772|NCT00778700|564397304|FG003|Overall Study|Other|0|||
156486581|NCT00975130|564874422|FG000|Study Part 1|Withdrew Consent|24|||
156486582|NCT00975130|564874423|FG001|Study Part 1|Withdrew Consent|0|||
156486583|NCT00975130|564874424|FG002|Study Part 1|Withdrew Consent|0|||
156486584|NCT00975130|564874422|FG000|Study Part 2|Adverse Event|0|||
156354773|NCT03227029|564397308|FG000|Overall Study|Child Wheezed (no treatment)|0|||
156354774|NCT03227029|564397309|FG001|Overall Study|Child Wheezed (no treatment)|1|||
156354775|NCT03227029|564397310|FG002|Overall Study|Child Wheezed (no treatment)|0|||
156354776|NCT03227029|564397308|FG000|Overall Study|No post RSV season visit due to COVID|3|||
156354777|NCT03227029|564397309|FG001|Overall Study|No post RSV season visit due to COVID|3|||
156354778|NCT03227029|564397310|FG002|Overall Study|No post RSV season visit due to COVID|2|||
156354779|NCT03227029|564397308|FG000|Overall Study|Not able to get to clinic|0|||
156354780|NCT03227029|564397309|FG001|Overall Study|Not able to get to clinic|0|||
156354781|NCT03227029|564397310|FG002|Overall Study|Not able to get to clinic|1|||
156354782|NCT03227029|564397308|FG000|Overall Study|Withdrawal by Subject|1|||
156354783|NCT03227029|564397309|FG001|Overall Study|Withdrawal by Subject|0|||
156354784|NCT03227029|564397310|FG002|Overall Study|Withdrawal by Subject|0|||
156354785|NCT03227029|564397308|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
156354786|NCT03227029|564397309|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
156354787|NCT03227029|564397310|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
156354788|NCT03274440|564397311|FG000|Overall Study|Time commitment too great|1|||
156486585|NCT00975130|564874423|FG001|Study Part 2|Adverse Event|14|||
156544572|NCT02370615|565087806|FG000|Overall Study|Adverse Event|1|||
156486586|NCT00975130|564874424|FG002|Study Part 2|Adverse Event|7|||
156486587|NCT00975130|564874422|FG000|Study Part 2|Lost to Follow-up|0|||
156486588|NCT00975130|564874423|FG001|Study Part 2|Lost to Follow-up|0|||
156486589|NCT00975130|564874424|FG002|Study Part 2|Lost to Follow-up|1|||
156486590|NCT00975130|564874422|FG000|Study Part 2|Withdrawal by Subject|0|||
156486591|NCT00975130|564874423|FG001|Study Part 2|Withdrawal by Subject|13|||
156486592|NCT00975130|564874424|FG002|Study Part 2|Withdrawal by Subject|5|||
156486593|NCT00975130|564874422|FG000|Study Part 2|Withdrew Consent|0|||
156486594|NCT00975130|564874423|FG001|Study Part 2|Withdrew Consent|6|||
156486595|NCT00975130|564874424|FG002|Study Part 2|Withdrew Consent|2|||
156354789|NCT03274440|564397312|FG001|Overall Study|Time commitment too great|0|||
156354790|NCT03274440|564397313|FG002|Overall Study|Time commitment too great|0|||
156354791|NCT03274440|564397314|FG003|Overall Study|Time commitment too great|1|||
156354792|NCT03274440|564397315|FG004|Overall Study|Time commitment too great|0|||
156486596|NCT00975130|564874422|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
156486597|NCT00975130|564874423|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
156486598|NCT00975130|564874424|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
156486599|NCT00975130|564874422|FG000|Study Part 2|Administrative|0|||
156486600|NCT00975130|564874423|FG001|Study Part 2|Administrative|1|||
156486601|NCT00975130|564874424|FG002|Study Part 2|Administrative|0|||
156486602|NCT00975130|564874422|FG000|Study Part 2|Protocol Violation|0|||
156486603|NCT00975130|564874423|FG001|Study Part 2|Protocol Violation|0|||
156486604|NCT00975130|564874424|FG002|Study Part 2|Protocol Violation|1|||
156486605|NCT03305458|564874425|FG000|Overall Study|Withdrawal by Subject|50|||
156486606|NCT03305458|564874426|FG001|Overall Study|Withdrawal by Subject|46|||
156486607|NCT03305458|564874427|FG002|Overall Study|Withdrawal by Subject|93|||
156486608|NCT03305458|564874425|FG000|Overall Study|Lost to Follow-up|85|||
156486609|NCT03305458|564874426|FG001|Overall Study|Lost to Follow-up|85|||
156486610|NCT03305458|564874427|FG002|Overall Study|Lost to Follow-up|35|||
156486611|NCT02332824|564874428|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
156486612|NCT02332824|564874429|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
156486613|NCT02332824|564874430|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
156486614|NCT02332824|564874431|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
156486615|NCT02332824|564874432|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
156486616|NCT02332824|564874433|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
156486617|NCT02332824|564874428|FG000|Overall Study|Voluntary Withdrawal|1|||
156486618|NCT02332824|564874429|FG001|Overall Study|Voluntary Withdrawal|0|||
156486619|NCT02332824|564874430|FG002|Overall Study|Voluntary Withdrawal|0|||
156486620|NCT02332824|564874431|FG003|Overall Study|Voluntary Withdrawal|0|||
156486621|NCT02332824|564874432|FG004|Overall Study|Voluntary Withdrawal|0|||
156486622|NCT02332824|564874433|FG005|Overall Study|Voluntary Withdrawal|0|||
156486623|NCT02332824|564874428|FG000|Overall Study|Inconvenient schedule|1|||
156486624|NCT02332824|564874429|FG001|Overall Study|Inconvenient schedule|1|||
156486625|NCT02332824|564874430|FG002|Overall Study|Inconvenient schedule|0|||
156486626|NCT02332824|564874431|FG003|Overall Study|Inconvenient schedule|0|||
156486627|NCT02332824|564874432|FG004|Overall Study|Inconvenient schedule|0|||
156486628|NCT02332824|564874433|FG005|Overall Study|Inconvenient schedule|0|||
156486629|NCT02332824|564874428|FG000|Overall Study|Transfer|0|||
156486630|NCT02332824|564874429|FG001|Overall Study|Transfer|0|||
156486631|NCT02332824|564874430|FG002|Overall Study|Transfer|1|||
156486632|NCT02332824|564874431|FG003|Overall Study|Transfer|1|||
156486633|NCT02332824|564874432|FG004|Overall Study|Transfer|0|||
156486634|NCT02332824|564874433|FG005|Overall Study|Transfer|0|||
156486635|NCT00498797|564874434|FG000|Overall Study|Withdrawal by Subject|4|||
156486636|NCT00498797|564874435|FG001|Overall Study|Withdrawal by Subject|2|||
156354793|NCT03274440|564397316|FG005|Overall Study|Time commitment too great|0|||
156486637|NCT00498797|564874434|FG000|Overall Study|Adverse Event|12|||
156486638|NCT00498797|564874435|FG001|Overall Study|Adverse Event|5|||
156486639|NCT00498797|564874434|FG000|Overall Study|Condition under investigation worsened|19|||
156486640|NCT00498797|564874435|FG001|Overall Study|Condition under investigation worsened|21|||
156544573|NCT02370615|565087807|FG001|Overall Study|Adverse Event|0|||
156486641|NCT00498797|564874434|FG000|Overall Study|Other|3|||
156486642|NCT00498797|564874435|FG001|Overall Study|Other|1|||
156486643|NCT03562117|564874436|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
156486644|NCT03562117|564874437|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
156486645|NCT03562117|564874438|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
156486646|NCT03928821|564874439|FG000|Overall Study|Death|0|||
156486647|NCT03928821|564874440|FG001|Overall Study|Death|1|||
156486648|NCT03928821|564874441|FG002|Overall Study|Death|0|||
156486649|NCT03928821|564874442|FG003|Overall Study|Death|0|||
156486650|NCT03928821|564874439|FG000|Overall Study|Lost to Follow-up|0|||
156486651|NCT03928821|564874440|FG001|Overall Study|Lost to Follow-up|2|||
156486652|NCT03928821|564874441|FG002|Overall Study|Lost to Follow-up|3|||
156486653|NCT03928821|564874442|FG003|Overall Study|Lost to Follow-up|0|||
156486654|NCT03928821|564874439|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
156486655|NCT03928821|564874440|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
156486656|NCT03928821|564874441|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
156486657|NCT03928821|564874442|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
156486658|NCT04743999|564874449|FG000|3-month Questionnaire|Death|1|||
156486659|NCT04743999|564874449|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
156486660|NCT04743999|564874449|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
156486661|NCT04743999|564874449|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
156486662|NCT01721759|564874450|FG000|Treatment Period|Disease Progression|85|||
156486663|NCT01721759|564874450|FG000|Treatment Period|Study drug toxicity|14|||
156486664|NCT01721759|564874450|FG000|Treatment Period|Death|1|||
156486665|NCT01721759|564874450|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
156486666|NCT01721759|564874450|FG000|Treatment Period|Participant request to withdraw|3|||
156486667|NCT01721759|564874450|FG000|Treatment Period|Other Reasons|3|||
156486668|NCT01721759|564874450|FG000|End of Study Period|Participant Withdrew Consent|5|||
156486669|NCT01721759|564874450|FG000|End of Study Period|Death|101|||
156486670|NCT01721759|564874450|FG000|End of Study Period|Lost to Follow-up|1|||
156486671|NCT01721759|564874450|FG000|End of Study Period|Other Reasons|10|||
156486672|NCT03138499|564874456|FG000|Overall Study|Lost to Follow-up|1|||
156486673|NCT03138499|564874457|FG001|Overall Study|Lost to Follow-up|0|||
156544574|NCT00506883|565087810|FG000|Overall Study|Lost to Follow-up|1|||
156486674|NCT03138499|564874456|FG000|Overall Study|Participants withdrew consent|1|||
156486675|NCT03138499|564874457|FG001|Overall Study|Participants withdrew consent|0|||
156486676|NCT03138499|564874456|FG000|Overall Study|Participant discontinued study before treatment|0|||
156486677|NCT03138499|564874457|FG001|Overall Study|Participant discontinued study before treatment|1|||
156486678|NCT03138499|564874456|FG000|Overall Study|Disease Progression|2|||
156544575|NCT00506883|565087811|FG001|Overall Study|Lost to Follow-up|1|||
156486679|NCT03138499|564874457|FG001|Overall Study|Disease Progression|6|||
156486680|NCT03138499|564874456|FG000|Overall Study|Study drug toxicity|2|||
156486681|NCT03138499|564874457|FG001|Overall Study|Study drug toxicity|2|||
156486682|NCT03138499|564874456|FG000|Overall Study|Participant request to discontinue study treatment|1|||
156486683|NCT03138499|564874457|FG001|Overall Study|Participant request to discontinue study treatment|1|||
156486684|NCT03138499|564874456|FG000|Overall Study|Other reasons|2|||
156486685|NCT03138499|564874457|FG001|Overall Study|Other reasons|0|||
156486686|NCT01052714|564874463|FG000|Overall Study|Adverse Event|6|||
156486687|NCT01052714|564874464|FG001|Overall Study|Adverse Event|3|||
156486688|NCT01052714|564874465|FG002|Overall Study|Adverse Event|0|||
156486689|NCT01052714|564874463|FG000|Overall Study|Death|1|||
156486690|NCT01052714|564874464|FG001|Overall Study|Death|2|||
156354794|NCT01291173|564397317|FG000|Overall Study|Adverse Event|0|||
156354795|NCT01291173|564397318|FG001|Overall Study|Adverse Event|3|||
156354796|NCT01291173|564397319|FG002|Overall Study|Adverse Event|1|||
156354797|NCT01291173|564397320|FG003|Overall Study|Adverse Event|3|||
156354798|NCT01291173|564397317|FG000|Overall Study|Protocol Violation|7|||
156354799|NCT01291173|564397318|FG001|Overall Study|Protocol Violation|2|||
156354800|NCT01291173|564397319|FG002|Overall Study|Protocol Violation|2|||
156354801|NCT01291173|564397320|FG003|Overall Study|Protocol Violation|5|||
156354802|NCT01291173|564397317|FG000|Overall Study|Withdrawal by Subject|6|||
156354803|NCT01291173|564397318|FG001|Overall Study|Withdrawal by Subject|4|||
156354804|NCT01291173|564397319|FG002|Overall Study|Withdrawal by Subject|4|||
156354805|NCT01291173|564397320|FG003|Overall Study|Withdrawal by Subject|2|||
156354806|NCT01291173|564397317|FG000|Overall Study|Lost to Follow-up|4|||
156354807|NCT01291173|564397318|FG001|Overall Study|Lost to Follow-up|6|||
156354808|NCT01291173|564397319|FG002|Overall Study|Lost to Follow-up|3|||
156354809|NCT01291173|564397320|FG003|Overall Study|Lost to Follow-up|2|||
156354810|NCT01291173|564397317|FG000|Overall Study|Unable to meet visit schedule|0|||
156354811|NCT01291173|564397318|FG001|Overall Study|Unable to meet visit schedule|0|||
156354812|NCT01291173|564397319|FG002|Overall Study|Unable to meet visit schedule|1|||
156354813|NCT01291173|564397320|FG003|Overall Study|Unable to meet visit schedule|0|||
156354814|NCT01291173|564397317|FG000|Overall Study|Lack of compliance|0|||
156354815|NCT01291173|564397318|FG001|Overall Study|Lack of compliance|0|||
156354816|NCT01291173|564397319|FG002|Overall Study|Lack of compliance|0|||
156354817|NCT01291173|564397320|FG003|Overall Study|Lack of compliance|1|||
156354818|NCT01291173|564397317|FG000|Overall Study|Subject was unblinded|0|||
156354819|NCT01291173|564397318|FG001|Overall Study|Subject was unblinded|0|||
156354820|NCT01291173|564397319|FG002|Overall Study|Subject was unblinded|1|||
156354821|NCT01291173|564397320|FG003|Overall Study|Subject was unblinded|0|||
156354822|NCT01291173|564397317|FG000|Overall Study|Excluded therapy|0|||
156354823|NCT01291173|564397318|FG001|Overall Study|Excluded therapy|0|||
156354824|NCT01291173|564397319|FG002|Overall Study|Excluded therapy|1|||
156354825|NCT01291173|564397320|FG003|Overall Study|Excluded therapy|0|||
156354826|NCT00937157|564397321|FG000|Overall Study|Pregnancy|1|||
156354827|NCT00937157|564397321|FG000|Overall Study|Lost to Follow-up|3|||
156354828|NCT02865187|564397322|FG000|Overall Study|Lost to Follow-up|12|||
156354829|NCT02865187|564397323|FG001|Overall Study|Lost to Follow-up|7|||
156354830|NCT02865187|564397322|FG000|Overall Study|Adverse Event|1|||
156354831|NCT02865187|564397323|FG001|Overall Study|Adverse Event|0|||
156354832|NCT04267133|564397324|FG000|Overall Study|Withdrawal by Subject|1|||
156354833|NCT04267133|564397324|FG000|Overall Study|Adverse Event|4|||
156354834|NCT02369341|564397325|FG000|Overall Study|Migrated/moved from study area|1|||
156354835|NCT02369341|564397326|FG001|Overall Study|Migrated/moved from study area|0|||
156354836|NCT00857220|564397332|FG000|Overall Study|Adverse Event|35|||
156354837|NCT00857220|564397332|FG000|Overall Study|Death|1|||
156354838|NCT00857220|564397332|FG000|Overall Study|Lack of Efficacy|11|||
156354839|NCT00857220|564397332|FG000|Overall Study|Lost to Follow-up|30|||
156354840|NCT00857220|564397332|FG000|Overall Study|Physician Decision|4|||
156354841|NCT00857220|564397332|FG000|Overall Study|Protocol Violation|16|||
156354842|NCT00857220|564397332|FG000|Overall Study|Withdrawal by Subject|67|||
156354843|NCT00857220|564397332|FG000|Overall Study|Clinical Hold|6|||
156486691|NCT01052714|564874465|FG002|Overall Study|Death|0|||
156354844|NCT00857220|564397332|FG000|Overall Study|Site Closed|5|||
156354845|NCT00857220|564397332|FG000|Overall Study|Miscellaneous|8|||
156354846|NCT00383149|564397333|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
156486692|NCT01052714|564874463|FG000|Overall Study|Lost to Follow-up|2|||
156486693|NCT01052714|564874464|FG001|Overall Study|Lost to Follow-up|3|||
156486694|NCT01052714|564874465|FG002|Overall Study|Lost to Follow-up|0|||
156486695|NCT01052714|564874463|FG000|Overall Study|Physician Decision|9|||
156486696|NCT01052714|564874464|FG001|Overall Study|Physician Decision|9|||
156486697|NCT01052714|564874465|FG002|Overall Study|Physician Decision|1|||
156486698|NCT01052714|564874463|FG000|Overall Study|Withdrawal by Subject|7|||
156486699|NCT01052714|564874464|FG001|Overall Study|Withdrawal by Subject|12|||
156354847|NCT00383149|564397333|FG000|Overall Study|Death|2|||
156486700|NCT01052714|564874465|FG002|Overall Study|Withdrawal by Subject|1|||
156486701|NCT00509821|564875686|FG000|Study Period 1 (Induction)|Death|0|||
156486702|NCT00509821|564875687|FG001|Study Period 1 (Induction)|Death|1|||
156486703|NCT00509821|564875686|FG000|Study Period 1 (Induction)|Adverse Event|0|||
156354848|NCT00383149|564397333|FG000|Overall Study|Disease Progression|38|||
156354849|NCT00383149|564397333|FG000|Overall Study|Lost to Follow-up|1|||
156354850|NCT00383149|564397333|FG000|Overall Study|Other|1|||
156354851|NCT00383149|564397333|FG000|Overall Study|Study Drug Toxicity|4|||
156354852|NCT00383149|564397333|FG000|Overall Study|Request to Discontinue Treatment|4|||
156354853|NCT00383149|564397333|FG000|Overall Study|Participant Withdrew Consent|1|||
156354854|NCT03721276|564397334|FG000|Overall Study|Lost to Follow-up|5|||
156354855|NCT03721276|564397335|FG001|Overall Study|Lost to Follow-up|3|||
156354856|NCT03721276|564397334|FG000|Overall Study|Adverse Event|0|||
156354857|NCT03721276|564397335|FG001|Overall Study|Adverse Event|1|||
156354858|NCT01340898|564397338|FG000|Primary Phase|Serious Adverse Events|0|||
156486704|NCT00509821|564875687|FG001|Study Period 1 (Induction)|Adverse Event|2|||
156354859|NCT01340898|564397339|FG001|Primary Phase|Serious Adverse Events|0|||
156354860|NCT01340898|564397340|FG002|Primary Phase|Serious Adverse Events|1|||
156354861|NCT01340898|564397338|FG000|Primary Phase|Withdrawal by Subject|8|||
156354862|NCT01340898|564397339|FG001|Primary Phase|Withdrawal by Subject|7|||
156354863|NCT01340898|564397340|FG002|Primary Phase|Withdrawal by Subject|5|||
156354864|NCT01340898|564397338|FG000|Primary Phase|Migrated/moved from study area|4|||
156354865|NCT01340898|564397339|FG001|Primary Phase|Migrated/moved from study area|1|||
156354866|NCT01340898|564397340|FG002|Primary Phase|Migrated/moved from study area|0|||
156354867|NCT01340898|564397338|FG000|Primary Phase|Lost to Follow-up|4|||
156354868|NCT01340898|564397339|FG001|Primary Phase|Lost to Follow-up|1|||
156354869|NCT01340898|564397340|FG002|Primary Phase|Lost to Follow-up|0|||
156354870|NCT01340898|564397338|FG000|Booster Phase|Withdrawal by Subject|3|||
156354871|NCT01340898|564397339|FG001|Booster Phase|Withdrawal by Subject|0|||
156354872|NCT01340898|564397340|FG002|Booster Phase|Withdrawal by Subject|4|||
156354873|NCT01340898|564397338|FG000|Booster Phase|Migrated/moved from study area|3|||
156354874|NCT01340898|564397339|FG001|Booster Phase|Migrated/moved from study area|0|||
156354875|NCT01340898|564397340|FG002|Booster Phase|Migrated/moved from study area|0|||
156354876|NCT01340898|564397338|FG000|Booster Phase|Lost to Follow-up|4|||
156354877|NCT01340898|564397339|FG001|Booster Phase|Lost to Follow-up|2|||
156354878|NCT01340898|564397340|FG002|Booster Phase|Lost to Follow-up|3|||
156354879|NCT00416078|564397345|FG000|Overall Study|Death|3|||
156354880|NCT00416078|564397346|FG001|Overall Study|Death|4|||
156354881|NCT00416078|564397345|FG000|Overall Study|Withdrawal by Subject|3|||
156354882|NCT00416078|564397346|FG001|Overall Study|Withdrawal by Subject|2|||
156354883|NCT00416078|564397345|FG000|Overall Study|Physician Decision|1|||
156354884|NCT00416078|564397346|FG001|Overall Study|Physician Decision|0|||
156486705|NCT00509821|564875686|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
156354885|NCT00416078|564397345|FG000|Overall Study|Lost to Follow-up|4|||
156354886|NCT00416078|564397346|FG001|Overall Study|Lost to Follow-up|2|||
156354887|NCT00969150|564397351|FG000|Overall Study|Adverse Event|4|||
156354888|NCT00969150|564397352|FG001|Overall Study|Adverse Event|14|||
156354889|NCT00969150|564397351|FG000|Overall Study|Lack of Efficacy|1|||
156354890|NCT00969150|564397352|FG001|Overall Study|Lack of Efficacy|1|||
156354891|NCT00969150|564397351|FG000|Overall Study|Protocol Violation|9|||
156354892|NCT00969150|564397352|FG001|Overall Study|Protocol Violation|12|||
156354893|NCT00969150|564397351|FG000|Overall Study|Withdrawal by Subject|13|||
156354894|NCT00969150|564397352|FG001|Overall Study|Withdrawal by Subject|9|||
156354895|NCT00969150|564397351|FG000|Overall Study|Lost to Follow-up|5|||
156354896|NCT00969150|564397352|FG001|Overall Study|Lost to Follow-up|4|||
156354897|NCT00969150|564397351|FG000|Overall Study|Other reasons|1|||
156354898|NCT00969150|564397352|FG001|Overall Study|Other reasons|0|||
156354899|NCT04128267|564397359|FG000|Overall Study|Withdrawal by Subject|6|||
156354900|NCT04128267|564397359|FG000|Overall Study|Death|2|||
156354901|NCT04128267|564397359|FG000|Overall Study|Disease progression|1|||
156354902|NCT04128267|564397359|FG000|Overall Study|Participant had other medical issues|4|||
156354903|NCT04128267|564397359|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
156354904|NCT00642941|564397360|FG000|Overall Study|Physician Decision|3|||
156354905|NCT00642941|564397361|FG001|Overall Study|Physician Decision|1|||
156354906|NCT00642941|564397362|FG002|Overall Study|Physician Decision|0|||
156354907|NCT00642941|564397363|FG003|Overall Study|Physician Decision|0|||
156354908|NCT00642941|564397364|FG004|Overall Study|Physician Decision|0|||
156354909|NCT00642941|564397365|FG005|Overall Study|Physician Decision|0|||
156354910|NCT00642941|564397366|FG006|Overall Study|Physician Decision|1|||
156354911|NCT00642941|564397367|FG007|Overall Study|Physician Decision|0|||
156354912|NCT00642941|564397368|FG008|Overall Study|Physician Decision|0|||
156354913|NCT00642941|564397369|FG009|Overall Study|Physician Decision|1|||
156354914|NCT00642941|564397370|FG010|Overall Study|Physician Decision|0|||
156354915|NCT00642941|564397371|FG011|Overall Study|Physician Decision|1|||
156354916|NCT00642941|564397360|FG000|Overall Study|Death|4|||
156354917|NCT00642941|564397361|FG001|Overall Study|Death|0|||
156354918|NCT00642941|564397362|FG002|Overall Study|Death|1|||
156354919|NCT00642941|564397363|FG003|Overall Study|Death|1|||
156354920|NCT00642941|564397364|FG004|Overall Study|Death|2|||
156354921|NCT00642941|564397365|FG005|Overall Study|Death|1|||
156354922|NCT00642941|564397366|FG006|Overall Study|Death|0|||
156354923|NCT00642941|564397367|FG007|Overall Study|Death|0|||
156354924|NCT00642941|564397368|FG008|Overall Study|Death|0|||
156354925|NCT00642941|564397369|FG009|Overall Study|Death|0|||
156354926|NCT00642941|564397370|FG010|Overall Study|Death|0|||
156354927|NCT00642941|564397371|FG011|Overall Study|Death|1|||
156354928|NCT00642941|564397360|FG000|Overall Study|Study closed by Sponsor|0|||
156354929|NCT00642941|564397361|FG001|Overall Study|Study closed by Sponsor|1|||
156486706|NCT00509821|564875687|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
156486707|NCT02720185|564875690|FG000|Overall Study|Lost to Follow-up|1|||
156486708|NCT01157351|564875691|FG000|Overall Study|Adverse Event|5|||
156486709|NCT01157351|564875692|FG001|Overall Study|Adverse Event|4|||
156354930|NCT00642941|564397362|FG002|Overall Study|Study closed by Sponsor|0|||
156354931|NCT00642941|564397363|FG003|Overall Study|Study closed by Sponsor|0|||
156354932|NCT00642941|564397364|FG004|Overall Study|Study closed by Sponsor|0|||
156354933|NCT00642941|564397365|FG005|Overall Study|Study closed by Sponsor|0|||
156354934|NCT00642941|564397366|FG006|Overall Study|Study closed by Sponsor|0|||
156354935|NCT00642941|564397367|FG007|Overall Study|Study closed by Sponsor|0|||
156354936|NCT00642941|564397368|FG008|Overall Study|Study closed by Sponsor|0|||
156354937|NCT00642941|564397369|FG009|Overall Study|Study closed by Sponsor|0|||
156354938|NCT00642941|564397370|FG010|Overall Study|Study closed by Sponsor|0|||
156354939|NCT00642941|564397371|FG011|Overall Study|Study closed by Sponsor|0|||
156354940|NCT00642941|564397360|FG000|Overall Study|Withdrawal by Subject|1|||
156354941|NCT00642941|564397361|FG001|Overall Study|Withdrawal by Subject|0|||
156354942|NCT00642941|564397362|FG002|Overall Study|Withdrawal by Subject|0|||
156354943|NCT00642941|564397363|FG003|Overall Study|Withdrawal by Subject|2|||
156354944|NCT00642941|564397364|FG004|Overall Study|Withdrawal by Subject|0|||
156354945|NCT00642941|564397365|FG005|Overall Study|Withdrawal by Subject|0|||
156486710|NCT01157351|564875691|FG000|Overall Study|Death|1|||
156354946|NCT00642941|564397366|FG006|Overall Study|Withdrawal by Subject|2|||
156354947|NCT00642941|564397367|FG007|Overall Study|Withdrawal by Subject|0|||
156354948|NCT00642941|564397368|FG008|Overall Study|Withdrawal by Subject|1|||
156354949|NCT00642941|564397369|FG009|Overall Study|Withdrawal by Subject|0|||
156354950|NCT00642941|564397370|FG010|Overall Study|Withdrawal by Subject|0|||
156354951|NCT00642941|564397371|FG011|Overall Study|Withdrawal by Subject|1|||
156354952|NCT00642941|564397360|FG000|Overall Study|Protocol Violation|0|||
156354953|NCT00642941|564397361|FG001|Overall Study|Protocol Violation|0|||
156354954|NCT00642941|564397362|FG002|Overall Study|Protocol Violation|0|||
156354955|NCT00642941|564397363|FG003|Overall Study|Protocol Violation|0|||
156354956|NCT00642941|564397364|FG004|Overall Study|Protocol Violation|0|||
156354957|NCT00642941|564397365|FG005|Overall Study|Protocol Violation|0|||
156354958|NCT00642941|564397366|FG006|Overall Study|Protocol Violation|1|||
156354959|NCT00642941|564397367|FG007|Overall Study|Protocol Violation|0|||
156354960|NCT00642941|564397368|FG008|Overall Study|Protocol Violation|0|||
156354961|NCT00642941|564397369|FG009|Overall Study|Protocol Violation|0|||
156354962|NCT00642941|564397370|FG010|Overall Study|Protocol Violation|0|||
156354963|NCT00642941|564397371|FG011|Overall Study|Protocol Violation|0|||
156354964|NCT00642941|564397360|FG000|Overall Study|Adverse Event|1|||
156354965|NCT00642941|564397361|FG001|Overall Study|Adverse Event|1|||
156354966|NCT00642941|564397362|FG002|Overall Study|Adverse Event|0|||
156354967|NCT00642941|564397363|FG003|Overall Study|Adverse Event|0|||
156354968|NCT00642941|564397364|FG004|Overall Study|Adverse Event|0|||
156354969|NCT00642941|564397365|FG005|Overall Study|Adverse Event|0|||
156354970|NCT00642941|564397366|FG006|Overall Study|Adverse Event|1|||
156354971|NCT00642941|564397367|FG007|Overall Study|Adverse Event|1|||
156354972|NCT00642941|564397368|FG008|Overall Study|Adverse Event|0|||
156354973|NCT00642941|564397369|FG009|Overall Study|Adverse Event|1|||
156354974|NCT00642941|564397370|FG010|Overall Study|Adverse Event|0|||
156354975|NCT00642941|564397371|FG011|Overall Study|Adverse Event|0|||
156354976|NCT00642941|564397360|FG000|Overall Study|Other|1|||
156354977|NCT00642941|564397361|FG001|Overall Study|Other|1|||
156354978|NCT00642941|564397362|FG002|Overall Study|Other|1|||
156354979|NCT00642941|564397363|FG003|Overall Study|Other|1|||
156354980|NCT00642941|564397364|FG004|Overall Study|Other|0|||
156354981|NCT00642941|564397365|FG005|Overall Study|Other|1|||
156354982|NCT00642941|564397366|FG006|Overall Study|Other|0|||
156354983|NCT00642941|564397367|FG007|Overall Study|Other|1|||
156354984|NCT00642941|564397368|FG008|Overall Study|Other|0|||
156354985|NCT00642941|564397369|FG009|Overall Study|Other|0|||
156354986|NCT00642941|564397370|FG010|Overall Study|Other|0|||
156354987|NCT00642941|564397371|FG011|Overall Study|Other|1|||
156354988|NCT00642941|564397360|FG000|Overall Study|Disease progression|60|||
156354989|NCT00642941|564397361|FG001|Overall Study|Disease progression|50|||
156354990|NCT00642941|564397362|FG002|Overall Study|Disease progression|5|||
156354991|NCT00642941|564397363|FG003|Overall Study|Disease progression|36|||
156354992|NCT00642941|564397364|FG004|Overall Study|Disease progression|23|||
156354993|NCT00642941|564397365|FG005|Overall Study|Disease progression|39|||
156354994|NCT00642941|564397366|FG006|Overall Study|Disease progression|18|||
156354995|NCT00642941|564397367|FG007|Overall Study|Disease progression|12|||
156354996|NCT00642941|564397368|FG008|Overall Study|Disease progression|10|||
156354997|NCT00642941|564397369|FG009|Overall Study|Disease progression|7|||
156354998|NCT00642941|564397370|FG010|Overall Study|Disease progression|12|||
156354999|NCT00642941|564397371|FG011|Overall Study|Disease progression|7|||
156355000|NCT00553150|564397372|FG000|Overall Study|Withdrawal by Subject|0|||
156355001|NCT00553150|564397373|FG001|Overall Study|Withdrawal by Subject|0|||
156355002|NCT00553150|564397374|FG002|Overall Study|Withdrawal by Subject|0|||
156355003|NCT00553150|564397375|FG003|Overall Study|Withdrawal by Subject|2|||
156355004|NCT00553150|564397372|FG000|Overall Study|Protocol Violation|0|||
156355005|NCT00553150|564397373|FG001|Overall Study|Protocol Violation|0|||
156355006|NCT00553150|564397374|FG002|Overall Study|Protocol Violation|0|||
156355007|NCT00553150|564397375|FG003|Overall Study|Protocol Violation|1|||
156355008|NCT00553150|564397372|FG000|Overall Study|Ineligible|0|||
156355009|NCT00553150|564397373|FG001|Overall Study|Ineligible|0|||
156355010|NCT00553150|564397374|FG002|Overall Study|Ineligible|0|||
156355011|NCT00553150|564397375|FG003|Overall Study|Ineligible|1|||
156355012|NCT00492115|564397386|FG000|Overall Study|Withdrawal by Subject|3|||
156355013|NCT00492115|564397387|FG001|Overall Study|Withdrawal by Subject|4|||
156486711|NCT01157351|564875692|FG001|Overall Study|Death|0|||
156486712|NCT01157351|564875691|FG000|Overall Study|Lost to Follow-up|53|||
156355014|NCT03915496|564397390|FG000|Overall Study|Adverse Event|2|||
156355015|NCT03915496|564397391|FG001|Overall Study|Adverse Event|1|||
156355016|NCT03915496|564397392|FG002|Overall Study|Adverse Event|2|||
156355017|NCT02472795|564397393|FG000|Overall Study|Adverse Event|0|||
156355018|NCT02472795|564397394|FG001|Overall Study|Adverse Event|1|||
156355019|NCT02472795|564397395|FG002|Overall Study|Adverse Event|0|||
156355020|NCT02472795|564397396|FG003|Overall Study|Adverse Event|0|||
156355021|NCT02472795|564397397|FG004|Overall Study|Adverse Event|2|||
156355022|NCT02472795|564397393|FG000|Overall Study|Withdrawal by Subject|0|||
156355023|NCT02472795|564397394|FG001|Overall Study|Withdrawal by Subject|0|||
156355024|NCT02472795|564397395|FG002|Overall Study|Withdrawal by Subject|0|||
156486713|NCT01157351|564875692|FG001|Overall Study|Lost to Follow-up|55|||
156355025|NCT02472795|564397396|FG003|Overall Study|Withdrawal by Subject|0|||
156355026|NCT02472795|564397397|FG004|Overall Study|Withdrawal by Subject|1|||
156486714|NCT01157351|564875691|FG000|Overall Study|Withdrawal by Subject|37|||
156355027|NCT04219891|564397398|FG000|Overall Study|Lost to Follow-up|3|||
156355028|NCT04219891|564397398|FG000|Overall Study|Withdrawal by Subject|2|||
156355029|NCT00597012|564397399|FG000|Overall Study|Death|1|||
156355030|NCT00597012|564397400|FG001|Overall Study|Death|1|||
156355031|NCT00597012|564397399|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
156355032|NCT00597012|564397400|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
156355033|NCT00597012|564397399|FG000|Overall Study|Withdrawal by Subject|7|||
156355034|NCT00597012|564397400|FG001|Overall Study|Withdrawal by Subject|4|||
156355035|NCT00597012|564397399|FG000|Overall Study|Ineligible|2|||
156355036|NCT00597012|564397400|FG001|Overall Study|Ineligible|0|||
156355037|NCT00597012|564397399|FG000|Overall Study|Lost to Follow-up|0|||
156355038|NCT00597012|564397400|FG001|Overall Study|Lost to Follow-up|2|||
156355039|NCT03712904|564398764|FG000|Overall Study|Death|0|||
156355040|NCT03712904|564398765|FG001|Overall Study|Death|1|||
156355041|NCT03712904|564398764|FG000|Overall Study|Withdrawal by Subject|0|||
156355042|NCT03712904|564398765|FG001|Overall Study|Withdrawal by Subject|1|||
156355043|NCT03712904|564398764|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
156355044|NCT03712904|564398765|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
156355045|NCT01852942|564398766|FG000|Overall Study|Physician Decision|1|||
156355046|NCT01852942|564398767|FG001|Overall Study|Physician Decision|0|||
156355047|NCT01852942|564398766|FG000|Overall Study|Death|1|||
156355048|NCT01852942|564398767|FG001|Overall Study|Death|1|||
156355049|NCT01852942|564398766|FG000|Overall Study|Withdrawal by Subject|2|||
156355050|NCT01852942|564398767|FG001|Overall Study|Withdrawal by Subject|3|||
156355051|NCT01852942|564398766|FG000|Overall Study|Lost to Follow-up|1|||
156355052|NCT01852942|564398767|FG001|Overall Study|Lost to Follow-up|2|||
156355053|NCT02642614|564398773|FG000|Overall Study|Adverse Event|1|||
156355054|NCT02642614|564398774|FG001|Overall Study|Adverse Event|1|||
156355055|NCT02642614|564398775|FG002|Overall Study|Adverse Event|2|||
156355056|NCT02642614|564398776|FG003|Overall Study|Adverse Event|2|||
156355057|NCT02642614|564398773|FG000|Overall Study|Lost to Follow-up|1|||
156355058|NCT02642614|564398774|FG001|Overall Study|Lost to Follow-up|0|||
156355059|NCT02642614|564398775|FG002|Overall Study|Lost to Follow-up|0|||
156355060|NCT02642614|564398776|FG003|Overall Study|Lost to Follow-up|0|||
156355061|NCT02642614|564398773|FG000|Overall Study|Withdrawal by Subject|1|||
156355062|NCT02642614|564398774|FG001|Overall Study|Withdrawal by Subject|1|||
156355063|NCT02642614|564398775|FG002|Overall Study|Withdrawal by Subject|0|||
156355064|NCT02642614|564398776|FG003|Overall Study|Withdrawal by Subject|0|||
156355065|NCT04708886|564398779|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
156355066|NCT04708886|564398779|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
156355067|NCT01729754|564398780|FG000|Part 1|Adverse Event|2|||
156355068|NCT01729754|564398781|FG001|Part 1|Adverse Event|0|||
156355069|NCT01729754|564398782|FG002|Part 1|Adverse Event|0|||
156355070|NCT01729754|564398783|FG003|Part 1|Adverse Event|1|||
156355071|NCT01729754|564398784|FG004|Part 1|Adverse Event|0|||
156355072|NCT01729754|564398785|FG005|Part 1|Adverse Event|0|||
156355073|NCT01729754|564398786|FG006|Part 1|Adverse Event|2|||
156355074|NCT01729754|564398787|FG007|Part 1|Adverse Event|0|||
156355075|NCT01729754|564398788|FG008|Part 1|Adverse Event|0|||
156355076|NCT01729754|564398789|FG009|Part 1|Adverse Event|5|||
156355077|NCT01729754|564398780|FG000|Part 1|Lack of Efficacy|1|||
156355078|NCT01729754|564398781|FG001|Part 1|Lack of Efficacy|0|||
156355079|NCT01729754|564398782|FG002|Part 1|Lack of Efficacy|0|||
156355080|NCT01729754|564398783|FG003|Part 1|Lack of Efficacy|0|||
156355081|NCT01729754|564398784|FG004|Part 1|Lack of Efficacy|0|||
156486715|NCT01157351|564875692|FG001|Overall Study|Withdrawal by Subject|27|||
156486716|NCT01157351|564875691|FG000|Overall Study|Physician Decision|5|||
156486717|NCT01157351|564875692|FG001|Overall Study|Physician Decision|4|||
156486718|NCT01157351|564875691|FG000|Overall Study|Protocol Violation|0|||
156486719|NCT01157351|564875692|FG001|Overall Study|Protocol Violation|1|||
156486720|NCT01157351|564875691|FG000|Overall Study|Other|32|||
156486721|NCT01157351|564875692|FG001|Overall Study|Other|36|||
156486722|NCT01157351|564875691|FG000|Overall Study|Noncompliance with Study Drug|0|||
156486723|NCT01157351|564875692|FG001|Overall Study|Noncompliance with Study Drug|3|||
156486724|NCT01157351|564875691|FG000|Overall Study|Randomized but not Treated|4|||
156486725|NCT01157351|564875692|FG001|Overall Study|Randomized but not Treated|2|||
156355082|NCT01729754|564398785|FG005|Part 1|Lack of Efficacy|0|||
156355083|NCT01729754|564398786|FG006|Part 1|Lack of Efficacy|2|||
156355084|NCT01729754|564398787|FG007|Part 1|Lack of Efficacy|0|||
156355085|NCT01729754|564398788|FG008|Part 1|Lack of Efficacy|0|||
156355086|NCT01729754|564398789|FG009|Part 1|Lack of Efficacy|0|||
156355087|NCT01729754|564398780|FG000|Part 1|Lost to Follow-up|1|||
156355088|NCT01729754|564398781|FG001|Part 1|Lost to Follow-up|0|||
156355089|NCT01729754|564398782|FG002|Part 1|Lost to Follow-up|0|||
156355090|NCT01729754|564398783|FG003|Part 1|Lost to Follow-up|2|||
156355091|NCT01729754|564398784|FG004|Part 1|Lost to Follow-up|0|||
156355092|NCT01729754|564398785|FG005|Part 1|Lost to Follow-up|0|||
156355093|NCT01729754|564398786|FG006|Part 1|Lost to Follow-up|3|||
156355094|NCT01729754|564398787|FG007|Part 1|Lost to Follow-up|0|||
156355095|NCT01729754|564398788|FG008|Part 1|Lost to Follow-up|0|||
156355096|NCT01729754|564398789|FG009|Part 1|Lost to Follow-up|3|||
156486726|NCT00792259|564875693|FG000|Overall Study|Poor Quality Scans|1|||
156486727|NCT00792259|564875694|FG001|Overall Study|Poor Quality Scans|0|||
156486728|NCT00792259|564875695|FG002|Overall Study|Poor Quality Scans|0|||
156486729|NCT00332488|564875696|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
156486730|NCT00332488|564875697|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
156486731|NCT00332488|564875698|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
156486732|NCT00332488|564875696|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
156486733|NCT00332488|564875697|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
156486734|NCT00332488|564875698|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
156486735|NCT00332488|564875696|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
156486736|NCT00332488|564875697|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
156486737|NCT00332488|564875698|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
156486738|NCT00332488|564875696|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
156486739|NCT00332488|564875697|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
156486740|NCT00332488|564875698|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
156544576|NCT00506883|565087812|FG002|Overall Study|Lost to Follow-up|1|||
156355097|NCT01729754|564398780|FG000|Part 1|Non-compliance with Study Drug|1|||
156355098|NCT01729754|564398781|FG001|Part 1|Non-compliance with Study Drug|0|||
156355099|NCT01729754|564398782|FG002|Part 1|Non-compliance with Study Drug|0|||
156355100|NCT01729754|564398783|FG003|Part 1|Non-compliance with Study Drug|0|||
156355101|NCT01729754|564398784|FG004|Part 1|Non-compliance with Study Drug|0|||
156355102|NCT01729754|564398785|FG005|Part 1|Non-compliance with Study Drug|0|||
156355103|NCT01729754|564398786|FG006|Part 1|Non-compliance with Study Drug|0|||
156355104|NCT01729754|564398787|FG007|Part 1|Non-compliance with Study Drug|0|||
156355105|NCT01729754|564398788|FG008|Part 1|Non-compliance with Study Drug|0|||
156355106|NCT01729754|564398789|FG009|Part 1|Non-compliance with Study Drug|0|||
156355107|NCT01729754|564398780|FG000|Part 1|Physician Decision|0|||
156355108|NCT01729754|564398781|FG001|Part 1|Physician Decision|0|||
156355109|NCT01729754|564398782|FG002|Part 1|Physician Decision|0|||
156355110|NCT01729754|564398783|FG003|Part 1|Physician Decision|0|||
156355111|NCT01729754|564398784|FG004|Part 1|Physician Decision|0|||
156355112|NCT01729754|564398785|FG005|Part 1|Physician Decision|0|||
156355113|NCT01729754|564398786|FG006|Part 1|Physician Decision|0|||
156355114|NCT01729754|564398787|FG007|Part 1|Physician Decision|0|||
156355115|NCT01729754|564398788|FG008|Part 1|Physician Decision|0|||
156355116|NCT01729754|564398789|FG009|Part 1|Physician Decision|4|||
156355117|NCT01729754|564398780|FG000|Part 1|Pregnancy|0|||
156355118|NCT01729754|564398781|FG001|Part 1|Pregnancy|0|||
156355119|NCT01729754|564398782|FG002|Part 1|Pregnancy|0|||
156355120|NCT01729754|564398783|FG003|Part 1|Pregnancy|1|||
156355121|NCT01729754|564398784|FG004|Part 1|Pregnancy|0|||
156355122|NCT01729754|564398785|FG005|Part 1|Pregnancy|0|||
156355123|NCT01729754|564398786|FG006|Part 1|Pregnancy|0|||
156355124|NCT01729754|564398787|FG007|Part 1|Pregnancy|0|||
156355125|NCT01729754|564398788|FG008|Part 1|Pregnancy|0|||
156355126|NCT01729754|564398789|FG009|Part 1|Pregnancy|1|||
156355127|NCT01729754|564398780|FG000|Part 1|Progressive Disease|0|||
156355128|NCT01729754|564398781|FG001|Part 1|Progressive Disease|0|||
156355129|NCT01729754|564398782|FG002|Part 1|Progressive Disease|0|||
156355130|NCT01729754|564398783|FG003|Part 1|Progressive Disease|0|||
156355131|NCT01729754|564398784|FG004|Part 1|Progressive Disease|0|||
156355132|NCT01729754|564398785|FG005|Part 1|Progressive Disease|0|||
156355133|NCT01729754|564398786|FG006|Part 1|Progressive Disease|0|||
156355134|NCT01729754|564398787|FG007|Part 1|Progressive Disease|0|||
156355135|NCT01729754|564398788|FG008|Part 1|Progressive Disease|0|||
156355136|NCT01729754|564398789|FG009|Part 1|Progressive Disease|1|||
156355137|NCT01729754|564398780|FG000|Part 1|Protocol Violation|2|||
156355138|NCT01729754|564398781|FG001|Part 1|Protocol Violation|0|||
156355139|NCT01729754|564398782|FG002|Part 1|Protocol Violation|0|||
156355140|NCT01729754|564398783|FG003|Part 1|Protocol Violation|1|||
156355141|NCT01729754|564398784|FG004|Part 1|Protocol Violation|0|||
156355142|NCT01729754|564398785|FG005|Part 1|Protocol Violation|0|||
156355143|NCT01729754|564398786|FG006|Part 1|Protocol Violation|1|||
156355144|NCT01729754|564398787|FG007|Part 1|Protocol Violation|0|||
156355145|NCT01729754|564398788|FG008|Part 1|Protocol Violation|0|||
156355146|NCT01729754|564398789|FG009|Part 1|Protocol Violation|0|||
156355147|NCT01729754|564398780|FG000|Part 1|Withdrawal by Subject|5|||
156355148|NCT01729754|564398781|FG001|Part 1|Withdrawal by Subject|0|||
156355149|NCT01729754|564398782|FG002|Part 1|Withdrawal by Subject|0|||
156355150|NCT01729754|564398783|FG003|Part 1|Withdrawal by Subject|7|||
156355151|NCT01729754|564398784|FG004|Part 1|Withdrawal by Subject|0|||
156355152|NCT01729754|564398785|FG005|Part 1|Withdrawal by Subject|0|||
156355153|NCT01729754|564398786|FG006|Part 1|Withdrawal by Subject|5|||
156355154|NCT01729754|564398787|FG007|Part 1|Withdrawal by Subject|0|||
156355155|NCT01729754|564398788|FG008|Part 1|Withdrawal by Subject|0|||
156355156|NCT01729754|564398789|FG009|Part 1|Withdrawal by Subject|6|||
156355157|NCT01729754|564398780|FG000|Part 1|Other Protocol Specified Criteria|2|||
156355158|NCT01729754|564398781|FG001|Part 1|Other Protocol Specified Criteria|0|||
156355159|NCT01729754|564398782|FG002|Part 1|Other Protocol Specified Criteria|0|||
156355160|NCT01729754|564398783|FG003|Part 1|Other Protocol Specified Criteria|0|||
156355161|NCT01729754|564398784|FG004|Part 1|Other Protocol Specified Criteria|0|||
156355162|NCT01729754|564398785|FG005|Part 1|Other Protocol Specified Criteria|0|||
156355163|NCT01729754|564398786|FG006|Part 1|Other Protocol Specified Criteria|1|||
156355164|NCT01729754|564398787|FG007|Part 1|Other Protocol Specified Criteria|0|||
156355165|NCT01729754|564398788|FG008|Part 1|Other Protocol Specified Criteria|0|||
156355166|NCT01729754|564398789|FG009|Part 1|Other Protocol Specified Criteria|4|||
156355167|NCT01729754|564398780|FG000|Part 2|Adverse Event|2|||
156355168|NCT01729754|564398781|FG001|Part 2|Adverse Event|0|||
156355169|NCT01729754|564398782|FG002|Part 2|Adverse Event|0|||
156355170|NCT01729754|564398783|FG003|Part 2|Adverse Event|0|||
156355171|NCT01729754|564398784|FG004|Part 2|Adverse Event|0|||
156355172|NCT01729754|564398785|FG005|Part 2|Adverse Event|0|||
156355173|NCT01729754|564398786|FG006|Part 2|Adverse Event|0|||
156355174|NCT01729754|564398787|FG007|Part 2|Adverse Event|0|||
156355175|NCT01729754|564398788|FG008|Part 2|Adverse Event|1|||
156355176|NCT01729754|564398789|FG009|Part 2|Adverse Event|2|||
156355177|NCT01729754|564398780|FG000|Part 2|Lack of Efficacy|0|||
156355178|NCT01729754|564398781|FG001|Part 2|Lack of Efficacy|0|||
156355179|NCT01729754|564398782|FG002|Part 2|Lack of Efficacy|0|||
156355180|NCT01729754|564398783|FG003|Part 2|Lack of Efficacy|0|||
156355181|NCT01729754|564398784|FG004|Part 2|Lack of Efficacy|0|||
156355182|NCT01729754|564398785|FG005|Part 2|Lack of Efficacy|0|||
156355183|NCT01729754|564398786|FG006|Part 2|Lack of Efficacy|0|||
156355184|NCT01729754|564398787|FG007|Part 2|Lack of Efficacy|0|||
156355185|NCT01729754|564398788|FG008|Part 2|Lack of Efficacy|2|||
156355186|NCT01729754|564398789|FG009|Part 2|Lack of Efficacy|2|||
156355187|NCT01729754|564398780|FG000|Part 2|Lost to Follow-up|0|||
156355188|NCT01729754|564398781|FG001|Part 2|Lost to Follow-up|0|||
156355189|NCT01729754|564398782|FG002|Part 2|Lost to Follow-up|0|||
156355190|NCT01729754|564398783|FG003|Part 2|Lost to Follow-up|2|||
156355191|NCT01729754|564398784|FG004|Part 2|Lost to Follow-up|0|||
156355192|NCT01729754|564398785|FG005|Part 2|Lost to Follow-up|0|||
156355193|NCT01729754|564398786|FG006|Part 2|Lost to Follow-up|0|||
156355194|NCT01729754|564398787|FG007|Part 2|Lost to Follow-up|1|||
156355195|NCT01729754|564398788|FG008|Part 2|Lost to Follow-up|0|||
156355196|NCT01729754|564398789|FG009|Part 2|Lost to Follow-up|2|||
156355197|NCT01729754|564398780|FG000|Part 2|Non-Compliance with Study Drug|0|||
156355198|NCT01729754|564398781|FG001|Part 2|Non-Compliance with Study Drug|0|||
156355199|NCT01729754|564398782|FG002|Part 2|Non-Compliance with Study Drug|0|||
156355200|NCT01729754|564398783|FG003|Part 2|Non-Compliance with Study Drug|0|||
156355201|NCT01729754|564398784|FG004|Part 2|Non-Compliance with Study Drug|0|||
156355202|NCT01729754|564398785|FG005|Part 2|Non-Compliance with Study Drug|0|||
156355203|NCT01729754|564398786|FG006|Part 2|Non-Compliance with Study Drug|0|||
156355204|NCT01729754|564398787|FG007|Part 2|Non-Compliance with Study Drug|0|||
156355205|NCT01729754|564398788|FG008|Part 2|Non-Compliance with Study Drug|0|||
156355206|NCT01729754|564398789|FG009|Part 2|Non-Compliance with Study Drug|1|||
156355207|NCT01729754|564398780|FG000|Part 2|Pregnancy|0|||
156355208|NCT01729754|564398781|FG001|Part 2|Pregnancy|0|||
156355209|NCT01729754|564398782|FG002|Part 2|Pregnancy|0|||
156355210|NCT01729754|564398783|FG003|Part 2|Pregnancy|1|||
156355211|NCT01729754|564398784|FG004|Part 2|Pregnancy|0|||
156355212|NCT01729754|564398785|FG005|Part 2|Pregnancy|0|||
156355213|NCT01729754|564398786|FG006|Part 2|Pregnancy|0|||
156355214|NCT01729754|564398787|FG007|Part 2|Pregnancy|0|||
156355215|NCT01729754|564398788|FG008|Part 2|Pregnancy|0|||
156355216|NCT01729754|564398789|FG009|Part 2|Pregnancy|1|||
156355217|NCT01729754|564398780|FG000|Part 2|Withdrawal by Subject|3|||
156355218|NCT01729754|564398781|FG001|Part 2|Withdrawal by Subject|0|||
156355219|NCT01729754|564398782|FG002|Part 2|Withdrawal by Subject|0|||
156355220|NCT01729754|564398783|FG003|Part 2|Withdrawal by Subject|2|||
156355221|NCT01729754|564398784|FG004|Part 2|Withdrawal by Subject|0|||
156355222|NCT01729754|564398785|FG005|Part 2|Withdrawal by Subject|0|||
156355223|NCT01729754|564398786|FG006|Part 2|Withdrawal by Subject|0|||
156355224|NCT01729754|564398787|FG007|Part 2|Withdrawal by Subject|1|||
156355225|NCT01729754|564398788|FG008|Part 2|Withdrawal by Subject|1|||
156355226|NCT01729754|564398789|FG009|Part 2|Withdrawal by Subject|4|||
156355227|NCT01729754|564398780|FG000|Part 2|Other Protocol Specified Criteria|1|||
156355228|NCT01729754|564398781|FG001|Part 2|Other Protocol Specified Criteria|0|||
156355229|NCT01729754|564398782|FG002|Part 2|Other Protocol Specified Criteria|0|||
156355230|NCT01729754|564398783|FG003|Part 2|Other Protocol Specified Criteria|0|||
156355231|NCT01729754|564398784|FG004|Part 2|Other Protocol Specified Criteria|0|||
156355232|NCT01729754|564398785|FG005|Part 2|Other Protocol Specified Criteria|0|||
156486741|NCT00332488|564875696|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
156486742|NCT00332488|564875697|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
156486743|NCT00332488|564875698|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
156486744|NCT00332488|564875696|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
156355233|NCT01729754|564398786|FG006|Part 2|Other Protocol Specified Criteria|0|||
156355234|NCT01729754|564398787|FG007|Part 2|Other Protocol Specified Criteria|1|||
156355235|NCT01729754|564398788|FG008|Part 2|Other Protocol Specified Criteria|0|||
156355236|NCT01729754|564398789|FG009|Part 2|Other Protocol Specified Criteria|0|||
156355237|NCT01729754|564398780|FG000|Part 3|Adverse Event|0|||
156355238|NCT01729754|564398781|FG001|Part 3|Adverse Event|0|||
156355239|NCT01729754|564398782|FG002|Part 3|Adverse Event|1|||
156355240|NCT01729754|564398783|FG003|Part 3|Adverse Event|0|||
156355241|NCT01729754|564398784|FG004|Part 3|Adverse Event|0|||
156355242|NCT01729754|564398785|FG005|Part 3|Adverse Event|5|||
156355243|NCT01729754|564398786|FG006|Part 3|Adverse Event|0|||
156355244|NCT01729754|564398787|FG007|Part 3|Adverse Event|0|||
156355245|NCT01729754|564398788|FG008|Part 3|Adverse Event|0|||
156355246|NCT01729754|564398789|FG009|Part 3|Adverse Event|3|||
156355247|NCT01729754|564398780|FG000|Part 3|Death|0|||
156486745|NCT00332488|564875697|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
156486746|NCT00332488|564875698|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
156486747|NCT00332488|564875696|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
156486748|NCT00332488|564875697|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
156486749|NCT00332488|564875698|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
156486750|NCT00332488|564875696|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
156486751|NCT00332488|564875697|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
156486752|NCT00332488|564875698|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
156486753|NCT00332488|564875696|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
156486754|NCT00332488|564875697|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
156486755|NCT00332488|564875698|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
156486756|NCT00332488|564875696|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
156486757|NCT00332488|564875697|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
156486758|NCT00332488|564875698|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
156486759|NCT00332488|564875696|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
156486760|NCT00332488|564875697|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
156486761|NCT00332488|564875698|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
156486762|NCT00332488|564875696|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
156486763|NCT00332488|564875697|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
156486764|NCT00332488|564875698|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
156486765|NCT05244226|564875699|FG000|Overall Study|Adverse Event|1|||
156486766|NCT05244226|564875700|FG001|Overall Study|Adverse Event|0|||
156486767|NCT05244226|564875701|FG002|Overall Study|Adverse Event|0|||
156486768|NCT05244226|564875699|FG000|Overall Study|Lost to Follow-up|0|||
156486769|NCT05244226|564875700|FG001|Overall Study|Lost to Follow-up|0|||
156486770|NCT05244226|564875701|FG002|Overall Study|Lost to Follow-up|1|||
156486771|NCT05244226|564875699|FG000|Overall Study|Protocol Violation|0|||
156486772|NCT05244226|564875700|FG001|Overall Study|Protocol Violation|2|||
156486773|NCT05244226|564875701|FG002|Overall Study|Protocol Violation|2|||
156486774|NCT04050722|564875710|FG000|Overall Study|Withdrawal by Subject|1|||
156486775|NCT04050722|564875711|FG001|Overall Study|Withdrawal by Subject|0|||
156486776|NCT00726388|564875715|FG000|Overall Study|Withdrawal by Subject|5|||
156486777|NCT00726388|564875715|FG000|Overall Study|Adverse Event|3|||
156486778|NCT00726388|564875715|FG000|Overall Study|Lost to Follow-up|10|||
156486779|NCT00726388|564875715|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
156486780|NCT00726388|564875715|FG000|Overall Study|Other|5|||
156486781|NCT00726388|564875715|FG000|Overall Study|Enrolled, Not Treated|79|||
156486782|NCT00377312|564875716|FG000|Overall Study|Adverse Event|1|||
156486783|NCT00377312|564875717|FG001|Overall Study|Adverse Event|1|||
156486784|NCT03451292|564875720|FG000|Overall Study|Death|44|||
156486785|NCT03451292|564875721|FG001|Overall Study|Death|59|||
156486786|NCT03451292|564875720|FG000|Overall Study|Withdrawal by Subject|18|||
156486787|NCT03451292|564875721|FG001|Overall Study|Withdrawal by Subject|13|||
156486788|NCT03451292|564875720|FG000|Overall Study|Transplantation|18|||
156486789|NCT03451292|564875721|FG001|Overall Study|Transplantation|12|||
156486790|NCT03451292|564875720|FG000|Overall Study|Lost to Follow-up|4|||
156486791|NCT03451292|564875721|FG001|Overall Study|Lost to Follow-up|12|||
156486792|NCT03451292|564875720|FG000|Overall Study|Physician Decision|4|||
156486793|NCT03451292|564875721|FG001|Overall Study|Physician Decision|3|||
156486794|NCT03451292|564875720|FG000|Overall Study|Adverse Event|3|||
156486795|NCT03451292|564875721|FG001|Overall Study|Adverse Event|3|||
156486796|NCT03451292|564875720|FG000|Overall Study|Non-compliance with Study Drug|2|||
156486797|NCT03451292|564875721|FG001|Overall Study|Non-compliance with Study Drug|0|||
156486798|NCT00609245|564875727|FG000|Overall Study|Adverse Event|1|||
156486799|NCT00191984|564875729|FG000|Overall Study|Disease Progression|21|||
156486800|NCT00191984|564875729|FG000|Overall Study|Adverse Event|4|||
156486801|NCT00191984|564875729|FG000|Overall Study|Death|2|||
156355248|NCT01729754|564398781|FG001|Part 3|Death|0|||
156355249|NCT01729754|564398782|FG002|Part 3|Death|0|||
156486802|NCT00191984|564875729|FG000|Overall Study|Entry Criteria Exclusion|1|||
156486803|NCT00191984|564875729|FG000|Overall Study|Withdrawal by Subject|7|||
156486804|NCT00191984|564875729|FG000|Overall Study|Physician Decision|4|||
156486805|NCT03303521|564875730|FG000|Overall Study|Withdrawal by Subject|2|||
156486806|NCT03303521|564875731|FG001|Overall Study|Withdrawal by Subject|0|||
156486807|NCT03303521|564875730|FG000|Overall Study|Death|1|||
156486808|NCT03303521|564875731|FG001|Overall Study|Death|0|||
156486809|NCT03303521|564875730|FG000|Overall Study|Kidney transplantation|0|||
156486810|NCT03303521|564875731|FG001|Overall Study|Kidney transplantation|1|||
156486811|NCT03303521|564875730|FG000|Overall Study|Investigational product discontinuation|0|||
156486812|NCT03303521|564875731|FG001|Overall Study|Investigational product discontinuation|1|||
156486813|NCT03303521|564875730|FG000|Overall Study|Transferred to non-study dialysis center|1|||
156486814|NCT03303521|564875731|FG001|Overall Study|Transferred to non-study dialysis center|0|||
156486815|NCT03303521|564875730|FG000|Overall Study|Non-comliance to study protocol|0|||
156486816|NCT03303521|564875731|FG001|Overall Study|Non-comliance to study protocol|1|||
156486817|NCT03303521|564875730|FG000|Overall Study|Adverse Event|1|||
156486818|NCT03303521|564875731|FG001|Overall Study|Adverse Event|0|||
156486819|NCT01654289|564875732|FG000|Overall Study|Withdrawal by Subject|10|||
156486820|NCT01654289|564875733|FG001|Overall Study|Withdrawal by Subject|8|||
156486821|NCT01654289|564875734|FG002|Overall Study|Withdrawal by Subject|5|||
156486822|NCT01654289|564875732|FG000|Overall Study|Withdrew from intervention only|17|||
156486823|NCT01654289|564875733|FG001|Overall Study|Withdrew from intervention only|20|||
156486824|NCT01654289|564875734|FG002|Overall Study|Withdrew from intervention only|0|||
156486825|NCT04748445|564875738|FG000|Overall Study|No longer met eligibility criteria|12|||
156486826|NCT04748445|564875738|FG000|Overall Study|Other|36|||
156486827|NCT04748445|564875738|FG000|Overall Study|Withdrawal by Subject|553|||
156486828|NCT04748445|564875738|FG000|Overall Study|Lost to Follow-up|30|||
156486829|NCT04736602|564875739|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
156486830|NCT04736602|564875739|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
156486831|NCT00938041|564875746|FG000|Overall Study|Lost to Follow-up|6|||
156486832|NCT00938041|564875746|FG000|Overall Study|Received Alternative Therapy|1|||
156486833|NCT00938041|564875746|FG000|Overall Study|Progressive Disease|5|||
156486834|NCT00938041|564875746|FG000|Overall Study|Death|12|||
156486835|NCT00938041|564875746|FG000|Overall Study|Adrenal Insufficiency|3|||
156486836|NCT03042559|564875750|FG000|Overall Study|drop out|1|||
156486837|NCT03042559|564875751|FG001|Overall Study|drop out|1|||
156486838|NCT01536535|564875752|FG000|Overall Study|Withdrawal by Subject|10|||
156486839|NCT01536535|564875753|FG001|Overall Study|Withdrawal by Subject|5|||
156486840|NCT01536535|564875752|FG000|Overall Study|Lost to Follow-up|4|||
156486841|NCT01536535|564875753|FG001|Overall Study|Lost to Follow-up|6|||
156486842|NCT01536535|564875752|FG000|Overall Study|Physician Decision|1|||
156355250|NCT01729754|564398783|FG003|Part 3|Death|0|||
156355251|NCT01729754|564398784|FG004|Part 3|Death|0|||
156355252|NCT01729754|564398785|FG005|Part 3|Death|2|||
156355253|NCT01729754|564398786|FG006|Part 3|Death|0|||
156355254|NCT01729754|564398787|FG007|Part 3|Death|0|||
156355255|NCT01729754|564398788|FG008|Part 3|Death|0|||
156355256|NCT01729754|564398789|FG009|Part 3|Death|0|||
156355257|NCT01729754|564398780|FG000|Part 3|Lack of Efficacy|0|||
156355258|NCT01729754|564398781|FG001|Part 3|Lack of Efficacy|0|||
156355259|NCT01729754|564398782|FG002|Part 3|Lack of Efficacy|0|||
156355260|NCT01729754|564398783|FG003|Part 3|Lack of Efficacy|0|||
156355261|NCT01729754|564398784|FG004|Part 3|Lack of Efficacy|2|||
156355262|NCT01729754|564398785|FG005|Part 3|Lack of Efficacy|0|||
156355263|NCT01729754|564398786|FG006|Part 3|Lack of Efficacy|0|||
156486843|NCT01536535|564875753|FG001|Overall Study|Physician Decision|1|||
156486844|NCT01536535|564875752|FG000|Overall Study|Participant moved|0|||
156486845|NCT01536535|564875753|FG001|Overall Study|Participant moved|1|||
156355264|NCT01729754|564398787|FG007|Part 3|Lack of Efficacy|0|||
156355265|NCT01729754|564398788|FG008|Part 3|Lack of Efficacy|0|||
156355266|NCT01729754|564398789|FG009|Part 3|Lack of Efficacy|4|||
156486846|NCT00404547|564875754|FG000|Overall Study|Adverse Event|39|||
156486847|NCT00404547|564875755|FG001|Overall Study|Adverse Event|6|||
156486848|NCT00404547|564875754|FG000|Overall Study|Withdrawal by Subject|19|||
156486849|NCT00404547|564875755|FG001|Overall Study|Withdrawal by Subject|2|||
156486850|NCT00404547|564875754|FG000|Overall Study|Protocol Violation|0|||
156486851|NCT00404547|564875755|FG001|Overall Study|Protocol Violation|1|||
156355267|NCT01729754|564398780|FG000|Part 3|Lost to Follow-up|0|||
156355268|NCT01729754|564398781|FG001|Part 3|Lost to Follow-up|1|||
156355269|NCT01729754|564398782|FG002|Part 3|Lost to Follow-up|2|||
156355270|NCT01729754|564398783|FG003|Part 3|Lost to Follow-up|0|||
156355271|NCT01729754|564398784|FG004|Part 3|Lost to Follow-up|0|||
156355272|NCT01729754|564398785|FG005|Part 3|Lost to Follow-up|3|||
156355273|NCT01729754|564398786|FG006|Part 3|Lost to Follow-up|0|||
156355274|NCT01729754|564398787|FG007|Part 3|Lost to Follow-up|0|||
156355275|NCT01729754|564398788|FG008|Part 3|Lost to Follow-up|1|||
156355276|NCT01729754|564398789|FG009|Part 3|Lost to Follow-up|0|||
156355277|NCT01729754|564398780|FG000|Part 3|Physician Decision|0|||
156486852|NCT00404547|564875754|FG000|Overall Study|Lost to Follow-up|20|||
156544577|NCT00506883|565087810|FG000|Overall Study|Withdrawal by Subject|1|||
156544578|NCT00506883|565087811|FG001|Overall Study|Withdrawal by Subject|0|||
156486853|NCT00404547|564875755|FG001|Overall Study|Lost to Follow-up|9|||
156486854|NCT00404547|564875754|FG000|Overall Study|Lack of compliance|5|||
156486855|NCT00404547|564875755|FG001|Overall Study|Lack of compliance|1|||
156486856|NCT00404547|564875754|FG000|Overall Study|Other|4|||
156486857|NCT00404547|564875755|FG001|Overall Study|Other|0|||
156486858|NCT00404547|564875754|FG000|Overall Study|Reason not stated|3|||
156486859|NCT00404547|564875755|FG001|Overall Study|Reason not stated|6|||
156486860|NCT01485991|564875756|FG000|Overall Study|Adverse Event|0|||
156486861|NCT01485991|564875757|FG001|Overall Study|Adverse Event|4|||
156486862|NCT01485991|564875756|FG000|Overall Study|Lost to Follow-up|13|||
156486863|NCT01485991|564875757|FG001|Overall Study|Lost to Follow-up|10|||
156486864|NCT01485991|564875756|FG000|Overall Study|Withdrawal by Subject|13|||
156486865|NCT01485991|564875757|FG001|Overall Study|Withdrawal by Subject|20|||
156486866|NCT01485991|564875756|FG000|Overall Study|randomized but not treated|6|||
156486867|NCT01485991|564875757|FG001|Overall Study|randomized but not treated|2|||
156486868|NCT01475370|564875758|FG000|Overall Study|Exacerbation of primary disease|2|||
156486869|NCT01475370|564875759|FG001|Overall Study|Exacerbation of primary disease|2|||
156486870|NCT01475370|564875760|FG002|Overall Study|Exacerbation of primary disease|2|||
156486871|NCT01475370|564875758|FG000|Overall Study|Study drug administration difficult|0|||
156486872|NCT01475370|564875759|FG001|Overall Study|Study drug administration difficult|1|||
156486873|NCT01475370|564875760|FG002|Overall Study|Study drug administration difficult|1|||
156486874|NCT01475370|564875758|FG000|Overall Study|Other than specified|1|||
156486875|NCT01475370|564875759|FG001|Overall Study|Other than specified|0|||
156486876|NCT01475370|564875760|FG002|Overall Study|Other than specified|0|||
156486877|NCT02538471|564875761|FG000|Overall Study|Progression of disease|2|||
156486878|NCT00475735|564875762|FG000|Treatment Period 1|Adverse Event|2|||
156486879|NCT00475735|564875763|FG001|Treatment Period 1|Adverse Event|0|||
156486880|NCT00475735|564875764|FG002|Treatment Period 1|Adverse Event|0|||
156486881|NCT00475735|564875765|FG003|Treatment Period 1|Adverse Event|0|||
156486882|NCT00475735|564875766|FG004|Treatment Period 1|Adverse Event|0|||
156486883|NCT00475735|564875767|FG005|Treatment Period 1|Adverse Event|0|||
156486884|NCT00475735|564875762|FG000|Treatment Period 1|Lack of Efficacy|1|||
156486885|NCT00475735|564875763|FG001|Treatment Period 1|Lack of Efficacy|0|||
156486886|NCT00475735|564875764|FG002|Treatment Period 1|Lack of Efficacy|0|||
156486887|NCT00475735|564875765|FG003|Treatment Period 1|Lack of Efficacy|0|||
156486888|NCT00475735|564875766|FG004|Treatment Period 1|Lack of Efficacy|0|||
156486889|NCT00475735|564875767|FG005|Treatment Period 1|Lack of Efficacy|0|||
156486890|NCT00475735|564875762|FG000|Treatment Period 1|Lost to Follow-up|0|||
156486891|NCT00475735|564875763|FG001|Treatment Period 1|Lost to Follow-up|0|||
156486892|NCT00475735|564875764|FG002|Treatment Period 1|Lost to Follow-up|0|||
156486893|NCT00475735|564875765|FG003|Treatment Period 1|Lost to Follow-up|0|||
156486894|NCT00475735|564875766|FG004|Treatment Period 1|Lost to Follow-up|0|||
156486895|NCT00475735|564875767|FG005|Treatment Period 1|Lost to Follow-up|1|||
156486896|NCT00475735|564875762|FG000|Treatment Period 1|Protocol Violation|0|||
156486897|NCT00475735|564875763|FG001|Treatment Period 1|Protocol Violation|0|||
156486898|NCT00475735|564875764|FG002|Treatment Period 1|Protocol Violation|0|||
156486899|NCT00475735|564875765|FG003|Treatment Period 1|Protocol Violation|1|||
156486900|NCT00475735|564875766|FG004|Treatment Period 1|Protocol Violation|0|||
156486901|NCT00475735|564875767|FG005|Treatment Period 1|Protocol Violation|0|||
156486902|NCT00475735|564875762|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156486903|NCT00475735|564875763|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156486904|NCT00475735|564875764|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156486905|NCT00475735|564875765|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156486906|NCT00475735|564875766|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156486907|NCT00475735|564875767|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156486908|NCT00475735|564875762|FG000|Treatment Period 1|DC due to AE but continuing|0|||
156486909|NCT00475735|564875763|FG001|Treatment Period 1|DC due to AE but continuing|0|||
156486910|NCT00475735|564875764|FG002|Treatment Period 1|DC due to AE but continuing|0|||
156486911|NCT00475735|564875765|FG003|Treatment Period 1|DC due to AE but continuing|1|||
156486912|NCT00475735|564875766|FG004|Treatment Period 1|DC due to AE but continuing|2|||
156486913|NCT00475735|564875767|FG005|Treatment Period 1|DC due to AE but continuing|2|||
156486914|NCT00475735|564875762|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
156486915|NCT00475735|564875763|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
156486916|NCT00475735|564875764|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
156486917|NCT00475735|564875765|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
156486918|NCT00475735|564875766|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
156486919|NCT00475735|564875767|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
156486920|NCT00475735|564875762|FG000|Treatment Washout|Lost to Follow-up|0|||
156486921|NCT00475735|564875763|FG001|Treatment Washout|Lost to Follow-up|1|||
156486922|NCT00475735|564875764|FG002|Treatment Washout|Lost to Follow-up|0|||
156486923|NCT00475735|564875765|FG003|Treatment Washout|Lost to Follow-up|0|||
156486924|NCT00475735|564875766|FG004|Treatment Washout|Lost to Follow-up|0|||
156486925|NCT00475735|564875767|FG005|Treatment Washout|Lost to Follow-up|0|||
156486926|NCT00475735|564875762|FG000|Treatment Washout|Protocol Violation|0|||
156486927|NCT00475735|564875763|FG001|Treatment Washout|Protocol Violation|1|||
156486928|NCT00475735|564875764|FG002|Treatment Washout|Protocol Violation|0|||
156486929|NCT00475735|564875765|FG003|Treatment Washout|Protocol Violation|0|||
156486930|NCT00475735|564875766|FG004|Treatment Washout|Protocol Violation|0|||
156486931|NCT00475735|564875767|FG005|Treatment Washout|Protocol Violation|0|||
156486932|NCT00475735|564875762|FG000|Treatment Period 2|Adverse Event|0|||
156486933|NCT00475735|564875763|FG001|Treatment Period 2|Adverse Event|1|||
156486934|NCT00475735|564875764|FG002|Treatment Period 2|Adverse Event|0|||
156486935|NCT00475735|564875765|FG003|Treatment Period 2|Adverse Event|2|||
156486936|NCT00475735|564875766|FG004|Treatment Period 2|Adverse Event|0|||
156486937|NCT00475735|564875767|FG005|Treatment Period 2|Adverse Event|0|||
156486938|NCT00475735|564875762|FG000|Treatment Period 2|Lack of Efficacy|0|||
156486939|NCT00475735|564875763|FG001|Treatment Period 2|Lack of Efficacy|0|||
156486940|NCT00475735|564875764|FG002|Treatment Period 2|Lack of Efficacy|0|||
156486941|NCT00475735|564875765|FG003|Treatment Period 2|Lack of Efficacy|0|||
156486942|NCT00475735|564875766|FG004|Treatment Period 2|Lack of Efficacy|0|||
156486943|NCT00475735|564875767|FG005|Treatment Period 2|Lack of Efficacy|1|||
156486944|NCT00475735|564875762|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156486945|NCT00475735|564875763|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156486946|NCT00475735|564875764|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156486947|NCT00475735|564875765|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156486948|NCT00475735|564875766|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156486949|NCT00475735|564875767|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156486950|NCT02350127|564875768|FG000|4-Month Assessment|Withdrawal by Subject|10|||
156486951|NCT02350127|564875769|FG001|4-Month Assessment|Withdrawal by Subject|9|||
156486952|NCT02350127|564875768|FG000|4-Month Assessment|Death|1|||
156486953|NCT02350127|564875769|FG001|4-Month Assessment|Death|0|||
156486954|NCT02350127|564875768|FG000|8-Month Assessment|Death|1|||
156486955|NCT02350127|564875769|FG001|8-Month Assessment|Death|1|||
156486956|NCT02350127|564875768|FG000|8-Month Assessment|Withdrawal by Subject|5|||
156486957|NCT02350127|564875769|FG001|8-Month Assessment|Withdrawal by Subject|8|||
156486958|NCT00050167|564875771|FG000|Overall Study|not eligible not invasive|1|||
156486959|NCT00050167|564875772|FG001|Overall Study|not eligible not invasive|1|||
156486960|NCT02038803|564875776|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
156486961|NCT02038803|564875776|FG000|Overall Study|Lost to Follow-up|1|||
156486962|NCT04754594|564875777|FG000|Blinded Period|Withdrawal by Subject|4|||
156486963|NCT04754594|564875778|FG001|Blinded Period|Withdrawal by Subject|9|||
156486964|NCT04754594|564875779|FG002|Blinded Period|Withdrawal by Subject|0|||
156486965|NCT04754594|564875780|FG003|Blinded Period|Withdrawal by Subject|0|||
156486966|NCT04754594|564875777|FG000|Blinded Period|Protocol Violation|2|||
156486967|NCT04754594|564875778|FG001|Blinded Period|Protocol Violation|2|||
156486968|NCT04754594|564875779|FG002|Blinded Period|Protocol Violation|0|||
156486969|NCT04754594|564875780|FG003|Blinded Period|Protocol Violation|0|||
156486970|NCT04754594|564875777|FG000|Blinded Period|Lost to Follow-up|1|||
156486971|NCT04754594|564875778|FG001|Blinded Period|Lost to Follow-up|1|||
156486972|NCT04754594|564875779|FG002|Blinded Period|Lost to Follow-up|0|||
156486973|NCT04754594|564875780|FG003|Blinded Period|Lost to Follow-up|0|||
156486974|NCT04754594|564875777|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
156486975|NCT04754594|564875778|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
156486976|NCT04754594|564875779|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
156486977|NCT04754594|564875780|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
156486978|NCT04754594|564875777|FG000|Unblinded Period|Withdrawal by Subject|6|||
156486979|NCT04754594|564875778|FG001|Unblinded Period|Withdrawal by Subject|8|||
156486980|NCT04754594|564875779|FG002|Unblinded Period|Withdrawal by Subject|0|||
156486981|NCT04754594|564875780|FG003|Unblinded Period|Withdrawal by Subject|0|||
156486982|NCT04754594|564875777|FG000|Unblinded Period|Lost to Follow-up|5|||
156486983|NCT04754594|564875778|FG001|Unblinded Period|Lost to Follow-up|3|||
156486984|NCT04754594|564875779|FG002|Unblinded Period|Lost to Follow-up|0|||
156486985|NCT04754594|564875780|FG003|Unblinded Period|Lost to Follow-up|0|||
156486986|NCT04754594|564875777|FG000|Unblinded Period|Protocol Violation|2|||
156544579|NCT00506883|565087812|FG002|Overall Study|Withdrawal by Subject|1|||
156486987|NCT04754594|564875778|FG001|Unblinded Period|Protocol Violation|4|||
156486988|NCT04754594|564875779|FG002|Unblinded Period|Protocol Violation|0|||
156486989|NCT04754594|564875780|FG003|Unblinded Period|Protocol Violation|0|||
156544580|NCT00506883|565087810|FG000|Overall Study|Lack of Efficacy|0|||
156486990|NCT04754594|564875777|FG000|Unblinded Period|Other|3|||
156486991|NCT04754594|564875778|FG001|Unblinded Period|Other|0|||
156544581|NCT00506883|565087811|FG001|Overall Study|Lack of Efficacy|1|||
156486992|NCT04754594|564875779|FG002|Unblinded Period|Other|0|||
156486993|NCT04754594|564875780|FG003|Unblinded Period|Other|0|||
156486994|NCT04754594|564875777|FG000|Infant Participants|Withdrawal by Subject|0|||
156486995|NCT04754594|564875778|FG001|Infant Participants|Withdrawal by Subject|0|||
156486996|NCT04754594|564875779|FG002|Infant Participants|Withdrawal by Subject|9|||
156486997|NCT04754594|564875780|FG003|Infant Participants|Withdrawal by Subject|17|||
156486998|NCT04754594|564875777|FG000|Infant Participants|Lost to Follow-up|0|||
156486999|NCT04754594|564875778|FG001|Infant Participants|Lost to Follow-up|0|||
156487000|NCT04754594|564875779|FG002|Infant Participants|Lost to Follow-up|4|||
156487001|NCT04754594|564875780|FG003|Infant Participants|Lost to Follow-up|10|||
156487002|NCT04754594|564875777|FG000|Infant Participants|Death|0|||
156487003|NCT04754594|564875778|FG001|Infant Participants|Death|0|||
156487004|NCT04754594|564875779|FG002|Infant Participants|Death|1|||
156487005|NCT04754594|564875780|FG003|Infant Participants|Death|1|||
156487006|NCT04754594|564875777|FG000|Infant Participants|Other|0|||
156487007|NCT04754594|564875778|FG001|Infant Participants|Other|0|||
156487008|NCT04754594|564875779|FG002|Infant Participants|Other|1|||
156487009|NCT04754594|564875780|FG003|Infant Participants|Other|1|||
156487010|NCT01247922|564875781|FG000|Overall Study|Disease progression|4|||
156487011|NCT04372186|564875782|FG000|Overall Study|Death|24|||
156487012|NCT04372186|564875783|FG001|Overall Study|Death|11|||
156487013|NCT04372186|564875782|FG000|Overall Study|Transferred to a different facility for care|0|||
156487014|NCT04372186|564875783|FG001|Overall Study|Transferred to a different facility for care|2|||
156487015|NCT04736472|564875784|FG000|Overall Study|Lost to Follow-up|1|||
156487016|NCT04736472|564875785|FG001|Overall Study|Lost to Follow-up|0|||
156487017|NCT04736472|564875786|FG002|Overall Study|Lost to Follow-up|0|||
156487018|NCT04736472|564875784|FG000|Overall Study|Withdrawal by Subject|2|||
156487019|NCT04736472|564875785|FG001|Overall Study|Withdrawal by Subject|0|||
156487020|NCT04736472|564875786|FG002|Overall Study|Withdrawal by Subject|0|||
156487021|NCT04736472|564875784|FG000|Overall Study|Protocol Violation|48|||
156487022|NCT04736472|564875785|FG001|Overall Study|Protocol Violation|0|||
156487023|NCT04736472|564875786|FG002|Overall Study|Protocol Violation|6|||
156487024|NCT03356145|564875789|FG000|Overall Study|Withdrawal by Subject|2|||
156487025|NCT03356145|564875790|FG001|Overall Study|Withdrawal by Subject|1|||
156487026|NCT03356145|564875789|FG000|Overall Study|Did not meet inclusion criteria|1|||
156487027|NCT03356145|564875790|FG001|Overall Study|Did not meet inclusion criteria|0|||
156487028|NCT01911819|564875791|FG000|Overall Study|Adverse Event|0|||
156487029|NCT01911819|564875792|FG001|Overall Study|Adverse Event|1|||
156487030|NCT01911819|564875793|FG002|Overall Study|Adverse Event|0|||
156487031|NCT01911819|564875791|FG000|Overall Study|Withdrawal by Subject|1|||
156487032|NCT01911819|564875792|FG001|Overall Study|Withdrawal by Subject|1|||
156487033|NCT01911819|564875793|FG002|Overall Study|Withdrawal by Subject|0|||
156487034|NCT04374253|564875796|FG000|Overall Study|Adverse Event|0|||
156487035|NCT04374253|564875797|FG001|Overall Study|Adverse Event|26|||
156487036|NCT04374253|564875798|FG002|Overall Study|Adverse Event|2|||
156487037|NCT04374253|564875799|FG003|Overall Study|Adverse Event|12|||
156487038|NCT04374253|564875796|FG000|Overall Study|Study terminated by sponsor|13|||
156487039|NCT04374253|564875797|FG001|Overall Study|Study terminated by sponsor|593|||
156487040|NCT04374253|564875798|FG002|Overall Study|Study terminated by sponsor|21|||
156487041|NCT04374253|564875799|FG003|Overall Study|Study terminated by sponsor|567|||
156487042|NCT04374253|564875796|FG000|Overall Study|Withdrawal by Subject|0|||
156487043|NCT04374253|564875797|FG001|Overall Study|Withdrawal by Subject|55|||
156487044|NCT04374253|564875798|FG002|Overall Study|Withdrawal by Subject|3|||
156487045|NCT04374253|564875799|FG003|Overall Study|Withdrawal by Subject|40|||
156487046|NCT04374253|564875796|FG000|Overall Study|Physician Decision|1|||
156487047|NCT04374253|564875797|FG001|Overall Study|Physician Decision|10|||
156487048|NCT04374253|564875798|FG002|Overall Study|Physician Decision|1|||
156487049|NCT04374253|564875799|FG003|Overall Study|Physician Decision|10|||
156487050|NCT04374253|564875796|FG000|Overall Study|Protocol Violation|0|||
156487051|NCT04374253|564875797|FG001|Overall Study|Protocol Violation|0|||
156487052|NCT04374253|564875798|FG002|Overall Study|Protocol Violation|0|||
156487053|NCT04374253|564875799|FG003|Overall Study|Protocol Violation|2|||
156487054|NCT04374253|564875796|FG000|Overall Study|Death|0|||
156487055|NCT04374253|564875797|FG001|Overall Study|Death|3|||
156487056|NCT04374253|564875798|FG002|Overall Study|Death|1|||
156487057|NCT04374253|564875799|FG003|Overall Study|Death|1|||
156487058|NCT04374253|564875796|FG000|Overall Study|Lack of Efficacy|0|||
156487059|NCT04374253|564875797|FG001|Overall Study|Lack of Efficacy|0|||
156487060|NCT04374253|564875798|FG002|Overall Study|Lack of Efficacy|0|||
156487061|NCT04374253|564875799|FG003|Overall Study|Lack of Efficacy|1|||
156487062|NCT04374253|564875796|FG000|Overall Study|Lost to Follow-up|1|||
156487063|NCT04374253|564875797|FG001|Overall Study|Lost to Follow-up|1|||
156487064|NCT04374253|564875798|FG002|Overall Study|Lost to Follow-up|0|||
156487065|NCT04374253|564875799|FG003|Overall Study|Lost to Follow-up|2|||
156487066|NCT04374253|564875796|FG000|Overall Study|Reason Not Specified|0|||
156487067|NCT04374253|564875797|FG001|Overall Study|Reason Not Specified|8|||
156487068|NCT04374253|564875798|FG002|Overall Study|Reason Not Specified|0|||
156487069|NCT04374253|564875799|FG003|Overall Study|Reason Not Specified|8|||
156487070|NCT00448344|564875800|FG000|Overall Study|Lost to Follow-up|20|||
156355278|NCT01729754|564398781|FG001|Part 3|Physician Decision|0|||
156355279|NCT01729754|564398782|FG002|Part 3|Physician Decision|1|||
156355280|NCT01729754|564398783|FG003|Part 3|Physician Decision|0|||
156355281|NCT01729754|564398784|FG004|Part 3|Physician Decision|0|||
156355282|NCT01729754|564398785|FG005|Part 3|Physician Decision|0|||
156355283|NCT01729754|564398786|FG006|Part 3|Physician Decision|0|||
156355284|NCT01729754|564398787|FG007|Part 3|Physician Decision|0|||
156355285|NCT01729754|564398788|FG008|Part 3|Physician Decision|0|||
156355286|NCT01729754|564398789|FG009|Part 3|Physician Decision|0|||
156355287|NCT01729754|564398780|FG000|Part 3|Withdrawal by Subject|0|||
156355288|NCT01729754|564398781|FG001|Part 3|Withdrawal by Subject|4|||
156355289|NCT01729754|564398782|FG002|Part 3|Withdrawal by Subject|1|||
156355290|NCT01729754|564398783|FG003|Part 3|Withdrawal by Subject|0|||
156355291|NCT01729754|564398784|FG004|Part 3|Withdrawal by Subject|2|||
156355292|NCT01729754|564398785|FG005|Part 3|Withdrawal by Subject|1|||
156355293|NCT01729754|564398786|FG006|Part 3|Withdrawal by Subject|0|||
156355294|NCT01729754|564398787|FG007|Part 3|Withdrawal by Subject|2|||
156355295|NCT01729754|564398788|FG008|Part 3|Withdrawal by Subject|0|||
156355296|NCT01729754|564398789|FG009|Part 3|Withdrawal by Subject|0|||
156355297|NCT01729754|564398780|FG000|Part 3|Other Protocol Specified Criteria|0|||
156355298|NCT01729754|564398781|FG001|Part 3|Other Protocol Specified Criteria|0|||
156355299|NCT01729754|564398782|FG002|Part 3|Other Protocol Specified Criteria|0|||
156355300|NCT01729754|564398783|FG003|Part 3|Other Protocol Specified Criteria|0|||
156355301|NCT01729754|564398784|FG004|Part 3|Other Protocol Specified Criteria|0|||
156355302|NCT01729754|564398785|FG005|Part 3|Other Protocol Specified Criteria|2|||
156355303|NCT01729754|564398786|FG006|Part 3|Other Protocol Specified Criteria|0|||
156355304|NCT01729754|564398787|FG007|Part 3|Other Protocol Specified Criteria|1|||
156355305|NCT01729754|564398788|FG008|Part 3|Other Protocol Specified Criteria|0|||
156355306|NCT01729754|564398789|FG009|Part 3|Other Protocol Specified Criteria|0|||
156355307|NCT01485640|564398790|FG000|Overall Study|Adverse Event|10|||
156355308|NCT01485640|564398790|FG000|Overall Study|Lack of Efficacy|2|||
156355309|NCT01485640|564398790|FG000|Overall Study|Protocol Violation|1|||
156355310|NCT01485640|564398790|FG000|Overall Study|Withdrawal by Subject|14|||
156355311|NCT01485640|564398790|FG000|Overall Study|Terminated by Sponsor|95|||
156355312|NCT03232281|564398794|FG000|Overall Study|Adverse Event|1|||
156355313|NCT03232281|564398795|FG001|Overall Study|Adverse Event|1|||
156355314|NCT03232281|564398794|FG000|Overall Study|Withdrawal by Subject|5|||
156355315|NCT03232281|564398795|FG001|Overall Study|Withdrawal by Subject|4|||
156355316|NCT03232281|564398794|FG000|Overall Study|Protocol Deviation|1|||
156355317|NCT03232281|564398795|FG001|Overall Study|Protocol Deviation|1|||
156355318|NCT01132482|564398797|FG000|Overall Study|Adverse Event|1|||
156355319|NCT01132482|564398798|FG001|Overall Study|Adverse Event|0|||
156355320|NCT05333900|564398800|FG000|Overall Study|Protocol Violation|0|||
156355321|NCT05333900|564398801|FG001|Overall Study|Protocol Violation|1|||
156355322|NCT05333900|564398800|FG000|Overall Study|Withdrawal by Subject|0|||
156355323|NCT05333900|564398801|FG001|Overall Study|Withdrawal by Subject|1|||
156355324|NCT05333900|564398800|FG000|Overall Study|COVID-19 Pandemic|1|||
156355325|NCT05333900|564398801|FG001|Overall Study|COVID-19 Pandemic|1|||
156355326|NCT03525574|564398802|FG000|Overall Study|Adverse Event|15|||
156355327|NCT03525574|564398803|FG001|Overall Study|Adverse Event|0|||
156355328|NCT03525574|564398802|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
156355329|NCT03525574|564398803|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
156355330|NCT03525574|564398802|FG000|Overall Study|Lost to Follow-up|4|||
156355331|NCT03525574|564398803|FG001|Overall Study|Lost to Follow-up|0|||
156355332|NCT03525574|564398802|FG000|Overall Study|Commercial drug is Available for participant|48|||
156355333|NCT03525574|564398803|FG001|Overall Study|Commercial drug is Available for participant|0|||
156355334|NCT03525574|564398802|FG000|Overall Study|Death|1|||
156355335|NCT03525574|564398803|FG001|Overall Study|Death|0|||
156355336|NCT03525574|564398802|FG000|Overall Study|Other non-compliance|2|||
156355337|NCT03525574|564398803|FG001|Overall Study|Other non-compliance|0|||
156355338|NCT03525574|564398802|FG000|Overall Study|Physician Decision|6|||
156487071|NCT00448344|564875801|FG001|Overall Study|Lost to Follow-up|22|||
156487072|NCT00448344|564875800|FG000|Overall Study|Withdrawal by Subject|6|||
156487073|NCT00448344|564875801|FG001|Overall Study|Withdrawal by Subject|8|||
156487074|NCT00448344|564875800|FG000|Overall Study|Death|3|||
156355339|NCT03525574|564398803|FG001|Overall Study|Physician Decision|0|||
156355340|NCT03525574|564398802|FG000|Overall Study|Other|58|||
156355341|NCT03525574|564398803|FG001|Overall Study|Other|0|||
156487075|NCT00448344|564875801|FG001|Overall Study|Death|4|||
156355342|NCT03525574|564398802|FG000|Overall Study|Enrolled but never dosed|1|||
156355343|NCT03525574|564398803|FG001|Overall Study|Enrolled but never dosed|0|||
156355344|NCT03525574|564398802|FG000|Overall Study|Not enrolled in 105 study|0|||
156355345|NCT03525574|564398803|FG001|Overall Study|Not enrolled in 105 study|3|||
156355346|NCT04741074|564398806|FG000|Overall Study|Withdrawal by Subject|1|||
156355347|NCT04741074|564398807|FG001|Overall Study|Withdrawal by Subject|1|||
156355348|NCT04741074|564398806|FG000|Overall Study|Study terminated prematurely|1|||
156355349|NCT04741074|564398807|FG001|Overall Study|Study terminated prematurely|0|||
156355350|NCT01074450|564398813|FG000|First Intervention|Emesis in Dosing Interval|0|||
156487076|NCT00448344|564875800|FG000|Overall Study|Physician Decision|1|||
156355351|NCT01074450|564398814|FG001|First Intervention|Emesis in Dosing Interval|2|||
156355352|NCT01074450|564398813|FG000|Second Intervention|Protocol Violation|1|||
156355353|NCT01074450|564398814|FG001|Second Intervention|Protocol Violation|0|||
156355354|NCT01074450|564398813|FG000|Second Intervention|Physician Decision|0|||
156355355|NCT01074450|564398814|FG001|Second Intervention|Physician Decision|1|||
156487077|NCT00448344|564875801|FG001|Overall Study|Physician Decision|2|||
156487078|NCT04382053|564875802|FG000|Overall Study|Death|6|||
156487079|NCT04382053|564875803|FG001|Overall Study|Death|8|||
156487080|NCT04382053|564875802|FG000|Overall Study|Lost to Follow-up|0|||
156487081|NCT04382053|564875803|FG001|Overall Study|Lost to Follow-up|2|||
156487082|NCT04382053|564875802|FG000|Overall Study|Protocol Deviation|1|||
156487083|NCT04382053|564875803|FG001|Overall Study|Protocol Deviation|2|||
156487084|NCT04382053|564875802|FG000|Overall Study|Withdrawal by Subject|2|||
156487085|NCT04382053|564875803|FG001|Overall Study|Withdrawal by Subject|1|||
156355356|NCT03226392|564398815|FG000|Overall Study|Protocol Deviation|1|||
156487086|NCT00417989|564875804|FG000|Overall Study|Withdrawal by Subject|13|||
156355357|NCT03226392|564398816|FG001|Overall Study|Protocol Deviation|0|||
156355358|NCT03226392|564398815|FG000|Overall Study|Physician Decision|1|||
156355359|NCT03226392|564398816|FG001|Overall Study|Physician Decision|0|||
156355360|NCT03226392|564398815|FG000|Overall Study|Lost to Follow-up|1|||
156355361|NCT03226392|564398816|FG001|Overall Study|Lost to Follow-up|0|||
156355362|NCT03226392|564398815|FG000|Overall Study|Adverse Event|1|||
156355363|NCT03226392|564398816|FG001|Overall Study|Adverse Event|0|||
156355364|NCT03226392|564398815|FG000|Overall Study|Technical Problems|0|||
156355365|NCT03226392|564398816|FG001|Overall Study|Technical Problems|2|||
156355366|NCT03226392|564398815|FG000|Overall Study|Subject/Guardian Decision|7|||
156355367|NCT03226392|564398816|FG001|Overall Study|Subject/Guardian Decision|6|||
156355368|NCT02728895|564398817|FG000|Overall Study|Other|1|||
156355369|NCT02728895|564398818|FG001|Overall Study|Other|2|||
156355370|NCT02728895|564398817|FG000|Overall Study|Withdrawal by Subject|0|||
156355371|NCT02728895|564398818|FG001|Overall Study|Withdrawal by Subject|3|||
156355372|NCT02769247|564398819|FG000|Overall Study|Withdrawal by Subject|1|||
156355373|NCT02769247|564398820|FG001|Overall Study|Withdrawal by Subject|0|||
156355374|NCT02769247|564398821|FG002|Overall Study|Withdrawal by Subject|0|||
156355375|NCT02769247|564398822|FG003|Overall Study|Withdrawal by Subject|1|||
156355376|NCT02769247|564398819|FG000|Overall Study|Protocol Violation|0|||
156355377|NCT02769247|564398820|FG001|Overall Study|Protocol Violation|0|||
156355378|NCT02769247|564398821|FG002|Overall Study|Protocol Violation|1|||
156355379|NCT02769247|564398822|FG003|Overall Study|Protocol Violation|0|||
156355380|NCT02769247|564398819|FG000|Overall Study|Physician Decision|1|||
156355381|NCT02769247|564398820|FG001|Overall Study|Physician Decision|0|||
156355382|NCT02769247|564398821|FG002|Overall Study|Physician Decision|0|||
156355383|NCT02769247|564398822|FG003|Overall Study|Physician Decision|0|||
156355384|NCT04788953|564398823|FG000|Overall Study|Adverse Event|1|||
156355385|NCT04788953|564398824|FG001|Overall Study|Adverse Event|1|||
156355386|NCT04788953|564398823|FG000|Overall Study|Withdrawal by Subject|1|||
156355387|NCT04788953|564398824|FG001|Overall Study|Withdrawal by Subject|0|||
156355388|NCT04788953|564398823|FG000|Overall Study|Protocol Violation|0|||
156355389|NCT04788953|564398824|FG001|Overall Study|Protocol Violation|1|||
156355390|NCT00469092|564398825|FG000|Overall Study|Adverse Event|5|||
156355391|NCT00469092|564398826|FG001|Overall Study|Adverse Event|4|||
156355392|NCT00469092|564398825|FG000|Overall Study|Lack of Efficacy|1|||
156355393|NCT00469092|564398826|FG001|Overall Study|Lack of Efficacy|0|||
156355394|NCT00469092|564398825|FG000|Overall Study|Lost to Follow-up|1|||
156355395|NCT00469092|564398826|FG001|Overall Study|Lost to Follow-up|2|||
156355396|NCT00469092|564398825|FG000|Overall Study|Protocol Violation|3|||
156355397|NCT00469092|564398826|FG001|Overall Study|Protocol Violation|3|||
156355398|NCT00469092|564398825|FG000|Overall Study|Withdrawal by Subject|4|||
156355399|NCT00469092|564398826|FG001|Overall Study|Withdrawal by Subject|4|||
156355400|NCT00469092|564398825|FG000|Overall Study|Withdrawal Criteria|3|||
156355401|NCT00469092|564398826|FG001|Overall Study|Withdrawal Criteria|4|||
156355402|NCT00469092|564398825|FG000|Overall Study|Incorrectly Randomised|4|||
156355403|NCT00469092|564398826|FG001|Overall Study|Incorrectly Randomised|3|||
156355404|NCT00469092|564398825|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
156355405|NCT00469092|564398826|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
156355406|NCT00469092|564398825|FG000|Overall Study|Use of lipid lowering drug|1|||
156355407|NCT00469092|564398826|FG001|Overall Study|Use of lipid lowering drug|0|||
156355408|NCT00469092|564398825|FG000|Overall Study|Hypoglycaemic Episodes|1|||
156355409|NCT00469092|564398826|FG001|Overall Study|Hypoglycaemic Episodes|1|||
156355410|NCT00469092|564398825|FG000|Overall Study|Abnormal lab value|1|||
156355411|NCT00469092|564398826|FG001|Overall Study|Abnormal lab value|0|||
156355412|NCT00469092|564398825|FG000|Overall Study|Use of Corticosteroid|1|||
156355413|NCT00469092|564398826|FG001|Overall Study|Use of Corticosteroid|0|||
156355414|NCT02024867|564398829|FG000|Overall Study|Protocol Violation|3|||
156355415|NCT02024867|564398830|FG001|Overall Study|Protocol Violation|3|||
156355416|NCT02024867|564398829|FG000|Overall Study|Lost to Follow-up|6|||
156355417|NCT02024867|564398830|FG001|Overall Study|Lost to Follow-up|4|||
156355418|NCT02150954|564398831|FG000|Overall Study|Protocol Violation|1|||
156355419|NCT02150954|564398832|FG001|Overall Study|Protocol Violation|0|||
156487087|NCT00417989|564875805|FG001|Overall Study|Withdrawal by Subject|13|||
156487088|NCT00417989|564875804|FG000|Overall Study|Lost to Follow-up|1|||
156487089|NCT00417989|564875805|FG001|Overall Study|Lost to Follow-up|6|||
156487090|NCT00417989|564875804|FG000|Overall Study|Protocol Violation|1|||
156487091|NCT00417989|564875805|FG001|Overall Study|Protocol Violation|0|||
156487092|NCT00417989|564875804|FG000|Overall Study|Death|0|||
156487093|NCT00417989|564875805|FG001|Overall Study|Death|1|||
156487094|NCT00417989|564875804|FG000|Overall Study|Physician Decision|5|||
156487095|NCT00417989|564875805|FG001|Overall Study|Physician Decision|2|||
156487096|NCT00990821|564875806|FG000|Overall Study|Withdrawal by Subject|0|||
156487097|NCT00990821|564875807|FG001|Overall Study|Withdrawal by Subject|2|||
156487098|NCT00990821|564875808|FG002|Overall Study|Withdrawal by Subject|0|||
156487099|NCT00990821|564875809|FG003|Overall Study|Withdrawal by Subject|0|||
156487100|NCT00990821|564875810|FG004|Overall Study|Withdrawal by Subject|3|||
156487101|NCT00990821|564875811|FG005|Overall Study|Withdrawal by Subject|3|||
156487102|NCT00990821|564875812|FG006|Overall Study|Withdrawal by Subject|1|||
156487103|NCT00990821|564875813|FG007|Overall Study|Withdrawal by Subject|0|||
156487104|NCT00990821|564875814|FG008|Overall Study|Withdrawal by Subject|0|||
156487105|NCT00990821|564875815|FG009|Overall Study|Withdrawal by Subject|1|||
156487106|NCT00990821|564875816|FG010|Overall Study|Withdrawal by Subject|3|||
156487107|NCT00990821|564875817|FG011|Overall Study|Withdrawal by Subject|5|||
156487108|NCT00990821|564875818|FG012|Overall Study|Withdrawal by Subject|2|||
156487109|NCT00990821|564875819|FG013|Overall Study|Withdrawal by Subject|1|||
156487110|NCT04150250|564875820|FG000|Overall Study|Lost to Follow-up|0|||
156487111|NCT04150250|564875821|FG001|Overall Study|Lost to Follow-up|2|||
156487112|NCT01945086|564875824|FG000|Overall Study|Withdrawal by Subject|1|||
156487113|NCT01945086|564875825|FG001|Overall Study|Withdrawal by Subject|0|||
156487114|NCT01945086|564875826|FG002|Overall Study|Withdrawal by Subject|1|||
156487115|NCT01945086|564875824|FG000|Overall Study|Adverse Event|0|||
156487116|NCT01945086|564875825|FG001|Overall Study|Adverse Event|0|||
156487117|NCT01945086|564875826|FG002|Overall Study|Adverse Event|1|||
156487118|NCT04212299|564875831|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
156487119|NCT03098797|564877660|FG000|Part 2 Open Label Extension|Adverse Event|2|||
156487120|NCT03098797|564877661|FG001|Part 2 Open Label Extension|Adverse Event|0|||
156487121|NCT02956278|564877662|FG000|Overall Study|Withdrawal by Subject|6|||
156487122|NCT02956278|564877663|FG001|Overall Study|Withdrawal by Subject|2|||
156487123|NCT02956278|564877664|FG002|Overall Study|Withdrawal by Subject|0|||
156487124|NCT02329223|564877665|FG000|Overall Study|Withdrawal by Subject|1|||
156487125|NCT02329223|564877666|FG001|Overall Study|Withdrawal by Subject|2|||
156487126|NCT02329223|564877667|FG002|Overall Study|Withdrawal by Subject|5|||
156487127|NCT02329223|564877665|FG000|Overall Study|Physician Decision|0|||
156487128|NCT02329223|564877666|FG001|Overall Study|Physician Decision|0|||
156487129|NCT02329223|564877667|FG002|Overall Study|Physician Decision|1|||
156487130|NCT02329223|564877665|FG000|Overall Study|Adverse Event|0|||
156487131|NCT02329223|564877666|FG001|Overall Study|Adverse Event|1|||
156487132|NCT02329223|564877667|FG002|Overall Study|Adverse Event|0|||
156487133|NCT01589523|564877668|FG000|Overall Study|Withdrawal by Subject|1|||
156487134|NCT00506922|564877669|FG000|Overall Study|Physician Decision|0|||
156487135|NCT00506922|564877670|FG001|Overall Study|Physician Decision|0|||
156487136|NCT00506922|564877671|FG002|Overall Study|Physician Decision|0|||
156487137|NCT00506922|564877672|FG003|Overall Study|Physician Decision|2|||
156487138|NCT00506922|564877673|FG004|Overall Study|Physician Decision|0|||
156487139|NCT00506922|564877669|FG000|Overall Study|Withdrawal by Subject|0|||
156487140|NCT00506922|564877670|FG001|Overall Study|Withdrawal by Subject|0|||
156487141|NCT00506922|564877671|FG002|Overall Study|Withdrawal by Subject|0|||
156487142|NCT00506922|564877672|FG003|Overall Study|Withdrawal by Subject|0|||
156487143|NCT00506922|564877673|FG004|Overall Study|Withdrawal by Subject|1|||
156487144|NCT02507687|564877676|FG000|Overall Study|Adverse Event|3|||
156487145|NCT02507687|564877677|FG001|Overall Study|Adverse Event|2|||
156487146|NCT02507687|564877678|FG002|Overall Study|Adverse Event|2|||
156487147|NCT02507687|564877679|FG003|Overall Study|Adverse Event|2|||
156487148|NCT02507687|564877676|FG000|Overall Study|Withdrawal by Subject|1|||
156487149|NCT02507687|564877677|FG001|Overall Study|Withdrawal by Subject|4|||
156487150|NCT02507687|564877678|FG002|Overall Study|Withdrawal by Subject|6|||
156487151|NCT02507687|564877679|FG003|Overall Study|Withdrawal by Subject|6|||
156487152|NCT02507687|564877676|FG000|Overall Study|Protocol Violation|1|||
156487153|NCT02507687|564877677|FG001|Overall Study|Protocol Violation|0|||
156487154|NCT02507687|564877678|FG002|Overall Study|Protocol Violation|2|||
156487155|NCT02507687|564877679|FG003|Overall Study|Protocol Violation|0|||
156487156|NCT02507687|564877676|FG000|Overall Study|Lost to Follow-up|0|||
156487157|NCT02507687|564877677|FG001|Overall Study|Lost to Follow-up|0|||
156487158|NCT02507687|564877678|FG002|Overall Study|Lost to Follow-up|2|||
156487159|NCT02507687|564877679|FG003|Overall Study|Lost to Follow-up|1|||
156487160|NCT02507687|564877676|FG000|Overall Study|Screen Failure|0|||
156487161|NCT02507687|564877677|FG001|Overall Study|Screen Failure|0|||
156487162|NCT02507687|564877678|FG002|Overall Study|Screen Failure|1|||
156355420|NCT01086540|564398840|FG000|Overall Study|Death|3|||
156355421|NCT01086540|564398841|FG001|Overall Study|Death|1|||
156355422|NCT01086540|564398840|FG000|Overall Study|Physician Decision|2|||
156355423|NCT01086540|564398841|FG001|Overall Study|Physician Decision|1|||
156355424|NCT01086540|564398840|FG000|Overall Study|Addition of new therapy for PAH|1|||
156355425|NCT01086540|564398841|FG001|Overall Study|Addition of new therapy for PAH|0|||
156355426|NCT01998737|564398842|FG000|Overall Study|Corrupted database|23|||
156355427|NCT01998737|564398843|FG001|Overall Study|Corrupted database|0|||
156355428|NCT02092662|564398844|FG000|Overall Study|Lost to Follow-up|13|||
156355429|NCT02092662|564398845|FG001|Overall Study|Lost to Follow-up|0|||
156355430|NCT02707991|564398847|FG000|Overall Study|Protocol Violation|1|||
156355431|NCT02707991|564398848|FG001|Overall Study|Protocol Violation|0|||
156355432|NCT02707991|564398847|FG000|Overall Study|Became ineligible|0|||
156355433|NCT02707991|564398848|FG001|Overall Study|Became ineligible|1|||
156355434|NCT02268864|564398849|FG000|Overall Study|Withdrawal by Subject|2|||
156355435|NCT02268864|564398850|FG001|Overall Study|Withdrawal by Subject|0|||
156355436|NCT02268864|564398851|FG002|Overall Study|Withdrawal by Subject|0|||
156355437|NCT02268864|564398849|FG000|Overall Study|Death|0|||
156355438|NCT02268864|564398850|FG001|Overall Study|Death|1|||
156355439|NCT02268864|564398851|FG002|Overall Study|Death|0|||
156355440|NCT05407675|564398854|FG000|Overall Study|Withdrawal by Subject|0|||
156355441|NCT05407675|564398855|FG001|Overall Study|Withdrawal by Subject|2|||
156355442|NCT05407675|564398856|FG002|Overall Study|Withdrawal by Subject|3|||
156355443|NCT05407675|564398857|FG003|Overall Study|Withdrawal by Subject|5|||
156355444|NCT05407675|564398858|FG004|Overall Study|Withdrawal by Subject|0|||
156355445|NCT05407675|564398859|FG005|Overall Study|Withdrawal by Subject|2|||
156355446|NCT05407675|564398860|FG006|Overall Study|Withdrawal by Subject|0|||
156355447|NCT05407675|564398861|FG007|Overall Study|Withdrawal by Subject|0|||
156355448|NCT05407675|564398862|FG008|Overall Study|Withdrawal by Subject|2|||
156355449|NCT05407675|564398863|FG009|Overall Study|Withdrawal by Subject|0|||
156355450|NCT05407675|564398864|FG010|Overall Study|Withdrawal by Subject|1|||
156355451|NCT05407675|564398865|FG011|Overall Study|Withdrawal by Subject|0|||
156355452|NCT05407675|564398866|FG012|Overall Study|Withdrawal by Subject|0|||
156355453|NCT05407675|564398854|FG000|Overall Study|Site terminated by sponsor|0|||
156355454|NCT05407675|564398855|FG001|Overall Study|Site terminated by sponsor|0|||
156355455|NCT05407675|564398856|FG002|Overall Study|Site terminated by sponsor|1|||
156355456|NCT05407675|564398857|FG003|Overall Study|Site terminated by sponsor|0|||
156355457|NCT05407675|564398858|FG004|Overall Study|Site terminated by sponsor|2|||
156355458|NCT05407675|564398859|FG005|Overall Study|Site terminated by sponsor|0|||
156355459|NCT05407675|564398860|FG006|Overall Study|Site terminated by sponsor|1|||
156355460|NCT05407675|564398861|FG007|Overall Study|Site terminated by sponsor|0|||
156355461|NCT05407675|564398862|FG008|Overall Study|Site terminated by sponsor|0|||
156355462|NCT05407675|564398863|FG009|Overall Study|Site terminated by sponsor|2|||
156355463|NCT05407675|564398864|FG010|Overall Study|Site terminated by sponsor|2|||
156355464|NCT05407675|564398865|FG011|Overall Study|Site terminated by sponsor|2|||
156355465|NCT05407675|564398866|FG012|Overall Study|Site terminated by sponsor|1|||
156355466|NCT05407675|564398854|FG000|Overall Study|Disease Progression|0|||
156355467|NCT05407675|564398855|FG001|Overall Study|Disease Progression|0|||
156355468|NCT05407675|564398856|FG002|Overall Study|Disease Progression|0|||
156355469|NCT05407675|564398857|FG003|Overall Study|Disease Progression|0|||
156355470|NCT05407675|564398858|FG004|Overall Study|Disease Progression|0|||
156355471|NCT05407675|564398859|FG005|Overall Study|Disease Progression|0|||
156355472|NCT05407675|564398860|FG006|Overall Study|Disease Progression|0|||
156355473|NCT05407675|564398861|FG007|Overall Study|Disease Progression|0|||
156355474|NCT05407675|564398862|FG008|Overall Study|Disease Progression|0|||
156355475|NCT05407675|564398863|FG009|Overall Study|Disease Progression|0|||
156355476|NCT05407675|564398864|FG010|Overall Study|Disease Progression|1|||
156355477|NCT05407675|564398865|FG011|Overall Study|Disease Progression|0|||
156355478|NCT05407675|564398866|FG012|Overall Study|Disease Progression|0|||
156355479|NCT05407675|564398854|FG000|Overall Study|Physician Decision|0|||
156355480|NCT05407675|564398855|FG001|Overall Study|Physician Decision|0|||
156355481|NCT05407675|564398856|FG002|Overall Study|Physician Decision|0|||
156355482|NCT05407675|564398857|FG003|Overall Study|Physician Decision|0|||
156355483|NCT05407675|564398858|FG004|Overall Study|Physician Decision|0|||
156355484|NCT05407675|564398859|FG005|Overall Study|Physician Decision|0|||
156355485|NCT05407675|564398860|FG006|Overall Study|Physician Decision|0|||
156355486|NCT05407675|564398861|FG007|Overall Study|Physician Decision|0|||
156355487|NCT05407675|564398862|FG008|Overall Study|Physician Decision|0|||
156355488|NCT05407675|564398863|FG009|Overall Study|Physician Decision|0|||
156355489|NCT05407675|564398864|FG010|Overall Study|Physician Decision|1|||
156355490|NCT05407675|564398865|FG011|Overall Study|Physician Decision|0|||
156355491|NCT05407675|564398866|FG012|Overall Study|Physician Decision|0|||
156355492|NCT05407675|564398854|FG000|Overall Study|Other reasons|0|||
156355493|NCT05407675|564398855|FG001|Overall Study|Other reasons|0|||
156355494|NCT05407675|564398856|FG002|Overall Study|Other reasons|0|||
156355495|NCT05407675|564398857|FG003|Overall Study|Other reasons|0|||
156355496|NCT05407675|564398858|FG004|Overall Study|Other reasons|0|||
156355497|NCT05407675|564398859|FG005|Overall Study|Other reasons|0|||
156355498|NCT05407675|564398860|FG006|Overall Study|Other reasons|0|||
156487163|NCT02507687|564877679|FG003|Overall Study|Screen Failure|0|||
156487164|NCT02507687|564877676|FG000|Overall Study|Other, Not Specified|0|||
156487165|NCT02507687|564877677|FG001|Overall Study|Other, Not Specified|0|||
156487166|NCT02507687|564877678|FG002|Overall Study|Other, Not Specified|2|||
156487167|NCT02507687|564877679|FG003|Overall Study|Other, Not Specified|4|||
156487168|NCT02675998|564877680|FG000|8-Week Treatment Period|Adverse Event|6|||
156487169|NCT02675998|564877681|FG001|8-Week Treatment Period|Adverse Event|5|||
156487170|NCT02675998|564877682|FG002|8-Week Treatment Period|Adverse Event|6|||
156487171|NCT02675998|564877683|FG003|8-Week Treatment Period|Adverse Event|0|||
156487172|NCT02675998|564877680|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
156487173|NCT02675998|564877681|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
156487174|NCT02675998|564877682|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
156487175|NCT02675998|564877683|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
156487176|NCT02675998|564877680|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
156487177|NCT02675998|564877681|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
156487178|NCT02675998|564877682|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
156487179|NCT02675998|564877683|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
156487180|NCT02675998|564877680|FG000|8-Week Treatment Period|Physician Decision|1|||
156487181|NCT02675998|564877681|FG001|8-Week Treatment Period|Physician Decision|0|||
156487182|NCT02675998|564877682|FG002|8-Week Treatment Period|Physician Decision|2|||
156487183|NCT02675998|564877683|FG003|8-Week Treatment Period|Physician Decision|0|||
156487184|NCT02675998|564877680|FG000|8-Week Treatment Period|GI side Effects|1|||
156487185|NCT02675998|564877681|FG001|8-Week Treatment Period|GI side Effects|4|||
156487186|NCT02675998|564877682|FG002|8-Week Treatment Period|GI side Effects|2|||
156487187|NCT02675998|564877683|FG003|8-Week Treatment Period|GI side Effects|0|||
156487188|NCT02675998|564877680|FG000|8-Week Treatment Period|Protocol Violation|1|||
156487189|NCT02675998|564877681|FG001|8-Week Treatment Period|Protocol Violation|1|||
156487190|NCT02675998|564877682|FG002|8-Week Treatment Period|Protocol Violation|1|||
156487191|NCT02675998|564877683|FG003|8-Week Treatment Period|Protocol Violation|0|||
156487192|NCT02675998|564877680|FG000|8-Week Treatment Period|Other|3|||
156487193|NCT02675998|564877681|FG001|8-Week Treatment Period|Other|1|||
156487194|NCT02675998|564877682|FG002|8-Week Treatment Period|Other|2|||
156487195|NCT02675998|564877683|FG003|8-Week Treatment Period|Other|0|||
156487196|NCT02675998|564877680|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
156487197|NCT02675998|564877681|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
156487198|NCT02675998|564877682|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
156487199|NCT02675998|564877683|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
156487200|NCT02675998|564877680|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
156487201|NCT02675998|564877681|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
156487202|NCT02675998|564877682|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
156487203|NCT02675998|564877683|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
156487204|NCT02675998|564877680|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
156487205|NCT02675998|564877681|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
156487206|NCT02675998|564877682|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
156487207|NCT02675998|564877683|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
156487208|NCT02675998|564877680|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
156487209|NCT02675998|564877681|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
156487210|NCT02675998|564877682|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
156487211|NCT02675998|564877683|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
156487212|NCT02675998|564877680|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
156487213|NCT02675998|564877681|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
156487214|NCT02675998|564877682|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
156487215|NCT02675998|564877683|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
156487216|NCT00275301|564877684|FG000|Overall Study|Adverse Event|5|||
156487217|NCT02561078|564877689|FG000|Overall Study|Adverse Event|5|||
156487218|NCT02561078|564877690|FG001|Overall Study|Adverse Event|2|||
156487219|NCT02561078|564877689|FG000|Overall Study|Death|2|||
156487220|NCT02561078|564877690|FG001|Overall Study|Death|1|||
156487221|NCT02561078|564877689|FG000|Overall Study|Lost to Follow-up|2|||
156487222|NCT02561078|564877690|FG001|Overall Study|Lost to Follow-up|6|||
156487223|NCT02561078|564877689|FG000|Overall Study|Non-Compliance with Study Drug|6|||
156487224|NCT02561078|564877690|FG001|Overall Study|Non-Compliance with Study Drug|3|||
156487225|NCT02561078|564877689|FG000|Overall Study|Physician Decision|2|||
156544582|NCT00506883|565087812|FG002|Overall Study|Lack of Efficacy|1|||
156544583|NCT00506883|565087810|FG000|Overall Study|Other|5|||
156487226|NCT02561078|564877690|FG001|Overall Study|Physician Decision|3|||
156487227|NCT02561078|564877689|FG000|Overall Study|Withdrawal by Subject|13|||
156487228|NCT02561078|564877690|FG001|Overall Study|Withdrawal by Subject|10|||
156544584|NCT00506883|565087811|FG001|Overall Study|Other|1|||
156544585|NCT00506883|565087812|FG002|Overall Study|Other|1|||
156544586|NCT00455013|565087813|FG000|Short Term Period|Adverse Event|2|||
156487229|NCT00598871|564877693|FG000|Overall Study|Adverse Event|0|||
156487230|NCT00598871|564877694|FG001|Overall Study|Adverse Event|1|||
156487231|NCT01194271|564877695|FG000|Overall Study|Withdrawal by Subject|1|||
156487232|NCT01194271|564877695|FG000|Overall Study|Ineligible, Screen Failure|1|||
156487233|NCT01194271|564877695|FG000|Overall Study|Death|1|||
156487234|NCT00349622|564877696|FG000|Overall Study|Death|168|||
156487235|NCT00349622|564877697|FG001|Overall Study|Death|86|||
156487236|NCT00349622|564877696|FG000|Overall Study|Lost to Follow-up|5|||
156487237|NCT00349622|564877697|FG001|Overall Study|Lost to Follow-up|1|||
156487238|NCT00349622|564877696|FG000|Overall Study|Withdrawal by Subject|5|||
156487239|NCT00349622|564877697|FG001|Overall Study|Withdrawal by Subject|9|||
156487240|NCT00508274|564877700|FG000|Overall Study|Adverse Event|5|||
156487241|NCT00508274|564877700|FG000|Overall Study|Death|7|||
156487242|NCT00508274|564877700|FG000|Overall Study|Disease progression|32|||
156487243|NCT00508274|564877700|FG000|Overall Study|Withdrawal by Subject|1|||
156487244|NCT00508274|564877700|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
156487245|NCT00508274|564877700|FG000|Overall Study|Missing|3|||
156487246|NCT03296566|564877701|FG000|Overall Study|Lost to Follow-up|19|||
156487247|NCT03296566|564877702|FG001|Overall Study|Lost to Follow-up|46|||
156487248|NCT03296566|564877701|FG000|Overall Study|Withdrawal by Subject|0|||
156487249|NCT03296566|564877702|FG001|Overall Study|Withdrawal by Subject|3|||
156487250|NCT01503515|564877708|FG000|Overall Study|Adverse Event|4|||
156487251|NCT01503515|564877709|FG001|Overall Study|Adverse Event|5|||
156487252|NCT01503515|564877708|FG000|Overall Study|Death|0|||
156487253|NCT01503515|564877709|FG001|Overall Study|Death|1|||
156355499|NCT05407675|564398861|FG007|Overall Study|Other reasons|0|||
156355500|NCT05407675|564398862|FG008|Overall Study|Other reasons|1|||
156355501|NCT05407675|564398863|FG009|Overall Study|Other reasons|1|||
156355502|NCT05407675|564398864|FG010|Overall Study|Other reasons|1|||
156355503|NCT05407675|564398865|FG011|Overall Study|Other reasons|1|||
156355504|NCT05407675|564398866|FG012|Overall Study|Other reasons|0|||
156355505|NCT05407675|564398854|FG000|Overall Study|Death|3|||
156355506|NCT05407675|564398855|FG001|Overall Study|Death|4|||
156355507|NCT05407675|564398856|FG002|Overall Study|Death|3|||
156355508|NCT05407675|564398857|FG003|Overall Study|Death|6|||
156355509|NCT05407675|564398858|FG004|Overall Study|Death|0|||
156355510|NCT05407675|564398859|FG005|Overall Study|Death|2|||
156355511|NCT05407675|564398860|FG006|Overall Study|Death|4|||
156355512|NCT05407675|564398861|FG007|Overall Study|Death|2|||
156355513|NCT05407675|564398862|FG008|Overall Study|Death|2|||
156355514|NCT05407675|564398863|FG009|Overall Study|Death|4|||
156355515|NCT05407675|564398864|FG010|Overall Study|Death|2|||
156355516|NCT05407675|564398865|FG011|Overall Study|Death|1|||
156355517|NCT05407675|564398866|FG012|Overall Study|Death|0|||
156355518|NCT05407675|564398854|FG000|Overall Study|Adverse Event|0|||
156355519|NCT05407675|564398855|FG001|Overall Study|Adverse Event|0|||
156355520|NCT05407675|564398856|FG002|Overall Study|Adverse Event|0|||
156355521|NCT05407675|564398857|FG003|Overall Study|Adverse Event|0|||
156355522|NCT05407675|564398858|FG004|Overall Study|Adverse Event|1|||
156355523|NCT05407675|564398859|FG005|Overall Study|Adverse Event|0|||
156355524|NCT05407675|564398860|FG006|Overall Study|Adverse Event|0|||
156355525|NCT05407675|564398861|FG007|Overall Study|Adverse Event|0|||
156355526|NCT05407675|564398862|FG008|Overall Study|Adverse Event|0|||
156355527|NCT05407675|564398863|FG009|Overall Study|Adverse Event|0|||
156355528|NCT05407675|564398864|FG010|Overall Study|Adverse Event|0|||
156355529|NCT05407675|564398865|FG011|Overall Study|Adverse Event|1|||
156355530|NCT05407675|564398866|FG012|Overall Study|Adverse Event|0|||
156355531|NCT05407675|564398854|FG000|Overall Study|Ongoing Treatment|0|||
156355532|NCT05407675|564398855|FG001|Overall Study|Ongoing Treatment|0|||
156355533|NCT05407675|564398856|FG002|Overall Study|Ongoing Treatment|0|||
156355534|NCT05407675|564398857|FG003|Overall Study|Ongoing Treatment|0|||
156487254|NCT01503515|564877708|FG000|Overall Study|Physician Decision|14|||
156355535|NCT05407675|564398858|FG004|Overall Study|Ongoing Treatment|0|||
156487255|NCT01503515|564877709|FG001|Overall Study|Physician Decision|23|||
156487256|NCT01503515|564877708|FG000|Overall Study|Withdrawal by Subject|0|||
156487257|NCT01503515|564877709|FG001|Overall Study|Withdrawal by Subject|1|||
156355536|NCT05407675|564398859|FG005|Overall Study|Ongoing Treatment|0|||
156355537|NCT05407675|564398860|FG006|Overall Study|Ongoing Treatment|0|||
156355538|NCT05407675|564398861|FG007|Overall Study|Ongoing Treatment|0|||
156355539|NCT05407675|564398862|FG008|Overall Study|Ongoing Treatment|1|||
156355540|NCT05407675|564398863|FG009|Overall Study|Ongoing Treatment|0|||
156355541|NCT05407675|564398864|FG010|Overall Study|Ongoing Treatment|0|||
156355542|NCT05407675|564398865|FG011|Overall Study|Ongoing Treatment|0|||
156487258|NCT01503515|564877708|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
156487259|NCT01503515|564877709|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
156487260|NCT01503515|564877708|FG000|Overall Study|Ineligible|1|||
156487261|NCT01503515|564877709|FG001|Overall Study|Ineligible|1|||
156487262|NCT01350102|564877710|FG000|Overall Study|Adverse Event|0|||
156487263|NCT01350102|564877711|FG001|Overall Study|Adverse Event|0|||
156487264|NCT01350102|564877712|FG002|Overall Study|Adverse Event|1|||
156487265|NCT01350102|564877713|FG003|Overall Study|Adverse Event|0|||
156487266|NCT00917462|564877717|FG000|Overall Study|Clinical Deterioration|1|||
156487267|NCT03341312|564877718|FG000|Period 1|Withdrawal by Subject|0|||
156355543|NCT05407675|564398866|FG012|Overall Study|Ongoing Treatment|0|||
156355544|NCT01050257|564398870|FG000|Overall Study|Adverse Event|4|||
156355545|NCT01050257|564398871|FG001|Overall Study|Adverse Event|4|||
156355546|NCT01050257|564398872|FG002|Overall Study|Adverse Event|2|||
156355547|NCT01050257|564398870|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
156355548|NCT01050257|564398871|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
156355549|NCT01050257|564398872|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
156355550|NCT01050257|564398870|FG000|Overall Study|Withdrawal by Subject|0|||
156355551|NCT01050257|564398871|FG001|Overall Study|Withdrawal by Subject|3|||
156355552|NCT01050257|564398872|FG002|Overall Study|Withdrawal by Subject|0|||
156355553|NCT01050257|564398870|FG000|Overall Study|No reason specified|0|||
156355554|NCT01050257|564398871|FG001|Overall Study|No reason specified|0|||
156355555|NCT01050257|564398872|FG002|Overall Study|No reason specified|2|||
156355556|NCT01050257|564398870|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
156355557|NCT01050257|564398871|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
156355558|NCT01050257|564398872|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
156355559|NCT01050257|564398870|FG000|Overall Study|Violation criteria|0|||
156355560|NCT01050257|564398871|FG001|Overall Study|Violation criteria|1|||
156355561|NCT01050257|564398872|FG002|Overall Study|Violation criteria|0|||
156355562|NCT01050257|564398870|FG000|Overall Study|Failure to return|0|||
156355563|NCT01050257|564398871|FG001|Overall Study|Failure to return|2|||
156355564|NCT01050257|564398872|FG002|Overall Study|Failure to return|0|||
156355565|NCT01050257|564398870|FG000|Overall Study|Death|0|||
156355566|NCT01050257|564398871|FG001|Overall Study|Death|0|||
156355567|NCT01050257|564398872|FG002|Overall Study|Death|1|||
156544587|NCT00455013|565087814|FG001|Short Term Period|Adverse Event|5|||
156544588|NCT00455013|565087815|FG002|Short Term Period|Adverse Event|0|||
156544589|NCT00455013|565087813|FG000|Short Term Period|Withdrawal by Subject|0|||
156544590|NCT00455013|565087814|FG001|Short Term Period|Withdrawal by Subject|0|||
156544591|NCT00455013|565087815|FG002|Short Term Period|Withdrawal by Subject|1|||
156544592|NCT00455013|565087813|FG000|Short Term Period|Lack of Efficacy|4|||
156544593|NCT00455013|565087814|FG001|Short Term Period|Lack of Efficacy|0|||
156544594|NCT00455013|565087815|FG002|Short Term Period|Lack of Efficacy|0|||
156544595|NCT00455013|565087813|FG000|Short Term Period|Other|0|||
156544596|NCT00455013|565087814|FG001|Short Term Period|Other|0|||
156544597|NCT00455013|565087815|FG002|Short Term Period|Other|1|||
156544598|NCT00455013|565087813|FG000|Long Term Extension (LTE)|Adverse Event|0|||
156544599|NCT00455013|565087814|FG001|Long Term Extension (LTE)|Adverse Event|1|||
156544600|NCT00455013|565087815|FG002|Long Term Extension (LTE)|Adverse Event|1|||
156544601|NCT00455013|565087813|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
156544602|NCT00455013|565087814|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
156544603|NCT00455013|565087815|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
156544604|NCT00455013|565087813|FG000|Long Term Extension (LTE)|Death|1|||
156544605|NCT00455013|565087814|FG001|Long Term Extension (LTE)|Death|1|||
156544606|NCT00455013|565087815|FG002|Long Term Extension (LTE)|Death|0|||
156544607|NCT00455013|565087813|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
156544608|NCT00455013|565087814|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
156544609|NCT00455013|565087815|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
156544610|NCT00455013|565087813|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
156544611|NCT00455013|565087814|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
156544612|NCT00455013|565087815|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
156355568|NCT00171223|564398873|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
156355569|NCT00171223|564398874|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
156355570|NCT00171223|564398875|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
156355571|NCT00171223|564398873|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
156355572|NCT00171223|564398874|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
156355573|NCT00171223|564398875|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
156355574|NCT00171223|564398873|FG000|Overall Study|Abnormal Procedure|1|||
156355575|NCT00171223|564398874|FG001|Overall Study|Abnormal Procedure|0|||
156355576|NCT00171223|564398875|FG002|Overall Study|Abnormal Procedure|0|||
156355577|NCT00171223|564398873|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
156355578|NCT00171223|564398874|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
156355579|NCT00171223|564398875|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
156355580|NCT00171223|564398873|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
156355581|NCT00171223|564398874|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
156355582|NCT00171223|564398875|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
156355583|NCT00171223|564398873|FG000|Overall Study|Protocol Violation|2|||
156355584|NCT00171223|564398874|FG001|Overall Study|Protocol Violation|2|||
156355585|NCT00171223|564398875|FG002|Overall Study|Protocol Violation|3|||
156487268|NCT03341312|564877719|FG001|Period 1|Withdrawal by Subject|1|||
156487269|NCT03341312|564877720|FG002|Period 1|Withdrawal by Subject|0|||
156487270|NCT03341312|564877721|FG003|Period 1|Withdrawal by Subject|0|||
156487271|NCT01631825|564877724|FG000|Overall Study|Adverse Event|42|||
156487272|NCT01631825|564877724|FG000|Overall Study|Lack of Efficacy|7|||
156487273|NCT01631825|564877724|FG000|Overall Study|Withdrawal by Subject|9|||
156487274|NCT01631825|564877724|FG000|Overall Study|Protocol Violation|4|||
156487275|NCT01631825|564877724|FG000|Overall Study|Discontinuation criteria|1|||
156487276|NCT01631825|564877724|FG000|Overall Study|Physician Decision|2|||
156487277|NCT02176018|564877725|FG000|Overall Study|Adverse Event|0|||
156487278|NCT02176018|564877726|FG001|Overall Study|Adverse Event|2|||
156487279|NCT02176018|564877725|FG000|Overall Study|Lost to Follow-up|3|||
156487280|NCT02176018|564877726|FG001|Overall Study|Lost to Follow-up|1|||
156487281|NCT02176018|564877725|FG000|Overall Study|Protocol Violation|1|||
156487282|NCT02176018|564877726|FG001|Overall Study|Protocol Violation|1|||
156487283|NCT02176018|564877725|FG000|Overall Study|Withdrawal by Subject|1|||
156487284|NCT02176018|564877726|FG001|Overall Study|Withdrawal by Subject|2|||
156487285|NCT03022045|564877729|FG000|Overall Study|Adverse Event|0|||
156487286|NCT03022045|564877730|FG001|Overall Study|Adverse Event|1|||
156487287|NCT03022045|564877729|FG000|Overall Study|Withdrawal by Subject|1|||
156487288|NCT03022045|564877730|FG001|Overall Study|Withdrawal by Subject|1|||
156487289|NCT05372913|564877731|FG000|Overall Study|Withdrawal by Subject|0|||
156487290|NCT05372913|564877732|FG001|Overall Study|Withdrawal by Subject|2|||
156487291|NCT05372913|564877731|FG000|Overall Study|Protocol Violation|2|||
156487292|NCT05372913|564877732|FG001|Overall Study|Protocol Violation|2|||
156487293|NCT05372913|564877731|FG000|Overall Study|Adverse Event|0|||
156487294|NCT05372913|564877732|FG001|Overall Study|Adverse Event|1|||
156487295|NCT02253147|564877736|FG000|Overall Study|Protocol Violation|30|||
156487296|NCT02253147|564877736|FG000|Overall Study|Did not consent to study extension|9|||
156487297|NCT02253147|564877736|FG000|Overall Study|Conditional re-treatment at W52|5|||
156487298|NCT02253147|564877736|FG000|Overall Study|Lost to Follow-up|2|||
156487299|NCT02253147|564877736|FG000|Overall Study|Withdrawal by Subject|1|||
156487300|NCT02469077|564877740|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
156487301|NCT02469077|564877741|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
156487302|NCT02469077|564877740|FG000|Post Randomization/Intervention Period|Relocated|1|||
156487303|NCT02469077|564877741|FG001|Post Randomization/Intervention Period|Relocated|1|||
156487304|NCT02469077|564877740|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
156487305|NCT02469077|564877741|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
156487306|NCT02469077|564877740|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
156487307|NCT02469077|564877741|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
156487308|NCT02973477|564877742|FG000|First Intervention|Lost to Follow-up|0|||
156487309|NCT02973477|564877743|FG001|First Intervention|Lost to Follow-up|2|||
156487310|NCT02973477|564877742|FG000|Washout|Withdrawal by Subject|1|||
156487311|NCT02973477|564877743|FG001|Washout|Withdrawal by Subject|0|||
156487312|NCT02973477|564877742|FG000|Second Intervention|Lost to Follow-up|1|||
156487313|NCT02973477|564877743|FG001|Second Intervention|Lost to Follow-up|0|||
156544613|NCT00455013|565087813|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
156355586|NCT00171223|564398873|FG000|Overall Study|Participant Withdrew Consent|12|||
156355587|NCT00171223|564398874|FG001|Overall Study|Participant Withdrew Consent|21|||
156487314|NCT03807700|564877744|FG000|Overall Study|Withdrawal by Subject|2|||
156487315|NCT03807700|564877745|FG001|Overall Study|Withdrawal by Subject|1|||
156487316|NCT01059526|564877746|FG000|Overall Study|Patient enrolled but not treated|20|||
156487317|NCT01059526|564877747|FG001|Overall Study|Patient enrolled but not treated|17|||
156487318|NCT01059526|564877746|FG000|Overall Study|Adverse Event|2|||
156487319|NCT01059526|564877747|FG001|Overall Study|Adverse Event|2|||
156487320|NCT01059526|564877746|FG000|Overall Study|Protocol Violation|0|||
156487321|NCT01059526|564877747|FG001|Overall Study|Protocol Violation|1|||
156544614|NCT00455013|565087814|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
156544615|NCT00455013|565087815|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
156355588|NCT00171223|564398875|FG002|Overall Study|Participant Withdrew Consent|15|||
156355589|NCT00171223|564398873|FG000|Overall Study|Lost to Follow-up|5|||
156355590|NCT00171223|564398874|FG001|Overall Study|Lost to Follow-up|2|||
156355591|NCT00171223|564398875|FG002|Overall Study|Lost to Follow-up|3|||
156355592|NCT00171223|564398873|FG000|Overall Study|Administrative Problems|4|||
156355593|NCT00171223|564398874|FG001|Overall Study|Administrative Problems|7|||
156355594|NCT00171223|564398875|FG002|Overall Study|Administrative Problems|6|||
156355595|NCT00171223|564398873|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
156355596|NCT00171223|564398874|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
156355597|NCT00171223|564398875|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
156355598|NCT00171223|564398873|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
156355599|NCT00171223|564398874|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
156355600|NCT00171223|564398875|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
156355601|NCT00278109|564398877|FG000|Overall Study|Adverse Event|3|||
156355602|NCT00278109|564398877|FG000|Overall Study|social circumstances|1|||
156355603|NCT02580357|564398878|FG000|Overall Study|Lost to Follow-up|2|||
156355604|NCT02580357|564398879|FG001|Overall Study|Lost to Follow-up|0|||
156355605|NCT02580357|564398880|FG002|Overall Study|Lost to Follow-up|0|||
156355606|NCT02580357|564398878|FG000|Overall Study|Protocol Violation|1|||
156355607|NCT02580357|564398879|FG001|Overall Study|Protocol Violation|0|||
156355608|NCT02580357|564398880|FG002|Overall Study|Protocol Violation|0|||
156355609|NCT02064166|564398881|FG000|Overall Study|Adverse Event|1|||
156355610|NCT02064166|564398882|FG001|Overall Study|Adverse Event|0|||
156355611|NCT04339296|564398883|FG000|Overall Study|Refuse to participate after allocation|1|||
156355612|NCT04339296|564398884|FG001|Overall Study|Refuse to participate after allocation|1|||
156355613|NCT04339296|564398883|FG000|Overall Study|Withdrew after completion of baseline|2|||
156355614|NCT04339296|564398884|FG001|Overall Study|Withdrew after completion of baseline|1|||
156355615|NCT04339296|564398883|FG000|Overall Study|Lost to Follow-up|0|||
156355616|NCT04339296|564398884|FG001|Overall Study|Lost to Follow-up|4|||
156355617|NCT04339296|564398883|FG000|Overall Study|Discontinued intervention|5|||
156355618|NCT04339296|564398884|FG001|Overall Study|Discontinued intervention|3|||
156355619|NCT00461682|564398893|FG000|Overall Study|Protocol Violation|1|||
156355620|NCT04501666|564398894|FG000|Overall Study|Physician Decision|0|||
156355621|NCT04501666|564398895|FG001|Overall Study|Physician Decision|1|||
156355622|NCT04501666|564398894|FG000|Overall Study|Adverse Event|12|||
156355623|NCT04501666|564398895|FG001|Overall Study|Adverse Event|4|||
156355624|NCT04501666|564398894|FG000|Overall Study|Subject's request|10|||
156355625|NCT04501666|564398895|FG001|Overall Study|Subject's request|6|||
156355626|NCT04501666|564398894|FG000|Overall Study|Protocol Deviation|2|||
156355627|NCT04501666|564398895|FG001|Overall Study|Protocol Deviation|1|||
156355628|NCT04501666|564398894|FG000|Overall Study|Other-- site permanently closing|0|||
156355629|NCT04501666|564398895|FG001|Overall Study|Other-- site permanently closing|1|||
156355630|NCT03251079|564398898|FG000|Overall Study|Withdrawal by Subject|1|||
156355631|NCT02626520|564398901|FG000|Overall Study|Physician Decision|1|||
156355632|NCT02626520|564398902|FG001|Overall Study|Physician Decision|1|||
156355633|NCT02626520|564398901|FG000|Overall Study|Adverse Event|0|||
156355634|NCT02626520|564398902|FG001|Overall Study|Adverse Event|4|||
156355635|NCT02626520|564398901|FG000|Overall Study|Lack of Efficacy|0|||
156355636|NCT02626520|564398902|FG001|Overall Study|Lack of Efficacy|2|||
156355637|NCT02626520|564398901|FG000|Overall Study|Did not start protocol therapy|0|||
156355638|NCT02626520|564398902|FG001|Overall Study|Did not start protocol therapy|2|||
156487322|NCT01059526|564877746|FG000|Overall Study|Withdrawal by Subject|3|||
156487323|NCT01059526|564877747|FG001|Overall Study|Withdrawal by Subject|1|||
156487324|NCT01059526|564877746|FG000|Overall Study|Lost to Follow-up|4|||
156487325|NCT01059526|564877747|FG001|Overall Study|Lost to Follow-up|1|||
156487326|NCT01059526|564877746|FG000|Overall Study|Patient found to be dermatographic|1|||
156487327|NCT01059526|564877747|FG001|Overall Study|Patient found to be dermatographic|0|||
156487328|NCT02720081|564877748|FG000|Overall Study|Adverse Event|0|||
156487329|NCT02720081|564877749|FG001|Overall Study|Adverse Event|3|||
156487330|NCT02720081|564877748|FG000|Overall Study|Protocol Violation|4|||
156487331|NCT02720081|564877749|FG001|Overall Study|Protocol Violation|1|||
156487332|NCT01732588|564877750|FG000|First Intervention (7 Days)|Adverse Event|0|||
156487333|NCT01732588|564877751|FG001|First Intervention (7 Days)|Adverse Event|1|||
156487334|NCT01732588|564877752|FG002|First Intervention (7 Days)|Adverse Event|0|||
156487335|NCT05012397|564877753|FG000|Overall Study|Death|10|||
156487336|NCT05012397|564877753|FG000|Overall Study|Physician Decision|9|||
156487337|NCT05012397|564877753|FG000|Overall Study|Withdrawal by Subject|5|||
156487338|NCT05012397|564877753|FG000|Overall Study|Lost to Follow-up|2|||
156487339|NCT03334747|564877754|FG000|Treatment Phase|Technical problems|0|||
156355639|NCT02626520|564398901|FG000|Overall Study|Study terminated|0|||
156355640|NCT02626520|564398902|FG001|Overall Study|Study terminated|1|||
156355641|NCT01190254|564400895|FG000|Overall Study|Adverse Event|3|||
156355642|NCT01190254|564400896|FG001|Overall Study|Adverse Event|6|||
156355643|NCT01190254|564400897|FG002|Overall Study|Adverse Event|8|||
156355644|NCT01190254|564400895|FG000|Overall Study|Lack of Efficacy|7|||
156355645|NCT01190254|564400896|FG001|Overall Study|Lack of Efficacy|4|||
156487340|NCT03334747|564877755|FG001|Treatment Phase|Technical problems|0|||
156487341|NCT03334747|564877756|FG002|Treatment Phase|Technical problems|0|||
156355646|NCT01190254|564400897|FG002|Overall Study|Lack of Efficacy|5|||
156355647|NCT01190254|564400895|FG000|Overall Study|Lost to Follow-up|4|||
156355648|NCT01190254|564400896|FG001|Overall Study|Lost to Follow-up|2|||
156355649|NCT01190254|564400897|FG002|Overall Study|Lost to Follow-up|0|||
156355650|NCT01190254|564400895|FG000|Overall Study|Withdrawal by Subject|4|||
156355651|NCT01190254|564400896|FG001|Overall Study|Withdrawal by Subject|5|||
156355652|NCT01190254|564400897|FG002|Overall Study|Withdrawal by Subject|7|||
156355653|NCT01190254|564400895|FG000|Overall Study|Protocol Violation|2|||
156355654|NCT01190254|564400896|FG001|Overall Study|Protocol Violation|0|||
156355655|NCT01190254|564400897|FG002|Overall Study|Protocol Violation|2|||
156355656|NCT01190254|564400895|FG000|Overall Study|Did not meet protocol eligibility|1|||
156355657|NCT01190254|564400896|FG001|Overall Study|Did not meet protocol eligibility|0|||
156355658|NCT01190254|564400897|FG002|Overall Study|Did not meet protocol eligibility|0|||
156355659|NCT00773292|564400898|FG000|Treatment 48 Weeks|Adverse Event|1|||
156355660|NCT00773292|564400898|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
156355661|NCT02489344|564400905|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
156355662|NCT02489344|564400905|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
156355663|NCT02489344|564400905|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
156355664|NCT02489344|564400905|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
156355665|NCT00227305|564400906|FG000|Overall Study|Adverse Event|40|||
156355666|NCT00227305|564400906|FG000|Overall Study|Withdrawal by Subject|42|||
156355667|NCT00227305|564400906|FG000|Overall Study|Lost to Follow-up|33|||
156355668|NCT00227305|564400906|FG000|Overall Study|Study specific discontinuation|13|||
156355669|NCT00227305|564400906|FG000|Overall Study|MOVED OUT OF AREA|3|||
156355670|NCT00227305|564400906|FG000|Overall Study|Lack of Efficacy|7|||
156355671|NCT00227305|564400906|FG000|Overall Study|Physician Decision|3|||
156355672|NCT00227305|564400906|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
156355673|NCT00227305|564400906|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
156355674|NCT00227305|564400906|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
156355675|NCT02604212|564400908|FG000|Overall Study|Study Terminated by Sponsor|2|||
156355676|NCT02604212|564400909|FG001|Overall Study|Study Terminated by Sponsor|1|||
156355677|NCT02604212|564400910|FG002|Overall Study|Study Terminated by Sponsor|3|||
156355678|NCT02604212|564400911|FG003|Overall Study|Study Terminated by Sponsor|3|||
156355679|NCT02604212|564400908|FG000|Overall Study|Withdrawal by Subject|0|||
156355680|NCT02604212|564400909|FG001|Overall Study|Withdrawal by Subject|0|||
156355681|NCT02604212|564400910|FG002|Overall Study|Withdrawal by Subject|1|||
156355682|NCT02604212|564400911|FG003|Overall Study|Withdrawal by Subject|0|||
156355683|NCT03742037|564400917|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156355684|NCT03742037|564400918|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
156487342|NCT03334747|564877757|FG003|Treatment Phase|Technical problems|0|||
156487343|NCT03334747|564877758|FG004|Treatment Phase|Technical problems|1|||
156487344|NCT03334747|564877759|FG005|Treatment Phase|Technical problems|0|||
156487345|NCT03334747|564877760|FG006|Treatment Phase|Technical problems|0|||
156487346|NCT03334747|564877761|FG007|Treatment Phase|Technical problems|0|||
156487347|NCT03334747|564877762|FG008|Treatment Phase|Technical problems|0|||
156487348|NCT03334747|564877754|FG000|Treatment Phase|Subject/guardian decision|1|||
156487349|NCT03334747|564877755|FG001|Treatment Phase|Subject/guardian decision|0|||
156487350|NCT03334747|564877756|FG002|Treatment Phase|Subject/guardian decision|0|||
156487351|NCT03334747|564877757|FG003|Treatment Phase|Subject/guardian decision|0|||
156487352|NCT03334747|564877758|FG004|Treatment Phase|Subject/guardian decision|0|||
156487353|NCT03334747|564877759|FG005|Treatment Phase|Subject/guardian decision|1|||
156487354|NCT03334747|564877760|FG006|Treatment Phase|Subject/guardian decision|0|||
156487355|NCT03334747|564877761|FG007|Treatment Phase|Subject/guardian decision|0|||
156487356|NCT03334747|564877762|FG008|Treatment Phase|Subject/guardian decision|0|||
156487357|NCT03334747|564877754|FG000|Follow-Up Phase|Subject/guardian decision|0|||
156487358|NCT03334747|564877755|FG001|Follow-Up Phase|Subject/guardian decision|0|||
156487359|NCT03334747|564877756|FG002|Follow-Up Phase|Subject/guardian decision|0|||
156487360|NCT03334747|564877757|FG003|Follow-Up Phase|Subject/guardian decision|0|||
156487361|NCT03334747|564877758|FG004|Follow-Up Phase|Subject/guardian decision|0|||
156487362|NCT03334747|564877759|FG005|Follow-Up Phase|Subject/guardian decision|0|||
156487363|NCT03334747|564877760|FG006|Follow-Up Phase|Subject/guardian decision|1|||
156487364|NCT03334747|564877761|FG007|Follow-Up Phase|Subject/guardian decision|0|||
156487365|NCT03334747|564877762|FG008|Follow-Up Phase|Subject/guardian decision|1|||
156487366|NCT00005908|564877763|FG000|Overall Study|Withdrawal by Subject|1|||
156487367|NCT00005908|564877764|FG001|Overall Study|Withdrawal by Subject|0|||
156487368|NCT01379521|564877765|FG000|Overall Study -Treatment Period|Adverse Event|3|||
156544616|NCT00455013|565087813|FG000|Long Term Extension (LTE)|non-specified|0|||
156544617|NCT00455013|565087814|FG001|Long Term Extension (LTE)|non-specified|0|||
156355685|NCT03742037|564400919|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156355686|NCT03742037|564400920|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156355687|NCT03742037|564400921|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156355688|NCT03742037|564400922|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156355689|NCT03742037|564400923|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156355690|NCT03742037|564400917|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
156355691|NCT03742037|564400918|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
156355692|NCT03742037|564400919|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
156355693|NCT03742037|564400920|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
156355694|NCT03742037|564400921|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
156355695|NCT03742037|564400922|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
156355696|NCT03742037|564400923|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
156355697|NCT03742037|564400917|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
156355698|NCT03742037|564400918|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
156355699|NCT03742037|564400919|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
156355700|NCT03742037|564400920|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
156355701|NCT03742037|564400921|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
156355702|NCT03742037|564400922|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
156355703|NCT03742037|564400923|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
156355704|NCT03742037|564400917|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156355705|NCT03742037|564400918|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
156355706|NCT03742037|564400919|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156355707|NCT03742037|564400920|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156355708|NCT03742037|564400921|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156355709|NCT03742037|564400922|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
156355710|NCT03742037|564400923|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156355711|NCT03742037|564400917|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
156355712|NCT03742037|564400918|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
156355713|NCT03742037|564400919|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
156355714|NCT03742037|564400920|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
156355715|NCT03742037|564400921|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
156355716|NCT03742037|564400922|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
156355717|NCT03742037|564400923|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
156355718|NCT03742037|564400917|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156355719|NCT03742037|564400918|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156355720|NCT03742037|564400919|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156355721|NCT03742037|564400920|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156355722|NCT03742037|564400921|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156355723|NCT03742037|564400922|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
156355724|NCT03742037|564400923|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156355725|NCT03742037|564400917|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
156355726|NCT03742037|564400918|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
156355727|NCT03742037|564400919|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
156355728|NCT03742037|564400920|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
156355729|NCT03742037|564400921|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
156355730|NCT03742037|564400922|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
156355731|NCT03742037|564400923|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
156355732|NCT03742037|564400917|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156355733|NCT03742037|564400918|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156355734|NCT03742037|564400919|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156355735|NCT03742037|564400920|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156355736|NCT03742037|564400921|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156487369|NCT01379521|564877766|FG001|Overall Study -Treatment Period|Adverse Event|0|||
156487370|NCT01379521|564877765|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
156487371|NCT01379521|564877766|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
156487372|NCT01379521|564877765|FG000|Overall Study -Treatment Period|Disease Progression|23|||
156487373|NCT01379521|564877766|FG001|Overall Study -Treatment Period|Disease Progression|22|||
156487374|NCT01379521|564877765|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
156487375|NCT01379521|564877766|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
156487376|NCT01379521|564877765|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
156487377|NCT01379521|564877766|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
156487378|NCT01379521|564877765|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
156487379|NCT01379521|564877766|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
156487380|NCT01379521|564877765|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
156487381|NCT01379521|564877766|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
156487382|NCT01379521|564877765|FG000|Overall Study -Treatment Period|Death|2|||
156487383|NCT01379521|564877766|FG001|Overall Study -Treatment Period|Death|1|||
156487384|NCT01379521|564877765|FG000|Post-Treatment Evaluations|Disease Progression|22|||
156487385|NCT01379521|564877766|FG001|Post-Treatment Evaluations|Disease Progression|20|||
156487386|NCT01379521|564877765|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
156487387|NCT01379521|564877766|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
156487388|NCT01379521|564877765|FG000|Post-Treatment Evaluations|Death|1|||
156487389|NCT01379521|564877766|FG001|Post-Treatment Evaluations|Death|0|||
156487390|NCT02504502|564877767|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
156487391|NCT02504502|564877768|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
156487392|NCT02504502|564877767|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
156487393|NCT02504502|564877768|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
156487394|NCT00577096|564877775|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
156487395|NCT00577096|564877776|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
156487396|NCT00577096|564877775|FG000|Short Term Participation|Withdrawal by Subject|3|||
156487397|NCT00577096|564877776|FG001|Short Term Participation|Withdrawal by Subject|5|||
156487398|NCT00577096|564877775|FG000|Short Term Participation|Death|1|||
156487399|NCT00577096|564877776|FG001|Short Term Participation|Death|1|||
156487400|NCT00832650|564877777|FG000|Overall Study|Randomized but not treated|0|||
156487401|NCT00832650|564877778|FG001|Overall Study|Randomized but not treated|0|||
156487402|NCT00832650|564877779|FG002|Overall Study|Randomized but not treated|1|||
156487403|NCT00440037|564877781|FG000|Overall Study|Withdrawal by Subject|6|||
156487404|NCT00440037|564877781|FG000|Overall Study|Administrative decision|3|||
156487405|NCT03740919|564877784|FG000|Lead-in Period|Lost to Follow-up|1|||
156487406|NCT03740919|564877785|FG001|Lead-in Period|Lost to Follow-up|0|||
156487407|NCT03740919|564877786|FG002|Lead-in Period|Lost to Follow-up|0|||
156487408|NCT03740919|564877787|FG003|Lead-in Period|Lost to Follow-up|0|||
156487409|NCT03740919|564877784|FG000|Lead-in Period|Physician Decision|2|||
156487410|NCT03740919|564877785|FG001|Lead-in Period|Physician Decision|0|||
156487411|NCT03740919|564877786|FG002|Lead-in Period|Physician Decision|0|||
156487412|NCT03740919|564877787|FG003|Lead-in Period|Physician Decision|0|||
156487413|NCT03740919|564877784|FG000|Lead-in Period|Protocol Violation|1|||
156487414|NCT03740919|564877785|FG001|Lead-in Period|Protocol Violation|0|||
156487415|NCT03740919|564877786|FG002|Lead-in Period|Protocol Violation|0|||
156487416|NCT03740919|564877787|FG003|Lead-in Period|Protocol Violation|0|||
156487417|NCT03740919|564877784|FG000|Lead-in Period|Withdrawal by Subject|10|||
156487418|NCT03740919|564877785|FG001|Lead-in Period|Withdrawal by Subject|0|||
156487419|NCT03740919|564877786|FG002|Lead-in Period|Withdrawal by Subject|0|||
156487420|NCT03740919|564877787|FG003|Lead-in Period|Withdrawal by Subject|0|||
156487421|NCT03740919|564877784|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
156487422|NCT03740919|564877785|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
156487423|NCT03740919|564877786|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
156487424|NCT03740919|564877787|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
156487425|NCT03740919|564877784|FG000|Lead-in Period|Study Task Too Burdensome|1|||
156487426|NCT03740919|564877785|FG001|Lead-in Period|Study Task Too Burdensome|0|||
156487427|NCT03740919|564877786|FG002|Lead-in Period|Study Task Too Burdensome|0|||
156487428|NCT03740919|564877787|FG003|Lead-in Period|Study Task Too Burdensome|0|||
156487429|NCT03740919|564877784|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
156487430|NCT03740919|564877785|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
156487431|NCT03740919|564877786|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
156487432|NCT03740919|564877787|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
156487433|NCT03740919|564877784|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
156487434|NCT03740919|564877785|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
156487435|NCT03740919|564877786|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
156487436|NCT03740919|564877787|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
156487437|NCT03740919|564877784|FG000|Treatment Period|Adverse Event|0|||
156487438|NCT03740919|564877785|FG001|Treatment Period|Adverse Event|0|||
156487439|NCT03740919|564877786|FG002|Treatment Period|Adverse Event|2|||
156355737|NCT03742037|564400922|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156355738|NCT03742037|564400923|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
156355739|NCT03742037|564400917|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
156355740|NCT03742037|564400918|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
156355741|NCT03742037|564400919|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
156355742|NCT03742037|564400920|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
156355743|NCT03742037|564400921|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
156355744|NCT03742037|564400922|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
156355745|NCT03742037|564400923|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
156355746|NCT03742037|564400917|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
156355747|NCT03742037|564400918|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
156355748|NCT03742037|564400919|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
156355749|NCT03742037|564400920|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
156355750|NCT03742037|564400921|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
156355751|NCT03742037|564400922|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
156355752|NCT03742037|564400923|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
156355753|NCT03742037|564400917|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156355754|NCT03742037|564400918|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
156355755|NCT03742037|564400919|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
156355756|NCT03742037|564400920|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156355757|NCT03742037|564400921|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156355758|NCT03742037|564400922|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156355759|NCT03742037|564400923|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156355760|NCT03742037|564400917|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
156355761|NCT03742037|564400918|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156355762|NCT03742037|564400919|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156355763|NCT03742037|564400920|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156355764|NCT03742037|564400921|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156355765|NCT03742037|564400922|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156355766|NCT03742037|564400923|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
156355767|NCT03742037|564400917|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
156355768|NCT03742037|564400918|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
156355769|NCT03742037|564400919|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
156355770|NCT03742037|564400920|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
156355771|NCT03742037|564400921|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
156355772|NCT03742037|564400922|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
156355773|NCT03742037|564400923|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
156355774|NCT03742037|564400917|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
156355775|NCT03742037|564400918|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
156355776|NCT03742037|564400919|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
156355777|NCT03742037|564400920|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
156355778|NCT03742037|564400921|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
156355779|NCT03742037|564400922|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
156355780|NCT03742037|564400923|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
156355781|NCT03742037|564400917|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156355782|NCT03742037|564400918|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156355783|NCT03742037|564400919|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
156355784|NCT03742037|564400920|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156355785|NCT03742037|564400921|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156355786|NCT03742037|564400922|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156355787|NCT03742037|564400923|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156355788|NCT04447755|564400924|FG000|Overall Study|Death|9|||
156355789|NCT04447755|564400925|FG001|Overall Study|Death|16|||
156355790|NCT04447755|564400926|FG002|Overall Study|Death|8|||
156355791|NCT04447755|564400927|FG003|Overall Study|Death|9|||
156355792|NCT04447755|564400928|FG004|Overall Study|Death|8|||
156355793|NCT04447755|564400929|FG005|Overall Study|Death|9|||
156355794|NCT04447755|564400930|FG006|Overall Study|Death|55|||
156355795|NCT04447755|564400924|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156487440|NCT03740919|564877787|FG003|Treatment Period|Adverse Event|0|||
156487441|NCT03740919|564877784|FG000|Treatment Period|Protocol Violation|0|||
156487442|NCT03740919|564877785|FG001|Treatment Period|Protocol Violation|1|||
156487443|NCT03740919|564877786|FG002|Treatment Period|Protocol Violation|0|||
156487444|NCT03740919|564877787|FG003|Treatment Period|Protocol Violation|0|||
156487445|NCT03740919|564877784|FG000|Treatment Period|Withdrawal by Subject|0|||
156487446|NCT03740919|564877785|FG001|Treatment Period|Withdrawal by Subject|7|||
156487447|NCT03740919|564877786|FG002|Treatment Period|Withdrawal by Subject|6|||
156487448|NCT03740919|564877787|FG003|Treatment Period|Withdrawal by Subject|2|||
156487449|NCT03740919|564877784|FG000|Treatment Period|Terminated by Sponsor|0|||
156487450|NCT03740919|564877785|FG001|Treatment Period|Terminated by Sponsor|1|||
156487451|NCT03740919|564877786|FG002|Treatment Period|Terminated by Sponsor|0|||
156487452|NCT03740919|564877787|FG003|Treatment Period|Terminated by Sponsor|0|||
156487453|NCT03740919|564877784|FG000|Treatment Period|Issue with Insulin Pump|0|||
156487454|NCT03740919|564877785|FG001|Treatment Period|Issue with Insulin Pump|1|||
156487455|NCT03740919|564877786|FG002|Treatment Period|Issue with Insulin Pump|0|||
156487456|NCT03740919|564877787|FG003|Treatment Period|Issue with Insulin Pump|0|||
156355796|NCT04447755|564400925|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156355797|NCT04447755|564400926|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156355798|NCT04447755|564400927|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156355799|NCT04447755|564400928|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156355800|NCT04447755|564400929|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156355801|NCT04447755|564400930|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
156355802|NCT04447755|564400924|FG000|Overall Study|Sponsor Decision|0|||
156355803|NCT04447755|564400925|FG001|Overall Study|Sponsor Decision|0|||
156355804|NCT04447755|564400926|FG002|Overall Study|Sponsor Decision|0|||
156355805|NCT04447755|564400927|FG003|Overall Study|Sponsor Decision|0|||
156355806|NCT04447755|564400928|FG004|Overall Study|Sponsor Decision|1|||
156355807|NCT04447755|564400929|FG005|Overall Study|Sponsor Decision|0|||
156355808|NCT04447755|564400930|FG006|Overall Study|Sponsor Decision|10|||
156355809|NCT04447755|564400924|FG000|Overall Study|Lost to Follow-up|0|||
156355810|NCT04447755|564400925|FG001|Overall Study|Lost to Follow-up|0|||
156355811|NCT04447755|564400926|FG002|Overall Study|Lost to Follow-up|0|||
156355812|NCT04447755|564400927|FG003|Overall Study|Lost to Follow-up|0|||
156355813|NCT04447755|564400928|FG004|Overall Study|Lost to Follow-up|0|||
156355814|NCT04447755|564400929|FG005|Overall Study|Lost to Follow-up|0|||
156355815|NCT04447755|564400930|FG006|Overall Study|Lost to Follow-up|1|||
156355816|NCT00071760|564400931|FG000|Overall Study|Adverse Event|2|||
156355817|NCT00071760|564400932|FG001|Overall Study|Adverse Event|1|||
156355818|NCT00071760|564400931|FG000|Overall Study|Lost to Follow-up|0|||
156355819|NCT00071760|564400932|FG001|Overall Study|Lost to Follow-up|3|||
156355820|NCT00071760|564400931|FG000|Overall Study|Protocol Violation|1|||
156355821|NCT00071760|564400932|FG001|Overall Study|Protocol Violation|0|||
156355822|NCT00071760|564400931|FG000|Overall Study|Withdrawal by Subject|0|||
156355823|NCT00071760|564400932|FG001|Overall Study|Withdrawal by Subject|1|||
156355824|NCT00071760|564400931|FG000|Overall Study|Insufficient Viral Load Response|1|||
156355825|NCT00071760|564400932|FG001|Overall Study|Insufficient Viral Load Response|1|||
156355826|NCT00071760|564400931|FG000|Overall Study|Lack of availability of RTV|1|||
156355827|NCT00071760|564400932|FG001|Overall Study|Lack of availability of RTV|0|||
156355828|NCT00071760|564400931|FG000|Overall Study|Physician Decision|2|||
156355829|NCT00071760|564400932|FG001|Overall Study|Physician Decision|1|||
156355830|NCT00071760|564400931|FG000|Overall Study|Relocation|0|||
156355831|NCT00071760|564400932|FG001|Overall Study|Relocation|1|||
156355832|NCT03424265|564400942|FG000|Overall Study|screening failure|1|||
156355833|NCT03424265|564400943|FG001|Overall Study|screening failure|0|||
156355834|NCT03424265|564400942|FG000|Overall Study|Withdrawal by Subject|0|||
156355835|NCT03424265|564400943|FG001|Overall Study|Withdrawal by Subject|2|||
156355836|NCT01558752|564400947|FG000|Overall Study|Physician Decision|2|||
156355837|NCT01558752|564400948|FG001|Overall Study|Physician Decision|0|||
156355838|NCT00619801|564400949|FG000|Overall Study|Lack of Efficacy|0|||
156355839|NCT00619801|564400950|FG001|Overall Study|Lack of Efficacy|1|||
156355840|NCT00619801|564400949|FG000|Overall Study|Withdrawal by Subject|1|||
156355841|NCT00619801|564400950|FG001|Overall Study|Withdrawal by Subject|1|||
156355842|NCT00619801|564400949|FG000|Overall Study|Loss of efficacy|0|||
156355843|NCT00619801|564400950|FG001|Overall Study|Loss of efficacy|1|||
156355844|NCT00450333|564400957|FG000|Overall Study|Study terminated|47|||
156355845|NCT00450333|564400958|FG001|Overall Study|Study terminated|54|||
156355846|NCT00450333|564400959|FG002|Overall Study|Study terminated|16|||
156487457|NCT03740919|564877784|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
156355847|NCT00450333|564400960|FG003|Overall Study|Study terminated|21|||
156487458|NCT03740919|564877785|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
156487459|NCT03740919|564877786|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
156487460|NCT03740919|564877787|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
156487461|NCT03740919|564877784|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
156487462|NCT03740919|564877785|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
156487463|NCT03740919|564877786|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
156487464|NCT03740919|564877787|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
156487465|NCT03740919|564877784|FG000|Treatment Period|Not Completing Diary|0|||
156355848|NCT00450333|564400957|FG000|Overall Study|Adverse Event|1|||
156355849|NCT00450333|564400958|FG001|Overall Study|Adverse Event|7|||
156355850|NCT00450333|564400959|FG002|Overall Study|Adverse Event|2|||
156355851|NCT00450333|564400960|FG003|Overall Study|Adverse Event|2|||
156355852|NCT00450333|564400957|FG000|Overall Study|Protocol Violation|1|||
156355853|NCT00450333|564400958|FG001|Overall Study|Protocol Violation|0|||
156355854|NCT00450333|564400959|FG002|Overall Study|Protocol Violation|1|||
156355855|NCT00450333|564400960|FG003|Overall Study|Protocol Violation|0|||
156355856|NCT00450333|564400957|FG000|Overall Study|Withdrawal by Subject|1|||
156355857|NCT00450333|564400958|FG001|Overall Study|Withdrawal by Subject|0|||
156355858|NCT00450333|564400959|FG002|Overall Study|Withdrawal by Subject|3|||
156355859|NCT00450333|564400960|FG003|Overall Study|Withdrawal by Subject|0|||
156355860|NCT00450333|564400957|FG000|Overall Study|Kidney transplant|1|||
156355861|NCT00450333|564400958|FG001|Overall Study|Kidney transplant|0|||
156355862|NCT00450333|564400959|FG002|Overall Study|Kidney transplant|1|||
156355863|NCT00450333|564400960|FG003|Overall Study|Kidney transplant|3|||
156355864|NCT00450333|564400957|FG000|Overall Study|Death|3|||
156355865|NCT00450333|564400958|FG001|Overall Study|Death|2|||
156355866|NCT00450333|564400959|FG002|Overall Study|Death|2|||
156355867|NCT00450333|564400960|FG003|Overall Study|Death|2|||
156355868|NCT02375113|564400967|FG000|Overall Study|Undisclosed Reason(s).|1|||
156355869|NCT02375113|564400968|FG001|Overall Study|Undisclosed Reason(s).|1|||
156355870|NCT02375113|564400967|FG000|Overall Study|Poor adherence (<70%).|1|||
156355871|NCT02375113|564400968|FG001|Overall Study|Poor adherence (<70%).|0|||
156355872|NCT02375113|564400967|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
156355873|NCT02375113|564400968|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
156355874|NCT01214629|564400969|FG000|Overall Study|Progressive Disease|1|||
156355875|NCT01214629|564400970|FG001|Overall Study|Progressive Disease|1|||
156355876|NCT01214629|564400971|FG002|Overall Study|Progressive Disease|0|||
156355877|NCT01214629|564400972|FG003|Overall Study|Progressive Disease|1|||
156355878|NCT01214629|564400973|FG004|Overall Study|Progressive Disease|2|||
156355879|NCT01214629|564400974|FG005|Overall Study|Progressive Disease|3|||
156355880|NCT01214629|564400975|FG006|Overall Study|Progressive Disease|1|||
156355881|NCT01214629|564400976|FG007|Overall Study|Progressive Disease|1|||
156355882|NCT01214629|564400977|FG008|Overall Study|Progressive Disease|1|||
156355883|NCT01214629|564400978|FG009|Overall Study|Progressive Disease|5|||
156355884|NCT01214629|564400979|FG010|Overall Study|Progressive Disease|1|||
156355885|NCT01214629|564400969|FG000|Overall Study|Adverse Event|0|||
156355886|NCT01214629|564400970|FG001|Overall Study|Adverse Event|0|||
156355887|NCT01214629|564400971|FG002|Overall Study|Adverse Event|0|||
156355888|NCT01214629|564400972|FG003|Overall Study|Adverse Event|1|||
156355889|NCT01214629|564400973|FG004|Overall Study|Adverse Event|0|||
156355890|NCT01214629|564400974|FG005|Overall Study|Adverse Event|1|||
156355891|NCT01214629|564400975|FG006|Overall Study|Adverse Event|0|||
156355892|NCT01214629|564400976|FG007|Overall Study|Adverse Event|0|||
156355893|NCT01214629|564400977|FG008|Overall Study|Adverse Event|0|||
156355894|NCT01214629|564400978|FG009|Overall Study|Adverse Event|1|||
156355895|NCT01214629|564400979|FG010|Overall Study|Adverse Event|0|||
156355896|NCT01214629|564400969|FG000|Overall Study|Physician Decision|0|||
156487466|NCT03740919|564877785|FG001|Treatment Period|Not Completing Diary|0|||
156487467|NCT03740919|564877786|FG002|Treatment Period|Not Completing Diary|1|||
156487468|NCT03740919|564877787|FG003|Treatment Period|Not Completing Diary|0|||
156487469|NCT03740919|564877784|FG000|Treatment Period|Insulin Painful to Participant|0|||
156487470|NCT03740919|564877785|FG001|Treatment Period|Insulin Painful to Participant|0|||
156487471|NCT03740919|564877786|FG002|Treatment Period|Insulin Painful to Participant|1|||
156355897|NCT01214629|564400970|FG001|Overall Study|Physician Decision|0|||
156355898|NCT01214629|564400971|FG002|Overall Study|Physician Decision|0|||
156355899|NCT01214629|564400972|FG003|Overall Study|Physician Decision|0|||
156355900|NCT01214629|564400973|FG004|Overall Study|Physician Decision|0|||
156487472|NCT03740919|564877787|FG003|Treatment Period|Insulin Painful to Participant|0|||
156487473|NCT00985621|564877790|FG000|Overall Study|Adverse Event|2|||
156487474|NCT00985621|564877791|FG001|Overall Study|Adverse Event|3|||
156487475|NCT00985621|564877792|FG002|Overall Study|Adverse Event|4|||
156487476|NCT00985621|564877793|FG003|Overall Study|Adverse Event|16|||
156487477|NCT00985621|564877790|FG000|Overall Study|Lack of Efficacy|10|||
156487478|NCT00985621|564877791|FG001|Overall Study|Lack of Efficacy|6|||
156487479|NCT00985621|564877792|FG002|Overall Study|Lack of Efficacy|5|||
156487480|NCT00985621|564877793|FG003|Overall Study|Lack of Efficacy|12|||
156487481|NCT00985621|564877790|FG000|Overall Study|Lost to Follow-up|2|||
156487482|NCT00985621|564877791|FG001|Overall Study|Lost to Follow-up|3|||
156487483|NCT00985621|564877792|FG002|Overall Study|Lost to Follow-up|4|||
156487484|NCT00985621|564877793|FG003|Overall Study|Lost to Follow-up|4|||
156487485|NCT00985621|564877790|FG000|Overall Study|Study Terminated by Sponsor|89|||
156487486|NCT00985621|564877791|FG001|Overall Study|Study Terminated by Sponsor|108|||
156487487|NCT00985621|564877792|FG002|Overall Study|Study Terminated by Sponsor|99|||
156487488|NCT00985621|564877793|FG003|Overall Study|Study Terminated by Sponsor|92|||
156487489|NCT00985621|564877790|FG000|Overall Study|Protocol Violation|1|||
156487490|NCT00985621|564877791|FG001|Overall Study|Protocol Violation|1|||
156487491|NCT00985621|564877792|FG002|Overall Study|Protocol Violation|1|||
156487492|NCT00985621|564877793|FG003|Overall Study|Protocol Violation|0|||
156487493|NCT00985621|564877790|FG000|Overall Study|Withdrawal by Subject|8|||
156487494|NCT00985621|564877791|FG001|Overall Study|Withdrawal by Subject|10|||
156487495|NCT00985621|564877792|FG002|Overall Study|Withdrawal by Subject|8|||
156487496|NCT00985621|564877793|FG003|Overall Study|Withdrawal by Subject|12|||
156487497|NCT00985621|564877790|FG000|Overall Study|Other|1|||
156487498|NCT00985621|564877791|FG001|Overall Study|Other|0|||
156487499|NCT00985621|564877792|FG002|Overall Study|Other|0|||
156487500|NCT00985621|564877793|FG003|Overall Study|Other|0|||
156487501|NCT00985621|564877790|FG000|Overall Study|Randomized but not Treated|1|||
156487502|NCT00985621|564877791|FG001|Overall Study|Randomized but not Treated|0|||
156487503|NCT00985621|564877792|FG002|Overall Study|Randomized but not Treated|2|||
156487504|NCT00985621|564877793|FG003|Overall Study|Randomized but not Treated|1|||
156487505|NCT04394624|564877797|FG000|Overall Study|Adverse Event|6|||
156487506|NCT04394624|564877798|FG001|Overall Study|Adverse Event|0|||
156487507|NCT04394624|564877797|FG000|Overall Study|Progressive disease|24|||
156487508|NCT04394624|564877798|FG001|Overall Study|Progressive disease|0|||
156487509|NCT04394624|564877797|FG000|Overall Study|Not related to COVID-19|1|||
156355901|NCT01214629|564400974|FG005|Overall Study|Physician Decision|0|||
156355902|NCT01214629|564400975|FG006|Overall Study|Physician Decision|0|||
156355903|NCT01214629|564400976|FG007|Overall Study|Physician Decision|0|||
156355904|NCT01214629|564400977|FG008|Overall Study|Physician Decision|0|||
156355905|NCT01214629|564400978|FG009|Overall Study|Physician Decision|0|||
156355906|NCT01214629|564400979|FG010|Overall Study|Physician Decision|1|||
156355907|NCT01214629|564400969|FG000|Overall Study|Withdrawal by Subject|0|||
156355908|NCT01214629|564400970|FG001|Overall Study|Withdrawal by Subject|0|||
156355909|NCT01214629|564400971|FG002|Overall Study|Withdrawal by Subject|0|||
156355910|NCT01214629|564400972|FG003|Overall Study|Withdrawal by Subject|0|||
156355911|NCT01214629|564400973|FG004|Overall Study|Withdrawal by Subject|0|||
156487510|NCT04394624|564877798|FG001|Overall Study|Not related to COVID-19|0|||
156487511|NCT00905255|564877799|FG000|Overall Study|Adverse Event|7|||
156487512|NCT00905255|564877800|FG001|Overall Study|Adverse Event|5|||
156487513|NCT00905255|564877799|FG000|Overall Study|Withdrawal by Subject|5|||
156487514|NCT00905255|564877800|FG001|Overall Study|Withdrawal by Subject|4|||
156487515|NCT00905255|564877799|FG000|Overall Study|Familial and Personal Reasons|1|||
156487516|NCT00905255|564877800|FG001|Overall Study|Familial and Personal Reasons|0|||
156487517|NCT00603278|564877803|FG000|Overall Study|Lack of Efficacy|35|||
156487518|NCT00603278|564877804|FG001|Overall Study|Lack of Efficacy|10|||
156487519|NCT00603278|564877805|FG002|Overall Study|Lack of Efficacy|11|||
156487520|NCT00603278|564877806|FG003|Overall Study|Lack of Efficacy|8|||
156487521|NCT00603278|564877807|FG004|Overall Study|Lack of Efficacy|7|||
156487522|NCT00603278|564877808|FG005|Overall Study|Lack of Efficacy|14|||
156487523|NCT00603278|564877803|FG000|Overall Study|Adverse Event|0|||
156487524|NCT00603278|564877804|FG001|Overall Study|Adverse Event|3|||
156487525|NCT00603278|564877805|FG002|Overall Study|Adverse Event|1|||
156487526|NCT00603278|564877806|FG003|Overall Study|Adverse Event|0|||
156487527|NCT00603278|564877807|FG004|Overall Study|Adverse Event|2|||
156487528|NCT00603278|564877808|FG005|Overall Study|Adverse Event|1|||
156487529|NCT00603278|564877803|FG000|Overall Study|Withdrawal by Subject|2|||
156487530|NCT00603278|564877804|FG001|Overall Study|Withdrawal by Subject|3|||
156487531|NCT00603278|564877805|FG002|Overall Study|Withdrawal by Subject|1|||
156487532|NCT00603278|564877806|FG003|Overall Study|Withdrawal by Subject|2|||
156487533|NCT00603278|564877807|FG004|Overall Study|Withdrawal by Subject|1|||
156487534|NCT00603278|564877808|FG005|Overall Study|Withdrawal by Subject|2|||
156487535|NCT00603278|564877803|FG000|Overall Study|Protocol Violation|3|||
156487536|NCT00603278|564877804|FG001|Overall Study|Protocol Violation|0|||
156487537|NCT00603278|564877805|FG002|Overall Study|Protocol Violation|1|||
156487538|NCT00603278|564877806|FG003|Overall Study|Protocol Violation|1|||
156487539|NCT00603278|564877807|FG004|Overall Study|Protocol Violation|0|||
156487540|NCT00603278|564877808|FG005|Overall Study|Protocol Violation|1|||
156487541|NCT00603278|564877803|FG000|Overall Study|Physician Decision|0|||
156487542|NCT00603278|564877804|FG001|Overall Study|Physician Decision|1|||
156487543|NCT00603278|564877805|FG002|Overall Study|Physician Decision|0|||
156487544|NCT00603278|564877806|FG003|Overall Study|Physician Decision|0|||
156487545|NCT00603278|564877807|FG004|Overall Study|Physician Decision|2|||
156487546|NCT00603278|564877808|FG005|Overall Study|Physician Decision|1|||
156487547|NCT00603278|564877803|FG000|Overall Study|Lost to Follow-up|1|||
156487548|NCT00603278|564877804|FG001|Overall Study|Lost to Follow-up|0|||
156487549|NCT00603278|564877805|FG002|Overall Study|Lost to Follow-up|0|||
156487550|NCT00603278|564877806|FG003|Overall Study|Lost to Follow-up|0|||
156487551|NCT00603278|564877807|FG004|Overall Study|Lost to Follow-up|1|||
156487552|NCT00603278|564877808|FG005|Overall Study|Lost to Follow-up|0|||
156355912|NCT01214629|564400974|FG005|Overall Study|Withdrawal by Subject|0|||
156355913|NCT01214629|564400975|FG006|Overall Study|Withdrawal by Subject|0|||
156355914|NCT01214629|564400976|FG007|Overall Study|Withdrawal by Subject|0|||
156355915|NCT01214629|564400977|FG008|Overall Study|Withdrawal by Subject|0|||
156355916|NCT01214629|564400978|FG009|Overall Study|Withdrawal by Subject|1|||
156355917|NCT01214629|564400979|FG010|Overall Study|Withdrawal by Subject|0|||
156355918|NCT00877383|564400982|FG000|Overall Study|Adverse Event|13|||
156355919|NCT00877383|564400983|FG001|Overall Study|Adverse Event|14|||
156487553|NCT02418819|564877810|FG000|Overall Study|Adverse Event|0|||
156487554|NCT02418819|564877811|FG001|Overall Study|Adverse Event|0|||
156355920|NCT00877383|564400982|FG000|Overall Study|Lost to Follow-up|5|||
156355921|NCT00877383|564400983|FG001|Overall Study|Lost to Follow-up|3|||
156487555|NCT02418819|564877812|FG002|Overall Study|Adverse Event|1|||
156487556|NCT02418819|564877813|FG003|Overall Study|Adverse Event|0|||
156487557|NCT02418819|564877810|FG000|Overall Study|Lost to Follow-up|1|||
156487558|NCT02418819|564877811|FG001|Overall Study|Lost to Follow-up|0|||
156487559|NCT02418819|564877812|FG002|Overall Study|Lost to Follow-up|0|||
156487560|NCT02418819|564877813|FG003|Overall Study|Lost to Follow-up|0|||
156487561|NCT02418819|564877810|FG000|Overall Study|No longer meets eligibility criteria|0|||
156355922|NCT00877383|564400982|FG000|Overall Study|Subject withdrew consent|3|||
156487562|NCT02418819|564877811|FG001|Overall Study|No longer meets eligibility criteria|0|||
156487563|NCT02418819|564877812|FG002|Overall Study|No longer meets eligibility criteria|1|||
156487564|NCT02418819|564877813|FG003|Overall Study|No longer meets eligibility criteria|0|||
156355923|NCT00877383|564400983|FG001|Overall Study|Subject withdrew consent|12|||
156355924|NCT00877383|564400982|FG000|Overall Study|Subject no longer requires study drug|2|||
156355925|NCT00877383|564400983|FG001|Overall Study|Subject no longer requires study drug|0|||
156355926|NCT00877383|564400982|FG000|Overall Study|Administrative problems|2|||
156355927|NCT00877383|564400983|FG001|Overall Study|Administrative problems|0|||
156355928|NCT00877383|564400982|FG000|Overall Study|Protocol deviation|2|||
156355929|NCT00877383|564400983|FG001|Overall Study|Protocol deviation|6|||
156355930|NCT00877383|564400982|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156355931|NCT00877383|564400983|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156355932|NCT00877383|564400982|FG000|Overall Study|Death|1|||
156355933|NCT00877383|564400983|FG001|Overall Study|Death|2|||
156355934|NCT00459108|564400984|FG000|Overall Study|Withdrawal by Subject|5|||
156355935|NCT00459108|564400984|FG000|Overall Study|Adverse Event|3|||
156355936|NCT00459108|564400984|FG000|Overall Study|Death|2|||
156355937|NCT00459108|564400984|FG000|Overall Study|Progression|1|||
156355938|NCT01829230|564400993|FG000|Overall Study|Protocol Violation|0|||
156355939|NCT01829230|564400994|FG001|Overall Study|Protocol Violation|2|||
156355940|NCT01829230|564400993|FG000|Overall Study|Withdrawal by Subject|0|||
156355941|NCT01829230|564400994|FG001|Overall Study|Withdrawal by Subject|1|||
156355942|NCT01829230|564400993|FG000|Overall Study|Lost to Follow-up|1|||
156355943|NCT01829230|564400994|FG001|Overall Study|Lost to Follow-up|1|||
156355944|NCT03051607|564400997|FG000|Overall Study|Adverse Event|66|||
156355945|NCT01505868|564400998|FG000|Overall Study|Withdrawal by Subject|1|||
156355946|NCT01505868|564400999|FG001|Overall Study|Withdrawal by Subject|0|||
156355947|NCT01505868|564401000|FG002|Overall Study|Withdrawal by Subject|0|||
156355948|NCT01505868|564401001|FG003|Overall Study|Withdrawal by Subject|0|||
156355949|NCT01505868|564401002|FG004|Overall Study|Withdrawal by Subject|0|||
156355950|NCT03204305|564401003|FG000|Overall Study|Lost to Follow-up|6|||
156355951|NCT03204305|564401004|FG001|Overall Study|Lost to Follow-up|4|||
156355952|NCT03204305|564401005|FG002|Overall Study|Lost to Follow-up|0|||
156355953|NCT03204305|564401006|FG003|Overall Study|Lost to Follow-up|0|||
156355954|NCT03204305|564401003|FG000|Overall Study|Physician Decision|1|||
156355955|NCT03204305|564401004|FG001|Overall Study|Physician Decision|0|||
156355956|NCT03204305|564401005|FG002|Overall Study|Physician Decision|0|||
156355957|NCT03204305|564401006|FG003|Overall Study|Physician Decision|0|||
156355958|NCT03204305|564401003|FG000|Overall Study|failure to place arterial line|2|||
156355959|NCT03204305|564401004|FG001|Overall Study|failure to place arterial line|1|||
156355960|NCT03204305|564401005|FG002|Overall Study|failure to place arterial line|0|||
156355961|NCT03204305|564401006|FG003|Overall Study|failure to place arterial line|0|||
156355962|NCT03204305|564401003|FG000|Overall Study|Withdrawal by Subject|2|||
156355963|NCT03204305|564401004|FG001|Overall Study|Withdrawal by Subject|0|||
156355964|NCT03204305|564401005|FG002|Overall Study|Withdrawal by Subject|0|||
156355965|NCT03204305|564401006|FG003|Overall Study|Withdrawal by Subject|0|||
156355966|NCT01603459|564401009|FG000|Overall Study|Adverse Event|5|||
156355967|NCT01603459|564401009|FG000|Overall Study|Withdrawal by Subject|5|||
156355968|NCT01603459|564401009|FG000|Overall Study|Lost to Follow-up|3|||
156355969|NCT01603459|564401009|FG000|Overall Study|Predefined discontinuation criteria|3|||
156355970|NCT01603459|564401009|FG000|Overall Study|Non-compliance|1|||
156355971|NCT01603459|564401009|FG000|Overall Study|Administrative reason|1|||
156355972|NCT00399360|564401010|FG000|Overall Study|Lost to Follow-up|2|||
156355973|NCT00399360|564401011|FG001|Overall Study|Lost to Follow-up|1|||
156355974|NCT00399360|564401012|FG002|Overall Study|Lost to Follow-up|2|||
156355975|NCT00399360|564401013|FG003|Overall Study|Lost to Follow-up|4|||
156355976|NCT00399360|564401010|FG000|Overall Study|Adverse Event|0|||
156355977|NCT00399360|564401011|FG001|Overall Study|Adverse Event|0|||
156355978|NCT00399360|564401012|FG002|Overall Study|Adverse Event|1|||
156355979|NCT00399360|564401013|FG003|Overall Study|Adverse Event|0|||
156355980|NCT00399360|564401010|FG000|Overall Study|Withdrawal by Subject|0|||
156355981|NCT00399360|564401011|FG001|Overall Study|Withdrawal by Subject|2|||
156355982|NCT00399360|564401012|FG002|Overall Study|Withdrawal by Subject|0|||
156355983|NCT00399360|564401013|FG003|Overall Study|Withdrawal by Subject|2|||
156355984|NCT00535223|564401015|FG000|Overall Study|Withdrawal by Subject|4|||
156355985|NCT00535223|564401016|FG001|Overall Study|Withdrawal by Subject|1|||
156355986|NCT01367158|564401020|FG000|Overall Study|Withdrew consent|0|||
156355987|NCT01367158|564401021|FG001|Overall Study|Withdrew consent|2|||
156487565|NCT02418819|564877810|FG000|Overall Study|No longer willing to participate|0|||
156355988|NCT01367158|564401022|FG002|Overall Study|Withdrew consent|1|||
156355989|NCT01367158|564401023|FG003|Overall Study|Withdrew consent|0|||
156355990|NCT01367158|564401024|FG004|Overall Study|Withdrew consent|2|||
156355991|NCT01367158|564401025|FG005|Overall Study|Withdrew consent|0|||
156355992|NCT01367158|564401026|FG006|Overall Study|Withdrew consent|0|||
156355993|NCT01367158|564401027|FG007|Overall Study|Withdrew consent|1|||
156355994|NCT01367158|564401028|FG008|Overall Study|Withdrew consent|0|||
156355995|NCT01367158|564401029|FG009|Overall Study|Withdrew consent|0|||
156355996|NCT01367158|564401030|FG010|Overall Study|Withdrew consent|0|||
156355997|NCT01367158|564401020|FG000|Overall Study|Lost to Follow-up|0|||
156355998|NCT01367158|564401021|FG001|Overall Study|Lost to Follow-up|0|||
156355999|NCT01367158|564401022|FG002|Overall Study|Lost to Follow-up|0|||
156356000|NCT01367158|564401023|FG003|Overall Study|Lost to Follow-up|1|||
156487566|NCT02418819|564877811|FG001|Overall Study|No longer willing to participate|0|||
156487567|NCT02418819|564877812|FG002|Overall Study|No longer willing to participate|2|||
156487568|NCT02418819|564877813|FG003|Overall Study|No longer willing to participate|1|||
156487569|NCT01332318|564877817|FG000|Overall Study|Adverse Event|0|||
156487570|NCT01332318|564877818|FG001|Overall Study|Adverse Event|3|||
156356001|NCT01367158|564401024|FG004|Overall Study|Lost to Follow-up|0|||
156356002|NCT01367158|564401025|FG005|Overall Study|Lost to Follow-up|2|||
156356003|NCT01367158|564401026|FG006|Overall Study|Lost to Follow-up|0|||
156356004|NCT01367158|564401027|FG007|Overall Study|Lost to Follow-up|1|||
156356005|NCT01367158|564401028|FG008|Overall Study|Lost to Follow-up|0|||
156356006|NCT01367158|564401029|FG009|Overall Study|Lost to Follow-up|0|||
156356007|NCT01367158|564401030|FG010|Overall Study|Lost to Follow-up|1|||
156356008|NCT01367158|564401020|FG000|Overall Study|Protocol Violation|0|||
156356009|NCT01367158|564401021|FG001|Overall Study|Protocol Violation|1|||
156356010|NCT01367158|564401022|FG002|Overall Study|Protocol Violation|0|||
156356011|NCT01367158|564401023|FG003|Overall Study|Protocol Violation|0|||
156356012|NCT01367158|564401024|FG004|Overall Study|Protocol Violation|0|||
156356013|NCT01367158|564401025|FG005|Overall Study|Protocol Violation|0|||
156356014|NCT01367158|564401026|FG006|Overall Study|Protocol Violation|0|||
156356015|NCT01367158|564401027|FG007|Overall Study|Protocol Violation|0|||
156356016|NCT01367158|564401028|FG008|Overall Study|Protocol Violation|0|||
156356017|NCT01367158|564401029|FG009|Overall Study|Protocol Violation|0|||
156356018|NCT01367158|564401030|FG010|Overall Study|Protocol Violation|0|||
156356019|NCT01765153|564401031|FG000|Training Phase 1|Format of intervention differed|1|||
156356020|NCT01765153|564401032|FG001|Training Phase 1|Format of intervention differed|0|||
156356021|NCT01765153|564401031|FG000|Training Phase 1|Poor participation in intervention|0|||
156356022|NCT01765153|564401032|FG001|Training Phase 1|Poor participation in intervention|1|||
156356023|NCT01765153|564401031|FG000|Rest Phase 1|Withdrawal by Subject|0|||
156356024|NCT01765153|564401032|FG001|Rest Phase 1|Withdrawal by Subject|1|||
156356025|NCT01765153|564401031|FG000|Training Phase 2|Withdrawal by Subject|0|||
156356026|NCT01765153|564401032|FG001|Training Phase 2|Withdrawal by Subject|1|||
156356027|NCT01765153|564401031|FG000|Rest Phase 2|Lost to Follow-up|2|||
156356028|NCT01765153|564401032|FG001|Rest Phase 2|Lost to Follow-up|1|||
156356029|NCT02663674|564401033|FG000|Overall Study|Lost to Follow-up|5|||
156356030|NCT02663674|564401034|FG001|Overall Study|Lost to Follow-up|4|||
156356031|NCT02663674|564401033|FG000|Overall Study|Withdrawal by Subject|1|||
156356032|NCT02663674|564401034|FG001|Overall Study|Withdrawal by Subject|4|||
156356033|NCT02663674|564401033|FG000|Overall Study|Physician Decision|1|||
156356034|NCT02663674|564401034|FG001|Overall Study|Physician Decision|1|||
156356035|NCT02663674|564401033|FG000|Overall Study|Other Event (Health Related)|0|||
156356036|NCT02663674|564401034|FG001|Overall Study|Other Event (Health Related)|1|||
156356037|NCT04568590|564402594|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
156356038|NCT00202644|564402597|FG000|Overall Study|Adverse Event|12|||
156356039|NCT00202644|564402598|FG001|Overall Study|Adverse Event|13|||
156356040|NCT00202644|564402597|FG000|Overall Study|Withdrawal by Subject|8|||
156487571|NCT01332318|564877819|FG002|Overall Study|Adverse Event|0|||
156487572|NCT01332318|564877820|FG003|Overall Study|Adverse Event|0|||
156356041|NCT00202644|564402598|FG001|Overall Study|Withdrawal by Subject|6|||
156356042|NCT00202644|564402597|FG000|Overall Study|Lack of Efficacy|6|||
156356043|NCT00202644|564402598|FG001|Overall Study|Lack of Efficacy|6|||
156356044|NCT00202644|564402597|FG000|Overall Study|Lost to Follow-up|0|||
156356045|NCT00202644|564402598|FG001|Overall Study|Lost to Follow-up|1|||
156356046|NCT00202644|564402597|FG000|Overall Study|Other|9|||
156356047|NCT00202644|564402598|FG001|Overall Study|Other|1|||
156356048|NCT02750592|564402599|FG000|Overall Study|Adverse Event|3|||
156356049|NCT02750592|564402599|FG000|Overall Study|Lack of Efficacy|2|||
156356050|NCT01372501|564402600|FG000|Overall Study|Adverse Event|4|||
156356051|NCT01372501|564402600|FG000|Overall Study|Device migration|1|||
156356052|NCT05811234|564402603|FG000|Overall Study|Loss of Effectiveness|2|||
156356053|NCT05811234|564402603|FG000|Overall Study|Adverse Event|4|||
156356054|NCT05811234|564402603|FG000|Overall Study|Pregnancy|1|||
156356055|NCT05811234|564402603|FG000|Overall Study|Disease progression|1|||
156356056|NCT05811234|564402603|FG000|Overall Study|Withdrawal by Subject|4|||
156356057|NCT05811234|564402603|FG000|Overall Study|Lost to Follow-up|13|||
156356058|NCT05811234|564402603|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
156356059|NCT02710045|564402604|FG000|Overall Study|Death|1|||
156356060|NCT02710045|564402605|FG001|Overall Study|Death|2|||
156356061|NCT02710045|564402606|FG002|Overall Study|Death|0|||
156356062|NCT02710045|564402604|FG000|Overall Study|Withdrawal by Subject|6|||
156356063|NCT02710045|564402605|FG001|Overall Study|Withdrawal by Subject|6|||
156356064|NCT02710045|564402606|FG002|Overall Study|Withdrawal by Subject|2|||
156356065|NCT02710045|564402604|FG000|Overall Study|Protocol Violation|1|||
156356066|NCT02710045|564402605|FG001|Overall Study|Protocol Violation|2|||
156356067|NCT02710045|564402606|FG002|Overall Study|Protocol Violation|3|||
156356068|NCT02710045|564402604|FG000|Overall Study|Lost to Follow-up|3|||
156356069|NCT02710045|564402605|FG001|Overall Study|Lost to Follow-up|6|||
156356070|NCT02710045|564402606|FG002|Overall Study|Lost to Follow-up|7|||
156356071|NCT02710045|564402604|FG000|Overall Study|Physician Decision|0|||
156356072|NCT02710045|564402605|FG001|Overall Study|Physician Decision|0|||
156356073|NCT02710045|564402606|FG002|Overall Study|Physician Decision|1|||
156356074|NCT02710045|564402604|FG000|Overall Study|Poor Attendance|0|||
156356075|NCT02710045|564402605|FG001|Overall Study|Poor Attendance|1|||
156356076|NCT02710045|564402606|FG002|Overall Study|Poor Attendance|0|||
156356077|NCT01275833|564402607|FG000|Overall Study|Study terminated|1|||
156356078|NCT01275833|564402608|FG001|Overall Study|Study terminated|1|||
156356079|NCT04105998|564402614|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
156356080|NCT04105998|564402615|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
156356081|NCT02073279|564402616|FG000|Double-blind Period|Adverse Event|1|||
156356082|NCT02073279|564402617|FG001|Double-blind Period|Adverse Event|1|||
156356083|NCT02073279|564402616|FG000|Double-blind Period|Switched to another treatment|1|||
156356084|NCT02073279|564402617|FG001|Double-blind Period|Switched to another treatment|2|||
156356085|NCT02073279|564402616|FG000|Double-blind Period|Protocol Violation|0|||
156356086|NCT02073279|564402617|FG001|Double-blind Period|Protocol Violation|1|||
156356087|NCT02073279|564402616|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
156356088|NCT02073279|564402617|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
156356089|NCT02073279|564402616|FG000|Double-blind Period|Withdrawal by Subject|2|||
156356090|NCT02073279|564402617|FG001|Double-blind Period|Withdrawal by Subject|2|||
156356091|NCT02073279|564402616|FG000|Open-label Extension Period|Adverse Event|1|||
156356092|NCT02073279|564402617|FG001|Open-label Extension Period|Adverse Event|0|||
156356093|NCT02073279|564402616|FG000|Open-label Extension Period|Lack of Efficacy|1|||
156356094|NCT02073279|564402617|FG001|Open-label Extension Period|Lack of Efficacy|0|||
156356095|NCT02073279|564402616|FG000|Open-label Extension Period|Lost to Follow-up|0|||
156356096|NCT02073279|564402617|FG001|Open-label Extension Period|Lost to Follow-up|4|||
156356097|NCT02073279|564402616|FG000|Open-label Extension Period|Switched to another treatment|1|||
156356098|NCT02073279|564402617|FG001|Open-label Extension Period|Switched to another treatment|4|||
156356099|NCT02073279|564402616|FG000|Open-label Extension Period|Protocol Violation|0|||
156356100|NCT02073279|564402617|FG001|Open-label Extension Period|Protocol Violation|1|||
156356101|NCT02073279|564402616|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
156356102|NCT02073279|564402617|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
156356103|NCT02073279|564402616|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
156356104|NCT02073279|564402617|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
156356105|NCT01994629|564402618|FG000|Overall Study|Withdrawal by Subject|1|||
156356106|NCT01994629|564402619|FG001|Overall Study|Withdrawal by Subject|0|||
156356107|NCT01994629|564402618|FG000|Overall Study|Lost to Follow-up|0|||
156356108|NCT01994629|564402619|FG001|Overall Study|Lost to Follow-up|3|||
156356109|NCT03338062|564402622|FG000|Overall Study|Alternative Therapy|1|||
156356110|NCT03338062|564402623|FG001|Overall Study|Alternative Therapy|0|||
156356111|NCT00453544|564402626|FG000|Overall Study|Withdrawal by Subject|1|||
156356112|NCT00453544|564402627|FG001|Overall Study|Withdrawal by Subject|0|||
156356113|NCT00453544|564402628|FG002|Overall Study|Withdrawal by Subject|0|||
156356114|NCT00453544|564402629|FG003|Overall Study|Withdrawal by Subject|0|||
156356115|NCT00453544|564402626|FG000|Overall Study|Primary outcome measure not completed|1|||
156356116|NCT00453544|564402627|FG001|Overall Study|Primary outcome measure not completed|1|||
156356117|NCT00453544|564402628|FG002|Overall Study|Primary outcome measure not completed|0|||
156356118|NCT00453544|564402629|FG003|Overall Study|Primary outcome measure not completed|1|||
156356119|NCT04340362|564402630|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
156356120|NCT03855280|564402634|FG000|Treatment Phase|Adverse Event|1|||
156356121|NCT03855280|564402634|FG000|Treatment Phase|Withdrawal by Subject|1|||
156487573|NCT01332318|564877817|FG000|Overall Study|Withdrawal by Subject|1|||
156487574|NCT01332318|564877818|FG001|Overall Study|Withdrawal by Subject|1|||
156487575|NCT01332318|564877819|FG002|Overall Study|Withdrawal by Subject|0|||
156356122|NCT03855280|564402634|FG000|Continuation Phase|Protocol Violation|1|||
156356123|NCT03855280|564402634|FG000|Continuation Phase|Adverse Event|1|||
156356124|NCT03855280|564402634|FG000|Continuation Phase|Sponsor Concluded Study|1|||
156356125|NCT00391274|564402635|FG000|Overall Study|Death Due to Study Disease|55|||
156356126|NCT00391274|564402636|FG001|Overall Study|Death Due to Study Disease|45|||
156356127|NCT00391274|564402635|FG000|Overall Study|Lost to Follow-up|0|||
156356128|NCT00391274|564402636|FG001|Overall Study|Lost to Follow-up|3|||
156356129|NCT00391274|564402635|FG000|Overall Study|Physician Decision|4|||
156356130|NCT00391274|564402636|FG001|Overall Study|Physician Decision|2|||
156356131|NCT00391274|564402635|FG000|Overall Study|Withdrawal by Subject|0|||
156356132|NCT00391274|564402636|FG001|Overall Study|Withdrawal by Subject|3|||
156356133|NCT00391274|564402635|FG000|Overall Study|Death Due to Adverse Event|1|||
156356134|NCT00391274|564402636|FG001|Overall Study|Death Due to Adverse Event|3|||
156356135|NCT00391274|564402635|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
156356136|NCT00391274|564402636|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
156356137|NCT00391274|564402635|FG000|Overall Study|Death Not Study Related|0|||
156356138|NCT00391274|564402636|FG001|Overall Study|Death Not Study Related|1|||
156356139|NCT00894322|564402637|FG000|Overall Study|Withdrawal by Subject|1|||
156356140|NCT00894322|564402638|FG001|Overall Study|Withdrawal by Subject|0|||
156356141|NCT00894322|564402639|FG002|Overall Study|Withdrawal by Subject|0|||
156356142|NCT03338855|564402642|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
156356143|NCT03338855|564402643|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
156356144|NCT00975481|564402652|FG000|Second Intervention Period|Adverse Event|2|||
156356145|NCT00975481|564402653|FG001|Second Intervention Period|Adverse Event|1|||
156356146|NCT00975481|564402654|FG002|Second Intervention Period|Adverse Event|0|||
156356147|NCT00975481|564402655|FG003|Second Intervention Period|Adverse Event|0|||
156356148|NCT00975481|564402656|FG004|Second Intervention Period|Adverse Event|0|||
156356149|NCT00975481|564402657|FG005|Second Intervention Period|Adverse Event|0|||
156356150|NCT00975481|564402652|FG000|Second Intervention Period|Withdrawal by Subject|0|||
156356151|NCT00975481|564402653|FG001|Second Intervention Period|Withdrawal by Subject|0|||
156356152|NCT00975481|564402654|FG002|Second Intervention Period|Withdrawal by Subject|1|||
156356153|NCT00975481|564402655|FG003|Second Intervention Period|Withdrawal by Subject|0|||
156356154|NCT00975481|564402656|FG004|Second Intervention Period|Withdrawal by Subject|0|||
156356155|NCT00975481|564402657|FG005|Second Intervention Period|Withdrawal by Subject|0|||
156356156|NCT00975481|564402652|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
156356157|NCT00975481|564402653|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
156356158|NCT00975481|564402654|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
156356159|NCT00975481|564402655|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
156356160|NCT00975481|564402656|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
156356161|NCT00975481|564402657|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
156356162|NCT00975481|564402652|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
156356163|NCT00975481|564402653|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
156356164|NCT00975481|564402654|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
156356165|NCT00975481|564402655|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
156356166|NCT00975481|564402656|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
156356167|NCT00975481|564402657|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
156356168|NCT03559257|564402660|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
156356169|NCT03559257|564402661|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
156356170|NCT03559257|564402660|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156356171|NCT03559257|564402661|FG001|Double Blind Treatment Period|Protocol Violation|4|||
156487576|NCT01332318|564877820|FG003|Overall Study|Withdrawal by Subject|1|||
156356172|NCT03559257|564402660|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
156356173|NCT03559257|564402661|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
156356174|NCT03559257|564402660|FG000|Double Blind Treatment Period|Adverse Event|0|||
156356175|NCT03559257|564402661|FG001|Double Blind Treatment Period|Adverse Event|1|||
156356176|NCT03559257|564402660|FG000|Double Blind Treatment Period|Screen Failure|0|||
156356177|NCT03559257|564402661|FG001|Double Blind Treatment Period|Screen Failure|1|||
156356178|NCT03559257|564402660|FG000|Open-label Treatment Period|Adverse Event|1|||
156356179|NCT03559257|564402661|FG001|Open-label Treatment Period|Adverse Event|4|||
156356180|NCT03559257|564402660|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
156356181|NCT03559257|564402661|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
156356182|NCT03559257|564402660|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
156356183|NCT03559257|564402661|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156356184|NCT03559257|564402660|FG000|Open-label Treatment Period|Protocol Violation|2|||
156356185|NCT03559257|564402661|FG001|Open-label Treatment Period|Protocol Violation|0|||
156356186|NCT03559257|564402660|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
156356187|NCT03559257|564402661|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
156356188|NCT03559257|564402660|FG000|Open-label Treatment Period|Physician Decision|0|||
156356189|NCT03559257|564402661|FG001|Open-label Treatment Period|Physician Decision|1|||
156356190|NCT02738450|564402662|FG000|Overall Study|Withdrawal by Subject|0|||
156356191|NCT02738450|564402663|FG001|Overall Study|Withdrawal by Subject|2|||
156356192|NCT02738450|564402664|FG002|Overall Study|Withdrawal by Subject|0|||
156356193|NCT03630120|564402665|FG000|Overall Study|Disease progression|0|||
156356194|NCT03630120|564402666|FG001|Overall Study|Disease progression|1|||
156356195|NCT03630120|564402667|FG002|Overall Study|Disease progression|1|||
156356196|NCT03630120|564402668|FG003|Overall Study|Disease progression|1|||
156356197|NCT01387347|564402669|FG000|Overall Study|Lost to Follow-up|2|||
156356198|NCT01387347|564402670|FG001|Overall Study|Lost to Follow-up|1|||
156356199|NCT01519960|564402671|FG000|Overall Study|Withdrawal from the study|26|||
156356200|NCT01519960|564402672|FG001|Overall Study|Withdrawal from the study|22|||
156356201|NCT01519960|564402673|FG002|Overall Study|Withdrawal from the study|5|||
156356202|NCT00561080|564402677|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
156356203|NCT00561080|564402678|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
156356204|NCT00561080|564402679|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
156356205|NCT00561080|564402677|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
156356206|NCT00561080|564402678|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
156356207|NCT00561080|564402679|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
156356208|NCT00561080|564402677|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
156356209|NCT00561080|564402678|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
156356210|NCT00561080|564402679|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
156356211|NCT00561080|564402677|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
156356212|NCT00561080|564402678|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
156356213|NCT00561080|564402679|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
156356214|NCT00561080|564402677|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
156356215|NCT00561080|564402678|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
156356216|NCT00561080|564402679|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
156356217|NCT00561080|564402677|FG000|Vaccination Period (up to Month 4)|Other|0|||
156356218|NCT00561080|564402678|FG001|Vaccination Period (up to Month 4)|Other|2|||
156356219|NCT00561080|564402679|FG002|Vaccination Period (up to Month 4)|Other|1|||
156356220|NCT00561080|564402677|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
156356221|NCT00561080|564402678|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
156356222|NCT00561080|564402679|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
156356223|NCT00561080|564402677|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
156356224|NCT00561080|564402678|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
156356225|NCT00561080|564402679|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
156356226|NCT00561080|564402677|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
156356227|NCT00561080|564402678|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
156356228|NCT00561080|564402679|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
156356229|NCT00561080|564402677|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
156487577|NCT01332318|564877817|FG000|Overall Study|Protocol Violation|1|||
156356230|NCT00561080|564402678|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
156356231|NCT00561080|564402679|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
156356232|NCT01165554|564402680|FG000|Overall Study|Withdrawal by Subject|23|||
156356233|NCT02953314|564402683|FG000|Overall Study|Adverse Event|0|||
156356234|NCT02953314|564402684|FG001|Overall Study|Adverse Event|1|||
156356235|NCT02953314|564402683|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156487578|NCT01332318|564877818|FG001|Overall Study|Protocol Violation|0|||
156487579|NCT01332318|564877819|FG002|Overall Study|Protocol Violation|1|||
156487580|NCT01332318|564877820|FG003|Overall Study|Protocol Violation|1|||
156356236|NCT02953314|564402684|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
156487581|NCT02040532|564877821|FG000|Overall Study|Lost to Follow-up|1|||
156487582|NCT02040532|564877821|FG000|Overall Study|Physician Decision|4|||
156487583|NCT02040532|564877821|FG000|Overall Study|Adverse Event|4|||
156487584|NCT02040532|564877821|FG000|Overall Study|Withdrawal by Subject|3|||
156487585|NCT01207453|564877822|FG000|First Intervention|Adverse Event|2|||
156487586|NCT01207453|564877823|FG001|First Intervention|Adverse Event|1|||
156487587|NCT01207453|564877822|FG000|Washout|Adverse Event|1|||
156487588|NCT01207453|564877823|FG001|Washout|Adverse Event|0|||
156487589|NCT01207453|564877822|FG000|Washout|Lost to Follow-up|1|||
156487590|NCT01207453|564877823|FG001|Washout|Lost to Follow-up|0|||
156487591|NCT01207453|564877822|FG000|2nd Intervention|Adverse Event|1|||
156487592|NCT01207453|564877823|FG001|2nd Intervention|Adverse Event|2|||
156487593|NCT01207453|564877822|FG000|2nd Intervention|Lost to Follow-up|1|||
156487594|NCT01207453|564877823|FG001|2nd Intervention|Lost to Follow-up|0|||
156487595|NCT00676663|564877824|FG000|Overall Study|Death|43|||
156487596|NCT00676663|564877825|FG001|Overall Study|Death|27|||
156487597|NCT00676663|564877824|FG000|Overall Study|Withdrew Consent|1|||
156487598|NCT00676663|564877825|FG001|Overall Study|Withdrew Consent|8|||
156487599|NCT00676663|564877824|FG000|Overall Study|Lost to Follow-up|1|||
156487600|NCT00676663|564877825|FG001|Overall Study|Lost to Follow-up|3|||
156487601|NCT01399905|564877826|FG000|Overall Study|Withdrawal by Subject|1|||
156487602|NCT01399905|564877827|FG001|Overall Study|Withdrawal by Subject|1|||
156487603|NCT00714688|564877835|FG000|Overall Study|Lack of Efficacy|14|||
156487604|NCT00714688|564877836|FG001|Overall Study|Lack of Efficacy|1|||
156487605|NCT00714688|564877837|FG002|Overall Study|Lack of Efficacy|4|||
156487606|NCT00714688|564877835|FG000|Overall Study|Withdrawal by Subject|4|||
156487607|NCT00714688|564877836|FG001|Overall Study|Withdrawal by Subject|3|||
156487608|NCT00714688|564877837|FG002|Overall Study|Withdrawal by Subject|3|||
156487609|NCT00714688|564877835|FG000|Overall Study|Lost to Follow-up|5|||
156487610|NCT00714688|564877836|FG001|Overall Study|Lost to Follow-up|2|||
156487611|NCT00714688|564877837|FG002|Overall Study|Lost to Follow-up|0|||
156487612|NCT00714688|564877835|FG000|Overall Study|Adverse Event|2|||
156487613|NCT00714688|564877836|FG001|Overall Study|Adverse Event|15|||
156487614|NCT00714688|564877837|FG002|Overall Study|Adverse Event|19|||
156487615|NCT00714688|564877835|FG000|Overall Study|Subject Non-compliant|3|||
156487616|NCT00714688|564877836|FG001|Overall Study|Subject Non-compliant|5|||
156487617|NCT00714688|564877837|FG002|Overall Study|Subject Non-compliant|5|||
156487618|NCT00714688|564877835|FG000|Overall Study|Ineligible to Continue the Study|0|||
156487619|NCT00714688|564877836|FG001|Overall Study|Ineligible to Continue the Study|1|||
156487620|NCT00714688|564877837|FG002|Overall Study|Ineligible to Continue the Study|1|||
156487621|NCT00714688|564877835|FG000|Overall Study|Sponsor's Decision|0|||
156487622|NCT00714688|564877836|FG001|Overall Study|Sponsor's Decision|2|||
156487623|NCT00714688|564877837|FG002|Overall Study|Sponsor's Decision|0|||
156487624|NCT00714688|564877835|FG000|Overall Study|Other|1|||
156487625|NCT00714688|564877836|FG001|Overall Study|Other|6|||
156487626|NCT00714688|564877837|FG002|Overall Study|Other|5|||
156487627|NCT01786551|564877838|FG000|Overall Study|Participant withdrew consent|2|||
156487628|NCT01524887|564877841|FG000|Overall Study|Withdrawal by Subject|6|||
156487629|NCT01524887|564877842|FG001|Overall Study|Withdrawal by Subject|2|||
156487630|NCT01524887|564877843|FG002|Overall Study|Withdrawal by Subject|3|||
156356237|NCT02335099|564402685|FG000|Treatment|Withdrawal by Subject|1|||
156487631|NCT01524887|564877841|FG000|Overall Study|Adverse Event|5|||
156487632|NCT01524887|564877842|FG001|Overall Study|Adverse Event|1|||
156487633|NCT01524887|564877843|FG002|Overall Study|Adverse Event|1|||
156487634|NCT01524887|564877841|FG000|Overall Study|Protocol Violation|0|||
156487635|NCT01524887|564877842|FG001|Overall Study|Protocol Violation|0|||
156487636|NCT01524887|564877843|FG002|Overall Study|Protocol Violation|1|||
156487637|NCT01524887|564877841|FG000|Overall Study|Study termination|73|||
156487638|NCT01524887|564877842|FG001|Overall Study|Study termination|87|||
156487639|NCT01524887|564877843|FG002|Overall Study|Study termination|79|||
156487640|NCT01524887|564877841|FG000|Overall Study|Withdrawal by Caregiver|0|||
156487641|NCT01524887|564877842|FG001|Overall Study|Withdrawal by Caregiver|0|||
156487642|NCT01524887|564877843|FG002|Overall Study|Withdrawal by Caregiver|2|||
156487643|NCT01524887|564877841|FG000|Overall Study|Use of prohibited medication|1|||
156487644|NCT01524887|564877842|FG001|Overall Study|Use of prohibited medication|0|||
156487645|NCT01524887|564877843|FG002|Overall Study|Use of prohibited medication|0|||
156487646|NCT04853394|564877844|FG000|Follow-up Interviews|Lost to Follow-up|22|||
156487647|NCT04853394|564877845|FG001|Follow-up Interviews|Lost to Follow-up|15|||
156356238|NCT02335099|564402686|FG001|Treatment|Withdrawal by Subject|3|||
156356239|NCT02335099|564402685|FG000|Treatment|Lost to Follow-up|2|||
156356240|NCT02335099|564402686|FG001|Treatment|Lost to Follow-up|0|||
156356241|NCT02335099|564402685|FG000|Treatment|Death|1|||
156356242|NCT02335099|564402686|FG001|Treatment|Death|0|||
156356243|NCT02335099|564402685|FG000|Treatment|Adverse Event|1|||
156356244|NCT02335099|564402686|FG001|Treatment|Adverse Event|2|||
156356245|NCT02335099|564402685|FG000|Follow-up|Death|0|||
156356246|NCT02335099|564402686|FG001|Follow-up|Death|1|||
156356247|NCT01288287|564402687|FG000|Overall Study|Lost to Follow-up|8|||
156356248|NCT01288287|564402687|FG000|Overall Study|Withdrawal by Subject|4|||
156356249|NCT01288287|564402687|FG000|Overall Study|Lack of Efficacy|13|||
156356250|NCT01288287|564402687|FG000|Overall Study|Other Reason|13|||
156356251|NCT01288287|564402687|FG000|Overall Study|Unknown Reason|1|||
156356252|NCT01288287|564402687|FG000|Overall Study|Unknown Status|7|||
156356253|NCT04948450|564402698|FG000|Overall Study|Return home|1|||
156356254|NCT04948450|564402699|FG001|Overall Study|Return home|3|||
156356255|NCT00101907|564402702|FG000|Overall Study|Adverse Event|1|||
156356256|NCT00101907|564402703|FG001|Overall Study|Adverse Event|0|||
156356257|NCT00101907|564402704|FG002|Overall Study|Adverse Event|0|||
156356258|NCT00101907|564402705|FG003|Overall Study|Adverse Event|0|||
156356259|NCT00101907|564402706|FG004|Overall Study|Adverse Event|0|||
156356260|NCT00101907|564402707|FG005|Overall Study|Adverse Event|0|||
156356261|NCT00101907|564402702|FG000|Overall Study|Death|0|||
156356262|NCT00101907|564402703|FG001|Overall Study|Death|1|||
156356263|NCT00101907|564402704|FG002|Overall Study|Death|0|||
156356264|NCT00101907|564402705|FG003|Overall Study|Death|0|||
156356265|NCT00101907|564402706|FG004|Overall Study|Death|3|||
156356266|NCT00101907|564402707|FG005|Overall Study|Death|0|||
156356267|NCT00101907|564402702|FG000|Overall Study|Physician Decision|0|||
156356268|NCT00101907|564402703|FG001|Overall Study|Physician Decision|0|||
156356269|NCT00101907|564402704|FG002|Overall Study|Physician Decision|0|||
156356270|NCT00101907|564402705|FG003|Overall Study|Physician Decision|1|||
156356271|NCT00101907|564402706|FG004|Overall Study|Physician Decision|1|||
156356272|NCT00101907|564402707|FG005|Overall Study|Physician Decision|0|||
156356273|NCT00101907|564402702|FG000|Overall Study|Withdrawal by Subject|1|||
156356274|NCT00101907|564402703|FG001|Overall Study|Withdrawal by Subject|0|||
156356275|NCT00101907|564402704|FG002|Overall Study|Withdrawal by Subject|1|||
156356276|NCT00101907|564402705|FG003|Overall Study|Withdrawal by Subject|0|||
156356277|NCT00101907|564402706|FG004|Overall Study|Withdrawal by Subject|1|||
156356278|NCT00101907|564402707|FG005|Overall Study|Withdrawal by Subject|0|||
156356279|NCT00624052|564402708|FG000|Overall Study|Adverse Event|7|||
156356280|NCT00624052|564402709|FG001|Overall Study|Adverse Event|6|||
156356281|NCT00624052|564402710|FG002|Overall Study|Adverse Event|0|||
156356282|NCT00624052|564402711|FG003|Overall Study|Adverse Event|3|||
156356283|NCT00624052|564402708|FG000|Overall Study|Lack of Efficacy|1|||
156356284|NCT00624052|564402709|FG001|Overall Study|Lack of Efficacy|1|||
156356285|NCT00624052|564402710|FG002|Overall Study|Lack of Efficacy|0|||
156356286|NCT00624052|564402711|FG003|Overall Study|Lack of Efficacy|0|||
156356287|NCT00624052|564402708|FG000|Overall Study|Lost to Follow-up|2|||
156356288|NCT00624052|564402709|FG001|Overall Study|Lost to Follow-up|3|||
156356289|NCT00624052|564402710|FG002|Overall Study|Lost to Follow-up|1|||
156356290|NCT00624052|564402711|FG003|Overall Study|Lost to Follow-up|0|||
156356291|NCT00624052|564402708|FG000|Overall Study|Non compliant with the protocol|2|||
156356292|NCT00624052|564402709|FG001|Overall Study|Non compliant with the protocol|1|||
156356293|NCT00624052|564402710|FG002|Overall Study|Non compliant with the protocol|1|||
156356294|NCT00624052|564402711|FG003|Overall Study|Non compliant with the protocol|1|||
156356295|NCT00624052|564402708|FG000|Overall Study|Consent withdrawn|3|||
156356296|NCT00624052|564402709|FG001|Overall Study|Consent withdrawn|1|||
156356297|NCT00624052|564402710|FG002|Overall Study|Consent withdrawn|1|||
156356298|NCT00624052|564402711|FG003|Overall Study|Consent withdrawn|0|||
156356299|NCT00624052|564402708|FG000|Overall Study|Changed job/ran out if meds|0|||
156356300|NCT00624052|564402709|FG001|Overall Study|Changed job/ran out if meds|2|||
156356301|NCT00624052|564402710|FG002|Overall Study|Changed job/ran out if meds|0|||
156356302|NCT00624052|564402711|FG003|Overall Study|Changed job/ran out if meds|0|||
156356303|NCT07114198|564402719|FG000|Overall Study|Protocol Violation|1|||
156356304|NCT07114198|564402720|FG001|Overall Study|Protocol Violation|1|||
156356305|NCT04734652|564404531|FG000|Overall Study|Withdrawal by Subject|2|||
156356306|NCT04734652|564404532|FG001|Overall Study|Withdrawal by Subject|0|||
156356307|NCT04734652|564404531|FG000|Overall Study|Death|0|||
156356308|NCT04734652|564404532|FG001|Overall Study|Death|1|||
156356309|NCT01921179|564404533|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
156356310|NCT01921179|564404534|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
156356311|NCT01921179|564404533|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
156356312|NCT01921179|564404534|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
156356313|NCT02981342|564404535|FG000|Overall Study|Adverse Event|0|||
156356314|NCT02981342|564404536|FG001|Overall Study|Adverse Event|0|||
156356315|NCT02981342|564404537|FG002|Overall Study|Adverse Event|0|||
156356316|NCT02981342|564404538|FG003|Overall Study|Adverse Event|1|||
156356317|NCT02981342|564404535|FG000|Overall Study|Death|0|||
156356318|NCT02981342|564404536|FG001|Overall Study|Death|9|||
156356319|NCT02981342|564404537|FG002|Overall Study|Death|9|||
156356320|NCT02981342|564404538|FG003|Overall Study|Death|4|||
156356321|NCT02981342|564404535|FG000|Overall Study|Withdrawal by Subject|0|||
156356322|NCT02981342|564404536|FG001|Overall Study|Withdrawal by Subject|0|||
156356323|NCT02981342|564404537|FG002|Overall Study|Withdrawal by Subject|3|||
156356324|NCT02981342|564404538|FG003|Overall Study|Withdrawal by Subject|1|||
156356325|NCT02981342|564404535|FG000|Overall Study|Study closed by sponsor|0|||
156356326|NCT02981342|564404536|FG001|Overall Study|Study closed by sponsor|0|||
156356327|NCT02981342|564404537|FG002|Overall Study|Study closed by sponsor|1|||
156356328|NCT02981342|564404538|FG003|Overall Study|Study closed by sponsor|1|||
156356329|NCT02981342|564404535|FG000|Overall Study|Randomized, Never Treated|0|||
156356330|NCT02981342|564404536|FG001|Overall Study|Randomized, Never Treated|1|||
156356331|NCT02981342|564404537|FG002|Overall Study|Randomized, Never Treated|0|||
156356332|NCT02981342|564404538|FG003|Overall Study|Randomized, Never Treated|7|||
156356333|NCT02981342|564404535|FG000|Overall Study|Lost to Follow-up|0|||
156356334|NCT02981342|564404536|FG001|Overall Study|Lost to Follow-up|1|||
156356335|NCT02981342|564404537|FG002|Overall Study|Lost to Follow-up|0|||
156356336|NCT02981342|564404538|FG003|Overall Study|Lost to Follow-up|0|||
156356337|NCT01277523|564404539|FG000|Overall Study|Adverse Event|1|||
156356338|NCT01277523|564404540|FG001|Overall Study|Adverse Event|0|||
156356339|NCT01277523|564404541|FG002|Overall Study|Adverse Event|0|||
156356340|NCT01277523|564404539|FG000|Overall Study|Protocol Violation|2|||
156356341|NCT01277523|564404540|FG001|Overall Study|Protocol Violation|0|||
156356342|NCT01277523|564404541|FG002|Overall Study|Protocol Violation|0|||
156356343|NCT01277523|564404539|FG000|Overall Study|Other Reason not Defined|0|||
156356344|NCT01277523|564404540|FG001|Overall Study|Other Reason not Defined|1|||
156356345|NCT01277523|564404541|FG002|Overall Study|Other Reason not Defined|0|||
156356346|NCT01217060|564404542|FG000|Overall Study|Withdrawal by Subject|1|||
156356347|NCT01859494|564404553|FG000|Overall Study|Adverse Event|1|||
156356348|NCT02432846|564404561|FG000|Overall Study (4 Arms/Strata)|Death|3|||
156356349|NCT02432846|564404562|FG001|Overall Study (4 Arms/Strata)|Death|2|||
156356350|NCT02432846|564404563|FG002|Overall Study (4 Arms/Strata)|Death|4|||
156356351|NCT02432846|564404564|FG003|Overall Study (4 Arms/Strata)|Death|3|||
156356352|NCT02432846|564404565|FG004|Overall Study (4 Arms/Strata)|Death|0|||
156356353|NCT02432846|564404566|FG005|Overall Study (4 Arms/Strata)|Death|0|||
156356354|NCT02432846|564404561|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
156356355|NCT02432846|564404562|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
156356356|NCT02432846|564404563|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
156356357|NCT02432846|564404564|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
156356358|NCT02432846|564404565|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
156356359|NCT02432846|564404566|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
156356360|NCT02432846|564404561|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
156356361|NCT02432846|564404562|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156356362|NCT02432846|564404563|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156356363|NCT02432846|564404564|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156356364|NCT02432846|564404565|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156356365|NCT02432846|564404566|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156356366|NCT02432846|564404561|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
156356367|NCT02432846|564404562|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
156356368|NCT02432846|564404563|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
156356369|NCT02432846|564404564|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
156356370|NCT02432846|564404565|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
156356371|NCT02432846|564404566|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
156356372|NCT02432846|564404561|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
156356373|NCT02432846|564404562|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
156356374|NCT02432846|564404563|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
156356375|NCT02432846|564404564|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
156356376|NCT02432846|564404565|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
156356377|NCT02432846|564404566|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
156356378|NCT02432846|564404561|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
156356379|NCT02432846|564404562|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
156356380|NCT02432846|564404563|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
156356381|NCT02432846|564404564|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
156356382|NCT02432846|564404565|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
156356383|NCT02432846|564404566|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
156356384|NCT02432846|564404561|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156356385|NCT02432846|564404562|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156356386|NCT02432846|564404563|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
156356387|NCT02432846|564404564|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156356388|NCT02432846|564404565|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156356389|NCT02432846|564404566|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156356390|NCT02432846|564404561|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
156356391|NCT02432846|564404562|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
156356392|NCT02432846|564404563|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
156356393|NCT02432846|564404564|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
156356394|NCT02432846|564404565|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
156356395|NCT02432846|564404566|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
156356396|NCT02432846|564404561|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
156356397|NCT02432846|564404562|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
156487648|NCT01808144|564877846|FG000|Overall Study|Death|1|||
156356398|NCT02432846|564404563|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
156356399|NCT02432846|564404564|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
156356400|NCT02432846|564404565|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
156356401|NCT02432846|564404566|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
156356402|NCT02432846|564404561|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156356403|NCT02432846|564404562|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156356404|NCT02432846|564404563|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156356405|NCT02432846|564404564|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156356406|NCT02432846|564404565|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
156356407|NCT02432846|564404566|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156356408|NCT02432846|564404561|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
156356409|NCT02432846|564404562|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
156356410|NCT02432846|564404563|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
156356411|NCT02432846|564404564|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
156356412|NCT02432846|564404565|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
156356413|NCT02432846|564404566|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
156356414|NCT02432846|564404561|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
156356415|NCT02432846|564404562|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
156356416|NCT02432846|564404563|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
156356417|NCT02432846|564404564|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
156356418|NCT02432846|564404565|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
156356419|NCT02432846|564404566|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
156356420|NCT02432846|564404561|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
156356421|NCT02432846|564404562|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
156356422|NCT02432846|564404563|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
156356423|NCT02432846|564404564|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
156356424|NCT02432846|564404565|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
156356425|NCT02432846|564404566|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
156356426|NCT02432846|564404561|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156356427|NCT02432846|564404562|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156356428|NCT02432846|564404563|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156356429|NCT02432846|564404564|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156356430|NCT02432846|564404565|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
156356431|NCT02432846|564404566|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156356432|NCT01912287|564404567|FG000|Overall Study|Ineligible|1|||
156356433|NCT01912287|564404568|FG001|Overall Study|Ineligible|0|||
156356434|NCT01912287|564404569|FG002|Overall Study|Ineligible|1|||
156356435|NCT01912287|564404567|FG000|Overall Study|No-show|0|||
156356436|NCT01912287|564404568|FG001|Overall Study|No-show|0|||
156356437|NCT01912287|564404569|FG002|Overall Study|No-show|1|||
156356438|NCT01912287|564404567|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
156356439|NCT01912287|564404568|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
156356440|NCT01912287|564404569|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
156356441|NCT01912287|564404567|FG000|Overall Study|Felt treatment no longer needed|0|||
156356442|NCT01912287|564404568|FG001|Overall Study|Felt treatment no longer needed|1|||
156487649|NCT01808144|564877847|FG001|Overall Study|Death|0|||
156487650|NCT01808144|564877846|FG000|Overall Study|Withdrawal by Subject|16|||
156487651|NCT01808144|564877847|FG001|Overall Study|Withdrawal by Subject|23|||
156487652|NCT01808144|564877846|FG000|Overall Study|Lost to Follow-up|6|||
156487653|NCT01808144|564877847|FG001|Overall Study|Lost to Follow-up|3|||
156487654|NCT01808144|564877846|FG000|Overall Study|Protocol Violation|6|||
156487655|NCT01808144|564877847|FG001|Overall Study|Protocol Violation|6|||
156487656|NCT01808144|564877846|FG000|Overall Study|Gout flare|0|||
156487657|NCT01808144|564877847|FG001|Overall Study|Gout flare|1|||
156487658|NCT01808144|564877846|FG000|Overall Study|Adverse Event|11|||
156487659|NCT01808144|564877847|FG001|Overall Study|Adverse Event|15|||
156487660|NCT00552513|564880122|FG000|Overall Study|Lost to Follow-up|5|||
156487661|NCT00552513|564880123|FG001|Overall Study|Lost to Follow-up|1|||
156487662|NCT04357964|564880124|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
156356443|NCT01912287|564404569|FG002|Overall Study|Felt treatment no longer needed|0|||
156356444|NCT01912287|564404567|FG000|Overall Study|Life circumstances|4|||
156356445|NCT01912287|564404568|FG001|Overall Study|Life circumstances|2|||
156356446|NCT01912287|564404569|FG002|Overall Study|Life circumstances|0|||
156356447|NCT01912287|564404567|FG000|Overall Study|Lost Interest|1|||
156356448|NCT01912287|564404568|FG001|Overall Study|Lost Interest|0|||
156356449|NCT01912287|564404569|FG002|Overall Study|Lost Interest|0|||
156356450|NCT01912287|564404567|FG000|Overall Study|Uknown reason - subject drop out|5|||
156356451|NCT01912287|564404568|FG001|Overall Study|Uknown reason - subject drop out|7|||
156356452|NCT01912287|564404569|FG002|Overall Study|Uknown reason - subject drop out|3|||
156356453|NCT01912287|564404567|FG000|Overall Study|Missed Assesment|1|||
156356454|NCT01912287|564404568|FG001|Overall Study|Missed Assesment|1|||
156356455|NCT01912287|564404569|FG002|Overall Study|Missed Assesment|1|||
156356456|NCT01912287|564404567|FG000|Overall Study|Scheduling/change in availability|17|||
156356457|NCT01912287|564404568|FG001|Overall Study|Scheduling/change in availability|10|||
156356458|NCT01912287|564404569|FG002|Overall Study|Scheduling/change in availability|8|||
156356459|NCT02631850|564404570|FG000|Treatment Period|Lost to Follow-up|0|||
156356460|NCT02631850|564404571|FG001|Treatment Period|Lost to Follow-up|1|||
156356461|NCT02631850|564404572|FG002|Treatment Period|Lost to Follow-up|0|||
156356462|NCT02631850|564404573|FG003|Treatment Period|Lost to Follow-up|0|||
156356463|NCT02631850|564404570|FG000|Treatment Period|Protocol Violation|1|||
156356464|NCT02631850|564404571|FG001|Treatment Period|Protocol Violation|0|||
156356465|NCT02631850|564404572|FG002|Treatment Period|Protocol Violation|0|||
156356466|NCT02631850|564404573|FG003|Treatment Period|Protocol Violation|0|||
156356467|NCT02631850|564404570|FG000|Treatment Period|Withdrawal by Subject|0|||
156356468|NCT02631850|564404571|FG001|Treatment Period|Withdrawal by Subject|5|||
156356469|NCT02631850|564404572|FG002|Treatment Period|Withdrawal by Subject|2|||
156356470|NCT02631850|564404573|FG003|Treatment Period|Withdrawal by Subject|2|||
156356471|NCT02631850|564404570|FG000|Treatment Period|Adverse Event|1|||
156356472|NCT02631850|564404571|FG001|Treatment Period|Adverse Event|0|||
156356473|NCT02631850|564404572|FG002|Treatment Period|Adverse Event|2|||
156356474|NCT02631850|564404573|FG003|Treatment Period|Adverse Event|3|||
156356475|NCT02631850|564404570|FG000|Treatment Period|Family medical issue|1|||
156356476|NCT02631850|564404571|FG001|Treatment Period|Family medical issue|0|||
156356477|NCT02631850|564404572|FG002|Treatment Period|Family medical issue|0|||
156356478|NCT02631850|564404573|FG003|Treatment Period|Family medical issue|0|||
156356479|NCT02631850|564404570|FG000|6 Month Follow up|Lost to Follow-up|5|||
156356480|NCT02631850|564404571|FG001|6 Month Follow up|Lost to Follow-up|8|||
156356481|NCT02631850|564404572|FG002|6 Month Follow up|Lost to Follow-up|3|||
156356482|NCT02631850|564404573|FG003|6 Month Follow up|Lost to Follow-up|5|||
156356483|NCT02631850|564404570|FG000|6 Month Follow up|Withdrawal by Subject|1|||
156356484|NCT02631850|564404571|FG001|6 Month Follow up|Withdrawal by Subject|0|||
156356485|NCT02631850|564404572|FG002|6 Month Follow up|Withdrawal by Subject|0|||
156356486|NCT02631850|564404573|FG003|6 Month Follow up|Withdrawal by Subject|2|||
156356487|NCT02631850|564404570|FG000|6 Month Follow up|Adverse Event|1|||
156356488|NCT02631850|564404571|FG001|6 Month Follow up|Adverse Event|4|||
156356489|NCT02631850|564404572|FG002|6 Month Follow up|Adverse Event|1|||
156356490|NCT02631850|564404573|FG003|6 Month Follow up|Adverse Event|3|||
156356491|NCT02631850|564404570|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
156356492|NCT02631850|564404571|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
156356493|NCT02631850|564404572|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
156356494|NCT02631850|564404573|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
156356495|NCT01462084|564404574|FG000|Overall Study|Withdrawal by Subject|1|||
156356496|NCT01462084|564404575|FG001|Overall Study|Withdrawal by Subject|0|||
156356497|NCT01462084|564404574|FG000|Overall Study|Protocol Violation|1|||
156356498|NCT01462084|564404575|FG001|Overall Study|Protocol Violation|1|||
156356499|NCT02278263|564404576|FG000|Overall Study|Protocol Violation|7|||
156356500|NCT02278263|564404577|FG001|Overall Study|Protocol Violation|0|||
156356501|NCT02278263|564404578|FG002|Overall Study|Protocol Violation|9|||
156356502|NCT01514760|564404579|FG000|Overall Study|Lost to Follow-up|2|||
156356503|NCT01266460|564404581|FG000|Overall Study|Adverse Event|3|||
156356504|NCT01266460|564404581|FG000|Overall Study|Withdrawal by Subject|5|||
156356505|NCT01266460|564404581|FG000|Overall Study|Disease Progression|18|||
156356506|NCT01266460|564404581|FG000|Overall Study|Not otherwise specified|8|||
156356507|NCT01132547|564404582|FG000|Overall Study|Withdrawal by Subject|3|||
156544618|NCT00455013|565087815|FG002|Long Term Extension (LTE)|non-specified|1|||
156356508|NCT01132547|564404583|FG001|Overall Study|Withdrawal by Subject|1|||
156356509|NCT01132547|564404582|FG000|Overall Study|Death|1|||
156356510|NCT01132547|564404583|FG001|Overall Study|Death|0|||
156356511|NCT02118012|564404584|FG000|Overall Study|Adverse Event|0|||
156356512|NCT02118012|564404585|FG001|Overall Study|Adverse Event|1|||
156356513|NCT02118012|564404584|FG000|Overall Study|Physician Decision|0|||
156356514|NCT02118012|564404585|FG001|Overall Study|Physician Decision|1|||
156356515|NCT00536107|564404588|FG000|Overall Study|Death|5|||
156356516|NCT00536107|564404589|FG001|Overall Study|Death|1|||
156356517|NCT00536107|564404588|FG000|Overall Study|Incorrect enrolment|1|||
156487663|NCT04357964|564880125|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
156487664|NCT04357964|564880124|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
156487665|NCT04357964|564880125|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
156487666|NCT04357964|564880124|FG000|Overall Study|Adipose sample was insufficient quality|0|||
156487667|NCT04357964|564880125|FG001|Overall Study|Adipose sample was insufficient quality|1|||
156487668|NCT00733226|564880126|FG000|Overall Study|Withdrawal by Subject|1|||
156487669|NCT00733226|564880127|FG001|Overall Study|Withdrawal by Subject|0|||
156487670|NCT00733226|564880126|FG000|Overall Study|Lost to Follow-up|2|||
156487671|NCT00733226|564880127|FG001|Overall Study|Lost to Follow-up|0|||
156487672|NCT00733226|564880126|FG000|Overall Study|moved to another place|2|||
156487673|NCT00733226|564880127|FG001|Overall Study|moved to another place|0|||
156487674|NCT00848393|564880130|FG000|Overall Study|Protocol Violation|0|||
156487675|NCT00848393|564880131|FG001|Overall Study|Protocol Violation|0|||
156487676|NCT00848393|564880132|FG002|Overall Study|Protocol Violation|1|||
156487677|NCT00848393|564880130|FG000|Overall Study|surgical complications unrelated to stud|0|||
156487678|NCT00848393|564880131|FG001|Overall Study|surgical complications unrelated to stud|0|||
156487679|NCT00848393|564880132|FG002|Overall Study|surgical complications unrelated to stud|2|||
156487680|NCT00443898|564880137|FG000|Overall Study|Adverse Event|0|||
156487681|NCT00443898|564880138|FG001|Overall Study|Adverse Event|0|||
156487682|NCT00443898|564880139|FG002|Overall Study|Adverse Event|1|||
156356518|NCT00536107|564404589|FG001|Overall Study|Incorrect enrolment|0|||
156356519|NCT00536107|564404588|FG000|Overall Study|Withdrawal by Subject|0|||
156356520|NCT00536107|564404589|FG001|Overall Study|Withdrawal by Subject|1|||
156356521|NCT00536107|564404588|FG000|Overall Study|Study Termination|2|||
156356522|NCT00536107|564404589|FG001|Overall Study|Study Termination|4|||
156356523|NCT00613015|564404595|FG000|Overall Study|Lost to Follow-up|0|||
156356524|NCT00613015|564404596|FG001|Overall Study|Lost to Follow-up|1|||
156356525|NCT00613015|564404597|FG002|Overall Study|Lost to Follow-up|3|||
156356526|NCT00613015|564404598|FG003|Overall Study|Lost to Follow-up|3|||
156356527|NCT00613015|564404599|FG004|Overall Study|Lost to Follow-up|2|||
156356528|NCT00613015|564404600|FG005|Overall Study|Lost to Follow-up|3|||
156356529|NCT04327388|564404603|FG000|Overall Study|Adverse Event|17|||
156356530|NCT04327388|564404604|FG001|Overall Study|Adverse Event|18|||
156356531|NCT04327388|564404605|FG002|Overall Study|Adverse Event|9|||
156356532|NCT04327388|564404603|FG000|Overall Study|Other|1|||
156356533|NCT04327388|564404604|FG001|Overall Study|Other|2|||
156356534|NCT04327388|564404605|FG002|Overall Study|Other|0|||
156356535|NCT04327388|564404603|FG000|Overall Study|Randomized and not treated|2|||
156356536|NCT04327388|564404604|FG001|Overall Study|Randomized and not treated|0|||
156356537|NCT04327388|564404605|FG002|Overall Study|Randomized and not treated|2|||
156356538|NCT04387435|564404610|FG000|Overall Study|Physician Decision|1|||
156356539|NCT02951156|564404612|FG000|Overall Study|Death|3|||
156356540|NCT02951156|564404613|FG001|Overall Study|Death|8|||
156356541|NCT02951156|564404614|FG002|Overall Study|Death|5|||
156356542|NCT02951156|564404612|FG000|Overall Study|Progressive disease|1|||
156356543|NCT02951156|564404613|FG001|Overall Study|Progressive disease|0|||
156356544|NCT02951156|564404614|FG002|Overall Study|Progressive disease|1|||
156356545|NCT02951156|564404612|FG000|Overall Study|Withdrawal by Subject|0|||
156356546|NCT02951156|564404613|FG001|Overall Study|Withdrawal by Subject|0|||
156356547|NCT02951156|564404614|FG002|Overall Study|Withdrawal by Subject|1|||
156356548|NCT02951156|564404612|FG000|Overall Study|Study terminated by sponsor|0|||
156356549|NCT02951156|564404613|FG001|Overall Study|Study terminated by sponsor|0|||
156356550|NCT02951156|564404614|FG002|Overall Study|Study terminated by sponsor|1|||
156356551|NCT02951156|564404612|FG000|Overall Study|Other|5|||
156356552|NCT02951156|564404613|FG001|Overall Study|Other|1|||
156356553|NCT02951156|564404614|FG002|Overall Study|Other|2|||
156356554|NCT01641692|564404615|FG000|Treatment Period 1|Adverse Event|1|||
156356555|NCT01641692|564404616|FG001|Treatment Period 1|Adverse Event|0|||
156356556|NCT01641692|564404617|FG002|Treatment Period 1|Adverse Event|0|||
156356557|NCT01641692|564404618|FG003|Treatment Period 1|Adverse Event|0|||
156356558|NCT01641692|564404619|FG004|Treatment Period 1|Adverse Event|0|||
156356559|NCT01641692|564404620|FG005|Treatment Period 1|Adverse Event|0|||
156356560|NCT01641692|564404621|FG006|Treatment Period 1|Adverse Event|0|||
156356561|NCT01641692|564404622|FG007|Treatment Period 1|Adverse Event|0|||
156356562|NCT01641692|564404615|FG000|Treatment Period 1|Lack of Efficacy|0|||
156356563|NCT01641692|564404616|FG001|Treatment Period 1|Lack of Efficacy|0|||
156356564|NCT01641692|564404617|FG002|Treatment Period 1|Lack of Efficacy|0|||
156356565|NCT01641692|564404618|FG003|Treatment Period 1|Lack of Efficacy|0|||
156356566|NCT01641692|564404619|FG004|Treatment Period 1|Lack of Efficacy|0|||
156544619|NCT00078325|565087816|FG000|Overall Study|Adverse Event|15|||
156356567|NCT01641692|564404620|FG005|Treatment Period 1|Lack of Efficacy|0|||
156356568|NCT01641692|564404621|FG006|Treatment Period 1|Lack of Efficacy|0|||
156356569|NCT01641692|564404622|FG007|Treatment Period 1|Lack of Efficacy|1|||
156356570|NCT01641692|564404615|FG000|Treatment Period 1|Protocol Violation|1|||
156356571|NCT01641692|564404616|FG001|Treatment Period 1|Protocol Violation|0|||
156356572|NCT01641692|564404617|FG002|Treatment Period 1|Protocol Violation|0|||
156356573|NCT01641692|564404618|FG003|Treatment Period 1|Protocol Violation|0|||
156356574|NCT01641692|564404619|FG004|Treatment Period 1|Protocol Violation|2|||
156356575|NCT01641692|564404620|FG005|Treatment Period 1|Protocol Violation|0|||
156356576|NCT01641692|564404621|FG006|Treatment Period 1|Protocol Violation|0|||
156544620|NCT00078325|565087817|FG001|Overall Study|Adverse Event|10|||
156356577|NCT01641692|564404622|FG007|Treatment Period 1|Protocol Violation|0|||
156356578|NCT01641692|564404615|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156356579|NCT01641692|564404616|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156356580|NCT01641692|564404617|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156356581|NCT01641692|564404618|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156356582|NCT01641692|564404619|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
156356583|NCT01641692|564404620|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156356584|NCT01641692|564404621|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156356585|NCT01641692|564404622|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
156356586|NCT01641692|564404615|FG000|Treatment Period 1|Lost to Follow-up|0|||
156356587|NCT01641692|564404616|FG001|Treatment Period 1|Lost to Follow-up|0|||
156356588|NCT01641692|564404617|FG002|Treatment Period 1|Lost to Follow-up|1|||
156356589|NCT01641692|564404618|FG003|Treatment Period 1|Lost to Follow-up|0|||
156356590|NCT01641692|564404619|FG004|Treatment Period 1|Lost to Follow-up|0|||
156356591|NCT01641692|564404620|FG005|Treatment Period 1|Lost to Follow-up|0|||
156356592|NCT01641692|564404621|FG006|Treatment Period 1|Lost to Follow-up|0|||
156356593|NCT01641692|564404622|FG007|Treatment Period 1|Lost to Follow-up|0|||
156356594|NCT01641692|564404615|FG000|Treatment Period 1|Physician Decision|0|||
156356595|NCT01641692|564404616|FG001|Treatment Period 1|Physician Decision|0|||
156356596|NCT01641692|564404617|FG002|Treatment Period 1|Physician Decision|0|||
156356597|NCT01641692|564404618|FG003|Treatment Period 1|Physician Decision|0|||
156356598|NCT01641692|564404619|FG004|Treatment Period 1|Physician Decision|1|||
156356599|NCT01641692|564404620|FG005|Treatment Period 1|Physician Decision|0|||
156356600|NCT01641692|564404621|FG006|Treatment Period 1|Physician Decision|0|||
156356601|NCT01641692|564404622|FG007|Treatment Period 1|Physician Decision|0|||
156356602|NCT01641692|564404615|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156356603|NCT01641692|564404616|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156356604|NCT01641692|564404617|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156356605|NCT01641692|564404618|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156487683|NCT00443898|564880140|FG003|Overall Study|Adverse Event|1|||
156487684|NCT00443898|564880137|FG000|Overall Study|Lack of Efficacy|2|||
156487685|NCT00443898|564880138|FG001|Overall Study|Lack of Efficacy|3|||
156487686|NCT00443898|564880139|FG002|Overall Study|Lack of Efficacy|3|||
156487687|NCT00443898|564880140|FG003|Overall Study|Lack of Efficacy|1|||
156487688|NCT00443898|564880137|FG000|Overall Study|Protocol Violation|1|||
156487689|NCT00443898|564880138|FG001|Overall Study|Protocol Violation|1|||
156487690|NCT00443898|564880139|FG002|Overall Study|Protocol Violation|1|||
156487691|NCT00443898|564880140|FG003|Overall Study|Protocol Violation|0|||
156487692|NCT00443898|564880137|FG000|Overall Study|Withdrawal by Subject|11|||
156356606|NCT01641692|564404619|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156356607|NCT01641692|564404620|FG005|Treatment Period 1|Withdrawal by Subject|2|||
156356608|NCT01641692|564404621|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156356609|NCT01641692|564404622|FG007|Treatment Period 1|Withdrawal by Subject|1|||
156487693|NCT00443898|564880138|FG001|Overall Study|Withdrawal by Subject|10|||
156487694|NCT00443898|564880139|FG002|Overall Study|Withdrawal by Subject|10|||
156544621|NCT00078325|565087818|FG002|Overall Study|Adverse Event|5|||
156356610|NCT01641692|564404615|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
156356611|NCT01641692|564404616|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156356612|NCT01641692|564404617|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156356613|NCT01641692|564404618|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156356614|NCT01641692|564404619|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156356615|NCT01641692|564404620|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156356616|NCT01641692|564404621|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156356617|NCT01641692|564404622|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156356618|NCT01641692|564404615|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156356619|NCT01641692|564404616|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156356620|NCT01641692|564404617|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156356621|NCT01641692|564404618|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156356622|NCT01641692|564404619|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156356623|NCT01641692|564404620|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156356624|NCT01641692|564404621|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
156356625|NCT01641692|564404622|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156356626|NCT01641692|564404615|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
156356627|NCT01641692|564404616|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356628|NCT01641692|564404617|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
156356629|NCT01641692|564404618|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
156356630|NCT01641692|564404619|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
156356631|NCT01641692|564404620|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356632|NCT01641692|564404621|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356633|NCT01641692|564404622|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
156356634|NCT01641692|564404615|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156356635|NCT01641692|564404616|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156356636|NCT01641692|564404617|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156356637|NCT01641692|564404618|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156356638|NCT01641692|564404619|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156356639|NCT01641692|564404620|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156356640|NCT01641692|564404621|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156356641|NCT01641692|564404622|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156356642|NCT01641692|564404615|FG000|Treatment Period 2|Lack of Efficacy|1|||
156356643|NCT01641692|564404616|FG001|Treatment Period 2|Lack of Efficacy|0|||
156356644|NCT01641692|564404617|FG002|Treatment Period 2|Lack of Efficacy|0|||
156356645|NCT01641692|564404618|FG003|Treatment Period 2|Lack of Efficacy|0|||
156356646|NCT01641692|564404619|FG004|Treatment Period 2|Lack of Efficacy|0|||
156356647|NCT01641692|564404620|FG005|Treatment Period 2|Lack of Efficacy|0|||
156356648|NCT01641692|564404621|FG006|Treatment Period 2|Lack of Efficacy|0|||
156356649|NCT01641692|564404622|FG007|Treatment Period 2|Lack of Efficacy|0|||
156356650|NCT01641692|564404615|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
156356651|NCT01641692|564404616|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156356652|NCT01641692|564404617|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156356653|NCT01641692|564404618|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156356654|NCT01641692|564404619|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156487695|NCT00443898|564880140|FG003|Overall Study|Withdrawal by Subject|6|||
156487696|NCT00443898|564880137|FG000|Overall Study|Lost to Follow-up|10|||
156487697|NCT00443898|564880138|FG001|Overall Study|Lost to Follow-up|10|||
156487698|NCT00443898|564880139|FG002|Overall Study|Lost to Follow-up|14|||
156487699|NCT00443898|564880140|FG003|Overall Study|Lost to Follow-up|10|||
156487700|NCT00443898|564880137|FG000|Overall Study|Death|0|||
156487701|NCT00443898|564880138|FG001|Overall Study|Death|1|||
156487702|NCT00443898|564880139|FG002|Overall Study|Death|0|||
156487703|NCT00443898|564880140|FG003|Overall Study|Death|0|||
156487704|NCT00043186|564880141|FG000|Overall Study|Physician Decision|0|||
156487705|NCT00043186|564880142|FG001|Overall Study|Physician Decision|0|||
156487706|NCT00043186|564880143|FG002|Overall Study|Physician Decision|3|||
156487707|NCT00043186|564880144|FG003|Overall Study|Physician Decision|0|||
156487708|NCT00043186|564880145|FG004|Overall Study|Physician Decision|1|||
156487709|NCT00043186|564880146|FG005|Overall Study|Physician Decision|0|||
156487710|NCT00043186|564880147|FG006|Overall Study|Physician Decision|0|||
156487711|NCT00043186|564880148|FG007|Overall Study|Physician Decision|1|||
156487712|NCT00043186|564880149|FG008|Overall Study|Physician Decision|1|||
156487713|NCT00043186|564880141|FG000|Overall Study|Adverse Event|2|||
156487714|NCT00043186|564880142|FG001|Overall Study|Adverse Event|2|||
156487715|NCT00043186|564880143|FG002|Overall Study|Adverse Event|2|||
156487716|NCT00043186|564880144|FG003|Overall Study|Adverse Event|3|||
156487717|NCT00043186|564880145|FG004|Overall Study|Adverse Event|2|||
156487718|NCT00043186|564880146|FG005|Overall Study|Adverse Event|1|||
156487719|NCT00043186|564880147|FG006|Overall Study|Adverse Event|2|||
156487720|NCT00043186|564880148|FG007|Overall Study|Adverse Event|1|||
156487721|NCT00043186|564880149|FG008|Overall Study|Adverse Event|3|||
156487722|NCT00043186|564880141|FG000|Overall Study|Withdrawal by Subject|11|||
156487723|NCT00043186|564880142|FG001|Overall Study|Withdrawal by Subject|8|||
156487724|NCT00043186|564880143|FG002|Overall Study|Withdrawal by Subject|11|||
156487725|NCT00043186|564880144|FG003|Overall Study|Withdrawal by Subject|13|||
156487726|NCT00043186|564880145|FG004|Overall Study|Withdrawal by Subject|14|||
156487727|NCT00043186|564880146|FG005|Overall Study|Withdrawal by Subject|6|||
156487728|NCT00043186|564880147|FG006|Overall Study|Withdrawal by Subject|12|||
156487729|NCT00043186|564880148|FG007|Overall Study|Withdrawal by Subject|9|||
156487730|NCT00043186|564880149|FG008|Overall Study|Withdrawal by Subject|10|||
156487731|NCT00043186|564880141|FG000|Overall Study|Death|0|||
156487732|NCT00043186|564880142|FG001|Overall Study|Death|0|||
156487733|NCT00043186|564880143|FG002|Overall Study|Death|1|||
156487734|NCT00043186|564880144|FG003|Overall Study|Death|0|||
156487735|NCT00043186|564880145|FG004|Overall Study|Death|0|||
156487736|NCT00043186|564880146|FG005|Overall Study|Death|0|||
156487737|NCT00043186|564880147|FG006|Overall Study|Death|2|||
156487738|NCT00043186|564880148|FG007|Overall Study|Death|0|||
156544622|NCT00078325|565087816|FG000|Overall Study|Protocol Violation|2|||
156356655|NCT01641692|564404620|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156487739|NCT00043186|564880149|FG008|Overall Study|Death|0|||
156487740|NCT00043186|564880141|FG000|Overall Study|Disease progression|1|||
156487741|NCT00043186|564880142|FG001|Overall Study|Disease progression|0|||
156487742|NCT00043186|564880143|FG002|Overall Study|Disease progression|0|||
156487743|NCT00043186|564880144|FG003|Overall Study|Disease progression|3|||
156356656|NCT01641692|564404621|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156544623|NCT00078325|565087817|FG001|Overall Study|Protocol Violation|2|||
156544624|NCT00078325|565087818|FG002|Overall Study|Protocol Violation|0|||
156356657|NCT01641692|564404622|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156356658|NCT01641692|564404615|FG000|Treatment Period 2|Lost to Follow-up|0|||
156356659|NCT01641692|564404616|FG001|Treatment Period 2|Lost to Follow-up|0|||
156356660|NCT01641692|564404617|FG002|Treatment Period 2|Lost to Follow-up|0|||
156356661|NCT01641692|564404618|FG003|Treatment Period 2|Lost to Follow-up|0|||
156356662|NCT01641692|564404619|FG004|Treatment Period 2|Lost to Follow-up|0|||
156356663|NCT01641692|564404620|FG005|Treatment Period 2|Lost to Follow-up|1|||
156356664|NCT01641692|564404621|FG006|Treatment Period 2|Lost to Follow-up|0|||
156356665|NCT01641692|564404622|FG007|Treatment Period 2|Lost to Follow-up|0|||
156356666|NCT01641692|564404615|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156487744|NCT00043186|564880145|FG004|Overall Study|Disease progression|0|||
156487745|NCT00043186|564880146|FG005|Overall Study|Disease progression|0|||
156487746|NCT00043186|564880147|FG006|Overall Study|Disease progression|0|||
156487747|NCT00043186|564880148|FG007|Overall Study|Disease progression|4|||
156487748|NCT00043186|564880149|FG008|Overall Study|Disease progression|0|||
156487749|NCT00043186|564880141|FG000|Overall Study|Ineligibility determined|0|||
156487750|NCT00043186|564880142|FG001|Overall Study|Ineligibility determined|0|||
156487751|NCT00043186|564880143|FG002|Overall Study|Ineligibility determined|0|||
156487752|NCT00043186|564880144|FG003|Overall Study|Ineligibility determined|0|||
156487753|NCT00043186|564880145|FG004|Overall Study|Ineligibility determined|0|||
156487754|NCT00043186|564880146|FG005|Overall Study|Ineligibility determined|0|||
156487755|NCT00043186|564880147|FG006|Overall Study|Ineligibility determined|0|||
156487756|NCT00043186|564880148|FG007|Overall Study|Ineligibility determined|0|||
156487757|NCT00043186|564880149|FG008|Overall Study|Ineligibility determined|1|||
156487758|NCT00043186|564880141|FG000|Overall Study|Lost to Follow-up|3|||
156487759|NCT00043186|564880142|FG001|Overall Study|Lost to Follow-up|5|||
156487760|NCT00043186|564880143|FG002|Overall Study|Lost to Follow-up|1|||
156487761|NCT00043186|564880144|FG003|Overall Study|Lost to Follow-up|1|||
156487762|NCT00043186|564880145|FG004|Overall Study|Lost to Follow-up|1|||
156487763|NCT00043186|564880146|FG005|Overall Study|Lost to Follow-up|1|||
156487764|NCT00043186|564880147|FG006|Overall Study|Lost to Follow-up|1|||
156487765|NCT00043186|564880148|FG007|Overall Study|Lost to Follow-up|1|||
156487766|NCT00043186|564880149|FG008|Overall Study|Lost to Follow-up|2|||
156487767|NCT00043186|564880141|FG000|Overall Study|Noncompliance|0|||
156487768|NCT00043186|564880142|FG001|Overall Study|Noncompliance|0|||
156487769|NCT00043186|564880143|FG002|Overall Study|Noncompliance|1|||
156487770|NCT00043186|564880144|FG003|Overall Study|Noncompliance|1|||
156487771|NCT00043186|564880145|FG004|Overall Study|Noncompliance|0|||
156487772|NCT00043186|564880146|FG005|Overall Study|Noncompliance|0|||
156356667|NCT01641692|564404616|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156356668|NCT01641692|564404617|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156487773|NCT00043186|564880147|FG006|Overall Study|Noncompliance|0|||
156487774|NCT00043186|564880148|FG007|Overall Study|Noncompliance|0|||
156487775|NCT00043186|564880149|FG008|Overall Study|Noncompliance|0|||
156487776|NCT00043186|564880141|FG000|Overall Study|Other|0|||
156487777|NCT00043186|564880142|FG001|Overall Study|Other|0|||
156544625|NCT00078325|565087816|FG000|Overall Study|Withdrawal by Subject|1|||
156356669|NCT01641692|564404618|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156487778|NCT00043186|564880143|FG002|Overall Study|Other|1|||
156544626|NCT00078325|565087817|FG001|Overall Study|Withdrawal by Subject|5|||
156356670|NCT01641692|564404619|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156356671|NCT01641692|564404620|FG005|Treatment Period 2|Withdrawal by Subject|1|||
156487779|NCT00043186|564880144|FG003|Overall Study|Other|1|||
156487780|NCT00043186|564880145|FG004|Overall Study|Other|0|||
156487781|NCT00043186|564880146|FG005|Overall Study|Other|0|||
156487782|NCT00043186|564880147|FG006|Overall Study|Other|0|||
156487783|NCT00043186|564880148|FG007|Overall Study|Other|0|||
156487784|NCT00043186|564880149|FG008|Overall Study|Other|0|||
156487785|NCT00550771|564880152|FG000|Overall Study|Adverse Event|11|||
156487786|NCT00550771|564880153|FG001|Overall Study|Adverse Event|3|||
156356672|NCT01641692|564404621|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156356673|NCT01641692|564404622|FG007|Treatment Period 2|Withdrawal by Subject|1|||
156356674|NCT01641692|564404615|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356675|NCT01641692|564404616|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356676|NCT01641692|564404617|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356677|NCT01641692|564404618|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356678|NCT01641692|564404619|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
156356679|NCT01641692|564404620|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356680|NCT01641692|564404621|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
156356681|NCT01641692|564404622|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156356682|NCT01641692|564404615|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156356683|NCT01641692|564404616|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156356684|NCT01641692|564404617|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156356685|NCT01641692|564404618|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156356686|NCT01641692|564404619|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156356687|NCT01641692|564404620|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156356688|NCT01641692|564404621|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156356689|NCT01641692|564404622|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156544627|NCT00078325|565087818|FG002|Overall Study|Withdrawal by Subject|3|||
156544628|NCT00078325|565087816|FG000|Overall Study|Lost to Follow-up|0|||
156544629|NCT00078325|565087817|FG001|Overall Study|Lost to Follow-up|1|||
156544630|NCT00078325|565087818|FG002|Overall Study|Lost to Follow-up|1|||
156544631|NCT00078325|565087816|FG000|Overall Study|Physician Decision|2|||
156544632|NCT00078325|565087817|FG001|Overall Study|Physician Decision|0|||
156544633|NCT00078325|565087818|FG002|Overall Study|Physician Decision|1|||
156544634|NCT00078325|565087816|FG000|Overall Study|Miscellaneous|1|||
156544635|NCT00078325|565087817|FG001|Overall Study|Miscellaneous|1|||
156544636|NCT00078325|565087818|FG002|Overall Study|Miscellaneous|1|||
156544637|NCT00754793|565087822|FG000|Overall Study|voluntary withdrawn from study|0|||
156544638|NCT00754793|565087823|FG001|Overall Study|voluntary withdrawn from study|1|||
156544639|NCT00993265|565087825|FG000|Overall Study|Adverse Event|1|||
156544640|NCT00993265|565087826|FG001|Overall Study|Adverse Event|0|||
156544641|NCT00993265|565087825|FG000|Overall Study|Changed dose of concomitant drug|2|||
156544642|NCT00993265|565087826|FG001|Overall Study|Changed dose of concomitant drug|0|||
156544643|NCT00993265|565087825|FG000|Overall Study|Non-compliant with study medication|1|||
156544644|NCT00993265|565087826|FG001|Overall Study|Non-compliant with study medication|0|||
156544645|NCT03116698|565087829|FG000|Overall Study|Adverse Event|1|||
156544646|NCT03116698|565087830|FG001|Overall Study|Adverse Event|1|||
156544647|NCT03116698|565087831|FG002|Overall Study|Adverse Event|1|||
156544648|NCT03116698|565087832|FG003|Overall Study|Adverse Event|0|||
156544649|NCT03116698|565087829|FG000|Overall Study|Withdrawal by Subject|1|||
156544650|NCT03116698|565087830|FG001|Overall Study|Withdrawal by Subject|4|||
156544651|NCT03116698|565087831|FG002|Overall Study|Withdrawal by Subject|5|||
156544652|NCT03116698|565087832|FG003|Overall Study|Withdrawal by Subject|2|||
156544653|NCT03116698|565087829|FG000|Overall Study|Lost to Follow-up|2|||
156544654|NCT03116698|565087830|FG001|Overall Study|Lost to Follow-up|0|||
156544655|NCT03116698|565087831|FG002|Overall Study|Lost to Follow-up|0|||
156544656|NCT03116698|565087832|FG003|Overall Study|Lost to Follow-up|0|||
156544657|NCT03116698|565087829|FG000|Overall Study|Physician Decision|1|||
156544658|NCT03116698|565087830|FG001|Overall Study|Physician Decision|1|||
156544659|NCT03116698|565087831|FG002|Overall Study|Physician Decision|0|||
156544660|NCT03116698|565087832|FG003|Overall Study|Physician Decision|0|||
156544661|NCT03116698|565087829|FG000|Overall Study|Protocol Violation|1|||
156487787|NCT00550771|564880152|FG000|Overall Study|Discontinued for study-related reasons|0|||
156487788|NCT00550771|564880153|FG001|Overall Study|Discontinued for study-related reasons|1|||
156487789|NCT00550771|564880152|FG000|Overall Study|Physician Decision|2|||
156487790|NCT00550771|564880153|FG001|Overall Study|Physician Decision|0|||
156487791|NCT00550771|564880152|FG000|Overall Study|Withdrawal by Subject|0|||
156487792|NCT00550771|564880153|FG001|Overall Study|Withdrawal by Subject|1|||
156487793|NCT00550771|564880152|FG000|Overall Study|Protocol Violation|4|||
156487794|NCT00550771|564880153|FG001|Overall Study|Protocol Violation|5|||
156487795|NCT03022578|564880154|FG000|Overall Study|Adverse Event|1|||
156487796|NCT03022578|564880154|FG000|Overall Study|Lack of Efficacy|2|||
156487797|NCT03022578|564880154|FG000|Overall Study|Withdrawal by Subject|1|||
156487798|NCT03681353|564880155|FG000|Overall Study|Lost to Follow-up|2|||
156487799|NCT03681353|564880155|FG000|Overall Study|Withdrawal by Subject|3|||
156487800|NCT03681353|564880155|FG000|Overall Study|withdrawn by PI|2|||
156487801|NCT00111839|564880161|FG000|Overall Study|Disease Progression|30|||
156487802|NCT00111839|564880162|FG001|Overall Study|Disease Progression|33|||
156487803|NCT00111839|564880163|FG002|Overall Study|Disease Progression|33|||
156487804|NCT00111839|564880161|FG000|Overall Study|Adverse Event|5|||
156487805|NCT00111839|564880162|FG001|Overall Study|Adverse Event|3|||
156487806|NCT00111839|564880163|FG002|Overall Study|Adverse Event|1|||
156487807|NCT00111839|564880161|FG000|Overall Study|Protocol Violation|2|||
156487808|NCT00111839|564880162|FG001|Overall Study|Protocol Violation|4|||
156487809|NCT00111839|564880163|FG002|Overall Study|Protocol Violation|2|||
156487810|NCT00111839|564880161|FG000|Overall Study|Death|1|||
156487811|NCT00111839|564880162|FG001|Overall Study|Death|1|||
156356690|NCT01641692|564404615|FG000|Treatment Period 3|Adverse Event|0|||
156356691|NCT01641692|564404616|FG001|Treatment Period 3|Adverse Event|0|||
156356692|NCT01641692|564404617|FG002|Treatment Period 3|Adverse Event|0|||
156356693|NCT01641692|564404618|FG003|Treatment Period 3|Adverse Event|0|||
156356694|NCT01641692|564404619|FG004|Treatment Period 3|Adverse Event|0|||
156356695|NCT01641692|564404620|FG005|Treatment Period 3|Adverse Event|0|||
156356696|NCT01641692|564404621|FG006|Treatment Period 3|Adverse Event|1|||
156356697|NCT01641692|564404622|FG007|Treatment Period 3|Adverse Event|0|||
156356698|NCT01641692|564404615|FG000|Treatment Period 3|Protocol Violation|0|||
156356699|NCT01641692|564404616|FG001|Treatment Period 3|Protocol Violation|0|||
156356700|NCT01641692|564404617|FG002|Treatment Period 3|Protocol Violation|1|||
156356701|NCT01641692|564404618|FG003|Treatment Period 3|Protocol Violation|0|||
156356702|NCT01641692|564404619|FG004|Treatment Period 3|Protocol Violation|0|||
156356703|NCT01641692|564404620|FG005|Treatment Period 3|Protocol Violation|0|||
156356704|NCT01641692|564404621|FG006|Treatment Period 3|Protocol Violation|0|||
156356705|NCT01641692|564404622|FG007|Treatment Period 3|Protocol Violation|0|||
156356706|NCT01641692|564404615|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156356707|NCT01641692|564404616|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156356708|NCT01641692|564404617|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156356709|NCT01641692|564404618|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156356710|NCT01641692|564404619|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156356711|NCT01641692|564404620|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156356712|NCT01641692|564404621|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
156356713|NCT01641692|564404622|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156356714|NCT01641692|564404615|FG000|Treatment Period 3|Lost to Follow-up|0|||
156356715|NCT01641692|564404616|FG001|Treatment Period 3|Lost to Follow-up|1|||
156356716|NCT01641692|564404617|FG002|Treatment Period 3|Lost to Follow-up|0|||
156356717|NCT01641692|564404618|FG003|Treatment Period 3|Lost to Follow-up|0|||
156356718|NCT01641692|564404619|FG004|Treatment Period 3|Lost to Follow-up|0|||
156356719|NCT01641692|564404620|FG005|Treatment Period 3|Lost to Follow-up|0|||
156356720|NCT01641692|564404621|FG006|Treatment Period 3|Lost to Follow-up|0|||
156356721|NCT01641692|564404622|FG007|Treatment Period 3|Lost to Follow-up|0|||
156356722|NCT01641692|564404615|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
156356723|NCT01641692|564404616|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
156356724|NCT01641692|564404617|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
156356725|NCT01641692|564404618|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
156356726|NCT01641692|564404619|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
156356727|NCT01641692|564404620|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
156356728|NCT01641692|564404621|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
156356729|NCT01641692|564404622|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
156356730|NCT01641692|564404615|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156356731|NCT01641692|564404616|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
156356732|NCT01641692|564404617|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156356733|NCT01641692|564404618|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156356734|NCT01641692|564404619|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
156356735|NCT01641692|564404620|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156356736|NCT01641692|564404621|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156356737|NCT01641692|564404622|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
156356738|NCT01166178|564404623|FG000|Overall Study|Withdrawal by Subject|1|||
156356739|NCT01166178|564404624|FG001|Overall Study|Withdrawal by Subject|0|||
156356740|NCT01166178|564404623|FG000|Overall Study|Study was terminated|20|||
156356741|NCT01166178|564404624|FG001|Overall Study|Study was terminated|8|||
156356742|NCT01474876|564404629|FG000|Overall Study|Adverse Event|11|||
156356743|NCT01474876|564404630|FG001|Overall Study|Adverse Event|5|||
156356744|NCT01474876|564404631|FG002|Overall Study|Adverse Event|0|||
156356745|NCT01474876|564404629|FG000|Overall Study|Serious Adverse Event|2|||
156356746|NCT01474876|564404630|FG001|Overall Study|Serious Adverse Event|3|||
156356747|NCT01474876|564404631|FG002|Overall Study|Serious Adverse Event|0|||
156356748|NCT01474876|564404629|FG000|Overall Study|Lost to Follow-up|5|||
156356749|NCT01474876|564404630|FG001|Overall Study|Lost to Follow-up|4|||
156544662|NCT03116698|565087830|FG001|Overall Study|Protocol Violation|0|||
156356750|NCT01474876|564404631|FG002|Overall Study|Lost to Follow-up|0|||
156356751|NCT01474876|564404629|FG000|Overall Study|Investigator's decision|28|||
156356752|NCT01474876|564404630|FG001|Overall Study|Investigator's decision|6|||
156356753|NCT01474876|564404631|FG002|Overall Study|Investigator's decision|0|||
156356754|NCT01474876|564404629|FG000|Overall Study|Patient's request|19|||
156356755|NCT01474876|564404630|FG001|Overall Study|Patient's request|5|||
156356756|NCT01474876|564404631|FG002|Overall Study|Patient's request|0|||
156356757|NCT01474876|564404629|FG000|Overall Study|Investigator's decision and pt request|1|||
156356758|NCT01474876|564404630|FG001|Overall Study|Investigator's decision and pt request|0|||
156356759|NCT01474876|564404631|FG002|Overall Study|Investigator's decision and pt request|0|||
156356760|NCT02291055|564404632|FG000|Overall Study|Death|2|||
156356761|NCT02291055|564404633|FG001|Overall Study|Death|2|||
156356762|NCT02291055|564404634|FG002|Overall Study|Death|5|||
156356763|NCT02291055|564404635|FG003|Overall Study|Death|8|||
156356764|NCT02291055|564404636|FG004|Overall Study|Death|12|||
156356765|NCT02291055|564404632|FG000|Overall Study|Lost to Follow-up|0|||
156356766|NCT02291055|564404633|FG001|Overall Study|Lost to Follow-up|0|||
156356767|NCT02291055|564404634|FG002|Overall Study|Lost to Follow-up|0|||
156356768|NCT02291055|564404635|FG003|Overall Study|Lost to Follow-up|1|||
156356769|NCT02291055|564404636|FG004|Overall Study|Lost to Follow-up|2|||
156356770|NCT02291055|564404632|FG000|Overall Study|Withdrawal by Subject|3|||
156356771|NCT02291055|564404633|FG001|Overall Study|Withdrawal by Subject|1|||
156356772|NCT02291055|564404634|FG002|Overall Study|Withdrawal by Subject|1|||
156356773|NCT02291055|564404635|FG003|Overall Study|Withdrawal by Subject|5|||
156356774|NCT02291055|564404636|FG004|Overall Study|Withdrawal by Subject|10|||
156356775|NCT02291055|564404632|FG000|Overall Study|Progressive Disease|0|||
156356776|NCT02291055|564404633|FG001|Overall Study|Progressive Disease|0|||
156356777|NCT02291055|564404634|FG002|Overall Study|Progressive Disease|1|||
156356778|NCT02291055|564404635|FG003|Overall Study|Progressive Disease|4|||
156356779|NCT02291055|564404636|FG004|Overall Study|Progressive Disease|2|||
156356780|NCT02291055|564404632|FG000|Overall Study|Study Terminated by Sponsor|0|||
156356781|NCT02291055|564404633|FG001|Overall Study|Study Terminated by Sponsor|0|||
156356782|NCT02291055|564404634|FG002|Overall Study|Study Terminated by Sponsor|0|||
156356783|NCT02291055|564404635|FG003|Overall Study|Study Terminated by Sponsor|5|||
156356784|NCT02291055|564404636|FG004|Overall Study|Study Terminated by Sponsor|1|||
156356785|NCT02291055|564404632|FG000|Overall Study|Other|0|||
156356786|NCT02291055|564404633|FG001|Overall Study|Other|2|||
156356787|NCT02291055|564404634|FG002|Overall Study|Other|1|||
156356788|NCT02291055|564404635|FG003|Overall Study|Other|4|||
156356789|NCT02291055|564404636|FG004|Overall Study|Other|0|||
156356790|NCT01523886|564404637|FG000|Overall Study|surgery cancelled|0|||
156356791|NCT01523886|564404638|FG001|Overall Study|surgery cancelled|1|||
156356792|NCT02113956|564404645|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
156356793|NCT02113956|564404646|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
156356794|NCT02113956|564404645|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
156356795|NCT02113956|564404646|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
156356796|NCT02113956|564404645|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
156356797|NCT02113956|564404646|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
156356798|NCT01499563|564404649|FG000|Overall Study|Withdrawal by Subject|10|||
156356799|NCT01499563|564404650|FG001|Overall Study|Withdrawal by Subject|11|||
156356800|NCT01499563|564404651|FG002|Overall Study|Withdrawal by Subject|7|||
156356801|NCT01499563|564404652|FG003|Overall Study|Withdrawal by Subject|8|||
156356802|NCT01499563|564404649|FG000|Overall Study|Physician Decision|2|||
156356803|NCT01499563|564404650|FG001|Overall Study|Physician Decision|1|||
156356804|NCT01499563|564404651|FG002|Overall Study|Physician Decision|3|||
156356805|NCT01499563|564404652|FG003|Overall Study|Physician Decision|0|||
156356806|NCT01499563|564404649|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
156356807|NCT01499563|564404650|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
156356808|NCT01499563|564404651|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
156356809|NCT01499563|564404652|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
156356810|NCT01499563|564404649|FG000|Overall Study|Adverse Event|2|||
156356811|NCT01499563|564404650|FG001|Overall Study|Adverse Event|0|||
156356812|NCT01499563|564404651|FG002|Overall Study|Adverse Event|1|||
156356813|NCT01499563|564404652|FG003|Overall Study|Adverse Event|3|||
156356814|NCT01499563|564404649|FG000|Overall Study|Lack of Efficacy|0|||
156356815|NCT01499563|564404650|FG001|Overall Study|Lack of Efficacy|1|||
156356816|NCT01499563|564404651|FG002|Overall Study|Lack of Efficacy|6|||
156356817|NCT01499563|564404652|FG003|Overall Study|Lack of Efficacy|3|||
156356818|NCT01499563|564404649|FG000|Overall Study|Other|8|||
156356819|NCT01499563|564404650|FG001|Overall Study|Other|6|||
156356820|NCT01499563|564404651|FG002|Overall Study|Other|6|||
156487812|NCT00111839|564880163|FG002|Overall Study|Death|6|||
156487813|NCT00111839|564880161|FG000|Overall Study|Withdrawal by Subject|2|||
156487814|NCT00111839|564880162|FG001|Overall Study|Withdrawal by Subject|2|||
156487815|NCT00111839|564880163|FG002|Overall Study|Withdrawal by Subject|2|||
156487816|NCT00111839|564880161|FG000|Overall Study|Lost to Follow-up|1|||
156356821|NCT01499563|564404652|FG003|Overall Study|Other|4|||
156356822|NCT03658538|564404653|FG000|Overall Study|Death|2|||
156356823|NCT03658538|564404654|FG001|Overall Study|Death|1|||
156356824|NCT03658538|564404653|FG000|Overall Study|Cancer diagnosis|1|||
156356825|NCT03658538|564404654|FG001|Overall Study|Cancer diagnosis|0|||
156356826|NCT03658538|564404653|FG000|Overall Study|Change residence|1|||
156356827|NCT03658538|564404654|FG001|Overall Study|Change residence|2|||
156356828|NCT03658538|564404653|FG000|Overall Study|Lost to Follow-up|3|||
156356829|NCT03658538|564404654|FG001|Overall Study|Lost to Follow-up|3|||
156487817|NCT00111839|564880162|FG001|Overall Study|Lost to Follow-up|0|||
156487818|NCT00111839|564880163|FG002|Overall Study|Lost to Follow-up|0|||
156487819|NCT00111839|564880161|FG000|Overall Study|Logistical Constraint|1|||
156487820|NCT00111839|564880162|FG001|Overall Study|Logistical Constraint|0|||
156487821|NCT00111839|564880163|FG002|Overall Study|Logistical Constraint|0|||
156487822|NCT00111839|564880161|FG000|Overall Study|Other|6|||
156487823|NCT00111839|564880162|FG001|Overall Study|Other|3|||
156487824|NCT00111839|564880163|FG002|Overall Study|Other|3|||
156487825|NCT00111839|564880161|FG000|Overall Study|Randomized but Not Treated|0|||
156487826|NCT00111839|564880162|FG001|Overall Study|Randomized but Not Treated|0|||
156487827|NCT00111839|564880163|FG002|Overall Study|Randomized but Not Treated|2|||
156487828|NCT00520403|564880164|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
156487829|NCT00520403|564880164|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
156487830|NCT00520403|564880164|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
156487831|NCT00520403|564880164|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
156487832|NCT00520403|564880164|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
156487833|NCT00520403|564880164|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
156487834|NCT00520403|564880164|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
156487835|NCT00520403|564880164|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
156487836|NCT01145417|564880165|FG000|Overall Study|Death|1|||
156487837|NCT01145417|564880166|FG001|Overall Study|Death|0|||
156487838|NCT01145417|564880165|FG000|Overall Study|Lost to Follow-up|2|||
156487839|NCT01145417|564880166|FG001|Overall Study|Lost to Follow-up|1|||
156487840|NCT01145417|564880165|FG000|Overall Study|Withdrawal by Subject|1|||
156487841|NCT01145417|564880166|FG001|Overall Study|Withdrawal by Subject|2|||
156487842|NCT01145417|564880165|FG000|Overall Study|Pregnancy|1|||
156487843|NCT01145417|564880166|FG001|Overall Study|Pregnancy|0|||
156487844|NCT01145417|564880165|FG000|Overall Study|Adverse Event|0|||
156487845|NCT01145417|564880166|FG001|Overall Study|Adverse Event|1|||
156487846|NCT01145417|564880165|FG000|Overall Study|Study terminated by sponsor|35|||
156487847|NCT01145417|564880166|FG001|Overall Study|Study terminated by sponsor|43|||
156487848|NCT01145417|564880165|FG000|Overall Study|Other|1|||
156356830|NCT03658538|564404653|FG000|Overall Study|Unblinded|2|||
156356831|NCT03658538|564404654|FG001|Overall Study|Unblinded|3|||
156356832|NCT03658538|564404653|FG000|Overall Study|Physician Decision|0|||
156356833|NCT03658538|564404654|FG001|Overall Study|Physician Decision|1|||
156356834|NCT03658538|564404653|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
156356835|NCT03658538|564404654|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
156356836|NCT03658538|564404653|FG000|Overall Study|Evicted from home|1|||
156356837|NCT03658538|564404654|FG001|Overall Study|Evicted from home|0|||
156356838|NCT03333044|564404656|FG000|Overall Study|Pregnancy|1|||
156356839|NCT03333044|564404657|FG001|Overall Study|Pregnancy|0|||
156356840|NCT03333044|564404658|FG002|Overall Study|Pregnancy|0|||
156356841|NCT03333044|564404656|FG000|Overall Study|Lost to Follow-up|0|||
156356842|NCT03333044|564404657|FG001|Overall Study|Lost to Follow-up|14|||
156356843|NCT03333044|564404658|FG002|Overall Study|Lost to Follow-up|6|||
156356844|NCT02921776|564404659|FG000|Overall Study|patient deterioration, fatigue|2|||
156356845|NCT02921776|564404660|FG001|Overall Study|patient deterioration, fatigue|6|||
156356846|NCT02921776|564404661|FG002|Overall Study|patient deterioration, fatigue|0|||
156356847|NCT02921776|564404662|FG003|Overall Study|patient deterioration, fatigue|0|||
156356848|NCT02921776|564404663|FG004|Overall Study|patient deterioration, fatigue|0|||
156356849|NCT02921776|564404664|FG005|Overall Study|patient deterioration, fatigue|0|||
156356850|NCT02921776|564404665|FG006|Overall Study|patient deterioration, fatigue|0|||
156356851|NCT02921776|564404666|FG007|Overall Study|patient deterioration, fatigue|0|||
156356852|NCT02921776|564404659|FG000|Overall Study|Withdrawal by Subject|0|||
156356853|NCT02921776|564404660|FG001|Overall Study|Withdrawal by Subject|2|||
156356854|NCT02921776|564404661|FG002|Overall Study|Withdrawal by Subject|0|||
156356855|NCT02921776|564404662|FG003|Overall Study|Withdrawal by Subject|1|||
156356856|NCT02921776|564404663|FG004|Overall Study|Withdrawal by Subject|1|||
156356857|NCT02921776|564404664|FG005|Overall Study|Withdrawal by Subject|0|||
156356858|NCT02921776|564404665|FG006|Overall Study|Withdrawal by Subject|8|||
156356859|NCT02921776|564404666|FG007|Overall Study|Withdrawal by Subject|1|||
156356860|NCT02921776|564404659|FG000|Overall Study|Death|0|||
156356861|NCT02921776|564404660|FG001|Overall Study|Death|0|||
156356862|NCT02921776|564404661|FG002|Overall Study|Death|0|||
156356863|NCT02921776|564404662|FG003|Overall Study|Death|2|||
156356864|NCT02921776|564404663|FG004|Overall Study|Death|0|||
156356865|NCT02921776|564404664|FG005|Overall Study|Death|0|||
156356866|NCT02921776|564404665|FG006|Overall Study|Death|0|||
156356867|NCT02921776|564404666|FG007|Overall Study|Death|0|||
156356868|NCT02921776|564404659|FG000|Overall Study|extubation or early discharge|0|||
156356869|NCT02921776|564404660|FG001|Overall Study|extubation or early discharge|0|||
156356870|NCT02921776|564404661|FG002|Overall Study|extubation or early discharge|0|||
156356871|NCT02921776|564404662|FG003|Overall Study|extubation or early discharge|5|||
156356872|NCT02921776|564404663|FG004|Overall Study|extubation or early discharge|5|||
156356873|NCT02921776|564404664|FG005|Overall Study|extubation or early discharge|0|||
156356874|NCT02921776|564404665|FG006|Overall Study|extubation or early discharge|0|||
156356875|NCT02921776|564404666|FG007|Overall Study|extubation or early discharge|0|||
156356876|NCT02921776|564404659|FG000|Overall Study|Lost to Follow-up|0|||
156356877|NCT02921776|564404660|FG001|Overall Study|Lost to Follow-up|0|||
156356878|NCT02921776|564404661|FG002|Overall Study|Lost to Follow-up|0|||
156356879|NCT02921776|564404662|FG003|Overall Study|Lost to Follow-up|0|||
156356880|NCT02921776|564404663|FG004|Overall Study|Lost to Follow-up|0|||
156356881|NCT02921776|564404664|FG005|Overall Study|Lost to Follow-up|2|||
156356882|NCT02921776|564404665|FG006|Overall Study|Lost to Follow-up|3|||
156356883|NCT02921776|564404666|FG007|Overall Study|Lost to Follow-up|6|||
156356884|NCT04537234|564404668|FG000|Overall Study|Withdrawal by Subject|2|||
156356885|NCT04537234|564404669|FG001|Overall Study|Withdrawal by Subject|0|||
156356886|NCT02070744|564404670|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
156356887|NCT02070744|564404671|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
156356888|NCT02070744|564404672|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
156356889|NCT02070744|564404673|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
156356890|NCT02070744|564404674|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
156356891|NCT02070744|564404670|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
156356892|NCT02070744|564404671|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
156356893|NCT02070744|564404672|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
156356894|NCT02070744|564404673|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
156356895|NCT02070744|564404674|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
156356896|NCT02070744|564404670|FG000|OLE Phase (48 Weeks)|Other|0|||
156356897|NCT02070744|564404671|FG001|OLE Phase (48 Weeks)|Other|0|||
156356898|NCT02070744|564404672|FG002|OLE Phase (48 Weeks)|Other|0|||
156356899|NCT02070744|564404673|FG003|OLE Phase (48 Weeks)|Other|0|||
156356900|NCT02070744|564404674|FG004|OLE Phase (48 Weeks)|Other|1|||
156356901|NCT04318080|564407611|FG000|Overall Study|Study closed by sponsor|10|||
156356902|NCT04318080|564407612|FG001|Overall Study|Study closed by sponsor|22|||
156356903|NCT04318080|564407611|FG000|Overall Study|Death|3|||
156356904|NCT04318080|564407612|FG001|Overall Study|Death|9|||
156356905|NCT04318080|564407611|FG000|Overall Study|Withdrawal by Subject|1|||
156356906|NCT04318080|564407612|FG001|Overall Study|Withdrawal by Subject|0|||
156356907|NCT04318080|564407611|FG000|Overall Study|Protocol Deviation|1|||
156356908|NCT04318080|564407612|FG001|Overall Study|Protocol Deviation|0|||
156544663|NCT03116698|565087831|FG002|Overall Study|Protocol Violation|0|||
156356909|NCT06308822|564407613|FG000|Overall Study|Mutation Status Not Confirmed|17|||
156356910|NCT06308822|564407613|FG000|Overall Study|Adverse Event|1|||
156356911|NCT06308822|564407613|FG000|Overall Study|Death|5|||
156356912|NCT06308822|564407613|FG000|Overall Study|Disease progression|8|||
156356913|NCT06308822|564407613|FG000|Overall Study|Withdrawal by Subject|1|||
156356914|NCT06308822|564407613|FG000|Overall Study|Physician Decision|3|||
156356915|NCT01536379|564407614|FG000|Overall Study|Adverse Event|1|||
156356916|NCT01536379|564407615|FG001|Overall Study|Adverse Event|2|||
156356917|NCT01536379|564407614|FG000|Overall Study|Withdrawal by Subject|1|||
156356918|NCT01536379|564407615|FG001|Overall Study|Withdrawal by Subject|1|||
156356919|NCT00939809|564407618|FG000|Overall Study|Adverse Event|2|||
156356920|NCT00939809|564407618|FG000|Overall Study|Death|1|||
156356921|NCT02356783|564407619|FG000|Overall Study|Lost to Follow-up|1|||
156356922|NCT02356783|564407620|FG001|Overall Study|Lost to Follow-up|3|||
156356923|NCT02603809|564407621|FG000|Overall Study|Withdrawal by Subject|4|||
156356924|NCT02603809|564407622|FG001|Overall Study|Withdrawal by Subject|1|||
156356925|NCT02603809|564407623|FG002|Overall Study|Withdrawal by Subject|2|||
156356926|NCT02603809|564407624|FG003|Overall Study|Withdrawal by Subject|3|||
156356927|NCT02603809|564407625|FG004|Overall Study|Withdrawal by Subject|3|||
156356928|NCT02603809|564407626|FG005|Overall Study|Withdrawal by Subject|4|||
156356929|NCT02603809|564407621|FG000|Overall Study|Lost to Follow-up|2|||
156356930|NCT02603809|564407622|FG001|Overall Study|Lost to Follow-up|3|||
156356931|NCT02603809|564407623|FG002|Overall Study|Lost to Follow-up|1|||
156356932|NCT02603809|564407624|FG003|Overall Study|Lost to Follow-up|4|||
156356933|NCT02603809|564407625|FG004|Overall Study|Lost to Follow-up|2|||
156356934|NCT02603809|564407626|FG005|Overall Study|Lost to Follow-up|2|||
156356935|NCT02603809|564407621|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
156356936|NCT02603809|564407622|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
156356937|NCT02603809|564407623|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
156356938|NCT02603809|564407624|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
156356939|NCT02603809|564407625|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
156356940|NCT02603809|564407626|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
156356941|NCT02603809|564407621|FG000|Overall Study|Physician Decision|0|||
156356942|NCT02603809|564407622|FG001|Overall Study|Physician Decision|0|||
156356943|NCT02603809|564407623|FG002|Overall Study|Physician Decision|0|||
156356944|NCT02603809|564407624|FG003|Overall Study|Physician Decision|1|||
156356945|NCT02603809|564407625|FG004|Overall Study|Physician Decision|2|||
156356946|NCT02603809|564407626|FG005|Overall Study|Physician Decision|1|||
156356947|NCT02603809|564407621|FG000|Overall Study|Adverse Event|3|||
156356948|NCT02603809|564407622|FG001|Overall Study|Adverse Event|0|||
156356949|NCT02603809|564407623|FG002|Overall Study|Adverse Event|2|||
156487849|NCT01145417|564880166|FG001|Overall Study|Other|0|||
156487850|NCT03924947|564880167|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
156487851|NCT03924947|564880168|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
156544664|NCT03116698|565087832|FG003|Overall Study|Protocol Violation|0|||
156356950|NCT02603809|564407624|FG003|Overall Study|Adverse Event|2|||
156487852|NCT03924947|564880169|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
156487853|NCT03924947|564880170|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
156544665|NCT03116698|565087829|FG000|Overall Study|Death|0|||
156356951|NCT02603809|564407625|FG004|Overall Study|Adverse Event|1|||
156356952|NCT02603809|564407626|FG005|Overall Study|Adverse Event|1|||
156487854|NCT03924947|564880171|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
156487855|NCT03924947|564880172|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
156487856|NCT01797562|564880173|FG000|Overall Study|Protocol Violation|5|||
156487857|NCT00805285|564880178|FG000|Overall Study|Lack of Efficacy|1|||
156487858|NCT01441583|564880179|FG000|Overall Study|Withdrawal by Subject|1|||
156487859|NCT01441583|564880180|FG001|Overall Study|Withdrawal by Subject|1|||
156487860|NCT01441583|564880181|FG002|Overall Study|Withdrawal by Subject|1|||
156487861|NCT01441583|564880179|FG000|Overall Study|Death|1|||
156487862|NCT01441583|564880180|FG001|Overall Study|Death|0|||
156356953|NCT02603809|564407621|FG000|Overall Study|Lack of Efficacy|0|||
156356954|NCT02603809|564407622|FG001|Overall Study|Lack of Efficacy|1|||
156544666|NCT03116698|565087830|FG001|Overall Study|Death|0|||
156544667|NCT03116698|565087831|FG002|Overall Study|Death|2|||
156356955|NCT02603809|564407623|FG002|Overall Study|Lack of Efficacy|0|||
156544668|NCT03116698|565087832|FG003|Overall Study|Death|0|||
156544669|NCT01246583|565087835|FG000|Overall Study|Lost to Follow-up|0|||
156544670|NCT01246583|565087836|FG001|Overall Study|Lost to Follow-up|0|||
156544671|NCT01246583|565087837|FG002|Overall Study|Lost to Follow-up|0|||
156487863|NCT01441583|564880181|FG002|Overall Study|Death|4|||
156487864|NCT01441583|564880179|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
156487865|NCT01441583|564880180|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
156487866|NCT01441583|564880181|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
156487867|NCT00839306|564880185|FG000|Overall Study|Adverse Event|3|||
156487868|NCT00839306|564880186|FG001|Overall Study|Adverse Event|5|||
156487869|NCT00839306|564880185|FG000|Overall Study|Lost to Follow-up|6|||
156487870|NCT00839306|564880186|FG001|Overall Study|Lost to Follow-up|9|||
156487871|NCT00839306|564880185|FG000|Overall Study|Withdrawal by Subject|5|||
156487872|NCT00839306|564880186|FG001|Overall Study|Withdrawal by Subject|7|||
156356956|NCT02603809|564407624|FG003|Overall Study|Lack of Efficacy|0|||
156356957|NCT02603809|564407625|FG004|Overall Study|Lack of Efficacy|0|||
156356958|NCT02603809|564407626|FG005|Overall Study|Lack of Efficacy|1|||
156356959|NCT00380978|564407627|FG000|Overall Study|Refused allocated intervention|0|||
156356960|NCT00380978|564407628|FG001|Overall Study|Refused allocated intervention|6|||
156356961|NCT00380978|564407627|FG000|Overall Study|Wrong study envelope|0|||
156356962|NCT00380978|564407628|FG001|Overall Study|Wrong study envelope|2|||
156356963|NCT00380978|564407627|FG000|Overall Study|Allocation prior to analgesia request|1|||
156356964|NCT00380978|564407628|FG001|Overall Study|Allocation prior to analgesia request|2|||
156356965|NCT00380978|564407627|FG000|Overall Study|Parous patient|1|||
156356966|NCT00380978|564407628|FG001|Overall Study|Parous patient|0|||
156356967|NCT04146545|564407629|FG000|Overall Study|deemed ineligible after randomization|1|||
156356968|NCT04146545|564407630|FG001|Overall Study|deemed ineligible after randomization|0|||
156356969|NCT04729127|564407631|FG000|Overall Study|Suspended/Terminated EI Services|4|||
156356970|NCT04729127|564407632|FG001|Overall Study|Suspended/Terminated EI Services|0|||
156356971|NCT04729127|564407633|FG002|Overall Study|Suspended/Terminated EI Services|4|||
156356972|NCT04729127|564407634|FG003|Overall Study|Suspended/Terminated EI Services|6|||
156356973|NCT04729127|564407635|FG004|Overall Study|Suspended/Terminated EI Services|0|||
156356974|NCT04729127|564407636|FG005|Overall Study|Suspended/Terminated EI Services|6|||
156356975|NCT04729127|564407637|FG006|Overall Study|Suspended/Terminated EI Services|2|||
156356976|NCT04729127|564407638|FG007|Overall Study|Suspended/Terminated EI Services|0|||
156487873|NCT00839306|564880185|FG000|Overall Study|Lack of Efficacy|5|||
156487874|NCT00839306|564880186|FG001|Overall Study|Lack of Efficacy|4|||
156487875|NCT00839306|564880185|FG000|Overall Study|Other|6|||
156487876|NCT00839306|564880186|FG001|Overall Study|Other|18|||
156487877|NCT01812707|564880187|FG000|Overall Study|Adverse Event|0|||
156487878|NCT01812707|564880188|FG001|Overall Study|Adverse Event|0|||
156487879|NCT01812707|564880189|FG002|Overall Study|Adverse Event|0|||
156487880|NCT01812707|564880190|FG003|Overall Study|Adverse Event|2|||
156356977|NCT04729127|564407639|FG008|Overall Study|Suspended/Terminated EI Services|2|||
156356978|NCT04729127|564407631|FG000|Overall Study|Withdrawal by Subject|1|||
156487881|NCT01812707|564880187|FG000|Overall Study|Poor compliance to protocol|1|||
156544672|NCT01246583|565087838|FG003|Overall Study|Lost to Follow-up|1|||
156544673|NCT01246583|565087835|FG000|Overall Study|Protocol Violation|0|||
156544674|NCT01246583|565087836|FG001|Overall Study|Protocol Violation|0|||
156544675|NCT01246583|565087837|FG002|Overall Study|Protocol Violation|1|||
156356979|NCT04729127|564407632|FG001|Overall Study|Withdrawal by Subject|0|||
156356980|NCT04729127|564407633|FG002|Overall Study|Withdrawal by Subject|1|||
156356981|NCT04729127|564407634|FG003|Overall Study|Withdrawal by Subject|0|||
156356982|NCT04729127|564407635|FG004|Overall Study|Withdrawal by Subject|0|||
156356983|NCT04729127|564407636|FG005|Overall Study|Withdrawal by Subject|0|||
156487882|NCT01812707|564880188|FG001|Overall Study|Poor compliance to protocol|0|||
156487883|NCT01812707|564880189|FG002|Overall Study|Poor compliance to protocol|0|||
156487884|NCT01812707|564880190|FG003|Overall Study|Poor compliance to protocol|0|||
156487885|NCT01812707|564880187|FG000|Overall Study|Consent withdrawn by participant|1|||
156487886|NCT01812707|564880188|FG001|Overall Study|Consent withdrawn by participant|0|||
156487887|NCT01812707|564880189|FG002|Overall Study|Consent withdrawn by participant|0|||
156487888|NCT01812707|564880190|FG003|Overall Study|Consent withdrawn by participant|0|||
156487889|NCT05060237|564880192|FG000|Overall Study|Withdrawal by Subject|4|||
156487890|NCT05060237|564880192|FG000|Overall Study|Screening failure|8|||
156487891|NCT01066897|564880193|FG000|Overall Study|Withdrawal by Subject|1|||
156487892|NCT01066897|564880194|FG001|Overall Study|Withdrawal by Subject|0|||
156487893|NCT01066897|564880193|FG000|Overall Study|stopped study after developing the flu.|1|||
156487894|NCT01066897|564880194|FG001|Overall Study|stopped study after developing the flu.|0|||
156487895|NCT01697592|564880195|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
156487896|NCT01697592|564880196|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487897|NCT01697592|564880197|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487898|NCT01697592|564880198|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487899|NCT01697592|564880199|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487900|NCT01697592|564880200|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487901|NCT01697592|564880201|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487902|NCT01697592|564880202|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487903|NCT01697592|564880203|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487904|NCT01697592|564880204|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
156487905|NCT01697592|564880195|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487906|NCT01697592|564880196|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487907|NCT01697592|564880197|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487908|NCT01697592|564880198|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487909|NCT01697592|564880199|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487910|NCT01697592|564880200|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
156487911|NCT01697592|564880201|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487912|NCT01697592|564880202|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487913|NCT01697592|564880203|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487914|NCT01697592|564880204|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156487915|NCT01697592|564880195|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
156487916|NCT01697592|564880196|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487917|NCT01697592|564880197|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487918|NCT01697592|564880198|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487919|NCT01697592|564880199|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487920|NCT01697592|564880200|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487921|NCT01697592|564880201|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487922|NCT01697592|564880202|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487923|NCT01697592|564880203|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487924|NCT01697592|564880204|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156487925|NCT01697592|564880195|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
156487926|NCT01697592|564880196|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
156487927|NCT01697592|564880197|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
156487928|NCT01697592|564880198|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
156487929|NCT01697592|564880199|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
156487930|NCT01697592|564880200|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
156487931|NCT01697592|564880201|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
156487932|NCT01697592|564880202|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
156487933|NCT01697592|564880203|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
156487934|NCT01697592|564880204|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
156487935|NCT01697592|564880195|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
156487936|NCT01697592|564880196|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
156487937|NCT01697592|564880197|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
156487938|NCT01697592|564880198|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
156487939|NCT01697592|564880199|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
156487940|NCT01697592|564880200|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
156487941|NCT01697592|564880201|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
156487942|NCT01697592|564880202|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
156487943|NCT01697592|564880203|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
156487944|NCT01697592|564880204|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
156487945|NCT01697592|564880195|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
156487946|NCT01697592|564880196|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
156487947|NCT01697592|564880197|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
156487948|NCT01697592|564880198|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
156544676|NCT01246583|565087838|FG003|Overall Study|Protocol Violation|0|||
156544677|NCT01246583|565087835|FG000|Overall Study|Withdrawal by Subject|1|||
156544678|NCT01246583|565087836|FG001|Overall Study|Withdrawal by Subject|0|||
156544679|NCT01246583|565087837|FG002|Overall Study|Withdrawal by Subject|0|||
156487949|NCT01697592|564880199|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
156487950|NCT01697592|564880200|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
156487951|NCT01697592|564880201|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
156487952|NCT01697592|564880202|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
156356984|NCT04729127|564407637|FG006|Overall Study|Withdrawal by Subject|0|||
156356985|NCT04729127|564407638|FG007|Overall Study|Withdrawal by Subject|0|||
156356986|NCT04729127|564407639|FG008|Overall Study|Withdrawal by Subject|0|||
156356987|NCT04729127|564407631|FG000|Overall Study|Switched Agency/Setting|1|||
156356988|NCT04729127|564407632|FG001|Overall Study|Switched Agency/Setting|0|||
156356989|NCT04729127|564407633|FG002|Overall Study|Switched Agency/Setting|1|||
156356990|NCT04729127|564407634|FG003|Overall Study|Switched Agency/Setting|1|||
156356991|NCT04729127|564407635|FG004|Overall Study|Switched Agency/Setting|0|||
156356992|NCT04729127|564407636|FG005|Overall Study|Switched Agency/Setting|1|||
156356993|NCT04729127|564407637|FG006|Overall Study|Switched Agency/Setting|1|||
156356994|NCT04729127|564407638|FG007|Overall Study|Switched Agency/Setting|0|||
156356995|NCT04729127|564407639|FG008|Overall Study|Switched Agency/Setting|1|||
156356996|NCT00112502|564407642|FG000|Overall Study|Withdrawal by Subject|0|||
156356997|NCT00112502|564407643|FG001|Overall Study|Withdrawal by Subject|1|||
156356998|NCT00112502|564407644|FG002|Overall Study|Withdrawal by Subject|1|||
156356999|NCT00112502|564407645|FG003|Overall Study|Withdrawal by Subject|4|||
156357000|NCT00112502|564407646|FG004|Overall Study|Withdrawal by Subject|2|||
156357001|NCT00112502|564407647|FG005|Overall Study|Withdrawal by Subject|5|||
156357002|NCT00112502|564407648|FG006|Overall Study|Withdrawal by Subject|3|||
156357003|NCT00112502|564407649|FG007|Overall Study|Withdrawal by Subject|7|||
156357004|NCT00265343|564407650|FG000|Overall Study|Adverse Event|10|||
156357005|NCT00265343|564407651|FG001|Overall Study|Adverse Event|7|||
156357006|NCT00265343|564407650|FG000|Overall Study|Withdrawal by Subject|3|||
156357007|NCT00265343|564407651|FG001|Overall Study|Withdrawal by Subject|9|||
156357008|NCT00265343|564407650|FG000|Overall Study|Other|8|||
156357009|NCT00265343|564407651|FG001|Overall Study|Other|3|||
156357010|NCT02608268|564407652|FG000|Overall Study|Adverse Event|0|||
156357011|NCT02608268|564407653|FG001|Overall Study|Adverse Event|0|||
156357012|NCT02608268|564407654|FG002|Overall Study|Adverse Event|1|||
156357013|NCT02608268|564407655|FG003|Overall Study|Adverse Event|0|||
156357014|NCT02608268|564407656|FG004|Overall Study|Adverse Event|0|||
156357015|NCT02608268|564407657|FG005|Overall Study|Adverse Event|0|||
156357016|NCT02608268|564407658|FG006|Overall Study|Adverse Event|0|||
156357017|NCT02608268|564407659|FG007|Overall Study|Adverse Event|0|||
156357018|NCT02608268|564407660|FG008|Overall Study|Adverse Event|0|||
156357019|NCT02608268|564407661|FG009|Overall Study|Adverse Event|0|||
156357020|NCT02608268|564407662|FG010|Overall Study|Adverse Event|0|||
156357021|NCT02608268|564407663|FG011|Overall Study|Adverse Event|0|||
156357022|NCT02608268|564407664|FG012|Overall Study|Adverse Event|2|||
156357023|NCT02608268|564407665|FG013|Overall Study|Adverse Event|0|||
156357024|NCT02608268|564407666|FG014|Overall Study|Adverse Event|0|||
156357025|NCT02608268|564407667|FG015|Overall Study|Adverse Event|0|||
156357026|NCT02608268|564407668|FG016|Overall Study|Adverse Event|0|||
156357027|NCT02608268|564407669|FG017|Overall Study|Adverse Event|0|||
156357028|NCT02608268|564407670|FG018|Overall Study|Adverse Event|0|||
156357029|NCT02608268|564407671|FG019|Overall Study|Adverse Event|0|||
156357030|NCT02608268|564407672|FG020|Overall Study|Adverse Event|1|||
156357031|NCT02608268|564407673|FG021|Overall Study|Adverse Event|1|||
156487953|NCT01697592|564880203|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
156357032|NCT02608268|564407674|FG022|Overall Study|Adverse Event|0|||
156357033|NCT02608268|564407675|FG023|Overall Study|Adverse Event|0|||
156357034|NCT02608268|564407676|FG024|Overall Study|Adverse Event|1|||
156487954|NCT01697592|564880204|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
156357035|NCT02608268|564407677|FG025|Overall Study|Adverse Event|0|||
156357036|NCT02608268|564407678|FG026|Overall Study|Adverse Event|0|||
156357037|NCT02608268|564407679|FG027|Overall Study|Adverse Event|0|||
156544680|NCT01246583|565087838|FG003|Overall Study|Withdrawal by Subject|0|||
156544681|NCT05264740|565087839|FG000|Baseline|Withdrawal by Subject|0|||
156544682|NCT05264740|565087840|FG001|Baseline|Withdrawal by Subject|1|||
156544683|NCT05264740|565087839|FG000|Follow Up 1|Lost to Follow-up|1|||
156544684|NCT05264740|565087840|FG001|Follow Up 1|Lost to Follow-up|1|||
156544685|NCT05264740|565087839|FG000|Follow Up 1|Withdrawal by Subject|0|||
156544686|NCT05264740|565087840|FG001|Follow Up 1|Withdrawal by Subject|1|||
156544687|NCT05264740|565087839|FG000|Follow Up 2|Lost to Follow-up|1|||
156544688|NCT05264740|565087840|FG001|Follow Up 2|Lost to Follow-up|4|||
156544689|NCT05264740|565087839|FG000|Follow Up 3|Lost to Follow-up|7|||
156544690|NCT05264740|565087840|FG001|Follow Up 3|Lost to Follow-up|4|||
156544691|NCT01423851|565087841|FG000|Whole Study|Disease progression|2|||
156544692|NCT01423851|565087842|FG001|Whole Study|Disease progression|1|||
156544693|NCT01423851|565087843|FG002|Whole Study|Disease progression|1|||
156544694|NCT01423851|565087844|FG003|Whole Study|Disease progression|4|||
156544695|NCT01423851|565087845|FG004|Whole Study|Disease progression|1|||
156544696|NCT01423851|565087846|FG005|Whole Study|Disease progression|3|||
156544697|NCT01423851|565087847|FG006|Whole Study|Disease progression|1|||
156544698|NCT01423851|565087848|FG007|Whole Study|Disease progression|4|||
156544699|NCT01423851|565087849|FG008|Whole Study|Disease progression|0|||
156544700|NCT01423851|565087850|FG009|Whole Study|Disease progression|2|||
156544701|NCT01423851|565087851|FG010|Whole Study|Disease progression|10|||
156544702|NCT01423851|565087841|FG000|Whole Study|Physician Decision|0|||
156544703|NCT01423851|565087842|FG001|Whole Study|Physician Decision|1|||
156544704|NCT01423851|565087843|FG002|Whole Study|Physician Decision|2|||
156544705|NCT01423851|565087844|FG003|Whole Study|Physician Decision|0|||
156544706|NCT01423851|565087845|FG004|Whole Study|Physician Decision|2|||
156544707|NCT01423851|565087846|FG005|Whole Study|Physician Decision|0|||
156544708|NCT01423851|565087847|FG006|Whole Study|Physician Decision|2|||
156544709|NCT01423851|565087848|FG007|Whole Study|Physician Decision|1|||
156544710|NCT01423851|565087849|FG008|Whole Study|Physician Decision|3|||
156544711|NCT01423851|565087850|FG009|Whole Study|Physician Decision|4|||
156544712|NCT01423851|565087851|FG010|Whole Study|Physician Decision|12|||
156544713|NCT01423851|565087841|FG000|Whole Study|Withdrawal by Subject|1|||
156544714|NCT01423851|565087842|FG001|Whole Study|Withdrawal by Subject|1|||
156544715|NCT01423851|565087843|FG002|Whole Study|Withdrawal by Subject|0|||
156544716|NCT01423851|565087844|FG003|Whole Study|Withdrawal by Subject|0|||
156544717|NCT01423851|565087845|FG004|Whole Study|Withdrawal by Subject|0|||
156544718|NCT01423851|565087846|FG005|Whole Study|Withdrawal by Subject|0|||
156544719|NCT01423851|565087847|FG006|Whole Study|Withdrawal by Subject|0|||
156544720|NCT01423851|565087848|FG007|Whole Study|Withdrawal by Subject|0|||
156487955|NCT01697592|564880195|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
156487956|NCT01697592|564880196|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
156487957|NCT01697592|564880197|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
156487958|NCT01697592|564880198|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
156487959|NCT01697592|564880199|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
156487960|NCT01697592|564880200|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
156487961|NCT01697592|564880201|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
156487962|NCT01697592|564880202|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
156487963|NCT01697592|564880203|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
156487964|NCT01697592|564880204|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
156487965|NCT01697592|564880195|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
156487966|NCT01697592|564880196|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
156487967|NCT01697592|564880197|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
156487968|NCT01697592|564880198|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
156487969|NCT01697592|564880199|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
156487970|NCT01697592|564880200|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
156487971|NCT01697592|564880201|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
156487972|NCT01697592|564880202|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
156544721|NCT01423851|565087849|FG008|Whole Study|Withdrawal by Subject|2|||
156544722|NCT01423851|565087850|FG009|Whole Study|Withdrawal by Subject|0|||
156544723|NCT01423851|565087851|FG010|Whole Study|Withdrawal by Subject|4|||
156544724|NCT01423851|565087841|FG000|Whole Study|Adverse Event|0|||
156544725|NCT01423851|565087842|FG001|Whole Study|Adverse Event|0|||
156544726|NCT01423851|565087843|FG002|Whole Study|Adverse Event|0|||
156544727|NCT01423851|565087844|FG003|Whole Study|Adverse Event|2|||
156487973|NCT01697592|564880203|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
156544728|NCT01423851|565087845|FG004|Whole Study|Adverse Event|0|||
156544729|NCT01423851|565087846|FG005|Whole Study|Adverse Event|0|||
156544730|NCT01423851|565087847|FG006|Whole Study|Adverse Event|0|||
156544731|NCT01423851|565087848|FG007|Whole Study|Adverse Event|3|||
156544732|NCT01423851|565087849|FG008|Whole Study|Adverse Event|3|||
156544733|NCT01423851|565087850|FG009|Whole Study|Adverse Event|2|||
156544734|NCT01423851|565087851|FG010|Whole Study|Adverse Event|3|||
156544735|NCT05885737|565087855|FG000|DB Period|Adverse Event|4|||
156544736|NCT05885737|565087856|FG001|DB Period|Adverse Event|4|||
156544737|NCT05885737|565087855|FG000|DB Period|Lost to Follow-up|0|||
156544738|NCT05885737|565087856|FG001|DB Period|Lost to Follow-up|1|||
156357038|NCT02608268|564407680|FG028|Overall Study|Adverse Event|1|||
156357039|NCT02608268|564407681|FG029|Overall Study|Adverse Event|0|||
156357040|NCT02608268|564407652|FG000|Overall Study|Death|1|||
156357041|NCT02608268|564407653|FG001|Overall Study|Death|0|||
156357042|NCT02608268|564407654|FG002|Overall Study|Death|0|||
156357043|NCT02608268|564407655|FG003|Overall Study|Death|0|||
156357044|NCT02608268|564407656|FG004|Overall Study|Death|0|||
156357045|NCT02608268|564407657|FG005|Overall Study|Death|0|||
156357046|NCT02608268|564407658|FG006|Overall Study|Death|0|||
156357047|NCT02608268|564407659|FG007|Overall Study|Death|0|||
156357048|NCT02608268|564407660|FG008|Overall Study|Death|1|||
156357049|NCT02608268|564407661|FG009|Overall Study|Death|1|||
156357050|NCT02608268|564407662|FG010|Overall Study|Death|0|||
156357051|NCT02608268|564407663|FG011|Overall Study|Death|0|||
156357052|NCT02608268|564407664|FG012|Overall Study|Death|0|||
156357053|NCT02608268|564407665|FG013|Overall Study|Death|0|||
156357054|NCT02608268|564407666|FG014|Overall Study|Death|0|||
156357055|NCT02608268|564407667|FG015|Overall Study|Death|1|||
156357056|NCT02608268|564407668|FG016|Overall Study|Death|0|||
156357057|NCT02608268|564407669|FG017|Overall Study|Death|1|||
156357058|NCT02608268|564407670|FG018|Overall Study|Death|0|||
156357059|NCT02608268|564407671|FG019|Overall Study|Death|1|||
156357060|NCT02608268|564407672|FG020|Overall Study|Death|1|||
156357061|NCT02608268|564407673|FG021|Overall Study|Death|0|||
156357062|NCT02608268|564407674|FG022|Overall Study|Death|0|||
156357063|NCT02608268|564407675|FG023|Overall Study|Death|0|||
156357064|NCT02608268|564407676|FG024|Overall Study|Death|1|||
156357065|NCT02608268|564407677|FG025|Overall Study|Death|2|||
156357066|NCT02608268|564407678|FG026|Overall Study|Death|0|||
156357067|NCT02608268|564407679|FG027|Overall Study|Death|1|||
156357068|NCT02608268|564407680|FG028|Overall Study|Death|4|||
156357069|NCT02608268|564407681|FG029|Overall Study|Death|0|||
156357070|NCT02608268|564407652|FG000|Overall Study|Physician Decision|0|||
156357071|NCT02608268|564407653|FG001|Overall Study|Physician Decision|0|||
156357072|NCT02608268|564407654|FG002|Overall Study|Physician Decision|0|||
156357073|NCT02608268|564407655|FG003|Overall Study|Physician Decision|0|||
156357074|NCT02608268|564407656|FG004|Overall Study|Physician Decision|0|||
156357075|NCT02608268|564407657|FG005|Overall Study|Physician Decision|0|||
156357076|NCT02608268|564407658|FG006|Overall Study|Physician Decision|0|||
156357077|NCT02608268|564407659|FG007|Overall Study|Physician Decision|0|||
156357078|NCT02608268|564407660|FG008|Overall Study|Physician Decision|0|||
156357079|NCT02608268|564407661|FG009|Overall Study|Physician Decision|0|||
156357080|NCT02608268|564407662|FG010|Overall Study|Physician Decision|1|||
156357081|NCT02608268|564407663|FG011|Overall Study|Physician Decision|0|||
156357082|NCT02608268|564407664|FG012|Overall Study|Physician Decision|0|||
156357083|NCT02608268|564407665|FG013|Overall Study|Physician Decision|1|||
156357084|NCT02608268|564407666|FG014|Overall Study|Physician Decision|0|||
156357085|NCT02608268|564407667|FG015|Overall Study|Physician Decision|0|||
156357086|NCT02608268|564407668|FG016|Overall Study|Physician Decision|0|||
156487974|NCT01697592|564880204|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
156487975|NCT02396758|564880205|FG000|Overall Study|Withdrawal by Subject|2|||
156357087|NCT02608268|564407669|FG017|Overall Study|Physician Decision|0|||
156357088|NCT02608268|564407670|FG018|Overall Study|Physician Decision|0|||
156357089|NCT02608268|564407671|FG019|Overall Study|Physician Decision|0|||
156357090|NCT02608268|564407672|FG020|Overall Study|Physician Decision|0|||
156357091|NCT02608268|564407673|FG021|Overall Study|Physician Decision|0|||
156357092|NCT02608268|564407674|FG022|Overall Study|Physician Decision|1|||
156357093|NCT02608268|564407675|FG023|Overall Study|Physician Decision|1|||
156357094|NCT02608268|564407676|FG024|Overall Study|Physician Decision|1|||
156357095|NCT02608268|564407677|FG025|Overall Study|Physician Decision|0|||
156357096|NCT02608268|564407678|FG026|Overall Study|Physician Decision|0|||
156357097|NCT02608268|564407679|FG027|Overall Study|Physician Decision|2|||
156357098|NCT02608268|564407680|FG028|Overall Study|Physician Decision|1|||
156357099|NCT02608268|564407681|FG029|Overall Study|Physician Decision|1|||
156357100|NCT02608268|564407652|FG000|Overall Study|Progressive disease|12|||
156357101|NCT02608268|564407653|FG001|Overall Study|Progressive disease|8|||
156357102|NCT02608268|564407654|FG002|Overall Study|Progressive disease|13|||
156357103|NCT02608268|564407655|FG003|Overall Study|Progressive disease|5|||
156357104|NCT02608268|564407656|FG004|Overall Study|Progressive disease|2|||
156487976|NCT02396758|564880206|FG001|Overall Study|Withdrawal by Subject|0|||
156487977|NCT02396758|564880207|FG002|Overall Study|Withdrawal by Subject|0|||
156487978|NCT02396758|564880208|FG003|Overall Study|Withdrawal by Subject|1|||
156487979|NCT02396758|564880205|FG000|Overall Study|Lost to Follow-up|8|||
156487980|NCT02396758|564880206|FG001|Overall Study|Lost to Follow-up|5|||
156487981|NCT02396758|564880207|FG002|Overall Study|Lost to Follow-up|3|||
156487982|NCT02396758|564880208|FG003|Overall Study|Lost to Follow-up|3|||
156487983|NCT02396758|564880205|FG000|Overall Study|Death|1|||
156487984|NCT02396758|564880206|FG001|Overall Study|Death|1|||
156487985|NCT02396758|564880207|FG002|Overall Study|Death|0|||
156357105|NCT02608268|564407657|FG005|Overall Study|Progressive disease|4|||
156357106|NCT02608268|564407658|FG006|Overall Study|Progressive disease|6|||
156357107|NCT02608268|564407659|FG007|Overall Study|Progressive disease|2|||
156357108|NCT02608268|564407660|FG008|Overall Study|Progressive disease|5|||
156357109|NCT02608268|564407661|FG009|Overall Study|Progressive disease|6|||
156357110|NCT02608268|564407662|FG010|Overall Study|Progressive disease|5|||
156357111|NCT02608268|564407663|FG011|Overall Study|Progressive disease|5|||
156357112|NCT02608268|564407664|FG012|Overall Study|Progressive disease|4|||
156357113|NCT02608268|564407665|FG013|Overall Study|Progressive disease|11|||
156357114|NCT02608268|564407666|FG014|Overall Study|Progressive disease|6|||
156357115|NCT02608268|564407667|FG015|Overall Study|Progressive disease|3|||
156357116|NCT02608268|564407668|FG016|Overall Study|Progressive disease|5|||
156357117|NCT02608268|564407669|FG017|Overall Study|Progressive disease|5|||
156357118|NCT02608268|564407670|FG018|Overall Study|Progressive disease|5|||
156357119|NCT02608268|564407671|FG019|Overall Study|Progressive disease|2|||
156357120|NCT02608268|564407672|FG020|Overall Study|Progressive disease|10|||
156357121|NCT02608268|564407673|FG021|Overall Study|Progressive disease|4|||
156357122|NCT02608268|564407674|FG022|Overall Study|Progressive disease|5|||
156357123|NCT02608268|564407675|FG023|Overall Study|Progressive disease|5|||
156357124|NCT02608268|564407676|FG024|Overall Study|Progressive disease|3|||
156357125|NCT02608268|564407677|FG025|Overall Study|Progressive disease|11|||
156357126|NCT02608268|564407678|FG026|Overall Study|Progressive disease|16|||
156357127|NCT02608268|564407679|FG027|Overall Study|Progressive disease|11|||
156357128|NCT02608268|564407680|FG028|Overall Study|Progressive disease|10|||
156357129|NCT02608268|564407681|FG029|Overall Study|Progressive disease|15|||
156357130|NCT02608268|564407652|FG000|Overall Study|Subject/guardian decision|1|||
156357131|NCT02608268|564407653|FG001|Overall Study|Subject/guardian decision|1|||
156357132|NCT02608268|564407654|FG002|Overall Study|Subject/guardian decision|2|||
156357133|NCT02608268|564407655|FG003|Overall Study|Subject/guardian decision|0|||
156357134|NCT02608268|564407656|FG004|Overall Study|Subject/guardian decision|0|||
156357135|NCT02608268|564407657|FG005|Overall Study|Subject/guardian decision|0|||
156357136|NCT02608268|564407658|FG006|Overall Study|Subject/guardian decision|0|||
156357137|NCT02608268|564407659|FG007|Overall Study|Subject/guardian decision|0|||
156357138|NCT02608268|564407660|FG008|Overall Study|Subject/guardian decision|2|||
156357139|NCT02608268|564407661|FG009|Overall Study|Subject/guardian decision|2|||
156357140|NCT02608268|564407662|FG010|Overall Study|Subject/guardian decision|0|||
156357141|NCT02608268|564407663|FG011|Overall Study|Subject/guardian decision|1|||
156357142|NCT02608268|564407664|FG012|Overall Study|Subject/guardian decision|0|||
156357143|NCT02608268|564407665|FG013|Overall Study|Subject/guardian decision|1|||
156357144|NCT02608268|564407666|FG014|Overall Study|Subject/guardian decision|0|||
156357145|NCT02608268|564407667|FG015|Overall Study|Subject/guardian decision|1|||
156357146|NCT02608268|564407668|FG016|Overall Study|Subject/guardian decision|0|||
156357147|NCT02608268|564407669|FG017|Overall Study|Subject/guardian decision|0|||
156357148|NCT02608268|564407670|FG018|Overall Study|Subject/guardian decision|1|||
156357149|NCT02608268|564407671|FG019|Overall Study|Subject/guardian decision|0|||
156357150|NCT02608268|564407672|FG020|Overall Study|Subject/guardian decision|0|||
156357151|NCT02608268|564407673|FG021|Overall Study|Subject/guardian decision|0|||
156357152|NCT02608268|564407674|FG022|Overall Study|Subject/guardian decision|1|||
156357153|NCT02608268|564407675|FG023|Overall Study|Subject/guardian decision|0|||
156357154|NCT02608268|564407676|FG024|Overall Study|Subject/guardian decision|0|||
156357155|NCT02608268|564407677|FG025|Overall Study|Subject/guardian decision|1|||
156357156|NCT02608268|564407678|FG026|Overall Study|Subject/guardian decision|1|||
156357157|NCT02608268|564407679|FG027|Overall Study|Subject/guardian decision|1|||
156357158|NCT02608268|564407680|FG028|Overall Study|Subject/guardian decision|1|||
156357159|NCT02608268|564407681|FG029|Overall Study|Subject/guardian decision|0|||
156357160|NCT03662542|564407685|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
156357161|NCT03662542|564407686|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156357162|NCT03662542|564407687|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156357163|NCT03662542|564407688|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156357164|NCT03662542|564407689|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156357165|NCT03662542|564407690|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156357166|NCT03662542|564407691|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156357167|NCT03662542|564407692|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156357168|NCT03662542|564407693|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156357169|NCT03662542|564407685|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156487986|NCT02396758|564880208|FG003|Overall Study|Death|1|||
156487987|NCT02396758|564880205|FG000|Overall Study|Randomized but not treated|1|||
156487988|NCT02396758|564880206|FG001|Overall Study|Randomized but not treated|0|||
156487989|NCT02396758|564880207|FG002|Overall Study|Randomized but not treated|1|||
156487990|NCT02396758|564880208|FG003|Overall Study|Randomized but not treated|0|||
156487991|NCT02110225|564880209|FG000|Overall Study|Lost to Follow-up|0|||
156487992|NCT02110225|564880210|FG001|Overall Study|Lost to Follow-up|1|||
156544739|NCT05885737|565087855|FG000|DB Period|Physician Decision|2|||
156544740|NCT05885737|565087856|FG001|DB Period|Physician Decision|0|||
156544741|NCT05885737|565087855|FG000|DB Period|Withdrawal by Subject|12|||
156544742|NCT05885737|565087856|FG001|DB Period|Withdrawal by Subject|6|||
156544743|NCT05885737|565087855|FG000|DB Period|Other: Unspecified|2|||
156544744|NCT05885737|565087856|FG001|DB Period|Other: Unspecified|2|||
156544745|NCT05885737|565087855|FG000|OLE Period|Adverse Event|3|||
156544746|NCT05885737|565087856|FG001|OLE Period|Adverse Event|2|||
156357170|NCT03662542|564407686|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
156357171|NCT03662542|564407687|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156357172|NCT03662542|564407688|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156357173|NCT03662542|564407689|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156357174|NCT03662542|564407690|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156357175|NCT03662542|564407691|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156357176|NCT03662542|564407692|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156357177|NCT03662542|564407693|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156357178|NCT03662542|564407685|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
156357179|NCT03662542|564407686|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
156357180|NCT03662542|564407687|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
156357181|NCT03662542|564407688|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
156357182|NCT03662542|564407689|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
156357183|NCT03662542|564407690|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
156357184|NCT03662542|564407691|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
156357185|NCT03662542|564407692|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
156357186|NCT03662542|564407693|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
156357187|NCT03662542|564407685|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
156357188|NCT03662542|564407686|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156357189|NCT03662542|564407687|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156357190|NCT03662542|564407688|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156357191|NCT03662542|564407689|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156357192|NCT03662542|564407690|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156357193|NCT03662542|564407691|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156357194|NCT03662542|564407692|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156357195|NCT03662542|564407693|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156357196|NCT03662542|564407685|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156357197|NCT03662542|564407686|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156357198|NCT03662542|564407687|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156357199|NCT03662542|564407688|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156357200|NCT03662542|564407689|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156357201|NCT03662542|564407690|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
156357202|NCT03662542|564407691|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156357203|NCT03662542|564407692|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156357204|NCT03662542|564407693|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156357205|NCT03662542|564407685|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156357206|NCT03662542|564407686|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156357207|NCT03662542|564407687|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156357208|NCT03662542|564407688|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
156357209|NCT03662542|564407689|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
156357210|NCT03662542|564407690|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156357211|NCT03662542|564407691|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156357212|NCT03662542|564407692|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156357213|NCT03662542|564407693|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156357214|NCT03662542|564407685|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156357215|NCT03662542|564407686|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156357216|NCT03662542|564407687|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156357217|NCT03662542|564407688|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
156357218|NCT03662542|564407689|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
156357219|NCT03662542|564407690|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
156357220|NCT03662542|564407691|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156357221|NCT03662542|564407692|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156487993|NCT02110225|564880211|FG002|Overall Study|Lost to Follow-up|0|||
156487994|NCT00265096|564880213|FG000|Overall Study|Adverse Event|14|||
156487995|NCT00265096|564880214|FG001|Overall Study|Adverse Event|18|||
156487996|NCT00265096|564880215|FG002|Overall Study|Adverse Event|18|||
156357222|NCT03662542|564407693|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156357223|NCT03662542|564407685|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156357224|NCT03662542|564407686|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156357225|NCT03662542|564407687|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156357226|NCT03662542|564407688|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156357227|NCT03662542|564407689|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
156357228|NCT03662542|564407690|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
156357229|NCT03662542|564407691|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156357230|NCT03662542|564407692|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156357231|NCT03662542|564407693|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156357232|NCT03662542|564407685|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156357233|NCT03662542|564407686|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156357234|NCT03662542|564407687|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156357235|NCT03662542|564407688|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156357236|NCT03662542|564407689|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156357237|NCT03662542|564407690|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
156357238|NCT03662542|564407691|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156357239|NCT03662542|564407692|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156357240|NCT03662542|564407693|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156357241|NCT03662542|564407685|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
156357242|NCT03662542|564407686|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
156357243|NCT03662542|564407687|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
156357244|NCT03662542|564407688|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
156357245|NCT03662542|564407689|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
156357246|NCT03662542|564407690|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
156357247|NCT03662542|564407691|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
156357248|NCT03662542|564407692|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
156357249|NCT03662542|564407693|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
156357250|NCT03662542|564407685|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156357251|NCT03662542|564407686|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156357252|NCT03662542|564407687|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156357253|NCT03662542|564407688|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156357254|NCT03662542|564407689|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156357255|NCT03662542|564407690|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156357256|NCT03662542|564407691|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
156357257|NCT03662542|564407692|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156357258|NCT03662542|564407693|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
156357259|NCT03662542|564407685|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156357260|NCT03662542|564407686|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156357261|NCT03662542|564407687|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156357262|NCT03662542|564407688|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156357263|NCT03662542|564407689|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156357264|NCT03662542|564407690|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156357265|NCT03662542|564407691|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
156357266|NCT03662542|564407692|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156357267|NCT03662542|564407693|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
156357268|NCT03662542|564407685|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
156357269|NCT03662542|564407686|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
156357270|NCT03662542|564407687|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
156357271|NCT03662542|564407688|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
156357272|NCT03662542|564407689|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
156357273|NCT03662542|564407690|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
156357274|NCT03662542|564407691|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
156357275|NCT03662542|564407692|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
156357276|NCT03662542|564407693|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
156357277|NCT04014075|564407695|FG000|Overall Study|Progressive Disease|53|||
156357278|NCT04014075|564407695|FG000|Overall Study|Adverse Event|15|||
156357279|NCT04014075|564407695|FG000|Overall Study|Clinical Progression|4|||
156357280|NCT04014075|564407695|FG000|Overall Study|Death|2|||
156357281|NCT04014075|564407695|FG000|Overall Study|Withdrawal by Subject|2|||
156357282|NCT04014075|564407695|FG000|Overall Study|Miscellaneous|2|||
156357283|NCT04014075|564407695|FG000|Overall Study|Physician Decision|1|||
156357284|NCT02584504|564407696|FG000|Double-blind Treatment|Participant withdrew consent|0|||
156357285|NCT02584504|564407697|FG001|Double-blind Treatment|Participant withdrew consent|0|||
156357286|NCT02584504|564407698|FG002|Double-blind Treatment|Participant withdrew consent|1|||
156357287|NCT02584504|564407696|FG000|Double-blind Treatment|Adverse Event|0|||
156357288|NCT02584504|564407697|FG001|Double-blind Treatment|Adverse Event|1|||
156357289|NCT02584504|564407698|FG002|Double-blind Treatment|Adverse Event|0|||
156357290|NCT02584504|564407696|FG000|Double-blind Treatment|Family Matter|0|||
156357291|NCT02584504|564407697|FG001|Double-blind Treatment|Family Matter|1|||
156357292|NCT02584504|564407698|FG002|Double-blind Treatment|Family Matter|0|||
156357293|NCT02584504|564407696|FG000|Open-label Treatment|Participant withdrew consent|0|||
156357294|NCT02584504|564407697|FG001|Open-label Treatment|Participant withdrew consent|0|||
156357295|NCT02584504|564407698|FG002|Open-label Treatment|Participant withdrew consent|4|||
156357296|NCT02584504|564407696|FG000|Open-label Treatment|Adverse Event|2|||
156357297|NCT02584504|564407697|FG001|Open-label Treatment|Adverse Event|2|||
156357298|NCT02584504|564407698|FG002|Open-label Treatment|Adverse Event|3|||
156357299|NCT02584504|564407696|FG000|Open-label Treatment|Physician Decision|0|||
156357300|NCT02584504|564407697|FG001|Open-label Treatment|Physician Decision|1|||
156357301|NCT02584504|564407698|FG002|Open-label Treatment|Physician Decision|0|||
156357302|NCT02584504|564407696|FG000|Open-label Treatment|Entered but not treated|0|||
156357303|NCT02584504|564407697|FG001|Open-label Treatment|Entered but not treated|1|||
156357304|NCT02584504|564407698|FG002|Open-label Treatment|Entered but not treated|1|||
156357305|NCT01998633|564407700|FG000|Overall Study|Death|1|||
156357306|NCT00413192|564407701|FG000|Overall Study|Disease progression|26|||
156357307|NCT00413192|564407702|FG001|Overall Study|Disease progression|31|||
156357308|NCT00413192|564407703|FG002|Overall Study|Disease progression|16|||
156357309|NCT00413192|564407704|FG003|Overall Study|Disease progression|25|||
156357310|NCT00413192|564407701|FG000|Overall Study|Toxicity|3|||
156357311|NCT00413192|564407702|FG001|Overall Study|Toxicity|2|||
156357312|NCT00413192|564407703|FG002|Overall Study|Toxicity|2|||
156357313|NCT00413192|564407704|FG003|Overall Study|Toxicity|2|||
156357314|NCT00413192|564407701|FG000|Overall Study|Withdrawal by Subject|3|||
156357315|NCT00413192|564407702|FG001|Overall Study|Withdrawal by Subject|5|||
156357316|NCT00413192|564407703|FG002|Overall Study|Withdrawal by Subject|0|||
156357317|NCT00413192|564407704|FG003|Overall Study|Withdrawal by Subject|1|||
156357318|NCT00413192|564407701|FG000|Overall Study|Intercurrent illness|0|||
156544747|NCT05885737|565087855|FG000|OLE Period|Physician Decision|1|||
156357319|NCT00413192|564407702|FG001|Overall Study|Intercurrent illness|0|||
156357320|NCT00413192|564407703|FG002|Overall Study|Intercurrent illness|0|||
156544748|NCT05885737|565087856|FG001|OLE Period|Physician Decision|0|||
156487997|NCT00265096|564880213|FG000|Overall Study|Lost to Follow-up|2|||
156487998|NCT00265096|564880214|FG001|Overall Study|Lost to Follow-up|5|||
156487999|NCT00265096|564880215|FG002|Overall Study|Lost to Follow-up|3|||
156488000|NCT00265096|564880213|FG000|Overall Study|Death|0|||
156488001|NCT00265096|564880214|FG001|Overall Study|Death|1|||
156488002|NCT00265096|564880215|FG002|Overall Study|Death|2|||
156488003|NCT00265096|564880213|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
156488004|NCT00265096|564880214|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
156488005|NCT00265096|564880215|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
156544749|NCT05885737|565087855|FG000|OLE Period|Withdrawal by Subject|5|||
156544750|NCT05885737|565087856|FG001|OLE Period|Withdrawal by Subject|5|||
156544751|NCT05885737|565087855|FG000|OLE Period|Other: Unspecified|2|||
156544752|NCT05885737|565087856|FG001|OLE Period|Other: Unspecified|1|||
156544753|NCT00789529|565089424|FG000|Overall Study|Withdrawal by Subject|0|||
156544754|NCT00789529|565089425|FG001|Overall Study|Withdrawal by Subject|1|||
156544755|NCT00789529|565089424|FG000|Overall Study|Other Reason|1|||
156544756|NCT00789529|565089425|FG001|Overall Study|Other Reason|0|||
156544757|NCT01870401|565089426|FG000|Overall Study|Death|48|||
156544758|NCT01870401|565089427|FG001|Overall Study|Death|24|||
156544759|NCT01870401|565089426|FG000|Overall Study|Withdrawal by Subject|39|||
156544760|NCT01870401|565089427|FG001|Overall Study|Withdrawal by Subject|26|||
156544761|NCT01870401|565089426|FG000|Overall Study|Lost to Follow-up|19|||
156544762|NCT01870401|565089427|FG001|Overall Study|Lost to Follow-up|14|||
156544763|NCT01870401|565089426|FG000|Overall Study|Other|9|||
156544764|NCT01870401|565089427|FG001|Overall Study|Other|7|||
156544765|NCT01870401|565089426|FG000|Overall Study|On-going in the Study|35|||
156544766|NCT01870401|565089427|FG001|Overall Study|On-going in the Study|25|||
156544767|NCT01135498|565089428|FG000|Overall Study|Adverse Event|20|||
156544768|NCT01135498|565089428|FG000|Overall Study|Progressive disease|38|||
156544769|NCT01135498|565089428|FG000|Overall Study|Investigator judgement|25|||
156544770|NCT01135498|565089428|FG000|Overall Study|Withdrawal by Subject|4|||
156544771|NCT01135498|565089428|FG000|Overall Study|Death|1|||
156544772|NCT01135498|565089428|FG000|Overall Study|Ongoing at time of analysis|2|||
156544773|NCT04839978|565089429|FG000|Overall Study|Lost to Follow-up|135|||
156544774|NCT04839978|565089430|FG001|Overall Study|Lost to Follow-up|147|||
156544775|NCT03551509|565089431|FG000|Overall Study|Lost to Follow-up|0|||
156544776|NCT03551509|565089432|FG001|Overall Study|Lost to Follow-up|1|||
156544777|NCT03551509|565089433|FG002|Overall Study|Lost to Follow-up|0|||
156544778|NCT03776175|565089434|FG000|Treatment Period (42 Days)|Adverse Event|0|||
156544779|NCT03776175|565089435|FG001|Treatment Period (42 Days)|Adverse Event|1|||
156544780|NCT03776175|565089436|FG002|Treatment Period (42 Days)|Adverse Event|1|||
156544781|NCT03776175|565089437|FG003|Treatment Period (42 Days)|Adverse Event|0|||
156544782|NCT03776175|565089434|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
156544783|NCT03776175|565089435|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
156544784|NCT03776175|565089436|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
156544785|NCT03776175|565089437|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
156544786|NCT03776175|565089434|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
156544787|NCT03776175|565089435|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
156488006|NCT00265096|564880213|FG000|Overall Study|Other|11|||
156488007|NCT00265096|564880214|FG001|Overall Study|Other|19|||
156488008|NCT00265096|564880215|FG002|Overall Study|Other|10|||
156488009|NCT01116440|564880216|FG000|Treatment|Withdrawal by Subject|2|||
156488010|NCT01116440|564880217|FG001|Treatment|Withdrawal by Subject|2|||
156488011|NCT01116440|564880216|FG000|Treatment|Lost to Follow-up|1|||
156488012|NCT01116440|564880217|FG001|Treatment|Lost to Follow-up|1|||
156488013|NCT01116440|564880216|FG000|Treatment|Protocol Violation|0|||
156488014|NCT01116440|564880217|FG001|Treatment|Protocol Violation|2|||
156488015|NCT01116440|564880216|FG000|Treatment|Lack of Efficacy|0|||
156544788|NCT03776175|565089436|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
156544789|NCT03776175|565089437|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
156544790|NCT03776175|565089434|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
156544791|NCT03776175|565089435|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
156544792|NCT03776175|565089436|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
156544793|NCT03776175|565089437|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
156488016|NCT01116440|564880217|FG001|Treatment|Lack of Efficacy|1|||
156488017|NCT01116440|564880216|FG000|Treatment|Adverse Event|0|||
156488018|NCT01116440|564880217|FG001|Treatment|Adverse Event|1|||
156544794|NCT03776175|565089434|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
156544795|NCT03776175|565089435|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
156544796|NCT03776175|565089436|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
156544797|NCT03776175|565089437|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
156544798|NCT03776175|565089434|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
156544799|NCT03776175|565089435|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
156544800|NCT03776175|565089436|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
156544801|NCT03776175|565089437|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
156544802|NCT02770547|565089441|FG000|Overall Study|Patient non-compliant|1|||
156544803|NCT02770547|565089442|FG001|Overall Study|Patient non-compliant|0|||
156544804|NCT02770547|565089441|FG000|Overall Study|Adverse Event|0|||
156544805|NCT02770547|565089442|FG001|Overall Study|Adverse Event|1|||
156544806|NCT01324232|565089443|FG000|Overall Study|Protocol Violation|0|||
156544807|NCT01324232|565089444|FG001|Overall Study|Protocol Violation|0|||
156488019|NCT01116440|564880216|FG000|Withdrawal|Withdrawal by Subject|0|||
156488020|NCT01116440|564880217|FG001|Withdrawal|Withdrawal by Subject|1|||
156488021|NCT01116440|564880216|FG000|Withdrawal|Lost to Follow-up|0|||
156544808|NCT01324232|565089445|FG002|Overall Study|Protocol Violation|0|||
156544809|NCT01324232|565089446|FG003|Overall Study|Protocol Violation|2|||
156357321|NCT00413192|564407704|FG003|Overall Study|Intercurrent illness|1|||
156357322|NCT00413192|564407701|FG000|Overall Study|Intercurrent death|0|||
156357323|NCT00413192|564407702|FG001|Overall Study|Intercurrent death|1|||
156357324|NCT00413192|564407703|FG002|Overall Study|Intercurrent death|0|||
156357325|NCT00413192|564407704|FG003|Overall Study|Intercurrent death|0|||
156357326|NCT00413192|564407701|FG000|Overall Study|Other|5|||
156357327|NCT00413192|564407702|FG001|Overall Study|Other|1|||
156357328|NCT00413192|564407703|FG002|Overall Study|Other|1|||
156357329|NCT00413192|564407704|FG003|Overall Study|Other|2|||
156357330|NCT00413192|564407701|FG000|Overall Study|Not treated|0|||
156357331|NCT00413192|564407702|FG001|Overall Study|Not treated|0|||
156357332|NCT00413192|564407703|FG002|Overall Study|Not treated|0|||
156357333|NCT00413192|564407704|FG003|Overall Study|Not treated|1|||
156357334|NCT03814746|564407705|FG000|Overall Study|Participant decision|9|||
156357335|NCT03814746|564407706|FG001|Overall Study|Participant decision|6|||
156357336|NCT03814746|564407707|FG002|Overall Study|Participant decision|15|||
156357337|NCT03814746|564407705|FG000|Overall Study|Physician Decision|2|||
156357338|NCT03814746|564407706|FG001|Overall Study|Physician Decision|2|||
156357339|NCT03814746|564407707|FG002|Overall Study|Physician Decision|4|||
156357340|NCT03814746|564407705|FG000|Overall Study|Death|2|||
156357341|NCT03814746|564407706|FG001|Overall Study|Death|2|||
156357342|NCT03814746|564407707|FG002|Overall Study|Death|2|||
156357343|NCT03814746|564407705|FG000|Overall Study|Adverse Event|2|||
156357344|NCT03814746|564407706|FG001|Overall Study|Adverse Event|2|||
156488022|NCT01116440|564880217|FG001|Withdrawal|Lost to Follow-up|1|||
156488023|NCT01116440|564880216|FG000|Follow-up|Lost to Follow-up|0|||
156488024|NCT01116440|564880217|FG001|Follow-up|Lost to Follow-up|1|||
156488025|NCT01116440|564880216|FG000|Follow-up|Withdrawal by Subject|0|||
156488026|NCT01116440|564880217|FG001|Follow-up|Withdrawal by Subject|1|||
156357345|NCT03814746|564407707|FG002|Overall Study|Adverse Event|1|||
156357346|NCT03814746|564407705|FG000|Overall Study|Lost to Follow-up|2|||
156357347|NCT03814746|564407706|FG001|Overall Study|Lost to Follow-up|1|||
156488027|NCT00774306|564880218|FG000|Overall Study|Adverse Event|3|||
156488028|NCT00774306|564880219|FG001|Overall Study|Adverse Event|0|||
156488029|NCT00774306|564880220|FG002|Overall Study|Adverse Event|0|||
156357348|NCT03814746|564407707|FG002|Overall Study|Lost to Follow-up|2|||
156357349|NCT03814746|564407705|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156488030|NCT00774306|564880221|FG003|Overall Study|Adverse Event|0|||
156544810|NCT01324232|565089443|FG000|Overall Study|Missing|0|||
156544811|NCT01324232|565089444|FG001|Overall Study|Missing|0|||
156544812|NCT01324232|565089445|FG002|Overall Study|Missing|1|||
156544813|NCT01324232|565089446|FG003|Overall Study|Missing|0|||
156544814|NCT01324232|565089443|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
156544815|NCT01324232|565089444|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
156544816|NCT01324232|565089445|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
156544817|NCT01324232|565089446|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
156544818|NCT01324232|565089443|FG000|Overall Study|Lack of Efficacy|2|||
156544819|NCT01324232|565089444|FG001|Overall Study|Lack of Efficacy|1|||
156544820|NCT01324232|565089445|FG002|Overall Study|Lack of Efficacy|2|||
156544821|NCT01324232|565089446|FG003|Overall Study|Lack of Efficacy|2|||
156544822|NCT01324232|565089443|FG000|Overall Study|Participant Refused Medication|0|||
156544823|NCT01324232|565089444|FG001|Overall Study|Participant Refused Medication|1|||
156544824|NCT01324232|565089445|FG002|Overall Study|Participant Refused Medication|0|||
156544825|NCT01324232|565089446|FG003|Overall Study|Participant Refused Medication|0|||
156544826|NCT01324232|565089443|FG000|Overall Study|Intercurrent illness|0|||
156544827|NCT01324232|565089444|FG001|Overall Study|Intercurrent illness|0|||
156544828|NCT01324232|565089445|FG002|Overall Study|Intercurrent illness|0|||
156544829|NCT01324232|565089446|FG003|Overall Study|Intercurrent illness|1|||
156544830|NCT01324232|565089443|FG000|Overall Study|Adverse Event|2|||
156544831|NCT01324232|565089444|FG001|Overall Study|Adverse Event|5|||
156544832|NCT01324232|565089445|FG002|Overall Study|Adverse Event|6|||
156544833|NCT01324232|565089446|FG003|Overall Study|Adverse Event|6|||
156544834|NCT01324232|565089443|FG000|Overall Study|Withdrawal by Subject|0|||
156544835|NCT01324232|565089444|FG001|Overall Study|Withdrawal by Subject|3|||
156544836|NCT01324232|565089445|FG002|Overall Study|Withdrawal by Subject|4|||
156544837|NCT01324232|565089446|FG003|Overall Study|Withdrawal by Subject|0|||
156544838|NCT01324232|565089443|FG000|Overall Study|Lost to Follow-up|1|||
156544839|NCT01324232|565089444|FG001|Overall Study|Lost to Follow-up|0|||
156544840|NCT01324232|565089445|FG002|Overall Study|Lost to Follow-up|0|||
156544841|NCT01324232|565089446|FG003|Overall Study|Lost to Follow-up|0|||
156544842|NCT00393887|565089447|FG000|Overall Study|Physician Decision|5|||
156544843|NCT00393887|565089448|FG001|Overall Study|Physician Decision|0|||
156544844|NCT00393887|565089447|FG000|Overall Study|Lost to Follow-up|11|||
156544845|NCT00393887|565089448|FG001|Overall Study|Lost to Follow-up|9|||
156544846|NCT01265615|565089449|FG000|Overall Study|Protocol Violation|2|||
156544847|NCT01265615|565089450|FG001|Overall Study|Protocol Violation|2|||
156544848|NCT01265615|565089451|FG002|Overall Study|Protocol Violation|4|||
156544849|NCT01265615|565089452|FG003|Overall Study|Protocol Violation|3|||
156544850|NCT00838331|565089453|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
156544851|NCT00957008|565089454|FG000|Overall Study|Withdrawal by Subject|13|||
156544852|NCT00957008|565089455|FG001|Overall Study|Withdrawal by Subject|10|||
156544853|NCT00957008|565089456|FG002|Overall Study|Withdrawal by Subject|12|||
156544854|NCT00957008|565089457|FG003|Overall Study|Withdrawal by Subject|16|||
156544855|NCT00957008|565089454|FG000|Overall Study|Lost to Follow-up|3|||
156544856|NCT00957008|565089455|FG001|Overall Study|Lost to Follow-up|1|||
156544857|NCT00957008|565089456|FG002|Overall Study|Lost to Follow-up|3|||
156544858|NCT00957008|565089457|FG003|Overall Study|Lost to Follow-up|4|||
156544859|NCT00957008|565089454|FG000|Overall Study|Physician Decision|1|||
156544860|NCT00957008|565089455|FG001|Overall Study|Physician Decision|0|||
156544861|NCT00957008|565089456|FG002|Overall Study|Physician Decision|1|||
156544862|NCT00957008|565089457|FG003|Overall Study|Physician Decision|1|||
156544863|NCT00957008|565089454|FG000|Overall Study|Relocated; Family conflict|4|||
156544864|NCT00957008|565089455|FG001|Overall Study|Relocated; Family conflict|1|||
156544865|NCT00957008|565089456|FG002|Overall Study|Relocated; Family conflict|1|||
156544866|NCT00957008|565089457|FG003|Overall Study|Relocated; Family conflict|3|||
156544867|NCT02411539|565089467|FG000|Overall Study|Lost to Follow-up|2|||
156544868|NCT02411539|565089468|FG001|Overall Study|Lost to Follow-up|0|||
156544869|NCT02411539|565089467|FG000|Overall Study|Confounding medical condition|0|||
156544870|NCT02411539|565089468|FG001|Overall Study|Confounding medical condition|1|||
156544871|NCT01422915|565089469|FG000|Overall Study|Adverse Event|1|||
156544872|NCT01265797|565089470|FG000|Run-in Month|Withdrawal by Subject|0|||
156544873|NCT01265797|565089471|FG001|Run-in Month|Withdrawal by Subject|4|||
156544874|NCT01265797|565089470|FG000|Run-in Month|1st seizure during run-in month|0|||
156544875|NCT01265797|565089471|FG001|Run-in Month|1st seizure during run-in month|1|||
156544876|NCT01265797|565089470|FG000|Blinded Month|Lack of Efficacy|5|||
156544877|NCT01265797|565089471|FG001|Blinded Month|Lack of Efficacy|0|||
156544878|NCT01265797|565089470|FG000|Blinded Month|Lost to Follow-up|1|||
156544879|NCT01265797|565089471|FG001|Blinded Month|Lost to Follow-up|0|||
156544880|NCT01265797|565089470|FG000|Blinded Month|Protocol Violation|2|||
156544881|NCT01265797|565089471|FG001|Blinded Month|Protocol Violation|1|||
156544882|NCT01265797|565089470|FG000|Blinded Month|Adverse Event|2|||
156544883|NCT01265797|565089471|FG001|Blinded Month|Adverse Event|0|||
156544884|NCT01265797|565089470|FG000|Blinded Month|Diary data incomplete|0|||
156544885|NCT01265797|565089471|FG001|Blinded Month|Diary data incomplete|1|||
156544886|NCT01265797|565089470|FG000|Open Label Month|Lost to Follow-up|0|||
156488031|NCT00774306|564880218|FG000|Overall Study|Protocol Violation|2|||
156488032|NCT00774306|564880219|FG001|Overall Study|Protocol Violation|0|||
156488033|NCT00774306|564880220|FG002|Overall Study|Protocol Violation|3|||
156488034|NCT00774306|564880221|FG003|Overall Study|Protocol Violation|0|||
156488035|NCT00774306|564880218|FG000|Overall Study|Withdrawal by Subject|6|||
156488036|NCT00774306|564880219|FG001|Overall Study|Withdrawal by Subject|1|||
156357350|NCT03814746|564407706|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156357351|NCT03814746|564407707|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156488037|NCT00774306|564880220|FG002|Overall Study|Withdrawal by Subject|1|||
156488038|NCT00774306|564880221|FG003|Overall Study|Withdrawal by Subject|0|||
156488039|NCT00774306|564880218|FG000|Overall Study|Lost to Follow-up|6|||
156488040|NCT00774306|564880219|FG001|Overall Study|Lost to Follow-up|0|||
156488041|NCT00774306|564880220|FG002|Overall Study|Lost to Follow-up|4|||
156488042|NCT00774306|564880221|FG003|Overall Study|Lost to Follow-up|5|||
156488043|NCT00774306|564880218|FG000|Overall Study|Death|1|||
156488044|NCT00774306|564880219|FG001|Overall Study|Death|1|||
156488045|NCT00774306|564880220|FG002|Overall Study|Death|0|||
156488046|NCT00774306|564880221|FG003|Overall Study|Death|0|||
156488047|NCT03568708|564880225|FG000|Overall Study|Withdrawal by Subject|1|||
156488048|NCT03568708|564880226|FG001|Overall Study|Withdrawal by Subject|1|||
156488049|NCT03568708|564880225|FG000|Overall Study|Lost to Follow-up|0|||
156488050|NCT03568708|564880226|FG001|Overall Study|Lost to Follow-up|1|||
156488051|NCT00666835|564880227|FG000|Overall Study|Withdrawal by Subject|5|||
156488052|NCT00666835|564880228|FG001|Overall Study|Withdrawal by Subject|2|||
156488053|NCT00666835|564880227|FG000|Overall Study|Lack of Efficacy|0|||
156488054|NCT00666835|564880228|FG001|Overall Study|Lack of Efficacy|1|||
156488055|NCT00666835|564880227|FG000|Overall Study|Incl./excl. not fulfilled|7|||
156488056|NCT00666835|564880228|FG001|Overall Study|Incl./excl. not fulfilled|2|||
156488057|NCT00666835|564880227|FG000|Overall Study|Adverse Event|7|||
156488058|NCT00666835|564880228|FG001|Overall Study|Adverse Event|6|||
156488059|NCT00666835|564880227|FG000|Overall Study|Protocol Violation|2|||
156488060|NCT00666835|564880228|FG001|Overall Study|Protocol Violation|0|||
156488061|NCT00666835|564880227|FG000|Overall Study|Death|15|||
156488062|NCT00666835|564880228|FG001|Overall Study|Death|4|||
156488063|NCT00666835|564880227|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
156488064|NCT00666835|564880228|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
156488065|NCT00666835|564880227|FG000|Overall Study|Hemoglobulin concentration|4|||
156488066|NCT00666835|564880228|FG001|Overall Study|Hemoglobulin concentration|3|||
156488067|NCT00666835|564880227|FG000|Overall Study|Planned operation|2|||
156488068|NCT00666835|564880228|FG001|Overall Study|Planned operation|0|||
156488069|NCT00666835|564880227|FG000|Overall Study|Physician Decision|1|||
156488070|NCT00666835|564880228|FG001|Overall Study|Physician Decision|2|||
156488071|NCT01126879|564880229|FG000|Overall Study|Progressive Disease|3|||
156488072|NCT01126879|564880230|FG001|Overall Study|Progressive Disease|1|||
156488073|NCT01126879|564880229|FG000|Overall Study|Withdrawal by Subject|1|||
156488074|NCT01126879|564880230|FG001|Overall Study|Withdrawal by Subject|0|||
156488075|NCT01126879|564880229|FG000|Overall Study|Adverse Event|0|||
156488076|NCT01126879|564880230|FG001|Overall Study|Adverse Event|1|||
156488077|NCT01126879|564880229|FG000|Overall Study|Physician Decision|1|||
156488078|NCT01126879|564880230|FG001|Overall Study|Physician Decision|0|||
156488079|NCT00511147|564880233|FG000|Overall Study|Withdrawal by Subject|1|||
156488080|NCT00511147|564880233|FG000|Overall Study|Disease progression|5|||
156488081|NCT00511147|564880233|FG000|Overall Study|Required platelet transfusion|1|||
156488082|NCT00899379|564880234|FG000|Overall Study|Adverse Event|2|||
156488083|NCT00899379|564880235|FG001|Overall Study|Adverse Event|2|||
156488084|NCT00899379|564880236|FG002|Overall Study|Adverse Event|1|||
156488085|NCT00899379|564880237|FG003|Overall Study|Adverse Event|1|||
156488086|NCT00899379|564880238|FG004|Overall Study|Adverse Event|2|||
156488087|NCT00899379|564880234|FG000|Overall Study|Lack of Efficacy|0|||
156488088|NCT00899379|564880235|FG001|Overall Study|Lack of Efficacy|4|||
156488089|NCT00899379|564880236|FG002|Overall Study|Lack of Efficacy|3|||
156488090|NCT00899379|564880237|FG003|Overall Study|Lack of Efficacy|0|||
156488091|NCT00899379|564880238|FG004|Overall Study|Lack of Efficacy|1|||
156488092|NCT00899379|564880234|FG000|Overall Study|Lost to Follow-up|9|||
156488093|NCT00899379|564880235|FG001|Overall Study|Lost to Follow-up|3|||
156488094|NCT00899379|564880236|FG002|Overall Study|Lost to Follow-up|0|||
156488095|NCT00899379|564880237|FG003|Overall Study|Lost to Follow-up|6|||
156488096|NCT00899379|564880238|FG004|Overall Study|Lost to Follow-up|2|||
156488097|NCT00899379|564880234|FG000|Overall Study|Protocol Violation|0|||
156357352|NCT03814746|564407705|FG000|Overall Study|Pregnancy|0|||
156488098|NCT00899379|564880235|FG001|Overall Study|Protocol Violation|0|||
156488099|NCT00899379|564880236|FG002|Overall Study|Protocol Violation|1|||
156357353|NCT03814746|564407706|FG001|Overall Study|Pregnancy|1|||
156357354|NCT03814746|564407707|FG002|Overall Study|Pregnancy|1|||
156488100|NCT00899379|564880237|FG003|Overall Study|Protocol Violation|1|||
156488101|NCT00899379|564880238|FG004|Overall Study|Protocol Violation|0|||
156488102|NCT00899379|564880234|FG000|Overall Study|Withdrawal by Subject|2|||
156488103|NCT00899379|564880235|FG001|Overall Study|Withdrawal by Subject|4|||
156488104|NCT00899379|564880236|FG002|Overall Study|Withdrawal by Subject|2|||
156488105|NCT00899379|564880237|FG003|Overall Study|Withdrawal by Subject|3|||
156488106|NCT00899379|564880238|FG004|Overall Study|Withdrawal by Subject|6|||
156488107|NCT00899379|564880234|FG000|Overall Study|Pregnancy|0|||
156488108|NCT00899379|564880235|FG001|Overall Study|Pregnancy|0|||
156488109|NCT00899379|564880236|FG002|Overall Study|Pregnancy|1|||
156488110|NCT00899379|564880237|FG003|Overall Study|Pregnancy|0|||
156488111|NCT00899379|564880238|FG004|Overall Study|Pregnancy|1|||
156357355|NCT03814746|564407705|FG000|Overall Study|Protocol Violation|1|||
156357356|NCT03814746|564407706|FG001|Overall Study|Protocol Violation|0|||
156357357|NCT03814746|564407707|FG002|Overall Study|Protocol Violation|0|||
156357358|NCT05089682|564407708|FG000|Overall Study|Withdrawal by Subject|2|||
156357359|NCT03992781|564407709|FG000|Overall Study|Lost to Follow-up|5|||
156357360|NCT03992781|564407709|FG000|Overall Study|Adverse Event|1|||
156357361|NCT03992781|564407709|FG000|Overall Study|Lack of Efficacy|5|||
156357362|NCT01996826|564407710|FG000|Overall Study|Lost to Follow-up|6|||
156357363|NCT01996826|564407711|FG001|Overall Study|Lost to Follow-up|2|||
156357364|NCT01996826|564407710|FG000|Overall Study|Physician Decision|1|||
156357365|NCT01996826|564407711|FG001|Overall Study|Physician Decision|1|||
156357366|NCT00695396|564407712|FG000|Overall Study|Study Closed Prematurely|5|||
156357367|NCT00695396|564407713|FG001|Overall Study|Study Closed Prematurely|6|||
156357368|NCT00695396|564407714|FG002|Overall Study|Study Closed Prematurely|8|||
156357369|NCT00695396|564407712|FG000|Overall Study|Withdrawal by Subject|2|||
156357370|NCT00695396|564407713|FG001|Overall Study|Withdrawal by Subject|2|||
156357371|NCT00695396|564407714|FG002|Overall Study|Withdrawal by Subject|0|||
156357372|NCT00518323|564407716|FG000|Overall Study|Lack of Efficacy|14|||
156357373|NCT00518323|564407717|FG001|Overall Study|Lack of Efficacy|2|||
156357374|NCT00518323|564407718|FG002|Overall Study|Lack of Efficacy|4|||
156357375|NCT00518323|564407719|FG003|Overall Study|Lack of Efficacy|20|||
156357376|NCT00518323|564407716|FG000|Overall Study|Withdrawal by Subject|1|||
156357377|NCT00518323|564407717|FG001|Overall Study|Withdrawal by Subject|2|||
156357378|NCT00518323|564407718|FG002|Overall Study|Withdrawal by Subject|4|||
156357379|NCT00518323|564407719|FG003|Overall Study|Withdrawal by Subject|2|||
156357380|NCT00518323|564407716|FG000|Overall Study|Lost to Follow-up|0|||
156357381|NCT00518323|564407717|FG001|Overall Study|Lost to Follow-up|2|||
156357382|NCT00518323|564407718|FG002|Overall Study|Lost to Follow-up|1|||
156357383|NCT00518323|564407719|FG003|Overall Study|Lost to Follow-up|3|||
156357384|NCT00518323|564407716|FG000|Overall Study|Adverse Event|1|||
156357385|NCT00518323|564407717|FG001|Overall Study|Adverse Event|1|||
156357386|NCT00518323|564407718|FG002|Overall Study|Adverse Event|1|||
156357387|NCT00518323|564407719|FG003|Overall Study|Adverse Event|0|||
156357388|NCT00518323|564407716|FG000|Overall Study|Prohibited medication and others|3|||
156357389|NCT00518323|564407717|FG001|Overall Study|Prohibited medication and others|1|||
156357390|NCT00518323|564407718|FG002|Overall Study|Prohibited medication and others|1|||
156357391|NCT00518323|564407719|FG003|Overall Study|Prohibited medication and others|0|||
156357392|NCT03164928|564407721|FG000|Overall Study|Lost to Follow-up|1|||
156357393|NCT03164928|564407722|FG001|Overall Study|Lost to Follow-up|0|||
156357394|NCT00326950|564407726|FG000|Overall Study|Progressive Disease|1|||
156357395|NCT00772707|564407728|FG000|Overall Study|Withdrawn|3|||
156357396|NCT04499781|564407729|FG000|Overall Study|Lost to Follow-up|2|||
156357397|NCT04499781|564407730|FG001|Overall Study|Lost to Follow-up|3|||
156357398|NCT04499781|564407729|FG000|Overall Study|Withdrawal by Subject|2|||
156357399|NCT04499781|564407730|FG001|Overall Study|Withdrawal by Subject|0|||
156357400|NCT00483379|564407731|FG000|Treatment Period|Adverse Event|1|||
156357401|NCT00483379|564407732|FG001|Treatment Period|Adverse Event|0|||
156357402|NCT00483379|564407731|FG000|Treatment Period|Withdrawal by Subject|1|||
156357403|NCT00483379|564407732|FG001|Treatment Period|Withdrawal by Subject|0|||
156357404|NCT00371254|564407734|FG000|Overall Study|Disease progression|13|||
156357405|NCT00371254|564407735|FG001|Overall Study|Disease progression|13|||
156357406|NCT00371254|564407734|FG000|Overall Study|Study drug toxicity|3|||
156357407|NCT00371254|564407735|FG001|Overall Study|Study drug toxicity|5|||
156357408|NCT00371254|564407734|FG000|Overall Study|Subject request|5|||
156357409|NCT00371254|564407735|FG001|Overall Study|Subject request|0|||
156357410|NCT00371254|564407734|FG000|Overall Study|Investigator Decision|2|||
156357411|NCT00371254|564407735|FG001|Overall Study|Investigator Decision|0|||
156357412|NCT00371254|564407734|FG000|Overall Study|Adverse event unrelated to study drug|0|||
156357413|NCT00371254|564407735|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156357414|NCT00371254|564407734|FG000|Overall Study|Lost to Follow-up|0|||
156357415|NCT00371254|564407735|FG001|Overall Study|Lost to Follow-up|1|||
156357416|NCT00371254|564407734|FG000|Overall Study|Withdrawal by Subject|0|||
156357417|NCT00371254|564407735|FG001|Overall Study|Withdrawal by Subject|1|||
156357418|NCT03329690|564407736|FG000|Overall Study|Progressive disease per RECIST|85|||
156357419|NCT03329690|564407737|FG001|Overall Study|Progressive disease per RECIST|44|||
156357420|NCT03329690|564407738|FG002|Overall Study|Progressive disease per RECIST|6|||
156357421|NCT03329690|564407739|FG003|Overall Study|Progressive disease per RECIST|16|||
156357422|NCT03329690|564407740|FG004|Overall Study|Progressive disease per RECIST|20|||
156357423|NCT03329690|564407736|FG000|Overall Study|Clinical progression|7|||
156357424|NCT03329690|564407737|FG001|Overall Study|Clinical progression|4|||
156357425|NCT03329690|564407738|FG002|Overall Study|Clinical progression|1|||
156357426|NCT03329690|564407739|FG003|Overall Study|Clinical progression|1|||
156488112|NCT00899379|564880234|FG000|Overall Study|Patient Uncooperative|0|||
156488113|NCT00899379|564880235|FG001|Overall Study|Patient Uncooperative|1|||
156357427|NCT03329690|564407740|FG004|Overall Study|Clinical progression|1|||
156488114|NCT00899379|564880236|FG002|Overall Study|Patient Uncooperative|0|||
156488115|NCT00899379|564880237|FG003|Overall Study|Patient Uncooperative|1|||
156488116|NCT00899379|564880238|FG004|Overall Study|Patient Uncooperative|2|||
156488117|NCT00899379|564880234|FG000|Overall Study|Abnormal Baseline ECG|0|||
156488118|NCT00899379|564880235|FG001|Overall Study|Abnormal Baseline ECG|0|||
156488119|NCT00899379|564880236|FG002|Overall Study|Abnormal Baseline ECG|0|||
156488120|NCT00899379|564880237|FG003|Overall Study|Abnormal Baseline ECG|1|||
156488121|NCT00899379|564880238|FG004|Overall Study|Abnormal Baseline ECG|0|||
156488122|NCT00899379|564880234|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
156488123|NCT00899379|564880235|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
156488124|NCT00899379|564880236|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
156488125|NCT00899379|564880237|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156488126|NCT00899379|564880238|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156488127|NCT00899379|564880234|FG000|Overall Study|Not Completed/Entered Extn|5|||
156488128|NCT00899379|564880235|FG001|Overall Study|Not Completed/Entered Extn|1|||
156488129|NCT00899379|564880236|FG002|Overall Study|Not Completed/Entered Extn|6|||
156488130|NCT00899379|564880237|FG003|Overall Study|Not Completed/Entered Extn|4|||
156488131|NCT00899379|564880238|FG004|Overall Study|Not Completed/Entered Extn|3|||
156488132|NCT00899379|564880234|FG000|Overall Study|Study Terminated|3|||
156488133|NCT00899379|564880235|FG001|Overall Study|Study Terminated|0|||
156488134|NCT00899379|564880236|FG002|Overall Study|Study Terminated|3|||
156488135|NCT00899379|564880237|FG003|Overall Study|Study Terminated|3|||
156488136|NCT00899379|564880238|FG004|Overall Study|Study Terminated|1|||
156488137|NCT00899379|564880234|FG000|Overall Study|Lost to Follow-up|3|||
156488138|NCT00899379|564880235|FG001|Overall Study|Lost to Follow-up|1|||
156488139|NCT00899379|564880236|FG002|Overall Study|Lost to Follow-up|0|||
156488140|NCT00899379|564880237|FG003|Overall Study|Lost to Follow-up|2|||
156488141|NCT00899379|564880238|FG004|Overall Study|Lost to Follow-up|5|||
156488142|NCT00899379|564880234|FG000|Overall Study|Withdrawal by Subject|4|||
156488143|NCT00899379|564880235|FG001|Overall Study|Withdrawal by Subject|7|||
156488144|NCT00899379|564880236|FG002|Overall Study|Withdrawal by Subject|4|||
156488145|NCT00899379|564880237|FG003|Overall Study|Withdrawal by Subject|7|||
156488146|NCT00899379|564880238|FG004|Overall Study|Withdrawal by Subject|2|||
156488147|NCT00899379|564880234|FG000|Overall Study|Pregnancy|1|||
156488148|NCT00899379|564880235|FG001|Overall Study|Pregnancy|0|||
156488149|NCT00899379|564880236|FG002|Overall Study|Pregnancy|0|||
156488150|NCT00899379|564880237|FG003|Overall Study|Pregnancy|0|||
156488151|NCT00899379|564880238|FG004|Overall Study|Pregnancy|0|||
156488152|NCT00899379|564880234|FG000|Overall Study|Patient Uncooperative|0|||
156488153|NCT00899379|564880235|FG001|Overall Study|Patient Uncooperative|0|||
156357428|NCT03329690|564407736|FG000|Overall Study|Adverse Event|22|||
156357429|NCT03329690|564407737|FG001|Overall Study|Adverse Event|4|||
156357430|NCT03329690|564407738|FG002|Overall Study|Adverse Event|0|||
156357431|NCT03329690|564407739|FG003|Overall Study|Adverse Event|1|||
156357432|NCT03329690|564407740|FG004|Overall Study|Adverse Event|2|||
156357433|NCT03329690|564407736|FG000|Overall Study|Death|2|||
156357434|NCT03329690|564407737|FG001|Overall Study|Death|0|||
156357435|NCT03329690|564407738|FG002|Overall Study|Death|0|||
156357436|NCT03329690|564407739|FG003|Overall Study|Death|1|||
156357437|NCT03329690|564407740|FG004|Overall Study|Death|0|||
156357438|NCT03329690|564407736|FG000|Overall Study|Withdrawal by Subject|2|||
156357439|NCT03329690|564407737|FG001|Overall Study|Withdrawal by Subject|3|||
156357440|NCT03329690|564407738|FG002|Overall Study|Withdrawal by Subject|0|||
156357441|NCT03329690|564407739|FG003|Overall Study|Withdrawal by Subject|1|||
156357442|NCT03329690|564407740|FG004|Overall Study|Withdrawal by Subject|0|||
156357443|NCT03329690|564407736|FG000|Overall Study|Physician Decision|1|||
156357444|NCT03329690|564407737|FG001|Overall Study|Physician Decision|0|||
156357445|NCT03329690|564407738|FG002|Overall Study|Physician Decision|0|||
156357446|NCT03329690|564407739|FG003|Overall Study|Physician Decision|0|||
156357447|NCT03329690|564407740|FG004|Overall Study|Physician Decision|1|||
156357448|NCT03329690|564407736|FG000|Overall Study|Miscellaneous|6|||
156357449|NCT03329690|564407737|FG001|Overall Study|Miscellaneous|0|||
156357450|NCT03329690|564407738|FG002|Overall Study|Miscellaneous|0|||
156357451|NCT03329690|564407739|FG003|Overall Study|Miscellaneous|0|||
156357452|NCT03329690|564407740|FG004|Overall Study|Miscellaneous|0|||
156357453|NCT03329690|564407736|FG000|Overall Study|Did not receive treatment|1|||
156357454|NCT03329690|564407737|FG001|Overall Study|Did not receive treatment|0|||
156357455|NCT03329690|564407738|FG002|Overall Study|Did not receive treatment|0|||
156357456|NCT03329690|564407739|FG003|Overall Study|Did not receive treatment|1|||
156357457|NCT03329690|564407740|FG004|Overall Study|Did not receive treatment|0|||
156357458|NCT01817725|564407741|FG000|Overall Study|Withdrawal by Subject|1|||
156357459|NCT02337907|564407742|FG000|Overall Study|Other than listed|1|||
156357460|NCT02337907|564407743|FG001|Overall Study|Other than listed|0|||
156357461|NCT02337907|564407744|FG002|Overall Study|Other than listed|0|||
156357462|NCT02337907|564407745|FG003|Overall Study|Other than listed|1|||
156357463|NCT02337907|564407746|FG004|Overall Study|Other than listed|1|||
156357464|NCT02337907|564407747|FG005|Overall Study|Other than listed|0|||
156357465|NCT02337907|564407742|FG000|Overall Study|Withdrawal by Subject|2|||
156357466|NCT02337907|564407743|FG001|Overall Study|Withdrawal by Subject|3|||
156357467|NCT02337907|564407744|FG002|Overall Study|Withdrawal by Subject|0|||
156357468|NCT02337907|564407745|FG003|Overall Study|Withdrawal by Subject|2|||
156357469|NCT02337907|564407746|FG004|Overall Study|Withdrawal by Subject|5|||
156357470|NCT02337907|564407747|FG005|Overall Study|Withdrawal by Subject|0|||
156357471|NCT02337907|564407742|FG000|Overall Study|Lost to Follow-up|0|||
156357472|NCT02337907|564407743|FG001|Overall Study|Lost to Follow-up|0|||
156357473|NCT02337907|564407744|FG002|Overall Study|Lost to Follow-up|0|||
156357474|NCT02337907|564407745|FG003|Overall Study|Lost to Follow-up|0|||
156357475|NCT02337907|564407746|FG004|Overall Study|Lost to Follow-up|0|||
156357476|NCT02337907|564407747|FG005|Overall Study|Lost to Follow-up|1|||
156357477|NCT02337907|564407742|FG000|Overall Study|Adverse Event|1|||
156357478|NCT02337907|564407743|FG001|Overall Study|Adverse Event|1|||
156357479|NCT02337907|564407744|FG002|Overall Study|Adverse Event|1|||
156357480|NCT02337907|564407745|FG003|Overall Study|Adverse Event|1|||
156357481|NCT02337907|564407746|FG004|Overall Study|Adverse Event|4|||
156357482|NCT02337907|564407747|FG005|Overall Study|Adverse Event|0|||
156357483|NCT04519645|564407750|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
156357484|NCT04519645|564407751|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
156357485|NCT04519645|564407752|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
156357486|NCT04519645|564407750|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
156357487|NCT04519645|564407751|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
156357488|NCT04519645|564407752|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
156357489|NCT04519645|564407750|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
156357490|NCT04519645|564407751|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
156357491|NCT04519645|564407752|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
156357492|NCT04519645|564407750|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
156357493|NCT04519645|564407751|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
156357494|NCT04519645|564407752|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
156488154|NCT00899379|564880236|FG002|Overall Study|Patient Uncooperative|0|||
156357495|NCT01679002|564407753|FG000|Overall Study|Adverse Event|1|||
156357496|NCT01679002|564407754|FG001|Overall Study|Adverse Event|1|||
156488155|NCT00899379|564880237|FG003|Overall Study|Patient Uncooperative|1|||
156488156|NCT00899379|564880238|FG004|Overall Study|Patient Uncooperative|0|||
156488157|NCT00899379|564880234|FG000|Overall Study|Abnormal Prestudy Labs|0|||
156357497|NCT01679002|564407755|FG002|Overall Study|Adverse Event|0|||
156357498|NCT05172544|564407758|FG000|Overall Study|Withdrawal by Subject|1|||
156357499|NCT05172544|564407759|FG001|Overall Study|Withdrawal by Subject|0|||
156544887|NCT01265797|565089471|FG001|Open Label Month|Lost to Follow-up|1|||
156544888|NCT00939783|565089473|FG000|Overall Study|Death|6|||
156544889|NCT00939783|565089473|FG000|Overall Study|Adverse Event|39|||
156544890|NCT00939783|565089473|FG000|Overall Study|Study Terminated by Sponsor|498|||
156544891|NCT00939783|565089473|FG000|Overall Study|Withdrawal by Subject|78|||
156544892|NCT00939783|565089473|FG000|Overall Study|Other|16|||
156544893|NCT00939783|565089473|FG000|Overall Study|Lost to Follow-up|8|||
156544894|NCT00939783|565089473|FG000|Overall Study|Protocol Violation|3|||
156544895|NCT00939783|565089473|FG000|Overall Study|Enrolled but not treated|1|||
156544896|NCT03631732|565089478|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
156544897|NCT03631732|565089479|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
156544898|NCT03631732|565089478|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
156544899|NCT03631732|565089479|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
156544900|NCT03631732|565089478|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
156544901|NCT03631732|565089479|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
156544902|NCT03631732|565089478|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
156544903|NCT03631732|565089479|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
156544904|NCT03631732|565089478|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
156544905|NCT03631732|565089479|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
156544906|NCT03631732|565089478|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
156544907|NCT03631732|565089479|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
156544908|NCT03631732|565089478|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
156544909|NCT03631732|565089479|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
156544910|NCT03631732|565089478|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
156544911|NCT03631732|565089479|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
156544912|NCT03631732|565089478|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
156544913|NCT03631732|565089479|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
156544914|NCT03631732|565089478|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
156544915|NCT03631732|565089479|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
156544916|NCT01439204|565089480|FG000|Overall Study|Withdrawal by Subject|0|||
156544917|NCT01439204|565089481|FG001|Overall Study|Withdrawal by Subject|1|||
156544918|NCT01439204|565089480|FG000|Overall Study|Lost to Follow-up|0|||
156544919|NCT01439204|565089481|FG001|Overall Study|Lost to Follow-up|2|||
156544920|NCT01439204|565089480|FG000|Overall Study|No longer meets study criteria|1|||
156544921|NCT01439204|565089481|FG001|Overall Study|No longer meets study criteria|0|||
156544922|NCT01439204|565089480|FG000|Overall Study|poor/non-compliance|3|||
156544923|NCT01439204|565089481|FG001|Overall Study|poor/non-compliance|0|||
156544924|NCT02255409|565089482|FG000|Overall Study|Administrative Reason|3|||
156544925|NCT02255409|565089483|FG001|Overall Study|Administrative Reason|7|||
156544926|NCT02255409|565089482|FG000|Overall Study|Withdrawal by Subject|1|||
156544927|NCT02255409|565089483|FG001|Overall Study|Withdrawal by Subject|5|||
156544928|NCT02255409|565089482|FG000|Overall Study|Lost to Follow-up|10|||
156544929|NCT02255409|565089483|FG001|Overall Study|Lost to Follow-up|19|||
156544930|NCT03775421|565089485|FG000|Overall Study|Lost to Follow-up|2|||
156544931|NCT03775421|565089485|FG000|Overall Study|Withdrawal by Subject|10|||
156544932|NCT03775421|565089485|FG000|Overall Study|Physician Decision|3|||
156544933|NCT03775421|565089485|FG000|Overall Study|Death|1|||
156544934|NCT03775421|565089485|FG000|Overall Study|Study Terminated by Sponsor|94|||
156544935|NCT02287623|565089493|FG000|Overall Study|Protocol Violation|0|||
156544936|NCT02287623|565089494|FG001|Overall Study|Protocol Violation|1|||
156544937|NCT02700997|565089495|FG000|Overall Study|Did not undergo CT imaging|1|||
156544938|NCT02700997|565089495|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
156544939|NCT01445951|565089499|FG000|Overall Study|Adverse Event|16|||
156544940|NCT01445951|565089500|FG001|Overall Study|Adverse Event|9|||
156544941|NCT01445951|565089501|FG002|Overall Study|Adverse Event|0|||
156544942|NCT01445951|565089499|FG000|Overall Study|Protocol Violation|2|||
156544943|NCT01445951|565089500|FG001|Overall Study|Protocol Violation|2|||
156544944|NCT01445951|565089501|FG002|Overall Study|Protocol Violation|2|||
156544945|NCT01445951|565089499|FG000|Overall Study|Withdrawal by Subject|21|||
156544946|NCT01445951|565089500|FG001|Overall Study|Withdrawal by Subject|16|||
156544947|NCT01445951|565089501|FG002|Overall Study|Withdrawal by Subject|8|||
156544948|NCT01445951|565089499|FG000|Overall Study|Physician Decision|3|||
156544949|NCT01445951|565089500|FG001|Overall Study|Physician Decision|1|||
156544950|NCT01445951|565089501|FG002|Overall Study|Physician Decision|0|||
156544951|NCT01445951|565089499|FG000|Overall Study|Lost to Follow-up|1|||
156544952|NCT01445951|565089500|FG001|Overall Study|Lost to Follow-up|2|||
156357500|NCT05172544|564407760|FG002|Overall Study|Withdrawal by Subject|0|||
156357501|NCT05172544|564407758|FG000|Overall Study|Physician Decision|0|||
156357502|NCT05172544|564407759|FG001|Overall Study|Physician Decision|0|||
156357503|NCT05172544|564407760|FG002|Overall Study|Physician Decision|1|||
156357504|NCT01179477|564407770|FG000|Overall Study|Death|542|||
156357505|NCT01179477|564407770|FG000|Overall Study|Unsuccessful implant|80|||
156357506|NCT01179477|564407770|FG000|Overall Study|Non-death withdrawal|438|||
156357507|NCT01179477|564407770|FG000|Overall Study|Did not complete final visit|27|||
156357508|NCT04829318|564407772|FG000|Overall Study|Adverse Event|6|||
156357509|NCT04829318|564407772|FG000|Overall Study|Death|1|||
156357510|NCT04829318|564407772|FG000|Overall Study|Lost to Follow-up|1|||
156357511|NCT04829318|564407772|FG000|Overall Study|Physician Decision|1|||
156357512|NCT04829318|564407772|FG000|Overall Study|Withdrawal by Subject|19|||
156357513|NCT04829318|564407772|FG000|Overall Study|Site terminated by sponsor|1|||
156357514|NCT04829318|564407772|FG000|Overall Study|Sponsor decision|5|||
156357515|NCT04829318|564407772|FG000|Overall Study|Other|1|||
156357516|NCT00728130|564407773|FG000|Overall Study|Withdrawal by Subject|1|||
156357517|NCT00728130|564407773|FG000|Overall Study|Paperwork not completed in time|1|||
156357518|NCT00728130|564407773|FG000|Overall Study|Physician Decision|1|||
156357519|NCT04053023|564407776|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
156357520|NCT04053023|564407777|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
156357521|NCT03447990|564407787|FG000|Overall Study|Withdrawal by Subject|0|||
156357522|NCT03447990|564407788|FG001|Overall Study|Withdrawal by Subject|0|||
156357523|NCT03447990|564407789|FG002|Overall Study|Withdrawal by Subject|0|||
156357524|NCT03447990|564407790|FG003|Overall Study|Withdrawal by Subject|0|||
156357525|NCT03447990|564407791|FG004|Overall Study|Withdrawal by Subject|0|||
156357526|NCT03447990|564407792|FG005|Overall Study|Withdrawal by Subject|0|||
156357527|NCT03447990|564407793|FG006|Overall Study|Withdrawal by Subject|1|||
156357528|NCT00423150|564407794|FG000|Overall Study|Adverse Event|11|||
156357529|NCT00423150|564407794|FG000|Overall Study|Progression of disease being studied|69|||
156357530|NCT00423150|564407794|FG000|Overall Study|Withdrawal by Subject|1|||
156357531|NCT00423150|564407794|FG000|Overall Study|Non-compliance with protocol|1|||
156357532|NCT00423150|564407794|FG000|Overall Study|Administrative|4|||
156357533|NCT00455429|564407795|FG000|Overall Study|Study Terminated by Sponsor|0|||
156357534|NCT00455429|564407796|FG001|Overall Study|Study Terminated by Sponsor|0|||
156357535|NCT00455429|564407797|FG002|Overall Study|Study Terminated by Sponsor|0|||
156357536|NCT00455429|564407798|FG003|Overall Study|Study Terminated by Sponsor|3|||
156357537|NCT00455429|564407795|FG000|Overall Study|Lost to Follow-up|1|||
156357538|NCT00455429|564407796|FG001|Overall Study|Lost to Follow-up|0|||
156357539|NCT00455429|564407797|FG002|Overall Study|Lost to Follow-up|0|||
156357540|NCT00455429|564407798|FG003|Overall Study|Lost to Follow-up|3|||
156357541|NCT00455429|564407795|FG000|Overall Study|Withdrawal by Subject|0|||
156357542|NCT00455429|564407796|FG001|Overall Study|Withdrawal by Subject|1|||
156357543|NCT00455429|564407797|FG002|Overall Study|Withdrawal by Subject|1|||
156357544|NCT00455429|564407798|FG003|Overall Study|Withdrawal by Subject|0|||
156357545|NCT00455429|564407795|FG000|Overall Study|Lack of Efficacy|0|||
156357546|NCT00455429|564407796|FG001|Overall Study|Lack of Efficacy|1|||
156357547|NCT00455429|564407797|FG002|Overall Study|Lack of Efficacy|0|||
156357548|NCT00455429|564407798|FG003|Overall Study|Lack of Efficacy|1|||
156357549|NCT00455429|564407795|FG000|Overall Study|Adverse Event|0|||
156357550|NCT00455429|564407796|FG001|Overall Study|Adverse Event|1|||
156357551|NCT00455429|564407797|FG002|Overall Study|Adverse Event|0|||
156357552|NCT00455429|564407798|FG003|Overall Study|Adverse Event|3|||
156357553|NCT00455429|564407795|FG000|Overall Study|Randomly assigned but not treated|0|||
156357554|NCT00455429|564407796|FG001|Overall Study|Randomly assigned but not treated|0|||
156357555|NCT00455429|564407797|FG002|Overall Study|Randomly assigned but not treated|0|||
156357556|NCT00455429|564407798|FG003|Overall Study|Randomly assigned but not treated|2|||
156357557|NCT00455429|564407795|FG000|Overall Study|Personal Reason|1|||
156357558|NCT00455429|564407796|FG001|Overall Study|Personal Reason|0|||
156357559|NCT00455429|564407797|FG002|Overall Study|Personal Reason|0|||
156357560|NCT00455429|564407798|FG003|Overall Study|Personal Reason|0|||
156357561|NCT00455429|564407795|FG000|Overall Study|Non-compliance|0|||
156357562|NCT00455429|564407796|FG001|Overall Study|Non-compliance|0|||
156357563|NCT00455429|564407797|FG002|Overall Study|Non-compliance|0|||
156357564|NCT00455429|564407798|FG003|Overall Study|Non-compliance|1|||
156357565|NCT00455429|564407795|FG000|Overall Study|Other|0|||
156357566|NCT00455429|564407796|FG001|Overall Study|Other|2|||
156357567|NCT00455429|564407797|FG002|Overall Study|Other|0|||
156357568|NCT00455429|564407798|FG003|Overall Study|Other|1|||
156357569|NCT03519347|564407799|FG000|Interventional Crossover Period 1|Death|0|||
156488158|NCT00899379|564880235|FG001|Overall Study|Abnormal Prestudy Labs|0|||
156357570|NCT03519347|564407800|FG001|Interventional Crossover Period 1|Death|0|||
156357571|NCT03519347|564407801|FG002|Interventional Crossover Period 1|Death|0|||
156357572|NCT03519347|564407802|FG003|Interventional Crossover Period 1|Death|1|||
156488159|NCT00899379|564880236|FG002|Overall Study|Abnormal Prestudy Labs|0|||
156357573|NCT01092182|564407803|FG000|Overall Study|Death|0|||
156357574|NCT01092182|564407804|FG001|Overall Study|Death|5|||
156357575|NCT01092182|564407805|FG002|Overall Study|Death|3|||
156357576|NCT01092182|564407803|FG000|Overall Study|participant safety|1|||
156357577|NCT01092182|564407804|FG001|Overall Study|participant safety|2|||
156357578|NCT01092182|564407805|FG002|Overall Study|participant safety|0|||
156544953|NCT01445951|565089501|FG002|Overall Study|Lost to Follow-up|4|||
156544954|NCT01445951|565089499|FG000|Overall Study|Pregnancy|0|||
156544955|NCT01445951|565089500|FG001|Overall Study|Pregnancy|1|||
156488160|NCT00899379|564880237|FG003|Overall Study|Abnormal Prestudy Labs|0|||
156488161|NCT00899379|564880238|FG004|Overall Study|Abnormal Prestudy Labs|2|||
156488162|NCT00899379|564880234|FG000|Overall Study|Abnormal Baseline ECG|0|||
156488163|NCT00899379|564880235|FG001|Overall Study|Abnormal Baseline ECG|0|||
156488164|NCT00899379|564880236|FG002|Overall Study|Abnormal Baseline ECG|1|||
156488165|NCT00899379|564880237|FG003|Overall Study|Abnormal Baseline ECG|1|||
156488166|NCT00899379|564880238|FG004|Overall Study|Abnormal Baseline ECG|0|||
156488167|NCT00899379|564880234|FG000|Overall Study|No Attack Pretreatment|3|||
156488168|NCT00899379|564880235|FG001|Overall Study|No Attack Pretreatment|5|||
156488169|NCT00899379|564880236|FG002|Overall Study|No Attack Pretreatment|5|||
156488170|NCT00899379|564880237|FG003|Overall Study|No Attack Pretreatment|6|||
156488171|NCT00899379|564880238|FG004|Overall Study|No Attack Pretreatment|4|||
156488172|NCT00899379|564880234|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
156488173|NCT00899379|564880235|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156488174|NCT00899379|564880236|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156488175|NCT00899379|564880237|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156488176|NCT00899379|564880238|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156488177|NCT00899379|564880234|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
156488178|NCT00899379|564880235|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
156488179|NCT00899379|564880236|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
156488180|NCT00899379|564880237|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
156488181|NCT00899379|564880238|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
156488182|NCT00809783|564880241|FG000|Overall Study|Death|1|||
156488183|NCT00809783|564880242|FG001|Overall Study|Death|0|||
156488184|NCT00809783|564880243|FG002|Overall Study|Death|0|||
156488185|NCT00809783|564880241|FG000|Overall Study|Adverse Event|34|||
156488186|NCT00809783|564880242|FG001|Overall Study|Adverse Event|52|||
156488187|NCT00809783|564880243|FG002|Overall Study|Adverse Event|71|||
156488188|NCT00809783|564880241|FG000|Overall Study|Lack of Efficacy|39|||
156488189|NCT00809783|564880242|FG001|Overall Study|Lack of Efficacy|52|||
156488190|NCT00809783|564880243|FG002|Overall Study|Lack of Efficacy|63|||
156488191|NCT00809783|564880241|FG000|Overall Study|Lost to Follow-up|0|||
156488192|NCT00809783|564880242|FG001|Overall Study|Lost to Follow-up|3|||
156488193|NCT00809783|564880243|FG002|Overall Study|Lost to Follow-up|4|||
156488194|NCT00809783|564880241|FG000|Overall Study|Withdrawal by Subject|47|||
156488195|NCT00809783|564880242|FG001|Overall Study|Withdrawal by Subject|72|||
156488196|NCT00809783|564880243|FG002|Overall Study|Withdrawal by Subject|64|||
156488197|NCT00809783|564880241|FG000|Overall Study|Protocol Violation|2|||
156488198|NCT00809783|564880242|FG001|Overall Study|Protocol Violation|6|||
156488199|NCT00809783|564880243|FG002|Overall Study|Protocol Violation|5|||
156488200|NCT00809783|564880241|FG000|Overall Study|Randomized, but not treated|3|||
156488201|NCT00809783|564880242|FG001|Overall Study|Randomized, but not treated|0|||
156488202|NCT00809783|564880243|FG002|Overall Study|Randomized, but not treated|2|||
156488203|NCT00809783|564880241|FG000|Overall Study|Study Terminated by Sponsor|378|||
156488204|NCT00809783|564880242|FG001|Overall Study|Study Terminated by Sponsor|626|||
156488205|NCT00809783|564880243|FG002|Overall Study|Study Terminated by Sponsor|565|||
156488206|NCT00809783|564880241|FG000|Overall Study|Other|21|||
156544956|NCT01445951|565089501|FG002|Overall Study|Pregnancy|4|||
156488207|NCT00809783|564880242|FG001|Overall Study|Other|21|||
156488208|NCT00809783|564880243|FG002|Overall Study|Other|16|||
156488209|NCT00126555|564880244|FG000|Overall Study|Withdrawal by Subject|1|||
156544957|NCT01445951|565089499|FG000|Overall Study|Death|0|||
156357579|NCT01092182|564407803|FG000|Overall Study|Physician Decision|0|||
156357580|NCT01092182|564407804|FG001|Overall Study|Physician Decision|6|||
156357581|NCT01092182|564407805|FG002|Overall Study|Physician Decision|0|||
156357582|NCT01092182|564407803|FG000|Overall Study|Did not meet criteria|0|||
156357583|NCT01092182|564407804|FG001|Overall Study|Did not meet criteria|0|||
156357584|NCT01092182|564407805|FG002|Overall Study|Did not meet criteria|25|||
156357585|NCT01092182|564407803|FG000|Overall Study|Non-compliance|0|||
156357586|NCT01092182|564407804|FG001|Overall Study|Non-compliance|3|||
156357587|NCT01092182|564407805|FG002|Overall Study|Non-compliance|0|||
156357588|NCT01092182|564407803|FG000|Overall Study|Participant refused follow-up|0|||
156357589|NCT01092182|564407804|FG001|Overall Study|Participant refused follow-up|2|||
156357590|NCT01092182|564407805|FG002|Overall Study|Participant refused follow-up|0|||
156357591|NCT02515045|564407806|FG000|Overall Study|Adverse Event|0|||
156357592|NCT02515045|564407807|FG001|Overall Study|Adverse Event|3|||
156357593|NCT02515045|564407808|FG002|Overall Study|Adverse Event|3|||
156357594|NCT02515045|564407806|FG000|Overall Study|Lost to Follow-up|0|||
156357595|NCT02515045|564407807|FG001|Overall Study|Lost to Follow-up|1|||
156357596|NCT02515045|564407808|FG002|Overall Study|Lost to Follow-up|1|||
156357597|NCT01412021|564407809|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
156357598|NCT01412021|564407809|FG000|Overall Study|Treatment Prior to Approval|3|||
156357599|NCT01412021|564407809|FG000|Overall Study|Transferred to Other Hospital|9|||
156357600|NCT03255382|564407810|FG000|Overall Study|Adverse Event|3|||
156357601|NCT03255382|564407811|FG001|Overall Study|Adverse Event|0|||
156357602|NCT03255382|564407810|FG000|Overall Study|Lost to Follow-up|2|||
156357603|NCT03255382|564407811|FG001|Overall Study|Lost to Follow-up|0|||
156357604|NCT03255382|564407810|FG000|Overall Study|Withdrawal by Subject|2|||
156357605|NCT03255382|564407811|FG001|Overall Study|Withdrawal by Subject|0|||
156357606|NCT03255382|564407810|FG000|Overall Study|Other|6|||
156357607|NCT03255382|564407811|FG001|Overall Study|Other|0|||
156357608|NCT00238121|564407814|FG000|Overall Study|Withdrawal by Subject|1|||
156357609|NCT00238121|564407815|FG001|Overall Study|Withdrawal by Subject|1|||
156357610|NCT00238121|564407814|FG000|Overall Study|Adverse Event|2|||
156357611|NCT00238121|564407815|FG001|Overall Study|Adverse Event|1|||
156357612|NCT02221284|564407816|FG000|Overall Study|Case Report Forms Uncollected|56|||
156357613|NCT02221284|564407816|FG000|Overall Study|Protocol Deviation|5|||
156357614|NCT00484939|564407817|FG000|Overall Study|Death|9|||
156357615|NCT00484939|564407818|FG001|Overall Study|Death|13|||
156488210|NCT00126555|564880244|FG000|Overall Study|Adverse Event|2|||
156488211|NCT00126555|564880244|FG000|Overall Study|Progressive Disease|3|||
156488212|NCT01780545|564880251|FG000|Overall Study|Withdrawal by Subject|3|||
156488213|NCT01780545|564880252|FG001|Overall Study|Withdrawal by Subject|1|||
156488214|NCT01780545|564880251|FG000|Overall Study|Lost to Follow-up|1|||
156488215|NCT01780545|564880252|FG001|Overall Study|Lost to Follow-up|1|||
156488216|NCT03441789|564880253|FG000|Overall Study|Withdrawal by Subject|1|||
156544958|NCT01445951|565089500|FG001|Overall Study|Death|0|||
156357616|NCT00484939|564407817|FG000|Overall Study|Adverse Event|22|||
156488217|NCT03441789|564880254|FG001|Overall Study|Withdrawal by Subject|1|||
156488218|NCT03441789|564880253|FG000|Overall Study|Adverse Event|0|||
156488219|NCT03441789|564880254|FG001|Overall Study|Adverse Event|1|||
156357617|NCT00484939|564407818|FG001|Overall Study|Adverse Event|12|||
156488220|NCT03441789|564880253|FG000|Overall Study|Protocol Violation|0|||
156488221|NCT03441789|564880254|FG001|Overall Study|Protocol Violation|1|||
156488222|NCT03441789|564880253|FG000|Overall Study|Lost to Follow-up|0|||
156357618|NCT00484939|564407817|FG000|Overall Study|Patient Withdrew Consent|19|||
156357619|NCT00484939|564407818|FG001|Overall Study|Patient Withdrew Consent|10|||
156357620|NCT00484939|564407817|FG000|Overall Study|Protocol Violation|3|||
156357621|NCT00484939|564407818|FG001|Overall Study|Protocol Violation|3|||
156357622|NCT00484939|564407817|FG000|Overall Study|Lost to Follow-up|0|||
156357623|NCT00484939|564407818|FG001|Overall Study|Lost to Follow-up|3|||
156357624|NCT00484939|564407817|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
156488223|NCT03441789|564880254|FG001|Overall Study|Lost to Follow-up|1|||
156488224|NCT00744796|564880259|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
156488225|NCT05135156|564880260|FG000|Overall Study|Lost to Follow-up|0|||
156357625|NCT00484939|564407818|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
156357626|NCT00484939|564407817|FG000|Overall Study|Disease progression|67|||
156357627|NCT00484939|564407818|FG001|Overall Study|Disease progression|88|||
156357628|NCT00484939|564407817|FG000|Overall Study|Screen Failure|2|||
156357629|NCT00484939|564407818|FG001|Overall Study|Screen Failure|2|||
156357630|NCT00484939|564407817|FG000|Overall Study|Reason Not Specified|11|||
156357631|NCT00484939|564407818|FG001|Overall Study|Reason Not Specified|6|||
156357632|NCT01239368|564409163|FG000|Overall Study|Principal investigator discretion|1|||
156357633|NCT01239368|564409164|FG001|Overall Study|Principal investigator discretion|0|||
156357634|NCT01239368|564409165|FG002|Overall Study|Principal investigator discretion|0|||
156357635|NCT01239368|564409166|FG003|Overall Study|Principal investigator discretion|0|||
156357636|NCT01239368|564409167|FG004|Overall Study|Principal investigator discretion|1|||
156357637|NCT01239368|564409168|FG005|Overall Study|Principal investigator discretion|2|||
156357638|NCT01239368|564409169|FG006|Overall Study|Principal investigator discretion|0|||
156357639|NCT01239368|564409170|FG007|Overall Study|Principal investigator discretion|0|||
156357640|NCT01239368|564409171|FG008|Overall Study|Principal investigator discretion|0|||
156357641|NCT01239368|564409172|FG009|Overall Study|Principal investigator discretion|1|||
156357642|NCT01239368|564409163|FG000|Overall Study|Disease progression on study|1|||
156357643|NCT01239368|564409164|FG001|Overall Study|Disease progression on study|1|||
156357644|NCT01239368|564409165|FG002|Overall Study|Disease progression on study|1|||
156357645|NCT01239368|564409166|FG003|Overall Study|Disease progression on study|1|||
156357646|NCT01239368|564409167|FG004|Overall Study|Disease progression on study|4|||
156357647|NCT01239368|564409168|FG005|Overall Study|Disease progression on study|2|||
156357648|NCT01239368|564409169|FG006|Overall Study|Disease progression on study|5|||
156357649|NCT01239368|564409170|FG007|Overall Study|Disease progression on study|0|||
156357650|NCT01239368|564409171|FG008|Overall Study|Disease progression on study|0|||
156357651|NCT01239368|564409172|FG009|Overall Study|Disease progression on study|2|||
156357652|NCT01239368|564409163|FG000|Overall Study|Refused further treatment|0|||
156357653|NCT01239368|564409164|FG001|Overall Study|Refused further treatment|0|||
156357654|NCT01239368|564409165|FG002|Overall Study|Refused further treatment|0|||
156357655|NCT01239368|564409166|FG003|Overall Study|Refused further treatment|0|||
156357656|NCT01239368|564409167|FG004|Overall Study|Refused further treatment|0|||
156357657|NCT01239368|564409168|FG005|Overall Study|Refused further treatment|0|||
156357658|NCT01239368|564409169|FG006|Overall Study|Refused further treatment|0|||
156357659|NCT01239368|564409170|FG007|Overall Study|Refused further treatment|0|||
156357660|NCT01239368|564409171|FG008|Overall Study|Refused further treatment|0|||
156357661|NCT01239368|564409172|FG009|Overall Study|Refused further treatment|1|||
156357662|NCT01239368|564409163|FG000|Overall Study|Death|0|||
156357663|NCT01239368|564409164|FG001|Overall Study|Death|0|||
156357664|NCT01239368|564409165|FG002|Overall Study|Death|0|||
156357665|NCT01239368|564409166|FG003|Overall Study|Death|0|||
156357666|NCT01239368|564409167|FG004|Overall Study|Death|0|||
156357667|NCT01239368|564409168|FG005|Overall Study|Death|0|||
156357668|NCT01239368|564409169|FG006|Overall Study|Death|1|||
156357669|NCT01239368|564409170|FG007|Overall Study|Death|0|||
156357670|NCT01239368|564409171|FG008|Overall Study|Death|0|||
156357671|NCT01239368|564409172|FG009|Overall Study|Death|0|||
156357672|NCT03181399|564409174|FG000|6 Months on Treatment|Protocol non-compliance|7|||
156357673|NCT03181399|564409174|FG000|6 Months on Treatment|Adverse Event|4|||
156357674|NCT03181399|564409174|FG000|6 Months on Treatment|Tried alternative treatment|2|||
156357675|NCT03181399|564409174|FG000|6 Months on Treatment|Lost to Follow-up|2|||
156357676|NCT03181399|564409174|FG000|6 Months on Treatment|Personal reasons|1|||
156357677|NCT03181399|564409174|FG000|3 Months Off-treatment|Parent unable to travel|1|||
156357678|NCT02926924|564409175|FG000|Overall Study|withdrawal - reason unknown|0|||
156357679|NCT02926924|564409176|FG001|Overall Study|withdrawal - reason unknown|1|||
156357680|NCT02436759|564409181|FG000|Overall Study|Adverse Event|3|||
156357681|NCT02436759|564409182|FG001|Overall Study|Adverse Event|0|||
156357682|NCT02436759|564409181|FG000|Overall Study|Protocol Violation|1|||
156357683|NCT02436759|564409182|FG001|Overall Study|Protocol Violation|0|||
156357684|NCT02436759|564409181|FG000|Overall Study|Withdrawal by Subject|0|||
156357685|NCT02436759|564409182|FG001|Overall Study|Withdrawal by Subject|1|||
156357686|NCT01290666|564409183|FG000|Overall Study|Lost to Follow-up|11|||
156357687|NCT01290666|564409183|FG000|Overall Study|Withdrawal by Subject|23|||
156357688|NCT01290666|564409183|FG000|Overall Study|Early Termination of Study|4|||
156357689|NCT01652664|564409186|FG000|Overall Study|Treatment Failure|5|||
156357690|NCT01652664|564409187|FG001|Overall Study|Treatment Failure|1|||
156357691|NCT01652664|564409186|FG000|Overall Study|Inadequate IOP control|1|||
156357692|NCT01652664|564409187|FG001|Overall Study|Inadequate IOP control|0|||
156357693|NCT00581776|564409188|FG000|Overall Study|Disease progression or no response|3|||
156357694|NCT02418468|564409192|FG000|Overall Study|Adverse Event|1|||
156357695|NCT02418468|564409193|FG001|Overall Study|Adverse Event|0|||
156357696|NCT02418468|564409192|FG000|Overall Study|Withdrawal of informed consent|1|||
156357697|NCT02418468|564409193|FG001|Overall Study|Withdrawal of informed consent|1|||
156357698|NCT00909779|564409194|FG000|Overall Study|Adverse Event|53|||
156544959|NCT01445951|565089501|FG002|Overall Study|Death|1|||
156544960|NCT01445951|565089499|FG000|Overall Study|Non-compliance with study drug|1|||
156357699|NCT00909779|564409195|FG001|Overall Study|Adverse Event|55|||
156488226|NCT05135156|564880261|FG001|Overall Study|Lost to Follow-up|0|||
156357700|NCT00909779|564409194|FG000|Overall Study|Lack of Efficacy|7|||
156357701|NCT00909779|564409195|FG001|Overall Study|Lack of Efficacy|4|||
156357702|NCT00909779|564409194|FG000|Overall Study|Lost to Follow-up|19|||
156357703|NCT00909779|564409195|FG001|Overall Study|Lost to Follow-up|15|||
156357704|NCT00909779|564409194|FG000|Overall Study|Physician Decision|8|||
156357705|NCT00909779|564409195|FG001|Overall Study|Physician Decision|2|||
156357706|NCT00909779|564409194|FG000|Overall Study|Protocol Violation|2|||
156357707|NCT00909779|564409195|FG001|Overall Study|Protocol Violation|5|||
156357708|NCT00909779|564409194|FG000|Overall Study|Withdrawal by Subject|116|||
156357709|NCT00909779|564409195|FG001|Overall Study|Withdrawal by Subject|80|||
156357710|NCT00909779|564409194|FG000|Overall Study|Site Ceasing Operation|2|||
156357711|NCT00909779|564409195|FG001|Overall Study|Site Ceasing Operation|2|||
156357712|NCT00909779|564409194|FG000|Overall Study|Medical Monitor Decision|1|||
156357713|NCT00909779|564409195|FG001|Overall Study|Medical Monitor Decision|0|||
156357714|NCT00909779|564409194|FG000|Overall Study|Noncompliance|1|||
156357715|NCT00909779|564409195|FG001|Overall Study|Noncompliance|1|||
156357716|NCT00909779|564409194|FG000|Overall Study|Randomized in error|1|||
156357717|NCT00909779|564409195|FG001|Overall Study|Randomized in error|1|||
156357718|NCT01592344|564409196|FG000|Overall Study|Adverse Event|1|||
156357719|NCT01592344|564409197|FG001|Overall Study|Adverse Event|1|||
156357720|NCT01592344|564409196|FG000|Overall Study|Lack of Efficacy|1|||
156357721|NCT01592344|564409197|FG001|Overall Study|Lack of Efficacy|0|||
156357722|NCT01592344|564409196|FG000|Overall Study|not available at primary outcome visit|2|||
156357723|NCT01592344|564409197|FG001|Overall Study|not available at primary outcome visit|4|||
156357724|NCT00099437|564409198|FG000|Overall Study|Lost to Follow-up|30|||
156357725|NCT00099437|564409199|FG001|Overall Study|Lost to Follow-up|33|||
156357726|NCT00099437|564409198|FG000|Overall Study|Death|293|||
156357727|NCT00099437|564409199|FG001|Overall Study|Death|261|||
156357728|NCT00099437|564409198|FG000|Overall Study|Withdrawal by Subject|6|||
156357729|NCT00099437|564409199|FG001|Overall Study|Withdrawal by Subject|10|||
156357730|NCT00099437|564409198|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
156357731|NCT00099437|564409199|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
156357732|NCT00949325|564409200|FG000|Overall Study|Adverse Event|0|||
156357733|NCT00949325|564409201|FG001|Overall Study|Adverse Event|2|||
156357734|NCT00949325|564409202|FG002|Overall Study|Adverse Event|0|||
156357735|NCT02809677|564409203|FG000|Overall Study|Withdrawal by Subject|8|||
156357736|NCT00730912|564409204|FG000|Overall Study|Discontinued|0|||
156357737|NCT00730912|564409205|FG001|Overall Study|Discontinued|0|||
156357738|NCT00730912|564409206|FG002|Overall Study|Discontinued|1|||
156357739|NCT03311659|564409207|FG000|Overall Study|Protocol Violation|1|||
156357740|NCT02205333|564409208|FG000|Overall Study|Death|5|||
156357741|NCT02205333|564409209|FG001|Overall Study|Death|6|||
156357742|NCT02205333|564409210|FG002|Overall Study|Death|2|||
156357743|NCT02205333|564409211|FG003|Overall Study|Death|6|||
156357744|NCT02205333|564409212|FG004|Overall Study|Death|5|||
156357745|NCT02205333|564409213|FG005|Overall Study|Death|3|||
156357746|NCT02205333|564409214|FG006|Overall Study|Death|3|||
156488227|NCT05135156|564880262|FG002|Overall Study|Lost to Follow-up|2|||
156488228|NCT02986659|564880263|FG000|First Intervention Period|Adverse Event|3|||
156488229|NCT02986659|564880264|FG001|First Intervention Period|Adverse Event|1|||
156488230|NCT02986659|564880263|FG000|First Intervention Period|Lost to Follow-up|1|||
156488231|NCT02986659|564880264|FG001|First Intervention Period|Lost to Follow-up|0|||
156488232|NCT02986659|564880263|FG000|First Intervention Period|Withdrawal by Subject|0|||
156488233|NCT02986659|564880264|FG001|First Intervention Period|Withdrawal by Subject|1|||
156488234|NCT02986659|564880263|FG000|Second Intervention Period|Adverse Event|0|||
156488235|NCT02986659|564880264|FG001|Second Intervention Period|Adverse Event|6|||
156488236|NCT02254681|564880270|FG000|Overall Study|Lack of Efficacy|6|||
156488237|NCT00396097|564880271|FG000|Overall Study|Withdrawal by Subject|17|||
156488238|NCT00396097|564880272|FG001|Overall Study|Withdrawal by Subject|17|||
156488239|NCT00396097|564880271|FG000|Overall Study|Lost to Follow-up|4|||
156488240|NCT00396097|564880272|FG001|Overall Study|Lost to Follow-up|9|||
156488241|NCT00396097|564880271|FG000|Overall Study|Other|3|||
156488242|NCT00396097|564880272|FG001|Overall Study|Other|5|||
156488243|NCT00396097|564880271|FG000|Overall Study|Protocol Violation|0|||
156488244|NCT00396097|564880272|FG001|Overall Study|Protocol Violation|6|||
156488245|NCT00396097|564880271|FG000|Overall Study|Adverse Event|1|||
156488246|NCT00396097|564880272|FG001|Overall Study|Adverse Event|5|||
156488247|NCT00396097|564880271|FG000|Overall Study|Insufficient Clinical Response|1|||
156488248|NCT00396097|564880272|FG001|Overall Study|Insufficient Clinical Response|4|||
156488249|NCT03461211|564880273|FG000|Overall Study|Adverse Event|1|||
156488250|NCT03461211|564880274|FG001|Overall Study|Adverse Event|1|||
156488251|NCT03461211|564880273|FG000|Overall Study|Lack of Efficacy|0|||
156488252|NCT03461211|564880274|FG001|Overall Study|Lack of Efficacy|1|||
156488253|NCT02005029|564880276|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
156488254|NCT02005029|564880277|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
156488255|NCT02316847|564880278|FG000|Overall Study|Adverse Event|0|||
156488256|NCT02316847|564880279|FG001|Overall Study|Adverse Event|3|||
156488257|NCT02316847|564880278|FG000|Overall Study|Lost to Follow-up|0|||
156488258|NCT02316847|564880279|FG001|Overall Study|Lost to Follow-up|2|||
156488259|NCT02316847|564880278|FG000|Overall Study|Physician Decision|0|||
156488260|NCT02316847|564880279|FG001|Overall Study|Physician Decision|1|||
156488261|NCT02316847|564880278|FG000|Overall Study|Pregnancy|0|||
156488262|NCT02316847|564880279|FG001|Overall Study|Pregnancy|1|||
156488263|NCT02316847|564880278|FG000|Overall Study|Withdrawal by Subject|2|||
156488264|NCT02316847|564880279|FG001|Overall Study|Withdrawal by Subject|9|||
156488265|NCT02316847|564880278|FG000|Overall Study|Noncompliance with study drug|0|||
156488266|NCT02316847|564880279|FG001|Overall Study|Noncompliance with study drug|3|||
156357747|NCT02205333|564409215|FG007|Overall Study|Death|2|||
156357748|NCT02205333|564409216|FG008|Overall Study|Death|0|||
156357749|NCT02205333|564409208|FG000|Overall Study|Withdrawal by Subject|1|||
156357750|NCT02205333|564409209|FG001|Overall Study|Withdrawal by Subject|0|||
156357751|NCT02205333|564409210|FG002|Overall Study|Withdrawal by Subject|0|||
156357752|NCT02205333|564409211|FG003|Overall Study|Withdrawal by Subject|1|||
156488267|NCT02316847|564880278|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
156488268|NCT02316847|564880279|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
156488269|NCT02621047|564880280|FG000|Overall Study|Adverse Event|0|||
156488270|NCT02621047|564880281|FG001|Overall Study|Adverse Event|0|||
156488271|NCT02621047|564880282|FG002|Overall Study|Adverse Event|1|||
156488272|NCT01370018|564880283|FG000|Overall Study|Did not meet criteria for analysis|1|||
156488273|NCT03772041|564880286|FG000|Overall Study|Adverse Event|8|||
156488274|NCT03772041|564880287|FG001|Overall Study|Adverse Event|3|||
156488275|NCT03772041|564880286|FG000|Overall Study|Withdrawal by Subject|0|||
156488276|NCT03772041|564880287|FG001|Overall Study|Withdrawal by Subject|2|||
156488277|NCT03772041|564880286|FG000|Overall Study|Protocol Violation|4|||
156488278|NCT03772041|564880287|FG001|Overall Study|Protocol Violation|2|||
156488279|NCT03772041|564880286|FG000|Overall Study|Physician Decision|2|||
156488280|NCT03772041|564880287|FG001|Overall Study|Physician Decision|3|||
156488281|NCT01525641|564880288|FG000|Overall Study|Case report form not collected|25|||
156488282|NCT01525641|564880288|FG000|Overall Study|No visit since the first visit|16|||
156488283|NCT01525641|564880288|FG000|Overall Study|Adverse Event|73|||
156488284|NCT01525641|564880288|FG000|Overall Study|Lack of Efficacy|24|||
156488285|NCT01525641|564880288|FG000|Overall Study|Improvement|5|||
156357753|NCT02205333|564409212|FG004|Overall Study|Withdrawal by Subject|0|||
156357754|NCT02205333|564409213|FG005|Overall Study|Withdrawal by Subject|0|||
156357755|NCT02205333|564409214|FG006|Overall Study|Withdrawal by Subject|2|||
156357756|NCT02205333|564409215|FG007|Overall Study|Withdrawal by Subject|0|||
156357757|NCT02205333|564409216|FG008|Overall Study|Withdrawal by Subject|0|||
156357758|NCT01176266|564409217|FG000|Overall Study|Death|6|||
156357759|NCT01176266|564409217|FG000|Overall Study|Withdrawal by Subject|3|||
156357760|NCT02466555|564409220|FG000|Overall Study|Lost to Follow-up|2|||
156357761|NCT00529542|564409223|FG000|Overall Study|Withdrawal by Subject|1|||
156357762|NCT00529542|564409224|FG001|Overall Study|Withdrawal by Subject|0|||
156357763|NCT00529542|564409223|FG000|Overall Study|Lost to Follow-up|0|||
156357764|NCT00529542|564409224|FG001|Overall Study|Lost to Follow-up|1|||
156357765|NCT03839212|564409231|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
156357766|NCT00679263|564409236|FG000|Visit 2/Dose 1|Adverse Event|1|||
156357767|NCT00679263|564409237|FG001|Visit 2/Dose 1|Adverse Event|0|||
156357768|NCT00679263|564409238|FG002|Visit 2/Dose 1|Adverse Event|0|||
156357769|NCT00679263|564409236|FG000|Visit 2/Dose 1|subject not compliance|1|||
156357770|NCT00679263|564409237|FG001|Visit 2/Dose 1|subject not compliance|1|||
156357771|NCT00679263|564409238|FG002|Visit 2/Dose 1|subject not compliance|0|||
156357772|NCT05104567|564409240|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156357773|NCT05104567|564409241|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
156357774|NCT05104567|564409242|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156357775|NCT05104567|564409243|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156357776|NCT05104567|564409244|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156357777|NCT05104567|564409245|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156357778|NCT05104567|564409246|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156357779|NCT05104567|564409240|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
156357780|NCT05104567|564409241|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
156357781|NCT05104567|564409242|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
156357782|NCT05104567|564409243|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
156357783|NCT05104567|564409244|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
156488286|NCT01525641|564880288|FG000|Overall Study|Lost to follow-up (relocation)|1|||
156488287|NCT01525641|564880288|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
156488288|NCT01525641|564880288|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
156488289|NCT01525641|564880288|FG000|Overall Study|Other than stated above|7|||
156488290|NCT02204319|564880293|FG000|Overall Study|Pregnancy|1|||
156488291|NCT02204319|564880293|FG000|Overall Study|Withdrawal by Subject|2|||
156488292|NCT03544229|564880296|FG000|Overall Study|Adverse Event|1|||
156488293|NCT03544229|564880297|FG001|Overall Study|Adverse Event|0|||
156488294|NCT03544229|564880298|FG002|Overall Study|Adverse Event|1|||
156488295|NCT03544229|564880299|FG003|Overall Study|Adverse Event|0|||
156357784|NCT05104567|564409245|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
156357785|NCT05104567|564409246|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
156357786|NCT05104567|564409240|FG000|Overall Study|Progressive disease|3|||
156357787|NCT05104567|564409241|FG001|Overall Study|Progressive disease|13|||
156488296|NCT03544229|564880296|FG000|Overall Study|Protocol Deviation|0|||
156488297|NCT03544229|564880297|FG001|Overall Study|Protocol Deviation|0|||
156488298|NCT03544229|564880298|FG002|Overall Study|Protocol Deviation|1|||
156488299|NCT03544229|564880299|FG003|Overall Study|Protocol Deviation|0|||
156488300|NCT03544229|564880296|FG000|Overall Study|Lost to Follow-up|3|||
156488301|NCT03544229|564880297|FG001|Overall Study|Lost to Follow-up|0|||
156488302|NCT03544229|564880298|FG002|Overall Study|Lost to Follow-up|0|||
156357788|NCT05104567|564409242|FG002|Overall Study|Progressive disease|13|||
156357789|NCT05104567|564409243|FG003|Overall Study|Progressive disease|17|||
156357790|NCT05104567|564409244|FG004|Overall Study|Progressive disease|17|||
156357791|NCT05104567|564409245|FG005|Overall Study|Progressive disease|28|||
156357792|NCT05104567|564409246|FG006|Overall Study|Progressive disease|24|||
156357793|NCT05104567|564409240|FG000|Overall Study|Withdrawal by Subject|1|||
156357794|NCT05104567|564409241|FG001|Overall Study|Withdrawal by Subject|1|||
156357795|NCT05104567|564409242|FG002|Overall Study|Withdrawal by Subject|2|||
156357796|NCT05104567|564409243|FG003|Overall Study|Withdrawal by Subject|0|||
156357797|NCT05104567|564409244|FG004|Overall Study|Withdrawal by Subject|0|||
156357798|NCT05104567|564409245|FG005|Overall Study|Withdrawal by Subject|0|||
156357799|NCT05104567|564409246|FG006|Overall Study|Withdrawal by Subject|0|||
156357800|NCT05104567|564409240|FG000|Overall Study|Other|1|||
156357801|NCT05104567|564409241|FG001|Overall Study|Other|1|||
156357802|NCT05104567|564409242|FG002|Overall Study|Other|1|||
156357803|NCT05104567|564409243|FG003|Overall Study|Other|0|||
156357804|NCT05104567|564409244|FG004|Overall Study|Other|0|||
156357805|NCT05104567|564409245|FG005|Overall Study|Other|0|||
156357806|NCT05104567|564409246|FG006|Overall Study|Other|0|||
156357807|NCT01464346|564409250|FG000|Overall Study|Withdrawal by Subject|0|||
156357808|NCT01464346|564409251|FG001|Overall Study|Withdrawal by Subject|0|||
156357809|NCT01464346|564409252|FG002|Overall Study|Withdrawal by Subject|1|||
156357810|NCT00733746|564409253|FG000|Overall Study|Ineligible|5|||
156357811|NCT02295995|564409254|FG000|Overall Study|Lost to Follow-up|5|||
156357812|NCT02295995|564409255|FG001|Overall Study|Lost to Follow-up|1|||
156357813|NCT01173718|564409256|FG000|Overall Study|Death|17|||
156357814|NCT01173718|564409256|FG000|Overall Study|Abandonment of study graft|27|||
156357815|NCT01498458|564409258|FG000|Overall Study|Adverse Event|4|||
156357816|NCT01498458|564409258|FG000|Overall Study|Physician Decision|3|||
156357817|NCT02226003|564409259|FG000|Overall Study|Lost to Follow-up|2|||
156357818|NCT02226003|564409260|FG001|Overall Study|Lost to Follow-up|1|||
156357819|NCT02226003|564409261|FG002|Overall Study|Lost to Follow-up|3|||
156357820|NCT02226003|564409259|FG000|Overall Study|Withdrawal by Subject|0|||
156357821|NCT02226003|564409260|FG001|Overall Study|Withdrawal by Subject|0|||
156357822|NCT02226003|564409261|FG002|Overall Study|Withdrawal by Subject|3|||
156357823|NCT03279692|564409268|FG000|Overall Study|Withdrawal by Subject|1|||
156357824|NCT05198843|564409271|FG000|Overall Study|Lack of Efficacy|1|||
156488303|NCT03544229|564880299|FG003|Overall Study|Lost to Follow-up|2|||
156488304|NCT03544229|564880296|FG000|Overall Study|Voluntary Withdrawal|2|||
156357825|NCT02446990|564409272|FG000|Overall Study|Death|485|||
156357826|NCT02446990|564409273|FG001|Overall Study|Death|458|||
156357827|NCT02446990|564409272|FG000|Overall Study|Lost to Follow-up|3|||
156357828|NCT02446990|564409273|FG001|Overall Study|Lost to Follow-up|1|||
156488305|NCT03544229|564880297|FG001|Overall Study|Voluntary Withdrawal|1|||
156357829|NCT02446990|564409272|FG000|Overall Study|Physician Decision|1|||
156357830|NCT02446990|564409273|FG001|Overall Study|Physician Decision|0|||
156488306|NCT03544229|564880298|FG002|Overall Study|Voluntary Withdrawal|3|||
156357831|NCT02446990|564409272|FG000|Overall Study|Withdrawal by Subject|231|||
156357832|NCT02446990|564409273|FG001|Overall Study|Withdrawal by Subject|199|||
156357833|NCT01064401|564409274|FG000|Overall Study|Adverse Event|47|||
156357834|NCT01064401|564409275|FG001|Overall Study|Adverse Event|56|||
156357835|NCT01064401|564409274|FG000|Overall Study|Lack of Efficacy|46|||
156357836|NCT01064401|564409275|FG001|Overall Study|Lack of Efficacy|23|||
156357837|NCT01064401|564409274|FG000|Overall Study|Lost to Follow-up|12|||
156357838|NCT01064401|564409275|FG001|Overall Study|Lost to Follow-up|9|||
156357839|NCT01064401|564409274|FG000|Overall Study|Consent Withdrawn|98|||
156357840|NCT01064401|564409275|FG001|Overall Study|Consent Withdrawn|80|||
156357841|NCT01064401|564409274|FG000|Overall Study|Investigator Decision|4|||
156357842|NCT01064401|564409275|FG001|Overall Study|Investigator Decision|6|||
156357843|NCT01064401|564409274|FG000|Overall Study|Death|4|||
156357844|NCT01064401|564409275|FG001|Overall Study|Death|0|||
156357845|NCT01064401|564409274|FG000|Overall Study|Pregnancy|4|||
156357846|NCT01064401|564409275|FG001|Overall Study|Pregnancy|7|||
156357847|NCT01064401|564409274|FG000|Overall Study|Noncompliance|7|||
156357848|NCT01064401|564409275|FG001|Overall Study|Noncompliance|8|||
156357849|NCT01064401|564409274|FG000|Overall Study|Site Closure|4|||
156357850|NCT01064401|564409275|FG001|Overall Study|Site Closure|5|||
156357851|NCT01064401|564409274|FG000|Overall Study|Other|2|||
156357852|NCT01064401|564409275|FG001|Overall Study|Other|1|||
156357853|NCT03158051|564409276|FG000|Overall Study|Lost to Follow-up|41|||
156357854|NCT03158051|564409277|FG001|Overall Study|Lost to Follow-up|47|||
156357855|NCT03158051|564409276|FG000|Overall Study|Physician Decision|6|||
156357856|NCT03158051|564409277|FG001|Overall Study|Physician Decision|7|||
156357857|NCT03158051|564409276|FG000|Overall Study|Withdrawal by Subject|24|||
156357858|NCT03158051|564409277|FG001|Overall Study|Withdrawal by Subject|15|||
156357859|NCT03158051|564409276|FG000|Overall Study|Death|0|||
156357860|NCT03158051|564409277|FG001|Overall Study|Death|1|||
156357861|NCT02588833|564409278|FG000|Part 1|Withdrawal by Subject|1|||
156357862|NCT02588833|564409279|FG001|Part 1|Withdrawal by Subject|0|||
156357863|NCT02588833|564409278|FG000|Part 2A|Physician Decision|0|||
156357864|NCT02588833|564409279|FG001|Part 2A|Physician Decision|1|||
156357865|NCT02588833|564409278|FG000|Part 2A|Withdrawal by Subject|0|||
156357866|NCT02588833|564409279|FG001|Part 2A|Withdrawal by Subject|1|||
156357867|NCT02588833|564409278|FG000|Part 2B|Adverse Event|0|||
156357868|NCT02588833|564409279|FG001|Part 2B|Adverse Event|1|||
156357869|NCT02588833|564409278|FG000|Part 2C|Adverse Event|0|||
156357870|NCT02588833|564409279|FG001|Part 2C|Adverse Event|1|||
156357871|NCT02588833|564409278|FG000|Part 2C|Withdrawal by Subject|0|||
156357872|NCT02588833|564409279|FG001|Part 2C|Withdrawal by Subject|1|||
156357873|NCT02588833|564409278|FG000|Part 3 (Safety Follow-up)|Other|0|||
156357874|NCT02588833|564409279|FG001|Part 3 (Safety Follow-up)|Other|2|||
156357875|NCT02738151|564409280|FG000|Overall Study|Randomized but not treated|4|||
156357876|NCT02738151|564409281|FG001|Overall Study|Randomized but not treated|1|||
156357877|NCT02738151|564409280|FG000|Overall Study|Adverse Event|4|||
156357878|NCT02738151|564409281|FG001|Overall Study|Adverse Event|5|||
156357879|NCT02738151|564409280|FG000|Overall Study|Hypoglycemia|0|||
156357880|NCT02738151|564409281|FG001|Overall Study|Hypoglycemia|1|||
156357881|NCT02738151|564409280|FG000|Overall Study|Poor Compliance to Protocol|4|||
156357882|NCT02738151|564409281|FG001|Overall Study|Poor Compliance to Protocol|3|||
156357883|NCT02738151|564409280|FG000|Overall Study|Other than specified above|11|||
156357884|NCT02738151|564409281|FG001|Overall Study|Other than specified above|21|||
156357885|NCT02005250|564409282|FG000|Overall Study|Lost to Follow-up|15|||
156357886|NCT02005250|564409283|FG001|Overall Study|Lost to Follow-up|5|||
156357887|NCT03649711|564409289|FG000|Overall Study|Adverse Event|0|||
156357888|NCT03649711|564409290|FG001|Overall Study|Adverse Event|1|||
156357889|NCT03649711|564409291|FG002|Overall Study|Adverse Event|0|||
156357890|NCT03649711|564409289|FG000|Overall Study|Kidney Transplant|1|||
156357891|NCT03649711|564409290|FG001|Overall Study|Kidney Transplant|0|||
156357892|NCT03649711|564409291|FG002|Overall Study|Kidney Transplant|0|||
156357893|NCT04007094|564409296|FG000|Overall Study|Lost to Follow-up|1|||
156357894|NCT04007094|564409297|FG001|Overall Study|Lost to Follow-up|1|||
156357895|NCT04350788|564409310|FG000|Overall Study|Lost to Follow-up|6|||
156357896|NCT04350788|564409311|FG001|Overall Study|Lost to Follow-up|2|||
156357897|NCT04350788|564409310|FG000|Overall Study|Withdrawal by Subject|2|||
156357898|NCT04350788|564409311|FG001|Overall Study|Withdrawal by Subject|4|||
156357899|NCT04350788|564409310|FG000|Overall Study|Protocol Violation|4|||
156357900|NCT04350788|564409311|FG001|Overall Study|Protocol Violation|0|||
156357901|NCT01581307|564409312|FG000|Overall Study|Withdrawal by Subject|1|||
156357902|NCT00378209|564409315|FG000|Overall Study|Progressive disease|11|||
156357903|NCT00378209|564409315|FG000|Overall Study|Adverse Event|3|||
156357904|NCT00378209|564409315|FG000|Overall Study|Initiation of non-protocol therapy|3|||
156357905|NCT00378209|564409315|FG000|Overall Study|Physician Decision|3|||
156357906|NCT00378209|564409315|FG000|Overall Study|Death|1|||
156357907|NCT00378209|564409315|FG000|Overall Study|Treatment delay|1|||
156357908|NCT04709575|564411106|FG000|Overall Study|Withdrawal by Subject|6|||
156357909|NCT04709575|564411107|FG001|Overall Study|Withdrawal by Subject|2|||
156357910|NCT04709575|564411106|FG000|Overall Study|Lost to Follow-up|2|||
156357911|NCT04709575|564411107|FG001|Overall Study|Lost to Follow-up|2|||
156357912|NCT04709575|564411106|FG000|Overall Study|Adverse Event|1|||
156357913|NCT04709575|564411107|FG001|Overall Study|Adverse Event|0|||
156357914|NCT04709575|564411106|FG000|Overall Study|Protocol Violation|1|||
156357915|NCT04709575|564411107|FG001|Overall Study|Protocol Violation|1|||
156357916|NCT00858442|564411115|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
156357917|NCT00858442|564411116|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
156357918|NCT02016625|564411117|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
156357919|NCT02016625|564411118|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
156357920|NCT02016625|564411117|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
156357921|NCT02016625|564411118|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
156357922|NCT02016625|564411117|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
156357923|NCT02016625|564411118|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
156357924|NCT02155738|564411119|FG000|Overall Study|Missing critical information|1|||
156357925|NCT02155738|564411120|FG001|Overall Study|Missing critical information|0|||
156357926|NCT02155738|564411121|FG002|Overall Study|Missing critical information|0|||
156357927|NCT02155738|564411122|FG003|Overall Study|Missing critical information|1|||
156488307|NCT03544229|564880299|FG003|Overall Study|Voluntary Withdrawal|0|||
156488308|NCT03544229|564880296|FG000|Overall Study|Lack of Efficacy|0|||
156488309|NCT03544229|564880297|FG001|Overall Study|Lack of Efficacy|1|||
156488310|NCT03544229|564880298|FG002|Overall Study|Lack of Efficacy|0|||
156488311|NCT03544229|564880299|FG003|Overall Study|Lack of Efficacy|0|||
156488312|NCT01954771|564880300|FG000|Overall Study|Missing HbA1c of end-point|1|||
156488313|NCT01954771|564880301|FG001|Overall Study|Missing HbA1c of end-point|1|||
156357928|NCT05123222|564411123|FG000|Overall Study|Lost to Follow-up|2|||
156357929|NCT05123222|564411124|FG001|Overall Study|Lost to Follow-up|0|||
156488314|NCT01954771|564880302|FG002|Overall Study|Missing HbA1c of end-point|0|||
156488315|NCT01954771|564880300|FG000|Overall Study|Missing CGMS of end-point|1|||
156488316|NCT01954771|564880301|FG001|Overall Study|Missing CGMS of end-point|1|||
156488317|NCT01954771|564880302|FG002|Overall Study|Missing CGMS of end-point|0|||
156357930|NCT05123222|564411125|FG002|Overall Study|Lost to Follow-up|0|||
156357931|NCT05123222|564411126|FG003|Overall Study|Lost to Follow-up|0|||
156357932|NCT05123222|564411123|FG000|Overall Study|Protocol Violation|0|||
156357933|NCT05123222|564411124|FG001|Overall Study|Protocol Violation|0|||
156357934|NCT05123222|564411125|FG002|Overall Study|Protocol Violation|1|||
156357935|NCT05123222|564411126|FG003|Overall Study|Protocol Violation|0|||
156357936|NCT02535741|564411129|FG000|Overall Study|Adverse Event|3|||
156488318|NCT01954771|564880300|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
156488319|NCT01954771|564880301|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
156488320|NCT01954771|564880302|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
156357937|NCT02535741|564411129|FG000|Overall Study|Withdrawal by Subject|9|||
156357938|NCT02535741|564411129|FG000|Overall Study|Lost to Follow-up|10|||
156357939|NCT02535741|564411129|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
156357940|NCT02535741|564411129|FG000|Overall Study|Missing data|6|||
156357941|NCT02082210|564411134|FG000|Overall Study|Death|0|||
156357942|NCT02082210|564411135|FG001|Overall Study|Death|0|||
156357943|NCT02082210|564411136|FG002|Overall Study|Death|1|||
156357944|NCT02082210|564411137|FG003|Overall Study|Death|1|||
156357945|NCT02082210|564411138|FG004|Overall Study|Death|1|||
156357946|NCT02082210|564411139|FG005|Overall Study|Death|0|||
156357947|NCT02082210|564411134|FG000|Overall Study|Withdrawal by Subject|0|||
156357948|NCT02082210|564411135|FG001|Overall Study|Withdrawal by Subject|0|||
156357949|NCT02082210|564411136|FG002|Overall Study|Withdrawal by Subject|0|||
156357950|NCT02082210|564411137|FG003|Overall Study|Withdrawal by Subject|1|||
156357951|NCT02082210|564411138|FG004|Overall Study|Withdrawal by Subject|2|||
156357952|NCT02082210|564411139|FG005|Overall Study|Withdrawal by Subject|2|||
156357953|NCT02082210|564411134|FG000|Overall Study|Clinical Progression|0|||
156357954|NCT02082210|564411135|FG001|Overall Study|Clinical Progression|0|||
156357955|NCT02082210|564411136|FG002|Overall Study|Clinical Progression|0|||
156357956|NCT02082210|564411137|FG003|Overall Study|Clinical Progression|1|||
156357957|NCT02082210|564411138|FG004|Overall Study|Clinical Progression|0|||
156357958|NCT02082210|564411139|FG005|Overall Study|Clinical Progression|0|||
156357959|NCT02082210|564411134|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
156357960|NCT02082210|564411135|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
156357961|NCT02082210|564411136|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
156357962|NCT02082210|564411137|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
156357963|NCT02082210|564411138|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
156357964|NCT02082210|564411139|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
156357965|NCT02082210|564411134|FG000|Overall Study|Physician Decision|0|||
156357966|NCT02082210|564411135|FG001|Overall Study|Physician Decision|0|||
156357967|NCT02082210|564411136|FG002|Overall Study|Physician Decision|1|||
156357968|NCT02082210|564411137|FG003|Overall Study|Physician Decision|1|||
156357969|NCT02082210|564411138|FG004|Overall Study|Physician Decision|0|||
156357970|NCT02082210|564411139|FG005|Overall Study|Physician Decision|0|||
156357971|NCT04762680|564411140|FG000|Phase 2|Adverse Event|0|||
156357972|NCT04762680|564411141|FG001|Phase 2|Adverse Event|1|||
156357973|NCT04762680|564411142|FG002|Phase 2|Adverse Event|0|||
156357974|NCT04762680|564411143|FG003|Phase 2|Adverse Event|0|||
156357975|NCT04762680|564411144|FG004|Phase 2|Adverse Event|0|||
156357976|NCT04762680|564411145|FG005|Phase 2|Adverse Event|0|||
156357977|NCT04762680|564411146|FG006|Phase 2|Adverse Event|0|||
156357978|NCT04762680|564411147|FG007|Phase 2|Adverse Event|0|||
156357979|NCT04762680|564411148|FG008|Phase 2|Adverse Event|0|||
156357980|NCT04762680|564411149|FG009|Phase 2|Adverse Event|0|||
156357981|NCT04762680|564411150|FG010|Phase 2|Adverse Event|0|||
156357982|NCT04762680|564411151|FG011|Phase 2|Adverse Event|0|||
156357983|NCT04762680|564411152|FG012|Phase 2|Adverse Event|0|||
156357984|NCT04762680|564411153|FG013|Phase 2|Adverse Event|0|||
156357985|NCT04762680|564411154|FG014|Phase 2|Adverse Event|0|||
156357986|NCT04762680|564411155|FG015|Phase 2|Adverse Event|0|||
156357987|NCT04762680|564411156|FG016|Phase 2|Adverse Event|0|||
156357988|NCT04762680|564411157|FG017|Phase 2|Adverse Event|0|||
156357989|NCT04762680|564411158|FG018|Phase 2|Adverse Event|0|||
156357990|NCT04762680|564411159|FG019|Phase 2|Adverse Event|0|||
156357991|NCT04762680|564411160|FG020|Phase 2|Adverse Event|0|||
156357992|NCT04762680|564411161|FG021|Phase 2|Adverse Event|0|||
156488321|NCT03635775|564880303|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
156488322|NCT03635775|564880304|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
156488323|NCT03635775|564880305|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
156488324|NCT03635775|564880306|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
156488325|NCT02588027|564880321|FG000|Overall Study|Withdrawal by Subject|1|||
156357993|NCT04762680|564411140|FG000|Phase 2|Protocol Violation|5|||
156357994|NCT04762680|564411141|FG001|Phase 2|Protocol Violation|5|||
156357995|NCT04762680|564411142|FG002|Phase 2|Protocol Violation|1|||
156488326|NCT02588027|564880322|FG001|Overall Study|Withdrawal by Subject|3|||
156488327|NCT02588027|564880321|FG000|Overall Study|Protocol Violation|4|||
156488328|NCT02588027|564880322|FG001|Overall Study|Protocol Violation|1|||
156357996|NCT04762680|564411143|FG003|Phase 2|Protocol Violation|0|||
156357997|NCT04762680|564411144|FG004|Phase 2|Protocol Violation|0|||
156357998|NCT04762680|564411145|FG005|Phase 2|Protocol Violation|0|||
156357999|NCT04762680|564411146|FG006|Phase 2|Protocol Violation|0|||
156358000|NCT04762680|564411147|FG007|Phase 2|Protocol Violation|0|||
156358001|NCT04762680|564411148|FG008|Phase 2|Protocol Violation|0|||
156358002|NCT04762680|564411149|FG009|Phase 2|Protocol Violation|0|||
156358003|NCT04762680|564411150|FG010|Phase 2|Protocol Violation|0|||
156358004|NCT04762680|564411151|FG011|Phase 2|Protocol Violation|0|||
156358005|NCT04762680|564411152|FG012|Phase 2|Protocol Violation|0|||
156358006|NCT04762680|564411153|FG013|Phase 2|Protocol Violation|0|||
156358007|NCT04762680|564411154|FG014|Phase 2|Protocol Violation|0|||
156544961|NCT01445951|565089500|FG001|Overall Study|Non-compliance with study drug|2|||
156544962|NCT01445951|565089501|FG002|Overall Study|Non-compliance with study drug|0|||
156544963|NCT01445951|565089499|FG000|Overall Study|Non-compliance with protocol|0|||
156544964|NCT01445951|565089500|FG001|Overall Study|Non-compliance with protocol|1|||
156544965|NCT01445951|565089501|FG002|Overall Study|Non-compliance with protocol|0|||
156544966|NCT01445951|565089499|FG000|Overall Study|Sponsor decision - subject travel|0|||
156544967|NCT01445951|565089500|FG001|Overall Study|Sponsor decision - subject travel|1|||
156544968|NCT01445951|565089501|FG002|Overall Study|Sponsor decision - subject travel|0|||
156544969|NCT01445951|565089499|FG000|Overall Study|Cough|0|||
156544970|NCT01445951|565089500|FG001|Overall Study|Cough|1|||
156544971|NCT01445951|565089501|FG002|Overall Study|Cough|0|||
156544972|NCT03610724|565089502|FG000|Overall Study|Death|17|||
156544973|NCT03610724|565089502|FG000|Overall Study|Lost to Follow-up|1|||
156544974|NCT03610724|565089502|FG000|Overall Study|Physician Decision|1|||
156544975|NCT03610724|565089502|FG000|Overall Study|Died prior to infusion|1|||
156544976|NCT01473563|565089503|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
156544977|NCT02739620|565089507|FG000|Overall Study|Lost to Follow-up|3|||
156544978|NCT02739620|565089508|FG001|Overall Study|Lost to Follow-up|1|||
156544979|NCT02739620|565089507|FG000|Overall Study|Adverse Event|0|||
156544980|NCT02739620|565089508|FG001|Overall Study|Adverse Event|1|||
156544981|NCT00786565|565089509|FG000|Enrollment Prior to Surgery|Site Closed|3|||
156544982|NCT00786565|565089509|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
156544983|NCT00786565|565089509|FG000|Post Surgery|Abnormal macular pucker|1|||
156544984|NCT00786565|565089509|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
156544985|NCT05513625|565089510|FG000|Overall Study|Withdrawal by Subject|1|||
156544986|NCT02943564|565089512|FG000|Overall Study|Miscellaneous Reasons|0|||
156544987|NCT02943564|565089513|FG001|Overall Study|Miscellaneous Reasons|0|||
156544988|NCT02943564|565089514|FG002|Overall Study|Miscellaneous Reasons|3|||
156544989|NCT02943564|565089512|FG000|Overall Study|Site terminated by sponsor|0|||
156544990|NCT02943564|565089513|FG001|Overall Study|Site terminated by sponsor|1|||
156544991|NCT02943564|565089514|FG002|Overall Study|Site terminated by sponsor|0|||
156544992|NCT02943564|565089512|FG000|Overall Study|Non-compliance with study drug|0|||
156544993|NCT02943564|565089513|FG001|Overall Study|Non-compliance with study drug|1|||
156544994|NCT02943564|565089514|FG002|Overall Study|Non-compliance with study drug|0|||
156544995|NCT02943564|565089512|FG000|Overall Study|Pregnancy|0|||
156544996|NCT02943564|565089513|FG001|Overall Study|Pregnancy|1|||
156544997|NCT02943564|565089514|FG002|Overall Study|Pregnancy|1|||
156544998|NCT02943564|565089512|FG000|Overall Study|Protocol Violation|2|||
156544999|NCT02943564|565089513|FG001|Overall Study|Protocol Violation|2|||
156545000|NCT02943564|565089514|FG002|Overall Study|Protocol Violation|2|||
156545001|NCT02943564|565089512|FG000|Overall Study|Lost to Follow-up|1|||
156545002|NCT02943564|565089513|FG001|Overall Study|Lost to Follow-up|0|||
156545003|NCT02943564|565089514|FG002|Overall Study|Lost to Follow-up|0|||
156545004|NCT02943564|565089512|FG000|Overall Study|Withdrawal by Subject|6|||
156545005|NCT02943564|565089513|FG001|Overall Study|Withdrawal by Subject|5|||
156545006|NCT02943564|565089514|FG002|Overall Study|Withdrawal by Subject|2|||
156545007|NCT02943564|565089512|FG000|Overall Study|Adverse Event|1|||
156545008|NCT02943564|565089513|FG001|Overall Study|Adverse Event|2|||
156545009|NCT02943564|565089514|FG002|Overall Study|Adverse Event|1|||
156545010|NCT02943564|565089512|FG000|Overall Study|Lack of Efficacy|0|||
156545011|NCT02943564|565089513|FG001|Overall Study|Lack of Efficacy|1|||
156545012|NCT02943564|565089514|FG002|Overall Study|Lack of Efficacy|0|||
156488329|NCT02116582|564880323|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
156488330|NCT02116582|564880323|FG000|Overall Study|Adverse Event|22|||
156488331|NCT02116582|564880323|FG000|Overall Study|Death|9|||
156488332|NCT02116582|564880323|FG000|Overall Study|Progressive Disease|148|||
156488333|NCT02116582|564880323|FG000|Overall Study|Protocol Violation|3|||
156488334|NCT02116582|564880323|FG000|Overall Study|Withdrawal by Subject|8|||
156488335|NCT02116582|564880323|FG000|Overall Study|Other: Miscellaneous|11|||
156488336|NCT02116582|564880323|FG000|Overall Study|Lost to Follow-up|1|||
156488337|NCT02116582|564880323|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
156488338|NCT01876823|564880324|FG000|Overall Study|Withdrawal by Subject|5|||
156488339|NCT01876823|564880324|FG000|Overall Study|Physician Decision|2|||
156488340|NCT01876823|564880324|FG000|Overall Study|Patients moved|2|||
156488341|NCT01123642|564880325|FG000|Overall Study|Lost to Follow-up|23|||
156488342|NCT01123642|564880325|FG000|Overall Study|Withdrawal by Subject|9|||
156488343|NCT01123642|564880325|FG000|Overall Study|ineligible at baseline assessment|36|||
156488344|NCT04853238|564880326|FG000|Overall Study|Death|4|||
156488345|NCT04853238|564880327|FG001|Overall Study|Death|0|||
156488346|NCT04853238|564880328|FG002|Overall Study|Death|2|||
156488347|NCT04853238|564880326|FG000|Overall Study|Lost to Follow-up|16|||
156488348|NCT04853238|564880327|FG001|Overall Study|Lost to Follow-up|2|||
156488349|NCT04853238|564880328|FG002|Overall Study|Lost to Follow-up|37|||
156358008|NCT04762680|564411155|FG015|Phase 2|Protocol Violation|0|||
156358009|NCT04762680|564411156|FG016|Phase 2|Protocol Violation|0|||
156358010|NCT04762680|564411157|FG017|Phase 2|Protocol Violation|0|||
156358011|NCT04762680|564411158|FG018|Phase 2|Protocol Violation|0|||
156358012|NCT04762680|564411159|FG019|Phase 2|Protocol Violation|0|||
156358013|NCT04762680|564411160|FG020|Phase 2|Protocol Violation|0|||
156358014|NCT04762680|564411161|FG021|Phase 2|Protocol Violation|0|||
156358015|NCT04762680|564411140|FG000|Phase 2|Withdrawal by Subject|23|||
156358016|NCT04762680|564411141|FG001|Phase 2|Withdrawal by Subject|21|||
156358017|NCT04762680|564411142|FG002|Phase 2|Withdrawal by Subject|28|||
156358018|NCT04762680|564411143|FG003|Phase 2|Withdrawal by Subject|0|||
156358019|NCT04762680|564411144|FG004|Phase 2|Withdrawal by Subject|0|||
156358020|NCT04762680|564411145|FG005|Phase 2|Withdrawal by Subject|0|||
156358021|NCT04762680|564411146|FG006|Phase 2|Withdrawal by Subject|0|||
156358022|NCT04762680|564411147|FG007|Phase 2|Withdrawal by Subject|0|||
156358023|NCT04762680|564411148|FG008|Phase 2|Withdrawal by Subject|0|||
156358024|NCT04762680|564411149|FG009|Phase 2|Withdrawal by Subject|0|||
156358025|NCT04762680|564411150|FG010|Phase 2|Withdrawal by Subject|0|||
156358026|NCT04762680|564411151|FG011|Phase 2|Withdrawal by Subject|0|||
156358027|NCT04762680|564411152|FG012|Phase 2|Withdrawal by Subject|0|||
156358028|NCT04762680|564411153|FG013|Phase 2|Withdrawal by Subject|0|||
156358029|NCT04762680|564411154|FG014|Phase 2|Withdrawal by Subject|0|||
156358030|NCT04762680|564411155|FG015|Phase 2|Withdrawal by Subject|0|||
156358031|NCT04762680|564411156|FG016|Phase 2|Withdrawal by Subject|0|||
156358032|NCT04762680|564411157|FG017|Phase 2|Withdrawal by Subject|0|||
156358033|NCT04762680|564411158|FG018|Phase 2|Withdrawal by Subject|0|||
156358034|NCT04762680|564411159|FG019|Phase 2|Withdrawal by Subject|0|||
156358035|NCT04762680|564411160|FG020|Phase 2|Withdrawal by Subject|0|||
156358036|NCT04762680|564411161|FG021|Phase 2|Withdrawal by Subject|0|||
156358037|NCT04762680|564411140|FG000|Phase 2|Lost to Follow-up|14|||
156358038|NCT04762680|564411141|FG001|Phase 2|Lost to Follow-up|8|||
156358039|NCT04762680|564411142|FG002|Phase 2|Lost to Follow-up|9|||
156358040|NCT04762680|564411143|FG003|Phase 2|Lost to Follow-up|0|||
156358041|NCT04762680|564411144|FG004|Phase 2|Lost to Follow-up|0|||
156358042|NCT04762680|564411145|FG005|Phase 2|Lost to Follow-up|0|||
156358043|NCT04762680|564411146|FG006|Phase 2|Lost to Follow-up|0|||
156358044|NCT04762680|564411147|FG007|Phase 2|Lost to Follow-up|0|||
156358045|NCT04762680|564411148|FG008|Phase 2|Lost to Follow-up|0|||
156358046|NCT04762680|564411149|FG009|Phase 2|Lost to Follow-up|0|||
156358047|NCT04762680|564411150|FG010|Phase 2|Lost to Follow-up|0|||
156358048|NCT04762680|564411151|FG011|Phase 2|Lost to Follow-up|0|||
156488350|NCT04853238|564880326|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
156488351|NCT04853238|564880327|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
156488352|NCT04853238|564880328|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
156488353|NCT04853238|564880326|FG000|Overall Study|Withdrawal by Subject|6|||
156488354|NCT04853238|564880327|FG001|Overall Study|Withdrawal by Subject|0|||
156358049|NCT04762680|564411152|FG012|Phase 2|Lost to Follow-up|0|||
156358050|NCT04762680|564411153|FG013|Phase 2|Lost to Follow-up|0|||
156358051|NCT04762680|564411154|FG014|Phase 2|Lost to Follow-up|0|||
156358052|NCT04762680|564411155|FG015|Phase 2|Lost to Follow-up|0|||
156358053|NCT04762680|564411156|FG016|Phase 2|Lost to Follow-up|0|||
156358054|NCT04762680|564411157|FG017|Phase 2|Lost to Follow-up|0|||
156358055|NCT04762680|564411158|FG018|Phase 2|Lost to Follow-up|0|||
156358056|NCT04762680|564411159|FG019|Phase 2|Lost to Follow-up|0|||
156358057|NCT04762680|564411160|FG020|Phase 2|Lost to Follow-up|0|||
156488355|NCT04853238|564880328|FG002|Overall Study|Withdrawal by Subject|21|||
156488356|NCT04853238|564880326|FG000|Overall Study|Physician Decision|0|||
156488357|NCT04853238|564880327|FG001|Overall Study|Physician Decision|0|||
156488358|NCT04853238|564880328|FG002|Overall Study|Physician Decision|2|||
156358058|NCT04762680|564411161|FG021|Phase 2|Lost to Follow-up|0|||
156358059|NCT04762680|564411140|FG000|Phase 3|Adverse Event|0|||
156358060|NCT04762680|564411141|FG001|Phase 3|Adverse Event|0|||
156358061|NCT04762680|564411142|FG002|Phase 3|Adverse Event|0|||
156358062|NCT04762680|564411143|FG003|Phase 3|Adverse Event|1|||
156358063|NCT04762680|564411144|FG004|Phase 3|Adverse Event|0|||
156358064|NCT04762680|564411145|FG005|Phase 3|Adverse Event|0|||
156358065|NCT04762680|564411146|FG006|Phase 3|Adverse Event|0|||
156358066|NCT04762680|564411147|FG007|Phase 3|Adverse Event|0|||
156358067|NCT04762680|564411148|FG008|Phase 3|Adverse Event|0|||
156358068|NCT04762680|564411149|FG009|Phase 3|Adverse Event|0|||
156358069|NCT04762680|564411150|FG010|Phase 3|Adverse Event|0|||
156358070|NCT04762680|564411151|FG011|Phase 3|Adverse Event|0|||
156358071|NCT04762680|564411152|FG012|Phase 3|Adverse Event|0|||
156358072|NCT04762680|564411153|FG013|Phase 3|Adverse Event|0|||
156358073|NCT04762680|564411154|FG014|Phase 3|Adverse Event|0|||
156358074|NCT04762680|564411155|FG015|Phase 3|Adverse Event|0|||
156358075|NCT04762680|564411156|FG016|Phase 3|Adverse Event|0|||
156358076|NCT04762680|564411157|FG017|Phase 3|Adverse Event|3|||
156358077|NCT04762680|564411158|FG018|Phase 3|Adverse Event|0|||
156358078|NCT04762680|564411159|FG019|Phase 3|Adverse Event|0|||
156358079|NCT04762680|564411160|FG020|Phase 3|Adverse Event|0|||
156358080|NCT04762680|564411161|FG021|Phase 3|Adverse Event|0|||
156358081|NCT04762680|564411140|FG000|Phase 3|Protocol Violation|0|||
156358082|NCT04762680|564411141|FG001|Phase 3|Protocol Violation|0|||
156358083|NCT04762680|564411142|FG002|Phase 3|Protocol Violation|0|||
156358084|NCT04762680|564411143|FG003|Phase 3|Protocol Violation|4|||
156358085|NCT04762680|564411144|FG004|Phase 3|Protocol Violation|1|||
156358086|NCT04762680|564411145|FG005|Phase 3|Protocol Violation|5|||
156358087|NCT04762680|564411146|FG006|Phase 3|Protocol Violation|1|||
156358088|NCT04762680|564411147|FG007|Phase 3|Protocol Violation|0|||
156358089|NCT04762680|564411148|FG008|Phase 3|Protocol Violation|0|||
156358090|NCT04762680|564411149|FG009|Phase 3|Protocol Violation|0|||
156358091|NCT04762680|564411150|FG010|Phase 3|Protocol Violation|0|||
156358092|NCT04762680|564411151|FG011|Phase 3|Protocol Violation|2|||
156358093|NCT04762680|564411152|FG012|Phase 3|Protocol Violation|3|||
156358094|NCT04762680|564411153|FG013|Phase 3|Protocol Violation|0|||
156358095|NCT04762680|564411154|FG014|Phase 3|Protocol Violation|0|||
156358096|NCT04762680|564411155|FG015|Phase 3|Protocol Violation|1|||
156358097|NCT04762680|564411156|FG016|Phase 3|Protocol Violation|0|||
156358098|NCT04762680|564411157|FG017|Phase 3|Protocol Violation|10|||
156358099|NCT04762680|564411158|FG018|Phase 3|Protocol Violation|0|||
156358100|NCT04762680|564411159|FG019|Phase 3|Protocol Violation|0|||
156358101|NCT04762680|564411160|FG020|Phase 3|Protocol Violation|0|||
156358102|NCT04762680|564411161|FG021|Phase 3|Protocol Violation|0|||
156358103|NCT04762680|564411140|FG000|Phase 3|Withdrawal by Subject|0|||
156358104|NCT04762680|564411141|FG001|Phase 3|Withdrawal by Subject|0|||
156358105|NCT04762680|564411142|FG002|Phase 3|Withdrawal by Subject|0|||
156358106|NCT04762680|564411143|FG003|Phase 3|Withdrawal by Subject|13|||
156358107|NCT04762680|564411144|FG004|Phase 3|Withdrawal by Subject|17|||
156358108|NCT04762680|564411145|FG005|Phase 3|Withdrawal by Subject|12|||
156358109|NCT04762680|564411146|FG006|Phase 3|Withdrawal by Subject|8|||
156358110|NCT04762680|564411147|FG007|Phase 3|Withdrawal by Subject|3|||
156358111|NCT04762680|564411148|FG008|Phase 3|Withdrawal by Subject|2|||
156358112|NCT04762680|564411149|FG009|Phase 3|Withdrawal by Subject|4|||
156358113|NCT04762680|564411150|FG010|Phase 3|Withdrawal by Subject|3|||
156358114|NCT04762680|564411151|FG011|Phase 3|Withdrawal by Subject|1|||
156358115|NCT04762680|564411152|FG012|Phase 3|Withdrawal by Subject|3|||
156358116|NCT04762680|564411153|FG013|Phase 3|Withdrawal by Subject|2|||
156488359|NCT04853238|564880326|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
156488360|NCT04853238|564880327|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
156488361|NCT04853238|564880328|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
156358117|NCT04762680|564411154|FG014|Phase 3|Withdrawal by Subject|1|||
156358118|NCT04762680|564411155|FG015|Phase 3|Withdrawal by Subject|4|||
156358119|NCT04762680|564411156|FG016|Phase 3|Withdrawal by Subject|6|||
156358120|NCT04762680|564411157|FG017|Phase 3|Withdrawal by Subject|32|||
156488362|NCT02972242|564881469|FG000|Overall Study|Withdrawal by Subject|1|||
156358121|NCT04762680|564411158|FG018|Phase 3|Withdrawal by Subject|0|||
156358122|NCT04762680|564411159|FG019|Phase 3|Withdrawal by Subject|0|||
156358123|NCT04762680|564411160|FG020|Phase 3|Withdrawal by Subject|0|||
156358124|NCT04762680|564411161|FG021|Phase 3|Withdrawal by Subject|0|||
156358125|NCT04762680|564411140|FG000|Phase 3|Lost to Follow-up|0|||
156358126|NCT04762680|564411141|FG001|Phase 3|Lost to Follow-up|0|||
156358127|NCT04762680|564411142|FG002|Phase 3|Lost to Follow-up|0|||
156358128|NCT04762680|564411143|FG003|Phase 3|Lost to Follow-up|9|||
156358129|NCT04762680|564411144|FG004|Phase 3|Lost to Follow-up|22|||
156358130|NCT04762680|564411145|FG005|Phase 3|Lost to Follow-up|24|||
156358131|NCT04762680|564411146|FG006|Phase 3|Lost to Follow-up|2|||
156358132|NCT04762680|564411147|FG007|Phase 3|Lost to Follow-up|4|||
156358133|NCT04762680|564411148|FG008|Phase 3|Lost to Follow-up|6|||
156358134|NCT04762680|564411149|FG009|Phase 3|Lost to Follow-up|4|||
156358135|NCT04762680|564411150|FG010|Phase 3|Lost to Follow-up|3|||
156358136|NCT04762680|564411151|FG011|Phase 3|Lost to Follow-up|0|||
156488363|NCT02972242|564881470|FG001|Overall Study|Withdrawal by Subject|0|||
156488364|NCT04572997|564881474|FG000|Overall Study|Adverse Event|1|||
156488365|NCT01967719|564881475|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
156488366|NCT01967719|564881476|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
156488367|NCT01967719|564881477|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
156488368|NCT01967719|564881478|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
156488369|NCT01967719|564881475|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
156488370|NCT01967719|564881476|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
156488371|NCT01967719|564881477|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
156488372|NCT01967719|564881478|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
156488373|NCT00961896|564881481|FG000|Overall Study|Abnormal laboratory value|0|||
156488374|NCT00961896|564881482|FG001|Overall Study|Abnormal laboratory value|0|||
156488375|NCT00961896|564881483|FG002|Overall Study|Abnormal laboratory value|1|||
156488376|NCT00371462|564881484|FG000|Overall Study|Withdrawal by Subject|1|||
156488377|NCT00371462|564881485|FG001|Overall Study|Withdrawal by Subject|0|||
156488378|NCT00371462|564881484|FG000|Overall Study|Other|7|||
156488379|NCT00371462|564881485|FG001|Overall Study|Other|8|||
156488380|NCT03511378|564881486|FG000|Overall Study|Withdrawal by Subject|2|||
156488381|NCT03511378|564881487|FG001|Overall Study|Withdrawal by Subject|2|||
156488382|NCT03511378|564881486|FG000|Overall Study|Patient not coming or schedule visit|1|||
156488383|NCT03511378|564881487|FG001|Overall Study|Patient not coming or schedule visit|0|||
156488384|NCT00755716|564881488|FG000|Overall Study|Adverse Event|1|||
156488385|NCT00755716|564881489|FG001|Overall Study|Adverse Event|4|||
156488386|NCT00755716|564881490|FG002|Overall Study|Adverse Event|1|||
156488387|NCT00755716|564881488|FG000|Overall Study|Lack of Efficacy|2|||
156488388|NCT00755716|564881489|FG001|Overall Study|Lack of Efficacy|0|||
156488389|NCT00755716|564881490|FG002|Overall Study|Lack of Efficacy|0|||
156488390|NCT00755716|564881488|FG000|Overall Study|Lost to Follow-up|5|||
156488391|NCT00755716|564881489|FG001|Overall Study|Lost to Follow-up|3|||
156488392|NCT00755716|564881490|FG002|Overall Study|Lost to Follow-up|1|||
156488393|NCT00755716|564881488|FG000|Overall Study|work schedule issues|0|||
156488394|NCT00755716|564881489|FG001|Overall Study|work schedule issues|1|||
156488395|NCT00755716|564881490|FG002|Overall Study|work schedule issues|1|||
156488396|NCT02581189|564881501|FG000|Overall Study|Failure to return|36|||
156488397|NCT02581189|564881501|FG000|Overall Study|Withdrew consent|5|||
156488398|NCT02581189|564881501|FG000|Overall Study|Death|3|||
156488399|NCT02581189|564881501|FG000|Overall Study|Insufficient virological response|2|||
156488400|NCT02581189|564881501|FG000|Overall Study|Other, not specified|7|||
156488401|NCT03275402|564881506|FG000|Overall Study|Death|17|||
156488402|NCT03275402|564881506|FG000|Overall Study|Study terminated by sponsor|21|||
156488403|NCT03275402|564881506|FG000|Overall Study|Withdrawal by Subject|1|||
156488404|NCT01514864|564881507|FG000|Overall Study|Disease progression|7|||
156488405|NCT01514864|564881508|FG001|Overall Study|Disease progression|5|||
156488406|NCT01514864|564881507|FG000|Overall Study|Study drug toxicity|2|||
156488407|NCT01514864|564881508|FG001|Overall Study|Study drug toxicity|0|||
156488408|NCT03371485|564881509|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
156488409|NCT03371485|564881509|FG000|2-year Follow-up|Death|5|||
156488410|NCT03187353|564881510|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
156488411|NCT03187353|564881511|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
156488412|NCT03187353|564881510|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
156488413|NCT03187353|564881511|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
156488414|NCT03187353|564881510|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
156488415|NCT03187353|564881511|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
156358137|NCT04762680|564411152|FG012|Phase 3|Lost to Follow-up|5|||
156358138|NCT04762680|564411153|FG013|Phase 3|Lost to Follow-up|4|||
156358139|NCT04762680|564411154|FG014|Phase 3|Lost to Follow-up|6|||
156358140|NCT04762680|564411155|FG015|Phase 3|Lost to Follow-up|1|||
156358141|NCT04762680|564411156|FG016|Phase 3|Lost to Follow-up|1|||
156358142|NCT04762680|564411157|FG017|Phase 3|Lost to Follow-up|66|||
156358143|NCT04762680|564411158|FG018|Phase 3|Lost to Follow-up|0|||
156358144|NCT04762680|564411159|FG019|Phase 3|Lost to Follow-up|0|||
156358145|NCT04762680|564411160|FG020|Phase 3|Lost to Follow-up|0|||
156358146|NCT04762680|564411161|FG021|Phase 3|Lost to Follow-up|0|||
156358147|NCT04762680|564411140|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358148|NCT04762680|564411141|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156488416|NCT03187353|564881510|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
156488417|NCT03187353|564881511|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
156488418|NCT03187353|564881510|FG000|Washout (2 Weeks)|Adverse Event|2|||
156488419|NCT03187353|564881511|FG001|Washout (2 Weeks)|Adverse Event|0|||
156488420|NCT03187353|564881510|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
156488421|NCT03187353|564881511|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
156488422|NCT00588341|564881512|FG000|Overall Study|Withdrawal by Subject|3|||
156358149|NCT04762680|564411142|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358150|NCT04762680|564411143|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156488423|NCT00588341|564881512|FG000|Overall Study|Not treated due to metastatic disease|1|||
156488424|NCT00588341|564881512|FG000|Overall Study|Patient ineligible|1|||
156488425|NCT02567227|564881513|FG000|9 Weeks|Adverse Event|5|||
156358151|NCT04762680|564411144|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358152|NCT04762680|564411145|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358153|NCT04762680|564411146|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156488426|NCT02567227|564881514|FG001|9 Weeks|Adverse Event|5|||
156488427|NCT02567227|564881513|FG000|9 Weeks|Withdrawal by Subject|18|||
156488428|NCT02567227|564881514|FG001|9 Weeks|Withdrawal by Subject|8|||
156488429|NCT02567227|564881513|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
156488430|NCT02567227|564881514|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
156488431|NCT02567227|564881513|FG000|6 Month|Death|2|||
156488432|NCT02567227|564881514|FG001|6 Month|Death|0|||
156488433|NCT02567227|564881513|FG000|6 Month|Lost to Follow-up|43|||
156488434|NCT02567227|564881514|FG001|6 Month|Lost to Follow-up|40|||
156488435|NCT02567227|564881513|FG000|12 Months|Lost to Follow-up|31|||
156488436|NCT02567227|564881514|FG001|12 Months|Lost to Follow-up|32|||
156488437|NCT02567227|564881513|FG000|12 Months|Death|0|||
156488438|NCT02567227|564881514|FG001|12 Months|Death|2|||
156488439|NCT03746483|564881515|FG000|Overall Study|Adverse Event|0|||
156488440|NCT03746483|564881516|FG001|Overall Study|Adverse Event|1|||
156488441|NCT03746483|564881515|FG000|Overall Study|Lack of Efficacy|3|||
156488442|NCT03746483|564881516|FG001|Overall Study|Lack of Efficacy|2|||
156488443|NCT03746483|564881515|FG000|Overall Study|Lost to Follow-up|1|||
156488444|NCT03746483|564881516|FG001|Overall Study|Lost to Follow-up|0|||
156488445|NCT03746483|564881515|FG000|Overall Study|Protocol Violation|2|||
156488446|NCT03746483|564881516|FG001|Overall Study|Protocol Violation|0|||
156488447|NCT01924806|564881521|FG000|Overall Study|Physician Decision|2|||
156488448|NCT01924806|564881522|FG001|Overall Study|Physician Decision|1|||
156488449|NCT02498418|564881527|FG000|Overall Study|Lack of Efficacy|0|||
156488450|NCT02498418|564881528|FG001|Overall Study|Lack of Efficacy|0|||
156488451|NCT02498418|564881529|FG002|Overall Study|Lack of Efficacy|1|||
156488452|NCT02498418|564881527|FG000|Overall Study|Withdrawal by Subject|2|||
156488453|NCT02498418|564881528|FG001|Overall Study|Withdrawal by Subject|0|||
156488454|NCT02498418|564881529|FG002|Overall Study|Withdrawal by Subject|3|||
156488455|NCT02498418|564881527|FG000|Overall Study|Lost to Follow-up|0|||
156488456|NCT02498418|564881528|FG001|Overall Study|Lost to Follow-up|1|||
156488457|NCT02498418|564881529|FG002|Overall Study|Lost to Follow-up|1|||
156488458|NCT02498418|564881527|FG000|Overall Study|Participant taken prohibited medication|0|||
156488459|NCT02498418|564881528|FG001|Overall Study|Participant taken prohibited medication|1|||
156488460|NCT02498418|564881529|FG002|Overall Study|Participant taken prohibited medication|1|||
156488461|NCT01026103|564881530|FG000|Overall Study|Physician Decision|1|||
156488462|NCT01026103|564881530|FG000|Overall Study|did not receive study device bc of error|1|||
156488463|NCT00762502|564881531|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
156488464|NCT00762502|564881532|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
156488465|NCT00762502|564881533|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
156488466|NCT00762502|564881531|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
156488467|NCT00762502|564881532|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
156488468|NCT00762502|564881533|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
156488469|NCT00762502|564881531|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
156488470|NCT00762502|564881532|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
156488471|NCT00762502|564881533|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
156488472|NCT01363297|564881542|FG000|Overall Study|Other|0|||
156488473|NCT01363297|564881543|FG001|Overall Study|Other|0|||
156488474|NCT01363297|564881544|FG002|Overall Study|Other|0|||
156488475|NCT01363297|564881545|FG003|Overall Study|Other|0|||
156488476|NCT01363297|564881546|FG004|Overall Study|Other|1|||
156488477|NCT01363297|564881542|FG000|Overall Study|Death|3|||
156488478|NCT01363297|564881543|FG001|Overall Study|Death|6|||
156488479|NCT01363297|564881544|FG002|Overall Study|Death|6|||
156488480|NCT01363297|564881545|FG003|Overall Study|Death|10|||
156488481|NCT01363297|564881546|FG004|Overall Study|Death|30|||
156488482|NCT01770509|564881553|FG000|Overall Study|Injury|0|||
156358154|NCT04762680|564411147|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156488483|NCT01770509|564881554|FG001|Overall Study|Injury|1|||
156488484|NCT01770509|564881553|FG000|Overall Study|Lost to Follow-up|1|||
156488485|NCT01770509|564881554|FG001|Overall Study|Lost to Follow-up|2|||
156488486|NCT00794573|564881559|FG000|Overall Study|Death|3|||
156488487|NCT00794573|564881560|FG001|Overall Study|Death|0|||
156488488|NCT00794573|564881559|FG000|Overall Study|Withdrawal by Subject|9|||
156488489|NCT00794573|564881560|FG001|Overall Study|Withdrawal by Subject|12|||
156488490|NCT00794573|564881559|FG000|Overall Study|Lost to Follow-up|26|||
156488491|NCT00794573|564881560|FG001|Overall Study|Lost to Follow-up|33|||
156488492|NCT01774929|564881563|FG000|Overall Study|Adverse Event|3|||
156488493|NCT00500539|564881564|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
156488494|NCT00500539|564881564|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
156488495|NCT00500539|564881564|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
156488496|NCT00500539|564881564|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
156488497|NCT00500539|564881564|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
156488498|NCT00500539|564881564|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
156358155|NCT04762680|564411148|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156488499|NCT00500539|564881564|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
156488500|NCT00500539|564881564|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
156488501|NCT00500539|564881564|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
156488502|NCT00500539|564881564|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
156488503|NCT00500539|564881564|FG000|Follow-up Period (16 Weeks)|Death|1|||
156488504|NCT00500539|564881564|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
156358156|NCT04762680|564411149|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358157|NCT04762680|564411150|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358158|NCT04762680|564411151|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358159|NCT04762680|564411152|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358160|NCT04762680|564411153|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358161|NCT04762680|564411154|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358162|NCT04762680|564411155|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358163|NCT04762680|564411156|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358164|NCT04762680|564411157|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358165|NCT04762680|564411158|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358166|NCT04762680|564411159|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358167|NCT04762680|564411160|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156358168|NCT04762680|564411161|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
156358169|NCT04762680|564411140|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358170|NCT04762680|564411141|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358171|NCT04762680|564411142|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358172|NCT04762680|564411143|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358173|NCT04762680|564411144|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358174|NCT04762680|564411145|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358175|NCT04762680|564411146|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358176|NCT04762680|564411147|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358177|NCT04762680|564411148|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358178|NCT04762680|564411149|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358179|NCT04762680|564411150|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358180|NCT04762680|564411151|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358181|NCT04762680|564411152|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358182|NCT04762680|564411153|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358183|NCT04762680|564411154|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358184|NCT04762680|564411155|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358185|NCT04762680|564411156|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358186|NCT04762680|564411157|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358187|NCT04762680|564411158|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358188|NCT04762680|564411159|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
156358189|NCT04762680|564411160|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358190|NCT04762680|564411161|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
156358191|NCT03388138|564411162|FG000|Overall Study|Protocol Violation|1|||
156358192|NCT03388138|564411163|FG001|Overall Study|Protocol Violation|0|||
156358193|NCT01528072|564411164|FG000|Overall Study|Withdrawal by Subject|5|||
156358194|NCT01528072|564411164|FG000|Overall Study|Physician Decision|1|||
156358195|NCT01528072|564411164|FG000|Overall Study|Determined not eligible by AEAC|1|||
156358196|NCT01528072|564411164|FG000|Overall Study|Missed Visit|2|||
156358197|NCT01528072|564411164|FG000|Overall Study|Lost to Follow-up|5|||
156358198|NCT01528072|564411164|FG000|Overall Study|Explanted|2|||
156358199|NCT01528072|564411164|FG000|Overall Study|Site Closure|4|||
156358200|NCT01528072|564411164|FG000|Overall Study|Death|2|||
156358201|NCT01528072|564411164|FG000|Overall Study|Early Termination of Study|52|||
156358202|NCT00297037|564411177|FG000|Overall Study|Withdrawal by Subject|2|||
156358203|NCT00297037|564411178|FG001|Overall Study|Withdrawal by Subject|0|||
156358204|NCT02357901|564411179|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
156358205|NCT02357901|564411180|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
156358206|NCT02357901|564411181|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
156358207|NCT02357901|564411182|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
156358208|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
156358209|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
156488505|NCT00500539|564881564|FG000|Follow-up Period (16 Weeks)|Missing|3|||
156488506|NCT03993054|564881567|FG000|Overall Study|PI Decision|1|||
156488507|NCT00383500|564881568|FG000|Overall Study|Withdrawal by Subject|8|||
156358210|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
156358211|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
156358212|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
156358213|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
156358214|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
156358215|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
156358216|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
156358217|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
156358218|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
156488508|NCT00383500|564881569|FG001|Overall Study|Withdrawal by Subject|3|||
156488509|NCT00383500|564881570|FG002|Overall Study|Withdrawal by Subject|0|||
156488510|NCT00383500|564881568|FG000|Overall Study|Lost to Follow-up|0|||
156488511|NCT00383500|564881569|FG001|Overall Study|Lost to Follow-up|0|||
156488512|NCT00383500|564881570|FG002|Overall Study|Lost to Follow-up|2|||
156488513|NCT02093897|564883226|FG000|Overall Study|Physician Decision|1|||
156488514|NCT02093897|564883226|FG000|Overall Study|Planned age group closure - no's reached|17|||
156488515|NCT02093897|564883226|FG000|Overall Study|Adverse event, non-fatal|1|||
156488516|NCT01983462|564883227|FG000|Overall Study|Adverse Event|1|||
156488517|NCT01983462|564883228|FG001|Overall Study|Adverse Event|0|||
156488518|NCT01983462|564883229|FG002|Overall Study|Adverse Event|0|||
156488519|NCT02229396|564883230|FG000|Overall Study|Adverse Event|6|||
156488520|NCT02229396|564883231|FG001|Overall Study|Adverse Event|12|||
156488521|NCT02229396|564883232|FG002|Overall Study|Adverse Event|12|||
156488522|NCT02229396|564883230|FG000|Overall Study|Death|2|||
156488523|NCT02229396|564883231|FG001|Overall Study|Death|3|||
156488524|NCT02229396|564883232|FG002|Overall Study|Death|1|||
156488525|NCT02229396|564883230|FG000|Overall Study|Lost to Follow-up|14|||
156488526|NCT02229396|564883231|FG001|Overall Study|Lost to Follow-up|14|||
156488527|NCT02229396|564883232|FG002|Overall Study|Lost to Follow-up|21|||
156488528|NCT02229396|564883230|FG000|Overall Study|Protocol Violation|2|||
156488529|NCT02229396|564883231|FG001|Overall Study|Protocol Violation|1|||
156488530|NCT02229396|564883232|FG002|Overall Study|Protocol Violation|0|||
156488531|NCT02229396|564883230|FG000|Overall Study|Patient Incorrectly Randomized|0|||
156488532|NCT02229396|564883231|FG001|Overall Study|Patient Incorrectly Randomized|0|||
156488533|NCT02229396|564883232|FG002|Overall Study|Patient Incorrectly Randomized|1|||
156488534|NCT02229396|564883230|FG000|Overall Study|Other|10|||
156488535|NCT02229396|564883231|FG001|Overall Study|Other|18|||
156488536|NCT02229396|564883232|FG002|Overall Study|Other|15|||
156488537|NCT02229396|564883230|FG000|Overall Study|Withdrawal by Subject|42|||
156488538|NCT02229396|564883231|FG001|Overall Study|Withdrawal by Subject|28|||
156488539|NCT02229396|564883232|FG002|Overall Study|Withdrawal by Subject|41|||
156488540|NCT02229396|564883230|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
156488541|NCT02229396|564883231|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
156488542|NCT02229396|564883232|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
156488543|NCT02229396|564883230|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
156488544|NCT02229396|564883231|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
156488545|NCT02229396|564883232|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
156488546|NCT02679079|564883234|FG000|Overall Study|Adverse Event|2|||
156488547|NCT02679079|564883235|FG001|Overall Study|Adverse Event|0|||
156488548|NCT02679079|564883236|FG002|Overall Study|Adverse Event|2|||
156488549|NCT02679079|564883234|FG000|Overall Study|Protocol Violation|0|||
156488550|NCT02679079|564883235|FG001|Overall Study|Protocol Violation|1|||
156488551|NCT02679079|564883236|FG002|Overall Study|Protocol Violation|0|||
156488552|NCT02679079|564883234|FG000|Overall Study|Withdrawal by Subject|2|||
156488553|NCT02679079|564883235|FG001|Overall Study|Withdrawal by Subject|1|||
156488554|NCT02679079|564883236|FG002|Overall Study|Withdrawal by Subject|0|||
156488555|NCT03193216|564883242|FG000|Overall Study|Lost to Follow-up|1|||
156488556|NCT03193216|564883243|FG001|Overall Study|Lost to Follow-up|0|||
156488557|NCT03193216|564883242|FG000|Overall Study|Withdrawal by Subject|5|||
156488558|NCT03193216|564883243|FG001|Overall Study|Withdrawal by Subject|0|||
156545013|NCT02536313|565089515|FG000|Overall Study|Lack of Efficacy|0|||
156545014|NCT02536313|565089516|FG001|Overall Study|Lack of Efficacy|1|||
156545015|NCT01924182|565089517|FG000|Overall Study|Withdrawal by Subject|1|||
156545016|NCT01924182|565089518|FG001|Overall Study|Withdrawal by Subject|0|||
156488559|NCT03193216|564883242|FG000|Overall Study|Physician Decision|4|||
156488560|NCT03193216|564883243|FG001|Overall Study|Physician Decision|0|||
156488561|NCT02490878|564883244|FG000|Overall Study|deemed ineligible|0|||
156488562|NCT02490878|564883245|FG001|Overall Study|deemed ineligible|1|||
156488563|NCT02490878|564883244|FG000|Overall Study|progression prior to treatment|0|||
156488564|NCT02490878|564883245|FG001|Overall Study|progression prior to treatment|1|||
156488565|NCT02490878|564883244|FG000|Overall Study|only submitted baseline QOL|0|||
156488566|NCT02490878|564883245|FG001|Overall Study|only submitted baseline QOL|1|||
156488567|NCT01264887|564883246|FG000|Overall Study|Adverse Event|5|||
156488568|NCT01264887|564883246|FG000|Overall Study|Death|7|||
156488569|NCT01264887|564883246|FG000|Overall Study|Lack of Efficacy|5|||
156488570|NCT01264887|564883246|FG000|Overall Study|Physician Decision|4|||
156488571|NCT01264887|564883246|FG000|Overall Study|Withdrawal by Subject|6|||
156488572|NCT01264887|564883246|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
156488573|NCT01264887|564883246|FG000|Overall Study|Other|2|||
156488574|NCT04531813|564883247|FG000|Overall Study|Protocol Violation|1|||
156488575|NCT04531813|564883247|FG000|Overall Study|Withdrawal by Subject|1|||
156488576|NCT02171130|564883248|FG000|Overall Study|Death|1|||
156488577|NCT02171130|564883248|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
156488578|NCT02171130|564883248|FG000|Overall Study|Discontinued; Site Termination|5|||
156488579|NCT02171130|564883248|FG000|Overall Study|Withdrawal by Subject|3|||
156488580|NCT02171130|564883248|FG000|Overall Study|Physician Decision|1|||
156488581|NCT02171130|564883248|FG000|Overall Study|Lost to Follow-up|1|||
156545017|NCT00219284|565089519|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
156545018|NCT00219284|565089520|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
156545019|NCT00219284|565089519|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
156358219|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
156358220|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
156358221|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
156358222|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
156358223|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
156358224|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
156358225|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
156358226|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
156358227|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
156358228|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
156358229|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
156358230|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
156358231|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
156358232|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
156358233|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
156358234|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
156358235|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
156358236|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
156358237|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
156358238|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
156358239|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
156358240|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
156358241|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
156358242|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
156358243|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
156358244|NCT02357901|564411179|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
156358245|NCT02357901|564411180|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
156358246|NCT02357901|564411181|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
156358247|NCT02357901|564411182|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
156358248|NCT00491387|564411189|FG000|Overall Study|study terminated|20|||
156358249|NCT01120756|564411196|FG000|Overall Study|Withdrawal by Subject|1|||
156358250|NCT01120756|564411197|FG001|Overall Study|Withdrawal by Subject|1|||
156358251|NCT00698581|564411198|FG000|Overall Study|Lack of Efficacy|23|||
156358252|NCT00698581|564411199|FG001|Overall Study|Lack of Efficacy|11|||
156358253|NCT00698581|564411198|FG000|Overall Study|Withdrawal by Subject|6|||
156358254|NCT00698581|564411199|FG001|Overall Study|Withdrawal by Subject|0|||
156358255|NCT00698581|564411198|FG000|Overall Study|Other reason|9|||
156358256|NCT00698581|564411199|FG001|Overall Study|Other reason|1|||
156358257|NCT00698581|564411198|FG000|Overall Study|SAE, non-fatal|1|||
156358258|NCT00698581|564411199|FG001|Overall Study|SAE, non-fatal|0|||
156358259|NCT00698581|564411198|FG000|Overall Study|AE, non-serious non-fatal|4|||
156358260|NCT00698581|564411199|FG001|Overall Study|AE, non-serious non-fatal|0|||
156358261|NCT00698581|564411198|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156358262|NCT00698581|564411199|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156358263|NCT00698581|564411198|FG000|Overall Study|AE of unknown type|1|||
156358264|NCT00698581|564411199|FG001|Overall Study|AE of unknown type|0|||
156358265|NCT03760146|564411200|FG000|Overall Study|Adverse Event|11|||
156358266|NCT03760146|564411201|FG001|Overall Study|Adverse Event|8|||
156358267|NCT03760146|564411202|FG002|Overall Study|Adverse Event|0|||
156358268|NCT03760146|564411203|FG003|Overall Study|Adverse Event|0|||
156358269|NCT03760146|564411204|FG004|Overall Study|Adverse Event|0|||
156358270|NCT03760146|564411205|FG005|Overall Study|Adverse Event|0|||
156358271|NCT03760146|564411200|FG000|Overall Study|Death|1|||
156358272|NCT03760146|564411201|FG001|Overall Study|Death|0|||
156358273|NCT03760146|564411202|FG002|Overall Study|Death|0|||
156358274|NCT03760146|564411203|FG003|Overall Study|Death|0|||
156358275|NCT03760146|564411204|FG004|Overall Study|Death|0|||
156358276|NCT03760146|564411205|FG005|Overall Study|Death|0|||
156358277|NCT03760146|564411200|FG000|Overall Study|Lost to Follow-up|41|||
156358278|NCT03760146|564411201|FG001|Overall Study|Lost to Follow-up|28|||
156358279|NCT03760146|564411202|FG002|Overall Study|Lost to Follow-up|9|||
156358280|NCT03760146|564411203|FG003|Overall Study|Lost to Follow-up|2|||
156358281|NCT03760146|564411204|FG004|Overall Study|Lost to Follow-up|14|||
156358282|NCT03760146|564411205|FG005|Overall Study|Lost to Follow-up|8|||
156358283|NCT03760146|564411200|FG000|Overall Study|No longer met eligibility criteria|3|||
156358284|NCT03760146|564411201|FG001|Overall Study|No longer met eligibility criteria|9|||
156358285|NCT03760146|564411202|FG002|Overall Study|No longer met eligibility criteria|0|||
156358286|NCT03760146|564411203|FG003|Overall Study|No longer met eligibility criteria|0|||
156358287|NCT03760146|564411204|FG004|Overall Study|No longer met eligibility criteria|1|||
156358288|NCT03760146|564411205|FG005|Overall Study|No longer met eligibility criteria|0|||
156358289|NCT03760146|564411200|FG000|Overall Study|Protocol Violation|21|||
156358290|NCT03760146|564411201|FG001|Overall Study|Protocol Violation|13|||
156358291|NCT03760146|564411202|FG002|Overall Study|Protocol Violation|1|||
156358292|NCT03760146|564411203|FG003|Overall Study|Protocol Violation|0|||
156358293|NCT03760146|564411204|FG004|Overall Study|Protocol Violation|1|||
156358294|NCT03760146|564411205|FG005|Overall Study|Protocol Violation|0|||
156358295|NCT03760146|564411200|FG000|Overall Study|Withdrawal by Subject|19|||
156358296|NCT03760146|564411201|FG001|Overall Study|Withdrawal by Subject|20|||
156358297|NCT03760146|564411202|FG002|Overall Study|Withdrawal by Subject|1|||
156358298|NCT03760146|564411203|FG003|Overall Study|Withdrawal by Subject|0|||
156358299|NCT03760146|564411204|FG004|Overall Study|Withdrawal by Subject|1|||
156358300|NCT03760146|564411205|FG005|Overall Study|Withdrawal by Subject|0|||
156358301|NCT00449644|564411206|FG000|Overall Study|Adverse Event|0|||
156358302|NCT00449644|564411207|FG001|Overall Study|Adverse Event|0|||
156358303|NCT00449644|564411208|FG002|Overall Study|Adverse Event|3|||
156358304|NCT00449644|564411209|FG003|Overall Study|Adverse Event|5|||
156358305|NCT00449644|564411206|FG000|Overall Study|Death|1|||
156358306|NCT00449644|564411207|FG001|Overall Study|Death|0|||
156358307|NCT00449644|564411208|FG002|Overall Study|Death|6|||
156358308|NCT00449644|564411209|FG003|Overall Study|Death|1|||
156358309|NCT00449644|564411206|FG000|Overall Study|Lost to Follow-up|1|||
156358310|NCT00449644|564411207|FG001|Overall Study|Lost to Follow-up|1|||
156358311|NCT00449644|564411208|FG002|Overall Study|Lost to Follow-up|5|||
156358312|NCT00449644|564411209|FG003|Overall Study|Lost to Follow-up|3|||
156358313|NCT00449644|564411206|FG000|Overall Study|Pregnancy|0|||
156358314|NCT00449644|564411207|FG001|Overall Study|Pregnancy|0|||
156358315|NCT00449644|564411208|FG002|Overall Study|Pregnancy|3|||
156358316|NCT00449644|564411209|FG003|Overall Study|Pregnancy|2|||
156358317|NCT00449644|564411206|FG000|Overall Study|Protocol Violation|4|||
156358318|NCT00449644|564411207|FG001|Overall Study|Protocol Violation|4|||
156358319|NCT00449644|564411208|FG002|Overall Study|Protocol Violation|3|||
156358320|NCT00449644|564411209|FG003|Overall Study|Protocol Violation|7|||
156358321|NCT00449644|564411206|FG000|Overall Study|Withdrawal by Subject|3|||
156358322|NCT00449644|564411207|FG001|Overall Study|Withdrawal by Subject|4|||
156358323|NCT00449644|564411208|FG002|Overall Study|Withdrawal by Subject|6|||
156358324|NCT00449644|564411209|FG003|Overall Study|Withdrawal by Subject|7|||
156358325|NCT00449644|564411206|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
156358326|NCT00449644|564411207|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
156358327|NCT00449644|564411208|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
156358328|NCT00449644|564411209|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
156358329|NCT00449644|564411206|FG000|Overall Study|Other|1|||
156358330|NCT00449644|564411207|FG001|Overall Study|Other|4|||
156358331|NCT00449644|564411208|FG002|Overall Study|Other|1|||
156358332|NCT00449644|564411209|FG003|Overall Study|Other|0|||
156358333|NCT00449644|564411206|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
156358334|NCT00449644|564411207|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
156358335|NCT00449644|564411208|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
156358336|NCT00449644|564411209|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
156358337|NCT03999892|564411210|FG000|Overall Study|Lost to Follow-up|1|||
156358338|NCT01848756|564411211|FG000|Overall Study|Adverse Event|1|||
156358339|NCT01848756|564411211|FG000|Overall Study|Withdrawal by Subject|1|||
156358340|NCT01848756|564411211|FG000|Overall Study|Enrolled in Error|1|||
156358341|NCT03245008|564411212|FG000|Overall Study|Adverse Event|15|||
156358342|NCT03245008|564411213|FG001|Overall Study|Adverse Event|18|||
156358343|NCT03245008|564411214|FG002|Overall Study|Adverse Event|15|||
156358344|NCT03245008|564411215|FG003|Overall Study|Adverse Event|0|||
156358345|NCT03245008|564411216|FG004|Overall Study|Adverse Event|1|||
156358346|NCT03245008|564411212|FG000|Overall Study|Lack of Efficacy|0|||
156358347|NCT03245008|564411213|FG001|Overall Study|Lack of Efficacy|1|||
156358348|NCT03245008|564411214|FG002|Overall Study|Lack of Efficacy|0|||
156358349|NCT03245008|564411215|FG003|Overall Study|Lack of Efficacy|0|||
156358350|NCT03245008|564411216|FG004|Overall Study|Lack of Efficacy|0|||
156488582|NCT02171130|564883248|FG000|Overall Study|Met Exclusion Criteria|1|||
156488583|NCT00677092|564883249|FG000|Overall Study|Adverse Event|1|||
156358351|NCT03245008|564411212|FG000|Overall Study|Lost to Follow-up|4|||
156358352|NCT03245008|564411213|FG001|Overall Study|Lost to Follow-up|1|||
156358353|NCT03245008|564411214|FG002|Overall Study|Lost to Follow-up|0|||
156358354|NCT03245008|564411215|FG003|Overall Study|Lost to Follow-up|0|||
156358355|NCT03245008|564411216|FG004|Overall Study|Lost to Follow-up|1|||
156358356|NCT03245008|564411212|FG000|Overall Study|Physician Decision|1|||
156358357|NCT03245008|564411213|FG001|Overall Study|Physician Decision|3|||
156358358|NCT03245008|564411214|FG002|Overall Study|Physician Decision|4|||
156358359|NCT03245008|564411215|FG003|Overall Study|Physician Decision|0|||
156358360|NCT03245008|564411216|FG004|Overall Study|Physician Decision|0|||
156358361|NCT03245008|564411212|FG000|Overall Study|Protocol Violation|0|||
156358362|NCT03245008|564411213|FG001|Overall Study|Protocol Violation|1|||
156358363|NCT03245008|564411214|FG002|Overall Study|Protocol Violation|0|||
156488584|NCT00677092|564883249|FG000|Overall Study|Lost to Follow-up|1|||
156488585|NCT00677092|564883249|FG000|Overall Study|Withdrawal by Subject|3|||
156488586|NCT00677092|564883249|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
156488587|NCT02381652|564883252|FG000|Overall Study|Withdrawal by Subject|0|||
156488588|NCT02381652|564883253|FG001|Overall Study|Withdrawal by Subject|0|||
156488589|NCT02381652|564883254|FG002|Overall Study|Withdrawal by Subject|1|||
156488590|NCT01340300|564883255|FG000|Overall Study|Lost to Follow-up|3|||
156545020|NCT00219284|565089520|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
156545021|NCT00219284|565089519|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
156545022|NCT00219284|565089520|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
156488591|NCT01340300|564883256|FG001|Overall Study|Lost to Follow-up|0|||
156545023|NCT00219284|565089519|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
156545024|NCT00219284|565089520|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
156545025|NCT00219284|565089519|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
156545026|NCT00219284|565089520|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
156545027|NCT00219284|565089519|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
156488592|NCT01340300|564883257|FG002|Overall Study|Lost to Follow-up|5|||
156488593|NCT01340300|564883258|FG003|Overall Study|Lost to Follow-up|10|||
156488594|NCT01340300|564883255|FG000|Overall Study|Withdrawal by Subject|5|||
156488595|NCT01340300|564883256|FG001|Overall Study|Withdrawal by Subject|6|||
156488596|NCT01340300|564883257|FG002|Overall Study|Withdrawal by Subject|6|||
156488597|NCT01340300|564883258|FG003|Overall Study|Withdrawal by Subject|3|||
156488598|NCT01340300|564883255|FG000|Overall Study|Adverse Event|1|||
156488599|NCT01340300|564883256|FG001|Overall Study|Adverse Event|0|||
156545028|NCT00219284|565089520|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
156488600|NCT01340300|564883257|FG002|Overall Study|Adverse Event|4|||
156488601|NCT01340300|564883258|FG003|Overall Study|Adverse Event|0|||
156488602|NCT01340300|564883255|FG000|Overall Study|Physician Decision|0|||
156488603|NCT01340300|564883256|FG001|Overall Study|Physician Decision|1|||
156488604|NCT01340300|564883257|FG002|Overall Study|Physician Decision|0|||
156488605|NCT01340300|564883258|FG003|Overall Study|Physician Decision|0|||
156488606|NCT01340300|564883255|FG000|Overall Study|Unrelated sickness|0|||
156488607|NCT01340300|564883256|FG001|Overall Study|Unrelated sickness|2|||
156488608|NCT01340300|564883257|FG002|Overall Study|Unrelated sickness|0|||
156488609|NCT01340300|564883258|FG003|Overall Study|Unrelated sickness|1|||
156488610|NCT04772313|564883259|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
156488611|NCT04772313|564883259|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
156358364|NCT03245008|564411215|FG003|Overall Study|Protocol Violation|0|||
156358365|NCT03245008|564411216|FG004|Overall Study|Protocol Violation|0|||
156358366|NCT03245008|564411212|FG000|Overall Study|Withdrawal by Subject|20|||
156358367|NCT03245008|564411213|FG001|Overall Study|Withdrawal by Subject|19|||
156358368|NCT03245008|564411214|FG002|Overall Study|Withdrawal by Subject|11|||
156358369|NCT03245008|564411215|FG003|Overall Study|Withdrawal by Subject|0|||
156358370|NCT03245008|564411216|FG004|Overall Study|Withdrawal by Subject|0|||
156358371|NCT03245008|564411212|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
156358372|NCT03245008|564411213|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
156358373|NCT03245008|564411214|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
156358374|NCT03245008|564411215|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
156358375|NCT03245008|564411216|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
156358376|NCT03245008|564411212|FG000|Overall Study|Failure to meet randomization criteria|0|||
156358377|NCT03245008|564411213|FG001|Overall Study|Failure to meet randomization criteria|1|||
156358378|NCT03245008|564411214|FG002|Overall Study|Failure to meet randomization criteria|0|||
156358379|NCT03245008|564411215|FG003|Overall Study|Failure to meet randomization criteria|1|||
156358380|NCT03245008|564411216|FG004|Overall Study|Failure to meet randomization criteria|0|||
156358381|NCT02075658|564411217|FG000|Overall Study|Physician Decision|2|||
156358382|NCT02075658|564411218|FG001|Overall Study|Physician Decision|2|||
156358383|NCT01286012|564411219|FG000|Overall Study|Adverse Event|3|||
156358384|NCT01286012|564411220|FG001|Overall Study|Adverse Event|3|||
156358385|NCT01286012|564411219|FG000|Overall Study|Death|2|||
156358386|NCT01286012|564411220|FG001|Overall Study|Death|3|||
156358387|NCT01286012|564411219|FG000|Overall Study|Protocol Violation|1|||
156358388|NCT01286012|564411220|FG001|Overall Study|Protocol Violation|1|||
156358389|NCT01286012|564411219|FG000|Overall Study|Withdrawal by Subject|4|||
156358390|NCT01286012|564411220|FG001|Overall Study|Withdrawal by Subject|4|||
156358391|NCT01286012|564411219|FG000|Overall Study|Physician Decision|2|||
156358392|NCT01286012|564411220|FG001|Overall Study|Physician Decision|0|||
156358393|NCT01286012|564411219|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
156358394|NCT01286012|564411220|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
156358395|NCT04056195|564411223|FG000|Overall Study|Adverse Event|1|||
156358396|NCT04056195|564411224|FG001|Overall Study|Adverse Event|0|||
156358397|NCT04056195|564411225|FG002|Overall Study|Adverse Event|0|||
156358398|NCT04056195|564411223|FG000|Overall Study|Withdrawal by Subject|0|||
156358399|NCT04056195|564411224|FG001|Overall Study|Withdrawal by Subject|1|||
156358400|NCT04056195|564411225|FG002|Overall Study|Withdrawal by Subject|1|||
156358401|NCT04056195|564411223|FG000|Overall Study|Physician Decision|1|||
156358402|NCT04056195|564411224|FG001|Overall Study|Physician Decision|1|||
156358403|NCT04056195|564411225|FG002|Overall Study|Physician Decision|1|||
156358404|NCT02406651|564411226|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
156358405|NCT00718328|564411230|FG000|Overall Study|Lost to Follow-up|1|||
156358406|NCT00718328|564411231|FG001|Overall Study|Lost to Follow-up|0|||
156358407|NCT02865915|564411232|FG000|Overall Study|Pregnancy|1|||
156358408|NCT02865915|564411233|FG001|Overall Study|Pregnancy|0|||
156358409|NCT02865915|564411232|FG000|Overall Study|Withdrawal by Subject|1|||
156358410|NCT02865915|564411233|FG001|Overall Study|Withdrawal by Subject|1|||
156358411|NCT02865915|564411232|FG000|Overall Study|Adverse Event|0|||
156358412|NCT02865915|564411233|FG001|Overall Study|Adverse Event|4|||
156358413|NCT02865915|564411232|FG000|Overall Study|Lost to Follow-up|0|||
156358414|NCT02865915|564411233|FG001|Overall Study|Lost to Follow-up|1|||
156358415|NCT02865915|564411232|FG000|Overall Study|Protocol Violation|0|||
156358416|NCT02865915|564411233|FG001|Overall Study|Protocol Violation|1|||
156358417|NCT02865915|564411232|FG000|Overall Study|Study terminated by sponsor|23|||
156358418|NCT02865915|564411233|FG001|Overall Study|Study terminated by sponsor|18|||
156358419|NCT02865915|564411232|FG000|Overall Study|Dosing group discontinued|0|||
156358420|NCT02865915|564411233|FG001|Overall Study|Dosing group discontinued|5|||
156358421|NCT00663052|564411234|FG000|Overall Study|Adverse Event|6|||
156358422|NCT00663052|564411235|FG001|Overall Study|Adverse Event|3|||
156358423|NCT00663052|564411234|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
156358424|NCT00663052|564411235|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
156358425|NCT00663052|564411234|FG000|Overall Study|Protocol Violation|1|||
156358426|NCT00663052|564411235|FG001|Overall Study|Protocol Violation|0|||
156358427|NCT00663052|564411234|FG000|Overall Study|Withdrawal by Subject|2|||
156358428|NCT00663052|564411235|FG001|Overall Study|Withdrawal by Subject|5|||
156358429|NCT00663052|564411234|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
156358430|NCT00663052|564411235|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
156358431|NCT00663052|564411234|FG000|Overall Study|Other|0|||
156358432|NCT00663052|564411235|FG001|Overall Study|Other|1|||
156358433|NCT01602380|564411238|FG000|Overall Study|Death|147|||
156358434|NCT01602380|564411239|FG001|Overall Study|Death|145|||
156358435|NCT01602380|564411238|FG000|Overall Study|Withdrawal by Subject|39|||
156358436|NCT01602380|564411239|FG001|Overall Study|Withdrawal by Subject|41|||
156358437|NCT01602380|564411238|FG000|Overall Study|Lost to Follow-up|15|||
156358438|NCT01602380|564411239|FG001|Overall Study|Lost to Follow-up|12|||
156358439|NCT01602380|564411238|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156358440|NCT01602380|564411239|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
156358441|NCT01602380|564411238|FG000|Overall Study|Other|2|||
156358442|NCT01602380|564411239|FG001|Overall Study|Other|0|||
156358443|NCT05760300|564411242|FG000|Overall Study|Adverse Event|0|||
156358444|NCT05760300|564411243|FG001|Overall Study|Adverse Event|0|||
156358445|NCT05760300|564411244|FG002|Overall Study|Adverse Event|1|||
156358446|NCT05760300|564411245|FG003|Overall Study|Adverse Event|0|||
156358447|NCT05760300|564411242|FG000|Overall Study|Participant Decision|1|||
156358448|NCT05760300|564411243|FG001|Overall Study|Participant Decision|0|||
156358449|NCT05760300|564411244|FG002|Overall Study|Participant Decision|0|||
156358450|NCT05760300|564411245|FG003|Overall Study|Participant Decision|0|||
156358451|NCT01894581|564411246|FG000|Overall Study|Withdrawal by Subject|2|||
156358452|NCT01894581|564411247|FG001|Overall Study|Withdrawal by Subject|3|||
156358453|NCT01894581|564411246|FG000|Overall Study|Screen Failure|3|||
156358454|NCT01894581|564411247|FG001|Overall Study|Screen Failure|4|||
156358455|NCT03795298|564411251|FG000|Overall Study|Death|34|||
156358456|NCT03795298|564411252|FG001|Overall Study|Death|29|||
156358457|NCT03795298|564411251|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
156358458|NCT03795298|564411252|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
156358459|NCT03795298|564411251|FG000|Overall Study|Lost to Follow-up|28|||
156358460|NCT03795298|564411252|FG001|Overall Study|Lost to Follow-up|17|||
156358461|NCT03795298|564411251|FG000|Overall Study|Physician Decision|5|||
156358462|NCT03795298|564411252|FG001|Overall Study|Physician Decision|4|||
156358463|NCT03795298|564411251|FG000|Overall Study|Withdrawal by Subject|43|||
156358464|NCT03795298|564411252|FG001|Overall Study|Withdrawal by Subject|28|||
156358465|NCT03795298|564411251|FG000|Overall Study|Reason not reported|7|||
156358466|NCT03795298|564411252|FG001|Overall Study|Reason not reported|9|||
156358467|NCT01252940|564411253|FG000|Main Study Phase|Randomized but not treated|4|||
156358468|NCT01252940|564411254|FG001|Main Study Phase|Randomized but not treated|2|||
156358469|NCT01252940|564411253|FG000|Main Study Phase|Adverse Event|3|||
156358470|NCT01252940|564411254|FG001|Main Study Phase|Adverse Event|1|||
156358471|NCT01252940|564411253|FG000|Main Study Phase|Lack of Efficacy|1|||
156358472|NCT01252940|564411254|FG001|Main Study Phase|Lack of Efficacy|0|||
156358473|NCT01252940|564411253|FG000|Main Study Phase|Lost to Follow-up|6|||
156358474|NCT01252940|564411254|FG001|Main Study Phase|Lost to Follow-up|1|||
156358475|NCT01252940|564411253|FG000|Main Study Phase|Physician Decision|1|||
156358476|NCT01252940|564411254|FG001|Main Study Phase|Physician Decision|0|||
156358477|NCT01252940|564411253|FG000|Main Study Phase|Protocol Violation|4|||
156358478|NCT01252940|564411254|FG001|Main Study Phase|Protocol Violation|2|||
156358479|NCT01252940|564411253|FG000|Main Study Phase|Withdrawal by Subject|6|||
156358480|NCT01252940|564411254|FG001|Main Study Phase|Withdrawal by Subject|5|||
156358481|NCT01252940|564411253|FG000|Main Study Phase|Subject Non-compliance|1|||
156358482|NCT01252940|564411254|FG001|Main Study Phase|Subject Non-compliance|1|||
156358483|NCT01252940|564411253|FG000|Extension Phase|Adverse Event|2|||
156358484|NCT01252940|564411254|FG001|Extension Phase|Adverse Event|1|||
156358485|NCT01252940|564411253|FG000|Extension Phase|Lack of Efficacy|1|||
156358486|NCT01252940|564411254|FG001|Extension Phase|Lack of Efficacy|0|||
156358487|NCT01252940|564411253|FG000|Extension Phase|Lost to Follow-up|5|||
156358488|NCT01252940|564411254|FG001|Extension Phase|Lost to Follow-up|0|||
156358489|NCT01252940|564411253|FG000|Extension Phase|Physician Decision|0|||
156358490|NCT01252940|564411254|FG001|Extension Phase|Physician Decision|1|||
156358491|NCT01252940|564411253|FG000|Extension Phase|Subject Non-compliance|1|||
156358492|NCT01252940|564411254|FG001|Extension Phase|Subject Non-compliance|0|||
156358493|NCT01252940|564411253|FG000|Extension Phase|Withdrawal by Subject|1|||
156358494|NCT01252940|564411254|FG001|Extension Phase|Withdrawal by Subject|1|||
156358495|NCT04199117|564411255|FG000|Overall Study|Withdrawal by Subject|3|||
156358496|NCT04199117|564411256|FG001|Overall Study|Withdrawal by Subject|0|||
156358497|NCT04199117|564411257|FG002|Overall Study|Withdrawal by Subject|0|||
156358498|NCT04199117|564411258|FG003|Overall Study|Withdrawal by Subject|1|||
156358499|NCT04199117|564411259|FG004|Overall Study|Withdrawal by Subject|1|||
156358500|NCT04199117|564411260|FG005|Overall Study|Withdrawal by Subject|0|||
156358501|NCT04199117|564411261|FG006|Overall Study|Withdrawal by Subject|0|||
156358502|NCT04199117|564411262|FG007|Overall Study|Withdrawal by Subject|2|||
156488612|NCT01836198|564883260|FG000|Part A, Period 2|Protocol Violation|0|||
156488613|NCT01836198|564883261|FG001|Part A, Period 2|Protocol Violation|1|||
156358503|NCT04199117|564411263|FG008|Overall Study|Withdrawal by Subject|0|||
156358504|NCT04199117|564411264|FG009|Overall Study|Withdrawal by Subject|0|||
156358505|NCT04199117|564411265|FG010|Overall Study|Withdrawal by Subject|1|||
156358506|NCT04199117|564411266|FG011|Overall Study|Withdrawal by Subject|1|||
156358507|NCT04199117|564411267|FG012|Overall Study|Withdrawal by Subject|2|||
156358508|NCT04199117|564411268|FG013|Overall Study|Withdrawal by Subject|1|||
156358509|NCT04199117|564411269|FG014|Overall Study|Withdrawal by Subject|1|||
156358510|NCT04199117|564411270|FG015|Overall Study|Withdrawal by Subject|1|||
156358511|NCT04199117|564411255|FG000|Overall Study|Death|1|||
156358512|NCT04199117|564411256|FG001|Overall Study|Death|1|||
156358513|NCT04199117|564411257|FG002|Overall Study|Death|0|||
156358514|NCT04199117|564411258|FG003|Overall Study|Death|0|||
156358515|NCT04199117|564411259|FG004|Overall Study|Death|0|||
156358516|NCT04199117|564411260|FG005|Overall Study|Death|0|||
156358517|NCT04199117|564411261|FG006|Overall Study|Death|0|||
156358518|NCT04199117|564411262|FG007|Overall Study|Death|0|||
156358519|NCT04199117|564411263|FG008|Overall Study|Death|0|||
156358520|NCT04199117|564411264|FG009|Overall Study|Death|0|||
156358521|NCT04199117|564411265|FG010|Overall Study|Death|0|||
156358522|NCT04199117|564411266|FG011|Overall Study|Death|1|||
156358523|NCT04199117|564411267|FG012|Overall Study|Death|0|||
156358524|NCT04199117|564411268|FG013|Overall Study|Death|1|||
156358525|NCT04199117|564411269|FG014|Overall Study|Death|0|||
156358526|NCT04199117|564411270|FG015|Overall Study|Death|0|||
156358527|NCT04199117|564411255|FG000|Overall Study|Withdrawal by PI|0|||
156358528|NCT04199117|564411256|FG001|Overall Study|Withdrawal by PI|0|||
156358529|NCT04199117|564411257|FG002|Overall Study|Withdrawal by PI|0|||
156358530|NCT04199117|564411258|FG003|Overall Study|Withdrawal by PI|0|||
156358531|NCT04199117|564411259|FG004|Overall Study|Withdrawal by PI|0|||
156358532|NCT04199117|564411260|FG005|Overall Study|Withdrawal by PI|0|||
156358533|NCT04199117|564411261|FG006|Overall Study|Withdrawal by PI|0|||
156358534|NCT04199117|564411262|FG007|Overall Study|Withdrawal by PI|0|||
156358535|NCT04199117|564411263|FG008|Overall Study|Withdrawal by PI|0|||
156358536|NCT04199117|564411264|FG009|Overall Study|Withdrawal by PI|0|||
156358537|NCT04199117|564411265|FG010|Overall Study|Withdrawal by PI|0|||
156358538|NCT04199117|564411266|FG011|Overall Study|Withdrawal by PI|0|||
156358539|NCT04199117|564411267|FG012|Overall Study|Withdrawal by PI|1|||
156358540|NCT04199117|564411268|FG013|Overall Study|Withdrawal by PI|0|||
156358541|NCT04199117|564411269|FG014|Overall Study|Withdrawal by PI|0|||
156358542|NCT04199117|564411270|FG015|Overall Study|Withdrawal by PI|0|||
156358543|NCT04383743|564411271|FG000|Overall Study|Withdrawal by Subject|1|||
156358544|NCT04383743|564411271|FG000|Overall Study|Adverse Event|1|||
156358545|NCT03482791|564411278|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
156358546|NCT03482791|564411279|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
156358547|NCT01721330|564411281|FG000|Overall Study|Withdrawal by Subject|0|||
156358548|NCT01721330|564411282|FG001|Overall Study|Withdrawal by Subject|1|||
156358549|NCT00296374|564411283|FG000|Overall Study|Adverse Event|14|||
156358550|NCT00296374|564411284|FG001|Overall Study|Adverse Event|10|||
156358551|NCT00296374|564411285|FG002|Overall Study|Adverse Event|7|||
156358552|NCT00296374|564411283|FG000|Overall Study|Withdrawal by Subject|3|||
156358553|NCT00296374|564411284|FG001|Overall Study|Withdrawal by Subject|5|||
156358554|NCT00296374|564411285|FG002|Overall Study|Withdrawal by Subject|11|||
156358555|NCT00296374|564411283|FG000|Overall Study|Incorrect enrollment|3|||
156358556|NCT00296374|564411284|FG001|Overall Study|Incorrect enrollment|3|||
156358557|NCT00296374|564411285|FG002|Overall Study|Incorrect enrollment|4|||
156358558|NCT00296374|564411283|FG000|Overall Study|Protocol Violation|1|||
156358559|NCT00296374|564411284|FG001|Overall Study|Protocol Violation|2|||
156358560|NCT00296374|564411285|FG002|Overall Study|Protocol Violation|3|||
156358561|NCT00296374|564411283|FG000|Overall Study|Lost to Follow-up|3|||
156358562|NCT00296374|564411284|FG001|Overall Study|Lost to Follow-up|1|||
156358563|NCT00296374|564411285|FG002|Overall Study|Lost to Follow-up|1|||
156358564|NCT00296374|564411283|FG000|Overall Study|Relocated to another state|1|||
156358565|NCT00296374|564411284|FG001|Overall Study|Relocated to another state|0|||
156358566|NCT00296374|564411285|FG002|Overall Study|Relocated to another state|0|||
156358567|NCT00296374|564411283|FG000|Overall Study|Stopped drug before end of study visit|0|||
156545029|NCT00219284|565089519|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
156545030|NCT00219284|565089520|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
156545031|NCT00219284|565089519|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
156545032|NCT00219284|565089520|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
156358568|NCT00296374|564411284|FG001|Overall Study|Stopped drug before end of study visit|1|||
156358569|NCT00296374|564411285|FG002|Overall Study|Stopped drug before end of study visit|0|||
156358570|NCT00296374|564411283|FG000|Overall Study|Nephrologist introduced ACE|0|||
156358571|NCT00296374|564411284|FG001|Overall Study|Nephrologist introduced ACE|1|||
156358572|NCT00296374|564411285|FG002|Overall Study|Nephrologist introduced ACE|0|||
156358573|NCT00296374|564411283|FG000|Overall Study|Pregnancy|0|||
156358574|NCT00296374|564411284|FG001|Overall Study|Pregnancy|0|||
156358575|NCT00296374|564411285|FG002|Overall Study|Pregnancy|2|||
156358576|NCT00296374|564411283|FG000|Overall Study|Other|0|||
156358577|NCT00296374|564411284|FG001|Overall Study|Other|0|||
156358578|NCT00296374|564411285|FG002|Overall Study|Other|1|||
156358579|NCT01816893|564411286|FG000|Washout Period|Withdrawal by Subject|2|||
156358580|NCT01816893|564411287|FG001|Washout Period|Withdrawal by Subject|0|||
156358581|NCT01254227|564412891|FG000|Overall Study|Withdrawal by Subject|6|||
156358582|NCT01254227|564412891|FG000|Overall Study|Lost to Follow-up|6|||
156358583|NCT01254227|564412891|FG000|Overall Study|Adverse Event|5|||
156358584|NCT01254227|564412891|FG000|Overall Study|Abnormal test procedure result|5|||
156358585|NCT01254227|564412891|FG000|Overall Study|Administrative problems|2|||
156358586|NCT01254227|564412891|FG000|Overall Study|Death|1|||
156358587|NCT01254227|564412891|FG000|Overall Study|Protocol deviation|1|||
156545033|NCT00219284|565089519|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
156488614|NCT01836198|564883262|FG002|Part A, Period 2|Protocol Violation|0|||
156488615|NCT02215954|564883263|FG000|Overall Study|Adverse Event|0|||
156488616|NCT02215954|564883264|FG001|Overall Study|Adverse Event|0|||
156488617|NCT02215954|564883265|FG002|Overall Study|Adverse Event|1|||
156488618|NCT02215954|564883263|FG000|Overall Study|Withdrawal by Subject|0|||
156488619|NCT02215954|564883264|FG001|Overall Study|Withdrawal by Subject|0|||
156488620|NCT02215954|564883265|FG002|Overall Study|Withdrawal by Subject|2|||
156488621|NCT02215954|564883263|FG000|Overall Study|Not exposed|1|||
156488622|NCT02215954|564883264|FG001|Overall Study|Not exposed|1|||
156488623|NCT02215954|564883265|FG002|Overall Study|Not exposed|3|||
156488624|NCT01061775|564883270|FG000|Overall Study|Physician Decision|2|||
156488625|NCT01061775|564883270|FG000|Overall Study|Lost to Follow-up|1|||
156488626|NCT00784277|564883271|FG000|IR Treatment|Adverse Event|4|||
156488627|NCT00784277|564883272|FG001|IR Treatment|Adverse Event|8|||
156488628|NCT00784277|564883273|FG002|IR Treatment|Adverse Event|19|||
156488629|NCT00784277|564883274|FG003|IR Treatment|Adverse Event|35|||
156488630|NCT00784277|564883275|FG004|IR Treatment|Adverse Event|0|||
156488631|NCT00784277|564883276|FG005|IR Treatment|Adverse Event|0|||
156488632|NCT00784277|564883277|FG006|IR Treatment|Adverse Event|0|||
156488633|NCT00784277|564883271|FG000|IR Treatment|Lack of Efficacy|4|||
156488634|NCT00784277|564883272|FG001|IR Treatment|Lack of Efficacy|4|||
156488635|NCT00784277|564883273|FG002|IR Treatment|Lack of Efficacy|1|||
156488636|NCT00784277|564883274|FG003|IR Treatment|Lack of Efficacy|0|||
156488637|NCT00784277|564883275|FG004|IR Treatment|Lack of Efficacy|0|||
156488638|NCT00784277|564883276|FG005|IR Treatment|Lack of Efficacy|0|||
156488639|NCT00784277|564883277|FG006|IR Treatment|Lack of Efficacy|0|||
156488640|NCT00784277|564883271|FG000|IR Treatment|Lost to Follow-up|1|||
156488641|NCT00784277|564883272|FG001|IR Treatment|Lost to Follow-up|0|||
156488642|NCT00784277|564883273|FG002|IR Treatment|Lost to Follow-up|1|||
156488643|NCT00784277|564883274|FG003|IR Treatment|Lost to Follow-up|0|||
156488644|NCT00784277|564883275|FG004|IR Treatment|Lost to Follow-up|0|||
156488645|NCT00784277|564883276|FG005|IR Treatment|Lost to Follow-up|0|||
156488646|NCT00784277|564883277|FG006|IR Treatment|Lost to Follow-up|0|||
156488647|NCT00784277|564883271|FG000|IR Treatment|Withdrawal by Subject|5|||
156488648|NCT00784277|564883272|FG001|IR Treatment|Withdrawal by Subject|1|||
156488649|NCT00784277|564883273|FG002|IR Treatment|Withdrawal by Subject|4|||
156488650|NCT00784277|564883274|FG003|IR Treatment|Withdrawal by Subject|6|||
156488651|NCT00784277|564883275|FG004|IR Treatment|Withdrawal by Subject|0|||
156488652|NCT00784277|564883276|FG005|IR Treatment|Withdrawal by Subject|0|||
156488653|NCT00784277|564883277|FG006|IR Treatment|Withdrawal by Subject|0|||
156488654|NCT00784277|564883271|FG000|IR Treatment|Resolution Of Pain|0|||
156488655|NCT00784277|564883272|FG001|IR Treatment|Resolution Of Pain|1|||
156488656|NCT00784277|564883273|FG002|IR Treatment|Resolution Of Pain|0|||
156488657|NCT00784277|564883274|FG003|IR Treatment|Resolution Of Pain|0|||
156488658|NCT00784277|564883275|FG004|IR Treatment|Resolution Of Pain|0|||
156488659|NCT00784277|564883276|FG005|IR Treatment|Resolution Of Pain|0|||
156488660|NCT00784277|564883277|FG006|IR Treatment|Resolution Of Pain|0|||
156488661|NCT00784277|564883271|FG000|IR Treatment|Other|2|||
156488662|NCT00784277|564883272|FG001|IR Treatment|Other|3|||
156488663|NCT00784277|564883273|FG002|IR Treatment|Other|3|||
156488664|NCT00784277|564883274|FG003|IR Treatment|Other|2|||
156488665|NCT00784277|564883275|FG004|IR Treatment|Other|0|||
156488666|NCT00784277|564883276|FG005|IR Treatment|Other|0|||
156488667|NCT00784277|564883277|FG006|IR Treatment|Other|0|||
156488668|NCT00784277|564883271|FG000|ER Treatment|Adverse Event|0|||
156488669|NCT00784277|564883272|FG001|ER Treatment|Adverse Event|0|||
156488670|NCT00784277|564883273|FG002|ER Treatment|Adverse Event|0|||
156488671|NCT00784277|564883274|FG003|ER Treatment|Adverse Event|0|||
156488672|NCT00784277|564883275|FG004|ER Treatment|Adverse Event|1|||
156488673|NCT00784277|564883276|FG005|ER Treatment|Adverse Event|7|||
156488674|NCT00784277|564883277|FG006|ER Treatment|Adverse Event|7|||
156488675|NCT00784277|564883271|FG000|ER Treatment|Lack of Efficacy|0|||
156488676|NCT00784277|564883272|FG001|ER Treatment|Lack of Efficacy|0|||
156488677|NCT00784277|564883273|FG002|ER Treatment|Lack of Efficacy|0|||
156545034|NCT00219284|565089520|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
156488678|NCT00784277|564883274|FG003|ER Treatment|Lack of Efficacy|0|||
156488679|NCT00784277|564883275|FG004|ER Treatment|Lack of Efficacy|3|||
156488680|NCT00784277|564883276|FG005|ER Treatment|Lack of Efficacy|4|||
156488681|NCT00784277|564883277|FG006|ER Treatment|Lack of Efficacy|0|||
156488682|NCT00784277|564883271|FG000|ER Treatment|Lost to Follow-up|0|||
156488683|NCT00784277|564883272|FG001|ER Treatment|Lost to Follow-up|0|||
156488684|NCT00784277|564883273|FG002|ER Treatment|Lost to Follow-up|0|||
156488685|NCT00784277|564883274|FG003|ER Treatment|Lost to Follow-up|0|||
156488686|NCT00784277|564883275|FG004|ER Treatment|Lost to Follow-up|0|||
156488687|NCT00784277|564883276|FG005|ER Treatment|Lost to Follow-up|2|||
156488688|NCT00784277|564883277|FG006|ER Treatment|Lost to Follow-up|0|||
156488689|NCT00784277|564883271|FG000|ER Treatment|Withdrawal by Subject|0|||
156488690|NCT00784277|564883272|FG001|ER Treatment|Withdrawal by Subject|0|||
156488691|NCT00784277|564883273|FG002|ER Treatment|Withdrawal by Subject|0|||
156488692|NCT00784277|564883274|FG003|ER Treatment|Withdrawal by Subject|0|||
156545035|NCT00788372|565089522|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
156358588|NCT03970733|564412892|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
156358589|NCT03970733|564412893|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
156358590|NCT03970733|564412894|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
156358591|NCT03970733|564412895|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
156358592|NCT03970733|564412896|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
156358593|NCT03970733|564412892|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
156358594|NCT03970733|564412893|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
156358595|NCT03970733|564412894|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
156358596|NCT03970733|564412895|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
156488693|NCT00784277|564883275|FG004|ER Treatment|Withdrawal by Subject|2|||
156488694|NCT00784277|564883276|FG005|ER Treatment|Withdrawal by Subject|5|||
156488695|NCT00784277|564883277|FG006|ER Treatment|Withdrawal by Subject|3|||
156488696|NCT00784277|564883271|FG000|ER Treatment|Study Medication Non-Compliant|0|||
156488697|NCT00784277|564883272|FG001|ER Treatment|Study Medication Non-Compliant|0|||
156488698|NCT00784277|564883273|FG002|ER Treatment|Study Medication Non-Compliant|0|||
156488699|NCT00784277|564883274|FG003|ER Treatment|Study Medication Non-Compliant|0|||
156488700|NCT00784277|564883275|FG004|ER Treatment|Study Medication Non-Compliant|2|||
156488701|NCT00784277|564883276|FG005|ER Treatment|Study Medication Non-Compliant|3|||
156488702|NCT00784277|564883277|FG006|ER Treatment|Study Medication Non-Compliant|3|||
156488703|NCT00784277|564883271|FG000|ER Treatment|Other|0|||
156488704|NCT00784277|564883272|FG001|ER Treatment|Other|0|||
156488705|NCT00784277|564883273|FG002|ER Treatment|Other|0|||
156488706|NCT00784277|564883274|FG003|ER Treatment|Other|0|||
156488707|NCT00784277|564883275|FG004|ER Treatment|Other|1|||
156488708|NCT00784277|564883276|FG005|ER Treatment|Other|3|||
156488709|NCT00784277|564883277|FG006|ER Treatment|Other|2|||
156488710|NCT01093222|564883278|FG000|Overall Study|Ineligible|6|||
156488711|NCT01093222|564883278|FG000|Overall Study|Adverse Event|7|||
156488712|NCT01093222|564883278|FG000|Overall Study|Progression/relapse|24|||
156488713|NCT01093222|564883278|FG000|Overall Study|Death|2|||
156358597|NCT03970733|564412896|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
156358598|NCT03970733|564412892|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
156488714|NCT01093222|564883278|FG000|Overall Study|Not protocol specified|1|||
156488715|NCT02642159|564883279|FG000|Overall Study|Randomized but not treated|1|||
156488716|NCT02642159|564883280|FG001|Overall Study|Randomized but not treated|0|||
156488717|NCT02642159|564883279|FG000|Overall Study|Adverse Event|10|||
156488718|NCT02642159|564883280|FG001|Overall Study|Adverse Event|4|||
156488719|NCT02642159|564883279|FG000|Overall Study|Withdrawal by Subject|9|||
156488720|NCT02642159|564883280|FG001|Overall Study|Withdrawal by Subject|1|||
156488721|NCT02642159|564883279|FG000|Overall Study|Poor compliance to study protocol|1|||
156545036|NCT00788372|565089522|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
156545037|NCT00788372|565089522|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
156545038|NCT00788372|565089522|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
156545039|NCT00788372|565089522|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
156545040|NCT00788372|565089522|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
156545041|NCT00788372|565089522|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
156545042|NCT03099187|565089531|FG000|Double-blind Treatment|Adverse Event|19|||
156545043|NCT03099187|565089532|FG001|Double-blind Treatment|Adverse Event|1|||
156545044|NCT03099187|565089533|FG002|Double-blind Treatment|Adverse Event|0|||
156545045|NCT03099187|565089534|FG003|Double-blind Treatment|Adverse Event|0|||
156545046|NCT03099187|565089531|FG000|Double-blind Treatment|Death|1|||
156545047|NCT03099187|565089532|FG001|Double-blind Treatment|Death|3|||
156545048|NCT03099187|565089533|FG002|Double-blind Treatment|Death|0|||
156488722|NCT02642159|564883280|FG001|Overall Study|Poor compliance to study protocol|0|||
156488723|NCT02642159|564883279|FG000|Overall Study|Other than specified above|10|||
156488724|NCT02642159|564883280|FG001|Overall Study|Other than specified above|3|||
156488725|NCT01675050|564883281|FG000|Period One Treatment|Withdrawal by Subject|1|||
156488726|NCT01675050|564883282|FG001|Period One Treatment|Withdrawal by Subject|0|||
156488727|NCT03280108|564883286|FG000|Overall Study|Lost to Follow-up|2|||
156488728|NCT03280108|564883287|FG001|Overall Study|Lost to Follow-up|0|||
156488729|NCT02996097|564883288|FG000|Overall Study|Lost to Follow-up|11|||
156488730|NCT02996097|564883289|FG001|Overall Study|Lost to Follow-up|11|||
156488731|NCT01187407|564883290|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
156488732|NCT01187407|564883291|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156488733|NCT01187407|564883292|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156488734|NCT01187407|564883293|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156488735|NCT01187407|564883294|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156488736|NCT01187407|564883290|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
156488737|NCT01187407|564883291|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156488738|NCT01187407|564883292|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156488739|NCT01187407|564883293|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156488740|NCT01187407|564883294|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156488741|NCT01187407|564883290|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
156488742|NCT01187407|564883291|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156488743|NCT01187407|564883292|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156488744|NCT01187407|564883293|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156488745|NCT01187407|564883294|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156488746|NCT01187407|564883290|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
156488747|NCT01187407|564883291|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156488748|NCT01187407|564883292|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156488749|NCT01187407|564883293|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156488750|NCT01187407|564883294|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156488751|NCT01187407|564883290|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
156488752|NCT01187407|564883291|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156488753|NCT01187407|564883292|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156488754|NCT01187407|564883293|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156488755|NCT01187407|564883294|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156488756|NCT01187407|564883290|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
156488757|NCT01187407|564883291|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156488758|NCT01187407|564883292|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156488759|NCT01187407|564883293|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156488760|NCT01187407|564883294|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156488761|NCT01187407|564883290|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
156488762|NCT01187407|564883291|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156545049|NCT03099187|565089534|FG003|Double-blind Treatment|Death|0|||
156545050|NCT03099187|565089531|FG000|Double-blind Treatment|Lack of Efficacy|1|||
156545051|NCT03099187|565089532|FG001|Double-blind Treatment|Lack of Efficacy|0|||
156545052|NCT03099187|565089533|FG002|Double-blind Treatment|Lack of Efficacy|0|||
156545053|NCT03099187|565089534|FG003|Double-blind Treatment|Lack of Efficacy|0|||
156545054|NCT03099187|565089531|FG000|Double-blind Treatment|Physician Decision|2|||
156488763|NCT01187407|564883292|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156488764|NCT01187407|564883293|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156488765|NCT01187407|564883294|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156545055|NCT03099187|565089532|FG001|Double-blind Treatment|Physician Decision|1|||
156545056|NCT03099187|565089533|FG002|Double-blind Treatment|Physician Decision|0|||
156545057|NCT03099187|565089534|FG003|Double-blind Treatment|Physician Decision|0|||
156358599|NCT03970733|564412893|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
156358600|NCT03970733|564412894|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
156358601|NCT03970733|564412895|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
156358602|NCT03970733|564412896|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
156358603|NCT03970733|564412892|FG000|Main Study Phase (18 Months)|Other|1|||
156358604|NCT03970733|564412893|FG001|Main Study Phase (18 Months)|Other|1|||
156358605|NCT03970733|564412894|FG002|Main Study Phase (18 Months)|Other|0|||
156358606|NCT03970733|564412895|FG003|Main Study Phase (18 Months)|Other|0|||
156358607|NCT03970733|564412896|FG004|Main Study Phase (18 Months)|Other|0|||
156358608|NCT03970733|564412892|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
156358609|NCT03970733|564412893|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
156358610|NCT03970733|564412894|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
156358611|NCT03970733|564412895|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
156358612|NCT03970733|564412896|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
156358613|NCT02189473|564412900|FG000|Overall Study|Death|22|||
156358614|NCT02189473|564412901|FG001|Overall Study|Death|23|||
156358615|NCT02189473|564412900|FG000|Overall Study|Lost to Follow-up|1|||
156358616|NCT02189473|564412901|FG001|Overall Study|Lost to Follow-up|2|||
156358617|NCT02784821|564412902|FG000|Overall Study|Death|0|||
156358618|NCT02784821|564412903|FG001|Overall Study|Death|5|||
156358619|NCT02784821|564412904|FG002|Overall Study|Death|4|||
156358620|NCT02784821|564412905|FG003|Overall Study|Death|5|||
156358621|NCT02794103|564412906|FG000|Overall Study|Loss to follow up due to high sedation|3|||
156358622|NCT01139450|564412907|FG000|Overall Study|Withdrawal by Subject|7|||
156358623|NCT01139450|564412908|FG001|Overall Study|Withdrawal by Subject|10|||
156358624|NCT01139450|564412909|FG002|Overall Study|Withdrawal by Subject|13|||
156358625|NCT01139450|564412907|FG000|Overall Study|Lack of Efficacy|3|||
156358626|NCT01139450|564412908|FG001|Overall Study|Lack of Efficacy|1|||
156358627|NCT01139450|564412909|FG002|Overall Study|Lack of Efficacy|8|||
156358628|NCT01139450|564412907|FG000|Overall Study|Protocol Violation|6|||
156358629|NCT01139450|564412908|FG001|Overall Study|Protocol Violation|5|||
156358630|NCT01139450|564412909|FG002|Overall Study|Protocol Violation|2|||
156358631|NCT01139450|564412907|FG000|Overall Study|Lost to Follow-up|9|||
156358632|NCT01139450|564412908|FG001|Overall Study|Lost to Follow-up|7|||
156358633|NCT01139450|564412909|FG002|Overall Study|Lost to Follow-up|11|||
156358634|NCT01139450|564412907|FG000|Overall Study|Administrative|0|||
156358635|NCT01139450|564412908|FG001|Overall Study|Administrative|0|||
156358636|NCT01139450|564412909|FG002|Overall Study|Administrative|1|||
156358637|NCT01139450|564412907|FG000|Overall Study|Adverse Event|2|||
156358638|NCT01139450|564412908|FG001|Overall Study|Adverse Event|2|||
156358639|NCT01139450|564412909|FG002|Overall Study|Adverse Event|3|||
156358640|NCT04608500|564412910|FG000|Overall Study|Adverse Event|2|||
156358641|NCT04608500|564412911|FG001|Overall Study|Adverse Event|0|||
156358642|NCT04608500|564412910|FG000|Overall Study|Lost to Follow-up|15|||
156358643|NCT04608500|564412911|FG001|Overall Study|Lost to Follow-up|9|||
156358644|NCT04608500|564412910|FG000|Overall Study|Participant request|11|||
156358645|NCT04608500|564412911|FG001|Overall Study|Participant request|7|||
156358646|NCT04608500|564412910|FG000|Overall Study|Protocol Violation|1|||
156358647|NCT04608500|564412911|FG001|Overall Study|Protocol Violation|0|||
156358648|NCT04608500|564412910|FG000|Overall Study|Other|6|||
156358649|NCT04608500|564412911|FG001|Overall Study|Other|2|||
156358650|NCT00542919|564412918|FG000|Overall Study|Adverse Event|1|||
156358651|NCT00542919|564412919|FG001|Overall Study|Adverse Event|5|||
156358652|NCT00542919|564412920|FG002|Overall Study|Adverse Event|1|||
156358653|NCT00542919|564412918|FG000|Overall Study|Withdrawal by Subject|1|||
156358654|NCT00542919|564412919|FG001|Overall Study|Withdrawal by Subject|0|||
156358655|NCT00542919|564412920|FG002|Overall Study|Withdrawal by Subject|3|||
156358656|NCT00542919|564412918|FG000|Overall Study|Physician Decision|2|||
156358657|NCT00542919|564412919|FG001|Overall Study|Physician Decision|2|||
156358658|NCT00542919|564412920|FG002|Overall Study|Physician Decision|1|||
156358659|NCT00542919|564412918|FG000|Overall Study|Sponsor Decision|1|||
156358660|NCT00542919|564412919|FG001|Overall Study|Sponsor Decision|0|||
156358661|NCT00542919|564412920|FG002|Overall Study|Sponsor Decision|0|||
156358662|NCT00542919|564412918|FG000|Overall Study|Lost to Follow-up|2|||
156358663|NCT00542919|564412919|FG001|Overall Study|Lost to Follow-up|0|||
156358664|NCT00542919|564412920|FG002|Overall Study|Lost to Follow-up|1|||
156358665|NCT02385266|564412921|FG000|Overall Study|Withdrawal by Subject|1|||
156358666|NCT02385266|564412922|FG001|Overall Study|Withdrawal by Subject|3|||
156358667|NCT00914810|564412925|FG000|Overall Study|Withdrawal by Subject|1|||
156358668|NCT00914810|564412926|FG001|Overall Study|Withdrawal by Subject|0|||
156358669|NCT00914810|564412925|FG000|Overall Study|Relocated out of state|1|||
156358670|NCT00914810|564412926|FG001|Overall Study|Relocated out of state|0|||
156358671|NCT00914810|564412925|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
156358672|NCT00914810|564412926|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
156358673|NCT02747420|564412927|FG000|Overall Study|Lost to Follow-up|4|||
156358674|NCT02747420|564412928|FG001|Overall Study|Lost to Follow-up|2|||
156358675|NCT02747420|564412927|FG000|Overall Study|Withdrawal by Subject|3|||
156488766|NCT01187407|564883290|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
156488767|NCT01187407|564883291|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
156488768|NCT01187407|564883292|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
156488769|NCT01187407|564883293|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
156545058|NCT03099187|565089531|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
156545059|NCT03099187|565089532|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
156545060|NCT03099187|565089533|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
156545061|NCT03099187|565089534|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
156545062|NCT03099187|565089531|FG000|Double-blind Treatment|Lung transplantation|0|||
156545063|NCT03099187|565089532|FG001|Double-blind Treatment|Lung transplantation|1|||
156545064|NCT03099187|565089533|FG002|Double-blind Treatment|Lung transplantation|0|||
156545065|NCT03099187|565089534|FG003|Double-blind Treatment|Lung transplantation|0|||
156545066|NCT03099187|565089531|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
156545067|NCT03099187|565089532|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
156545068|NCT03099187|565089533|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
156545069|NCT03099187|565089534|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
156545070|NCT03099187|565089531|FG000|Double-blind Treatment|Disease progression|0|||
156545071|NCT03099187|565089532|FG001|Double-blind Treatment|Disease progression|1|||
156545072|NCT03099187|565089533|FG002|Double-blind Treatment|Disease progression|0|||
156358676|NCT02747420|564412928|FG001|Overall Study|Withdrawal by Subject|2|||
156545073|NCT03099187|565089534|FG003|Double-blind Treatment|Disease progression|0|||
156545074|NCT03099187|565089531|FG000|Double-blind Treatment|Randomization error|0|||
156545075|NCT03099187|565089532|FG001|Double-blind Treatment|Randomization error|2|||
156545076|NCT03099187|565089533|FG002|Double-blind Treatment|Randomization error|0|||
156545077|NCT03099187|565089534|FG003|Double-blind Treatment|Randomization error|0|||
156545078|NCT03099187|565089531|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
156545079|NCT03099187|565089532|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
156545080|NCT03099187|565089533|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
156545081|NCT03099187|565089534|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
156545082|NCT03099187|565089531|FG000|12-month Safety Follow-up|Adverse Event|0|||
156545083|NCT03099187|565089532|FG001|12-month Safety Follow-up|Adverse Event|0|||
156545084|NCT03099187|565089533|FG002|12-month Safety Follow-up|Adverse Event|5|||
156545085|NCT03099187|565089534|FG003|12-month Safety Follow-up|Adverse Event|12|||
156545086|NCT03099187|565089531|FG000|12-month Safety Follow-up|Death|0|||
156545087|NCT03099187|565089532|FG001|12-month Safety Follow-up|Death|0|||
156545088|NCT03099187|565089533|FG002|12-month Safety Follow-up|Death|7|||
156545089|NCT03099187|565089534|FG003|12-month Safety Follow-up|Death|9|||
156545090|NCT03099187|565089531|FG000|12-month Safety Follow-up|Lung transplantation|0|||
156545091|NCT03099187|565089532|FG001|12-month Safety Follow-up|Lung transplantation|0|||
156545092|NCT03099187|565089533|FG002|12-month Safety Follow-up|Lung transplantation|2|||
156545093|NCT03099187|565089534|FG003|12-month Safety Follow-up|Lung transplantation|1|||
156545094|NCT03099187|565089531|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
156545095|NCT03099187|565089532|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
156545096|NCT03099187|565089533|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
156545097|NCT03099187|565089534|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
156545098|NCT03099187|565089531|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
156545099|NCT03099187|565089532|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
156545100|NCT03099187|565089533|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
156545101|NCT03099187|565089534|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
156545102|NCT03099187|565089531|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
156545103|NCT03099187|565089532|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
156545104|NCT03099187|565089533|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
156545105|NCT03099187|565089534|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
156545106|NCT03099187|565089531|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
156545107|NCT03099187|565089532|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
156358677|NCT03020823|564412929|FG000|Overall Study|Physician Decision|4|||
156358678|NCT03020823|564412929|FG000|Overall Study|Lack of Efficacy|4|||
156358679|NCT03020823|564412929|FG000|Overall Study|Adverse Event|2|||
156358680|NCT03739112|564412930|FG000|Overall Study|Adverse Event|2|||
156358681|NCT03739112|564412931|FG001|Overall Study|Adverse Event|2|||
156358682|NCT03739112|564412930|FG000|Overall Study|Withdrawal by Subject|38|||
156358683|NCT03739112|564412931|FG001|Overall Study|Withdrawal by Subject|19|||
156358684|NCT03739112|564412930|FG000|Overall Study|Lost to Follow-up|31|||
156358685|NCT03739112|564412931|FG001|Overall Study|Lost to Follow-up|33|||
156358686|NCT03739112|564412930|FG000|Overall Study|Protocol Deviation|12|||
156358687|NCT03739112|564412931|FG001|Overall Study|Protocol Deviation|9|||
156358688|NCT03739112|564412930|FG000|Overall Study|Physician Decision|1|||
156358689|NCT03739112|564412931|FG001|Overall Study|Physician Decision|0|||
156545108|NCT03099187|565089533|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
156545109|NCT03099187|565089534|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
156545110|NCT01210690|565089537|FG000|Overall Study|Adverse Event|7|||
156545111|NCT01210690|565089537|FG000|Overall Study|Lack of Efficacy|12|||
156545112|NCT01210690|565089537|FG000|Overall Study|Lost to Follow-up|3|||
156545113|NCT01210690|565089537|FG000|Overall Study|Disease Remission|1|||
156545114|NCT01210690|565089537|FG000|Overall Study|Withdrawal by Subject|1|||
156545115|NCT01210690|565089537|FG000|Overall Study|Patient refused to swallow|1|||
156358690|NCT03739112|564412930|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
156358691|NCT03739112|564412931|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
156358692|NCT03739112|564412930|FG000|Overall Study|Site went on hold|65|||
156358693|NCT03739112|564412931|FG001|Overall Study|Site went on hold|67|||
156358694|NCT03739112|564412930|FG000|Overall Study|Other than specified|8|||
156358695|NCT03739112|564412931|FG001|Overall Study|Other than specified|5|||
156358696|NCT03739112|564412930|FG000|Overall Study|Randomized but not vaccinated|31|||
156358697|NCT03739112|564412931|FG001|Overall Study|Randomized but not vaccinated|25|||
156358698|NCT00588822|564412932|FG000|Overall Study|progression of disease|8|||
156358699|NCT02529137|564412933|FG000|Overall Study|Discontinuation for different reasons|8|||
156488770|NCT01187407|564883294|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
156488771|NCT01187407|564883290|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
156488772|NCT01187407|564883291|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
156488773|NCT01187407|564883292|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
156488774|NCT01187407|564883293|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
156488775|NCT01187407|564883294|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
156358700|NCT00952341|564412934|FG000|Cycle 1|Adverse Event|4|||
156358701|NCT00952341|564412935|FG001|Cycle 1|Adverse Event|1|||
156358702|NCT00952341|564412934|FG000|Cycle 1|Withdrawal by Subject|3|||
156358703|NCT00952341|564412935|FG001|Cycle 1|Withdrawal by Subject|8|||
156358704|NCT00952341|564412934|FG000|Cycle 1|Protocol Violation|2|||
156358705|NCT00952341|564412935|FG001|Cycle 1|Protocol Violation|1|||
156358706|NCT00952341|564412934|FG000|Cycle 1|Lost to Follow-up|11|||
156358707|NCT00952341|564412935|FG001|Cycle 1|Lost to Follow-up|2|||
156358708|NCT00952341|564412934|FG000|Cycle 1|Physician Decision|0|||
156358709|NCT00952341|564412935|FG001|Cycle 1|Physician Decision|1|||
156358710|NCT00952341|564412934|FG000|Cycle 2|Withdrawal by Subject|1|||
156358711|NCT00952341|564412935|FG001|Cycle 2|Withdrawal by Subject|1|||
156358712|NCT00952341|564412934|FG000|Cycle 2|Protocol Violation|1|||
156358713|NCT00952341|564412935|FG001|Cycle 2|Protocol Violation|0|||
156358714|NCT00952341|564412934|FG000|Cycle 2|Lost to Follow-up|6|||
156358715|NCT00952341|564412935|FG001|Cycle 2|Lost to Follow-up|9|||
156358716|NCT00952341|564412934|FG000|Cycle 2|Physician Decision|1|||
156358717|NCT00952341|564412935|FG001|Cycle 2|Physician Decision|1|||
156358718|NCT00952341|564412934|FG000|Cycle 2|Progressive Disease|0|||
156358719|NCT00952341|564412935|FG001|Cycle 2|Progressive Disease|1|||
156358720|NCT03538158|564412940|FG000|Overall Study|Lost to Follow-up|13|||
156358721|NCT03538158|564412941|FG001|Overall Study|Lost to Follow-up|7|||
156358722|NCT03538158|564412940|FG000|Overall Study|Withdrawal by Subject|2|||
156358723|NCT03538158|564412941|FG001|Overall Study|Withdrawal by Subject|1|||
156358724|NCT01413360|564412948|FG000|Overall Study|Lost to Follow-up|2|||
156358725|NCT01413360|564412948|FG000|Overall Study|Adverse Event|1|||
156358726|NCT02246673|564412951|FG000|Overall Study|Sponsor Decision|1|||
156358727|NCT02246673|564412952|FG001|Overall Study|Sponsor Decision|0|||
156358728|NCT02246673|564412953|FG002|Overall Study|Sponsor Decision|0|||
156358729|NCT02246673|564412954|FG003|Overall Study|Sponsor Decision|0|||
156358730|NCT02246673|564412955|FG004|Overall Study|Sponsor Decision|0|||
156358731|NCT02246673|564412951|FG000|Overall Study|Withdrawal by Subject|0|||
156358732|NCT02246673|564412952|FG001|Overall Study|Withdrawal by Subject|0|||
156358733|NCT02246673|564412953|FG002|Overall Study|Withdrawal by Subject|0|||
156488776|NCT01187407|564883290|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
156488777|NCT01187407|564883291|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
156488778|NCT01187407|564883292|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
156488779|NCT01187407|564883293|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
156488780|NCT01187407|564883294|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
156488781|NCT01187407|564883290|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156488782|NCT01187407|564883291|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156488783|NCT01187407|564883292|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156488784|NCT01187407|564883293|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
156488785|NCT01187407|564883294|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
156545116|NCT01210690|565089537|FG000|Overall Study|Patient could not take glucose|1|||
156358734|NCT02246673|564412954|FG003|Overall Study|Withdrawal by Subject|0|||
156358735|NCT02246673|564412955|FG004|Overall Study|Withdrawal by Subject|1|||
156358736|NCT02246673|564412951|FG000|Overall Study|Lost to Follow-up|0|||
156358737|NCT02246673|564412952|FG001|Overall Study|Lost to Follow-up|0|||
156545117|NCT00470054|565089538|FG000|Overall Study|Ineligible|1|||
156545118|NCT04869345|565089542|FG000|Overall Study|Lost to Follow-up|8|||
156358738|NCT02246673|564412953|FG002|Overall Study|Lost to Follow-up|0|||
156358739|NCT02246673|564412954|FG003|Overall Study|Lost to Follow-up|1|||
156358740|NCT02246673|564412955|FG004|Overall Study|Lost to Follow-up|0|||
156358741|NCT02246673|564412951|FG000|Overall Study|Protocol Violation|0|||
156358742|NCT02246673|564412952|FG001|Overall Study|Protocol Violation|0|||
156358743|NCT02246673|564412953|FG002|Overall Study|Protocol Violation|0|||
156358744|NCT02246673|564412954|FG003|Overall Study|Protocol Violation|1|||
156488786|NCT01187407|564883290|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
156488787|NCT01187407|564883291|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
156488788|NCT01187407|564883292|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
156488789|NCT01187407|564883293|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
156358745|NCT02246673|564412955|FG004|Overall Study|Protocol Violation|0|||
156358746|NCT02914769|564412956|FG000|Overall Study|Protocol Violation|3|||
156358747|NCT02914769|564412957|FG001|Overall Study|Protocol Violation|2|||
156358748|NCT02914769|564412956|FG000|Overall Study|Withdrawal by Subject|0|||
156358749|NCT02914769|564412957|FG001|Overall Study|Withdrawal by Subject|1|||
156358750|NCT04356963|564412958|FG000|First Session|Withdrawal by Subject|1|||
156358751|NCT04356963|564412958|FG000|Second Session|Withdrawal by Subject|3|||
156358752|NCT04356963|564412958|FG000|Second Session|Lost to Follow-up|1|||
156358753|NCT04356963|564412958|FG000|Third Session|Lost to Follow-up|6|||
156358754|NCT04356963|564412958|FG000|Third Session|Withdrawal by Subject|1|||
156358755|NCT02410954|564412960|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
156358756|NCT02410954|564412961|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
156358757|NCT02410954|564412960|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
156358758|NCT02410954|564412961|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
156358759|NCT02738333|564412962|FG000|Overall Study|Death|1|||
156358760|NCT02738333|564412963|FG001|Overall Study|Death|0|||
156358761|NCT02738333|564412964|FG002|Overall Study|Death|0|||
156358762|NCT02738333|564412962|FG000|Overall Study|Lost to Follow-up|1|||
156358763|NCT02738333|564412963|FG001|Overall Study|Lost to Follow-up|0|||
156358764|NCT02738333|564412964|FG002|Overall Study|Lost to Follow-up|0|||
156358765|NCT00791518|564412965|FG000|Overall Study|Protocol Violation|93|||
156358766|NCT05413369|564412966|FG000|Overall Study|Adverse Event|1|||
156358767|NCT05413369|564412967|FG001|Overall Study|Adverse Event|1|||
156358768|NCT05413369|564412966|FG000|Overall Study|Withdrawal by Subject|13|||
156358769|NCT05413369|564412967|FG001|Overall Study|Withdrawal by Subject|4|||
156358770|NCT05413369|564412966|FG000|Overall Study|Non-compliance with study schedule|2|||
156358771|NCT05413369|564412967|FG001|Overall Study|Non-compliance with study schedule|1|||
156358772|NCT05413369|564412966|FG000|Overall Study|Other|1|||
156358773|NCT05413369|564412967|FG001|Overall Study|Other|1|||
156358774|NCT03165110|564412971|FG000|Overall Study|Anroid phone software incompatibility|1|||
156358775|NCT00454987|564412980|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
156358776|NCT00454987|564412981|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
156358777|NCT00454987|564412982|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
156358778|NCT00454987|564412980|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
156358779|NCT00454987|564412981|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
156358780|NCT00454987|564412982|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
156358781|NCT00454987|564412980|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
156358782|NCT00454987|564412981|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
156358783|NCT00454987|564412982|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
156358784|NCT04256785|564412983|FG000|Overall Study|Adverse Event|8|||
156358785|NCT04256785|564412984|FG001|Overall Study|Adverse Event|6|||
156358786|NCT04256785|564412983|FG000|Overall Study|Lack of Efficacy|3|||
156358787|NCT04256785|564412984|FG001|Overall Study|Lack of Efficacy|4|||
156358788|NCT04256785|564412983|FG000|Overall Study|Lost to Follow-up|7|||
156358789|NCT04256785|564412984|FG001|Overall Study|Lost to Follow-up|7|||
156358790|NCT04256785|564412983|FG000|Overall Study|Protocol Violation|1|||
156358791|NCT04256785|564412984|FG001|Overall Study|Protocol Violation|0|||
156358792|NCT04256785|564412983|FG000|Overall Study|Withdrawal by Subject|4|||
156358793|NCT04256785|564412984|FG001|Overall Study|Withdrawal by Subject|1|||
156358794|NCT04256785|564412983|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
156358795|NCT04256785|564412984|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
156358796|NCT00643682|564412986|FG000|Overall Study|did not keep appointment|522|||
156358797|NCT00643682|564412987|FG001|Overall Study|did not keep appointment|509|||
156358798|NCT03755414|564412990|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
156358799|NCT03755414|564412991|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
156358800|NCT03755414|564412992|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
156358801|NCT03755414|564412990|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
156358802|NCT03755414|564412991|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
156358803|NCT03755414|564412992|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
156358804|NCT03755414|564412990|FG000|Overall Study|Non-compliance|0|||
156358805|NCT03755414|564412991|FG001|Overall Study|Non-compliance|1|||
156358806|NCT03755414|564412992|FG002|Overall Study|Non-compliance|0|||
156358807|NCT02153112|564412993|FG000|Overall Study|Adverse Event|0|||
156358808|NCT02153112|564412994|FG001|Overall Study|Adverse Event|0|||
156358809|NCT02153112|564412995|FG002|Overall Study|Adverse Event|1|||
156358810|NCT02153112|564412996|FG003|Overall Study|Adverse Event|0|||
156358811|NCT02153112|564412997|FG004|Overall Study|Adverse Event|0|||
156358812|NCT02153112|564412998|FG005|Overall Study|Adverse Event|0|||
156358813|NCT02153112|564412999|FG006|Overall Study|Adverse Event|0|||
156358814|NCT02153112|564413000|FG007|Overall Study|Adverse Event|0|||
156358815|NCT02153112|564413001|FG008|Overall Study|Adverse Event|0|||
156358816|NCT02153112|564413002|FG009|Overall Study|Adverse Event|0|||
156358817|NCT02153112|564412993|FG000|Overall Study|Lost to Follow-up|1|||
156358818|NCT02153112|564412994|FG001|Overall Study|Lost to Follow-up|1|||
156488790|NCT01187407|564883294|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
156488791|NCT01187407|564883290|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
156488792|NCT01187407|564883291|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
156488793|NCT01187407|564883292|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
156488794|NCT01187407|564883293|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
156488795|NCT01187407|564883294|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
156488796|NCT01187407|564883290|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156488797|NCT01187407|564883291|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
156488798|NCT01187407|564883292|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
156488799|NCT01187407|564883293|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
156488800|NCT01187407|564883294|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
156488801|NCT00264498|564883295|FG000|Randomized Treatment|Death|0|||
156488802|NCT00264498|564883296|FG001|Randomized Treatment|Death|3|||
156488803|NCT00264498|564883295|FG000|Randomized Treatment|Withdrawal by Subject|0|||
156358819|NCT02153112|564412995|FG002|Overall Study|Lost to Follow-up|0|||
156358820|NCT02153112|564412996|FG003|Overall Study|Lost to Follow-up|0|||
156358821|NCT02153112|564412997|FG004|Overall Study|Lost to Follow-up|2|||
156358822|NCT02153112|564412998|FG005|Overall Study|Lost to Follow-up|1|||
156358823|NCT02153112|564412999|FG006|Overall Study|Lost to Follow-up|1|||
156358824|NCT02153112|564413000|FG007|Overall Study|Lost to Follow-up|0|||
156358825|NCT02153112|564413001|FG008|Overall Study|Lost to Follow-up|1|||
156358826|NCT02153112|564413002|FG009|Overall Study|Lost to Follow-up|1|||
156358827|NCT02153112|564412993|FG000|Overall Study|Withdrawal by Subject|3|||
156358828|NCT02153112|564412994|FG001|Overall Study|Withdrawal by Subject|1|||
156358829|NCT02153112|564412995|FG002|Overall Study|Withdrawal by Subject|2|||
156358830|NCT02153112|564412996|FG003|Overall Study|Withdrawal by Subject|2|||
156358831|NCT02153112|564412997|FG004|Overall Study|Withdrawal by Subject|1|||
156358832|NCT02153112|564412998|FG005|Overall Study|Withdrawal by Subject|1|||
156358833|NCT02153112|564412999|FG006|Overall Study|Withdrawal by Subject|7|||
156358834|NCT02153112|564413000|FG007|Overall Study|Withdrawal by Subject|2|||
156358835|NCT02153112|564413001|FG008|Overall Study|Withdrawal by Subject|13|||
156358836|NCT02153112|564413002|FG009|Overall Study|Withdrawal by Subject|12|||
156358837|NCT02153112|564412993|FG000|Overall Study|Reason not Specified|0|||
156358838|NCT02153112|564412994|FG001|Overall Study|Reason not Specified|0|||
156358839|NCT02153112|564412995|FG002|Overall Study|Reason not Specified|0|||
156358840|NCT02153112|564412996|FG003|Overall Study|Reason not Specified|0|||
156358841|NCT02153112|564412997|FG004|Overall Study|Reason not Specified|0|||
156358842|NCT02153112|564412998|FG005|Overall Study|Reason not Specified|0|||
156358843|NCT02153112|564412999|FG006|Overall Study|Reason not Specified|0|||
156358844|NCT02153112|564413000|FG007|Overall Study|Reason not Specified|0|||
156358845|NCT02153112|564413001|FG008|Overall Study|Reason not Specified|1|||
156358846|NCT02153112|564413002|FG009|Overall Study|Reason not Specified|1|||
156358847|NCT04351087|564413003|FG000|Overall Study|Lost to Follow-up|7|||
156358848|NCT04351087|564413004|FG001|Overall Study|Lost to Follow-up|3|||
156358849|NCT04351087|564413003|FG000|Overall Study|Withdrawal by Subject|3|||
156358850|NCT04351087|564413004|FG001|Overall Study|Withdrawal by Subject|4|||
156358851|NCT04351087|564413003|FG000|Overall Study|Lack of Efficacy|3|||
156358852|NCT04351087|564413004|FG001|Overall Study|Lack of Efficacy|2|||
156358853|NCT05517382|564413005|FG000|Overall Study|Lost to Follow-up|0|||
156358854|NCT05517382|564413006|FG001|Overall Study|Lost to Follow-up|1|||
156358855|NCT01374087|564413009|FG000|Overall Study|Adverse Event|1|||
156358856|NCT01374087|564413010|FG001|Overall Study|Adverse Event|0|||
156358857|NCT01374087|564413009|FG000|Overall Study|Disease progression|2|||
156358858|NCT01374087|564413010|FG001|Overall Study|Disease progression|2|||
156358859|NCT01374087|564413009|FG000|Overall Study|Study discontinued|13|||
156358860|NCT01374087|564413010|FG001|Overall Study|Study discontinued|13|||
156358861|NCT00271947|564413013|FG000|Overall Study|Lost to Follow-up|1|||
156358862|NCT01522365|564413016|FG000|Overall Study|Withdrawal by Subject|1|||
156358863|NCT01522365|564413017|FG001|Overall Study|Withdrawal by Subject|1|||
156358864|NCT01522365|564413016|FG000|Overall Study|Lost to Follow-up|1|||
156358865|NCT01522365|564413017|FG001|Overall Study|Lost to Follow-up|1|||
156358866|NCT00651755|564413018|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
156358867|NCT00651755|564413019|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
156358868|NCT00651755|564413018|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
156358869|NCT00651755|564413019|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
156358870|NCT04170348|564413022|FG000|Overall Study|Lost to Follow-up|2|||
156545119|NCT04869345|565089543|FG001|Overall Study|Lost to Follow-up|3|||
156545120|NCT04194528|565089551|FG000|Overall Study|Adverse Event|1|||
156545121|NCT00528021|565089553|FG000|Overall Study|Lack of Efficacy|17|||
156545122|NCT00528021|565089554|FG001|Overall Study|Lack of Efficacy|13|||
156545123|NCT00528021|565089555|FG002|Overall Study|Lack of Efficacy|7|||
156545124|NCT00528021|565089556|FG003|Overall Study|Lack of Efficacy|9|||
156545125|NCT00102960|565089567|FG000|Overall Study|Death|23|||
156545126|NCT00102960|565089568|FG001|Overall Study|Death|11|||
156545127|NCT00102960|565089569|FG002|Overall Study|Death|11|||
156545128|NCT00102960|565089567|FG000|Overall Study|Lost to Follow-up|6|||
156545129|NCT00102960|565089568|FG001|Overall Study|Lost to Follow-up|12|||
156545130|NCT00102960|565089569|FG002|Overall Study|Lost to Follow-up|16|||
156358871|NCT04170348|564413023|FG001|Overall Study|Lost to Follow-up|2|||
156358872|NCT04170348|564413022|FG000|Overall Study|Withdrawal by Subject|1|||
156358873|NCT04170348|564413023|FG001|Overall Study|Withdrawal by Subject|5|||
156358874|NCT04170348|564413022|FG000|Overall Study|Non-adherence|1|||
156358875|NCT04170348|564413023|FG001|Overall Study|Non-adherence|1|||
156358876|NCT04170348|564413022|FG000|Overall Study|Adverse Event|1|||
156358877|NCT04170348|564413023|FG001|Overall Study|Adverse Event|0|||
156358878|NCT02642432|564413024|FG000|Overall Study|Adverse Event|2|||
156358879|NCT02642432|564413024|FG000|Overall Study|Withdrew Consent|1|||
156358880|NCT02642432|564413024|FG000|Overall Study|Lost to Follow-up|2|||
156358881|NCT02642432|564413024|FG000|Overall Study|Other|3|||
156358882|NCT01545817|564414547|FG000|Pazopanib|Disease progression|51|||
156358883|NCT01545817|564414548|FG001|Pazopanib|Disease progression|0|||
156545131|NCT00102960|565089567|FG000|Overall Study|Withdrawal by Subject|1|||
156545132|NCT00102960|565089568|FG001|Overall Study|Withdrawal by Subject|0|||
156545133|NCT00102960|565089569|FG002|Overall Study|Withdrawal by Subject|1|||
156545134|NCT01395394|565091519|FG000|Baseline Study Visit|Protocol Violation|1|||
156545135|NCT01395394|565091520|FG001|Baseline Study Visit|Protocol Violation|0|||
156545136|NCT01395394|565091521|FG002|Baseline Study Visit|Protocol Violation|0|||
156545137|NCT05121480|565091522|FG000|Overall Study|Lack of Efficacy|2|||
156545138|NCT05121480|565091523|FG001|Overall Study|Lack of Efficacy|2|||
156545139|NCT05121480|565091524|FG002|Overall Study|Lack of Efficacy|1|||
156545140|NCT05121480|565091525|FG003|Overall Study|Lack of Efficacy|4|||
156545141|NCT05121480|565091526|FG004|Overall Study|Lack of Efficacy|0|||
156545142|NCT05121480|565091527|FG005|Overall Study|Lack of Efficacy|1|||
156545143|NCT05121480|565091528|FG006|Overall Study|Lack of Efficacy|0|||
156545144|NCT05121480|565091529|FG007|Overall Study|Lack of Efficacy|2|||
156545145|NCT05121480|565091522|FG000|Overall Study|Treatment Failure|0|||
156545146|NCT05121480|565091523|FG001|Overall Study|Treatment Failure|2|||
156358884|NCT01545817|564414547|FG000|Pazopanib|Adverse Event|19|||
156358885|NCT01545817|564414548|FG001|Pazopanib|Adverse Event|0|||
156358886|NCT01545817|564414547|FG000|Pazopanib|Other reason|4|||
156358887|NCT01545817|564414548|FG001|Pazopanib|Other reason|0|||
156358888|NCT01545817|564414547|FG000|Everolimus|Other reason|0|||
156358889|NCT01545817|564414548|FG001|Everolimus|Other reason|7|||
156358890|NCT01545817|564414547|FG000|Everolimus|Disease progression|0|||
156358891|NCT01545817|564414548|FG001|Everolimus|Disease progression|25|||
156358892|NCT01545817|564414547|FG000|Everolimus|Adverse Event|0|||
156358893|NCT01545817|564414548|FG001|Everolimus|Adverse Event|6|||
156358894|NCT02967692|564414549|FG000|Overall Study|Progressive disease|3|||
156358895|NCT02967692|564414550|FG001|Overall Study|Progressive disease|15|||
156358896|NCT02967692|564414551|FG002|Overall Study|Progressive disease|114|||
156358897|NCT02967692|564414552|FG003|Overall Study|Progressive disease|151|||
156358898|NCT02967692|564414549|FG000|Overall Study|Subject/guardian decision|1|||
156358899|NCT02967692|564414550|FG001|Overall Study|Subject/guardian decision|1|||
156358900|NCT02967692|564414551|FG002|Overall Study|Subject/guardian decision|14|||
156358901|NCT02967692|564414552|FG003|Overall Study|Subject/guardian decision|22|||
156358902|NCT02967692|564414549|FG000|Overall Study|Death|0|||
156358903|NCT02967692|564414550|FG001|Overall Study|Death|1|||
156358904|NCT02967692|564414551|FG002|Overall Study|Death|13|||
156358905|NCT02967692|564414552|FG003|Overall Study|Death|13|||
156358906|NCT02967692|564414549|FG000|Overall Study|Protocol deviation|1|||
156358907|NCT02967692|564414550|FG001|Overall Study|Protocol deviation|0|||
156358908|NCT02967692|564414551|FG002|Overall Study|Protocol deviation|1|||
156358909|NCT02967692|564414552|FG003|Overall Study|Protocol deviation|1|||
156358910|NCT02967692|564414549|FG000|Overall Study|Lost to Follow-up|0|||
156358911|NCT02967692|564414550|FG001|Overall Study|Lost to Follow-up|0|||
156358912|NCT02967692|564414551|FG002|Overall Study|Lost to Follow-up|1|||
156358913|NCT02967692|564414552|FG003|Overall Study|Lost to Follow-up|0|||
156358914|NCT02967692|564414549|FG000|Overall Study|Physician Decision|0|||
156358915|NCT02967692|564414550|FG001|Overall Study|Physician Decision|0|||
156358916|NCT02967692|564414551|FG002|Overall Study|Physician Decision|22|||
156358917|NCT02967692|564414552|FG003|Overall Study|Physician Decision|13|||
156358918|NCT02967692|564414549|FG000|Overall Study|Adverse Event|2|||
156358919|NCT02967692|564414550|FG001|Overall Study|Adverse Event|9|||
156358920|NCT02967692|564414551|FG002|Overall Study|Adverse Event|60|||
156358921|NCT02967692|564414552|FG003|Overall Study|Adverse Event|28|||
156358922|NCT02967692|564414549|FG000|Overall Study|Study terminated by sponsor|2|||
156358923|NCT02967692|564414550|FG001|Overall Study|Study terminated by sponsor|1|||
156358924|NCT02967692|564414551|FG002|Overall Study|Study terminated by sponsor|42|||
156358925|NCT02967692|564414552|FG003|Overall Study|Study terminated by sponsor|37|||
156358926|NCT04439253|564414553|FG000|Overall Study|Adverse Event|1|||
156358927|NCT04439253|564414553|FG000|Overall Study|Disease progression|2|||
156358928|NCT04439253|564414553|FG000|Overall Study|Complicating disease|1|||
156358929|NCT03971695|564414554|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156358930|NCT03971695|564414555|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156358931|NCT03971695|564414556|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156545147|NCT05121480|565091524|FG002|Overall Study|Treatment Failure|0|||
156545148|NCT05121480|565091525|FG003|Overall Study|Treatment Failure|1|||
156358932|NCT03971695|564414557|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
156358933|NCT03971695|564414558|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
156358934|NCT03971695|564414559|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156358935|NCT03971695|564414560|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156358936|NCT03971695|564414561|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156358937|NCT03971695|564414562|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
156358938|NCT03971695|564414563|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156358939|NCT03971695|564414564|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
156545149|NCT05121480|565091526|FG004|Overall Study|Treatment Failure|0|||
156545150|NCT05121480|565091527|FG005|Overall Study|Treatment Failure|0|||
156545151|NCT05121480|565091528|FG006|Overall Study|Treatment Failure|0|||
156545152|NCT05121480|565091529|FG007|Overall Study|Treatment Failure|0|||
156358940|NCT03971695|564414565|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
156358941|NCT03971695|564414566|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
156358942|NCT04447417|564414567|FG000|Overall Study|Withdrawal by Subject|1|||
156358943|NCT04447417|564414568|FG001|Overall Study|Withdrawal by Subject|0|||
156358944|NCT04447417|564414567|FG000|Overall Study|Failure to meet inclusion criteria|1|||
156358945|NCT04447417|564414568|FG001|Overall Study|Failure to meet inclusion criteria|0|||
156358946|NCT04447417|564414567|FG000|Overall Study|Lost to Follow-up|1|||
156358947|NCT04447417|564414568|FG001|Overall Study|Lost to Follow-up|0|||
156358948|NCT00702403|564414569|FG000|From Consent to Engraftment|Progressive leukemia|6|||
156358949|NCT00702403|564414569|FG000|From Consent to Engraftment|Critically ill|2|||
156358950|NCT00702403|564414569|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
156358951|NCT00702403|564414569|FG000|From Consent to Engraftment|Myocardial infarction|1|||
156358952|NCT00702403|564414569|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
156358953|NCT00702403|564414569|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
156358954|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
156358955|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
156358956|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Non-compliance|2|||
156358957|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
156358958|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
156358959|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Suicide|1|||
156358960|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
156358961|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
156358962|NCT00702403|564414569|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
156358963|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
156358964|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
156358965|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
156358966|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
156358967|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
156358968|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
156358969|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
156358970|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
156358971|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
156358972|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
156358973|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
156358974|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
156358975|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
156358976|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
156358977|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
156358978|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
156358979|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
156358980|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
156358981|NCT00887354|564414577|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
156358982|NCT00887354|564414578|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
156358983|NCT00887354|564414577|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
156358984|NCT00887354|564414578|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
156358985|NCT00887354|564414577|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
156358986|NCT00887354|564414578|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
156358987|NCT00887354|564414577|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
156358988|NCT00887354|564414578|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
156358989|NCT00887354|564414577|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
156358990|NCT00887354|564414578|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
156358991|NCT00887354|564414577|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
156358992|NCT00887354|564414578|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
156358993|NCT01466348|564414581|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
156358994|NCT01466348|564414582|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
156358995|NCT00192504|564414585|FG000|Overall Study|Lost to Follow-up|1|||
156358996|NCT00192504|564414586|FG001|Overall Study|Lost to Follow-up|0|||
156358997|NCT00192504|564414587|FG002|Overall Study|Lost to Follow-up|0|||
156358998|NCT00192504|564414588|FG003|Overall Study|Lost to Follow-up|0|||
156358999|NCT00192504|564414585|FG000|Overall Study|Dosing window missed|0|||
156359000|NCT00192504|564414586|FG001|Overall Study|Dosing window missed|0|||
156359001|NCT00192504|564414587|FG002|Overall Study|Dosing window missed|1|||
156359002|NCT00192504|564414588|FG003|Overall Study|Dosing window missed|0|||
156359003|NCT03989440|564414589|FG000|Overall Study|COVID-19 travel restrictions|0|||
156359004|NCT03989440|564414590|FG001|Overall Study|COVID-19 travel restrictions|0|||
156359005|NCT03989440|564414591|FG002|Overall Study|COVID-19 travel restrictions|1|||
156359006|NCT03989440|564414592|FG003|Overall Study|COVID-19 travel restrictions|0|||
156359007|NCT03989440|564414593|FG004|Overall Study|COVID-19 travel restrictions|0|||
156488804|NCT00264498|564883296|FG001|Randomized Treatment|Withdrawal by Subject|1|||
156488805|NCT00264498|564883295|FG000|Randomized Treatment|Objective disease Progression|13|||
156488806|NCT00264498|564883296|FG001|Randomized Treatment|Objective disease Progression|14|||
156488807|NCT00264498|564883295|FG000|Randomized Treatment|Physician Decision|1|||
156488808|NCT00264498|564883296|FG001|Randomized Treatment|Physician Decision|0|||
156488809|NCT00264498|564883295|FG000|Randomized Treatment|Incorrectly randomized|1|||
156488810|NCT00264498|564883296|FG001|Randomized Treatment|Incorrectly randomized|0|||
156488811|NCT00264498|564883295|FG000|Randomized Treatment|Study Closure|1|||
156488812|NCT00264498|564883296|FG001|Randomized Treatment|Study Closure|0|||
156488813|NCT00264498|564883295|FG000|Randomized Treatment|Protocol Violation|1|||
156488814|NCT00264498|564883296|FG001|Randomized Treatment|Protocol Violation|0|||
156488815|NCT00264498|564883295|FG000|Crossover Treatment|Death|1|||
156488816|NCT00264498|564883296|FG001|Crossover Treatment|Death|3|||
156488817|NCT00264498|564883295|FG000|Crossover Treatment|Objective disease progression|4|||
156488818|NCT00264498|564883296|FG001|Crossover Treatment|Objective disease progression|5|||
156359008|NCT03989440|564414594|FG005|Overall Study|COVID-19 travel restrictions|0|||
156359009|NCT03989440|564414589|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
156359010|NCT03989440|564414590|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
156359011|NCT03989440|564414591|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
156359012|NCT03989440|564414592|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
156359013|NCT03989440|564414593|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
156359014|NCT03989440|564414594|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
156359015|NCT01955161|564414597|FG000|Overall Study|Withdrawal before treatment|2|||
156359016|NCT01955161|564414598|FG001|Overall Study|Withdrawal before treatment|0|||
156359017|NCT01955161|564414599|FG002|Overall Study|Withdrawal before treatment|1|||
156359018|NCT01955161|564414597|FG000|Overall Study|Adverse Event|10|||
156359019|NCT01955161|564414598|FG001|Overall Study|Adverse Event|14|||
156359020|NCT01955161|564414599|FG002|Overall Study|Adverse Event|15|||
156359021|NCT01955161|564414597|FG000|Overall Study|Death|1|||
156359022|NCT01955161|564414598|FG001|Overall Study|Death|1|||
156359023|NCT01955161|564414599|FG002|Overall Study|Death|3|||
156359024|NCT01955161|564414597|FG000|Overall Study|Withdrawal by Subject|9|||
156359025|NCT01955161|564414598|FG001|Overall Study|Withdrawal by Subject|8|||
156359026|NCT01955161|564414599|FG002|Overall Study|Withdrawal by Subject|12|||
156359027|NCT01955161|564414597|FG000|Overall Study|Protocol Violation|2|||
156359028|NCT01955161|564414598|FG001|Overall Study|Protocol Violation|0|||
156359029|NCT01955161|564414599|FG002|Overall Study|Protocol Violation|0|||
156359030|NCT01955161|564414597|FG000|Overall Study|Other reason: physician decision|0|||
156359031|NCT01955161|564414598|FG001|Overall Study|Other reason: physician decision|1|||
156359032|NCT01955161|564414599|FG002|Overall Study|Other reason: physician decision|1|||
156359033|NCT01955161|564414597|FG000|Overall Study|Other reason: disallowed medication|1|||
156359034|NCT01955161|564414598|FG001|Overall Study|Other reason: disallowed medication|0|||
156359035|NCT01955161|564414599|FG002|Overall Study|Other reason: disallowed medication|1|||
156359036|NCT01955161|564414597|FG000|Overall Study|Other reason: caregiver unavailable|1|||
156359037|NCT01955161|564414598|FG001|Overall Study|Other reason: caregiver unavailable|0|||
156359038|NCT01955161|564414599|FG002|Overall Study|Other reason: caregiver unavailable|0|||
156359039|NCT01955161|564414597|FG000|Overall Study|Other reason: moved to nursing home|0|||
156359040|NCT01955161|564414598|FG001|Overall Study|Other reason: moved to nursing home|1|||
156359041|NCT01955161|564414599|FG002|Overall Study|Other reason: moved to nursing home|0|||
156359042|NCT01955161|564414597|FG000|Overall Study|Other reason: insufficient compliance|0|||
156359043|NCT01955161|564414598|FG001|Overall Study|Other reason: insufficient compliance|0|||
156359044|NCT01955161|564414599|FG002|Overall Study|Other reason: insufficient compliance|1|||
156359045|NCT01955161|564414597|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
156359046|NCT01955161|564414598|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
156359047|NCT01955161|564414599|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
156359048|NCT01955161|564414597|FG000|Overall Study|Other reason: patient's will|0|||
156359049|NCT01955161|564414598|FG001|Overall Study|Other reason: patient's will|0|||
156359050|NCT01955161|564414599|FG002|Overall Study|Other reason: patient's will|1|||
156359051|NCT01881230|564414605|FG000|Overall Study|Death|2|||
156359052|NCT01881230|564414606|FG001|Overall Study|Death|0|||
156488819|NCT00264498|564883295|FG000|Crossover Treatment|Study closure|0|||
156488820|NCT00264498|564883296|FG001|Crossover Treatment|Study closure|1|||
156359053|NCT01881230|564414607|FG002|Overall Study|Death|1|||
156359054|NCT01881230|564414605|FG000|Overall Study|Adverse Event|9|||
156359055|NCT01881230|564414606|FG001|Overall Study|Adverse Event|13|||
156359056|NCT01881230|564414607|FG002|Overall Study|Adverse Event|12|||
156359057|NCT01881230|564414605|FG000|Overall Study|Progressive Disease|31|||
156359058|NCT01881230|564414606|FG001|Overall Study|Progressive Disease|35|||
156359059|NCT01881230|564414607|FG002|Overall Study|Progressive Disease|36|||
156359060|NCT01881230|564414605|FG000|Overall Study|Symptomatic Deterioration|3|||
156359061|NCT01881230|564414606|FG001|Overall Study|Symptomatic Deterioration|3|||
156359062|NCT01881230|564414607|FG002|Overall Study|Symptomatic Deterioration|1|||
156359063|NCT01881230|564414605|FG000|Overall Study|Withdrawal by Subject|6|||
156359064|NCT01881230|564414606|FG001|Overall Study|Withdrawal by Subject|4|||
156359065|NCT01881230|564414607|FG002|Overall Study|Withdrawal by Subject|6|||
156359066|NCT01881230|564414605|FG000|Overall Study|Physician Decision|4|||
156359067|NCT01881230|564414606|FG001|Overall Study|Physician Decision|3|||
156359068|NCT01881230|564414607|FG002|Overall Study|Physician Decision|6|||
156359069|NCT01881230|564414605|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156359070|NCT01881230|564414606|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156359071|NCT01881230|564414607|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156359072|NCT01881230|564414605|FG000|Overall Study|Given Commercially Available Drug|0|||
156359073|NCT01881230|564414606|FG001|Overall Study|Given Commercially Available Drug|0|||
156359074|NCT01881230|564414607|FG002|Overall Study|Given Commercially Available Drug|2|||
156359075|NCT01881230|564414605|FG000|Overall Study|Protocol Violation|1|||
156359076|NCT01881230|564414606|FG001|Overall Study|Protocol Violation|1|||
156359077|NCT01881230|564414607|FG002|Overall Study|Protocol Violation|0|||
156359078|NCT01881230|564414605|FG000|Overall Study|Miscellaneous|3|||
156359079|NCT01881230|564414606|FG001|Overall Study|Miscellaneous|3|||
156359080|NCT01881230|564414607|FG002|Overall Study|Miscellaneous|0|||
156359081|NCT01881230|564414605|FG000|Overall Study|Untreated: Other|0|||
156359082|NCT01881230|564414606|FG001|Overall Study|Untreated: Other|0|||
156359083|NCT01881230|564414607|FG002|Overall Study|Untreated: Other|1|||
156359084|NCT01881230|564414605|FG000|Overall Study|Untreated: Death|0|||
156359085|NCT01881230|564414606|FG001|Overall Study|Untreated: Death|0|||
156359086|NCT01881230|564414607|FG002|Overall Study|Untreated: Death|1|||
156359087|NCT01881230|564414605|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
156359088|NCT01881230|564414606|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
156359089|NCT01881230|564414607|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
156359090|NCT05129488|564414608|FG000|Overall Study|Protocol Violation|3|||
156359091|NCT00706641|564414613|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
156359092|NCT00706641|564414613|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
156359093|NCT00706641|564414613|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
156359094|NCT04782856|564414614|FG000|Overall Study|Withdrawal by Subject|0|||
156359095|NCT04782856|564414615|FG001|Overall Study|Withdrawal by Subject|1|||
156359096|NCT01030523|564414616|FG000|Initial Study (5 Years)|Death|1|||
156359097|NCT01030523|564414617|FG001|Initial Study (5 Years)|Death|0|||
156359098|NCT01030523|564414616|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
156359099|NCT01030523|564414617|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
156359100|NCT01030523|564414616|FG000|Initial Study (5 Years)|Implant failure|1|||
156359101|NCT01030523|564414617|FG001|Initial Study (5 Years)|Implant failure|0|||
156359102|NCT01030523|564414616|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
156359103|NCT01030523|564414617|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
156359104|NCT01030523|564414616|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
156359105|NCT01030523|564414617|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
156359106|NCT01030523|564414616|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
156359107|NCT01030523|564414617|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
156359108|NCT00798369|564414620|FG000|Overall Study|Subject withdrew consent|0|||
156359109|NCT00798369|564414621|FG001|Overall Study|Subject withdrew consent|0|||
156359110|NCT00798369|564414622|FG002|Overall Study|Subject withdrew consent|1|||
156359111|NCT00798369|564414623|FG003|Overall Study|Subject withdrew consent|1|||
156359112|NCT00798369|564414624|FG004|Overall Study|Subject withdrew consent|0|||
156359113|NCT00798369|564414625|FG005|Overall Study|Subject withdrew consent|2|||
156359114|NCT00798369|564414620|FG000|Overall Study|Lost to Follow-up|1|||
156359115|NCT00798369|564414621|FG001|Overall Study|Lost to Follow-up|1|||
156359116|NCT00798369|564414622|FG002|Overall Study|Lost to Follow-up|1|||
156359117|NCT00798369|564414623|FG003|Overall Study|Lost to Follow-up|0|||
156359118|NCT00798369|564414624|FG004|Overall Study|Lost to Follow-up|1|||
156359119|NCT00798369|564414625|FG005|Overall Study|Lost to Follow-up|0|||
156359120|NCT00798369|564414620|FG000|Overall Study|Adminstrative problems|0|||
156359121|NCT00798369|564414621|FG001|Overall Study|Adminstrative problems|0|||
156359122|NCT00798369|564414622|FG002|Overall Study|Adminstrative problems|0|||
156359123|NCT00798369|564414623|FG003|Overall Study|Adminstrative problems|0|||
156359124|NCT00798369|564414624|FG004|Overall Study|Adminstrative problems|0|||
156359125|NCT00798369|564414625|FG005|Overall Study|Adminstrative problems|1|||
156359126|NCT04475588|564414626|FG000|Overall Study|Adverse Event|2|||
156359127|NCT04475588|564414627|FG001|Overall Study|Adverse Event|0|||
156359128|NCT01327300|564414628|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
156359129|NCT01327300|564414629|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
156359130|NCT04307446|564414631|FG000|Overall Study|Lost to Follow-up|2|||
156359131|NCT04307446|564414632|FG001|Overall Study|Lost to Follow-up|0|||
156359132|NCT01063764|564414633|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
156359133|NCT01063764|564414633|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
156359134|NCT01063764|564414633|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
156359135|NCT01063764|564414633|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
156359136|NCT01063764|564414633|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
156359137|NCT01063764|564414633|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
156488821|NCT00264498|564883295|FG000|Crossover Treatment|Withdrawal by Subject|1|||
156488822|NCT00264498|564883296|FG001|Crossover Treatment|Withdrawal by Subject|0|||
156488823|NCT02382406|564883297|FG000|Study Treatment|Disease Progression|8|||
156488824|NCT02382406|564883298|FG001|Study Treatment|Disease Progression|0|||
156488825|NCT02382406|564883299|FG002|Study Treatment|Disease Progression|20|||
156488826|NCT02382406|564883297|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
156488827|NCT02382406|564883298|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
156488828|NCT02382406|564883299|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
156488829|NCT02382406|564883297|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
156488830|NCT02382406|564883298|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
156488831|NCT02382406|564883299|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
156488832|NCT02382406|564883297|FG000|Study Treatment|symptomatic deterioration|1|||
156488833|NCT02382406|564883298|FG001|Study Treatment|symptomatic deterioration|0|||
156488834|NCT02382406|564883299|FG002|Study Treatment|symptomatic deterioration|1|||
156488835|NCT02382406|564883297|FG000|Study Treatment|Death|0|||
156488836|NCT02382406|564883298|FG001|Study Treatment|Death|0|||
156488837|NCT02382406|564883299|FG002|Study Treatment|Death|2|||
156488838|NCT02382406|564883297|FG000|Follow up|Death|11|||
156488839|NCT02382406|564883298|FG001|Follow up|Death|0|||
156488840|NCT02382406|564883299|FG002|Follow up|Death|19|||
156488841|NCT02382406|564883297|FG000|Follow up|Symptomatic deterioration|1|||
156488842|NCT02382406|564883298|FG001|Follow up|Symptomatic deterioration|0|||
156488843|NCT02382406|564883299|FG002|Follow up|Symptomatic deterioration|1|||
156488844|NCT02382406|564883297|FG000|Follow up|Patient Refused Follow-up|1|||
156488845|NCT02382406|564883298|FG001|Follow up|Patient Refused Follow-up|0|||
156488846|NCT02382406|564883299|FG002|Follow up|Patient Refused Follow-up|0|||
156488847|NCT02382406|564883297|FG000|Follow up|Study Terminated|1|||
156488848|NCT02382406|564883298|FG001|Follow up|Study Terminated|0|||
156488849|NCT02382406|564883299|FG002|Follow up|Study Terminated|8|||
156488850|NCT02382406|564883297|FG000|Follow up|Withdrawal by Subject|0|||
156488851|NCT02382406|564883298|FG001|Follow up|Withdrawal by Subject|0|||
156488852|NCT02382406|564883299|FG002|Follow up|Withdrawal by Subject|2|||
156488853|NCT01713998|564883300|FG000|Overall Study|Lost to Follow-up|2|||
156488854|NCT01713998|564883301|FG001|Overall Study|Lost to Follow-up|0|||
156488855|NCT01713998|564883302|FG002|Overall Study|Lost to Follow-up|2|||
156488856|NCT01713998|564883300|FG000|Overall Study|Withdrawal by Subject|1|||
156488857|NCT01713998|564883301|FG001|Overall Study|Withdrawal by Subject|0|||
156488858|NCT01713998|564883302|FG002|Overall Study|Withdrawal by Subject|0|||
156488859|NCT03794609|564883303|FG000|Overall Study|Other|10|||
156488860|NCT03794609|564883303|FG000|Overall Study|Withdrawal by Subject|66|||
156488861|NCT03794609|564883303|FG000|Overall Study|The child is enrolled in an interventional study|70|||
156488862|NCT03794609|564883303|FG000|Overall Study|Inclusion/exclusion criteria|8|||
156488863|NCT03794609|564883303|FG000|Overall Study|At sponsor's request|151|||
156488864|NCT03794609|564883303|FG000|Overall Study|Physician Decision|1|||
156488865|NCT03794609|564883303|FG000|Overall Study|Lost to Follow-up|5|||
156488866|NCT03638258|564883304|FG000|Overall Study|Adverse Event|1|||
156488867|NCT03638258|564883305|FG001|Overall Study|Adverse Event|0|||
156488868|NCT03638258|564883306|FG002|Overall Study|Adverse Event|2|||
156488869|NCT03638258|564883304|FG000|Overall Study|Lost to Follow-up|2|||
156488870|NCT03638258|564883305|FG001|Overall Study|Lost to Follow-up|4|||
156488871|NCT03638258|564883306|FG002|Overall Study|Lost to Follow-up|5|||
156488872|NCT03638258|564883304|FG000|Overall Study|Pregnancy|0|||
156488873|NCT03638258|564883305|FG001|Overall Study|Pregnancy|0|||
156488874|NCT03638258|564883306|FG002|Overall Study|Pregnancy|1|||
156488875|NCT03638258|564883304|FG000|Overall Study|Protocol Violation|0|||
156488876|NCT03638258|564883305|FG001|Overall Study|Protocol Violation|0|||
156488877|NCT03638258|564883306|FG002|Overall Study|Protocol Violation|1|||
156488878|NCT03638258|564883304|FG000|Overall Study|Withdrawal by Subject|4|||
156488879|NCT03638258|564883305|FG001|Overall Study|Withdrawal by Subject|5|||
156488880|NCT03638258|564883306|FG002|Overall Study|Withdrawal by Subject|12|||
156488881|NCT03638258|564883304|FG000|Overall Study|Lack of Efficacy|0|||
156488882|NCT03638258|564883305|FG001|Overall Study|Lack of Efficacy|0|||
156488883|NCT03638258|564883306|FG002|Overall Study|Lack of Efficacy|2|||
156488884|NCT04543942|564883307|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
156488885|NCT04543942|564883308|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
156488886|NCT04543942|564883307|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
156488887|NCT04543942|564883308|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
156488888|NCT02205476|564883309|FG000|Overall Study|Study termination by Sponsor|7|||
156488889|NCT02205476|564883310|FG001|Overall Study|Study termination by Sponsor|3|||
156488890|NCT00139659|564883315|FG000|Overall Study|Adverse Event|12|||
156359138|NCT01063764|564414633|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
156488891|NCT00139659|564883316|FG001|Overall Study|Adverse Event|1|||
156488892|NCT00139659|564883315|FG000|Overall Study|Lack of Efficacy|1|||
156488893|NCT00139659|564883316|FG001|Overall Study|Lack of Efficacy|1|||
156488894|NCT00139659|564883315|FG000|Overall Study|Lost to Follow-up|7|||
156488895|NCT00139659|564883316|FG001|Overall Study|Lost to Follow-up|3|||
156488896|NCT00139659|564883315|FG000|Overall Study|Reason not Specified|6|||
156488897|NCT00139659|564883316|FG001|Overall Study|Reason not Specified|3|||
156488898|NCT00139659|564883315|FG000|Overall Study|Withdrawal by Subject|14|||
156488899|NCT00139659|564883316|FG001|Overall Study|Withdrawal by Subject|10|||
156488900|NCT02625922|564883322|FG000|Overall Study|Non-availability of IMP|1|||
156488901|NCT02625922|564883323|FG001|Overall Study|Non-availability of IMP|1|||
156488902|NCT02625922|564883322|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
156488903|NCT02625922|564883323|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
156488904|NCT00640042|564883324|FG000|Enrollment|Did not receive study drug|83|||
156488905|NCT02359552|564883325|FG000|Overall Study|Lost to Follow-up|3|||
156488906|NCT02359552|564883326|FG001|Overall Study|Lost to Follow-up|4|||
156488907|NCT02391116|564883337|FG000|Treatment|Withdrawal by Subject|1|||
156488908|NCT02391116|564883337|FG000|Treatment|Protocol Violation|1|||
156488909|NCT02391116|564883337|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
156488910|NCT02391116|564883337|FG000|Treatment|AE with Clinical PD|3|||
156488911|NCT02391116|564883337|FG000|Safety Follow-up|Adverse Event|1|||
156488912|NCT02391116|564883337|FG000|Safety Follow-up|Withdrawal by Subject|4|||
156488913|NCT02391116|564883337|FG000|Safety Follow-up|Switching to Other Therapy|4|||
156488914|NCT02391116|564883337|FG000|Safety Follow-up|No Follow Up|1|||
156488915|NCT02391116|564883337|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
156488916|NCT02391116|564883337|FG000|Active Follow-up|Withdrawal by Subject|1|||
156488917|NCT02391116|564883337|FG000|Active Follow-up|Switching to Other Therapy|2|||
156488918|NCT02391116|564883337|FG000|Survival Follow-up|Withdrawal by Subject|3|||
156488919|NCT02391116|564883337|FG000|Survival Follow-up|Switching to Other Therapy|1|||
156488920|NCT01747629|564883339|FG000|Overall Study|Adverse Event|1|||
156488921|NCT01747629|564883340|FG001|Overall Study|Adverse Event|2|||
156488922|NCT01747629|564883339|FG000|Overall Study|Withdrawal by Subject|2|||
156488923|NCT01747629|564883340|FG001|Overall Study|Withdrawal by Subject|2|||
156488924|NCT01747629|564883339|FG000|Overall Study|Noncompliance|1|||
156488925|NCT01747629|564883340|FG001|Overall Study|Noncompliance|1|||
156488926|NCT01747629|564883339|FG000|Overall Study|Inclusion criteria not met|1|||
156488927|NCT01747629|564883340|FG001|Overall Study|Inclusion criteria not met|0|||
156488928|NCT01747629|564883339|FG000|Overall Study|Not treated|1|||
156488929|NCT01747629|564883340|FG001|Overall Study|Not treated|0|||
156488930|NCT01747629|564883339|FG000|Overall Study|Other|2|||
156488931|NCT01747629|564883340|FG001|Overall Study|Other|1|||
156488932|NCT01313299|564883341|FG000|Overall Study|Adverse Event|3|||
156488933|NCT01313299|564883342|FG001|Overall Study|Adverse Event|1|||
156488934|NCT01313299|564883343|FG002|Overall Study|Adverse Event|1|||
156488935|NCT01313299|564883341|FG000|Overall Study|Lost to Follow-up|1|||
156488936|NCT01313299|564883342|FG001|Overall Study|Lost to Follow-up|0|||
156488937|NCT01313299|564883343|FG002|Overall Study|Lost to Follow-up|0|||
156488938|NCT01313299|564883341|FG000|Overall Study|Protocol Violation|2|||
156488939|NCT01313299|564883342|FG001|Overall Study|Protocol Violation|0|||
156488940|NCT01313299|564883343|FG002|Overall Study|Protocol Violation|0|||
156488941|NCT01313299|564883341|FG000|Overall Study|Withdrawal by Subject|1|||
156488942|NCT01313299|564883342|FG001|Overall Study|Withdrawal by Subject|0|||
156488943|NCT01313299|564883343|FG002|Overall Study|Withdrawal by Subject|2|||
156488944|NCT01313299|564883341|FG000|Overall Study|Family reason and moved out of state|0|||
156488945|NCT01313299|564883342|FG001|Overall Study|Family reason and moved out of state|2|||
156488946|NCT01313299|564883343|FG002|Overall Study|Family reason and moved out of state|0|||
156488947|NCT01313299|564883341|FG000|Overall Study|Lack of subject compliance|0|||
156488948|NCT01313299|564883342|FG001|Overall Study|Lack of subject compliance|0|||
156488949|NCT01313299|564883343|FG002|Overall Study|Lack of subject compliance|1|||
156488950|NCT02506881|564883344|FG000|First Intervention (Day 1)|Protocol Violation|0|||
156488951|NCT02506881|564883345|FG001|First Intervention (Day 1)|Protocol Violation|0|||
156488952|NCT02506881|564883346|FG002|First Intervention (Day 1)|Protocol Violation|1|||
156488953|NCT02506881|564883347|FG003|First Intervention (Day 1)|Protocol Violation|0|||
156488954|NCT02506881|564883344|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
156488955|NCT02506881|564883345|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
156488956|NCT02506881|564883346|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
156488957|NCT02506881|564883347|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
156488958|NCT02506881|564883344|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
156488959|NCT02506881|564883345|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
156488960|NCT02506881|564883346|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
156488961|NCT02506881|564883347|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
156488962|NCT01919398|564883348|FG000|Overall Study|Progressive Disease|0|||
156359139|NCT01727141|564414634|FG000|Overall Study|Physician Decision|0|||
156488963|NCT01919398|564883349|FG001|Overall Study|Progressive Disease|0|||
156488964|NCT01919398|564883350|FG002|Overall Study|Progressive Disease|4|||
156488965|NCT02391545|564883352|FG000|Overall Study|Death|0|||
156488966|NCT02391545|564883353|FG001|Overall Study|Death|2|||
156488967|NCT02391545|564883352|FG000|Overall Study|Lost to Follow-up|0|||
156488968|NCT02391545|564883353|FG001|Overall Study|Lost to Follow-up|1|||
156488969|NCT02391545|564883352|FG000|Overall Study|Termination of study by sponsor|20|||
156488970|NCT02391545|564883353|FG001|Overall Study|Termination of study by sponsor|20|||
156359140|NCT01727141|564414635|FG001|Overall Study|Physician Decision|1|||
156488971|NCT02391545|564883352|FG000|Overall Study|Withdrawal by Subject|0|||
156488972|NCT02391545|564883353|FG001|Overall Study|Withdrawal by Subject|1|||
156488973|NCT02391545|564883352|FG000|Overall Study|Other Reasons|6|||
156359141|NCT01727141|564414636|FG002|Overall Study|Physician Decision|0|||
156545153|NCT05121480|565091522|FG000|Overall Study|Adverse Event|0|||
156545154|NCT05121480|565091523|FG001|Overall Study|Adverse Event|1|||
156545155|NCT05121480|565091524|FG002|Overall Study|Adverse Event|0|||
156545156|NCT05121480|565091525|FG003|Overall Study|Adverse Event|5|||
156545157|NCT05121480|565091526|FG004|Overall Study|Adverse Event|3|||
156545158|NCT05121480|565091527|FG005|Overall Study|Adverse Event|2|||
156545159|NCT05121480|565091528|FG006|Overall Study|Adverse Event|0|||
156545160|NCT05121480|565091529|FG007|Overall Study|Adverse Event|4|||
156545161|NCT05121480|565091522|FG000|Overall Study|Withdrawal by Subject|4|||
156545162|NCT05121480|565091523|FG001|Overall Study|Withdrawal by Subject|9|||
156545163|NCT05121480|565091524|FG002|Overall Study|Withdrawal by Subject|1|||
156545164|NCT05121480|565091525|FG003|Overall Study|Withdrawal by Subject|8|||
156545165|NCT05121480|565091526|FG004|Overall Study|Withdrawal by Subject|0|||
156545166|NCT05121480|565091527|FG005|Overall Study|Withdrawal by Subject|9|||
156545167|NCT05121480|565091528|FG006|Overall Study|Withdrawal by Subject|0|||
156545168|NCT05121480|565091529|FG007|Overall Study|Withdrawal by Subject|4|||
156545169|NCT05121480|565091522|FG000|Overall Study|Non-compliance with the protocol|0|||
156545170|NCT05121480|565091523|FG001|Overall Study|Non-compliance with the protocol|0|||
156545171|NCT05121480|565091524|FG002|Overall Study|Non-compliance with the protocol|0|||
156545172|NCT05121480|565091525|FG003|Overall Study|Non-compliance with the protocol|0|||
156545173|NCT05121480|565091526|FG004|Overall Study|Non-compliance with the protocol|1|||
156545174|NCT05121480|565091527|FG005|Overall Study|Non-compliance with the protocol|6|||
156545175|NCT05121480|565091528|FG006|Overall Study|Non-compliance with the protocol|0|||
156545176|NCT05121480|565091529|FG007|Overall Study|Non-compliance with the protocol|1|||
156545177|NCT05121480|565091522|FG000|Overall Study|Lost to Follow-up|0|||
156545178|NCT05121480|565091523|FG001|Overall Study|Lost to Follow-up|4|||
156545179|NCT05121480|565091524|FG002|Overall Study|Lost to Follow-up|1|||
156545180|NCT05121480|565091525|FG003|Overall Study|Lost to Follow-up|3|||
156545181|NCT05121480|565091526|FG004|Overall Study|Lost to Follow-up|1|||
156545182|NCT05121480|565091527|FG005|Overall Study|Lost to Follow-up|1|||
156545183|NCT05121480|565091528|FG006|Overall Study|Lost to Follow-up|1|||
156545184|NCT05121480|565091529|FG007|Overall Study|Lost to Follow-up|4|||
156545185|NCT05121480|565091522|FG000|Overall Study|Physician Decision|0|||
156545186|NCT05121480|565091523|FG001|Overall Study|Physician Decision|0|||
156545187|NCT05121480|565091524|FG002|Overall Study|Physician Decision|0|||
156545188|NCT05121480|565091525|FG003|Overall Study|Physician Decision|0|||
156545189|NCT05121480|565091526|FG004|Overall Study|Physician Decision|0|||
156545190|NCT05121480|565091527|FG005|Overall Study|Physician Decision|1|||
156545191|NCT05121480|565091528|FG006|Overall Study|Physician Decision|0|||
156545192|NCT05121480|565091529|FG007|Overall Study|Physician Decision|1|||
156545193|NCT05121480|565091522|FG000|Overall Study|Other Reason|0|||
156545194|NCT05121480|565091523|FG001|Overall Study|Other Reason|0|||
156545195|NCT05121480|565091524|FG002|Overall Study|Other Reason|0|||
156545196|NCT05121480|565091525|FG003|Overall Study|Other Reason|0|||
156545197|NCT05121480|565091526|FG004|Overall Study|Other Reason|0|||
156545198|NCT05121480|565091527|FG005|Overall Study|Other Reason|1|||
156545199|NCT05121480|565091528|FG006|Overall Study|Other Reason|1|||
156545200|NCT05121480|565091529|FG007|Overall Study|Other Reason|1|||
156545201|NCT02356562|565091530|FG000|Overall Study|Withdrawal by Subject|0|||
156545202|NCT02356562|565091531|FG001|Overall Study|Withdrawal by Subject|1|||
156545203|NCT02356562|565091530|FG000|Overall Study|Re-entered treatment in a previous study|1|||
156545204|NCT02356562|565091531|FG001|Overall Study|Re-entered treatment in a previous study|0|||
156545205|NCT02356562|565091530|FG000|Overall Study|site closure|1|||
156545206|NCT02356562|565091531|FG001|Overall Study|site closure|0|||
156545207|NCT00412750|565091532|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156545208|NCT00412750|565091533|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156545209|NCT00412750|565091534|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156545210|NCT00412750|565091532|FG000|Overall Study|Administrative problems|21|||
156545211|NCT00412750|565091533|FG001|Overall Study|Administrative problems|17|||
156545212|NCT00412750|565091534|FG002|Overall Study|Administrative problems|14|||
156545213|NCT00412750|565091532|FG000|Overall Study|Adverse Event|8|||
156545214|NCT00412750|565091533|FG001|Overall Study|Adverse Event|3|||
156545215|NCT00412750|565091534|FG002|Overall Study|Adverse Event|3|||
156545216|NCT00412750|565091532|FG000|Overall Study|Lost to Follow-up|1|||
156545217|NCT00412750|565091533|FG001|Overall Study|Lost to Follow-up|0|||
156545218|NCT00412750|565091534|FG002|Overall Study|Lost to Follow-up|1|||
156545219|NCT00412750|565091532|FG000|Overall Study|Withdrawal by Subject|0|||
156545220|NCT00412750|565091533|FG001|Overall Study|Withdrawal by Subject|1|||
156545221|NCT00412750|565091534|FG002|Overall Study|Withdrawal by Subject|2|||
156545222|NCT00412750|565091532|FG000|Overall Study|Lack of Efficacy|0|||
156545223|NCT00412750|565091533|FG001|Overall Study|Lack of Efficacy|0|||
156545224|NCT00412750|565091534|FG002|Overall Study|Lack of Efficacy|3|||
156545225|NCT00874120|565091535|FG000|First Intervention|Adverse Event|0|||
156545226|NCT00874120|565091536|FG001|First Intervention|Adverse Event|1|||
156545227|NCT00874120|565091535|FG000|First Intervention|Withdrawal by Subject|2|||
156545228|NCT00874120|565091536|FG001|First Intervention|Withdrawal by Subject|0|||
156545229|NCT00874120|565091535|FG000|First Intervention|Lost to Follow-up|0|||
156545230|NCT00874120|565091536|FG001|First Intervention|Lost to Follow-up|1|||
156545231|NCT00874120|565091535|FG000|First Intervention|Protocol Violation|3|||
156545232|NCT00874120|565091536|FG001|First Intervention|Protocol Violation|0|||
156545233|NCT00874120|565091535|FG000|First Intervention|positive drug test|1|||
156545234|NCT00874120|565091536|FG001|First Intervention|positive drug test|0|||
156545235|NCT00874120|565091535|FG000|Second Intervention|Withdrawal by Subject|1|||
156545236|NCT00874120|565091536|FG001|Second Intervention|Withdrawal by Subject|0|||
156545237|NCT00874120|565091535|FG000|Second Intervention|Protocol Violation|1|||
156545238|NCT00874120|565091536|FG001|Second Intervention|Protocol Violation|0|||
156545239|NCT01823679|565091537|FG000|Overall Study|Death|1|||
156545240|NCT01157078|565091541|FG000|Overall Study|Withdrawal by Subject|12|||
156545241|NCT01157078|565091542|FG001|Overall Study|Withdrawal by Subject|14|||
156545242|NCT01157078|565091541|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156545243|NCT01157078|565091542|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156545244|NCT01157078|565091541|FG000|Overall Study|Adverse Event|6|||
156545245|NCT01157078|565091542|FG001|Overall Study|Adverse Event|6|||
156545246|NCT01157078|565091541|FG000|Overall Study|Severe non-compliance to protocol|2|||
156545247|NCT01157078|565091542|FG001|Overall Study|Severe non-compliance to protocol|4|||
156545248|NCT01157078|565091541|FG000|Overall Study|Condition under investigation worsened|0|||
156545249|NCT01157078|565091542|FG001|Overall Study|Condition under investigation worsened|1|||
156545250|NCT01157078|565091541|FG000|Overall Study|Lack of Efficacy|2|||
156545251|NCT01157078|565091542|FG001|Overall Study|Lack of Efficacy|0|||
156545252|NCT01157078|565091541|FG000|Overall Study|Study-specific withdrawal criteria|2|||
156545253|NCT01157078|565091542|FG001|Overall Study|Study-specific withdrawal criteria|2|||
156545254|NCT01157078|565091541|FG000|Overall Study|Lost to Follow-up|7|||
156488974|NCT02391545|564883353|FG001|Overall Study|Other Reasons|4|||
156488975|NCT02016690|564883354|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
156488976|NCT02016690|564883354|FG000|Overall Study|Excluded from SAS: Duplication|2|||
156488977|NCT02016690|564883354|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
156488978|NCT02016690|564883354|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
156488979|NCT02016690|564883354|FG000|Overall Study|Did not meet inclusion criteria|13|||
156488980|NCT02016690|564883354|FG000|Overall Study|Hospitalized for RSV at study start|3|||
156488981|NCT01222078|564883355|FG000|Overall Study|Early termination of the study|1|||
156488982|NCT04089332|564883356|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
156488983|NCT04089332|564883356|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
156488984|NCT04089332|564883356|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
156488985|NCT00495612|564883360|FG000|Overall Study|Lost to Follow-up|1|||
156488986|NCT00495612|564883361|FG001|Overall Study|Lost to Follow-up|0|||
156488987|NCT00495612|564883360|FG000|Overall Study|Subject's Decision to Withdraw|3|||
156488988|NCT00495612|564883361|FG001|Overall Study|Subject's Decision to Withdraw|0|||
156488989|NCT00853021|564883364|FG000|Overall Study|Adverse Event|2|||
156488990|NCT00853021|564883364|FG000|Overall Study|Withdrawal by Subject|2|||
156488991|NCT00853021|564883364|FG000|Overall Study|Death|1|||
156488992|NCT02864147|564883365|FG000|Overall Study|Withdrawal by Subject|3|||
156488993|NCT02864147|564883366|FG001|Overall Study|Withdrawal by Subject|2|||
156488994|NCT02864147|564883367|FG002|Overall Study|Withdrawal by Subject|1|||
156488995|NCT02864147|564883365|FG000|Overall Study|Lost to Follow-up|0|||
156488996|NCT02864147|564883366|FG001|Overall Study|Lost to Follow-up|4|||
156488997|NCT02864147|564883367|FG002|Overall Study|Lost to Follow-up|0|||
156488998|NCT02864147|564883365|FG000|Overall Study|Adverse Event|0|||
156488999|NCT02864147|564883366|FG001|Overall Study|Adverse Event|1|||
156489000|NCT02864147|564883367|FG002|Overall Study|Adverse Event|0|||
156489001|NCT02864147|564883365|FG000|Overall Study|Pregnancy|4|||
156489002|NCT02864147|564883366|FG001|Overall Study|Pregnancy|0|||
156489003|NCT02864147|564883367|FG002|Overall Study|Pregnancy|0|||
156489004|NCT02864147|564883365|FG000|Overall Study|Physician Decision|0|||
156489005|NCT02864147|564883366|FG001|Overall Study|Physician Decision|0|||
156489006|NCT02864147|564883367|FG002|Overall Study|Physician Decision|1|||
156489007|NCT02864147|564883365|FG000|Overall Study|Opted for excisional procedures|0|||
156489008|NCT02864147|564883366|FG001|Overall Study|Opted for excisional procedures|0|||
156489009|NCT02864147|564883367|FG002|Overall Study|Opted for excisional procedures|3|||
156359142|NCT01727141|564414637|FG003|Overall Study|Physician Decision|2|||
156489010|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
156489011|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
156489012|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
156489013|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
156489014|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
156489015|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
156545255|NCT01157078|565091542|FG001|Overall Study|Lost to Follow-up|5|||
156545256|NCT01157078|565091541|FG000|Overall Study|Other|2|||
156545257|NCT01157078|565091542|FG001|Overall Study|Other|4|||
156545258|NCT01623271|565091545|FG000|Overall Study|Withdrawal by Subject|2|||
156545259|NCT01611974|565091546|FG000|Overall Study|Death|10|||
156545260|NCT01611974|565091547|FG001|Overall Study|Death|12|||
156545261|NCT01611974|565091548|FG002|Overall Study|Death|10|||
156545262|NCT01611974|565091546|FG000|Overall Study|Lost to Follow-up|0|||
156545263|NCT01611974|565091547|FG001|Overall Study|Lost to Follow-up|1|||
156545264|NCT01611974|565091548|FG002|Overall Study|Lost to Follow-up|0|||
156545265|NCT01611974|565091546|FG000|Overall Study|Physician Decision|5|||
156545266|NCT01611974|565091547|FG001|Overall Study|Physician Decision|1|||
156545267|NCT01611974|565091548|FG002|Overall Study|Physician Decision|2|||
156545268|NCT01611974|565091546|FG000|Overall Study|Withdrawal by Subject|0|||
156545269|NCT01611974|565091547|FG001|Overall Study|Withdrawal by Subject|1|||
156545270|NCT01611974|565091548|FG002|Overall Study|Withdrawal by Subject|4|||
156545271|NCT00522431|565091549|FG000|Overall Study|Adverse Event|5|||
156545272|NCT00522431|565091549|FG000|Overall Study|Protocol Violation|2|||
156545273|NCT00522431|565091549|FG000|Overall Study|Withdrawal by Subject|2|||
156545274|NCT00522431|565091549|FG000|Overall Study|Subject non-compliance|1|||
156545275|NCT00522431|565091549|FG000|Overall Study|Other/unknown|1|||
156545276|NCT01192022|565091552|FG000|Overall Study|Withdrawal of Consent|3|||
156545277|NCT01192022|565091553|FG001|Overall Study|Withdrawal of Consent|1|||
156545278|NCT01192022|565091554|FG002|Overall Study|Withdrawal of Consent|0|||
156545279|NCT01192022|565091555|FG003|Overall Study|Withdrawal of Consent|0|||
156545280|NCT01192022|565091556|FG004|Overall Study|Withdrawal of Consent|0|||
156545281|NCT01192022|565091552|FG000|Overall Study|Lost to Follow-up|4|||
156545282|NCT01192022|565091553|FG001|Overall Study|Lost to Follow-up|2|||
156545283|NCT01192022|565091554|FG002|Overall Study|Lost to Follow-up|1|||
156545284|NCT01192022|565091555|FG003|Overall Study|Lost to Follow-up|1|||
156545285|NCT01192022|565091556|FG004|Overall Study|Lost to Follow-up|0|||
156545286|NCT01192022|565091552|FG000|Overall Study|Adverse Event|1|||
156545287|NCT01192022|565091553|FG001|Overall Study|Adverse Event|0|||
156545288|NCT01192022|565091554|FG002|Overall Study|Adverse Event|0|||
156545289|NCT01192022|565091555|FG003|Overall Study|Adverse Event|0|||
156545290|NCT01192022|565091556|FG004|Overall Study|Adverse Event|0|||
156545291|NCT01192022|565091552|FG000|Overall Study|Fatal Adverse Event|4|||
156545292|NCT01192022|565091553|FG001|Overall Study|Fatal Adverse Event|6|||
156545293|NCT01192022|565091554|FG002|Overall Study|Fatal Adverse Event|0|||
156545294|NCT01192022|565091555|FG003|Overall Study|Fatal Adverse Event|0|||
156545295|NCT01192022|565091556|FG004|Overall Study|Fatal Adverse Event|1|||
156545296|NCT01192022|565091552|FG000|Overall Study|Physician withdrew-patient hardship|1|||
156545297|NCT01192022|565091553|FG001|Overall Study|Physician withdrew-patient hardship|0|||
156545298|NCT01192022|565091554|FG002|Overall Study|Physician withdrew-patient hardship|0|||
156545299|NCT01192022|565091555|FG003|Overall Study|Physician withdrew-patient hardship|0|||
156545300|NCT01192022|565091556|FG004|Overall Study|Physician withdrew-patient hardship|0|||
156545301|NCT01192022|565091552|FG000|Overall Study|Patient too sick from chemotherapy|0|||
156545302|NCT01192022|565091553|FG001|Overall Study|Patient too sick from chemotherapy|1|||
156545303|NCT01192022|565091554|FG002|Overall Study|Patient too sick from chemotherapy|0|||
156545304|NCT01192022|565091555|FG003|Overall Study|Patient too sick from chemotherapy|0|||
156545305|NCT01192022|565091556|FG004|Overall Study|Patient too sick from chemotherapy|0|||
156545306|NCT01192022|565091552|FG000|Overall Study|Patient needed surgery|0|||
156545307|NCT01192022|565091553|FG001|Overall Study|Patient needed surgery|1|||
156359143|NCT01727141|564414634|FG000|Overall Study|Lost to Follow-up|0|||
156545308|NCT01192022|565091554|FG002|Overall Study|Patient needed surgery|0|||
156545309|NCT01192022|565091555|FG003|Overall Study|Patient needed surgery|0|||
156545310|NCT01192022|565091556|FG004|Overall Study|Patient needed surgery|0|||
156545311|NCT01192022|565091552|FG000|Overall Study|Parents did not allow all follow up|0|||
156545312|NCT01192022|565091553|FG001|Overall Study|Parents did not allow all follow up|0|||
156545313|NCT01192022|565091554|FG002|Overall Study|Parents did not allow all follow up|0|||
156545314|NCT01192022|565091555|FG003|Overall Study|Parents did not allow all follow up|1|||
156545315|NCT01192022|565091556|FG004|Overall Study|Parents did not allow all follow up|0|||
156489016|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
156489017|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
156489018|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
156489019|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
156489020|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
156545316|NCT00783094|565091562|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
156545317|NCT00783094|565091563|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
156545318|NCT00783094|565091564|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
156545319|NCT00783094|565091562|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
156545320|NCT00783094|565091563|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
156545321|NCT00783094|565091564|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
156545322|NCT00783094|565091562|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
156545323|NCT00783094|565091563|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
156545324|NCT00783094|565091564|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
156545325|NCT00783094|565091562|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
156545326|NCT00783094|565091563|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
156545327|NCT00783094|565091564|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
156545328|NCT00783094|565091562|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
156545329|NCT00783094|565091563|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
156545330|NCT00783094|565091564|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
156545331|NCT00783094|565091562|FG000|Open-Label Extension Period|Adverse Event|12|||
156545332|NCT00783094|565091563|FG001|Open-Label Extension Period|Adverse Event|7|||
156545333|NCT00783094|565091564|FG002|Open-Label Extension Period|Adverse Event|16|||
156545334|NCT00783094|565091562|FG000|Open-Label Extension Period|Death|0|||
156545335|NCT00783094|565091563|FG001|Open-Label Extension Period|Death|0|||
156489021|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
156489022|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
156489023|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
156489024|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
156489025|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
156489026|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
156489027|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
156359144|NCT01727141|564414635|FG001|Overall Study|Lost to Follow-up|2|||
156359145|NCT01727141|564414636|FG002|Overall Study|Lost to Follow-up|0|||
156359146|NCT01727141|564414637|FG003|Overall Study|Lost to Follow-up|0|||
156359147|NCT01727141|564414634|FG000|Overall Study|Death|0|||
156359148|NCT01727141|564414635|FG001|Overall Study|Death|1|||
156359149|NCT01727141|564414636|FG002|Overall Study|Death|1|||
156359150|NCT01727141|564414637|FG003|Overall Study|Death|1|||
156359151|NCT01727141|564414634|FG000|Overall Study|Protocol deviation|1|||
156359152|NCT01727141|564414635|FG001|Overall Study|Protocol deviation|1|||
156359153|NCT01727141|564414636|FG002|Overall Study|Protocol deviation|0|||
156359154|NCT01727141|564414637|FG003|Overall Study|Protocol deviation|1|||
156359155|NCT01727141|564414634|FG000|Overall Study|Withdrawal by Subject|4|||
156359156|NCT01727141|564414635|FG001|Overall Study|Withdrawal by Subject|4|||
156359157|NCT01727141|564414636|FG002|Overall Study|Withdrawal by Subject|2|||
156359158|NCT01727141|564414637|FG003|Overall Study|Withdrawal by Subject|11|||
156359159|NCT02731729|564414642|FG000|Overall Study|Death|2|||
156359160|NCT02731729|564414643|FG001|Overall Study|Death|2|||
156359161|NCT02731729|564414642|FG000|Overall Study|Study terminated by Sponsor|6|||
156359162|NCT02731729|564414643|FG001|Overall Study|Study terminated by Sponsor|6|||
156359163|NCT02731729|564414642|FG000|Overall Study|Withdrawal by Subject|1|||
156359164|NCT02731729|564414643|FG001|Overall Study|Withdrawal by Subject|0|||
156359165|NCT01344447|564414644|FG000|Overall Study|Adverse Event|1|||
156359166|NCT01344447|564414644|FG000|Overall Study|Protocol Violation|1|||
156359167|NCT01344447|564414644|FG000|Overall Study|Withdrawal by Subject|1|||
156359168|NCT01344447|564414644|FG000|Overall Study|The contrast was not seen|1|||
156359169|NCT01344447|564414644|FG000|Overall Study|Physician Decision|1|||
156359170|NCT01344447|564414644|FG000|Overall Study|MRA unsuccessful|1|||
156359171|NCT01344447|564414644|FG000|Overall Study|Bolus tracking failed|1|||
156359172|NCT01344447|564414644|FG000|Overall Study|Error of power injector|1|||
156359173|NCT01660711|564414645|FG000|Overall Study|Adverse Event|7|||
156359174|NCT01660711|564414645|FG000|Overall Study|Withdrawal by Subject|1|||
156359175|NCT02066467|564414651|FG000|Overall Study|Did not undergo implant procedure|24|||
156359176|NCT02066467|564414651|FG000|Overall Study|Attempted to implant withoput success|43|||
156359177|NCT02066467|564414651|FG000|Overall Study|Consent ineligible|1|||
156359178|NCT02066467|564414651|FG000|Overall Study|Death|54|||
156359179|NCT02066467|564414651|FG000|Overall Study|Lost to Follow-up|51|||
156359180|NCT02066467|564414651|FG000|Overall Study|Adverse Event|20|||
156359181|NCT02066467|564414651|FG000|Overall Study|Withdrawal by Subject|16|||
156359182|NCT02066467|564414651|FG000|Overall Study|Physician Decision|2|||
156359183|NCT02066467|564414651|FG000|Overall Study|Not defined|4|||
156359184|NCT02759120|564414654|FG000|Overall Study|Death|34|||
156359185|NCT02759120|564414655|FG001|Overall Study|Death|36|||
156359186|NCT02759120|564414654|FG000|Overall Study|Lost to Follow-up|4|||
156359187|NCT02759120|564414655|FG001|Overall Study|Lost to Follow-up|7|||
156359188|NCT02759120|564414654|FG000|Overall Study|Physician Decision|3|||
156359189|NCT02759120|564414655|FG001|Overall Study|Physician Decision|0|||
156359190|NCT02759120|564414654|FG000|Overall Study|Withdrawal by Subject|28|||
156359191|NCT02759120|564414655|FG001|Overall Study|Withdrawal by Subject|15|||
156359192|NCT02759120|564414654|FG000|Overall Study|Moved out of area|3|||
156359193|NCT02759120|564414655|FG001|Overall Study|Moved out of area|4|||
156359194|NCT02759120|564414654|FG000|Overall Study|Lung transplant|3|||
156359195|NCT02759120|564414655|FG001|Overall Study|Lung transplant|5|||
156359196|NCT02759120|564414654|FG000|Overall Study|Other reason not completed|10|||
156359197|NCT02759120|564414655|FG001|Overall Study|Other reason not completed|12|||
156359198|NCT04461015|564414657|FG000|Overall Study|IV access lost during the study|0|||
156359199|NCT04461015|564414658|FG001|Overall Study|IV access lost during the study|1|||
156359200|NCT04461015|564414657|FG000|Overall Study|Withdrawal by Subject|0|||
156359201|NCT04461015|564414658|FG001|Overall Study|Withdrawal by Subject|1|||
156359202|NCT02063854|564414664|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
156359203|NCT02063854|564414665|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
156489028|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
156489029|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
156489030|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
156359204|NCT02063854|564414666|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
156359205|NCT02063854|564414667|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
156359206|NCT02063854|564414668|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
156359207|NCT02063854|564414669|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
156359208|NCT02063854|564414670|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
156359209|NCT02063854|564414664|FG000|Overall Study|Major Protocol Deviation|0|||
156489031|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
156359210|NCT02063854|564414665|FG001|Overall Study|Major Protocol Deviation|0|||
156359211|NCT02063854|564414666|FG002|Overall Study|Major Protocol Deviation|3|||
156359212|NCT02063854|564414667|FG003|Overall Study|Major Protocol Deviation|0|||
156359213|NCT02063854|564414668|FG004|Overall Study|Major Protocol Deviation|0|||
156359214|NCT02063854|564414669|FG005|Overall Study|Major Protocol Deviation|0|||
156359215|NCT02063854|564414670|FG006|Overall Study|Major Protocol Deviation|0|||
156359216|NCT02063854|564414664|FG000|Overall Study|Voluntary Withdrawal|2|||
156359217|NCT02063854|564414665|FG001|Overall Study|Voluntary Withdrawal|0|||
156359218|NCT02063854|564414666|FG002|Overall Study|Voluntary Withdrawal|8|||
156359219|NCT02063854|564414667|FG003|Overall Study|Voluntary Withdrawal|1|||
156359220|NCT02063854|564414668|FG004|Overall Study|Voluntary Withdrawal|3|||
156359221|NCT02063854|564414669|FG005|Overall Study|Voluntary Withdrawal|6|||
156359222|NCT02063854|564414670|FG006|Overall Study|Voluntary Withdrawal|1|||
156359223|NCT02063854|564414664|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
156359224|NCT02063854|564414665|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
156359225|NCT02063854|564414666|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
156359226|NCT02063854|564414667|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
156359227|NCT02063854|564414668|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
156359228|NCT02063854|564414669|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
156359229|NCT02063854|564414670|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
156359230|NCT02063854|564414664|FG000|Overall Study|Reason Not Specified|1|||
156359231|NCT02063854|564414665|FG001|Overall Study|Reason Not Specified|0|||
156359232|NCT02063854|564414666|FG002|Overall Study|Reason Not Specified|0|||
156359233|NCT02063854|564414667|FG003|Overall Study|Reason Not Specified|0|||
156359234|NCT02063854|564414668|FG004|Overall Study|Reason Not Specified|0|||
156359235|NCT02063854|564414669|FG005|Overall Study|Reason Not Specified|0|||
156359236|NCT02063854|564414670|FG006|Overall Study|Reason Not Specified|0|||
156359237|NCT02063854|564414664|FG000|Overall Study|Did Not Receive Study Drug|0|||
156359238|NCT02063854|564414665|FG001|Overall Study|Did Not Receive Study Drug|0|||
156359239|NCT02063854|564414666|FG002|Overall Study|Did Not Receive Study Drug|0|||
156359240|NCT02063854|564414667|FG003|Overall Study|Did Not Receive Study Drug|0|||
156359241|NCT02063854|564414668|FG004|Overall Study|Did Not Receive Study Drug|0|||
156359242|NCT02063854|564414669|FG005|Overall Study|Did Not Receive Study Drug|1|||
156359243|NCT02063854|564414670|FG006|Overall Study|Did Not Receive Study Drug|0|||
156359244|NCT02419742|564414675|FG000|Overall Study|Adverse Event|2|||
156359245|NCT02419742|564414676|FG001|Overall Study|Adverse Event|0|||
156359246|NCT02419742|564414675|FG000|Overall Study|Disease Progression|0|||
156359247|NCT02419742|564414676|FG001|Overall Study|Disease Progression|1|||
156359248|NCT02419742|564414675|FG000|Overall Study|Withdrew Consent|2|||
156359249|NCT02419742|564414676|FG001|Overall Study|Withdrew Consent|1|||
156359250|NCT02419742|564414675|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
156359251|NCT02419742|564414676|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
156359252|NCT02255981|564414677|FG000|Overall Study|Lost to Follow-up|3|||
156359253|NCT02255981|564414677|FG000|Overall Study|Withdrawal by Subject|1|||
156359254|NCT03425331|564414680|FG000|Overall Study|Withdrawal by Subject|1|||
156359255|NCT03425331|564414680|FG000|Overall Study|Death|1|||
156359256|NCT03425331|564414680|FG000|Overall Study|Adverse Event|1|||
156359257|NCT03425331|564414680|FG000|Overall Study|Disease Progression|2|||
156359258|NCT01454570|564414683|FG000|Overall Study|Withdrawal by Subject|2|||
156359259|NCT01454570|564414683|FG000|Overall Study|Screen Failure|7|||
156359260|NCT00973479|564414690|FG000|Overall Study|Lost to Follow-up|0|||
156359261|NCT00973479|564414691|FG001|Overall Study|Lost to Follow-up|3|||
156359262|NCT00973479|564414690|FG000|Overall Study|Death|2|||
156359263|NCT00973479|564414691|FG001|Overall Study|Death|2|||
156359264|NCT00973479|564414690|FG000|Overall Study|Withdrawal by Subject|15|||
156359265|NCT00973479|564414691|FG001|Overall Study|Withdrawal by Subject|16|||
156359266|NCT00973479|564414690|FG000|Overall Study|Lack of Efficacy|5|||
156359267|NCT00973479|564414691|FG001|Overall Study|Lack of Efficacy|7|||
156359268|NCT00973479|564414690|FG000|Overall Study|Adverse Event|12|||
156359269|NCT00973479|564414691|FG001|Overall Study|Adverse Event|32|||
156359270|NCT00973479|564414690|FG000|Overall Study|Protocol Violation|2|||
156359271|NCT00973479|564414691|FG001|Overall Study|Protocol Violation|2|||
156359272|NCT00973479|564414690|FG000|Overall Study|Other|1|||
156359273|NCT00973479|564414691|FG001|Overall Study|Other|7|||
156359274|NCT05075850|564414692|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
156359275|NCT03194321|564414693|FG000|Overall Study|Withdrawal by Subject|1|||
156359276|NCT03194321|564414693|FG000|Overall Study|Lost to Follow-up|1|||
156359277|NCT03194321|564414693|FG000|Overall Study|Travel for Follow-up|1|||
156359278|NCT00271609|564414694|FG000|Overall Study|Adverse Event|11|||
156359279|NCT00271609|564414695|FG001|Overall Study|Adverse Event|3|||
156359280|NCT00271609|564414694|FG000|Overall Study|Withdrawal by Subject|2|||
156359281|NCT00271609|564414695|FG001|Overall Study|Withdrawal by Subject|0|||
156545336|NCT00783094|565091564|FG002|Open-Label Extension Period|Death|1|||
156489032|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
156489033|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
156489034|NCT02269917|564883368|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
156489035|NCT02269917|564883369|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
156489036|NCT02269917|564883370|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
156489037|NCT02269917|564883368|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
156489038|NCT02269917|564883369|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
156489039|NCT02269917|564883370|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
156489040|NCT02269917|564883368|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
156489041|NCT02269917|564883369|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
156489042|NCT02269917|564883370|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
156489043|NCT02269917|564883368|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
156489044|NCT02269917|564883369|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
156489045|NCT02269917|564883370|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
156489046|NCT02269917|564883368|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
156489047|NCT02269917|564883369|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
156489048|NCT02269917|564883370|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
156489049|NCT02269917|564883368|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
156489050|NCT02269917|564883369|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
156489051|NCT02269917|564883370|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
156489052|NCT02269917|564883368|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
156489053|NCT02269917|564883369|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
156489054|NCT02269917|564883370|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
156489055|NCT02269917|564883368|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
156489056|NCT02269917|564883369|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
156489057|NCT02269917|564883370|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
156489058|NCT02865135|564883374|FG000|Overall Study|Death|0|||
156489059|NCT02865135|564883375|FG001|Overall Study|Death|1|||
156489060|NCT02865135|564883376|FG002|Overall Study|Death|0|||
156489061|NCT02865135|564883374|FG000|Overall Study|Progression|6|||
156489062|NCT02865135|564883375|FG001|Overall Study|Progression|2|||
156489063|NCT02865135|564883376|FG002|Overall Study|Progression|2|||
156489064|NCT00746785|564885481|FG000|Overall Study|Lost to Follow-up|29|||
156489065|NCT00746785|564885482|FG001|Overall Study|Lost to Follow-up|25|||
156489066|NCT00746785|564885483|FG002|Overall Study|Lost to Follow-up|27|||
156489067|NCT00381797|564885491|FG000|Overall Study|Withdrawal by Subject|1|||
156489068|NCT00381797|564885492|FG001|Overall Study|Withdrawal by Subject|1|||
156489069|NCT00381797|564885493|FG002|Overall Study|Withdrawal by Subject|0|||
156489070|NCT00381797|564885494|FG003|Overall Study|Withdrawal by Subject|0|||
156489071|NCT00381797|564885495|FG004|Overall Study|Withdrawal by Subject|2|||
156489072|NCT00381797|564885491|FG000|Overall Study|Ineligible|0|||
156489073|NCT00381797|564885492|FG001|Overall Study|Ineligible|0|||
156489074|NCT00381797|564885493|FG002|Overall Study|Ineligible|0|||
156489075|NCT00381797|564885494|FG003|Overall Study|Ineligible|1|||
156489076|NCT00381797|564885495|FG004|Overall Study|Ineligible|0|||
156489077|NCT00684203|564885496|FG000|Overall Study|Adverse Event|6|||
156489078|NCT00684203|564885497|FG001|Overall Study|Adverse Event|4|||
156489079|NCT00684203|564885498|FG002|Overall Study|Adverse Event|8|||
156489080|NCT00684203|564885499|FG003|Overall Study|Adverse Event|0|||
156489081|NCT00684203|564885500|FG004|Overall Study|Adverse Event|0|||
156489082|NCT00684203|564885501|FG005|Overall Study|Adverse Event|0|||
156489083|NCT00684203|564885496|FG000|Overall Study|Protocol-defined clinical event|3|||
156489084|NCT00684203|564885497|FG001|Overall Study|Protocol-defined clinical event|1|||
156489085|NCT00684203|564885498|FG002|Overall Study|Protocol-defined clinical event|0|||
156489086|NCT00684203|564885499|FG003|Overall Study|Protocol-defined clinical event|0|||
156489087|NCT00684203|564885500|FG004|Overall Study|Protocol-defined clinical event|0|||
156489088|NCT00684203|564885501|FG005|Overall Study|Protocol-defined clinical event|0|||
156489089|NCT00684203|564885496|FG000|Overall Study|Withdrawal by Subject|0|||
156489090|NCT00684203|564885497|FG001|Overall Study|Withdrawal by Subject|2|||
156489091|NCT00684203|564885498|FG002|Overall Study|Withdrawal by Subject|1|||
156489092|NCT00684203|564885499|FG003|Overall Study|Withdrawal by Subject|0|||
156489093|NCT00684203|564885500|FG004|Overall Study|Withdrawal by Subject|0|||
156489094|NCT00684203|564885501|FG005|Overall Study|Withdrawal by Subject|0|||
156489095|NCT00684203|564885496|FG000|Overall Study|Did not meet protocol eligibility|0|||
156489096|NCT00684203|564885497|FG001|Overall Study|Did not meet protocol eligibility|1|||
156489097|NCT00684203|564885498|FG002|Overall Study|Did not meet protocol eligibility|0|||
156489098|NCT00684203|564885499|FG003|Overall Study|Did not meet protocol eligibility|0|||
156489099|NCT00684203|564885500|FG004|Overall Study|Did not meet protocol eligibility|0|||
156489100|NCT00684203|564885501|FG005|Overall Study|Did not meet protocol eligibility|0|||
156489101|NCT02762500|564885506|FG000|Overall Study|Lack of Efficacy|1|||
156489102|NCT02762500|564885507|FG001|Overall Study|Lack of Efficacy|0|||
156489103|NCT02762500|564885506|FG000|Overall Study|Withdrawal by Subject|1|||
156489104|NCT02762500|564885507|FG001|Overall Study|Withdrawal by Subject|1|||
156489105|NCT02762500|564885506|FG000|Overall Study|Adverse Event|0|||
156359282|NCT03341533|564414696|FG000|Overall Study|Withdrawal by Subject|1|||
156359283|NCT03341533|564414697|FG001|Overall Study|Withdrawal by Subject|1|||
156359284|NCT03341533|564414696|FG000|Overall Study|Not eligible after randomization|2|||
156359285|NCT03341533|564414697|FG001|Overall Study|Not eligible after randomization|1|||
156359286|NCT03886220|564414700|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
156359287|NCT03886220|564414701|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
156359288|NCT03886220|564414700|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
156359289|NCT03886220|564414701|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156359290|NCT03886220|564414700|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
156359291|NCT03886220|564414701|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
156359292|NCT03313804|564414702|FG000|Treatment|Death|5|||
156359293|NCT03313804|564414702|FG000|Treatment|still on treatment|2|||
156359294|NCT03313804|564414702|FG000|Follow Up|still on follow up|3|||
156359295|NCT01502423|564414703|FG000|Overall Study|Withdrawal by Subject|0|||
156359296|NCT01502423|564414704|FG001|Overall Study|Withdrawal by Subject|1|||
156359297|NCT00567892|564414705|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156359298|NCT00567892|564414706|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156359299|NCT00567892|564414707|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
156359300|NCT00567892|564414708|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
156359301|NCT00567892|564414705|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156359302|NCT00567892|564414706|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156359303|NCT00567892|564414707|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156359304|NCT00567892|564414708|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
156359305|NCT04814433|564414709|FG000|Overall Study|Survey not returned|4|||
156359306|NCT04814433|564414710|FG001|Overall Study|Survey not returned|8|||
156359307|NCT04814433|564414711|FG002|Overall Study|Survey not returned|4|||
156359308|NCT04814433|564414712|FG003|Overall Study|Survey not returned|5|||
156359309|NCT00066066|564416518|FG000|Overall Study|Lost to Follow-up|6|||
156359310|NCT00066066|564416519|FG001|Overall Study|Lost to Follow-up|4|||
156359311|NCT00066066|564416520|FG002|Overall Study|Lost to Follow-up|7|||
156359312|NCT00066066|564416521|FG003|Overall Study|Lost to Follow-up|4|||
156359313|NCT00066066|564416522|FG004|Overall Study|Lost to Follow-up|3|||
156359314|NCT00066066|564416523|FG005|Overall Study|Lost to Follow-up|5|||
156359315|NCT02515942|564416526|FG000|Overall Study|Adverse Event|5|||
156359316|NCT02515942|564416527|FG001|Overall Study|Adverse Event|0|||
156359317|NCT02515942|564416528|FG002|Overall Study|Adverse Event|0|||
156359318|NCT02515942|564416526|FG000|Overall Study|Death|0|||
156359319|NCT02515942|564416527|FG001|Overall Study|Death|0|||
156359320|NCT02515942|564416528|FG002|Overall Study|Death|1|||
156359321|NCT02515942|564416526|FG000|Overall Study|Lack of Efficacy|0|||
156359322|NCT02515942|564416527|FG001|Overall Study|Lack of Efficacy|0|||
156359323|NCT02515942|564416528|FG002|Overall Study|Lack of Efficacy|1|||
156359324|NCT02515942|564416526|FG000|Overall Study|Lost to Follow-up|2|||
156359325|NCT02515942|564416527|FG001|Overall Study|Lost to Follow-up|0|||
156359326|NCT02515942|564416528|FG002|Overall Study|Lost to Follow-up|0|||
156359327|NCT02515942|564416526|FG000|Overall Study|Withdrawal by Subject|0|||
156359328|NCT02515942|564416527|FG001|Overall Study|Withdrawal by Subject|3|||
156359329|NCT02515942|564416528|FG002|Overall Study|Withdrawal by Subject|2|||
156359330|NCT00697515|564416529|FG000|Dose Optimization Period|Adverse Event|4|||
156359331|NCT00697515|564416530|FG001|Dose Optimization Period|Adverse Event|0|||
156359332|NCT00697515|564416529|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
156359333|NCT00697515|564416530|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
156489106|NCT02762500|564885507|FG001|Overall Study|Adverse Event|2|||
156489107|NCT00730847|564885508|FG000|Overall Study|Adverse Event|1|||
156489108|NCT00730847|564885508|FG000|Overall Study|Protocol Violation|2|||
156489109|NCT00730847|564885508|FG000|Overall Study|Withdrawal by Subject|16|||
156489110|NCT00730847|564885508|FG000|Overall Study|Lost to Follow-up|67|||
156489111|NCT00730847|564885508|FG000|Overall Study|Unknown completion status|21|||
156489112|NCT00730847|564885508|FG000|Overall Study|Other|24|||
156489113|NCT00280683|564885509|FG000|Overall Study|Withdrawal by Subject|1|||
156489114|NCT00280683|564885510|FG001|Overall Study|Withdrawal by Subject|2|||
156489115|NCT00280683|564885509|FG000|Overall Study|Adverse Event|1|||
156489116|NCT00280683|564885510|FG001|Overall Study|Adverse Event|1|||
156489117|NCT01243411|564885511|FG000|Overall Study|Withdrawal by Subject|18|||
156489118|NCT01243411|564885511|FG000|Overall Study|Lost to Follow-up|10|||
156489119|NCT01243411|564885511|FG000|Overall Study|Adverse Event|5|||
156489120|NCT01243411|564885511|FG000|Overall Study|Other|8|||
156489121|NCT00488319|564885520|FG000|Overall Study|Adverse Event|1|||
156489122|NCT00488319|564885521|FG001|Overall Study|Adverse Event|2|||
156489123|NCT00488319|564885522|FG002|Overall Study|Adverse Event|23|||
156359334|NCT00697515|564416529|FG000|Dose Optimization Period|Lost to Follow-up|2|||
156359335|NCT00697515|564416530|FG001|Dose Optimization Period|Lost to Follow-up|0|||
156359336|NCT00697515|564416529|FG000|Dose Optimization Period|sponsor request|2|||
156359337|NCT00697515|564416530|FG001|Dose Optimization Period|sponsor request|0|||
156359338|NCT00697515|564416529|FG000|Dose Optimization Period|called to active duty|1|||
156489124|NCT00488319|564885520|FG000|Overall Study|Lack of Efficacy|6|||
156359339|NCT00697515|564416530|FG001|Dose Optimization Period|called to active duty|0|||
156489125|NCT00488319|564885521|FG001|Overall Study|Lack of Efficacy|12|||
156489126|NCT00488319|564885522|FG002|Overall Study|Lack of Efficacy|27|||
156489127|NCT00488319|564885520|FG000|Overall Study|Lost to Follow-up|3|||
156489128|NCT00488319|564885521|FG001|Overall Study|Lost to Follow-up|5|||
156489129|NCT00488319|564885522|FG002|Overall Study|Lost to Follow-up|16|||
156489130|NCT00488319|564885520|FG000|Overall Study|Withdrawal by Subject|5|||
156489131|NCT00488319|564885521|FG001|Overall Study|Withdrawal by Subject|20|||
156489132|NCT00488319|564885522|FG002|Overall Study|Withdrawal by Subject|44|||
156489133|NCT00488319|564885520|FG000|Overall Study|Other reasons for withdrawal|0|||
156489134|NCT00488319|564885521|FG001|Overall Study|Other reasons for withdrawal|4|||
156489135|NCT00488319|564885522|FG002|Overall Study|Other reasons for withdrawal|12|||
156489136|NCT00352053|564885523|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
156489137|NCT00352053|564885524|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
156489138|NCT00352053|564885523|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
156489139|NCT00352053|564885524|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
156489140|NCT00352053|564885523|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
156489141|NCT00352053|564885524|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
156489142|NCT00352053|564885523|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
156489143|NCT00352053|564885524|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
156489144|NCT00352053|564885523|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
156489145|NCT00352053|564885524|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
156489146|NCT00352053|564885523|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
156489147|NCT00352053|564885524|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
156359340|NCT00697515|564416529|FG000|Dose Optimization Period|elevated QTc|1|||
156359341|NCT00697515|564416530|FG001|Dose Optimization Period|elevated QTc|0|||
156359342|NCT00697515|564416529|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
156359343|NCT00697515|564416530|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
156359344|NCT00697515|564416529|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
156359345|NCT00697515|564416530|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
156359346|NCT00697515|564416529|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
156359347|NCT00697515|564416530|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
156359348|NCT00697515|564416529|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
156359349|NCT00697515|564416530|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
156359350|NCT02603432|564416531|FG000|Overall Study|Adverse Event|1|||
156359351|NCT02603432|564416532|FG001|Overall Study|Adverse Event|0|||
156359352|NCT02603432|564416531|FG000|Overall Study|Death|221|||
156359353|NCT02603432|564416532|FG001|Overall Study|Death|242|||
156359354|NCT02603432|564416531|FG000|Overall Study|Lost to Follow-up|3|||
156359355|NCT02603432|564416532|FG001|Overall Study|Lost to Follow-up|9|||
156489148|NCT00352053|564885523|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
156489149|NCT00352053|564885524|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
156489150|NCT00352053|564885523|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
156489151|NCT00352053|564885524|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
156489152|NCT00352053|564885523|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
156489153|NCT00352053|564885524|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
156489154|NCT00352053|564885523|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
156489155|NCT00352053|564885524|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
156489156|NCT00352053|564885523|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
156489157|NCT00352053|564885524|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
156489158|NCT00352053|564885523|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
156489159|NCT00352053|564885524|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
156489160|NCT00352053|564885523|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
156489161|NCT00352053|564885524|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
156489162|NCT02499835|564885530|FG000|Overall Study|Withdrawal by Subject|1|||
156489163|NCT02499835|564885531|FG001|Overall Study|Withdrawal by Subject|0|||
156489164|NCT02499835|564885532|FG002|Overall Study|Withdrawal by Subject|0|||
156489165|NCT02499835|564885533|FG003|Overall Study|Withdrawal by Subject|1|||
156489166|NCT02499835|564885530|FG000|Overall Study|Physician Decision|0|||
156489167|NCT02499835|564885531|FG001|Overall Study|Physician Decision|3|||
156359356|NCT02603432|564416531|FG000|Overall Study|Progressive Disease|7|||
156359357|NCT02603432|564416532|FG001|Overall Study|Progressive Disease|5|||
156359358|NCT02603432|564416531|FG000|Overall Study|Withdrawal by Subject|12|||
156545337|NCT00783094|565091562|FG000|Open-Label Extension Period|Protocol Violation|4|||
156359359|NCT02603432|564416532|FG001|Overall Study|Withdrawal by Subject|18|||
156489168|NCT02499835|564885532|FG002|Overall Study|Physician Decision|18|||
156489169|NCT02499835|564885533|FG003|Overall Study|Physician Decision|7|||
156489170|NCT02499835|564885530|FG000|Overall Study|Adverse Event|0|||
156489171|NCT02499835|564885531|FG001|Overall Study|Adverse Event|0|||
156489172|NCT02499835|564885532|FG002|Overall Study|Adverse Event|0|||
156489173|NCT02499835|564885533|FG003|Overall Study|Adverse Event|1|||
156489174|NCT02499835|564885530|FG000|Overall Study|Disease progression|2|||
156489175|NCT02499835|564885531|FG001|Overall Study|Disease progression|1|||
156489176|NCT02499835|564885532|FG002|Overall Study|Disease progression|0|||
156489177|NCT02499835|564885533|FG003|Overall Study|Disease progression|7|||
156489178|NCT03226353|564885542|FG000|Overall Study|Withdrawal by Subject|1|||
156489179|NCT03226353|564885542|FG000|Overall Study|Screen Failure|5|||
156489180|NCT03319719|564885543|FG000|Overall Study|Lost to Follow-up|1|||
156489181|NCT00843115|564885546|FG000|Overall Study|Death|4|||
156489182|NCT00843115|564885546|FG000|Overall Study|Adverse Event|30|||
156489183|NCT00843115|564885546|FG000|Overall Study|Lost to Follow-up|4|||
156489184|NCT00843115|564885546|FG000|Overall Study|Withdrawal by Subject|17|||
156489185|NCT00843115|564885546|FG000|Overall Study|Family wanted meds stopped|1|||
156489186|NCT00843115|564885546|FG000|Overall Study|Family does not want continuation|1|||
156489187|NCT00843115|564885546|FG000|Overall Study|Patient forgot to take meds|1|||
156489188|NCT00843115|564885546|FG000|Overall Study|Does not meet entrance criteria|1|||
156489189|NCT00843115|564885546|FG000|Overall Study|Physician Decision|1|||
156489190|NCT00843115|564885546|FG000|Overall Study|Family discontinued meds|1|||
156489191|NCT00843115|564885546|FG000|Overall Study|patient took for 2 days then stopped|1|||
156489192|NCT00843115|564885546|FG000|Overall Study|patient never took the medication|1|||
156489193|NCT00843115|564885546|FG000|Overall Study|hospitalized due to deterioration|1|||
156489194|NCT00843115|564885546|FG000|Overall Study|week 12 not done|1|||
156489195|NCT00843115|564885546|FG000|Overall Study|Syndrome De Glissement|1|||
156489196|NCT02959177|564885553|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
156489197|NCT02959177|564885554|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
156489198|NCT02959177|564885555|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
156489199|NCT02959177|564885553|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
156489200|NCT02959177|564885554|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
156489201|NCT02959177|564885555|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
156489202|NCT02959177|564885553|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
156489203|NCT02959177|564885554|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
156489204|NCT02959177|564885555|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
156489205|NCT02959177|564885553|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
156489206|NCT02959177|564885554|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156489207|NCT02959177|564885555|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
156489208|NCT02959177|564885553|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
156489209|NCT02959177|564885554|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
156489210|NCT02959177|564885555|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
156489211|NCT02959177|564885553|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
156489212|NCT02959177|564885554|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
156489213|NCT02959177|564885555|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
156489214|NCT02959177|564885553|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
156489215|NCT02959177|564885554|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
156489216|NCT02959177|564885555|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
156489217|NCT00591409|564885559|FG000|Overall Study|Not Treated|0|||
156489218|NCT00591409|564885560|FG001|Overall Study|Not Treated|0|||
156489219|NCT00591409|564885561|FG002|Overall Study|Not Treated|0|||
156489220|NCT00591409|564885562|FG003|Overall Study|Not Treated|0|||
156489221|NCT00591409|564885563|FG004|Overall Study|Not Treated|1|||
156489222|NCT00591409|564885564|FG005|Overall Study|Not Treated|0|||
156489223|NCT00591409|564885565|FG006|Overall Study|Not Treated|0|||
156489224|NCT00591409|564885566|FG007|Overall Study|Not Treated|0|||
156489225|NCT00591409|564885567|FG008|Overall Study|Not Treated|0|||
156489226|NCT00591409|564885568|FG009|Overall Study|Not Treated|1|||
156489227|NCT02853305|564885569|FG000|Overall Study|Death|287|||
156489228|NCT02853305|564885570|FG001|Overall Study|Death|249|||
156489229|NCT02853305|564885571|FG002|Overall Study|Death|300|||
156489230|NCT02853305|564885569|FG000|Overall Study|Withdrawal by Subject|2|||
156489231|NCT02853305|564885570|FG001|Overall Study|Withdrawal by Subject|8|||
156489232|NCT02853305|564885571|FG002|Overall Study|Withdrawal by Subject|3|||
156489233|NCT02853305|564885569|FG000|Overall Study|Transferred to Extension Study|46|||
156489234|NCT02853305|564885570|FG001|Overall Study|Transferred to Extension Study|30|||
156489235|NCT02853305|564885571|FG002|Overall Study|Transferred to Extension Study|25|||
156489236|NCT02853305|564885569|FG000|Overall Study|Did Not Continue on Extension Study|16|||
156489237|NCT02853305|564885570|FG001|Overall Study|Did Not Continue on Extension Study|20|||
156489238|NCT02853305|564885571|FG002|Overall Study|Did Not Continue on Extension Study|24|||
156489239|NCT02460562|564885575|FG000|Overall Study|Lost to Follow-up|15|||
156489240|NCT02460562|564885576|FG001|Overall Study|Lost to Follow-up|16|||
156489241|NCT04194541|564885577|FG000|Day 1 Through 13|Lost to Follow-up|3|||
156489242|NCT04194541|564885577|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
156489243|NCT04194541|564885577|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
156489244|NCT00187135|564885580|FG000|Visit One|Withdrawal by Subject|1|||
156489245|NCT00187135|564885581|FG001|Visit One|Withdrawal by Subject|0|||
156359360|NCT02603432|564416531|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
156359361|NCT02603432|564416532|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156359362|NCT02603432|564416531|FG000|Overall Study|Study terminated by sponsor|74|||
156359363|NCT02603432|564416532|FG001|Overall Study|Study terminated by sponsor|75|||
156359364|NCT02603432|564416531|FG000|Overall Study|Other|13|||
156359365|NCT02603432|564416532|FG001|Overall Study|Other|0|||
156359366|NCT00666757|564416533|FG000|Overall Study|Lost to Follow-up|39|||
156359367|NCT00666757|564416534|FG001|Overall Study|Lost to Follow-up|35|||
156359368|NCT00666757|564416533|FG000|Overall Study|Protocol Violation|23|||
156359369|NCT00666757|564416534|FG001|Overall Study|Protocol Violation|24|||
156359370|NCT00666757|564416533|FG000|Overall Study|Adverse Event|22|||
156359371|NCT00666757|564416534|FG001|Overall Study|Adverse Event|12|||
156359372|NCT00666757|564416533|FG000|Overall Study|Withdrawal by Subject|13|||
156359373|NCT00666757|564416534|FG001|Overall Study|Withdrawal by Subject|17|||
156359374|NCT00666757|564416533|FG000|Overall Study|Lack of Efficacy|3|||
156359375|NCT00666757|564416534|FG001|Overall Study|Lack of Efficacy|6|||
156359376|NCT00666757|564416533|FG000|Overall Study|Physician Decision|0|||
156359377|NCT00666757|564416534|FG001|Overall Study|Physician Decision|2|||
156359378|NCT00666757|564416533|FG000|Overall Study|Sponsor decision|0|||
156359379|NCT00666757|564416534|FG001|Overall Study|Sponsor decision|1|||
156359380|NCT05954052|564416535|FG000|Overall Study|Adverse Event|1|||
156359381|NCT01957462|564416536|FG000|Test Period 1|Withdrawal by Subject|1|||
156359382|NCT01957462|564416537|FG001|Test Period 1|Withdrawal by Subject|0|||
156359383|NCT01957462|564416536|FG000|Test Period 1|Adverse Event|1|||
156359384|NCT01957462|564416537|FG001|Test Period 1|Adverse Event|0|||
156359385|NCT01723163|564416540|FG000|Treatment Phase|Withdrawal by Subject|14|||
156359386|NCT01723163|564416541|FG001|Treatment Phase|Withdrawal by Subject|6|||
156359387|NCT01723163|564416540|FG000|Treatment Phase|Withdrawal by PI|5|||
156359388|NCT01723163|564416541|FG001|Treatment Phase|Withdrawal by PI|1|||
156359389|NCT01723163|564416540|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
156359390|NCT01723163|564416541|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
156359391|NCT01723163|564416540|FG000|3-Month Follow-up|Unable to Contact|12|||
156359392|NCT01723163|564416541|FG001|3-Month Follow-up|Unable to Contact|19|||
156359393|NCT01723163|564416540|FG000|6-Month Follow-up|Death|1|||
156359394|NCT01723163|564416541|FG001|6-Month Follow-up|Death|0|||
156359395|NCT01723163|564416540|FG000|6-Month Follow-up|Unable to Contact|17|||
156359396|NCT01723163|564416541|FG001|6-Month Follow-up|Unable to Contact|15|||
156359397|NCT01723163|564416540|FG000|12-Month Follow-up|Death|1|||
156359398|NCT01723163|564416541|FG001|12-Month Follow-up|Death|0|||
156359399|NCT01723163|564416540|FG000|12-Month Follow-up|Unable to Contact|23|||
156359400|NCT01723163|564416541|FG001|12-Month Follow-up|Unable to Contact|28|||
156359401|NCT02510794|564416542|FG000|Overall Study|Adverse Event|0|||
156359402|NCT02510794|564416543|FG001|Overall Study|Adverse Event|1|||
156359403|NCT02510794|564416544|FG002|Overall Study|Adverse Event|0|||
156359404|NCT02510794|564416545|FG003|Overall Study|Adverse Event|0|||
156359405|NCT02510794|564416542|FG000|Overall Study|Death|1|||
156359406|NCT02510794|564416543|FG001|Overall Study|Death|2|||
156359407|NCT02510794|564416544|FG002|Overall Study|Death|1|||
156359408|NCT02510794|564416545|FG003|Overall Study|Death|1|||
156359409|NCT02510794|564416542|FG000|Overall Study|Lack of Efficacy|3|||
156359410|NCT02510794|564416543|FG001|Overall Study|Lack of Efficacy|1|||
156359411|NCT02510794|564416544|FG002|Overall Study|Lack of Efficacy|1|||
156359412|NCT02510794|564416545|FG003|Overall Study|Lack of Efficacy|0|||
156359413|NCT02510794|564416542|FG000|Overall Study|Participant moved out of the area|0|||
156489246|NCT00187135|564885582|FG002|Visit One|Withdrawal by Subject|0|||
156489247|NCT00187135|564885583|FG003|Visit One|Withdrawal by Subject|0|||
156489248|NCT00187135|564885584|FG004|Visit One|Withdrawal by Subject|0|||
156489249|NCT00187135|564885585|FG005|Visit One|Withdrawal by Subject|1|||
156489250|NCT00187135|564885580|FG000|Visit One|Physician Decision|3|||
156489251|NCT00187135|564885581|FG001|Visit One|Physician Decision|1|||
156489252|NCT00187135|564885582|FG002|Visit One|Physician Decision|0|||
156359414|NCT02510794|564416543|FG001|Overall Study|Participant moved out of the area|0|||
156489253|NCT00187135|564885583|FG003|Visit One|Physician Decision|0|||
156489254|NCT00187135|564885584|FG004|Visit One|Physician Decision|0|||
156489255|NCT00187135|564885585|FG005|Visit One|Physician Decision|1|||
156489256|NCT00187135|564885580|FG000|Visit Two|Death|0|||
156489257|NCT00187135|564885581|FG001|Visit Two|Death|0|||
156489258|NCT00187135|564885582|FG002|Visit Two|Death|0|||
156359415|NCT02510794|564416544|FG002|Overall Study|Participant moved out of the area|0|||
156359416|NCT02510794|564416545|FG003|Overall Study|Participant moved out of the area|1|||
156359417|NCT02510794|564416542|FG000|Overall Study|Physician Decision|3|||
156359418|NCT02510794|564416543|FG001|Overall Study|Physician Decision|0|||
156359419|NCT02510794|564416544|FG002|Overall Study|Physician Decision|0|||
156359420|NCT02510794|564416545|FG003|Overall Study|Physician Decision|0|||
156359421|NCT02510794|564416542|FG000|Overall Study|Protocol Violation|0|||
156359422|NCT02510794|564416543|FG001|Overall Study|Protocol Violation|0|||
156359423|NCT02510794|564416544|FG002|Overall Study|Protocol Violation|1|||
156359424|NCT02510794|564416545|FG003|Overall Study|Protocol Violation|0|||
156359425|NCT02510794|564416542|FG000|Overall Study|Withdrawal by Subject|1|||
156359426|NCT02510794|564416543|FG001|Overall Study|Withdrawal by Subject|2|||
156359427|NCT02510794|564416544|FG002|Overall Study|Withdrawal by Subject|4|||
156359428|NCT02510794|564416545|FG003|Overall Study|Withdrawal by Subject|3|||
156359429|NCT01649375|564416546|FG000|Up to Week 16|Adverse Event|2|||
156359430|NCT01649375|564416547|FG001|Up to Week 16|Adverse Event|5|||
156359431|NCT01649375|564416548|FG002|Up to Week 16|Adverse Event|4|||
156359432|NCT01649375|564416549|FG003|Up to Week 16|Adverse Event|0|||
156359433|NCT01649375|564416550|FG004|Up to Week 16|Adverse Event|0|||
156359434|NCT01649375|564416546|FG000|Up to Week 16|Lack of Efficacy|0|||
156359435|NCT01649375|564416547|FG001|Up to Week 16|Lack of Efficacy|0|||
156359436|NCT01649375|564416548|FG002|Up to Week 16|Lack of Efficacy|1|||
156359437|NCT01649375|564416549|FG003|Up to Week 16|Lack of Efficacy|0|||
156359438|NCT01649375|564416550|FG004|Up to Week 16|Lack of Efficacy|0|||
156359439|NCT01649375|564416546|FG000|Up to Week 16|Physician Decision|0|||
156359440|NCT01649375|564416547|FG001|Up to Week 16|Physician Decision|0|||
156359441|NCT01649375|564416548|FG002|Up to Week 16|Physician Decision|1|||
156359442|NCT01649375|564416549|FG003|Up to Week 16|Physician Decision|0|||
156359443|NCT01649375|564416550|FG004|Up to Week 16|Physician Decision|0|||
156359444|NCT01649375|564416546|FG000|Up to Week 16|Withdrawal by Subject|2|||
156359445|NCT01649375|564416547|FG001|Up to Week 16|Withdrawal by Subject|1|||
156359446|NCT01649375|564416548|FG002|Up to Week 16|Withdrawal by Subject|2|||
156359447|NCT01649375|564416549|FG003|Up to Week 16|Withdrawal by Subject|0|||
156359448|NCT01649375|564416550|FG004|Up to Week 16|Withdrawal by Subject|0|||
156359449|NCT01649375|564416546|FG000|Up to Week 16|Death|1|||
156359450|NCT01649375|564416547|FG001|Up to Week 16|Death|0|||
156359451|NCT01649375|564416548|FG002|Up to Week 16|Death|0|||
156359452|NCT01649375|564416549|FG003|Up to Week 16|Death|0|||
156359453|NCT01649375|564416550|FG004|Up to Week 16|Death|0|||
156359454|NCT01649375|564416546|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
156359455|NCT01649375|564416547|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
156359456|NCT01649375|564416548|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
156359457|NCT01649375|564416549|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
156359458|NCT01649375|564416550|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
156359459|NCT01649375|564416546|FG000|Week 16 up to Week 260|Non-compliance|0|||
156359460|NCT01649375|564416547|FG001|Week 16 up to Week 260|Non-compliance|1|||
156359461|NCT01649375|564416548|FG002|Week 16 up to Week 260|Non-compliance|0|||
156359462|NCT01649375|564416549|FG003|Week 16 up to Week 260|Non-compliance|1|||
156359463|NCT01649375|564416550|FG004|Week 16 up to Week 260|Non-compliance|0|||
156359464|NCT01649375|564416546|FG000|Week 16 up to Week 260|Physician Decision|0|||
156359465|NCT01649375|564416547|FG001|Week 16 up to Week 260|Physician Decision|2|||
156359466|NCT01649375|564416548|FG002|Week 16 up to Week 260|Physician Decision|0|||
156359467|NCT01649375|564416549|FG003|Week 16 up to Week 260|Physician Decision|0|||
156359468|NCT01649375|564416550|FG004|Week 16 up to Week 260|Physician Decision|0|||
156359469|NCT01649375|564416546|FG000|Week 16 up to Week 260|Technical issues|0|||
156359470|NCT01649375|564416547|FG001|Week 16 up to Week 260|Technical issues|1|||
156359471|NCT01649375|564416548|FG002|Week 16 up to Week 260|Technical issues|0|||
156359472|NCT01649375|564416549|FG003|Week 16 up to Week 260|Technical issues|1|||
156359473|NCT01649375|564416550|FG004|Week 16 up to Week 260|Technical issues|0|||
156359474|NCT01649375|564416546|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
156359475|NCT01649375|564416547|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
156359476|NCT01649375|564416548|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
156359477|NCT01649375|564416549|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
156359478|NCT01649375|564416550|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
156359479|NCT01649375|564416546|FG000|Week 16 up to Week 260|Death|1|||
156359480|NCT01649375|564416547|FG001|Week 16 up to Week 260|Death|1|||
156359481|NCT01649375|564416548|FG002|Week 16 up to Week 260|Death|0|||
156359482|NCT01649375|564416549|FG003|Week 16 up to Week 260|Death|0|||
156359483|NCT01649375|564416550|FG004|Week 16 up to Week 260|Death|0|||
156359484|NCT01649375|564416546|FG000|Week 16 up to Week 260|Adverse Event|5|||
156359485|NCT01649375|564416547|FG001|Week 16 up to Week 260|Adverse Event|2|||
156359486|NCT01649375|564416548|FG002|Week 16 up to Week 260|Adverse Event|0|||
156359487|NCT01649375|564416549|FG003|Week 16 up to Week 260|Adverse Event|3|||
156359488|NCT01649375|564416550|FG004|Week 16 up to Week 260|Adverse Event|2|||
156489259|NCT00187135|564885583|FG003|Visit Two|Death|1|||
156359489|NCT01856790|564416553|FG000|Closed Loop Control|Withdrawal by Subject|2|||
156359490|NCT01856790|564416553|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
156359491|NCT01921829|564416554|FG000|Overall Study|Withdrawal by Subject|0|||
156359492|NCT01921829|564416555|FG001|Overall Study|Withdrawal by Subject|1|||
156359493|NCT04091646|564416556|FG000|Overall Study|Adverse Event|2|||
156359494|NCT04091646|564416557|FG001|Overall Study|Adverse Event|1|||
156359495|NCT04091646|564416556|FG000|Overall Study|Lost to Follow-up|6|||
156359496|NCT04091646|564416557|FG001|Overall Study|Lost to Follow-up|2|||
156359497|NCT04091646|564416556|FG000|Overall Study|Protocol Violation|0|||
156359498|NCT04091646|564416557|FG001|Overall Study|Protocol Violation|1|||
156359499|NCT04091646|564416556|FG000|Overall Study|Withdrawal by Subject|4|||
156359500|NCT04091646|564416557|FG001|Overall Study|Withdrawal by Subject|1|||
156359501|NCT04091646|564416556|FG000|Overall Study|Participant Incarcerated|1|||
156359502|NCT04091646|564416557|FG001|Overall Study|Participant Incarcerated|0|||
156489260|NCT00187135|564885584|FG004|Visit Two|Death|0|||
156359503|NCT03102918|564416558|FG000|Overall Study|Protocol Violation|1|||
156359504|NCT03102918|564416559|FG001|Overall Study|Protocol Violation|0|||
156359505|NCT04765358|564416564|FG000|Overall Study|Withdrawal by Subject|1|||
156359506|NCT01852812|564416567|FG000|Overall Study|Adverse Event|0|||
156359507|NCT01852812|564416568|FG001|Overall Study|Adverse Event|0|||
156359508|NCT01852812|564416569|FG002|Overall Study|Adverse Event|1|||
156359509|NCT01852812|564416567|FG000|Overall Study|Non-compliance With Study Drug|0|||
156359510|NCT01852812|564416568|FG001|Overall Study|Non-compliance With Study Drug|1|||
156359511|NCT01852812|564416569|FG002|Overall Study|Non-compliance With Study Drug|0|||
156359512|NCT02488681|564416576|FG000|Overall Study|Implant unsuccessful|7|||
156359513|NCT00720057|564416577|FG000|Overall Study|Lost to Follow-up|0|||
156359514|NCT00720057|564416578|FG001|Overall Study|Lost to Follow-up|2|||
156359515|NCT00720057|564416577|FG000|Overall Study|Protocol Violation|1|||
156359516|NCT00720057|564416578|FG001|Overall Study|Protocol Violation|0|||
156359517|NCT00720057|564416577|FG000|Overall Study|Withdrawal by Subject|0|||
156359518|NCT00720057|564416578|FG001|Overall Study|Withdrawal by Subject|1|||
156359519|NCT04969224|564416579|FG000|Overall Study|Adverse Event|1|||
156359520|NCT04969224|564416579|FG000|Overall Study|Enrolled but never dosed|1|||
156359521|NCT01498952|564416580|FG000|Overall Study|Death|2|||
156359522|NCT01498952|564416581|FG001|Overall Study|Death|2|||
156359523|NCT01498952|564416582|FG002|Overall Study|Death|0|||
156359524|NCT01498952|564416583|FG003|Overall Study|Death|0|||
156359525|NCT01498952|564416584|FG004|Overall Study|Death|0|||
156359526|NCT05533632|564416585|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
156359527|NCT05533632|564416585|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
156359528|NCT05533632|564416585|FG000|Overall Study|Lost to Follow-up|1|||
156359529|NCT05533632|564416585|FG000|Overall Study|Withdrawal by Subject|4|||
156359530|NCT05533632|564416585|FG000|Overall Study|Adverse Event|4|||
156359531|NCT02726074|564416586|FG000|Overall Study|Withdrawal by Subject|4|||
156359532|NCT02726074|564416586|FG000|Overall Study|Adverse Event|14|||
156359533|NCT02726074|564416586|FG000|Overall Study|Protocol Violation|3|||
156359534|NCT02726074|564416586|FG000|Overall Study|Lost to Follow-up|2|||
156359535|NCT02726074|564416586|FG000|Overall Study|Others|3|||
156359536|NCT00579826|564416587|FG000|Overall Study|Withdrawal by Subject|5|||
156359537|NCT00579826|564416588|FG001|Overall Study|Withdrawal by Subject|3|||
156359538|NCT03054870|564416592|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
156359539|NCT03054870|564416592|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
156359540|NCT02009046|564416593|FG000|Overall Study|Lost to Follow-up|256|||
156359541|NCT02009046|564416594|FG001|Overall Study|Lost to Follow-up|206|||
156359542|NCT01154218|564416596|FG000|Third Intervention Period|Adverse Event|0|||
156359543|NCT01154218|564416597|FG001|Third Intervention Period|Adverse Event|1|||
156359544|NCT01154218|564416598|FG002|Third Intervention Period|Adverse Event|0|||
156359545|NCT01154218|564416599|FG003|Third Intervention Period|Adverse Event|0|||
156359546|NCT01154218|564416596|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156359547|NCT01154218|564416597|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156359548|NCT01154218|564416598|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156359549|NCT01154218|564416599|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
156359550|NCT01154218|564416596|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
156359551|NCT01154218|564416597|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
156359552|NCT01154218|564416598|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
156359553|NCT01154218|564416599|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
156359554|NCT01265849|564416600|FG000|Overall Study|Randomized//Treatment not initiated|1|||
156359555|NCT01265849|564416601|FG001|Overall Study|Randomized//Treatment not initiated|4|||
156359556|NCT01265849|564416602|FG002|Overall Study|Randomized//Treatment not initiated|0|||
156359557|NCT01265849|564416600|FG000|Overall Study|Physician Decision|1|||
156359558|NCT01265849|564416601|FG001|Overall Study|Physician Decision|2|||
156359559|NCT01265849|564416602|FG002|Overall Study|Physician Decision|0|||
156359560|NCT01265849|564416600|FG000|Overall Study|Lost to Follow-up|18|||
156359561|NCT01265849|564416601|FG001|Overall Study|Lost to Follow-up|15|||
156359562|NCT01265849|564416602|FG002|Overall Study|Lost to Follow-up|5|||
156489261|NCT00187135|564885585|FG005|Visit Two|Death|1|||
156489262|NCT00187135|564885580|FG000|Visit Two|Physician Decision|1|||
156489263|NCT00187135|564885581|FG001|Visit Two|Physician Decision|0|||
156359563|NCT01265849|564416600|FG000|Overall Study|Not otherwise specified|1|||
156359564|NCT01265849|564416601|FG001|Overall Study|Not otherwise specified|6|||
156359565|NCT01265849|564416602|FG002|Overall Study|Not otherwise specified|1|||
156359566|NCT01265849|564416600|FG000|Overall Study|Withdrawal by Subject|25|||
156359567|NCT01265849|564416601|FG001|Overall Study|Withdrawal by Subject|34|||
156359568|NCT01265849|564416602|FG002|Overall Study|Withdrawal by Subject|13|||
156359569|NCT00362115|564416603|FG000|Overall Study|Adverse Event|0|||
156359570|NCT00362115|564416604|FG001|Overall Study|Adverse Event|1|||
156359571|NCT00362115|564416605|FG002|Overall Study|Adverse Event|1|||
156359572|NCT00362115|564416606|FG003|Overall Study|Adverse Event|1|||
156359573|NCT00362115|564416607|FG004|Overall Study|Adverse Event|2|||
156359574|NCT00362115|564416608|FG005|Overall Study|Adverse Event|2|||
156359575|NCT00362115|564416609|FG006|Overall Study|Adverse Event|1|||
156545338|NCT00783094|565091563|FG001|Open-Label Extension Period|Protocol Violation|5|||
156545339|NCT00783094|565091564|FG002|Open-Label Extension Period|Protocol Violation|7|||
156545340|NCT00783094|565091562|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
156545341|NCT00783094|565091563|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
156545342|NCT00783094|565091564|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
156545343|NCT00783094|565091562|FG000|Open-Label Extension Period|Physician Decision|4|||
156545344|NCT00783094|565091563|FG001|Open-Label Extension Period|Physician Decision|2|||
156545345|NCT00783094|565091564|FG002|Open-Label Extension Period|Physician Decision|3|||
156545346|NCT00783094|565091562|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
156545347|NCT00783094|565091563|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
156545348|NCT00783094|565091564|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
156545349|NCT02513329|565091565|FG000|Overall Study|Lost to Follow-up|5|||
156545350|NCT02513329|565091566|FG001|Overall Study|Lost to Follow-up|2|||
156545351|NCT05440539|565091568|FG000|Overall Study|Lost to Follow-up|4|||
156545352|NCT05440539|565091569|FG001|Overall Study|Lost to Follow-up|4|||
156545353|NCT05440539|565091568|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
156545354|NCT05440539|565091569|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
156545355|NCT03808077|565091570|FG000|Overall Study|Physician Decision|2|||
156545356|NCT03808077|565091571|FG001|Overall Study|Physician Decision|3|||
156545357|NCT03808077|565091570|FG000|Overall Study|Withdrawal by Subject|1|||
156545358|NCT03808077|565091571|FG001|Overall Study|Withdrawal by Subject|0|||
156545359|NCT03808077|565091570|FG000|Overall Study|Equipment Issues|2|||
156545360|NCT03808077|565091571|FG001|Overall Study|Equipment Issues|1|||
156545361|NCT02004262|565091576|FG000|Overall Study|Death|67|||
156545362|NCT02004262|565091577|FG001|Overall Study|Death|64|||
156545363|NCT02004262|565091578|FG002|Overall Study|Death|66|||
156545364|NCT02004262|565091579|FG003|Overall Study|Death|28|||
156545365|NCT02004262|565091580|FG004|Overall Study|Death|29|||
156545366|NCT02004262|565091581|FG005|Overall Study|Death|22|||
156545367|NCT02004262|565091576|FG000|Overall Study|Withdrawal by Subject|1|||
156545368|NCT02004262|565091577|FG001|Overall Study|Withdrawal by Subject|0|||
156545369|NCT02004262|565091578|FG002|Overall Study|Withdrawal by Subject|4|||
156545370|NCT02004262|565091579|FG003|Overall Study|Withdrawal by Subject|0|||
156545371|NCT02004262|565091580|FG004|Overall Study|Withdrawal by Subject|1|||
156545372|NCT02004262|565091581|FG005|Overall Study|Withdrawal by Subject|3|||
156545373|NCT02004262|565091576|FG000|Overall Study|Lost to Follow-up|1|||
156545374|NCT02004262|565091577|FG001|Overall Study|Lost to Follow-up|1|||
156545375|NCT02004262|565091578|FG002|Overall Study|Lost to Follow-up|0|||
156545376|NCT02004262|565091579|FG003|Overall Study|Lost to Follow-up|0|||
156545377|NCT02004262|565091580|FG004|Overall Study|Lost to Follow-up|0|||
156545378|NCT02004262|565091581|FG005|Overall Study|Lost to Follow-up|0|||
156545379|NCT02004262|565091576|FG000|Overall Study|Study Terminated by Sponsor|4|||
156545380|NCT02004262|565091577|FG001|Overall Study|Study Terminated by Sponsor|3|||
156545381|NCT02004262|565091578|FG002|Overall Study|Study Terminated by Sponsor|2|||
156545382|NCT02004262|565091579|FG003|Overall Study|Study Terminated by Sponsor|1|||
156545383|NCT02004262|565091580|FG004|Overall Study|Study Terminated by Sponsor|1|||
156545384|NCT02004262|565091581|FG005|Overall Study|Study Terminated by Sponsor|5|||
156545385|NCT03703102|565091582|FG000|Overall Study|Adverse Event|4|||
156545386|NCT03703102|565091583|FG001|Overall Study|Adverse Event|3|||
156359576|NCT00362115|564416603|FG000|Overall Study|Protocol Violation|0|||
156359577|NCT00362115|564416604|FG001|Overall Study|Protocol Violation|0|||
156359578|NCT00362115|564416605|FG002|Overall Study|Protocol Violation|0|||
156359579|NCT00362115|564416606|FG003|Overall Study|Protocol Violation|0|||
156359580|NCT00362115|564416607|FG004|Overall Study|Protocol Violation|0|||
156359581|NCT00362115|564416608|FG005|Overall Study|Protocol Violation|1|||
156359582|NCT00362115|564416609|FG006|Overall Study|Protocol Violation|0|||
156359583|NCT00362115|564416603|FG000|Overall Study|Lost to Follow-up|0|||
156359584|NCT00362115|564416604|FG001|Overall Study|Lost to Follow-up|1|||
156359585|NCT00362115|564416605|FG002|Overall Study|Lost to Follow-up|0|||
156359586|NCT00362115|564416606|FG003|Overall Study|Lost to Follow-up|0|||
156359587|NCT00362115|564416607|FG004|Overall Study|Lost to Follow-up|2|||
156545387|NCT03703102|565091584|FG002|Overall Study|Adverse Event|7|||
156545388|NCT03703102|565091585|FG003|Overall Study|Adverse Event|3|||
156545389|NCT03703102|565091586|FG004|Overall Study|Adverse Event|13|||
156545390|NCT03703102|565091582|FG000|Overall Study|Lack of Efficacy|4|||
156545391|NCT03703102|565091583|FG001|Overall Study|Lack of Efficacy|0|||
156545392|NCT03703102|565091584|FG002|Overall Study|Lack of Efficacy|1|||
156359588|NCT00362115|564416608|FG005|Overall Study|Lost to Follow-up|0|||
156359589|NCT00362115|564416609|FG006|Overall Study|Lost to Follow-up|1|||
156359590|NCT00362115|564416603|FG000|Overall Study|Withdrawal by Subject|1|||
156545393|NCT03703102|565091585|FG003|Overall Study|Lack of Efficacy|4|||
156545394|NCT03703102|565091586|FG004|Overall Study|Lack of Efficacy|1|||
156545395|NCT03703102|565091582|FG000|Overall Study|Lost to Follow-up|0|||
156545396|NCT03703102|565091583|FG001|Overall Study|Lost to Follow-up|0|||
156545397|NCT03703102|565091584|FG002|Overall Study|Lost to Follow-up|1|||
156545398|NCT03703102|565091585|FG003|Overall Study|Lost to Follow-up|2|||
156545399|NCT03703102|565091586|FG004|Overall Study|Lost to Follow-up|2|||
156545400|NCT03703102|565091582|FG000|Overall Study|Physician Decision|2|||
156359591|NCT00362115|564416604|FG001|Overall Study|Withdrawal by Subject|3|||
156359592|NCT00362115|564416605|FG002|Overall Study|Withdrawal by Subject|1|||
156359593|NCT00362115|564416606|FG003|Overall Study|Withdrawal by Subject|0|||
156359594|NCT00362115|564416607|FG004|Overall Study|Withdrawal by Subject|1|||
156359595|NCT00362115|564416608|FG005|Overall Study|Withdrawal by Subject|3|||
156359596|NCT00362115|564416609|FG006|Overall Study|Withdrawal by Subject|4|||
156359597|NCT00362115|564416603|FG000|Overall Study|Lack of Efficacy|1|||
156359598|NCT00362115|564416604|FG001|Overall Study|Lack of Efficacy|0|||
156359599|NCT00362115|564416605|FG002|Overall Study|Lack of Efficacy|5|||
156359600|NCT00362115|564416606|FG003|Overall Study|Lack of Efficacy|2|||
156359601|NCT00362115|564416607|FG004|Overall Study|Lack of Efficacy|2|||
156359602|NCT00362115|564416608|FG005|Overall Study|Lack of Efficacy|0|||
156359603|NCT00362115|564416609|FG006|Overall Study|Lack of Efficacy|3|||
156359604|NCT00362115|564416603|FG000|Overall Study|Physician Decision|0|||
156359605|NCT00362115|564416604|FG001|Overall Study|Physician Decision|0|||
156359606|NCT00362115|564416605|FG002|Overall Study|Physician Decision|0|||
156359607|NCT00362115|564416606|FG003|Overall Study|Physician Decision|0|||
156359608|NCT00362115|564416607|FG004|Overall Study|Physician Decision|0|||
156359609|NCT00362115|564416608|FG005|Overall Study|Physician Decision|0|||
156359610|NCT00362115|564416609|FG006|Overall Study|Physician Decision|3|||
156359611|NCT00362115|564416603|FG000|Overall Study|Other|0|||
156489264|NCT00187135|564885582|FG002|Visit Two|Physician Decision|0|||
156489265|NCT00187135|564885583|FG003|Visit Two|Physician Decision|0|||
156489266|NCT00187135|564885584|FG004|Visit Two|Physician Decision|0|||
156489267|NCT00187135|564885585|FG005|Visit Two|Physician Decision|0|||
156489268|NCT00187135|564885580|FG000|Visit Two|Withdrawal by Subject|1|||
156489269|NCT00187135|564885581|FG001|Visit Two|Withdrawal by Subject|1|||
156489270|NCT00187135|564885582|FG002|Visit Two|Withdrawal by Subject|1|||
156489271|NCT00187135|564885583|FG003|Visit Two|Withdrawal by Subject|0|||
156489272|NCT00187135|564885584|FG004|Visit Two|Withdrawal by Subject|1|||
156489273|NCT00187135|564885585|FG005|Visit Two|Withdrawal by Subject|1|||
156489274|NCT00187135|564885580|FG000|Visit Two|Study Discontinued|3|||
156489275|NCT00187135|564885581|FG001|Visit Two|Study Discontinued|2|||
156489276|NCT00187135|564885582|FG002|Visit Two|Study Discontinued|1|||
156489277|NCT00187135|564885583|FG003|Visit Two|Study Discontinued|7|||
156489278|NCT00187135|564885584|FG004|Visit Two|Study Discontinued|5|||
156489279|NCT00187135|564885585|FG005|Visit Two|Study Discontinued|6|||
156489280|NCT00187135|564885580|FG000|Visit Three|Death|0|||
156489281|NCT00187135|564885581|FG001|Visit Three|Death|0|||
156359612|NCT00362115|564416604|FG001|Overall Study|Other|1|||
156359613|NCT00362115|564416605|FG002|Overall Study|Other|0|||
156359614|NCT00362115|564416606|FG003|Overall Study|Other|1|||
156359615|NCT00362115|564416607|FG004|Overall Study|Other|0|||
156359616|NCT00362115|564416608|FG005|Overall Study|Other|1|||
156359617|NCT00362115|564416609|FG006|Overall Study|Other|0|||
156489282|NCT00187135|564885582|FG002|Visit Three|Death|1|||
156489283|NCT00187135|564885583|FG003|Visit Three|Death|0|||
156489284|NCT00187135|564885584|FG004|Visit Three|Death|1|||
156359618|NCT01170091|564416610|FG000|Overall Study|Missing efficacy evaluation|3|||
156359619|NCT01170091|564416610|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
156359620|NCT02188589|564416611|FG000|Overall Study|Withdrawal by Subject|5|||
156359621|NCT00003641|564416619|FG000|Overall Study|Withdrawal by Subject|0|||
156359622|NCT00003641|564416620|FG001|Overall Study|Withdrawal by Subject|100|||
156359623|NCT00003641|564416619|FG000|Overall Study|Adverse Event|0|||
156359624|NCT00003641|564416620|FG001|Overall Study|Adverse Event|38|||
156359625|NCT00003641|564416619|FG000|Overall Study|Disease progression|0|||
156359626|NCT00003641|564416620|FG001|Overall Study|Disease progression|2|||
156359627|NCT00003641|564416619|FG000|Overall Study|Unknown/missing|0|||
156359628|NCT00003641|564416620|FG001|Overall Study|Unknown/missing|22|||
156359629|NCT00003641|564416619|FG000|Overall Study|Should not receive interferon therapy|2|||
156359630|NCT00003641|564416620|FG001|Overall Study|Should not receive interferon therapy|0|||
156359631|NCT00003641|564416619|FG000|Overall Study|Never started interferon|567|||
156359632|NCT00003641|564416620|FG001|Overall Study|Never started interferon|12|||
156359633|NCT02154581|564416623|FG000|Overall Study|Lost to Follow-up|7|||
156359634|NCT02154581|564416624|FG001|Overall Study|Lost to Follow-up|8|||
156359635|NCT03082599|564416627|FG000|Overall Study|Lost to Follow-up|1|||
156359636|NCT03082599|564416628|FG001|Overall Study|Lost to Follow-up|0|||
156359637|NCT01675128|564416633|FG000|Overall Study|Disease progression on study|1|||
156359638|NCT01675128|564416634|FG001|Overall Study|Disease progression on study|1|||
156359639|NCT01675128|564416635|FG002|Overall Study|Disease progression on study|1|||
156359640|NCT01675128|564416633|FG000|Overall Study|Refused further treatment|1|||
156359641|NCT01675128|564416634|FG001|Overall Study|Refused further treatment|0|||
156359642|NCT01675128|564416635|FG002|Overall Study|Refused further treatment|0|||
156359643|NCT01675128|564416633|FG000|Overall Study|Pulmonary complication; off study|0|||
156359644|NCT01675128|564416634|FG001|Overall Study|Pulmonary complication; off study|1|||
156359645|NCT01675128|564416635|FG002|Overall Study|Pulmonary complication; off study|0|||
156359646|NCT00832585|564416636|FG000|Overall Study|Withdrawal by Subject|1|||
156359647|NCT00832585|564416636|FG000|Overall Study|Lost to Follow-up|1|||
156359648|NCT03011307|564416640|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
156359649|NCT03011307|564416641|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
156359650|NCT03011307|564416640|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
156359651|NCT03011307|564416641|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
156359652|NCT03011307|564416640|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
156359653|NCT03011307|564416641|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
156359654|NCT03526458|564416642|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
156359655|NCT03526458|564416643|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
156359656|NCT03526458|564416642|FG000|Overall Study|Stone passed, surgery cancelled|2|||
156359657|NCT03526458|564416643|FG001|Overall Study|Stone passed, surgery cancelled|1|||
156359658|NCT03526458|564416642|FG000|Overall Study|Withdrawal by Subject|1|||
156359659|NCT03526458|564416643|FG001|Overall Study|Withdrawal by Subject|0|||
156359660|NCT03526458|564416642|FG000|Overall Study|Physician Decision|2|||
156359661|NCT03526458|564416643|FG001|Overall Study|Physician Decision|1|||
156359662|NCT03526458|564416642|FG000|Overall Study|Lack of equipment|1|||
156359663|NCT03526458|564416643|FG001|Overall Study|Lack of equipment|1|||
156359664|NCT01782664|564416644|FG000|Overall Study|Adverse Event|2|||
156359665|NCT01782664|564416645|FG001|Overall Study|Adverse Event|2|||
156359666|NCT01782664|564416646|FG002|Overall Study|Adverse Event|2|||
156359667|NCT01782664|564416647|FG003|Overall Study|Adverse Event|2|||
156359668|NCT01782664|564416648|FG004|Overall Study|Adverse Event|0|||
156359669|NCT01782664|564416649|FG005|Overall Study|Adverse Event|0|||
156359670|NCT01782664|564416644|FG000|Overall Study|Lack of Efficacy|2|||
156359671|NCT01782664|564416645|FG001|Overall Study|Lack of Efficacy|0|||
156359672|NCT01782664|564416646|FG002|Overall Study|Lack of Efficacy|2|||
156359673|NCT01782664|564416647|FG003|Overall Study|Lack of Efficacy|2|||
156359674|NCT01782664|564416648|FG004|Overall Study|Lack of Efficacy|0|||
156545401|NCT03703102|565091583|FG001|Overall Study|Physician Decision|2|||
156545402|NCT03703102|565091584|FG002|Overall Study|Physician Decision|2|||
156359675|NCT01782664|564416649|FG005|Overall Study|Lack of Efficacy|0|||
156359676|NCT01782664|564416644|FG000|Overall Study|Protocol Violation|0|||
156545403|NCT03703102|565091585|FG003|Overall Study|Physician Decision|2|||
156545404|NCT03703102|565091586|FG004|Overall Study|Physician Decision|4|||
156359677|NCT01782664|564416645|FG001|Overall Study|Protocol Violation|1|||
156359678|NCT01782664|564416646|FG002|Overall Study|Protocol Violation|0|||
156359679|NCT01782664|564416647|FG003|Overall Study|Protocol Violation|1|||
156359680|NCT01782664|564416648|FG004|Overall Study|Protocol Violation|0|||
156359681|NCT01782664|564416649|FG005|Overall Study|Protocol Violation|0|||
156359682|NCT01782664|564416644|FG000|Overall Study|Withdrawal by Subject|2|||
156359683|NCT01782664|564416645|FG001|Overall Study|Withdrawal by Subject|2|||
156359684|NCT01782664|564416646|FG002|Overall Study|Withdrawal by Subject|0|||
156359685|NCT01782664|564416647|FG003|Overall Study|Withdrawal by Subject|0|||
156359686|NCT01782664|564416648|FG004|Overall Study|Withdrawal by Subject|0|||
156359687|NCT01782664|564416649|FG005|Overall Study|Withdrawal by Subject|0|||
156545405|NCT03703102|565091582|FG000|Overall Study|Withdrawal by Subject|7|||
156545406|NCT03703102|565091583|FG001|Overall Study|Withdrawal by Subject|5|||
156545407|NCT03703102|565091584|FG002|Overall Study|Withdrawal by Subject|5|||
156545408|NCT03703102|565091585|FG003|Overall Study|Withdrawal by Subject|5|||
156545409|NCT03703102|565091586|FG004|Overall Study|Withdrawal by Subject|9|||
156545410|NCT03703102|565091582|FG000|Overall Study|Ineligibility|0|||
156545411|NCT03703102|565091583|FG001|Overall Study|Ineligibility|0|||
156545412|NCT03703102|565091584|FG002|Overall Study|Ineligibility|1|||
156545413|NCT03703102|565091585|FG003|Overall Study|Ineligibility|0|||
156545414|NCT03703102|565091586|FG004|Overall Study|Ineligibility|0|||
156545415|NCT03703102|565091582|FG000|Overall Study|Protocol Deviation|4|||
156545416|NCT03703102|565091583|FG001|Overall Study|Protocol Deviation|4|||
156545417|NCT03703102|565091584|FG002|Overall Study|Protocol Deviation|3|||
156545418|NCT03703102|565091585|FG003|Overall Study|Protocol Deviation|0|||
156545419|NCT03703102|565091586|FG004|Overall Study|Protocol Deviation|0|||
156545420|NCT03703102|565091582|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156545421|NCT03703102|565091583|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156545422|NCT03703102|565091584|FG002|Overall Study|Non-Compliance with Study Drug|2|||
156545423|NCT03703102|565091585|FG003|Overall Study|Non-Compliance with Study Drug|1|||
156545424|NCT03703102|565091586|FG004|Overall Study|Non-Compliance with Study Drug|4|||
156545425|NCT02311153|565091587|FG000|Overall Study|Lost to Follow-up|5|||
156545426|NCT02311153|565091588|FG001|Overall Study|Lost to Follow-up|7|||
156545427|NCT01967628|565091589|FG000|Overall Study|Withdrawal by Subject|2|||
156545428|NCT01967628|565091590|FG001|Overall Study|Withdrawal by Subject|0|||
156545429|NCT01967628|565091589|FG000|Overall Study|Unable to complete bronchoscopy|4|||
156545430|NCT01967628|565091590|FG001|Overall Study|Unable to complete bronchoscopy|6|||
156545431|NCT01967628|565091589|FG000|Overall Study|Lost to Follow-up|1|||
156545432|NCT01967628|565091590|FG001|Overall Study|Lost to Follow-up|0|||
156545433|NCT01967628|565091589|FG000|Overall Study|Low protein concentration in sample|20|||
156545434|NCT01967628|565091590|FG001|Overall Study|Low protein concentration in sample|25|||
156545435|NCT01650636|565091595|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
156545436|NCT01650636|565091596|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
156545437|NCT01650636|565091595|FG000|Washout up to 5 Months|Physician Decision|2|||
156545438|NCT01650636|565091596|FG001|Washout up to 5 Months|Physician Decision|2|||
156545439|NCT01650636|565091595|FG000|Washout up to 5 Months|Death|1|||
156545440|NCT01650636|565091596|FG001|Washout up to 5 Months|Death|0|||
156545441|NCT01650636|565091595|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
156545442|NCT01650636|565091596|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
156545443|NCT01650636|565091595|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
156545444|NCT01650636|565091596|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
156545445|NCT01650636|565091595|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
156545446|NCT01650636|565091596|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
156545447|NCT01560780|565091597|FG000|Overall Study|Death|2|||
156545448|NCT01560780|565091598|FG001|Overall Study|Death|1|||
156545449|NCT01560780|565091597|FG000|Overall Study|Patient Preference|11|||
156359688|NCT04404855|564416650|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
156359689|NCT04404855|564416651|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
156359690|NCT00735878|564416652|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
156359691|NCT00735878|564416653|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
156359692|NCT00735878|564416654|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
156359693|NCT01082965|564416658|FG000|Overall Study|Protocol Violation|0|||
156359694|NCT01082965|564416659|FG001|Overall Study|Protocol Violation|1|||
156359695|NCT01082965|564416658|FG000|Overall Study|Other|1|||
156359696|NCT01082965|564416659|FG001|Overall Study|Other|1|||
156359697|NCT03642717|564416660|FG000|Overall Study|Lost to Follow-up|2|||
156359698|NCT03642717|564416660|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
156359699|NCT03642717|564416660|FG000|Overall Study|Taken study drug prior to contract date|3|||
156545450|NCT01560780|565091598|FG001|Overall Study|Patient Preference|11|||
156545451|NCT02192827|565091599|FG000|Overall Study|Lost to Follow-up|25|||
156545452|NCT02192827|565091600|FG001|Overall Study|Lost to Follow-up|27|||
156359700|NCT02587065|564416661|FG000|Overall Study|Adverse Event|14|||
156545453|NCT02192827|565091599|FG000|Overall Study|Given additional steroids with admission|13|||
156359701|NCT02587065|564416661|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
156359702|NCT02587065|564416661|FG000|Overall Study|Non-adherence to the Protocol|3|||
156359703|NCT02587065|564416661|FG000|Overall Study|Discontinuation of Study Medication|2|||
156359704|NCT02587065|564416661|FG000|Overall Study|Reason not Specified|3|||
156359705|NCT01559012|564416662|FG000|Overall Study|Withdrawal by Subject|0|||
156359706|NCT01559012|564416663|FG001|Overall Study|Withdrawal by Subject|1|||
156545454|NCT02192827|565091600|FG001|Overall Study|Given additional steroids with admission|11|||
156545455|NCT01970995|565091602|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
156359707|NCT00302458|564416666|FG000|Overall Study|Lost to Follow-up|1|||
156545456|NCT01970995|565091603|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
156545457|NCT01970995|565091604|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
156359708|NCT00302458|564416666|FG000|Overall Study|Ineligible after screening|1|||
156359709|NCT00302458|564416666|FG000|Overall Study|Withdrawal by Subject|1|||
156359710|NCT00946712|564416667|FG000|Overall Study|Adverse Event|118|||
156359711|NCT00946712|564416668|FG001|Overall Study|Adverse Event|124|||
156359712|NCT00946712|564416667|FG000|Overall Study|Disease progression|308|||
156359713|NCT00946712|564416668|FG001|Overall Study|Disease progression|404|||
156359714|NCT00946712|564416667|FG000|Overall Study|Death|21|||
156359715|NCT00946712|564416668|FG001|Overall Study|Death|22|||
156359716|NCT00946712|564416667|FG000|Overall Study|No treatment given|25|||
156359717|NCT00946712|564416668|FG001|Overall Study|No treatment given|29|||
156359718|NCT00946712|564416667|FG000|Overall Study|Other reasons|61|||
156359719|NCT00946712|564416668|FG001|Overall Study|Other reasons|73|||
156359720|NCT00946712|564416667|FG000|Overall Study|On Treatment|0|||
156359721|NCT00946712|564416668|FG001|Overall Study|On Treatment|4|||
156359722|NCT00946712|564416667|FG000|Overall Study|Ineligible|14|||
156359723|NCT00946712|564416668|FG001|Overall Study|Ineligible|6|||
156359724|NCT00853723|564416670|FG000|Overall Study|Adverse Event|3|||
156359725|NCT00853723|564416671|FG001|Overall Study|Adverse Event|4|||
156359726|NCT00853723|564416672|FG002|Overall Study|Adverse Event|1|||
156359727|NCT00853723|564416670|FG000|Overall Study|Withdrawal by Subject|2|||
156359728|NCT00853723|564416671|FG001|Overall Study|Withdrawal by Subject|1|||
156359729|NCT00853723|564416672|FG002|Overall Study|Withdrawal by Subject|0|||
156359730|NCT00853723|564416670|FG000|Overall Study|Protocol Violation|1|||
156359731|NCT00853723|564416671|FG001|Overall Study|Protocol Violation|2|||
156359732|NCT00853723|564416672|FG002|Overall Study|Protocol Violation|1|||
156359733|NCT04248933|564416675|FG000|Overall Study|Lost to Follow-up|9|||
156359734|NCT04248933|564416675|FG000|Overall Study|Withdrawal by Subject|2|||
156359735|NCT02447081|564416676|FG000|Overall Study|Death|161|||
156359736|NCT02447081|564416676|FG000|Overall Study|Lost to Follow-up|36|||
156359737|NCT02447081|564416676|FG000|Overall Study|Visit not completed|17|||
156359738|NCT02447081|564416676|FG000|Overall Study|unsuccessful implant procedure|10|||
156359739|NCT05778786|564416679|FG000|Period 1|COVID-19 Related|3|||
156359740|NCT05778786|564416680|FG001|Period 1|COVID-19 Related|3|||
156359741|NCT05778786|564416679|FG000|Period 1|Withdrew Consent during Study|1|||
156359742|NCT05778786|564416680|FG001|Period 1|Withdrew Consent during Study|0|||
156359743|NCT05778786|564416679|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
156359744|NCT05778786|564416680|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
156359745|NCT05778786|564416679|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
156359746|NCT05778786|564416680|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
156359747|NCT05497284|564416682|FG000|Overall Study|Adverse Event|1|||
156359748|NCT05497284|564416683|FG001|Overall Study|Adverse Event|0|||
156359749|NCT05497284|564416682|FG000|Overall Study|Physician Decision|0|||
156359750|NCT05497284|564416683|FG001|Overall Study|Physician Decision|1|||
156359751|NCT05497284|564416682|FG000|Overall Study|Study terminated by sponsor|7|||
156359752|NCT05497284|564416683|FG001|Overall Study|Study terminated by sponsor|4|||
156359753|NCT05497284|564416682|FG000|Overall Study|Subject Decision|0|||
156359754|NCT05497284|564416683|FG001|Overall Study|Subject Decision|1|||
156359755|NCT02596854|564417574|FG000|Overall Study|Withdrawn|8|||
156359756|NCT00885755|564417581|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
156359757|NCT00885755|564417582|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
156359758|NCT00885755|564417583|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
156359759|NCT00885755|564417581|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
156359760|NCT00885755|564417582|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
156359761|NCT00885755|564417583|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
156359762|NCT00885755|564417581|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
156359763|NCT00885755|564417582|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
156359764|NCT00885755|564417583|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
156359765|NCT00885755|564417581|FG000|Part I: Trastuzumab+Taxane|Death|0|||
156359766|NCT00885755|564417582|FG001|Part I: Trastuzumab+Taxane|Death|0|||
156359767|NCT00885755|564417583|FG002|Part I: Trastuzumab+Taxane|Death|1|||
156359768|NCT00885755|564417581|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
156359769|NCT00885755|564417582|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
156359770|NCT00885755|564417583|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
156359771|NCT00107198|564417585|FG000|Overall Study|Lack of Efficacy|28|||
156359772|NCT00107198|564417585|FG000|Overall Study|Lost to Follow-up|12|||
156359773|NCT00107198|564417585|FG000|Overall Study|Protocol Violation|1|||
156359774|NCT00107198|564417585|FG000|Overall Study|Withdrawal by Subject|6|||
156359775|NCT00107198|564417585|FG000|Overall Study|Ineligible|5|||
156359776|NCT02625090|564417586|FG000|Overall Study|Participant wants to be pregnant|2|||
156359777|NCT02625090|564417586|FG000|Overall Study|For the Promoter|1|||
156359778|NCT02625090|564417586|FG000|Overall Study|Sponsor's Decision|9|||
156359779|NCT02625090|564417586|FG000|Overall Study|Somnolence|1|||
156359780|NCT02625090|564417586|FG000|Overall Study|Study terminated by Sponsor|7|||
156359781|NCT02625090|564417586|FG000|Overall Study|Negative Benefit/Risk|1|||
156359782|NCT02625090|564417586|FG000|Overall Study|Protocol Deviation|2|||
156359783|NCT02625090|564417586|FG000|Overall Study|Lack of Efficacy|16|||
156359784|NCT02625090|564417586|FG000|Overall Study|Adverse Event|3|||
156359785|NCT02250443|564417587|FG000|Overall Study|Administrative problems|7|||
156359786|NCT02250443|564417587|FG000|Overall Study|Adverse Event|3|||
156359787|NCT03168464|564417588|FG000|Overall Study|Death|9|||
156359788|NCT03168464|564417588|FG000|Overall Study|Progression of disease|6|||
156359789|NCT04649164|564417589|FG000|Overall Study|Withdrawal by Subject|1|||
156359790|NCT04649164|564417590|FG001|Overall Study|Withdrawal by Subject|1|||
156359791|NCT04649164|564417591|FG002|Overall Study|Withdrawal by Subject|2|||
156359792|NCT04649164|564417589|FG000|Overall Study|Participant's care recipient expired|0|||
156359793|NCT04649164|564417590|FG001|Overall Study|Participant's care recipient expired|0|||
156359794|NCT04649164|564417591|FG002|Overall Study|Participant's care recipient expired|2|||
156359795|NCT01549964|564417592|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
156359796|NCT01549964|564417593|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
156359797|NCT01549964|564417594|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
156359798|NCT01549964|564417595|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
156359799|NCT01549964|564417592|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
156359800|NCT01549964|564417593|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
156359801|NCT01549964|564417594|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
156359802|NCT01549964|564417595|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
156359803|NCT01549964|564417592|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
156359804|NCT01549964|564417593|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
156359805|NCT01549964|564417594|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
156359806|NCT01549964|564417595|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
156359807|NCT01549964|564417592|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
156359808|NCT01549964|564417593|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
156359809|NCT01549964|564417594|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
156359810|NCT01549964|564417595|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
156359811|NCT01549964|564417592|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
156359812|NCT01549964|564417593|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
156359813|NCT01549964|564417594|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
156359814|NCT01549964|564417595|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
156359815|NCT01549964|564417592|FG000|24-Week Treatment Period|Other|1|||
156359816|NCT01549964|564417593|FG001|24-Week Treatment Period|Other|0|||
156359817|NCT01549964|564417594|FG002|24-Week Treatment Period|Other|1|||
156359818|NCT01549964|564417595|FG003|24-Week Treatment Period|Other|0|||
156359819|NCT01549964|564417592|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
156359820|NCT01549964|564417593|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
156359821|NCT01549964|564417594|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
156359822|NCT01549964|564417595|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
156359823|NCT01549964|564417592|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
156359824|NCT01549964|564417593|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
156359825|NCT01549964|564417594|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
156359826|NCT01549964|564417595|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
156359827|NCT01549964|564417592|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
156359828|NCT01549964|564417593|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
156359829|NCT01549964|564417594|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
156359830|NCT01549964|564417595|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
156359831|NCT01549964|564417592|FG000|80-Week Extension Period|Pregnancy|0|||
156359832|NCT01549964|564417593|FG001|80-Week Extension Period|Pregnancy|0|||
156359833|NCT01549964|564417594|FG002|80-Week Extension Period|Pregnancy|1|||
156359834|NCT01549964|564417595|FG003|80-Week Extension Period|Pregnancy|0|||
156359835|NCT01549964|564417592|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
156359836|NCT01549964|564417593|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
156359837|NCT01549964|564417594|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
156359838|NCT01549964|564417595|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
156359839|NCT01549964|564417592|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
156359840|NCT01549964|564417593|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
156359841|NCT01549964|564417594|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
156359842|NCT01549964|564417595|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
156359843|NCT01549964|564417592|FG000|80-Week Extension Period|Lost to Follow-up|1|||
156359844|NCT01549964|564417593|FG001|80-Week Extension Period|Lost to Follow-up|0|||
156359845|NCT01549964|564417594|FG002|80-Week Extension Period|Lost to Follow-up|2|||
156359846|NCT01549964|564417595|FG003|80-Week Extension Period|Lost to Follow-up|1|||
156359847|NCT01549964|564417592|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
156359848|NCT01549964|564417593|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
156359849|NCT01549964|564417594|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
156359850|NCT01549964|564417595|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
156359851|NCT00634088|564417596|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
156359852|NCT00634088|564417597|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
156359853|NCT00634088|564417598|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
156545458|NCT01970995|565091602|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
156489285|NCT00187135|564885585|FG005|Visit Three|Death|0|||
156489286|NCT00187135|564885580|FG000|Visit Three|Withdrawal by Subject|0|||
156489287|NCT00187135|564885581|FG001|Visit Three|Withdrawal by Subject|1|||
156489288|NCT00187135|564885582|FG002|Visit Three|Withdrawal by Subject|1|||
156489289|NCT00187135|564885583|FG003|Visit Three|Withdrawal by Subject|2|||
156489290|NCT00187135|564885584|FG004|Visit Three|Withdrawal by Subject|0|||
156489291|NCT00187135|564885585|FG005|Visit Three|Withdrawal by Subject|0|||
156489292|NCT00187135|564885580|FG000|Visit Three|Study Discontinued|7|||
156489293|NCT00187135|564885581|FG001|Visit Three|Study Discontinued|6|||
156489294|NCT00187135|564885582|FG002|Visit Three|Study Discontinued|7|||
156489295|NCT00187135|564885583|FG003|Visit Three|Study Discontinued|7|||
156489296|NCT00187135|564885584|FG004|Visit Three|Study Discontinued|7|||
156489297|NCT00187135|564885585|FG005|Visit Three|Study Discontinued|6|||
156489298|NCT00745121|564885589|FG000|Overall Study|Death|3|||
156489299|NCT00745121|564885590|FG001|Overall Study|Death|0|||
156489300|NCT00745121|564885589|FG000|Overall Study|Adverse Event|1|||
156489301|NCT00745121|564885590|FG001|Overall Study|Adverse Event|0|||
156489302|NCT00745121|564885589|FG000|Overall Study|Lost to Follow-up|1|||
156489303|NCT00745121|564885590|FG001|Overall Study|Lost to Follow-up|0|||
156489304|NCT00745121|564885589|FG000|Overall Study|Withdrawal by Subject|4|||
156489305|NCT00745121|564885590|FG001|Overall Study|Withdrawal by Subject|2|||
156489306|NCT01820637|564885591|FG000|Overall Study|Death|2|||
156489307|NCT01820637|564885591|FG000|Overall Study|Withdrawal by Subject|1|||
156489308|NCT00607789|564885593|FG000|Overall Study|Adverse Event|3|||
156489309|NCT00607789|564885594|FG001|Overall Study|Adverse Event|0|||
156489310|NCT00607789|564885593|FG000|Overall Study|Lack of Efficacy|0|||
156489311|NCT00607789|564885594|FG001|Overall Study|Lack of Efficacy|1|||
156489312|NCT00607789|564885593|FG000|Overall Study|Inadequate adherence|3|||
156489313|NCT00607789|564885594|FG001|Overall Study|Inadequate adherence|0|||
156489314|NCT00607789|564885593|FG000|Overall Study|Lost to Follow-up|0|||
156489315|NCT00607789|564885594|FG001|Overall Study|Lost to Follow-up|5|||
156489316|NCT00607789|564885593|FG000|Overall Study|Withdrawal by Subject|1|||
156489317|NCT00607789|564885594|FG001|Overall Study|Withdrawal by Subject|0|||
156489318|NCT06016127|564885597|FG000|Overall Study|Withdrawal by Subject|4|||
156489319|NCT06016127|564885598|FG001|Overall Study|Withdrawal by Subject|3|||
156489320|NCT03340766|564885603|FG000|Overall Study|Withdrawal by Subject|2|||
156489321|NCT03340766|564885604|FG001|Overall Study|Withdrawal by Subject|1|||
156489322|NCT03340766|564885605|FG002|Overall Study|Withdrawal by Subject|3|||
156489323|NCT03340766|564885603|FG000|Overall Study|Lost to Follow-up|0|||
156489324|NCT03340766|564885604|FG001|Overall Study|Lost to Follow-up|0|||
156489325|NCT03340766|564885605|FG002|Overall Study|Lost to Follow-up|1|||
156489326|NCT03340766|564885603|FG000|Overall Study|Death|6|||
156489327|NCT03340766|564885604|FG001|Overall Study|Death|7|||
156489328|NCT03340766|564885605|FG002|Overall Study|Death|4|||
156489329|NCT00240097|564885606|FG000|Part I|Adverse Event|1|||
156489330|NCT00240097|564885606|FG000|Part I|Death|1|||
156489331|NCT00240097|564885606|FG000|Part I|histology|1|||
156489332|NCT00240097|564885606|FG000|Part I|unevaluable|1|||
156489333|NCT00240097|564885606|FG000|Part II|did not continue from Part I|23|||
156489334|NCT00981578|564885610|FG000|Overall Study|Death|1|||
156489335|NCT00981578|564885610|FG000|Overall Study|Withdrawal by Subject|2|||
156489336|NCT01294358|564885613|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
156489337|NCT01294358|564885614|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
156489338|NCT01294358|564885615|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
156489339|NCT01294358|564885616|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
156489340|NCT01294358|564885617|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
156489341|NCT01294358|564885613|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
156489342|NCT01294358|564885614|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
156489343|NCT01294358|564885615|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
156489344|NCT01294358|564885616|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
156489345|NCT01294358|564885617|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
156489346|NCT01294358|564885613|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
156489347|NCT01294358|564885614|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
156489348|NCT01294358|564885615|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
156489349|NCT01294358|564885616|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
156489350|NCT01294358|564885617|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
156489351|NCT01294358|564885613|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
156489352|NCT01294358|564885614|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
156489353|NCT01294358|564885615|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
156489354|NCT01294358|564885616|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
156489355|NCT01294358|564885617|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
156489356|NCT02963922|564885618|FG000|Overall Study|Adverse Event|15|||
156489357|NCT02963922|564885619|FG001|Overall Study|Adverse Event|6|||
156489358|NCT02963922|564885618|FG000|Overall Study|Protocol deviation|6|||
156489359|NCT02963922|564885619|FG001|Overall Study|Protocol deviation|6|||
156489360|NCT02963922|564885618|FG000|Overall Study|Lack of Efficacy|1|||
156359854|NCT00634088|564417599|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
156359855|NCT00634088|564417596|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
156359856|NCT00634088|564417597|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
156359857|NCT00634088|564417598|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
156359858|NCT00634088|564417599|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
156359859|NCT00634088|564417596|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
156359860|NCT00634088|564417597|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
156359861|NCT00634088|564417598|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
156359862|NCT00634088|564417599|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
156359863|NCT00634088|564417596|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
156359864|NCT00634088|564417597|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
156359865|NCT00634088|564417598|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
156359866|NCT00634088|564417599|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
156359867|NCT00634088|564417596|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
156359868|NCT00634088|564417597|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
156359869|NCT00634088|564417598|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
156359870|NCT00634088|564417599|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
156359871|NCT00634088|564417596|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
156359872|NCT00634088|564417597|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
156359873|NCT00634088|564417598|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
156359874|NCT00634088|564417599|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
156359875|NCT02290821|564417602|FG000|Overall Study|Withdrawal by Subject|1|||
156359876|NCT02290821|564417603|FG001|Overall Study|Withdrawal by Subject|1|||
156359877|NCT02290821|564417602|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
156359878|NCT02290821|564417603|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
156359879|NCT02290821|564417602|FG000|Overall Study|Lost to Follow-up|3|||
156359880|NCT02290821|564417603|FG001|Overall Study|Lost to Follow-up|2|||
156359881|NCT02439320|564417604|FG000|Overall Study|Adverse Event|0|||
156359882|NCT02439320|564417605|FG001|Overall Study|Adverse Event|2|||
156359883|NCT02439320|564417606|FG002|Overall Study|Adverse Event|0|||
156359884|NCT02439320|564417604|FG000|Overall Study|Lost to Follow-up|37|||
156359885|NCT02439320|564417605|FG001|Overall Study|Lost to Follow-up|34|||
156359886|NCT02439320|564417606|FG002|Overall Study|Lost to Follow-up|42|||
156359887|NCT02439320|564417604|FG000|Overall Study|Death|0|||
156359888|NCT02439320|564417605|FG001|Overall Study|Death|1|||
156359889|NCT02439320|564417606|FG002|Overall Study|Death|0|||
156359890|NCT02439320|564417604|FG000|Overall Study|Noncompliance with Protocol|10|||
156359891|NCT02439320|564417605|FG001|Overall Study|Noncompliance with Protocol|11|||
156359892|NCT02439320|564417606|FG002|Overall Study|Noncompliance with Protocol|7|||
156359893|NCT02439320|564417604|FG000|Overall Study|Pregnancy|0|||
156359894|NCT02439320|564417605|FG001|Overall Study|Pregnancy|1|||
156359895|NCT02439320|564417606|FG002|Overall Study|Pregnancy|1|||
156359896|NCT02439320|564417604|FG000|Overall Study|Withdrawal by Subject|12|||
156359897|NCT02439320|564417605|FG001|Overall Study|Withdrawal by Subject|16|||
156359898|NCT02439320|564417606|FG002|Overall Study|Withdrawal by Subject|14|||
156359899|NCT02439320|564417604|FG000|Overall Study|Physician Decision|2|||
156359900|NCT02439320|564417605|FG001|Overall Study|Physician Decision|1|||
156359901|NCT02439320|564417606|FG002|Overall Study|Physician Decision|0|||
156359902|NCT02439320|564417604|FG000|Overall Study|Sponsor Request|0|||
156359903|NCT02439320|564417605|FG001|Overall Study|Sponsor Request|2|||
156359904|NCT02439320|564417606|FG002|Overall Study|Sponsor Request|1|||
156359905|NCT02439320|564417604|FG000|Overall Study|Randomization Failure|35|||
156359906|NCT02439320|564417605|FG001|Overall Study|Randomization Failure|46|||
156359907|NCT02439320|564417606|FG002|Overall Study|Randomization Failure|34|||
156359908|NCT01520363|564417609|FG000|Overall Study|Withdrawal by Subject|2|||
156359909|NCT01520363|564417610|FG001|Overall Study|Withdrawal by Subject|0|||
156359910|NCT04191382|564417614|FG000|Overall Study|Withdrawal by Subject|1|||
156359911|NCT04191382|564417615|FG001|Overall Study|Withdrawal by Subject|0|||
156359912|NCT04191382|564417616|FG002|Overall Study|Withdrawal by Subject|0|||
156359913|NCT00304356|564417619|FG000|Nitazoxanide|Physician Decision|5|||
156359914|NCT00304356|564417619|FG000|Nitazoxanide|Physician Decision|1|||
156359915|NCT00304356|564417619|FG000|Nitazoxanide|number is 0|1|||
156359916|NCT00304356|564417619|FG000|Nitazoxanide|Physician Decision|1|||
156359917|NCT00304356|564417619|FG000|Nitazoxanide|Physician Decision|1|||
156359918|NCT00304356|564417619|FG000|Nitazoxanide|Physician Decision|1|||
156359919|NCT04120974|564417620|FG000|Overall Study|Death|1|||
156359920|NCT04120974|564417620|FG000|Overall Study|Physician Decision|1|||
156359921|NCT04120974|564417620|FG000|Overall Study|Lost to Follow-up|6|||
156359922|NCT00741039|564417626|FG000|Overall Study|Patient non-compliance|2|||
156359923|NCT00741039|564417627|FG001|Overall Study|Patient non-compliance|0|||
156359924|NCT00878709|564417628|FG000|Overall Study|Withdrawal by Subject|197|||
156359925|NCT00878709|564417629|FG001|Overall Study|Withdrawal by Subject|120|||
156359926|NCT00878709|564417628|FG000|Overall Study|Lost to Follow-up|35|||
156359927|NCT00878709|564417629|FG001|Overall Study|Lost to Follow-up|33|||
156359928|NCT00878709|564417628|FG000|Overall Study|Other Reasons|93|||
156359929|NCT00878709|564417629|FG001|Overall Study|Other Reasons|84|||
156359930|NCT00768300|564417630|FG000|Overall Study|Randomized but not treated|1|||
156359931|NCT00768300|564417631|FG001|Overall Study|Randomized but not treated|1|||
156359932|NCT00768300|564417630|FG000|Overall Study|Adverse Event|10|||
156359933|NCT00768300|564417631|FG001|Overall Study|Adverse Event|2|||
156359934|NCT00768300|564417630|FG000|Overall Study|Protocol Violation|6|||
156359935|NCT00768300|564417631|FG001|Overall Study|Protocol Violation|1|||
156359936|NCT00768300|564417630|FG000|Overall Study|Withdrawal by Subject|13|||
156359937|NCT00768300|564417631|FG001|Overall Study|Withdrawal by Subject|7|||
156359938|NCT00768300|564417630|FG000|Overall Study|Physician Decision|2|||
156359939|NCT00768300|564417631|FG001|Overall Study|Physician Decision|3|||
156359940|NCT00768300|564417630|FG000|Overall Study|Study discontinued by Sponsor|271|||
156359941|NCT00768300|564417631|FG001|Overall Study|Study discontinued by Sponsor|140|||
156359942|NCT00768300|564417630|FG000|Overall Study|Death|21|||
156359943|NCT00768300|564417631|FG001|Overall Study|Death|5|||
156359944|NCT00768300|564417630|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
156359945|NCT00768300|564417631|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
156359946|NCT00768300|564417630|FG000|Overall Study|Screen failure following randomization|1|||
156359947|NCT00768300|564417631|FG001|Overall Study|Screen failure following randomization|0|||
156359948|NCT00768300|564417630|FG000|Overall Study|Received lung transplant|1|||
156359949|NCT00768300|564417631|FG001|Overall Study|Received lung transplant|1|||
156359950|NCT00768300|564417630|FG000|Overall Study|Lost to Follow-up|0|||
156359951|NCT00768300|564417631|FG001|Overall Study|Lost to Follow-up|1|||
156359952|NCT00768300|564417630|FG000|Overall Study|Began prohibited concomitant medication|0|||
156359953|NCT00768300|564417631|FG001|Overall Study|Began prohibited concomitant medication|1|||
156359954|NCT00768300|564417630|FG000|Overall Study|Treated but never dosed with Study drug|1|||
156359955|NCT00768300|564417631|FG001|Overall Study|Treated but never dosed with Study drug|0|||
156359956|NCT00768300|564417630|FG000|Overall Study|Missing data|1|||
156359957|NCT00768300|564417631|FG001|Overall Study|Missing data|0|||
156359958|NCT02068222|564417632|FG000|Overall Study|Lost to Follow-up|1|||
156359959|NCT00445965|564417635|FG000|Overall Study|Adverse Event|2|||
156359960|NCT00445965|564417635|FG000|Overall Study|Physician Decision|1|||
156359961|NCT00445965|564417635|FG000|Overall Study|Enrolled but not treated|1|||
156359962|NCT00445965|564417635|FG000|Overall Study|Removed due to progressive disease|29|||
156359963|NCT02867709|564417636|FG000|Treatment Period|Adverse Event|1|||
156359964|NCT02867709|564417637|FG001|Treatment Period|Adverse Event|1|||
156359965|NCT02867709|564417638|FG002|Treatment Period|Adverse Event|2|||
156359966|NCT02867709|564417636|FG000|Treatment Period|Withdrawal of Consent|7|||
156359967|NCT02867709|564417637|FG001|Treatment Period|Withdrawal of Consent|9|||
156359968|NCT02867709|564417638|FG002|Treatment Period|Withdrawal of Consent|8|||
156359969|NCT02867709|564417636|FG000|Treatment Period|Lost to Follow-up|17|||
156359970|NCT02867709|564417637|FG001|Treatment Period|Lost to Follow-up|20|||
156359971|NCT02867709|564417638|FG002|Treatment Period|Lost to Follow-up|20|||
156359972|NCT02867709|564417636|FG000|Treatment Period|Lack of Qualifying Event|42|||
156359973|NCT02867709|564417637|FG001|Treatment Period|Lack of Qualifying Event|55|||
156359974|NCT02867709|564417638|FG002|Treatment Period|Lack of Qualifying Event|42|||
156359975|NCT02867709|564417636|FG000|Treatment Period|Protocol Violation|3|||
156359976|NCT02867709|564417637|FG001|Treatment Period|Protocol Violation|2|||
156359977|NCT02867709|564417638|FG002|Treatment Period|Protocol Violation|3|||
156359978|NCT02867709|564417636|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
156359979|NCT02867709|564417637|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
156489361|NCT02963922|564885619|FG001|Overall Study|Lack of Efficacy|1|||
156489362|NCT02963922|564885618|FG000|Overall Study|Lost to Follow-up|2|||
156489363|NCT02963922|564885619|FG001|Overall Study|Lost to Follow-up|3|||
156489364|NCT02963922|564885618|FG000|Overall Study|Other|8|||
156489365|NCT02963922|564885619|FG001|Overall Study|Other|14|||
156489366|NCT01180790|564885629|FG000|Overall Study|Adverse Event|1|||
156489367|NCT01180790|564885630|FG001|Overall Study|Adverse Event|1|||
156489368|NCT01180790|564885631|FG002|Overall Study|Adverse Event|2|||
156489369|NCT01180790|564885632|FG003|Overall Study|Adverse Event|0|||
156489370|NCT01180790|564885633|FG004|Overall Study|Adverse Event|1|||
156489371|NCT01180790|564885634|FG005|Overall Study|Adverse Event|3|||
156489372|NCT01180790|564885635|FG006|Overall Study|Adverse Event|0|||
156489373|NCT01180790|564885629|FG000|Overall Study|Withdrawal by Subject|3|||
156359980|NCT02867709|564417638|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
156359981|NCT02867709|564417636|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
156359982|NCT02867709|564417637|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
156489374|NCT01180790|564885630|FG001|Overall Study|Withdrawal by Subject|0|||
156359983|NCT02867709|564417638|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
156359984|NCT02867709|564417636|FG000|Safety Follow-up Period|Pregnancy|0|||
156359985|NCT02867709|564417637|FG001|Safety Follow-up Period|Pregnancy|1|||
156489375|NCT01180790|564885631|FG002|Overall Study|Withdrawal by Subject|5|||
156359986|NCT02867709|564417638|FG002|Safety Follow-up Period|Pregnancy|0|||
156359987|NCT02867709|564417636|FG000|Safety Follow-up Period|Protocol Violation|0|||
156359988|NCT02867709|564417637|FG001|Safety Follow-up Period|Protocol Violation|1|||
156359989|NCT02867709|564417638|FG002|Safety Follow-up Period|Protocol Violation|1|||
156489376|NCT01180790|564885632|FG003|Overall Study|Withdrawal by Subject|0|||
156489377|NCT01180790|564885633|FG004|Overall Study|Withdrawal by Subject|2|||
156359990|NCT03188094|564417644|FG000|Overall Study|Screen failure|1|||
156359991|NCT03188094|564417645|FG001|Overall Study|Screen failure|0|||
156359992|NCT03188094|564417646|FG002|Overall Study|Screen failure|0|||
156359993|NCT03188094|564417644|FG000|Overall Study|Pregnancy|3|||
156359994|NCT03188094|564417645|FG001|Overall Study|Pregnancy|0|||
156359995|NCT03188094|564417646|FG002|Overall Study|Pregnancy|0|||
156359996|NCT03188094|564417644|FG000|Overall Study|Ineligible|1|||
156359997|NCT03188094|564417645|FG001|Overall Study|Ineligible|0|||
156359998|NCT03188094|564417646|FG002|Overall Study|Ineligible|0|||
156359999|NCT03188094|564417644|FG000|Overall Study|Lost to Follow-up|0|||
156360000|NCT03188094|564417645|FG001|Overall Study|Lost to Follow-up|0|||
156360001|NCT03188094|564417646|FG002|Overall Study|Lost to Follow-up|17|||
156360002|NCT02946047|564417647|FG000|Overall Study|Adverse Event|1|||
156360003|NCT02946047|564417648|FG001|Overall Study|Adverse Event|0|||
156360004|NCT02946047|564417649|FG002|Overall Study|Adverse Event|0|||
156360005|NCT02946047|564417650|FG003|Overall Study|Adverse Event|0|||
156360006|NCT03615105|564417651|FG000|Overall Study|Protocol Violation|1|||
156360007|NCT03615105|564417652|FG001|Overall Study|Protocol Violation|0|||
156360008|NCT03615105|564417653|FG002|Overall Study|Protocol Violation|0|||
156360009|NCT03615105|564417651|FG000|Overall Study|Death|0|||
156360010|NCT03615105|564417652|FG001|Overall Study|Death|2|||
156360011|NCT03615105|564417653|FG002|Overall Study|Death|0|||
156360012|NCT05041322|564417654|FG000|Baseline|Withdrawal by Subject|1|||
156360013|NCT05041322|564417655|FG001|Baseline|Withdrawal by Subject|0|||
156360014|NCT05041322|564417654|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
156360015|NCT05041322|564417655|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
156360016|NCT05041322|564417654|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
156360017|NCT05041322|564417655|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
156360018|NCT01344161|564417657|FG000|Overall Study|Lost to Follow-up|4|||
156360019|NCT01344161|564417658|FG001|Overall Study|Lost to Follow-up|1|||
156360020|NCT01344161|564417657|FG000|Overall Study|Pregnancy|0|||
156360021|NCT01344161|564417658|FG001|Overall Study|Pregnancy|1|||
156360022|NCT01344161|564417657|FG000|Overall Study|Protocol Violation|1|||
156360023|NCT01344161|564417658|FG001|Overall Study|Protocol Violation|1|||
156360024|NCT04690751|564417659|FG000|Overall Study|Protocol Violation|0|||
156360025|NCT04690751|564417660|FG001|Overall Study|Protocol Violation|1|||
156360026|NCT04690751|564417661|FG002|Overall Study|Protocol Violation|0|||
156360027|NCT04690751|564417662|FG003|Overall Study|Protocol Violation|1|||
156360028|NCT04690751|564417663|FG004|Overall Study|Protocol Violation|2|||
156360029|NCT04690751|564417664|FG005|Overall Study|Protocol Violation|0|||
156360030|NCT04690751|564417659|FG000|Overall Study|Adverse Event|0|||
156360031|NCT04690751|564417660|FG001|Overall Study|Adverse Event|0|||
156360032|NCT04690751|564417661|FG002|Overall Study|Adverse Event|1|||
156360033|NCT04690751|564417662|FG003|Overall Study|Adverse Event|0|||
156360034|NCT04690751|564417663|FG004|Overall Study|Adverse Event|0|||
156360035|NCT04690751|564417664|FG005|Overall Study|Adverse Event|0|||
156360036|NCT04690751|564417659|FG000|Overall Study|Positive urine drug screen test|0|||
156360037|NCT04690751|564417660|FG001|Overall Study|Positive urine drug screen test|0|||
156360038|NCT04690751|564417661|FG002|Overall Study|Positive urine drug screen test|0|||
156360039|NCT04690751|564417662|FG003|Overall Study|Positive urine drug screen test|0|||
156360040|NCT04690751|564417663|FG004|Overall Study|Positive urine drug screen test|1|||
156360041|NCT04690751|564417664|FG005|Overall Study|Positive urine drug screen test|0|||
156360042|NCT04364620|564417665|FG000|Overall Study|Disease Progression|20|||
156360043|NCT04364620|564417665|FG000|Overall Study|Adverse Event|5|||
156360044|NCT04364620|564417665|FG000|Overall Study|Physician Decision|4|||
156360045|NCT04364620|564417665|FG000|Overall Study|Death|3|||
156360046|NCT04364620|564417665|FG000|Overall Study|Other|2|||
156360047|NCT04364620|564417665|FG000|Overall Study|Withdrawal by Subject|1|||
156360048|NCT00699972|564420301|FG000|Overall Study|Adverse Event|7|||
156360049|NCT00699972|564420302|FG001|Overall Study|Adverse Event|9|||
156360050|NCT00699972|564420303|FG002|Overall Study|Adverse Event|24|||
156360051|NCT00699972|564420301|FG000|Overall Study|Lost to Follow-up|0|||
156360052|NCT00699972|564420302|FG001|Overall Study|Lost to Follow-up|2|||
156360053|NCT00699972|564420303|FG002|Overall Study|Lost to Follow-up|0|||
156360054|NCT00699972|564420301|FG000|Overall Study|Withdrawal by Subject|3|||
156360055|NCT00699972|564420302|FG001|Overall Study|Withdrawal by Subject|7|||
156360056|NCT00699972|564420303|FG002|Overall Study|Withdrawal by Subject|4|||
156360057|NCT00699972|564420301|FG000|Overall Study|Lack of Efficacy|2|||
156360058|NCT00699972|564420302|FG001|Overall Study|Lack of Efficacy|0|||
156360059|NCT00699972|564420303|FG002|Overall Study|Lack of Efficacy|2|||
156360060|NCT00699972|564420301|FG000|Overall Study|Administrative/Other|3|||
156360061|NCT00699972|564420302|FG001|Overall Study|Administrative/Other|1|||
156360062|NCT00699972|564420303|FG002|Overall Study|Administrative/Other|4|||
156360063|NCT00699972|564420301|FG000|Overall Study|Randomized, Not Treated|1|||
156360064|NCT00699972|564420302|FG001|Overall Study|Randomized, Not Treated|0|||
156360065|NCT00699972|564420303|FG002|Overall Study|Randomized, Not Treated|1|||
156360066|NCT00902564|564420307|FG000|Overall Study|Withdrawal by Subject|2|||
156360067|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
156360068|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
156360069|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
156360070|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
156360071|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
156360072|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
156360073|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
156360074|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
156360075|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
156360076|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
156360077|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
156360078|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
156360079|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
156360080|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
156360081|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
156360082|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
156360083|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
156360084|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
156360085|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
156360086|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
156360087|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
156360088|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
156360089|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
156360090|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
156360091|NCT00277212|564420308|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
156360092|NCT00277212|564420309|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
156360093|NCT00277212|564420310|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
156360094|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
156360095|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
156360096|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
156360097|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
156360098|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
156360099|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
156360100|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
156360101|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
156360102|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
156360103|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
156360104|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
156360105|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
156360106|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
156360107|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
156360108|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
156360109|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
156360110|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
156360111|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
156360112|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
156360113|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
156360114|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
156360115|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
156360116|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
156360117|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
156360118|NCT00277212|564420308|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
156360119|NCT00277212|564420309|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
156360120|NCT00277212|564420310|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
156360121|NCT05620576|564420313|FG000|Overall Study|Adverse Event|1|||
156360122|NCT05620576|564420314|FG001|Overall Study|Adverse Event|1|||
156360123|NCT05620576|564420313|FG000|Overall Study|Lost to Follow-up|3|||
156360124|NCT05620576|564420314|FG001|Overall Study|Lost to Follow-up|1|||
156360125|NCT05620576|564420313|FG000|Overall Study|Physician Decision|0|||
156360126|NCT05620576|564420314|FG001|Overall Study|Physician Decision|1|||
156360127|NCT05620576|564420313|FG000|Overall Study|Protocol Deviation|1|||
156360128|NCT05620576|564420314|FG001|Overall Study|Protocol Deviation|1|||
156360129|NCT05620576|564420313|FG000|Overall Study|Withdrawal by Subject|2|||
156360130|NCT05620576|564420314|FG001|Overall Study|Withdrawal by Subject|3|||
156360131|NCT03336216|564420315|FG000|Randomization|Not reported|2|||
156360132|NCT03336216|564420316|FG001|Randomization|Not reported|0|||
156360133|NCT03336216|564420317|FG002|Randomization|Not reported|1|||
156360134|NCT03336216|564420318|FG003|Randomization|Not reported|0|||
156360135|NCT03336216|564420315|FG000|Randomization|Other reasons|1|||
156360136|NCT03336216|564420316|FG001|Randomization|Other reasons|1|||
156360137|NCT03336216|564420317|FG002|Randomization|Other reasons|1|||
156360138|NCT03336216|564420318|FG003|Randomization|Other reasons|0|||
156360139|NCT03336216|564420315|FG000|Randomization|Participant no longer meets study criteria|0|||
156360140|NCT03336216|564420316|FG001|Randomization|Participant no longer meets study criteria|2|||
156360141|NCT03336216|564420317|FG002|Randomization|Participant no longer meets study criteria|4|||
156360142|NCT03336216|564420318|FG003|Randomization|Participant no longer meets study criteria|1|||
156360143|NCT03336216|564420315|FG000|Randomization|Lost to Follow-up|1|||
156360144|NCT03336216|564420316|FG001|Randomization|Lost to Follow-up|0|||
156360145|NCT03336216|564420317|FG002|Randomization|Lost to Follow-up|0|||
156360146|NCT03336216|564420318|FG003|Randomization|Lost to Follow-up|0|||
156360147|NCT03336216|564420315|FG000|Randomization|Participant withdrew consent|9|||
156360148|NCT03336216|564420316|FG001|Randomization|Participant withdrew consent|1|||
156360149|NCT03336216|564420317|FG002|Randomization|Participant withdrew consent|0|||
156360150|NCT03336216|564420318|FG003|Randomization|Participant withdrew consent|0|||
156360151|NCT03336216|564420315|FG000|Randomization|Adverse Event|1|||
156360152|NCT03336216|564420316|FG001|Randomization|Adverse Event|1|||
156360153|NCT03336216|564420317|FG002|Randomization|Adverse Event|0|||
156360154|NCT03336216|564420318|FG003|Randomization|Adverse Event|0|||
156360155|NCT03336216|564420315|FG000|Treatment|Adverse Event|2|||
156360156|NCT03336216|564420316|FG001|Treatment|Adverse Event|3|||
156360157|NCT03336216|564420317|FG002|Treatment|Adverse Event|4|||
156360158|NCT03336216|564420318|FG003|Treatment|Adverse Event|4|||
156360159|NCT03336216|564420315|FG000|Treatment|Participant request to discontinue treatment|2|||
156360160|NCT03336216|564420316|FG001|Treatment|Participant request to discontinue treatment|1|||
156360161|NCT03336216|564420317|FG002|Treatment|Participant request to discontinue treatment|2|||
156360162|NCT03336216|564420318|FG003|Treatment|Participant request to discontinue treatment|2|||
156360163|NCT03336216|564420315|FG000|Treatment|Participant withdrew consent|7|||
156360164|NCT03336216|564420316|FG001|Treatment|Participant withdrew consent|2|||
156360165|NCT03336216|564420317|FG002|Treatment|Participant withdrew consent|3|||
156360166|NCT03336216|564420318|FG003|Treatment|Participant withdrew consent|2|||
156360167|NCT03336216|564420315|FG000|Treatment|Death|2|||
156360168|NCT03336216|564420316|FG001|Treatment|Death|3|||
156360169|NCT03336216|564420317|FG002|Treatment|Death|3|||
156360170|NCT03336216|564420318|FG003|Treatment|Death|4|||
156360171|NCT03336216|564420315|FG000|Treatment|Participant no longer meets study criteria|0|||
156360172|NCT03336216|564420316|FG001|Treatment|Participant no longer meets study criteria|1|||
156360173|NCT03336216|564420317|FG002|Treatment|Participant no longer meets study criteria|0|||
156360174|NCT03336216|564420318|FG003|Treatment|Participant no longer meets study criteria|0|||
156360175|NCT03336216|564420315|FG000|Treatment|Other reasons|2|||
156360176|NCT03336216|564420316|FG001|Treatment|Other reasons|0|||
156360177|NCT03336216|564420317|FG002|Treatment|Other reasons|0|||
156360178|NCT03336216|564420318|FG003|Treatment|Other reasons|3|||
156360179|NCT03336216|564420315|FG000|Treatment|Disease progression|23|||
156360180|NCT03336216|564420316|FG001|Treatment|Disease progression|34|||
156360181|NCT03336216|564420317|FG002|Treatment|Disease progression|33|||
156360182|NCT03336216|564420318|FG003|Treatment|Disease progression|26|||
156360183|NCT03336216|564420315|FG000|Treatment|Study drug toxicity|0|||
156360184|NCT03336216|564420316|FG001|Treatment|Study drug toxicity|3|||
156360185|NCT03336216|564420317|FG002|Treatment|Study drug toxicity|2|||
156360186|NCT03336216|564420318|FG003|Treatment|Study drug toxicity|0|||
156360187|NCT03336216|564420315|FG000|Treatment|Adverse Event unrelated to study drug|1|||
156360188|NCT03336216|564420316|FG001|Treatment|Adverse Event unrelated to study drug|1|||
156360189|NCT03336216|564420317|FG002|Treatment|Adverse Event unrelated to study drug|1|||
156360190|NCT03336216|564420318|FG003|Treatment|Adverse Event unrelated to study drug|0|||
156360191|NCT03336216|564420315|FG000|Treatment|Disease Recurrence|1|||
156360192|NCT03336216|564420316|FG001|Treatment|Disease Recurrence|0|||
156360193|NCT03336216|564420317|FG002|Treatment|Disease Recurrence|0|||
156360194|NCT03336216|564420318|FG003|Treatment|Disease Recurrence|0|||
156360195|NCT00539838|564420321|FG000|Overall Study|Fail to return|2|||
156360196|NCT00539838|564420322|FG001|Overall Study|Fail to return|0|||
156360197|NCT00539838|564420323|FG002|Overall Study|Fail to return|0|||
156360198|NCT00539838|564420321|FG000|Overall Study|Withdrawal by Subject|0|||
156360199|NCT00539838|564420322|FG001|Overall Study|Withdrawal by Subject|4|||
156360200|NCT00539838|564420323|FG002|Overall Study|Withdrawal by Subject|0|||
156360201|NCT00539838|564420321|FG000|Overall Study|Death|0|||
156360202|NCT00539838|564420322|FG001|Overall Study|Death|2|||
156360203|NCT00539838|564420323|FG002|Overall Study|Death|0|||
156360204|NCT00539838|564420321|FG000|Overall Study|Did not cooperate|1|||
156360205|NCT00539838|564420322|FG001|Overall Study|Did not cooperate|0|||
156360206|NCT00539838|564420323|FG002|Overall Study|Did not cooperate|1|||
156360207|NCT00539838|564420321|FG000|Overall Study|Administrative|4|||
156360208|NCT00539838|564420322|FG001|Overall Study|Administrative|0|||
156360209|NCT00539838|564420323|FG002|Overall Study|Administrative|8|||
156360210|NCT02658890|564420326|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360211|NCT02658890|564420327|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360212|NCT02658890|564420328|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360213|NCT02658890|564420329|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360214|NCT02658890|564420330|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360215|NCT02658890|564420331|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360216|NCT02658890|564420332|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360217|NCT02658890|564420333|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360218|NCT02658890|564420334|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156360219|NCT02658890|564420335|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360220|NCT02658890|564420336|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360221|NCT02658890|564420337|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360222|NCT02658890|564420338|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360223|NCT02658890|564420339|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360224|NCT02658890|564420340|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360225|NCT02658890|564420341|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360226|NCT02658890|564420342|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360227|NCT02658890|564420343|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360228|NCT02658890|564420344|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360229|NCT02658890|564420345|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360230|NCT02658890|564420346|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360231|NCT02658890|564420347|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360232|NCT02658890|564420348|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360233|NCT02658890|564420349|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360234|NCT02658890|564420350|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360235|NCT02658890|564420351|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360236|NCT02658890|564420352|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360237|NCT02658890|564420326|FG000|Treatment Phase|Adverse Event|0|||
156360238|NCT02658890|564420327|FG001|Treatment Phase|Adverse Event|1|||
156360239|NCT02658890|564420328|FG002|Treatment Phase|Adverse Event|2|||
156360240|NCT02658890|564420329|FG003|Treatment Phase|Adverse Event|2|||
156360241|NCT02658890|564420330|FG004|Treatment Phase|Adverse Event|1|||
156360242|NCT02658890|564420331|FG005|Treatment Phase|Adverse Event|0|||
156360243|NCT02658890|564420332|FG006|Treatment Phase|Adverse Event|0|||
156360244|NCT02658890|564420333|FG007|Treatment Phase|Adverse Event|2|||
156360245|NCT02658890|564420334|FG008|Treatment Phase|Adverse Event|1|||
156360246|NCT02658890|564420335|FG009|Treatment Phase|Adverse Event|2|||
156360247|NCT02658890|564420336|FG010|Treatment Phase|Adverse Event|3|||
156360248|NCT02658890|564420337|FG011|Treatment Phase|Adverse Event|0|||
156360249|NCT02658890|564420338|FG012|Treatment Phase|Adverse Event|1|||
156360250|NCT02658890|564420339|FG013|Treatment Phase|Adverse Event|4|||
156360251|NCT02658890|564420340|FG014|Treatment Phase|Adverse Event|0|||
156360252|NCT02658890|564420341|FG015|Treatment Phase|Adverse Event|0|||
156360253|NCT02658890|564420342|FG016|Treatment Phase|Adverse Event|0|||
156360254|NCT02658890|564420343|FG017|Treatment Phase|Adverse Event|0|||
156360255|NCT02658890|564420344|FG018|Treatment Phase|Adverse Event|5|||
156360256|NCT02658890|564420345|FG019|Treatment Phase|Adverse Event|1|||
156360257|NCT02658890|564420346|FG020|Treatment Phase|Adverse Event|3|||
156360258|NCT02658890|564420347|FG021|Treatment Phase|Adverse Event|0|||
156360259|NCT02658890|564420348|FG022|Treatment Phase|Adverse Event|5|||
156360260|NCT02658890|564420349|FG023|Treatment Phase|Adverse Event|0|||
156360261|NCT02658890|564420350|FG024|Treatment Phase|Adverse Event|0|||
156360262|NCT02658890|564420351|FG025|Treatment Phase|Adverse Event|2|||
156360263|NCT02658890|564420352|FG026|Treatment Phase|Adverse Event|1|||
156360264|NCT02658890|564420326|FG000|Treatment Phase|Death|0|||
156360265|NCT02658890|564420327|FG001|Treatment Phase|Death|0|||
156360266|NCT02658890|564420328|FG002|Treatment Phase|Death|0|||
156360267|NCT02658890|564420329|FG003|Treatment Phase|Death|0|||
156360268|NCT02658890|564420330|FG004|Treatment Phase|Death|0|||
156360269|NCT02658890|564420331|FG005|Treatment Phase|Death|0|||
156360270|NCT02658890|564420332|FG006|Treatment Phase|Death|0|||
156360271|NCT02658890|564420333|FG007|Treatment Phase|Death|0|||
156360272|NCT02658890|564420334|FG008|Treatment Phase|Death|0|||
156489378|NCT01180790|564885634|FG005|Overall Study|Withdrawal by Subject|1|||
156489379|NCT01180790|564885635|FG006|Overall Study|Withdrawal by Subject|0|||
156360273|NCT02658890|564420335|FG009|Treatment Phase|Death|0|||
156360274|NCT02658890|564420336|FG010|Treatment Phase|Death|0|||
156360275|NCT02658890|564420337|FG011|Treatment Phase|Death|0|||
156360276|NCT02658890|564420338|FG012|Treatment Phase|Death|0|||
156360277|NCT02658890|564420339|FG013|Treatment Phase|Death|0|||
156489380|NCT01180790|564885629|FG000|Overall Study|Lost to Follow-up|3|||
156489381|NCT01180790|564885630|FG001|Overall Study|Lost to Follow-up|1|||
156360278|NCT02658890|564420340|FG014|Treatment Phase|Death|0|||
156360279|NCT02658890|564420341|FG015|Treatment Phase|Death|0|||
156360280|NCT02658890|564420342|FG016|Treatment Phase|Death|0|||
156360281|NCT02658890|564420343|FG017|Treatment Phase|Death|0|||
156360282|NCT02658890|564420344|FG018|Treatment Phase|Death|1|||
156489382|NCT01180790|564885631|FG002|Overall Study|Lost to Follow-up|0|||
156489383|NCT01180790|564885632|FG003|Overall Study|Lost to Follow-up|2|||
156360283|NCT02658890|564420345|FG019|Treatment Phase|Death|0|||
156360284|NCT02658890|564420346|FG020|Treatment Phase|Death|0|||
156360285|NCT02658890|564420347|FG021|Treatment Phase|Death|0|||
156360286|NCT02658890|564420348|FG022|Treatment Phase|Death|0|||
156360287|NCT02658890|564420349|FG023|Treatment Phase|Death|0|||
156360288|NCT02658890|564420350|FG024|Treatment Phase|Death|0|||
156360289|NCT02658890|564420351|FG025|Treatment Phase|Death|0|||
156360290|NCT02658890|564420352|FG026|Treatment Phase|Death|0|||
156360291|NCT02658890|564420326|FG000|Treatment Phase|Lost to Follow-up|0|||
156360292|NCT02658890|564420327|FG001|Treatment Phase|Lost to Follow-up|0|||
156360293|NCT02658890|564420328|FG002|Treatment Phase|Lost to Follow-up|0|||
156360294|NCT02658890|564420329|FG003|Treatment Phase|Lost to Follow-up|0|||
156360295|NCT02658890|564420330|FG004|Treatment Phase|Lost to Follow-up|0|||
156360296|NCT02658890|564420331|FG005|Treatment Phase|Lost to Follow-up|0|||
156360297|NCT02658890|564420332|FG006|Treatment Phase|Lost to Follow-up|1|||
156360298|NCT02658890|564420333|FG007|Treatment Phase|Lost to Follow-up|0|||
156360299|NCT02658890|564420334|FG008|Treatment Phase|Lost to Follow-up|0|||
156360300|NCT02658890|564420335|FG009|Treatment Phase|Lost to Follow-up|0|||
156360301|NCT02658890|564420336|FG010|Treatment Phase|Lost to Follow-up|0|||
156360302|NCT02658890|564420337|FG011|Treatment Phase|Lost to Follow-up|0|||
156360303|NCT02658890|564420338|FG012|Treatment Phase|Lost to Follow-up|0|||
156360304|NCT02658890|564420339|FG013|Treatment Phase|Lost to Follow-up|0|||
156360305|NCT02658890|564420340|FG014|Treatment Phase|Lost to Follow-up|0|||
156360306|NCT02658890|564420341|FG015|Treatment Phase|Lost to Follow-up|0|||
156360307|NCT02658890|564420342|FG016|Treatment Phase|Lost to Follow-up|0|||
156360308|NCT02658890|564420343|FG017|Treatment Phase|Lost to Follow-up|0|||
156360309|NCT02658890|564420344|FG018|Treatment Phase|Lost to Follow-up|0|||
156360310|NCT02658890|564420345|FG019|Treatment Phase|Lost to Follow-up|0|||
156360311|NCT02658890|564420346|FG020|Treatment Phase|Lost to Follow-up|0|||
156360312|NCT02658890|564420347|FG021|Treatment Phase|Lost to Follow-up|0|||
156360313|NCT02658890|564420348|FG022|Treatment Phase|Lost to Follow-up|0|||
156360314|NCT02658890|564420349|FG023|Treatment Phase|Lost to Follow-up|0|||
156360315|NCT02658890|564420350|FG024|Treatment Phase|Lost to Follow-up|0|||
156360316|NCT02658890|564420351|FG025|Treatment Phase|Lost to Follow-up|0|||
156360317|NCT02658890|564420352|FG026|Treatment Phase|Lost to Follow-up|0|||
156360318|NCT02658890|564420326|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
156360319|NCT02658890|564420327|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
156360320|NCT02658890|564420328|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
156360321|NCT02658890|564420329|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
156360322|NCT02658890|564420330|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
156360323|NCT02658890|564420331|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
156360324|NCT02658890|564420332|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
156360325|NCT02658890|564420333|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
156360326|NCT02658890|564420334|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
156360327|NCT02658890|564420335|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
156360328|NCT02658890|564420336|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
156360329|NCT02658890|564420337|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
156360330|NCT02658890|564420338|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
156360331|NCT02658890|564420339|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
156360332|NCT02658890|564420340|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
156360333|NCT02658890|564420341|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
156360334|NCT02658890|564420342|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
156360335|NCT02658890|564420343|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
156360336|NCT02658890|564420344|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
156360337|NCT02658890|564420345|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
156360338|NCT02658890|564420346|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
156360339|NCT02658890|564420347|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
156360340|NCT02658890|564420348|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
156360341|NCT02658890|564420349|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
156489384|NCT01180790|564885633|FG004|Overall Study|Lost to Follow-up|1|||
156489385|NCT01180790|564885634|FG005|Overall Study|Lost to Follow-up|0|||
156489386|NCT01180790|564885635|FG006|Overall Study|Lost to Follow-up|1|||
156360342|NCT02658890|564420350|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
156360343|NCT02658890|564420351|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
156360344|NCT02658890|564420352|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
156360345|NCT02658890|564420326|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
156360346|NCT02658890|564420327|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
156360347|NCT02658890|564420328|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
156360348|NCT02658890|564420329|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
156360349|NCT02658890|564420330|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
156360350|NCT02658890|564420331|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
156360351|NCT02658890|564420332|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
156360352|NCT02658890|564420333|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
156360353|NCT02658890|564420334|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
156360354|NCT02658890|564420335|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
156360355|NCT02658890|564420336|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
156360356|NCT02658890|564420337|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
156360357|NCT02658890|564420338|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
156489387|NCT01180790|564885629|FG000|Overall Study|Physician Decision|1|||
156489388|NCT01180790|564885630|FG001|Overall Study|Physician Decision|0|||
156360358|NCT02658890|564420339|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
156360359|NCT02658890|564420340|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
156360360|NCT02658890|564420341|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
156360361|NCT02658890|564420342|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
156360362|NCT02658890|564420343|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
156360363|NCT02658890|564420344|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
156360364|NCT02658890|564420345|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
156360365|NCT02658890|564420346|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
156360366|NCT02658890|564420347|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
156360367|NCT02658890|564420348|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
156360368|NCT02658890|564420349|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
156360369|NCT02658890|564420350|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
156360370|NCT02658890|564420351|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
156360371|NCT02658890|564420352|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
156360372|NCT02658890|564420326|FG000|Treatment Phase|Other Reasons|0|||
156360373|NCT02658890|564420327|FG001|Treatment Phase|Other Reasons|0|||
156360374|NCT02658890|564420328|FG002|Treatment Phase|Other Reasons|0|||
156360375|NCT02658890|564420329|FG003|Treatment Phase|Other Reasons|0|||
156360376|NCT02658890|564420330|FG004|Treatment Phase|Other Reasons|0|||
156360377|NCT02658890|564420331|FG005|Treatment Phase|Other Reasons|0|||
156360378|NCT02658890|564420332|FG006|Treatment Phase|Other Reasons|1|||
156360379|NCT02658890|564420333|FG007|Treatment Phase|Other Reasons|0|||
156360380|NCT02658890|564420334|FG008|Treatment Phase|Other Reasons|1|||
156360381|NCT02658890|564420335|FG009|Treatment Phase|Other Reasons|0|||
156360382|NCT02658890|564420336|FG010|Treatment Phase|Other Reasons|0|||
156360383|NCT02658890|564420337|FG011|Treatment Phase|Other Reasons|0|||
156360384|NCT02658890|564420338|FG012|Treatment Phase|Other Reasons|0|||
156360385|NCT02658890|564420339|FG013|Treatment Phase|Other Reasons|2|||
156360386|NCT02658890|564420340|FG014|Treatment Phase|Other Reasons|0|||
156360387|NCT02658890|564420341|FG015|Treatment Phase|Other Reasons|0|||
156360388|NCT02658890|564420342|FG016|Treatment Phase|Other Reasons|0|||
156360389|NCT02658890|564420343|FG017|Treatment Phase|Other Reasons|0|||
156360390|NCT02658890|564420344|FG018|Treatment Phase|Other Reasons|1|||
156360391|NCT02658890|564420345|FG019|Treatment Phase|Other Reasons|0|||
156360392|NCT02658890|564420346|FG020|Treatment Phase|Other Reasons|0|||
156360393|NCT02658890|564420347|FG021|Treatment Phase|Other Reasons|0|||
156360394|NCT02658890|564420348|FG022|Treatment Phase|Other Reasons|0|||
156360395|NCT02658890|564420349|FG023|Treatment Phase|Other Reasons|0|||
156360396|NCT02658890|564420350|FG024|Treatment Phase|Other Reasons|1|||
156360397|NCT02658890|564420351|FG025|Treatment Phase|Other Reasons|0|||
156360398|NCT02658890|564420352|FG026|Treatment Phase|Other Reasons|1|||
156360399|NCT02658890|564420326|FG000|Treatment Phase|Progressive Disease|6|||
156360400|NCT02658890|564420327|FG001|Treatment Phase|Progressive Disease|7|||
156360401|NCT02658890|564420328|FG002|Treatment Phase|Progressive Disease|6|||
156360402|NCT02658890|564420329|FG003|Treatment Phase|Progressive Disease|12|||
156360403|NCT02658890|564420330|FG004|Treatment Phase|Progressive Disease|6|||
156360404|NCT02658890|564420331|FG005|Treatment Phase|Progressive Disease|18|||
156360405|NCT02658890|564420332|FG006|Treatment Phase|Progressive Disease|12|||
156360406|NCT02658890|564420333|FG007|Treatment Phase|Progressive Disease|19|||
156360407|NCT02658890|564420334|FG008|Treatment Phase|Progressive Disease|26|||
156360408|NCT02658890|564420335|FG009|Treatment Phase|Progressive Disease|8|||
156360409|NCT02658890|564420336|FG010|Treatment Phase|Progressive Disease|7|||
156360410|NCT02658890|564420337|FG011|Treatment Phase|Progressive Disease|9|||
156360411|NCT02658890|564420338|FG012|Treatment Phase|Progressive Disease|8|||
156360412|NCT02658890|564420339|FG013|Treatment Phase|Progressive Disease|29|||
156360413|NCT02658890|564420340|FG014|Treatment Phase|Progressive Disease|6|||
156360414|NCT02658890|564420341|FG015|Treatment Phase|Progressive Disease|2|||
156360415|NCT02658890|564420342|FG016|Treatment Phase|Progressive Disease|32|||
156360416|NCT02658890|564420343|FG017|Treatment Phase|Progressive Disease|14|||
156489389|NCT01180790|564885631|FG002|Overall Study|Physician Decision|0|||
156489390|NCT01180790|564885632|FG003|Overall Study|Physician Decision|1|||
156360417|NCT02658890|564420344|FG018|Treatment Phase|Progressive Disease|40|||
156360418|NCT02658890|564420345|FG019|Treatment Phase|Progressive Disease|32|||
156360419|NCT02658890|564420346|FG020|Treatment Phase|Progressive Disease|19|||
156360420|NCT02658890|564420347|FG021|Treatment Phase|Progressive Disease|30|||
156489391|NCT01180790|564885633|FG004|Overall Study|Physician Decision|0|||
156489392|NCT01180790|564885634|FG005|Overall Study|Physician Decision|0|||
156489393|NCT01180790|564885635|FG006|Overall Study|Physician Decision|0|||
156360421|NCT02658890|564420348|FG022|Treatment Phase|Progressive Disease|15|||
156360422|NCT02658890|564420349|FG023|Treatment Phase|Progressive Disease|0|||
156360423|NCT02658890|564420350|FG024|Treatment Phase|Progressive Disease|0|||
156360424|NCT02658890|564420351|FG025|Treatment Phase|Progressive Disease|14|||
156489394|NCT01180790|564885629|FG000|Overall Study|Lack of Efficacy|1|||
156360425|NCT02658890|564420352|FG026|Treatment Phase|Progressive Disease|11|||
156489395|NCT01180790|564885630|FG001|Overall Study|Lack of Efficacy|2|||
156360426|NCT02658890|564420326|FG000|Treatment Phase|Study Drug Toxicity|0|||
156360427|NCT02658890|564420327|FG001|Treatment Phase|Study Drug Toxicity|0|||
156360428|NCT02658890|564420328|FG002|Treatment Phase|Study Drug Toxicity|2|||
156360429|NCT02658890|564420329|FG003|Treatment Phase|Study Drug Toxicity|0|||
156360430|NCT02658890|564420330|FG004|Treatment Phase|Study Drug Toxicity|0|||
156360431|NCT02658890|564420331|FG005|Treatment Phase|Study Drug Toxicity|0|||
156360432|NCT02658890|564420332|FG006|Treatment Phase|Study Drug Toxicity|0|||
156360433|NCT02658890|564420333|FG007|Treatment Phase|Study Drug Toxicity|0|||
156360434|NCT02658890|564420334|FG008|Treatment Phase|Study Drug Toxicity|3|||
156360435|NCT02658890|564420335|FG009|Treatment Phase|Study Drug Toxicity|0|||
156360436|NCT02658890|564420336|FG010|Treatment Phase|Study Drug Toxicity|1|||
156360437|NCT02658890|564420337|FG011|Treatment Phase|Study Drug Toxicity|1|||
156360438|NCT02658890|564420338|FG012|Treatment Phase|Study Drug Toxicity|2|||
156360439|NCT02658890|564420339|FG013|Treatment Phase|Study Drug Toxicity|9|||
156360440|NCT02658890|564420340|FG014|Treatment Phase|Study Drug Toxicity|0|||
156360441|NCT02658890|564420341|FG015|Treatment Phase|Study Drug Toxicity|1|||
156360442|NCT02658890|564420342|FG016|Treatment Phase|Study Drug Toxicity|1|||
156360443|NCT02658890|564420343|FG017|Treatment Phase|Study Drug Toxicity|0|||
156360444|NCT02658890|564420344|FG018|Treatment Phase|Study Drug Toxicity|8|||
156360445|NCT02658890|564420345|FG019|Treatment Phase|Study Drug Toxicity|3|||
156360446|NCT02658890|564420346|FG020|Treatment Phase|Study Drug Toxicity|2|||
156360447|NCT02658890|564420347|FG021|Treatment Phase|Study Drug Toxicity|0|||
156360448|NCT02658890|564420348|FG022|Treatment Phase|Study Drug Toxicity|8|||
156360449|NCT02658890|564420349|FG023|Treatment Phase|Study Drug Toxicity|0|||
156360450|NCT02658890|564420350|FG024|Treatment Phase|Study Drug Toxicity|0|||
156360451|NCT02658890|564420351|FG025|Treatment Phase|Study Drug Toxicity|2|||
156360452|NCT02658890|564420352|FG026|Treatment Phase|Study Drug Toxicity|0|||
156360453|NCT02658890|564420326|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360454|NCT02658890|564420327|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360455|NCT02658890|564420328|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360456|NCT02658890|564420329|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156360457|NCT02658890|564420330|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360458|NCT02658890|564420331|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360459|NCT02658890|564420332|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360460|NCT02658890|564420333|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360461|NCT02658890|564420334|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360462|NCT02658890|564420335|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156360463|NCT02658890|564420336|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360464|NCT02658890|564420337|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360465|NCT02658890|564420338|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360466|NCT02658890|564420339|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360467|NCT02658890|564420340|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360468|NCT02658890|564420341|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360469|NCT02658890|564420342|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360470|NCT02658890|564420343|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360471|NCT02658890|564420344|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156360472|NCT02658890|564420345|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360473|NCT02658890|564420346|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360474|NCT02658890|564420347|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360475|NCT02658890|564420348|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156360476|NCT02658890|564420349|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360477|NCT02658890|564420350|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360478|NCT02658890|564420351|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360479|NCT02658890|564420352|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156360480|NCT02658890|564420326|FG000|Treatment Phase|Withdrawal by Subject|0|||
156360481|NCT02658890|564420327|FG001|Treatment Phase|Withdrawal by Subject|1|||
156360482|NCT02658890|564420328|FG002|Treatment Phase|Withdrawal by Subject|0|||
156489396|NCT01180790|564885631|FG002|Overall Study|Lack of Efficacy|5|||
156489397|NCT01180790|564885632|FG003|Overall Study|Lack of Efficacy|6|||
156489398|NCT01180790|564885633|FG004|Overall Study|Lack of Efficacy|1|||
156489399|NCT01180790|564885634|FG005|Overall Study|Lack of Efficacy|3|||
156360483|NCT02658890|564420329|FG003|Treatment Phase|Withdrawal by Subject|0|||
156360484|NCT02658890|564420330|FG004|Treatment Phase|Withdrawal by Subject|0|||
156360485|NCT02658890|564420331|FG005|Treatment Phase|Withdrawal by Subject|0|||
156360486|NCT02658890|564420332|FG006|Treatment Phase|Withdrawal by Subject|1|||
156360487|NCT02658890|564420333|FG007|Treatment Phase|Withdrawal by Subject|0|||
156360488|NCT02658890|564420334|FG008|Treatment Phase|Withdrawal by Subject|0|||
156489400|NCT01180790|564885635|FG006|Overall Study|Lack of Efficacy|0|||
156489401|NCT01180790|564885629|FG000|Overall Study|compliance|0|||
156360489|NCT02658890|564420335|FG009|Treatment Phase|Withdrawal by Subject|1|||
156489402|NCT01180790|564885630|FG001|Overall Study|compliance|1|||
156489403|NCT01180790|564885631|FG002|Overall Study|compliance|0|||
156489404|NCT01180790|564885632|FG003|Overall Study|compliance|0|||
156489405|NCT01180790|564885633|FG004|Overall Study|compliance|0|||
156489406|NCT01180790|564885634|FG005|Overall Study|compliance|0|||
156489407|NCT01180790|564885635|FG006|Overall Study|compliance|0|||
156489408|NCT01180790|564885629|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
156489409|NCT01180790|564885630|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
156489410|NCT01180790|564885631|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
156489411|NCT01180790|564885632|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
156489412|NCT01180790|564885633|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
156489413|NCT01180790|564885634|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
156489414|NCT01180790|564885635|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
156489415|NCT00655668|564885636|FG000|Overall Study|Adverse Event|6|||
156489416|NCT00655668|564885636|FG000|Overall Study|Death|5|||
156489417|NCT00655668|564885636|FG000|Overall Study|Disease Progression|27|||
156489418|NCT00655668|564885636|FG000|Overall Study|Study Terminated|9|||
156489419|NCT00655668|564885636|FG000|Overall Study|Other|1|||
156489420|NCT00655668|564885636|FG000|Overall Study|New Lymphoma Treatment Started|4|||
156489421|NCT00655668|564885636|FG000|Overall Study|Withdrawal by Subject|2|||
156489422|NCT02335242|564885637|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
156489423|NCT02335242|564885638|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
156489424|NCT02335242|564885637|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
156489425|NCT02335242|564885638|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
156489426|NCT02335242|564885637|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
156489427|NCT02335242|564885638|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
156489428|NCT03840148|564885639|FG000|Study Drug Disposition|Adverse Event|13|||
156489429|NCT03840148|564885640|FG001|Study Drug Disposition|Adverse Event|2|||
156489430|NCT03840148|564885639|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
156489431|NCT03840148|564885640|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
156489432|NCT03840148|564885639|FG000|Study Drug Disposition|Lack of Efficacy|3|||
156489433|NCT03840148|564885640|FG001|Study Drug Disposition|Lack of Efficacy|0|||
156489434|NCT03840148|564885639|FG000|Study Drug Disposition|Physician Decision|2|||
156489435|NCT03840148|564885640|FG001|Study Drug Disposition|Physician Decision|0|||
156489436|NCT03840148|564885639|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
156489437|NCT03840148|564885640|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
156489438|NCT03840148|564885639|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
156489439|NCT03840148|564885640|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
156489440|NCT03840148|564885639|FG000|Study Completion Disposition|Physician Decision|2|||
156489441|NCT03840148|564885640|FG001|Study Completion Disposition|Physician Decision|0|||
156489442|NCT03840148|564885639|FG000|Study Completion Disposition|Covid-19 related|2|||
156489443|NCT03840148|564885640|FG001|Study Completion Disposition|Covid-19 related|0|||
156489444|NCT03840148|564885639|FG000|Study Completion Disposition|Lost to Follow-up|1|||
156489445|NCT03840148|564885640|FG001|Study Completion Disposition|Lost to Follow-up|1|||
156489446|NCT03840148|564885639|FG000|Study Completion Disposition|Death|1|||
156489447|NCT03840148|564885640|FG001|Study Completion Disposition|Death|0|||
156489448|NCT03840148|564885639|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
156489449|NCT03840148|564885640|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
156489450|NCT03615404|564885641|FG000|Overall Study|Death|1|||
156489451|NCT03615404|564885641|FG000|Overall Study|vaccine did not pass quality assurance|1|||
156489452|NCT00257556|564885642|FG000|Overall Study|Adverse Event|1|||
156489453|NCT00257556|564885643|FG001|Overall Study|Adverse Event|4|||
156489454|NCT00257556|564885642|FG000|Overall Study|Physician Decision|6|||
156489455|NCT00257556|564885643|FG001|Overall Study|Physician Decision|0|||
156489456|NCT00257556|564885642|FG000|Overall Study|Did not meet hCG criterion|3|||
156489457|NCT00257556|564885643|FG001|Overall Study|Did not meet hCG criterion|0|||
156489458|NCT00257556|564885642|FG000|Overall Study|other reason|4|||
156489459|NCT00257556|564885643|FG001|Overall Study|other reason|6|||
156489460|NCT03873038|564885645|FG000|Part 2|Withdrawal by Subject|0|||
156360490|NCT02658890|564420336|FG010|Treatment Phase|Withdrawal by Subject|0|||
156360491|NCT02658890|564420337|FG011|Treatment Phase|Withdrawal by Subject|0|||
156360492|NCT02658890|564420338|FG012|Treatment Phase|Withdrawal by Subject|1|||
156360493|NCT02658890|564420339|FG013|Treatment Phase|Withdrawal by Subject|3|||
156360494|NCT02658890|564420340|FG014|Treatment Phase|Withdrawal by Subject|0|||
156489461|NCT03873038|564885646|FG001|Part 2|Withdrawal by Subject|0|||
156489462|NCT03873038|564885647|FG002|Part 2|Withdrawal by Subject|0|||
156489463|NCT03873038|564885648|FG003|Part 2|Withdrawal by Subject|0|||
156489464|NCT03873038|564885649|FG004|Part 2|Withdrawal by Subject|0|||
156489465|NCT03873038|564885650|FG005|Part 2|Withdrawal by Subject|1|||
156360495|NCT02658890|564420341|FG015|Treatment Phase|Withdrawal by Subject|0|||
156489466|NCT03873038|564885645|FG000|Part 2|Unknon|0|||
156489467|NCT03873038|564885646|FG001|Part 2|Unknon|0|||
156360496|NCT02658890|564420342|FG016|Treatment Phase|Withdrawal by Subject|1|||
156360497|NCT02658890|564420343|FG017|Treatment Phase|Withdrawal by Subject|0|||
156360498|NCT02658890|564420344|FG018|Treatment Phase|Withdrawal by Subject|4|||
156360499|NCT02658890|564420345|FG019|Treatment Phase|Withdrawal by Subject|3|||
156360500|NCT02658890|564420346|FG020|Treatment Phase|Withdrawal by Subject|0|||
156360501|NCT02658890|564420347|FG021|Treatment Phase|Withdrawal by Subject|4|||
156360502|NCT02658890|564420348|FG022|Treatment Phase|Withdrawal by Subject|1|||
156360503|NCT02658890|564420349|FG023|Treatment Phase|Withdrawal by Subject|1|||
156360504|NCT02658890|564420350|FG024|Treatment Phase|Withdrawal by Subject|0|||
156360505|NCT02658890|564420351|FG025|Treatment Phase|Withdrawal by Subject|0|||
156360506|NCT02658890|564420352|FG026|Treatment Phase|Withdrawal by Subject|0|||
156360507|NCT02474199|564420356|FG000|Overall Study|Lost to Follow-up|1|||
156360508|NCT02474199|564420357|FG001|Overall Study|Lost to Follow-up|0|||
156360509|NCT02474199|564420358|FG002|Overall Study|Lost to Follow-up|0|||
156360510|NCT02474199|564420359|FG003|Overall Study|Lost to Follow-up|0|||
156360511|NCT02474199|564420356|FG000|Overall Study|Withdrawal by Subject|1|||
156360512|NCT02474199|564420357|FG001|Overall Study|Withdrawal by Subject|2|||
156360513|NCT02474199|564420358|FG002|Overall Study|Withdrawal by Subject|0|||
156360514|NCT02474199|564420359|FG003|Overall Study|Withdrawal by Subject|1|||
156360515|NCT02474199|564420356|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
156360516|NCT02474199|564420357|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
156360517|NCT02474199|564420358|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
156360518|NCT02474199|564420359|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
156360519|NCT02474199|564420356|FG000|Overall Study|Did not meet eligibility criteria|0|||
156360520|NCT02474199|564420357|FG001|Overall Study|Did not meet eligibility criteria|0|||
156360521|NCT02474199|564420358|FG002|Overall Study|Did not meet eligibility criteria|2|||
156360522|NCT02474199|564420359|FG003|Overall Study|Did not meet eligibility criteria|2|||
156360523|NCT03090100|564420360|FG000|Overall Study|Adverse Event|9|||
156360524|NCT03090100|564420361|FG001|Overall Study|Adverse Event|11|||
156360525|NCT03090100|564420360|FG000|Overall Study|Pregnancy|1|||
156360526|NCT03090100|564420361|FG001|Overall Study|Pregnancy|1|||
156360527|NCT03090100|564420360|FG000|Overall Study|Lack of Efficacy|2|||
156360528|NCT03090100|564420361|FG001|Overall Study|Lack of Efficacy|7|||
156360529|NCT03090100|564420360|FG000|Overall Study|Lost to Follow-up|2|||
156360530|NCT03090100|564420361|FG001|Overall Study|Lost to Follow-up|2|||
156360531|NCT03090100|564420360|FG000|Overall Study|Withdrawal by Subject|7|||
156360532|NCT03090100|564420361|FG001|Overall Study|Withdrawal by Subject|19|||
156489468|NCT03873038|564885647|FG002|Part 2|Unknon|0|||
156489469|NCT03873038|564885648|FG003|Part 2|Unknon|0|||
156489470|NCT03873038|564885649|FG004|Part 2|Unknon|1|||
156489471|NCT03873038|564885650|FG005|Part 2|Unknon|0|||
156489472|NCT00595764|564885651|FG000|Overall Study|Protocol Violation|24|||
156489473|NCT00595764|564885652|FG001|Overall Study|Protocol Violation|19|||
156489474|NCT00595764|564885651|FG000|Overall Study|Missed Medication >1 week|10|||
156489475|NCT00595764|564885652|FG001|Overall Study|Missed Medication >1 week|17|||
156489476|NCT00595764|564885651|FG000|Overall Study|Missed 3 PM visits|1|||
156489477|NCT00595764|564885652|FG001|Overall Study|Missed 3 PM visits|7|||
156489478|NCT00595764|564885651|FG000|Overall Study|Withdrawal by Subject|4|||
156489479|NCT00595764|564885652|FG001|Overall Study|Withdrawal by Subject|0|||
156489480|NCT04222088|564885653|FG000|Overall Study|Lost to Follow-up|5|||
156489481|NCT04222088|564885654|FG001|Overall Study|Lost to Follow-up|1|||
156489482|NCT04222088|564885653|FG000|Overall Study|Withdrawal by Subject|4|||
156489483|NCT04222088|564885654|FG001|Overall Study|Withdrawal by Subject|0|||
156489484|NCT03849300|564885655|FG000|Overall Study|move out to different area|1|||
156489485|NCT03849300|564885656|FG001|Overall Study|move out to different area|3|||
156489486|NCT03849300|564885657|FG002|Overall Study|move out to different area|1|||
156489487|NCT03849300|564885658|FG003|Overall Study|move out to different area|4|||
156489488|NCT03849300|564885655|FG000|Overall Study|scheduling/transportation conflict|4|||
156489489|NCT03849300|564885656|FG001|Overall Study|scheduling/transportation conflict|4|||
156489490|NCT03849300|564885657|FG002|Overall Study|scheduling/transportation conflict|3|||
156489491|NCT03849300|564885658|FG003|Overall Study|scheduling/transportation conflict|2|||
156489492|NCT04839289|564885659|FG000|Overall Study|Withdrawal by Subject|1|||
156489493|NCT04839289|564885660|FG001|Overall Study|Withdrawal by Subject|0|||
156489494|NCT00663923|564885663|FG000|Overall Study|Lost to Follow-up|2|||
156489495|NCT02785900|564885664|FG000|Overall Study|Study Termination by Sponsor|64|||
156489496|NCT02785900|564885665|FG001|Overall Study|Study Termination by Sponsor|81|||
156489497|NCT02785900|564885664|FG000|Overall Study|Death|46|||
156489498|NCT02785900|564885665|FG001|Overall Study|Death|32|||
156489499|NCT02785900|564885664|FG000|Overall Study|Withdrawal by Subject|4|||
156489500|NCT02785900|564885665|FG001|Overall Study|Withdrawal by Subject|8|||
156489501|NCT02785900|564885664|FG000|Overall Study|Physician Decision|3|||
156360533|NCT03090100|564420360|FG000|Overall Study|Protocol Violation|2|||
156360534|NCT03090100|564420361|FG001|Overall Study|Protocol Violation|6|||
156489502|NCT02785900|564885665|FG001|Overall Study|Physician Decision|2|||
156489503|NCT04341584|564885666|FG000|Overall Study|Withdrew consent|0|||
156489504|NCT04341584|564885667|FG001|Overall Study|Withdrew consent|2|||
156489505|NCT04341584|564885668|FG002|Overall Study|Withdrew consent|2|||
156489506|NCT04341584|564885669|FG003|Overall Study|Withdrew consent|1|||
156360535|NCT03090100|564420360|FG000|Overall Study|Non-compliance|2|||
156360536|NCT03090100|564420361|FG001|Overall Study|Non-compliance|0|||
156360537|NCT03090100|564420360|FG000|Overall Study|Other|2|||
156360538|NCT03090100|564420361|FG001|Overall Study|Other|2|||
156360539|NCT00159588|564420362|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
156360540|NCT00159588|564420363|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
156360541|NCT00159588|564420364|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
156360542|NCT03446040|564420365|FG000|Overall Study|Disease progression|3|||
156360543|NCT03446040|564420366|FG001|Overall Study|Disease progression|3|||
156360544|NCT03446040|564420367|FG002|Overall Study|Disease progression|3|||
156360545|NCT03446040|564420368|FG003|Overall Study|Disease progression|4|||
156360546|NCT03446040|564420369|FG004|Overall Study|Disease progression|4|||
156360547|NCT03446040|564420370|FG005|Overall Study|Disease progression|6|||
156360548|NCT03446040|564420371|FG006|Overall Study|Disease progression|3|||
156360549|NCT03446040|564420372|FG007|Overall Study|Disease progression|4|||
156360550|NCT03446040|564420373|FG008|Overall Study|Disease progression|2|||
156360551|NCT03446040|564420374|FG009|Overall Study|Disease progression|4|||
156360552|NCT03446040|564420375|FG010|Overall Study|Disease progression|9|||
156360553|NCT03446040|564420376|FG011|Overall Study|Disease progression|3|||
156360554|NCT03446040|564420377|FG012|Overall Study|Disease progression|7|||
156360555|NCT03446040|564420378|FG013|Overall Study|Disease progression|7|||
156360556|NCT03446040|564420365|FG000|Overall Study|Study drug toxicity|0|||
156360557|NCT03446040|564420366|FG001|Overall Study|Study drug toxicity|0|||
156360558|NCT03446040|564420367|FG002|Overall Study|Study drug toxicity|0|||
156360559|NCT03446040|564420368|FG003|Overall Study|Study drug toxicity|0|||
156360560|NCT03446040|564420369|FG004|Overall Study|Study drug toxicity|0|||
156360561|NCT03446040|564420370|FG005|Overall Study|Study drug toxicity|0|||
156360562|NCT03446040|564420371|FG006|Overall Study|Study drug toxicity|0|||
156360563|NCT03446040|564420372|FG007|Overall Study|Study drug toxicity|0|||
156360564|NCT03446040|564420373|FG008|Overall Study|Study drug toxicity|1|||
156360565|NCT03446040|564420374|FG009|Overall Study|Study drug toxicity|0|||
156360566|NCT03446040|564420375|FG010|Overall Study|Study drug toxicity|0|||
156360567|NCT03446040|564420376|FG011|Overall Study|Study drug toxicity|0|||
156360568|NCT03446040|564420377|FG012|Overall Study|Study drug toxicity|0|||
156360569|NCT03446040|564420378|FG013|Overall Study|Study drug toxicity|0|||
156360570|NCT03446040|564420365|FG000|Overall Study|Adverse Event|0|||
156360571|NCT03446040|564420366|FG001|Overall Study|Adverse Event|0|||
156360572|NCT03446040|564420367|FG002|Overall Study|Adverse Event|0|||
156360573|NCT03446040|564420368|FG003|Overall Study|Adverse Event|0|||
156360574|NCT03446040|564420369|FG004|Overall Study|Adverse Event|0|||
156360575|NCT03446040|564420370|FG005|Overall Study|Adverse Event|2|||
156360576|NCT03446040|564420371|FG006|Overall Study|Adverse Event|0|||
156360577|NCT03446040|564420372|FG007|Overall Study|Adverse Event|0|||
156360578|NCT03446040|564420373|FG008|Overall Study|Adverse Event|1|||
156360579|NCT03446040|564420374|FG009|Overall Study|Adverse Event|0|||
156360580|NCT03446040|564420375|FG010|Overall Study|Adverse Event|0|||
156360581|NCT03446040|564420376|FG011|Overall Study|Adverse Event|0|||
156360582|NCT03446040|564420377|FG012|Overall Study|Adverse Event|0|||
156360583|NCT03446040|564420378|FG013|Overall Study|Adverse Event|0|||
156360584|NCT03446040|564420365|FG000|Overall Study|Death|0|||
156360585|NCT03446040|564420366|FG001|Overall Study|Death|0|||
156360586|NCT03446040|564420367|FG002|Overall Study|Death|0|||
156360587|NCT03446040|564420368|FG003|Overall Study|Death|0|||
156360588|NCT03446040|564420369|FG004|Overall Study|Death|0|||
156360589|NCT03446040|564420370|FG005|Overall Study|Death|0|||
156360590|NCT03446040|564420371|FG006|Overall Study|Death|0|||
156360591|NCT03446040|564420372|FG007|Overall Study|Death|0|||
156360592|NCT03446040|564420373|FG008|Overall Study|Death|0|||
156360593|NCT03446040|564420374|FG009|Overall Study|Death|0|||
156360594|NCT03446040|564420375|FG010|Overall Study|Death|1|||
156360595|NCT03446040|564420376|FG011|Overall Study|Death|0|||
156360596|NCT03446040|564420377|FG012|Overall Study|Death|0|||
156360597|NCT03446040|564420378|FG013|Overall Study|Death|2|||
156360598|NCT03446040|564420365|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
156360599|NCT03446040|564420366|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
156360600|NCT03446040|564420367|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
156360601|NCT03446040|564420368|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
156360602|NCT03446040|564420369|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
156360603|NCT03446040|564420370|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
156489507|NCT00497198|564885670|FG000|Overall Study|Adverse Event|4|||
156360604|NCT03446040|564420371|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
156360605|NCT03446040|564420372|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
156360606|NCT03446040|564420373|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
156360607|NCT03446040|564420374|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
156360608|NCT03446040|564420375|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
156360609|NCT03446040|564420376|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
156360610|NCT03446040|564420377|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
156360611|NCT03446040|564420378|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
156360612|NCT03446040|564420365|FG000|Overall Study|Participant withdrew consent|0|||
156360613|NCT03446040|564420366|FG001|Overall Study|Participant withdrew consent|0|||
156360614|NCT03446040|564420367|FG002|Overall Study|Participant withdrew consent|0|||
156360615|NCT03446040|564420368|FG003|Overall Study|Participant withdrew consent|0|||
156360616|NCT03446040|564420369|FG004|Overall Study|Participant withdrew consent|0|||
156360617|NCT03446040|564420370|FG005|Overall Study|Participant withdrew consent|1|||
156360618|NCT03446040|564420371|FG006|Overall Study|Participant withdrew consent|0|||
156360619|NCT03446040|564420372|FG007|Overall Study|Participant withdrew consent|1|||
156360620|NCT03446040|564420373|FG008|Overall Study|Participant withdrew consent|0|||
156360621|NCT03446040|564420374|FG009|Overall Study|Participant withdrew consent|0|||
156360622|NCT03446040|564420375|FG010|Overall Study|Participant withdrew consent|0|||
156360623|NCT03446040|564420376|FG011|Overall Study|Participant withdrew consent|0|||
156360624|NCT03446040|564420377|FG012|Overall Study|Participant withdrew consent|0|||
156360625|NCT03446040|564420378|FG013|Overall Study|Participant withdrew consent|0|||
156360626|NCT03446040|564420365|FG000|Overall Study|Not reported|0|||
156360627|NCT03446040|564420366|FG001|Overall Study|Not reported|0|||
156360628|NCT03446040|564420367|FG002|Overall Study|Not reported|1|||
156360629|NCT03446040|564420368|FG003|Overall Study|Not reported|0|||
156360630|NCT03446040|564420369|FG004|Overall Study|Not reported|0|||
156360631|NCT03446040|564420370|FG005|Overall Study|Not reported|0|||
156360632|NCT03446040|564420371|FG006|Overall Study|Not reported|0|||
156360633|NCT03446040|564420372|FG007|Overall Study|Not reported|0|||
156360634|NCT03446040|564420373|FG008|Overall Study|Not reported|0|||
156360635|NCT03446040|564420374|FG009|Overall Study|Not reported|0|||
156360636|NCT03446040|564420375|FG010|Overall Study|Not reported|0|||
156360637|NCT03446040|564420376|FG011|Overall Study|Not reported|0|||
156360638|NCT03446040|564420377|FG012|Overall Study|Not reported|0|||
156360639|NCT03446040|564420378|FG013|Overall Study|Not reported|0|||
156360640|NCT00456521|564420379|FG000|Overall Study|Adverse Event|150|||
156360641|NCT00456521|564420380|FG001|Overall Study|Adverse Event|25|||
156360642|NCT00456521|564420379|FG000|Overall Study|Withdrawal by Subject|43|||
156360643|NCT00456521|564420380|FG001|Overall Study|Withdrawal by Subject|24|||
156360644|NCT00456521|564420379|FG000|Overall Study|Lost to Follow-up|22|||
156360645|NCT00456521|564420380|FG001|Overall Study|Lost to Follow-up|17|||
156360646|NCT00456521|564420379|FG000|Overall Study|Lack of Efficacy|3|||
156360647|NCT00456521|564420380|FG001|Overall Study|Lack of Efficacy|6|||
156360648|NCT00456521|564420379|FG000|Overall Study|Protocol Violation|4|||
156360649|NCT00456521|564420380|FG001|Overall Study|Protocol Violation|0|||
156360650|NCT00456521|564420379|FG000|Overall Study|Pregnancy|1|||
156360651|NCT00456521|564420380|FG001|Overall Study|Pregnancy|1|||
156360652|NCT00456521|564420379|FG000|Overall Study|Drug non-compliance, moved, other|26|||
156360653|NCT00456521|564420380|FG001|Overall Study|Drug non-compliance, moved, other|11|||
156360654|NCT01316276|564420381|FG000|Overall Study|Death|1|||
156360655|NCT01316276|564420381|FG000|Overall Study|Adverse Event|19|||
156360656|NCT01316276|564420381|FG000|Overall Study|Withdrawal of consent|24|||
156360657|NCT01316276|564420381|FG000|Overall Study|Lost to Follow-up|1|||
156360658|NCT01316276|564420381|FG000|Overall Study|Other|22|||
156360659|NCT00605475|564420382|FG000|Overall Study|Abnormal Laboratory Values|0|||
156360660|NCT00605475|564420383|FG001|Overall Study|Abnormal Laboratory Values|0|||
156360661|NCT00605475|564420384|FG002|Overall Study|Abnormal Laboratory Values|0|||
156360662|NCT00605475|564420385|FG003|Overall Study|Abnormal Laboratory Values|0|||
156360663|NCT00605475|564420386|FG004|Overall Study|Abnormal Laboratory Values|0|||
156360664|NCT00605475|564420387|FG005|Overall Study|Abnormal Laboratory Values|0|||
156360665|NCT00605475|564420388|FG006|Overall Study|Abnormal Laboratory Values|0|||
156360666|NCT00605475|564420389|FG007|Overall Study|Abnormal Laboratory Values|0|||
156360667|NCT00605475|564420390|FG008|Overall Study|Abnormal Laboratory Values|1|||
156360668|NCT00605475|564420391|FG009|Overall Study|Abnormal Laboratory Values|0|||
156360669|NCT00605475|564420382|FG000|Overall Study|Administrative problems|0|||
156360670|NCT00605475|564420383|FG001|Overall Study|Administrative problems|0|||
156360671|NCT00605475|564420384|FG002|Overall Study|Administrative problems|0|||
156360672|NCT00605475|564420385|FG003|Overall Study|Administrative problems|0|||
156360673|NCT00605475|564420386|FG004|Overall Study|Administrative problems|0|||
156360674|NCT00605475|564420387|FG005|Overall Study|Administrative problems|0|||
156360675|NCT00605475|564420388|FG006|Overall Study|Administrative problems|1|||
156360676|NCT00605475|564420389|FG007|Overall Study|Administrative problems|0|||
156360677|NCT00605475|564420390|FG008|Overall Study|Administrative problems|0|||
156360678|NCT00605475|564420391|FG009|Overall Study|Administrative problems|0|||
156360679|NCT00605475|564420382|FG000|Overall Study|Lost to Follow-up|0|||
156360680|NCT00605475|564420383|FG001|Overall Study|Lost to Follow-up|0|||
156360681|NCT00605475|564420384|FG002|Overall Study|Lost to Follow-up|0|||
156360682|NCT00605475|564420385|FG003|Overall Study|Lost to Follow-up|0|||
156360683|NCT00605475|564420386|FG004|Overall Study|Lost to Follow-up|0|||
156360684|NCT00605475|564420387|FG005|Overall Study|Lost to Follow-up|0|||
156360685|NCT00605475|564420388|FG006|Overall Study|Lost to Follow-up|0|||
156360686|NCT00605475|564420389|FG007|Overall Study|Lost to Follow-up|0|||
156489508|NCT00497198|564885671|FG001|Overall Study|Adverse Event|2|||
156360687|NCT00605475|564420390|FG008|Overall Study|Lost to Follow-up|1|||
156360688|NCT00605475|564420391|FG009|Overall Study|Lost to Follow-up|1|||
156360689|NCT00605475|564420382|FG000|Overall Study|Protocol Violation|0|||
156360690|NCT00605475|564420383|FG001|Overall Study|Protocol Violation|0|||
156360691|NCT00605475|564420384|FG002|Overall Study|Protocol Violation|0|||
156360692|NCT00605475|564420385|FG003|Overall Study|Protocol Violation|0|||
156360693|NCT00605475|564420386|FG004|Overall Study|Protocol Violation|1|||
156360694|NCT00605475|564420387|FG005|Overall Study|Protocol Violation|0|||
156360695|NCT00605475|564420388|FG006|Overall Study|Protocol Violation|0|||
156360696|NCT00605475|564420389|FG007|Overall Study|Protocol Violation|0|||
156360697|NCT00605475|564420390|FG008|Overall Study|Protocol Violation|0|||
156360698|NCT00605475|564420391|FG009|Overall Study|Protocol Violation|0|||
156360699|NCT00605475|564420382|FG000|Overall Study|Withdrawal by Subject|0|||
156360700|NCT00605475|564420383|FG001|Overall Study|Withdrawal by Subject|0|||
156360701|NCT00605475|564420384|FG002|Overall Study|Withdrawal by Subject|0|||
156360702|NCT00605475|564420385|FG003|Overall Study|Withdrawal by Subject|0|||
156360703|NCT00605475|564420386|FG004|Overall Study|Withdrawal by Subject|0|||
156360704|NCT00605475|564420387|FG005|Overall Study|Withdrawal by Subject|2|||
156360705|NCT00605475|564420388|FG006|Overall Study|Withdrawal by Subject|0|||
156360706|NCT00605475|564420389|FG007|Overall Study|Withdrawal by Subject|0|||
156360707|NCT00605475|564420390|FG008|Overall Study|Withdrawal by Subject|0|||
156360708|NCT00605475|564420391|FG009|Overall Study|Withdrawal by Subject|1|||
156360709|NCT00464568|564420398|FG000|Overall Study|Adverse Event|2|||
156360710|NCT03406858|564420399|FG000|Overall Study|Failure to receive treatment drug.|1|||
156360711|NCT03406858|564420399|FG000|Overall Study|ineligible|1|||
156360712|NCT00405587|564420400|FG000|Overall Study|Death|0|||
156360713|NCT00405587|564420401|FG001|Overall Study|Death|0|||
156360714|NCT00405587|564420402|FG002|Overall Study|Death|0|||
156360715|NCT00405587|564420403|FG003|Overall Study|Death|1|||
156360716|NCT00405587|564420400|FG000|Overall Study|Disease Progression|22|||
156360717|NCT00405587|564420401|FG001|Overall Study|Disease Progression|23|||
156360718|NCT00405587|564420402|FG002|Overall Study|Disease Progression|21|||
156360719|NCT00405587|564420403|FG003|Overall Study|Disease Progression|17|||
156360720|NCT00405587|564420400|FG000|Overall Study|Physician Decision|3|||
156360721|NCT00405587|564420401|FG001|Overall Study|Physician Decision|2|||
156360722|NCT00405587|564420402|FG002|Overall Study|Physician Decision|0|||
156360723|NCT00405587|564420403|FG003|Overall Study|Physician Decision|0|||
156360724|NCT00405587|564420400|FG000|Overall Study|Adverse Event|1|||
156360725|NCT00405587|564420401|FG001|Overall Study|Adverse Event|0|||
156360726|NCT00405587|564420402|FG002|Overall Study|Adverse Event|0|||
156360727|NCT00405587|564420403|FG003|Overall Study|Adverse Event|0|||
156360728|NCT00405587|564420400|FG000|Overall Study|Lost to Follow-up|0|||
156360729|NCT00405587|564420401|FG001|Overall Study|Lost to Follow-up|1|||
156360730|NCT00405587|564420402|FG002|Overall Study|Lost to Follow-up|1|||
156360731|NCT00405587|564420403|FG003|Overall Study|Lost to Follow-up|0|||
156360732|NCT00405587|564420400|FG000|Overall Study|Radiation induced necrosis|0|||
156360733|NCT00405587|564420401|FG001|Overall Study|Radiation induced necrosis|1|||
156360734|NCT00405587|564420402|FG002|Overall Study|Radiation induced necrosis|0|||
156360735|NCT00405587|564420403|FG003|Overall Study|Radiation induced necrosis|0|||
156360736|NCT00405587|564420400|FG000|Overall Study|Withdrawal by Subject|0|||
156360737|NCT00405587|564420401|FG001|Overall Study|Withdrawal by Subject|0|||
156360738|NCT00405587|564420402|FG002|Overall Study|Withdrawal by Subject|0|||
156360739|NCT00405587|564420403|FG003|Overall Study|Withdrawal by Subject|2|||
156360740|NCT00405587|564420400|FG000|Overall Study|Participant not dosed|0|||
156360741|NCT00405587|564420401|FG001|Overall Study|Participant not dosed|1|||
156360742|NCT00405587|564420402|FG002|Overall Study|Participant not dosed|0|||
156360743|NCT00405587|564420403|FG003|Overall Study|Participant not dosed|0|||
156360744|NCT06027866|564420404|FG000|Overall Study|Withdrawal by Subject|2|||
156360745|NCT00507442|564420407|FG000|Overall Study|Adverse Event|8|||
156360746|NCT00507442|564420408|FG001|Overall Study|Adverse Event|11|||
156360747|NCT00507442|564420409|FG002|Overall Study|Adverse Event|4|||
156360748|NCT00507442|564420410|FG003|Overall Study|Adverse Event|1|||
156360749|NCT00507442|564420407|FG000|Overall Study|Protocol Violation|0|||
156360750|NCT00507442|564420408|FG001|Overall Study|Protocol Violation|1|||
156489509|NCT00497198|564885670|FG000|Overall Study|Physician Decision|1|||
156489510|NCT00497198|564885671|FG001|Overall Study|Physician Decision|2|||
156360751|NCT00507442|564420409|FG002|Overall Study|Protocol Violation|0|||
156360752|NCT00507442|564420410|FG003|Overall Study|Protocol Violation|0|||
156360753|NCT00507442|564420407|FG000|Overall Study|Lost to Follow-up|0|||
156360754|NCT00507442|564420408|FG001|Overall Study|Lost to Follow-up|0|||
156360755|NCT00507442|564420409|FG002|Overall Study|Lost to Follow-up|1|||
156360756|NCT00507442|564420410|FG003|Overall Study|Lost to Follow-up|0|||
156360757|NCT00507442|564420407|FG000|Overall Study|Physician Decision|0|||
156360758|NCT00507442|564420408|FG001|Overall Study|Physician Decision|2|||
156360759|NCT00507442|564420409|FG002|Overall Study|Physician Decision|4|||
156360760|NCT00507442|564420410|FG003|Overall Study|Physician Decision|1|||
156360761|NCT00507442|564420407|FG000|Overall Study|Progressive Disease|2|||
156360762|NCT00507442|564420408|FG001|Overall Study|Progressive Disease|4|||
156360763|NCT00507442|564420409|FG002|Overall Study|Progressive Disease|2|||
156360764|NCT00507442|564420410|FG003|Overall Study|Progressive Disease|0|||
156360765|NCT00507442|564420407|FG000|Overall Study|Withdrawal by Subject|4|||
156360766|NCT00507442|564420408|FG001|Overall Study|Withdrawal by Subject|4|||
156360767|NCT00507442|564420409|FG002|Overall Study|Withdrawal by Subject|2|||
156360768|NCT00507442|564420410|FG003|Overall Study|Withdrawal by Subject|1|||
156360769|NCT00507442|564420407|FG000|Overall Study|Other|2|||
156360770|NCT00507442|564420408|FG001|Overall Study|Other|5|||
156360771|NCT00507442|564420409|FG002|Overall Study|Other|2|||
156360772|NCT00507442|564420410|FG003|Overall Study|Other|2|||
156360773|NCT02672423|564420412|FG000|Period 1|Adverse Event|0|||
156360774|NCT02672423|564420413|FG001|Period 1|Adverse Event|0|||
156360775|NCT02672423|564420414|FG002|Period 1|Adverse Event|0|||
156360776|NCT02672423|564420415|FG003|Period 1|Adverse Event|0|||
156360777|NCT02672423|564420416|FG004|Period 1|Adverse Event|1|||
156360778|NCT02672423|564420417|FG005|Period 1|Adverse Event|0|||
156360779|NCT02672423|564420418|FG006|Period 1|Adverse Event|0|||
156360780|NCT02672423|564420419|FG007|Period 1|Adverse Event|0|||
156360781|NCT02672423|564420420|FG008|Period 1|Adverse Event|0|||
156360782|NCT02672423|564420421|FG009|Period 1|Adverse Event|0|||
156360783|NCT02672423|564420412|FG000|Period 2|Withdrawal by Subject|0|||
156360784|NCT02672423|564420413|FG001|Period 2|Withdrawal by Subject|0|||
156360785|NCT02672423|564420414|FG002|Period 2|Withdrawal by Subject|1|||
156360786|NCT02672423|564420415|FG003|Period 2|Withdrawal by Subject|0|||
156360787|NCT02672423|564420416|FG004|Period 2|Withdrawal by Subject|0|||
156360788|NCT02672423|564420417|FG005|Period 2|Withdrawal by Subject|0|||
156360789|NCT02672423|564420418|FG006|Period 2|Withdrawal by Subject|0|||
156360790|NCT02672423|564420419|FG007|Period 2|Withdrawal by Subject|0|||
156360791|NCT02672423|564420420|FG008|Period 2|Withdrawal by Subject|0|||
156360792|NCT02672423|564420421|FG009|Period 2|Withdrawal by Subject|0|||
156360793|NCT02672423|564420412|FG000|Period 3|Withdrawal by Subject|0|||
156360794|NCT02672423|564420413|FG001|Period 3|Withdrawal by Subject|0|||
156360795|NCT02672423|564420414|FG002|Period 3|Withdrawal by Subject|0|||
156360796|NCT02672423|564420415|FG003|Period 3|Withdrawal by Subject|0|||
156360797|NCT02672423|564420416|FG004|Period 3|Withdrawal by Subject|0|||
156360798|NCT02672423|564420417|FG005|Period 3|Withdrawal by Subject|0|||
156360799|NCT02672423|564420418|FG006|Period 3|Withdrawal by Subject|0|||
156360800|NCT02672423|564420419|FG007|Period 3|Withdrawal by Subject|1|||
156360801|NCT02672423|564420420|FG008|Period 3|Withdrawal by Subject|0|||
156360802|NCT02672423|564420421|FG009|Period 3|Withdrawal by Subject|0|||
156360803|NCT02672423|564420412|FG000|Period 3|Physician Decision|0|||
156360804|NCT02672423|564420413|FG001|Period 3|Physician Decision|0|||
156360805|NCT02672423|564420414|FG002|Period 3|Physician Decision|0|||
156360806|NCT02672423|564420415|FG003|Period 3|Physician Decision|0|||
156360807|NCT02672423|564420416|FG004|Period 3|Physician Decision|0|||
156360808|NCT02672423|564420417|FG005|Period 3|Physician Decision|1|||
156360809|NCT02672423|564420418|FG006|Period 3|Physician Decision|0|||
156360810|NCT02672423|564420419|FG007|Period 3|Physician Decision|0|||
156360811|NCT02672423|564420420|FG008|Period 3|Physician Decision|0|||
156360812|NCT02672423|564420421|FG009|Period 3|Physician Decision|0|||
156360813|NCT02046148|564420424|FG000|Overall Study|Lost to Follow-up|1|||
156360814|NCT02046148|564420425|FG001|Overall Study|Lost to Follow-up|1|||
156360815|NCT02046148|564420424|FG000|Overall Study|Withdrawal by Subject|0|||
156360816|NCT02046148|564420425|FG001|Overall Study|Withdrawal by Subject|2|||
156360817|NCT03506373|564420427|FG000|Overall Study|Adverse Event|6|||
156360818|NCT03506373|564420427|FG000|Overall Study|Withdrawal by Subject|2|||
156360819|NCT03506373|564420427|FG000|Overall Study|Disease progression|5|||
156360820|NCT03506373|564420427|FG000|Overall Study|Other|3|||
156360821|NCT02939560|564420431|FG000|Overall Study|Withdrawal by Subject|2|||
156360822|NCT02939560|564420431|FG000|Overall Study|Protocol Violation|1|||
156360823|NCT03340025|564420434|FG000|Overall Study|Lost to Follow-up|2|||
156360824|NCT03340025|564420435|FG001|Overall Study|Lost to Follow-up|2|||
156360825|NCT02420691|564420438|FG000|Overall Study|Adverse Event|3|||
156360826|NCT02420691|564420438|FG000|Overall Study|Withdrawal by Subject|3|||
156360827|NCT01480076|564420439|FG000|Overall Study|Run-in Failure|52|||
156360828|NCT01480076|564420439|FG000|Overall Study|Adverse Event|39|||
156360829|NCT01480076|564420439|FG000|Overall Study|Death|2|||
156360830|NCT01480076|564420439|FG000|Overall Study|Disease Progression|5|||
156360831|NCT01480076|564420439|FG000|Overall Study|Non-compliance With Study Protocol|15|||
156360832|NCT01480076|564420439|FG000|Overall Study|Withdrawal by Subject|105|||
156360833|NCT01480076|564420439|FG000|Overall Study|Lost to Follow-up|7|||
156360834|NCT01480076|564420439|FG000|Overall Study|Investigator Decision|13|||
156360835|NCT01480076|564420439|FG000|Overall Study|Other|52|||
156360836|NCT05694546|564420440|FG000|Overall Study|Lost to Follow-up|11|||
156360837|NCT00325754|564420441|FG000|Overall Study|Adverse Event|4|||
156360838|NCT00325754|564420442|FG001|Overall Study|Adverse Event|1|||
156360839|NCT01752855|564420451|FG000|Overall Study|Adverse Event|1|||
156360840|NCT01752855|564420452|FG001|Overall Study|Adverse Event|0|||
156360841|NCT01752855|564420451|FG000|Overall Study|Withdrew Consent|0|||
156360842|NCT01752855|564420452|FG001|Overall Study|Withdrew Consent|2|||
156360843|NCT01752855|564420451|FG000|Overall Study|Lack of Efficacy|0|||
156360844|NCT01752855|564420452|FG001|Overall Study|Lack of Efficacy|2|||
156360845|NCT02438722|564420459|FG000|Overall Study|Adverse Event|12|||
156360846|NCT02438722|564420460|FG001|Overall Study|Adverse Event|9|||
156545459|NCT01970995|565091603|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
156545460|NCT01970995|565091604|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
156545461|NCT01157364|565091605|FG000|Overall Study|Other Reasons|1|||
156545462|NCT01157364|565091606|FG001|Overall Study|Other Reasons|1|||
156545463|NCT01157364|565091607|FG002|Overall Study|Other Reasons|2|||
156545464|NCT01157364|565091608|FG003|Overall Study|Other Reasons|1|||
156545465|NCT01157364|565091609|FG004|Overall Study|Other Reasons|0|||
156545466|NCT01157364|565091610|FG005|Overall Study|Other Reasons|0|||
156545467|NCT01157364|565091605|FG000|Overall Study|Personal Reasons|0|||
156545468|NCT01157364|565091606|FG001|Overall Study|Personal Reasons|2|||
156545469|NCT01157364|565091607|FG002|Overall Study|Personal Reasons|0|||
156545470|NCT01157364|565091608|FG003|Overall Study|Personal Reasons|0|||
156545471|NCT01157364|565091609|FG004|Overall Study|Personal Reasons|1|||
156545472|NCT01157364|565091610|FG005|Overall Study|Personal Reasons|1|||
156545473|NCT01157364|565091605|FG000|Overall Study|Lost to Follow-up|1|||
156545474|NCT01157364|565091606|FG001|Overall Study|Lost to Follow-up|0|||
156545475|NCT01157364|565091607|FG002|Overall Study|Lost to Follow-up|1|||
156545476|NCT01157364|565091608|FG003|Overall Study|Lost to Follow-up|0|||
156545477|NCT01157364|565091609|FG004|Overall Study|Lost to Follow-up|0|||
156545478|NCT01157364|565091610|FG005|Overall Study|Lost to Follow-up|0|||
156545479|NCT01157364|565091605|FG000|Overall Study|Lack of Efficacy|0|||
156545480|NCT01157364|565091606|FG001|Overall Study|Lack of Efficacy|0|||
156545481|NCT01157364|565091607|FG002|Overall Study|Lack of Efficacy|0|||
156545482|NCT01157364|565091608|FG003|Overall Study|Lack of Efficacy|1|||
156545483|NCT01157364|565091609|FG004|Overall Study|Lack of Efficacy|0|||
156545484|NCT01157364|565091610|FG005|Overall Study|Lack of Efficacy|0|||
156545485|NCT01157364|565091605|FG000|Overall Study|Adverse Event|0|||
156545486|NCT01157364|565091606|FG001|Overall Study|Adverse Event|1|||
156545487|NCT01157364|565091607|FG002|Overall Study|Adverse Event|1|||
156360847|NCT02438722|564420459|FG000|Overall Study|Refusal unrelated to AE|2|||
156360848|NCT02438722|564420460|FG001|Overall Study|Refusal unrelated to AE|5|||
156360849|NCT02438722|564420459|FG000|Overall Study|Disease progression/relapse|46|||
156360850|NCT02438722|564420460|FG001|Overall Study|Disease progression/relapse|51|||
156360851|NCT02438722|564420459|FG000|Overall Study|Death|0|||
156360852|NCT02438722|564420460|FG001|Overall Study|Death|3|||
156360853|NCT02438722|564420459|FG000|Overall Study|Physician Decision|2|||
156360854|NCT02438722|564420460|FG001|Overall Study|Physician Decision|2|||
156360855|NCT02438722|564420459|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
156360856|NCT02438722|564420460|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
156360857|NCT02438722|564420459|FG000|Overall Study|Withdrawal by Subject|0|||
156360858|NCT02438722|564420460|FG001|Overall Study|Withdrawal by Subject|1|||
156360859|NCT02438722|564420459|FG000|Overall Study|On protocol treatment|15|||
156360860|NCT02438722|564420460|FG001|Overall Study|On protocol treatment|14|||
156360861|NCT02438722|564420459|FG000|Overall Study|Did not receive protocol treatment|5|||
156360862|NCT02438722|564420460|FG001|Overall Study|Did not receive protocol treatment|0|||
156360863|NCT02404350|564420464|FG000|Overall Study|Adverse Event|2|||
156360864|NCT02404350|564420465|FG001|Overall Study|Adverse Event|2|||
156360865|NCT02404350|564420466|FG002|Overall Study|Adverse Event|3|||
156360866|NCT02404350|564420467|FG003|Overall Study|Adverse Event|9|||
156360867|NCT02404350|564420464|FG000|Overall Study|Lack of Efficacy|3|||
156360868|NCT02404350|564420465|FG001|Overall Study|Lack of Efficacy|1|||
156360869|NCT02404350|564420466|FG002|Overall Study|Lack of Efficacy|0|||
156360870|NCT02404350|564420467|FG003|Overall Study|Lack of Efficacy|3|||
156360871|NCT02404350|564420464|FG000|Overall Study|Lost to Follow-up|2|||
156360872|NCT02404350|564420465|FG001|Overall Study|Lost to Follow-up|0|||
156360873|NCT02404350|564420466|FG002|Overall Study|Lost to Follow-up|0|||
156360874|NCT02404350|564420467|FG003|Overall Study|Lost to Follow-up|1|||
156360875|NCT02404350|564420464|FG000|Overall Study|Physician Decision|1|||
156360876|NCT02404350|564420465|FG001|Overall Study|Physician Decision|0|||
156360877|NCT02404350|564420466|FG002|Overall Study|Physician Decision|0|||
156360878|NCT02404350|564420467|FG003|Overall Study|Physician Decision|2|||
156360879|NCT02404350|564420464|FG000|Overall Study|Pregnancy|0|||
156360880|NCT02404350|564420465|FG001|Overall Study|Pregnancy|0|||
156360881|NCT02404350|564420466|FG002|Overall Study|Pregnancy|0|||
156360882|NCT02404350|564420467|FG003|Overall Study|Pregnancy|1|||
156360883|NCT02404350|564420464|FG000|Overall Study|Withdrawal by Subject|7|||
156360884|NCT02404350|564420465|FG001|Overall Study|Withdrawal by Subject|3|||
156360885|NCT02404350|564420466|FG002|Overall Study|Withdrawal by Subject|3|||
156360886|NCT02404350|564420467|FG003|Overall Study|Withdrawal by Subject|19|||
156360887|NCT02404350|564420464|FG000|Overall Study|Due to Non-compliance with treatment|0|||
156360888|NCT02404350|564420465|FG001|Overall Study|Due to Non-compliance with treatment|0|||
156360889|NCT02404350|564420466|FG002|Overall Study|Due to Non-compliance with treatment|0|||
156360890|NCT02404350|564420467|FG003|Overall Study|Due to Non-compliance with treatment|1|||
156360891|NCT02404350|564420464|FG000|Overall Study|Due to Technical problems|0|||
156360892|NCT02404350|564420465|FG001|Overall Study|Due to Technical problems|0|||
156360893|NCT02404350|564420466|FG002|Overall Study|Due to Technical problems|0|||
156360894|NCT02404350|564420467|FG003|Overall Study|Due to Technical problems|1|||
156360895|NCT05389657|564420468|FG000|Overall Study|Lost to Follow-up|7|||
156360896|NCT05389657|564420469|FG001|Overall Study|Lost to Follow-up|8|||
156360897|NCT05237206|564420471|FG000|Overall Study|screen failure-did not receive treatment|8|||
156360898|NCT05237206|564420471|FG000|Overall Study|did not receive treatment|3|||
156360899|NCT03261947|564420472|FG000|Overall Study|Death|10|||
156360900|NCT03261947|564420473|FG001|Overall Study|Death|13|||
156360901|NCT03261947|564420474|FG002|Overall Study|Death|17|||
156360902|NCT03261947|564420475|FG003|Overall Study|Death|12|||
156360903|NCT03261947|564420476|FG004|Overall Study|Death|8|||
156360904|NCT03261947|564420472|FG000|Overall Study|Lost to Follow-up|0|||
156360905|NCT03261947|564420473|FG001|Overall Study|Lost to Follow-up|0|||
156360906|NCT03261947|564420474|FG002|Overall Study|Lost to Follow-up|2|||
156360907|NCT03261947|564420475|FG003|Overall Study|Lost to Follow-up|1|||
156360908|NCT03261947|564420476|FG004|Overall Study|Lost to Follow-up|0|||
156360909|NCT03261947|564420472|FG000|Overall Study|Withdrawal by Subject|0|||
156360910|NCT03261947|564420473|FG001|Overall Study|Withdrawal by Subject|0|||
156360911|NCT03261947|564420474|FG002|Overall Study|Withdrawal by Subject|3|||
156360912|NCT03261947|564420475|FG003|Overall Study|Withdrawal by Subject|0|||
156360913|NCT03261947|564420476|FG004|Overall Study|Withdrawal by Subject|1|||
156545488|NCT01157364|565091608|FG003|Overall Study|Adverse Event|0|||
156360914|NCT03261947|564420472|FG000|Overall Study|Site Terminated by Sponsor|0|||
156360915|NCT03261947|564420473|FG001|Overall Study|Site Terminated by Sponsor|0|||
156360916|NCT03261947|564420474|FG002|Overall Study|Site Terminated by Sponsor|4|||
156360917|NCT03261947|564420475|FG003|Overall Study|Site Terminated by Sponsor|7|||
156360918|NCT03261947|564420476|FG004|Overall Study|Site Terminated by Sponsor|5|||
156360919|NCT03261947|564420472|FG000|Overall Study|Reason not Specified|2|||
156360920|NCT03261947|564420473|FG001|Overall Study|Reason not Specified|0|||
156360921|NCT03261947|564420474|FG002|Overall Study|Reason not Specified|4|||
156360922|NCT03261947|564420475|FG003|Overall Study|Reason not Specified|1|||
156360923|NCT03261947|564420476|FG004|Overall Study|Reason not Specified|3|||
156360924|NCT03969992|564420477|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
156360925|NCT03969992|564420478|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
156360926|NCT03969992|564420479|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
156360927|NCT03969992|564420477|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
156360928|NCT03969992|564420478|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
156360929|NCT03969992|564420479|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
156360930|NCT03969992|564420477|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
156360931|NCT03969992|564420478|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
156360932|NCT03969992|564420479|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
156360933|NCT03969992|564420477|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
156360934|NCT03969992|564420478|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
156360935|NCT03969992|564420479|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
156360936|NCT03969992|564420477|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
156360937|NCT03969992|564420478|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
156360938|NCT03969992|564420479|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
156360939|NCT01476696|564420480|FG000|Overall Study|Sponsor decision|2|||
156360940|NCT01476696|564420481|FG001|Overall Study|Sponsor decision|1|||
156360941|NCT01476696|564420482|FG002|Overall Study|Sponsor decision|0|||
156360942|NCT01476696|564420480|FG000|Overall Study|Withdrawal by Subject|1|||
156360943|NCT01476696|564420481|FG001|Overall Study|Withdrawal by Subject|0|||
156360944|NCT01476696|564420482|FG002|Overall Study|Withdrawal by Subject|0|||
156360945|NCT03965962|564420490|FG000|Overall Study|Adverse Event|1|||
156360946|NCT03965962|564420491|FG001|Overall Study|Adverse Event|0|||
156360947|NCT03965962|564420492|FG002|Overall Study|Adverse Event|0|||
156360948|NCT03965962|564420493|FG003|Overall Study|Adverse Event|0|||
156360949|NCT03965962|564420490|FG000|Overall Study|Protocol Violation|21|||
156360950|NCT03965962|564420491|FG001|Overall Study|Protocol Violation|4|||
156360951|NCT03965962|564420492|FG002|Overall Study|Protocol Violation|10|||
156360952|NCT03965962|564420493|FG003|Overall Study|Protocol Violation|5|||
156360953|NCT03965962|564420490|FG000|Overall Study|Lost to Follow-up|0|||
156360954|NCT03965962|564420491|FG001|Overall Study|Lost to Follow-up|1|||
156360955|NCT03965962|564420492|FG002|Overall Study|Lost to Follow-up|0|||
156360956|NCT03965962|564420493|FG003|Overall Study|Lost to Follow-up|0|||
156360957|NCT03965962|564420490|FG000|Overall Study|Withdrawal by Subject|3|||
156360958|NCT03965962|564420491|FG001|Overall Study|Withdrawal by Subject|0|||
156360959|NCT03965962|564420492|FG002|Overall Study|Withdrawal by Subject|0|||
156360960|NCT03965962|564420493|FG003|Overall Study|Withdrawal by Subject|1|||
156360961|NCT02225743|564420494|FG000|Overall Study|Withdrawal by Subject|18|||
156360962|NCT00322842|564420497|FG000|Overall Study|Withdrawal by Subject|0|||
156360963|NCT00322842|564420498|FG001|Overall Study|Withdrawal by Subject|1|||
156360964|NCT00322842|564420497|FG000|Overall Study|Lost to Follow-up|0|||
156360965|NCT00322842|564420498|FG001|Overall Study|Lost to Follow-up|1|||
156360966|NCT00322842|564420497|FG000|Overall Study|Refused transplant|1|||
156360967|NCT00322842|564420498|FG001|Overall Study|Refused transplant|0|||
156360968|NCT00322842|564420497|FG000|Overall Study|Death|1|||
156360969|NCT00322842|564420498|FG001|Overall Study|Death|0|||
156360970|NCT00323492|564420499|FG000|Study Phase 1|Adverse Event|2|||
156360971|NCT00323492|564420500|FG001|Study Phase 1|Adverse Event|0|||
156360972|NCT00323492|564420501|FG002|Study Phase 1|Adverse Event|0|||
156360973|NCT00323492|564420499|FG000|Study Phase 2|Adverse Event|1|||
156360974|NCT00323492|564420500|FG001|Study Phase 2|Adverse Event|0|||
156360975|NCT00323492|564420501|FG002|Study Phase 2|Adverse Event|0|||
156360976|NCT00323492|564420499|FG000|Study Phase 2|Physician Decision|1|||
156360977|NCT00323492|564420500|FG001|Study Phase 2|Physician Decision|0|||
156360978|NCT00323492|564420501|FG002|Study Phase 2|Physician Decision|0|||
156360979|NCT00323492|564420499|FG000|Study Phase 2|Lost to Follow-up|1|||
156360980|NCT00323492|564420500|FG001|Study Phase 2|Lost to Follow-up|0|||
156360981|NCT00323492|564420501|FG002|Study Phase 2|Lost to Follow-up|0|||
156360982|NCT00323492|564420499|FG000|Study Phase 2|Withdrawal by Subject|0|||
156360983|NCT00323492|564420500|FG001|Study Phase 2|Withdrawal by Subject|1|||
156360984|NCT00323492|564420501|FG002|Study Phase 2|Withdrawal by Subject|0|||
156360985|NCT00323492|564420499|FG000|Study Phase 2|Noncompliance with study schedule|0|||
156360986|NCT00323492|564420500|FG001|Study Phase 2|Noncompliance with study schedule|0|||
156360987|NCT00323492|564420501|FG002|Study Phase 2|Noncompliance with study schedule|1|||
156360988|NCT00323492|564420499|FG000|Study Phase 2|Protocol Violation|1|||
156360989|NCT00323492|564420500|FG001|Study Phase 2|Protocol Violation|0|||
156360990|NCT00323492|564420501|FG002|Study Phase 2|Protocol Violation|0|||
156360991|NCT02486042|564420502|FG000|Overall Study|Physician Decision|1|||
156360992|NCT02486042|564420503|FG001|Overall Study|Physician Decision|7|||
156360993|NCT02486042|564420502|FG000|Overall Study|Hospital transfer|2|||
156360994|NCT02486042|564420503|FG001|Overall Study|Hospital transfer|2|||
156360995|NCT02486042|564420502|FG000|Overall Study|Withdrawal by Subject|0|||
156360996|NCT02486042|564420503|FG001|Overall Study|Withdrawal by Subject|2|||
156360997|NCT00281684|564420517|FG000|Overall Study|Lost to Follow-up|0|||
156360998|NCT00281684|564420518|FG001|Overall Study|Lost to Follow-up|0|||
156360999|NCT00281684|564420519|FG002|Overall Study|Lost to Follow-up|1|||
156361000|NCT00281684|564420520|FG003|Overall Study|Lost to Follow-up|0|||
156361001|NCT00281684|564420517|FG000|Overall Study|Withdrawal by Subject|1|||
156361002|NCT00281684|564420518|FG001|Overall Study|Withdrawal by Subject|0|||
156361003|NCT00281684|564420519|FG002|Overall Study|Withdrawal by Subject|0|||
156361004|NCT00281684|564420520|FG003|Overall Study|Withdrawal by Subject|0|||
156361005|NCT03979638|564420521|FG000|Period 1|Physician Decision|1|||
156361006|NCT03979638|564420522|FG001|Period 1|Physician Decision|1|||
156361007|NCT03979638|564420521|FG000|Period 1|Withdrawal by Subject|4|||
156361008|NCT03979638|564420522|FG001|Period 1|Withdrawal by Subject|3|||
156489511|NCT00497198|564885670|FG000|Overall Study|Withdrawal by Subject|0|||
156489512|NCT00497198|564885671|FG001|Overall Study|Withdrawal by Subject|1|||
156489513|NCT01772147|564887344|FG000|Overall Study|Adverse Event|13|||
156489514|NCT01772147|564887345|FG001|Overall Study|Adverse Event|10|||
156489515|NCT01772147|564887346|FG002|Overall Study|Adverse Event|6|||
156489516|NCT01772147|564887344|FG000|Overall Study|Withdrew Consent|7|||
156489517|NCT01772147|564887345|FG001|Overall Study|Withdrew Consent|8|||
156489518|NCT01772147|564887346|FG002|Overall Study|Withdrew Consent|4|||
156489519|NCT01772147|564887344|FG000|Overall Study|Lost to Follow-up|1|||
156489520|NCT01772147|564887345|FG001|Overall Study|Lost to Follow-up|0|||
156489521|NCT01772147|564887346|FG002|Overall Study|Lost to Follow-up|1|||
156489522|NCT01772147|564887344|FG000|Overall Study|Protocol Deviation|2|||
156489523|NCT01772147|564887345|FG001|Overall Study|Protocol Deviation|1|||
156489524|NCT01772147|564887346|FG002|Overall Study|Protocol Deviation|1|||
156489525|NCT01772147|564887344|FG000|Overall Study|Lack of Efficacy|8|||
156489526|NCT01772147|564887345|FG001|Overall Study|Lack of Efficacy|6|||
156489527|NCT01772147|564887346|FG002|Overall Study|Lack of Efficacy|6|||
156489528|NCT00796614|564887354|FG000|Overall Study|Adverse Event|1|||
156489529|NCT00796614|564887355|FG001|Overall Study|Adverse Event|2|||
156489530|NCT00796614|564887356|FG002|Overall Study|Adverse Event|0|||
156489531|NCT00796614|564887357|FG003|Overall Study|Adverse Event|0|||
156489532|NCT00796614|564887354|FG000|Overall Study|Protocol Violation|0|||
156489533|NCT00796614|564887355|FG001|Overall Study|Protocol Violation|0|||
156489534|NCT00796614|564887356|FG002|Overall Study|Protocol Violation|2|||
156489535|NCT00796614|564887357|FG003|Overall Study|Protocol Violation|0|||
156489536|NCT00796614|564887354|FG000|Overall Study|Lost to Follow-up|2|||
156489537|NCT00796614|564887355|FG001|Overall Study|Lost to Follow-up|2|||
156489538|NCT00796614|564887356|FG002|Overall Study|Lost to Follow-up|1|||
156489539|NCT00796614|564887357|FG003|Overall Study|Lost to Follow-up|0|||
156489540|NCT00796614|564887354|FG000|Overall Study|Withdrawal by Subject|1|||
156489541|NCT00796614|564887355|FG001|Overall Study|Withdrawal by Subject|0|||
156489542|NCT00796614|564887356|FG002|Overall Study|Withdrawal by Subject|0|||
156489543|NCT00796614|564887357|FG003|Overall Study|Withdrawal by Subject|1|||
156489544|NCT00796614|564887354|FG000|Overall Study|Other than stated|1|||
156489545|NCT00796614|564887355|FG001|Overall Study|Other than stated|0|||
156489546|NCT00796614|564887356|FG002|Overall Study|Other than stated|0|||
156489547|NCT00796614|564887357|FG003|Overall Study|Other than stated|0|||
156489548|NCT00740597|564887358|FG000|Overall Study|insurance would not cover treatment|1|||
156489549|NCT01231464|564887360|FG000|Overall Study|Adverse Event|0|||
156489550|NCT01231464|564887361|FG001|Overall Study|Adverse Event|1|||
156489551|NCT01231464|564887360|FG000|Overall Study|Protocol Violation|1|||
156489552|NCT01231464|564887361|FG001|Overall Study|Protocol Violation|2|||
156489553|NCT01231464|564887360|FG000|Overall Study|Lost to Follow-up|1|||
156489554|NCT01231464|564887361|FG001|Overall Study|Lost to Follow-up|2|||
156489555|NCT01231464|564887360|FG000|Overall Study|Withdrawal by Subject|3|||
156489556|NCT01231464|564887361|FG001|Overall Study|Withdrawal by Subject|2|||
156489557|NCT00957996|564887367|FG000|Overall Study|Death|4|||
156489558|NCT00957996|564887368|FG001|Overall Study|Death|10|||
156489559|NCT00957996|564887367|FG000|Overall Study|Lost to Follow-up|4|||
156489560|NCT00957996|564887368|FG001|Overall Study|Lost to Follow-up|7|||
156489561|NCT00957996|564887367|FG000|Overall Study|Withdrawal by Subject|9|||
156489562|NCT00957996|564887368|FG001|Overall Study|Withdrawal by Subject|2|||
156489563|NCT00957996|564887367|FG000|Overall Study|Adverse Event|2|||
156489564|NCT00957996|564887368|FG001|Overall Study|Adverse Event|1|||
156489565|NCT00957996|564887367|FG000|Overall Study|Physician Decision|1|||
156489566|NCT00957996|564887368|FG001|Overall Study|Physician Decision|1|||
156489567|NCT00957996|564887367|FG000|Overall Study|Influenza-related complication|0|||
156489568|NCT00957996|564887368|FG001|Overall Study|Influenza-related complication|1|||
156489569|NCT00957996|564887367|FG000|Overall Study|Missing|1|||
156489570|NCT00957996|564887368|FG001|Overall Study|Missing|0|||
156489571|NCT00957996|564887367|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
156489572|NCT00957996|564887368|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
156489573|NCT01902381|564887369|FG000|Overall Study|Withdrawal by Subject|1|||
156489574|NCT03972137|564887373|FG000|Overall Study|Lost to Follow-up|2|||
156489575|NCT03972137|564887373|FG000|Overall Study|Withdrawal by Subject|4|||
156489576|NCT00498433|564887374|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
156489577|NCT00498433|564887375|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
156489578|NCT00498433|564887376|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
156489579|NCT00498433|564887374|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
156545489|NCT01157364|565091609|FG004|Overall Study|Adverse Event|1|||
156545490|NCT01157364|565091610|FG005|Overall Study|Adverse Event|0|||
156361009|NCT03979638|564420521|FG000|Period 1|Study terminated by Sponsor|1|||
156361010|NCT03979638|564420522|FG001|Period 1|Study terminated by Sponsor|3|||
156361011|NCT03979638|564420521|FG000|Period 1|Protocol Violation|1|||
156361012|NCT03979638|564420522|FG001|Period 1|Protocol Violation|0|||
156361013|NCT03979638|564420521|FG000|Period 2|Study terminated by Sponsor|1|||
156361014|NCT03979638|564420522|FG001|Period 2|Study terminated by Sponsor|1|||
156361015|NCT00578942|564420525|FG000|Overall Study|Lost to Follow-up|1|||
156361016|NCT03200899|564420526|FG000|Overall Study|Lost to Follow-up|10|||
156361017|NCT03200899|564420527|FG001|Overall Study|Lost to Follow-up|23|||
156361018|NCT01400516|564420536|FG000|Primary Trial|Withdrawal by Subject|0|||
156361019|NCT01400516|564420537|FG001|Primary Trial|Withdrawal by Subject|2|||
156361020|NCT00549562|564420538|FG000|Overall Study|Adverse Event|1|||
156361021|NCT00549562|564420538|FG000|Overall Study|Lack of Efficacy|1|||
156361022|NCT00156533|564421889|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
156361023|NCT00156533|564421890|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
156361024|NCT00156533|564421891|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
156361025|NCT00156533|564421892|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
156361026|NCT00156533|564421889|FG000|Overall Study|Withdrawal by Subject|1|||
156361027|NCT00156533|564421890|FG001|Overall Study|Withdrawal by Subject|0|||
156361028|NCT00156533|564421891|FG002|Overall Study|Withdrawal by Subject|0|||
156361029|NCT00156533|564421892|FG003|Overall Study|Withdrawal by Subject|1|||
156361030|NCT00156533|564421889|FG000|Overall Study|Failed Screening|1|||
156361031|NCT00156533|564421890|FG001|Overall Study|Failed Screening|0|||
156361032|NCT00156533|564421891|FG002|Overall Study|Failed Screening|1|||
156361033|NCT00156533|564421892|FG003|Overall Study|Failed Screening|1|||
156361034|NCT04254978|564421893|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
156361035|NCT04254978|564421893|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
156361036|NCT04254978|564421893|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
156361037|NCT04254978|564421893|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
156361038|NCT04254978|564421893|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
156361039|NCT04254978|564421893|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
156361040|NCT03257631|564421894|FG000|Overall Study|Death|1|||
156361041|NCT03257631|564421895|FG001|Overall Study|Death|0|||
156361042|NCT03257631|564421896|FG002|Overall Study|Death|1|||
156361043|NCT03257631|564421897|FG003|Overall Study|Death|1|||
156361044|NCT03257631|564421894|FG000|Overall Study|Progressive Disease|10|||
156361045|NCT03257631|564421895|FG001|Overall Study|Progressive Disease|9|||
156361046|NCT03257631|564421896|FG002|Overall Study|Progressive Disease|17|||
156361047|NCT03257631|564421897|FG003|Overall Study|Progressive Disease|8|||
156361048|NCT03257631|564421894|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156361049|NCT03257631|564421895|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156361050|NCT03257631|564421896|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156361051|NCT03257631|564421897|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
156361052|NCT03257631|564421894|FG000|Overall Study|Adverse Event|0|||
156361053|NCT03257631|564421895|FG001|Overall Study|Adverse Event|0|||
156361054|NCT03257631|564421896|FG002|Overall Study|Adverse Event|2|||
156361055|NCT03257631|564421897|FG003|Overall Study|Adverse Event|0|||
156361056|NCT03509675|564421899|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
156361057|NCT03509675|564421900|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
156361058|NCT03509675|564421899|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
156361059|NCT03509675|564421900|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
156361060|NCT03509675|564421899|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
156361061|NCT03509675|564421900|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
156361062|NCT03509675|564421899|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
156361063|NCT03509675|564421900|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
156361064|NCT00922766|564421901|FG000|Overall Study|Death|3|||
156545491|NCT01709435|565091611|FG000|Overall Study|Adverse Event|1|||
156545492|NCT01709435|565091612|FG001|Overall Study|Adverse Event|1|||
156545493|NCT01709435|565091613|FG002|Overall Study|Adverse Event|1|||
156361065|NCT00922766|564421901|FG000|Overall Study|Withdrawal by Subject|2|||
156361066|NCT00922766|564421901|FG000|Overall Study|Other|1|||
156361067|NCT00922766|564421901|FG000|Overall Study|Adverse Event|1|||
156361068|NCT02622828|564421904|FG000|Overall Study|participant withdrew|3|||
156545494|NCT01709435|565091614|FG003|Overall Study|Adverse Event|0|||
156545495|NCT01709435|565091615|FG004|Overall Study|Adverse Event|0|||
156361069|NCT01231581|564421908|FG000|Overall Study|Lost to Follow-up|2|||
156361070|NCT01231581|564421909|FG001|Overall Study|Lost to Follow-up|2|||
156361071|NCT01231581|564421908|FG000|Overall Study|Withdrawal by Subject|6|||
156361072|NCT01231581|564421909|FG001|Overall Study|Withdrawal by Subject|9|||
156361073|NCT01231581|564421908|FG000|Overall Study|Study Closed/Terminated|6|||
156361074|NCT01231581|564421909|FG001|Overall Study|Study Closed/Terminated|5|||
156361075|NCT01231581|564421908|FG000|Overall Study|Death|65|||
156361076|NCT01231581|564421909|FG001|Overall Study|Death|64|||
156361077|NCT01231581|564421908|FG000|Overall Study|Ongoing|1|||
156361078|NCT01231581|564421909|FG001|Overall Study|Ongoing|0|||
156361079|NCT03616912|564421910|FG000|Overall Study|Adverse Event|17|||
156361080|NCT03616912|564421911|FG001|Overall Study|Adverse Event|21|||
156361081|NCT03616912|564421912|FG002|Overall Study|Adverse Event|9|||
156361082|NCT03616912|564421913|FG003|Overall Study|Adverse Event|0|||
156361083|NCT03616912|564421914|FG004|Overall Study|Adverse Event|0|||
156361084|NCT03616912|564421915|FG005|Overall Study|Adverse Event|0|||
156361085|NCT03616912|564421910|FG000|Overall Study|Death|1|||
156361086|NCT03616912|564421911|FG001|Overall Study|Death|1|||
156361087|NCT03616912|564421912|FG002|Overall Study|Death|0|||
156361088|NCT03616912|564421913|FG003|Overall Study|Death|0|||
156361089|NCT03616912|564421914|FG004|Overall Study|Death|0|||
156361090|NCT03616912|564421915|FG005|Overall Study|Death|0|||
156361091|NCT03616912|564421910|FG000|Overall Study|Lack of Efficacy|13|||
156361092|NCT03616912|564421911|FG001|Overall Study|Lack of Efficacy|6|||
156361093|NCT03616912|564421912|FG002|Overall Study|Lack of Efficacy|8|||
156361094|NCT03616912|564421913|FG003|Overall Study|Lack of Efficacy|4|||
156361095|NCT03616912|564421914|FG004|Overall Study|Lack of Efficacy|5|||
156361096|NCT03616912|564421915|FG005|Overall Study|Lack of Efficacy|1|||
156361097|NCT03616912|564421910|FG000|Overall Study|Lost to Follow-up|1|||
156361098|NCT03616912|564421911|FG001|Overall Study|Lost to Follow-up|2|||
156361099|NCT03616912|564421912|FG002|Overall Study|Lost to Follow-up|3|||
156361100|NCT03616912|564421913|FG003|Overall Study|Lost to Follow-up|0|||
156361101|NCT03616912|564421914|FG004|Overall Study|Lost to Follow-up|0|||
156361102|NCT03616912|564421915|FG005|Overall Study|Lost to Follow-up|0|||
156361103|NCT03616912|564421910|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
156361104|NCT03616912|564421911|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
156361105|NCT03616912|564421912|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
156361106|NCT03616912|564421913|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
156361107|NCT03616912|564421914|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
156361108|NCT03616912|564421915|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
156361109|NCT03616912|564421910|FG000|Overall Study|Withdrawal by Subject|12|||
156361110|NCT03616912|564421911|FG001|Overall Study|Withdrawal by Subject|12|||
156361111|NCT03616912|564421912|FG002|Overall Study|Withdrawal by Subject|15|||
156361112|NCT03616912|564421913|FG003|Overall Study|Withdrawal by Subject|2|||
156361113|NCT03616912|564421914|FG004|Overall Study|Withdrawal by Subject|0|||
156361114|NCT03616912|564421915|FG005|Overall Study|Withdrawal by Subject|2|||
156361115|NCT03616912|564421910|FG000|Overall Study|Study Terminated by Sponsor|0|||
156361116|NCT03616912|564421911|FG001|Overall Study|Study Terminated by Sponsor|0|||
156361117|NCT03616912|564421912|FG002|Overall Study|Study Terminated by Sponsor|0|||
156361118|NCT03616912|564421913|FG003|Overall Study|Study Terminated by Sponsor|10|||
156361119|NCT03616912|564421914|FG004|Overall Study|Study Terminated by Sponsor|9|||
156361120|NCT03616912|564421915|FG005|Overall Study|Study Terminated by Sponsor|11|||
156361121|NCT03616912|564421910|FG000|Overall Study|Protocol Deviation|1|||
156361122|NCT03616912|564421911|FG001|Overall Study|Protocol Deviation|1|||
156361123|NCT03616912|564421912|FG002|Overall Study|Protocol Deviation|0|||
156361124|NCT03616912|564421913|FG003|Overall Study|Protocol Deviation|0|||
156361125|NCT03616912|564421914|FG004|Overall Study|Protocol Deviation|0|||
156361126|NCT03616912|564421915|FG005|Overall Study|Protocol Deviation|0|||
156361127|NCT03616912|564421910|FG000|Overall Study|Pregnancy|1|||
156361128|NCT03616912|564421911|FG001|Overall Study|Pregnancy|0|||
156361129|NCT03616912|564421912|FG002|Overall Study|Pregnancy|4|||
156361130|NCT03616912|564421913|FG003|Overall Study|Pregnancy|0|||
156361131|NCT03616912|564421914|FG004|Overall Study|Pregnancy|0|||
156361132|NCT03616912|564421915|FG005|Overall Study|Pregnancy|0|||
156361133|NCT03616912|564421910|FG000|Overall Study|Protocol Violation|1|||
156361134|NCT03616912|564421911|FG001|Overall Study|Protocol Violation|0|||
156361135|NCT03616912|564421912|FG002|Overall Study|Protocol Violation|2|||
156361136|NCT03616912|564421913|FG003|Overall Study|Protocol Violation|0|||
156361137|NCT03616912|564421914|FG004|Overall Study|Protocol Violation|0|||
156361138|NCT03616912|564421915|FG005|Overall Study|Protocol Violation|0|||
156361139|NCT03616912|564421910|FG000|Overall Study|Physician Decision|2|||
156361140|NCT03616912|564421911|FG001|Overall Study|Physician Decision|0|||
156361141|NCT03616912|564421912|FG002|Overall Study|Physician Decision|0|||
156361142|NCT03616912|564421913|FG003|Overall Study|Physician Decision|0|||
156489580|NCT00498433|564887375|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
156489581|NCT00498433|564887376|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
156489582|NCT00498433|564887374|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
156489583|NCT00498433|564887375|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
156489584|NCT00498433|564887376|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
156489585|NCT00498433|564887374|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
156489586|NCT00498433|564887375|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
156489587|NCT00498433|564887376|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
156489588|NCT00922441|564887377|FG000|Overall Study|Protocol Violation|0|||
156361143|NCT03616912|564421914|FG004|Overall Study|Physician Decision|1|||
156361144|NCT03616912|564421915|FG005|Overall Study|Physician Decision|0|||
156361145|NCT03616912|564421910|FG000|Overall Study|Randomized But Never Treated|0|||
156361146|NCT03616912|564421911|FG001|Overall Study|Randomized But Never Treated|2|||
156361147|NCT03616912|564421912|FG002|Overall Study|Randomized But Never Treated|0|||
156489589|NCT00922441|564887378|FG001|Overall Study|Protocol Violation|0|||
156545496|NCT01709435|565091616|FG005|Overall Study|Adverse Event|1|||
156545497|NCT01709435|565091611|FG000|Overall Study|Lack of Efficacy|5|||
156545498|NCT01709435|565091612|FG001|Overall Study|Lack of Efficacy|7|||
156545499|NCT01709435|565091613|FG002|Overall Study|Lack of Efficacy|2|||
156545500|NCT01709435|565091614|FG003|Overall Study|Lack of Efficacy|2|||
156545501|NCT01709435|565091615|FG004|Overall Study|Lack of Efficacy|6|||
156545502|NCT01709435|565091616|FG005|Overall Study|Lack of Efficacy|3|||
156545503|NCT01709435|565091611|FG000|Overall Study|Physician Decision|0|||
156545504|NCT01709435|565091612|FG001|Overall Study|Physician Decision|1|||
156545505|NCT01709435|565091613|FG002|Overall Study|Physician Decision|0|||
156545506|NCT01709435|565091614|FG003|Overall Study|Physician Decision|1|||
156545507|NCT01709435|565091615|FG004|Overall Study|Physician Decision|2|||
156545508|NCT01709435|565091616|FG005|Overall Study|Physician Decision|0|||
156545509|NCT01709435|565091611|FG000|Overall Study|Withdrawal by Subject|0|||
156545510|NCT01709435|565091612|FG001|Overall Study|Withdrawal by Subject|0|||
156545511|NCT01709435|565091613|FG002|Overall Study|Withdrawal by Subject|3|||
156545512|NCT01709435|565091614|FG003|Overall Study|Withdrawal by Subject|0|||
156545513|NCT01709435|565091615|FG004|Overall Study|Withdrawal by Subject|2|||
156545514|NCT01709435|565091616|FG005|Overall Study|Withdrawal by Subject|2|||
156545515|NCT01263639|565091617|FG000|Overall Study|Lost to Follow-up|66|||
156545516|NCT01263639|565091618|FG001|Overall Study|Lost to Follow-up|70|||
156545517|NCT01263639|565091617|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
156545518|NCT01263639|565091618|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
156545519|NCT01780662|565091619|FG000|Overall Study|Adverse Event|1|||
156545520|NCT01780662|565091620|FG001|Overall Study|Adverse Event|0|||
156545521|NCT01780662|565091621|FG002|Overall Study|Adverse Event|2|||
156545522|NCT01780662|565091619|FG000|Overall Study|Physician Decision|0|||
156545523|NCT01780662|565091620|FG001|Overall Study|Physician Decision|5|||
156545524|NCT01780662|565091621|FG002|Overall Study|Physician Decision|7|||
156545525|NCT01780662|565091619|FG000|Overall Study|Protocol Violation|0|||
156545526|NCT01780662|565091620|FG001|Overall Study|Protocol Violation|1|||
156545527|NCT01780662|565091621|FG002|Overall Study|Protocol Violation|0|||
156545528|NCT01780662|565091619|FG000|Overall Study|Ineligible|0|||
156545529|NCT01780662|565091620|FG001|Overall Study|Ineligible|0|||
156545530|NCT01780662|565091621|FG002|Overall Study|Ineligible|1|||
156545531|NCT03975920|565091623|FG000|Overall Study|Lost to Follow-up|1|||
156545532|NCT03975920|565091624|FG001|Overall Study|Lost to Follow-up|2|||
156545533|NCT03975920|565091623|FG000|Overall Study|Protocol Violation|1|||
156545534|NCT03975920|565091624|FG001|Overall Study|Protocol Violation|1|||
156545535|NCT03975920|565091623|FG000|Overall Study|Did not complete survey|2|||
156545536|NCT03975920|565091624|FG001|Overall Study|Did not complete survey|1|||
156545537|NCT01081249|565091625|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
156545538|NCT01081249|565091626|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
156545539|NCT04839380|565091627|FG000|Overall Study|Withdrawal by Subject|2|||
156545540|NCT04839380|565091627|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
156545541|NCT01378104|565091630|FG000|Overall Study|Adverse Event|8|||
156545542|NCT01378104|565091631|FG001|Overall Study|Adverse Event|8|||
156545543|NCT01378104|565091630|FG000|Overall Study|Lack of Efficacy|7|||
156545544|NCT01378104|565091631|FG001|Overall Study|Lack of Efficacy|5|||
156545545|NCT01378104|565091630|FG000|Overall Study|Withdrawal by Subject|12|||
156545546|NCT01378104|565091631|FG001|Overall Study|Withdrawal by Subject|13|||
156545547|NCT00205855|565091640|FG000|Overall Study|Only received temporary implants|16|||
156545548|NCT00205855|565091640|FG000|Overall Study|Withdrawal by Subject|5|||
156545549|NCT02354222|565091643|FG000|Overall Study|Adverse Event|0|||
156545550|NCT02354222|565091644|FG001|Overall Study|Adverse Event|3|||
156545551|NCT02354222|565091643|FG000|Overall Study|Physician Decision|1|||
156545552|NCT02354222|565091644|FG001|Overall Study|Physician Decision|1|||
156545553|NCT02354222|565091643|FG000|Overall Study|Pregnancy|1|||
156545554|NCT02354222|565091644|FG001|Overall Study|Pregnancy|0|||
156545555|NCT02354222|565091643|FG000|Overall Study|Withdrawal by Subject|2|||
156545556|NCT02354222|565091644|FG001|Overall Study|Withdrawal by Subject|3|||
156545557|NCT02354222|565091643|FG000|Overall Study|Conflict with the stopping criteria|0|||
156545558|NCT02354222|565091644|FG001|Overall Study|Conflict with the stopping criteria|4|||
156545559|NCT02039375|565091645|FG000|Overall Study|Lost to Follow-up|2|||
156545560|NCT00917150|565091646|FG000|Overall Study|Adverse Event|12|||
156545561|NCT00917150|565091647|FG001|Overall Study|Adverse Event|7|||
156545562|NCT00917150|565091648|FG002|Overall Study|Adverse Event|12|||
156545563|NCT00917150|565091649|FG003|Overall Study|Adverse Event|11|||
156545564|NCT00917150|565091646|FG000|Overall Study|Death|1|||
156545565|NCT00917150|565091647|FG001|Overall Study|Death|4|||
156545566|NCT00917150|565091648|FG002|Overall Study|Death|3|||
156545567|NCT00917150|565091649|FG003|Overall Study|Death|2|||
156545568|NCT00917150|565091646|FG000|Overall Study|Lost to Follow-up|1|||
156545569|NCT00917150|565091647|FG001|Overall Study|Lost to Follow-up|0|||
156545570|NCT00917150|565091648|FG002|Overall Study|Lost to Follow-up|4|||
156545571|NCT00917150|565091649|FG003|Overall Study|Lost to Follow-up|2|||
156545572|NCT00917150|565091646|FG000|Overall Study|Physician Decision|0|||
156545573|NCT00917150|565091647|FG001|Overall Study|Physician Decision|2|||
156545574|NCT00917150|565091648|FG002|Overall Study|Physician Decision|0|||
156361148|NCT03616912|564421913|FG003|Overall Study|Randomized But Never Treated|0|||
156361149|NCT03616912|564421914|FG004|Overall Study|Randomized But Never Treated|0|||
156361150|NCT03616912|564421915|FG005|Overall Study|Randomized But Never Treated|0|||
156361151|NCT01124604|564421916|FG000|Overall Study|Adverse Event|10|||
156361152|NCT01124604|564421917|FG001|Overall Study|Adverse Event|1|||
156361153|NCT01124604|564421916|FG000|Overall Study|Lack of Efficacy|1|||
156361154|NCT01124604|564421917|FG001|Overall Study|Lack of Efficacy|0|||
156361155|NCT01124604|564421916|FG000|Overall Study|Withdrawal by Subject|4|||
156361156|NCT01124604|564421917|FG001|Overall Study|Withdrawal by Subject|0|||
156361157|NCT01124604|564421916|FG000|Overall Study|Disease Progression|0|||
156361158|NCT01124604|564421917|FG001|Overall Study|Disease Progression|1|||
156361159|NCT01859507|564421918|FG000|Overall Study|left the country|4|||
156361160|NCT01762943|564421920|FG000|Overall Study|Physician Decision|1|||
156361161|NCT01762943|564421921|FG001|Overall Study|Physician Decision|1|||
156361162|NCT01762943|564421920|FG000|Overall Study|Protocol Violation|1|||
156361163|NCT01762943|564421921|FG001|Overall Study|Protocol Violation|0|||
156361164|NCT01762943|564421920|FG000|Overall Study|Withdrawal by Subject|2|||
156361165|NCT01762943|564421921|FG001|Overall Study|Withdrawal by Subject|1|||
156361166|NCT02404311|564421922|FG000|Part A: Month 0-18|Death|2|||
156361167|NCT02404311|564421923|FG001|Part A: Month 0-18|Death|0|||
156361168|NCT02404311|564421924|FG002|Part A: Month 0-18|Death|0|||
156361169|NCT02404311|564421925|FG003|Part A: Month 0-18|Death|0|||
156361170|NCT02404311|564421926|FG004|Part A: Month 0-18|Death|0|||
156361171|NCT02404311|564421922|FG000|Part A: Month 0-18|Physician Decision|1|||
156361172|NCT02404311|564421923|FG001|Part A: Month 0-18|Physician Decision|0|||
156361173|NCT02404311|564421924|FG002|Part A: Month 0-18|Physician Decision|0|||
156361174|NCT02404311|564421925|FG003|Part A: Month 0-18|Physician Decision|0|||
156361175|NCT02404311|564421926|FG004|Part A: Month 0-18|Physician Decision|0|||
156361176|NCT02404311|564421922|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
156361177|NCT02404311|564421923|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
156361178|NCT02404311|564421924|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
156361179|NCT02404311|564421925|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
156361180|NCT02404311|564421926|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
156361181|NCT02404311|564421922|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
156361182|NCT02404311|564421923|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
156361183|NCT02404311|564421924|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
156361184|NCT02404311|564421925|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
156361185|NCT02404311|564421926|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
156361186|NCT02404311|564421922|FG000|Part A: Month 0-18|HIV Infection|6|||
156361187|NCT02404311|564421923|FG001|Part A: Month 0-18|HIV Infection|2|||
156361188|NCT02404311|564421924|FG002|Part A: Month 0-18|HIV Infection|0|||
156361189|NCT02404311|564421925|FG003|Part A: Month 0-18|HIV Infection|0|||
156361190|NCT02404311|564421926|FG004|Part A: Month 0-18|HIV Infection|0|||
156361191|NCT02404311|564421922|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
156361192|NCT02404311|564421923|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
156361193|NCT02404311|564421924|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
156361194|NCT02404311|564421925|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
156361195|NCT02404311|564421926|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
156489590|NCT00922441|564887379|FG002|Overall Study|Protocol Violation|2|||
156489591|NCT00922441|564887377|FG000|Overall Study|Withdrawal by Subject|0|||
156361196|NCT00076011|564421931|FG000|Overall Study|Death|1|||
156361197|NCT00076011|564421931|FG000|Overall Study|Adverse Event|10|||
156361198|NCT00076011|564421931|FG000|Overall Study|Lack of Efficacy|25|||
156361199|NCT00076011|564421931|FG000|Overall Study|Withdrawal by Subject|1|||
156361200|NCT00076011|564421931|FG000|Overall Study|Study terminated by sponsor|3|||
156361201|NCT00076011|564421931|FG000|Overall Study|Other|11|||
156361202|NCT00076011|564421931|FG000|Overall Study|Ongoing|1|||
156361203|NCT03314584|564421935|FG000|Overall Study|Withdrawal by Subject|3|||
156361204|NCT03314584|564421936|FG001|Overall Study|Withdrawal by Subject|3|||
156361205|NCT03314584|564421935|FG000|Overall Study|Lost to Follow-up|4|||
156361206|NCT03314584|564421936|FG001|Overall Study|Lost to Follow-up|0|||
156361207|NCT06134817|564421937|FG000|Overall Study|Physician Departure - termination of study|1|||
156361208|NCT00930579|564421944|FG000|Overall Study|Withdrawal by Subject|1|||
156361209|NCT00930579|564421944|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
156361210|NCT01046682|564421949|FG000|Overall Study|Adverse Event|2|||
156361211|NCT01046682|564421950|FG001|Overall Study|Adverse Event|0|||
156361212|NCT05071183|564421951|FG000|Overall Study|Death|1|||
156361213|NCT05071183|564421952|FG001|Overall Study|Death|2|||
156361214|NCT05071183|564421953|FG002|Overall Study|Death|0|||
156361215|NCT05071183|564421951|FG000|Overall Study|Other Reasons|1|||
156361216|NCT05071183|564421952|FG001|Overall Study|Other Reasons|3|||
156361217|NCT05071183|564421953|FG002|Overall Study|Other Reasons|2|||
156361218|NCT02864251|564421954|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
156361219|NCT02864251|564421955|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
156361220|NCT02864251|564421956|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
156361221|NCT02864251|564421954|FG000|Pre-Treatment|Withdrawal by Participant|0|||
156361222|NCT02864251|564421955|FG001|Pre-Treatment|Withdrawal by Participant|0|||
156361223|NCT02864251|564421956|FG002|Pre-Treatment|Withdrawal by Participant|4|||
156361224|NCT02864251|564421954|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
156361225|NCT02864251|564421955|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
156361226|NCT02864251|564421956|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
156361227|NCT02864251|564421954|FG000|Pre-Treatment|Other Reasons|0|||
156361228|NCT02864251|564421955|FG001|Pre-Treatment|Other Reasons|1|||
156361229|NCT02864251|564421956|FG002|Pre-Treatment|Other Reasons|1|||
156361230|NCT02864251|564421954|FG000|Treatment|Disease Progression|109|||
156361231|NCT02864251|564421955|FG001|Treatment|Disease Progression|52|||
156361232|NCT02864251|564421956|FG002|Treatment|Disease Progression|101|||
156361233|NCT02864251|564421954|FG000|Treatment|Study Drug Toxicity|9|||
156361234|NCT02864251|564421955|FG001|Treatment|Study Drug Toxicity|4|||
156361235|NCT02864251|564421956|FG002|Treatment|Study Drug Toxicity|10|||
156361236|NCT02864251|564421954|FG000|Treatment|Death|0|||
156361237|NCT02864251|564421955|FG001|Treatment|Death|2|||
156361238|NCT02864251|564421956|FG002|Treatment|Death|3|||
156361239|NCT02864251|564421954|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
156361240|NCT02864251|564421955|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
156361241|NCT02864251|564421956|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
156361242|NCT02864251|564421954|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
156361243|NCT02864251|564421955|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
156361244|NCT02864251|564421956|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
156361245|NCT02864251|564421954|FG000|Treatment|Withdrawal by Participant|8|||
156361246|NCT02864251|564421955|FG001|Treatment|Withdrawal by Participant|5|||
156361247|NCT02864251|564421956|FG002|Treatment|Withdrawal by Participant|13|||
156361248|NCT02864251|564421954|FG000|Treatment|Maximum Clinical Benefit|1|||
156361249|NCT02864251|564421955|FG001|Treatment|Maximum Clinical Benefit|0|||
156361250|NCT02864251|564421956|FG002|Treatment|Maximum Clinical Benefit|1|||
156361251|NCT02864251|564421954|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
156361252|NCT02864251|564421955|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
156361253|NCT02864251|564421956|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
156361254|NCT02864251|564421954|FG000|Treatment|Other Reasons|1|||
156361255|NCT02864251|564421955|FG001|Treatment|Other Reasons|1|||
156361256|NCT02864251|564421956|FG002|Treatment|Other Reasons|4|||
156361257|NCT02864251|564421954|FG000|Treatment|Administrative Reason by Sponsor|1|||
156361258|NCT02864251|564421955|FG001|Treatment|Administrative Reason by Sponsor|0|||
156361259|NCT02864251|564421956|FG002|Treatment|Administrative Reason by Sponsor|0|||
156361260|NCT04343521|564421959|FG000|Overall Study|Adverse Event|0|||
156361261|NCT04343521|564421960|FG001|Overall Study|Adverse Event|2|||
156361262|NCT04343521|564421959|FG000|Overall Study|Death|1|||
156361263|NCT04343521|564421960|FG001|Overall Study|Death|2|||
156361264|NCT04343521|564421959|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
156361265|NCT04343521|564421960|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
156361266|NCT04343521|564421959|FG000|Overall Study|Withdrawal by Subject|70|||
156361267|NCT04343521|564421960|FG001|Overall Study|Withdrawal by Subject|95|||
156361268|NCT04343521|564421959|FG000|Overall Study|Withdrawal by study team|6|||
156361269|NCT04343521|564421960|FG001|Overall Study|Withdrawal by study team|12|||
156361270|NCT02532647|564421961|FG000|Overall Study|Did not receive trial medication|1|||
156361271|NCT02532647|564421962|FG001|Overall Study|Did not receive trial medication|0|||
156361272|NCT02532647|564421963|FG002|Overall Study|Did not receive trial medication|1|||
156361273|NCT00704535|564421967|FG000|Overall Study|Adverse Event|2|||
156361274|NCT00704535|564421967|FG000|Overall Study|Death|2|||
156361275|NCT00704535|564421967|FG000|Overall Study|Lost to Follow-up|8|||
156361276|NCT00704535|564421967|FG000|Overall Study|Protocol Violation|10|||
156361277|NCT00704535|564421967|FG000|Overall Study|Completed status not on Case Report Form|124|||
156361278|NCT02503332|564421969|FG000|Overall Study|Adverse Event|17|||
156361279|NCT02503332|564421970|FG001|Overall Study|Adverse Event|5|||
156361280|NCT02503332|564421971|FG002|Overall Study|Adverse Event|3|||
156361281|NCT02503332|564421972|FG003|Overall Study|Adverse Event|1|||
156361282|NCT02503332|564421969|FG000|Overall Study|Investigator's Decision|5|||
156361283|NCT02503332|564421970|FG001|Overall Study|Investigator's Decision|1|||
156361284|NCT02503332|564421971|FG002|Overall Study|Investigator's Decision|0|||
156361285|NCT02503332|564421972|FG003|Overall Study|Investigator's Decision|0|||
156361286|NCT02503332|564421969|FG000|Overall Study|Sponsor's Decision|1|||
156361287|NCT02503332|564421970|FG001|Overall Study|Sponsor's Decision|0|||
156361288|NCT02503332|564421971|FG002|Overall Study|Sponsor's Decision|0|||
156361289|NCT02503332|564421972|FG003|Overall Study|Sponsor's Decision|1|||
156361290|NCT02503332|564421969|FG000|Overall Study|Subject Request|6|||
156361291|NCT02503332|564421970|FG001|Overall Study|Subject Request|5|||
156361292|NCT02503332|564421971|FG002|Overall Study|Subject Request|2|||
156361293|NCT02503332|564421972|FG003|Overall Study|Subject Request|1|||
156361294|NCT02503332|564421969|FG000|Overall Study|Death|0|||
156361295|NCT02503332|564421970|FG001|Overall Study|Death|2|||
156361296|NCT02503332|564421971|FG002|Overall Study|Death|2|||
156361297|NCT02503332|564421972|FG003|Overall Study|Death|0|||
156361298|NCT02503332|564421969|FG000|Overall Study|Other|5|||
156361299|NCT02503332|564421970|FG001|Overall Study|Other|6|||
156361300|NCT02503332|564421971|FG002|Overall Study|Other|1|||
156361301|NCT02503332|564421972|FG003|Overall Study|Other|1|||
156361302|NCT02120950|564421973|FG000|Overall Study|Adverse Event|5|||
156361303|NCT02120950|564421974|FG001|Overall Study|Adverse Event|4|||
156361304|NCT02120950|564421975|FG002|Overall Study|Adverse Event|3|||
156361305|NCT02120950|564421973|FG000|Overall Study|Death|3|||
156361306|NCT02120950|564421974|FG001|Overall Study|Death|0|||
156361307|NCT02120950|564421975|FG002|Overall Study|Death|1|||
156361308|NCT02120950|564421973|FG000|Overall Study|Withdrawal by Subject|6|||
156361309|NCT02120950|564421974|FG001|Overall Study|Withdrawal by Subject|3|||
156361310|NCT02120950|564421975|FG002|Overall Study|Withdrawal by Subject|2|||
156361311|NCT02120950|564421973|FG000|Overall Study|Protocol Violation|1|||
156361312|NCT02120950|564421974|FG001|Overall Study|Protocol Violation|1|||
156361313|NCT02120950|564421975|FG002|Overall Study|Protocol Violation|7|||
156361314|NCT02120950|564421973|FG000|Overall Study|Other reasons|5|||
156361315|NCT02120950|564421974|FG001|Overall Study|Other reasons|4|||
156361316|NCT02120950|564421975|FG002|Overall Study|Other reasons|1|||
156361317|NCT02120950|564421973|FG000|Overall Study|Lost to Follow-up|0|||
156361318|NCT02120950|564421974|FG001|Overall Study|Lost to Follow-up|2|||
156361319|NCT02120950|564421975|FG002|Overall Study|Lost to Follow-up|1|||
156361320|NCT02424383|564421976|FG000|Overall Study|Withdrawal by Subject|32|||
156361321|NCT02424383|564421976|FG000|Overall Study|Death|170|||
156361322|NCT02424383|564421976|FG000|Overall Study|Sponsor's decision|3|||
156361323|NCT02424383|564421976|FG000|Overall Study|Investigator's decision|44|||
156361324|NCT02424383|564421976|FG000|Overall Study|Lost to Follow-up|81|||
156361325|NCT02424383|564421976|FG000|Overall Study|Other|7|||
156361326|NCT02424383|564421976|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
156361327|NCT03343483|564421983|FG000|Overall Study|Death|0|||
156361328|NCT03343483|564421984|FG001|Overall Study|Death|3|||
156361329|NCT03343483|564421983|FG000|Overall Study|Lost to Follow-up|9|||
156361330|NCT03343483|564421984|FG001|Overall Study|Lost to Follow-up|13|||
156361331|NCT03343483|564421983|FG000|Overall Study|Withdrawal by Subject|8|||
156361332|NCT03343483|564421984|FG001|Overall Study|Withdrawal by Subject|17|||
156361333|NCT01488097|564421987|FG000|Overall Study|Lost to Follow-up|1|||
156361334|NCT01577758|564421988|FG000|Dose Escalation Phase|Adverse Event|0|||
156361335|NCT01577758|564421989|FG001|Dose Escalation Phase|Adverse Event|0|||
156361336|NCT01577758|564421990|FG002|Dose Escalation Phase|Adverse Event|0|||
156361337|NCT01577758|564421991|FG003|Dose Escalation Phase|Adverse Event|0|||
156489592|NCT00922441|564887378|FG001|Overall Study|Withdrawal by Subject|0|||
156489593|NCT00922441|564887379|FG002|Overall Study|Withdrawal by Subject|1|||
156361338|NCT01577758|564421992|FG004|Dose Escalation Phase|Adverse Event|0|||
156361339|NCT01577758|564421993|FG005|Dose Escalation Phase|Adverse Event|2|||
156361340|NCT01577758|564421994|FG006|Dose Escalation Phase|Adverse Event|1|||
156361341|NCT01577758|564421995|FG007|Dose Escalation Phase|Adverse Event|0|||
156361342|NCT01577758|564421988|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
156361343|NCT01577758|564421989|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
156361344|NCT01577758|564421990|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
156361345|NCT01577758|564421991|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
156361346|NCT01577758|564421992|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
156361347|NCT01577758|564421993|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
156361348|NCT01577758|564421994|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
156361349|NCT01577758|564421995|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
156361350|NCT01577758|564421988|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
156361351|NCT01577758|564421989|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
156361352|NCT01577758|564421990|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
156361353|NCT01577758|564421991|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156361354|NCT01577758|564421992|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
156361355|NCT01577758|564421993|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
156361356|NCT01577758|564421994|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
156361357|NCT01577758|564421995|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
156361358|NCT01577758|564421988|FG000|Dose Escalation Phase|Progression Disease|2|||
156361359|NCT01577758|564421989|FG001|Dose Escalation Phase|Progression Disease|2|||
156361360|NCT01577758|564421990|FG002|Dose Escalation Phase|Progression Disease|1|||
156361361|NCT01577758|564421991|FG003|Dose Escalation Phase|Progression Disease|2|||
156361362|NCT01577758|564421992|FG004|Dose Escalation Phase|Progression Disease|5|||
156361363|NCT01577758|564421993|FG005|Dose Escalation Phase|Progression Disease|0|||
156361364|NCT01577758|564421994|FG006|Dose Escalation Phase|Progression Disease|0|||
156361365|NCT01577758|564421995|FG007|Dose Escalation Phase|Progression Disease|0|||
156361366|NCT01577758|564421988|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156361367|NCT01577758|564421989|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156361368|NCT01577758|564421990|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156361369|NCT01577758|564421991|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156361370|NCT01577758|564421992|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156361371|NCT01577758|564421993|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156361372|NCT01577758|564421994|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156361373|NCT01577758|564421995|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
156361374|NCT01577758|564421988|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
156361375|NCT01577758|564421989|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
156361376|NCT01577758|564421990|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
156361377|NCT01577758|564421991|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
156361378|NCT01577758|564421992|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
156361379|NCT01577758|564421993|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
156361380|NCT01577758|564421994|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
156361381|NCT01577758|564421995|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
156361382|NCT01577758|564421988|FG000|mCRC Expansion Phase|Progression Disease|0|||
156361383|NCT01577758|564421989|FG001|mCRC Expansion Phase|Progression Disease|0|||
156361384|NCT01577758|564421990|FG002|mCRC Expansion Phase|Progression Disease|0|||
156361385|NCT01577758|564421991|FG003|mCRC Expansion Phase|Progression Disease|0|||
156361386|NCT01577758|564421992|FG004|mCRC Expansion Phase|Progression Disease|0|||
156361387|NCT01577758|564421993|FG005|mCRC Expansion Phase|Progression Disease|0|||
156361388|NCT01577758|564421994|FG006|mCRC Expansion Phase|Progression Disease|0|||
156361389|NCT01577758|564421995|FG007|mCRC Expansion Phase|Progression Disease|19|||
156361390|NCT01293240|564421996|FG000|Overall Study|Noncompliance|2|||
156361391|NCT01251380|564422000|FG000|Overall Study|Other (Not otherwise specified)|12|||
156361392|NCT01251380|564422000|FG000|Overall Study|Withdrawal by Subject|6|||
156361393|NCT01251380|564422000|FG000|Overall Study|Lack of Efficacy|1|||
156361394|NCT01251380|564422000|FG000|Overall Study|Adverse Event|1|||
156361395|NCT01251380|564422000|FG000|Overall Study|Lost to Follow-up|2|||
156361396|NCT00751348|564422001|FG000|Overall Study|Withdrawal by Subject|5|||
156361397|NCT00751348|564422002|FG001|Overall Study|Withdrawal by Subject|2|||
156361398|NCT00751348|564422001|FG000|Overall Study|Migration from study area|1|||
156361399|NCT00751348|564422002|FG001|Overall Study|Migration from study area|0|||
156361400|NCT02590939|564422008|FG000|Overall Study|Withdrawal by Subject|3|||
156361401|NCT02590939|564422009|FG001|Overall Study|Withdrawal by Subject|1|||
156361402|NCT02590939|564422008|FG000|Overall Study|Failed the nociceptive test|2|||
156361403|NCT02590939|564422009|FG001|Overall Study|Failed the nociceptive test|1|||
156361404|NCT00600938|564422017|FG000|Core Study|Abnormal test procedure result(s)|3|||
156361405|NCT00600938|564422018|FG001|Core Study|Abnormal test procedure result(s)|2|||
156361406|NCT00600938|564422019|FG002|Core Study|Abnormal test procedure result(s)|0|||
156361407|NCT00600938|564422020|FG003|Core Study|Abnormal test procedure result(s)|0|||
156361408|NCT00600938|564422017|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
156361409|NCT00600938|564422018|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
156361410|NCT00600938|564422019|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
156361411|NCT00600938|564422020|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
156361412|NCT00600938|564422017|FG000|Core Study|Patient withdrew consent|7|||
156361413|NCT00600938|564422018|FG001|Core Study|Patient withdrew consent|12|||
156545575|NCT00917150|565091649|FG003|Overall Study|Physician Decision|1|||
156545576|NCT00917150|565091646|FG000|Overall Study|Protocol Violation|5|||
156361414|NCT00600938|564422019|FG002|Core Study|Patient withdrew consent|0|||
156361415|NCT00600938|564422020|FG003|Core Study|Patient withdrew consent|0|||
156361416|NCT00600938|564422017|FG000|Core Study|Lost to Follow-up|3|||
156361417|NCT00600938|564422018|FG001|Core Study|Lost to Follow-up|2|||
156361418|NCT00600938|564422019|FG002|Core Study|Lost to Follow-up|0|||
156361419|NCT00600938|564422020|FG003|Core Study|Lost to Follow-up|0|||
156545577|NCT00917150|565091647|FG001|Overall Study|Protocol Violation|5|||
156545578|NCT00917150|565091648|FG002|Overall Study|Protocol Violation|3|||
156545579|NCT00917150|565091649|FG003|Overall Study|Protocol Violation|5|||
156545580|NCT00917150|565091646|FG000|Overall Study|Withdrawal by Subject|15|||
156545581|NCT00917150|565091647|FG001|Overall Study|Withdrawal by Subject|16|||
156545582|NCT00917150|565091648|FG002|Overall Study|Withdrawal by Subject|18|||
156545583|NCT00917150|565091649|FG003|Overall Study|Withdrawal by Subject|11|||
156545584|NCT00917150|565091646|FG000|Overall Study|Other than specified|3|||
156545585|NCT00917150|565091647|FG001|Overall Study|Other than specified|3|||
156545586|NCT00917150|565091648|FG002|Overall Study|Other than specified|2|||
156545587|NCT00917150|565091649|FG003|Overall Study|Other than specified|2|||
156545588|NCT03891264|565091651|FG000|Overall Study|Adverse Event|1|||
156545589|NCT03891264|565091651|FG000|Overall Study|Withdrawal by Subject|2|||
156545590|NCT03891264|565091651|FG000|Overall Study|Physician Decision|2|||
156489594|NCT01885936|564887380|FG000|Overall Study|Withdrawal by Subject|1|||
156489595|NCT01885936|564887381|FG001|Overall Study|Withdrawal by Subject|0|||
156489596|NCT03214250|564887382|FG000|Overall Study|Death|5|||
156489597|NCT03214250|564887383|FG001|Overall Study|Death|5|||
156489598|NCT03214250|564887384|FG002|Overall Study|Death|7|||
156489599|NCT03214250|564887385|FG003|Overall Study|Death|4|||
156489600|NCT03214250|564887386|FG004|Overall Study|Death|23|||
156489601|NCT03214250|564887387|FG005|Overall Study|Death|23|||
156489602|NCT03214250|564887388|FG006|Overall Study|Death|24|||
156489603|NCT03214250|564887382|FG000|Overall Study|Lost to Follow-up|0|||
156489604|NCT03214250|564887383|FG001|Overall Study|Lost to Follow-up|0|||
156545591|NCT01692275|565091652|FG000|Overall Study|Lost to Follow-up|57|||
156545592|NCT01692275|565091653|FG001|Overall Study|Lost to Follow-up|48|||
156545593|NCT01692275|565091652|FG000|Overall Study|Withdrawal by Subject|9|||
156545594|NCT01692275|565091653|FG001|Overall Study|Withdrawal by Subject|11|||
156545595|NCT00640328|565091654|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
156545596|NCT00640328|565091655|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
156545597|NCT00640328|565091656|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
156545598|NCT00640328|565091657|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
156545599|NCT00640328|565091658|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
156545600|NCT00640328|565091659|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
156545601|NCT00640328|565091654|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
156545602|NCT00640328|565091655|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
156489605|NCT03214250|564887384|FG002|Overall Study|Lost to Follow-up|0|||
156489606|NCT03214250|564887385|FG003|Overall Study|Lost to Follow-up|1|||
156489607|NCT03214250|564887386|FG004|Overall Study|Lost to Follow-up|1|||
156489608|NCT03214250|564887387|FG005|Overall Study|Lost to Follow-up|2|||
156489609|NCT03214250|564887388|FG006|Overall Study|Lost to Follow-up|0|||
156489610|NCT03214250|564887382|FG000|Overall Study|Other|0|||
156489611|NCT03214250|564887383|FG001|Overall Study|Other|0|||
156489612|NCT03214250|564887384|FG002|Overall Study|Other|0|||
156489613|NCT03214250|564887385|FG003|Overall Study|Other|0|||
156489614|NCT03214250|564887386|FG004|Overall Study|Other|1|||
156489615|NCT03214250|564887387|FG005|Overall Study|Other|1|||
156489616|NCT03214250|564887388|FG006|Overall Study|Other|2|||
156489617|NCT03214250|564887382|FG000|Overall Study|Remains on Study|2|||
156489618|NCT03214250|564887383|FG001|Overall Study|Remains on Study|2|||
156489619|NCT03214250|564887384|FG002|Overall Study|Remains on Study|0|||
156489620|NCT03214250|564887385|FG003|Overall Study|Remains on Study|1|||
156545603|NCT00640328|565091656|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
156361420|NCT00600938|564422017|FG000|Core Study|Death|1|||
156361421|NCT00600938|564422018|FG001|Core Study|Death|1|||
156361422|NCT00600938|564422019|FG002|Core Study|Death|0|||
156361423|NCT00600938|564422020|FG003|Core Study|Death|0|||
156361424|NCT00600938|564422017|FG000|Core Study|Protocol Violation|1|||
156361425|NCT00600938|564422018|FG001|Core Study|Protocol Violation|2|||
156361426|NCT00600938|564422019|FG002|Core Study|Protocol Violation|0|||
156361427|NCT00600938|564422020|FG003|Core Study|Protocol Violation|0|||
156361428|NCT00600938|564422017|FG000|Extension Study|Adverse Event|1|||
156361429|NCT00600938|564422018|FG001|Extension Study|Adverse Event|0|||
156489621|NCT03214250|564887386|FG004|Overall Study|Remains on Study|7|||
156489622|NCT03214250|564887387|FG005|Overall Study|Remains on Study|5|||
156489623|NCT03214250|564887388|FG006|Overall Study|Remains on Study|3|||
156489624|NCT03214250|564887382|FG000|Overall Study|Withdrawal by Subject|0|||
156489625|NCT03214250|564887383|FG001|Overall Study|Withdrawal by Subject|0|||
156545604|NCT00640328|565091657|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
156489626|NCT03214250|564887384|FG002|Overall Study|Withdrawal by Subject|1|||
156489627|NCT03214250|564887385|FG003|Overall Study|Withdrawal by Subject|2|||
156489628|NCT03214250|564887386|FG004|Overall Study|Withdrawal by Subject|5|||
156489629|NCT03214250|564887387|FG005|Overall Study|Withdrawal by Subject|0|||
156489630|NCT03214250|564887388|FG006|Overall Study|Withdrawal by Subject|2|||
156361430|NCT00600938|564422019|FG002|Extension Study|Adverse Event|2|||
156361431|NCT00600938|564422020|FG003|Extension Study|Adverse Event|0|||
156361432|NCT00600938|564422017|FG000|Extension Study|Abnormal test procedure results|0|||
156489631|NCT00317603|564887389|FG000|Overall Study|Progressive Disease|3|||
156361433|NCT00600938|564422018|FG001|Extension Study|Abnormal test procedure results|1|||
156361434|NCT00600938|564422019|FG002|Extension Study|Abnormal test procedure results|1|||
156361435|NCT00600938|564422020|FG003|Extension Study|Abnormal test procedure results|1|||
156361436|NCT00600938|564422017|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
156361437|NCT00600938|564422018|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
156361438|NCT00600938|564422019|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
156361439|NCT00600938|564422020|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
156361440|NCT00600938|564422017|FG000|Extension Study|Withdrawal by Subject|2|||
156361441|NCT00600938|564422018|FG001|Extension Study|Withdrawal by Subject|2|||
156361442|NCT00600938|564422019|FG002|Extension Study|Withdrawal by Subject|3|||
156361443|NCT00600938|564422020|FG003|Extension Study|Withdrawal by Subject|0|||
156361444|NCT00600938|564422017|FG000|Extension Study|Lost to Follow-up|1|||
156361445|NCT00600938|564422018|FG001|Extension Study|Lost to Follow-up|1|||
156361446|NCT00600938|564422019|FG002|Extension Study|Lost to Follow-up|2|||
156361447|NCT00600938|564422020|FG003|Extension Study|Lost to Follow-up|0|||
156361448|NCT00600938|564422017|FG000|Extension Study|Death|1|||
156361449|NCT00600938|564422018|FG001|Extension Study|Death|0|||
156361450|NCT00600938|564422019|FG002|Extension Study|Death|0|||
156361451|NCT00600938|564422020|FG003|Extension Study|Death|0|||
156361452|NCT02496533|564422029|FG000|Overall Study|Lack of data on outcome|3|||
156361453|NCT02496533|564422030|FG001|Overall Study|Lack of data on outcome|0|||
156361454|NCT02496533|564422029|FG000|Overall Study|Patient did not complete all measures|0|||
156361455|NCT02496533|564422030|FG001|Overall Study|Patient did not complete all measures|4|||
156361456|NCT02496533|564422029|FG000|Overall Study|Late for radiologic testing|0|||
156361457|NCT02496533|564422030|FG001|Overall Study|Late for radiologic testing|2|||
156361458|NCT05756790|564422031|FG000|Overall Study|Withdrawal by Subject|1|||
156361459|NCT05756790|564422032|FG001|Overall Study|Withdrawal by Subject|1|||
156361460|NCT05756790|564422033|FG002|Overall Study|Withdrawal by Subject|1|||
156361461|NCT05756790|564422034|FG003|Overall Study|Withdrawal by Subject|1|||
156361462|NCT05756790|564422035|FG004|Overall Study|Withdrawal by Subject|0|||
156361463|NCT05756790|564422036|FG005|Overall Study|Withdrawal by Subject|0|||
156361464|NCT05756790|564422031|FG000|Overall Study|Protocol Violation|0|||
156361465|NCT05756790|564422032|FG001|Overall Study|Protocol Violation|0|||
156361466|NCT05756790|564422033|FG002|Overall Study|Protocol Violation|1|||
156361467|NCT05756790|564422034|FG003|Overall Study|Protocol Violation|1|||
156361468|NCT05756790|564422035|FG004|Overall Study|Protocol Violation|0|||
156361469|NCT05756790|564422036|FG005|Overall Study|Protocol Violation|0|||
156361470|NCT05756790|564422031|FG000|Overall Study|Ineligible|0|||
156361471|NCT05756790|564422032|FG001|Overall Study|Ineligible|0|||
156361472|NCT05756790|564422033|FG002|Overall Study|Ineligible|0|||
156361473|NCT05756790|564422034|FG003|Overall Study|Ineligible|0|||
156361474|NCT05756790|564422035|FG004|Overall Study|Ineligible|2|||
156361475|NCT05756790|564422036|FG005|Overall Study|Ineligible|2|||
156361476|NCT01541969|564423464|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
156361477|NCT01541969|564423465|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
156361478|NCT01541969|564423464|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
156361479|NCT01541969|564423465|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
156361480|NCT01541969|564423464|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
156361481|NCT01541969|564423465|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
156361482|NCT01541969|564423464|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
156361483|NCT01541969|564423465|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
156361484|NCT01541969|564423464|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
156489632|NCT00523549|564887390|FG000|Overall Study|Adverse Event|6|||
156489633|NCT00523549|564887391|FG001|Overall Study|Adverse Event|3|||
156489634|NCT00523549|564887390|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156489635|NCT00523549|564887391|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156489636|NCT00523549|564887390|FG000|Overall Study|Protocol Deviation|3|||
156489637|NCT00523549|564887391|FG001|Overall Study|Protocol Deviation|1|||
156489638|NCT00523549|564887390|FG000|Overall Study|Patient withdrew consent|7|||
156489639|NCT00523549|564887391|FG001|Overall Study|Patient withdrew consent|6|||
156489640|NCT00523549|564887390|FG000|Overall Study|Lost to Follow-up|3|||
156489641|NCT00523549|564887391|FG001|Overall Study|Lost to Follow-up|5|||
156489642|NCT00427778|564887396|FG000|First Intervention (4 Weeks)|no longer interested|1|||
156489643|NCT00427778|564887397|FG001|First Intervention (4 Weeks)|no longer interested|0|||
156489644|NCT00427778|564887396|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
156361485|NCT01541969|564423465|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
156361486|NCT01541969|564423464|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
156361487|NCT01541969|564423465|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
156361488|NCT01541969|564423464|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
156361489|NCT01541969|564423465|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
156361490|NCT01541969|564423464|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
156361491|NCT01541969|564423465|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
156361492|NCT01541969|564423464|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
156361493|NCT01541969|564423465|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
156361494|NCT01541969|564423464|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
156361495|NCT01541969|564423465|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
156361496|NCT01365507|564423466|FG000|Overall Study|Withdrawal Criteria|8|||
156361497|NCT01365507|564423467|FG001|Overall Study|Withdrawal Criteria|5|||
156361498|NCT01365507|564423466|FG000|Overall Study|Unclassified|1|||
156361499|NCT01365507|564423467|FG001|Overall Study|Unclassified|4|||
156361500|NCT03265249|564423470|FG000|Overall Study|Withdrawal by Subject|0|||
156361501|NCT03265249|564423471|FG001|Overall Study|Withdrawal by Subject|1|||
156361502|NCT01614990|564423472|FG000|Overall Study|Protocol Violation|1|||
156361503|NCT01614990|564423473|FG001|Overall Study|Protocol Violation|1|||
156361504|NCT02255500|564423480|FG000|Overall Study|Withdrawal by Subject|1|||
156361505|NCT02255500|564423481|FG001|Overall Study|Withdrawal by Subject|0|||
156361506|NCT01012622|564423482|FG000|Overall Study|Withdrawal by Subject|6|||
156361507|NCT01012622|564423482|FG000|Overall Study|Lost to Follow-up|5|||
156361508|NCT01012622|564423482|FG000|Overall Study|Adverse Event|7|||
156361509|NCT01012622|564423482|FG000|Overall Study|non-compliance with the drug|9|||
156361510|NCT01012622|564423482|FG000|Overall Study|Other|1|||
156361511|NCT01012622|564423482|FG000|Overall Study|screening failure|1|||
156361512|NCT01012622|564423482|FG000|Overall Study|withdrawal of consent by a parent|2|||
156361513|NCT02449239|564423485|FG000|Induction Phase|Lack of Efficacy|64|||
156361514|NCT02449239|564423485|FG000|Induction Phase|Adverse Event|1|||
156361515|NCT02449239|564423485|FG000|Induction Phase|Lost to Follow-up|1|||
156361516|NCT02449239|564423485|FG000|Induction Phase|Protocol Violation|1|||
156361517|NCT02449239|564423485|FG000|Induction Phase|Physician Decision|1|||
156361518|NCT02449239|564423485|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
156361519|NCT02449239|564423485|FG000|Induction Phase|Withdrawal by Subject|1|||
156361520|NCT02449239|564423485|FG000|Maintenance Month 3|Lack of Efficacy|14|||
156361521|NCT02449239|564423485|FG000|Maintenance Month 6|Lack of Efficacy|10|||
156361522|NCT02449239|564423485|FG000|Maintenance Month 6|Adverse Event|2|||
156361523|NCT02449239|564423485|FG000|Maintenance Month 6|Physician Decision|1|||
156361524|NCT02449239|564423485|FG000|Maintenance Month 9|Lack of Efficacy|2|||
156361525|NCT02449239|564423485|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
156361526|NCT02449239|564423485|FG000|Maintenance Month 12|Lack of Efficacy|5|||
156361527|NCT02449239|564423485|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
156361528|NCT02449239|564423485|FG000|Maintenance Month 12|Subject moved from area|1|||
156361529|NCT02449239|564423485|FG000|Maintenance Month 15|Lack of Efficacy|1|||
156361530|NCT02449239|564423485|FG000|Maintenance Month 21|Lack of Efficacy|1|||
156361531|NCT02449239|564423485|FG000|Maintenance Month 21|Sponsor decision|1|||
156361532|NCT03239470|564423493|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
156361533|NCT03239470|564423494|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
156361534|NCT01023581|564423495|FG000|Overall Study|Adverse Event|4|||
156361535|NCT01023581|564423496|FG001|Overall Study|Adverse Event|4|||
156361536|NCT01023581|564423497|FG002|Overall Study|Adverse Event|7|||
156361537|NCT01023581|564423498|FG003|Overall Study|Adverse Event|3|||
156361538|NCT01023581|564423499|FG004|Overall Study|Adverse Event|2|||
156361539|NCT01023581|564423500|FG005|Overall Study|Adverse Event|5|||
156361540|NCT01023581|564423501|FG006|Overall Study|Adverse Event|11|||
156361541|NCT01023581|564423495|FG000|Overall Study|Major protocol deviation|2|||
156361542|NCT01023581|564423496|FG001|Overall Study|Major protocol deviation|0|||
156361543|NCT01023581|564423497|FG002|Overall Study|Major protocol deviation|3|||
156361544|NCT01023581|564423498|FG003|Overall Study|Major protocol deviation|0|||
156361545|NCT01023581|564423499|FG004|Overall Study|Major protocol deviation|0|||
156361546|NCT01023581|564423500|FG005|Overall Study|Major protocol deviation|0|||
156361547|NCT01023581|564423501|FG006|Overall Study|Major protocol deviation|0|||
156361548|NCT01023581|564423495|FG000|Overall Study|Lost to Follow-up|4|||
156361549|NCT01023581|564423496|FG001|Overall Study|Lost to Follow-up|8|||
156361550|NCT01023581|564423497|FG002|Overall Study|Lost to Follow-up|7|||
156361551|NCT01023581|564423498|FG003|Overall Study|Lost to Follow-up|2|||
156361552|NCT01023581|564423499|FG004|Overall Study|Lost to Follow-up|5|||
156361553|NCT01023581|564423500|FG005|Overall Study|Lost to Follow-up|2|||
156361554|NCT01023581|564423501|FG006|Overall Study|Lost to Follow-up|2|||
156361555|NCT01023581|564423495|FG000|Overall Study|Withdrawal by Subject|13|||
156361556|NCT01023581|564423496|FG001|Overall Study|Withdrawal by Subject|8|||
156361557|NCT01023581|564423497|FG002|Overall Study|Withdrawal by Subject|16|||
156361558|NCT01023581|564423498|FG003|Overall Study|Withdrawal by Subject|10|||
156361559|NCT01023581|564423499|FG004|Overall Study|Withdrawal by Subject|6|||
156361560|NCT01023581|564423500|FG005|Overall Study|Withdrawal by Subject|8|||
156361561|NCT01023581|564423501|FG006|Overall Study|Withdrawal by Subject|5|||
156361562|NCT01023581|564423495|FG000|Overall Study|Pregnancy|0|||
156361563|NCT01023581|564423496|FG001|Overall Study|Pregnancy|0|||
156361564|NCT01023581|564423497|FG002|Overall Study|Pregnancy|0|||
156361565|NCT01023581|564423498|FG003|Overall Study|Pregnancy|2|||
156361566|NCT01023581|564423499|FG004|Overall Study|Pregnancy|0|||
156361567|NCT01023581|564423500|FG005|Overall Study|Pregnancy|1|||
156361568|NCT01023581|564423501|FG006|Overall Study|Pregnancy|0|||
156361569|NCT01023581|564423495|FG000|Overall Study|Lack of Efficacy|9|||
156361570|NCT01023581|564423496|FG001|Overall Study|Lack of Efficacy|3|||
156361571|NCT01023581|564423497|FG002|Overall Study|Lack of Efficacy|6|||
156361572|NCT01023581|564423498|FG003|Overall Study|Lack of Efficacy|2|||
156361573|NCT01023581|564423499|FG004|Overall Study|Lack of Efficacy|1|||
156361574|NCT01023581|564423500|FG005|Overall Study|Lack of Efficacy|2|||
156361575|NCT01023581|564423501|FG006|Overall Study|Lack of Efficacy|1|||
156361576|NCT01023581|564423495|FG000|Overall Study|Physician Decision|2|||
156361577|NCT01023581|564423496|FG001|Overall Study|Physician Decision|0|||
156361578|NCT01023581|564423497|FG002|Overall Study|Physician Decision|2|||
156361579|NCT01023581|564423498|FG003|Overall Study|Physician Decision|1|||
156361580|NCT01023581|564423499|FG004|Overall Study|Physician Decision|1|||
156361581|NCT01023581|564423500|FG005|Overall Study|Physician Decision|1|||
156361582|NCT01023581|564423501|FG006|Overall Study|Physician Decision|1|||
156361583|NCT01023581|564423495|FG000|Overall Study|Other|1|||
156361584|NCT01023581|564423496|FG001|Overall Study|Other|0|||
156361585|NCT01023581|564423497|FG002|Overall Study|Other|1|||
156361586|NCT01023581|564423498|FG003|Overall Study|Other|0|||
156361587|NCT01023581|564423499|FG004|Overall Study|Other|1|||
156361588|NCT01023581|564423500|FG005|Overall Study|Other|0|||
156361589|NCT01023581|564423501|FG006|Overall Study|Other|0|||
156361590|NCT01176292|564423505|FG000|Overall Study|Lost to Follow-up|2|||
156361591|NCT01176292|564423506|FG001|Overall Study|Lost to Follow-up|4|||
156361592|NCT01176292|564423505|FG000|Overall Study|Adverse Event|1|||
156361593|NCT01176292|564423506|FG001|Overall Study|Adverse Event|1|||
156361594|NCT01176292|564423505|FG000|Overall Study|Physician Decision|0|||
156361595|NCT01176292|564423506|FG001|Overall Study|Physician Decision|2|||
156361596|NCT01176292|564423505|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
156361597|NCT01176292|564423506|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
156361598|NCT00380393|564423507|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
156361599|NCT00380393|564423508|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
156361600|NCT00380393|564423507|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
156361601|NCT00380393|564423508|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
156361602|NCT00380393|564423507|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
156361603|NCT00380393|564423508|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
156361604|NCT00380393|564423507|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
156361605|NCT00380393|564423508|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
156361606|NCT00380393|564423507|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
156361607|NCT00380393|564423508|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
156361608|NCT00380393|564423507|FG000|Month 14|Withdrawal by Subject|9|||
156361609|NCT00380393|564423508|FG001|Month 14|Withdrawal by Subject|7|||
156361610|NCT00380393|564423507|FG000|Month 14|Death|1|||
156361611|NCT00380393|564423508|FG001|Month 14|Death|0|||
156361612|NCT00380393|564423507|FG000|Month 14|Lost to Follow-up|0|||
156361613|NCT00380393|564423508|FG001|Month 14|Lost to Follow-up|1|||
156361614|NCT00380393|564423507|FG000|Month 14|Migrated/moved from study area|39|||
156361615|NCT00380393|564423508|FG001|Month 14|Migrated/moved from study area|42|||
156361616|NCT00380393|564423507|FG000|Month 14|Protocol Violation|2|||
156361617|NCT00380393|564423508|FG001|Month 14|Protocol Violation|0|||
156361618|NCT00380393|564423507|FG000|Month 14|Others|6|||
156361619|NCT00380393|564423508|FG001|Month 14|Others|6|||
156361620|NCT02780804|564423509|FG000|Overall Study|Death|1|||
156361621|NCT02780804|564423510|FG001|Overall Study|Death|0|||
156361622|NCT02780804|564423511|FG002|Overall Study|Death|0|||
156489645|NCT00427778|564887397|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
156489646|NCT00427778|564887396|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
156489647|NCT00427778|564887397|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
156489648|NCT00427778|564887396|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
156489649|NCT00427778|564887397|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
156489650|NCT00439647|564887398|FG000|Overall Study|Withdrawal by Subject|25|||
156489651|NCT00439647|564887399|FG001|Overall Study|Withdrawal by Subject|22|||
156489652|NCT00439647|564887398|FG000|Overall Study|Death|15|||
156489653|NCT00439647|564887399|FG001|Overall Study|Death|18|||
156489654|NCT00439647|564887398|FG000|Overall Study|Adverse Event|11|||
156489655|NCT00439647|564887399|FG001|Overall Study|Adverse Event|11|||
156489656|NCT00439647|564887398|FG000|Overall Study|Lost to Follow-up|4|||
156361623|NCT02780804|564423509|FG000|Overall Study|Lack of Efficacy|5|||
156361624|NCT02780804|564423510|FG001|Overall Study|Lack of Efficacy|8|||
156361625|NCT02780804|564423511|FG002|Overall Study|Lack of Efficacy|4|||
156361626|NCT02780804|564423509|FG000|Overall Study|Physician Decision|0|||
156361627|NCT02780804|564423510|FG001|Overall Study|Physician Decision|0|||
156361628|NCT02780804|564423511|FG002|Overall Study|Physician Decision|2|||
156361629|NCT02780804|564423509|FG000|Overall Study|Withdrawal by Subject|0|||
156361630|NCT02780804|564423510|FG001|Overall Study|Withdrawal by Subject|1|||
156361631|NCT02780804|564423511|FG002|Overall Study|Withdrawal by Subject|0|||
156361632|NCT02476968|564423512|FG000|Overall Study|Other|0|||
156361633|NCT02476968|564423513|FG001|Overall Study|Other|2|||
156361634|NCT02476968|564423514|FG002|Overall Study|Other|0|||
156361635|NCT02476968|564423512|FG000|Overall Study|Lost to Follow-up|10|||
156361636|NCT02476968|564423513|FG001|Overall Study|Lost to Follow-up|0|||
156361637|NCT02476968|564423514|FG002|Overall Study|Lost to Follow-up|1|||
156361638|NCT02476968|564423512|FG000|Overall Study|Death|48|||
156361639|NCT02476968|564423513|FG001|Overall Study|Death|8|||
156361640|NCT02476968|564423514|FG002|Overall Study|Death|1|||
156361641|NCT02476968|564423512|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156361642|NCT02476968|564423513|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156361643|NCT02476968|564423514|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156361644|NCT02476968|564423512|FG000|Overall Study|Patient decision|37|||
156361645|NCT02476968|564423513|FG001|Overall Study|Patient decision|8|||
156361646|NCT02476968|564423514|FG002|Overall Study|Patient decision|0|||
156361647|NCT04171414|564423517|FG000|Overall Study|Death|1|||
156361648|NCT04171414|564423517|FG000|Overall Study|Withdrawal by Subject|1|||
156361649|NCT02586493|564423520|FG000|Overall Study|Adverse Event|4|||
156361650|NCT02586493|564423520|FG000|Overall Study|Protocol Violation|6|||
156361651|NCT02586493|564423520|FG000|Overall Study|Lost to Follow-up|1|||
156361652|NCT02586493|564423520|FG000|Overall Study|Withdrawal by Subject|1|||
156361653|NCT03897179|564423533|FG000|Overall Study|Withdrawal by Subject|1|||
156361654|NCT01505608|564423534|FG000|Phase I|Lack of Efficacy|0|||
156361655|NCT01505608|564423535|FG001|Phase I|Lack of Efficacy|4|||
156489657|NCT00439647|564887399|FG001|Overall Study|Lost to Follow-up|12|||
156489658|NCT00439647|564887398|FG000|Overall Study|Protocol Violation|3|||
156489659|NCT00439647|564887399|FG001|Overall Study|Protocol Violation|4|||
156489660|NCT00439647|564887398|FG000|Overall Study|Lack of Efficacy|0|||
156361656|NCT01505608|564423534|FG000|Phase I|Adverse Event|0|||
156361657|NCT01505608|564423535|FG001|Phase I|Adverse Event|1|||
156361658|NCT01505608|564423534|FG000|Phase I|Withdrawal by Subject|0|||
156361659|NCT01505608|564423535|FG001|Phase I|Withdrawal by Subject|1|||
156361660|NCT01505608|564423534|FG000|Phase II|Lack of Efficacy|2|||
156361661|NCT01505608|564423535|FG001|Phase II|Lack of Efficacy|1|||
156361662|NCT01505608|564423534|FG000|Phase II|Protocol Violation|0|||
156361663|NCT01505608|564423535|FG001|Phase II|Protocol Violation|1|||
156361664|NCT01085097|564423538|FG000|Overall Study|Adverse Event|0|||
156361665|NCT01085097|564423539|FG001|Overall Study|Adverse Event|0|||
156361666|NCT01085097|564423540|FG002|Overall Study|Adverse Event|2|||
156361667|NCT01085097|564423538|FG000|Overall Study|Treatment failure|2|||
156361668|NCT01085097|564423539|FG001|Overall Study|Treatment failure|0|||
156361669|NCT01085097|564423540|FG002|Overall Study|Treatment failure|0|||
156361670|NCT01737047|564423543|FG000|Overall Study|Death|10|||
156361671|NCT01737047|564423544|FG001|Overall Study|Death|0|||
156361672|NCT01737047|564423545|FG002|Overall Study|Death|1|||
156361673|NCT01737047|564423543|FG000|Overall Study|Withdrawal by Subject|17|||
156361674|NCT01737047|564423544|FG001|Overall Study|Withdrawal by Subject|11|||
156361675|NCT01737047|564423545|FG002|Overall Study|Withdrawal by Subject|4|||
156361676|NCT06049043|564423546|FG000|Overall Study|Lost to Follow-up|11|||
156361677|NCT06049043|564423547|FG001|Overall Study|Lost to Follow-up|9|||
156361678|NCT03089606|564423548|FG000|Overall Study|Progression after Cycle 1|1|||
156361679|NCT01358357|564423549|FG000|Open Label Phase|Adverse Event|0|||
156361680|NCT01358357|564423550|FG001|Open Label Phase|Adverse Event|0|||
156361681|NCT01358357|564423551|FG002|Open Label Phase|Adverse Event|59|||
156361682|NCT01358357|564423549|FG000|Open Label Phase|Lack of Efficacy|0|||
156361683|NCT01358357|564423550|FG001|Open Label Phase|Lack of Efficacy|0|||
156361684|NCT01358357|564423551|FG002|Open Label Phase|Lack of Efficacy|107|||
156361685|NCT01358357|564423549|FG000|Open Label Phase|Lost to Follow-up|0|||
156361686|NCT01358357|564423550|FG001|Open Label Phase|Lost to Follow-up|0|||
156361687|NCT01358357|564423551|FG002|Open Label Phase|Lost to Follow-up|76|||
156361688|NCT01358357|564423549|FG000|Open Label Phase|Protocol Violation|0|||
156361689|NCT01358357|564423550|FG001|Open Label Phase|Protocol Violation|0|||
156361690|NCT01358357|564423551|FG002|Open Label Phase|Protocol Violation|45|||
156361691|NCT01358357|564423549|FG000|Open Label Phase|Withdrawal by Subject|0|||
156489661|NCT00439647|564887399|FG001|Overall Study|Lack of Efficacy|4|||
156361692|NCT01358357|564423550|FG001|Open Label Phase|Withdrawal by Subject|0|||
156361693|NCT01358357|564423551|FG002|Open Label Phase|Withdrawal by Subject|112|||
156361694|NCT01358357|564423549|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
156361695|NCT01358357|564423550|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
156489662|NCT02845375|564887401|FG000|Overall Study|upper airway obstruction|1|||
156361696|NCT01358357|564423551|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
156361697|NCT01358357|564423549|FG000|Open Label Phase|Terminated at study completion|0|||
156361698|NCT01358357|564423550|FG001|Open Label Phase|Terminated at study completion|0|||
156361699|NCT01358357|564423551|FG002|Open Label Phase|Terminated at study completion|5|||
156361700|NCT01358357|564423549|FG000|Open Label Phase|Mood episode|0|||
156361701|NCT01358357|564423550|FG001|Open Label Phase|Mood episode|0|||
156361702|NCT01358357|564423551|FG002|Open Label Phase|Mood episode|42|||
156361703|NCT01358357|564423549|FG000|Double-Blind Phase|Adverse Event|8|||
156361704|NCT01358357|564423550|FG001|Double-Blind Phase|Adverse Event|5|||
156361705|NCT01358357|564423551|FG002|Double-Blind Phase|Adverse Event|0|||
156361706|NCT01358357|564423549|FG000|Double-Blind Phase|Lost to Follow-up|5|||
156361707|NCT01358357|564423550|FG001|Double-Blind Phase|Lost to Follow-up|7|||
156361708|NCT01358357|564423551|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156361709|NCT01358357|564423549|FG000|Double-Blind Phase|Protocol Violation|1|||
156361710|NCT01358357|564423550|FG001|Double-Blind Phase|Protocol Violation|11|||
156361711|NCT01358357|564423551|FG002|Double-Blind Phase|Protocol Violation|0|||
156361712|NCT01358357|564423549|FG000|Double-Blind Phase|Protocol Violation|16|||
156361713|NCT01358357|564423550|FG001|Double-Blind Phase|Protocol Violation|12|||
156361714|NCT01358357|564423551|FG002|Double-Blind Phase|Protocol Violation|0|||
156361715|NCT01358357|564423549|FG000|Double-Blind Phase|Terminated at study completion|2|||
156361716|NCT01358357|564423550|FG001|Double-Blind Phase|Terminated at study completion|0|||
156361717|NCT01358357|564423551|FG002|Double-Blind Phase|Terminated at study completion|0|||
156361718|NCT01358357|564423549|FG000|Double-Blind Phase|Recurrence of mood event|48|||
156361719|NCT01358357|564423550|FG001|Double-Blind Phase|Recurrence of mood event|64|||
156361720|NCT01358357|564423551|FG002|Double-Blind Phase|Recurrence of mood event|0|||
156361721|NCT01358357|564423549|FG000|Double-Blind Phase|Administrative|0|||
156361722|NCT01358357|564423550|FG001|Double-Blind Phase|Administrative|1|||
156361723|NCT01358357|564423551|FG002|Double-Blind Phase|Administrative|0|||
156361724|NCT00768144|564423552|FG000|Overall Study|Adverse Event|13|||
156361725|NCT00768144|564423552|FG000|Overall Study|Progressive Disease|21|||
156361726|NCT00768144|564423552|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
156361727|NCT00768144|564423552|FG000|Overall Study|Pt Withdrew Consent|1|||
156361728|NCT01712854|564423553|FG000|Overall Study|Physician Decision|1|||
156361729|NCT01150123|564423554|FG000|Overall Study|Withdrawal by Subject|1|||
156361730|NCT01150123|564423555|FG001|Overall Study|Withdrawal by Subject|1|||
156361731|NCT01150123|564423556|FG002|Overall Study|Withdrawal by Subject|2|||
156361732|NCT01150123|564423557|FG003|Overall Study|Withdrawal by Subject|1|||
156361733|NCT01150123|564423558|FG004|Overall Study|Withdrawal by Subject|1|||
156361734|NCT01150123|564423559|FG005|Overall Study|Withdrawal by Subject|1|||
156361735|NCT01150123|564423560|FG006|Overall Study|Withdrawal by Subject|0|||
156361736|NCT01150123|564423561|FG007|Overall Study|Withdrawal by Subject|3|||
156361737|NCT01150123|564423562|FG008|Overall Study|Withdrawal by Subject|2|||
156361738|NCT01150123|564423563|FG009|Overall Study|Withdrawal by Subject|0|||
156361739|NCT01150123|564423564|FG010|Overall Study|Withdrawal by Subject|1|||
156361740|NCT01150123|564423565|FG011|Overall Study|Withdrawal by Subject|0|||
156361741|NCT01150123|564423566|FG012|Overall Study|Withdrawal by Subject|1|||
156361742|NCT01150123|564423567|FG013|Overall Study|Withdrawal by Subject|0|||
156361743|NCT01150123|564423568|FG014|Overall Study|Withdrawal by Subject|0|||
156361744|NCT01150123|564423569|FG015|Overall Study|Withdrawal by Subject|1|||
156361745|NCT01150123|564423570|FG016|Overall Study|Withdrawal by Subject|0|||
156361746|NCT01150123|564423571|FG017|Overall Study|Withdrawal by Subject|1|||
156361747|NCT01150123|564423554|FG000|Overall Study|Lost to Follow-up|2|||
156361748|NCT01150123|564423555|FG001|Overall Study|Lost to Follow-up|1|||
156361749|NCT01150123|564423556|FG002|Overall Study|Lost to Follow-up|2|||
156361750|NCT01150123|564423557|FG003|Overall Study|Lost to Follow-up|2|||
156361751|NCT01150123|564423558|FG004|Overall Study|Lost to Follow-up|2|||
156361752|NCT01150123|564423559|FG005|Overall Study|Lost to Follow-up|5|||
156361753|NCT01150123|564423560|FG006|Overall Study|Lost to Follow-up|0|||
156361754|NCT01150123|564423561|FG007|Overall Study|Lost to Follow-up|0|||
156361755|NCT01150123|564423562|FG008|Overall Study|Lost to Follow-up|3|||
156361756|NCT01150123|564423563|FG009|Overall Study|Lost to Follow-up|1|||
156361757|NCT01150123|564423564|FG010|Overall Study|Lost to Follow-up|1|||
156361758|NCT01150123|564423565|FG011|Overall Study|Lost to Follow-up|1|||
156361759|NCT01150123|564423566|FG012|Overall Study|Lost to Follow-up|2|||
156361760|NCT01150123|564423567|FG013|Overall Study|Lost to Follow-up|0|||
156361761|NCT01150123|564423568|FG014|Overall Study|Lost to Follow-up|0|||
156361762|NCT01150123|564423569|FG015|Overall Study|Lost to Follow-up|0|||
156361763|NCT01150123|564423570|FG016|Overall Study|Lost to Follow-up|0|||
156361764|NCT01150123|564423571|FG017|Overall Study|Lost to Follow-up|0|||
156361765|NCT02171260|564423572|FG000|Overall Study|Death|0|||
156361766|NCT02171260|564423573|FG001|Overall Study|Death|0|||
156489663|NCT02845375|564887402|FG001|Overall Study|upper airway obstruction|2|||
156489664|NCT02845375|564887403|FG002|Overall Study|upper airway obstruction|1|||
156489665|NCT01951261|564887406|FG000|Overall Study|Death|1|||
156361767|NCT02171260|564423574|FG002|Overall Study|Death|0|||
156361768|NCT02171260|564423575|FG003|Overall Study|Death|1|||
156361769|NCT02171260|564423572|FG000|Overall Study|Physician Decision|1|||
156361770|NCT02171260|564423573|FG001|Overall Study|Physician Decision|0|||
156361771|NCT02171260|564423574|FG002|Overall Study|Physician Decision|1|||
156361772|NCT02171260|564423575|FG003|Overall Study|Physician Decision|0|||
156361773|NCT02171260|564423572|FG000|Overall Study|Withdrawal by Subject|1|||
156361774|NCT02171260|564423573|FG001|Overall Study|Withdrawal by Subject|0|||
156361775|NCT02171260|564423574|FG002|Overall Study|Withdrawal by Subject|0|||
156361776|NCT02171260|564423575|FG003|Overall Study|Withdrawal by Subject|0|||
156361777|NCT02171260|564423572|FG000|Overall Study|Evidence of progressive disease|4|||
156361778|NCT02171260|564423573|FG001|Overall Study|Evidence of progressive disease|6|||
156361779|NCT02171260|564423574|FG002|Overall Study|Evidence of progressive disease|4|||
156361780|NCT02171260|564423575|FG003|Overall Study|Evidence of progressive disease|4|||
156361781|NCT01466387|564423578|FG000|Overall Study|Adverse Event|0|||
156361782|NCT01466387|564423579|FG001|Overall Study|Adverse Event|0|||
156361783|NCT01466387|564423580|FG002|Overall Study|Adverse Event|1|||
156361784|NCT01466387|564423581|FG003|Overall Study|Adverse Event|1|||
156361785|NCT01466387|564423582|FG004|Overall Study|Adverse Event|0|||
156361786|NCT01466387|564423583|FG005|Overall Study|Adverse Event|0|||
156361787|NCT01466387|564423578|FG000|Overall Study|Lost to Follow-up|0|||
156361788|NCT01466387|564423579|FG001|Overall Study|Lost to Follow-up|0|||
156361789|NCT01466387|564423580|FG002|Overall Study|Lost to Follow-up|0|||
156361790|NCT01466387|564423581|FG003|Overall Study|Lost to Follow-up|0|||
156361791|NCT01466387|564423582|FG004|Overall Study|Lost to Follow-up|0|||
156361792|NCT01466387|564423583|FG005|Overall Study|Lost to Follow-up|1|||
156361793|NCT01466387|564423578|FG000|Overall Study|Protocol Violation|1|||
156361794|NCT01466387|564423579|FG001|Overall Study|Protocol Violation|0|||
156361795|NCT01466387|564423580|FG002|Overall Study|Protocol Violation|0|||
156361796|NCT01466387|564423581|FG003|Overall Study|Protocol Violation|1|||
156361797|NCT01466387|564423582|FG004|Overall Study|Protocol Violation|0|||
156361798|NCT01466387|564423583|FG005|Overall Study|Protocol Violation|0|||
156361799|NCT01319877|564423584|FG000|Overall Study|Lost to Follow-up|100|||
156361800|NCT01319877|564423585|FG001|Overall Study|Lost to Follow-up|37|||
156361801|NCT01319877|564423584|FG000|Overall Study|Physician Decision|2|||
156361802|NCT01319877|564423585|FG001|Overall Study|Physician Decision|0|||
156361803|NCT01319877|564423584|FG000|Overall Study|Disease Progression|2|||
156361804|NCT01319877|564423585|FG001|Overall Study|Disease Progression|2|||
156361805|NCT01319877|564423584|FG000|Overall Study|Withdrawal by Subject|0|||
156361806|NCT01319877|564423585|FG001|Overall Study|Withdrawal by Subject|1|||
156361807|NCT01319877|564423584|FG000|Overall Study|Reason Not Specified|4|||
156361808|NCT01319877|564423585|FG001|Overall Study|Reason Not Specified|5|||
156361809|NCT02347189|564423588|FG000|Overall Study|No implant attempted of study device|9|||
156361810|NCT02347189|564423588|FG000|Overall Study|No primary outcome data available|2|||
156361811|NCT02677987|564423590|FG000|Overall Study|Withdrawal by Subject|3|||
156361812|NCT02677987|564423591|FG001|Overall Study|Withdrawal by Subject|0|||
156361813|NCT02677987|564423590|FG000|Overall Study|Lost to Follow-up|1|||
156361814|NCT02677987|564423591|FG001|Overall Study|Lost to Follow-up|0|||
156361815|NCT03320564|564423592|FG000|Overall Study|Protocol Violation|1|||
156361816|NCT00673179|564423593|FG000|Overall Study|Toxicity/Complications|3|||
156361817|NCT00673179|564423594|FG001|Overall Study|Toxicity/Complications|0|||
156361818|NCT00352846|564423595|FG000|Overall Study|Disease progression|0|||
156361819|NCT00352846|564423596|FG001|Overall Study|Disease progression|2|||
156361820|NCT00352846|564423595|FG000|Overall Study|Withdrawal by Subject|3|||
156361821|NCT00352846|564423596|FG001|Overall Study|Withdrawal by Subject|8|||
156361822|NCT00352846|564423595|FG000|Overall Study|Ineligible|3|||
156361823|NCT00352846|564423596|FG001|Overall Study|Ineligible|2|||
156361824|NCT00352846|564423595|FG000|Overall Study|Non-compliance|2|||
156361825|NCT00352846|564423596|FG001|Overall Study|Non-compliance|0|||
156361826|NCT00352846|564423595|FG000|Overall Study|Death|0|||
156361827|NCT00352846|564423596|FG001|Overall Study|Death|1|||
156361828|NCT01527682|564423597|FG000|Overall Study|Protocol Violation|8|||
156361829|NCT04668950|564423599|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
156361830|NCT04668950|564423600|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
156361831|NCT04668950|564423599|FG000|Overall Study|Could not confirm started study medication|15|||
156361832|NCT04668950|564423600|FG001|Overall Study|Could not confirm started study medication|15|||
156361833|NCT04668950|564423599|FG000|Overall Study|Could not confirm baseline status|6|||
156361834|NCT04668950|564423600|FG001|Overall Study|Could not confirm baseline status|2|||
156361835|NCT04668950|564423599|FG000|Overall Study|Drop out and did not start medication|15|||
156361836|NCT04668950|564423600|FG001|Overall Study|Drop out and did not start medication|17|||
156361837|NCT04668950|564423599|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
156361838|NCT04668950|564423600|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
156361839|NCT04668950|564423599|FG000|Overall Study|Other|2|||
156361840|NCT04668950|564423600|FG001|Overall Study|Other|4|||
156361841|NCT01531387|564423601|FG000|Overall Study|Early termination of study|11|||
156361842|NCT01531387|564423602|FG001|Overall Study|Early termination of study|11|||
156361843|NCT01124643|564423603|FG000|Overall Study|Death|1|||
156361844|NCT04220411|564423604|FG000|Overall Study|Adverse Event|0|||
156361845|NCT04220411|564423605|FG001|Overall Study|Adverse Event|0|||
156361846|NCT04220411|564423606|FG002|Overall Study|Adverse Event|0|||
156361847|NCT04220411|564423607|FG003|Overall Study|Adverse Event|1|||
156361848|NCT02680639|564423608|FG000|Screening Period|Screen Failure|7|||
156489666|NCT01951261|564887407|FG001|Overall Study|Death|0|||
156361849|NCT02680639|564423609|FG001|Screening Period|Screen Failure|0|||
156361850|NCT02680639|564423610|FG002|Screening Period|Screen Failure|0|||
156361851|NCT02678676|564423611|FG000|Overall Study|Death|619|||
156361852|NCT02678676|564423612|FG001|Overall Study|Death|649|||
156361853|NCT02678676|564423611|FG000|Overall Study|Withdrawal by Subject|13|||
156361854|NCT02678676|564423612|FG001|Overall Study|Withdrawal by Subject|5|||
156361855|NCT02678676|564423611|FG000|Overall Study|Lost to Follow-up|171|||
156361856|NCT02678676|564423612|FG001|Overall Study|Lost to Follow-up|151|||
156361857|NCT02678676|564423611|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
156489667|NCT01951261|564887406|FG000|Overall Study|Lost to Follow-up|4|||
156361858|NCT02678676|564423612|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
156361859|NCT00323115|564423616|FG000|Vaccine Administration|Adverse Event|1|||
156361860|NCT00323115|564423616|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
156361861|NCT04365556|564423617|FG000|Overall Study|No longer eligible due to treatment plan|1|||
156361862|NCT04365556|564423618|FG001|Overall Study|No longer eligible due to treatment plan|0|||
156361863|NCT04365556|564423617|FG000|Overall Study|Lost to Follow-up|3|||
156361864|NCT04365556|564423618|FG001|Overall Study|Lost to Follow-up|2|||
156361865|NCT00427635|564424792|FG000|Treatment Phase|Withdrawal by Subject|1|||
156361866|NCT00427635|564424793|FG001|Treatment Phase|Withdrawal by Subject|0|||
156361867|NCT00427635|564424792|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
156361868|NCT00427635|564424793|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
156361869|NCT00136084|564424796|FG000|Overall Study|Death|12|||
156361870|NCT00136084|564424797|FG001|Overall Study|Death|5|||
156361871|NCT00136084|564424796|FG000|Overall Study|Unacceptable toxicity|8|||
156361872|NCT00136084|564424797|FG001|Overall Study|Unacceptable toxicity|11|||
156361873|NCT00136084|564424796|FG000|Overall Study|Relapse|20|||
156361874|NCT00136084|564424797|FG001|Overall Study|Relapse|23|||
156361875|NCT00136084|564424796|FG000|Overall Study|Lost to Follow-up|2|||
156361876|NCT00136084|564424797|FG001|Overall Study|Lost to Follow-up|0|||
156361877|NCT00136084|564424796|FG000|Overall Study|No Response|1|||
156361878|NCT00136084|564424797|FG001|Overall Study|No Response|2|||
156361879|NCT00136084|564424796|FG000|Overall Study|Withdrawal by Subject|5|||
156361880|NCT00136084|564424797|FG001|Overall Study|Withdrawal by Subject|1|||
156361881|NCT00997503|564424798|FG000|Overall Study|Death|53|||
156361882|NCT00997503|564424798|FG000|Overall Study|Withdrawal by Subject|76|||
156361883|NCT00997503|564424798|FG000|Overall Study|Lost to Follow-up|33|||
156361884|NCT00997503|564424798|FG000|Overall Study|Adverse Event|3|||
156361885|NCT00997503|564424798|FG000|Overall Study|Physician Decision|10|||
156361886|NCT00997503|564424798|FG000|Overall Study|Missed 12-month follow-up|85|||
156361887|NCT00997503|564424798|FG000|Overall Study|Other reason|13|||
156361888|NCT01933048|564424799|FG000|Overall Study|Lost to Follow-up|15|||
156361889|NCT01933048|564424800|FG001|Overall Study|Lost to Follow-up|18|||
156361890|NCT01933048|564424799|FG000|Overall Study|personal reasons|1|||
156361891|NCT01933048|564424800|FG001|Overall Study|personal reasons|1|||
156361892|NCT01933048|564424799|FG000|Overall Study|Protocol Violation|7|||
156361893|NCT01933048|564424800|FG001|Overall Study|Protocol Violation|8|||
156361894|NCT01933048|564424799|FG000|Overall Study|Physician Decision|1|||
156361895|NCT01933048|564424800|FG001|Overall Study|Physician Decision|0|||
156361896|NCT01933048|564424799|FG000|Overall Study|unknown reasons|1|||
156361897|NCT01933048|564424800|FG001|Overall Study|unknown reasons|1|||
156361898|NCT02211131|564424805|FG000|Overall Study|Death|26|||
156361899|NCT02211131|564424806|FG001|Overall Study|Death|16|||
156361900|NCT02211131|564424805|FG000|Overall Study|Lost to Follow-up|4|||
156361901|NCT02211131|564424806|FG001|Overall Study|Lost to Follow-up|3|||
156361902|NCT02211131|564424805|FG000|Overall Study|Decision by Sponsor|1|||
156361903|NCT02211131|564424806|FG001|Overall Study|Decision by Sponsor|1|||
156361904|NCT02211131|564424805|FG000|Overall Study|Withdrawal by Subject|3|||
156361905|NCT02211131|564424806|FG001|Overall Study|Withdrawal by Subject|8|||
156361906|NCT05664490|564424807|FG000|Overall Study|Withdrawal by Subject|0|||
156361907|NCT05664490|564424808|FG001|Overall Study|Withdrawal by Subject|1|||
156361908|NCT05664490|564424807|FG000|Overall Study|Lost to Follow-up|14|||
156361909|NCT05664490|564424808|FG001|Overall Study|Lost to Follow-up|22|||
156361910|NCT01589445|564424815|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
156361911|NCT01589445|564424815|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
156361912|NCT01589445|564424815|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
156361913|NCT01589445|564424815|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
156361914|NCT01589445|564424815|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
156361915|NCT01589445|564424815|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
156361916|NCT01589445|564424815|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
156361917|NCT01589445|564424815|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
156361918|NCT01589445|564424815|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
156361919|NCT01589445|564424815|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
156361920|NCT01990495|564424816|FG000|Overall Study|Physician Decision|5|||
156361921|NCT01990495|564424817|FG001|Overall Study|Physician Decision|4|||
156361922|NCT03412084|564424818|FG000|Overall Study|Withdrawal by Subject|2|||
156361923|NCT03412084|564424819|FG001|Overall Study|Withdrawal by Subject|0|||
156361924|NCT03412084|564424818|FG000|Overall Study|Participant moved|1|||
156361925|NCT03412084|564424819|FG001|Overall Study|Participant moved|0|||
156361926|NCT03412084|564424818|FG000|Overall Study|Lost to Follow-up|1|||
156361927|NCT03412084|564424819|FG001|Overall Study|Lost to Follow-up|1|||
156361928|NCT01928862|564424825|FG000|Overall Study|Lost to Follow-up|1|||
156361929|NCT01928862|564424826|FG001|Overall Study|Lost to Follow-up|0|||
156361930|NCT01928862|564424827|FG002|Overall Study|Lost to Follow-up|0|||
156361931|NCT01928862|564424828|FG003|Overall Study|Lost to Follow-up|0|||
156361932|NCT01928862|564424829|FG004|Overall Study|Lost to Follow-up|1|||
156361933|NCT01478321|564424831|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
156361934|NCT01478321|564424831|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
156361935|NCT01478321|564424831|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
156361936|NCT01478321|564424831|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
156361937|NCT01478321|564424831|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
156361938|NCT01478321|564424831|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
156361939|NCT01478321|564424831|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
156361940|NCT01478321|564424831|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
156361941|NCT00314574|564424835|FG000|Overall Study|Death|3|||
156361942|NCT00314574|564424836|FG001|Overall Study|Death|0|||
156361943|NCT00314574|564424835|FG000|Overall Study|Adverse Event|11|||
156361944|NCT00314574|564424836|FG001|Overall Study|Adverse Event|16|||
156361945|NCT00314574|564424835|FG000|Overall Study|Lost to Follow-up|19|||
156361946|NCT00314574|564424836|FG001|Overall Study|Lost to Follow-up|25|||
156361947|NCT00314574|564424835|FG000|Overall Study|Withdrawal by Subject|33|||
156361948|NCT00314574|564424836|FG001|Overall Study|Withdrawal by Subject|22|||
156361949|NCT00314574|564424835|FG000|Overall Study|Physician Decision|22|||
156361950|NCT00314574|564424836|FG001|Overall Study|Physician Decision|15|||
156361951|NCT00314574|564424835|FG000|Overall Study|Pregnancy|6|||
156361952|NCT00314574|564424836|FG001|Overall Study|Pregnancy|4|||
156361953|NCT00314574|564424835|FG000|Overall Study|Data unknown at database lock|0|||
156361954|NCT00314574|564424836|FG001|Overall Study|Data unknown at database lock|1|||
156361955|NCT02053753|564424841|FG000|Overall Study|Withdrawal by Subject|2|||
156361956|NCT02053753|564424842|FG001|Overall Study|Withdrawal by Subject|4|||
156361957|NCT02053753|564424841|FG000|Overall Study|Decision by Sponsor|1|||
156361958|NCT02053753|564424842|FG001|Overall Study|Decision by Sponsor|1|||
156361959|NCT02053753|564424841|FG000|Overall Study|Lost to Follow-up|4|||
156361960|NCT02053753|564424842|FG001|Overall Study|Lost to Follow-up|3|||
156361961|NCT00449956|564424843|FG000|Overall Study|Adverse Event|7|||
156361962|NCT00449956|564424844|FG001|Overall Study|Adverse Event|1|||
156361963|NCT00449956|564424845|FG002|Overall Study|Adverse Event|6|||
156361964|NCT00449956|564424843|FG000|Overall Study|Lack of Efficacy|0|||
156361965|NCT00449956|564424844|FG001|Overall Study|Lack of Efficacy|0|||
156361966|NCT00449956|564424845|FG002|Overall Study|Lack of Efficacy|1|||
156361967|NCT00449956|564424843|FG000|Overall Study|Protocol Violation|1|||
156361968|NCT00449956|564424844|FG001|Overall Study|Protocol Violation|1|||
156361969|NCT00449956|564424845|FG002|Overall Study|Protocol Violation|1|||
156361970|NCT00449956|564424843|FG000|Overall Study|Withdrawal by Subject|0|||
156361971|NCT00449956|564424844|FG001|Overall Study|Withdrawal by Subject|1|||
156361972|NCT00449956|564424845|FG002|Overall Study|Withdrawal by Subject|0|||
156361973|NCT00449956|564424843|FG000|Overall Study|Physician Decision|2|||
156361974|NCT00449956|564424844|FG001|Overall Study|Physician Decision|1|||
156361975|NCT00449956|564424845|FG002|Overall Study|Physician Decision|1|||
156361976|NCT00600756|564424849|FG000|Analysis After 6 Months|Adverse Event|43|||
156361977|NCT00600756|564424850|FG001|Analysis After 6 Months|Adverse Event|33|||
156361978|NCT00600756|564424849|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
156361979|NCT00600756|564424850|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
156361980|NCT00600756|564424849|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
156361981|NCT00600756|564424850|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
156361982|NCT00600756|564424849|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
156361983|NCT00600756|564424850|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
156361984|NCT00600756|564424849|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
156361985|NCT00600756|564424850|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
156361986|NCT00600756|564424849|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
156361987|NCT00600756|564424850|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
156361988|NCT00600756|564424849|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
156361989|NCT00600756|564424850|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
156361990|NCT00600756|564424849|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
156361991|NCT00600756|564424850|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
156489668|NCT01951261|564887407|FG001|Overall Study|Lost to Follow-up|3|||
156489669|NCT01951261|564887406|FG000|Overall Study|Protocol Violation|4|||
156489670|NCT01951261|564887407|FG001|Overall Study|Protocol Violation|3|||
156489671|NCT03927222|564887411|FG000|Overall Study|Progression|3|||
156361992|NCT00600756|564424849|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
156489672|NCT03927222|564887411|FG000|Overall Study|CMV testing results inconclusive|1|||
156489673|NCT03927222|564887411|FG000|Overall Study|Unable to generate enough vaccines|1|||
156489674|NCT03927222|564887411|FG000|Overall Study|Early study termination|1|||
156489675|NCT03723915|564887417|FG000|Screening|Failed to meet screening requirements.|2|||
156361993|NCT00600756|564424850|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
156361994|NCT00600756|564424849|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
156489676|NCT03723915|564887417|FG000|On Treatment|Failed to meet treatment requirements|2|||
156361995|NCT00600756|564424850|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
156361996|NCT00600756|564424849|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
156361997|NCT00600756|564424850|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
156361998|NCT00600756|564424849|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
156361999|NCT00600756|564424850|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
156362000|NCT00600756|564424849|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
156362001|NCT00600756|564424850|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
156362002|NCT00600756|564424849|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
156362003|NCT00600756|564424850|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
156362004|NCT02063737|564424851|FG000|Overall Study|Lost to Follow-up|11|||
156362005|NCT02063737|564424852|FG001|Overall Study|Lost to Follow-up|4|||
156362006|NCT00850395|564424859|FG000|Overall Study|Death|1|||
156362007|NCT00850395|564424859|FG000|Overall Study|Adverse Event|1|||
156362008|NCT00850395|564424859|FG000|Overall Study|Insufficient clinical response|3|||
156362009|NCT00850395|564424859|FG000|Overall Study|Other|5|||
156362010|NCT00129129|564424860|FG000|Primary Phase|Adverse Event|2|||
156362011|NCT00129129|564424861|FG001|Primary Phase|Adverse Event|1|||
156362012|NCT00129129|564424862|FG002|Primary Phase|Adverse Event|0|||
156362013|NCT00129129|564424863|FG003|Primary Phase|Adverse Event|0|||
156362014|NCT00129129|564424864|FG004|Primary Phase|Adverse Event|0|||
156362015|NCT00129129|564424860|FG000|Primary Phase|Withdrawal by Subject|12|||
156362016|NCT00129129|564424861|FG001|Primary Phase|Withdrawal by Subject|10|||
156362017|NCT00129129|564424862|FG002|Primary Phase|Withdrawal by Subject|0|||
156362018|NCT00129129|564424863|FG003|Primary Phase|Withdrawal by Subject|0|||
156362019|NCT00129129|564424864|FG004|Primary Phase|Withdrawal by Subject|0|||
156362020|NCT00129129|564424860|FG000|Primary Phase|Migration from study area|1|||
156362021|NCT00129129|564424861|FG001|Primary Phase|Migration from study area|3|||
156362022|NCT00129129|564424862|FG002|Primary Phase|Migration from study area|0|||
156362023|NCT00129129|564424863|FG003|Primary Phase|Migration from study area|0|||
156362024|NCT00129129|564424864|FG004|Primary Phase|Migration from study area|0|||
156362025|NCT00129129|564424860|FG000|Primary Phase|Lost to Follow-up|8|||
156362026|NCT00129129|564424861|FG001|Primary Phase|Lost to Follow-up|6|||
156362027|NCT00129129|564424862|FG002|Primary Phase|Lost to Follow-up|0|||
156362028|NCT00129129|564424863|FG003|Primary Phase|Lost to Follow-up|0|||
156362029|NCT00129129|564424864|FG004|Primary Phase|Lost to Follow-up|0|||
156362030|NCT00129129|564424860|FG000|Primary Phase|Other|2|||
156362031|NCT00129129|564424861|FG001|Primary Phase|Other|5|||
156362032|NCT00129129|564424862|FG002|Primary Phase|Other|0|||
156362033|NCT00129129|564424863|FG003|Primary Phase|Other|0|||
156362034|NCT00129129|564424864|FG004|Primary Phase|Other|0|||
156362035|NCT00129129|564424860|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
156362036|NCT00129129|564424861|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
156362037|NCT00129129|564424862|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
156362038|NCT00129129|564424863|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
156362039|NCT00129129|564424864|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
156362040|NCT00129129|564424860|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
156362041|NCT00129129|564424861|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
156362042|NCT00129129|564424862|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
156362043|NCT00129129|564424863|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
156362044|NCT00129129|564424864|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
156362045|NCT00129129|564424860|FG000|Fourth Dose Phase|Migration from study area|0|||
156362046|NCT00129129|564424861|FG001|Fourth Dose Phase|Migration from study area|0|||
156362047|NCT00129129|564424862|FG002|Fourth Dose Phase|Migration from study area|0|||
156362048|NCT00129129|564424863|FG003|Fourth Dose Phase|Migration from study area|0|||
156362049|NCT00129129|564424864|FG004|Fourth Dose Phase|Migration from study area|2|||
156362050|NCT00129129|564424860|FG000|Fourth Dose Phase|Other|0|||
156362051|NCT00129129|564424861|FG001|Fourth Dose Phase|Other|0|||
156362052|NCT00129129|564424862|FG002|Fourth Dose Phase|Other|0|||
156362053|NCT00129129|564424863|FG003|Fourth Dose Phase|Other|1|||
156362054|NCT00129129|564424864|FG004|Fourth Dose Phase|Other|1|||
156362055|NCT00129129|564424860|FG000|Fourth Dose Phase|Protocol Violation|0|||
156362056|NCT00129129|564424861|FG001|Fourth Dose Phase|Protocol Violation|0|||
156362057|NCT00129129|564424862|FG002|Fourth Dose Phase|Protocol Violation|0|||
156362058|NCT00129129|564424863|FG003|Fourth Dose Phase|Protocol Violation|1|||
156362059|NCT00129129|564424864|FG004|Fourth Dose Phase|Protocol Violation|0|||
156362060|NCT00335972|564424865|FG000|Overall Study|not given treatments|0|||
156362061|NCT00335972|564424866|FG001|Overall Study|not given treatments|3|||
156362062|NCT02140567|564424872|FG000|Overall Study|Problems with recording equipment|6|||
156489677|NCT00297778|564887418|FG000|Overall Study|Adverse Event|16|||
156489678|NCT00297778|564887419|FG001|Overall Study|Adverse Event|10|||
156489679|NCT00297778|564887418|FG000|Overall Study|Withdrawal by Subject|1|||
156362063|NCT02802592|564424873|FG000|Overall Study|Study terminated due to loss of funding|4|||
156489680|NCT00297778|564887419|FG001|Overall Study|Withdrawal by Subject|5|||
156489681|NCT00297778|564887418|FG000|Overall Study|Lack of Efficacy|2|||
156362064|NCT02882854|564424874|FG000|Overall Study|Lost to Follow-up|1|||
156362065|NCT02882854|564424875|FG001|Overall Study|Lost to Follow-up|2|||
156362066|NCT02882854|564424874|FG000|Overall Study|Physician Decision|0|||
156362067|NCT02882854|564424875|FG001|Overall Study|Physician Decision|1|||
156362068|NCT01826487|564424878|FG000|Overall Study|Adverse Event|1|||
156362069|NCT01826487|564424879|FG001|Overall Study|Adverse Event|1|||
156489682|NCT00297778|564887419|FG001|Overall Study|Lack of Efficacy|1|||
156362070|NCT01826487|564424878|FG000|Overall Study|Lost to Follow-up|1|||
156362071|NCT01826487|564424879|FG001|Overall Study|Lost to Follow-up|0|||
156362072|NCT01826487|564424878|FG000|Overall Study|Withdrawal by Subject|1|||
156362073|NCT01826487|564424879|FG001|Overall Study|Withdrawal by Subject|3|||
156362074|NCT01826487|564424878|FG000|Overall Study|Protocol Violation|1|||
156362075|NCT01826487|564424879|FG001|Overall Study|Protocol Violation|1|||
156362076|NCT03774433|564424880|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
156362077|NCT00108160|564424881|FG000|Overall Study|Lost to Follow-up|25|||
156362078|NCT00108160|564424882|FG001|Overall Study|Lost to Follow-up|12|||
156362079|NCT00108160|564424881|FG000|Overall Study|Death|1|||
156362080|NCT00108160|564424882|FG001|Overall Study|Death|2|||
156362081|NCT00108160|564424881|FG000|Overall Study|Withdrawal by Subject|4|||
156362082|NCT00108160|564424882|FG001|Overall Study|Withdrawal by Subject|2|||
156362083|NCT00108160|564424881|FG000|Overall Study|Protocol Violation|9|||
156362084|NCT00108160|564424882|FG001|Overall Study|Protocol Violation|5|||
156362085|NCT01062555|564424883|FG000|Phase 1|Death|10|||
156362086|NCT01062555|564424884|FG001|Phase 1|Death|17|||
156362087|NCT01062555|564424885|FG002|Phase 1|Death|0|||
156362088|NCT01062555|564424886|FG003|Phase 1|Death|0|||
156362089|NCT01062555|564424883|FG000|Phase 1|Graft Failure|12|||
156362090|NCT01062555|564424884|FG001|Phase 1|Graft Failure|8|||
156362091|NCT01062555|564424885|FG002|Phase 1|Graft Failure|0|||
156362092|NCT01062555|564424886|FG003|Phase 1|Graft Failure|0|||
156362093|NCT01062555|564424883|FG000|Phase 1|Withdrawal by Subject|1|||
156362094|NCT01062555|564424884|FG001|Phase 1|Withdrawal by Subject|1|||
156362095|NCT01062555|564424885|FG002|Phase 1|Withdrawal by Subject|0|||
156362096|NCT01062555|564424886|FG003|Phase 1|Withdrawal by Subject|0|||
156362097|NCT01062555|564424883|FG000|Phase 2|Death|0|||
156362098|NCT01062555|564424884|FG001|Phase 2|Death|0|||
156362099|NCT01062555|564424885|FG002|Phase 2|Death|8|||
156362100|NCT01062555|564424886|FG003|Phase 2|Death|3|||
156362101|NCT01062555|564424883|FG000|Phase 2|Graft failure|0|||
156362102|NCT01062555|564424884|FG001|Phase 2|Graft failure|0|||
156362103|NCT01062555|564424885|FG002|Phase 2|Graft failure|7|||
156362104|NCT01062555|564424886|FG003|Phase 2|Graft failure|4|||
156362105|NCT01062555|564424883|FG000|Phase 2|Withdrawal by Subject|0|||
156362106|NCT01062555|564424884|FG001|Phase 2|Withdrawal by Subject|0|||
156362107|NCT01062555|564424885|FG002|Phase 2|Withdrawal by Subject|0|||
156362108|NCT01062555|564424886|FG003|Phase 2|Withdrawal by Subject|7|||
156362109|NCT01062555|564424883|FG000|Phase 2|Protocol Violation|0|||
156362110|NCT01062555|564424884|FG001|Phase 2|Protocol Violation|0|||
156362111|NCT01062555|564424885|FG002|Phase 2|Protocol Violation|0|||
156489683|NCT00297778|564887418|FG000|Overall Study|Non-compliant with trial protocol|0|||
156489684|NCT00297778|564887419|FG001|Overall Study|Non-compliant with trial protocol|3|||
156489685|NCT00297778|564887418|FG000|Overall Study|Other|0|||
156489686|NCT00297778|564887419|FG001|Overall Study|Other|1|||
156489687|NCT02201771|564887420|FG000|Overall Study|Death|3|||
156489688|NCT02201771|564887421|FG001|Overall Study|Death|2|||
156489689|NCT02201771|564887422|FG002|Overall Study|Death|0|||
156489690|NCT02201771|564887420|FG000|Overall Study|Protocol Violation|10|||
156489691|NCT02201771|564887421|FG001|Overall Study|Protocol Violation|8|||
156489692|NCT02201771|564887422|FG002|Overall Study|Protocol Violation|10|||
156489693|NCT00583115|564887423|FG000|Overall Study|Death|1|||
156489694|NCT03569475|564887424|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
156362112|NCT01062555|564424886|FG003|Phase 2|Protocol Violation|3|||
156362113|NCT01062555|564424883|FG000|Phase 2|Physician Decision|0|||
156362114|NCT01062555|564424884|FG001|Phase 2|Physician Decision|0|||
156489695|NCT03569475|564887425|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
156489696|NCT03569475|564887426|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
156489697|NCT03569475|564887424|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
156489698|NCT03569475|564887425|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
156489699|NCT03569475|564887426|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
156362115|NCT01062555|564424885|FG002|Phase 2|Physician Decision|0|||
156362116|NCT01062555|564424886|FG003|Phase 2|Physician Decision|17|||
156362117|NCT00729183|564424887|FG000|Overall Study|Adverse Event|11|||
156362118|NCT00729183|564424888|FG001|Overall Study|Adverse Event|5|||
156362119|NCT00729183|564424887|FG000|Overall Study|Lack of Efficacy|0|||
156362120|NCT00729183|564424888|FG001|Overall Study|Lack of Efficacy|1|||
156362121|NCT00729183|564424887|FG000|Overall Study|Lost to Follow-up|3|||
156362122|NCT00729183|564424888|FG001|Overall Study|Lost to Follow-up|1|||
156362123|NCT00729183|564424887|FG000|Overall Study|Physician Decision|1|||
156362124|NCT00729183|564424888|FG001|Overall Study|Physician Decision|1|||
156362125|NCT00729183|564424887|FG000|Overall Study|Protocol Violation|1|||
156362126|NCT00729183|564424888|FG001|Overall Study|Protocol Violation|0|||
156362127|NCT00729183|564424887|FG000|Overall Study|Withdrawal by Subject|9|||
156362128|NCT00729183|564424888|FG001|Overall Study|Withdrawal by Subject|7|||
156362129|NCT01359254|564424891|FG000|Overall Study|Death|1|||
156362130|NCT01359254|564424892|FG001|Overall Study|Death|0|||
156489700|NCT03569475|564887424|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
156489701|NCT03569475|564887425|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
156362131|NCT02028988|564424898|FG000|Overall Study|Withdrawal by Subject|2|||
156362132|NCT01342510|564424901|FG000|Overall Study|Protocol Violation|12|||
156362133|NCT01342510|564424902|FG001|Overall Study|Protocol Violation|6|||
156362134|NCT01342510|564424903|FG002|Overall Study|Protocol Violation|13|||
156362135|NCT01342510|564424904|FG003|Overall Study|Protocol Violation|11|||
156362136|NCT04837131|564424905|FG000|Overall Study|Death|1|||
156362137|NCT04837131|564424905|FG000|Overall Study|Withdrawal by Subject|1|||
156362138|NCT04837131|564424905|FG000|Overall Study|Adverse Event|1|||
156362139|NCT04837131|564424905|FG000|Overall Study|Protocol Violation|1|||
156362140|NCT04439318|564424906|FG000|Overall Study|Ineligible|1|||
156362141|NCT04439318|564424906|FG000|Overall Study|Never Started Treatment|3|||
156362142|NCT04439318|564424906|FG000|Overall Study|Adverse Event|10|||
156362143|NCT04439318|564424906|FG000|Overall Study|Death|2|||
156362144|NCT04439318|564424906|FG000|Overall Study|Disease Progression|25|||
156362145|NCT04439318|564424906|FG000|Overall Study|Other Complicating Disease|2|||
156362146|NCT04439318|564424906|FG000|Overall Study|Withdrawal by Subject|4|||
156362147|NCT04439318|564424906|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
156362148|NCT04439318|564424906|FG000|Overall Study|Non-Compliance|1|||
156362149|NCT04439318|564424906|FG000|Overall Study|Still on Treatment|1|||
156362150|NCT03256552|564426689|FG000|Overall Study|Protocol Violation|1|||
156362151|NCT03256552|564426689|FG000|Overall Study|Physician Decision|1|||
156362152|NCT03256552|564426689|FG000|Overall Study|Adverse Event|1|||
156362153|NCT03256552|564426689|FG000|Overall Study|Withdrawal by Subject|2|||
156362154|NCT02268409|564426694|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
156362155|NCT02268409|564426694|FG000|Overall Study|Death|1|||
156362156|NCT02268409|564426694|FG000|Overall Study|Lost to Follow-up|1|||
156362157|NCT02268409|564426694|FG000|Overall Study|Protocol Violation|3|||
156362158|NCT02268409|564426694|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
156362159|NCT02268409|564426694|FG000|Overall Study|Withdrawal by Subject|5|||
156362160|NCT00838201|564426695|FG000|Overall Study|Investigator decision, or other reasons|2|||
156362161|NCT00838201|564426696|FG001|Overall Study|Investigator decision, or other reasons|3|||
156362162|NCT00838201|564426695|FG000|Overall Study|Noncompliance|0|||
156362163|NCT00838201|564426696|FG001|Overall Study|Noncompliance|1|||
156362164|NCT00838201|564426695|FG000|Overall Study|Administrative decision|1|||
156362165|NCT00838201|564426696|FG001|Overall Study|Administrative decision|2|||
156362166|NCT00838201|564426695|FG000|Overall Study|Disease progression|3|||
156362167|NCT00838201|564426696|FG001|Overall Study|Disease progression|3|||
156362168|NCT00838201|564426695|FG000|Overall Study|Consent withdrawn|16|||
156362169|NCT00838201|564426696|FG001|Overall Study|Consent withdrawn|19|||
156362170|NCT00838201|564426695|FG000|Overall Study|Lost to Follow-up|4|||
156362171|NCT00838201|564426696|FG001|Overall Study|Lost to Follow-up|3|||
156362172|NCT00838201|564426695|FG000|Overall Study|Adverse Event|5|||
156362173|NCT00838201|564426696|FG001|Overall Study|Adverse Event|9|||
156362174|NCT00838201|564426695|FG000|Overall Study|Death|11|||
156362175|NCT00838201|564426696|FG001|Overall Study|Death|13|||
156362176|NCT00489853|564426697|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
156362177|NCT00489853|564426698|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
156362178|NCT00489853|564426699|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
156362179|NCT00489853|564426697|FG000|Wash-out Period 1|Adverse Event|0|||
156362180|NCT00489853|564426698|FG001|Wash-out Period 1|Adverse Event|1|||
156362181|NCT00489853|564426699|FG002|Wash-out Period 1|Adverse Event|1|||
156362182|NCT00489853|564426697|FG000|Wash-out Period 1|Protocol Violation|0|||
156362183|NCT00489853|564426698|FG001|Wash-out Period 1|Protocol Violation|1|||
156362184|NCT00489853|564426699|FG002|Wash-out Period 1|Protocol Violation|1|||
156362185|NCT00489853|564426697|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
156362186|NCT00489853|564426698|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
156362187|NCT00489853|564426699|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
156362188|NCT00489853|564426697|FG000|Wash-out Period 2|Adverse Event|1|||
156362189|NCT00489853|564426698|FG001|Wash-out Period 2|Adverse Event|1|||
156362190|NCT00489853|564426699|FG002|Wash-out Period 2|Adverse Event|0|||
156362191|NCT00489853|564426697|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
156362192|NCT00489853|564426698|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
156362193|NCT00489853|564426699|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
156362194|NCT00489853|564426697|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
156362195|NCT00489853|564426698|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
156362196|NCT00489853|564426699|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
156362197|NCT05083442|564426700|FG000|Overall Study|Lost to Follow-up|1|||
156362198|NCT05083442|564426701|FG001|Overall Study|Lost to Follow-up|0|||
156362199|NCT05083442|564426700|FG000|Overall Study|Lack of Efficacy|0|||
156362200|NCT05083442|564426701|FG001|Overall Study|Lack of Efficacy|1|||
156362201|NCT05083442|564426700|FG000|Overall Study|Withdrawal by Subject|1|||
156362202|NCT05083442|564426701|FG001|Overall Study|Withdrawal by Subject|3|||
156362203|NCT05083442|564426700|FG000|Overall Study|scheduling difficulties|1|||
156362204|NCT05083442|564426701|FG001|Overall Study|scheduling difficulties|2|||
156362205|NCT04865354|564426712|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
156362206|NCT04865354|564426713|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
156362207|NCT04865354|564426712|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
156362208|NCT04865354|564426713|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
156362209|NCT04865354|564426712|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
156362210|NCT04865354|564426713|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
156362211|NCT03873987|564426714|FG000|Overall Study|Adverse Event|1|||
156362212|NCT03873987|564426715|FG001|Overall Study|Adverse Event|0|||
156362213|NCT03873987|564426714|FG000|Overall Study|staff was unable to start a new IV line|1|||
156362214|NCT03873987|564426715|FG001|Overall Study|staff was unable to start a new IV line|0|||
156362215|NCT03873987|564426714|FG000|Overall Study|Lost to Follow-up|0|||
156362216|NCT03873987|564426715|FG001|Overall Study|Lost to Follow-up|1|||
156362217|NCT01465022|564426716|FG000|Overall Study|Lost to Follow-up|15|||
156362218|NCT01465022|564426717|FG001|Overall Study|Lost to Follow-up|14|||
156362219|NCT01465022|564426718|FG002|Overall Study|Lost to Follow-up|0|||
156362220|NCT01465022|564426716|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
156362221|NCT01465022|564426717|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
156362222|NCT01465022|564426718|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
156362223|NCT01465022|564426716|FG000|Overall Study|Not Randomized|0|||
156362224|NCT01465022|564426717|FG001|Overall Study|Not Randomized|0|||
156362225|NCT01465022|564426718|FG002|Overall Study|Not Randomized|70|||
156362226|NCT00004888|564426719|FG000|Overall Study|Adverse Event|5|||
156362227|NCT00004888|564426720|FG001|Overall Study|Adverse Event|10|||
156362228|NCT00004888|564426719|FG000|Overall Study|Withdrawal by Subject|0|||
156362229|NCT00004888|564426720|FG001|Overall Study|Withdrawal by Subject|3|||
156362230|NCT00004888|564426719|FG000|Overall Study|Physician Decision|1|||
156362231|NCT00004888|564426720|FG001|Overall Study|Physician Decision|1|||
156362232|NCT00004888|564426719|FG000|Overall Study|Progressive Disease|4|||
156362233|NCT00004888|564426720|FG001|Overall Study|Progressive Disease|9|||
156362234|NCT00004888|564426719|FG000|Overall Study|Death without progressive disease|0|||
156362235|NCT00004888|564426720|FG001|Overall Study|Death without progressive disease|1|||
156362236|NCT00004888|564426719|FG000|Overall Study|Toxic death|1|||
156362237|NCT00004888|564426720|FG001|Overall Study|Toxic death|0|||
156362238|NCT02579265|564426721|FG000|Overall Study|Weaned off earlier than 28 days|44|||
156362239|NCT02579265|564426722|FG001|Overall Study|Weaned off earlier than 28 days|43|||
156362240|NCT02579265|564426721|FG000|Overall Study|Adverse Event|2|||
156362241|NCT02579265|564426722|FG001|Overall Study|Adverse Event|0|||
156362242|NCT02579265|564426721|FG000|Overall Study|Any other reason not specified|0|||
156362243|NCT02579265|564426722|FG001|Overall Study|Any other reason not specified|2|||
156362244|NCT02579265|564426721|FG000|Overall Study|Withdrawal by Subject|2|||
156362245|NCT02579265|564426722|FG001|Overall Study|Withdrawal by Subject|0|||
156362246|NCT02579265|564426721|FG000|Overall Study|Physician Decision|1|||
156362247|NCT02579265|564426722|FG001|Overall Study|Physician Decision|0|||
156362248|NCT02579265|564426721|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
156362249|NCT02579265|564426722|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
156362250|NCT02174848|564426723|FG000|Overall Study|Adverse Event|2|||
156362251|NCT02174848|564426724|FG001|Overall Study|Adverse Event|1|||
156362252|NCT02174848|564426723|FG000|Overall Study|Withdrawal by Subject|3|||
156362253|NCT02174848|564426724|FG001|Overall Study|Withdrawal by Subject|3|||
156362254|NCT02174848|564426723|FG000|Overall Study|Lost to Follow-up|0|||
156362255|NCT02174848|564426724|FG001|Overall Study|Lost to Follow-up|1|||
156362256|NCT02174848|564426723|FG000|Overall Study|Worsening of disease|1|||
156362257|NCT02174848|564426724|FG001|Overall Study|Worsening of disease|1|||
156362258|NCT02174848|564426723|FG000|Overall Study|Unable to comply with study requirements|1|||
156362259|NCT02174848|564426724|FG001|Overall Study|Unable to comply with study requirements|0|||
156362260|NCT02520011|564426726|FG000|Overall Study|Adverse Event|0|||
156362261|NCT02520011|564426727|FG001|Overall Study|Adverse Event|1|||
156362262|NCT02520011|564426728|FG002|Overall Study|Adverse Event|2|||
156362263|NCT02520011|564426726|FG000|Overall Study|Death|0|||
156362264|NCT02520011|564426727|FG001|Overall Study|Death|8|||
156362265|NCT02520011|564426728|FG002|Overall Study|Death|1|||
156362266|NCT02520011|564426726|FG000|Overall Study|Lack of Efficacy|4|||
156362267|NCT02520011|564426727|FG001|Overall Study|Lack of Efficacy|26|||
156362268|NCT02520011|564426728|FG002|Overall Study|Lack of Efficacy|4|||
156362269|NCT02520011|564426726|FG000|Overall Study|Physician Decision|0|||
156362270|NCT02520011|564426727|FG001|Overall Study|Physician Decision|2|||
156362271|NCT02520011|564426728|FG002|Overall Study|Physician Decision|0|||
156362272|NCT02520011|564426726|FG000|Overall Study|Withdrawal by Subject|1|||
156362273|NCT02520011|564426727|FG001|Overall Study|Withdrawal by Subject|3|||
156362274|NCT02520011|564426728|FG002|Overall Study|Withdrawal by Subject|0|||
156362275|NCT02520011|564426726|FG000|Overall Study|Protocol Deviation|0|||
156362276|NCT02520011|564426727|FG001|Overall Study|Protocol Deviation|1|||
156362277|NCT02520011|564426728|FG002|Overall Study|Protocol Deviation|0|||
156362278|NCT02520011|564426726|FG000|Overall Study|Patient went to hospice|0|||
156362279|NCT02520011|564426727|FG001|Overall Study|Patient went to hospice|1|||
156362280|NCT02520011|564426728|FG002|Overall Study|Patient went to hospice|0|||
156362281|NCT02520011|564426726|FG000|Overall Study|Progressive disease following response|0|||
156362282|NCT02520011|564426727|FG001|Overall Study|Progressive disease following response|4|||
156362283|NCT02520011|564426728|FG002|Overall Study|Progressive disease following response|2|||
156362284|NCT00644969|564426729|FG000|Treatment Phase|Randomized, not treated|1|||
156362285|NCT00644969|564426730|FG001|Treatment Phase|Randomized, not treated|0|||
156362286|NCT00644969|564426729|FG000|Treatment Phase|Adverse Event|3|||
156362287|NCT00644969|564426730|FG001|Treatment Phase|Adverse Event|0|||
156362288|NCT00644969|564426729|FG000|Treatment Phase|Withdrawal by Subject|4|||
156362289|NCT00644969|564426730|FG001|Treatment Phase|Withdrawal by Subject|0|||
156362290|NCT00644969|564426729|FG000|Treatment Phase|Lost to Follow-up|2|||
156362291|NCT00644969|564426730|FG001|Treatment Phase|Lost to Follow-up|2|||
156362292|NCT00644969|564426729|FG000|Treatment Phase|Other|4|||
156362293|NCT00644969|564426730|FG001|Treatment Phase|Other|1|||
156362294|NCT00644969|564426729|FG000|Post Treatment Phase|Death|1|||
156362295|NCT00644969|564426730|FG001|Post Treatment Phase|Death|0|||
156362296|NCT00644969|564426729|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
156362297|NCT00644969|564426730|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
156362298|NCT00644969|564426729|FG000|Post Treatment Phase|Lost to Follow-up|4|||
156362299|NCT00644969|564426730|FG001|Post Treatment Phase|Lost to Follow-up|1|||
156362300|NCT00644969|564426729|FG000|Post Treatment Phase|Other|1|||
156362301|NCT00644969|564426730|FG001|Post Treatment Phase|Other|0|||
156362302|NCT04476030|564426731|FG000|Overall Study|Withdrawal by Subject|20|||
156362303|NCT04476030|564426732|FG001|Overall Study|Withdrawal by Subject|16|||
156362304|NCT04476030|564426731|FG000|Overall Study|Adverse Event|10|||
156362305|NCT04476030|564426732|FG001|Overall Study|Adverse Event|11|||
156362306|NCT04476030|564426731|FG000|Overall Study|Lost to Follow-up|7|||
156362307|NCT04476030|564426732|FG001|Overall Study|Lost to Follow-up|4|||
156362308|NCT04476030|564426731|FG000|Overall Study|Physician Decision|1|||
156362309|NCT04476030|564426732|FG001|Overall Study|Physician Decision|1|||
156362310|NCT04476030|564426731|FG000|Overall Study|Protocol Deviation|2|||
156362311|NCT04476030|564426732|FG001|Overall Study|Protocol Deviation|0|||
156362312|NCT04476030|564426731|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
156362313|NCT04476030|564426732|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
156362314|NCT04476030|564426731|FG000|Overall Study|Randomized but not Dosed|2|||
156362315|NCT04476030|564426732|FG001|Overall Study|Randomized but not Dosed|8|||
156362316|NCT02042924|564426733|FG000|Overall Study|Early Death|1|||
156362317|NCT02256891|564426736|FG000|Overall Study|Death|0|||
156362318|NCT02256891|564426737|FG001|Overall Study|Death|2|||
156362319|NCT02256891|564426736|FG000|Overall Study|Lost to Follow-up|0|||
156362320|NCT02256891|564426737|FG001|Overall Study|Lost to Follow-up|3|||
156362321|NCT02256891|564426736|FG000|Overall Study|Physician Decision|7|||
156362322|NCT02256891|564426737|FG001|Overall Study|Physician Decision|3|||
156362323|NCT02256891|564426736|FG000|Overall Study|Screen Fail|5|||
156362324|NCT02256891|564426737|FG001|Overall Study|Screen Fail|4|||
156362325|NCT02256891|564426736|FG000|Overall Study|Equipment Malfunction|0|||
156362326|NCT02256891|564426737|FG001|Overall Study|Equipment Malfunction|1|||
156362327|NCT02487394|564426746|FG000|Phase 1|Withdrawal by Subject|0|||
156362328|NCT02487394|564426747|FG001|Phase 1|Withdrawal by Subject|1|||
156362329|NCT04920123|564426752|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
156362330|NCT04920123|564426753|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
156362331|NCT04920123|564426754|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
156362332|NCT00218296|564426760|FG000|Overall Study|Lost to Follow-up|9|||
156362333|NCT00218296|564426761|FG001|Overall Study|Lost to Follow-up|7|||
156362334|NCT00218296|564426760|FG000|Overall Study|Withdrawal by Subject|36|||
156362335|NCT00218296|564426761|FG001|Overall Study|Withdrawal by Subject|47|||
156362336|NCT00218296|564426760|FG000|Overall Study|Randomized but did not enter treatment|66|||
156362337|NCT00218296|564426761|FG001|Overall Study|Randomized but did not enter treatment|67|||
156362338|NCT02711800|564426778|FG000|Overall Study|Lost to Follow-up|1|||
156362339|NCT02711800|564426778|FG000|Overall Study|Withdrawal by Subject|1|||
156362340|NCT00278954|564426779|FG000|Overall Study|Adverse Event|3|||
156362341|NCT00278954|564426779|FG000|Overall Study|Lost to Follow-up|1|||
156362342|NCT00278954|564426779|FG000|Overall Study|Withdrawal by Subject|1|||
156362343|NCT01828034|564426789|FG000|Overall Study|Withdrawal by Subject|0|||
156362344|NCT01828034|564426790|FG001|Overall Study|Withdrawal by Subject|0|||
156362345|NCT01828034|564426791|FG002|Overall Study|Withdrawal by Subject|0|||
156362346|NCT01828034|564426792|FG003|Overall Study|Withdrawal by Subject|1|||
156362347|NCT04064294|564426793|FG000|Overall Study|Adverse Event|1|||
156362348|NCT04064294|564426794|FG001|Overall Study|Adverse Event|0|||
156362349|NCT04064294|564426795|FG002|Overall Study|Adverse Event|0|||
156362350|NCT01988571|564426796|FG000|Overall Study|Death|3|||
156362351|NCT01988571|564426797|FG001|Overall Study|Death|1|||
156362352|NCT01988571|564426796|FG000|Overall Study|Physician Decision|2|||
156362353|NCT01988571|564426797|FG001|Overall Study|Physician Decision|1|||
156362354|NCT01988571|564426796|FG000|Overall Study|Lost to Follow-up|3|||
156362355|NCT01988571|564426797|FG001|Overall Study|Lost to Follow-up|0|||
156362356|NCT01988571|564426796|FG000|Overall Study|Withdrawal by Subject|31|||
156362357|NCT01988571|564426797|FG001|Overall Study|Withdrawal by Subject|33|||
156362358|NCT00481195|564426798|FG000|Overall Study|Adverse Event|16|||
156362359|NCT00481195|564426799|FG001|Overall Study|Adverse Event|11|||
156362360|NCT00481195|564426798|FG000|Overall Study|Lack of Efficacy|1|||
156362361|NCT00481195|564426799|FG001|Overall Study|Lack of Efficacy|3|||
156362362|NCT00481195|564426798|FG000|Overall Study|Lost to Follow-up|4|||
156362363|NCT00481195|564426799|FG001|Overall Study|Lost to Follow-up|6|||
156362364|NCT00481195|564426798|FG000|Overall Study|Physician Decision|3|||
156362365|NCT00481195|564426799|FG001|Overall Study|Physician Decision|1|||
156362366|NCT00481195|564426798|FG000|Overall Study|Protocol Violation|10|||
156362367|NCT00481195|564426799|FG001|Overall Study|Protocol Violation|7|||
156362368|NCT00481195|564426798|FG000|Overall Study|Withdrawal by Subject|3|||
156362369|NCT00481195|564426799|FG001|Overall Study|Withdrawal by Subject|9|||
156362370|NCT00481195|564426798|FG000|Overall Study|Miscellaneous|2|||
156362371|NCT00481195|564426799|FG001|Overall Study|Miscellaneous|2|||
156362372|NCT02932904|564426801|FG000|Overall Study|Reason not Specified|1|||
156362373|NCT02932904|564426802|FG001|Overall Study|Reason not Specified|0|||
156362374|NCT02932904|564426803|FG002|Overall Study|Reason not Specified|2|||
156362375|NCT02932904|564426804|FG003|Overall Study|Reason not Specified|2|||
156362376|NCT02932904|564426801|FG000|Overall Study|Noncompliance with Study Drug|2|||
156362377|NCT02932904|564426802|FG001|Overall Study|Noncompliance with Study Drug|3|||
156362378|NCT02932904|564426803|FG002|Overall Study|Noncompliance with Study Drug|3|||
156362379|NCT02932904|564426804|FG003|Overall Study|Noncompliance with Study Drug|4|||
156362380|NCT02932904|564426801|FG000|Overall Study|Pregnancy|0|||
156362381|NCT02932904|564426802|FG001|Overall Study|Pregnancy|1|||
156362382|NCT02932904|564426803|FG002|Overall Study|Pregnancy|1|||
156362383|NCT02932904|564426804|FG003|Overall Study|Pregnancy|0|||
156362384|NCT02932904|564426801|FG000|Overall Study|Study Termination|0|||
156362385|NCT02932904|564426802|FG001|Overall Study|Study Termination|1|||
156362386|NCT02932904|564426803|FG002|Overall Study|Study Termination|0|||
156362387|NCT02932904|564426804|FG003|Overall Study|Study Termination|0|||
156362388|NCT02932904|564426801|FG000|Overall Study|Voluntary Withdrawal|2|||
156362389|NCT02932904|564426802|FG001|Overall Study|Voluntary Withdrawal|1|||
156362390|NCT02932904|564426803|FG002|Overall Study|Voluntary Withdrawal|4|||
156362391|NCT02932904|564426804|FG003|Overall Study|Voluntary Withdrawal|2|||
156362392|NCT02932904|564426801|FG000|Overall Study|Lost to Follow-up|5|||
156362393|NCT02932904|564426802|FG001|Overall Study|Lost to Follow-up|3|||
156362394|NCT02932904|564426803|FG002|Overall Study|Lost to Follow-up|6|||
156362395|NCT02932904|564426804|FG003|Overall Study|Lost to Follow-up|0|||
156362396|NCT02932904|564426801|FG000|Overall Study|Significant Protocol Deviation|2|||
156362397|NCT02932904|564426802|FG001|Overall Study|Significant Protocol Deviation|3|||
156362398|NCT02932904|564426803|FG002|Overall Study|Significant Protocol Deviation|6|||
156362399|NCT02932904|564426804|FG003|Overall Study|Significant Protocol Deviation|1|||
156362400|NCT02932904|564426801|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
156362401|NCT02932904|564426802|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
156362402|NCT02932904|564426803|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
156362403|NCT02932904|564426804|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
156362404|NCT02932904|564426801|FG000|Overall Study|Randomized But Not Treated|1|||
156362405|NCT02932904|564426802|FG001|Overall Study|Randomized But Not Treated|1|||
156362406|NCT02932904|564426803|FG002|Overall Study|Randomized But Not Treated|0|||
156362407|NCT02932904|564426804|FG003|Overall Study|Randomized But Not Treated|2|||
156362408|NCT03144180|564426808|FG000|Overall Study|STAT Delivery|1|||
156362409|NCT03144180|564426809|FG001|Overall Study|STAT Delivery|1|||
156362410|NCT03144180|564426808|FG000|Overall Study|Provider forgot to fill out forms|1|||
156362411|NCT03144180|564426809|FG001|Overall Study|Provider forgot to fill out forms|3|||
156362412|NCT03144180|564426808|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
156362413|NCT03144180|564426809|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
156362414|NCT03144180|564426808|FG000|Overall Study|Scrub tech removed tube cap|0|||
156362415|NCT03144180|564426809|FG001|Overall Study|Scrub tech removed tube cap|1|||
156362416|NCT00337103|564426810|FG000|Overall Study|Progressive Disease|414|||
156362417|NCT00337103|564426811|FG001|Overall Study|Progressive Disease|410|||
156362418|NCT00337103|564426810|FG000|Overall Study|Adverse Event|45|||
156362419|NCT00337103|564426811|FG001|Overall Study|Adverse Event|59|||
156362420|NCT00337103|564426810|FG000|Overall Study|Subject Choice|34|||
156362421|NCT00337103|564426811|FG001|Overall Study|Subject Choice|27|||
156362422|NCT00337103|564426810|FG000|Overall Study|Clinical Progression|27|||
156362423|NCT00337103|564426811|FG001|Overall Study|Clinical Progression|24|||
156362424|NCT00337103|564426810|FG000|Overall Study|Physician Decision|15|||
156362425|NCT00337103|564426811|FG001|Overall Study|Physician Decision|14|||
156362426|NCT00337103|564426810|FG000|Overall Study|Withdrawal by Subject|8|||
156362427|NCT00337103|564426811|FG001|Overall Study|Withdrawal by Subject|5|||
156362428|NCT00337103|564426810|FG000|Overall Study|Other|5|||
156362429|NCT00337103|564426811|FG001|Overall Study|Other|6|||
156362430|NCT00337103|564426810|FG000|Overall Study|Entry Criteria Not Met|4|||
156362431|NCT00337103|564426811|FG001|Overall Study|Entry Criteria Not Met|1|||
156362432|NCT00337103|564426810|FG000|Overall Study|Lost to Follow-up|1|||
156362433|NCT00337103|564426811|FG001|Overall Study|Lost to Follow-up|2|||
156362434|NCT00337103|564426810|FG000|Overall Study|Death|1|||
156362435|NCT00337103|564426811|FG001|Overall Study|Death|0|||
156362436|NCT01289847|564426814|FG000|Overall Study|Patient could not comply with visits|1|||
156362437|NCT00439556|564426828|FG000|Overall Study|Patient was taken off study for non-comp|0|||
156362438|NCT00439556|564426829|FG001|Overall Study|Patient was taken off study for non-comp|1|||
156362439|NCT00439556|564426830|FG002|Overall Study|Patient was taken off study for non-comp|0|||
156362440|NCT03818516|564426831|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
156362441|NCT04372602|564426834|FG000|Overall Study|Withdrawal by Subject|1|||
156362442|NCT04372602|564426835|FG001|Overall Study|Withdrawal by Subject|1|||
156362443|NCT04372602|564426834|FG000|Overall Study|Adverse Event|0|||
156362444|NCT04372602|564426835|FG001|Overall Study|Adverse Event|1|||
156362445|NCT04372602|564426834|FG000|Overall Study|Transitioned to comfort care|0|||
156362446|NCT04372602|564426835|FG001|Overall Study|Transitioned to comfort care|1|||
156362447|NCT01324388|564426836|FG000|Part 1 of Study|Adverse Event|2|||
156362448|NCT01324388|564426837|FG001|Part 1 of Study|Adverse Event|0|||
156362449|NCT01324388|564426838|FG002|Part 1 of Study|Adverse Event|0|||
156362450|NCT01324388|564426839|FG003|Part 1 of Study|Adverse Event|0|||
156362451|NCT01324388|564426836|FG000|Part 1 of Study|Protocol Violation|1|||
156362452|NCT01324388|564426837|FG001|Part 1 of Study|Protocol Violation|2|||
156362453|NCT01324388|564426838|FG002|Part 1 of Study|Protocol Violation|0|||
156362454|NCT01324388|564426839|FG003|Part 1 of Study|Protocol Violation|0|||
156362455|NCT01324388|564426836|FG000|Part 1 of Study|Physician Decision|1|||
156362456|NCT01324388|564426837|FG001|Part 1 of Study|Physician Decision|0|||
156362457|NCT01324388|564426838|FG002|Part 1 of Study|Physician Decision|0|||
156362458|NCT01324388|564426839|FG003|Part 1 of Study|Physician Decision|0|||
156362459|NCT01324388|564426836|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
156362460|NCT01324388|564426837|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
156362461|NCT01324388|564426838|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
156362462|NCT01324388|564426839|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
156362463|NCT01324388|564426836|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
156362464|NCT01324388|564426837|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
156362465|NCT01324388|564426838|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
156362466|NCT01324388|564426839|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
156362467|NCT01405963|564426840|FG000|Overall Study|Moved Away|2|||
156362468|NCT01405963|564426841|FG001|Overall Study|Moved Away|0|||
156362469|NCT01405963|564426840|FG000|Overall Study|Adverse Event|0|||
156362470|NCT01405963|564426841|FG001|Overall Study|Adverse Event|1|||
156362471|NCT01405963|564426840|FG000|Overall Study|Lost to Follow-up|0|||
156362472|NCT01405963|564426841|FG001|Overall Study|Lost to Follow-up|1|||
156362473|NCT03742141|564426844|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
156362474|NCT01498640|564426845|FG000|Overall Study|Lost to Follow-up|1|||
156362475|NCT01498640|564426845|FG000|Overall Study|Death|1|||
156362476|NCT01498640|564426845|FG000|Overall Study|Other|3|||
156362477|NCT02968979|564426851|FG000|Overall Study|Protocol Violation|7|||
156362478|NCT02968979|564426851|FG000|Overall Study|Withdrawal by Subject|1|||
156362479|NCT01471379|564426852|FG000|Overall Study|Adverse Event|1|||
156362480|NCT01471379|564426853|FG001|Overall Study|Adverse Event|0|||
156362481|NCT01471379|564426854|FG002|Overall Study|Adverse Event|0|||
156362482|NCT01471379|564426852|FG000|Overall Study|Study terminated|0|||
156362483|NCT01471379|564426853|FG001|Overall Study|Study terminated|1|||
156362484|NCT01471379|564426854|FG002|Overall Study|Study terminated|0|||
156362485|NCT00788827|564426855|FG000|Overall Study|Lack of Efficacy|2|||
156362486|NCT01200797|564426862|FG000|Overall Study|symptomatic deterioration|2|||
156362487|NCT01200797|564426862|FG000|Overall Study|Adverse Event|4|||
156362488|NCT01200797|564426862|FG000|Overall Study|Disease Progression|13|||
156362489|NCT03608774|564426863|FG000|Overall Study|Lost to Follow-up|5|||
156362490|NCT03608774|564426864|FG001|Overall Study|Lost to Follow-up|5|||
156362491|NCT03608774|564426863|FG000|Overall Study|Withdrawal by Subject|1|||
156362492|NCT03608774|564426864|FG001|Overall Study|Withdrawal by Subject|0|||
156362493|NCT03608774|564426863|FG000|Overall Study|Protocol Violation|1|||
156489702|NCT03569475|564887426|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
156489703|NCT03569475|564887424|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
156489704|NCT03569475|564887425|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
156489705|NCT03569475|564887426|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
156489706|NCT03569475|564887424|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
156489707|NCT03569475|564887425|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
156489708|NCT03569475|564887426|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
156362494|NCT03608774|564426864|FG001|Overall Study|Protocol Violation|0|||
156362495|NCT03608774|564426863|FG000|Overall Study|Not eligible at enrollment|0|||
156362496|NCT03608774|564426864|FG001|Overall Study|Not eligible at enrollment|1|||
156362497|NCT03608774|564426863|FG000|Overall Study|Health related event|0|||
156362498|NCT03608774|564426864|FG001|Overall Study|Health related event|1|||
156362499|NCT00851799|564426867|FG000|Overall Study|Death|1|||
156362500|NCT00851799|564426868|FG001|Overall Study|Death|0|||
156362501|NCT00851799|564426869|FG002|Overall Study|Death|1|||
156362502|NCT00851799|564426867|FG000|Overall Study|Lost to Follow-up|5|||
156362503|NCT00851799|564426868|FG001|Overall Study|Lost to Follow-up|3|||
156489709|NCT03569475|564887424|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
156489710|NCT03569475|564887425|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
156489711|NCT03569475|564887426|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
156489712|NCT03569475|564887424|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
156489713|NCT03569475|564887425|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
156489714|NCT03569475|564887426|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
156489715|NCT03569475|564887424|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
156489716|NCT03569475|564887425|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
156489717|NCT03569475|564887426|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
156489718|NCT03569475|564887424|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
156489719|NCT03569475|564887425|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
156489720|NCT03569475|564887426|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
156489721|NCT01287416|564887429|FG000|Pre-post Training|Withdrawal by Subject|17|||
156489722|NCT01287416|564887430|FG001|Pre-post Training|Withdrawal by Subject|24|||
156489723|NCT01287416|564887429|FG000|Pre-post Training|Lost to Follow-up|5|||
156489724|NCT01287416|564887430|FG001|Pre-post Training|Lost to Follow-up|1|||
156489725|NCT01287416|564887429|FG000|6 Month Follow-up|Lost to Follow-up|3|||
156489726|NCT01287416|564887430|FG001|6 Month Follow-up|Lost to Follow-up|2|||
156489727|NCT02109107|564887435|FG000|Overall Study|Lost to Follow-up|2|||
156489728|NCT02383927|564887439|FG000|Overall Study|Disease Progression|8|||
156489729|NCT02383927|564887440|FG001|Overall Study|Disease Progression|8|||
156489730|NCT02383927|564887441|FG002|Overall Study|Disease Progression|15|||
156489731|NCT02383927|564887442|FG003|Overall Study|Disease Progression|4|||
156489732|NCT02383927|564887439|FG000|Overall Study|Physician Decision|0|||
156489733|NCT02383927|564887440|FG001|Overall Study|Physician Decision|0|||
156489734|NCT02383927|564887441|FG002|Overall Study|Physician Decision|2|||
156489735|NCT02383927|564887442|FG003|Overall Study|Physician Decision|0|||
156489736|NCT02383927|564887439|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
156489737|NCT02383927|564887440|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
156489738|NCT02383927|564887441|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
156489739|NCT02383927|564887442|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
156489740|NCT02383927|564887439|FG000|Overall Study|Adverse Event|4|||
156489741|NCT02383927|564887440|FG001|Overall Study|Adverse Event|1|||
156489742|NCT02383927|564887441|FG002|Overall Study|Adverse Event|3|||
156489743|NCT02383927|564887442|FG003|Overall Study|Adverse Event|5|||
156489744|NCT02383927|564887439|FG000|Overall Study|Miscellaneous|1|||
156489745|NCT02383927|564887440|FG001|Overall Study|Miscellaneous|0|||
156489746|NCT02383927|564887441|FG002|Overall Study|Miscellaneous|0|||
156489747|NCT02383927|564887442|FG003|Overall Study|Miscellaneous|1|||
156489748|NCT02383927|564887439|FG000|Overall Study|Withdrawal by Subject|0|||
156489749|NCT02383927|564887440|FG001|Overall Study|Withdrawal by Subject|1|||
156489750|NCT02383927|564887441|FG002|Overall Study|Withdrawal by Subject|4|||
156489751|NCT02383927|564887442|FG003|Overall Study|Withdrawal by Subject|0|||
156489752|NCT00734851|564887443|FG000|Overall Study|Withdrawal by Subject|2|||
156489753|NCT00734851|564887443|FG000|Overall Study|Lost to Follow-up|1|||
156489754|NCT00734851|564887443|FG000|Overall Study|Physician Decision|18|||
156489755|NCT03613454|564887446|FG000|Overall Study|Protocol Violation|1|||
156489756|NCT03613454|564887447|FG001|Overall Study|Protocol Violation|0|||
156489757|NCT03613454|564887446|FG000|Overall Study|Protocol Violation|0|||
156489758|NCT03613454|564887447|FG001|Overall Study|Protocol Violation|1|||
156489759|NCT04167085|564887448|FG000|Baseline|Withdrawal by Subject|2|||
156489760|NCT04167085|564887449|FG001|Baseline|Withdrawal by Subject|1|||
156489761|NCT04167085|564887448|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
156489762|NCT04167085|564887449|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
156489763|NCT00464737|564887451|FG000|Overall Study|Adverse Event|12|||
156489764|NCT00464737|564887452|FG001|Overall Study|Adverse Event|17|||
156489765|NCT00464737|564887453|FG002|Overall Study|Adverse Event|33|||
156489766|NCT00464737|564887451|FG000|Overall Study|Lack of Efficacy|7|||
156489767|NCT00464737|564887452|FG001|Overall Study|Lack of Efficacy|7|||
156489768|NCT00464737|564887453|FG002|Overall Study|Lack of Efficacy|4|||
156489769|NCT00464737|564887451|FG000|Overall Study|Withdrawal by Subject|5|||
156489770|NCT00464737|564887452|FG001|Overall Study|Withdrawal by Subject|3|||
156489771|NCT00464737|564887453|FG002|Overall Study|Withdrawal by Subject|5|||
156489772|NCT00464737|564887451|FG000|Overall Study|Protocol Violation|1|||
156489773|NCT00464737|564887452|FG001|Overall Study|Protocol Violation|1|||
156489774|NCT00464737|564887453|FG002|Overall Study|Protocol Violation|5|||
156489775|NCT00464737|564887451|FG000|Overall Study|Non-compliance|0|||
156489776|NCT00464737|564887452|FG001|Overall Study|Non-compliance|1|||
156489777|NCT00464737|564887453|FG002|Overall Study|Non-compliance|1|||
156489778|NCT00464737|564887451|FG000|Overall Study|Lost to Follow-up|5|||
156489779|NCT00464737|564887452|FG001|Overall Study|Lost to Follow-up|2|||
156489780|NCT00464737|564887453|FG002|Overall Study|Lost to Follow-up|5|||
156489781|NCT00464737|564887451|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
156489782|NCT00464737|564887452|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
156489783|NCT00464737|564887453|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
156489784|NCT00464737|564887451|FG000|Overall Study|Other: Subject left town; family illness|1|||
156489785|NCT00464737|564887452|FG001|Overall Study|Other: Subject left town; family illness|0|||
156489786|NCT00464737|564887453|FG002|Overall Study|Other: Subject left town; family illness|0|||
156489787|NCT00464737|564887451|FG000|Overall Study|Other: Study demands too great|0|||
156489788|NCT00464737|564887452|FG001|Overall Study|Other: Study demands too great|1|||
156489789|NCT00464737|564887453|FG002|Overall Study|Other: Study demands too great|0|||
156489790|NCT00464737|564887451|FG000|Overall Study|Other: Personal family reasons|0|||
156489791|NCT00464737|564887452|FG001|Overall Study|Other: Personal family reasons|0|||
156489792|NCT00464737|564887453|FG002|Overall Study|Other: Personal family reasons|1|||
156489793|NCT00464737|564887451|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
156489794|NCT00464737|564887452|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
156489795|NCT00464737|564887453|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
156489796|NCT00580047|564887456|FG000|Overall Study|Lost to Follow-up|1|||
156489797|NCT00580047|564887457|FG001|Overall Study|Lost to Follow-up|1|||
156489798|NCT00580047|564887458|FG002|Overall Study|Lost to Follow-up|0|||
156489799|NCT00580047|564887456|FG000|Overall Study|Withdrawal by Subject|1|||
156489800|NCT00580047|564887457|FG001|Overall Study|Withdrawal by Subject|1|||
156489801|NCT00580047|564887458|FG002|Overall Study|Withdrawal by Subject|2|||
156489802|NCT00580047|564887456|FG000|Overall Study|Withdrawal by Subject|1|||
156489803|NCT00580047|564887457|FG001|Overall Study|Withdrawal by Subject|0|||
156489804|NCT00580047|564887458|FG002|Overall Study|Withdrawal by Subject|0|||
156489805|NCT01894256|564887459|FG000|Part A|Adverse Event|0|||
156489806|NCT01894256|564887460|FG001|Part A|Adverse Event|1|||
156489807|NCT01894256|564887461|FG002|Part A|Adverse Event|0|||
156489808|NCT01894256|564887459|FG000|Part B|Death|0|||
156489809|NCT01894256|564887460|FG001|Part B|Death|1|||
156489810|NCT01894256|564887461|FG002|Part B|Death|1|||
156489811|NCT01894256|564887459|FG000|Part B|Withdrawal by Subject|0|||
156489812|NCT01894256|564887460|FG001|Part B|Withdrawal by Subject|1|||
156489813|NCT01894256|564887461|FG002|Part B|Withdrawal by Subject|0|||
156489814|NCT01894256|564887459|FG000|Part B|Lack of Efficacy|15|||
156489815|NCT01894256|564887460|FG001|Part B|Lack of Efficacy|12|||
156489816|NCT01894256|564887461|FG002|Part B|Lack of Efficacy|13|||
156489817|NCT01780584|564887462|FG000|Overall Study|Death|1|||
156489818|NCT01780584|564887463|FG001|Overall Study|Death|0|||
156489819|NCT01780584|564887464|FG002|Overall Study|Death|1|||
156489820|NCT01780584|564887462|FG000|Overall Study|Adverse Event|0|||
156489821|NCT01780584|564887463|FG001|Overall Study|Adverse Event|1|||
156489822|NCT01780584|564887464|FG002|Overall Study|Adverse Event|0|||
156489823|NCT01780584|564887462|FG000|Overall Study|Protocol Violation|0|||
156489824|NCT01780584|564887463|FG001|Overall Study|Protocol Violation|0|||
156489825|NCT01780584|564887464|FG002|Overall Study|Protocol Violation|1|||
156489826|NCT00141271|564887469|FG000|Overall Study|Adverse Event|31|||
156489827|NCT00141271|564887470|FG001|Overall Study|Adverse Event|19|||
156489828|NCT00141271|564887471|FG002|Overall Study|Adverse Event|17|||
156489829|NCT00141271|564887469|FG000|Overall Study|Laboratory Abnormality|2|||
156489830|NCT00141271|564887470|FG001|Overall Study|Laboratory Abnormality|1|||
156489831|NCT00141271|564887471|FG002|Overall Study|Laboratory Abnormality|1|||
156489832|NCT00141271|564887469|FG000|Overall Study|Lack of Efficacy|7|||
156489833|NCT00141271|564887470|FG001|Overall Study|Lack of Efficacy|7|||
156489834|NCT00141271|564887471|FG002|Overall Study|Lack of Efficacy|3|||
156489835|NCT00141271|564887469|FG000|Overall Study|Lost to Follow-up|15|||
156489836|NCT00141271|564887470|FG001|Overall Study|Lost to Follow-up|15|||
156489837|NCT00141271|564887471|FG002|Overall Study|Lost to Follow-up|21|||
156489838|NCT00141271|564887469|FG000|Overall Study|Withdrawal by Subject|14|||
156489839|NCT00141271|564887470|FG001|Overall Study|Withdrawal by Subject|9|||
156489840|NCT00141271|564887471|FG002|Overall Study|Withdrawal by Subject|10|||
156489841|NCT00141271|564887469|FG000|Overall Study|Other|11|||
156489842|NCT00141271|564887470|FG001|Overall Study|Other|12|||
156489843|NCT00141271|564887471|FG002|Overall Study|Other|5|||
156489844|NCT01544153|564887477|FG000|Overall Study|Under 18|0|||
156489845|NCT01544153|564887478|FG001|Overall Study|Under 18|1|||
156489846|NCT01544153|564887479|FG002|Overall Study|Under 18|0|||
156489847|NCT01544153|564887480|FG003|Overall Study|Under 18|0|||
156489848|NCT01544153|564887477|FG000|Overall Study|Non-smoker|0|||
156489849|NCT01544153|564887478|FG001|Overall Study|Non-smoker|0|||
156489850|NCT01544153|564887479|FG002|Overall Study|Non-smoker|1|||
156489851|NCT01544153|564887480|FG003|Overall Study|Non-smoker|0|||
156489852|NCT00390806|564887485|FG000|Overall Study|Lost to Follow-up|7|||
156489853|NCT00390806|564887486|FG001|Overall Study|Lost to Follow-up|6|||
156489854|NCT00390806|564887485|FG000|Overall Study|Protocol Violation|2|||
156489855|NCT00390806|564887486|FG001|Overall Study|Protocol Violation|2|||
156489856|NCT00390806|564887485|FG000|Overall Study|Withdrawal by Subject|12|||
156489857|NCT00390806|564887486|FG001|Overall Study|Withdrawal by Subject|15|||
156489858|NCT00390806|564887485|FG000|Overall Study|Investigator Decision|4|||
156489859|NCT00390806|564887486|FG001|Overall Study|Investigator Decision|6|||
156489860|NCT00390806|564887485|FG000|Overall Study|Death|1|||
156489861|NCT00390806|564887486|FG001|Overall Study|Death|0|||
156489862|NCT00390806|564887485|FG000|Overall Study|Physician Decision|0|||
156489863|NCT00390806|564887486|FG001|Overall Study|Physician Decision|1|||
156489864|NCT00390806|564887485|FG000|Overall Study|Ongoing|4|||
156489865|NCT00390806|564887486|FG001|Overall Study|Ongoing|2|||
156489866|NCT04783519|564887489|FG000|Overall Study|Withdrawal by Subject|2|||
156489867|NCT04783519|564887490|FG001|Overall Study|Withdrawal by Subject|7|||
156489868|NCT04783519|564887491|FG002|Overall Study|Withdrawal by Subject|3|||
156489869|NCT04783519|564887489|FG000|Overall Study|Lost to Follow-up|9|||
156489870|NCT04783519|564887490|FG001|Overall Study|Lost to Follow-up|7|||
156489871|NCT04783519|564887491|FG002|Overall Study|Lost to Follow-up|6|||
156489872|NCT00884793|564887492|FG000|Overall Study|Withdrawal by Subject|1|||
156489873|NCT03169530|564887493|FG000|Overall Study|Study ended by NIH|15|||
156489874|NCT03169530|564887494|FG001|Overall Study|Study ended by NIH|17|||
156489875|NCT01032200|564887495|FG000|Overall Study|Death|1|||
156489876|NCT01032200|564887496|FG001|Overall Study|Death|1|||
156489877|NCT01032200|564887495|FG000|Overall Study|Withdrawal by Subject|1|||
156489878|NCT01032200|564887496|FG001|Overall Study|Withdrawal by Subject|3|||
156489879|NCT01032200|564887495|FG000|Overall Study|Toxicity|0|||
156489880|NCT01032200|564887496|FG001|Overall Study|Toxicity|2|||
156489881|NCT01032200|564887495|FG000|Overall Study|Progression|1|||
156489882|NCT01032200|564887496|FG001|Overall Study|Progression|0|||
156489883|NCT01032200|564887495|FG000|Overall Study|Multiple|1|||
156489884|NCT01032200|564887496|FG001|Overall Study|Multiple|1|||
156489885|NCT00727259|564887500|FG000|Overall Study|Not all questionnaires completed|1055|||
156489886|NCT01021683|564887501|FG000|Overall Study|Lack of Efficacy|12|||
156489887|NCT01021683|564887501|FG000|Overall Study|Recovery of neutrophil count|51|||
156489888|NCT01021683|564887501|FG000|Overall Study|Other|8|||
156489889|NCT01374971|564887502|FG000|Overall Study|Withdrawal by Subject|1|||
156489890|NCT02273180|564887503|FG000|Overall Study|Adverse Event|2|||
156489891|NCT02273180|564887504|FG001|Overall Study|Adverse Event|2|||
156489892|NCT02273180|564887503|FG000|Overall Study|Lack of Efficacy|1|||
156489893|NCT02273180|564887504|FG001|Overall Study|Lack of Efficacy|0|||
156489894|NCT02273180|564887503|FG000|Overall Study|Protocol Violation|1|||
156489895|NCT02273180|564887504|FG001|Overall Study|Protocol Violation|7|||
156489896|NCT02273180|564887503|FG000|Overall Study|Randomized but not treated|1|||
156489897|NCT02273180|564887504|FG001|Overall Study|Randomized but not treated|0|||
156489898|NCT02273180|564887503|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
156489899|NCT02273180|564887504|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
156489900|NCT02273180|564887503|FG000|Overall Study|Other than specified above|21|||
156489901|NCT02273180|564887504|FG001|Overall Study|Other than specified above|10|||
156489902|NCT00645099|564887505|FG000|Overall Study|Lack of Efficacy|15|||
156489903|NCT00645099|564887506|FG001|Overall Study|Lack of Efficacy|6|||
156489904|NCT00645099|564887505|FG000|Overall Study|Withdrawal by Subject|30|||
156489905|NCT00645099|564887506|FG001|Overall Study|Withdrawal by Subject|22|||
156489906|NCT00645099|564887505|FG000|Overall Study|Lost to Follow-up|6|||
156489907|NCT00645099|564887506|FG001|Overall Study|Lost to Follow-up|4|||
156489908|NCT00645099|564887505|FG000|Overall Study|Adverse Event|11|||
156362504|NCT00851799|564426869|FG002|Overall Study|Lost to Follow-up|10|||
156362505|NCT00851799|564426867|FG000|Overall Study|Not able to get to clinic|8|||
156362506|NCT00851799|564426868|FG001|Overall Study|Not able to get to clinic|5|||
156362507|NCT00851799|564426869|FG002|Overall Study|Not able to get to clinic|9|||
156362508|NCT00851799|564426867|FG000|Overall Study|Not willing to adhere to requirements|1|||
156362509|NCT00851799|564426868|FG001|Overall Study|Not willing to adhere to requirements|2|||
156362510|NCT00851799|564426869|FG002|Overall Study|Not willing to adhere to requirements|2|||
156362511|NCT00851799|564426867|FG000|Overall Study|Withdrew consent prior study completion|1|||
156362512|NCT00851799|564426868|FG001|Overall Study|Withdrew consent prior study completion|2|||
156489909|NCT00645099|564887506|FG001|Overall Study|Adverse Event|5|||
156489910|NCT00645099|564887505|FG000|Overall Study|Other|9|||
156489911|NCT00645099|564887506|FG001|Overall Study|Other|5|||
156489912|NCT01201915|564887507|FG000|Overall Study|Adverse Event|2|||
156489913|NCT01201915|564887508|FG001|Overall Study|Adverse Event|1|||
156362513|NCT00851799|564426869|FG002|Overall Study|Withdrew consent prior study completion|1|||
156362514|NCT00851799|564426867|FG000|Overall Study|Severe Debilitation|0|||
156489914|NCT01201915|564887509|FG002|Overall Study|Adverse Event|1|||
156489915|NCT01201915|564887507|FG000|Overall Study|Lost to Follow-up|0|||
156489916|NCT01201915|564887508|FG001|Overall Study|Lost to Follow-up|4|||
156362515|NCT00851799|564426868|FG001|Overall Study|Severe Debilitation|1|||
156489917|NCT01201915|564887509|FG002|Overall Study|Lost to Follow-up|0|||
156489918|NCT01201915|564887507|FG000|Overall Study|Physician Decision|3|||
156489919|NCT01201915|564887508|FG001|Overall Study|Physician Decision|0|||
156489920|NCT01201915|564887509|FG002|Overall Study|Physician Decision|0|||
156489921|NCT01201915|564887507|FG000|Overall Study|Subject Decision|3|||
156489922|NCT01201915|564887508|FG001|Overall Study|Subject Decision|3|||
156489923|NCT01201915|564887509|FG002|Overall Study|Subject Decision|5|||
156489924|NCT01201915|564887507|FG000|Overall Study|Target Lesion Progression|0|||
156489925|NCT01201915|564887508|FG001|Overall Study|Target Lesion Progression|3|||
156489926|NCT01201915|564887509|FG002|Overall Study|Target Lesion Progression|0|||
156489927|NCT02154516|564887510|FG000|Overall Study|Withdrawal by Subject|0|||
156489928|NCT02154516|564887511|FG001|Overall Study|Withdrawal by Subject|1|||
156489929|NCT02154516|564887510|FG000|Overall Study|Lost to Follow-up|1|||
156489930|NCT02154516|564887511|FG001|Overall Study|Lost to Follow-up|0|||
156489931|NCT02154516|564887510|FG000|Overall Study|Removal/revision of device|1|||
156489932|NCT02154516|564887511|FG001|Overall Study|Removal/revision of device|0|||
156489933|NCT02154516|564887510|FG000|Overall Study|Death|2|||
156489934|NCT02154516|564887511|FG001|Overall Study|Death|1|||
156489935|NCT02316171|564887514|FG000|Overall Study|difficulties with urinary catheter|1|||
156489936|NCT02316171|564887515|FG001|Overall Study|difficulties with urinary catheter|0|||
156489937|NCT02316171|564887516|FG002|Overall Study|difficulties with urinary catheter|0|||
156489938|NCT02316171|564887517|FG003|Overall Study|difficulties with urinary catheter|0|||
156489939|NCT04130061|564887518|FG000|Overall Study|OR team forgot to request membrane|1|||
156489940|NCT04130061|564887519|FG001|Overall Study|OR team forgot to request membrane|0|||
156489941|NCT03449134|564889261|FG000|52-Week Treatment Period|Death|2|||
156489942|NCT03449134|564889262|FG001|52-Week Treatment Period|Death|1|||
156489943|NCT03449134|564889263|FG002|52-Week Treatment Period|Death|0|||
156489944|NCT03449134|564889261|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
156489945|NCT03449134|564889262|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
156489946|NCT03449134|564889263|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
156489947|NCT03449134|564889261|FG000|52-Week Treatment Period|Physician Decision|2|||
156489948|NCT03449134|564889262|FG001|52-Week Treatment Period|Physician Decision|3|||
156489949|NCT03449134|564889263|FG002|52-Week Treatment Period|Physician Decision|3|||
156489950|NCT03449134|564889261|FG000|52-Week Treatment Period|Screen Failure|1|||
156489951|NCT03449134|564889262|FG001|52-Week Treatment Period|Screen Failure|0|||
156489952|NCT03449134|564889263|FG002|52-Week Treatment Period|Screen Failure|1|||
156489953|NCT03449134|564889261|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
156489954|NCT03449134|564889262|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
156489955|NCT03449134|564889263|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
156489956|NCT03449134|564889261|FG000|52-Week Treatment Period|Site Closure|1|||
156489957|NCT03449134|564889262|FG001|52-Week Treatment Period|Site Closure|0|||
156489958|NCT03449134|564889263|FG002|52-Week Treatment Period|Site Closure|0|||
156489959|NCT02916706|564889264|FG000|Overall Study|Adverse Event|0|||
156489960|NCT02916706|564889265|FG001|Overall Study|Adverse Event|1|||
156489961|NCT02916706|564889264|FG000|Overall Study|Lost to Follow-up|0|||
156489962|NCT02916706|564889265|FG001|Overall Study|Lost to Follow-up|1|||
156489963|NCT02916706|564889264|FG000|Overall Study|Physician Decision|1|||
156489964|NCT02916706|564889265|FG001|Overall Study|Physician Decision|0|||
156489965|NCT02916706|564889264|FG000|Overall Study|Protocol Violation|3|||
156489966|NCT02916706|564889265|FG001|Overall Study|Protocol Violation|1|||
156362516|NCT00851799|564426869|FG002|Overall Study|Severe Debilitation|0|||
156362517|NCT00851799|564426867|FG000|Overall Study|Completed protocol due to pregnancy|0|||
156489967|NCT02916706|564889264|FG000|Overall Study|Withdrawal by Subject|6|||
156362518|NCT00851799|564426868|FG001|Overall Study|Completed protocol due to pregnancy|0|||
156362519|NCT00851799|564426869|FG002|Overall Study|Completed protocol due to pregnancy|1|||
156362520|NCT00403273|564428626|FG000|Overall Study|Lost to Follow-up|3|||
156362521|NCT00403273|564428627|FG001|Overall Study|Lost to Follow-up|2|||
156362522|NCT00403273|564428626|FG000|Overall Study|Physician Decision|0|||
156362523|NCT00403273|564428627|FG001|Overall Study|Physician Decision|1|||
156362524|NCT00403273|564428626|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
156362525|NCT00403273|564428627|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
156362526|NCT00502697|564428633|FG000|Overall Study|Withdrawal by Subject|3|||
156362527|NCT00502697|564428634|FG001|Overall Study|Withdrawal by Subject|1|||
156362528|NCT00502697|564428633|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
156362529|NCT00502697|564428634|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
156362530|NCT00502697|564428633|FG000|Overall Study|found not to meet eligibility criteria|3|||
156362531|NCT00502697|564428634|FG001|Overall Study|found not to meet eligibility criteria|4|||
156362532|NCT00502697|564428633|FG000|Overall Study|did not meet assignment criteria|4|||
156362533|NCT00502697|564428634|FG001|Overall Study|did not meet assignment criteria|2|||
156362534|NCT00589108|564428637|FG000|Overall Study|Lost to Follow-up|1|||
156362535|NCT00589108|564428638|FG001|Overall Study|Lost to Follow-up|1|||
156362536|NCT00589108|564428639|FG002|Overall Study|Lost to Follow-up|1|||
156362537|NCT00589108|564428637|FG000|Overall Study|Death|3|||
156362538|NCT00589108|564428638|FG001|Overall Study|Death|3|||
156362539|NCT00589108|564428639|FG002|Overall Study|Death|4|||
156362540|NCT03026257|564428642|FG000|Overall Study|Adverse Event|3|||
156362541|NCT03026257|564428643|FG001|Overall Study|Adverse Event|0|||
156362542|NCT03026257|564428644|FG002|Overall Study|Adverse Event|0|||
156362543|NCT03026257|564428645|FG003|Overall Study|Adverse Event|0|||
156362544|NCT03026257|564428646|FG004|Overall Study|Adverse Event|0|||
156362545|NCT03026257|564428647|FG005|Overall Study|Adverse Event|0|||
156362546|NCT03026257|564428642|FG000|Overall Study|Lost to Follow-up|1|||
156362547|NCT03026257|564428643|FG001|Overall Study|Lost to Follow-up|0|||
156362548|NCT03026257|564428644|FG002|Overall Study|Lost to Follow-up|0|||
156362549|NCT03026257|564428645|FG003|Overall Study|Lost to Follow-up|0|||
156362550|NCT03026257|564428646|FG004|Overall Study|Lost to Follow-up|0|||
156362551|NCT03026257|564428647|FG005|Overall Study|Lost to Follow-up|0|||
156362552|NCT03026257|564428642|FG000|Overall Study|Protocol Violation|1|||
156362553|NCT03026257|564428643|FG001|Overall Study|Protocol Violation|0|||
156362554|NCT03026257|564428644|FG002|Overall Study|Protocol Violation|0|||
156362555|NCT03026257|564428645|FG003|Overall Study|Protocol Violation|1|||
156362556|NCT03026257|564428646|FG004|Overall Study|Protocol Violation|1|||
156362557|NCT03026257|564428647|FG005|Overall Study|Protocol Violation|0|||
156362558|NCT03026257|564428642|FG000|Overall Study|Withdrawal by Subject|1|||
156362559|NCT03026257|564428643|FG001|Overall Study|Withdrawal by Subject|1|||
156362560|NCT03026257|564428644|FG002|Overall Study|Withdrawal by Subject|0|||
156362561|NCT03026257|564428645|FG003|Overall Study|Withdrawal by Subject|0|||
156362562|NCT03026257|564428646|FG004|Overall Study|Withdrawal by Subject|0|||
156362563|NCT03026257|564428647|FG005|Overall Study|Withdrawal by Subject|0|||
156362564|NCT02181556|564428649|FG000|Overall Study|Withdrawal by Subject|1|||
156362565|NCT04380857|564428650|FG000|Overall Study|Lost to Follow-up|3|||
156362566|NCT04380857|564428651|FG001|Overall Study|Lost to Follow-up|3|||
156362567|NCT02558790|564428652|FG000|Overall Study|Lost to Follow-up|2|||
156362568|NCT02558790|564428652|FG000|Overall Study|Physician Decision|1|||
156362569|NCT02558790|564428652|FG000|Overall Study|Withdrawal by Subject|1|||
156362570|NCT02558790|564428652|FG000|Overall Study|Screen Fail|3|||
156489968|NCT02916706|564889265|FG001|Overall Study|Withdrawal by Subject|9|||
156489969|NCT02916706|564889264|FG000|Overall Study|Other|5|||
156489970|NCT02916706|564889265|FG001|Overall Study|Other|19|||
156489971|NCT01093599|564889266|FG000|Overall Study|Lost to Follow-up|32|||
156362571|NCT05442554|564428662|FG000|Overall Study|Adverse Event|1|||
156362572|NCT02972632|564428664|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
156362573|NCT02972632|564428664|FG000|Overall Study|Lost to Follow-up|4|||
156362574|NCT02972632|564428664|FG000|Overall Study|Voluntary Withdrawal|10|||
156362575|NCT01446965|564428665|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
156362576|NCT01446965|564428666|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
156362577|NCT01446965|564428665|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
156362578|NCT01446965|564428666|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
156362579|NCT02023151|564428667|FG000|Overall Study|Lost to Follow-up|4|||
156362580|NCT03450707|564428668|FG000|Overall Study|Outside enrollment window|4|||
156362581|NCT03450707|564428669|FG001|Overall Study|Outside enrollment window|1|||
156362582|NCT03450707|564428668|FG000|Overall Study|Death|1|||
156362583|NCT03450707|564428669|FG001|Overall Study|Death|0|||
156362584|NCT03450707|564428668|FG000|Overall Study|Indication for thiamine|1|||
156362585|NCT03450707|564428669|FG001|Overall Study|Indication for thiamine|1|||
156362586|NCT03450707|564428668|FG000|Overall Study|Evidence of traumatic brain injury|1|||
156362587|NCT03450707|564428669|FG001|Overall Study|Evidence of traumatic brain injury|0|||
156362588|NCT03450707|564428668|FG000|Overall Study|Following commands|0|||
156362589|NCT03450707|564428669|FG001|Overall Study|Following commands|3|||
156362590|NCT03450707|564428668|FG000|Overall Study|Lactate < 3.5|0|||
156362591|NCT03450707|564428669|FG001|Overall Study|Lactate < 3.5|2|||
156362592|NCT03450707|564428668|FG000|Overall Study|Rearrest with ECMO|0|||
156362593|NCT03450707|564428669|FG001|Overall Study|Rearrest with ECMO|1|||
156362594|NCT03450707|564428668|FG000|Overall Study|Indication for thiamine + head CT results|0|||
156362595|NCT03450707|564428669|FG001|Overall Study|Indication for thiamine + head CT results|1|||
156362596|NCT03450707|564428668|FG000|Overall Study|Family/patient goals of care|0|||
156362597|NCT03450707|564428669|FG001|Overall Study|Family/patient goals of care|1|||
156362598|NCT00004412|564428670|FG000|Randomized Period|Moved to Crossover Period|3|||
156362599|NCT00004412|564428671|FG001|Randomized Period|Moved to Crossover Period|0|||
156362600|NCT00004412|564428672|FG002|Randomized Period|Moved to Crossover Period|0|||
156362601|NCT02016482|564428682|FG000|Period A|Adverse Event|3|||
156362602|NCT02016482|564428683|FG001|Period A|Adverse Event|5|||
156362603|NCT02016482|564428682|FG000|Period A|Withdrawal by Subject|3|||
156362604|NCT02016482|564428683|FG001|Period A|Withdrawal by Subject|4|||
156362605|NCT02016482|564428682|FG000|Period A|Lost to Follow-up|3|||
156362606|NCT02016482|564428683|FG001|Period A|Lost to Follow-up|3|||
156362607|NCT02016482|564428682|FG000|Period A|Lack of Efficacy|2|||
156362608|NCT02016482|564428683|FG001|Period A|Lack of Efficacy|1|||
156362609|NCT02016482|564428682|FG000|Period A|Other|3|||
156362610|NCT02016482|564428683|FG001|Period A|Other|0|||
156362611|NCT02016482|564428682|FG000|Period A|Protocol Violation|0|||
156362612|NCT02016482|564428683|FG001|Period A|Protocol Violation|1|||
156362613|NCT02016482|564428682|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
156362614|NCT02016482|564428683|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
156362615|NCT02016482|564428682|FG000|Period B|Withdrawal by Subject|1|||
156362616|NCT02016482|564428683|FG001|Period B|Withdrawal by Subject|1|||
156362617|NCT02016482|564428682|FG000|Period B|Lost to Follow-up|2|||
156362618|NCT02016482|564428683|FG001|Period B|Lost to Follow-up|0|||
156362619|NCT02016482|564428682|FG000|Period B|Lack of Efficacy|6|||
156362620|NCT02016482|564428683|FG001|Period B|Lack of Efficacy|4|||
156362621|NCT02016482|564428682|FG000|Period B|Other|4|||
156362622|NCT02016482|564428683|FG001|Period B|Other|0|||
156362623|NCT02016482|564428682|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
156362624|NCT02016482|564428683|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
156362625|NCT03387813|564428684|FG000|Overall Study|Death|40|||
156362626|NCT03387813|564428685|FG001|Overall Study|Death|37|||
156362627|NCT03387813|564428686|FG002|Overall Study|Death|190|||
156362628|NCT03387813|564428684|FG000|Overall Study|Withdrawal by Subject|9|||
156362629|NCT03387813|564428685|FG001|Overall Study|Withdrawal by Subject|19|||
156362630|NCT03387813|564428686|FG002|Overall Study|Withdrawal by Subject|32|||
156362631|NCT03387813|564428684|FG000|Overall Study|Lost to Follow-up|3|||
156362632|NCT03387813|564428685|FG001|Overall Study|Lost to Follow-up|9|||
156362633|NCT03387813|564428686|FG002|Overall Study|Lost to Follow-up|15|||
156362634|NCT03387813|564428684|FG000|Overall Study|Non-Compliance|6|||
156362635|NCT03387813|564428685|FG001|Overall Study|Non-Compliance|6|||
156362636|NCT03387813|564428686|FG002|Overall Study|Non-Compliance|31|||
156362637|NCT03387813|564428684|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
156362638|NCT03387813|564428685|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
156362639|NCT03387813|564428686|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
156362640|NCT00006478|564428687|FG000|Overall Study|Vaccine could not be produced|1|||
156362641|NCT00006478|564428687|FG000|Overall Study|Physician Decision|6|||
156362642|NCT03161483|564428690|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
156362643|NCT03161483|564428691|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
156362644|NCT03161483|564428692|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
156362645|NCT03161483|564428693|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
156362646|NCT03161483|564428690|FG000|Treatment Period|Death|1|||
156362647|NCT03161483|564428691|FG001|Treatment Period|Death|0|||
156362648|NCT03161483|564428692|FG002|Treatment Period|Death|0|||
156362649|NCT03161483|564428693|FG003|Treatment Period|Death|0|||
156362650|NCT03161483|564428690|FG000|Treatment Period|Adverse Event|5|||
156362651|NCT03161483|564428691|FG001|Treatment Period|Adverse Event|2|||
156362652|NCT03161483|564428692|FG002|Treatment Period|Adverse Event|1|||
156362653|NCT03161483|564428693|FG003|Treatment Period|Adverse Event|11|||
156362654|NCT03161483|564428690|FG000|Treatment Period|Pregnancy|1|||
156362655|NCT03161483|564428691|FG001|Treatment Period|Pregnancy|0|||
156362656|NCT03161483|564428692|FG002|Treatment Period|Pregnancy|0|||
156362657|NCT03161483|564428693|FG003|Treatment Period|Pregnancy|0|||
156362658|NCT03161483|564428690|FG000|Treatment Period|Lack of Efficacy|0|||
156362659|NCT03161483|564428691|FG001|Treatment Period|Lack of Efficacy|0|||
156362660|NCT03161483|564428692|FG002|Treatment Period|Lack of Efficacy|0|||
156362661|NCT03161483|564428693|FG003|Treatment Period|Lack of Efficacy|1|||
156362662|NCT03161483|564428690|FG000|Treatment Period|Withdrawal by Subject|2|||
156362663|NCT03161483|564428691|FG001|Treatment Period|Withdrawal by Subject|5|||
156362664|NCT03161483|564428692|FG002|Treatment Period|Withdrawal by Subject|2|||
156362665|NCT03161483|564428693|FG003|Treatment Period|Withdrawal by Subject|6|||
156362666|NCT03161483|564428690|FG000|Treatment Period|Lost to Follow-up|0|||
156362667|NCT03161483|564428691|FG001|Treatment Period|Lost to Follow-up|0|||
156362668|NCT03161483|564428692|FG002|Treatment Period|Lost to Follow-up|0|||
156362669|NCT03161483|564428693|FG003|Treatment Period|Lost to Follow-up|1|||
156362670|NCT03161483|564428690|FG000|Treatment Period|Protocol Violation|0|||
156362671|NCT03161483|564428691|FG001|Treatment Period|Protocol Violation|0|||
156362672|NCT03161483|564428692|FG002|Treatment Period|Protocol Violation|0|||
156362673|NCT03161483|564428693|FG003|Treatment Period|Protocol Violation|1|||
156362674|NCT03161483|564428690|FG000|Treatment Period|Other reasons|1|||
156362675|NCT03161483|564428691|FG001|Treatment Period|Other reasons|1|||
156362676|NCT03161483|564428692|FG002|Treatment Period|Other reasons|0|||
156362677|NCT03161483|564428693|FG003|Treatment Period|Other reasons|0|||
156362678|NCT00743652|564428701|FG000|Overall Study|Parent/Legal Guardian Request|3|||
156362679|NCT00743652|564428702|FG001|Overall Study|Parent/Legal Guardian Request|2|||
156362680|NCT00743652|564428703|FG002|Overall Study|Parent/Legal Guardian Request|2|||
156362681|NCT00743652|564428704|FG003|Overall Study|Parent/Legal Guardian Request|2|||
156362682|NCT00743652|564428705|FG004|Overall Study|Parent/Legal Guardian Request|0|||
156362683|NCT00743652|564428701|FG000|Overall Study|Adverse Event|3|||
156362684|NCT00743652|564428702|FG001|Overall Study|Adverse Event|0|||
156362685|NCT00743652|564428703|FG002|Overall Study|Adverse Event|0|||
156362686|NCT00743652|564428704|FG003|Overall Study|Adverse Event|0|||
156362687|NCT00743652|564428705|FG004|Overall Study|Adverse Event|0|||
156362688|NCT00743652|564428701|FG000|Overall Study|Death|2|||
156362689|NCT00743652|564428702|FG001|Overall Study|Death|0|||
156362690|NCT00743652|564428703|FG002|Overall Study|Death|0|||
156362691|NCT00743652|564428704|FG003|Overall Study|Death|0|||
156362692|NCT00743652|564428705|FG004|Overall Study|Death|0|||
156362693|NCT00743652|564428701|FG000|Overall Study|Investigator Request|0|||
156362694|NCT00743652|564428702|FG001|Overall Study|Investigator Request|0|||
156362695|NCT00743652|564428703|FG002|Overall Study|Investigator Request|0|||
156362696|NCT00743652|564428704|FG003|Overall Study|Investigator Request|2|||
156362697|NCT00743652|564428705|FG004|Overall Study|Investigator Request|0|||
156362698|NCT00743652|564428701|FG000|Overall Study|Other|1|||
156362699|NCT00743652|564428702|FG001|Overall Study|Other|1|||
156362700|NCT00743652|564428703|FG002|Overall Study|Other|0|||
156362701|NCT00743652|564428704|FG003|Overall Study|Other|0|||
156362702|NCT00743652|564428705|FG004|Overall Study|Other|0|||
156362703|NCT00743652|564428701|FG000|Overall Study|Lost to Follow-up|1|||
156362704|NCT00743652|564428702|FG001|Overall Study|Lost to Follow-up|0|||
156362705|NCT00743652|564428703|FG002|Overall Study|Lost to Follow-up|0|||
156362706|NCT00743652|564428704|FG003|Overall Study|Lost to Follow-up|0|||
156362707|NCT00743652|564428705|FG004|Overall Study|Lost to Follow-up|0|||
156362708|NCT00805766|564428706|FG000|Screening Period|Adverse Event|1|||
156362709|NCT00805766|564428706|FG000|Screening Period|Lack of Efficacy|2|||
156362710|NCT00805766|564428706|FG000|Screening Period|Pregnancy|1|||
156362711|NCT00805766|564428706|FG000|Screening Period|Responder|2|||
156362712|NCT00805766|564428706|FG000|Increased Dose Period|Adverse Event|4|||
156362713|NCT00805766|564428706|FG000|Increased Dose Period|Lack of Efficacy|7|||
156362714|NCT00805766|564428706|FG000|Increased Dose Period|Pregnancy|1|||
156362715|NCT00805766|564428706|FG000|Increased Dose Period|Withdrawal by Subject|1|||
156362716|NCT00228917|564428713|FG000|Overall Study|Migrated/moved from study area|0|||
156362717|NCT00228917|564428714|FG001|Overall Study|Migrated/moved from study area|0|||
156362718|NCT00228917|564428715|FG002|Overall Study|Migrated/moved from study area|0|||
156362719|NCT00228917|564428716|FG003|Overall Study|Migrated/moved from study area|0|||
156362720|NCT00228917|564428717|FG004|Overall Study|Migrated/moved from study area|0|||
156362721|NCT00228917|564428718|FG005|Overall Study|Migrated/moved from study area|2|||
156362722|NCT00228917|564428719|FG006|Overall Study|Migrated/moved from study area|0|||
156362723|NCT00228917|564428720|FG007|Overall Study|Migrated/moved from study area|0|||
156362724|NCT00409617|564428721|FG000|Overall Study|Adverse Event|57|||
156362725|NCT00409617|564428721|FG000|Overall Study|Lack of Efficacy|54|||
156362726|NCT00409617|564428721|FG000|Overall Study|Lost to Follow-up|2|||
156362727|NCT00409617|564428721|FG000|Overall Study|Protocol Violation|24|||
156362728|NCT00409617|564428721|FG000|Overall Study|Withdrawal by Subject|8|||
156362729|NCT00409617|564428721|FG000|Overall Study|Administrative reasons|1|||
156362730|NCT00409617|564428721|FG000|Overall Study|Not described|14|||
156362731|NCT00149747|564428729|FG000|Overall Study|Death|1|||
156362732|NCT00149747|564428730|FG001|Overall Study|Death|0|||
156362733|NCT00149747|564428729|FG000|Overall Study|Withdrawal by Subject|3|||
156362734|NCT00149747|564428730|FG001|Overall Study|Withdrawal by Subject|3|||
156362735|NCT03373383|564428731|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
156362736|NCT03373383|564428732|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
156362737|NCT03373383|564428733|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
156362738|NCT03373383|564428734|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
156362739|NCT03373383|564428735|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
156362740|NCT03373383|564428731|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
156362741|NCT03373383|564428732|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
156362742|NCT03373383|564428733|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156362743|NCT03373383|564428734|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156362744|NCT03373383|564428735|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156362745|NCT03373383|564428731|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
156362746|NCT03373383|564428732|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
156362747|NCT03373383|564428733|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
156362748|NCT03373383|564428734|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
156362749|NCT03373383|564428735|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
156362750|NCT03373383|564428731|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
156362751|NCT03373383|564428732|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
156362752|NCT03373383|564428733|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
156362753|NCT03373383|564428734|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
156362754|NCT03373383|564428735|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
156362755|NCT03373383|564428731|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
156362756|NCT03373383|564428732|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
156362757|NCT03373383|564428733|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
156362758|NCT03373383|564428734|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
156362759|NCT03373383|564428735|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
156362760|NCT03373383|564428731|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
156362761|NCT03373383|564428732|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
156362762|NCT03373383|564428733|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
156362763|NCT03373383|564428734|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
156362764|NCT03373383|564428735|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
156362765|NCT03373383|564428731|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
156362766|NCT03373383|564428732|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
156362767|NCT03373383|564428733|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
156362768|NCT03373383|564428734|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
156362769|NCT03373383|564428735|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
156362770|NCT03373383|564428731|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
156362771|NCT03373383|564428732|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
156362772|NCT03373383|564428733|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
156362773|NCT03373383|564428734|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
156362774|NCT03373383|564428735|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
156362775|NCT03373383|564428731|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
156362776|NCT03373383|564428732|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
156362777|NCT03373383|564428733|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
156362778|NCT03373383|564428734|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
156362779|NCT03373383|564428735|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
156362780|NCT00694369|564428736|FG000|Overall Study|Adverse Event|0|||
156362781|NCT00694369|564428737|FG001|Overall Study|Adverse Event|1|||
156362782|NCT00694369|564428738|FG002|Overall Study|Adverse Event|0|||
156362783|NCT00694369|564428739|FG003|Overall Study|Adverse Event|1|||
156362784|NCT00694369|564428740|FG004|Overall Study|Adverse Event|3|||
156362785|NCT00694369|564428736|FG000|Overall Study|Lost to Follow-up|0|||
156362786|NCT00694369|564428737|FG001|Overall Study|Lost to Follow-up|0|||
156362787|NCT00694369|564428738|FG002|Overall Study|Lost to Follow-up|1|||
156362788|NCT00694369|564428739|FG003|Overall Study|Lost to Follow-up|1|||
156362789|NCT00694369|564428740|FG004|Overall Study|Lost to Follow-up|0|||
156362790|NCT00694369|564428736|FG000|Overall Study|Physician Decision|0|||
156362791|NCT00694369|564428737|FG001|Overall Study|Physician Decision|0|||
156362792|NCT00694369|564428738|FG002|Overall Study|Physician Decision|0|||
156362793|NCT00694369|564428739|FG003|Overall Study|Physician Decision|0|||
156362794|NCT00694369|564428740|FG004|Overall Study|Physician Decision|1|||
156362795|NCT00694369|564428736|FG000|Overall Study|Protocol Violation|0|||
156362796|NCT00694369|564428737|FG001|Overall Study|Protocol Violation|1|||
156362797|NCT00694369|564428738|FG002|Overall Study|Protocol Violation|0|||
156362798|NCT00694369|564428739|FG003|Overall Study|Protocol Violation|0|||
156362799|NCT00694369|564428740|FG004|Overall Study|Protocol Violation|0|||
156362800|NCT00694369|564428736|FG000|Overall Study|Withdrawal by Subject|1|||
156362801|NCT00694369|564428737|FG001|Overall Study|Withdrawal by Subject|1|||
156362802|NCT00694369|564428738|FG002|Overall Study|Withdrawal by Subject|1|||
156362803|NCT00694369|564428739|FG003|Overall Study|Withdrawal by Subject|1|||
156362804|NCT00694369|564428740|FG004|Overall Study|Withdrawal by Subject|2|||
156362805|NCT00907374|564428741|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
156362806|NCT00907374|564428742|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
156362807|NCT01524692|564428748|FG000|Overall Study|Withdrawal by Subject|3|||
156362808|NCT03190889|564428749|FG000|Overall Study|Lost to Follow-up|7|||
156362809|NCT03190889|564428750|FG001|Overall Study|Lost to Follow-up|7|||
156362810|NCT03190889|564428751|FG002|Overall Study|Lost to Follow-up|3|||
156362811|NCT03190889|564428749|FG000|Overall Study|Withdrawal by Subject|1|||
156362812|NCT03190889|564428750|FG001|Overall Study|Withdrawal by Subject|1|||
156362813|NCT03190889|564428751|FG002|Overall Study|Withdrawal by Subject|2|||
156362814|NCT03190889|564428749|FG000|Overall Study|Did not complete protocol|4|||
156362815|NCT03190889|564428750|FG001|Overall Study|Did not complete protocol|9|||
156362816|NCT03190889|564428751|FG002|Overall Study|Did not complete protocol|0|||
156362817|NCT03190889|564428749|FG000|Overall Study|COVID-19|1|||
156362818|NCT03190889|564428750|FG001|Overall Study|COVID-19|0|||
156362819|NCT03190889|564428751|FG002|Overall Study|COVID-19|2|||
156362820|NCT01709695|564428752|FG000|Overall Study|Withdrawal by Subject|1|||
156362821|NCT01709695|564428753|FG001|Overall Study|Withdrawal by Subject|1|||
156362822|NCT04007523|564428754|FG000|Overall Study|Withdrawal by Subject|0|||
156362823|NCT04007523|564428755|FG001|Overall Study|Withdrawal by Subject|1|||
156362824|NCT04007523|564428756|FG002|Overall Study|Withdrawal by Subject|1|||
156362825|NCT04007523|564428757|FG003|Overall Study|Withdrawal by Subject|0|||
156362826|NCT04007523|564428754|FG000|Overall Study|ICU Transfer|0|||
156362827|NCT04007523|564428755|FG001|Overall Study|ICU Transfer|1|||
156362828|NCT04007523|564428756|FG002|Overall Study|ICU Transfer|0|||
156362829|NCT04007523|564428757|FG003|Overall Study|ICU Transfer|0|||
156362830|NCT04007523|564428754|FG000|Overall Study|COVID hospital closure|0|||
156362831|NCT04007523|564428755|FG001|Overall Study|COVID hospital closure|0|||
156362832|NCT04007523|564428756|FG002|Overall Study|COVID hospital closure|1|||
156362833|NCT04007523|564428757|FG003|Overall Study|COVID hospital closure|2|||
156362834|NCT04007523|564428754|FG000|Overall Study|Surgery cancelled|0|||
156362835|NCT04007523|564428755|FG001|Overall Study|Surgery cancelled|0|||
156362836|NCT04007523|564428756|FG002|Overall Study|Surgery cancelled|1|||
156362837|NCT04007523|564428757|FG003|Overall Study|Surgery cancelled|1|||
156362838|NCT02039674|564428761|FG000|Overall Study|Adverse Event|0|||
156362839|NCT02039674|564428762|FG001|Overall Study|Adverse Event|0|||
156362840|NCT02039674|564428763|FG002|Overall Study|Adverse Event|0|||
156362841|NCT02039674|564428764|FG003|Overall Study|Adverse Event|1|||
156362842|NCT02039674|564428765|FG004|Overall Study|Adverse Event|0|||
156362843|NCT02039674|564428766|FG005|Overall Study|Adverse Event|0|||
156362844|NCT02039674|564428767|FG006|Overall Study|Adverse Event|0|||
156362845|NCT02039674|564428768|FG007|Overall Study|Adverse Event|0|||
156362846|NCT02039674|564428769|FG008|Overall Study|Adverse Event|2|||
156362847|NCT02039674|564428770|FG009|Overall Study|Adverse Event|1|||
156362848|NCT02039674|564428771|FG010|Overall Study|Adverse Event|0|||
156362849|NCT02039674|564428772|FG011|Overall Study|Adverse Event|2|||
156362850|NCT02039674|564428773|FG012|Overall Study|Adverse Event|3|||
156362851|NCT02039674|564428774|FG013|Overall Study|Adverse Event|1|||
156362852|NCT02039674|564428761|FG000|Overall Study|Death|2|||
156362853|NCT02039674|564428762|FG001|Overall Study|Death|0|||
156362854|NCT02039674|564428763|FG002|Overall Study|Death|2|||
156362855|NCT02039674|564428764|FG003|Overall Study|Death|3|||
156362856|NCT02039674|564428765|FG004|Overall Study|Death|0|||
156362857|NCT02039674|564428766|FG005|Overall Study|Death|0|||
156362858|NCT02039674|564428767|FG006|Overall Study|Death|1|||
156362859|NCT02039674|564428768|FG007|Overall Study|Death|0|||
156362860|NCT02039674|564428769|FG008|Overall Study|Death|2|||
156362861|NCT02039674|564428770|FG009|Overall Study|Death|0|||
156362862|NCT02039674|564428771|FG010|Overall Study|Death|1|||
156362863|NCT02039674|564428772|FG011|Overall Study|Death|3|||
156362864|NCT02039674|564428773|FG012|Overall Study|Death|2|||
156362865|NCT02039674|564428774|FG013|Overall Study|Death|8|||
156362866|NCT02039674|564428761|FG000|Overall Study|Excluded Medication|1|||
156362867|NCT02039674|564428762|FG001|Overall Study|Excluded Medication|1|||
156362868|NCT02039674|564428763|FG002|Overall Study|Excluded Medication|0|||
156362869|NCT02039674|564428764|FG003|Overall Study|Excluded Medication|1|||
156362870|NCT02039674|564428765|FG004|Overall Study|Excluded Medication|0|||
156362871|NCT02039674|564428766|FG005|Overall Study|Excluded Medication|1|||
156362872|NCT02039674|564428767|FG006|Overall Study|Excluded Medication|0|||
156362873|NCT02039674|564428768|FG007|Overall Study|Excluded Medication|0|||
156362874|NCT02039674|564428769|FG008|Overall Study|Excluded Medication|2|||
156362875|NCT02039674|564428770|FG009|Overall Study|Excluded Medication|3|||
156362876|NCT02039674|564428771|FG010|Overall Study|Excluded Medication|5|||
156362877|NCT02039674|564428772|FG011|Overall Study|Excluded Medication|6|||
156362878|NCT02039674|564428773|FG012|Overall Study|Excluded Medication|8|||
156362879|NCT02039674|564428774|FG013|Overall Study|Excluded Medication|3|||
156362880|NCT02039674|564428761|FG000|Overall Study|Lost to Follow-up|0|||
156489972|NCT01093599|564889267|FG001|Overall Study|Lost to Follow-up|46|||
156489973|NCT01703845|564889268|FG000|Overall Study|Adverse Event|1|||
156489974|NCT01703845|564889269|FG001|Overall Study|Adverse Event|0|||
156489975|NCT01703845|564889268|FG000|Overall Study|Protocol Violation|1|||
156489976|NCT01703845|564889269|FG001|Overall Study|Protocol Violation|0|||
156362881|NCT02039674|564428762|FG001|Overall Study|Lost to Follow-up|0|||
156362882|NCT02039674|564428763|FG002|Overall Study|Lost to Follow-up|0|||
156362883|NCT02039674|564428764|FG003|Overall Study|Lost to Follow-up|0|||
156362884|NCT02039674|564428765|FG004|Overall Study|Lost to Follow-up|1|||
156362885|NCT02039674|564428766|FG005|Overall Study|Lost to Follow-up|1|||
156362886|NCT02039674|564428767|FG006|Overall Study|Lost to Follow-up|0|||
156362887|NCT02039674|564428768|FG007|Overall Study|Lost to Follow-up|0|||
156362888|NCT02039674|564428769|FG008|Overall Study|Lost to Follow-up|0|||
156362889|NCT02039674|564428770|FG009|Overall Study|Lost to Follow-up|0|||
156362890|NCT02039674|564428771|FG010|Overall Study|Lost to Follow-up|0|||
156362891|NCT02039674|564428772|FG011|Overall Study|Lost to Follow-up|2|||
156362892|NCT02039674|564428773|FG012|Overall Study|Lost to Follow-up|2|||
156362893|NCT02039674|564428774|FG013|Overall Study|Lost to Follow-up|1|||
156362894|NCT02039674|564428761|FG000|Overall Study|Physician Decision|0|||
156362895|NCT02039674|564428762|FG001|Overall Study|Physician Decision|0|||
156362896|NCT02039674|564428763|FG002|Overall Study|Physician Decision|0|||
156362897|NCT02039674|564428764|FG003|Overall Study|Physician Decision|0|||
156362898|NCT02039674|564428765|FG004|Overall Study|Physician Decision|0|||
156362899|NCT02039674|564428766|FG005|Overall Study|Physician Decision|0|||
156362900|NCT02039674|564428767|FG006|Overall Study|Physician Decision|0|||
156362901|NCT02039674|564428768|FG007|Overall Study|Physician Decision|0|||
156362902|NCT02039674|564428769|FG008|Overall Study|Physician Decision|0|||
156362903|NCT02039674|564428770|FG009|Overall Study|Physician Decision|0|||
156362904|NCT02039674|564428771|FG010|Overall Study|Physician Decision|0|||
156362905|NCT02039674|564428772|FG011|Overall Study|Physician Decision|1|||
156362906|NCT02039674|564428773|FG012|Overall Study|Physician Decision|1|||
156362907|NCT02039674|564428774|FG013|Overall Study|Physician Decision|0|||
156362908|NCT02039674|564428761|FG000|Overall Study|Progressive Disease|8|||
156362909|NCT02039674|564428762|FG001|Overall Study|Progressive Disease|8|||
156362910|NCT02039674|564428763|FG002|Overall Study|Progressive Disease|6|||
156489977|NCT01703845|564889268|FG000|Overall Study|other than stated above|1|||
156489978|NCT01703845|564889269|FG001|Overall Study|other than stated above|0|||
156489979|NCT00719212|564889270|FG000|Overall Study|Death|41|||
156489980|NCT00719212|564889270|FG000|Overall Study|Lost to Follow-up|2|||
156489981|NCT00719212|564889270|FG000|Overall Study|Withdrawal by Subject|1|||
156489982|NCT00526097|564889271|FG000|Overall Study|Adverse Event|6|||
156489983|NCT00526097|564889272|FG001|Overall Study|Adverse Event|44|||
156489984|NCT00526097|564889271|FG000|Overall Study|Protocol Violation|4|||
156489985|NCT00526097|564889272|FG001|Overall Study|Protocol Violation|10|||
156489986|NCT00526097|564889271|FG000|Overall Study|Withdrawal by Subject|3|||
156489987|NCT00526097|564889272|FG001|Overall Study|Withdrawal by Subject|1|||
156489988|NCT00526097|564889271|FG000|Overall Study|Other|2|||
156489989|NCT00526097|564889272|FG001|Overall Study|Other|1|||
156489990|NCT00966979|564889273|FG000|Overall Study|Death|1|||
156489991|NCT00966979|564889273|FG000|Overall Study|Lost to Follow-up|6|||
156489992|NCT00966979|564889273|FG000|Overall Study|Withdrawal by Subject|14|||
156489993|NCT00966979|564889273|FG000|Overall Study|Adverse Event|5|||
156489994|NCT00966979|564889273|FG000|Overall Study|Sponsor terminated early|49|||
156489995|NCT00966979|564889273|FG000|Overall Study|Censored because surgery not done|2|||
156489996|NCT00966979|564889273|FG000|Overall Study|Censored because study device was not implanted|14|||
156489997|NCT00966979|564889273|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
156489998|NCT00943618|564889277|FG000|Overall Study|Lost to Follow-up|38|||
156489999|NCT00943618|564889278|FG001|Overall Study|Lost to Follow-up|48|||
156490000|NCT00943618|564889279|FG002|Overall Study|Lost to Follow-up|20|||
156490001|NCT00943618|564889277|FG000|Overall Study|Discontinued Medication|17|||
156490002|NCT00943618|564889278|FG001|Overall Study|Discontinued Medication|29|||
156490003|NCT00943618|564889279|FG002|Overall Study|Discontinued Medication|11|||
156490004|NCT03713281|564889284|FG000|Overall Study|Lens handling difficuluties|2|||
156490005|NCT03713281|564889284|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
156490006|NCT01990313|564889286|FG000|Overall Study|Lost to Follow-up|1|||
156490007|NCT02412111|564889287|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
156490008|NCT02412111|564889288|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
156490009|NCT02412111|564889289|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
156490010|NCT02412111|564889287|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
156490011|NCT02412111|564889288|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
156490012|NCT02412111|564889289|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
156490013|NCT02412111|564889287|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
156490014|NCT02412111|564889288|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
156490015|NCT02412111|564889289|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
156490016|NCT02412111|564889287|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
156490017|NCT02412111|564889288|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
156490018|NCT02412111|564889289|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
156490019|NCT02412111|564889287|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
156490020|NCT02412111|564889288|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
156490021|NCT02412111|564889289|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
156490022|NCT02412111|564889287|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
156490023|NCT02412111|564889288|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
156490024|NCT02412111|564889289|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
156490025|NCT02412111|564889287|FG000|Active Comparator Period (8 Weeks)|Other|0|||
156490026|NCT02412111|564889288|FG001|Active Comparator Period (8 Weeks)|Other|0|||
156490027|NCT02412111|564889289|FG002|Active Comparator Period (8 Weeks)|Other|2|||
156490028|NCT00837096|564889290|FG000|Overall Study|Physician Decision|1|||
156490029|NCT00837096|564889291|FG001|Overall Study|Physician Decision|1|||
156490030|NCT00837096|564889290|FG000|Overall Study|Not reported|9|||
156490031|NCT00837096|564889291|FG001|Overall Study|Not reported|8|||
156490032|NCT00983905|564889292|FG000|Theophylline Alone|Adverse Event|1|||
156490033|NCT00983905|564889292|FG000|Colchicine Alone|Adverse Event|2|||
156490034|NCT00329550|564889294|FG000|Overall Study|Adverse Event|3|||
156490035|NCT00329550|564889295|FG001|Overall Study|Adverse Event|4|||
156490036|NCT00329550|564889296|FG002|Overall Study|Adverse Event|2|||
156490037|NCT00329550|564889294|FG000|Overall Study|Withdrawal of Consent|1|||
156490038|NCT00329550|564889295|FG001|Overall Study|Withdrawal of Consent|0|||
156490039|NCT00329550|564889296|FG002|Overall Study|Withdrawal of Consent|1|||
156362911|NCT02039674|564428764|FG003|Overall Study|Progressive Disease|7|||
156490040|NCT00329550|564889294|FG000|Overall Study|Due to Relocation|0|||
156490041|NCT00329550|564889295|FG001|Overall Study|Due to Relocation|0|||
156490042|NCT00329550|564889296|FG002|Overall Study|Due to Relocation|1|||
156490043|NCT00494026|564889297|FG000|Overall Study|Sponsor Decision|4|||
156490044|NCT02466243|564889298|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
156490045|NCT02466243|564889299|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
156490046|NCT02466243|564889298|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
156490047|NCT02466243|564889299|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
156490048|NCT02466243|564889298|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
156490049|NCT02466243|564889299|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
156490050|NCT02466243|564889298|FG000|Part B Open-label Treatment Period|Missing|2|||
156490051|NCT02466243|564889299|FG001|Part B Open-label Treatment Period|Missing|2|||
156490052|NCT01649557|564889301|FG000|Overall Study|Lost to Follow-up|5|||
156490053|NCT01649557|564889302|FG001|Overall Study|Lost to Follow-up|0|||
156490054|NCT01649557|564889303|FG002|Overall Study|Lost to Follow-up|3|||
156490055|NCT01649557|564889301|FG000|Overall Study|Adverse Event|7|||
156490056|NCT01649557|564889302|FG001|Overall Study|Adverse Event|5|||
156490057|NCT01649557|564889303|FG002|Overall Study|Adverse Event|1|||
156490058|NCT01649557|564889301|FG000|Overall Study|Met withdrawal criteria|4|||
156490059|NCT01649557|564889302|FG001|Overall Study|Met withdrawal criteria|0|||
156490060|NCT01649557|564889303|FG002|Overall Study|Met withdrawal criteria|0|||
156490061|NCT01649557|564889301|FG000|Overall Study|Physician Decision|8|||
156490062|NCT01649557|564889302|FG001|Overall Study|Physician Decision|2|||
156490063|NCT01649557|564889303|FG002|Overall Study|Physician Decision|1|||
156490064|NCT01649557|564889301|FG000|Overall Study|Withdrawal by Subject|15|||
156490065|NCT01649557|564889302|FG001|Overall Study|Withdrawal by Subject|5|||
156490066|NCT01649557|564889303|FG002|Overall Study|Withdrawal by Subject|4|||
156490067|NCT01649557|564889301|FG000|Overall Study|Protocol deviation|0|||
156490068|NCT01649557|564889302|FG001|Overall Study|Protocol deviation|2|||
156490069|NCT01649557|564889303|FG002|Overall Study|Protocol deviation|0|||
156490070|NCT01649557|564889301|FG000|Overall Study|Lack of Efficacy|5|||
156490071|NCT01649557|564889302|FG001|Overall Study|Lack of Efficacy|0|||
156490072|NCT01649557|564889303|FG002|Overall Study|Lack of Efficacy|0|||
156490073|NCT00875615|564889306|FG000|Overall Study|Withdrawal by Subject|1|||
156490074|NCT00405912|564889308|FG000|Overall Study|Withdrawal by Subject|12|||
156490075|NCT00405912|564889309|FG001|Overall Study|Withdrawal by Subject|11|||
156490076|NCT00405912|564889310|FG002|Overall Study|Withdrawal by Subject|12|||
156490077|NCT00405912|564889308|FG000|Overall Study|Lost to Follow-up|4|||
156490078|NCT00405912|564889309|FG001|Overall Study|Lost to Follow-up|8|||
156490079|NCT00405912|564889310|FG002|Overall Study|Lost to Follow-up|4|||
156490080|NCT03730662|564889316|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
156490081|NCT03730662|564889317|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
156490082|NCT03730662|564889318|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
156490083|NCT03730662|564889319|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
156490084|NCT03730662|564889316|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
156362912|NCT02039674|564428765|FG004|Overall Study|Progressive Disease|9|||
156490085|NCT03730662|564889317|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
156490086|NCT03730662|564889318|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
156490087|NCT03730662|564889319|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
156490088|NCT03730662|564889316|FG000|Treatment Period (52 Weeks)|Death|6|||
156490089|NCT03730662|564889317|FG001|Treatment Period (52 Weeks)|Death|2|||
156490090|NCT03730662|564889318|FG002|Treatment Period (52 Weeks)|Death|2|||
156490091|NCT03730662|564889319|FG003|Treatment Period (52 Weeks)|Death|9|||
156490092|NCT03730662|564889316|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
156490093|NCT03730662|564889317|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
156490094|NCT03730662|564889318|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
156490095|NCT03730662|564889319|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
156490096|NCT03730662|564889316|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
156490097|NCT03730662|564889317|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
156490098|NCT03730662|564889318|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
156490099|NCT03730662|564889319|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
156490100|NCT03730662|564889316|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
156490101|NCT03730662|564889317|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
156490102|NCT03730662|564889318|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
156490103|NCT03730662|564889319|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
156490104|NCT03730662|564889316|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
156490105|NCT03730662|564889317|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
156490106|NCT03730662|564889318|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
156490107|NCT03730662|564889319|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
156490108|NCT03730662|564889316|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
156490109|NCT03730662|564889317|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
156490110|NCT03730662|564889318|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
156490111|NCT03730662|564889319|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
156490112|NCT03730662|564889316|FG000|Variable Treatment Period|Adverse Event|1|||
156490113|NCT03730662|564889317|FG001|Variable Treatment Period|Adverse Event|2|||
156490114|NCT03730662|564889318|FG002|Variable Treatment Period|Adverse Event|0|||
156490115|NCT03730662|564889319|FG003|Variable Treatment Period|Adverse Event|7|||
156490116|NCT03730662|564889316|FG000|Variable Treatment Period|Death|9|||
156490117|NCT03730662|564889317|FG001|Variable Treatment Period|Death|0|||
156490118|NCT03730662|564889318|FG002|Variable Treatment Period|Death|6|||
156362913|NCT02039674|564428766|FG005|Overall Study|Progressive Disease|10|||
156362914|NCT02039674|564428767|FG006|Overall Study|Progressive Disease|1|||
156362915|NCT02039674|564428768|FG007|Overall Study|Progressive Disease|3|||
156362916|NCT02039674|564428769|FG008|Overall Study|Progressive Disease|6|||
156362917|NCT02039674|564428770|FG009|Overall Study|Progressive Disease|4|||
156362918|NCT02039674|564428771|FG010|Overall Study|Progressive Disease|0|||
156362919|NCT02039674|564428772|FG011|Overall Study|Progressive Disease|34|||
156362920|NCT02039674|564428773|FG012|Overall Study|Progressive Disease|34|||
156362921|NCT02039674|564428774|FG013|Overall Study|Progressive Disease|18|||
156362922|NCT02039674|564428761|FG000|Overall Study|Withdrawal by Subject|1|||
156362923|NCT02039674|564428762|FG001|Overall Study|Withdrawal by Subject|2|||
156362924|NCT02039674|564428763|FG002|Overall Study|Withdrawal by Subject|3|||
156362925|NCT02039674|564428764|FG003|Overall Study|Withdrawal by Subject|0|||
156362926|NCT02039674|564428765|FG004|Overall Study|Withdrawal by Subject|1|||
156362927|NCT02039674|564428766|FG005|Overall Study|Withdrawal by Subject|0|||
156362928|NCT02039674|564428767|FG006|Overall Study|Withdrawal by Subject|0|||
156362929|NCT02039674|564428768|FG007|Overall Study|Withdrawal by Subject|0|||
156362930|NCT02039674|564428769|FG008|Overall Study|Withdrawal by Subject|0|||
156362931|NCT02039674|564428770|FG009|Overall Study|Withdrawal by Subject|1|||
156362932|NCT02039674|564428771|FG010|Overall Study|Withdrawal by Subject|1|||
156362933|NCT02039674|564428772|FG011|Overall Study|Withdrawal by Subject|4|||
156362934|NCT02039674|564428773|FG012|Overall Study|Withdrawal by Subject|6|||
156362935|NCT02039674|564428774|FG013|Overall Study|Withdrawal by Subject|2|||
156362936|NCT02039674|564428761|FG000|Overall Study|Clinical Progression|0|||
156362937|NCT02039674|564428762|FG001|Overall Study|Clinical Progression|0|||
156362938|NCT02039674|564428763|FG002|Overall Study|Clinical Progression|0|||
156362939|NCT02039674|564428764|FG003|Overall Study|Clinical Progression|0|||
156362940|NCT02039674|564428765|FG004|Overall Study|Clinical Progression|0|||
156362941|NCT02039674|564428766|FG005|Overall Study|Clinical Progression|0|||
156362942|NCT02039674|564428767|FG006|Overall Study|Clinical Progression|1|||
156362943|NCT02039674|564428768|FG007|Overall Study|Clinical Progression|0|||
156362944|NCT02039674|564428769|FG008|Overall Study|Clinical Progression|0|||
156362945|NCT02039674|564428770|FG009|Overall Study|Clinical Progression|0|||
156362946|NCT02039674|564428771|FG010|Overall Study|Clinical Progression|0|||
156362947|NCT02039674|564428772|FG011|Overall Study|Clinical Progression|0|||
156362948|NCT02039674|564428773|FG012|Overall Study|Clinical Progression|1|||
156362949|NCT02039674|564428774|FG013|Overall Study|Clinical Progression|0|||
156362950|NCT02039674|564428761|FG000|Overall Study|Sponsor Decision|1|||
156362951|NCT02039674|564428762|FG001|Overall Study|Sponsor Decision|1|||
156362952|NCT02039674|564428763|FG002|Overall Study|Sponsor Decision|1|||
156362953|NCT02039674|564428764|FG003|Overall Study|Sponsor Decision|1|||
156362954|NCT02039674|564428765|FG004|Overall Study|Sponsor Decision|1|||
156362955|NCT02039674|564428766|FG005|Overall Study|Sponsor Decision|0|||
156362956|NCT02039674|564428767|FG006|Overall Study|Sponsor Decision|0|||
156362957|NCT02039674|564428768|FG007|Overall Study|Sponsor Decision|0|||
156362958|NCT02039674|564428769|FG008|Overall Study|Sponsor Decision|0|||
156362959|NCT02039674|564428770|FG009|Overall Study|Sponsor Decision|3|||
156362960|NCT02039674|564428771|FG010|Overall Study|Sponsor Decision|0|||
156362961|NCT02039674|564428772|FG011|Overall Study|Sponsor Decision|8|||
156362962|NCT02039674|564428773|FG012|Overall Study|Sponsor Decision|5|||
156362963|NCT02039674|564428774|FG013|Overall Study|Sponsor Decision|0|||
156362964|NCT02039674|564428761|FG000|Overall Study|Other|0|||
156362965|NCT02039674|564428762|FG001|Overall Study|Other|0|||
156362966|NCT02039674|564428763|FG002|Overall Study|Other|0|||
156362967|NCT02039674|564428764|FG003|Overall Study|Other|0|||
156362968|NCT02039674|564428765|FG004|Overall Study|Other|0|||
156362969|NCT02039674|564428766|FG005|Overall Study|Other|0|||
156362970|NCT02039674|564428767|FG006|Overall Study|Other|0|||
156362971|NCT02039674|564428768|FG007|Overall Study|Other|0|||
156362972|NCT02039674|564428769|FG008|Overall Study|Other|0|||
156362973|NCT02039674|564428770|FG009|Overall Study|Other|0|||
156362974|NCT02039674|564428771|FG010|Overall Study|Other|0|||
156362975|NCT02039674|564428772|FG011|Overall Study|Other|0|||
156362976|NCT02039674|564428773|FG012|Overall Study|Other|1|||
156362977|NCT02039674|564428774|FG013|Overall Study|Other|0|||
156362978|NCT01408030|564428775|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
156362979|NCT01408030|564428776|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
156362980|NCT01408030|564428777|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
156362981|NCT01408030|564428778|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
156362982|NCT01408030|564428775|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
156362983|NCT01408030|564428776|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
156362984|NCT01408030|564428777|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
156362985|NCT01408030|564428778|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
156362986|NCT01408030|564428775|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
156362987|NCT01408030|564428776|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
156362988|NCT01408030|564428777|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
156362989|NCT01408030|564428778|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
156362990|NCT01408030|564428775|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
156362991|NCT01408030|564428776|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
156362992|NCT01408030|564428777|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
156362993|NCT01408030|564428778|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
156362994|NCT01408030|564428775|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
156362995|NCT01408030|564428776|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
156362996|NCT01408030|564428777|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
156362997|NCT01408030|564428778|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
156362998|NCT01408030|564428775|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
156362999|NCT01408030|564428776|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
156363000|NCT01408030|564428777|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
156363001|NCT01408030|564428778|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
156363002|NCT01408030|564428775|FG000|Observation Phase (Off Drug)|Other|1|||
156363003|NCT01408030|564428776|FG001|Observation Phase (Off Drug)|Other|1|||
156363004|NCT01408030|564428777|FG002|Observation Phase (Off Drug)|Other|1|||
156363005|NCT01408030|564428778|FG003|Observation Phase (Off Drug)|Other|1|||
156363006|NCT03717480|564428779|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
156363007|NCT01894152|564428780|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
156363008|NCT01774786|564428781|FG000|Overall Study|Death|300|||
156363009|NCT01774786|564428782|FG001|Overall Study|Death|319|||
156363010|NCT01774786|564428781|FG000|Overall Study|Lost to Follow-up|6|||
156363011|NCT01774786|564428782|FG001|Overall Study|Lost to Follow-up|7|||
156363012|NCT01774786|564428781|FG000|Overall Study|Withdrawal by Subject|18|||
156363013|NCT01774786|564428782|FG001|Overall Study|Withdrawal by Subject|14|||
156363014|NCT01774786|564428781|FG000|Overall Study|Physician Decision|2|||
156363015|NCT01774786|564428782|FG001|Overall Study|Physician Decision|0|||
156363016|NCT01774786|564428781|FG000|Overall Study|Non-compliance|0|||
156363017|NCT01774786|564428782|FG001|Overall Study|Non-compliance|1|||
156363018|NCT01774786|564428781|FG000|Overall Study|Reason Not Specified|2|||
156363019|NCT01774786|564428782|FG001|Overall Study|Reason Not Specified|5|||
156363020|NCT02965703|564428787|FG000|Overall Study|Withdrawal by Subject|6|||
156363021|NCT02965703|564428788|FG001|Overall Study|Withdrawal by Subject|3|||
156363022|NCT02965703|564428789|FG002|Overall Study|Withdrawal by Subject|1|||
156363023|NCT02965703|564428787|FG000|Overall Study|Protocol Violation|1|||
156363024|NCT02965703|564428788|FG001|Overall Study|Protocol Violation|0|||
156363025|NCT02965703|564428789|FG002|Overall Study|Protocol Violation|0|||
156363026|NCT02965703|564428787|FG000|Overall Study|Adverse Event|1|||
156363027|NCT02965703|564428788|FG001|Overall Study|Adverse Event|1|||
156363028|NCT02965703|564428789|FG002|Overall Study|Adverse Event|0|||
156363029|NCT02965703|564428787|FG000|Overall Study|Lost to Follow-up|2|||
156363030|NCT02965703|564428788|FG001|Overall Study|Lost to Follow-up|1|||
156363031|NCT02965703|564428789|FG002|Overall Study|Lost to Follow-up|1|||
156363032|NCT02081079|564428790|FG000|Overall Study|Lack of Efficacy|3|||
156363033|NCT02081079|564428791|FG001|Overall Study|Lack of Efficacy|2|||
156363034|NCT02081079|564428790|FG000|Overall Study|Lost to Follow-up|1|||
156363035|NCT02081079|564428791|FG001|Overall Study|Lost to Follow-up|0|||
156363036|NCT01886833|564430789|FG000|Overall Study|IgA not available from both periods|204|||
156363037|NCT01454726|564430790|FG000|Overall Study|Withdrawal by Subject|0|||
156363038|NCT01454726|564430791|FG001|Overall Study|Withdrawal by Subject|1|||
156363039|NCT04033003|564430794|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
156363040|NCT04033003|564430795|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
156363041|NCT04033003|564430794|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
156363042|NCT04033003|564430795|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
156363043|NCT04033003|564430794|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
156363044|NCT04033003|564430795|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
156363045|NCT04033003|564430794|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
156363046|NCT04033003|564430795|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
156363047|NCT04033003|564430794|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
156363048|NCT04033003|564430795|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
156363049|NCT04033003|564430794|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
156363050|NCT04033003|564430795|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
156363051|NCT04033003|564430794|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
156363052|NCT04033003|564430795|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
156363053|NCT04033003|564430794|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
156363054|NCT04033003|564430795|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
156363055|NCT04033003|564430794|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
156363056|NCT04033003|564430795|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
156363057|NCT04033003|564430794|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
156363058|NCT04033003|564430795|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
156363059|NCT04033003|564430794|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
156363060|NCT04033003|564430795|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
156363061|NCT04033003|564430794|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
156363062|NCT04033003|564430795|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
156363063|NCT04033003|564430794|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
156363064|NCT04033003|564430795|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
156363065|NCT02919670|564430796|FG000|Overall Study|Only 17 participants met compliance|43|||
156363066|NCT02919670|564430797|FG001|Overall Study|Only 17 participants met compliance|39|||
156363067|NCT01714310|564430798|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
156363068|NCT01714310|564430799|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
156363069|NCT01714310|564430800|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
156363070|NCT01714310|564430798|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
156363071|NCT01714310|564430799|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
156363072|NCT01714310|564430800|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
156363073|NCT01714310|564430798|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
156363074|NCT01714310|564430799|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
156363075|NCT01714310|564430800|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
156363076|NCT01714310|564430798|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
156363077|NCT01714310|564430799|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
156363078|NCT01714310|564430800|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
156363079|NCT01641367|564430801|FG000|Cohorts|Death|18|||
156363080|NCT01641367|564430802|FG001|Cohorts|Death|1|||
156363081|NCT01641367|564430803|FG002|Cohorts|Death|2|||
156363082|NCT01641367|564430804|FG003|Cohorts|Death|0|||
156363083|NCT01641367|564430805|FG004|Cohorts|Death|1|||
156363084|NCT01641367|564430806|FG005|Cohorts|Death|1|||
156363085|NCT01641367|564430807|FG006|Cohorts|Death|0|||
156363086|NCT01641367|564430808|FG007|Cohorts|Death|0|||
156363087|NCT01641367|564430801|FG000|Cohorts|Lost to Follow-up|16|||
156363088|NCT01641367|564430802|FG001|Cohorts|Lost to Follow-up|0|||
156363089|NCT01641367|564430803|FG002|Cohorts|Lost to Follow-up|2|||
156363090|NCT01641367|564430804|FG003|Cohorts|Lost to Follow-up|0|||
156363091|NCT01641367|564430805|FG004|Cohorts|Lost to Follow-up|2|||
156363092|NCT01641367|564430806|FG005|Cohorts|Lost to Follow-up|0|||
156363093|NCT01641367|564430807|FG006|Cohorts|Lost to Follow-up|0|||
156363094|NCT01641367|564430808|FG007|Cohorts|Lost to Follow-up|0|||
156363095|NCT01641367|564430801|FG000|Randomized Adherence Intervention|Death|0|||
156363096|NCT01641367|564430802|FG001|Randomized Adherence Intervention|Death|0|||
156363097|NCT01641367|564430803|FG002|Randomized Adherence Intervention|Death|0|||
156363098|NCT01641367|564430804|FG003|Randomized Adherence Intervention|Death|0|||
156363099|NCT01641367|564430805|FG004|Randomized Adherence Intervention|Death|0|||
156363100|NCT01641367|564430806|FG005|Randomized Adherence Intervention|Death|0|||
156490119|NCT03730662|564889319|FG003|Variable Treatment Period|Death|26|||
156490120|NCT03730662|564889316|FG000|Variable Treatment Period|Lost to Follow-up|2|||
156490121|NCT03730662|564889317|FG001|Variable Treatment Period|Lost to Follow-up|1|||
156490122|NCT03730662|564889318|FG002|Variable Treatment Period|Lost to Follow-up|4|||
156490123|NCT03730662|564889319|FG003|Variable Treatment Period|Lost to Follow-up|11|||
156490124|NCT03730662|564889316|FG000|Variable Treatment Period|Personal Reason|0|||
156490125|NCT03730662|564889317|FG001|Variable Treatment Period|Personal Reason|2|||
156490126|NCT03730662|564889318|FG002|Variable Treatment Period|Personal Reason|1|||
156490127|NCT03730662|564889319|FG003|Variable Treatment Period|Personal Reason|6|||
156490128|NCT03730662|564889316|FG000|Variable Treatment Period|Physician Decision|0|||
156490129|NCT03730662|564889317|FG001|Variable Treatment Period|Physician Decision|0|||
156490130|NCT03730662|564889318|FG002|Variable Treatment Period|Physician Decision|0|||
156490131|NCT03730662|564889319|FG003|Variable Treatment Period|Physician Decision|3|||
156490132|NCT03730662|564889316|FG000|Variable Treatment Period|Protocol Violation|0|||
156490133|NCT03730662|564889317|FG001|Variable Treatment Period|Protocol Violation|1|||
156490134|NCT03730662|564889318|FG002|Variable Treatment Period|Protocol Violation|1|||
156490135|NCT03730662|564889319|FG003|Variable Treatment Period|Protocol Violation|1|||
156490136|NCT03730662|564889316|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
156490137|NCT03730662|564889317|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
156490138|NCT03730662|564889318|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
156490139|NCT03730662|564889319|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
156490140|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
156490141|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
156490142|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
156490143|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
156490144|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Death|0|||
156490145|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Death|1|||
156490146|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
156490147|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
156490148|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
156490149|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
156490150|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
156490151|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
156490152|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
156545605|NCT00640328|565091658|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
156363101|NCT01641367|564430807|FG006|Randomized Adherence Intervention|Death|11|||
156363102|NCT01641367|564430808|FG007|Randomized Adherence Intervention|Death|12|||
156490153|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
156490154|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
156490155|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
156490156|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
156490157|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
156490158|NCT01309243|564889320|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
156490159|NCT01309243|564889321|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
156490160|NCT01309243|564889320|FG000|Extension Phase|Lost to Follow-up|6|||
156490161|NCT01309243|564889321|FG001|Extension Phase|Lost to Follow-up|0|||
156490162|NCT00632931|564889322|FG000|Part 1, Period 1|Protocol Violation|1|||
156490163|NCT00632931|564889323|FG001|Part 1, Period 1|Protocol Violation|0|||
156490164|NCT00632931|564889324|FG002|Part 1, Period 1|Protocol Violation|0|||
156490165|NCT00632931|564889322|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
156490166|NCT00632931|564889323|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
156490167|NCT00632931|564889324|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
156490168|NCT00632931|564889322|FG000|Part 2|Adverse Event|0|||
156490169|NCT00632931|564889323|FG001|Part 2|Adverse Event|0|||
156490170|NCT00632931|564889324|FG002|Part 2|Adverse Event|3|||
156490171|NCT00632931|564889322|FG000|Part 2|Death|0|||
156490172|NCT00632931|564889323|FG001|Part 2|Death|0|||
156490173|NCT00632931|564889324|FG002|Part 2|Death|1|||
156490174|NCT00632931|564889322|FG000|Part 2|Lack of Efficacy|0|||
156490175|NCT00632931|564889323|FG001|Part 2|Lack of Efficacy|0|||
156490176|NCT00632931|564889324|FG002|Part 2|Lack of Efficacy|17|||
156490177|NCT00632931|564889322|FG000|Part 2|Withdrawal by Subject|0|||
156490178|NCT00632931|564889323|FG001|Part 2|Withdrawal by Subject|0|||
156490179|NCT00632931|564889324|FG002|Part 2|Withdrawal by Subject|3|||
156490180|NCT00833898|564889325|FG000|Overall Study|Withdrawal by Subject|33|||
156490181|NCT00833898|564889326|FG001|Overall Study|Withdrawal by Subject|27|||
156490182|NCT00833898|564889325|FG000|Overall Study|Lost to Follow-up|7|||
156490183|NCT00833898|564889326|FG001|Overall Study|Lost to Follow-up|7|||
156490184|NCT00833898|564889325|FG000|Overall Study|Patient did not receive transplant|0|||
156490185|NCT00833898|564889326|FG001|Overall Study|Patient did not receive transplant|2|||
156490186|NCT05153499|564889327|FG000|Overall Study|Withdrawal by Subject|1|||
156490187|NCT05153499|564889328|FG001|Overall Study|Withdrawal by Subject|0|||
156490188|NCT05153499|564889327|FG000|Overall Study|Clinical Hold|1|||
156490189|NCT05153499|564889328|FG001|Overall Study|Clinical Hold|0|||
156490190|NCT05153499|564889327|FG000|Overall Study|Study Termination|6|||
156490191|NCT05153499|564889328|FG001|Overall Study|Study Termination|5|||
156490192|NCT05109117|564889331|FG000|Overall Study|Lost to Follow-up|1|||
156490193|NCT05109117|564889331|FG000|Overall Study|Discontinued for non-compliance|1|||
156490194|NCT03168425|564889334|FG000|Overall Study|Lost to Follow-up|5|||
156490195|NCT03168425|564889335|FG001|Overall Study|Lost to Follow-up|8|||
156490196|NCT03168425|564889334|FG000|Overall Study|unable to confirm post op opioids|2|||
156490197|NCT03168425|564889335|FG001|Overall Study|unable to confirm post op opioids|3|||
156490198|NCT01960114|564889336|FG000|Overall Study|Adverse Event|1|||
156490199|NCT01960114|564889337|FG001|Overall Study|Adverse Event|0|||
156490200|NCT01960114|564889336|FG000|Overall Study|Could not swallow study medication|0|||
156490201|NCT01960114|564889337|FG001|Overall Study|Could not swallow study medication|1|||
156490202|NCT00468858|564889343|FG000|Overall Study|Adverse Event|0|||
156490203|NCT00468858|564889344|FG001|Overall Study|Adverse Event|1|||
156490204|NCT00468858|564889345|FG002|Overall Study|Adverse Event|0|||
156490205|NCT00468858|564889343|FG000|Overall Study|Withdrawal by Subject|7|||
156490206|NCT00468858|564889344|FG001|Overall Study|Withdrawal by Subject|4|||
156490207|NCT00468858|564889345|FG002|Overall Study|Withdrawal by Subject|5|||
156490208|NCT00468858|564889343|FG000|Overall Study|Relocation|1|||
156490209|NCT00468858|564889344|FG001|Overall Study|Relocation|3|||
156490210|NCT00468858|564889345|FG002|Overall Study|Relocation|3|||
156490211|NCT00468858|564889343|FG000|Overall Study|Lost to Follow-up|1|||
156490212|NCT00468858|564889344|FG001|Overall Study|Lost to Follow-up|2|||
156490213|NCT00468858|564889345|FG002|Overall Study|Lost to Follow-up|5|||
156490214|NCT00468858|564889343|FG000|Overall Study|Other|0|||
156490215|NCT00468858|564889344|FG001|Overall Study|Other|0|||
156490216|NCT00468858|564889345|FG002|Overall Study|Other|1|||
156490217|NCT00225277|564889348|FG000|Overall Study|Adverse Event|30|||
156490218|NCT00225277|564889349|FG001|Overall Study|Adverse Event|34|||
156490219|NCT00225277|564889348|FG000|Overall Study|Lack of Efficacy|4|||
156490220|NCT00225277|564889349|FG001|Overall Study|Lack of Efficacy|1|||
156490221|NCT00225277|564889348|FG000|Overall Study|Lost to Follow-up|4|||
156490222|NCT00225277|564889349|FG001|Overall Study|Lost to Follow-up|6|||
156490223|NCT00225277|564889348|FG000|Overall Study|Physician Decision|6|||
156490224|NCT00225277|564889349|FG001|Overall Study|Physician Decision|8|||
156490225|NCT00225277|564889348|FG000|Overall Study|Protocol Violation|6|||
156490226|NCT00225277|564889349|FG001|Overall Study|Protocol Violation|3|||
156490227|NCT00225277|564889348|FG000|Overall Study|Withdrawal by Subject|40|||
156490228|NCT00225277|564889349|FG001|Overall Study|Withdrawal by Subject|34|||
156490229|NCT00225277|564889348|FG000|Overall Study|Other|7|||
156490230|NCT00225277|564889349|FG001|Overall Study|Other|9|||
156490231|NCT01177137|564889352|FG000|Overall Study|Withdrawal by Subject|10|||
156490232|NCT01177137|564889353|FG001|Overall Study|Withdrawal by Subject|10|||
156490233|NCT01177137|564889354|FG002|Overall Study|Withdrawal by Subject|2|||
156490234|NCT00818519|564889356|FG000|Overall Study|Adverse Event|2|||
156490235|NCT00818519|564889357|FG001|Overall Study|Adverse Event|2|||
156490236|NCT00818519|564889356|FG000|Overall Study|Lost to Follow-up|4|||
156490237|NCT00818519|564889357|FG001|Overall Study|Lost to Follow-up|6|||
156490238|NCT00818519|564889356|FG000|Overall Study|Protocol Violation|2|||
156490239|NCT00818519|564889357|FG001|Overall Study|Protocol Violation|1|||
156490240|NCT00818519|564889356|FG000|Overall Study|Pregnancy|0|||
156490241|NCT00818519|564889357|FG001|Overall Study|Pregnancy|1|||
156490242|NCT00818519|564889356|FG000|Overall Study|Withdrawal by Subject|4|||
156490243|NCT00818519|564889357|FG001|Overall Study|Withdrawal by Subject|9|||
156490244|NCT00818519|564889356|FG000|Overall Study|participant recovered completely|1|||
156490245|NCT00818519|564889357|FG001|Overall Study|participant recovered completely|0|||
156490246|NCT00818519|564889356|FG000|Overall Study|participant will leave for long tme|1|||
156490247|NCT00818519|564889357|FG001|Overall Study|participant will leave for long tme|0|||
156490248|NCT02820298|564889360|FG000|Overall Study|Withdrawal by Subject|0|||
156490249|NCT02820298|564889361|FG001|Overall Study|Withdrawal by Subject|1|||
156490250|NCT02820298|564889360|FG000|Overall Study|Physician Decision|1|||
156490251|NCT02820298|564889361|FG001|Overall Study|Physician Decision|0|||
156490252|NCT02820298|564889360|FG000|Overall Study|Protocol Violation|0|||
156490253|NCT02820298|564889361|FG001|Overall Study|Protocol Violation|1|||
156490254|NCT03406507|564889362|FG000|Extension Period|Lack of Efficacy|0|||
156490255|NCT03406507|564889363|FG001|Extension Period|Lack of Efficacy|1|||
156490256|NCT01804140|564889366|FG000|Overall Study|No sampling or biopsy procedures done|114|||
156490257|NCT00547300|564889367|FG000|Overall Study|Study was Administratively Terminated|25|||
156490258|NCT00547300|564889368|FG001|Overall Study|Study was Administratively Terminated|24|||
156490259|NCT00547300|564889367|FG000|Overall Study|Did not Meet Entry Criteria|0|||
156490260|NCT00547300|564889368|FG001|Overall Study|Did not Meet Entry Criteria|2|||
156490261|NCT02965599|564889371|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
156490262|NCT02965599|564889372|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
156490263|NCT04435522|564889376|FG000|Overall Study|Withdrawal by Subject|2|||
156490264|NCT02799745|564889377|FG000|Overall Study|Participant moved out of state|1|||
156490265|NCT02799745|564889378|FG001|Overall Study|Participant moved out of state|0|||
156490266|NCT02799745|564889377|FG000|Overall Study|Discontinued due to planned surgery|1|||
156490267|NCT02799745|564889378|FG001|Overall Study|Discontinued due to planned surgery|0|||
156490268|NCT02799745|564889377|FG000|Overall Study|Withdrawal by Subject|16|||
156490269|NCT02799745|564889378|FG001|Overall Study|Withdrawal by Subject|25|||
156490270|NCT02799745|564889377|FG000|Overall Study|Protocol Deviation|4|||
156490271|NCT02799745|564889378|FG001|Overall Study|Protocol Deviation|5|||
156490272|NCT02799745|564889377|FG000|Overall Study|Progressive Disease|28|||
156490273|NCT02799745|564889378|FG001|Overall Study|Progressive Disease|38|||
156490274|NCT02799745|564889377|FG000|Overall Study|Lost to Follow-up|3|||
156490275|NCT02799745|564889378|FG001|Overall Study|Lost to Follow-up|2|||
156490276|NCT02799745|564889377|FG000|Overall Study|Death|3|||
156490277|NCT02799745|564889378|FG001|Overall Study|Death|0|||
156490278|NCT02799745|564889377|FG000|Overall Study|Adverse Event|0|||
156490279|NCT02799745|564889378|FG001|Overall Study|Adverse Event|1|||
156363103|NCT01641367|564430801|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
156363104|NCT01641367|564430802|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
156363105|NCT01641367|564430803|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
156363106|NCT01641367|564430804|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
156363107|NCT01641367|564430805|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
156363108|NCT01641367|564430806|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
156363109|NCT01641367|564430807|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
156363110|NCT01641367|564430808|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
156363111|NCT00826267|564430809|FG000|Overall Study|Other Adverse Event|1|||
156363112|NCT00826267|564430810|FG001|Overall Study|Other Adverse Event|0|||
156363113|NCT00826267|564430811|FG002|Overall Study|Other Adverse Event|0|||
156363114|NCT01675882|564430814|FG000|Overall Study|Adverse Event|0|||
156363115|NCT01675882|564430815|FG001|Overall Study|Adverse Event|2|||
156363116|NCT01675882|564430816|FG002|Overall Study|Adverse Event|1|||
156363117|NCT01675882|564430817|FG003|Overall Study|Adverse Event|0|||
156363118|NCT01675882|564430814|FG000|Overall Study|Participant unwilling to continue|2|||
156363119|NCT01675882|564430815|FG001|Overall Study|Participant unwilling to continue|4|||
156363120|NCT01675882|564430816|FG002|Overall Study|Participant unwilling to continue|2|||
156363121|NCT01675882|564430817|FG003|Overall Study|Participant unwilling to continue|1|||
156363122|NCT01675882|564430814|FG000|Overall Study|Lost to Follow-up|0|||
156363123|NCT01675882|564430815|FG001|Overall Study|Lost to Follow-up|1|||
156363124|NCT01675882|564430816|FG002|Overall Study|Lost to Follow-up|0|||
156363125|NCT01675882|564430817|FG003|Overall Study|Lost to Follow-up|0|||
156363126|NCT01675882|564430814|FG000|Overall Study|Non-compliance|0|||
156363127|NCT01675882|564430815|FG001|Overall Study|Non-compliance|0|||
156363128|NCT01675882|564430816|FG002|Overall Study|Non-compliance|0|||
156363129|NCT01675882|564430817|FG003|Overall Study|Non-compliance|1|||
156363130|NCT01604343|564430818|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
156363131|NCT01604343|564430819|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
156363132|NCT01604343|564430820|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
156363133|NCT01604343|564430821|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
156363134|NCT01604343|564430822|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
156363135|NCT01604343|564430818|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
156363136|NCT01604343|564430819|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
156363137|NCT01604343|564430820|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
156363138|NCT01604343|564430821|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
156363139|NCT01604343|564430822|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
156363140|NCT01604343|564430818|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
156363141|NCT01604343|564430819|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
156363142|NCT01604343|564430820|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
156363143|NCT01604343|564430821|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
156363144|NCT01604343|564430822|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
156363145|NCT01604343|564430818|FG000|Prior to W52 Administration(Through W52)|Death|5|||
156363146|NCT01604343|564430819|FG001|Prior to W52 Administration(Through W52)|Death|0|||
156363147|NCT01604343|564430820|FG002|Prior to W52 Administration(Through W52)|Death|2|||
156363148|NCT01604343|564430821|FG003|Prior to W52 Administration(Through W52)|Death|0|||
156363149|NCT01604343|564430822|FG004|Prior to W52 Administration(Through W52)|Death|4|||
156363150|NCT01604343|564430818|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
156363151|NCT01604343|564430819|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
156363152|NCT01604343|564430820|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
156363153|NCT01604343|564430821|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
156363154|NCT01604343|564430822|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
156363155|NCT01604343|564430818|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
156363156|NCT01604343|564430819|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
156490280|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
156363157|NCT01604343|564430820|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
156363158|NCT01604343|564430821|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
156363159|NCT01604343|564430822|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
156363160|NCT01604343|564430818|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
156363161|NCT01604343|564430819|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
156363162|NCT01604343|564430820|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
156363163|NCT01604343|564430821|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
156363164|NCT01604343|564430822|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
156363165|NCT01604343|564430818|FG000|Prior to W52 Administration(Through W52)|Other|15|||
156363166|NCT01604343|564430819|FG001|Prior to W52 Administration(Through W52)|Other|0|||
156363167|NCT01604343|564430820|FG002|Prior to W52 Administration(Through W52)|Other|10|||
156363168|NCT01604343|564430821|FG003|Prior to W52 Administration(Through W52)|Other|0|||
156363169|NCT01604343|564430822|FG004|Prior to W52 Administration(Through W52)|Other|6|||
156363170|NCT01604343|564430818|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
156363171|NCT01604343|564430819|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
156363172|NCT01604343|564430820|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
156363173|NCT01604343|564430821|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
156363174|NCT01604343|564430822|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
156363175|NCT01604343|564430818|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
156363176|NCT01604343|564430819|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
156363177|NCT01604343|564430820|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
156363178|NCT01604343|564430821|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
156363179|NCT01604343|564430822|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
156363180|NCT01604343|564430818|FG000|Week 52 to Week 104|Adverse Event|0|||
156363181|NCT01604343|564430819|FG001|Week 52 to Week 104|Adverse Event|12|||
156363182|NCT01604343|564430820|FG002|Week 52 to Week 104|Adverse Event|26|||
156363183|NCT01604343|564430821|FG003|Week 52 to Week 104|Adverse Event|21|||
156363184|NCT01604343|564430822|FG004|Week 52 to Week 104|Adverse Event|27|||
156363185|NCT01604343|564430818|FG000|Week 52 to Week 104|Death|0|||
156363186|NCT01604343|564430819|FG001|Week 52 to Week 104|Death|4|||
156363187|NCT01604343|564430820|FG002|Week 52 to Week 104|Death|2|||
156363188|NCT01604343|564430821|FG003|Week 52 to Week 104|Death|5|||
156363189|NCT01604343|564430822|FG004|Week 52 to Week 104|Death|0|||
156363190|NCT01604343|564430818|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
156363191|NCT01604343|564430819|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
156363192|NCT01604343|564430820|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
156363193|NCT01604343|564430821|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
156363194|NCT01604343|564430822|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
156363195|NCT01604343|564430818|FG000|Week 52 to Week 104|Physician Decision|0|||
156363196|NCT01604343|564430819|FG001|Week 52 to Week 104|Physician Decision|1|||
156363197|NCT01604343|564430820|FG002|Week 52 to Week 104|Physician Decision|0|||
156363198|NCT01604343|564430821|FG003|Week 52 to Week 104|Physician Decision|0|||
156363199|NCT01604343|564430822|FG004|Week 52 to Week 104|Physician Decision|2|||
156363200|NCT01604343|564430818|FG000|Week 52 to Week 104|Pregnancy|0|||
156363201|NCT01604343|564430819|FG001|Week 52 to Week 104|Pregnancy|0|||
156363202|NCT01604343|564430820|FG002|Week 52 to Week 104|Pregnancy|1|||
156363203|NCT01604343|564430821|FG003|Week 52 to Week 104|Pregnancy|2|||
156363204|NCT01604343|564430822|FG004|Week 52 to Week 104|Pregnancy|1|||
156363205|NCT01604343|564430818|FG000|Week 52 to Week 104|Other|0|||
156363206|NCT01604343|564430819|FG001|Week 52 to Week 104|Other|11|||
156363207|NCT01604343|564430820|FG002|Week 52 to Week 104|Other|11|||
156363208|NCT01604343|564430821|FG003|Week 52 to Week 104|Other|6|||
156363209|NCT01604343|564430822|FG004|Week 52 to Week 104|Other|3|||
156363210|NCT01604343|564430818|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
156363211|NCT01604343|564430819|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
156363212|NCT01604343|564430820|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
156363213|NCT01604343|564430821|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
156363214|NCT01604343|564430822|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
156363215|NCT01604343|564430818|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
156363216|NCT01604343|564430819|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
156490281|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
156490282|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
156490283|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
156363217|NCT01604343|564430820|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
156363218|NCT01604343|564430821|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
156363219|NCT01604343|564430822|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
156363220|NCT01604343|564430818|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
156363221|NCT01604343|564430819|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
156363222|NCT01604343|564430820|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
156363223|NCT01604343|564430821|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
156363224|NCT01604343|564430822|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
156545606|NCT00640328|565091659|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
156545607|NCT00640328|565091654|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
156545608|NCT00640328|565091655|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
156545609|NCT00640328|565091656|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
156545610|NCT00640328|565091657|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
156545611|NCT00640328|565091658|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
156545612|NCT00640328|565091659|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
156545613|NCT00640328|565091654|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
156363225|NCT00850200|564430823|FG000|Overall Study|Physician Decision|2|||
156363226|NCT00850200|564430823|FG000|Overall Study|Did not recieve treatment|2|||
156363227|NCT00850200|564430823|FG000|Overall Study|Withdrawal by Subject|1|||
156363228|NCT02129803|564430837|FG000|Overall Study|Protocol Violation|4|||
156363229|NCT02129803|564430838|FG001|Overall Study|Protocol Violation|0|||
156363230|NCT02129803|564430837|FG000|Overall Study|Physician Decision|0|||
156363231|NCT02129803|564430838|FG001|Overall Study|Physician Decision|1|||
156363232|NCT02129803|564430837|FG000|Overall Study|Difficulty sleeping|1|||
156363233|NCT02129803|564430838|FG001|Overall Study|Difficulty sleeping|0|||
156363234|NCT02129803|564430837|FG000|Overall Study|Morning headache|0|||
156363235|NCT02129803|564430838|FG001|Overall Study|Morning headache|1|||
156363236|NCT02129803|564430837|FG000|Overall Study|Withdrawal by Subject|1|||
156363237|NCT02129803|564430838|FG001|Overall Study|Withdrawal by Subject|1|||
156363238|NCT02689258|564430842|FG000|Overall Study|Subject Non-Compliance|0|||
156363239|NCT02689258|564430843|FG001|Overall Study|Subject Non-Compliance|1|||
156363240|NCT02689258|564430844|FG002|Overall Study|Subject Non-Compliance|0|||
156363241|NCT02689258|564430845|FG003|Overall Study|Subject Non-Compliance|0|||
156363242|NCT02689258|564430846|FG004|Overall Study|Subject Non-Compliance|0|||
156363243|NCT02689258|564430847|FG005|Overall Study|Subject Non-Compliance|0|||
156490284|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
156490285|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
156490286|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
156490287|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
156490288|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
156490289|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
156490290|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
156490291|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
156490292|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
156490293|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
156490294|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
156490295|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
156490296|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
156490297|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
156490298|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
156490299|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
156490300|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
156490301|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
156490302|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
156490303|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
156490304|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
156490305|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
156490306|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
156490307|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
156490308|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
156490309|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
156490310|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
156490311|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
156490312|NCT00092521|564890748|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
156490313|NCT00092521|564890749|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
156490314|NCT00092521|564890750|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
156490315|NCT00092521|564890751|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
156490316|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
156490317|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
156490318|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
156545614|NCT00640328|565091655|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
156545615|NCT00640328|565091656|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
156363244|NCT02689258|564430848|FG006|Overall Study|Subject Non-Compliance|0|||
156490319|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
156363245|NCT02689258|564430849|FG007|Overall Study|Subject Non-Compliance|0|||
156363246|NCT02689258|564430850|FG008|Overall Study|Subject Non-Compliance|0|||
156363247|NCT02689258|564430851|FG009|Overall Study|Subject Non-Compliance|0|||
156363248|NCT02689258|564430852|FG010|Overall Study|Subject Non-Compliance|0|||
156363249|NCT02689258|564430853|FG011|Overall Study|Subject Non-Compliance|0|||
156363250|NCT02689258|564430842|FG000|Overall Study|Subject Refusal to Continue|0|||
156363251|NCT02689258|564430843|FG001|Overall Study|Subject Refusal to Continue|1|||
156363252|NCT02689258|564430844|FG002|Overall Study|Subject Refusal to Continue|0|||
156363253|NCT02689258|564430845|FG003|Overall Study|Subject Refusal to Continue|0|||
156363254|NCT02689258|564430846|FG004|Overall Study|Subject Refusal to Continue|0|||
156363255|NCT02689258|564430847|FG005|Overall Study|Subject Refusal to Continue|0|||
156363256|NCT02689258|564430848|FG006|Overall Study|Subject Refusal to Continue|0|||
156363257|NCT02689258|564430849|FG007|Overall Study|Subject Refusal to Continue|0|||
156363258|NCT02689258|564430850|FG008|Overall Study|Subject Refusal to Continue|1|||
156363259|NCT02689258|564430851|FG009|Overall Study|Subject Refusal to Continue|0|||
156363260|NCT02689258|564430852|FG010|Overall Study|Subject Refusal to Continue|0|||
156363261|NCT02689258|564430853|FG011|Overall Study|Subject Refusal to Continue|1|||
156363262|NCT02689258|564430842|FG000|Overall Study|Other|0|||
156363263|NCT02689258|564430843|FG001|Overall Study|Other|2|||
156363264|NCT02689258|564430844|FG002|Overall Study|Other|0|||
156363265|NCT02689258|564430845|FG003|Overall Study|Other|0|||
156363266|NCT02689258|564430846|FG004|Overall Study|Other|1|||
156363267|NCT02689258|564430847|FG005|Overall Study|Other|0|||
156363268|NCT02689258|564430848|FG006|Overall Study|Other|0|||
156363269|NCT02689258|564430849|FG007|Overall Study|Other|0|||
156363270|NCT02689258|564430850|FG008|Overall Study|Other|1|||
156363271|NCT02689258|564430851|FG009|Overall Study|Other|0|||
156363272|NCT02689258|564430852|FG010|Overall Study|Other|0|||
156363273|NCT02689258|564430853|FG011|Overall Study|Other|0|||
156363274|NCT02159521|564430855|FG000|Overall Study|Enrolled but not treated|3|||
156363275|NCT02159521|564430855|FG000|Overall Study|Withdrawal by Subject|7|||
156363276|NCT02159521|564430855|FG000|Overall Study|Lost to Follow-up|6|||
156363277|NCT02159521|564430855|FG000|Overall Study|Death|1|||
156363278|NCT02159521|564430855|FG000|Overall Study|Other than specified|1|||
156363279|NCT04753164|564430858|FG000|Overall Study|Adverse Event|0|||
156363280|NCT04753164|564430859|FG001|Overall Study|Adverse Event|2|||
156363281|NCT04753164|564430858|FG000|Overall Study|Withdrawal by Subject|9|||
156363282|NCT04753164|564430859|FG001|Overall Study|Withdrawal by Subject|7|||
156363283|NCT04753164|564430858|FG000|Overall Study|Lost to Follow-up|6|||
156363284|NCT04753164|564430859|FG001|Overall Study|Lost to Follow-up|6|||
156363285|NCT04753164|564430858|FG000|Overall Study|Other|12|||
156363286|NCT04753164|564430859|FG001|Overall Study|Other|5|||
156363287|NCT02871739|564430860|FG000|Overall Study|Lost to Follow-up|3|||
156363288|NCT02871739|564430861|FG001|Overall Study|Lost to Follow-up|2|||
156363289|NCT02871739|564430862|FG002|Overall Study|Lost to Follow-up|0|||
156363290|NCT02871739|564430863|FG003|Overall Study|Lost to Follow-up|2|||
156363291|NCT02907359|564430864|FG000|Overall Study|Death|234|||
156363292|NCT02907359|564430865|FG001|Overall Study|Death|117|||
156363293|NCT02907359|564430864|FG000|Overall Study|Withdrawal by Subject|6|||
156363294|NCT02907359|564430865|FG001|Overall Study|Withdrawal by Subject|11|||
156363295|NCT02907359|564430864|FG000|Overall Study|Lost to Follow-up|1|||
156363296|NCT02907359|564430865|FG001|Overall Study|Lost to Follow-up|0|||
156363297|NCT01354496|564430872|FG000|Period 1|Adverse Event|0|||
156363298|NCT01354496|564430873|FG001|Period 1|Adverse Event|0|||
156363299|NCT01354496|564430874|FG002|Period 1|Adverse Event|1|||
156363300|NCT01354496|564430875|FG003|Period 1|Adverse Event|0|||
156363301|NCT01354496|564430876|FG004|Period 1|Adverse Event|0|||
156363302|NCT01354496|564430877|FG005|Period 1|Adverse Event|0|||
156363303|NCT01354496|564430872|FG000|Period 1|Physician Decision|0|||
156363304|NCT01354496|564430873|FG001|Period 1|Physician Decision|0|||
156363305|NCT01354496|564430874|FG002|Period 1|Physician Decision|1|||
156490320|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
156490321|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
156490322|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
156490323|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
156363306|NCT01354496|564430875|FG003|Period 1|Physician Decision|0|||
156490324|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
156490325|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
156363307|NCT01354496|564430876|FG004|Period 1|Physician Decision|0|||
156363308|NCT01354496|564430877|FG005|Period 1|Physician Decision|0|||
156363309|NCT01354496|564430872|FG000|Period 2|Adverse Event|0|||
156363310|NCT01354496|564430873|FG001|Period 2|Adverse Event|0|||
156363311|NCT01354496|564430874|FG002|Period 2|Adverse Event|0|||
156490326|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
156490327|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
156490328|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Death|2|||
156363312|NCT01354496|564430875|FG003|Period 2|Adverse Event|1|||
156363313|NCT01354496|564430876|FG004|Period 2|Adverse Event|0|||
156363314|NCT01354496|564430877|FG005|Period 2|Adverse Event|0|||
156363315|NCT01354496|564430872|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
156363316|NCT01354496|564430873|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
156363317|NCT01354496|564430874|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
156363318|NCT01354496|564430875|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
156545616|NCT00640328|565091657|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
156545617|NCT00640328|565091658|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
156545618|NCT00640328|565091659|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
156363319|NCT01354496|564430876|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
156363320|NCT01354496|564430877|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
156363321|NCT02136576|564430878|FG000|Overall Study|Lost to Follow-up|2|||
156363322|NCT02136576|564430879|FG001|Overall Study|Lost to Follow-up|0|||
156363323|NCT02136576|564430880|FG002|Overall Study|Lost to Follow-up|0|||
156363324|NCT02197806|564430881|FG000|Overall Study|Adverse Event|0|||
156363325|NCT02197806|564430882|FG001|Overall Study|Adverse Event|1|||
156363326|NCT02197806|564430883|FG002|Overall Study|Adverse Event|0|||
156363327|NCT02197806|564430884|FG003|Overall Study|Adverse Event|1|||
156545619|NCT02374099|565091660|FG000|Overall Study|Adverse Event|1|||
156545620|NCT02374099|565091661|FG001|Overall Study|Adverse Event|0|||
156545621|NCT02374099|565091660|FG000|Overall Study|Progressive Disease|35|||
156363328|NCT00537381|564430885|FG000|Overall Study|Adverse Event|13|||
156363329|NCT00537381|564430886|FG001|Overall Study|Adverse Event|9|||
156363330|NCT00537381|564430885|FG000|Overall Study|Death|3|||
156363331|NCT00537381|564430886|FG001|Overall Study|Death|3|||
156363332|NCT00537381|564430885|FG000|Overall Study|Withdrawal by Subject|5|||
156363333|NCT00537381|564430886|FG001|Overall Study|Withdrawal by Subject|14|||
156363334|NCT00537381|564430885|FG000|Overall Study|Physician Decision|7|||
156363335|NCT00537381|564430886|FG001|Overall Study|Physician Decision|6|||
156363336|NCT00537381|564430885|FG000|Overall Study|Disease Progression|9|||
156363337|NCT00537381|564430886|FG001|Overall Study|Disease Progression|18|||
156545622|NCT02374099|565091661|FG001|Overall Study|Progressive Disease|40|||
156545623|NCT02374099|565091660|FG000|Overall Study|Withdrawal by Subject|5|||
156545624|NCT02374099|565091661|FG001|Overall Study|Withdrawal by Subject|1|||
156545625|NCT02374099|565091660|FG000|Overall Study|Miscellaneous|2|||
156545626|NCT02374099|565091661|FG001|Overall Study|Miscellaneous|3|||
156545627|NCT02374099|565091660|FG000|Overall Study|Randomized, but not treated|2|||
156545628|NCT02374099|565091661|FG001|Overall Study|Randomized, but not treated|1|||
156545629|NCT02374099|565091660|FG000|Overall Study|Study Terminated by Sponsor|3|||
156545630|NCT02374099|565091661|FG001|Overall Study|Study Terminated by Sponsor|4|||
156545631|NCT01033825|565091662|FG000|Overall Study|Withdrawal by Subject|2|||
156545632|NCT01033825|565091663|FG001|Overall Study|Withdrawal by Subject|3|||
156545633|NCT01033825|565091664|FG002|Overall Study|Withdrawal by Subject|2|||
156545634|NCT01033825|565091665|FG003|Overall Study|Withdrawal by Subject|1|||
156545635|NCT01033825|565091666|FG004|Overall Study|Withdrawal by Subject|1|||
156545636|NCT01033825|565091667|FG005|Overall Study|Withdrawal by Subject|0|||
156545637|NCT01033825|565091668|FG006|Overall Study|Withdrawal by Subject|0|||
156545638|NCT01033825|565091662|FG000|Overall Study|Adverse Event|0|||
156545639|NCT01033825|565091663|FG001|Overall Study|Adverse Event|0|||
156545640|NCT01033825|565091664|FG002|Overall Study|Adverse Event|0|||
156545641|NCT01033825|565091665|FG003|Overall Study|Adverse Event|1|||
156545642|NCT01033825|565091666|FG004|Overall Study|Adverse Event|0|||
156545643|NCT01033825|565091667|FG005|Overall Study|Adverse Event|0|||
156545644|NCT01033825|565091668|FG006|Overall Study|Adverse Event|0|||
156545645|NCT01033825|565091662|FG000|Overall Study|Protocol Violation|1|||
156545646|NCT01033825|565091663|FG001|Overall Study|Protocol Violation|0|||
156545647|NCT01033825|565091664|FG002|Overall Study|Protocol Violation|0|||
156545648|NCT01033825|565091665|FG003|Overall Study|Protocol Violation|0|||
156545649|NCT01033825|565091666|FG004|Overall Study|Protocol Violation|0|||
156363338|NCT00537381|564430885|FG000|Overall Study|Sponsor decision|14|||
156363339|NCT00537381|564430886|FG001|Overall Study|Sponsor decision|9|||
156363340|NCT00537381|564430885|FG000|Overall Study|Other|5|||
156363341|NCT00537381|564430886|FG001|Overall Study|Other|3|||
156363342|NCT00680901|564430887|FG000|Overall Study|Ongoing: On Study Treatment|1|||
156363343|NCT00680901|564430888|FG001|Overall Study|Ongoing: On Study Treatment|0|||
156363344|NCT00680901|564430887|FG000|Overall Study|Ongoing: In Follow Up|1|||
156363345|NCT00680901|564430888|FG001|Overall Study|Ongoing: In Follow Up|0|||
156363346|NCT00680901|564430887|FG000|Overall Study|Adverse Event|1|||
156363347|NCT00680901|564430888|FG001|Overall Study|Adverse Event|1|||
156545650|NCT01033825|565091667|FG005|Overall Study|Protocol Violation|0|||
156545651|NCT01033825|565091668|FG006|Overall Study|Protocol Violation|0|||
156545652|NCT01033825|565091662|FG000|Overall Study|Other|0|||
156545653|NCT01033825|565091663|FG001|Overall Study|Other|0|||
156363348|NCT00680901|564430887|FG000|Overall Study|Lost to Follow-up|3|||
156363349|NCT00680901|564430888|FG001|Overall Study|Lost to Follow-up|5|||
156363350|NCT00680901|564430887|FG000|Overall Study|Subject decided to withdraw from the study|4|||
156363351|NCT00680901|564430888|FG001|Overall Study|Subject decided to withdraw from the study|15|||
156545654|NCT01033825|565091664|FG002|Overall Study|Other|0|||
156545655|NCT01033825|565091665|FG003|Overall Study|Other|0|||
156545656|NCT01033825|565091666|FG004|Overall Study|Other|1|||
156545657|NCT01033825|565091667|FG005|Overall Study|Other|0|||
156545658|NCT01033825|565091668|FG006|Overall Study|Other|0|||
156545659|NCT01714687|565091669|FG000|Overall Study|Withdrawal by Subject|1|||
156545660|NCT01714687|565091670|FG001|Overall Study|Withdrawal by Subject|0|||
156490329|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Death|0|||
156490330|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Death|1|||
156490331|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Death|0|||
156490332|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
156490333|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
156490334|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
156490335|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
156490336|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
156490337|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
156490338|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
156490339|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
156490340|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
156490341|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
156490342|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
156490343|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
156490344|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Moved|32|||
156490345|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Moved|2|||
156490346|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Moved|28|||
156490347|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Moved|0|||
156490348|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
156490349|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
156490350|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
156490351|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
156490352|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Travel|2|||
156490353|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Travel|0|||
156490354|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Travel|0|||
156490355|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Travel|0|||
156490356|NCT00092521|564890748|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
156490357|NCT00092521|564890749|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
156490358|NCT00092521|564890750|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
156490359|NCT00092521|564890751|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
156490360|NCT00092521|564890748|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
156490361|NCT00092521|564890749|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
156490362|NCT00092521|564890750|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
156490363|NCT00092521|564890751|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
156490364|NCT00092521|564890748|FG000|Extension Study (Group 4)|Adverse Event|0|||
156490365|NCT00092521|564890749|FG001|Extension Study (Group 4)|Adverse Event|0|||
156490366|NCT00092521|564890750|FG002|Extension Study (Group 4)|Adverse Event|0|||
156490367|NCT00092521|564890751|FG003|Extension Study (Group 4)|Adverse Event|2|||
156490368|NCT00092521|564890748|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
156490369|NCT00092521|564890749|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
156490370|NCT00092521|564890750|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
156490371|NCT00092521|564890751|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
156490372|NCT00092521|564890748|FG000|Extension Study (Group 4)|Pregnancy|0|||
156490373|NCT00092521|564890749|FG001|Extension Study (Group 4)|Pregnancy|0|||
156490374|NCT00092521|564890750|FG002|Extension Study (Group 4)|Pregnancy|0|||
156490375|NCT00092521|564890751|FG003|Extension Study (Group 4)|Pregnancy|4|||
156490376|NCT00092521|564890748|FG000|Extension Study (Group 4)|Protocol Violation|0|||
156490377|NCT00092521|564890749|FG001|Extension Study (Group 4)|Protocol Violation|0|||
156490378|NCT00092521|564890750|FG002|Extension Study (Group 4)|Protocol Violation|0|||
156490379|NCT00092521|564890751|FG003|Extension Study (Group 4)|Protocol Violation|2|||
156490380|NCT00092521|564890748|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
156490381|NCT00092521|564890749|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
156490382|NCT00092521|564890750|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
156490383|NCT00092521|564890751|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
156490384|NCT00092521|564890748|FG000|Extension Study (Group 4)|Moved|0|||
156490385|NCT00092521|564890749|FG001|Extension Study (Group 4)|Moved|0|||
156490386|NCT00092521|564890750|FG002|Extension Study (Group 4)|Moved|0|||
156490387|NCT00092521|564890751|FG003|Extension Study (Group 4)|Moved|16|||
156490388|NCT00092521|564890748|FG000|Extension Study (Group 4)|Site Terminated|0|||
156490389|NCT00092521|564890749|FG001|Extension Study (Group 4)|Site Terminated|0|||
156490390|NCT00092521|564890750|FG002|Extension Study (Group 4)|Site Terminated|0|||
156490391|NCT00092521|564890751|FG003|Extension Study (Group 4)|Site Terminated|4|||
156490392|NCT00092521|564890748|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
156490393|NCT00092521|564890749|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
156490394|NCT00092521|564890750|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
156490395|NCT00092521|564890751|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
156490396|NCT01878383|564890752|FG000|Overall Study|Lost to Follow-up|0|||
156490397|NCT01878383|564890753|FG001|Overall Study|Lost to Follow-up|1499|||
156490398|NCT03464383|564890754|FG000|Overall Study|Lost to Follow-up|1|||
156363352|NCT00680901|564430887|FG000|Overall Study|Sponsor decision|1|||
156490399|NCT03464383|564890755|FG001|Overall Study|Lost to Follow-up|0|||
156363353|NCT00680901|564430888|FG001|Overall Study|Sponsor decision|0|||
156363354|NCT00680901|564430887|FG000|Overall Study|Physician Decision|0|||
156490400|NCT03464383|564890756|FG002|Overall Study|Lost to Follow-up|0|||
156490401|NCT03464383|564890754|FG000|Overall Study|Withdrawal by Subject|0|||
156363355|NCT00680901|564430888|FG001|Overall Study|Physician Decision|2|||
156490402|NCT03464383|564890755|FG001|Overall Study|Withdrawal by Subject|1|||
156490403|NCT03464383|564890756|FG002|Overall Study|Withdrawal by Subject|0|||
156490404|NCT00560313|564890757|FG000|Overall Study|Adverse Events or Death|2|||
156363356|NCT00680901|564430887|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
156490405|NCT00560313|564890757|FG000|Overall Study|Withdrawal by Subject|2|||
156490406|NCT00560313|564890757|FG000|Overall Study|Lost to Follow-up|1|||
156490407|NCT00560313|564890757|FG000|Overall Study|Protocol Violation|1|||
156490408|NCT03475056|564890758|FG000|Overall Study|Lost to Follow-up|0|||
156490409|NCT03475056|564890759|FG001|Overall Study|Lost to Follow-up|1|||
156490410|NCT03475056|564890758|FG000|Overall Study|Moved from Area|0|||
156490411|NCT03475056|564890759|FG001|Overall Study|Moved from Area|2|||
156490412|NCT00113269|564890762|FG000|Overall Study|Not transplanted, donor issues|4|||
156490413|NCT00113269|564890763|FG001|Overall Study|Not transplanted, donor issues|0|||
156490414|NCT00113269|564890764|FG002|Overall Study|Not transplanted, donor issues|2|||
156490415|NCT00113269|564890765|FG003|Overall Study|Not transplanted, donor issues|2|||
156490416|NCT00113269|564890762|FG000|Overall Study|Not transplanted, recipient issues|2|||
156490417|NCT00113269|564890763|FG001|Overall Study|Not transplanted, recipient issues|1|||
156490418|NCT00113269|564890764|FG002|Overall Study|Not transplanted, recipient issues|7|||
156490419|NCT00113269|564890765|FG003|Overall Study|Not transplanted, recipient issues|4|||
156490420|NCT00113269|564890762|FG000|Overall Study|Early graft loss, technical|0|||
156490421|NCT00113269|564890763|FG001|Overall Study|Early graft loss, technical|0|||
156490422|NCT00113269|564890764|FG002|Overall Study|Early graft loss, technical|2|||
156490423|NCT00113269|564890765|FG003|Overall Study|Early graft loss, technical|0|||
156490424|NCT00113269|564890762|FG000|Overall Study|Death in operating room|0|||
156490425|NCT00113269|564890763|FG001|Overall Study|Death in operating room|0|||
156490426|NCT00113269|564890764|FG002|Overall Study|Death in operating room|0|||
156490427|NCT00113269|564890765|FG003|Overall Study|Death in operating room|1|||
156490428|NCT00113269|564890762|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
156490429|NCT00113269|564890763|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
156490430|NCT00113269|564890764|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
156490431|NCT00113269|564890765|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
156490432|NCT00113269|564890762|FG000|Overall Study|Adverse Event|2|||
156490433|NCT00113269|564890763|FG001|Overall Study|Adverse Event|7|||
156490434|NCT00113269|564890764|FG002|Overall Study|Adverse Event|11|||
156490435|NCT00113269|564890765|FG003|Overall Study|Adverse Event|7|||
156490436|NCT00113269|564890762|FG000|Overall Study|Withdrawal by Subject|4|||
156490437|NCT00113269|564890763|FG001|Overall Study|Withdrawal by Subject|3|||
156490438|NCT00113269|564890764|FG002|Overall Study|Withdrawal by Subject|4|||
156490439|NCT00113269|564890765|FG003|Overall Study|Withdrawal by Subject|2|||
156490440|NCT00113269|564890762|FG000|Overall Study|Graft loss|6|||
156490441|NCT00113269|564890763|FG001|Overall Study|Graft loss|6|||
156490442|NCT00113269|564890764|FG002|Overall Study|Graft loss|4|||
156490443|NCT00113269|564890765|FG003|Overall Study|Graft loss|9|||
156490444|NCT00113269|564890762|FG000|Overall Study|Protocol Violation|1|||
156490445|NCT00113269|564890763|FG001|Overall Study|Protocol Violation|0|||
156490446|NCT00113269|564890764|FG002|Overall Study|Protocol Violation|4|||
156490447|NCT00113269|564890765|FG003|Overall Study|Protocol Violation|2|||
156490448|NCT00113269|564890762|FG000|Overall Study|Lost to Follow-up|2|||
156490449|NCT00113269|564890763|FG001|Overall Study|Lost to Follow-up|3|||
156490450|NCT00113269|564890764|FG002|Overall Study|Lost to Follow-up|6|||
156490451|NCT00113269|564890765|FG003|Overall Study|Lost to Follow-up|3|||
156490452|NCT00113269|564890762|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
156490453|NCT00113269|564890763|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
156490454|NCT00113269|564890764|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
156490455|NCT00113269|564890765|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
156490456|NCT00113269|564890762|FG000|Overall Study|Discontinued due to rejection|0|||
156490457|NCT00113269|564890763|FG001|Overall Study|Discontinued due to rejection|0|||
156490458|NCT00113269|564890764|FG002|Overall Study|Discontinued due to rejection|1|||
156490459|NCT00113269|564890765|FG003|Overall Study|Discontinued due to rejection|0|||
156490460|NCT00113269|564890762|FG000|Overall Study|Moved|0|||
156490461|NCT00113269|564890763|FG001|Overall Study|Moved|1|||
156490462|NCT00113269|564890764|FG002|Overall Study|Moved|0|||
156490463|NCT00113269|564890765|FG003|Overall Study|Moved|3|||
156490464|NCT00113269|564890762|FG000|Overall Study|Received pancreas transplant|0|||
156490465|NCT00113269|564890763|FG001|Overall Study|Received pancreas transplant|0|||
156490466|NCT00113269|564890764|FG002|Overall Study|Received pancreas transplant|0|||
156490467|NCT00113269|564890765|FG003|Overall Study|Received pancreas transplant|2|||
156490468|NCT00113269|564890762|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
156490469|NCT00113269|564890763|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
156490470|NCT00113269|564890764|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
156490471|NCT00113269|564890765|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
156490472|NCT00113269|564890762|FG000|Overall Study|Did not meet eligibility criteria|1|||
156490473|NCT00113269|564890763|FG001|Overall Study|Did not meet eligibility criteria|0|||
156490474|NCT00113269|564890764|FG002|Overall Study|Did not meet eligibility criteria|0|||
156490475|NCT00113269|564890765|FG003|Overall Study|Did not meet eligibility criteria|1|||
156490476|NCT00113269|564890762|FG000|Overall Study|Unable to return for follow up|2|||
156490477|NCT00113269|564890763|FG001|Overall Study|Unable to return for follow up|1|||
156490478|NCT00113269|564890764|FG002|Overall Study|Unable to return for follow up|0|||
156545661|NCT01714687|565091669|FG000|Overall Study|Lost to Follow-up|2|||
156545662|NCT01714687|565091670|FG001|Overall Study|Lost to Follow-up|4|||
156545663|NCT03885089|565091671|FG000|Overall Study|No informed consent for publication of study results|2|||
156545664|NCT03349099|565091672|FG000|Overall Study|Physician Decision|3|||
156545665|NCT03349099|565091673|FG001|Overall Study|Physician Decision|4|||
156363357|NCT00680901|564430888|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
156363358|NCT00680901|564430887|FG000|Overall Study|Other protocol defined stopping criteria|17|||
156363359|NCT00680901|564430888|FG001|Overall Study|Other protocol defined stopping criteria|17|||
156363360|NCT00500292|564430895|FG000|Overall Study|Adverse Event|3|||
156363361|NCT00500292|564430896|FG001|Overall Study|Adverse Event|6|||
156363362|NCT00500292|564430897|FG002|Overall Study|Adverse Event|4|||
156363363|NCT00500292|564430895|FG000|Overall Study|Condition under investigation worsened|21|||
156363364|NCT00500292|564430896|FG001|Overall Study|Condition under investigation worsened|23|||
156363365|NCT00500292|564430897|FG002|Overall Study|Condition under investigation worsened|19|||
156363366|NCT00500292|564430895|FG000|Overall Study|Withdrawal by Subject|0|||
156363367|NCT00500292|564430896|FG001|Overall Study|Withdrawal by Subject|1|||
156363368|NCT00500292|564430897|FG002|Overall Study|Withdrawal by Subject|0|||
156363369|NCT00500292|564430895|FG000|Overall Study|Other|1|||
156363370|NCT00500292|564430896|FG001|Overall Study|Other|1|||
156363371|NCT00500292|564430897|FG002|Overall Study|Other|4|||
156363372|NCT03065244|564430898|FG000|Overall Study|Lost to Follow-up|1|||
156363373|NCT03065244|564430899|FG001|Overall Study|Lost to Follow-up|1|||
156363374|NCT03065244|564430898|FG000|Overall Study|Diagnosed with a different disease|1|||
156363375|NCT03065244|564430899|FG001|Overall Study|Diagnosed with a different disease|1|||
156363376|NCT03065244|564430898|FG000|Overall Study|Protocol Violation|0|||
156363377|NCT03065244|564430899|FG001|Overall Study|Protocol Violation|1|||
156363378|NCT03065244|564430898|FG000|Overall Study|Withdrawal by Subject|1|||
156363379|NCT03065244|564430899|FG001|Overall Study|Withdrawal by Subject|1|||
156363380|NCT01708174|564430900|FG000|Treatment Period|Withdrawal by Subject|1|||
156363381|NCT01708174|564430901|FG001|Treatment Period|Withdrawal by Subject|0|||
156363382|NCT01708174|564430902|FG002|Treatment Period|Withdrawal by Subject|0|||
156363383|NCT01708174|564430900|FG000|Treatment Period|Progressive disease|0|||
156363384|NCT01708174|564430901|FG001|Treatment Period|Progressive disease|1|||
156363385|NCT01708174|564430902|FG002|Treatment Period|Progressive disease|0|||
156363386|NCT01708174|564430900|FG000|Treatment Period|Death|0|||
156363387|NCT01708174|564430901|FG001|Treatment Period|Death|0|||
156363388|NCT01708174|564430902|FG002|Treatment Period|Death|1|||
156363389|NCT01708174|564430900|FG000|Treatment Period|Adverse Event|0|||
156363390|NCT01708174|564430901|FG001|Treatment Period|Adverse Event|1|||
156363391|NCT01708174|564430902|FG002|Treatment Period|Adverse Event|0|||
156363392|NCT02741700|564430903|FG000|Overall Study|Lost to Follow-up|17|||
156363393|NCT02741700|564430904|FG001|Overall Study|Lost to Follow-up|8|||
156363394|NCT02741700|564430903|FG000|Overall Study|Withdrawal by Subject|2|||
156363395|NCT02741700|564430904|FG001|Overall Study|Withdrawal by Subject|5|||
156363396|NCT02741700|564430903|FG000|Overall Study|Physician Decision|3|||
156363397|NCT02741700|564430904|FG001|Overall Study|Physician Decision|0|||
156363398|NCT02741700|564430903|FG000|Overall Study|Moved out of State|0|||
156363399|NCT02741700|564430904|FG001|Overall Study|Moved out of State|1|||
156363400|NCT02741700|564430903|FG000|Overall Study|Death|4|||
156363401|NCT02741700|564430904|FG001|Overall Study|Death|5|||
156545666|NCT03349099|565091672|FG000|Overall Study|Stone migrated from the kidney|1|||
156545667|NCT03349099|565091673|FG001|Overall Study|Stone migrated from the kidney|0|||
156545668|NCT00278993|565091674|FG000|Overall Study|Adverse Event|24|||
156545669|NCT00278993|565091674|FG000|Overall Study|Withdrawal by Subject|5|||
156545670|NCT00278993|565091674|FG000|Overall Study|Progressive Disease|65|||
156545671|NCT00278993|565091674|FG000|Overall Study|Physician Decision|9|||
156545672|NCT00278993|565091674|FG000|Overall Study|Not Otherwise Specified|4|||
156545673|NCT01439555|565091676|FG000|Overall Study|Protocol Violation|1|||
156545674|NCT01979536|565091679|FG000|Overall Study|Physician Decision|2|||
156363402|NCT00923559|564430905|FG000|Overall Study|Lost to Follow-up|2|||
156363403|NCT00923559|564430906|FG001|Overall Study|Lost to Follow-up|3|||
156363404|NCT00075582|564430908|FG000|Overall Study|Adverse Event|3|||
156363405|NCT00075582|564430909|FG001|Overall Study|Adverse Event|1|||
156363406|NCT00075582|564430908|FG000|Overall Study|Lack of Efficacy|4|||
156363407|NCT00075582|564430909|FG001|Overall Study|Lack of Efficacy|8|||
156363408|NCT00075582|564430908|FG000|Overall Study|Physician Decision|5|||
156363409|NCT00075582|564430909|FG001|Overall Study|Physician Decision|8|||
156363410|NCT00075582|564430908|FG000|Overall Study|Withdrawal by Subject|2|||
156363411|NCT00075582|564430909|FG001|Overall Study|Withdrawal by Subject|2|||
156363412|NCT00075582|564430908|FG000|Overall Study|Ineligible for study|36|||
156363413|NCT00075582|564430909|FG001|Overall Study|Ineligible for study|16|||
156363414|NCT02268812|564430910|FG000|Overall Study|Adverse Event|8|||
156545675|NCT01979536|565091680|FG001|Overall Study|Physician Decision|3|||
156363415|NCT02268812|564430911|FG001|Overall Study|Adverse Event|26|||
156545676|NCT01979536|565091679|FG000|Overall Study|Withdrawal by Subject|0|||
156545677|NCT01979536|565091680|FG001|Overall Study|Withdrawal by Subject|1|||
156545678|NCT01979536|565091679|FG000|Overall Study|Refusal|0|||
156363416|NCT02268812|564430912|FG002|Overall Study|Adverse Event|7|||
156545679|NCT01979536|565091680|FG001|Overall Study|Refusal|1|||
156545680|NCT01979536|565091679|FG000|Overall Study|Relapse|0|||
156545681|NCT01979536|565091680|FG001|Overall Study|Relapse|1|||
156545682|NCT01979536|565091679|FG000|Overall Study|Study terminated by Sponsor|0|||
156363417|NCT02268812|564430913|FG003|Overall Study|Adverse Event|10|||
156490479|NCT00113269|564890765|FG003|Overall Study|Unable to return for follow up|0|||
156490480|NCT01960348|564890772|FG000|Overall Study|Adverse event, not serious|2|||
156490481|NCT01960348|564890773|FG001|Overall Study|Adverse event, not serious|2|||
156490482|NCT01960348|564890772|FG000|Overall Study|Adverse event, serious fatal|6|||
156490483|NCT01960348|564890773|FG001|Overall Study|Adverse event, serious fatal|5|||
156490484|NCT01960348|564890772|FG000|Overall Study|Adverse event, serious non-fatal|0|||
156490485|NCT01960348|564890773|FG001|Overall Study|Adverse event, serious non-fatal|3|||
156490486|NCT01960348|564890772|FG000|Overall Study|Withdrawal by Subject|1|||
156490487|NCT01960348|564890773|FG001|Overall Study|Withdrawal by Subject|11|||
156490488|NCT01960348|564890772|FG000|Overall Study|Physician Decision|0|||
156490489|NCT01960348|564890773|FG001|Overall Study|Physician Decision|1|||
156490490|NCT01960348|564890772|FG000|Overall Study|Protocol Violation|1|||
156490491|NCT01960348|564890773|FG001|Overall Study|Protocol Violation|0|||
156490492|NCT01580995|564890774|FG000|Overall Study|Lost to Follow-up|2|||
156490493|NCT01580995|564890775|FG001|Overall Study|Lost to Follow-up|2|||
156490494|NCT01821729|564890776|FG000|Overall Study|Withdrawal by Subject|1|||
156490495|NCT02517528|564890777|FG000|Overall Study|Withdrawal by Subject|1|||
156490496|NCT01644188|564890781|FG000|Overall Study|Adverse Event|44|||
156490497|NCT01644188|564890782|FG001|Overall Study|Adverse Event|20|||
156490498|NCT01644188|564890781|FG000|Overall Study|Poor compliance to protocol|26|||
156490499|NCT01644188|564890782|FG001|Overall Study|Poor compliance to protocol|14|||
156490500|NCT01644188|564890781|FG000|Overall Study|Physician Decision|1|||
156490501|NCT01644188|564890782|FG001|Overall Study|Physician Decision|3|||
156490502|NCT01644188|564890781|FG000|Overall Study|Participant moved|7|||
156490503|NCT01644188|564890782|FG001|Overall Study|Participant moved|2|||
156490504|NCT01644188|564890781|FG000|Overall Study|Related to auto-injector administration|2|||
156490505|NCT01644188|564890782|FG001|Overall Study|Related to auto-injector administration|2|||
156490506|NCT01644188|564890781|FG000|Overall Study|Consent withdrawn by participant|14|||
156490507|NCT01644188|564890782|FG001|Overall Study|Consent withdrawn by participant|7|||
156490508|NCT01644188|564890781|FG000|Overall Study|Selection criteria finally not met|2|||
156490509|NCT01644188|564890782|FG001|Overall Study|Selection criteria finally not met|0|||
156490510|NCT01644188|564890781|FG000|Overall Study|Lost to Follow-up|1|||
156490511|NCT01644188|564890782|FG001|Overall Study|Lost to Follow-up|0|||
156490512|NCT01644188|564890781|FG000|Overall Study|Death|4|||
156490513|NCT01644188|564890782|FG001|Overall Study|Death|3|||
156490514|NCT01644188|564890781|FG000|Overall Study|Last visit outside protocol visit window|14|||
156490515|NCT01644188|564890782|FG001|Overall Study|Last visit outside protocol visit window|16|||
156490516|NCT01644188|564890781|FG000|Overall Study|Site closure|1|||
156490517|NCT01644188|564890782|FG001|Overall Study|Site closure|1|||
156490518|NCT01644188|564890781|FG000|Overall Study|Other than specified above|6|||
156490519|NCT01644188|564890782|FG001|Overall Study|Other than specified above|7|||
156490520|NCT01845649|564890788|FG000|Overall Study|Adverse Event|7|||
156490521|NCT01845649|564890789|FG001|Overall Study|Adverse Event|10|||
156490522|NCT01845649|564890788|FG000|Overall Study|Lack of Efficacy|1|||
156490523|NCT01845649|564890789|FG001|Overall Study|Lack of Efficacy|1|||
156490524|NCT01845649|564890788|FG000|Overall Study|Lost to Follow-up|2|||
156490525|NCT01845649|564890789|FG001|Overall Study|Lost to Follow-up|2|||
156490526|NCT01845649|564890788|FG000|Overall Study|Withdrew Consent|12|||
156490527|NCT01845649|564890789|FG001|Overall Study|Withdrew Consent|4|||
156490528|NCT01845649|564890788|FG000|Overall Study|Protocol Deviation|7|||
156490529|NCT01845649|564890789|FG001|Overall Study|Protocol Deviation|4|||
156490530|NCT01845649|564890788|FG000|Overall Study|Reason not Specified|2|||
156490531|NCT01845649|564890789|FG001|Overall Study|Reason not Specified|1|||
156490532|NCT04140266|564890795|FG000|Overall Study|Physician Decision|2|||
156490533|NCT04140266|564890796|FG001|Overall Study|Physician Decision|0|||
156490534|NCT04140266|564890795|FG000|Overall Study|Withdrawal by Subject|4|||
156490535|NCT04140266|564890796|FG001|Overall Study|Withdrawal by Subject|2|||
156490536|NCT00721214|564890797|FG000|Overall Study|Chose another center for transplant|1|||
156490537|NCT00721214|564890797|FG000|Overall Study|Death|3|||
156490538|NCT01169636|564890798|FG000|Overall Study|Adverse Event|0|||
156490539|NCT01169636|564890799|FG001|Overall Study|Adverse Event|0|||
156490540|NCT01169636|564890800|FG002|Overall Study|Adverse Event|1|||
156490541|NCT01169636|564890801|FG003|Overall Study|Adverse Event|1|||
156490542|NCT01169636|564890802|FG004|Overall Study|Adverse Event|0|||
156490543|NCT01169636|564890798|FG000|Overall Study|Screen failure|0|||
156490544|NCT01169636|564890799|FG001|Overall Study|Screen failure|0|||
156490545|NCT01169636|564890800|FG002|Overall Study|Screen failure|2|||
156490546|NCT01169636|564890801|FG003|Overall Study|Screen failure|0|||
156490547|NCT01169636|564890802|FG004|Overall Study|Screen failure|0|||
156490548|NCT01169636|564890798|FG000|Overall Study|Withdrawal by Subject|0|||
156363418|NCT02268812|564430910|FG000|Overall Study|Protocol deviation|0|||
156363419|NCT02268812|564430911|FG001|Overall Study|Protocol deviation|0|||
156490549|NCT01169636|564890799|FG001|Overall Study|Withdrawal by Subject|0|||
156363420|NCT02268812|564430912|FG002|Overall Study|Protocol deviation|1|||
156363421|NCT02268812|564430913|FG003|Overall Study|Protocol deviation|0|||
156363422|NCT02268812|564430910|FG000|Overall Study|Withdrawal by Subject|0|||
156363423|NCT02268812|564430911|FG001|Overall Study|Withdrawal by Subject|1|||
156363424|NCT02268812|564430912|FG002|Overall Study|Withdrawal by Subject|0|||
156363425|NCT02268812|564430913|FG003|Overall Study|Withdrawal by Subject|0|||
156363426|NCT02268812|564430910|FG000|Overall Study|Physician Decision|3|||
156363427|NCT02268812|564430911|FG001|Overall Study|Physician Decision|1|||
156363428|NCT02268812|564430912|FG002|Overall Study|Physician Decision|0|||
156363429|NCT02268812|564430913|FG003|Overall Study|Physician Decision|1|||
156363430|NCT02268812|564430910|FG000|Overall Study|Other|5|||
156363431|NCT02268812|564430911|FG001|Overall Study|Other|4|||
156490550|NCT01169636|564890800|FG002|Overall Study|Withdrawal by Subject|0|||
156490551|NCT01169636|564890801|FG003|Overall Study|Withdrawal by Subject|0|||
156490552|NCT01169636|564890802|FG004|Overall Study|Withdrawal by Subject|3|||
156490553|NCT02396953|564890803|FG000|Overall Study|Withdrawal by Subject|0|||
156490554|NCT02396953|564890804|FG001|Overall Study|Withdrawal by Subject|0|||
156490555|NCT02396953|564890805|FG002|Overall Study|Withdrawal by Subject|1|||
156363432|NCT02268812|564430912|FG002|Overall Study|Other|1|||
156545683|NCT01979536|565091680|FG001|Overall Study|Study terminated by Sponsor|1|||
156545684|NCT01979536|565091679|FG000|Overall Study|Did not start treatment|0|||
156545685|NCT01979536|565091680|FG001|Overall Study|Did not start treatment|1|||
156545686|NCT03077685|565091683|FG000|Overall Study|Lost to Follow-up|0|||
156545687|NCT03077685|565091684|FG001|Overall Study|Lost to Follow-up|0|||
156545688|NCT03077685|565091685|FG002|Overall Study|Lost to Follow-up|0|||
156545689|NCT03077685|565091686|FG003|Overall Study|Lost to Follow-up|0|||
156545690|NCT03077685|565091687|FG004|Overall Study|Lost to Follow-up|1|||
156545691|NCT03077685|565091683|FG000|Overall Study|Death|0|||
156545692|NCT03077685|565091684|FG001|Overall Study|Death|0|||
156545693|NCT03077685|565091685|FG002|Overall Study|Death|1|||
156545694|NCT03077685|565091686|FG003|Overall Study|Death|1|||
156545695|NCT03077685|565091687|FG004|Overall Study|Death|3|||
156545696|NCT03077685|565091683|FG000|Overall Study|Withdrawal by Subject|0|||
156545697|NCT03077685|565091684|FG001|Overall Study|Withdrawal by Subject|0|||
156545698|NCT03077685|565091685|FG002|Overall Study|Withdrawal by Subject|0|||
156545699|NCT03077685|565091686|FG003|Overall Study|Withdrawal by Subject|2|||
156545700|NCT03077685|565091687|FG004|Overall Study|Withdrawal by Subject|1|||
156545701|NCT03077685|565091683|FG000|Overall Study|Physician Decision|0|||
156545702|NCT03077685|565091684|FG001|Overall Study|Physician Decision|0|||
156545703|NCT03077685|565091685|FG002|Overall Study|Physician Decision|1|||
156545704|NCT03077685|565091686|FG003|Overall Study|Physician Decision|0|||
156545705|NCT03077685|565091687|FG004|Overall Study|Physician Decision|3|||
156545706|NCT03077685|565091683|FG000|Overall Study|Disease Progression|1|||
156545707|NCT03077685|565091684|FG001|Overall Study|Disease Progression|0|||
156545708|NCT03077685|565091685|FG002|Overall Study|Disease Progression|0|||
156545709|NCT03077685|565091686|FG003|Overall Study|Disease Progression|2|||
156545710|NCT03077685|565091687|FG004|Overall Study|Disease Progression|1|||
156545711|NCT03077685|565091683|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
156545712|NCT03077685|565091684|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
156545713|NCT03077685|565091685|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
156545714|NCT03077685|565091686|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
156545715|NCT03077685|565091687|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
156545716|NCT03077685|565091683|FG000|Overall Study|Subject entered hospice care|0|||
156545717|NCT03077685|565091684|FG001|Overall Study|Subject entered hospice care|0|||
156545718|NCT03077685|565091685|FG002|Overall Study|Subject entered hospice care|0|||
156545719|NCT03077685|565091686|FG003|Overall Study|Subject entered hospice care|0|||
156545720|NCT03077685|565091687|FG004|Overall Study|Subject entered hospice care|1|||
156545721|NCT02116777|565091688|FG000|Overall Study|Adverse Event|0|||
156545722|NCT02116777|565091689|FG001|Overall Study|Adverse Event|0|||
156545723|NCT02116777|565091690|FG002|Overall Study|Adverse Event|0|||
156545724|NCT02116777|565091691|FG003|Overall Study|Adverse Event|0|||
156545725|NCT02116777|565091692|FG004|Overall Study|Adverse Event|2|||
156545726|NCT02116777|565091693|FG005|Overall Study|Adverse Event|2|||
156545727|NCT02116777|565091694|FG006|Overall Study|Adverse Event|0|||
156545728|NCT02116777|565091688|FG000|Overall Study|Death|0|||
156545729|NCT02116777|565091689|FG001|Overall Study|Death|0|||
156545730|NCT02116777|565091690|FG002|Overall Study|Death|0|||
156545731|NCT02116777|565091691|FG003|Overall Study|Death|1|||
156545732|NCT02116777|565091692|FG004|Overall Study|Death|0|||
156545733|NCT02116777|565091693|FG005|Overall Study|Death|0|||
156545734|NCT02116777|565091694|FG006|Overall Study|Death|0|||
156545735|NCT02116777|565091688|FG000|Overall Study|Lack of Efficacy|3|||
156545736|NCT02116777|565091689|FG001|Overall Study|Lack of Efficacy|3|||
156545737|NCT02116777|565091690|FG002|Overall Study|Lack of Efficacy|3|||
156545738|NCT02116777|565091691|FG003|Overall Study|Lack of Efficacy|8|||
156545739|NCT02116777|565091692|FG004|Overall Study|Lack of Efficacy|4|||
156545740|NCT02116777|565091693|FG005|Overall Study|Lack of Efficacy|1|||
156545741|NCT02116777|565091694|FG006|Overall Study|Lack of Efficacy|9|||
156545742|NCT02116777|565091688|FG000|Overall Study|Physician Decision|0|||
156545743|NCT02116777|565091689|FG001|Overall Study|Physician Decision|0|||
156545744|NCT02116777|565091690|FG002|Overall Study|Physician Decision|0|||
156545745|NCT02116777|565091691|FG003|Overall Study|Physician Decision|2|||
156545746|NCT02116777|565091692|FG004|Overall Study|Physician Decision|0|||
156545747|NCT02116777|565091693|FG005|Overall Study|Physician Decision|0|||
156545748|NCT02116777|565091694|FG006|Overall Study|Physician Decision|0|||
156545749|NCT02116777|565091688|FG000|Overall Study|Protocol Violation|0|||
156545750|NCT02116777|565091689|FG001|Overall Study|Protocol Violation|0|||
156545751|NCT02116777|565091690|FG002|Overall Study|Protocol Violation|0|||
156545752|NCT02116777|565091691|FG003|Overall Study|Protocol Violation|1|||
156545753|NCT02116777|565091692|FG004|Overall Study|Protocol Violation|0|||
156545754|NCT02116777|565091693|FG005|Overall Study|Protocol Violation|0|||
156545755|NCT02116777|565091694|FG006|Overall Study|Protocol Violation|0|||
156545756|NCT02116777|565091688|FG000|Overall Study|Withdrawal by Subject|0|||
156545757|NCT02116777|565091689|FG001|Overall Study|Withdrawal by Subject|0|||
156545758|NCT02116777|565091690|FG002|Overall Study|Withdrawal by Subject|0|||
156545759|NCT02116777|565091691|FG003|Overall Study|Withdrawal by Subject|1|||
156545760|NCT02116777|565091692|FG004|Overall Study|Withdrawal by Subject|0|||
156545761|NCT02116777|565091693|FG005|Overall Study|Withdrawal by Subject|0|||
156363433|NCT02268812|564430913|FG003|Overall Study|Other|3|||
156363434|NCT04544293|564430914|FG000|Double-blind|Adverse Event|2|||
156363435|NCT04544293|564430915|FG001|Double-blind|Adverse Event|1|||
156363436|NCT04544293|564430914|FG000|Double-blind|Pregnancy|0|||
156363437|NCT04544293|564430915|FG001|Double-blind|Pregnancy|1|||
156363438|NCT04544293|564430914|FG000|Double-blind|Lost to Follow-up|0|||
156363439|NCT04544293|564430915|FG001|Double-blind|Lost to Follow-up|1|||
156363440|NCT04544293|564430914|FG000|Open-Label Extension|Study ongoing|79|||
156363441|NCT04544293|564430915|FG001|Open-Label Extension|Study ongoing|81|||
156363442|NCT02385084|564430916|FG000|Period 2|Protocol Violation|0|||
156363443|NCT02385084|564430917|FG001|Period 2|Protocol Violation|0|||
156363444|NCT02385084|564430918|FG002|Period 2|Protocol Violation|1|||
156363445|NCT02385084|564430919|FG003|Period 2|Protocol Violation|0|||
156363446|NCT02385084|564430920|FG004|Period 2|Protocol Violation|0|||
156363447|NCT02385084|564430921|FG005|Period 2|Protocol Violation|0|||
156363448|NCT05045144|564430922|FG000|Overall Study|Lost to Follow-up|3|||
156363449|NCT05045144|564430923|FG001|Overall Study|Lost to Follow-up|2|||
156363450|NCT05045144|564430924|FG002|Overall Study|Lost to Follow-up|3|||
156363451|NCT05045144|564430925|FG003|Overall Study|Lost to Follow-up|5|||
156363452|NCT05045144|564430926|FG004|Overall Study|Lost to Follow-up|13|||
156363453|NCT05045144|564430922|FG000|Overall Study|Withdrawal by Subject|0|||
156363454|NCT05045144|564430923|FG001|Overall Study|Withdrawal by Subject|1|||
156363455|NCT05045144|564430924|FG002|Overall Study|Withdrawal by Subject|0|||
156363456|NCT05045144|564430925|FG003|Overall Study|Withdrawal by Subject|0|||
156363457|NCT05045144|564430926|FG004|Overall Study|Withdrawal by Subject|0|||
156363458|NCT05045144|564430922|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156363459|NCT05045144|564430923|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156363460|NCT05045144|564430924|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156363461|NCT05045144|564430925|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156363462|NCT05045144|564430926|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156363463|NCT01951157|564430929|FG000|Overall Study|Progressive Disease|12|||
156363464|NCT01951157|564430930|FG001|Overall Study|Progressive Disease|13|||
156363465|NCT01951157|564430931|FG002|Overall Study|Progressive Disease|10|||
156363466|NCT01951157|564430929|FG000|Overall Study|Treatment-unrelated AE|1|||
156363467|NCT01951157|564430930|FG001|Overall Study|Treatment-unrelated AE|0|||
156363468|NCT01951157|564430931|FG002|Overall Study|Treatment-unrelated AE|3|||
156363469|NCT01951157|564430929|FG000|Overall Study|Study Termination|0|||
156490556|NCT02396953|564890803|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
156363470|NCT01951157|564430930|FG001|Overall Study|Study Termination|0|||
156363471|NCT01951157|564430931|FG002|Overall Study|Study Termination|1|||
156363472|NCT01951157|564430929|FG000|Overall Study|Physician Decision|5|||
156363473|NCT01951157|564430930|FG001|Overall Study|Physician Decision|3|||
156363474|NCT01951157|564430931|FG002|Overall Study|Physician Decision|2|||
156363475|NCT01951157|564430929|FG000|Overall Study|Non-treatmentrelated death|2|||
156363476|NCT01951157|564430930|FG001|Overall Study|Non-treatmentrelated death|2|||
156363477|NCT01951157|564430931|FG002|Overall Study|Non-treatmentrelated death|2|||
156363478|NCT01951157|564430929|FG000|Overall Study|No treated|0|||
156363479|NCT01951157|564430930|FG001|Overall Study|No treated|1|||
156363480|NCT01951157|564430931|FG002|Overall Study|No treated|0|||
156363481|NCT01951157|564430929|FG000|Overall Study|Treatment-related AE|2|||
156363482|NCT01951157|564430930|FG001|Overall Study|Treatment-related AE|0|||
156363483|NCT01951157|564430931|FG002|Overall Study|Treatment-related AE|4|||
156363484|NCT01951157|564430929|FG000|Overall Study|Consent withdrawn by subject|0|||
156363485|NCT01951157|564430930|FG001|Overall Study|Consent withdrawn by subject|1|||
156363486|NCT01951157|564430931|FG002|Overall Study|Consent withdrawn by subject|3|||
156363487|NCT01951157|564430929|FG000|Overall Study|Treatment-related death|0|||
156363488|NCT01951157|564430930|FG001|Overall Study|Treatment-related death|2|||
156363489|NCT01951157|564430931|FG002|Overall Study|Treatment-related death|0|||
156363490|NCT02268786|564430932|FG000|Overall Study|No Euploid Embryos available|42|||
156363491|NCT02268786|564430933|FG001|Overall Study|No Euploid Embryos available|0|||
156363492|NCT02268786|564430932|FG000|Overall Study|Withdrawal by Subject|7|||
156490557|NCT02396953|564890804|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
156490558|NCT02396953|564890805|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
156490559|NCT02396953|564890803|FG000|Overall Study|Personal Reasons|1|||
156490560|NCT02396953|564890804|FG001|Overall Study|Personal Reasons|1|||
156363493|NCT02268786|564430933|FG001|Overall Study|Withdrawal by Subject|14|||
156363494|NCT02268786|564430932|FG000|Overall Study|Thaw Failure|6|||
156363495|NCT02268786|564430933|FG001|Overall Study|Thaw Failure|4|||
156363496|NCT02268786|564430932|FG000|Overall Study|Protocol Violation|1|||
156363497|NCT02268786|564430933|FG001|Overall Study|Protocol Violation|0|||
156363498|NCT00744627|564430934|FG000|Overall Study|Adverse Event|6|||
156363499|NCT00744627|564430935|FG001|Overall Study|Adverse Event|9|||
156490561|NCT02396953|564890805|FG002|Overall Study|Personal Reasons|0|||
156490562|NCT02994784|564890806|FG000|6 Months Follow-up|Lost to Follow-up|3|||
156363500|NCT00744627|564430934|FG000|Overall Study|Lack of Efficacy|7|||
156490563|NCT01011049|564890807|FG000|Overall Study|Protocol Violation|0|||
156363501|NCT00744627|564430935|FG001|Overall Study|Lack of Efficacy|3|||
156363502|NCT00744627|564430934|FG000|Overall Study|Noncompliance|0|||
156363503|NCT00744627|564430935|FG001|Overall Study|Noncompliance|1|||
156363504|NCT00744627|564430934|FG000|Overall Study|Protocol Deviations|0|||
156363505|NCT00744627|564430935|FG001|Overall Study|Protocol Deviations|2|||
156363506|NCT00744627|564430934|FG000|Overall Study|Voluntary Withdrawal|9|||
156363507|NCT00744627|564430935|FG001|Overall Study|Voluntary Withdrawal|6|||
156363508|NCT00744627|564430934|FG000|Overall Study|Lost to Follow-up|2|||
156363509|NCT00744627|564430935|FG001|Overall Study|Lost to Follow-up|1|||
156363510|NCT00744627|564430934|FG000|Overall Study|Other|1|||
156363511|NCT00744627|564430935|FG001|Overall Study|Other|0|||
156363512|NCT04809220|564430938|FG000|Overall Study|Adverse Event|4|||
156363513|NCT04809220|564430939|FG001|Overall Study|Adverse Event|0|||
156363514|NCT04809220|564430938|FG000|Overall Study|Death|1|||
156363515|NCT04809220|564430939|FG001|Overall Study|Death|0|||
156363516|NCT04809220|564430938|FG000|Overall Study|Lost to Follow-up|3|||
156363517|NCT04809220|564430939|FG001|Overall Study|Lost to Follow-up|0|||
156363518|NCT04809220|564430938|FG000|Overall Study|Physician Decision|0|||
156363519|NCT04809220|564430939|FG001|Overall Study|Physician Decision|1|||
156363520|NCT04809220|564430938|FG000|Overall Study|Withdrawal by Subject|9|||
156363521|NCT04809220|564430939|FG001|Overall Study|Withdrawal by Subject|5|||
156363522|NCT04809220|564430938|FG000|Overall Study|Due to long-term overseas business trips|1|||
156490564|NCT01011049|564890808|FG001|Overall Study|Protocol Violation|0|||
156490565|NCT01011049|564890809|FG002|Overall Study|Protocol Violation|2|||
156490566|NCT01011049|564890810|FG003|Overall Study|Protocol Violation|0|||
156490567|NCT01011049|564890807|FG000|Overall Study|Lost to Follow-up|1|||
156490568|NCT01011049|564890808|FG001|Overall Study|Lost to Follow-up|2|||
156490569|NCT01011049|564890809|FG002|Overall Study|Lost to Follow-up|1|||
156490570|NCT01011049|564890810|FG003|Overall Study|Lost to Follow-up|0|||
156490571|NCT01011049|564890807|FG000|Overall Study|Withdrawal by Subject|0|||
156490572|NCT01011049|564890808|FG001|Overall Study|Withdrawal by Subject|0|||
156490573|NCT01011049|564890809|FG002|Overall Study|Withdrawal by Subject|1|||
156490574|NCT01011049|564890810|FG003|Overall Study|Withdrawal by Subject|0|||
156490575|NCT02435381|564890811|FG000|Overall Study|Lost to Follow-up|2|||
156490576|NCT02435381|564890812|FG001|Overall Study|Lost to Follow-up|1|||
156490577|NCT04150341|564890813|FG000|Overall Study|Physician Decision|0|||
156490578|NCT04150341|564890814|FG001|Overall Study|Physician Decision|0|||
156490579|NCT04150341|564890815|FG002|Overall Study|Physician Decision|1|||
156490580|NCT04150341|564890816|FG003|Overall Study|Physician Decision|0|||
156490581|NCT04150341|564890817|FG004|Overall Study|Physician Decision|0|||
156490582|NCT04150341|564890818|FG005|Overall Study|Physician Decision|0|||
156490583|NCT04150341|564890813|FG000|Overall Study|Adverse Event|0|||
156490584|NCT04150341|564890814|FG001|Overall Study|Adverse Event|0|||
156490585|NCT04150341|564890815|FG002|Overall Study|Adverse Event|0|||
156490586|NCT04150341|564890816|FG003|Overall Study|Adverse Event|0|||
156490587|NCT04150341|564890817|FG004|Overall Study|Adverse Event|1|||
156490588|NCT04150341|564890818|FG005|Overall Study|Adverse Event|0|||
156490589|NCT01402063|564890821|FG000|Overall Study|Withdrawal by Subject|3|||
156490590|NCT01402063|564890822|FG001|Overall Study|Withdrawal by Subject|3|||
156490591|NCT03712449|564890827|FG000|Overall Study|Withdraw Consent|0|||
156490592|NCT03712449|564890828|FG001|Overall Study|Withdraw Consent|1|||
156490593|NCT00666198|564890829|FG000|Overall Study|Protocol Violation|10|||
156490594|NCT00666198|564890829|FG000|Overall Study|No Visit After First Day of Treatment|13|||
156490595|NCT00666198|564890829|FG000|Overall Study|Safety Not Assessable|6|||
156490596|NCT00666198|564890829|FG000|Overall Study|No Drug Administration|4|||
156490597|NCT03220776|564890830|FG000|Overall Study|Claustrophobia|0|||
156490598|NCT03220776|564890831|FG001|Overall Study|Claustrophobia|1|||
156490599|NCT03220776|564890832|FG002|Overall Study|Claustrophobia|1|||
156490600|NCT03220776|564890833|FG003|Overall Study|Claustrophobia|0|||
156490601|NCT03220776|564890834|FG004|Overall Study|Claustrophobia|1|||
156490602|NCT03220776|564890835|FG005|Overall Study|Claustrophobia|0|||
156490603|NCT03220776|564890830|FG000|Overall Study|MRI Equipment Failure|1|||
156490604|NCT03220776|564890831|FG001|Overall Study|MRI Equipment Failure|0|||
156490605|NCT03220776|564890832|FG002|Overall Study|MRI Equipment Failure|0|||
156490606|NCT03220776|564890833|FG003|Overall Study|MRI Equipment Failure|0|||
156490607|NCT03220776|564890834|FG004|Overall Study|MRI Equipment Failure|0|||
156490608|NCT03220776|564890835|FG005|Overall Study|MRI Equipment Failure|0|||
156490609|NCT03220776|564890830|FG000|Overall Study|Inclimate Weather|0|||
156490610|NCT03220776|564890831|FG001|Overall Study|Inclimate Weather|0|||
156490611|NCT03220776|564890832|FG002|Overall Study|Inclimate Weather|0|||
156363523|NCT04809220|564430939|FG001|Overall Study|Due to long-term overseas business trips|0|||
156363524|NCT03560531|564430946|FG000|Overall Study|Death|4|||
156363525|NCT03560531|564430947|FG001|Overall Study|Death|1|||
156363526|NCT03560531|564430948|FG002|Overall Study|Death|1|||
156490612|NCT03220776|564890833|FG003|Overall Study|Inclimate Weather|0|||
156490613|NCT03220776|564890834|FG004|Overall Study|Inclimate Weather|0|||
156490614|NCT03220776|564890835|FG005|Overall Study|Inclimate Weather|1|||
156490615|NCT03220776|564890830|FG000|Overall Study|Physician Decision|0|||
156490616|NCT03220776|564890831|FG001|Overall Study|Physician Decision|0|||
156490617|NCT03220776|564890832|FG002|Overall Study|Physician Decision|0|||
156490618|NCT03220776|564890833|FG003|Overall Study|Physician Decision|1|||
156363527|NCT03560531|564430949|FG003|Overall Study|Death|2|||
156363528|NCT03560531|564430950|FG004|Overall Study|Death|6|||
156363529|NCT03560531|564430951|FG005|Overall Study|Death|1|||
156363530|NCT03560531|564430952|FG006|Overall Study|Death|4|||
156363531|NCT03560531|564430953|FG007|Overall Study|Death|8|||
156363532|NCT03560531|564430954|FG008|Overall Study|Death|1|||
156363533|NCT03560531|564430955|FG009|Overall Study|Death|3|||
156363534|NCT03560531|564430956|FG010|Overall Study|Death|2|||
156363535|NCT03560531|564430957|FG011|Overall Study|Death|0|||
156363536|NCT03560531|564430958|FG012|Overall Study|Death|4|||
156363537|NCT03560531|564430959|FG013|Overall Study|Death|1|||
156363538|NCT03560531|564430946|FG000|Overall Study|Lost to Follow-up|1|||
156363539|NCT03560531|564430947|FG001|Overall Study|Lost to Follow-up|1|||
156363540|NCT03560531|564430948|FG002|Overall Study|Lost to Follow-up|0|||
156363541|NCT03560531|564430949|FG003|Overall Study|Lost to Follow-up|0|||
156363542|NCT03560531|564430950|FG004|Overall Study|Lost to Follow-up|0|||
156363543|NCT03560531|564430951|FG005|Overall Study|Lost to Follow-up|0|||
156363544|NCT03560531|564430952|FG006|Overall Study|Lost to Follow-up|1|||
156363545|NCT03560531|564430953|FG007|Overall Study|Lost to Follow-up|0|||
156363546|NCT03560531|564430954|FG008|Overall Study|Lost to Follow-up|0|||
156363547|NCT03560531|564430955|FG009|Overall Study|Lost to Follow-up|0|||
156363548|NCT03560531|564430956|FG010|Overall Study|Lost to Follow-up|0|||
156363549|NCT03560531|564430957|FG011|Overall Study|Lost to Follow-up|0|||
156363550|NCT03560531|564430958|FG012|Overall Study|Lost to Follow-up|0|||
156363551|NCT03560531|564430959|FG013|Overall Study|Lost to Follow-up|0|||
156363552|NCT03560531|564430946|FG000|Overall Study|Withdrawal by Subject|1|||
156363553|NCT03560531|564430947|FG001|Overall Study|Withdrawal by Subject|0|||
156363554|NCT03560531|564430948|FG002|Overall Study|Withdrawal by Subject|0|||
156363555|NCT03560531|564430949|FG003|Overall Study|Withdrawal by Subject|0|||
156363556|NCT03560531|564430950|FG004|Overall Study|Withdrawal by Subject|0|||
156363557|NCT03560531|564430951|FG005|Overall Study|Withdrawal by Subject|0|||
156363558|NCT03560531|564430952|FG006|Overall Study|Withdrawal by Subject|0|||
156363559|NCT03560531|564430953|FG007|Overall Study|Withdrawal by Subject|3|||
156363560|NCT03560531|564430954|FG008|Overall Study|Withdrawal by Subject|2|||
156363561|NCT03560531|564430955|FG009|Overall Study|Withdrawal by Subject|0|||
156363562|NCT03560531|564430956|FG010|Overall Study|Withdrawal by Subject|0|||
156363563|NCT03560531|564430957|FG011|Overall Study|Withdrawal by Subject|0|||
156363564|NCT03560531|564430958|FG012|Overall Study|Withdrawal by Subject|2|||
156363565|NCT03560531|564430959|FG013|Overall Study|Withdrawal by Subject|0|||
156363566|NCT03560531|564430946|FG000|Overall Study|Study end per-protocol|1|||
156363567|NCT03560531|564430947|FG001|Overall Study|Study end per-protocol|1|||
156363568|NCT03560531|564430948|FG002|Overall Study|Study end per-protocol|2|||
156363569|NCT03560531|564430949|FG003|Overall Study|Study end per-protocol|0|||
156363570|NCT03560531|564430950|FG004|Overall Study|Study end per-protocol|1|||
156363571|NCT03560531|564430951|FG005|Overall Study|Study end per-protocol|0|||
156363572|NCT03560531|564430952|FG006|Overall Study|Study end per-protocol|0|||
156363573|NCT03560531|564430953|FG007|Overall Study|Study end per-protocol|0|||
156363574|NCT03560531|564430954|FG008|Overall Study|Study end per-protocol|0|||
156363575|NCT03560531|564430955|FG009|Overall Study|Study end per-protocol|0|||
156363576|NCT03560531|564430956|FG010|Overall Study|Study end per-protocol|0|||
156363577|NCT03560531|564430957|FG011|Overall Study|Study end per-protocol|0|||
156363578|NCT03560531|564430958|FG012|Overall Study|Study end per-protocol|0|||
156363579|NCT03560531|564430959|FG013|Overall Study|Study end per-protocol|0|||
156363580|NCT03560531|564430946|FG000|Overall Study|Early study termination by sponsor|9|||
156363581|NCT03560531|564430947|FG001|Overall Study|Early study termination by sponsor|0|||
156363582|NCT03560531|564430948|FG002|Overall Study|Early study termination by sponsor|0|||
156363583|NCT03560531|564430949|FG003|Overall Study|Early study termination by sponsor|4|||
156363584|NCT03560531|564430950|FG004|Overall Study|Early study termination by sponsor|8|||
156363585|NCT03560531|564430951|FG005|Overall Study|Early study termination by sponsor|2|||
156363586|NCT03560531|564430952|FG006|Overall Study|Early study termination by sponsor|5|||
156363587|NCT03560531|564430953|FG007|Overall Study|Early study termination by sponsor|64|||
156363588|NCT03560531|564430954|FG008|Overall Study|Early study termination by sponsor|7|||
156363589|NCT03560531|564430955|FG009|Overall Study|Early study termination by sponsor|2|||
156363590|NCT03560531|564430956|FG010|Overall Study|Early study termination by sponsor|16|||
156363591|NCT03560531|564430957|FG011|Overall Study|Early study termination by sponsor|2|||
156363592|NCT03560531|564430958|FG012|Overall Study|Early study termination by sponsor|6|||
156363593|NCT03560531|564430959|FG013|Overall Study|Early study termination by sponsor|2|||
156363594|NCT03745144|564430960|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
156363595|NCT03745144|564430961|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
156363596|NCT03745144|564430962|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
156363597|NCT03745144|564430960|FG000|Period 1|Other|0|||
156363598|NCT03745144|564430961|FG001|Period 1|Other|0|||
156363599|NCT03745144|564430962|FG002|Period 1|Other|1|||
156363600|NCT00642668|564430967|FG000|Overall Study|Lost to Follow-up|1|||
156363601|NCT00642668|564430967|FG000|Overall Study|Adverse Event|2|||
156363602|NCT00642668|564430967|FG000|Overall Study|Death|2|||
156363603|NCT00642668|564430967|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156363604|NCT00642668|564430967|FG000|Overall Study|Failure to Return|1|||
156363605|NCT00642668|564430967|FG000|Overall Study|Dialysis Initiation|5|||
156363606|NCT00642668|564430967|FG000|Overall Study|Blood Transfusion|2|||
156363607|NCT01177540|564430968|FG000|Overall Study|Adverse Event|1|||
156363608|NCT01177540|564430969|FG001|Overall Study|Adverse Event|0|||
156363609|NCT01586819|564430970|FG000|Overall Study|Withdrawal by Subject|1|||
156363610|NCT01586819|564430971|FG001|Overall Study|Withdrawal by Subject|0|||
156363611|NCT00896337|564430972|FG000|Overall Study|Death|7|||
156363612|NCT00896337|564430972|FG000|Overall Study|Withdrawal by Subject|7|||
156363613|NCT00896337|564430972|FG000|Overall Study|Lost to Follow-up|11|||
156363614|NCT00574405|564432556|FG000|Overall Study|Withdrawal by Subject|3|||
156363615|NCT00574405|564432557|FG001|Overall Study|Withdrawal by Subject|2|||
156363616|NCT01336738|564432558|FG000|Overall Study|Adverse Event|0|||
156363617|NCT01336738|564432559|FG001|Overall Study|Adverse Event|3|||
156363618|NCT01336738|564432560|FG002|Overall Study|Adverse Event|2|||
156363619|NCT01336738|564432561|FG003|Overall Study|Adverse Event|1|||
156363620|NCT01336738|564432562|FG004|Overall Study|Adverse Event|3|||
156363621|NCT01336738|564432558|FG000|Overall Study|Lost to Follow-up|2|||
156363622|NCT01336738|564432559|FG001|Overall Study|Lost to Follow-up|1|||
156363623|NCT01336738|564432560|FG002|Overall Study|Lost to Follow-up|2|||
156363624|NCT01336738|564432561|FG003|Overall Study|Lost to Follow-up|2|||
156363625|NCT01336738|564432562|FG004|Overall Study|Lost to Follow-up|2|||
156363626|NCT01336738|564432558|FG000|Overall Study|Did not meet entrance criteria|0|||
156363627|NCT01336738|564432559|FG001|Overall Study|Did not meet entrance criteria|1|||
156363628|NCT01336738|564432560|FG002|Overall Study|Did not meet entrance criteria|0|||
156363629|NCT01336738|564432561|FG003|Overall Study|Did not meet entrance criteria|0|||
156363630|NCT01336738|564432562|FG004|Overall Study|Did not meet entrance criteria|0|||
156363631|NCT01336738|564432558|FG000|Overall Study|Protocol Violation|0|||
156363632|NCT01336738|564432559|FG001|Overall Study|Protocol Violation|1|||
156363633|NCT01336738|564432560|FG002|Overall Study|Protocol Violation|0|||
156363634|NCT01336738|564432561|FG003|Overall Study|Protocol Violation|0|||
156363635|NCT01336738|564432562|FG004|Overall Study|Protocol Violation|0|||
156363636|NCT01336738|564432558|FG000|Overall Study|Withdrawal by Subject|2|||
156363637|NCT01336738|564432559|FG001|Overall Study|Withdrawal by Subject|0|||
156363638|NCT01336738|564432560|FG002|Overall Study|Withdrawal by Subject|2|||
156363639|NCT01336738|564432561|FG003|Overall Study|Withdrawal by Subject|1|||
156363640|NCT01336738|564432562|FG004|Overall Study|Withdrawal by Subject|1|||
156363641|NCT01336738|564432558|FG000|Overall Study|Other|3|||
156363642|NCT01336738|564432559|FG001|Overall Study|Other|3|||
156363643|NCT01336738|564432560|FG002|Overall Study|Other|2|||
156363644|NCT01336738|564432561|FG003|Overall Study|Other|3|||
156363645|NCT01336738|564432562|FG004|Overall Study|Other|4|||
156363646|NCT01083433|564432563|FG000|Overall Study|Lost to Follow-up|2|||
156363647|NCT01083433|564432564|FG001|Overall Study|Lost to Follow-up|1|||
156363648|NCT01083433|564432565|FG002|Overall Study|Lost to Follow-up|1|||
156363649|NCT01083433|564432563|FG000|Overall Study|Withdrawal by Subject|0|||
156363650|NCT01083433|564432564|FG001|Overall Study|Withdrawal by Subject|5|||
156363651|NCT01083433|564432565|FG002|Overall Study|Withdrawal by Subject|3|||
156490619|NCT03220776|564890834|FG004|Overall Study|Physician Decision|0|||
156490620|NCT03220776|564890835|FG005|Overall Study|Physician Decision|0|||
156490621|NCT03220776|564890830|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
156490622|NCT03220776|564890831|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
156363652|NCT01083433|564432563|FG000|Overall Study|Pregnancy|0|||
156363653|NCT01083433|564432564|FG001|Overall Study|Pregnancy|0|||
156363654|NCT01083433|564432565|FG002|Overall Study|Pregnancy|1|||
156363655|NCT01332149|564432567|FG000|Overall Study|Adverse Event|11|||
156363656|NCT01332149|564432568|FG001|Overall Study|Adverse Event|9|||
156363657|NCT01332149|564432567|FG000|Overall Study|Other unspecified|5|||
156363658|NCT01332149|564432568|FG001|Overall Study|Other unspecified|7|||
156363659|NCT01332149|564432567|FG000|Overall Study|Protocol Violation|1|||
156363660|NCT01332149|564432568|FG001|Overall Study|Protocol Violation|3|||
156363661|NCT01332149|564432567|FG000|Overall Study|Withdrawal by Subject|4|||
156363662|NCT01332149|564432568|FG001|Overall Study|Withdrawal by Subject|5|||
156363663|NCT01332149|564432567|FG000|Overall Study|Lost to Follow-up|1|||
156363664|NCT01332149|564432568|FG001|Overall Study|Lost to Follow-up|1|||
156363665|NCT01332149|564432567|FG000|Overall Study|Insufficient clinical response|4|||
156363666|NCT01332149|564432568|FG001|Overall Study|Insufficient clinical response|7|||
156363667|NCT01332149|564432567|FG000|Overall Study|Did not meet entrance criteria|3|||
156363668|NCT01332149|564432568|FG001|Overall Study|Did not meet entrance criteria|4|||
156363669|NCT01332149|564432567|FG000|Overall Study|Randomized but not treated|1|||
156363670|NCT01332149|564432568|FG001|Overall Study|Randomized but not treated|2|||
156363671|NCT04982029|564432569|FG000|Overall Study|Lost to Follow-up|2|||
156363672|NCT04982029|564432570|FG001|Overall Study|Lost to Follow-up|3|||
156363673|NCT04615949|564432571|FG000|Overall Study|Withdrawal by Subject|2|||
156363674|NCT04615949|564432572|FG001|Overall Study|Withdrawal by Subject|4|||
156363675|NCT04615949|564432571|FG000|Overall Study|Lost to Follow-up|2|||
156363676|NCT04615949|564432572|FG001|Overall Study|Lost to Follow-up|2|||
156363677|NCT04615949|564432571|FG000|Overall Study|Death|0|||
156363678|NCT04615949|564432572|FG001|Overall Study|Death|2|||
156363679|NCT03036566|564432573|FG000|Overall Study|Lost to Follow-up|3|||
156363680|NCT05458856|564432574|FG000|Overall Study|Withdrawal by Subject|5|||
156363681|NCT05458856|564432574|FG000|Overall Study|Death|4|||
156363682|NCT05458856|564432574|FG000|Overall Study|Protocol Deviation|3|||
156363683|NCT05458856|564432574|FG000|Overall Study|Physician Decision|1|||
156363684|NCT03240133|564432577|FG000|Overall Study|Withdrawal by Subject|0|||
156363685|NCT03240133|564432578|FG001|Overall Study|Withdrawal by Subject|1|||
156363686|NCT03240133|564432579|FG002|Overall Study|Withdrawal by Subject|0|||
156363687|NCT03240133|564432577|FG000|Overall Study|Adverse Event|1|||
156363688|NCT03240133|564432578|FG001|Overall Study|Adverse Event|1|||
156363689|NCT03240133|564432579|FG002|Overall Study|Adverse Event|0|||
156363690|NCT03240133|564432577|FG000|Overall Study|Rash|1|||
156363691|NCT03240133|564432578|FG001|Overall Study|Rash|0|||
156363692|NCT03240133|564432579|FG002|Overall Study|Rash|0|||
156363693|NCT03240133|564432577|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
156363694|NCT03240133|564432578|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
156363695|NCT03240133|564432579|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
156363696|NCT03240133|564432577|FG000|Overall Study|Intercurrent illness.|0|||
156363697|NCT03240133|564432578|FG001|Overall Study|Intercurrent illness.|1|||
156363698|NCT03240133|564432579|FG002|Overall Study|Intercurrent illness.|0|||
156363699|NCT03240133|564432577|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
156363700|NCT03240133|564432578|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
156363701|NCT03240133|564432579|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
156363702|NCT00116831|564432580|FG000|Overall Study|Adverse Event|14|||
156363703|NCT00116831|564432581|FG001|Overall Study|Adverse Event|16|||
156363704|NCT00116831|564432580|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
156363705|NCT00116831|564432581|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
156363706|NCT00116831|564432580|FG000|Overall Study|Lost to Follow-up|8|||
156363707|NCT00116831|564432581|FG001|Overall Study|Lost to Follow-up|6|||
156363708|NCT00116831|564432580|FG000|Overall Study|Protocol Violation|3|||
156363709|NCT00116831|564432581|FG001|Overall Study|Protocol Violation|6|||
156363710|NCT00116831|564432580|FG000|Overall Study|Hypoglycaemic events|1|||
156363711|NCT00116831|564432581|FG001|Overall Study|Hypoglycaemic events|0|||
156363712|NCT00116831|564432580|FG000|Overall Study|Low haemoglobin on screening|1|||
156490623|NCT03220776|564890832|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
156490624|NCT03220776|564890833|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
156490625|NCT03220776|564890834|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
156490626|NCT03220776|564890835|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
156490627|NCT03220776|564890830|FG000|Overall Study|Protocol Violation|0|||
156490628|NCT03220776|564890831|FG001|Overall Study|Protocol Violation|0|||
156490629|NCT03220776|564890832|FG002|Overall Study|Protocol Violation|0|||
156490630|NCT03220776|564890833|FG003|Overall Study|Protocol Violation|2|||
156490631|NCT03220776|564890834|FG004|Overall Study|Protocol Violation|0|||
156490632|NCT03220776|564890835|FG005|Overall Study|Protocol Violation|1|||
156490633|NCT03220776|564890830|FG000|Overall Study|Withdrawal by Subject|1|||
156545762|NCT02116777|565091694|FG006|Overall Study|Withdrawal by Subject|0|||
156545763|NCT00733954|565091696|FG000|Overall Study|Lost to Follow-up|5|||
156545764|NCT00733954|565091697|FG001|Overall Study|Lost to Follow-up|2|||
156545765|NCT00733954|565091696|FG000|Overall Study|Protocol Violation|1|||
156545766|NCT00733954|565091697|FG001|Overall Study|Protocol Violation|0|||
156545767|NCT00733954|565091696|FG000|Overall Study|Withdrawal by Subject|2|||
156545768|NCT00733954|565091697|FG001|Overall Study|Withdrawal by Subject|0|||
156545769|NCT02663453|565091698|FG000|Overall Study|Death|4|||
156363713|NCT00116831|564432581|FG001|Overall Study|Low haemoglobin on screening|0|||
156363714|NCT00116831|564432580|FG000|Overall Study|Withdrawn investigational product|1|||
156363715|NCT00116831|564432581|FG001|Overall Study|Withdrawn investigational product|0|||
156363716|NCT00116831|564432580|FG000|Overall Study|Withdrawal by Subject|32|||
156363717|NCT00116831|564432581|FG001|Overall Study|Withdrawal by Subject|32|||
156363718|NCT00116831|564432580|FG000|Overall Study|Insufficient therapeutic effect|0|||
156363719|NCT00116831|564432581|FG001|Overall Study|Insufficient therapeutic effect|1|||
156363720|NCT00116831|564432580|FG000|Overall Study|Missing data for participant|1|||
156363721|NCT00116831|564432581|FG001|Overall Study|Missing data for participant|0|||
156490634|NCT03220776|564890831|FG001|Overall Study|Withdrawal by Subject|0|||
156363722|NCT04200248|564432586|FG000|Overall Study|Personal reasons|0|||
156363723|NCT04200248|564432587|FG001|Overall Study|Personal reasons|0|||
156363724|NCT04200248|564432588|FG002|Overall Study|Personal reasons|1|||
156363725|NCT04200248|564432586|FG000|Overall Study|Discontinued prior to treatment|3|||
156363726|NCT04200248|564432587|FG001|Overall Study|Discontinued prior to treatment|3|||
156363727|NCT04200248|564432588|FG002|Overall Study|Discontinued prior to treatment|2|||
156363728|NCT00302003|564432591|FG000|Overall Study|Lack of Efficacy|62|||
156363729|NCT00302003|564432591|FG000|Overall Study|Lost to Follow-up|1|||
156363730|NCT00302003|564432591|FG000|Overall Study|Physician Decision|2|||
156363731|NCT00302003|564432591|FG000|Overall Study|Withdrawal by Subject|5|||
156363732|NCT00302003|564432591|FG000|Overall Study|Ineligible|9|||
156363733|NCT00302003|564432591|FG000|Overall Study|Protocol Violation|1|||
156363734|NCT04627064|564432602|FG000|Overall Study|Progressive disease|8|||
156363735|NCT04627064|564432603|FG001|Overall Study|Progressive disease|0|||
156363736|NCT04627064|564432602|FG000|Overall Study|Withdrawal by Subject|2|||
156363737|NCT04627064|564432603|FG001|Overall Study|Withdrawal by Subject|0|||
156363738|NCT04627064|564432602|FG000|Overall Study|Physician Decision|1|||
156363739|NCT04627064|564432603|FG001|Overall Study|Physician Decision|0|||
156363740|NCT01533246|564432608|FG000|Overall Study|Adverse Event|1|||
156490635|NCT03220776|564890832|FG002|Overall Study|Withdrawal by Subject|0|||
156490636|NCT03220776|564890833|FG003|Overall Study|Withdrawal by Subject|0|||
156490637|NCT03220776|564890834|FG004|Overall Study|Withdrawal by Subject|0|||
156490638|NCT03220776|564890835|FG005|Overall Study|Withdrawal by Subject|0|||
156490639|NCT03029234|564890837|FG000|Overall Study|Sponsor Decision|1|||
156363741|NCT01533246|564432608|FG000|Overall Study|Withdrawal by Subject|1|||
156363742|NCT04238728|564432609|FG000|Overall Study|Withdrawal by Subject|1|||
156363743|NCT04238728|564432609|FG000|Overall Study|Lost to Follow-up|2|||
156363744|NCT00829296|564432612|FG000|Overall Study|Adverse Event|5|||
156363745|NCT00829296|564432613|FG001|Overall Study|Adverse Event|4|||
156363746|NCT04960228|564432615|FG000|Overall Study|Withdrawal by Subject|216|||
156363747|NCT04960228|564432616|FG001|Overall Study|Withdrawal by Subject|35|||
156363748|NCT04960228|564432615|FG000|Overall Study|Failed attention check|69|||
156363749|NCT04960228|564432616|FG001|Overall Study|Failed attention check|148|||
156363750|NCT04960228|564432615|FG000|Overall Study|Flagged for response quality by Dynata|3|||
156363751|NCT04960228|564432616|FG001|Overall Study|Flagged for response quality by Dynata|3|||
156490640|NCT03029234|564890837|FG000|Overall Study|Withdrawal by Subject|5|||
156490641|NCT03029234|564890837|FG000|Overall Study|Death|91|||
156490642|NCT03029234|564890837|FG000|Overall Study|Lost to Follow-up|2|||
156490643|NCT04491006|564890838|FG000|Overall Study|Adverse Event|0|||
156490644|NCT04491006|564890839|FG001|Overall Study|Adverse Event|3|||
156490645|NCT04491006|564890840|FG002|Overall Study|Adverse Event|5|||
156490646|NCT04491006|564890838|FG000|Overall Study|Withdrawal by Subject|1|||
156490647|NCT04491006|564890839|FG001|Overall Study|Withdrawal by Subject|0|||
156490648|NCT04491006|564890840|FG002|Overall Study|Withdrawal by Subject|2|||
156490649|NCT02166047|564890841|FG000|Overall Study|Withdrawal by Participant|0|||
156490650|NCT02166047|564890842|FG001|Overall Study|Withdrawal by Participant|1|||
156490651|NCT02166047|564890843|FG002|Overall Study|Withdrawal by Participant|2|||
156490652|NCT02166047|564890844|FG003|Overall Study|Withdrawal by Participant|0|||
156490653|NCT02166047|564890845|FG004|Overall Study|Withdrawal by Participant|0|||
156490654|NCT02166047|564890846|FG005|Overall Study|Withdrawal by Participant|0|||
156490655|NCT02166047|564890847|FG006|Overall Study|Withdrawal by Participant|1|||
156490656|NCT02166047|564890848|FG007|Overall Study|Withdrawal by Participant|0|||
156490657|NCT02166047|564890849|FG008|Overall Study|Withdrawal by Participant|0|||
156490658|NCT02166047|564890850|FG009|Overall Study|Withdrawal by Participant|0|||
156490659|NCT02166047|564890851|FG010|Overall Study|Withdrawal by Participant|0|||
156490660|NCT02166047|564890852|FG011|Overall Study|Withdrawal by Participant|0|||
156490661|NCT02166047|564890841|FG000|Overall Study|Adverse Event|0|||
156490662|NCT02166047|564890842|FG001|Overall Study|Adverse Event|0|||
156490663|NCT02166047|564890843|FG002|Overall Study|Adverse Event|0|||
156490664|NCT02166047|564890844|FG003|Overall Study|Adverse Event|0|||
156490665|NCT02166047|564890845|FG004|Overall Study|Adverse Event|1|||
156490666|NCT02166047|564890846|FG005|Overall Study|Adverse Event|0|||
156490667|NCT02166047|564890847|FG006|Overall Study|Adverse Event|1|||
156490668|NCT02166047|564890848|FG007|Overall Study|Adverse Event|0|||
156490669|NCT02166047|564890849|FG008|Overall Study|Adverse Event|0|||
156363752|NCT01987427|564432617|FG000|Overall Study|Adverse Event|4|||
156363753|NCT01987427|564432618|FG001|Overall Study|Adverse Event|2|||
156363754|NCT01987427|564432619|FG002|Overall Study|Adverse Event|8|||
156363755|NCT01987427|564432617|FG000|Overall Study|Lost to Follow-up|6|||
156363756|NCT01987427|564432618|FG001|Overall Study|Lost to Follow-up|6|||
156490670|NCT02166047|564890850|FG009|Overall Study|Adverse Event|0|||
156490671|NCT02166047|564890851|FG010|Overall Study|Adverse Event|2|||
156490672|NCT02166047|564890852|FG011|Overall Study|Adverse Event|0|||
156490673|NCT00451555|564890858|FG000|Overall Study|Protocol Violation|2|||
156490674|NCT00451555|564890859|FG001|Overall Study|Protocol Violation|2|||
156363757|NCT01987427|564432619|FG002|Overall Study|Lost to Follow-up|9|||
156363758|NCT01987427|564432617|FG000|Overall Study|Withdrawal by Subject|2|||
156363759|NCT01987427|564432618|FG001|Overall Study|Withdrawal by Subject|1|||
156363760|NCT01987427|564432619|FG002|Overall Study|Withdrawal by Subject|3|||
156363761|NCT01987427|564432617|FG000|Overall Study|Lack of Efficacy|1|||
156363762|NCT01987427|564432618|FG001|Overall Study|Lack of Efficacy|0|||
156363763|NCT01987427|564432619|FG002|Overall Study|Lack of Efficacy|0|||
156363764|NCT01987427|564432617|FG000|Overall Study|Other|1|||
156363765|NCT01987427|564432618|FG001|Overall Study|Other|1|||
156363766|NCT01987427|564432619|FG002|Overall Study|Other|0|||
156363767|NCT00594464|564432625|FG000|Overall Study|Withdrawal by Subject|1|||
156363768|NCT00594464|564432625|FG000|Overall Study|Delay in operation|2|||
156363769|NCT00785486|564432626|FG000|Midazolam Alone|Withdrawal by Subject|1|||
156363770|NCT03131440|564432631|FG000|Overall Study|Withdrawal by Subject|1|||
156363771|NCT03131440|564432632|FG001|Overall Study|Withdrawal by Subject|3|||
156363772|NCT03131440|564432633|FG002|Overall Study|Withdrawal by Subject|0|||
156363773|NCT03131440|564432634|FG003|Overall Study|Withdrawal by Subject|0|||
156363774|NCT03131440|564432635|FG004|Overall Study|Withdrawal by Subject|1|||
156363775|NCT03131440|564432636|FG005|Overall Study|Withdrawal by Subject|0|||
156363776|NCT03131440|564432637|FG006|Overall Study|Withdrawal by Subject|0|||
156363777|NCT03131440|564432638|FG007|Overall Study|Withdrawal by Subject|1|||
156363778|NCT03131440|564432639|FG008|Overall Study|Withdrawal by Subject|1|||
156363779|NCT03131440|564432640|FG009|Overall Study|Withdrawal by Subject|1|||
156363780|NCT03131440|564432641|FG010|Overall Study|Withdrawal by Subject|0|||
156363781|NCT03131440|564432642|FG011|Overall Study|Withdrawal by Subject|1|||
156363782|NCT03131440|564432643|FG012|Overall Study|Withdrawal by Subject|1|||
156363783|NCT03131440|564432644|FG013|Overall Study|Withdrawal by Subject|0|||
156363784|NCT03131440|564432645|FG014|Overall Study|Withdrawal by Subject|1|||
156363785|NCT03131440|564432646|FG015|Overall Study|Withdrawal by Subject|0|||
156363786|NCT03131440|564432647|FG016|Overall Study|Withdrawal by Subject|0|||
156363787|NCT03131440|564432648|FG017|Overall Study|Withdrawal by Subject|0|||
156363788|NCT03131440|564432649|FG018|Overall Study|Withdrawal by Subject|1|||
156363789|NCT03131440|564432650|FG019|Overall Study|Withdrawal by Subject|0|||
156363790|NCT03131440|564432651|FG020|Overall Study|Withdrawal by Subject|1|||
156363791|NCT03131440|564432652|FG021|Overall Study|Withdrawal by Subject|1|||
156363792|NCT03131440|564432653|FG022|Overall Study|Withdrawal by Subject|1|||
156363793|NCT03131440|564432654|FG023|Overall Study|Withdrawal by Subject|0|||
156363794|NCT03131440|564432655|FG024|Overall Study|Withdrawal by Subject|0|||
156363795|NCT03131440|564432656|FG025|Overall Study|Withdrawal by Subject|0|||
156363796|NCT03131440|564432657|FG026|Overall Study|Withdrawal by Subject|0|||
156363797|NCT03131440|564432658|FG027|Overall Study|Withdrawal by Subject|0|||
156363798|NCT03131440|564432659|FG028|Overall Study|Withdrawal by Subject|0|||
156363799|NCT03131440|564432660|FG029|Overall Study|Withdrawal by Subject|0|||
156363800|NCT03131440|564432661|FG030|Overall Study|Withdrawal by Subject|1|||
156363801|NCT03131440|564432662|FG031|Overall Study|Withdrawal by Subject|0|||
156363802|NCT03131440|564432631|FG000|Overall Study|Lost to Follow-up|0|||
156363803|NCT03131440|564432632|FG001|Overall Study|Lost to Follow-up|0|||
156363804|NCT03131440|564432633|FG002|Overall Study|Lost to Follow-up|0|||
156363805|NCT03131440|564432634|FG003|Overall Study|Lost to Follow-up|0|||
156363806|NCT03131440|564432635|FG004|Overall Study|Lost to Follow-up|0|||
156363807|NCT03131440|564432636|FG005|Overall Study|Lost to Follow-up|1|||
156363808|NCT03131440|564432637|FG006|Overall Study|Lost to Follow-up|0|||
156363809|NCT03131440|564432638|FG007|Overall Study|Lost to Follow-up|0|||
156363810|NCT03131440|564432639|FG008|Overall Study|Lost to Follow-up|0|||
156363811|NCT03131440|564432640|FG009|Overall Study|Lost to Follow-up|0|||
156363812|NCT03131440|564432641|FG010|Overall Study|Lost to Follow-up|0|||
156363813|NCT03131440|564432642|FG011|Overall Study|Lost to Follow-up|0|||
156363814|NCT03131440|564432643|FG012|Overall Study|Lost to Follow-up|0|||
156363815|NCT03131440|564432644|FG013|Overall Study|Lost to Follow-up|0|||
156363816|NCT03131440|564432645|FG014|Overall Study|Lost to Follow-up|0|||
156363817|NCT03131440|564432646|FG015|Overall Study|Lost to Follow-up|0|||
156363818|NCT03131440|564432647|FG016|Overall Study|Lost to Follow-up|0|||
156490675|NCT00451555|564890858|FG000|Overall Study|Adverse Event|3|||
156363819|NCT03131440|564432648|FG017|Overall Study|Lost to Follow-up|0|||
156363820|NCT03131440|564432649|FG018|Overall Study|Lost to Follow-up|0|||
156363821|NCT03131440|564432650|FG019|Overall Study|Lost to Follow-up|2|||
156490676|NCT00451555|564890859|FG001|Overall Study|Adverse Event|1|||
156363822|NCT03131440|564432651|FG020|Overall Study|Lost to Follow-up|1|||
156363823|NCT03131440|564432652|FG021|Overall Study|Lost to Follow-up|0|||
156490677|NCT00451555|564890858|FG000|Overall Study|Withdrawal by Subject|6|||
156490678|NCT00451555|564890859|FG001|Overall Study|Withdrawal by Subject|0|||
156363824|NCT03131440|564432653|FG022|Overall Study|Lost to Follow-up|1|||
156363825|NCT03131440|564432654|FG023|Overall Study|Lost to Follow-up|0|||
156363826|NCT03131440|564432655|FG024|Overall Study|Lost to Follow-up|1|||
156363827|NCT03131440|564432656|FG025|Overall Study|Lost to Follow-up|0|||
156363828|NCT03131440|564432657|FG026|Overall Study|Lost to Follow-up|0|||
156363829|NCT03131440|564432658|FG027|Overall Study|Lost to Follow-up|2|||
156363830|NCT03131440|564432659|FG028|Overall Study|Lost to Follow-up|0|||
156363831|NCT03131440|564432660|FG029|Overall Study|Lost to Follow-up|2|||
156363832|NCT03131440|564432661|FG030|Overall Study|Lost to Follow-up|0|||
156363833|NCT03131440|564432662|FG031|Overall Study|Lost to Follow-up|0|||
156363834|NCT03131440|564432631|FG000|Overall Study|Death|0|||
156363835|NCT03131440|564432632|FG001|Overall Study|Death|0|||
156363836|NCT03131440|564432633|FG002|Overall Study|Death|0|||
156363837|NCT03131440|564432634|FG003|Overall Study|Death|0|||
156363838|NCT03131440|564432635|FG004|Overall Study|Death|0|||
156363839|NCT03131440|564432636|FG005|Overall Study|Death|0|||
156363840|NCT03131440|564432637|FG006|Overall Study|Death|0|||
156363841|NCT03131440|564432638|FG007|Overall Study|Death|0|||
156363842|NCT03131440|564432639|FG008|Overall Study|Death|0|||
156363843|NCT03131440|564432640|FG009|Overall Study|Death|0|||
156363844|NCT03131440|564432641|FG010|Overall Study|Death|0|||
156363845|NCT03131440|564432642|FG011|Overall Study|Death|0|||
156363846|NCT03131440|564432643|FG012|Overall Study|Death|0|||
156363847|NCT03131440|564432644|FG013|Overall Study|Death|0|||
156363848|NCT03131440|564432645|FG014|Overall Study|Death|0|||
156363849|NCT03131440|564432646|FG015|Overall Study|Death|0|||
156363850|NCT03131440|564432647|FG016|Overall Study|Death|0|||
156363851|NCT03131440|564432648|FG017|Overall Study|Death|0|||
156363852|NCT03131440|564432649|FG018|Overall Study|Death|0|||
156363853|NCT03131440|564432650|FG019|Overall Study|Death|0|||
156363854|NCT03131440|564432651|FG020|Overall Study|Death|0|||
156363855|NCT03131440|564432652|FG021|Overall Study|Death|0|||
156363856|NCT03131440|564432653|FG022|Overall Study|Death|0|||
156363857|NCT03131440|564432654|FG023|Overall Study|Death|0|||
156363858|NCT03131440|564432655|FG024|Overall Study|Death|0|||
156363859|NCT03131440|564432656|FG025|Overall Study|Death|1|||
156363860|NCT03131440|564432657|FG026|Overall Study|Death|0|||
156363861|NCT03131440|564432658|FG027|Overall Study|Death|0|||
156363862|NCT03131440|564432659|FG028|Overall Study|Death|0|||
156363863|NCT03131440|564432660|FG029|Overall Study|Death|0|||
156363864|NCT03131440|564432661|FG030|Overall Study|Death|0|||
156363865|NCT03131440|564432662|FG031|Overall Study|Death|0|||
156363866|NCT00746941|564432665|FG000|Overall Study|Death|2|||
156363867|NCT00746941|564432666|FG001|Overall Study|Death|0|||
156363868|NCT00746941|564432667|FG002|Overall Study|Death|0|||
156363869|NCT00746941|564432668|FG003|Overall Study|Death|6|||
156363870|NCT00746941|564432665|FG000|Overall Study|Physician Decision|0|||
156363871|NCT00746941|564432666|FG001|Overall Study|Physician Decision|0|||
156363872|NCT00746941|564432667|FG002|Overall Study|Physician Decision|2|||
156363873|NCT00746941|564432668|FG003|Overall Study|Physician Decision|0|||
156363874|NCT00746941|564432665|FG000|Overall Study|Withdrawal by Subject|3|||
156363875|NCT00746941|564432666|FG001|Overall Study|Withdrawal by Subject|0|||
156363876|NCT00746941|564432667|FG002|Overall Study|Withdrawal by Subject|0|||
156363877|NCT00746941|564432668|FG003|Overall Study|Withdrawal by Subject|2|||
156363878|NCT00746941|564432665|FG000|Overall Study|Other, reason not provided|2|||
156363879|NCT00746941|564432666|FG001|Overall Study|Other, reason not provided|4|||
156363880|NCT00746941|564432667|FG002|Overall Study|Other, reason not provided|0|||
156363881|NCT00746941|564432668|FG003|Overall Study|Other, reason not provided|4|||
156363882|NCT00746941|564432665|FG000|Overall Study|Adverse Event|0|||
156363883|NCT00746941|564432666|FG001|Overall Study|Adverse Event|0|||
156363884|NCT00746941|564432667|FG002|Overall Study|Adverse Event|0|||
156363885|NCT00746941|564432668|FG003|Overall Study|Adverse Event|1|||
156363886|NCT02818777|564432684|FG000|Overall Study|Adverse Event|3|||
156363887|NCT00747435|564432696|FG000|Overall Study|Lost to Follow-up|2|||
156363888|NCT00747435|564432696|FG000|Overall Study|Withdrawal by Subject|3|||
156363889|NCT00747435|564432696|FG000|Overall Study|Still undergoing follow up|1|||
156363890|NCT02013167|564432697|FG000|Overall Study|Withdrawal by Subject|15|||
156363891|NCT02013167|564432698|FG001|Overall Study|Withdrawal by Subject|14|||
156363892|NCT02013167|564432697|FG000|Overall Study|Sponsor Decision|1|||
156363893|NCT02013167|564432698|FG001|Overall Study|Sponsor Decision|3|||
156363894|NCT02013167|564432697|FG000|Overall Study|Lost to Follow-up|0|||
156363895|NCT02013167|564432698|FG001|Overall Study|Lost to Follow-up|1|||
156363896|NCT02013167|564432697|FG000|Overall Study|Death|85|||
156363897|NCT02013167|564432698|FG001|Overall Study|Death|160|||
156363898|NCT01113879|564432703|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
156363899|NCT01113879|564432704|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
156363900|NCT04151290|564432705|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
156363901|NCT01449526|564432706|FG000|Overall Study|Lost to Follow-up|1|||
156363902|NCT01449526|564432707|FG001|Overall Study|Lost to Follow-up|2|||
156363903|NCT01449526|564432706|FG000|Overall Study|Withdrawal by Subject|1|||
156363904|NCT01449526|564432707|FG001|Overall Study|Withdrawal by Subject|1|||
156363905|NCT01449526|564432706|FG000|Overall Study|Symptoms/complaints|0|||
156363906|NCT01449526|564432707|FG001|Overall Study|Symptoms/complaints|1|||
156363907|NCT01449526|564432706|FG000|Overall Study|Lack of Motivation|0|||
156363908|NCT01449526|564432707|FG001|Overall Study|Lack of Motivation|1|||
156363909|NCT01449526|564432706|FG000|Overall Study|Cannot maintain visits|0|||
156363910|NCT01449526|564432707|FG001|Overall Study|Cannot maintain visits|1|||
156363911|NCT01132495|564432708|FG000|Overall Study|Various reasons|40|||
156363912|NCT01132495|564432709|FG001|Overall Study|Various reasons|38|||
156363913|NCT01132495|564432710|FG002|Overall Study|Various reasons|20|||
156363914|NCT01132495|564432711|FG003|Overall Study|Various reasons|12|||
156363915|NCT00082433|564432715|FG000|Overall Study|Adverse Event|12|||
156545770|NCT02663453|565091699|FG001|Overall Study|Death|4|||
156545771|NCT02663453|565091698|FG000|Overall Study|Withdrawal by Subject|1|||
156545772|NCT02663453|565091699|FG001|Overall Study|Withdrawal by Subject|0|||
156545773|NCT01964352|565093234|FG000|Overall Study|Adverse Event|13|||
156490679|NCT00451555|564890858|FG000|Overall Study|Physician Decision|2|||
156490680|NCT00451555|564890859|FG001|Overall Study|Physician Decision|1|||
156490681|NCT01004185|564890868|FG000|Overall Study|Adverse Event|1|||
156490682|NCT01004185|564890869|FG001|Overall Study|Adverse Event|1|||
156490683|NCT01004185|564890868|FG000|Overall Study|Lost to Follow-up|0|||
156490684|NCT01004185|564890869|FG001|Overall Study|Lost to Follow-up|1|||
156490685|NCT01004185|564890868|FG000|Overall Study|Lack of Efficacy|2|||
156490686|NCT01004185|564890869|FG001|Overall Study|Lack of Efficacy|1|||
156490687|NCT01004185|564890868|FG000|Overall Study|Sponsor Terminated Study|4|||
156490688|NCT01004185|564890869|FG001|Overall Study|Sponsor Terminated Study|5|||
156490689|NCT01004185|564890868|FG000|Overall Study|Withdrawal by Subject|2|||
156490690|NCT01004185|564890869|FG001|Overall Study|Withdrawal by Subject|1|||
156490691|NCT00797511|564890870|FG000|Overall Study|Withdrawal by Subject|1|||
156490692|NCT01990664|564890871|FG000|Overall Study|Lost to Follow-up|2|||
156490693|NCT01990664|564890872|FG001|Overall Study|Lost to Follow-up|6|||
156490694|NCT01990664|564890871|FG000|Overall Study|Withdrawal by Subject|2|||
156490695|NCT01990664|564890872|FG001|Overall Study|Withdrawal by Subject|3|||
156490696|NCT01990664|564890871|FG000|Overall Study|Protocol Violation|1|||
156490697|NCT01990664|564890872|FG001|Overall Study|Protocol Violation|0|||
156490698|NCT01990664|564890871|FG000|Overall Study|Lens Discomfort|1|||
156490699|NCT01990664|564890872|FG001|Overall Study|Lens Discomfort|1|||
156490700|NCT01990664|564890871|FG000|Overall Study|Lens Handling Difficulties|1|||
156490701|NCT01990664|564890872|FG001|Overall Study|Lens Handling Difficulties|0|||
156490702|NCT01990664|564890871|FG000|Overall Study|Unsatisfactory Visual Response|0|||
156490703|NCT01990664|564890872|FG001|Overall Study|Unsatisfactory Visual Response|1|||
156490704|NCT02630706|564890877|FG000|Overall Study|Adverse Event|2|||
156490705|NCT02630706|564890878|FG001|Overall Study|Adverse Event|1|||
156490706|NCT02630706|564890879|FG002|Overall Study|Adverse Event|1|||
156490707|NCT02630706|564890877|FG000|Overall Study|Lost to Follow-up|0|||
156490708|NCT02630706|564890878|FG001|Overall Study|Lost to Follow-up|1|||
156490709|NCT02630706|564890879|FG002|Overall Study|Lost to Follow-up|2|||
156490710|NCT02630706|564890877|FG000|Overall Study|Physician Decision|1|||
156490711|NCT02630706|564890878|FG001|Overall Study|Physician Decision|1|||
156490712|NCT02630706|564890879|FG002|Overall Study|Physician Decision|0|||
156490713|NCT02630706|564890877|FG000|Overall Study|Pregnancy|0|||
156490714|NCT02630706|564890878|FG001|Overall Study|Pregnancy|1|||
156490715|NCT02630706|564890879|FG002|Overall Study|Pregnancy|0|||
156490716|NCT02630706|564890877|FG000|Overall Study|Withdrawal by Subject|4|||
156490717|NCT02630706|564890878|FG001|Overall Study|Withdrawal by Subject|5|||
156490718|NCT02630706|564890879|FG002|Overall Study|Withdrawal by Subject|7|||
156490719|NCT01678898|564890881|FG000|PB-102-F01|Adverse Event|0|||
156490720|NCT01678898|564890882|FG001|PB-102-F01|Adverse Event|1|||
156490721|NCT01678898|564890883|FG002|PB-102-F01|Adverse Event|0|||
156490722|NCT01678898|564890881|FG000|PB-102-F01|Physician Decision|0|||
156490723|NCT01678898|564890882|FG001|PB-102-F01|Physician Decision|1|||
156490724|NCT01678898|564890883|FG002|PB-102-F01|Physician Decision|0|||
156490725|NCT00509925|564890884|FG000|Overall Study|Personal reasons|0|||
156490726|NCT00509925|564890885|FG001|Overall Study|Personal reasons|1|||
156490727|NCT00230971|564890887|FG000|Randomization|No study drug administered|3|||
156490728|NCT00230971|564890888|FG001|Randomization|No study drug administered|3|||
156490729|NCT00230971|564890887|FG000|Baseline Participants|Lost to Follow-up|5|||
156490730|NCT00230971|564890888|FG001|Baseline Participants|Lost to Follow-up|12|||
156490731|NCT00230971|564890887|FG000|Baseline Participants|Death|6|||
156490732|NCT00230971|564890888|FG001|Baseline Participants|Death|5|||
156490733|NCT00230971|564890887|FG000|Baseline Participants|Withdrawal by Subject|7|||
156490734|NCT00230971|564890888|FG001|Baseline Participants|Withdrawal by Subject|1|||
156490735|NCT00230971|564890887|FG000|Baseline Participants|Adverse Event|1|||
156490736|NCT00230971|564890888|FG001|Baseline Participants|Adverse Event|0|||
156490737|NCT00230971|564890887|FG000|Baseline Participants|No bacteria observed|1|||
156490738|NCT00230971|564890888|FG001|Baseline Participants|No bacteria observed|0|||
156490739|NCT00230971|564890887|FG000|Baseline Participants|Failure to return|1|||
156490740|NCT00230971|564890888|FG001|Baseline Participants|Failure to return|1|||
156490741|NCT00230971|564890887|FG000|Baseline Participants|Reintervention|1|||
156545774|NCT01964352|565093235|FG001|Overall Study|Adverse Event|3|||
156545775|NCT01964352|565093236|FG002|Overall Study|Adverse Event|4|||
156490742|NCT00230971|564890888|FG001|Baseline Participants|Reintervention|0|||
156490743|NCT05294328|564890891|FG000|Overall Study|Adverse Event|1|||
156490744|NCT05294328|564890892|FG001|Overall Study|Adverse Event|0|||
156490745|NCT05294328|564890893|FG002|Overall Study|Adverse Event|0|||
156490746|NCT05294328|564890891|FG000|Overall Study|Physician Decision|1|||
156545776|NCT01964352|565093237|FG003|Overall Study|Adverse Event|3|||
156545777|NCT01964352|565093234|FG000|Overall Study|Lack of Efficacy|6|||
156490747|NCT05294328|564890892|FG001|Overall Study|Physician Decision|1|||
156490748|NCT05294328|564890893|FG002|Overall Study|Physician Decision|0|||
156490749|NCT05294328|564890891|FG000|Overall Study|Withdrawal by Subject|0|||
156490750|NCT05294328|564890892|FG001|Overall Study|Withdrawal by Subject|2|||
156490751|NCT05294328|564890893|FG002|Overall Study|Withdrawal by Subject|1|||
156490752|NCT05294328|564890891|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
156490753|NCT05294328|564890892|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
156490754|NCT05294328|564890893|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
156490755|NCT04267393|564890894|FG000|Randomization|Adverse Event|1|||
156490756|NCT04267393|564890895|FG001|Randomization|Adverse Event|0|||
156545778|NCT01964352|565093235|FG001|Overall Study|Lack of Efficacy|0|||
156545779|NCT01964352|565093236|FG002|Overall Study|Lack of Efficacy|0|||
156545780|NCT01964352|565093237|FG003|Overall Study|Lack of Efficacy|0|||
156545781|NCT01964352|565093234|FG000|Overall Study|Protocol Violation|2|||
156545782|NCT01964352|565093235|FG001|Overall Study|Protocol Violation|4|||
156545783|NCT01964352|565093236|FG002|Overall Study|Protocol Violation|0|||
156545784|NCT01964352|565093237|FG003|Overall Study|Protocol Violation|2|||
156545785|NCT01964352|565093234|FG000|Overall Study|Lost to Follow-up|1|||
156545786|NCT01964352|565093235|FG001|Overall Study|Lost to Follow-up|0|||
156545787|NCT01964352|565093236|FG002|Overall Study|Lost to Follow-up|0|||
156545788|NCT01964352|565093237|FG003|Overall Study|Lost to Follow-up|1|||
156545789|NCT01964352|565093234|FG000|Overall Study|Withdrawal by Subject|4|||
156545790|NCT01964352|565093235|FG001|Overall Study|Withdrawal by Subject|2|||
156545791|NCT01964352|565093236|FG002|Overall Study|Withdrawal by Subject|1|||
156545792|NCT01964352|565093237|FG003|Overall Study|Withdrawal by Subject|0|||
156545793|NCT01964352|565093234|FG000|Overall Study|Other than stated above|0|||
156545794|NCT01964352|565093235|FG001|Overall Study|Other than stated above|2|||
156545795|NCT01964352|565093236|FG002|Overall Study|Other than stated above|1|||
156545796|NCT01964352|565093237|FG003|Overall Study|Other than stated above|2|||
156545797|NCT01394939|565093238|FG000|Overall Study|Adverse Event|1|||
156545798|NCT01394939|565093239|FG001|Overall Study|Adverse Event|3|||
156545799|NCT01394939|565093240|FG002|Overall Study|Adverse Event|0|||
156545800|NCT01394939|565093241|FG003|Overall Study|Adverse Event|2|||
156545801|NCT01394939|565093238|FG000|Overall Study|Death|0|||
156545802|NCT01394939|565093239|FG001|Overall Study|Death|2|||
156545803|NCT01394939|565093240|FG002|Overall Study|Death|0|||
156545804|NCT01394939|565093241|FG003|Overall Study|Death|0|||
156545805|NCT01394939|565093238|FG000|Overall Study|Physician Decision|0|||
156545806|NCT01394939|565093239|FG001|Overall Study|Physician Decision|1|||
156545807|NCT01394939|565093240|FG002|Overall Study|Physician Decision|0|||
156545808|NCT01394939|565093241|FG003|Overall Study|Physician Decision|0|||
156545809|NCT01394939|565093238|FG000|Overall Study|Withdrawal by Subject|0|||
156545810|NCT01394939|565093239|FG001|Overall Study|Withdrawal by Subject|2|||
156545811|NCT01394939|565093240|FG002|Overall Study|Withdrawal by Subject|0|||
156545812|NCT01394939|565093241|FG003|Overall Study|Withdrawal by Subject|2|||
156545813|NCT01394939|565093238|FG000|Overall Study|Others|0|||
156545814|NCT01394939|565093239|FG001|Overall Study|Others|2|||
156545815|NCT01394939|565093240|FG002|Overall Study|Others|0|||
156545816|NCT01394939|565093241|FG003|Overall Study|Others|3|||
156545817|NCT02831673|565093244|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
156545818|NCT02831673|565093245|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
156545819|NCT02831673|565093246|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
156545820|NCT02831673|565093247|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
156545821|NCT02831673|565093248|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
156545822|NCT02831673|565093244|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
156545823|NCT02831673|565093245|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
156545824|NCT02831673|565093246|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
156545825|NCT02831673|565093247|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
156545826|NCT02831673|565093248|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
156545827|NCT02831673|565093244|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
156545828|NCT02831673|565093245|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
156545829|NCT02831673|565093246|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
156545830|NCT02831673|565093247|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
156545831|NCT02831673|565093248|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
156545832|NCT02831673|565093244|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
156545833|NCT02831673|565093245|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
156545834|NCT02831673|565093246|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
156545835|NCT02831673|565093247|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
156545836|NCT02831673|565093248|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
156545837|NCT02831673|565093244|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
156545838|NCT02831673|565093245|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
156545839|NCT02831673|565093246|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
156545840|NCT02831673|565093247|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
156545841|NCT02831673|565093248|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
156545842|NCT02831673|565093244|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
156545843|NCT02831673|565093245|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
156545844|NCT02831673|565093246|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
156545845|NCT02831673|565093247|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
156545846|NCT02831673|565093248|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
156545847|NCT02831673|565093244|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
156545848|NCT02831673|565093245|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
156545849|NCT02831673|565093246|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
156545850|NCT02831673|565093247|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
156545851|NCT02831673|565093248|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
156545852|NCT02831673|565093244|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
156545853|NCT02831673|565093245|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
156545854|NCT02831673|565093246|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
156363916|NCT00082433|564432716|FG001|Overall Study|Adverse Event|17|||
156363917|NCT00082433|564432715|FG000|Overall Study|Death|8|||
156363918|NCT00082433|564432716|FG001|Overall Study|Death|18|||
156363919|NCT00082433|564432715|FG000|Overall Study|Disease Progression/Relapse|270|||
156363920|NCT00082433|564432716|FG001|Overall Study|Disease Progression/Relapse|388|||
156363921|NCT00082433|564432715|FG000|Overall Study|Physician Decision|50|||
156363922|NCT00082433|564432716|FG001|Overall Study|Physician Decision|61|||
156363923|NCT00082433|564432715|FG000|Overall Study|Lost to Follow-up|1|||
156363924|NCT00082433|564432716|FG001|Overall Study|Lost to Follow-up|2|||
156363925|NCT00082433|564432715|FG000|Overall Study|Study Drug Toxicity|179|||
156363926|NCT00082433|564432716|FG001|Overall Study|Study Drug Toxicity|66|||
156363927|NCT00082433|564432715|FG000|Overall Study|Withdrawal by Subject|55|||
156363928|NCT00082433|564432716|FG001|Overall Study|Withdrawal by Subject|30|||
156363929|NCT00082433|564432715|FG000|Overall Study|Still On Treatment|2|||
156363930|NCT00082433|564432716|FG001|Overall Study|Still On Treatment|1|||
156363931|NCT00082433|564432715|FG000|Overall Study|Not Treated|12|||
156363932|NCT00082433|564432716|FG001|Overall Study|Not Treated|11|||
156363933|NCT00082433|564432715|FG000|Overall Study|Ineligible|2|||
156363934|NCT00082433|564432716|FG001|Overall Study|Ineligible|1|||
156490757|NCT04267393|564890896|FG002|Randomization|Adverse Event|0|||
156490758|NCT04267393|564890894|FG000|Randomization|Administrative Reasons by Sponsor|0|||
156490759|NCT04267393|564890895|FG001|Randomization|Administrative Reasons by Sponsor|1|||
156490760|NCT04267393|564890896|FG002|Randomization|Administrative Reasons by Sponsor|0|||
156490761|NCT04267393|564890894|FG000|Treatment Period|Adverse Event|0|||
156490762|NCT04267393|564890895|FG001|Treatment Period|Adverse Event|2|||
156490763|NCT04267393|564890896|FG002|Treatment Period|Adverse Event|3|||
156490764|NCT04267393|564890894|FG000|Treatment Period|Participant Withdrew Consent|0|||
156490765|NCT04267393|564890895|FG001|Treatment Period|Participant Withdrew Consent|0|||
156490766|NCT04267393|564890896|FG002|Treatment Period|Participant Withdrew Consent|1|||
156490767|NCT04267393|564890894|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
156490768|NCT04267393|564890895|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
156490769|NCT04267393|564890896|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
156490770|NCT00853372|564892254|FG000|Overall Study|Death|30|||
156490771|NCT00853372|564892255|FG001|Overall Study|Death|26|||
156490772|NCT00853372|564892254|FG000|Overall Study|Lost to Follow-up|1|||
156490773|NCT00853372|564892255|FG001|Overall Study|Lost to Follow-up|2|||
156490774|NCT00853372|564892254|FG000|Overall Study|Full Consent Withdrawn|1|||
156490775|NCT00853372|564892255|FG001|Overall Study|Full Consent Withdrawn|1|||
156490776|NCT01268098|564892258|FG000|Overall Study|Adverse Event|1|||
156490777|NCT01268098|564892259|FG001|Overall Study|Adverse Event|0|||
156490778|NCT02624869|564892263|FG000|Overall Study|Lost to Follow-up|0|||
156490779|NCT02624869|564892264|FG001|Overall Study|Lost to Follow-up|0|||
156490780|NCT02624869|564892265|FG002|Overall Study|Lost to Follow-up|1|||
156490781|NCT02624869|564892263|FG000|Overall Study|Withdrawal by Subject|1|||
156490782|NCT02624869|564892264|FG001|Overall Study|Withdrawal by Subject|3|||
156490783|NCT02624869|564892265|FG002|Overall Study|Withdrawal by Subject|1|||
156490784|NCT00510198|564892266|FG000|Overall Study|Withdrawal by Subject|5|||
156490785|NCT00510198|564892267|FG001|Overall Study|Withdrawal by Subject|4|||
156490786|NCT02895360|564892270|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
156490787|NCT02895360|564892271|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
156490788|NCT02895360|564892272|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
156490789|NCT02895360|564892273|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
156490790|NCT02895360|564892274|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
156490791|NCT02895360|564892275|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
156490792|NCT02895360|564892270|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
156490793|NCT02895360|564892271|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
156490794|NCT02895360|564892272|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
156490795|NCT02895360|564892273|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
156490796|NCT02895360|564892274|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
156490797|NCT02895360|564892275|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
156490798|NCT02895360|564892270|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
156363935|NCT00082433|564432715|FG000|Overall Study|Noncompliance|2|||
156363936|NCT00082433|564432716|FG001|Overall Study|Noncompliance|1|||
156490799|NCT02895360|564892271|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
156490800|NCT02895360|564892272|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
156490801|NCT02895360|564892273|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
156490802|NCT02895360|564892274|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
156363937|NCT00082433|564432715|FG000|Overall Study|New primary cancer|1|||
156363938|NCT00082433|564432716|FG001|Overall Study|New primary cancer|0|||
156363939|NCT00082433|564432715|FG000|Overall Study|Impending surgery|0|||
156363940|NCT00082433|564432716|FG001|Overall Study|Impending surgery|1|||
156363941|NCT02276612|564432719|FG000|Overall Study|Death|1|||
156363942|NCT02276612|564432720|FG001|Overall Study|Death|0|||
156363943|NCT02276612|564432719|FG000|Overall Study|Pregnancy|1|||
156363944|NCT02276612|564432720|FG001|Overall Study|Pregnancy|0|||
156363945|NCT02276612|564432719|FG000|Overall Study|Withdrew Consent|1|||
156363946|NCT02276612|564432720|FG001|Overall Study|Withdrew Consent|0|||
156363947|NCT02276612|564432719|FG000|Overall Study|Lost to Follow-up|1|||
156363948|NCT02276612|564432720|FG001|Overall Study|Lost to Follow-up|0|||
156363949|NCT01796197|564432721|FG000|Overall Study|Lost to Follow-up|1|||
156363950|NCT01796197|564432721|FG000|Overall Study|Lack of Efficacy|1|||
156363951|NCT04097821|564432722|FG000|Overall Study|Subject Decision|0|||
156363952|NCT04097821|564432723|FG001|Overall Study|Subject Decision|0|||
156363953|NCT04097821|564432724|FG002|Overall Study|Subject Decision|0|||
156363954|NCT04097821|564432725|FG003|Overall Study|Subject Decision|1|||
156363955|NCT04097821|564432726|FG004|Overall Study|Subject Decision|2|||
156363956|NCT04097821|564432727|FG005|Overall Study|Subject Decision|2|||
156363957|NCT04097821|564432728|FG006|Overall Study|Subject Decision|0|||
156363958|NCT04097821|564432729|FG007|Overall Study|Subject Decision|1|||
156363959|NCT04097821|564432722|FG000|Overall Study|Death|0|||
156363960|NCT04097821|564432723|FG001|Overall Study|Death|0|||
156363961|NCT04097821|564432724|FG002|Overall Study|Death|3|||
156363962|NCT04097821|564432725|FG003|Overall Study|Death|1|||
156363963|NCT04097821|564432726|FG004|Overall Study|Death|0|||
156363964|NCT04097821|564432727|FG005|Overall Study|Death|0|||
156363965|NCT04097821|564432728|FG006|Overall Study|Death|0|||
156363966|NCT04097821|564432729|FG007|Overall Study|Death|0|||
156363967|NCT04097821|564432722|FG000|Overall Study|Physician Decision|1|||
156363968|NCT04097821|564432723|FG001|Overall Study|Physician Decision|2|||
156363969|NCT04097821|564432724|FG002|Overall Study|Physician Decision|0|||
156363970|NCT04097821|564432725|FG003|Overall Study|Physician Decision|0|||
156363971|NCT04097821|564432726|FG004|Overall Study|Physician Decision|0|||
156363972|NCT04097821|564432727|FG005|Overall Study|Physician Decision|0|||
156363973|NCT04097821|564432728|FG006|Overall Study|Physician Decision|0|||
156363974|NCT04097821|564432729|FG007|Overall Study|Physician Decision|0|||
156363975|NCT04097821|564432722|FG000|Overall Study|Adverse Event|0|||
156363976|NCT04097821|564432723|FG001|Overall Study|Adverse Event|0|||
156363977|NCT04097821|564432724|FG002|Overall Study|Adverse Event|1|||
156363978|NCT04097821|564432725|FG003|Overall Study|Adverse Event|1|||
156363979|NCT04097821|564432726|FG004|Overall Study|Adverse Event|0|||
156363980|NCT04097821|564432727|FG005|Overall Study|Adverse Event|0|||
156363981|NCT04097821|564432728|FG006|Overall Study|Adverse Event|0|||
156363982|NCT04097821|564432729|FG007|Overall Study|Adverse Event|0|||
156363983|NCT04097821|564432722|FG000|Overall Study|New Therapy For Study Indication|0|||
156363984|NCT04097821|564432723|FG001|Overall Study|New Therapy For Study Indication|0|||
156363985|NCT04097821|564432724|FG002|Overall Study|New Therapy For Study Indication|0|||
156363986|NCT04097821|564432725|FG003|Overall Study|New Therapy For Study Indication|0|||
156363987|NCT04097821|564432726|FG004|Overall Study|New Therapy For Study Indication|0|||
156363988|NCT04097821|564432727|FG005|Overall Study|New Therapy For Study Indication|0|||
156363989|NCT04097821|564432728|FG006|Overall Study|New Therapy For Study Indication|1|||
156363990|NCT04097821|564432729|FG007|Overall Study|New Therapy For Study Indication|0|||
156490803|NCT02895360|564892275|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
156490804|NCT02895360|564892270|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
156490805|NCT02895360|564892271|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
156490806|NCT02895360|564892272|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
156490807|NCT02895360|564892273|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
156490808|NCT02895360|564892274|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
156490809|NCT02895360|564892275|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
156490810|NCT02895360|564892270|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
156490811|NCT02895360|564892271|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
156490812|NCT02895360|564892272|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
156490813|NCT02895360|564892273|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
156363991|NCT00244712|564432730|FG000|Overall Study|Adverse Event|20|||
156363992|NCT00244712|564432731|FG001|Overall Study|Adverse Event|21|||
156363993|NCT00244712|564432730|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
156363994|NCT00244712|564432731|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
156363995|NCT00244712|564432730|FG000|Overall Study|Lack of Compliance|10|||
156363996|NCT00244712|564432731|FG001|Overall Study|Lack of Compliance|11|||
156363997|NCT00244712|564432730|FG000|Overall Study|Lost to Follow-up|45|||
156363998|NCT00244712|564432731|FG001|Overall Study|Lost to Follow-up|52|||
156363999|NCT00244712|564432730|FG000|Overall Study|Withdrawal by Subject|13|||
156364000|NCT00244712|564432731|FG001|Overall Study|Withdrawal by Subject|23|||
156364001|NCT00244712|564432730|FG000|Overall Study|Protocol Violation, disease progression|13|||
156364002|NCT00244712|564432731|FG001|Overall Study|Protocol Violation, disease progression|11|||
156364003|NCT01077804|564432734|FG000|Overall Study|Unreachable|102|||
156364004|NCT01077804|564432734|FG000|Overall Study|Refused to continue|79|||
156364005|NCT01077804|564432734|FG000|Overall Study|Other|18|||
156364006|NCT02776917|564432735|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
156364007|NCT03003520|564434341|FG000|Overall Study|Adverse Event|9|||
156364008|NCT03003520|564434342|FG001|Overall Study|Adverse Event|0|||
156364009|NCT03003520|564434341|FG000|Overall Study|Death|1|||
156364010|NCT03003520|564434342|FG001|Overall Study|Death|0|||
156364011|NCT03003520|564434341|FG000|Overall Study|Other reasons|4|||
156364012|NCT03003520|564434342|FG001|Overall Study|Other reasons|0|||
156364013|NCT03003520|564434341|FG000|Overall Study|Withdrawal by Subject|6|||
156364014|NCT03003520|564434342|FG001|Overall Study|Withdrawal by Subject|0|||
156364015|NCT03003520|564434341|FG000|Overall Study|Progressive disease|9|||
156364016|NCT03003520|564434342|FG001|Overall Study|Progressive disease|1|||
156364017|NCT03264404|564434343|FG000|Overall Study|Death|2|||
156364018|NCT03264404|564434343|FG000|Overall Study|Physician Decision|1|||
156364019|NCT03264404|564434343|FG000|Overall Study|Disease Progression|28|||
156364020|NCT03264404|564434343|FG000|Overall Study|Adverse Event|1|||
156364021|NCT03264404|564434343|FG000|Overall Study|Off study prior to treatment|2|||
156364022|NCT01852292|564434349|FG000|Overall Study|Untreated - did not receive study drug|3|||
156364023|NCT01852292|564434350|FG001|Overall Study|Untreated - did not receive study drug|1|||
156364024|NCT01852292|564434349|FG000|Overall Study|Death|9|||
156364025|NCT01852292|564434350|FG001|Overall Study|Death|8|||
156364026|NCT01852292|564434349|FG000|Overall Study|Patient/guardian decision|8|||
156364027|NCT01852292|564434350|FG001|Overall Study|Patient/guardian decision|4|||
156364028|NCT01852292|564434349|FG000|Overall Study|Adverse Event|8|||
156364029|NCT01852292|564434350|FG001|Overall Study|Adverse Event|11|||
156364030|NCT01852292|564434349|FG000|Overall Study|Physician Decision|6|||
156364031|NCT01852292|564434350|FG001|Overall Study|Physician Decision|2|||
156364032|NCT01852292|564434349|FG000|Overall Study|Protocol Violation|2|||
156364033|NCT01852292|564434350|FG001|Overall Study|Protocol Violation|0|||
156364034|NCT01852292|564434349|FG000|Overall Study|Non-compliance with study treatment|1|||
156364035|NCT01852292|564434350|FG001|Overall Study|Non-compliance with study treatment|0|||
156364036|NCT01852292|564434349|FG000|Overall Study|Study terminated by Sponsor|0|||
156364037|NCT01852292|564434350|FG001|Overall Study|Study terminated by Sponsor|1|||
156364038|NCT01852292|564434349|FG000|Overall Study|Progressive disease|42|||
156364039|NCT01852292|564434350|FG001|Overall Study|Progressive disease|52|||
156364040|NCT01914666|564434351|FG000|Treatment Period|Lack of Efficacy|0|||
156364041|NCT01914666|564434352|FG001|Treatment Period|Lack of Efficacy|0|||
156364042|NCT01914666|564434353|FG002|Treatment Period|Lack of Efficacy|2|||
156364043|NCT01914666|564434351|FG000|Treatment Period|Adverse Event|10|||
156364044|NCT01914666|564434352|FG001|Treatment Period|Adverse Event|4|||
156364045|NCT01914666|564434353|FG002|Treatment Period|Adverse Event|2|||
156364046|NCT01914666|564434351|FG000|Treatment Period|Withdrawal by Subject|3|||
156364047|NCT01914666|564434352|FG001|Treatment Period|Withdrawal by Subject|2|||
156364048|NCT01914666|564434353|FG002|Treatment Period|Withdrawal by Subject|2|||
156364049|NCT01914666|564434351|FG000|Treatment Period|Physician Decision|0|||
156364050|NCT01914666|564434352|FG001|Treatment Period|Physician Decision|0|||
156364051|NCT01914666|564434353|FG002|Treatment Period|Physician Decision|2|||
156364052|NCT01572038|564434356|FG000|Overall Study|Death|648|||
156364053|NCT01572038|564434356|FG000|Overall Study|Withdrawal by Subject|204|||
156364054|NCT01572038|564434356|FG000|Overall Study|Lost to Follow-up|81|||
156364055|NCT01572038|564434356|FG000|Overall Study|Physician Decision|20|||
156364056|NCT01572038|564434356|FG000|Overall Study|Patient Decision|14|||
156364057|NCT01572038|564434356|FG000|Overall Study|Progressive Disease|8|||
156364058|NCT01572038|564434356|FG000|Overall Study|Site Closed Before Completing Form|6|||
156364059|NCT01572038|564434356|FG000|Overall Study|Enrolled into Another Trial|3|||
156364060|NCT01572038|564434356|FG000|Overall Study|Participated in Another Trial|3|||
156364061|NCT01572038|564434356|FG000|Overall Study|Termination by Sponsor|2|||
156364062|NCT01572038|564434356|FG000|Overall Study|Patient Deterioration|1|||
156364063|NCT01572038|564434356|FG000|Overall Study|Sponsor Decision|1|||
156364064|NCT03711162|564434357|FG000|Overall Study|Adverse Event|5|||
156364065|NCT03711162|564434358|FG001|Overall Study|Adverse Event|2|||
156364066|NCT03711162|564434359|FG002|Overall Study|Adverse Event|4|||
156364067|NCT03711162|564434357|FG000|Overall Study|Death|11|||
156364068|NCT03711162|564434358|FG001|Overall Study|Death|7|||
156364069|NCT03711162|564434359|FG002|Overall Study|Death|8|||
156364070|NCT03711162|564434357|FG000|Overall Study|Lost to Follow-up|1|||
156364071|NCT03711162|564434358|FG001|Overall Study|Lost to Follow-up|0|||
156364072|NCT03711162|564434359|FG002|Overall Study|Lost to Follow-up|1|||
156364073|NCT03711162|564434357|FG000|Overall Study|Study Terminated by Sponsor|139|||
156545855|NCT02831673|565093247|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
156364074|NCT03711162|564434358|FG001|Overall Study|Study Terminated by Sponsor|152|||
156364075|NCT03711162|564434359|FG002|Overall Study|Study Terminated by Sponsor|146|||
156364076|NCT03711162|564434357|FG000|Overall Study|Withdrawal by Subject|17|||
156364077|NCT03711162|564434358|FG001|Overall Study|Withdrawal by Subject|10|||
156364078|NCT03711162|564434359|FG002|Overall Study|Withdrawal by Subject|10|||
156364079|NCT03711162|564434357|FG000|Overall Study|Miscellaneous|1|||
156364080|NCT03711162|564434358|FG001|Overall Study|Miscellaneous|2|||
156364081|NCT03711162|564434359|FG002|Overall Study|Miscellaneous|2|||
156364082|NCT03711162|564434357|FG000|Overall Study|Not Treated|1|||
156364083|NCT03711162|564434358|FG001|Overall Study|Not Treated|0|||
156364084|NCT03711162|564434359|FG002|Overall Study|Not Treated|1|||
156545856|NCT02831673|565093248|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
156545857|NCT02831673|565093244|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156545858|NCT02831673|565093245|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156545859|NCT02831673|565093246|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
156545860|NCT02831673|565093247|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
156545861|NCT02831673|565093248|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156545862|NCT02831673|565093244|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156545863|NCT02831673|565093245|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156545864|NCT02831673|565093246|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
156545865|NCT02831673|565093247|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
156545866|NCT02831673|565093248|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156545867|NCT02831673|565093244|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156545868|NCT02831673|565093245|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156545869|NCT02831673|565093246|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156545870|NCT02831673|565093247|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
156545871|NCT02831673|565093248|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156545872|NCT02831673|565093244|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
156545873|NCT02831673|565093245|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
156545874|NCT02831673|565093246|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
156545875|NCT02831673|565093247|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
156545876|NCT02831673|565093248|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
156545877|NCT02831673|565093244|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156545878|NCT02831673|565093245|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156545879|NCT02831673|565093246|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
156545880|NCT02831673|565093247|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
156545881|NCT02831673|565093248|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156545882|NCT02831673|565093244|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156545883|NCT02831673|565093245|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156545884|NCT02831673|565093246|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
156545885|NCT02831673|565093247|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
156545886|NCT02831673|565093248|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156545887|NCT02831673|565093244|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156545888|NCT02831673|565093245|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156545889|NCT02831673|565093246|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
156545890|NCT02831673|565093247|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
156545891|NCT02831673|565093248|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156545892|NCT02831673|565093244|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
156545893|NCT02831673|565093245|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
156545894|NCT02831673|565093246|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
156545895|NCT02831673|565093247|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
156545896|NCT02831673|565093248|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
156545897|NCT02831673|565093244|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156545898|NCT02831673|565093245|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156545899|NCT02831673|565093246|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156545900|NCT02831673|565093247|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156364085|NCT03711162|564434357|FG000|Overall Study|Physician Decision|0|||
156364086|NCT03711162|564434358|FG001|Overall Study|Physician Decision|2|||
156364087|NCT03711162|564434359|FG002|Overall Study|Physician Decision|0|||
156364088|NCT03711162|564434357|FG000|Overall Study|Lack of Efficacy|0|||
156364089|NCT03711162|564434358|FG001|Overall Study|Lack of Efficacy|0|||
156364090|NCT03711162|564434359|FG002|Overall Study|Lack of Efficacy|2|||
156364091|NCT03711162|564434357|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
156364092|NCT03711162|564434358|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
156364093|NCT03711162|564434359|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
156364094|NCT01275066|564434362|FG000|Overall Study|Withdrawal by Subject|0|||
156364095|NCT01275066|564434363|FG001|Overall Study|Withdrawal by Subject|0|||
156364096|NCT01275066|564434364|FG002|Overall Study|Withdrawal by Subject|1|||
156364097|NCT01275066|564434362|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
156364098|NCT01275066|564434363|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
156364099|NCT01275066|564434364|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
156364100|NCT00394212|564434367|FG000|Overall Study|Lost to Follow-up|3|||
156364101|NCT00394212|564434368|FG001|Overall Study|Lost to Follow-up|0|||
156364102|NCT00394212|564434367|FG000|Overall Study|Withdrawal by Subject|4|||
156364103|NCT00394212|564434368|FG001|Overall Study|Withdrawal by Subject|1|||
156364104|NCT00588445|564434369|FG000|Overall Study|Protocol Violation|1|||
156364105|NCT00588445|564434369|FG000|Overall Study|Withdrawal by Subject|3|||
156364106|NCT00588445|564434369|FG000|Overall Study|Disease Progression|1|||
156364107|NCT00588445|564434369|FG000|Overall Study|Not Treated|10|||
156364108|NCT04904185|564434372|FG000|Overall Study|Expansion failure|1|||
156364109|NCT04904185|564434373|FG001|Overall Study|Expansion failure|0|||
156364110|NCT04904185|564434372|FG000|Overall Study|Late response on prior treatment|1|||
156364111|NCT04904185|564434373|FG001|Overall Study|Late response on prior treatment|0|||
156364112|NCT02945410|564434374|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156364113|NCT02945410|564434375|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
156364114|NCT02945410|564434376|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156364115|NCT02945410|564434377|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156364116|NCT02945410|564434378|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156364117|NCT02945410|564434379|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156364118|NCT02945410|564434374|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
156364119|NCT02945410|564434375|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
156364120|NCT02945410|564434376|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
156364121|NCT02945410|564434377|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
156364122|NCT02945410|564434378|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
156364123|NCT02945410|564434379|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
156364124|NCT02945410|564434374|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
156364125|NCT02945410|564434375|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
156364126|NCT02945410|564434376|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
156364127|NCT02945410|564434377|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
156364128|NCT02945410|564434378|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
156364129|NCT02945410|564434379|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
156364130|NCT01344369|564434380|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
156364131|NCT01344369|564434381|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
156364132|NCT01344369|564434380|FG000|Washout of 28 Days|Physician Decision|0|||
156364133|NCT01344369|564434381|FG001|Washout of 28 Days|Physician Decision|1|||
156364134|NCT01344369|564434380|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
156364135|NCT01344369|564434381|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
156364136|NCT00110812|564434382|FG000|Main Study|Death|0|||
156364137|NCT00110812|564434383|FG001|Main Study|Death|0|||
156364138|NCT00110812|564434384|FG002|Main Study|Death|2|||
156364139|NCT00110812|564434382|FG000|Main Study|Withdrawal by Subject|0|||
156364140|NCT00110812|564434383|FG001|Main Study|Withdrawal by Subject|0|||
156364141|NCT00110812|564434384|FG002|Main Study|Withdrawal by Subject|1|||
156364142|NCT00110812|564434382|FG000|Main Study|Lost to Follow-up|8|||
156364143|NCT00110812|564434383|FG001|Main Study|Lost to Follow-up|11|||
156364144|NCT00110812|564434384|FG002|Main Study|Lost to Follow-up|10|||
156364145|NCT00110812|564434382|FG000|Extended Follow-up|Death|1|||
156364146|NCT00110812|564434383|FG001|Extended Follow-up|Death|0|||
156364147|NCT00110812|564434384|FG002|Extended Follow-up|Death|3|||
156364148|NCT00110812|564434382|FG000|Extended Follow-up|Withdrawal by Subject|0|||
156364149|NCT00110812|564434383|FG001|Extended Follow-up|Withdrawal by Subject|1|||
156364150|NCT00110812|564434384|FG002|Extended Follow-up|Withdrawal by Subject|0|||
156364151|NCT00110812|564434382|FG000|Extended Follow-up|Lost to Follow-up|1|||
156364152|NCT00110812|564434383|FG001|Extended Follow-up|Lost to Follow-up|3|||
156364153|NCT00110812|564434384|FG002|Extended Follow-up|Lost to Follow-up|1|||
156364154|NCT02342704|564434387|FG000|Overall Study|Physician Decision|0|||
156364155|NCT02342704|564434388|FG001|Overall Study|Physician Decision|3|||
156364156|NCT02342704|564434387|FG000|Overall Study|Sponsor Termination|49|||
156364157|NCT02342704|564434388|FG001|Overall Study|Sponsor Termination|43|||
156364158|NCT02342704|564434387|FG000|Overall Study|Other|0|||
156364159|NCT02342704|564434388|FG001|Overall Study|Other|1|||
156364160|NCT02342704|564434387|FG000|Overall Study|Withdrawal by Subject|1|||
156364161|NCT02342704|564434388|FG001|Overall Study|Withdrawal by Subject|0|||
156364162|NCT02342704|564434387|FG000|Overall Study|Lost to Follow-up|2|||
156364163|NCT02342704|564434388|FG001|Overall Study|Lost to Follow-up|1|||
156364164|NCT02342704|564434387|FG000|Overall Study|Adverse Event|1|||
156364165|NCT02342704|564434388|FG001|Overall Study|Adverse Event|3|||
156364166|NCT01539226|564434389|FG000|Overall Study|Withdrawal by Subject|24|||
156364167|NCT01539226|564434390|FG001|Overall Study|Withdrawal by Subject|54|||
156364168|NCT01539226|564434389|FG000|Overall Study|Lost to Follow-up|20|||
156490814|NCT02895360|564892274|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
156490815|NCT02895360|564892275|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
156490816|NCT02895360|564892270|FG000|Phase 2a|Adverse Event|0|||
156364169|NCT01539226|564434390|FG001|Overall Study|Lost to Follow-up|54|||
156364170|NCT01539226|564434389|FG000|Overall Study|Death|1|||
156364171|NCT01539226|564434390|FG001|Overall Study|Death|2|||
156490817|NCT02895360|564892271|FG001|Phase 2a|Adverse Event|0|||
156490818|NCT02895360|564892272|FG002|Phase 2a|Adverse Event|0|||
156490819|NCT02895360|564892273|FG003|Phase 2a|Adverse Event|0|||
156490820|NCT02895360|564892274|FG004|Phase 2a|Adverse Event|0|||
156364172|NCT01539226|564434389|FG000|Overall Study|Adverse Event|2|||
156364173|NCT01539226|564434390|FG001|Overall Study|Adverse Event|0|||
156364174|NCT01539226|564434389|FG000|Overall Study|Pregnancy|13|||
156364175|NCT01539226|564434390|FG001|Overall Study|Pregnancy|29|||
156364176|NCT01539226|564434389|FG000|Overall Study|inappropriate enrollment|0|||
156364177|NCT01539226|564434390|FG001|Overall Study|inappropriate enrollment|1|||
156490821|NCT02895360|564892275|FG005|Phase 2a|Adverse Event|1|||
156364178|NCT01539226|564434389|FG000|Overall Study|Multiple Reasons|3|||
156364179|NCT01539226|564434390|FG001|Overall Study|Multiple Reasons|1|||
156364180|NCT01539226|564434389|FG000|Overall Study|not HIV seroconversion-related|93|||
156364181|NCT01539226|564434390|FG001|Overall Study|not HIV seroconversion-related|176|||
156364182|NCT01539226|564434389|FG000|Overall Study|HIV seroconversion-related|55|||
156364183|NCT01539226|564434390|FG001|Overall Study|HIV seroconversion-related|80|||
156364184|NCT01539226|564434389|FG000|Overall Study|Non-compliance|6|||
156364185|NCT01539226|564434390|FG001|Overall Study|Non-compliance|8|||
156364186|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
156364187|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
156364188|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
156364189|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
156364190|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
156364191|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
156364192|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
156364193|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
156364194|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
156364195|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
156364196|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
156364197|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
156364198|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
156364199|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
156364200|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
156364201|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
156364202|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
156364203|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
156364204|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
156364205|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
156364206|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
156364207|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
156364208|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
156364209|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
156364210|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
156364211|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
156364212|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
156364213|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
156364214|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
156364215|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
156364216|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
156364217|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
156364218|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
156364219|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
156364220|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
156364221|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
156364222|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
156364223|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
156364224|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
156364225|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
156364226|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
156364227|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
156364228|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
156364229|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
156364230|NCT01218516|564434391|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
156364231|NCT01218516|564434392|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
156364232|NCT01218516|564434393|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
156364233|NCT01218516|564434394|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
156364234|NCT01632891|564434395|FG000|Overall Study|Lost to Follow-up|0|||
156490822|NCT02895360|564892270|FG000|Phase 2a|Progressive disease|0|||
156490823|NCT02895360|564892271|FG001|Phase 2a|Progressive disease|0|||
156490824|NCT02895360|564892272|FG002|Phase 2a|Progressive disease|0|||
156490825|NCT02895360|564892273|FG003|Phase 2a|Progressive disease|0|||
156490826|NCT02895360|564892274|FG004|Phase 2a|Progressive disease|11|||
156490827|NCT02895360|564892275|FG005|Phase 2a|Progressive disease|11|||
156490828|NCT00307164|564892276|FG000|Overall Study|Death|1|||
156490829|NCT00307164|564892277|FG001|Overall Study|Death|0|||
156364235|NCT01632891|564434396|FG001|Overall Study|Lost to Follow-up|1|||
156364236|NCT01632891|564434395|FG000|Overall Study|Withdrawal by Subject|1|||
156364237|NCT01632891|564434396|FG001|Overall Study|Withdrawal by Subject|0|||
156364238|NCT02118428|564434399|FG000|Overall Study|Physician Decision|0|||
156364239|NCT02118428|564434400|FG001|Overall Study|Physician Decision|1|||
156364240|NCT02118428|564434401|FG002|Overall Study|Physician Decision|0|||
156364241|NCT02118428|564434399|FG000|Overall Study|Withdrawal by Subject|2|||
156364242|NCT02118428|564434400|FG001|Overall Study|Withdrawal by Subject|2|||
156364243|NCT02118428|564434401|FG002|Overall Study|Withdrawal by Subject|0|||
156364244|NCT02118428|564434399|FG000|Overall Study|Death|7|||
156364245|NCT02118428|564434400|FG001|Overall Study|Death|5|||
156364246|NCT02118428|564434401|FG002|Overall Study|Death|0|||
156364247|NCT02118428|564434399|FG000|Overall Study|Lost to Follow-up|3|||
156364248|NCT02118428|564434400|FG001|Overall Study|Lost to Follow-up|1|||
156364249|NCT02118428|564434401|FG002|Overall Study|Lost to Follow-up|0|||
156364250|NCT02118428|564434399|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
156364251|NCT02118428|564434400|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
156364252|NCT02118428|564434401|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
156364253|NCT00735371|564434405|FG000|Overall Study|Adverse Event|3|||
156364254|NCT00735371|564434406|FG001|Overall Study|Adverse Event|3|||
156364255|NCT00735371|564434407|FG002|Overall Study|Adverse Event|4|||
156364256|NCT00735371|564434408|FG003|Overall Study|Adverse Event|1|||
156364257|NCT00735371|564434405|FG000|Overall Study|Protocol Violation|2|||
156364258|NCT00735371|564434406|FG001|Overall Study|Protocol Violation|2|||
156364259|NCT00735371|564434407|FG002|Overall Study|Protocol Violation|0|||
156364260|NCT00735371|564434408|FG003|Overall Study|Protocol Violation|3|||
156364261|NCT00735371|564434405|FG000|Overall Study|Withdrawal by Subject|0|||
156364262|NCT00735371|564434406|FG001|Overall Study|Withdrawal by Subject|2|||
156364263|NCT00735371|564434407|FG002|Overall Study|Withdrawal by Subject|2|||
156364264|NCT00735371|564434408|FG003|Overall Study|Withdrawal by Subject|0|||
156364265|NCT00735371|564434405|FG000|Overall Study|Lost to Follow-up|1|||
156364266|NCT00735371|564434406|FG001|Overall Study|Lost to Follow-up|1|||
156364267|NCT00735371|564434407|FG002|Overall Study|Lost to Follow-up|3|||
156364268|NCT00735371|564434408|FG003|Overall Study|Lost to Follow-up|1|||
156364269|NCT00735371|564434405|FG000|Overall Study|Lack of Efficacy|4|||
156364270|NCT00735371|564434406|FG001|Overall Study|Lack of Efficacy|2|||
156364271|NCT00735371|564434407|FG002|Overall Study|Lack of Efficacy|0|||
156364272|NCT00735371|564434408|FG003|Overall Study|Lack of Efficacy|4|||
156364273|NCT00735371|564434405|FG000|Overall Study|Sponsor Decision|3|||
156364274|NCT00735371|564434406|FG001|Overall Study|Sponsor Decision|1|||
156364275|NCT00735371|564434407|FG002|Overall Study|Sponsor Decision|0|||
156364276|NCT00735371|564434408|FG003|Overall Study|Sponsor Decision|1|||
156364277|NCT00735371|564434405|FG000|Overall Study|Protocol Violation|0|||
156364278|NCT00735371|564434406|FG001|Overall Study|Protocol Violation|1|||
156364279|NCT00735371|564434407|FG002|Overall Study|Protocol Violation|2|||
156364280|NCT00735371|564434408|FG003|Overall Study|Protocol Violation|0|||
156364281|NCT00735371|564434405|FG000|Overall Study|Prior Vyvanse Exposure|1|||
156364282|NCT00735371|564434406|FG001|Overall Study|Prior Vyvanse Exposure|1|||
156364283|NCT00735371|564434407|FG002|Overall Study|Prior Vyvanse Exposure|0|||
156364284|NCT00735371|564434408|FG003|Overall Study|Prior Vyvanse Exposure|0|||
156364285|NCT00735371|564434405|FG000|Overall Study|Exclusion criteria|1|||
156364286|NCT00735371|564434406|FG001|Overall Study|Exclusion criteria|0|||
156364287|NCT00735371|564434407|FG002|Overall Study|Exclusion criteria|0|||
156364288|NCT00735371|564434408|FG003|Overall Study|Exclusion criteria|0|||
156364289|NCT00436748|564434411|FG000|Overall Study|Ineligibility Determined|1|||
156364290|NCT00436748|564434412|FG001|Overall Study|Ineligibility Determined|1|||
156364291|NCT00436748|564434411|FG000|Overall Study|Adverse Event|0|||
156490830|NCT00307164|564892276|FG000|Overall Study|Severe debilitation, unable to continue|1|||
156490831|NCT00307164|564892277|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156490832|NCT00307164|564892276|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
156490833|NCT00307164|564892277|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
156364292|NCT00436748|564434412|FG001|Overall Study|Adverse Event|2|||
156364293|NCT00436748|564434411|FG000|Overall Study|Consent Withdrawn|1|||
156490834|NCT00307164|564892276|FG000|Overall Study|Withdrawal by Subject|1|||
156364294|NCT00436748|564434412|FG001|Overall Study|Consent Withdrawn|4|||
156364295|NCT00436748|564434411|FG000|Overall Study|Administrative Decision|1|||
156490835|NCT00307164|564892277|FG001|Overall Study|Withdrawal by Subject|8|||
156364296|NCT00436748|564434412|FG001|Overall Study|Administrative Decision|0|||
156364297|NCT00436748|564434411|FG000|Overall Study|Lost to Follow-up|0|||
156364298|NCT00436748|564434412|FG001|Overall Study|Lost to Follow-up|1|||
156364299|NCT00436748|564434411|FG000|Overall Study|Protocol-specified Criteria|5|||
156364300|NCT00436748|564434412|FG001|Overall Study|Protocol-specified Criteria|4|||
156364301|NCT00436748|564434411|FG000|Overall Study|Other|3|||
156364302|NCT00436748|564434412|FG001|Overall Study|Other|0|||
156364303|NCT01610791|564434413|FG000|Overall Study|Lost to Follow-up|7|||
156490836|NCT00307164|564892276|FG000|Overall Study|Not compliant with requirements|4|||
156364304|NCT01610791|564434413|FG000|Overall Study|Adverse Event|6|||
156364305|NCT01610791|564434413|FG000|Overall Study|Physician Decision|1|||
156490837|NCT00307164|564892277|FG001|Overall Study|Not compliant with requirements|4|||
156490838|NCT00307164|564892276|FG000|Overall Study|Lost to Follow-up|6|||
156490839|NCT00307164|564892277|FG001|Overall Study|Lost to Follow-up|1|||
156490840|NCT00053352|564892283|FG000|Overall Study|Lost to Follow-up|0|||
156490841|NCT00053352|564892284|FG001|Overall Study|Lost to Follow-up|1|||
156364306|NCT01610791|564434413|FG000|Overall Study|Adverse event and Investigator decision|1|||
156364307|NCT01610791|564434413|FG000|Overall Study|Death|1|||
156364308|NCT01610791|564434413|FG000|Overall Study|Not determined|5|||
156364309|NCT00097721|564434416|FG000|Overall Study|Adverse Event|8|||
156364310|NCT00097721|564434417|FG001|Overall Study|Adverse Event|1|||
156364311|NCT00097721|564434416|FG000|Overall Study|Withdrawal by Subject|6|||
156364312|NCT00097721|564434417|FG001|Overall Study|Withdrawal by Subject|1|||
156364313|NCT00097721|564434416|FG000|Overall Study|Progressive Disease|55|||
156364314|NCT00097721|564434417|FG001|Overall Study|Progressive Disease|27|||
156364315|NCT00097721|564434416|FG000|Overall Study|Physician Decision|1|||
156364316|NCT00097721|564434417|FG001|Overall Study|Physician Decision|3|||
156364317|NCT00097721|564434416|FG000|Overall Study|Reason not given|1|||
156364318|NCT00097721|564434417|FG001|Overall Study|Reason not given|1|||
156364319|NCT02126969|564434418|FG000|Overall Study|Withdrawal by Subject|1|||
156364320|NCT02126969|564434419|FG001|Overall Study|Withdrawal by Subject|2|||
156364321|NCT00354172|564434420|FG000|Overall Study|Did not receive transplant|1|||
156364322|NCT03792672|564434427|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
156364323|NCT03792672|564434428|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
156364324|NCT03792672|564434429|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
156364325|NCT03792672|564434430|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
156364326|NCT03792672|564434431|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
156364327|NCT03792672|564434432|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
156364328|NCT03792672|564434427|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
156364329|NCT03792672|564434428|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
156364330|NCT03792672|564434429|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
156364331|NCT03792672|564434430|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
156364332|NCT03792672|564434431|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
156364333|NCT03792672|564434432|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
156364334|NCT03792672|564434427|FG000|Treatment Period 4 (2 Days)|Other|1|||
156364335|NCT03792672|564434428|FG001|Treatment Period 4 (2 Days)|Other|0|||
156364336|NCT03792672|564434429|FG002|Treatment Period 4 (2 Days)|Other|0|||
156364337|NCT03792672|564434430|FG003|Treatment Period 4 (2 Days)|Other|0|||
156364338|NCT03792672|564434431|FG004|Treatment Period 4 (2 Days)|Other|0|||
156364339|NCT03792672|564434432|FG005|Treatment Period 4 (2 Days)|Other|0|||
156364340|NCT00453999|564434433|FG000|Overall Study|Adverse Event|1|||
156364341|NCT00453999|564434434|FG001|Overall Study|Adverse Event|2|||
156364342|NCT00453999|564434435|FG002|Overall Study|Adverse Event|1|||
156364343|NCT00453999|564434433|FG000|Overall Study|Lost to Follow-up|0|||
156364344|NCT00453999|564434434|FG001|Overall Study|Lost to Follow-up|1|||
156364345|NCT00453999|564434435|FG002|Overall Study|Lost to Follow-up|1|||
156364346|NCT00453999|564434433|FG000|Overall Study|Withdrawal by Subject|2|||
156364347|NCT00453999|564434434|FG001|Overall Study|Withdrawal by Subject|1|||
156364348|NCT00453999|564434435|FG002|Overall Study|Withdrawal by Subject|1|||
156364349|NCT00453999|564434433|FG000|Overall Study|Subject Request|2|||
156364350|NCT00453999|564434434|FG001|Overall Study|Subject Request|1|||
156364351|NCT00453999|564434435|FG002|Overall Study|Subject Request|0|||
156364352|NCT00606892|564434438|FG000|First Intervention|Protocol Violation|1|||
156364353|NCT00606892|564434439|FG001|First Intervention|Protocol Violation|4|||
156364354|NCT04225923|564434449|FG000|Overall Study|Protocol Violation|1|||
156364355|NCT04225923|564434450|FG001|Overall Study|Protocol Violation|0|||
156364356|NCT04225923|564434451|FG002|Overall Study|Protocol Violation|1|||
156364357|NCT04225923|564434449|FG000|Overall Study|Withdrawal by Subject|4|||
156364358|NCT04225923|564434450|FG001|Overall Study|Withdrawal by Subject|1|||
156364359|NCT04225923|564434451|FG002|Overall Study|Withdrawal by Subject|3|||
156364360|NCT04225923|564434449|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
156490842|NCT00053352|564892283|FG000|Overall Study|Physician Decision|11|||
156490843|NCT00053352|564892284|FG001|Overall Study|Physician Decision|1|||
156490844|NCT00053352|564892283|FG000|Overall Study|Withdrawal by Subject|1|||
156364361|NCT04225923|564434450|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
156364362|NCT04225923|564434451|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
156364363|NCT00855309|564434457|FG000|Overall Study|patient never recieved drug|1|||
156364364|NCT00855309|564434458|FG001|Overall Study|patient never recieved drug|0|||
156364365|NCT01907828|564434459|FG000|Overall Study|Exclusion criteria not met|0|||
156364366|NCT01907828|564434460|FG001|Overall Study|Exclusion criteria not met|1|||
156364367|NCT01907828|564434459|FG000|Overall Study|Withdrawal by Subject|3|||
156364368|NCT01907828|564434460|FG001|Overall Study|Withdrawal by Subject|4|||
156364369|NCT01907828|564434459|FG000|Overall Study|Lost to Follow-up|3|||
156364370|NCT01907828|564434460|FG001|Overall Study|Lost to Follow-up|0|||
156364371|NCT01907828|564434459|FG000|Overall Study|Participant refused 24-month follow-up|1|||
156490845|NCT00053352|564892284|FG001|Overall Study|Withdrawal by Subject|0|||
156545901|NCT02831673|565093248|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
156545902|NCT02831673|565093244|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156545903|NCT02831673|565093245|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156545904|NCT02831673|565093246|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156545905|NCT02831673|565093247|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156545906|NCT02831673|565093248|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
156545907|NCT02831673|565093244|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156545908|NCT02831673|565093245|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156545909|NCT02831673|565093246|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156545910|NCT02831673|565093247|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156545911|NCT02831673|565093248|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
156545912|NCT02831673|565093244|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156545913|NCT02831673|565093245|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156545914|NCT02831673|565093246|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156545915|NCT02831673|565093247|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156545916|NCT02831673|565093248|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
156545917|NCT00150592|565093249|FG000|Overall Study|Adverse Event|4|||
156545918|NCT00150592|565093250|FG001|Overall Study|Adverse Event|1|||
156545919|NCT00150592|565093249|FG000|Overall Study|Protocol Violation|1|||
156545920|NCT00150592|565093250|FG001|Overall Study|Protocol Violation|0|||
156545921|NCT00150592|565093249|FG000|Overall Study|Withdrawal by Subject|1|||
156545922|NCT00150592|565093250|FG001|Overall Study|Withdrawal by Subject|2|||
156545923|NCT00150592|565093249|FG000|Overall Study|Non-compliance|1|||
156545924|NCT00150592|565093250|FG001|Overall Study|Non-compliance|0|||
156545925|NCT00477165|565093258|FG000|Overall Study|Adverse Event|7|||
156545926|NCT00477165|565093259|FG001|Overall Study|Adverse Event|2|||
156545927|NCT00105443|565093265|FG000|Double-Blind Treatment|Adverse Event|1|||
156545928|NCT00105443|565093266|FG001|Double-Blind Treatment|Adverse Event|0|||
156545929|NCT00105443|565093267|FG002|Double-Blind Treatment|Adverse Event|0|||
156545930|NCT00105443|565093268|FG003|Double-Blind Treatment|Adverse Event|0|||
156545931|NCT00105443|565093265|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
156545932|NCT00105443|565093266|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
156545933|NCT00105443|565093267|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
156545934|NCT00105443|565093268|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
156545935|NCT00105443|565093265|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
156545936|NCT00105443|565093266|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
156545937|NCT00105443|565093267|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
156545938|NCT00105443|565093268|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
156545939|NCT00105443|565093265|FG000|Double-Blind Treatment|Physician Decision|1|||
156545940|NCT00105443|565093266|FG001|Double-Blind Treatment|Physician Decision|0|||
156545941|NCT00105443|565093267|FG002|Double-Blind Treatment|Physician Decision|2|||
156545942|NCT00105443|565093268|FG003|Double-Blind Treatment|Physician Decision|0|||
156545943|NCT00105443|565093265|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
156545944|NCT00105443|565093266|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
156545945|NCT00105443|565093267|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
156545946|NCT00105443|565093268|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
156545947|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
156545948|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
156490846|NCT00053352|564892283|FG000|Overall Study|Ineligible|8|||
156490847|NCT00053352|564892284|FG001|Overall Study|Ineligible|8|||
156490848|NCT00053352|564892283|FG000|Overall Study|Disease at new site|1|||
156490849|NCT00053352|564892284|FG001|Overall Study|Disease at new site|0|||
156490850|NCT02741713|564892287|FG000|Overall Study|Surgery type changed intra-operatively|2|||
156490851|NCT02741713|564892288|FG001|Overall Study|Surgery type changed intra-operatively|1|||
156490852|NCT01037413|564892289|FG000|Part A: Skin Testing|Adverse Event|1|||
156490853|NCT01037413|564892290|FG001|Part A: Skin Testing|Adverse Event|0|||
156490854|NCT01037413|564892289|FG000|Part A: Skin Testing|Protocol Violation|1|||
156490855|NCT01037413|564892290|FG001|Part A: Skin Testing|Protocol Violation|0|||
156490856|NCT01037413|564892289|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
156490857|NCT01037413|564892290|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
156490858|NCT01037413|564892289|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
156490859|NCT01037413|564892290|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
156490860|NCT00619983|564892291|FG000|Test Drug Alone|Withdrawal by Subject|1|||
156490861|NCT00619983|564892292|FG001|Test Drug Alone|Withdrawal by Subject|0|||
156490862|NCT00619983|564892293|FG002|Test Drug Alone|Withdrawal by Subject|0|||
156490863|NCT00619983|564892294|FG003|Test Drug Alone|Withdrawal by Subject|1|||
156490864|NCT00619983|564892291|FG000|Test Drug Alone|Failure of daily diary device|1|||
156364372|NCT01907828|564434460|FG001|Overall Study|Participant refused 24-month follow-up|0|||
156364373|NCT01907828|564434459|FG000|Overall Study|Participant met exclusion criteria|0|||
156364374|NCT01907828|564434460|FG001|Overall Study|Participant met exclusion criteria|1|||
156364375|NCT01585766|564434465|FG000|Overall Study|Withdrawal by Subject|0|||
156364376|NCT01585766|564434466|FG001|Overall Study|Withdrawal by Subject|1|||
156364377|NCT01585766|564434467|FG002|Overall Study|Withdrawal by Subject|1|||
156364378|NCT01585766|564434468|FG003|Overall Study|Withdrawal by Subject|0|||
156364379|NCT01585766|564434469|FG004|Overall Study|Withdrawal by Subject|0|||
156364380|NCT01585766|564434470|FG005|Overall Study|Withdrawal by Subject|0|||
156364381|NCT01585766|564434465|FG000|Overall Study|Death|0|||
156364382|NCT01585766|564434466|FG001|Overall Study|Death|1|||
156364383|NCT01585766|564434467|FG002|Overall Study|Death|0|||
156364384|NCT01585766|564434468|FG003|Overall Study|Death|0|||
156364385|NCT01585766|564434469|FG004|Overall Study|Death|0|||
156364386|NCT01585766|564434470|FG005|Overall Study|Death|0|||
156364387|NCT01585766|564434465|FG000|Overall Study|Physician Decision|0|||
156364388|NCT01585766|564434466|FG001|Overall Study|Physician Decision|0|||
156364389|NCT01585766|564434467|FG002|Overall Study|Physician Decision|1|||
156364390|NCT01585766|564434468|FG003|Overall Study|Physician Decision|0|||
156364391|NCT01585766|564434469|FG004|Overall Study|Physician Decision|0|||
156364392|NCT01585766|564434470|FG005|Overall Study|Physician Decision|0|||
156364393|NCT01364428|564434471|FG000|Overall Study|Adverse Event|1|||
156364394|NCT01364428|564434472|FG001|Overall Study|Adverse Event|2|||
156364395|NCT01364428|564434471|FG000|Overall Study|Protocol Violation|2|||
156364396|NCT01364428|564434472|FG001|Overall Study|Protocol Violation|0|||
156364397|NCT01364428|564434471|FG000|Overall Study|Withdrawal Criteria|14|||
156364398|NCT01364428|564434472|FG001|Overall Study|Withdrawal Criteria|10|||
156364399|NCT01364428|564434471|FG000|Overall Study|Other|3|||
156364400|NCT01364428|564434472|FG001|Overall Study|Other|3|||
156364401|NCT01073865|564434473|FG000|Overall Study|Reasons other than below|19|||
156364402|NCT01073865|564434474|FG001|Overall Study|Reasons other than below|31|||
156364403|NCT01073865|564434473|FG000|Overall Study|Lost to Follow-up|1|||
156364404|NCT01073865|564434474|FG001|Overall Study|Lost to Follow-up|1|||
156364405|NCT01073865|564434473|FG000|Overall Study|Death|3|||
156364406|NCT01073865|564434474|FG001|Overall Study|Death|2|||
156364407|NCT01073865|564434473|FG000|Overall Study|Withdrawal by Subject|5|||
156364408|NCT01073865|564434474|FG001|Overall Study|Withdrawal by Subject|5|||
156364409|NCT02547129|564434475|FG000|Overall Study|Difficulty with ongoing infection|1|||
156364410|NCT02547129|564434476|FG001|Overall Study|Difficulty with ongoing infection|0|||
156364411|NCT03925324|564434477|FG000|Overall Study|Death|1|||
156364412|NCT03925324|564434478|FG001|Overall Study|Death|1|||
156364413|NCT00794196|564434479|FG000|Overall Study|Lost to Follow-up|5|||
156364414|NCT00794196|564434480|FG001|Overall Study|Lost to Follow-up|23|||
156364415|NCT04414553|564434481|FG000|Overall Study|Lost to Follow-up|20|||
156490865|NCT00619983|564892292|FG001|Test Drug Alone|Failure of daily diary device|1|||
156490866|NCT00619983|564892293|FG002|Test Drug Alone|Failure of daily diary device|2|||
156490867|NCT00619983|564892294|FG003|Test Drug Alone|Failure of daily diary device|2|||
156490868|NCT00809341|564892295|FG000|Overall Study|Physician Decision|0|||
156490869|NCT00809341|564892296|FG001|Overall Study|Physician Decision|1|||
156364416|NCT02319031|564434485|FG000|Treatment Period|Death|1|||
156364417|NCT02319031|564434486|FG001|Treatment Period|Death|0|||
156490870|NCT00496626|564892297|FG000|Overall Study|Lost to Follow-up|0|||
156490871|NCT00496626|564892298|FG001|Overall Study|Lost to Follow-up|1|||
156364418|NCT04371380|564434497|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
156364419|NCT04371380|564434498|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
156364420|NCT04371380|564434499|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
156364421|NCT02244580|564434504|FG000|Overall Study|No cancer tissues available|241|||
156364422|NCT04964128|564434505|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
156364423|NCT04964128|564434505|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
156364424|NCT02120794|564434506|FG000|Overall Study|Withdrawal by Subject|43|||
156364425|NCT02120794|564434506|FG000|Overall Study|Adverse Event|10|||
156364426|NCT02120794|564434506|FG000|Overall Study|Physician Decision|4|||
156364427|NCT02120794|564434506|FG000|Overall Study|Due to insurance coverage|1|||
156364428|NCT00994240|564434509|FG000|Overall Study|Lost to Follow-up|3|||
156364429|NCT00994240|564434510|FG001|Overall Study|Lost to Follow-up|2|||
156364430|NCT00994240|564434509|FG000|Overall Study|Withdrawal by Subject|1|||
156364431|NCT00994240|564434510|FG001|Overall Study|Withdrawal by Subject|0|||
156364432|NCT00994240|564434509|FG000|Overall Study|study termination|2|||
156364433|NCT00994240|564434510|FG001|Overall Study|study termination|3|||
156364434|NCT01148511|564434511|FG000|Exposed to Study Drug|Protocol Violation|2|||
156364435|NCT01148511|564434512|FG001|Exposed to Study Drug|Protocol Violation|0|||
156364436|NCT01148511|564434513|FG002|Exposed to Study Drug|Protocol Violation|0|||
156364437|NCT01148511|564434511|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
156364438|NCT01148511|564434512|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
156364439|NCT01148511|564434513|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
156364440|NCT01148511|564434511|FG000|Randomized|Adverse Event|0|||
156364441|NCT01148511|564434512|FG001|Randomized|Adverse Event|1|||
156364442|NCT01148511|564434513|FG002|Randomized|Adverse Event|0|||
156364443|NCT01148511|564434511|FG000|Randomized|Protocol Violation|0|||
156364444|NCT01148511|564434512|FG001|Randomized|Protocol Violation|2|||
156364445|NCT01148511|564434513|FG002|Randomized|Protocol Violation|1|||
156364446|NCT01148511|564434511|FG000|Randomized|Lost to Follow-up|0|||
156364447|NCT01148511|564434512|FG001|Randomized|Lost to Follow-up|1|||
156364448|NCT01148511|564434513|FG002|Randomized|Lost to Follow-up|1|||
156364449|NCT01148511|564434511|FG000|Randomized|Consent withdrawal|0|||
156364450|NCT01148511|564434512|FG001|Randomized|Consent withdrawal|5|||
156364451|NCT01148511|564434513|FG002|Randomized|Consent withdrawal|3|||
156364452|NCT01148511|564434511|FG000|Randomized|Other|0|||
156364453|NCT01148511|564434512|FG001|Randomized|Other|1|||
156364454|NCT01148511|564434513|FG002|Randomized|Other|1|||
156364455|NCT01324349|564434516|FG000|Overall Study|Death|1|||
156364456|NCT01324349|564434517|FG001|Overall Study|Death|1|||
156364457|NCT01324349|564434516|FG000|Overall Study|Withdrawal by Subject|0|||
156364458|NCT01324349|564434517|FG001|Overall Study|Withdrawal by Subject|1|||
156364459|NCT00748215|564434518|FG000|Overall Study|Withdrawal by Subject|7|||
156364460|NCT00748215|564434519|FG001|Overall Study|Withdrawal by Subject|7|||
156364461|NCT00748215|564434518|FG000|Overall Study|Treatment change|2|||
156364462|NCT00748215|564434519|FG001|Overall Study|Treatment change|1|||
156364463|NCT00748215|564434518|FG000|Overall Study|Change in patient condition|0|||
156364464|NCT00748215|564434519|FG001|Overall Study|Change in patient condition|3|||
156364465|NCT00748215|564434518|FG000|Overall Study|Non-compliant|0|||
156364466|NCT00748215|564434519|FG001|Overall Study|Non-compliant|2|||
156364467|NCT00748215|564434518|FG000|Overall Study|Adverse Event|0|||
156364468|NCT00748215|564434519|FG001|Overall Study|Adverse Event|5|||
156364469|NCT02388737|564436352|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
156364470|NCT02388737|564436353|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
156364471|NCT02388737|564436354|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
156364472|NCT02388737|564436352|FG000|Overall Study|Major Protocol Deviation|18|||
156364473|NCT02388737|564436353|FG001|Overall Study|Major Protocol Deviation|25|||
156364474|NCT02388737|564436354|FG002|Overall Study|Major Protocol Deviation|22|||
156364475|NCT02388737|564436352|FG000|Overall Study|Lost to Follow-up|5|||
156364476|NCT02388737|564436353|FG001|Overall Study|Lost to Follow-up|1|||
156364477|NCT02388737|564436354|FG002|Overall Study|Lost to Follow-up|4|||
156364478|NCT02388737|564436352|FG000|Overall Study|Voluntary Withdrawal|10|||
156364479|NCT02388737|564436353|FG001|Overall Study|Voluntary Withdrawal|18|||
156364480|NCT02388737|564436354|FG002|Overall Study|Voluntary Withdrawal|17|||
156364481|NCT02388737|564436352|FG000|Overall Study|Lack of Efficacy|3|||
156364482|NCT02388737|564436353|FG001|Overall Study|Lack of Efficacy|0|||
156364483|NCT02388737|564436354|FG002|Overall Study|Lack of Efficacy|3|||
156490872|NCT00496626|564892297|FG000|Overall Study|Protocol Violation|1|||
156490873|NCT00496626|564892298|FG001|Overall Study|Protocol Violation|0|||
156490874|NCT00496626|564892297|FG000|Overall Study|Withdrawal by Subject|5|||
156490875|NCT00496626|564892298|FG001|Overall Study|Withdrawal by Subject|4|||
156490876|NCT00496626|564892297|FG000|Overall Study|Relocated|0|||
156364484|NCT02388737|564436352|FG000|Overall Study|Reason Not Specified|5|||
156364485|NCT02388737|564436353|FG001|Overall Study|Reason Not Specified|5|||
156490877|NCT00496626|564892298|FG001|Overall Study|Relocated|1|||
156490878|NCT00570921|564892302|FG000|Overall Study|Protocol Violation|1|||
156364486|NCT02388737|564436354|FG002|Overall Study|Reason Not Specified|4|||
156364487|NCT03252522|564436355|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
156364488|NCT03252522|564436356|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
156364489|NCT03252522|564436357|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
156364490|NCT03252522|564436355|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
156364491|NCT03252522|564436356|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
156490879|NCT00570921|564892302|FG000|Overall Study|Physician Decision|1|||
156490880|NCT02560389|564892309|FG000|Overall Study|Lost to Follow-up|1|||
156364492|NCT03252522|564436357|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
156364493|NCT03252522|564436355|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
156364494|NCT03252522|564436356|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
156364495|NCT03252522|564436357|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
156364496|NCT03252522|564436355|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
156364497|NCT03252522|564436356|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
156364498|NCT03252522|564436357|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
156364499|NCT03252522|564436355|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
156364500|NCT03252522|564436356|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
156364501|NCT03252522|564436357|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
156364502|NCT03252522|564436355|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
156364503|NCT03252522|564436356|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
156364504|NCT03252522|564436357|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
156364505|NCT03252522|564436355|FG000|Phase 2: Open Label|Adverse Event|0|||
156364506|NCT03252522|564436356|FG001|Phase 2: Open Label|Adverse Event|0|||
156364507|NCT03252522|564436357|FG002|Phase 2: Open Label|Adverse Event|2|||
156364508|NCT03252522|564436355|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
156364509|NCT03252522|564436356|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
156364510|NCT03252522|564436357|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
156364511|NCT03299842|564436359|FG000|Overall Study|Caregiver withdrew consent|2|||
156364512|NCT03299842|564436359|FG000|Overall Study|Child would not keep the watch on|3|||
156364513|NCT03034954|564436362|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
156364514|NCT03034954|564436363|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
156364515|NCT03568942|564436366|FG000|Overall Study|Family emergency|1|||
156364516|NCT03568942|564436366|FG000|Overall Study|Lost to Follow-up|1|||
156364517|NCT00358527|564436369|FG000|Overall Study|Adverse Event|4|||
156364518|NCT00358527|564436370|FG001|Overall Study|Adverse Event|0|||
156364519|NCT00358527|564436369|FG000|Overall Study|Withdrawal by Subject|1|||
156364520|NCT00358527|564436370|FG001|Overall Study|Withdrawal by Subject|1|||
156364521|NCT00358527|564436369|FG000|Overall Study|Non-compliance with protocol|6|||
156364522|NCT00358527|564436370|FG001|Overall Study|Non-compliance with protocol|1|||
156364523|NCT00358527|564436369|FG000|Overall Study|Administrative|2|||
156364524|NCT00358527|564436370|FG001|Overall Study|Administrative|1|||
156364525|NCT04144166|564436371|FG000|Overall Study|Discharged before study start|1|||
156364526|NCT04144166|564436371|FG000|Overall Study|Pregnancy|1|||
156364527|NCT04144166|564436371|FG000|Overall Study|Nail polish could not be removed from finger|1|||
156364528|NCT00749463|564436372|FG000|Overall Study|Adverse Event|0|||
156364529|NCT00749463|564436373|FG001|Overall Study|Adverse Event|4|||
156364530|NCT00749463|564436374|FG002|Overall Study|Adverse Event|1|||
156364531|NCT00749463|564436372|FG000|Overall Study|Withdrawal by Subject|1|||
156364532|NCT00749463|564436373|FG001|Overall Study|Withdrawal by Subject|0|||
156364533|NCT00749463|564436374|FG002|Overall Study|Withdrawal by Subject|0|||
156364534|NCT00913744|564436377|FG000|Overall Study|Adverse Event|2|||
156364535|NCT00913744|564436378|FG001|Overall Study|Adverse Event|0|||
156364536|NCT00913744|564436377|FG000|Overall Study|Withdrawal by Subject|2|||
156364537|NCT00913744|564436378|FG001|Overall Study|Withdrawal by Subject|1|||
156364538|NCT00913744|564436377|FG000|Overall Study|Death|1|||
156364539|NCT00913744|564436378|FG001|Overall Study|Death|0|||
156364540|NCT00805935|564436379|FG000|Overall Study|Stimulation Failure|1|||
156364541|NCT00805935|564436380|FG001|Overall Study|Stimulation Failure|5|||
156364542|NCT00805935|564436381|FG002|Overall Study|Stimulation Failure|2|||
156364543|NCT00805935|564436382|FG003|Overall Study|Stimulation Failure|2|||
156364544|NCT00805935|564436379|FG000|Overall Study|Cycle cancelled|0|||
156364545|NCT00805935|564436380|FG001|Overall Study|Cycle cancelled|0|||
156364546|NCT00805935|564436381|FG002|Overall Study|Cycle cancelled|2|||
156364547|NCT00805935|564436382|FG003|Overall Study|Cycle cancelled|0|||
156364548|NCT00805935|564436379|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
156364549|NCT00805935|564436380|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
156364550|NCT00805935|564436381|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
156364551|NCT00805935|564436382|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
156364552|NCT00805935|564436379|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
156364553|NCT00805935|564436380|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
156364554|NCT00805935|564436381|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
156364555|NCT00805935|564436382|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
156364556|NCT00805935|564436379|FG000|Overall Study|Lost to Follow-up|1|||
156364557|NCT00805935|564436380|FG001|Overall Study|Lost to Follow-up|0|||
156364558|NCT00805935|564436381|FG002|Overall Study|Lost to Follow-up|0|||
156364559|NCT00805935|564436382|FG003|Overall Study|Lost to Follow-up|0|||
156364560|NCT00805935|564436379|FG000|Overall Study|No positive serum pregnancy|8|||
156364561|NCT00805935|564436380|FG001|Overall Study|No positive serum pregnancy|7|||
156364562|NCT00805935|564436381|FG002|Overall Study|No positive serum pregnancy|6|||
156364563|NCT00805935|564436382|FG003|Overall Study|No positive serum pregnancy|5|||
156364564|NCT00805935|564436379|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
156364565|NCT00805935|564436380|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
156490881|NCT02560389|564892310|FG001|Overall Study|Lost to Follow-up|2|||
156490882|NCT02560389|564892311|FG002|Overall Study|Lost to Follow-up|2|||
156490883|NCT02560389|564892309|FG000|Overall Study|Tested positive for illicit substance|0|||
156490884|NCT02560389|564892310|FG001|Overall Study|Tested positive for illicit substance|1|||
156490885|NCT02560389|564892311|FG002|Overall Study|Tested positive for illicit substance|0|||
156490886|NCT02716298|564892312|FG000|First Intervention (1 Month)|Lens discomfort|1|||
156490887|NCT02716298|564892313|FG001|First Intervention (1 Month)|Lens discomfort|1|||
156490888|NCT04081389|564892322|FG000|Overall Study|Withdrawal by Subject|0|||
156490889|NCT04081389|564892323|FG001|Overall Study|Withdrawal by Subject|0|||
156490890|NCT04081389|564892324|FG002|Overall Study|Withdrawal by Subject|1|||
156490891|NCT04081389|564892325|FG003|Overall Study|Withdrawal by Subject|0|||
156490892|NCT02212301|564892326|FG000|Period 1|Lost to Follow-up|0|||
156490893|NCT02212301|564892327|FG001|Period 1|Lost to Follow-up|1|||
156490894|NCT00866918|564892330|FG000|Overall Study|Death|1|||
156490895|NCT00866918|564892331|FG001|Overall Study|Death|5|||
156490896|NCT00866918|564892330|FG000|Overall Study|Lack of Efficacy|1|||
156490897|NCT00866918|564892331|FG001|Overall Study|Lack of Efficacy|1|||
156490898|NCT00866918|564892330|FG000|Overall Study|Physician Decision|10|||
156490899|NCT00866918|564892331|FG001|Overall Study|Physician Decision|2|||
156490900|NCT00866918|564892330|FG000|Overall Study|Ineligible|2|||
156490901|NCT00866918|564892331|FG001|Overall Study|Ineligible|4|||
156490902|NCT00866918|564892330|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
156490903|NCT00866918|564892331|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
156490904|NCT00866918|564892330|FG000|Overall Study|Secondary malignancy|1|||
156490905|NCT00866918|564892331|FG001|Overall Study|Secondary malignancy|0|||
156490906|NCT00527514|564892332|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
156490907|NCT00527514|564892332|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
156490908|NCT00527514|564892332|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
156490909|NCT00527514|564892332|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
156490910|NCT00527514|564892332|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
156490911|NCT00527514|564892332|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
156490912|NCT00527514|564892332|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
156490913|NCT03041701|564892333|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
156490914|NCT03041701|564892334|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
156490915|NCT03041701|564892335|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
156490916|NCT03041701|564892333|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
156490917|NCT03041701|564892334|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
156490918|NCT03041701|564892335|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
156490919|NCT01281917|564892347|FG000|Overall Study|Withdrawal by Subject|1|||
156490920|NCT00802438|564892348|FG000|Overall Study|Screen Failure|20|||
156490921|NCT00802438|564892348|FG000|Overall Study|Withdrawal by Subject|7|||
156490922|NCT00802438|564892348|FG000|Overall Study|Physician Decision|1|||
156490923|NCT04016805|564892350|FG000|Overall Study|Sponsor's Discretion|30|||
156490924|NCT04016805|564892351|FG001|Overall Study|Sponsor's Discretion|6|||
156490925|NCT04016805|564892352|FG002|Overall Study|Sponsor's Discretion|5|||
156490926|NCT00740870|564892353|FG000|Overall Study|Not Catheterized|4|||
156490927|NCT00740870|564892353|FG000|Overall Study|Further testing contraindicated implant|17|||
156490928|NCT00819013|564892354|FG000|Overall Study|Not meeting continuing study eligibility|2|||
156490929|NCT00819013|564892355|FG001|Overall Study|Not meeting continuing study eligibility|1|||
156490930|NCT00819013|564892356|FG002|Overall Study|Not meeting continuing study eligibility|2|||
156490931|NCT00819013|564892357|FG003|Overall Study|Not meeting continuing study eligibility|1|||
156364566|NCT00805935|564436381|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
156364567|NCT00805935|564436382|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
156364568|NCT00805935|564436379|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
156364569|NCT00805935|564436380|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
156364570|NCT00805935|564436381|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
156364571|NCT00805935|564436382|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
156364572|NCT00805935|564436379|FG000|Overall Study|Biochemical pregnancy|0|||
156364573|NCT00805935|564436380|FG001|Overall Study|Biochemical pregnancy|1|||
156364574|NCT00805935|564436381|FG002|Overall Study|Biochemical pregnancy|0|||
156364575|NCT00805935|564436382|FG003|Overall Study|Biochemical pregnancy|0|||
156364576|NCT00805935|564436379|FG000|Overall Study|Chemical pregnancy|0|||
156364577|NCT00805935|564436380|FG001|Overall Study|Chemical pregnancy|5|||
156364578|NCT00805935|564436381|FG002|Overall Study|Chemical pregnancy|3|||
156364579|NCT00805935|564436382|FG003|Overall Study|Chemical pregnancy|2|||
156364580|NCT00805935|564436379|FG000|Overall Study|Ectopic pregnancy|0|||
156364581|NCT00805935|564436380|FG001|Overall Study|Ectopic pregnancy|0|||
156364582|NCT00805935|564436381|FG002|Overall Study|Ectopic pregnancy|1|||
156364583|NCT00805935|564436382|FG003|Overall Study|Ectopic pregnancy|0|||
156364584|NCT00805935|564436379|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
156364585|NCT00805935|564436380|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
156364586|NCT00805935|564436381|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
156364587|NCT00805935|564436382|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
156364588|NCT00283439|564436384|FG000|Overall Study|Adverse Event|0|||
156364589|NCT00283439|564436385|FG001|Overall Study|Adverse Event|0|||
156364590|NCT00283439|564436386|FG002|Overall Study|Adverse Event|0|||
156364591|NCT00283439|564436387|FG003|Overall Study|Adverse Event|1|||
156364592|NCT00283439|564436384|FG000|Overall Study|Death|0|||
156364593|NCT00283439|564436385|FG001|Overall Study|Death|0|||
156364594|NCT00283439|564436386|FG002|Overall Study|Death|1|||
156364595|NCT00283439|564436387|FG003|Overall Study|Death|0|||
156364596|NCT00283439|564436384|FG000|Overall Study|Disease progression|0|||
156364597|NCT00283439|564436385|FG001|Overall Study|Disease progression|1|||
156364598|NCT00283439|564436386|FG002|Overall Study|Disease progression|0|||
156364599|NCT00283439|564436387|FG003|Overall Study|Disease progression|0|||
156364600|NCT00283439|564436384|FG000|Overall Study|Requirement for alternative therapy|1|||
156364601|NCT00283439|564436385|FG001|Overall Study|Requirement for alternative therapy|2|||
156364602|NCT00283439|564436386|FG002|Overall Study|Requirement for alternative therapy|5|||
156364603|NCT00283439|564436387|FG003|Overall Study|Requirement for alternative therapy|2|||
156364604|NCT00283439|564436384|FG000|Overall Study|Stem cell transplant|6|||
156364605|NCT00283439|564436385|FG001|Overall Study|Stem cell transplant|6|||
156364606|NCT00283439|564436386|FG002|Overall Study|Stem cell transplant|4|||
156364607|NCT00283439|564436387|FG003|Overall Study|Stem cell transplant|3|||
156364608|NCT00283439|564436384|FG000|Overall Study|Treatment discontinued|0|||
156364609|NCT00283439|564436385|FG001|Overall Study|Treatment discontinued|2|||
156364610|NCT00283439|564436386|FG002|Overall Study|Treatment discontinued|1|||
156364611|NCT00283439|564436387|FG003|Overall Study|Treatment discontinued|3|||
156364612|NCT00283439|564436384|FG000|Overall Study|Other|1|||
156364613|NCT00283439|564436385|FG001|Overall Study|Other|0|||
156364614|NCT00283439|564436386|FG002|Overall Study|Other|0|||
156364615|NCT00283439|564436387|FG003|Overall Study|Other|0|||
156364616|NCT00333229|564436390|FG000|Overall Study|Lack of Efficacy|0|||
156364617|NCT00333229|564436391|FG001|Overall Study|Lack of Efficacy|1|||
156364618|NCT00782210|564436392|FG000|Overall Study|Adverse Event|21|||
156364619|NCT00782210|564436393|FG001|Overall Study|Adverse Event|17|||
156364620|NCT00782210|564436394|FG002|Overall Study|Adverse Event|16|||
156364621|NCT00782210|564436392|FG000|Overall Study|Lost to Follow-up|2|||
156364622|NCT00782210|564436393|FG001|Overall Study|Lost to Follow-up|1|||
156364623|NCT00782210|564436394|FG002|Overall Study|Lost to Follow-up|2|||
156364624|NCT00782210|564436392|FG000|Overall Study|Withdrawal by Subject|11|||
156364625|NCT00782210|564436393|FG001|Overall Study|Withdrawal by Subject|8|||
156364626|NCT00782210|564436394|FG002|Overall Study|Withdrawal by Subject|11|||
156364627|NCT00782210|564436392|FG000|Overall Study|Non compliance with protocol|0|||
156364628|NCT00782210|564436393|FG001|Overall Study|Non compliance with protocol|3|||
156364629|NCT00782210|564436394|FG002|Overall Study|Non compliance with protocol|2|||
156364630|NCT00782210|564436392|FG000|Overall Study|Lack of Efficacy|13|||
156364631|NCT00782210|564436393|FG001|Overall Study|Lack of Efficacy|4|||
156364632|NCT00782210|564436394|FG002|Overall Study|Lack of Efficacy|1|||
156364633|NCT00782210|564436392|FG000|Overall Study|Other reason not described above|3|||
156490932|NCT00819013|564892354|FG000|Overall Study|Adverse Event|0|||
156490933|NCT00819013|564892355|FG001|Overall Study|Adverse Event|0|||
156490934|NCT00819013|564892356|FG002|Overall Study|Adverse Event|1|||
156490935|NCT00819013|564892357|FG003|Overall Study|Adverse Event|0|||
156490936|NCT00819013|564892354|FG000|Overall Study|Withdrawal by Subject|1|||
156490937|NCT00819013|564892355|FG001|Overall Study|Withdrawal by Subject|0|||
156490938|NCT00819013|564892356|FG002|Overall Study|Withdrawal by Subject|1|||
156490939|NCT00819013|564892357|FG003|Overall Study|Withdrawal by Subject|0|||
156490940|NCT00819013|564892354|FG000|Overall Study|Lost to Follow-up|0|||
156490941|NCT00819013|564892355|FG001|Overall Study|Lost to Follow-up|0|||
156364634|NCT00782210|564436393|FG001|Overall Study|Other reason not described above|2|||
156364635|NCT00782210|564436394|FG002|Overall Study|Other reason not described above|3|||
156364636|NCT05358821|564436397|FG000|Overall Study|Withdrawal by Subject|0|||
156364637|NCT05358821|564436398|FG001|Overall Study|Withdrawal by Subject|1|||
156364638|NCT05358821|564436399|FG002|Overall Study|Withdrawal by Subject|0|||
156364639|NCT05358821|564436397|FG000|Overall Study|Withdrawal of Consent|0|||
156364640|NCT05358821|564436398|FG001|Overall Study|Withdrawal of Consent|0|||
156364641|NCT05358821|564436399|FG002|Overall Study|Withdrawal of Consent|1|||
156364642|NCT02704364|564436400|FG000|Overall Study|Adverse Event|1|||
156364643|NCT02704364|564436401|FG001|Overall Study|Adverse Event|1|||
156364644|NCT02704364|564436402|FG002|Overall Study|Adverse Event|0|||
156364645|NCT02704364|564436400|FG000|Overall Study|Noncompliance with study drug|1|||
156364646|NCT02704364|564436401|FG001|Overall Study|Noncompliance with study drug|1|||
156364647|NCT02704364|564436402|FG002|Overall Study|Noncompliance with study drug|0|||
156364648|NCT02704364|564436400|FG000|Overall Study|Other|0|||
156364649|NCT02704364|564436401|FG001|Overall Study|Other|1|||
156364650|NCT02704364|564436402|FG002|Overall Study|Other|1|||
156364651|NCT02086110|564436405|FG000|Overall Study|Withdrawal by Subject|1|||
156364652|NCT02086110|564436406|FG001|Overall Study|Withdrawal by Subject|1|||
156364653|NCT01869192|564436407|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
156364654|NCT01869192|564436408|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
156364655|NCT01869192|564436407|FG000|Postoperative Chemotherapy|Physician Decision|0|||
156364656|NCT01869192|564436408|FG001|Postoperative Chemotherapy|Physician Decision|2|||
156364657|NCT01203072|564436412|FG000|Overall Study|Adverse Event|5|||
156364658|NCT01203072|564436413|FG001|Overall Study|Adverse Event|3|||
156364659|NCT01203072|564436414|FG002|Overall Study|Adverse Event|2|||
156364660|NCT01203072|564436415|FG003|Overall Study|Adverse Event|4|||
156364661|NCT01203072|564436416|FG004|Overall Study|Adverse Event|2|||
156364662|NCT01203072|564436412|FG000|Overall Study|Lack of Efficacy|1|||
156364663|NCT01203072|564436413|FG001|Overall Study|Lack of Efficacy|0|||
156364664|NCT01203072|564436414|FG002|Overall Study|Lack of Efficacy|0|||
156364665|NCT01203072|564436415|FG003|Overall Study|Lack of Efficacy|0|||
156364666|NCT01203072|564436416|FG004|Overall Study|Lack of Efficacy|0|||
156364667|NCT01203072|564436412|FG000|Overall Study|Lost to Follow-up|0|||
156364668|NCT01203072|564436413|FG001|Overall Study|Lost to Follow-up|1|||
156364669|NCT01203072|564436414|FG002|Overall Study|Lost to Follow-up|0|||
156364670|NCT01203072|564436415|FG003|Overall Study|Lost to Follow-up|0|||
156364671|NCT01203072|564436416|FG004|Overall Study|Lost to Follow-up|0|||
156364672|NCT01203072|564436412|FG000|Overall Study|Protocol Violation|2|||
156364673|NCT01203072|564436413|FG001|Overall Study|Protocol Violation|0|||
156364674|NCT01203072|564436414|FG002|Overall Study|Protocol Violation|0|||
156364675|NCT01203072|564436415|FG003|Overall Study|Protocol Violation|0|||
156364676|NCT01203072|564436416|FG004|Overall Study|Protocol Violation|1|||
156364677|NCT01203072|564436412|FG000|Overall Study|Withdrawal by Subject|2|||
156364678|NCT01203072|564436413|FG001|Overall Study|Withdrawal by Subject|2|||
156364679|NCT01203072|564436414|FG002|Overall Study|Withdrawal by Subject|1|||
156364680|NCT01203072|564436415|FG003|Overall Study|Withdrawal by Subject|2|||
156364681|NCT01203072|564436416|FG004|Overall Study|Withdrawal by Subject|3|||
156364682|NCT02272413|564436418|FG000|Randomized Through Treatment Start|Not treated|3|||
156364683|NCT02272413|564436419|FG001|Randomized Through Treatment Start|Not treated|5|||
156364684|NCT02272413|564436418|FG000|Pre-switch Period|Adverse Event|38|||
156364685|NCT02272413|564436419|FG001|Pre-switch Period|Adverse Event|37|||
156364686|NCT02272413|564436418|FG000|Pre-switch Period|Death|26|||
156364687|NCT02272413|564436419|FG001|Pre-switch Period|Death|26|||
156364688|NCT02272413|564436418|FG000|Pre-switch Period|Withdrawal by Subject|27|||
156364689|NCT02272413|564436419|FG001|Pre-switch Period|Withdrawal by Subject|15|||
156364690|NCT02272413|564436418|FG000|Pre-switch Period|Physician Decision|6|||
156364691|NCT02272413|564436419|FG001|Pre-switch Period|Physician Decision|18|||
156364692|NCT02272413|564436418|FG000|Pre-switch Period|Progressive disease|185|||
156364693|NCT02272413|564436419|FG001|Pre-switch Period|Progressive disease|173|||
156364694|NCT02272413|564436418|FG000|Pre-switch Period|Lost to Follow-up|0|||
156364695|NCT02272413|564436419|FG001|Pre-switch Period|Lost to Follow-up|2|||
156364696|NCT02272413|564436418|FG000|Pre-switch Period|Protocol Violation|1|||
156364697|NCT02272413|564436419|FG001|Pre-switch Period|Protocol Violation|0|||
156364698|NCT02272413|564436418|FG000|Pre-switch Period|Other than listed|10|||
156364699|NCT02272413|564436419|FG001|Pre-switch Period|Other than listed|11|||
156364700|NCT02272413|564436418|FG000|Post-switch Period|Adverse Event|4|||
156364701|NCT02272413|564436419|FG001|Post-switch Period|Adverse Event|4|||
156364702|NCT02272413|564436418|FG000|Post-switch Period|Death|3|||
156364703|NCT02272413|564436419|FG001|Post-switch Period|Death|2|||
156364704|NCT02272413|564436418|FG000|Post-switch Period|Withdrawal by Subject|1|||
156364705|NCT02272413|564436419|FG001|Post-switch Period|Withdrawal by Subject|2|||
156364706|NCT02272413|564436418|FG000|Post-switch Period|Physician Decision|1|||
156364707|NCT02272413|564436419|FG001|Post-switch Period|Physician Decision|1|||
156364708|NCT02272413|564436418|FG000|Post-switch Period|Progressive disease|21|||
156364709|NCT02272413|564436419|FG001|Post-switch Period|Progressive disease|21|||
156364710|NCT02272413|564436418|FG000|Post-switch Period|Study terminated by sponsor|8|||
156364711|NCT02272413|564436419|FG001|Post-switch Period|Study terminated by sponsor|11|||
156364712|NCT02272413|564436418|FG000|Post-switch Period|Other than listed|4|||
156364713|NCT02272413|564436419|FG001|Post-switch Period|Other than listed|5|||
156364714|NCT02286193|564436425|FG000|Overall Study|Referred: CRS unable to make contact|62|||
156364715|NCT02286193|564436425|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
156364716|NCT02286193|564436425|FG000|Overall Study|Referred: Declined service|38|||
156364717|NCT00423891|564436426|FG000|Enrolled|Withdrawal by Subject|0|||
156364718|NCT00423891|564436427|FG001|Enrolled|Withdrawal by Subject|0|||
156364719|NCT00423891|564436428|FG002|Enrolled|Withdrawal by Subject|1|||
156364720|NCT00423891|564436426|FG000|Enrolled|Lost to Follow-up|0|||
156364721|NCT00423891|564436427|FG001|Enrolled|Lost to Follow-up|0|||
156364722|NCT00423891|564436428|FG002|Enrolled|Lost to Follow-up|1|||
156364723|NCT00423891|564436426|FG000|Enrolled|No longer met criteria|11|||
156364724|NCT00423891|564436427|FG001|Enrolled|No longer met criteria|2|||
156364725|NCT00423891|564436428|FG002|Enrolled|No longer met criteria|1|||
156364726|NCT00423891|564436426|FG000|Treatment|Withdrawal by Subject|1|||
156364727|NCT00423891|564436427|FG001|Treatment|Withdrawal by Subject|0|||
156364728|NCT00423891|564436428|FG002|Treatment|Withdrawal by Subject|0|||
156364729|NCT00423891|564436426|FG000|Treatment|Lost to Follow-up|1|||
156364730|NCT00423891|564436427|FG001|Treatment|Lost to Follow-up|0|||
156364731|NCT00423891|564436428|FG002|Treatment|Lost to Follow-up|0|||
156364732|NCT00423891|564436426|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
156364733|NCT00423891|564436427|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
156364734|NCT00423891|564436428|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
156364735|NCT00423891|564436426|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
156364736|NCT00423891|564436427|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
156364737|NCT00423891|564436428|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
156364738|NCT02871375|564436429|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
156364739|NCT02871375|564436430|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
156364740|NCT04327999|564436438|FG000|Overall Study|Protocol Violation|1|||
156364741|NCT02872116|564436443|FG000|Pre-Treatment|Disease Progression|0|||
156364742|NCT02872116|564436444|FG001|Pre-Treatment|Disease Progression|1|||
156364743|NCT02872116|564436445|FG002|Pre-Treatment|Disease Progression|0|||
156364744|NCT02872116|564436443|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
156364745|NCT02872116|564436444|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
156364746|NCT02872116|564436445|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
156364747|NCT02872116|564436443|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
156364748|NCT02872116|564436444|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
156364749|NCT02872116|564436445|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
156364750|NCT02872116|564436443|FG000|Pre-Treatment|Participant withdrew consent|2|||
156364751|NCT02872116|564436444|FG001|Pre-Treatment|Participant withdrew consent|20|||
156364752|NCT02872116|564436445|FG002|Pre-Treatment|Participant withdrew consent|3|||
156364753|NCT02872116|564436443|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
156364754|NCT02872116|564436444|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
156364755|NCT02872116|564436445|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
156364756|NCT02872116|564436443|FG000|Pre-Treatment|Other reasons|1|||
156364757|NCT02872116|564436444|FG001|Pre-Treatment|Other reasons|2|||
156364758|NCT02872116|564436445|FG002|Pre-Treatment|Other reasons|2|||
156364759|NCT02872116|564436443|FG000|Treatment|Death|121|||
156364760|NCT02872116|564436444|FG001|Treatment|Death|94|||
156364761|NCT02872116|564436445|FG002|Treatment|Death|68|||
156364762|NCT02872116|564436443|FG000|Treatment|Lost to Follow-up|5|||
156364763|NCT02872116|564436444|FG001|Treatment|Lost to Follow-up|7|||
156364764|NCT02872116|564436445|FG002|Treatment|Lost to Follow-up|3|||
156364765|NCT02872116|564436443|FG000|Treatment|Participant withdrew consent|20|||
156364766|NCT02872116|564436444|FG001|Treatment|Participant withdrew consent|40|||
156364767|NCT02872116|564436445|FG002|Treatment|Participant withdrew consent|8|||
156364768|NCT02872116|564436443|FG000|Treatment|Other reasons|13|||
156364769|NCT02872116|564436444|FG001|Treatment|Other reasons|12|||
156364770|NCT02872116|564436445|FG002|Treatment|Other reasons|5|||
156364771|NCT02346136|564436446|FG000|Overall Study|Withdrawal by Subject|7|||
156364772|NCT02346136|564436447|FG001|Overall Study|Withdrawal by Subject|5|||
156364773|NCT02346136|564436446|FG000|Overall Study|Death|1|||
156364774|NCT02346136|564436447|FG001|Overall Study|Death|0|||
156364775|NCT02346136|564436446|FG000|Overall Study|Study termination|14|||
156364776|NCT02346136|564436447|FG001|Overall Study|Study termination|18|||
156364777|NCT00582933|564436448|FG000|Overall Study|Physician Decision|3|||
156364778|NCT01371656|564436454|FG000|Overall Study|Death|7|||
156364779|NCT01371656|564436455|FG001|Overall Study|Death|4|||
156364780|NCT01371656|564436454|FG000|Overall Study|Physician Decision|46|||
156364781|NCT01371656|564436455|FG001|Overall Study|Physician Decision|7|||
156364782|NCT01371656|564436454|FG000|Overall Study|Withdrawal by Subject|7|||
156364783|NCT01371656|564436455|FG001|Overall Study|Withdrawal by Subject|0|||
156364784|NCT01371656|564436454|FG000|Overall Study|Ineligible|4|||
156364785|NCT01371656|564436455|FG001|Overall Study|Ineligible|3|||
156364786|NCT00696137|564436456|FG000|Overall Study|Withdrawal by Subject|2|||
156364787|NCT01465464|564436472|FG000|Overall Study|Adverse Event|96|||
156364788|NCT01465464|564436473|FG001|Overall Study|Adverse Event|49|||
156364789|NCT01465464|564436472|FG000|Overall Study|Lack of Efficacy|139|||
156364790|NCT01465464|564436473|FG001|Overall Study|Lack of Efficacy|190|||
156364791|NCT01465464|564436472|FG000|Overall Study|Physician Decision|13|||
156364792|NCT01465464|564436473|FG001|Overall Study|Physician Decision|5|||
156364793|NCT01465464|564436472|FG000|Overall Study|Protocol Violation|1|||
156364794|NCT01465464|564436473|FG001|Overall Study|Protocol Violation|1|||
156364795|NCT01465464|564436472|FG000|Overall Study|Withdrawal by Subject|46|||
156364796|NCT01465464|564436473|FG001|Overall Study|Withdrawal by Subject|30|||
156364797|NCT01465464|564436472|FG000|Overall Study|Other|9|||
156364798|NCT01465464|564436473|FG001|Overall Study|Other|3|||
156364799|NCT01465464|564436472|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
156364800|NCT01465464|564436473|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
156364801|NCT04334460|564436474|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
156364802|NCT04334460|564436475|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
156364803|NCT04334460|564436474|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
156364804|NCT04334460|564436475|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
156364805|NCT00775437|564436478|FG000|Overall Study|Loss of efficacy|2|||
156364806|NCT00775437|564436478|FG000|Overall Study|Withdrawal by Subject|3|||
156364807|NCT00775437|564436478|FG000|Overall Study|Lost to Follow-up|1|||
156364808|NCT01183975|564436479|FG000|Overall Study|Lost to Follow-up|73|||
156364809|NCT03316885|564436480|FG000|Overall Study|Adverse Event|1|||
156364810|NCT03316885|564436480|FG000|Overall Study|Death|10|||
156364811|NCT03316885|564436480|FG000|Overall Study|Lost to Follow-up|4|||
156364812|NCT03316885|564436480|FG000|Overall Study|Withdrawal by Subject|9|||
156364813|NCT03316885|564436480|FG000|Overall Study|COVID related|8|||
156364814|NCT04258605|564436483|FG000|Overall Study|Death|1|||
156364815|NCT04258605|564436484|FG001|Overall Study|Death|0|||
156364816|NCT04258605|564436483|FG000|Overall Study|Early study termination|21|||
156364817|NCT04258605|564436484|FG001|Overall Study|Early study termination|2|||
156364818|NCT02910167|564436485|FG000|Overall Study|Adverse Event|1|||
156364819|NCT02910167|564436485|FG000|Overall Study|Lost to Follow-up|18|||
156364820|NCT01418937|564436486|FG000|Overall Study|Lost to Follow-up|5|||
156364821|NCT01418937|564436486|FG000|Overall Study|Protocol Violation|1|||
156364822|NCT01418937|564436486|FG000|Overall Study|Pregnancy|1|||
156364823|NCT01418937|564436486|FG000|Overall Study|Withdrawal by Subject|1|||
156364824|NCT00856908|564436502|FG000|Overall Study|Lost to Follow-up|1|||
156364825|NCT00856908|564436503|FG001|Overall Study|Lost to Follow-up|0|||
156364826|NCT01063595|564436506|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
156364827|NCT01063595|564436507|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
156364828|NCT01063595|564436506|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
156364829|NCT01063595|564436507|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
156364830|NCT01063595|564436506|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
156364831|NCT01063595|564436507|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
156364832|NCT01063595|564436506|FG000|First Intervention|Adverse Event|1|||
156364833|NCT01063595|564436507|FG001|First Intervention|Adverse Event|4|||
156364834|NCT01063595|564436506|FG000|First Intervention|Withdrawal by Subject|1|||
156364835|NCT01063595|564436507|FG001|First Intervention|Withdrawal by Subject|0|||
156364836|NCT01063595|564436506|FG000|First Intervention|Reason not Specified|0|||
156364837|NCT01063595|564436507|FG001|First Intervention|Reason not Specified|1|||
156364838|NCT04059146|564436510|FG000|Overall Study|Withdrawal by Subject|0|||
156364839|NCT04059146|564436511|FG001|Overall Study|Withdrawal by Subject|1|||
156364840|NCT01623596|564436512|FG000|Overall Study|Abnormal laboratory values|2|||
156364841|NCT01623596|564436513|FG001|Overall Study|Abnormal laboratory values|0|||
156364842|NCT01623596|564436512|FG000|Overall Study|Administrative problems|9|||
156364843|NCT01623596|564436513|FG001|Overall Study|Administrative problems|13|||
156364844|NCT01623596|564436512|FG000|Overall Study|Adverse Event|20|||
156364845|NCT01623596|564436513|FG001|Overall Study|Adverse Event|29|||
156364846|NCT01623596|564436512|FG000|Overall Study|Death|0|||
156364847|NCT01623596|564436513|FG001|Overall Study|Death|2|||
156364848|NCT01623596|564436512|FG000|Overall Study|Lost to Follow-up|12|||
156364849|NCT01623596|564436513|FG001|Overall Study|Lost to Follow-up|16|||
156364850|NCT01623596|564436512|FG000|Overall Study|Withdrawal by Subject|13|||
156364851|NCT01623596|564436513|FG001|Overall Study|Withdrawal by Subject|31|||
156490942|NCT00819013|564892356|FG002|Overall Study|Lost to Follow-up|1|||
156490943|NCT00819013|564892357|FG003|Overall Study|Lost to Follow-up|2|||
156490944|NCT00819013|564892354|FG000|Overall Study|Death|0|||
156490945|NCT00819013|564892355|FG001|Overall Study|Death|0|||
156490946|NCT00819013|564892356|FG002|Overall Study|Death|0|||
156490947|NCT00819013|564892357|FG003|Overall Study|Death|1|||
156490948|NCT00607997|564892359|FG000|Overall Study|Lack of Efficacy|6|||
156490949|NCT00607997|564892360|FG001|Overall Study|Lack of Efficacy|20|||
156490950|NCT00607997|564892361|FG002|Overall Study|Lack of Efficacy|14|||
156490951|NCT00607997|564892362|FG003|Overall Study|Lack of Efficacy|10|||
156364852|NCT01623596|564436512|FG000|Overall Study|Patient no longer requires study drug|1|||
156490952|NCT00607997|564892359|FG000|Overall Study|Death|8|||
156364853|NCT01623596|564436513|FG001|Overall Study|Patient no longer requires study drug|0|||
156364854|NCT01623596|564436512|FG000|Overall Study|Protocol Violation|0|||
156364855|NCT01623596|564436513|FG001|Overall Study|Protocol Violation|6|||
156364856|NCT01623596|564436512|FG000|Overall Study|Lack of Efficacy|5|||
156364857|NCT01623596|564436513|FG001|Overall Study|Lack of Efficacy|3|||
156364858|NCT01070316|564436514|FG000|Extension Phase|Lack of Efficacy|3|||
156364859|NCT01070316|564436514|FG000|Extension Phase|Withdrawal by Subject|1|||
156364860|NCT00842348|564436518|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
156364861|NCT00842348|564436519|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
156364862|NCT00842348|564436518|FG000|Study 729|Disease progression/death|19|||
156364863|NCT00842348|564436519|FG001|Study 729|Disease progression/death|30|||
156364864|NCT00842348|564436518|FG000|Study 729|Adverse Event|1|||
156364865|NCT00842348|564436519|FG001|Study 729|Adverse Event|1|||
156364866|NCT00842348|564436518|FG000|Study 729|Protocol Violation|1|||
156364867|NCT00842348|564436519|FG001|Study 729|Protocol Violation|1|||
156364868|NCT00842348|564436518|FG000|Study 729|Withdrawal by Subject|2|||
156364869|NCT00842348|564436519|FG001|Study 729|Withdrawal by Subject|4|||
156364870|NCT00842348|564436518|FG000|Study 729|Due to Sponsor stopping the study|1|||
156364871|NCT00842348|564436519|FG001|Study 729|Due to Sponsor stopping the study|1|||
156364872|NCT00842348|564436518|FG000|Study 729|Due to non-availability of IP|0|||
156364873|NCT00842348|564436519|FG001|Study 729|Due to non-availability of IP|1|||
156364874|NCT00842348|564436518|FG000|Study 729|Sponsor's decision|1|||
156364875|NCT00842348|564436519|FG001|Study 729|Sponsor's decision|0|||
156364876|NCT00842348|564436518|FG000|Study 729|Surgical resection|1|||
156364877|NCT00842348|564436519|FG001|Study 729|Surgical resection|0|||
156364878|NCT00026793|564436520|FG000|Overall Study|Death on study due to underlying disease|4|||
156364879|NCT00026793|564436520|FG000|Overall Study|Physician Decision|2|||
156364880|NCT00026793|564436520|FG000|Overall Study|Off study|2|||
156364881|NCT04243538|564436521|FG000|Overall Study|Withdrawal by Subject|0|||
156364882|NCT04243538|564436522|FG001|Overall Study|Withdrawal by Subject|2|||
156364883|NCT04243538|564436521|FG000|Overall Study|Lost to Follow-up|0|||
156364884|NCT04243538|564436522|FG001|Overall Study|Lost to Follow-up|3|||
156364885|NCT00655564|564436523|FG000|Overall Study|Adverse Event|1|||
156364886|NCT00655564|564436523|FG000|Overall Study|Lost to Follow-up|1|||
156364887|NCT00655564|564436523|FG000|Overall Study|Desired Alternate Therapy|1|||
156364888|NCT04536727|564436524|FG000|Overall Study|Lost to Follow-up|1|||
156364889|NCT04536727|564436525|FG001|Overall Study|Lost to Follow-up|1|||
156364890|NCT04536727|564436524|FG000|Overall Study|Death|0|||
156364891|NCT04536727|564436525|FG001|Overall Study|Death|1|||
156364892|NCT00500370|564436529|FG000|Overall Study|Adverse Event|9|||
156364893|NCT00500370|564436530|FG001|Overall Study|Adverse Event|3|||
156364894|NCT00500370|564436529|FG000|Overall Study|Lost to Follow-up|10|||
156364895|NCT00500370|564436530|FG001|Overall Study|Lost to Follow-up|10|||
156364896|NCT00500370|564436529|FG000|Overall Study|Protocol Violation|2|||
156364897|NCT00500370|564436530|FG001|Overall Study|Protocol Violation|4|||
156364898|NCT00500370|564436529|FG000|Overall Study|Sponsor Decision|2|||
156364899|NCT00500370|564436530|FG001|Overall Study|Sponsor Decision|0|||
156364900|NCT00500370|564436529|FG000|Overall Study|Subject Decision|10|||
156364901|NCT00500370|564436530|FG001|Overall Study|Subject Decision|17|||
156364902|NCT05627518|564436531|FG000|Treatment Period 1|Adverse Event|0|||
156364903|NCT05627518|564436532|FG001|Treatment Period 1|Adverse Event|0|||
156364904|NCT05627518|564436533|FG002|Treatment Period 1|Adverse Event|1|||
156364905|NCT05627518|564436534|FG003|Treatment Period 1|Adverse Event|0|||
156364906|NCT05627518|564436535|FG004|Treatment Period 1|Adverse Event|0|||
156364907|NCT05627518|564436536|FG005|Treatment Period 1|Adverse Event|0|||
156364908|NCT05627518|564436537|FG006|Treatment Period 1|Adverse Event|0|||
156364909|NCT05627518|564436538|FG007|Treatment Period 1|Adverse Event|1|||
156364910|NCT05627518|564436531|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156364911|NCT05627518|564436532|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156364912|NCT05627518|564436533|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156364913|NCT05627518|564436534|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156364914|NCT05627518|564436535|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156364915|NCT05627518|564436536|FG005|Treatment Period 1|Withdrawal by Subject|1|||
156364916|NCT05627518|564436537|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156364917|NCT05627518|564436538|FG007|Treatment Period 1|Withdrawal by Subject|0|||
156364918|NCT05627518|564436531|FG000|Treatment Period 1|Protocol Violation|0|||
156364919|NCT05627518|564436532|FG001|Treatment Period 1|Protocol Violation|0|||
156364920|NCT05627518|564436533|FG002|Treatment Period 1|Protocol Violation|0|||
156364921|NCT05627518|564436534|FG003|Treatment Period 1|Protocol Violation|0|||
156364922|NCT05627518|564436535|FG004|Treatment Period 1|Protocol Violation|0|||
156364923|NCT05627518|564436536|FG005|Treatment Period 1|Protocol Violation|0|||
156364924|NCT05627518|564436537|FG006|Treatment Period 1|Protocol Violation|6|||
156364925|NCT05627518|564436538|FG007|Treatment Period 1|Protocol Violation|6|||
156364926|NCT05627518|564436531|FG000|Treatment Period 2|Adverse Event|1|||
156364927|NCT05627518|564436532|FG001|Treatment Period 2|Adverse Event|0|||
156364928|NCT05627518|564436533|FG002|Treatment Period 2|Adverse Event|0|||
156364929|NCT05627518|564436534|FG003|Treatment Period 2|Adverse Event|0|||
156364930|NCT05627518|564436535|FG004|Treatment Period 2|Adverse Event|0|||
156364931|NCT05627518|564436536|FG005|Treatment Period 2|Adverse Event|0|||
156364932|NCT05627518|564436537|FG006|Treatment Period 2|Adverse Event|0|||
156364933|NCT05627518|564436538|FG007|Treatment Period 2|Adverse Event|0|||
156364934|NCT05627518|564436531|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156364935|NCT05627518|564436532|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156364936|NCT05627518|564436533|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156364937|NCT05627518|564436534|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156364938|NCT05627518|564436535|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156364939|NCT05627518|564436536|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156364940|NCT05627518|564436537|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156364941|NCT05627518|564436538|FG007|Treatment Period 2|Withdrawal by Subject|0|||
156364942|NCT02970968|564438418|FG000|Overall Study|Withdrawal by Subject|3|||
156364943|NCT02970968|564438419|FG001|Overall Study|Withdrawal by Subject|3|||
156364944|NCT02970968|564438418|FG000|Overall Study|Adverse Event|1|||
156364945|NCT02970968|564438419|FG001|Overall Study|Adverse Event|2|||
156364946|NCT02970968|564438418|FG000|Overall Study|Lost to Follow-up|1|||
156364947|NCT02970968|564438419|FG001|Overall Study|Lost to Follow-up|1|||
156364948|NCT02970968|564438418|FG000|Overall Study|Non-Compliance|0|||
156364949|NCT02970968|564438419|FG001|Overall Study|Non-Compliance|1|||
156364950|NCT02565381|564438420|FG000|Overall Study|Lost to Follow-up|1|||
156364951|NCT02565381|564438421|FG001|Overall Study|Lost to Follow-up|0|||
156364952|NCT02565381|564438422|FG002|Overall Study|Lost to Follow-up|1|||
156364953|NCT01816139|564438423|FG000|Overall Study|Adverse Event|6|||
156364954|NCT01816139|564438424|FG001|Overall Study|Adverse Event|8|||
156364955|NCT01816139|564438423|FG000|Overall Study|Lack of Efficacy|1|||
156364956|NCT01816139|564438424|FG001|Overall Study|Lack of Efficacy|2|||
156364957|NCT01816139|564438423|FG000|Overall Study|Lost to Follow-up|5|||
156364958|NCT01816139|564438424|FG001|Overall Study|Lost to Follow-up|3|||
156364959|NCT01816139|564438423|FG000|Overall Study|Withdrew Consent|6|||
156364960|NCT01816139|564438424|FG001|Overall Study|Withdrew Consent|4|||
156364961|NCT01816139|564438423|FG000|Overall Study|Protocol Violation|6|||
156364962|NCT01816139|564438424|FG001|Overall Study|Protocol Violation|3|||
156364963|NCT01816139|564438423|FG000|Overall Study|Reason not Specified|4|||
156364964|NCT01816139|564438424|FG001|Overall Study|Reason not Specified|2|||
156364965|NCT01940120|564438425|FG000|Overall Study|Death|40|||
156364966|NCT01940120|564438425|FG000|Overall Study|Withdrawal by Subject|8|||
156364967|NCT02554656|564438426|FG000|Overall Study|Protocol Violation|3|||
156364968|NCT01888497|564438427|FG000|Washout Period 1|Withdrawal by Subject|0|||
156364969|NCT01888497|564438428|FG001|Washout Period 1|Withdrawal by Subject|0|||
156364970|NCT01888497|564438429|FG002|Washout Period 1|Withdrawal by Subject|1|||
156364971|NCT01888497|564438430|FG003|Washout Period 1|Withdrawal by Subject|1|||
156364972|NCT01888497|564438427|FG000|Washout Period 2|Adverse Event|0|||
156364973|NCT01888497|564438428|FG001|Washout Period 2|Adverse Event|0|||
156364974|NCT01888497|564438429|FG002|Washout Period 2|Adverse Event|0|||
156364975|NCT01888497|564438430|FG003|Washout Period 2|Adverse Event|1|||
156364976|NCT01888497|564438427|FG000|Washout Period 2|Withdrawal by Subject|0|||
156364977|NCT01888497|564438428|FG001|Washout Period 2|Withdrawal by Subject|0|||
156364978|NCT01888497|564438429|FG002|Washout Period 2|Withdrawal by Subject|0|||
156364979|NCT01888497|564438430|FG003|Washout Period 2|Withdrawal by Subject|1|||
156364980|NCT04152447|564438431|FG000|Overall Study|Lost to Follow-up|1|||
156364981|NCT04152447|564438432|FG001|Overall Study|Lost to Follow-up|0|||
156364982|NCT04152447|564438431|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
156364983|NCT04152447|564438432|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
156364984|NCT04152447|564438431|FG000|Overall Study|Withdrawal by Subject|0|||
156364985|NCT04152447|564438432|FG001|Overall Study|Withdrawal by Subject|1|||
156364986|NCT04152447|564438431|FG000|Overall Study|Found ineligible after enrolling|1|||
156364987|NCT04152447|564438432|FG001|Overall Study|Found ineligible after enrolling|1|||
156364988|NCT04152447|564438431|FG000|Overall Study|Did not receive VR headset in time.|0|||
156364989|NCT04152447|564438432|FG001|Overall Study|Did not receive VR headset in time.|2|||
156364990|NCT03240575|564438433|FG000|Overall Study|Adverse Event|0|||
156364991|NCT03240575|564438434|FG001|Overall Study|Adverse Event|2|||
156364992|NCT03240575|564438435|FG002|Overall Study|Adverse Event|0|||
156364993|NCT03240575|564438436|FG003|Overall Study|Adverse Event|1|||
156364994|NCT03240575|564438433|FG000|Overall Study|Withdrawal by Subject|2|||
156364995|NCT03240575|564438434|FG001|Overall Study|Withdrawal by Subject|11|||
156364996|NCT03240575|564438435|FG002|Overall Study|Withdrawal by Subject|0|||
156364997|NCT03240575|564438436|FG003|Overall Study|Withdrawal by Subject|1|||
156364998|NCT03240575|564438433|FG000|Overall Study|Other|0|||
156364999|NCT03240575|564438434|FG001|Overall Study|Other|1|||
156365000|NCT03240575|564438435|FG002|Overall Study|Other|0|||
156365001|NCT03240575|564438436|FG003|Overall Study|Other|0|||
156365002|NCT01140477|564438439|FG000|Overall Study|Lost to Follow-up|4|||
156365003|NCT01140477|564438440|FG001|Overall Study|Lost to Follow-up|0|||
156365004|NCT01140477|564438439|FG000|Overall Study|Withdrawal by Subject|1|||
156365005|NCT01140477|564438440|FG001|Overall Study|Withdrawal by Subject|4|||
156365006|NCT01140477|564438439|FG000|Overall Study|Surgical complication preventing implant|2|||
156365007|NCT01140477|564438440|FG001|Overall Study|Surgical complication preventing implant|0|||
156365008|NCT01140477|564438439|FG000|Overall Study|Death|1|||
156490953|NCT00607997|564892360|FG001|Overall Study|Death|5|||
156490954|NCT00607997|564892361|FG002|Overall Study|Death|2|||
156490955|NCT00607997|564892362|FG003|Overall Study|Death|5|||
156490956|NCT00607997|564892359|FG000|Overall Study|Adverse Event|3|||
156490957|NCT00607997|564892360|FG001|Overall Study|Adverse Event|1|||
156490958|NCT00607997|564892361|FG002|Overall Study|Adverse Event|2|||
156490959|NCT00607997|564892362|FG003|Overall Study|Adverse Event|0|||
156490960|NCT00607997|564892359|FG000|Overall Study|Physician Decision|4|||
156490961|NCT00607997|564892360|FG001|Overall Study|Physician Decision|1|||
156490962|NCT00607997|564892361|FG002|Overall Study|Physician Decision|0|||
156490963|NCT00607997|564892362|FG003|Overall Study|Physician Decision|0|||
156490964|NCT00607997|564892359|FG000|Overall Study|Relapse, recurrent illness|4|||
156490965|NCT00607997|564892360|FG001|Overall Study|Relapse, recurrent illness|0|||
156490966|NCT00607997|564892361|FG002|Overall Study|Relapse, recurrent illness|2|||
156490967|NCT00607997|564892362|FG003|Overall Study|Relapse, recurrent illness|0|||
156490968|NCT00607997|564892359|FG000|Overall Study|Other without explanation|2|||
156490969|NCT00607997|564892360|FG001|Overall Study|Other without explanation|0|||
156490970|NCT00607997|564892361|FG002|Overall Study|Other without explanation|4|||
156490971|NCT00607997|564892362|FG003|Overall Study|Other without explanation|1|||
156490972|NCT00839332|564892363|FG000|Phase 1|Disease Progression|38|||
156490973|NCT00839332|564892364|FG001|Phase 1|Disease Progression|0|||
156490974|NCT00839332|564892365|FG002|Phase 1|Disease Progression|0|||
156490975|NCT00839332|564892363|FG000|Phase 1|Adverse Event|6|||
156490976|NCT00839332|564892364|FG001|Phase 1|Adverse Event|0|||
156490977|NCT00839332|564892365|FG002|Phase 1|Adverse Event|0|||
156490978|NCT00839332|564892363|FG000|Phase 1|Withdrawal by Subject|4|||
156490979|NCT00839332|564892364|FG001|Phase 1|Withdrawal by Subject|0|||
156490980|NCT00839332|564892365|FG002|Phase 1|Withdrawal by Subject|0|||
156490981|NCT00839332|564892363|FG000|Phase 1|Physician Decision|2|||
156490982|NCT00839332|564892364|FG001|Phase 1|Physician Decision|0|||
156490983|NCT00839332|564892365|FG002|Phase 1|Physician Decision|0|||
156490984|NCT00839332|564892363|FG000|Phase 2|Protocol Violation|0|||
156490985|NCT00839332|564892364|FG001|Phase 2|Protocol Violation|1|||
156490986|NCT00839332|564892365|FG002|Phase 2|Protocol Violation|0|||
156490987|NCT00839332|564892363|FG000|Phase 2|Disease Progression|0|||
156490988|NCT00839332|564892364|FG001|Phase 2|Disease Progression|46|||
156490989|NCT00839332|564892365|FG002|Phase 2|Disease Progression|21|||
156490990|NCT00839332|564892363|FG000|Phase 2|Adverse Event|0|||
156490991|NCT00839332|564892364|FG001|Phase 2|Adverse Event|8|||
156490992|NCT00839332|564892365|FG002|Phase 2|Adverse Event|6|||
156490993|NCT00839332|564892363|FG000|Phase 2|Death|0|||
156490994|NCT00839332|564892364|FG001|Phase 2|Death|4|||
156490995|NCT00839332|564892365|FG002|Phase 2|Death|2|||
156490996|NCT00839332|564892363|FG000|Phase 2|Withdrawal by Subject|0|||
156490997|NCT00839332|564892364|FG001|Phase 2|Withdrawal by Subject|5|||
156490998|NCT00839332|564892365|FG002|Phase 2|Withdrawal by Subject|8|||
156490999|NCT00839332|564892363|FG000|Phase 2|Physician Decision|0|||
156491000|NCT00839332|564892364|FG001|Phase 2|Physician Decision|4|||
156491001|NCT00839332|564892365|FG002|Phase 2|Physician Decision|1|||
156491002|NCT00839332|564892363|FG000|Phase 2|Lost to Follow-up|0|||
156491003|NCT00839332|564892364|FG001|Phase 2|Lost to Follow-up|0|||
156491004|NCT00839332|564892365|FG002|Phase 2|Lost to Follow-up|1|||
156491005|NCT01200485|564892366|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
156491006|NCT01200485|564892367|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
156491007|NCT01200485|564892368|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
156491008|NCT01200485|564892366|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
156491009|NCT01200485|564892367|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
156491010|NCT01200485|564892368|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
156491011|NCT06080438|564892369|FG000|Overall Study|Lost to Follow-up|2|||
156491012|NCT03078751|564892374|FG000|Overall Study|Adverse Event|4|||
156491013|NCT03078751|564892375|FG001|Overall Study|Adverse Event|0|||
156491014|NCT03078751|564892374|FG000|Overall Study|Physician Decision|1|||
156545949|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
156491015|NCT03078751|564892375|FG001|Overall Study|Physician Decision|0|||
156491016|NCT03078751|564892374|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
156491017|NCT03078751|564892375|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
156491018|NCT03078751|564892374|FG000|Overall Study|Subject/guardian decision|8|||
156491019|NCT03078751|564892375|FG001|Overall Study|Subject/guardian decision|1|||
156491020|NCT03078751|564892374|FG000|Overall Study|Untreated|0|||
156491021|NCT03078751|564892375|FG001|Overall Study|Untreated|4|||
156491022|NCT04414397|564892376|FG000|Control Period|Withdrawal by Subject|2|||
156491023|NCT04414397|564892377|FG001|Control Period|Withdrawal by Subject|2|||
156491024|NCT04414397|564892376|FG000|Control Period|Lost to Follow-up|0|||
156491025|NCT04414397|564892377|FG001|Control Period|Lost to Follow-up|4|||
156491026|NCT04414397|564892376|FG000|Control Period|Protocol deviation|0|||
156491027|NCT04414397|564892377|FG001|Control Period|Protocol deviation|1|||
156365009|NCT01140477|564438440|FG001|Overall Study|Death|1|||
156365010|NCT01140477|564438439|FG000|Overall Study|Subject explanted|0|||
156365011|NCT01140477|564438440|FG001|Overall Study|Subject explanted|1|||
156365012|NCT04013191|564438441|FG000|Overall Study|Adverse Event|1|||
156365013|NCT04013191|564438442|FG001|Overall Study|Adverse Event|0|||
156365014|NCT04482179|564438451|FG000|Overall Study|Death|1|||
156365015|NCT04482179|564438452|FG001|Overall Study|Death|0|||
156365016|NCT04482179|564438451|FG000|Overall Study|Withdrawal by Subject|1|||
156365017|NCT04482179|564438452|FG001|Overall Study|Withdrawal by Subject|0|||
156365018|NCT04127786|564438455|FG000|Primary Series|Adverse Event|1|||
156365019|NCT04127786|564438456|FG001|Primary Series|Adverse Event|0|||
156365020|NCT04127786|564438457|FG002|Primary Series|Adverse Event|0|||
156365021|NCT04127786|564438458|FG003|Primary Series|Adverse Event|1|||
156365022|NCT04127786|564438459|FG004|Primary Series|Adverse Event|0|||
156365023|NCT04127786|564438460|FG005|Primary Series|Adverse Event|1|||
156365024|NCT04127786|564438455|FG000|Primary Series|Protocol Violation|5|||
156365025|NCT04127786|564438456|FG001|Primary Series|Protocol Violation|3|||
156365026|NCT04127786|564438457|FG002|Primary Series|Protocol Violation|4|||
156365027|NCT04127786|564438458|FG003|Primary Series|Protocol Violation|3|||
156365028|NCT04127786|564438459|FG004|Primary Series|Protocol Violation|2|||
156365029|NCT04127786|564438460|FG005|Primary Series|Protocol Violation|0|||
156365030|NCT04127786|564438455|FG000|Primary Series|Withdrawal by Subject|0|||
156365031|NCT04127786|564438456|FG001|Primary Series|Withdrawal by Subject|0|||
156365032|NCT04127786|564438457|FG002|Primary Series|Withdrawal by Subject|0|||
156365033|NCT04127786|564438458|FG003|Primary Series|Withdrawal by Subject|1|||
156365034|NCT04127786|564438459|FG004|Primary Series|Withdrawal by Subject|0|||
156365035|NCT04127786|564438460|FG005|Primary Series|Withdrawal by Subject|0|||
156365036|NCT04127786|564438455|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
156365037|NCT04127786|564438456|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
156365038|NCT04127786|564438457|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
156365039|NCT04127786|564438458|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
156365040|NCT04127786|564438459|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
156365041|NCT04127786|564438460|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
156365042|NCT04127786|564438455|FG000|Booster Phase|Withdrawal by Subject|2|||
156365043|NCT04127786|564438456|FG001|Booster Phase|Withdrawal by Subject|0|||
156365044|NCT04127786|564438457|FG002|Booster Phase|Withdrawal by Subject|0|||
156365045|NCT04127786|564438458|FG003|Booster Phase|Withdrawal by Subject|0|||
156365046|NCT04127786|564438459|FG004|Booster Phase|Withdrawal by Subject|0|||
156365047|NCT04127786|564438460|FG005|Booster Phase|Withdrawal by Subject|0|||
156365048|NCT01481116|564438461|FG000|Overall Study|Adverse Event|26|||
156365049|NCT01481116|564438462|FG001|Overall Study|Adverse Event|26|||
156365050|NCT01481116|564438463|FG002|Overall Study|Adverse Event|42|||
156365051|NCT01481116|564438461|FG000|Overall Study|Major Protocol Deviation|3|||
156365052|NCT01481116|564438462|FG001|Overall Study|Major Protocol Deviation|7|||
156365053|NCT01481116|564438463|FG002|Overall Study|Major Protocol Deviation|1|||
156365054|NCT01481116|564438461|FG000|Overall Study|Lost to Follow-up|8|||
156365055|NCT01481116|564438462|FG001|Overall Study|Lost to Follow-up|12|||
156365056|NCT01481116|564438463|FG002|Overall Study|Lost to Follow-up|11|||
156365057|NCT01481116|564438461|FG000|Overall Study|Withdrawal by Subject|37|||
156365058|NCT01481116|564438462|FG001|Overall Study|Withdrawal by Subject|33|||
156365059|NCT01481116|564438463|FG002|Overall Study|Withdrawal by Subject|37|||
156365060|NCT01481116|564438461|FG000|Overall Study|Study Termination|730|||
156365061|NCT01481116|564438462|FG001|Overall Study|Study Termination|729|||
156365062|NCT01481116|564438463|FG002|Overall Study|Study Termination|713|||
156365063|NCT01481116|564438461|FG000|Overall Study|Pregnancy|0|||
156365064|NCT01481116|564438462|FG001|Overall Study|Pregnancy|0|||
156365065|NCT01481116|564438463|FG002|Overall Study|Pregnancy|1|||
156365066|NCT01481116|564438461|FG000|Overall Study|Lack of Efficacy|3|||
156365067|NCT01481116|564438462|FG001|Overall Study|Lack of Efficacy|3|||
156365068|NCT01481116|564438463|FG002|Overall Study|Lack of Efficacy|1|||
156365069|NCT01481116|564438461|FG000|Overall Study|Contraindications|1|||
156365070|NCT01481116|564438462|FG001|Overall Study|Contraindications|1|||
156365071|NCT01481116|564438463|FG002|Overall Study|Contraindications|0|||
156365072|NCT01481116|564438461|FG000|Overall Study|Other|1|||
156365073|NCT01481116|564438462|FG001|Overall Study|Other|1|||
156365074|NCT01481116|564438463|FG002|Overall Study|Other|0|||
156365075|NCT01481116|564438461|FG000|Overall Study|Participant Started Taking Glipizide|1|||
156365076|NCT01481116|564438462|FG001|Overall Study|Participant Started Taking Glipizide|0|||
156491028|NCT04414397|564892376|FG000|Post-Control Period|Withdrawal by Subject|3|||
156491029|NCT04414397|564892377|FG001|Post-Control Period|Withdrawal by Subject|6|||
156491030|NCT04414397|564892376|FG000|Post-Control Period|Lost to Follow-up|4|||
156365077|NCT01481116|564438463|FG002|Overall Study|Participant Started Taking Glipizide|0|||
156365078|NCT01481116|564438461|FG000|Overall Study|Participant Moved Out of Area|2|||
156365079|NCT01481116|564438462|FG001|Overall Study|Participant Moved Out of Area|0|||
156365080|NCT01481116|564438463|FG002|Overall Study|Participant Moved Out of Area|1|||
156491031|NCT04414397|564892377|FG001|Post-Control Period|Lost to Follow-up|9|||
156365081|NCT01481116|564438461|FG000|Overall Study|Participant Moved Out of Country|1|||
156365082|NCT01481116|564438462|FG001|Overall Study|Participant Moved Out of Country|0|||
156365083|NCT01481116|564438463|FG002|Overall Study|Participant Moved Out of Country|1|||
156365084|NCT01481116|564438461|FG000|Overall Study|Investigator Decision|3|||
156365085|NCT01481116|564438462|FG001|Overall Study|Investigator Decision|2|||
156365086|NCT01481116|564438463|FG002|Overall Study|Investigator Decision|1|||
156365087|NCT01481116|564438461|FG000|Overall Study|Sponsor Decision|0|||
156365088|NCT01481116|564438462|FG001|Overall Study|Sponsor Decision|1|||
156365089|NCT01481116|564438463|FG002|Overall Study|Sponsor Decision|3|||
156365090|NCT01481116|564438461|FG000|Overall Study|Non-Compliant With Study Drug|0|||
156365091|NCT01481116|564438462|FG001|Overall Study|Non-Compliant With Study Drug|1|||
156365092|NCT01481116|564438463|FG002|Overall Study|Non-Compliant With Study Drug|1|||
156365093|NCT01481116|564438461|FG000|Overall Study|Investigator's Discretion|2|||
156365094|NCT01481116|564438462|FG001|Overall Study|Investigator's Discretion|0|||
156365095|NCT01481116|564438463|FG002|Overall Study|Investigator's Discretion|0|||
156365096|NCT01481116|564438461|FG000|Overall Study|Death|2|||
156365097|NCT01481116|564438462|FG001|Overall Study|Death|1|||
156365098|NCT01481116|564438463|FG002|Overall Study|Death|0|||
156365099|NCT01481116|564438461|FG000|Overall Study|Hypoglycemic Event|4|||
156365100|NCT01481116|564438462|FG001|Overall Study|Hypoglycemic Event|0|||
156365101|NCT01481116|564438463|FG002|Overall Study|Hypoglycemic Event|0|||
156365102|NCT01944059|564438464|FG000|Overall Study|Lost to Follow-up|1|||
156365103|NCT01944059|564438464|FG000|Overall Study|Physician Decision|3|||
156365104|NCT01944059|564438464|FG000|Overall Study|Withdrawal by Subject|1|||
156365105|NCT01944059|564438464|FG000|Overall Study|Adverse Event|2|||
156365106|NCT00430092|564438466|FG000|Overall Study|Adverse Event|0|||
156365107|NCT00430092|564438467|FG001|Overall Study|Adverse Event|0|||
156365108|NCT00430092|564438468|FG002|Overall Study|Adverse Event|1|||
156365109|NCT00430092|564438466|FG000|Overall Study|Lack of Efficacy|5|||
156365110|NCT00430092|564438467|FG001|Overall Study|Lack of Efficacy|2|||
156365111|NCT00430092|564438468|FG002|Overall Study|Lack of Efficacy|54|||
156365112|NCT00430092|564438466|FG000|Overall Study|Lost to Follow-up|1|||
156365113|NCT00430092|564438467|FG001|Overall Study|Lost to Follow-up|0|||
156491032|NCT04414397|564892376|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
156491033|NCT04414397|564892377|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
156491034|NCT04414397|564892376|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
156491035|NCT04414397|564892377|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
156491036|NCT02515097|564892383|FG000|Overall Study|Lost to Follow-up|4|||
156491037|NCT02515097|564892384|FG001|Overall Study|Lost to Follow-up|2|||
156491038|NCT02515097|564892383|FG000|Overall Study|Withdrawal by Subject|1|||
156365114|NCT00430092|564438468|FG002|Overall Study|Lost to Follow-up|0|||
156365115|NCT00430092|564438466|FG000|Overall Study|Protocol Violation|0|||
156491039|NCT02515097|564892384|FG001|Overall Study|Withdrawal by Subject|3|||
156491040|NCT02515097|564892383|FG000|Overall Study|Adverse Event|2|||
156491041|NCT02515097|564892384|FG001|Overall Study|Adverse Event|1|||
156365116|NCT00430092|564438467|FG001|Overall Study|Protocol Violation|1|||
156365117|NCT00430092|564438468|FG002|Overall Study|Protocol Violation|1|||
156365118|NCT00430092|564438466|FG000|Overall Study|Withdrawal by Subject|0|||
156491042|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
156365119|NCT00430092|564438467|FG001|Overall Study|Withdrawal by Subject|1|||
156365120|NCT00430092|564438468|FG002|Overall Study|Withdrawal by Subject|1|||
156365121|NCT00006489|564438476|FG000|Overall Study|Adverse Event|3|||
156365122|NCT00006489|564438477|FG001|Overall Study|Adverse Event|2|||
156365123|NCT00006489|564438478|FG002|Overall Study|Adverse Event|4|||
156365124|NCT00006489|564438479|FG003|Overall Study|Adverse Event|3|||
156365125|NCT00006489|564438476|FG000|Overall Study|Withdrawal by Subject|10|||
156365126|NCT00006489|564438477|FG001|Overall Study|Withdrawal by Subject|9|||
156365127|NCT00006489|564438478|FG002|Overall Study|Withdrawal by Subject|9|||
156365128|NCT00006489|564438479|FG003|Overall Study|Withdrawal by Subject|6|||
156365129|NCT00006489|564438476|FG000|Overall Study|Scheduling Conflict|0|||
156365130|NCT00006489|564438477|FG001|Overall Study|Scheduling Conflict|3|||
156365131|NCT00006489|564438478|FG002|Overall Study|Scheduling Conflict|2|||
156365132|NCT00006489|564438479|FG003|Overall Study|Scheduling Conflict|1|||
156365133|NCT00006489|564438476|FG000|Overall Study|Death|0|||
156365134|NCT00006489|564438477|FG001|Overall Study|Death|0|||
156491043|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
156491044|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
156491045|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Other|1|||
156491046|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Other|0|||
156491047|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Other|0|||
156491048|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Physician Decision|3|||
156491049|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Physician Decision|0|||
156491050|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Physician Decision|0|||
156491051|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
156491052|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
156491053|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
156491054|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
156491055|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
156491056|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
156491057|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Adverse Event|18|||
156491058|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Adverse Event|0|||
156491059|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Adverse Event|0|||
156491060|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
156491061|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
156491062|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
156491063|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
156491064|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
156491065|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
156491066|NCT03030599|564892387|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
156491067|NCT03030599|564892388|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
156491068|NCT03030599|564892389|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
156491069|NCT03030599|564892387|FG000|Stable Dose|Protocol deviation|3|||
156491070|NCT03030599|564892388|FG001|Stable Dose|Protocol deviation|0|||
156491071|NCT03030599|564892389|FG002|Stable Dose|Protocol deviation|0|||
156491072|NCT03030599|564892387|FG000|Stable Dose|Adverse Event|1|||
156491073|NCT03030599|564892388|FG001|Stable Dose|Adverse Event|0|||
156491074|NCT03030599|564892389|FG002|Stable Dose|Adverse Event|0|||
156491075|NCT03030599|564892387|FG000|Stable Dose|Lost to Follow-up|1|||
156491076|NCT03030599|564892388|FG001|Stable Dose|Lost to Follow-up|0|||
156491077|NCT03030599|564892389|FG002|Stable Dose|Lost to Follow-up|0|||
156491078|NCT03030599|564892387|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
156491079|NCT03030599|564892388|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
156491080|NCT03030599|564892389|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
156491081|NCT03030599|564892387|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
156491082|NCT03030599|564892388|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
156491083|NCT03030599|564892389|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
156491084|NCT03030599|564892387|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
156365135|NCT00006489|564438478|FG002|Overall Study|Death|0|||
156365136|NCT00006489|564438479|FG003|Overall Study|Death|1|||
156365137|NCT03029624|564438485|FG000|Overall Study|Adverse Event|1|||
156365138|NCT03029624|564438485|FG000|Overall Study|Withdrawal by Subject|1|||
156365139|NCT03029624|564438485|FG000|Overall Study|Lack of Efficacy|1|||
156365140|NCT03029624|564438485|FG000|Overall Study|MRI need|2|||
156365141|NCT02376166|564438488|FG000|Overall Study|Adverse Event|1|||
156365142|NCT02376166|564438488|FG000|Overall Study|Discontinued metformin early|2|||
156365143|NCT04180020|564438489|FG000|Overall Study|missed visit|18|||
156365144|NCT04180020|564438490|FG001|Overall Study|missed visit|16|||
156365145|NCT04180020|564438489|FG000|Overall Study|Death|2|||
156491085|NCT03030599|564892388|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
156491086|NCT03030599|564892389|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
156491087|NCT03030599|564892387|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
156491088|NCT03030599|564892388|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
156365146|NCT04180020|564438490|FG001|Overall Study|Death|3|||
156365147|NCT04180020|564438489|FG000|Overall Study|Withdrawal by Subject|1|||
156365148|NCT04180020|564438490|FG001|Overall Study|Withdrawal by Subject|5|||
156365149|NCT04180020|564438489|FG000|Overall Study|incarcerated|1|||
156365150|NCT04180020|564438490|FG001|Overall Study|incarcerated|1|||
156365151|NCT04180020|564438489|FG000|Overall Study|Physician Decision|0|||
156365152|NCT04180020|564438490|FG001|Overall Study|Physician Decision|2|||
156365153|NCT01640366|564438492|FG000|Overall Study|Withdrawal by Subject|1|||
156365154|NCT01640366|564438492|FG000|Overall Study|Protocol Violation|16|||
156365155|NCT01640366|564438492|FG000|Overall Study|Lost to Follow-up|5|||
156365156|NCT02739269|564438495|FG000|Overall Study|Protocol Violation|5|||
156365157|NCT02739269|564438496|FG001|Overall Study|Protocol Violation|0|||
156365158|NCT02739269|564438495|FG000|Overall Study|Cycle cancellation|2|||
156365159|NCT02739269|564438496|FG001|Overall Study|Cycle cancellation|2|||
156365160|NCT02739269|564438495|FG000|Overall Study|Withdrawal by Subject|0|||
156365161|NCT02739269|564438496|FG001|Overall Study|Withdrawal by Subject|2|||
156365162|NCT03554291|564438499|FG000|Overall Study|Death|2|||
156365163|NCT03554291|564438500|FG001|Overall Study|Death|1|||
156365164|NCT03554291|564438499|FG000|Overall Study|Lost to Follow-up|1|||
156365165|NCT03554291|564438500|FG001|Overall Study|Lost to Follow-up|0|||
156365166|NCT03554291|564438499|FG000|Overall Study|Withdrawal by Subject|1|||
156365167|NCT03554291|564438500|FG001|Overall Study|Withdrawal by Subject|0|||
156365168|NCT03554291|564438499|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
156365169|NCT03554291|564438500|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
156365170|NCT01228747|564438501|FG000|Overall Study|Adverse Event|8|||
156365171|NCT01228747|564438502|FG001|Overall Study|Adverse Event|4|||
156365172|NCT01228747|564438501|FG000|Overall Study|Lack of Efficacy|40|||
156365173|NCT01228747|564438502|FG001|Overall Study|Lack of Efficacy|27|||
156365174|NCT01228747|564438501|FG000|Overall Study|Protocol Violation|6|||
156365175|NCT01228747|564438502|FG001|Overall Study|Protocol Violation|5|||
156365176|NCT01228747|564438501|FG000|Overall Study|Lost to Follow-up|4|||
156365177|NCT01228747|564438502|FG001|Overall Study|Lost to Follow-up|3|||
156365178|NCT01228747|564438501|FG000|Overall Study|Withdrawal by Subject|5|||
156365179|NCT01228747|564438502|FG001|Overall Study|Withdrawal by Subject|1|||
156365180|NCT01228747|564438501|FG000|Overall Study|Other Reason|2|||
156365181|NCT01228747|564438502|FG001|Overall Study|Other Reason|5|||
156365182|NCT04251221|564438508|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
156365183|NCT04251221|564438509|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
156365184|NCT02641379|564438510|FG000|Overall Study|Exclusion criterion during screening|1|||
156365185|NCT02641379|564438511|FG001|Overall Study|Exclusion criterion during screening|0|||
156365186|NCT02641379|564438512|FG002|Overall Study|Exclusion criterion during screening|0|||
156365187|NCT02641379|564438513|FG003|Overall Study|Exclusion criterion during screening|1|||
156365188|NCT02641379|564438514|FG004|Overall Study|Exclusion criterion during screening|2|||
156365189|NCT02641379|564438515|FG005|Overall Study|Exclusion criterion during screening|0|||
156365190|NCT02641379|564438516|FG006|Overall Study|Exclusion criterion during screening|0|||
156365191|NCT02641379|564438517|FG007|Overall Study|Exclusion criterion during screening|0|||
156365192|NCT02641379|564438518|FG008|Overall Study|Exclusion criterion during screening|0|||
156365193|NCT02641379|564438519|FG009|Overall Study|Exclusion criterion during screening|0|||
156365194|NCT02641379|564438520|FG010|Overall Study|Exclusion criterion during screening|0|||
156365195|NCT02641379|564438510|FG000|Overall Study|Withdrawal of informed consent|0|||
156365196|NCT02641379|564438511|FG001|Overall Study|Withdrawal of informed consent|1|||
156365197|NCT02641379|564438512|FG002|Overall Study|Withdrawal of informed consent|0|||
156365198|NCT02641379|564438513|FG003|Overall Study|Withdrawal of informed consent|0|||
156365199|NCT02641379|564438514|FG004|Overall Study|Withdrawal of informed consent|0|||
156365200|NCT02641379|564438515|FG005|Overall Study|Withdrawal of informed consent|0|||
156365201|NCT02641379|564438516|FG006|Overall Study|Withdrawal of informed consent|0|||
156365202|NCT02641379|564438517|FG007|Overall Study|Withdrawal of informed consent|1|||
156365203|NCT02641379|564438518|FG008|Overall Study|Withdrawal of informed consent|0|||
156365204|NCT02641379|564438519|FG009|Overall Study|Withdrawal of informed consent|0|||
156365205|NCT02641379|564438520|FG010|Overall Study|Withdrawal of informed consent|0|||
156365206|NCT02641379|564438510|FG000|Overall Study|Adverse Event|7|||
156365207|NCT02641379|564438511|FG001|Overall Study|Adverse Event|8|||
156365208|NCT02641379|564438512|FG002|Overall Study|Adverse Event|2|||
156365209|NCT02641379|564438513|FG003|Overall Study|Adverse Event|2|||
156365210|NCT02641379|564438514|FG004|Overall Study|Adverse Event|5|||
156365211|NCT02641379|564438515|FG005|Overall Study|Adverse Event|1|||
156365212|NCT02641379|564438516|FG006|Overall Study|Adverse Event|5|||
156365213|NCT02641379|564438517|FG007|Overall Study|Adverse Event|0|||
156365214|NCT02641379|564438518|FG008|Overall Study|Adverse Event|1|||
156365215|NCT02641379|564438519|FG009|Overall Study|Adverse Event|1|||
156365216|NCT02641379|564438520|FG010|Overall Study|Adverse Event|5|||
156365217|NCT02641379|564438510|FG000|Overall Study|Lack of Efficacy|0|||
156365218|NCT02641379|564438511|FG001|Overall Study|Lack of Efficacy|0|||
156365219|NCT02641379|564438512|FG002|Overall Study|Lack of Efficacy|2|||
156365220|NCT02641379|564438513|FG003|Overall Study|Lack of Efficacy|0|||
156365221|NCT02641379|564438514|FG004|Overall Study|Lack of Efficacy|0|||
156365222|NCT02641379|564438515|FG005|Overall Study|Lack of Efficacy|2|||
156365223|NCT02641379|564438516|FG006|Overall Study|Lack of Efficacy|0|||
156365224|NCT02641379|564438517|FG007|Overall Study|Lack of Efficacy|5|||
156365225|NCT02641379|564438518|FG008|Overall Study|Lack of Efficacy|0|||
156365226|NCT02641379|564438519|FG009|Overall Study|Lack of Efficacy|0|||
156365227|NCT02641379|564438520|FG010|Overall Study|Lack of Efficacy|0|||
156365228|NCT02641379|564438510|FG000|Overall Study|Participant unable to attend study visit|4|||
156365229|NCT02641379|564438511|FG001|Overall Study|Participant unable to attend study visit|10|||
156365230|NCT02641379|564438512|FG002|Overall Study|Participant unable to attend study visit|1|||
156365231|NCT02641379|564438513|FG003|Overall Study|Participant unable to attend study visit|2|||
156365232|NCT02641379|564438514|FG004|Overall Study|Participant unable to attend study visit|5|||
156365233|NCT02641379|564438515|FG005|Overall Study|Participant unable to attend study visit|1|||
156365234|NCT02641379|564438516|FG006|Overall Study|Participant unable to attend study visit|1|||
156365235|NCT02641379|564438517|FG007|Overall Study|Participant unable to attend study visit|1|||
156365236|NCT02641379|564438518|FG008|Overall Study|Participant unable to attend study visit|0|||
156365237|NCT02641379|564438519|FG009|Overall Study|Participant unable to attend study visit|2|||
156365238|NCT02641379|564438520|FG010|Overall Study|Participant unable to attend study visit|0|||
156365239|NCT02641379|564438510|FG000|Overall Study|Participant's compliance|0|||
156365240|NCT02641379|564438511|FG001|Overall Study|Participant's compliance|1|||
156365241|NCT02641379|564438512|FG002|Overall Study|Participant's compliance|0|||
156365242|NCT02641379|564438513|FG003|Overall Study|Participant's compliance|1|||
156365243|NCT02641379|564438514|FG004|Overall Study|Participant's compliance|0|||
156365244|NCT02641379|564438515|FG005|Overall Study|Participant's compliance|2|||
156365245|NCT02641379|564438516|FG006|Overall Study|Participant's compliance|0|||
156365246|NCT02641379|564438517|FG007|Overall Study|Participant's compliance|0|||
156365247|NCT02641379|564438518|FG008|Overall Study|Participant's compliance|1|||
156365248|NCT02641379|564438519|FG009|Overall Study|Participant's compliance|1|||
156365249|NCT02641379|564438520|FG010|Overall Study|Participant's compliance|1|||
156365250|NCT02641379|564438510|FG000|Overall Study|Participant cannot be reached|4|||
156365251|NCT02641379|564438511|FG001|Overall Study|Participant cannot be reached|4|||
156365252|NCT02641379|564438512|FG002|Overall Study|Participant cannot be reached|0|||
156365253|NCT02641379|564438513|FG003|Overall Study|Participant cannot be reached|8|||
156365254|NCT02641379|564438514|FG004|Overall Study|Participant cannot be reached|2|||
156365255|NCT02641379|564438515|FG005|Overall Study|Participant cannot be reached|1|||
156365256|NCT02641379|564438516|FG006|Overall Study|Participant cannot be reached|0|||
156365257|NCT02641379|564438517|FG007|Overall Study|Participant cannot be reached|1|||
156365258|NCT02641379|564438518|FG008|Overall Study|Participant cannot be reached|0|||
156365259|NCT02641379|564438519|FG009|Overall Study|Participant cannot be reached|2|||
156365260|NCT02641379|564438520|FG010|Overall Study|Participant cannot be reached|1|||
156365261|NCT02641379|564438510|FG000|Overall Study|PCR positive at Week 24|15|||
156365262|NCT02641379|564438511|FG001|Overall Study|PCR positive at Week 24|21|||
156365263|NCT02641379|564438512|FG002|Overall Study|PCR positive at Week 24|62|||
156365264|NCT02641379|564438513|FG003|Overall Study|PCR positive at Week 24|0|||
156365265|NCT02641379|564438514|FG004|Overall Study|PCR positive at Week 24|0|||
156545950|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
156545951|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
156545952|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
156545953|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
156545954|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
156545955|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
156545956|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
156545957|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
156545958|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
156545959|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
156545960|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
156545961|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
156545962|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
156545963|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
156545964|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
156545965|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
156545966|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
156545967|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
156545968|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
156545969|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
156545970|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
156545971|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
156545972|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
156491089|NCT03030599|564892389|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
156491090|NCT03030599|564892387|FG000|Open-label Extension|Adverse Event|3|||
156491091|NCT03030599|564892388|FG001|Open-label Extension|Adverse Event|0|||
156365266|NCT02641379|564438515|FG005|Overall Study|PCR positive at Week 24|6|||
156365267|NCT02641379|564438516|FG006|Overall Study|PCR positive at Week 24|3|||
156365268|NCT02641379|564438517|FG007|Overall Study|PCR positive at Week 24|8|||
156365269|NCT02641379|564438518|FG008|Overall Study|PCR positive at Week 24|0|||
156365270|NCT02641379|564438519|FG009|Overall Study|PCR positive at Week 24|1|||
156365271|NCT02641379|564438520|FG010|Overall Study|PCR positive at Week 24|0|||
156365272|NCT02641379|564438510|FG000|Overall Study|PCR positive at follow up 2|1|||
156365273|NCT02641379|564438511|FG001|Overall Study|PCR positive at follow up 2|0|||
156365274|NCT02641379|564438512|FG002|Overall Study|PCR positive at follow up 2|0|||
156365275|NCT02641379|564438513|FG003|Overall Study|PCR positive at follow up 2|0|||
156365276|NCT02641379|564438514|FG004|Overall Study|PCR positive at follow up 2|0|||
156365277|NCT02641379|564438515|FG005|Overall Study|PCR positive at follow up 2|0|||
156365278|NCT02641379|564438516|FG006|Overall Study|PCR positive at follow up 2|0|||
156365279|NCT02641379|564438517|FG007|Overall Study|PCR positive at follow up 2|0|||
156365280|NCT02641379|564438518|FG008|Overall Study|PCR positive at follow up 2|0|||
156365281|NCT02641379|564438519|FG009|Overall Study|PCR positive at follow up 2|0|||
156365282|NCT02641379|564438520|FG010|Overall Study|PCR positive at follow up 2|0|||
156365283|NCT02641379|564438510|FG000|Overall Study|Participant showed relapse|1|||
156365284|NCT02641379|564438511|FG001|Overall Study|Participant showed relapse|0|||
156365285|NCT02641379|564438512|FG002|Overall Study|Participant showed relapse|0|||
156365286|NCT02641379|564438513|FG003|Overall Study|Participant showed relapse|0|||
156365287|NCT02641379|564438514|FG004|Overall Study|Participant showed relapse|0|||
156365288|NCT02641379|564438515|FG005|Overall Study|Participant showed relapse|0|||
156365289|NCT02641379|564438516|FG006|Overall Study|Participant showed relapse|1|||
156365290|NCT02641379|564438517|FG007|Overall Study|Participant showed relapse|0|||
156365291|NCT02641379|564438518|FG008|Overall Study|Participant showed relapse|0|||
156365292|NCT02641379|564438519|FG009|Overall Study|Participant showed relapse|0|||
156365293|NCT02641379|564438520|FG010|Overall Study|Participant showed relapse|0|||
156365294|NCT02641379|564438510|FG000|Overall Study|Participant stopped study/treatment|1|||
156491092|NCT03030599|564892389|FG002|Open-label Extension|Adverse Event|0|||
156491093|NCT03030599|564892387|FG000|Open-label Extension|Lost to Follow-up|2|||
156491094|NCT03030599|564892388|FG001|Open-label Extension|Lost to Follow-up|0|||
156491095|NCT03030599|564892389|FG002|Open-label Extension|Lost to Follow-up|0|||
156491096|NCT03030599|564892387|FG000|Open-label Extension|Lack of Efficacy|1|||
156491097|NCT03030599|564892388|FG001|Open-label Extension|Lack of Efficacy|0|||
156491098|NCT03030599|564892389|FG002|Open-label Extension|Lack of Efficacy|0|||
156491099|NCT03030599|564892387|FG000|Open-label Extension|Other Reason|1|||
156491100|NCT03030599|564892388|FG001|Open-label Extension|Other Reason|0|||
156491101|NCT03030599|564892389|FG002|Open-label Extension|Other Reason|0|||
156491102|NCT01592383|564892390|FG000|Overall Study|Adverse Event|1|||
156491103|NCT01064856|564892391|FG000|Double-blind (DB) Period|Adverse Event|1|||
156491104|NCT01064856|564892392|FG001|Double-blind (DB) Period|Adverse Event|0|||
156491105|NCT01064856|564892393|FG002|Double-blind (DB) Period|Adverse Event|0|||
156491106|NCT01064856|564892394|FG003|Double-blind (DB) Period|Adverse Event|0|||
156491107|NCT01064856|564892391|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
156491108|NCT01064856|564892392|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
156491109|NCT01064856|564892393|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
156491110|NCT01064856|564892394|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
156491111|NCT01064856|564892391|FG000|Open-label (OL) Period|Adverse Event|0|||
156491112|NCT01064856|564892392|FG001|Open-label (OL) Period|Adverse Event|0|||
156491113|NCT01064856|564892393|FG002|Open-label (OL) Period|Adverse Event|12|||
156491114|NCT01064856|564892394|FG003|Open-label (OL) Period|Adverse Event|6|||
156491115|NCT01064856|564892391|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
156491116|NCT01064856|564892392|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
156491117|NCT01064856|564892393|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
156491118|NCT01064856|564892394|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
156491119|NCT01064856|564892391|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
156491120|NCT01064856|564892392|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
156491121|NCT01064856|564892393|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
156365295|NCT02641379|564438511|FG001|Overall Study|Participant stopped study/treatment|3|||
156491122|NCT01064856|564892394|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
156491123|NCT01064856|564892391|FG000|Open-label (OL) Period|Other|0|||
156491124|NCT01064856|564892392|FG001|Open-label (OL) Period|Other|0|||
156491125|NCT01064856|564892393|FG002|Open-label (OL) Period|Other|7|||
156491126|NCT01064856|564892394|FG003|Open-label (OL) Period|Other|7|||
156491127|NCT02133131|564892395|FG000|Overall Study|Adverse Event|0|||
156365296|NCT02641379|564438512|FG002|Overall Study|Participant stopped study/treatment|1|||
156365297|NCT02641379|564438513|FG003|Overall Study|Participant stopped study/treatment|0|||
156491128|NCT02133131|564892396|FG001|Overall Study|Adverse Event|0|||
156491129|NCT02133131|564892397|FG002|Overall Study|Adverse Event|0|||
156491130|NCT02133131|564892398|FG003|Overall Study|Adverse Event|1|||
156491131|NCT02133131|564892399|FG004|Overall Study|Adverse Event|0|||
156491132|NCT02133131|564892400|FG005|Overall Study|Adverse Event|0|||
156491133|NCT02133131|564892401|FG006|Overall Study|Adverse Event|0|||
156365298|NCT02641379|564438514|FG004|Overall Study|Participant stopped study/treatment|0|||
156365299|NCT02641379|564438515|FG005|Overall Study|Participant stopped study/treatment|1|||
156365300|NCT02641379|564438516|FG006|Overall Study|Participant stopped study/treatment|2|||
156365301|NCT02641379|564438517|FG007|Overall Study|Participant stopped study/treatment|0|||
156365302|NCT02641379|564438518|FG008|Overall Study|Participant stopped study/treatment|1|||
156365303|NCT02641379|564438519|FG009|Overall Study|Participant stopped study/treatment|0|||
156365304|NCT02641379|564438520|FG010|Overall Study|Participant stopped study/treatment|0|||
156365305|NCT02641379|564438510|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
156365306|NCT02641379|564438511|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
156365307|NCT02641379|564438512|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
156365308|NCT02641379|564438513|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
156365309|NCT02641379|564438514|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
156365310|NCT02641379|564438515|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
156365311|NCT02641379|564438516|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
156365312|NCT02641379|564438517|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
156365313|NCT02641379|564438518|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
156365314|NCT02641379|564438519|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
156365315|NCT02641379|564438520|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
156365316|NCT02641379|564438510|FG000|Overall Study|Financial problems|0|||
156365317|NCT02641379|564438511|FG001|Overall Study|Financial problems|1|||
156365318|NCT02641379|564438512|FG002|Overall Study|Financial problems|0|||
156491134|NCT02133131|564892395|FG000|Overall Study|Lost to Follow-up|1|||
156491135|NCT02133131|564892396|FG001|Overall Study|Lost to Follow-up|0|||
156491136|NCT02133131|564892397|FG002|Overall Study|Lost to Follow-up|0|||
156491137|NCT02133131|564892398|FG003|Overall Study|Lost to Follow-up|1|||
156491138|NCT02133131|564892399|FG004|Overall Study|Lost to Follow-up|0|||
156491139|NCT02133131|564892400|FG005|Overall Study|Lost to Follow-up|0|||
156491140|NCT02133131|564892401|FG006|Overall Study|Lost to Follow-up|0|||
156491141|NCT02133131|564892395|FG000|Overall Study|Status not recorded|4|||
156491142|NCT02133131|564892396|FG001|Overall Study|Status not recorded|5|||
156491143|NCT02133131|564892397|FG002|Overall Study|Status not recorded|1|||
156491144|NCT02133131|564892398|FG003|Overall Study|Status not recorded|4|||
156491145|NCT02133131|564892399|FG004|Overall Study|Status not recorded|0|||
156491146|NCT02133131|564892400|FG005|Overall Study|Status not recorded|0|||
156491147|NCT02133131|564892401|FG006|Overall Study|Status not recorded|0|||
156491148|NCT02133131|564892395|FG000|Overall Study|Ongoing in study|0|||
156491149|NCT02133131|564892396|FG001|Overall Study|Ongoing in study|0|||
156491150|NCT02133131|564892397|FG002|Overall Study|Ongoing in study|0|||
156491151|NCT02133131|564892398|FG003|Overall Study|Ongoing in study|0|||
156491152|NCT02133131|564892399|FG004|Overall Study|Ongoing in study|15|||
156491153|NCT02133131|564892400|FG005|Overall Study|Ongoing in study|14|||
156491154|NCT02133131|564892401|FG006|Overall Study|Ongoing in study|11|||
156491155|NCT02133131|564892395|FG000|Overall Study|Protocol Violation|0|||
156491156|NCT02133131|564892396|FG001|Overall Study|Protocol Violation|0|||
156491157|NCT02133131|564892397|FG002|Overall Study|Protocol Violation|0|||
156491158|NCT02133131|564892398|FG003|Overall Study|Protocol Violation|0|||
156491159|NCT02133131|564892399|FG004|Overall Study|Protocol Violation|0|||
156491160|NCT02133131|564892400|FG005|Overall Study|Protocol Violation|0|||
156491161|NCT02133131|564892401|FG006|Overall Study|Protocol Violation|1|||
156491162|NCT00951171|564892402|FG000|Overall Study|Adverse Event|2|||
156491163|NCT00951171|564892403|FG001|Overall Study|Adverse Event|0|||
156491164|NCT00605566|564894806|FG000|Overall Study|Adverse Event|1|||
156491165|NCT00605566|564894806|FG000|Overall Study|Clinical deterioration|1|||
156491166|NCT00605566|564894806|FG000|Overall Study|Poor compliance in run-in period|1|||
156491167|NCT03864341|564894807|FG000|Overall Study|Withdrawal by Subject|1|||
156491168|NCT01066936|564894808|FG000|Overall Study|Death|2|||
156491169|NCT01066936|564894808|FG000|Overall Study|Device revised/removed|1|||
156491170|NCT01066936|564894808|FG000|Overall Study|Lost to Follow-up|3|||
156491171|NCT01066936|564894808|FG000|Overall Study|Withdrawal by Subject|4|||
156491172|NCT01904136|564894809|FG000|Overall Study|Physician Decision|0|||
156491173|NCT01904136|564894810|FG001|Overall Study|Physician Decision|0|||
156491174|NCT01904136|564894811|FG002|Overall Study|Physician Decision|0|||
156491175|NCT01904136|564894812|FG003|Overall Study|Physician Decision|0|||
156491176|NCT01904136|564894813|FG004|Overall Study|Physician Decision|0|||
156491177|NCT01904136|564894814|FG005|Overall Study|Physician Decision|1|||
156491178|NCT01904136|564894815|FG006|Overall Study|Physician Decision|0|||
156491179|NCT01904136|564894816|FG007|Overall Study|Physician Decision|0|||
156365319|NCT02641379|564438513|FG003|Overall Study|Financial problems|0|||
156365320|NCT02641379|564438514|FG004|Overall Study|Financial problems|0|||
156365321|NCT02641379|564438515|FG005|Overall Study|Financial problems|0|||
156365322|NCT02641379|564438516|FG006|Overall Study|Financial problems|0|||
156491180|NCT01904136|564894817|FG008|Overall Study|Physician Decision|0|||
156365323|NCT02641379|564438517|FG007|Overall Study|Financial problems|0|||
156365324|NCT02641379|564438518|FG008|Overall Study|Financial problems|0|||
156491181|NCT02202109|564894820|FG000|Overall Study|Lost to Follow-up|88|||
156491182|NCT02202109|564894821|FG001|Overall Study|Lost to Follow-up|87|||
156491183|NCT02202109|564894820|FG000|Overall Study|Withdrawal by Subject|2|||
156491184|NCT02202109|564894821|FG001|Overall Study|Withdrawal by Subject|0|||
156365325|NCT02641379|564438519|FG009|Overall Study|Financial problems|0|||
156365326|NCT02641379|564438520|FG010|Overall Study|Financial problems|0|||
156365327|NCT02641379|564438510|FG000|Overall Study|PCR positive at Week 68|0|||
156365328|NCT02641379|564438511|FG001|Overall Study|PCR positive at Week 68|1|||
156365329|NCT02641379|564438512|FG002|Overall Study|PCR positive at Week 68|0|||
156365330|NCT02641379|564438513|FG003|Overall Study|PCR positive at Week 68|0|||
156365331|NCT02641379|564438514|FG004|Overall Study|PCR positive at Week 68|0|||
156365332|NCT02641379|564438515|FG005|Overall Study|PCR positive at Week 68|0|||
156365333|NCT02641379|564438516|FG006|Overall Study|PCR positive at Week 68|0|||
156365334|NCT02641379|564438517|FG007|Overall Study|PCR positive at Week 68|0|||
156365335|NCT02641379|564438518|FG008|Overall Study|PCR positive at Week 68|0|||
156365336|NCT02641379|564438519|FG009|Overall Study|PCR positive at Week 68|0|||
156365337|NCT02641379|564438520|FG010|Overall Study|PCR positive at Week 68|0|||
156365338|NCT02641379|564438510|FG000|Overall Study|PCR positive at Week 48|0|||
156365339|NCT02641379|564438511|FG001|Overall Study|PCR positive at Week 48|1|||
156365340|NCT02641379|564438512|FG002|Overall Study|PCR positive at Week 48|0|||
156365341|NCT02641379|564438513|FG003|Overall Study|PCR positive at Week 48|0|||
156365342|NCT02641379|564438514|FG004|Overall Study|PCR positive at Week 48|0|||
156365343|NCT02641379|564438515|FG005|Overall Study|PCR positive at Week 48|0|||
156365344|NCT02641379|564438516|FG006|Overall Study|PCR positive at Week 48|0|||
156365345|NCT02641379|564438517|FG007|Overall Study|PCR positive at Week 48|0|||
156365346|NCT02641379|564438518|FG008|Overall Study|PCR positive at Week 48|0|||
156365347|NCT02641379|564438519|FG009|Overall Study|PCR positive at Week 48|0|||
156365348|NCT02641379|564438520|FG010|Overall Study|PCR positive at Week 48|0|||
156365349|NCT02641379|564438510|FG000|Overall Study|PCR not performed at Week 12|0|||
156365350|NCT02641379|564438511|FG001|Overall Study|PCR not performed at Week 12|0|||
156365351|NCT02641379|564438512|FG002|Overall Study|PCR not performed at Week 12|1|||
156365352|NCT02641379|564438513|FG003|Overall Study|PCR not performed at Week 12|0|||
156365353|NCT02641379|564438514|FG004|Overall Study|PCR not performed at Week 12|0|||
156365354|NCT02641379|564438515|FG005|Overall Study|PCR not performed at Week 12|0|||
156365355|NCT02641379|564438516|FG006|Overall Study|PCR not performed at Week 12|0|||
156365356|NCT02641379|564438517|FG007|Overall Study|PCR not performed at Week 12|0|||
156365357|NCT02641379|564438518|FG008|Overall Study|PCR not performed at Week 12|0|||
156365358|NCT02641379|564438519|FG009|Overall Study|PCR not performed at Week 12|0|||
156365359|NCT02641379|564438520|FG010|Overall Study|PCR not performed at Week 12|0|||
156365360|NCT02641379|564438510|FG000|Overall Study|No PCR at baseline|0|||
156365361|NCT02641379|564438511|FG001|Overall Study|No PCR at baseline|0|||
156365362|NCT02641379|564438512|FG002|Overall Study|No PCR at baseline|1|||
156365363|NCT02641379|564438513|FG003|Overall Study|No PCR at baseline|0|||
156365364|NCT02641379|564438514|FG004|Overall Study|No PCR at baseline|0|||
156365365|NCT02641379|564438515|FG005|Overall Study|No PCR at baseline|0|||
156365366|NCT02641379|564438516|FG006|Overall Study|No PCR at baseline|0|||
156365367|NCT02641379|564438517|FG007|Overall Study|No PCR at baseline|0|||
156365368|NCT02641379|564438518|FG008|Overall Study|No PCR at baseline|0|||
156365369|NCT02641379|564438519|FG009|Overall Study|No PCR at baseline|0|||
156365370|NCT02641379|564438520|FG010|Overall Study|No PCR at baseline|0|||
156365371|NCT02641379|564438510|FG000|Overall Study|PCR positive at Week 28|0|||
156365372|NCT02641379|564438511|FG001|Overall Study|PCR positive at Week 28|0|||
156365373|NCT02641379|564438512|FG002|Overall Study|PCR positive at Week 28|1|||
156365374|NCT02641379|564438513|FG003|Overall Study|PCR positive at Week 28|0|||
156365375|NCT02641379|564438514|FG004|Overall Study|PCR positive at Week 28|0|||
156365376|NCT02641379|564438515|FG005|Overall Study|PCR positive at Week 28|0|||
156365377|NCT02641379|564438516|FG006|Overall Study|PCR positive at Week 28|0|||
156365378|NCT02641379|564438517|FG007|Overall Study|PCR positive at Week 28|0|||
156365379|NCT02641379|564438518|FG008|Overall Study|PCR positive at Week 28|0|||
156365380|NCT02641379|564438519|FG009|Overall Study|PCR positive at Week 28|0|||
156365381|NCT02641379|564438520|FG010|Overall Study|PCR positive at Week 28|0|||
156365382|NCT02641379|564438510|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
156365383|NCT02641379|564438511|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
156491185|NCT04156399|564894828|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
156491186|NCT04156399|564894828|FG000|Overall Study|study suspension due to COVID pandemic|3|||
156491187|NCT01929876|564894831|FG000|Period 2|Non-Compliance|1|||
156491188|NCT03991988|564894832|FG000|Overall Study|Withdrawal by Subject|2|||
156491189|NCT03991988|564894833|FG001|Overall Study|Withdrawal by Subject|2|||
156365384|NCT02641379|564438512|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
156365385|NCT02641379|564438513|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
156365386|NCT02641379|564438514|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
156365387|NCT02641379|564438515|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
156365388|NCT02641379|564438516|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
156365389|NCT02641379|564438517|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
156365390|NCT02641379|564438518|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
156365391|NCT02641379|564438519|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
156365392|NCT02641379|564438520|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
156365393|NCT02641379|564438510|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
156365394|NCT02641379|564438511|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
156365395|NCT02641379|564438512|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
156365396|NCT02641379|564438513|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
156365397|NCT02641379|564438514|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
156365398|NCT02641379|564438515|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
156365399|NCT02641379|564438516|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
156365400|NCT02641379|564438517|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
156365401|NCT02641379|564438518|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
156365402|NCT02641379|564438519|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
156365403|NCT02641379|564438520|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
156365404|NCT02641379|564438510|FG000|Overall Study|Baseline viral load unavailable|0|||
156365405|NCT02641379|564438511|FG001|Overall Study|Baseline viral load unavailable|0|||
156365406|NCT02641379|564438512|FG002|Overall Study|Baseline viral load unavailable|0|||
156365407|NCT02641379|564438513|FG003|Overall Study|Baseline viral load unavailable|1|||
156365408|NCT02641379|564438514|FG004|Overall Study|Baseline viral load unavailable|0|||
156365409|NCT02641379|564438515|FG005|Overall Study|Baseline viral load unavailable|0|||
156365410|NCT02641379|564438516|FG006|Overall Study|Baseline viral load unavailable|0|||
156365411|NCT02641379|564438517|FG007|Overall Study|Baseline viral load unavailable|0|||
156365412|NCT02641379|564438518|FG008|Overall Study|Baseline viral load unavailable|0|||
156365413|NCT02641379|564438519|FG009|Overall Study|Baseline viral load unavailable|0|||
156365414|NCT02641379|564438520|FG010|Overall Study|Baseline viral load unavailable|0|||
156365415|NCT02641379|564438510|FG000|Overall Study|Blood could not be drawn|0|||
156365416|NCT02641379|564438511|FG001|Overall Study|Blood could not be drawn|0|||
156365417|NCT02641379|564438512|FG002|Overall Study|Blood could not be drawn|0|||
156365418|NCT02641379|564438513|FG003|Overall Study|Blood could not be drawn|0|||
156365419|NCT02641379|564438514|FG004|Overall Study|Blood could not be drawn|1|||
156365420|NCT02641379|564438515|FG005|Overall Study|Blood could not be drawn|0|||
156365421|NCT02641379|564438516|FG006|Overall Study|Blood could not be drawn|0|||
156365422|NCT02641379|564438517|FG007|Overall Study|Blood could not be drawn|0|||
156365423|NCT02641379|564438518|FG008|Overall Study|Blood could not be drawn|0|||
156365424|NCT02641379|564438519|FG009|Overall Study|Blood could not be drawn|0|||
156365425|NCT02641379|564438520|FG010|Overall Study|Blood could not be drawn|0|||
156365426|NCT02641379|564438510|FG000|Overall Study|Protocol Violation|0|||
156365427|NCT02641379|564438511|FG001|Overall Study|Protocol Violation|0|||
156365428|NCT02641379|564438512|FG002|Overall Study|Protocol Violation|0|||
156365429|NCT02641379|564438513|FG003|Overall Study|Protocol Violation|0|||
156365430|NCT02641379|564438514|FG004|Overall Study|Protocol Violation|2|||
156365431|NCT02641379|564438515|FG005|Overall Study|Protocol Violation|0|||
156365432|NCT02641379|564438516|FG006|Overall Study|Protocol Violation|0|||
156365433|NCT02641379|564438517|FG007|Overall Study|Protocol Violation|0|||
156365434|NCT02641379|564438518|FG008|Overall Study|Protocol Violation|1|||
156365435|NCT02641379|564438519|FG009|Overall Study|Protocol Violation|0|||
156365436|NCT02641379|564438520|FG010|Overall Study|Protocol Violation|0|||
156365437|NCT02641379|564438510|FG000|Overall Study|Participation in sili rescue study|0|||
156365438|NCT02641379|564438511|FG001|Overall Study|Participation in sili rescue study|0|||
156365439|NCT02641379|564438512|FG002|Overall Study|Participation in sili rescue study|0|||
156365440|NCT02641379|564438513|FG003|Overall Study|Participation in sili rescue study|0|||
156365441|NCT02641379|564438514|FG004|Overall Study|Participation in sili rescue study|0|||
156365442|NCT02641379|564438515|FG005|Overall Study|Participation in sili rescue study|1|||
156365443|NCT02641379|564438516|FG006|Overall Study|Participation in sili rescue study|0|||
156365444|NCT02641379|564438517|FG007|Overall Study|Participation in sili rescue study|0|||
156365445|NCT02641379|564438518|FG008|Overall Study|Participation in sili rescue study|0|||
156365446|NCT02641379|564438519|FG009|Overall Study|Participation in sili rescue study|0|||
156365447|NCT02641379|564438520|FG010|Overall Study|Participation in sili rescue study|0|||
156365448|NCT02641379|564438510|FG000|Overall Study|Lost to Follow-up|0|||
156365449|NCT02641379|564438511|FG001|Overall Study|Lost to Follow-up|0|||
156365450|NCT02641379|564438512|FG002|Overall Study|Lost to Follow-up|0|||
156365451|NCT02641379|564438513|FG003|Overall Study|Lost to Follow-up|0|||
156365452|NCT02641379|564438514|FG004|Overall Study|Lost to Follow-up|0|||
156365453|NCT02641379|564438515|FG005|Overall Study|Lost to Follow-up|0|||
156365454|NCT02641379|564438516|FG006|Overall Study|Lost to Follow-up|0|||
156365455|NCT02641379|564438517|FG007|Overall Study|Lost to Follow-up|0|||
156491190|NCT01222533|564894835|FG000|Overall Study|Adverse Event|5|||
156365456|NCT02641379|564438518|FG008|Overall Study|Lost to Follow-up|1|||
156365457|NCT02641379|564438519|FG009|Overall Study|Lost to Follow-up|0|||
156365458|NCT02641379|564438520|FG010|Overall Study|Lost to Follow-up|0|||
156365459|NCT02641379|564438510|FG000|Overall Study|Source data not found|0|||
156365460|NCT02641379|564438511|FG001|Overall Study|Source data not found|0|||
156365461|NCT02641379|564438512|FG002|Overall Study|Source data not found|0|||
156365462|NCT02641379|564438513|FG003|Overall Study|Source data not found|0|||
156365463|NCT02641379|564438514|FG004|Overall Study|Source data not found|0|||
156365464|NCT02641379|564438515|FG005|Overall Study|Source data not found|1|||
156365465|NCT02641379|564438516|FG006|Overall Study|Source data not found|0|||
156365466|NCT02641379|564438517|FG007|Overall Study|Source data not found|0|||
156365467|NCT02641379|564438518|FG008|Overall Study|Source data not found|0|||
156365468|NCT02641379|564438519|FG009|Overall Study|Source data not found|0|||
156365469|NCT02641379|564438520|FG010|Overall Study|Source data not found|0|||
156365470|NCT02641379|564438510|FG000|Overall Study|Participant showed weight reduction|0|||
156365471|NCT02641379|564438511|FG001|Overall Study|Participant showed weight reduction|0|||
156365472|NCT02641379|564438512|FG002|Overall Study|Participant showed weight reduction|0|||
156365473|NCT02641379|564438513|FG003|Overall Study|Participant showed weight reduction|0|||
156365474|NCT02641379|564438514|FG004|Overall Study|Participant showed weight reduction|0|||
156365475|NCT02641379|564438515|FG005|Overall Study|Participant showed weight reduction|0|||
156365476|NCT02641379|564438516|FG006|Overall Study|Participant showed weight reduction|0|||
156365477|NCT02641379|564438517|FG007|Overall Study|Participant showed weight reduction|1|||
156365478|NCT02641379|564438518|FG008|Overall Study|Participant showed weight reduction|0|||
156365479|NCT02641379|564438519|FG009|Overall Study|Participant showed weight reduction|0|||
156365480|NCT02641379|564438520|FG010|Overall Study|Participant showed weight reduction|0|||
156365481|NCT02641379|564438510|FG000|Overall Study|Non-response Week 12|0|||
156365482|NCT02641379|564438511|FG001|Overall Study|Non-response Week 12|0|||
156365483|NCT02641379|564438512|FG002|Overall Study|Non-response Week 12|0|||
156365484|NCT02641379|564438513|FG003|Overall Study|Non-response Week 12|0|||
156365485|NCT02641379|564438514|FG004|Overall Study|Non-response Week 12|0|||
156365486|NCT02641379|564438515|FG005|Overall Study|Non-response Week 12|0|||
156365487|NCT02641379|564438516|FG006|Overall Study|Non-response Week 12|0|||
156365488|NCT02641379|564438517|FG007|Overall Study|Non-response Week 12|1|||
156365489|NCT02641379|564438518|FG008|Overall Study|Non-response Week 12|0|||
156365490|NCT02641379|564438519|FG009|Overall Study|Non-response Week 12|0|||
156365491|NCT02641379|564438520|FG010|Overall Study|Non-response Week 12|0|||
156365492|NCT02641379|564438510|FG000|Overall Study|No 2 Log drop at Week 12|0|||
156365493|NCT02641379|564438511|FG001|Overall Study|No 2 Log drop at Week 12|0|||
156365494|NCT02641379|564438512|FG002|Overall Study|No 2 Log drop at Week 12|0|||
156365495|NCT02641379|564438513|FG003|Overall Study|No 2 Log drop at Week 12|0|||
156365496|NCT02641379|564438514|FG004|Overall Study|No 2 Log drop at Week 12|0|||
156365497|NCT02641379|564438515|FG005|Overall Study|No 2 Log drop at Week 12|0|||
156365498|NCT02641379|564438516|FG006|Overall Study|No 2 Log drop at Week 12|0|||
156365499|NCT02641379|564438517|FG007|Overall Study|No 2 Log drop at Week 12|0|||
156365500|NCT02641379|564438518|FG008|Overall Study|No 2 Log drop at Week 12|0|||
156365501|NCT02641379|564438519|FG009|Overall Study|No 2 Log drop at Week 12|0|||
156365502|NCT02641379|564438520|FG010|Overall Study|No 2 Log drop at Week 12|1|||
156365503|NCT02641379|564438510|FG000|Overall Study|Negative PCR result|0|||
156365504|NCT02641379|564438511|FG001|Overall Study|Negative PCR result|0|||
156365505|NCT02641379|564438512|FG002|Overall Study|Negative PCR result|0|||
156365506|NCT02641379|564438513|FG003|Overall Study|Negative PCR result|0|||
156365507|NCT02641379|564438514|FG004|Overall Study|Negative PCR result|0|||
156365508|NCT02641379|564438515|FG005|Overall Study|Negative PCR result|0|||
156365509|NCT02641379|564438516|FG006|Overall Study|Negative PCR result|0|||
156365510|NCT02641379|564438517|FG007|Overall Study|Negative PCR result|0|||
156365511|NCT02641379|564438518|FG008|Overall Study|Negative PCR result|0|||
156365512|NCT02641379|564438519|FG009|Overall Study|Negative PCR result|1|||
156365513|NCT02641379|564438520|FG010|Overall Study|Negative PCR result|0|||
156365514|NCT02641379|564438510|FG000|Overall Study|Participant's PCR high|0|||
156365515|NCT02641379|564438511|FG001|Overall Study|Participant's PCR high|0|||
156365516|NCT02641379|564438512|FG002|Overall Study|Participant's PCR high|0|||
156365517|NCT02641379|564438513|FG003|Overall Study|Participant's PCR high|0|||
156365518|NCT02641379|564438514|FG004|Overall Study|Participant's PCR high|0|||
156365519|NCT02641379|564438515|FG005|Overall Study|Participant's PCR high|0|||
156365520|NCT02641379|564438516|FG006|Overall Study|Participant's PCR high|0|||
156365521|NCT02641379|564438517|FG007|Overall Study|Participant's PCR high|1|||
156365522|NCT02641379|564438518|FG008|Overall Study|Participant's PCR high|0|||
156365523|NCT02641379|564438519|FG009|Overall Study|Participant's PCR high|0|||
156365524|NCT02641379|564438520|FG010|Overall Study|Participant's PCR high|0|||
156365525|NCT02641379|564438510|FG000|Overall Study|Participant treated after Week 24|0|||
156365526|NCT02641379|564438511|FG001|Overall Study|Participant treated after Week 24|0|||
156565221|NCT02660580|565157658|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
156365527|NCT02641379|564438512|FG002|Overall Study|Participant treated after Week 24|0|||
156365528|NCT02641379|564438513|FG003|Overall Study|Participant treated after Week 24|0|||
156365529|NCT02641379|564438514|FG004|Overall Study|Participant treated after Week 24|0|||
156365530|NCT02641379|564438515|FG005|Overall Study|Participant treated after Week 24|0|||
156365531|NCT02641379|564438516|FG006|Overall Study|Participant treated after Week 24|0|||
156365532|NCT02641379|564438517|FG007|Overall Study|Participant treated after Week 24|0|||
156365533|NCT02641379|564438518|FG008|Overall Study|Participant treated after Week 24|1|||
156365534|NCT02641379|564438519|FG009|Overall Study|Participant treated after Week 24|0|||
156365535|NCT02641379|564438520|FG010|Overall Study|Participant treated after Week 24|0|||
156365536|NCT02641379|564438510|FG000|Overall Study|Missing PCR result at Week 8|0|||
156365537|NCT02641379|564438511|FG001|Overall Study|Missing PCR result at Week 8|0|||
156365538|NCT02641379|564438512|FG002|Overall Study|Missing PCR result at Week 8|0|||
156365539|NCT02641379|564438513|FG003|Overall Study|Missing PCR result at Week 8|0|||
156365540|NCT02641379|564438514|FG004|Overall Study|Missing PCR result at Week 8|0|||
156365541|NCT02641379|564438515|FG005|Overall Study|Missing PCR result at Week 8|0|||
156365542|NCT02641379|564438516|FG006|Overall Study|Missing PCR result at Week 8|0|||
156365543|NCT02641379|564438517|FG007|Overall Study|Missing PCR result at Week 8|0|||
156365544|NCT02641379|564438518|FG008|Overall Study|Missing PCR result at Week 8|0|||
156365545|NCT02641379|564438519|FG009|Overall Study|Missing PCR result at Week 8|1|||
156365546|NCT02641379|564438520|FG010|Overall Study|Missing PCR result at Week 8|0|||
156365547|NCT02641379|564438510|FG000|Overall Study|PCR positive|0|||
156365548|NCT02641379|564438511|FG001|Overall Study|PCR positive|0|||
156365549|NCT02641379|564438512|FG002|Overall Study|PCR positive|0|||
156365550|NCT02641379|564438513|FG003|Overall Study|PCR positive|0|||
156365551|NCT02641379|564438514|FG004|Overall Study|PCR positive|0|||
156365552|NCT02641379|564438515|FG005|Overall Study|PCR positive|0|||
156365553|NCT02641379|564438516|FG006|Overall Study|PCR positive|1|||
156365554|NCT02641379|564438517|FG007|Overall Study|PCR positive|0|||
156365555|NCT02641379|564438518|FG008|Overall Study|PCR positive|0|||
156365556|NCT02641379|564438519|FG009|Overall Study|PCR positive|0|||
156365557|NCT02641379|564438520|FG010|Overall Study|PCR positive|0|||
156365558|NCT01165138|564438521|FG000|Overall Study|Adverse Event|0|||
156365559|NCT01165138|564438522|FG001|Overall Study|Adverse Event|1|||
156365560|NCT01165138|564438523|FG002|Overall Study|Adverse Event|0|||
156365561|NCT01165138|564438524|FG003|Overall Study|Adverse Event|2|||
156365562|NCT01165138|564438521|FG000|Overall Study|Lack of Efficacy|0|||
156365563|NCT01165138|564438522|FG001|Overall Study|Lack of Efficacy|32|||
156365564|NCT01165138|564438523|FG002|Overall Study|Lack of Efficacy|6|||
156365565|NCT01165138|564438524|FG003|Overall Study|Lack of Efficacy|7|||
156365566|NCT01165138|564438521|FG000|Overall Study|Protocol Violation|0|||
156365567|NCT01165138|564438522|FG001|Overall Study|Protocol Violation|7|||
156365568|NCT01165138|564438523|FG002|Overall Study|Protocol Violation|0|||
156365569|NCT01165138|564438524|FG003|Overall Study|Protocol Violation|2|||
156491191|NCT01222533|564894835|FG000|Overall Study|Withdrawal by Subject|5|||
156491192|NCT01222533|564894835|FG000|Overall Study|Other|4|||
156491193|NCT03834623|564894836|FG000|Overall Study|Progression|0|||
156491194|NCT03834623|564894837|FG001|Overall Study|Progression|1|||
156491195|NCT03418493|564894838|FG000|Overall Study|Adverse Event|1|||
156491196|NCT03418493|564894839|FG001|Overall Study|Adverse Event|0|||
156491197|NCT03418493|564894840|FG002|Overall Study|Adverse Event|0|||
156365570|NCT01165138|564438521|FG000|Overall Study|Lost to Follow-up|0|||
156365571|NCT01165138|564438522|FG001|Overall Study|Lost to Follow-up|0|||
156365572|NCT01165138|564438523|FG002|Overall Study|Lost to Follow-up|1|||
156365573|NCT01165138|564438524|FG003|Overall Study|Lost to Follow-up|2|||
156365574|NCT01165138|564438521|FG000|Overall Study|Physician Decision|0|||
156491198|NCT03418493|564894841|FG003|Overall Study|Adverse Event|0|||
156365575|NCT01165138|564438522|FG001|Overall Study|Physician Decision|6|||
156365576|NCT01165138|564438523|FG002|Overall Study|Physician Decision|7|||
156365577|NCT01165138|564438524|FG003|Overall Study|Physician Decision|6|||
156365578|NCT01165138|564438521|FG000|Overall Study|Withdrawal by Subject|0|||
156365579|NCT01165138|564438522|FG001|Overall Study|Withdrawal by Subject|6|||
156365580|NCT01165138|564438523|FG002|Overall Study|Withdrawal by Subject|6|||
156365581|NCT01165138|564438524|FG003|Overall Study|Withdrawal by Subject|3|||
156365582|NCT01398956|564438525|FG000|Overall Study|Withdrawal by Subject|4|||
156365583|NCT01398956|564438525|FG000|Overall Study|AE, non-serious non-fatal|4|||
156365584|NCT01398956|564438525|FG000|Overall Study|Withdrawal Criteria No.3|1|||
156365585|NCT01398956|564438525|FG000|Overall Study|Subject moved a long distance|1|||
156365586|NCT00962104|564438528|FG000|Overall Study|Adverse Event|10|||
156365587|NCT00962104|564438529|FG001|Overall Study|Adverse Event|3|||
156365588|NCT00962104|564438528|FG000|Overall Study|Entry Criteria Not Met|1|||
156365589|NCT00962104|564438529|FG001|Overall Study|Entry Criteria Not Met|2|||
156365590|NCT00962104|564438528|FG000|Overall Study|Lack of Efficacy|0|||
156365591|NCT00962104|564438529|FG001|Overall Study|Lack of Efficacy|1|||
156365592|NCT00962104|564438528|FG000|Overall Study|Lost to Follow-up|10|||
156365593|NCT00962104|564438529|FG001|Overall Study|Lost to Follow-up|4|||
156365594|NCT00962104|564438528|FG000|Overall Study|Physician Decision|1|||
156365595|NCT00962104|564438529|FG001|Overall Study|Physician Decision|0|||
156365596|NCT00962104|564438528|FG000|Overall Study|Protocol Violation|6|||
156365597|NCT00962104|564438529|FG001|Overall Study|Protocol Violation|8|||
156365598|NCT00962104|564438528|FG000|Overall Study|Sponsor Decision|0|||
156365599|NCT00962104|564438529|FG001|Overall Study|Sponsor Decision|1|||
156365600|NCT00962104|564438528|FG000|Overall Study|Withdrawal by Subject|10|||
156365601|NCT00962104|564438529|FG001|Overall Study|Withdrawal by Subject|6|||
156365602|NCT00962104|564438528|FG000|Overall Study|Other|2|||
156365603|NCT00962104|564438529|FG001|Overall Study|Other|0|||
156365604|NCT03274986|564438530|FG000|Overall Study|Withdrawal by Subject|0|||
156365605|NCT03274986|564438531|FG001|Overall Study|Withdrawal by Subject|1|||
156365606|NCT03274986|564438530|FG000|Overall Study|Lost to Follow-up|0|||
156491199|NCT03418493|564894842|FG004|Overall Study|Adverse Event|0|||
156491200|NCT03418493|564894843|FG005|Overall Study|Adverse Event|0|||
156491201|NCT03418493|564894844|FG006|Overall Study|Adverse Event|0|||
156491202|NCT03418493|564894845|FG007|Overall Study|Adverse Event|0|||
156365607|NCT03274986|564438531|FG001|Overall Study|Lost to Follow-up|1|||
156365608|NCT00603746|564438534|FG000|Overall Study|Adverse Event|2|||
156365609|NCT00603746|564438535|FG001|Overall Study|Adverse Event|3|||
156365610|NCT00603746|564438536|FG002|Overall Study|Adverse Event|0|||
156365611|NCT00603746|564438537|FG003|Overall Study|Adverse Event|1|||
156365612|NCT00603746|564438538|FG004|Overall Study|Adverse Event|0|||
156365613|NCT00603746|564438539|FG005|Overall Study|Adverse Event|4|||
156365614|NCT00603746|564438534|FG000|Overall Study|Lack of Efficacy|34|||
156365615|NCT00603746|564438535|FG001|Overall Study|Lack of Efficacy|11|||
156365616|NCT00603746|564438536|FG002|Overall Study|Lack of Efficacy|6|||
156365617|NCT00603746|564438537|FG003|Overall Study|Lack of Efficacy|11|||
156365618|NCT00603746|564438538|FG004|Overall Study|Lack of Efficacy|12|||
156365619|NCT00603746|564438539|FG005|Overall Study|Lack of Efficacy|8|||
156365620|NCT00603746|564438534|FG000|Overall Study|Protocol Violation|0|||
156365621|NCT00603746|564438535|FG001|Overall Study|Protocol Violation|3|||
156365622|NCT00603746|564438536|FG002|Overall Study|Protocol Violation|1|||
156365623|NCT00603746|564438537|FG003|Overall Study|Protocol Violation|0|||
156365624|NCT00603746|564438538|FG004|Overall Study|Protocol Violation|1|||
156365625|NCT00603746|564438539|FG005|Overall Study|Protocol Violation|0|||
156365626|NCT00603746|564438534|FG000|Overall Study|Lost to Follow-up|0|||
156365627|NCT00603746|564438535|FG001|Overall Study|Lost to Follow-up|1|||
156365628|NCT00603746|564438536|FG002|Overall Study|Lost to Follow-up|1|||
156365629|NCT00603746|564438537|FG003|Overall Study|Lost to Follow-up|0|||
156365630|NCT00603746|564438538|FG004|Overall Study|Lost to Follow-up|0|||
156365631|NCT00603746|564438539|FG005|Overall Study|Lost to Follow-up|0|||
156365632|NCT00603746|564438534|FG000|Overall Study|Physician Decision|1|||
156365633|NCT00603746|564438535|FG001|Overall Study|Physician Decision|0|||
156365634|NCT00603746|564438536|FG002|Overall Study|Physician Decision|0|||
156365635|NCT00603746|564438537|FG003|Overall Study|Physician Decision|0|||
156365636|NCT00603746|564438538|FG004|Overall Study|Physician Decision|1|||
156365637|NCT00603746|564438539|FG005|Overall Study|Physician Decision|0|||
156365638|NCT00603746|564438534|FG000|Overall Study|Withdrawal by Subject|1|||
156365639|NCT00603746|564438535|FG001|Overall Study|Withdrawal by Subject|0|||
156365640|NCT00603746|564438536|FG002|Overall Study|Withdrawal by Subject|0|||
156365641|NCT00603746|564438537|FG003|Overall Study|Withdrawal by Subject|1|||
156365642|NCT00603746|564438538|FG004|Overall Study|Withdrawal by Subject|3|||
156365643|NCT00603746|564438539|FG005|Overall Study|Withdrawal by Subject|1|||
156365644|NCT01524627|564438546|FG000|Overall Study|Physician Decision|0|||
156365645|NCT01524627|564438547|FG001|Overall Study|Physician Decision|1|||
156365646|NCT01524627|564438546|FG000|Overall Study|Lost to Follow-up|1|||
156365647|NCT01524627|564438547|FG001|Overall Study|Lost to Follow-up|1|||
156365648|NCT03323658|564438548|FG000|Overall Study|Adverse Event|0|||
156365649|NCT03323658|564438549|FG001|Overall Study|Adverse Event|1|||
156365650|NCT03323658|564438550|FG002|Overall Study|Adverse Event|0|||
156365651|NCT03913091|564438551|FG000|Overall Study|Lost to Follow-up|18|||
156365652|NCT03913091|564438552|FG001|Overall Study|Lost to Follow-up|11|||
156365653|NCT03913091|564438551|FG000|Overall Study|Required additional meds/surgery|1|||
156365654|NCT03913091|564438552|FG001|Overall Study|Required additional meds/surgery|2|||
156365655|NCT03913091|564438551|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
156365656|NCT03913091|564438552|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
156365657|NCT00615056|564438553|FG000|Overall Study|Death|31|||
156365658|NCT00615056|564438554|FG001|Overall Study|Death|31|||
156491203|NCT03418493|564894846|FG008|Overall Study|Adverse Event|0|||
156491204|NCT03418493|564894847|FG009|Overall Study|Adverse Event|0|||
156365659|NCT00615056|564438555|FG002|Overall Study|Death|21|||
156365660|NCT00615056|564438556|FG003|Overall Study|Death|23|||
156365661|NCT00615056|564438553|FG000|Overall Study|Lost to Follow-up|1|||
156365662|NCT00615056|564438554|FG001|Overall Study|Lost to Follow-up|2|||
156365663|NCT00615056|564438555|FG002|Overall Study|Lost to Follow-up|4|||
156365664|NCT00615056|564438556|FG003|Overall Study|Lost to Follow-up|5|||
156365665|NCT00615056|564438553|FG000|Overall Study|Other|13|||
156365666|NCT00615056|564438554|FG001|Overall Study|Other|15|||
156365667|NCT00615056|564438555|FG002|Overall Study|Other|10|||
156365668|NCT00615056|564438556|FG003|Overall Study|Other|7|||
156365669|NCT00615056|564438553|FG000|Overall Study|Objective progression or relapse|0|||
156365670|NCT00615056|564438554|FG001|Overall Study|Objective progression or relapse|2|||
156365671|NCT00615056|564438555|FG002|Overall Study|Objective progression or relapse|0|||
156365672|NCT00615056|564438556|FG003|Overall Study|Objective progression or relapse|0|||
156365673|NCT00615056|564438553|FG000|Overall Study|Withdrawal by Subject|0|||
156365674|NCT00615056|564438554|FG001|Overall Study|Withdrawal by Subject|1|||
156365675|NCT00615056|564438555|FG002|Overall Study|Withdrawal by Subject|1|||
156365676|NCT00615056|564438556|FG003|Overall Study|Withdrawal by Subject|0|||
156365677|NCT00615056|564438553|FG000|Overall Study|Discontinued by Sponsor|1|||
156365678|NCT00615056|564438554|FG001|Overall Study|Discontinued by Sponsor|0|||
156365679|NCT00615056|564438555|FG002|Overall Study|Discontinued by Sponsor|0|||
156365680|NCT00615056|564438556|FG003|Overall Study|Discontinued by Sponsor|0|||
156365681|NCT00615056|564438553|FG000|Overall Study|Randomized but not treated|3|||
156365682|NCT00615056|564438554|FG001|Overall Study|Randomized but not treated|0|||
156365683|NCT00615056|564438555|FG002|Overall Study|Randomized but not treated|0|||
156365684|NCT00615056|564438556|FG003|Overall Study|Randomized but not treated|0|||
156365685|NCT00969553|564438557|FG000|Overall Study|Progressive disease (PD)|2|||
156365686|NCT00969553|564438558|FG001|Overall Study|Progressive disease (PD)|2|||
156365687|NCT00969553|564438559|FG002|Overall Study|Progressive disease (PD)|6|||
156365688|NCT00969553|564438560|FG003|Overall Study|Progressive disease (PD)|9|||
156365689|NCT00969553|564438561|FG004|Overall Study|Progressive disease (PD)|2|||
156365690|NCT00969553|564438562|FG005|Overall Study|Progressive disease (PD)|4|||
156365691|NCT00969553|564438563|FG006|Overall Study|Progressive disease (PD)|2|||
156365692|NCT00969553|564438564|FG007|Overall Study|Progressive disease (PD)|12|||
156365693|NCT00969553|564438565|FG008|Overall Study|Progressive disease (PD)|3|||
156365694|NCT00969553|564438557|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
156365695|NCT00969553|564438558|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
156365696|NCT00969553|564438559|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
156365697|NCT00969553|564438560|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
156365698|NCT00969553|564438561|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
156365699|NCT00969553|564438562|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
156365700|NCT00969553|564438563|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
156491205|NCT03418493|564894848|FG010|Overall Study|Adverse Event|0|||
156491206|NCT03418493|564894838|FG000|Overall Study|Protocol Violation|0|||
156491207|NCT03418493|564894839|FG001|Overall Study|Protocol Violation|0|||
156491208|NCT03418493|564894840|FG002|Overall Study|Protocol Violation|0|||
156491209|NCT03418493|564894841|FG003|Overall Study|Protocol Violation|0|||
156365701|NCT00969553|564438564|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
156365702|NCT00969553|564438565|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
156365703|NCT00969553|564438557|FG000|Overall Study|Other Adverse Event|0|||
156491210|NCT03418493|564894842|FG004|Overall Study|Protocol Violation|0|||
156491211|NCT03418493|564894843|FG005|Overall Study|Protocol Violation|0|||
156491212|NCT03418493|564894844|FG006|Overall Study|Protocol Violation|0|||
156491213|NCT03418493|564894845|FG007|Overall Study|Protocol Violation|0|||
156365704|NCT00969553|564438558|FG001|Overall Study|Other Adverse Event|0|||
156365705|NCT00969553|564438559|FG002|Overall Study|Other Adverse Event|0|||
156365706|NCT00969553|564438560|FG003|Overall Study|Other Adverse Event|1|||
156365707|NCT00969553|564438561|FG004|Overall Study|Other Adverse Event|0|||
156365708|NCT00969553|564438562|FG005|Overall Study|Other Adverse Event|0|||
156365709|NCT00969553|564438563|FG006|Overall Study|Other Adverse Event|1|||
156365710|NCT00969553|564438564|FG007|Overall Study|Other Adverse Event|0|||
156365711|NCT00969553|564438565|FG008|Overall Study|Other Adverse Event|0|||
156365712|NCT00969553|564438557|FG000|Overall Study|Refused cont. medication|1|||
156365713|NCT00969553|564438558|FG001|Overall Study|Refused cont. medication|1|||
156365714|NCT00969553|564438559|FG002|Overall Study|Refused cont. medication|0|||
156365715|NCT00969553|564438560|FG003|Overall Study|Refused cont. medication|2|||
156365716|NCT00969553|564438561|FG004|Overall Study|Refused cont. medication|0|||
156365717|NCT00969553|564438562|FG005|Overall Study|Refused cont. medication|0|||
156365718|NCT00969553|564438563|FG006|Overall Study|Refused cont. medication|0|||
156365719|NCT00969553|564438564|FG007|Overall Study|Refused cont. medication|1|||
156365720|NCT00969553|564438565|FG008|Overall Study|Refused cont. medication|0|||
156365721|NCT00969553|564438557|FG000|Overall Study|Not specified above|0|||
156365722|NCT00969553|564438558|FG001|Overall Study|Not specified above|0|||
156365723|NCT00969553|564438559|FG002|Overall Study|Not specified above|0|||
156365724|NCT00969553|564438560|FG003|Overall Study|Not specified above|4|||
156365725|NCT00969553|564438561|FG004|Overall Study|Not specified above|0|||
156365726|NCT00969553|564438562|FG005|Overall Study|Not specified above|0|||
156365727|NCT00969553|564438563|FG006|Overall Study|Not specified above|1|||
156365728|NCT00969553|564438564|FG007|Overall Study|Not specified above|1|||
156365729|NCT00969553|564438565|FG008|Overall Study|Not specified above|0|||
156365730|NCT02196324|564438569|FG000|Overall Study|Withdrawal by Subject|8|||
156365731|NCT02196324|564438570|FG001|Overall Study|Withdrawal by Subject|4|||
156365732|NCT02196324|564438569|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
156365733|NCT02196324|564438570|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
156365734|NCT02196324|564438569|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
156491214|NCT03418493|564894846|FG008|Overall Study|Protocol Violation|0|||
156491215|NCT03418493|564894847|FG009|Overall Study|Protocol Violation|1|||
156365735|NCT02196324|564438570|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
156365736|NCT02196324|564438569|FG000|Overall Study|Other|1|||
156365737|NCT02196324|564438570|FG001|Overall Study|Other|0|||
156365738|NCT01380184|564438571|FG000|Part 1 (19 Days)|Adverse Event|1|||
156491216|NCT03418493|564894848|FG010|Overall Study|Protocol Violation|0|||
156365739|NCT01380184|564438571|FG000|Part 2|Adverse Event|5|||
156365740|NCT01380184|564438571|FG000|Part 2|Disease Progression|8|||
156365741|NCT01380184|564438571|FG000|Part 2|Lost to Follow-up|1|||
156365742|NCT04248816|564438572|FG000|Overall Study|Ineligible post-randomization|7|||
156565222|NCT02660580|565157659|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
156365743|NCT04248816|564438573|FG001|Overall Study|Ineligible post-randomization|21|||
156365744|NCT04248816|564438574|FG002|Overall Study|Ineligible post-randomization|25|||
156365745|NCT03350503|564438575|FG000|Overall Study|Adverse Event|5|||
156365746|NCT03350503|564438575|FG000|Overall Study|Withdrawal by Subject|5|||
156365747|NCT03350503|564438575|FG000|Overall Study|Continuation impossible due to move|4|||
156365748|NCT03350503|564438575|FG000|Overall Study|Physician Decision|3|||
156365749|NCT03829046|564438578|FG000|Overall Study|Withdrawal by Subject|1|||
156365750|NCT03829046|564438579|FG001|Overall Study|Withdrawal by Subject|0|||
156365751|NCT00262067|564438580|FG000|Overall Study|Death|190|||
156365752|NCT00262067|564438581|FG001|Overall Study|Death|89|||
156365753|NCT00262067|564438582|FG002|Overall Study|Death|186|||
156365754|NCT00262067|564438583|FG003|Overall Study|Death|99|||
156365755|NCT00262067|564438580|FG000|Overall Study|Lost to Follow-up|5|||
156365756|NCT00262067|564438581|FG001|Overall Study|Lost to Follow-up|4|||
156365757|NCT00262067|564438582|FG002|Overall Study|Lost to Follow-up|7|||
156365758|NCT00262067|564438583|FG003|Overall Study|Lost to Follow-up|5|||
156365759|NCT00262067|564438580|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
156365760|NCT00262067|564438581|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
156365761|NCT00262067|564438582|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
156365762|NCT00262067|564438583|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
156365763|NCT00262067|564438580|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
156365764|NCT00262067|564438581|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
156365765|NCT00262067|564438582|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
156365766|NCT00262067|564438583|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
156365767|NCT02620046|564438588|FG000|Overall Study|Adverse Event|22|||
156365768|NCT02620046|564438589|FG001|Overall Study|Adverse Event|42|||
156365769|NCT02620046|564438588|FG000|Overall Study|Lost to Follow-up|4|||
156365770|NCT02620046|564438589|FG001|Overall Study|Lost to Follow-up|10|||
156365771|NCT02620046|564438588|FG000|Overall Study|Withdrawal by Subject|36|||
156365772|NCT02620046|564438589|FG001|Overall Study|Withdrawal by Subject|66|||
156365773|NCT02620046|564438588|FG000|Overall Study|Site Termination|3|||
156365774|NCT02620046|564438589|FG001|Overall Study|Site Termination|3|||
156365775|NCT02620046|564438588|FG000|Overall Study|Pregnancy|3|||
156365776|NCT02620046|564438589|FG001|Overall Study|Pregnancy|7|||
156365777|NCT02620046|564438588|FG000|Overall Study|Lack of Efficacy|81|||
156365778|NCT02620046|564438589|FG001|Overall Study|Lack of Efficacy|146|||
156365779|NCT02620046|564438588|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
156365780|NCT02620046|564438589|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
156365781|NCT02620046|564438588|FG000|Overall Study|Reason Not Specified|13|||
156365782|NCT02620046|564438589|FG001|Overall Study|Reason Not Specified|21|||
156365783|NCT02620046|564438588|FG000|Overall Study|Significant Protocol Deviation|0|||
156365784|NCT02620046|564438589|FG001|Overall Study|Significant Protocol Deviation|1|||
156365785|NCT00560950|564438592|FG000|Overall Study|Lost to Follow-up|1|||
156365786|NCT00560950|564438593|FG001|Overall Study|Lost to Follow-up|0|||
156365787|NCT01581593|564440814|FG000|Overall Study|Withdrawal by Subject|1|||
156365788|NCT05308901|564440817|FG000|Overall Study|Death|6|||
156365789|NCT00071812|564440818|FG000|24-Week Double-Blind Period|Adverse Event|2|||
156365790|NCT00071812|564440819|FG001|24-Week Double-Blind Period|Adverse Event|3|||
156365791|NCT00071812|564440820|FG002|24-Week Double-Blind Period|Adverse Event|4|||
156365792|NCT00071812|564440821|FG003|24-Week Double-Blind Period|Adverse Event|4|||
156365793|NCT00071812|564440818|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
156365794|NCT00071812|564440819|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
156365795|NCT00071812|564440820|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
156365796|NCT00071812|564440821|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
156365797|NCT00071812|564440818|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
156365798|NCT00071812|564440819|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
156365799|NCT00071812|564440820|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
156365800|NCT00071812|564440821|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
156365801|NCT00071812|564440818|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
156365802|NCT00071812|564440819|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
156365803|NCT00071812|564440820|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
156365804|NCT00071812|564440821|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
156365805|NCT00071812|564440818|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
156365806|NCT00071812|564440819|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
156365807|NCT00071812|564440820|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
156365808|NCT00071812|564440821|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
156365809|NCT00071812|564440818|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
156365810|NCT00071812|564440819|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
156365811|NCT00071812|564440820|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
156365812|NCT00071812|564440821|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
156365813|NCT00071812|564440818|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156365814|NCT00071812|564440819|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156365815|NCT00071812|564440820|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156365816|NCT00071812|564440821|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
156365817|NCT00071812|564440818|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156365818|NCT00071812|564440819|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156365819|NCT00071812|564440820|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156365820|NCT00071812|564440821|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
156491217|NCT01947517|564894849|FG000|Overall Study|Withdrawal by Subject|1|||
156491218|NCT01947517|564894850|FG001|Overall Study|Withdrawal by Subject|1|||
156491219|NCT05446714|564894851|FG000|Overall Study|Lost to Follow-up|1|||
156491220|NCT05446714|564894852|FG001|Overall Study|Lost to Follow-up|3|||
156491221|NCT05446714|564894853|FG002|Overall Study|Lost to Follow-up|2|||
156491222|NCT05446714|564894851|FG000|Overall Study|Protocol Violation|2|||
156365821|NCT00071812|564440818|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156365822|NCT00071812|564440819|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156491223|NCT05446714|564894852|FG001|Overall Study|Protocol Violation|0|||
156491224|NCT05446714|564894853|FG002|Overall Study|Protocol Violation|0|||
156491225|NCT03024996|564894858|FG000|Overall Study|Death|57|||
156545973|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
156545974|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
156545975|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
156545976|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
156545977|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
156545978|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
156545979|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
156365823|NCT00071812|564440820|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156365824|NCT00071812|564440821|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
156365825|NCT00071812|564440818|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156365826|NCT00071812|564440819|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156365827|NCT00071812|564440820|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
156365828|NCT00071812|564440821|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
156491226|NCT03024996|564894859|FG001|Overall Study|Death|55|||
156491227|NCT03024996|564894858|FG000|Overall Study|Disease relapse|1|||
156365829|NCT01904604|564440826|FG000|Overall Study|Withdrew before receiving dosing|0|||
156365830|NCT01904604|564440827|FG001|Overall Study|Withdrew before receiving dosing|1|||
156365831|NCT01904604|564440828|FG002|Overall Study|Withdrew before receiving dosing|0|||
156491228|NCT03024996|564894859|FG001|Overall Study|Disease relapse|0|||
156491229|NCT03024996|564894858|FG000|Overall Study|Lost to Follow-up|5|||
156545980|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
156545981|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
156491230|NCT03024996|564894859|FG001|Overall Study|Lost to Follow-up|10|||
156491231|NCT03024996|564894858|FG000|Overall Study|Other|3|||
156491232|NCT03024996|564894859|FG001|Overall Study|Other|3|||
156491233|NCT03024996|564894858|FG000|Overall Study|Physician Decision|0|||
156491234|NCT03024996|564894859|FG001|Overall Study|Physician Decision|1|||
156491235|NCT03024996|564894858|FG000|Overall Study|Study terminated by sponsor|303|||
156491236|NCT03024996|564894859|FG001|Overall Study|Study terminated by sponsor|283|||
156491237|NCT03024996|564894858|FG000|Overall Study|Withdrawal by Subject|21|||
156545982|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
156491238|NCT03024996|564894859|FG001|Overall Study|Withdrawal by Subject|36|||
156491239|NCT02418845|564894862|FG000|Overall Study|Lost to Follow-up|7|||
156491240|NCT02418845|564894863|FG001|Overall Study|Lost to Follow-up|2|||
156491241|NCT02418845|564894862|FG000|Overall Study|Lack of Efficacy|0|||
156491242|NCT02418845|564894863|FG001|Overall Study|Lack of Efficacy|3|||
156491243|NCT02418845|564894862|FG000|Overall Study|Physician Decision|5|||
156491244|NCT02418845|564894863|FG001|Overall Study|Physician Decision|5|||
156491245|NCT02418845|564894862|FG000|Overall Study|Protocol Violation|1|||
156491246|NCT02418845|564894863|FG001|Overall Study|Protocol Violation|0|||
156491247|NCT02418845|564894862|FG000|Overall Study|Withdrawal by Subject|3|||
156491248|NCT02418845|564894863|FG001|Overall Study|Withdrawal by Subject|2|||
156491249|NCT00478647|564894864|FG000|Overall Study|Adverse Event|1|||
156491250|NCT00478647|564894864|FG000|Overall Study|Withdrawal by Subject|1|||
156491251|NCT00460564|564894865|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
156491252|NCT00460564|564894866|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
156491253|NCT00460564|564894867|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156491254|NCT00460564|564894868|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156491255|NCT00460564|564894869|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156491256|NCT00460564|564894870|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156491257|NCT00460564|564894871|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156491258|NCT00460564|564894872|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156491259|NCT00460564|564894865|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
156491260|NCT00460564|564894866|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156491261|NCT00460564|564894867|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156491262|NCT00460564|564894868|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156491263|NCT00460564|564894869|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156491264|NCT00460564|564894870|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156491265|NCT00460564|564894871|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156491266|NCT00460564|564894872|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156491267|NCT00460564|564894865|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
156491268|NCT00460564|564894866|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
156491269|NCT00460564|564894867|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
156491270|NCT00460564|564894868|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
156491271|NCT00460564|564894869|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
156491272|NCT00460564|564894870|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
156491273|NCT00460564|564894871|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
156491274|NCT00460564|564894872|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
156491275|NCT00460564|564894865|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156491276|NCT00460564|564894866|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156491277|NCT00460564|564894867|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156491278|NCT00460564|564894868|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156491279|NCT00460564|564894869|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
156491280|NCT00460564|564894870|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
156491281|NCT00460564|564894871|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156491282|NCT00460564|564894872|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156491283|NCT00460564|564894865|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
156491284|NCT00460564|564894866|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
156491285|NCT00460564|564894867|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
156491286|NCT00460564|564894868|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
156491287|NCT00460564|564894869|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
156491288|NCT00460564|564894870|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
156491289|NCT00460564|564894871|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
156491290|NCT00460564|564894872|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
156491291|NCT00630552|564894876|FG000|Overall Study|Adverse Event|0|||
156491292|NCT00630552|564894877|FG001|Overall Study|Adverse Event|1|||
156491293|NCT00630552|564894878|FG002|Overall Study|Adverse Event|5|||
156491294|NCT00630552|564894879|FG003|Overall Study|Adverse Event|4|||
156491295|NCT00630552|564894880|FG004|Overall Study|Adverse Event|2|||
156491296|NCT00630552|564894876|FG000|Overall Study|Disease progression|5|||
156491297|NCT00630552|564894877|FG001|Overall Study|Disease progression|6|||
156491298|NCT00630552|564894878|FG002|Overall Study|Disease progression|27|||
156491299|NCT00630552|564894879|FG003|Overall Study|Disease progression|22|||
156491300|NCT00630552|564894880|FG004|Overall Study|Disease progression|31|||
156491301|NCT00630552|564894876|FG000|Overall Study|Never received IP|0|||
156491302|NCT00630552|564894877|FG001|Overall Study|Never received IP|0|||
156491303|NCT00630552|564894878|FG002|Overall Study|Never received IP|0|||
156491304|NCT00630552|564894879|FG003|Overall Study|Never received IP|2|||
156491305|NCT00630552|564894880|FG004|Overall Study|Never received IP|2|||
156491306|NCT00630552|564894876|FG000|Overall Study|Ineligibility determined|0|||
156491307|NCT00630552|564894877|FG001|Overall Study|Ineligibility determined|0|||
156491308|NCT00630552|564894878|FG002|Overall Study|Ineligibility determined|0|||
156491309|NCT00630552|564894879|FG003|Overall Study|Ineligibility determined|0|||
156491310|NCT00630552|564894880|FG004|Overall Study|Ineligibility determined|1|||
156491311|NCT00630552|564894876|FG000|Overall Study|Protocol Violation|0|||
156491312|NCT00630552|564894877|FG001|Overall Study|Protocol Violation|0|||
156491313|NCT00630552|564894878|FG002|Overall Study|Protocol Violation|0|||
156491314|NCT00630552|564894879|FG003|Overall Study|Protocol Violation|1|||
156491315|NCT00630552|564894880|FG004|Overall Study|Protocol Violation|0|||
156491316|NCT00630552|564894876|FG000|Overall Study|Physician Decision|0|||
156491317|NCT00630552|564894877|FG001|Overall Study|Physician Decision|0|||
156491318|NCT00630552|564894878|FG002|Overall Study|Physician Decision|0|||
156491319|NCT00630552|564894879|FG003|Overall Study|Physician Decision|0|||
156491320|NCT00630552|564894880|FG004|Overall Study|Physician Decision|1|||
156491321|NCT00630552|564894876|FG000|Overall Study|Death|0|||
156491322|NCT00630552|564894877|FG001|Overall Study|Death|0|||
156491323|NCT00630552|564894878|FG002|Overall Study|Death|1|||
156491324|NCT00630552|564894879|FG003|Overall Study|Death|2|||
156491325|NCT00630552|564894880|FG004|Overall Study|Death|2|||
156491326|NCT00630552|564894876|FG000|Overall Study|Withdrawal by Subject|0|||
156491327|NCT00630552|564894877|FG001|Overall Study|Withdrawal by Subject|0|||
156491328|NCT00630552|564894878|FG002|Overall Study|Withdrawal by Subject|0|||
156491329|NCT00630552|564894879|FG003|Overall Study|Withdrawal by Subject|1|||
156491330|NCT00630552|564894880|FG004|Overall Study|Withdrawal by Subject|0|||
156491331|NCT00630552|564894876|FG000|Overall Study|Other|0|||
156491332|NCT00630552|564894877|FG001|Overall Study|Other|0|||
156491333|NCT00630552|564894878|FG002|Overall Study|Other|4|||
156491334|NCT00630552|564894879|FG003|Overall Study|Other|2|||
156491335|NCT00630552|564894880|FG004|Overall Study|Other|0|||
156491336|NCT03226106|564894881|FG000|Overall Study|Withdrawal by Subject|2|||
156491337|NCT03226106|564894882|FG001|Overall Study|Withdrawal by Subject|0|||
156491338|NCT03226106|564894881|FG000|Overall Study|Adverse Event|1|||
156491339|NCT03226106|564894882|FG001|Overall Study|Adverse Event|0|||
156491340|NCT03226106|564894881|FG000|Overall Study|Lost to Follow-up|2|||
156491341|NCT03226106|564894882|FG001|Overall Study|Lost to Follow-up|0|||
156491342|NCT04349644|564894883|FG000|Allocation/Pretest|Lost to pretest|0|||
156491343|NCT04349644|564894884|FG001|Allocation/Pretest|Lost to pretest|3|||
156491344|NCT04349644|564894883|FG000|Posttest|Lost to posttest|0|||
156491345|NCT04349644|564894884|FG001|Posttest|Lost to posttest|8|||
156491346|NCT04349644|564894883|FG000|Posttest|Discontinued intervention|6|||
156491347|NCT04349644|564894884|FG001|Posttest|Discontinued intervention|0|||
156491348|NCT04349644|564894883|FG000|Follow-up|Lost to Follow-up|0|||
156491349|NCT04349644|564894884|FG001|Follow-up|Lost to Follow-up|2|||
156491350|NCT01084239|564894885|FG000|28-Day Follow-up|Lost to Follow-up|4|||
156491351|NCT01084239|564894886|FG001|28-Day Follow-up|Lost to Follow-up|9|||
156491352|NCT05006417|564894887|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
156491353|NCT00863798|564894888|FG000|Overall Study|Adverse Event|5|||
156491354|NCT00863798|564894889|FG001|Overall Study|Adverse Event|2|||
156491355|NCT00863798|564894890|FG002|Overall Study|Adverse Event|4|||
156491356|NCT00863798|564894888|FG000|Overall Study|Participant failed to return|2|||
156491357|NCT00863798|564894889|FG001|Overall Study|Participant failed to return|1|||
156491358|NCT00863798|564894890|FG002|Overall Study|Participant failed to return|0|||
156491359|NCT00863798|564894888|FG000|Overall Study|Investigator request|1|||
156491360|NCT00863798|564894889|FG001|Overall Study|Investigator request|2|||
156491361|NCT00863798|564894890|FG002|Overall Study|Investigator request|1|||
156491362|NCT00863798|564894888|FG000|Overall Study|Lack of Efficacy|4|||
156491363|NCT00863798|564894889|FG001|Overall Study|Lack of Efficacy|3|||
156491364|NCT00863798|564894890|FG002|Overall Study|Lack of Efficacy|6|||
156491365|NCT00863798|564894888|FG000|Overall Study|Lost to Follow-up|6|||
156491366|NCT00863798|564894889|FG001|Overall Study|Lost to Follow-up|9|||
156491367|NCT00863798|564894890|FG002|Overall Study|Lost to Follow-up|5|||
156491368|NCT00863798|564894888|FG000|Overall Study|Other|2|||
156491369|NCT00863798|564894889|FG001|Overall Study|Other|3|||
156491370|NCT00863798|564894890|FG002|Overall Study|Other|1|||
156491371|NCT00863798|564894888|FG000|Overall Study|Protocol Violation|0|||
156491372|NCT00863798|564894889|FG001|Overall Study|Protocol Violation|1|||
156491373|NCT00863798|564894890|FG002|Overall Study|Protocol Violation|1|||
156491374|NCT00863798|564894888|FG000|Overall Study|Withdrawal by Subject|8|||
156491375|NCT00863798|564894889|FG001|Overall Study|Withdrawal by Subject|7|||
156491376|NCT00863798|564894890|FG002|Overall Study|Withdrawal by Subject|4|||
156491377|NCT00863798|564894888|FG000|Overall Study|Randomized not treated|4|||
156491378|NCT00863798|564894889|FG001|Overall Study|Randomized not treated|2|||
156491379|NCT00863798|564894890|FG002|Overall Study|Randomized not treated|3|||
156491380|NCT04238520|564894891|FG000|Overall Study|Withdrawal by Subject|1|||
156491381|NCT04238520|564894892|FG001|Overall Study|Withdrawal by Subject|1|||
156491382|NCT04238520|564894891|FG000|Overall Study|Lost to Follow-up|1|||
156491383|NCT04238520|564894892|FG001|Overall Study|Lost to Follow-up|2|||
156491384|NCT04238520|564894891|FG000|Overall Study|Death|0|||
156491385|NCT04238520|564894892|FG001|Overall Study|Death|2|||
156491386|NCT04238520|564894891|FG000|Overall Study|Unsafe home environment for research staff|0|||
156491387|NCT04238520|564894892|FG001|Overall Study|Unsafe home environment for research staff|1|||
156491388|NCT01470599|564894893|FG000|Overall Study|Did not meet entrance criteria|1|||
156491389|NCT01470599|564894894|FG001|Overall Study|Did not meet entrance criteria|0|||
156491390|NCT01470599|564894893|FG000|Overall Study|Lost to Follow-up|2|||
156545983|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
156545984|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
156545985|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
156545986|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
156545987|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
156545988|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
156545989|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
156545990|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
156545991|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
156545992|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
156545993|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
156545994|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
156545995|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
156545996|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
156545997|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
156545998|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
156545999|NCT00105443|565093265|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
156546000|NCT00105443|565093266|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
156546001|NCT00105443|565093267|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
156546002|NCT00105443|565093268|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
156546003|NCT02135692|565093269|FG000|Overall Study|Adverse Event|3|||
156546004|NCT02135692|565093269|FG000|Overall Study|Lack of Efficacy|2|||
156546005|NCT02135692|565093269|FG000|Overall Study|Protocol Violation|2|||
156546006|NCT02135692|565093269|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
156546007|NCT02135692|565093269|FG000|Overall Study|Product commercially available|159|||
156546008|NCT02135692|565093269|FG000|Overall Study|Study closed/terminated|153|||
156546009|NCT02135692|565093269|FG000|Overall Study|Lost to Follow-up|4|||
156546010|NCT02135692|565093269|FG000|Overall Study|Withdrawal by Subject|15|||
156546011|NCT01097746|565093271|FG000|Overall Study|Adverse Event|4|||
156546012|NCT01097746|565093271|FG000|Overall Study|taken off study before any treatment given|1|||
156546013|NCT02495844|565093276|FG000|Overall Study|Lack of Efficacy|1|||
156546014|NCT02495844|565093277|FG001|Overall Study|Lack of Efficacy|2|||
156546015|NCT02495844|565093276|FG000|Overall Study|AE, non-fatal|0|||
156546016|NCT02495844|565093277|FG001|Overall Study|AE, non-fatal|1|||
156546017|NCT02495844|565093276|FG000|Overall Study|Hepatitis Positivity|0|||
156546018|NCT02495844|565093277|FG001|Overall Study|Hepatitis Positivity|1|||
156546019|NCT01514682|565093278|FG000|Overall Study|Withdrawal by Subject|2|||
156546020|NCT01514682|565093279|FG001|Overall Study|Withdrawal by Subject|3|||
156546021|NCT01514682|565093278|FG000|Overall Study|Physician Decision|4|||
156546022|NCT01514682|565093279|FG001|Overall Study|Physician Decision|3|||
156546023|NCT02145741|565093280|FG000|Overall Study|Progressive disease|3|||
156546024|NCT02145741|565093281|FG001|Overall Study|Progressive disease|6|||
156546025|NCT02145741|565093282|FG002|Overall Study|Progressive disease|6|||
156546026|NCT02145741|565093280|FG000|Overall Study|quality issue with the administered drug|3|||
156546027|NCT02145741|565093281|FG001|Overall Study|quality issue with the administered drug|0|||
156546028|NCT02145741|565093282|FG002|Overall Study|quality issue with the administered drug|0|||
156546029|NCT00623480|565093283|FG000|Overall Study|Lost to Follow-up|0|||
156546030|NCT00623480|565093284|FG001|Overall Study|Lost to Follow-up|1|||
156546031|NCT00623480|565093283|FG000|Overall Study|Withdrawal by Subject|2|||
156546032|NCT00623480|565093284|FG001|Overall Study|Withdrawal by Subject|4|||
156546033|NCT00623480|565093283|FG000|Overall Study|Lack of Efficacy|1|||
156546034|NCT00623480|565093284|FG001|Overall Study|Lack of Efficacy|0|||
156546035|NCT00623480|565093283|FG000|Overall Study|Non-compliant with study medication|4|||
156546036|NCT00623480|565093284|FG001|Overall Study|Non-compliant with study medication|0|||
156546037|NCT00623480|565093283|FG000|Overall Study|Protocol Violation|0|||
156546038|NCT00623480|565093284|FG001|Overall Study|Protocol Violation|1|||
156546039|NCT00623480|565093283|FG000|Overall Study|Site closed by sponsor|0|||
156546040|NCT00623480|565093284|FG001|Overall Study|Site closed by sponsor|1|||
156546041|NCT01594853|565093285|FG000|Overall Study|Withdrawal by Subject|1|||
156546042|NCT01594853|565093286|FG001|Overall Study|Withdrawal by Subject|1|||
156546043|NCT01594853|565093285|FG000|Overall Study|Lost to Follow-up|1|||
156546044|NCT01594853|565093286|FG001|Overall Study|Lost to Follow-up|1|||
156546045|NCT01594853|565093285|FG000|Overall Study|noncompliance with exercise|0|||
156546046|NCT01594853|565093286|FG001|Overall Study|noncompliance with exercise|1|||
156546047|NCT00960661|565093287|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
156546048|NCT00960661|565093288|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
156546049|NCT00960661|565093289|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
156546050|NCT00960661|565093287|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
156546051|NCT00960661|565093288|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
156365832|NCT01904604|564440826|FG000|Overall Study|Non-compliance|1|||
156365833|NCT01904604|564440827|FG001|Overall Study|Non-compliance|0|||
156365834|NCT01904604|564440828|FG002|Overall Study|Non-compliance|0|||
156365835|NCT01904604|564440826|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
156365836|NCT01904604|564440827|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
156365837|NCT01904604|564440828|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
156365838|NCT01904604|564440826|FG000|Overall Study|Patch site reactions|1|||
156365839|NCT01904604|564440827|FG001|Overall Study|Patch site reactions|1|||
156365840|NCT01904604|564440828|FG002|Overall Study|Patch site reactions|0|||
156365841|NCT01904604|564440826|FG000|Overall Study|Increased syncope|0|||
156365842|NCT01904604|564440827|FG001|Overall Study|Increased syncope|1|||
156365843|NCT01904604|564440828|FG002|Overall Study|Increased syncope|0|||
156365844|NCT01904604|564440826|FG000|Overall Study|Unrelated illness|0|||
156365845|NCT01904604|564440827|FG001|Overall Study|Unrelated illness|1|||
156365846|NCT01904604|564440828|FG002|Overall Study|Unrelated illness|0|||
156365847|NCT01904604|564440826|FG000|Overall Study|Passed Week 52 OFC|1|||
156365848|NCT01904604|564440827|FG001|Overall Study|Passed Week 52 OFC|0|||
156365849|NCT01904604|564440828|FG002|Overall Study|Passed Week 52 OFC|0|||
156365850|NCT01904604|564440826|FG000|Overall Study|Withdrawal by Subject|1|||
156365851|NCT01904604|564440827|FG001|Overall Study|Withdrawal by Subject|2|||
156365852|NCT01904604|564440828|FG002|Overall Study|Withdrawal by Subject|0|||
156365853|NCT01904604|564440826|FG000|Overall Study|Participant Relocated|1|||
156365854|NCT01904604|564440827|FG001|Overall Study|Participant Relocated|1|||
156365855|NCT01904604|564440828|FG002|Overall Study|Participant Relocated|1|||
156491391|NCT01470599|564894894|FG001|Overall Study|Lost to Follow-up|1|||
156491392|NCT01470599|564894893|FG000|Overall Study|Withdrawal by Subject|3|||
156365856|NCT01904604|564440826|FG000|Overall Study|Lost to Follow-up|0|||
156365857|NCT01904604|564440827|FG001|Overall Study|Lost to Follow-up|0|||
156365858|NCT01904604|564440828|FG002|Overall Study|Lost to Follow-up|1|||
156365859|NCT02433834|564440831|FG000|Overall Study|Protocol-specified criteria|7|||
156365860|NCT02433834|564440831|FG000|Overall Study|Protocol Violation|3|||
156365861|NCT02433834|564440831|FG000|Overall Study|Lost to Follow-up|6|||
156365862|NCT02433834|564440831|FG000|Overall Study|Withdrawal by Subject|14|||
156365863|NCT02433834|564440831|FG000|Overall Study|Adverse Event|6|||
156365864|NCT02433834|564440831|FG000|Overall Study|Physician Decision|1|||
156365865|NCT00934544|564440832|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
156365866|NCT00934544|564440833|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
156365867|NCT00934544|564440834|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
156365868|NCT00934544|564440832|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
156365869|NCT00934544|564440833|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
156365870|NCT00934544|564440834|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
156365871|NCT00934544|564440832|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
156365872|NCT00934544|564440833|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
156365873|NCT00934544|564440834|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
156365874|NCT00934544|564440832|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
156365875|NCT00934544|564440833|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
156365876|NCT00934544|564440834|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
156365877|NCT00934544|564440832|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
156491393|NCT01470599|564894894|FG001|Overall Study|Withdrawal by Subject|4|||
156491394|NCT01470599|564894893|FG000|Overall Study|Other|1|||
156491395|NCT01470599|564894894|FG001|Overall Study|Other|0|||
156491396|NCT01470599|564894893|FG000|Overall Study|Protocol Violation|3|||
156491397|NCT01470599|564894894|FG001|Overall Study|Protocol Violation|1|||
156365878|NCT00934544|564440833|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
156365879|NCT00934544|564440834|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
156491398|NCT01470599|564894893|FG000|Overall Study|Adverse event related to study drug|2|||
156491399|NCT01470599|564894894|FG001|Overall Study|Adverse event related to study drug|5|||
156365880|NCT00934544|564440832|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
156365881|NCT00934544|564440833|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
156365882|NCT00934544|564440834|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
156365883|NCT00934544|564440832|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
156365884|NCT00934544|564440833|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
156365885|NCT00934544|564440834|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
156365886|NCT00934544|564440832|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
156365887|NCT00934544|564440833|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
156365888|NCT00934544|564440834|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
156365889|NCT00934544|564440832|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
156365890|NCT00934544|564440833|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
156365891|NCT00934544|564440834|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
156365892|NCT00934544|564440832|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
156365893|NCT00934544|564440833|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
156365894|NCT00934544|564440834|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
156365895|NCT00934544|564440832|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
156365896|NCT00934544|564440833|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
156365897|NCT00934544|564440834|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
156365898|NCT00934544|564440832|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
156365899|NCT00934544|564440833|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
156365900|NCT00934544|564440834|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
156365901|NCT00934544|564440832|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
156365902|NCT00934544|564440833|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
156365903|NCT00934544|564440834|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
156365904|NCT00934544|564440832|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
156365905|NCT00934544|564440833|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
156365906|NCT00934544|564440834|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
156365907|NCT00934544|564440832|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
156365908|NCT00934544|564440833|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
156365909|NCT00934544|564440834|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
156365910|NCT00934544|564440832|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
156365911|NCT00934544|564440833|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
156491400|NCT01470599|564894893|FG000|Overall Study|Insufficient clinical response|6|||
156491401|NCT01470599|564894894|FG001|Overall Study|Insufficient clinical response|27|||
156491402|NCT01470599|564894893|FG000|Overall Study|Adverse event not related to study drug|1|||
156491403|NCT01470599|564894894|FG001|Overall Study|Adverse event not related to study drug|5|||
156491404|NCT00195442|564894895|FG000|Overall Study|Less than expected therapeutic effect|38|||
156491405|NCT00195442|564894895|FG000|Overall Study|Lost to Follow-up|27|||
156491406|NCT00195442|564894895|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
156491407|NCT00195442|564894895|FG000|Overall Study|Intermittent product shortage|21|||
156491408|NCT00195442|564894895|FG000|Overall Study|Death|7|||
156491409|NCT00195442|564894895|FG000|Overall Study|No reason specified|4|||
156491410|NCT00195442|564894895|FG000|Overall Study|Poor cooperation|2|||
156546052|NCT00960661|565093289|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
156546053|NCT00960661|565093287|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
156546054|NCT00960661|565093288|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
156546055|NCT00960661|565093289|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
156546056|NCT00960661|565093287|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
156546057|NCT00960661|565093288|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
156546058|NCT00960661|565093289|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
156546059|NCT00960661|565093287|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
156365912|NCT00934544|564440834|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
156365913|NCT02643251|564440835|FG000|Overall Study|Adverse Event|3|||
156365914|NCT02643251|564440836|FG001|Overall Study|Adverse Event|1|||
156365915|NCT02643251|564440835|FG000|Overall Study|Withdrawal by Subject|2|||
156365916|NCT02643251|564440836|FG001|Overall Study|Withdrawal by Subject|0|||
156365917|NCT02643251|564440835|FG000|Overall Study|Lost to Follow-up|4|||
156365918|NCT02643251|564440836|FG001|Overall Study|Lost to Follow-up|1|||
156365919|NCT02643251|564440835|FG000|Overall Study|Protocol Violation|1|||
156365920|NCT02643251|564440836|FG001|Overall Study|Protocol Violation|0|||
156365921|NCT02643251|564440835|FG000|Overall Study|PI Decision to terminate patient|1|||
156365922|NCT02643251|564440836|FG001|Overall Study|PI Decision to terminate patient|0|||
156365923|NCT00348556|564440837|FG000|Overall Study|Adverse Event|1|||
156365924|NCT00240071|564440838|FG000|Overall Study|Withdrawal by Subject|3|||
156365925|NCT01466270|564440839|FG000|Overall Study|Withdrawal by Subject|4|||
156365926|NCT01466270|564440840|FG001|Overall Study|Withdrawal by Subject|1|||
156365927|NCT01466270|564440839|FG000|Overall Study|Physician Decision|1|||
156365928|NCT01466270|564440840|FG001|Overall Study|Physician Decision|0|||
156546060|NCT00960661|565093288|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
156365929|NCT01466270|564440839|FG000|Overall Study|Lost to Follow-up|1|||
156365930|NCT01466270|564440840|FG001|Overall Study|Lost to Follow-up|3|||
156365931|NCT01466270|564440839|FG000|Overall Study|Progression|1|||
156546061|NCT00960661|565093289|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
156491411|NCT00195442|564894895|FG000|Overall Study|Other|14|||
156491412|NCT01917006|564894896|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
156491413|NCT01917006|564894897|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
156491414|NCT01917006|564894898|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
156491415|NCT01917006|564894899|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
156365932|NCT01466270|564440840|FG001|Overall Study|Progression|0|||
156365933|NCT01466270|564440839|FG000|Overall Study|Toxicity|4|||
156365934|NCT01466270|564440840|FG001|Overall Study|Toxicity|1|||
156365935|NCT01466270|564440839|FG000|Overall Study|Multiple|1|||
156365936|NCT01466270|564440840|FG001|Overall Study|Multiple|1|||
156365937|NCT02821962|564440841|FG000|Overall Study|Lost to Follow-up|2|||
156365938|NCT02821962|564440842|FG001|Overall Study|Lost to Follow-up|0|||
156365939|NCT04206293|564440854|FG000|Overall Study|Consent withdrawal|1|||
156365940|NCT01956110|564440859|FG000|Overall Study|Protocol Violation|25|||
156365941|NCT01956110|564440860|FG001|Overall Study|Protocol Violation|11|||
156365942|NCT01956110|564440859|FG000|Overall Study|Adverse Event|9|||
156365943|NCT01956110|564440860|FG001|Overall Study|Adverse Event|10|||
156365944|NCT01956110|564440859|FG000|Overall Study|Personal reasons|1|||
156365945|NCT01956110|564440860|FG001|Overall Study|Personal reasons|1|||
156365946|NCT03325166|564440865|FG000|Overall Study|Adverse Event|1|||
156365947|NCT00706966|564440867|FG000|Overall Study|Adverse Event|1|||
156365948|NCT01631474|564440872|FG000|Overall Study|Lost to Follow-up|8|||
156365949|NCT01631474|564440873|FG001|Overall Study|Lost to Follow-up|5|||
156365950|NCT01631474|564440874|FG002|Overall Study|Lost to Follow-up|7|||
156365951|NCT01631474|564440875|FG003|Overall Study|Lost to Follow-up|5|||
156365952|NCT01631474|564440876|FG004|Overall Study|Lost to Follow-up|5|||
156365953|NCT01631474|564440872|FG000|Overall Study|Withdrawal by Subject|4|||
156365954|NCT01631474|564440873|FG001|Overall Study|Withdrawal by Subject|4|||
156365955|NCT01631474|564440874|FG002|Overall Study|Withdrawal by Subject|2|||
156365956|NCT01631474|564440875|FG003|Overall Study|Withdrawal by Subject|6|||
156365957|NCT01631474|564440876|FG004|Overall Study|Withdrawal by Subject|5|||
156365958|NCT01631474|564440872|FG000|Overall Study|Lack of Efficacy|2|||
156365959|NCT01631474|564440873|FG001|Overall Study|Lack of Efficacy|2|||
156365960|NCT01631474|564440874|FG002|Overall Study|Lack of Efficacy|0|||
156365961|NCT01631474|564440875|FG003|Overall Study|Lack of Efficacy|0|||
156365962|NCT01631474|564440876|FG004|Overall Study|Lack of Efficacy|2|||
156365963|NCT01631474|564440872|FG000|Overall Study|Noncompliance with Study Drug|0|||
156365964|NCT01631474|564440873|FG001|Overall Study|Noncompliance with Study Drug|0|||
156365965|NCT01631474|564440874|FG002|Overall Study|Noncompliance with Study Drug|0|||
156365966|NCT01631474|564440875|FG003|Overall Study|Noncompliance with Study Drug|0|||
156365967|NCT01631474|564440876|FG004|Overall Study|Noncompliance with Study Drug|1|||
156365968|NCT01631474|564440872|FG000|Overall Study|Adverse Event|0|||
156365969|NCT01631474|564440873|FG001|Overall Study|Adverse Event|1|||
156365970|NCT01631474|564440874|FG002|Overall Study|Adverse Event|0|||
156365971|NCT01631474|564440875|FG003|Overall Study|Adverse Event|0|||
156365972|NCT01631474|564440876|FG004|Overall Study|Adverse Event|0|||
156365973|NCT01467076|564440877|FG000|Overall Study|Lost to Follow-up|1|||
156365974|NCT01467076|564440878|FG001|Overall Study|Lost to Follow-up|0|||
156365975|NCT01467076|564440879|FG002|Overall Study|Lost to Follow-up|0|||
156365976|NCT03354429|564440880|FG000|Overall Study|Withdrawal by Subject|8|||
156365977|NCT03354429|564440881|FG001|Overall Study|Withdrawal by Subject|7|||
156365978|NCT03354429|564440880|FG000|Overall Study|Lost to Follow-up|1|||
156365979|NCT03354429|564440881|FG001|Overall Study|Lost to Follow-up|0|||
156365980|NCT00654381|564440882|FG000|1st Stage|Adverse Event|3|||
156365981|NCT00654381|564440883|FG001|1st Stage|Adverse Event|3|||
156365982|NCT00654381|564440884|FG002|1st Stage|Adverse Event|3|||
156365983|NCT00654381|564440885|FG003|1st Stage|Adverse Event|3|||
156365984|NCT00654381|564440886|FG004|1st Stage|Adverse Event|2|||
156365985|NCT00654381|564440887|FG005|1st Stage|Adverse Event|1|||
156365986|NCT00654381|564440882|FG000|1st Stage|Withdrawal by Subject|0|||
156365987|NCT00654381|564440883|FG001|1st Stage|Withdrawal by Subject|0|||
156365988|NCT00654381|564440884|FG002|1st Stage|Withdrawal by Subject|0|||
156365989|NCT00654381|564440885|FG003|1st Stage|Withdrawal by Subject|1|||
156365990|NCT00654381|564440886|FG004|1st Stage|Withdrawal by Subject|0|||
156365991|NCT00654381|564440887|FG005|1st Stage|Withdrawal by Subject|1|||
156365992|NCT00654381|564440882|FG000|1st Stage|Investigator's decision|0|||
156365993|NCT00654381|564440883|FG001|1st Stage|Investigator's decision|0|||
156365994|NCT00654381|564440884|FG002|1st Stage|Investigator's decision|0|||
156365995|NCT00654381|564440885|FG003|1st Stage|Investigator's decision|1|||
156365996|NCT00654381|564440886|FG004|1st Stage|Investigator's decision|0|||
156365997|NCT00654381|564440887|FG005|1st Stage|Investigator's decision|0|||
156365998|NCT00654381|564440882|FG000|2nd Stage|Adverse Event|2|||
156365999|NCT00654381|564440883|FG001|2nd Stage|Adverse Event|0|||
156366000|NCT00654381|564440884|FG002|2nd Stage|Adverse Event|2|||
156366001|NCT00654381|564440885|FG003|2nd Stage|Adverse Event|3|||
156366002|NCT00654381|564440886|FG004|2nd Stage|Adverse Event|7|||
156366003|NCT00654381|564440887|FG005|2nd Stage|Adverse Event|2|||
156366004|NCT00654381|564440882|FG000|2nd Stage|Withdrawal by Subject|0|||
156366005|NCT00654381|564440883|FG001|2nd Stage|Withdrawal by Subject|0|||
156366006|NCT00654381|564440884|FG002|2nd Stage|Withdrawal by Subject|0|||
156366007|NCT00654381|564440885|FG003|2nd Stage|Withdrawal by Subject|0|||
156366008|NCT00654381|564440886|FG004|2nd Stage|Withdrawal by Subject|1|||
156366009|NCT00654381|564440887|FG005|2nd Stage|Withdrawal by Subject|1|||
156366010|NCT00654381|564440882|FG000|2nd Stage|Investigator's decision|0|||
156366011|NCT00654381|564440883|FG001|2nd Stage|Investigator's decision|0|||
156366012|NCT00654381|564440884|FG002|2nd Stage|Investigator's decision|1|||
156366013|NCT00654381|564440885|FG003|2nd Stage|Investigator's decision|1|||
156366014|NCT00654381|564440886|FG004|2nd Stage|Investigator's decision|0|||
156366015|NCT00654381|564440887|FG005|2nd Stage|Investigator's decision|0|||
156366016|NCT00654381|564440882|FG000|Extension Stage|Adverse Event|1|||
156366017|NCT00654381|564440883|FG001|Extension Stage|Adverse Event|2|||
156366018|NCT00654381|564440884|FG002|Extension Stage|Adverse Event|9|||
156366019|NCT00654381|564440885|FG003|Extension Stage|Adverse Event|7|||
156366020|NCT00654381|564440886|FG004|Extension Stage|Adverse Event|1|||
156366021|NCT00654381|564440887|FG005|Extension Stage|Adverse Event|1|||
156366022|NCT00654381|564440882|FG000|Extension Stage|Protocol Violation|0|||
156366023|NCT00654381|564440883|FG001|Extension Stage|Protocol Violation|0|||
156366024|NCT00654381|564440884|FG002|Extension Stage|Protocol Violation|0|||
156366025|NCT00654381|564440885|FG003|Extension Stage|Protocol Violation|1|||
156366026|NCT00654381|564440886|FG004|Extension Stage|Protocol Violation|0|||
156366027|NCT00654381|564440887|FG005|Extension Stage|Protocol Violation|0|||
156366028|NCT00654381|564440882|FG000|Extension Stage|Lack of Efficacy|0|||
156366029|NCT00654381|564440883|FG001|Extension Stage|Lack of Efficacy|0|||
156366030|NCT00654381|564440884|FG002|Extension Stage|Lack of Efficacy|1|||
156366031|NCT00654381|564440885|FG003|Extension Stage|Lack of Efficacy|0|||
156366032|NCT00654381|564440886|FG004|Extension Stage|Lack of Efficacy|0|||
156366033|NCT00654381|564440887|FG005|Extension Stage|Lack of Efficacy|0|||
156366034|NCT00654381|564440882|FG000|Extension Stage|Withdrawal by Subject|0|||
156366035|NCT00654381|564440883|FG001|Extension Stage|Withdrawal by Subject|0|||
156366036|NCT00654381|564440884|FG002|Extension Stage|Withdrawal by Subject|1|||
156366037|NCT00654381|564440885|FG003|Extension Stage|Withdrawal by Subject|1|||
156366038|NCT00654381|564440886|FG004|Extension Stage|Withdrawal by Subject|1|||
156366039|NCT00654381|564440887|FG005|Extension Stage|Withdrawal by Subject|1|||
156366040|NCT00654381|564440882|FG000|Extension Stage|Closure of the trial site|0|||
156366041|NCT00654381|564440883|FG001|Extension Stage|Closure of the trial site|0|||
156366042|NCT00654381|564440884|FG002|Extension Stage|Closure of the trial site|0|||
156366043|NCT00654381|564440885|FG003|Extension Stage|Closure of the trial site|0|||
156366044|NCT00654381|564440886|FG004|Extension Stage|Closure of the trial site|1|||
156366045|NCT00654381|564440887|FG005|Extension Stage|Closure of the trial site|1|||
156366046|NCT00048542|564440895|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156366047|NCT00048542|564440896|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
156366048|NCT00048542|564440897|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156366049|NCT00048542|564440898|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156366050|NCT00048542|564440899|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156366051|NCT00048542|564440900|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
156366052|NCT00048542|564440901|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
156366053|NCT00048542|564440902|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
156366054|NCT00048542|564440895|FG000|Double-Blind Phase|Protocol Violation|0|||
156366055|NCT00048542|564440896|FG001|Double-Blind Phase|Protocol Violation|0|||
156366056|NCT00048542|564440897|FG002|Double-Blind Phase|Protocol Violation|1|||
156366057|NCT00048542|564440898|FG003|Double-Blind Phase|Protocol Violation|0|||
156366058|NCT00048542|564440899|FG004|Double-Blind Phase|Protocol Violation|0|||
156366059|NCT00048542|564440900|FG005|Double-Blind Phase|Protocol Violation|0|||
156366060|NCT00048542|564440901|FG006|Double-Blind Phase|Protocol Violation|0|||
156366061|NCT00048542|564440902|FG007|Double-Blind Phase|Protocol Violation|0|||
156366062|NCT00048542|564440895|FG000|Double-Blind Phase|Sponsor request or decision|2|||
156366063|NCT00048542|564440896|FG001|Double-Blind Phase|Sponsor request or decision|0|||
156366064|NCT00048542|564440897|FG002|Double-Blind Phase|Sponsor request or decision|0|||
156366065|NCT00048542|564440898|FG003|Double-Blind Phase|Sponsor request or decision|0|||
156366066|NCT00048542|564440899|FG004|Double-Blind Phase|Sponsor request or decision|0|||
156366067|NCT00048542|564440900|FG005|Double-Blind Phase|Sponsor request or decision|0|||
156366068|NCT00048542|564440901|FG006|Double-Blind Phase|Sponsor request or decision|0|||
156366069|NCT00048542|564440902|FG007|Double-Blind Phase|Sponsor request or decision|0|||
156366070|NCT00048542|564440895|FG000|Double-Blind Phase|Randomized in error|1|||
156366071|NCT00048542|564440896|FG001|Double-Blind Phase|Randomized in error|0|||
156366072|NCT00048542|564440897|FG002|Double-Blind Phase|Randomized in error|0|||
156366073|NCT00048542|564440898|FG003|Double-Blind Phase|Randomized in error|0|||
156366074|NCT00048542|564440899|FG004|Double-Blind Phase|Randomized in error|0|||
156366075|NCT00048542|564440900|FG005|Double-Blind Phase|Randomized in error|0|||
156366076|NCT00048542|564440901|FG006|Double-Blind Phase|Randomized in error|0|||
156491416|NCT01917006|564894900|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
156491417|NCT01917006|564894901|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
156491418|NCT01917006|564894902|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
156491419|NCT01917006|564894903|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
156366077|NCT00048542|564440902|FG007|Double-Blind Phase|Randomized in error|0|||
156366078|NCT00048542|564440895|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156366079|NCT00048542|564440896|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156366080|NCT00048542|564440897|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156366081|NCT00048542|564440898|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156366082|NCT00048542|564440899|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
156366083|NCT00048542|564440900|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
156366084|NCT00048542|564440901|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156366085|NCT00048542|564440902|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156366086|NCT00048542|564440895|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
156366087|NCT00048542|564440896|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
156366088|NCT00048542|564440897|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
156366089|NCT00048542|564440898|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
156366090|NCT00048542|564440899|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
156366091|NCT00048542|564440900|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
156366092|NCT00048542|564440901|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
156366093|NCT00048542|564440902|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
156366094|NCT00048542|564440895|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156366095|NCT00048542|564440896|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156366096|NCT00048542|564440897|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156366097|NCT00048542|564440898|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156366098|NCT00048542|564440899|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
156366099|NCT00048542|564440900|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
156366100|NCT00048542|564440901|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156366101|NCT00048542|564440902|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156366102|NCT00048542|564440895|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
156366103|NCT00048542|564440896|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
156366104|NCT00048542|564440897|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
156366105|NCT00048542|564440898|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
156366106|NCT00048542|564440899|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
156366107|NCT00048542|564440900|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
156366108|NCT00048542|564440901|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
156366109|NCT00048542|564440902|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
156366110|NCT00048542|564440895|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156366111|NCT00048542|564440896|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156366112|NCT00048542|564440897|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156366113|NCT00048542|564440898|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156366114|NCT00048542|564440899|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
156366115|NCT00048542|564440900|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
156366116|NCT00048542|564440901|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156366117|NCT00048542|564440902|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156491420|NCT01917006|564894896|FG000|Randomized-treatment Period|Personal Reasons|0|||
156491421|NCT01917006|564894897|FG001|Randomized-treatment Period|Personal Reasons|0|||
156366118|NCT00048542|564440895|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156366119|NCT00048542|564440896|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156366120|NCT00048542|564440897|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156491422|NCT01917006|564894898|FG002|Randomized-treatment Period|Personal Reasons|0|||
156491423|NCT01917006|564894899|FG003|Randomized-treatment Period|Personal Reasons|0|||
156366121|NCT00048542|564440898|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156366122|NCT00048542|564440899|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156366123|NCT00048542|564440900|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156366124|NCT00048542|564440901|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
156366125|NCT00048542|564440902|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
156366126|NCT00048542|564440895|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156366127|NCT00048542|564440896|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156366128|NCT00048542|564440897|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156491424|NCT01917006|564894900|FG004|Randomized-treatment Period|Personal Reasons|0|||
156491425|NCT01917006|564894901|FG005|Randomized-treatment Period|Personal Reasons|1|||
156491426|NCT01917006|564894902|FG006|Randomized-treatment Period|Personal Reasons|0|||
156491427|NCT01917006|564894903|FG007|Randomized-treatment Period|Personal Reasons|0|||
156491428|NCT01917006|564894896|FG000|Randomized-treatment Period|Protocol Violation|1|||
156491429|NCT01917006|564894897|FG001|Randomized-treatment Period|Protocol Violation|0|||
156491430|NCT01917006|564894898|FG002|Randomized-treatment Period|Protocol Violation|0|||
156491431|NCT01917006|564894899|FG003|Randomized-treatment Period|Protocol Violation|0|||
156491432|NCT01917006|564894900|FG004|Randomized-treatment Period|Protocol Violation|0|||
156491433|NCT01917006|564894901|FG005|Randomized-treatment Period|Protocol Violation|0|||
156546062|NCT00960661|565093287|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
156546063|NCT00960661|565093288|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
156546064|NCT00960661|565093289|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
156546065|NCT00960661|565093287|FG000|Interventional Phase|Adverse Event|0|||
156546066|NCT00960661|565093288|FG001|Interventional Phase|Adverse Event|17|||
156546067|NCT00960661|565093289|FG002|Interventional Phase|Adverse Event|8|||
156546068|NCT00960661|565093287|FG000|Interventional Phase|Death|0|||
156546069|NCT00960661|565093288|FG001|Interventional Phase|Death|1|||
156546070|NCT00960661|565093289|FG002|Interventional Phase|Death|0|||
156546071|NCT00960661|565093287|FG000|Interventional Phase|Lost to Follow-up|0|||
156546072|NCT00960661|565093288|FG001|Interventional Phase|Lost to Follow-up|0|||
156546073|NCT00960661|565093289|FG002|Interventional Phase|Lost to Follow-up|2|||
156546074|NCT00960661|565093287|FG000|Interventional Phase|entry criteria not met|0|||
156546075|NCT00960661|565093288|FG001|Interventional Phase|entry criteria not met|3|||
156546076|NCT00960661|565093289|FG002|Interventional Phase|entry criteria not met|0|||
156546077|NCT00960661|565093287|FG000|Interventional Phase|Protocol Violation|0|||
156546078|NCT00960661|565093288|FG001|Interventional Phase|Protocol Violation|7|||
156366129|NCT00048542|564440898|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156366130|NCT00048542|564440899|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156366131|NCT00048542|564440900|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156366132|NCT00048542|564440901|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
156491434|NCT01917006|564894902|FG006|Randomized-treatment Period|Protocol Violation|0|||
156491435|NCT01917006|564894903|FG007|Randomized-treatment Period|Protocol Violation|0|||
156491436|NCT01917006|564894896|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
156491437|NCT01917006|564894897|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
156366133|NCT00048542|564440902|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
156366134|NCT00048542|564440895|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156366135|NCT00048542|564440896|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156366136|NCT00048542|564440897|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156366137|NCT00048542|564440898|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156491438|NCT01917006|564894898|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
156491439|NCT01917006|564894899|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
156491440|NCT01917006|564894900|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
156491441|NCT01917006|564894901|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
156491442|NCT01917006|564894902|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
156491443|NCT01917006|564894903|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
156491444|NCT01917006|564894896|FG000|Open-label Period|Adverse Event|0|||
156491445|NCT01917006|564894897|FG001|Open-label Period|Adverse Event|0|||
156491446|NCT01917006|564894898|FG002|Open-label Period|Adverse Event|0|||
156491447|NCT01917006|564894899|FG003|Open-label Period|Adverse Event|0|||
156491448|NCT01917006|564894900|FG004|Open-label Period|Adverse Event|0|||
156491449|NCT01917006|564894901|FG005|Open-label Period|Adverse Event|0|||
156491450|NCT01917006|564894902|FG006|Open-label Period|Adverse Event|0|||
156491451|NCT01917006|564894903|FG007|Open-label Period|Adverse Event|1|||
156491452|NCT01917006|564894896|FG000|Open-label Period|Lost to Follow-up|0|||
156491453|NCT01917006|564894897|FG001|Open-label Period|Lost to Follow-up|0|||
156491454|NCT01917006|564894898|FG002|Open-label Period|Lost to Follow-up|0|||
156491455|NCT01917006|564894899|FG003|Open-label Period|Lost to Follow-up|0|||
156491456|NCT01917006|564894900|FG004|Open-label Period|Lost to Follow-up|0|||
156491457|NCT01917006|564894901|FG005|Open-label Period|Lost to Follow-up|0|||
156546079|NCT00960661|565093289|FG002|Interventional Phase|Protocol Violation|2|||
156546080|NCT00960661|565093287|FG000|Interventional Phase|Withdrawal by Subject|0|||
156366138|NCT00048542|564440899|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156366139|NCT00048542|564440900|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156366140|NCT00048542|564440901|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
156366141|NCT00048542|564440902|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
156366142|NCT00048542|564440895|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156366143|NCT00048542|564440896|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156366144|NCT00048542|564440897|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156366145|NCT00048542|564440898|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156366146|NCT00048542|564440899|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156366147|NCT00048542|564440900|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156366148|NCT00048542|564440901|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
156366149|NCT00048542|564440902|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
156366150|NCT00048542|564440895|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156366151|NCT00048542|564440896|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156366152|NCT00048542|564440897|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156366153|NCT00048542|564440898|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156366154|NCT00048542|564440899|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156366155|NCT00048542|564440900|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156366156|NCT00048542|564440901|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
156366157|NCT00048542|564440902|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
156366158|NCT00048542|564440895|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156366159|NCT00048542|564440896|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156366160|NCT00048542|564440897|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156366161|NCT00048542|564440898|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156366162|NCT00048542|564440899|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156366163|NCT00048542|564440900|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156366164|NCT00048542|564440901|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
156366165|NCT00048542|564440902|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
156366166|NCT00578175|564440903|FG000|Overall Study|Adverse Event|0|||
156366167|NCT00578175|564440904|FG001|Overall Study|Adverse Event|1|||
156366168|NCT00578175|564440905|FG002|Overall Study|Adverse Event|1|||
156366169|NCT00578175|564440903|FG000|Overall Study|Other reasons|70|||
156366170|NCT00578175|564440904|FG001|Overall Study|Other reasons|42|||
156366171|NCT00578175|564440905|FG002|Overall Study|Other reasons|23|||
156366172|NCT01232296|564440906|FG000|Overall Study|Adverse Event|24|||
156366173|NCT01232296|564440907|FG001|Overall Study|Adverse Event|12|||
156366174|NCT01232296|564440906|FG000|Overall Study|Physician Decision|1|||
156366175|NCT01232296|564440907|FG001|Overall Study|Physician Decision|1|||
156366176|NCT01232296|564440906|FG000|Overall Study|Progressive disease|43|||
156366177|NCT01232296|564440907|FG001|Overall Study|Progressive disease|61|||
156366178|NCT01232296|564440906|FG000|Overall Study|Study terminated by sponsor|0|||
156366179|NCT01232296|564440907|FG001|Overall Study|Study terminated by sponsor|1|||
156366180|NCT01232296|564440906|FG000|Overall Study|Technical problems|3|||
156366181|NCT01232296|564440907|FG001|Overall Study|Technical problems|0|||
156366182|NCT01232296|564440906|FG000|Overall Study|Subject/guardian decision|10|||
156366183|NCT01232296|564440907|FG001|Overall Study|Subject/guardian decision|2|||
156366184|NCT01232296|564440906|FG000|Overall Study|Death|1|||
156366185|NCT01232296|564440907|FG001|Overall Study|Death|6|||
156366186|NCT00559962|564440908|FG000|Overall Study|Adverse Event|1|||
156366187|NCT00559962|564440909|FG001|Overall Study|Adverse Event|7|||
156366188|NCT00559962|564440910|FG002|Overall Study|Adverse Event|8|||
156366189|NCT00559962|564440911|FG003|Overall Study|Adverse Event|5|||
156366190|NCT00559962|564440912|FG004|Overall Study|Adverse Event|11|||
156366191|NCT00559962|564440913|FG005|Overall Study|Adverse Event|4|||
156366192|NCT00559962|564440914|FG006|Overall Study|Adverse Event|4|||
156366193|NCT00559962|564440915|FG007|Overall Study|Adverse Event|2|||
156366194|NCT00559962|564440908|FG000|Overall Study|Lost to Follow-up|0|||
156491458|NCT01917006|564894902|FG006|Open-label Period|Lost to Follow-up|0|||
156491459|NCT01917006|564894903|FG007|Open-label Period|Lost to Follow-up|1|||
156491460|NCT02158247|564894909|FG000|Overall Study|Invisible vocal cords|5|||
156491461|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
156366195|NCT00559962|564440909|FG001|Overall Study|Lost to Follow-up|1|||
156491462|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
156366196|NCT00559962|564440910|FG002|Overall Study|Lost to Follow-up|0|||
156366197|NCT00559962|564440911|FG003|Overall Study|Lost to Follow-up|0|||
156366198|NCT00559962|564440912|FG004|Overall Study|Lost to Follow-up|0|||
156366199|NCT00559962|564440913|FG005|Overall Study|Lost to Follow-up|0|||
156366200|NCT00559962|564440914|FG006|Overall Study|Lost to Follow-up|0|||
156366201|NCT00559962|564440915|FG007|Overall Study|Lost to Follow-up|0|||
156366202|NCT00559962|564440908|FG000|Overall Study|Withdrawal by Subject|1|||
156491463|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
156491464|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
156491465|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
156491466|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
156491467|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
156491468|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
156491469|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
156491470|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
156491471|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
156491472|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
156491473|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
156491474|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
156491475|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
156491476|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
156491477|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
156491478|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
156491479|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
156491480|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
156491481|NCT02637856|564894916|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
156491482|NCT02637856|564894917|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
156491483|NCT02637856|564894916|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
156491484|NCT02637856|564894917|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
156491485|NCT02637856|564894916|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
156491486|NCT02637856|564894917|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
156491487|NCT02509312|564894918|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
156491488|NCT02509312|564894919|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
156491489|NCT02509312|564894918|FG000|Overall Study|Obstetrician refusal|0|||
156491490|NCT02509312|564894919|FG001|Overall Study|Obstetrician refusal|1|||
156366203|NCT00559962|564440909|FG001|Overall Study|Withdrawal by Subject|1|||
156366204|NCT00559962|564440910|FG002|Overall Study|Withdrawal by Subject|2|||
156366205|NCT00559962|564440911|FG003|Overall Study|Withdrawal by Subject|0|||
156366206|NCT00559962|564440912|FG004|Overall Study|Withdrawal by Subject|3|||
156366207|NCT00559962|564440913|FG005|Overall Study|Withdrawal by Subject|1|||
156366208|NCT00559962|564440914|FG006|Overall Study|Withdrawal by Subject|0|||
156366209|NCT00559962|564440915|FG007|Overall Study|Withdrawal by Subject|2|||
156366210|NCT00559962|564440908|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
156366211|NCT00559962|564440909|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
156366212|NCT00559962|564440910|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
156366213|NCT00559962|564440911|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
156366214|NCT00559962|564440912|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
156366215|NCT00559962|564440913|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
156366216|NCT00559962|564440914|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
156366217|NCT00559962|564440915|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
156366218|NCT04889625|564440916|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
156366219|NCT04889625|564440917|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
156366220|NCT04889625|564440916|FG000|Period 1|Subject out of window|0|||
156366221|NCT04889625|564440917|FG001|Period 1|Subject out of window|1|||
156366222|NCT04889625|564440916|FG000|Period 1|Wrong add power dispensed|0|||
156366223|NCT04889625|564440917|FG001|Period 1|Wrong add power dispensed|1|||
156366224|NCT04889625|564440916|FG000|Period 1|Discontinued due to fitting guide error|1|||
156366225|NCT04889625|564440917|FG001|Period 1|Discontinued due to fitting guide error|1|||
156366226|NCT04889625|564440916|FG000|Period 2|Test article no longer available|1|||
156366227|NCT04889625|564440917|FG001|Period 2|Test article no longer available|0|||
156366228|NCT04889625|564440916|FG000|Period 2|Incorrect lens dispensed|1|||
156366229|NCT04889625|564440917|FG001|Period 2|Incorrect lens dispensed|0|||
156366230|NCT04889625|564440916|FG000|Period 2|Wrong add power dispensed|0|||
156366231|NCT04889625|564440917|FG001|Period 2|Wrong add power dispensed|1|||
156366232|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
156366233|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
156366234|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
156366235|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
156366236|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
156366237|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
156366238|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
156366239|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
156491491|NCT02509312|564894918|FG000|Overall Study|Patient elected for TOLAC|1|||
156366240|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
156366241|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
156366242|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
156491492|NCT02509312|564894919|FG001|Overall Study|Patient elected for TOLAC|0|||
156491493|NCT02509312|564894918|FG000|Overall Study|Cesarean deemed stat|1|||
156491494|NCT02509312|564894919|FG001|Overall Study|Cesarean deemed stat|0|||
156366243|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
156366244|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
156366245|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
156366246|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
156366247|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
156366248|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
156366249|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
156366250|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Death|0|||
156366251|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Death|0|||
156366252|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Death|1|||
156366253|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Death|0|||
156366254|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Death|0|||
156366255|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Death|0|||
156366256|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Death|0|||
156366257|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Death|0|||
156366258|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Death|0|||
156366259|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
156366260|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
156366261|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
156366262|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156366263|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156366264|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156366265|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156366266|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156366267|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156366268|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
156366269|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
156366270|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
156366271|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156366272|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156366273|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156366274|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156366275|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156366276|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156366277|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
156366278|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
156366279|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
156366280|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
156366281|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
156366282|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
156366283|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
156366284|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
156366285|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
156366286|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
156366287|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
156366288|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
156366289|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
156366290|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
156366291|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
156366292|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
156366293|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
156366294|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
156366295|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
156366296|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
156366297|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
156366298|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156366299|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156366300|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156366301|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156366302|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156366303|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156366304|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156366305|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
156366306|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156366307|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156366308|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156366309|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156491495|NCT02509312|564894918|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
156366310|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156366311|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156366312|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156366313|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
156366314|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
156366315|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
156366316|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
156366317|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
156366318|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
156366319|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
156366320|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
156366321|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
156366322|NCT00404352|564440918|FG000|Double Blind (up to 24 Month)|Other|0|||
156366323|NCT00404352|564440919|FG001|Double Blind (up to 24 Month)|Other|1|||
156366324|NCT00404352|564440920|FG002|Double Blind (up to 24 Month)|Other|0|||
156366325|NCT00404352|564440921|FG003|Double Blind (up to 24 Month)|Other|0|||
156366326|NCT00404352|564440922|FG004|Double Blind (up to 24 Month)|Other|0|||
156366327|NCT00404352|564440923|FG005|Double Blind (up to 24 Month)|Other|0|||
156366328|NCT00404352|564440924|FG006|Double Blind (up to 24 Month)|Other|0|||
156366329|NCT00404352|564440925|FG007|Double Blind (up to 24 Month)|Other|0|||
156366330|NCT00404352|564440926|FG008|Double Blind (up to 24 Month)|Other|0|||
156366331|NCT00404352|564440918|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
156366332|NCT00404352|564440919|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
156366333|NCT00404352|564440920|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
156491496|NCT02509312|564894919|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
156491497|NCT02815735|564894920|FG000|First Intervention (4 Weeks)|Discomfort|1|||
156366334|NCT00404352|564440921|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
156366335|NCT00404352|564440922|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
156366336|NCT00404352|564440923|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
156366337|NCT00404352|564440924|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
156366338|NCT00404352|564440925|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
156366339|NCT00404352|564440926|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
156366340|NCT00404352|564440918|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
156366341|NCT00404352|564440919|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
156366342|NCT00404352|564440920|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
156366343|NCT00404352|564440921|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
156366344|NCT00404352|564440922|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
156366345|NCT00404352|564440923|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
156366346|NCT00404352|564440924|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
156366347|NCT00404352|564440925|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
156366348|NCT00404352|564440926|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
156366349|NCT00404352|564440918|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156366350|NCT00404352|564440919|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156366351|NCT00404352|564440920|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156366352|NCT00404352|564440921|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156366353|NCT00404352|564440922|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
156366354|NCT00404352|564440923|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156366355|NCT00404352|564440924|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156491498|NCT02815735|564894921|FG001|First Intervention (4 Weeks)|Discomfort|0|||
156491499|NCT02815735|564894920|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
156491500|NCT02815735|564894921|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
156491501|NCT02815735|564894920|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
156491502|NCT02815735|564894921|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
156491503|NCT02815735|564894920|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
156491504|NCT02815735|564894921|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
156491505|NCT00702650|564894922|FG000|Overall Study|Withdrawal by Subject|9|||
156491506|NCT00702650|564894922|FG000|Overall Study|Non-Compliance of Study Drug|3|||
156491507|NCT00702650|564894922|FG000|Overall Study|Lost to Follow-up|2|||
156491508|NCT00702650|564894922|FG000|Overall Study|Non-Compliance with Site Directives|1|||
156491509|NCT00702650|564894922|FG000|Overall Study|Sponsor Request|1|||
156491510|NCT00702650|564894922|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
156491511|NCT00702650|564894922|FG000|Overall Study|Adverse Event|3|||
156546081|NCT00960661|565093288|FG001|Interventional Phase|Withdrawal by Subject|18|||
156366356|NCT00404352|564440925|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156366357|NCT00404352|564440926|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156366358|NCT00404352|564440918|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156366359|NCT00404352|564440919|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156366360|NCT00404352|564440920|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156491512|NCT00943722|564894924|FG000|Base Study|Adverse Event|0|||
156366361|NCT00404352|564440921|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156366362|NCT00404352|564440922|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156491513|NCT00943722|564894925|FG001|Base Study|Adverse Event|0|||
156366363|NCT00404352|564440923|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
156366364|NCT00404352|564440924|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156366365|NCT00404352|564440925|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156366366|NCT00404352|564440926|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156366367|NCT00404352|564440918|FG000|Open Label (up to 24 Month)|Disease progression|0|||
156366368|NCT00404352|564440919|FG001|Open Label (up to 24 Month)|Disease progression|0|||
156366369|NCT00404352|564440920|FG002|Open Label (up to 24 Month)|Disease progression|0|||
156366370|NCT00404352|564440921|FG003|Open Label (up to 24 Month)|Disease progression|1|||
156366371|NCT00404352|564440922|FG004|Open Label (up to 24 Month)|Disease progression|0|||
156366372|NCT00404352|564440923|FG005|Open Label (up to 24 Month)|Disease progression|0|||
156366373|NCT00404352|564440924|FG006|Open Label (up to 24 Month)|Disease progression|0|||
156366374|NCT00404352|564440925|FG007|Open Label (up to 24 Month)|Disease progression|0|||
156366375|NCT00404352|564440926|FG008|Open Label (up to 24 Month)|Disease progression|0|||
156366376|NCT00404352|564440918|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156366377|NCT00404352|564440919|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156366378|NCT00404352|564440920|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156366379|NCT00404352|564440921|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156366380|NCT00404352|564440922|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156366381|NCT00404352|564440923|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156366382|NCT00404352|564440924|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
156366383|NCT00404352|564440925|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
156366384|NCT00404352|564440926|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156366385|NCT00404352|564440918|FG000|Open Label Extension (up to 36 Months)|Other|0|||
156366386|NCT00404352|564440919|FG001|Open Label Extension (up to 36 Months)|Other|0|||
156366387|NCT00404352|564440920|FG002|Open Label Extension (up to 36 Months)|Other|0|||
156366388|NCT00404352|564440921|FG003|Open Label Extension (up to 36 Months)|Other|0|||
156366389|NCT00404352|564440922|FG004|Open Label Extension (up to 36 Months)|Other|0|||
156366390|NCT00404352|564440923|FG005|Open Label Extension (up to 36 Months)|Other|0|||
156366391|NCT00404352|564440924|FG006|Open Label Extension (up to 36 Months)|Other|0|||
156366392|NCT00404352|564440925|FG007|Open Label Extension (up to 36 Months)|Other|0|||
156366393|NCT00404352|564440926|FG008|Open Label Extension (up to 36 Months)|Other|2|||
156491514|NCT00943722|564894926|FG002|Base Study|Adverse Event|0|||
156366394|NCT01479621|564440929|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
156366395|NCT01479621|564440930|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156366396|NCT01479621|564440931|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156366397|NCT01479621|564440932|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156366398|NCT01479621|564440933|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156366399|NCT01479621|564440934|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156366400|NCT01479621|564440935|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156366401|NCT01479621|564440929|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
156366402|NCT01479621|564440930|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156366403|NCT01479621|564440931|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156366404|NCT01479621|564440932|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156366405|NCT01479621|564440933|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156366406|NCT01479621|564440934|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156366407|NCT01479621|564440935|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156366408|NCT01479621|564440929|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
156366409|NCT01479621|564440930|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156366410|NCT01479621|564440931|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156366411|NCT01479621|564440932|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156366412|NCT01479621|564440933|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156366413|NCT01479621|564440934|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156366414|NCT01479621|564440935|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156366415|NCT01479621|564440929|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
156366416|NCT01479621|564440930|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156366417|NCT01479621|564440931|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156366418|NCT01479621|564440932|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156366419|NCT01479621|564440933|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156366420|NCT01479621|564440934|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156366421|NCT01479621|564440935|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156366422|NCT01479621|564440929|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
156366423|NCT01479621|564440930|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156366424|NCT01479621|564440931|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156366425|NCT01479621|564440932|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156366426|NCT01479621|564440933|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156366427|NCT01479621|564440934|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156366428|NCT01479621|564440935|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156366429|NCT01479621|564440929|FG000|Treatment Period|Adverse Event|0|||
156366430|NCT01479621|564440930|FG001|Treatment Period|Adverse Event|0|||
156366431|NCT01479621|564440931|FG002|Treatment Period|Adverse Event|0|||
156366432|NCT01479621|564440932|FG003|Treatment Period|Adverse Event|0|||
156366433|NCT01479621|564440933|FG004|Treatment Period|Adverse Event|1|||
156366434|NCT01479621|564440934|FG005|Treatment Period|Adverse Event|2|||
156366435|NCT01479621|564440935|FG006|Treatment Period|Adverse Event|2|||
156366436|NCT01479621|564440929|FG000|Treatment Period|Withdrawal by Subject|0|||
156366437|NCT01479621|564440930|FG001|Treatment Period|Withdrawal by Subject|4|||
156366438|NCT01479621|564440931|FG002|Treatment Period|Withdrawal by Subject|2|||
156366439|NCT01479621|564440932|FG003|Treatment Period|Withdrawal by Subject|2|||
156366440|NCT01479621|564440933|FG004|Treatment Period|Withdrawal by Subject|5|||
156366441|NCT01479621|564440934|FG005|Treatment Period|Withdrawal by Subject|5|||
156366442|NCT01479621|564440935|FG006|Treatment Period|Withdrawal by Subject|1|||
156366443|NCT01479621|564440929|FG000|Treatment Period|Physician Decision|0|||
156366444|NCT01479621|564440930|FG001|Treatment Period|Physician Decision|0|||
156366445|NCT01479621|564440931|FG002|Treatment Period|Physician Decision|0|||
156366446|NCT01479621|564440932|FG003|Treatment Period|Physician Decision|0|||
156366447|NCT01479621|564440933|FG004|Treatment Period|Physician Decision|1|||
156366448|NCT01479621|564440934|FG005|Treatment Period|Physician Decision|1|||
156366449|NCT01479621|564440935|FG006|Treatment Period|Physician Decision|0|||
156366450|NCT01479621|564440929|FG000|Treatment Period|Non-compliance to study drug|0|||
156366451|NCT01479621|564440930|FG001|Treatment Period|Non-compliance to study drug|1|||
156546082|NCT00960661|565093289|FG002|Interventional Phase|Withdrawal by Subject|29|||
156546083|NCT00960661|565093287|FG000|Interventional Phase|Physician Decision|0|||
156366452|NCT01479621|564440931|FG002|Treatment Period|Non-compliance to study drug|0|||
156366453|NCT01479621|564440932|FG003|Treatment Period|Non-compliance to study drug|0|||
156366454|NCT01479621|564440933|FG004|Treatment Period|Non-compliance to study drug|0|||
156366455|NCT01479621|564440934|FG005|Treatment Period|Non-compliance to study drug|0|||
156366456|NCT01479621|564440935|FG006|Treatment Period|Non-compliance to study drug|1|||
156366457|NCT01479621|564440929|FG000|Treatment Period|Protocol Violation|0|||
156366458|NCT01479621|564440930|FG001|Treatment Period|Protocol Violation|9|||
156366459|NCT01479621|564440931|FG002|Treatment Period|Protocol Violation|6|||
156366460|NCT01479621|564440932|FG003|Treatment Period|Protocol Violation|5|||
156366461|NCT01479621|564440933|FG004|Treatment Period|Protocol Violation|2|||
156366462|NCT01479621|564440934|FG005|Treatment Period|Protocol Violation|10|||
156366463|NCT01479621|564440935|FG006|Treatment Period|Protocol Violation|6|||
156366464|NCT01479621|564440929|FG000|Treatment Period|Pregnancy|0|||
156366465|NCT01479621|564440930|FG001|Treatment Period|Pregnancy|0|||
156366466|NCT01479621|564440931|FG002|Treatment Period|Pregnancy|2|||
156366467|NCT01479621|564440932|FG003|Treatment Period|Pregnancy|0|||
156366468|NCT01479621|564440933|FG004|Treatment Period|Pregnancy|0|||
156366469|NCT01479621|564440934|FG005|Treatment Period|Pregnancy|0|||
156366470|NCT01479621|564440935|FG006|Treatment Period|Pregnancy|0|||
156366471|NCT01479621|564440929|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
156366472|NCT01479621|564440930|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
156366473|NCT01479621|564440931|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
156366474|NCT01479621|564440932|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
156366475|NCT01479621|564440933|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
156366476|NCT01479621|564440934|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
156366477|NCT01479621|564440935|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
156366478|NCT01479621|564440929|FG000|Treatment Period|Lost to Follow-up|0|||
156366479|NCT01479621|564440930|FG001|Treatment Period|Lost to Follow-up|0|||
156366480|NCT01479621|564440931|FG002|Treatment Period|Lost to Follow-up|1|||
156366481|NCT01479621|564440932|FG003|Treatment Period|Lost to Follow-up|0|||
156366482|NCT01479621|564440933|FG004|Treatment Period|Lost to Follow-up|2|||
156366483|NCT01479621|564440934|FG005|Treatment Period|Lost to Follow-up|2|||
156366484|NCT01479621|564440935|FG006|Treatment Period|Lost to Follow-up|1|||
156366485|NCT01479621|564440929|FG000|Treatment Period|Met stopping criteria|0|||
156366486|NCT01479621|564440930|FG001|Treatment Period|Met stopping criteria|8|||
156366487|NCT01479621|564440931|FG002|Treatment Period|Met stopping criteria|7|||
156366488|NCT01479621|564440932|FG003|Treatment Period|Met stopping criteria|4|||
156366489|NCT01479621|564440933|FG004|Treatment Period|Met stopping criteria|9|||
156366490|NCT01479621|564440934|FG005|Treatment Period|Met stopping criteria|20|||
156366491|NCT01479621|564440935|FG006|Treatment Period|Met stopping criteria|6|||
156366492|NCT02308735|564440936|FG000|Overall Study|Physician Decision|2|||
156366493|NCT02308735|564440937|FG001|Overall Study|Physician Decision|0|||
156366494|NCT02308735|564440938|FG002|Overall Study|Physician Decision|0|||
156366495|NCT02308735|564440939|FG003|Overall Study|Physician Decision|2|||
156366496|NCT01417481|564440943|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
156366497|NCT01417481|564440944|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156366498|NCT03216850|564440955|FG000|Overall Study|Pre-analytical error|6|||
156366499|NCT00405548|564440956|FG000|Overall Study|Cognitive Memory problems on study day|1|||
156366500|NCT00405548|564440957|FG001|Overall Study|Cognitive Memory problems on study day|0|||
156366501|NCT00405548|564440956|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
156366502|NCT00405548|564440957|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
156366503|NCT00405548|564440956|FG000|Overall Study|Unable to self-administer shots|1|||
156366504|NCT00405548|564440957|FG001|Overall Study|Unable to self-administer shots|0|||
156366505|NCT00405548|564440956|FG000|Overall Study|Venous access failed during study day|1|||
156366506|NCT00405548|564440957|FG001|Overall Study|Venous access failed during study day|0|||
156366507|NCT00405548|564440956|FG000|Overall Study|Withdrawal by Subject|1|||
156366508|NCT00405548|564440957|FG001|Overall Study|Withdrawal by Subject|0|||
156366509|NCT01116232|564440958|FG000|Overall Study|Progressive diease|4|||
156366510|NCT02036502|564440959|FG000|Part 1:Dose Determination/Escalation|Death|3|||
156366511|NCT02036502|564440960|FG001|Part 1:Dose Determination/Escalation|Death|2|||
156366512|NCT02036502|564440961|FG002|Part 1:Dose Determination/Escalation|Death|0|||
156366513|NCT02036502|564440962|FG003|Part 1:Dose Determination/Escalation|Death|0|||
156366514|NCT02036502|564440963|FG004|Part 1:Dose Determination/Escalation|Death|0|||
156366515|NCT02036502|564440964|FG005|Part 1:Dose Determination/Escalation|Death|0|||
156366516|NCT02036502|564440965|FG006|Part 1:Dose Determination/Escalation|Death|0|||
156366517|NCT02036502|564440966|FG007|Part 1:Dose Determination/Escalation|Death|0|||
156366518|NCT02036502|564440959|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
156366519|NCT02036502|564440960|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156366520|NCT02036502|564440961|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156366521|NCT02036502|564440962|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156366522|NCT02036502|564440963|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156366523|NCT02036502|564440964|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156366524|NCT02036502|564440965|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156366525|NCT02036502|564440966|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156366526|NCT02036502|564440959|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156366527|NCT02036502|564440960|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
156366528|NCT02036502|564440961|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156366529|NCT02036502|564440962|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156366530|NCT02036502|564440963|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156366531|NCT02036502|564440964|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156366532|NCT02036502|564440965|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156366533|NCT02036502|564440966|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156366534|NCT02036502|564440959|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
156366535|NCT02036502|564440960|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
156366536|NCT02036502|564440961|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
156366537|NCT02036502|564440962|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
156366538|NCT02036502|564440963|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
156366539|NCT02036502|564440964|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
156366540|NCT02036502|564440965|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
156366541|NCT02036502|564440966|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
156366542|NCT02036502|564440959|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156366543|NCT02036502|564440960|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156366544|NCT02036502|564440961|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
156366545|NCT02036502|564440962|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
156366546|NCT02036502|564440963|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
156366547|NCT02036502|564440964|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156366548|NCT02036502|564440965|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156366549|NCT02036502|564440966|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156366550|NCT02036502|564440959|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156366551|NCT02036502|564440960|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156366552|NCT02036502|564440961|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
156366553|NCT02036502|564440962|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156366554|NCT02036502|564440963|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156366555|NCT02036502|564440964|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156366556|NCT02036502|564440965|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156366557|NCT02036502|564440966|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156366558|NCT02036502|564440959|FG000|Part 2:Dose Confirmation|Death|0|||
156366559|NCT02036502|564440960|FG001|Part 2:Dose Confirmation|Death|0|||
156366560|NCT02036502|564440961|FG002|Part 2:Dose Confirmation|Death|1|||
156366561|NCT02036502|564440962|FG003|Part 2:Dose Confirmation|Death|0|||
156366562|NCT02036502|564440963|FG004|Part 2:Dose Confirmation|Death|0|||
156366563|NCT02036502|564440964|FG005|Part 2:Dose Confirmation|Death|0|||
156366564|NCT02036502|564440965|FG006|Part 2:Dose Confirmation|Death|0|||
156366565|NCT02036502|564440966|FG007|Part 2:Dose Confirmation|Death|0|||
156366566|NCT02036502|564440959|FG000|Part 2:Dose Confirmation|Not treated|0|||
156366567|NCT02036502|564440960|FG001|Part 2:Dose Confirmation|Not treated|0|||
156366568|NCT02036502|564440961|FG002|Part 2:Dose Confirmation|Not treated|0|||
156366569|NCT02036502|564440962|FG003|Part 2:Dose Confirmation|Not treated|1|||
156366570|NCT02036502|564440963|FG004|Part 2:Dose Confirmation|Not treated|0|||
156366571|NCT02036502|564440964|FG005|Part 2:Dose Confirmation|Not treated|0|||
156366572|NCT02036502|564440965|FG006|Part 2:Dose Confirmation|Not treated|0|||
156366573|NCT02036502|564440966|FG007|Part 2:Dose Confirmation|Not treated|0|||
156366574|NCT02036502|564440959|FG000|Part 3:Dose Expansion|Adverse Event|0|||
156366575|NCT02036502|564440960|FG001|Part 3:Dose Expansion|Adverse Event|0|||
156366576|NCT02036502|564440961|FG002|Part 3:Dose Expansion|Adverse Event|0|||
156366577|NCT02036502|564440962|FG003|Part 3:Dose Expansion|Adverse Event|0|||
156366578|NCT02036502|564440963|FG004|Part 3:Dose Expansion|Adverse Event|0|||
156366579|NCT02036502|564440964|FG005|Part 3:Dose Expansion|Adverse Event|4|||
156366580|NCT02036502|564440965|FG006|Part 3:Dose Expansion|Adverse Event|0|||
156366581|NCT02036502|564440966|FG007|Part 3:Dose Expansion|Adverse Event|2|||
156366582|NCT02036502|564440959|FG000|Part 3:Dose Expansion|Death|0|||
156366583|NCT02036502|564440960|FG001|Part 3:Dose Expansion|Death|0|||
156366584|NCT02036502|564440961|FG002|Part 3:Dose Expansion|Death|0|||
156366585|NCT02036502|564440962|FG003|Part 3:Dose Expansion|Death|0|||
156366586|NCT02036502|564440963|FG004|Part 3:Dose Expansion|Death|0|||
156366587|NCT02036502|564440964|FG005|Part 3:Dose Expansion|Death|24|||
156366588|NCT02036502|564440965|FG006|Part 3:Dose Expansion|Death|0|||
156366589|NCT02036502|564440966|FG007|Part 3:Dose Expansion|Death|3|||
156366590|NCT02036502|564440959|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
156366591|NCT02036502|564440960|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
156366592|NCT02036502|564440961|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
156366593|NCT02036502|564440962|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
156366594|NCT02036502|564440963|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
156366595|NCT02036502|564440964|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
156366596|NCT02036502|564440965|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
156366597|NCT02036502|564440966|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
156366598|NCT02036502|564440959|FG000|Part 3:Dose Expansion|Physician Decision|0|||
156366599|NCT02036502|564440960|FG001|Part 3:Dose Expansion|Physician Decision|0|||
156366600|NCT02036502|564440961|FG002|Part 3:Dose Expansion|Physician Decision|0|||
156366601|NCT02036502|564440962|FG003|Part 3:Dose Expansion|Physician Decision|0|||
156366602|NCT02036502|564440963|FG004|Part 3:Dose Expansion|Physician Decision|0|||
156366603|NCT02036502|564440964|FG005|Part 3:Dose Expansion|Physician Decision|1|||
156366604|NCT02036502|564440965|FG006|Part 3:Dose Expansion|Physician Decision|0|||
156366605|NCT02036502|564440966|FG007|Part 3:Dose Expansion|Physician Decision|0|||
156366606|NCT02036502|564440959|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
156366607|NCT02036502|564440960|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
156366608|NCT02036502|564440961|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
156366609|NCT02036502|564440962|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
156366610|NCT02036502|564440963|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
156366611|NCT02036502|564440964|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
156366612|NCT02036502|564440965|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
156366613|NCT02036502|564440966|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
156366614|NCT02036502|564440959|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156366615|NCT02036502|564440960|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156366616|NCT02036502|564440961|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156366617|NCT02036502|564440962|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156366618|NCT02036502|564440963|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156366619|NCT02036502|564440964|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
156366620|NCT02036502|564440965|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156366621|NCT02036502|564440966|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
156366622|NCT02036502|564440959|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156366623|NCT02036502|564440960|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156366624|NCT02036502|564440961|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156366625|NCT02036502|564440962|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156366626|NCT02036502|564440963|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156366627|NCT02036502|564440964|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
156366628|NCT02036502|564440965|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
156366629|NCT02036502|564440966|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
156366630|NCT02036502|564440959|FG000|Part 3:Dose Expansion|Not Treated|0|||
156366631|NCT02036502|564440960|FG001|Part 3:Dose Expansion|Not Treated|0|||
156366632|NCT02036502|564440961|FG002|Part 3:Dose Expansion|Not Treated|0|||
156366633|NCT02036502|564440962|FG003|Part 3:Dose Expansion|Not Treated|0|||
156366634|NCT02036502|564440963|FG004|Part 3:Dose Expansion|Not Treated|0|||
156366635|NCT02036502|564440964|FG005|Part 3:Dose Expansion|Not Treated|2|||
156366636|NCT02036502|564440965|FG006|Part 3:Dose Expansion|Not Treated|0|||
156366637|NCT02036502|564440966|FG007|Part 3:Dose Expansion|Not Treated|0|||
156366638|NCT00811577|564440972|FG000|Overall Study|Lost to Follow-up|7|||
156366639|NCT00811577|564440973|FG001|Overall Study|Lost to Follow-up|1|||
156366640|NCT00811577|564440972|FG000|Overall Study|Withdrawal by Subject|3|||
156366641|NCT00811577|564440973|FG001|Overall Study|Withdrawal by Subject|0|||
156366642|NCT01068509|564440974|FG000|Overall Study|Death|0|||
156366643|NCT01068509|564440975|FG001|Overall Study|Death|0|||
156366644|NCT01068509|564440976|FG002|Overall Study|Death|1|||
156366645|NCT01068509|564440974|FG000|Overall Study|Disease Progression|5|||
156366646|NCT01068509|564440975|FG001|Overall Study|Disease Progression|20|||
156366647|NCT01068509|564440976|FG002|Overall Study|Disease Progression|18|||
156366648|NCT01068509|564440974|FG000|Overall Study|Lost to Follow-up|1|||
156366649|NCT01068509|564440975|FG001|Overall Study|Lost to Follow-up|0|||
156366650|NCT01068509|564440976|FG002|Overall Study|Lost to Follow-up|0|||
156366651|NCT01068509|564440974|FG000|Overall Study|Withdrew Consent|0|||
156366652|NCT01068509|564440975|FG001|Overall Study|Withdrew Consent|1|||
156366653|NCT01068509|564440976|FG002|Overall Study|Withdrew Consent|2|||
156366654|NCT01068509|564440974|FG000|Overall Study|Reason Not Specified|0|||
156366655|NCT01068509|564440975|FG001|Overall Study|Reason Not Specified|1|||
156366656|NCT01068509|564440976|FG002|Overall Study|Reason Not Specified|0|||
156366657|NCT00329407|564440981|FG000|Overall Study|Withdrawal by Subject|1|||
156366658|NCT02357940|564440982|FG000|Overall Study|Adverse Event|0|||
156366659|NCT02357940|564440983|FG001|Overall Study|Adverse Event|1|||
156366660|NCT02357940|564440982|FG000|Overall Study|Investigator's judgement|0|||
156366661|NCT02357940|564440983|FG001|Overall Study|Investigator's judgement|1|||
156366662|NCT00978068|564440984|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
156366663|NCT00978068|564440985|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
156366664|NCT00978068|564440984|FG000|Overall Study|Death|1|||
156366665|NCT00978068|564440985|FG001|Overall Study|Death|2|||
156366666|NCT00978068|564440984|FG000|Overall Study|Lost to Follow-up|1|||
156366667|NCT00978068|564440985|FG001|Overall Study|Lost to Follow-up|2|||
156491515|NCT00943722|564894927|FG003|Base Study|Adverse Event|1|||
156491516|NCT00943722|564894928|FG004|Base Study|Adverse Event|0|||
156491517|NCT00943722|564894929|FG005|Base Study|Adverse Event|0|||
156491518|NCT00943722|564894930|FG006|Base Study|Adverse Event|0|||
156366668|NCT00978068|564440984|FG000|Overall Study|Physician Decision|0|||
156366669|NCT00978068|564440985|FG001|Overall Study|Physician Decision|1|||
156366670|NCT00978068|564440984|FG000|Overall Study|Unable to Comply with Study|0|||
156366671|NCT00978068|564440985|FG001|Overall Study|Unable to Comply with Study|2|||
156366672|NCT02442778|564440986|FG000|Overall Study|Adverse Event|2|||
156366673|NCT02442778|564440987|FG001|Overall Study|Adverse Event|6|||
156366674|NCT02442778|564440988|FG002|Overall Study|Adverse Event|6|||
156366675|NCT02442778|564440986|FG000|Overall Study|Death|0|||
156366676|NCT02442778|564440987|FG001|Overall Study|Death|2|||
156366677|NCT02442778|564440988|FG002|Overall Study|Death|0|||
156491519|NCT00943722|564894924|FG000|Base Study|Lost to Follow-up|12|||
156366678|NCT02442778|564440986|FG000|Overall Study|Lack of Efficacy|1|||
156366679|NCT02442778|564440987|FG001|Overall Study|Lack of Efficacy|0|||
156366680|NCT02442778|564440988|FG002|Overall Study|Lack of Efficacy|0|||
156366681|NCT02442778|564440986|FG000|Overall Study|Lost to Follow-up|1|||
156366682|NCT02442778|564440987|FG001|Overall Study|Lost to Follow-up|1|||
156366683|NCT02442778|564440988|FG002|Overall Study|Lost to Follow-up|1|||
156366684|NCT02442778|564440986|FG000|Overall Study|Non-compliance with study drug|2|||
156366685|NCT02442778|564440987|FG001|Overall Study|Non-compliance with study drug|0|||
156366686|NCT02442778|564440988|FG002|Overall Study|Non-compliance with study drug|1|||
156366687|NCT02442778|564440986|FG000|Overall Study|Physician Decision|1|||
156366688|NCT02442778|564440987|FG001|Overall Study|Physician Decision|1|||
156366689|NCT02442778|564440988|FG002|Overall Study|Physician Decision|1|||
156366690|NCT02442778|564440986|FG000|Overall Study|Protocol Deviation|3|||
156366691|NCT02442778|564440987|FG001|Overall Study|Protocol Deviation|0|||
156366692|NCT02442778|564440988|FG002|Overall Study|Protocol Deviation|1|||
156366693|NCT02442778|564440986|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
156366694|NCT02442778|564440987|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
156366695|NCT02442778|564440988|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
156366696|NCT02442778|564440986|FG000|Overall Study|Withdrawal by Subject|4|||
156366697|NCT02442778|564440987|FG001|Overall Study|Withdrawal by Subject|4|||
156366698|NCT02442778|564440988|FG002|Overall Study|Withdrawal by Subject|3|||
156366699|NCT02442778|564440986|FG000|Overall Study|Reason not specified|1|||
156366700|NCT02442778|564440987|FG001|Overall Study|Reason not specified|4|||
156366701|NCT02442778|564440988|FG002|Overall Study|Reason not specified|0|||
156366702|NCT01644175|564440993|FG000|Overall Study|Randomized But Not Treated|0|||
156366703|NCT01644175|564440994|FG001|Overall Study|Randomized But Not Treated|2|||
156366704|NCT01644175|564440993|FG000|Overall Study|Adverse Event|8|||
156366705|NCT01644175|564440994|FG001|Overall Study|Adverse Event|13|||
156366706|NCT01644175|564440993|FG000|Overall Study|Death|1|||
156366707|NCT01644175|564440994|FG001|Overall Study|Death|2|||
156366708|NCT01644175|564440993|FG000|Overall Study|Poor compliance to protocol|9|||
156366709|NCT01644175|564440994|FG001|Overall Study|Poor compliance to protocol|10|||
156366710|NCT01644175|564440993|FG000|Overall Study|Physician Decision|1|||
156366711|NCT01644175|564440994|FG001|Overall Study|Physician Decision|2|||
156366712|NCT01644175|564440993|FG000|Overall Study|Participant Moved|1|||
156366713|NCT01644175|564440994|FG001|Overall Study|Participant Moved|2|||
156366714|NCT01644175|564440993|FG000|Overall Study|Consent withdrawn by participant|3|||
156366715|NCT01644175|564440994|FG001|Overall Study|Consent withdrawn by participant|4|||
156366716|NCT01644175|564440993|FG000|Overall Study|Related to Autoinjector Administration|2|||
156366717|NCT01644175|564440994|FG001|Overall Study|Related to Autoinjector Administration|1|||
156366718|NCT01644175|564440993|FG000|Overall Study|Last visit outside protocol visit window|4|||
156366719|NCT01644175|564440994|FG001|Overall Study|Last visit outside protocol visit window|11|||
156366720|NCT01644175|564440993|FG000|Overall Study|Selection criteria finally not met|0|||
156366721|NCT01644175|564440994|FG001|Overall Study|Selection criteria finally not met|1|||
156366722|NCT01644175|564440993|FG000|Overall Study|Site closure|2|||
156366723|NCT01644175|564440994|FG001|Overall Study|Site closure|2|||
156366724|NCT01644175|564440993|FG000|Overall Study|Lost to Follow-up|1|||
156366725|NCT01644175|564440994|FG001|Overall Study|Lost to Follow-up|0|||
156366726|NCT01644175|564440993|FG000|Overall Study|Other than specified above|0|||
156366727|NCT01644175|564440994|FG001|Overall Study|Other than specified above|3|||
156366728|NCT00451035|564441001|FG000|Overall Study|Disease progression|11|||
156366729|NCT00451035|564441001|FG000|Overall Study|Death|3|||
156366730|NCT00451035|564441001|FG000|Overall Study|New anti-neoplastic therapy|3|||
156366731|NCT01712256|564441007|FG000|Overall Study|Lost to Follow-up|1|||
156366732|NCT01399593|564441016|FG000|Overall Study|Physician Decision|1|||
156366733|NCT01399593|564441017|FG001|Overall Study|Physician Decision|0|||
156366734|NCT01399593|564441016|FG000|Overall Study|Adverse Event|1|||
156366735|NCT01399593|564441017|FG001|Overall Study|Adverse Event|0|||
156366736|NCT01399593|564441016|FG000|Overall Study|Death|1|||
156366737|NCT01399593|564441017|FG001|Overall Study|Death|1|||
156366738|NCT01399593|564441016|FG000|Overall Study|Transplantectomy|0|||
156366739|NCT01399593|564441017|FG001|Overall Study|Transplantectomy|1|||
156366740|NCT00653224|564442536|FG000|Overall Study|Adverse Event|2|||
156366741|NCT00653224|564442537|FG001|Overall Study|Adverse Event|1|||
156366742|NCT00653224|564442536|FG000|Overall Study|Lack of Efficacy|1|||
156366743|NCT00653224|564442537|FG001|Overall Study|Lack of Efficacy|2|||
156366744|NCT00653224|564442536|FG000|Overall Study|Loss of efficacy|1|||
156366745|NCT00653224|564442537|FG001|Overall Study|Loss of efficacy|0|||
156366746|NCT00653224|564442536|FG000|Overall Study|Lost to Follow-up|1|||
156366747|NCT00653224|564442537|FG001|Overall Study|Lost to Follow-up|0|||
156366748|NCT00653224|564442536|FG000|Overall Study|Other|2|||
156366749|NCT00653224|564442537|FG001|Overall Study|Other|4|||
156366750|NCT03756558|564442538|FG000|Overall Study|Death|1|||
156366751|NCT03756558|564442538|FG000|Overall Study|Lost to Follow-up|2|||
156366752|NCT03756558|564442538|FG000|Overall Study|Withdrawal by Subject|2|||
156366753|NCT02586012|564442539|FG000|Overall Study|Withdrawal by Subject|1|||
156366754|NCT02586012|564442540|FG001|Overall Study|Withdrawal by Subject|1|||
156491520|NCT00943722|564894925|FG001|Base Study|Lost to Follow-up|8|||
156366755|NCT02586012|564442541|FG002|Overall Study|Withdrawal by Subject|0|||
156366756|NCT02586012|564442542|FG003|Overall Study|Withdrawal by Subject|1|||
156366757|NCT02586012|564442543|FG004|Overall Study|Withdrawal by Subject|0|||
156366758|NCT02586012|564442544|FG005|Overall Study|Withdrawal by Subject|2|||
156366759|NCT02586012|564442539|FG000|Overall Study|Protocol Violation|0|||
156366760|NCT02586012|564442540|FG001|Overall Study|Protocol Violation|0|||
156366761|NCT02586012|564442541|FG002|Overall Study|Protocol Violation|0|||
156366762|NCT02586012|564442542|FG003|Overall Study|Protocol Violation|0|||
156366763|NCT02586012|564442543|FG004|Overall Study|Protocol Violation|0|||
156366764|NCT02586012|564442544|FG005|Overall Study|Protocol Violation|1|||
156366765|NCT02586012|564442539|FG000|Overall Study|study terminated|0|||
156366766|NCT02586012|564442540|FG001|Overall Study|study terminated|2|||
156366767|NCT02586012|564442541|FG002|Overall Study|study terminated|1|||
156366768|NCT02586012|564442542|FG003|Overall Study|study terminated|1|||
156366769|NCT02586012|564442543|FG004|Overall Study|study terminated|1|||
156366770|NCT02586012|564442544|FG005|Overall Study|study terminated|0|||
156366771|NCT03277846|564442545|FG000|Overall Study|Inpatient stay too brief|12|||
156366772|NCT03277846|564442546|FG001|Overall Study|Inpatient stay too brief|11|||
156366773|NCT05168475|564442547|FG000|Period 1|Protocol Violation|1|||
156366774|NCT05168475|564442547|FG000|Period 1|IMP shortage|2|||
156366775|NCT05168475|564442547|FG000|Period 1|Not randomised|2|||
156366776|NCT05168475|564442547|FG000|Period 2|IMP shortage|1|||
156366777|NCT01589822|564442548|FG000|Overall Study|Withdrawal by Subject|1|||
156366778|NCT01589822|564442549|FG001|Overall Study|Withdrawal by Subject|2|||
156366779|NCT01589822|564442550|FG002|Overall Study|Withdrawal by Subject|0|||
156366780|NCT01589822|564442548|FG000|Overall Study|Death|1|||
156366781|NCT01589822|564442549|FG001|Overall Study|Death|0|||
156366782|NCT01589822|564442550|FG002|Overall Study|Death|0|||
156366783|NCT01589822|564442548|FG000|Overall Study|Missed 90 day visit|2|||
156366784|NCT01589822|564442549|FG001|Overall Study|Missed 90 day visit|1|||
156366785|NCT01589822|564442550|FG002|Overall Study|Missed 90 day visit|1|||
156366786|NCT01302964|564442551|FG000|Overall Study|Adverse Event|1|||
156366787|NCT01302964|564442552|FG001|Overall Study|Adverse Event|0|||
156366788|NCT01945489|564442555|FG000|Cycle 1|Adverse Event|2|||
156366789|NCT01945489|564442556|FG001|Cycle 1|Adverse Event|0|||
156366790|NCT01945489|564442555|FG000|Cycle 1|Lost to Follow-up|4|||
156366791|NCT01945489|564442556|FG001|Cycle 1|Lost to Follow-up|0|||
156366792|NCT01945489|564442555|FG000|Cycle 1|Personal Reasons|4|||
156366793|NCT01945489|564442556|FG001|Cycle 1|Personal Reasons|2|||
156366794|NCT01945489|564442555|FG000|Cycle 1|Protocol Violation|0|||
156366795|NCT01945489|564442556|FG001|Cycle 1|Protocol Violation|1|||
156366796|NCT01945489|564442555|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
156366797|NCT01945489|564442556|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
156366798|NCT01945489|564442555|FG000|Cycle 2|Adverse Event|1|||
156366799|NCT01945489|564442556|FG001|Cycle 2|Adverse Event|0|||
156366800|NCT01945489|564442555|FG000|Cycle 2|Lost to Follow-up|0|||
156366801|NCT01945489|564442556|FG001|Cycle 2|Lost to Follow-up|1|||
156366802|NCT00697346|564442558|FG000|Overall Study|Adverse Event|4|||
156366803|NCT00697346|564442559|FG001|Overall Study|Adverse Event|5|||
156366804|NCT00697346|564442560|FG002|Overall Study|Adverse Event|0|||
156366805|NCT00697346|564442558|FG000|Overall Study|Progressive Disease|19|||
156366806|NCT00697346|564442559|FG001|Overall Study|Progressive Disease|18|||
156366807|NCT00697346|564442560|FG002|Overall Study|Progressive Disease|0|||
156366808|NCT00697346|564442558|FG000|Overall Study|Symptomatic Deterioration|0|||
156366809|NCT00697346|564442559|FG001|Overall Study|Symptomatic Deterioration|1|||
156366810|NCT00697346|564442560|FG002|Overall Study|Symptomatic Deterioration|0|||
156366811|NCT00697346|564442558|FG000|Overall Study|Withdrawal by Subject|2|||
156366812|NCT00697346|564442559|FG001|Overall Study|Withdrawal by Subject|2|||
156366813|NCT00697346|564442560|FG002|Overall Study|Withdrawal by Subject|0|||
156366814|NCT00697346|564442558|FG000|Overall Study|Reason not Specified|3|||
156366815|NCT00697346|564442559|FG001|Overall Study|Reason not Specified|0|||
156366816|NCT00697346|564442560|FG002|Overall Study|Reason not Specified|1|||
156366817|NCT03569371|564442561|FG000|Overall Study|Lack of Efficacy|1|||
156366818|NCT03569371|564442561|FG000|Overall Study|Lost to Follow-up|1|||
156366819|NCT03569371|564442561|FG000|Overall Study|Adverse Event|1|||
156366820|NCT03643562|564442562|FG000|Overall Study|Adverse Event|1|||
156366821|NCT03643562|564442563|FG001|Overall Study|Adverse Event|0|||
156366822|NCT03643562|564442562|FG000|Overall Study|Lack of Efficacy|0|||
156366823|NCT03643562|564442563|FG001|Overall Study|Lack of Efficacy|1|||
156366824|NCT03643562|564442562|FG000|Overall Study|Physician Decision|0|||
156366825|NCT03643562|564442563|FG001|Overall Study|Physician Decision|1|||
156366826|NCT03643562|564442562|FG000|Overall Study|Study Terminated by Sponsor|2|||
156366827|NCT03643562|564442563|FG001|Overall Study|Study Terminated by Sponsor|10|||
156366828|NCT03643562|564442562|FG000|Overall Study|Withdrawal by Subject|2|||
156366829|NCT03643562|564442563|FG001|Overall Study|Withdrawal by Subject|2|||
156366830|NCT03643562|564442562|FG000|Overall Study|Other than specified|3|||
156366831|NCT03643562|564442563|FG001|Overall Study|Other than specified|2|||
156366832|NCT04145895|564442564|FG000|Overall Study|Physician Decision|2|||
156366833|NCT04145895|564442565|FG001|Overall Study|Physician Decision|0|||
156366834|NCT04145895|564442564|FG000|Overall Study|Withdrawal by Subject|0|||
156366835|NCT04145895|564442565|FG001|Overall Study|Withdrawal by Subject|2|||
156366836|NCT01236755|564442566|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
156366837|NCT01236755|564442566|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
156366838|NCT01236755|564442566|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
156366839|NCT01236755|564442566|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
156366840|NCT03848845|564442567|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
156366841|NCT03848845|564442568|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
156366842|NCT03848845|564442569|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
156366843|NCT03848845|564442570|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
156366844|NCT03848845|564442567|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
156366845|NCT03848845|564442568|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
156366846|NCT03848845|564442569|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
156366847|NCT03848845|564442570|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
156366848|NCT03848845|564442567|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
156366849|NCT03848845|564442568|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
156366850|NCT03848845|564442569|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
156366851|NCT03848845|564442570|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
156366852|NCT03848845|564442567|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
156366853|NCT03848845|564442568|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
156366854|NCT03848845|564442569|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
156366855|NCT03848845|564442570|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
156366856|NCT02789176|564442572|FG000|Overall Study|Death|0|||
156366857|NCT02789176|564442573|FG001|Overall Study|Death|0|||
156366858|NCT02789176|564442574|FG002|Overall Study|Death|3|||
156366859|NCT02789176|564442575|FG003|Overall Study|Death|0|||
156366860|NCT02789176|564442572|FG000|Overall Study|Withdrawal by Subject|0|||
156366861|NCT02789176|564442573|FG001|Overall Study|Withdrawal by Subject|0|||
156366862|NCT02789176|564442574|FG002|Overall Study|Withdrawal by Subject|1|||
156366863|NCT02789176|564442575|FG003|Overall Study|Withdrawal by Subject|0|||
156366864|NCT02789176|564442572|FG000|Overall Study|Lost to Follow-up|8|||
156366865|NCT02789176|564442573|FG001|Overall Study|Lost to Follow-up|2|||
156366866|NCT02789176|564442574|FG002|Overall Study|Lost to Follow-up|6|||
156366867|NCT02789176|564442575|FG003|Overall Study|Lost to Follow-up|1|||
156366868|NCT02223767|564442576|FG000|Overall Study|Withdrawal by Subject|4|||
156366869|NCT02223767|564442577|FG001|Overall Study|Withdrawal by Subject|4|||
156366870|NCT02347527|564442579|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
156366871|NCT02347527|564442580|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
156366872|NCT02347527|564442581|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
156366873|NCT02347527|564442582|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
156366874|NCT02347527|564442579|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
156366875|NCT02347527|564442580|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
156366876|NCT02347527|564442581|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
156366877|NCT02347527|564442582|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
156366878|NCT02347527|564442579|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
156366879|NCT02347527|564442580|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
156366880|NCT02347527|564442581|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
156366881|NCT02347527|564442582|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
156366882|NCT02347527|564442579|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
156366883|NCT02347527|564442580|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
156366884|NCT02347527|564442581|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
156366885|NCT02347527|564442582|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
156366886|NCT02347527|564442579|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
156366887|NCT02347527|564442580|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
156366888|NCT02347527|564442581|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
156366889|NCT02347527|564442582|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
156366890|NCT00596011|564442583|FG000|Overall Study|Withdrawal by Subject|2|||
156366891|NCT00596011|564442584|FG001|Overall Study|Withdrawal by Subject|3|||
156366892|NCT00596011|564442583|FG000|Overall Study|Adverse Event|11|||
156366893|NCT00596011|564442584|FG001|Overall Study|Adverse Event|7|||
156366894|NCT00192075|564442585|FG000|Overall Study|Disease Progression|23|||
156366895|NCT00192075|564442586|FG001|Overall Study|Disease Progression|6|||
156491521|NCT00943722|564894926|FG002|Base Study|Lost to Follow-up|10|||
156491522|NCT00943722|564894927|FG003|Base Study|Lost to Follow-up|8|||
156491523|NCT00943722|564894928|FG004|Base Study|Lost to Follow-up|11|||
156491524|NCT00943722|564894929|FG005|Base Study|Lost to Follow-up|0|||
156491525|NCT00943722|564894930|FG006|Base Study|Lost to Follow-up|0|||
156491526|NCT00943722|564894924|FG000|Base Study|Physician Decision|1|||
156366896|NCT00192075|564442585|FG000|Overall Study|Adverse Event|1|||
156366897|NCT00192075|564442586|FG001|Overall Study|Adverse Event|3|||
156366898|NCT00192075|564442585|FG000|Overall Study|Death|0|||
156366899|NCT00192075|564442586|FG001|Overall Study|Death|1|||
156366900|NCT00192075|564442585|FG000|Overall Study|Lack of Efficacy|0|||
156366901|NCT00192075|564442586|FG001|Overall Study|Lack of Efficacy|0|||
156366902|NCT00192075|564442585|FG000|Overall Study|Physician Decision|3|||
156366903|NCT00192075|564442586|FG001|Overall Study|Physician Decision|0|||
156366904|NCT00192075|564442585|FG000|Overall Study|Withdrawal by Subject|5|||
156366905|NCT00192075|564442586|FG001|Overall Study|Withdrawal by Subject|5|||
156366906|NCT00192075|564442585|FG000|Overall Study|Patient Non-Compliance|0|||
156366907|NCT00192075|564442586|FG001|Overall Study|Patient Non-Compliance|1|||
156366908|NCT00192075|564442585|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
156366909|NCT00192075|564442586|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
156366910|NCT00192075|564442585|FG000|Overall Study|Other|5|||
156366911|NCT00192075|564442586|FG001|Overall Study|Other|2|||
156366912|NCT00910715|564442589|FG000|Overall Study|Lost to Follow-up|22|||
156366913|NCT00910715|564442590|FG001|Overall Study|Lost to Follow-up|26|||
156366914|NCT00910715|564442591|FG002|Overall Study|Lost to Follow-up|0|||
156366915|NCT02412631|564442592|FG000|Overall Study|Adverse Event|1|||
156366916|NCT02412631|564442593|FG001|Overall Study|Adverse Event|2|||
156366917|NCT02412631|564442592|FG000|Overall Study|Lost to Follow-up|5|||
156366918|NCT02412631|564442593|FG001|Overall Study|Lost to Follow-up|9|||
156366919|NCT02412631|564442592|FG000|Overall Study|Withdrawal by Subject|9|||
156366920|NCT02412631|564442593|FG001|Overall Study|Withdrawal by Subject|3|||
156366921|NCT02412631|564442592|FG000|Overall Study|Early stop by FDA|5|||
156366922|NCT02412631|564442593|FG001|Overall Study|Early stop by FDA|2|||
156366923|NCT02412631|564442592|FG000|Overall Study|Unspecified reason|6|||
156366924|NCT02412631|564442593|FG001|Overall Study|Unspecified reason|8|||
156366925|NCT02884089|564442594|FG000|Period 1|Dosing error|2|||
156366926|NCT02884089|564442595|FG001|Period 1|Dosing error|2|||
156366927|NCT02884089|564442596|FG002|Period 1|Dosing error|0|||
156366928|NCT02884089|564442597|FG003|Period 1|Dosing error|0|||
156366929|NCT02884089|564442594|FG000|Washout Period 1|Lost to Follow-up|0|||
156366930|NCT02884089|564442595|FG001|Washout Period 1|Lost to Follow-up|1|||
156366931|NCT02884089|564442596|FG002|Washout Period 1|Lost to Follow-up|0|||
156366932|NCT02884089|564442597|FG003|Washout Period 1|Lost to Follow-up|1|||
156366933|NCT02884089|564442594|FG000|Washout Period 1|Withdrawal by Subject|0|||
156366934|NCT02884089|564442595|FG001|Washout Period 1|Withdrawal by Subject|1|||
156366935|NCT02884089|564442596|FG002|Washout Period 1|Withdrawal by Subject|0|||
156366936|NCT02884089|564442597|FG003|Washout Period 1|Withdrawal by Subject|0|||
156366937|NCT02884089|564442594|FG000|Period 2|Adverse Event|1|||
156366938|NCT02884089|564442595|FG001|Period 2|Adverse Event|0|||
156366939|NCT02884089|564442596|FG002|Period 2|Adverse Event|0|||
156366940|NCT02884089|564442597|FG003|Period 2|Adverse Event|0|||
156366941|NCT02884089|564442594|FG000|Period 3|Withdrawal by Subject|0|||
156366942|NCT02884089|564442595|FG001|Period 3|Withdrawal by Subject|0|||
156366943|NCT02884089|564442596|FG002|Period 3|Withdrawal by Subject|1|||
156366944|NCT02884089|564442597|FG003|Period 3|Withdrawal by Subject|0|||
156366945|NCT02884089|564442594|FG000|Washout Period 3|Withdrawal by Subject|0|||
156366946|NCT02884089|564442595|FG001|Washout Period 3|Withdrawal by Subject|0|||
156366947|NCT02884089|564442596|FG002|Washout Period 3|Withdrawal by Subject|1|||
156366948|NCT02884089|564442597|FG003|Washout Period 3|Withdrawal by Subject|0|||
156366949|NCT02884089|564442594|FG000|Washout Period 3|Lost to Follow-up|0|||
156366950|NCT02884089|564442595|FG001|Washout Period 3|Lost to Follow-up|0|||
156366951|NCT02884089|564442596|FG002|Washout Period 3|Lost to Follow-up|0|||
156366952|NCT02884089|564442597|FG003|Washout Period 3|Lost to Follow-up|1|||
156366953|NCT02884089|564442594|FG000|Period 4|Withdrawal by Subject|0|||
156366954|NCT02884089|564442595|FG001|Period 4|Withdrawal by Subject|1|||
156366955|NCT02884089|564442596|FG002|Period 4|Withdrawal by Subject|0|||
156491527|NCT00943722|564894925|FG001|Base Study|Physician Decision|0|||
156366956|NCT02884089|564442597|FG003|Period 4|Withdrawal by Subject|0|||
156491528|NCT00943722|564894926|FG002|Base Study|Physician Decision|0|||
156366957|NCT02884089|564442594|FG000|Period 4|Lost to Follow-up|1|||
156366958|NCT02884089|564442595|FG001|Period 4|Lost to Follow-up|0|||
156366959|NCT02884089|564442596|FG002|Period 4|Lost to Follow-up|0|||
156366960|NCT02884089|564442597|FG003|Period 4|Lost to Follow-up|0|||
156491529|NCT00943722|564894927|FG003|Base Study|Physician Decision|0|||
156491530|NCT00943722|564894928|FG004|Base Study|Physician Decision|1|||
156366961|NCT02884089|564442594|FG000|Follow-up Visit|Withdrawal by Subject|1|||
156366962|NCT02884089|564442595|FG001|Follow-up Visit|Withdrawal by Subject|0|||
156366963|NCT02884089|564442596|FG002|Follow-up Visit|Withdrawal by Subject|0|||
156366964|NCT02884089|564442597|FG003|Follow-up Visit|Withdrawal by Subject|1|||
156366965|NCT03100825|564442603|FG000|Overall Study|Participant/Guardian Decision|7|||
156366966|NCT03100825|564442603|FG000|Overall Study|Physician Decision|1|||
156366967|NCT00994448|564442605|FG000|Overall Study|Adverse Event|1|||
156366968|NCT00994448|564442606|FG001|Overall Study|Adverse Event|0|||
156366969|NCT00994448|564442605|FG000|Overall Study|Lost to Follow-up|5|||
156366970|NCT00994448|564442606|FG001|Overall Study|Lost to Follow-up|1|||
156366971|NCT00994448|564442605|FG000|Overall Study|Withdrawal by Subject|1|||
156366972|NCT00994448|564442606|FG001|Overall Study|Withdrawal by Subject|1|||
156366973|NCT00994448|564442605|FG000|Overall Study|Physician Decision|1|||
156366974|NCT00994448|564442606|FG001|Overall Study|Physician Decision|0|||
156366975|NCT05923229|564442609|FG000|Overall Study|Withdrawal by Subject|3|||
156366976|NCT05923229|564442610|FG001|Overall Study|Withdrawal by Subject|0|||
156366977|NCT05923229|564442609|FG000|Overall Study|Health related|2|||
156366978|NCT05923229|564442610|FG001|Overall Study|Health related|1|||
156366979|NCT04164901|564442611|FG000|Overall Study|Withdrawal by Subject|4|||
156366980|NCT04164901|564442612|FG001|Overall Study|Withdrawal by Subject|4|||
156366981|NCT05288556|564442613|FG000|Overall Study|Protocol Violation|1|||
156366982|NCT05288556|564442613|FG000|Overall Study|Withdrawal by Subject|1|||
156366983|NCT02465528|564442614|FG000|Overall Study|Progressive disease|0|||
156366984|NCT02465528|564442615|FG001|Overall Study|Progressive disease|2|||
156366985|NCT02465528|564442616|FG002|Overall Study|Progressive disease|9|||
156366986|NCT02465528|564442617|FG003|Overall Study|Progressive disease|4|||
156366987|NCT02465528|564442614|FG000|Overall Study|Study terminated by sponsor|1|||
156366988|NCT02465528|564442615|FG001|Overall Study|Study terminated by sponsor|2|||
156366989|NCT02465528|564442616|FG002|Overall Study|Study terminated by sponsor|0|||
156366990|NCT02465528|564442617|FG003|Overall Study|Study terminated by sponsor|0|||
156366991|NCT02465528|564442614|FG000|Overall Study|Withdrawal by Subject|0|||
156366992|NCT02465528|564442615|FG001|Overall Study|Withdrawal by Subject|0|||
156366993|NCT02465528|564442616|FG002|Overall Study|Withdrawal by Subject|2|||
156366994|NCT02465528|564442617|FG003|Overall Study|Withdrawal by Subject|0|||
156366995|NCT02465528|564442614|FG000|Overall Study|Adverse Event|0|||
156366996|NCT02465528|564442615|FG001|Overall Study|Adverse Event|0|||
156366997|NCT02465528|564442616|FG002|Overall Study|Adverse Event|0|||
156366998|NCT02465528|564442617|FG003|Overall Study|Adverse Event|1|||
156366999|NCT02465528|564442614|FG000|Overall Study|Physician Decision|0|||
156367000|NCT02465528|564442615|FG001|Overall Study|Physician Decision|0|||
156367001|NCT02465528|564442616|FG002|Overall Study|Physician Decision|1|||
156367002|NCT02465528|564442617|FG003|Overall Study|Physician Decision|0|||
156367003|NCT05040152|564442622|FG000|Overall Study|Withdrawal by Subject|5|||
156367004|NCT05040152|564442623|FG001|Overall Study|Withdrawal by Subject|0|||
156367005|NCT05040152|564442622|FG000|Overall Study|Lost to Follow-up|0|||
156367006|NCT05040152|564442623|FG001|Overall Study|Lost to Follow-up|2|||
156367007|NCT03400332|564442624|FG000|Pre-Treatment|Other reasons|0|||
156367008|NCT03400332|564442625|FG001|Pre-Treatment|Other reasons|0|||
156367009|NCT03400332|564442626|FG002|Pre-Treatment|Other reasons|0|||
156367010|NCT03400332|564442627|FG003|Pre-Treatment|Other reasons|0|||
156367011|NCT03400332|564442628|FG004|Pre-Treatment|Other reasons|0|||
156367012|NCT03400332|564442629|FG005|Pre-Treatment|Other reasons|0|||
156367013|NCT03400332|564442630|FG006|Pre-Treatment|Other reasons|0|||
156367014|NCT03400332|564442631|FG007|Pre-Treatment|Other reasons|0|||
156367015|NCT03400332|564442632|FG008|Pre-Treatment|Other reasons|1|||
156367016|NCT03400332|564442624|FG000|Pre-Treatment|No longer met study criteria|0|||
156367017|NCT03400332|564442625|FG001|Pre-Treatment|No longer met study criteria|0|||
156367018|NCT03400332|564442626|FG002|Pre-Treatment|No longer met study criteria|0|||
156367019|NCT03400332|564442627|FG003|Pre-Treatment|No longer met study criteria|0|||
156367020|NCT03400332|564442628|FG004|Pre-Treatment|No longer met study criteria|0|||
156367021|NCT03400332|564442629|FG005|Pre-Treatment|No longer met study criteria|0|||
156367022|NCT03400332|564442630|FG006|Pre-Treatment|No longer met study criteria|0|||
156367023|NCT03400332|564442631|FG007|Pre-Treatment|No longer met study criteria|0|||
156367024|NCT03400332|564442632|FG008|Pre-Treatment|No longer met study criteria|1|||
156367025|NCT03400332|564442624|FG000|Pre-Treatment|Withdrawal by Subject|0|||
156367026|NCT03400332|564442625|FG001|Pre-Treatment|Withdrawal by Subject|0|||
156367027|NCT03400332|564442626|FG002|Pre-Treatment|Withdrawal by Subject|0|||
156367028|NCT03400332|564442627|FG003|Pre-Treatment|Withdrawal by Subject|0|||
156367029|NCT03400332|564442628|FG004|Pre-Treatment|Withdrawal by Subject|0|||
156367030|NCT03400332|564442629|FG005|Pre-Treatment|Withdrawal by Subject|0|||
156367031|NCT03400332|564442630|FG006|Pre-Treatment|Withdrawal by Subject|0|||
156367032|NCT03400332|564442631|FG007|Pre-Treatment|Withdrawal by Subject|0|||
156367033|NCT03400332|564442632|FG008|Pre-Treatment|Withdrawal by Subject|1|||
156367034|NCT03400332|564442624|FG000|Treatment|Participant withdrew consent|2|||
156491531|NCT00943722|564894929|FG005|Base Study|Physician Decision|0|||
156491532|NCT00943722|564894930|FG006|Base Study|Physician Decision|0|||
156367035|NCT03400332|564442625|FG001|Treatment|Participant withdrew consent|2|||
156491533|NCT00943722|564894924|FG000|Base Study|Pregnancy|0|||
156367036|NCT03400332|564442626|FG002|Treatment|Participant withdrew consent|0|||
156367037|NCT03400332|564442627|FG003|Treatment|Participant withdrew consent|0|||
156367038|NCT03400332|564442628|FG004|Treatment|Participant withdrew consent|3|||
156367039|NCT03400332|564442629|FG005|Treatment|Participant withdrew consent|3|||
156367040|NCT03400332|564442630|FG006|Treatment|Participant withdrew consent|1|||
156367041|NCT03400332|564442631|FG007|Treatment|Participant withdrew consent|1|||
156367042|NCT03400332|564442632|FG008|Treatment|Participant withdrew consent|1|||
156367043|NCT03400332|564442624|FG000|Treatment|Other reasons|0|||
156367044|NCT03400332|564442625|FG001|Treatment|Other reasons|1|||
156367045|NCT03400332|564442626|FG002|Treatment|Other reasons|1|||
156367046|NCT03400332|564442627|FG003|Treatment|Other reasons|0|||
156367047|NCT03400332|564442628|FG004|Treatment|Other reasons|3|||
156367048|NCT03400332|564442629|FG005|Treatment|Other reasons|1|||
156367049|NCT03400332|564442630|FG006|Treatment|Other reasons|2|||
156367050|NCT03400332|564442631|FG007|Treatment|Other reasons|0|||
156367051|NCT03400332|564442632|FG008|Treatment|Other reasons|1|||
156367052|NCT03400332|564442624|FG000|Treatment|Lost to Follow-up|0|||
156367053|NCT03400332|564442625|FG001|Treatment|Lost to Follow-up|1|||
156367054|NCT03400332|564442626|FG002|Treatment|Lost to Follow-up|0|||
156367055|NCT03400332|564442627|FG003|Treatment|Lost to Follow-up|0|||
156367056|NCT03400332|564442628|FG004|Treatment|Lost to Follow-up|0|||
156367057|NCT03400332|564442629|FG005|Treatment|Lost to Follow-up|0|||
156367058|NCT03400332|564442630|FG006|Treatment|Lost to Follow-up|0|||
156367059|NCT03400332|564442631|FG007|Treatment|Lost to Follow-up|0|||
156367060|NCT03400332|564442632|FG008|Treatment|Lost to Follow-up|0|||
156367061|NCT03400332|564442624|FG000|Treatment|Death|3|||
156367062|NCT03400332|564442625|FG001|Treatment|Death|1|||
156367063|NCT03400332|564442626|FG002|Treatment|Death|2|||
156367064|NCT03400332|564442627|FG003|Treatment|Death|3|||
156367065|NCT03400332|564442628|FG004|Treatment|Death|6|||
156367066|NCT03400332|564442629|FG005|Treatment|Death|2|||
156367067|NCT03400332|564442630|FG006|Treatment|Death|1|||
156367068|NCT03400332|564442631|FG007|Treatment|Death|3|||
156367069|NCT03400332|564442632|FG008|Treatment|Death|6|||
156367070|NCT03795610|564442636|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
156367071|NCT03795610|564442636|FG000|Overall Study|Withdrawal by Subject|1|||
156367072|NCT03795610|564442636|FG000|Overall Study|Screen Failure (Unknown)|1|||
156367073|NCT02775344|564442637|FG000|Overall Study|No ovarian cyst identified|3|||
156367074|NCT02775344|564442638|FG001|Overall Study|No ovarian cyst identified|2|||
156367075|NCT04098458|564442639|FG000|Overall Study|Death|1|||
156367076|NCT04098458|564442639|FG000|Overall Study|did not meet study inclusion criteria|3|||
156367077|NCT01800916|564442640|FG000|Test Period 1 (1 Week)|Convex product user|0|||
156367078|NCT01800916|564442641|FG001|Test Period 1 (1 Week)|Convex product user|0|||
156367079|NCT01800916|564442642|FG002|Test Period 1 (1 Week)|Convex product user|0|||
156367080|NCT01800916|564442643|FG003|Test Period 1 (1 Week)|Convex product user|1|||
156367081|NCT01800916|564442644|FG004|Test Period 1 (1 Week)|Convex product user|0|||
156367082|NCT01800916|564442645|FG005|Test Period 1 (1 Week)|Convex product user|0|||
156367083|NCT01800916|564442646|FG006|Test Period 1 (1 Week)|Convex product user|0|||
156367084|NCT01800916|564442647|FG007|Test Period 1 (1 Week)|Convex product user|0|||
156367085|NCT01800916|564442648|FG008|Test Period 1 (1 Week)|Convex product user|0|||
156367086|NCT01800916|564442640|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
156367087|NCT01800916|564442641|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
156367088|NCT01800916|564442642|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
156367089|NCT01800916|564442643|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
156367090|NCT01800916|564442644|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
156367091|NCT01800916|564442645|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
156367092|NCT01800916|564442646|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
156367093|NCT01800916|564442647|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
156491534|NCT00943722|564894925|FG001|Base Study|Pregnancy|0|||
156491535|NCT00943722|564894926|FG002|Base Study|Pregnancy|1|||
156367094|NCT01800916|564442648|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
156367095|NCT01461096|564442649|FG000|Overall Study|Death|3|||
156367096|NCT01461096|564442650|FG001|Overall Study|Death|6|||
156367097|NCT01461096|564442649|FG000|Overall Study|Severe debilitation, unable to continue|1|||
156491536|NCT00943722|564894927|FG003|Base Study|Pregnancy|0|||
156491537|NCT00943722|564894928|FG004|Base Study|Pregnancy|2|||
156491538|NCT00943722|564894929|FG005|Base Study|Pregnancy|0|||
156491539|NCT00943722|564894930|FG006|Base Study|Pregnancy|0|||
156491540|NCT00943722|564894924|FG000|Base Study|Protocol Violation|0|||
156491541|NCT00943722|564894925|FG001|Base Study|Protocol Violation|1|||
156491542|NCT00943722|564894926|FG002|Base Study|Protocol Violation|0|||
156491543|NCT00943722|564894927|FG003|Base Study|Protocol Violation|0|||
156491544|NCT00943722|564894928|FG004|Base Study|Protocol Violation|2|||
156491545|NCT00943722|564894929|FG005|Base Study|Protocol Violation|0|||
156491546|NCT00943722|564894930|FG006|Base Study|Protocol Violation|0|||
156491547|NCT00943722|564894924|FG000|Base Study|Withdrawal by Subject|12|||
156367098|NCT01461096|564442650|FG001|Overall Study|Severe debilitation, unable to continue|1|||
156367099|NCT01461096|564442649|FG000|Overall Study|Subj not able to get to clinic|15|||
156367100|NCT01461096|564442650|FG001|Overall Study|Subj not able to get to clinic|13|||
156367101|NCT01461096|564442649|FG000|Overall Study|Site is closing|27|||
156367102|NCT01461096|564442650|FG001|Overall Study|Site is closing|30|||
156367103|NCT01461096|564442649|FG000|Overall Study|Withdrawal by Subject|5|||
156367104|NCT01461096|564442650|FG001|Overall Study|Withdrawal by Subject|3|||
156367105|NCT01461096|564442649|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
156367106|NCT01461096|564442650|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
156367107|NCT01461096|564442649|FG000|Overall Study|Lost to Follow-up|8|||
156367108|NCT01461096|564442650|FG001|Overall Study|Lost to Follow-up|4|||
156491548|NCT00943722|564894925|FG001|Base Study|Withdrawal by Subject|13|||
156491549|NCT00943722|564894926|FG002|Base Study|Withdrawal by Subject|2|||
156491550|NCT00943722|564894927|FG003|Base Study|Withdrawal by Subject|13|||
156491551|NCT00943722|564894928|FG004|Base Study|Withdrawal by Subject|8|||
156491552|NCT00943722|564894929|FG005|Base Study|Withdrawal by Subject|0|||
156367109|NCT03047135|564442663|FG000|Overall Study|Still being treated|3|||
156367110|NCT01256593|564442666|FG000|Overall Study|Protocol Violation|26|||
156367111|NCT01256593|564442666|FG000|Overall Study|No Drug Administration Information|2|||
156367112|NCT01256593|564442666|FG000|Overall Study|No Visit After Treatment|186|||
156367113|NCT05619692|564442667|FG000|Overall Study|Adverse Event|2|||
156367114|NCT05619692|564442668|FG001|Overall Study|Adverse Event|2|||
156367115|NCT05619692|564442667|FG000|Overall Study|Withdrawal by Participant|3|||
156367116|NCT05619692|564442668|FG001|Overall Study|Withdrawal by Participant|4|||
156367117|NCT05619692|564442667|FG000|Overall Study|Lost to Follow-up|2|||
156367118|NCT05619692|564442668|FG001|Overall Study|Lost to Follow-up|1|||
156367119|NCT05619692|564442667|FG000|Overall Study|Randomized but not treated|1|||
156367120|NCT05619692|564442668|FG001|Overall Study|Randomized but not treated|3|||
156367121|NCT00344773|564442669|FG000|Overall Study|Adverse Event|2|||
156367122|NCT00344773|564442669|FG000|Overall Study|Objective Disease Progression|16|||
156367123|NCT00344773|564442669|FG000|Overall Study|Withdrawal by Subject|1|||
156367124|NCT00344773|564442669|FG000|Overall Study|Not Eligible for the study|2|||
156367125|NCT02849548|564442679|FG000|Overall Study|Lost to Follow-up|1|||
156367126|NCT02849548|564442680|FG001|Overall Study|Lost to Follow-up|2|||
156367127|NCT02849548|564442679|FG000|Overall Study|Protocol Violation|1|||
156367128|NCT02849548|564442680|FG001|Overall Study|Protocol Violation|0|||
156367129|NCT00714259|564442681|FG000|Overall Study|Death|2|||
156367130|NCT04804813|564442683|FG000|Overall Study|Protocol Violation|2|||
156367131|NCT04804813|564442684|FG001|Overall Study|Protocol Violation|0|||
156367132|NCT04804813|564442683|FG000|Overall Study|Withdrawal by Subject|1|||
156367133|NCT04804813|564442684|FG001|Overall Study|Withdrawal by Subject|0|||
156367134|NCT02357147|564442685|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
156367135|NCT02357147|564442686|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
156367136|NCT02357147|564442685|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
156367137|NCT02357147|564442686|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
156367138|NCT02357147|564442685|FG000|Combination Treatment Phase|Investigator Discretion|1|||
156367139|NCT02357147|564442686|FG001|Combination Treatment Phase|Investigator Discretion|1|||
156367140|NCT02357147|564442685|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
156367141|NCT02357147|564442686|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
156367142|NCT02357147|564442685|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
156367143|NCT02357147|564442686|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
156367144|NCT02357147|564442685|FG000|Combination Treatment Phase|Adverse Event|12|||
156367145|NCT02357147|564442686|FG001|Combination Treatment Phase|Adverse Event|4|||
156367146|NCT02357147|564442685|FG000|Combination Treatment Phase|Death|1|||
156367147|NCT02357147|564442686|FG001|Combination Treatment Phase|Death|1|||
156367148|NCT02357147|564442685|FG000|Combination Treatment Phase|Sponsor Decision|0|||
156367149|NCT02357147|564442686|FG001|Combination Treatment Phase|Sponsor Decision|12|||
156367150|NCT02357147|564442685|FG000|Combination Treatment Phase|Other|1|||
156367151|NCT02357147|564442686|FG001|Combination Treatment Phase|Other|0|||
156367152|NCT02357147|564442685|FG000|Combination Treatment Phase|Not treated|0|||
156367153|NCT02357147|564442686|FG001|Combination Treatment Phase|Not treated|2|||
156367154|NCT02357147|564442685|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
156367155|NCT02357147|564442686|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
156367156|NCT02357147|564442685|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156367157|NCT02357147|564442686|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
156367158|NCT02357147|564442685|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
156367159|NCT02357147|564442686|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
156367160|NCT02357147|564442685|FG000|Maintenance Treatment Phase|Adverse Event|0|||
156367161|NCT02357147|564442686|FG001|Maintenance Treatment Phase|Adverse Event|3|||
156367162|NCT02357147|564442685|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
156367163|NCT02357147|564442686|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
156367164|NCT02357147|564442685|FG000|Maintenance Treatment Phase|Not Treated|1|||
156367165|NCT02357147|564442686|FG001|Maintenance Treatment Phase|Not Treated|0|||
156367166|NCT01101841|564444376|FG000|Overall Study|Adverse Event|15|||
156491553|NCT00943722|564894930|FG006|Base Study|Withdrawal by Subject|0|||
156491554|NCT00943722|564894924|FG000|Base Study|Month 12 visit not completed|0|||
156367167|NCT01101841|564444377|FG001|Overall Study|Adverse Event|15|||
156367168|NCT01101841|564444376|FG000|Overall Study|Lost to Follow-up|9|||
156367169|NCT01101841|564444377|FG001|Overall Study|Lost to Follow-up|3|||
156367170|NCT01101841|564444376|FG000|Overall Study|Withdrawal by Subject|21|||
156367171|NCT01101841|564444377|FG001|Overall Study|Withdrawal by Subject|40|||
156367172|NCT01101841|564444376|FG000|Overall Study|Protocol Violation|1|||
156367173|NCT01101841|564444377|FG001|Overall Study|Protocol Violation|1|||
156367174|NCT01101841|564444376|FG000|Overall Study|Physician Decision|0|||
156367175|NCT01101841|564444377|FG001|Overall Study|Physician Decision|2|||
156367176|NCT01101841|564444376|FG000|Overall Study|Lack of Efficacy|0|||
156491555|NCT00943722|564894925|FG001|Base Study|Month 12 visit not completed|0|||
156367177|NCT01101841|564444377|FG001|Overall Study|Lack of Efficacy|2|||
156367178|NCT01101841|564444376|FG000|Overall Study|Other|0|||
156367179|NCT01101841|564444377|FG001|Overall Study|Other|1|||
156367180|NCT01101841|564444376|FG000|Overall Study|Suicidality Tracking Scale|3|||
156367181|NCT01101841|564444377|FG001|Overall Study|Suicidality Tracking Scale|1|||
156367182|NCT01101841|564444376|FG000|Overall Study|Eligibility Criteria|1|||
156367183|NCT01101841|564444377|FG001|Overall Study|Eligibility Criteria|2|||
156367184|NCT02896400|564444379|FG000|1 Month Follow-up|Lost to Follow-up|7|||
156367185|NCT02896400|564444380|FG001|1 Month Follow-up|Lost to Follow-up|7|||
156367186|NCT02896400|564444381|FG002|1 Month Follow-up|Lost to Follow-up|5|||
156367187|NCT02896400|564444382|FG003|1 Month Follow-up|Lost to Follow-up|8|||
156367188|NCT02896400|564444383|FG004|1 Month Follow-up|Lost to Follow-up|9|||
156367189|NCT02896400|564444384|FG005|1 Month Follow-up|Lost to Follow-up|6|||
156367190|NCT02896400|564444385|FG006|1 Month Follow-up|Lost to Follow-up|5|||
156367191|NCT02896400|564444386|FG007|1 Month Follow-up|Lost to Follow-up|6|||
156367192|NCT02896400|564444387|FG008|1 Month Follow-up|Lost to Follow-up|4|||
156367193|NCT02896400|564444388|FG009|1 Month Follow-up|Lost to Follow-up|7|||
156367194|NCT02896400|564444389|FG010|1 Month Follow-up|Lost to Follow-up|5|||
156367195|NCT02896400|564444390|FG011|1 Month Follow-up|Lost to Follow-up|5|||
156367196|NCT02896400|564444391|FG012|1 Month Follow-up|Lost to Follow-up|3|||
156367197|NCT02896400|564444392|FG013|1 Month Follow-up|Lost to Follow-up|4|||
156367198|NCT02896400|564444393|FG014|1 Month Follow-up|Lost to Follow-up|1|||
156367199|NCT02896400|564444394|FG015|1 Month Follow-up|Lost to Follow-up|2|||
156367200|NCT02896400|564444379|FG000|1 Month Follow-up|Death|0|||
156367201|NCT02896400|564444380|FG001|1 Month Follow-up|Death|0|||
156367202|NCT02896400|564444381|FG002|1 Month Follow-up|Death|0|||
156367203|NCT02896400|564444382|FG003|1 Month Follow-up|Death|0|||
156367204|NCT02896400|564444383|FG004|1 Month Follow-up|Death|0|||
156367205|NCT02896400|564444384|FG005|1 Month Follow-up|Death|0|||
156367206|NCT02896400|564444385|FG006|1 Month Follow-up|Death|0|||
156367207|NCT02896400|564444386|FG007|1 Month Follow-up|Death|0|||
156367208|NCT02896400|564444387|FG008|1 Month Follow-up|Death|0|||
156367209|NCT02896400|564444388|FG009|1 Month Follow-up|Death|0|||
156367210|NCT02896400|564444389|FG010|1 Month Follow-up|Death|0|||
156367211|NCT02896400|564444390|FG011|1 Month Follow-up|Death|0|||
156367212|NCT02896400|564444391|FG012|1 Month Follow-up|Death|0|||
156367213|NCT02896400|564444392|FG013|1 Month Follow-up|Death|0|||
156367214|NCT02896400|564444393|FG014|1 Month Follow-up|Death|0|||
156367215|NCT02896400|564444394|FG015|1 Month Follow-up|Death|1|||
156367216|NCT02896400|564444379|FG000|3 Month Follow-up|Lost to Follow-up|6|||
156367217|NCT02896400|564444380|FG001|3 Month Follow-up|Lost to Follow-up|3|||
156367218|NCT02896400|564444381|FG002|3 Month Follow-up|Lost to Follow-up|6|||
156367219|NCT02896400|564444382|FG003|3 Month Follow-up|Lost to Follow-up|11|||
156367220|NCT02896400|564444383|FG004|3 Month Follow-up|Lost to Follow-up|12|||
156367221|NCT02896400|564444384|FG005|3 Month Follow-up|Lost to Follow-up|6|||
156491556|NCT00943722|564894926|FG002|Base Study|Month 12 visit not completed|0|||
156491557|NCT00943722|564894927|FG003|Base Study|Month 12 visit not completed|0|||
156491558|NCT00943722|564894928|FG004|Base Study|Month 12 visit not completed|2|||
156491559|NCT00943722|564894929|FG005|Base Study|Month 12 visit not completed|0|||
156491560|NCT00943722|564894930|FG006|Base Study|Month 12 visit not completed|0|||
156491561|NCT00943722|564894924|FG000|First Extension Study: EXT 1|Adverse Event|0|||
156491562|NCT00943722|564894925|FG001|First Extension Study: EXT 1|Adverse Event|0|||
156367222|NCT02896400|564444385|FG006|3 Month Follow-up|Lost to Follow-up|4|||
156367223|NCT02896400|564444386|FG007|3 Month Follow-up|Lost to Follow-up|3|||
156367224|NCT02896400|564444387|FG008|3 Month Follow-up|Lost to Follow-up|6|||
156367225|NCT02896400|564444388|FG009|3 Month Follow-up|Lost to Follow-up|5|||
156367226|NCT02896400|564444389|FG010|3 Month Follow-up|Lost to Follow-up|6|||
156367227|NCT02896400|564444390|FG011|3 Month Follow-up|Lost to Follow-up|6|||
156367228|NCT02896400|564444391|FG012|3 Month Follow-up|Lost to Follow-up|3|||
156367229|NCT02896400|564444392|FG013|3 Month Follow-up|Lost to Follow-up|5|||
156367230|NCT02896400|564444393|FG014|3 Month Follow-up|Lost to Follow-up|3|||
156367231|NCT02896400|564444394|FG015|3 Month Follow-up|Lost to Follow-up|2|||
156367232|NCT02896400|564444379|FG000|3 Month Follow-up|Death|0|||
156367233|NCT02896400|564444380|FG001|3 Month Follow-up|Death|0|||
156491563|NCT00943722|564894926|FG002|First Extension Study: EXT 1|Adverse Event|0|||
156491564|NCT00943722|564894927|FG003|First Extension Study: EXT 1|Adverse Event|0|||
156367234|NCT02896400|564444381|FG002|3 Month Follow-up|Death|0|||
156367235|NCT02896400|564444382|FG003|3 Month Follow-up|Death|0|||
156367236|NCT02896400|564444383|FG004|3 Month Follow-up|Death|0|||
156367237|NCT02896400|564444384|FG005|3 Month Follow-up|Death|0|||
156367238|NCT02896400|564444385|FG006|3 Month Follow-up|Death|0|||
156367239|NCT02896400|564444386|FG007|3 Month Follow-up|Death|0|||
156367240|NCT02896400|564444387|FG008|3 Month Follow-up|Death|0|||
156367241|NCT02896400|564444388|FG009|3 Month Follow-up|Death|0|||
156367242|NCT02896400|564444389|FG010|3 Month Follow-up|Death|0|||
156367243|NCT02896400|564444390|FG011|3 Month Follow-up|Death|0|||
156367244|NCT02896400|564444391|FG012|3 Month Follow-up|Death|0|||
156367245|NCT02896400|564444392|FG013|3 Month Follow-up|Death|1|||
156367246|NCT02896400|564444393|FG014|3 Month Follow-up|Death|1|||
156367247|NCT02896400|564444394|FG015|3 Month Follow-up|Death|0|||
156367248|NCT02896400|564444379|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156367249|NCT02896400|564444380|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156367250|NCT02896400|564444381|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156367251|NCT02896400|564444382|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156367252|NCT02896400|564444383|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156367253|NCT02896400|564444384|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156367254|NCT02896400|564444385|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
156367255|NCT02896400|564444386|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
156367256|NCT02896400|564444387|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156367257|NCT02896400|564444388|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156367258|NCT02896400|564444389|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156367259|NCT02896400|564444390|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156367260|NCT02896400|564444391|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156367261|NCT02896400|564444392|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156367262|NCT02896400|564444393|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
156367263|NCT02896400|564444394|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156367264|NCT02896400|564444379|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
156367265|NCT02896400|564444380|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
156367266|NCT02896400|564444381|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
156367267|NCT02896400|564444382|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
156367268|NCT02896400|564444383|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
156367269|NCT02896400|564444384|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
156367270|NCT02896400|564444385|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
156367271|NCT02896400|564444386|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
156367272|NCT02896400|564444387|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
156367273|NCT02896400|564444388|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
156367274|NCT02896400|564444389|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
156367275|NCT02896400|564444390|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
156367276|NCT02896400|564444391|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
156367277|NCT02896400|564444392|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
156367278|NCT02896400|564444393|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
156367279|NCT02896400|564444394|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
156367280|NCT02984020|564444395|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
156367281|NCT02984020|564444395|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
156367282|NCT02984020|564444395|FG000|Overall Study|Other significant protocol violation|2|||
156367283|NCT01700179|564444396|FG000|Overall Study|Physician Decision|2|||
156367284|NCT01896895|564444397|FG000|Double-blind MP|Physician Decision|0|||
156367285|NCT01896895|564444398|FG001|Double-blind MP|Physician Decision|0|||
156367286|NCT01896895|564444399|FG002|Double-blind MP|Physician Decision|1|||
156367287|NCT01896895|564444400|FG003|Double-blind MP|Physician Decision|0|||
156367288|NCT01896895|564444397|FG000|Double-blind MP|Withdrawal by Subject|0|||
156367289|NCT01896895|564444398|FG001|Double-blind MP|Withdrawal by Subject|2|||
156367290|NCT01896895|564444399|FG002|Double-blind MP|Withdrawal by Subject|1|||
156367291|NCT01896895|564444400|FG003|Double-blind MP|Withdrawal by Subject|0|||
156367292|NCT01896895|564444397|FG000|Double-blind MP|Lost to Follow-up|1|||
156367293|NCT01896895|564444398|FG001|Double-blind MP|Lost to Follow-up|0|||
156367294|NCT01896895|564444399|FG002|Double-blind MP|Lost to Follow-up|1|||
156367295|NCT01896895|564444400|FG003|Double-blind MP|Lost to Follow-up|0|||
156367296|NCT00773175|564444404|FG000|Overall Study|Adverse Event|2|||
156367297|NCT00773175|564444405|FG001|Overall Study|Adverse Event|0|||
156367298|NCT00773175|564444404|FG000|Overall Study|Consent Withdrawn|0|||
156367299|NCT00773175|564444405|FG001|Overall Study|Consent Withdrawn|2|||
156367300|NCT00503841|564444406|FG000|Overall Study|All screen failures|44|||
156367301|NCT01982253|564444412|FG000|Overall Study|Withdrawal by Subject|1|||
156367302|NCT01982253|564444413|FG001|Overall Study|Withdrawal by Subject|0|||
156367303|NCT01982253|564444414|FG002|Overall Study|Withdrawal by Subject|0|||
156367304|NCT01982253|564444412|FG000|Overall Study|Study terminated by sponsor|1|||
156367305|NCT01982253|564444413|FG001|Overall Study|Study terminated by sponsor|4|||
156367306|NCT01982253|564444414|FG002|Overall Study|Study terminated by sponsor|4|||
156491565|NCT00943722|564894928|FG004|First Extension Study: EXT 1|Adverse Event|0|||
156491566|NCT00943722|564894929|FG005|First Extension Study: EXT 1|Adverse Event|1|||
156491567|NCT00943722|564894930|FG006|First Extension Study: EXT 1|Adverse Event|0|||
156491568|NCT00943722|564894924|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
156491569|NCT00943722|564894925|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
156367307|NCT00779675|564444419|FG000|Treatment Period|Adverse Event|87|||
156367308|NCT00779675|564444419|FG000|Treatment Period|Treatment Failure|80|||
156367309|NCT00779675|564444419|FG000|Treatment Period|Transferred to Another Study|38|||
156546084|NCT00960661|565093288|FG001|Interventional Phase|Physician Decision|3|||
156546085|NCT00960661|565093289|FG002|Interventional Phase|Physician Decision|5|||
156546086|NCT00960661|565093287|FG000|Interventional Phase|sponsor decision|0|||
156546087|NCT00960661|565093288|FG001|Interventional Phase|sponsor decision|1|||
156546088|NCT00960661|565093289|FG002|Interventional Phase|sponsor decision|0|||
156546089|NCT00960661|565093287|FG000|Interventional Phase|Lack of Efficacy|0|||
156546090|NCT00960661|565093288|FG001|Interventional Phase|Lack of Efficacy|2|||
156546091|NCT00960661|565093289|FG002|Interventional Phase|Lack of Efficacy|0|||
156546092|NCT02699892|565093290|FG000|Overall Study|Other|36|||
156546093|NCT00711100|565093291|FG000|Overall Study|Lack of Efficacy|5|||
156367310|NCT00779675|564444419|FG000|Treatment Period|Lost to Follow-up|23|||
156367311|NCT00779675|564444419|FG000|Treatment Period|Withdrawal by Subject|46|||
156367312|NCT00779675|564444419|FG000|Treatment Period|Protocol Violation|54|||
156367313|NCT00779675|564444419|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
156367314|NCT00779675|564444419|FG000|Treatment Period|Administrative|3|||
156367315|NCT00779675|564444419|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
156367316|NCT00779675|564444419|FG000|Extended Treatment Period|Protocol Violation|13|||
156367317|NCT00779675|564444419|FG000|Extended Treatment Period|Adverse Event|6|||
156367318|NCT00779675|564444419|FG000|Extended Treatment Period|Treatment Failure|11|||
156367319|NCT00779675|564444419|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
156367320|NCT00779675|564444419|FG000|Extended Treatment Period|Lost to Follow-up|6|||
156367321|NCT01633944|564444432|FG000|Open-label Titration Phase|Adverse Event|109|||
156491570|NCT00943722|564894926|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
156491571|NCT00943722|564894927|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
156491572|NCT00943722|564894928|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
156491573|NCT00943722|564894929|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
156491574|NCT00943722|564894930|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
156491575|NCT00943722|564894924|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
156491576|NCT00943722|564894925|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
156491577|NCT00943722|564894926|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
156491578|NCT00943722|564894927|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
156491579|NCT00943722|564894928|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
156491580|NCT00943722|564894929|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
156491581|NCT00943722|564894930|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
156491582|NCT00943722|564894924|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
156491583|NCT00943722|564894925|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
156491584|NCT00943722|564894926|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
156491585|NCT00943722|564894927|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
156491586|NCT00943722|564894928|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
156491587|NCT00943722|564894929|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
156491588|NCT00943722|564894930|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
156491589|NCT00943722|564894924|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
156491590|NCT00943722|564894925|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
156491591|NCT00943722|564894926|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
156491592|NCT00943722|564894927|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
156491593|NCT00943722|564894928|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
156491594|NCT00943722|564894929|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
156491595|NCT00943722|564894930|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
156491596|NCT00943722|564894924|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
156491597|NCT00943722|564894925|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
156491598|NCT00943722|564894926|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
156491599|NCT00943722|564894927|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
156491600|NCT00943722|564894928|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
156491601|NCT00943722|564894929|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
156491602|NCT00943722|564894930|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
156491603|NCT00943722|564894924|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
156491604|NCT00943722|564894925|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
156491605|NCT00943722|564894926|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
156491606|NCT00943722|564894927|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
156491607|NCT00943722|564894928|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
156491608|NCT00943722|564894929|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
156491609|NCT00943722|564894930|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
156491610|NCT00943722|564894924|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
156491611|NCT00943722|564894925|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
156491612|NCT00943722|564894926|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
156491613|NCT00943722|564894927|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
156491614|NCT00943722|564894928|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
156546094|NCT00711100|565093291|FG000|Overall Study|Withdrawal by Subject|8|||
156546095|NCT02412787|565093292|FG000|Overall Study|Withdrawal by Subject|9|||
156367322|NCT01633944|564444433|FG001|Open-label Titration Phase|Adverse Event|0|||
156367323|NCT01633944|564444434|FG002|Open-label Titration Phase|Adverse Event|0|||
156491615|NCT00943722|564894929|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
156491616|NCT00943722|564894930|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
156491617|NCT00943722|564894924|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
156491618|NCT00943722|564894925|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
156491619|NCT00943722|564894926|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
156491620|NCT00943722|564894927|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
156491621|NCT00943722|564894928|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
156491622|NCT00943722|564894929|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
156491623|NCT00943722|564894930|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
156491624|NCT01772823|564894931|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
156491625|NCT01772823|564894932|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
156491626|NCT01772823|564894931|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
156491627|NCT01772823|564894932|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
156491628|NCT01772823|564894931|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
156491629|NCT01772823|564894932|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
156367324|NCT01633944|564444432|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
156367325|NCT01633944|564444433|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
156367326|NCT01633944|564444434|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
156367327|NCT01633944|564444432|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
156367328|NCT01633944|564444433|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
156367329|NCT01633944|564444434|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
156367330|NCT01633944|564444432|FG000|Open-label Titration Phase|Protocol Violation|24|||
156367331|NCT01633944|564444433|FG001|Open-label Titration Phase|Protocol Violation|0|||
156367332|NCT01633944|564444434|FG002|Open-label Titration Phase|Protocol Violation|0|||
156367333|NCT01633944|564444432|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
156367334|NCT01633944|564444433|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
156367335|NCT01633944|564444434|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
156367336|NCT01633944|564444432|FG000|Open-label Titration Phase|Other|68|||
156367337|NCT01633944|564444433|FG001|Open-label Titration Phase|Other|0|||
156367338|NCT01633944|564444434|FG002|Open-label Titration Phase|Other|0|||
156367339|NCT01633944|564444432|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156367340|NCT01633944|564444433|FG001|Double-blind Treatment Phase|Adverse Event|13|||
156367341|NCT01633944|564444434|FG002|Double-blind Treatment Phase|Adverse Event|7|||
156367342|NCT01633944|564444432|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
156367343|NCT01633944|564444433|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
156367344|NCT01633944|564444434|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
156367345|NCT01633944|564444432|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156367346|NCT01633944|564444433|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
156367347|NCT01633944|564444434|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
156367348|NCT01633944|564444432|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
156367349|NCT01633944|564444433|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
156367350|NCT01633944|564444434|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
156367351|NCT01633944|564444432|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156367352|NCT01633944|564444433|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
156367353|NCT01633944|564444434|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
156367354|NCT01633944|564444432|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
156367355|NCT01633944|564444433|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
156367356|NCT01633944|564444434|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
156367357|NCT01633944|564444432|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
156367358|NCT01633944|564444433|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
156367359|NCT01633944|564444434|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
156367360|NCT01633944|564444432|FG000|Double-blind Treatment Phase|Other|0|||
156367361|NCT01633944|564444433|FG001|Double-blind Treatment Phase|Other|7|||
156367362|NCT01633944|564444434|FG002|Double-blind Treatment Phase|Other|0|||
156367363|NCT00463060|564444438|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
156367364|NCT00463060|564444438|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
156367365|NCT00701129|564444439|FG000|Overall Study|Death|2|||
156367366|NCT01400841|564444440|FG000|Initial Study Phase (6 Months)|Death|1|||
156367367|NCT01400841|564444440|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
156367368|NCT00770120|564444443|FG000|Overall Study|Progression|31|||
156367369|NCT00770120|564444443|FG000|Overall Study|Adverse Event|11|||
156367370|NCT00770120|564444443|FG000|Overall Study|Not Protocol Specified|11|||
156367371|NCT00770120|564444443|FG000|Overall Study|Death|3|||
156367372|NCT00770120|564444443|FG000|Overall Study|Withdrawal by Subject|2|||
156367373|NCT00770120|564444443|FG000|Overall Study|Ineligible|1|||
156367374|NCT00770120|564444443|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
156367375|NCT00770120|564444443|FG000|Overall Study|Reason under Review|1|||
156367376|NCT04304001|564444444|FG000|Overall Study|Lost to Follow-up|13|||
156367377|NCT04304001|564444445|FG001|Overall Study|Lost to Follow-up|9|||
156367378|NCT03752619|564444446|FG000|Overall Study|Lost to Follow-up|2|||
156367379|NCT03752619|564444447|FG001|Overall Study|Lost to Follow-up|1|||
156367380|NCT03752619|564444446|FG000|Overall Study|Withdrawal by Subject|1|||
156367381|NCT03752619|564444447|FG001|Overall Study|Withdrawal by Subject|1|||
156367382|NCT03752619|564444446|FG000|Overall Study|Adverse Event|0|||
156367383|NCT03752619|564444447|FG001|Overall Study|Adverse Event|1|||
156367384|NCT03907683|564444448|FG000|Overall Study|Pregnancy|1|||
156367385|NCT03907683|564444448|FG000|Overall Study|Withdrawal by Subject|1|||
156367386|NCT00235872|564444449|FG000|Overall Study|Adverse Event|34|||
156367387|NCT00235872|564444449|FG000|Overall Study|Death|1|||
156367388|NCT00235872|564444449|FG000|Overall Study|Lost to Follow-up|1|||
156367389|NCT00235872|564444449|FG000|Overall Study|Withdrawal by Subject|50|||
156367390|NCT00235872|564444449|FG000|Overall Study|Administrative reason|61|||
156367391|NCT02027844|564444450|FG000|Overall Study|Withdrawal by Subject|3|||
156367392|NCT02027844|564444451|FG001|Overall Study|Withdrawal by Subject|2|||
156367393|NCT02027844|564444452|FG002|Overall Study|Withdrawal by Subject|1|||
156367394|NCT02027844|564444450|FG000|Overall Study|Lost to Follow-up|0|||
156367395|NCT02027844|564444451|FG001|Overall Study|Lost to Follow-up|2|||
156367396|NCT02027844|564444452|FG002|Overall Study|Lost to Follow-up|1|||
156491630|NCT01772823|564894931|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
156491631|NCT01772823|564894932|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
156491632|NCT01772823|564894931|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
156491633|NCT01772823|564894932|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
156491634|NCT01772823|564894931|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
156491635|NCT01772823|564894932|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
156491636|NCT01772823|564894931|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
156491637|NCT01772823|564894932|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
156491638|NCT01772823|564894931|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
156491639|NCT01772823|564894932|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
156491640|NCT01772823|564894931|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
156491641|NCT01772823|564894932|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
156491642|NCT01772823|564894931|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
156491643|NCT01772823|564894932|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
156491644|NCT01772823|564894931|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
156491645|NCT01772823|564894932|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
156491646|NCT01772823|564894931|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
156491647|NCT01772823|564894932|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
156491648|NCT01772823|564894931|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
156491649|NCT01772823|564894932|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
156491650|NCT01772823|564894931|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
156491651|NCT01772823|564894932|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
156491652|NCT01772823|564894931|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
156491653|NCT01772823|564894932|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
156491654|NCT01772823|564894931|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
156491655|NCT01772823|564894932|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
156491656|NCT01036165|564894937|FG000|Overall Study|Adverse Event|6|||
156367397|NCT02027844|564444450|FG000|Overall Study|Protocol Violation|0|||
156367398|NCT02027844|564444451|FG001|Overall Study|Protocol Violation|2|||
156367399|NCT02027844|564444452|FG002|Overall Study|Protocol Violation|0|||
156367400|NCT02027844|564444450|FG000|Overall Study|Incomlete data|2|||
156367401|NCT02027844|564444451|FG001|Overall Study|Incomlete data|0|||
156367402|NCT02027844|564444452|FG002|Overall Study|Incomlete data|0|||
156367403|NCT00378014|564444453|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
156367404|NCT00378014|564444454|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
156367405|NCT00378014|564444453|FG000|Core (Randomization to Month 11)|Graft loss|1|||
156367406|NCT00378014|564444454|FG001|Core (Randomization to Month 11)|Graft loss|2|||
156367407|NCT00378014|564444453|FG000|Core (Randomization to Month 11)|Death|5|||
156367408|NCT00378014|564444454|FG001|Core (Randomization to Month 11)|Death|3|||
156367409|NCT00378014|564444453|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
156367410|NCT00378014|564444454|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
156367411|NCT00378014|564444453|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
156367412|NCT00378014|564444454|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
156367413|NCT00378014|564444453|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
156367414|NCT00378014|564444454|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
156367415|NCT00378014|564444453|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
156367416|NCT00378014|564444454|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
156367417|NCT00378014|564444453|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
156367418|NCT00378014|564444454|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
156367419|NCT00378014|564444453|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
156367420|NCT00378014|564444454|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
156367421|NCT00378014|564444453|FG000|Extension (Month 12 to Month 59)|Death|1|||
156367422|NCT00378014|564444454|FG001|Extension (Month 12 to Month 59)|Death|2|||
156367423|NCT00378014|564444453|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
156367424|NCT00378014|564444454|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
156491657|NCT01036165|564894937|FG000|Overall Study|Lost to Follow-up|2|||
156491658|NCT01036165|564894937|FG000|Overall Study|Withdrawal by Subject|3|||
156491659|NCT01036165|564894937|FG000|Overall Study|Device Related Issues|3|||
156491660|NCT01036165|564894937|FG000|Overall Study|Problems finding proper area to inject|1|||
156491661|NCT02544113|564894942|FG000|Overall Study|Death|3|||
156491662|NCT02544113|564894943|FG001|Overall Study|Death|4|||
156491663|NCT02847637|564894945|FG000|Overall Study|Withdrawal by Subject|0|||
156491664|NCT02847637|564894946|FG001|Overall Study|Withdrawal by Subject|1|||
156491665|NCT02847637|564894947|FG002|Overall Study|Withdrawal by Subject|1|||
156491666|NCT02847637|564894948|FG003|Overall Study|Withdrawal by Subject|0|||
156491667|NCT02847637|564894945|FG000|Overall Study|Lost to Follow-up|1|||
156491668|NCT02847637|564894946|FG001|Overall Study|Lost to Follow-up|1|||
156491669|NCT02847637|564894947|FG002|Overall Study|Lost to Follow-up|0|||
156491670|NCT02847637|564894948|FG003|Overall Study|Lost to Follow-up|0|||
156491671|NCT01746108|564894951|FG000|Overall Study|Migrated /moved from study area|0|||
156491672|NCT01746108|564894952|FG001|Overall Study|Migrated /moved from study area|1|||
156491673|NCT01746108|564894953|FG002|Overall Study|Migrated /moved from study area|0|||
156491674|NCT01746108|564894951|FG000|Overall Study|Adverse event, non-fatal|0|||
156491675|NCT01746108|564894952|FG001|Overall Study|Adverse event, non-fatal|1|||
156491676|NCT01746108|564894953|FG002|Overall Study|Adverse event, non-fatal|0|||
156491677|NCT01746108|564894951|FG000|Overall Study|Withdrawal by Subject|0|||
156491678|NCT01746108|564894952|FG001|Overall Study|Withdrawal by Subject|1|||
156367425|NCT00378014|564444453|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
156367426|NCT00378014|564444454|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
156367427|NCT00378014|564444453|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
156491679|NCT01746108|564894953|FG002|Overall Study|Withdrawal by Subject|0|||
156491680|NCT01746108|564894951|FG000|Overall Study|Lost to Follow-up|0|||
156491681|NCT01746108|564894952|FG001|Overall Study|Lost to Follow-up|1|||
156491682|NCT01746108|564894953|FG002|Overall Study|Lost to Follow-up|0|||
156367428|NCT00378014|564444454|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
156367429|NCT00378014|564444453|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
156367430|NCT00378014|564444454|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
156367431|NCT00414661|564444455|FG000|Overall Study|Death|2|||
156367432|NCT00414661|564444456|FG001|Overall Study|Death|5|||
156367433|NCT00414661|564444457|FG002|Overall Study|Death|0|||
156367434|NCT00414661|564444458|FG003|Overall Study|Death|0|||
156367435|NCT00414661|564444455|FG000|Overall Study|Lost to Follow-up|1|||
156546096|NCT02412787|565093292|FG000|Overall Study|Participation Terminated by Investigator|1|||
156367436|NCT00414661|564444456|FG001|Overall Study|Lost to Follow-up|4|||
156367437|NCT00414661|564444457|FG002|Overall Study|Lost to Follow-up|0|||
156367438|NCT00414661|564444458|FG003|Overall Study|Lost to Follow-up|1|||
156367439|NCT00414661|564444455|FG000|Overall Study|Withdrawal by Subject|5|||
156367440|NCT00414661|564444456|FG001|Overall Study|Withdrawal by Subject|2|||
156367441|NCT00414661|564444457|FG002|Overall Study|Withdrawal by Subject|2|||
156367442|NCT00414661|564444458|FG003|Overall Study|Withdrawal by Subject|2|||
156367443|NCT00414661|564444455|FG000|Overall Study|Other|6|||
156367444|NCT00414661|564444456|FG001|Overall Study|Other|3|||
156367445|NCT00414661|564444457|FG002|Overall Study|Other|0|||
156367446|NCT00414661|564444458|FG003|Overall Study|Other|0|||
156367447|NCT02852265|564444462|FG000|3-month Follow-up|Lost to Follow-up|1|||
156367448|NCT02852265|564444463|FG001|3-month Follow-up|Lost to Follow-up|1|||
156367449|NCT04370691|564444474|FG000|Overall Study|Pending visit|48|||
156367450|NCT04370691|564444474|FG000|Overall Study|Have Not Reached Lower Window|15|||
156367451|NCT04370691|564444474|FG000|Overall Study|Termination|14|||
156367452|NCT04370691|564444474|FG000|Overall Study|Missed or Overdue|10|||
156367453|NCT00486265|564444475|FG000|Overall Study|Adverse Event|1|||
156367454|NCT00486265|564444475|FG000|Overall Study|Lack of Efficacy|8|||
156367455|NCT01452412|564444476|FG000|Overall Study|Withdrawal by Subject|15|||
156367456|NCT01452412|564444477|FG001|Overall Study|Withdrawal by Subject|11|||
156367457|NCT01452412|564444476|FG000|Overall Study|Adverse Event|4|||
156367458|NCT01452412|564444477|FG001|Overall Study|Adverse Event|3|||
156367459|NCT01452412|564444476|FG000|Overall Study|Lost to Follow-up|5|||
156367460|NCT01452412|564444477|FG001|Overall Study|Lost to Follow-up|3|||
156367461|NCT01452412|564444476|FG000|Overall Study|Death|1|||
156367462|NCT01452412|564444477|FG001|Overall Study|Death|0|||
156367463|NCT01452412|564444476|FG000|Overall Study|Initiated dialysis|1|||
156367464|NCT01452412|564444477|FG001|Overall Study|Initiated dialysis|0|||
156367465|NCT01452412|564444476|FG000|Overall Study|Other|2|||
156367466|NCT01452412|564444477|FG001|Overall Study|Other|0|||
156367467|NCT03013543|564444478|FG000|Overall Study|Withdrawal by Subject|0|||
156367468|NCT03013543|564444479|FG001|Overall Study|Withdrawal by Subject|2|||
156367469|NCT03013543|564444480|FG002|Overall Study|Withdrawal by Subject|0|||
156367470|NCT03013543|564444481|FG003|Overall Study|Withdrawal by Subject|5|||
156367471|NCT03013543|564444482|FG004|Overall Study|Withdrawal by Subject|6|||
156367472|NCT03013543|564444483|FG005|Overall Study|Withdrawal by Subject|2|||
156367473|NCT03013543|564444484|FG006|Overall Study|Withdrawal by Subject|3|||
156367474|NCT03013543|564444485|FG007|Overall Study|Withdrawal by Subject|1|||
156367475|NCT03013543|564444486|FG008|Overall Study|Withdrawal by Subject|0|||
156367476|NCT03013543|564444487|FG009|Overall Study|Withdrawal by Subject|4|||
156367477|NCT03013543|564444478|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156367478|NCT03013543|564444479|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
156367479|NCT03013543|564444480|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
156367480|NCT03013543|564444481|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
156367481|NCT03013543|564444482|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
156367482|NCT03013543|564444483|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
156367483|NCT03013543|564444484|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
156367484|NCT03013543|564444485|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
156367485|NCT03013543|564444486|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
156367486|NCT03013543|564444487|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
156367487|NCT03013543|564444478|FG000|Overall Study|Other|0|||
156367488|NCT03013543|564444479|FG001|Overall Study|Other|0|||
156367489|NCT03013543|564444480|FG002|Overall Study|Other|2|||
156367490|NCT03013543|564444481|FG003|Overall Study|Other|0|||
156367491|NCT03013543|564444482|FG004|Overall Study|Other|2|||
156367492|NCT03013543|564444483|FG005|Overall Study|Other|0|||
156367493|NCT03013543|564444484|FG006|Overall Study|Other|0|||
156367494|NCT03013543|564444485|FG007|Overall Study|Other|0|||
156367495|NCT03013543|564444486|FG008|Overall Study|Other|1|||
156367496|NCT03013543|564444487|FG009|Overall Study|Other|0|||
156367497|NCT03013543|564444478|FG000|Overall Study|Adverse Event|0|||
156367498|NCT03013543|564444479|FG001|Overall Study|Adverse Event|0|||
156367499|NCT03013543|564444480|FG002|Overall Study|Adverse Event|0|||
156367500|NCT03013543|564444481|FG003|Overall Study|Adverse Event|3|||
156367501|NCT03013543|564444482|FG004|Overall Study|Adverse Event|2|||
156367502|NCT03013543|564444483|FG005|Overall Study|Adverse Event|1|||
156367503|NCT03013543|564444484|FG006|Overall Study|Adverse Event|3|||
156367504|NCT03013543|564444485|FG007|Overall Study|Adverse Event|8|||
156367505|NCT03013543|564444486|FG008|Overall Study|Adverse Event|0|||
156491683|NCT03036150|564894954|FG000|Overall Study|Withdrawal by Subject|8|||
156491684|NCT03036150|564894955|FG001|Overall Study|Withdrawal by Subject|3|||
156491685|NCT03036150|564894954|FG000|Overall Study|Lost to Follow-up|2|||
156491686|NCT03036150|564894955|FG001|Overall Study|Lost to Follow-up|2|||
156491687|NCT01388478|564894961|FG000|Overall Study|Adverse Event|4|||
156491688|NCT01388478|564894961|FG000|Overall Study|Withdrawal by Subject|1|||
156491689|NCT00550446|564894964|FG000|Up To Week 12|Adverse Event|2|||
156491690|NCT00550446|564894965|FG001|Up To Week 12|Adverse Event|2|||
156491691|NCT00550446|564894966|FG002|Up To Week 12|Adverse Event|0|||
156491692|NCT00550446|564894967|FG003|Up To Week 12|Adverse Event|0|||
156491693|NCT00550446|564894968|FG004|Up To Week 12|Adverse Event|2|||
156491694|NCT00550446|564894969|FG005|Up To Week 12|Adverse Event|2|||
156491695|NCT00550446|564894970|FG006|Up To Week 12|Adverse Event|1|||
156491696|NCT00550446|564894971|FG007|Up To Week 12|Adverse Event|0|||
156367506|NCT03013543|564444487|FG009|Overall Study|Adverse Event|2|||
156367507|NCT03013543|564444478|FG000|Overall Study|Death|0|||
156367508|NCT03013543|564444479|FG001|Overall Study|Death|0|||
156367509|NCT03013543|564444480|FG002|Overall Study|Death|0|||
156367510|NCT03013543|564444481|FG003|Overall Study|Death|1|||
156367511|NCT03013543|564444482|FG004|Overall Study|Death|0|||
156367512|NCT03013543|564444483|FG005|Overall Study|Death|0|||
156367513|NCT03013543|564444484|FG006|Overall Study|Death|0|||
156367514|NCT03013543|564444485|FG007|Overall Study|Death|0|||
156367515|NCT03013543|564444486|FG008|Overall Study|Death|0|||
156367516|NCT03013543|564444487|FG009|Overall Study|Death|0|||
156367517|NCT03013543|564444478|FG000|Overall Study|Lack of Efficacy|0|||
156367518|NCT03013543|564444479|FG001|Overall Study|Lack of Efficacy|0|||
156367519|NCT03013543|564444480|FG002|Overall Study|Lack of Efficacy|0|||
156367520|NCT03013543|564444481|FG003|Overall Study|Lack of Efficacy|1|||
156367521|NCT03013543|564444482|FG004|Overall Study|Lack of Efficacy|0|||
156367522|NCT03013543|564444483|FG005|Overall Study|Lack of Efficacy|0|||
156367523|NCT03013543|564444484|FG006|Overall Study|Lack of Efficacy|0|||
156367524|NCT03013543|564444485|FG007|Overall Study|Lack of Efficacy|0|||
156367525|NCT03013543|564444486|FG008|Overall Study|Lack of Efficacy|0|||
156367526|NCT03013543|564444487|FG009|Overall Study|Lack of Efficacy|0|||
156367527|NCT03013543|564444478|FG000|Overall Study|Lost to Follow-up|0|||
156367528|NCT03013543|564444479|FG001|Overall Study|Lost to Follow-up|0|||
156367529|NCT03013543|564444480|FG002|Overall Study|Lost to Follow-up|0|||
156367530|NCT03013543|564444481|FG003|Overall Study|Lost to Follow-up|1|||
156367531|NCT03013543|564444482|FG004|Overall Study|Lost to Follow-up|0|||
156367532|NCT03013543|564444483|FG005|Overall Study|Lost to Follow-up|0|||
156367533|NCT03013543|564444484|FG006|Overall Study|Lost to Follow-up|1|||
156367534|NCT03013543|564444485|FG007|Overall Study|Lost to Follow-up|0|||
156367535|NCT03013543|564444486|FG008|Overall Study|Lost to Follow-up|0|||
156367536|NCT03013543|564444487|FG009|Overall Study|Lost to Follow-up|2|||
156367537|NCT03013543|564444478|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156367538|NCT03013543|564444479|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156367539|NCT03013543|564444480|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156367540|NCT03013543|564444481|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156367541|NCT03013543|564444482|FG004|Overall Study|Non-Compliance With Study Drug|0|||
156367542|NCT03013543|564444483|FG005|Overall Study|Non-Compliance With Study Drug|0|||
156367543|NCT03013543|564444484|FG006|Overall Study|Non-Compliance With Study Drug|0|||
156367544|NCT03013543|564444485|FG007|Overall Study|Non-Compliance With Study Drug|0|||
156367545|NCT03013543|564444486|FG008|Overall Study|Non-Compliance With Study Drug|1|||
156367546|NCT03013543|564444487|FG009|Overall Study|Non-Compliance With Study Drug|0|||
156367547|NCT03013543|564444478|FG000|Overall Study|Physician Decision|0|||
156491697|NCT00550446|564894972|FG008|Up To Week 12|Adverse Event|0|||
156491698|NCT00550446|564894973|FG009|Up To Week 12|Adverse Event|0|||
156491699|NCT00550446|564894974|FG010|Up To Week 12|Adverse Event|0|||
156367548|NCT03013543|564444479|FG001|Overall Study|Physician Decision|0|||
156367549|NCT03013543|564444480|FG002|Overall Study|Physician Decision|0|||
156367550|NCT03013543|564444481|FG003|Overall Study|Physician Decision|0|||
156367551|NCT03013543|564444482|FG004|Overall Study|Physician Decision|1|||
156367552|NCT03013543|564444483|FG005|Overall Study|Physician Decision|0|||
156367553|NCT03013543|564444484|FG006|Overall Study|Physician Decision|0|||
156491700|NCT00550446|564894964|FG000|Up To Week 12|Lack of Efficacy|3|||
156491701|NCT00550446|564894965|FG001|Up To Week 12|Lack of Efficacy|1|||
156491702|NCT00550446|564894966|FG002|Up To Week 12|Lack of Efficacy|0|||
156367554|NCT03013543|564444485|FG007|Overall Study|Physician Decision|0|||
156367555|NCT03013543|564444486|FG008|Overall Study|Physician Decision|0|||
156491703|NCT00550446|564894967|FG003|Up To Week 12|Lack of Efficacy|1|||
156491704|NCT00550446|564894968|FG004|Up To Week 12|Lack of Efficacy|0|||
156491705|NCT00550446|564894969|FG005|Up To Week 12|Lack of Efficacy|3|||
156491706|NCT00550446|564894970|FG006|Up To Week 12|Lack of Efficacy|3|||
156491707|NCT00550446|564894971|FG007|Up To Week 12|Lack of Efficacy|0|||
156491708|NCT00550446|564894972|FG008|Up To Week 12|Lack of Efficacy|0|||
156367556|NCT03013543|564444487|FG009|Overall Study|Physician Decision|0|||
156367557|NCT03013543|564444478|FG000|Overall Study|Protocol Violation|0|||
156367558|NCT03013543|564444479|FG001|Overall Study|Protocol Violation|0|||
156367559|NCT03013543|564444480|FG002|Overall Study|Protocol Violation|0|||
156367560|NCT03013543|564444481|FG003|Overall Study|Protocol Violation|0|||
156367561|NCT03013543|564444482|FG004|Overall Study|Protocol Violation|0|||
156367562|NCT03013543|564444483|FG005|Overall Study|Protocol Violation|0|||
156367563|NCT03013543|564444484|FG006|Overall Study|Protocol Violation|0|||
156367564|NCT03013543|564444485|FG007|Overall Study|Protocol Violation|0|||
156367565|NCT03013543|564444486|FG008|Overall Study|Protocol Violation|0|||
156367566|NCT03013543|564444487|FG009|Overall Study|Protocol Violation|1|||
156367567|NCT00323414|564444488|FG000|Overall Study|Withdrawal by Subject|0|||
156367568|NCT00323414|564444489|FG001|Overall Study|Withdrawal by Subject|1|||
156367569|NCT02552316|564444491|FG000|Overall Study|Withdrawal by Subject|1|||
156367570|NCT02552316|564444491|FG000|Overall Study|Withdrawal due to non-compliance|1|||
156367571|NCT04116710|564444495|FG000|Overall Study|Death|4|||
156367572|NCT04116710|564444496|FG001|Overall Study|Death|6|||
156367573|NCT04116710|564444497|FG002|Overall Study|Death|3|||
156367574|NCT04116710|564444498|FG003|Overall Study|Death|1|||
156367575|NCT04116710|564444495|FG000|Overall Study|Withdrawal by Subject|0|||
156367576|NCT04116710|564444496|FG001|Overall Study|Withdrawal by Subject|0|||
156367577|NCT04116710|564444497|FG002|Overall Study|Withdrawal by Subject|0|||
156367578|NCT04116710|564444498|FG003|Overall Study|Withdrawal by Subject|1|||
156367579|NCT01120210|564444499|FG000|MAIN INFUSION|Adverse Event|1|||
156367580|NCT01120210|564444500|FG001|MAIN INFUSION|Adverse Event|0|||
156367581|NCT01120210|564444499|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
156367582|NCT01120210|564444500|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
156367583|NCT04049760|564444514|FG000|Overall Study|Withdrawal by Subject|1|||
156367584|NCT00974571|564444515|FG000|Overall Study|Adverse Event|31|||
156367585|NCT00974571|564444516|FG001|Overall Study|Adverse Event|4|||
156367586|NCT00974571|564444517|FG002|Overall Study|Adverse Event|27|||
156367587|NCT00974571|564444515|FG000|Overall Study|Lack of Efficacy|3|||
156367588|NCT00974571|564444516|FG001|Overall Study|Lack of Efficacy|2|||
156367589|NCT00974571|564444517|FG002|Overall Study|Lack of Efficacy|9|||
156367590|NCT00974571|564444515|FG000|Overall Study|Lost to Follow-up|2|||
156367591|NCT00974571|564444516|FG001|Overall Study|Lost to Follow-up|1|||
156367592|NCT00974571|564444517|FG002|Overall Study|Lost to Follow-up|2|||
156367593|NCT00974571|564444515|FG000|Overall Study|Protocol Violation|13|||
156367594|NCT00974571|564444516|FG001|Overall Study|Protocol Violation|4|||
156367595|NCT00974571|564444517|FG002|Overall Study|Protocol Violation|18|||
156367596|NCT00974571|564444515|FG000|Overall Study|Withdrawal by Subject|14|||
156367597|NCT00974571|564444516|FG001|Overall Study|Withdrawal by Subject|5|||
156367598|NCT00974571|564444517|FG002|Overall Study|Withdrawal by Subject|16|||
156367599|NCT00974571|564444515|FG000|Overall Study|Patient Moved|1|||
156367600|NCT00974571|564444516|FG001|Overall Study|Patient Moved|0|||
156367601|NCT00974571|564444517|FG002|Overall Study|Patient Moved|1|||
156367602|NCT00974571|564444515|FG000|Overall Study|Other|4|||
156367603|NCT00974571|564444516|FG001|Overall Study|Other|0|||
156367604|NCT00974571|564444517|FG002|Overall Study|Other|10|||
156367605|NCT02703636|564444521|FG000|Overall Study|Adverse Event|14|||
156367606|NCT02703636|564444521|FG000|Overall Study|Study stopped by sponsor|1|||
156367607|NCT02703636|564444521|FG000|Overall Study|Withdrawal by Subject|1|||
156367608|NCT03778931|564444527|FG000|Overall Study|Withdrawal by Subject|12|||
156367609|NCT03778931|564444528|FG001|Overall Study|Withdrawal by Subject|25|||
156367610|NCT03778931|564444527|FG000|Overall Study|Physician Decision|1|||
156367611|NCT03778931|564444528|FG001|Overall Study|Physician Decision|3|||
156367612|NCT03778931|564444527|FG000|Overall Study|Participant Noncompliance|1|||
156367613|NCT03778931|564444528|FG001|Overall Study|Participant Noncompliance|1|||
156367614|NCT03778931|564444527|FG000|Overall Study|Lost to Follow-up|4|||
156367615|NCT03778931|564444528|FG001|Overall Study|Lost to Follow-up|1|||
156367616|NCT03778931|564444527|FG000|Overall Study|Death|69|||
156367617|NCT03778931|564444528|FG001|Overall Study|Death|79|||
156367618|NCT02130765|564444529|FG000|Overall Study|Did not receive treatment|4|||
156367619|NCT02130765|564444530|FG001|Overall Study|Did not receive treatment|0|||
156491709|NCT00550446|564894973|FG009|Up To Week 12|Lack of Efficacy|0|||
156491710|NCT00550446|564894974|FG010|Up To Week 12|Lack of Efficacy|0|||
156367620|NCT02130765|564444531|FG002|Overall Study|Did not receive treatment|0|||
156367621|NCT02130765|564444532|FG003|Overall Study|Did not receive treatment|0|||
156491711|NCT00550446|564894964|FG000|Up To Week 12|Lost to Follow-up|0|||
156367622|NCT00717769|564444552|FG000|Overall Study|Adverse Event|9|||
156367623|NCT00717769|564444553|FG001|Overall Study|Adverse Event|6|||
156367624|NCT00717769|564444554|FG002|Overall Study|Adverse Event|1|||
156367625|NCT00717769|564444552|FG000|Overall Study|Lack of compliance|0|||
156367626|NCT00717769|564444553|FG001|Overall Study|Lack of compliance|2|||
156367627|NCT00717769|564444554|FG002|Overall Study|Lack of compliance|0|||
156367628|NCT00717769|564444552|FG000|Overall Study|Lost to Follow-up|3|||
156367629|NCT00717769|564444553|FG001|Overall Study|Lost to Follow-up|4|||
156367630|NCT00717769|564444554|FG002|Overall Study|Lost to Follow-up|0|||
156367631|NCT00717769|564444552|FG000|Overall Study|Lack of Efficacy|1|||
156367632|NCT00717769|564444553|FG001|Overall Study|Lack of Efficacy|2|||
156367633|NCT00717769|564444554|FG002|Overall Study|Lack of Efficacy|0|||
156367634|NCT00717769|564444552|FG000|Overall Study|Protocol Violation|0|||
156367635|NCT00717769|564444553|FG001|Overall Study|Protocol Violation|2|||
156491712|NCT00550446|564894965|FG001|Up To Week 12|Lost to Follow-up|1|||
156367636|NCT00717769|564444554|FG002|Overall Study|Protocol Violation|0|||
156367637|NCT00717769|564444552|FG000|Overall Study|Sponsor decision|1|||
156367638|NCT00717769|564444553|FG001|Overall Study|Sponsor decision|0|||
156367639|NCT00717769|564444554|FG002|Overall Study|Sponsor decision|10|||
156367640|NCT00717769|564444552|FG000|Overall Study|Withdrew consent|2|||
156367641|NCT00717769|564444553|FG001|Overall Study|Withdrew consent|2|||
156367642|NCT00717769|564444554|FG002|Overall Study|Withdrew consent|0|||
156367643|NCT00692770|564444555|FG000|Overall Study|Protocol Violation|2|||
156367644|NCT00692770|564444556|FG001|Overall Study|Protocol Violation|7|||
156367645|NCT00692770|564444555|FG000|Overall Study|Withdrawal by Subject|97|||
156367646|NCT00692770|564444556|FG001|Overall Study|Withdrawal by Subject|36|||
156367647|NCT00692770|564444555|FG000|Overall Study|Adverse Event|136|||
156367648|NCT00692770|564444556|FG001|Overall Study|Adverse Event|41|||
156367649|NCT00692770|564444555|FG000|Overall Study|Death|10|||
156367650|NCT00692770|564444556|FG001|Overall Study|Death|5|||
156367651|NCT00692770|564444555|FG000|Overall Study|Lost to Follow-up|7|||
156367652|NCT00692770|564444556|FG001|Overall Study|Lost to Follow-up|3|||
156367653|NCT00692770|564444555|FG000|Overall Study|Non-compliant with study medication|11|||
156367654|NCT00692770|564444556|FG001|Overall Study|Non-compliant with study medication|5|||
156367655|NCT00692770|564444555|FG000|Overall Study|Progression by clinical judgment|2|||
156367656|NCT00692770|564444556|FG001|Overall Study|Progression by clinical judgment|3|||
156367657|NCT00692770|564444555|FG000|Overall Study|Physician decision not protocol driven|10|||
156367658|NCT00692770|564444556|FG001|Overall Study|Physician decision not protocol driven|14|||
156367659|NCT00692770|564444555|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
156367660|NCT00692770|564444556|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
156367661|NCT00692770|564444555|FG000|Overall Study|Protocol driven decision point|3|||
156367662|NCT00692770|564444556|FG001|Overall Study|Protocol driven decision point|7|||
156367663|NCT00692770|564444555|FG000|Overall Study|Completed all planned assessments|79|||
156367664|NCT00692770|564444556|FG001|Overall Study|Completed all planned assessments|101|||
156367665|NCT00692770|564444555|FG000|Overall Study|Radiological and clinical progression|8|||
156367666|NCT00692770|564444556|FG001|Overall Study|Radiological and clinical progression|8|||
156367667|NCT00692770|564444555|FG000|Overall Study|Clinical endpoint reached|16|||
156367668|NCT00692770|564444556|FG001|Overall Study|Clinical endpoint reached|43|||
156367669|NCT00692770|564444555|FG000|Overall Study|Study terminated by sponsor|2|||
156367670|NCT00692770|564444556|FG001|Overall Study|Study terminated by sponsor|2|||
156367671|NCT00692770|564444555|FG000|Overall Study|Randomized but not treated|3|||
156367672|NCT00692770|564444556|FG001|Overall Study|Randomized but not treated|4|||
156367673|NCT04327986|564444557|FG000|Overall Study|Physician Decision|2|||
156367674|NCT04327986|564444558|FG001|Overall Study|Physician Decision|0|||
156367675|NCT04327986|564444559|FG002|Overall Study|Physician Decision|0|||
156367676|NCT04327986|564444557|FG000|Overall Study|Death|1|||
156367677|NCT04327986|564444558|FG001|Overall Study|Death|0|||
156367678|NCT04327986|564444559|FG002|Overall Study|Death|0|||
156367679|NCT03962543|564444561|FG000|Treatment Phase|Death|0|||
156367680|NCT03962543|564444562|FG001|Treatment Phase|Death|1|||
156367681|NCT03962543|564444561|FG000|Treatment Phase|Withdrawal by Subject|3|||
156367682|NCT03962543|564444562|FG001|Treatment Phase|Withdrawal by Subject|0|||
156367683|NCT03962543|564444561|FG000|Treatment Phase|Adverse Event|3|||
156367684|NCT03962543|564444562|FG001|Treatment Phase|Adverse Event|12|||
156367685|NCT03962543|564444561|FG000|Treatment Phase|Lost to Follow-up|1|||
156367686|NCT03962543|564444562|FG001|Treatment Phase|Lost to Follow-up|2|||
156367687|NCT03962543|564444561|FG000|Treatment Phase|Radiographic PD|9|||
156367688|NCT03962543|564444562|FG001|Treatment Phase|Radiographic PD|3|||
156367689|NCT03962543|564444561|FG000|Treatment Phase|Participant Decision|3|||
156367690|NCT03962543|564444562|FG001|Treatment Phase|Participant Decision|8|||
156367691|NCT03962543|564444561|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
156367692|NCT03962543|564444562|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
156491713|NCT00550446|564894966|FG002|Up To Week 12|Lost to Follow-up|0|||
156491714|NCT00550446|564894967|FG003|Up To Week 12|Lost to Follow-up|0|||
156491715|NCT00550446|564894968|FG004|Up To Week 12|Lost to Follow-up|1|||
156491716|NCT00550446|564894969|FG005|Up To Week 12|Lost to Follow-up|1|||
156491717|NCT00550446|564894970|FG006|Up To Week 12|Lost to Follow-up|2|||
156491718|NCT00550446|564894971|FG007|Up To Week 12|Lost to Follow-up|0|||
156367693|NCT03962543|564444561|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
156367694|NCT03962543|564444562|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
156367695|NCT03962543|564444561|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
156367696|NCT03962543|564444562|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
156367697|NCT03962543|564444561|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
156491719|NCT00550446|564894972|FG008|Up To Week 12|Lost to Follow-up|0|||
156491720|NCT00550446|564894973|FG009|Up To Week 12|Lost to Follow-up|0|||
156367698|NCT03962543|564444562|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
156367699|NCT03962543|564444561|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
156367700|NCT03962543|564444562|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
156367701|NCT03962543|564444561|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
156491721|NCT00550446|564894974|FG010|Up To Week 12|Lost to Follow-up|0|||
156491722|NCT00550446|564894964|FG000|Up To Week 12|Withdrawal by Subject|2|||
156367702|NCT03962543|564444562|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
156367703|NCT03962543|564444561|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
156367704|NCT03962543|564444562|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
156367705|NCT03962543|564444561|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
156367706|NCT03962543|564444562|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
156367707|NCT03962543|564444561|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
156367708|NCT03962543|564444562|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
156367709|NCT03962543|564444561|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
156367710|NCT03962543|564444562|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
156367711|NCT01207778|564446123|FG000|Overall Study|Lost to Follow-up|0|||
156367712|NCT01207778|564446124|FG001|Overall Study|Lost to Follow-up|3|||
156367713|NCT01207778|564446125|FG002|Overall Study|Lost to Follow-up|3|||
156367714|NCT00646204|564446128|FG000|Overall Study|Adverse Event|3|||
156367715|NCT00646204|564446129|FG001|Overall Study|Adverse Event|0|||
156367716|NCT00646204|564446128|FG000|Overall Study|Withdrawal by Subject|1|||
156367717|NCT00646204|564446129|FG001|Overall Study|Withdrawal by Subject|0|||
156367718|NCT01340976|564446130|FG000|Overall Study|Physician Decision|2|||
156367719|NCT01340976|564446131|FG001|Overall Study|Physician Decision|0|||
156367720|NCT01340976|564446132|FG002|Overall Study|Physician Decision|1|||
156367721|NCT01340976|564446133|FG003|Overall Study|Physician Decision|1|||
156367722|NCT01340976|564446134|FG004|Overall Study|Physician Decision|1|||
156367723|NCT01340976|564446135|FG005|Overall Study|Physician Decision|0|||
156367724|NCT01340976|564446130|FG000|Overall Study|Death|0|||
156367725|NCT01340976|564446131|FG001|Overall Study|Death|1|||
156367726|NCT01340976|564446132|FG002|Overall Study|Death|0|||
156367727|NCT01340976|564446133|FG003|Overall Study|Death|0|||
156367728|NCT01340976|564446134|FG004|Overall Study|Death|0|||
156367729|NCT01340976|564446135|FG005|Overall Study|Death|0|||
156367730|NCT01340976|564446130|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
156367731|NCT01340976|564446131|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156367732|NCT01340976|564446132|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156367733|NCT01340976|564446133|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156367734|NCT01340976|564446134|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156367735|NCT01340976|564446135|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156367736|NCT01340976|564446130|FG000|Overall Study|Withdrawal by Subject|0|||
156367737|NCT01340976|564446131|FG001|Overall Study|Withdrawal by Subject|0|||
156367738|NCT01340976|564446132|FG002|Overall Study|Withdrawal by Subject|0|||
156367739|NCT01340976|564446133|FG003|Overall Study|Withdrawal by Subject|1|||
156367740|NCT01340976|564446134|FG004|Overall Study|Withdrawal by Subject|1|||
156367741|NCT01340976|564446135|FG005|Overall Study|Withdrawal by Subject|0|||
156367742|NCT01340976|564446130|FG000|Overall Study|Other anemia treatment|1|||
156367743|NCT01340976|564446131|FG001|Overall Study|Other anemia treatment|0|||
156367744|NCT01340976|564446132|FG002|Overall Study|Other anemia treatment|2|||
156367745|NCT01340976|564446133|FG003|Overall Study|Other anemia treatment|1|||
156367746|NCT01340976|564446134|FG004|Overall Study|Other anemia treatment|0|||
156367747|NCT01340976|564446135|FG005|Overall Study|Other anemia treatment|1|||
156367748|NCT01340976|564446130|FG000|Overall Study|Adverse Event|0|||
156367749|NCT01340976|564446131|FG001|Overall Study|Adverse Event|1|||
156367750|NCT01340976|564446132|FG002|Overall Study|Adverse Event|0|||
156367751|NCT01340976|564446133|FG003|Overall Study|Adverse Event|0|||
156367752|NCT01340976|564446134|FG004|Overall Study|Adverse Event|0|||
156367753|NCT01340976|564446135|FG005|Overall Study|Adverse Event|0|||
156367754|NCT02953821|564446136|FG000|Overall Study|Adverse Event|0|||
156367755|NCT02953821|564446137|FG001|Overall Study|Adverse Event|4|||
156367756|NCT02953821|564446136|FG000|Overall Study|Death|1|||
156367757|NCT02953821|564446137|FG001|Overall Study|Death|0|||
156367758|NCT02953821|564446136|FG000|Overall Study|Progressive Disease|5|||
156367759|NCT02953821|564446137|FG001|Overall Study|Progressive Disease|1|||
156367760|NCT02953821|564446136|FG000|Overall Study|Lost to Follow-up|2|||
156367761|NCT02953821|564446137|FG001|Overall Study|Lost to Follow-up|0|||
156367762|NCT02953821|564446136|FG000|Overall Study|Physician Decision|1|||
156367763|NCT02953821|564446137|FG001|Overall Study|Physician Decision|1|||
156367764|NCT02953821|564446136|FG000|Overall Study|Withdrawal by Subject|3|||
156367765|NCT02953821|564446137|FG001|Overall Study|Withdrawal by Subject|3|||
156367766|NCT02953821|564446136|FG000|Overall Study|Change of address|0|||
156367767|NCT02953821|564446137|FG001|Overall Study|Change of address|1|||
156367768|NCT02953821|564446136|FG000|Overall Study|Lack of Efficacy|1|||
156367769|NCT02953821|564446137|FG001|Overall Study|Lack of Efficacy|0|||
156367770|NCT02953821|564446136|FG000|Overall Study|Out of state for indeterminate time|0|||
156367771|NCT02953821|564446137|FG001|Overall Study|Out of state for indeterminate time|1|||
156367772|NCT02953821|564446136|FG000|Overall Study|No improvement|0|||
156367773|NCT02953821|564446137|FG001|Overall Study|No improvement|1|||
156367774|NCT02953821|564446136|FG000|Overall Study|Refused follow-up visit|2|||
156367775|NCT02953821|564446137|FG001|Overall Study|Refused follow-up visit|1|||
156367776|NCT01067352|564446138|FG000|Overall Study|Withdrawal by Subject|1|||
156367777|NCT01067352|564446139|FG001|Overall Study|Withdrawal by Subject|2|||
156367778|NCT01067352|564446140|FG002|Overall Study|Withdrawal by Subject|1|||
156367779|NCT01067352|564446138|FG000|Overall Study|Physician Decision|0|||
156367780|NCT01067352|564446139|FG001|Overall Study|Physician Decision|1|||
156367781|NCT01067352|564446140|FG002|Overall Study|Physician Decision|0|||
156367782|NCT02566759|564446141|FG000|All Parts|Withdrawal by Subject|0|||
156367783|NCT02566759|564446142|FG001|All Parts|Withdrawal by Subject|1|||
156367784|NCT02566759|564446143|FG002|All Parts|Withdrawal by Subject|0|||
156367785|NCT02566759|564446144|FG003|All Parts|Withdrawal by Subject|0|||
156367786|NCT02566759|564446145|FG004|All Parts|Withdrawal by Subject|0|||
156367787|NCT02566759|564446146|FG005|All Parts|Withdrawal by Subject|0|||
156367788|NCT02566759|564446147|FG006|All Parts|Withdrawal by Subject|0|||
156367789|NCT02566759|564446148|FG007|All Parts|Withdrawal by Subject|0|||
156367790|NCT02566759|564446149|FG008|All Parts|Withdrawal by Subject|0|||
156367791|NCT02566759|564446150|FG009|All Parts|Withdrawal by Subject|0|||
156367792|NCT02566759|564446151|FG010|All Parts|Withdrawal by Subject|0|||
156367793|NCT02566759|564446152|FG011|All Parts|Withdrawal by Subject|0|||
156367794|NCT02566759|564446153|FG012|All Parts|Withdrawal by Subject|0|||
156367795|NCT02566759|564446154|FG013|All Parts|Withdrawal by Subject|0|||
156367796|NCT02566759|564446155|FG014|All Parts|Withdrawal by Subject|0|||
156367797|NCT02566759|564446156|FG015|All Parts|Withdrawal by Subject|0|||
156367798|NCT02566759|564446157|FG016|All Parts|Withdrawal by Subject|0|||
156367799|NCT02566759|564446141|FG000|All Parts|Adverse Event|0|||
156367800|NCT02566759|564446142|FG001|All Parts|Adverse Event|0|||
156367801|NCT02566759|564446143|FG002|All Parts|Adverse Event|0|||
156367802|NCT02566759|564446144|FG003|All Parts|Adverse Event|0|||
156367803|NCT02566759|564446145|FG004|All Parts|Adverse Event|0|||
156367804|NCT02566759|564446146|FG005|All Parts|Adverse Event|0|||
156367805|NCT02566759|564446147|FG006|All Parts|Adverse Event|0|||
156367806|NCT02566759|564446148|FG007|All Parts|Adverse Event|0|||
156367807|NCT02566759|564446149|FG008|All Parts|Adverse Event|0|||
156367808|NCT02566759|564446150|FG009|All Parts|Adverse Event|0|||
156367809|NCT02566759|564446151|FG010|All Parts|Adverse Event|0|||
156367810|NCT02566759|564446152|FG011|All Parts|Adverse Event|0|||
156367811|NCT02566759|564446153|FG012|All Parts|Adverse Event|1|||
156367812|NCT02566759|564446154|FG013|All Parts|Adverse Event|3|||
156367813|NCT02566759|564446155|FG014|All Parts|Adverse Event|0|||
156367814|NCT02566759|564446156|FG015|All Parts|Adverse Event|0|||
156367815|NCT02566759|564446157|FG016|All Parts|Adverse Event|0|||
156367816|NCT02566759|564446141|FG000|All Parts|Other|0|||
156367817|NCT02566759|564446142|FG001|All Parts|Other|0|||
156367818|NCT02566759|564446143|FG002|All Parts|Other|0|||
156367819|NCT02566759|564446144|FG003|All Parts|Other|0|||
156367820|NCT02566759|564446145|FG004|All Parts|Other|0|||
156367821|NCT02566759|564446146|FG005|All Parts|Other|0|||
156367822|NCT02566759|564446147|FG006|All Parts|Other|0|||
156367823|NCT02566759|564446148|FG007|All Parts|Other|0|||
156367824|NCT02566759|564446149|FG008|All Parts|Other|0|||
156367825|NCT02566759|564446150|FG009|All Parts|Other|0|||
156367826|NCT02566759|564446151|FG010|All Parts|Other|0|||
156367827|NCT02566759|564446152|FG011|All Parts|Other|0|||
156367828|NCT02566759|564446153|FG012|All Parts|Other|0|||
156367829|NCT02566759|564446154|FG013|All Parts|Other|2|||
156367830|NCT02566759|564446155|FG014|All Parts|Other|0|||
156367831|NCT02566759|564446156|FG015|All Parts|Other|0|||
156367832|NCT02566759|564446157|FG016|All Parts|Other|0|||
156367833|NCT02566759|564446141|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367834|NCT02566759|564446142|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367835|NCT02566759|564446143|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367836|NCT02566759|564446144|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367837|NCT02566759|564446145|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367838|NCT02566759|564446146|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367839|NCT02566759|564446147|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367840|NCT02566759|564446148|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367841|NCT02566759|564446149|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367842|NCT02566759|564446150|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367843|NCT02566759|564446151|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367844|NCT02566759|564446152|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367845|NCT02566759|564446153|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156491723|NCT00550446|564894965|FG001|Up To Week 12|Withdrawal by Subject|0|||
156491724|NCT00550446|564894966|FG002|Up To Week 12|Withdrawal by Subject|3|||
156491725|NCT00550446|564894967|FG003|Up To Week 12|Withdrawal by Subject|2|||
156367846|NCT02566759|564446154|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367847|NCT02566759|564446155|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367848|NCT02566759|564446156|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156367849|NCT02566759|564446157|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
156367850|NCT01096784|564446158|FG000|Overall Study|Withdrawal by Subject|2|||
156367851|NCT01096784|564446159|FG001|Overall Study|Withdrawal by Subject|1|||
156491726|NCT00550446|564894968|FG004|Up To Week 12|Withdrawal by Subject|0|||
156367852|NCT01096784|564446158|FG000|Overall Study|Adverse Event|11|||
156367853|NCT01096784|564446159|FG001|Overall Study|Adverse Event|9|||
156367854|NCT01096784|564446158|FG000|Overall Study|Protocol Deviation|2|||
156367855|NCT01096784|564446159|FG001|Overall Study|Protocol Deviation|2|||
156367856|NCT01096784|564446158|FG000|Overall Study|Administrative Decision|0|||
156367857|NCT01096784|564446159|FG001|Overall Study|Administrative Decision|1|||
156367858|NCT01096784|564446158|FG000|Overall Study|Other Unspecified|0|||
156367859|NCT01096784|564446159|FG001|Overall Study|Other Unspecified|1|||
156367860|NCT00976898|564446160|FG000|Overall Study|Protocol Violation|1|||
156367861|NCT00976898|564446160|FG000|Overall Study|Adverse Event|1|||
156367862|NCT00976898|564446160|FG000|Overall Study|Physician Decision|1|||
156367863|NCT00976898|564446160|FG000|Overall Study|Liver Transplant|1|||
156367864|NCT00976898|564446160|FG000|Overall Study|Progressive Disease|1|||
156367865|NCT05107128|564446161|FG000|Overall Study|Adverse Event|2|||
156367866|NCT05107128|564446162|FG001|Overall Study|Adverse Event|0|||
156367867|NCT05107128|564446161|FG000|Overall Study|Withdrawal by Subject|3|||
156367868|NCT05107128|564446162|FG001|Overall Study|Withdrawal by Subject|3|||
156367869|NCT05107128|564446161|FG000|Overall Study|Withdrawal of Consent|0|||
156367870|NCT05107128|564446162|FG001|Overall Study|Withdrawal of Consent|1|||
156367871|NCT05107128|564446161|FG000|Overall Study|Reason Not Specified|2|||
156367872|NCT05107128|564446162|FG001|Overall Study|Reason Not Specified|0|||
156367873|NCT03761628|564446163|FG000|Overall Study|Withdrawal by Subject|3|||
156367874|NCT03761628|564446163|FG000|Overall Study|Physician Decision|1|||
156367875|NCT03761628|564446163|FG000|Overall Study|Pregnancy|1|||
156367876|NCT03761628|564446163|FG000|Overall Study|Lost to Follow-up|1|||
156367877|NCT00727714|564446166|FG000|Overall Study|Lost to Follow-up|2|||
156367878|NCT05132127|564446167|FG000|Overall Study|Adverse Event|1|||
156367879|NCT02659020|564446168|FG000|Overall Study|Adverse Event|0|||
156367880|NCT02659020|564446169|FG001|Overall Study|Adverse Event|0|||
156367881|NCT02659020|564446170|FG002|Overall Study|Adverse Event|0|||
156367882|NCT02659020|564446171|FG003|Overall Study|Adverse Event|2|||
156367883|NCT02659020|564446172|FG004|Overall Study|Adverse Event|0|||
156367884|NCT02659020|564446173|FG005|Overall Study|Adverse Event|0|||
156367885|NCT02659020|564446174|FG006|Overall Study|Adverse Event|2|||
156367886|NCT02659020|564446168|FG000|Overall Study|Lost to Follow-up|1|||
156367887|NCT02659020|564446169|FG001|Overall Study|Lost to Follow-up|2|||
156367888|NCT02659020|564446170|FG002|Overall Study|Lost to Follow-up|1|||
156367889|NCT02659020|564446171|FG003|Overall Study|Lost to Follow-up|6|||
156367890|NCT02659020|564446172|FG004|Overall Study|Lost to Follow-up|1|||
156367891|NCT02659020|564446173|FG005|Overall Study|Lost to Follow-up|5|||
156367892|NCT02659020|564446174|FG006|Overall Study|Lost to Follow-up|0|||
156367893|NCT02659020|564446168|FG000|Overall Study|Physician Decision|0|||
156367894|NCT02659020|564446169|FG001|Overall Study|Physician Decision|0|||
156367895|NCT02659020|564446170|FG002|Overall Study|Physician Decision|0|||
156367896|NCT02659020|564446171|FG003|Overall Study|Physician Decision|1|||
156367897|NCT02659020|564446172|FG004|Overall Study|Physician Decision|1|||
156367898|NCT02659020|564446173|FG005|Overall Study|Physician Decision|0|||
156367899|NCT02659020|564446174|FG006|Overall Study|Physician Decision|1|||
156367900|NCT02659020|564446168|FG000|Overall Study|Withdrawal by Subject|2|||
156367901|NCT02659020|564446169|FG001|Overall Study|Withdrawal by Subject|1|||
156367902|NCT02659020|564446170|FG002|Overall Study|Withdrawal by Subject|0|||
156367903|NCT02659020|564446171|FG003|Overall Study|Withdrawal by Subject|3|||
156367904|NCT02659020|564446172|FG004|Overall Study|Withdrawal by Subject|3|||
156367905|NCT02659020|564446173|FG005|Overall Study|Withdrawal by Subject|6|||
156367906|NCT02659020|564446174|FG006|Overall Study|Withdrawal by Subject|3|||
156367907|NCT02659020|564446168|FG000|Overall Study|Progressive Disease|0|||
156367908|NCT02659020|564446169|FG001|Overall Study|Progressive Disease|0|||
156367909|NCT02659020|564446170|FG002|Overall Study|Progressive Disease|0|||
156367910|NCT02659020|564446171|FG003|Overall Study|Progressive Disease|4|||
156367911|NCT02659020|564446172|FG004|Overall Study|Progressive Disease|1|||
156367912|NCT02659020|564446173|FG005|Overall Study|Progressive Disease|0|||
156367913|NCT02659020|564446174|FG006|Overall Study|Progressive Disease|2|||
156367914|NCT04382911|564446175|FG000|Overall Study|unable to be imaged prior to surgery|2|||
156367915|NCT01110915|564446180|FG000|Overall Study|Death|2|||
156367916|NCT01110915|564446181|FG001|Overall Study|Death|1|||
156367917|NCT01110915|564446180|FG000|Overall Study|Lost to Follow-up|1|||
156367918|NCT01110915|564446181|FG001|Overall Study|Lost to Follow-up|0|||
156367919|NCT01110915|564446180|FG000|Overall Study|Withdrawal by Subject|7|||
156367920|NCT01110915|564446181|FG001|Overall Study|Withdrawal by Subject|1|||
156367921|NCT02948842|564446183|FG000|Overall Study|Withdrawal by Subject|4|||
156367922|NCT01537783|564446184|FG000|Overall Study|Lost to Follow-up|11|||
156367923|NCT01537783|564446185|FG001|Overall Study|Lost to Follow-up|2|||
156546097|NCT02412787|565093292|FG000|Overall Study|Site Terminated by Sponsor|21|||
156367924|NCT02350309|564446186|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
156367925|NCT02350309|564446187|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
156367926|NCT02350309|564446188|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
156367927|NCT02350309|564446189|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
156367928|NCT02350309|564446190|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
156367929|NCT02350309|564446191|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
156367930|NCT02350309|564446186|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
156367931|NCT02350309|564446187|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
156367932|NCT02350309|564446188|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
156491727|NCT00550446|564894969|FG005|Up To Week 12|Withdrawal by Subject|1|||
156491728|NCT00550446|564894970|FG006|Up To Week 12|Withdrawal by Subject|3|||
156491729|NCT00550446|564894971|FG007|Up To Week 12|Withdrawal by Subject|0|||
156491730|NCT00550446|564894972|FG008|Up To Week 12|Withdrawal by Subject|0|||
156367933|NCT02350309|564446189|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
156367934|NCT02350309|564446190|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
156367935|NCT02350309|564446191|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
156367936|NCT01554618|564446192|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
156367937|NCT01554618|564446193|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
156367938|NCT01554618|564446192|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
156367939|NCT01554618|564446193|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
156367940|NCT01554618|564446192|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
156367941|NCT01554618|564446193|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
156367942|NCT01554618|564446192|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
156367943|NCT01554618|564446193|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
156367944|NCT01554618|564446192|FG000|Open-Label Extension Period|Physician Decision|0|||
156367945|NCT01554618|564446193|FG001|Open-Label Extension Period|Physician Decision|1|||
156367946|NCT01554618|564446192|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
156367947|NCT01554618|564446193|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
156367948|NCT01205165|564446194|FG000|Overall Study|Lost to Follow-up|2|||
156367949|NCT00477672|564446197|FG000|Overall Study|Adverse Event|3|||
156367950|NCT00477672|564446198|FG001|Overall Study|Adverse Event|5|||
156367951|NCT00477672|564446199|FG002|Overall Study|Adverse Event|6|||
156367952|NCT00477672|564446197|FG000|Overall Study|Death|0|||
156367953|NCT00477672|564446198|FG001|Overall Study|Death|1|||
156367954|NCT00477672|564446199|FG002|Overall Study|Death|0|||
156367955|NCT00477672|564446197|FG000|Overall Study|Disease progression|0|||
156367956|NCT00477672|564446198|FG001|Overall Study|Disease progression|1|||
156367957|NCT00477672|564446199|FG002|Overall Study|Disease progression|0|||
156367958|NCT00477672|564446197|FG000|Overall Study|Physician Decision|1|||
156367959|NCT00477672|564446198|FG001|Overall Study|Physician Decision|0|||
156367960|NCT00477672|564446199|FG002|Overall Study|Physician Decision|0|||
156367961|NCT00477672|564446197|FG000|Overall Study|Protocol noncompliance|0|||
156367962|NCT00477672|564446198|FG001|Overall Study|Protocol noncompliance|2|||
156367963|NCT00477672|564446199|FG002|Overall Study|Protocol noncompliance|0|||
156367964|NCT00477672|564446197|FG000|Overall Study|Consent withdrawn|2|||
156367965|NCT00477672|564446198|FG001|Overall Study|Consent withdrawn|5|||
156367966|NCT00477672|564446199|FG002|Overall Study|Consent withdrawn|10|||
156367967|NCT00477672|564446197|FG000|Overall Study|Discretion of Sponsor|1|||
156367968|NCT00477672|564446198|FG001|Overall Study|Discretion of Sponsor|2|||
156367969|NCT00477672|564446199|FG002|Overall Study|Discretion of Sponsor|0|||
156367970|NCT01736696|564446200|FG000|Overall Study|Withdrawal by Subject|0|||
156367971|NCT01736696|564446201|FG001|Overall Study|Withdrawal by Subject|0|||
156367972|NCT01736696|564446202|FG002|Overall Study|Withdrawal by Subject|1|||
156367973|NCT01736696|564446203|FG003|Overall Study|Withdrawal by Subject|0|||
156367974|NCT01736696|564446204|FG004|Overall Study|Withdrawal by Subject|0|||
156491731|NCT00550446|564894973|FG009|Up To Week 12|Withdrawal by Subject|0|||
156367975|NCT01736696|564446205|FG005|Overall Study|Withdrawal by Subject|0|||
156367976|NCT01736696|564446206|FG006|Overall Study|Withdrawal by Subject|0|||
156367977|NCT04011410|564446207|FG000|Overall Study|Withdrawal by Subject|1|||
156367978|NCT02275481|564446208|FG000|Overall Study|Death|2|||
156367979|NCT02275481|564446209|FG001|Overall Study|Death|1|||
156367980|NCT02275481|564446208|FG000|Overall Study|Lost to Follow-up|2|||
156367981|NCT02275481|564446209|FG001|Overall Study|Lost to Follow-up|0|||
156367982|NCT02275481|564446208|FG000|Overall Study|Withdrawal by Subject|3|||
156367983|NCT02275481|564446209|FG001|Overall Study|Withdrawal by Subject|0|||
156367984|NCT02275481|564446208|FG000|Overall Study|all other reasons combined|2|||
156367985|NCT02275481|564446209|FG001|Overall Study|all other reasons combined|1|||
156367986|NCT02275481|564446208|FG000|Overall Study|Physician Decision|0|||
156367987|NCT02275481|564446209|FG001|Overall Study|Physician Decision|1|||
156367988|NCT01455012|564446210|FG000|Overall Study|Adverse Event|0|||
156367989|NCT01455012|564446211|FG001|Overall Study|Adverse Event|2|||
156367990|NCT01455012|564446210|FG000|Overall Study|Lack of Efficacy|6|||
156367991|NCT01455012|564446211|FG001|Overall Study|Lack of Efficacy|1|||
156367992|NCT01455012|564446210|FG000|Overall Study|Withdrawal by Subject|3|||
156367993|NCT01455012|564446211|FG001|Overall Study|Withdrawal by Subject|1|||
156367994|NCT01455012|564446210|FG000|Overall Study|Unknown reason|2|||
156367995|NCT01455012|564446211|FG001|Overall Study|Unknown reason|0|||
156367996|NCT01215227|564446212|FG000|Overall Study|Adverse Event|11|||
156367997|NCT01215227|564446213|FG001|Overall Study|Adverse Event|11|||
156367998|NCT01215227|564446214|FG002|Overall Study|Adverse Event|4|||
156367999|NCT01215227|564446215|FG003|Overall Study|Adverse Event|8|||
156491732|NCT00550446|564894974|FG010|Up To Week 12|Withdrawal by Subject|0|||
156491733|NCT00550446|564894964|FG000|Up To Week 12|Other|3|||
156368000|NCT01215227|564446216|FG004|Overall Study|Adverse Event|7|||
156368001|NCT01215227|564446217|FG005|Overall Study|Adverse Event|6|||
156368002|NCT01215227|564446212|FG000|Overall Study|Treatment Failure|8|||
156491734|NCT00550446|564894965|FG001|Up To Week 12|Other|0|||
156368003|NCT01215227|564446213|FG001|Overall Study|Treatment Failure|4|||
156368004|NCT01215227|564446214|FG002|Overall Study|Treatment Failure|1|||
156368005|NCT01215227|564446215|FG003|Overall Study|Treatment Failure|5|||
156368006|NCT01215227|564446216|FG004|Overall Study|Treatment Failure|1|||
156368007|NCT01215227|564446217|FG005|Overall Study|Treatment Failure|1|||
156368008|NCT01215227|564446212|FG000|Overall Study|Lost to Follow-up|1|||
156368009|NCT01215227|564446213|FG001|Overall Study|Lost to Follow-up|4|||
156368010|NCT01215227|564446214|FG002|Overall Study|Lost to Follow-up|1|||
156368011|NCT01215227|564446215|FG003|Overall Study|Lost to Follow-up|1|||
156368012|NCT01215227|564446216|FG004|Overall Study|Lost to Follow-up|1|||
156368013|NCT01215227|564446217|FG005|Overall Study|Lost to Follow-up|2|||
156368014|NCT01215227|564446212|FG000|Overall Study|Subject Withdrew Consent|16|||
156368015|NCT01215227|564446213|FG001|Overall Study|Subject Withdrew Consent|20|||
156368016|NCT01215227|564446214|FG002|Overall Study|Subject Withdrew Consent|7|||
156368017|NCT01215227|564446215|FG003|Overall Study|Subject Withdrew Consent|10|||
156368018|NCT01215227|564446216|FG004|Overall Study|Subject Withdrew Consent|11|||
156368019|NCT01215227|564446217|FG005|Overall Study|Subject Withdrew Consent|8|||
156368020|NCT01215227|564446212|FG000|Overall Study|Non-Compliance With Protocol|2|||
156368021|NCT01215227|564446213|FG001|Overall Study|Non-Compliance With Protocol|6|||
156368022|NCT01215227|564446214|FG002|Overall Study|Non-Compliance With Protocol|1|||
156368023|NCT01215227|564446215|FG003|Overall Study|Non-Compliance With Protocol|0|||
156368024|NCT01215227|564446216|FG004|Overall Study|Non-Compliance With Protocol|0|||
156368025|NCT01215227|564446217|FG005|Overall Study|Non-Compliance With Protocol|0|||
156368026|NCT01215227|564446212|FG000|Overall Study|Administrative|83|||
156368027|NCT01215227|564446213|FG001|Overall Study|Administrative|73|||
156368028|NCT01215227|564446214|FG002|Overall Study|Administrative|42|||
156368029|NCT01215227|564446215|FG003|Overall Study|Administrative|24|||
156368030|NCT01215227|564446216|FG004|Overall Study|Administrative|28|||
156368031|NCT01215227|564446217|FG005|Overall Study|Administrative|40|||
156368032|NCT01215227|564446212|FG000|Overall Study|Missing Status|0|||
156368033|NCT01215227|564446213|FG001|Overall Study|Missing Status|1|||
156368034|NCT01215227|564446214|FG002|Overall Study|Missing Status|0|||
156368035|NCT01215227|564446215|FG003|Overall Study|Missing Status|0|||
156368036|NCT01215227|564446216|FG004|Overall Study|Missing Status|0|||
156368037|NCT01215227|564446217|FG005|Overall Study|Missing Status|0|||
156368038|NCT01215227|564446212|FG000|Overall Study|Randomized but not treated|0|||
156368039|NCT01215227|564446213|FG001|Overall Study|Randomized but not treated|0|||
156368040|NCT01215227|564446214|FG002|Overall Study|Randomized but not treated|1|||
156368041|NCT01215227|564446215|FG003|Overall Study|Randomized but not treated|1|||
156368042|NCT01215227|564446216|FG004|Overall Study|Randomized but not treated|0|||
156368043|NCT01215227|564446217|FG005|Overall Study|Randomized but not treated|1|||
156368044|NCT01393405|564446228|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
156368045|NCT01393405|564446229|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
156368046|NCT01393405|564446230|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
156368047|NCT01393405|564446228|FG000|Induction Period (week1-16)|Adverse Event|16|||
156368048|NCT01393405|564446229|FG001|Induction Period (week1-16)|Adverse Event|0|||
156368049|NCT01393405|564446230|FG002|Induction Period (week1-16)|Adverse Event|0|||
156368050|NCT01393405|564446228|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
156368051|NCT01393405|564446229|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
156368052|NCT01393405|564446230|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
156368053|NCT01393405|564446228|FG000|Maintenance Period Week|Lack of Efficacy|0|||
156368054|NCT01393405|564446229|FG001|Maintenance Period Week|Lack of Efficacy|22|||
156368055|NCT01393405|564446230|FG002|Maintenance Period Week|Lack of Efficacy|22|||
156368056|NCT01393405|564446228|FG000|Maintenance Period Week|Adverse Event|0|||
156368057|NCT01393405|564446229|FG001|Maintenance Period Week|Adverse Event|5|||
156368058|NCT01393405|564446230|FG002|Maintenance Period Week|Adverse Event|2|||
156368059|NCT01393405|564446228|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
156368060|NCT01393405|564446229|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
156368061|NCT01393405|564446230|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
156368062|NCT01393405|564446228|FG000|Maintenance Period Week|Lost to Follow-up|0|||
156368063|NCT01393405|564446229|FG001|Maintenance Period Week|Lost to Follow-up|1|||
156368064|NCT01393405|564446230|FG002|Maintenance Period Week|Lost to Follow-up|0|||
156368065|NCT01434290|564446231|FG000|Overall Study|Protocol Violation|6|||
156368066|NCT01434290|564446232|FG001|Overall Study|Protocol Violation|3|||
156368067|NCT01434290|564446231|FG000|Overall Study|No protocol treatment|2|||
156368068|NCT01434290|564446232|FG001|Overall Study|No protocol treatment|4|||
156368069|NCT02281552|564446233|FG000|Overall Study|Medication error|1|||
156368070|NCT02281552|564446234|FG001|Overall Study|Medication error|0|||
156368071|NCT02281552|564446233|FG000|Overall Study|Insufficient clinical response|0|||
156368072|NCT02281552|564446234|FG001|Overall Study|Insufficient clinical response|1|||
156368073|NCT02281552|564446233|FG000|Overall Study|Adverse Event|3|||
156368074|NCT02281552|564446234|FG001|Overall Study|Adverse Event|9|||
156368075|NCT01224639|564446235|FG000|Overall Study|Withdrawal by Subject|0|||
156368076|NCT01224639|564446236|FG001|Overall Study|Withdrawal by Subject|0|||
156368077|NCT01224639|564446237|FG002|Overall Study|Withdrawal by Subject|0|||
156368078|NCT01224639|564446238|FG003|Overall Study|Withdrawal by Subject|0|||
156368079|NCT01224639|564446239|FG004|Overall Study|Withdrawal by Subject|2|||
156368080|NCT01224639|564446240|FG005|Overall Study|Withdrawal by Subject|0|||
156368081|NCT01224639|564446241|FG006|Overall Study|Withdrawal by Subject|1|||
156368082|NCT01224639|564446242|FG007|Overall Study|Withdrawal by Subject|1|||
156368083|NCT01224639|564446235|FG000|Overall Study|Adverse Event|0|||
156368084|NCT01224639|564446236|FG001|Overall Study|Adverse Event|0|||
156368085|NCT01224639|564446237|FG002|Overall Study|Adverse Event|0|||
156368086|NCT01224639|564446238|FG003|Overall Study|Adverse Event|0|||
156368087|NCT01224639|564446239|FG004|Overall Study|Adverse Event|0|||
156368088|NCT01224639|564446240|FG005|Overall Study|Adverse Event|0|||
156368089|NCT01224639|564446241|FG006|Overall Study|Adverse Event|0|||
156368090|NCT01224639|564446242|FG007|Overall Study|Adverse Event|1|||
156368091|NCT04656132|564446243|FG000|Overall Study|Lost to Follow-up|4|||
156368092|NCT04656132|564446243|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
156368093|NCT04365699|564446244|FG000|Overall Study|Death|2|||
156368094|NCT04365699|564446245|FG001|Overall Study|Death|5|||
156368095|NCT04365699|564446246|FG002|Overall Study|Death|15|||
156368096|NCT03925727|564446248|FG000|Overall Study|Adverse Event|4|||
156368097|NCT03925727|564446249|FG001|Overall Study|Adverse Event|0|||
156368098|NCT03925727|564446250|FG002|Overall Study|Adverse Event|3|||
156368099|NCT03925727|564446248|FG000|Overall Study|Protocol Violation|1|||
156368100|NCT03925727|564446249|FG001|Overall Study|Protocol Violation|2|||
156368101|NCT03925727|564446250|FG002|Overall Study|Protocol Violation|2|||
156368102|NCT03925727|564446248|FG000|Overall Study|Withdrawal by Subject|3|||
156368103|NCT03925727|564446249|FG001|Overall Study|Withdrawal by Subject|2|||
156368104|NCT03925727|564446250|FG002|Overall Study|Withdrawal by Subject|4|||
156368105|NCT03925727|564446248|FG000|Overall Study|Administrative Reasons|3|||
156368106|NCT03925727|564446249|FG001|Overall Study|Administrative Reasons|1|||
156368107|NCT03925727|564446250|FG002|Overall Study|Administrative Reasons|2|||
156368108|NCT03925727|564446248|FG000|Overall Study|Randomized in error or Disqualified|8|||
156368109|NCT03925727|564446249|FG001|Overall Study|Randomized in error or Disqualified|1|||
156368110|NCT03925727|564446250|FG002|Overall Study|Randomized in error or Disqualified|7|||
156368111|NCT02321462|564446253|FG000|Overall Study|Withdrawal by Subject|5|||
156368112|NCT02321462|564446254|FG001|Overall Study|Withdrawal by Subject|2|||
156368113|NCT02321462|564446253|FG000|Overall Study|Subject withdrawn before any treatment|1|||
156368114|NCT02321462|564446254|FG001|Overall Study|Subject withdrawn before any treatment|1|||
156368115|NCT03044197|564446265|FG000|Overall Study|Withdrawal by Subject|3|||
156368116|NCT03044197|564446266|FG001|Overall Study|Withdrawal by Subject|1|||
156368117|NCT00834912|564446267|FG000|Treatment Period 1|Adverse Event|0|||
156368118|NCT00834912|564446268|FG001|Treatment Period 1|Adverse Event|1|||
156368119|NCT00834912|564446269|FG002|Treatment Period 1|Adverse Event|0|||
156368120|NCT00834912|564446270|FG003|Treatment Period 1|Adverse Event|1|||
156368121|NCT00834912|564446271|FG004|Treatment Period 1|Adverse Event|0|||
156368122|NCT00834912|564446272|FG005|Treatment Period 1|Adverse Event|0|||
156368123|NCT00834912|564446267|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156368124|NCT00834912|564446268|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156368125|NCT00834912|564446269|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156368126|NCT00834912|564446270|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156368127|NCT00834912|564446271|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156368128|NCT00834912|564446272|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156368129|NCT02917031|564446273|FG000|Overall Study|Reason not specified|7|||
156368130|NCT02917031|564446274|FG001|Overall Study|Reason not specified|5|||
156368131|NCT02917031|564446275|FG002|Overall Study|Reason not specified|6|||
156368132|NCT02917031|564446273|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
156368133|NCT02917031|564446274|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
156368134|NCT02917031|564446275|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
156368135|NCT02917031|564446273|FG000|Overall Study|Withdrawal by Subject|3|||
156368136|NCT02917031|564446274|FG001|Overall Study|Withdrawal by Subject|3|||
156368137|NCT02917031|564446275|FG002|Overall Study|Withdrawal by Subject|0|||
156368138|NCT02917031|564446273|FG000|Overall Study|Physician Decision|1|||
156368139|NCT02917031|564446274|FG001|Overall Study|Physician Decision|0|||
156368140|NCT02917031|564446275|FG002|Overall Study|Physician Decision|0|||
156368141|NCT02917031|564446273|FG000|Overall Study|Adverse Event|4|||
156368142|NCT02917031|564446274|FG001|Overall Study|Adverse Event|1|||
156368143|NCT02917031|564446275|FG002|Overall Study|Adverse Event|5|||
156368144|NCT02917031|564446273|FG000|Overall Study|Death|2|||
156491735|NCT00550446|564894966|FG002|Up To Week 12|Other|0|||
156368145|NCT02917031|564446274|FG001|Overall Study|Death|3|||
156368146|NCT02917031|564446275|FG002|Overall Study|Death|4|||
156368147|NCT05723770|564448225|FG000|Overall Study|Lost to Follow-up|4|||
156368148|NCT05723770|564448225|FG000|Overall Study|Withdrawal by Subject|2|||
156368149|NCT00145509|564448226|FG000|Overall Study|Adverse Event|10|||
156368150|NCT00145509|564448227|FG001|Overall Study|Adverse Event|3|||
156368151|NCT00145509|564448226|FG000|Overall Study|Lack of Efficacy|3|||
156368152|NCT00145509|564448227|FG001|Overall Study|Lack of Efficacy|1|||
156368153|NCT00145509|564448226|FG000|Overall Study|Lost to Follow-up|5|||
156368154|NCT00145509|564448227|FG001|Overall Study|Lost to Follow-up|9|||
156368155|NCT00145509|564448226|FG000|Overall Study|Withdrew Consent|2|||
156368156|NCT00145509|564448227|FG001|Overall Study|Withdrew Consent|7|||
156368157|NCT00145509|564448226|FG000|Overall Study|Reason not provided|2|||
156491736|NCT00550446|564894967|FG003|Up To Week 12|Other|0|||
156368158|NCT00145509|564448227|FG001|Overall Study|Reason not provided|1|||
156368159|NCT01359592|564448228|FG000|Initial Registration|Adverse Event|1|||
156368160|NCT01359592|564448229|FG001|Initial Registration|Adverse Event|0|||
156368161|NCT01359592|564448230|FG002|Initial Registration|Adverse Event|0|||
156368162|NCT01359592|564448231|FG003|Initial Registration|Adverse Event|0|||
156368163|NCT01359592|564448228|FG000|Initial Registration|Death|1|||
156368164|NCT01359592|564448229|FG001|Initial Registration|Death|0|||
156368165|NCT01359592|564448230|FG002|Initial Registration|Death|0|||
156368166|NCT01359592|564448231|FG003|Initial Registration|Death|0|||
156368167|NCT01359592|564448228|FG000|Initial Registration|Other reason not protocol specified|1|||
156368168|NCT01359592|564448229|FG001|Initial Registration|Other reason not protocol specified|0|||
156368169|NCT01359592|564448230|FG002|Initial Registration|Other reason not protocol specified|0|||
156368170|NCT01359592|564448231|FG003|Initial Registration|Other reason not protocol specified|0|||
156368171|NCT01359592|564448228|FG000|Initial Registration|Ineligible|26|||
156368172|NCT01359592|564448229|FG001|Initial Registration|Ineligible|0|||
156368173|NCT01359592|564448230|FG002|Initial Registration|Ineligible|0|||
156368174|NCT01359592|564448231|FG003|Initial Registration|Ineligible|0|||
156368175|NCT01359592|564448228|FG000|PET-Directed Therapy|Adverse Event|0|||
156368176|NCT01359592|564448229|FG001|PET-Directed Therapy|Adverse Event|0|||
156368177|NCT01359592|564448230|FG002|PET-Directed Therapy|Adverse Event|1|||
156368178|NCT01359592|564448231|FG003|PET-Directed Therapy|Adverse Event|0|||
156368179|NCT01359592|564448228|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
156368180|NCT01359592|564448229|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
156368181|NCT01359592|564448230|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
156368182|NCT01359592|564448231|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
156368183|NCT01359592|564448228|FG000|PET-Directed Therapy|Ineligible|0|||
156368184|NCT01359592|564448229|FG001|PET-Directed Therapy|Ineligible|0|||
156368185|NCT01359592|564448230|FG002|PET-Directed Therapy|Ineligible|24|||
156368186|NCT01359592|564448231|FG003|PET-Directed Therapy|Ineligible|0|||
156368187|NCT00326612|564448236|FG000|Overall Study|They did not have a seizure requiring tx|129|||
156368188|NCT00326612|564448237|FG001|Overall Study|They did not have a seizure requiring tx|137|||
156368189|NCT00419562|564448238|FG000|Overall Study|Lost to Follow-up|12|||
156368190|NCT00419562|564448239|FG001|Overall Study|Lost to Follow-up|13|||
156368191|NCT00419562|564448238|FG000|Overall Study|Withdrawal by Subject|20|||
156368192|NCT00419562|564448239|FG001|Overall Study|Withdrawal by Subject|18|||
156368193|NCT00419562|564448238|FG000|Overall Study|Participant Institutionalized|1|||
156368194|NCT00419562|564448239|FG001|Overall Study|Participant Institutionalized|0|||
156368195|NCT02365636|564448244|FG000|Overall Study|Adverse Event|3|||
156368196|NCT02365636|564448245|FG001|Overall Study|Adverse Event|3|||
156368197|NCT02365636|564448246|FG002|Overall Study|Adverse Event|2|||
156368198|NCT02365636|564448244|FG000|Overall Study|Protocol Violation|1|||
156368199|NCT02365636|564448245|FG001|Overall Study|Protocol Violation|4|||
156368200|NCT02365636|564448246|FG002|Overall Study|Protocol Violation|0|||
156368201|NCT02365636|564448244|FG000|Overall Study|Lost to Follow-up|0|||
156368202|NCT02365636|564448245|FG001|Overall Study|Lost to Follow-up|0|||
156368203|NCT02365636|564448246|FG002|Overall Study|Lost to Follow-up|1|||
156368204|NCT02365636|564448244|FG000|Overall Study|Other|2|||
156368205|NCT02365636|564448245|FG001|Overall Study|Other|0|||
156368206|NCT02365636|564448246|FG002|Overall Study|Other|0|||
156368207|NCT00355238|564448247|FG000|Overall Study|Adverse event unrelated to study drug|2|||
156368208|NCT00355238|564448248|FG001|Overall Study|Adverse event unrelated to study drug|2|||
156368209|NCT00355238|564448249|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156368210|NCT00355238|564448250|FG003|Overall Study|Adverse event unrelated to study drug|1|||
156368211|NCT00355238|564448247|FG000|Overall Study|Death|1|||
156368212|NCT00355238|564448248|FG001|Overall Study|Death|0|||
156368213|NCT00355238|564448249|FG002|Overall Study|Death|0|||
156368214|NCT00355238|564448250|FG003|Overall Study|Death|0|||
156368215|NCT00355238|564448247|FG000|Overall Study|Disease progression|37|||
156368216|NCT00355238|564448248|FG001|Overall Study|Disease progression|36|||
156368217|NCT00355238|564448249|FG002|Overall Study|Disease progression|16|||
156368218|NCT00355238|564448250|FG003|Overall Study|Disease progression|11|||
156368219|NCT00355238|564448247|FG000|Overall Study|Study drug toxicity|11|||
156368220|NCT00355238|564448248|FG001|Overall Study|Study drug toxicity|7|||
156368221|NCT00355238|564448249|FG002|Overall Study|Study drug toxicity|5|||
156368222|NCT00355238|564448250|FG003|Overall Study|Study drug toxicity|2|||
156368223|NCT00355238|564448247|FG000|Overall Study|Participant withdrew consent|3|||
156368224|NCT00355238|564448248|FG001|Overall Study|Participant withdrew consent|1|||
156368225|NCT00355238|564448249|FG002|Overall Study|Participant withdrew consent|0|||
156368226|NCT00355238|564448250|FG003|Overall Study|Participant withdrew consent|0|||
156368227|NCT00355238|564448247|FG000|Overall Study|Participant request to discontinue study treatment|1|||
156368228|NCT00355238|564448248|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156368229|NCT00355238|564448249|FG002|Overall Study|Participant request to discontinue study treatment|1|||
156368230|NCT00355238|564448250|FG003|Overall Study|Participant request to discontinue study treatment|0|||
156368231|NCT01454934|564448251|FG000|Overall Study|Clinical progression|28|||
156368232|NCT01454934|564448252|FG001|Overall Study|Clinical progression|25|||
156368233|NCT01454934|564448251|FG000|Overall Study|Other|6|||
156368234|NCT01454934|564448252|FG001|Overall Study|Other|17|||
156368235|NCT01454934|564448251|FG000|Overall Study|Adverse Event|28|||
156368236|NCT01454934|564448252|FG001|Overall Study|Adverse Event|24|||
156368237|NCT01454934|564448251|FG000|Overall Study|Withdrawn consent|2|||
156368238|NCT01454934|564448252|FG001|Overall Study|Withdrawn consent|5|||
156368239|NCT01454934|564448251|FG000|Overall Study|Withdrawal by Subject|11|||
156368240|NCT01454934|564448252|FG001|Overall Study|Withdrawal by Subject|15|||
156368241|NCT01454934|564448251|FG000|Overall Study|Disease progression|194|||
156368242|NCT01454934|564448252|FG001|Overall Study|Disease progression|181|||
156368243|NCT01454934|564448251|FG000|Overall Study|Lost to Follow-up|0|||
156368244|NCT01454934|564448252|FG001|Overall Study|Lost to Follow-up|1|||
156368245|NCT01454934|564448251|FG000|Overall Study|Not treated|1|||
156368246|NCT01454934|564448252|FG001|Overall Study|Not treated|2|||
156368247|NCT00749775|564448253|FG000|Overall Study|Protocol Violation|24|||
156368248|NCT00749775|564448253|FG000|Overall Study|Lost to Follow-up|36|||
156368249|NCT00749775|564448253|FG000|Overall Study|No visit after first day of treatment|44|||
156368250|NCT00749775|564448253|FG000|Overall Study|No drug administration|3|||
156368251|NCT05044234|564448254|FG000|Overall Study|Lost to Follow-up|2|||
156368252|NCT05044234|564448255|FG001|Overall Study|Lost to Follow-up|1|||
156368253|NCT05044234|564448256|FG002|Overall Study|Lost to Follow-up|1|||
156368254|NCT05044234|564448257|FG003|Overall Study|Lost to Follow-up|2|||
156368255|NCT05044234|564448254|FG000|Overall Study|Withdrawal by Subject|6|||
156368256|NCT05044234|564448255|FG001|Overall Study|Withdrawal by Subject|4|||
156368257|NCT05044234|564448256|FG002|Overall Study|Withdrawal by Subject|5|||
156368258|NCT05044234|564448257|FG003|Overall Study|Withdrawal by Subject|8|||
156368259|NCT05044234|564448254|FG000|Overall Study|Study terminated by Sponsor|21|||
156368260|NCT05044234|564448255|FG001|Overall Study|Study terminated by Sponsor|21|||
156368261|NCT05044234|564448256|FG002|Overall Study|Study terminated by Sponsor|20|||
156368262|NCT05044234|564448257|FG003|Overall Study|Study terminated by Sponsor|14|||
156368263|NCT05044234|564448254|FG000|Overall Study|Other, not specified|0|||
156368264|NCT05044234|564448255|FG001|Overall Study|Other, not specified|0|||
156368265|NCT05044234|564448256|FG002|Overall Study|Other, not specified|1|||
156368266|NCT05044234|564448257|FG003|Overall Study|Other, not specified|2|||
156368267|NCT05044234|564448254|FG000|Overall Study|Delayed data entry|0|||
156368268|NCT05044234|564448255|FG001|Overall Study|Delayed data entry|0|||
156368269|NCT05044234|564448256|FG002|Overall Study|Delayed data entry|0|||
156368270|NCT05044234|564448257|FG003|Overall Study|Delayed data entry|1|||
156368271|NCT00480636|564448258|FG000|Overall Study|Death|12|||
156368272|NCT00480636|564448258|FG000|Overall Study|Lost to Follow-up|4|||
156368273|NCT00480636|564448258|FG000|Overall Study|Other|2|||
156368274|NCT00480636|564448258|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
156368275|NCT03912233|564448259|FG000|Overall Study|Adverse Event|1|||
156368276|NCT03912233|564448260|FG001|Overall Study|Adverse Event|0|||
156368277|NCT03912233|564448261|FG002|Overall Study|Adverse Event|0|||
156368278|NCT03912233|564448262|FG003|Overall Study|Adverse Event|0|||
156368279|NCT03912233|564448263|FG004|Overall Study|Adverse Event|0|||
156368280|NCT03912233|564448264|FG005|Overall Study|Adverse Event|0|||
156368281|NCT03912233|564448259|FG000|Overall Study|Physician Decision|1|||
156368282|NCT03912233|564448260|FG001|Overall Study|Physician Decision|0|||
156368283|NCT03912233|564448261|FG002|Overall Study|Physician Decision|0|||
156368284|NCT03912233|564448262|FG003|Overall Study|Physician Decision|0|||
156368285|NCT03912233|564448263|FG004|Overall Study|Physician Decision|0|||
156368286|NCT03912233|564448264|FG005|Overall Study|Physician Decision|0|||
156368287|NCT03912233|564448259|FG000|Overall Study|Other|0|||
156368288|NCT03912233|564448260|FG001|Overall Study|Other|0|||
156368289|NCT03912233|564448261|FG002|Overall Study|Other|0|||
156368290|NCT03912233|564448262|FG003|Overall Study|Other|0|||
156368291|NCT03912233|564448263|FG004|Overall Study|Other|7|||
156368292|NCT03912233|564448264|FG005|Overall Study|Other|12|||
156368293|NCT02583256|564448265|FG000|Overall Study|Withdrawal by Subject|0|||
156368294|NCT02583256|564448266|FG001|Overall Study|Withdrawal by Subject|1|||
156368295|NCT02583256|564448267|FG002|Overall Study|Withdrawal by Subject|1|||
156368296|NCT02583256|564448268|FG003|Overall Study|Withdrawal by Subject|0|||
156368297|NCT02583256|564448265|FG000|Overall Study|Lost to Follow-up|1|||
156368298|NCT02583256|564448266|FG001|Overall Study|Lost to Follow-up|1|||
156368299|NCT02583256|564448267|FG002|Overall Study|Lost to Follow-up|0|||
156368300|NCT02583256|564448268|FG003|Overall Study|Lost to Follow-up|1|||
156368301|NCT02583256|564448265|FG000|Overall Study|Administrative/Other|2|||
156368302|NCT02583256|564448266|FG001|Overall Study|Administrative/Other|0|||
156368303|NCT02583256|564448267|FG002|Overall Study|Administrative/Other|1|||
156368304|NCT02583256|564448268|FG003|Overall Study|Administrative/Other|2|||
156368305|NCT02177266|564448276|FG000|Overall Study|Adverse Event|0|||
156368306|NCT02177266|564448277|FG001|Overall Study|Adverse Event|1|||
156368307|NCT02177266|564448276|FG000|Overall Study|Withdrawal by Subject|1|||
156368308|NCT02177266|564448277|FG001|Overall Study|Withdrawal by Subject|0|||
156368309|NCT01023659|564448278|FG000|Overall Study|Lost to Follow-up|73|||
156368310|NCT01023659|564448279|FG001|Overall Study|Lost to Follow-up|228|||
156368311|NCT01023659|564448280|FG002|Overall Study|Lost to Follow-up|99|||
156368312|NCT04537806|564448281|FG000|Overall Study|Randomized but not treated|1|||
156368313|NCT04537806|564448282|FG001|Overall Study|Randomized but not treated|0|||
156368314|NCT04537806|564448281|FG000|Overall Study|Adverse Event|1|||
156368315|NCT04537806|564448282|FG001|Overall Study|Adverse Event|1|||
156368316|NCT03019627|564448285|FG000|Overall Study|Adverse Event|8|||
156368317|NCT03019627|564448286|FG001|Overall Study|Adverse Event|0|||
156368318|NCT03019627|564448285|FG000|Overall Study|Unrelated to adverse event|1|||
156368319|NCT03019627|564448286|FG001|Overall Study|Unrelated to adverse event|3|||
156368320|NCT03019627|564448285|FG000|Overall Study|Lost to Follow-up|2|||
156368321|NCT03019627|564448286|FG001|Overall Study|Lost to Follow-up|1|||
156368322|NCT03019627|564448285|FG000|Overall Study|not compliance|2|||
156368323|NCT03019627|564448286|FG001|Overall Study|not compliance|2|||
156368324|NCT03019627|564448285|FG000|Overall Study|Other|2|||
156368325|NCT03019627|564448286|FG001|Overall Study|Other|2|||
156368326|NCT03364049|564448287|FG000|Overall Study|Death|6|||
156368327|NCT03364049|564448288|FG001|Overall Study|Death|4|||
156368328|NCT03364049|564448289|FG002|Overall Study|Death|5|||
156368329|NCT03364049|564448290|FG003|Overall Study|Death|14|||
156368330|NCT03364049|564448287|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
156368331|NCT03364049|564448288|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
156368332|NCT03364049|564448289|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
156368333|NCT03364049|564448290|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
156368334|NCT03364049|564448287|FG000|Overall Study|Withdrawal by Subject|0|||
156368335|NCT03364049|564448288|FG001|Overall Study|Withdrawal by Subject|1|||
156368336|NCT03364049|564448289|FG002|Overall Study|Withdrawal by Subject|1|||
156368337|NCT03364049|564448290|FG003|Overall Study|Withdrawal by Subject|1|||
156368338|NCT05459129|564448291|FG000|Overall Study|Death|1|||
156368339|NCT05459129|564448292|FG001|Overall Study|Death|0|||
156368340|NCT05459129|564448291|FG000|Overall Study|Study Terminated By Sponsor|5|||
156368341|NCT05459129|564448292|FG001|Overall Study|Study Terminated By Sponsor|6|||
156368342|NCT03064126|564448293|FG000|Overall Study|Death|40|||
156368343|NCT03064126|564448294|FG001|Overall Study|Death|16|||
156368344|NCT03064126|564448295|FG002|Overall Study|Death|4|||
156368345|NCT03064126|564448296|FG003|Overall Study|Death|2|||
156368346|NCT03064126|564448293|FG000|Overall Study|Withdrawal by Subject|17|||
156368347|NCT03064126|564448294|FG001|Overall Study|Withdrawal by Subject|9|||
156368348|NCT03064126|564448295|FG002|Overall Study|Withdrawal by Subject|0|||
156368349|NCT03064126|564448296|FG003|Overall Study|Withdrawal by Subject|2|||
156368350|NCT03064126|564448293|FG000|Overall Study|Lost to Follow-up|7|||
156368351|NCT03064126|564448294|FG001|Overall Study|Lost to Follow-up|3|||
156368352|NCT03064126|564448295|FG002|Overall Study|Lost to Follow-up|0|||
156368353|NCT03064126|564448296|FG003|Overall Study|Lost to Follow-up|0|||
156368354|NCT03064126|564448293|FG000|Overall Study|Adverse Event|2|||
156368355|NCT03064126|564448294|FG001|Overall Study|Adverse Event|0|||
156368356|NCT03064126|564448295|FG002|Overall Study|Adverse Event|0|||
156368357|NCT03064126|564448296|FG003|Overall Study|Adverse Event|0|||
156368358|NCT03064126|564448293|FG000|Overall Study|Physician Decision|3|||
156368359|NCT03064126|564448294|FG001|Overall Study|Physician Decision|0|||
156368360|NCT03064126|564448295|FG002|Overall Study|Physician Decision|0|||
156368361|NCT03064126|564448296|FG003|Overall Study|Physician Decision|0|||
156368362|NCT03064126|564448293|FG000|Overall Study|Other reason for early termination|3|||
156368363|NCT03064126|564448294|FG001|Overall Study|Other reason for early termination|2|||
156368364|NCT03064126|564448295|FG002|Overall Study|Other reason for early termination|0|||
156368365|NCT03064126|564448296|FG003|Overall Study|Other reason for early termination|0|||
156368366|NCT03064126|564448293|FG000|Overall Study|Missed Visit|3|||
156368367|NCT03064126|564448294|FG001|Overall Study|Missed Visit|1|||
156368368|NCT03064126|564448295|FG002|Overall Study|Missed Visit|0|||
156368369|NCT03064126|564448296|FG003|Overall Study|Missed Visit|0|||
156368370|NCT04649151|564448302|FG000|Overall Study|Pregnancy|0|||
156368371|NCT04649151|564448303|FG001|Overall Study|Pregnancy|0|||
156368372|NCT04649151|564448304|FG002|Overall Study|Pregnancy|0|||
156368373|NCT04649151|564448305|FG003|Overall Study|Pregnancy|0|||
156368374|NCT04649151|564448306|FG004|Overall Study|Pregnancy|3|||
156368375|NCT04649151|564448302|FG000|Overall Study|Physician Decision|10|||
156368376|NCT04649151|564448303|FG001|Overall Study|Physician Decision|0|||
156368377|NCT04649151|564448304|FG002|Overall Study|Physician Decision|0|||
156368378|NCT04649151|564448305|FG003|Overall Study|Physician Decision|1|||
156368379|NCT04649151|564448306|FG004|Overall Study|Physician Decision|1|||
156368380|NCT04649151|564448302|FG000|Overall Study|Protocol Deviation|25|||
156368381|NCT04649151|564448303|FG001|Overall Study|Protocol Deviation|3|||
156368382|NCT04649151|564448304|FG002|Overall Study|Protocol Deviation|0|||
156368383|NCT04649151|564448305|FG003|Overall Study|Protocol Deviation|0|||
156368384|NCT04649151|564448306|FG004|Overall Study|Protocol Deviation|0|||
156368385|NCT04649151|564448302|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
156368386|NCT04649151|564448303|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
156368387|NCT04649151|564448304|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
156368388|NCT04649151|564448305|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
156491737|NCT00550446|564894968|FG004|Up To Week 12|Other|0|||
156368389|NCT04649151|564448306|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
156368390|NCT04649151|564448302|FG000|Overall Study|Withdrawal by Subject|370|||
156368391|NCT04649151|564448303|FG001|Overall Study|Withdrawal by Subject|113|||
156368392|NCT04649151|564448304|FG002|Overall Study|Withdrawal by Subject|2|||
156368393|NCT04649151|564448305|FG003|Overall Study|Withdrawal by Subject|7|||
156368394|NCT04649151|564448306|FG004|Overall Study|Withdrawal by Subject|15|||
156368395|NCT04649151|564448302|FG000|Overall Study|Adverse Event|1|||
156368396|NCT04649151|564448303|FG001|Overall Study|Adverse Event|0|||
156368397|NCT04649151|564448304|FG002|Overall Study|Adverse Event|0|||
156368398|NCT04649151|564448305|FG003|Overall Study|Adverse Event|0|||
156368399|NCT04649151|564448306|FG004|Overall Study|Adverse Event|0|||
156368400|NCT04649151|564448302|FG000|Overall Study|Lost to Follow-up|256|||
156368401|NCT04649151|564448303|FG001|Overall Study|Lost to Follow-up|29|||
156368402|NCT04649151|564448304|FG002|Overall Study|Lost to Follow-up|10|||
156368403|NCT04649151|564448305|FG003|Overall Study|Lost to Follow-up|3|||
156368404|NCT04649151|564448306|FG004|Overall Study|Lost to Follow-up|6|||
156368405|NCT04649151|564448302|FG000|Overall Study|Other than specified|59|||
156368406|NCT04649151|564448303|FG001|Overall Study|Other than specified|294|||
156368407|NCT04649151|564448304|FG002|Overall Study|Other than specified|0|||
156368408|NCT04649151|564448305|FG003|Overall Study|Other than specified|0|||
156368409|NCT04649151|564448306|FG004|Overall Study|Other than specified|4|||
156368410|NCT04649151|564448302|FG000|Overall Study|Death|0|||
156368411|NCT04649151|564448303|FG001|Overall Study|Death|0|||
156368412|NCT04649151|564448304|FG002|Overall Study|Death|0|||
156368413|NCT04649151|564448305|FG003|Overall Study|Death|0|||
156368414|NCT04649151|564448306|FG004|Overall Study|Death|1|||
156368415|NCT04476017|564448307|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
156368416|NCT04476017|564448308|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
156368417|NCT03909165|564448316|FG000|Overall Study|Physician Decision|0|||
156368418|NCT03909165|564448317|FG001|Overall Study|Physician Decision|1|||
156368419|NCT03909165|564448318|FG002|Overall Study|Physician Decision|0|||
156368420|NCT03909165|564448319|FG003|Overall Study|Physician Decision|0|||
156368421|NCT03909165|564448320|FG004|Overall Study|Physician Decision|0|||
156368422|NCT03909165|564448316|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156368423|NCT03909165|564448317|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156368424|NCT03909165|564448318|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156368425|NCT03909165|564448319|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156368426|NCT03909165|564448320|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156368427|NCT03909165|564448316|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156368428|NCT03909165|564448317|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
156368429|NCT03909165|564448318|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
156368430|NCT03909165|564448319|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
156368431|NCT03909165|564448320|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
156368432|NCT03909165|564448316|FG000|Overall Study|Previous Drug Exposure|0|||
156368433|NCT03909165|564448317|FG001|Overall Study|Previous Drug Exposure|0|||
156368434|NCT03909165|564448318|FG002|Overall Study|Previous Drug Exposure|1|||
156368435|NCT03909165|564448319|FG003|Overall Study|Previous Drug Exposure|0|||
156368436|NCT03909165|564448320|FG004|Overall Study|Previous Drug Exposure|0|||
156368437|NCT03909165|564448316|FG000|Overall Study|Early Discharge|1|||
156368438|NCT03909165|564448317|FG001|Overall Study|Early Discharge|0|||
156368439|NCT03909165|564448318|FG002|Overall Study|Early Discharge|0|||
156368440|NCT03909165|564448319|FG003|Overall Study|Early Discharge|0|||
156368441|NCT03909165|564448320|FG004|Overall Study|Early Discharge|0|||
156368442|NCT06034496|564448321|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
156368443|NCT06034496|564448322|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
156368444|NCT06034496|564448321|FG000|Overall Study|Withdrawal by Subject|5|||
156368445|NCT06034496|564448322|FG001|Overall Study|Withdrawal by Subject|4|||
156368446|NCT02018458|564448323|FG000|Overall Study|Death|4|||
156368447|NCT04033159|564448324|FG000|Washout Period|Physician Decision|0|||
156368448|NCT04033159|564448325|FG001|Washout Period|Physician Decision|1|||
156368449|NCT04033159|564448326|FG002|Washout Period|Physician Decision|0|||
156368450|NCT04033159|564448324|FG000|Washout Period|Study terminated by Sponsor|0|||
156368451|NCT04033159|564448325|FG001|Washout Period|Study terminated by Sponsor|7|||
156368452|NCT04033159|564448326|FG002|Washout Period|Study terminated by Sponsor|0|||
156368453|NCT04033159|564448324|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
156368454|NCT04033159|564448325|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
156368455|NCT04033159|564448326|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
156368456|NCT01428193|564448329|FG000|Overall Study|Physician Decision|1|||
156368457|NCT01428193|564448329|FG000|Overall Study|Elevated screening liver enzymes|1|||
156368458|NCT03277261|564448336|FG000|Overall Study|Adverse Event|17|||
156368459|NCT03277261|564448337|FG001|Overall Study|Adverse Event|1|||
156368460|NCT03277261|564448336|FG000|Overall Study|Participant Withdrawal of Consent|6|||
156368461|NCT03277261|564448337|FG001|Overall Study|Participant Withdrawal of Consent|15|||
156368462|NCT03277261|564448336|FG000|Overall Study|Investigator / Sponsor Decision|4|||
156368463|NCT03277261|564448337|FG001|Overall Study|Investigator / Sponsor Decision|2|||
156368464|NCT03277261|564448336|FG000|Overall Study|Pregnancy|2|||
156491738|NCT00550446|564894969|FG005|Up To Week 12|Other|1|||
156491739|NCT00550446|564894970|FG006|Up To Week 12|Other|4|||
156491740|NCT00550446|564894971|FG007|Up To Week 12|Other|0|||
156491741|NCT00550446|564894972|FG008|Up To Week 12|Other|0|||
156491742|NCT00550446|564894973|FG009|Up To Week 12|Other|0|||
156491743|NCT00550446|564894974|FG010|Up To Week 12|Other|0|||
156491744|NCT00550446|564894964|FG000|Up To Week 12|Randomized not treated|0|||
156491745|NCT00550446|564894965|FG001|Up To Week 12|Randomized not treated|1|||
156491746|NCT00550446|564894966|FG002|Up To Week 12|Randomized not treated|1|||
156491747|NCT00550446|564894967|FG003|Up To Week 12|Randomized not treated|0|||
156491748|NCT00550446|564894968|FG004|Up To Week 12|Randomized not treated|0|||
156491749|NCT00550446|564894969|FG005|Up To Week 12|Randomized not treated|0|||
156491750|NCT00550446|564894970|FG006|Up To Week 12|Randomized not treated|0|||
156491751|NCT00550446|564894971|FG007|Up To Week 12|Randomized not treated|0|||
156491752|NCT00550446|564894972|FG008|Up To Week 12|Randomized not treated|0|||
156491753|NCT00550446|564894973|FG009|Up To Week 12|Randomized not treated|0|||
156491754|NCT00550446|564894974|FG010|Up To Week 12|Randomized not treated|0|||
156491755|NCT00550446|564894964|FG000|Post Week 12|Adverse Event|2|||
156491756|NCT00550446|564894965|FG001|Post Week 12|Adverse Event|1|||
156491757|NCT00550446|564894966|FG002|Post Week 12|Adverse Event|1|||
156491758|NCT00550446|564894967|FG003|Post Week 12|Adverse Event|1|||
156491759|NCT00550446|564894968|FG004|Post Week 12|Adverse Event|1|||
156491760|NCT00550446|564894969|FG005|Post Week 12|Adverse Event|1|||
156491761|NCT00550446|564894970|FG006|Post Week 12|Adverse Event|0|||
156368465|NCT03277261|564448337|FG001|Overall Study|Pregnancy|0|||
156368466|NCT03277261|564448336|FG000|Overall Study|Lost to Follow-up|2|||
156368467|NCT03277261|564448337|FG001|Overall Study|Lost to Follow-up|2|||
156368468|NCT03277261|564448336|FG000|Overall Study|Lack of Efficacy|2|||
156368469|NCT03277261|564448337|FG001|Overall Study|Lack of Efficacy|2|||
156368470|NCT03277261|564448336|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
156368471|NCT03277261|564448337|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
156368472|NCT03762083|564448338|FG000|Overall Study|Withdrawal by Subject|2|||
156368473|NCT03762083|564448338|FG000|Overall Study|Physician Decision|1|||
156368474|NCT00116558|564448339|FG000|Overall Study|Death|11|||
156368475|NCT00116558|564448340|FG001|Overall Study|Death|5|||
156368476|NCT00116558|564448341|FG002|Overall Study|Death|3|||
156368477|NCT00116558|564448339|FG000|Overall Study|Withdrawal by Subject|17|||
156368478|NCT00116558|564448340|FG001|Overall Study|Withdrawal by Subject|3|||
156368479|NCT00116558|564448341|FG002|Overall Study|Withdrawal by Subject|12|||
156368480|NCT00116558|564448339|FG000|Overall Study|disease progression|3|||
156368481|NCT00116558|564448340|FG001|Overall Study|disease progression|7|||
156368482|NCT00116558|564448341|FG002|Overall Study|disease progression|18|||
156368483|NCT00357370|564448342|FG000|Cohort 2|Lack of Efficacy|0|||
156368484|NCT00357370|564448343|FG001|Cohort 2|Lack of Efficacy|2|||
156368485|NCT00357370|564448344|FG002|Cohort 2|Lack of Efficacy|1|||
156368486|NCT00357370|564448342|FG000|Cohort 2|Adverse Event|1|||
156368487|NCT00357370|564448343|FG001|Cohort 2|Adverse Event|1|||
156368488|NCT00357370|564448344|FG002|Cohort 2|Adverse Event|1|||
156368489|NCT00357370|564448342|FG000|Cohort 2|Lost to Follow-up|0|||
156368490|NCT00357370|564448343|FG001|Cohort 2|Lost to Follow-up|1|||
156368491|NCT00357370|564448344|FG002|Cohort 2|Lost to Follow-up|0|||
156368492|NCT00357370|564448342|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
156368493|NCT00357370|564448343|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
156368494|NCT00357370|564448344|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
156368495|NCT00357370|564448342|FG000|Cohort 2|Withdrawal by Subject|0|||
156491762|NCT00550446|564894971|FG007|Post Week 12|Adverse Event|0|||
156491763|NCT00550446|564894972|FG008|Post Week 12|Adverse Event|0|||
156491764|NCT00550446|564894973|FG009|Post Week 12|Adverse Event|4|||
156491765|NCT00550446|564894974|FG010|Post Week 12|Adverse Event|0|||
156491766|NCT00550446|564894964|FG000|Post Week 12|Lack of Efficacy|0|||
156546098|NCT02412787|565093292|FG000|Overall Study|Technical Problems|1|||
156491767|NCT00550446|564894965|FG001|Post Week 12|Lack of Efficacy|0|||
156491768|NCT00550446|564894966|FG002|Post Week 12|Lack of Efficacy|1|||
156491769|NCT00550446|564894967|FG003|Post Week 12|Lack of Efficacy|0|||
156491770|NCT00550446|564894968|FG004|Post Week 12|Lack of Efficacy|0|||
156491771|NCT00550446|564894969|FG005|Post Week 12|Lack of Efficacy|0|||
156368496|NCT00357370|564448343|FG001|Cohort 2|Withdrawal by Subject|2|||
156368497|NCT00357370|564448344|FG002|Cohort 2|Withdrawal by Subject|0|||
156368498|NCT01143090|564448345|FG000|Overall Study|Lack of Efficacy|2|||
156368499|NCT01143090|564448345|FG000|Overall Study|Adverse Event|17|||
156368500|NCT01143090|564448345|FG000|Overall Study|Lost to Follow-up|9|||
156368501|NCT01143090|564448345|FG000|Overall Study|Protocol Violation|2|||
156368502|NCT01143090|564448345|FG000|Overall Study|Withdrawal by Subject|18|||
156491772|NCT00550446|564894970|FG006|Post Week 12|Lack of Efficacy|0|||
156368503|NCT01143090|564448345|FG000|Overall Study|Non-compliance with study drug|1|||
156491773|NCT00550446|564894971|FG007|Post Week 12|Lack of Efficacy|1|||
156491774|NCT00550446|564894972|FG008|Post Week 12|Lack of Efficacy|1|||
156491775|NCT00550446|564894973|FG009|Post Week 12|Lack of Efficacy|2|||
156491776|NCT00550446|564894974|FG010|Post Week 12|Lack of Efficacy|1|||
156491777|NCT00550446|564894964|FG000|Post Week 12|Lost to Follow-up|0|||
156491778|NCT00550446|564894965|FG001|Post Week 12|Lost to Follow-up|0|||
156491779|NCT00550446|564894966|FG002|Post Week 12|Lost to Follow-up|1|||
156491780|NCT00550446|564894967|FG003|Post Week 12|Lost to Follow-up|1|||
156491781|NCT00550446|564894968|FG004|Post Week 12|Lost to Follow-up|0|||
156368504|NCT01143090|564448345|FG000|Overall Study|Failure to meet eligibility criteria|1|||
156368505|NCT01143090|564448345|FG000|Overall Study|Administrative|1|||
156368506|NCT00499603|564448350|FG000|Overall Study|Adverse Event|0|||
156368507|NCT00499603|564448351|FG001|Overall Study|Adverse Event|1|||
156368508|NCT00937547|564448354|FG000|Overall Study|misdiagnosis|1|||
156368509|NCT00937547|564448355|FG001|Overall Study|misdiagnosis|6|||
156368510|NCT00937547|564448356|FG002|Overall Study|misdiagnosis|7|||
156368511|NCT02287896|564448360|FG000|Second Injection Visit|Withdrawal by Subject|0|||
156368512|NCT02287896|564448361|FG001|Second Injection Visit|Withdrawal by Subject|1|||
156368513|NCT01639040|564448362|FG000|Overall Study|Adverse Event|1|||
156368514|NCT01639040|564448363|FG001|Overall Study|Adverse Event|0|||
156368515|NCT05220397|564448365|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
156368516|NCT05220397|564448366|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
156368517|NCT05220397|564448367|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
156491782|NCT00550446|564894969|FG005|Post Week 12|Lost to Follow-up|0|||
156368518|NCT05220397|564448368|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
156368519|NCT05220397|564448369|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
156368520|NCT02052739|564448370|FG000|Overall Study|Withdrew due to Adverse Event|3|||
156368521|NCT02052739|564448371|FG001|Overall Study|Withdrew due to Adverse Event|0|||
156368522|NCT02052739|564448370|FG000|Overall Study|Participant Died|2|||
156368523|NCT02052739|564448371|FG001|Overall Study|Participant Died|1|||
156368524|NCT02043015|564448372|FG000|Overall Study|Lost to Follow-up|4|||
156368525|NCT02043015|564448372|FG000|Overall Study|Withdrawal by Subject|4|||
156368526|NCT02043015|564448372|FG000|Overall Study|Removed once target enrollment reached|15|||
156368527|NCT02043015|564448372|FG000|Overall Study|Participant moved away from study city|4|||
156368528|NCT02043015|564448372|FG000|Overall Study|Incarceration|1|||
156368529|NCT02457598|564448373|FG000|Overall Study|Progressive Disease|2|||
156368530|NCT02457598|564448374|FG001|Overall Study|Progressive Disease|2|||
156368531|NCT02457598|564448375|FG002|Overall Study|Progressive Disease|1|||
156368532|NCT02457598|564448376|FG003|Overall Study|Progressive Disease|11|||
156368533|NCT02457598|564448377|FG004|Overall Study|Progressive Disease|7|||
156368534|NCT02457598|564448378|FG005|Overall Study|Progressive Disease|3|||
156368535|NCT02457598|564448379|FG006|Overall Study|Progressive Disease|2|||
156368536|NCT02457598|564448380|FG007|Overall Study|Progressive Disease|1|||
156368537|NCT02457598|564448381|FG008|Overall Study|Progressive Disease|1|||
156368538|NCT02457598|564448382|FG009|Overall Study|Progressive Disease|2|||
156368539|NCT02457598|564448383|FG010|Overall Study|Progressive Disease|45|||
156368540|NCT02457598|564448384|FG011|Overall Study|Progressive Disease|6|||
156368541|NCT02457598|564448385|FG012|Overall Study|Progressive Disease|2|||
156368542|NCT02457598|564448386|FG013|Overall Study|Progressive Disease|2|||
156368543|NCT02457598|564448387|FG014|Overall Study|Progressive Disease|10|||
156368544|NCT02457598|564448388|FG015|Overall Study|Progressive Disease|1|||
156368545|NCT02457598|564448389|FG016|Overall Study|Progressive Disease|1|||
156368546|NCT02457598|564448373|FG000|Overall Study|Investigator's Discretion|0|||
156368547|NCT02457598|564448374|FG001|Overall Study|Investigator's Discretion|2|||
156368548|NCT02457598|564448375|FG002|Overall Study|Investigator's Discretion|2|||
156368549|NCT02457598|564448376|FG003|Overall Study|Investigator's Discretion|2|||
156368550|NCT02457598|564448377|FG004|Overall Study|Investigator's Discretion|0|||
156368551|NCT02457598|564448378|FG005|Overall Study|Investigator's Discretion|0|||
156368552|NCT02457598|564448379|FG006|Overall Study|Investigator's Discretion|0|||
156368553|NCT02457598|564448380|FG007|Overall Study|Investigator's Discretion|1|||
156368554|NCT02457598|564448381|FG008|Overall Study|Investigator's Discretion|2|||
156368555|NCT02457598|564448382|FG009|Overall Study|Investigator's Discretion|0|||
156368556|NCT02457598|564448383|FG010|Overall Study|Investigator's Discretion|10|||
156368557|NCT02457598|564448384|FG011|Overall Study|Investigator's Discretion|2|||
156491783|NCT00550446|564894970|FG006|Post Week 12|Lost to Follow-up|1|||
156368558|NCT02457598|564448385|FG012|Overall Study|Investigator's Discretion|2|||
156491784|NCT00550446|564894971|FG007|Post Week 12|Lost to Follow-up|0|||
156491785|NCT00550446|564894972|FG008|Post Week 12|Lost to Follow-up|0|||
156491786|NCT00550446|564894973|FG009|Post Week 12|Lost to Follow-up|0|||
156491787|NCT00550446|564894974|FG010|Post Week 12|Lost to Follow-up|0|||
156491788|NCT00550446|564894964|FG000|Post Week 12|Withdrawal by Subject|0|||
156491789|NCT00550446|564894965|FG001|Post Week 12|Withdrawal by Subject|0|||
156368559|NCT02457598|564448386|FG013|Overall Study|Investigator's Discretion|1|||
156368560|NCT02457598|564448387|FG014|Overall Study|Investigator's Discretion|5|||
156368561|NCT02457598|564448388|FG015|Overall Study|Investigator's Discretion|0|||
156368562|NCT02457598|564448389|FG016|Overall Study|Investigator's Discretion|0|||
156368563|NCT02457598|564448373|FG000|Overall Study|Study Terminated by Sponsor|0|||
156368564|NCT02457598|564448374|FG001|Overall Study|Study Terminated by Sponsor|1|||
156491790|NCT00550446|564894966|FG002|Post Week 12|Withdrawal by Subject|0|||
156491791|NCT00550446|564894967|FG003|Post Week 12|Withdrawal by Subject|0|||
156368565|NCT02457598|564448375|FG002|Overall Study|Study Terminated by Sponsor|0|||
156368566|NCT02457598|564448376|FG003|Overall Study|Study Terminated by Sponsor|4|||
156368567|NCT02457598|564448377|FG004|Overall Study|Study Terminated by Sponsor|1|||
156368568|NCT02457598|564448378|FG005|Overall Study|Study Terminated by Sponsor|0|||
156368569|NCT02457598|564448379|FG006|Overall Study|Study Terminated by Sponsor|1|||
156368570|NCT02457598|564448380|FG007|Overall Study|Study Terminated by Sponsor|0|||
156368571|NCT02457598|564448381|FG008|Overall Study|Study Terminated by Sponsor|0|||
156368572|NCT02457598|564448382|FG009|Overall Study|Study Terminated by Sponsor|0|||
156368573|NCT02457598|564448383|FG010|Overall Study|Study Terminated by Sponsor|4|||
156368574|NCT02457598|564448384|FG011|Overall Study|Study Terminated by Sponsor|0|||
156368575|NCT02457598|564448385|FG012|Overall Study|Study Terminated by Sponsor|1|||
156368576|NCT02457598|564448386|FG013|Overall Study|Study Terminated by Sponsor|0|||
156368577|NCT02457598|564448387|FG014|Overall Study|Study Terminated by Sponsor|8|||
156491792|NCT00550446|564894968|FG004|Post Week 12|Withdrawal by Subject|1|||
156491793|NCT00550446|564894969|FG005|Post Week 12|Withdrawal by Subject|0|||
156491794|NCT00550446|564894970|FG006|Post Week 12|Withdrawal by Subject|0|||
156491795|NCT00550446|564894971|FG007|Post Week 12|Withdrawal by Subject|0|||
156491796|NCT00550446|564894972|FG008|Post Week 12|Withdrawal by Subject|0|||
156491797|NCT00550446|564894973|FG009|Post Week 12|Withdrawal by Subject|0|||
156491798|NCT00550446|564894974|FG010|Post Week 12|Withdrawal by Subject|0|||
156491799|NCT00550446|564894964|FG000|Post Week 12|Other|1|||
156546099|NCT02412787|565093292|FG000|Overall Study|Reason Not Specified|1|||
156546100|NCT00001379|565093293|FG000|Initial Treatment|Disease progression|21|||
156546101|NCT00001379|565093294|FG001|Initial Treatment|Disease progression|3|||
156368578|NCT02457598|564448388|FG015|Overall Study|Study Terminated by Sponsor|1|||
156368579|NCT02457598|564448389|FG016|Overall Study|Study Terminated by Sponsor|0|||
156368580|NCT02457598|564448373|FG000|Overall Study|Adverse Event|0|||
156368581|NCT02457598|564448374|FG001|Overall Study|Adverse Event|1|||
156368582|NCT02457598|564448375|FG002|Overall Study|Adverse Event|1|||
156368583|NCT02457598|564448376|FG003|Overall Study|Adverse Event|4|||
156368584|NCT02457598|564448377|FG004|Overall Study|Adverse Event|1|||
156368585|NCT02457598|564448378|FG005|Overall Study|Adverse Event|0|||
156368586|NCT02457598|564448379|FG006|Overall Study|Adverse Event|0|||
156368587|NCT02457598|564448380|FG007|Overall Study|Adverse Event|1|||
156368588|NCT02457598|564448381|FG008|Overall Study|Adverse Event|0|||
156368589|NCT02457598|564448382|FG009|Overall Study|Adverse Event|1|||
156368590|NCT02457598|564448383|FG010|Overall Study|Adverse Event|6|||
156368591|NCT02457598|564448384|FG011|Overall Study|Adverse Event|0|||
156368592|NCT02457598|564448385|FG012|Overall Study|Adverse Event|0|||
156368593|NCT02457598|564448386|FG013|Overall Study|Adverse Event|1|||
156368594|NCT02457598|564448387|FG014|Overall Study|Adverse Event|2|||
156368595|NCT02457598|564448388|FG015|Overall Study|Adverse Event|0|||
156368596|NCT02457598|564448389|FG016|Overall Study|Adverse Event|0|||
156368597|NCT02457598|564448373|FG000|Overall Study|Death|0|||
156368598|NCT02457598|564448374|FG001|Overall Study|Death|0|||
156368599|NCT02457598|564448375|FG002|Overall Study|Death|0|||
156368600|NCT02457598|564448376|FG003|Overall Study|Death|3|||
156368601|NCT02457598|564448377|FG004|Overall Study|Death|0|||
156368602|NCT02457598|564448378|FG005|Overall Study|Death|1|||
156368603|NCT02457598|564448379|FG006|Overall Study|Death|0|||
156368604|NCT02457598|564448380|FG007|Overall Study|Death|0|||
156368605|NCT02457598|564448381|FG008|Overall Study|Death|0|||
156368606|NCT02457598|564448382|FG009|Overall Study|Death|0|||
156368607|NCT02457598|564448383|FG010|Overall Study|Death|3|||
156368608|NCT02457598|564448384|FG011|Overall Study|Death|0|||
156491800|NCT00550446|564894965|FG001|Post Week 12|Other|1|||
156491801|NCT00550446|564894966|FG002|Post Week 12|Other|0|||
156491802|NCT00550446|564894967|FG003|Post Week 12|Other|1|||
156491803|NCT00550446|564894968|FG004|Post Week 12|Other|0|||
156491804|NCT00550446|564894969|FG005|Post Week 12|Other|0|||
156491805|NCT00550446|564894970|FG006|Post Week 12|Other|1|||
156491806|NCT00550446|564894971|FG007|Post Week 12|Other|0|||
156491807|NCT00550446|564894972|FG008|Post Week 12|Other|1|||
156491808|NCT00550446|564894973|FG009|Post Week 12|Other|1|||
156368609|NCT02457598|564448385|FG012|Overall Study|Death|0|||
156368610|NCT02457598|564448386|FG013|Overall Study|Death|1|||
156491809|NCT00550446|564894974|FG010|Post Week 12|Other|0|||
156491810|NCT01114672|564894975|FG000|Overall Study|Death|0|||
156491811|NCT01114672|564894976|FG001|Overall Study|Death|1|||
156491812|NCT01114672|564894975|FG000|Overall Study|Withdrawal by Subject|2|||
156546102|NCT00001379|565093295|FG002|Initial Treatment|Disease progression|0|||
156368611|NCT02457598|564448387|FG014|Overall Study|Death|2|||
156368612|NCT02457598|564448388|FG015|Overall Study|Death|0|||
156368613|NCT02457598|564448389|FG016|Overall Study|Death|1|||
156368614|NCT02457598|564448373|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368615|NCT02457598|564448374|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
156368616|NCT02457598|564448375|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368617|NCT02457598|564448376|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
156546103|NCT00001379|565093296|FG003|Initial Treatment|Disease progression|0|||
156368618|NCT02457598|564448377|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
156491813|NCT01114672|564894976|FG001|Overall Study|Withdrawal by Subject|1|||
156491814|NCT01114672|564894975|FG000|Overall Study|Lost to Follow-up|1|||
156491815|NCT01114672|564894976|FG001|Overall Study|Lost to Follow-up|0|||
156491816|NCT01114672|564894975|FG000|Overall Study|transplanted|1|||
156491817|NCT01114672|564894976|FG001|Overall Study|transplanted|0|||
156368619|NCT02457598|564448378|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368620|NCT02457598|564448379|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368621|NCT02457598|564448380|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
156368622|NCT02457598|564448381|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368623|NCT02457598|564448382|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368624|NCT02457598|564448383|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
156368625|NCT02457598|564448384|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368626|NCT02457598|564448385|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368627|NCT02457598|564448386|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
156368628|NCT02457598|564448387|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
156368629|NCT02457598|564448388|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
156368630|NCT02457598|564448389|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
156368631|NCT02457598|564448373|FG000|Overall Study|Withdrew Consent|0|||
156368632|NCT02457598|564448374|FG001|Overall Study|Withdrew Consent|0|||
156368633|NCT02457598|564448375|FG002|Overall Study|Withdrew Consent|0|||
156368634|NCT02457598|564448376|FG003|Overall Study|Withdrew Consent|0|||
156368635|NCT02457598|564448377|FG004|Overall Study|Withdrew Consent|0|||
156368636|NCT02457598|564448378|FG005|Overall Study|Withdrew Consent|0|||
156368637|NCT02457598|564448379|FG006|Overall Study|Withdrew Consent|0|||
156368638|NCT02457598|564448380|FG007|Overall Study|Withdrew Consent|2|||
156368639|NCT02457598|564448381|FG008|Overall Study|Withdrew Consent|0|||
156368640|NCT02457598|564448382|FG009|Overall Study|Withdrew Consent|0|||
156368641|NCT02457598|564448383|FG010|Overall Study|Withdrew Consent|3|||
156368642|NCT02457598|564448384|FG011|Overall Study|Withdrew Consent|0|||
156368643|NCT02457598|564448385|FG012|Overall Study|Withdrew Consent|0|||
156368644|NCT02457598|564448386|FG013|Overall Study|Withdrew Consent|1|||
156368645|NCT02457598|564448387|FG014|Overall Study|Withdrew Consent|0|||
156368646|NCT02457598|564448388|FG015|Overall Study|Withdrew Consent|0|||
156368647|NCT02457598|564448389|FG016|Overall Study|Withdrew Consent|0|||
156368648|NCT02457598|564448373|FG000|Overall Study|Unacceptable Toxicity|0|||
156368649|NCT02457598|564448374|FG001|Overall Study|Unacceptable Toxicity|0|||
156368650|NCT02457598|564448375|FG002|Overall Study|Unacceptable Toxicity|0|||
156368651|NCT02457598|564448376|FG003|Overall Study|Unacceptable Toxicity|0|||
156368652|NCT02457598|564448377|FG004|Overall Study|Unacceptable Toxicity|0|||
156368653|NCT02457598|564448378|FG005|Overall Study|Unacceptable Toxicity|0|||
156368654|NCT02457598|564448379|FG006|Overall Study|Unacceptable Toxicity|0|||
156368655|NCT02457598|564448380|FG007|Overall Study|Unacceptable Toxicity|0|||
156368656|NCT02457598|564448381|FG008|Overall Study|Unacceptable Toxicity|0|||
156368657|NCT02457598|564448382|FG009|Overall Study|Unacceptable Toxicity|0|||
156368658|NCT02457598|564448383|FG010|Overall Study|Unacceptable Toxicity|1|||
156368659|NCT02457598|564448384|FG011|Overall Study|Unacceptable Toxicity|0|||
156368660|NCT02457598|564448385|FG012|Overall Study|Unacceptable Toxicity|1|||
156368661|NCT02457598|564448386|FG013|Overall Study|Unacceptable Toxicity|1|||
156368662|NCT02457598|564448387|FG014|Overall Study|Unacceptable Toxicity|1|||
156368663|NCT02457598|564448388|FG015|Overall Study|Unacceptable Toxicity|0|||
156368664|NCT02457598|564448389|FG016|Overall Study|Unacceptable Toxicity|0|||
156368665|NCT02457598|564448373|FG000|Overall Study|Intercurrent Illness|0|||
156368666|NCT02457598|564448374|FG001|Overall Study|Intercurrent Illness|0|||
156368667|NCT02457598|564448375|FG002|Overall Study|Intercurrent Illness|0|||
156368668|NCT02457598|564448376|FG003|Overall Study|Intercurrent Illness|0|||
156368669|NCT02457598|564448377|FG004|Overall Study|Intercurrent Illness|0|||
156368670|NCT02457598|564448378|FG005|Overall Study|Intercurrent Illness|0|||
156368671|NCT02457598|564448379|FG006|Overall Study|Intercurrent Illness|0|||
156368672|NCT02457598|564448380|FG007|Overall Study|Intercurrent Illness|0|||
156368673|NCT02457598|564448381|FG008|Overall Study|Intercurrent Illness|0|||
156368674|NCT02457598|564448382|FG009|Overall Study|Intercurrent Illness|0|||
156368675|NCT02457598|564448383|FG010|Overall Study|Intercurrent Illness|1|||
156368676|NCT02457598|564448384|FG011|Overall Study|Intercurrent Illness|0|||
156368677|NCT02457598|564448385|FG012|Overall Study|Intercurrent Illness|0|||
156368678|NCT02457598|564448386|FG013|Overall Study|Intercurrent Illness|0|||
156368679|NCT02457598|564448387|FG014|Overall Study|Intercurrent Illness|0|||
156368680|NCT02457598|564448388|FG015|Overall Study|Intercurrent Illness|0|||
156368681|NCT02457598|564448389|FG016|Overall Study|Intercurrent Illness|0|||
156368682|NCT02457598|564448373|FG000|Overall Study|Protocol Violation|0|||
156368683|NCT02457598|564448374|FG001|Overall Study|Protocol Violation|0|||
156368684|NCT02457598|564448375|FG002|Overall Study|Protocol Violation|0|||
156368685|NCT02457598|564448376|FG003|Overall Study|Protocol Violation|0|||
156368686|NCT02457598|564448377|FG004|Overall Study|Protocol Violation|0|||
156368687|NCT02457598|564448378|FG005|Overall Study|Protocol Violation|0|||
156368688|NCT02457598|564448379|FG006|Overall Study|Protocol Violation|0|||
156368689|NCT02457598|564448380|FG007|Overall Study|Protocol Violation|0|||
156368690|NCT02457598|564448381|FG008|Overall Study|Protocol Violation|0|||
156368691|NCT02457598|564448382|FG009|Overall Study|Protocol Violation|0|||
156368692|NCT02457598|564448383|FG010|Overall Study|Protocol Violation|1|||
156368693|NCT02457598|564448384|FG011|Overall Study|Protocol Violation|0|||
156368694|NCT02457598|564448385|FG012|Overall Study|Protocol Violation|0|||
156368695|NCT02457598|564448386|FG013|Overall Study|Protocol Violation|0|||
156368696|NCT02457598|564448387|FG014|Overall Study|Protocol Violation|0|||
156368697|NCT02457598|564448388|FG015|Overall Study|Protocol Violation|0|||
156368698|NCT02457598|564448389|FG016|Overall Study|Protocol Violation|0|||
156368699|NCT01403974|564448390|FG000|Overall Study|Progressive disease according to RECIST|3|||
156368700|NCT01403974|564448391|FG001|Overall Study|Progressive disease according to RECIST|3|||
156368701|NCT01403974|564448392|FG002|Overall Study|Progressive disease according to RECIST|2|||
156368702|NCT01403974|564448393|FG003|Overall Study|Progressive disease according to RECIST|3|||
156368703|NCT01403974|564448394|FG004|Overall Study|Progressive disease according to RECIST|3|||
156368704|NCT01403974|564448395|FG005|Overall Study|Progressive disease according to RECIST|2|||
156368705|NCT01403974|564448396|FG006|Overall Study|Progressive disease according to RECIST|3|||
156368706|NCT01403974|564448397|FG007|Overall Study|Progressive disease according to RECIST|2|||
156368707|NCT01403974|564448398|FG008|Overall Study|Progressive disease according to RECIST|6|||
156368708|NCT01403974|564448399|FG009|Overall Study|Progressive disease according to RECIST|2|||
156368709|NCT01403974|564448400|FG010|Overall Study|Progressive disease according to RECIST|3|||
156368710|NCT01403974|564448401|FG011|Overall Study|Progressive disease according to RECIST|2|||
156368711|NCT01403974|564448402|FG012|Overall Study|Progressive disease according to RECIST|2|||
156368712|NCT01403974|564448403|FG013|Overall Study|Progressive disease according to RECIST|3|||
156368713|NCT01403974|564448404|FG014|Overall Study|Progressive disease according to RECIST|1|||
156368714|NCT01403974|564448405|FG015|Overall Study|Progressive disease according to RECIST|8|||
156368715|NCT01403974|564448390|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
156368716|NCT01403974|564448391|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
156368717|NCT01403974|564448392|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
156368718|NCT01403974|564448393|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
156368719|NCT01403974|564448394|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
156368720|NCT01403974|564448395|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
156368721|NCT01403974|564448396|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
156368722|NCT01403974|564448397|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
156368723|NCT01403974|564448398|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
156368724|NCT01403974|564448399|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
156368725|NCT01403974|564448400|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
156368726|NCT01403974|564448401|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
156368727|NCT01403974|564448402|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
156368728|NCT01403974|564448403|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
156368729|NCT01403974|564448404|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
156368730|NCT01403974|564448405|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
156368731|NCT01403974|564448390|FG000|Overall Study|Refused to continue study medication|0|||
156368732|NCT01403974|564448391|FG001|Overall Study|Refused to continue study medication|0|||
156368733|NCT01403974|564448392|FG002|Overall Study|Refused to continue study medication|0|||
156368734|NCT01403974|564448393|FG003|Overall Study|Refused to continue study medication|0|||
156368735|NCT01403974|564448394|FG004|Overall Study|Refused to continue study medication|0|||
156368736|NCT01403974|564448395|FG005|Overall Study|Refused to continue study medication|1|||
156368737|NCT01403974|564448396|FG006|Overall Study|Refused to continue study medication|0|||
156491818|NCT01710800|564894982|FG000|Overall Study|Withdrawal by Subject|21|||
156491819|NCT01710800|564894982|FG000|Overall Study|Protocol Violation|1|||
156491820|NCT00827775|564894983|FG000|Overall Study|Withdrawal by Subject|0|||
156491821|NCT00827775|564894984|FG001|Overall Study|Withdrawal by Subject|5|||
156491822|NCT03891641|564894985|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
156491823|NCT03891641|564894986|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
156491824|NCT00001941|564894987|FG000|Overall Study|not treated- rapidly progressing disease|0|||
156491825|NCT00001941|564894988|FG001|Overall Study|not treated- rapidly progressing disease|0|||
156491826|NCT00001941|564894989|FG002|Overall Study|not treated- rapidly progressing disease|0|||
156491827|NCT00001941|564894990|FG003|Overall Study|not treated- rapidly progressing disease|0|||
156491828|NCT00001941|564894991|FG004|Overall Study|not treated- rapidly progressing disease|1|||
156491829|NCT02551692|564894995|FG000|Overall Study|Lost to Follow-up|0|||
156491830|NCT02551692|564894996|FG001|Overall Study|Lost to Follow-up|1|||
156491831|NCT02551692|564894997|FG002|Overall Study|Lost to Follow-up|4|||
156491832|NCT02551692|564894995|FG000|Overall Study|Withdrawal by Subject|1|||
156491833|NCT02551692|564894996|FG001|Overall Study|Withdrawal by Subject|0|||
156491834|NCT02551692|564894997|FG002|Overall Study|Withdrawal by Subject|1|||
156491835|NCT01196741|564894998|FG000|Overall Study|Disease progression|34|||
156491836|NCT01196741|564894999|FG001|Overall Study|Disease progression|14|||
156491837|NCT01196741|564894998|FG000|Overall Study|Adverse Event|10|||
156491838|NCT01196741|564894999|FG001|Overall Study|Adverse Event|6|||
156491839|NCT01196741|564894998|FG000|Overall Study|Serious Adverse Event|3|||
156368738|NCT01403974|564448397|FG007|Overall Study|Refused to continue study medication|0|||
156491840|NCT01196741|564894999|FG001|Overall Study|Serious Adverse Event|1|||
156491841|NCT01196741|564894998|FG000|Overall Study|Dose limiting Adverse Event|2|||
156491842|NCT01196741|564894999|FG001|Overall Study|Dose limiting Adverse Event|1|||
156368739|NCT01403974|564448398|FG008|Overall Study|Refused to continue study medication|1|||
156368740|NCT01403974|564448399|FG009|Overall Study|Refused to continue study medication|0|||
156368741|NCT01403974|564448400|FG010|Overall Study|Refused to continue study medication|1|||
156368742|NCT01403974|564448401|FG011|Overall Study|Refused to continue study medication|0|||
156368743|NCT01403974|564448402|FG012|Overall Study|Refused to continue study medication|0|||
156491843|NCT01196741|564894998|FG000|Overall Study|Withdrawal by Subject|3|||
156491844|NCT01196741|564894999|FG001|Overall Study|Withdrawal by Subject|0|||
156491845|NCT01196741|564894998|FG000|Overall Study|Other reason|3|||
156491846|NCT01196741|564894999|FG001|Overall Study|Other reason|3|||
156491847|NCT01196741|564894998|FG000|Overall Study|Other|3|||
156491848|NCT01196741|564894999|FG001|Overall Study|Other|2|||
156491849|NCT01196741|564894998|FG000|Overall Study|Protocol Violation|2|||
156491850|NCT01196741|564894999|FG001|Overall Study|Protocol Violation|1|||
156491851|NCT04380688|564895000|FG000|Overall Study|Death|2|||
156491852|NCT04380688|564895001|FG001|Overall Study|Death|2|||
156491853|NCT04380688|564895000|FG000|Overall Study|Lost to Follow-up|2|||
156491854|NCT04380688|564895001|FG001|Overall Study|Lost to Follow-up|4|||
156491855|NCT04380688|564895000|FG000|Overall Study|Withdrawal by Subject|3|||
156491856|NCT04380688|564895001|FG001|Overall Study|Withdrawal by Subject|3|||
156491857|NCT00919061|564895002|FG000|Overall Study|Adverse Event|1|||
156491858|NCT00919061|564895002|FG000|Overall Study|Withdrawal by Subject|1|||
156491859|NCT02056873|564895003|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
156491860|NCT01932762|564896903|FG000|Overall Study|Withdrawal by Subject|1|||
156491861|NCT01932762|564896904|FG001|Overall Study|Withdrawal by Subject|2|||
156491862|NCT01932762|564896905|FG002|Overall Study|Withdrawal by Subject|0|||
156491863|NCT01932762|564896906|FG003|Overall Study|Withdrawal by Subject|0|||
156491864|NCT01932762|564896903|FG000|Overall Study|Lost to Follow-up|4|||
156491865|NCT01932762|564896904|FG001|Overall Study|Lost to Follow-up|0|||
156491866|NCT01932762|564896905|FG002|Overall Study|Lost to Follow-up|0|||
156491867|NCT01932762|564896906|FG003|Overall Study|Lost to Follow-up|1|||
156491868|NCT01932762|564896903|FG000|Overall Study|Physician Decision|1|||
156491869|NCT01932762|564896904|FG001|Overall Study|Physician Decision|0|||
156491870|NCT01932762|564896905|FG002|Overall Study|Physician Decision|0|||
156491871|NCT01932762|564896906|FG003|Overall Study|Physician Decision|0|||
156491872|NCT02210208|564896907|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
156491873|NCT02210208|564896907|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
156491874|NCT02210208|564896907|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
156491875|NCT00695136|564896908|FG000|Overall Study|Withdrawal by Subject|1|||
156491876|NCT00695136|564896908|FG000|Overall Study|unrelated adverse event|1|||
156491877|NCT01726049|564896910|FG000|Overall Study|Death|1|||
156491878|NCT01726049|564896911|FG001|Overall Study|Death|1|||
156491879|NCT01726049|564896910|FG000|Overall Study|Adverse Event|4|||
156491880|NCT01726049|564896911|FG001|Overall Study|Adverse Event|1|||
156491881|NCT01726049|564896910|FG000|Overall Study|refused second HC|0|||
156491882|NCT01726049|564896911|FG001|Overall Study|refused second HC|2|||
156491883|NCT00487552|564896921|FG000|Overall Study|Unsuccessful magnet placements|3|||
156491884|NCT00487552|564896921|FG000|Overall Study|Death due to progressive malignancy|2|||
156491885|NCT00487552|564896921|FG000|Overall Study|Stent not placed|1|||
156491886|NCT03119688|564896922|FG000|Overall Study|Adverse Event|4|||
156491887|NCT00320398|564896923|FG000|Overall Study|Adverse Event|1|||
156491888|NCT00320398|564896924|FG001|Overall Study|Adverse Event|4|||
156491889|NCT00320398|564896923|FG000|Overall Study|Other|1|||
156491890|NCT00320398|564896924|FG001|Overall Study|Other|0|||
156491891|NCT02705625|564896925|FG000|Overall Study|Protocol Violation|1|||
156491892|NCT02705625|564896926|FG001|Overall Study|Protocol Violation|0|||
156491893|NCT02705625|564896927|FG002|Overall Study|Protocol Violation|0|||
156491894|NCT02705625|564896925|FG000|Overall Study|Adverse Event|6|||
156491895|NCT02705625|564896926|FG001|Overall Study|Adverse Event|5|||
156491896|NCT02705625|564896927|FG002|Overall Study|Adverse Event|2|||
156491897|NCT02705625|564896925|FG000|Overall Study|Death|0|||
156368744|NCT01403974|564448403|FG013|Overall Study|Refused to continue study medication|0|||
156368745|NCT01403974|564448404|FG014|Overall Study|Refused to continue study medication|0|||
156368746|NCT01403974|564448405|FG015|Overall Study|Refused to continue study medication|4|||
156368747|NCT01403974|564448390|FG000|Overall Study|Adverse Event|0|||
156368748|NCT01403974|564448391|FG001|Overall Study|Adverse Event|0|||
156368749|NCT01403974|564448392|FG002|Overall Study|Adverse Event|1|||
156368750|NCT01403974|564448393|FG003|Overall Study|Adverse Event|0|||
156368751|NCT01403974|564448394|FG004|Overall Study|Adverse Event|0|||
156368752|NCT01403974|564448395|FG005|Overall Study|Adverse Event|0|||
156368753|NCT01403974|564448396|FG006|Overall Study|Adverse Event|0|||
156368754|NCT01403974|564448397|FG007|Overall Study|Adverse Event|1|||
156368755|NCT01403974|564448398|FG008|Overall Study|Adverse Event|0|||
156368756|NCT01403974|564448399|FG009|Overall Study|Adverse Event|0|||
156368757|NCT01403974|564448400|FG010|Overall Study|Adverse Event|0|||
156368758|NCT01403974|564448401|FG011|Overall Study|Adverse Event|0|||
156368759|NCT01403974|564448402|FG012|Overall Study|Adverse Event|1|||
156368760|NCT01403974|564448403|FG013|Overall Study|Adverse Event|0|||
156368761|NCT01403974|564448404|FG014|Overall Study|Adverse Event|0|||
156368762|NCT01403974|564448405|FG015|Overall Study|Adverse Event|0|||
156368763|NCT01403974|564448390|FG000|Overall Study|Other than specified|0|||
156368764|NCT01403974|564448391|FG001|Overall Study|Other than specified|0|||
156368765|NCT01403974|564448392|FG002|Overall Study|Other than specified|0|||
156368766|NCT01403974|564448393|FG003|Overall Study|Other than specified|0|||
156368767|NCT01403974|564448394|FG004|Overall Study|Other than specified|0|||
156368768|NCT01403974|564448395|FG005|Overall Study|Other than specified|0|||
156368769|NCT01403974|564448396|FG006|Overall Study|Other than specified|0|||
156368770|NCT01403974|564448397|FG007|Overall Study|Other than specified|0|||
156368771|NCT01403974|564448398|FG008|Overall Study|Other than specified|0|||
156368772|NCT01403974|564448399|FG009|Overall Study|Other than specified|1|||
156368773|NCT01403974|564448400|FG010|Overall Study|Other than specified|0|||
156368774|NCT01403974|564448401|FG011|Overall Study|Other than specified|1|||
156368775|NCT01403974|564448402|FG012|Overall Study|Other than specified|0|||
156368776|NCT01403974|564448403|FG013|Overall Study|Other than specified|0|||
156368777|NCT01403974|564448404|FG014|Overall Study|Other than specified|0|||
156368778|NCT01403974|564448405|FG015|Overall Study|Other than specified|0|||
156368779|NCT01526889|564448406|FG000|Treatment Period|Adverse Event|2|||
156368780|NCT01526889|564448407|FG001|Treatment Period|Adverse Event|0|||
156368781|NCT01526889|564448406|FG000|Treatment Extension Period|Administrative problems|1|||
156368782|NCT01526889|564448407|FG001|Treatment Extension Period|Administrative problems|0|||
156368783|NCT01494610|564448408|FG000|Period 1|Withdrawal by Subject|1|||
156368784|NCT01494610|564448409|FG001|Period 1|Withdrawal by Subject|1|||
156368785|NCT01494610|564448408|FG000|Period 3|Adverse Event|1|||
156368786|NCT01494610|564448409|FG001|Period 3|Adverse Event|0|||
156368787|NCT01494610|564448408|FG000|Period 3|Withdrawal by Subject|1|||
156368788|NCT01494610|564448409|FG001|Period 3|Withdrawal by Subject|0|||
156368789|NCT01494610|564448408|FG000|Period 4|Protocol Violation|1|||
156368790|NCT01494610|564448409|FG001|Period 4|Protocol Violation|0|||
156368791|NCT02385799|564448410|FG000|Overall Study|Lost to Follow-up|1|||
156368792|NCT02385799|564448411|FG001|Overall Study|Lost to Follow-up|2|||
156368793|NCT02385799|564448410|FG000|Overall Study|Adverse Event|4|||
156368794|NCT02385799|564448411|FG001|Overall Study|Adverse Event|2|||
156368795|NCT02385799|564448410|FG000|Overall Study|Withdrawal by Subject|0|||
156368796|NCT02385799|564448411|FG001|Overall Study|Withdrawal by Subject|4|||
156368797|NCT00006184|564448412|FG000|Overall Study|Death|1|||
156368798|NCT00006184|564448413|FG001|Overall Study|Death|0|||
156368799|NCT01574352|564448417|FG000|Overall Study|Withdrawal by Subject|6|||
156368800|NCT01574352|564448418|FG001|Overall Study|Withdrawal by Subject|13|||
156368801|NCT01574352|564448417|FG000|Overall Study|Injury in non-camp related sport|1|||
156368802|NCT01574352|564448418|FG001|Overall Study|Injury in non-camp related sport|0|||
156368803|NCT06425458|564448419|FG000|Overall Study|Removed by study team|2|||
156368804|NCT06425458|564448419|FG000|Overall Study|Lost to Follow-up|5|||
156368805|NCT03945981|564448422|FG000|Overall Study|Lost to Follow-up|12|||
156368806|NCT03945981|564448422|FG000|Overall Study|Physician Decision|4|||
156368807|NCT03945981|564448422|FG000|Overall Study|Withdrawal by Subject|6|||
156368808|NCT03945981|564448422|FG000|Overall Study|Protocol Violation|1|||
156368809|NCT00256698|564448425|FG000|Overall Study|Withdrawal by Subject|7|||
156368810|NCT00256698|564448426|FG001|Overall Study|Withdrawal by Subject|7|||
156368811|NCT00256698|564448425|FG000|Overall Study|Adverse Event|13|||
156368812|NCT00256698|564448426|FG001|Overall Study|Adverse Event|6|||
156368813|NCT00256698|564448425|FG000|Overall Study|Protocol Violation|6|||
156368814|NCT00256698|564448426|FG001|Overall Study|Protocol Violation|5|||
156368815|NCT00256698|564448425|FG000|Overall Study|Lost to Follow-up|1|||
156368816|NCT00256698|564448426|FG001|Overall Study|Lost to Follow-up|3|||
156491898|NCT02705625|564896926|FG001|Overall Study|Death|0|||
156368817|NCT00256698|564448425|FG000|Overall Study|disease progression|97|||
156368818|NCT00256698|564448426|FG001|Overall Study|disease progression|105|||
156368819|NCT00256698|564448425|FG000|Overall Study|still ongoing at data cut-off|41|||
156368820|NCT00256698|564448426|FG001|Overall Study|still ongoing at data cut-off|46|||
156368821|NCT00256698|564448425|FG000|Overall Study|withdrawn due to osteoporosis|1|||
156368822|NCT00256698|564448426|FG001|Overall Study|withdrawn due to osteoporosis|0|||
156368823|NCT00256698|564448425|FG000|Overall Study|Prematurely Discontinued|1|||
156368824|NCT00256698|564448426|FG001|Overall Study|Prematurely Discontinued|0|||
156368825|NCT02777125|564448429|FG000|Overall Study|Consent form violation|14|||
156368826|NCT02777125|564448430|FG001|Overall Study|Consent form violation|12|||
156368827|NCT02777125|564448429|FG000|Overall Study|Assent form violation|21|||
156368828|NCT02777125|564448430|FG001|Overall Study|Assent form violation|23|||
156368829|NCT02777125|564448429|FG000|Overall Study|Protocol Violation|8|||
156368830|NCT02777125|564448430|FG001|Overall Study|Protocol Violation|12|||
156368831|NCT03548584|564450183|FG000|Overall Study|Lost to Follow-up|0|||
156368832|NCT03548584|564450184|FG001|Overall Study|Lost to Follow-up|0|||
156368833|NCT03548584|564450185|FG002|Overall Study|Lost to Follow-up|1|||
156368834|NCT03548584|564450183|FG000|Overall Study|Adverse Event|1|||
156368835|NCT03548584|564450184|FG001|Overall Study|Adverse Event|11|||
156368836|NCT03548584|564450185|FG002|Overall Study|Adverse Event|5|||
156368837|NCT03548584|564450183|FG000|Overall Study|Site Terminated by Sponsor|1|||
156368838|NCT03548584|564450184|FG001|Overall Study|Site Terminated by Sponsor|3|||
156368839|NCT03548584|564450185|FG002|Overall Study|Site Terminated by Sponsor|2|||
156368840|NCT03548584|564450183|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
156368841|NCT03548584|564450184|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
156368842|NCT03548584|564450185|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
156368843|NCT03548584|564450183|FG000|Overall Study|Lack of Efficacy|0|||
156368844|NCT03548584|564450184|FG001|Overall Study|Lack of Efficacy|1|||
156368845|NCT03548584|564450185|FG002|Overall Study|Lack of Efficacy|0|||
156368846|NCT03548584|564450183|FG000|Overall Study|Non-compliance with Study Drug|0|||
156368847|NCT03548584|564450184|FG001|Overall Study|Non-compliance with Study Drug|1|||
156368848|NCT03548584|564450185|FG002|Overall Study|Non-compliance with Study Drug|0|||
156368849|NCT03548584|564450183|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
156368850|NCT03548584|564450184|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
156368851|NCT03548584|564450185|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
156368852|NCT00634647|564450186|FG000|Overall Study|death on study|3|||
156368853|NCT00634647|564450186|FG000|Overall Study|refused further treatment|3|||
156368854|NCT00634647|564450186|FG000|Overall Study|declined to participate before treatment|1|||
156368855|NCT00667342|564450187|FG000|Overall Study|Protocol Violation|1|||
156368856|NCT00667342|564450188|FG001|Overall Study|Protocol Violation|0|||
156368857|NCT00667342|564450189|FG002|Overall Study|Protocol Violation|0|||
156368858|NCT00667342|564450187|FG000|Overall Study|Withdrawal by Subject|1|||
156368859|NCT00667342|564450188|FG001|Overall Study|Withdrawal by Subject|0|||
156368860|NCT00667342|564450189|FG002|Overall Study|Withdrawal by Subject|0|||
156368861|NCT00667342|564450187|FG000|Overall Study|Physician Decision|3|||
156368862|NCT00667342|564450188|FG001|Overall Study|Physician Decision|0|||
156368863|NCT00667342|564450189|FG002|Overall Study|Physician Decision|0|||
156368864|NCT00667342|564450187|FG000|Overall Study|Relapse or tumor progression|9|||
156368865|NCT00667342|564450188|FG001|Overall Study|Relapse or tumor progression|0|||
156368866|NCT00667342|564450189|FG002|Overall Study|Relapse or tumor progression|7|||
156368867|NCT00667342|564450187|FG000|Overall Study|Adverse Event|0|||
156368868|NCT00667342|564450188|FG001|Overall Study|Adverse Event|0|||
156368869|NCT00667342|564450189|FG002|Overall Study|Adverse Event|1|||
156368870|NCT00667342|564450187|FG000|Overall Study|Ineligible|0|||
156368871|NCT00667342|564450188|FG001|Overall Study|Ineligible|0|||
156368872|NCT00667342|564450189|FG002|Overall Study|Ineligible|1|||
156368873|NCT01433263|564450190|FG000|Overall Study|Adverse Event|3|||
156491899|NCT02705625|564896927|FG002|Overall Study|Death|1|||
156491900|NCT02705625|564896925|FG000|Overall Study|Withdrawal by Subject|1|||
156491901|NCT02705625|564896926|FG001|Overall Study|Withdrawal by Subject|4|||
156491902|NCT02705625|564896927|FG002|Overall Study|Withdrawal by Subject|5|||
156491903|NCT02705625|564896925|FG000|Overall Study|Lost to Follow-up|0|||
156491904|NCT02705625|564896926|FG001|Overall Study|Lost to Follow-up|0|||
156491905|NCT02705625|564896927|FG002|Overall Study|Lost to Follow-up|1|||
156491906|NCT02705625|564896925|FG000|Overall Study|Non-compliance|0|||
156491907|NCT02705625|564896926|FG001|Overall Study|Non-compliance|1|||
156491908|NCT02705625|564896927|FG002|Overall Study|Non-compliance|1|||
156491909|NCT02705625|564896925|FG000|Overall Study|Overdosing|0|||
156491910|NCT02705625|564896926|FG001|Overall Study|Overdosing|0|||
156491911|NCT02705625|564896927|FG002|Overall Study|Overdosing|1|||
156491912|NCT03596242|564896929|FG000|Overall Study|Lost to Follow-up|2|||
156491913|NCT03596242|564896930|FG001|Overall Study|Lost to Follow-up|2|||
156491914|NCT04544865|564896931|FG000|Overall Study|Death|0|||
156491915|NCT04544865|564896932|FG001|Overall Study|Death|2|||
156368874|NCT01433263|564450191|FG001|Overall Study|Adverse Event|1|||
156368875|NCT01433263|564450190|FG000|Overall Study|Death|5|||
156368876|NCT01433263|564450191|FG001|Overall Study|Death|3|||
156368877|NCT01433263|564450190|FG000|Overall Study|Lost to Follow-up|0|||
156368878|NCT01433263|564450191|FG001|Overall Study|Lost to Follow-up|1|||
156368879|NCT01433263|564450190|FG000|Overall Study|Protocol Deviation|1|||
156368880|NCT01433263|564450191|FG001|Overall Study|Protocol Deviation|0|||
156368881|NCT01433263|564450190|FG000|Overall Study|Withdrawal by Subject|10|||
156368882|NCT01433263|564450191|FG001|Overall Study|Withdrawal by Subject|7|||
156368883|NCT00293384|564450192|FG000|Overall Study|Non-compliance|2|||
156368884|NCT00293384|564450192|FG000|Overall Study|Missed dosage/study drug|1|||
156368885|NCT00293384|564450192|FG000|Overall Study|Ineligible|2|||
156368886|NCT04709237|564450194|FG000|Overall Study|Lost to Follow-up|1|||
156368887|NCT04709237|564450195|FG001|Overall Study|Lost to Follow-up|0|||
156368888|NCT04709237|564450196|FG002|Overall Study|Lost to Follow-up|0|||
156368889|NCT02610192|564450197|FG000|Overall Study|Received other treatment|8|||
156368890|NCT02610192|564450197|FG000|Overall Study|Physician Decision|1|||
156368891|NCT00640510|564450203|FG000|Overall Study|Lack of Efficacy|0|||
156368892|NCT00640510|564450204|FG001|Overall Study|Lack of Efficacy|1|||
156368893|NCT00640510|564450203|FG000|Overall Study|Protocol Violation|1|||
156368894|NCT00640510|564450204|FG001|Overall Study|Protocol Violation|0|||
156368895|NCT00640510|564450203|FG000|Overall Study|Physician Decision|0|||
156368896|NCT00640510|564450204|FG001|Overall Study|Physician Decision|1|||
156368897|NCT01440322|564450205|FG000|Overall Study|Discomfort|2|||
156368898|NCT01440322|564450206|FG001|Overall Study|Discomfort|0|||
156368899|NCT01440322|564450205|FG000|Overall Study|Biomicroscopy|1|||
156368900|NCT01440322|564450206|FG001|Overall Study|Biomicroscopy|0|||
156368901|NCT01440322|564450205|FG000|Overall Study|Symptoms and Problems|1|||
156368902|NCT01440322|564450206|FG001|Overall Study|Symptoms and Problems|0|||
156368903|NCT01440322|564450205|FG000|Overall Study|Unacceptable Subjective Vision|1|||
156368904|NCT01440322|564450206|FG001|Overall Study|Unacceptable Subjective Vision|0|||
156368905|NCT01440322|564450205|FG000|Overall Study|Other Product Related|1|||
156368906|NCT01440322|564450206|FG001|Overall Study|Other Product Related|0|||
156368907|NCT01440322|564450205|FG000|Overall Study|Unrelated Medical Problem|0|||
156368908|NCT01440322|564450206|FG001|Overall Study|Unrelated Medical Problem|1|||
156368909|NCT01440322|564450205|FG000|Overall Study|Other Non-Product Related|1|||
156368910|NCT01440322|564450206|FG001|Overall Study|Other Non-Product Related|0|||
156368911|NCT00546715|564450215|FG000|Overall Study|Withdrawal by Subject|0|||
156368912|NCT00546715|564450216|FG001|Overall Study|Withdrawal by Subject|1|||
156368913|NCT00546715|564450217|FG002|Overall Study|Withdrawal by Subject|0|||
156368914|NCT00546715|564450218|FG003|Overall Study|Withdrawal by Subject|0|||
156368915|NCT00418691|564450219|FG000|Overall Study|Lost to Follow-up|1|||
156368916|NCT00418691|564450220|FG001|Overall Study|Lost to Follow-up|2|||
156368917|NCT00418691|564450221|FG002|Overall Study|Lost to Follow-up|3|||
156368918|NCT00418691|564450219|FG000|Overall Study|Started new medication voiding entry|0|||
156368919|NCT00418691|564450220|FG001|Overall Study|Started new medication voiding entry|0|||
156368920|NCT00418691|564450221|FG002|Overall Study|Started new medication voiding entry|1|||
156368921|NCT00418691|564450219|FG000|Overall Study|Progressive Disease|1|||
156368922|NCT00418691|564450220|FG001|Overall Study|Progressive Disease|0|||
156368923|NCT00418691|564450221|FG002|Overall Study|Progressive Disease|1|||
156368924|NCT02477020|564450224|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
156368925|NCT02477020|564450225|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
156368926|NCT02477020|564450224|FG000|Overall Study|Voluntary Withdrawal|7|||
156368927|NCT02477020|564450225|FG001|Overall Study|Voluntary Withdrawal|16|||
156368928|NCT02477020|564450224|FG000|Overall Study|Reason not Specified|3|||
156368929|NCT02477020|564450225|FG001|Overall Study|Reason not Specified|1|||
156368930|NCT02477020|564450224|FG000|Overall Study|Lack of Efficacy|14|||
156368931|NCT02477020|564450225|FG001|Overall Study|Lack of Efficacy|5|||
156368932|NCT01802775|564450226|FG000|Overall Study|Death|0|||
156368933|NCT01802775|564450227|FG001|Overall Study|Death|3|||
156368934|NCT01802775|564450226|FG000|Overall Study|Reason not provided|0|||
156368935|NCT01802775|564450227|FG001|Overall Study|Reason not provided|1|||
156368936|NCT01802775|564450226|FG000|Overall Study|Physician Decision|1|||
156368937|NCT01802775|564450227|FG001|Overall Study|Physician Decision|0|||
156368938|NCT01802775|564450226|FG000|Overall Study|Adverse Event|1|||
156368939|NCT01802775|564450227|FG001|Overall Study|Adverse Event|1|||
156368940|NCT01802775|564450226|FG000|Overall Study|Withdrawal by Subject|3|||
156368941|NCT01802775|564450227|FG001|Overall Study|Withdrawal by Subject|5|||
156368942|NCT01802775|564450226|FG000|Overall Study|Lost to Follow-up|1|||
156368943|NCT01802775|564450227|FG001|Overall Study|Lost to Follow-up|2|||
156368944|NCT00519649|564450230|FG000|Overall Study|Withdrawal by Subject|1|||
156368945|NCT01465802|564450231|FG000|Overall Study|Study terminated by sponsor|1|||
156368946|NCT01465802|564450232|FG001|Overall Study|Study terminated by sponsor|0|||
156368947|NCT01465802|564450233|FG002|Overall Study|Study terminated by sponsor|0|||
156368948|NCT01465802|564450234|FG003|Overall Study|Study terminated by sponsor|1|||
156368949|NCT01465802|564450235|FG004|Overall Study|Study terminated by sponsor|7|||
156491916|NCT04544865|564896931|FG000|Overall Study|Lost to Follow-up|11|||
156491917|NCT04544865|564896932|FG001|Overall Study|Lost to Follow-up|7|||
156368950|NCT01465802|564450231|FG000|Overall Study|Withdrawal by Subject|7|||
156368951|NCT01465802|564450232|FG001|Overall Study|Withdrawal by Subject|7|||
156368952|NCT01465802|564450233|FG002|Overall Study|Withdrawal by Subject|0|||
156368953|NCT01465802|564450234|FG003|Overall Study|Withdrawal by Subject|8|||
156368954|NCT01465802|564450235|FG004|Overall Study|Withdrawal by Subject|1|||
156368955|NCT01465802|564450231|FG000|Overall Study|Lost to Follow-up|1|||
156368956|NCT01465802|564450232|FG001|Overall Study|Lost to Follow-up|1|||
156368957|NCT01465802|564450233|FG002|Overall Study|Lost to Follow-up|0|||
156368958|NCT01465802|564450234|FG003|Overall Study|Lost to Follow-up|0|||
156368959|NCT01465802|564450235|FG004|Overall Study|Lost to Follow-up|0|||
156368960|NCT01465802|564450231|FG000|Overall Study|Reason not specified|9|||
156368961|NCT01465802|564450232|FG001|Overall Study|Reason not specified|4|||
156368962|NCT01465802|564450233|FG002|Overall Study|Reason not specified|0|||
156368963|NCT01465802|564450234|FG003|Overall Study|Reason not specified|10|||
156368964|NCT01465802|564450235|FG004|Overall Study|Reason not specified|2|||
156368965|NCT01465802|564450231|FG000|Overall Study|Death|15|||
156368966|NCT01465802|564450232|FG001|Overall Study|Death|12|||
156368967|NCT01465802|564450233|FG002|Overall Study|Death|0|||
156368968|NCT01465802|564450234|FG003|Overall Study|Death|10|||
156368969|NCT01465802|564450235|FG004|Overall Study|Death|2|||
156368970|NCT03852316|564450236|FG000|Overall Study|Protocol Violation|1|||
156368971|NCT03852316|564450236|FG000|Overall Study|Withdrawal by Subject|2|||
156368972|NCT03852316|564450236|FG000|Overall Study|Enrolled but Device not Utilized|1|||
156368973|NCT02103478|564450237|FG000|Overall Study|Adverse Event|0|||
156368974|NCT02103478|564450238|FG001|Overall Study|Adverse Event|0|||
156368975|NCT02103478|564450239|FG002|Overall Study|Adverse Event|1|||
156368976|NCT02103478|564450240|FG003|Overall Study|Adverse Event|1|||
156368977|NCT02103478|564450241|FG004|Overall Study|Adverse Event|2|||
156368978|NCT02103478|564450242|FG005|Overall Study|Adverse Event|1|||
156368979|NCT02103478|564450243|FG006|Overall Study|Adverse Event|0|||
156368980|NCT02103478|564450244|FG007|Overall Study|Adverse Event|0|||
156368981|NCT02103478|564450245|FG008|Overall Study|Adverse Event|0|||
156368982|NCT02103478|564450237|FG000|Overall Study|Death|2|||
156368983|NCT02103478|564450238|FG001|Overall Study|Death|2|||
156368984|NCT02103478|564450239|FG002|Overall Study|Death|1|||
156368985|NCT02103478|564450240|FG003|Overall Study|Death|1|||
156368986|NCT02103478|564450241|FG004|Overall Study|Death|5|||
156368987|NCT02103478|564450242|FG005|Overall Study|Death|15|||
156368988|NCT02103478|564450243|FG006|Overall Study|Death|14|||
156368989|NCT02103478|564450244|FG007|Overall Study|Death|10|||
156368990|NCT02103478|564450245|FG008|Overall Study|Death|11|||
156368991|NCT02103478|564450237|FG000|Overall Study|Progressive Disease|2|||
156368992|NCT02103478|564450238|FG001|Overall Study|Progressive Disease|1|||
156368993|NCT02103478|564450239|FG002|Overall Study|Progressive Disease|2|||
156368994|NCT02103478|564450240|FG003|Overall Study|Progressive Disease|0|||
156368995|NCT02103478|564450241|FG004|Overall Study|Progressive Disease|9|||
156368996|NCT02103478|564450242|FG005|Overall Study|Progressive Disease|1|||
156368997|NCT02103478|564450243|FG006|Overall Study|Progressive Disease|2|||
156368998|NCT02103478|564450244|FG007|Overall Study|Progressive Disease|0|||
156368999|NCT02103478|564450245|FG008|Overall Study|Progressive Disease|1|||
156369000|NCT02103478|564450237|FG000|Overall Study|Withdrawal by Subject|2|||
156369001|NCT02103478|564450238|FG001|Overall Study|Withdrawal by Subject|0|||
156369002|NCT02103478|564450239|FG002|Overall Study|Withdrawal by Subject|0|||
156369003|NCT02103478|564450240|FG003|Overall Study|Withdrawal by Subject|4|||
156369004|NCT02103478|564450241|FG004|Overall Study|Withdrawal by Subject|0|||
156369005|NCT02103478|564450242|FG005|Overall Study|Withdrawal by Subject|0|||
156369006|NCT02103478|564450243|FG006|Overall Study|Withdrawal by Subject|1|||
156369007|NCT02103478|564450244|FG007|Overall Study|Withdrawal by Subject|1|||
156369008|NCT02103478|564450245|FG008|Overall Study|Withdrawal by Subject|0|||
156369009|NCT02103478|564450237|FG000|Overall Study|Lost to Follow-up|0|||
156369010|NCT02103478|564450238|FG001|Overall Study|Lost to Follow-up|0|||
156369011|NCT02103478|564450239|FG002|Overall Study|Lost to Follow-up|0|||
156369012|NCT02103478|564450240|FG003|Overall Study|Lost to Follow-up|0|||
156369013|NCT02103478|564450241|FG004|Overall Study|Lost to Follow-up|0|||
156369014|NCT02103478|564450242|FG005|Overall Study|Lost to Follow-up|0|||
156369015|NCT02103478|564450243|FG006|Overall Study|Lost to Follow-up|0|||
156369016|NCT02103478|564450244|FG007|Overall Study|Lost to Follow-up|1|||
156369017|NCT02103478|564450245|FG008|Overall Study|Lost to Follow-up|0|||
156369018|NCT02103478|564450237|FG000|Overall Study|Other|1|||
156369019|NCT02103478|564450238|FG001|Overall Study|Other|3|||
156369020|NCT02103478|564450239|FG002|Overall Study|Other|2|||
156369021|NCT02103478|564450240|FG003|Overall Study|Other|0|||
156369022|NCT02103478|564450241|FG004|Overall Study|Other|3|||
156369023|NCT02103478|564450242|FG005|Overall Study|Other|8|||
156369024|NCT02103478|564450243|FG006|Overall Study|Other|8|||
156369025|NCT02103478|564450244|FG007|Overall Study|Other|4|||
156369026|NCT02103478|564450245|FG008|Overall Study|Other|2|||
156369027|NCT03219333|564450246|FG000|Overall Study|Withdrawal by Subject|9|||
156369028|NCT03219333|564450247|FG001|Overall Study|Withdrawal by Subject|4|||
156369029|NCT03219333|564450246|FG000|Overall Study|Lost to Follow-up|1|||
156369030|NCT03219333|564450247|FG001|Overall Study|Lost to Follow-up|1|||
156369031|NCT03219333|564450246|FG000|Overall Study|Death|104|||
156369032|NCT03219333|564450247|FG001|Overall Study|Death|72|||
156369033|NCT03219333|564450246|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
156369034|NCT03219333|564450247|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
156369035|NCT03219333|564450246|FG000|Overall Study|Other|2|||
156546104|NCT00001379|565093293|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
156546105|NCT00001379|565093294|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
156546106|NCT00001379|565093295|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
156369036|NCT03219333|564450247|FG001|Overall Study|Other|2|||
156369037|NCT00723606|564450248|FG000|Overall Study|Adverse Event|2|||
156369038|NCT00723606|564450249|FG001|Overall Study|Adverse Event|5|||
156369039|NCT00723606|564450248|FG000|Overall Study|Other|2|||
156369040|NCT00723606|564450249|FG001|Overall Study|Other|0|||
156369041|NCT00723606|564450248|FG000|Overall Study|Withdrawal by Subject|0|||
156369042|NCT00723606|564450249|FG001|Overall Study|Withdrawal by Subject|2|||
156369043|NCT01470469|564450250|FG000|Overall Study|Withdrawal by Subject|4|||
156369044|NCT01470469|564450251|FG001|Overall Study|Withdrawal by Subject|6|||
156369045|NCT01470469|564450250|FG000|Overall Study|Lack of Efficacy|1|||
156369046|NCT01470469|564450251|FG001|Overall Study|Lack of Efficacy|7|||
156369047|NCT01470469|564450250|FG000|Overall Study|Adverse Event|0|||
156369048|NCT01470469|564450251|FG001|Overall Study|Adverse Event|7|||
156369049|NCT01470469|564450250|FG000|Overall Study|Lost to Follow-up|2|||
156369050|NCT01470469|564450251|FG001|Overall Study|Lost to Follow-up|2|||
156369051|NCT01470469|564450250|FG000|Overall Study|Protocol Violation|1|||
156369052|NCT01470469|564450251|FG001|Overall Study|Protocol Violation|1|||
156369053|NCT01470469|564450250|FG000|Overall Study|Other|2|||
156369054|NCT01470469|564450251|FG001|Overall Study|Other|1|||
156369055|NCT03362502|564450252|FG000|Overall Study|Death|0|||
156369056|NCT03362502|564450253|FG001|Overall Study|Death|0|||
156369057|NCT03362502|564450254|FG002|Overall Study|Death|1|||
156369058|NCT02075840|564450255|FG000|Overall Study|Withdrawal by Subject|13|||
156369059|NCT02075840|564450256|FG001|Overall Study|Withdrawal by Subject|22|||
156369060|NCT02075840|564450255|FG000|Overall Study|Reason not specified|1|||
156369061|NCT02075840|564450256|FG001|Overall Study|Reason not specified|0|||
156369062|NCT02075840|564450255|FG000|Overall Study|Adverse Event|0|||
156369063|NCT02075840|564450256|FG001|Overall Study|Adverse Event|2|||
156369064|NCT02075840|564450255|FG000|Overall Study|Death|35|||
156369065|NCT02075840|564450256|FG001|Overall Study|Death|40|||
156369066|NCT02075840|564450255|FG000|Overall Study|Lost to Follow-up|3|||
156369067|NCT02075840|564450256|FG001|Overall Study|Lost to Follow-up|2|||
156369068|NCT02075840|564450255|FG000|Overall Study|Physician Decision|1|||
156369069|NCT02075840|564450256|FG001|Overall Study|Physician Decision|3|||
156369070|NCT02075840|564450255|FG000|Overall Study|Ongoing at CCOD|99|||
156369071|NCT02075840|564450256|FG001|Overall Study|Ongoing at CCOD|82|||
156369072|NCT03491150|564450286|FG000|Overall Study|Adverse Event|1|||
156369073|NCT03491150|564450287|FG001|Overall Study|Adverse Event|0|||
156369074|NCT03491150|564450286|FG000|Overall Study|Study Terminated by Sponsor|74|||
156369075|NCT03491150|564450287|FG001|Overall Study|Study Terminated by Sponsor|70|||
156369076|NCT03491150|564450286|FG000|Overall Study|Other|0|||
156369077|NCT03491150|564450287|FG001|Overall Study|Other|1|||
156369078|NCT03491150|564450286|FG000|Overall Study|Withdrawal by Subject|1|||
156369079|NCT03491150|564450287|FG001|Overall Study|Withdrawal by Subject|2|||
156369080|NCT00325234|564450290|FG000|Overall Study|Adverse Event|10|||
156369081|NCT00325234|564450291|FG001|Overall Study|Adverse Event|7|||
156369082|NCT00325234|564450290|FG000|Overall Study|Death due to Study Disease|1|||
156369083|NCT00325234|564450291|FG001|Overall Study|Death due to Study Disease|0|||
156369084|NCT00325234|564450290|FG000|Overall Study|Entry Criteria Not Met|1|||
156369085|NCT00325234|564450291|FG001|Overall Study|Entry Criteria Not Met|2|||
156369086|NCT00325234|564450290|FG000|Overall Study|Subject Decision|6|||
156369087|NCT00325234|564450291|FG001|Overall Study|Subject Decision|8|||
156369088|NCT00325234|564450290|FG000|Overall Study|Physician Decision|17|||
156369089|NCT00325234|564450291|FG001|Overall Study|Physician Decision|12|||
156369090|NCT00325234|564450290|FG000|Overall Study|Progressive Disease|34|||
156369091|NCT00325234|564450291|FG001|Overall Study|Progressive Disease|37|||
156369092|NCT01234467|564450292|FG000|Overall Study|Adverse Event|3|||
156369093|NCT01234467|564450292|FG000|Overall Study|Death|2|||
156369094|NCT01234467|564450292|FG000|Overall Study|Withdrawal by Subject|2|||
156369095|NCT01234467|564450292|FG000|Overall Study|Disease Progression|2|||
156369096|NCT01234467|564450292|FG000|Overall Study|Clinical deterioration|1|||
156369097|NCT01234467|564450292|FG000|Overall Study|Physician Decision|1|||
156369098|NCT01234467|564450292|FG000|Overall Study|Other complicating disease (stroke)|1|||
156369099|NCT02644967|564450295|FG000|Overall Study|Death|26|||
156369100|NCT02644967|564450295|FG000|Overall Study|Physician Decision|1|||
156369101|NCT02644967|564450295|FG000|Overall Study|Withdrawal by Subject|2|||
156369102|NCT02644967|564450295|FG000|Overall Study|Protocol Violation|1|||
156369103|NCT02644967|564450295|FG000|Overall Study|Progressive Disease|1|||
156369104|NCT02644967|564450295|FG000|Overall Study|Study Terminated by Sponsor|4|||
156369105|NCT05179421|564450296|FG000|First Infusion Day|Adverse Event|1|||
156369106|NCT05179421|564450297|FG001|First Infusion Day|Adverse Event|0|||
156369107|NCT03746522|564450299|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
156369108|NCT03746522|564450300|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
156369109|NCT03746522|564450301|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
156369110|NCT03746522|564450299|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
156369111|NCT03746522|564450300|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
156369112|NCT03746522|564450301|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
156369113|NCT03746522|564450299|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
156369114|NCT03746522|564450300|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
156369115|NCT03746522|564450301|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
156369116|NCT03746522|564450299|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
156369117|NCT03746522|564450300|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
156369118|NCT03746522|564450301|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
156369119|NCT03746522|564450299|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
156369120|NCT03746522|564450300|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
156369121|NCT03746522|564450301|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
156369122|NCT01077960|564450304|FG000|Overall Study|Adverse Event|6|||
156369123|NCT01077960|564450304|FG000|Overall Study|Protocol Violation|3|||
156369124|NCT01077960|564450304|FG000|Overall Study|Lost to Follow-up|5|||
156369125|NCT01077960|564450304|FG000|Overall Study|Subject decision|1|||
156369126|NCT01077960|564450304|FG000|Overall Study|Reason unspecified|1|||
156369127|NCT03837899|564450305|FG000|Overall Study|Death|6|||
156369128|NCT03837899|564450306|FG001|Overall Study|Death|8|||
156369129|NCT03837899|564450307|FG002|Overall Study|Death|3|||
156369130|NCT03837899|564450308|FG003|Overall Study|Death|7|||
156369131|NCT03837899|564450309|FG004|Overall Study|Death|8|||
156369132|NCT03837899|564450310|FG005|Overall Study|Death|7|||
156369133|NCT03837899|564450305|FG000|Overall Study|Moved to post-trial access program|0|||
156369134|NCT03837899|564450306|FG001|Overall Study|Moved to post-trial access program|1|||
156369135|NCT03837899|564450307|FG002|Overall Study|Moved to post-trial access program|0|||
156369136|NCT03837899|564450308|FG003|Overall Study|Moved to post-trial access program|0|||
156369137|NCT03837899|564450309|FG004|Overall Study|Moved to post-trial access program|0|||
156369138|NCT03837899|564450310|FG005|Overall Study|Moved to post-trial access program|0|||
156369139|NCT03837899|564450305|FG000|Overall Study|Other|0|||
156369140|NCT03837899|564450306|FG001|Overall Study|Other|0|||
156369141|NCT03837899|564450307|FG002|Overall Study|Other|0|||
156369142|NCT03837899|564450308|FG003|Overall Study|Other|0|||
156369143|NCT03837899|564450309|FG004|Overall Study|Other|0|||
156369144|NCT03837899|564450310|FG005|Overall Study|Other|2|||
156369145|NCT03837899|564450305|FG000|Overall Study|Lost to Follow-up|0|||
156369146|NCT03837899|564450306|FG001|Overall Study|Lost to Follow-up|1|||
156369147|NCT03837899|564450307|FG002|Overall Study|Lost to Follow-up|0|||
156369148|NCT03837899|564450308|FG003|Overall Study|Lost to Follow-up|0|||
156369149|NCT03837899|564450309|FG004|Overall Study|Lost to Follow-up|0|||
156369150|NCT03837899|564450310|FG005|Overall Study|Lost to Follow-up|0|||
156369151|NCT03837899|564450305|FG000|Overall Study|Withdrawal by Subject|0|||
156369152|NCT03837899|564450306|FG001|Overall Study|Withdrawal by Subject|0|||
156369153|NCT03837899|564450307|FG002|Overall Study|Withdrawal by Subject|0|||
156369154|NCT03837899|564450308|FG003|Overall Study|Withdrawal by Subject|1|||
156369155|NCT03837899|564450309|FG004|Overall Study|Withdrawal by Subject|0|||
156369156|NCT03837899|564450310|FG005|Overall Study|Withdrawal by Subject|0|||
156369157|NCT03837899|564450305|FG000|Overall Study|Study specific discontinuation criteria|0|||
156369158|NCT03837899|564450306|FG001|Overall Study|Study specific discontinuation criteria|1|||
156369159|NCT03837899|564450307|FG002|Overall Study|Study specific discontinuation criteria|0|||
156369160|NCT03837899|564450308|FG003|Overall Study|Study specific discontinuation criteria|0|||
156369161|NCT03837899|564450309|FG004|Overall Study|Study specific discontinuation criteria|3|||
156369162|NCT03837899|564450310|FG005|Overall Study|Study specific discontinuation criteria|1|||
156369163|NCT00393939|564450316|FG000|Overall Study|Protocol Violation|1|||
156369164|NCT00393939|564450317|FG001|Overall Study|Protocol Violation|1|||
156369165|NCT00393939|564450316|FG000|Overall Study|Lost to Follow-up|2|||
156369166|NCT00393939|564450317|FG001|Overall Study|Lost to Follow-up|4|||
156369167|NCT00393939|564450316|FG000|Overall Study|Death|10|||
156369168|NCT00393939|564450317|FG001|Overall Study|Death|4|||
156369169|NCT00393939|564450316|FG000|Overall Study|Sponsor|5|||
156491918|NCT04544865|564896931|FG000|Overall Study|Withdrawal by Subject|0|||
156491919|NCT04544865|564896932|FG001|Overall Study|Withdrawal by Subject|1|||
156491920|NCT04544865|564896931|FG000|Overall Study|Other|0|||
156491921|NCT04544865|564896932|FG001|Overall Study|Other|1|||
156491922|NCT01649297|564896934|FG000|Overall Study|Adverse Event|5|||
156491923|NCT01649297|564896935|FG001|Overall Study|Adverse Event|5|||
156491924|NCT01649297|564896936|FG002|Overall Study|Adverse Event|4|||
156491925|NCT01649297|564896937|FG003|Overall Study|Adverse Event|13|||
156491926|NCT01649297|564896938|FG004|Overall Study|Adverse Event|1|||
156369170|NCT00393939|564450317|FG001|Overall Study|Sponsor|13|||
156369171|NCT00393939|564450316|FG000|Overall Study|Objective progression or relapse|239|||
156369172|NCT00393939|564450317|FG001|Overall Study|Objective progression or relapse|223|||
156369173|NCT00393939|564450316|FG000|Overall Study|Withdrawal by Subject|2|||
156369174|NCT00393939|564450317|FG001|Overall Study|Withdrawal by Subject|7|||
156369175|NCT00393939|564450316|FG000|Overall Study|Other|37|||
156369176|NCT00393939|564450317|FG001|Overall Study|Other|45|||
156369177|NCT03995953|564450318|FG000|Overall Study|Death|3|||
156491927|NCT01649297|564896934|FG000|Overall Study|Lack of Efficacy|0|||
156546107|NCT00001379|565093296|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
156369178|NCT03995953|564450319|FG001|Overall Study|Death|0|||
156369179|NCT03995953|564450320|FG002|Overall Study|Death|3|||
156369180|NCT03995953|564450321|FG003|Overall Study|Death|0|||
156369181|NCT03995953|564450322|FG004|Overall Study|Death|3|||
156369182|NCT03995953|564450323|FG005|Overall Study|Death|0|||
156369183|NCT03995953|564450324|FG006|Overall Study|Death|0|||
156369184|NCT03995953|564450325|FG007|Overall Study|Death|0|||
156369185|NCT03995953|564450326|FG008|Overall Study|Death|1|||
156369186|NCT03995953|564450327|FG009|Overall Study|Death|0|||
156369187|NCT03995953|564450328|FG010|Overall Study|Death|0|||
156369188|NCT03995953|564450329|FG011|Overall Study|Death|0|||
156369189|NCT03995953|564450318|FG000|Overall Study|Lost to Follow-up|6|||
156369190|NCT03995953|564450319|FG001|Overall Study|Lost to Follow-up|54|||
156369191|NCT03995953|564450320|FG002|Overall Study|Lost to Follow-up|3|||
156369192|NCT03995953|564450321|FG003|Overall Study|Lost to Follow-up|32|||
156369193|NCT03995953|564450322|FG004|Overall Study|Lost to Follow-up|5|||
156369194|NCT03995953|564450323|FG005|Overall Study|Lost to Follow-up|44|||
156369195|NCT03995953|564450324|FG006|Overall Study|Lost to Follow-up|0|||
156369196|NCT03995953|564450325|FG007|Overall Study|Lost to Follow-up|31|||
156369197|NCT03995953|564450326|FG008|Overall Study|Lost to Follow-up|8|||
156369198|NCT03995953|564450327|FG009|Overall Study|Lost to Follow-up|36|||
156369199|NCT03995953|564450328|FG010|Overall Study|Lost to Follow-up|5|||
156369200|NCT03995953|564450329|FG011|Overall Study|Lost to Follow-up|41|||
156369201|NCT03995953|564450318|FG000|Overall Study|Withdrawal by Subject|4|||
156369202|NCT03995953|564450319|FG001|Overall Study|Withdrawal by Subject|0|||
156369203|NCT03995953|564450320|FG002|Overall Study|Withdrawal by Subject|1|||
156369204|NCT03995953|564450321|FG003|Overall Study|Withdrawal by Subject|0|||
156369205|NCT03995953|564450322|FG004|Overall Study|Withdrawal by Subject|1|||
156369206|NCT03995953|564450323|FG005|Overall Study|Withdrawal by Subject|0|||
156369207|NCT03995953|564450324|FG006|Overall Study|Withdrawal by Subject|1|||
156369208|NCT03995953|564450325|FG007|Overall Study|Withdrawal by Subject|0|||
156369209|NCT03995953|564450326|FG008|Overall Study|Withdrawal by Subject|3|||
156369210|NCT03995953|564450327|FG009|Overall Study|Withdrawal by Subject|0|||
156369211|NCT03995953|564450328|FG010|Overall Study|Withdrawal by Subject|3|||
156369212|NCT03995953|564450329|FG011|Overall Study|Withdrawal by Subject|0|||
156369213|NCT03995953|564450318|FG000|Overall Study|Health Issues|0|||
156369214|NCT03995953|564450319|FG001|Overall Study|Health Issues|0|||
156369215|NCT03995953|564450320|FG002|Overall Study|Health Issues|0|||
156369216|NCT03995953|564450321|FG003|Overall Study|Health Issues|0|||
156369217|NCT03995953|564450322|FG004|Overall Study|Health Issues|1|||
156369218|NCT03995953|564450323|FG005|Overall Study|Health Issues|0|||
156369219|NCT03995953|564450324|FG006|Overall Study|Health Issues|0|||
156369220|NCT03995953|564450325|FG007|Overall Study|Health Issues|0|||
156369221|NCT03995953|564450326|FG008|Overall Study|Health Issues|4|||
156369222|NCT03995953|564450327|FG009|Overall Study|Health Issues|0|||
156369223|NCT03995953|564450328|FG010|Overall Study|Health Issues|0|||
156369224|NCT03995953|564450329|FG011|Overall Study|Health Issues|0|||
156369225|NCT03995953|564450318|FG000|Overall Study|Relocated|11|||
156369226|NCT03995953|564450319|FG001|Overall Study|Relocated|0|||
156369227|NCT03995953|564450320|FG002|Overall Study|Relocated|16|||
156369228|NCT03995953|564450321|FG003|Overall Study|Relocated|0|||
156369229|NCT03995953|564450322|FG004|Overall Study|Relocated|14|||
156369230|NCT03995953|564450323|FG005|Overall Study|Relocated|0|||
156369231|NCT03995953|564450324|FG006|Overall Study|Relocated|16|||
156369232|NCT03995953|564450325|FG007|Overall Study|Relocated|0|||
156369233|NCT03995953|564450326|FG008|Overall Study|Relocated|14|||
156369234|NCT03995953|564450327|FG009|Overall Study|Relocated|0|||
156369235|NCT03995953|564450328|FG010|Overall Study|Relocated|15|||
156369236|NCT03995953|564450329|FG011|Overall Study|Relocated|0|||
156369237|NCT02388997|564450330|FG000|Overall Study|Adverse Event|1|||
156369238|NCT02388997|564450331|FG001|Overall Study|Adverse Event|2|||
156369239|NCT02388997|564450330|FG000|Overall Study|Withdrawal by Subject|2|||
156369240|NCT02388997|564450331|FG001|Overall Study|Withdrawal by Subject|1|||
156369241|NCT02388997|564450330|FG000|Overall Study|Lung function exclusion criteria|0|||
156369242|NCT02388997|564450331|FG001|Overall Study|Lung function exclusion criteria|2|||
156369243|NCT02388997|564450330|FG000|Overall Study|Tested positive for virus during run-in|0|||
156369244|NCT02388997|564450331|FG001|Overall Study|Tested positive for virus during run-in|1|||
156369245|NCT02161718|564450334|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
156369246|NCT02161718|564450335|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
156369247|NCT02161718|564450336|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
156369248|NCT02161718|564450334|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
156369249|NCT02161718|564450335|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
156369250|NCT02161718|564450336|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
156369251|NCT02161718|564450334|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
156369252|NCT02161718|564450335|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
156369253|NCT02161718|564450336|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
156369254|NCT02161718|564450334|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
156369255|NCT02161718|564450335|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
156369256|NCT02161718|564450336|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
156369257|NCT02161718|564450334|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
156369258|NCT02161718|564450335|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
156369259|NCT02161718|564450336|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
156369260|NCT02161718|564450334|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
156369261|NCT02161718|564450335|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
156369262|NCT02161718|564450336|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
156369263|NCT02161718|564450334|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
156369264|NCT02161718|564450335|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
156369265|NCT02161718|564450336|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
156369266|NCT02161718|564450334|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
156369267|NCT02161718|564450335|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
156369268|NCT02161718|564450336|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
156369269|NCT02161718|564450334|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
156369270|NCT02161718|564450335|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
156369271|NCT02161718|564450336|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
156369272|NCT02161718|564450334|FG000|Post- Randomization Period|Lost to Follow-up|0|||
156369273|NCT02161718|564450335|FG001|Post- Randomization Period|Lost to Follow-up|9|||
156369274|NCT02161718|564450336|FG002|Post- Randomization Period|Lost to Follow-up|15|||
156369275|NCT02161718|564450334|FG000|Post- Randomization Period|Adverse Event|0|||
156369276|NCT02161718|564450335|FG001|Post- Randomization Period|Adverse Event|9|||
156369277|NCT02161718|564450336|FG002|Post- Randomization Period|Adverse Event|10|||
156369278|NCT02161718|564450334|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
156369279|NCT02161718|564450335|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
156369280|NCT02161718|564450336|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
156369281|NCT02161718|564450334|FG000|Post- Randomization Period|Physician Decision|0|||
156369282|NCT02161718|564450335|FG001|Post- Randomization Period|Physician Decision|2|||
156369283|NCT02161718|564450336|FG002|Post- Randomization Period|Physician Decision|4|||
156369284|NCT02161718|564450334|FG000|Post- Randomization Period|Protocol Violation|0|||
156369285|NCT02161718|564450335|FG001|Post- Randomization Period|Protocol Violation|2|||
156369286|NCT02161718|564450336|FG002|Post- Randomization Period|Protocol Violation|3|||
156369287|NCT02161718|564450334|FG000|Post- Randomization Period|Lack of Efficacy|0|||
156369288|NCT02161718|564450335|FG001|Post- Randomization Period|Lack of Efficacy|0|||
156369289|NCT02161718|564450336|FG002|Post- Randomization Period|Lack of Efficacy|1|||
156369290|NCT02161718|564450334|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
156369291|NCT02161718|564450335|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
156369292|NCT02161718|564450336|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
156369293|NCT02161718|564450334|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
156369294|NCT02161718|564450335|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
156369295|NCT02161718|564450336|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
156369296|NCT02161718|564450334|FG000|Post- Randomization Period|Relocation|0|||
156369297|NCT02161718|564450335|FG001|Post- Randomization Period|Relocation|3|||
156369298|NCT02161718|564450336|FG002|Post- Randomization Period|Relocation|0|||
156369299|NCT00207142|564450338|FG000|Induction Phase|Adverse Event|9|||
156369300|NCT00207142|564450339|FG001|Induction Phase|Adverse Event|0|||
156369301|NCT00207142|564450340|FG002|Induction Phase|Adverse Event|0|||
156369302|NCT00207142|564450341|FG003|Induction Phase|Adverse Event|0|||
156369303|NCT00207142|564450338|FG000|Induction Phase|Death|1|||
156369304|NCT00207142|564450339|FG001|Induction Phase|Death|0|||
156369305|NCT00207142|564450340|FG002|Induction Phase|Death|0|||
156369306|NCT00207142|564450341|FG003|Induction Phase|Death|0|||
156369307|NCT00207142|564450338|FG000|Induction Phase|Lack of Efficacy|1|||
156369308|NCT00207142|564450339|FG001|Induction Phase|Lack of Efficacy|0|||
156369309|NCT00207142|564450340|FG002|Induction Phase|Lack of Efficacy|0|||
156369310|NCT00207142|564450341|FG003|Induction Phase|Lack of Efficacy|0|||
156369311|NCT00207142|564450338|FG000|Induction Phase|Lost to Follow-up|5|||
156369312|NCT00207142|564450339|FG001|Induction Phase|Lost to Follow-up|0|||
156369313|NCT00207142|564450340|FG002|Induction Phase|Lost to Follow-up|0|||
156369314|NCT00207142|564450341|FG003|Induction Phase|Lost to Follow-up|0|||
156369315|NCT00207142|564450338|FG000|Induction Phase|Physician Decision|2|||
156369316|NCT00207142|564450339|FG001|Induction Phase|Physician Decision|0|||
156369317|NCT00207142|564450340|FG002|Induction Phase|Physician Decision|0|||
156369318|NCT00207142|564450341|FG003|Induction Phase|Physician Decision|0|||
156369319|NCT00207142|564450338|FG000|Induction Phase|Poor/noncompliance|2|||
156369320|NCT00207142|564450339|FG001|Induction Phase|Poor/noncompliance|0|||
156369321|NCT00207142|564450340|FG002|Induction Phase|Poor/noncompliance|0|||
156369322|NCT00207142|564450341|FG003|Induction Phase|Poor/noncompliance|0|||
156369323|NCT00207142|564450338|FG000|Induction Phase|Pregnancy|1|||
156369324|NCT00207142|564450339|FG001|Induction Phase|Pregnancy|0|||
156369325|NCT00207142|564450340|FG002|Induction Phase|Pregnancy|0|||
156369326|NCT00207142|564450341|FG003|Induction Phase|Pregnancy|0|||
156369327|NCT00207142|564450338|FG000|Induction Phase|Subject no longer meets study criteria|3|||
156369328|NCT00207142|564450339|FG001|Induction Phase|Subject no longer meets study criteria|0|||
156369329|NCT00207142|564450340|FG002|Induction Phase|Subject no longer meets study criteria|0|||
156491928|NCT01649297|564896935|FG001|Overall Study|Lack of Efficacy|0|||
156369330|NCT00207142|564450341|FG003|Induction Phase|Subject no longer meets study criteria|0|||
156369331|NCT00207142|564450338|FG000|Induction Phase|Withdrawal by Subject|4|||
156369332|NCT00207142|564450339|FG001|Induction Phase|Withdrawal by Subject|0|||
156369333|NCT00207142|564450340|FG002|Induction Phase|Withdrawal by Subject|0|||
156369334|NCT00207142|564450341|FG003|Induction Phase|Withdrawal by Subject|0|||
156369335|NCT00207142|564450338|FG000|Induction Phase|Incarceration|1|||
156369336|NCT00207142|564450339|FG001|Induction Phase|Incarceration|0|||
156369337|NCT00207142|564450340|FG002|Induction Phase|Incarceration|0|||
156369338|NCT00207142|564450341|FG003|Induction Phase|Incarceration|0|||
156369339|NCT00207142|564450338|FG000|Induction Phase|Missing lab data|1|||
156369340|NCT00207142|564450339|FG001|Induction Phase|Missing lab data|0|||
156369341|NCT00207142|564450340|FG002|Induction Phase|Missing lab data|0|||
156369342|NCT00207142|564450341|FG003|Induction Phase|Missing lab data|0|||
156369343|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
156369344|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
156369345|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
156369346|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
156369347|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
156369348|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
156369349|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
156369350|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
156369351|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
156369352|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
156369353|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
156369354|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
156369355|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
156369356|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
156369357|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
156369358|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
156369359|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
156369360|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
156369361|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
156369362|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
156369363|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
156369364|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
156369365|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
156369366|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
156369367|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
156369368|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
156369369|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
156369370|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
156369371|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|Death|0|||
156369372|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|Death|0|||
156369373|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|Death|0|||
156369374|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|Death|1|||
156369375|NCT00207142|564450338|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
156369376|NCT00207142|564450339|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
156369377|NCT00207142|564450340|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
156369378|NCT00207142|564450341|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
156369379|NCT01857063|564450342|FG000|Period 1 (7 Days)|Adverse Event|0|||
156369380|NCT01857063|564450343|FG001|Period 1 (7 Days)|Adverse Event|1|||
156369381|NCT01857063|564450342|FG000|Period 1 (7 Days)|Physician Decision|1|||
156369382|NCT01857063|564450343|FG001|Period 1 (7 Days)|Physician Decision|0|||
156369383|NCT01857063|564450342|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
156369384|NCT01857063|564450343|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
156369385|NCT01857063|564450342|FG000|Period 2 (7 Days)|Adverse Event|2|||
156369386|NCT01857063|564450343|FG001|Period 2 (7 Days)|Adverse Event|1|||
156369387|NCT01857063|564450342|FG000|Period 2 (7 Days)|Physician Decision|1|||
156369388|NCT01857063|564450343|FG001|Period 2 (7 Days)|Physician Decision|1|||
156369389|NCT01857063|564450342|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
156491929|NCT01649297|564896936|FG002|Overall Study|Lack of Efficacy|0|||
156369390|NCT01857063|564450343|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
156369391|NCT01256710|564450344|FG000|Overall Study|Death|449|||
156369392|NCT01256710|564450344|FG000|Overall Study|System Explant|67|||
156369393|NCT01256710|564450344|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
156369394|NCT01256710|564450344|FG000|Overall Study|Lost to Follow-up|67|||
156369395|NCT01256710|564450344|FG000|Overall Study|Withdrawal by Subject|29|||
156369396|NCT01256710|564450344|FG000|Overall Study|Physician Decision|9|||
156369397|NCT01256710|564450344|FG000|Overall Study|Subject Noncompliance|2|||
156369398|NCT01256710|564450344|FG000|Overall Study|Study Terminated by Sponsor|273|||
156369399|NCT00058825|564450345|FG000|Overall Study|Relapse|9|||
156369400|NCT00058825|564450345|FG000|Overall Study|Progressive Disease|5|||
156491930|NCT01649297|564896937|FG003|Overall Study|Lack of Efficacy|0|||
156491931|NCT01649297|564896938|FG004|Overall Study|Lack of Efficacy|1|||
156491932|NCT01649297|564896934|FG000|Overall Study|Non compliant with Protocol|1|||
156369401|NCT00058825|564450345|FG000|Overall Study|Graft Failure|5|||
156369402|NCT00058825|564450345|FG000|Overall Study|Death|3|||
156369403|NCT02346240|564450347|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369404|NCT02346240|564450348|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
156369405|NCT02346240|564450349|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
156369406|NCT02346240|564450350|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
156369407|NCT02346240|564450351|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369408|NCT02346240|564450352|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369409|NCT02346240|564450353|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369410|NCT02346240|564450354|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369411|NCT02346240|564450355|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369412|NCT02346240|564450356|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369413|NCT02346240|564450357|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369414|NCT02346240|564450358|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369415|NCT02346240|564450359|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369416|NCT02346240|564450360|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369417|NCT02346240|564450361|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369418|NCT02346240|564450362|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369419|NCT02346240|564450363|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369420|NCT02346240|564450364|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369421|NCT02346240|564450365|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369422|NCT02346240|564450366|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369423|NCT02346240|564450367|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369424|NCT02346240|564450368|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369425|NCT02346240|564450369|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369426|NCT02346240|564450370|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156369427|NCT02346240|564450347|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369428|NCT02346240|564450348|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
156369429|NCT02346240|564450349|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369430|NCT02346240|564450350|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369431|NCT02346240|564450351|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369432|NCT02346240|564450352|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369433|NCT02346240|564450353|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369434|NCT02346240|564450354|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369435|NCT02346240|564450355|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369436|NCT02346240|564450356|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369437|NCT02346240|564450357|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369438|NCT02346240|564450358|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369439|NCT02346240|564450359|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369440|NCT02346240|564450360|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369441|NCT02346240|564450361|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369442|NCT02346240|564450362|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369443|NCT02346240|564450363|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369444|NCT02346240|564450364|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369445|NCT02346240|564450365|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369446|NCT02346240|564450366|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369447|NCT02346240|564450367|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369448|NCT02346240|564450368|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369449|NCT02346240|564450369|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369450|NCT02346240|564450370|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156369451|NCT02346240|564450347|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369452|NCT02346240|564450348|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
156369453|NCT02346240|564450349|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369454|NCT02346240|564450350|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369455|NCT02346240|564450351|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369456|NCT02346240|564450352|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369457|NCT02346240|564450353|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369458|NCT02346240|564450354|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369459|NCT02346240|564450355|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369460|NCT02346240|564450356|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369461|NCT02346240|564450357|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369462|NCT02346240|564450358|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369463|NCT02346240|564450359|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369464|NCT02346240|564450360|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369465|NCT02346240|564450361|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369466|NCT02346240|564450362|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369467|NCT02346240|564450363|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369468|NCT02346240|564450364|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369469|NCT02346240|564450365|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369470|NCT02346240|564450366|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369471|NCT02346240|564450367|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369472|NCT02346240|564450368|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369473|NCT02346240|564450369|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369474|NCT02346240|564450370|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156369475|NCT02346240|564450347|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
156369476|NCT02346240|564450348|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
156369477|NCT02346240|564450349|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
156369478|NCT02346240|564450350|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
156369479|NCT02346240|564450351|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369480|NCT02346240|564450352|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369481|NCT02346240|564450353|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369482|NCT02346240|564450354|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369483|NCT02346240|564450355|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369484|NCT02346240|564450356|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369485|NCT02346240|564450357|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369486|NCT02346240|564450358|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369487|NCT02346240|564450359|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369488|NCT02346240|564450360|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369489|NCT02346240|564450361|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369490|NCT02346240|564450362|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369491|NCT02346240|564450363|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369492|NCT02346240|564450364|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369493|NCT02346240|564450365|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156491933|NCT01649297|564896935|FG001|Overall Study|Non compliant with Protocol|0|||
156491934|NCT01649297|564896936|FG002|Overall Study|Non compliant with Protocol|3|||
156491935|NCT01649297|564896937|FG003|Overall Study|Non compliant with Protocol|2|||
156491936|NCT01649297|564896938|FG004|Overall Study|Non compliant with Protocol|1|||
156491937|NCT01649297|564896934|FG000|Overall Study|Lost to Follow-up|1|||
156491938|NCT01649297|564896935|FG001|Overall Study|Lost to Follow-up|1|||
156491939|NCT01649297|564896936|FG002|Overall Study|Lost to Follow-up|4|||
156491940|NCT01649297|564896937|FG003|Overall Study|Lost to Follow-up|3|||
156491941|NCT01649297|564896938|FG004|Overall Study|Lost to Follow-up|0|||
156491942|NCT01649297|564896934|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
156491943|NCT01649297|564896935|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
156491944|NCT01649297|564896936|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
156491945|NCT01649297|564896937|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
156491946|NCT01649297|564896938|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
156491947|NCT01649297|564896934|FG000|Overall Study|For other reason|4|||
156491948|NCT01649297|564896935|FG001|Overall Study|For other reason|1|||
156491949|NCT01649297|564896936|FG002|Overall Study|For other reason|2|||
156491950|NCT01649297|564896937|FG003|Overall Study|For other reason|0|||
156491951|NCT01649297|564896938|FG004|Overall Study|For other reason|0|||
156491952|NCT01685047|564896939|FG000|Overall Study|Withdrawal by Subject|20|||
156491953|NCT01685047|564896939|FG000|Overall Study|Death|26|||
156491954|NCT01685047|564896939|FG000|Overall Study|Lost to Follow-up|8|||
156491955|NCT01685047|564896939|FG000|Overall Study|Physician Decision|25|||
156491956|NCT01685047|564896939|FG000|Overall Study|Adverse Event|5|||
156491957|NCT01685047|564896939|FG000|Overall Study|patient withdrawn by sponsor|1|||
156491958|NCT01732926|564896941|FG000|Overall Study|Study Terminated by Sponsor|168|||
156491959|NCT01732926|564896942|FG001|Overall Study|Study Terminated by Sponsor|80|||
156491960|NCT01732926|564896941|FG000|Overall Study|Withdrawal by Subject|46|||
156491961|NCT01732926|564896942|FG001|Overall Study|Withdrawal by Subject|8|||
156491962|NCT01732926|564896941|FG000|Overall Study|Physician Decision|24|||
156491963|NCT01732926|564896942|FG001|Overall Study|Physician Decision|11|||
156491964|NCT01732926|564896941|FG000|Overall Study|Other Reason|21|||
156491965|NCT01732926|564896942|FG001|Overall Study|Other Reason|4|||
156491966|NCT01732926|564896941|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
156491967|NCT01732926|564896942|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
156491968|NCT01732926|564896941|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
156491969|NCT01732926|564896942|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
156491970|NCT02262364|564896945|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
156369494|NCT02346240|564450366|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369495|NCT02346240|564450367|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369496|NCT02346240|564450368|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369497|NCT02346240|564450369|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369498|NCT02346240|564450370|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156369499|NCT02346240|564450347|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
156369500|NCT02346240|564450348|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
156369501|NCT02346240|564450349|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
156369502|NCT02346240|564450350|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
156369503|NCT02346240|564450351|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369504|NCT02346240|564450352|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369505|NCT02346240|564450353|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369506|NCT02346240|564450354|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369507|NCT02346240|564450355|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369508|NCT02346240|564450356|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369509|NCT02346240|564450357|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369510|NCT02346240|564450358|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369511|NCT02346240|564450359|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369512|NCT02346240|564450360|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369513|NCT02346240|564450361|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369514|NCT02346240|564450362|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369515|NCT02346240|564450363|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369516|NCT02346240|564450364|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369517|NCT02346240|564450365|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369518|NCT02346240|564450366|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369519|NCT02346240|564450367|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369520|NCT02346240|564450368|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369521|NCT02346240|564450369|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369522|NCT02346240|564450370|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156369523|NCT02346240|564450347|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369524|NCT02346240|564450348|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
156369525|NCT02346240|564450349|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369526|NCT02346240|564450350|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
156369527|NCT02346240|564450351|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369528|NCT02346240|564450352|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369529|NCT02346240|564450353|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369530|NCT02346240|564450354|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369531|NCT02346240|564450355|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369532|NCT02346240|564450356|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369533|NCT02346240|564450357|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369534|NCT02346240|564450358|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369535|NCT02346240|564450359|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369536|NCT02346240|564450360|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369537|NCT02346240|564450361|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369538|NCT02346240|564450362|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369539|NCT02346240|564450363|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369540|NCT02346240|564450364|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369541|NCT02346240|564450365|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369542|NCT02346240|564450366|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369543|NCT02346240|564450367|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369544|NCT02346240|564450368|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369545|NCT02346240|564450369|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369546|NCT02346240|564450370|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156369547|NCT02346240|564450347|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369548|NCT02346240|564450348|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369549|NCT02346240|564450349|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
156369550|NCT02346240|564450350|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369551|NCT02346240|564450351|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369552|NCT02346240|564450352|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369553|NCT02346240|564450353|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369554|NCT02346240|564450354|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369555|NCT02346240|564450355|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369556|NCT02346240|564450356|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369557|NCT02346240|564450357|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369558|NCT02346240|564450358|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369559|NCT02346240|564450359|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369560|NCT02346240|564450360|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369561|NCT02346240|564450361|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369562|NCT02346240|564450362|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369563|NCT02346240|564450363|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369564|NCT02346240|564450364|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369565|NCT02346240|564450365|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369566|NCT02346240|564450366|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369567|NCT02346240|564450367|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369568|NCT02346240|564450368|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369569|NCT02346240|564450369|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369570|NCT02346240|564450370|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156369571|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369572|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369573|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369574|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369575|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369576|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369577|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369578|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156369579|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
156491971|NCT01049984|564896946|FG000|Overall Study|Withdrawal by Subject|1|||
156491972|NCT01049984|564896947|FG001|Overall Study|Withdrawal by Subject|5|||
156491973|NCT01049984|564896946|FG000|Overall Study|Protocol Violation|3|||
156546108|NCT00001379|565093293|FG000|Initial Treatment|Received alternative treatment|2|||
156546109|NCT00001379|565093294|FG001|Initial Treatment|Received alternative treatment|1|||
156546110|NCT00001379|565093295|FG002|Initial Treatment|Received alternative treatment|0|||
156546111|NCT00001379|565093296|FG003|Initial Treatment|Received alternative treatment|0|||
156546112|NCT00001379|565093293|FG000|Initial Treatment|Refused further treatment|2|||
156546113|NCT00001379|565093294|FG001|Initial Treatment|Refused further treatment|0|||
156546114|NCT00001379|565093295|FG002|Initial Treatment|Refused further treatment|0|||
156546115|NCT00001379|565093296|FG003|Initial Treatment|Refused further treatment|0|||
156546116|NCT00001379|565093293|FG000|Initial Treatment|Did not receive protocol treatment|0|||
156546117|NCT00001379|565093294|FG001|Initial Treatment|Did not receive protocol treatment|0|||
156546118|NCT00001379|565093295|FG002|Initial Treatment|Did not receive protocol treatment|5|||
156546119|NCT00001379|565093296|FG003|Initial Treatment|Did not receive protocol treatment|0|||
156491974|NCT01049984|564896947|FG001|Overall Study|Protocol Violation|4|||
156546120|NCT00001379|565093293|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
156546121|NCT00001379|565093294|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
156546122|NCT00001379|565093295|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
156546123|NCT00001379|565093296|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
156491975|NCT01049984|564896946|FG000|Overall Study|Lost to Follow-up|2|||
156491976|NCT01049984|564896947|FG001|Overall Study|Lost to Follow-up|1|||
156491977|NCT01049984|564896946|FG000|Overall Study|Adverse Event|13|||
156491978|NCT01049984|564896947|FG001|Overall Study|Adverse Event|7|||
156491979|NCT01049984|564896946|FG000|Overall Study|Treatment failure|0|||
156491980|NCT01049984|564896947|FG001|Overall Study|Treatment failure|2|||
156491981|NCT00337285|564896948|FG000|Overall Study|Withdrawal by Subject|42|||
156491982|NCT00337285|564896948|FG000|Overall Study|Lost to Follow-up|41|||
156491983|NCT00337285|564896948|FG000|Overall Study|Adverse Event|28|||
156491984|NCT00337285|564896948|FG000|Overall Study|Protocol Violation|27|||
156491985|NCT00337285|564896948|FG000|Overall Study|Lack of Efficacy|11|||
156491986|NCT00337285|564896948|FG000|Overall Study|Death|1|||
156491987|NCT00337285|564896948|FG000|Overall Study|Physician Decision|1|||
156491988|NCT00337285|564896948|FG000|Overall Study|Lack of protocol compliance|7|||
156491989|NCT01040403|564896949|FG000|Overall Study|Adverse Event|10|||
156491990|NCT01040403|564896949|FG000|Overall Study|Protocol Violation|2|||
156491991|NCT01040403|564896949|FG000|Overall Study|Lost to Follow-up|1|||
156491992|NCT01040403|564896949|FG000|Overall Study|Not treated|1|||
156491993|NCT01040403|564896949|FG000|Overall Study|Other reason not defined above|6|||
156491994|NCT00931918|564896953|FG000|Overall Study|Adverse Event|4|||
156546124|NCT00001379|565093293|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
156546125|NCT00001379|565093294|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
156491995|NCT00931918|564896954|FG001|Overall Study|Adverse Event|6|||
156491996|NCT00931918|564896953|FG000|Overall Study|Progressive Disease|2|||
156491997|NCT00931918|564896954|FG001|Overall Study|Progressive Disease|1|||
156491998|NCT00931918|564896953|FG000|Overall Study|Symptomatic Deterioration|1|||
156491999|NCT00931918|564896954|FG001|Overall Study|Symptomatic Deterioration|0|||
156492000|NCT00931918|564896953|FG000|Overall Study|Withdrawal by Patient|3|||
156369580|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369581|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369582|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369583|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369584|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156369585|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
156369586|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156369587|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
156369588|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369589|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369590|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369591|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369592|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369593|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369594|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156369595|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369596|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369597|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369598|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369599|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369600|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369601|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369602|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369603|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369604|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369605|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369606|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369607|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369608|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
156369609|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369610|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
156369611|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369612|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369613|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369614|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369615|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369616|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369617|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369618|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156369619|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369620|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369621|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369622|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369623|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369624|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369625|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369626|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369627|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369628|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369629|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369630|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369631|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369632|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369633|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
156369634|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369635|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369636|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369637|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369638|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369639|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369640|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369641|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156492001|NCT00931918|564896954|FG001|Overall Study|Withdrawal by Patient|4|||
156492002|NCT00931918|564896953|FG000|Overall Study|Other Reason not Specified|4|||
156492003|NCT00931918|564896954|FG001|Overall Study|Other Reason not Specified|4|||
156369642|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156369643|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369644|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369645|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369646|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369647|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369648|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156369649|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156369650|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156369651|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156369652|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369653|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156369654|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
156369655|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369656|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
156369657|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
156369658|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
156369659|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156369660|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369661|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369662|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369663|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369664|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369665|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369666|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156369667|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369668|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369669|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369670|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369671|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369672|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369673|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369674|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369675|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369676|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369677|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369678|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369679|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369680|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
156369681|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
156369682|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
156369683|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
156369684|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369685|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369686|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369687|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369688|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369689|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369690|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156369691|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369692|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369693|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369694|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369695|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369696|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369697|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
156369698|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369699|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369700|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369701|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369702|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156546126|NCT00001379|565093295|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
156546127|NCT00001379|565093296|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
156369703|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369704|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369705|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156546128|NCT00001379|565093293|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
156546129|NCT00001379|565093294|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
156546130|NCT00001379|565093295|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
156546131|NCT00001379|565093296|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
156546132|NCT00001379|565093293|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
156546133|NCT00001379|565093294|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
156546134|NCT00001379|565093295|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
156546135|NCT00001379|565093296|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
156369706|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369707|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369708|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369709|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369710|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369711|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369712|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369713|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369714|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156369715|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369716|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369717|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369718|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369719|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369720|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369721|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369722|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369723|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
156369724|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369725|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369726|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
156369727|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369728|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
156369729|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
156369730|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369731|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369732|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369733|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369734|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369735|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369736|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369737|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369738|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156369739|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369740|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369741|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369742|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369743|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369744|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369745|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369746|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369747|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369748|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
156369749|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369750|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156546136|NCT00001379|565093293|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
156546137|NCT00001379|565093294|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
156492004|NCT00931918|564896953|FG000|Overall Study|Did not receive study drug|3|||
156492005|NCT00931918|564896954|FG001|Overall Study|Did not receive study drug|2|||
156492006|NCT04191148|564896957|FG000|Overall Study|Withdrawal by Subject|1|||
156492007|NCT04191148|564896958|FG001|Overall Study|Withdrawal by Subject|0|||
156492008|NCT04191148|564896957|FG000|Overall Study|Adverse Event|1|||
156492009|NCT04191148|564896958|FG001|Overall Study|Adverse Event|0|||
156492010|NCT02647788|564896959|FG000|Overall Study|Lost to Follow-up|13|||
156546138|NCT00001379|565093295|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
156492011|NCT02647788|564896960|FG001|Overall Study|Lost to Follow-up|11|||
156546139|NCT00001379|565093296|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
156369751|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369752|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369753|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369754|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369755|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369756|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369757|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369758|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369759|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369760|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369761|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369762|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156369763|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369764|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369765|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369766|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369767|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369768|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369769|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369770|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369771|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369772|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369773|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
156369774|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369775|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369776|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369777|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369778|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369779|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369780|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369781|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369782|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369783|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369784|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369785|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369786|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156369787|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369788|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369789|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369790|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369791|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369792|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369793|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369794|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369795|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369796|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369797|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369798|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369799|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369800|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369801|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
156369802|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369803|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369804|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369805|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369806|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369807|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156492012|NCT02647788|564896959|FG000|Overall Study|Did not want opiate|0|||
156369808|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156492013|NCT02647788|564896960|FG001|Overall Study|Did not want opiate|1|||
156492014|NCT02647788|564896959|FG000|Overall Study|Withdrawal by Subject|1|||
156492015|NCT02647788|564896960|FG001|Overall Study|Withdrawal by Subject|0|||
156492016|NCT02647788|564896959|FG000|Overall Study|Felt itchy with assigned medication|1|||
156492017|NCT02647788|564896960|FG001|Overall Study|Felt itchy with assigned medication|0|||
156369809|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369810|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156369811|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369812|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369813|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369814|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369815|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369816|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369817|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369818|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369819|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369820|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369821|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369822|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369823|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369824|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369825|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
156369826|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369827|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369828|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369829|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369830|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369831|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369832|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369833|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369834|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156369835|NCT02346240|564450347|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369836|NCT02346240|564450348|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369837|NCT02346240|564450349|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369838|NCT02346240|564450350|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369839|NCT02346240|564450351|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369840|NCT02346240|564450352|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369841|NCT02346240|564450353|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369842|NCT02346240|564450354|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369843|NCT02346240|564450355|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369844|NCT02346240|564450356|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369845|NCT02346240|564450357|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369846|NCT02346240|564450358|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369847|NCT02346240|564450359|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369848|NCT02346240|564450360|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369849|NCT02346240|564450361|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
156369850|NCT02346240|564450362|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369851|NCT02346240|564450363|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369852|NCT02346240|564450364|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369853|NCT02346240|564450365|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369854|NCT02346240|564450366|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369855|NCT02346240|564450367|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369856|NCT02346240|564450368|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369857|NCT02346240|564450369|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156369858|NCT02346240|564450370|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156492018|NCT02647788|564896959|FG000|Overall Study|Felt nauseous with assigned medication|1|||
156492019|NCT02647788|564896960|FG001|Overall Study|Felt nauseous with assigned medication|1|||
156492020|NCT03245619|564896961|FG000|Part A (Up to Day 22)|Physician Decision|4|||
156369859|NCT02346240|564450347|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369860|NCT02346240|564450348|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369861|NCT02346240|564450349|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369862|NCT02346240|564450350|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369863|NCT02346240|564450351|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369864|NCT02346240|564450352|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369865|NCT02346240|564450353|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369866|NCT02346240|564450354|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369867|NCT02346240|564450355|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369868|NCT02346240|564450356|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369869|NCT02346240|564450357|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369870|NCT02346240|564450358|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369871|NCT02346240|564450359|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369872|NCT02346240|564450360|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369873|NCT02346240|564450361|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369874|NCT02346240|564450362|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369875|NCT02346240|564450363|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156369876|NCT02346240|564450364|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
156369877|NCT02346240|564450365|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
156369878|NCT02346240|564450366|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
156369879|NCT02346240|564450367|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
156369880|NCT02346240|564450368|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
156369881|NCT02346240|564450369|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
156369882|NCT02346240|564450370|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
156369883|NCT02346240|564450347|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369884|NCT02346240|564450348|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369885|NCT02346240|564450349|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369886|NCT02346240|564450350|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369887|NCT02346240|564450351|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369888|NCT02346240|564450352|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369889|NCT02346240|564450353|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369890|NCT02346240|564450354|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369891|NCT02346240|564450355|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369892|NCT02346240|564450356|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369893|NCT02346240|564450357|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369894|NCT02346240|564450358|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369895|NCT02346240|564450359|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369896|NCT02346240|564450360|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369897|NCT02346240|564450361|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369898|NCT02346240|564450362|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369899|NCT02346240|564450363|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369900|NCT02346240|564450364|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369901|NCT02346240|564450365|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
156369902|NCT02346240|564450366|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
156369903|NCT02346240|564450367|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369904|NCT02346240|564450368|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
156369905|NCT02346240|564450369|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369906|NCT02346240|564450370|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
156369907|NCT02346240|564450347|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369908|NCT02346240|564450348|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369909|NCT02346240|564450349|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369910|NCT02346240|564450350|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369911|NCT02346240|564450351|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369912|NCT02346240|564450352|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369913|NCT02346240|564450353|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369914|NCT02346240|564450354|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369915|NCT02346240|564450355|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369916|NCT02346240|564450356|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369917|NCT02346240|564450357|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369918|NCT02346240|564450358|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369919|NCT02346240|564450359|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156546140|NCT03246958|565093297|FG000|Overall Study|Withdrawal by Subject|0|||
156369920|NCT02346240|564450360|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369921|NCT02346240|564450361|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369922|NCT02346240|564450362|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369923|NCT02346240|564450363|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156546141|NCT03246958|565093298|FG001|Overall Study|Withdrawal by Subject|1|||
156546142|NCT03246958|565093299|FG002|Overall Study|Withdrawal by Subject|0|||
156546143|NCT03246958|565093300|FG003|Overall Study|Withdrawal by Subject|0|||
156546144|NCT03246958|565093301|FG004|Overall Study|Withdrawal by Subject|0|||
156546145|NCT03246958|565093302|FG005|Overall Study|Withdrawal by Subject|1|||
156546146|NCT03246958|565093303|FG006|Overall Study|Withdrawal by Subject|0|||
156546147|NCT03246958|565093297|FG000|Overall Study|Progression|13|||
156546148|NCT03246958|565093298|FG001|Overall Study|Progression|9|||
156546149|NCT03246958|565093299|FG002|Overall Study|Progression|3|||
156546150|NCT03246958|565093300|FG003|Overall Study|Progression|2|||
156546151|NCT03246958|565093301|FG004|Overall Study|Progression|1|||
156546152|NCT03246958|565093302|FG005|Overall Study|Progression|2|||
156546153|NCT03246958|565093303|FG006|Overall Study|Progression|1|||
156546154|NCT03246958|565093297|FG000|Overall Study|Adverse Event|2|||
156546155|NCT03246958|565093298|FG001|Overall Study|Adverse Event|2|||
156546156|NCT03246958|565093299|FG002|Overall Study|Adverse Event|0|||
156546157|NCT03246958|565093300|FG003|Overall Study|Adverse Event|1|||
156546158|NCT03246958|565093301|FG004|Overall Study|Adverse Event|1|||
156546159|NCT03246958|565093302|FG005|Overall Study|Adverse Event|0|||
156369924|NCT02346240|564450364|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369925|NCT02346240|564450365|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156369926|NCT02346240|564450366|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369927|NCT02346240|564450367|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369928|NCT02346240|564450368|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156369929|NCT02346240|564450369|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369930|NCT02346240|564450370|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156369931|NCT02346240|564450347|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369932|NCT02346240|564450348|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369933|NCT02346240|564450349|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369934|NCT02346240|564450350|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369935|NCT02346240|564450351|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369936|NCT02346240|564450352|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369937|NCT02346240|564450353|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369938|NCT02346240|564450354|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369939|NCT02346240|564450355|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369940|NCT02346240|564450356|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369941|NCT02346240|564450357|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369942|NCT02346240|564450358|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369943|NCT02346240|564450359|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369944|NCT02346240|564450360|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369945|NCT02346240|564450361|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369946|NCT02346240|564450362|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369947|NCT02346240|564450363|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369948|NCT02346240|564450364|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369949|NCT02346240|564450365|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369950|NCT02346240|564450366|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369951|NCT02346240|564450367|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369952|NCT02346240|564450368|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
156369953|NCT02346240|564450369|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369954|NCT02346240|564450370|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156369955|NCT02346240|564450347|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369956|NCT02346240|564450348|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369957|NCT02346240|564450349|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369958|NCT02346240|564450350|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369959|NCT02346240|564450351|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369960|NCT02346240|564450352|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369961|NCT02346240|564450353|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369962|NCT02346240|564450354|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369963|NCT02346240|564450355|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369964|NCT02346240|564450356|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369965|NCT02346240|564450357|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369966|NCT02346240|564450358|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369967|NCT02346240|564450359|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369968|NCT02346240|564450360|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369969|NCT02346240|564450361|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369970|NCT02346240|564450362|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369971|NCT02346240|564450363|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369972|NCT02346240|564450364|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
156369973|NCT02346240|564450365|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
156369974|NCT02346240|564450366|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
156369975|NCT02346240|564450367|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156369976|NCT02346240|564450368|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
156369977|NCT02346240|564450369|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
156369978|NCT02346240|564450370|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
156369979|NCT02346240|564450347|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369980|NCT02346240|564450348|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156492021|NCT03245619|564896962|FG001|Part A (Up to Day 22)|Physician Decision|6|||
156492022|NCT03245619|564896963|FG002|Part A (Up to Day 22)|Physician Decision|6|||
156492023|NCT03245619|564896964|FG003|Part A (Up to Day 22)|Physician Decision|0|||
156492024|NCT03245619|564896965|FG004|Part A (Up to Day 22)|Physician Decision|0|||
156369981|NCT02346240|564450349|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369982|NCT02346240|564450350|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156492025|NCT03245619|564896966|FG005|Part A (Up to Day 22)|Physician Decision|0|||
156369983|NCT02346240|564450351|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369984|NCT02346240|564450352|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369985|NCT02346240|564450353|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369986|NCT02346240|564450354|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369987|NCT02346240|564450355|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369988|NCT02346240|564450356|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369989|NCT02346240|564450357|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369990|NCT02346240|564450358|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369991|NCT02346240|564450359|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369992|NCT02346240|564450360|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369993|NCT02346240|564450361|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369994|NCT02346240|564450362|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369995|NCT02346240|564450363|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369996|NCT02346240|564450364|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156369997|NCT02346240|564450365|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
156369998|NCT02346240|564450366|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
156369999|NCT02346240|564450367|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156370000|NCT02346240|564450368|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
156370001|NCT02346240|564450369|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
156370002|NCT02346240|564450370|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
156370003|NCT02346240|564450347|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370004|NCT02346240|564450348|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370005|NCT02346240|564450349|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370006|NCT02346240|564450350|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370007|NCT02346240|564450351|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370008|NCT02346240|564450352|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370009|NCT02346240|564450353|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370010|NCT02346240|564450354|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370011|NCT02346240|564450355|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370012|NCT02346240|564450356|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370013|NCT02346240|564450357|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370014|NCT02346240|564450358|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370015|NCT02346240|564450359|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370016|NCT02346240|564450360|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370017|NCT02346240|564450361|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370018|NCT02346240|564450362|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370019|NCT02346240|564450363|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370020|NCT02346240|564450364|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370021|NCT02346240|564450365|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
156370022|NCT02346240|564450366|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370023|NCT02346240|564450367|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156370024|NCT02346240|564450368|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
156370025|NCT02346240|564450369|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
156370026|NCT02346240|564450370|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
156492026|NCT03245619|564896967|FG006|Part A (Up to Day 22)|Physician Decision|0|||
156492027|NCT03245619|564896968|FG007|Part A (Up to Day 22)|Physician Decision|0|||
156492028|NCT03245619|564896969|FG008|Part A (Up to Day 22)|Physician Decision|0|||
156492029|NCT03245619|564896970|FG009|Part A (Up to Day 22)|Physician Decision|0|||
156492030|NCT03245619|564896971|FG010|Part A (Up to Day 22)|Physician Decision|0|||
156492031|NCT03245619|564896972|FG011|Part A (Up to Day 22)|Physician Decision|0|||
156492032|NCT03245619|564896973|FG012|Part A (Up to Day 22)|Physician Decision|0|||
156492033|NCT03245619|564896974|FG013|Part A (Up to Day 22)|Physician Decision|0|||
156492034|NCT03245619|564896975|FG014|Part A (Up to Day 22)|Physician Decision|0|||
156492035|NCT03245619|564896976|FG015|Part A (Up to Day 22)|Physician Decision|0|||
156492036|NCT03245619|564896977|FG016|Part A (Up to Day 22)|Physician Decision|0|||
156492037|NCT03201900|564896979|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
156492038|NCT03201900|564896979|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
156492039|NCT03201900|564896979|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
156492040|NCT03201900|564896979|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
156492041|NCT03201900|564896979|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
156370027|NCT02346240|564450347|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156492042|NCT03201900|564896979|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
156492043|NCT03201900|564896979|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
156492044|NCT03201900|564896979|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
156546160|NCT03246958|565093303|FG006|Overall Study|Adverse Event|2|||
156546161|NCT03246958|565093297|FG000|Overall Study|Death|0|||
156546162|NCT03246958|565093298|FG001|Overall Study|Death|1|||
156546163|NCT03246958|565093299|FG002|Overall Study|Death|0|||
156546164|NCT03246958|565093300|FG003|Overall Study|Death|0|||
156546165|NCT03246958|565093301|FG004|Overall Study|Death|0|||
156546166|NCT03246958|565093302|FG005|Overall Study|Death|0|||
156546167|NCT03246958|565093303|FG006|Overall Study|Death|0|||
156546168|NCT03246958|565093297|FG000|Overall Study|Physician Decision|0|||
156546169|NCT03246958|565093298|FG001|Overall Study|Physician Decision|0|||
156546170|NCT03246958|565093299|FG002|Overall Study|Physician Decision|0|||
156546171|NCT03246958|565093300|FG003|Overall Study|Physician Decision|1|||
156546172|NCT03246958|565093301|FG004|Overall Study|Physician Decision|0|||
156546173|NCT03246958|565093302|FG005|Overall Study|Physician Decision|0|||
156546174|NCT03246958|565093303|FG006|Overall Study|Physician Decision|0|||
156546175|NCT03246958|565093297|FG000|Overall Study|Never start treatment|1|||
156546176|NCT03246958|565093298|FG001|Overall Study|Never start treatment|0|||
156546177|NCT03246958|565093299|FG002|Overall Study|Never start treatment|0|||
156546178|NCT03246958|565093300|FG003|Overall Study|Never start treatment|0|||
156546179|NCT03246958|565093301|FG004|Overall Study|Never start treatment|0|||
156546180|NCT03246958|565093302|FG005|Overall Study|Never start treatment|0|||
156546181|NCT03246958|565093303|FG006|Overall Study|Never start treatment|0|||
156546182|NCT03246958|565093297|FG000|Overall Study|Over enrollment|0|||
156546183|NCT03246958|565093298|FG001|Overall Study|Over enrollment|2|||
156546184|NCT03246958|565093299|FG002|Overall Study|Over enrollment|0|||
156546185|NCT03246958|565093300|FG003|Overall Study|Over enrollment|0|||
156546186|NCT03246958|565093301|FG004|Overall Study|Over enrollment|0|||
156546187|NCT03246958|565093302|FG005|Overall Study|Over enrollment|0|||
156546188|NCT03246958|565093303|FG006|Overall Study|Over enrollment|0|||
156546189|NCT01118351|565093307|FG000|Overall Study|Adverse Event|3|||
156546190|NCT01118351|565093307|FG000|Overall Study|Withdrawal by Subject|1|||
156546191|NCT00811135|565093308|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
156546192|NCT00811135|565093308|FG000|Overall Study|Death|3|||
156546193|NCT00811135|565093308|FG000|Overall Study|Protocol Violation|2|||
156546194|NCT00811135|565093308|FG000|Overall Study|Violation of Selection Criteria|1|||
156546195|NCT00811135|565093308|FG000|Overall Study|Refused Treatment|1|||
156546196|NCT00811135|565093308|FG000|Overall Study|Withdrawal by Subject|3|||
156546197|NCT00811135|565093308|FG000|Overall Study|Administrative/Other Unspecified|11|||
156546198|NCT00811135|565093308|FG000|Overall Study|Ongoing|59|||
156546199|NCT02797808|565093310|FG000|Overall Study|Withdrawal by Subject|1|||
156546200|NCT02797808|565093311|FG001|Overall Study|Withdrawal by Subject|1|||
156546201|NCT02797808|565093310|FG000|Overall Study|Physician Decision|6|||
156546202|NCT02797808|565093311|FG001|Overall Study|Physician Decision|2|||
156546203|NCT00535132|565093315|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
156546204|NCT00535132|565093316|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
156546205|NCT00535132|565093315|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
156546206|NCT00535132|565093316|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
156546207|NCT00264875|565093317|FG000|Overall Study|Adverse Event|6|||
156546208|NCT00264875|565093317|FG000|Overall Study|Lost to Follow-up|6|||
156546209|NCT00264875|565093317|FG000|Overall Study|Protocol Violation|11|||
156546210|NCT00264875|565093317|FG000|Overall Study|Withdrawal by Subject|7|||
156546211|NCT01500278|565093318|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
156546212|NCT01500278|565093319|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
156546213|NCT01500278|565093318|FG000|Week 0 - Week 12|Protocol Violation|10|||
156546214|NCT01500278|565093319|FG001|Week 0 - Week 12|Protocol Violation|16|||
156546215|NCT01500278|565093318|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
156546216|NCT01500278|565093319|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
156546217|NCT01500278|565093318|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
156546218|NCT01500278|565093319|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
156546219|NCT01500278|565093318|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
156546220|NCT01500278|565093319|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
156546221|NCT01500278|565093318|FG000|Week 0 - Week 12|Patient decision|1|||
156546222|NCT01500278|565093319|FG001|Week 0 - Week 12|Patient decision|0|||
156546223|NCT01500278|565093318|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
156546224|NCT01500278|565093319|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
156546225|NCT01500278|565093318|FG000|Week 0 - Week 12|Investigator decision|1|||
156546226|NCT01500278|565093319|FG001|Week 0 - Week 12|Investigator decision|0|||
156546227|NCT01500278|565093318|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
156546228|NCT01500278|565093319|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
156546229|NCT01500278|565093318|FG000|Week 0 - Week 12|Sponsor decision|1|||
156546230|NCT01500278|565093319|FG001|Week 0 - Week 12|Sponsor decision|0|||
156546231|NCT01500278|565093318|FG000|Week 0 - Week 12|Personal reason|0|||
156546232|NCT01500278|565093319|FG001|Week 0 - Week 12|Personal reason|1|||
156546233|NCT01500278|565093318|FG000|Week 0 - Week 12|Other serious disease|0|||
156546234|NCT01500278|565093319|FG001|Week 0 - Week 12|Other serious disease|1|||
156546235|NCT01500278|565093318|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
156546236|NCT01500278|565093319|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
156370028|NCT02346240|564450348|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370029|NCT02346240|564450349|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370030|NCT02346240|564450350|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370031|NCT02346240|564450351|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370032|NCT02346240|564450352|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370033|NCT02346240|564450353|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370034|NCT02346240|564450354|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370035|NCT02346240|564450355|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370036|NCT02346240|564450356|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370037|NCT02346240|564450357|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370038|NCT02346240|564450358|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370039|NCT02346240|564450359|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370040|NCT02346240|564450360|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370041|NCT02346240|564450361|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370042|NCT02346240|564450362|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370043|NCT02346240|564450363|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370044|NCT02346240|564450364|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370045|NCT02346240|564450365|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
156370046|NCT02346240|564450366|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370047|NCT02346240|564450367|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370048|NCT02346240|564450368|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370049|NCT02346240|564450369|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370050|NCT02346240|564450370|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156370051|NCT02942017|564450371|FG000|Overall Study|Adverse Event|0|||
156370052|NCT02942017|564450372|FG001|Overall Study|Adverse Event|1|||
156492045|NCT03201900|564896979|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
156492046|NCT03201900|564896979|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
156492047|NCT03201900|564896979|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
156492048|NCT03201900|564896979|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
156492049|NCT03201900|564896979|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
156492050|NCT02971228|564896995|FG000|Overall Study|Withdrawal by Subject|1|||
156492051|NCT02971228|564896996|FG001|Overall Study|Withdrawal by Subject|1|||
156492052|NCT02971228|564896997|FG002|Overall Study|Withdrawal by Subject|0|||
156492053|NCT02971228|564896998|FG003|Overall Study|Withdrawal by Subject|0|||
156492054|NCT02971228|564896999|FG004|Overall Study|Withdrawal by Subject|0|||
156492055|NCT02971228|564896995|FG000|Overall Study|Logistical challenges|0|||
156492056|NCT02971228|564896996|FG001|Overall Study|Logistical challenges|1|||
156492057|NCT02971228|564896997|FG002|Overall Study|Logistical challenges|0|||
156492058|NCT02971228|564896998|FG003|Overall Study|Logistical challenges|0|||
156492059|NCT02971228|564896999|FG004|Overall Study|Logistical challenges|0|||
156492060|NCT01233999|564897000|FG000|Overall Study|Withdrawal by Subject|1|||
156492061|NCT01233999|564897000|FG000|Overall Study|Lost to Follow-up|1|||
156492062|NCT00129649|564897001|FG000|Overall Study|Withdrawal by Subject|76|||
156492063|NCT00129649|564897002|FG001|Overall Study|Withdrawal by Subject|65|||
156492064|NCT00025506|564897003|FG000|Overall Study|Ineligible: clerical error|1|||
156492065|NCT00025506|564897003|FG000|Overall Study|Ineligible: wrong cell type|5|||
156492066|NCT00025506|564897003|FG000|Overall Study|Ineligible: inadequate pathology|2|||
156492067|NCT00025506|564897003|FG000|Overall Study|Never Treated|2|||
156492068|NCT00713206|564897004|FG000|Overall Study|Lost to Follow-up|4|||
156492069|NCT00713206|564897005|FG001|Overall Study|Lost to Follow-up|4|||
156492070|NCT00713206|564897004|FG000|Overall Study|Death|1|||
156492071|NCT00713206|564897005|FG001|Overall Study|Death|0|||
156492072|NCT04952701|564897006|FG000|Control Lens|Physician Decision|4|||
156492073|NCT04952701|564897006|FG000|Test Lens|Physician Decision|1|||
156492074|NCT01657877|564897007|FG000|Overall Study|Withdrawal by Subject|4|||
156492075|NCT01657877|564897007|FG000|Overall Study|Protocol Violation|6|||
156492076|NCT01657877|564897007|FG000|Overall Study|Adverse Event|2|||
156492077|NCT01657877|564897007|FG000|Overall Study|Other Reason|2|||
156492078|NCT01670188|564897015|FG000|Overall Study|Death|0|||
156370053|NCT02942017|564450371|FG000|Overall Study|Withdrawal by Subject|0|||
156492079|NCT01670188|564897016|FG001|Overall Study|Death|1|||
156492080|NCT02427958|564897019|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
156492081|NCT02427958|564897019|FG000|Overall Study|Lost to Follow-up|6|||
156492082|NCT02427958|564897019|FG000|Overall Study|Withdrawal by Subject|14|||
156492083|NCT02427958|564897019|FG000|Overall Study|Lack of Efficacy|1|||
156492084|NCT00578318|564897020|FG000|Overall Study|Lost to Follow-up|2|||
156546237|NCT01500278|565093318|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
156492085|NCT00578318|564897021|FG001|Overall Study|Lost to Follow-up|0|||
156492086|NCT00578318|564897020|FG000|Overall Study|Physician Decision|1|||
156370054|NCT02942017|564450372|FG001|Overall Study|Withdrawal by Subject|1|||
156370055|NCT02942017|564450371|FG000|Overall Study|Lost to Follow-up|1|||
156370056|NCT02942017|564450372|FG001|Overall Study|Lost to Follow-up|1|||
156370057|NCT02942017|564450371|FG000|Overall Study|Randomized but not dosed|1|||
156370058|NCT02942017|564450372|FG001|Overall Study|Randomized but not dosed|3|||
156370059|NCT03417141|564450373|FG000|Overall Study|Withdrawal by Subject|1|||
156370060|NCT03417141|564450373|FG000|Overall Study|Protocol Violation|3|||
156370061|NCT00458484|564450374|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
156370062|NCT00458484|564450375|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
156370063|NCT00458484|564450376|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
156370064|NCT00458484|564450377|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
156370065|NCT00458484|564450378|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
156370066|NCT00458484|564450379|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
156370067|NCT00458484|564450380|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
156370068|NCT01838642|564450381|FG000|Overall Study|Died on study|1|||
156370069|NCT01557400|564450382|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
156370070|NCT01557400|564450382|FG000|Overall Study|Adverse Event|3|||
156370071|NCT01557400|564450382|FG000|Overall Study|Lost to Follow-up|5|||
156370072|NCT01557400|564450382|FG000|Overall Study|Withdrawal by Subject|9|||
156370073|NCT00245765|564450384|FG000|Overall Study|Adverse Event|1|||
156370074|NCT00245765|564450385|FG001|Overall Study|Adverse Event|1|||
156370075|NCT00245765|564450386|FG002|Overall Study|Adverse Event|0|||
156370076|NCT00245765|564450384|FG000|Overall Study|Lack of Efficacy|14|||
156370077|NCT00245765|564450385|FG001|Overall Study|Lack of Efficacy|7|||
156370078|NCT00245765|564450386|FG002|Overall Study|Lack of Efficacy|0|||
156370079|NCT00245765|564450384|FG000|Overall Study|Lost to Follow-up|1|||
156370080|NCT00245765|564450385|FG001|Overall Study|Lost to Follow-up|2|||
156370081|NCT00245765|564450386|FG002|Overall Study|Lost to Follow-up|0|||
156370082|NCT00245765|564450384|FG000|Overall Study|Withdrawal by Subject|1|||
156370083|NCT00245765|564450385|FG001|Overall Study|Withdrawal by Subject|0|||
156370084|NCT00245765|564450386|FG002|Overall Study|Withdrawal by Subject|3|||
156370085|NCT00245765|564450384|FG000|Overall Study|Other reason|2|||
156370086|NCT00245765|564450385|FG001|Overall Study|Other reason|0|||
156370087|NCT00245765|564450386|FG002|Overall Study|Other reason|1|||
156370088|NCT00245765|564450384|FG000|Overall Study|Other|13|||
156370089|NCT00245765|564450385|FG001|Overall Study|Other|4|||
156370090|NCT00245765|564450386|FG002|Overall Study|Other|4|||
156370091|NCT04477304|564450389|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
156370092|NCT04477304|564450390|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
156370093|NCT04368429|564451800|FG000|Overall Study|Adverse Event|1|||
156370094|NCT04368429|564451801|FG001|Overall Study|Adverse Event|0|||
156370095|NCT00023673|564451802|FG000|Overall Study|Ineligible / no protocol treatment|0|||
156370096|NCT00023673|564451803|FG001|Overall Study|Ineligible / no protocol treatment|0|||
156370097|NCT00023673|564451804|FG002|Overall Study|Ineligible / no protocol treatment|0|||
156370098|NCT00023673|564451805|FG003|Overall Study|Ineligible / no protocol treatment|1|||
156370099|NCT00023673|564451802|FG000|Overall Study|Patient withdrew consent|0|||
156370100|NCT00023673|564451803|FG001|Overall Study|Patient withdrew consent|0|||
156370101|NCT00023673|564451804|FG002|Overall Study|Patient withdrew consent|0|||
156370102|NCT00023673|564451805|FG003|Overall Study|Patient withdrew consent|1|||
156370103|NCT00279708|564451806|FG000|Overall Study|Withdrawal by Subject|2|||
156370104|NCT00279708|564451807|FG001|Overall Study|Withdrawal by Subject|3|||
156370105|NCT00279708|564451806|FG000|Overall Study|Adverse Event|1|||
156370106|NCT00279708|564451807|FG001|Overall Study|Adverse Event|1|||
156370107|NCT02624284|564451808|FG000|Overall Study|Withdrawal by Subject|3|||
156370108|NCT02624284|564451809|FG001|Overall Study|Withdrawal by Subject|6|||
156370109|NCT02624284|564451810|FG002|Overall Study|Withdrawal by Subject|3|||
156370110|NCT02624284|564451808|FG000|Overall Study|Protocol Violation|9|||
156370111|NCT02624284|564451809|FG001|Overall Study|Protocol Violation|10|||
156370112|NCT02624284|564451810|FG002|Overall Study|Protocol Violation|7|||
156370113|NCT02624284|564451808|FG000|Overall Study|Revealed exclusionary condition|2|||
156370114|NCT02624284|564451809|FG001|Overall Study|Revealed exclusionary condition|2|||
156370115|NCT02624284|564451810|FG002|Overall Study|Revealed exclusionary condition|0|||
156370116|NCT02624284|564451808|FG000|Overall Study|Adverse Event|0|||
156370117|NCT02624284|564451809|FG001|Overall Study|Adverse Event|0|||
156370118|NCT02624284|564451810|FG002|Overall Study|Adverse Event|1|||
156370119|NCT01782313|564451811|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
156370120|NCT01782313|564451811|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
156370121|NCT01782313|564451811|FG000|Treated Cycle 3|Progressive Disease|21|||
156370122|NCT01782313|564451811|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
156370123|NCT01782313|564451811|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
156370124|NCT01782313|564451811|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
156370125|NCT01782313|564451811|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
156370126|NCT01782313|564451811|FG000|Survival Follow up|Lost to Follow-up|1|||
156370127|NCT00958776|564451812|FG000|Overall Study|Adverse Event|0|||
156546238|NCT01500278|565093319|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
156546239|NCT01500278|565093318|FG000|Week 13 - Week 104|Protocol Violation|6|||
156370128|NCT00958776|564451813|FG001|Overall Study|Adverse Event|1|||
156370129|NCT00958776|564451812|FG000|Overall Study|Physician Decision|1|||
156370130|NCT00958776|564451813|FG001|Overall Study|Physician Decision|0|||
156370131|NCT00958776|564451812|FG000|Overall Study|Lost to Follow-up|2|||
156370132|NCT00958776|564451813|FG001|Overall Study|Lost to Follow-up|6|||
156370133|NCT00958776|564451812|FG000|Overall Study|Withdrawal by Subject|7|||
156370134|NCT00958776|564451813|FG001|Overall Study|Withdrawal by Subject|16|||
156492087|NCT00578318|564897021|FG001|Overall Study|Physician Decision|0|||
156492088|NCT02025985|564897022|FG000|Overall Study|Consent withdrawn|0|||
156492089|NCT02025985|564897023|FG001|Overall Study|Consent withdrawn|0|||
156492090|NCT02025985|564897024|FG002|Overall Study|Consent withdrawn|1|||
156492091|NCT02025985|564897025|FG003|Overall Study|Consent withdrawn|0|||
156492092|NCT02025985|564897026|FG004|Overall Study|Consent withdrawn|0|||
156492093|NCT02025985|564897022|FG000|Overall Study|Termination of study by Sponsor|4|||
156492094|NCT02025985|564897023|FG001|Overall Study|Termination of study by Sponsor|3|||
156492095|NCT02025985|564897024|FG002|Overall Study|Termination of study by Sponsor|1|||
156492096|NCT02025985|564897025|FG003|Overall Study|Termination of study by Sponsor|1|||
156492097|NCT02025985|564897026|FG004|Overall Study|Termination of study by Sponsor|3|||
156492098|NCT02025985|564897022|FG000|Overall Study|Death|21|||
156492099|NCT02025985|564897023|FG001|Overall Study|Death|20|||
156370135|NCT00958776|564451812|FG000|Overall Study|Protocol Violation|1|||
156370136|NCT00958776|564451813|FG001|Overall Study|Protocol Violation|1|||
156370137|NCT00958776|564451812|FG000|Overall Study|Death|2|||
156370138|NCT00958776|564451813|FG001|Overall Study|Death|1|||
156370139|NCT00958776|564451812|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
156370140|NCT00958776|564451813|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
156370141|NCT00958776|564451812|FG000|Overall Study|Missing|1|||
156370142|NCT00958776|564451813|FG001|Overall Study|Missing|1|||
156370143|NCT00326911|564451814|FG000|Overall Study|Hospitalization prior to treatment|0|||
156370144|NCT00326911|564451815|FG001|Overall Study|Hospitalization prior to treatment|1|||
156370145|NCT00326911|564451814|FG000|Overall Study|Physician decision prior to treatment|1|||
156370146|NCT00326911|564451815|FG001|Overall Study|Physician decision prior to treatment|0|||
156370147|NCT00326911|564451814|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
156370148|NCT00326911|564451815|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
156370149|NCT02506816|564451822|FG000|Overall Study|Adverse Event|3|||
156370150|NCT02975934|564451827|FG000|Treatment Phase|Never initiated study drug|0|||
156370151|NCT02975934|564451828|FG001|Treatment Phase|Never initiated study drug|5|||
156370152|NCT02975934|564451829|FG002|Treatment Phase|Never initiated study drug|0|||
156370153|NCT00433654|564451833|FG000|Overall Study|Death|4|||
156370154|NCT00433654|564451834|FG001|Overall Study|Death|0|||
156370155|NCT00433654|564451833|FG000|Overall Study|Missed visit|6|||
156370156|NCT00433654|564451834|FG001|Overall Study|Missed visit|3|||
156370157|NCT00433654|564451833|FG000|Overall Study|Subject not yet due for visit|4|||
156370158|NCT00433654|564451834|FG001|Overall Study|Subject not yet due for visit|0|||
156370159|NCT00433654|564451833|FG000|Overall Study|Withdrawal by Subject|1|||
156370160|NCT00433654|564451834|FG001|Overall Study|Withdrawal by Subject|2|||
156370161|NCT04958109|564451838|FG000|Overall Study|Withdrawal by Subject|0|||
156370162|NCT04958109|564451839|FG001|Overall Study|Withdrawal by Subject|1|||
156370163|NCT04958109|564451838|FG000|Overall Study|Lost to Follow-up|0|||
156370164|NCT04958109|564451839|FG001|Overall Study|Lost to Follow-up|1|||
156370165|NCT00715793|564451840|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
156370166|NCT00715793|564451841|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
156370167|NCT00715793|564451840|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
156370168|NCT00715793|564451841|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
156370169|NCT01573624|564451842|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156492100|NCT02025985|564897024|FG002|Overall Study|Death|23|||
156370170|NCT01573624|564451843|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156492101|NCT02025985|564897025|FG003|Overall Study|Death|20|||
156492102|NCT02025985|564897026|FG004|Overall Study|Death|17|||
156492103|NCT00920699|564897032|FG000|Overall Study|Withdrawal by Subject|2|||
156492104|NCT00920699|564897033|FG001|Overall Study|Withdrawal by Subject|0|||
156492105|NCT00920699|564897034|FG002|Overall Study|Withdrawal by Subject|2|||
156370171|NCT01573624|564451844|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
156370172|NCT01573624|564451845|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156370173|NCT01573624|564451846|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156370174|NCT01573624|564451847|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
156370175|NCT01573624|564451848|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156370176|NCT01573624|564451842|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
156370177|NCT01573624|564451843|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
156370178|NCT01573624|564451844|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
156492106|NCT00920699|564897032|FG000|Overall Study|no longer met eligibility|0|||
156492107|NCT00920699|564897033|FG001|Overall Study|no longer met eligibility|1|||
156492108|NCT00920699|564897034|FG002|Overall Study|no longer met eligibility|0|||
156492109|NCT00920699|564897032|FG000|Overall Study|Lost to Follow-up|0|||
156370179|NCT01573624|564451845|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
156370180|NCT01573624|564451846|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
156370181|NCT01573624|564451847|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156370182|NCT01573624|564451848|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
156370183|NCT01573624|564451842|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
156370184|NCT01573624|564451843|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156370185|NCT01573624|564451844|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156370186|NCT01573624|564451845|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156370187|NCT01573624|564451846|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156370188|NCT01573624|564451847|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156370189|NCT01573624|564451848|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156370190|NCT01573624|564451842|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156370191|NCT01573624|564451843|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156370192|NCT01573624|564451844|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156370193|NCT01573624|564451845|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156370194|NCT01573624|564451846|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156370195|NCT01573624|564451847|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
156370196|NCT01573624|564451848|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156370197|NCT01573624|564451842|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
156370198|NCT01573624|564451843|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
156370199|NCT01573624|564451844|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
156370200|NCT01573624|564451845|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
156370201|NCT01573624|564451846|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
156370202|NCT01573624|564451847|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
156370203|NCT01573624|564451848|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
156370204|NCT01573624|564451842|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156370205|NCT01573624|564451843|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156370206|NCT01573624|564451844|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156370207|NCT01573624|564451845|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156370208|NCT01573624|564451846|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156370209|NCT01573624|564451847|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
156370210|NCT01573624|564451848|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156370211|NCT01573624|564451842|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
156370212|NCT01573624|564451843|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
156370213|NCT01573624|564451844|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
156370214|NCT01573624|564451845|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
156370215|NCT01573624|564451846|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
156370216|NCT01573624|564451847|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
156370217|NCT01573624|564451848|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
156370218|NCT01573624|564451842|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
156370219|NCT01573624|564451843|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156370220|NCT01573624|564451844|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
156370221|NCT01573624|564451845|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
156370222|NCT01573624|564451846|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156370223|NCT01573624|564451847|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156370224|NCT01573624|564451848|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156370225|NCT01573624|564451842|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156370226|NCT01573624|564451843|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156370227|NCT01573624|564451844|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156370228|NCT01573624|564451845|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156370229|NCT01573624|564451846|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156370230|NCT01573624|564451847|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
156370231|NCT01573624|564451848|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156370232|NCT01573624|564451842|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156370233|NCT01573624|564451843|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156370234|NCT01573624|564451844|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156370235|NCT01573624|564451845|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
156492110|NCT00920699|564897033|FG001|Overall Study|Lost to Follow-up|0|||
156492111|NCT00920699|564897034|FG002|Overall Study|Lost to Follow-up|2|||
156492112|NCT02287883|564897038|FG000|Overall Study|Death|8|||
156492113|NCT02287883|564897039|FG001|Overall Study|Death|7|||
156492114|NCT02287883|564897038|FG000|Overall Study|No longer eligible|222|||
156492115|NCT02287883|564897039|FG001|Overall Study|No longer eligible|182|||
156370236|NCT01573624|564451846|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156370237|NCT01573624|564451847|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156370238|NCT01573624|564451848|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156370239|NCT01573624|564451842|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
156370240|NCT01573624|564451843|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
156370241|NCT01573624|564451844|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
156370242|NCT01573624|564451845|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
156370243|NCT01573624|564451846|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
156370244|NCT01573624|564451847|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
156370245|NCT01573624|564451848|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
156370246|NCT01573624|564451842|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
156370247|NCT01573624|564451843|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
156370248|NCT01573624|564451844|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
156370249|NCT01573624|564451845|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
156370250|NCT01573624|564451846|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
156370251|NCT01573624|564451847|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
156370252|NCT01573624|564451848|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
156370253|NCT01573624|564451842|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156370254|NCT01573624|564451843|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
156370255|NCT01573624|564451844|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156370256|NCT01573624|564451845|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156370257|NCT01573624|564451846|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156370258|NCT01573624|564451847|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
156370259|NCT01573624|564451848|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156370260|NCT01573624|564451842|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
156370261|NCT01573624|564451843|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156370262|NCT01573624|564451844|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156370263|NCT01573624|564451845|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156370264|NCT01573624|564451846|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156370265|NCT01573624|564451847|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156370266|NCT01573624|564451848|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156370267|NCT01573624|564451842|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156370268|NCT01573624|564451843|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
156370269|NCT01573624|564451844|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
156370270|NCT01573624|564451845|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156370271|NCT01573624|564451846|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156370272|NCT01573624|564451847|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
156370273|NCT01573624|564451848|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156370274|NCT01573624|564451842|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
156370275|NCT01573624|564451843|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156370276|NCT01573624|564451844|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156370277|NCT01573624|564451845|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156370278|NCT01573624|564451846|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156370279|NCT01573624|564451847|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156370280|NCT01573624|564451848|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156370281|NCT01573624|564451842|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
156370282|NCT01573624|564451843|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156370283|NCT01573624|564451844|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156370284|NCT01573624|564451845|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156370285|NCT01573624|564451846|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156370286|NCT01573624|564451847|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156370287|NCT01573624|564451848|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
156370288|NCT01573624|564451842|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
156370289|NCT01573624|564451843|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156370290|NCT01573624|564451844|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156370291|NCT01573624|564451845|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156370292|NCT01573624|564451846|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156370293|NCT01573624|564451847|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
156370294|NCT01573624|564451848|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156370295|NCT01573624|564451842|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156370296|NCT01573624|564451843|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
156370297|NCT01573624|564451844|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156370298|NCT01573624|564451845|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156370299|NCT01573624|564451846|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156370300|NCT01573624|564451847|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156370301|NCT01573624|564451848|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156370302|NCT01573624|564451842|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156370303|NCT01573624|564451843|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
156370304|NCT01573624|564451844|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156370305|NCT01573624|564451845|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156370306|NCT01573624|564451846|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156370307|NCT01573624|564451847|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156370308|NCT01573624|564451848|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156370309|NCT01573624|564451842|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156370310|NCT01573624|564451843|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156370311|NCT01573624|564451844|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156370312|NCT01573624|564451845|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156370313|NCT01573624|564451846|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156370314|NCT01573624|564451847|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156370315|NCT01573624|564451848|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156370316|NCT01573624|564451842|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
156370317|NCT01573624|564451843|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
156370318|NCT01573624|564451844|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
156370319|NCT01573624|564451845|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
156370320|NCT01573624|564451846|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
156370321|NCT01573624|564451847|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
156370322|NCT01573624|564451848|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
156370323|NCT01573624|564451842|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
156370324|NCT01573624|564451843|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156370325|NCT01573624|564451844|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156370326|NCT01573624|564451845|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156370327|NCT01573624|564451846|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
156370328|NCT01573624|564451847|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
156370329|NCT01573624|564451848|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
156370330|NCT01573624|564451842|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156370331|NCT01573624|564451843|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
156370332|NCT01573624|564451844|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156370333|NCT01573624|564451845|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156370334|NCT01573624|564451846|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156370335|NCT01573624|564451847|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
156370336|NCT01573624|564451848|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156370337|NCT01573624|564451842|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
156370338|NCT01573624|564451843|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156370339|NCT01573624|564451844|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156370340|NCT01573624|564451845|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156370341|NCT01573624|564451846|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156370342|NCT01573624|564451847|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156370343|NCT01573624|564451848|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156370344|NCT01573624|564451842|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156370345|NCT01573624|564451843|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156370346|NCT01573624|564451844|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156370347|NCT01573624|564451845|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156370348|NCT01573624|564451846|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
156370349|NCT01573624|564451847|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
156370350|NCT01573624|564451848|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156370351|NCT01573624|564451842|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
156370352|NCT01573624|564451843|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156370353|NCT01573624|564451844|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156370354|NCT01573624|564451845|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156370355|NCT01573624|564451846|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156370356|NCT01573624|564451847|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156370357|NCT01573624|564451848|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156370358|NCT02681302|564451849|FG000|Overall Study|Withdrawal by Subject|1|||
156370359|NCT02681302|564451850|FG001|Overall Study|Withdrawal by Subject|1|||
156370360|NCT02681302|564451851|FG002|Overall Study|Withdrawal by Subject|0|||
156370361|NCT02681302|564451852|FG003|Overall Study|Withdrawal by Subject|0|||
156370362|NCT02681302|564451853|FG004|Overall Study|Withdrawal by Subject|1|||
156370363|NCT02681302|564451854|FG005|Overall Study|Withdrawal by Subject|0|||
156370364|NCT02681302|564451849|FG000|Overall Study|Screen Failure|2|||
156370365|NCT02681302|564451850|FG001|Overall Study|Screen Failure|4|||
156370366|NCT02681302|564451851|FG002|Overall Study|Screen Failure|2|||
156370367|NCT02681302|564451852|FG003|Overall Study|Screen Failure|0|||
156370368|NCT02681302|564451853|FG004|Overall Study|Screen Failure|1|||
156370369|NCT02681302|564451854|FG005|Overall Study|Screen Failure|1|||
156370370|NCT02681302|564451849|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156370371|NCT02681302|564451850|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156370372|NCT02681302|564451851|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156370373|NCT02681302|564451852|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156370374|NCT02681302|564451853|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156370375|NCT02681302|564451854|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
156370376|NCT04399161|564451855|FG000|Overall Study|Withdrawal by Subject|1|||
156370377|NCT04399161|564451856|FG001|Overall Study|Withdrawal by Subject|0|||
156370378|NCT04399161|564451857|FG002|Overall Study|Withdrawal by Subject|2|||
156370379|NCT04399161|564451855|FG000|Overall Study|Protocol Violation|1|||
156492116|NCT02287883|564897038|FG000|Overall Study|Non-response to survey|229|||
156492117|NCT02287883|564897039|FG001|Overall Study|Non-response to survey|237|||
156370380|NCT04399161|564451856|FG001|Overall Study|Protocol Violation|2|||
156370381|NCT04399161|564451857|FG002|Overall Study|Protocol Violation|0|||
156370382|NCT00838565|564451858|FG000|Overall Study|Withdrawal by Subject|0|||
156370383|NCT00838565|564451859|FG001|Overall Study|Withdrawal by Subject|0|||
156370384|NCT00838565|564451860|FG002|Overall Study|Withdrawal by Subject|1|||
156370385|NCT00838565|564451861|FG003|Overall Study|Withdrawal by Subject|0|||
156370386|NCT00838565|564451862|FG004|Overall Study|Withdrawal by Subject|0|||
156370387|NCT00838565|564451863|FG005|Overall Study|Withdrawal by Subject|2|||
156370388|NCT00838565|564451858|FG000|Overall Study|Other|0|||
156370389|NCT00838565|564451859|FG001|Overall Study|Other|2|||
156370390|NCT00838565|564451860|FG002|Overall Study|Other|0|||
156370391|NCT00838565|564451861|FG003|Overall Study|Other|0|||
156370392|NCT00838565|564451862|FG004|Overall Study|Other|0|||
156370393|NCT00838565|564451863|FG005|Overall Study|Other|0|||
156370394|NCT00838565|564451858|FG000|Overall Study|Randomized but not Treated|0|||
156370395|NCT00838565|564451859|FG001|Overall Study|Randomized but not Treated|1|||
156370396|NCT00838565|564451860|FG002|Overall Study|Randomized but not Treated|0|||
156370397|NCT00838565|564451861|FG003|Overall Study|Randomized but not Treated|0|||
156370398|NCT00838565|564451862|FG004|Overall Study|Randomized but not Treated|0|||
156370399|NCT00838565|564451863|FG005|Overall Study|Randomized but not Treated|0|||
156370400|NCT03571516|564451864|FG000|Overall Study|Severe diarrhea|1|||
156370401|NCT03571516|564451865|FG001|Overall Study|Severe diarrhea|0|||
156370402|NCT03571516|564451864|FG000|Overall Study|Withdrawal by Subject|0|||
156370403|NCT03571516|564451865|FG001|Overall Study|Withdrawal by Subject|1|||
156370404|NCT04552587|564451866|FG000|Overall Study|Lost to Follow-up|4|||
156370405|NCT01822132|564451867|FG000|Overall Study|Lost to Follow-up|4|||
156370406|NCT01822132|564451868|FG001|Overall Study|Lost to Follow-up|2|||
156370407|NCT04907032|564451869|FG000|Overall Study|Withdrawal by Subject|7|||
156370408|NCT04907032|564451870|FG001|Overall Study|Withdrawal by Subject|1|||
156370409|NCT02253810|564451871|FG000|Overall Study|Withdrawal by Subject|2|||
156370410|NCT02253810|564451872|FG001|Overall Study|Withdrawal by Subject|1|||
156370411|NCT02253810|564451871|FG000|Overall Study|Unknown concomitant procedure|3|||
156370412|NCT02253810|564451872|FG001|Overall Study|Unknown concomitant procedure|2|||
156370413|NCT00291668|564451874|FG000|Overall Study|Lack of Efficacy|1|||
156370414|NCT00291668|564451875|FG001|Overall Study|Lack of Efficacy|0|||
156370415|NCT00291668|564451876|FG002|Overall Study|Lack of Efficacy|0|||
156370416|NCT00291668|564451874|FG000|Overall Study|SAE, non-fatal|1|||
156370417|NCT00291668|564451875|FG001|Overall Study|SAE, non-fatal|1|||
156370418|NCT00291668|564451876|FG002|Overall Study|SAE, non-fatal|1|||
156370419|NCT00291668|564451874|FG000|Overall Study|AE, non-serious non-fatal|1|||
156370420|NCT00291668|564451875|FG001|Overall Study|AE, non-serious non-fatal|0|||
156370421|NCT00291668|564451876|FG002|Overall Study|AE, non-serious non-fatal|0|||
156370422|NCT00291668|564451874|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156370423|NCT00291668|564451875|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156370424|NCT00291668|564451876|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156370425|NCT00313612|564451877|FG000|Overall Study|Patient never received treatment|0|||
156370426|NCT00313612|564451878|FG001|Overall Study|Patient never received treatment|1|||
156370427|NCT03465878|564451881|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
156370428|NCT03465878|564451882|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
156370429|NCT03465878|564451883|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
156370430|NCT03465878|564451884|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
156370431|NCT03465878|564451881|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
156370432|NCT03465878|564451882|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
156370433|NCT03465878|564451883|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
156370434|NCT03465878|564451884|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
156370435|NCT03465878|564451881|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
156492118|NCT02101268|564897045|FG000|Randomized Treatment Phase|Subject Decision|8|||
156492119|NCT02101268|564897046|FG001|Randomized Treatment Phase|Subject Decision|4|||
156492120|NCT02101268|564897047|FG002|Randomized Treatment Phase|Subject Decision|0|||
156492121|NCT02101268|564897048|FG003|Randomized Treatment Phase|Subject Decision|0|||
156492122|NCT02101268|564897045|FG000|Randomized Treatment Phase|Physician Decision|4|||
156492123|NCT02101268|564897046|FG001|Randomized Treatment Phase|Physician Decision|1|||
156492124|NCT02101268|564897047|FG002|Randomized Treatment Phase|Physician Decision|0|||
156492125|NCT02101268|564897048|FG003|Randomized Treatment Phase|Physician Decision|0|||
156492126|NCT02101268|564897045|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
156492127|NCT02101268|564897046|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
156492128|NCT02101268|564897047|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
156492129|NCT02101268|564897048|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
156492130|NCT02101268|564897045|FG000|Randomized Treatment Phase|Adverse Event|6|||
156492131|NCT02101268|564897046|FG001|Randomized Treatment Phase|Adverse Event|0|||
156492132|NCT02101268|564897047|FG002|Randomized Treatment Phase|Adverse Event|0|||
156492133|NCT02101268|564897048|FG003|Randomized Treatment Phase|Adverse Event|0|||
156492134|NCT02101268|564897045|FG000|Randomized Treatment Phase|Death|5|||
156492135|NCT02101268|564897046|FG001|Randomized Treatment Phase|Death|4|||
156492136|NCT02101268|564897047|FG002|Randomized Treatment Phase|Death|0|||
156492137|NCT02101268|564897048|FG003|Randomized Treatment Phase|Death|0|||
156492138|NCT02101268|564897045|FG000|Randomized Treatment Phase|Disease Progression|4|||
156370436|NCT03465878|564451882|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
156370437|NCT03465878|564451883|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
156370438|NCT03465878|564451884|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
156370439|NCT04019041|564451885|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
156370440|NCT04019041|564451886|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
156370441|NCT04019041|564451887|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
156370442|NCT04019041|564451888|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156370443|NCT04019041|564451889|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156370444|NCT04019041|564451890|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156370445|NCT04019041|564451885|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156370446|NCT04019041|564451886|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156370447|NCT04019041|564451887|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
156370448|NCT04019041|564451888|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156370449|NCT04019041|564451889|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156370450|NCT04019041|564451890|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156370451|NCT04019041|564451885|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
156370452|NCT04019041|564451886|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
156370453|NCT04019041|564451887|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
156370454|NCT04019041|564451888|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156370455|NCT04019041|564451889|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156370456|NCT04019041|564451890|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156370457|NCT04019041|564451885|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156370458|NCT04019041|564451886|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156370459|NCT04019041|564451887|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
156370460|NCT04019041|564451888|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156370461|NCT04019041|564451889|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156370462|NCT04019041|564451890|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156370463|NCT04019041|564451885|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156370464|NCT04019041|564451886|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156370465|NCT04019041|564451887|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156370466|NCT04019041|564451888|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
156370467|NCT04019041|564451889|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
156370468|NCT04019041|564451890|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
156370469|NCT04019041|564451885|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156370470|NCT04019041|564451886|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156370471|NCT04019041|564451887|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156370472|NCT04019041|564451888|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
156370473|NCT04019041|564451889|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156370474|NCT04019041|564451890|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156370475|NCT04019041|564451885|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156370476|NCT04019041|564451886|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156370477|NCT04019041|564451887|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156370478|NCT04019041|564451888|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156370479|NCT04019041|564451889|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
156370480|NCT04019041|564451890|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156370481|NCT04019041|564451885|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156370482|NCT04019041|564451886|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156370483|NCT04019041|564451887|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156370484|NCT04019041|564451888|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
156370485|NCT04019041|564451889|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
156370486|NCT04019041|564451890|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
156370487|NCT04019041|564451885|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156370488|NCT04019041|564451886|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156370489|NCT04019041|564451887|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156370490|NCT04019041|564451888|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156370491|NCT04019041|564451889|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
156370492|NCT04019041|564451890|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
156370493|NCT02540954|564451891|FG000|Overall Study|Physician Decision|3|||
156370494|NCT02540954|564451892|FG001|Overall Study|Physician Decision|1|||
156370495|NCT02540954|564451891|FG000|Overall Study|Withdrawal by Subject|6|||
156370496|NCT02540954|564451892|FG001|Overall Study|Withdrawal by Subject|5|||
156370497|NCT02540954|564451891|FG000|Overall Study|Lost to Follow-up|1|||
156370498|NCT02540954|564451892|FG001|Overall Study|Lost to Follow-up|1|||
156370499|NCT02540954|564451891|FG000|Overall Study|Adverse Event|4|||
156370500|NCT02540954|564451892|FG001|Overall Study|Adverse Event|2|||
156370501|NCT02540954|564451891|FG000|Overall Study|Death|0|||
156370502|NCT02540954|564451892|FG001|Overall Study|Death|3|||
156370503|NCT02540954|564451891|FG000|Overall Study|Treatment failure|1|||
156370504|NCT02540954|564451892|FG001|Overall Study|Treatment failure|0|||
156370505|NCT02540954|564451891|FG000|Overall Study|Other reason|4|||
156370506|NCT02540954|564451892|FG001|Overall Study|Other reason|2|||
156370507|NCT01393743|564451893|FG000|Core Study|Adverse Event|5|||
156370508|NCT01393743|564451894|FG001|Core Study|Adverse Event|9|||
156370509|NCT01393743|564451895|FG002|Core Study|Adverse Event|0|||
156492139|NCT02101268|564897046|FG001|Randomized Treatment Phase|Disease Progression|1|||
156492140|NCT02101268|564897047|FG002|Randomized Treatment Phase|Disease Progression|0|||
156492141|NCT02101268|564897048|FG003|Randomized Treatment Phase|Disease Progression|0|||
156492142|NCT02101268|564897045|FG000|Extended Treatment Phase|Subject Decision|0|||
156492143|NCT02101268|564897046|FG001|Extended Treatment Phase|Subject Decision|0|||
156492144|NCT02101268|564897047|FG002|Extended Treatment Phase|Subject Decision|3|||
156492145|NCT02101268|564897048|FG003|Extended Treatment Phase|Subject Decision|2|||
156492146|NCT02101268|564897045|FG000|Extended Treatment Phase|Physician Decision|0|||
156492147|NCT02101268|564897046|FG001|Extended Treatment Phase|Physician Decision|0|||
156492148|NCT02101268|564897047|FG002|Extended Treatment Phase|Physician Decision|5|||
156492149|NCT02101268|564897048|FG003|Extended Treatment Phase|Physician Decision|2|||
156492150|NCT02101268|564897045|FG000|Extended Treatment Phase|Adverse Event|0|||
156492151|NCT02101268|564897046|FG001|Extended Treatment Phase|Adverse Event|0|||
156492152|NCT02101268|564897047|FG002|Extended Treatment Phase|Adverse Event|14|||
156492153|NCT02101268|564897048|FG003|Extended Treatment Phase|Adverse Event|18|||
156492154|NCT02101268|564897045|FG000|Extended Treatment Phase|Death|0|||
156492155|NCT02101268|564897046|FG001|Extended Treatment Phase|Death|0|||
156492156|NCT02101268|564897047|FG002|Extended Treatment Phase|Death|5|||
156492157|NCT02101268|564897048|FG003|Extended Treatment Phase|Death|1|||
156492158|NCT02101268|564897045|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
156370510|NCT01393743|564451893|FG000|Core Study|Lost to Follow-up|1|||
156370511|NCT01393743|564451894|FG001|Core Study|Lost to Follow-up|1|||
156370512|NCT01393743|564451895|FG002|Core Study|Lost to Follow-up|0|||
156370513|NCT01393743|564451893|FG000|Core Study|Participant's Choice|2|||
156370514|NCT01393743|564451894|FG001|Core Study|Participant's Choice|3|||
156370515|NCT01393743|564451895|FG002|Core Study|Participant's Choice|0|||
156370516|NCT01393743|564451893|FG000|Core Study|Inadequate therapeutic effect|2|||
156370517|NCT01393743|564451894|FG001|Core Study|Inadequate therapeutic effect|0|||
156370518|NCT01393743|564451895|FG002|Core Study|Inadequate therapeutic effect|0|||
156370519|NCT01393743|564451893|FG000|Extension Phase|Adverse Event|0|||
156370520|NCT01393743|564451894|FG001|Extension Phase|Adverse Event|0|||
156370521|NCT01393743|564451895|FG002|Extension Phase|Adverse Event|12|||
156370522|NCT01393743|564451893|FG000|Extension Phase|Lost to Follow-up|0|||
156370523|NCT01393743|564451894|FG001|Extension Phase|Lost to Follow-up|0|||
156370524|NCT01393743|564451895|FG002|Extension Phase|Lost to Follow-up|2|||
156370525|NCT01393743|564451893|FG000|Extension Phase|Participant choice|0|||
156370526|NCT01393743|564451894|FG001|Extension Phase|Participant choice|0|||
156370527|NCT01393743|564451895|FG002|Extension Phase|Participant choice|16|||
156370528|NCT01393743|564451893|FG000|Extension Phase|Inadequate therapeutic effect|0|||
156370529|NCT01393743|564451894|FG001|Extension Phase|Inadequate therapeutic effect|0|||
156370530|NCT01393743|564451895|FG002|Extension Phase|Inadequate therapeutic effect|7|||
156370531|NCT01393743|564451893|FG000|Extension Phase|Withdrawal by Subject|0|||
156370532|NCT01393743|564451894|FG001|Extension Phase|Withdrawal by Subject|0|||
156370533|NCT01393743|564451895|FG002|Extension Phase|Withdrawal by Subject|8|||
156370534|NCT01393743|564451893|FG000|Extension Phase|Pregnancy|0|||
156370535|NCT01393743|564451894|FG001|Extension Phase|Pregnancy|0|||
156370536|NCT01393743|564451895|FG002|Extension Phase|Pregnancy|1|||
156370537|NCT01393743|564451893|FG000|Extension Phase|Other|0|||
156370538|NCT01393743|564451894|FG001|Extension Phase|Other|0|||
156370539|NCT01393743|564451895|FG002|Extension Phase|Other|14|||
156370540|NCT00213148|564451896|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
156370541|NCT00213148|564451897|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
156370542|NCT00213148|564451898|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
156370543|NCT00213148|564451899|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
156370544|NCT00213148|564451900|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
156370545|NCT00213148|564451896|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
156370546|NCT00213148|564451897|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
156370547|NCT00213148|564451898|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
156492159|NCT02101268|564897046|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
156492160|NCT02101268|564897047|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
156492161|NCT02101268|564897048|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
156492162|NCT02101268|564897045|FG000|Extended Treatment Phase|Disease Progression|0|||
156492163|NCT02101268|564897046|FG001|Extended Treatment Phase|Disease Progression|0|||
156492164|NCT02101268|564897047|FG002|Extended Treatment Phase|Disease Progression|13|||
156492165|NCT02101268|564897048|FG003|Extended Treatment Phase|Disease Progression|6|||
156370548|NCT00213148|564451899|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
156370549|NCT00213148|564451900|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
156370550|NCT00213148|564451896|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
156370551|NCT00213148|564451897|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
156492166|NCT02101268|564897045|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
156492167|NCT02101268|564897046|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
156492168|NCT02101268|564897047|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
156370552|NCT00213148|564451898|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
156370553|NCT00213148|564451899|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
156370554|NCT00213148|564451900|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
156370555|NCT00213148|564451896|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
156370556|NCT00213148|564451897|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
156370557|NCT00213148|564451898|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
156370558|NCT00213148|564451899|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
156370559|NCT00213148|564451900|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
156370560|NCT00213148|564451896|FG000|Cycle 1 (1 Month)|Other|3|||
156370561|NCT00213148|564451897|FG001|Cycle 1 (1 Month)|Other|0|||
156370562|NCT00213148|564451898|FG002|Cycle 1 (1 Month)|Other|2|||
156370563|NCT00213148|564451899|FG003|Cycle 1 (1 Month)|Other|2|||
156370564|NCT00213148|564451900|FG004|Cycle 1 (1 Month)|Other|7|||
156370565|NCT00213148|564451896|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156370566|NCT00213148|564451897|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156370567|NCT00213148|564451898|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156370568|NCT00213148|564451899|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
156370569|NCT00213148|564451900|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156370570|NCT00213148|564451896|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
156370571|NCT00213148|564451897|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
156370572|NCT00213148|564451898|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
156370573|NCT00213148|564451899|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
156370574|NCT00213148|564451900|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
156370575|NCT00213148|564451896|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
156370576|NCT00213148|564451897|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
156370577|NCT00213148|564451898|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
156370578|NCT00213148|564451899|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
156370579|NCT00213148|564451900|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
156370580|NCT00213148|564451896|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
156370581|NCT00213148|564451897|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
156370582|NCT00213148|564451898|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
156370583|NCT00213148|564451899|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
156370584|NCT00213148|564451900|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
156370585|NCT00213148|564451896|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
156370586|NCT00213148|564451897|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
156370587|NCT00213148|564451898|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
156370588|NCT00213148|564451899|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
156370589|NCT00213148|564451900|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
156370590|NCT00213148|564451896|FG000|Cycle 2 (1 Month)|Other|2|||
156370591|NCT00213148|564451897|FG001|Cycle 2 (1 Month)|Other|1|||
156370592|NCT00213148|564451898|FG002|Cycle 2 (1 Month)|Other|2|||
156370593|NCT00213148|564451899|FG003|Cycle 2 (1 Month)|Other|8|||
156370594|NCT00213148|564451900|FG004|Cycle 2 (1 Month)|Other|7|||
156370595|NCT00213148|564451896|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156370596|NCT00213148|564451897|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
156370597|NCT00213148|564451898|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156370598|NCT00213148|564451899|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156370599|NCT00213148|564451900|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156370600|NCT00213148|564451896|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
156370601|NCT00213148|564451897|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
156370602|NCT00213148|564451898|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
156370603|NCT00213148|564451899|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
156370604|NCT00213148|564451900|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
156370605|NCT00213148|564451896|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
156370606|NCT00213148|564451897|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
156370607|NCT00213148|564451898|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
156370608|NCT00213148|564451899|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
156370609|NCT00213148|564451900|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
156370610|NCT00213148|564451896|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
156370611|NCT00213148|564451897|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
156370612|NCT00213148|564451898|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
156370613|NCT00213148|564451899|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
156370614|NCT00213148|564451900|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
156370615|NCT00213148|564451896|FG000|Cycle 3 (1 Month)|Other|0|||
156370616|NCT00213148|564451897|FG001|Cycle 3 (1 Month)|Other|0|||
156370617|NCT00213148|564451898|FG002|Cycle 3 (1 Month)|Other|1|||
156370618|NCT00213148|564451899|FG003|Cycle 3 (1 Month)|Other|1|||
156370619|NCT00213148|564451900|FG004|Cycle 3 (1 Month)|Other|0|||
156370620|NCT01723228|564451906|FG000|Overall Study|Adverse Event|2|||
156370621|NCT01723228|564451907|FG001|Overall Study|Adverse Event|6|||
156370622|NCT01723228|564451906|FG000|Overall Study|Withdrawal by Subject|2|||
156370623|NCT01723228|564451907|FG001|Overall Study|Withdrawal by Subject|1|||
156492169|NCT02101268|564897048|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
156492170|NCT00576823|564897052|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
156492171|NCT00576823|564897053|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
156492172|NCT00576823|564897054|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
156492173|NCT00576823|564897052|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
156492174|NCT00576823|564897053|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
156492175|NCT00576823|564897054|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
156370624|NCT01723228|564451906|FG000|Overall Study|Protocol Violation|0|||
156370625|NCT01723228|564451907|FG001|Overall Study|Protocol Violation|2|||
156370626|NCT01723228|564451906|FG000|Overall Study|Lost to Follow-up|2|||
156370627|NCT01723228|564451907|FG001|Overall Study|Lost to Follow-up|1|||
156370628|NCT01723228|564451906|FG000|Overall Study|Other|2|||
156370629|NCT01723228|564451907|FG001|Overall Study|Other|1|||
156492176|NCT01242371|564897055|FG000|Overall Study|Withdrawal by Subject|2|||
156492177|NCT01242371|564897056|FG001|Overall Study|Withdrawal by Subject|2|||
156492178|NCT01242371|564897055|FG000|Overall Study|Protocol Violation|0|||
156492179|NCT01242371|564897056|FG001|Overall Study|Protocol Violation|3|||
156492180|NCT00510146|564897059|FG000|Double-Blind Treatment|Adverse Event|30|||
156492181|NCT00510146|564897060|FG001|Double-Blind Treatment|Adverse Event|13|||
156492182|NCT00510146|564897059|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
156492183|NCT00510146|564897060|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
156492184|NCT00510146|564897059|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
156492185|NCT00510146|564897060|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
156492186|NCT00510146|564897059|FG000|Double-Blind Treatment|Physician Decision|6|||
156492187|NCT00510146|564897060|FG001|Double-Blind Treatment|Physician Decision|0|||
156492188|NCT00510146|564897059|FG000|Double-Blind Treatment|Protocol Violation|1|||
156492189|NCT00510146|564897060|FG001|Double-Blind Treatment|Protocol Violation|2|||
156492190|NCT00510146|564897059|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
156492191|NCT00510146|564897060|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
156492192|NCT00510146|564897059|FG000|Double-Blind Treatment|Clinical Relapse|0|||
156492193|NCT00510146|564897060|FG001|Double-Blind Treatment|Clinical Relapse|1|||
156492194|NCT00510146|564897059|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
156492195|NCT00510146|564897060|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
156492196|NCT00510146|564897059|FG000|Open-Label Treatment|Adverse Event|22|||
156492197|NCT00510146|564897060|FG001|Open-Label Treatment|Adverse Event|8|||
156492198|NCT00510146|564897059|FG000|Open-Label Treatment|Death|1|||
156492199|NCT00510146|564897060|FG001|Open-Label Treatment|Death|1|||
156492200|NCT00510146|564897059|FG000|Open-Label Treatment|Lack of Efficacy|4|||
156492201|NCT00510146|564897060|FG001|Open-Label Treatment|Lack of Efficacy|0|||
156492202|NCT00510146|564897059|FG000|Open-Label Treatment|Lost to Follow-up|10|||
156492203|NCT00510146|564897060|FG001|Open-Label Treatment|Lost to Follow-up|1|||
156492204|NCT00510146|564897059|FG000|Open-Label Treatment|Physician Decision|3|||
156492205|NCT00510146|564897060|FG001|Open-Label Treatment|Physician Decision|1|||
156492206|NCT00510146|564897059|FG000|Open-Label Treatment|Protocol Violation|4|||
156546240|NCT01500278|565093319|FG001|Week 13 - Week 104|Protocol Violation|6|||
156546241|NCT01500278|565093318|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
156546242|NCT01500278|565093319|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
156370630|NCT01282216|564451908|FG000|Overall Study|Graft failure|0|||
156370631|NCT01282216|564451909|FG001|Overall Study|Graft failure|0|||
156370632|NCT01282216|564451910|FG002|Overall Study|Graft failure|3|||
156370633|NCT01282216|564451911|FG003|Overall Study|Graft failure|2|||
156370634|NCT01282216|564451908|FG000|Overall Study|Physician Decision|0|||
156370635|NCT01282216|564451909|FG001|Overall Study|Physician Decision|0|||
156370636|NCT01282216|564451910|FG002|Overall Study|Physician Decision|11|||
156370637|NCT01282216|564451911|FG003|Overall Study|Physician Decision|0|||
156370638|NCT01282216|564451908|FG000|Overall Study|Relapse|0|||
156370639|NCT01282216|564451909|FG001|Overall Study|Relapse|0|||
156370640|NCT01282216|564451910|FG002|Overall Study|Relapse|17|||
156370641|NCT01282216|564451911|FG003|Overall Study|Relapse|6|||
156370642|NCT01282216|564451908|FG000|Overall Study|Death|0|||
156370643|NCT01282216|564451909|FG001|Overall Study|Death|0|||
156370644|NCT01282216|564451910|FG002|Overall Study|Death|2|||
156370645|NCT01282216|564451911|FG003|Overall Study|Death|0|||
156370646|NCT01806896|564451912|FG000|Overall Study|Adverse Event|2|||
156370647|NCT01806896|564451913|FG001|Overall Study|Adverse Event|0|||
156370648|NCT01806896|564451912|FG000|Overall Study|Other|1|||
156370649|NCT01806896|564451913|FG001|Overall Study|Other|0|||
156370650|NCT01864291|564451914|FG000|Overall Study|need for revision surgery|2|||
156370651|NCT02448875|564451915|FG000|Overall Study|Adverse Event|2|||
156492207|NCT00510146|564897060|FG001|Open-Label Treatment|Protocol Violation|2|||
156492208|NCT00510146|564897059|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
156492209|NCT00510146|564897060|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
156492210|NCT00510146|564897059|FG000|Open-Label Treatment|Clinical Relapse|1|||
156492211|NCT00510146|564897060|FG001|Open-Label Treatment|Clinical Relapse|1|||
156492212|NCT00510146|564897059|FG000|Open-Label Treatment|Sponsor Decision|2|||
156492213|NCT00510146|564897060|FG001|Open-Label Treatment|Sponsor Decision|0|||
156492214|NCT02132117|564897061|FG000|Overall Study|Adverse Event|6|||
156546243|NCT01500278|565093318|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
156492215|NCT02132117|564897062|FG001|Overall Study|Adverse Event|1|||
156370652|NCT02448875|564451916|FG001|Overall Study|Adverse Event|1|||
156370653|NCT02448875|564451917|FG002|Overall Study|Adverse Event|0|||
156370654|NCT02448875|564451915|FG000|Overall Study|Lost to Follow-up|1|||
156370655|NCT02448875|564451916|FG001|Overall Study|Lost to Follow-up|0|||
156370656|NCT02448875|564451917|FG002|Overall Study|Lost to Follow-up|0|||
156370657|NCT02448875|564451915|FG000|Overall Study|Investigator Decision|3|||
156370658|NCT02448875|564451916|FG001|Overall Study|Investigator Decision|0|||
156370659|NCT02448875|564451917|FG002|Overall Study|Investigator Decision|1|||
156370660|NCT02448875|564451915|FG000|Overall Study|Withdrawal by Subject|1|||
156370661|NCT02448875|564451916|FG001|Overall Study|Withdrawal by Subject|0|||
156370662|NCT02448875|564451917|FG002|Overall Study|Withdrawal by Subject|0|||
156370663|NCT02434770|564451919|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
156370664|NCT02434770|564451920|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
156370665|NCT02434770|564451921|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
156370666|NCT02434770|564451919|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
156370667|NCT02434770|564451920|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
156370668|NCT02434770|564451921|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
156370669|NCT02434770|564451919|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
156370670|NCT02434770|564451920|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
156370671|NCT02434770|564451921|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
156370672|NCT02434770|564451919|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
156370673|NCT02434770|564451920|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
156370674|NCT02434770|564451921|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
156370675|NCT02434770|564451919|FG000|Week 1 to Week 18|Death|1|||
156370676|NCT02434770|564451920|FG001|Week 1 to Week 18|Death|0|||
156370677|NCT02434770|564451921|FG002|Week 1 to Week 18|Death|0|||
156370678|NCT02434770|564451919|FG000|Week 18 to Week|Lost to Follow-up|2|||
156370679|NCT02434770|564451920|FG001|Week 18 to Week|Lost to Follow-up|2|||
156370680|NCT02434770|564451921|FG002|Week 18 to Week|Lost to Follow-up|1|||
156370681|NCT02434770|564451919|FG000|Week 18 to Week|Withdrawal by Subject|0|||
156370682|NCT02434770|564451920|FG001|Week 18 to Week|Withdrawal by Subject|0|||
156370683|NCT02434770|564451921|FG002|Week 18 to Week|Withdrawal by Subject|2|||
156370684|NCT02434770|564451919|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
156370685|NCT02434770|564451920|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
156370686|NCT02434770|564451921|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
156370687|NCT00660348|564451922|FG000|Overall Study|Withdrawal by Subject|1|||
156370688|NCT00660348|564451923|FG001|Overall Study|Withdrawal by Subject|0|||
156370689|NCT01282424|564451929|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
156370690|NCT01282424|564451929|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
156370691|NCT01282424|564451929|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
156370692|NCT01282424|564451929|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
156370693|NCT01282424|564451929|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
156370694|NCT01282424|564451929|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
156370695|NCT01282424|564451929|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
156370696|NCT01282424|564451929|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
156370697|NCT02741115|564451930|FG000|Overall Study|Adverse Event|1|||
156370698|NCT02741115|564451931|FG001|Overall Study|Adverse Event|0|||
156370699|NCT02741115|564451930|FG000|Overall Study|Lost to Follow-up|7|||
156370700|NCT02741115|564451931|FG001|Overall Study|Lost to Follow-up|4|||
156370701|NCT02741115|564451930|FG000|Overall Study|Withdrawal by Subject|4|||
156370702|NCT02741115|564451931|FG001|Overall Study|Withdrawal by Subject|2|||
156370703|NCT04602624|564451932|FG000|Overall Study|Protocol Deviation|1|||
156370704|NCT04602624|564451932|FG000|Overall Study|Withdrawal by Participant|1|||
156370705|NCT00445328|564451933|FG000|Overall Study|Death|0|||
156370706|NCT00445328|564451934|FG001|Overall Study|Death|1|||
156370707|NCT00445328|564451933|FG000|Overall Study|Adverse Event|0|||
156370708|NCT00445328|564451934|FG001|Overall Study|Adverse Event|3|||
156370709|NCT00445328|564451933|FG000|Overall Study|Other|0|||
156370710|NCT00445328|564451934|FG001|Overall Study|Other|2|||
156370711|NCT00445328|564451933|FG000|Overall Study|Withdrawal by Subject|2|||
156370712|NCT00445328|564451934|FG001|Overall Study|Withdrawal by Subject|0|||
156370713|NCT00445328|564451933|FG000|Overall Study|Protocol Violation|1|||
156492216|NCT02132117|564897061|FG000|Overall Study|Lost to Follow-up|2|||
156492217|NCT02132117|564897062|FG001|Overall Study|Lost to Follow-up|2|||
156492218|NCT02132117|564897061|FG000|Overall Study|Personal Reasons|1|||
156492219|NCT02132117|564897062|FG001|Overall Study|Personal Reasons|2|||
156492220|NCT02132117|564897061|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156370714|NCT00445328|564451934|FG001|Overall Study|Protocol Violation|0|||
156370715|NCT00316199|564451935|FG000|Overall Study|Adverse Event|2|||
156370716|NCT00316199|564451935|FG000|Overall Study|Death|8|||
156370717|NCT00316199|564451935|FG000|Overall Study|Lost to Follow-up|2|||
156370718|NCT00590954|564451936|FG000|Overall Study|Inevaluable|2|||
156492221|NCT02132117|564897062|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156370719|NCT03316872|564451937|FG000|Overall Study|Death|1|||
156370720|NCT04346615|564453289|FG000|Overall Study|Lost to Follow-up|0|||
156370721|NCT04346615|564453290|FG001|Overall Study|Lost to Follow-up|2|||
156492222|NCT03589300|564897064|FG000|Overall Study|Adverse Event|2|||
156370722|NCT04346615|564453289|FG000|Overall Study|Withdrawal by Subject|1|||
156370723|NCT04346615|564453290|FG001|Overall Study|Withdrawal by Subject|0|||
156370724|NCT04346615|564453289|FG000|Overall Study|Death|5|||
156370725|NCT04346615|564453290|FG001|Overall Study|Death|1|||
156370726|NCT04346615|564453289|FG000|Overall Study|Other|0|||
156492223|NCT03589300|564897064|FG000|Overall Study|Death|4|||
156370727|NCT04346615|564453290|FG001|Overall Study|Other|2|||
156370728|NCT04346615|564453289|FG000|Overall Study|Randomized not treated|1|||
156370729|NCT04346615|564453290|FG001|Overall Study|Randomized not treated|0|||
156370730|NCT00533949|564453293|FG000|Overall Study|Protocol Violation|12|||
156370731|NCT00533949|564453294|FG001|Overall Study|Protocol Violation|12|||
156370732|NCT00533949|564453295|FG002|Overall Study|Protocol Violation|9|||
156370733|NCT00533949|564453296|FG003|Overall Study|Protocol Violation|9|||
156370734|NCT00533949|564453293|FG000|Overall Study|Withdrawal by Subject|3|||
156370735|NCT00533949|564453294|FG001|Overall Study|Withdrawal by Subject|2|||
156370736|NCT00533949|564453295|FG002|Overall Study|Withdrawal by Subject|1|||
156370737|NCT00533949|564453296|FG003|Overall Study|Withdrawal by Subject|1|||
156370738|NCT00727194|564453297|FG000|Screening Period|Low QMG scores|0|||
156370739|NCT00727194|564453298|FG001|Screening Period|Low QMG scores|0|||
156370740|NCT00727194|564453299|FG002|Screening Period|Low QMG scores|6|||
156370741|NCT00727194|564453297|FG000|Screening Period|Lacked AChR antibodies|0|||
156370742|NCT00727194|564453298|FG001|Screening Period|Lacked AChR antibodies|0|||
156370743|NCT00727194|564453299|FG002|Screening Period|Lacked AChR antibodies|5|||
156370744|NCT00727194|564453297|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
156370745|NCT00727194|564453298|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
156370746|NCT00727194|564453299|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
156370747|NCT00727194|564453297|FG000|Screening Period|Severe infections|0|||
156370748|NCT00727194|564453298|FG001|Screening Period|Severe infections|0|||
156370749|NCT00727194|564453299|FG002|Screening Period|Severe infections|2|||
156370750|NCT00727194|564453297|FG000|Screening Period|History of thymoma|0|||
156370751|NCT00727194|564453298|FG001|Screening Period|History of thymoma|0|||
156370752|NCT00727194|564453299|FG002|Screening Period|History of thymoma|1|||
156370753|NCT00727194|564453297|FG000|Treatment Period 2|Lack of Efficacy|0|||
156370754|NCT00727194|564453298|FG001|Treatment Period 2|Lack of Efficacy|1|||
156370755|NCT00727194|564453299|FG002|Treatment Period 2|Lack of Efficacy|0|||
156370756|NCT01677195|564453302|FG000|Overall Study|Lost to Follow-up|14|||
156370757|NCT01677195|564453303|FG001|Overall Study|Lost to Follow-up|22|||
156370758|NCT01677195|564453304|FG002|Overall Study|Lost to Follow-up|22|||
156370759|NCT01677195|564453302|FG000|Overall Study|Withdrawal by Subject|1|||
156370760|NCT01677195|564453303|FG001|Overall Study|Withdrawal by Subject|0|||
156370761|NCT01677195|564453304|FG002|Overall Study|Withdrawal by Subject|1|||
156370762|NCT01677195|564453302|FG000|Overall Study|Adverse Event|6|||
156370763|NCT01677195|564453303|FG001|Overall Study|Adverse Event|4|||
156370764|NCT01677195|564453304|FG002|Overall Study|Adverse Event|1|||
156370765|NCT01677195|564453302|FG000|Overall Study|Physician Decision|1|||
156370766|NCT01677195|564453303|FG001|Overall Study|Physician Decision|2|||
156370767|NCT01677195|564453304|FG002|Overall Study|Physician Decision|2|||
156370768|NCT01677195|564453302|FG000|Overall Study|Pregnancy|0|||
156370769|NCT01677195|564453303|FG001|Overall Study|Pregnancy|1|||
156370770|NCT01677195|564453304|FG002|Overall Study|Pregnancy|0|||
156370771|NCT01677195|564453302|FG000|Overall Study|Protocol Violation|7|||
156370772|NCT01677195|564453303|FG001|Overall Study|Protocol Violation|3|||
156370773|NCT01677195|564453304|FG002|Overall Study|Protocol Violation|4|||
156370774|NCT03633396|564453307|FG000|Overall Study|Withdrawal by Subject|4|||
156370775|NCT03633396|564453308|FG001|Overall Study|Withdrawal by Subject|4|||
156370776|NCT03633396|564453307|FG000|Overall Study|Adverse Event|1|||
156370777|NCT03633396|564453308|FG001|Overall Study|Adverse Event|1|||
156370778|NCT03633396|564453307|FG000|Overall Study|Lack of Efficacy|1|||
156370779|NCT03633396|564453308|FG001|Overall Study|Lack of Efficacy|0|||
156370780|NCT03633396|564453307|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
156370781|NCT03633396|564453308|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
156370782|NCT01012817|564453309|FG000|Overall Study|Withdrawal by Subject|0|||
156370783|NCT01012817|564453310|FG001|Overall Study|Withdrawal by Subject|0|||
156370784|NCT01012817|564453311|FG002|Overall Study|Withdrawal by Subject|0|||
156370785|NCT01012817|564453312|FG003|Overall Study|Withdrawal by Subject|1|||
156370786|NCT01012817|564453313|FG004|Overall Study|Withdrawal by Subject|0|||
156370787|NCT01012817|564453314|FG005|Overall Study|Withdrawal by Subject|0|||
156492224|NCT03589300|564897064|FG000|Overall Study|Lost to Follow-up|12|||
156370788|NCT01012817|564453315|FG006|Overall Study|Withdrawal by Subject|0|||
156370789|NCT01012817|564453316|FG007|Overall Study|Withdrawal by Subject|1|||
156370790|NCT01012817|564453317|FG008|Overall Study|Withdrawal by Subject|0|||
156370791|NCT01012817|564453318|FG009|Overall Study|Withdrawal by Subject|0|||
156370792|NCT01012817|564453319|FG010|Overall Study|Withdrawal by Subject|1|||
156370793|NCT01012817|564453320|FG011|Overall Study|Withdrawal by Subject|1|||
156370794|NCT01012817|564453321|FG012|Overall Study|Withdrawal by Subject|0|||
156370795|NCT01012817|564453322|FG013|Overall Study|Withdrawal by Subject|1|||
156370796|NCT01012817|564453309|FG000|Overall Study|Adverse Event|0|||
156370797|NCT01012817|564453310|FG001|Overall Study|Adverse Event|0|||
156370798|NCT01012817|564453311|FG002|Overall Study|Adverse Event|0|||
156370799|NCT01012817|564453312|FG003|Overall Study|Adverse Event|0|||
156370800|NCT01012817|564453313|FG004|Overall Study|Adverse Event|0|||
156370801|NCT01012817|564453314|FG005|Overall Study|Adverse Event|1|||
156370802|NCT01012817|564453315|FG006|Overall Study|Adverse Event|0|||
156370803|NCT01012817|564453316|FG007|Overall Study|Adverse Event|0|||
156370804|NCT01012817|564453317|FG008|Overall Study|Adverse Event|0|||
156370805|NCT01012817|564453318|FG009|Overall Study|Adverse Event|0|||
156370806|NCT01012817|564453319|FG010|Overall Study|Adverse Event|1|||
156370807|NCT01012817|564453320|FG011|Overall Study|Adverse Event|0|||
156370808|NCT01012817|564453321|FG012|Overall Study|Adverse Event|0|||
156370809|NCT01012817|564453322|FG013|Overall Study|Adverse Event|1|||
156370810|NCT00110266|564453323|FG000|Overall Study|Adverse Event|27|||
156370811|NCT00110266|564453323|FG000|Overall Study|Abnormal laboratory value|15|||
156370812|NCT00110266|564453323|FG000|Overall Study|Withdrawal by Subject|16|||
156370813|NCT00110266|564453323|FG000|Overall Study|Death|17|||
156370814|NCT00110266|564453323|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156370815|NCT00110266|564453323|FG000|Overall Study|Participant condition no longer requires study drug|1|||
156370816|NCT01344057|564453330|FG000|Overall Study|Premature Withdrawal|1|||
156370817|NCT00548808|564453336|FG000|Overall Study|Lost to Follow-up|9|||
156370818|NCT00548808|564453337|FG001|Overall Study|Lost to Follow-up|3|||
156370819|NCT00548808|564453336|FG000|Overall Study|Protocol Violation|8|||
156370820|NCT00548808|564453337|FG001|Overall Study|Protocol Violation|8|||
156370821|NCT00548808|564453336|FG000|Overall Study|Withdrawal by Subject|8|||
156370822|NCT00548808|564453337|FG001|Overall Study|Withdrawal by Subject|4|||
156370823|NCT00548808|564453336|FG000|Overall Study|Physician Decision|6|||
156370824|NCT00548808|564453337|FG001|Overall Study|Physician Decision|3|||
156370825|NCT00548808|564453336|FG000|Overall Study|Adverse Event|4|||
156370826|NCT00548808|564453337|FG001|Overall Study|Adverse Event|5|||
156370827|NCT00548808|564453336|FG000|Overall Study|Death|2|||
156370828|NCT00548808|564453337|FG001|Overall Study|Death|0|||
156370829|NCT00548808|564453336|FG000|Overall Study|Entry Criteria Not Met|2|||
156370830|NCT00548808|564453337|FG001|Overall Study|Entry Criteria Not Met|2|||
156370831|NCT00548808|564453336|FG000|Overall Study|Lack of Efficacy|2|||
156370832|NCT00548808|564453337|FG001|Overall Study|Lack of Efficacy|0|||
156370833|NCT00548808|564453336|FG000|Overall Study|Sponsor Decision|1|||
156370834|NCT00548808|564453337|FG001|Overall Study|Sponsor Decision|1|||
156370835|NCT04300296|564453340|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
156370836|NCT04300296|564453341|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156370837|NCT04300296|564453342|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156370838|NCT04300296|564453343|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156370839|NCT04300296|564453344|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156370840|NCT04300296|564453345|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156370841|NCT04300296|564453340|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156370842|NCT04300296|564453341|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156370843|NCT04300296|564453342|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156370844|NCT04300296|564453343|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156370845|NCT04300296|564453344|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
156370846|NCT04300296|564453345|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156370847|NCT04300296|564453340|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
156370848|NCT04300296|564453341|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
156370849|NCT04300296|564453342|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
156370850|NCT04300296|564453343|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
156370851|NCT04300296|564453344|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
156370852|NCT04300296|564453345|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
156370853|NCT04300296|564453340|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
156370854|NCT04300296|564453341|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
156370855|NCT04300296|564453342|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
156370856|NCT04300296|564453343|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
156370857|NCT04300296|564453344|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
156370858|NCT04300296|564453345|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
156370859|NCT04300296|564453340|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
156370860|NCT04300296|564453341|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
156370861|NCT04300296|564453342|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
156492225|NCT03589300|564897064|FG000|Overall Study|Withdrawal by Subject|5|||
156370862|NCT04300296|564453343|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
156370863|NCT04300296|564453344|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
156370864|NCT04300296|564453345|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
156370865|NCT04300296|564453340|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156370866|NCT04300296|564453341|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
156370867|NCT04300296|564453342|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156370868|NCT04300296|564453343|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156370869|NCT04300296|564453344|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156492226|NCT04947436|564897065|FG000|Overall Study|Lost to Follow-up|3|||
156370870|NCT04300296|564453345|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156492227|NCT04947436|564897066|FG001|Overall Study|Lost to Follow-up|7|||
156492228|NCT04947436|564897067|FG002|Overall Study|Lost to Follow-up|5|||
156370871|NCT04300296|564453340|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
156370872|NCT04300296|564453341|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
156370873|NCT04300296|564453342|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
156370874|NCT04300296|564453343|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
156370875|NCT04300296|564453344|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
156370876|NCT04300296|564453345|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
156370877|NCT02896127|564453346|FG000|COMPLETED WEEK 52|Adverse Event|9|||
156370878|NCT02896127|564453347|FG001|COMPLETED WEEK 52|Adverse Event|2|||
156370879|NCT02896127|564453346|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
156370880|NCT02896127|564453347|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
156370881|NCT02896127|564453346|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
156370882|NCT02896127|564453347|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
156370883|NCT02896127|564453346|FG000|COMPLETED WEEK 52|Physician Decision|1|||
156370884|NCT02896127|564453347|FG001|COMPLETED WEEK 52|Physician Decision|1|||
156370885|NCT02896127|564453346|FG000|COMPLETED WEEK 52|Pregnancy|2|||
156370886|NCT02896127|564453347|FG001|COMPLETED WEEK 52|Pregnancy|0|||
156370887|NCT02896127|564453346|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
156370888|NCT02896127|564453347|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
156370889|NCT02896127|564453346|FG000|COMPLETED WEEK 52|Technical problems|1|||
156370890|NCT02896127|564453347|FG001|COMPLETED WEEK 52|Technical problems|0|||
156370891|NCT02896127|564453346|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
156370892|NCT02896127|564453347|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
156370893|NCT02896127|564453346|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
156370894|NCT02896127|564453347|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
156370895|NCT02896127|564453346|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
156370896|NCT02896127|564453347|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
156370897|NCT02896127|564453346|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
156370898|NCT02896127|564453347|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
156370899|NCT02896127|564453346|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
156370900|NCT02896127|564453347|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
156370901|NCT02940691|564453348|FG000|Overall Study|Lost to Follow-up|5|||
156370902|NCT02940691|564453348|FG000|Overall Study|Incarceration|1|||
156370903|NCT01049919|564453351|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
156370904|NCT01049919|564453352|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
156370905|NCT01049919|564453351|FG000|Overall Study|Withdrawal by Subject|5|||
156370906|NCT01049919|564453352|FG001|Overall Study|Withdrawal by Subject|0|||
156370907|NCT01049919|564453351|FG000|Overall Study|Lost to Follow-up|6|||
156370908|NCT01049919|564453352|FG001|Overall Study|Lost to Follow-up|1|||
156370909|NCT01049919|564453351|FG000|Overall Study|Physician Decision|2|||
156370910|NCT01049919|564453352|FG001|Overall Study|Physician Decision|0|||
156370911|NCT01049919|564453351|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
156370912|NCT01049919|564453352|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
156370913|NCT01049919|564453351|FG000|Overall Study|Early study termination by sponsor.|2|||
156370914|NCT01049919|564453352|FG001|Overall Study|Early study termination by sponsor.|0|||
156370915|NCT02984995|564453353|FG000|Overall Study|Required stem cell transplant|13|||
156370916|NCT02984995|564453354|FG001|Overall Study|Required stem cell transplant|2|||
156370917|NCT02984995|564453353|FG000|Overall Study|Progressive disease|11|||
156370918|NCT02984995|564453354|FG001|Overall Study|Progressive disease|1|||
156370919|NCT02984995|564453353|FG000|Overall Study|Adverse Event|1|||
156370920|NCT02984995|564453354|FG001|Overall Study|Adverse Event|0|||
156370921|NCT04354831|564453355|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
156370922|NCT04354831|564453356|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
156492229|NCT04947436|564897065|FG000|Overall Study|Death|1|||
156492230|NCT04947436|564897066|FG001|Overall Study|Death|1|||
156492231|NCT04947436|564897067|FG002|Overall Study|Death|1|||
156492232|NCT01544309|564897070|FG000|Overall Study|Withdrawal by Subject|12|||
156492233|NCT01544309|564897071|FG001|Overall Study|Withdrawal by Subject|7|||
156492234|NCT01544309|564897070|FG000|Overall Study|Protocol Violation|2|||
156492235|NCT01544309|564897071|FG001|Overall Study|Protocol Violation|1|||
156370923|NCT01018264|564453357|FG000|Overall Study|Withdrawal by Subject|1|||
156370924|NCT01018264|564453358|FG001|Overall Study|Withdrawal by Subject|0|||
156370925|NCT01018264|564453357|FG000|Overall Study|Lost to Follow-up|0|||
156370926|NCT01018264|564453358|FG001|Overall Study|Lost to Follow-up|1|||
156370927|NCT00812929|564453359|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
156370928|NCT00812929|564453360|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
156370929|NCT00812929|564453361|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
156370930|NCT00812929|564453362|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
156370931|NCT00812929|564453363|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
156492236|NCT01544309|564897070|FG000|Overall Study|Physician Decision|4|||
156492237|NCT01544309|564897071|FG001|Overall Study|Physician Decision|1|||
156492238|NCT01544309|564897070|FG000|Overall Study|Not performed pre-dose examination|1|||
156492239|NCT01544309|564897071|FG001|Overall Study|Not performed pre-dose examination|2|||
156492240|NCT01544309|564897070|FG000|Overall Study|Administered prohibit prior medication|1|||
156492241|NCT01544309|564897071|FG001|Overall Study|Administered prohibit prior medication|0|||
156492242|NCT04582864|564897072|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
156492243|NCT04582864|564897072|FG000|Overall Study|Death|1|||
156492244|NCT03640754|564897073|FG000|Overall Study|Withdrawal by Subject|1|||
156492245|NCT03640754|564897074|FG001|Overall Study|Withdrawal by Subject|0|||
156492246|NCT03640754|564897073|FG000|Overall Study|Lost to Follow-up|0|||
156492247|NCT03640754|564897074|FG001|Overall Study|Lost to Follow-up|1|||
156492248|NCT01679613|564897077|FG000|Overall Study|other than stated above|0|||
156492249|NCT01679613|564897078|FG001|Overall Study|other than stated above|1|||
156492250|NCT01679613|564897079|FG002|Overall Study|other than stated above|2|||
156492251|NCT01679613|564897080|FG003|Overall Study|other than stated above|2|||
156492252|NCT01333111|564899013|FG000|Overall Study|patient undergoing major surgery|0|||
156492253|NCT01333111|564899014|FG001|Overall Study|patient undergoing major surgery|2|||
156492254|NCT01333111|564899015|FG002|Overall Study|patient undergoing major surgery|0|||
156492255|NCT01333111|564899013|FG000|Overall Study|personal reasons|0|||
156492256|NCT01333111|564899014|FG001|Overall Study|personal reasons|0|||
156492257|NCT01333111|564899015|FG002|Overall Study|personal reasons|1|||
156492258|NCT01333111|564899013|FG000|Overall Study|unclassified|1|||
156492259|NCT01333111|564899014|FG001|Overall Study|unclassified|0|||
156492260|NCT01333111|564899015|FG002|Overall Study|unclassified|0|||
156492261|NCT01333111|564899013|FG000|Overall Study|withdrawal criteria|0|||
156492262|NCT01333111|564899014|FG001|Overall Study|withdrawal criteria|1|||
156492263|NCT01333111|564899015|FG002|Overall Study|withdrawal criteria|0|||
156492264|NCT01333111|564899013|FG000|Overall Study|Non-compliance|1|||
156492265|NCT01333111|564899014|FG001|Overall Study|Non-compliance|0|||
156492266|NCT01333111|564899015|FG002|Overall Study|Non-compliance|0|||
156492267|NCT01333111|564899013|FG000|Overall Study|Ineffective therapy|0|||
156492268|NCT01333111|564899014|FG001|Overall Study|Ineffective therapy|0|||
156492269|NCT01333111|564899015|FG002|Overall Study|Ineffective therapy|1|||
156492270|NCT02161406|564899016|FG000|Overall Study|Death|2|||
156492271|NCT02161406|564899017|FG001|Overall Study|Death|1|||
156492272|NCT02161406|564899016|FG000|Overall Study|Lost to Follow-up|2|||
156492273|NCT02161406|564899017|FG001|Overall Study|Lost to Follow-up|1|||
156492274|NCT02161406|564899016|FG000|Overall Study|Withdrawal by Subject|2|||
156492275|NCT02161406|564899017|FG001|Overall Study|Withdrawal by Subject|4|||
156492276|NCT02161406|564899016|FG000|Overall Study|investigator withdrew subject|3|||
156492277|NCT02161406|564899017|FG001|Overall Study|investigator withdrew subject|1|||
156492278|NCT02161406|564899016|FG000|Overall Study|Lack of Efficacy|1|||
156492279|NCT02161406|564899017|FG001|Overall Study|Lack of Efficacy|1|||
156546244|NCT01500278|565093319|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
156546245|NCT01500278|565093318|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
156370932|NCT00812929|564453364|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
156370933|NCT00812929|564453365|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
156370934|NCT00812929|564453366|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
156370935|NCT00812929|564453367|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
156370936|NCT00812929|564453368|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
156370937|NCT00812929|564453359|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
156370938|NCT00812929|564453360|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
156370939|NCT00812929|564453361|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
156370940|NCT00812929|564453362|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
156370941|NCT00812929|564453363|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
156370942|NCT00812929|564453364|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
156370943|NCT00812929|564453365|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
156370944|NCT00812929|564453366|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
156370945|NCT00812929|564453367|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
156370946|NCT00812929|564453368|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
156370947|NCT00812929|564453359|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
156370948|NCT00812929|564453360|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
156370949|NCT00812929|564453361|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
156492280|NCT02161406|564899016|FG000|Overall Study|relocation|0|||
156370950|NCT00812929|564453362|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
156492281|NCT02161406|564899017|FG001|Overall Study|relocation|1|||
156492282|NCT00664105|564899018|FG000|Overall Study|Death|3|||
156492283|NCT00664105|564899018|FG000|Overall Study|Withdrawal by Subject|5|||
156492284|NCT00664105|564899018|FG000|Overall Study|Adverse Event|9|||
156492285|NCT00664105|564899018|FG000|Overall Study|Disease progression|7|||
156492286|NCT01468077|564899022|FG000|Overall Study|Adverse Event|2|||
156492287|NCT01468077|564899023|FG001|Overall Study|Adverse Event|2|||
156492288|NCT01468077|564899022|FG000|Overall Study|Lack of Efficacy|1|||
156492289|NCT01468077|564899023|FG001|Overall Study|Lack of Efficacy|1|||
156492290|NCT01468077|564899022|FG000|Overall Study|Physician Decision|1|||
156492291|NCT01468077|564899023|FG001|Overall Study|Physician Decision|0|||
156492292|NCT04333147|564899024|FG000|Overall Study|Adverse Event|43|||
156492293|NCT04333147|564899025|FG001|Overall Study|Adverse Event|40|||
156370951|NCT00812929|564453363|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
156370952|NCT00812929|564453364|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
156370953|NCT00812929|564453365|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
156370954|NCT00812929|564453366|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
156370955|NCT00812929|564453367|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
156370956|NCT00812929|564453368|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
156370957|NCT02504372|564453370|FG000|Overall Study|Death|136|||
156370958|NCT02504372|564453371|FG001|Overall Study|Death|154|||
156370959|NCT02504372|564453370|FG000|Overall Study|Lost to Follow-up|0|||
156370960|NCT02504372|564453371|FG001|Overall Study|Lost to Follow-up|2|||
156370961|NCT02504372|564453370|FG000|Overall Study|Withdrawal of consent|25|||
156370962|NCT02504372|564453371|FG001|Overall Study|Withdrawal of consent|16|||
156370963|NCT02504372|564453370|FG000|Overall Study|Participants ongoing|429|||
156370964|NCT02504372|564453371|FG001|Overall Study|Participants ongoing|415|||
156370965|NCT03323099|564453372|FG000|Overall Study|Withdrawal by Subject|6|||
156370966|NCT03323099|564453373|FG001|Overall Study|Withdrawal by Subject|12|||
156370967|NCT03323099|564453372|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
156370968|NCT03323099|564453373|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
156370969|NCT00079274|564453376|FG000|Overall Study|Withdrawal by Subject|111|||
156370970|NCT00079274|564453377|FG001|Overall Study|Withdrawal by Subject|10|||
156370971|NCT00079274|564453378|FG002|Overall Study|Withdrawal by Subject|12|||
156370972|NCT00079274|564453379|FG003|Overall Study|Withdrawal by Subject|163|||
156370973|NCT00079274|564453380|FG004|Overall Study|Withdrawal by Subject|7|||
156370974|NCT00079274|564453381|FG005|Overall Study|Withdrawal by Subject|8|||
156370975|NCT00079274|564453382|FG006|Overall Study|Withdrawal by Subject|0|||
156370976|NCT00079274|564453376|FG000|Overall Study|Adverse Event|130|||
156370977|NCT00079274|564453377|FG001|Overall Study|Adverse Event|8|||
156370978|NCT00079274|564453378|FG002|Overall Study|Adverse Event|8|||
156370979|NCT00079274|564453379|FG003|Overall Study|Adverse Event|184|||
156370980|NCT00079274|564453380|FG004|Overall Study|Adverse Event|7|||
156370981|NCT00079274|564453381|FG005|Overall Study|Adverse Event|8|||
156370982|NCT00079274|564453382|FG006|Overall Study|Adverse Event|0|||
156370983|NCT00079274|564453376|FG000|Overall Study|Recurrence|21|||
156370984|NCT00079274|564453377|FG001|Overall Study|Recurrence|0|||
156370985|NCT00079274|564453378|FG002|Overall Study|Recurrence|1|||
156370986|NCT00079274|564453379|FG003|Overall Study|Recurrence|15|||
156370987|NCT00079274|564453380|FG004|Overall Study|Recurrence|0|||
156370988|NCT00079274|564453381|FG005|Overall Study|Recurrence|2|||
156370989|NCT00079274|564453382|FG006|Overall Study|Recurrence|0|||
156370990|NCT00079274|564453376|FG000|Overall Study|Alternate Treatment|6|||
156370991|NCT00079274|564453377|FG001|Overall Study|Alternate Treatment|1|||
156370992|NCT00079274|564453378|FG002|Overall Study|Alternate Treatment|0|||
156370993|NCT00079274|564453379|FG003|Overall Study|Alternate Treatment|3|||
156370994|NCT00079274|564453380|FG004|Overall Study|Alternate Treatment|0|||
156370995|NCT00079274|564453381|FG005|Overall Study|Alternate Treatment|0|||
156370996|NCT00079274|564453382|FG006|Overall Study|Alternate Treatment|0|||
156370997|NCT00079274|564453376|FG000|Overall Study|Other Medical Problems|6|||
156370998|NCT00079274|564453377|FG001|Overall Study|Other Medical Problems|1|||
156370999|NCT00079274|564453378|FG002|Overall Study|Other Medical Problems|0|||
156371000|NCT00079274|564453379|FG003|Overall Study|Other Medical Problems|7|||
156371001|NCT00079274|564453380|FG004|Overall Study|Other Medical Problems|0|||
156371002|NCT00079274|564453381|FG005|Overall Study|Other Medical Problems|0|||
156371003|NCT00079274|564453382|FG006|Overall Study|Other Medical Problems|0|||
156371004|NCT00079274|564453376|FG000|Overall Study|Death|4|||
156371005|NCT00079274|564453377|FG001|Overall Study|Death|0|||
156371006|NCT00079274|564453378|FG002|Overall Study|Death|1|||
156371007|NCT00079274|564453379|FG003|Overall Study|Death|15|||
156371008|NCT00079274|564453380|FG004|Overall Study|Death|0|||
156371009|NCT00079274|564453381|FG005|Overall Study|Death|0|||
156371010|NCT00079274|564453382|FG006|Overall Study|Death|0|||
156371011|NCT00079274|564453376|FG000|Overall Study|Cytogenetic resistance|0|||
156371012|NCT00079274|564453377|FG001|Overall Study|Cytogenetic resistance|0|||
156492294|NCT04333147|564899024|FG000|Overall Study|Lack of Efficacy|49|||
156492295|NCT04333147|564899025|FG001|Overall Study|Lack of Efficacy|48|||
156492296|NCT04333147|564899024|FG000|Overall Study|Lost to Follow-up|19|||
156492297|NCT04333147|564899025|FG001|Overall Study|Lost to Follow-up|16|||
156371013|NCT00079274|564453378|FG002|Overall Study|Cytogenetic resistance|0|||
156371014|NCT00079274|564453379|FG003|Overall Study|Cytogenetic resistance|2|||
156371015|NCT00079274|564453380|FG004|Overall Study|Cytogenetic resistance|0|||
156371016|NCT00079274|564453381|FG005|Overall Study|Cytogenetic resistance|0|||
156371017|NCT00079274|564453382|FG006|Overall Study|Cytogenetic resistance|0|||
156371018|NCT00079274|564453376|FG000|Overall Study|Other|43|||
156371019|NCT00079274|564453377|FG001|Overall Study|Other|7|||
156371020|NCT00079274|564453378|FG002|Overall Study|Other|5|||
156492298|NCT04333147|564899024|FG000|Overall Study|Physician Decision|17|||
156492299|NCT04333147|564899025|FG001|Overall Study|Physician Decision|20|||
156492300|NCT04333147|564899024|FG000|Overall Study|Withdrawal by Subject|65|||
156371021|NCT00079274|564453379|FG003|Overall Study|Other|55|||
156371022|NCT00079274|564453380|FG004|Overall Study|Other|1|||
156492301|NCT04333147|564899025|FG001|Overall Study|Withdrawal by Subject|68|||
156492302|NCT04333147|564899024|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
156492303|NCT04333147|564899025|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
156492304|NCT04333147|564899024|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
156492305|NCT04333147|564899025|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
156492306|NCT04333147|564899024|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
156492307|NCT04333147|564899025|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
156492308|NCT00847132|564899029|FG000|Overall Study|Death|1|||
156492309|NCT00847132|564899030|FG001|Overall Study|Death|1|||
156492310|NCT00784147|564899031|FG000|Overall Study|Lost to Follow-up|2|||
156492311|NCT00784147|564899032|FG001|Overall Study|Lost to Follow-up|4|||
156492312|NCT00784147|564899031|FG000|Overall Study|Withdrawal by Subject|1|||
156492313|NCT00784147|564899032|FG001|Overall Study|Withdrawal by Subject|3|||
156492314|NCT00784147|564899031|FG000|Overall Study|Physician Decision|2|||
156492315|NCT00784147|564899032|FG001|Overall Study|Physician Decision|1|||
156492316|NCT00784147|564899031|FG000|Overall Study|Protocol Violation|1|||
156492317|NCT00784147|564899032|FG001|Overall Study|Protocol Violation|1|||
156492318|NCT00784147|564899031|FG000|Overall Study|Death|2|||
156492319|NCT00784147|564899032|FG001|Overall Study|Death|0|||
156492320|NCT01057251|564899033|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
156492321|NCT01057251|564899034|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
156492322|NCT01057251|564899033|FG000|Overall Study|Adverse Event|4|||
156492323|NCT01057251|564899034|FG001|Overall Study|Adverse Event|2|||
156492324|NCT01057251|564899033|FG000|Overall Study|Lack of Efficacy|2|||
156492325|NCT01057251|564899034|FG001|Overall Study|Lack of Efficacy|11|||
156492326|NCT01057251|564899033|FG000|Overall Study|Protocol Violation|6|||
156492327|NCT01057251|564899034|FG001|Overall Study|Protocol Violation|2|||
156492328|NCT01057251|564899033|FG000|Overall Study|Withdrawal by Subject|4|||
156492329|NCT01057251|564899034|FG001|Overall Study|Withdrawal by Subject|5|||
156492330|NCT01057251|564899033|FG000|Overall Study|Lost to Follow-up|7|||
156492331|NCT01057251|564899034|FG001|Overall Study|Lost to Follow-up|6|||
156371023|NCT00079274|564453381|FG005|Overall Study|Other|2|||
156371024|NCT00079274|564453382|FG006|Overall Study|Other|0|||
156492332|NCT01057251|564899033|FG000|Overall Study|Other Reason|1|||
156492333|NCT01057251|564899034|FG001|Overall Study|Other Reason|1|||
156371025|NCT00767676|564453383|FG000|Overall Study|Investigator error|54|||
156371026|NCT01502644|564453384|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
156371027|NCT01502644|564453385|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
156371028|NCT01502644|564453386|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
156371029|NCT01502644|564453387|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
156371030|NCT01502644|564453384|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
156371031|NCT01502644|564453385|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
156371032|NCT01502644|564453386|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
156371033|NCT01502644|564453387|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
156371034|NCT01502644|564453384|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
156371035|NCT01502644|564453385|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
156371036|NCT01502644|564453386|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
156371037|NCT01502644|564453387|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
156371038|NCT01502644|564453384|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
156371039|NCT01502644|564453385|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
156371040|NCT01502644|564453386|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
156371041|NCT01502644|564453387|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
156371042|NCT01502644|564453384|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
156371043|NCT01502644|564453385|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
156371044|NCT01502644|564453386|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
156371045|NCT01502644|564453387|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
156371046|NCT00547703|564453390|FG000|Overall Study|Lost to Follow-up|1|||
156371047|NCT00547703|564453391|FG001|Overall Study|Lost to Follow-up|0|||
156371048|NCT00376168|564453394|FG000|Overall Study|Adverse Event|1|||
156371049|NCT00376168|564453395|FG001|Overall Study|Adverse Event|1|||
156371050|NCT00376168|564453394|FG000|Overall Study|Pregnancy|1|||
156371051|NCT00376168|564453395|FG001|Overall Study|Pregnancy|0|||
156371052|NCT04115358|564453398|FG000|Overall Study|exfoliation|0|||
156371053|NCT04115358|564453399|FG001|Overall Study|exfoliation|0|||
156371054|NCT04115358|564453400|FG002|Overall Study|exfoliation|1|||
156371055|NCT02722928|564453405|FG000|Overall Study|Standard CT was not as required per prot|5|||
156371056|NCT02722928|564453406|FG001|Overall Study|Standard CT was not as required per prot|13|||
156371057|NCT02722928|564453405|FG000|Overall Study|Required Intraoperative MRI|5|||
156371058|NCT02722928|564453406|FG001|Overall Study|Required Intraoperative MRI|7|||
156371059|NCT03120013|564453407|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156371060|NCT03120013|564453408|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156371061|NCT05059600|564453409|FG000|Overall Study|Enrolled but not Treated|10|||
156371062|NCT02098109|564453410|FG000|Overall Study|Protocol Violation|3|||
156371063|NCT02098109|564453411|FG001|Overall Study|Protocol Violation|0|||
156371064|NCT01565291|564453413|FG000|Overall Study|Withdrawal by Subject|1|||
156371065|NCT01565291|564453414|FG001|Overall Study|Withdrawal by Subject|0|||
156371066|NCT01524770|564453424|FG000|First Intervention|Withdrawal by Subject|1|||
156371067|NCT01524770|564453425|FG001|First Intervention|Withdrawal by Subject|0|||
156371068|NCT01524770|564453424|FG000|First Intervention|Adverse Event|1|||
156371069|NCT01524770|564453425|FG001|First Intervention|Adverse Event|1|||
156371070|NCT01524770|564453424|FG000|First Intervention|Protocol Violation|1|||
156371071|NCT01524770|564453425|FG001|First Intervention|Protocol Violation|0|||
156371072|NCT03080961|564453427|FG000|Overall Study|Withdrawal by Subject|3|||
156371073|NCT03508219|564453430|FG000|Overall Study|Death|2|||
156371074|NCT03508219|564453430|FG000|Overall Study|Withdrawal by Subject|1|||
156371075|NCT03508219|564453430|FG000|Overall Study|Lost to Follow-up|4|||
156371076|NCT03508219|564453430|FG000|Overall Study|Missed visit|2|||
156371077|NCT04466891|564453431|FG000|Overall Study|Death|60|||
156371078|NCT04466891|564453432|FG001|Overall Study|Death|6|||
156371079|NCT04466891|564453431|FG000|Overall Study|Withdrawal by Subject|8|||
156371080|NCT04466891|564453432|FG001|Overall Study|Withdrawal by Subject|1|||
156371081|NCT04466891|564453431|FG000|Overall Study|Study terminated by sponsor|5|||
156371082|NCT04466891|564453432|FG001|Overall Study|Study terminated by sponsor|0|||
156371083|NCT04466891|564453431|FG000|Overall Study|Lost to Follow-up|2|||
156371084|NCT04466891|564453432|FG001|Overall Study|Lost to Follow-up|0|||
156371085|NCT04466891|564453431|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
156371086|NCT04466891|564453432|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
156492334|NCT02973802|564899041|FG000|Overall Study|Lost to Follow-up|1|||
156492335|NCT02973802|564899041|FG000|Overall Study|Withdrawal by Subject|1|||
156492336|NCT03357471|564899042|FG000|Overall Study|Adverse Event|1|||
156371087|NCT02239536|564453435|FG000|Overall Study|Non-neoplastic polyp|23|||
156371088|NCT02239536|564453436|FG001|Overall Study|Non-neoplastic polyp|17|||
156371089|NCT04074317|564453437|FG000|Third Period|Withdrawal by Subject|0|||
156371090|NCT04074317|564453438|FG001|Third Period|Withdrawal by Subject|0|||
156371091|NCT04074317|564453439|FG002|Third Period|Withdrawal by Subject|0|||
156492337|NCT03357471|564899043|FG001|Overall Study|Adverse Event|0|||
156492338|NCT03357471|564899042|FG000|Overall Study|Lost to Follow-up|1|||
156371092|NCT04074317|564453440|FG003|Third Period|Withdrawal by Subject|1|||
156371093|NCT04074317|564453441|FG004|Third Period|Withdrawal by Subject|0|||
156371094|NCT04074317|564453442|FG005|Third Period|Withdrawal by Subject|0|||
156546246|NCT01500278|565093319|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
156546247|NCT01500278|565093318|FG000|Week 13 - Week 104|Non/bad compliance|7|||
156371095|NCT03091192|564453443|FG000|Overall Study|Study terminated by sponsor|21|||
156371096|NCT03091192|564453444|FG001|Overall Study|Study terminated by sponsor|14|||
156371097|NCT03091192|564453443|FG000|Overall Study|Death|9|||
156371098|NCT03091192|564453444|FG001|Overall Study|Death|13|||
156371099|NCT03091192|564453443|FG000|Overall Study|Withdrawal by Subject|2|||
156371100|NCT03091192|564453444|FG001|Overall Study|Withdrawal by Subject|0|||
156371101|NCT03091192|564453443|FG000|Overall Study|Lost to Follow-up|1|||
156371102|NCT03091192|564453444|FG001|Overall Study|Lost to Follow-up|0|||
156371103|NCT01038778|564453445|FG000|Overall Study|Withdrawal by Subject|0|||
156371104|NCT01038778|564453446|FG001|Overall Study|Withdrawal by Subject|2|||
156371105|NCT01038778|564453447|FG002|Overall Study|Withdrawal by Subject|3|||
156371106|NCT02283788|564453448|FG000|Overall Study|Adverse Event|1|||
156546248|NCT01500278|565093319|FG001|Week 13 - Week 104|Non/bad compliance|5|||
156371107|NCT02283788|564453449|FG001|Overall Study|Adverse Event|3|||
156371108|NCT02283788|564453450|FG002|Overall Study|Adverse Event|5|||
156371109|NCT02283788|564453451|FG003|Overall Study|Adverse Event|1|||
156546249|NCT01500278|565093318|FG000|Week 13 - Week 104|Recurrent infections|1|||
156492339|NCT03357471|564899043|FG001|Overall Study|Lost to Follow-up|0|||
156492340|NCT00706914|564899044|FG000|Overall Study|Lack of Efficacy|0|||
156492341|NCT00706914|564899045|FG001|Overall Study|Lack of Efficacy|1|||
156492342|NCT00706914|564899046|FG002|Overall Study|Lack of Efficacy|0|||
156492343|NCT00706914|564899044|FG000|Overall Study|Lost to Follow-up|1|||
156492344|NCT00706914|564899045|FG001|Overall Study|Lost to Follow-up|0|||
156492345|NCT00706914|564899046|FG002|Overall Study|Lost to Follow-up|0|||
156492346|NCT00706914|564899044|FG000|Overall Study|Adverse Event|2|||
156492347|NCT00706914|564899045|FG001|Overall Study|Adverse Event|2|||
156492348|NCT00706914|564899046|FG002|Overall Study|Adverse Event|0|||
156492349|NCT00706914|564899044|FG000|Overall Study|Protocol Violation|3|||
156492350|NCT00706914|564899045|FG001|Overall Study|Protocol Violation|1|||
156492351|NCT00706914|564899046|FG002|Overall Study|Protocol Violation|1|||
156492352|NCT01850823|564899048|FG000|Overall Study|Early Visit Window|0|||
156492353|NCT01850823|564899049|FG001|Overall Study|Early Visit Window|1|||
156492354|NCT01850823|564899050|FG002|Overall Study|Early Visit Window|4|||
156492355|NCT01850823|564899048|FG000|Overall Study|Enrolled in Error|0|||
156492356|NCT01850823|564899049|FG001|Overall Study|Enrolled in Error|1|||
156492357|NCT01850823|564899050|FG002|Overall Study|Enrolled in Error|2|||
156492358|NCT01850823|564899048|FG000|Overall Study|Lack of Efficacy|1|||
156492359|NCT01850823|564899049|FG001|Overall Study|Lack of Efficacy|0|||
156492360|NCT01850823|564899050|FG002|Overall Study|Lack of Efficacy|0|||
156492361|NCT01850823|564899048|FG000|Overall Study|Lost to Follow-up|0|||
156492362|NCT01850823|564899049|FG001|Overall Study|Lost to Follow-up|0|||
156492363|NCT01850823|564899050|FG002|Overall Study|Lost to Follow-up|1|||
156492364|NCT01850823|564899048|FG000|Overall Study|Restricted Medication|0|||
156492365|NCT01850823|564899049|FG001|Overall Study|Restricted Medication|0|||
156492366|NCT01850823|564899050|FG002|Overall Study|Restricted Medication|2|||
156492367|NCT01850823|564899048|FG000|Overall Study|Significant worstening of SAR|0|||
156492368|NCT01850823|564899049|FG001|Overall Study|Significant worstening of SAR|1|||
156492369|NCT01850823|564899050|FG002|Overall Study|Significant worstening of SAR|0|||
156492370|NCT01850823|564899048|FG000|Overall Study|Withdrawal by Subject|2|||
156492371|NCT01850823|564899049|FG001|Overall Study|Withdrawal by Subject|0|||
156492372|NCT01850823|564899050|FG002|Overall Study|Withdrawal by Subject|1|||
156492373|NCT01751165|564899051|FG000|Overall Study|Adverse event, serious fatal|1|||
156492374|NCT01751165|564899052|FG001|Overall Study|Adverse event, serious fatal|0|||
156492375|NCT01751165|564899053|FG002|Overall Study|Adverse event, serious fatal|1|||
156492376|NCT01751165|564899051|FG000|Overall Study|Withdrawal by Subject|0|||
156371110|NCT02283788|564453448|FG000|Overall Study|Withdrawal by Subject|0|||
156371111|NCT02283788|564453449|FG001|Overall Study|Withdrawal by Subject|1|||
156371112|NCT02283788|564453450|FG002|Overall Study|Withdrawal by Subject|0|||
156371113|NCT02283788|564453451|FG003|Overall Study|Withdrawal by Subject|1|||
156371114|NCT02742103|564454696|FG000|Overall Study|Protocol Violation|1|||
156371115|NCT02742103|564454697|FG001|Overall Study|Protocol Violation|0|||
156371116|NCT02742103|564454696|FG000|Overall Study|Death|2|||
156371117|NCT02742103|564454697|FG001|Overall Study|Death|2|||
156371118|NCT02742103|564454696|FG000|Overall Study|Adverse Event|1|||
156371119|NCT02742103|564454697|FG001|Overall Study|Adverse Event|0|||
156371120|NCT02742103|564454696|FG000|Overall Study|Moved to another town|0|||
156371121|NCT02742103|564454697|FG001|Overall Study|Moved to another town|1|||
156371122|NCT02742103|564454696|FG000|Overall Study|Withdrawal by Subject|5|||
156371123|NCT02742103|564454697|FG001|Overall Study|Withdrawal by Subject|2|||
156371124|NCT04269161|564454706|FG000|Overall Study|Change of modality and no longer eligible|3|||
156371125|NCT04269161|564454707|FG001|Overall Study|Change of modality and no longer eligible|3|||
156371126|NCT04269161|564454706|FG000|Overall Study|Required procedure outside of NICU|1|||
156371127|NCT04269161|564454707|FG001|Overall Study|Required procedure outside of NICU|0|||
156371128|NCT04269161|564454706|FG000|Overall Study|Equipment issue|1|||
156371129|NCT04269161|564454707|FG001|Overall Study|Equipment issue|1|||
156371130|NCT02096835|564454708|FG000|Overall Study|Withdrawal by Subject|1|||
156371131|NCT02096835|564454709|FG001|Overall Study|Withdrawal by Subject|0|||
156371132|NCT02096835|564454710|FG002|Overall Study|Withdrawal by Subject|0|||
156371133|NCT02096835|564454708|FG000|Overall Study|converted to open procedures|1|||
156371134|NCT02096835|564454709|FG001|Overall Study|converted to open procedures|0|||
156371135|NCT02096835|564454710|FG002|Overall Study|converted to open procedures|0|||
156371136|NCT02096835|564454708|FG000|Overall Study|Lost to Follow-up|1|||
156371137|NCT02096835|564454709|FG001|Overall Study|Lost to Follow-up|0|||
156371138|NCT02096835|564454710|FG002|Overall Study|Lost to Follow-up|1|||
156371139|NCT02472756|564454711|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
156371140|NCT02472756|564454711|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
156371141|NCT02472756|564454711|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
156371142|NCT02472756|564454711|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
156492377|NCT01751165|564899052|FG001|Overall Study|Withdrawal by Subject|0|||
156492378|NCT01751165|564899053|FG002|Overall Study|Withdrawal by Subject|1|||
156492379|NCT01751165|564899051|FG000|Overall Study|Serious adverse event|0|||
156492380|NCT01751165|564899052|FG001|Overall Study|Serious adverse event|2|||
156492381|NCT01751165|564899053|FG002|Overall Study|Serious adverse event|0|||
156492382|NCT01751165|564899051|FG000|Overall Study|Lost to Follow-up|1|||
156492383|NCT01751165|564899052|FG001|Overall Study|Lost to Follow-up|1|||
156492384|NCT01751165|564899053|FG002|Overall Study|Lost to Follow-up|1|||
156492385|NCT00988533|564899054|FG000|Overall Study|Lost to Follow-up|3|||
156492386|NCT01202409|564899055|FG000|Overall Study|Adverse Event|1|||
156492387|NCT01202409|564899055|FG000|Overall Study|Ineligible - KRAS mutants|7|||
156492388|NCT00292981|564899060|FG000|Overall Study|Adverse Event|1|||
156492389|NCT00292981|564899060|FG000|Overall Study|Lost to Follow-up|13|||
156492390|NCT00292981|564899060|FG000|Overall Study|Withdrawal by Subject|22|||
156492391|NCT00292981|564899060|FG000|Overall Study|Other|3|||
156492392|NCT01085812|564899061|FG000|Open-Label Period|Adverse Event|0|||
156492393|NCT01085812|564899062|FG001|Open-Label Period|Adverse Event|80|||
156492394|NCT01085812|564899061|FG000|Open-Label Period|Lack of Efficacy|0|||
156492395|NCT01085812|564899062|FG001|Open-Label Period|Lack of Efficacy|26|||
156492396|NCT01085812|564899061|FG000|Open-Label Period|Protocol Violation|0|||
156492397|NCT01085812|564899062|FG001|Open-Label Period|Protocol Violation|39|||
156492398|NCT01085812|564899061|FG000|Open-Label Period|Withdrawal by Subject|0|||
156492399|NCT01085812|564899062|FG001|Open-Label Period|Withdrawal by Subject|53|||
156492400|NCT01085812|564899061|FG000|Open-Label Period|Lost to Follow-up|0|||
156492401|NCT01085812|564899062|FG001|Open-Label Period|Lost to Follow-up|42|||
156492402|NCT01085812|564899061|FG000|Double-Blind Period|Adverse Event|3|||
156371143|NCT02472756|564454711|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
156492403|NCT01085812|564899062|FG001|Double-Blind Period|Adverse Event|8|||
156492404|NCT01085812|564899061|FG000|Double-Blind Period|Protocol Violation|2|||
156371144|NCT03107988|564454714|FG000|Overall Study|Adverse Event|0|||
156371145|NCT03107988|564454715|FG001|Overall Study|Adverse Event|0|||
156371146|NCT03107988|564454716|FG002|Overall Study|Adverse Event|0|||
156492405|NCT01085812|564899062|FG001|Double-Blind Period|Protocol Violation|7|||
156492406|NCT01085812|564899061|FG000|Double-Blind Period|Withdrawal by Subject|11|||
156492407|NCT01085812|564899062|FG001|Double-Blind Period|Withdrawal by Subject|24|||
156492408|NCT01085812|564899061|FG000|Double-Blind Period|Lost to Follow-up|5|||
156492409|NCT01085812|564899062|FG001|Double-Blind Period|Lost to Follow-up|17|||
156492410|NCT01085812|564899061|FG000|Double-Blind Period|Other Reasons|0|||
156492411|NCT01085812|564899062|FG001|Double-Blind Period|Other Reasons|2|||
156492412|NCT01085812|564899061|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
156371147|NCT03107988|564454717|FG003|Overall Study|Adverse Event|1|||
156371148|NCT03107988|564454718|FG004|Overall Study|Adverse Event|0|||
156371149|NCT03107988|564454719|FG005|Overall Study|Adverse Event|1|||
156546250|NCT01500278|565093319|FG001|Week 13 - Week 104|Recurrent infections|0|||
156546251|NCT01500278|565093318|FG000|Week 13 - Week 104|False positive test|1|||
156546252|NCT01500278|565093319|FG001|Week 13 - Week 104|False positive test|2|||
156546253|NCT01500278|565093318|FG000|Week 13 - Week 104|Sponsor request|4|||
156546254|NCT01500278|565093319|FG001|Week 13 - Week 104|Sponsor request|0|||
156546255|NCT01500278|565093318|FG000|Week 13 - Week 104|Withdrawn in error|1|||
156546256|NCT01500278|565093319|FG001|Week 13 - Week 104|Withdrawn in error|0|||
156546257|NCT01500278|565093318|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
156546258|NCT01500278|565093319|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
156546259|NCT01500278|565093318|FG000|Week 13 - Week 104|Protocol deviation|1|||
156546260|NCT01500278|565093319|FG001|Week 13 - Week 104|Protocol deviation|0|||
156546261|NCT01500278|565093318|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
156546262|NCT01500278|565093319|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
156546263|NCT01500278|565093318|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
156546264|NCT01500278|565093319|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
156546265|NCT01500278|565093318|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
156546266|NCT01500278|565093319|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
156546267|NCT01500278|565093318|FG000|Week 13 - Week 104|Relocation|0|||
156546268|NCT01500278|565093319|FG001|Week 13 - Week 104|Relocation|1|||
156546269|NCT01500278|565093318|FG000|Week 13 - Week 104|Sponsor decision|0|||
156546270|NCT01500278|565093319|FG001|Week 13 - Week 104|Sponsor decision|2|||
156546271|NCT01500278|565093318|FG000|Week 13 - Week 104|Medical monitor decision|0|||
156546272|NCT01500278|565093319|FG001|Week 13 - Week 104|Medical monitor decision|2|||
156546273|NCT01500278|565093318|FG000|Week 13 - Week 104|Personal reason|0|||
156546274|NCT01500278|565093319|FG001|Week 13 - Week 104|Personal reason|1|||
156371150|NCT03107988|564454720|FG006|Overall Study|Adverse Event|0|||
156371151|NCT03107988|564454721|FG007|Overall Study|Adverse Event|1|||
156371152|NCT03107988|564454722|FG008|Overall Study|Adverse Event|0|||
156371153|NCT03107988|564454723|FG009|Overall Study|Adverse Event|0|||
156371154|NCT03107988|564454724|FG010|Overall Study|Adverse Event|0|||
156371155|NCT03107988|564454725|FG011|Overall Study|Adverse Event|0|||
156371156|NCT03107988|564454726|FG012|Overall Study|Adverse Event|0|||
156371157|NCT03107988|564454714|FG000|Overall Study|Disease Progression or Relapse|1|||
156371158|NCT03107988|564454715|FG001|Overall Study|Disease Progression or Relapse|2|||
156371159|NCT03107988|564454716|FG002|Overall Study|Disease Progression or Relapse|2|||
156371160|NCT03107988|564454717|FG003|Overall Study|Disease Progression or Relapse|5|||
156371161|NCT03107988|564454718|FG004|Overall Study|Disease Progression or Relapse|1|||
156371162|NCT03107988|564454719|FG005|Overall Study|Disease Progression or Relapse|1|||
156371163|NCT03107988|564454720|FG006|Overall Study|Disease Progression or Relapse|0|||
156371164|NCT03107988|564454721|FG007|Overall Study|Disease Progression or Relapse|0|||
156371165|NCT03107988|564454722|FG008|Overall Study|Disease Progression or Relapse|0|||
156371166|NCT03107988|564454723|FG009|Overall Study|Disease Progression or Relapse|1|||
156371167|NCT03107988|564454724|FG010|Overall Study|Disease Progression or Relapse|4|||
156371168|NCT03107988|564454725|FG011|Overall Study|Disease Progression or Relapse|0|||
156371169|NCT03107988|564454726|FG012|Overall Study|Disease Progression or Relapse|0|||
156371170|NCT03107988|564454714|FG000|Overall Study|Ineligible|0|||
156371171|NCT03107988|564454715|FG001|Overall Study|Ineligible|0|||
156371172|NCT03107988|564454716|FG002|Overall Study|Ineligible|0|||
156371173|NCT03107988|564454717|FG003|Overall Study|Ineligible|0|||
156371174|NCT03107988|564454718|FG004|Overall Study|Ineligible|0|||
156371175|NCT03107988|564454719|FG005|Overall Study|Ineligible|0|||
156371176|NCT03107988|564454720|FG006|Overall Study|Ineligible|0|||
156371177|NCT03107988|564454721|FG007|Overall Study|Ineligible|0|||
156371178|NCT03107988|564454722|FG008|Overall Study|Ineligible|1|||
156371179|NCT03107988|564454723|FG009|Overall Study|Ineligible|0|||
156371180|NCT03107988|564454724|FG010|Overall Study|Ineligible|0|||
156371181|NCT03107988|564454725|FG011|Overall Study|Ineligible|0|||
156371182|NCT03107988|564454726|FG012|Overall Study|Ineligible|0|||
156371183|NCT00501540|564454728|FG000|Overall Study|Death|5|||
156371184|NCT02331446|564454729|FG000|Overall Study|Lost to Follow-up|2|||
156371185|NCT02331446|564454730|FG001|Overall Study|Lost to Follow-up|1|||
156546275|NCT01500278|565093318|FG000|Week 13 - Week 104|Not completed|0|||
156546276|NCT01500278|565093319|FG001|Week 13 - Week 104|Not completed|1|||
156546277|NCT01500278|565093318|FG000|Week 13 - Week 104|Death|2|||
156371186|NCT02331446|564454731|FG002|Overall Study|Lost to Follow-up|0|||
156371187|NCT02331446|564454732|FG003|Overall Study|Lost to Follow-up|1|||
156371188|NCT02331446|564454729|FG000|Overall Study|Personal Problem|2|||
156371189|NCT02331446|564454730|FG001|Overall Study|Personal Problem|0|||
156371190|NCT02331446|564454731|FG002|Overall Study|Personal Problem|0|||
156371191|NCT02331446|564454732|FG003|Overall Study|Personal Problem|0|||
156546278|NCT01500278|565093319|FG001|Week 13 - Week 104|Death|4|||
156371192|NCT02331446|564454729|FG000|Overall Study|Disease|0|||
156371193|NCT02331446|564454730|FG001|Overall Study|Disease|2|||
156371194|NCT02331446|564454731|FG002|Overall Study|Disease|2|||
156371195|NCT02331446|564454732|FG003|Overall Study|Disease|1|||
156371196|NCT02331446|564454729|FG000|Overall Study|Physician Decision|0|||
156371197|NCT02331446|564454730|FG001|Overall Study|Physician Decision|1|||
156371198|NCT02331446|564454731|FG002|Overall Study|Physician Decision|0|||
156371199|NCT02331446|564454732|FG003|Overall Study|Physician Decision|1|||
156371200|NCT02331446|564454729|FG000|Overall Study|Lost before baseline analysis|0|||
156371201|NCT02331446|564454730|FG001|Overall Study|Lost before baseline analysis|1|||
156371202|NCT02331446|564454731|FG002|Overall Study|Lost before baseline analysis|1|||
156371203|NCT02331446|564454732|FG003|Overall Study|Lost before baseline analysis|0|||
156371204|NCT04879745|564454733|FG000|Overall Study|Lost to Follow-up|4|||
156371205|NCT04879745|564454734|FG001|Overall Study|Lost to Follow-up|1|||
156371206|NCT00120042|564454735|FG000|Overall Study|all completed protocl|0|||
156371207|NCT00120042|564454736|FG001|Overall Study|all completed protocl|0|||
156371208|NCT00120042|564454737|FG002|Overall Study|all completed protocl|0|||
156371209|NCT00529386|564454740|FG000|Overall Study|Lost to Follow-up|1|||
156371210|NCT04532112|564454741|FG000|Overall Study|Adverse Event|3|||
156371211|NCT04532112|564454742|FG001|Overall Study|Adverse Event|0|||
156371212|NCT03592641|564454743|FG000|Overall Study|Withdrawal by Subject|1|||
156371213|NCT01126541|564454745|FG000|Overall Study|Adverse Event|0|||
156371214|NCT01126541|564454746|FG001|Overall Study|Adverse Event|2|||
156371215|NCT01126541|564454747|FG002|Overall Study|Adverse Event|4|||
156371216|NCT01126541|564454745|FG000|Overall Study|Death|0|||
156371217|NCT01126541|564454746|FG001|Overall Study|Death|1|||
156371218|NCT01126541|564454747|FG002|Overall Study|Death|0|||
156371219|NCT01126541|564454745|FG000|Overall Study|Lack of Efficacy|6|||
156371220|NCT01126541|564454746|FG001|Overall Study|Lack of Efficacy|1|||
156371221|NCT01126541|564454747|FG002|Overall Study|Lack of Efficacy|11|||
156371222|NCT01126541|564454745|FG000|Overall Study|Lost to Follow-up|1|||
156371223|NCT01126541|564454746|FG001|Overall Study|Lost to Follow-up|2|||
156371224|NCT01126541|564454747|FG002|Overall Study|Lost to Follow-up|2|||
156371225|NCT01126541|564454745|FG000|Overall Study|Withdrawal by Subject|2|||
156371226|NCT01126541|564454746|FG001|Overall Study|Withdrawal by Subject|5|||
156371227|NCT01126541|564454747|FG002|Overall Study|Withdrawal by Subject|6|||
156371228|NCT01126541|564454745|FG000|Overall Study|Protocol Violation|0|||
156371229|NCT01126541|564454746|FG001|Overall Study|Protocol Violation|0|||
156371230|NCT01126541|564454747|FG002|Overall Study|Protocol Violation|1|||
156371231|NCT01126541|564454745|FG000|Overall Study|Administrative reason or other|1|||
156371232|NCT01126541|564454746|FG001|Overall Study|Administrative reason or other|1|||
156371233|NCT01126541|564454747|FG002|Overall Study|Administrative reason or other|2|||
156371234|NCT04027686|564454748|FG000|Overall Study|Lost to Follow-up|2|||
156371235|NCT04027686|564454749|FG001|Overall Study|Lost to Follow-up|0|||
156371236|NCT04027686|564454748|FG000|Overall Study|Withdrawal by Subject|0|||
156371237|NCT04027686|564454749|FG001|Overall Study|Withdrawal by Subject|1|||
156371238|NCT02939404|564454750|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
156371239|NCT02939404|564454751|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
156371240|NCT02939404|564454750|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
156371241|NCT02939404|564454751|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
156371242|NCT04182100|564454752|FG000|Overall Study|Adverse Event|1|||
156371243|NCT04182100|564454752|FG000|Overall Study|Withdrawal by Subject|1|||
156371244|NCT04439240|564454758|FG000|Overall Study|Ineligible|2|||
156371245|NCT04439240|564454758|FG000|Overall Study|Never started treatment|2|||
156371246|NCT04439240|564454758|FG000|Overall Study|Adverse Event|12|||
156371247|NCT04439240|564454758|FG000|Overall Study|Death|2|||
156371248|NCT04439240|564454758|FG000|Overall Study|Disease progression|25|||
156371249|NCT04439240|564454758|FG000|Overall Study|Other diseases|2|||
156371250|NCT04439240|564454758|FG000|Overall Study|Withdrawal by Subject|3|||
156371251|NCT04439240|564454758|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
156371252|NCT04439240|564454758|FG000|Overall Study|Symptomatic decline|1|||
156371253|NCT04439240|564454758|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
156371254|NCT04439240|564454758|FG000|Overall Study|Clinical progression|1|||
156371255|NCT00280566|564454759|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
156371256|NCT00280566|564454760|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
156371257|NCT00280566|564454761|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
156371258|NCT00280566|564454759|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
156371259|NCT00280566|564454760|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
156371260|NCT00280566|564454761|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
156492413|NCT01085812|564899062|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
156492414|NCT01085812|564899061|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
156492415|NCT01085812|564899062|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
156371261|NCT00280566|564454759|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
156371262|NCT00280566|564454760|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
156371263|NCT00280566|564454761|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
156371264|NCT00280566|564454759|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
156371265|NCT00280566|564454760|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
156371266|NCT00280566|564454761|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
156371267|NCT00280566|564454759|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
156371268|NCT00280566|564454760|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
156371269|NCT00280566|564454761|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
156371270|NCT00280566|564454759|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
156371271|NCT00280566|564454760|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
156371272|NCT00280566|564454761|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
156492416|NCT01085812|564899061|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
156492417|NCT01085812|564899062|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
156492418|NCT01085812|564899061|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
156492419|NCT01085812|564899062|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
156492420|NCT01085812|564899061|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
156492421|NCT01085812|564899062|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
156492422|NCT00594178|564899065|FG000|Overall Study|Physician Decision|5|||
156492423|NCT04582669|564899068|FG000|Overall Study|Subject missed appointment(s).|1|||
156492424|NCT04582669|564899069|FG001|Overall Study|Subject missed appointment(s).|0|||
156492425|NCT04582669|564899070|FG002|Overall Study|Subject missed appointment(s).|1|||
156492426|NCT04582669|564899071|FG003|Overall Study|Subject missed appointment(s).|2|||
156492427|NCT04582669|564899068|FG000|Overall Study|Protocol Violation|0|||
156492428|NCT04582669|564899069|FG001|Overall Study|Protocol Violation|1|||
156492429|NCT04582669|564899070|FG002|Overall Study|Protocol Violation|1|||
156492430|NCT04582669|564899071|FG003|Overall Study|Protocol Violation|0|||
156492431|NCT01274559|564899072|FG000|Overall Study|Adverse Event|57|||
156492432|NCT01274559|564899073|FG001|Overall Study|Adverse Event|13|||
156492433|NCT01274559|564899072|FG000|Overall Study|Death|1|||
156492434|NCT01274559|564899073|FG001|Overall Study|Death|1|||
156492435|NCT01274559|564899072|FG000|Overall Study|Lost to Follow-up|3|||
156492436|NCT01274559|564899073|FG001|Overall Study|Lost to Follow-up|3|||
156492437|NCT01274559|564899072|FG000|Overall Study|Non-compliance with Study Drug|2|||
156492438|NCT01274559|564899073|FG001|Overall Study|Non-compliance with Study Drug|4|||
156492439|NCT01274559|564899072|FG000|Overall Study|Physician Decision|2|||
156492440|NCT01274559|564899073|FG001|Overall Study|Physician Decision|1|||
156492441|NCT01274559|564899072|FG000|Overall Study|Protocol Violation|28|||
156492442|NCT01274559|564899073|FG001|Overall Study|Protocol Violation|23|||
156492443|NCT01274559|564899072|FG000|Overall Study|Study Terminated by Sponsor|79|||
156492444|NCT01274559|564899073|FG001|Overall Study|Study Terminated by Sponsor|87|||
156371273|NCT00280566|564454759|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
156371274|NCT00280566|564454760|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
156371275|NCT00280566|564454761|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
156371276|NCT00280566|564454759|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
156371277|NCT00280566|564454760|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
156371278|NCT00280566|564454761|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
156371279|NCT00280566|564454759|FG000|Period 2 Double Blind|Adverse Event|0|||
156371280|NCT00280566|564454760|FG001|Period 2 Double Blind|Adverse Event|11|||
156371281|NCT00280566|564454761|FG002|Period 2 Double Blind|Adverse Event|15|||
156371282|NCT00280566|564454759|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
156371283|NCT00280566|564454760|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
156371284|NCT00280566|564454761|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
156371285|NCT00280566|564454759|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
156371286|NCT00280566|564454760|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
156371287|NCT00280566|564454761|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
156371288|NCT00280566|564454759|FG000|Period 2 Double Blind|miscellaneous|0|||
156371289|NCT00280566|564454760|FG001|Period 2 Double Blind|miscellaneous|10|||
156371290|NCT00280566|564454761|FG002|Period 2 Double Blind|miscellaneous|5|||
156371291|NCT00637195|564454762|FG000|Overall Study|Lost to Follow-up|1|||
156371292|NCT00637195|564454763|FG001|Overall Study|Lost to Follow-up|0|||
156371293|NCT00637195|564454762|FG000|Overall Study|Other|2|||
156371294|NCT00637195|564454763|FG001|Overall Study|Other|0|||
156371295|NCT00637195|564454762|FG000|Overall Study|Withdrawal by Subject|0|||
156371296|NCT00637195|564454763|FG001|Overall Study|Withdrawal by Subject|1|||
156371297|NCT01696032|564454764|FG000|Overall Study|Withdrawal by Subject|0|||
156371298|NCT01696032|564454765|FG001|Overall Study|Withdrawal by Subject|0|||
156371299|NCT01696032|564454766|FG002|Overall Study|Withdrawal by Subject|1|||
156371300|NCT01696032|564454767|FG003|Overall Study|Withdrawal by Subject|2|||
156371301|NCT01696032|564454764|FG000|Overall Study|Death|14|||
156492445|NCT01274559|564899072|FG000|Overall Study|Withdrawal by Subject|25|||
156492446|NCT01274559|564899073|FG001|Overall Study|Withdrawal by Subject|13|||
156492447|NCT01167192|564899076|FG000|Overall Study|Adverse Event|1|||
156492448|NCT01167192|564899076|FG000|Overall Study|Death|1|||
156546279|NCT01500278|565093318|FG000|Week 13 - Week 104|Adverse Event|54|||
156492449|NCT01167192|564899076|FG000|Overall Study|Withdrawal by Subject|1|||
156371302|NCT01696032|564454765|FG001|Overall Study|Death|4|||
156371303|NCT01696032|564454766|FG002|Overall Study|Death|43|||
156371304|NCT01696032|564454767|FG003|Overall Study|Death|18|||
156371305|NCT01696032|564454764|FG000|Overall Study|Lost to Follow-up|0|||
156371306|NCT01696032|564454765|FG001|Overall Study|Lost to Follow-up|1|||
156492450|NCT01167192|564899076|FG000|Overall Study|Insurance denial|1|||
156492451|NCT02482935|564899090|FG000|Period 1|Withdrawal by Subject|1|||
156371307|NCT01696032|564454766|FG002|Overall Study|Lost to Follow-up|0|||
156371308|NCT01696032|564454767|FG003|Overall Study|Lost to Follow-up|0|||
156371309|NCT01696032|564454764|FG000|Overall Study|Database lock|0|||
156371310|NCT01696032|564454765|FG001|Overall Study|Database lock|1|||
156371311|NCT01696032|564454766|FG002|Overall Study|Database lock|7|||
156371312|NCT01696032|564454767|FG003|Overall Study|Database lock|2|||
156371313|NCT02214121|564454768|FG000|Part A|Patient decision|2|||
156371314|NCT02214121|564454769|FG001|Part A|Patient decision|0|||
156371315|NCT02214121|564454770|FG002|Part A|Patient decision|0|||
156371316|NCT02214121|564454768|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
156371317|NCT02214121|564454769|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
156371318|NCT02214121|564454770|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
156371319|NCT02214121|564454768|FG000|Part A|Other|1|||
156371320|NCT02214121|564454769|FG001|Part A|Other|0|||
156371321|NCT02214121|564454770|FG002|Part A|Other|0|||
156371322|NCT02214121|564454768|FG000|Part B|Patient decision|0|||
156371323|NCT02214121|564454769|FG001|Part B|Patient decision|1|||
156371324|NCT02214121|564454770|FG002|Part B|Patient decision|0|||
156371325|NCT02214121|564454768|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
156371326|NCT02214121|564454769|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
156371327|NCT02214121|564454770|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
156371328|NCT02214121|564454768|FG000|Part B|Lost to Follow-up|0|||
156371329|NCT02214121|564454769|FG001|Part B|Lost to Follow-up|0|||
156371330|NCT02214121|564454770|FG002|Part B|Lost to Follow-up|1|||
156371331|NCT00613509|564454775|FG000|Cycle 1|Adverse Event|2|||
156371332|NCT00613509|564454776|FG001|Cycle 1|Adverse Event|1|||
156371333|NCT00613509|564454775|FG000|Cycle 1|Disease Progression|2|||
156371334|NCT00613509|564454776|FG001|Cycle 1|Disease Progression|6|||
156371335|NCT00613509|564454775|FG000|Cycle 1|Unacceptable Toxicity|1|||
156371336|NCT00613509|564454776|FG001|Cycle 1|Unacceptable Toxicity|0|||
156371337|NCT00613509|564454775|FG000|Cycle 1|Other administrative reason|0|||
156371338|NCT00613509|564454776|FG001|Cycle 1|Other administrative reason|1|||
156371339|NCT04847674|564454777|FG000|Overall Study|Withdrawal by Subject|0|||
156371340|NCT04847674|564454778|FG001|Overall Study|Withdrawal by Subject|1|||
156371341|NCT04847674|564454779|FG002|Overall Study|Withdrawal by Subject|0|||
156371342|NCT04847674|564454777|FG000|Overall Study|Lost to Follow-up|0|||
156371343|NCT04847674|564454778|FG001|Overall Study|Lost to Follow-up|0|||
156492452|NCT02482935|564899091|FG001|Period 1|Withdrawal by Subject|0|||
156492453|NCT03503162|564899092|FG000|Overall Study|did not meet eligibility|1|||
156492454|NCT02835092|564899093|FG000|Overall Study|Withdrawal by Subject|3|||
156492455|NCT02835092|564899094|FG001|Overall Study|Withdrawal by Subject|6|||
156492456|NCT02835092|564899095|FG002|Overall Study|Withdrawal by Subject|3|||
156492457|NCT02835092|564899093|FG000|Overall Study|Lost to Follow-up|0|||
156492458|NCT02835092|564899094|FG001|Overall Study|Lost to Follow-up|2|||
156492459|NCT02835092|564899095|FG002|Overall Study|Lost to Follow-up|0|||
156492460|NCT01321723|564899096|FG000|Overall Study|Adverse Event|3|||
156492461|NCT01321723|564899097|FG001|Overall Study|Adverse Event|5|||
156492462|NCT01321723|564899098|FG002|Overall Study|Adverse Event|2|||
156492463|NCT01321723|564899096|FG000|Overall Study|Withdrawal by Subject|2|||
156492464|NCT01321723|564899097|FG001|Overall Study|Withdrawal by Subject|0|||
156492465|NCT01321723|564899098|FG002|Overall Study|Withdrawal by Subject|2|||
156492466|NCT02246218|564899099|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156492467|NCT02246218|564899100|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156492468|NCT02246218|564899099|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
156492469|NCT02246218|564899100|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
156371344|NCT04847674|564454779|FG002|Overall Study|Lost to Follow-up|2|||
156371345|NCT04847674|564454777|FG000|Overall Study|Other than specified|21|||
156371346|NCT04847674|564454778|FG001|Overall Study|Other than specified|20|||
156371347|NCT04847674|564454779|FG002|Overall Study|Other than specified|20|||
156371348|NCT00677807|564454780|FG000|Overall Study|Adverse Event|4|||
156371349|NCT00677807|564454781|FG001|Overall Study|Adverse Event|1|||
156371350|NCT00677807|564454782|FG002|Overall Study|Adverse Event|6|||
156371351|NCT00677807|564454780|FG000|Overall Study|Lack of Efficacy|0|||
156371352|NCT00677807|564454781|FG001|Overall Study|Lack of Efficacy|0|||
156371353|NCT00677807|564454782|FG002|Overall Study|Lack of Efficacy|2|||
156371354|NCT00677807|564454780|FG000|Overall Study|Participant no longer needs study drug|0|||
156371355|NCT00677807|564454781|FG001|Overall Study|Participant no longer needs study drug|0|||
156371356|NCT00677807|564454782|FG002|Overall Study|Participant no longer needs study drug|1|||
156492470|NCT02246218|564899099|FG000|Overall Study|Adverse Event|1|||
156492471|NCT02246218|564899100|FG001|Overall Study|Adverse Event|1|||
156492472|NCT02246218|564899099|FG000|Overall Study|Lost to Follow-up|1|||
156492473|NCT02246218|564899100|FG001|Overall Study|Lost to Follow-up|0|||
156492474|NCT02561806|564899101|FG000|Induction Period|Adverse Event|0|||
156492475|NCT02561806|564899102|FG001|Induction Period|Adverse Event|2|||
156371357|NCT00677807|564454780|FG000|Overall Study|Withdrawal by Subject|10|||
156371358|NCT00677807|564454781|FG001|Overall Study|Withdrawal by Subject|3|||
156371359|NCT00677807|564454782|FG002|Overall Study|Withdrawal by Subject|6|||
156371360|NCT00677807|564454780|FG000|Overall Study|Lost to Follow-up|2|||
156371361|NCT00677807|564454781|FG001|Overall Study|Lost to Follow-up|2|||
156371362|NCT00677807|564454782|FG002|Overall Study|Lost to Follow-up|2|||
156371363|NCT00677807|564454780|FG000|Overall Study|Administrative problems|1|||
156371364|NCT00677807|564454781|FG001|Overall Study|Administrative problems|1|||
156371365|NCT00677807|564454782|FG002|Overall Study|Administrative problems|2|||
156371366|NCT00677807|564454780|FG000|Overall Study|Death|0|||
156371367|NCT00677807|564454781|FG001|Overall Study|Death|1|||
156371368|NCT00677807|564454782|FG002|Overall Study|Death|1|||
156371369|NCT00677807|564454780|FG000|Overall Study|Protocol Deviation|1|||
156371370|NCT00677807|564454781|FG001|Overall Study|Protocol Deviation|3|||
156371371|NCT00677807|564454782|FG002|Overall Study|Protocol Deviation|0|||
156371372|NCT00689481|564454783|FG000|Overall Study|Adverse Event|7|||
156371373|NCT00689481|564454784|FG001|Overall Study|Adverse Event|1|||
156371374|NCT00689481|564454783|FG000|Overall Study|Lost to Follow-up|4|||
156371375|NCT00689481|564454784|FG001|Overall Study|Lost to Follow-up|3|||
156371376|NCT00689481|564454783|FG000|Overall Study|Lack of Efficacy|4|||
156371377|NCT00689481|564454784|FG001|Overall Study|Lack of Efficacy|3|||
156371378|NCT00689481|564454783|FG000|Overall Study|Non-compliance with study treatment|1|||
156371379|NCT00689481|564454784|FG001|Overall Study|Non-compliance with study treatment|1|||
156371380|NCT00689481|564454783|FG000|Overall Study|Withdrawal by Subject|8|||
156371381|NCT00689481|564454784|FG001|Overall Study|Withdrawal by Subject|4|||
156371382|NCT00689481|564454783|FG000|Overall Study|Excluded medication started during study|0|||
156371383|NCT00689481|564454784|FG001|Overall Study|Excluded medication started during study|1|||
156371384|NCT00689481|564454783|FG000|Overall Study|Subject early term, left on vacation|0|||
156371385|NCT00689481|564454784|FG001|Overall Study|Subject early term, left on vacation|1|||
156371386|NCT02782949|564454785|FG000|Overall Study|Protocol Violation|1|||
156371387|NCT02782949|564454786|FG001|Overall Study|Protocol Violation|0|||
156371388|NCT02782949|564454785|FG000|Overall Study|Withdrawal by Subject|0|||
156371389|NCT02782949|564454786|FG001|Overall Study|Withdrawal by Subject|1|||
156371390|NCT03238911|564454789|FG000|Overall Study|Withdrawal by Subject|1|||
156371391|NCT03238911|564454790|FG001|Overall Study|Withdrawal by Subject|2|||
156371392|NCT03238911|564454789|FG000|Overall Study|Lost to Follow-up|2|||
156371393|NCT03238911|564454790|FG001|Overall Study|Lost to Follow-up|1|||
156371394|NCT06023394|564454791|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
156371395|NCT06023394|564454792|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
156371396|NCT06023394|564454791|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
156371397|NCT06023394|564454792|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
156371398|NCT06023394|564454791|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
156371399|NCT06023394|564454792|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
156371400|NCT06023394|564454791|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
156371401|NCT06023394|564454792|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
156371402|NCT05645432|564454793|FG000|Overall Study|Withdrawal by Subject|1|||
156371403|NCT03195478|564454794|FG000|Overall Study|Disease Progression|5|||
156371404|NCT03195478|564454795|FG001|Overall Study|Disease Progression|4|||
156371405|NCT03195478|564454796|FG002|Overall Study|Disease Progression|6|||
156371406|NCT03195478|564454797|FG003|Overall Study|Disease Progression|1|||
156371407|NCT03195478|564454794|FG000|Overall Study|Study Drug Toxicity|2|||
156371408|NCT03195478|564454795|FG001|Overall Study|Study Drug Toxicity|0|||
156371409|NCT03195478|564454796|FG002|Overall Study|Study Drug Toxicity|0|||
156371410|NCT03195478|564454797|FG003|Overall Study|Study Drug Toxicity|1|||
156371411|NCT03195478|564454794|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
156371412|NCT03195478|564454795|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
156371413|NCT03195478|564454796|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
156492476|NCT02561806|564899101|FG000|Induction Period|Lack of Efficacy|1|||
156371414|NCT03195478|564454797|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
156371415|NCT03195478|564454794|FG000|Overall Study|Participant Withdrew Consent|1|||
156371416|NCT03195478|564454795|FG001|Overall Study|Participant Withdrew Consent|0|||
156371417|NCT03195478|564454796|FG002|Overall Study|Participant Withdrew Consent|0|||
156371418|NCT03195478|564454797|FG003|Overall Study|Participant Withdrew Consent|0|||
156371419|NCT03195478|564454794|FG000|Overall Study|Maximum Clinical benefit|0|||
156371420|NCT03195478|564454795|FG001|Overall Study|Maximum Clinical benefit|0|||
156371421|NCT03195478|564454796|FG002|Overall Study|Maximum Clinical benefit|1|||
156492477|NCT02561806|564899102|FG001|Induction Period|Lack of Efficacy|0|||
156371422|NCT03195478|564454797|FG003|Overall Study|Maximum Clinical benefit|0|||
156371423|NCT03195478|564454794|FG000|Overall Study|Other Reasons|0|||
156371424|NCT03195478|564454795|FG001|Overall Study|Other Reasons|0|||
156371425|NCT03195478|564454796|FG002|Overall Study|Other Reasons|1|||
156371426|NCT03195478|564454797|FG003|Overall Study|Other Reasons|0|||
156371427|NCT02143414|564456383|FG000|Induction|Adverse Event|1|||
156371428|NCT02143414|564456384|FG001|Induction|Adverse Event|2|||
156371429|NCT02143414|564456383|FG000|Induction|Death|1|||
156371430|NCT02143414|564456384|FG001|Induction|Death|2|||
156492478|NCT02561806|564899101|FG000|Induction Period|Withdrawal by Subject|0|||
156492479|NCT02561806|564899102|FG001|Induction Period|Withdrawal by Subject|2|||
156371431|NCT02143414|564456383|FG000|Induction|Patient refusal|1|||
156371432|NCT02143414|564456384|FG001|Induction|Patient refusal|1|||
156371433|NCT02143414|564456383|FG000|Induction|Refractory|1|||
156371434|NCT02143414|564456384|FG001|Induction|Refractory|0|||
156371435|NCT02143414|564456383|FG000|Induction|Began alternative treatment|1|||
156371436|NCT02143414|564456384|FG001|Induction|Began alternative treatment|0|||
156371437|NCT02143414|564456383|FG000|Induction|Ineligible for postremission|5|||
156371438|NCT02143414|564456384|FG001|Induction|Ineligible for postremission|1|||
156371439|NCT02143414|564456383|FG000|Post-remission|Adverse Event|0|||
156371440|NCT02143414|564456384|FG001|Post-remission|Adverse Event|2|||
156371441|NCT02143414|564456383|FG000|Post-remission|Disease progression/relapse|5|||
156371442|NCT02143414|564456384|FG001|Post-remission|Disease progression/relapse|0|||
156371443|NCT02143414|564456383|FG000|Maintenance|Adverse Event|4|||
156371444|NCT02143414|564456384|FG001|Maintenance|Adverse Event|6|||
156371445|NCT02143414|564456383|FG000|Maintenance|Disease progression/relapse|3|||
156371446|NCT02143414|564456384|FG001|Maintenance|Disease progression/relapse|2|||
156371447|NCT02143414|564456383|FG000|Maintenance|Patient refusal|2|||
156371448|NCT02143414|564456384|FG001|Maintenance|Patient refusal|1|||
156371449|NCT02143414|564456383|FG000|Maintenance|Physician Decision|1|||
156371450|NCT02143414|564456384|FG001|Maintenance|Physician Decision|0|||
156371451|NCT02143414|564456383|FG000|Maintenance|Death|0|||
156371452|NCT02143414|564456384|FG001|Maintenance|Death|1|||
156371453|NCT02143414|564456383|FG000|Maintenance|On protocol treatment|0|||
156371454|NCT02143414|564456384|FG001|Maintenance|On protocol treatment|6|||
156371455|NCT00978731|564456388|FG000|Overall Study|Death|4|||
156371456|NCT00978731|564456389|FG001|Overall Study|Death|1|||
156371457|NCT00978731|564456390|FG002|Overall Study|Death|1|||
156371458|NCT00978731|564456391|FG003|Overall Study|Death|0|||
156371459|NCT00978731|564456388|FG000|Overall Study|Lost to Follow-up|0|||
156371460|NCT00978731|564456389|FG001|Overall Study|Lost to Follow-up|0|||
156371461|NCT00978731|564456390|FG002|Overall Study|Lost to Follow-up|0|||
156371462|NCT00978731|564456391|FG003|Overall Study|Lost to Follow-up|1|||
156371463|NCT00978731|564456388|FG000|Overall Study|Adverse Event|5|||
156371464|NCT00978731|564456389|FG001|Overall Study|Adverse Event|2|||
156371465|NCT00978731|564456390|FG002|Overall Study|Adverse Event|0|||
156371466|NCT00978731|564456391|FG003|Overall Study|Adverse Event|0|||
156371467|NCT00978731|564456388|FG000|Overall Study|Participant's request|1|||
156371468|NCT00978731|564456389|FG001|Overall Study|Participant's request|0|||
156371469|NCT00978731|564456390|FG002|Overall Study|Participant's request|0|||
156371470|NCT00978731|564456391|FG003|Overall Study|Participant's request|0|||
156371471|NCT00978731|564456388|FG000|Overall Study|Administrative reason|3|||
156371472|NCT00978731|564456389|FG001|Overall Study|Administrative reason|3|||
156371473|NCT00978731|564456390|FG002|Overall Study|Administrative reason|1|||
156371474|NCT00978731|564456391|FG003|Overall Study|Administrative reason|0|||
156371475|NCT00978731|564456388|FG000|Overall Study|Deterioration without progression|0|||
156371476|NCT00978731|564456389|FG001|Overall Study|Deterioration without progression|1|||
156371477|NCT00978731|564456390|FG002|Overall Study|Deterioration without progression|0|||
156371478|NCT00978731|564456391|FG003|Overall Study|Deterioration without progression|0|||
156371479|NCT00978731|564456388|FG000|Overall Study|Disease progression/relapse|5|||
156371480|NCT00978731|564456389|FG001|Overall Study|Disease progression/relapse|4|||
156371481|NCT00978731|564456390|FG002|Overall Study|Disease progression/relapse|2|||
156371482|NCT00978731|564456391|FG003|Overall Study|Disease progression/relapse|2|||
156371483|NCT00978731|564456388|FG000|Overall Study|Study closure|3|||
156371484|NCT00978731|564456389|FG001|Overall Study|Study closure|4|||
156371485|NCT00978731|564456390|FG002|Overall Study|Study closure|1|||
156371486|NCT00978731|564456391|FG003|Overall Study|Study closure|1|||
156371487|NCT00978731|564456388|FG000|Overall Study|No response|1|||
156371488|NCT00978731|564456389|FG001|Overall Study|No response|0|||
156371489|NCT00978731|564456390|FG002|Overall Study|No response|0|||
156371490|NCT00978731|564456391|FG003|Overall Study|No response|0|||
156371491|NCT02649972|564456397|FG000|Overall Study|Not treated|1|||
156371492|NCT00813124|564456403|FG000|Overall Study|Death|2|||
156371493|NCT00813124|564456403|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
156371494|NCT00813124|564456403|FG000|Overall Study|Withdrawal by Subject|1|||
156371495|NCT01147653|564456410|FG000|Year 2|Withdrawal by Subject|2|||
156371496|NCT01147653|564456411|FG001|Year 2|Withdrawal by Subject|3|||
156371497|NCT01302392|564456412|FG000|Overall Study|Lost to Follow-up|1|||
156371498|NCT01302392|564456413|FG001|Overall Study|Lost to Follow-up|0|||
156371499|NCT01302392|564456412|FG000|Overall Study|Withdrawal by Subject|6|||
156492480|NCT02561806|564899101|FG000|Induction Period|Site staff became unblinded|1|||
156492481|NCT02561806|564899102|FG001|Induction Period|Site staff became unblinded|0|||
156492482|NCT02561806|564899101|FG000|Induction Period|Randomized but not treated|0|||
156371500|NCT01302392|564456413|FG001|Overall Study|Withdrawal by Subject|1|||
156371501|NCT00670228|564456414|FG000|Overall Study|Adverse Event|1|||
156371502|NCT00670228|564456415|FG001|Overall Study|Adverse Event|0|||
156492483|NCT02561806|564899102|FG001|Induction Period|Randomized but not treated|1|||
156371503|NCT00670228|564456414|FG000|Overall Study|Death or MACE|0|||
156371504|NCT00670228|564456415|FG001|Overall Study|Death or MACE|1|||
156371505|NCT00670228|564456414|FG000|Overall Study|Not treated|2|||
156371506|NCT00670228|564456415|FG001|Overall Study|Not treated|2|||
156371507|NCT00670228|564456414|FG000|Overall Study|Not meeting the selection criteria|2|||
156371508|NCT00670228|564456415|FG001|Overall Study|Not meeting the selection criteria|0|||
156371509|NCT03604692|564456419|FG000|Overall Study|Investigator's Decision|0|||
156371510|NCT03604692|564456420|FG001|Overall Study|Investigator's Decision|0|||
156371511|NCT03604692|564456421|FG002|Overall Study|Investigator's Decision|0|||
156371512|NCT03604692|564456422|FG003|Overall Study|Investigator's Decision|1|||
156371513|NCT03604692|564456423|FG004|Overall Study|Investigator's Decision|0|||
156371514|NCT03604692|564456424|FG005|Overall Study|Investigator's Decision|7|||
156371515|NCT03604692|564456419|FG000|Overall Study|Withdrawal by Subject|0|||
156371516|NCT03604692|564456420|FG001|Overall Study|Withdrawal by Subject|0|||
156371517|NCT03604692|564456421|FG002|Overall Study|Withdrawal by Subject|0|||
156371518|NCT03604692|564456422|FG003|Overall Study|Withdrawal by Subject|0|||
156371519|NCT03604692|564456423|FG004|Overall Study|Withdrawal by Subject|0|||
156371520|NCT03604692|564456424|FG005|Overall Study|Withdrawal by Subject|2|||
156371521|NCT03604692|564456419|FG000|Overall Study|Progressive Disease|1|||
156371522|NCT03604692|564456420|FG001|Overall Study|Progressive Disease|0|||
156371523|NCT03604692|564456421|FG002|Overall Study|Progressive Disease|1|||
156371524|NCT03604692|564456422|FG003|Overall Study|Progressive Disease|0|||
156371525|NCT03604692|564456423|FG004|Overall Study|Progressive Disease|3|||
156371526|NCT03604692|564456424|FG005|Overall Study|Progressive Disease|4|||
156371527|NCT03604692|564456419|FG000|Overall Study|Difficulty Coming into Site|0|||
156371528|NCT03604692|564456420|FG001|Overall Study|Difficulty Coming into Site|0|||
156371529|NCT03604692|564456421|FG002|Overall Study|Difficulty Coming into Site|0|||
156371530|NCT03604692|564456422|FG003|Overall Study|Difficulty Coming into Site|0|||
156371531|NCT03604692|564456423|FG004|Overall Study|Difficulty Coming into Site|0|||
156371532|NCT03604692|564456424|FG005|Overall Study|Difficulty Coming into Site|1|||
156371533|NCT03604692|564456419|FG000|Overall Study|Death|0|||
156371534|NCT03604692|564456420|FG001|Overall Study|Death|0|||
156371535|NCT03604692|564456421|FG002|Overall Study|Death|1|||
156371536|NCT03604692|564456422|FG003|Overall Study|Death|0|||
156371537|NCT03604692|564456423|FG004|Overall Study|Death|0|||
156371538|NCT03604692|564456424|FG005|Overall Study|Death|0|||
156371539|NCT03604692|564456419|FG000|Overall Study|Drug Intolerance|0|||
156371540|NCT03604692|564456420|FG001|Overall Study|Drug Intolerance|0|||
156371541|NCT03604692|564456421|FG002|Overall Study|Drug Intolerance|0|||
156371542|NCT03604692|564456422|FG003|Overall Study|Drug Intolerance|1|||
156371543|NCT03604692|564456423|FG004|Overall Study|Drug Intolerance|0|||
156371544|NCT03604692|564456424|FG005|Overall Study|Drug Intolerance|0|||
156371545|NCT03604692|564456419|FG000|Overall Study|Noncompliance with follow-up visit|0|||
156371546|NCT03604692|564456420|FG001|Overall Study|Noncompliance with follow-up visit|0|||
156371547|NCT03604692|564456421|FG002|Overall Study|Noncompliance with follow-up visit|0|||
156371548|NCT03604692|564456422|FG003|Overall Study|Noncompliance with follow-up visit|1|||
156371549|NCT03604692|564456423|FG004|Overall Study|Noncompliance with follow-up visit|0|||
156371550|NCT03604692|564456424|FG005|Overall Study|Noncompliance with follow-up visit|0|||
156371551|NCT03604692|564456419|FG000|Overall Study|Not Treated|0|||
156371552|NCT03604692|564456420|FG001|Overall Study|Not Treated|0|||
156371553|NCT03604692|564456421|FG002|Overall Study|Not Treated|0|||
156371554|NCT03604692|564456422|FG003|Overall Study|Not Treated|0|||
156371555|NCT03604692|564456423|FG004|Overall Study|Not Treated|1|||
156371556|NCT03604692|564456424|FG005|Overall Study|Not Treated|0|||
156371557|NCT01193556|564456429|FG000|Overall Study|Study termination|26|||
156371558|NCT01193556|564456430|FG001|Overall Study|Study termination|25|||
156371559|NCT01020019|564456431|FG000|Overall Study|Lost to Follow-up|21|||
156371560|NCT01020019|564456432|FG001|Overall Study|Lost to Follow-up|18|||
156371561|NCT01020019|564456431|FG000|Overall Study|Adverse Event|1|||
156371562|NCT01020019|564456432|FG001|Overall Study|Adverse Event|5|||
156371563|NCT01020019|564456431|FG000|Overall Study|not interested in treatment|4|||
156371564|NCT01020019|564456432|FG001|Overall Study|not interested in treatment|4|||
156371565|NCT01020019|564456431|FG000|Overall Study|moving|0|||
156371566|NCT01020019|564456432|FG001|Overall Study|moving|2|||
156371567|NCT05091528|564456433|FG000|Overall Study|Study Termination by Sponsor|0|||
156371568|NCT05091528|564456434|FG001|Overall Study|Study Termination by Sponsor|1|||
156371569|NCT05091528|564456435|FG002|Overall Study|Study Termination by Sponsor|0|||
156371570|NCT05091528|564456436|FG003|Overall Study|Study Termination by Sponsor|1|||
156371571|NCT02375672|564456437|FG000|Overall Study|remain on follow up|20|||
156371572|NCT02203591|564456438|FG000|Overall Study|Did not meet treatment day baseline|147|||
156371573|NCT02203591|564456439|FG001|Overall Study|Did not meet treatment day baseline|141|||
156371574|NCT02203591|564456440|FG002|Overall Study|Did not meet treatment day baseline|150|||
156371575|NCT02203591|564456441|FG003|Overall Study|Did not meet treatment day baseline|45|||
156371576|NCT02203591|564456442|FG004|Overall Study|Did not meet treatment day baseline|33|||
156371577|NCT02203591|564456443|FG005|Overall Study|Did not meet treatment day baseline|35|||
156371578|NCT02203591|564456444|FG006|Overall Study|Did not meet treatment day baseline|29|||
156371579|NCT02203591|564456445|FG007|Overall Study|Did not meet treatment day baseline|12|||
156371580|NCT02203591|564456438|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
156371581|NCT02203591|564456439|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
156371582|NCT02203591|564456440|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
156371583|NCT02203591|564456441|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
156371584|NCT02203591|564456442|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
156371585|NCT02203591|564456443|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
156371586|NCT02203591|564456444|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
156371587|NCT02203591|564456445|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
156371588|NCT03306264|564456446|FG000|Overall Study|Death|33|||
156371589|NCT03306264|564456447|FG001|Overall Study|Death|25|||
156371590|NCT03306264|564456448|FG002|Overall Study|Death|34|||
156371591|NCT03306264|564456449|FG003|Overall Study|Death|34|||
156371592|NCT03306264|564456446|FG000|Overall Study|Complete Consent Withdrawal|4|||
156371593|NCT03306264|564456447|FG001|Overall Study|Complete Consent Withdrawal|4|||
156371594|NCT03306264|564456448|FG002|Overall Study|Complete Consent Withdrawal|1|||
156371595|NCT03306264|564456449|FG003|Overall Study|Complete Consent Withdrawal|8|||
156371596|NCT03306264|564456446|FG000|Overall Study|Lost to Follow-up|1|||
156371597|NCT03306264|564456447|FG001|Overall Study|Lost to Follow-up|0|||
156371598|NCT03306264|564456448|FG002|Overall Study|Lost to Follow-up|1|||
156371599|NCT03306264|564456449|FG003|Overall Study|Lost to Follow-up|0|||
156371600|NCT03306264|564456446|FG000|Overall Study|Rollover to ASTX727-06|10|||
156371601|NCT03306264|564456447|FG001|Overall Study|Rollover to ASTX727-06|18|||
156371602|NCT03306264|564456448|FG002|Overall Study|Rollover to ASTX727-06|4|||
156371603|NCT03306264|564456449|FG003|Overall Study|Rollover to ASTX727-06|2|||
156371604|NCT03306264|564456446|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
156371605|NCT03306264|564456447|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
156371606|NCT03306264|564456448|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
156371607|NCT03306264|564456449|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
156371608|NCT02114879|564456453|FG000|Overall Study|Withdrawal by Subject|9|||
156371609|NCT02114879|564456454|FG001|Overall Study|Withdrawal by Subject|5|||
156371610|NCT02114879|564456453|FG000|Overall Study|Death|6|||
156371611|NCT02114879|564456454|FG001|Overall Study|Death|11|||
156371612|NCT02114879|564456453|FG000|Overall Study|Lost to Follow-up|4|||
156371613|NCT02114879|564456454|FG001|Overall Study|Lost to Follow-up|6|||
156371614|NCT02114879|564456453|FG000|Overall Study|Physician Decision|0|||
156371615|NCT02114879|564456454|FG001|Overall Study|Physician Decision|2|||
156371616|NCT02152995|564456456|FG000|Overall Study|Withdrawal by Subject|1|||
156371617|NCT02152995|564456457|FG001|Overall Study|Withdrawal by Subject|0|||
156371618|NCT01541826|564456458|FG000|Overall Study|Lost to Follow-up|2|||
156371619|NCT01541826|564456459|FG001|Overall Study|Lost to Follow-up|3|||
156371620|NCT01541826|564456460|FG002|Overall Study|Lost to Follow-up|0|||
156371621|NCT01541826|564456458|FG000|Overall Study|Withdrawal by Subject|2|||
156371622|NCT01541826|564456459|FG001|Overall Study|Withdrawal by Subject|0|||
156371623|NCT01541826|564456460|FG002|Overall Study|Withdrawal by Subject|0|||
156371624|NCT01365273|564456463|FG000|Overall Study|Lost to Follow-up|1|||
156371625|NCT01365273|564456464|FG001|Overall Study|Lost to Follow-up|0|||
156371626|NCT01365273|564456463|FG000|Overall Study|Protocol Violation|0|||
156371627|NCT01365273|564456464|FG001|Overall Study|Protocol Violation|1|||
156371628|NCT01365273|564456463|FG000|Overall Study|Physician Decision|1|||
156371629|NCT01365273|564456464|FG001|Overall Study|Physician Decision|0|||
156371630|NCT02519712|564456469|FG000|Overall Study|Disease Relapse|1|||
156371631|NCT02519712|564456469|FG000|Overall Study|Disease Progression|1|||
156371632|NCT02519712|564456469|FG000|Overall Study|Accruals are donors|2|||
156371633|NCT02705820|564456470|FG000|Overall Study|Death|2|||
156371634|NCT02705820|564456470|FG000|Overall Study|Disease Progression|34|||
156492484|NCT02561806|564899101|FG000|Maintenance Period|Adverse Event|2|||
156492485|NCT02561806|564899102|FG001|Maintenance Period|Adverse Event|1|||
156492486|NCT02561806|564899101|FG000|Maintenance Period|Lack of Efficacy|3|||
156492487|NCT02561806|564899102|FG001|Maintenance Period|Lack of Efficacy|1|||
156492488|NCT02561806|564899101|FG000|Maintenance Period|Lost to Follow-up|2|||
156492489|NCT02561806|564899102|FG001|Maintenance Period|Lost to Follow-up|2|||
156492490|NCT02561806|564899101|FG000|Maintenance Period|Protocol Violation|1|||
156371635|NCT02705820|564456470|FG000|Overall Study|Clinical Deterioration|3|||
156371636|NCT02702401|564456471|FG000|Overall Study|Death|242|||
156371637|NCT02702401|564456472|FG001|Overall Study|Death|125|||
156492491|NCT02561806|564899102|FG001|Maintenance Period|Protocol Violation|0|||
156492492|NCT02561806|564899101|FG000|Maintenance Period|Withdrawal by Subject|5|||
156492493|NCT02561806|564899102|FG001|Maintenance Period|Withdrawal by Subject|3|||
156371638|NCT02702401|564456471|FG000|Overall Study|Withdrawal by Subject|15|||
156371639|NCT02702401|564456472|FG001|Overall Study|Withdrawal by Subject|5|||
156492494|NCT02561806|564899101|FG000|Maintenance Period|Site staff became unblinded|0|||
156492495|NCT02561806|564899102|FG001|Maintenance Period|Site staff became unblinded|1|||
156371640|NCT02702401|564456471|FG000|Overall Study|Sponsor Decision|19|||
156492496|NCT02561806|564899101|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
156492497|NCT02561806|564899102|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
156492498|NCT02561806|564899101|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
156492499|NCT02561806|564899102|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
156492500|NCT02547441|564899103|FG000|Double-Blind Study Period|Adverse Event|4|||
156546280|NCT01500278|565093319|FG001|Week 13 - Week 104|Adverse Event|54|||
156371641|NCT02702401|564456472|FG001|Overall Study|Sponsor Decision|3|||
156371642|NCT02702401|564456471|FG000|Overall Study|Physician Decision|1|||
156371643|NCT02702401|564456472|FG001|Overall Study|Physician Decision|2|||
156371644|NCT02702401|564456471|FG000|Overall Study|Lost to Follow-up|1|||
156371645|NCT02702401|564456472|FG001|Overall Study|Lost to Follow-up|0|||
156371646|NCT03400033|564456473|FG000|Overall Study|Withdrawal by Subject|1|||
156371647|NCT03400033|564456474|FG001|Overall Study|Withdrawal by Subject|2|||
156371648|NCT00006916|564456475|FG000|Overall Study|Device not inserted|4|||
156371649|NCT00006916|564456475|FG000|Overall Study|Complication of device insertion|1|||
156371650|NCT00558103|564456476|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
156371651|NCT00558103|564456477|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
156371652|NCT00558103|564456478|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
156371653|NCT00558103|564456479|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
156371654|NCT00558103|564456480|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
156371655|NCT00558103|564456481|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
156371656|NCT00558103|564456476|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
156371657|NCT00558103|564456477|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
156371658|NCT00558103|564456478|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
156371659|NCT00558103|564456479|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
156371660|NCT00558103|564456480|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
156371661|NCT00558103|564456481|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
156371662|NCT00558103|564456476|FG000|Randomized Treatment Phase|Disease Progression|1|||
156371663|NCT00558103|564456477|FG001|Randomized Treatment Phase|Disease Progression|0|||
156371664|NCT00558103|564456478|FG002|Randomized Treatment Phase|Disease Progression|1|||
156371665|NCT00558103|564456479|FG003|Randomized Treatment Phase|Disease Progression|0|||
156371666|NCT00558103|564456480|FG004|Randomized Treatment Phase|Disease Progression|0|||
156371667|NCT00558103|564456481|FG005|Randomized Treatment Phase|Disease Progression|0|||
156371668|NCT00558103|564456476|FG000|Randomized Treatment Phase|Adverse Event|0|||
156371669|NCT00558103|564456477|FG001|Randomized Treatment Phase|Adverse Event|0|||
156371670|NCT00558103|564456478|FG002|Randomized Treatment Phase|Adverse Event|0|||
156371671|NCT00558103|564456479|FG003|Randomized Treatment Phase|Adverse Event|1|||
156371672|NCT00558103|564456480|FG004|Randomized Treatment Phase|Adverse Event|1|||
156371673|NCT00558103|564456481|FG005|Randomized Treatment Phase|Adverse Event|0|||
156371674|NCT00558103|564456476|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
156371675|NCT00558103|564456477|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
156371676|NCT00558103|564456478|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
156371677|NCT00558103|564456479|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
156371678|NCT00558103|564456480|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
156371679|NCT00558103|564456481|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
156371680|NCT00558103|564456476|FG000|Monotherapy Extension Phase|Disease Progression|0|||
156371681|NCT00558103|564456477|FG001|Monotherapy Extension Phase|Disease Progression|0|||
156371682|NCT00558103|564456478|FG002|Monotherapy Extension Phase|Disease Progression|0|||
156371683|NCT00558103|564456479|FG003|Monotherapy Extension Phase|Disease Progression|0|||
156371684|NCT00558103|564456480|FG004|Monotherapy Extension Phase|Disease Progression|0|||
156371685|NCT00558103|564456481|FG005|Monotherapy Extension Phase|Disease Progression|8|||
156371686|NCT02457325|564456482|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
156371687|NCT02457325|564456483|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
156371688|NCT01574703|564456484|FG000|Overall Study|Adverse Event|0|||
156371689|NCT01574703|564456485|FG001|Overall Study|Adverse Event|2|||
156371690|NCT01574703|564456486|FG002|Overall Study|Adverse Event|1|||
156371691|NCT01574703|564456487|FG003|Overall Study|Adverse Event|1|||
156371692|NCT01574703|564456484|FG000|Overall Study|Protocol Violation|0|||
156371693|NCT01574703|564456485|FG001|Overall Study|Protocol Violation|0|||
156371694|NCT01574703|564456486|FG002|Overall Study|Protocol Violation|0|||
156371695|NCT01574703|564456487|FG003|Overall Study|Protocol Violation|1|||
156371696|NCT01574703|564456484|FG000|Overall Study|Unspecified Reason|27|||
156371697|NCT01574703|564456485|FG001|Overall Study|Unspecified Reason|15|||
156371698|NCT01574703|564456486|FG002|Overall Study|Unspecified Reason|20|||
156371699|NCT01574703|564456487|FG003|Overall Study|Unspecified Reason|16|||
156371700|NCT01574703|564456484|FG000|Overall Study|Withdrawal by Subject|53|||
156371701|NCT01574703|564456485|FG001|Overall Study|Withdrawal by Subject|52|||
156371702|NCT01574703|564456486|FG002|Overall Study|Withdrawal by Subject|36|||
156371703|NCT01574703|564456487|FG003|Overall Study|Withdrawal by Subject|61|||
156371704|NCT01574703|564456484|FG000|Overall Study|Met Withdrawal Criteria|0|||
156371705|NCT01574703|564456485|FG001|Overall Study|Met Withdrawal Criteria|1|||
156371706|NCT01574703|564456486|FG002|Overall Study|Met Withdrawal Criteria|1|||
156371707|NCT01574703|564456487|FG003|Overall Study|Met Withdrawal Criteria|0|||
156371708|NCT01574703|564456484|FG000|Overall Study|Lost to Follow-up|43|||
156371709|NCT01574703|564456485|FG001|Overall Study|Lost to Follow-up|41|||
156371710|NCT01574703|564456486|FG002|Overall Study|Lost to Follow-up|46|||
156371711|NCT01574703|564456487|FG003|Overall Study|Lost to Follow-up|35|||
156371712|NCT01574703|564456484|FG000|Overall Study|Death|2|||
156371713|NCT01574703|564456485|FG001|Overall Study|Death|1|||
156371714|NCT01574703|564456486|FG002|Overall Study|Death|1|||
156371715|NCT01574703|564456487|FG003|Overall Study|Death|0|||
156371716|NCT01420081|564456491|FG000|Overall Study|Death|1|||
156371717|NCT01420081|564456492|FG001|Overall Study|Death|0|||
156371718|NCT01420081|564456493|FG002|Overall Study|Death|8|||
156371719|NCT01420081|564456494|FG003|Overall Study|Death|0|||
156371720|NCT01420081|564456495|FG004|Overall Study|Death|7|||
156371721|NCT01420081|564456496|FG005|Overall Study|Death|12|||
156371722|NCT01420081|564456497|FG006|Overall Study|Death|0|||
156371723|NCT01420081|564456498|FG007|Overall Study|Death|1|||
156371724|NCT01420081|564456499|FG008|Overall Study|Death|1|||
156371725|NCT01420081|564456491|FG000|Overall Study|Lost to Follow-up|0|||
156371726|NCT01420081|564456492|FG001|Overall Study|Lost to Follow-up|0|||
156371727|NCT01420081|564456493|FG002|Overall Study|Lost to Follow-up|0|||
156371728|NCT01420081|564456494|FG003|Overall Study|Lost to Follow-up|0|||
156371729|NCT01420081|564456495|FG004|Overall Study|Lost to Follow-up|1|||
156371730|NCT01420081|564456496|FG005|Overall Study|Lost to Follow-up|1|||
156371731|NCT01420081|564456497|FG006|Overall Study|Lost to Follow-up|0|||
156371732|NCT01420081|564456498|FG007|Overall Study|Lost to Follow-up|0|||
156371733|NCT01420081|564456499|FG008|Overall Study|Lost to Follow-up|0|||
156371734|NCT01420081|564456491|FG000|Overall Study|Study Terminated by Sponsor|2|||
156371735|NCT01420081|564456492|FG001|Overall Study|Study Terminated by Sponsor|1|||
156371736|NCT01420081|564456493|FG002|Overall Study|Study Terminated by Sponsor|1|||
156371737|NCT01420081|564456494|FG003|Overall Study|Study Terminated by Sponsor|3|||
156371738|NCT01420081|564456495|FG004|Overall Study|Study Terminated by Sponsor|11|||
156371739|NCT01420081|564456496|FG005|Overall Study|Study Terminated by Sponsor|7|||
156371740|NCT01420081|564456497|FG006|Overall Study|Study Terminated by Sponsor|3|||
156371741|NCT01420081|564456498|FG007|Overall Study|Study Terminated by Sponsor|2|||
156371742|NCT01420081|564456499|FG008|Overall Study|Study Terminated by Sponsor|2|||
156371743|NCT01420081|564456491|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
156371744|NCT01420081|564456492|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
156371745|NCT01420081|564456493|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
156371746|NCT01420081|564456494|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
156371747|NCT01420081|564456495|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
156371748|NCT01420081|564456496|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
156371749|NCT01420081|564456497|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
156371750|NCT01420081|564456498|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
156371751|NCT01420081|564456499|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
156371752|NCT01420081|564456491|FG000|Overall Study|Other Reasons|0|||
156371753|NCT01420081|564456492|FG001|Overall Study|Other Reasons|0|||
156371754|NCT01420081|564456493|FG002|Overall Study|Other Reasons|1|||
156371755|NCT01420081|564456494|FG003|Overall Study|Other Reasons|0|||
156371756|NCT01420081|564456495|FG004|Overall Study|Other Reasons|0|||
156371757|NCT01420081|564456496|FG005|Overall Study|Other Reasons|0|||
156371758|NCT01420081|564456497|FG006|Overall Study|Other Reasons|0|||
156371759|NCT01420081|564456498|FG007|Overall Study|Other Reasons|0|||
156371760|NCT01420081|564456499|FG008|Overall Study|Other Reasons|0|||
156371761|NCT02469610|564456500|FG000|Overall Study|Death|1|||
156371762|NCT02469610|564456501|FG001|Overall Study|Death|0|||
156371763|NCT02469610|564456500|FG000|Overall Study|Lost to Follow-up|1|||
156371764|NCT02469610|564456501|FG001|Overall Study|Lost to Follow-up|0|||
156371765|NCT02469610|564456500|FG000|Overall Study|exclusion criteria|2|||
156371766|NCT02469610|564456501|FG001|Overall Study|exclusion criteria|1|||
156371767|NCT00414388|564456504|FG000|Overall Study|Adverse Event|1|||
156371768|NCT03467425|564456505|FG000|Overall Study|Adverse Event|9|||
156371769|NCT03467425|564456506|FG001|Overall Study|Adverse Event|9|||
156371770|NCT03467425|564456505|FG000|Overall Study|Lack of Efficacy|3|||
156371771|NCT03467425|564456506|FG001|Overall Study|Lack of Efficacy|1|||
156371772|NCT03467425|564456505|FG000|Overall Study|Protocol Violation|0|||
156371773|NCT03467425|564456506|FG001|Overall Study|Protocol Violation|1|||
156492501|NCT02547441|564899104|FG001|Double-Blind Study Period|Adverse Event|9|||
156492502|NCT02547441|564899103|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
156492503|NCT02547441|564899104|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
156492504|NCT02547441|564899103|FG000|Double-Blind Study Period|Physician Decision|1|||
156371774|NCT03467425|564456505|FG000|Overall Study|Lost to Follow-up|18|||
156371775|NCT03467425|564456506|FG001|Overall Study|Lost to Follow-up|25|||
156371776|NCT03467425|564456505|FG000|Overall Study|Physician Decision|2|||
156371777|NCT03467425|564456506|FG001|Overall Study|Physician Decision|1|||
156371778|NCT03467425|564456505|FG000|Overall Study|Withdrawal by Subject|15|||
156371779|NCT03467425|564456506|FG001|Overall Study|Withdrawal by Subject|17|||
156371780|NCT00025883|564456508|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
156371781|NCT00025883|564456508|FG000|Overall Study|no baseline data|1|||
156371782|NCT00025883|564456508|FG000|Overall Study|Death|1|||
156492505|NCT02547441|564899104|FG001|Double-Blind Study Period|Physician Decision|0|||
156546281|NCT00414453|565093322|FG000|Overall Study|Abnormal lab work|16|||
156371783|NCT00025883|564456508|FG000|Overall Study|Adverse Event|1|||
156371784|NCT00025883|564456508|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
156371785|NCT00218543|564456509|FG000|Overall Study|Lost to Follow-up|8|||
156371786|NCT00218543|564456509|FG000|Overall Study|relocated|1|||
156371787|NCT00218543|564456509|FG000|Overall Study|Withdrawal by Subject|1|||
156371788|NCT00218543|564456509|FG000|Overall Study|Physician Decision|3|||
156371789|NCT00218543|564456509|FG000|Overall Study|Adverse Event|2|||
156492506|NCT02547441|564899103|FG000|Double-Blind Study Period|Protocol Violation|1|||
156492507|NCT02547441|564899104|FG001|Double-Blind Study Period|Protocol Violation|2|||
156492508|NCT02547441|564899103|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
156492509|NCT02547441|564899104|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
156492510|NCT02547441|564899103|FG000|Double-Blind Study Period|Sponsor Decision|1|||
156492511|NCT02547441|564899104|FG001|Double-Blind Study Period|Sponsor Decision|0|||
156492512|NCT02547441|564899103|FG000|Open-Label Study Period|Adverse Event|10|||
156492513|NCT02547441|564899104|FG001|Open-Label Study Period|Adverse Event|11|||
156492514|NCT02547441|564899103|FG000|Open-Label Study Period|Lack of Efficacy|3|||
156492515|NCT02547441|564899104|FG001|Open-Label Study Period|Lack of Efficacy|2|||
156492516|NCT02547441|564899103|FG000|Open-Label Study Period|Lost to Follow-up|7|||
156492517|NCT02547441|564899104|FG001|Open-Label Study Period|Lost to Follow-up|8|||
156492518|NCT02547441|564899103|FG000|Open-Label Study Period|Physician Decision|1|||
156492519|NCT02547441|564899104|FG001|Open-Label Study Period|Physician Decision|0|||
156492520|NCT02547441|564899103|FG000|Open-Label Study Period|Protocol Violation|2|||
156492521|NCT02547441|564899104|FG001|Open-Label Study Period|Protocol Violation|0|||
156492522|NCT02547441|564899103|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
156492523|NCT02547441|564899104|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
156492524|NCT02547441|564899103|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
156492525|NCT02547441|564899104|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
156492526|NCT01322009|564899105|FG000|Overall Study|Death|0|||
156492527|NCT01322009|564899106|FG001|Overall Study|Death|1|||
156492528|NCT01322009|564899105|FG000|Overall Study|Adverse Event|0|||
156492529|NCT01322009|564899106|FG001|Overall Study|Adverse Event|1|||
156492530|NCT01322009|564899105|FG000|Overall Study|ng tube discontinued|0|||
156492531|NCT01322009|564899106|FG001|Overall Study|ng tube discontinued|1|||
156492532|NCT00905034|564899107|FG000|Overall Study|Withdrawal by Subject|1|||
156492533|NCT00394589|564899108|FG000|Overall Study|Adverse Event|2|||
156492534|NCT00394589|564899109|FG001|Overall Study|Adverse Event|1|||
156492535|NCT00394589|564899110|FG002|Overall Study|Adverse Event|2|||
156492536|NCT00394589|564899108|FG000|Overall Study|Lack of Efficacy|2|||
156492537|NCT00394589|564899109|FG001|Overall Study|Lack of Efficacy|2|||
156492538|NCT00394589|564899110|FG002|Overall Study|Lack of Efficacy|3|||
156492539|NCT00394589|564899108|FG000|Overall Study|Protocol Violation|4|||
156492540|NCT00394589|564899109|FG001|Overall Study|Protocol Violation|0|||
156492541|NCT00394589|564899110|FG002|Overall Study|Protocol Violation|2|||
156492542|NCT03409731|564899111|FG000|Overall Study|Withdrawal by Subject|17|||
156492543|NCT03409731|564899111|FG000|Overall Study|Death|4|||
156492544|NCT04545476|564899112|FG000|Overall Study|Lost to Follow-up|1|||
156492545|NCT04545476|564899113|FG001|Overall Study|Lost to Follow-up|1|||
156492546|NCT04545476|564899114|FG002|Overall Study|Lost to Follow-up|0|||
156492547|NCT04545476|564899115|FG003|Overall Study|Lost to Follow-up|0|||
156492548|NCT03175198|564899118|FG000|Overall Study|Adverse Event|480|||
156492549|NCT03175198|564899118|FG000|Overall Study|No actual visit|120|||
156492550|NCT03175198|564899118|FG000|Overall Study|Registration rule not followed|4|||
156492551|NCT03175198|564899118|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
156492552|NCT03175198|564899118|FG000|Overall Study|Other personal reason|509|||
156492553|NCT03175198|564899118|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
156492554|NCT03175198|564899118|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
156492555|NCT03175198|564899118|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
156492556|NCT03175198|564899118|FG000|Overall Study|To conduct invasive treatment of operation|53|||
156492557|NCT03175198|564899118|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
156492558|NCT00634920|564899120|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
156492559|NCT00634920|564899121|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
156492560|NCT00634920|564899122|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
156492561|NCT00634920|564899120|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
156492562|NCT00634920|564899121|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
156492563|NCT00634920|564899122|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
156492564|NCT00634920|564899120|FG000|Period 1 - Pre-Randomization|Rejections|0|||
156492565|NCT00634920|564899121|FG001|Period 1 - Pre-Randomization|Rejections|0|||
156492566|NCT00634920|564899122|FG002|Period 1 - Pre-Randomization|Rejections|55|||
156492567|NCT00634920|564899120|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
156492568|NCT00634920|564899121|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
156492569|NCT00634920|564899122|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
156492570|NCT00634920|564899120|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
156546282|NCT00183274|565093325|FG000|Phase 1: Open-Label|Adverse Event|31|||
156546283|NCT00183274|565093326|FG001|Phase 1: Open-Label|Adverse Event|0|||
156492571|NCT00634920|564899121|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
156492572|NCT00634920|564899122|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
156492573|NCT00634920|564899120|FG000|Period 1 - Pre-Randomization|Other issues|0|||
156492574|NCT00634920|564899121|FG001|Period 1 - Pre-Randomization|Other issues|0|||
156492575|NCT00634920|564899122|FG002|Period 1 - Pre-Randomization|Other issues|6|||
156492576|NCT00634920|564899120|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
156546284|NCT00183274|565093327|FG002|Phase 1: Open-Label|Adverse Event|0|||
156492577|NCT00634920|564899121|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
156492578|NCT00634920|564899122|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
156492579|NCT00634920|564899120|FG000|Period 2 - Post-Randomization|Rejection|11|||
156492580|NCT00634920|564899121|FG001|Period 2 - Post-Randomization|Rejection|5|||
156492581|NCT00634920|564899122|FG002|Period 2 - Post-Randomization|Rejection|0|||
156492582|NCT00634920|564899120|FG000|Period 2 - Post-Randomization|Death|2|||
156492583|NCT00634920|564899121|FG001|Period 2 - Post-Randomization|Death|5|||
156492584|NCT00634920|564899122|FG002|Period 2 - Post-Randomization|Death|0|||
156492585|NCT00634920|564899120|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
156492586|NCT00634920|564899121|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
156492587|NCT00634920|564899122|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
156492588|NCT00634920|564899120|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
156492589|NCT00634920|564899121|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
156492590|NCT00634920|564899122|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
156492591|NCT01193218|564899123|FG000|0-12 Weeks|Adverse Event|6|||
156492592|NCT01193218|564899124|FG001|0-12 Weeks|Adverse Event|0|||
156492593|NCT01193218|564899125|FG002|0-12 Weeks|Adverse Event|1|||
156492594|NCT01193218|564899126|FG003|0-12 Weeks|Adverse Event|0|||
156492595|NCT01193218|564899127|FG004|0-12 Weeks|Adverse Event|0|||
156492596|NCT01193218|564899128|FG005|0-12 Weeks|Adverse Event|2|||
156492597|NCT01193218|564899129|FG006|0-12 Weeks|Adverse Event|2|||
156492598|NCT01193218|564899130|FG007|0-12 Weeks|Adverse Event|0|||
156492599|NCT01193218|564899123|FG000|0-12 Weeks|Protocol Violation|0|||
156492600|NCT01193218|564899124|FG001|0-12 Weeks|Protocol Violation|0|||
156492601|NCT01193218|564899125|FG002|0-12 Weeks|Protocol Violation|0|||
156492602|NCT01193218|564899126|FG003|0-12 Weeks|Protocol Violation|0|||
156492603|NCT01193218|564899127|FG004|0-12 Weeks|Protocol Violation|1|||
156492604|NCT01193218|564899128|FG005|0-12 Weeks|Protocol Violation|1|||
156492605|NCT01193218|564899129|FG006|0-12 Weeks|Protocol Violation|0|||
156492606|NCT01193218|564899130|FG007|0-12 Weeks|Protocol Violation|0|||
156492607|NCT01193218|564899123|FG000|0-12 Weeks|Withdrawal by Subject|3|||
156492608|NCT01193218|564899124|FG001|0-12 Weeks|Withdrawal by Subject|0|||
156492609|NCT01193218|564899125|FG002|0-12 Weeks|Withdrawal by Subject|2|||
156492610|NCT01193218|564899126|FG003|0-12 Weeks|Withdrawal by Subject|0|||
156492611|NCT01193218|564899127|FG004|0-12 Weeks|Withdrawal by Subject|0|||
156492612|NCT01193218|564899128|FG005|0-12 Weeks|Withdrawal by Subject|0|||
156492613|NCT01193218|564899129|FG006|0-12 Weeks|Withdrawal by Subject|1|||
156492614|NCT01193218|564899130|FG007|0-12 Weeks|Withdrawal by Subject|0|||
156492615|NCT01193218|564899123|FG000|12-52 Weeks|Adverse Event|1|||
156492616|NCT01193218|564899124|FG001|12-52 Weeks|Adverse Event|0|||
156492617|NCT01193218|564899125|FG002|12-52 Weeks|Adverse Event|1|||
156492618|NCT01193218|564899126|FG003|12-52 Weeks|Adverse Event|2|||
156492619|NCT01193218|564899127|FG004|12-52 Weeks|Adverse Event|3|||
156492620|NCT01193218|564899128|FG005|12-52 Weeks|Adverse Event|3|||
156492621|NCT01193218|564899129|FG006|12-52 Weeks|Adverse Event|1|||
156492622|NCT01193218|564899130|FG007|12-52 Weeks|Adverse Event|2|||
156492623|NCT01193218|564899123|FG000|12-52 Weeks|Lack of Efficacy|0|||
156492624|NCT01193218|564899124|FG001|12-52 Weeks|Lack of Efficacy|0|||
156492625|NCT01193218|564899125|FG002|12-52 Weeks|Lack of Efficacy|0|||
156492626|NCT01193218|564899126|FG003|12-52 Weeks|Lack of Efficacy|0|||
156492627|NCT01193218|564899127|FG004|12-52 Weeks|Lack of Efficacy|0|||
156492628|NCT01193218|564899128|FG005|12-52 Weeks|Lack of Efficacy|0|||
156492629|NCT01193218|564899129|FG006|12-52 Weeks|Lack of Efficacy|1|||
156492630|NCT01193218|564899130|FG007|12-52 Weeks|Lack of Efficacy|0|||
156546285|NCT00183274|565093328|FG003|Phase 1: Open-Label|Adverse Event|0|||
156546286|NCT00183274|565093329|FG004|Phase 1: Open-Label|Adverse Event|0|||
156546287|NCT00183274|565093330|FG005|Phase 1: Open-Label|Adverse Event|0|||
156546288|NCT00183274|565093325|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
156546289|NCT00183274|565093326|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
156546290|NCT00183274|565093327|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
156546291|NCT00183274|565093328|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
156546292|NCT00183274|565093329|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
156546293|NCT00183274|565093330|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
156546294|NCT00183274|565093325|FG000|Phase 1: Open-Label|Protocol Violation|11|||
156546295|NCT00183274|565093326|FG001|Phase 1: Open-Label|Protocol Violation|0|||
156546296|NCT00183274|565093327|FG002|Phase 1: Open-Label|Protocol Violation|0|||
156546297|NCT00183274|565093328|FG003|Phase 1: Open-Label|Protocol Violation|0|||
156492631|NCT01193218|564899123|FG000|12-52 Weeks|Withdrawal by Subject|3|||
156492632|NCT01193218|564899124|FG001|12-52 Weeks|Withdrawal by Subject|0|||
156492633|NCT01193218|564899125|FG002|12-52 Weeks|Withdrawal by Subject|3|||
156492634|NCT01193218|564899126|FG003|12-52 Weeks|Withdrawal by Subject|0|||
156492635|NCT01193218|564899127|FG004|12-52 Weeks|Withdrawal by Subject|0|||
156492636|NCT01193218|564899128|FG005|12-52 Weeks|Withdrawal by Subject|2|||
156492637|NCT01193218|564899129|FG006|12-52 Weeks|Withdrawal by Subject|1|||
156492638|NCT01193218|564899130|FG007|12-52 Weeks|Withdrawal by Subject|2|||
156492639|NCT01193218|564899123|FG000|12-52 Weeks|Other reason than above|1|||
156492640|NCT01193218|564899124|FG001|12-52 Weeks|Other reason than above|0|||
156546298|NCT00183274|565093329|FG004|Phase 1: Open-Label|Protocol Violation|0|||
156546299|NCT00183274|565093330|FG005|Phase 1: Open-Label|Protocol Violation|0|||
156492641|NCT01193218|564899125|FG002|12-52 Weeks|Other reason than above|0|||
156492642|NCT01193218|564899126|FG003|12-52 Weeks|Other reason than above|1|||
156492643|NCT01193218|564899127|FG004|12-52 Weeks|Other reason than above|1|||
156492644|NCT01193218|564899128|FG005|12-52 Weeks|Other reason than above|0|||
156492645|NCT01193218|564899129|FG006|12-52 Weeks|Other reason than above|0|||
156492646|NCT01193218|564899130|FG007|12-52 Weeks|Other reason than above|0|||
156492647|NCT00363649|564899131|FG000|Overall Study|Withdrawal by Subject|1|||
156492648|NCT00363649|564899132|FG001|Overall Study|Withdrawal by Subject|1|||
156492649|NCT00363649|564899131|FG000|Overall Study|Adverse Event|6|||
156492650|NCT00363649|564899132|FG001|Overall Study|Adverse Event|0|||
156492651|NCT01013740|564899133|FG000|Overall Study|Lost to Follow-up|3|||
156492652|NCT01013740|564899134|FG001|Overall Study|Lost to Follow-up|5|||
156492653|NCT01013740|564899133|FG000|Overall Study|Physician Decision|2|||
156492654|NCT01013740|564899134|FG001|Overall Study|Physician Decision|0|||
156492655|NCT01013740|564899133|FG000|Overall Study|Withdrawal by Subject|2|||
156492656|NCT01013740|564899134|FG001|Overall Study|Withdrawal by Subject|10|||
156492657|NCT01013740|564899133|FG000|Overall Study|study close / terminated : done in error|2|||
156492658|NCT01013740|564899134|FG001|Overall Study|study close / terminated : done in error|1|||
156492659|NCT01013740|564899133|FG000|Overall Study|Missing|2|||
156492660|NCT01013740|564899134|FG001|Overall Study|Missing|1|||
156492661|NCT01013740|564899133|FG000|Overall Study|Ongoing: Study records not completed|0|||
156492662|NCT01013740|564899134|FG001|Overall Study|Ongoing: Study records not completed|2|||
156492663|NCT02161185|564899135|FG000|Treatment Phase|Administrative/Other|7|||
156492664|NCT00776984|564899137|FG000|Overall Study|Adverse Event|8|||
156492665|NCT00776984|564899138|FG001|Overall Study|Adverse Event|2|||
156492666|NCT00776984|564899137|FG000|Overall Study|Protocol Violation|4|||
156492667|NCT00776984|564899138|FG001|Overall Study|Protocol Violation|2|||
156492668|NCT00776984|564899137|FG000|Overall Study|Lost to Follow-up|2|||
156492669|NCT00776984|564899138|FG001|Overall Study|Lost to Follow-up|0|||
156492670|NCT00776984|564899137|FG000|Overall Study|Withdrawal by Subject|12|||
156492671|NCT00776984|564899138|FG001|Overall Study|Withdrawal by Subject|7|||
156492672|NCT00776984|564899137|FG000|Overall Study|Lack of Efficacy|0|||
156492673|NCT00776984|564899138|FG001|Overall Study|Lack of Efficacy|1|||
156492674|NCT00776984|564899137|FG000|Overall Study|Other|5|||
156492675|NCT00776984|564899138|FG001|Overall Study|Other|9|||
156492676|NCT01125566|564899150|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
156492677|NCT01125566|564899151|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
156492678|NCT01125566|564899152|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
156492679|NCT01125566|564899150|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
156492680|NCT01125566|564899151|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
156492681|NCT01125566|564899152|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
156492682|NCT01125566|564899150|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
156492683|NCT01125566|564899151|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
156492684|NCT01125566|564899152|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
156492685|NCT01125566|564899150|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
156492686|NCT01125566|564899151|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
156492687|NCT01125566|564899152|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
156492688|NCT01125566|564899150|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
156371790|NCT00678561|564456510|FG000|Overall Study|Adverse Event|0|||
156371791|NCT00678561|564456511|FG001|Overall Study|Adverse Event|1|||
156371792|NCT00678561|564456512|FG002|Overall Study|Adverse Event|1|||
156371793|NCT00678561|564456513|FG003|Overall Study|Adverse Event|0|||
156371794|NCT00678561|564456514|FG004|Overall Study|Adverse Event|1|||
156371795|NCT00678561|564456515|FG005|Overall Study|Adverse Event|0|||
156371796|NCT00678561|564456516|FG006|Overall Study|Adverse Event|0|||
156371797|NCT00678561|564456517|FG007|Overall Study|Adverse Event|0|||
156371798|NCT00678561|564456510|FG000|Overall Study|Protocol Violation|0|||
156371799|NCT00678561|564456511|FG001|Overall Study|Protocol Violation|0|||
156492689|NCT01125566|564899151|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
156492690|NCT01125566|564899152|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
156492691|NCT01125566|564899150|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
156492692|NCT01125566|564899151|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
156492693|NCT01125566|564899152|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
156492694|NCT01125566|564899150|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
156492695|NCT01125566|564899151|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
156492696|NCT01125566|564899152|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
156371800|NCT00678561|564456512|FG002|Overall Study|Protocol Violation|0|||
156492697|NCT01125566|564899150|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
156371801|NCT00678561|564456513|FG003|Overall Study|Protocol Violation|0|||
156371802|NCT00678561|564456514|FG004|Overall Study|Protocol Violation|1|||
156371803|NCT00678561|564456515|FG005|Overall Study|Protocol Violation|1|||
156492698|NCT01125566|564899151|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
156492699|NCT01125566|564899152|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
156492700|NCT01125566|564899150|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
156492701|NCT01125566|564899151|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
156492702|NCT01125566|564899152|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
156492703|NCT01125566|564899150|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
156492704|NCT01125566|564899151|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
156492705|NCT01125566|564899152|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
156492706|NCT01125566|564899150|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
156492707|NCT01125566|564899151|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
156492708|NCT01125566|564899152|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
156492709|NCT01125566|564899150|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
156492710|NCT01125566|564899151|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
156492711|NCT01125566|564899152|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
156492712|NCT00988117|564899153|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
156492713|NCT00988117|564899153|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
156492714|NCT04088500|564899154|FG000|Overall Study|Reason unknown|1|||
156492715|NCT04088500|564899154|FG000|Overall Study|Participant withdrew consent|1|||
156492716|NCT04088500|564899154|FG000|Overall Study|Disease progression|3|||
156492717|NCT01208870|564899155|FG000|Overall Study|Lost to Follow-up|2|||
156492718|NCT01208870|564899156|FG001|Overall Study|Lost to Follow-up|8|||
156492719|NCT01121185|564899157|FG000|Overall Study|Not infused|0|||
156492720|NCT01121185|564899158|FG001|Overall Study|Not infused|1|||
156492721|NCT01121185|564899157|FG000|Overall Study|Not transplanted|1|||
156492722|NCT01121185|564899158|FG001|Overall Study|Not transplanted|0|||
156492723|NCT01260142|564899159|FG000|Treatment Period 1|Study on hold|1|||
156492724|NCT01260142|564899160|FG001|Treatment Period 1|Study on hold|1|||
156492725|NCT01260142|564899161|FG002|Treatment Period 1|Study on hold|0|||
156492726|NCT01260142|564899162|FG003|Treatment Period 1|Study on hold|0|||
156492727|NCT01260142|564899163|FG004|Treatment Period 1|Study on hold|1|||
156492728|NCT01260142|564899164|FG005|Treatment Period 1|Study on hold|2|||
156492729|NCT01260142|564899159|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
156492730|NCT01260142|564899160|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
156492731|NCT01260142|564899161|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
156492732|NCT01260142|564899162|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
156492733|NCT01260142|564899163|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
156492734|NCT01260142|564899164|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
156492735|NCT01260142|564899159|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156492736|NCT01260142|564899160|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156492737|NCT01260142|564899161|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156492738|NCT01260142|564899162|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156492739|NCT01260142|564899163|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156492740|NCT01260142|564899164|FG005|Treatment Period 1|Withdrawal by Subject|1|||
156492741|NCT01091519|564899172|FG000|Overall Study|Adverse Event|12|||
156492742|NCT01091519|564899173|FG001|Overall Study|Adverse Event|16|||
156492743|NCT01091519|564899172|FG000|Overall Study|Death|1|||
156492744|NCT01091519|564899173|FG001|Overall Study|Death|0|||
156492745|NCT01091519|564899172|FG000|Overall Study|Lack of Efficacy|16|||
156492746|NCT01091519|564899173|FG001|Overall Study|Lack of Efficacy|19|||
156492747|NCT01091519|564899172|FG000|Overall Study|Lost to Follow-up|14|||
156492748|NCT01091519|564899173|FG001|Overall Study|Lost to Follow-up|24|||
156492749|NCT01091519|564899172|FG000|Overall Study|Withdrawal by Subject|2|||
156492750|NCT01091519|564899173|FG001|Overall Study|Withdrawal by Subject|2|||
156492751|NCT01091519|564899172|FG000|Overall Study|Other|6|||
156492752|NCT01091519|564899173|FG001|Overall Study|Other|8|||
156492753|NCT01091519|564899172|FG000|Overall Study|Randomized not treated|4|||
156492754|NCT01091519|564899173|FG001|Overall Study|Randomized not treated|4|||
156492755|NCT00496834|564899176|FG000|Overall Study|Withdrawal by Subject|4|||
156492756|NCT00496834|564899177|FG001|Overall Study|Withdrawal by Subject|6|||
156492757|NCT00496834|564899176|FG000|Overall Study|Contraindicated medication administered|0|||
156492758|NCT00496834|564899177|FG001|Overall Study|Contraindicated medication administered|1|||
156492759|NCT00496834|564899176|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
156492760|NCT00496834|564899177|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
156492761|NCT00496834|564899176|FG000|Overall Study|Adverse Event|5|||
156492762|NCT00496834|564899177|FG001|Overall Study|Adverse Event|3|||
156492763|NCT00496834|564899176|FG000|Overall Study|IP administration violation|2|||
156546300|NCT00183274|565093325|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
156492764|NCT00496834|564899177|FG001|Overall Study|IP administration violation|0|||
156492765|NCT00496834|564899176|FG000|Overall Study|Lost to Follow-up|2|||
156492766|NCT00496834|564899177|FG001|Overall Study|Lost to Follow-up|0|||
156492767|NCT00496834|564899176|FG000|Overall Study|Blood Pressure control failure|2|||
156492768|NCT00496834|564899177|FG001|Overall Study|Blood Pressure control failure|1|||
156371804|NCT00678561|564456516|FG006|Overall Study|Protocol Violation|0|||
156371805|NCT00678561|564456517|FG007|Overall Study|Protocol Violation|0|||
156371806|NCT00678561|564456510|FG000|Overall Study|Withdrawal by Subject|0|||
156371807|NCT00678561|564456511|FG001|Overall Study|Withdrawal by Subject|0|||
156371808|NCT00678561|564456512|FG002|Overall Study|Withdrawal by Subject|0|||
156371809|NCT00678561|564456513|FG003|Overall Study|Withdrawal by Subject|0|||
156371810|NCT00678561|564456514|FG004|Overall Study|Withdrawal by Subject|0|||
156371811|NCT00678561|564456515|FG005|Overall Study|Withdrawal by Subject|0|||
156371812|NCT00678561|564456516|FG006|Overall Study|Withdrawal by Subject|0|||
156371813|NCT00678561|564456517|FG007|Overall Study|Withdrawal by Subject|1|||
156371814|NCT02920983|564456518|FG000|Dispense 1|Unacceptable Lens Fit|0|||
156371815|NCT02920983|564456519|FG001|Dispense 1|Unacceptable Lens Fit|0|||
156371816|NCT02920983|564456520|FG002|Dispense 1|Unacceptable Lens Fit|0|||
156371817|NCT02920983|564456521|FG003|Dispense 1|Unacceptable Lens Fit|0|||
156371818|NCT02920983|564456522|FG004|Dispense 1|Unacceptable Lens Fit|1|||
156371819|NCT02920983|564456523|FG005|Dispense 1|Unacceptable Lens Fit|0|||
156371820|NCT02920983|564456518|FG000|Dispense 2|Unscceptable lens fit|1|||
156371821|NCT02920983|564456519|FG001|Dispense 2|Unscceptable lens fit|0|||
156371822|NCT02920983|564456520|FG002|Dispense 2|Unscceptable lens fit|0|||
156371823|NCT02920983|564456521|FG003|Dispense 2|Unscceptable lens fit|0|||
156371824|NCT02920983|564456522|FG004|Dispense 2|Unscceptable lens fit|1|||
156371825|NCT02920983|564456523|FG005|Dispense 2|Unscceptable lens fit|0|||
156371826|NCT02920983|564456518|FG000|Dispense 3|Unacceptable Lens Fit|1|||
156371827|NCT02920983|564456519|FG001|Dispense 3|Unacceptable Lens Fit|1|||
156371828|NCT02920983|564456520|FG002|Dispense 3|Unacceptable Lens Fit|0|||
156371829|NCT02920983|564456521|FG003|Dispense 3|Unacceptable Lens Fit|0|||
156371830|NCT02920983|564456522|FG004|Dispense 3|Unacceptable Lens Fit|1|||
156371831|NCT02920983|564456523|FG005|Dispense 3|Unacceptable Lens Fit|0|||
156371832|NCT01451424|564456524|FG000|Overall Study|Withdrawal by Subject|1|||
156371833|NCT01451424|564456525|FG001|Overall Study|Withdrawal by Subject|1|||
156371834|NCT01451424|564456526|FG002|Overall Study|Withdrawal by Subject|0|||
156371835|NCT01451424|564456527|FG003|Overall Study|Withdrawal by Subject|2|||
156371836|NCT01451424|564456524|FG000|Overall Study|Lost to Follow-up|0|||
156371837|NCT01451424|564456525|FG001|Overall Study|Lost to Follow-up|1|||
156371838|NCT01451424|564456526|FG002|Overall Study|Lost to Follow-up|0|||
156371839|NCT01451424|564456527|FG003|Overall Study|Lost to Follow-up|1|||
156371840|NCT01451424|564456524|FG000|Overall Study|Physician Decision|0|||
156371841|NCT01451424|564456525|FG001|Overall Study|Physician Decision|0|||
156371842|NCT01451424|564456526|FG002|Overall Study|Physician Decision|1|||
156371843|NCT01451424|564456527|FG003|Overall Study|Physician Decision|1|||
156371844|NCT01451424|564456524|FG000|Overall Study|Adverse Event|0|||
156371845|NCT01451424|564456525|FG001|Overall Study|Adverse Event|0|||
156371846|NCT01451424|564456526|FG002|Overall Study|Adverse Event|0|||
156371847|NCT01451424|564456527|FG003|Overall Study|Adverse Event|1|||
156371848|NCT01387607|564456533|FG000|Overall Study|Adverse Event|23|||
156371849|NCT01387607|564456534|FG001|Overall Study|Adverse Event|11|||
156371850|NCT01387607|564456533|FG000|Overall Study|Lack of Efficacy|8|||
156371851|NCT01387607|564456534|FG001|Overall Study|Lack of Efficacy|6|||
156371852|NCT01387607|564456533|FG000|Overall Study|Lost to Follow-up|2|||
156371853|NCT01387607|564456534|FG001|Overall Study|Lost to Follow-up|1|||
156371854|NCT01387607|564456533|FG000|Overall Study|No longer meets eligibility criteria|0|||
156371855|NCT01387607|564456534|FG001|Overall Study|No longer meets eligibility criteria|1|||
156371856|NCT01387607|564456533|FG000|Overall Study|Protocol Violation|1|||
156371857|NCT01387607|564456534|FG001|Overall Study|Protocol Violation|5|||
156371858|NCT01387607|564456533|FG000|Overall Study|Withdrawal by Subject|13|||
156371859|NCT01387607|564456534|FG001|Overall Study|Withdrawal by Subject|14|||
156371860|NCT01387607|564456533|FG000|Overall Study|Other|1|||
156371861|NCT01387607|564456534|FG001|Overall Study|Other|1|||
156371862|NCT01387607|564456533|FG000|Overall Study|Randomized, not treated|3|||
156371863|NCT01387607|564456534|FG001|Overall Study|Randomized, not treated|6|||
156371864|NCT02908529|564456536|FG000|Overall Study|Lost to Follow-up|0|||
156371865|NCT02908529|564456537|FG001|Overall Study|Lost to Follow-up|2|||
156371866|NCT04497987|564456538|FG000|Overall Study|Adverse Event|1|||
156371867|NCT04497987|564456539|FG001|Overall Study|Adverse Event|0|||
156371868|NCT04497987|564456538|FG000|Overall Study|Death|21|||
156371869|NCT04497987|564456539|FG001|Overall Study|Death|13|||
156371870|NCT04497987|564456538|FG000|Overall Study|Lost to Follow-up|19|||
156371871|NCT04497987|564456539|FG001|Overall Study|Lost to Follow-up|17|||
156371872|NCT04497987|564456538|FG000|Overall Study|Other - as reported by the investigator|22|||
156371873|NCT04497987|564456539|FG001|Overall Study|Other - as reported by the investigator|16|||
156371874|NCT04497987|564456538|FG000|Overall Study|Physician Decision|1|||
156492769|NCT01227928|564899178|FG000|Overall Study|Lost to Follow-up|4|||
156371875|NCT04497987|564456539|FG001|Overall Study|Physician Decision|0|||
156371876|NCT04497987|564456538|FG000|Overall Study|Withdrawal by Subject|35|||
156371877|NCT04497987|564456539|FG001|Overall Study|Withdrawal by Subject|21|||
156371878|NCT03337724|564456548|FG000|Overall Study|Reason not Specified|12|||
156371879|NCT03337724|564456549|FG001|Overall Study|Reason not Specified|21|||
156371880|NCT03337724|564456550|FG002|Overall Study|Reason not Specified|9|||
156371881|NCT03337724|564456551|FG003|Overall Study|Reason not Specified|9|||
156492770|NCT01227928|564899179|FG001|Overall Study|Lost to Follow-up|2|||
156492771|NCT01227928|564899178|FG000|Overall Study|Withdrawal by Subject|4|||
156492772|NCT01227928|564899179|FG001|Overall Study|Withdrawal by Subject|3|||
156492773|NCT01227928|564899178|FG000|Overall Study|Death|14|||
156492774|NCT01227928|564899179|FG001|Overall Study|Death|12|||
156492775|NCT01204775|564899180|FG000|Overall Study|Poor/non-compliance|0|||
156492776|NCT01204775|564899181|FG001|Overall Study|Poor/non-compliance|1|||
156492777|NCT01204775|564899180|FG000|Overall Study|Withdrawal by Subject|1|||
156492778|NCT01204775|564899181|FG001|Overall Study|Withdrawal by Subject|0|||
156492779|NCT00276016|564899182|FG000|Intervention 1|Withdrawal by Subject|0|||
156492780|NCT00276016|564899183|FG001|Intervention 1|Withdrawal by Subject|1|||
156492781|NCT00276016|564899184|FG002|Intervention 1|Withdrawal by Subject|0|||
156492782|NCT00276016|564899185|FG003|Intervention 1|Withdrawal by Subject|0|||
156492783|NCT00276016|564899186|FG004|Intervention 1|Withdrawal by Subject|0|||
156492784|NCT00276016|564899187|FG005|Intervention 1|Withdrawal by Subject|0|||
156492785|NCT00913523|564900824|FG000|Overall Study|Withdrawal by Subject|3|||
156492786|NCT00913523|564900825|FG001|Overall Study|Withdrawal by Subject|2|||
156492787|NCT00913523|564900826|FG002|Overall Study|Withdrawal by Subject|2|||
156492788|NCT00913523|564900824|FG000|Overall Study|Lost to Follow-up|1|||
156492789|NCT00913523|564900825|FG001|Overall Study|Lost to Follow-up|1|||
156492790|NCT00913523|564900826|FG002|Overall Study|Lost to Follow-up|1|||
156492791|NCT00913523|564900824|FG000|Overall Study|Adverse Event|1|||
156492792|NCT00913523|564900825|FG001|Overall Study|Adverse Event|0|||
156492793|NCT00913523|564900826|FG002|Overall Study|Adverse Event|0|||
156492794|NCT00913523|564900824|FG000|Overall Study|Protocol Violation|5|||
156492795|NCT00913523|564900825|FG001|Overall Study|Protocol Violation|8|||
156492796|NCT00913523|564900826|FG002|Overall Study|Protocol Violation|8|||
156492797|NCT00913523|564900824|FG000|Overall Study|Pregnancy|1|||
156492798|NCT00913523|564900825|FG001|Overall Study|Pregnancy|3|||
156492799|NCT00913523|564900826|FG002|Overall Study|Pregnancy|0|||
156492800|NCT00913523|564900824|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
156492801|NCT00913523|564900825|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
156492802|NCT00913523|564900826|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
156492803|NCT01475461|564900827|FG000|Run-in Period|Not meet eligibility criteria|16|||
156492804|NCT01475461|564900828|FG001|Run-in Period|Not meet eligibility criteria|0|||
156492805|NCT01475461|564900829|FG002|Run-in Period|Not meet eligibility criteria|0|||
156492806|NCT01475461|564900830|FG003|Run-in Period|Not meet eligibility criteria|0|||
156492807|NCT01475461|564900831|FG004|Run-in Period|Not meet eligibility criteria|0|||
156492808|NCT01475461|564900832|FG005|Run-in Period|Not meet eligibility criteria|0|||
156492809|NCT01475461|564900833|FG006|Run-in Period|Not meet eligibility criteria|0|||
156492810|NCT01475461|564900827|FG000|Run-in Period|Lost to Follow-up|7|||
156492811|NCT01475461|564900828|FG001|Run-in Period|Lost to Follow-up|0|||
156492812|NCT01475461|564900829|FG002|Run-in Period|Lost to Follow-up|0|||
156492813|NCT01475461|564900830|FG003|Run-in Period|Lost to Follow-up|0|||
156492814|NCT01475461|564900831|FG004|Run-in Period|Lost to Follow-up|0|||
156546301|NCT00183274|565093326|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
156492815|NCT01475461|564900832|FG005|Run-in Period|Lost to Follow-up|0|||
156492816|NCT01475461|564900833|FG006|Run-in Period|Lost to Follow-up|0|||
156492817|NCT01475461|564900827|FG000|Run-in Period|Withdrawal by Subject|11|||
156492818|NCT01475461|564900828|FG001|Run-in Period|Withdrawal by Subject|0|||
156492819|NCT01475461|564900829|FG002|Run-in Period|Withdrawal by Subject|0|||
156492820|NCT01475461|564900830|FG003|Run-in Period|Withdrawal by Subject|0|||
156492821|NCT01475461|564900831|FG004|Run-in Period|Withdrawal by Subject|0|||
156492822|NCT01475461|564900832|FG005|Run-in Period|Withdrawal by Subject|0|||
156492823|NCT01475461|564900833|FG006|Run-in Period|Withdrawal by Subject|0|||
156492824|NCT01475461|564900827|FG000|Run-in Period|Other|3|||
156492825|NCT01475461|564900828|FG001|Run-in Period|Other|0|||
156492826|NCT01475461|564900829|FG002|Run-in Period|Other|0|||
156492827|NCT01475461|564900830|FG003|Run-in Period|Other|0|||
156492828|NCT01475461|564900831|FG004|Run-in Period|Other|0|||
156492829|NCT01475461|564900832|FG005|Run-in Period|Other|0|||
156492830|NCT01475461|564900833|FG006|Run-in Period|Other|0|||
156492831|NCT01475461|564900827|FG000|Run-in Period|Protocol Violation|4|||
156492832|NCT01475461|564900828|FG001|Run-in Period|Protocol Violation|0|||
156492833|NCT01475461|564900829|FG002|Run-in Period|Protocol Violation|0|||
156492834|NCT01475461|564900830|FG003|Run-in Period|Protocol Violation|0|||
156492835|NCT01475461|564900831|FG004|Run-in Period|Protocol Violation|0|||
156371882|NCT03337724|564456552|FG004|Overall Study|Reason not Specified|29|||
156371883|NCT03337724|564456548|FG000|Overall Study|Withdrawal by Subject|13|||
156371884|NCT03337724|564456549|FG001|Overall Study|Withdrawal by Subject|15|||
156371885|NCT03337724|564456550|FG002|Overall Study|Withdrawal by Subject|4|||
156371886|NCT03337724|564456551|FG003|Overall Study|Withdrawal by Subject|15|||
156371887|NCT03337724|564456552|FG004|Overall Study|Withdrawal by Subject|6|||
156371888|NCT03337724|564456548|FG000|Overall Study|Protocol Deviation|0|||
156371889|NCT03337724|564456549|FG001|Overall Study|Protocol Deviation|1|||
156371890|NCT03337724|564456550|FG002|Overall Study|Protocol Deviation|1|||
156371891|NCT03337724|564456551|FG003|Overall Study|Protocol Deviation|1|||
156371892|NCT03337724|564456552|FG004|Overall Study|Protocol Deviation|0|||
156371893|NCT03337724|564456548|FG000|Overall Study|Adverse Event|1|||
156371894|NCT03337724|564456549|FG001|Overall Study|Adverse Event|1|||
156371895|NCT03337724|564456550|FG002|Overall Study|Adverse Event|0|||
156371896|NCT03337724|564456551|FG003|Overall Study|Adverse Event|1|||
156371897|NCT03337724|564456552|FG004|Overall Study|Adverse Event|0|||
156371898|NCT03337724|564456548|FG000|Overall Study|Death|40|||
156371899|NCT03337724|564456549|FG001|Overall Study|Death|89|||
156371900|NCT03337724|564456550|FG002|Overall Study|Death|43|||
156371901|NCT03337724|564456551|FG003|Overall Study|Death|76|||
156371902|NCT03337724|564456552|FG004|Overall Study|Death|50|||
156371903|NCT03337724|564456548|FG000|Overall Study|Lost to Follow-up|5|||
156371904|NCT03337724|564456549|FG001|Overall Study|Lost to Follow-up|5|||
156371905|NCT03337724|564456550|FG002|Overall Study|Lost to Follow-up|4|||
156371906|NCT03337724|564456551|FG003|Overall Study|Lost to Follow-up|7|||
156371907|NCT03337724|564456552|FG004|Overall Study|Lost to Follow-up|4|||
156371908|NCT03337724|564456548|FG000|Overall Study|Physician Decision|16|||
156371909|NCT03337724|564456549|FG001|Overall Study|Physician Decision|34|||
156371910|NCT03337724|564456550|FG002|Overall Study|Physician Decision|14|||
156371911|NCT03337724|564456551|FG003|Overall Study|Physician Decision|34|||
156371912|NCT03337724|564456552|FG004|Overall Study|Physician Decision|13|||
156371913|NCT03337724|564456548|FG000|Overall Study|Progressive Disease|0|||
156371914|NCT03337724|564456549|FG001|Overall Study|Progressive Disease|2|||
156371915|NCT03337724|564456550|FG002|Overall Study|Progressive Disease|1|||
156371916|NCT03337724|564456551|FG003|Overall Study|Progressive Disease|2|||
156371917|NCT03337724|564456552|FG004|Overall Study|Progressive Disease|0|||
156371918|NCT03337724|564456548|FG000|Overall Study|Symptomatic Deterioration|0|||
156371919|NCT03337724|564456549|FG001|Overall Study|Symptomatic Deterioration|0|||
156371920|NCT03337724|564456550|FG002|Overall Study|Symptomatic Deterioration|0|||
156371921|NCT03337724|564456551|FG003|Overall Study|Symptomatic Deterioration|1|||
156371922|NCT03337724|564456552|FG004|Overall Study|Symptomatic Deterioration|0|||
156371923|NCT00528528|564456553|FG000|Overall Study|Lost to Follow-up|0|||
156371924|NCT00528528|564456554|FG001|Overall Study|Lost to Follow-up|0|||
156371925|NCT00528528|564456555|FG002|Overall Study|Lost to Follow-up|1|||
156371926|NCT00528528|564456556|FG003|Overall Study|Lost to Follow-up|1|||
156371927|NCT00528528|564456553|FG000|Overall Study|Ineligible to continue the trial|0|||
156371928|NCT00528528|564456554|FG001|Overall Study|Ineligible to continue the trial|0|||
156371929|NCT00528528|564456555|FG002|Overall Study|Ineligible to continue the trial|0|||
156371930|NCT00528528|564456556|FG003|Overall Study|Ineligible to continue the trial|1|||
156371931|NCT00528528|564456553|FG000|Overall Study|Other|0|||
156371932|NCT00528528|564456554|FG001|Overall Study|Other|1|||
156371933|NCT00528528|564456555|FG002|Overall Study|Other|0|||
156371934|NCT00528528|564456556|FG003|Overall Study|Other|0|||
156371935|NCT00528528|564456553|FG000|Overall Study|Withdrawal by Subject|3|||
156371936|NCT00528528|564456554|FG001|Overall Study|Withdrawal by Subject|2|||
156371937|NCT00528528|564456555|FG002|Overall Study|Withdrawal by Subject|1|||
156371938|NCT00528528|564456556|FG003|Overall Study|Withdrawal by Subject|1|||
156371939|NCT00528528|564456553|FG000|Overall Study|Ongoing participant|0|||
156371940|NCT00528528|564456554|FG001|Overall Study|Ongoing participant|0|||
156492836|NCT01475461|564900832|FG005|Run-in Period|Protocol Violation|0|||
156492837|NCT01475461|564900833|FG006|Run-in Period|Protocol Violation|0|||
156492838|NCT01475461|564900827|FG000|Treatment Period|Death|0|||
156492839|NCT01475461|564900828|FG001|Treatment Period|Death|0|||
156492840|NCT01475461|564900829|FG002|Treatment Period|Death|0|||
156371941|NCT00528528|564456555|FG002|Overall Study|Ongoing participant|1|||
156371942|NCT00528528|564456556|FG003|Overall Study|Ongoing participant|0|||
156371943|NCT00773097|564456557|FG000|Overall Study|Withdrawal by Subject|1|||
156371944|NCT00773097|564456557|FG000|Overall Study|Physician Decision|6|||
156371945|NCT02573324|564458349|FG000|Overall Study|Withdrawal by Subject|26|||
156371946|NCT02573324|564458350|FG001|Overall Study|Withdrawal by Subject|23|||
156371947|NCT02573324|564458351|FG002|Overall Study|Withdrawal by Subject|3|||
156492841|NCT01475461|564900830|FG003|Treatment Period|Death|1|||
156371948|NCT02573324|564458349|FG000|Overall Study|Lost to Follow-up|4|||
156371949|NCT02573324|564458350|FG001|Overall Study|Lost to Follow-up|5|||
156371950|NCT02573324|564458351|FG002|Overall Study|Lost to Follow-up|0|||
156371951|NCT02573324|564458349|FG000|Overall Study|Study Terminated by Sponsor|107|||
156371952|NCT02573324|564458350|FG001|Overall Study|Study Terminated by Sponsor|89|||
156371953|NCT02573324|564458351|FG002|Overall Study|Study Terminated by Sponsor|2|||
156492842|NCT01475461|564900831|FG004|Treatment Period|Death|0|||
156492843|NCT01475461|564900832|FG005|Treatment Period|Death|0|||
156492844|NCT01475461|564900833|FG006|Treatment Period|Death|0|||
156492845|NCT01475461|564900827|FG000|Treatment Period|Lost to Follow-up|0|||
156492846|NCT01475461|564900828|FG001|Treatment Period|Lost to Follow-up|3|||
156492847|NCT01475461|564900829|FG002|Treatment Period|Lost to Follow-up|2|||
156492848|NCT01475461|564900830|FG003|Treatment Period|Lost to Follow-up|3|||
156492849|NCT01475461|564900831|FG004|Treatment Period|Lost to Follow-up|1|||
156492850|NCT01475461|564900832|FG005|Treatment Period|Lost to Follow-up|2|||
156492851|NCT01475461|564900833|FG006|Treatment Period|Lost to Follow-up|1|||
156492852|NCT01475461|564900827|FG000|Treatment Period|Withdrawal by Subject|0|||
156492853|NCT01475461|564900828|FG001|Treatment Period|Withdrawal by Subject|2|||
156492854|NCT01475461|564900829|FG002|Treatment Period|Withdrawal by Subject|2|||
156492855|NCT01475461|564900830|FG003|Treatment Period|Withdrawal by Subject|0|||
156492856|NCT01475461|564900831|FG004|Treatment Period|Withdrawal by Subject|2|||
156492857|NCT01475461|564900832|FG005|Treatment Period|Withdrawal by Subject|2|||
156492858|NCT01475461|564900833|FG006|Treatment Period|Withdrawal by Subject|0|||
156492859|NCT01475461|564900827|FG000|Treatment Period|Other|0|||
156492860|NCT01475461|564900828|FG001|Treatment Period|Other|1|||
156492861|NCT01475461|564900829|FG002|Treatment Period|Other|0|||
156492862|NCT01475461|564900830|FG003|Treatment Period|Other|0|||
156492863|NCT01475461|564900831|FG004|Treatment Period|Other|0|||
156492864|NCT01475461|564900832|FG005|Treatment Period|Other|0|||
156492865|NCT01475461|564900833|FG006|Treatment Period|Other|0|||
156492866|NCT01475461|564900827|FG000|Treatment Period|Protocol Violation|0|||
156492867|NCT01475461|564900828|FG001|Treatment Period|Protocol Violation|1|||
156492868|NCT01475461|564900829|FG002|Treatment Period|Protocol Violation|0|||
156492869|NCT01475461|564900830|FG003|Treatment Period|Protocol Violation|0|||
156492870|NCT01475461|564900831|FG004|Treatment Period|Protocol Violation|0|||
156492871|NCT01475461|564900832|FG005|Treatment Period|Protocol Violation|0|||
156492872|NCT01475461|564900833|FG006|Treatment Period|Protocol Violation|1|||
156492873|NCT01475461|564900827|FG000|Treatment Period|Lack of Efficacy|0|||
156492874|NCT01475461|564900828|FG001|Treatment Period|Lack of Efficacy|2|||
156492875|NCT01475461|564900829|FG002|Treatment Period|Lack of Efficacy|0|||
156492876|NCT01475461|564900830|FG003|Treatment Period|Lack of Efficacy|2|||
156492877|NCT01475461|564900831|FG004|Treatment Period|Lack of Efficacy|1|||
156492878|NCT01475461|564900832|FG005|Treatment Period|Lack of Efficacy|1|||
156492879|NCT01475461|564900833|FG006|Treatment Period|Lack of Efficacy|0|||
156492880|NCT01475461|564900827|FG000|Treatment Period|Medication Error|0|||
156492881|NCT01475461|564900828|FG001|Treatment Period|Medication Error|0|||
156492882|NCT01475461|564900829|FG002|Treatment Period|Medication Error|0|||
156492883|NCT01475461|564900830|FG003|Treatment Period|Medication Error|1|||
156492884|NCT01475461|564900831|FG004|Treatment Period|Medication Error|0|||
156492885|NCT01475461|564900832|FG005|Treatment Period|Medication Error|0|||
156492886|NCT01475461|564900833|FG006|Treatment Period|Medication Error|0|||
156492887|NCT01475461|564900827|FG000|Treatment Period|Adverse Event|0|||
156492888|NCT01475461|564900828|FG001|Treatment Period|Adverse Event|0|||
156492889|NCT01475461|564900829|FG002|Treatment Period|Adverse Event|0|||
156492890|NCT01475461|564900830|FG003|Treatment Period|Adverse Event|1|||
156492891|NCT01475461|564900831|FG004|Treatment Period|Adverse Event|0|||
156492892|NCT01475461|564900832|FG005|Treatment Period|Adverse Event|0|||
156371954|NCT02573324|564458349|FG000|Overall Study|Death|182|||
156371955|NCT02573324|564458350|FG001|Overall Study|Death|200|||
156371956|NCT02573324|564458351|FG002|Overall Study|Death|1|||
156371957|NCT02573324|564458349|FG000|Overall Study|Other, Not Specified|20|||
156371958|NCT02573324|564458350|FG001|Overall Study|Other, Not Specified|27|||
156492893|NCT01475461|564900833|FG006|Treatment Period|Adverse Event|0|||
156492894|NCT04051242|564900834|FG000|Overall Study|Withdrawal by Subject|1|||
156492895|NCT04051242|564900834|FG000|Overall Study|Physician Decision|1|||
156371959|NCT02573324|564458351|FG002|Overall Study|Other, Not Specified|0|||
156492896|NCT02512861|564900837|FG000|Overall Study|Protocol Violation|3|||
156492897|NCT02512861|564900838|FG001|Overall Study|Protocol Violation|7|||
156492898|NCT02512861|564900837|FG000|Overall Study|Physician Decision|3|||
156492899|NCT02512861|564900838|FG001|Overall Study|Physician Decision|1|||
156492900|NCT02512861|564900837|FG000|Overall Study|Withdrawal by Subject|0|||
156492901|NCT02512861|564900838|FG001|Overall Study|Withdrawal by Subject|1|||
156492902|NCT00553605|564900839|FG000|Overall Study|Did not meet entrance criteria|1|||
156492903|NCT00553605|564900840|FG001|Overall Study|Did not meet entrance criteria|3|||
156492904|NCT00553605|564900839|FG000|Overall Study|Did not receive full dose|1|||
156492905|NCT00553605|564900840|FG001|Overall Study|Did not receive full dose|0|||
156492906|NCT00553605|564900839|FG000|Overall Study|Randomized but not treated|2|||
156492907|NCT00553605|564900840|FG001|Overall Study|Randomized but not treated|0|||
156492908|NCT01874665|564900842|FG000|Overall Study|Adverse Event|6|||
156492909|NCT01874665|564900843|FG001|Overall Study|Adverse Event|2|||
156492910|NCT01874665|564900842|FG000|Overall Study|Withdrawal by Subject|4|||
156492911|NCT01874665|564900843|FG001|Overall Study|Withdrawal by Subject|1|||
156492912|NCT01874665|564900842|FG000|Overall Study|Physician Decision|3|||
156492913|NCT01874665|564900843|FG001|Overall Study|Physician Decision|0|||
156492914|NCT01874665|564900842|FG000|Overall Study|Clinical Progressive Disease|4|||
156492915|NCT01874665|564900843|FG001|Overall Study|Clinical Progressive Disease|3|||
156492916|NCT01874665|564900842|FG000|Overall Study|Study Terminated by Sponsor|0|||
156492917|NCT01874665|564900843|FG001|Overall Study|Study Terminated by Sponsor|2|||
156492918|NCT01874665|564900842|FG000|Overall Study|Documented Progressive Disease|11|||
156492919|NCT01874665|564900843|FG001|Overall Study|Documented Progressive Disease|7|||
156492920|NCT01874665|564900842|FG000|Overall Study|Other|2|||
156492921|NCT01874665|564900843|FG001|Overall Study|Other|0|||
156492922|NCT02447432|564900846|FG000|Epoch 001|Adverse Event|1|||
156492923|NCT02447432|564900847|FG001|Epoch 001|Adverse Event|1|||
156492924|NCT02447432|564900846|FG000|Epoch 001|Withdrawal by Subject|0|||
156492925|NCT02447432|564900847|FG001|Epoch 001|Withdrawal by Subject|4|||
156492926|NCT02447432|564900846|FG000|Epoch 001|Migrated/moved from study area|3|||
156492927|NCT02447432|564900847|FG001|Epoch 001|Migrated/moved from study area|5|||
156492928|NCT02447432|564900846|FG000|Epoch 001|Lost to Follow-up|1|||
156492929|NCT02447432|564900847|FG001|Epoch 001|Lost to Follow-up|3|||
156492930|NCT00776659|564900850|FG000|Overall Study|Lost to Follow-up|15|||
156492931|NCT00776659|564900850|FG000|Overall Study|Withdrawal by Subject|10|||
156492932|NCT00776659|564900850|FG000|Overall Study|Study Terminated by Sponsor|1|||
156492933|NCT01585298|564900851|FG000|Overall Study|Study completion was not documented.|1|||
156492934|NCT01585298|564900851|FG000|Overall Study|Protocol deviation|1|||
156492935|NCT01585298|564900851|FG000|Overall Study|Administrative problems|4|||
156492936|NCT01585298|564900851|FG000|Overall Study|Lost to Follow-up|2|||
156492937|NCT01585298|564900851|FG000|Overall Study|Withdrawal by Subject|4|||
156492938|NCT01585298|564900851|FG000|Overall Study|Abnormal test procedure results|1|||
156492939|NCT01585298|564900851|FG000|Overall Study|Adverse Event|24|||
156492940|NCT00545571|564900856|FG000|Overall Study|Administrative Reasons|1|||
156492941|NCT00545571|564900856|FG000|Overall Study|Adverse Event|2|||
156492942|NCT00545571|564900856|FG000|Overall Study|Death|5|||
156492943|NCT00545571|564900856|FG000|Overall Study|Lack of Efficacy|1|||
156492944|NCT00545571|564900856|FG000|Overall Study|Protocol Violation|2|||
156492945|NCT00545571|564900856|FG000|Overall Study|Refused Treatment|1|||
156492946|NCT00545571|564900856|FG000|Overall Study|Screen Failure|16|||
156492947|NCT00545571|564900856|FG000|Overall Study|Transfusion|12|||
156492948|NCT00545571|564900856|FG000|Overall Study|Early Termination of Study|24|||
156492949|NCT00545571|564900856|FG000|Overall Study|Kidney Transplantation|3|||
156492950|NCT01978236|564900857|FG000|Overall Study|Discontinued due to study close|2|||
156492951|NCT00874497|564900858|FG000|Overall Study|Lost to Follow-up|2|||
156492952|NCT00874497|564900859|FG001|Overall Study|Lost to Follow-up|4|||
156492953|NCT00874497|564900858|FG000|Overall Study|Adverse Event|9|||
156492954|NCT00874497|564900859|FG001|Overall Study|Adverse Event|4|||
156492955|NCT00874497|564900858|FG000|Overall Study|Sponsor Discontinued Trial|7|||
156492956|NCT00874497|564900859|FG001|Overall Study|Sponsor Discontinued Trial|3|||
156492957|NCT00874497|564900858|FG000|Overall Study|Met Withdrawal Criteria|4|||
156492958|NCT00874497|564900859|FG001|Overall Study|Met Withdrawal Criteria|2|||
156492959|NCT00874497|564900858|FG000|Overall Study|Physician Decision|1|||
156492960|NCT00874497|564900859|FG001|Overall Study|Physician Decision|1|||
156492961|NCT00874497|564900858|FG000|Overall Study|Withdrawal by Subject|5|||
156492962|NCT00874497|564900859|FG001|Overall Study|Withdrawal by Subject|4|||
156492963|NCT04353817|564900862|FG000|Overall Study|Adverse Event|0|||
156492964|NCT04353817|564900863|FG001|Overall Study|Adverse Event|1|||
156492965|NCT00665223|564900866|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
156492966|NCT00665223|564900867|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
156492967|NCT00665223|564900868|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
156492968|NCT00665223|564900866|FG000|Randomized Phase (26 Weeks)|Death|0|||
156492969|NCT00665223|564900867|FG001|Randomized Phase (26 Weeks)|Death|0|||
156492970|NCT00665223|564900868|FG002|Randomized Phase (26 Weeks)|Death|1|||
156492971|NCT00665223|564900866|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
156492972|NCT00665223|564900867|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
156492973|NCT00665223|564900868|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
156492974|NCT00665223|564900866|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
156492975|NCT00665223|564900867|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
156492976|NCT00665223|564900868|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
156492977|NCT00665223|564900866|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
156546302|NCT00183274|565093327|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
156492978|NCT00665223|564900867|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
156492979|NCT00665223|564900868|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
156492980|NCT00665223|564900866|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
156492981|NCT00665223|564900867|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
156492982|NCT00665223|564900868|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
156492983|NCT00665223|564900866|FG000|Open-Label Period (26 Weeks)|Death|0|||
156492984|NCT00665223|564900867|FG001|Open-Label Period (26 Weeks)|Death|1|||
156492985|NCT00665223|564900868|FG002|Open-Label Period (26 Weeks)|Death|0|||
156492986|NCT00665223|564900866|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
156492987|NCT00665223|564900867|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
156492988|NCT00665223|564900868|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
156492989|NCT00665223|564900866|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
156492990|NCT00665223|564900867|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
156492991|NCT00665223|564900868|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
156492992|NCT00665223|564900866|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
156492993|NCT00665223|564900867|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
156492994|NCT00665223|564900868|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
156492995|NCT00665223|564900866|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
156492996|NCT00665223|564900867|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
156492997|NCT00665223|564900868|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
156492998|NCT00591591|564900869|FG000|Overall Study|Withdrawal by Subject|1|||
156492999|NCT00591591|564900870|FG001|Overall Study|Withdrawal by Subject|37|||
156493000|NCT00591591|564900869|FG000|Overall Study|Lack of Efficacy|10|||
156493001|NCT00591591|564900870|FG001|Overall Study|Lack of Efficacy|2|||
156493002|NCT00002597|564900871|FG000|Overall Study|Protocol Violation|19|||
156493003|NCT00002597|564900872|FG001|Overall Study|Protocol Violation|17|||
156493004|NCT00002597|564900871|FG000|Overall Study|Withdrawal by Subject|7|||
156493005|NCT00002597|564900872|FG001|Overall Study|Withdrawal by Subject|6|||
156493006|NCT03811834|564900873|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
156493007|NCT01527500|564900874|FG000|Part A|Administrative|11|||
156493008|NCT01527500|564900875|FG001|Part A|Administrative|7|||
156493009|NCT01527500|564900874|FG000|Part A|Adverse Event|4|||
156493010|NCT01527500|564900875|FG001|Part A|Adverse Event|2|||
156493011|NCT01527500|564900874|FG000|Part A|Death|4|||
156493012|NCT01527500|564900875|FG001|Part A|Death|1|||
156493013|NCT01527500|564900874|FG000|Part A|Lost to Follow-up|0|||
156493014|NCT01527500|564900875|FG001|Part A|Lost to Follow-up|1|||
156493015|NCT01527500|564900874|FG000|Part A|Protocol Deviation|9|||
156493016|NCT01527500|564900875|FG001|Part A|Protocol Deviation|2|||
156493017|NCT01527500|564900874|FG000|Part A|Withdrawal by Subject|2|||
156493018|NCT01527500|564900875|FG001|Part A|Withdrawal by Subject|0|||
156493019|NCT01527500|564900874|FG000|Part B|Adverse Event|1|||
156493020|NCT01527500|564900875|FG001|Part B|Adverse Event|0|||
156493021|NCT00372255|564900876|FG000|Overall Study|Withdrawn for other reasons|2|||
156493022|NCT00372255|564900877|FG001|Overall Study|Withdrawn for other reasons|1|||
156493023|NCT02573883|564900881|FG000|Six Month Follow Up|Lost to Follow-up|1|||
156493024|NCT02573883|564900882|FG001|Six Month Follow Up|Lost to Follow-up|0|||
156493025|NCT02573883|564900883|FG002|Six Month Follow Up|Lost to Follow-up|0|||
156493026|NCT02573883|564900884|FG003|Six Month Follow Up|Lost to Follow-up|0|||
156493027|NCT02573883|564900881|FG000|One Year Follow Up|Lost to Follow-up|2|||
156493028|NCT02573883|564900882|FG001|One Year Follow Up|Lost to Follow-up|1|||
156493029|NCT02573883|564900883|FG002|One Year Follow Up|Lost to Follow-up|0|||
156493030|NCT02573883|564900884|FG003|One Year Follow Up|Lost to Follow-up|0|||
156493031|NCT00582114|564900885|FG000|Overall Study|Death|4|||
156493032|NCT00582114|564900886|FG001|Overall Study|Death|4|||
156493033|NCT00582114|564900885|FG000|Overall Study|Kidney Transplant|3|||
156493034|NCT00582114|564900886|FG001|Overall Study|Kidney Transplant|1|||
156493035|NCT00582114|564900885|FG000|Overall Study|Lost to Follow-up|7|||
156493036|NCT00582114|564900886|FG001|Overall Study|Lost to Follow-up|6|||
156493037|NCT00582114|564900885|FG000|Overall Study|Withdrawal by Subject|8|||
156493038|NCT00582114|564900886|FG001|Overall Study|Withdrawal by Subject|16|||
156493039|NCT00582114|564900885|FG000|Overall Study|Adverse Event|1|||
156493040|NCT00582114|564900886|FG001|Overall Study|Adverse Event|1|||
156493041|NCT00582114|564900885|FG000|Overall Study|Physician Decision|0|||
156493042|NCT00582114|564900886|FG001|Overall Study|Physician Decision|6|||
156493043|NCT00582114|564900885|FG000|Overall Study|Stopped by data safety monitoring board|19|||
156493044|NCT00582114|564900886|FG001|Overall Study|Stopped by data safety monitoring board|20|||
156493045|NCT00130728|564900887|FG000|Overall Study|Death|258|||
156493046|NCT00130728|564900888|FG001|Overall Study|Death|258|||
156493047|NCT00130728|564900887|FG000|Overall Study|Lost to Follow-up|4|||
156493048|NCT00130728|564900888|FG001|Overall Study|Lost to Follow-up|0|||
156493049|NCT00130728|564900887|FG000|Overall Study|Withdrawal by Subject|0|||
156493050|NCT00130728|564900888|FG001|Overall Study|Withdrawal by Subject|2|||
156493051|NCT03796208|564900890|FG000|Overall Study|Withdrawal by Subject|3|||
156493052|NCT03796208|564900891|FG001|Overall Study|Withdrawal by Subject|0|||
156493053|NCT03796208|564900890|FG000|Overall Study|Loss of pregnancy|1|||
156493054|NCT03796208|564900891|FG001|Overall Study|Loss of pregnancy|1|||
156493055|NCT03796208|564900890|FG000|Overall Study|Changed prenatal clinics|0|||
156493056|NCT03796208|564900891|FG001|Overall Study|Changed prenatal clinics|5|||
156493057|NCT03796208|564900890|FG000|Overall Study|Lost to Follow-up|20|||
156493058|NCT03796208|564900891|FG001|Overall Study|Lost to Follow-up|16|||
156493059|NCT01560585|564900893|FG000|Overall Study|Physician Decision|3|||
156493060|NCT00519285|564900894|FG000|Overall Study|Adverse Event|127|||
156493061|NCT00519285|564900895|FG001|Overall Study|Adverse Event|266|||
156493062|NCT00519285|564900894|FG000|Overall Study|Disease progression|334|||
156493063|NCT00519285|564900895|FG001|Overall Study|Disease progression|186|||
156493064|NCT00519285|564900894|FG000|Overall Study|Physician Decision|75|||
156493065|NCT00519285|564900895|FG001|Overall Study|Physician Decision|47|||
156493066|NCT00519285|564900894|FG000|Overall Study|Participant's request|53|||
156493067|NCT00519285|564900895|FG001|Overall Study|Participant's request|84|||
156493068|NCT00519285|564900894|FG000|Overall Study|Consent withdrawn|4|||
156493069|NCT00519285|564900895|FG001|Overall Study|Consent withdrawn|5|||
156493070|NCT00519285|564900894|FG000|Overall Study|Poor compliance to protocol|5|||
156493071|NCT00519285|564900895|FG001|Overall Study|Poor compliance to protocol|7|||
156493072|NCT00519285|564900894|FG000|Overall Study|Reason unspecified|5|||
156493073|NCT00519285|564900895|FG001|Overall Study|Reason unspecified|8|||
156493074|NCT00519285|564900894|FG000|Overall Study|Not treated|8|||
156493075|NCT00519285|564900895|FG001|Overall Study|Not treated|7|||
156493076|NCT00519285|564900894|FG000|Overall Study|Treatment ongoing|1|||
156493077|NCT00519285|564900895|FG001|Overall Study|Treatment ongoing|2|||
156493078|NCT00983892|564900896|FG000|Overall Study|Withdrawal by Subject|10|||
156493079|NCT00983892|564900897|FG001|Overall Study|Withdrawal by Subject|12|||
156493080|NCT02175745|564900898|FG000|Overall Study|Not Eligible|1|||
156493081|NCT01726517|564900900|FG000|Overall Study|Withdrawal by Subject|0|||
156493082|NCT01726517|564900901|FG001|Overall Study|Withdrawal by Subject|0|||
156493083|NCT01726517|564900902|FG002|Overall Study|Withdrawal by Subject|1|||
156493084|NCT01726517|564900903|FG003|Overall Study|Withdrawal by Subject|0|||
156493085|NCT01726517|564900904|FG004|Overall Study|Withdrawal by Subject|0|||
156493086|NCT03765164|564900905|FG000|Pre-intervention|Withdrawal by Subject|5|||
156493087|NCT03765164|564900906|FG001|Pre-intervention|Withdrawal by Subject|6|||
156493088|NCT00770588|564900907|FG000|Overall Study|Adverse Event|9|||
156493089|NCT00770588|564900908|FG001|Overall Study|Adverse Event|2|||
156493090|NCT00770588|564900907|FG000|Overall Study|Death caused by progression of disease|70|||
156493091|NCT00770588|564900908|FG001|Overall Study|Death caused by progression of disease|91|||
156493092|NCT00770588|564900907|FG000|Overall Study|Lost to Follow-up|1|||
156493093|NCT00770588|564900908|FG001|Overall Study|Lost to Follow-up|1|||
156493094|NCT00770588|564900907|FG000|Overall Study|Withdrawal by Subject|1|||
156493095|NCT00770588|564900908|FG001|Overall Study|Withdrawal by Subject|1|||
156493096|NCT01424189|564900909|FG000|Overall Study|Adverse Event|1|||
156493097|NCT01424189|564900910|FG001|Overall Study|Adverse Event|0|||
156493098|NCT01424189|564900909|FG000|Overall Study|Lost to Follow-up|4|||
156493099|NCT01424189|564900910|FG001|Overall Study|Lost to Follow-up|1|||
156493100|NCT01424189|564900909|FG000|Overall Study|Withdrawal by Subject|4|||
156493101|NCT01424189|564900910|FG001|Overall Study|Withdrawal by Subject|4|||
156493102|NCT01424189|564900909|FG000|Overall Study|Subject moved|1|||
156493103|NCT01424189|564900910|FG001|Overall Study|Subject moved|0|||
156493104|NCT01424189|564900909|FG000|Overall Study|Death|3|||
156493105|NCT01424189|564900910|FG001|Overall Study|Death|1|||
156493106|NCT03120949|564900911|FG000|Overall Study|randomized in error|1|||
156493107|NCT03120949|564900912|FG001|Overall Study|randomized in error|0|||
156493108|NCT03120949|564900911|FG000|Overall Study|Death|13|||
156493109|NCT03120949|564900912|FG001|Overall Study|Death|13|||
156493110|NCT03120949|564900911|FG000|Overall Study|Lost to Follow-up|23|||
156493111|NCT03120949|564900912|FG001|Overall Study|Lost to Follow-up|13|||
156493112|NCT03120949|564900911|FG000|Overall Study|Withdrawal by Subject|139|||
156493113|NCT03120949|564900912|FG001|Overall Study|Withdrawal by Subject|124|||
156493114|NCT03120949|564900911|FG000|Overall Study|Covid-19|43|||
156493115|NCT03120949|564900912|FG001|Overall Study|Covid-19|34|||
156493116|NCT03120949|564900911|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
156493117|NCT03120949|564900912|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
156493118|NCT03120949|564900911|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
156493119|NCT03120949|564900912|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
156493120|NCT03120949|564900911|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
156493121|NCT03120949|564900912|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
156493122|NCT03120949|564900911|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
156493123|NCT03120949|564900912|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
156493124|NCT03120949|564900911|FG000|Overall Study|Site was closed|2|||
156493125|NCT03120949|564900912|FG001|Overall Study|Site was closed|3|||
156493126|NCT03120949|564900911|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
156493127|NCT03120949|564900912|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
156493128|NCT03120949|564900911|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
156493129|NCT03120949|564900912|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
156493130|NCT03120949|564900911|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
156493131|NCT03120949|564900912|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
156493132|NCT03120949|564900911|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
156493133|NCT03120949|564900912|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
156493134|NCT03120949|564900911|FG000|Overall Study|Other: Adverse Event|0|||
156493135|NCT03120949|564900912|FG001|Overall Study|Other: Adverse Event|1|||
156493136|NCT03120949|564900911|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
156493137|NCT03120949|564900912|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
156493138|NCT03120949|564900911|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
156493139|NCT03120949|564900912|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
156493140|NCT03120949|564900911|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
156493141|NCT03120949|564900912|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
156493142|NCT03120949|564900911|FG000|Overall Study|Personal Reasons|0|||
156493143|NCT03120949|564900912|FG001|Overall Study|Personal Reasons|1|||
156493144|NCT03120949|564900911|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
156493145|NCT03120949|564900912|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
156493146|NCT03120949|564900911|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
156493147|NCT03120949|564900912|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
156493148|NCT03120949|564900911|FG000|Overall Study|Compliance With Medication|0|||
156493149|NCT03120949|564900912|FG001|Overall Study|Compliance With Medication|1|||
156493150|NCT03120949|564900911|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
156493151|NCT03120949|564900912|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
156493152|NCT03120949|564900911|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
156493153|NCT03120949|564900912|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
156493154|NCT03120949|564900911|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
156493155|NCT03120949|564900912|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
156493156|NCT04206384|564900914|FG000|Overall Study|Withdrawal by Subject|8|||
156493157|NCT04206384|564900914|FG000|Overall Study|Adverse Event|2|||
156493158|NCT01078584|564900915|FG000|Overall Study|Final Status Unknown|1073|||
156493159|NCT01078584|564900915|FG000|Overall Study|Lost to Follow-up|670|||
156493160|NCT01078584|564900915|FG000|Overall Study|Non-serious Adverse Event|577|||
156493161|NCT01078584|564900915|FG000|Overall Study|Withdrawal of Consent|244|||
156493162|NCT01078584|564900915|FG000|Overall Study|Physician Withdrew from Study|90|||
156493163|NCT01078584|564900915|FG000|Overall Study|Non-compliance|67|||
156493164|NCT01078584|564900915|FG000|Overall Study|Blood Pressure Controlled|49|||
156493165|NCT01078584|564900915|FG000|Overall Study|Physician Switched Medication|26|||
156493166|NCT01078584|564900915|FG000|Overall Study|Physician Discontinued Patient|12|||
156493167|NCT01078584|564900915|FG000|Overall Study|Lack of Efficacy|98|||
156493168|NCT01078584|564900915|FG000|Overall Study|Protocol Violation|75|||
156493169|NCT01078584|564900915|FG000|Overall Study|Serious Adverse Event|27|||
156493170|NCT01078584|564900915|FG000|Overall Study|Multiple Reasons|2|||
156493171|NCT00356759|564900920|FG000|Overall Study|Death|5|||
156493172|NCT00356759|564900921|FG001|Overall Study|Death|2|||
156493173|NCT00356759|564900920|FG000|Overall Study|Withdrawal by Subject|2|||
156493174|NCT00356759|564900921|FG001|Overall Study|Withdrawal by Subject|2|||
156493175|NCT00356759|564900920|FG000|Overall Study|Adverse Event|1|||
156493176|NCT00356759|564900921|FG001|Overall Study|Adverse Event|3|||
156493177|NCT00356759|564900920|FG000|Overall Study|Lost to Follow-up|1|||
156493178|NCT00356759|564900921|FG001|Overall Study|Lost to Follow-up|1|||
156493179|NCT00356759|564900920|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
156493180|NCT00356759|564900921|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
156493181|NCT01494298|564900922|FG000|Overall Study|Protocol Violation|2|||
156493182|NCT01494298|564900923|FG001|Overall Study|Protocol Violation|8|||
156493183|NCT04159805|564900924|FG000|Overall Study|Withdrawal by Subject|0|||
156493184|NCT04159805|564900925|FG001|Overall Study|Withdrawal by Subject|2|||
156493185|NCT04159805|564900926|FG002|Overall Study|Withdrawal by Subject|2|||
156493186|NCT02930837|564900927|FG000|Overall Study|Adverse Event|6|||
156493187|NCT02930837|564900927|FG000|Overall Study|Lost to Follow-up|5|||
156493188|NCT02930837|564900927|FG000|Overall Study|Withdrawal by Subject|1|||
156493189|NCT01393613|564900928|FG000|Overall Study|Adverse Event|11|||
156493190|NCT01393613|564900929|FG001|Overall Study|Adverse Event|11|||
156493191|NCT01393613|564900930|FG002|Overall Study|Adverse Event|13|||
156493192|NCT01393613|564900931|FG003|Overall Study|Adverse Event|22|||
156493193|NCT01393613|564900928|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
156493194|NCT01393613|564900929|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
156493195|NCT01393613|564900930|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
156493196|NCT01393613|564900931|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
156493197|NCT01393613|564900928|FG000|Overall Study|Physician Decision|2|||
156493198|NCT01393613|564900929|FG001|Overall Study|Physician Decision|0|||
156493199|NCT01393613|564900930|FG002|Overall Study|Physician Decision|0|||
156493200|NCT01393613|564900931|FG003|Overall Study|Physician Decision|1|||
156493201|NCT01393613|564900928|FG000|Overall Study|Withdrawal by Subject|15|||
156493202|NCT01393613|564900929|FG001|Overall Study|Withdrawal by Subject|25|||
156493203|NCT01393613|564900930|FG002|Overall Study|Withdrawal by Subject|23|||
156371960|NCT02573324|564458349|FG000|Overall Study|Unknown Reason|2|||
156371961|NCT02573324|564458350|FG001|Overall Study|Unknown Reason|0|||
156371962|NCT02573324|564458351|FG002|Overall Study|Unknown Reason|0|||
156371963|NCT02349711|564458352|FG000|Overall Study|Withdrawal by Subject|2|||
156493204|NCT01393613|564900931|FG003|Overall Study|Withdrawal by Subject|21|||
156546303|NCT00183274|565093328|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
156371964|NCT02349711|564458353|FG001|Overall Study|Withdrawal by Subject|1|||
156371965|NCT02349711|564458352|FG000|Overall Study|Lost to Follow-up|1|||
156371966|NCT02349711|564458353|FG001|Overall Study|Lost to Follow-up|1|||
156371967|NCT00941733|564458354|FG000|Overall Study|Death|24|||
156371968|NCT00941733|564458355|FG001|Overall Study|Death|10|||
156371969|NCT00941733|564458354|FG000|Overall Study|Withdrawal by Subject|14|||
156371970|NCT00941733|564458355|FG001|Overall Study|Withdrawal by Subject|6|||
156371971|NCT00941733|564458354|FG000|Overall Study|Adverse Event|20|||
156371972|NCT00941733|564458355|FG001|Overall Study|Adverse Event|4|||
156371973|NCT00941733|564458354|FG000|Overall Study|Lost to Follow-up|1|||
156371974|NCT00941733|564458355|FG001|Overall Study|Lost to Follow-up|2|||
156371975|NCT00941733|564458354|FG000|Overall Study|Protocol Violation|15|||
156371976|NCT00941733|564458355|FG001|Overall Study|Protocol Violation|6|||
156371977|NCT00194012|564458356|FG000|Randomized Phase|Lack of Efficacy|8|||
156371978|NCT00194012|564458357|FG001|Randomized Phase|Lack of Efficacy|18|||
156371979|NCT00194012|564458356|FG000|Randomized Phase|Study nonadherence|2|||
156371980|NCT00194012|564458357|FG001|Randomized Phase|Study nonadherence|1|||
156371981|NCT00194012|564458356|FG000|Randomized Phase|Withdrawal by Subject|3|||
156371982|NCT00194012|564458357|FG001|Randomized Phase|Withdrawal by Subject|3|||
156371983|NCT00194012|564458356|FG000|Randomized Phase|Adverse Event|2|||
156371984|NCT00194012|564458357|FG001|Randomized Phase|Adverse Event|1|||
156371985|NCT00194012|564458356|FG000|Randomized Phase|Participant reported having a rash|1|||
156371986|NCT00194012|564458357|FG001|Randomized Phase|Participant reported having a rash|0|||
156371987|NCT00194012|564458356|FG000|Randomized Phase|Emesis and enuresis|0|||
156371988|NCT00194012|564458357|FG001|Randomized Phase|Emesis and enuresis|1|||
156371989|NCT00194012|564458356|FG000|Randomized Phase|Oral/nasal twitching|0|||
156371990|NCT00194012|564458357|FG001|Randomized Phase|Oral/nasal twitching|1|||
156371991|NCT00194012|564458356|FG000|Open Label Extension (OLE)|Weight Gain|1|||
156371992|NCT00194012|564458357|FG001|Open Label Extension (OLE)|Weight Gain|0|||
156371993|NCT00194012|564458356|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
156371994|NCT00194012|564458357|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
156371995|NCT00194012|564458356|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
156371996|NCT00194012|564458357|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
156371997|NCT00194012|564458356|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
156371998|NCT00194012|564458357|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
156371999|NCT02097134|564458361|FG000|Overall Study|Physician Decision|4|||
156372000|NCT02097134|564458361|FG000|Overall Study|Non-Protocol Therapy|1|||
156372001|NCT02097134|564458361|FG000|Overall Study|Progressive Disease|3|||
156372002|NCT02097134|564458361|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
156372003|NCT02660359|564458363|FG000|Overall Study|Protocol Deviation|0|||
156372004|NCT02660359|564458364|FG001|Overall Study|Protocol Deviation|0|||
156372005|NCT02660359|564458365|FG002|Overall Study|Protocol Deviation|1|||
156372006|NCT02660359|564458363|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
156372007|NCT02660359|564458364|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
156372008|NCT02660359|564458365|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
156372009|NCT02660359|564458363|FG000|Overall Study|Lack of Efficacy|1|||
156372010|NCT02660359|564458364|FG001|Overall Study|Lack of Efficacy|1|||
156372011|NCT02660359|564458365|FG002|Overall Study|Lack of Efficacy|1|||
156372012|NCT02660359|564458363|FG000|Overall Study|Adverse Event|0|||
156372013|NCT02660359|564458364|FG001|Overall Study|Adverse Event|1|||
156372014|NCT02660359|564458365|FG002|Overall Study|Adverse Event|0|||
156372015|NCT02660359|564458363|FG000|Overall Study|Other|2|||
156372016|NCT02660359|564458364|FG001|Overall Study|Other|1|||
156372017|NCT02660359|564458365|FG002|Overall Study|Other|3|||
156493205|NCT01393613|564900928|FG000|Overall Study|Protocol Deviation|2|||
156493206|NCT01393613|564900929|FG001|Overall Study|Protocol Deviation|1|||
156493207|NCT01393613|564900930|FG002|Overall Study|Protocol Deviation|0|||
156372018|NCT02660359|564458363|FG000|Overall Study|Withdrawal by Subject|7|||
156372019|NCT02660359|564458364|FG001|Overall Study|Withdrawal by Subject|5|||
156372020|NCT02660359|564458365|FG002|Overall Study|Withdrawal by Subject|8|||
156372021|NCT02660359|564458363|FG000|Overall Study|Lost to Follow-up|3|||
156372022|NCT02660359|564458364|FG001|Overall Study|Lost to Follow-up|3|||
156372023|NCT02660359|564458365|FG002|Overall Study|Lost to Follow-up|0|||
156493208|NCT01393613|564900931|FG003|Overall Study|Protocol Deviation|0|||
156493209|NCT01393613|564900928|FG000|Overall Study|Lack of Efficacy|9|||
156493210|NCT01393613|564900929|FG001|Overall Study|Lack of Efficacy|20|||
156493211|NCT01393613|564900930|FG002|Overall Study|Lack of Efficacy|16|||
156493212|NCT01393613|564900931|FG003|Overall Study|Lack of Efficacy|21|||
156493213|NCT02998918|564900937|FG000|Overall Study|Withdrawal by Subject|1|||
156493214|NCT02998918|564900938|FG001|Overall Study|Withdrawal by Subject|0|||
156493215|NCT01071317|564900939|FG000|Overall Study|Lost to Follow-up|2|||
156493216|NCT01071317|564900940|FG001|Overall Study|Lost to Follow-up|2|||
156493217|NCT00316589|564900941|FG000|Overall Study|Withdrawal by Subject|0|||
156493218|NCT00316589|564900942|FG001|Overall Study|Withdrawal by Subject|5|||
156493219|NCT00316589|564900943|FG002|Overall Study|Withdrawal by Subject|0|||
156493220|NCT00316589|564900944|FG003|Overall Study|Withdrawal by Subject|1|||
156493221|NCT00316589|564900941|FG000|Overall Study|Subject unwilling/unable to comply|0|||
156493222|NCT00316589|564900942|FG001|Overall Study|Subject unwilling/unable to comply|6|||
156493223|NCT00316589|564900943|FG002|Overall Study|Subject unwilling/unable to comply|0|||
156493224|NCT00316589|564900944|FG003|Overall Study|Subject unwilling/unable to comply|2|||
156493225|NCT00316589|564900941|FG000|Overall Study|Adverse Event|1|||
156493226|NCT00316589|564900942|FG001|Overall Study|Adverse Event|0|||
156493227|NCT00316589|564900943|FG002|Overall Study|Adverse Event|0|||
156493228|NCT00316589|564900944|FG003|Overall Study|Adverse Event|1|||
156493229|NCT00316589|564900941|FG000|Overall Study|Physician Decision|0|||
156493230|NCT00316589|564900942|FG001|Overall Study|Physician Decision|1|||
156493231|NCT00316589|564900943|FG002|Overall Study|Physician Decision|0|||
156493232|NCT00316589|564900944|FG003|Overall Study|Physician Decision|0|||
156493233|NCT00316589|564900941|FG000|Overall Study|Other reason|0|||
156493234|NCT00316589|564900942|FG001|Overall Study|Other reason|12|||
156493235|NCT00316589|564900943|FG002|Overall Study|Other reason|1|||
156493236|NCT00316589|564900944|FG003|Overall Study|Other reason|1|||
156493237|NCT01283971|564900949|FG000|Overall Study|Adverse Event|3|||
156493238|NCT01283971|564900950|FG001|Overall Study|Adverse Event|5|||
156493239|NCT01283971|564900949|FG000|Overall Study|Insufficient therapeutic responses|3|||
156493240|NCT01283971|564900950|FG001|Overall Study|Insufficient therapeutic responses|3|||
156493241|NCT01283971|564900949|FG000|Overall Study|Protocol Violation|5|||
156493242|NCT01283971|564900950|FG001|Overall Study|Protocol Violation|1|||
156493243|NCT01283971|564900949|FG000|Overall Study|Refused treatment|3|||
156493244|NCT01283971|564900950|FG001|Overall Study|Refused treatment|1|||
156493245|NCT01283971|564900949|FG000|Overall Study|Failure to return|0|||
156493246|NCT01283971|564900950|FG001|Overall Study|Failure to return|1|||
156493247|NCT01283971|564900949|FG000|Overall Study|Administrative reasons|1|||
156493248|NCT01283971|564900950|FG001|Overall Study|Administrative reasons|1|||
156493249|NCT00562484|564900959|FG000|Overall Study|Adverse Event|6|||
156493250|NCT00562484|564900960|FG001|Overall Study|Adverse Event|1|||
156493251|NCT00562484|564900959|FG000|Overall Study|Protocol Violation|11|||
156493252|NCT00562484|564900960|FG001|Overall Study|Protocol Violation|2|||
156493253|NCT00562484|564900959|FG000|Overall Study|Withdrawal by Subject|12|||
156493254|NCT00562484|564900960|FG001|Overall Study|Withdrawal by Subject|9|||
156493255|NCT00562484|564900959|FG000|Overall Study|Moved away from the study area|20|||
156493256|NCT00562484|564900960|FG001|Overall Study|Moved away from the study area|9|||
156493257|NCT00562484|564900959|FG000|Overall Study|Lost to Follow-up|132|||
156493258|NCT00562484|564900960|FG001|Overall Study|Lost to Follow-up|71|||
156493259|NCT00562484|564900959|FG000|Overall Study|Reason not provided or not specified|25|||
156493260|NCT00562484|564900960|FG001|Overall Study|Reason not provided or not specified|12|||
156493261|NCT02598934|564900961|FG000|Overall Study|Adverse Event|11|||
156493262|NCT02598934|564900962|FG001|Overall Study|Adverse Event|13|||
156493263|NCT02598934|564900961|FG000|Overall Study|Failure to Return|3|||
156493264|NCT02598934|564900962|FG001|Overall Study|Failure to Return|3|||
156493265|NCT02598934|564900961|FG000|Overall Study|Withdrawal by Subject|2|||
156493266|NCT02598934|564900962|FG001|Overall Study|Withdrawal by Subject|3|||
156493267|NCT02598934|564900961|FG000|Overall Study|Administrative|2|||
156493268|NCT02598934|564900962|FG001|Overall Study|Administrative|1|||
156493269|NCT02598934|564900961|FG000|Overall Study|Protocol Violation|1|||
156493270|NCT02598934|564900962|FG001|Overall Study|Protocol Violation|2|||
156493271|NCT00702520|564900964|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
156493272|NCT00702520|564900965|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
156493273|NCT00702520|564900966|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
156493274|NCT00702520|564900967|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
156493275|NCT00702520|564900964|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
156493276|NCT00702520|564900965|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
156493277|NCT00702520|564900966|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
156493278|NCT00702520|564900967|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
156493279|NCT00702520|564900964|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
156493280|NCT00702520|564900965|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
156493281|NCT00702520|564900966|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
156493282|NCT00702520|564900967|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
156493283|NCT02154347|564900968|FG000|Double-blind Period|Adverse Event|1|||
156493284|NCT02154347|564900969|FG001|Double-blind Period|Adverse Event|2|||
156493285|NCT02154347|564900968|FG000|Double-blind Period|Lack of Efficacy|1|||
156493286|NCT02154347|564900969|FG001|Double-blind Period|Lack of Efficacy|0|||
156493287|NCT02154347|564900968|FG000|Double-blind Period|Physician Decision|0|||
156493288|NCT02154347|564900969|FG001|Double-blind Period|Physician Decision|1|||
156493289|NCT02154347|564900968|FG000|Double-blind Period|Withdrawal by Subject|1|||
156493290|NCT02154347|564900969|FG001|Double-blind Period|Withdrawal by Subject|1|||
156493291|NCT02154347|564900968|FG000|Open-label Period|Adverse Event|3|||
156493292|NCT02154347|564900969|FG001|Open-label Period|Adverse Event|4|||
156493293|NCT02154347|564900968|FG000|Open-label Period|Lack of Efficacy|4|||
156493294|NCT02154347|564900969|FG001|Open-label Period|Lack of Efficacy|19|||
156493295|NCT02154347|564900968|FG000|Open-label Period|Protocol Violation|0|||
156493296|NCT02154347|564900969|FG001|Open-label Period|Protocol Violation|1|||
156493297|NCT02154347|564900968|FG000|Open-label Period|Withdrawal by Subject|0|||
156493298|NCT02154347|564900969|FG001|Open-label Period|Withdrawal by Subject|1|||
156493299|NCT02481934|564900970|FG000|Overall Study|Death|2|||
156493300|NCT02979613|564900971|FG000|Double-Blind Phase|Withdrew Consent|2|||
156493301|NCT02979613|564900972|FG001|Double-Blind Phase|Withdrew Consent|4|||
156493302|NCT02979613|564900971|FG000|Double-Blind Phase|Pregnancy|2|||
156493303|NCT02979613|564900972|FG001|Double-Blind Phase|Pregnancy|2|||
156493304|NCT02979613|564900971|FG000|Double-Blind Phase|Adverse Event|2|||
156493305|NCT02979613|564900972|FG001|Double-Blind Phase|Adverse Event|0|||
156493306|NCT02979613|564900971|FG000|Double-Blind Phase|Lost to Follow-up|1|||
156493307|NCT02979613|564900972|FG001|Double-Blind Phase|Lost to Follow-up|1|||
156493308|NCT02979613|564900971|FG000|Double-Blind Phase|Protocol Violation|1|||
156493309|NCT02979613|564900972|FG001|Double-Blind Phase|Protocol Violation|1|||
156493310|NCT02979613|564900971|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
156493311|NCT02979613|564900972|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
156493312|NCT02979613|564900971|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
156493313|NCT02979613|564900972|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
156493314|NCT02979613|564900971|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
156493315|NCT02979613|564900972|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
156493316|NCT02979613|564900971|FG000|Open-Label Extension (OLE) Phase|Death|0|||
156493317|NCT02979613|564900972|FG001|Open-Label Extension (OLE) Phase|Death|1|||
156493318|NCT02979613|564900971|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
156493319|NCT02979613|564900972|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
156493320|NCT02250183|564900973|FG000|Overall Study|Withdrawal by Subject|2|||
156493321|NCT02250183|564900973|FG000|Overall Study|Adverse Event|5|||
156493322|NCT02250183|564900973|FG000|Overall Study|Lost to Follow-up|1|||
156493323|NCT03282799|564900974|FG000|Overall Study|Pregnancy|1|||
156493324|NCT03282799|564900975|FG001|Overall Study|Pregnancy|0|||
156493325|NCT03282799|564900974|FG000|Overall Study|Physician Decision|1|||
156493326|NCT03282799|564900975|FG001|Overall Study|Physician Decision|0|||
156493327|NCT03749616|564900979|FG000|Overall Study|Lost to Follow-up|4|||
156493328|NCT03749616|564900980|FG001|Overall Study|Lost to Follow-up|7|||
156493329|NCT03749616|564900979|FG000|Overall Study|Screen Failure|1|||
156493330|NCT03749616|564900980|FG001|Overall Study|Screen Failure|1|||
156493331|NCT03749616|564900979|FG000|Overall Study|Withdrawal by Subject|2|||
156493332|NCT03749616|564900980|FG001|Overall Study|Withdrawal by Subject|0|||
156493333|NCT03302559|564900981|FG000|Overall Study|Adverse Event|2|||
156493334|NCT03302559|564900981|FG000|Overall Study|Lost to Follow-up|1|||
156493335|NCT03302559|564900981|FG000|Overall Study|Withdrew Consent|3|||
156493336|NCT01181609|564902581|FG000|Overall Study|Adverse Event|1|||
156493337|NCT01181609|564902581|FG000|Overall Study|Withdrawal by Subject|1|||
156493338|NCT01181609|564902581|FG000|Overall Study|Lost to Follow-up|1|||
156493339|NCT01181609|564902581|FG000|Overall Study|Death|50|||
156493340|NCT00612352|564902582|FG000|Overall Study|Adverse Event|1|||
156493341|NCT00612352|564902583|FG001|Overall Study|Adverse Event|0|||
156493342|NCT00612352|564902582|FG000|Overall Study|Withdrawal by Subject|3|||
156493343|NCT00612352|564902583|FG001|Overall Study|Withdrawal by Subject|5|||
156493344|NCT00612352|564902582|FG000|Overall Study|moved out of state|1|||
156493345|NCT00612352|564902583|FG001|Overall Study|moved out of state|0|||
156493346|NCT00612352|564902582|FG000|Overall Study|didn't return calls/show up on test date|4|||
156493347|NCT00612352|564902583|FG001|Overall Study|didn't return calls/show up on test date|1|||
156493348|NCT00263211|564902586|FG000|Overall Study|Death|1|||
156493349|NCT00263211|564902587|FG001|Overall Study|Death|0|||
156493350|NCT00263211|564902586|FG000|Overall Study|Withdrawal by Subject|3|||
156493351|NCT00263211|564902587|FG001|Overall Study|Withdrawal by Subject|0|||
156493352|NCT00263211|564902586|FG000|Overall Study|Protocol Violation|1|||
156493353|NCT00263211|564902587|FG001|Overall Study|Protocol Violation|0|||
156493354|NCT00263211|564902586|FG000|Overall Study|Disease Progression|0|||
156493355|NCT00263211|564902587|FG001|Overall Study|Disease Progression|1|||
156493356|NCT02820597|564902588|FG000|Overall Study|Lost to Follow-up|12|||
156493357|NCT04606199|564902589|FG000|Overall Study|Withdrawal by Subject|2|||
156493358|NCT00408928|564902590|FG000|Overall Study|Withdrawal by Subject|1|||
156493359|NCT00408928|564902590|FG000|Overall Study|Death|1|||
156493360|NCT00408928|564902590|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
156493361|NCT01774019|564902595|FG000|Overall Study|No longer meets protocol criteria|2|||
156493362|NCT01774019|564902596|FG001|Overall Study|No longer meets protocol criteria|0|||
156493363|NCT01774019|564902595|FG000|Overall Study|Withdrawal by Subject|1|||
156493364|NCT01774019|564902596|FG001|Overall Study|Withdrawal by Subject|0|||
156493365|NCT01774019|564902595|FG000|Overall Study|Surgery delayed > 120 days|1|||
156493366|NCT01774019|564902596|FG001|Overall Study|Surgery delayed > 120 days|0|||
156493367|NCT01774019|564902595|FG000|Overall Study|Patient refused surgery|1|||
156493368|NCT01774019|564902596|FG001|Overall Study|Patient refused surgery|1|||
156493369|NCT01774019|564902595|FG000|Overall Study|Unable to implant study device|1|||
156493370|NCT01774019|564902596|FG001|Overall Study|Unable to implant study device|0|||
156493371|NCT01774019|564902595|FG000|Overall Study|Lost to Follow-up|0|||
156493372|NCT01774019|564902596|FG001|Overall Study|Lost to Follow-up|3|||
156493373|NCT00644878|564902597|FG000|Overall Study|Adverse Event|2|||
156493374|NCT00644878|564902597|FG000|Overall Study|Abnormal laboratory value|3|||
156493375|NCT00644878|564902597|FG000|Overall Study|Protocol deviation|2|||
156493376|NCT00644878|564902597|FG000|Overall Study|Treatment duration completed as per protocol|11|||
156493377|NCT00338949|564902602|FG000|Subject Screening|Screen failures|11|||
156493378|NCT00338949|564902603|FG001|Subject Screening|Screen failures|11|||
156493379|NCT00338949|564902602|FG000|Randomization|Withdrawal by Subject|1|||
156493380|NCT00338949|564902603|FG001|Randomization|Withdrawal by Subject|0|||
156493381|NCT00338949|564902602|FG000|Randomization|Adverse Event|0|||
156493382|NCT00338949|564902603|FG001|Randomization|Adverse Event|5|||
156493383|NCT02143063|564902604|FG000|Overall Study|Lost to Follow-up|16|||
156493384|NCT02143063|564902605|FG001|Overall Study|Lost to Follow-up|28|||
156493385|NCT02143063|564902606|FG002|Overall Study|Lost to Follow-up|29|||
156493386|NCT02143063|564902604|FG000|Overall Study|Withdrawal by Subject|0|||
156493387|NCT02143063|564902605|FG001|Overall Study|Withdrawal by Subject|1|||
156493388|NCT02143063|564902606|FG002|Overall Study|Withdrawal by Subject|0|||
156372024|NCT04456699|564458373|FG000|Overall Study|Death|48|||
156493389|NCT02143063|564902604|FG000|Overall Study|Death|0|||
156493390|NCT02143063|564902605|FG001|Overall Study|Death|1|||
156372025|NCT04456699|564458374|FG001|Overall Study|Death|50|||
156493391|NCT02143063|564902606|FG002|Overall Study|Death|1|||
156372026|NCT04456699|564458375|FG002|Overall Study|Death|52|||
156493392|NCT00878553|564902609|FG000|Sleep Study|Withdrawal by Subject|2|||
156493393|NCT00878553|564902610|FG001|Sleep Study|Withdrawal by Subject|0|||
156493394|NCT00878553|564902611|FG002|Sleep Study|Withdrawal by Subject|0|||
156493395|NCT00878553|564902612|FG003|Sleep Study|Withdrawal by Subject|0|||
156493396|NCT00878553|564902613|FG004|Sleep Study|Withdrawal by Subject|0|||
156493397|NCT00878553|564902609|FG000|Sleep Study|Lost to Follow-up|1|||
156493398|NCT00878553|564902610|FG001|Sleep Study|Lost to Follow-up|0|||
156493399|NCT00878553|564902611|FG002|Sleep Study|Lost to Follow-up|0|||
156493400|NCT00878553|564902612|FG003|Sleep Study|Lost to Follow-up|0|||
156493401|NCT00878553|564902613|FG004|Sleep Study|Lost to Follow-up|0|||
156493402|NCT00878553|564902609|FG000|Sleep Study|car accident|1|||
156493403|NCT00878553|564902610|FG001|Sleep Study|car accident|0|||
156493404|NCT00878553|564902611|FG002|Sleep Study|car accident|0|||
156493405|NCT00878553|564902612|FG003|Sleep Study|car accident|0|||
156493406|NCT00878553|564902613|FG004|Sleep Study|car accident|0|||
156493407|NCT00878553|564902609|FG000|Sleep Study|family emergency|1|||
156493408|NCT00878553|564902610|FG001|Sleep Study|family emergency|0|||
156493409|NCT00878553|564902611|FG002|Sleep Study|family emergency|0|||
156493410|NCT00878553|564902612|FG003|Sleep Study|family emergency|0|||
156493411|NCT00878553|564902613|FG004|Sleep Study|family emergency|0|||
156493412|NCT00878553|564902609|FG000|PK Study|Withdrawal by Subject|0|||
156493413|NCT00878553|564902610|FG001|PK Study|Withdrawal by Subject|0|||
156493414|NCT00878553|564902611|FG002|PK Study|Withdrawal by Subject|0|||
156493415|NCT00878553|564902612|FG003|PK Study|Withdrawal by Subject|1|||
156493416|NCT00878553|564902613|FG004|PK Study|Withdrawal by Subject|0|||
156493417|NCT03517111|564902614|FG000|Enrolled|Withdrawal by Subject|0|||
156493418|NCT03517111|564902615|FG001|Enrolled|Withdrawal by Subject|1|||
156493419|NCT03517111|564902616|FG002|Enrolled|Withdrawal by Subject|0|||
156493420|NCT03517111|564902614|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
156493421|NCT03517111|564902615|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
156493422|NCT03517111|564902616|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
156493423|NCT03517111|564902614|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
156493424|NCT03517111|564902615|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
156493425|NCT03517111|564902616|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
156493426|NCT03517111|564902614|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
156493427|NCT03517111|564902615|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
156493428|NCT03517111|564902616|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
156493429|NCT03517111|564902614|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
156493430|NCT03517111|564902615|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
156493431|NCT03517111|564902616|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
156493432|NCT00912223|564902617|FG000|Overall Study|Withdrawal by Subject|1|||
156493433|NCT00912223|564902617|FG000|Overall Study|Not transplanted|1|||
156493434|NCT00912223|564902617|FG000|Overall Study|Transformed disease|1|||
156493435|NCT03188536|564902618|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
156493436|NCT03188536|564902618|FG000|Overall Study|Not participated/met inclusion criteria|1|||
156493437|NCT01930214|564902619|FG000|Overall Study|Death|4|||
156493438|NCT01930214|564902620|FG001|Overall Study|Death|4|||
156493439|NCT01930214|564902621|FG002|Overall Study|Death|11|||
156493440|NCT01930214|564902619|FG000|Overall Study|Lost to Follow-up|12|||
156493441|NCT01930214|564902620|FG001|Overall Study|Lost to Follow-up|13|||
156493442|NCT01930214|564902621|FG002|Overall Study|Lost to Follow-up|12|||
156493443|NCT01930214|564902619|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
156493444|NCT01930214|564902620|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
156493445|NCT01930214|564902621|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
156493446|NCT01930214|564902619|FG000|Overall Study|Physician Decision|2|||
156493447|NCT01930214|564902620|FG001|Overall Study|Physician Decision|0|||
156493448|NCT01930214|564902621|FG002|Overall Study|Physician Decision|0|||
156493449|NCT00025662|564902624|FG000|Overall Study|Withdrawal by Subject|2|||
156493450|NCT00025662|564902624|FG000|Overall Study|Technical failure of manipulation|1|||
156493451|NCT02062645|564902627|FG000|Overall Study|Adverse Event|2|||
156493452|NCT02062645|564902627|FG000|Overall Study|Protocol Violation|8|||
156493453|NCT02062645|564902627|FG000|Overall Study|Lost to Follow-up|5|||
156493454|NCT02864342|564902629|FG000|Overall Study|Eligibility Criteria Deviation|2|||
156493455|NCT02864342|564902630|FG001|Overall Study|Eligibility Criteria Deviation|3|||
156493456|NCT02864342|564902629|FG000|Overall Study|Withdrawal by Subject|4|||
156493457|NCT02864342|564902630|FG001|Overall Study|Withdrawal by Subject|2|||
156493458|NCT02864342|564902629|FG000|Overall Study|Device Technology Issue|6|||
156493459|NCT02864342|564902630|FG001|Overall Study|Device Technology Issue|7|||
156493460|NCT02864342|564902629|FG000|Overall Study|Death|0|||
156493461|NCT02864342|564902630|FG001|Overall Study|Death|1|||
156493462|NCT02864342|564902629|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
156493463|NCT02864342|564902630|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
156493464|NCT02864342|564902629|FG000|Overall Study|Lost to Follow-up|1|||
156493465|NCT02864342|564902630|FG001|Overall Study|Lost to Follow-up|5|||
156493466|NCT02864342|564902629|FG000|Overall Study|Lost Device|1|||
156493467|NCT02864342|564902630|FG001|Overall Study|Lost Device|0|||
156493468|NCT02864342|564902629|FG000|Overall Study|Adverse Event|1|||
156493469|NCT02864342|564902630|FG001|Overall Study|Adverse Event|0|||
156493470|NCT00118703|564902631|FG000|Overall Study|Protocol Violation|1|||
156493471|NCT00118703|564902632|FG001|Overall Study|Protocol Violation|0|||
156493472|NCT00118703|564902631|FG000|Overall Study|Adverse Event|1|||
156493473|NCT00118703|564902632|FG001|Overall Study|Adverse Event|1|||
156493474|NCT00118703|564902631|FG000|Overall Study|Participant took two different treatment|0|||
156493475|NCT00118703|564902632|FG001|Overall Study|Participant took two different treatment|1|||
156493476|NCT00118703|564902631|FG000|Overall Study|Withdrawal by Subject|2|||
156493477|NCT00118703|564902632|FG001|Overall Study|Withdrawal by Subject|5|||
156493478|NCT00118703|564902631|FG000|Overall Study|Lost to Follow-up|1|||
156493479|NCT00118703|564902632|FG001|Overall Study|Lost to Follow-up|2|||
156493480|NCT02261285|564902633|FG000|Overall Study|Disease progression|0|||
156493481|NCT02261285|564902634|FG001|Overall Study|Disease progression|0|||
156493482|NCT02261285|564902635|FG002|Overall Study|Disease progression|1|||
156493483|NCT02344173|564902636|FG000|Procedure|Ablation Procedure Not Performed|7|||
156493484|NCT02344173|564902636|FG000|12-month Visit|Death|8|||
156493485|NCT02344173|564902636|FG000|12-month Visit|Withdrawal by Subject|30|||
156493486|NCT02344173|564902636|FG000|12-month Visit|Lost to Follow-up|58|||
156493487|NCT01209286|564902637|FG000|Overall Study|Adverse Event|4|||
156493488|NCT01209286|564902638|FG001|Overall Study|Adverse Event|3|||
156493489|NCT01209286|564902639|FG002|Overall Study|Adverse Event|1|||
156493490|NCT01209286|564902637|FG000|Overall Study|Hematological Relapse After Remission|0|||
156493491|NCT01209286|564902638|FG001|Overall Study|Hematological Relapse After Remission|1|||
156493492|NCT01209286|564902639|FG002|Overall Study|Hematological Relapse After Remission|1|||
156493493|NCT01209286|564902637|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
156493494|NCT01209286|564902638|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
156493495|NCT01209286|564902639|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
156493496|NCT01209286|564902637|FG000|Overall Study|Physician Decision|0|||
156493497|NCT01209286|564902638|FG001|Overall Study|Physician Decision|2|||
156493498|NCT01209286|564902639|FG002|Overall Study|Physician Decision|0|||
156493499|NCT01209286|564902637|FG000|Overall Study|Other|0|||
156493500|NCT01209286|564902638|FG001|Overall Study|Other|1|||
156493501|NCT01209286|564902639|FG002|Overall Study|Other|0|||
156493502|NCT01349036|564902640|FG000|Overall Study|Disease progression|13|||
156493503|NCT01349036|564902641|FG001|Overall Study|Disease progression|22|||
156493504|NCT01349036|564902640|FG000|Overall Study|Other|1|||
156493505|NCT01349036|564902641|FG001|Overall Study|Other|0|||
156493506|NCT01349036|564902640|FG000|Overall Study|Withdrawal by Subject|0|||
156493507|NCT01349036|564902641|FG001|Overall Study|Withdrawal by Subject|2|||
156493508|NCT01161628|564902642|FG000|Overall Study|Death|6|||
156493509|NCT01161628|564902642|FG000|Overall Study|Lack of Efficacy|2|||
156493510|NCT00746356|564902647|FG000|Overall Study|Withdrawal by Subject|2|||
156493511|NCT00746356|564902648|FG001|Overall Study|Withdrawal by Subject|3|||
156493512|NCT00746356|564902647|FG000|Overall Study|Death|7|||
156493513|NCT00746356|564902648|FG001|Overall Study|Death|3|||
156493514|NCT00746356|564902647|FG000|Overall Study|Lost to Follow-up|1|||
156493515|NCT00746356|564902648|FG001|Overall Study|Lost to Follow-up|0|||
156493516|NCT00746356|564902647|FG000|Overall Study|Removal of Device|0|||
156493517|NCT00746356|564902648|FG001|Overall Study|Removal of Device|1|||
156493518|NCT00746356|564902647|FG000|Overall Study|Patient relocated|1|||
156493519|NCT00746356|564902648|FG001|Overall Study|Patient relocated|0|||
156493520|NCT01263925|564902649|FG000|Overall Study|Protocol Violation|1|||
156493521|NCT01263925|564902650|FG001|Overall Study|Protocol Violation|0|||
156493522|NCT01263925|564902649|FG000|Overall Study|Lack of Efficacy|0|||
156493523|NCT01263925|564902650|FG001|Overall Study|Lack of Efficacy|1|||
156493524|NCT01263925|564902649|FG000|Overall Study|Adverse Event|23|||
156493525|NCT01263925|564902650|FG001|Overall Study|Adverse Event|22|||
156493526|NCT01263925|564902649|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
156493527|NCT01263925|564902650|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
156493528|NCT01263925|564902649|FG000|Overall Study|Withdrawal by Subject|6|||
156493529|NCT01263925|564902650|FG001|Overall Study|Withdrawal by Subject|8|||
156493530|NCT01263925|564902649|FG000|Overall Study|Other|4|||
156493531|NCT01263925|564902650|FG001|Overall Study|Other|4|||
156493532|NCT01263925|564902649|FG000|Overall Study|Lost to Follow-up|3|||
156493533|NCT01263925|564902650|FG001|Overall Study|Lost to Follow-up|1|||
156493534|NCT01263925|564902649|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
156493535|NCT01263925|564902650|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
156493536|NCT01263925|564902649|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
156493537|NCT01263925|564902650|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
156493538|NCT01263925|564902649|FG000|Overall Study|AE/ Withdrawal|1|||
156493539|NCT01263925|564902650|FG001|Overall Study|AE/ Withdrawal|4|||
156493540|NCT01263925|564902649|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
156493541|NCT01263925|564902650|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
156493542|NCT01263925|564902649|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
156493543|NCT01263925|564902650|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
156493544|NCT01263925|564902649|FG000|Overall Study|Withdrawal/ Not specified|0|||
156493545|NCT01263925|564902650|FG001|Overall Study|Withdrawal/ Not specified|1|||
156493546|NCT03029819|564902651|FG000|Overall Study|Lost to Follow-up|3|||
156493547|NCT03029819|564902652|FG001|Overall Study|Lost to Follow-up|5|||
156493548|NCT03029819|564902651|FG000|Overall Study|Removed due to disruptive behavior|0|||
156493549|NCT03029819|564902652|FG001|Overall Study|Removed due to disruptive behavior|1|||
156493550|NCT01215032|564902658|FG000|Overall Study|Adverse Event|3|||
156493551|NCT01215032|564902658|FG000|Overall Study|Lack of Efficacy|17|||
156493552|NCT01020747|564902665|FG000|Overall Study|Withdrawal by Subject|1|||
156493553|NCT02970305|564902666|FG000|Overall Study|Adverse Event|10|||
156493554|NCT02970305|564902667|FG001|Overall Study|Adverse Event|6|||
156493555|NCT02970305|564902666|FG000|Overall Study|Lack of Efficacy|1|||
156493556|NCT02970305|564902667|FG001|Overall Study|Lack of Efficacy|1|||
156493557|NCT02970305|564902666|FG000|Overall Study|Noncompliance with study drug|2|||
156493558|NCT02970305|564902667|FG001|Overall Study|Noncompliance with study drug|4|||
156493559|NCT02970305|564902666|FG000|Overall Study|Protocol Violation|2|||
156493560|NCT02970305|564902667|FG001|Overall Study|Protocol Violation|2|||
156493561|NCT02970305|564902666|FG000|Overall Study|Withdrawal by Subject|12|||
156493562|NCT02970305|564902667|FG001|Overall Study|Withdrawal by Subject|11|||
156493563|NCT02970305|564902666|FG000|Overall Study|Not further specified|1|||
156493564|NCT02970305|564902667|FG001|Overall Study|Not further specified|2|||
156493565|NCT02970305|564902666|FG000|Overall Study|Lost to Follow-up|1|||
156493566|NCT02970305|564902667|FG001|Overall Study|Lost to Follow-up|2|||
156493567|NCT00808899|564902668|FG000|Overall Study|Death|1|||
156493568|NCT00808899|564902668|FG000|Overall Study|Physician Decision|3|||
156493569|NCT02881047|564902669|FG000|Overall Study|Adverse Event|1|||
156493570|NCT02881047|564902669|FG000|Overall Study|Withdrawal by Subject|1|||
156493571|NCT03028012|564902670|FG000|Overall Study|Lost to Follow-up|2|||
156493572|NCT03028012|564902671|FG001|Overall Study|Lost to Follow-up|3|||
156493573|NCT03028012|564902672|FG002|Overall Study|Lost to Follow-up|3|||
156493574|NCT01813305|564902677|FG000|Overall Study|Withdrawal by Subject|12|||
156493575|NCT01813305|564902678|FG001|Overall Study|Withdrawal by Subject|5|||
156493576|NCT01813305|564902677|FG000|Overall Study|Safety Concern|4|||
156493577|NCT01813305|564902678|FG001|Overall Study|Safety Concern|0|||
156493578|NCT01813305|564902677|FG000|Overall Study|Ulcer became worse|4|||
156493579|NCT01813305|564902678|FG001|Overall Study|Ulcer became worse|0|||
156493580|NCT01813305|564902677|FG000|Overall Study|Physician Decision|4|||
156493581|NCT01813305|564902678|FG001|Overall Study|Physician Decision|0|||
156493582|NCT01813305|564902677|FG000|Overall Study|Lost to Follow-up|3|||
156493583|NCT01813305|564902678|FG001|Overall Study|Lost to Follow-up|1|||
156493584|NCT01813305|564902677|FG000|Overall Study|Protocol Violation|1|||
156493585|NCT01813305|564902678|FG001|Overall Study|Protocol Violation|0|||
156493586|NCT01813305|564902677|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
156493587|NCT01813305|564902678|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
156493588|NCT03448536|564902679|FG000|Overall Study|Protocol Violation|2|||
156493589|NCT03448536|564902680|FG001|Overall Study|Protocol Violation|0|||
156493590|NCT03448536|564902679|FG000|Overall Study|Pregnancy|1|||
156493591|NCT03448536|564902680|FG001|Overall Study|Pregnancy|0|||
156493592|NCT03448536|564902679|FG000|Overall Study|Withdrawal by Subject|1|||
156493593|NCT03448536|564902680|FG001|Overall Study|Withdrawal by Subject|2|||
156493594|NCT03448536|564902679|FG000|Overall Study|Lost to Follow-up|3|||
156493595|NCT03448536|564902680|FG001|Overall Study|Lost to Follow-up|2|||
156493596|NCT03448536|564902679|FG000|Overall Study|Inadequate pain reporter|1|||
156493597|NCT03448536|564902680|FG001|Overall Study|Inadequate pain reporter|0|||
156493598|NCT03448536|564902679|FG000|Overall Study|Other|3|||
156493599|NCT03448536|564902680|FG001|Overall Study|Other|0|||
156493600|NCT03448536|564902679|FG000|Overall Study|Physician Decision|1|||
156493601|NCT03448536|564902680|FG001|Overall Study|Physician Decision|0|||
156493602|NCT01665599|564902684|FG000|Overall Study|Adverse Event|1|||
156493603|NCT01665599|564902684|FG000|Overall Study|Consent Withdrawn|1|||
156493604|NCT01665599|564902684|FG000|Overall Study|Investigator/Sponsor decision|1|||
156493605|NCT01665599|564902684|FG000|Overall Study|Death|1|||
156493606|NCT01665599|564902684|FG000|Overall Study|Lost to Follow-up|2|||
156493607|NCT01665599|564902684|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
156493608|NCT01665599|564902684|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
156493609|NCT01705145|564902685|FG000|Part B|Adverse Event|1|||
156493610|NCT01203956|564902686|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
156493611|NCT01203956|564902687|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
156493612|NCT02230306|564902690|FG000|Overall Study|Did not receive study treatment|1|||
156493613|NCT00312845|564902692|FG000|Overall Study|Adverse Event|19|||
156493614|NCT00312845|564902693|FG001|Overall Study|Adverse Event|5|||
156493615|NCT00312845|564902692|FG000|Overall Study|Death|2|||
156493616|NCT00312845|564902693|FG001|Overall Study|Death|2|||
156493617|NCT00312845|564902692|FG000|Overall Study|Withdrawal by Subject|14|||
156493618|NCT00312845|564902693|FG001|Overall Study|Withdrawal by Subject|6|||
156493619|NCT00312845|564902692|FG000|Overall Study|Disease Progression|56|||
156493620|NCT00312845|564902693|FG001|Overall Study|Disease Progression|77|||
156493621|NCT00312845|564902692|FG000|Overall Study|Lost to Follow-up|2|||
156493622|NCT00312845|564902693|FG001|Overall Study|Lost to Follow-up|0|||
156493623|NCT00312845|564902692|FG000|Overall Study|Other|6|||
156493624|NCT00312845|564902693|FG001|Overall Study|Other|5|||
156493625|NCT02212197|564902694|FG000|Overall Study|Need for radiotherapy|1|||
156493626|NCT02212197|564902695|FG001|Overall Study|Need for radiotherapy|0|||
156493627|NCT02212197|564902696|FG002|Overall Study|Need for radiotherapy|0|||
156493628|NCT01077622|564902698|FG000|Overall Study|Physician Decision|2|||
156493629|NCT01077622|564902698|FG000|Overall Study|Withdrawal by Subject|1|||
156493630|NCT00424177|564902699|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
156493631|NCT00424177|564902699|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
156493632|NCT00424177|564902699|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
156493633|NCT00424177|564902699|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
156493634|NCT00424177|564902699|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
156493635|NCT00424177|564902699|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
156493636|NCT00424177|564902699|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
156493637|NCT00424177|564902699|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
156493638|NCT00424177|564902699|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
156493639|NCT00424177|564902699|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
156493640|NCT01503164|564902700|FG000|Overall Study|Withdrawal by Subject|2|||
156493641|NCT01503164|564902701|FG001|Overall Study|Withdrawal by Subject|1|||
156493642|NCT04088136|564902702|FG000|Overall Study|Withdrawal by Subject|5|||
156493643|NCT04088136|564902703|FG001|Overall Study|Withdrawal by Subject|0|||
156493644|NCT04088136|564902702|FG000|Overall Study|Lack of Efficacy|0|||
156493645|NCT04088136|564902703|FG001|Overall Study|Lack of Efficacy|1|||
156493646|NCT02473913|564902704|FG000|Overall Study|Lost to Follow-up|3|||
156493647|NCT02473913|564902705|FG001|Overall Study|Lost to Follow-up|3|||
156493648|NCT05041439|564902706|FG000|Overall Study|Withdrawal by Subject|1|||
156493649|NCT05041439|564902707|FG001|Overall Study|Withdrawal by Subject|1|||
156493650|NCT05041439|564902706|FG000|Overall Study|Death|1|||
156493651|NCT05041439|564902707|FG001|Overall Study|Death|0|||
156546304|NCT00183274|565093329|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
156546305|NCT00183274|565093330|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
156546306|NCT00183274|565093325|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
156546307|NCT00183274|565093326|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
156546308|NCT00183274|565093327|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
156546309|NCT00183274|565093328|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
156546310|NCT00183274|565093329|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
156546311|NCT00183274|565093330|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
156546312|NCT00183274|565093325|FG000|Phase 1: Open-Label|Other|9|||
156546313|NCT00183274|565093326|FG001|Phase 1: Open-Label|Other|0|||
156546314|NCT00183274|565093327|FG002|Phase 1: Open-Label|Other|0|||
156546315|NCT00183274|565093328|FG003|Phase 1: Open-Label|Other|0|||
156546316|NCT00183274|565093329|FG004|Phase 1: Open-Label|Other|0|||
156546317|NCT00183274|565093330|FG005|Phase 1: Open-Label|Other|0|||
156546318|NCT00183274|565093325|FG000|Phase 2: Double-Blind|Relapsed|0|||
156546319|NCT00183274|565093326|FG001|Phase 2: Double-Blind|Relapsed|8|||
156546320|NCT00183274|565093327|FG002|Phase 2: Double-Blind|Relapsed|29|||
156546321|NCT00183274|565093328|FG003|Phase 2: Double-Blind|Relapsed|0|||
156546322|NCT00183274|565093329|FG004|Phase 2: Double-Blind|Relapsed|0|||
156546323|NCT00183274|565093330|FG005|Phase 2: Double-Blind|Relapsed|0|||
156546324|NCT00183274|565093325|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
156546325|NCT00183274|565093326|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
156546326|NCT00183274|565093327|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
156546327|NCT00183274|565093328|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
156546328|NCT00183274|565093329|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
156546329|NCT00183274|565093330|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
156546330|NCT00183274|565093325|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
156546331|NCT00183274|565093326|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
156546332|NCT00183274|565093327|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
156546333|NCT00183274|565093328|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
156546334|NCT00183274|565093329|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
156546335|NCT00183274|565093330|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
156546336|NCT00183274|565093325|FG000|Phase 3: Double-Blind|Relapsed|0|||
156546337|NCT00183274|565093326|FG001|Phase 3: Double-Blind|Relapsed|0|||
156546338|NCT00183274|565093327|FG002|Phase 3: Double-Blind|Relapsed|0|||
156546339|NCT00183274|565093328|FG003|Phase 3: Double-Blind|Relapsed|1|||
156546340|NCT00183274|565093329|FG004|Phase 3: Double-Blind|Relapsed|11|||
156546341|NCT00183274|565093330|FG005|Phase 3: Double-Blind|Relapsed|2|||
156546342|NCT00586495|565093333|FG000|Treatment Period|Adverse Event|11|||
156546343|NCT00586495|565093333|FG000|Treatment Period|Death|1|||
156546344|NCT00586495|565093333|FG000|Treatment Period|Protocol Violation|1|||
156546345|NCT00586495|565093333|FG000|Treatment Period|Withdrawal by Subject|1|||
156546346|NCT00586495|565093333|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
156546347|NCT00586495|565093333|FG000|Treatment Period|Switch to commercial drug|10|||
156546348|NCT00586495|565093333|FG000|Follow-up|Death|40|||
156546349|NCT00586495|565093333|FG000|Follow-up|Lost to Follow-up|1|||
156546350|NCT00586495|565093333|FG000|Follow-up|Withdrawal by Subject|4|||
156546351|NCT00586495|565093333|FG000|Follow-up|Protocol driven decision point|37|||
156493652|NCT03614676|564904226|FG000|Overall Study|Delivery before planned visit|2|||
156493653|NCT03614676|564904227|FG001|Overall Study|Delivery before planned visit|0|||
156493654|NCT03614676|564904226|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
156493655|NCT03614676|564904227|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
156493656|NCT03614676|564904226|FG000|Overall Study|Migrated / moved from the study area|30|||
156493657|NCT03614676|564904227|FG001|Overall Study|Migrated / moved from the study area|22|||
156493658|NCT03614676|564904226|FG000|Overall Study|Lost to Follow-up|17|||
156493659|NCT03614676|564904227|FG001|Overall Study|Lost to Follow-up|42|||
156493660|NCT03614676|564904226|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
156493661|NCT03614676|564904227|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
156493662|NCT03614676|564904226|FG000|Overall Study|Other|16|||
156493663|NCT03614676|564904227|FG001|Overall Study|Other|47|||
156493664|NCT03614676|564904226|FG000|Overall Study|Protocol Violation|0|||
156493665|NCT03614676|564904227|FG001|Overall Study|Protocol Violation|2|||
156493666|NCT03614676|564904226|FG000|Overall Study|Neonatal event of interest|0|||
156493667|NCT03614676|564904227|FG001|Overall Study|Neonatal event of interest|6|||
156493668|NCT03614676|564904226|FG000|Overall Study|Death in infant greater than 28 days old|0|||
156493669|NCT03614676|564904227|FG001|Overall Study|Death in infant greater than 28 days old|12|||
156493670|NCT03614676|564904226|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
156493671|NCT03614676|564904227|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
156493672|NCT02388347|564904228|FG000|Overall Study|Withdrawal by Subject|0|||
156493673|NCT02388347|564904229|FG001|Overall Study|Withdrawal by Subject|0|||
156493674|NCT02388347|564904230|FG002|Overall Study|Withdrawal by Subject|1|||
156493675|NCT02388347|564904231|FG003|Overall Study|Withdrawal by Subject|0|||
156493676|NCT02388347|564904232|FG004|Overall Study|Withdrawal by Subject|0|||
156493677|NCT00497874|564904233|FG000|Overall Study|Withdrawal by Subject|48|||
156493678|NCT00497874|564904234|FG001|Overall Study|Withdrawal by Subject|17|||
156493679|NCT00497874|564904233|FG000|Overall Study|Illness|8|||
156493680|NCT00497874|564904234|FG001|Overall Study|Illness|4|||
156493681|NCT00497874|564904233|FG000|Overall Study|Death|2|||
156493682|NCT00497874|564904234|FG001|Overall Study|Death|4|||
156493683|NCT00497874|564904233|FG000|Overall Study|Unable to contact|52|||
156493684|NCT00497874|564904234|FG001|Overall Study|Unable to contact|67|||
156493685|NCT00497874|564904233|FG000|Overall Study|Unable to schedule|37|||
156493686|NCT00497874|564904234|FG001|Overall Study|Unable to schedule|24|||
156493687|NCT02080403|564904235|FG000|Overall Study|Adverse Event|5|||
156493688|NCT02080403|564904236|FG001|Overall Study|Adverse Event|1|||
156493689|NCT02080403|564904235|FG000|Overall Study|Death|0|||
156493690|NCT02080403|564904236|FG001|Overall Study|Death|2|||
156493691|NCT02080403|564904235|FG000|Overall Study|Lost to Follow-up|2|||
156493692|NCT02080403|564904236|FG001|Overall Study|Lost to Follow-up|0|||
156493693|NCT02080403|564904235|FG000|Overall Study|Pregnancy|0|||
156493694|NCT02080403|564904236|FG001|Overall Study|Pregnancy|1|||
156493695|NCT02080403|564904235|FG000|Overall Study|Protocol Violation|3|||
156493696|NCT02080403|564904236|FG001|Overall Study|Protocol Violation|7|||
156493697|NCT02080403|564904235|FG000|Overall Study|Withdrawal by Subject|5|||
156493698|NCT02080403|564904236|FG001|Overall Study|Withdrawal by Subject|1|||
156493699|NCT01999972|564904237|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
156493700|NCT01999972|564904238|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
156493701|NCT01999972|564904239|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
156493702|NCT01999972|564904240|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
156493703|NCT01999972|564904241|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
156493704|NCT01999972|564904242|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
156493705|NCT01999972|564904237|FG000|Dose Escalation Part|Death|0|||
156493706|NCT01999972|564904238|FG001|Dose Escalation Part|Death|1|||
156493707|NCT01999972|564904239|FG002|Dose Escalation Part|Death|0|||
156493708|NCT01999972|564904240|FG003|Dose Escalation Part|Death|0|||
156493709|NCT01999972|564904241|FG004|Dose Escalation Part|Death|0|||
156493710|NCT01999972|564904242|FG005|Dose Escalation Part|Death|0|||
156493711|NCT01999972|564904237|FG000|Dose Escalation Part|Enrolled but not treated|0|||
156493712|NCT01999972|564904238|FG001|Dose Escalation Part|Enrolled but not treated|0|||
156493713|NCT01999972|564904239|FG002|Dose Escalation Part|Enrolled but not treated|1|||
156493714|NCT01999972|564904240|FG003|Dose Escalation Part|Enrolled but not treated|1|||
156493715|NCT01999972|564904241|FG004|Dose Escalation Part|Enrolled but not treated|0|||
156493716|NCT01999972|564904242|FG005|Dose Escalation Part|Enrolled but not treated|0|||
156493717|NCT01999972|564904237|FG000|Dose Escalation Part|Disease progression|3|||
156493718|NCT01999972|564904238|FG001|Dose Escalation Part|Disease progression|2|||
156493719|NCT01999972|564904239|FG002|Dose Escalation Part|Disease progression|3|||
156493720|NCT01999972|564904240|FG003|Dose Escalation Part|Disease progression|6|||
156493721|NCT01999972|564904241|FG004|Dose Escalation Part|Disease progression|0|||
156493722|NCT01999972|564904242|FG005|Dose Escalation Part|Disease progression|0|||
156493723|NCT01999972|564904237|FG000|Dose Escalation Part|Adverse Event|0|||
156493724|NCT01999972|564904238|FG001|Dose Escalation Part|Adverse Event|0|||
156493725|NCT01999972|564904239|FG002|Dose Escalation Part|Adverse Event|0|||
156493726|NCT01999972|564904240|FG003|Dose Escalation Part|Adverse Event|2|||
156493727|NCT01999972|564904241|FG004|Dose Escalation Part|Adverse Event|0|||
156493728|NCT01999972|564904242|FG005|Dose Escalation Part|Adverse Event|0|||
156493729|NCT01999972|564904237|FG000|Dose Escalation Part|Global deterioration of health status|1|||
156493730|NCT01999972|564904238|FG001|Dose Escalation Part|Global deterioration of health status|0|||
156493731|NCT01999972|564904239|FG002|Dose Escalation Part|Global deterioration of health status|0|||
156493732|NCT01999972|564904240|FG003|Dose Escalation Part|Global deterioration of health status|1|||
156493733|NCT01999972|564904241|FG004|Dose Escalation Part|Global deterioration of health status|0|||
156493734|NCT01999972|564904242|FG005|Dose Escalation Part|Global deterioration of health status|0|||
156493735|NCT01999972|564904237|FG000|Dose Expansion Part|Death|0|||
156493736|NCT01999972|564904238|FG001|Dose Expansion Part|Death|0|||
156493737|NCT01999972|564904239|FG002|Dose Expansion Part|Death|0|||
156493738|NCT01999972|564904240|FG003|Dose Expansion Part|Death|0|||
156493739|NCT01999972|564904241|FG004|Dose Expansion Part|Death|2|||
156493740|NCT01999972|564904242|FG005|Dose Expansion Part|Death|1|||
156493741|NCT01999972|564904237|FG000|Dose Expansion Part|Disease progression|0|||
156493742|NCT01999972|564904238|FG001|Dose Expansion Part|Disease progression|0|||
156493743|NCT01999972|564904239|FG002|Dose Expansion Part|Disease progression|0|||
156493744|NCT01999972|564904240|FG003|Dose Expansion Part|Disease progression|0|||
156493745|NCT01999972|564904241|FG004|Dose Expansion Part|Disease progression|9|||
156493746|NCT01999972|564904242|FG005|Dose Expansion Part|Disease progression|3|||
156493747|NCT01999972|564904237|FG000|Dose Expansion Part|Sponsor decision|0|||
156493748|NCT01999972|564904238|FG001|Dose Expansion Part|Sponsor decision|0|||
156493749|NCT01999972|564904239|FG002|Dose Expansion Part|Sponsor decision|0|||
156493750|NCT01999972|564904240|FG003|Dose Expansion Part|Sponsor decision|0|||
156493751|NCT01999972|564904241|FG004|Dose Expansion Part|Sponsor decision|1|||
156493752|NCT01999972|564904242|FG005|Dose Expansion Part|Sponsor decision|0|||
156493753|NCT01999972|564904237|FG000|Dose Expansion Part|Adverse Event|0|||
156493754|NCT01999972|564904238|FG001|Dose Expansion Part|Adverse Event|0|||
156493755|NCT01999972|564904239|FG002|Dose Expansion Part|Adverse Event|0|||
156493756|NCT01999972|564904240|FG003|Dose Expansion Part|Adverse Event|0|||
156493757|NCT01999972|564904241|FG004|Dose Expansion Part|Adverse Event|4|||
156493758|NCT01999972|564904242|FG005|Dose Expansion Part|Adverse Event|2|||
156493759|NCT01999972|564904237|FG000|Dose Expansion Part|Participant's non-compliance|0|||
156493760|NCT01999972|564904238|FG001|Dose Expansion Part|Participant's non-compliance|0|||
156493761|NCT01999972|564904239|FG002|Dose Expansion Part|Participant's non-compliance|0|||
156493762|NCT01999972|564904240|FG003|Dose Expansion Part|Participant's non-compliance|0|||
156493763|NCT01999972|564904241|FG004|Dose Expansion Part|Participant's non-compliance|0|||
156493764|NCT01999972|564904242|FG005|Dose Expansion Part|Participant's non-compliance|1|||
156493765|NCT01999972|564904237|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
156493766|NCT01999972|564904238|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
156493767|NCT01999972|564904239|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
156493768|NCT01999972|564904240|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
156493769|NCT01999972|564904241|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
156493770|NCT01999972|564904242|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
156493771|NCT01999972|564904237|FG000|Dose Expansion Part|Changed to standard of care|0|||
156493772|NCT01999972|564904238|FG001|Dose Expansion Part|Changed to standard of care|0|||
156493773|NCT01999972|564904239|FG002|Dose Expansion Part|Changed to standard of care|0|||
156493774|NCT01999972|564904240|FG003|Dose Expansion Part|Changed to standard of care|0|||
156493775|NCT01999972|564904241|FG004|Dose Expansion Part|Changed to standard of care|1|||
156493776|NCT01999972|564904242|FG005|Dose Expansion Part|Changed to standard of care|0|||
156493777|NCT01171183|564904243|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
156493778|NCT01171183|564904244|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
156493779|NCT01171183|564904243|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
156493780|NCT01171183|564904244|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
156493781|NCT01171183|564904243|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
156493782|NCT01171183|564904244|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
156493783|NCT01171183|564904243|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
156493784|NCT01171183|564904244|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
156493785|NCT01171183|564904243|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
156493786|NCT01171183|564904244|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
156493787|NCT01171183|564904243|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
156493788|NCT01171183|564904244|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
156493789|NCT01101334|564904245|FG000|Overall Study|Adverse Event|9|||
156493790|NCT01101334|564904246|FG001|Overall Study|Adverse Event|4|||
156493791|NCT01101334|564904245|FG000|Overall Study|Death|7|||
156493792|NCT01101334|564904246|FG001|Overall Study|Death|1|||
156493793|NCT01101334|564904245|FG000|Overall Study|Withdrawal by Subject|4|||
156493794|NCT01101334|564904246|FG001|Overall Study|Withdrawal by Subject|3|||
156493795|NCT01101334|564904245|FG000|Overall Study|Withdrawal by Sponsor|1|||
156493796|NCT01101334|564904246|FG001|Overall Study|Withdrawal by Sponsor|1|||
156493797|NCT01101334|564904245|FG000|Overall Study|Progressive Disease|22|||
156493798|NCT01101334|564904246|FG001|Overall Study|Progressive Disease|35|||
156493799|NCT01101334|564904245|FG000|Overall Study|Other|2|||
156546352|NCT00586495|565093333|FG000|Follow-up|Switch to commercial drug|10|||
156546353|NCT03882970|565093336|FG000|Overall Study|Adverse Event|5|||
156493800|NCT01101334|564904246|FG001|Overall Study|Other|1|||
156493801|NCT02826798|564904249|FG000|Overall Study|Withdrawal by Subject|0|||
156493802|NCT02826798|564904250|FG001|Overall Study|Withdrawal by Subject|1|||
156493803|NCT02826798|564904251|FG002|Overall Study|Withdrawal by Subject|0|||
156493804|NCT02826798|564904252|FG003|Overall Study|Withdrawal by Subject|1|||
156493805|NCT02826798|564904253|FG004|Overall Study|Withdrawal by Subject|0|||
156493806|NCT02806505|564904254|FG000|Overall Study|Adverse event/intercurrent illness|1|||
156493807|NCT02806505|564904255|FG001|Overall Study|Adverse event/intercurrent illness|3|||
156493808|NCT02806505|564904254|FG000|Overall Study|Death|4|||
156493809|NCT02806505|564904255|FG001|Overall Study|Death|0|||
156493810|NCT02806505|564904254|FG000|Overall Study|Did not cooperate/refused treatment|3|||
156493811|NCT02806505|564904255|FG001|Overall Study|Did not cooperate/refused treatment|3|||
156493812|NCT02806505|564904254|FG000|Overall Study|Failure to return|0|||
156493813|NCT02806505|564904255|FG001|Overall Study|Failure to return|1|||
156493814|NCT02806505|564904254|FG000|Overall Study|Insufficient therapeutic response|2|||
156493815|NCT02806505|564904255|FG001|Overall Study|Insufficient therapeutic response|4|||
156493816|NCT03440047|564904257|FG000|Overall Study|Withdrawal by Subject|2|||
156493817|NCT04843579|564904266|FG000|Overall Study|Adverse Event|1|||
156493818|NCT04843579|564904266|FG000|Overall Study|Disease Progression|1|||
156493819|NCT04009629|564904267|FG000|Overall Study|Withdrawal by Subject|2|||
156493820|NCT04009629|564904268|FG001|Overall Study|Withdrawal by Subject|0|||
156493821|NCT04398368|564904269|FG000|Overall Study|Withdrawal by Subject|2|||
156493822|NCT00511836|564904272|FG000|Double-blind Period|Lost to Follow-up|1|||
156493823|NCT00511836|564904273|FG001|Double-blind Period|Lost to Follow-up|0|||
156493824|NCT00030823|564904274|FG000|Overall Study|Withdrawal by Subject|1|||
156493825|NCT04702893|564904280|FG000|Overall Study|Other reasons than listed|11|||
156493826|NCT04702893|564904280|FG000|Overall Study|Withdrawal by Subject|3|||
156493827|NCT04702893|564904280|FG000|Overall Study|Lost to Follow-up|7|||
156493828|NCT04702893|564904280|FG000|Overall Study|Death|10|||
156493829|NCT04702893|564904280|FG000|Overall Study|Not treated|6|||
156493830|NCT01114139|564904282|FG000|Overall Study|Adverse Event|3|||
156493831|NCT01114139|564904283|FG001|Overall Study|Adverse Event|2|||
156493832|NCT01114139|564904282|FG000|Overall Study|Lost to Follow-up|15|||
156493833|NCT01114139|564904283|FG001|Overall Study|Lost to Follow-up|3|||
156493834|NCT01114139|564904282|FG000|Overall Study|Withdrawal by Subject|17|||
156493835|NCT01114139|564904283|FG001|Overall Study|Withdrawal by Subject|6|||
156493836|NCT01114139|564904282|FG000|Overall Study|Other-Missed 1 visit|1|||
156493837|NCT01114139|564904283|FG001|Overall Study|Other-Missed 1 visit|0|||
156493838|NCT01114139|564904282|FG000|Overall Study|Other-Protocol Violation|1|||
156493839|NCT01114139|564904283|FG001|Overall Study|Other-Protocol Violation|0|||
156493840|NCT01114139|564904282|FG000|Overall Study|Other-Out of window for study drug dose|1|||
156493841|NCT01114139|564904283|FG001|Overall Study|Other-Out of window for study drug dose|0|||
156493842|NCT01114139|564904282|FG000|Overall Study|Other-Participant falsified records|0|||
156493843|NCT01114139|564904283|FG001|Overall Study|Other-Participant falsified records|1|||
156493844|NCT01114139|564904282|FG000|Overall Study|Other-Participant went on hospice|0|||
156493845|NCT01114139|564904283|FG001|Overall Study|Other-Participant went on hospice|1|||
156493846|NCT01114139|564904282|FG000|Overall Study|Other-Physician changed treatment|1|||
156493847|NCT01114139|564904283|FG001|Overall Study|Other-Physician changed treatment|0|||
156493848|NCT01114139|564904282|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
156493849|NCT01114139|564904283|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
156493850|NCT01951378|564904284|FG000|Overall Study|Study Terminated-Not completed|23|||
156493851|NCT01951378|564904285|FG001|Overall Study|Study Terminated-Not completed|17|||
156493852|NCT00477464|564904287|FG000|Overall Study|Lost to Follow-up|1|||
156493853|NCT00477464|564904287|FG000|Overall Study|Death|36|||
156493854|NCT00477464|564904287|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
156493855|NCT03568812|564904288|FG000|Overall Study|Physician Decision|0|||
156493856|NCT03568812|564904289|FG001|Overall Study|Physician Decision|1|||
156493857|NCT00639769|564904291|FG000|Overall Study|Death|2|||
156493858|NCT00639769|564904291|FG000|Overall Study|Adverse Event|7|||
156493859|NCT00639769|564904291|FG000|Overall Study|Lack of Efficacy|1|||
156493860|NCT00639769|564904291|FG000|Overall Study|Disease progression|26|||
156493861|NCT00639769|564904291|FG000|Overall Study|Withdrawal by Subject|4|||
156493862|NCT00634842|564904292|FG000|Overall Study|Adverse Event|2|||
156493863|NCT00634842|564904293|FG001|Overall Study|Adverse Event|3|||
156493864|NCT00634842|564904292|FG000|Overall Study|Protocol Violation|8|||
156493865|NCT00634842|564904293|FG001|Overall Study|Protocol Violation|4|||
156493866|NCT00634842|564904292|FG000|Overall Study|Move to another state|1|||
156493867|NCT00634842|564904293|FG001|Overall Study|Move to another state|0|||
156493868|NCT00634842|564904292|FG000|Overall Study|Inclusion criteria were not met|1|||
156546354|NCT03882970|565093337|FG001|Overall Study|Adverse Event|7|||
156546355|NCT03882970|565093338|FG002|Overall Study|Adverse Event|3|||
156546356|NCT03882970|565093339|FG003|Overall Study|Adverse Event|1|||
156493869|NCT00634842|564904293|FG001|Overall Study|Inclusion criteria were not met|0|||
156493870|NCT00634842|564904292|FG000|Overall Study|Lost to Follow-up|1|||
156493871|NCT00634842|564904293|FG001|Overall Study|Lost to Follow-up|2|||
156493872|NCT00634842|564904292|FG000|Overall Study|Physician Decision|1|||
156493873|NCT00634842|564904293|FG001|Overall Study|Physician Decision|0|||
156493874|NCT00634842|564904292|FG000|Overall Study|Withdrawal by Subject|1|||
156493875|NCT00634842|564904293|FG001|Overall Study|Withdrawal by Subject|3|||
156493876|NCT00634842|564904292|FG000|Overall Study|Lack of time and intolerance to drug|0|||
156493877|NCT00634842|564904293|FG001|Overall Study|Lack of time and intolerance to drug|1|||
156493878|NCT00634842|564904292|FG000|Overall Study|Discontinued due to injection|0|||
156493879|NCT00634842|564904293|FG001|Overall Study|Discontinued due to injection|2|||
156493880|NCT00634842|564904292|FG000|Overall Study|No need of study drug to treat diabetes|0|||
156493881|NCT00634842|564904293|FG001|Overall Study|No need of study drug to treat diabetes|1|||
156493882|NCT00634842|564904292|FG000|Overall Study|No wish to keep taking Avandia|0|||
156493883|NCT00634842|564904293|FG001|Overall Study|No wish to keep taking Avandia|1|||
156493884|NCT00634842|564904292|FG000|Overall Study|Subject off study drug for too long|0|||
156493885|NCT00634842|564904293|FG001|Overall Study|Subject off study drug for too long|1|||
156493886|NCT03470545|564904297|FG000|Overall Study|Death|0|||
156493887|NCT03470545|564904298|FG001|Overall Study|Death|1|||
156493888|NCT03470545|564904297|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
156493889|NCT03470545|564904298|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
156493890|NCT03470545|564904297|FG000|Overall Study|Adverse Event|2|||
156493891|NCT03470545|564904298|FG001|Overall Study|Adverse Event|0|||
156493892|NCT03470545|564904297|FG000|Overall Study|Withdrawal by Subject|1|||
156493893|NCT03470545|564904298|FG001|Overall Study|Withdrawal by Subject|1|||
156493894|NCT03470545|564904297|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
156493895|NCT03470545|564904298|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
156493896|NCT01664923|564904299|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
156493897|NCT01664923|564904300|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
156493898|NCT01664923|564904299|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
156493899|NCT01664923|564904300|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
156493900|NCT01664923|564904299|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
156493901|NCT01664923|564904300|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
156493902|NCT01664923|564904299|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
156493903|NCT01664923|564904300|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
156493904|NCT01664923|564904299|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
156493905|NCT01664923|564904300|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
156493906|NCT01664923|564904299|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
156493907|NCT01664923|564904300|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
156493908|NCT01664923|564904299|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
156493909|NCT01664923|564904300|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
156493910|NCT01664923|564904299|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
156493911|NCT01664923|564904300|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
156493912|NCT01664923|564904299|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
156493913|NCT01664923|564904300|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
156493914|NCT01664923|564904299|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
156493915|NCT01664923|564904300|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
156493916|NCT01664923|564904299|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
156493917|NCT01664923|564904300|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
156493918|NCT01664923|564904299|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
156493919|NCT01664923|564904300|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
156493920|NCT01664923|564904299|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
156493921|NCT01664923|564904300|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
156493922|NCT01664923|564904299|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
156493923|NCT01664923|564904300|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
156493924|NCT01336205|564904301|FG000|Overall Study|Other|22|||
156493925|NCT01336205|564904302|FG001|Overall Study|Other|9|||
156493926|NCT01336205|564904301|FG000|Overall Study|Lost to Follow-up|40|||
156493927|NCT01336205|564904302|FG001|Overall Study|Lost to Follow-up|20|||
156493928|NCT01336205|564904301|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
156493929|NCT01336205|564904302|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
156493930|NCT01336205|564904301|FG000|Overall Study|Lack of Efficacy|4|||
156493931|NCT01336205|564904302|FG001|Overall Study|Lack of Efficacy|0|||
156493932|NCT01336205|564904301|FG000|Overall Study|Severe noncompliance with protocol|9|||
156493933|NCT01336205|564904302|FG001|Overall Study|Severe noncompliance with protocol|2|||
156493934|NCT01336205|564904301|FG000|Overall Study|Adverse Event|56|||
156493935|NCT01336205|564904302|FG001|Overall Study|Adverse Event|6|||
156493936|NCT01336205|564904301|FG000|Overall Study|Death|1|||
156546357|NCT03882970|565093336|FG000|Overall Study|Death|1|||
156546358|NCT03882970|565093337|FG001|Overall Study|Death|2|||
156493937|NCT01336205|564904302|FG001|Overall Study|Death|1|||
156493938|NCT01336205|564904301|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
156493939|NCT01336205|564904302|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
156493940|NCT01336205|564904301|FG000|Overall Study|Withdrawal by Subject|72|||
156493941|NCT01336205|564904302|FG001|Overall Study|Withdrawal by Subject|38|||
156493942|NCT01336205|564904301|FG000|Overall Study|Did not receive treatment|4|||
156546359|NCT03882970|565093338|FG002|Overall Study|Death|1|||
156546360|NCT03882970|565093339|FG003|Overall Study|Death|1|||
156546361|NCT03882970|565093336|FG000|Overall Study|Lost to Follow-up|8|||
156546362|NCT03882970|565093337|FG001|Overall Study|Lost to Follow-up|9|||
156493943|NCT01336205|564904302|FG001|Overall Study|Did not receive treatment|0|||
156493944|NCT00937521|564904307|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
156493945|NCT00937521|564904308|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
156493946|NCT00937521|564904309|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
156493947|NCT00937521|564904310|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
156493948|NCT00937521|564904311|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
156493949|NCT00937521|564904312|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
156493950|NCT00937521|564904313|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
156493951|NCT00937521|564904314|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
156493952|NCT00937521|564904307|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
156493953|NCT00937521|564904308|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
156493954|NCT00937521|564904309|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
156493955|NCT00937521|564904310|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
156493956|NCT00937521|564904311|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
156493957|NCT00937521|564904312|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
156493958|NCT00937521|564904313|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
156493959|NCT00937521|564904314|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
156493960|NCT00937521|564904307|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
156493961|NCT00937521|564904308|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
156493962|NCT00937521|564904309|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
156493963|NCT00937521|564904310|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
156493964|NCT00937521|564904311|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
156493965|NCT00937521|564904312|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
156493966|NCT00937521|564904313|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
156493967|NCT00937521|564904314|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
156493968|NCT00937521|564904307|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
156493969|NCT00937521|564904308|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
156493970|NCT00937521|564904309|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
156493971|NCT00937521|564904310|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
156493972|NCT00937521|564904311|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
156493973|NCT00937521|564904312|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
156493974|NCT00937521|564904313|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
156493975|NCT00937521|564904314|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
156493976|NCT00937521|564904307|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
156493977|NCT00937521|564904308|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
156493978|NCT00937521|564904309|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
156493979|NCT00937521|564904310|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
156493980|NCT00937521|564904311|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
156493981|NCT00937521|564904312|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
156493982|NCT00937521|564904313|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
156493983|NCT00937521|564904314|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
156493984|NCT00937521|564904307|FG000|Booster Phase|Adverse Event|0|||
156493985|NCT00937521|564904308|FG001|Booster Phase|Adverse Event|0|||
156493986|NCT00937521|564904309|FG002|Booster Phase|Adverse Event|0|||
156493987|NCT00937521|564904310|FG003|Booster Phase|Adverse Event|0|||
156493988|NCT00937521|564904311|FG004|Booster Phase|Adverse Event|0|||
156493989|NCT00937521|564904312|FG005|Booster Phase|Adverse Event|0|||
156493990|NCT00937521|564904313|FG006|Booster Phase|Adverse Event|1|||
156493991|NCT00937521|564904314|FG007|Booster Phase|Adverse Event|0|||
156493992|NCT00937521|564904307|FG000|Booster Phase|Withdrawal by Subject|1|||
156493993|NCT00937521|564904308|FG001|Booster Phase|Withdrawal by Subject|0|||
156493994|NCT00937521|564904309|FG002|Booster Phase|Withdrawal by Subject|0|||
156493995|NCT00937521|564904310|FG003|Booster Phase|Withdrawal by Subject|1|||
156493996|NCT00937521|564904311|FG004|Booster Phase|Withdrawal by Subject|0|||
156493997|NCT00937521|564904312|FG005|Booster Phase|Withdrawal by Subject|0|||
156493998|NCT00937521|564904313|FG006|Booster Phase|Withdrawal by Subject|0|||
156493999|NCT00937521|564904314|FG007|Booster Phase|Withdrawal by Subject|2|||
156494000|NCT00937521|564904307|FG000|Booster Phase|Lost to Follow-up|2|||
156494001|NCT00937521|564904308|FG001|Booster Phase|Lost to Follow-up|2|||
156494002|NCT00937521|564904309|FG002|Booster Phase|Lost to Follow-up|4|||
156494003|NCT00937521|564904310|FG003|Booster Phase|Lost to Follow-up|2|||
156494004|NCT00937521|564904311|FG004|Booster Phase|Lost to Follow-up|4|||
156494005|NCT00937521|564904312|FG005|Booster Phase|Lost to Follow-up|4|||
156494006|NCT00937521|564904313|FG006|Booster Phase|Lost to Follow-up|3|||
156494007|NCT00937521|564904314|FG007|Booster Phase|Lost to Follow-up|0|||
156494008|NCT00937521|564904307|FG000|Booster Phase|Administrative Reason|0|||
156494009|NCT00937521|564904308|FG001|Booster Phase|Administrative Reason|0|||
156494010|NCT00937521|564904309|FG002|Booster Phase|Administrative Reason|1|||
156546363|NCT03882970|565093338|FG002|Overall Study|Lost to Follow-up|5|||
156494011|NCT00937521|564904310|FG003|Booster Phase|Administrative Reason|0|||
156494012|NCT00937521|564904311|FG004|Booster Phase|Administrative Reason|1|||
156494013|NCT00937521|564904312|FG005|Booster Phase|Administrative Reason|1|||
156494014|NCT00937521|564904313|FG006|Booster Phase|Administrative Reason|0|||
156494015|NCT00937521|564904314|FG007|Booster Phase|Administrative Reason|0|||
156372027|NCT04456699|564458373|FG000|Overall Study|Physician Decision|0|||
156372028|NCT04456699|564458374|FG001|Overall Study|Physician Decision|0|||
156372029|NCT04456699|564458375|FG002|Overall Study|Physician Decision|2|||
156494016|NCT00937521|564904307|FG000|Booster Phase|Protocol Deviation|0|||
156372030|NCT04456699|564458373|FG000|Overall Study|Sponsor Decision|55|||
156546364|NCT03882970|565093339|FG003|Overall Study|Lost to Follow-up|5|||
156546365|NCT03882970|565093336|FG000|Overall Study|Physician Decision|0|||
156546366|NCT03882970|565093337|FG001|Overall Study|Physician Decision|2|||
156372031|NCT04456699|564458374|FG001|Overall Study|Sponsor Decision|61|||
156494017|NCT00937521|564904308|FG001|Booster Phase|Protocol Deviation|0|||
156494018|NCT00937521|564904309|FG002|Booster Phase|Protocol Deviation|0|||
156494019|NCT00937521|564904310|FG003|Booster Phase|Protocol Deviation|0|||
156494020|NCT00937521|564904311|FG004|Booster Phase|Protocol Deviation|0|||
156494021|NCT00937521|564904312|FG005|Booster Phase|Protocol Deviation|0|||
156494022|NCT00937521|564904313|FG006|Booster Phase|Protocol Deviation|1|||
156494023|NCT00937521|564904314|FG007|Booster Phase|Protocol Deviation|0|||
156494024|NCT04035577|564904315|FG000|Overall Study|Lost to Follow-up|1|||
156494025|NCT04035577|564904315|FG000|Overall Study|Withdrawal by Subject|1|||
156494026|NCT00505414|564904316|FG000|Titration Phase|Adverse Event|0|||
156494027|NCT00505414|564904317|FG001|Titration Phase|Adverse Event|0|||
156494028|NCT00505414|564904318|FG002|Titration Phase|Adverse Event|0|||
156494029|NCT00505414|564904319|FG003|Titration Phase|Adverse Event|8|||
156494030|NCT00505414|564904320|FG004|Titration Phase|Adverse Event|3|||
156494031|NCT00505414|564904316|FG000|Titration Phase|Death|0|||
156494032|NCT00505414|564904317|FG001|Titration Phase|Death|0|||
156494033|NCT00505414|564904318|FG002|Titration Phase|Death|0|||
156494034|NCT00505414|564904319|FG003|Titration Phase|Death|2|||
156494035|NCT00505414|564904320|FG004|Titration Phase|Death|0|||
156494036|NCT00505414|564904316|FG000|Titration Phase|Lack of Efficacy|0|||
156494037|NCT00505414|564904317|FG001|Titration Phase|Lack of Efficacy|0|||
156494038|NCT00505414|564904318|FG002|Titration Phase|Lack of Efficacy|0|||
156494039|NCT00505414|564904319|FG003|Titration Phase|Lack of Efficacy|10|||
156494040|NCT00505414|564904320|FG004|Titration Phase|Lack of Efficacy|1|||
156494041|NCT00505414|564904316|FG000|Titration Phase|Protocol Violation|0|||
156494042|NCT00505414|564904317|FG001|Titration Phase|Protocol Violation|0|||
156494043|NCT00505414|564904318|FG002|Titration Phase|Protocol Violation|0|||
156494044|NCT00505414|564904319|FG003|Titration Phase|Protocol Violation|0|||
156494045|NCT00505414|564904320|FG004|Titration Phase|Protocol Violation|1|||
156494046|NCT00505414|564904316|FG000|Titration Phase|Withdrawal by Subject|0|||
156494047|NCT00505414|564904317|FG001|Titration Phase|Withdrawal by Subject|0|||
156494048|NCT00505414|564904318|FG002|Titration Phase|Withdrawal by Subject|0|||
156494049|NCT00505414|564904319|FG003|Titration Phase|Withdrawal by Subject|3|||
156494050|NCT00505414|564904320|FG004|Titration Phase|Withdrawal by Subject|4|||
156494051|NCT00505414|564904316|FG000|Titration Phase|Underlying disease and therapy required|0|||
156494052|NCT00505414|564904317|FG001|Titration Phase|Underlying disease and therapy required|0|||
156494053|NCT00505414|564904318|FG002|Titration Phase|Underlying disease and therapy required|0|||
156494054|NCT00505414|564904319|FG003|Titration Phase|Underlying disease and therapy required|7|||
156494055|NCT00505414|564904320|FG004|Titration Phase|Underlying disease and therapy required|3|||
156494056|NCT00505414|564904316|FG000|Maintenance Phase|Adverse Event|2|||
156494057|NCT00505414|564904317|FG001|Maintenance Phase|Adverse Event|2|||
156494058|NCT00505414|564904318|FG002|Maintenance Phase|Adverse Event|3|||
156494059|NCT00505414|564904319|FG003|Maintenance Phase|Adverse Event|0|||
156494060|NCT00505414|564904320|FG004|Maintenance Phase|Adverse Event|0|||
156494061|NCT00505414|564904316|FG000|Maintenance Phase|Death|2|||
156494062|NCT00505414|564904317|FG001|Maintenance Phase|Death|0|||
156494063|NCT00505414|564904318|FG002|Maintenance Phase|Death|1|||
156494064|NCT00505414|564904319|FG003|Maintenance Phase|Death|0|||
156494065|NCT00505414|564904320|FG004|Maintenance Phase|Death|0|||
156494066|NCT00505414|564904316|FG000|Maintenance Phase|Lack of Efficacy|2|||
156494067|NCT00505414|564904317|FG001|Maintenance Phase|Lack of Efficacy|1|||
156494068|NCT00505414|564904318|FG002|Maintenance Phase|Lack of Efficacy|1|||
156494069|NCT00505414|564904319|FG003|Maintenance Phase|Lack of Efficacy|0|||
156494070|NCT00505414|564904320|FG004|Maintenance Phase|Lack of Efficacy|0|||
156494071|NCT00505414|564904316|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156494072|NCT00505414|564904317|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156494073|NCT00505414|564904318|FG002|Maintenance Phase|Withdrawal by Subject|1|||
156494074|NCT00505414|564904319|FG003|Maintenance Phase|Withdrawal by Subject|0|||
156494075|NCT00505414|564904320|FG004|Maintenance Phase|Withdrawal by Subject|0|||
156494076|NCT00505414|564904316|FG000|Maintenance Phase|underlying disease and therapy required|0|||
156494077|NCT00505414|564904317|FG001|Maintenance Phase|underlying disease and therapy required|2|||
156494078|NCT00505414|564904318|FG002|Maintenance Phase|underlying disease and therapy required|2|||
156494079|NCT00505414|564904319|FG003|Maintenance Phase|underlying disease and therapy required|0|||
156494080|NCT00505414|564904320|FG004|Maintenance Phase|underlying disease and therapy required|0|||
156494081|NCT00846768|564904321|FG000|Overall Study|Adverse Event|0|||
156494082|NCT00846768|564904322|FG001|Overall Study|Adverse Event|1|||
156494083|NCT00846768|564904323|FG002|Overall Study|Adverse Event|0|||
156494084|NCT00846768|564904324|FG003|Overall Study|Adverse Event|0|||
156494085|NCT04358068|564904325|FG000|Overall Study|Did not initiate study treatment|2|||
156494086|NCT04358068|564904326|FG001|Overall Study|Did not initiate study treatment|2|||
156494087|NCT02601209|564904327|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
156494088|NCT02601209|564904328|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
156494089|NCT02601209|564904329|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
156494090|NCT02601209|564904330|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
156494091|NCT02601209|564904331|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
156494092|NCT02601209|564904332|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
156494093|NCT02601209|564904333|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
156494094|NCT02601209|564904334|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
156494095|NCT02601209|564904335|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
156494096|NCT02601209|564904327|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
156494097|NCT02601209|564904328|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
156494098|NCT02601209|564904329|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
156372032|NCT04456699|564458375|FG002|Overall Study|Sponsor Decision|50|||
156546367|NCT03882970|565093338|FG002|Overall Study|Physician Decision|2|||
156546368|NCT03882970|565093339|FG003|Overall Study|Physician Decision|2|||
156546369|NCT03882970|565093336|FG000|Overall Study|Protocol Violation|2|||
156546370|NCT03882970|565093337|FG001|Overall Study|Protocol Violation|0|||
156546371|NCT03882970|565093338|FG002|Overall Study|Protocol Violation|0|||
156546372|NCT03882970|565093339|FG003|Overall Study|Protocol Violation|0|||
156546373|NCT03882970|565093336|FG000|Overall Study|Withdrawal by Subject|8|||
156546374|NCT03882970|565093337|FG001|Overall Study|Withdrawal by Subject|17|||
156546375|NCT03882970|565093338|FG002|Overall Study|Withdrawal by Subject|7|||
156546376|NCT03882970|565093339|FG003|Overall Study|Withdrawal by Subject|22|||
156372033|NCT04456699|564458373|FG000|Overall Study|Withdrawal by Subject|8|||
156372034|NCT04456699|564458374|FG001|Overall Study|Withdrawal by Subject|4|||
156372035|NCT04456699|564458375|FG002|Overall Study|Withdrawal by Subject|5|||
156546377|NCT03882970|565093336|FG000|Overall Study|Personal Reason|2|||
156372036|NCT02075437|564458383|FG000|Overall Study|Withdrawal by Subject|5|||
156372037|NCT02075437|564458383|FG000|Overall Study|Lost to Follow-up|1|||
156372038|NCT01632800|564458384|FG000|Overall Study|Subject did not fit in apparatus|1|||
156372039|NCT00673452|564458386|FG000|Acute Double-Blind Phase|Adverse Event|41|||
156372040|NCT00673452|564458387|FG001|Acute Double-Blind Phase|Adverse Event|24|||
156372041|NCT00673452|564458386|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
156372042|NCT00673452|564458387|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
156372043|NCT00673452|564458386|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
156372044|NCT00673452|564458387|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
156372045|NCT00673452|564458386|FG000|Acute Double-Blind Phase|Physician Decision|0|||
156372046|NCT00673452|564458387|FG001|Acute Double-Blind Phase|Physician Decision|6|||
156372047|NCT00673452|564458386|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
156372048|NCT00673452|564458387|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
156372049|NCT00673452|564458386|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
156372050|NCT00673452|564458387|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
156372051|NCT00673452|564458386|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
156372052|NCT00673452|564458387|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
156372053|NCT00673452|564458386|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
156372054|NCT00673452|564458387|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
156372055|NCT00673452|564458386|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
156372056|NCT00673452|564458387|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
156372057|NCT00673452|564458386|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
156372058|NCT00673452|564458387|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
156372059|NCT00673452|564458386|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
156372060|NCT00673452|564458387|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
156372061|NCT00673452|564458386|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
156372062|NCT00673452|564458387|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
156372063|NCT00673452|564458386|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
156372064|NCT00673452|564458387|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
156372065|NCT00673452|564458386|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
156372066|NCT00673452|564458387|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
156372067|NCT00673452|564458386|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
156372068|NCT00673452|564458387|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
156372069|NCT00617240|564458388|FG000|Overall Study|Lack of Efficacy|1|||
156372070|NCT00617240|564458389|FG001|Overall Study|Lack of Efficacy|0|||
156372071|NCT01611259|564458390|FG000|Overall Study|Physician Decision|1|||
156372072|NCT01611259|564458390|FG000|Overall Study|Lack of Efficacy|2|||
156372073|NCT01611259|564458390|FG000|Overall Study|Adverse Event|4|||
156372074|NCT01611259|564458390|FG000|Overall Study|Withdrawal by Subject|7|||
156372075|NCT04936685|564458391|FG000|Overall Study|Protocol Violation|1|||
156372076|NCT04936685|564458392|FG001|Overall Study|Protocol Violation|0|||
156372077|NCT02410811|564458396|FG000|Overall Study|Withdrawal by Subject|0|||
156372078|NCT02410811|564458397|FG001|Overall Study|Withdrawal by Subject|0|||
156546378|NCT03882970|565093337|FG001|Overall Study|Personal Reason|3|||
156546379|NCT03882970|565093338|FG002|Overall Study|Personal Reason|1|||
156372079|NCT02410811|564458398|FG002|Overall Study|Withdrawal by Subject|1|||
156372080|NCT02410811|564458399|FG003|Overall Study|Withdrawal by Subject|0|||
156372081|NCT00353366|564458400|FG000|Overall Study|Adverse Event|8|||
156372082|NCT00353366|564458400|FG000|Overall Study|Protocol Violation|12|||
156546380|NCT03882970|565093339|FG003|Overall Study|Personal Reason|3|||
156372083|NCT00353366|564458400|FG000|Overall Study|Withdrawal by Subject|12|||
156372084|NCT00353366|564458400|FG000|Overall Study|Lost to Follow-up|92|||
156372085|NCT00353366|564458400|FG000|Overall Study|Other|19|||
156372086|NCT00259857|564458401|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
156372087|NCT00259857|564458402|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
156372088|NCT00259857|564458401|FG000|24 Months Treatment|Lost to Follow-up|0|||
156372089|NCT00259857|564458402|FG001|24 Months Treatment|Lost to Follow-up|3|||
156372090|NCT05267054|564458403|FG000|Overall Study|Death|13|||
156372091|NCT05267054|564458404|FG001|Overall Study|Death|14|||
156372092|NCT05267054|564458403|FG000|Overall Study|Study Ended by Sponsor|9|||
156372093|NCT05267054|564458404|FG001|Overall Study|Study Ended by Sponsor|13|||
156372094|NCT05267054|564458403|FG000|Overall Study|Lost to Follow-up|1|||
156372095|NCT05267054|564458404|FG001|Overall Study|Lost to Follow-up|1|||
156372096|NCT05267054|564458403|FG000|Overall Study|Withdrawal by Subject|1|||
156372097|NCT05267054|564458404|FG001|Overall Study|Withdrawal by Subject|1|||
156372098|NCT01813019|564458410|FG000|Overall Study|Adverse Event|0|||
156372099|NCT01813019|564458411|FG001|Overall Study|Adverse Event|3|||
156372100|NCT01813019|564458410|FG000|Overall Study|Withdrawal by Subject|3|||
156372101|NCT01813019|564458411|FG001|Overall Study|Withdrawal by Subject|2|||
156372102|NCT01813019|564458410|FG000|Overall Study|administrative problems|2|||
156372103|NCT01813019|564458411|FG001|Overall Study|administrative problems|0|||
156372104|NCT01813019|564458410|FG000|Overall Study|Protocol Deviation|2|||
156372105|NCT01813019|564458411|FG001|Overall Study|Protocol Deviation|1|||
156372106|NCT00094653|564458414|FG000|Overall Study|Death|306|||
156372107|NCT00094653|564458415|FG001|Overall Study|Death|100|||
156372108|NCT00094653|564458416|FG002|Overall Study|Death|119|||
156372109|NCT00094653|564458414|FG000|Overall Study|Subject Withdrew Consent|10|||
156372110|NCT00094653|564458415|FG001|Overall Study|Subject Withdrew Consent|2|||
156372111|NCT00094653|564458416|FG002|Overall Study|Subject Withdrew Consent|3|||
156372112|NCT00094653|564458414|FG000|Overall Study|Other|2|||
156372113|NCT00094653|564458415|FG001|Overall Study|Other|2|||
156372114|NCT00094653|564458416|FG002|Overall Study|Other|2|||
156372115|NCT00094653|564458414|FG000|Overall Study|Lost to Follow-up|3|||
156372116|NCT00094653|564458415|FG001|Overall Study|Lost to Follow-up|2|||
156372117|NCT00094653|564458416|FG002|Overall Study|Lost to Follow-up|1|||
156372118|NCT00094653|564458414|FG000|Overall Study|Protocol Violation|0|||
156372119|NCT00094653|564458415|FG001|Overall Study|Protocol Violation|0|||
156372120|NCT00094653|564458416|FG002|Overall Study|Protocol Violation|1|||
156372121|NCT03921411|564458417|FG000|Overall Study|Withdrawal by Subject|1|||
156372122|NCT03921411|564458417|FG000|Overall Study|Protocol Deviation|2|||
156372123|NCT03921411|564458417|FG000|Overall Study|Enrolled, but never treated|2|||
156372124|NCT00854581|564458428|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
156372125|NCT00854581|564458428|FG000|Induction (Up to Day 21)|Death|1|||
156372126|NCT00854581|564458428|FG000|Induction (Up to Day 21)|Physician Decision|1|||
156372127|NCT00854581|564458428|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
156372128|NCT03181542|564458431|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
156372129|NCT03181542|564458432|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
156372130|NCT01462357|564458440|FG000|Overall Study|Death|0|||
156372131|NCT01462357|564458441|FG001|Overall Study|Death|0|||
156372132|NCT01462357|564458442|FG002|Overall Study|Death|1|||
156372133|NCT01462357|564458440|FG000|Overall Study|Withdrawal by Subject|3|||
156372134|NCT01462357|564458441|FG001|Overall Study|Withdrawal by Subject|11|||
156372135|NCT01462357|564458442|FG002|Overall Study|Withdrawal by Subject|3|||
156372136|NCT01462357|564458440|FG000|Overall Study|Migrated/moved from study area|2|||
156372137|NCT01462357|564458441|FG001|Overall Study|Migrated/moved from study area|3|||
156372138|NCT01462357|564458442|FG002|Overall Study|Migrated/moved from study area|1|||
156372139|NCT01462357|564458440|FG000|Overall Study|Lost to Follow-up|3|||
156372140|NCT01462357|564458441|FG001|Overall Study|Lost to Follow-up|5|||
156372141|NCT01462357|564458442|FG002|Overall Study|Lost to Follow-up|7|||
156372142|NCT04292730|564458451|FG000|Overall Study|Lost to Follow-up|8|||
156372143|NCT04292730|564458452|FG001|Overall Study|Lost to Follow-up|12|||
156372144|NCT04292730|564458453|FG002|Overall Study|Lost to Follow-up|12|||
156494099|NCT02601209|564904330|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
156494100|NCT02601209|564904331|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
156372145|NCT04292730|564458454|FG003|Overall Study|Lost to Follow-up|48|||
156372146|NCT04292730|564458451|FG000|Overall Study|Death|2|||
156372147|NCT04292730|564458452|FG001|Overall Study|Death|2|||
156372148|NCT04292730|564458453|FG002|Overall Study|Death|4|||
156372149|NCT04292730|564458454|FG003|Overall Study|Death|12|||
156372150|NCT04292730|564458451|FG000|Overall Study|Withdrew Consent|2|||
156372151|NCT04292730|564458452|FG001|Overall Study|Withdrew Consent|2|||
156372152|NCT04292730|564458453|FG002|Overall Study|Withdrew Consent|5|||
156372153|NCT04292730|564458454|FG003|Overall Study|Withdrew Consent|6|||
156372154|NCT04292730|564458451|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156372155|NCT04292730|564458452|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156372156|NCT04292730|564458453|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156372157|NCT04292730|564458454|FG003|Overall Study|Non-Compliance with Study Drug|0|||
156372158|NCT04292730|564458451|FG000|Overall Study|Protocol Violation|0|||
156372159|NCT04292730|564458452|FG001|Overall Study|Protocol Violation|0|||
156372160|NCT04292730|564458453|FG002|Overall Study|Protocol Violation|1|||
156372161|NCT04292730|564458454|FG003|Overall Study|Protocol Violation|0|||
156372162|NCT04292730|564458451|FG000|Overall Study|Randomized but not Treated|8|||
156372163|NCT04292730|564458452|FG001|Overall Study|Randomized but not Treated|4|||
156372164|NCT04292730|564458453|FG002|Overall Study|Randomized but not Treated|0|||
156372165|NCT04292730|564458454|FG003|Overall Study|Randomized but not Treated|14|||
156372166|NCT01527292|564458456|FG000|Overall Study|Physician Decision|0|||
156372167|NCT01527292|564458457|FG001|Overall Study|Physician Decision|3|||
156372168|NCT00314366|564458460|FG000|Overall Study|not treated due to patient medical condi|1|||
156372169|NCT00314366|564458461|FG001|Overall Study|not treated due to patient medical condi|0|||
156372170|NCT00806546|564458471|FG000|Overall Study|Enrolled, not treated|35|||
156372171|NCT00806546|564458471|FG000|Overall Study|Lost to Follow-up|32|||
156372172|NCT00806546|564458471|FG000|Overall Study|Adverse Event|74|||
156372173|NCT00806546|564458471|FG000|Overall Study|Withdrawal by Subject|75|||
156372174|NCT00806546|564458471|FG000|Overall Study|Protocol Violation|49|||
156372175|NCT00806546|564458471|FG000|Overall Study|Various|42|||
156372176|NCT01247090|564458472|FG000|Overall Study|Physician Decision|1|||
156372177|NCT01247090|564458473|FG001|Overall Study|Physician Decision|0|||
156372178|NCT01247090|564458474|FG002|Overall Study|Physician Decision|0|||
156372179|NCT01247090|564458472|FG000|Overall Study|Withdrawal by Subject|0|||
156372180|NCT01247090|564458473|FG001|Overall Study|Withdrawal by Subject|1|||
156372181|NCT01247090|564458474|FG002|Overall Study|Withdrawal by Subject|0|||
156372182|NCT02751983|564458477|FG000|Treatment|Stopped ACT, but Remained in study|2|||
156372183|NCT02751983|564458478|FG001|Treatment|Stopped ACT, but Remained in study|0|||
156372184|NCT02751983|564458477|FG000|Treatment|Discharged prior to beginning ACT|2|||
156372185|NCT02751983|564458478|FG001|Treatment|Discharged prior to beginning ACT|0|||
156372186|NCT02751983|564458477|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
156372187|NCT02751983|564458478|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
156372188|NCT02751983|564458477|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
156372189|NCT02751983|564458478|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
156372190|NCT02751983|564458477|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
156372191|NCT02751983|564458478|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
156372192|NCT00989833|564458479|FG000|Overall Study|Lost to Follow-up|0|||
156372193|NCT00989833|564458480|FG001|Overall Study|Lost to Follow-up|1|||
156372194|NCT00989833|564458481|FG002|Overall Study|Lost to Follow-up|0|||
156372195|NCT00989833|564458479|FG000|Overall Study|Protocol Violation|1|||
156372196|NCT00989833|564458480|FG001|Overall Study|Protocol Violation|2|||
156372197|NCT00989833|564458481|FG002|Overall Study|Protocol Violation|1|||
156372198|NCT00989833|564458479|FG000|Overall Study|Withdrawal by Subject|0|||
156372199|NCT00989833|564458480|FG001|Overall Study|Withdrawal by Subject|0|||
156372200|NCT00989833|564458481|FG002|Overall Study|Withdrawal by Subject|1|||
156372201|NCT00989833|564458479|FG000|Overall Study|Incorrectly randomized|1|||
156372202|NCT00989833|564458480|FG001|Overall Study|Incorrectly randomized|0|||
156372203|NCT00989833|564458481|FG002|Overall Study|Incorrectly randomized|0|||
156372204|NCT00308711|564458482|FG000|Overall Study|Withdrawal by Subject|1|||
156372205|NCT00308711|564458483|FG001|Overall Study|Withdrawal by Subject|0|||
156372206|NCT00308711|564458484|FG002|Overall Study|Withdrawal by Subject|1|||
156372207|NCT00308711|564458482|FG000|Overall Study|Protocol Violation|0|||
156372208|NCT00308711|564458483|FG001|Overall Study|Protocol Violation|1|||
156372209|NCT00308711|564458484|FG002|Overall Study|Protocol Violation|1|||
156372210|NCT00308711|564458482|FG000|Overall Study|Lost to Follow-up|0|||
156372211|NCT00308711|564458483|FG001|Overall Study|Lost to Follow-up|1|||
156372212|NCT00308711|564458484|FG002|Overall Study|Lost to Follow-up|0|||
156372213|NCT00308711|564458482|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
156372214|NCT00308711|564458483|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
156372215|NCT00308711|564458484|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
156372216|NCT00308711|564458482|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
156372217|NCT00308711|564458483|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
156372218|NCT00308711|564458484|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
156372219|NCT02318693|564458485|FG000|Overall Study|Protocol Violation|0|||
156494101|NCT02601209|564904332|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
156494102|NCT02601209|564904333|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
156372220|NCT02318693|564458486|FG001|Overall Study|Protocol Violation|1|||
156372221|NCT02553421|564458487|FG000|Overall Study|Lost to Follow-up|21|||
156372222|NCT02553421|564458488|FG001|Overall Study|Lost to Follow-up|1|||
156372223|NCT02553421|564458487|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
156372224|NCT02553421|564458488|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
156372225|NCT02553421|564458487|FG000|Overall Study|Improper Device Placement|3|||
156372226|NCT02553421|564458488|FG001|Overall Study|Improper Device Placement|0|||
156372227|NCT04084769|564458492|FG000|Overall Study|Protocol Violation|1|||
156372228|NCT04084769|564458493|FG001|Overall Study|Protocol Violation|3|||
156372229|NCT04084769|564458494|FG002|Overall Study|Protocol Violation|0|||
156372230|NCT04084769|564458495|FG003|Overall Study|Protocol Violation|1|||
156372231|NCT04084769|564458492|FG000|Overall Study|Withdrawal by Subject|0|||
156372232|NCT04084769|564458493|FG001|Overall Study|Withdrawal by Subject|1|||
156372233|NCT04084769|564458494|FG002|Overall Study|Withdrawal by Subject|0|||
156372234|NCT04084769|564458495|FG003|Overall Study|Withdrawal by Subject|0|||
156372235|NCT04084769|564458492|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156372236|NCT04084769|564458493|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156372237|NCT04084769|564458494|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156372238|NCT04084769|564458495|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156372239|NCT04084769|564458492|FG000|Overall Study|Lost to Follow-up|2|||
156372240|NCT04084769|564458493|FG001|Overall Study|Lost to Follow-up|0|||
156372241|NCT04084769|564458494|FG002|Overall Study|Lost to Follow-up|0|||
156372242|NCT04084769|564458495|FG003|Overall Study|Lost to Follow-up|0|||
156372243|NCT04579679|564458496|FG000|Overall Study|New Antitumor Therapy|6|||
156372244|NCT04579679|564458497|FG001|Overall Study|New Antitumor Therapy|4|||
156372245|NCT04579679|564458498|FG002|Overall Study|New Antitumor Therapy|7|||
156372246|NCT04579679|564458499|FG003|Overall Study|New Antitumor Therapy|0|||
156372247|NCT04579679|564458496|FG000|Overall Study|Withdrawal of Consent|1|||
156372248|NCT04579679|564458497|FG001|Overall Study|Withdrawal of Consent|1|||
156372249|NCT04579679|564458498|FG002|Overall Study|Withdrawal of Consent|2|||
156372250|NCT04579679|564458499|FG003|Overall Study|Withdrawal of Consent|4|||
156372251|NCT04579679|564458496|FG000|Overall Study|Death|2|||
156372252|NCT04579679|564458497|FG001|Overall Study|Death|2|||
156372253|NCT04579679|564458498|FG002|Overall Study|Death|2|||
156372254|NCT04579679|564458499|FG003|Overall Study|Death|0|||
156372255|NCT04579679|564458496|FG000|Overall Study|Adverse Event|0|||
156372256|NCT04579679|564458497|FG001|Overall Study|Adverse Event|4|||
156372257|NCT04579679|564458498|FG002|Overall Study|Adverse Event|0|||
156372258|NCT04579679|564458499|FG003|Overall Study|Adverse Event|0|||
156372259|NCT04579679|564458496|FG000|Overall Study|Disease Progression|9|||
156372260|NCT04579679|564458497|FG001|Overall Study|Disease Progression|13|||
156372261|NCT04579679|564458498|FG002|Overall Study|Disease Progression|7|||
156372262|NCT04579679|564458499|FG003|Overall Study|Disease Progression|0|||
156372263|NCT04579679|564458496|FG000|Overall Study|Physician Decision|0|||
156372264|NCT04579679|564458497|FG001|Overall Study|Physician Decision|0|||
156372265|NCT04579679|564458498|FG002|Overall Study|Physician Decision|1|||
156372266|NCT04579679|564458499|FG003|Overall Study|Physician Decision|0|||
156372267|NCT04579679|564458496|FG000|Overall Study|Study Terminated by Sponsor|2|||
156372268|NCT04579679|564458497|FG001|Overall Study|Study Terminated by Sponsor|7|||
156372269|NCT04579679|564458498|FG002|Overall Study|Study Terminated by Sponsor|1|||
156372270|NCT04579679|564458499|FG003|Overall Study|Study Terminated by Sponsor|0|||
156372271|NCT01707004|564460358|FG000|Overall Study|Physician Decision|3|||
156372272|NCT03085927|564460360|FG000|Overall Study|Withdrawal by Subject|1|||
156372273|NCT03085927|564460361|FG001|Overall Study|Withdrawal by Subject|4|||
156372274|NCT03085927|564460360|FG000|Overall Study|Lost to Follow-up|3|||
156372275|NCT03085927|564460361|FG001|Overall Study|Lost to Follow-up|1|||
156372276|NCT03085927|564460360|FG000|Overall Study|Death|1|||
156372277|NCT03085927|564460361|FG001|Overall Study|Death|0|||
156372278|NCT03085927|564460360|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
156372279|NCT03085927|564460361|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
156372280|NCT03085927|564460360|FG000|Overall Study|Dyad Became Ineligible|0|||
156372281|NCT03085927|564460361|FG001|Overall Study|Dyad Became Ineligible|1|||
156372282|NCT01105533|564460366|FG000|Overall Study|Death|0|||
156372283|NCT01105533|564460367|FG001|Overall Study|Death|0|||
156372284|NCT01105533|564460368|FG002|Overall Study|Death|0|||
156372285|NCT01105533|564460369|FG003|Overall Study|Death|0|||
156372286|NCT01105533|564460370|FG004|Overall Study|Death|1|||
156372287|NCT01105533|564460371|FG005|Overall Study|Death|0|||
156372288|NCT01105533|564460372|FG006|Overall Study|Death|0|||
156372289|NCT01105533|564460373|FG007|Overall Study|Death|0|||
156372290|NCT01105533|564460374|FG008|Overall Study|Death|0|||
156372291|NCT01105533|564460366|FG000|Overall Study|Lack of Efficacy|1|||
156372292|NCT01105533|564460367|FG001|Overall Study|Lack of Efficacy|1|||
156372293|NCT01105533|564460368|FG002|Overall Study|Lack of Efficacy|3|||
156372294|NCT01105533|564460369|FG003|Overall Study|Lack of Efficacy|3|||
156372295|NCT01105533|564460370|FG004|Overall Study|Lack of Efficacy|4|||
156372296|NCT01105533|564460371|FG005|Overall Study|Lack of Efficacy|5|||
156372297|NCT01105533|564460372|FG006|Overall Study|Lack of Efficacy|3|||
156372298|NCT01105533|564460373|FG007|Overall Study|Lack of Efficacy|2|||
156372299|NCT01105533|564460374|FG008|Overall Study|Lack of Efficacy|9|||
156372300|NCT01105533|564460366|FG000|Overall Study|Adverse Event|0|||
156372301|NCT01105533|564460367|FG001|Overall Study|Adverse Event|0|||
156372302|NCT01105533|564460368|FG002|Overall Study|Adverse Event|0|||
156372303|NCT01105533|564460369|FG003|Overall Study|Adverse Event|0|||
156372304|NCT01105533|564460370|FG004|Overall Study|Adverse Event|1|||
156372305|NCT01105533|564460371|FG005|Overall Study|Adverse Event|2|||
156372306|NCT01105533|564460372|FG006|Overall Study|Adverse Event|2|||
156372307|NCT01105533|564460373|FG007|Overall Study|Adverse Event|0|||
156372308|NCT01105533|564460374|FG008|Overall Study|Adverse Event|1|||
156372309|NCT01105533|564460366|FG000|Overall Study|Other|0|||
156372310|NCT01105533|564460367|FG001|Overall Study|Other|0|||
156372311|NCT01105533|564460368|FG002|Overall Study|Other|0|||
156372312|NCT01105533|564460369|FG003|Overall Study|Other|0|||
156372313|NCT01105533|564460370|FG004|Overall Study|Other|1|||
156372314|NCT01105533|564460371|FG005|Overall Study|Other|0|||
156372315|NCT01105533|564460372|FG006|Overall Study|Other|3|||
156372316|NCT01105533|564460373|FG007|Overall Study|Other|1|||
156372317|NCT01105533|564460374|FG008|Overall Study|Other|2|||
156372318|NCT01105533|564460366|FG000|Overall Study|Physician Decision|0|||
156372319|NCT01105533|564460367|FG001|Overall Study|Physician Decision|0|||
156372320|NCT01105533|564460368|FG002|Overall Study|Physician Decision|0|||
156372321|NCT01105533|564460369|FG003|Overall Study|Physician Decision|0|||
156372322|NCT01105533|564460370|FG004|Overall Study|Physician Decision|0|||
156372323|NCT01105533|564460371|FG005|Overall Study|Physician Decision|0|||
156372324|NCT01105533|564460372|FG006|Overall Study|Physician Decision|0|||
156372325|NCT01105533|564460373|FG007|Overall Study|Physician Decision|1|||
156372326|NCT01105533|564460374|FG008|Overall Study|Physician Decision|0|||
156372327|NCT03892889|564460376|FG000|Overall Study|Adverse Event|17|||
156372328|NCT03892889|564460376|FG000|Overall Study|Lack of Efficacy|1|||
156372329|NCT03892889|564460376|FG000|Overall Study|Lost to Follow-up|46|||
156372330|NCT03892889|564460376|FG000|Overall Study|Non-compliance with study drug|22|||
156372331|NCT03892889|564460376|FG000|Overall Study|Pregnancy|1|||
156372332|NCT03892889|564460376|FG000|Overall Study|Protocol Deviation|3|||
156372333|NCT03892889|564460376|FG000|Overall Study|Withdrawal by Subject|50|||
156372334|NCT03892889|564460376|FG000|Overall Study|Withdrawal by Caregiver|1|||
156372335|NCT03892889|564460376|FG000|Overall Study|Study Terminated by Sponsor|50|||
156372336|NCT03892889|564460376|FG000|Overall Study|Physician Decision|8|||
156372337|NCT03892889|564460376|FG000|Overall Study|Reason not Specified|5|||
156372338|NCT01610700|564460381|FG000|Overall Study|Adverse Event|3|||
156372339|NCT01610700|564460382|FG001|Overall Study|Adverse Event|1|||
156372340|NCT01610700|564460381|FG000|Overall Study|Withdrawal by Subject|0|||
156372341|NCT01610700|564460382|FG001|Overall Study|Withdrawal by Subject|1|||
156372342|NCT01610700|564460381|FG000|Overall Study|subject took one dose of street cannabis|0|||
156372343|NCT01610700|564460382|FG001|Overall Study|subject took one dose of street cannabis|1|||
156372344|NCT01639001|564460388|FG000|Overall Study|Refused further follow-up|9|||
156372345|NCT01639001|564460389|FG001|Overall Study|Refused further follow-up|12|||
156372346|NCT01639001|564460388|FG000|Overall Study|Lost to Follow-up|3|||
156494103|NCT02601209|564904334|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
156494104|NCT02601209|564904335|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
156372347|NCT01639001|564460389|FG001|Overall Study|Lost to Follow-up|0|||
156372348|NCT01639001|564460388|FG000|Overall Study|Death|62|||
156372349|NCT01639001|564460389|FG001|Overall Study|Death|61|||
156372350|NCT01639001|564460388|FG000|Overall Study|Randomized but not treated|0|||
156372351|NCT01639001|564460389|FG001|Overall Study|Randomized but not treated|2|||
156372352|NCT01639001|564460388|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
156372353|NCT01639001|564460389|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
156372354|NCT02453594|564460390|FG000|Overall Study|Protocol Violation|0|||
156372355|NCT02453594|564460391|FG001|Overall Study|Protocol Violation|0|||
156372356|NCT02453594|564460392|FG002|Overall Study|Protocol Violation|1|||
156372357|NCT02453594|564460390|FG000|Overall Study|Cohort Was Closed|17|||
156372358|NCT02453594|564460391|FG001|Overall Study|Cohort Was Closed|21|||
156372359|NCT02453594|564460392|FG002|Overall Study|Cohort Was Closed|14|||
156372360|NCT02453594|564460390|FG000|Overall Study|Death|20|||
156372361|NCT02453594|564460391|FG001|Overall Study|Death|24|||
156372362|NCT02453594|564460392|FG002|Overall Study|Death|16|||
156372363|NCT02453594|564460390|FG000|Overall Study|Lost to Follow-up|6|||
156372364|NCT02453594|564460391|FG001|Overall Study|Lost to Follow-up|14|||
156372365|NCT02453594|564460392|FG002|Overall Study|Lost to Follow-up|2|||
156372366|NCT02453594|564460390|FG000|Overall Study|Physician Decision|2|||
156372367|NCT02453594|564460391|FG001|Overall Study|Physician Decision|4|||
156372368|NCT02453594|564460392|FG002|Overall Study|Physician Decision|0|||
156372369|NCT02453594|564460390|FG000|Overall Study|Site Terminated by Sponsor|1|||
156372370|NCT02453594|564460391|FG001|Overall Study|Site Terminated by Sponsor|0|||
156372371|NCT02453594|564460392|FG002|Overall Study|Site Terminated by Sponsor|1|||
156372372|NCT02453594|564460390|FG000|Overall Study|Transitioned to Extension Study|16|||
156372373|NCT02453594|564460391|FG001|Overall Study|Transitioned to Extension Study|9|||
156372374|NCT02453594|564460392|FG002|Overall Study|Transitioned to Extension Study|16|||
156372375|NCT02453594|564460390|FG000|Overall Study|Withdrawal by Subject|7|||
156372376|NCT02453594|564460391|FG001|Overall Study|Withdrawal by Subject|9|||
156372377|NCT02453594|564460392|FG002|Overall Study|Withdrawal by Subject|11|||
156372378|NCT00679341|564460393|FG000|Overall Study|Disease progression|42|||
156372379|NCT00679341|564460394|FG001|Overall Study|Disease progression|36|||
156372380|NCT00679341|564460393|FG000|Overall Study|Adverse Event|5|||
156372381|NCT00679341|564460394|FG001|Overall Study|Adverse Event|6|||
156372382|NCT00679341|564460393|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
156372383|NCT00679341|564460394|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
156372384|NCT00679341|564460393|FG000|Overall Study|Death|1|||
156372385|NCT00679341|564460394|FG001|Overall Study|Death|1|||
156372386|NCT00679341|564460393|FG000|Overall Study|Other|1|||
156372387|NCT00679341|564460394|FG001|Overall Study|Other|0|||
156372388|NCT00679341|564460393|FG000|Overall Study|Physician Decision|1|||
156372389|NCT00679341|564460394|FG001|Overall Study|Physician Decision|0|||
156372390|NCT00679341|564460393|FG000|Overall Study|Not treated|0|||
156372391|NCT00679341|564460394|FG001|Overall Study|Not treated|2|||
156372392|NCT00679341|564460393|FG000|Overall Study|Physician/patient decision to withdraw|0|||
156372393|NCT00679341|564460394|FG001|Overall Study|Physician/patient decision to withdraw|6|||
156372394|NCT03285646|564460401|FG000|Overall Study|Adverse Event|1|||
156372395|NCT03285646|564460402|FG001|Overall Study|Adverse Event|0|||
156372396|NCT03285646|564460401|FG000|Overall Study|Withdrawal by Subject|10|||
156372397|NCT03285646|564460402|FG001|Overall Study|Withdrawal by Subject|2|||
156372398|NCT03285646|564460401|FG000|Overall Study|Lost to Follow-up|2|||
156372399|NCT03285646|564460402|FG001|Overall Study|Lost to Follow-up|1|||
156372400|NCT03285646|564460401|FG000|Overall Study|Investigator/Sponsor Decision|0|||
156372401|NCT03285646|564460402|FG001|Overall Study|Investigator/Sponsor Decision|1|||
156372402|NCT00306592|564460406|FG000|Overall Study|Adverse Event|8|||
156372403|NCT00306592|564460407|FG001|Overall Study|Adverse Event|15|||
156372404|NCT00306592|564460406|FG000|Overall Study|Lost to Follow-up|1|||
156372405|NCT00306592|564460407|FG001|Overall Study|Lost to Follow-up|0|||
156372406|NCT00306592|564460406|FG000|Overall Study|Noncompliance|0|||
156372407|NCT00306592|564460407|FG001|Overall Study|Noncompliance|2|||
156372408|NCT00306592|564460406|FG000|Overall Study|Persistent Antibodies|6|||
156372409|NCT00306592|564460407|FG001|Overall Study|Persistent Antibodies|3|||
156372410|NCT00306592|564460406|FG000|Overall Study|Voluntary|10|||
156372411|NCT00306592|564460407|FG001|Overall Study|Voluntary|6|||
156372412|NCT00306592|564460406|FG000|Overall Study|Other|5|||
156372413|NCT00306592|564460407|FG001|Overall Study|Other|10|||
156372414|NCT00306592|564460406|FG000|Overall Study|Other|1|||
156372415|NCT00306592|564460407|FG001|Overall Study|Other|2|||
156372416|NCT00306592|564460406|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
156372417|NCT00306592|564460407|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
156372418|NCT04101526|564460408|FG000|Overall Study|Did not complete all sleep diary entries|0|||
156372419|NCT04101526|564460409|FG001|Overall Study|Did not complete all sleep diary entries|1|||
156372420|NCT00424372|564460411|FG000|Overall Study|Death|1|||
156372421|NCT00424372|564460411|FG000|Overall Study|Adverse Event|18|||
156372422|NCT00424372|564460411|FG000|Overall Study|Lack of Efficacy|6|||
156372423|NCT00424372|564460411|FG000|Overall Study|Withdrawal by Subject|4|||
156494105|NCT00927901|564904336|FG000|Treatment Period 1|Subject withdrew consent|0|||
156372424|NCT00424372|564460411|FG000|Overall Study|Protocol Violation|1|||
156372425|NCT00424372|564460411|FG000|Overall Study|Health deterioration|1|||
156372426|NCT02488629|564460412|FG000|Overall Study|Lack of Efficacy|3|||
156372427|NCT02488629|564460413|FG001|Overall Study|Lack of Efficacy|1|||
156372428|NCT02488629|564460414|FG002|Overall Study|Lack of Efficacy|0|||
156372429|NCT02488629|564460415|FG003|Overall Study|Lack of Efficacy|0|||
156372430|NCT02488629|564460412|FG000|Overall Study|Withdrawal by Subject|0|||
156372431|NCT02488629|564460413|FG001|Overall Study|Withdrawal by Subject|1|||
156372432|NCT02488629|564460414|FG002|Overall Study|Withdrawal by Subject|0|||
156372433|NCT02488629|564460415|FG003|Overall Study|Withdrawal by Subject|0|||
156372434|NCT02652624|564460416|FG000|Randomized Phase|Pregnancy|3|||
156372435|NCT02652624|564460417|FG001|Randomized Phase|Pregnancy|1|||
156372436|NCT02652624|564460416|FG000|Randomized Phase|Investigator's Discretion|0|||
156372437|NCT02652624|564460417|FG001|Randomized Phase|Investigator's Discretion|2|||
156372438|NCT02652624|564460416|FG000|Randomized Phase|Death|0|||
156372439|NCT02652624|564460417|FG001|Randomized Phase|Death|1|||
156372440|NCT02652624|564460416|FG000|Randomized Phase|Lost to Follow-up|0|||
156372441|NCT02652624|564460417|FG001|Randomized Phase|Lost to Follow-up|1|||
156372442|NCT02652624|564460416|FG000|Extension Phase|Lost to Follow-up|3|||
156372443|NCT02652624|564460417|FG001|Extension Phase|Lost to Follow-up|1|||
156372444|NCT02652624|564460416|FG000|Extension Phase|Pregnancy|1|||
156372445|NCT02652624|564460417|FG001|Extension Phase|Pregnancy|1|||
156372446|NCT02652624|564460416|FG000|Extension Phase|Adverse Event|0|||
156372447|NCT02652624|564460417|FG001|Extension Phase|Adverse Event|1|||
156372448|NCT02652624|564460416|FG000|Extension Phase|Withdrew Consent|0|||
156372449|NCT02652624|564460417|FG001|Extension Phase|Withdrew Consent|1|||
156372450|NCT00654628|564460418|FG000|6-week Active Treatment Period|Adverse Event|9|||
156372451|NCT00654628|564460418|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
156372452|NCT00654628|564460418|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
156372453|NCT00654628|564460418|FG000|6-week Active Treatment Period|Out of window period|1|||
156372454|NCT00654628|564460418|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
156372455|NCT00654628|564460418|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
156372456|NCT00912405|564460421|FG000|Overall Study|Lost to Follow-up|5|||
156372457|NCT00953329|564460422|FG000|Overall Study|Lack of Efficacy|1|||
156372458|NCT01434823|564460423|FG000|Overall Study|Incomplete data in medical record|4|||
156372459|NCT01434823|564460424|FG001|Overall Study|Incomplete data in medical record|7|||
156372460|NCT01797536|564460427|FG000|Overall Study|Adverse Event|0|||
156372461|NCT01797536|564460428|FG001|Overall Study|Adverse Event|1|||
156372462|NCT01797536|564460429|FG002|Overall Study|Adverse Event|0|||
156372463|NCT01797536|564460430|FG003|Overall Study|Adverse Event|0|||
156372464|NCT00796861|564460431|FG000|Overall Study|Withdrawal by Subject|2|||
156372465|NCT00796861|564460431|FG000|Overall Study|Death|2|||
156372466|NCT01401530|564460436|FG000|Overall Study|Disease Progression|1|||
156372467|NCT01401530|564460437|FG001|Overall Study|Disease Progression|2|||
156372468|NCT01401530|564460438|FG002|Overall Study|Disease Progression|1|||
156372469|NCT01401530|564460436|FG000|Overall Study|Adverse Event|1|||
156372470|NCT01401530|564460437|FG001|Overall Study|Adverse Event|1|||
156372471|NCT01401530|564460438|FG002|Overall Study|Adverse Event|1|||
156372472|NCT01401530|564460436|FG000|Overall Study|Participant Choice|1|||
156372473|NCT01401530|564460437|FG001|Overall Study|Participant Choice|2|||
156372474|NCT01401530|564460438|FG002|Overall Study|Participant Choice|1|||
156372475|NCT01401530|564460436|FG000|Overall Study|Physician Decision|0|||
156372476|NCT01401530|564460437|FG001|Overall Study|Physician Decision|1|||
156372477|NCT01401530|564460438|FG002|Overall Study|Physician Decision|0|||
156372478|NCT03670810|564460439|FG000|Main Study|Adverse Event|37|||
156546381|NCT02863809|565093340|FG000|Overall Study|Adverse Event|8|||
156546382|NCT02863809|565093341|FG001|Overall Study|Adverse Event|8|||
156372479|NCT03670810|564460440|FG001|Main Study|Adverse Event|38|||
156372480|NCT03670810|564460441|FG002|Main Study|Adverse Event|3|||
156372481|NCT03670810|564460442|FG003|Main Study|Adverse Event|4|||
156372482|NCT03670810|564460443|FG004|Main Study|Adverse Event|4|||
156372483|NCT03670810|564460444|FG005|Main Study|Adverse Event|5|||
156372484|NCT03670810|564460445|FG006|Main Study|Adverse Event|0|||
156372485|NCT03670810|564460446|FG007|Main Study|Adverse Event|0|||
156372486|NCT03670810|564460447|FG008|Main Study|Adverse Event|0|||
156372487|NCT03670810|564460439|FG000|Main Study|Lack of Efficacy|8|||
156372488|NCT03670810|564460440|FG001|Main Study|Lack of Efficacy|9|||
156372489|NCT03670810|564460441|FG002|Main Study|Lack of Efficacy|3|||
156372490|NCT03670810|564460442|FG003|Main Study|Lack of Efficacy|4|||
156372491|NCT03670810|564460443|FG004|Main Study|Lack of Efficacy|0|||
156372492|NCT03670810|564460444|FG005|Main Study|Lack of Efficacy|0|||
156372493|NCT03670810|564460445|FG006|Main Study|Lack of Efficacy|0|||
156372494|NCT03670810|564460446|FG007|Main Study|Lack of Efficacy|0|||
156372495|NCT03670810|564460447|FG008|Main Study|Lack of Efficacy|0|||
156372496|NCT03670810|564460439|FG000|Main Study|Lost to Follow-up|9|||
156372497|NCT03670810|564460440|FG001|Main Study|Lost to Follow-up|7|||
156372498|NCT03670810|564460441|FG002|Main Study|Lost to Follow-up|4|||
156372499|NCT03670810|564460442|FG003|Main Study|Lost to Follow-up|6|||
156372500|NCT03670810|564460443|FG004|Main Study|Lost to Follow-up|1|||
156546383|NCT02863809|565093340|FG000|Overall Study|Withdrawal by Subject|0|||
156372501|NCT03670810|564460444|FG005|Main Study|Lost to Follow-up|0|||
156372502|NCT03670810|564460445|FG006|Main Study|Lost to Follow-up|0|||
156372503|NCT03670810|564460446|FG007|Main Study|Lost to Follow-up|0|||
156372504|NCT03670810|564460447|FG008|Main Study|Lost to Follow-up|0|||
156372505|NCT03670810|564460439|FG000|Main Study|Non-compliance with Study Drug|0|||
156372506|NCT03670810|564460440|FG001|Main Study|Non-compliance with Study Drug|2|||
156372507|NCT03670810|564460441|FG002|Main Study|Non-compliance with Study Drug|3|||
156372508|NCT03670810|564460442|FG003|Main Study|Non-compliance with Study Drug|0|||
156372509|NCT03670810|564460443|FG004|Main Study|Non-compliance with Study Drug|0|||
156372510|NCT03670810|564460444|FG005|Main Study|Non-compliance with Study Drug|0|||
156372511|NCT03670810|564460445|FG006|Main Study|Non-compliance with Study Drug|0|||
156372512|NCT03670810|564460446|FG007|Main Study|Non-compliance with Study Drug|1|||
156372513|NCT03670810|564460447|FG008|Main Study|Non-compliance with Study Drug|0|||
156372514|NCT03670810|564460439|FG000|Main Study|Physician Decision|3|||
156372515|NCT03670810|564460440|FG001|Main Study|Physician Decision|0|||
156372516|NCT03670810|564460441|FG002|Main Study|Physician Decision|1|||
156372517|NCT03670810|564460442|FG003|Main Study|Physician Decision|0|||
156372518|NCT03670810|564460443|FG004|Main Study|Physician Decision|0|||
156372519|NCT03670810|564460444|FG005|Main Study|Physician Decision|0|||
156372520|NCT03670810|564460445|FG006|Main Study|Physician Decision|1|||
156372521|NCT03670810|564460446|FG007|Main Study|Physician Decision|1|||
156372522|NCT03670810|564460447|FG008|Main Study|Physician Decision|0|||
156372523|NCT03670810|564460439|FG000|Main Study|Pregnancy|1|||
156372524|NCT03670810|564460440|FG001|Main Study|Pregnancy|2|||
156372525|NCT03670810|564460441|FG002|Main Study|Pregnancy|0|||
156372526|NCT03670810|564460442|FG003|Main Study|Pregnancy|0|||
156372527|NCT03670810|564460443|FG004|Main Study|Pregnancy|0|||
156372528|NCT03670810|564460444|FG005|Main Study|Pregnancy|0|||
156372529|NCT03670810|564460445|FG006|Main Study|Pregnancy|0|||
156372530|NCT03670810|564460446|FG007|Main Study|Pregnancy|0|||
156372531|NCT03670810|564460447|FG008|Main Study|Pregnancy|0|||
156372532|NCT03670810|564460439|FG000|Main Study|Protocol Deviation|2|||
156372533|NCT03670810|564460440|FG001|Main Study|Protocol Deviation|12|||
156372534|NCT03670810|564460441|FG002|Main Study|Protocol Deviation|8|||
156372535|NCT03670810|564460442|FG003|Main Study|Protocol Deviation|4|||
156372536|NCT03670810|564460443|FG004|Main Study|Protocol Deviation|0|||
156372537|NCT03670810|564460444|FG005|Main Study|Protocol Deviation|0|||
156372538|NCT03670810|564460445|FG006|Main Study|Protocol Deviation|0|||
156372539|NCT03670810|564460446|FG007|Main Study|Protocol Deviation|0|||
156372540|NCT03670810|564460447|FG008|Main Study|Protocol Deviation|0|||
156372541|NCT03670810|564460439|FG000|Main Study|Withdrawal by Subject|21|||
156372542|NCT03670810|564460440|FG001|Main Study|Withdrawal by Subject|21|||
156372543|NCT03670810|564460441|FG002|Main Study|Withdrawal by Subject|8|||
156372544|NCT03670810|564460442|FG003|Main Study|Withdrawal by Subject|9|||
156372545|NCT03670810|564460443|FG004|Main Study|Withdrawal by Subject|5|||
156372546|NCT03670810|564460444|FG005|Main Study|Withdrawal by Subject|2|||
156372547|NCT03670810|564460445|FG006|Main Study|Withdrawal by Subject|1|||
156372548|NCT03670810|564460446|FG007|Main Study|Withdrawal by Subject|1|||
156372549|NCT03670810|564460447|FG008|Main Study|Withdrawal by Subject|0|||
156372550|NCT03670810|564460439|FG000|Main Study|Participant did not want to take the three other treatments|1|||
156372551|NCT03670810|564460440|FG001|Main Study|Participant did not want to take the three other treatments|0|||
156372552|NCT03670810|564460441|FG002|Main Study|Participant did not want to take the three other treatments|0|||
156372553|NCT03670810|564460442|FG003|Main Study|Participant did not want to take the three other treatments|0|||
156372554|NCT03670810|564460443|FG004|Main Study|Participant did not want to take the three other treatments|0|||
156372555|NCT03670810|564460444|FG005|Main Study|Participant did not want to take the three other treatments|0|||
156372556|NCT03670810|564460445|FG006|Main Study|Participant did not want to take the three other treatments|0|||
156372557|NCT03670810|564460446|FG007|Main Study|Participant did not want to take the three other treatments|0|||
156372558|NCT03670810|564460447|FG008|Main Study|Participant did not want to take the three other treatments|0|||
156372559|NCT03670810|564460439|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156372560|NCT03670810|564460440|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
156372561|NCT03670810|564460441|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156372562|NCT03670810|564460442|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156372563|NCT03670810|564460443|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156372564|NCT03670810|564460444|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156372565|NCT03670810|564460445|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156372566|NCT03670810|564460446|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156372567|NCT03670810|564460447|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156372568|NCT03670810|564460439|FG000|Main Study|Travel and Coronavirus issues|0|||
156372569|NCT03670810|564460440|FG001|Main Study|Travel and Coronavirus issues|0|||
156372570|NCT03670810|564460441|FG002|Main Study|Travel and Coronavirus issues|0|||
156372571|NCT03670810|564460442|FG003|Main Study|Travel and Coronavirus issues|1|||
156372572|NCT03670810|564460443|FG004|Main Study|Travel and Coronavirus issues|0|||
156494106|NCT00927901|564904337|FG001|Treatment Period 1|Subject withdrew consent|0|||
156372573|NCT03670810|564460444|FG005|Main Study|Travel and Coronavirus issues|0|||
156372574|NCT03670810|564460445|FG006|Main Study|Travel and Coronavirus issues|0|||
156372575|NCT03670810|564460446|FG007|Main Study|Travel and Coronavirus issues|0|||
156372576|NCT03670810|564460447|FG008|Main Study|Travel and Coronavirus issues|0|||
156372577|NCT03670810|564460439|FG000|Open Label Extension|Protocol Deviation|0|||
156372578|NCT03670810|564460440|FG001|Open Label Extension|Protocol Deviation|0|||
156372579|NCT03670810|564460441|FG002|Open Label Extension|Protocol Deviation|0|||
156372580|NCT03670810|564460442|FG003|Open Label Extension|Protocol Deviation|0|||
156372581|NCT03670810|564460443|FG004|Open Label Extension|Protocol Deviation|0|||
156372582|NCT03670810|564460444|FG005|Open Label Extension|Protocol Deviation|0|||
156372583|NCT03670810|564460445|FG006|Open Label Extension|Protocol Deviation|0|||
156372584|NCT03670810|564460446|FG007|Open Label Extension|Protocol Deviation|0|||
156372585|NCT03670810|564460447|FG008|Open Label Extension|Protocol Deviation|5|||
156372586|NCT03670810|564460439|FG000|Open Label Extension|Death|0|||
156372587|NCT03670810|564460440|FG001|Open Label Extension|Death|0|||
156372588|NCT03670810|564460441|FG002|Open Label Extension|Death|0|||
156372589|NCT03670810|564460442|FG003|Open Label Extension|Death|0|||
156372590|NCT03670810|564460443|FG004|Open Label Extension|Death|0|||
156372591|NCT03670810|564460444|FG005|Open Label Extension|Death|0|||
156372592|NCT03670810|564460445|FG006|Open Label Extension|Death|0|||
156372593|NCT03670810|564460446|FG007|Open Label Extension|Death|0|||
156372594|NCT03670810|564460447|FG008|Open Label Extension|Death|1|||
156372595|NCT03670810|564460439|FG000|Open Label Extension|COVID-19|0|||
156372596|NCT03670810|564460440|FG001|Open Label Extension|COVID-19|0|||
156372597|NCT03670810|564460441|FG002|Open Label Extension|COVID-19|0|||
156372598|NCT03670810|564460442|FG003|Open Label Extension|COVID-19|0|||
156372599|NCT03670810|564460443|FG004|Open Label Extension|COVID-19|0|||
156372600|NCT03670810|564460444|FG005|Open Label Extension|COVID-19|0|||
156372601|NCT03670810|564460445|FG006|Open Label Extension|COVID-19|0|||
156372602|NCT03670810|564460446|FG007|Open Label Extension|COVID-19|0|||
156372603|NCT03670810|564460447|FG008|Open Label Extension|COVID-19|1|||
156372604|NCT03670810|564460439|FG000|Open Label Extension|Lack of Efficacy|0|||
156372605|NCT03670810|564460440|FG001|Open Label Extension|Lack of Efficacy|0|||
156372606|NCT03670810|564460441|FG002|Open Label Extension|Lack of Efficacy|0|||
156372607|NCT03670810|564460442|FG003|Open Label Extension|Lack of Efficacy|0|||
156372608|NCT03670810|564460443|FG004|Open Label Extension|Lack of Efficacy|0|||
156372609|NCT03670810|564460444|FG005|Open Label Extension|Lack of Efficacy|0|||
156372610|NCT03670810|564460445|FG006|Open Label Extension|Lack of Efficacy|0|||
156372611|NCT03670810|564460446|FG007|Open Label Extension|Lack of Efficacy|0|||
156372612|NCT03670810|564460447|FG008|Open Label Extension|Lack of Efficacy|39|||
156372613|NCT03670810|564460439|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
156372614|NCT03670810|564460440|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
156372615|NCT03670810|564460441|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
156372616|NCT03670810|564460442|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
156372617|NCT03670810|564460443|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
156372618|NCT03670810|564460444|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
156372619|NCT03670810|564460445|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
156372620|NCT03670810|564460446|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
156372621|NCT03670810|564460447|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
156372622|NCT03670810|564460439|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156372623|NCT03670810|564460440|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156372624|NCT03670810|564460441|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156372625|NCT03670810|564460442|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156372626|NCT03670810|564460443|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156372627|NCT03670810|564460444|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156372628|NCT03670810|564460445|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156372629|NCT03670810|564460446|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156372630|NCT03670810|564460447|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
156372631|NCT03670810|564460439|FG000|Open Label Extension|Withdrawal by Subject|0|||
156372632|NCT03670810|564460440|FG001|Open Label Extension|Withdrawal by Subject|0|||
156372633|NCT03670810|564460441|FG002|Open Label Extension|Withdrawal by Subject|0|||
156372634|NCT03670810|564460442|FG003|Open Label Extension|Withdrawal by Subject|0|||
156372635|NCT03670810|564460443|FG004|Open Label Extension|Withdrawal by Subject|0|||
156546384|NCT02863809|565093341|FG001|Overall Study|Withdrawal by Subject|1|||
156546385|NCT02863809|565093340|FG000|Overall Study|Lost to Follow-up|1|||
156546386|NCT02863809|565093341|FG001|Overall Study|Lost to Follow-up|1|||
156546387|NCT02863809|565093340|FG000|Overall Study|Death|1|||
156372636|NCT03670810|564460444|FG005|Open Label Extension|Withdrawal by Subject|0|||
156372637|NCT03670810|564460445|FG006|Open Label Extension|Withdrawal by Subject|0|||
156372638|NCT03670810|564460446|FG007|Open Label Extension|Withdrawal by Subject|0|||
156546388|NCT02863809|565093341|FG001|Overall Study|Death|0|||
156372639|NCT03670810|564460447|FG008|Open Label Extension|Withdrawal by Subject|46|||
156372640|NCT03670810|564460439|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156372641|NCT03670810|564460440|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156372642|NCT03670810|564460441|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156372643|NCT03670810|564460442|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156372644|NCT03670810|564460443|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156372645|NCT03670810|564460444|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156372646|NCT03670810|564460445|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156372647|NCT03670810|564460446|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156372648|NCT03670810|564460447|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
156372649|NCT03670810|564460439|FG000|Open Label Extension|Physician Decision|0|||
156372650|NCT03670810|564460440|FG001|Open Label Extension|Physician Decision|0|||
156372651|NCT03670810|564460441|FG002|Open Label Extension|Physician Decision|0|||
156372652|NCT03670810|564460442|FG003|Open Label Extension|Physician Decision|0|||
156372653|NCT03670810|564460443|FG004|Open Label Extension|Physician Decision|0|||
156372654|NCT03670810|564460444|FG005|Open Label Extension|Physician Decision|0|||
156372655|NCT03670810|564460445|FG006|Open Label Extension|Physician Decision|0|||
156372656|NCT03670810|564460446|FG007|Open Label Extension|Physician Decision|0|||
156372657|NCT03670810|564460447|FG008|Open Label Extension|Physician Decision|2|||
156372658|NCT03670810|564460439|FG000|Open Label Extension|Non-compliance with study drug|0|||
156372659|NCT03670810|564460440|FG001|Open Label Extension|Non-compliance with study drug|0|||
156372660|NCT03670810|564460441|FG002|Open Label Extension|Non-compliance with study drug|0|||
156372661|NCT03670810|564460442|FG003|Open Label Extension|Non-compliance with study drug|0|||
156372662|NCT03670810|564460443|FG004|Open Label Extension|Non-compliance with study drug|0|||
156372663|NCT03670810|564460444|FG005|Open Label Extension|Non-compliance with study drug|0|||
156372664|NCT03670810|564460445|FG006|Open Label Extension|Non-compliance with study drug|0|||
156372665|NCT03670810|564460446|FG007|Open Label Extension|Non-compliance with study drug|0|||
156372666|NCT03670810|564460447|FG008|Open Label Extension|Non-compliance with study drug|5|||
156372667|NCT03670810|564460439|FG000|Open Label Extension|Pregnancy|0|||
156372668|NCT03670810|564460440|FG001|Open Label Extension|Pregnancy|0|||
156372669|NCT03670810|564460441|FG002|Open Label Extension|Pregnancy|0|||
156372670|NCT03670810|564460442|FG003|Open Label Extension|Pregnancy|0|||
156372671|NCT03670810|564460443|FG004|Open Label Extension|Pregnancy|0|||
156372672|NCT03670810|564460444|FG005|Open Label Extension|Pregnancy|0|||
156372673|NCT03670810|564460445|FG006|Open Label Extension|Pregnancy|0|||
156372674|NCT03670810|564460446|FG007|Open Label Extension|Pregnancy|0|||
156372675|NCT03670810|564460447|FG008|Open Label Extension|Pregnancy|3|||
156372676|NCT03670810|564460439|FG000|Open Label Extension|Adverse Event|0|||
156372677|NCT03670810|564460440|FG001|Open Label Extension|Adverse Event|0|||
156372678|NCT03670810|564460441|FG002|Open Label Extension|Adverse Event|0|||
156546389|NCT02980224|565093345|FG000|Overall Study|Adverse Event|4|||
156372679|NCT03670810|564460442|FG003|Open Label Extension|Adverse Event|0|||
156372680|NCT03670810|564460443|FG004|Open Label Extension|Adverse Event|0|||
156372681|NCT03670810|564460444|FG005|Open Label Extension|Adverse Event|0|||
156372682|NCT03670810|564460445|FG006|Open Label Extension|Adverse Event|0|||
156372683|NCT03670810|564460446|FG007|Open Label Extension|Adverse Event|0|||
156372684|NCT03670810|564460447|FG008|Open Label Extension|Adverse Event|24|||
156372685|NCT03670810|564460439|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
156372686|NCT03670810|564460440|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
156372687|NCT03670810|564460441|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
156372688|NCT03670810|564460442|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
156372689|NCT03670810|564460443|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
156372690|NCT03670810|564460444|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
156372691|NCT03670810|564460445|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
156372692|NCT03670810|564460446|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
156372693|NCT03670810|564460447|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
156372694|NCT03670810|564460439|FG000|Open Label Extension|Lost to Follow-up|0|||
156372695|NCT03670810|564460440|FG001|Open Label Extension|Lost to Follow-up|0|||
156372696|NCT03670810|564460441|FG002|Open Label Extension|Lost to Follow-up|0|||
156372697|NCT03670810|564460442|FG003|Open Label Extension|Lost to Follow-up|0|||
156372698|NCT03670810|564460443|FG004|Open Label Extension|Lost to Follow-up|0|||
156372699|NCT03670810|564460444|FG005|Open Label Extension|Lost to Follow-up|0|||
156372700|NCT03670810|564460445|FG006|Open Label Extension|Lost to Follow-up|0|||
156372701|NCT03670810|564460446|FG007|Open Label Extension|Lost to Follow-up|0|||
156372702|NCT03670810|564460447|FG008|Open Label Extension|Lost to Follow-up|23|||
156372703|NCT00678691|564460448|FG000|Overall Study|Adverse Event|6|||
156372704|NCT00678691|564460449|FG001|Overall Study|Adverse Event|4|||
156372705|NCT02664038|564460462|FG000|13 Week|Lost to Follow-up|7|||
156372706|NCT02664038|564460463|FG001|13 Week|Lost to Follow-up|14|||
156372707|NCT02664038|564460462|FG000|13 Week|Withdrawal by Subject|1|||
156372708|NCT02664038|564460463|FG001|13 Week|Withdrawal by Subject|0|||
156372709|NCT02664038|564460462|FG000|26 Week|Lost to Follow-up|5|||
156372710|NCT02664038|564460463|FG001|26 Week|Lost to Follow-up|4|||
156372711|NCT02606136|564460473|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
156372712|NCT02606136|564460473|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
156372713|NCT02606136|564460473|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
156372714|NCT02606136|564460473|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
156372715|NCT06640829|564460474|FG000|Overall Study|Withdrawal by Subject|1|||
156372716|NCT06640829|564460474|FG000|Overall Study|Lost to Follow-up|1|||
156372717|NCT01252290|564460475|FG000|Overall Study|Withdrawal by Subject|1|||
156372718|NCT02247349|564460476|FG000|Overall Study|Disease Progression|7|||
156494107|NCT00927901|564904338|FG002|Treatment Period 1|Subject withdrew consent|1|||
156372719|NCT02247349|564460477|FG001|Overall Study|Disease Progression|4|||
156372720|NCT02247349|564460478|FG002|Overall Study|Disease Progression|26|||
156372721|NCT02247349|564460479|FG003|Overall Study|Disease Progression|31|||
156372722|NCT02247349|564460480|FG004|Overall Study|Disease Progression|16|||
156372723|NCT02247349|564460481|FG005|Overall Study|Disease Progression|6|||
156372724|NCT02247349|564460476|FG000|Overall Study|Study drug toxicity|0|||
156372725|NCT02247349|564460477|FG001|Overall Study|Study drug toxicity|1|||
156372726|NCT02247349|564460478|FG002|Overall Study|Study drug toxicity|1|||
156372727|NCT02247349|564460479|FG003|Overall Study|Study drug toxicity|1|||
156372728|NCT02247349|564460480|FG004|Overall Study|Study drug toxicity|2|||
156372729|NCT02247349|564460481|FG005|Overall Study|Study drug toxicity|2|||
156372730|NCT02247349|564460476|FG000|Overall Study|Death|0|||
156372731|NCT02247349|564460477|FG001|Overall Study|Death|0|||
156372732|NCT02247349|564460478|FG002|Overall Study|Death|0|||
156372733|NCT02247349|564460479|FG003|Overall Study|Death|1|||
156372734|NCT02247349|564460480|FG004|Overall Study|Death|0|||
156372735|NCT02247349|564460481|FG005|Overall Study|Death|0|||
156372736|NCT02247349|564460476|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
156372737|NCT02247349|564460477|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
156372738|NCT02247349|564460478|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
156372739|NCT02247349|564460479|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
156372740|NCT02247349|564460480|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
156372741|NCT02247349|564460481|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
156372742|NCT02247349|564460476|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156372743|NCT02247349|564460477|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156372744|NCT02247349|564460478|FG002|Overall Study|Participant request to discontinue study treatment|1|||
156372745|NCT02247349|564460479|FG003|Overall Study|Participant request to discontinue study treatment|2|||
156372746|NCT02247349|564460480|FG004|Overall Study|Participant request to discontinue study treatment|1|||
156372747|NCT02247349|564460481|FG005|Overall Study|Participant request to discontinue study treatment|0|||
156372748|NCT02247349|564460476|FG000|Overall Study|Withdrawal by Subject|0|||
156372749|NCT02247349|564460477|FG001|Overall Study|Withdrawal by Subject|1|||
156372750|NCT02247349|564460478|FG002|Overall Study|Withdrawal by Subject|0|||
156372751|NCT02247349|564460479|FG003|Overall Study|Withdrawal by Subject|0|||
156372752|NCT02247349|564460480|FG004|Overall Study|Withdrawal by Subject|0|||
156372753|NCT02247349|564460481|FG005|Overall Study|Withdrawal by Subject|0|||
156372754|NCT02247349|564460476|FG000|Overall Study|Administrative reason by sponsor|0|||
156372755|NCT02247349|564460477|FG001|Overall Study|Administrative reason by sponsor|0|||
156372756|NCT02247349|564460478|FG002|Overall Study|Administrative reason by sponsor|0|||
156372757|NCT02247349|564460479|FG003|Overall Study|Administrative reason by sponsor|0|||
156372758|NCT02247349|564460480|FG004|Overall Study|Administrative reason by sponsor|1|||
156372759|NCT02247349|564460481|FG005|Overall Study|Administrative reason by sponsor|0|||
156372760|NCT02247349|564460476|FG000|Overall Study|Other reasons|0|||
156372761|NCT02247349|564460477|FG001|Overall Study|Other reasons|0|||
156372762|NCT02247349|564460478|FG002|Overall Study|Other reasons|1|||
156372763|NCT02247349|564460479|FG003|Overall Study|Other reasons|0|||
156372764|NCT02247349|564460480|FG004|Overall Study|Other reasons|0|||
156372765|NCT02247349|564460481|FG005|Overall Study|Other reasons|0|||
156494108|NCT00927901|564904339|FG003|Treatment Period 1|Subject withdrew consent|0|||
156494109|NCT00927901|564904336|FG000|Treatment Period 4|Adverse Event|0|||
156494110|NCT00927901|564904337|FG001|Treatment Period 4|Adverse Event|0|||
156494111|NCT00927901|564904338|FG002|Treatment Period 4|Adverse Event|0|||
156494112|NCT00927901|564904339|FG003|Treatment Period 4|Adverse Event|1|||
156494113|NCT00927901|564904336|FG000|Treatment Period 4|Subject withdrew consent|0|||
156494114|NCT00927901|564904337|FG001|Treatment Period 4|Subject withdrew consent|0|||
156494115|NCT00927901|564904338|FG002|Treatment Period 4|Subject withdrew consent|1|||
156494116|NCT00927901|564904339|FG003|Treatment Period 4|Subject withdrew consent|0|||
156494117|NCT03605368|564904340|FG000|Overall Study|Lost to Follow-up|2|||
156494118|NCT03605368|564904341|FG001|Overall Study|Lost to Follow-up|1|||
156494119|NCT03605368|564904342|FG002|Overall Study|Lost to Follow-up|3|||
156494120|NCT03605368|564904343|FG003|Overall Study|Lost to Follow-up|2|||
156494121|NCT03605368|564904340|FG000|Overall Study|Withdrawal by Subject|0|||
156494122|NCT03605368|564904341|FG001|Overall Study|Withdrawal by Subject|0|||
156494123|NCT03605368|564904342|FG002|Overall Study|Withdrawal by Subject|4|||
156494124|NCT03605368|564904343|FG003|Overall Study|Withdrawal by Subject|3|||
156494125|NCT02484547|564904348|FG000|Placebo-Controlled Period|Adverse Event|10|||
156494126|NCT02484547|564904349|FG001|Placebo-Controlled Period|Adverse Event|13|||
156494127|NCT02484547|564904350|FG002|Placebo-Controlled Period|Adverse Event|20|||
156494128|NCT02484547|564904351|FG003|Placebo-Controlled Period|Adverse Event|0|||
156494129|NCT02484547|564904352|FG004|Placebo-Controlled Period|Adverse Event|0|||
156372766|NCT01552226|564460482|FG000|Overall Study|Withdrawal by Subject|4|||
156494130|NCT02484547|564904353|FG005|Placebo-Controlled Period|Adverse Event|0|||
156372767|NCT01552226|564460483|FG001|Overall Study|Withdrawal by Subject|4|||
156372768|NCT03511560|564460484|FG000|Overall Study|Death|0|||
156372769|NCT03511560|564460485|FG001|Overall Study|Death|1|||
156372770|NCT03511560|564460484|FG000|Overall Study|Adverse Event|0|||
156372771|NCT03511560|564460485|FG001|Overall Study|Adverse Event|2|||
156372772|NCT03511560|564460484|FG000|Overall Study|Transplant cancelled|0|||
156372773|NCT03511560|564460485|FG001|Overall Study|Transplant cancelled|1|||
156372774|NCT03511560|564460484|FG000|Overall Study|Patient switched to another drug|1|||
156372775|NCT03511560|564460485|FG001|Overall Study|Patient switched to another drug|0|||
156372776|NCT00578565|564460491|FG000|Overall Study|Adverse Event|3|||
156372777|NCT03025828|564460492|FG000|Overall Study|Lost to Follow-up|1|||
156372778|NCT02143843|564460493|FG000|Overall Study|Adverse Event|8|||
156372779|NCT02143843|564460493|FG000|Overall Study|Lack of Efficacy|2|||
156372780|NCT02143843|564460493|FG000|Overall Study|Withdrawal by Subject|2|||
156372781|NCT00480779|564460494|FG000|Overall Study|Other|2|||
156372782|NCT00480779|564460495|FG001|Overall Study|Other|0|||
156372783|NCT00480779|564460494|FG000|Overall Study|Job and Health-related|0|||
156372784|NCT00480779|564460495|FG001|Overall Study|Job and Health-related|3|||
156372785|NCT01339390|564460498|FG000|Overall Study|Death|32|||
156372786|NCT01339390|564460499|FG001|Overall Study|Death|29|||
156372787|NCT01339390|564460498|FG000|Overall Study|Lost to Follow-up|125|||
156372788|NCT01339390|564460499|FG001|Overall Study|Lost to Follow-up|127|||
156372789|NCT00378703|564460502|FG000|Overall Study|Disease progression|59|||
156372790|NCT00378703|564460503|FG001|Overall Study|Disease progression|43|||
156372791|NCT00378703|564460504|FG002|Overall Study|Disease progression|48|||
156372792|NCT00378703|564460505|FG003|Overall Study|Disease progression|49|||
156372793|NCT00378703|564460502|FG000|Overall Study|Adverse Event|11|||
156372794|NCT00378703|564460503|FG001|Overall Study|Adverse Event|17|||
156372795|NCT00378703|564460504|FG002|Overall Study|Adverse Event|20|||
156372796|NCT00378703|564460505|FG003|Overall Study|Adverse Event|18|||
156372797|NCT00378703|564460502|FG000|Overall Study|Death|2|||
156372798|NCT00378703|564460503|FG001|Overall Study|Death|2|||
156372799|NCT00378703|564460504|FG002|Overall Study|Death|4|||
156372800|NCT00378703|564460505|FG003|Overall Study|Death|3|||
156372801|NCT00378703|564460502|FG000|Overall Study|Withdrawal by Subject|4|||
156372802|NCT00378703|564460503|FG001|Overall Study|Withdrawal by Subject|8|||
156372803|NCT00378703|564460504|FG002|Overall Study|Withdrawal by Subject|5|||
156372804|NCT00378703|564460505|FG003|Overall Study|Withdrawal by Subject|7|||
156372805|NCT00378703|564460502|FG000|Overall Study|Physician Decision|1|||
156372806|NCT00378703|564460503|FG001|Overall Study|Physician Decision|4|||
156372807|NCT00378703|564460504|FG002|Overall Study|Physician Decision|1|||
156372808|NCT00378703|564460505|FG003|Overall Study|Physician Decision|0|||
156372809|NCT00378703|564460502|FG000|Overall Study|Alternative therapy|4|||
156372810|NCT00378703|564460503|FG001|Overall Study|Alternative therapy|2|||
156372811|NCT00378703|564460504|FG002|Overall Study|Alternative therapy|0|||
156372812|NCT00378703|564460505|FG003|Overall Study|Alternative therapy|0|||
156372813|NCT00378703|564460502|FG000|Overall Study|Other complicated disease|0|||
156372814|NCT00378703|564460503|FG001|Overall Study|Other complicated disease|2|||
156372815|NCT00378703|564460504|FG002|Overall Study|Other complicated disease|2|||
156372816|NCT00378703|564460505|FG003|Overall Study|Other complicated disease|0|||
156372817|NCT00378703|564460502|FG000|Overall Study|Symptomatic deterioration|0|||
156372818|NCT00378703|564460503|FG001|Overall Study|Symptomatic deterioration|1|||
156372819|NCT00378703|564460504|FG002|Overall Study|Symptomatic deterioration|0|||
156372820|NCT00378703|564460505|FG003|Overall Study|Symptomatic deterioration|2|||
156372821|NCT00378703|564460502|FG000|Overall Study|Surgery|1|||
156372822|NCT00378703|564460503|FG001|Overall Study|Surgery|0|||
156372823|NCT00378703|564460504|FG002|Overall Study|Surgery|0|||
156372824|NCT00378703|564460505|FG003|Overall Study|Surgery|1|||
156372825|NCT00378703|564460502|FG000|Overall Study|Joint decision of physician and patient|1|||
156372826|NCT00378703|564460503|FG001|Overall Study|Joint decision of physician and patient|0|||
156372827|NCT00378703|564460504|FG002|Overall Study|Joint decision of physician and patient|0|||
156372828|NCT00378703|564460505|FG003|Overall Study|Joint decision of physician and patient|0|||
156372829|NCT00378703|564460502|FG000|Overall Study|Adverse events and progressive disease|0|||
156372830|NCT00378703|564460503|FG001|Overall Study|Adverse events and progressive disease|0|||
156372831|NCT00378703|564460504|FG002|Overall Study|Adverse events and progressive disease|0|||
156372832|NCT00378703|564460505|FG003|Overall Study|Adverse events and progressive disease|1|||
156372833|NCT00378703|564460502|FG000|Overall Study|Relocation|0|||
156372834|NCT00378703|564460503|FG001|Overall Study|Relocation|0|||
156494131|NCT02484547|564904354|FG006|Placebo-Controlled Period|Adverse Event|0|||
156494132|NCT02484547|564904348|FG000|Placebo-Controlled Period|Change of Treatment|0|||
156372835|NCT00378703|564460504|FG002|Overall Study|Relocation|1|||
156372836|NCT00378703|564460505|FG003|Overall Study|Relocation|0|||
156372837|NCT00378703|564460502|FG000|Overall Study|Ineligible|4|||
156372838|NCT00378703|564460503|FG001|Overall Study|Ineligible|7|||
156372839|NCT00378703|564460504|FG002|Overall Study|Ineligible|7|||
156372840|NCT00378703|564460505|FG003|Overall Study|Ineligible|7|||
156372841|NCT00378703|564460502|FG000|Overall Study|Never started treatment|1|||
156372842|NCT00378703|564460503|FG001|Overall Study|Never started treatment|4|||
156372843|NCT00378703|564460504|FG002|Overall Study|Never started treatment|0|||
156372844|NCT00378703|564460505|FG003|Overall Study|Never started treatment|0|||
156372845|NCT00378703|564460502|FG000|Overall Study|Other|1|||
156372846|NCT00378703|564460503|FG001|Overall Study|Other|1|||
156372847|NCT00378703|564460504|FG002|Overall Study|Other|2|||
156372848|NCT00378703|564460505|FG003|Overall Study|Other|3|||
156372849|NCT03385239|564460518|FG000|Overall Study|Voluntary Withdrawal|2|||
156372850|NCT03385239|564460519|FG001|Overall Study|Voluntary Withdrawal|3|||
156372851|NCT03385239|564460520|FG002|Overall Study|Voluntary Withdrawal|2|||
156372852|NCT03385239|564460521|FG003|Overall Study|Voluntary Withdrawal|3|||
156372853|NCT03385239|564460522|FG004|Overall Study|Voluntary Withdrawal|0|||
156372854|NCT03385239|564460518|FG000|Overall Study|Adverse Event|0|||
156372855|NCT03385239|564460519|FG001|Overall Study|Adverse Event|0|||
156372856|NCT03385239|564460520|FG002|Overall Study|Adverse Event|1|||
156372857|NCT03385239|564460521|FG003|Overall Study|Adverse Event|0|||
156372858|NCT03385239|564460522|FG004|Overall Study|Adverse Event|0|||
156372859|NCT03385239|564460518|FG000|Overall Study|Other|0|||
156372860|NCT03385239|564460519|FG001|Overall Study|Other|0|||
156372861|NCT03385239|564460520|FG002|Overall Study|Other|0|||
156372862|NCT03385239|564460521|FG003|Overall Study|Other|1|||
156372863|NCT03385239|564460522|FG004|Overall Study|Other|0|||
156372864|NCT02167256|564460523|FG000|Overall Study|Adverse Event|13|||
156372865|NCT02167256|564460524|FG001|Overall Study|Adverse Event|6|||
156372866|NCT02167256|564460523|FG000|Overall Study|Withdrawal by Subject|4|||
156372867|NCT02167256|564460524|FG001|Overall Study|Withdrawal by Subject|4|||
156372868|NCT02167256|564460523|FG000|Overall Study|non-compliance|3|||
156372869|NCT02167256|564460524|FG001|Overall Study|non-compliance|0|||
156372870|NCT02167256|564460523|FG000|Overall Study|Study partner unable to participate|1|||
156372871|NCT02167256|564460524|FG001|Overall Study|Study partner unable to participate|0|||
156372872|NCT03139916|564460525|FG000|Overall Study|Withdrawal by Subject|2|||
156372873|NCT03139916|564460525|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
156372874|NCT01957475|564460526|FG000|Test Period 1|Withdrawal by Subject|1|||
156372875|NCT01957475|564460527|FG001|Test Period 1|Withdrawal by Subject|0|||
156372876|NCT01957475|564460526|FG000|Test Period 1|Other|1|||
156372877|NCT01957475|564460527|FG001|Test Period 1|Other|0|||
156372878|NCT01957475|564460526|FG000|Test Period 1|Lack of Efficacy|0|||
156372879|NCT01957475|564460527|FG001|Test Period 1|Lack of Efficacy|1|||
156372880|NCT01957475|564460526|FG000|Test Period 2|Adverse Event|1|||
156372881|NCT01957475|564460527|FG001|Test Period 2|Adverse Event|0|||
156372882|NCT00813358|564460530|FG000|Overall Study|Death|32|||
156372883|NCT00813358|564460530|FG000|Overall Study|Lost to Follow-up|12|||
156372884|NCT00813358|564460530|FG000|Overall Study|other endpoints|5|||
156372885|NCT00813358|564460530|FG000|Overall Study|Withdrawal by Subject|20|||
156372886|NCT00700011|564460531|FG000|Overall Study|Death|0|||
156372887|NCT00700011|564460532|FG001|Overall Study|Death|1|||
156372888|NCT03890367|564460538|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156372889|NCT03890367|564460539|FG001|Overall Study|Withdrawal by parent/guardian|3|||
156372890|NCT03890367|564460540|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156372891|NCT03890367|564460538|FG000|Overall Study|Protocol deviation|2|||
156372892|NCT03890367|564460539|FG001|Overall Study|Protocol deviation|2|||
156372893|NCT03890367|564460540|FG002|Overall Study|Protocol deviation|1|||
156372894|NCT03890367|564460538|FG000|Overall Study|Lost to Follow-up|1|||
156372895|NCT03890367|564460539|FG001|Overall Study|Lost to Follow-up|1|||
156372896|NCT03890367|564460540|FG002|Overall Study|Lost to Follow-up|0|||
156372897|NCT00991302|564462591|FG000|Overall Study|Death|0|||
156372898|NCT00991302|564462592|FG001|Overall Study|Death|1|||
156372899|NCT00991302|564462591|FG000|Overall Study|Lost to Follow-up|14|||
156372900|NCT00991302|564462592|FG001|Overall Study|Lost to Follow-up|12|||
156372901|NCT03370341|564462593|FG000|Overall Study|Lost to Follow-up|0|||
156372902|NCT03370341|564462594|FG001|Overall Study|Lost to Follow-up|1|||
156372903|NCT02383758|564462595|FG000|Overall Study|Withdrawal by Subject|0|||
156372904|NCT02383758|564462596|FG001|Overall Study|Withdrawal by Subject|2|||
156372905|NCT01607905|564462601|FG000|Overall Study|Withdrawal by participant|7|||
156372906|NCT01607905|564462602|FG001|Overall Study|Withdrawal by participant|2|||
156372907|NCT01607905|564462603|FG002|Overall Study|Withdrawal by participant|4|||
156372908|NCT01607905|564462604|FG003|Overall Study|Withdrawal by participant|6|||
156372909|NCT01607905|564462605|FG004|Overall Study|Withdrawal by participant|0|||
156372910|NCT01607905|564462606|FG005|Overall Study|Withdrawal by participant|4|||
156372911|NCT01607905|564462607|FG006|Overall Study|Withdrawal by participant|12|||
156372912|NCT01607905|564462601|FG000|Overall Study|Incidence or severity of AEs|5|||
156372913|NCT01607905|564462602|FG001|Overall Study|Incidence or severity of AEs|1|||
156372914|NCT01607905|564462603|FG002|Overall Study|Incidence or severity of AEs|1|||
156372915|NCT01607905|564462604|FG003|Overall Study|Incidence or severity of AEs|3|||
156372916|NCT01607905|564462605|FG004|Overall Study|Incidence or severity of AEs|0|||
156372917|NCT01607905|564462606|FG005|Overall Study|Incidence or severity of AEs|2|||
156494133|NCT02484547|564904349|FG001|Placebo-Controlled Period|Change of Treatment|0|||
156372918|NCT01607905|564462607|FG006|Overall Study|Incidence or severity of AEs|8|||
156372919|NCT01607905|564462601|FG000|Overall Study|Disease progression|44|||
156494134|NCT02484547|564904350|FG002|Placebo-Controlled Period|Change of Treatment|1|||
156494135|NCT02484547|564904351|FG003|Placebo-Controlled Period|Change of Treatment|0|||
156372920|NCT01607905|564462602|FG001|Overall Study|Disease progression|16|||
156372921|NCT01607905|564462603|FG002|Overall Study|Disease progression|15|||
156372922|NCT01607905|564462604|FG003|Overall Study|Disease progression|11|||
156372923|NCT01607905|564462605|FG004|Overall Study|Disease progression|6|||
156372924|NCT01607905|564462606|FG005|Overall Study|Disease progression|7|||
156372925|NCT01607905|564462607|FG006|Overall Study|Disease progression|21|||
156372926|NCT01607905|564462601|FG000|Overall Study|Non-compliance with study procedures|0|||
156372927|NCT01607905|564462602|FG001|Overall Study|Non-compliance with study procedures|0|||
156372928|NCT01607905|564462603|FG002|Overall Study|Non-compliance with study procedures|0|||
156372929|NCT01607905|564462604|FG003|Overall Study|Non-compliance with study procedures|0|||
156372930|NCT01607905|564462605|FG004|Overall Study|Non-compliance with study procedures|0|||
156372931|NCT01607905|564462606|FG005|Overall Study|Non-compliance with study procedures|0|||
156372932|NCT01607905|564462607|FG006|Overall Study|Non-compliance with study procedures|1|||
156372933|NCT01607905|564462601|FG000|Overall Study|Death|1|||
156372934|NCT01607905|564462602|FG001|Overall Study|Death|1|||
156372935|NCT01607905|564462603|FG002|Overall Study|Death|1|||
156372936|NCT01607905|564462604|FG003|Overall Study|Death|1|||
156372937|NCT01607905|564462605|FG004|Overall Study|Death|0|||
156372938|NCT01607905|564462606|FG005|Overall Study|Death|0|||
156372939|NCT01607905|564462607|FG006|Overall Study|Death|3|||
156372940|NCT01607905|564462601|FG000|Overall Study|Other treatments become available|1|||
156372941|NCT01607905|564462602|FG001|Overall Study|Other treatments become available|0|||
156372942|NCT01607905|564462603|FG002|Overall Study|Other treatments become available|0|||
156372943|NCT01607905|564462604|FG003|Overall Study|Other treatments become available|0|||
156372944|NCT01607905|564462605|FG004|Overall Study|Other treatments become available|0|||
156372945|NCT01607905|564462606|FG005|Overall Study|Other treatments become available|0|||
156372946|NCT01607905|564462607|FG006|Overall Study|Other treatments become available|1|||
156372947|NCT01607905|564462601|FG000|Overall Study|Investigator discretion|0|||
156372948|NCT01607905|564462602|FG001|Overall Study|Investigator discretion|0|||
156372949|NCT01607905|564462603|FG002|Overall Study|Investigator discretion|0|||
156372950|NCT01607905|564462604|FG003|Overall Study|Investigator discretion|0|||
156372951|NCT01607905|564462605|FG004|Overall Study|Investigator discretion|0|||
156372952|NCT01607905|564462606|FG005|Overall Study|Investigator discretion|1|||
156372953|NCT01607905|564462607|FG006|Overall Study|Investigator discretion|0|||
156372954|NCT01607905|564462601|FG000|Overall Study|Other|1|||
156372955|NCT01607905|564462602|FG001|Overall Study|Other|0|||
156372956|NCT01607905|564462603|FG002|Overall Study|Other|0|||
156372957|NCT01607905|564462604|FG003|Overall Study|Other|0|||
156372958|NCT01607905|564462605|FG004|Overall Study|Other|0|||
156372959|NCT01607905|564462606|FG005|Overall Study|Other|0|||
156372960|NCT01607905|564462607|FG006|Overall Study|Other|1|||
156372961|NCT01607905|564462601|FG000|Overall Study|Randomized but not treated|1|||
156372962|NCT01607905|564462602|FG001|Overall Study|Randomized but not treated|0|||
156372963|NCT01607905|564462603|FG002|Overall Study|Randomized but not treated|0|||
156372964|NCT01607905|564462604|FG003|Overall Study|Randomized but not treated|0|||
156372965|NCT01607905|564462605|FG004|Overall Study|Randomized but not treated|1|||
156372966|NCT01607905|564462606|FG005|Overall Study|Randomized but not treated|1|||
156372967|NCT01607905|564462607|FG006|Overall Study|Randomized but not treated|0|||
156372968|NCT01519518|564462608|FG000|Overall Study|Consent not available|7|||
156372969|NCT01519518|564462609|FG001|Overall Study|Consent not available|10|||
156372970|NCT00298896|564462611|FG000|Overall Study|Death|3|||
156372971|NCT00298896|564462611|FG000|Overall Study|Physician Decision|2|||
156372972|NCT00298896|564462611|FG000|Overall Study|Intercurrent Illness|1|||
156372973|NCT00298896|564462611|FG000|Overall Study|Disease Progression|41|||
156372974|NCT00298896|564462611|FG000|Overall Study|Withdrawal by Subject|2|||
156372975|NCT00298896|564462611|FG000|Overall Study|Assigned to treatment in error|1|||
156372976|NCT02880371|564462612|FG000|Phase 1b|Lost to Follow-up|1|||
156372977|NCT02880371|564462613|FG001|Phase 1b|Lost to Follow-up|0|||
156372978|NCT02880371|564462614|FG002|Phase 1b|Lost to Follow-up|0|||
156372979|NCT02880371|564462615|FG003|Phase 1b|Lost to Follow-up|0|||
156372980|NCT02880371|564462616|FG004|Phase 1b|Lost to Follow-up|0|||
156372981|NCT02880371|564462617|FG005|Phase 1b|Lost to Follow-up|0|||
156372982|NCT02880371|564462618|FG006|Phase 1b|Lost to Follow-up|0|||
156372983|NCT02880371|564462619|FG007|Phase 1b|Lost to Follow-up|0|||
156372984|NCT02880371|564462612|FG000|Phase 1b|Participants terminated by Sponsor|1|||
156372985|NCT02880371|564462613|FG001|Phase 1b|Participants terminated by Sponsor|0|||
156546390|NCT02980224|565093346|FG001|Overall Study|Adverse Event|1|||
156546391|NCT02980224|565093345|FG000|Overall Study|Withdrawal by Subject|0|||
156546392|NCT02980224|565093346|FG001|Overall Study|Withdrawal by Subject|2|||
156546393|NCT00606320|565093347|FG000|Overall Study|Adverse Event|3|||
156546394|NCT00606320|565093347|FG000|Overall Study|Lack of Efficacy|5|||
156372986|NCT02880371|564462614|FG002|Phase 1b|Participants terminated by Sponsor|0|||
156372987|NCT02880371|564462615|FG003|Phase 1b|Participants terminated by Sponsor|0|||
156372988|NCT02880371|564462616|FG004|Phase 1b|Participants terminated by Sponsor|0|||
156372989|NCT02880371|564462617|FG005|Phase 1b|Participants terminated by Sponsor|0|||
156372990|NCT02880371|564462618|FG006|Phase 1b|Participants terminated by Sponsor|0|||
156372991|NCT02880371|564462619|FG007|Phase 1b|Participants terminated by Sponsor|0|||
156372992|NCT02880371|564462612|FG000|Phase 1b|Withdrawal by Subject|0|||
156372993|NCT02880371|564462613|FG001|Phase 1b|Withdrawal by Subject|0|||
156372994|NCT02880371|564462614|FG002|Phase 1b|Withdrawal by Subject|1|||
156372995|NCT02880371|564462615|FG003|Phase 1b|Withdrawal by Subject|0|||
156372996|NCT02880371|564462616|FG004|Phase 1b|Withdrawal by Subject|0|||
156372997|NCT02880371|564462617|FG005|Phase 1b|Withdrawal by Subject|0|||
156546395|NCT00606320|565093347|FG000|Overall Study|Physician Decision|7|||
156372998|NCT02880371|564462618|FG006|Phase 1b|Withdrawal by Subject|0|||
156372999|NCT02880371|564462619|FG007|Phase 1b|Withdrawal by Subject|0|||
156373000|NCT02880371|564462612|FG000|Phase 1b|Death|4|||
156373001|NCT02880371|564462613|FG001|Phase 1b|Death|6|||
156373002|NCT02880371|564462614|FG002|Phase 1b|Death|5|||
156373003|NCT02880371|564462615|FG003|Phase 1b|Death|1|||
156373004|NCT02880371|564462616|FG004|Phase 1b|Death|0|||
156373005|NCT02880371|564462617|FG005|Phase 1b|Death|0|||
156373006|NCT02880371|564462618|FG006|Phase 1b|Death|0|||
156373007|NCT02880371|564462619|FG007|Phase 1b|Death|0|||
156373008|NCT02880371|564462612|FG000|Phase 1b|Enrolled but not Treated|0|||
156373009|NCT02880371|564462613|FG001|Phase 1b|Enrolled but not Treated|1|||
156373010|NCT02880371|564462614|FG002|Phase 1b|Enrolled but not Treated|0|||
156373011|NCT02880371|564462615|FG003|Phase 1b|Enrolled but not Treated|0|||
156373012|NCT02880371|564462616|FG004|Phase 1b|Enrolled but not Treated|0|||
156373013|NCT02880371|564462617|FG005|Phase 1b|Enrolled but not Treated|0|||
156373014|NCT02880371|564462618|FG006|Phase 1b|Enrolled but not Treated|0|||
156373015|NCT02880371|564462619|FG007|Phase 1b|Enrolled but not Treated|0|||
156373016|NCT02880371|564462612|FG000|Phase 2|Enrolled but not Treated|0|||
156373017|NCT02880371|564462613|FG001|Phase 2|Enrolled but not Treated|0|||
156373018|NCT02880371|564462614|FG002|Phase 2|Enrolled but not Treated|0|||
156373019|NCT02880371|564462615|FG003|Phase 2|Enrolled but not Treated|0|||
156373020|NCT02880371|564462616|FG004|Phase 2|Enrolled but not Treated|0|||
156373021|NCT02880371|564462617|FG005|Phase 2|Enrolled but not Treated|1|||
156373022|NCT02880371|564462618|FG006|Phase 2|Enrolled but not Treated|1|||
156373023|NCT02880371|564462619|FG007|Phase 2|Enrolled but not Treated|0|||
156373024|NCT02880371|564462612|FG000|Phase 2|Other|0|||
156373025|NCT02880371|564462613|FG001|Phase 2|Other|0|||
156373026|NCT02880371|564462614|FG002|Phase 2|Other|0|||
156373027|NCT02880371|564462615|FG003|Phase 2|Other|0|||
156373028|NCT02880371|564462616|FG004|Phase 2|Other|0|||
156373029|NCT02880371|564462617|FG005|Phase 2|Other|1|||
156373030|NCT02880371|564462618|FG006|Phase 2|Other|2|||
156373031|NCT02880371|564462619|FG007|Phase 2|Other|1|||
156373032|NCT02880371|564462612|FG000|Phase 2|Participants terminated by Sponsor|0|||
156373033|NCT02880371|564462613|FG001|Phase 2|Participants terminated by Sponsor|0|||
156373034|NCT02880371|564462614|FG002|Phase 2|Participants terminated by Sponsor|0|||
156373035|NCT02880371|564462615|FG003|Phase 2|Participants terminated by Sponsor|0|||
156373036|NCT02880371|564462616|FG004|Phase 2|Participants terminated by Sponsor|1|||
156373037|NCT02880371|564462617|FG005|Phase 2|Participants terminated by Sponsor|6|||
156373038|NCT02880371|564462618|FG006|Phase 2|Participants terminated by Sponsor|1|||
156373039|NCT02880371|564462619|FG007|Phase 2|Participants terminated by Sponsor|5|||
156373040|NCT02880371|564462612|FG000|Phase 2|Death|0|||
156373041|NCT02880371|564462613|FG001|Phase 2|Death|0|||
156373042|NCT02880371|564462614|FG002|Phase 2|Death|0|||
156373043|NCT02880371|564462615|FG003|Phase 2|Death|0|||
156373044|NCT02880371|564462616|FG004|Phase 2|Death|1|||
156373045|NCT02880371|564462617|FG005|Phase 2|Death|10|||
156373046|NCT02880371|564462618|FG006|Phase 2|Death|20|||
156373047|NCT02880371|564462619|FG007|Phase 2|Death|5|||
156373048|NCT02880371|564462612|FG000|Phase 2|Lost to Follow-up|0|||
156373049|NCT02880371|564462613|FG001|Phase 2|Lost to Follow-up|0|||
156373050|NCT02880371|564462614|FG002|Phase 2|Lost to Follow-up|0|||
156373051|NCT02880371|564462615|FG003|Phase 2|Lost to Follow-up|0|||
156373052|NCT02880371|564462616|FG004|Phase 2|Lost to Follow-up|0|||
156373053|NCT02880371|564462617|FG005|Phase 2|Lost to Follow-up|0|||
156373054|NCT02880371|564462618|FG006|Phase 2|Lost to Follow-up|3|||
156373055|NCT02880371|564462619|FG007|Phase 2|Lost to Follow-up|0|||
156373056|NCT02880371|564462612|FG000|Phase 2|Withdrawal by Subject|0|||
156373057|NCT02880371|564462613|FG001|Phase 2|Withdrawal by Subject|0|||
156373058|NCT02880371|564462614|FG002|Phase 2|Withdrawal by Subject|0|||
156373059|NCT02880371|564462615|FG003|Phase 2|Withdrawal by Subject|0|||
156373060|NCT02880371|564462616|FG004|Phase 2|Withdrawal by Subject|0|||
156373061|NCT02880371|564462617|FG005|Phase 2|Withdrawal by Subject|1|||
156373062|NCT02880371|564462618|FG006|Phase 2|Withdrawal by Subject|1|||
156373063|NCT02880371|564462619|FG007|Phase 2|Withdrawal by Subject|0|||
156373064|NCT02880371|564462612|FG000|Phase 2|End of Study page not completed by error|0|||
156373065|NCT02880371|564462613|FG001|Phase 2|End of Study page not completed by error|0|||
156373066|NCT02880371|564462614|FG002|Phase 2|End of Study page not completed by error|0|||
156373067|NCT02880371|564462615|FG003|Phase 2|End of Study page not completed by error|0|||
156373068|NCT02880371|564462616|FG004|Phase 2|End of Study page not completed by error|0|||
156373069|NCT02880371|564462617|FG005|Phase 2|End of Study page not completed by error|1|||
156373070|NCT02880371|564462618|FG006|Phase 2|End of Study page not completed by error|0|||
156373071|NCT02880371|564462619|FG007|Phase 2|End of Study page not completed by error|0|||
156373072|NCT01777997|564462622|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
156373073|NCT01777997|564462622|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
156373074|NCT01777997|564462622|FG000|Weeks 48 to 72/96 on ART|Death|1|||
156373075|NCT01777997|564462622|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
156373076|NCT00451282|564462627|FG000|Overall Study|Lost to Follow-up|6|||
156373077|NCT00451282|564462628|FG001|Overall Study|Lost to Follow-up|5|||
156373078|NCT00098839|564462629|FG000|Overall Study|Adverse Event|5|||
156373079|NCT00098839|564462630|FG001|Overall Study|Adverse Event|2|||
156373080|NCT00098839|564462629|FG000|Overall Study|Death|1|||
156373081|NCT00098839|564462630|FG001|Overall Study|Death|2|||
156373082|NCT00098839|564462629|FG000|Overall Study|Physician Decision|4|||
156373083|NCT00098839|564462630|FG001|Overall Study|Physician Decision|14|||
156373084|NCT00098839|564462629|FG000|Overall Study|Withdrawal by Subject|1|||
156373085|NCT00098839|564462630|FG001|Overall Study|Withdrawal by Subject|0|||
156373086|NCT00098839|564462629|FG000|Overall Study|Refusal of further protocol therapy|3|||
156373087|NCT00098839|564462630|FG001|Overall Study|Refusal of further protocol therapy|1|||
156373088|NCT00098839|564462629|FG000|Overall Study|Relapse|6|||
156373089|NCT00098839|564462630|FG001|Overall Study|Relapse|3|||
156373090|NCT00098839|564462629|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
156373091|NCT00098839|564462630|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
156373092|NCT00098839|564462629|FG000|Overall Study|Ineligible|2|||
156373093|NCT00098839|564462630|FG001|Overall Study|Ineligible|0|||
156373094|NCT00577122|564462631|FG000|Overall Study|Adverse Event|0|||
156373095|NCT00577122|564462632|FG001|Overall Study|Adverse Event|2|||
156373096|NCT00577122|564462631|FG000|Overall Study|Progression, relapse during active trt|6|||
156373097|NCT00577122|564462632|FG001|Overall Study|Progression, relapse during active trt|8|||
156373098|NCT00577122|564462631|FG000|Overall Study|Prog, refract disease during active trt|8|||
156373099|NCT00577122|564462632|FG001|Overall Study|Prog, refract disease during active trt|5|||
156373100|NCT00577122|564462631|FG000|Overall Study|Alternative Therapy|0|||
156373101|NCT00577122|564462632|FG001|Overall Study|Alternative Therapy|1|||
156373102|NCT00844545|564462634|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
156373103|NCT00844545|564462634|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
156373104|NCT00844545|564462634|FG000|Extension Treatment Period|Adverse Event|2|||
156373105|NCT00844545|564462634|FG000|Post Treatment Period|Withdrawal by Subject|1|||
156373106|NCT00403455|564462638|FG000|Overall Study|Withdrawal by Subject|1|||
156373107|NCT01358981|564462639|FG000|Period 1|Withdrawal by Subject|0|||
156373108|NCT01358981|564462640|FG001|Period 1|Withdrawal by Subject|0|||
156373109|NCT01358981|564462641|FG002|Period 1|Withdrawal by Subject|0|||
156373110|NCT01358981|564462642|FG003|Period 1|Withdrawal by Subject|1|||
156373111|NCT01358981|564462643|FG004|Period 1|Withdrawal by Subject|0|||
156373112|NCT01358981|564462644|FG005|Period 1|Withdrawal by Subject|0|||
156373113|NCT01358981|564462645|FG006|Period 1|Withdrawal by Subject|0|||
156373114|NCT02992899|564462646|FG000|Overall Study|Withdrawal by Subject|1|||
156373115|NCT02992899|564462647|FG001|Overall Study|Withdrawal by Subject|0|||
156373116|NCT02992899|564462646|FG000|Overall Study|Lost to Follow-up|1|||
156373117|NCT02992899|564462647|FG001|Overall Study|Lost to Follow-up|3|||
156373118|NCT02738775|564462648|FG000|Overall Study|Withdrawal by Subject|0|||
156373119|NCT02738775|564462649|FG001|Overall Study|Withdrawal by Subject|1|||
156373120|NCT02738775|564462650|FG002|Overall Study|Withdrawal by Subject|0|||
156373121|NCT02738775|564462651|FG003|Overall Study|Withdrawal by Subject|0|||
156373122|NCT02738775|564462652|FG004|Overall Study|Withdrawal by Subject|0|||
156373123|NCT02738775|564462653|FG005|Overall Study|Withdrawal by Subject|0|||
156373124|NCT02738775|564462648|FG000|Overall Study|Adverse Event|0|||
156373125|NCT02738775|564462649|FG001|Overall Study|Adverse Event|0|||
156373126|NCT02738775|564462650|FG002|Overall Study|Adverse Event|0|||
156373127|NCT02738775|564462651|FG003|Overall Study|Adverse Event|1|||
156373128|NCT02738775|564462652|FG004|Overall Study|Adverse Event|0|||
156373129|NCT02738775|564462653|FG005|Overall Study|Adverse Event|0|||
156373130|NCT02738775|564462648|FG000|Overall Study|Pregnancy|0|||
156373131|NCT02738775|564462649|FG001|Overall Study|Pregnancy|1|||
156373132|NCT02738775|564462650|FG002|Overall Study|Pregnancy|0|||
156373133|NCT02738775|564462651|FG003|Overall Study|Pregnancy|0|||
156373134|NCT02738775|564462652|FG004|Overall Study|Pregnancy|0|||
156373135|NCT02738775|564462653|FG005|Overall Study|Pregnancy|0|||
156373136|NCT02738775|564462648|FG000|Overall Study|Missing|0|||
156373137|NCT02738775|564462649|FG001|Overall Study|Missing|0|||
156373138|NCT02738775|564462650|FG002|Overall Study|Missing|0|||
156373139|NCT02738775|564462651|FG003|Overall Study|Missing|0|||
156373140|NCT02738775|564462652|FG004|Overall Study|Missing|0|||
156373141|NCT02738775|564462653|FG005|Overall Study|Missing|1|||
156373142|NCT01060384|564462654|FG000|Overall Study|Withdrawal by Subject|0|||
156373143|NCT01060384|564462655|FG001|Overall Study|Withdrawal by Subject|1|||
156373144|NCT01060384|564462656|FG002|Overall Study|Withdrawal by Subject|0|||
156373145|NCT01060384|564462657|FG003|Overall Study|Withdrawal by Subject|0|||
156373146|NCT01060384|564462658|FG004|Overall Study|Withdrawal by Subject|0|||
156373147|NCT01060384|564462654|FG000|Overall Study|Death|0|||
156373148|NCT01060384|564462655|FG001|Overall Study|Death|0|||
156373149|NCT01060384|564462656|FG002|Overall Study|Death|0|||
156373150|NCT01060384|564462657|FG003|Overall Study|Death|0|||
156373151|NCT01060384|564462658|FG004|Overall Study|Death|1|||
156373152|NCT01060384|564462654|FG000|Overall Study|Intercurrent illness|0|||
156373153|NCT01060384|564462655|FG001|Overall Study|Intercurrent illness|0|||
156373154|NCT01060384|564462656|FG002|Overall Study|Intercurrent illness|0|||
156373155|NCT01060384|564462657|FG003|Overall Study|Intercurrent illness|0|||
156373156|NCT01060384|564462658|FG004|Overall Study|Intercurrent illness|1|||
156373157|NCT01332305|564462661|FG000|Overall Study|Adverse Event|1|||
156373158|NCT01332305|564462662|FG001|Overall Study|Adverse Event|4|||
156373159|NCT01332305|564462663|FG002|Overall Study|Adverse Event|6|||
156373160|NCT01332305|564462664|FG003|Overall Study|Adverse Event|3|||
156373161|NCT01332305|564462665|FG004|Overall Study|Adverse Event|5|||
156373162|NCT01332305|564462661|FG000|Overall Study|Withdrawal by Subject|6|||
156373163|NCT01332305|564462662|FG001|Overall Study|Withdrawal by Subject|5|||
156373164|NCT01332305|564462663|FG002|Overall Study|Withdrawal by Subject|4|||
156373165|NCT01332305|564462664|FG003|Overall Study|Withdrawal by Subject|1|||
156373166|NCT01332305|564462665|FG004|Overall Study|Withdrawal by Subject|0|||
156373167|NCT01332305|564462661|FG000|Overall Study|Lost to Follow-up|0|||
156373168|NCT01332305|564462662|FG001|Overall Study|Lost to Follow-up|2|||
156373169|NCT01332305|564462663|FG002|Overall Study|Lost to Follow-up|3|||
156373170|NCT01332305|564462664|FG003|Overall Study|Lost to Follow-up|2|||
156373171|NCT01332305|564462665|FG004|Overall Study|Lost to Follow-up|3|||
156373172|NCT01332305|564462661|FG000|Overall Study|Protocol Violation|1|||
156373173|NCT01332305|564462662|FG001|Overall Study|Protocol Violation|2|||
156373174|NCT01332305|564462663|FG002|Overall Study|Protocol Violation|1|||
156373175|NCT01332305|564462664|FG003|Overall Study|Protocol Violation|0|||
156373176|NCT01332305|564462665|FG004|Overall Study|Protocol Violation|3|||
156373177|NCT01332305|564462661|FG000|Overall Study|Withdrawal by Sponsor|1|||
156373178|NCT01332305|564462662|FG001|Overall Study|Withdrawal by Sponsor|0|||
156373179|NCT01332305|564462663|FG002|Overall Study|Withdrawal by Sponsor|0|||
156373180|NCT01332305|564462664|FG003|Overall Study|Withdrawal by Sponsor|1|||
156373181|NCT01332305|564462665|FG004|Overall Study|Withdrawal by Sponsor|1|||
156373182|NCT01332305|564462661|FG000|Overall Study|Treatment Failure|1|||
156373183|NCT01332305|564462662|FG001|Overall Study|Treatment Failure|1|||
156373184|NCT01332305|564462663|FG002|Overall Study|Treatment Failure|0|||
156373185|NCT01332305|564462664|FG003|Overall Study|Treatment Failure|0|||
156373186|NCT01332305|564462665|FG004|Overall Study|Treatment Failure|0|||
156373187|NCT01332305|564462661|FG000|Overall Study|Physician Decision|0|||
156373188|NCT01332305|564462662|FG001|Overall Study|Physician Decision|0|||
156373189|NCT01332305|564462663|FG002|Overall Study|Physician Decision|0|||
156373190|NCT01332305|564462664|FG003|Overall Study|Physician Decision|1|||
156373191|NCT01332305|564462665|FG004|Overall Study|Physician Decision|0|||
156373192|NCT03217136|564462673|FG000|Overall Study|Lost to Follow-up|2|||
156373193|NCT03217136|564462674|FG001|Overall Study|Lost to Follow-up|1|||
156373194|NCT03217136|564462673|FG000|Overall Study|Site Randomized Participant in Error|0|||
156373195|NCT03217136|564462674|FG001|Overall Study|Site Randomized Participant in Error|1|||
156373196|NCT03217136|564462673|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
156373197|NCT03217136|564462674|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
156373198|NCT03217136|564462673|FG000|Overall Study|Dispensing Error|1|||
156373199|NCT03217136|564462674|FG001|Overall Study|Dispensing Error|0|||
156373200|NCT03217136|564462673|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156373201|NCT03217136|564462674|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156373202|NCT01350128|564462675|FG000|Overall Study|Withdrawal by Subject|3|||
156373203|NCT01350128|564462675|FG000|Overall Study|Protocol discontinuation criteria|8|||
156373204|NCT01350128|564462675|FG000|Overall Study|Physician Decision|1|||
156373205|NCT01350128|564462675|FG000|Overall Study|Lost to Follow-up|2|||
156373206|NCT03969212|564462679|FG000|Overall Study|Adverse Event|1|||
156373207|NCT03969212|564462680|FG001|Overall Study|Adverse Event|0|||
156373208|NCT03969212|564462681|FG002|Overall Study|Adverse Event|0|||
156373209|NCT03969212|564462682|FG003|Overall Study|Adverse Event|0|||
156373210|NCT03969212|564462679|FG000|Overall Study|Lost to Follow-up|2|||
156373211|NCT03969212|564462680|FG001|Overall Study|Lost to Follow-up|2|||
156373212|NCT03969212|564462681|FG002|Overall Study|Lost to Follow-up|2|||
156373213|NCT03969212|564462682|FG003|Overall Study|Lost to Follow-up|2|||
156373214|NCT03969212|564462679|FG000|Overall Study|Protocol Violation|0|||
156373215|NCT03969212|564462680|FG001|Overall Study|Protocol Violation|0|||
156373216|NCT03969212|564462681|FG002|Overall Study|Protocol Violation|0|||
156373217|NCT03969212|564462682|FG003|Overall Study|Protocol Violation|1|||
156373218|NCT03969212|564462679|FG000|Overall Study|Withdrawal by Subject|7|||
156373219|NCT03969212|564462680|FG001|Overall Study|Withdrawal by Subject|13|||
156494136|NCT02484547|564904352|FG004|Placebo-Controlled Period|Change of Treatment|0|||
156373220|NCT03969212|564462681|FG002|Overall Study|Withdrawal by Subject|5|||
156373221|NCT03969212|564462682|FG003|Overall Study|Withdrawal by Subject|11|||
156373222|NCT03969212|564462679|FG000|Overall Study|Physician Decision|0|||
156373223|NCT03969212|564462680|FG001|Overall Study|Physician Decision|0|||
156373224|NCT03969212|564462681|FG002|Overall Study|Physician Decision|1|||
156373225|NCT03969212|564462682|FG003|Overall Study|Physician Decision|0|||
156373226|NCT03969212|564462679|FG000|Overall Study|Reason not Specified|22|||
156373227|NCT03969212|564462680|FG001|Overall Study|Reason not Specified|23|||
156373228|NCT03969212|564462681|FG002|Overall Study|Reason not Specified|28|||
156373229|NCT03969212|564462682|FG003|Overall Study|Reason not Specified|26|||
156373230|NCT03773757|564462683|FG000|Overall Study|Withdrawal by Subject|2|||
156373231|NCT03773757|564462684|FG001|Overall Study|Withdrawal by Subject|4|||
156373232|NCT01469065|564462688|FG000|Overall Study|Lack of Efficacy|0|||
156373233|NCT01469065|564462689|FG001|Overall Study|Lack of Efficacy|0|||
156373234|NCT01469065|564462690|FG002|Overall Study|Lack of Efficacy|0|||
156373235|NCT01469065|564462691|FG003|Overall Study|Lack of Efficacy|0|||
156546396|NCT00606320|565093347|FG000|Overall Study|Protocol Violation|8|||
156546397|NCT00606320|565093347|FG000|Overall Study|Withdrawal by Subject|10|||
156373236|NCT01469065|564462692|FG004|Overall Study|Lack of Efficacy|1|||
156373237|NCT01469065|564462688|FG000|Overall Study|Other|0|||
156373238|NCT01469065|564462689|FG001|Overall Study|Other|1|||
156373239|NCT01469065|564462690|FG002|Overall Study|Other|0|||
156373240|NCT01469065|564462691|FG003|Overall Study|Other|0|||
156373241|NCT01469065|564462692|FG004|Overall Study|Other|0|||
156373242|NCT04542070|564462693|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
156373243|NCT04542070|564462694|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
156373244|NCT04542070|564462695|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
156373245|NCT04542070|564462696|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
156373246|NCT04542070|564462693|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
156373247|NCT04542070|564462694|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
156373248|NCT04542070|564462695|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
156373249|NCT04542070|564462696|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
156373250|NCT04542070|564462693|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
156373251|NCT04542070|564462694|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
156373252|NCT04542070|564462695|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
156373253|NCT04542070|564462696|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
156373254|NCT04542070|564462693|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
156373255|NCT04542070|564462694|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
156373256|NCT04542070|564462695|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
156373257|NCT04542070|564462696|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
156373258|NCT04542070|564462693|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
156373259|NCT04542070|564462694|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
156373260|NCT04542070|564462695|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
156373261|NCT04542070|564462696|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
156373262|NCT04542070|564462693|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
156373263|NCT04542070|564462694|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
156373264|NCT04542070|564462695|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
156373265|NCT04542070|564462696|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
156373266|NCT04542070|564462693|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
156373267|NCT04542070|564462694|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
156373268|NCT04542070|564462695|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
156373269|NCT04542070|564462696|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
156373270|NCT04542070|564462693|FG000|Maintenance + Extension Period|Adverse Event|10|||
156373271|NCT04542070|564462694|FG001|Maintenance + Extension Period|Adverse Event|2|||
156373272|NCT04542070|564462695|FG002|Maintenance + Extension Period|Adverse Event|0|||
156373273|NCT04542070|564462696|FG003|Maintenance + Extension Period|Adverse Event|0|||
156373274|NCT04542070|564462693|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
156373275|NCT04542070|564462694|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
156373276|NCT04542070|564462695|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
156373277|NCT04542070|564462696|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
156373278|NCT04542070|564462693|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
156373279|NCT04542070|564462694|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
156373280|NCT04542070|564462695|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
156373281|NCT04542070|564462696|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
156373282|NCT04542070|564462693|FG000|Maintenance + Extension Period|Physician Decision|1|||
156373283|NCT04542070|564462694|FG001|Maintenance + Extension Period|Physician Decision|1|||
156373284|NCT04542070|564462695|FG002|Maintenance + Extension Period|Physician Decision|0|||
156373285|NCT04542070|564462696|FG003|Maintenance + Extension Period|Physician Decision|0|||
156373286|NCT04542070|564462693|FG000|Maintenance + Extension Period|Protocol Violation|2|||
156373287|NCT04542070|564462694|FG001|Maintenance + Extension Period|Protocol Violation|5|||
156373288|NCT04542070|564462695|FG002|Maintenance + Extension Period|Protocol Violation|0|||
156373289|NCT04542070|564462696|FG003|Maintenance + Extension Period|Protocol Violation|0|||
156373290|NCT04542070|564462693|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
156373291|NCT04542070|564462694|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
156373292|NCT04542070|564462695|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
156373293|NCT04542070|564462696|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
156373294|NCT04542070|564462693|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
156373295|NCT04542070|564462694|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
156373296|NCT04542070|564462695|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
156373297|NCT04542070|564462696|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
156373298|NCT04542070|564462693|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
156494137|NCT02484547|564904353|FG005|Placebo-Controlled Period|Change of Treatment|0|||
156494138|NCT02484547|564904354|FG006|Placebo-Controlled Period|Change of Treatment|0|||
156494139|NCT02484547|564904348|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
156494140|NCT02484547|564904349|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
156494141|NCT02484547|564904350|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
156373299|NCT04542070|564462694|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
156373300|NCT04542070|564462695|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
156494142|NCT02484547|564904351|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
156373301|NCT04542070|564462696|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
156373302|NCT04542070|564462693|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
156373303|NCT04542070|564462694|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
156373304|NCT04542070|564462695|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
156373305|NCT04542070|564462696|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
156373306|NCT04542070|564462693|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
156373307|NCT04542070|564462694|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
156373308|NCT04542070|564462695|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
156373309|NCT04542070|564462696|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
156373310|NCT04542070|564462693|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
156373311|NCT04542070|564462694|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
156373312|NCT04542070|564462695|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
156373313|NCT04542070|564462696|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
156373314|NCT04542070|564462693|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
156373315|NCT04542070|564462694|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
156373316|NCT04542070|564462695|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
156373317|NCT04542070|564462696|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
156373318|NCT02985736|564462697|FG000|Overall Study|Lost to Follow-up|3|||
156373319|NCT00382733|564462698|FG000|Overall Study|Withdrawal by Subject|0|||
156373320|NCT00382733|564462699|FG001|Overall Study|Withdrawal by Subject|1|||
156373321|NCT00382733|564462700|FG002|Overall Study|Withdrawal by Subject|0|||
156373322|NCT00382733|564462701|FG003|Overall Study|Withdrawal by Subject|0|||
156373323|NCT00382733|564462702|FG004|Overall Study|Withdrawal by Subject|0|||
156373324|NCT03049813|564462703|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
156373325|NCT03049813|564462704|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
156373326|NCT03049813|564462705|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
156373327|NCT03049813|564462706|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
156373328|NCT03049813|564462703|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
156373329|NCT03049813|564462704|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
156373330|NCT03049813|564462705|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
156373331|NCT03049813|564462706|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
156373332|NCT03049813|564462703|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
156373333|NCT03049813|564462704|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
156373334|NCT03049813|564462705|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
156373335|NCT03049813|564462706|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
156373336|NCT03049813|564462703|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
156373337|NCT03049813|564462704|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
156373338|NCT03049813|564462705|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
156373339|NCT03049813|564462706|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
156373340|NCT00179413|564462707|FG000|Overall Study|Adverse Event|38|||
156546398|NCT00606320|565093347|FG000|Overall Study|Progression to depressive phase|4|||
156546399|NCT00879645|565093348|FG000|Overall Study|Adverse Event|1|||
156546400|NCT00879645|565093349|FG001|Overall Study|Adverse Event|0|||
156546401|NCT00879645|565093350|FG002|Overall Study|Adverse Event|0|||
156373341|NCT00179413|564462708|FG001|Overall Study|Adverse Event|20|||
156373342|NCT00179413|564462707|FG000|Overall Study|Withdrawal by Subject|87|||
156373343|NCT00179413|564462708|FG001|Overall Study|Withdrawal by Subject|95|||
156373344|NCT00550836|564462709|FG000|Overall Study|Withdrawal by Subject|3|||
156546402|NCT00879645|565093351|FG003|Overall Study|Adverse Event|0|||
156373345|NCT00550836|564462710|FG001|Overall Study|Withdrawal by Subject|9|||
156373346|NCT03075644|564462713|FG000|Overall Study|Withdrawal by Subject|1|||
156373347|NCT03075644|564462714|FG001|Overall Study|Withdrawal by Subject|1|||
156373348|NCT00439140|564462717|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
156373349|NCT00439140|564462718|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
156373350|NCT00439140|564462719|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
156373351|NCT00439140|564462717|FG000|Treatment Cycle 1|Personal reasons|0|||
156373352|NCT00439140|564462718|FG001|Treatment Cycle 1|Personal reasons|2|||
156373353|NCT00439140|564462719|FG002|Treatment Cycle 1|Personal reasons|0|||
156373354|NCT00439140|564462717|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
156373355|NCT00439140|564462718|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
156373356|NCT00439140|564462719|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
156373357|NCT00439140|564462717|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
156373358|NCT00439140|564462718|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
156373359|NCT00439140|564462719|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
156373360|NCT00439140|564462717|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
156373361|NCT00439140|564462718|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
156373362|NCT00439140|564462719|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
156373363|NCT01458171|564462723|FG000|Overall Study|Adverse Event|1|||
156373364|NCT01192152|564462727|FG000|Period 1|left prematurely (while on treatment B)|0|||
156373365|NCT01192152|564462728|FG001|Period 1|left prematurely (while on treatment B)|1|||
156373366|NCT01192152|564462727|FG000|Period 3|family emergency|1|||
156373367|NCT01192152|564462728|FG001|Period 3|family emergency|0|||
156373368|NCT01482767|564462732|FG000|Overall Study|Death|1|||
156373369|NCT01482767|564462733|FG001|Overall Study|Death|1|||
156373370|NCT01482767|564462732|FG000|Overall Study|Withdrawal by Subject|7|||
156373371|NCT01482767|564462733|FG001|Overall Study|Withdrawal by Subject|5|||
156373372|NCT01482767|564462732|FG000|Overall Study|Lost to Follow-up|12|||
156373373|NCT01482767|564462733|FG001|Overall Study|Lost to Follow-up|6|||
156373374|NCT01482767|564462732|FG000|Overall Study|Adverse Event|0|||
156373375|NCT01482767|564462733|FG001|Overall Study|Adverse Event|3|||
156373376|NCT01482767|564462732|FG000|Overall Study|Site closure|22|||
156373377|NCT01482767|564462733|FG001|Overall Study|Site closure|14|||
156373378|NCT01482767|564462732|FG000|Overall Study|Non-adherence to study requirements|4|||
156373379|NCT01482767|564462733|FG001|Overall Study|Non-adherence to study requirements|7|||
156373380|NCT01482767|564462732|FG000|Overall Study|Alternate HCV treatment|7|||
156373381|NCT01482767|564462733|FG001|Overall Study|Alternate HCV treatment|8|||
156373382|NCT01482767|564462732|FG000|Overall Study|Ineligible|0|||
156373383|NCT01482767|564462733|FG001|Overall Study|Ineligible|5|||
156373384|NCT01482767|564462732|FG000|Overall Study|Nurse error|1|||
156373385|NCT01482767|564462733|FG001|Overall Study|Nurse error|0|||
156373386|NCT01541930|564462738|FG000|Overall Study|Withdrawal by Subject|1|||
156373387|NCT01466192|564462741|FG000|Overall Study|Physician Decision|1|||
156373388|NCT01466192|564462741|FG000|Overall Study|Withdrawal by Subject|3|||
156373389|NCT03591575|564462742|FG000|Overall Study|Adverse Event|2|||
156373390|NCT03591575|564462743|FG001|Overall Study|Adverse Event|0|||
156373391|NCT03591575|564462742|FG000|Overall Study|Withdrawal by Subject|4|||
156373392|NCT03591575|564462743|FG001|Overall Study|Withdrawal by Subject|1|||
156373393|NCT00004031|564462745|FG000|Overall Study|Adverse Event|5|||
156373394|NCT00004031|564462746|FG001|Overall Study|Adverse Event|0|||
156373395|NCT00004031|564462745|FG000|Overall Study|Refusal unrelated to adverse events|2|||
156373396|NCT00004031|564462746|FG001|Overall Study|Refusal unrelated to adverse events|11|||
156373397|NCT00004031|564462745|FG000|Overall Study|Progression/relapse|9|||
156373398|NCT00004031|564462746|FG001|Overall Study|Progression/relapse|4|||
156373399|NCT00004031|564462745|FG000|Overall Study|Death|3|||
156373400|NCT00004031|564462746|FG001|Overall Study|Death|1|||
156373401|NCT00004031|564462745|FG000|Overall Study|Other- not protocol specified|3|||
156373402|NCT00004031|564462746|FG001|Overall Study|Other- not protocol specified|3|||
156373403|NCT00004031|564462745|FG000|Overall Study|Reason under review|3|||
156373404|NCT00004031|564462746|FG001|Overall Study|Reason under review|2|||
156373405|NCT03665038|564462747|FG000|Overall Study|Lost to Follow-up|0|||
156373406|NCT03665038|564462748|FG001|Overall Study|Lost to Follow-up|0|||
156373407|NCT03665038|564462749|FG002|Overall Study|Lost to Follow-up|1|||
156373408|NCT03013491|564462750|FG000|Main Study|Death|2|||
156373409|NCT03013491|564462751|FG001|Main Study|Death|2|||
156373410|NCT03013491|564462752|FG002|Main Study|Death|5|||
156373411|NCT03013491|564462753|FG003|Main Study|Death|3|||
156373412|NCT03013491|564462754|FG004|Main Study|Death|9|||
156373413|NCT03013491|564462755|FG005|Main Study|Death|12|||
156373414|NCT03013491|564462756|FG006|Main Study|Death|3|||
156373415|NCT03013491|564462757|FG007|Main Study|Death|5|||
156373416|NCT03013491|564462758|FG008|Main Study|Death|1|||
156373417|NCT03013491|564462759|FG009|Main Study|Death|2|||
156373418|NCT03013491|564462760|FG010|Main Study|Death|4|||
156373419|NCT03013491|564462761|FG011|Main Study|Death|1|||
156373420|NCT03013491|564462762|FG012|Main Study|Death|1|||
156373421|NCT03013491|564462763|FG013|Main Study|Death|4|||
156373422|NCT03013491|564462764|FG014|Main Study|Death|0|||
156373423|NCT03013491|564462765|FG015|Main Study|Death|3|||
156373424|NCT03013491|564462766|FG016|Main Study|Death|5|||
156373425|NCT03013491|564462767|FG017|Main Study|Death|1|||
156373426|NCT03013491|564462768|FG018|Main Study|Death|47|||
156373427|NCT03013491|564462750|FG000|Main Study|Lost to Follow-up|0|||
156373428|NCT03013491|564462751|FG001|Main Study|Lost to Follow-up|0|||
156373429|NCT03013491|564462752|FG002|Main Study|Lost to Follow-up|1|||
156373430|NCT03013491|564462753|FG003|Main Study|Lost to Follow-up|0|||
156373431|NCT03013491|564462754|FG004|Main Study|Lost to Follow-up|1|||
156373432|NCT03013491|564462755|FG005|Main Study|Lost to Follow-up|0|||
156373433|NCT03013491|564462756|FG006|Main Study|Lost to Follow-up|0|||
156373434|NCT03013491|564462757|FG007|Main Study|Lost to Follow-up|0|||
156373435|NCT03013491|564462758|FG008|Main Study|Lost to Follow-up|0|||
156373436|NCT03013491|564462759|FG009|Main Study|Lost to Follow-up|0|||
156373437|NCT03013491|564462760|FG010|Main Study|Lost to Follow-up|0|||
156373438|NCT03013491|564462761|FG011|Main Study|Lost to Follow-up|0|||
156373439|NCT03013491|564462762|FG012|Main Study|Lost to Follow-up|0|||
156373440|NCT03013491|564462763|FG013|Main Study|Lost to Follow-up|0|||
156373441|NCT03013491|564462764|FG014|Main Study|Lost to Follow-up|0|||
156373442|NCT03013491|564462765|FG015|Main Study|Lost to Follow-up|0|||
156373443|NCT03013491|564462766|FG016|Main Study|Lost to Follow-up|0|||
156373444|NCT03013491|564462767|FG017|Main Study|Lost to Follow-up|0|||
156373445|NCT03013491|564462768|FG018|Main Study|Lost to Follow-up|3|||
156373446|NCT03013491|564462750|FG000|Main Study|Termination of the study by Sponsor|0|||
156373447|NCT03013491|564462751|FG001|Main Study|Termination of the study by Sponsor|0|||
156373448|NCT03013491|564462752|FG002|Main Study|Termination of the study by Sponsor|2|||
156373449|NCT03013491|564462753|FG003|Main Study|Termination of the study by Sponsor|0|||
156373450|NCT03013491|564462754|FG004|Main Study|Termination of the study by Sponsor|1|||
156373451|NCT03013491|564462755|FG005|Main Study|Termination of the study by Sponsor|2|||
156373452|NCT03013491|564462756|FG006|Main Study|Termination of the study by Sponsor|0|||
156373453|NCT03013491|564462757|FG007|Main Study|Termination of the study by Sponsor|0|||
156373454|NCT03013491|564462758|FG008|Main Study|Termination of the study by Sponsor|1|||
156373455|NCT03013491|564462759|FG009|Main Study|Termination of the study by Sponsor|1|||
156373456|NCT03013491|564462760|FG010|Main Study|Termination of the study by Sponsor|1|||
156373457|NCT03013491|564462761|FG011|Main Study|Termination of the study by Sponsor|2|||
156373458|NCT03013491|564462762|FG012|Main Study|Termination of the study by Sponsor|0|||
156373459|NCT03013491|564462763|FG013|Main Study|Termination of the study by Sponsor|0|||
156373460|NCT03013491|564462764|FG014|Main Study|Termination of the study by Sponsor|0|||
156373461|NCT03013491|564462765|FG015|Main Study|Termination of the study by Sponsor|0|||
156373462|NCT03013491|564462766|FG016|Main Study|Termination of the study by Sponsor|0|||
156373463|NCT03013491|564462767|FG017|Main Study|Termination of the study by Sponsor|1|||
156373464|NCT03013491|564462768|FG018|Main Study|Termination of the study by Sponsor|13|||
156373465|NCT03013491|564462750|FG000|Main Study|Withdrawal by Subject|0|||
156373466|NCT03013491|564462751|FG001|Main Study|Withdrawal by Subject|0|||
156373467|NCT03013491|564462752|FG002|Main Study|Withdrawal by Subject|0|||
156373468|NCT03013491|564462753|FG003|Main Study|Withdrawal by Subject|4|||
156373469|NCT03013491|564462754|FG004|Main Study|Withdrawal by Subject|2|||
156373470|NCT03013491|564462755|FG005|Main Study|Withdrawal by Subject|1|||
156373471|NCT03013491|564462756|FG006|Main Study|Withdrawal by Subject|0|||
156373472|NCT03013491|564462757|FG007|Main Study|Withdrawal by Subject|0|||
156373473|NCT03013491|564462758|FG008|Main Study|Withdrawal by Subject|0|||
156373474|NCT03013491|564462759|FG009|Main Study|Withdrawal by Subject|0|||
156373475|NCT03013491|564462760|FG010|Main Study|Withdrawal by Subject|1|||
156373476|NCT03013491|564462761|FG011|Main Study|Withdrawal by Subject|2|||
156373477|NCT03013491|564462762|FG012|Main Study|Withdrawal by Subject|0|||
156373478|NCT03013491|564462763|FG013|Main Study|Withdrawal by Subject|2|||
156373479|NCT03013491|564462764|FG014|Main Study|Withdrawal by Subject|0|||
156373480|NCT03013491|564462765|FG015|Main Study|Withdrawal by Subject|0|||
156373481|NCT03013491|564462766|FG016|Main Study|Withdrawal by Subject|0|||
156373482|NCT03013491|564462767|FG017|Main Study|Withdrawal by Subject|0|||
156373483|NCT03013491|564462768|FG018|Main Study|Withdrawal by Subject|18|||
156373484|NCT03013491|564462750|FG000|Main Study|Disease progression|0|||
156373485|NCT03013491|564462751|FG001|Main Study|Disease progression|0|||
156373486|NCT03013491|564462752|FG002|Main Study|Disease progression|0|||
156373487|NCT03013491|564462753|FG003|Main Study|Disease progression|1|||
156373488|NCT03013491|564462754|FG004|Main Study|Disease progression|0|||
156373489|NCT03013491|564462755|FG005|Main Study|Disease progression|0|||
156373490|NCT03013491|564462756|FG006|Main Study|Disease progression|0|||
156373491|NCT03013491|564462757|FG007|Main Study|Disease progression|0|||
156373492|NCT03013491|564462758|FG008|Main Study|Disease progression|1|||
156373493|NCT03013491|564462759|FG009|Main Study|Disease progression|0|||
156373494|NCT03013491|564462760|FG010|Main Study|Disease progression|1|||
156373495|NCT03013491|564462761|FG011|Main Study|Disease progression|0|||
156373496|NCT03013491|564462762|FG012|Main Study|Disease progression|0|||
156373497|NCT03013491|564462763|FG013|Main Study|Disease progression|0|||
156373498|NCT03013491|564462764|FG014|Main Study|Disease progression|0|||
156373499|NCT03013491|564462765|FG015|Main Study|Disease progression|0|||
156373500|NCT03013491|564462766|FG016|Main Study|Disease progression|0|||
156373501|NCT03013491|564462767|FG017|Main Study|Disease progression|0|||
156373502|NCT03013491|564462768|FG018|Main Study|Disease progression|4|||
156373503|NCT03013491|564462750|FG000|Main Study|Symptomatic deterioration|0|||
156373504|NCT03013491|564462751|FG001|Main Study|Symptomatic deterioration|0|||
156373505|NCT03013491|564462752|FG002|Main Study|Symptomatic deterioration|0|||
156373506|NCT03013491|564462753|FG003|Main Study|Symptomatic deterioration|0|||
156373507|NCT03013491|564462754|FG004|Main Study|Symptomatic deterioration|0|||
156373508|NCT03013491|564462755|FG005|Main Study|Symptomatic deterioration|1|||
156373509|NCT03013491|564462756|FG006|Main Study|Symptomatic deterioration|0|||
156373510|NCT03013491|564462757|FG007|Main Study|Symptomatic deterioration|0|||
156373511|NCT03013491|564462758|FG008|Main Study|Symptomatic deterioration|0|||
156373512|NCT03013491|564462759|FG009|Main Study|Symptomatic deterioration|0|||
156373513|NCT03013491|564462760|FG010|Main Study|Symptomatic deterioration|0|||
156373514|NCT03013491|564462761|FG011|Main Study|Symptomatic deterioration|0|||
156373515|NCT03013491|564462762|FG012|Main Study|Symptomatic deterioration|0|||
156373516|NCT03013491|564462763|FG013|Main Study|Symptomatic deterioration|0|||
156373517|NCT03013491|564462764|FG014|Main Study|Symptomatic deterioration|0|||
156373518|NCT03013491|564462765|FG015|Main Study|Symptomatic deterioration|0|||
156373519|NCT03013491|564462766|FG016|Main Study|Symptomatic deterioration|0|||
156373520|NCT03013491|564462767|FG017|Main Study|Symptomatic deterioration|0|||
156373521|NCT03013491|564462768|FG018|Main Study|Symptomatic deterioration|0|||
156373522|NCT03013491|564462750|FG000|Main Study|Protocol version 8.0 approval|0|||
156373523|NCT03013491|564462751|FG001|Main Study|Protocol version 8.0 approval|0|||
156373524|NCT03013491|564462752|FG002|Main Study|Protocol version 8.0 approval|0|||
156373525|NCT03013491|564462753|FG003|Main Study|Protocol version 8.0 approval|0|||
156373526|NCT03013491|564462754|FG004|Main Study|Protocol version 8.0 approval|0|||
156373527|NCT03013491|564462755|FG005|Main Study|Protocol version 8.0 approval|0|||
156373528|NCT03013491|564462756|FG006|Main Study|Protocol version 8.0 approval|0|||
156373529|NCT03013491|564462757|FG007|Main Study|Protocol version 8.0 approval|0|||
156373530|NCT03013491|564462758|FG008|Main Study|Protocol version 8.0 approval|0|||
156373531|NCT03013491|564462759|FG009|Main Study|Protocol version 8.0 approval|0|||
156373532|NCT03013491|564462760|FG010|Main Study|Protocol version 8.0 approval|1|||
156373533|NCT03013491|564462761|FG011|Main Study|Protocol version 8.0 approval|0|||
156373534|NCT03013491|564462762|FG012|Main Study|Protocol version 8.0 approval|0|||
156373535|NCT03013491|564462763|FG013|Main Study|Protocol version 8.0 approval|0|||
156373536|NCT03013491|564462764|FG014|Main Study|Protocol version 8.0 approval|0|||
156373537|NCT03013491|564462765|FG015|Main Study|Protocol version 8.0 approval|0|||
156373538|NCT03013491|564462766|FG016|Main Study|Protocol version 8.0 approval|0|||
156373539|NCT03013491|564462767|FG017|Main Study|Protocol version 8.0 approval|0|||
156373540|NCT03013491|564462768|FG018|Main Study|Protocol version 8.0 approval|0|||
156373541|NCT03013491|564462750|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
156373542|NCT03013491|564462751|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
156373543|NCT03013491|564462752|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
156373544|NCT03013491|564462753|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
156373545|NCT03013491|564462754|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
156373546|NCT03013491|564462755|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
156373547|NCT03013491|564462756|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
156373548|NCT03013491|564462757|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
156373549|NCT03013491|564462758|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
156373550|NCT03013491|564462759|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
156373551|NCT03013491|564462760|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
156373552|NCT03013491|564462761|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
156373553|NCT03013491|564462762|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
156373554|NCT03013491|564462763|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
156373555|NCT03013491|564462764|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
156373556|NCT03013491|564462765|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
156373557|NCT03013491|564462766|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
156494143|NCT02484547|564904352|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
156494144|NCT02484547|564904353|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
156494145|NCT02484547|564904354|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
156494146|NCT02484547|564904348|FG000|Placebo-Controlled Period|Death|5|||
156494147|NCT02484547|564904349|FG001|Placebo-Controlled Period|Death|0|||
156494148|NCT02484547|564904350|FG002|Placebo-Controlled Period|Death|6|||
156494149|NCT02484547|564904351|FG003|Placebo-Controlled Period|Death|0|||
156494150|NCT02484547|564904352|FG004|Placebo-Controlled Period|Death|0|||
156494151|NCT02484547|564904353|FG005|Placebo-Controlled Period|Death|0|||
156494152|NCT02484547|564904354|FG006|Placebo-Controlled Period|Death|0|||
156373558|NCT03013491|564462767|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
156373559|NCT03013491|564462768|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
156373560|NCT03013491|564462750|FG000|Main Study|Start of new anticancer therapy|0|||
156373561|NCT03013491|564462751|FG001|Main Study|Start of new anticancer therapy|0|||
156373562|NCT03013491|564462752|FG002|Main Study|Start of new anticancer therapy|0|||
156373563|NCT03013491|564462753|FG003|Main Study|Start of new anticancer therapy|0|||
156373564|NCT03013491|564462754|FG004|Main Study|Start of new anticancer therapy|0|||
156494153|NCT02484547|564904348|FG000|Placebo-Controlled Period|Disease Progression|2|||
156373565|NCT03013491|564462755|FG005|Main Study|Start of new anticancer therapy|0|||
156373566|NCT03013491|564462756|FG006|Main Study|Start of new anticancer therapy|0|||
156373567|NCT03013491|564462757|FG007|Main Study|Start of new anticancer therapy|0|||
156373568|NCT03013491|564462758|FG008|Main Study|Start of new anticancer therapy|0|||
156373569|NCT03013491|564462759|FG009|Main Study|Start of new anticancer therapy|0|||
156373570|NCT03013491|564462760|FG010|Main Study|Start of new anticancer therapy|0|||
156373571|NCT03013491|564462761|FG011|Main Study|Start of new anticancer therapy|0|||
156373572|NCT03013491|564462762|FG012|Main Study|Start of new anticancer therapy|0|||
156373573|NCT03013491|564462763|FG013|Main Study|Start of new anticancer therapy|0|||
156373574|NCT03013491|564462764|FG014|Main Study|Start of new anticancer therapy|0|||
156373575|NCT03013491|564462765|FG015|Main Study|Start of new anticancer therapy|0|||
156373576|NCT03013491|564462766|FG016|Main Study|Start of new anticancer therapy|0|||
156373577|NCT03013491|564462767|FG017|Main Study|Start of new anticancer therapy|0|||
156373578|NCT03013491|564462768|FG018|Main Study|Start of new anticancer therapy|2|||
156373579|NCT03013491|564462750|FG000|Long-term Extension|Disease progression|0|||
156373580|NCT03013491|564462751|FG001|Long-term Extension|Disease progression|0|||
156373581|NCT03013491|564462752|FG002|Long-term Extension|Disease progression|0|||
156373582|NCT03013491|564462753|FG003|Long-term Extension|Disease progression|1|||
156373583|NCT03013491|564462754|FG004|Long-term Extension|Disease progression|0|||
156373584|NCT03013491|564462755|FG005|Long-term Extension|Disease progression|0|||
156373585|NCT03013491|564462756|FG006|Long-term Extension|Disease progression|0|||
156373586|NCT03013491|564462757|FG007|Long-term Extension|Disease progression|0|||
156373587|NCT03013491|564462758|FG008|Long-term Extension|Disease progression|0|||
156373588|NCT03013491|564462759|FG009|Long-term Extension|Disease progression|0|||
156373589|NCT03013491|564462760|FG010|Long-term Extension|Disease progression|0|||
156373590|NCT03013491|564462761|FG011|Long-term Extension|Disease progression|0|||
156373591|NCT03013491|564462762|FG012|Long-term Extension|Disease progression|0|||
156373592|NCT03013491|564462763|FG013|Long-term Extension|Disease progression|0|||
156373593|NCT03013491|564462764|FG014|Long-term Extension|Disease progression|0|||
156373594|NCT03013491|564462765|FG015|Long-term Extension|Disease progression|0|||
156373595|NCT03013491|564462766|FG016|Long-term Extension|Disease progression|0|||
156373596|NCT03013491|564462767|FG017|Long-term Extension|Disease progression|0|||
156373597|NCT03013491|564462768|FG018|Long-term Extension|Disease progression|1|||
156373598|NCT03013491|564462750|FG000|Long-term Extension|Withdrawal by Subject|0|||
156373599|NCT03013491|564462751|FG001|Long-term Extension|Withdrawal by Subject|0|||
156373600|NCT03013491|564462752|FG002|Long-term Extension|Withdrawal by Subject|0|||
156373601|NCT03013491|564462753|FG003|Long-term Extension|Withdrawal by Subject|0|||
156373602|NCT03013491|564462754|FG004|Long-term Extension|Withdrawal by Subject|0|||
156373603|NCT03013491|564462755|FG005|Long-term Extension|Withdrawal by Subject|0|||
156373604|NCT03013491|564462756|FG006|Long-term Extension|Withdrawal by Subject|0|||
156373605|NCT03013491|564462757|FG007|Long-term Extension|Withdrawal by Subject|1|||
156373606|NCT03013491|564462758|FG008|Long-term Extension|Withdrawal by Subject|0|||
156373607|NCT03013491|564462759|FG009|Long-term Extension|Withdrawal by Subject|0|||
156373608|NCT03013491|564462760|FG010|Long-term Extension|Withdrawal by Subject|0|||
156373609|NCT03013491|564462761|FG011|Long-term Extension|Withdrawal by Subject|0|||
156373610|NCT03013491|564462762|FG012|Long-term Extension|Withdrawal by Subject|0|||
156373611|NCT03013491|564462763|FG013|Long-term Extension|Withdrawal by Subject|0|||
156373612|NCT03013491|564462764|FG014|Long-term Extension|Withdrawal by Subject|0|||
156373613|NCT03013491|564462765|FG015|Long-term Extension|Withdrawal by Subject|0|||
156373614|NCT03013491|564462766|FG016|Long-term Extension|Withdrawal by Subject|0|||
156373615|NCT03013491|564462767|FG017|Long-term Extension|Withdrawal by Subject|0|||
156373616|NCT03013491|564462768|FG018|Long-term Extension|Withdrawal by Subject|0|||
156373617|NCT03013491|564462750|FG000|Long-term Extension|Adverse Event|0|||
156373618|NCT03013491|564462751|FG001|Long-term Extension|Adverse Event|0|||
156373619|NCT03013491|564462752|FG002|Long-term Extension|Adverse Event|0|||
156373620|NCT03013491|564462753|FG003|Long-term Extension|Adverse Event|0|||
156373621|NCT03013491|564462754|FG004|Long-term Extension|Adverse Event|0|||
156373622|NCT03013491|564462755|FG005|Long-term Extension|Adverse Event|0|||
156373623|NCT03013491|564462756|FG006|Long-term Extension|Adverse Event|0|||
156373624|NCT03013491|564462757|FG007|Long-term Extension|Adverse Event|0|||
156373625|NCT03013491|564462758|FG008|Long-term Extension|Adverse Event|0|||
156373626|NCT03013491|564462759|FG009|Long-term Extension|Adverse Event|0|||
156373627|NCT03013491|564462760|FG010|Long-term Extension|Adverse Event|0|||
156373628|NCT03013491|564462761|FG011|Long-term Extension|Adverse Event|0|||
156494154|NCT02484547|564904349|FG001|Placebo-Controlled Period|Disease Progression|0|||
156494155|NCT02484547|564904350|FG002|Placebo-Controlled Period|Disease Progression|1|||
156373629|NCT03013491|564462762|FG012|Long-term Extension|Adverse Event|0|||
156373630|NCT03013491|564462763|FG013|Long-term Extension|Adverse Event|0|||
156373631|NCT03013491|564462764|FG014|Long-term Extension|Adverse Event|0|||
156373632|NCT03013491|564462765|FG015|Long-term Extension|Adverse Event|0|||
156373633|NCT03013491|564462766|FG016|Long-term Extension|Adverse Event|0|||
156373634|NCT03013491|564462767|FG017|Long-term Extension|Adverse Event|0|||
156373635|NCT03013491|564462768|FG018|Long-term Extension|Adverse Event|1|||
156373636|NCT03013491|564462750|FG000|Long-term Extension|Death|0|||
156373637|NCT03013491|564462751|FG001|Long-term Extension|Death|0|||
156373638|NCT03013491|564462752|FG002|Long-term Extension|Death|0|||
156373639|NCT03013491|564462753|FG003|Long-term Extension|Death|0|||
156373640|NCT03013491|564462754|FG004|Long-term Extension|Death|0|||
156373641|NCT03013491|564462755|FG005|Long-term Extension|Death|0|||
156373642|NCT03013491|564462756|FG006|Long-term Extension|Death|0|||
156373643|NCT03013491|564462757|FG007|Long-term Extension|Death|0|||
156373644|NCT03013491|564462758|FG008|Long-term Extension|Death|0|||
156373645|NCT03013491|564462759|FG009|Long-term Extension|Death|0|||
156373646|NCT03013491|564462760|FG010|Long-term Extension|Death|0|||
156373647|NCT03013491|564462761|FG011|Long-term Extension|Death|0|||
156373648|NCT03013491|564462762|FG012|Long-term Extension|Death|0|||
156373649|NCT03013491|564462763|FG013|Long-term Extension|Death|0|||
156373650|NCT03013491|564462764|FG014|Long-term Extension|Death|0|||
156373651|NCT03013491|564462765|FG015|Long-term Extension|Death|0|||
156373652|NCT03013491|564462766|FG016|Long-term Extension|Death|0|||
156373653|NCT03013491|564462767|FG017|Long-term Extension|Death|0|||
156373654|NCT03013491|564462768|FG018|Long-term Extension|Death|1|||
156373655|NCT04740034|564462771|FG000|Overall Study|Death|0|||
156373656|NCT04740034|564462772|FG001|Overall Study|Death|1|||
156373657|NCT04740034|564462773|FG002|Overall Study|Death|2|||
156373658|NCT04740034|564462774|FG003|Overall Study|Death|3|||
156373659|NCT04740034|564462775|FG004|Overall Study|Death|4|||
156373660|NCT04740034|564462776|FG005|Overall Study|Death|4|||
156373661|NCT04740034|564462777|FG006|Overall Study|Death|2|||
156373662|NCT04740034|564462778|FG007|Overall Study|Death|2|||
156373663|NCT04740034|564462779|FG008|Overall Study|Death|2|||
156373664|NCT04740034|564462780|FG009|Overall Study|Death|4|||
156373665|NCT04740034|564462781|FG010|Overall Study|Death|0|||
156373666|NCT04740034|564462771|FG000|Overall Study|Lost to Follow-up|0|||
156373667|NCT04740034|564462772|FG001|Overall Study|Lost to Follow-up|0|||
156373668|NCT04740034|564462773|FG002|Overall Study|Lost to Follow-up|0|||
156373669|NCT04740034|564462774|FG003|Overall Study|Lost to Follow-up|1|||
156373670|NCT04740034|564462775|FG004|Overall Study|Lost to Follow-up|2|||
156373671|NCT04740034|564462776|FG005|Overall Study|Lost to Follow-up|2|||
156373672|NCT04740034|564462777|FG006|Overall Study|Lost to Follow-up|0|||
156373673|NCT04740034|564462778|FG007|Overall Study|Lost to Follow-up|0|||
156373674|NCT04740034|564462779|FG008|Overall Study|Lost to Follow-up|0|||
156373675|NCT04740034|564462780|FG009|Overall Study|Lost to Follow-up|1|||
156373676|NCT04740034|564462781|FG010|Overall Study|Lost to Follow-up|0|||
156373677|NCT04740034|564462771|FG000|Overall Study|Withdrawal by Subject|1|||
156373678|NCT04740034|564462772|FG001|Overall Study|Withdrawal by Subject|0|||
156373679|NCT04740034|564462773|FG002|Overall Study|Withdrawal by Subject|0|||
156373680|NCT04740034|564462774|FG003|Overall Study|Withdrawal by Subject|0|||
156373681|NCT04740034|564462775|FG004|Overall Study|Withdrawal by Subject|0|||
156373682|NCT04740034|564462776|FG005|Overall Study|Withdrawal by Subject|0|||
156373683|NCT04740034|564462777|FG006|Overall Study|Withdrawal by Subject|0|||
156373684|NCT04740034|564462778|FG007|Overall Study|Withdrawal by Subject|1|||
156373685|NCT04740034|564462779|FG008|Overall Study|Withdrawal by Subject|0|||
156373686|NCT04740034|564462780|FG009|Overall Study|Withdrawal by Subject|1|||
156373687|NCT04740034|564462781|FG010|Overall Study|Withdrawal by Subject|0|||
156373688|NCT04740034|564462771|FG000|Overall Study|Decision by sponsor|0|||
156373689|NCT04740034|564462772|FG001|Overall Study|Decision by sponsor|0|||
156373690|NCT04740034|564462773|FG002|Overall Study|Decision by sponsor|1|||
156373691|NCT04740034|564462774|FG003|Overall Study|Decision by sponsor|0|||
156373692|NCT04740034|564462775|FG004|Overall Study|Decision by sponsor|0|||
156373693|NCT04740034|564462776|FG005|Overall Study|Decision by sponsor|0|||
156373694|NCT04740034|564462777|FG006|Overall Study|Decision by sponsor|1|||
156373695|NCT04740034|564462778|FG007|Overall Study|Decision by sponsor|2|||
156373696|NCT04740034|564462779|FG008|Overall Study|Decision by sponsor|1|||
156546403|NCT00749996|565093352|FG000|Overall Study|Lost to Follow-up|7|||
156373697|NCT04740034|564462780|FG009|Overall Study|Decision by sponsor|1|||
156373698|NCT04740034|564462781|FG010|Overall Study|Decision by sponsor|2|||
156373699|NCT02556710|564465208|FG000|Overall Study|Surgical treatment|3|||
156373700|NCT02556710|564465209|FG001|Overall Study|Surgical treatment|0|||
156373701|NCT02556710|564465208|FG000|Overall Study|Required proscribed pain medication|2|||
156373702|NCT02556710|564465209|FG001|Overall Study|Required proscribed pain medication|1|||
156373703|NCT02556710|564465208|FG000|Overall Study|Lack of Efficacy|1|||
156373704|NCT02556710|564465209|FG001|Overall Study|Lack of Efficacy|0|||
156373705|NCT02556710|564465208|FG000|Overall Study|Worsening osteoarthritis|1|||
156373706|NCT02556710|564465209|FG001|Overall Study|Worsening osteoarthritis|0|||
156373707|NCT02556710|564465208|FG000|Overall Study|Moved out of state|1|||
156373708|NCT02556710|564465209|FG001|Overall Study|Moved out of state|0|||
156373709|NCT02556710|564465208|FG000|Overall Study|Missing reason|3|||
156373710|NCT02556710|564465209|FG001|Overall Study|Missing reason|1|||
156373711|NCT02556710|564465208|FG000|Overall Study|Pain as lack of efficacy|0|||
156373712|NCT02556710|564465209|FG001|Overall Study|Pain as lack of efficacy|4|||
156373713|NCT04524403|564465212|FG000|Overall Study|Withdrawal by Subject|10|||
156373714|NCT04524403|564465213|FG001|Overall Study|Withdrawal by Subject|3|||
156373715|NCT04524403|564465214|FG002|Overall Study|Withdrawal by Subject|8|||
156373716|NCT04524403|564465212|FG000|Overall Study|Lost to Follow-up|3|||
156373717|NCT04524403|564465213|FG001|Overall Study|Lost to Follow-up|4|||
156373718|NCT04524403|564465214|FG002|Overall Study|Lost to Follow-up|3|||
156373719|NCT04524403|564465212|FG000|Overall Study|Adverse Event|3|||
156373720|NCT04524403|564465213|FG001|Overall Study|Adverse Event|1|||
156373721|NCT04524403|564465214|FG002|Overall Study|Adverse Event|4|||
156373722|NCT04524403|564465212|FG000|Overall Study|Non-compliant with study drug|1|||
156373723|NCT04524403|564465213|FG001|Overall Study|Non-compliant with study drug|2|||
156373724|NCT04524403|564465214|FG002|Overall Study|Non-compliant with study drug|3|||
156373725|NCT04524403|564465212|FG000|Overall Study|Moved|0|||
156373726|NCT04524403|564465213|FG001|Overall Study|Moved|1|||
156373727|NCT04524403|564465214|FG002|Overall Study|Moved|0|||
156373728|NCT01709318|564465215|FG000|Overall Study|Adverse Event|3|||
156373729|NCT01709318|564465216|FG001|Overall Study|Adverse Event|4|||
156373730|NCT01709318|564465217|FG002|Overall Study|Adverse Event|2|||
156373731|NCT01709318|564465218|FG003|Overall Study|Adverse Event|2|||
156373732|NCT01709318|564465219|FG004|Overall Study|Adverse Event|0|||
156373733|NCT01709318|564465220|FG005|Overall Study|Adverse Event|1|||
156373734|NCT01709318|564465221|FG006|Overall Study|Adverse Event|2|||
156373735|NCT01709318|564465215|FG000|Overall Study|Lost to Follow-up|2|||
156373736|NCT01709318|564465216|FG001|Overall Study|Lost to Follow-up|0|||
156373737|NCT01709318|564465217|FG002|Overall Study|Lost to Follow-up|0|||
156373738|NCT01709318|564465218|FG003|Overall Study|Lost to Follow-up|0|||
156373739|NCT01709318|564465219|FG004|Overall Study|Lost to Follow-up|1|||
156373740|NCT01709318|564465220|FG005|Overall Study|Lost to Follow-up|1|||
156373741|NCT01709318|564465221|FG006|Overall Study|Lost to Follow-up|1|||
156373742|NCT01709318|564465215|FG000|Overall Study|Non-compliance with Study Drug|0|||
156373743|NCT01709318|564465216|FG001|Overall Study|Non-compliance with Study Drug|2|||
156373744|NCT01709318|564465217|FG002|Overall Study|Non-compliance with Study Drug|1|||
156373745|NCT01709318|564465218|FG003|Overall Study|Non-compliance with Study Drug|1|||
156373746|NCT01709318|564465219|FG004|Overall Study|Non-compliance with Study Drug|0|||
156373747|NCT01709318|564465220|FG005|Overall Study|Non-compliance with Study Drug|0|||
156373748|NCT01709318|564465221|FG006|Overall Study|Non-compliance with Study Drug|2|||
156373749|NCT01709318|564465215|FG000|Overall Study|Physician Decision|0|||
156373750|NCT01709318|564465216|FG001|Overall Study|Physician Decision|0|||
156373751|NCT01709318|564465217|FG002|Overall Study|Physician Decision|0|||
156373752|NCT01709318|564465218|FG003|Overall Study|Physician Decision|0|||
156373753|NCT01709318|564465219|FG004|Overall Study|Physician Decision|0|||
156373754|NCT01709318|564465220|FG005|Overall Study|Physician Decision|0|||
156373755|NCT01709318|564465221|FG006|Overall Study|Physician Decision|1|||
156373756|NCT01709318|564465215|FG000|Overall Study|Pregnancy|0|||
156373757|NCT01709318|564465216|FG001|Overall Study|Pregnancy|0|||
156373758|NCT01709318|564465217|FG002|Overall Study|Pregnancy|0|||
156373759|NCT01709318|564465218|FG003|Overall Study|Pregnancy|0|||
156373760|NCT01709318|564465219|FG004|Overall Study|Pregnancy|1|||
156373761|NCT01709318|564465220|FG005|Overall Study|Pregnancy|0|||
156373762|NCT01709318|564465221|FG006|Overall Study|Pregnancy|0|||
156373763|NCT01709318|564465215|FG000|Overall Study|Protocol Violation|0|||
156373764|NCT01709318|564465216|FG001|Overall Study|Protocol Violation|0|||
156373765|NCT01709318|564465217|FG002|Overall Study|Protocol Violation|0|||
156373766|NCT01709318|564465218|FG003|Overall Study|Protocol Violation|0|||
156373767|NCT01709318|564465219|FG004|Overall Study|Protocol Violation|2|||
156373768|NCT01709318|564465220|FG005|Overall Study|Protocol Violation|0|||
156373769|NCT01709318|564465221|FG006|Overall Study|Protocol Violation|1|||
156373770|NCT01709318|564465215|FG000|Overall Study|Technical Problems|1|||
156373771|NCT01709318|564465216|FG001|Overall Study|Technical Problems|0|||
156373772|NCT01709318|564465217|FG002|Overall Study|Technical Problems|0|||
156373773|NCT01709318|564465218|FG003|Overall Study|Technical Problems|0|||
156373774|NCT01709318|564465219|FG004|Overall Study|Technical Problems|0|||
156373775|NCT01709318|564465220|FG005|Overall Study|Technical Problems|0|||
156373776|NCT01709318|564465221|FG006|Overall Study|Technical Problems|0|||
156373777|NCT01709318|564465215|FG000|Overall Study|Withdrawal by Subject|3|||
156373778|NCT01709318|564465216|FG001|Overall Study|Withdrawal by Subject|0|||
156373779|NCT01709318|564465217|FG002|Overall Study|Withdrawal by Subject|3|||
156373780|NCT01709318|564465218|FG003|Overall Study|Withdrawal by Subject|3|||
156373781|NCT01709318|564465219|FG004|Overall Study|Withdrawal by Subject|0|||
156373782|NCT01709318|564465220|FG005|Overall Study|Withdrawal by Subject|2|||
156373783|NCT01709318|564465221|FG006|Overall Study|Withdrawal by Subject|4|||
156494156|NCT02484547|564904351|FG003|Placebo-Controlled Period|Disease Progression|0|||
156494157|NCT02484547|564904352|FG004|Placebo-Controlled Period|Disease Progression|0|||
156373784|NCT01709318|564465215|FG000|Overall Study|Other Protocol Specified Criteria|0|||
156373785|NCT01709318|564465216|FG001|Overall Study|Other Protocol Specified Criteria|1|||
156373786|NCT01709318|564465217|FG002|Overall Study|Other Protocol Specified Criteria|0|||
156373787|NCT01709318|564465218|FG003|Overall Study|Other Protocol Specified Criteria|0|||
156494158|NCT02484547|564904353|FG005|Placebo-Controlled Period|Disease Progression|0|||
156373788|NCT01709318|564465219|FG004|Overall Study|Other Protocol Specified Criteria|0|||
156373789|NCT01709318|564465220|FG005|Overall Study|Other Protocol Specified Criteria|0|||
156373790|NCT01709318|564465221|FG006|Overall Study|Other Protocol Specified Criteria|0|||
156373791|NCT00646958|564465226|FG000|Overall Study|Lack of Efficacy|1|||
156373792|NCT00646958|564465227|FG001|Overall Study|Lack of Efficacy|0|||
156373793|NCT00646958|564465228|FG002|Overall Study|Lack of Efficacy|0|||
156373794|NCT00646958|564465226|FG000|Overall Study|Adverse Event|4|||
156373795|NCT00646958|564465227|FG001|Overall Study|Adverse Event|0|||
156373796|NCT00646958|564465228|FG002|Overall Study|Adverse Event|0|||
156373797|NCT00646958|564465226|FG000|Overall Study|Lost to Follow-up|1|||
156373798|NCT00646958|564465227|FG001|Overall Study|Lost to Follow-up|5|||
156373799|NCT00646958|564465228|FG002|Overall Study|Lost to Follow-up|7|||
156373800|NCT00646958|564465226|FG000|Overall Study|Protocol Violation|1|||
156373801|NCT00646958|564465227|FG001|Overall Study|Protocol Violation|1|||
156373802|NCT00646958|564465228|FG002|Overall Study|Protocol Violation|0|||
156373803|NCT00646958|564465226|FG000|Overall Study|Abnormal screening lab tests|1|||
156373804|NCT00646958|564465227|FG001|Overall Study|Abnormal screening lab tests|1|||
156373805|NCT00646958|564465228|FG002|Overall Study|Abnormal screening lab tests|0|||
156373806|NCT00646958|564465226|FG000|Overall Study|Withdrawal by Subject|1|||
156373807|NCT00646958|564465227|FG001|Overall Study|Withdrawal by Subject|2|||
156373808|NCT00646958|564465228|FG002|Overall Study|Withdrawal by Subject|0|||
156373809|NCT00646958|564465226|FG000|Overall Study|Did not receive study drug|2|||
156373810|NCT00646958|564465227|FG001|Overall Study|Did not receive study drug|0|||
156373811|NCT00646958|564465228|FG002|Overall Study|Did not receive study drug|2|||
156373812|NCT00827372|564465229|FG000|Overall Study|Adverse Event|5|||
156373813|NCT00827372|564465229|FG000|Overall Study|Lack of Efficacy|3|||
156373814|NCT01310413|564465230|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
156373815|NCT01310413|564465231|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
156373816|NCT01310413|564465232|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
156373817|NCT01310413|564465233|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
156373818|NCT01310413|564465234|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
156373819|NCT01310413|564465235|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
156373820|NCT01310413|564465236|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
156373821|NCT01310413|564465230|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
156373822|NCT01310413|564465231|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
156373823|NCT01310413|564465232|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
156373824|NCT01310413|564465233|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
156373825|NCT01310413|564465234|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
156373826|NCT01310413|564465235|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
156373827|NCT01310413|564465236|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
156373828|NCT01310413|564465230|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
156373829|NCT01310413|564465231|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
156373830|NCT01310413|564465232|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
156373831|NCT01310413|564465233|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
156373832|NCT01310413|564465234|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
156373833|NCT01310413|564465235|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
156373834|NCT01310413|564465236|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
156373835|NCT01310413|564465230|FG000|Day 0 to Day 385|Other|1|||
156373836|NCT01310413|564465231|FG001|Day 0 to Day 385|Other|0|||
156373837|NCT01310413|564465232|FG002|Day 0 to Day 385|Other|3|||
156373838|NCT01310413|564465233|FG003|Day 0 to Day 385|Other|0|||
156373839|NCT01310413|564465234|FG004|Day 0 to Day 385|Other|0|||
156373840|NCT01310413|564465235|FG005|Day 0 to Day 385|Other|0|||
156373841|NCT01310413|564465236|FG006|Day 0 to Day 385|Other|0|||
156373842|NCT01310413|564465230|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
156373843|NCT01310413|564465231|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
156373844|NCT01310413|564465232|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
156373845|NCT01310413|564465233|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
156373846|NCT01310413|564465234|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
156373847|NCT01310413|564465235|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
156373848|NCT01310413|564465236|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
156373849|NCT01310413|564465230|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
156373850|NCT01310413|564465231|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
156373851|NCT01310413|564465232|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
156373852|NCT01310413|564465233|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
156373853|NCT01310413|564465234|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
156373854|NCT01310413|564465235|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
156373855|NCT01310413|564465236|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
156373856|NCT02564471|564465237|FG000|Overall Study|Adverse Event|1|||
156373857|NCT02564471|564465238|FG001|Overall Study|Adverse Event|0|||
156373858|NCT02564471|564465239|FG002|Overall Study|Adverse Event|0|||
156373859|NCT02564471|564465240|FG003|Overall Study|Adverse Event|0|||
156373860|NCT02564471|564465237|FG000|Overall Study|Withdrawal by Subject|2|||
156373861|NCT02564471|564465238|FG001|Overall Study|Withdrawal by Subject|1|||
156373862|NCT02564471|564465239|FG002|Overall Study|Withdrawal by Subject|3|||
156373863|NCT02564471|564465240|FG003|Overall Study|Withdrawal by Subject|0|||
156373864|NCT02564471|564465237|FG000|Overall Study|Lost to Follow-up|0|||
156373865|NCT02564471|564465238|FG001|Overall Study|Lost to Follow-up|2|||
156373866|NCT02564471|564465239|FG002|Overall Study|Lost to Follow-up|0|||
156373867|NCT02564471|564465240|FG003|Overall Study|Lost to Follow-up|0|||
156373868|NCT02066298|564465241|FG000|Overall Study|Lost to Follow-up|3|||
156373869|NCT02066298|564465242|FG001|Overall Study|Lost to Follow-up|2|||
156373870|NCT02066298|564465243|FG002|Overall Study|Lost to Follow-up|3|||
156494159|NCT02484547|564904354|FG006|Placebo-Controlled Period|Disease Progression|0|||
156373871|NCT02066298|564465244|FG003|Overall Study|Lost to Follow-up|2|||
156373872|NCT02066298|564465245|FG004|Overall Study|Lost to Follow-up|3|||
156373873|NCT02066298|564465246|FG005|Overall Study|Lost to Follow-up|4|||
156373874|NCT02066298|564465241|FG000|Overall Study|Withdrawal by Subject|6|||
156373875|NCT02066298|564465242|FG001|Overall Study|Withdrawal by Subject|6|||
156373876|NCT02066298|564465243|FG002|Overall Study|Withdrawal by Subject|6|||
156373877|NCT02066298|564465244|FG003|Overall Study|Withdrawal by Subject|4|||
156373878|NCT02066298|564465245|FG004|Overall Study|Withdrawal by Subject|5|||
156373879|NCT02066298|564465246|FG005|Overall Study|Withdrawal by Subject|8|||
156373880|NCT02066298|564465241|FG000|Overall Study|Physician Decision|0|||
156373881|NCT02066298|564465242|FG001|Overall Study|Physician Decision|0|||
156373882|NCT02066298|564465243|FG002|Overall Study|Physician Decision|1|||
156373883|NCT02066298|564465244|FG003|Overall Study|Physician Decision|0|||
156373884|NCT02066298|564465245|FG004|Overall Study|Physician Decision|1|||
156373885|NCT02066298|564465246|FG005|Overall Study|Physician Decision|0|||
156373886|NCT04260191|564465247|FG000|Overall Study|Decision by Sponsor|0|||
156373887|NCT04260191|564465248|FG001|Overall Study|Decision by Sponsor|1|||
156373888|NCT04260191|564465249|FG002|Overall Study|Decision by Sponsor|0|||
156373889|NCT04260191|564465247|FG000|Overall Study|Withdrawal by Subject|1|||
156373890|NCT04260191|564465248|FG001|Overall Study|Withdrawal by Subject|0|||
156373891|NCT04260191|564465249|FG002|Overall Study|Withdrawal by Subject|3|||
156373892|NCT04260191|564465247|FG000|Overall Study|Death|4|||
156373893|NCT04260191|564465248|FG001|Overall Study|Death|3|||
156373894|NCT04260191|564465249|FG002|Overall Study|Death|2|||
156373895|NCT00630877|564465252|FG000|Overall Study|Adverse Event|11|||
156373896|NCT00630877|564465253|FG001|Overall Study|Adverse Event|8|||
156373897|NCT00630877|564465254|FG002|Overall Study|Adverse Event|7|||
156373898|NCT00630877|564465252|FG000|Overall Study|Withdrawal by Subject|3|||
156373899|NCT00630877|564465253|FG001|Overall Study|Withdrawal by Subject|4|||
156373900|NCT00630877|564465254|FG002|Overall Study|Withdrawal by Subject|0|||
156373901|NCT00630877|564465252|FG000|Overall Study|Lost to Follow-up|2|||
156373902|NCT00630877|564465253|FG001|Overall Study|Lost to Follow-up|0|||
156373903|NCT00630877|564465254|FG002|Overall Study|Lost to Follow-up|0|||
156373904|NCT00630877|564465252|FG000|Overall Study|Noncompliance|2|||
156373905|NCT00630877|564465253|FG001|Overall Study|Noncompliance|3|||
156373906|NCT00630877|564465254|FG002|Overall Study|Noncompliance|1|||
156373907|NCT00630877|564465252|FG000|Overall Study|Protocol violation|1|||
156373908|NCT00630877|564465253|FG001|Overall Study|Protocol violation|0|||
156373909|NCT00630877|564465254|FG002|Overall Study|Protocol violation|1|||
156373910|NCT00630877|564465252|FG000|Overall Study|Personal reasons|0|||
156373911|NCT00630877|564465253|FG001|Overall Study|Personal reasons|0|||
156373912|NCT00630877|564465254|FG002|Overall Study|Personal reasons|1|||
156373913|NCT01643473|564465255|FG000|Overall Study|Lost to Follow-up|1|||
156373914|NCT01643473|564465256|FG001|Overall Study|Lost to Follow-up|0|||
156373915|NCT02033889|564465257|FG000|Overall Study|Adverse Event|3|||
156373916|NCT02033889|564465258|FG001|Overall Study|Adverse Event|1|||
156373917|NCT02033889|564465259|FG002|Overall Study|Adverse Event|3|||
156373918|NCT02033889|564465257|FG000|Overall Study|Death|3|||
156373919|NCT02033889|564465258|FG001|Overall Study|Death|1|||
156373920|NCT02033889|564465259|FG002|Overall Study|Death|2|||
156373921|NCT02033889|564465257|FG000|Overall Study|Excluded Medication|1|||
156373922|NCT02033889|564465258|FG001|Overall Study|Excluded Medication|1|||
156373923|NCT02033889|564465259|FG002|Overall Study|Excluded Medication|0|||
156373924|NCT02033889|564465257|FG000|Overall Study|Lost to Follow-up|8|||
156373925|NCT02033889|564465258|FG001|Overall Study|Lost to Follow-up|5|||
156373926|NCT02033889|564465259|FG002|Overall Study|Lost to Follow-up|6|||
156373927|NCT02033889|564465257|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156373928|NCT02033889|564465258|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156373929|NCT02033889|564465259|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156373930|NCT02033889|564465257|FG000|Overall Study|Physician Decision|0|||
156373931|NCT02033889|564465258|FG001|Overall Study|Physician Decision|1|||
156373932|NCT02033889|564465259|FG002|Overall Study|Physician Decision|1|||
156373933|NCT02033889|564465257|FG000|Overall Study|Participant moved|0|||
156373934|NCT02033889|564465258|FG001|Overall Study|Participant moved|1|||
156373935|NCT02033889|564465259|FG002|Overall Study|Participant moved|0|||
156373936|NCT02033889|564465257|FG000|Overall Study|Withdrawal by Subject|18|||
156373937|NCT02033889|564465258|FG001|Overall Study|Withdrawal by Subject|10|||
156373938|NCT02033889|564465259|FG002|Overall Study|Withdrawal by Subject|13|||
156373939|NCT02343458|564465260|FG000|Overall Study|Adverse Event|15|||
156373940|NCT02343458|564465261|FG001|Overall Study|Adverse Event|14|||
156373941|NCT02343458|564465262|FG002|Overall Study|Adverse Event|15|||
156373942|NCT02343458|564465263|FG003|Overall Study|Adverse Event|3|||
156373943|NCT02343458|564465260|FG000|Overall Study|Lack of Efficacy|3|||
156373944|NCT02343458|564465261|FG001|Overall Study|Lack of Efficacy|8|||
156373945|NCT02343458|564465262|FG002|Overall Study|Lack of Efficacy|4|||
156373946|NCT02343458|564465263|FG003|Overall Study|Lack of Efficacy|8|||
156373947|NCT02343458|564465260|FG000|Overall Study|Withdrawal by Subject|18|||
156373948|NCT02343458|564465261|FG001|Overall Study|Withdrawal by Subject|17|||
156373949|NCT02343458|564465262|FG002|Overall Study|Withdrawal by Subject|23|||
156373950|NCT02343458|564465263|FG003|Overall Study|Withdrawal by Subject|14|||
156373951|NCT02343458|564465260|FG000|Overall Study|Physician Decision|1|||
156373952|NCT02343458|564465261|FG001|Overall Study|Physician Decision|4|||
156373953|NCT02343458|564465262|FG002|Overall Study|Physician Decision|2|||
156373954|NCT02343458|564465263|FG003|Overall Study|Physician Decision|2|||
156373955|NCT02343458|564465260|FG000|Overall Study|Lost to Follow-up|5|||
156373956|NCT02343458|564465261|FG001|Overall Study|Lost to Follow-up|5|||
156373957|NCT02343458|564465262|FG002|Overall Study|Lost to Follow-up|3|||
156373958|NCT02343458|564465263|FG003|Overall Study|Lost to Follow-up|1|||
156373959|NCT02343458|564465260|FG000|Overall Study|Protocol Violation|2|||
156373960|NCT02343458|564465261|FG001|Overall Study|Protocol Violation|5|||
156373961|NCT02343458|564465262|FG002|Overall Study|Protocol Violation|2|||
156373962|NCT02343458|564465263|FG003|Overall Study|Protocol Violation|2|||
156373963|NCT02343458|564465260|FG000|Overall Study|Protocol Specified Criteria|17|||
156373964|NCT02343458|564465261|FG001|Overall Study|Protocol Specified Criteria|13|||
156373965|NCT02343458|564465262|FG002|Overall Study|Protocol Specified Criteria|14|||
156373966|NCT02343458|564465263|FG003|Overall Study|Protocol Specified Criteria|8|||
156373967|NCT01312909|564465264|FG000|Overall Study|Randomized but not treated|1|||
156373968|NCT01312909|564465265|FG001|Overall Study|Randomized but not treated|3|||
156373969|NCT01312909|564465266|FG002|Overall Study|Randomized but not treated|1|||
156373970|NCT01312909|564465264|FG000|Overall Study|Adverse Event|1|||
156373971|NCT01312909|564465265|FG001|Overall Study|Adverse Event|0|||
156373972|NCT01312909|564465266|FG002|Overall Study|Adverse Event|3|||
156373973|NCT01312909|564465264|FG000|Overall Study|Protocol Violation|2|||
156373974|NCT01312909|564465265|FG001|Overall Study|Protocol Violation|0|||
156373975|NCT01312909|564465266|FG002|Overall Study|Protocol Violation|2|||
156373976|NCT01312909|564465264|FG000|Overall Study|Other|9|||
156373977|NCT01312909|564465265|FG001|Overall Study|Other|6|||
156373978|NCT01312909|564465266|FG002|Overall Study|Other|11|||
156373979|NCT01312909|564465264|FG000|Overall Study|Withdrawal by Subject|8|||
156373980|NCT01312909|564465265|FG001|Overall Study|Withdrawal by Subject|10|||
156373981|NCT01312909|564465266|FG002|Overall Study|Withdrawal by Subject|7|||
156373982|NCT01312909|564465264|FG000|Overall Study|Lost to Follow-up|21|||
156373983|NCT01312909|564465265|FG001|Overall Study|Lost to Follow-up|17|||
156373984|NCT01312909|564465266|FG002|Overall Study|Lost to Follow-up|20|||
156373985|NCT01312909|564465264|FG000|Overall Study|Insufficient clinical response|0|||
156373986|NCT01312909|564465265|FG001|Overall Study|Insufficient clinical response|0|||
156373987|NCT01312909|564465266|FG002|Overall Study|Insufficient clinical response|1|||
156373988|NCT01312909|564465264|FG000|Overall Study|Entrance criteria not met|0|||
156373989|NCT01312909|564465265|FG001|Overall Study|Entrance criteria not met|0|||
156373990|NCT01312909|564465266|FG002|Overall Study|Entrance criteria not met|2|||
156373991|NCT01913041|564465272|FG000|Overall Study|Protocol Violation|35|||
156373992|NCT01913041|564465272|FG000|Overall Study|Withdrawal by Subject|3|||
156373993|NCT01913041|564465272|FG000|Overall Study|Physician Decision|1|||
156373994|NCT01513317|564465273|FG000|Overall Study|Withdrawal by Subject|15|||
156373995|NCT01513317|564465274|FG001|Overall Study|Withdrawal by Subject|4|||
156373996|NCT01513317|564465273|FG000|Overall Study|Death|1|||
156373997|NCT01513317|564465274|FG001|Overall Study|Death|1|||
156373998|NCT01513317|564465273|FG000|Overall Study|Study terminated by sponsor|18|||
156373999|NCT01513317|564465274|FG001|Overall Study|Study terminated by sponsor|18|||
156374000|NCT01513317|564465273|FG000|Overall Study|Other|0|||
156374001|NCT01513317|564465274|FG001|Overall Study|Other|1|||
156374002|NCT00182689|564465275|FG000|Overall Study|Adverse Event|8|||
156374003|NCT00182689|564465276|FG001|Overall Study|Adverse Event|11|||
156374004|NCT00182689|564465275|FG000|Overall Study|Withdrawal by Subject|2|||
156374005|NCT00182689|564465276|FG001|Overall Study|Withdrawal by Subject|2|||
156374006|NCT00182689|564465275|FG000|Overall Study|Progression|27|||
156374007|NCT00182689|564465276|FG001|Overall Study|Progression|29|||
156374008|NCT00182689|564465275|FG000|Overall Study|Death|1|||
156374009|NCT00182689|564465276|FG001|Overall Study|Death|0|||
156374010|NCT00182689|564465275|FG000|Overall Study|not protocol specified|0|||
156374011|NCT00182689|564465276|FG001|Overall Study|not protocol specified|3|||
156374012|NCT00182689|564465275|FG000|Overall Study|Ineligible|1|||
156374013|NCT00182689|564465276|FG001|Overall Study|Ineligible|4|||
156374014|NCT00182689|564465275|FG000|Overall Study|Never received treatment|1|||
156374015|NCT00182689|564465276|FG001|Overall Study|Never received treatment|0|||
156374016|NCT02564198|564465277|FG000|Overall Study|Withdrawal by Subject|2|||
156494160|NCT02484547|564904348|FG000|Placebo-Controlled Period|Investigator Decision|2|||
156494161|NCT02484547|564904349|FG001|Placebo-Controlled Period|Investigator Decision|2|||
156494162|NCT02484547|564904350|FG002|Placebo-Controlled Period|Investigator Decision|5|||
156494163|NCT02484547|564904351|FG003|Placebo-Controlled Period|Investigator Decision|0|||
156494164|NCT02484547|564904352|FG004|Placebo-Controlled Period|Investigator Decision|0|||
156374017|NCT02564198|564465278|FG001|Overall Study|Withdrawal by Subject|4|||
156374018|NCT02564198|564465279|FG002|Overall Study|Withdrawal by Subject|0|||
156374019|NCT02564198|564465277|FG000|Overall Study|Adverse Event|0|||
156374020|NCT02564198|564465278|FG001|Overall Study|Adverse Event|1|||
156374021|NCT02564198|564465279|FG002|Overall Study|Adverse Event|0|||
156374022|NCT00659646|564465280|FG000|Overall Study|Protocol Violation|12|||
156374023|NCT00659646|564465281|FG001|Overall Study|Protocol Violation|8|||
156494165|NCT02484547|564904353|FG005|Placebo-Controlled Period|Investigator Decision|0|||
156374024|NCT00659646|564465280|FG000|Overall Study|Adverse Event|1|||
156374025|NCT00659646|564465281|FG001|Overall Study|Adverse Event|0|||
156374026|NCT00659646|564465280|FG000|Overall Study|Lost to Follow-up|1|||
156374027|NCT00659646|564465281|FG001|Overall Study|Lost to Follow-up|0|||
156374028|NCT00659646|564465280|FG000|Overall Study|protocol noncompliance after randomized|1|||
156374029|NCT00659646|564465281|FG001|Overall Study|protocol noncompliance after randomized|0|||
156374030|NCT01640301|564465282|FG000|Overall Study|Death|0|||
156374031|NCT01640301|564465283|FG001|Overall Study|Death|8|||
156374032|NCT02200042|564465287|FG000|Overall Study|Withdrawal by Subject|0|||
156374033|NCT02200042|564465288|FG001|Overall Study|Withdrawal by Subject|1|||
156374034|NCT01969838|564465289|FG000|Double-blind Phase|Adverse Event|10|||
156374035|NCT01969838|564465290|FG001|Double-blind Phase|Adverse Event|4|||
156374036|NCT01969838|564465291|FG002|Double-blind Phase|Adverse Event|0|||
156374037|NCT01969838|564465292|FG003|Double-blind Phase|Adverse Event|0|||
156374038|NCT01969838|564465289|FG000|Double-blind Phase|Death|5|||
156374039|NCT01969838|564465290|FG001|Double-blind Phase|Death|2|||
156374040|NCT01969838|564465291|FG002|Double-blind Phase|Death|0|||
156374041|NCT01969838|564465292|FG003|Double-blind Phase|Death|0|||
156374042|NCT01969838|564465289|FG000|Double-blind Phase|Physician Decision|5|||
156374043|NCT01969838|564465290|FG001|Double-blind Phase|Physician Decision|1|||
156374044|NCT01969838|564465291|FG002|Double-blind Phase|Physician Decision|0|||
156374045|NCT01969838|564465292|FG003|Double-blind Phase|Physician Decision|0|||
156374046|NCT01969838|564465289|FG000|Double-blind Phase|Subject Decision|4|||
156374047|NCT01969838|564465290|FG001|Double-blind Phase|Subject Decision|2|||
156374048|NCT01969838|564465291|FG002|Double-blind Phase|Subject Decision|0|||
156374049|NCT01969838|564465292|FG003|Double-blind Phase|Subject Decision|0|||
156374050|NCT01969838|564465289|FG000|Double-blind Phase|Disease Progression|2|||
156374051|NCT01969838|564465290|FG001|Double-blind Phase|Disease Progression|0|||
156374052|NCT01969838|564465291|FG002|Double-blind Phase|Disease Progression|0|||
156374053|NCT01969838|564465292|FG003|Double-blind Phase|Disease Progression|0|||
156374054|NCT01969838|564465289|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
156374055|NCT01969838|564465290|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
156374056|NCT01969838|564465291|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
156374057|NCT01969838|564465292|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
156374058|NCT01969838|564465289|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
156374059|NCT01969838|564465290|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
156374060|NCT01969838|564465291|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
156374061|NCT01969838|564465292|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
156374062|NCT01969838|564465289|FG000|Open-label Phase|Adverse Event|0|||
156374063|NCT01969838|564465290|FG001|Open-label Phase|Adverse Event|0|||
156374064|NCT01969838|564465291|FG002|Open-label Phase|Adverse Event|37|||
156374065|NCT01969838|564465292|FG003|Open-label Phase|Adverse Event|49|||
156374066|NCT01969838|564465289|FG000|Open-label Phase|Disease Progression|0|||
156374067|NCT01969838|564465290|FG001|Open-label Phase|Disease Progression|0|||
156374068|NCT01969838|564465291|FG002|Open-label Phase|Disease Progression|26|||
156374069|NCT01969838|564465292|FG003|Open-label Phase|Disease Progression|27|||
156494166|NCT02484547|564904354|FG006|Placebo-Controlled Period|Investigator Decision|0|||
156494167|NCT02484547|564904348|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
156494168|NCT02484547|564904349|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
156494169|NCT02484547|564904350|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
156494170|NCT02484547|564904351|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
156494171|NCT02484547|564904352|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
156374070|NCT01969838|564465289|FG000|Open-label Phase|Lack of Efficacy|0|||
156374071|NCT01969838|564465290|FG001|Open-label Phase|Lack of Efficacy|0|||
156374072|NCT01969838|564465291|FG002|Open-label Phase|Lack of Efficacy|17|||
156374073|NCT01969838|564465292|FG003|Open-label Phase|Lack of Efficacy|19|||
156374074|NCT01969838|564465289|FG000|Open-label Phase|Subject Decision|0|||
156374075|NCT01969838|564465290|FG001|Open-label Phase|Subject Decision|0|||
156374076|NCT01969838|564465291|FG002|Open-label Phase|Subject Decision|14|||
156546404|NCT00749996|565093353|FG001|Overall Study|Lost to Follow-up|4|||
156374077|NCT01969838|564465292|FG003|Open-label Phase|Subject Decision|15|||
156374078|NCT01969838|564465289|FG000|Open-label Phase|Death|0|||
156374079|NCT01969838|564465290|FG001|Open-label Phase|Death|0|||
156374080|NCT01969838|564465291|FG002|Open-label Phase|Death|13|||
156374081|NCT01969838|564465292|FG003|Open-label Phase|Death|11|||
156374082|NCT01969838|564465289|FG000|Open-label Phase|Physician Decision|0|||
156374083|NCT01969838|564465290|FG001|Open-label Phase|Physician Decision|0|||
156374084|NCT01969838|564465291|FG002|Open-label Phase|Physician Decision|9|||
156374085|NCT01969838|564465292|FG003|Open-label Phase|Physician Decision|14|||
156374086|NCT01969838|564465289|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
156374087|NCT01969838|564465290|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
156374088|NCT01969838|564465291|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
156374089|NCT01969838|564465292|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
156374090|NCT00408993|564465293|FG000|Overall Study|Adverse Event|15|||
156374091|NCT00408993|564465294|FG001|Overall Study|Adverse Event|4|||
156374092|NCT00408993|564465293|FG000|Overall Study|Protocol Violation|1|||
156374093|NCT00408993|564465294|FG001|Overall Study|Protocol Violation|6|||
156374094|NCT00408993|564465293|FG000|Overall Study|Lack of Efficacy|1|||
156374095|NCT00408993|564465294|FG001|Overall Study|Lack of Efficacy|4|||
156374096|NCT00408993|564465293|FG000|Overall Study|Withdrawal by Subject|2|||
156374097|NCT00408993|564465294|FG001|Overall Study|Withdrawal by Subject|3|||
156374098|NCT01694706|564465295|FG000|Overall Study|Adverse Event|0|||
156374099|NCT01694706|564465296|FG001|Overall Study|Adverse Event|1|||
156374100|NCT01694706|564465297|FG002|Overall Study|Adverse Event|0|||
156374101|NCT01694706|564465295|FG000|Overall Study|other reason not defined above|1|||
156374102|NCT01694706|564465296|FG001|Overall Study|other reason not defined above|0|||
156374103|NCT01694706|564465297|FG002|Overall Study|other reason not defined above|0|||
156374104|NCT01923181|564465298|FG000|Overall Study|Protocol Violation|2|||
156374105|NCT01923181|564465299|FG001|Overall Study|Protocol Violation|2|||
156374106|NCT01923181|564465300|FG002|Overall Study|Protocol Violation|0|||
156374107|NCT01923181|564465301|FG003|Overall Study|Protocol Violation|2|||
156374108|NCT01923181|564465302|FG004|Overall Study|Protocol Violation|2|||
156374109|NCT01923181|564465303|FG005|Overall Study|Protocol Violation|1|||
156374110|NCT01923181|564465304|FG006|Overall Study|Protocol Violation|1|||
156374111|NCT01923181|564465305|FG007|Overall Study|Protocol Violation|2|||
156374112|NCT01923181|564465306|FG008|Overall Study|Protocol Violation|1|||
156374113|NCT01923181|564465298|FG000|Overall Study|Withdrawal by Subject|0|||
156374114|NCT01923181|564465299|FG001|Overall Study|Withdrawal by Subject|1|||
156374115|NCT01923181|564465300|FG002|Overall Study|Withdrawal by Subject|0|||
156374116|NCT01923181|564465301|FG003|Overall Study|Withdrawal by Subject|1|||
156374117|NCT01923181|564465302|FG004|Overall Study|Withdrawal by Subject|4|||
156374118|NCT01923181|564465303|FG005|Overall Study|Withdrawal by Subject|2|||
156374119|NCT01923181|564465304|FG006|Overall Study|Withdrawal by Subject|4|||
156374120|NCT01923181|564465305|FG007|Overall Study|Withdrawal by Subject|3|||
156374121|NCT01923181|564465306|FG008|Overall Study|Withdrawal by Subject|1|||
156374122|NCT01923181|564465298|FG000|Overall Study|Other|1|||
156374123|NCT01923181|564465299|FG001|Overall Study|Other|0|||
156374124|NCT01923181|564465300|FG002|Overall Study|Other|0|||
156374125|NCT01923181|564465301|FG003|Overall Study|Other|1|||
156374126|NCT01923181|564465302|FG004|Overall Study|Other|0|||
156374127|NCT01923181|564465303|FG005|Overall Study|Other|0|||
156374128|NCT01923181|564465304|FG006|Overall Study|Other|0|||
156374129|NCT01923181|564465305|FG007|Overall Study|Other|0|||
156374130|NCT01923181|564465306|FG008|Overall Study|Other|0|||
156374131|NCT01923181|564465298|FG000|Overall Study|Lost to Follow-up|0|||
156374132|NCT01923181|564465299|FG001|Overall Study|Lost to Follow-up|3|||
156374133|NCT01923181|564465300|FG002|Overall Study|Lost to Follow-up|2|||
156374134|NCT01923181|564465301|FG003|Overall Study|Lost to Follow-up|1|||
156374135|NCT01923181|564465302|FG004|Overall Study|Lost to Follow-up|2|||
156494172|NCT02484547|564904353|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
156494173|NCT02484547|564904354|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
156494174|NCT02484547|564904348|FG000|Placebo-Controlled Period|Relocation|1|||
156494175|NCT02484547|564904349|FG001|Placebo-Controlled Period|Relocation|1|||
156494176|NCT02484547|564904350|FG002|Placebo-Controlled Period|Relocation|1|||
156494177|NCT02484547|564904351|FG003|Placebo-Controlled Period|Relocation|0|||
156494178|NCT02484547|564904352|FG004|Placebo-Controlled Period|Relocation|0|||
156494179|NCT02484547|564904353|FG005|Placebo-Controlled Period|Relocation|0|||
156494180|NCT02484547|564904354|FG006|Placebo-Controlled Period|Relocation|0|||
156494181|NCT02484547|564904348|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
156374136|NCT01923181|564465303|FG005|Overall Study|Lost to Follow-up|1|||
156374137|NCT01923181|564465304|FG006|Overall Study|Lost to Follow-up|3|||
156374138|NCT01923181|564465305|FG007|Overall Study|Lost to Follow-up|3|||
156374139|NCT01923181|564465306|FG008|Overall Study|Lost to Follow-up|1|||
156374140|NCT02944578|564465307|FG000|Overall Study|Physician Decision|1|||
156374141|NCT02944578|564465308|FG001|Overall Study|Physician Decision|0|||
156374142|NCT00456092|564465309|FG000|Extension Phase|Grade 2 or Greater AE|2|||
156494182|NCT02484547|564904349|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
156494183|NCT02484547|564904350|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
156374143|NCT00456092|564465310|FG001|Extension Phase|Grade 2 or Greater AE|2|||
156374144|NCT00456092|564465311|FG002|Extension Phase|Grade 2 or Greater AE|0|||
156374145|NCT00456092|564465312|FG003|Extension Phase|Grade 2 or Greater AE|0|||
156374146|NCT00456092|564465313|FG004|Extension Phase|Grade 2 or Greater AE|2|||
156374147|NCT00456092|564465309|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
156374148|NCT00456092|564465310|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
156374149|NCT00456092|564465311|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
156374150|NCT00456092|564465312|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
156374151|NCT00456092|564465313|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
156374152|NCT00456092|564465309|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
156374153|NCT00456092|564465310|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
156374154|NCT00456092|564465311|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
156374155|NCT00456092|564465312|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
156374156|NCT00456092|564465313|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
156374157|NCT00456092|564465309|FG000|Extension Phase|Withdrew Consent|2|||
156374158|NCT00456092|564465310|FG001|Extension Phase|Withdrew Consent|0|||
156374159|NCT00456092|564465311|FG002|Extension Phase|Withdrew Consent|0|||
156374160|NCT00456092|564465312|FG003|Extension Phase|Withdrew Consent|0|||
156374161|NCT00456092|564465313|FG004|Extension Phase|Withdrew Consent|0|||
156374162|NCT00456092|564465309|FG000|Extension Phase|Lost to Follow-up|1|||
156374163|NCT00456092|564465310|FG001|Extension Phase|Lost to Follow-up|1|||
156374164|NCT00456092|564465311|FG002|Extension Phase|Lost to Follow-up|0|||
156374165|NCT00456092|564465312|FG003|Extension Phase|Lost to Follow-up|0|||
156374166|NCT00456092|564465313|FG004|Extension Phase|Lost to Follow-up|1|||
156374167|NCT00456092|564465309|FG000|Extension Phase|Other|2|||
156374168|NCT00456092|564465310|FG001|Extension Phase|Other|0|||
156374169|NCT00456092|564465311|FG002|Extension Phase|Other|0|||
156374170|NCT00456092|564465312|FG003|Extension Phase|Other|1|||
156374171|NCT00456092|564465313|FG004|Extension Phase|Other|1|||
156374172|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
156374173|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
156374174|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
156374175|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
156374176|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
156374177|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
156374178|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
156374179|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
156374180|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
156374181|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
156374182|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
156374183|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
156374184|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
156374185|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
156374186|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
156374187|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
156374188|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
156374189|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
156374190|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
156374191|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
156374192|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
156374193|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
156374194|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
156374195|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
156374196|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
156374197|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
156374198|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
156374199|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
156374200|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
156374201|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
156374202|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
156374203|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
156374204|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
156494184|NCT02484547|564904351|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
156494185|NCT02484547|564904352|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
156494186|NCT02484547|564904353|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
156494187|NCT02484547|564904354|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
156494188|NCT02484547|564904348|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
156494189|NCT02484547|564904349|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
156546405|NCT00749996|565093352|FG000|Overall Study|Withdrawal by Subject|5|||
156374205|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
156374206|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
156374207|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156374208|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
156374209|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
156374210|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156374211|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156374212|NCT00456092|564465309|FG000|Treatment Phase (12 Weeks)|Other|1|||
156374213|NCT00456092|564465310|FG001|Treatment Phase (12 Weeks)|Other|0|||
156374214|NCT00456092|564465311|FG002|Treatment Phase (12 Weeks)|Other|1|||
156374215|NCT00456092|564465312|FG003|Treatment Phase (12 Weeks)|Other|0|||
156374216|NCT00456092|564465313|FG004|Treatment Phase (12 Weeks)|Other|0|||
156374217|NCT03228680|564465314|FG000|Overall Study|Adverse Event|13|||
156374218|NCT03228680|564465315|FG001|Overall Study|Adverse Event|18|||
156374219|NCT03228680|564465314|FG000|Overall Study|Randomization failure|0|||
156374220|NCT03228680|564465315|FG001|Overall Study|Randomization failure|1|||
156374221|NCT03228680|564465314|FG000|Overall Study|Withdrawal by Subject|1|||
156374222|NCT03228680|564465315|FG001|Overall Study|Withdrawal by Subject|0|||
156374223|NCT03228680|564465314|FG000|Overall Study|Other|9|||
156374224|NCT03228680|564465315|FG001|Overall Study|Other|16|||
156374225|NCT01532687|564465326|FG000|Overall Study|Death|2|||
156374226|NCT01532687|564465327|FG001|Overall Study|Death|0|||
156374227|NCT01532687|564465326|FG000|Overall Study|Adverse Event|6|||
156374228|NCT01532687|564465327|FG001|Overall Study|Adverse Event|1|||
156374229|NCT01532687|564465326|FG000|Overall Study|Withdrawal by Subject|1|||
156374230|NCT01532687|564465327|FG001|Overall Study|Withdrawal by Subject|0|||
156374231|NCT01532687|564465326|FG000|Overall Study|Physician Decision|2|||
156374232|NCT01532687|564465327|FG001|Overall Study|Physician Decision|1|||
156374233|NCT01532687|564465326|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
156374234|NCT01532687|564465327|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
156374235|NCT03160703|564465328|FG000|Overall Study|Withdrawal by Subject|0|||
156374236|NCT03160703|564465329|FG001|Overall Study|Withdrawal by Subject|0|||
156374237|NCT03160703|564465330|FG002|Overall Study|Withdrawal by Subject|0|||
156374238|NCT03160703|564465331|FG003|Overall Study|Withdrawal by Subject|1|||
156374239|NCT00087568|564465338|FG000|Overall Study|Adverse Event|4|||
156374240|NCT00087568|564465339|FG001|Overall Study|Adverse Event|0|||
156374241|NCT00087568|564465338|FG000|Overall Study|Withdrawal by Subject|1|||
156374242|NCT00087568|564465339|FG001|Overall Study|Withdrawal by Subject|1|||
156374243|NCT00087568|564465338|FG000|Overall Study|Lost to Follow-up|1|||
156374244|NCT00087568|564465339|FG001|Overall Study|Lost to Follow-up|0|||
156374245|NCT00087568|564465338|FG000|Overall Study|Lack of Efficacy|24|||
156374246|NCT00087568|564465339|FG001|Overall Study|Lack of Efficacy|1|||
156374247|NCT00226941|564465340|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
156374248|NCT00226941|564465341|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
156374249|NCT00226941|564465342|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
156374250|NCT00226941|564465343|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
156374251|NCT00226941|564465340|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
156374252|NCT00226941|564465341|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
156374253|NCT00226941|564465342|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
156374254|NCT00226941|564465343|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
156374255|NCT01513291|564465344|FG000|Treatment Period|Adverse Event|8|||
156374256|NCT01513291|564465345|FG001|Treatment Period|Adverse Event|4|||
156374257|NCT01513291|564465346|FG002|Treatment Period|Adverse Event|0|||
156374258|NCT01513291|564465347|FG003|Treatment Period|Adverse Event|0|||
156374259|NCT01513291|564465348|FG004|Treatment Period|Adverse Event|0|||
156374260|NCT01513291|564465344|FG000|Treatment Period|Lack of Efficacy|3|||
156374261|NCT01513291|564465345|FG001|Treatment Period|Lack of Efficacy|0|||
156374262|NCT01513291|564465346|FG002|Treatment Period|Lack of Efficacy|0|||
156374263|NCT01513291|564465347|FG003|Treatment Period|Lack of Efficacy|0|||
156374264|NCT01513291|564465348|FG004|Treatment Period|Lack of Efficacy|0|||
156374265|NCT01513291|564465344|FG000|Treatment Period|Lost to Follow-up|2|||
156374266|NCT01513291|564465345|FG001|Treatment Period|Lost to Follow-up|3|||
156374267|NCT01513291|564465346|FG002|Treatment Period|Lost to Follow-up|0|||
156374268|NCT01513291|564465347|FG003|Treatment Period|Lost to Follow-up|0|||
156374269|NCT01513291|564465348|FG004|Treatment Period|Lost to Follow-up|0|||
156374270|NCT01513291|564465344|FG000|Treatment Period|Physician Decision|1|||
156374271|NCT01513291|564465345|FG001|Treatment Period|Physician Decision|0|||
156374272|NCT01513291|564465346|FG002|Treatment Period|Physician Decision|0|||
156374273|NCT01513291|564465347|FG003|Treatment Period|Physician Decision|0|||
156374274|NCT01513291|564465348|FG004|Treatment Period|Physician Decision|0|||
156374275|NCT01513291|564465344|FG000|Treatment Period|Protocol Violation|1|||
156374276|NCT01513291|564465345|FG001|Treatment Period|Protocol Violation|2|||
156374277|NCT01513291|564465346|FG002|Treatment Period|Protocol Violation|0|||
156494190|NCT02484547|564904350|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
156374278|NCT01513291|564465347|FG003|Treatment Period|Protocol Violation|0|||
156374279|NCT01513291|564465348|FG004|Treatment Period|Protocol Violation|0|||
156374280|NCT01513291|564465344|FG000|Treatment Period|Withdrawal by Subject|8|||
156374281|NCT01513291|564465345|FG001|Treatment Period|Withdrawal by Subject|5|||
156374282|NCT01513291|564465346|FG002|Treatment Period|Withdrawal by Subject|0|||
156374283|NCT01513291|564465347|FG003|Treatment Period|Withdrawal by Subject|0|||
156374284|NCT01513291|564465348|FG004|Treatment Period|Withdrawal by Subject|0|||
156374285|NCT01513291|564465344|FG000|Treatment Period|Randomized not treated|0|||
156374286|NCT01513291|564465345|FG001|Treatment Period|Randomized not treated|2|||
156374287|NCT01513291|564465346|FG002|Treatment Period|Randomized not treated|0|||
156374288|NCT01513291|564465347|FG003|Treatment Period|Randomized not treated|0|||
156374289|NCT01513291|564465348|FG004|Treatment Period|Randomized not treated|0|||
156374290|NCT01513291|564465344|FG000|Run-out Period|Lost to Follow-up|0|||
156374291|NCT01513291|564465345|FG001|Run-out Period|Lost to Follow-up|0|||
156374292|NCT01513291|564465346|FG002|Run-out Period|Lost to Follow-up|0|||
156374293|NCT01513291|564465347|FG003|Run-out Period|Lost to Follow-up|1|||
156374294|NCT01513291|564465348|FG004|Run-out Period|Lost to Follow-up|0|||
156374295|NCT01513291|564465344|FG000|Run-out Period|Withdrawal by Subject|0|||
156374296|NCT01513291|564465345|FG001|Run-out Period|Withdrawal by Subject|0|||
156374297|NCT01513291|564465346|FG002|Run-out Period|Withdrawal by Subject|0|||
156374298|NCT01513291|564465347|FG003|Run-out Period|Withdrawal by Subject|1|||
156374299|NCT01513291|564465348|FG004|Run-out Period|Withdrawal by Subject|0|||
156374300|NCT03732638|564465349|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
156374301|NCT03732638|564465350|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
156374302|NCT03732638|564465349|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
156374303|NCT03732638|564465350|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
156374304|NCT03732638|564465349|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
156374305|NCT03732638|564465350|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
156374306|NCT03732638|564465349|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
156374307|NCT03732638|564465350|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
156374308|NCT03732638|564465349|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
156546406|NCT00749996|565093353|FG001|Overall Study|Withdrawal by Subject|4|||
156546407|NCT00749996|565093352|FG000|Overall Study|Protocol Violation|2|||
156546408|NCT00749996|565093353|FG001|Overall Study|Protocol Violation|3|||
156546409|NCT00749996|565093352|FG000|Overall Study|Physician Decision|2|||
156546410|NCT00749996|565093353|FG001|Overall Study|Physician Decision|0|||
156546411|NCT00749996|565093352|FG000|Overall Study|Pregnancy|0|||
156546412|NCT00749996|565093353|FG001|Overall Study|Pregnancy|2|||
156546413|NCT00749996|565093352|FG000|Overall Study|Adverse Event|1|||
156546414|NCT00749996|565093353|FG001|Overall Study|Adverse Event|0|||
156546415|NCT00749996|565093352|FG000|Overall Study|Death|1|||
156546416|NCT00749996|565093353|FG001|Overall Study|Death|0|||
156374309|NCT03732638|564465350|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
156374310|NCT03732638|564465349|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
156374311|NCT03732638|564465350|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
156374312|NCT03732638|564465349|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
156374313|NCT03732638|564465350|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
156374314|NCT03732638|564465349|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
156374315|NCT03732638|564465350|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
156374316|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
156374317|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
156374318|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
156374319|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
156374320|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
156374321|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
156374322|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
156374323|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
156374324|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
156374325|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
156374326|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
156374327|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
156374328|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
156374329|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
156374330|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
156374331|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
156374332|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
156374333|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
156374334|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
156374335|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
156374336|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
156374337|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
156374338|NCT03732638|564465349|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
156374339|NCT03732638|564465350|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
156374340|NCT03732638|564465349|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
156374341|NCT03732638|564465350|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
156374342|NCT03732638|564465349|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
156374343|NCT03732638|564465350|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
156374344|NCT03732638|564465349|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
156374345|NCT03732638|564465350|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
156374346|NCT03732638|564465349|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
156374347|NCT03732638|564465350|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
156374348|NCT03728582|564465355|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
156374349|NCT03728582|564465356|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
156374350|NCT03728582|564465355|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
156374351|NCT03728582|564465356|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
156374352|NCT02732847|564465357|FG000|Overall Study|some filled early|42|||
156374353|NCT02732847|564465358|FG001|Overall Study|some filled early|42|||
156374354|NCT01034397|564465359|FG000|Overall Study|Lack of compliance|0|||
156374355|NCT01034397|564465360|FG001|Overall Study|Lack of compliance|1|||
156374356|NCT01034397|564465359|FG000|Overall Study|Lack of Efficacy|3|||
156374357|NCT01034397|564465360|FG001|Overall Study|Lack of Efficacy|0|||
156374358|NCT01034397|564465359|FG000|Overall Study|Adverse Event|4|||
156374359|NCT01034397|564465360|FG001|Overall Study|Adverse Event|0|||
156374360|NCT01034397|564465359|FG000|Overall Study|Other|0|||
156374361|NCT01034397|564465360|FG001|Overall Study|Other|1|||
156374362|NCT01600040|564465361|FG000|Overall Study|Withdrawal by Subject|1|||
156374363|NCT01263873|564465362|FG000|Overall Study|One provider unable to complete numbers|1|||
156374364|NCT01263873|564465363|FG001|Overall Study|One provider unable to complete numbers|1|||
156374365|NCT00642304|564465368|FG000|Overall Study|Adverse Event|1|||
156374366|NCT00642304|564465368|FG000|Overall Study|Death|1|||
156374367|NCT00642304|564465368|FG000|Overall Study|Blood transfusion|2|||
156374368|NCT00642304|564465368|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
156374369|NCT00642304|564465368|FG000|Overall Study|Transplantation|1|||
156374370|NCT02104557|564465369|FG000|Overall Study|Adverse Event|24|||
156374371|NCT02104557|564465369|FG000|Overall Study|Lost to Follow-up|34|||
156374372|NCT02104557|564465369|FG000|Overall Study|Violated the usage and dosage|14|||
156374373|NCT02104557|564465369|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
156374374|NCT02104557|564465369|FG000|Overall Study|Administered Sayana prior to the contract|1|||
156374375|NCT02104557|564465369|FG000|Overall Study|Other|17|||
156374376|NCT02104557|564465369|FG000|Overall Study|Change to other contraception methods|5|||
156374377|NCT02104557|564465369|FG000|Overall Study|Discontinuation due to no pain|1|||
156546417|NCT00996944|565093354|FG000|Double-blind Treatment Period|Adverse Event|2|||
156374378|NCT02104557|564465369|FG000|Overall Study|Withdrawal consent|2|||
156374379|NCT02104557|564465369|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
156374380|NCT02104557|564465369|FG000|Overall Study|Discontinuation of contraception|9|||
156374381|NCT03192150|564465370|FG000|Overall Study|Adverse Event|14|||
156374382|NCT03192150|564465371|FG001|Overall Study|Adverse Event|12|||
156374383|NCT03192150|564465370|FG000|Overall Study|Lack of Efficacy|23|||
156374384|NCT03192150|564465371|FG001|Overall Study|Lack of Efficacy|30|||
156374385|NCT03192150|564465370|FG000|Overall Study|Lost to Follow-up|1|||
156374386|NCT03192150|564465371|FG001|Overall Study|Lost to Follow-up|1|||
156374387|NCT03192150|564465370|FG000|Overall Study|Withdrawal by Subject|4|||
156374388|NCT03192150|564465371|FG001|Overall Study|Withdrawal by Subject|2|||
156374389|NCT03192150|564465370|FG000|Overall Study|Protocol Violation|5|||
156374390|NCT03192150|564465371|FG001|Overall Study|Protocol Violation|2|||
156374391|NCT03192150|564465370|FG000|Overall Study|Surgery Canceled|6|||
156374392|NCT03192150|564465371|FG001|Overall Study|Surgery Canceled|2|||
156374393|NCT03192150|564465370|FG000|Overall Study|Other-Various Administrative Reasons|2|||
156374394|NCT03192150|564465371|FG001|Overall Study|Other-Various Administrative Reasons|5|||
156374395|NCT00779766|564465372|FG000|Month 24|Serious Adverse Event|2|||
156374396|NCT00779766|564465373|FG001|Month 24|Serious Adverse Event|3|||
156374397|NCT00779766|564465372|FG000|Month 24|Adverse Event|3|||
156374398|NCT00779766|564465373|FG001|Month 24|Adverse Event|3|||
156374399|NCT00779766|564465372|FG000|Month 24|Protocol Violation|3|||
156374400|NCT00779766|564465373|FG001|Month 24|Protocol Violation|1|||
156374401|NCT00779766|564465372|FG000|Month 24|Withdrawal by Subject|159|||
156374402|NCT00779766|564465373|FG001|Month 24|Withdrawal by Subject|127|||
156374403|NCT00779766|564465372|FG000|Month 24|Migrated/moved from study area|138|||
156374404|NCT00779766|564465373|FG001|Month 24|Migrated/moved from study area|162|||
156374405|NCT00779766|564465372|FG000|Month 24|Lost to Follow-up|9|||
156374406|NCT00779766|564465373|FG001|Month 24|Lost to Follow-up|9|||
156374407|NCT00779766|564465372|FG000|Month 24|Other|18|||
156374408|NCT00779766|564465373|FG001|Month 24|Other|27|||
156374409|NCT00779766|564465372|FG000|Month 48|Withdrawal by Subject|68|||
156374410|NCT00779766|564465373|FG001|Month 48|Withdrawal by Subject|63|||
156374411|NCT00779766|564465372|FG000|Month 48|Migrated/moved from study area|76|||
156374412|NCT00779766|564465373|FG001|Month 48|Migrated/moved from study area|75|||
156374413|NCT00779766|564465372|FG000|Month 48|Lost to Follow-up|29|||
156374414|NCT00779766|564465373|FG001|Month 48|Lost to Follow-up|30|||
156374415|NCT00779766|564465372|FG000|Month 48|Other|1|||
156374416|NCT00779766|564465373|FG001|Month 48|Other|0|||
156374417|NCT00779766|564465372|FG000|Month 72|Withdrawal by Subject|55|||
156374418|NCT00779766|564465373|FG001|Month 72|Withdrawal by Subject|71|||
156374419|NCT00779766|564465372|FG000|Month 72|Migrated/moved from study area|124|||
156374420|NCT00779766|564465373|FG001|Month 72|Migrated/moved from study area|109|||
156374421|NCT00779766|564465372|FG000|Month 72|Lost to Follow-up|6|||
156374422|NCT00779766|564465373|FG001|Month 72|Lost to Follow-up|8|||
156374423|NCT00779766|564465372|FG000|Month 72|Other|0|||
156374424|NCT00779766|564465373|FG001|Month 72|Other|1|||
156374425|NCT01412424|564465374|FG000|Core Treatment Period|Treatment Failure|24|||
156374426|NCT01412424|564465374|FG000|Core Treatment Period|Adverse Event|21|||
156374427|NCT01412424|564465374|FG000|Core Treatment Period|Patient Request|5|||
156374428|NCT01412424|564465374|FG000|Core Treatment Period|Lost to Follow-up|2|||
156374429|NCT01412424|564465374|FG000|Core Treatment Period|Sponsor Request|1|||
156546418|NCT00996944|565093355|FG001|Double-blind Treatment Period|Adverse Event|1|||
156546419|NCT00996944|565093354|FG000|Double-blind Treatment Period|Protocol Violation|1|||
156546420|NCT00996944|565093355|FG001|Double-blind Treatment Period|Protocol Violation|0|||
156546421|NCT00996944|565093354|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
156546422|NCT00996944|565093355|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
156546423|NCT00996944|565093354|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
156546424|NCT00996944|565093355|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
156374430|NCT01412424|564465374|FG000|Extension Treatment Period|Adverse Event|2|||
156374431|NCT01412424|564465374|FG000|Extension Treatment Period|Treatment Failure|2|||
156374432|NCT01412424|564465374|FG000|Extension Treatment Period|Patient Request|2|||
156374433|NCT01824303|564465377|FG000|Randomized Study|Withdrawal by Subject|1|||
156374434|NCT01824303|564465378|FG001|Randomized Study|Withdrawal by Subject|1|||
156374435|NCT01824303|564465377|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
156374436|NCT01824303|564465378|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
156374437|NCT03296696|564465379|FG000|Overall Study|Started Other Antitumor Therapy|1|||
156374438|NCT03296696|564465380|FG001|Overall Study|Started Other Antitumor Therapy|2|||
156374439|NCT03296696|564465381|FG002|Overall Study|Started Other Antitumor Therapy|1|||
156374440|NCT03296696|564465382|FG003|Overall Study|Started Other Antitumor Therapy|2|||
156374441|NCT03296696|564465383|FG004|Overall Study|Started Other Antitumor Therapy|1|||
156374442|NCT03296696|564465384|FG005|Overall Study|Started Other Antitumor Therapy|1|||
156374443|NCT03296696|564465385|FG006|Overall Study|Started Other Antitumor Therapy|2|||
156374444|NCT03296696|564465386|FG007|Overall Study|Started Other Antitumor Therapy|3|||
156374445|NCT03296696|564465387|FG008|Overall Study|Started Other Antitumor Therapy|1|||
156374446|NCT03296696|564465388|FG009|Overall Study|Started Other Antitumor Therapy|0|||
156374447|NCT03296696|564465379|FG000|Overall Study|Death|0|||
156374448|NCT03296696|564465380|FG001|Overall Study|Death|1|||
156374449|NCT03296696|564465381|FG002|Overall Study|Death|1|||
156494191|NCT02484547|564904351|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156374450|NCT03296696|564465382|FG003|Overall Study|Death|2|||
156374451|NCT03296696|564465383|FG004|Overall Study|Death|2|||
156374452|NCT03296696|564465384|FG005|Overall Study|Death|3|||
156374453|NCT03296696|564465385|FG006|Overall Study|Death|1|||
156374454|NCT03296696|564465386|FG007|Overall Study|Death|2|||
156374455|NCT03296696|564465387|FG008|Overall Study|Death|0|||
156374456|NCT03296696|564465388|FG009|Overall Study|Death|0|||
156374457|NCT03296696|564465379|FG000|Overall Study|Withdrawal by Subject|0|||
156374458|NCT03296696|564465380|FG001|Overall Study|Withdrawal by Subject|0|||
156374459|NCT03296696|564465381|FG002|Overall Study|Withdrawal by Subject|1|||
156374460|NCT03296696|564465382|FG003|Overall Study|Withdrawal by Subject|0|||
156374461|NCT03296696|564465383|FG004|Overall Study|Withdrawal by Subject|1|||
156374462|NCT03296696|564465384|FG005|Overall Study|Withdrawal by Subject|0|||
156374463|NCT03296696|564465385|FG006|Overall Study|Withdrawal by Subject|0|||
156374464|NCT03296696|564465386|FG007|Overall Study|Withdrawal by Subject|0|||
156374465|NCT03296696|564465387|FG008|Overall Study|Withdrawal by Subject|0|||
156374466|NCT03296696|564465388|FG009|Overall Study|Withdrawal by Subject|1|||
156374467|NCT04694131|564465389|FG000|Overall Study|Withdrawal by Subject|7|||
156374468|NCT04694131|564465389|FG000|Overall Study|Screen Failure|1|||
156374469|NCT04694131|564465389|FG000|Overall Study|High stimulation threshold|3|||
156374470|NCT00086580|564465393|FG000|Treatment Period|Disease progression|9|||
156374471|NCT00086580|564465394|FG001|Treatment Period|Disease progression|8|||
156374472|NCT00086580|564465393|FG000|Treatment Period|Unable to comply with protocol|3|||
156374473|NCT00086580|564465394|FG001|Treatment Period|Unable to comply with protocol|1|||
156374474|NCT00086580|564465393|FG000|Treatment Period|Withdrawal by Subject|7|||
156374475|NCT00086580|564465394|FG001|Treatment Period|Withdrawal by Subject|8|||
156374476|NCT00086580|564465393|FG000|Treatment Period|Physician Decision|13|||
156374477|NCT00086580|564465394|FG001|Treatment Period|Physician Decision|7|||
156374478|NCT00086580|564465393|FG000|Treatment Period|AE - not treatment related|7|||
156374479|NCT00086580|564465394|FG001|Treatment Period|AE - not treatment related|7|||
156374480|NCT00086580|564465393|FG000|Treatment Period|Toxicity - treatment related|15|||
156374481|NCT00086580|564465394|FG001|Treatment Period|Toxicity - treatment related|15|||
156374482|NCT00086580|564465393|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
156374483|NCT00086580|564465394|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
156374484|NCT00086580|564465393|FG000|Treatment Period|Death|5|||
156374485|NCT00086580|564465394|FG001|Treatment Period|Death|7|||
156374486|NCT00086580|564465393|FG000|Treatment Period|Other|5|||
156374487|NCT00086580|564465394|FG001|Treatment Period|Other|3|||
156374488|NCT00086580|564465393|FG000|Follow-up Period|Disease progression|72|||
156374489|NCT00086580|564465394|FG001|Follow-up Period|Disease progression|99|||
156374490|NCT00086580|564465393|FG000|Follow-up Period|Unable to comply with protocol|5|||
156374491|NCT00086580|564465394|FG001|Follow-up Period|Unable to comply with protocol|0|||
156374492|NCT00086580|564465393|FG000|Follow-up Period|Withdrawal by Subject|6|||
156374493|NCT00086580|564465394|FG001|Follow-up Period|Withdrawal by Subject|6|||
156374494|NCT00086580|564465393|FG000|Follow-up Period|Physician Decision|0|||
156374495|NCT00086580|564465394|FG001|Follow-up Period|Physician Decision|1|||
156374496|NCT00086580|564465393|FG000|Follow-up Period|AE - not related|1|||
156374497|NCT00086580|564465394|FG001|Follow-up Period|AE - not related|0|||
156374498|NCT00086580|564465393|FG000|Follow-up Period|Death|13|||
156374499|NCT00086580|564465394|FG001|Follow-up Period|Death|7|||
156374500|NCT00086580|564465393|FG000|Follow-up Period|Other|7|||
156374501|NCT00086580|564465394|FG001|Follow-up Period|Other|6|||
156374502|NCT00086580|564465393|FG000|Observation Period|Unable to comply with protocol|1|||
156374503|NCT00086580|564465394|FG001|Observation Period|Unable to comply with protocol|1|||
156374504|NCT00086580|564465393|FG000|Observation Period|Withdrawal by Subject|4|||
156374505|NCT00086580|564465394|FG001|Observation Period|Withdrawal by Subject|2|||
156374506|NCT00086580|564465393|FG000|Observation Period|Death|33|||
156374507|NCT00086580|564465394|FG001|Observation Period|Death|55|||
156374508|NCT00086580|564465393|FG000|Observation Period|Other|8|||
156374509|NCT00086580|564465394|FG001|Observation Period|Other|7|||
156374510|NCT00261716|564465396|FG000|Overall Study|Withdrawal by Subject|6|||
156374511|NCT00261716|564465397|FG001|Overall Study|Withdrawal by Subject|8|||
156374512|NCT00261716|564465396|FG000|Overall Study|Lost to Follow-up|0|||
156374513|NCT00261716|564465397|FG001|Overall Study|Lost to Follow-up|2|||
156374514|NCT00705575|564465400|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156374515|NCT00705575|564465401|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156374516|NCT00705575|564465400|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156374517|NCT00705575|564465401|FG001|Overall Study|Abnormal test procedure result(s)|12|||
156374518|NCT00705575|564465400|FG000|Overall Study|Adverse Event|11|||
156374519|NCT00705575|564465401|FG001|Overall Study|Adverse Event|15|||
156374520|NCT00705575|564465400|FG000|Overall Study|Lost to Follow-up|3|||
156374521|NCT00705575|564465401|FG001|Overall Study|Lost to Follow-up|4|||
156374522|NCT00705575|564465400|FG000|Overall Study|Protocol Violation|2|||
156374523|NCT00705575|564465401|FG001|Overall Study|Protocol Violation|2|||
156374524|NCT00705575|564465400|FG000|Overall Study|Withdrawal by Subject|5|||
156374525|NCT00705575|564465401|FG001|Overall Study|Withdrawal by Subject|10|||
156374526|NCT01000051|564465405|FG000|Overall Study|Withdrawal by Subject|1|||
156374527|NCT01000051|564465406|FG001|Overall Study|Withdrawal by Subject|1|||
156546425|NCT00996944|565093354|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
156546426|NCT00996944|565093355|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
156374528|NCT01000051|564465405|FG000|Overall Study|Disease Progression|1|||
156374529|NCT01000051|564465406|FG001|Overall Study|Disease Progression|0|||
156374530|NCT01000051|564465405|FG000|Overall Study|Serious noncompliance|1|||
156374531|NCT01000051|564465406|FG001|Overall Study|Serious noncompliance|0|||
156374532|NCT02170727|564465407|FG000|Overall Study|Lost to Follow-up|1|||
156374533|NCT02170727|564465408|FG001|Overall Study|Lost to Follow-up|0|||
156374534|NCT02170727|564465407|FG000|Overall Study|Withdrawal by Subject|2|||
156374535|NCT02170727|564465408|FG001|Overall Study|Withdrawal by Subject|0|||
156374536|NCT01959581|564465411|FG000|Overall Study|Lost to Follow-up|5|||
156374537|NCT01660412|564465414|FG000|Overall Study|Protocol Violation|0|||
156374538|NCT01660412|564465415|FG001|Overall Study|Protocol Violation|3|||
156374539|NCT02139644|564466661|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
156374540|NCT02139644|564466662|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156374541|NCT02139644|564466663|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156374542|NCT02139644|564466664|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156374543|NCT02139644|564466665|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156374544|NCT02139644|564466666|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156374545|NCT02139644|564466661|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
156374546|NCT02139644|564466662|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156374547|NCT02139644|564466663|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156374548|NCT02139644|564466664|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156374549|NCT02139644|564466665|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156374550|NCT02139644|564466666|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156374551|NCT02139644|564466661|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
156374552|NCT02139644|564466662|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156374553|NCT02139644|564466663|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156374554|NCT02139644|564466664|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156374555|NCT02139644|564466665|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156374556|NCT02139644|564466666|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156374557|NCT02139644|564466661|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
156374558|NCT02139644|564466662|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156374559|NCT02139644|564466663|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156374560|NCT02139644|564466664|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156374561|NCT02139644|564466665|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156374562|NCT02139644|564466666|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156374563|NCT02139644|564466661|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
156374564|NCT02139644|564466662|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156374565|NCT02139644|564466663|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156374566|NCT02139644|564466664|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156374567|NCT02139644|564466665|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156374568|NCT02139644|564466666|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156374569|NCT02139644|564466661|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
156374570|NCT02139644|564466662|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
156374571|NCT02139644|564466663|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
156374572|NCT02139644|564466664|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
156374573|NCT02139644|564466665|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
156374574|NCT02139644|564466666|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
156374575|NCT02139644|564466661|FG000|Run-In Period (Pre-assignment)|Other|6|||
156374576|NCT02139644|564466662|FG001|Run-In Period (Pre-assignment)|Other|0|||
156374577|NCT02139644|564466663|FG002|Run-In Period (Pre-assignment)|Other|0|||
156374578|NCT02139644|564466664|FG003|Run-In Period (Pre-assignment)|Other|0|||
156374579|NCT02139644|564466665|FG004|Run-In Period (Pre-assignment)|Other|0|||
156374580|NCT02139644|564466666|FG005|Run-In Period (Pre-assignment)|Other|0|||
156374581|NCT02139644|564466661|FG000|Treatment Period|Adverse Event|0|||
156374582|NCT02139644|564466662|FG001|Treatment Period|Adverse Event|0|||
156374583|NCT02139644|564466663|FG002|Treatment Period|Adverse Event|3|||
156374584|NCT02139644|564466664|FG003|Treatment Period|Adverse Event|2|||
156374585|NCT02139644|564466665|FG004|Treatment Period|Adverse Event|1|||
156374586|NCT02139644|564466666|FG005|Treatment Period|Adverse Event|6|||
156374587|NCT02139644|564466661|FG000|Treatment Period|Withdrawal by Subject|0|||
156374588|NCT02139644|564466662|FG001|Treatment Period|Withdrawal by Subject|0|||
156374589|NCT02139644|564466663|FG002|Treatment Period|Withdrawal by Subject|2|||
156374590|NCT02139644|564466664|FG003|Treatment Period|Withdrawal by Subject|2|||
156374591|NCT02139644|564466665|FG004|Treatment Period|Withdrawal by Subject|3|||
156374592|NCT02139644|564466666|FG005|Treatment Period|Withdrawal by Subject|2|||
156374593|NCT02139644|564466661|FG000|Treatment Period|Non-compliance|0|||
156374594|NCT02139644|564466662|FG001|Treatment Period|Non-compliance|0|||
156374595|NCT02139644|564466663|FG002|Treatment Period|Non-compliance|0|||
156374596|NCT02139644|564466664|FG003|Treatment Period|Non-compliance|1|||
156374597|NCT02139644|564466665|FG004|Treatment Period|Non-compliance|0|||
156374598|NCT02139644|564466666|FG005|Treatment Period|Non-compliance|0|||
156374599|NCT02139644|564466661|FG000|Treatment Period|Protocol Violation|0|||
156374600|NCT02139644|564466662|FG001|Treatment Period|Protocol Violation|0|||
156374601|NCT02139644|564466663|FG002|Treatment Period|Protocol Violation|0|||
156374602|NCT02139644|564466664|FG003|Treatment Period|Protocol Violation|1|||
156374603|NCT02139644|564466665|FG004|Treatment Period|Protocol Violation|1|||
156374604|NCT02139644|564466666|FG005|Treatment Period|Protocol Violation|1|||
156374605|NCT02139644|564466661|FG000|Treatment Period|Disease progression|0|||
156374606|NCT02139644|564466662|FG001|Treatment Period|Disease progression|0|||
156374607|NCT02139644|564466663|FG002|Treatment Period|Disease progression|0|||
156374608|NCT02139644|564466664|FG003|Treatment Period|Disease progression|1|||
156374609|NCT02139644|564466665|FG004|Treatment Period|Disease progression|1|||
156374610|NCT02139644|564466666|FG005|Treatment Period|Disease progression|2|||
156374611|NCT02139644|564466661|FG000|Treatment Period|Lost to Follow-up|0|||
156374612|NCT02139644|564466662|FG001|Treatment Period|Lost to Follow-up|0|||
156374613|NCT02139644|564466663|FG002|Treatment Period|Lost to Follow-up|1|||
156374614|NCT02139644|564466664|FG003|Treatment Period|Lost to Follow-up|1|||
156374615|NCT02139644|564466665|FG004|Treatment Period|Lost to Follow-up|1|||
156374616|NCT02139644|564466666|FG005|Treatment Period|Lost to Follow-up|1|||
156374617|NCT02139644|564466661|FG000|Treatment Period|Lack of Efficacy|0|||
156374618|NCT02139644|564466662|FG001|Treatment Period|Lack of Efficacy|0|||
156374619|NCT02139644|564466663|FG002|Treatment Period|Lack of Efficacy|1|||
156374620|NCT02139644|564466664|FG003|Treatment Period|Lack of Efficacy|0|||
156374621|NCT02139644|564466665|FG004|Treatment Period|Lack of Efficacy|1|||
156374622|NCT02139644|564466666|FG005|Treatment Period|Lack of Efficacy|4|||
156374623|NCT02139644|564466661|FG000|Treatment Period|Other|0|||
156374624|NCT02139644|564466662|FG001|Treatment Period|Other|3|||
156374625|NCT02139644|564466663|FG002|Treatment Period|Other|1|||
156374626|NCT02139644|564466664|FG003|Treatment Period|Other|1|||
156374627|NCT02139644|564466665|FG004|Treatment Period|Other|0|||
156374628|NCT02139644|564466666|FG005|Treatment Period|Other|1|||
156374629|NCT02602288|564466673|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
156374630|NCT02602288|564466674|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
156374631|NCT02602288|564466673|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
156374632|NCT02602288|564466674|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
156374633|NCT02602288|564466673|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
156374634|NCT02602288|564466674|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
156374635|NCT02602288|564466673|FG000|12 Month Follow-up|Lost to Follow-up|0|||
156374636|NCT02602288|564466674|FG001|12 Month Follow-up|Lost to Follow-up|4|||
156374637|NCT02602288|564466673|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
156374638|NCT02602288|564466674|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
156374639|NCT02080091|564466678|FG000|Overall Study|Study Terminated|22|||
156374640|NCT02080091|564466678|FG000|Overall Study|Death|1|||
156374641|NCT02080091|564466678|FG000|Overall Study|Withdrawal by Subject|1|||
156374642|NCT02080091|564466678|FG000|Overall Study|Other|1|||
156374643|NCT02348489|564466681|FG000|Overall Study|Death|336|||
156374644|NCT02348489|564466682|FG001|Overall Study|Death|335|||
156374645|NCT02348489|564466681|FG000|Overall Study|Withdrawal by Subject|14|||
156374646|NCT02348489|564466682|FG001|Overall Study|Withdrawal by Subject|27|||
156374647|NCT02348489|564466681|FG000|Overall Study|Lost to Follow-up|3|||
156374648|NCT02348489|564466682|FG001|Overall Study|Lost to Follow-up|5|||
156374649|NCT02866682|564466683|FG000|Overall Study|Death|0|||
156374650|NCT02866682|564466684|FG001|Overall Study|Death|1|||
156374651|NCT02866682|564466683|FG000|Overall Study|Lost to Follow-up|0|||
156374652|NCT02866682|564466684|FG001|Overall Study|Lost to Follow-up|4|||
156374653|NCT02866682|564466683|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
156374654|NCT02866682|564466684|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
156374655|NCT02866682|564466683|FG000|Overall Study|Other|0|||
156374656|NCT02866682|564466684|FG001|Overall Study|Other|1|||
156374657|NCT00201006|564466685|FG000|Overall Study|Withdrawal by Subject|7|||
156374658|NCT00201006|564466686|FG001|Overall Study|Withdrawal by Subject|2|||
156374659|NCT00201006|564466687|FG002|Overall Study|Withdrawal by Subject|3|||
156374660|NCT00201006|564466685|FG000|Overall Study|Adverse Event|1|||
156374661|NCT00201006|564466686|FG001|Overall Study|Adverse Event|0|||
156374662|NCT00201006|564466687|FG002|Overall Study|Adverse Event|1|||
156374663|NCT01750268|564466689|FG000|Overall Study|Lost to Follow-up|0|||
156494192|NCT02484547|564904352|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156494193|NCT02484547|564904353|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156374664|NCT01750268|564466690|FG001|Overall Study|Lost to Follow-up|2|||
156374665|NCT01750268|564466689|FG000|Overall Study|Physician Decision|0|||
156494194|NCT02484547|564904354|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156374666|NCT01750268|564466690|FG001|Overall Study|Physician Decision|3|||
156374667|NCT01750268|564466689|FG000|Overall Study|Withdrawal by Subject|2|||
156374668|NCT01750268|564466690|FG001|Overall Study|Withdrawal by Subject|0|||
156374669|NCT02086591|564466695|FG000|Overall Study|Adverse Event|1|||
156374670|NCT02086591|564466695|FG000|Overall Study|Withdrawal by Subject|1|||
156374671|NCT02086591|564466695|FG000|Overall Study|protocol terminated|3|||
156374672|NCT01529645|564466696|FG000|Overall Study|Lost to Follow-up|0|||
156374673|NCT01529645|564466697|FG001|Overall Study|Lost to Follow-up|1|||
156374674|NCT01529645|564466698|FG002|Overall Study|Lost to Follow-up|1|||
156374675|NCT01529645|564466699|FG003|Overall Study|Lost to Follow-up|1|||
156374676|NCT01529645|564466700|FG004|Overall Study|Lost to Follow-up|1|||
156374677|NCT01529645|564466701|FG005|Overall Study|Lost to Follow-up|0|||
156374678|NCT01529645|564466702|FG006|Overall Study|Lost to Follow-up|2|||
156374679|NCT01529645|564466703|FG007|Overall Study|Lost to Follow-up|0|||
156374680|NCT01529645|564466704|FG008|Overall Study|Lost to Follow-up|1|||
156374681|NCT01529645|564466705|FG009|Overall Study|Lost to Follow-up|0|||
156374682|NCT01529645|564466696|FG000|Overall Study|SAE - Premature contractions|0|||
156374683|NCT01529645|564466697|FG001|Overall Study|SAE - Premature contractions|0|||
156374684|NCT01529645|564466698|FG002|Overall Study|SAE - Premature contractions|1|||
156374685|NCT01529645|564466699|FG003|Overall Study|SAE - Premature contractions|0|||
156374686|NCT01529645|564466700|FG004|Overall Study|SAE - Premature contractions|0|||
156374687|NCT01529645|564466701|FG005|Overall Study|SAE - Premature contractions|0|||
156374688|NCT01529645|564466702|FG006|Overall Study|SAE - Premature contractions|0|||
156374689|NCT01529645|564466703|FG007|Overall Study|SAE - Premature contractions|0|||
156374690|NCT01529645|564466704|FG008|Overall Study|SAE - Premature contractions|0|||
156374691|NCT01529645|564466705|FG009|Overall Study|SAE - Premature contractions|0|||
156374692|NCT01529645|564466696|FG000|Overall Study|Withdrawal by Subject|2|||
156374693|NCT01529645|564466697|FG001|Overall Study|Withdrawal by Subject|0|||
156374694|NCT01529645|564466698|FG002|Overall Study|Withdrawal by Subject|0|||
156374695|NCT01529645|564466699|FG003|Overall Study|Withdrawal by Subject|1|||
156374696|NCT01529645|564466700|FG004|Overall Study|Withdrawal by Subject|1|||
156374697|NCT01529645|564466701|FG005|Overall Study|Withdrawal by Subject|1|||
156374698|NCT01529645|564466702|FG006|Overall Study|Withdrawal by Subject|0|||
156374699|NCT01529645|564466703|FG007|Overall Study|Withdrawal by Subject|0|||
156374700|NCT01529645|564466704|FG008|Overall Study|Withdrawal by Subject|0|||
156374701|NCT01529645|564466705|FG009|Overall Study|Withdrawal by Subject|0|||
156374702|NCT00274716|564466710|FG000|Phase A|Other non-reported reason|4|||
156374703|NCT00274716|564466711|FG001|Phase A|Other non-reported reason|2|||
156374704|NCT00274716|564466712|FG002|Phase A|Other non-reported reason|1|||
156374705|NCT00274716|564466713|FG003|Phase A|Other non-reported reason|2|||
156374706|NCT00274716|564466714|FG004|Phase A|Other non-reported reason|0|||
156374707|NCT00274716|564466715|FG005|Phase A|Other non-reported reason|1|||
156374708|NCT00274716|564466710|FG000|Phase A|Participant moved|0|||
156374709|NCT00274716|564466711|FG001|Phase A|Participant moved|0|||
156374710|NCT00274716|564466712|FG002|Phase A|Participant moved|1|||
156374711|NCT00274716|564466713|FG003|Phase A|Participant moved|0|||
156374712|NCT00274716|564466714|FG004|Phase A|Participant moved|0|||
156374713|NCT00274716|564466715|FG005|Phase A|Participant moved|1|||
156374714|NCT00274716|564466710|FG000|Phase A|Site Terminated|0|||
156374715|NCT00274716|564466711|FG001|Phase A|Site Terminated|0|||
156374716|NCT00274716|564466712|FG002|Phase A|Site Terminated|0|||
156374717|NCT00274716|564466713|FG003|Phase A|Site Terminated|1|||
156374718|NCT00274716|564466714|FG004|Phase A|Site Terminated|0|||
156374719|NCT00274716|564466715|FG005|Phase A|Site Terminated|0|||
156374720|NCT00274716|564466710|FG000|Phase A|Protocol Violation|1|||
156374721|NCT00274716|564466711|FG001|Phase A|Protocol Violation|0|||
156374722|NCT00274716|564466712|FG002|Phase A|Protocol Violation|0|||
156374723|NCT00274716|564466713|FG003|Phase A|Protocol Violation|1|||
156374724|NCT00274716|564466714|FG004|Phase A|Protocol Violation|0|||
156374725|NCT00274716|564466715|FG005|Phase A|Protocol Violation|0|||
156374726|NCT00274716|564466710|FG000|Phase A|Met criteria for discontinuation|1|||
156374727|NCT00274716|564466711|FG001|Phase A|Met criteria for discontinuation|1|||
156374728|NCT00274716|564466712|FG002|Phase A|Met criteria for discontinuation|0|||
156374729|NCT00274716|564466713|FG003|Phase A|Met criteria for discontinuation|0|||
156374730|NCT00274716|564466714|FG004|Phase A|Met criteria for discontinuation|0|||
156374731|NCT00274716|564466715|FG005|Phase A|Met criteria for discontinuation|0|||
156374732|NCT00274716|564466710|FG000|Phase A|Withdrawal by Subject|2|||
156374733|NCT00274716|564466711|FG001|Phase A|Withdrawal by Subject|2|||
156374734|NCT00274716|564466712|FG002|Phase A|Withdrawal by Subject|1|||
156374735|NCT00274716|564466713|FG003|Phase A|Withdrawal by Subject|3|||
156374736|NCT00274716|564466714|FG004|Phase A|Withdrawal by Subject|0|||
156374737|NCT00274716|564466715|FG005|Phase A|Withdrawal by Subject|1|||
156374738|NCT00274716|564466710|FG000|Phase A|Adverse Event|2|||
156374739|NCT00274716|564466711|FG001|Phase A|Adverse Event|3|||
156374740|NCT00274716|564466712|FG002|Phase A|Adverse Event|3|||
156374741|NCT00274716|564466713|FG003|Phase A|Adverse Event|0|||
156374742|NCT00274716|564466714|FG004|Phase A|Adverse Event|2|||
156374743|NCT00274716|564466715|FG005|Phase A|Adverse Event|0|||
156374744|NCT00274716|564466710|FG000|Phase A|Completed but did not enter Phase B|1|||
156374745|NCT00274716|564466711|FG001|Phase A|Completed but did not enter Phase B|2|||
156374746|NCT00274716|564466712|FG002|Phase A|Completed but did not enter Phase B|2|||
156374747|NCT00274716|564466713|FG003|Phase A|Completed but did not enter Phase B|2|||
156374748|NCT00274716|564466714|FG004|Phase A|Completed but did not enter Phase B|1|||
156374749|NCT00274716|564466715|FG005|Phase A|Completed but did not enter Phase B|1|||
156374750|NCT00274716|564466710|FG000|Phase B|Adverse Event|0|||
156374751|NCT00274716|564466711|FG001|Phase B|Adverse Event|0|||
156374752|NCT00274716|564466712|FG002|Phase B|Adverse Event|2|||
156374753|NCT00274716|564466713|FG003|Phase B|Adverse Event|0|||
156374754|NCT00274716|564466714|FG004|Phase B|Adverse Event|0|||
156374755|NCT00274716|564466715|FG005|Phase B|Adverse Event|1|||
156374756|NCT00274716|564466710|FG000|Phase B|Protocol Violation|0|||
156374757|NCT00274716|564466711|FG001|Phase B|Protocol Violation|2|||
156374758|NCT00274716|564466712|FG002|Phase B|Protocol Violation|0|||
156374759|NCT00274716|564466713|FG003|Phase B|Protocol Violation|0|||
156374760|NCT00274716|564466714|FG004|Phase B|Protocol Violation|0|||
156374761|NCT00274716|564466715|FG005|Phase B|Protocol Violation|0|||
156374762|NCT00274716|564466710|FG000|Phase B|Withdrawal by Subject|0|||
156374763|NCT00274716|564466711|FG001|Phase B|Withdrawal by Subject|1|||
156374764|NCT00274716|564466712|FG002|Phase B|Withdrawal by Subject|0|||
156374765|NCT00274716|564466713|FG003|Phase B|Withdrawal by Subject|0|||
156374766|NCT00274716|564466714|FG004|Phase B|Withdrawal by Subject|0|||
156374767|NCT00274716|564466715|FG005|Phase B|Withdrawal by Subject|0|||
156374768|NCT00274716|564466710|FG000|Phase B|Participant moved|1|||
156374769|NCT00274716|564466711|FG001|Phase B|Participant moved|0|||
156374770|NCT00274716|564466712|FG002|Phase B|Participant moved|0|||
156374771|NCT00274716|564466713|FG003|Phase B|Participant moved|0|||
156374772|NCT00274716|564466714|FG004|Phase B|Participant moved|0|||
156494195|NCT02484547|564904348|FG000|Placebo-Controlled Period|Reason not Specified|216|||
156494196|NCT02484547|564904349|FG001|Placebo-Controlled Period|Reason not Specified|194|||
156494197|NCT02484547|564904350|FG002|Placebo-Controlled Period|Reason not Specified|183|||
156494198|NCT02484547|564904351|FG003|Placebo-Controlled Period|Reason not Specified|0|||
156494199|NCT02484547|564904352|FG004|Placebo-Controlled Period|Reason not Specified|0|||
156494200|NCT02484547|564904353|FG005|Placebo-Controlled Period|Reason not Specified|0|||
156494201|NCT02484547|564904354|FG006|Placebo-Controlled Period|Reason not Specified|0|||
156494202|NCT02484547|564904348|FG000|Long-Term Extension Period|Adverse Event|0|||
156494203|NCT02484547|564904349|FG001|Long-Term Extension Period|Adverse Event|0|||
156494204|NCT02484547|564904350|FG002|Long-Term Extension Period|Adverse Event|0|||
156494205|NCT02484547|564904351|FG003|Long-Term Extension Period|Adverse Event|0|||
156494206|NCT02484547|564904352|FG004|Long-Term Extension Period|Adverse Event|1|||
156374773|NCT00274716|564466715|FG005|Phase B|Participant moved|0|||
156374774|NCT00274716|564466710|FG000|Phase B|Other non-reported reason|0|||
156374775|NCT00274716|564466711|FG001|Phase B|Other non-reported reason|0|||
156374776|NCT00274716|564466712|FG002|Phase B|Other non-reported reason|1|||
156374777|NCT00274716|564466713|FG003|Phase B|Other non-reported reason|1|||
156374778|NCT00274716|564466714|FG004|Phase B|Other non-reported reason|0|||
156546427|NCT01227044|565093356|FG000|Overall Study|Lost to Follow-up|5|||
156546428|NCT01227044|565093357|FG001|Overall Study|Lost to Follow-up|7|||
156546429|NCT01227044|565093356|FG000|Overall Study|Discontinued Intervention|1|||
156546430|NCT01227044|565093357|FG001|Overall Study|Discontinued Intervention|2|||
156546431|NCT02250274|565093358|FG000|Overall Study|Insufficient blood draw amount|7|||
156546432|NCT02250274|565093359|FG001|Overall Study|Insufficient blood draw amount|6|||
156546433|NCT00583362|565093360|FG000|Overall Study|Adverse Event|44|||
156546434|NCT00583362|565093360|FG000|Overall Study|Lack of Efficacy|22|||
156546435|NCT00583362|565093360|FG000|Overall Study|Lost to Follow-up|4|||
156546436|NCT00583362|565093360|FG000|Overall Study|Non-compliance with study drug|28|||
156546437|NCT00583362|565093360|FG000|Overall Study|Pregnancy|7|||
156546438|NCT00583362|565093360|FG000|Overall Study|Miscommunication of visit window|5|||
156546439|NCT00583362|565093360|FG000|Overall Study|Current site closed|7|||
156546440|NCT00583362|565093360|FG000|Overall Study|Subject not dosed in LBSL99|1|||
156546441|NCT00583362|565093360|FG000|Overall Study|Subject moved out of the country/state|2|||
156546442|NCT00583362|565093360|FG000|Overall Study|Missed visits due to staff changes|1|||
156494207|NCT02484547|564904353|FG005|Long-Term Extension Period|Adverse Event|3|||
156494208|NCT02484547|564904354|FG006|Long-Term Extension Period|Adverse Event|2|||
156494209|NCT02484547|564904348|FG000|Long-Term Extension Period|Death|0|||
156494210|NCT02484547|564904349|FG001|Long-Term Extension Period|Death|0|||
156494211|NCT02484547|564904350|FG002|Long-Term Extension Period|Death|0|||
156494212|NCT02484547|564904351|FG003|Long-Term Extension Period|Death|0|||
156494213|NCT02484547|564904352|FG004|Long-Term Extension Period|Death|0|||
156494214|NCT02484547|564904353|FG005|Long-Term Extension Period|Death|3|||
156494215|NCT02484547|564904354|FG006|Long-Term Extension Period|Death|0|||
156494216|NCT02484547|564904348|FG000|Long-Term Extension Period|Disease Progression|0|||
156494217|NCT02484547|564904349|FG001|Long-Term Extension Period|Disease Progression|0|||
156494218|NCT02484547|564904350|FG002|Long-Term Extension Period|Disease Progression|0|||
156494219|NCT02484547|564904351|FG003|Long-Term Extension Period|Disease Progression|0|||
156494220|NCT02484547|564904352|FG004|Long-Term Extension Period|Disease Progression|2|||
156494221|NCT02484547|564904353|FG005|Long-Term Extension Period|Disease Progression|4|||
156494222|NCT02484547|564904354|FG006|Long-Term Extension Period|Disease Progression|0|||
156494223|NCT02484547|564904348|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
156494224|NCT02484547|564904349|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
156494225|NCT02484547|564904350|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
156494226|NCT02484547|564904351|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
156494227|NCT02484547|564904352|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
156494228|NCT02484547|564904353|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
156494229|NCT02484547|564904354|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
156494230|NCT02484547|564904348|FG000|Long-Term Extension Period|Loss of Capacity|0|||
156494231|NCT02484547|564904349|FG001|Long-Term Extension Period|Loss of Capacity|0|||
156494232|NCT02484547|564904350|FG002|Long-Term Extension Period|Loss of Capacity|0|||
156494233|NCT02484547|564904351|FG003|Long-Term Extension Period|Loss of Capacity|0|||
156494234|NCT02484547|564904352|FG004|Long-Term Extension Period|Loss of Capacity|1|||
156494235|NCT02484547|564904353|FG005|Long-Term Extension Period|Loss of Capacity|0|||
156494236|NCT02484547|564904354|FG006|Long-Term Extension Period|Loss of Capacity|0|||
156494237|NCT02484547|564904348|FG000|Long-Term Extension Period|Change of Treatment|0|||
156494238|NCT02484547|564904349|FG001|Long-Term Extension Period|Change of Treatment|0|||
156494239|NCT02484547|564904350|FG002|Long-Term Extension Period|Change of Treatment|0|||
156494240|NCT02484547|564904351|FG003|Long-Term Extension Period|Change of Treatment|0|||
156494241|NCT02484547|564904352|FG004|Long-Term Extension Period|Change of Treatment|0|||
156494242|NCT02484547|564904353|FG005|Long-Term Extension Period|Change of Treatment|0|||
156494243|NCT02484547|564904354|FG006|Long-Term Extension Period|Change of Treatment|1|||
156494244|NCT02484547|564904348|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
156494245|NCT02484547|564904349|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
156494246|NCT02484547|564904350|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
156494247|NCT02484547|564904351|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
156546443|NCT00583362|565093360|FG000|Overall Study|Misunderstanding of protocol|1|||
156494248|NCT02484547|564904352|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
156494249|NCT02484547|564904353|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
156494250|NCT02484547|564904354|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
156494251|NCT02484547|564904348|FG000|Long-Term Extension Period|Investigator Decision|0|||
156494252|NCT02484547|564904349|FG001|Long-Term Extension Period|Investigator Decision|0|||
156494253|NCT02484547|564904350|FG002|Long-Term Extension Period|Investigator Decision|0|||
156494254|NCT02484547|564904351|FG003|Long-Term Extension Period|Investigator Decision|2|||
156546444|NCT00583362|565093360|FG000|Overall Study|Behavioral problems and non-compliance|1|||
156494255|NCT02484547|564904352|FG004|Long-Term Extension Period|Investigator Decision|1|||
156494256|NCT02484547|564904353|FG005|Long-Term Extension Period|Investigator Decision|0|||
156494257|NCT02484547|564904354|FG006|Long-Term Extension Period|Investigator Decision|1|||
156494258|NCT02484547|564904348|FG000|Long-Term Extension Period|Relocation|0|||
156494259|NCT02484547|564904349|FG001|Long-Term Extension Period|Relocation|0|||
156494260|NCT02484547|564904350|FG002|Long-Term Extension Period|Relocation|0|||
156494261|NCT02484547|564904351|FG003|Long-Term Extension Period|Relocation|1|||
156494262|NCT02484547|564904352|FG004|Long-Term Extension Period|Relocation|1|||
156494263|NCT02484547|564904353|FG005|Long-Term Extension Period|Relocation|0|||
156494264|NCT02484547|564904354|FG006|Long-Term Extension Period|Relocation|0|||
156494265|NCT02484547|564904348|FG000|Long-Term Extension Period|Study Visit Burden|0|||
156494266|NCT02484547|564904349|FG001|Long-Term Extension Period|Study Visit Burden|0|||
156494267|NCT02484547|564904350|FG002|Long-Term Extension Period|Study Visit Burden|0|||
156494268|NCT02484547|564904351|FG003|Long-Term Extension Period|Study Visit Burden|2|||
156494269|NCT02484547|564904352|FG004|Long-Term Extension Period|Study Visit Burden|0|||
156494270|NCT02484547|564904353|FG005|Long-Term Extension Period|Study Visit Burden|0|||
156494271|NCT02484547|564904354|FG006|Long-Term Extension Period|Study Visit Burden|3|||
156494272|NCT02484547|564904348|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
156494273|NCT02484547|564904349|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
156494274|NCT02484547|564904350|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
156494275|NCT02484547|564904351|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
156494276|NCT02484547|564904352|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
156494277|NCT02484547|564904353|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
156494278|NCT02484547|564904354|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
156494279|NCT02484547|564904348|FG000|Long-Term Extension Period|Reason not Specified|0|||
156494280|NCT02484547|564904349|FG001|Long-Term Extension Period|Reason not Specified|0|||
156494281|NCT02484547|564904350|FG002|Long-Term Extension Period|Reason not Specified|0|||
156494282|NCT02484547|564904351|FG003|Long-Term Extension Period|Reason not Specified|119|||
156494283|NCT02484547|564904352|FG004|Long-Term Extension Period|Reason not Specified|117|||
156494284|NCT02484547|564904353|FG005|Long-Term Extension Period|Reason not Specified|223|||
156494285|NCT02484547|564904354|FG006|Long-Term Extension Period|Reason not Specified|231|||
156494286|NCT04688086|564904355|FG000|Overall Study|Lost to Follow-up|164|||
156494287|NCT04688086|564904355|FG000|Overall Study|Imaging error;|64|||
156494288|NCT03015181|564904358|FG000|Overall Study|Enrolled, but product never administered|1|||
156494289|NCT03015181|564904359|FG001|Overall Study|Enrolled, but product never administered|0|||
156494290|NCT03015181|564904360|FG002|Overall Study|Enrolled, but product never administered|0|||
156494291|NCT03015181|564904361|FG003|Overall Study|Enrolled, but product never administered|0|||
156494292|NCT03015181|564904362|FG004|Overall Study|Enrolled, but product never administered|0|||
156494293|NCT03015181|564904363|FG005|Overall Study|Enrolled, but product never administered|0|||
156494294|NCT03015181|564904364|FG006|Overall Study|Enrolled, but product never administered|0|||
156494295|NCT03015181|564904358|FG000|Overall Study|Withdrawal by Subject|0|||
156494296|NCT03015181|564904359|FG001|Overall Study|Withdrawal by Subject|0|||
156494297|NCT03015181|564904360|FG002|Overall Study|Withdrawal by Subject|0|||
156494298|NCT03015181|564904361|FG003|Overall Study|Withdrawal by Subject|0|||
156494299|NCT03015181|564904362|FG004|Overall Study|Withdrawal by Subject|0|||
156494300|NCT03015181|564904363|FG005|Overall Study|Withdrawal by Subject|1|||
156494301|NCT03015181|564904364|FG006|Overall Study|Withdrawal by Subject|0|||
156494302|NCT03015181|564904358|FG000|Overall Study|Physician Decision|0|||
156494303|NCT03015181|564904359|FG001|Overall Study|Physician Decision|0|||
156494304|NCT03015181|564904360|FG002|Overall Study|Physician Decision|0|||
156494305|NCT03015181|564904361|FG003|Overall Study|Physician Decision|0|||
156494306|NCT03015181|564904362|FG004|Overall Study|Physician Decision|0|||
156494307|NCT03015181|564904363|FG005|Overall Study|Physician Decision|0|||
156494308|NCT03015181|564904364|FG006|Overall Study|Physician Decision|1|||
156494309|NCT01831726|564904367|FG000|Overall Study|Adverse Event|16|||
156494310|NCT01831726|564904367|FG000|Overall Study|Death|7|||
156494311|NCT01831726|564904367|FG000|Overall Study|Disease Progression|49|||
156494312|NCT01831726|564904367|FG000|Overall Study|Physician Decision|1|||
156494313|NCT01831726|564904367|FG000|Overall Study|Subject/guardian decision|7|||
156494314|NCT03821064|564904368|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
156494315|NCT00474383|564904370|FG000|Main Study|Adverse Event|11|||
156494316|NCT00474383|564904371|FG001|Main Study|Adverse Event|0|||
156494317|NCT00474383|564904370|FG000|Main Study|Symptomatic Deterioration|1|||
156494318|NCT00474383|564904371|FG001|Main Study|Symptomatic Deterioration|0|||
156494319|NCT00474383|564904370|FG000|Main Study|Progressive Disease|23|||
156494320|NCT00474383|564904371|FG001|Main Study|Progressive Disease|0|||
156494321|NCT00474383|564904370|FG000|Main Study|Other|1|||
156494322|NCT00474383|564904371|FG001|Main Study|Other|0|||
156374779|NCT00274716|564466715|FG005|Phase B|Other non-reported reason|0|||
156494323|NCT00474383|564904370|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
156494324|NCT00474383|564904371|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
156494325|NCT00474383|564904370|FG000|Extension|Progressive Disease|0|||
156494326|NCT00474383|564904371|FG001|Extension|Progressive Disease|5|||
156494327|NCT01482819|564904374|FG000|Overall Study|Lost to Follow-up|2|||
156494328|NCT01502371|564904377|FG000|Overall Study|Withdrawal by Subject|1|||
156494329|NCT01502371|564904378|FG001|Overall Study|Withdrawal by Subject|2|||
156494330|NCT01502371|564904379|FG002|Overall Study|Withdrawal by Subject|1|||
156546445|NCT00583362|565093360|FG000|Overall Study|Sponsor request due to missed doses|1|||
156546446|NCT00583362|565093360|FG000|Overall Study|Physician Decision|19|||
156546447|NCT00583362|565093360|FG000|Overall Study|Protocol Violation|2|||
156546448|NCT00583362|565093360|FG000|Overall Study|Withdrawal by Subject|57|||
156546449|NCT04247061|565093361|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
156546450|NCT04247061|565093361|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
156546451|NCT04247061|565093361|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
156546452|NCT04770389|565093364|FG000|Overall Study|Adverse Event|1|||
156546453|NCT04770389|565093365|FG001|Overall Study|Adverse Event|2|||
156546454|NCT04770389|565093366|FG002|Overall Study|Adverse Event|0|||
156546455|NCT04770389|565093367|FG003|Overall Study|Adverse Event|1|||
156546456|NCT04770389|565093364|FG000|Overall Study|Withdrawal by Subject|0|||
156546457|NCT04770389|565093365|FG001|Overall Study|Withdrawal by Subject|2|||
156546458|NCT04770389|565093366|FG002|Overall Study|Withdrawal by Subject|1|||
156546459|NCT04770389|565093367|FG003|Overall Study|Withdrawal by Subject|0|||
156546460|NCT04770389|565093364|FG000|Overall Study|Failed attempt to draw blood|1|||
156546461|NCT04770389|565093365|FG001|Overall Study|Failed attempt to draw blood|0|||
156546462|NCT04770389|565093366|FG002|Overall Study|Failed attempt to draw blood|0|||
156546463|NCT04770389|565093367|FG003|Overall Study|Failed attempt to draw blood|0|||
156546464|NCT04770389|565093364|FG000|Overall Study|Left the country|0|||
156546465|NCT04770389|565093365|FG001|Overall Study|Left the country|0|||
156546466|NCT04770389|565093366|FG002|Overall Study|Left the country|1|||
156546467|NCT04770389|565093367|FG003|Overall Study|Left the country|2|||
156546468|NCT04770389|565093364|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
156546469|NCT04770389|565093365|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
156546470|NCT04770389|565093366|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
156546471|NCT04770389|565093367|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
156546472|NCT04770389|565093364|FG000|Overall Study|Lost to Follow-up|0|||
156546473|NCT04770389|565093365|FG001|Overall Study|Lost to Follow-up|0|||
156546474|NCT04770389|565093366|FG002|Overall Study|Lost to Follow-up|0|||
156546475|NCT04770389|565093367|FG003|Overall Study|Lost to Follow-up|1|||
156546476|NCT04770389|565093364|FG000|Overall Study|Moved away from study site|0|||
156546477|NCT04770389|565093365|FG001|Overall Study|Moved away from study site|1|||
156546478|NCT04770389|565093366|FG002|Overall Study|Moved away from study site|0|||
156546479|NCT04770389|565093367|FG003|Overall Study|Moved away from study site|0|||
156546480|NCT03765138|565093368|FG000|Overall Study|Lost to Follow-up|1|||
156546481|NCT02821715|565093373|FG000|Overall Study|Protocol Violation|1|||
156546482|NCT02821715|565093374|FG001|Overall Study|Protocol Violation|0|||
156374780|NCT00274716|564466710|FG000|Phase B|Lost to Follow-up|0|||
156374781|NCT00274716|564466711|FG001|Phase B|Lost to Follow-up|1|||
156374782|NCT00274716|564466712|FG002|Phase B|Lost to Follow-up|0|||
156374783|NCT00274716|564466713|FG003|Phase B|Lost to Follow-up|0|||
156374784|NCT00274716|564466714|FG004|Phase B|Lost to Follow-up|0|||
156374785|NCT00274716|564466715|FG005|Phase B|Lost to Follow-up|0|||
156374786|NCT04193202|564466716|FG000|Overall Study|Adverse Event|2|||
156374787|NCT04193202|564466717|FG001|Overall Study|Adverse Event|1|||
156374788|NCT04193202|564466716|FG000|Overall Study|Death|0|||
156374789|NCT04193202|564466717|FG001|Overall Study|Death|1|||
156374790|NCT04193202|564466716|FG000|Overall Study|Physician Decision|1|||
156374791|NCT04193202|564466717|FG001|Overall Study|Physician Decision|1|||
156374792|NCT04193202|564466716|FG000|Overall Study|Protocol Violation|2|||
156374793|NCT04193202|564466717|FG001|Overall Study|Protocol Violation|2|||
156374794|NCT04193202|564466716|FG000|Overall Study|Withdrawal by Subject|11|||
156374795|NCT04193202|564466717|FG001|Overall Study|Withdrawal by Subject|5|||
156374796|NCT01257204|564466718|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
156374797|NCT01257204|564466719|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
156374798|NCT01257204|564466720|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
156374799|NCT01257204|564466718|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
156374800|NCT01257204|564466719|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
156374801|NCT01257204|564466720|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
156374802|NCT01257204|564466718|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
156374803|NCT01257204|564466719|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
156374804|NCT01257204|564466720|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
156546483|NCT02821715|565093375|FG002|Overall Study|Protocol Violation|0|||
156546484|NCT02821715|565093376|FG003|Overall Study|Protocol Violation|0|||
156546485|NCT02821715|565093377|FG004|Overall Study|Protocol Violation|0|||
156546486|NCT02821715|565093378|FG005|Overall Study|Protocol Violation|0|||
156546487|NCT04294719|565093379|FG000|Overall Study|Withdrawal by Subject|1|||
156546488|NCT03921424|565093381|FG000|Overall Study|Lost to Follow-up|0|||
156546489|NCT03921424|565093382|FG001|Overall Study|Lost to Follow-up|1|||
156374805|NCT01257204|564466718|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
156374806|NCT01257204|564466719|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
156374807|NCT01257204|564466720|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
156374808|NCT01257204|564466718|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
156494331|NCT01502371|564904380|FG003|Overall Study|Withdrawal by Subject|1|||
156494332|NCT01502371|564904381|FG004|Overall Study|Withdrawal by Subject|1|||
156494333|NCT01502371|564904377|FG000|Overall Study|Adverse Event|2|||
156494334|NCT01502371|564904378|FG001|Overall Study|Adverse Event|1|||
156494335|NCT01502371|564904379|FG002|Overall Study|Adverse Event|0|||
156494336|NCT01502371|564904380|FG003|Overall Study|Adverse Event|4|||
156494337|NCT01502371|564904381|FG004|Overall Study|Adverse Event|3|||
156494338|NCT01502371|564904377|FG000|Overall Study|Treatment Failure|22|||
156494339|NCT01502371|564904378|FG001|Overall Study|Treatment Failure|20|||
156494340|NCT01502371|564904379|FG002|Overall Study|Treatment Failure|12|||
156494341|NCT01502371|564904380|FG003|Overall Study|Treatment Failure|19|||
156494342|NCT01502371|564904381|FG004|Overall Study|Treatment Failure|30|||
156494343|NCT01502371|564904377|FG000|Overall Study|Lack of Efficacy|3|||
156494344|NCT01502371|564904378|FG001|Overall Study|Lack of Efficacy|3|||
156494345|NCT01502371|564904379|FG002|Overall Study|Lack of Efficacy|2|||
156494346|NCT01502371|564904380|FG003|Overall Study|Lack of Efficacy|2|||
156494347|NCT01502371|564904381|FG004|Overall Study|Lack of Efficacy|4|||
156494348|NCT01502371|564904377|FG000|Overall Study|Physician Decision|3|||
156494349|NCT01502371|564904378|FG001|Overall Study|Physician Decision|0|||
156494350|NCT01502371|564904379|FG002|Overall Study|Physician Decision|0|||
156494351|NCT01502371|564904380|FG003|Overall Study|Physician Decision|0|||
156494352|NCT01502371|564904381|FG004|Overall Study|Physician Decision|1|||
156494353|NCT01502371|564904377|FG000|Overall Study|Noncompliance with Study Drug|0|||
156494354|NCT01502371|564904378|FG001|Overall Study|Noncompliance with Study Drug|0|||
156494355|NCT01502371|564904379|FG002|Overall Study|Noncompliance with Study Drug|1|||
156494356|NCT01502371|564904380|FG003|Overall Study|Noncompliance with Study Drug|2|||
156546490|NCT03921424|565093381|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156546491|NCT03921424|565093382|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
156546492|NCT00805480|565093392|FG000|Overall Study|Withdrawal by Subject|13|||
156546493|NCT00805480|565093393|FG001|Overall Study|Withdrawal by Subject|5|||
156546494|NCT00805480|565093394|FG002|Overall Study|Withdrawal by Subject|11|||
156546495|NCT00805480|565093395|FG003|Overall Study|Withdrawal by Subject|5|||
156546496|NCT00805480|565093392|FG000|Overall Study|Lost to Follow-up|1|||
156546497|NCT00805480|565093393|FG001|Overall Study|Lost to Follow-up|2|||
156546498|NCT00805480|565093394|FG002|Overall Study|Lost to Follow-up|0|||
156546499|NCT00805480|565093395|FG003|Overall Study|Lost to Follow-up|0|||
156494357|NCT01502371|564904381|FG004|Overall Study|Noncompliance with Study Drug|1|||
156494358|NCT01502371|564904377|FG000|Overall Study|Technical Problems|1|||
156494359|NCT01502371|564904378|FG001|Overall Study|Technical Problems|0|||
156494360|NCT01502371|564904379|FG002|Overall Study|Technical Problems|2|||
156494361|NCT01502371|564904380|FG003|Overall Study|Technical Problems|4|||
156374809|NCT01257204|564466719|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
156374810|NCT01257204|564466720|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
156374811|NCT01257204|564466718|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
156374812|NCT01257204|564466719|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
156374813|NCT01257204|564466720|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
156374814|NCT01257204|564466718|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
156374815|NCT01257204|564466719|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
156374816|NCT01257204|564466720|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
156374817|NCT01257204|564466718|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
156374818|NCT01257204|564466719|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
156374819|NCT01257204|564466720|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
156374820|NCT01257204|564466718|FG000|Follow-up Period (up to Week 48)|Other|0|||
156374821|NCT01257204|564466719|FG001|Follow-up Period (up to Week 48)|Other|0|||
156374822|NCT01257204|564466720|FG002|Follow-up Period (up to Week 48)|Other|5|||
156374823|NCT03394391|564466722|FG000|Overall Study|Lost to Follow-up|1|||
156374824|NCT03394391|564466723|FG001|Overall Study|Lost to Follow-up|2|||
156374825|NCT02932891|564466724|FG000|Overall Study|Lost to Follow-up|2|||
156374826|NCT02932891|564466724|FG000|Overall Study|HPA Suppress|2|||
156374827|NCT04622254|564466725|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156374828|NCT04622254|564466726|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
156374829|NCT04622254|564466727|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156374830|NCT04622254|564466728|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156374831|NCT04622254|564466729|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156374832|NCT04622254|564466730|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156374833|NCT04622254|564466725|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
156374834|NCT04622254|564466726|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
156374835|NCT04622254|564466727|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
156374836|NCT04622254|564466728|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
156374837|NCT04622254|564466729|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
156374838|NCT04622254|564466730|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
156374839|NCT04622254|564466725|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
156374840|NCT04622254|564466726|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156374841|NCT04622254|564466727|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156374842|NCT04622254|564466728|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156374843|NCT04622254|564466729|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156374844|NCT04622254|564466730|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156374845|NCT04622254|564466725|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156374846|NCT04622254|564466726|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
156374847|NCT04622254|564466727|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
156374848|NCT04622254|564466728|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156374849|NCT04622254|564466729|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156374850|NCT04622254|564466730|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156374851|NCT04622254|564466725|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156374852|NCT04622254|564466726|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156374853|NCT04622254|564466727|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156374854|NCT04622254|564466728|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
156374855|NCT04622254|564466729|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156374856|NCT04622254|564466730|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156374857|NCT04622254|564466725|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156374858|NCT04622254|564466726|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156374859|NCT04622254|564466727|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156374860|NCT04622254|564466728|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
156374861|NCT04622254|564466729|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156374862|NCT04622254|564466730|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
156374863|NCT04622254|564466725|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156374864|NCT04622254|564466726|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156374865|NCT04622254|564466727|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156374866|NCT04622254|564466728|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
156374867|NCT04622254|564466729|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156374868|NCT04622254|564466730|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156374869|NCT04622254|564466725|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156374870|NCT04622254|564466726|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156374871|NCT04622254|564466727|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156374872|NCT04622254|564466728|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
156374873|NCT04622254|564466729|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156374874|NCT04622254|564466730|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156374875|NCT04622254|564466725|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156546500|NCT00805480|565093392|FG000|Overall Study|Adverse Event|0|||
156374876|NCT04622254|564466726|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156374877|NCT04622254|564466727|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156374878|NCT04622254|564466728|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
156374879|NCT04622254|564466729|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
156374880|NCT04622254|564466730|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
156374881|NCT04622254|564466725|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156374882|NCT04622254|564466726|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156374883|NCT04622254|564466727|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156374884|NCT04622254|564466728|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
156374885|NCT04622254|564466729|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
156374886|NCT04622254|564466730|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
156374887|NCT04622254|564466725|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
156374888|NCT04622254|564466726|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
156374889|NCT04622254|564466727|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
156374890|NCT04622254|564466728|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
156374891|NCT04622254|564466729|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
156374892|NCT04622254|564466730|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
156374893|NCT00723801|564466732|FG000|Overall Study|Lost to Follow-up|1|||
156374894|NCT00723801|564466733|FG001|Overall Study|Lost to Follow-up|2|||
156374895|NCT00723801|564466732|FG000|Overall Study|Protocol Violation|2|||
156374896|NCT00723801|564466733|FG001|Overall Study|Protocol Violation|1|||
156374897|NCT02167035|564466734|FG000|Overall Study|Adverse Event|2|||
156374898|NCT02167035|564466735|FG001|Overall Study|Adverse Event|2|||
156374899|NCT02167035|564466734|FG000|Overall Study|Lost to Follow-up|3|||
156374900|NCT02167035|564466735|FG001|Overall Study|Lost to Follow-up|3|||
156374901|NCT02167035|564466734|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
156374902|NCT02167035|564466735|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
156374903|NCT02148003|564466736|FG000|Overall Study|Failed inclusion criteria|1|||
156374904|NCT02148003|564466737|FG001|Overall Study|Failed inclusion criteria|0|||
156374905|NCT02148003|564466736|FG000|Overall Study|Met exclusion criteria|0|||
156374906|NCT02148003|564466737|FG001|Overall Study|Met exclusion criteria|1|||
156374907|NCT02148003|564466736|FG000|Overall Study|Withdrawal by Subject|0|||
156374908|NCT02148003|564466737|FG001|Overall Study|Withdrawal by Subject|1|||
156374909|NCT02489981|564466738|FG000|Overall Study|Adverse Event|21|||
156374910|NCT02489981|564466738|FG000|Overall Study|Insufficient effectiveness|16|||
156374911|NCT02489981|564466738|FG000|Overall Study|Improved|31|||
156374912|NCT02489981|564466738|FG000|Overall Study|Lost to Follow-up|31|||
156374913|NCT02489981|564466738|FG000|Overall Study|Other than listed|28|||
156374914|NCT01565993|564466746|FG000|Overall Study|Physician Decision|0|||
156374915|NCT01565993|564466747|FG001|Overall Study|Physician Decision|3|||
156374916|NCT02039427|564466748|FG000|Overall Study|Duration of surgery > 3h|1|||
156374917|NCT02039427|564466749|FG001|Overall Study|Duration of surgery > 3h|1|||
156374918|NCT02039427|564466750|FG002|Overall Study|Duration of surgery > 3h|0|||
156374919|NCT02039427|564466751|FG003|Overall Study|Duration of surgery > 3h|0|||
156374920|NCT02039427|564466748|FG000|Overall Study|Withdrawal on concent|0|||
156374921|NCT02039427|564466749|FG001|Overall Study|Withdrawal on concent|0|||
156374922|NCT02039427|564466750|FG002|Overall Study|Withdrawal on concent|0|||
156374923|NCT02039427|564466751|FG003|Overall Study|Withdrawal on concent|1|||
156374924|NCT02039427|564466748|FG000|Overall Study|Cancellation of surgery|0|||
156374925|NCT02039427|564466749|FG001|Overall Study|Cancellation of surgery|0|||
156374926|NCT02039427|564466750|FG002|Overall Study|Cancellation of surgery|1|||
156374927|NCT02039427|564466751|FG003|Overall Study|Cancellation of surgery|0|||
156374928|NCT02039427|564466748|FG000|Overall Study|Loss of follow - up|1|||
156374929|NCT02039427|564466749|FG001|Overall Study|Loss of follow - up|0|||
156374930|NCT02039427|564466750|FG002|Overall Study|Loss of follow - up|2|||
156374931|NCT02039427|564466751|FG003|Overall Study|Loss of follow - up|4|||
156374932|NCT02039427|564466748|FG000|Overall Study|Steroid Use|1|||
156374933|NCT02039427|564466749|FG001|Overall Study|Steroid Use|0|||
156374934|NCT02039427|564466750|FG002|Overall Study|Steroid Use|0|||
156374935|NCT02039427|564466751|FG003|Overall Study|Steroid Use|0|||
156374936|NCT02370888|564466752|FG000|Overall Study|disease progression|2|||
156374937|NCT02370888|564466752|FG000|Overall Study|did not meet chimerism criteria|6|||
156374938|NCT04574362|564466753|FG000|Overall Study|Other|0|||
156374939|NCT04574362|564466754|FG001|Overall Study|Other|5|||
156374940|NCT04574362|564466753|FG000|Overall Study|COVID-19|0|||
156374941|NCT04574362|564466754|FG001|Overall Study|COVID-19|1|||
156374942|NCT04574362|564466753|FG000|Overall Study|Adverse Event|1|||
156374943|NCT04574362|564466754|FG001|Overall Study|Adverse Event|1|||
156374944|NCT04574362|564466753|FG000|Overall Study|Withdrawal by Subject|2|||
156374945|NCT04574362|564466754|FG001|Overall Study|Withdrawal by Subject|4|||
156374946|NCT04574362|564466753|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
156374947|NCT04574362|564466754|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
156374948|NCT04574362|564466753|FG000|Overall Study|Participant refused to come to the hospital|1|||
156374949|NCT04574362|564466754|FG001|Overall Study|Participant refused to come to the hospital|0|||
156374950|NCT04574362|564466753|FG000|Overall Study|Participant refused the visit|1|||
156374951|NCT04574362|564466754|FG001|Overall Study|Participant refused the visit|0|||
156374952|NCT04574362|564466753|FG000|Overall Study|Participant quit early because of business trip|1|||
156374953|NCT04574362|564466754|FG001|Overall Study|Participant quit early because of business trip|0|||
156374954|NCT01785524|564466755|FG000|Overall Study|Withdrawal by Subject|2|||
156374955|NCT01785524|564466756|FG001|Overall Study|Withdrawal by Subject|2|||
156374956|NCT02178475|564466757|FG000|Overall Study|Withdrawal by Subject|7|||
156374957|NCT02178475|564466757|FG000|Overall Study|Lost to Follow-up|10|||
156374958|NCT02178475|564466757|FG000|Overall Study|Death|13|||
156374959|NCT02178475|564466757|FG000|Overall Study|Protocol-specified Criteria|99|||
156374960|NCT01430585|564466758|FG000|Overall Study|Death|1|||
156374961|NCT01430585|564466758|FG000|Overall Study|Objective Progression or Relapse|3|||
156374962|NCT01430585|564466758|FG000|Overall Study|Study Terminated by Sponsor|3|||
156374963|NCT01430585|564466758|FG000|Overall Study|Other|7|||
156374964|NCT01448850|564466759|FG000|Overall Study|Death|3|||
156374965|NCT01448850|564466760|FG001|Overall Study|Death|6|||
156374966|NCT01448850|564466759|FG000|Overall Study|Withdrawal by Subject|13|||
156374967|NCT01448850|564466760|FG001|Overall Study|Withdrawal by Subject|21|||
156374968|NCT01448850|564466759|FG000|Overall Study|Lost to Follow-up|3|||
156374969|NCT01448850|564466760|FG001|Overall Study|Lost to Follow-up|1|||
156374970|NCT01448850|564466759|FG000|Overall Study|Other|15|||
156374971|NCT01448850|564466760|FG001|Overall Study|Other|12|||
156374972|NCT00482391|564466761|FG000|Overall Study|Withdrawal by Subject|1|||
156374973|NCT00482391|564466761|FG000|Overall Study|Adverse Event|1|||
156374974|NCT00482391|564466761|FG000|Overall Study|Death|1|||
156374975|NCT01274637|564466768|FG000|Overall Study|Withdrawal by Subject|0|||
156374976|NCT01274637|564466769|FG001|Overall Study|Withdrawal by Subject|1|||
156374977|NCT01274637|564466768|FG000|Overall Study|Lost to Follow-up|0|||
156374978|NCT01274637|564466769|FG001|Overall Study|Lost to Follow-up|1|||
156374979|NCT01859715|564466776|FG000|Overall Study|No 2nd VAS|16|||
156374980|NCT01859715|564466777|FG001|Overall Study|No 2nd VAS|8|||
156374981|NCT01859715|564466778|FG002|Overall Study|No 2nd VAS|23|||
156374982|NCT03235024|564466779|FG000|Overall Study|Adverse Event|2|||
156374983|NCT03235024|564466780|FG001|Overall Study|Adverse Event|2|||
156374984|NCT03235024|564466779|FG000|Overall Study|Death|1|||
156374985|NCT03235024|564466780|FG001|Overall Study|Death|0|||
156374986|NCT03235024|564466779|FG000|Overall Study|Lost to Follow-up|2|||
156374987|NCT03235024|564466780|FG001|Overall Study|Lost to Follow-up|5|||
156374988|NCT03235024|564466779|FG000|Overall Study|Protocol Violation|1|||
156374989|NCT03235024|564466780|FG001|Overall Study|Protocol Violation|0|||
156374990|NCT03235024|564466779|FG000|Overall Study|Withdrawal by Subject|0|||
156374991|NCT03235024|564466780|FG001|Overall Study|Withdrawal by Subject|3|||
156374992|NCT02047110|564466781|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
156374993|NCT02047110|564466782|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
156374994|NCT02047110|564466783|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
156374995|NCT02047110|564466784|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
156374996|NCT02047110|564466781|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
156374997|NCT02047110|564466782|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
156374998|NCT02047110|564466783|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
156374999|NCT02047110|564466784|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
156546501|NCT00805480|565093393|FG001|Overall Study|Adverse Event|0|||
156546502|NCT00805480|565093394|FG002|Overall Study|Adverse Event|1|||
156546503|NCT00805480|565093395|FG003|Overall Study|Adverse Event|0|||
156546504|NCT02595450|565093398|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
156546505|NCT02595450|565093398|FG000|Overall Study|Enrolled, but not treated|8|||
156375000|NCT02047110|564466781|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
156375001|NCT02047110|564466782|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
156375002|NCT02047110|564466783|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
156375003|NCT02047110|564466784|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
156375004|NCT02047110|564466781|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
156375005|NCT02047110|564466782|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
156375006|NCT02047110|564466783|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
156375007|NCT02047110|564466784|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
156375008|NCT02047110|564466781|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
156375009|NCT02047110|564466782|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
156375010|NCT02047110|564466783|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
156375011|NCT02047110|564466784|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
156375012|NCT02047110|564466781|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
156375013|NCT02047110|564466782|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
156375014|NCT02047110|564466783|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
156375015|NCT02047110|564466784|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
156375016|NCT02047110|564466781|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
156375017|NCT02047110|564466782|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
156375018|NCT02047110|564466783|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
156375019|NCT02047110|564466784|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
156375020|NCT02047110|564466781|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
156375021|NCT02047110|564466782|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
156546506|NCT01934556|565093402|FG000|Overall Study|Withdrawal by Subject|0|||
156546507|NCT01934556|565093403|FG001|Overall Study|Withdrawal by Subject|1|||
156546508|NCT01934556|565093404|FG002|Overall Study|Withdrawal by Subject|1|||
156546509|NCT01934556|565093402|FG000|Overall Study|Lost to Follow-up|4|||
156546510|NCT01934556|565093403|FG001|Overall Study|Lost to Follow-up|10|||
156546511|NCT01934556|565093404|FG002|Overall Study|Lost to Follow-up|7|||
156546512|NCT01934556|565093402|FG000|Overall Study|Death|1|||
156546513|NCT01934556|565093403|FG001|Overall Study|Death|5|||
156546514|NCT01934556|565093404|FG002|Overall Study|Death|2|||
156546515|NCT05038020|565093406|FG000|Overall Study|Early Termination|3|||
156546516|NCT05038020|565093407|FG001|Overall Study|Early Termination|0|||
156546517|NCT03416153|565093408|FG000|Overall Study|Physician Decision|1|||
156546518|NCT03416153|565093409|FG001|Overall Study|Physician Decision|1|||
156546519|NCT03416153|565093408|FG000|Overall Study|Withdrawal by Subject|1|||
156546520|NCT03416153|565093409|FG001|Overall Study|Withdrawal by Subject|0|||
156546521|NCT03770260|565094888|FG000|Overall Study|Disease progression|0|||
156375022|NCT02047110|564466783|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
156494362|NCT01502371|564904381|FG004|Overall Study|Technical Problems|1|||
156494363|NCT01502371|564904377|FG000|Overall Study|Protocol Violation|9|||
156494364|NCT01502371|564904378|FG001|Overall Study|Protocol Violation|5|||
156494365|NCT01502371|564904379|FG002|Overall Study|Protocol Violation|6|||
156494366|NCT01502371|564904380|FG003|Overall Study|Protocol Violation|5|||
156494367|NCT01502371|564904381|FG004|Overall Study|Protocol Violation|10|||
156494368|NCT01502371|564904377|FG000|Overall Study|Excluded Medication|0|||
156494369|NCT01502371|564904378|FG001|Overall Study|Excluded Medication|1|||
156494370|NCT01502371|564904379|FG002|Overall Study|Excluded Medication|1|||
156494371|NCT01502371|564904380|FG003|Overall Study|Excluded Medication|0|||
156494372|NCT01502371|564904381|FG004|Overall Study|Excluded Medication|1|||
156494373|NCT00514813|564904386|FG000|Overall Study|Study terminated|14|||
156494374|NCT00514813|564904387|FG001|Overall Study|Study terminated|74|||
156494375|NCT00514813|564904388|FG002|Overall Study|Study terminated|40|||
156494376|NCT00514813|564904389|FG003|Overall Study|Study terminated|2|||
156494377|NCT00514813|564904386|FG000|Overall Study|Adverse Event|0|||
156494378|NCT00514813|564904387|FG001|Overall Study|Adverse Event|2|||
156546522|NCT03770260|565094889|FG001|Overall Study|Disease progression|1|||
156546523|NCT03770260|565094890|FG002|Overall Study|Disease progression|0|||
156546524|NCT03770260|565094891|FG003|Overall Study|Disease progression|0|||
156546525|NCT01908101|565094898|FG000|Overall Study|Physician Decision|1|||
156546526|NCT01908101|565094898|FG000|Overall Study|Withdrawal by Subject|1|||
156546527|NCT01908101|565094898|FG000|Overall Study|Incorrect Diagnosis|2|||
156546528|NCT01908101|565094898|FG000|Overall Study|Incorrect Starting Dose|1|||
156546529|NCT01908101|565094898|FG000|Overall Study|Did not complete the first cycle|4|||
156375023|NCT02047110|564466784|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
156494379|NCT00514813|564904388|FG002|Overall Study|Adverse Event|2|||
156494380|NCT00514813|564904389|FG003|Overall Study|Adverse Event|0|||
156494381|NCT00514813|564904386|FG000|Overall Study|Protocol Violation|1|||
156546530|NCT00772954|565094900|FG000|Overall Study|Adverse Event|0|||
156494382|NCT00514813|564904387|FG001|Overall Study|Protocol Violation|0|||
156546531|NCT00772954|565094901|FG001|Overall Study|Adverse Event|0|||
156546532|NCT00772954|565094902|FG002|Overall Study|Adverse Event|1|||
156494383|NCT00514813|564904388|FG002|Overall Study|Protocol Violation|0|||
156546533|NCT01659320|565094907|FG000|Overall Study|Withdrawal by Subject|2|||
156546534|NCT01659320|565094907|FG000|Overall Study|Physician Decision|1|||
156546535|NCT00590590|565094908|FG000|Overall Study|Lack of Efficacy|1|||
156494384|NCT00514813|564904389|FG003|Overall Study|Protocol Violation|0|||
156494385|NCT00514813|564904386|FG000|Overall Study|Withdrawal by Subject|0|||
156494386|NCT00514813|564904387|FG001|Overall Study|Withdrawal by Subject|1|||
156494387|NCT00514813|564904388|FG002|Overall Study|Withdrawal by Subject|0|||
156494388|NCT00514813|564904389|FG003|Overall Study|Withdrawal by Subject|0|||
156494389|NCT00514813|564904386|FG000|Overall Study|Lack of Efficacy|0|||
156494390|NCT00514813|564904387|FG001|Overall Study|Lack of Efficacy|1|||
156494391|NCT00514813|564904388|FG002|Overall Study|Lack of Efficacy|0|||
156494392|NCT00514813|564904389|FG003|Overall Study|Lack of Efficacy|0|||
156494393|NCT00514813|564904386|FG000|Overall Study|Kidney transplant|0|||
156494394|NCT00514813|564904387|FG001|Overall Study|Kidney transplant|6|||
156494395|NCT00514813|564904388|FG002|Overall Study|Kidney transplant|2|||
156494396|NCT00514813|564904389|FG003|Overall Study|Kidney transplant|0|||
156494397|NCT00514813|564904386|FG000|Overall Study|Death|0|||
156494398|NCT00514813|564904387|FG001|Overall Study|Death|2|||
156494399|NCT00514813|564904388|FG002|Overall Study|Death|3|||
156494400|NCT00514813|564904389|FG003|Overall Study|Death|2|||
156494401|NCT01075100|564904394|FG000|Overall Study|Adverse Event|15|||
156494402|NCT01075100|564904395|FG001|Overall Study|Adverse Event|18|||
156494403|NCT01075100|564904394|FG000|Overall Study|Patient Request|4|||
156494404|NCT01075100|564904395|FG001|Overall Study|Patient Request|4|||
156494405|NCT01075100|564904394|FG000|Overall Study|Investigator Request|2|||
156494406|NCT01075100|564904395|FG001|Overall Study|Investigator Request|1|||
156494407|NCT01075100|564904394|FG000|Overall Study|Disease Progression|25|||
156546536|NCT00590590|565094909|FG001|Overall Study|Lack of Efficacy|2|||
156546537|NCT00590590|565094910|FG002|Overall Study|Lack of Efficacy|0|||
156546538|NCT00590590|565094908|FG000|Overall Study|Adverse Event|1|||
156546539|NCT00590590|565094909|FG001|Overall Study|Adverse Event|0|||
156546540|NCT00590590|565094910|FG002|Overall Study|Adverse Event|0|||
156546541|NCT00590590|565094908|FG000|Overall Study|Protocol Violation|0|||
156546542|NCT00590590|565094909|FG001|Overall Study|Protocol Violation|0|||
156546543|NCT00590590|565094910|FG002|Overall Study|Protocol Violation|2|||
156546544|NCT00590590|565094908|FG000|Overall Study|Lost to Follow-up|4|||
156546545|NCT00590590|565094909|FG001|Overall Study|Lost to Follow-up|1|||
156546546|NCT00590590|565094910|FG002|Overall Study|Lost to Follow-up|2|||
156546547|NCT00590590|565094908|FG000|Overall Study|Withdrawal by Subject|0|||
156546548|NCT00590590|565094909|FG001|Overall Study|Withdrawal by Subject|1|||
156546549|NCT00590590|565094910|FG002|Overall Study|Withdrawal by Subject|1|||
156546550|NCT00590590|565094908|FG000|Overall Study|Did not complete due to study closure|1|||
156546551|NCT00590590|565094909|FG001|Overall Study|Did not complete due to study closure|1|||
156546552|NCT00590590|565094910|FG002|Overall Study|Did not complete due to study closure|1|||
156546553|NCT00590590|565094908|FG000|Overall Study|Did not complete study|0|||
156546554|NCT00590590|565094909|FG001|Overall Study|Did not complete study|1|||
156546555|NCT00590590|565094910|FG002|Overall Study|Did not complete study|0|||
156546556|NCT00132132|565094911|FG000|Overall Study|Lost to Follow-up|7|||
156546557|NCT00132132|565094912|FG001|Overall Study|Lost to Follow-up|2|||
156546558|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
156546559|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
156546560|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
156546561|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
156546562|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
156546563|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
156546564|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
156546565|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
156546566|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
156546567|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
156546568|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
156546569|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
156546570|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
156546571|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
156546572|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
156546573|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
156546574|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
156546575|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
156546576|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
156494408|NCT01075100|564904395|FG001|Overall Study|Disease Progression|29|||
156494409|NCT01075100|564904394|FG000|Overall Study|Other|3|||
156494410|NCT01075100|564904395|FG001|Overall Study|Other|1|||
156494411|NCT04944784|564904396|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
156494412|NCT04944784|564904397|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
156494413|NCT04944784|564904398|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
156494414|NCT04944784|564904399|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
156494415|NCT04944784|564904396|FG000|Double-blind Period|Adverse Event|20|||
156494416|NCT04944784|564904397|FG001|Double-blind Period|Adverse Event|4|||
156494417|NCT04944784|564904398|FG002|Double-blind Period|Adverse Event|0|||
156494418|NCT04944784|564904399|FG003|Double-blind Period|Adverse Event|0|||
156494419|NCT04944784|564904396|FG000|Double-blind Period|Withdrawal by Subject|15|||
156494420|NCT04944784|564904397|FG001|Double-blind Period|Withdrawal by Subject|4|||
156494421|NCT04944784|564904398|FG002|Double-blind Period|Withdrawal by Subject|0|||
156494422|NCT04944784|564904399|FG003|Double-blind Period|Withdrawal by Subject|0|||
156494423|NCT04944784|564904396|FG000|Double-blind Period|Death|7|||
156494424|NCT04944784|564904397|FG001|Double-blind Period|Death|2|||
156494425|NCT04944784|564904398|FG002|Double-blind Period|Death|0|||
156494426|NCT04944784|564904399|FG003|Double-blind Period|Death|0|||
156494427|NCT04944784|564904396|FG000|Double-blind Period|Physician Decision|2|||
156494428|NCT04944784|564904397|FG001|Double-blind Period|Physician Decision|1|||
156494429|NCT04944784|564904398|FG002|Double-blind Period|Physician Decision|0|||
156494430|NCT04944784|564904399|FG003|Double-blind Period|Physician Decision|0|||
156494431|NCT04944784|564904396|FG000|Double-blind Period|Lack of Efficacy|0|||
156494432|NCT04944784|564904397|FG001|Double-blind Period|Lack of Efficacy|1|||
156494433|NCT04944784|564904398|FG002|Double-blind Period|Lack of Efficacy|0|||
156494434|NCT04944784|564904399|FG003|Double-blind Period|Lack of Efficacy|0|||
156494435|NCT04944784|564904396|FG000|Double-blind Period|Sponsor Request|2|||
156494436|NCT04944784|564904397|FG001|Double-blind Period|Sponsor Request|1|||
156494437|NCT04944784|564904398|FG002|Double-blind Period|Sponsor Request|0|||
156494438|NCT04944784|564904399|FG003|Double-blind Period|Sponsor Request|0|||
156494439|NCT04944784|564904396|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
156494440|NCT04944784|564904397|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
156494441|NCT04944784|564904398|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
156494442|NCT04944784|564904399|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
156494443|NCT04944784|564904396|FG000|Double-blind Period|Participant Choice|1|||
156494444|NCT04944784|564904397|FG001|Double-blind Period|Participant Choice|1|||
156494445|NCT04944784|564904398|FG002|Double-blind Period|Participant Choice|0|||
156494446|NCT04944784|564904399|FG003|Double-blind Period|Participant Choice|0|||
156494447|NCT04944784|564904396|FG000|Double-blind Period|Progressive Disease|2|||
156494448|NCT04944784|564904397|FG001|Double-blind Period|Progressive Disease|2|||
156494449|NCT04944784|564904398|FG002|Double-blind Period|Progressive Disease|0|||
156494450|NCT04944784|564904399|FG003|Double-blind Period|Progressive Disease|0|||
156494451|NCT04944784|564904396|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
156494452|NCT04944784|564904397|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
156494453|NCT04944784|564904398|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
156494454|NCT04944784|564904399|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
156494455|NCT04944784|564904396|FG000|Active Drug Period|Adverse Event|0|||
156494456|NCT04944784|564904397|FG001|Active Drug Period|Adverse Event|0|||
156494457|NCT04944784|564904398|FG002|Active Drug Period|Adverse Event|3|||
156494458|NCT04944784|564904399|FG003|Active Drug Period|Adverse Event|6|||
156494459|NCT04944784|564904396|FG000|Active Drug Period|Withdrawal by Subject|0|||
156494460|NCT04944784|564904397|FG001|Active Drug Period|Withdrawal by Subject|0|||
156494461|NCT04944784|564904398|FG002|Active Drug Period|Withdrawal by Subject|4|||
156494462|NCT04944784|564904399|FG003|Active Drug Period|Withdrawal by Subject|7|||
156494463|NCT04944784|564904396|FG000|Active Drug Period|Death|0|||
156494464|NCT04944784|564904397|FG001|Active Drug Period|Death|0|||
156494465|NCT04944784|564904398|FG002|Active Drug Period|Death|3|||
156494466|NCT04944784|564904399|FG003|Active Drug Period|Death|4|||
156494467|NCT04944784|564904396|FG000|Active Drug Period|Lack of Efficacy|0|||
156494468|NCT04944784|564904397|FG001|Active Drug Period|Lack of Efficacy|0|||
156494469|NCT04944784|564904398|FG002|Active Drug Period|Lack of Efficacy|2|||
156494470|NCT04944784|564904399|FG003|Active Drug Period|Lack of Efficacy|2|||
156494471|NCT04944784|564904396|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
156494472|NCT04944784|564904397|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
156494473|NCT04944784|564904398|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
156494474|NCT04944784|564904399|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
156494475|NCT04944784|564904396|FG000|Active Drug Period|Participant Choice|0|||
156494476|NCT04944784|564904397|FG001|Active Drug Period|Participant Choice|0|||
156494477|NCT04944784|564904398|FG002|Active Drug Period|Participant Choice|0|||
156494478|NCT04944784|564904399|FG003|Active Drug Period|Participant Choice|1|||
156494479|NCT04944784|564904396|FG000|Active Drug Period|Progressive Disease|0|||
156494480|NCT04944784|564904397|FG001|Active Drug Period|Progressive Disease|0|||
156494481|NCT04944784|564904398|FG002|Active Drug Period|Progressive Disease|4|||
156494482|NCT04944784|564904399|FG003|Active Drug Period|Progressive Disease|4|||
156494483|NCT04944784|564904396|FG000|Active Drug Period|Lost to Follow-up|0|||
156494484|NCT04944784|564904397|FG001|Active Drug Period|Lost to Follow-up|0|||
156494485|NCT04944784|564904398|FG002|Active Drug Period|Lost to Follow-up|0|||
156494486|NCT04944784|564904399|FG003|Active Drug Period|Lost to Follow-up|1|||
156494487|NCT01722045|564906112|FG000|Overall Study|Adverse Event|8|||
156494488|NCT01722045|564906112|FG000|Overall Study|Death|3|||
156494489|NCT01722045|564906112|FG000|Overall Study|Withdrawal by Subject|8|||
156494490|NCT01722045|564906112|FG000|Overall Study|Lost to Follow-up|4|||
156494491|NCT01722045|564906112|FG000|Overall Study|Protocol Deviation|1|||
156494492|NCT01722045|564906112|FG000|Overall Study|Physician Decision|3|||
156494493|NCT01722045|564906112|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
156494494|NCT01053247|564906113|FG000|Overall Study|Withdrawal by Subject|9|||
156494495|NCT01053247|564906114|FG001|Overall Study|Withdrawal by Subject|4|||
156494496|NCT01053247|564906115|FG002|Overall Study|Withdrawal by Subject|15|||
156494497|NCT01053247|564906113|FG000|Overall Study|Lack of Efficacy|1|||
156494498|NCT01053247|564906114|FG001|Overall Study|Lack of Efficacy|0|||
156494499|NCT01053247|564906115|FG002|Overall Study|Lack of Efficacy|1|||
156494500|NCT01053247|564906113|FG000|Overall Study|Protocol Violation|2|||
156494501|NCT01053247|564906114|FG001|Overall Study|Protocol Violation|1|||
156494502|NCT01053247|564906115|FG002|Overall Study|Protocol Violation|2|||
156494503|NCT01053247|564906113|FG000|Overall Study|Lost to Follow-up|8|||
156494504|NCT01053247|564906114|FG001|Overall Study|Lost to Follow-up|5|||
156494505|NCT01053247|564906115|FG002|Overall Study|Lost to Follow-up|7|||
156494506|NCT01053247|564906113|FG000|Overall Study|Adverse Event|0|||
156494507|NCT01053247|564906114|FG001|Overall Study|Adverse Event|9|||
156494508|NCT01053247|564906115|FG002|Overall Study|Adverse Event|3|||
156494509|NCT03602586|564906116|FG000|Overall Study|Withdrawal by Subject|3|||
156494510|NCT01755546|564906119|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
156494511|NCT01755546|564906119|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
156494512|NCT01755546|564906119|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
156494513|NCT01755546|564906119|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
156494514|NCT01755546|564906119|FG000|Titration Phase|Adverse Event|11|||
156494515|NCT01755546|564906119|FG000|Titration Phase|Lack of Efficacy|18|||
156494516|NCT01755546|564906119|FG000|Titration Phase|Protocol Violation|9|||
156494517|NCT01755546|564906119|FG000|Titration Phase|Lost to Follow-up|2|||
156494518|NCT01755546|564906119|FG000|Titration Phase|Other and Continuing|22|||
156494519|NCT01755546|564906119|FG000|Titration Phase|Withdrawal by Subject|8|||
156494520|NCT01755546|564906119|FG000|Long Term Treatment|Adverse Event|12|||
156494521|NCT01755546|564906119|FG000|Long Term Treatment|Lack of Efficacy|6|||
156494522|NCT01755546|564906119|FG000|Long Term Treatment|Protocol Violation|10|||
156494523|NCT01755546|564906119|FG000|Long Term Treatment|Withdrawal by Subject|35|||
156494524|NCT01755546|564906119|FG000|Long Term Treatment|Lost to Follow-up|17|||
156494525|NCT01755546|564906119|FG000|Long Term Treatment|other and ongoing|41|||
156494526|NCT00891046|564906120|FG000|Overall Study|Protocol Violation|1|||
156494527|NCT00891046|564906121|FG001|Overall Study|Protocol Violation|1|||
156494528|NCT00891046|564906122|FG002|Overall Study|Protocol Violation|0|||
156494529|NCT00891046|564906123|FG003|Overall Study|Protocol Violation|0|||
156494530|NCT00891046|564906124|FG004|Overall Study|Protocol Violation|1|||
156494531|NCT00891046|564906120|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
156494532|NCT00891046|564906121|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156494533|NCT00891046|564906122|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
156494534|NCT00891046|564906123|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
156494535|NCT00891046|564906124|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
156494536|NCT00891046|564906120|FG000|Overall Study|Administrative problems|0|||
156494537|NCT00891046|564906121|FG001|Overall Study|Administrative problems|0|||
156494538|NCT00891046|564906122|FG002|Overall Study|Administrative problems|0|||
156494539|NCT00891046|564906123|FG003|Overall Study|Administrative problems|0|||
156494540|NCT00891046|564906124|FG004|Overall Study|Administrative problems|1|||
156494541|NCT00891046|564906120|FG000|Overall Study|Participant no longer required drug|0|||
156494542|NCT00891046|564906121|FG001|Overall Study|Participant no longer required drug|2|||
156494543|NCT00891046|564906122|FG002|Overall Study|Participant no longer required drug|0|||
156494544|NCT00891046|564906123|FG003|Overall Study|Participant no longer required drug|0|||
156494545|NCT00891046|564906124|FG004|Overall Study|Participant no longer required drug|1|||
156494546|NCT00891046|564906120|FG000|Overall Study|Adverse Event|4|||
156494547|NCT00891046|564906121|FG001|Overall Study|Adverse Event|3|||
156494548|NCT00891046|564906122|FG002|Overall Study|Adverse Event|2|||
156494549|NCT00891046|564906123|FG003|Overall Study|Adverse Event|0|||
156494550|NCT00891046|564906124|FG004|Overall Study|Adverse Event|14|||
156494551|NCT00891046|564906120|FG000|Overall Study|Withdrawal by Subject|2|||
156494552|NCT00891046|564906121|FG001|Overall Study|Withdrawal by Subject|1|||
156494553|NCT00891046|564906122|FG002|Overall Study|Withdrawal by Subject|2|||
156494554|NCT00891046|564906123|FG003|Overall Study|Withdrawal by Subject|1|||
156494555|NCT00891046|564906124|FG004|Overall Study|Withdrawal by Subject|1|||
156494556|NCT00891046|564906120|FG000|Overall Study|Lost to Follow-up|0|||
156494557|NCT00891046|564906121|FG001|Overall Study|Lost to Follow-up|0|||
156494558|NCT00891046|564906122|FG002|Overall Study|Lost to Follow-up|0|||
156494559|NCT00891046|564906123|FG003|Overall Study|Lost to Follow-up|0|||
156494560|NCT00891046|564906124|FG004|Overall Study|Lost to Follow-up|1|||
156494561|NCT00362375|564906125|FG000|Overall Study|Lost to Follow-up|40|||
156494562|NCT00362375|564906126|FG001|Overall Study|Lost to Follow-up|35|||
156494563|NCT02106195|564906127|FG000|Overall Study|Adverse Event|2|||
156494564|NCT02106195|564906127|FG000|Overall Study|Protocol Violation|1|||
156494565|NCT04984239|564906128|FG000|Overall Study|Lost to Follow-up|1|||
156494566|NCT03294941|564906129|FG000|Overall Study|Withdrawal by Subject|0|||
156494567|NCT03294941|564906130|FG001|Overall Study|Withdrawal by Subject|2|||
156494568|NCT04629443|564906131|FG000|Overall Study|Adverse Event|2|||
156375024|NCT02047110|564466781|FG000|Escape Treatment Period|Adverse Event|1|||
156375025|NCT02047110|564466782|FG001|Escape Treatment Period|Adverse Event|2|||
156375026|NCT02047110|564466783|FG002|Escape Treatment Period|Adverse Event|2|||
156375027|NCT02047110|564466784|FG003|Escape Treatment Period|Adverse Event|0|||
156375028|NCT02047110|564466781|FG000|Escape Treatment Period|Other than specified|1|||
156375029|NCT02047110|564466782|FG001|Escape Treatment Period|Other than specified|2|||
156375030|NCT02047110|564466783|FG002|Escape Treatment Period|Other than specified|0|||
156375031|NCT02047110|564466784|FG003|Escape Treatment Period|Other than specified|1|||
156375032|NCT02047110|564466781|FG000|OLE Treatment Period|Other than specified|0|||
156375033|NCT02047110|564466782|FG001|OLE Treatment Period|Other than specified|0|||
156375034|NCT02047110|564466783|FG002|OLE Treatment Period|Other than specified|1|||
156375035|NCT02047110|564466784|FG003|OLE Treatment Period|Other than specified|0|||
156375036|NCT02802345|564466788|FG000|Overall Study|Not Treated|0|||
156375037|NCT02802345|564466789|FG001|Overall Study|Not Treated|1|||
156375038|NCT02802345|564466788|FG000|Overall Study|Adverse Event|28|||
156375039|NCT02802345|564466789|FG001|Overall Study|Adverse Event|20|||
156375040|NCT02802345|564466788|FG000|Overall Study|Withdrawal by Subject|3|||
156375041|NCT02802345|564466789|FG001|Overall Study|Withdrawal by Subject|3|||
156375042|NCT02802345|564466788|FG000|Overall Study|Protocol Violation|0|||
156375043|NCT02802345|564466789|FG001|Overall Study|Protocol Violation|1|||
156375044|NCT02802345|564466788|FG000|Overall Study|Other than listed|1|||
156375045|NCT02802345|564466789|FG001|Overall Study|Other than listed|5|||
156375046|NCT02075320|564466790|FG000|Overall Study|Withdrawal by Subject|2|||
156375047|NCT00057746|564466792|FG000|Overall Study|Withdrawal by Subject|0|||
156375048|NCT00057746|564466793|FG001|Overall Study|Withdrawal by Subject|0|||
156375049|NCT00057746|564466794|FG002|Overall Study|Withdrawal by Subject|1|||
156375050|NCT00600821|564468350|FG000|Overall Study|Death|45|||
156375051|NCT00600821|564468351|FG001|Overall Study|Death|46|||
156375052|NCT00600821|564468350|FG000|Overall Study|Lost to Follow-up|2|||
156375053|NCT00600821|564468351|FG001|Overall Study|Lost to Follow-up|2|||
156375054|NCT00600821|564468350|FG000|Overall Study|Withdrawal by Subject|1|||
156375055|NCT00600821|564468351|FG001|Overall Study|Withdrawal by Subject|1|||
156375056|NCT00600821|564468350|FG000|Overall Study|Terminated by sponsor|8|||
156375057|NCT00600821|564468351|FG001|Overall Study|Terminated by sponsor|6|||
156375058|NCT00600821|564468350|FG000|Overall Study|Objective progression or relapse|0|||
156375059|NCT00600821|564468351|FG001|Overall Study|Objective progression or relapse|1|||
156375060|NCT00600821|564468350|FG000|Overall Study|Randomized but not treated|0|||
156375061|NCT00600821|564468351|FG001|Overall Study|Randomized but not treated|1|||
156375062|NCT00600821|564468350|FG000|Overall Study|Other|2|||
156375063|NCT00600821|564468351|FG001|Overall Study|Other|3|||
156375064|NCT01076400|564468355|FG000|Overall Study|Adverse Event|2|||
156375065|NCT01076400|564468356|FG001|Overall Study|Adverse Event|0|||
156375066|NCT01076400|564468357|FG002|Overall Study|Adverse Event|0|||
156375067|NCT01076400|564468355|FG000|Overall Study|Progressive Disease|5|||
156375068|NCT01076400|564468356|FG001|Overall Study|Progressive Disease|0|||
156375069|NCT01076400|564468357|FG002|Overall Study|Progressive Disease|0|||
156375070|NCT02766608|564468358|FG000|Overall Study|Adverse Event|27|||
156375071|NCT02766608|564468359|FG001|Overall Study|Adverse Event|22|||
156375072|NCT02766608|564468360|FG002|Overall Study|Adverse Event|17|||
156375073|NCT02766608|564468361|FG003|Overall Study|Adverse Event|13|||
156375074|NCT02766608|564468362|FG004|Overall Study|Adverse Event|12|||
156375075|NCT02766608|564468358|FG000|Overall Study|Withdrawal by Subject|21|||
156375076|NCT02766608|564468359|FG001|Overall Study|Withdrawal by Subject|20|||
156375077|NCT02766608|564468360|FG002|Overall Study|Withdrawal by Subject|24|||
156375078|NCT02766608|564468361|FG003|Overall Study|Withdrawal by Subject|13|||
156375079|NCT02766608|564468362|FG004|Overall Study|Withdrawal by Subject|10|||
156375080|NCT02766608|564468358|FG000|Overall Study|Lack of Efficacy|16|||
156375081|NCT02766608|564468359|FG001|Overall Study|Lack of Efficacy|15|||
156375082|NCT02766608|564468360|FG002|Overall Study|Lack of Efficacy|32|||
156375083|NCT02766608|564468361|FG003|Overall Study|Lack of Efficacy|8|||
156494569|NCT04629443|564906132|FG001|Overall Study|Adverse Event|1|||
156494570|NCT04629443|564906133|FG002|Overall Study|Adverse Event|2|||
156494571|NCT04629443|564906131|FG000|Overall Study|Progressive Disease|2|||
156494572|NCT04629443|564906132|FG001|Overall Study|Progressive Disease|3|||
156375084|NCT02766608|564468362|FG004|Overall Study|Lack of Efficacy|2|||
156375085|NCT02766608|564468358|FG000|Overall Study|Lost to Follow-up|6|||
156375086|NCT02766608|564468359|FG001|Overall Study|Lost to Follow-up|3|||
156375087|NCT02766608|564468360|FG002|Overall Study|Lost to Follow-up|5|||
156375088|NCT02766608|564468361|FG003|Overall Study|Lost to Follow-up|2|||
156375089|NCT02766608|564468362|FG004|Overall Study|Lost to Follow-up|2|||
156375090|NCT02766608|564468358|FG000|Overall Study|Physician Decision|3|||
156375091|NCT02766608|564468359|FG001|Overall Study|Physician Decision|2|||
156375092|NCT02766608|564468360|FG002|Overall Study|Physician Decision|3|||
156375093|NCT02766608|564468361|FG003|Overall Study|Physician Decision|1|||
156494573|NCT04629443|564906133|FG002|Overall Study|Progressive Disease|3|||
156375094|NCT02766608|564468362|FG004|Overall Study|Physician Decision|2|||
156375095|NCT02766608|564468358|FG000|Overall Study|Protocol disc criteria|3|||
156375096|NCT02766608|564468359|FG001|Overall Study|Protocol disc criteria|3|||
156494574|NCT04629443|564906131|FG000|Overall Study|Physician Decision|1|||
156494575|NCT04629443|564906132|FG001|Overall Study|Physician Decision|3|||
156494576|NCT04629443|564906133|FG002|Overall Study|Physician Decision|0|||
156494577|NCT00916305|564906139|FG000|Overall Study|Lost to Follow-up|21|||
156494578|NCT00916305|564906140|FG001|Overall Study|Lost to Follow-up|27|||
156494579|NCT00916305|564906139|FG000|Overall Study|Withdrawal by Subject|0|||
156494580|NCT00916305|564906140|FG001|Overall Study|Withdrawal by Subject|1|||
156494581|NCT01844726|564906141|FG000|Overall Study|Withdrawal by Subject|0|||
156494582|NCT01844726|564906142|FG001|Overall Study|Withdrawal by Subject|1|||
156494583|NCT01844726|564906141|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
156494584|NCT01844726|564906142|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
156494585|NCT00858247|564906147|FG000|Baseline Assessment|Withdrawal by Subject|1|||
156494586|NCT00858247|564906148|FG001|Baseline Assessment|Withdrawal by Subject|1|||
156494587|NCT00858247|564906147|FG000|Baseline Assessment|Poor IV access|1|||
156494588|NCT00858247|564906148|FG001|Baseline Assessment|Poor IV access|0|||
156494589|NCT00858247|564906147|FG000|Baseline Assessment|Protocol Violation|0|||
156494590|NCT00858247|564906148|FG001|Baseline Assessment|Protocol Violation|1|||
156494591|NCT00858247|564906147|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
156494592|NCT00858247|564906148|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
156494593|NCT01379703|564906149|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
156494594|NCT01379703|564906150|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
156494595|NCT01379703|564906151|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
156494596|NCT01379703|564906149|FG000|Study Start Through 9 Months|Adverse Event|0|||
156494597|NCT01379703|564906150|FG001|Study Start Through 9 Months|Adverse Event|14|||
156494598|NCT01379703|564906151|FG002|Study Start Through 9 Months|Adverse Event|10|||
156494599|NCT01379703|564906149|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
156494600|NCT01379703|564906150|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
156494601|NCT01379703|564906151|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
156494602|NCT01379703|564906149|FG000|Study Start Through 9 Months|Treatment Failure|0|||
156494603|NCT01379703|564906150|FG001|Study Start Through 9 Months|Treatment Failure|2|||
156494604|NCT01379703|564906151|FG002|Study Start Through 9 Months|Treatment Failure|2|||
156494605|NCT01379703|564906149|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
156494606|NCT01379703|564906150|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
156494607|NCT01379703|564906151|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
156494608|NCT01379703|564906149|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
156494609|NCT01379703|564906150|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
156494610|NCT01379703|564906151|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
156494611|NCT01379703|564906149|FG000|Study Start Through 9 Months|Medication not available|0|||
156494612|NCT01379703|564906150|FG001|Study Start Through 9 Months|Medication not available|2|||
156494613|NCT01379703|564906151|FG002|Study Start Through 9 Months|Medication not available|1|||
156494614|NCT01379703|564906149|FG000|Study Start Through 9 Months|Poor general condition|0|||
156494615|NCT01379703|564906150|FG001|Study Start Through 9 Months|Poor general condition|1|||
156494616|NCT01379703|564906151|FG002|Study Start Through 9 Months|Poor general condition|0|||
156494617|NCT01379703|564906149|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
156494618|NCT01379703|564906150|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
156494619|NCT01379703|564906151|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
156494620|NCT01379703|564906149|FG000|Study Start Through 9 Months|Reason unknown|2|||
156494621|NCT01379703|564906150|FG001|Study Start Through 9 Months|Reason unknown|31|||
156494622|NCT01379703|564906151|FG002|Study Start Through 9 Months|Reason unknown|24|||
156494623|NCT01379703|564906149|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
156494624|NCT01379703|564906150|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
156494625|NCT01379703|564906151|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
156494626|NCT01379703|564906149|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
156494627|NCT01379703|564906150|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
156494628|NCT01379703|564906151|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
156494629|NCT01379703|564906149|FG000|9 Months Through 18 Months|Adverse Event|0|||
156494630|NCT01379703|564906150|FG001|9 Months Through 18 Months|Adverse Event|6|||
156494631|NCT01379703|564906151|FG002|9 Months Through 18 Months|Adverse Event|0|||
156494632|NCT01379703|564906149|FG000|9 Months Through 18 Months|Treatment failure|0|||
156494633|NCT01379703|564906150|FG001|9 Months Through 18 Months|Treatment failure|5|||
156494634|NCT01379703|564906151|FG002|9 Months Through 18 Months|Treatment failure|0|||
156494635|NCT01379703|564906149|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
156494636|NCT01379703|564906150|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
156494637|NCT01379703|564906151|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
156375097|NCT02766608|564468360|FG002|Overall Study|Protocol disc criteria|4|||
156375098|NCT02766608|564468361|FG003|Overall Study|Protocol disc criteria|0|||
156494638|NCT01379703|564906149|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
156494639|NCT01379703|564906150|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
156494640|NCT01379703|564906151|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
156494641|NCT01379703|564906149|FG000|9 Months Through 18 Months|Fatigue|0|||
156494642|NCT01379703|564906150|FG001|9 Months Through 18 Months|Fatigue|1|||
156375099|NCT02766608|564468362|FG004|Overall Study|Protocol disc criteria|0|||
156375100|NCT02766608|564468358|FG000|Overall Study|Protocol Violation|0|||
156375101|NCT02766608|564468359|FG001|Overall Study|Protocol Violation|4|||
156375102|NCT02766608|564468360|FG002|Overall Study|Protocol Violation|4|||
156375103|NCT02766608|564468361|FG003|Overall Study|Protocol Violation|0|||
156375104|NCT02766608|564468362|FG004|Overall Study|Protocol Violation|1|||
156375105|NCT02766608|564468358|FG000|Overall Study|Administrative Reasons|3|||
156375106|NCT02766608|564468359|FG001|Overall Study|Administrative Reasons|1|||
156375107|NCT02766608|564468360|FG002|Overall Study|Administrative Reasons|1|||
156375108|NCT02766608|564468361|FG003|Overall Study|Administrative Reasons|0|||
156375109|NCT02766608|564468362|FG004|Overall Study|Administrative Reasons|0|||
156375110|NCT03019536|564468363|FG000|Overall Study|Withdrawal by Subject|1|||
156375111|NCT03019536|564468364|FG001|Overall Study|Withdrawal by Subject|1|||
156375112|NCT03019536|564468365|FG002|Overall Study|Withdrawal by Subject|0|||
156375113|NCT03019536|564468363|FG000|Overall Study|Adverse Event|0|||
156375114|NCT03019536|564468364|FG001|Overall Study|Adverse Event|0|||
156375115|NCT03019536|564468365|FG002|Overall Study|Adverse Event|2|||
156375116|NCT01265953|564468366|FG000|Overall Study|Non compliance|5|||
156375117|NCT01265953|564468367|FG001|Overall Study|Non compliance|3|||
156375118|NCT02391948|564468368|FG000|6-month Assessment|Death|0|||
156375119|NCT02391948|564468369|FG001|6-month Assessment|Death|0|||
156375120|NCT02391948|564468370|FG002|6-month Assessment|Death|0|||
156375121|NCT02391948|564468371|FG003|6-month Assessment|Death|0|||
156375122|NCT02391948|564468372|FG004|6-month Assessment|Death|1|||
156375123|NCT02391948|564468368|FG000|6-month Assessment|Withdrawal by Subject|0|||
156375124|NCT02391948|564468369|FG001|6-month Assessment|Withdrawal by Subject|0|||
156375125|NCT02391948|564468370|FG002|6-month Assessment|Withdrawal by Subject|1|||
156375126|NCT02391948|564468371|FG003|6-month Assessment|Withdrawal by Subject|2|||
156375127|NCT02391948|564468372|FG004|6-month Assessment|Withdrawal by Subject|0|||
156375128|NCT02391948|564468368|FG000|6-month Assessment|Lost to Follow-up|4|||
156375129|NCT02391948|564468369|FG001|6-month Assessment|Lost to Follow-up|5|||
156375130|NCT02391948|564468370|FG002|6-month Assessment|Lost to Follow-up|2|||
156375131|NCT02391948|564468371|FG003|6-month Assessment|Lost to Follow-up|3|||
156375132|NCT02391948|564468372|FG004|6-month Assessment|Lost to Follow-up|1|||
156375133|NCT02391948|564468368|FG000|6-month Assessment|Medical issue/illness|1|||
156375134|NCT02391948|564468369|FG001|6-month Assessment|Medical issue/illness|1|||
156375135|NCT02391948|564468370|FG002|6-month Assessment|Medical issue/illness|0|||
156375136|NCT02391948|564468371|FG003|6-month Assessment|Medical issue/illness|0|||
156375137|NCT02391948|564468372|FG004|6-month Assessment|Medical issue/illness|0|||
156375138|NCT02391948|564468368|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
156375139|NCT02391948|564468369|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
156375140|NCT02391948|564468370|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
156375141|NCT02391948|564468371|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
156375142|NCT02391948|564468372|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
156375143|NCT02391948|564468368|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
156375144|NCT02391948|564468369|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
156375145|NCT02391948|564468370|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
156375146|NCT02391948|564468371|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
156375147|NCT02391948|564468372|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
156375148|NCT02391948|564468368|FG000|12-month Assessment|Death|0|||
156375149|NCT02391948|564468369|FG001|12-month Assessment|Death|0|||
156375150|NCT02391948|564468370|FG002|12-month Assessment|Death|0|||
156375151|NCT02391948|564468371|FG003|12-month Assessment|Death|1|||
156375152|NCT02391948|564468372|FG004|12-month Assessment|Death|0|||
156375153|NCT02391948|564468368|FG000|12-month Assessment|Withdrawal by Subject|1|||
156375154|NCT02391948|564468369|FG001|12-month Assessment|Withdrawal by Subject|0|||
156375155|NCT02391948|564468370|FG002|12-month Assessment|Withdrawal by Subject|0|||
156375156|NCT02391948|564468371|FG003|12-month Assessment|Withdrawal by Subject|1|||
156375157|NCT02391948|564468372|FG004|12-month Assessment|Withdrawal by Subject|0|||
156375158|NCT02391948|564468368|FG000|12-month Assessment|Lost to Follow-up|5|||
156375159|NCT02391948|564468369|FG001|12-month Assessment|Lost to Follow-up|4|||
156375160|NCT02391948|564468370|FG002|12-month Assessment|Lost to Follow-up|4|||
156494643|NCT01379703|564906151|FG002|9 Months Through 18 Months|Fatigue|0|||
156494644|NCT01379703|564906149|FG000|9 Months Through 18 Months|Reason Unknown|0|||
156494645|NCT01379703|564906150|FG001|9 Months Through 18 Months|Reason Unknown|23|||
156494646|NCT01379703|564906151|FG002|9 Months Through 18 Months|Reason Unknown|0|||
156494647|NCT03481556|564906152|FG000|Overall Study|Adverse Event|1|||
156494648|NCT03481556|564906153|FG001|Overall Study|Adverse Event|0|||
156375161|NCT02391948|564468371|FG003|12-month Assessment|Lost to Follow-up|4|||
156375162|NCT02391948|564468372|FG004|12-month Assessment|Lost to Follow-up|5|||
156375163|NCT02391948|564468368|FG000|12-month Assessment|Medical issue/illness|0|||
156375164|NCT02391948|564468369|FG001|12-month Assessment|Medical issue/illness|1|||
156375165|NCT02391948|564468370|FG002|12-month Assessment|Medical issue/illness|0|||
156375166|NCT02391948|564468371|FG003|12-month Assessment|Medical issue/illness|1|||
156375167|NCT02391948|564468372|FG004|12-month Assessment|Medical issue/illness|0|||
156494649|NCT03481556|564906154|FG002|Overall Study|Adverse Event|0|||
156546577|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
156546578|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
156546579|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
156546580|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
156546581|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
156546582|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
156546583|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
156546584|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
156546585|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
156546586|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
156546587|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
156546588|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
156546589|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
156546590|NCT03605680|565094915|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
156546591|NCT03605680|565094916|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
156546592|NCT03605680|565094917|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
156546593|NCT03605680|565094918|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
156546594|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
156546595|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
156546596|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
156546597|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
156494650|NCT03481556|564906155|FG003|Overall Study|Adverse Event|0|||
156494651|NCT03481556|564906152|FG000|Overall Study|Death|4|||
156494652|NCT03481556|564906153|FG001|Overall Study|Death|2|||
156494653|NCT03481556|564906154|FG002|Overall Study|Death|3|||
156494654|NCT03481556|564906155|FG003|Overall Study|Death|16|||
156494655|NCT03481556|564906152|FG000|Overall Study|Study Terminated by Sponsor|10|||
156494656|NCT03481556|564906153|FG001|Overall Study|Study Terminated by Sponsor|5|||
156494657|NCT03481556|564906154|FG002|Overall Study|Study Terminated by Sponsor|2|||
156494658|NCT03481556|564906155|FG003|Overall Study|Study Terminated by Sponsor|9|||
156494659|NCT01101997|564906156|FG000|Overall Study|Withdrawal by Subject|2|||
156494660|NCT01172639|564906157|FG000|Overall Study|Death|1|||
156494661|NCT01172639|564906158|FG001|Overall Study|Death|1|||
156494662|NCT01172639|564906159|FG002|Overall Study|Death|0|||
156494663|NCT01172639|564906160|FG003|Overall Study|Death|0|||
156494664|NCT01172639|564906161|FG004|Overall Study|Death|0|||
156494665|NCT01172639|564906157|FG000|Overall Study|Lost to Follow-up|9|||
156494666|NCT01172639|564906158|FG001|Overall Study|Lost to Follow-up|7|||
156494667|NCT01172639|564906159|FG002|Overall Study|Lost to Follow-up|11|||
156494668|NCT01172639|564906160|FG003|Overall Study|Lost to Follow-up|6|||
156494669|NCT01172639|564906161|FG004|Overall Study|Lost to Follow-up|6|||
156494670|NCT01172639|564906157|FG000|Overall Study|Withdrawal by Subject|3|||
156494671|NCT01172639|564906158|FG001|Overall Study|Withdrawal by Subject|3|||
156494672|NCT01172639|564906159|FG002|Overall Study|Withdrawal by Subject|5|||
156494673|NCT01172639|564906160|FG003|Overall Study|Withdrawal by Subject|5|||
156494674|NCT01172639|564906161|FG004|Overall Study|Withdrawal by Subject|0|||
156494675|NCT02172950|564906162|FG000|Overall Study|Physician Decision|3|||
156494676|NCT02172950|564906163|FG001|Overall Study|Physician Decision|3|||
156494677|NCT02172950|564906162|FG000|Overall Study|Lack of Efficacy|1|||
156494678|NCT02172950|564906163|FG001|Overall Study|Lack of Efficacy|0|||
156494679|NCT02172950|564906162|FG000|Overall Study|Adverse Event|4|||
156494680|NCT02172950|564906163|FG001|Overall Study|Adverse Event|1|||
156494681|NCT02172950|564906162|FG000|Overall Study|Withdrawal by Subject|10|||
156494682|NCT02172950|564906163|FG001|Overall Study|Withdrawal by Subject|0|||
156494683|NCT02172950|564906162|FG000|Overall Study|Protocol Violation|1|||
156494684|NCT02172950|564906163|FG001|Overall Study|Protocol Violation|0|||
156494685|NCT02172950|564906162|FG000|Overall Study|Lost to Follow-up|1|||
156494686|NCT02172950|564906163|FG001|Overall Study|Lost to Follow-up|0|||
156494687|NCT02172950|564906162|FG000|Overall Study|Death|1|||
156494688|NCT02172950|564906163|FG001|Overall Study|Death|0|||
156494689|NCT02172950|564906162|FG000|Overall Study|Patient traveling|1|||
156494690|NCT02172950|564906163|FG001|Overall Study|Patient traveling|0|||
156494691|NCT02172950|564906162|FG000|Overall Study|Patient went to other country|1|||
156494692|NCT02172950|564906163|FG001|Overall Study|Patient went to other country|0|||
156494693|NCT02172950|564906162|FG000|Overall Study|Patient relocated overseas|1|||
156494694|NCT02172950|564906163|FG001|Overall Study|Patient relocated overseas|1|||
156494695|NCT02172950|564906162|FG000|Overall Study|Patient moving|1|||
156494696|NCT02172950|564906163|FG001|Overall Study|Patient moving|0|||
156494697|NCT01086384|564906169|FG000|2-week Run-in Period|Adverse Event|1|||
156494698|NCT01086384|564906170|FG001|2-week Run-in Period|Adverse Event|0|||
156494699|NCT01086384|564906171|FG002|2-week Run-in Period|Adverse Event|0|||
156494700|NCT01086384|564906169|FG000|2-week Run-in Period|Protocol Violation|1|||
156494701|NCT01086384|564906170|FG001|2-week Run-in Period|Protocol Violation|0|||
156494702|NCT01086384|564906171|FG002|2-week Run-in Period|Protocol Violation|0|||
156494703|NCT01086384|564906169|FG000|2-week Run-in Period|Lost to Follow-up|1|||
156494704|NCT01086384|564906170|FG001|2-week Run-in Period|Lost to Follow-up|0|||
156494705|NCT01086384|564906171|FG002|2-week Run-in Period|Lost to Follow-up|0|||
156494706|NCT01086384|564906169|FG000|2-week Run-in Period|Physician Decision|6|||
156494707|NCT01086384|564906170|FG001|2-week Run-in Period|Physician Decision|0|||
156494708|NCT01086384|564906171|FG002|2-week Run-in Period|Physician Decision|0|||
156494709|NCT01086384|564906169|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
156494710|NCT01086384|564906170|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156494711|NCT01086384|564906171|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156494712|NCT01086384|564906169|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
156494713|NCT01086384|564906170|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
156494714|NCT01086384|564906171|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
156494715|NCT01086384|564906169|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
156494716|NCT01086384|564906170|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
156494717|NCT01086384|564906171|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
156494718|NCT01086384|564906169|FG000|2-week Run-in Period|Randomized in Error|1|||
156494719|NCT01086384|564906170|FG001|2-week Run-in Period|Randomized in Error|0|||
156494720|NCT01086384|564906171|FG002|2-week Run-in Period|Randomized in Error|0|||
156494721|NCT01086384|564906169|FG000|Treatment Period|Withdrawal by Subject|0|||
156494722|NCT01086384|564906170|FG001|Treatment Period|Withdrawal by Subject|53|||
156494723|NCT01086384|564906171|FG002|Treatment Period|Withdrawal by Subject|55|||
156494724|NCT01086384|564906169|FG000|Treatment Period|Protocol Violation|0|||
156375168|NCT02391948|564468368|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
156375169|NCT02391948|564468369|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
156494725|NCT01086384|564906170|FG001|Treatment Period|Protocol Violation|26|||
156494726|NCT01086384|564906171|FG002|Treatment Period|Protocol Violation|17|||
156494727|NCT01086384|564906169|FG000|Treatment Period|Lack of Efficacy|0|||
156494728|NCT01086384|564906170|FG001|Treatment Period|Lack of Efficacy|22|||
156494729|NCT01086384|564906171|FG002|Treatment Period|Lack of Efficacy|13|||
156494730|NCT01086384|564906169|FG000|Treatment Period|Adverse Event|0|||
156494731|NCT01086384|564906170|FG001|Treatment Period|Adverse Event|19|||
156494732|NCT01086384|564906171|FG002|Treatment Period|Adverse Event|15|||
156494733|NCT01086384|564906169|FG000|Treatment Period|Lost to Follow-up|0|||
156494734|NCT01086384|564906170|FG001|Treatment Period|Lost to Follow-up|11|||
156494735|NCT01086384|564906171|FG002|Treatment Period|Lost to Follow-up|9|||
156494736|NCT01086384|564906169|FG000|Treatment Period|Physician Decision|0|||
156494737|NCT01086384|564906170|FG001|Treatment Period|Physician Decision|9|||
156494738|NCT01086384|564906171|FG002|Treatment Period|Physician Decision|6|||
156494739|NCT01086384|564906169|FG000|Treatment Period|Study Closed/Terminated|0|||
156494740|NCT01086384|564906170|FG001|Treatment Period|Study Closed/Terminated|7|||
156494741|NCT01086384|564906171|FG002|Treatment Period|Study Closed/Terminated|8|||
156494742|NCT01086384|564906169|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
156494743|NCT01086384|564906170|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
156494744|NCT01086384|564906171|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
156494745|NCT01086384|564906169|FG000|Treatment Period|Received Treatment in Error|0|||
156494746|NCT01086384|564906170|FG001|Treatment Period|Received Treatment in Error|1|||
156494747|NCT01086384|564906171|FG002|Treatment Period|Received Treatment in Error|0|||
156494748|NCT02586415|564906174|FG000|Overall Study|Death|13|||
156494749|NCT02586415|564906175|FG001|Overall Study|Death|23|||
156494750|NCT02586415|564906174|FG000|Overall Study|Lost to Follow-up|1|||
156494751|NCT02586415|564906175|FG001|Overall Study|Lost to Follow-up|2|||
156494752|NCT00832000|564906176|FG000|Overall Study|Adverse Event|2|||
156494753|NCT00832000|564906177|FG001|Overall Study|Adverse Event|0|||
156494754|NCT00832000|564906176|FG000|Overall Study|Withdrawal by Subject|1|||
156494755|NCT00832000|564906177|FG001|Overall Study|Withdrawal by Subject|0|||
156494756|NCT00832000|564906176|FG000|Overall Study|No calls to IVR in either period|1|||
156494757|NCT00832000|564906177|FG001|Overall Study|No calls to IVR in either period|1|||
156494758|NCT00832000|564906176|FG000|Overall Study|No calls to IVR in period 2|2|||
156494759|NCT00832000|564906177|FG001|Overall Study|No calls to IVR in period 2|0|||
156494760|NCT01898442|564906178|FG000|Overall Study|Hemolysis/technical problems|1|||
156494761|NCT01898442|564906179|FG001|Overall Study|Hemolysis/technical problems|2|||
156494762|NCT01898442|564906180|FG002|Overall Study|Hemolysis/technical problems|2|||
156494763|NCT01898442|564906178|FG000|Overall Study|Patient vomited pills|0|||
156494764|NCT01898442|564906179|FG001|Overall Study|Patient vomited pills|0|||
156494765|NCT01898442|564906180|FG002|Overall Study|Patient vomited pills|1|||
156494766|NCT03974100|564906181|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
156494767|NCT03974100|564906182|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
156494768|NCT03974100|564906183|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
156494769|NCT03974100|564906184|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
156494770|NCT03974100|564906185|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
156494771|NCT03974100|564906181|FG000|TP1 - Day 1 to Week 52|Death|1|||
156494772|NCT03974100|564906182|FG001|TP1 - Day 1 to Week 52|Death|0|||
156494773|NCT03974100|564906183|FG002|TP1 - Day 1 to Week 52|Death|0|||
156494774|NCT03974100|564906184|FG003|TP1 - Day 1 to Week 52|Death|0|||
156494775|NCT03974100|564906185|FG004|TP1 - Day 1 to Week 52|Death|0|||
156494776|NCT03974100|564906181|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
156494777|NCT03974100|564906182|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
156494778|NCT03974100|564906183|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
156494779|NCT03974100|564906184|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
156494780|NCT03974100|564906185|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
156494781|NCT03974100|564906181|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
156494782|NCT03974100|564906182|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
156494783|NCT03974100|564906183|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
156494784|NCT03974100|564906184|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
156494785|NCT03974100|564906185|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
156494786|NCT03974100|564906181|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
156494787|NCT03974100|564906182|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
156494788|NCT03974100|564906183|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
156494789|NCT03974100|564906184|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
156494790|NCT03974100|564906185|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
156494791|NCT03974100|564906181|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
156494792|NCT03974100|564906182|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
156494793|NCT03974100|564906183|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
156494794|NCT03974100|564906184|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
156494795|NCT03974100|564906185|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
156494796|NCT03974100|564906181|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
156494797|NCT03974100|564906182|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
156494798|NCT03974100|564906183|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
156494799|NCT03974100|564906184|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
156494800|NCT03974100|564906185|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
156494801|NCT03318783|564906186|FG000|Overall Study|Withdrawal by Subject|0|||
156494802|NCT03318783|564906187|FG001|Overall Study|Withdrawal by Subject|1|||
156494803|NCT03318783|564906186|FG000|Overall Study|Death|0|||
156546598|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
156546599|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
156494804|NCT03318783|564906187|FG001|Overall Study|Death|1|||
156494805|NCT01426113|564906192|FG000|Overall Study|Study Discontinued|1|||
156494806|NCT01426113|564906193|FG001|Overall Study|Study Discontinued|1|||
156494807|NCT01426113|564906192|FG000|Overall Study|Adverse Event|0|||
156494808|NCT01426113|564906193|FG001|Overall Study|Adverse Event|1|||
156494809|NCT00436956|564906196|FG000|Overall Study|Not evaluable|1|||
156494810|NCT00436956|564906197|FG001|Overall Study|Not evaluable|0|||
156494811|NCT01841112|564906199|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
156494812|NCT01841112|564906200|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
156494813|NCT01841112|564906201|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
156494814|NCT01841112|564906202|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
156494815|NCT01841112|564906203|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
156494816|NCT02719743|564906204|FG000|Overall Study|Consent withdrawal|0|||
156494817|NCT02719743|564906205|FG001|Overall Study|Consent withdrawal|2|||
156494818|NCT02719743|564906206|FG002|Overall Study|Consent withdrawal|0|||
156494819|NCT02719743|564906207|FG003|Overall Study|Consent withdrawal|1|||
156494820|NCT02719743|564906208|FG004|Overall Study|Consent withdrawal|0|||
156494821|NCT02719743|564906204|FG000|Overall Study|Migrated/moved from study area|0|||
156494822|NCT02719743|564906205|FG001|Overall Study|Migrated/moved from study area|0|||
156494823|NCT02719743|564906206|FG002|Overall Study|Migrated/moved from study area|0|||
156494824|NCT02719743|564906207|FG003|Overall Study|Migrated/moved from study area|0|||
156494825|NCT02719743|564906208|FG004|Overall Study|Migrated/moved from study area|2|||
156494826|NCT02719743|564906204|FG000|Overall Study|Lost to Follow-up|1|||
156494827|NCT02719743|564906205|FG001|Overall Study|Lost to Follow-up|1|||
156494828|NCT02719743|564906206|FG002|Overall Study|Lost to Follow-up|0|||
156494829|NCT02719743|564906207|FG003|Overall Study|Lost to Follow-up|0|||
156494830|NCT02719743|564906208|FG004|Overall Study|Lost to Follow-up|0|||
156494831|NCT01438840|564906209|FG000|Core Study|Adverse Event|0|||
156494832|NCT01438840|564906210|FG001|Core Study|Adverse Event|3|||
156494833|NCT01438840|564906211|FG002|Core Study|Adverse Event|0|||
156494834|NCT01438840|564906209|FG000|Core Study|Lack of Efficacy|15|||
156494835|NCT01438840|564906210|FG001|Core Study|Lack of Efficacy|7|||
156494836|NCT01438840|564906211|FG002|Core Study|Lack of Efficacy|0|||
156494837|NCT01438840|564906209|FG000|Core Study|Withdrawal of consent|1|||
156494838|NCT01438840|564906210|FG001|Core Study|Withdrawal of consent|0|||
156494839|NCT01438840|564906211|FG002|Core Study|Withdrawal of consent|0|||
156494840|NCT01438840|564906209|FG000|Extension Phase|Adverse Event|0|||
156494841|NCT01438840|564906210|FG001|Extension Phase|Adverse Event|0|||
156494842|NCT01438840|564906211|FG002|Extension Phase|Adverse Event|3|||
156494843|NCT01438840|564906209|FG000|Extension Phase|Lost to Follow-up|0|||
156494844|NCT01438840|564906210|FG001|Extension Phase|Lost to Follow-up|0|||
156494845|NCT01438840|564906211|FG002|Extension Phase|Lost to Follow-up|1|||
156494846|NCT01438840|564906209|FG000|Extension Phase|Withdrawal by Subject|0|||
156494847|NCT01438840|564906210|FG001|Extension Phase|Withdrawal by Subject|0|||
156375170|NCT02391948|564468370|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
156375171|NCT02391948|564468371|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
156375172|NCT02391948|564468372|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
156375173|NCT02391948|564468368|FG000|18-month Assessment|Death|0|||
156375174|NCT02391948|564468369|FG001|18-month Assessment|Death|0|||
156375175|NCT02391948|564468370|FG002|18-month Assessment|Death|0|||
156375176|NCT02391948|564468371|FG003|18-month Assessment|Death|1|||
156375177|NCT02391948|564468372|FG004|18-month Assessment|Death|1|||
156375178|NCT02391948|564468368|FG000|18-month Assessment|Withdrawal by Subject|1|||
156375179|NCT02391948|564468369|FG001|18-month Assessment|Withdrawal by Subject|0|||
156375180|NCT02391948|564468370|FG002|18-month Assessment|Withdrawal by Subject|0|||
156375181|NCT02391948|564468371|FG003|18-month Assessment|Withdrawal by Subject|1|||
156375182|NCT02391948|564468372|FG004|18-month Assessment|Withdrawal by Subject|0|||
156375183|NCT02391948|564468368|FG000|18-month Assessment|Lost to Follow-up|2|||
156375184|NCT02391948|564468369|FG001|18-month Assessment|Lost to Follow-up|6|||
156375185|NCT02391948|564468370|FG002|18-month Assessment|Lost to Follow-up|2|||
156375186|NCT02391948|564468371|FG003|18-month Assessment|Lost to Follow-up|2|||
156375187|NCT02391948|564468372|FG004|18-month Assessment|Lost to Follow-up|3|||
156375188|NCT02391948|564468368|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
156375189|NCT02391948|564468369|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
156375190|NCT02391948|564468370|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
156375191|NCT02391948|564468371|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
156375192|NCT02391948|564468372|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
156494848|NCT01438840|564906211|FG002|Extension Phase|Withdrawal by Subject|3|||
156494849|NCT01438840|564906209|FG000|Extension Phase|Lack of Efficacy|0|||
156494850|NCT01438840|564906210|FG001|Extension Phase|Lack of Efficacy|0|||
156494851|NCT01438840|564906211|FG002|Extension Phase|Lack of Efficacy|2|||
156494852|NCT01438840|564906209|FG000|Extension Phase|Other|0|||
156494853|NCT01438840|564906210|FG001|Extension Phase|Other|0|||
156375193|NCT02391948|564468368|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
156375194|NCT02391948|564468369|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
156375195|NCT02391948|564468370|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
156494854|NCT01438840|564906211|FG002|Extension Phase|Other|1|||
156494855|NCT00461123|564906214|FG000|Overall Study|Adverse Event|1|||
156494856|NCT00461123|564906215|FG001|Overall Study|Adverse Event|0|||
156494857|NCT00461123|564906214|FG000|Overall Study|Lost to Follow-up|1|||
156494858|NCT00461123|564906215|FG001|Overall Study|Lost to Follow-up|1|||
156494859|NCT00461123|564906214|FG000|Overall Study|Protocol Violation|3|||
156494860|NCT00461123|564906215|FG001|Overall Study|Protocol Violation|2|||
156494861|NCT00461123|564906214|FG000|Overall Study|Withdrawal by Subject|1|||
156494862|NCT00461123|564906215|FG001|Overall Study|Withdrawal by Subject|3|||
156494863|NCT02024750|564906216|FG000|Overall Study|Withdrawal by Subject|2|||
156494864|NCT02024750|564906217|FG001|Overall Study|Withdrawal by Subject|1|||
156375196|NCT02391948|564468371|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
156375197|NCT02391948|564468372|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
156375198|NCT02391948|564468368|FG000|24-month Assessment|Death|0|||
156375199|NCT02391948|564468369|FG001|24-month Assessment|Death|0|||
156375200|NCT02391948|564468370|FG002|24-month Assessment|Death|0|||
156375201|NCT02391948|564468371|FG003|24-month Assessment|Death|0|||
156375202|NCT02391948|564468372|FG004|24-month Assessment|Death|1|||
156375203|NCT02391948|564468368|FG000|24-month Assessment|Withdrawal by Subject|1|||
156375204|NCT02391948|564468369|FG001|24-month Assessment|Withdrawal by Subject|1|||
156375205|NCT02391948|564468370|FG002|24-month Assessment|Withdrawal by Subject|0|||
156375206|NCT02391948|564468371|FG003|24-month Assessment|Withdrawal by Subject|0|||
156375207|NCT02391948|564468372|FG004|24-month Assessment|Withdrawal by Subject|1|||
156375208|NCT02391948|564468368|FG000|24-month Assessment|Lost to Follow-up|5|||
156375209|NCT02391948|564468369|FG001|24-month Assessment|Lost to Follow-up|4|||
156375210|NCT02391948|564468370|FG002|24-month Assessment|Lost to Follow-up|0|||
156375211|NCT02391948|564468371|FG003|24-month Assessment|Lost to Follow-up|0|||
156375212|NCT02391948|564468372|FG004|24-month Assessment|Lost to Follow-up|0|||
156375213|NCT02391948|564468368|FG000|24-month Assessment|Medical issue/illness|0|||
156375214|NCT02391948|564468369|FG001|24-month Assessment|Medical issue/illness|0|||
156375215|NCT02391948|564468370|FG002|24-month Assessment|Medical issue/illness|1|||
156375216|NCT02391948|564468371|FG003|24-month Assessment|Medical issue/illness|0|||
156375217|NCT02391948|564468372|FG004|24-month Assessment|Medical issue/illness|0|||
156375218|NCT02391948|564468368|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
156375219|NCT02391948|564468369|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
156375220|NCT02391948|564468370|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
156375221|NCT02391948|564468371|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
156375222|NCT02391948|564468372|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
156375223|NCT02212730|564468373|FG000|Overall Study|Tumor not of the required cell histology|1|||
156375224|NCT02212730|564468374|FG001|Overall Study|Tumor not of the required cell histology|0|||
156375225|NCT02212730|564468373|FG000|Overall Study|Withdrawal by Subject|1|||
156375226|NCT02212730|564468374|FG001|Overall Study|Withdrawal by Subject|0|||
156375227|NCT02212730|564468373|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
156375228|NCT02212730|564468374|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
156375229|NCT02691455|564468377|FG000|Overall Study|Withdrawal by Subject|1|||
156375230|NCT02691455|564468378|FG001|Overall Study|Withdrawal by Subject|2|||
156375231|NCT02691455|564468377|FG000|Overall Study|Lost to Follow-up|15|||
156375232|NCT02691455|564468378|FG001|Overall Study|Lost to Follow-up|15|||
156375233|NCT02057757|564468379|FG000|Overall Study|Withdrawal by Subject|3|||
156375234|NCT02057757|564468380|FG001|Overall Study|Withdrawal by Subject|5|||
156375235|NCT02057757|564468379|FG000|Overall Study|Death|2|||
156375236|NCT02057757|564468380|FG001|Overall Study|Death|0|||
156375237|NCT02057757|564468379|FG000|Overall Study|Lost to Follow-up|8|||
156375238|NCT02057757|564468380|FG001|Overall Study|Lost to Follow-up|3|||
156375239|NCT02057757|564468379|FG000|Overall Study|Non-compliance|1|||
156375240|NCT02057757|564468380|FG001|Overall Study|Non-compliance|0|||
156375241|NCT00436280|564468389|FG000|Period 1: Induction|Adverse Event|8|||
156375242|NCT00436280|564468389|FG000|Period 1: Induction|Progressive Disease|12|||
156375243|NCT00436280|564468389|FG000|Period 1: Induction|Stable Disease|6|||
156375244|NCT00436280|564468389|FG000|Period 1: Induction|Withdrawal by Subject|1|||
156375245|NCT00436280|564468389|FG000|Period 1: Induction|Death|1|||
156375246|NCT00436280|564468389|FG000|Period 2: Consolidation|Adverse Event|1|||
156375247|NCT00436280|564468389|FG000|Period 2: Consolidation|Progressive Disease|10|||
156375248|NCT00436280|564468389|FG000|Period 2: Consolidation|Stable Disease|1|||
156375249|NCT00436280|564468389|FG000|Period 2: Consolidation|Physician Decision|2|||
156375250|NCT00436280|564468389|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
156375251|NCT00436280|564468389|FG000|Period 2: Consolidation|Death|1|||
156375252|NCT00436280|564468389|FG000|Period 3: Maintenance|Adverse Event|6|||
156375253|NCT00436280|564468389|FG000|Period 3: Maintenance|Progressive Disease|12|||
156375254|NCT03603964|564468390|FG000|Overall Study|Death|9|||
156375255|NCT03603964|564468390|FG000|Overall Study|Withdrawal by participant|7|||
156375256|NCT03603964|564468390|FG000|Overall Study|Study terminated by Sponsor|19|||
156375257|NCT00563797|564468391|FG000|Overall Study|Lost to Follow-up|7|||
156375258|NCT00563797|564468392|FG001|Overall Study|Lost to Follow-up|2|||
156375259|NCT03586869|564468393|FG000|Overall Study|Progressive Disease|3|||
156375260|NCT04116229|564468394|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
156375261|NCT04116229|564468395|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
156375262|NCT04116229|564468394|FG000|Overall Study|Scheduling not possible.|0|||
156375263|NCT04116229|564468395|FG001|Overall Study|Scheduling not possible.|1|||
156375264|NCT02809976|564468398|FG000|Overall Study|Lost to Follow-up|1|||
156494865|NCT01891890|564906219|FG000|Overall Study|Lost to Follow-up|0|||
156375265|NCT02809976|564468398|FG000|Overall Study|Withdrawal by Subject|1|||
156375266|NCT00211081|564468400|FG000|Overall Study|Withdrawal by Subject|2|||
156375267|NCT00047463|564468401|FG000|Overall Study|Withdrawal by Subject|0|||
156494866|NCT01891890|564906220|FG001|Overall Study|Lost to Follow-up|0|||
156375268|NCT00047463|564468402|FG001|Overall Study|Withdrawal by Subject|3|||
156375269|NCT00113516|564468403|FG000|Part 1|Adverse Event|6|||
156375270|NCT00113516|564468404|FG001|Part 1|Adverse Event|0|||
156375271|NCT00113516|564468403|FG000|Part 1|Death|3|||
156375272|NCT00113516|564468404|FG001|Part 1|Death|0|||
156375273|NCT00113516|564468403|FG000|Part 1|Other|3|||
156375274|NCT00113516|564468404|FG001|Part 1|Other|0|||
156375275|NCT00113516|564468403|FG000|Part 1|Withdrawal by Subject|2|||
156375276|NCT00113516|564468404|FG001|Part 1|Withdrawal by Subject|0|||
156375277|NCT00113516|564468403|FG000|Part 1|Lack of Efficacy|2|||
156375278|NCT00113516|564468404|FG001|Part 1|Lack of Efficacy|0|||
156375279|NCT00113516|564468403|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
156375280|NCT00113516|564468404|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
156375281|NCT00113516|564468403|FG000|Part 1|Laboratory Abnormality|1|||
156375282|NCT00113516|564468404|FG001|Part 1|Laboratory Abnormality|0|||
156375283|NCT00113516|564468403|FG000|Part 1|Ongoing|1|||
156375284|NCT00113516|564468404|FG001|Part 1|Ongoing|0|||
156375285|NCT00113516|564468403|FG000|Part 1|Missing|65|||
156375286|NCT00113516|564468404|FG001|Part 1|Missing|0|||
156375287|NCT00113516|564468403|FG000|Part 2|Adverse Event|0|||
156375288|NCT00113516|564468404|FG001|Part 2|Adverse Event|16|||
156375289|NCT00113516|564468403|FG000|Part 2|Death|0|||
156375290|NCT00113516|564468404|FG001|Part 2|Death|5|||
156375291|NCT00113516|564468403|FG000|Part 2|Lack of Efficacy|0|||
156375292|NCT00113516|564468404|FG001|Part 2|Lack of Efficacy|37|||
156494867|NCT01891890|564906221|FG002|Overall Study|Lost to Follow-up|1|||
156494868|NCT01891890|564906219|FG000|Overall Study|Study ended before endpoint reached|7|||
156494869|NCT01891890|564906220|FG001|Overall Study|Study ended before endpoint reached|3|||
156494870|NCT01891890|564906221|FG002|Overall Study|Study ended before endpoint reached|6|||
156494871|NCT02725008|564906224|FG000|Overall Study|Lost to Follow-up|7|||
156494872|NCT02725008|564906225|FG001|Overall Study|Lost to Follow-up|9|||
156494873|NCT02725008|564906224|FG000|Overall Study|Withdrawal by Subject|2|||
156494874|NCT02725008|564906225|FG001|Overall Study|Withdrawal by Subject|2|||
156494875|NCT02725008|564906224|FG000|Overall Study|Admitted to hospital|0|||
156494876|NCT02725008|564906225|FG001|Overall Study|Admitted to hospital|1|||
156375293|NCT00113516|564468403|FG000|Part 2|Withdrawal by Subject|0|||
156375294|NCT00113516|564468404|FG001|Part 2|Withdrawal by Subject|3|||
156375295|NCT00113516|564468403|FG000|Part 2|Other|0|||
156375296|NCT00113516|564468404|FG001|Part 2|Other|3|||
156375297|NCT00113516|564468403|FG000|Part 2|Laboratory Abnormality|0|||
156375298|NCT00113516|564468404|FG001|Part 2|Laboratory Abnormality|1|||
156494877|NCT01329419|564906228|FG000|Overall Study|Protocol Violation|235|||
156375299|NCT00113516|564468403|FG000|Part 2|Ongoing|0|||
156375300|NCT00113516|564468404|FG001|Part 2|Ongoing|1|||
156375301|NCT03755765|564468409|FG000|Overall Study|Withdrawal by Subject|2|||
156375302|NCT03755765|564468410|FG001|Overall Study|Withdrawal by Subject|4|||
156375303|NCT03755765|564468411|FG002|Overall Study|Withdrawal by Subject|4|||
156375304|NCT01158222|564468414|FG000|Overall Study|Not eligible for intermediate phase|17|||
156375305|NCT00111228|564468417|FG000|Overall Study|Withdrawal by Subject|5|||
156494878|NCT00361842|564906229|FG000|Overall Study|Withdrawal by Subject|2|||
156494879|NCT00361842|564906230|FG001|Overall Study|Withdrawal by Subject|3|||
156494880|NCT00361842|564906229|FG000|Overall Study|Death|2|||
156494881|NCT00361842|564906230|FG001|Overall Study|Death|1|||
156494882|NCT00361842|564906229|FG000|Overall Study|Disease progression|19|||
156494883|NCT00361842|564906230|FG001|Overall Study|Disease progression|20|||
156494884|NCT00361842|564906229|FG000|Overall Study|Adverse Event|2|||
156494885|NCT00361842|564906230|FG001|Overall Study|Adverse Event|3|||
156494886|NCT00361842|564906229|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
156494887|NCT00361842|564906230|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
156494888|NCT00361842|564906229|FG000|Overall Study|Other|1|||
156494889|NCT00361842|564906230|FG001|Overall Study|Other|0|||
156494890|NCT00361842|564906229|FG000|Overall Study|Other|0|||
156494891|NCT00361842|564906230|FG001|Overall Study|Other|2|||
156494892|NCT03512288|564906231|FG000|Overall Study|Adverse Event|1|||
156494893|NCT03512288|564906232|FG001|Overall Study|Adverse Event|0|||
156494894|NCT03512288|564906231|FG000|Overall Study|Lost to Follow-up|12|||
156494895|NCT03512288|564906232|FG001|Overall Study|Lost to Follow-up|15|||
156494896|NCT03512288|564906231|FG000|Overall Study|Physician Decision|0|||
156494897|NCT03512288|564906232|FG001|Overall Study|Physician Decision|2|||
156494898|NCT03512288|564906231|FG000|Overall Study|Protocol Violation|6|||
156494899|NCT03512288|564906232|FG001|Overall Study|Protocol Violation|4|||
156494900|NCT03512288|564906231|FG000|Overall Study|Medication error without associated adverse event|1|||
156494901|NCT03512288|564906232|FG001|Overall Study|Medication error without associated adverse event|0|||
156494902|NCT03512288|564906231|FG000|Overall Study|No longer met eligibility criteria|5|||
156494903|NCT03512288|564906232|FG001|Overall Study|No longer met eligibility criteria|2|||
156494904|NCT03512288|564906231|FG000|Overall Study|Withdrawal by parent/guardian|14|||
156494905|NCT03512288|564906232|FG001|Overall Study|Withdrawal by parent/guardian|18|||
156494906|NCT03512288|564906231|FG000|Overall Study|Other|1|||
156494907|NCT03512288|564906232|FG001|Overall Study|Other|1|||
156494908|NCT03512288|564906231|FG000|Overall Study|Randomized but not treated|1|||
156494909|NCT03512288|564906232|FG001|Overall Study|Randomized but not treated|1|||
156494910|NCT01177228|564906242|FG000|Overall Study|Positive tuberculosis test|0|||
156494911|NCT01177228|564906243|FG001|Overall Study|Positive tuberculosis test|1|||
156494912|NCT01177228|564906244|FG002|Overall Study|Positive tuberculosis test|0|||
156494913|NCT01177228|564906245|FG003|Overall Study|Positive tuberculosis test|0|||
156494914|NCT01177228|564906242|FG000|Overall Study|Worsening disease activity|1|||
156494915|NCT01177228|564906243|FG001|Overall Study|Worsening disease activity|0|||
156494916|NCT01177228|564906244|FG002|Overall Study|Worsening disease activity|0|||
156494917|NCT01177228|564906245|FG003|Overall Study|Worsening disease activity|0|||
156494918|NCT01177228|564906242|FG000|Overall Study|Withdrawal by Subject|0|||
156494919|NCT01177228|564906243|FG001|Overall Study|Withdrawal by Subject|1|||
156494920|NCT01177228|564906244|FG002|Overall Study|Withdrawal by Subject|0|||
156494921|NCT01177228|564906245|FG003|Overall Study|Withdrawal by Subject|0|||
156494922|NCT01251887|564906246|FG000|Overall Study|Scheduling conflict|1|||
156494923|NCT01251887|564906247|FG001|Overall Study|Scheduling conflict|2|||
156494924|NCT01251887|564906248|FG002|Overall Study|Scheduling conflict|2|||
156494925|NCT01251887|564906246|FG000|Overall Study|Physician Decision|0|||
156494926|NCT01251887|564906247|FG001|Overall Study|Physician Decision|1|||
156375306|NCT00111228|564468418|FG001|Overall Study|Withdrawal by Subject|1|||
156375307|NCT00111228|564468419|FG002|Overall Study|Withdrawal by Subject|0|||
156375308|NCT02579616|564468420|FG000|Overall Study|Participants did not receive treatment|3|||
156375309|NCT03698773|564468429|FG000|Overall Study|Lost to Follow-up|2|||
156375310|NCT03698773|564468430|FG001|Overall Study|Lost to Follow-up|1|||
156375311|NCT02399085|564468431|FG000|Overall Study|Adverse Event|16|||
156375312|NCT02399085|564468431|FG000|Overall Study|Death|2|||
156375313|NCT02399085|564468431|FG000|Overall Study|Withdrawal by Subject|8|||
156375314|NCT02399085|564468431|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
156494927|NCT01251887|564906248|FG002|Overall Study|Physician Decision|0|||
156494928|NCT03325608|564906249|FG000|Overall Study|Lost to Follow-up|23|||
156494929|NCT03325608|564906250|FG001|Overall Study|Lost to Follow-up|23|||
156375315|NCT02399085|564468431|FG000|Overall Study|Physician Decision|5|||
156494930|NCT03325608|564906251|FG002|Overall Study|Lost to Follow-up|30|||
156494931|NCT03325608|564906252|FG003|Overall Study|Lost to Follow-up|30|||
156494932|NCT03325608|564906249|FG000|Overall Study|Death of Caregiver|0|||
156494933|NCT03325608|564906250|FG001|Overall Study|Death of Caregiver|0|||
156494934|NCT03325608|564906251|FG002|Overall Study|Death of Caregiver|2|||
156494935|NCT03325608|564906252|FG003|Overall Study|Death of Caregiver|2|||
156494936|NCT03325608|564906249|FG000|Overall Study|Death of Care Recipient|34|||
156494937|NCT03325608|564906250|FG001|Overall Study|Death of Care Recipient|34|||
156494938|NCT03325608|564906251|FG002|Overall Study|Death of Care Recipient|28|||
156375316|NCT02357576|564468432|FG000|Treatment Period|Withdrawal by Subject|0|||
156375317|NCT02357576|564468433|FG001|Treatment Period|Withdrawal by Subject|1|||
156375318|NCT02357576|564468432|FG000|Treatment Period|Physician Decision|0|||
156375319|NCT02357576|564468433|FG001|Treatment Period|Physician Decision|1|||
156375320|NCT02357576|564468432|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
156375321|NCT02357576|564468433|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
156375322|NCT02357576|564468432|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
156375323|NCT02357576|564468433|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
156375324|NCT02357576|564468432|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
156375325|NCT02357576|564468433|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
156375326|NCT02357576|564468432|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
156375327|NCT02357576|564468433|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
156375328|NCT00414050|564468434|FG000|Overall Study|Adverse Event|1|||
156375329|NCT00414050|564468435|FG001|Overall Study|Adverse Event|1|||
156375330|NCT00414050|564468436|FG002|Overall Study|Adverse Event|1|||
156375331|NCT00414050|564468437|FG003|Overall Study|Adverse Event|1|||
156375332|NCT00414050|564468434|FG000|Overall Study|Lost to Follow-up|2|||
156375333|NCT00414050|564468435|FG001|Overall Study|Lost to Follow-up|2|||
156375334|NCT00414050|564468436|FG002|Overall Study|Lost to Follow-up|1|||
156375335|NCT00414050|564468437|FG003|Overall Study|Lost to Follow-up|1|||
156375336|NCT00414050|564468434|FG000|Overall Study|Withdrawal by Subject|5|||
156375337|NCT00414050|564468435|FG001|Overall Study|Withdrawal by Subject|3|||
156375338|NCT00414050|564468436|FG002|Overall Study|Withdrawal by Subject|2|||
156375339|NCT00414050|564468437|FG003|Overall Study|Withdrawal by Subject|4|||
156375340|NCT00414050|564468434|FG000|Overall Study|Subject discontinued for other reason|1|||
156375341|NCT00414050|564468435|FG001|Overall Study|Subject discontinued for other reason|2|||
156375342|NCT00414050|564468436|FG002|Overall Study|Subject discontinued for other reason|2|||
156375343|NCT00414050|564468437|FG003|Overall Study|Subject discontinued for other reason|1|||
156375344|NCT00414050|564468434|FG000|Overall Study|Subject Moved|0|||
156375345|NCT00414050|564468435|FG001|Overall Study|Subject Moved|0|||
156375346|NCT00414050|564468436|FG002|Overall Study|Subject Moved|0|||
156375347|NCT00414050|564468437|FG003|Overall Study|Subject Moved|1|||
156375348|NCT00720876|564468448|FG000|Overall Study|found to be ineligible after starting tx|2|||
156375349|NCT03495908|564468450|FG000|Overall Study|Withdrawal by Subject|3|||
156375350|NCT03495908|564468451|FG001|Overall Study|Withdrawal by Subject|1|||
156375351|NCT03495908|564468450|FG000|Overall Study|Lost to Follow-up|1|||
156375352|NCT03495908|564468451|FG001|Overall Study|Lost to Follow-up|4|||
156375353|NCT03495908|564468450|FG000|Overall Study|Adverse Event|0|||
156375354|NCT03495908|564468451|FG001|Overall Study|Adverse Event|2|||
156375355|NCT03495908|564468450|FG000|Overall Study|Death|1|||
156375356|NCT03495908|564468451|FG001|Overall Study|Death|0|||
156375357|NCT03495908|564468450|FG000|Overall Study|Physician Decision|5|||
156375358|NCT03495908|564468451|FG001|Overall Study|Physician Decision|4|||
156375359|NCT03495908|564468450|FG000|Overall Study|No documented reason|0|||
156375360|NCT03495908|564468451|FG001|Overall Study|No documented reason|2|||
156375361|NCT03304379|564468452|FG000|Overall Study|Protocol Violation|8|||
156375362|NCT03304379|564468453|FG001|Overall Study|Protocol Violation|10|||
156375363|NCT03304379|564468454|FG002|Overall Study|Protocol Violation|5|||
156375364|NCT03304379|564468455|FG003|Overall Study|Protocol Violation|0|||
156375365|NCT03304379|564468456|FG004|Overall Study|Protocol Violation|2|||
156375366|NCT03304379|564468452|FG000|Overall Study|Adverse Event|4|||
156375367|NCT03304379|564468453|FG001|Overall Study|Adverse Event|20|||
156375368|NCT03304379|564468454|FG002|Overall Study|Adverse Event|17|||
156375369|NCT03304379|564468455|FG003|Overall Study|Adverse Event|1|||
156375370|NCT03304379|564468456|FG004|Overall Study|Adverse Event|0|||
156375371|NCT03304379|564468452|FG000|Overall Study|Lack of Efficacy|17|||
156375372|NCT03304379|564468453|FG001|Overall Study|Lack of Efficacy|16|||
156375373|NCT03304379|564468454|FG002|Overall Study|Lack of Efficacy|20|||
156375374|NCT03304379|564468455|FG003|Overall Study|Lack of Efficacy|0|||
156375375|NCT03304379|564468456|FG004|Overall Study|Lack of Efficacy|0|||
156375376|NCT03304379|564468452|FG000|Overall Study|Physician Decision|6|||
156375377|NCT03304379|564468453|FG001|Overall Study|Physician Decision|10|||
156375378|NCT03304379|564468454|FG002|Overall Study|Physician Decision|6|||
156375379|NCT03304379|564468455|FG003|Overall Study|Physician Decision|9|||
156375380|NCT03304379|564468456|FG004|Overall Study|Physician Decision|10|||
156375381|NCT03304379|564468452|FG000|Overall Study|Withdrawal by Subject|26|||
156375382|NCT03304379|564468453|FG001|Overall Study|Withdrawal by Subject|58|||
156375383|NCT03304379|564468454|FG002|Overall Study|Withdrawal by Subject|66|||
156375384|NCT03304379|564468455|FG003|Overall Study|Withdrawal by Subject|3|||
156375385|NCT03304379|564468456|FG004|Overall Study|Withdrawal by Subject|5|||
156375386|NCT03304379|564468452|FG000|Overall Study|Lost to Follow-up|8|||
156375387|NCT03304379|564468453|FG001|Overall Study|Lost to Follow-up|24|||
156375388|NCT03304379|564468454|FG002|Overall Study|Lost to Follow-up|35|||
156375389|NCT03304379|564468455|FG003|Overall Study|Lost to Follow-up|4|||
156375390|NCT03304379|564468456|FG004|Overall Study|Lost to Follow-up|0|||
156375391|NCT03304379|564468452|FG000|Overall Study|Death|1|||
156375392|NCT03304379|564468453|FG001|Overall Study|Death|2|||
156494939|NCT03325608|564906252|FG003|Overall Study|Death of Care Recipient|28|||
156494940|NCT03325608|564906249|FG000|Overall Study|Withdrawal by Subject|49|||
156494941|NCT03325608|564906250|FG001|Overall Study|Withdrawal by Subject|49|||
156494942|NCT03325608|564906251|FG002|Overall Study|Withdrawal by Subject|35|||
156494943|NCT03325608|564906252|FG003|Overall Study|Withdrawal by Subject|35|||
156494944|NCT03325608|564906249|FG000|Overall Study|Ineligible|7|||
156494945|NCT03325608|564906250|FG001|Overall Study|Ineligible|7|||
156494946|NCT03325608|564906251|FG002|Overall Study|Ineligible|5|||
156494947|NCT03325608|564906252|FG003|Overall Study|Ineligible|5|||
156494948|NCT00942188|564906253|FG000|Overall Study|Adverse Event|0|||
156494949|NCT00942188|564906254|FG001|Overall Study|Adverse Event|3|||
156494950|NCT00942188|564906255|FG002|Overall Study|Adverse Event|2|||
156494951|NCT00942188|564906256|FG003|Overall Study|Adverse Event|0|||
156494952|NCT00942188|564906253|FG000|Overall Study|Lack of Efficacy|0|||
156494953|NCT00942188|564906254|FG001|Overall Study|Lack of Efficacy|0|||
156494954|NCT00942188|564906255|FG002|Overall Study|Lack of Efficacy|0|||
156494955|NCT00942188|564906256|FG003|Overall Study|Lack of Efficacy|1|||
156494956|NCT00942188|564906253|FG000|Overall Study|Protocol Violation|1|||
156494957|NCT00942188|564906254|FG001|Overall Study|Protocol Violation|1|||
156494958|NCT00942188|564906255|FG002|Overall Study|Protocol Violation|0|||
156494959|NCT00942188|564906256|FG003|Overall Study|Protocol Violation|0|||
156494960|NCT00942188|564906253|FG000|Overall Study|Lost to Follow-up|2|||
156494961|NCT00942188|564906254|FG001|Overall Study|Lost to Follow-up|1|||
156494962|NCT00942188|564906255|FG002|Overall Study|Lost to Follow-up|2|||
156494963|NCT00942188|564906256|FG003|Overall Study|Lost to Follow-up|0|||
156494964|NCT00942188|564906253|FG000|Overall Study|Withdrawal by Subject|1|||
156494965|NCT00942188|564906254|FG001|Overall Study|Withdrawal by Subject|3|||
156494966|NCT00942188|564906255|FG002|Overall Study|Withdrawal by Subject|4|||
156546600|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
156546601|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
156546602|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156546603|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156546604|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156546605|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
156546606|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
156546607|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
156546608|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
156546609|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
156546610|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
156546611|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
156546612|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
156546613|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
156546614|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
156546615|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
156546616|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
156546617|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
156546618|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
156546619|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
156546620|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
156546621|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
156546622|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
156546623|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
156546624|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
156546625|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
156546626|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
156546627|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
156546628|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
156546629|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
156546630|NCT03605680|565094915|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
156546631|NCT03605680|565094916|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
156494967|NCT00942188|564906256|FG003|Overall Study|Withdrawal by Subject|2|||
156494968|NCT00942188|564906253|FG000|Overall Study|Physician Decision|0|||
156494969|NCT00942188|564906254|FG001|Overall Study|Physician Decision|0|||
156494970|NCT00942188|564906255|FG002|Overall Study|Physician Decision|1|||
156494971|NCT00942188|564906256|FG003|Overall Study|Physician Decision|0|||
156494972|NCT00942188|564906253|FG000|Overall Study|Sponsor Decision|0|||
156494973|NCT00942188|564906254|FG001|Overall Study|Sponsor Decision|2|||
156494974|NCT00942188|564906255|FG002|Overall Study|Sponsor Decision|0|||
156494975|NCT00942188|564906256|FG003|Overall Study|Sponsor Decision|1|||
156494976|NCT02188784|564906257|FG000|Overall Study|Death|3|||
156494977|NCT02188784|564906258|FG001|Overall Study|Death|1|||
156494978|NCT02188784|564906257|FG000|Overall Study|Lost to Follow-up|1|||
156494979|NCT02188784|564906258|FG001|Overall Study|Lost to Follow-up|0|||
156494980|NCT02188784|564906257|FG000|Overall Study|Withdrawal by Subject|3|||
156494981|NCT02188784|564906258|FG001|Overall Study|Withdrawal by Subject|9|||
156494982|NCT02188784|564906257|FG000|Overall Study|Physician Decision|2|||
156494983|NCT02188784|564906258|FG001|Overall Study|Physician Decision|3|||
156494984|NCT00143598|564906262|FG000|Overall Study|Lost to Follow-up|23|||
156494985|NCT00143598|564906263|FG001|Overall Study|Lost to Follow-up|21|||
156494986|NCT00143598|564906262|FG000|Overall Study|Withdrawal by Subject|33|||
156494987|NCT00143598|564906263|FG001|Overall Study|Withdrawal by Subject|37|||
156494988|NCT00143598|564906262|FG000|Overall Study|Death|36|||
156494989|NCT00143598|564906263|FG001|Overall Study|Death|36|||
156494990|NCT01568112|564906266|FG000|Overall Study|Randomized But Not Treated|0|||
156494991|NCT01568112|564906267|FG001|Overall Study|Randomized But Not Treated|1|||
156494992|NCT01568112|564906268|FG002|Overall Study|Randomized But Not Treated|0|||
156494993|NCT01568112|564906269|FG003|Overall Study|Randomized But Not Treated|0|||
156494994|NCT01568112|564906266|FG000|Overall Study|Withdrew due to Adverse Event|2|||
156494995|NCT01568112|564906267|FG001|Overall Study|Withdrew due to Adverse Event|4|||
156494996|NCT01568112|564906268|FG002|Overall Study|Withdrew due to Adverse Event|6|||
156494997|NCT01568112|564906269|FG003|Overall Study|Withdrew due to Adverse Event|3|||
156494998|NCT01568112|564906266|FG000|Overall Study|Lost to Follow-up|0|||
156494999|NCT01568112|564906267|FG001|Overall Study|Lost to Follow-up|0|||
156495000|NCT01568112|564906268|FG002|Overall Study|Lost to Follow-up|0|||
156495001|NCT01568112|564906269|FG003|Overall Study|Lost to Follow-up|1|||
156495002|NCT01568112|564906266|FG000|Overall Study|Withdrawal by Subject|2|||
156495003|NCT01568112|564906267|FG001|Overall Study|Withdrawal by Subject|3|||
156495004|NCT01568112|564906268|FG002|Overall Study|Withdrawal by Subject|0|||
156495005|NCT01568112|564906269|FG003|Overall Study|Withdrawal by Subject|7|||
156495006|NCT01568112|564906266|FG000|Overall Study|Withdrawal by Physician|1|||
156495007|NCT01568112|564906267|FG001|Overall Study|Withdrawal by Physician|0|||
156495008|NCT01568112|564906268|FG002|Overall Study|Withdrawal by Physician|1|||
156495009|NCT01568112|564906269|FG003|Overall Study|Withdrawal by Physician|1|||
156495010|NCT02034162|564907947|FG000|Double-blind|Lost to Follow-up|3|||
156495011|NCT02034162|564907948|FG001|Double-blind|Lost to Follow-up|0|||
156495012|NCT02034162|564907949|FG002|Double-blind|Lost to Follow-up|0|||
156495013|NCT02034162|564907947|FG000|Double-blind|Physician Decision|1|||
156495014|NCT02034162|564907948|FG001|Double-blind|Physician Decision|0|||
156495015|NCT02034162|564907949|FG002|Double-blind|Physician Decision|0|||
156495016|NCT02034162|564907947|FG000|Double-blind|Protocol Violation|0|||
156375393|NCT03304379|564468454|FG002|Overall Study|Death|0|||
156375394|NCT03304379|564468455|FG003|Overall Study|Death|0|||
156375395|NCT03304379|564468456|FG004|Overall Study|Death|0|||
156375396|NCT03304379|564468452|FG000|Overall Study|Other|0|||
156375397|NCT03304379|564468453|FG001|Overall Study|Other|1|||
156375398|NCT03304379|564468454|FG002|Overall Study|Other|0|||
156375399|NCT03304379|564468455|FG003|Overall Study|Other|0|||
156375400|NCT03304379|564468456|FG004|Overall Study|Other|0|||
156375401|NCT01109316|564468465|FG000|Study Period 1|Adverse Event|0|||
156375402|NCT01109316|564468466|FG001|Study Period 1|Adverse Event|0|||
156375403|NCT01109316|564468467|FG002|Study Period 1|Adverse Event|1|||
156375404|NCT01109316|564468468|FG003|Study Period 1|Adverse Event|0|||
156375405|NCT01109316|564468469|FG004|Study Period 1|Adverse Event|0|||
156375406|NCT01109316|564468470|FG005|Study Period 1|Adverse Event|0|||
156375407|NCT01109316|564468465|FG000|Study Period 1|Lost to Follow-up|0|||
156375408|NCT01109316|564468466|FG001|Study Period 1|Lost to Follow-up|0|||
156375409|NCT01109316|564468467|FG002|Study Period 1|Lost to Follow-up|1|||
156375410|NCT01109316|564468468|FG003|Study Period 1|Lost to Follow-up|1|||
156375411|NCT01109316|564468469|FG004|Study Period 1|Lost to Follow-up|0|||
156375412|NCT01109316|564468470|FG005|Study Period 1|Lost to Follow-up|0|||
156375413|NCT01109316|564468465|FG000|Study Period 1|Withdrawal by Subject|0|||
156375414|NCT01109316|564468466|FG001|Study Period 1|Withdrawal by Subject|0|||
156495017|NCT02034162|564907948|FG001|Double-blind|Protocol Violation|1|||
156495018|NCT02034162|564907949|FG002|Double-blind|Protocol Violation|0|||
156495019|NCT02034162|564907947|FG000|Double-blind|Withdrawal by Subject|5|||
156495020|NCT02034162|564907948|FG001|Double-blind|Withdrawal by Subject|7|||
156495021|NCT02034162|564907949|FG002|Double-blind|Withdrawal by Subject|0|||
156375415|NCT01109316|564468467|FG002|Study Period 1|Withdrawal by Subject|1|||
156375416|NCT01109316|564468468|FG003|Study Period 1|Withdrawal by Subject|0|||
156495022|NCT00760513|564907950|FG000|Overall Study|Withdrawal by Subject|5|||
156495023|NCT00760513|564907951|FG001|Overall Study|Withdrawal by Subject|7|||
156495024|NCT03458728|564907952|FG000|Overall Study|Adverse Event|1|||
156495025|NCT03458728|564907953|FG001|Overall Study|Adverse Event|0|||
156495026|NCT03458728|564907952|FG000|Overall Study|Physician Decision|1|||
156495027|NCT03458728|564907953|FG001|Overall Study|Physician Decision|0|||
156495028|NCT03458728|564907952|FG000|Overall Study|Progressive disease - clinical assessment|1|||
156495029|NCT03458728|564907953|FG001|Overall Study|Progressive disease - clinical assessment|0|||
156495030|NCT03458728|564907952|FG000|Overall Study|Progressive disease - radiological progression|21|||
156495031|NCT03458728|564907953|FG001|Overall Study|Progressive disease - radiological progression|6|||
156495032|NCT03458728|564907952|FG000|Overall Study|Withdrawal by Subject|0|||
156495033|NCT03458728|564907953|FG001|Overall Study|Withdrawal by Subject|1|||
156495034|NCT03898700|564907956|FG000|Overall Study|Withdrawal by Subject|2|||
156495035|NCT00701909|564907960|FG000|Overall Study|Withdrawal by Subject|0|||
156495036|NCT00701909|564907961|FG001|Overall Study|Withdrawal by Subject|1|||
156495037|NCT00908349|564907962|FG000|Overall Study|Adverse Event|10|||
156495038|NCT00908349|564907962|FG000|Overall Study|Withdrawal by Subject|9|||
156495039|NCT00908349|564907962|FG000|Overall Study|Physician Decision|5|||
156495040|NCT00908349|564907962|FG000|Overall Study|Lost to Follow-up|5|||
156495041|NCT00908349|564907962|FG000|Overall Study|Various|6|||
156495042|NCT00971997|564907965|FG000|Overall Study|Adverse Event|2|||
156495043|NCT00971997|564907965|FG000|Overall Study|Death|1|||
156495044|NCT00971997|564907965|FG000|Overall Study|Protocol Violation|4|||
156495045|NCT00971997|564907965|FG000|Overall Study|Withdrawal by Subject|5|||
156495046|NCT00971997|564907965|FG000|Overall Study|Physician Decision|7|||
156495047|NCT00761956|564907970|FG000|Overall Study|Lost to Follow-up|6|||
156495048|NCT00761956|564907971|FG001|Overall Study|Lost to Follow-up|11|||
156495049|NCT00761956|564907970|FG000|Overall Study|Withdrawal by Subject|3|||
156495050|NCT00761956|564907971|FG001|Overall Study|Withdrawal by Subject|8|||
156495051|NCT00761956|564907970|FG000|Overall Study|Death|0|||
156495052|NCT00761956|564907971|FG001|Overall Study|Death|1|||
156495053|NCT00761956|564907970|FG000|Overall Study|Adverse Event|26|||
156495054|NCT00761956|564907971|FG001|Overall Study|Adverse Event|34|||
156495055|NCT02808975|564907974|FG000|Overall Study|Adverse Event|3|||
156495056|NCT02808975|564907975|FG001|Overall Study|Adverse Event|4|||
156495057|NCT02808975|564907974|FG000|Overall Study|Withdrew consent|9|||
156495058|NCT02808975|564907975|FG001|Overall Study|Withdrew consent|8|||
156495059|NCT02808975|564907974|FG000|Overall Study|Lost to Follow-up|4|||
156495060|NCT02808975|564907975|FG001|Overall Study|Lost to Follow-up|6|||
156495061|NCT02808975|564907974|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
156495062|NCT02808975|564907975|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
156495063|NCT02808975|564907974|FG000|Overall Study|Other, not specified|5|||
156495064|NCT02808975|564907975|FG001|Overall Study|Other, not specified|1|||
156495065|NCT01288209|564907976|FG000|Overall Study|Withdrawal by Subject|1|||
156495066|NCT01288209|564907977|FG001|Overall Study|Withdrawal by Subject|3|||
156495067|NCT01288209|564907976|FG000|Overall Study|Other|1|||
156495068|NCT01288209|564907977|FG001|Overall Study|Other|0|||
156495069|NCT03463577|564907978|FG000|Overall Study|Lost to Follow-up|238|||
156495070|NCT03463577|564907979|FG001|Overall Study|Lost to Follow-up|435|||
156495071|NCT03463577|564907980|FG002|Overall Study|Lost to Follow-up|0|||
156495072|NCT03463577|564907981|FG003|Overall Study|Lost to Follow-up|0|||
156495073|NCT03463577|564907982|FG004|Overall Study|Lost to Follow-up|0|||
156495074|NCT03463577|564907983|FG005|Overall Study|Lost to Follow-up|0|||
156495075|NCT03463577|564907978|FG000|Overall Study|With unknown pregnancy outcome|0|||
156495076|NCT03463577|564907979|FG001|Overall Study|With unknown pregnancy outcome|5|||
156495077|NCT03463577|564907980|FG002|Overall Study|With unknown pregnancy outcome|0|||
156495078|NCT03463577|564907981|FG003|Overall Study|With unknown pregnancy outcome|0|||
156495079|NCT03463577|564907982|FG004|Overall Study|With unknown pregnancy outcome|0|||
156495080|NCT03463577|564907983|FG005|Overall Study|With unknown pregnancy outcome|0|||
156495081|NCT03463577|564907978|FG000|Overall Study|Maternal death|2|||
156495082|NCT03463577|564907979|FG001|Overall Study|Maternal death|0|||
156495083|NCT03463577|564907980|FG002|Overall Study|Maternal death|0|||
156495084|NCT03463577|564907981|FG003|Overall Study|Maternal death|0|||
156495085|NCT03463577|564907982|FG004|Overall Study|Maternal death|0|||
156495086|NCT03463577|564907983|FG005|Overall Study|Maternal death|0|||
156495087|NCT03463577|564907978|FG000|Overall Study|Neonatal death|0|||
156495088|NCT03463577|564907979|FG001|Overall Study|Neonatal death|0|||
156495089|NCT03463577|564907980|FG002|Overall Study|Neonatal death|0|||
156495090|NCT03463577|564907981|FG003|Overall Study|Neonatal death|15|||
156495091|NCT03463577|564907982|FG004|Overall Study|Neonatal death|17|||
156495092|NCT03463577|564907983|FG005|Overall Study|Neonatal death|0|||
156495093|NCT00236184|564907984|FG000|Overall Study|Adverse Event|5|||
156495094|NCT00236184|564907985|FG001|Overall Study|Adverse Event|2|||
156495095|NCT00236184|564907984|FG000|Overall Study|Lack of Efficacy|0|||
156495096|NCT00236184|564907985|FG001|Overall Study|Lack of Efficacy|1|||
156495097|NCT00236184|564907984|FG000|Overall Study|Lost to Follow-up|3|||
156495098|NCT00236184|564907985|FG001|Overall Study|Lost to Follow-up|4|||
156495099|NCT00236184|564907984|FG000|Overall Study|Physician Decision|1|||
156495100|NCT00236184|564907985|FG001|Overall Study|Physician Decision|1|||
156495101|NCT00236184|564907984|FG000|Overall Study|Withdrawal by Subject|3|||
156495102|NCT00236184|564907985|FG001|Overall Study|Withdrawal by Subject|0|||
156495103|NCT00236184|564907984|FG000|Overall Study|Protocol Violation|3|||
156495104|NCT00236184|564907985|FG001|Overall Study|Protocol Violation|0|||
156495105|NCT00236184|564907984|FG000|Overall Study|non-compliance with study drug|2|||
156495106|NCT00236184|564907985|FG001|Overall Study|non-compliance with study drug|1|||
156495107|NCT00236184|564907984|FG000|Overall Study|other|1|||
156495108|NCT00236184|564907985|FG001|Overall Study|other|2|||
156495109|NCT01316887|564907986|FG000|Overall Study|Adverse Event|13|||
156495110|NCT01316887|564907987|FG001|Overall Study|Adverse Event|21|||
156495111|NCT01316887|564907988|FG002|Overall Study|Adverse Event|17|||
156495112|NCT01316887|564907986|FG000|Overall Study|Lack of Efficacy|9|||
156495113|NCT01316887|564907987|FG001|Overall Study|Lack of Efficacy|3|||
156495114|NCT01316887|564907988|FG002|Overall Study|Lack of Efficacy|1|||
156495115|NCT01316887|564907986|FG000|Overall Study|Protocol Violation|2|||
156495116|NCT01316887|564907987|FG001|Overall Study|Protocol Violation|6|||
156495117|NCT01316887|564907988|FG002|Overall Study|Protocol Violation|6|||
156495118|NCT01316887|564907986|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
156495119|NCT01316887|564907987|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
156495120|NCT01316887|564907988|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
156495121|NCT01316887|564907986|FG000|Overall Study|Study Closed/Terminated|2|||
156495122|NCT01316887|564907987|FG001|Overall Study|Study Closed/Terminated|4|||
156495123|NCT01316887|564907988|FG002|Overall Study|Study Closed/Terminated|3|||
156495124|NCT01316887|564907986|FG000|Overall Study|Lost to Follow-up|1|||
156495125|NCT01316887|564907987|FG001|Overall Study|Lost to Follow-up|7|||
156495126|NCT01316887|564907988|FG002|Overall Study|Lost to Follow-up|5|||
156495127|NCT01316887|564907986|FG000|Overall Study|Withdrawal by Subject|8|||
156495128|NCT01316887|564907987|FG001|Overall Study|Withdrawal by Subject|16|||
156495129|NCT01316887|564907988|FG002|Overall Study|Withdrawal by Subject|15|||
156495130|NCT00469456|564907989|FG000|Overall Study|Adverse Event|4|||
156495131|NCT00469456|564907990|FG001|Overall Study|Adverse Event|3|||
156495132|NCT00469456|564907989|FG000|Overall Study|Protocol Violation|1|||
156495133|NCT00469456|564907990|FG001|Overall Study|Protocol Violation|0|||
156495134|NCT00469456|564907989|FG000|Overall Study|Withdrawal by Subject|4|||
156495135|NCT00469456|564907990|FG001|Overall Study|Withdrawal by Subject|1|||
156495136|NCT00704171|564907991|FG000|Overall Study|Withdrawal by Subject|1|||
156495137|NCT00704171|564907992|FG001|Overall Study|Withdrawal by Subject|0|||
156495138|NCT00813098|564907997|FG000|Overall Study|Adverse Event|2|||
156495139|NCT00813098|564907998|FG001|Overall Study|Adverse Event|4|||
156495140|NCT00813098|564907999|FG002|Overall Study|Adverse Event|1|||
156495141|NCT00813098|564907997|FG000|Overall Study|Withdrawal by Subject|0|||
156495142|NCT00813098|564907998|FG001|Overall Study|Withdrawal by Subject|1|||
156495143|NCT00813098|564907999|FG002|Overall Study|Withdrawal by Subject|0|||
156495144|NCT00813098|564907997|FG000|Overall Study|Inability to complete study procedures|1|||
156495145|NCT00813098|564907998|FG001|Overall Study|Inability to complete study procedures|0|||
156495146|NCT00813098|564907999|FG002|Overall Study|Inability to complete study procedures|0|||
156495147|NCT00813098|564907997|FG000|Overall Study|Lost to Follow-up|0|||
156495148|NCT00813098|564907998|FG001|Overall Study|Lost to Follow-up|1|||
156495149|NCT00813098|564907999|FG002|Overall Study|Lost to Follow-up|0|||
156495150|NCT00813098|564907997|FG000|Overall Study|Protocol Violation|0|||
156495151|NCT00813098|564907998|FG001|Overall Study|Protocol Violation|0|||
156495152|NCT00813098|564907999|FG002|Overall Study|Protocol Violation|1|||
156495153|NCT00813098|564907997|FG000|Overall Study|Principal Investigator decision|0|||
156495154|NCT00813098|564907998|FG001|Overall Study|Principal Investigator decision|1|||
156546632|NCT03605680|565094917|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
156546633|NCT03605680|565094918|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
156546634|NCT00647556|565094919|FG000|Overall Study|Adverse Event|0|||
156495155|NCT00813098|564907999|FG002|Overall Study|Principal Investigator decision|0|||
156495156|NCT00813098|564907997|FG000|Overall Study|Withdrew Consent|0|||
156495157|NCT00813098|564907998|FG001|Overall Study|Withdrew Consent|1|||
156495158|NCT00813098|564907999|FG002|Overall Study|Withdrew Consent|0|||
156495159|NCT01777490|564908002|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
156495160|NCT01777490|564908003|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
156495161|NCT01777490|564908004|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
156495162|NCT01777490|564908005|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
156375417|NCT01109316|564468469|FG004|Study Period 1|Withdrawal by Subject|2|||
156375418|NCT01109316|564468470|FG005|Study Period 1|Withdrawal by Subject|0|||
156375419|NCT01109316|564468465|FG000|Study Period 1|Sponsor Decision|0|||
156495163|NCT03672175|564908008|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
156495164|NCT03672175|564908009|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
156495165|NCT03672175|564908010|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
156495166|NCT03672175|564908008|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
156495167|NCT03672175|564908009|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
156546635|NCT00647556|565094920|FG001|Overall Study|Adverse Event|1|||
156495168|NCT03672175|564908010|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
156495169|NCT03672175|564908008|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
156495170|NCT03672175|564908009|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
156546636|NCT00647556|565094919|FG000|Overall Study|Lost to Follow-up|1|||
156495171|NCT03672175|564908010|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
156495172|NCT03672175|564908008|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
156495173|NCT03672175|564908009|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
156495174|NCT03672175|564908010|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
156495175|NCT03672175|564908008|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
156495176|NCT03672175|564908009|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
156495177|NCT03672175|564908010|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
156495178|NCT03672175|564908008|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
156495179|NCT03672175|564908009|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
156495180|NCT03672175|564908010|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
156495181|NCT03672175|564908008|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
156495182|NCT03672175|564908009|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
156495183|NCT03672175|564908010|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
156495184|NCT03672175|564908008|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
156495185|NCT03672175|564908009|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
156495186|NCT03672175|564908010|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
156495187|NCT03672175|564908008|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
156495188|NCT03672175|564908009|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
156495189|NCT03672175|564908010|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
156495190|NCT03672175|564908008|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
156495191|NCT03672175|564908009|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
156495192|NCT03672175|564908010|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
156495193|NCT03672175|564908008|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
156495194|NCT03672175|564908009|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
156495195|NCT03672175|564908010|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
156495196|NCT03672175|564908008|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
156495197|NCT03672175|564908009|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
156495198|NCT03672175|564908010|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
156495199|NCT01772563|564908011|FG000|Cycle 1|Dose limiting toxicity|2|||
156495200|NCT01772563|564908011|FG000|Cycle 1|Progressive disease|2|||
156495201|NCT01772563|564908011|FG000|Cycle 2 and Beyond|Progressive disease|17|||
156495202|NCT01772563|564908011|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
156495203|NCT01772563|564908011|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
156495204|NCT00255944|564908015|FG000|Overall Study|Lost to Follow-up|797|||
156495205|NCT00255944|564908016|FG001|Overall Study|Lost to Follow-up|834|||
156495206|NCT01121913|564908018|FG000|First Intervention Period|Adverse Event|0|||
156495207|NCT01121913|564908019|FG001|First Intervention Period|Adverse Event|0|||
156495208|NCT01121913|564908020|FG002|First Intervention Period|Adverse Event|1|||
156495209|NCT01121913|564908021|FG003|First Intervention Period|Adverse Event|0|||
156495210|NCT01121913|564908018|FG000|First Washout Period|Withdrawal by Subject|1|||
156495211|NCT01121913|564908019|FG001|First Washout Period|Withdrawal by Subject|0|||
156495212|NCT01121913|564908020|FG002|First Washout Period|Withdrawal by Subject|0|||
156495213|NCT01121913|564908021|FG003|First Washout Period|Withdrawal by Subject|0|||
156495214|NCT01121913|564908018|FG000|Second Intervention Period|Adverse Event|0|||
156495215|NCT01121913|564908019|FG001|Second Intervention Period|Adverse Event|0|||
156495216|NCT01121913|564908020|FG002|Second Intervention Period|Adverse Event|1|||
156495217|NCT01121913|564908021|FG003|Second Intervention Period|Adverse Event|0|||
156495218|NCT01121913|564908018|FG000|Second Washout Period|Withdrawal by Subject|0|||
156495219|NCT01121913|564908019|FG001|Second Washout Period|Withdrawal by Subject|0|||
156495220|NCT01121913|564908020|FG002|Second Washout Period|Withdrawal by Subject|1|||
156495221|NCT01121913|564908021|FG003|Second Washout Period|Withdrawal by Subject|0|||
156495222|NCT01121913|564908018|FG000|Third Washout Period|Adverse Event|1|||
156495223|NCT01121913|564908019|FG001|Third Washout Period|Adverse Event|0|||
156495224|NCT01121913|564908020|FG002|Third Washout Period|Adverse Event|0|||
156495225|NCT01121913|564908021|FG003|Third Washout Period|Adverse Event|0|||
156495226|NCT00690378|564908028|FG000|Overall Study|Adverse Event|1|||
156495227|NCT00690378|564908029|FG001|Overall Study|Adverse Event|0|||
156495228|NCT00690378|564908028|FG000|Overall Study|Withdrawal by Subject|2|||
156495229|NCT00690378|564908029|FG001|Overall Study|Withdrawal by Subject|0|||
156495230|NCT00690378|564908028|FG000|Overall Study|Protocol Violation|1|||
156495231|NCT00690378|564908029|FG001|Overall Study|Protocol Violation|0|||
156495232|NCT00690378|564908028|FG000|Overall Study|Lost to Follow-up|2|||
156495233|NCT00690378|564908029|FG001|Overall Study|Lost to Follow-up|3|||
156495234|NCT00690378|564908028|FG000|Overall Study|Did not meet inc/exc criteria|13|||
156495235|NCT00690378|564908029|FG001|Overall Study|Did not meet inc/exc criteria|11|||
156495236|NCT00690378|564908028|FG000|Overall Study|Social problem|1|||
156495237|NCT00690378|564908029|FG001|Overall Study|Social problem|0|||
156495238|NCT02019641|564908033|FG000|10-Week Follow up|Withdrawal by investigator|2|||
156495239|NCT02019641|564908034|FG001|10-Week Follow up|Withdrawal by investigator|0|||
156495240|NCT02019641|564908035|FG002|10-Week Follow up|Withdrawal by investigator|0|||
156495241|NCT02019641|564908033|FG000|10-Week Follow up|Withdrawal by Subject|1|||
156546637|NCT00647556|565094920|FG001|Overall Study|Lost to Follow-up|0|||
156495242|NCT02019641|564908034|FG001|10-Week Follow up|Withdrawal by Subject|1|||
156495243|NCT02019641|564908035|FG002|10-Week Follow up|Withdrawal by Subject|0|||
156495244|NCT02019641|564908033|FG000|20-Week Follow up|Withdrawal by investigator|0|||
156495245|NCT02019641|564908034|FG001|20-Week Follow up|Withdrawal by investigator|0|||
156495246|NCT02019641|564908035|FG002|20-Week Follow up|Withdrawal by investigator|1|||
156495247|NCT00468130|564908036|FG000|Overall Study|Adverse Event|2|||
156495248|NCT00468130|564908037|FG001|Overall Study|Adverse Event|1|||
156495249|NCT00468130|564908036|FG000|Overall Study|Withdrawal by Subject|0|||
156495250|NCT00468130|564908037|FG001|Overall Study|Withdrawal by Subject|1|||
156495251|NCT02485899|564908038|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
156495252|NCT02485899|564908039|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156495253|NCT02485899|564908038|FG000|Overall Study|Withdrawal by Subject|1|||
156495254|NCT02485899|564908039|FG001|Overall Study|Withdrawal by Subject|0|||
156495255|NCT02485899|564908038|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
156495256|NCT02485899|564908039|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
156495257|NCT00623363|564908040|FG000|Overall Study|Adverse Event|2|||
156495258|NCT00623363|564908041|FG001|Overall Study|Adverse Event|2|||
156495259|NCT03713320|564908042|FG000|Randomized Period|Adverse Event|1|||
156495260|NCT03713320|564908043|FG001|Randomized Period|Adverse Event|5|||
156495261|NCT03713320|564908044|FG002|Randomized Period|Adverse Event|0|||
156495262|NCT03713320|564908042|FG000|Randomized Period|Physician Decision|1|||
156495263|NCT03713320|564908043|FG001|Randomized Period|Physician Decision|1|||
156495264|NCT03713320|564908044|FG002|Randomized Period|Physician Decision|0|||
156495265|NCT03713320|564908042|FG000|Randomized Period|Withdrawal by Subject|4|||
156495266|NCT03713320|564908043|FG001|Randomized Period|Withdrawal by Subject|0|||
156495267|NCT03713320|564908044|FG002|Randomized Period|Withdrawal by Subject|0|||
156495268|NCT03713320|564908042|FG000|Randomized Period|Participant decision|3|||
156495269|NCT03713320|564908043|FG001|Randomized Period|Participant decision|1|||
156495270|NCT03713320|564908044|FG002|Randomized Period|Participant decision|0|||
156495271|NCT03713320|564908042|FG000|Randomized Period|Study terminated by sponsor|6|||
156495272|NCT03713320|564908043|FG001|Randomized Period|Study terminated by sponsor|3|||
156495273|NCT03713320|564908044|FG002|Randomized Period|Study terminated by sponsor|0|||
156495274|NCT03713320|564908042|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
156495275|NCT03713320|564908043|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
156495276|NCT03713320|564908044|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
156495277|NCT03713320|564908042|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
156495278|NCT03713320|564908043|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
156495279|NCT03713320|564908044|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
156495280|NCT01880437|564908045|FG000|Overall Study|Death|12|||
156495281|NCT01880437|564908046|FG001|Overall Study|Death|4|||
156495282|NCT01880437|564908047|FG002|Overall Study|Death|17|||
156495283|NCT01880437|564908045|FG000|Overall Study|Study terminated by Sponsor|3|||
156495284|NCT01880437|564908046|FG001|Overall Study|Study terminated by Sponsor|0|||
156495285|NCT01880437|564908047|FG002|Overall Study|Study terminated by Sponsor|2|||
156495286|NCT00909532|564908048|FG000|Overall Study|Adverse Event|4|||
156495287|NCT00909532|564908049|FG001|Overall Study|Adverse Event|1|||
156495288|NCT00909532|564908048|FG000|Overall Study|Pregnancy|0|||
156495289|NCT00909532|564908049|FG001|Overall Study|Pregnancy|1|||
156495290|NCT00909532|564908048|FG000|Overall Study|Prohibited Medication|2|||
156495291|NCT00909532|564908049|FG001|Overall Study|Prohibited Medication|1|||
156495292|NCT00909532|564908048|FG000|Overall Study|Withdrawal of Consent|1|||
156495293|NCT00909532|564908049|FG001|Overall Study|Withdrawal of Consent|1|||
156495294|NCT00909532|564908048|FG000|Overall Study|Noncompliance with Study Requirements|0|||
156495295|NCT00909532|564908049|FG001|Overall Study|Noncompliance with Study Requirements|2|||
156495296|NCT00909532|564908048|FG000|Overall Study|Physician Decision|1|||
156495297|NCT00909532|564908049|FG001|Overall Study|Physician Decision|0|||
156495298|NCT00909532|564908048|FG000|Overall Study|Wrong Genotype|1|||
156495299|NCT00909532|564908049|FG001|Overall Study|Wrong Genotype|0|||
156495300|NCT00909532|564908048|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
156495301|NCT00909532|564908049|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
156495302|NCT01209598|564908050|FG000|Overall Study|Withdrawal by Subject|1|||
156495303|NCT01209598|564908051|FG001|Overall Study|Withdrawal by Subject|0|||
156495304|NCT00085566|564908053|FG000|Overall Study|Adverse Event|0|||
156546638|NCT00647556|565094919|FG000|Overall Study|Protocol Violation|0|||
156546639|NCT00647556|565094920|FG001|Overall Study|Protocol Violation|1|||
156495305|NCT00085566|564908054|FG001|Overall Study|Adverse Event|0|||
156495306|NCT00085566|564908055|FG002|Overall Study|Adverse Event|10|||
156495307|NCT00085566|564908053|FG000|Overall Study|Patient Not treated|0|||
156546640|NCT00647556|565094919|FG000|Overall Study|Withdrawal by Subject|1|||
156495308|NCT00085566|564908054|FG001|Overall Study|Patient Not treated|0|||
156495309|NCT00085566|564908055|FG002|Overall Study|Patient Not treated|3|||
156495310|NCT00085566|564908053|FG000|Overall Study|Clinical progression|0|||
156495311|NCT00085566|564908054|FG001|Overall Study|Clinical progression|0|||
156495312|NCT00085566|564908055|FG002|Overall Study|Clinical progression|1|||
156495313|NCT02604342|564908057|FG000|Overall Study|Death|32|||
156495314|NCT02604342|564908058|FG001|Overall Study|Death|16|||
156495315|NCT02604342|564908057|FG000|Overall Study|Progression of disease|1|||
156495316|NCT02604342|564908058|FG001|Overall Study|Progression of disease|0|||
156495317|NCT02604342|564908057|FG000|Overall Study|Withdrawal by Subject|5|||
156495318|NCT02604342|564908058|FG001|Overall Study|Withdrawal by Subject|6|||
156495319|NCT02604342|564908057|FG000|Overall Study|Other|1|||
156495320|NCT02604342|564908058|FG001|Overall Study|Other|0|||
156495321|NCT02604342|564908057|FG000|Overall Study|Study Termination by Sponsor|1|||
156495322|NCT02604342|564908058|FG001|Overall Study|Study Termination by Sponsor|0|||
156495323|NCT02604342|564908057|FG000|Overall Study|Lost to Follow-up|1|||
156495324|NCT02604342|564908058|FG001|Overall Study|Lost to Follow-up|1|||
156495325|NCT02604342|564908057|FG000|Overall Study|Physician Decision|2|||
156495326|NCT02604342|564908058|FG001|Overall Study|Physician Decision|0|||
156495327|NCT01702519|564908059|FG000|Washout Period|Lost to Follow-up|1|||
156495328|NCT01702519|564908060|FG001|Washout Period|Lost to Follow-up|0|||
156495329|NCT01702519|564908059|FG000|Washout Period|Withdrawal by Subject|0|||
156495330|NCT01702519|564908060|FG001|Washout Period|Withdrawal by Subject|2|||
156495331|NCT01837797|564908063|FG000|Period 1|Adverse Event|9|||
156495332|NCT01837797|564908064|FG001|Period 1|Adverse Event|0|||
156495333|NCT01837797|564908065|FG002|Period 1|Adverse Event|0|||
156495334|NCT01837797|564908066|FG003|Period 1|Adverse Event|0|||
156495335|NCT01837797|564908067|FG004|Period 1|Adverse Event|0|||
156495336|NCT01837797|564908063|FG000|Period 1|Withdrawal by Subject|6|||
156495337|NCT01837797|564908064|FG001|Period 1|Withdrawal by Subject|0|||
156495338|NCT01837797|564908065|FG002|Period 1|Withdrawal by Subject|0|||
156495339|NCT01837797|564908066|FG003|Period 1|Withdrawal by Subject|0|||
156495340|NCT01837797|564908067|FG004|Period 1|Withdrawal by Subject|0|||
156495341|NCT01837797|564908063|FG000|Period 1|Administrative reasons|76|||
156495342|NCT01837797|564908064|FG001|Period 1|Administrative reasons|0|||
156495343|NCT01837797|564908065|FG002|Period 1|Administrative reasons|0|||
156495344|NCT01837797|564908066|FG003|Period 1|Administrative reasons|0|||
156495345|NCT01837797|564908067|FG004|Period 1|Administrative reasons|0|||
156495346|NCT01837797|564908063|FG000|Period 1|Withdrawal of consent before treatment|1|||
156495347|NCT01837797|564908064|FG001|Period 1|Withdrawal of consent before treatment|0|||
156495348|NCT01837797|564908065|FG002|Period 1|Withdrawal of consent before treatment|0|||
156495349|NCT01837797|564908066|FG003|Period 1|Withdrawal of consent before treatment|0|||
156495350|NCT01837797|564908067|FG004|Period 1|Withdrawal of consent before treatment|0|||
156495351|NCT01837797|564908063|FG000|Period 1|Other|10|||
156495352|NCT01837797|564908064|FG001|Period 1|Other|0|||
156495353|NCT01837797|564908065|FG002|Period 1|Other|0|||
156495354|NCT01837797|564908066|FG003|Period 1|Other|0|||
156495355|NCT01837797|564908067|FG004|Period 1|Other|0|||
156495356|NCT01837797|564908063|FG000|Period 2|Administrative or other reasons|0|||
156495357|NCT01837797|564908064|FG001|Period 2|Administrative or other reasons|5|||
156495358|NCT01837797|564908065|FG002|Period 2|Administrative or other reasons|2|||
156495359|NCT01837797|564908066|FG003|Period 2|Administrative or other reasons|4|||
156495360|NCT01837797|564908067|FG004|Period 2|Administrative or other reasons|0|||
156495361|NCT01837797|564908063|FG000|Period 2|Adverse Event|0|||
156495362|NCT01837797|564908064|FG001|Period 2|Adverse Event|0|||
156495363|NCT01837797|564908065|FG002|Period 2|Adverse Event|0|||
156495364|NCT01837797|564908066|FG003|Period 2|Adverse Event|1|||
156495365|NCT01837797|564908067|FG004|Period 2|Adverse Event|0|||
156495366|NCT01837797|564908063|FG000|Period 3|Adverse Event|0|||
156495367|NCT01837797|564908064|FG001|Period 3|Adverse Event|0|||
156495368|NCT01837797|564908065|FG002|Period 3|Adverse Event|0|||
156495369|NCT01837797|564908066|FG003|Period 3|Adverse Event|0|||
156495370|NCT01837797|564908067|FG004|Period 3|Adverse Event|1|||
156495371|NCT01837797|564908063|FG000|Period 3|Administrative reasons|0|||
156495372|NCT01837797|564908064|FG001|Period 3|Administrative reasons|0|||
156495373|NCT01837797|564908065|FG002|Period 3|Administrative reasons|0|||
156495374|NCT01837797|564908066|FG003|Period 3|Administrative reasons|0|||
156375420|NCT01109316|564468466|FG001|Study Period 1|Sponsor Decision|0|||
156375421|NCT01109316|564468467|FG002|Study Period 1|Sponsor Decision|0|||
156375422|NCT01109316|564468468|FG003|Study Period 1|Sponsor Decision|0|||
156375423|NCT01109316|564468469|FG004|Study Period 1|Sponsor Decision|0|||
156495375|NCT01837797|564908067|FG004|Period 3|Administrative reasons|20|||
156495376|NCT01837797|564908063|FG000|Period 3|Other|0|||
156495377|NCT01837797|564908064|FG001|Period 3|Other|0|||
156495378|NCT01837797|564908065|FG002|Period 3|Other|0|||
156495379|NCT01837797|564908066|FG003|Period 3|Other|0|||
156495380|NCT01837797|564908067|FG004|Period 3|Other|2|||
156375424|NCT01109316|564468470|FG005|Study Period 1|Sponsor Decision|2|||
156495381|NCT04522778|564908089|FG000|Overall Study|Patient did not want to wear the device|1|||
156375425|NCT01109316|564468465|FG000|Study Period 2|Entry Criteria Not Met|0|||
156495382|NCT04522778|564908090|FG001|Overall Study|Patient did not want to wear the device|0|||
156375426|NCT01109316|564468466|FG001|Study Period 2|Entry Criteria Not Met|1|||
156495383|NCT04522778|564908089|FG000|Overall Study|Lost to Follow-up|0|||
156495384|NCT04522778|564908090|FG001|Overall Study|Lost to Follow-up|1|||
156495385|NCT00069277|564908091|FG000|Overall Study|Adverse Event|3|||
156495386|NCT00069277|564908091|FG000|Overall Study|Withdrawal by Subject|1|||
156495387|NCT00069277|564908091|FG000|Overall Study|Progressive Disease|15|||
156495388|NCT00069277|564908091|FG000|Overall Study|Physician Decision|2|||
156495389|NCT01225159|564908094|FG000|Overall Study|Change operation|1|||
156495390|NCT01225159|564908095|FG001|Overall Study|Change operation|0|||
156495391|NCT01220856|564908102|FG000|Overall Study|graft loss|3|||
156495392|NCT01220856|564908103|FG001|Overall Study|graft loss|3|||
156495393|NCT01220856|564908102|FG000|Overall Study|Lost to Follow-up|1|||
156495394|NCT01220856|564908103|FG001|Overall Study|Lost to Follow-up|0|||
156495395|NCT01024036|564908104|FG000|Blinded Treatment|Adverse Event|1|||
156495396|NCT01024036|564908105|FG001|Blinded Treatment|Adverse Event|1|||
156495397|NCT01024036|564908104|FG000|Blinded Treatment|Lack of Efficacy|16|||
156495398|NCT01024036|564908105|FG001|Blinded Treatment|Lack of Efficacy|14|||
156495399|NCT01024036|564908104|FG000|Blinded Treatment|Physician Decision|1|||
156495400|NCT01024036|564908105|FG001|Blinded Treatment|Physician Decision|0|||
156495401|NCT01024036|564908104|FG000|Blinded Treatment|Death|0|||
156495402|NCT01024036|564908105|FG001|Blinded Treatment|Death|2|||
156495403|NCT01024036|564908104|FG000|Blinded Treatment|Withdrawal by Subject|4|||
156495404|NCT01024036|564908105|FG001|Blinded Treatment|Withdrawal by Subject|3|||
156495405|NCT01024036|564908104|FG000|Unblinded Treatment|Adverse Event|0|||
156495406|NCT01024036|564908105|FG001|Unblinded Treatment|Adverse Event|1|||
156495407|NCT01024036|564908104|FG000|Unblinded Treatment|Lack of Efficacy|0|||
156495408|NCT01024036|564908105|FG001|Unblinded Treatment|Lack of Efficacy|2|||
156495409|NCT01024036|564908104|FG000|Follow-Up Period|Lost to Follow-up|1|||
156495410|NCT01024036|564908105|FG001|Follow-Up Period|Lost to Follow-up|1|||
156495411|NCT01024036|564908104|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156495412|NCT01024036|564908105|FG001|Follow-Up Period|Withdrawal by Subject|1|||
156495413|NCT01024036|564908104|FG000|Follow-Up Period|Adverse Event|4|||
156495414|NCT01024036|564908105|FG001|Follow-Up Period|Adverse Event|1|||
156495415|NCT04814992|564908106|FG000|Overall Study|Withdrawal by Subject|6|||
156495416|NCT04814992|564908107|FG001|Overall Study|Withdrawal by Subject|3|||
156495417|NCT04814992|564908106|FG000|Overall Study|Lost to Follow-up|1|||
156495418|NCT04814992|564908107|FG001|Overall Study|Lost to Follow-up|4|||
156495419|NCT00934700|564908108|FG000|Overall Study|missing scan|5|||
156495420|NCT00934700|564908109|FG001|Overall Study|missing scan|9|||
156495421|NCT00934700|564908108|FG000|Overall Study|Death|8|||
156495422|NCT00934700|564908109|FG001|Overall Study|Death|3|||
156495423|NCT03900715|564908110|FG000|Overall Study|Protocol Deviation|1|||
156495424|NCT03900715|564908110|FG000|Overall Study|Lack of Efficacy|1|||
156495425|NCT03900715|564908110|FG000|Overall Study|Progressive Disease|6|||
156495426|NCT03900715|564908110|FG000|Overall Study|Adverse Event|2|||
156495427|NCT03900715|564908110|FG000|Overall Study|Other reasons|11|||
156495428|NCT01131104|564909742|FG000|Overall Study|Withdrawal by Subject|3|||
156495429|NCT01131104|564909742|FG000|Overall Study|Physician Decision|4|||
156495430|NCT01131104|564909742|FG000|Overall Study|Information Not Available|5|||
156495431|NCT01131104|564909742|FG000|Overall Study|No Information on Index Date of Onset|1|||
156495432|NCT04523207|564909745|FG000|Overall Study|Adverse Event|5|||
156495433|NCT04523207|564909746|FG001|Overall Study|Adverse Event|1|||
156495434|NCT04523207|564909745|FG000|Overall Study|Lost to Follow-up|2|||
156375427|NCT01109316|564468467|FG002|Study Period 2|Entry Criteria Not Met|0|||
156375428|NCT01109316|564468468|FG003|Study Period 2|Entry Criteria Not Met|0|||
156375429|NCT01109316|564468469|FG004|Study Period 2|Entry Criteria Not Met|0|||
156495435|NCT04523207|564909746|FG001|Overall Study|Lost to Follow-up|0|||
156495436|NCT04523207|564909745|FG000|Overall Study|Withdrawal by Subject|2|||
156495437|NCT04523207|564909746|FG001|Overall Study|Withdrawal by Subject|0|||
156495438|NCT04523207|564909745|FG000|Overall Study|Progressive Disease|2|||
156495439|NCT04523207|564909746|FG001|Overall Study|Progressive Disease|1|||
156495440|NCT04523207|564909745|FG000|Overall Study|Other|7|||
156495441|NCT04523207|564909746|FG001|Overall Study|Other|1|||
156495442|NCT03113383|564909747|FG000|Overall Study|Death|4|||
156495443|NCT03113383|564909748|FG001|Overall Study|Death|0|||
156495444|NCT03062449|564909750|FG000|Overall Study|Withdrawal by Subject|7|||
156495445|NCT03062449|564909751|FG001|Overall Study|Withdrawal by Subject|1|||
156495446|NCT03194867|564909756|FG000|Overall Study|Incorrect completion of end of study form|0|||
156495447|NCT03194867|564909757|FG001|Overall Study|Incorrect completion of end of study form|0|||
156495448|NCT03194867|564909758|FG002|Overall Study|Incorrect completion of end of study form|1|||
156375430|NCT01109316|564468470|FG005|Study Period 2|Entry Criteria Not Met|0|||
156495449|NCT03194867|564909759|FG003|Overall Study|Incorrect completion of end of study form|0|||
156495450|NCT00543062|564909760|FG000|Overall Study|Withdrawal by Subject|1|||
156495451|NCT00543062|564909761|FG001|Overall Study|Withdrawal by Subject|0|||
156495452|NCT00543062|564909762|FG002|Overall Study|Withdrawal by Subject|2|||
156495453|NCT00543062|564909763|FG003|Overall Study|Withdrawal by Subject|0|||
156495454|NCT00543062|564909760|FG000|Overall Study|Adverse Event|0|||
156495455|NCT00543062|564909761|FG001|Overall Study|Adverse Event|1|||
156495456|NCT00543062|564909762|FG002|Overall Study|Adverse Event|1|||
156495457|NCT00543062|564909763|FG003|Overall Study|Adverse Event|1|||
156495458|NCT00543062|564909760|FG000|Overall Study|Protocol Violation|1|||
156495459|NCT00543062|564909761|FG001|Overall Study|Protocol Violation|0|||
156495460|NCT00543062|564909762|FG002|Overall Study|Protocol Violation|0|||
156495461|NCT00543062|564909763|FG003|Overall Study|Protocol Violation|0|||
156495462|NCT00464945|564909764|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
156375431|NCT01109316|564468465|FG000|Study Period 2|Physician Decision|0|||
156375432|NCT01109316|564468466|FG001|Study Period 2|Physician Decision|0|||
156375433|NCT01109316|564468467|FG002|Study Period 2|Physician Decision|0|||
156375434|NCT01109316|564468468|FG003|Study Period 2|Physician Decision|1|||
156375435|NCT01109316|564468469|FG004|Study Period 2|Physician Decision|0|||
156375436|NCT01109316|564468470|FG005|Study Period 2|Physician Decision|0|||
156375437|NCT01109316|564468465|FG000|Study Period 2|Protocol Violation|1|||
156375438|NCT01109316|564468466|FG001|Study Period 2|Protocol Violation|0|||
156375439|NCT01109316|564468467|FG002|Study Period 2|Protocol Violation|0|||
156375440|NCT01109316|564468468|FG003|Study Period 2|Protocol Violation|0|||
156375441|NCT01109316|564468469|FG004|Study Period 2|Protocol Violation|0|||
156375442|NCT01109316|564468470|FG005|Study Period 2|Protocol Violation|0|||
156375443|NCT01109316|564468465|FG000|Study Period 2|Withdrawal by Subject|0|||
156375444|NCT01109316|564468466|FG001|Study Period 2|Withdrawal by Subject|0|||
156375445|NCT01109316|564468467|FG002|Study Period 2|Withdrawal by Subject|1|||
156375446|NCT01109316|564468468|FG003|Study Period 2|Withdrawal by Subject|0|||
156375447|NCT01109316|564468469|FG004|Study Period 2|Withdrawal by Subject|0|||
156375448|NCT01109316|564468470|FG005|Study Period 2|Withdrawal by Subject|1|||
156375449|NCT01109316|564468465|FG000|Study Period 3|Lost to Follow-up|0|||
156375450|NCT01109316|564468466|FG001|Study Period 3|Lost to Follow-up|0|||
156375451|NCT01109316|564468467|FG002|Study Period 3|Lost to Follow-up|0|||
156375452|NCT01109316|564468468|FG003|Study Period 3|Lost to Follow-up|0|||
156375453|NCT01109316|564468469|FG004|Study Period 3|Lost to Follow-up|1|||
156375454|NCT01109316|564468470|FG005|Study Period 3|Lost to Follow-up|0|||
156375455|NCT01109316|564468465|FG000|Study Period 3|Withdrawal by Subject|1|||
156375456|NCT01109316|564468466|FG001|Study Period 3|Withdrawal by Subject|0|||
156375457|NCT01109316|564468467|FG002|Study Period 3|Withdrawal by Subject|0|||
156375458|NCT01109316|564468468|FG003|Study Period 3|Withdrawal by Subject|0|||
156375459|NCT01109316|564468469|FG004|Study Period 3|Withdrawal by Subject|1|||
156375460|NCT01109316|564468470|FG005|Study Period 3|Withdrawal by Subject|0|||
156375461|NCT01826825|564468477|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
156375462|NCT01826825|564468478|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
156375463|NCT00515827|564468479|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
156375464|NCT00515827|564468480|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
156375465|NCT00515827|564468479|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
156375466|NCT00515827|564468480|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
156375467|NCT03254134|564468482|FG000|Overall Study|Not eligible patients|599|||
156375468|NCT03254134|564468483|FG001|Overall Study|Not eligible patients|3630|||
156375469|NCT01712984|564468488|FG000|Overall Study|Adverse Event|0|||
156375470|NCT01712984|564468489|FG001|Overall Study|Adverse Event|0|||
156375471|NCT01712984|564468490|FG002|Overall Study|Adverse Event|1|||
156375472|NCT01712984|564468488|FG000|Overall Study|Protocol Violation|2|||
156375473|NCT01712984|564468489|FG001|Overall Study|Protocol Violation|0|||
156375474|NCT01712984|564468490|FG002|Overall Study|Protocol Violation|1|||
156375475|NCT01712984|564468488|FG000|Overall Study|Lost to Follow-up|8|||
156375476|NCT01712984|564468489|FG001|Overall Study|Lost to Follow-up|10|||
156375477|NCT01712984|564468490|FG002|Overall Study|Lost to Follow-up|1|||
156375478|NCT01712984|564468488|FG000|Overall Study|Withdrawal by Subject|6|||
156375479|NCT01712984|564468489|FG001|Overall Study|Withdrawal by Subject|6|||
156375480|NCT01712984|564468490|FG002|Overall Study|Withdrawal by Subject|7|||
156375481|NCT01552772|564468491|FG000|Overall Study|Lost to Follow-up|2|||
156375482|NCT01552772|564468491|FG000|Overall Study|Adverse Event|1|||
156375483|NCT01552772|564468491|FG000|Overall Study|Protocol Deviation|1|||
156375484|NCT01848990|564468492|FG000|Overall Study|Adverse Event|6|||
156375485|NCT01848990|564468493|FG001|Overall Study|Adverse Event|2|||
156495463|NCT00464945|564909765|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
156495464|NCT00464945|564909764|FG000|Infant Series|Protocol Violation|1|||
156375486|NCT01848990|564468494|FG002|Overall Study|Adverse Event|0|||
156375487|NCT01848990|564468492|FG000|Overall Study|Lost to Follow-up|6|||
156375488|NCT01848990|564468493|FG001|Overall Study|Lost to Follow-up|2|||
156375489|NCT01848990|564468494|FG002|Overall Study|Lost to Follow-up|2|||
156375490|NCT01848990|564468492|FG000|Overall Study|Protocol Violation|1|||
156375491|NCT01848990|564468493|FG001|Overall Study|Protocol Violation|1|||
156375492|NCT01848990|564468494|FG002|Overall Study|Protocol Violation|0|||
156375493|NCT01848990|564468492|FG000|Overall Study|Withdrawal by Subject|29|||
156375494|NCT01848990|564468493|FG001|Overall Study|Withdrawal by Subject|10|||
156375495|NCT01848990|564468494|FG002|Overall Study|Withdrawal by Subject|11|||
156375496|NCT01848990|564468492|FG000|Overall Study|Physician Decision|1|||
156375497|NCT01848990|564468493|FG001|Overall Study|Physician Decision|1|||
156375498|NCT01848990|564468494|FG002|Overall Study|Physician Decision|0|||
156375499|NCT01848990|564468492|FG000|Overall Study|Non Compliance|1|||
156375500|NCT01848990|564468493|FG001|Overall Study|Non Compliance|0|||
156375501|NCT01848990|564468494|FG002|Overall Study|Non Compliance|0|||
156375502|NCT01848990|564468492|FG000|Overall Study|Death|1|||
156375503|NCT01848990|564468493|FG001|Overall Study|Death|0|||
156375504|NCT01848990|564468494|FG002|Overall Study|Death|1|||
156375505|NCT01848990|564468492|FG000|Overall Study|Other|1|||
156495465|NCT00464945|564909765|FG001|Infant Series|Protocol Violation|0|||
156495466|NCT00464945|564909764|FG000|Infant Series|Lost to Follow-up|1|||
156495467|NCT00464945|564909765|FG001|Infant Series|Lost to Follow-up|0|||
156495468|NCT00464945|564909764|FG000|After Infant Series|Withdrawal by Subject|0|||
156495469|NCT00464945|564909765|FG001|After Infant Series|Withdrawal by Subject|2|||
156495470|NCT00464945|564909764|FG000|Toddler Dose|Lost to Follow-up|0|||
156495471|NCT00464945|564909765|FG001|Toddler Dose|Lost to Follow-up|1|||
156495472|NCT02438371|564909768|FG000|Overall Study|Lost to Follow-up|3|||
156495473|NCT02438371|564909769|FG001|Overall Study|Lost to Follow-up|2|||
156495474|NCT02438371|564909768|FG000|Overall Study|Withdrawal by Subject|1|||
156495475|NCT02438371|564909769|FG001|Overall Study|Withdrawal by Subject|1|||
156495476|NCT01161446|564909770|FG000|Overall Study|Lost to Follow-up|18|||
156495477|NCT01161446|564909771|FG001|Overall Study|Lost to Follow-up|14|||
156495478|NCT01161446|564909770|FG000|Overall Study|Withdrawal by Subject|0|||
156495479|NCT01161446|564909771|FG001|Overall Study|Withdrawal by Subject|1|||
156495480|NCT02536742|564909772|FG000|Overall Study|Did not start protocol therapy|1|||
156495481|NCT02536742|564909772|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
156495482|NCT01496365|564909773|FG000|Overall Study|Adverse Event|2|||
156495483|NCT01496365|564909774|FG001|Overall Study|Adverse Event|3|||
156495484|NCT01496365|564909775|FG002|Overall Study|Adverse Event|3|||
156495485|NCT01496365|564909776|FG003|Overall Study|Adverse Event|2|||
156495486|NCT01496365|564909777|FG004|Overall Study|Adverse Event|5|||
156495487|NCT01496365|564909778|FG005|Overall Study|Adverse Event|6|||
156495488|NCT01496365|564909779|FG006|Overall Study|Adverse Event|4|||
156495489|NCT01496365|564909773|FG000|Overall Study|Withdrawal by Subject|6|||
156495490|NCT01496365|564909774|FG001|Overall Study|Withdrawal by Subject|6|||
156495491|NCT01496365|564909775|FG002|Overall Study|Withdrawal by Subject|0|||
156495492|NCT01496365|564909776|FG003|Overall Study|Withdrawal by Subject|1|||
156495493|NCT01496365|564909777|FG004|Overall Study|Withdrawal by Subject|3|||
156495494|NCT01496365|564909778|FG005|Overall Study|Withdrawal by Subject|2|||
156495495|NCT01496365|564909779|FG006|Overall Study|Withdrawal by Subject|1|||
156495496|NCT01496365|564909773|FG000|Overall Study|Protocol Violation|2|||
156495497|NCT01496365|564909774|FG001|Overall Study|Protocol Violation|1|||
156495498|NCT01496365|564909775|FG002|Overall Study|Protocol Violation|1|||
156495499|NCT01496365|564909776|FG003|Overall Study|Protocol Violation|0|||
156495500|NCT01496365|564909777|FG004|Overall Study|Protocol Violation|0|||
156495501|NCT01496365|564909778|FG005|Overall Study|Protocol Violation|1|||
156495502|NCT01496365|564909779|FG006|Overall Study|Protocol Violation|0|||
156495503|NCT01496365|564909773|FG000|Overall Study|Lack of Efficacy|1|||
156495504|NCT01496365|564909774|FG001|Overall Study|Lack of Efficacy|0|||
156495505|NCT01496365|564909775|FG002|Overall Study|Lack of Efficacy|0|||
156495506|NCT01496365|564909776|FG003|Overall Study|Lack of Efficacy|0|||
156495507|NCT01496365|564909777|FG004|Overall Study|Lack of Efficacy|0|||
156495508|NCT01496365|564909778|FG005|Overall Study|Lack of Efficacy|1|||
156495509|NCT01496365|564909779|FG006|Overall Study|Lack of Efficacy|0|||
156495510|NCT01496365|564909773|FG000|Overall Study|Lost to Follow-up|0|||
156495511|NCT01496365|564909774|FG001|Overall Study|Lost to Follow-up|1|||
156495512|NCT01496365|564909775|FG002|Overall Study|Lost to Follow-up|0|||
156495513|NCT01496365|564909776|FG003|Overall Study|Lost to Follow-up|0|||
156495514|NCT01496365|564909777|FG004|Overall Study|Lost to Follow-up|2|||
156495515|NCT01496365|564909778|FG005|Overall Study|Lost to Follow-up|0|||
156495516|NCT01496365|564909779|FG006|Overall Study|Lost to Follow-up|0|||
156495517|NCT01496365|564909773|FG000|Overall Study|Other|4|||
156495518|NCT01496365|564909774|FG001|Overall Study|Other|4|||
156495519|NCT01496365|564909775|FG002|Overall Study|Other|2|||
156495520|NCT01496365|564909776|FG003|Overall Study|Other|1|||
156495521|NCT01496365|564909777|FG004|Overall Study|Other|3|||
156495522|NCT01496365|564909778|FG005|Overall Study|Other|0|||
156495523|NCT01496365|564909779|FG006|Overall Study|Other|1|||
156495524|NCT01015677|564909780|FG000|Overall Study|Adverse Event|0|||
156495525|NCT01015677|564909781|FG001|Overall Study|Adverse Event|1|||
156495526|NCT01015677|564909782|FG002|Overall Study|Adverse Event|0|||
156495527|NCT01015677|564909780|FG000|Overall Study|Lack of Efficacy|0|||
156375506|NCT01848990|564468493|FG001|Overall Study|Other|4|||
156375507|NCT01848990|564468494|FG002|Overall Study|Other|2|||
156375508|NCT00512096|564468503|FG000|Overall Study|Adverse Event|2|||
156375509|NCT00512096|564468503|FG000|Overall Study|Withdrawal by Subject|2|||
156375510|NCT00512096|564468503|FG000|Overall Study|Lack of Efficacy|3|||
156375511|NCT03551210|564468507|FG000|Overall Study|Adverse Event|5|||
156375512|NCT03551210|564468508|FG001|Overall Study|Adverse Event|6|||
156375513|NCT03551210|564468507|FG000|Overall Study|Withdrawal by Subject|1|||
156375514|NCT03551210|564468508|FG001|Overall Study|Withdrawal by Subject|7|||
156375515|NCT03551210|564468507|FG000|Overall Study|Needed in other antibiotic treatment|2|||
156375516|NCT03551210|564468508|FG001|Overall Study|Needed in other antibiotic treatment|5|||
156375517|NCT03551210|564468507|FG000|Overall Study|Lost to Follow-up|1|||
156375518|NCT03551210|564468508|FG001|Overall Study|Lost to Follow-up|1|||
156375519|NCT03551210|564468507|FG000|Overall Study|Absence of visit 4 and 5|1|||
156375520|NCT03551210|564468508|FG001|Overall Study|Absence of visit 4 and 5|0|||
156375521|NCT03551210|564468507|FG000|Overall Study|No drug for dispensing|0|||
156375522|NCT03551210|564468508|FG001|Overall Study|No drug for dispensing|1|||
156375523|NCT03265119|564468509|FG000|Overall Study|Adverse Event|2|||
156375524|NCT03265119|564468510|FG001|Overall Study|Adverse Event|1|||
156375525|NCT03265119|564468509|FG000|Overall Study|Lack of Efficacy|3|||
156495528|NCT01015677|564909781|FG001|Overall Study|Lack of Efficacy|1|||
156495529|NCT01015677|564909782|FG002|Overall Study|Lack of Efficacy|0|||
156495530|NCT01015677|564909780|FG000|Overall Study|Protocol Violation|0|||
156495531|NCT01015677|564909781|FG001|Overall Study|Protocol Violation|1|||
156495532|NCT01015677|564909782|FG002|Overall Study|Protocol Violation|0|||
156495533|NCT01015677|564909780|FG000|Overall Study|Withdrawal by Subject|1|||
156495534|NCT01015677|564909781|FG001|Overall Study|Withdrawal by Subject|1|||
156495535|NCT01015677|564909782|FG002|Overall Study|Withdrawal by Subject|0|||
156495536|NCT01660256|564909783|FG000|Overall Study|Adverse Event|4|||
156495537|NCT01660256|564909784|FG001|Overall Study|Adverse Event|0|||
156495538|NCT01660256|564909785|FG002|Overall Study|Adverse Event|2|||
156495539|NCT01660256|564909783|FG000|Overall Study|Withdrawal by Subject|1|||
156495540|NCT01660256|564909784|FG001|Overall Study|Withdrawal by Subject|0|||
156495541|NCT01660256|564909785|FG002|Overall Study|Withdrawal by Subject|2|||
156495542|NCT01646385|564909787|FG000|Overall Study|Death|202|||
156495543|NCT01646385|564909788|FG001|Overall Study|Death|222|||
156495544|NCT01646385|564909787|FG000|Overall Study|Switched to alternate biologic|636|||
156495545|NCT01646385|564909788|FG001|Overall Study|Switched to alternate biologic|649|||
156495546|NCT03898960|564909789|FG000|Overall Study|Death|10|||
156495547|NCT01129115|564909792|FG000|Overall Study|Adverse Event|1|||
156495548|NCT01129115|564909793|FG001|Overall Study|Adverse Event|2|||
156495549|NCT01129115|564909794|FG002|Overall Study|Adverse Event|3|||
156495550|NCT01129115|564909795|FG003|Overall Study|Adverse Event|3|||
156495551|NCT01129115|564909792|FG000|Overall Study|Withdrawal by Subject|1|||
156495552|NCT01129115|564909793|FG001|Overall Study|Withdrawal by Subject|3|||
156495553|NCT01129115|564909794|FG002|Overall Study|Withdrawal by Subject|1|||
156495554|NCT01129115|564909795|FG003|Overall Study|Withdrawal by Subject|4|||
156495555|NCT01129115|564909792|FG000|Overall Study|Protocol Violation|0|||
156495556|NCT01129115|564909793|FG001|Overall Study|Protocol Violation|2|||
156495557|NCT01129115|564909794|FG002|Overall Study|Protocol Violation|2|||
156495558|NCT01129115|564909795|FG003|Overall Study|Protocol Violation|2|||
156495559|NCT01747837|564909796|FG000|Overall Study|Lost to Follow-up|5|||
156495560|NCT01747837|564909797|FG001|Overall Study|Lost to Follow-up|2|||
156495561|NCT01747837|564909796|FG000|Overall Study|Death|4|||
156495562|NCT01747837|564909797|FG001|Overall Study|Death|4|||
156495563|NCT00935259|564909799|FG000|Period 1|Administrative (scheduling conflict)|1|||
156495564|NCT00935259|564909800|FG001|Period 1|Administrative (scheduling conflict)|1|||
156495565|NCT03410108|564909803|FG000|Overall Study|Ongoing|41|||
156495566|NCT03410108|564909803|FG000|Overall Study|Adverse Event|4|||
156495567|NCT03410108|564909803|FG000|Overall Study|Progressive Disease|58|||
156495568|NCT03410108|564909803|FG000|Overall Study|Withdrawal by Subject|1|||
156495569|NCT03856047|564909804|FG000|Overall Study|Withdrawal by Subject|0|||
156495570|NCT03856047|564909805|FG001|Overall Study|Withdrawal by Subject|1|||
156546641|NCT00647556|565094920|FG001|Overall Study|Withdrawal by Subject|0|||
156375526|NCT03265119|564468510|FG001|Overall Study|Lack of Efficacy|0|||
156375527|NCT03265119|564468509|FG000|Overall Study|Protocol Violation|1|||
156375528|NCT03265119|564468510|FG001|Overall Study|Protocol Violation|2|||
156375529|NCT03265119|564468509|FG000|Overall Study|Withdrawal by Subject|2|||
156375530|NCT03265119|564468510|FG001|Overall Study|Withdrawal by Subject|4|||
156375531|NCT03265119|564468509|FG000|Overall Study|Lost to Follow-up|1|||
156375532|NCT03265119|564468510|FG001|Overall Study|Lost to Follow-up|0|||
156375533|NCT03265119|564468509|FG000|Overall Study|Lack of Compliance|1|||
156495571|NCT03856047|564909806|FG002|Overall Study|Withdrawal by Subject|1|||
156495572|NCT03856047|564909807|FG003|Overall Study|Withdrawal by Subject|0|||
156495573|NCT03856047|564909808|FG004|Overall Study|Withdrawal by Subject|3|||
156495574|NCT03856047|564909809|FG005|Overall Study|Withdrawal by Subject|0|||
156495575|NCT03856047|564909810|FG006|Overall Study|Withdrawal by Subject|2|||
156495576|NCT03856047|564909804|FG000|Overall Study|Lost to Follow-up|4|||
156495577|NCT03856047|564909805|FG001|Overall Study|Lost to Follow-up|2|||
156495578|NCT03856047|564909806|FG002|Overall Study|Lost to Follow-up|3|||
156495579|NCT03856047|564909807|FG003|Overall Study|Lost to Follow-up|1|||
156495580|NCT03856047|564909808|FG004|Overall Study|Lost to Follow-up|4|||
156495581|NCT03856047|564909809|FG005|Overall Study|Lost to Follow-up|4|||
156495582|NCT03856047|564909810|FG006|Overall Study|Lost to Follow-up|4|||
156495583|NCT03269695|564909815|FG000|Overall Study|Adverse Event|2|||
156495584|NCT03269695|564909816|FG001|Overall Study|Adverse Event|1|||
156495585|NCT03269695|564909815|FG000|Overall Study|Lack of Efficacy|0|||
156495586|NCT03269695|564909816|FG001|Overall Study|Lack of Efficacy|1|||
156495587|NCT03269695|564909815|FG000|Overall Study|Withdrawal by Subject|0|||
156495588|NCT03269695|564909816|FG001|Overall Study|Withdrawal by Subject|1|||
156495589|NCT01313624|564909817|FG000|Double-Blind Phase|Adverse Event|27|||
156495590|NCT01313624|564909818|FG001|Double-Blind Phase|Adverse Event|4|||
156495591|NCT01313624|564909817|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
156495592|NCT01313624|564909818|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
156495593|NCT01313624|564909817|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156495594|NCT01313624|564909818|FG001|Double-Blind Phase|Lost to Follow-up|2|||
156375534|NCT03265119|564468510|FG001|Overall Study|Lack of Compliance|0|||
156375535|NCT02293005|564470028|FG000|Overall Study|Adverse Event|2|||
156375536|NCT02293005|564470028|FG000|Overall Study|Death|4|||
156375537|NCT02293005|564470028|FG000|Overall Study|Lost to Follow-up|1|||
156375538|NCT02293005|564470028|FG000|Overall Study|Withdrawal by Subject|2|||
156375539|NCT02293005|564470028|FG000|Overall Study|Progression|17|||
156375540|NCT03143829|564470034|FG000|Overall Study|Withdrawal by Subject|2|||
156375541|NCT03143829|564470035|FG001|Overall Study|Withdrawal by Subject|5|||
156375542|NCT03143829|564470034|FG000|Overall Study|Lost to Follow-up|0|||
156375543|NCT03143829|564470035|FG001|Overall Study|Lost to Follow-up|2|||
156375544|NCT03143829|564470034|FG000|Overall Study|Death|1|||
156375545|NCT03143829|564470035|FG001|Overall Study|Death|1|||
156375546|NCT03143829|564470034|FG000|Overall Study|changed treatment, no longer eligible|2|||
156375547|NCT03143829|564470035|FG001|Overall Study|changed treatment, no longer eligible|2|||
156375548|NCT00938431|564470038|FG000|Overall Study|Adverse Event|5|||
156375549|NCT00938431|564470039|FG001|Overall Study|Adverse Event|8|||
156375550|NCT00938431|564470040|FG002|Overall Study|Adverse Event|6|||
156375551|NCT00938431|564470038|FG000|Overall Study|Lack of Efficacy|0|||
156375552|NCT00938431|564470039|FG001|Overall Study|Lack of Efficacy|1|||
156375553|NCT00938431|564470040|FG002|Overall Study|Lack of Efficacy|0|||
156375554|NCT00938431|564470038|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
156375555|NCT00938431|564470039|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
156375556|NCT00938431|564470040|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
156375557|NCT00938431|564470038|FG000|Overall Study|Dosing compliance issue|0|||
156375558|NCT00938431|564470039|FG001|Overall Study|Dosing compliance issue|0|||
156375559|NCT00938431|564470040|FG002|Overall Study|Dosing compliance issue|1|||
156375560|NCT00938431|564470038|FG000|Overall Study|Reached maximum dose early|0|||
156375561|NCT00938431|564470039|FG001|Overall Study|Reached maximum dose early|0|||
156375562|NCT00938431|564470040|FG002|Overall Study|Reached maximum dose early|1|||
156375563|NCT03738865|564470045|FG000|Overall Study|Withdrawal by Subject|3|||
156375564|NCT03738865|564470046|FG001|Overall Study|Withdrawal by Subject|3|||
156375565|NCT03738865|564470045|FG000|Overall Study|Adverse Event|2|||
156375566|NCT03738865|564470046|FG001|Overall Study|Adverse Event|0|||
156375567|NCT03738865|564470045|FG000|Overall Study|Physician Decision|0|||
156375568|NCT03738865|564470046|FG001|Overall Study|Physician Decision|1|||
156375569|NCT01774903|564470047|FG000|Overall Study|Adverse Event|7|||
156375570|NCT01774903|564470047|FG000|Overall Study|Withdrawal by Subject|2|||
156375571|NCT01774903|564470047|FG000|Overall Study|Lack of Efficacy|1|||
156375572|NCT01774903|564470047|FG000|Overall Study|Ineligible to continue the trial|1|||
156375573|NCT01602315|564470048|FG000|Overall Study|Protocol Violation|0|||
156495595|NCT01313624|564909817|FG000|Double-Blind Phase|Physician Decision|1|||
156495596|NCT01313624|564909818|FG001|Double-Blind Phase|Physician Decision|0|||
156546642|NCT00647556|565094919|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
156375574|NCT01602315|564470049|FG001|Overall Study|Protocol Violation|0|||
156375575|NCT01602315|564470050|FG002|Overall Study|Protocol Violation|0|||
156375576|NCT01602315|564470051|FG003|Overall Study|Protocol Violation|0|||
156375577|NCT01602315|564470052|FG004|Overall Study|Protocol Violation|0|||
156375578|NCT01602315|564470053|FG005|Overall Study|Protocol Violation|1|||
156375579|NCT01602315|564470054|FG006|Overall Study|Protocol Violation|0|||
156375580|NCT01602315|564470048|FG000|Overall Study|Physician Decision|2|||
156375581|NCT01602315|564470049|FG001|Overall Study|Physician Decision|0|||
156375582|NCT01602315|564470050|FG002|Overall Study|Physician Decision|0|||
156375583|NCT01602315|564470051|FG003|Overall Study|Physician Decision|0|||
156375584|NCT01602315|564470052|FG004|Overall Study|Physician Decision|2|||
156375585|NCT01602315|564470053|FG005|Overall Study|Physician Decision|1|||
156375586|NCT01602315|564470054|FG006|Overall Study|Physician Decision|1|||
156375587|NCT01602315|564470048|FG000|Overall Study|Disease progression|6|||
156375588|NCT01602315|564470049|FG001|Overall Study|Disease progression|3|||
156375589|NCT01602315|564470050|FG002|Overall Study|Disease progression|10|||
156495597|NCT01313624|564909817|FG000|Double-Blind Phase|Lack of Efficacy|1|||
156495598|NCT01313624|564909818|FG001|Double-Blind Phase|Lack of Efficacy|0|||
156495599|NCT01313624|564909817|FG000|Open-Label Phase|Adverse Event|1|||
156495600|NCT01313624|564909818|FG001|Open-Label Phase|Adverse Event|10|||
156495601|NCT01313624|564909817|FG000|Open-Label Phase|Withdrawal by Subject|2|||
156495602|NCT01313624|564909818|FG001|Open-Label Phase|Withdrawal by Subject|2|||
156495603|NCT01313624|564909817|FG000|Open-Label Phase|Lost to Follow-up|1|||
156495604|NCT01313624|564909818|FG001|Open-Label Phase|Lost to Follow-up|1|||
156495605|NCT01017263|564909819|FG000|Overall Study|not eligible|12|||
156495606|NCT05043883|564909820|FG000|Overall Study|Minimum required measurements could not be taken|4|||
156495607|NCT02980705|564909821|FG000|Overall Study|Adverse Event|0|||
156495608|NCT02980705|564909822|FG001|Overall Study|Adverse Event|1|||
156495609|NCT02980705|564909821|FG000|Overall Study|Withdrawal by Subject|6|||
156495610|NCT02980705|564909822|FG001|Overall Study|Withdrawal by Subject|9|||
156495611|NCT02980705|564909821|FG000|Overall Study|withdrew participation|0|||
156495612|NCT02980705|564909822|FG001|Overall Study|withdrew participation|1|||
156495613|NCT02980705|564909821|FG000|Overall Study|Lost to Follow-up|2|||
156495614|NCT02980705|564909822|FG001|Overall Study|Lost to Follow-up|0|||
156495615|NCT01721746|564909823|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
156495616|NCT01721746|564909824|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
156495617|NCT01721746|564909823|FG000|Pre-Treatment|Withdrawal by Subject|1|||
156495618|NCT01721746|564909824|FG001|Pre-Treatment|Withdrawal by Subject|16|||
156495619|NCT01721746|564909823|FG000|Pre-Treatment|Poor/Non-compliance|1|||
156495620|NCT01721746|564909824|FG001|Pre-Treatment|Poor/Non-compliance|0|||
156495621|NCT01721746|564909823|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
156495622|NCT01721746|564909824|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
156495623|NCT01721746|564909823|FG000|Treatment|Disease Progression|192|||
156495624|NCT01721746|564909824|FG001|Treatment|Disease Progression|74|||
156495625|NCT01721746|564909823|FG000|Treatment|Study Drug Toxicity|19|||
156495626|NCT01721746|564909824|FG001|Treatment|Study Drug Toxicity|11|||
156495627|NCT01721746|564909823|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
156495628|NCT01721746|564909824|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
156495629|NCT01721746|564909823|FG000|Treatment|Participant request to discontinue Study treatment|26|||
156495630|NCT01721746|564909824|FG001|Treatment|Participant request to discontinue Study treatment|7|||
156495631|NCT01721746|564909823|FG000|Treatment|Participant withdrew consent|4|||
156495632|NCT01721746|564909824|FG001|Treatment|Participant withdrew consent|2|||
156495633|NCT01721746|564909823|FG000|Treatment|Maximum Clinical Benefit|9|||
156495634|NCT01721746|564909824|FG001|Treatment|Maximum Clinical Benefit|3|||
156495635|NCT01721746|564909823|FG000|Treatment|Poor/Non-compliance|2|||
156495636|NCT01721746|564909824|FG001|Treatment|Poor/Non-compliance|0|||
156495637|NCT01721746|564909823|FG000|Treatment|Participant no longer met Study criteria|4|||
156495638|NCT01721746|564909824|FG001|Treatment|Participant no longer met Study criteria|0|||
156495639|NCT01721746|564909823|FG000|Treatment|Other reasons|6|||
156495640|NCT01721746|564909824|FG001|Treatment|Other reasons|2|||
156495641|NCT00263575|564909825|FG000|Titration Period|Adverse Event|14|||
156495642|NCT00263575|564909825|FG000|Titration Period|Withdrawal by Subject|10|||
156495643|NCT00263575|564909825|FG000|Titration Period|Protocol Violation|9|||
156495644|NCT00263575|564909825|FG000|Titration Period|Sponsor Decision|2|||
156495645|NCT00263575|564909825|FG000|Titration Period|Other|2|||
156495646|NCT00263575|564909825|FG000|Titration Period|Lack of Efficacy|6|||
156495647|NCT00263575|564909825|FG000|Maintence Period|Adverse Event|23|||
156495648|NCT00263575|564909825|FG000|Maintence Period|Withdrawal by Subject|8|||
156495649|NCT00263575|564909825|FG000|Maintence Period|Protocol Violation|4|||
156495650|NCT00263575|564909825|FG000|Maintence Period|Lack of Efficacy|4|||
156495651|NCT00263575|564909825|FG000|Maintence Period|Physician Decision|6|||
156495652|NCT00263575|564909825|FG000|Maintence Period|Lost to Follow-up|1|||
156495653|NCT00263575|564909825|FG000|Maintence Period|Sponsor Decision|24|||
156495654|NCT00263575|564909825|FG000|Maintence Period|Other|7|||
156495655|NCT00239681|564909828|FG000|Overall Study|Adverse Event|100|||
156495656|NCT00239681|564909829|FG001|Overall Study|Adverse Event|99|||
156495657|NCT00239681|564909828|FG000|Overall Study|Withdrawal by Subject|458|||
156495658|NCT00239681|564909829|FG001|Overall Study|Withdrawal by Subject|489|||
156495659|NCT00239681|564909828|FG000|Overall Study|Lost to Follow-up|28|||
156495660|NCT00239681|564909829|FG001|Overall Study|Lost to Follow-up|22|||
156495661|NCT00239681|564909828|FG000|Overall Study|Protocol Violation|4|||
156495662|NCT00239681|564909829|FG001|Overall Study|Protocol Violation|4|||
156495663|NCT00239681|564909828|FG000|Overall Study|Physician Decision|13|||
156495664|NCT00239681|564909829|FG001|Overall Study|Physician Decision|17|||
156495665|NCT00239681|564909828|FG000|Overall Study|No information chacked on CaseReportForm|90|||
156495666|NCT00239681|564909829|FG001|Overall Study|No information chacked on CaseReportForm|84|||
156495667|NCT02447718|564909830|FG000|Overall Study|Lost to Follow-up|8|||
156495668|NCT02447718|564909831|FG001|Overall Study|Lost to Follow-up|0|||
156495669|NCT02447718|564909830|FG000|Overall Study|Withdrawal by Subject|3|||
156495670|NCT02447718|564909831|FG001|Overall Study|Withdrawal by Subject|0|||
156495671|NCT02447718|564909830|FG000|Overall Study|Screen Failure|1|||
156495672|NCT02447718|564909831|FG001|Overall Study|Screen Failure|0|||
156495673|NCT02654132|564909834|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
156495674|NCT02654132|564909835|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
156495675|NCT02654132|564909834|FG000|Treatment Period|Disease progression|43|||
156495676|NCT02654132|564909835|FG001|Treatment Period|Disease progression|38|||
156495677|NCT02654132|564909834|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
156495678|NCT02654132|564909835|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
156495679|NCT02654132|564909834|FG000|Treatment Period|Other reasons|4|||
156495680|NCT02654132|564909835|FG001|Treatment Period|Other reasons|2|||
156495681|NCT02654132|564909834|FG000|Treatment Period|Study drug toxicity|2|||
156495682|NCT02654132|564909835|FG001|Treatment Period|Study drug toxicity|2|||
156495683|NCT02654132|564909834|FG000|Treatment Period|Withdrawal by Subject|2|||
156495684|NCT02654132|564909835|FG001|Treatment Period|Withdrawal by Subject|1|||
156495685|NCT02654132|564909834|FG000|Treatment Period|Maximum Clinical Benefit|0|||
156495686|NCT02654132|564909835|FG001|Treatment Period|Maximum Clinical Benefit|2|||
156495687|NCT02654132|564909834|FG000|Treatment Period|Participant request to discontinue|2|||
156495688|NCT02654132|564909835|FG001|Treatment Period|Participant request to discontinue|0|||
156495689|NCT02654132|564909834|FG000|Treatment Period|Administrative reasons by sponsor|0|||
156495690|NCT02654132|564909835|FG001|Treatment Period|Administrative reasons by sponsor|1|||
156495691|NCT02654132|564909834|FG000|Treatment Period|Death|1|||
156495692|NCT02654132|564909835|FG001|Treatment Period|Death|0|||
156495693|NCT01781832|564909844|FG000|Overall Study|Withdrawal by Subject|1|||
156495694|NCT02287233|564909845|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
156495695|NCT02287233|564909846|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
156495696|NCT02287233|564909847|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
156495697|NCT02287233|564909845|FG000|Overall Study|Adverse Event Related to Progression|0|||
156495698|NCT02287233|564909846|FG001|Overall Study|Adverse Event Related to Progression|2|||
156495699|NCT02287233|564909847|FG002|Overall Study|Adverse Event Related to Progression|8|||
156495700|NCT02287233|564909845|FG000|Overall Study|Physician Decision|1|||
156495701|NCT02287233|564909846|FG001|Overall Study|Physician Decision|2|||
156495702|NCT02287233|564909847|FG002|Overall Study|Physician Decision|4|||
156495703|NCT02287233|564909845|FG000|Overall Study|Progressive Disease with Death|0|||
156495704|NCT02287233|564909846|FG001|Overall Study|Progressive Disease with Death|0|||
156495705|NCT02287233|564909847|FG002|Overall Study|Progressive Disease with Death|10|||
156495706|NCT02287233|564909845|FG000|Overall Study|Progressive Disease Without Death|2|||
156495707|NCT02287233|564909846|FG001|Overall Study|Progressive Disease Without Death|3|||
156495708|NCT02287233|564909847|FG002|Overall Study|Progressive Disease Without Death|20|||
156495709|NCT02287233|564909845|FG000|Overall Study|Withdrawal by Subject|1|||
156495710|NCT02287233|564909846|FG001|Overall Study|Withdrawal by Subject|1|||
156495711|NCT02287233|564909847|FG002|Overall Study|Withdrawal by Subject|7|||
156495712|NCT02287233|564909845|FG000|Overall Study|Other|3|||
156495713|NCT02287233|564909846|FG001|Overall Study|Other|0|||
156495714|NCT02287233|564909847|FG002|Overall Study|Other|15|||
156495715|NCT02287233|564909845|FG000|Overall Study|Did Not Receive Treatment|0|||
156495716|NCT02287233|564909846|FG001|Overall Study|Did Not Receive Treatment|0|||
156495717|NCT02287233|564909847|FG002|Overall Study|Did Not Receive Treatment|2|||
156495718|NCT03772613|564909849|FG000|Overall Study|Lost to Follow-up|0|||
156495719|NCT03772613|564909850|FG001|Overall Study|Lost to Follow-up|1|||
156495720|NCT03772613|564909851|FG002|Overall Study|Lost to Follow-up|1|||
156495721|NCT01185171|564909854|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
156495722|NCT01185171|564909854|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
156495723|NCT01185171|564909854|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
156495724|NCT01185171|564909854|FG000|Maintenance|Elevated liver transaminases|3|||
156495725|NCT01185171|564909854|FG000|Maintenance|Rush|2|||
156495726|NCT01185171|564909854|FG000|Maintenance|Diarrhea|1|||
156495727|NCT01185171|564909854|FG000|Maintenance|Xerostomia|1|||
156495728|NCT01185171|564909854|FG000|Maintenance|Nausea|1|||
156495729|NCT01185171|564909854|FG000|Maintenance|Comorbid Illness|2|||
156495730|NCT01185171|564909854|FG000|Maintenance|Withdrawal by Subject|1|||
156495731|NCT01185171|564909854|FG000|Maintenance|Disease Recurrence|1|||
156495732|NCT01482429|564909855|FG000|Care Usual|Protocol Violation|0|||
156495733|NCT01482429|564909856|FG001|Care Usual|Protocol Violation|172|||
156495734|NCT01482429|564909855|FG000|Care Usual|Lost to Follow-up|0|||
156495735|NCT01482429|564909856|FG001|Care Usual|Lost to Follow-up|1|||
156495736|NCT01482429|564909855|FG000|Protocol|Protocol Violation|275|||
156495737|NCT01482429|564909856|FG001|Protocol|Protocol Violation|0|||
156495738|NCT03561597|564909860|FG000|Overall Study|Lost to Follow-up|20|||
156495739|NCT00573651|564909861|FG000|Overall Study|Lost to Follow-up|3|||
156495740|NCT00573651|564909861|FG000|Overall Study|Withdrawal by Subject|1|||
156495741|NCT03797989|564909868|FG000|VAC069A|Withdrawal by Subject|0|||
156495742|NCT03797989|564909869|FG001|VAC069A|Withdrawal by Subject|0|||
156495743|NCT03797989|564909870|FG002|VAC069A|Withdrawal by Subject|1|||
156495744|NCT03797989|564909871|FG003|VAC069A|Withdrawal by Subject|0|||
156495745|NCT03797989|564909872|FG004|VAC069A|Withdrawal by Subject|0|||
156495746|NCT03797989|564909873|FG005|VAC069A|Withdrawal by Subject|0|||
156495747|NCT03797989|564909874|FG006|VAC069A|Withdrawal by Subject|0|||
156495748|NCT03797989|564909875|FG007|VAC069A|Withdrawal by Subject|0|||
156495749|NCT03797989|564909876|FG008|VAC069A|Withdrawal by Subject|0|||
156495750|NCT03797989|564909877|FG009|VAC069A|Withdrawal by Subject|0|||
156495751|NCT03797989|564909878|FG010|VAC069A|Withdrawal by Subject|0|||
156495752|NCT03797989|564909879|FG011|VAC069A|Withdrawal by Subject|0|||
156495753|NCT04052997|564909880|FG000|Overall Study|Withdrawal by Subject|17|||
156495754|NCT04052997|564909880|FG000|Overall Study|Physician Decision|50|||
156495755|NCT04052997|564909880|FG000|Overall Study|Death|43|||
156495756|NCT04052997|564909880|FG000|Overall Study|Lost to Follow-up|5|||
156495757|NCT04052997|564909880|FG000|Overall Study|Progression of Disease|1|||
156495758|NCT04594733|564909881|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
156495759|NCT04594733|564909882|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
156495760|NCT04594733|564909881|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
156495761|NCT04594733|564909882|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
156495762|NCT04594733|564909881|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
156495763|NCT04594733|564909882|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
156495764|NCT04811339|564909891|FG000|Overall Study|lack of transportation not wanting to return|4|||
156495765|NCT04811339|564909892|FG001|Overall Study|lack of transportation not wanting to return|8|||
156495766|NCT04811339|564909893|FG002|Overall Study|lack of transportation not wanting to return|0|||
156495767|NCT04811339|564909891|FG000|Overall Study|Adverse Event|3|||
156495768|NCT04811339|564909892|FG001|Overall Study|Adverse Event|0|||
156495769|NCT04811339|564909893|FG002|Overall Study|Adverse Event|0|||
156495770|NCT04811339|564909891|FG000|Overall Study|Lost to Follow-up|1|||
156495771|NCT04811339|564909892|FG001|Overall Study|Lost to Follow-up|0|||
156495772|NCT04811339|564909893|FG002|Overall Study|Lost to Follow-up|0|||
156495773|NCT04811339|564909891|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
156495774|NCT04811339|564909892|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
156495775|NCT04811339|564909893|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
156495776|NCT04811339|564909891|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
156495777|NCT04811339|564909892|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
156495778|NCT04811339|564909893|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
156495779|NCT04811339|564909891|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
156495780|NCT04811339|564909892|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
156495781|NCT04811339|564909893|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
156495782|NCT04811339|564909891|FG000|Overall Study|Withdrawal by Subject|0|||
156495783|NCT04811339|564909892|FG001|Overall Study|Withdrawal by Subject|3|||
156495784|NCT04811339|564909893|FG002|Overall Study|Withdrawal by Subject|0|||
156495785|NCT04811339|564909891|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
156495786|NCT04811339|564909892|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
156495787|NCT04811339|564909893|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
156495788|NCT04811339|564909891|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
156495789|NCT04811339|564909892|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
156495790|NCT04811339|564909893|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
156495791|NCT05896696|564909896|FG000|Overall Study|Screening Failure|7|||
156495792|NCT05896696|564909896|FG000|Overall Study|Withdrawal by Subject|2|||
156495793|NCT02166476|564911854|FG000|Overall Study|Withdrawal by Subject|5|||
156495794|NCT02166476|564911855|FG001|Overall Study|Withdrawal by Subject|7|||
156495795|NCT02166476|564911854|FG000|Overall Study|Adverse Event|3|||
156495796|NCT02166476|564911855|FG001|Overall Study|Adverse Event|3|||
156495797|NCT02166476|564911854|FG000|Overall Study|Lost to Follow-up|5|||
156495798|NCT02166476|564911855|FG001|Overall Study|Lost to Follow-up|10|||
156495799|NCT02166476|564911854|FG000|Overall Study|Physician Decision|1|||
156495800|NCT02166476|564911855|FG001|Overall Study|Physician Decision|0|||
156495801|NCT02166476|564911854|FG000|Overall Study|Unable to Come for Visit|0|||
156495802|NCT02166476|564911855|FG001|Overall Study|Unable to Come for Visit|3|||
156495803|NCT04367480|564911862|FG000|Overall Study|Adverse Event|1|||
156495804|NCT04367480|564911863|FG001|Overall Study|Adverse Event|1|||
156495805|NCT04367480|564911862|FG000|Overall Study|Death|1|||
156495806|NCT04367480|564911863|FG001|Overall Study|Death|0|||
156495807|NCT04367480|564911862|FG000|Overall Study|Lost to Follow-up|1|||
156495808|NCT04367480|564911863|FG001|Overall Study|Lost to Follow-up|1|||
156495809|NCT04367480|564911862|FG000|Overall Study|Withdrawal by Subject|0|||
156495810|NCT04367480|564911863|FG001|Overall Study|Withdrawal by Subject|3|||
156495811|NCT04367480|564911862|FG000|Overall Study|App glitch during the study|1|||
156495812|NCT04367480|564911863|FG001|Overall Study|App glitch during the study|0|||
156495813|NCT04367480|564911862|FG000|Overall Study|Device Distribution Error|0|||
156495814|NCT04367480|564911863|FG001|Overall Study|Device Distribution Error|2|||
156495815|NCT04367480|564911862|FG000|Overall Study|Ineligible after Randomization|0|||
156495816|NCT04367480|564911863|FG001|Overall Study|Ineligible after Randomization|1|||
156495817|NCT04367480|564911862|FG000|Overall Study|Other Medical Reasons|0|||
156495818|NCT04367480|564911863|FG001|Overall Study|Other Medical Reasons|2|||
156495819|NCT03382561|564911864|FG000|Overall Study|Disease progression|47|||
156495820|NCT03382561|564911865|FG001|Overall Study|Disease progression|6|||
156546643|NCT00647556|565094920|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
156546644|NCT03865706|565094924|FG000|Overall Study|Death|0|||
156495821|NCT03382561|564911864|FG000|Overall Study|Adverse Event|10|||
156495822|NCT03382561|564911865|FG001|Overall Study|Adverse Event|2|||
156495823|NCT03382561|564911864|FG000|Overall Study|Death|8|||
156546645|NCT03865706|565094925|FG001|Overall Study|Death|3|||
156546646|NCT03865706|565094926|FG002|Overall Study|Death|1|||
156495824|NCT03382561|564911865|FG001|Overall Study|Death|3|||
156495825|NCT03382561|564911864|FG000|Overall Study|Withdrawal by Subject|6|||
156495826|NCT03382561|564911865|FG001|Overall Study|Withdrawal by Subject|5|||
156495827|NCT03382561|564911864|FG000|Overall Study|Alternative therapy|2|||
156495828|NCT03382561|564911865|FG001|Overall Study|Alternative therapy|8|||
156495829|NCT03382561|564911864|FG000|Overall Study|Never started treatment|3|||
156495830|NCT03382561|564911865|FG001|Overall Study|Never started treatment|6|||
156495831|NCT03382561|564911864|FG000|Overall Study|Lack of Efficacy|0|||
156495832|NCT03382561|564911865|FG001|Overall Study|Lack of Efficacy|1|||
156495833|NCT03382561|564911864|FG000|Overall Study|Physician Decision|0|||
156495834|NCT03382561|564911865|FG001|Overall Study|Physician Decision|1|||
156495835|NCT03382561|564911864|FG000|Overall Study|Other complicating disease|0|||
156495836|NCT03382561|564911865|FG001|Overall Study|Other complicating disease|1|||
156495837|NCT02641587|564911867|FG000|Confinement Period|Adverse Event|1|||
156495838|NCT02641587|564911868|FG001|Confinement Period|Adverse Event|0|||
156495839|NCT02641587|564911867|FG000|Confinement Period|Withdrawal by Subject|2|||
156495840|NCT02641587|564911868|FG001|Confinement Period|Withdrawal by Subject|1|||
156495841|NCT02641587|564911867|FG000|Ambulatory Period|Withdrawal by Subject|1|||
156495842|NCT02641587|564911868|FG001|Ambulatory Period|Withdrawal by Subject|0|||
156495843|NCT01663506|564911870|FG000|Overall Study|Lack of Efficacy|3|||
156495844|NCT01663506|564911870|FG000|Overall Study|Consent Withdrawal by Subject|1|||
156495845|NCT01663506|564911870|FG000|Overall Study|Lost to Follow-up|1|||
156495846|NCT01663506|564911870|FG000|Overall Study|Adverse Event|1|||
156495847|NCT01663506|564911870|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
156495848|NCT02094898|564911876|FG000|Overall Study|Clinical Worsening|2|||
156495849|NCT02094898|564911876|FG000|Overall Study|Adverse Event|2|||
156495850|NCT02094898|564911876|FG000|Overall Study|Lack of Efficacy|1|||
156495851|NCT03520075|564911877|FG000|Phase 1 (Dose Escalation)|Death|2|||
156495852|NCT03520075|564911878|FG001|Phase 1 (Dose Escalation)|Death|2|||
156495853|NCT03520075|564911879|FG002|Phase 1 (Dose Escalation)|Death|3|||
156495854|NCT03520075|564911880|FG003|Phase 1 (Dose Escalation)|Death|2|||
156495855|NCT03520075|564911881|FG004|Phase 1 (Dose Escalation)|Death|6|||
156495856|NCT03520075|564911882|FG005|Phase 1 (Dose Escalation)|Death|5|||
156495857|NCT03520075|564911883|FG006|Phase 1 (Dose Escalation)|Death|3|||
156495858|NCT03520075|564911884|FG007|Phase 1 (Dose Escalation)|Death|2|||
156495859|NCT03520075|564911885|FG008|Phase 1 (Dose Escalation)|Death|3|||
156495860|NCT03520075|564911886|FG009|Phase 1 (Dose Escalation)|Death|1|||
156495861|NCT03520075|564911887|FG010|Phase 1 (Dose Escalation)|Death|5|||
156495862|NCT03520075|564911888|FG011|Phase 1 (Dose Escalation)|Death|7|||
156495863|NCT03520075|564911889|FG012|Phase 1 (Dose Escalation)|Death|11|||
156495864|NCT03520075|564911890|FG013|Phase 1 (Dose Escalation)|Death|0|||
156495865|NCT03520075|564911891|FG014|Phase 1 (Dose Escalation)|Death|0|||
156495866|NCT03520075|564911892|FG015|Phase 1 (Dose Escalation)|Death|0|||
156495867|NCT03520075|564911893|FG016|Phase 1 (Dose Escalation)|Death|0|||
156495868|NCT03520075|564911894|FG017|Phase 1 (Dose Escalation)|Death|0|||
156495869|NCT03520075|564911895|FG018|Phase 1 (Dose Escalation)|Death|0|||
156495870|NCT03520075|564911877|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
156495871|NCT03520075|564911878|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495872|NCT03520075|564911879|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495873|NCT03520075|564911880|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
156495874|NCT03520075|564911881|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
156495875|NCT03520075|564911882|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
156495876|NCT03520075|564911883|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495877|NCT03520075|564911884|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
156495878|NCT03520075|564911885|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495879|NCT03520075|564911886|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
156495880|NCT03520075|564911887|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495881|NCT03520075|564911888|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495882|NCT03520075|564911889|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
156495883|NCT03520075|564911890|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495884|NCT03520075|564911891|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495885|NCT03520075|564911892|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495886|NCT03520075|564911893|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495887|NCT03520075|564911894|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495888|NCT03520075|564911895|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
156495889|NCT03520075|564911877|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495890|NCT03520075|564911878|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
156495891|NCT03520075|564911879|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495892|NCT03520075|564911880|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
156495893|NCT03520075|564911881|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
156495894|NCT03520075|564911882|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495895|NCT03520075|564911883|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495896|NCT03520075|564911884|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495897|NCT03520075|564911885|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495898|NCT03520075|564911886|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495899|NCT03520075|564911887|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
156495900|NCT03520075|564911888|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495901|NCT03520075|564911889|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
156546647|NCT02095535|565094927|FG000|Recruitment|Protocol Violation|2|||
156375590|NCT01602315|564470051|FG003|Overall Study|Disease progression|1|||
156375591|NCT01602315|564470052|FG004|Overall Study|Disease progression|41|||
156375592|NCT01602315|564470053|FG005|Overall Study|Disease progression|12|||
156375593|NCT01602315|564470054|FG006|Overall Study|Disease progression|15|||
156375594|NCT01602315|564470048|FG000|Overall Study|Death|1|||
156375595|NCT01602315|564470049|FG001|Overall Study|Death|1|||
156375596|NCT01602315|564470050|FG002|Overall Study|Death|1|||
156375597|NCT01602315|564470051|FG003|Overall Study|Death|1|||
156375598|NCT01602315|564470052|FG004|Overall Study|Death|7|||
156375599|NCT01602315|564470053|FG005|Overall Study|Death|2|||
156375600|NCT01602315|564470054|FG006|Overall Study|Death|2|||
156375601|NCT01602315|564470048|FG000|Overall Study|Withdrawal by Subject|2|||
156375602|NCT01602315|564470049|FG001|Overall Study|Withdrawal by Subject|0|||
156375603|NCT01602315|564470050|FG002|Overall Study|Withdrawal by Subject|2|||
156375604|NCT01602315|564470051|FG003|Overall Study|Withdrawal by Subject|0|||
156375605|NCT01602315|564470052|FG004|Overall Study|Withdrawal by Subject|6|||
156375606|NCT01602315|564470053|FG005|Overall Study|Withdrawal by Subject|0|||
156375607|NCT01602315|564470054|FG006|Overall Study|Withdrawal by Subject|1|||
156375608|NCT01602315|564470048|FG000|Overall Study|Adverse Event|5|||
156375609|NCT01602315|564470049|FG001|Overall Study|Adverse Event|1|||
156375610|NCT01602315|564470050|FG002|Overall Study|Adverse Event|5|||
156375611|NCT01602315|564470051|FG003|Overall Study|Adverse Event|4|||
156375612|NCT01602315|564470052|FG004|Overall Study|Adverse Event|15|||
156375613|NCT01602315|564470053|FG005|Overall Study|Adverse Event|3|||
156375614|NCT01602315|564470054|FG006|Overall Study|Adverse Event|9|||
156375615|NCT01602315|564470048|FG000|Overall Study|Subject/guardian decision|0|||
156375616|NCT01602315|564470049|FG001|Overall Study|Subject/guardian decision|0|||
156375617|NCT01602315|564470050|FG002|Overall Study|Subject/guardian decision|0|||
156375618|NCT01602315|564470051|FG003|Overall Study|Subject/guardian decision|0|||
156375619|NCT01602315|564470052|FG004|Overall Study|Subject/guardian decision|0|||
156375620|NCT01602315|564470053|FG005|Overall Study|Subject/guardian decision|0|||
156375621|NCT01602315|564470054|FG006|Overall Study|Subject/guardian decision|1|||
156375622|NCT01602315|564470048|FG000|Overall Study|Cross-over patients to combo treatment|0|||
156375623|NCT01602315|564470049|FG001|Overall Study|Cross-over patients to combo treatment|0|||
156375624|NCT01602315|564470050|FG002|Overall Study|Cross-over patients to combo treatment|0|||
156375625|NCT01602315|564470051|FG003|Overall Study|Cross-over patients to combo treatment|0|||
156375626|NCT01602315|564470052|FG004|Overall Study|Cross-over patients to combo treatment|0|||
156375627|NCT01602315|564470053|FG005|Overall Study|Cross-over patients to combo treatment|16|||
156375628|NCT01602315|564470054|FG006|Overall Study|Cross-over patients to combo treatment|0|||
156375629|NCT00961259|564470061|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
156375630|NCT00961259|564470062|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
156375631|NCT00961259|564470063|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
156375632|NCT01252251|564470064|FG000|Overall Study|Withdrawal by Subject|1|||
156375633|NCT00440271|564470065|FG000|Overall Study|Protocol Violation|1|||
156375634|NCT00440271|564470066|FG001|Overall Study|Protocol Violation|1|||
156375635|NCT00440271|564470065|FG000|Overall Study|Adverse Event|0|||
156375636|NCT00440271|564470066|FG001|Overall Study|Adverse Event|1|||
156375637|NCT00440271|564470065|FG000|Overall Study|Lost to Follow-up|1|||
156375638|NCT00440271|564470066|FG001|Overall Study|Lost to Follow-up|0|||
156375639|NCT00440271|564470065|FG000|Overall Study|Withdrawal by Subject|0|||
156375640|NCT00440271|564470066|FG001|Overall Study|Withdrawal by Subject|2|||
156375641|NCT00440271|564470065|FG000|Overall Study|Lack of Efficacy|0|||
156375642|NCT00440271|564470066|FG001|Overall Study|Lack of Efficacy|1|||
156375643|NCT00440271|564470065|FG000|Overall Study|Due to closure of trial|8|||
156375644|NCT00440271|564470066|FG001|Overall Study|Due to closure of trial|10|||
156375645|NCT00440271|564470065|FG000|Overall Study|Other|2|||
156375646|NCT00440271|564470066|FG001|Overall Study|Other|0|||
156375647|NCT03348904|564470076|FG000|Overall Study|Administrative reason by the sponsor|0|||
156375648|NCT03348904|564470077|FG001|Overall Study|Administrative reason by the sponsor|1|||
156375649|NCT03348904|564470078|FG002|Overall Study|Administrative reason by the sponsor|0|||
156375650|NCT04086472|564470079|FG000|Overall Study|Lost to Follow-up|1|||
156375651|NCT04086472|564470080|FG001|Overall Study|Lost to Follow-up|0|||
156375652|NCT04086472|564470081|FG002|Overall Study|Lost to Follow-up|0|||
156375653|NCT04086472|564470082|FG003|Overall Study|Lost to Follow-up|0|||
156375654|NCT04086472|564470083|FG004|Overall Study|Lost to Follow-up|1|||
156375655|NCT04086472|564470079|FG000|Overall Study|Physician Decision|0|||
156375656|NCT04086472|564470080|FG001|Overall Study|Physician Decision|1|||
156375657|NCT04086472|564470081|FG002|Overall Study|Physician Decision|1|||
156375658|NCT04086472|564470082|FG003|Overall Study|Physician Decision|0|||
156375659|NCT04086472|564470083|FG004|Overall Study|Physician Decision|0|||
156375660|NCT04086472|564470079|FG000|Overall Study|Withdrawal by Subject|1|||
156375661|NCT04086472|564470080|FG001|Overall Study|Withdrawal by Subject|1|||
156375662|NCT04086472|564470081|FG002|Overall Study|Withdrawal by Subject|1|||
156375663|NCT04086472|564470082|FG003|Overall Study|Withdrawal by Subject|0|||
156375664|NCT04086472|564470083|FG004|Overall Study|Withdrawal by Subject|0|||
156375665|NCT04086472|564470079|FG000|Overall Study|Various reasons|2|||
156375666|NCT04086472|564470080|FG001|Overall Study|Various reasons|0|||
156375667|NCT04086472|564470081|FG002|Overall Study|Various reasons|0|||
156375668|NCT04086472|564470082|FG003|Overall Study|Various reasons|3|||
156495902|NCT03520075|564911890|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495903|NCT03520075|564911891|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495904|NCT03520075|564911892|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495905|NCT03520075|564911893|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495906|NCT03520075|564911894|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495907|NCT03520075|564911895|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
156495908|NCT03520075|564911877|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495909|NCT03520075|564911878|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495910|NCT03520075|564911879|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495911|NCT03520075|564911880|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495912|NCT03520075|564911881|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495913|NCT03520075|564911882|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495914|NCT03520075|564911883|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495915|NCT03520075|564911884|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495916|NCT03520075|564911885|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495917|NCT03520075|564911886|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
156495918|NCT03520075|564911887|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495919|NCT03520075|564911888|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495920|NCT03520075|564911889|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
156495921|NCT03520075|564911890|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495922|NCT03520075|564911891|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495923|NCT03520075|564911892|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495924|NCT03520075|564911893|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495925|NCT03520075|564911894|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495926|NCT03520075|564911895|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
156495927|NCT03520075|564911877|FG000|Phase 2 (Dose Expansion)|Death|0|||
156495928|NCT03520075|564911878|FG001|Phase 2 (Dose Expansion)|Death|0|||
156495929|NCT03520075|564911879|FG002|Phase 2 (Dose Expansion)|Death|0|||
156495930|NCT03520075|564911880|FG003|Phase 2 (Dose Expansion)|Death|0|||
156495931|NCT03520075|564911881|FG004|Phase 2 (Dose Expansion)|Death|0|||
156495932|NCT03520075|564911882|FG005|Phase 2 (Dose Expansion)|Death|0|||
156495933|NCT03520075|564911883|FG006|Phase 2 (Dose Expansion)|Death|0|||
156375669|NCT04086472|564470083|FG004|Overall Study|Various reasons|1|||
156375670|NCT02252081|564470084|FG000|Overall Study|Withdrawal by Subject|2|||
156495934|NCT03520075|564911884|FG007|Phase 2 (Dose Expansion)|Death|0|||
156495935|NCT03520075|564911885|FG008|Phase 2 (Dose Expansion)|Death|0|||
156495936|NCT03520075|564911886|FG009|Phase 2 (Dose Expansion)|Death|0|||
156495937|NCT03520075|564911887|FG010|Phase 2 (Dose Expansion)|Death|0|||
156495938|NCT03520075|564911888|FG011|Phase 2 (Dose Expansion)|Death|0|||
156495939|NCT03520075|564911889|FG012|Phase 2 (Dose Expansion)|Death|0|||
156495940|NCT03520075|564911890|FG013|Phase 2 (Dose Expansion)|Death|20|||
156495941|NCT03520075|564911891|FG014|Phase 2 (Dose Expansion)|Death|13|||
156495942|NCT03520075|564911892|FG015|Phase 2 (Dose Expansion)|Death|9|||
156495943|NCT03520075|564911893|FG016|Phase 2 (Dose Expansion)|Death|5|||
156495944|NCT03520075|564911894|FG017|Phase 2 (Dose Expansion)|Death|14|||
156495945|NCT03520075|564911895|FG018|Phase 2 (Dose Expansion)|Death|12|||
156495946|NCT03520075|564911877|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495947|NCT03520075|564911878|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495948|NCT03520075|564911879|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495949|NCT03520075|564911880|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495950|NCT03520075|564911881|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495951|NCT03520075|564911882|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495952|NCT03520075|564911883|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495953|NCT03520075|564911884|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495954|NCT03520075|564911885|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156375671|NCT02252081|564470085|FG001|Overall Study|Withdrawal by Subject|1|||
156375672|NCT02252081|564470084|FG000|Overall Study|Adverse Event|4|||
156495955|NCT03520075|564911886|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495956|NCT03520075|564911887|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495957|NCT03520075|564911888|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156546648|NCT02646982|565094928|FG000|Overall Study|Adverse Event|1|||
156495958|NCT03520075|564911889|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156495959|NCT03520075|564911890|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
156375673|NCT02252081|564470085|FG001|Overall Study|Adverse Event|1|||
156495960|NCT03520075|564911891|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
156495961|NCT03520075|564911892|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
156495962|NCT03520075|564911893|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
156546649|NCT02646982|565094929|FG001|Overall Study|Adverse Event|1|||
156375674|NCT02252081|564470084|FG000|Overall Study|non compliance & others|0|||
156495963|NCT03520075|564911894|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
156495964|NCT03520075|564911895|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
156495965|NCT03520075|564911877|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495966|NCT03520075|564911878|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495967|NCT03520075|564911879|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495968|NCT03520075|564911880|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495969|NCT03520075|564911881|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495970|NCT03520075|564911882|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495971|NCT03520075|564911883|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495972|NCT03520075|564911884|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495973|NCT03520075|564911885|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495974|NCT03520075|564911886|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495975|NCT03520075|564911887|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495976|NCT03520075|564911888|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495977|NCT03520075|564911889|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495978|NCT03520075|564911890|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495979|NCT03520075|564911891|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
156495980|NCT03520075|564911892|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
156495981|NCT03520075|564911893|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495982|NCT03520075|564911894|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156495983|NCT03520075|564911895|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
156495984|NCT03520075|564911877|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495985|NCT03520075|564911878|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495986|NCT03520075|564911879|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495987|NCT03520075|564911880|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495988|NCT03520075|564911881|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495989|NCT03520075|564911882|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495990|NCT03520075|564911883|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495991|NCT03520075|564911884|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495992|NCT03520075|564911885|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495993|NCT03520075|564911886|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495994|NCT03520075|564911887|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495995|NCT03520075|564911888|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495996|NCT03520075|564911889|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495997|NCT03520075|564911890|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
156495998|NCT03520075|564911891|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156495999|NCT03520075|564911892|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156496000|NCT03520075|564911893|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
156496001|NCT03520075|564911894|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
156496002|NCT03520075|564911895|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
156496003|NCT01432626|564911898|FG000|Overall Study|LV function recovered|2|||
156496004|NCT01432626|564911898|FG000|Overall Study|Withdrawal by Subject|2|||
156496005|NCT01432626|564911898|FG000|Overall Study|Only 1 image competed|2|||
156496006|NCT01432626|564911898|FG000|Overall Study|Imaging agent not available|1|||
156496007|NCT00328562|564911899|FG000|Overall Study|Disease progression|1|||
156496008|NCT03305809|564911900|FG000|Overall Study|Adverse Event|2|||
156496009|NCT03305809|564911901|FG001|Overall Study|Adverse Event|2|||
156496010|NCT03305809|564911902|FG002|Overall Study|Adverse Event|6|||
156496011|NCT03305809|564911903|FG003|Overall Study|Adverse Event|6|||
156496012|NCT03305809|564911900|FG000|Overall Study|Death|0|||
156496013|NCT03305809|564911901|FG001|Overall Study|Death|0|||
156496014|NCT03305809|564911902|FG002|Overall Study|Death|1|||
156496015|NCT03305809|564911903|FG003|Overall Study|Death|1|||
156496016|NCT03305809|564911900|FG000|Overall Study|Lost to Follow-up|1|||
156496017|NCT03305809|564911901|FG001|Overall Study|Lost to Follow-up|2|||
156496018|NCT03305809|564911902|FG002|Overall Study|Lost to Follow-up|0|||
156496019|NCT03305809|564911903|FG003|Overall Study|Lost to Follow-up|0|||
156496020|NCT03305809|564911900|FG000|Overall Study|Sponsor Decision|1|||
156496021|NCT03305809|564911901|FG001|Overall Study|Sponsor Decision|0|||
156496022|NCT03305809|564911902|FG002|Overall Study|Sponsor Decision|1|||
156496023|NCT03305809|564911903|FG003|Overall Study|Sponsor Decision|8|||
156496024|NCT03305809|564911900|FG000|Overall Study|Physician Decision|0|||
156496025|NCT03305809|564911901|FG001|Overall Study|Physician Decision|0|||
156496026|NCT03305809|564911902|FG002|Overall Study|Physician Decision|2|||
156496027|NCT03305809|564911903|FG003|Overall Study|Physician Decision|4|||
156496028|NCT03305809|564911900|FG000|Overall Study|Progressive Disease|0|||
156496029|NCT03305809|564911901|FG001|Overall Study|Progressive Disease|0|||
156496030|NCT03305809|564911902|FG002|Overall Study|Progressive Disease|1|||
156496031|NCT03305809|564911903|FG003|Overall Study|Progressive Disease|0|||
156496032|NCT03305809|564911900|FG000|Overall Study|Protocol Violation|1|||
156496033|NCT03305809|564911901|FG001|Overall Study|Protocol Violation|0|||
156496034|NCT03305809|564911902|FG002|Overall Study|Protocol Violation|2|||
156546650|NCT02646982|565094928|FG000|Overall Study|Withdrawal by Subject|2|||
156496035|NCT03305809|564911903|FG003|Overall Study|Protocol Violation|3|||
156496036|NCT03305809|564911900|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
156496037|NCT03305809|564911901|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
156496038|NCT03305809|564911902|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
156496039|NCT03305809|564911903|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
156496040|NCT03305809|564911900|FG000|Overall Study|Withdrawal by Subject|2|||
156496041|NCT03305809|564911901|FG001|Overall Study|Withdrawal by Subject|4|||
156496042|NCT03305809|564911902|FG002|Overall Study|Withdrawal by Subject|5|||
156496043|NCT03305809|564911903|FG003|Overall Study|Withdrawal by Subject|2|||
156496044|NCT03305809|564911900|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
156496045|NCT03305809|564911901|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
156496046|NCT03305809|564911902|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
156496047|NCT03305809|564911903|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
156496048|NCT04014790|564911904|FG000|Overall Study|Death|4|||
156496049|NCT04014790|564911904|FG000|Overall Study|Adverse Event|1|||
156496050|NCT04014790|564911904|FG000|Overall Study|Withdrawal by Subject|1|||
156496051|NCT00816556|564911905|FG000|Overall Study|Adverse Event|1|||
156496052|NCT00816556|564911906|FG001|Overall Study|Adverse Event|1|||
156496053|NCT00816556|564911907|FG002|Overall Study|Adverse Event|1|||
156496054|NCT00816556|564911905|FG000|Overall Study|Withdrawal by Subject|1|||
156496055|NCT00816556|564911906|FG001|Overall Study|Withdrawal by Subject|1|||
156496056|NCT00816556|564911907|FG002|Overall Study|Withdrawal by Subject|1|||
156496057|NCT00816556|564911905|FG000|Overall Study|Lost to Follow-up|0|||
156496058|NCT00816556|564911906|FG001|Overall Study|Lost to Follow-up|0|||
156496059|NCT00816556|564911907|FG002|Overall Study|Lost to Follow-up|1|||
156496060|NCT03546816|564911910|FG000|Overall Study|Adverse Event|5|||
156496061|NCT03546816|564911911|FG001|Overall Study|Adverse Event|3|||
156496062|NCT03546816|564911910|FG000|Overall Study|Lack of Efficacy|2|||
156496063|NCT03546816|564911911|FG001|Overall Study|Lack of Efficacy|4|||
156496064|NCT03546816|564911910|FG000|Overall Study|Pregnancy|1|||
156496065|NCT03546816|564911911|FG001|Overall Study|Pregnancy|0|||
156496066|NCT03546816|564911910|FG000|Overall Study|Physician Decision|2|||
156496067|NCT03546816|564911911|FG001|Overall Study|Physician Decision|0|||
156496068|NCT03546816|564911910|FG000|Overall Study|Withdrawal by Subject|8|||
156496069|NCT03546816|564911911|FG001|Overall Study|Withdrawal by Subject|10|||
156496070|NCT03546816|564911910|FG000|Overall Study|Lost to Follow-up|3|||
156496071|NCT03546816|564911911|FG001|Overall Study|Lost to Follow-up|2|||
156496072|NCT00810342|564911914|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
156496073|NCT00810342|564911915|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
156496074|NCT00810342|564911914|FG000|Month 1 Follow-up|Pregnancy|1|||
156496075|NCT00810342|564911915|FG001|Month 1 Follow-up|Pregnancy|0|||
156496076|NCT00810342|564911914|FG000|6-month Follow-up|Lost to Follow-up|18|||
156496077|NCT00810342|564911915|FG001|6-month Follow-up|Lost to Follow-up|6|||
156496078|NCT00810342|564911914|FG000|6-month Follow-up|Pregnancy|6|||
156496079|NCT00810342|564911915|FG001|6-month Follow-up|Pregnancy|2|||
156496080|NCT00810342|564911914|FG000|12-month Followup|Pregnancy|9|||
156496081|NCT00810342|564911915|FG001|12-month Followup|Pregnancy|10|||
156496082|NCT00810342|564911914|FG000|12-month Followup|Lost to Follow-up|3|||
156496083|NCT00810342|564911915|FG001|12-month Followup|Lost to Follow-up|1|||
156496084|NCT03065933|564911917|FG000|Overall Study|study terminated|5|||
156496085|NCT04504630|564911918|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
156496086|NCT04504630|564911919|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
156496087|NCT04504630|564911918|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
156496088|NCT04504630|564911919|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
156496089|NCT01010204|564911920|FG000|Overall Study|Lost to Follow-up|2|||
156496090|NCT01010204|564911921|FG001|Overall Study|Lost to Follow-up|2|||
156496091|NCT01010204|564911920|FG000|Overall Study|Adverse Event|1|||
156496092|NCT01010204|564911921|FG001|Overall Study|Adverse Event|3|||
156496093|NCT01010204|564911920|FG000|Overall Study|Withdrawal by Subject|2|||
156496094|NCT01010204|564911921|FG001|Overall Study|Withdrawal by Subject|3|||
156496095|NCT01010204|564911920|FG000|Overall Study|psychiatric hospitalization|2|||
156496096|NCT01010204|564911921|FG001|Overall Study|psychiatric hospitalization|1|||
156496097|NCT01513330|564911922|FG000|SenSura Mio First,|Adverse Event|2|||
156496098|NCT01513330|564911923|FG001|SenSura Mio First,|Adverse Event|0|||
156496099|NCT01513330|564911922|FG000|SenSura Mio First,|Lack of Efficacy|0|||
156546651|NCT02646982|565094929|FG001|Overall Study|Withdrawal by Subject|1|||
156496100|NCT01513330|564911923|FG001|SenSura Mio First,|Lack of Efficacy|1|||
156496101|NCT01513330|564911922|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
156496102|NCT01513330|564911923|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
156496103|NCT01513330|564911922|FG000|SenSura Mio First,|Other|1|||
156496104|NCT01513330|564911923|FG001|SenSura Mio First,|Other|0|||
156496105|NCT01513330|564911922|FG000|Standard Care First,|Lack of Efficacy|2|||
156496106|NCT01513330|564911923|FG001|Standard Care First,|Lack of Efficacy|2|||
156496107|NCT01513330|564911922|FG000|Standard Care First,|Withdrawal by Subject|1|||
156496108|NCT01513330|564911923|FG001|Standard Care First,|Withdrawal by Subject|2|||
156496109|NCT01513330|564911922|FG000|Standard Care First,|Other|1|||
156496110|NCT01513330|564911923|FG001|Standard Care First,|Other|0|||
156496111|NCT01519778|564911924|FG000|Overall Study|Withdrawal by Subject|3|||
156496112|NCT01519778|564911924|FG000|Overall Study|Lost to Follow-up|10|||
156496113|NCT01519778|564911924|FG000|Overall Study|Physician Decision|1|||
156496114|NCT02270671|564911925|FG000|Overall Study|Withdrawal by Subject|1|||
156496115|NCT02270671|564911926|FG001|Overall Study|Withdrawal by Subject|1|||
156496116|NCT02270671|564911925|FG000|Overall Study|Protocol Violation|0|||
156496117|NCT02270671|564911926|FG001|Overall Study|Protocol Violation|1|||
156496118|NCT02270671|564911925|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
156496119|NCT02270671|564911926|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
156496120|NCT02270671|564911925|FG000|Overall Study|Lost to Follow-up|2|||
156496121|NCT02270671|564911926|FG001|Overall Study|Lost to Follow-up|1|||
156496122|NCT02330562|564911934|FG000|Overall Study|Adverse Event|0|||
156496123|NCT02330562|564911935|FG001|Overall Study|Adverse Event|0|||
156496124|NCT02330562|564911936|FG002|Overall Study|Adverse Event|3|||
156496125|NCT02330562|564911937|FG003|Overall Study|Adverse Event|0|||
156496126|NCT02330562|564911938|FG004|Overall Study|Adverse Event|3|||
156496127|NCT02330562|564911939|FG005|Overall Study|Adverse Event|1|||
156496128|NCT02330562|564911940|FG006|Overall Study|Adverse Event|0|||
156496129|NCT02330562|564911941|FG007|Overall Study|Adverse Event|0|||
156496130|NCT02330562|564911942|FG008|Overall Study|Adverse Event|0|||
156496131|NCT02330562|564911943|FG009|Overall Study|Adverse Event|1|||
156496132|NCT02330562|564911944|FG010|Overall Study|Adverse Event|1|||
156496133|NCT02330562|564911934|FG000|Overall Study|Participant decision|1|||
156496134|NCT02330562|564911935|FG001|Overall Study|Participant decision|0|||
156496135|NCT02330562|564911936|FG002|Overall Study|Participant decision|4|||
156496136|NCT02330562|564911937|FG003|Overall Study|Participant decision|1|||
156496137|NCT02330562|564911938|FG004|Overall Study|Participant decision|5|||
156496138|NCT02330562|564911939|FG005|Overall Study|Participant decision|2|||
156496139|NCT02330562|564911940|FG006|Overall Study|Participant decision|0|||
156496140|NCT02330562|564911941|FG007|Overall Study|Participant decision|0|||
156496141|NCT02330562|564911942|FG008|Overall Study|Participant decision|0|||
156496142|NCT02330562|564911943|FG009|Overall Study|Participant decision|3|||
156496143|NCT02330562|564911944|FG010|Overall Study|Participant decision|0|||
156496144|NCT02330562|564911934|FG000|Overall Study|Disease progression|5|||
156496145|NCT02330562|564911935|FG001|Overall Study|Disease progression|3|||
156496146|NCT02330562|564911936|FG002|Overall Study|Disease progression|20|||
156496147|NCT02330562|564911937|FG003|Overall Study|Disease progression|28|||
156496148|NCT02330562|564911938|FG004|Overall Study|Disease progression|23|||
156496149|NCT02330562|564911939|FG005|Overall Study|Disease progression|7|||
156496150|NCT02330562|564911940|FG006|Overall Study|Disease progression|1|||
156496151|NCT02330562|564911941|FG007|Overall Study|Disease progression|1|||
156496152|NCT02330562|564911942|FG008|Overall Study|Disease progression|1|||
156496153|NCT02330562|564911943|FG009|Overall Study|Disease progression|0|||
156496154|NCT02330562|564911944|FG010|Overall Study|Disease progression|5|||
156496155|NCT02330562|564911934|FG000|Overall Study|Other reasons|0|||
156496156|NCT02330562|564911935|FG001|Overall Study|Other reasons|0|||
156496157|NCT02330562|564911936|FG002|Overall Study|Other reasons|0|||
156496158|NCT02330562|564911937|FG003|Overall Study|Other reasons|1|||
156496159|NCT02330562|564911938|FG004|Overall Study|Other reasons|0|||
156496160|NCT02330562|564911939|FG005|Overall Study|Other reasons|0|||
156496161|NCT02330562|564911940|FG006|Overall Study|Other reasons|0|||
156496162|NCT02330562|564911941|FG007|Overall Study|Other reasons|0|||
156496163|NCT02330562|564911942|FG008|Overall Study|Other reasons|0|||
156496164|NCT02330562|564911943|FG009|Overall Study|Other reasons|0|||
156496165|NCT02330562|564911944|FG010|Overall Study|Other reasons|0|||
156496166|NCT02330562|564911934|FG000|Overall Study|Withdrawal by Subject|0|||
156496167|NCT02330562|564911935|FG001|Overall Study|Withdrawal by Subject|0|||
156496168|NCT02330562|564911936|FG002|Overall Study|Withdrawal by Subject|0|||
156496169|NCT02330562|564911937|FG003|Overall Study|Withdrawal by Subject|0|||
156496170|NCT02330562|564911938|FG004|Overall Study|Withdrawal by Subject|0|||
156496171|NCT02330562|564911939|FG005|Overall Study|Withdrawal by Subject|0|||
156496172|NCT02330562|564911940|FG006|Overall Study|Withdrawal by Subject|0|||
156496173|NCT02330562|564911941|FG007|Overall Study|Withdrawal by Subject|0|||
156496174|NCT02330562|564911942|FG008|Overall Study|Withdrawal by Subject|0|||
156496175|NCT02330562|564911943|FG009|Overall Study|Withdrawal by Subject|1|||
156496176|NCT02330562|564911944|FG010|Overall Study|Withdrawal by Subject|0|||
156496177|NCT01547117|564911945|FG000|Overall Study|Physician Decision|0|||
156496178|NCT01547117|564911946|FG001|Overall Study|Physician Decision|1|||
156496179|NCT01547117|564911947|FG002|Overall Study|Physician Decision|1|||
156496180|NCT01547117|564911948|FG003|Overall Study|Physician Decision|3|||
156496181|NCT01547117|564911945|FG000|Overall Study|Withdrawal by Subject|1|||
156496182|NCT01547117|564911946|FG001|Overall Study|Withdrawal by Subject|2|||
156496183|NCT01547117|564911947|FG002|Overall Study|Withdrawal by Subject|1|||
156496184|NCT01547117|564911948|FG003|Overall Study|Withdrawal by Subject|2|||
156496185|NCT03927690|564911950|FG000|Overall Study|Withdrawal by Subject|3|||
156496186|NCT03927690|564911951|FG001|Overall Study|Withdrawal by Subject|1|||
156496187|NCT03927690|564911952|FG002|Overall Study|Withdrawal by Subject|1|||
156496188|NCT03927690|564911950|FG000|Overall Study|Adverse Event|1|||
156496189|NCT03927690|564911951|FG001|Overall Study|Adverse Event|0|||
156496190|NCT03927690|564911952|FG002|Overall Study|Adverse Event|0|||
156496191|NCT03927690|564911950|FG000|Overall Study|Death|1|||
156496192|NCT03927690|564911951|FG001|Overall Study|Death|0|||
156496193|NCT03927690|564911952|FG002|Overall Study|Death|0|||
156496194|NCT03927690|564911950|FG000|Overall Study|Lost to Follow-up|2|||
156496195|NCT03927690|564911951|FG001|Overall Study|Lost to Follow-up|2|||
156496196|NCT03927690|564911952|FG002|Overall Study|Lost to Follow-up|1|||
156496197|NCT00174447|564911959|FG000|Overall Study|Adverse Event|19|||
156496198|NCT00174447|564911959|FG000|Overall Study|Withdrawal by Subject|15|||
156496199|NCT00174447|564911959|FG000|Overall Study|Protocol Violation|1|||
156496200|NCT00174447|564911959|FG000|Overall Study|Lack of Efficacy|1|||
156496201|NCT00174447|564911959|FG000|Overall Study|Administrative reason/Other|2|||
156496202|NCT03491215|564911966|FG000|Overall Study|Death|6|||
156496203|NCT03491215|564911967|FG001|Overall Study|Death|2|||
156496204|NCT03491215|564911968|FG002|Overall Study|Death|1|||
156496205|NCT03491215|564911969|FG003|Overall Study|Death|0|||
156496206|NCT03491215|564911966|FG000|Overall Study|Physician Decision|1|||
156496207|NCT03491215|564911967|FG001|Overall Study|Physician Decision|0|||
156496208|NCT03491215|564911968|FG002|Overall Study|Physician Decision|0|||
156496209|NCT03491215|564911969|FG003|Overall Study|Physician Decision|0|||
156496210|NCT03603639|564911973|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
156496211|NCT03603639|564911974|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
156496212|NCT03603639|564911975|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
156496213|NCT03603639|564911976|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
156496214|NCT03603639|564911977|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
156496215|NCT03603639|564911978|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
156496216|NCT03603639|564911973|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
156496217|NCT03603639|564911974|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
156496218|NCT03603639|564911975|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
156496219|NCT03603639|564911976|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
156496220|NCT03603639|564911977|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
156496221|NCT03603639|564911978|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
156496222|NCT00551135|564911984|FG000|Overall Study|Adverse Event|1|||
156496223|NCT00551135|564911985|FG001|Overall Study|Adverse Event|0|||
156496224|NCT00551135|564911986|FG002|Overall Study|Adverse Event|1|||
156496225|NCT00551135|564911987|FG003|Overall Study|Adverse Event|1|||
156496226|NCT00551135|564911984|FG000|Overall Study|Lost to Follow-up|0|||
156496227|NCT00551135|564911985|FG001|Overall Study|Lost to Follow-up|0|||
156496228|NCT00551135|564911986|FG002|Overall Study|Lost to Follow-up|0|||
156496229|NCT00551135|564911987|FG003|Overall Study|Lost to Follow-up|1|||
156496230|NCT00551135|564911984|FG000|Overall Study|Other|3|||
156496231|NCT00551135|564911985|FG001|Overall Study|Other|2|||
156496232|NCT00551135|564911986|FG002|Overall Study|Other|1|||
156496233|NCT00551135|564911987|FG003|Overall Study|Other|2|||
156496234|NCT00551135|564911984|FG000|Overall Study|Withdrawal by Subject|1|||
156496235|NCT00551135|564911985|FG001|Overall Study|Withdrawal by Subject|0|||
156496236|NCT00551135|564911986|FG002|Overall Study|Withdrawal by Subject|3|||
156496237|NCT00551135|564911987|FG003|Overall Study|Withdrawal by Subject|1|||
156496238|NCT04599855|564911988|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
156496239|NCT04599855|564911989|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
156496240|NCT04599855|564911990|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
156496241|NCT04599855|564911988|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
156496242|NCT04599855|564911989|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
156496243|NCT04599855|564911990|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
156496244|NCT04599855|564911988|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
156496245|NCT04599855|564911989|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
156496246|NCT04599855|564911990|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
156496247|NCT04599855|564911988|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
156496248|NCT04599855|564911989|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
156496249|NCT04599855|564911990|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
156496250|NCT04599855|564911988|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
156496251|NCT04599855|564911989|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
156496252|NCT04599855|564911990|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
156496253|NCT04599855|564911988|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
156496254|NCT04599855|564911989|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
156496255|NCT04599855|564911990|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
156496256|NCT04599855|564911988|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
156496257|NCT04599855|564911989|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
156496258|NCT04599855|564911990|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
156496259|NCT04599855|564911988|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
156546652|NCT00769002|565094930|FG000|Overall Study|Study was not completed, no data|9|||
156375675|NCT02252081|564470085|FG001|Overall Study|non compliance & others|2|||
156375676|NCT00048724|564470086|FG000|Overall Study|Adverse Event|53|||
156375677|NCT00048724|564470087|FG001|Overall Study|Adverse Event|12|||
156375678|NCT00048724|564470086|FG000|Overall Study|Withdrawal by Subject|34|||
156375679|NCT00048724|564470087|FG001|Overall Study|Withdrawal by Subject|54|||
156375680|NCT00048724|564470086|FG000|Overall Study|Lost to Follow-up|5|||
156375681|NCT00048724|564470087|FG001|Overall Study|Lost to Follow-up|5|||
156375682|NCT00048724|564470086|FG000|Overall Study|Protocol-defined Clinical Event|17|||
156375683|NCT00048724|564470087|FG001|Overall Study|Protocol-defined Clinical Event|32|||
156375684|NCT00048724|564470086|FG000|Overall Study|Noncompliance With Protocol|4|||
156375685|NCT00048724|564470087|FG001|Overall Study|Noncompliance With Protocol|12|||
156375686|NCT00048724|564470086|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
156375687|NCT00048724|564470087|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
156375688|NCT00048724|564470086|FG000|Overall Study|Administrative|1|||
156375689|NCT00048724|564470087|FG001|Overall Study|Administrative|1|||
156375690|NCT01743092|564470088|FG000|Overall Study|Lost to Follow-up|14|||
156375691|NCT01743092|564470089|FG001|Overall Study|Lost to Follow-up|15|||
156375692|NCT01490060|564470091|FG000|Cycle 1|Change of Treatment|0|||
156375693|NCT01490060|564470092|FG001|Cycle 1|Change of Treatment|1|||
156375694|NCT01490060|564470093|FG002|Cycle 1|Change of Treatment|1|||
156375695|NCT01490060|564470094|FG003|Cycle 1|Change of Treatment|1|||
156375696|NCT01490060|564470091|FG000|Cycle 1|Insurance Denied|0|||
156375697|NCT01490060|564470092|FG001|Cycle 1|Insurance Denied|0|||
156375698|NCT01490060|564470093|FG002|Cycle 1|Insurance Denied|2|||
156375699|NCT01490060|564470094|FG003|Cycle 1|Insurance Denied|0|||
156375700|NCT01490060|564470091|FG000|Cycle 1|Withdrawal by Subject|0|||
156375701|NCT01490060|564470092|FG001|Cycle 1|Withdrawal by Subject|0|||
156375702|NCT01490060|564470093|FG002|Cycle 1|Withdrawal by Subject|0|||
156375703|NCT01490060|564470094|FG003|Cycle 1|Withdrawal by Subject|1|||
156375704|NCT01490060|564470091|FG000|Cycle 1|Treatment at Another Facility|0|||
156375705|NCT01490060|564470092|FG001|Cycle 1|Treatment at Another Facility|0|||
156375706|NCT01490060|564470093|FG002|Cycle 1|Treatment at Another Facility|0|||
156375707|NCT01490060|564470094|FG003|Cycle 1|Treatment at Another Facility|1|||
156375708|NCT01490060|564470091|FG000|Cycle 2|Change of Treatment|1|||
156375709|NCT01490060|564470092|FG001|Cycle 2|Change of Treatment|1|||
156375710|NCT01490060|564470093|FG002|Cycle 2|Change of Treatment|0|||
156375711|NCT01490060|564470094|FG003|Cycle 2|Change of Treatment|0|||
156375712|NCT01490060|564470091|FG000|Cycle 2|Non-Compliance|0|||
156375713|NCT01490060|564470092|FG001|Cycle 2|Non-Compliance|0|||
156375714|NCT01490060|564470093|FG002|Cycle 2|Non-Compliance|1|||
156375715|NCT01490060|564470094|FG003|Cycle 2|Non-Compliance|0|||
156375716|NCT01490060|564470091|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
156375717|NCT01490060|564470092|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
156375718|NCT01490060|564470093|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
156375719|NCT01490060|564470094|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
156375720|NCT02464969|564470095|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
156375721|NCT02464969|564470096|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
156375722|NCT02464969|564470095|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
156375723|NCT02464969|564470096|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
156375724|NCT02464969|564470095|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
156375725|NCT02464969|564470096|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
156375726|NCT02464969|564470095|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
156496260|NCT04599855|564911989|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
156496261|NCT04599855|564911990|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
156496262|NCT04599855|564911988|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
156496263|NCT04599855|564911989|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
156496264|NCT04599855|564911990|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
156496265|NCT04599855|564911988|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
156496266|NCT04599855|564911989|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
156496267|NCT04599855|564911990|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
156496268|NCT04599855|564911988|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
156496269|NCT04599855|564911989|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
156496270|NCT04599855|564911990|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
156496271|NCT04599855|564911988|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
156496272|NCT04599855|564911989|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
156496273|NCT04599855|564911990|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
156496274|NCT04599855|564911988|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
156375727|NCT02464969|564470096|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
156496275|NCT04599855|564911989|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
156496276|NCT04599855|564911990|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
156375728|NCT02464969|564470095|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
156375729|NCT02464969|564470096|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
156375730|NCT02464969|564470095|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
156496277|NCT04599855|564911988|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
156496278|NCT04599855|564911989|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
156496279|NCT04599855|564911990|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
156496280|NCT04294667|564911991|FG000|Overall Study|Lack of Efficacy|4|||
156496281|NCT04294667|564911992|FG001|Overall Study|Lack of Efficacy|4|||
156496282|NCT04294667|564911991|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
156496283|NCT04294667|564911992|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
156496284|NCT04294667|564911991|FG000|Overall Study|Patient has a Renal Flare|1|||
156496285|NCT04294667|564911992|FG001|Overall Study|Patient has a Renal Flare|0|||
156496286|NCT04294667|564911991|FG000|Overall Study|SLE Worsening|0|||
156496287|NCT04294667|564911992|FG001|Overall Study|SLE Worsening|1|||
156496288|NCT04294667|564911991|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
156496289|NCT04294667|564911992|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
156496290|NCT04294667|564911991|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
156496291|NCT04294667|564911992|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
156496292|NCT04294667|564911991|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
156496293|NCT04294667|564911992|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
156496294|NCT04294667|564911991|FG000|Overall Study|Subject Moved to Another State|0|||
156496295|NCT04294667|564911992|FG001|Overall Study|Subject Moved to Another State|1|||
156496296|NCT04294667|564911991|FG000|Overall Study|Adverse event, serious fatal|0|||
156496297|NCT04294667|564911992|FG001|Overall Study|Adverse event, serious fatal|1|||
156496298|NCT04294667|564911991|FG000|Overall Study|Adverse event, non-fatal|3|||
156496299|NCT04294667|564911992|FG001|Overall Study|Adverse event, non-fatal|4|||
156496300|NCT02165397|564911995|FG000|Overall Study|Death|7|||
156496301|NCT02165397|564911996|FG001|Overall Study|Death|10|||
156496302|NCT02165397|564911997|FG002|Overall Study|Death|8|||
156496303|NCT02165397|564911995|FG000|Overall Study|Lost to Follow-up|1|||
156496304|NCT02165397|564911996|FG001|Overall Study|Lost to Follow-up|3|||
156496305|NCT02165397|564911997|FG002|Overall Study|Lost to Follow-up|0|||
156496306|NCT02165397|564911995|FG000|Overall Study|Withdrawal by Subject|6|||
156496307|NCT02165397|564911996|FG001|Overall Study|Withdrawal by Subject|6|||
156496308|NCT02165397|564911997|FG002|Overall Study|Withdrawal by Subject|1|||
156496309|NCT02165397|564911995|FG000|Overall Study|Other, Not Specified|0|||
156496310|NCT02165397|564911996|FG001|Overall Study|Other, Not Specified|0|||
156496311|NCT02165397|564911997|FG002|Overall Study|Other, Not Specified|1|||
156496312|NCT00548847|564911998|FG000|Overall Study|Disease progression|7|||
156496313|NCT01841697|564912001|FG000|Overall Study|Death|0|||
156496314|NCT01841697|564912002|FG001|Overall Study|Death|1|||
156496315|NCT01841697|564912001|FG000|Overall Study|Lost to Follow-up|4|||
156496316|NCT01841697|564912002|FG001|Overall Study|Lost to Follow-up|1|||
156496317|NCT01841697|564912001|FG000|Overall Study|Withdrawal by Subject|16|||
156496318|NCT01841697|564912002|FG001|Overall Study|Withdrawal by Subject|16|||
156496319|NCT00727415|564912003|FG000|Phase I|Dose Limiting Toxicity|2|||
156496320|NCT00511797|564912006|FG000|Overall Study|Adverse Event|1|||
156496321|NCT00511797|564912007|FG001|Overall Study|Adverse Event|2|||
156496322|NCT00511797|564912008|FG002|Overall Study|Adverse Event|2|||
156496323|NCT00511797|564912009|FG003|Overall Study|Adverse Event|2|||
156496324|NCT00511797|564912006|FG000|Overall Study|Lost to Follow-up|1|||
156496325|NCT00511797|564912007|FG001|Overall Study|Lost to Follow-up|0|||
156496326|NCT00511797|564912008|FG002|Overall Study|Lost to Follow-up|0|||
156496327|NCT00511797|564912009|FG003|Overall Study|Lost to Follow-up|1|||
156496328|NCT00511797|564912006|FG000|Overall Study|Pregnancy|0|||
156496329|NCT00511797|564912007|FG001|Overall Study|Pregnancy|0|||
156496330|NCT00511797|564912008|FG002|Overall Study|Pregnancy|0|||
156496331|NCT00511797|564912009|FG003|Overall Study|Pregnancy|1|||
156496332|NCT00511797|564912006|FG000|Overall Study|Protocol Violation|0|||
156496333|NCT00511797|564912007|FG001|Overall Study|Protocol Violation|2|||
156496334|NCT00511797|564912008|FG002|Overall Study|Protocol Violation|2|||
156496335|NCT00511797|564912009|FG003|Overall Study|Protocol Violation|3|||
156496336|NCT00511797|564912006|FG000|Overall Study|Withdrawal by Subject|3|||
156496337|NCT00511797|564912007|FG001|Overall Study|Withdrawal by Subject|3|||
156496338|NCT00511797|564912008|FG002|Overall Study|Withdrawal by Subject|4|||
156496339|NCT00511797|564912009|FG003|Overall Study|Withdrawal by Subject|2|||
156496340|NCT00511797|564912006|FG000|Overall Study|Never dispensed|1|||
156496341|NCT00511797|564912007|FG001|Overall Study|Never dispensed|0|||
156496342|NCT00511797|564912008|FG002|Overall Study|Never dispensed|1|||
156496343|NCT00511797|564912009|FG003|Overall Study|Never dispensed|3|||
156496344|NCT00511797|564912006|FG000|Overall Study|Study drug not taken|0|||
156546653|NCT00769002|565094931|FG001|Overall Study|Study was not completed, no data|9|||
156375731|NCT02464969|564470096|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
156375732|NCT02464969|564470095|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
156375733|NCT02464969|564470096|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
156375734|NCT02464969|564470095|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
156375735|NCT02464969|564470096|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
156375736|NCT02464969|564470095|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
156375737|NCT02464969|564470096|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
156375738|NCT02464969|564470095|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
156375739|NCT02464969|564470096|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
156375740|NCT02464969|564470095|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
156375741|NCT02464969|564470096|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
156375742|NCT00699699|564470097|FG000|Overall Study|Adverse Event|36|||
156375743|NCT00699699|564470097|FG000|Overall Study|Individual different reasons|21|||
156375744|NCT01559311|564470098|FG000|Overall Study|Protocol Violation|0|||
156375745|NCT01559311|564470099|FG001|Overall Study|Protocol Violation|0|||
156375746|NCT01559311|564470100|FG002|Overall Study|Protocol Violation|2|||
156375747|NCT01559311|564470098|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
156375748|NCT01559311|564470099|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
156375749|NCT01559311|564470100|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
156375750|NCT01559311|564470098|FG000|Overall Study|Withdrawal by Subject|2|||
156375751|NCT01559311|564470099|FG001|Overall Study|Withdrawal by Subject|1|||
156375752|NCT01559311|564470100|FG002|Overall Study|Withdrawal by Subject|0|||
156375753|NCT01559311|564470098|FG000|Overall Study|Death|0|||
156375754|NCT01559311|564470099|FG001|Overall Study|Death|2|||
156375755|NCT01559311|564470100|FG002|Overall Study|Death|3|||
156375756|NCT01559311|564470098|FG000|Overall Study|Lost to Follow-up|0|||
156375757|NCT01559311|564470099|FG001|Overall Study|Lost to Follow-up|3|||
156375758|NCT01559311|564470100|FG002|Overall Study|Lost to Follow-up|2|||
156375759|NCT01559311|564470098|FG000|Overall Study|Adverse Event|0|||
156375760|NCT01559311|564470099|FG001|Overall Study|Adverse Event|0|||
156375761|NCT01559311|564470100|FG002|Overall Study|Adverse Event|1|||
156375762|NCT01649856|564470101|FG000|Overall Study|Withdrawal by Subject|14|||
156375763|NCT01649856|564470102|FG001|Overall Study|Withdrawal by Subject|14|||
156375764|NCT01649856|564470101|FG000|Overall Study|Protocol Violation|4|||
156375765|NCT01649856|564470102|FG001|Overall Study|Protocol Violation|4|||
156375766|NCT01649856|564470101|FG000|Overall Study|Treatment Failure|1|||
156375767|NCT01649856|564470102|FG001|Overall Study|Treatment Failure|1|||
156375768|NCT01649856|564470101|FG000|Overall Study|Death|69|||
156375769|NCT01649856|564470102|FG001|Overall Study|Death|34|||
156375770|NCT01649856|564470101|FG000|Overall Study|Stable or Progressed Disease|5|||
156375771|NCT01649856|564470102|FG001|Overall Study|Stable or Progressed Disease|3|||
156375772|NCT01649856|564470101|FG000|Overall Study|Lost to Follow-up|20|||
156375773|NCT01649856|564470102|FG001|Overall Study|Lost to Follow-up|16|||
156375774|NCT01649856|564470101|FG000|Overall Study|Lack of Compliance|6|||
156375775|NCT01649856|564470102|FG001|Overall Study|Lack of Compliance|1|||
156546654|NCT04677712|565094932|FG000|Overall Study|Lost to Follow-up|0|||
156546655|NCT04677712|565094933|FG001|Overall Study|Lost to Follow-up|1|||
156546656|NCT04677712|565094934|FG002|Overall Study|Lost to Follow-up|0|||
156546657|NCT04677712|565094935|FG003|Overall Study|Lost to Follow-up|0|||
156546658|NCT04677712|565094936|FG004|Overall Study|Lost to Follow-up|0|||
156546659|NCT04677712|565094937|FG005|Overall Study|Lost to Follow-up|0|||
156546660|NCT00847912|565094938|FG000|Overall Study|Protocol Violation|6|||
156546661|NCT00847912|565094939|FG001|Overall Study|Protocol Violation|7|||
156375776|NCT01649856|564470101|FG000|Overall Study|Other|20|||
156375777|NCT01649856|564470102|FG001|Overall Study|Other|5|||
156375778|NCT00179647|564470103|FG000|Overall Study|Adverse Event|294|||
156375779|NCT00179647|564470103|FG000|Overall Study|Lack of Efficacy|478|||
156375780|NCT00179647|564470103|FG000|Overall Study|Withdrawal by Subject|83|||
156375781|NCT00179647|564470103|FG000|Overall Study|Lost to Follow-up|4|||
156375782|NCT00179647|564470103|FG000|Overall Study|Death|94|||
156375783|NCT00179647|564470103|FG000|Overall Study|Other|960|||
156375784|NCT05013905|564470104|FG000|Overall Study|Adverse Event|1|||
156375785|NCT05013905|564470104|FG000|Overall Study|Lack of Efficacy|1|||
156546662|NCT00847912|565094938|FG000|Overall Study|Withdrawal by Subject|3|||
156546663|NCT00847912|565094939|FG001|Overall Study|Withdrawal by Subject|6|||
156546664|NCT01496885|565094940|FG000|Overall Study|Lost to Follow-up|13|||
156546665|NCT01496885|565094940|FG000|Overall Study|Withdrawal by Subject|7|||
156375786|NCT01849588|564470106|FG000|Overall Study|Lack of Efficacy|3|||
156375787|NCT02550652|564470114|FG000|Overall Study|Death|1|||
156375788|NCT02550652|564470115|FG001|Overall Study|Death|4|||
156375789|NCT02550652|564470114|FG000|Overall Study|Lack of Efficacy|1|||
156375790|NCT02550652|564470115|FG001|Overall Study|Lack of Efficacy|0|||
156375791|NCT02550652|564470114|FG000|Overall Study|Withdrawal by Subject|4|||
156375792|NCT02550652|564470115|FG001|Overall Study|Withdrawal by Subject|7|||
156375793|NCT02550652|564470114|FG000|Overall Study|Post Trial Access|1|||
156375794|NCT02550652|564470115|FG001|Overall Study|Post Trial Access|0|||
156375795|NCT02550652|564470114|FG000|Overall Study|Lost to Follow-up|1|||
156496345|NCT00511797|564912007|FG001|Overall Study|Study drug not taken|1|||
156496346|NCT00511797|564912008|FG002|Overall Study|Study drug not taken|0|||
156496347|NCT00511797|564912009|FG003|Overall Study|Study drug not taken|1|||
156496348|NCT00511797|564912006|FG000|Overall Study|Partially missing diary|0|||
156496349|NCT00511797|564912007|FG001|Overall Study|Partially missing diary|0|||
156496350|NCT00511797|564912008|FG002|Overall Study|Partially missing diary|1|||
156496351|NCT00511797|564912009|FG003|Overall Study|Partially missing diary|0|||
156496352|NCT00511797|564912006|FG000|Overall Study|Other (moving etc)|1|||
156496353|NCT00511797|564912007|FG001|Overall Study|Other (moving etc)|0|||
156496354|NCT00511797|564912008|FG002|Overall Study|Other (moving etc)|1|||
156496355|NCT00511797|564912009|FG003|Overall Study|Other (moving etc)|2|||
156496356|NCT00905359|564912014|FG000|Overall Study|Lost to Follow-up|17|||
156496357|NCT00905359|564912015|FG001|Overall Study|Lost to Follow-up|10|||
156496358|NCT00905359|564912014|FG000|Overall Study|Death|2|||
156496359|NCT00905359|564912015|FG001|Overall Study|Death|0|||
156496360|NCT00905359|564912014|FG000|Overall Study|Withdrawal consent|5|||
156496361|NCT00905359|564912015|FG001|Overall Study|Withdrawal consent|6|||
156496362|NCT04354168|564912017|FG000|Overall Study|Lost to Follow-up|22|||
156496363|NCT02804399|564912020|FG000|Period 2|Adverse Event|0|||
156496364|NCT02804399|564912021|FG001|Period 2|Adverse Event|1|||
156496365|NCT01174264|564912022|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
156496366|NCT01174264|564912023|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
156496367|NCT01174264|564912024|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
156496368|NCT01174264|564912022|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
156496369|NCT01174264|564912023|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
156496370|NCT01174264|564912024|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
156496371|NCT01174264|564912022|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
156496372|NCT01174264|564912023|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
156496373|NCT01174264|564912024|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
156496374|NCT03432390|564912025|FG000|Apnea Period|Protocol Violation|2|||
156496375|NCT03432390|564912026|FG001|Apnea Period|Protocol Violation|2|||
156496376|NCT01774305|564912029|FG000|Overall Study|Physician Decision|1|||
156496377|NCT01774305|564912030|FG001|Overall Study|Physician Decision|0|||
156496378|NCT03738397|564912031|FG000|Overall Study|Adverse Event|3|||
156496379|NCT03738397|564912032|FG001|Overall Study|Adverse Event|7|||
156496380|NCT03738397|564912031|FG000|Overall Study|Withdrawal by Subject|8|||
156496381|NCT03738397|564912032|FG001|Overall Study|Withdrawal by Subject|11|||
156496382|NCT03738397|564912031|FG000|Overall Study|Lost to Follow-up|7|||
156496383|NCT03738397|564912032|FG001|Overall Study|Lost to Follow-up|5|||
156496384|NCT03738397|564912031|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
156496385|NCT03738397|564912032|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
156496386|NCT03738397|564912031|FG000|Overall Study|Other|4|||
156496387|NCT03738397|564912032|FG001|Overall Study|Other|6|||
156496388|NCT00691678|564912033|FG000|Overall Study|Adverse Event|5|||
156496389|NCT00691678|564912033|FG000|Overall Study|life events, pain|11|||
156496390|NCT03049306|564912034|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
156496391|NCT03049306|564912035|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
156496392|NCT03526679|564913948|FG000|Overall Study|still under treatment|2|||
156496393|NCT00966264|564913949|FG000|Overall Study|Lost to Follow-up|4|||
156496394|NCT00966264|564913950|FG001|Overall Study|Lost to Follow-up|3|||
156496395|NCT00903760|564913951|FG000|Overall Study|Disease Progression/Death|8|||
156546666|NCT01496885|565094940|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
156546667|NCT01496885|565094940|FG000|Overall Study|Death|1|||
156546668|NCT03273166|565094941|FG000|Overall Study|Withdrawn prior to Completion|31|||
156546669|NCT01294670|565094942|FG000|Overall Study|Not treated|1|||
156546670|NCT01294670|565094943|FG001|Overall Study|Not treated|0|||
156546671|NCT01294670|565094944|FG002|Overall Study|Not treated|0|||
156546672|NCT01294670|565094945|FG003|Overall Study|Not treated|0|||
156546673|NCT01294670|565094946|FG004|Overall Study|Not treated|0|||
156546674|NCT02083380|565094948|FG000|Overall Study|Lack of Efficacy|68|||
156546675|NCT02083380|565094949|FG001|Overall Study|Lack of Efficacy|79|||
156496396|NCT00903760|564913952|FG001|Overall Study|Disease Progression/Death|6|||
156496397|NCT00903760|564913951|FG000|Overall Study|Stem Cell Transplant|8|||
156496398|NCT00903760|564913952|FG001|Overall Study|Stem Cell Transplant|4|||
156496399|NCT00903760|564913951|FG000|Overall Study|Physician Decision|1|||
156496400|NCT00903760|564913952|FG001|Overall Study|Physician Decision|2|||
156496401|NCT00903760|564913951|FG000|Overall Study|Death|0|||
156496402|NCT00903760|564913952|FG001|Overall Study|Death|1|||
156496403|NCT00903760|564913951|FG000|Overall Study|Lost to Follow-up|1|||
156496404|NCT00903760|564913952|FG001|Overall Study|Lost to Follow-up|0|||
156496405|NCT00903760|564913951|FG000|Overall Study|Withdrawal by Subject|1|||
156496406|NCT00903760|564913952|FG001|Overall Study|Withdrawal by Subject|2|||
156496407|NCT00903760|564913951|FG000|Overall Study|Off treatment for long period|0|||
156496408|NCT00903760|564913952|FG001|Overall Study|Off treatment for long period|1|||
156496409|NCT01639742|564913956|FG000|Overall Study|Study Ongoing|17|||
156496410|NCT01639742|564913956|FG000|Overall Study|Lost to Follow-up|1|||
156496411|NCT01256671|564913960|FG000|Overall Study|Adverse Event|29|||
156496412|NCT01256671|564913960|FG000|Overall Study|Lost to Follow-up|16|||
156496413|NCT01256671|564913960|FG000|Overall Study|Withdrawal by Subject|31|||
156496414|NCT01256671|564913960|FG000|Overall Study|Physician Decision|3|||
156496415|NCT01256671|564913960|FG000|Overall Study|Lack of Efficacy|4|||
156496416|NCT01256671|564913960|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
156496417|NCT02366143|564913961|FG000|Overall Study|Death|307|||
156496418|NCT02366143|564913962|FG001|Overall Study|Death|278|||
156496419|NCT02366143|564913963|FG002|Overall Study|Death|280|||
156496420|NCT02366143|564913961|FG000|Overall Study|Lost to Follow-up|2|||
156496421|NCT02366143|564913962|FG001|Overall Study|Lost to Follow-up|4|||
156496422|NCT02366143|564913963|FG002|Overall Study|Lost to Follow-up|2|||
156496423|NCT02366143|564913961|FG000|Overall Study|Physician Decision|1|||
156496424|NCT02366143|564913962|FG001|Overall Study|Physician Decision|2|||
156496425|NCT02366143|564913963|FG002|Overall Study|Physician Decision|1|||
156496426|NCT02366143|564913961|FG000|Overall Study|Protocol Violation|0|||
156496427|NCT02366143|564913962|FG001|Overall Study|Protocol Violation|0|||
156496428|NCT02366143|564913963|FG002|Overall Study|Protocol Violation|2|||
156496429|NCT02366143|564913961|FG000|Overall Study|Withdrawal by Subject|16|||
156496430|NCT02366143|564913962|FG001|Overall Study|Withdrawal by Subject|17|||
156496431|NCT02366143|564913963|FG002|Overall Study|Withdrawal by Subject|22|||
156496432|NCT02366143|564913961|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
156496433|NCT02366143|564913962|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
156496434|NCT02366143|564913963|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
156496435|NCT02366143|564913961|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
156496436|NCT02366143|564913962|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
156496437|NCT02366143|564913963|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
156496438|NCT02366143|564913961|FG000|Overall Study|Randomization Error|1|||
156496439|NCT02366143|564913962|FG001|Overall Study|Randomization Error|0|||
156496440|NCT02366143|564913963|FG002|Overall Study|Randomization Error|0|||
156496441|NCT02366143|564913961|FG000|Overall Study|PI Move and Site Closure|1|||
156496442|NCT02366143|564913962|FG001|Overall Study|PI Move and Site Closure|0|||
156496443|NCT02366143|564913963|FG002|Overall Study|PI Move and Site Closure|1|||
156496444|NCT02366143|564913961|FG000|Overall Study|Study Terminated By Sponsor|0|||
156496445|NCT02366143|564913962|FG001|Overall Study|Study Terminated By Sponsor|0|||
156496446|NCT02366143|564913963|FG002|Overall Study|Study Terminated By Sponsor|2|||
156496447|NCT02366143|564913961|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
156496448|NCT02366143|564913962|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
156496449|NCT02366143|564913963|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
156496450|NCT02366143|564913961|FG000|Overall Study|Patient moved to roll-over study|1|||
156496451|NCT02366143|564913962|FG001|Overall Study|Patient moved to roll-over study|19|||
156496452|NCT02366143|564913963|FG002|Overall Study|Patient moved to roll-over study|28|||
156496453|NCT02366143|564913961|FG000|Overall Study|Patient moved to commercial stock|0|||
156496454|NCT02366143|564913962|FG001|Overall Study|Patient moved to commercial stock|0|||
156496455|NCT02366143|564913963|FG002|Overall Study|Patient moved to commercial stock|1|||
156496456|NCT02366143|564913961|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
156496457|NCT02366143|564913962|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
156496458|NCT02366143|564913963|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
156496459|NCT02366143|564913961|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
156496460|NCT02366143|564913962|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
156496461|NCT02366143|564913963|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
156496462|NCT02366143|564913961|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
156496463|NCT02366143|564913962|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
156496464|NCT02366143|564913963|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
156496465|NCT02366143|564913961|FG000|Overall Study|Requester's instructions|1|||
156375796|NCT02550652|564470115|FG001|Overall Study|Lost to Follow-up|3|||
156375797|NCT02550652|564470114|FG000|Overall Study|Physician Decision|0|||
156375798|NCT02550652|564470115|FG001|Overall Study|Physician Decision|2|||
156375799|NCT02550652|564470114|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
156375800|NCT02550652|564470115|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
156375801|NCT03027466|564470116|FG000|Overall Study|Opting out of the app|1869|||
156375802|NCT03027466|564470117|FG001|Overall Study|Opting out of the app|1819|||
156375803|NCT03027466|564470118|FG002|Overall Study|Opting out of the app|1743|||
156375804|NCT03027466|564470119|FG003|Overall Study|Opting out of the app|1821|||
156375805|NCT01706250|564470120|FG000|Overall Study|Lost to Follow-up|2|||
156375806|NCT03286140|564470121|FG000|Overall Study|Withdrawal by Subject|10|||
156375807|NCT03286140|564470122|FG001|Overall Study|Withdrawal by Subject|5|||
156375808|NCT03286140|564470121|FG000|Overall Study|Lost to Follow-up|5|||
156375809|NCT03286140|564470122|FG001|Overall Study|Lost to Follow-up|10|||
156375810|NCT03286140|564470121|FG000|Overall Study|Failure to comply|0|||
156375811|NCT03286140|564470122|FG001|Overall Study|Failure to comply|1|||
156375812|NCT02158039|564470123|FG000|Overall Study|Withdrawal by Subject|1|||
156375813|NCT02158039|564470123|FG000|Overall Study|Screen Failure|9|||
156375814|NCT02563028|564470125|FG000|Overall Study|Lack of equipment|1|||
156375815|NCT02563028|564470125|FG000|Overall Study|Unable to elicit VEP post induction|1|||
156375816|NCT01009099|564470126|FG000|Overall Study|Lost to Follow-up|1|||
156375817|NCT01009099|564470127|FG001|Overall Study|Lost to Follow-up|0|||
156375818|NCT01009099|564470126|FG000|Overall Study|Physician Decision|3|||
156375819|NCT01009099|564470127|FG001|Overall Study|Physician Decision|2|||
156375820|NCT01009099|564470126|FG000|Overall Study|Withdrawal by Subject|1|||
156375821|NCT01009099|564470127|FG001|Overall Study|Withdrawal by Subject|1|||
156375822|NCT01009099|564470126|FG000|Overall Study|Death|0|||
156375823|NCT01009099|564470127|FG001|Overall Study|Death|1|||
156375824|NCT01856543|564470128|FG000|Overall Study|Treatment discontinued|6|||
156375825|NCT01856543|564470129|FG001|Overall Study|Treatment discontinued|3|||
156375826|NCT01856543|564470128|FG000|Overall Study|Withdrawn before start|7|||
156375827|NCT01856543|564470129|FG001|Overall Study|Withdrawn before start|3|||
156375828|NCT02188485|564470130|FG000|Overall Study|Withdrawal by Subject|2|||
156375829|NCT02188485|564470131|FG001|Overall Study|Withdrawal by Subject|1|||
156375830|NCT02188485|564470130|FG000|Overall Study|PI withdrew, lack of capacity|0|||
156375831|NCT02188485|564470131|FG001|Overall Study|PI withdrew, lack of capacity|2|||
156375832|NCT00799617|564470132|FG000|Main Testosterone Trial|Randomized in error|1|||
156375833|NCT00799617|564470133|FG001|Main Testosterone Trial|Randomized in error|1|||
156375834|NCT00799617|564470132|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
156375835|NCT00799617|564470133|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
156375836|NCT00799617|564470132|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
156375837|NCT00799617|564470133|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
156375838|NCT00799617|564470132|FG000|Sexual Funtion Trial|No Baseline Data|4|||
156375839|NCT00799617|564470133|FG001|Sexual Funtion Trial|No Baseline Data|7|||
156375840|NCT00799617|564470132|FG000|Physical Function Trial|Lost to Follow-up|6|||
156375841|NCT00799617|564470133|FG001|Physical Function Trial|Lost to Follow-up|11|||
156375842|NCT00799617|564470132|FG000|Vitality Trial|Lost to Follow-up|7|||
156375843|NCT00799617|564470133|FG001|Vitality Trial|Lost to Follow-up|22|||
156375844|NCT00799617|564470132|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
156375845|NCT00799617|564470133|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
156375846|NCT00799617|564470132|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
156375847|NCT00799617|564470133|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
156375848|NCT00799617|564470132|FG000|Bone Trial|Month 12 scan not available|6|||
156496466|NCT02366143|564913962|FG001|Overall Study|Requester's instructions|1|||
156496467|NCT02366143|564913963|FG002|Overall Study|Requester's instructions|1|||
156496468|NCT02366143|564913961|FG000|Overall Study|Uneligible|0|||
156496469|NCT02366143|564913962|FG001|Overall Study|Uneligible|1|||
156496470|NCT02366143|564913963|FG002|Overall Study|Uneligible|0|||
156496471|NCT02366143|564913961|FG000|Overall Study|Post Trial Migration|0|||
156496472|NCT02366143|564913962|FG001|Overall Study|Post Trial Migration|1|||
156496473|NCT02366143|564913963|FG002|Overall Study|Post Trial Migration|0|||
156496474|NCT02366143|564913961|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
156496475|NCT02366143|564913962|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
156496476|NCT02366143|564913963|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
156496477|NCT02366143|564913961|FG000|Overall Study|Patient switched to PTAP|0|||
156496478|NCT02366143|564913962|FG001|Overall Study|Patient switched to PTAP|1|||
156496479|NCT02366143|564913963|FG002|Overall Study|Patient switched to PTAP|0|||
156496480|NCT02366143|564913961|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
156375849|NCT00799617|564470133|FG001|Bone Trial|Month 12 scan not available|16|||
156375850|NCT00799617|564470132|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
156375851|NCT00799617|564470133|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
156375852|NCT00799617|564470132|FG000|Anemia Trial|Withdrawal by Subject|3|||
156375853|NCT00799617|564470133|FG001|Anemia Trial|Withdrawal by Subject|3|||
156375854|NCT04545515|564470134|FG000|Overall Study|Adverse Event|1|||
156496481|NCT02366143|564913962|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
156496482|NCT02366143|564913963|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
156496483|NCT00575042|564913964|FG000|Overall Study|Adverse Event|2|||
156496484|NCT00575042|564913964|FG000|Overall Study|Lost to Follow-up|1|||
156496485|NCT01266018|564913969|FG000|Overall Study|Physician Decision|1|||
156496486|NCT01266018|564913970|FG001|Overall Study|Physician Decision|0|||
156496487|NCT01266018|564913969|FG000|Overall Study|Progressive disease|0|||
156496488|NCT01266018|564913970|FG001|Overall Study|Progressive disease|1|||
156496489|NCT03167151|564913971|FG000|Overall Study|Withdrawal by Subject|1|||
156496490|NCT03167151|564913972|FG001|Overall Study|Withdrawal by Subject|0|||
156496491|NCT03167151|564913973|FG002|Overall Study|Withdrawal by Subject|0|||
156496492|NCT03167151|564913971|FG000|Overall Study|No evidence of tumour at surgery|0|||
156496493|NCT03167151|564913972|FG001|Overall Study|No evidence of tumour at surgery|1|||
156496494|NCT03167151|564913973|FG002|Overall Study|No evidence of tumour at surgery|1|||
156496495|NCT01458522|564913974|FG000|Overall Study|Withdrawal by Subject|2|||
156496496|NCT01458522|564913975|FG001|Overall Study|Withdrawal by Subject|2|||
156496497|NCT01458522|564913974|FG000|Overall Study|Physician Decision|1|||
156496498|NCT01458522|564913975|FG001|Overall Study|Physician Decision|9|||
156496499|NCT00516139|564913976|FG000|Overall Study|Adverse Event|27|||
156496500|NCT00516139|564913976|FG000|Overall Study|Lost to Follow-up|1|||
156496501|NCT00516139|564913976|FG000|Overall Study|Protocol Violation|1|||
156496502|NCT00516139|564913976|FG000|Overall Study|Withdrawal by Subject|8|||
156496503|NCT00516139|564913976|FG000|Overall Study|Lack of Efficacy|1|||
156496504|NCT00416598|564913977|FG000|Induction & Intensification|Adverse Event|38|||
156496505|NCT00416598|564913977|FG000|Induction & Intensification|Death|32|||
156496506|NCT00416598|564913977|FG000|Induction & Intensification|Withdrawal by Subject|46|||
156496507|NCT00416598|564913977|FG000|Induction & Intensification|Alternative Treatment|135|||
156496508|NCT00416598|564913977|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
156496509|NCT00416598|564913977|FG000|Induction & Intensification|Relapse/progression|29|||
156496510|NCT00416598|564913977|FG000|Induction & Intensification|Failed induction|87|||
156496511|NCT00416598|564913977|FG000|Decitabine Maintenance|Adverse Event|5|||
156496512|NCT00416598|564913977|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
156496513|NCT00416598|564913977|FG000|Decitabine Maintenance|Progression/relapse|38|||
156496514|NCT00416598|564913977|FG000|Decitabine Maintenance|Alternative treatment|2|||
156496515|NCT00416598|564913977|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
156496516|NCT02370251|564913978|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
156496517|NCT02370251|564913978|FG000|Overall Study|Death|4|||
156496518|NCT04469465|564913979|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
156496519|NCT04469465|564913980|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
156496520|NCT04469465|564913979|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
156496521|NCT04469465|564913980|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
156496522|NCT04469465|564913979|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
156496523|NCT04469465|564913980|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
156496524|NCT04469465|564913979|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
156496525|NCT04469465|564913980|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
156496526|NCT04469465|564913979|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
156496527|NCT04469465|564913980|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
156496528|NCT04469465|564913979|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
156496529|NCT04469465|564913980|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
156496530|NCT04469465|564913979|FG000|Long-Term Extension (LTE)|Death|0|||
156496531|NCT04469465|564913980|FG001|Long-Term Extension (LTE)|Death|1|||
156496532|NCT04469465|564913979|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
156496533|NCT04469465|564913980|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
156496534|NCT01165177|564913981|FG000|Overall Study|Serious Adverse Event|227|||
156496535|NCT01165177|564913982|FG001|Overall Study|Serious Adverse Event|235|||
156496536|NCT01165177|564913981|FG000|Overall Study|Withdrawal by Subject|368|||
156496537|NCT01165177|564913982|FG001|Overall Study|Withdrawal by Subject|354|||
156496538|NCT01165177|564913981|FG000|Overall Study|Protocol Violation|19|||
156496539|NCT01165177|564913982|FG001|Overall Study|Protocol Violation|21|||
156496540|NCT01165177|564913981|FG000|Overall Study|Non-serious adverse event|30|||
156496541|NCT01165177|564913982|FG001|Overall Study|Non-serious adverse event|18|||
156496542|NCT01165177|564913981|FG000|Overall Study|Other unspecified reasons|47|||
156496543|NCT01165177|564913982|FG001|Overall Study|Other unspecified reasons|35|||
156496544|NCT01165177|564913981|FG000|Overall Study|Suspected HZ episode|0|||
156496545|NCT01165177|564913982|FG001|Overall Study|Suspected HZ episode|2|||
156496546|NCT01165177|564913981|FG000|Overall Study|Lost to Follow-up|183|||
156496547|NCT01165177|564913982|FG001|Overall Study|Lost to Follow-up|194|||
156496548|NCT01165177|564913981|FG000|Overall Study|Migrated/ moved from study area|48|||
156496549|NCT01165177|564913982|FG001|Overall Study|Migrated/ moved from study area|43|||
156375855|NCT04545515|564470134|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
156496550|NCT00781937|564913984|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
156375856|NCT04545515|564470134|FG000|Overall Study|Commercial drug is available for participant|7|||
156496551|NCT00781937|564913985|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
156496552|NCT00781937|564913984|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
156375857|NCT03149237|564470137|FG000|Overall Study|Withdrawal by Subject|4|||
156375858|NCT03149237|564470138|FG001|Overall Study|Withdrawal by Subject|5|||
156375859|NCT04587193|564470139|FG000|Overall Study|Screen failure after consent|3|||
156375860|NCT04587193|564470140|FG001|Overall Study|Screen failure after consent|0|||
156375861|NCT04587193|564470139|FG000|Overall Study|Device broke during study|3|||
156375862|NCT04587193|564470140|FG001|Overall Study|Device broke during study|2|||
156375863|NCT02501096|564470141|FG000|Overall Study|Lost to Follow-up|0|||
156375864|NCT02501096|564470142|FG001|Overall Study|Lost to Follow-up|0|||
156375865|NCT02501096|564470143|FG002|Overall Study|Lost to Follow-up|0|||
156375866|NCT02501096|564470144|FG003|Overall Study|Lost to Follow-up|0|||
156375867|NCT02501096|564470145|FG004|Overall Study|Lost to Follow-up|1|||
156375868|NCT02501096|564470146|FG005|Overall Study|Lost to Follow-up|1|||
156375869|NCT02501096|564470147|FG006|Overall Study|Lost to Follow-up|3|||
156375870|NCT02501096|564470148|FG007|Overall Study|Lost to Follow-up|0|||
156375871|NCT02501096|564470149|FG008|Overall Study|Lost to Follow-up|0|||
156375872|NCT02501096|564470141|FG000|Overall Study|Withdrawal by Subject|1|||
156375873|NCT02501096|564470142|FG001|Overall Study|Withdrawal by Subject|0|||
156375874|NCT02501096|564470143|FG002|Overall Study|Withdrawal by Subject|7|||
156375875|NCT02501096|564470144|FG003|Overall Study|Withdrawal by Subject|13|||
156375876|NCT02501096|564470145|FG004|Overall Study|Withdrawal by Subject|2|||
156375877|NCT02501096|564470146|FG005|Overall Study|Withdrawal by Subject|2|||
156375878|NCT02501096|564470147|FG006|Overall Study|Withdrawal by Subject|2|||
156375879|NCT02501096|564470148|FG007|Overall Study|Withdrawal by Subject|3|||
156375880|NCT02501096|564470149|FG008|Overall Study|Withdrawal by Subject|0|||
156375881|NCT02501096|564470141|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
156375882|NCT02501096|564470142|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
156375883|NCT02501096|564470143|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
156375884|NCT02501096|564470144|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
156375885|NCT02501096|564470145|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
156375886|NCT02501096|564470146|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
156375887|NCT02501096|564470147|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
156375888|NCT02501096|564470148|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
156375889|NCT02501096|564470149|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
156375890|NCT02501096|564470141|FG000|Overall Study|Death|1|||
156375891|NCT02501096|564470142|FG001|Overall Study|Death|1|||
156375892|NCT02501096|564470143|FG002|Overall Study|Death|88|||
156375893|NCT02501096|564470144|FG003|Overall Study|Death|74|||
156375894|NCT02501096|564470145|FG004|Overall Study|Death|15|||
156375895|NCT02501096|564470146|FG005|Overall Study|Death|16|||
156375896|NCT02501096|564470147|FG006|Overall Study|Death|15|||
156375897|NCT02501096|564470148|FG007|Overall Study|Death|16|||
156375898|NCT02501096|564470149|FG008|Overall Study|Death|1|||
156375899|NCT03851016|564470150|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156375900|NCT03851016|564470151|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
156375901|NCT03878134|564470152|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
156375902|NCT00853658|564470153|FG000|Overall Study|Death|713|||
156375903|NCT00853658|564470154|FG001|Overall Study|Death|768|||
156375904|NCT00853658|564470155|FG002|Overall Study|Death|753|||
156375905|NCT00853658|564470153|FG000|Overall Study|Lost to Follow-up|11|||
156375906|NCT00853658|564470154|FG001|Overall Study|Lost to Follow-up|6|||
156375907|NCT00853658|564470155|FG002|Overall Study|Lost to Follow-up|11|||
156375908|NCT00853658|564470153|FG000|Overall Study|H.A. Request|26|||
156375909|NCT00853658|564470154|FG001|Overall Study|H.A. Request|23|||
156375910|NCT00853658|564470155|FG002|Overall Study|H.A. Request|19|||
156375911|NCT00853658|564470153|FG000|Overall Study|IRB request|0|||
156375912|NCT00853658|564470154|FG001|Overall Study|IRB request|0|||
156375913|NCT00853658|564470155|FG002|Overall Study|IRB request|2|||
156375914|NCT00853658|564470153|FG000|Overall Study|Vital Status known (alive) at study end|2|||
156375915|NCT00853658|564470154|FG001|Overall Study|Vital Status known (alive) at study end|3|||
156375916|NCT00853658|564470155|FG002|Overall Study|Vital Status known (alive) at study end|3|||
156375917|NCT00853658|564470153|FG000|Overall Study|Vital Status unknown at study end|1|||
156375918|NCT00853658|564470154|FG001|Overall Study|Vital Status unknown at study end|1|||
156375919|NCT00853658|564470155|FG002|Overall Study|Vital Status unknown at study end|0|||
156375920|NCT00853658|564470153|FG000|Overall Study|Vital Status at study end N/A|8|||
156375921|NCT00853658|564470154|FG001|Overall Study|Vital Status at study end N/A|10|||
156496553|NCT00781937|564913985|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
156496554|NCT00781937|564913984|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
156496555|NCT00781937|564913985|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
156496556|NCT00781937|564913984|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
156496557|NCT00781937|564913985|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
156375922|NCT00853658|564470155|FG002|Overall Study|Vital Status at study end N/A|10|||
156375923|NCT00853658|564470153|FG000|Overall Study|Patient's request|21|||
156375924|NCT00853658|564470154|FG001|Overall Study|Patient's request|17|||
156375925|NCT00853658|564470155|FG002|Overall Study|Patient's request|11|||
156375926|NCT00853658|564470153|FG000|Overall Study|Missing study completion information|5|||
156496558|NCT00781937|564913984|FG000|Main Trial Period Through Week 56|Unclassified|10|||
156496559|NCT00781937|564913985|FG001|Main Trial Period Through Week 56|Unclassified|15|||
156496560|NCT00781937|564913984|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
156496561|NCT00781937|564913985|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
156496562|NCT00781937|564913984|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
156496563|NCT00781937|564913985|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
156496564|NCT00013611|564913986|FG000|Overall Study|Lost to Follow-up|91|||
156496565|NCT00013611|564913987|FG001|Overall Study|Lost to Follow-up|100|||
156496566|NCT01150045|564913988|FG000|Overall Study|Protocol Violation|0|||
156496567|NCT01150045|564913989|FG001|Overall Study|Protocol Violation|1|||
156496568|NCT01150045|564913990|FG002|Overall Study|Protocol Violation|0|||
156496569|NCT01150045|564913991|FG003|Overall Study|Protocol Violation|1|||
156496570|NCT01657799|564913992|FG000|Overall Study|Adverse Event Related to progression|6|||
156496571|NCT01657799|564913993|FG001|Overall Study|Adverse Event Related to progression|8|||
156496572|NCT01657799|564913994|FG002|Overall Study|Adverse Event Related to progression|12|||
156496573|NCT01657799|564913992|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
156496574|NCT01657799|564913993|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
156496575|NCT01657799|564913994|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
156496576|NCT01657799|564913992|FG000|Overall Study|Withdrawal by Subject|13|||
156496577|NCT01657799|564913993|FG001|Overall Study|Withdrawal by Subject|10|||
156496578|NCT01657799|564913994|FG002|Overall Study|Withdrawal by Subject|10|||
156496579|NCT01657799|564913992|FG000|Overall Study|Lost to Follow-up|1|||
156496580|NCT01657799|564913993|FG001|Overall Study|Lost to Follow-up|0|||
156496581|NCT01657799|564913994|FG002|Overall Study|Lost to Follow-up|1|||
156496582|NCT01657799|564913992|FG000|Overall Study|Disease Progression|2|||
156496583|NCT01657799|564913993|FG001|Overall Study|Disease Progression|4|||
156496584|NCT01657799|564913994|FG002|Overall Study|Disease Progression|4|||
156496585|NCT01657799|564913992|FG000|Overall Study|Progressive Disease Clinical|7|||
156496586|NCT01657799|564913993|FG001|Overall Study|Progressive Disease Clinical|4|||
156496587|NCT01657799|564913994|FG002|Overall Study|Progressive Disease Clinical|7|||
156496588|NCT01657799|564913992|FG000|Overall Study|Radiographic & Clinical Progression|16|||
156496589|NCT01657799|564913993|FG001|Overall Study|Radiographic & Clinical Progression|11|||
156496590|NCT01657799|564913994|FG002|Overall Study|Radiographic & Clinical Progression|15|||
156496591|NCT01657799|564913992|FG000|Overall Study|Other|52|||
156496592|NCT01657799|564913993|FG001|Overall Study|Other|62|||
156496593|NCT01657799|564913994|FG002|Overall Study|Other|49|||
156496594|NCT03021551|564913997|FG000|Overall Study|Equipment Issues|2|||
156496595|NCT03021551|564913997|FG000|Overall Study|Protocol Violation|1|||
156496596|NCT02229578|564913998|FG000|Overall Study|Withdrawal by Subject|1|||
156496597|NCT02229578|564913999|FG001|Overall Study|Withdrawal by Subject|3|||
156496598|NCT02229578|564913998|FG000|Overall Study|Protocol Violation|2|||
156496599|NCT02229578|564913999|FG001|Overall Study|Protocol Violation|0|||
156496600|NCT00412880|564914002|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
156496601|NCT00412880|564914002|FG000|Overall Study|Consent withdrawn|1|||
156496602|NCT00412880|564914002|FG000|Overall Study|Adverse Event|1|||
156496603|NCT00412880|564914002|FG000|Overall Study|Progressive disease|20|||
156496604|NCT02232399|564914004|FG000|Overall Study|Adverse Event|1|||
156496605|NCT02232399|564914005|FG001|Overall Study|Adverse Event|0|||
156496606|NCT02232399|564914004|FG000|Overall Study|Withdrawal by Subject|0|||
156496607|NCT02232399|564914005|FG001|Overall Study|Withdrawal by Subject|1|||
156496608|NCT02706951|564914007|FG000|Period 1|Adverse Event|1|||
156496609|NCT02706951|564914008|FG001|Period 1|Adverse Event|5|||
156496610|NCT02706951|564914009|FG002|Period 1|Adverse Event|3|||
156496611|NCT02706951|564914010|FG003|Period 1|Adverse Event|0|||
156496612|NCT02706951|564914011|FG004|Period 1|Adverse Event|0|||
156496613|NCT02706951|564914007|FG000|Period 1|Withdrawal by Subject|10|||
156496614|NCT02706951|564914008|FG001|Period 1|Withdrawal by Subject|6|||
156496615|NCT02706951|564914009|FG002|Period 1|Withdrawal by Subject|6|||
156496616|NCT02706951|564914010|FG003|Period 1|Withdrawal by Subject|0|||
156496617|NCT02706951|564914011|FG004|Period 1|Withdrawal by Subject|0|||
156496618|NCT02706951|564914007|FG000|Period 1|Lost to Follow-up|0|||
156496619|NCT02706951|564914008|FG001|Period 1|Lost to Follow-up|4|||
156546676|NCT02083380|565094950|FG002|Overall Study|Lack of Efficacy|64|||
156496620|NCT02706951|564914009|FG002|Period 1|Lost to Follow-up|1|||
156496621|NCT02706951|564914010|FG003|Period 1|Lost to Follow-up|0|||
156496622|NCT02706951|564914011|FG004|Period 1|Lost to Follow-up|0|||
156496623|NCT02706951|564914007|FG000|Period 1|Other|2|||
156496624|NCT02706951|564914008|FG001|Period 1|Other|1|||
156496625|NCT02706951|564914009|FG002|Period 1|Other|0|||
156496626|NCT02706951|564914010|FG003|Period 1|Other|0|||
156496627|NCT02706951|564914011|FG004|Period 1|Other|0|||
156496628|NCT02706951|564914007|FG000|Period 2|Adverse Event|0|||
156496629|NCT02706951|564914008|FG001|Period 2|Adverse Event|0|||
156496630|NCT02706951|564914009|FG002|Period 2|Adverse Event|0|||
156496631|NCT02706951|564914010|FG003|Period 2|Adverse Event|25|||
156496632|NCT02706951|564914011|FG004|Period 2|Adverse Event|34|||
156496633|NCT02706951|564914007|FG000|Period 2|Withdrawal by Subject|0|||
156496634|NCT02706951|564914008|FG001|Period 2|Withdrawal by Subject|0|||
156496635|NCT02706951|564914009|FG002|Period 2|Withdrawal by Subject|0|||
156375927|NCT00853658|564470154|FG001|Overall Study|Missing study completion information|4|||
156375928|NCT00853658|564470155|FG002|Overall Study|Missing study completion information|6|||
156375929|NCT01227512|564470156|FG000|Overall Study|Physician Decision|6|||
156375930|NCT01227512|564470157|FG001|Overall Study|Physician Decision|6|||
156375931|NCT01227512|564470156|FG000|Overall Study|Adverse Event|4|||
156375932|NCT01227512|564470157|FG001|Overall Study|Adverse Event|3|||
156375933|NCT01227512|564470156|FG000|Overall Study|Withdrawal by Subject|3|||
156375934|NCT01227512|564470157|FG001|Overall Study|Withdrawal by Subject|0|||
156375935|NCT01227512|564470156|FG000|Overall Study|Participant met withdrawal criteria|0|||
156375936|NCT01227512|564470157|FG001|Overall Study|Participant met withdrawal criteria|1|||
156375937|NCT02774681|564470164|FG000|Treatment on Study|Progressive Disease|7|||
156375938|NCT02774681|564470164|FG000|Follow-Up for 3 Years|Death|11|||
156375939|NCT02774681|564470164|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
156375940|NCT01069289|564470165|FG000|Overall Study|Withdrawal by Subject|15|||
156375941|NCT01069289|564470166|FG001|Overall Study|Withdrawal by Subject|26|||
156375942|NCT01069289|564470165|FG000|Overall Study|Adverse Event|21|||
156375943|NCT01069289|564470166|FG001|Overall Study|Adverse Event|28|||
156375944|NCT01069289|564470165|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156375945|NCT01069289|564470166|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156375946|NCT01069289|564470165|FG000|Overall Study|Severe non-compliance to protocol|3|||
156375947|NCT01069289|564470166|FG001|Overall Study|Severe non-compliance to protocol|2|||
156375948|NCT01069289|564470165|FG000|Overall Study|Due to deteriorating health condition|1|||
156375949|NCT01069289|564470166|FG001|Overall Study|Due to deteriorating health condition|0|||
156375950|NCT00298038|564470167|FG000|Overall Study|Lost to Follow-up|0|||
156375951|NCT00298038|564470168|FG001|Overall Study|Lost to Follow-up|1|||
156375952|NCT00298038|564470167|FG000|Overall Study|Liver Transplant|0|||
156375953|NCT00298038|564470168|FG001|Overall Study|Liver Transplant|1|||
156375954|NCT00298038|564470167|FG000|Overall Study|Protocol Violation|1|||
156375955|NCT00298038|564470168|FG001|Overall Study|Protocol Violation|3|||
156375956|NCT00298038|564470167|FG000|Overall Study|Death|6|||
156375957|NCT00298038|564470168|FG001|Overall Study|Death|3|||
156375958|NCT00298038|564470167|FG000|Overall Study|Withdrawal by Subject|6|||
156375959|NCT00298038|564470168|FG001|Overall Study|Withdrawal by Subject|9|||
156375960|NCT00298038|564470167|FG000|Overall Study|Adverse Event|8|||
156375961|NCT00298038|564470168|FG001|Overall Study|Adverse Event|7|||
156375962|NCT00298038|564470167|FG000|Overall Study|Breakthrough overt HE episode|28|||
156375963|NCT00298038|564470168|FG001|Overall Study|Breakthrough overt HE episode|69|||
156375964|NCT00298038|564470167|FG000|Overall Study|Noncompliance|1|||
156375965|NCT00298038|564470168|FG001|Overall Study|Noncompliance|0|||
156375966|NCT00298038|564470167|FG000|Overall Study|Cocaine Abuse|1|||
156375967|NCT00298038|564470168|FG001|Overall Study|Cocaine Abuse|0|||
156375968|NCT00298038|564470167|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
156375969|NCT00298038|564470168|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
156375970|NCT02696096|564470169|FG000|Overall Study|ruled out at screening|1|||
156375971|NCT02696096|564470169|FG000|Overall Study|did not attend second fMRI|1|||
156375972|NCT01940705|564470173|FG000|Overall Study|Lost to Follow-up|1|||
156375973|NCT01940705|564470174|FG001|Overall Study|Lost to Follow-up|3|||
156375974|NCT01940705|564470175|FG002|Overall Study|Lost to Follow-up|2|||
156375975|NCT01940705|564470176|FG003|Overall Study|Lost to Follow-up|2|||
156375976|NCT01940705|564470173|FG000|Overall Study|Withdrawal by Subject|2|||
156375977|NCT01940705|564470174|FG001|Overall Study|Withdrawal by Subject|2|||
156375978|NCT01940705|564470175|FG002|Overall Study|Withdrawal by Subject|3|||
156375979|NCT01940705|564470176|FG003|Overall Study|Withdrawal by Subject|2|||
156375980|NCT01940705|564470173|FG000|Overall Study|Intervention not given|0|||
156375981|NCT01940705|564470174|FG001|Overall Study|Intervention not given|3|||
156375982|NCT01940705|564470175|FG002|Overall Study|Intervention not given|3|||
156375983|NCT01940705|564470176|FG003|Overall Study|Intervention not given|0|||
156375984|NCT01940705|564470173|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
156375985|NCT01940705|564470174|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
156375986|NCT01940705|564470175|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
156375987|NCT01940705|564470176|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
156496636|NCT02706951|564914010|FG003|Period 2|Withdrawal by Subject|38|||
156496637|NCT02706951|564914011|FG004|Period 2|Withdrawal by Subject|44|||
156496638|NCT02706951|564914007|FG000|Period 2|Lost to Follow-up|0|||
156496639|NCT02706951|564914008|FG001|Period 2|Lost to Follow-up|0|||
156496640|NCT02706951|564914009|FG002|Period 2|Lost to Follow-up|0|||
156375988|NCT02447991|564470177|FG000|Overall Study|Withdrawn by subject - no data|0|||
156375989|NCT02447991|564470178|FG001|Overall Study|Withdrawn by subject - no data|2|||
156496641|NCT02706951|564914010|FG003|Period 2|Lost to Follow-up|17|||
156496642|NCT02706951|564914011|FG004|Period 2|Lost to Follow-up|9|||
156496643|NCT02706951|564914007|FG000|Period 2|COVID-19 Related|0|||
156375990|NCT02447991|564470177|FG000|Overall Study|Withdrawn by Subject - with data|4|||
156375991|NCT02447991|564470178|FG001|Overall Study|Withdrawn by Subject - with data|4|||
156375992|NCT02447991|564470177|FG000|Overall Study|Lost to Follow-up - no data|3|||
156375993|NCT02447991|564470178|FG001|Overall Study|Lost to Follow-up - no data|6|||
156496644|NCT02706951|564914008|FG001|Period 2|COVID-19 Related|0|||
156496645|NCT02706951|564914009|FG002|Period 2|COVID-19 Related|0|||
156496646|NCT02706951|564914010|FG003|Period 2|COVID-19 Related|1|||
156496647|NCT02706951|564914011|FG004|Period 2|COVID-19 Related|2|||
156496648|NCT02706951|564914007|FG000|Period 2|Other|0|||
156496649|NCT02706951|564914008|FG001|Period 2|Other|0|||
156496650|NCT02706951|564914009|FG002|Period 2|Other|0|||
156496651|NCT02706951|564914010|FG003|Period 2|Other|37|||
156496652|NCT02706951|564914011|FG004|Period 2|Other|31|||
156496653|NCT04799418|564914016|FG000|Overall Study|Death|1|||
156496654|NCT04799418|564914017|FG001|Overall Study|Death|1|||
156496655|NCT04799418|564914016|FG000|Overall Study|Lack of Efficacy|14|||
156496656|NCT04799418|564914017|FG001|Overall Study|Lack of Efficacy|14|||
156496657|NCT04799418|564914016|FG000|Overall Study|Withdrawal by Subject|10|||
156496658|NCT04799418|564914017|FG001|Overall Study|Withdrawal by Subject|7|||
156496659|NCT04799418|564914016|FG000|Overall Study|Adverse Event|3|||
156496660|NCT04799418|564914017|FG001|Overall Study|Adverse Event|2|||
156496661|NCT03297398|564914018|FG000|Overall Study|Sponsor's decision|6|||
156496662|NCT03297398|564914019|FG001|Overall Study|Sponsor's decision|9|||
156496663|NCT03297398|564914020|FG002|Overall Study|Sponsor's decision|7|||
156496664|NCT03297398|564914018|FG000|Overall Study|Adverse Event|1|||
156496665|NCT03297398|564914019|FG001|Overall Study|Adverse Event|4|||
156496666|NCT03297398|564914020|FG002|Overall Study|Adverse Event|4|||
156496667|NCT03297398|564914018|FG000|Overall Study|Withdrawal by Subject|1|||
156496668|NCT03297398|564914019|FG001|Overall Study|Withdrawal by Subject|2|||
156496669|NCT03297398|564914020|FG002|Overall Study|Withdrawal by Subject|2|||
156496670|NCT03297398|564914018|FG000|Overall Study|Protocol Violation|0|||
156496671|NCT03297398|564914019|FG001|Overall Study|Protocol Violation|2|||
156496672|NCT03297398|564914020|FG002|Overall Study|Protocol Violation|0|||
156496673|NCT03297398|564914018|FG000|Overall Study|Physician Decision|0|||
156496674|NCT03297398|564914019|FG001|Overall Study|Physician Decision|0|||
156496675|NCT03297398|564914020|FG002|Overall Study|Physician Decision|1|||
156496676|NCT03297398|564914018|FG000|Overall Study|Lost to Follow-up|0|||
156496677|NCT03297398|564914019|FG001|Overall Study|Lost to Follow-up|0|||
156496678|NCT03297398|564914020|FG002|Overall Study|Lost to Follow-up|1|||
156496679|NCT00611715|564914025|FG000|Overall Study|Disease Progression|24|||
156496680|NCT00611715|564914026|FG001|Overall Study|Disease Progression|4|||
156496681|NCT00611715|564914025|FG000|Overall Study|Withdrawal by Subject|5|||
156496682|NCT00611715|564914026|FG001|Overall Study|Withdrawal by Subject|1|||
156496683|NCT00611715|564914025|FG000|Overall Study|Adverse Event|9|||
156496684|NCT00611715|564914026|FG001|Overall Study|Adverse Event|1|||
156496685|NCT00611715|564914025|FG000|Overall Study|Death|1|||
156496686|NCT00611715|564914026|FG001|Overall Study|Death|0|||
156496687|NCT00611715|564914025|FG000|Overall Study|two patients are still on treatment|2|||
156496688|NCT00611715|564914026|FG001|Overall Study|two patients are still on treatment|0|||
156496689|NCT00107978|564914027|FG000|Overall Study|Adverse Event|1|||
156496690|NCT00107978|564914028|FG001|Overall Study|Adverse Event|5|||
156496691|NCT00107978|564914027|FG000|Overall Study|Death|3|||
156496692|NCT00107978|564914028|FG001|Overall Study|Death|3|||
156496693|NCT00107978|564914027|FG000|Overall Study|Lost to Follow-up|20|||
156496694|NCT00107978|564914028|FG001|Overall Study|Lost to Follow-up|28|||
156496695|NCT00107978|564914027|FG000|Overall Study|Withdrawal by Subject|4|||
156496696|NCT00107978|564914028|FG001|Overall Study|Withdrawal by Subject|9|||
156496697|NCT00107978|564914027|FG000|Overall Study|Protocol Violation|0|||
156496698|NCT00107978|564914028|FG001|Overall Study|Protocol Violation|1|||
156496699|NCT00107978|564914027|FG000|Overall Study|Other|5|||
156496700|NCT00107978|564914028|FG001|Overall Study|Other|4|||
156496701|NCT02669407|564914029|FG000|Overall Study|Physician Decision|3|||
156496702|NCT00350298|564914032|FG000|Overall Study|Death|7|||
156496703|NCT00350298|564914033|FG001|Overall Study|Death|8|||
156496704|NCT00350298|564914032|FG000|Overall Study|Lost to Follow-up|1|||
156496705|NCT00350298|564914033|FG001|Overall Study|Lost to Follow-up|2|||
156496706|NCT00350298|564914032|FG000|Overall Study|Withdrawal by Subject|1|||
156496707|NCT00350298|564914033|FG001|Overall Study|Withdrawal by Subject|3|||
156496708|NCT03634839|564914034|FG000|First Intervention (2 Hours)|Adverse Event|0|||
156496709|NCT03634839|564914035|FG001|First Intervention (2 Hours)|Adverse Event|2|||
156496710|NCT00233389|564914038|FG000|Overall Study|Adverse Event|5|||
156496711|NCT00233389|564914039|FG001|Overall Study|Adverse Event|5|||
156496712|NCT00233389|564914038|FG000|Overall Study|Lack of Efficacy|11|||
156496713|NCT00233389|564914039|FG001|Overall Study|Lack of Efficacy|8|||
156496714|NCT00233389|564914038|FG000|Overall Study|Lost to Follow-up|1|||
156496715|NCT00233389|564914039|FG001|Overall Study|Lost to Follow-up|1|||
156496716|NCT00233389|564914038|FG000|Overall Study|Physician Decision|1|||
156496717|NCT00233389|564914039|FG001|Overall Study|Physician Decision|0|||
156496718|NCT00233389|564914038|FG000|Overall Study|Protocol Violation|0|||
156496719|NCT00233389|564914039|FG001|Overall Study|Protocol Violation|1|||
156496720|NCT00233389|564914038|FG000|Overall Study|Withdrawal by Subject|0|||
156496721|NCT00233389|564914039|FG001|Overall Study|Withdrawal by Subject|1|||
156496722|NCT00719043|564914045|FG000|Overall Study|Adverse Event|5|||
156496723|NCT00719043|564914046|FG001|Overall Study|Adverse Event|1|||
156496724|NCT00719043|564914047|FG002|Overall Study|Adverse Event|2|||
156496725|NCT00719043|564914048|FG003|Overall Study|Adverse Event|2|||
156375994|NCT02447991|564470177|FG000|Overall Study|Lost to follow-up - with data|0|||
156375995|NCT02447991|564470178|FG001|Overall Study|Lost to follow-up - with data|3|||
156375996|NCT02447991|564470177|FG000|Overall Study|End of study - no treatment results|3|||
156496726|NCT00719043|564914049|FG004|Overall Study|Adverse Event|1|||
156496727|NCT00719043|564914050|FG005|Overall Study|Adverse Event|4|||
156496728|NCT00719043|564914051|FG006|Overall Study|Adverse Event|4|||
156496729|NCT00719043|564914045|FG000|Overall Study|Lost to Follow-up|14|||
156496730|NCT00719043|564914046|FG001|Overall Study|Lost to Follow-up|10|||
156496731|NCT00719043|564914047|FG002|Overall Study|Lost to Follow-up|8|||
156496732|NCT00719043|564914048|FG003|Overall Study|Lost to Follow-up|9|||
156496733|NCT00719043|564914049|FG004|Overall Study|Lost to Follow-up|10|||
156496734|NCT00719043|564914050|FG005|Overall Study|Lost to Follow-up|9|||
156496735|NCT00719043|564914051|FG006|Overall Study|Lost to Follow-up|9|||
156496736|NCT00719043|564914045|FG000|Overall Study|Protocol Violation|0|||
156496737|NCT00719043|564914046|FG001|Overall Study|Protocol Violation|0|||
156496738|NCT00719043|564914047|FG002|Overall Study|Protocol Violation|0|||
156496739|NCT00719043|564914048|FG003|Overall Study|Protocol Violation|0|||
156496740|NCT00719043|564914049|FG004|Overall Study|Protocol Violation|0|||
156496741|NCT00719043|564914050|FG005|Overall Study|Protocol Violation|1|||
156496742|NCT00719043|564914051|FG006|Overall Study|Protocol Violation|0|||
156496743|NCT00719043|564914045|FG000|Overall Study|Other|1|||
156496744|NCT00719043|564914046|FG001|Overall Study|Other|0|||
156496745|NCT00719043|564914047|FG002|Overall Study|Other|1|||
156496746|NCT00719043|564914048|FG003|Overall Study|Other|2|||
156496747|NCT00719043|564914049|FG004|Overall Study|Other|0|||
156496748|NCT00719043|564914050|FG005|Overall Study|Other|2|||
156496749|NCT00719043|564914051|FG006|Overall Study|Other|1|||
156496750|NCT00719043|564914045|FG000|Overall Study|Withdrawal by Subject|12|||
156496751|NCT00719043|564914046|FG001|Overall Study|Withdrawal by Subject|14|||
156496752|NCT00719043|564914047|FG002|Overall Study|Withdrawal by Subject|9|||
156496753|NCT00719043|564914048|FG003|Overall Study|Withdrawal by Subject|10|||
156496754|NCT00719043|564914049|FG004|Overall Study|Withdrawal by Subject|16|||
156496755|NCT00719043|564914050|FG005|Overall Study|Withdrawal by Subject|18|||
156496756|NCT00719043|564914051|FG006|Overall Study|Withdrawal by Subject|14|||
156496757|NCT01588366|564914052|FG000|Overall Study|Adverse Event|0|||
156496758|NCT01588366|564914053|FG001|Overall Study|Adverse Event|1|||
156496759|NCT01588366|564914054|FG002|Overall Study|Adverse Event|0|||
156496760|NCT01588366|564914055|FG003|Overall Study|Adverse Event|1|||
156496761|NCT01588366|564914056|FG004|Overall Study|Adverse Event|0|||
156496762|NCT01588366|564914057|FG005|Overall Study|Adverse Event|2|||
156496763|NCT00302159|564914060|FG000|Overall Study|pt declined before treatment started|1|||
156496764|NCT00302159|564914060|FG000|Overall Study|pt started Avastin|1|||
156496765|NCT04962698|564914063|FG000|Motor Imagery|Technical difficulty|1|||
156496766|NCT04962698|564914064|FG001|Motor Imagery|Technical difficulty|0|||
156496767|NCT04962698|564914063|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
156496768|NCT04962698|564914064|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
156496769|NCT04962698|564914063|FG000|Kinesthetic MI|Technical difficulty|1|||
156496770|NCT04962698|564914064|FG001|Kinesthetic MI|Technical difficulty|0|||
156375997|NCT02447991|564470178|FG001|Overall Study|End of study - no treatment results|6|||
156375998|NCT02447991|564470177|FG000|Overall Study|End of study - partial treatment results|0|||
156375999|NCT02447991|564470178|FG001|Overall Study|End of study - partial treatment results|9|||
156376000|NCT00829621|564470179|FG000|Overall Study|Death|1|||
156376001|NCT00829621|564470180|FG001|Overall Study|Death|0|||
156376002|NCT00829621|564470179|FG000|Overall Study|Lost to Follow-up|3|||
156376003|NCT00829621|564470180|FG001|Overall Study|Lost to Follow-up|4|||
156376004|NCT02770391|564470183|FG000|Overall Study|Lost to Follow-up|2|||
156376005|NCT02770391|564470183|FG000|Overall Study|Withdrawal by Subject|1|||
156376006|NCT02770391|564470183|FG000|Overall Study|Surgery delayed unevaluable|2|||
156376007|NCT02770391|564470183|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
156376008|NCT01976845|564470186|FG000|Overall Study|Physician Decision|8|||
156376009|NCT01976845|564470187|FG001|Overall Study|Physician Decision|8|||
156376010|NCT01976845|564470188|FG002|Overall Study|Physician Decision|3|||
156376011|NCT03042312|564472190|FG000|Overall Study|Administrative Reason|1|||
156376012|NCT03042312|564472191|FG001|Overall Study|Administrative Reason|1|||
156376013|NCT03042312|564472190|FG000|Overall Study|Adverse Event|0|||
156376014|NCT03042312|564472191|FG001|Overall Study|Adverse Event|1|||
156376015|NCT03042312|564472190|FG000|Overall Study|Lost to Follow-up|1|||
156376016|NCT03042312|564472191|FG001|Overall Study|Lost to Follow-up|3|||
156376017|NCT03042312|564472190|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
156496771|NCT04962698|564914063|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
156496772|NCT04962698|564914064|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
156496773|NCT04962698|564914063|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
156496774|NCT04962698|564914064|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
156496775|NCT04962698|564914063|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
156496776|NCT04962698|564914064|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
156496777|NCT04962698|564914063|FG000|Virtual-hand Interaction|Technical difficulty|1|||
156376018|NCT03042312|564472191|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
156376019|NCT03042312|564472190|FG000|Overall Study|Withdrawal by Subject|4|||
156376020|NCT03042312|564472191|FG001|Overall Study|Withdrawal by Subject|5|||
156376021|NCT04258839|564472194|FG000|Overall Study|Adverse Event|2|||
156376022|NCT04258839|564472195|FG001|Overall Study|Adverse Event|4|||
156376023|NCT04258839|564472194|FG000|Overall Study|Lack of Efficacy|0|||
156376024|NCT04258839|564472195|FG001|Overall Study|Lack of Efficacy|2|||
156376025|NCT04258839|564472194|FG000|Overall Study|Lost to Follow-up|2|||
156376026|NCT04258839|564472195|FG001|Overall Study|Lost to Follow-up|0|||
156376027|NCT04258839|564472194|FG000|Overall Study|Withdrawal by Subject|1|||
156376028|NCT04258839|564472195|FG001|Overall Study|Withdrawal by Subject|2|||
156376029|NCT04258839|564472194|FG000|Overall Study|Withdrawal by Caregiver|5|||
156376030|NCT04258839|564472195|FG001|Overall Study|Withdrawal by Caregiver|6|||
156376031|NCT04258839|564472194|FG000|Overall Study|Reason not Specified|0|||
156376032|NCT04258839|564472195|FG001|Overall Study|Reason not Specified|1|||
156376033|NCT03328897|564472196|FG000|Randomized-treatment Epoch|Adverse Event|4|||
156376034|NCT03328897|564472197|FG001|Randomized-treatment Epoch|Adverse Event|1|||
156376035|NCT03328897|564472198|FG002|Randomized-treatment Epoch|Adverse Event|1|||
156376036|NCT03328897|564472196|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
156376037|NCT03328897|564472197|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
156376038|NCT03328897|564472198|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
156376039|NCT03328897|564472196|FG000|Randomized-treatment Epoch|Pregnancy|3|||
156376040|NCT03328897|564472197|FG001|Randomized-treatment Epoch|Pregnancy|0|||
156376041|NCT03328897|564472198|FG002|Randomized-treatment Epoch|Pregnancy|0|||
156376042|NCT03328897|564472196|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
156376043|NCT03328897|564472197|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
156376044|NCT03328897|564472198|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
156376045|NCT03328897|564472196|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
156376046|NCT03328897|564472197|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
156376047|NCT03328897|564472198|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
156376048|NCT03328897|564472196|FG000|Follow-up Epoch|Adverse Event|4|||
156376049|NCT03328897|564472197|FG001|Follow-up Epoch|Adverse Event|0|||
156376050|NCT03328897|564472198|FG002|Follow-up Epoch|Adverse Event|1|||
156376051|NCT03328897|564472196|FG000|Follow-up Epoch|Lack of Efficacy|1|||
156376052|NCT03328897|564472197|FG001|Follow-up Epoch|Lack of Efficacy|1|||
156376053|NCT03328897|564472198|FG002|Follow-up Epoch|Lack of Efficacy|1|||
156376054|NCT03328897|564472196|FG000|Follow-up Epoch|Lost to Follow-up|0|||
156376055|NCT03328897|564472197|FG001|Follow-up Epoch|Lost to Follow-up|1|||
156376056|NCT03328897|564472198|FG002|Follow-up Epoch|Lost to Follow-up|0|||
156376057|NCT03328897|564472196|FG000|Follow-up Epoch|Pregnancy|1|||
156376058|NCT03328897|564472197|FG001|Follow-up Epoch|Pregnancy|0|||
156376059|NCT03328897|564472198|FG002|Follow-up Epoch|Pregnancy|0|||
156376060|NCT03328897|564472196|FG000|Follow-up Epoch|Patient/guardian decision|2|||
156376061|NCT03328897|564472197|FG001|Follow-up Epoch|Patient/guardian decision|1|||
156376062|NCT03328897|564472198|FG002|Follow-up Epoch|Patient/guardian decision|0|||
156376063|NCT02648698|564472202|FG000|Overall Study|Protocol Violation|1|||
156376064|NCT02648698|564472203|FG001|Overall Study|Protocol Violation|5|||
156376065|NCT00317772|564472206|FG000|Overall Study|Adverse Event|0|||
156376066|NCT00317772|564472207|FG001|Overall Study|Adverse Event|0|||
156376067|NCT00317772|564472208|FG002|Overall Study|Adverse Event|0|||
156376068|NCT00317772|564472209|FG003|Overall Study|Adverse Event|2|||
156376069|NCT00317772|564472206|FG000|Overall Study|Disease Progression|2|||
156376070|NCT00317772|564472207|FG001|Overall Study|Disease Progression|2|||
156376071|NCT00317772|564472208|FG002|Overall Study|Disease Progression|1|||
156376072|NCT00317772|564472209|FG003|Overall Study|Disease Progression|7|||
156376073|NCT00966940|564472210|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
156376074|NCT00966940|564472211|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
156376075|NCT00966940|564472210|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
156376076|NCT00966940|564472211|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
156376077|NCT01040871|564472214|FG000|Overall Study|Adverse Event|6|||
156376078|NCT01040871|564472215|FG001|Overall Study|Adverse Event|2|||
156496778|NCT04962698|564914064|FG001|Virtual-hand Interaction|Technical difficulty|0|||
156496779|NCT04962698|564914063|FG000|Robotic Action Observation|Technical difficulty|1|||
156496780|NCT04962698|564914064|FG001|Robotic Action Observation|Technical difficulty|0|||
156496781|NCT04962698|564914063|FG000|Rest|Technical difficulty|1|||
156496782|NCT04962698|564914064|FG001|Rest|Technical difficulty|0|||
156496783|NCT04962698|564914063|FG000|Rest|Exclusion criteria met after enrollment|0|||
156496784|NCT04962698|564914064|FG001|Rest|Exclusion criteria met after enrollment|2|||
156496785|NCT00853229|564914065|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
156496786|NCT00853229|564914066|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
156496787|NCT00585975|564914070|FG000|Overall Study|Withdrawal by Subject|3|||
156496788|NCT00585975|564914071|FG001|Overall Study|Withdrawal by Subject|3|||
156496789|NCT00585975|564914070|FG000|Overall Study|Lost to Follow-up|2|||
156376079|NCT01040871|564472214|FG000|Overall Study|Withdrawal by Subject|2|||
156376080|NCT01040871|564472215|FG001|Overall Study|Withdrawal by Subject|0|||
156376081|NCT01040871|564472214|FG000|Overall Study|Death|1|||
156496790|NCT00585975|564914071|FG001|Overall Study|Lost to Follow-up|1|||
156496791|NCT00585975|564914070|FG000|Overall Study|Enrollment met/over-enrolled|10|||
156496792|NCT00585975|564914071|FG001|Overall Study|Enrollment met/over-enrolled|9|||
156496793|NCT03082612|564914072|FG000|Overall Study|Lost to Follow-up|2|||
156496794|NCT03082612|564914073|FG001|Overall Study|Lost to Follow-up|0|||
156496795|NCT00952848|564914078|FG000|Overall Study|Withdrawal by Subject|4|||
156496796|NCT02725567|564914079|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
156376082|NCT01040871|564472215|FG001|Overall Study|Death|3|||
156496797|NCT02725567|564914080|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
156496798|NCT02725567|564914079|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
156496799|NCT02725567|564914080|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
156496800|NCT02725567|564914079|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
156496801|NCT02725567|564914080|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
156496802|NCT02413593|564914081|FG000|Overall Study|Lost to Follow-up|3|||
156496803|NCT02413593|564914081|FG000|Overall Study|Adverse Event|1|||
156496804|NCT03845075|564914082|FG000|Part 1 - DB|Withdrawal by Subject|1|||
156496805|NCT03845075|564914083|FG001|Part 1 - DB|Withdrawal by Subject|1|||
156496806|NCT03845075|564914084|FG002|Part 1 - DB|Withdrawal by Subject|0|||
156496807|NCT03845075|564914085|FG003|Part 1 - DB|Withdrawal by Subject|0|||
156496808|NCT03845075|564914082|FG000|Part 1 - DB|Adverse Event|0|||
156496809|NCT03845075|564914083|FG001|Part 1 - DB|Adverse Event|1|||
156496810|NCT03845075|564914084|FG002|Part 1 - DB|Adverse Event|0|||
156496811|NCT03845075|564914085|FG003|Part 1 - DB|Adverse Event|0|||
156496812|NCT03845075|564914082|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
156496813|NCT03845075|564914083|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
156496814|NCT03845075|564914084|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
156496815|NCT03845075|564914085|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
156496816|NCT02564718|564914086|FG000|Overall Study|Withdrew from treatment|0|||
156496817|NCT02564718|564914087|FG001|Overall Study|Withdrew from treatment|1|||
156496818|NCT00104637|564914088|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
156496819|NCT00104637|564914089|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
156496820|NCT00857233|564914090|FG000|Overall Study|Adverse Event|24|||
156496821|NCT00857233|564914090|FG000|Overall Study|Lack of Efficacy|1|||
156496822|NCT00857233|564914090|FG000|Overall Study|Non-compliance|1|||
156496823|NCT00857233|564914090|FG000|Overall Study|Withdrawal of Consent|9|||
156496824|NCT00857233|564914090|FG000|Overall Study|Lost to Follow-up|4|||
156496825|NCT00857233|564914090|FG000|Overall Study|Nursing Home Placement|14|||
156496826|NCT00857233|564914090|FG000|Overall Study|Other Reasons|2|||
156496827|NCT00823836|564914093|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
156496828|NCT00823836|564914094|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
156496829|NCT00823836|564914093|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
156496830|NCT00823836|564914094|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
156496831|NCT00823836|564914093|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
156496832|NCT00823836|564914094|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
156496833|NCT00823836|564914093|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
156496834|NCT00823836|564914094|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
156496835|NCT00823836|564914093|FG000|Long-term Phase|Adverse Event|3|||
156496836|NCT00823836|564914094|FG001|Long-term Phase|Adverse Event|2|||
156496837|NCT00823836|564914093|FG000|Long-term Phase|Physician Decision|1|||
156496838|NCT00823836|564914094|FG001|Long-term Phase|Physician Decision|2|||
156496839|NCT00823836|564914093|FG000|Long-term Phase|Withdrawal by Subject|1|||
156496840|NCT00823836|564914094|FG001|Long-term Phase|Withdrawal by Subject|1|||
156496841|NCT01130168|564914095|FG000|Period 1|Withdrawal by Subject|0|||
156496842|NCT01130168|564914096|FG001|Period 1|Withdrawal by Subject|1|||
156496843|NCT01130168|564914097|FG002|Period 1|Withdrawal by Subject|0|||
156496844|NCT01130168|564914098|FG003|Period 1|Withdrawal by Subject|1|||
156496845|NCT01130168|564914099|FG004|Period 1|Withdrawal by Subject|0|||
156496846|NCT01130168|564914100|FG005|Period 1|Withdrawal by Subject|0|||
156496847|NCT01130168|564914095|FG000|Period 1|Discontinued For Other Reason|0|||
156496848|NCT01130168|564914096|FG001|Period 1|Discontinued For Other Reason|0|||
156496849|NCT01130168|564914097|FG002|Period 1|Discontinued For Other Reason|1|||
156496850|NCT01130168|564914098|FG003|Period 1|Discontinued For Other Reason|1|||
156496851|NCT01130168|564914099|FG004|Period 1|Discontinued For Other Reason|0|||
156496852|NCT01130168|564914100|FG005|Period 1|Discontinued For Other Reason|0|||
156496853|NCT01130168|564914095|FG000|Period 1|Adverse Event|0|||
156496854|NCT01130168|564914096|FG001|Period 1|Adverse Event|0|||
156496855|NCT01130168|564914097|FG002|Period 1|Adverse Event|0|||
156496856|NCT01130168|564914098|FG003|Period 1|Adverse Event|1|||
156496857|NCT01130168|564914099|FG004|Period 1|Adverse Event|0|||
156496858|NCT01130168|564914100|FG005|Period 1|Adverse Event|0|||
156496859|NCT02725528|564914101|FG000|Overall Study|Lost to Follow-up|1|||
156496860|NCT02725528|564914102|FG001|Overall Study|Lost to Follow-up|4|||
156496861|NCT02725528|564914101|FG000|Overall Study|Withdrawal by Subject|0|||
156496862|NCT02725528|564914102|FG001|Overall Study|Withdrawal by Subject|1|||
156496863|NCT02058836|564914103|FG000|Overall Study|Withdrawal by Subject|1|||
156496864|NCT02058836|564914104|FG001|Overall Study|Withdrawal by Subject|1|||
156496865|NCT00727506|564914106|FG000|Overall Study|Adverse Event|0|||
156496866|NCT00727506|564914107|FG001|Overall Study|Adverse Event|0|||
156496867|NCT00727506|564914108|FG002|Overall Study|Adverse Event|4|||
156496868|NCT00727506|564914109|FG003|Overall Study|Adverse Event|4|||
156496869|NCT00727506|564914110|FG004|Overall Study|Adverse Event|1|||
156496870|NCT00727506|564914111|FG005|Overall Study|Adverse Event|8|||
156496871|NCT00727506|564914106|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156496872|NCT00727506|564914107|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156496873|NCT00727506|564914108|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156496874|NCT00727506|564914109|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156496875|NCT00727506|564914110|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156496876|NCT00727506|564914111|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156496877|NCT00727506|564914106|FG000|Overall Study|Progressive disease|4|||
156496878|NCT00727506|564914107|FG001|Overall Study|Progressive disease|7|||
156496879|NCT00727506|564914108|FG002|Overall Study|Progressive disease|9|||
156496880|NCT00727506|564914109|FG003|Overall Study|Progressive disease|28|||
156496881|NCT00727506|564914110|FG004|Overall Study|Progressive disease|38|||
156496882|NCT00727506|564914111|FG005|Overall Study|Progressive disease|28|||
156496883|NCT00727506|564914106|FG000|Overall Study|Refused to continue medication|0|||
156496884|NCT00727506|564914107|FG001|Overall Study|Refused to continue medication|1|||
156496885|NCT00727506|564914108|FG002|Overall Study|Refused to continue medication|2|||
156496886|NCT00727506|564914109|FG003|Overall Study|Refused to continue medication|3|||
156496887|NCT00727506|564914110|FG004|Overall Study|Refused to continue medication|1|||
156496888|NCT00727506|564914111|FG005|Overall Study|Refused to continue medication|2|||
156496889|NCT00727506|564914106|FG000|Overall Study|Other reason not described above|0|||
156496890|NCT00727506|564914107|FG001|Overall Study|Other reason not described above|0|||
156496891|NCT00727506|564914108|FG002|Overall Study|Other reason not described above|1|||
156376083|NCT01040871|564472214|FG000|Overall Study|Lack of Efficacy|1|||
156376084|NCT01040871|564472215|FG001|Overall Study|Lack of Efficacy|1|||
156376085|NCT01040871|564472214|FG000|Overall Study|drug supply issue|1|||
156376086|NCT01040871|564472215|FG001|Overall Study|drug supply issue|0|||
156376087|NCT01040871|564472214|FG000|Overall Study|Randomized and Not Treated|2|||
156376088|NCT01040871|564472215|FG001|Overall Study|Randomized and Not Treated|1|||
156376089|NCT02886572|564472216|FG000|Overall Study|Death|8|||
156376090|NCT02621606|564472217|FG000|Overall Study|Withdrawal by Subject|0|||
156376091|NCT02621606|564472218|FG001|Overall Study|Withdrawal by Subject|1|||
156376092|NCT02621606|564472219|FG002|Overall Study|Withdrawal by Subject|0|||
156376093|NCT01175824|564472220|FG000|Overall Study|Adverse Event|2|||
156376094|NCT01175824|564472221|FG001|Overall Study|Adverse Event|1|||
156376095|NCT01175824|564472220|FG000|Overall Study|Lack of Efficacy|2|||
156376096|NCT01175824|564472221|FG001|Overall Study|Lack of Efficacy|0|||
156376097|NCT01175824|564472220|FG000|Overall Study|Lost to Follow-up|0|||
156376098|NCT01175824|564472221|FG001|Overall Study|Lost to Follow-up|1|||
156496892|NCT00727506|564914109|FG003|Overall Study|Other reason not described above|4|||
156496893|NCT00727506|564914110|FG004|Overall Study|Other reason not described above|1|||
156496894|NCT00727506|564914111|FG005|Overall Study|Other reason not described above|1|||
156496895|NCT03783689|564914113|FG000|Overall Study|Adverse Event|2|||
156496896|NCT03783689|564914114|FG001|Overall Study|Adverse Event|0|||
156496897|NCT03783689|564914113|FG000|Overall Study|Lost to Follow-up|2|||
156496898|NCT03783689|564914114|FG001|Overall Study|Lost to Follow-up|1|||
156496899|NCT03783689|564914113|FG000|Overall Study|Physician Decision|2|||
156496900|NCT03783689|564914114|FG001|Overall Study|Physician Decision|1|||
156496901|NCT03783689|564914113|FG000|Overall Study|Withdrawal by Subject|3|||
156496902|NCT03783689|564914114|FG001|Overall Study|Withdrawal by Subject|3|||
156496903|NCT04887506|564914115|FG000|Overall Study|Death|1|||
156496904|NCT04887506|564914116|FG001|Overall Study|Death|1|||
156496905|NCT04887506|564914115|FG000|Overall Study|Withdrawal by Subject|0|||
156496906|NCT04887506|564914116|FG001|Overall Study|Withdrawal by Subject|3|||
156496907|NCT04887506|564914115|FG000|Overall Study|Adverse Event|4|||
156496908|NCT04887506|564914116|FG001|Overall Study|Adverse Event|3|||
156496909|NCT04887506|564914115|FG000|Overall Study|Other - Not Reported|1|||
156496910|NCT04887506|564914116|FG001|Overall Study|Other - Not Reported|1|||
156496911|NCT03151551|564914123|FG000|Open-Label Treatment Period|Adverse Event|0|||
156496912|NCT03151551|564914124|FG001|Open-Label Treatment Period|Adverse Event|2|||
156496913|NCT03151551|564914123|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
156496914|NCT03151551|564914124|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
156496915|NCT03151551|564914123|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
156496916|NCT03151551|564914124|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
156496917|NCT03151551|564914123|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
156376099|NCT01175824|564472220|FG000|Overall Study|Physician Decision|0|||
156376100|NCT01175824|564472221|FG001|Overall Study|Physician Decision|4|||
156376101|NCT01175824|564472220|FG000|Overall Study|Protocol Violation|2|||
156376102|NCT01175824|564472221|FG001|Overall Study|Protocol Violation|5|||
156376103|NCT01175824|564472220|FG000|Overall Study|Withdrawal by Subject|3|||
156376104|NCT01175824|564472221|FG001|Overall Study|Withdrawal by Subject|7|||
156376105|NCT01175824|564472220|FG000|Overall Study|Sponsor Decision|1|||
156376106|NCT01175824|564472221|FG001|Overall Study|Sponsor Decision|0|||
156376107|NCT01175824|564472220|FG000|Overall Study|Entry Criteria Not Met|6|||
156376108|NCT01175824|564472221|FG001|Overall Study|Entry Criteria Not Met|4|||
156376109|NCT03455855|564472222|FG000|Overall Study|Lost to Follow-up|4|||
156376110|NCT03455855|564472223|FG001|Overall Study|Lost to Follow-up|2|||
156376111|NCT00924950|564472224|FG000|Overall Study|Lost to Follow-up|2|||
156376112|NCT01324024|564472225|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
156376113|NCT01324024|564472226|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156376114|NCT00009737|564472227|FG000|Overall Study|Adverse Event|112|||
156376115|NCT00009737|564472228|FG001|Overall Study|Adverse Event|75|||
156376116|NCT00009737|564472227|FG000|Overall Study|Death|4|||
156546677|NCT02083380|565094948|FG000|Overall Study|Withdrawal by Subject|9|||
156546678|NCT02083380|565094949|FG001|Overall Study|Withdrawal by Subject|3|||
156496918|NCT03151551|564914124|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
156546679|NCT02083380|565094950|FG002|Overall Study|Withdrawal by Subject|7|||
156376117|NCT00009737|564472228|FG001|Overall Study|Death|6|||
156376118|NCT00009737|564472227|FG000|Overall Study|Lack of Efficacy|17|||
156496919|NCT03151551|564914123|FG000|Open-Label Treatment Period|Physician Decision|3|||
156496920|NCT03151551|564914124|FG001|Open-Label Treatment Period|Physician Decision|0|||
156496921|NCT03151551|564914123|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
156546680|NCT02083380|565094948|FG000|Overall Study|Physician Decision|1|||
156496922|NCT03151551|564914124|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
156546681|NCT02083380|565094949|FG001|Overall Study|Physician Decision|6|||
156546682|NCT02083380|565094950|FG002|Overall Study|Physician Decision|3|||
156376119|NCT00009737|564472228|FG001|Overall Study|Lack of Efficacy|15|||
156376120|NCT00009737|564472227|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
156376121|NCT00009737|564472228|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
156376122|NCT00009737|564472227|FG000|Overall Study|Other Protocol Violation|1|||
156496923|NCT03151551|564914123|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
156496924|NCT03151551|564914124|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
156496925|NCT03151551|564914123|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
156496926|NCT03151551|564914124|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
156496927|NCT03151551|564914123|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
156496928|NCT03151551|564914124|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
156496929|NCT03151551|564914123|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
156496930|NCT03151551|564914124|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
156496931|NCT01190449|564914125|FG000|Overall Study|Ineligible|0|||
156496932|NCT01190449|564914126|FG001|Overall Study|Ineligible|4|||
156496933|NCT00487825|564915730|FG000|Overall Study|Adverse Event|2|||
156496934|NCT00487825|564915731|FG001|Overall Study|Adverse Event|2|||
156496935|NCT00487825|564915730|FG000|Overall Study|Lack of Efficacy|1|||
156496936|NCT00487825|564915731|FG001|Overall Study|Lack of Efficacy|1|||
156496937|NCT00487825|564915730|FG000|Overall Study|Other|3|||
156496938|NCT00487825|564915731|FG001|Overall Study|Other|2|||
156496939|NCT01986114|564915732|FG000|Overall Study|Adverse Event|59|||
156496940|NCT01986114|564915732|FG000|Overall Study|Lack of Efficacy|23|||
156496941|NCT01986114|564915732|FG000|Overall Study|Withdrawal by Subject|58|||
156496942|NCT01986114|564915732|FG000|Overall Study|Noncompliance|3|||
156496943|NCT01986114|564915732|FG000|Overall Study|Protocol Violation|1|||
156496944|NCT01986114|564915732|FG000|Overall Study|Lost to Follow-up|5|||
156496945|NCT01986114|564915732|FG000|Overall Study|Other reason|7|||
156496946|NCT01190644|564915733|FG000|Overall Study|Death|2|||
156496947|NCT01190644|564915733|FG000|Overall Study|Disease progression|1|||
156496948|NCT04411186|564915734|FG000|Overall Study|Withdrawn due to protocol violation|0|||
156496949|NCT04411186|564915735|FG001|Overall Study|Withdrawn due to protocol violation|1|||
156496950|NCT02172911|564915736|FG000|Overall Study|Serious Adverse Event|0|||
156496951|NCT02172911|564915737|FG001|Overall Study|Serious Adverse Event|1|||
156496952|NCT02172911|564915736|FG000|Overall Study|Progression of Disease|0|||
156496953|NCT02172911|564915737|FG001|Overall Study|Progression of Disease|1|||
156496954|NCT02172911|564915736|FG000|Overall Study|Loss of insurance coverage|1|||
156496955|NCT02172911|564915737|FG001|Overall Study|Loss of insurance coverage|0|||
156496956|NCT04795336|564915742|FG000|Overall Study|Withdrawal by Subject|3|||
156496957|NCT04795336|564915743|FG001|Overall Study|Withdrawal by Subject|4|||
156496958|NCT04795336|564915744|FG002|Overall Study|Withdrawal by Subject|3|||
156496959|NCT04795336|564915745|FG003|Overall Study|Withdrawal by Subject|12|||
156496960|NCT04795336|564915742|FG000|Overall Study|Lost study logs|0|||
156496961|NCT04795336|564915743|FG001|Overall Study|Lost study logs|1|||
156496962|NCT04795336|564915744|FG002|Overall Study|Lost study logs|0|||
156496963|NCT04795336|564915745|FG003|Overall Study|Lost study logs|2|||
156496964|NCT04795336|564915742|FG000|Overall Study|Did not take study medication|2|||
156496965|NCT04795336|564915743|FG001|Overall Study|Did not take study medication|0|||
156496966|NCT04795336|564915744|FG002|Overall Study|Did not take study medication|0|||
156496967|NCT04795336|564915745|FG003|Overall Study|Did not take study medication|0|||
156496968|NCT00589303|564915746|FG000|Overall Study|Withdrawal by Subject|2|||
156496969|NCT00589303|564915747|FG001|Overall Study|Withdrawal by Subject|1|||
156496970|NCT04836559|564915748|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
156496971|NCT04836559|564915749|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
156496972|NCT04836559|564915750|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
156496973|NCT04836559|564915751|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
156496974|NCT04836559|564915752|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
156496975|NCT04836559|564915753|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
156496976|NCT04836559|564915754|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
156496977|NCT04836559|564915755|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
156496978|NCT04836559|564915748|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
156496979|NCT04836559|564915749|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
156496980|NCT04836559|564915750|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
156496981|NCT04836559|564915751|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
156546683|NCT02083380|565094948|FG000|Overall Study|Adverse Event|0|||
156546684|NCT02083380|565094949|FG001|Overall Study|Adverse Event|0|||
156546685|NCT02083380|565094950|FG002|Overall Study|Adverse Event|1|||
156546686|NCT02083380|565094948|FG000|Overall Study|Lost to Follow-up|5|||
156546687|NCT02083380|565094949|FG001|Overall Study|Lost to Follow-up|3|||
156546688|NCT02083380|565094950|FG002|Overall Study|Lost to Follow-up|3|||
156496982|NCT04836559|564915752|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
156496983|NCT04836559|564915753|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
156496984|NCT04836559|564915754|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
156496985|NCT04836559|564915755|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
156496986|NCT04836559|564915748|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
156496987|NCT04836559|564915749|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
156496988|NCT04836559|564915750|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
156496989|NCT04836559|564915751|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
156496990|NCT04836559|564915752|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
156496991|NCT04836559|564915753|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
156496992|NCT04836559|564915754|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
156496993|NCT04836559|564915755|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
156496994|NCT04836559|564915748|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
156496995|NCT04836559|564915749|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
156496996|NCT04836559|564915750|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
156496997|NCT04836559|564915751|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
156496998|NCT04836559|564915752|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
156496999|NCT04836559|564915753|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
156497000|NCT04836559|564915754|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
156497001|NCT04836559|564915755|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
156497002|NCT04836559|564915748|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
156497003|NCT04836559|564915749|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
156497004|NCT04836559|564915750|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
156497005|NCT04836559|564915751|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
156497006|NCT04836559|564915752|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
156497007|NCT04836559|564915753|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
156497008|NCT04836559|564915754|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
156497009|NCT04836559|564915755|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
156497010|NCT04836559|564915748|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
156497011|NCT04836559|564915749|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
156497012|NCT04836559|564915750|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
156497013|NCT04836559|564915751|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
156497014|NCT04836559|564915752|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
156497015|NCT04836559|564915753|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
156497016|NCT04836559|564915754|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
156497017|NCT04836559|564915755|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
156497018|NCT04836559|564915748|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
156497019|NCT04836559|564915749|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
156497020|NCT04836559|564915750|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
156497021|NCT04836559|564915751|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
156497022|NCT04836559|564915752|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
156497023|NCT04836559|564915753|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
156497024|NCT04836559|564915754|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
156497025|NCT04836559|564915755|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
156497026|NCT04836559|564915748|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
156497027|NCT04836559|564915749|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
156497028|NCT04836559|564915750|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
156497029|NCT04836559|564915751|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
156497030|NCT04836559|564915752|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
156497031|NCT04836559|564915753|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
156497032|NCT04836559|564915754|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
156497033|NCT04836559|564915755|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
156497034|NCT04836559|564915748|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
156497035|NCT04836559|564915749|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
156497036|NCT04836559|564915750|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
156497037|NCT04836559|564915751|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
156497038|NCT04836559|564915752|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
156497039|NCT04836559|564915753|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
156497040|NCT04836559|564915754|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
156497041|NCT04836559|564915755|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
156497042|NCT00730015|564915756|FG000|Overall Study|Adverse Event|11|||
156497043|NCT00730015|564915757|FG001|Overall Study|Adverse Event|10|||
156497044|NCT00730015|564915758|FG002|Overall Study|Adverse Event|8|||
156497045|NCT00730015|564915756|FG000|Overall Study|Protocol Violation|2|||
156497046|NCT00730015|564915757|FG001|Overall Study|Protocol Violation|6|||
156497047|NCT00730015|564915758|FG002|Overall Study|Protocol Violation|4|||
156497048|NCT00730015|564915756|FG000|Overall Study|Withdrawal by Subject|12|||
156497049|NCT00730015|564915757|FG001|Overall Study|Withdrawal by Subject|12|||
156497050|NCT00730015|564915758|FG002|Overall Study|Withdrawal by Subject|8|||
156546689|NCT02083380|565094948|FG000|Overall Study|Other|8|||
156546690|NCT02083380|565094949|FG001|Overall Study|Other|4|||
156546691|NCT02083380|565094950|FG002|Overall Study|Other|6|||
156497051|NCT00730015|564915756|FG000|Overall Study|Lost to Follow-up|4|||
156497052|NCT00730015|564915757|FG001|Overall Study|Lost to Follow-up|10|||
156497053|NCT00730015|564915758|FG002|Overall Study|Lost to Follow-up|3|||
156497054|NCT00730015|564915756|FG000|Overall Study|Lack of Efficacy|1|||
156497055|NCT00730015|564915757|FG001|Overall Study|Lack of Efficacy|2|||
156497056|NCT00730015|564915758|FG002|Overall Study|Lack of Efficacy|8|||
156497057|NCT00730015|564915756|FG000|Overall Study|Other Reason|1|||
156497058|NCT00730015|564915757|FG001|Overall Study|Other Reason|0|||
156497059|NCT00730015|564915758|FG002|Overall Study|Other Reason|1|||
156497060|NCT04978350|564915759|FG000|Overall Study|Lost to Follow-up|6|||
156497061|NCT04120376|564915760|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
156497062|NCT04120376|564915761|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
156497063|NCT02053610|564915762|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
156497064|NCT02053610|564915763|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
156497065|NCT02053610|564915762|FG000|Overall Study|Withdrew Consent|2|||
156497066|NCT02053610|564915763|FG001|Overall Study|Withdrew Consent|9|||
156497067|NCT02053610|564915762|FG000|Overall Study|Death|5|||
156497068|NCT02053610|564915763|FG001|Overall Study|Death|5|||
156497069|NCT02053610|564915762|FG000|Overall Study|Administrative/Other|1|||
156497070|NCT02053610|564915763|FG001|Overall Study|Administrative/Other|1|||
156497071|NCT02053610|564915762|FG000|Overall Study|Disease Progression|2|||
156497072|NCT02053610|564915763|FG001|Overall Study|Disease Progression|3|||
156497073|NCT02053610|564915762|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
156497074|NCT02053610|564915763|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
156497075|NCT02053610|564915762|FG000|Overall Study|Did not Receive Treatment|4|||
156497076|NCT02053610|564915763|FG001|Overall Study|Did not Receive Treatment|2|||
156497077|NCT02053610|564915762|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156497078|NCT02053610|564915763|FG001|Overall Study|Insufficient Therapeutic Response|1|||
156497079|NCT02053610|564915762|FG000|Overall Study|Violation of Selection Criteria|1|||
156497080|NCT02053610|564915763|FG001|Overall Study|Violation of Selection Criteria|0|||
156497081|NCT05499130|564915764|FG000|Overall Study|Adverse Event|2|||
156497082|NCT05499130|564915765|FG001|Overall Study|Adverse Event|0|||
156497083|NCT05499130|564915766|FG002|Overall Study|Adverse Event|1|||
156497084|NCT05499130|564915767|FG003|Overall Study|Adverse Event|0|||
156497085|NCT05499130|564915768|FG004|Overall Study|Adverse Event|1|||
156497086|NCT05499130|564915769|FG005|Overall Study|Adverse Event|4|||
156376123|NCT00009737|564472228|FG001|Overall Study|Other Protocol Violation|0|||
156376124|NCT00009737|564472227|FG000|Overall Study|Refused Treatment|15|||
156376125|NCT00009737|564472228|FG001|Overall Study|Refused Treatment|16|||
156376126|NCT00009737|564472227|FG000|Overall Study|Lost to Follow-up|1|||
156376127|NCT00009737|564472228|FG001|Overall Study|Lost to Follow-up|1|||
156376128|NCT00009737|564472227|FG000|Overall Study|Administrative/Other Reasons|7|||
156376129|NCT00009737|564472228|FG001|Overall Study|Administrative/Other Reasons|1|||
156376130|NCT01163682|564472229|FG000|Overall Study|Lost to Follow-up|6|||
156376131|NCT01163682|564472230|FG001|Overall Study|Lost to Follow-up|9|||
156376132|NCT00530023|564472232|FG000|Overall Study|Withdrawal by Subject|0|||
156376133|NCT00530023|564472233|FG001|Overall Study|Withdrawal by Subject|1|||
156376134|NCT01931839|564472234|FG000|Overall Study|Death|0|||
156376135|NCT01931839|564472235|FG001|Overall Study|Death|1|||
156376136|NCT01931839|564472236|FG002|Overall Study|Death|2|||
156376137|NCT01931839|564472237|FG003|Overall Study|Death|0|||
156376138|NCT01931839|564472238|FG004|Overall Study|Death|0|||
156376139|NCT01931839|564472239|FG005|Overall Study|Death|0|||
156376140|NCT01931839|564472240|FG006|Overall Study|Death|0|||
156376141|NCT01931839|564472234|FG000|Overall Study|Physician Decision|1|||
156376142|NCT01931839|564472235|FG001|Overall Study|Physician Decision|0|||
156376143|NCT01931839|564472236|FG002|Overall Study|Physician Decision|1|||
156376144|NCT01931839|564472237|FG003|Overall Study|Physician Decision|0|||
156376145|NCT01931839|564472238|FG004|Overall Study|Physician Decision|0|||
156376146|NCT01931839|564472239|FG005|Overall Study|Physician Decision|0|||
156376147|NCT01931839|564472240|FG006|Overall Study|Physician Decision|1|||
156497087|NCT05499130|564915770|FG006|Overall Study|Adverse Event|1|||
156497088|NCT05499130|564915771|FG007|Overall Study|Adverse Event|0|||
156497089|NCT05499130|564915764|FG000|Overall Study|Lack of Efficacy|1|||
156497090|NCT05499130|564915765|FG001|Overall Study|Lack of Efficacy|0|||
156497091|NCT05499130|564915766|FG002|Overall Study|Lack of Efficacy|0|||
156497092|NCT05499130|564915767|FG003|Overall Study|Lack of Efficacy|0|||
156497093|NCT05499130|564915768|FG004|Overall Study|Lack of Efficacy|5|||
156376148|NCT01931839|564472234|FG000|Overall Study|Withdrawal of consent|0|||
156376149|NCT01931839|564472235|FG001|Overall Study|Withdrawal of consent|0|||
156376150|NCT01931839|564472236|FG002|Overall Study|Withdrawal of consent|0|||
156376151|NCT01931839|564472237|FG003|Overall Study|Withdrawal of consent|0|||
156376152|NCT01931839|564472238|FG004|Overall Study|Withdrawal of consent|1|||
156497094|NCT05499130|564915769|FG005|Overall Study|Lack of Efficacy|0|||
156497095|NCT05499130|564915770|FG006|Overall Study|Lack of Efficacy|1|||
156376153|NCT01931839|564472239|FG005|Overall Study|Withdrawal of consent|0|||
156376154|NCT01931839|564472240|FG006|Overall Study|Withdrawal of consent|0|||
156376155|NCT01931839|564472234|FG000|Overall Study|Adverse Event|9|||
156376156|NCT01931839|564472235|FG001|Overall Study|Adverse Event|4|||
156497096|NCT05499130|564915771|FG007|Overall Study|Lack of Efficacy|0|||
156497097|NCT05499130|564915764|FG000|Overall Study|Withdrawal by Subject|2|||
156497098|NCT05499130|564915765|FG001|Overall Study|Withdrawal by Subject|0|||
156497099|NCT05499130|564915766|FG002|Overall Study|Withdrawal by Subject|0|||
156497100|NCT05499130|564915767|FG003|Overall Study|Withdrawal by Subject|0|||
156497101|NCT05499130|564915768|FG004|Overall Study|Withdrawal by Subject|1|||
156497102|NCT05499130|564915769|FG005|Overall Study|Withdrawal by Subject|2|||
156497103|NCT05499130|564915770|FG006|Overall Study|Withdrawal by Subject|0|||
156497104|NCT05499130|564915771|FG007|Overall Study|Withdrawal by Subject|0|||
156497105|NCT05499130|564915764|FG000|Overall Study|Lost to Follow-up|0|||
156497106|NCT05499130|564915765|FG001|Overall Study|Lost to Follow-up|0|||
156497107|NCT05499130|564915766|FG002|Overall Study|Lost to Follow-up|0|||
156497108|NCT05499130|564915767|FG003|Overall Study|Lost to Follow-up|0|||
156497109|NCT05499130|564915768|FG004|Overall Study|Lost to Follow-up|0|||
156497110|NCT05499130|564915769|FG005|Overall Study|Lost to Follow-up|2|||
156497111|NCT05499130|564915770|FG006|Overall Study|Lost to Follow-up|0|||
156497112|NCT05499130|564915771|FG007|Overall Study|Lost to Follow-up|0|||
156497113|NCT05499130|564915764|FG000|Overall Study|Other Than Specified|0|||
156497114|NCT05499130|564915765|FG001|Overall Study|Other Than Specified|0|||
156497115|NCT05499130|564915766|FG002|Overall Study|Other Than Specified|0|||
156497116|NCT05499130|564915767|FG003|Overall Study|Other Than Specified|0|||
156497117|NCT05499130|564915768|FG004|Overall Study|Other Than Specified|1|||
156497118|NCT05499130|564915769|FG005|Overall Study|Other Than Specified|1|||
156497119|NCT05499130|564915770|FG006|Overall Study|Other Than Specified|2|||
156497120|NCT05499130|564915771|FG007|Overall Study|Other Than Specified|0|||
156497121|NCT05499130|564915764|FG000|Overall Study|Protocol Violation|0|||
156497122|NCT05499130|564915765|FG001|Overall Study|Protocol Violation|0|||
156497123|NCT05499130|564915766|FG002|Overall Study|Protocol Violation|0|||
156497124|NCT05499130|564915767|FG003|Overall Study|Protocol Violation|0|||
156497125|NCT05499130|564915768|FG004|Overall Study|Protocol Violation|1|||
156497126|NCT05499130|564915769|FG005|Overall Study|Protocol Violation|0|||
156497127|NCT05499130|564915770|FG006|Overall Study|Protocol Violation|0|||
156497128|NCT05499130|564915771|FG007|Overall Study|Protocol Violation|0|||
156497129|NCT00126659|564915772|FG000|Overall Study|Adverse Event|0|||
156497130|NCT00126659|564915773|FG001|Overall Study|Adverse Event|0|||
156497131|NCT00126659|564915774|FG002|Overall Study|Adverse Event|2|||
156497132|NCT00490945|564915785|FG000|Overall Study|Adverse Event|0|||
156497133|NCT00490945|564915786|FG001|Overall Study|Adverse Event|1|||
156497134|NCT00490945|564915787|FG002|Overall Study|Adverse Event|0|||
156497135|NCT00490945|564915788|FG003|Overall Study|Adverse Event|0|||
156497136|NCT00490945|564915789|FG004|Overall Study|Adverse Event|0|||
156497137|NCT02312206|564915800|FG000|Overall Study|Adverse Event|3|||
156497138|NCT02312206|564915801|FG001|Overall Study|Adverse Event|6|||
156497139|NCT02312206|564915800|FG000|Overall Study|Withdrawal by Subject|6|||
156497140|NCT02312206|564915801|FG001|Overall Study|Withdrawal by Subject|6|||
156497141|NCT02312206|564915800|FG000|Overall Study|Physician Decision|7|||
156497142|NCT02312206|564915801|FG001|Overall Study|Physician Decision|6|||
156497143|NCT02312206|564915800|FG000|Overall Study|Death|31|||
156497144|NCT02312206|564915801|FG001|Overall Study|Death|36|||
156497145|NCT02312206|564915800|FG000|Overall Study|Study Terminated by Sponsor|81|||
156497146|NCT02312206|564915801|FG001|Overall Study|Study Terminated by Sponsor|74|||
156497147|NCT02312206|564915800|FG000|Overall Study|Patient transferred to hospice|0|||
156497148|NCT02312206|564915801|FG001|Overall Study|Patient transferred to hospice|1|||
156497149|NCT02312206|564915800|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
156497150|NCT02312206|564915801|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
156497151|NCT02312206|564915800|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
156497152|NCT02312206|564915801|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
156497153|NCT02312206|564915800|FG000|Overall Study|Disease Progression|1|||
156497154|NCT02312206|564915801|FG001|Overall Study|Disease Progression|0|||
156497155|NCT01006616|564915804|FG000|Period 1 (6 Months)|Adverse Event|10|||
156497156|NCT01006616|564915805|FG001|Period 1 (6 Months)|Adverse Event|31|||
156497157|NCT01006616|564915806|FG002|Period 1 (6 Months)|Adverse Event|37|||
156376157|NCT01931839|564472236|FG002|Overall Study|Adverse Event|1|||
156376158|NCT01931839|564472237|FG003|Overall Study|Adverse Event|3|||
156376159|NCT01931839|564472238|FG004|Overall Study|Adverse Event|0|||
156376160|NCT01931839|564472239|FG005|Overall Study|Adverse Event|0|||
156497158|NCT01006616|564915807|FG003|Period 1 (6 Months)|Adverse Event|9|||
156497159|NCT01006616|564915804|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
156497160|NCT01006616|564915805|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
156497161|NCT01006616|564915806|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
156497162|NCT01006616|564915807|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
156497163|NCT01006616|564915804|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
156376161|NCT01931839|564472240|FG006|Overall Study|Adverse Event|1|||
156497164|NCT01006616|564915805|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
156497165|NCT01006616|564915806|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
156497166|NCT01006616|564915807|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
156546692|NCT01032915|565094953|FG000|Overall Study|Adverse Event|2|||
156546693|NCT01032915|565094954|FG001|Overall Study|Adverse Event|2|||
156546694|NCT01032915|565094955|FG002|Overall Study|Adverse Event|1|||
156546695|NCT01032915|565094956|FG003|Overall Study|Adverse Event|1|||
156546696|NCT01032915|565094953|FG000|Overall Study|Abnormal test procedure result|0|||
156546697|NCT01032915|565094954|FG001|Overall Study|Abnormal test procedure result|0|||
156546698|NCT01032915|565094955|FG002|Overall Study|Abnormal test procedure result|1|||
156546699|NCT01032915|565094956|FG003|Overall Study|Abnormal test procedure result|0|||
156546700|NCT01032915|565094953|FG000|Overall Study|Withdrawal by Subject|0|||
156546701|NCT01032915|565094954|FG001|Overall Study|Withdrawal by Subject|3|||
156546702|NCT01032915|565094955|FG002|Overall Study|Withdrawal by Subject|1|||
156546703|NCT01032915|565094956|FG003|Overall Study|Withdrawal by Subject|1|||
156546704|NCT01032915|565094953|FG000|Overall Study|Administrative reasons|5|||
156546705|NCT01032915|565094954|FG001|Overall Study|Administrative reasons|6|||
156546706|NCT01032915|565094955|FG002|Overall Study|Administrative reasons|4|||
156546707|NCT01032915|565094956|FG003|Overall Study|Administrative reasons|4|||
156546708|NCT01032915|565094953|FG000|Overall Study|Protocol Violation|1|||
156546709|NCT01032915|565094954|FG001|Overall Study|Protocol Violation|0|||
156546710|NCT01032915|565094955|FG002|Overall Study|Protocol Violation|0|||
156546711|NCT01032915|565094956|FG003|Overall Study|Protocol Violation|1|||
156546712|NCT01577186|565094957|FG000|Overall Study|Adverse Event|23|||
156376162|NCT01931839|564472234|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
156376163|NCT01931839|564472235|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
156376164|NCT01931839|564472236|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
156376165|NCT01931839|564472237|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
156376166|NCT01931839|564472238|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
156376167|NCT01931839|564472239|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
156376168|NCT01931839|564472240|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
156497167|NCT01006616|564915804|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
156497168|NCT01006616|564915805|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
156497169|NCT01006616|564915806|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
156497170|NCT01006616|564915807|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
156497171|NCT01006616|564915804|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
156497172|NCT01006616|564915805|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
156497173|NCT01006616|564915806|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
156497174|NCT01006616|564915807|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
156497175|NCT01006616|564915804|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
156497176|NCT01006616|564915805|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
156497177|NCT01006616|564915806|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
156497178|NCT01006616|564915807|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
156497179|NCT01006616|564915804|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
156497180|NCT01006616|564915805|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
156497181|NCT01006616|564915806|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
156497182|NCT01006616|564915807|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
156497183|NCT01006616|564915804|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
156497184|NCT01006616|564915805|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
156497185|NCT01006616|564915806|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
156497186|NCT01006616|564915807|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
156497187|NCT01006616|564915804|FG000|Period 1 (6 Months)|Not Treated|0|||
156497188|NCT01006616|564915805|FG001|Period 1 (6 Months)|Not Treated|0|||
156497189|NCT01006616|564915806|FG002|Period 1 (6 Months)|Not Treated|1|||
156497190|NCT01006616|564915807|FG003|Period 1 (6 Months)|Not Treated|1|||
156497191|NCT01006616|564915804|FG000|Period 2 (18 Months)|Adverse Event|6|||
156497192|NCT01006616|564915805|FG001|Period 2 (18 Months)|Adverse Event|6|||
156497193|NCT01006616|564915806|FG002|Period 2 (18 Months)|Adverse Event|6|||
156497194|NCT01006616|564915807|FG003|Period 2 (18 Months)|Adverse Event|4|||
156497195|NCT01006616|564915804|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
156497196|NCT01006616|564915805|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
156497197|NCT01006616|564915806|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
156497198|NCT01006616|564915807|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
156497199|NCT01006616|564915804|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
156546713|NCT01577186|565094957|FG000|Overall Study|Death|1|||
156546714|NCT01577186|565094957|FG000|Overall Study|Lost to Follow-up|28|||
156546715|NCT01577186|565094957|FG000|Overall Study|Withdrawal by Subject|35|||
156546716|NCT01577186|565094957|FG000|Overall Study|Insufficient Response|18|||
156546717|NCT01577186|565094957|FG000|Overall Study|Ineligible to Continue|15|||
156546718|NCT01577186|565094957|FG000|Overall Study|Non-Compliant|8|||
156497200|NCT01006616|564915805|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
156546719|NCT01577186|565094957|FG000|Overall Study|Other|2|||
156546720|NCT02915523|565094959|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
156546721|NCT02915523|565094960|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
156546722|NCT02915523|565094961|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
156546723|NCT02915523|565094962|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
156497201|NCT01006616|564915806|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
156497202|NCT01006616|564915807|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
156497203|NCT01006616|564915804|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
156497204|NCT01006616|564915805|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
156497205|NCT01006616|564915806|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
156497206|NCT01006616|564915807|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
156497207|NCT01006616|564915804|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
156497208|NCT01006616|564915805|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
156497209|NCT01006616|564915806|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
156497210|NCT01006616|564915807|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
156497211|NCT01006616|564915804|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
156497212|NCT01006616|564915805|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
156497213|NCT01006616|564915806|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
156497214|NCT01006616|564915807|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
156497215|NCT01006616|564915804|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
156497216|NCT01006616|564915805|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
156497217|NCT01006616|564915806|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
156497218|NCT01006616|564915807|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
156497219|NCT01006616|564915804|FG000|Period 2 (18 Months)|Study Terminated|63|||
156497220|NCT01006616|564915805|FG001|Period 2 (18 Months)|Study Terminated|46|||
156497221|NCT01006616|564915806|FG002|Period 2 (18 Months)|Study Terminated|44|||
156497222|NCT01006616|564915807|FG003|Period 2 (18 Months)|Study Terminated|70|||
156497223|NCT03414047|564915808|FG000|Overall Study|Adverse Event|0|||
156497224|NCT03414047|564915809|FG001|Overall Study|Adverse Event|0|||
156497225|NCT03414047|564915810|FG002|Overall Study|Adverse Event|1|||
156497226|NCT03414047|564915811|FG003|Overall Study|Adverse Event|1|||
156497227|NCT03414047|564915808|FG000|Overall Study|Physician Decision|1|||
156497228|NCT03414047|564915809|FG001|Overall Study|Physician Decision|0|||
156497229|NCT03414047|564915810|FG002|Overall Study|Physician Decision|0|||
156497230|NCT03414047|564915811|FG003|Overall Study|Physician Decision|1|||
156497231|NCT03414047|564915808|FG000|Overall Study|Withdrawal by Subject|1|||
156497232|NCT03414047|564915809|FG001|Overall Study|Withdrawal by Subject|0|||
156497233|NCT03414047|564915810|FG002|Overall Study|Withdrawal by Subject|2|||
156497234|NCT03414047|564915811|FG003|Overall Study|Withdrawal by Subject|0|||
156497235|NCT04593823|564915812|FG000|Overall Study|Withdrawal by Subject|1|||
156497236|NCT04593823|564915813|FG001|Overall Study|Withdrawal by Subject|1|||
156497237|NCT04593823|564915812|FG000|Overall Study|Lost to Follow-up|0|||
156497238|NCT04593823|564915813|FG001|Overall Study|Lost to Follow-up|1|||
156497239|NCT00992992|564915819|FG000|Overall Study|Lost to Follow-up|3|||
156497240|NCT00992992|564915819|FG000|Overall Study|Death|16|||
156497241|NCT00992992|564915819|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
156497242|NCT00992992|564915819|FG000|Overall Study|Sponsor Closed the Study|4|||
156497243|NCT00217022|564915821|FG000|Overall Study|Withdrawal by Subject|1|||
156497244|NCT00217022|564915822|FG001|Overall Study|Withdrawal by Subject|1|||
156497245|NCT00458393|564915823|FG000|Overall Study|Withdrawal by Subject|67|||
156497246|NCT00458393|564915824|FG001|Overall Study|Withdrawal by Subject|80|||
156497247|NCT00458393|564915823|FG000|Overall Study|Physician Decision|31|||
156497248|NCT00458393|564915824|FG001|Overall Study|Physician Decision|22|||
156497249|NCT00458393|564915823|FG000|Overall Study|Relocated|77|||
156497250|NCT00458393|564915824|FG001|Overall Study|Relocated|81|||
156497251|NCT00458393|564915823|FG000|Overall Study|Lost to Follow-up|115|||
156497252|NCT00458393|564915824|FG001|Overall Study|Lost to Follow-up|92|||
156497253|NCT00458393|564915823|FG000|Overall Study|Sites marked other on the form.|19|||
156497254|NCT00458393|564915824|FG001|Overall Study|Sites marked other on the form.|20|||
156497255|NCT02777242|564915826|FG000|Overall Study|Other|2|||
156497256|NCT02777242|564915826|FG000|Overall Study|Lost to Follow-up|1|||
156497257|NCT02777242|564915826|FG000|Overall Study|Multiple|1|||
156497258|NCT02777242|564915826|FG000|Overall Study|Sponsor's request|1|||
156497259|NCT02777242|564915826|FG000|Overall Study|Withdrawal by Subject|1|||
156497260|NCT05178979|564915827|FG000|Overall Study|Death|0|||
156497261|NCT05178979|564915828|FG001|Overall Study|Death|5|||
156497262|NCT05178979|564915829|FG002|Overall Study|Death|0|||
156497263|NCT05178979|564915830|FG003|Overall Study|Death|3|||
156497264|NCT05178979|564915827|FG000|Overall Study|Adverse Event|0|||
156497265|NCT05178979|564915828|FG001|Overall Study|Adverse Event|1|||
156497266|NCT05178979|564915829|FG002|Overall Study|Adverse Event|0|||
156497267|NCT05178979|564915830|FG003|Overall Study|Adverse Event|0|||
156497268|NCT05178979|564915827|FG000|Overall Study|Lost to Follow-up|1|||
156497269|NCT05178979|564915828|FG001|Overall Study|Lost to Follow-up|8|||
156497270|NCT05178979|564915829|FG002|Overall Study|Lost to Follow-up|3|||
156497271|NCT05178979|564915830|FG003|Overall Study|Lost to Follow-up|8|||
156497272|NCT01253447|564915832|FG000|Overall Study|Adverse Event|2|||
156497273|NCT00817336|564915833|FG000|Overall Study|Withdrawal by Subject|1|||
156497274|NCT00817336|564915834|FG001|Overall Study|Withdrawal by Subject|1|||
156497275|NCT02299427|564915835|FG000|Overall Study|Withdrawal by Subject|1|||
156497276|NCT02299427|564915836|FG001|Overall Study|Withdrawal by Subject|0|||
156497277|NCT02299427|564915835|FG000|Overall Study|Lost to Follow-up|1|||
156497278|NCT02299427|564915836|FG001|Overall Study|Lost to Follow-up|3|||
156497279|NCT02299427|564915835|FG000|Overall Study|not adherent to dog website use|21|||
156497280|NCT02299427|564915836|FG001|Overall Study|not adherent to dog website use|0|||
156497281|NCT02108652|564915837|FG000|Overall Study|Death|253|||
156497282|NCT02108652|564915837|FG000|Overall Study|Lost to Follow-up|2|||
156376169|NCT01931839|564472234|FG000|Overall Study|Other non-compliance|15|||
156376170|NCT01931839|564472235|FG001|Overall Study|Other non-compliance|9|||
156497283|NCT02108652|564915837|FG000|Overall Study|Withdrawal by Subject|16|||
156497284|NCT02108652|564915837|FG000|Overall Study|Study Terminated By Sponsor|31|||
156497285|NCT02108652|564915837|FG000|Overall Study|Non-Compliance|1|||
156497286|NCT02108652|564915837|FG000|Overall Study|Physician Decision|6|||
156497287|NCT02108652|564915837|FG000|Overall Study|Progression Of Disease|1|||
156497288|NCT01182181|564915845|FG000|First Intervention|Adverse Event|1|||
156497289|NCT01182181|564915846|FG001|First Intervention|Adverse Event|0|||
156497290|NCT01182181|564915845|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
156497291|NCT01182181|564915846|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
156497292|NCT04706793|564915850|FG000|Treatment|Disease worsening|10|||
156497293|NCT04706793|564915851|FG001|Treatment|Disease worsening|10|||
156497294|NCT04706793|564915850|FG000|Follow-up|Lack of Efficacy|1|||
156497295|NCT04706793|564915851|FG001|Follow-up|Lack of Efficacy|0|||
156497296|NCT04706793|564915850|FG000|Follow-up|Disease worsening|8|||
156497297|NCT04706793|564915851|FG001|Follow-up|Disease worsening|10|||
156497298|NCT04706793|564915850|FG000|Follow-up|Adverse Event|1|||
156497299|NCT04706793|564915851|FG001|Follow-up|Adverse Event|0|||
156497300|NCT00745498|564915854|FG000|Overall Study|Lost to Follow-up|1|||
156497301|NCT00745498|564915855|FG001|Overall Study|Lost to Follow-up|1|||
156497302|NCT00745498|564915856|FG002|Overall Study|Lost to Follow-up|3|||
156497303|NCT00745498|564915854|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
156497304|NCT00745498|564915855|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
156497305|NCT00745498|564915856|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
156497306|NCT00745498|564915854|FG000|Overall Study|Non-PDR related VH|0|||
156497307|NCT00745498|564915855|FG001|Overall Study|Non-PDR related VH|1|||
156497308|NCT00745498|564915856|FG002|Overall Study|Non-PDR related VH|1|||
156497309|NCT00745498|564915854|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
156497310|NCT00745498|564915855|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
156497311|NCT00745498|564915856|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
156497312|NCT02706847|564915857|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
156497313|NCT02706847|564915858|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
156497314|NCT02706847|564915859|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
156497315|NCT02706847|564915860|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
156497316|NCT02706847|564915857|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
156497317|NCT02706847|564915858|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
156497318|NCT02706847|564915859|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
156497319|NCT02706847|564915860|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
156497320|NCT02706847|564915857|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
156497321|NCT02706847|564915858|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
156497322|NCT02706847|564915859|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
156497323|NCT02706847|564915860|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
156497324|NCT02706847|564915857|FG000|Period 1: Day 1 to Week 12|Other|4|||
156497325|NCT02706847|564915858|FG001|Period 1: Day 1 to Week 12|Other|4|||
156376171|NCT01931839|564472236|FG002|Overall Study|Other non-compliance|12|||
156376172|NCT01931839|564472237|FG003|Overall Study|Other non-compliance|3|||
156376173|NCT01931839|564472238|FG004|Overall Study|Other non-compliance|0|||
156376174|NCT01931839|564472239|FG005|Overall Study|Other non-compliance|3|||
156376175|NCT01931839|564472240|FG006|Overall Study|Other non-compliance|0|||
156376176|NCT01931839|564472234|FG000|Overall Study|Lost to Follow-up|1|||
156376177|NCT01931839|564472235|FG001|Overall Study|Lost to Follow-up|2|||
156376178|NCT01931839|564472236|FG002|Overall Study|Lost to Follow-up|4|||
156376179|NCT01931839|564472237|FG003|Overall Study|Lost to Follow-up|5|||
156376180|NCT01931839|564472238|FG004|Overall Study|Lost to Follow-up|0|||
156497326|NCT02706847|564915859|FG002|Period 1: Day 1 to Week 12|Other|2|||
156497327|NCT02706847|564915860|FG003|Period 1: Day 1 to Week 12|Other|2|||
156546724|NCT02915523|565094959|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
156546725|NCT02915523|565094960|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
156376181|NCT01931839|564472239|FG005|Overall Study|Lost to Follow-up|0|||
156376182|NCT01931839|564472240|FG006|Overall Study|Lost to Follow-up|0|||
156376183|NCT01931839|564472234|FG000|Overall Study|Other|4|||
156497328|NCT02706847|564915857|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
156497329|NCT02706847|564915858|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
156497330|NCT02706847|564915859|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
156497331|NCT02706847|564915860|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
156497332|NCT02706847|564915857|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
156497333|NCT02706847|564915858|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
156376184|NCT01931839|564472235|FG001|Overall Study|Other|2|||
156376185|NCT01931839|564472236|FG002|Overall Study|Other|6|||
156497334|NCT02706847|564915859|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
156497335|NCT02706847|564915860|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
156497336|NCT02706847|564915857|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
156497337|NCT02706847|564915858|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
156497338|NCT02706847|564915859|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
156497339|NCT02706847|564915860|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
156497340|NCT02706847|564915857|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
156497341|NCT02706847|564915858|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
156497342|NCT02706847|564915859|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
156497343|NCT02706847|564915860|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
156497344|NCT02706847|564915857|FG000|Period 1: Week 12 to Week 24|Other|1|||
156497345|NCT02706847|564915858|FG001|Period 1: Week 12 to Week 24|Other|0|||
156497346|NCT02706847|564915859|FG002|Period 1: Week 12 to Week 24|Other|1|||
156497347|NCT02706847|564915860|FG003|Period 1: Week 12 to Week 24|Other|4|||
156497348|NCT02706847|564915857|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
156497349|NCT02706847|564915858|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
156497350|NCT02706847|564915859|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
156497351|NCT02706847|564915860|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
156497352|NCT02706847|564915857|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
156497353|NCT02706847|564915858|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
156497354|NCT02706847|564915859|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
156497355|NCT02706847|564915860|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
156497356|NCT02706847|564915857|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
156497357|NCT02706847|564915858|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
156497358|NCT02706847|564915859|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
156497359|NCT02706847|564915860|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
156497360|NCT02706847|564915857|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
156497361|NCT02706847|564915858|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
156497362|NCT02706847|564915859|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
156497363|NCT02706847|564915860|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
156497364|NCT02706847|564915857|FG000|Period 2: Week 24 to Week 260|Other|8|||
156497365|NCT02706847|564915858|FG001|Period 2: Week 24 to Week 260|Other|5|||
156497366|NCT02706847|564915859|FG002|Period 2: Week 24 to Week 260|Other|15|||
156497367|NCT02706847|564915860|FG003|Period 2: Week 24 to Week 260|Other|15|||
156497368|NCT00725543|564915861|FG000|Overall Study|Adverse Event|10|||
156497369|NCT00725543|564915861|FG000|Overall Study|Lack of Efficacy|3|||
156497370|NCT00725543|564915861|FG000|Overall Study|Withdrawal by Subject|10|||
156497371|NCT00725543|564915861|FG000|Overall Study|Physician Decision|5|||
156497372|NCT00725543|564915861|FG000|Overall Study|Lost to Follow-up|4|||
156497373|NCT00725543|564915861|FG000|Overall Study|Non-compliance|2|||
156497374|NCT00725543|564915861|FG000|Overall Study|Other|119|||
156497375|NCT01157377|564915862|FG000|Overall Study|Lost to Follow-up|0|||
156497376|NCT01157377|564915863|FG001|Overall Study|Lost to Follow-up|0|||
156497377|NCT01157377|564915864|FG002|Overall Study|Lost to Follow-up|1|||
156497378|NCT01157377|564915865|FG003|Overall Study|Lost to Follow-up|0|||
156497379|NCT01157377|564915866|FG004|Overall Study|Lost to Follow-up|1|||
156497380|NCT01157377|564915867|FG005|Overall Study|Lost to Follow-up|1|||
156497381|NCT01157377|564915868|FG006|Overall Study|Lost to Follow-up|0|||
156497382|NCT01157377|564915862|FG000|Overall Study|Personal Reasons|2|||
156497383|NCT01157377|564915863|FG001|Overall Study|Personal Reasons|1|||
156497384|NCT01157377|564915864|FG002|Overall Study|Personal Reasons|0|||
156497385|NCT01157377|564915865|FG003|Overall Study|Personal Reasons|1|||
156497386|NCT01157377|564915866|FG004|Overall Study|Personal Reasons|0|||
156497387|NCT01157377|564915867|FG005|Overall Study|Personal Reasons|0|||
156497388|NCT01157377|564915868|FG006|Overall Study|Personal Reasons|0|||
156497389|NCT01157377|564915862|FG000|Overall Study|Protocol Violation|0|||
156497390|NCT01157377|564915863|FG001|Overall Study|Protocol Violation|0|||
156497391|NCT01157377|564915864|FG002|Overall Study|Protocol Violation|0|||
156497392|NCT01157377|564915865|FG003|Overall Study|Protocol Violation|0|||
156497393|NCT01157377|564915866|FG004|Overall Study|Protocol Violation|0|||
156497394|NCT01157377|564915867|FG005|Overall Study|Protocol Violation|1|||
156497395|NCT01157377|564915868|FG006|Overall Study|Protocol Violation|0|||
156497396|NCT01157377|564915862|FG000|Overall Study|Lack of Efficacy|0|||
156497397|NCT01157377|564915863|FG001|Overall Study|Lack of Efficacy|0|||
156497398|NCT01157377|564915864|FG002|Overall Study|Lack of Efficacy|0|||
156497399|NCT01157377|564915865|FG003|Overall Study|Lack of Efficacy|0|||
156497400|NCT01157377|564915866|FG004|Overall Study|Lack of Efficacy|0|||
156497401|NCT01157377|564915867|FG005|Overall Study|Lack of Efficacy|0|||
156497402|NCT01157377|564915868|FG006|Overall Study|Lack of Efficacy|1|||
156497403|NCT01157377|564915862|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156497404|NCT01157377|564915863|FG001|Overall Study|Other Miscellaneous Reasons|2|||
156497405|NCT01157377|564915864|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156497406|NCT01157377|564915865|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156497407|NCT01157377|564915866|FG004|Overall Study|Other Miscellaneous Reasons|1|||
156497408|NCT01157377|564915867|FG005|Overall Study|Other Miscellaneous Reasons|1|||
156497409|NCT01157377|564915868|FG006|Overall Study|Other Miscellaneous Reasons|1|||
156497410|NCT00087555|564915869|FG000|Overall Study|Adverse Event|3|||
156497411|NCT00087555|564915870|FG001|Overall Study|Adverse Event|6|||
156497412|NCT00087555|564915871|FG002|Overall Study|Adverse Event|14|||
156497413|NCT00087555|564915869|FG000|Overall Study|Lost to Follow-up|0|||
156497414|NCT00087555|564915870|FG001|Overall Study|Lost to Follow-up|1|||
156497415|NCT00087555|564915871|FG002|Overall Study|Lost to Follow-up|1|||
156497416|NCT00087555|564915869|FG000|Overall Study|Non - Compliance|1|||
156497417|NCT00087555|564915870|FG001|Overall Study|Non - Compliance|0|||
156497418|NCT00087555|564915871|FG002|Overall Study|Non - Compliance|0|||
156497419|NCT00087555|564915869|FG000|Overall Study|Protocol Violation|0|||
156497420|NCT00087555|564915870|FG001|Overall Study|Protocol Violation|0|||
156497421|NCT00087555|564915871|FG002|Overall Study|Protocol Violation|2|||
156497422|NCT00087555|564915869|FG000|Overall Study|Screen Failure|1|||
156497423|NCT00087555|564915870|FG001|Overall Study|Screen Failure|1|||
156497424|NCT00087555|564915871|FG002|Overall Study|Screen Failure|0|||
156497425|NCT00087555|564915869|FG000|Overall Study|Pregnancy|0|||
156497426|NCT00087555|564915870|FG001|Overall Study|Pregnancy|1|||
156497427|NCT00087555|564915871|FG002|Overall Study|Pregnancy|1|||
156497428|NCT00087555|564915869|FG000|Overall Study|Withdrawal by Subject|3|||
156497429|NCT00087555|564915870|FG001|Overall Study|Withdrawal by Subject|2|||
156497430|NCT00087555|564915871|FG002|Overall Study|Withdrawal by Subject|1|||
156497431|NCT00087555|564915869|FG000|Overall Study|Lack of Efficacy|2|||
156497432|NCT00087555|564915870|FG001|Overall Study|Lack of Efficacy|0|||
156497433|NCT00087555|564915871|FG002|Overall Study|Lack of Efficacy|1|||
156497434|NCT00087555|564915869|FG000|Overall Study|Non Compliance|0|||
156497435|NCT00087555|564915870|FG001|Overall Study|Non Compliance|0|||
156497436|NCT00087555|564915871|FG002|Overall Study|Non Compliance|1|||
156497437|NCT00087555|564915869|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
156497438|NCT00087555|564915870|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
156497439|NCT00087555|564915871|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
156497440|NCT00087555|564915869|FG000|Overall Study|Patient wanted to go back on Med|1|||
156497441|NCT00087555|564915870|FG001|Overall Study|Patient wanted to go back on Med|0|||
156497442|NCT00087555|564915871|FG002|Overall Study|Patient wanted to go back on Med|0|||
156497443|NCT01062971|564915872|FG000|Overall Study|Protocol Violation|1|||
156497444|NCT01062971|564915873|FG001|Overall Study|Protocol Violation|3|||
156497445|NCT01062971|564915872|FG000|Overall Study|Lost to Follow-up|3|||
156497446|NCT01062971|564915873|FG001|Overall Study|Lost to Follow-up|4|||
156497447|NCT00904722|564915884|FG000|Overall Study|Physician Decision|1|||
156497448|NCT00661713|564915885|FG000|Overall Study|Death|1|||
156497449|NCT00661713|564915886|FG001|Overall Study|Death|0|||
156497450|NCT00661713|564915887|FG002|Overall Study|Death|0|||
156497451|NCT00661713|564915888|FG003|Overall Study|Death|0|||
156497452|NCT00661713|564915889|FG004|Overall Study|Death|1|||
156497453|NCT00661713|564915890|FG005|Overall Study|Death|0|||
156497454|NCT00661713|564915891|FG006|Overall Study|Death|0|||
156497455|NCT00661713|564915892|FG007|Overall Study|Death|0|||
156497456|NCT00661713|564915885|FG000|Overall Study|Unable to Classify|1|||
156497457|NCT00661713|564915886|FG001|Overall Study|Unable to Classify|0|||
156497458|NCT00661713|564915887|FG002|Overall Study|Unable to Classify|0|||
156497459|NCT00661713|564915888|FG003|Overall Study|Unable to Classify|0|||
156497460|NCT00661713|564915889|FG004|Overall Study|Unable to Classify|0|||
156497461|NCT00661713|564915890|FG005|Overall Study|Unable to Classify|0|||
156497462|NCT00661713|564915891|FG006|Overall Study|Unable to Classify|0|||
156497463|NCT00661713|564915892|FG007|Overall Study|Unable to Classify|0|||
156497464|NCT00661713|564915885|FG000|Overall Study|Protocol Violation|1|||
156497465|NCT00661713|564915886|FG001|Overall Study|Protocol Violation|6|||
156497466|NCT00661713|564915887|FG002|Overall Study|Protocol Violation|3|||
156497467|NCT00661713|564915888|FG003|Overall Study|Protocol Violation|3|||
156497468|NCT00661713|564915889|FG004|Overall Study|Protocol Violation|0|||
156497469|NCT00661713|564915890|FG005|Overall Study|Protocol Violation|2|||
156497470|NCT00661713|564915891|FG006|Overall Study|Protocol Violation|2|||
156497471|NCT00661713|564915892|FG007|Overall Study|Protocol Violation|1|||
156497472|NCT00661713|564915885|FG000|Overall Study|Withdrawal by Subject|11|||
156497473|NCT00661713|564915886|FG001|Overall Study|Withdrawal by Subject|25|||
156497474|NCT00661713|564915887|FG002|Overall Study|Withdrawal by Subject|12|||
156497475|NCT00661713|564915888|FG003|Overall Study|Withdrawal by Subject|21|||
156497476|NCT00661713|564915889|FG004|Overall Study|Withdrawal by Subject|12|||
156497477|NCT00661713|564915890|FG005|Overall Study|Withdrawal by Subject|26|||
156497478|NCT00661713|564915891|FG006|Overall Study|Withdrawal by Subject|45|||
156497479|NCT00661713|564915892|FG007|Overall Study|Withdrawal by Subject|9|||
156497480|NCT00661713|564915885|FG000|Overall Study|Lost to Follow-up|2|||
156497481|NCT00661713|564915886|FG001|Overall Study|Lost to Follow-up|7|||
156497482|NCT00661713|564915887|FG002|Overall Study|Lost to Follow-up|2|||
156497483|NCT00661713|564915888|FG003|Overall Study|Lost to Follow-up|2|||
156497484|NCT00661713|564915889|FG004|Overall Study|Lost to Follow-up|5|||
156497485|NCT00661713|564915890|FG005|Overall Study|Lost to Follow-up|7|||
156497486|NCT00661713|564915891|FG006|Overall Study|Lost to Follow-up|14|||
156497487|NCT00661713|564915892|FG007|Overall Study|Lost to Follow-up|1|||
156497488|NCT00661713|564915885|FG000|Overall Study|Administrative Reason|0|||
156497489|NCT00661713|564915886|FG001|Overall Study|Administrative Reason|1|||
156497490|NCT00661713|564915887|FG002|Overall Study|Administrative Reason|0|||
156497491|NCT00661713|564915888|FG003|Overall Study|Administrative Reason|2|||
156497492|NCT00661713|564915889|FG004|Overall Study|Administrative Reason|2|||
156497493|NCT00661713|564915890|FG005|Overall Study|Administrative Reason|2|||
156497494|NCT00661713|564915891|FG006|Overall Study|Administrative Reason|1|||
156497495|NCT00661713|564915892|FG007|Overall Study|Administrative Reason|0|||
156497496|NCT00661713|564915885|FG000|Overall Study|Adverse Event|0|||
156497497|NCT00661713|564915886|FG001|Overall Study|Adverse Event|0|||
156497498|NCT00661713|564915887|FG002|Overall Study|Adverse Event|0|||
156497499|NCT00661713|564915888|FG003|Overall Study|Adverse Event|0|||
156497500|NCT00661713|564915889|FG004|Overall Study|Adverse Event|0|||
156497501|NCT00661713|564915890|FG005|Overall Study|Adverse Event|0|||
156497502|NCT00661713|564915891|FG006|Overall Study|Adverse Event|1|||
156497503|NCT00661713|564915892|FG007|Overall Study|Adverse Event|0|||
156497504|NCT00661713|564915885|FG000|Overall Study|Inappropriate Enrollment|0|||
156497505|NCT00661713|564915886|FG001|Overall Study|Inappropriate Enrollment|0|||
156497506|NCT00661713|564915887|FG002|Overall Study|Inappropriate Enrollment|0|||
156497507|NCT00661713|564915888|FG003|Overall Study|Inappropriate Enrollment|0|||
156497508|NCT00661713|564915889|FG004|Overall Study|Inappropriate Enrollment|0|||
156497509|NCT00661713|564915890|FG005|Overall Study|Inappropriate Enrollment|0|||
156497510|NCT00661713|564915891|FG006|Overall Study|Inappropriate Enrollment|1|||
156497511|NCT00661713|564915892|FG007|Overall Study|Inappropriate Enrollment|0|||
156497512|NCT01801982|564915893|FG000|Overall Study|Lost to Follow-up|1|||
156497513|NCT02650466|564915896|FG000|Overall Study|Physician Decision|1|||
156497514|NCT02650466|564915896|FG000|Overall Study|Withdrawal by Subject|5|||
156497515|NCT02650466|564915896|FG000|Overall Study|Lost to Follow-up|1|||
156497516|NCT01214421|564915897|FG000|Overall Study|Lost to Follow-up|7|||
156497517|NCT01214421|564915898|FG001|Overall Study|Lost to Follow-up|3|||
156497518|NCT01214421|564915899|FG002|Overall Study|Lost to Follow-up|7|||
156497519|NCT01214421|564915900|FG003|Overall Study|Lost to Follow-up|3|||
156497520|NCT01214421|564915897|FG000|Overall Study|Adverse Event|16|||
156497521|NCT01214421|564915898|FG001|Overall Study|Adverse Event|35|||
156497522|NCT01214421|564915899|FG002|Overall Study|Adverse Event|14|||
156497523|NCT01214421|564915900|FG003|Overall Study|Adverse Event|3|||
156497524|NCT01214421|564915897|FG000|Overall Study|Sponsor Discontinued Site|1|||
156497525|NCT01214421|564915898|FG001|Overall Study|Sponsor Discontinued Site|2|||
156497526|NCT01214421|564915899|FG002|Overall Study|Sponsor Discontinued Site|0|||
156497527|NCT01214421|564915900|FG003|Overall Study|Sponsor Discontinued Site|0|||
156497528|NCT01214421|564915897|FG000|Overall Study|Withdrawal Criteria Met|3|||
156497529|NCT01214421|564915898|FG001|Overall Study|Withdrawal Criteria Met|0|||
156497530|NCT01214421|564915899|FG002|Overall Study|Withdrawal Criteria Met|2|||
156497531|NCT01214421|564915900|FG003|Overall Study|Withdrawal Criteria Met|1|||
156497532|NCT01214421|564915897|FG000|Overall Study|Physician Decision|2|||
156497533|NCT01214421|564915898|FG001|Overall Study|Physician Decision|0|||
156497534|NCT01214421|564915899|FG002|Overall Study|Physician Decision|4|||
156497535|NCT01214421|564915900|FG003|Overall Study|Physician Decision|0|||
156497536|NCT01214421|564915897|FG000|Overall Study|Withdrawal by Subject|21|||
156497537|NCT01214421|564915898|FG001|Overall Study|Withdrawal by Subject|18|||
156497538|NCT01214421|564915899|FG002|Overall Study|Withdrawal by Subject|11|||
156497539|NCT01214421|564915900|FG003|Overall Study|Withdrawal by Subject|2|||
156497540|NCT02392104|564915903|FG000|Overall Study|discontinuation of warfarin|3|||
156497541|NCT02392104|564915903|FG000|Overall Study|bleeding event|1|||
156497542|NCT02392104|564915903|FG000|Overall Study|transferred care to another doctor|2|||
156497543|NCT02392104|564915903|FG000|Overall Study|INR goal range changed|1|||
156497544|NCT02392104|564915903|FG000|Overall Study|admitted to skilled nursing facility|3|||
156497545|NCT02392104|564915903|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
156497546|NCT05093504|564915904|FG000|Overall Study|Death|0|||
156497547|NCT05093504|564915905|FG001|Overall Study|Death|1|||
156497548|NCT05347485|564915908|FG000|Overall Study|Death|14|||
156497549|NCT05347485|564915908|FG000|Overall Study|Lost to Follow-up|2|||
156497550|NCT05347485|564915908|FG000|Overall Study|Withdrawal by Subject|13|||
156497551|NCT05347485|564915908|FG000|Overall Study|Progressive Disease|1|||
156497552|NCT05347485|564915908|FG000|Overall Study|Study Terminated by Sponsor|49|||
156497553|NCT05347485|564915908|FG000|Overall Study|Other|1|||
156497554|NCT05347485|564915908|FG000|Overall Study|Enrolled (consented) but not treated|4|||
156497555|NCT05347485|564915908|FG000|Overall Study|Disease Relapse|2|||
156497556|NCT01638390|564917512|FG000|Overall Study|screening failures|21|||
156497557|NCT04596995|564917515|FG000|Overall Study|Lack of Efficacy|8|||
156497558|NCT04596995|564917515|FG000|Overall Study|Lost to Follow-up|3|||
156497559|NCT04596995|564917515|FG000|Overall Study|Withdrawal by Subject|12|||
156497560|NCT04596995|564917515|FG000|Overall Study|Sponsor decision|3|||
156497561|NCT04596995|564917515|FG000|Overall Study|Enrolled in managed access program|3|||
156497562|NCT05382039|564917516|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
156497563|NCT05382039|564917517|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
156497564|NCT05382039|564917518|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
156497565|NCT05382039|564917516|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
156497566|NCT05382039|564917517|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
156497567|NCT05382039|564917518|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
156497568|NCT05382039|564917516|FG000|Overall Study|waiting for confirmation|0|||
156497569|NCT05382039|564917517|FG001|Overall Study|waiting for confirmation|0|||
156497570|NCT05382039|564917518|FG002|Overall Study|waiting for confirmation|1|||
156497571|NCT04464421|564917519|FG000|Overall Study|Lost to Follow-up|2|||
156497572|NCT04464421|564917520|FG001|Overall Study|Lost to Follow-up|2|||
156497573|NCT02577003|564917521|FG000|Overall Study|Adverse Event|2|||
156497574|NCT02577003|564917522|FG001|Overall Study|Adverse Event|4|||
156497575|NCT02577003|564917521|FG000|Overall Study|Withdrawal by Subject|0|||
156497576|NCT02577003|564917522|FG001|Overall Study|Withdrawal by Subject|1|||
156546726|NCT02915523|565094961|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
156546727|NCT02915523|565094962|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
156376186|NCT01931839|564472237|FG003|Overall Study|Other|0|||
156376187|NCT01931839|564472238|FG004|Overall Study|Other|0|||
156376188|NCT01931839|564472239|FG005|Overall Study|Other|0|||
156376189|NCT01931839|564472240|FG006|Overall Study|Other|0|||
156376190|NCT03224468|564472241|FG000|Overall Study|Did not obtain MM card|53|||
156376191|NCT03224468|564472242|FG001|Overall Study|Did not obtain MM card|0|||
156376192|NCT03224468|564472241|FG000|Overall Study|Lost to Follow-up|4|||
156376193|NCT03224468|564472242|FG001|Overall Study|Lost to Follow-up|11|||
156376194|NCT03224468|564472241|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
156376195|NCT03224468|564472242|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
156376196|NCT02571452|564472243|FG000|Overall Study Treatment|Protocol Violation|0|||
156376197|NCT02571452|564472244|FG001|Overall Study Treatment|Protocol Violation|1|||
156376198|NCT02571452|564472243|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
156376199|NCT02571452|564472244|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
156376200|NCT02571452|564472243|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
156376201|NCT02571452|564472244|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
156376202|NCT02863354|564472247|FG000|Year 1|Lost to Follow-up|1|||
156376203|NCT02863354|564472248|FG001|Year 1|Lost to Follow-up|1|||
156376204|NCT02863354|564472247|FG000|Year 1|Withdrawal by Subject|3|||
156376205|NCT02863354|564472248|FG001|Year 1|Withdrawal by Subject|0|||
156376206|NCT02863354|564472247|FG000|Year 1|Death|0|||
156376207|NCT02863354|564472248|FG001|Year 1|Death|1|||
156376208|NCT02863354|564472247|FG000|Year 2|Lost to Follow-up|2|||
156376209|NCT02863354|564472248|FG001|Year 2|Lost to Follow-up|2|||
156376210|NCT00724451|564472254|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
156376211|NCT00724451|564472254|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
156376212|NCT00724451|564472254|FG000|Overall Study|Not Eligible for Treatment|431|||
156376213|NCT00724451|564472254|FG000|Overall Study|Participant Refused Treatment|89|||
156376214|NCT00724451|564472254|FG000|Overall Study|Never Started Treatment|89|||
156376215|NCT00724451|564472254|FG000|Overall Study|Unknown; No Data Sources Available|9|||
156376216|NCT00724451|564472254|FG000|Overall Study|Physician Decision|116|||
156376217|NCT00724451|564472254|FG000|Overall Study|Withdrawal by Subject|45|||
156376218|NCT00724451|564472254|FG000|Overall Study|Investigator + Participant Decision|13|||
156376219|NCT01858194|564472264|FG000|Overall Study|Total Artificial Heart Implant|0|||
156376220|NCT01858194|564472265|FG001|Overall Study|Total Artificial Heart Implant|1|||
156376221|NCT01858194|564472264|FG000|Overall Study|Lost to Follow-up|0|||
156376222|NCT01858194|564472265|FG001|Overall Study|Lost to Follow-up|1|||
156497577|NCT02786004|564917523|FG000|Overall Study|Withdrawal by Subject|0|||
156376223|NCT00205712|564472277|FG000|Overall Study|Lost to Follow-up|0|||
156376224|NCT00205712|564472278|FG001|Overall Study|Lost to Follow-up|1|||
156376225|NCT00096044|564472279|FG000|Overall Study|Withdrawal by Subject|9|||
156376226|NCT00096044|564472279|FG000|Overall Study|Adverse Event|21|||
156376227|NCT00096044|564472279|FG000|Overall Study|Disease Progression|4|||
156497578|NCT02786004|564917524|FG001|Overall Study|Withdrawal by Subject|1|||
156497579|NCT01234883|564917525|FG000|Overall Study|Early treatment release|8|||
156376228|NCT02442830|564472280|FG000|Overall Study|Technical Failure|0|||
156376229|NCT02442830|564472281|FG001|Overall Study|Technical Failure|1|||
156376230|NCT02052466|564472282|FG000|Overall Study|Withdrawal by Subject|1|||
156497580|NCT01234883|564917526|FG001|Overall Study|Early treatment release|10|||
156497581|NCT01234883|564917525|FG000|Overall Study|Parent/guardian withdrew consent|1|||
156497582|NCT01234883|564917526|FG001|Overall Study|Parent/guardian withdrew consent|2|||
156497583|NCT01234883|564917525|FG000|Overall Study|Technical difficulties with IV infusion|0|||
156497584|NCT01234883|564917526|FG001|Overall Study|Technical difficulties with IV infusion|1|||
156497585|NCT01234883|564917525|FG000|Overall Study|Inclusion/exclusion failure|1|||
156497586|NCT01234883|564917526|FG001|Overall Study|Inclusion/exclusion failure|0|||
156497587|NCT03210519|564917527|FG000|Overall Study|Adverse Event|2|||
156497588|NCT03210519|564917528|FG001|Overall Study|Adverse Event|0|||
156497589|NCT03865953|564917531|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
156497590|NCT03865953|564917532|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
156497591|NCT03865953|564917531|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
156497592|NCT03865953|564917532|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
156497593|NCT03865953|564917531|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
156497594|NCT03865953|564917532|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
156497595|NCT01216072|564917538|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
156497596|NCT01216072|564917539|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
156497597|NCT01216072|564917538|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
156497598|NCT01216072|564917539|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
156497599|NCT01216072|564917538|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
156497600|NCT01216072|564917539|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
156497601|NCT01216072|564917538|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
156497602|NCT01216072|564917539|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
156497603|NCT01216072|564917538|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
156497604|NCT01216072|564917539|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
156497605|NCT01216072|564917538|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
156497606|NCT01216072|564917539|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
156497607|NCT01216072|564917538|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
156497608|NCT01216072|564917539|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
156497609|NCT01216072|564917538|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
156497610|NCT01216072|564917539|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
156497611|NCT01216072|564917538|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
156497612|NCT01216072|564917539|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
156497613|NCT01216072|564917538|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
156497614|NCT01216072|564917539|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
156497615|NCT01704547|564917543|FG000|Overall Study|Physician Decision|4|||
156497616|NCT01704547|564917543|FG000|Overall Study|Withdrawal by Subject|1|||
156497617|NCT01560871|564917544|FG000|Overall Study|transportation issues|2|||
156497618|NCT01560871|564917545|FG001|Overall Study|transportation issues|1|||
156497619|NCT01560871|564917544|FG000|Overall Study|relocation|1|||
156497620|NCT01560871|564917545|FG001|Overall Study|relocation|0|||
156497621|NCT01560871|564917544|FG000|Overall Study|readmission to a hospital|2|||
156497622|NCT01560871|564917545|FG001|Overall Study|readmission to a hospital|1|||
156497623|NCT01560871|564917544|FG000|Overall Study|Lost to Follow-up|1|||
156497624|NCT01560871|564917545|FG001|Overall Study|Lost to Follow-up|0|||
156497625|NCT00409409|564917546|FG000|Overall Study|Adverse Event|7|||
156497626|NCT00409409|564917547|FG001|Overall Study|Adverse Event|2|||
156497627|NCT00409409|564917546|FG000|Overall Study|Withdrawal by Subject|1|||
156497628|NCT00409409|564917547|FG001|Overall Study|Withdrawal by Subject|1|||
156497629|NCT00409409|564917546|FG000|Overall Study|Any other reason not above-mentioned|0|||
156497630|NCT00409409|564917547|FG001|Overall Study|Any other reason not above-mentioned|1|||
156497631|NCT03599622|564917548|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
156497632|NCT03599622|564917549|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
156497633|NCT03599622|564917550|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
156497634|NCT03599622|564917551|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
156497635|NCT03599622|564917548|FG000|Pre-Treatment Period|Other reasons|1|||
156497636|NCT03599622|564917549|FG001|Pre-Treatment Period|Other reasons|1|||
156497637|NCT03599622|564917550|FG002|Pre-Treatment Period|Other reasons|1|||
156497638|NCT03599622|564917551|FG003|Pre-Treatment Period|Other reasons|0|||
156497639|NCT03599622|564917548|FG000|Treatment Period|Adverse Event|11|||
156497640|NCT03599622|564917549|FG001|Treatment Period|Adverse Event|20|||
156497641|NCT03599622|564917550|FG002|Treatment Period|Adverse Event|18|||
156497642|NCT03599622|564917551|FG003|Treatment Period|Adverse Event|2|||
156546728|NCT02915523|565094959|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
156497643|NCT03599622|564917548|FG000|Treatment Period|Lack of Efficacy|18|||
156497644|NCT03599622|564917549|FG001|Treatment Period|Lack of Efficacy|12|||
156497645|NCT03599622|564917550|FG002|Treatment Period|Lack of Efficacy|13|||
156497646|NCT03599622|564917551|FG003|Treatment Period|Lack of Efficacy|2|||
156497647|NCT03599622|564917548|FG000|Treatment Period|Withdrawal by Subject|5|||
156497648|NCT03599622|564917549|FG001|Treatment Period|Withdrawal by Subject|11|||
156497649|NCT03599622|564917550|FG002|Treatment Period|Withdrawal by Subject|16|||
156497650|NCT03599622|564917551|FG003|Treatment Period|Withdrawal by Subject|1|||
156497651|NCT03599622|564917548|FG000|Treatment Period|Other reasons|4|||
156497652|NCT03599622|564917549|FG001|Treatment Period|Other reasons|6|||
156497653|NCT03599622|564917550|FG002|Treatment Period|Other reasons|7|||
156497654|NCT03599622|564917551|FG003|Treatment Period|Other reasons|0|||
156497655|NCT03599622|564917548|FG000|Treatment Period|Lost to Follow-up|1|||
156497656|NCT03599622|564917549|FG001|Treatment Period|Lost to Follow-up|0|||
156497657|NCT03599622|564917550|FG002|Treatment Period|Lost to Follow-up|0|||
156497658|NCT03599622|564917551|FG003|Treatment Period|Lost to Follow-up|0|||
156497659|NCT03599622|564917548|FG000|Treatment Period|Study terminated by sponsor|7|||
156497660|NCT03599622|564917549|FG001|Treatment Period|Study terminated by sponsor|20|||
156497661|NCT03599622|564917550|FG002|Treatment Period|Study terminated by sponsor|15|||
156497662|NCT03599622|564917551|FG003|Treatment Period|Study terminated by sponsor|0|||
156497663|NCT03599622|564917548|FG000|Treatment Period|Site terminated by sponsor|0|||
156497664|NCT03599622|564917549|FG001|Treatment Period|Site terminated by sponsor|1|||
156497665|NCT03599622|564917550|FG002|Treatment Period|Site terminated by sponsor|0|||
156497666|NCT03599622|564917551|FG003|Treatment Period|Site terminated by sponsor|0|||
156497667|NCT01278615|564917552|FG000|Overall Study|Withdrawal by Subject|2|||
156497668|NCT02138253|564917553|FG000|Overall Study|Adverse Event|3|||
156497669|NCT02138253|564917554|FG001|Overall Study|Adverse Event|3|||
156497670|NCT02138253|564917553|FG000|Overall Study|Lost to Follow-up|2|||
156497671|NCT02138253|564917554|FG001|Overall Study|Lost to Follow-up|1|||
156497672|NCT02138253|564917553|FG000|Overall Study|Physician Decision|2|||
156497673|NCT02138253|564917554|FG001|Overall Study|Physician Decision|0|||
156497674|NCT02138253|564917553|FG000|Overall Study|Non compliance|1|||
156497675|NCT02138253|564917554|FG001|Overall Study|Non compliance|0|||
156497676|NCT02138253|564917553|FG000|Overall Study|Withdrawal by Subject|1|||
156497677|NCT02138253|564917554|FG001|Overall Study|Withdrawal by Subject|0|||
156497678|NCT01918371|564917555|FG000|Overall Study|Missing Data|1|||
156497679|NCT01918371|564917556|FG001|Overall Study|Missing Data|1|||
156497680|NCT01006889|564917557|FG000|Overall Study|Withdrawal by Subject|3|||
156497681|NCT00243022|564917558|FG000|Overall Study|Withdrawal by Subject|1|||
156497682|NCT00243022|564917559|FG001|Overall Study|Withdrawal by Subject|0|||
156497683|NCT00243022|564917558|FG000|Overall Study|Death|1|||
156497684|NCT00243022|564917559|FG001|Overall Study|Death|0|||
156497685|NCT00243022|564917558|FG000|Overall Study|Difficult Travel Distance|0|||
156497686|NCT00243022|564917559|FG001|Overall Study|Difficult Travel Distance|1|||
156497687|NCT01390441|564917564|FG000|Treatment Period|Protocol Violation|0|||
156497688|NCT01390441|564917565|FG001|Treatment Period|Protocol Violation|1|||
156497689|NCT01390441|564917566|FG002|Treatment Period|Protocol Violation|0|||
156497690|NCT01390441|564917567|FG003|Treatment Period|Protocol Violation|0|||
156497691|NCT01390441|564917568|FG004|Treatment Period|Protocol Violation|0|||
156497692|NCT01390441|564917564|FG000|Treatment Period|Physician Decision|0|||
156497693|NCT01390441|564917565|FG001|Treatment Period|Physician Decision|0|||
156497694|NCT01390441|564917566|FG002|Treatment Period|Physician Decision|0|||
156497695|NCT01390441|564917567|FG003|Treatment Period|Physician Decision|1|||
156497696|NCT01390441|564917568|FG004|Treatment Period|Physician Decision|0|||
156497697|NCT01390441|564917564|FG000|Treatment Period|Lack of Efficacy|0|||
156497698|NCT01390441|564917565|FG001|Treatment Period|Lack of Efficacy|0|||
156497699|NCT01390441|564917566|FG002|Treatment Period|Lack of Efficacy|0|||
156497700|NCT01390441|564917567|FG003|Treatment Period|Lack of Efficacy|0|||
156497701|NCT01390441|564917568|FG004|Treatment Period|Lack of Efficacy|1|||
156497702|NCT01390441|564917564|FG000|Treatment Period|Unknown due to early stopping of study|0|||
156497703|NCT01390441|564917565|FG001|Treatment Period|Unknown due to early stopping of study|0|||
156497704|NCT01390441|564917566|FG002|Treatment Period|Unknown due to early stopping of study|8|||
156497705|NCT01390441|564917567|FG003|Treatment Period|Unknown due to early stopping of study|11|||
156497706|NCT01390441|564917568|FG004|Treatment Period|Unknown due to early stopping of study|7|||
156497707|NCT01390441|564917564|FG000|Treatment Period|Adverse Event|0|||
156497708|NCT01390441|564917565|FG001|Treatment Period|Adverse Event|0|||
156497709|NCT01390441|564917566|FG002|Treatment Period|Adverse Event|1|||
156497710|NCT01390441|564917567|FG003|Treatment Period|Adverse Event|1|||
156497711|NCT01390441|564917568|FG004|Treatment Period|Adverse Event|2|||
156497712|NCT01390441|564917564|FG000|Treatment Period|Withdrawal by Subject|0|||
156497713|NCT01390441|564917565|FG001|Treatment Period|Withdrawal by Subject|0|||
156497714|NCT01390441|564917566|FG002|Treatment Period|Withdrawal by Subject|1|||
156497715|NCT01390441|564917567|FG003|Treatment Period|Withdrawal by Subject|0|||
156497716|NCT01390441|564917568|FG004|Treatment Period|Withdrawal by Subject|1|||
156497717|NCT01390441|564917564|FG000|Treatment Period|Lost to Follow-up|1|||
156497718|NCT01390441|564917565|FG001|Treatment Period|Lost to Follow-up|0|||
156497719|NCT01390441|564917566|FG002|Treatment Period|Lost to Follow-up|0|||
156497720|NCT01390441|564917567|FG003|Treatment Period|Lost to Follow-up|0|||
156497721|NCT01390441|564917568|FG004|Treatment Period|Lost to Follow-up|0|||
156497722|NCT01390441|564917564|FG000|Extension Period|Protocol Violation|3|||
156497723|NCT01390441|564917565|FG001|Extension Period|Protocol Violation|1|||
156497724|NCT01390441|564917566|FG002|Extension Period|Protocol Violation|0|||
156497725|NCT01390441|564917567|FG003|Extension Period|Protocol Violation|1|||
156376231|NCT02052466|564472282|FG000|Overall Study|Acromial fracture|1|||
156376232|NCT00508742|564472283|FG000|Period 1: Infant Series|Adverse Event|5|||
156376233|NCT00508742|564472284|FG001|Period 1: Infant Series|Adverse Event|4|||
156376234|NCT00508742|564472283|FG000|Period 1: Infant Series|Protocol Violation|1|||
156376235|NCT00508742|564472284|FG001|Period 1: Infant Series|Protocol Violation|0|||
156376236|NCT00508742|564472283|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
156376237|NCT00508742|564472284|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
156376238|NCT00508742|564472283|FG000|Period 1: Infant Series|Physician Decision|1|||
156376239|NCT00508742|564472284|FG001|Period 1: Infant Series|Physician Decision|0|||
156376240|NCT00508742|564472283|FG000|Period 1: Infant Series|Other|4|||
156376241|NCT00508742|564472284|FG001|Period 1: Infant Series|Other|1|||
156376242|NCT00508742|564472283|FG000|Period 2: After Infant Series|Adverse Event|2|||
156376243|NCT00508742|564472284|FG001|Period 2: After Infant Series|Adverse Event|6|||
156376244|NCT00508742|564472283|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
156376245|NCT00508742|564472284|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
156376246|NCT00508742|564472283|FG000|Period 2: After Infant Series|Protocol Violation|1|||
156376247|NCT00508742|564472284|FG001|Period 2: After Infant Series|Protocol Violation|0|||
156376248|NCT00508742|564472283|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
156376249|NCT00508742|564472284|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
156376250|NCT00508742|564472283|FG000|Period 2: After Infant Series|Failed to Return|1|||
156376251|NCT00508742|564472284|FG001|Period 2: After Infant Series|Failed to Return|0|||
156376252|NCT00508742|564472283|FG000|Period 2: After Infant Series|Other|2|||
156376253|NCT00508742|564472284|FG001|Period 2: After Infant Series|Other|1|||
156376254|NCT00508742|564472283|FG000|Period 3: Toddler Dose|Adverse Event|1|||
156376255|NCT00508742|564472284|FG001|Period 3: Toddler Dose|Adverse Event|0|||
156376256|NCT00508742|564472283|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
156376257|NCT00508742|564472284|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
156376258|NCT00508742|564472283|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
156376259|NCT00508742|564472284|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
156376260|NCT00508742|564472283|FG000|Period 3: Toddler Dose|Other|5|||
156376261|NCT00508742|564472284|FG001|Period 3: Toddler Dose|Other|4|||
156376262|NCT00437034|564472285|FG000|Overall Study|Adverse Event|1|||
156376263|NCT00437034|564472285|FG000|Overall Study|Disease progression during treatment|5|||
156376264|NCT00595582|564472287|FG000|Overall Study|Pilot study that PI terminated|2|||
156376265|NCT00595582|564472287|FG000|Overall Study|Lost to Follow-up|1|||
156376266|NCT00595582|564472287|FG000|Overall Study|Adverse Event|2|||
156376267|NCT00595582|564472287|FG000|Overall Study|Physician Decision|5|||
156376268|NCT02460224|564472289|FG000|Overall Study|Adverse Event|0|||
156376269|NCT02460224|564472290|FG001|Overall Study|Adverse Event|0|||
156376270|NCT02460224|564472291|FG002|Overall Study|Adverse Event|0|||
156376271|NCT02460224|564472292|FG003|Overall Study|Adverse Event|0|||
156376272|NCT02460224|564472293|FG004|Overall Study|Adverse Event|0|||
156376273|NCT02460224|564472294|FG005|Overall Study|Adverse Event|0|||
156376274|NCT02460224|564472295|FG006|Overall Study|Adverse Event|1|||
156376275|NCT02460224|564472296|FG007|Overall Study|Adverse Event|0|||
156376276|NCT02460224|564472297|FG008|Overall Study|Adverse Event|0|||
156376277|NCT02460224|564472298|FG009|Overall Study|Adverse Event|0|||
156376278|NCT02460224|564472299|FG010|Overall Study|Adverse Event|0|||
156376279|NCT02460224|564472300|FG011|Overall Study|Adverse Event|0|||
156376280|NCT02460224|564472301|FG012|Overall Study|Adverse Event|1|||
156376281|NCT02460224|564472302|FG013|Overall Study|Adverse Event|0|||
156376282|NCT02460224|564472303|FG014|Overall Study|Adverse Event|0|||
156376283|NCT02460224|564472304|FG015|Overall Study|Adverse Event|0|||
156376284|NCT02460224|564472305|FG016|Overall Study|Adverse Event|1|||
156376285|NCT02460224|564472306|FG017|Overall Study|Adverse Event|0|||
156376286|NCT02460224|564472307|FG018|Overall Study|Adverse Event|1|||
156376287|NCT02460224|564472308|FG019|Overall Study|Adverse Event|0|||
156376288|NCT02460224|564472309|FG020|Overall Study|Adverse Event|1|||
156497726|NCT01390441|564917568|FG004|Extension Period|Protocol Violation|0|||
156497727|NCT03802617|564917569|FG000|Overall Study|Adverse Event|0|||
156497728|NCT03802617|564917570|FG001|Overall Study|Adverse Event|4|||
156497729|NCT03802617|564917571|FG002|Overall Study|Adverse Event|5|||
156376289|NCT02460224|564472310|FG021|Overall Study|Adverse Event|1|||
156376290|NCT02460224|564472311|FG022|Overall Study|Adverse Event|1|||
156376291|NCT02460224|564472312|FG023|Overall Study|Adverse Event|0|||
156376292|NCT02460224|564472313|FG024|Overall Study|Adverse Event|0|||
156376293|NCT02460224|564472314|FG025|Overall Study|Adverse Event|0|||
156376294|NCT02460224|564472315|FG026|Overall Study|Adverse Event|11|||
156376295|NCT02460224|564472316|FG027|Overall Study|Adverse Event|1|||
156376296|NCT02460224|564472317|FG028|Overall Study|Adverse Event|6|||
156376297|NCT02460224|564472289|FG000|Overall Study|Death|0|||
156497730|NCT03802617|564917572|FG003|Overall Study|Adverse Event|1|||
156497731|NCT03802617|564917569|FG000|Overall Study|Lack of Efficacy|0|||
156376298|NCT02460224|564472290|FG001|Overall Study|Death|0|||
156376299|NCT02460224|564472291|FG002|Overall Study|Death|0|||
156376300|NCT02460224|564472292|FG003|Overall Study|Death|0|||
156497732|NCT03802617|564917570|FG001|Overall Study|Lack of Efficacy|1|||
156497733|NCT03802617|564917571|FG002|Overall Study|Lack of Efficacy|0|||
156497734|NCT03802617|564917572|FG003|Overall Study|Lack of Efficacy|2|||
156497735|NCT03802617|564917569|FG000|Overall Study|Protocol Violation|1|||
156497736|NCT03802617|564917570|FG001|Overall Study|Protocol Violation|1|||
156497737|NCT03802617|564917571|FG002|Overall Study|Protocol Violation|1|||
156497738|NCT03802617|564917572|FG003|Overall Study|Protocol Violation|0|||
156497739|NCT03802617|564917569|FG000|Overall Study|Withdrawal by Subject|1|||
156497740|NCT03802617|564917570|FG001|Overall Study|Withdrawal by Subject|1|||
156497741|NCT03802617|564917571|FG002|Overall Study|Withdrawal by Subject|1|||
156497742|NCT03802617|564917572|FG003|Overall Study|Withdrawal by Subject|0|||
156497743|NCT03802617|564917569|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
156497744|NCT03802617|564917570|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
156497745|NCT03802617|564917571|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
156497746|NCT03802617|564917572|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
156497747|NCT00621192|564917573|FG000|Overall Study|Withdrawal by Subject|0|||
156497748|NCT00621192|564917574|FG001|Overall Study|Withdrawal by Subject|0|||
156497749|NCT00621192|564917575|FG002|Overall Study|Withdrawal by Subject|2|||
156497750|NCT00621192|564917576|FG003|Overall Study|Withdrawal by Subject|0|||
156497751|NCT00621192|564917573|FG000|Overall Study|Physician Decision|1|||
156497752|NCT00621192|564917574|FG001|Overall Study|Physician Decision|3|||
156497753|NCT00621192|564917575|FG002|Overall Study|Physician Decision|0|||
156497754|NCT00621192|564917576|FG003|Overall Study|Physician Decision|0|||
156497755|NCT00621192|564917573|FG000|Overall Study|Protocol Violation|1|||
156497756|NCT00621192|564917574|FG001|Overall Study|Protocol Violation|0|||
156497757|NCT00621192|564917575|FG002|Overall Study|Protocol Violation|0|||
156497758|NCT00621192|564917576|FG003|Overall Study|Protocol Violation|1|||
156497759|NCT00621192|564917573|FG000|Overall Study|Adverse Event|0|||
156497760|NCT00621192|564917574|FG001|Overall Study|Adverse Event|1|||
156497761|NCT00621192|564917575|FG002|Overall Study|Adverse Event|0|||
156497762|NCT00621192|564917576|FG003|Overall Study|Adverse Event|1|||
156497763|NCT00621192|564917573|FG000|Overall Study|Death|2|||
156497764|NCT00621192|564917574|FG001|Overall Study|Death|5|||
156497765|NCT00621192|564917575|FG002|Overall Study|Death|0|||
156497766|NCT00621192|564917576|FG003|Overall Study|Death|0|||
156497767|NCT00621192|564917573|FG000|Overall Study|Final Assessments not Completed|0|||
156497768|NCT00621192|564917574|FG001|Overall Study|Final Assessments not Completed|0|||
156497769|NCT00621192|564917575|FG002|Overall Study|Final Assessments not Completed|3|||
156497770|NCT00621192|564917576|FG003|Overall Study|Final Assessments not Completed|1|||
156497771|NCT01099579|564917577|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
156497772|NCT01099579|564917578|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
156497773|NCT01099579|564917579|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
156497774|NCT01099579|564917577|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
156497775|NCT01099579|564917578|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
156497776|NCT01099579|564917579|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
156497777|NCT01099579|564917577|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
156497778|NCT01099579|564917578|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
156497779|NCT01099579|564917579|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
156497780|NCT01099579|564917577|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
156497781|NCT01099579|564917578|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
156497782|NCT01099579|564917579|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
156497783|NCT01099579|564917577|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
156497784|NCT01099579|564917578|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
156497785|NCT01099579|564917579|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
156497786|NCT01099579|564917577|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
156497787|NCT01099579|564917578|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
156497788|NCT01099579|564917579|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
156497789|NCT01099579|564917577|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
156497790|NCT01099579|564917578|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
156497791|NCT01099579|564917579|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
156497792|NCT01099579|564917577|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
156546729|NCT02915523|565094960|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
156546730|NCT02915523|565094961|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
156497793|NCT01099579|564917578|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
156497794|NCT01099579|564917579|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
156497795|NCT01099579|564917577|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
156497796|NCT01099579|564917578|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
156497797|NCT01099579|564917579|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
156497798|NCT01099579|564917577|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
156497799|NCT01099579|564917578|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
156497800|NCT01099579|564917579|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
156497801|NCT02569957|564917580|FG000|Overall Study|Withdrawal by Subject|0|||
156497802|NCT02569957|564917581|FG001|Overall Study|Withdrawal by Subject|1|||
156376301|NCT02460224|564472293|FG004|Overall Study|Death|0|||
156376302|NCT02460224|564472294|FG005|Overall Study|Death|2|||
156376303|NCT02460224|564472295|FG006|Overall Study|Death|1|||
156376304|NCT02460224|564472296|FG007|Overall Study|Death|0|||
156376305|NCT02460224|564472297|FG008|Overall Study|Death|0|||
156376306|NCT02460224|564472298|FG009|Overall Study|Death|1|||
156376307|NCT02460224|564472299|FG010|Overall Study|Death|0|||
156376308|NCT02460224|564472300|FG011|Overall Study|Death|0|||
156376309|NCT02460224|564472301|FG012|Overall Study|Death|0|||
156376310|NCT02460224|564472302|FG013|Overall Study|Death|1|||
156376311|NCT02460224|564472303|FG014|Overall Study|Death|0|||
156376312|NCT02460224|564472304|FG015|Overall Study|Death|0|||
156376313|NCT02460224|564472305|FG016|Overall Study|Death|2|||
156376314|NCT02460224|564472306|FG017|Overall Study|Death|1|||
156376315|NCT02460224|564472307|FG018|Overall Study|Death|0|||
156376316|NCT02460224|564472308|FG019|Overall Study|Death|2|||
156376317|NCT02460224|564472309|FG020|Overall Study|Death|0|||
156376318|NCT02460224|564472310|FG021|Overall Study|Death|0|||
156376319|NCT02460224|564472311|FG022|Overall Study|Death|0|||
156376320|NCT02460224|564472312|FG023|Overall Study|Death|0|||
156376321|NCT02460224|564472313|FG024|Overall Study|Death|1|||
156376322|NCT02460224|564472314|FG025|Overall Study|Death|1|||
156376323|NCT02460224|564472315|FG026|Overall Study|Death|5|||
156376324|NCT02460224|564472316|FG027|Overall Study|Death|0|||
156376325|NCT02460224|564472317|FG028|Overall Study|Death|1|||
156376326|NCT02460224|564472289|FG000|Overall Study|Lost to Follow-up|0|||
156376327|NCT02460224|564472290|FG001|Overall Study|Lost to Follow-up|0|||
156376328|NCT02460224|564472291|FG002|Overall Study|Lost to Follow-up|0|||
156376329|NCT02460224|564472292|FG003|Overall Study|Lost to Follow-up|0|||
156376330|NCT02460224|564472293|FG004|Overall Study|Lost to Follow-up|0|||
156376331|NCT02460224|564472294|FG005|Overall Study|Lost to Follow-up|0|||
156376332|NCT02460224|564472295|FG006|Overall Study|Lost to Follow-up|0|||
156376333|NCT02460224|564472296|FG007|Overall Study|Lost to Follow-up|0|||
156376334|NCT02460224|564472297|FG008|Overall Study|Lost to Follow-up|0|||
156376335|NCT02460224|564472298|FG009|Overall Study|Lost to Follow-up|0|||
156376336|NCT02460224|564472299|FG010|Overall Study|Lost to Follow-up|0|||
156376337|NCT02460224|564472300|FG011|Overall Study|Lost to Follow-up|0|||
156376338|NCT02460224|564472301|FG012|Overall Study|Lost to Follow-up|0|||
156376339|NCT02460224|564472302|FG013|Overall Study|Lost to Follow-up|0|||
156376340|NCT02460224|564472303|FG014|Overall Study|Lost to Follow-up|0|||
156376341|NCT02460224|564472304|FG015|Overall Study|Lost to Follow-up|0|||
156376342|NCT02460224|564472305|FG016|Overall Study|Lost to Follow-up|0|||
156376343|NCT02460224|564472306|FG017|Overall Study|Lost to Follow-up|0|||
156376344|NCT02460224|564472307|FG018|Overall Study|Lost to Follow-up|0|||
156376345|NCT02460224|564472308|FG019|Overall Study|Lost to Follow-up|0|||
156376346|NCT02460224|564472309|FG020|Overall Study|Lost to Follow-up|0|||
156376347|NCT02460224|564472310|FG021|Overall Study|Lost to Follow-up|0|||
156376348|NCT02460224|564472311|FG022|Overall Study|Lost to Follow-up|1|||
156376349|NCT02460224|564472312|FG023|Overall Study|Lost to Follow-up|0|||
156376350|NCT02460224|564472313|FG024|Overall Study|Lost to Follow-up|0|||
156376351|NCT02460224|564472314|FG025|Overall Study|Lost to Follow-up|0|||
156376352|NCT02460224|564472315|FG026|Overall Study|Lost to Follow-up|0|||
156376353|NCT02460224|564472316|FG027|Overall Study|Lost to Follow-up|0|||
156376354|NCT02460224|564472317|FG028|Overall Study|Lost to Follow-up|0|||
156376355|NCT02460224|564472289|FG000|Overall Study|Physician Decision|0|||
156376356|NCT02460224|564472290|FG001|Overall Study|Physician Decision|1|||
156497803|NCT02635386|564917582|FG000|Overall Study|Pregnancy|2|||
156497804|NCT02635386|564917583|FG001|Overall Study|Pregnancy|0|||
156376357|NCT02460224|564472291|FG002|Overall Study|Physician Decision|0|||
156376358|NCT02460224|564472292|FG003|Overall Study|Physician Decision|0|||
156376359|NCT02460224|564472293|FG004|Overall Study|Physician Decision|1|||
156376360|NCT02460224|564472294|FG005|Overall Study|Physician Decision|0|||
156376361|NCT02460224|564472295|FG006|Overall Study|Physician Decision|0|||
156376362|NCT02460224|564472296|FG007|Overall Study|Physician Decision|1|||
156376363|NCT02460224|564472297|FG008|Overall Study|Physician Decision|0|||
156376364|NCT02460224|564472298|FG009|Overall Study|Physician Decision|0|||
156376365|NCT02460224|564472299|FG010|Overall Study|Physician Decision|0|||
156376366|NCT02460224|564472300|FG011|Overall Study|Physician Decision|1|||
156376367|NCT02460224|564472301|FG012|Overall Study|Physician Decision|0|||
156376368|NCT02460224|564472302|FG013|Overall Study|Physician Decision|1|||
156376369|NCT02460224|564472303|FG014|Overall Study|Physician Decision|0|||
156376370|NCT02460224|564472304|FG015|Overall Study|Physician Decision|0|||
156376371|NCT02460224|564472305|FG016|Overall Study|Physician Decision|2|||
156497805|NCT02635386|564917584|FG002|Overall Study|Pregnancy|0|||
156376372|NCT02460224|564472306|FG017|Overall Study|Physician Decision|1|||
156376373|NCT02460224|564472307|FG018|Overall Study|Physician Decision|1|||
156376374|NCT02460224|564472308|FG019|Overall Study|Physician Decision|2|||
156497806|NCT02635386|564917585|FG003|Overall Study|Pregnancy|0|||
156376375|NCT02460224|564472309|FG020|Overall Study|Physician Decision|1|||
156376376|NCT02460224|564472310|FG021|Overall Study|Physician Decision|1|||
156376377|NCT02460224|564472311|FG022|Overall Study|Physician Decision|0|||
156376378|NCT02460224|564472312|FG023|Overall Study|Physician Decision|0|||
156497807|NCT02635386|564917586|FG004|Overall Study|Pregnancy|2|||
156497808|NCT02635386|564917582|FG000|Overall Study|Withdrawal by Subject|1|||
156497809|NCT02635386|564917583|FG001|Overall Study|Withdrawal by Subject|1|||
156497810|NCT02635386|564917584|FG002|Overall Study|Withdrawal by Subject|0|||
156497811|NCT02635386|564917585|FG003|Overall Study|Withdrawal by Subject|1|||
156497812|NCT02635386|564917586|FG004|Overall Study|Withdrawal by Subject|0|||
156497813|NCT02635386|564917582|FG000|Overall Study|Physician Decision|0|||
156497814|NCT02635386|564917583|FG001|Overall Study|Physician Decision|1|||
156497815|NCT02635386|564917584|FG002|Overall Study|Physician Decision|0|||
156497816|NCT02635386|564917585|FG003|Overall Study|Physician Decision|0|||
156497817|NCT02635386|564917586|FG004|Overall Study|Physician Decision|0|||
156497818|NCT02635386|564917582|FG000|Overall Study|Moved Out of State|0|||
156497819|NCT02635386|564917583|FG001|Overall Study|Moved Out of State|1|||
156497820|NCT02635386|564917584|FG002|Overall Study|Moved Out of State|0|||
156497821|NCT02635386|564917585|FG003|Overall Study|Moved Out of State|0|||
156497822|NCT02635386|564917586|FG004|Overall Study|Moved Out of State|0|||
156497823|NCT02635386|564917582|FG000|Overall Study|Noncompliant|0|||
156497824|NCT02635386|564917583|FG001|Overall Study|Noncompliant|2|||
156497825|NCT02635386|564917584|FG002|Overall Study|Noncompliant|1|||
156497826|NCT02635386|564917585|FG003|Overall Study|Noncompliant|1|||
156497827|NCT02635386|564917586|FG004|Overall Study|Noncompliant|1|||
156497828|NCT02635386|564917582|FG000|Overall Study|side effects|0|||
156497829|NCT02635386|564917583|FG001|Overall Study|side effects|0|||
156497830|NCT02635386|564917584|FG002|Overall Study|side effects|1|||
156497831|NCT02635386|564917585|FG003|Overall Study|side effects|4|||
156497832|NCT02635386|564917586|FG004|Overall Study|side effects|6|||
156497833|NCT02635386|564917582|FG000|Overall Study|needed other major surgery|0|||
156497834|NCT02635386|564917583|FG001|Overall Study|needed other major surgery|1|||
156497835|NCT02635386|564917584|FG002|Overall Study|needed other major surgery|0|||
156497836|NCT02635386|564917585|FG003|Overall Study|needed other major surgery|0|||
156497837|NCT02635386|564917586|FG004|Overall Study|needed other major surgery|0|||
156497838|NCT02635386|564917582|FG000|Overall Study|Other medical problems not drug related|0|||
156497839|NCT02635386|564917583|FG001|Overall Study|Other medical problems not drug related|0|||
156497840|NCT02635386|564917584|FG002|Overall Study|Other medical problems not drug related|0|||
156497841|NCT02635386|564917585|FG003|Overall Study|Other medical problems not drug related|1|||
156497842|NCT02635386|564917586|FG004|Overall Study|Other medical problems not drug related|0|||
156497843|NCT03174782|564917587|FG000|Overall Study|Protocol Violation|1|||
156497844|NCT03174782|564917588|FG001|Overall Study|Protocol Violation|0|||
156497845|NCT03174782|564917587|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
156497846|NCT03174782|564917588|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
156497847|NCT03178045|564917589|FG000|Overall Study|Withdrawal by Subject|5|||
156497848|NCT03178045|564917590|FG001|Overall Study|Withdrawal by Subject|7|||
156497849|NCT03178045|564917589|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
156497850|NCT03178045|564917590|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
156497851|NCT03178045|564917589|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
156497852|NCT03178045|564917590|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
156497853|NCT01078922|564917591|FG000|Overall Study|Adverse Event|1|||
156497854|NCT00798304|564917592|FG000|Overall Study|Adverse Event|0|||
156497855|NCT00798304|564917593|FG001|Overall Study|Adverse Event|1|||
156497856|NCT00798304|564917594|FG002|Overall Study|Adverse Event|1|||
156497857|NCT00798304|564917592|FG000|Overall Study|Discontinuation by Sponsor|14|||
156497858|NCT00798304|564917593|FG001|Overall Study|Discontinuation by Sponsor|21|||
156497859|NCT00798304|564917594|FG002|Overall Study|Discontinuation by Sponsor|9|||
156497860|NCT00547534|564917597|FG000|Overall Study|Adverse Event|7|||
156497861|NCT00547534|564917597|FG000|Overall Study|Disease Progression|4|||
156497862|NCT02168478|564917612|FG000|Overall Study|Withdrawal by Subject|1|||
156497863|NCT02168478|564917612|FG000|Overall Study|Did Not Consent to Participation|2|||
156497864|NCT02168478|564917612|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
156497865|NCT05523219|564917613|FG000|Overall Study|Wrong inclusion|1|||
156497866|NCT05523219|564917613|FG000|Overall Study|Lost to Follow-up|7|||
156497867|NCT02760485|564917614|FG000|Phase 1|Death|3|||
156497868|NCT02760485|564917615|FG001|Phase 1|Death|6|||
156497869|NCT02760485|564917616|FG002|Phase 1|Death|0|||
156497870|NCT02760485|564917614|FG000|Phase 1|Withdrawal by Subject|2|||
156497871|NCT02760485|564917615|FG001|Phase 1|Withdrawal by Subject|0|||
156497872|NCT02760485|564917616|FG002|Phase 1|Withdrawal by Subject|0|||
156497873|NCT02760485|564917614|FG000|Phase 1|Progressive Disease|1|||
156497874|NCT02760485|564917615|FG001|Phase 1|Progressive Disease|0|||
156497875|NCT02760485|564917616|FG002|Phase 1|Progressive Disease|0|||
156497876|NCT02760485|564917614|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
156497877|NCT02760485|564917615|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
156497878|NCT02760485|564917616|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
156497879|NCT02760485|564917614|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
156497880|NCT02760485|564917615|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
156497881|NCT02760485|564917616|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
156497882|NCT02760485|564917614|FG000|Phase 2|Death|0|||
156497883|NCT02760485|564917615|FG001|Phase 2|Death|0|||
156497884|NCT02760485|564917616|FG002|Phase 2|Death|12|||
156497885|NCT02760485|564917614|FG000|Phase 2|Withdrawal by Subject|0|||
156497886|NCT02760485|564917615|FG001|Phase 2|Withdrawal by Subject|0|||
156497887|NCT02760485|564917616|FG002|Phase 2|Withdrawal by Subject|3|||
156497888|NCT02760485|564917614|FG000|Phase 2|Progressive Disease|0|||
156497889|NCT02760485|564917615|FG001|Phase 2|Progressive Disease|0|||
156497890|NCT02760485|564917616|FG002|Phase 2|Progressive Disease|1|||
156497891|NCT02760485|564917614|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
156497892|NCT02760485|564917615|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
156497893|NCT02760485|564917616|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
156497894|NCT03845023|564917617|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
156497895|NCT03845023|564917618|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
156497896|NCT03845023|564917619|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
156497897|NCT03845023|564917620|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
156497898|NCT03845023|564917617|FG000|Follow-Up (14 Days)|Adverse Event|0|||
156497899|NCT03845023|564917618|FG001|Follow-Up (14 Days)|Adverse Event|0|||
156376379|NCT02460224|564472313|FG024|Overall Study|Physician Decision|1|||
156376380|NCT02460224|564472314|FG025|Overall Study|Physician Decision|0|||
156376381|NCT02460224|564472315|FG026|Overall Study|Physician Decision|14|||
156376382|NCT02460224|564472316|FG027|Overall Study|Physician Decision|1|||
156376383|NCT02460224|564472317|FG028|Overall Study|Physician Decision|6|||
156376384|NCT02460224|564472289|FG000|Overall Study|Progressive disease|15|||
156376385|NCT02460224|564472290|FG001|Overall Study|Progressive disease|11|||
156376386|NCT02460224|564472291|FG002|Overall Study|Progressive disease|5|||
156376387|NCT02460224|564472292|FG003|Overall Study|Progressive disease|6|||
156376388|NCT02460224|564472293|FG004|Overall Study|Progressive disease|3|||
156376389|NCT02460224|564472294|FG005|Overall Study|Progressive disease|26|||
156376390|NCT02460224|564472295|FG006|Overall Study|Progressive disease|28|||
156376391|NCT02460224|564472296|FG007|Overall Study|Progressive disease|4|||
156376392|NCT02460224|564472297|FG008|Overall Study|Progressive disease|5|||
156376393|NCT02460224|564472298|FG009|Overall Study|Progressive disease|9|||
156376394|NCT02460224|564472299|FG010|Overall Study|Progressive disease|5|||
156376395|NCT02460224|564472300|FG011|Overall Study|Progressive disease|4|||
156376396|NCT02460224|564472301|FG012|Overall Study|Progressive disease|5|||
156376397|NCT02460224|564472302|FG013|Overall Study|Progressive disease|4|||
156376398|NCT02460224|564472303|FG014|Overall Study|Progressive disease|5|||
156376399|NCT02460224|564472304|FG015|Overall Study|Progressive disease|5|||
156376400|NCT02460224|564472305|FG016|Overall Study|Progressive disease|15|||
156376401|NCT02460224|564472306|FG017|Overall Study|Progressive disease|3|||
156376402|NCT02460224|564472307|FG018|Overall Study|Progressive disease|8|||
156376403|NCT02460224|564472308|FG019|Overall Study|Progressive disease|3|||
156376404|NCT02460224|564472309|FG020|Overall Study|Progressive disease|4|||
156376405|NCT02460224|564472310|FG021|Overall Study|Progressive disease|9|||
156376406|NCT02460224|564472311|FG022|Overall Study|Progressive disease|4|||
156376407|NCT02460224|564472312|FG023|Overall Study|Progressive disease|11|||
156376408|NCT02460224|564472313|FG024|Overall Study|Progressive disease|4|||
156376409|NCT02460224|564472314|FG025|Overall Study|Progressive disease|5|||
156376410|NCT02460224|564472315|FG026|Overall Study|Progressive disease|85|||
156376411|NCT02460224|564472316|FG027|Overall Study|Progressive disease|17|||
156376412|NCT02460224|564472317|FG028|Overall Study|Progressive disease|77|||
156376413|NCT02460224|564472289|FG000|Overall Study|Subject/guardian decision|2|||
156376414|NCT02460224|564472290|FG001|Overall Study|Subject/guardian decision|0|||
156376415|NCT02460224|564472291|FG002|Overall Study|Subject/guardian decision|1|||
156376416|NCT02460224|564472292|FG003|Overall Study|Subject/guardian decision|0|||
156376417|NCT02460224|564472293|FG004|Overall Study|Subject/guardian decision|2|||
156376418|NCT02460224|564472294|FG005|Overall Study|Subject/guardian decision|2|||
156376419|NCT02460224|564472295|FG006|Overall Study|Subject/guardian decision|0|||
156497900|NCT03845023|564917619|FG002|Follow-Up (14 Days)|Adverse Event|1|||
156497901|NCT03845023|564917620|FG003|Follow-Up (14 Days)|Adverse Event|1|||
156497902|NCT01182207|564917621|FG000|First Intervention|Positive Hepatitis Results|0|||
156497903|NCT01182207|564917622|FG001|First Intervention|Positive Hepatitis Results|1|||
156376420|NCT02460224|564472296|FG007|Overall Study|Subject/guardian decision|0|||
156376421|NCT02460224|564472297|FG008|Overall Study|Subject/guardian decision|1|||
156376422|NCT02460224|564472298|FG009|Overall Study|Subject/guardian decision|1|||
156376423|NCT02460224|564472299|FG010|Overall Study|Subject/guardian decision|0|||
156376424|NCT02460224|564472300|FG011|Overall Study|Subject/guardian decision|1|||
156376425|NCT02460224|564472301|FG012|Overall Study|Subject/guardian decision|0|||
156376426|NCT02460224|564472302|FG013|Overall Study|Subject/guardian decision|0|||
156376427|NCT02460224|564472303|FG014|Overall Study|Subject/guardian decision|0|||
156376428|NCT02460224|564472304|FG015|Overall Study|Subject/guardian decision|1|||
156376429|NCT02460224|564472305|FG016|Overall Study|Subject/guardian decision|0|||
156376430|NCT02460224|564472306|FG017|Overall Study|Subject/guardian decision|1|||
156376431|NCT02460224|564472307|FG018|Overall Study|Subject/guardian decision|2|||
156376432|NCT02460224|564472308|FG019|Overall Study|Subject/guardian decision|0|||
156376433|NCT02460224|564472309|FG020|Overall Study|Subject/guardian decision|0|||
156497904|NCT01182207|564917621|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
156497905|NCT01182207|564917622|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
156497906|NCT01087814|564917623|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
156497907|NCT01087814|564917624|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
156497908|NCT01087814|564917623|FG000|Second Intervention (5 Days)|Physician Decision|1|||
156497909|NCT01087814|564917624|FG001|Second Intervention (5 Days)|Physician Decision|0|||
156497910|NCT01427738|564917625|FG000|Overall Study|Death|12|||
156497911|NCT01427738|564917626|FG001|Overall Study|Death|9|||
156497912|NCT01427738|564917625|FG000|Overall Study|Severe debilitation, unable to continue|0|||
156497913|NCT01427738|564917626|FG001|Overall Study|Severe debilitation, unable to continue|1|||
156497914|NCT01427738|564917625|FG000|Overall Study|Subject unable to get to clinic|5|||
156497915|NCT01427738|564917626|FG001|Overall Study|Subject unable to get to clinic|2|||
156497916|NCT01427738|564917625|FG000|Overall Study|Withdrawal by Subject|0|||
156497917|NCT01427738|564917626|FG001|Overall Study|Withdrawal by Subject|2|||
156497918|NCT01427738|564917625|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
156497919|NCT01427738|564917626|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
156497920|NCT01427738|564917625|FG000|Overall Study|Lost to Follow-up|1|||
156497921|NCT01427738|564917626|FG001|Overall Study|Lost to Follow-up|5|||
156497922|NCT02918292|564917627|FG000|Study Enrollment Prior to Transplant|Death|1|||
156497923|NCT02918292|564917627|FG000|Study Follow up After Transplant|Death|6|||
156497924|NCT02636608|564917631|FG000|Overall Study|Failure to Return|4|||
156497925|NCT02636608|564917631|FG000|Overall Study|Insufficient Virological Response|1|||
156497926|NCT02636608|564917631|FG000|Overall Study|Death|3|||
156497927|NCT02636608|564917631|FG000|Overall Study|Other|2|||
156497928|NCT02636608|564917631|FG000|Overall Study|Did Not Receive Treatment|1|||
156497929|NCT03912532|564917632|FG000|Overall Study|Adverse Event|3|||
156497930|NCT03912532|564917633|FG001|Overall Study|Adverse Event|3|||
156497931|NCT03912532|564917634|FG002|Overall Study|Adverse Event|2|||
156497932|NCT03912532|564917635|FG003|Overall Study|Adverse Event|2|||
156497933|NCT03912532|564917632|FG000|Overall Study|Lost to Follow-up|3|||
156497934|NCT03912532|564917633|FG001|Overall Study|Lost to Follow-up|2|||
156497935|NCT03912532|564917634|FG002|Overall Study|Lost to Follow-up|1|||
156497936|NCT03912532|564917635|FG003|Overall Study|Lost to Follow-up|2|||
156497937|NCT03912532|564917632|FG000|Overall Study|Withdrawal by Subject|1|||
156497938|NCT03912532|564917633|FG001|Overall Study|Withdrawal by Subject|1|||
156497939|NCT03912532|564917634|FG002|Overall Study|Withdrawal by Subject|2|||
156497940|NCT03912532|564917635|FG003|Overall Study|Withdrawal by Subject|0|||
156497941|NCT03912532|564917632|FG000|Overall Study|Physician Decision|1|||
156497942|NCT03912532|564917633|FG001|Overall Study|Physician Decision|0|||
156497943|NCT03912532|564917634|FG002|Overall Study|Physician Decision|0|||
156497944|NCT03912532|564917635|FG003|Overall Study|Physician Decision|3|||
156497945|NCT03912532|564917632|FG000|Overall Study|Other|0|||
156497946|NCT03912532|564917633|FG001|Overall Study|Other|1|||
156497947|NCT03912532|564917634|FG002|Overall Study|Other|1|||
156497948|NCT03912532|564917635|FG003|Overall Study|Other|0|||
156497949|NCT04913948|564917636|FG000|Overall Study|Withdrawal by Subject|2|||
156497950|NCT04913948|564917636|FG000|Overall Study|Sample processing issues|1|||
156497951|NCT04913948|564917636|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
156497952|NCT03783871|564917639|FG000|Overall Study|Withdrawal by Subject|15|||
156497953|NCT03783871|564917639|FG000|Overall Study|Death|13|||
156497954|NCT03783871|564917639|FG000|Overall Study|Lost to Follow-up|2|||
156497955|NCT05990387|564917641|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
156497956|NCT05990387|564917642|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
156497957|NCT00815919|564917643|FG000|Overall Study|Unrelated Fungal Infection|1|||
156497958|NCT00815919|564917643|FG000|Overall Study|AML Relapse|1|||
156497959|NCT00815919|564917643|FG000|Overall Study|Lack of Efficacy|2|||
156497960|NCT03522389|564917644|FG000|Overall Study|Lost to Follow-up|1|||
156497961|NCT03522389|564917645|FG001|Overall Study|Lost to Follow-up|1|||
156497962|NCT03522389|564917646|FG002|Overall Study|Lost to Follow-up|2|||
156497963|NCT03522389|564917644|FG000|Overall Study|had herniated nucleus pulposus|0|||
156497964|NCT03522389|564917645|FG001|Overall Study|had herniated nucleus pulposus|1|||
156497965|NCT03522389|564917646|FG002|Overall Study|had herniated nucleus pulposus|0|||
156497966|NCT03522389|564917644|FG000|Overall Study|go to work in other province|1|||
156497967|NCT03522389|564917645|FG001|Overall Study|go to work in other province|0|||
156497968|NCT03522389|564917646|FG002|Overall Study|go to work in other province|0|||
156497969|NCT00604188|564917647|FG000|Overall Study|Adverse Event|1|||
156497970|NCT00604188|564917648|FG001|Overall Study|Adverse Event|4|||
156497971|NCT00604188|564917647|FG000|Overall Study|Lost to Follow-up|17|||
156497972|NCT00604188|564917648|FG001|Overall Study|Lost to Follow-up|15|||
156497973|NCT00604188|564917647|FG000|Overall Study|Withdrawal by Subject|5|||
156497974|NCT00604188|564917648|FG001|Overall Study|Withdrawal by Subject|1|||
156497975|NCT00604188|564917647|FG000|Overall Study|Non-compliance with protocol|4|||
156497976|NCT00604188|564917648|FG001|Overall Study|Non-compliance with protocol|4|||
156497977|NCT00604188|564917647|FG000|Overall Study|Did not receive study drug|0|||
156497978|NCT00604188|564917648|FG001|Overall Study|Did not receive study drug|1|||
156497979|NCT04680637|564917649|FG000|Overall Study|Lost to Follow-up|0|||
156497980|NCT04680637|564917650|FG001|Overall Study|Lost to Follow-up|1|||
156497981|NCT04680637|564917651|FG002|Overall Study|Lost to Follow-up|0|||
156497982|NCT04680637|564917652|FG003|Overall Study|Lost to Follow-up|1|||
156497983|NCT04680637|564917649|FG000|Overall Study|Death|1|||
156497984|NCT04680637|564917650|FG001|Overall Study|Death|0|||
156497985|NCT04680637|564917651|FG002|Overall Study|Death|0|||
156497986|NCT04680637|564917652|FG003|Overall Study|Death|0|||
156497987|NCT04680637|564917649|FG000|Overall Study|Withdrawal by Subject|7|||
156497988|NCT04680637|564917650|FG001|Overall Study|Withdrawal by Subject|10|||
156497989|NCT04680637|564917651|FG002|Overall Study|Withdrawal by Subject|17|||
156497990|NCT04680637|564917652|FG003|Overall Study|Withdrawal by Subject|15|||
156497991|NCT04680637|564917649|FG000|Overall Study|Decision by Sponsor|21|||
156497992|NCT04680637|564917650|FG001|Overall Study|Decision by Sponsor|15|||
156497993|NCT04680637|564917651|FG002|Overall Study|Decision by Sponsor|7|||
156497994|NCT04680637|564917652|FG003|Overall Study|Decision by Sponsor|32|||
156497995|NCT02242643|564917655|FG000|Overall Study|Protocol Violation|1|||
156497996|NCT02242643|564917656|FG001|Overall Study|Protocol Violation|2|||
156497997|NCT02242643|564917655|FG000|Overall Study|Withdrawal by Subject|15|||
156497998|NCT02242643|564917656|FG001|Overall Study|Withdrawal by Subject|10|||
156497999|NCT02242643|564917655|FG000|Overall Study|Migrated/moved from study area|1|||
156498000|NCT02242643|564917656|FG001|Overall Study|Migrated/moved from study area|3|||
156498001|NCT02242643|564917655|FG000|Overall Study|Lost to Follow-up|54|||
156498002|NCT02242643|564917656|FG001|Overall Study|Lost to Follow-up|61|||
156498003|NCT02242643|564917655|FG000|Overall Study|Child placed in foster care by family|0|||
156498004|NCT02242643|564917656|FG001|Overall Study|Child placed in foster care by family|1|||
156498005|NCT02242643|564917655|FG000|Overall Study|Non-compliance|1|||
156498006|NCT02242643|564917656|FG001|Overall Study|Non-compliance|0|||
156498007|NCT02242643|564917655|FG000|Overall Study|Consent withdrawal by parent|1|||
156498008|NCT02242643|564917656|FG001|Overall Study|Consent withdrawal by parent|0|||
156498009|NCT02242643|564917655|FG000|Overall Study|Protocol requirements not followed|1|||
156498010|NCT02242643|564917656|FG001|Overall Study|Protocol requirements not followed|0|||
156498011|NCT02242643|564917655|FG000|Overall Study|Language barrier|1|||
156498012|NCT02242643|564917656|FG001|Overall Study|Language barrier|0|||
156498013|NCT02242643|564917655|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
156498014|NCT02242643|564917656|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
156498015|NCT01103232|564917658|FG000|Overall Study|Withdrawal by Subject|1|||
156498016|NCT01103232|564917659|FG001|Overall Study|Withdrawal by Subject|1|||
156498017|NCT01103232|564917658|FG000|Overall Study|Protocol Violation|0|||
156498018|NCT01103232|564917659|FG001|Overall Study|Protocol Violation|1|||
156498019|NCT00443599|564917663|FG000|Overall Study|Physician Decision|2|||
156498020|NCT00443599|564917664|FG001|Overall Study|Physician Decision|1|||
156498021|NCT00443599|564917663|FG000|Overall Study|Death|1|||
156498022|NCT00443599|564917664|FG001|Overall Study|Death|1|||
156498023|NCT00443599|564917663|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
156498024|NCT00443599|564917664|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
156498025|NCT01536587|564919217|FG000|Overall Study|Adverse Event|2|||
156498026|NCT02666664|564919218|FG000|Overall Study|Physician Decision|0|||
156498027|NCT02666664|564919219|FG001|Overall Study|Physician Decision|1|||
156498028|NCT02666664|564919218|FG000|Overall Study|Protocol Violation|0|||
156498029|NCT02666664|564919219|FG001|Overall Study|Protocol Violation|2|||
156498030|NCT02666664|564919218|FG000|Overall Study|Other|0|||
156498031|NCT02666664|564919219|FG001|Overall Study|Other|1|||
156498032|NCT02666664|564919218|FG000|Overall Study|Adverse Event|12|||
156498033|NCT02666664|564919219|FG001|Overall Study|Adverse Event|37|||
156498034|NCT02666664|564919218|FG000|Overall Study|Withdrawal by participant|23|||
156498035|NCT02666664|564919219|FG001|Overall Study|Withdrawal by participant|40|||
156498036|NCT02666664|564919218|FG000|Overall Study|Sponsor decision|0|||
156498037|NCT02666664|564919219|FG001|Overall Study|Sponsor decision|1|||
156498038|NCT02666664|564919218|FG000|Overall Study|Lost to Follow-up|1|||
156498039|NCT02666664|564919219|FG001|Overall Study|Lost to Follow-up|2|||
156498040|NCT03616964|564919220|FG000|Overall Study|Adverse Event|15|||
156498041|NCT03616964|564919221|FG001|Overall Study|Adverse Event|10|||
156498042|NCT03616964|564919222|FG002|Overall Study|Adverse Event|16|||
156498043|NCT03616964|564919220|FG000|Overall Study|Death|3|||
156498044|NCT03616964|564919221|FG001|Overall Study|Death|0|||
156498045|NCT03616964|564919222|FG002|Overall Study|Death|4|||
156498046|NCT03616964|564919220|FG000|Overall Study|Lack of Efficacy|4|||
156498047|NCT03616964|564919221|FG001|Overall Study|Lack of Efficacy|8|||
156498048|NCT03616964|564919222|FG002|Overall Study|Lack of Efficacy|8|||
156498049|NCT03616964|564919220|FG000|Overall Study|Lost to Follow-up|2|||
156498050|NCT03616964|564919221|FG001|Overall Study|Lost to Follow-up|1|||
156498051|NCT03616964|564919222|FG002|Overall Study|Lost to Follow-up|3|||
156498052|NCT03616964|564919220|FG000|Overall Study|Withdrawal by Subject|18|||
156498053|NCT03616964|564919221|FG001|Overall Study|Withdrawal by Subject|14|||
156498054|NCT03616964|564919222|FG002|Overall Study|Withdrawal by Subject|21|||
156498055|NCT03616964|564919220|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
156498056|NCT03616964|564919221|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
156498057|NCT03616964|564919222|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
156498058|NCT03616964|564919220|FG000|Overall Study|Sponsor's Decision|1|||
156498059|NCT03616964|564919221|FG001|Overall Study|Sponsor's Decision|0|||
156498060|NCT03616964|564919222|FG002|Overall Study|Sponsor's Decision|0|||
156498061|NCT03616964|564919220|FG000|Overall Study|Physician Decision|0|||
156498062|NCT03616964|564919221|FG001|Overall Study|Physician Decision|2|||
156498063|NCT03616964|564919222|FG002|Overall Study|Physician Decision|0|||
156498064|NCT03616964|564919220|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
156498065|NCT03616964|564919221|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
156498066|NCT03616964|564919222|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
156498067|NCT03616964|564919220|FG000|Overall Study|Protocol Violation|0|||
156498068|NCT03616964|564919221|FG001|Overall Study|Protocol Violation|1|||
156498069|NCT03616964|564919222|FG002|Overall Study|Protocol Violation|0|||
156498070|NCT03616964|564919220|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
156498071|NCT03616964|564919221|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
156498072|NCT03616964|564919222|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
156498073|NCT03616964|564919220|FG000|Overall Study|Randomized but Never Treated|1|||
156498074|NCT03616964|564919221|FG001|Overall Study|Randomized but Never Treated|1|||
156498075|NCT03616964|564919222|FG002|Overall Study|Randomized but Never Treated|1|||
156498076|NCT00129935|564919223|FG000|Overall Study|Adverse Event|18|||
156498077|NCT00129935|564919224|FG001|Overall Study|Adverse Event|56|||
156498078|NCT00129935|564919223|FG000|Overall Study|Death|1|||
156498079|NCT00129935|564919224|FG001|Overall Study|Death|1|||
156498080|NCT00129935|564919223|FG000|Overall Study|Withdrawal by Subject|7|||
156498081|NCT00129935|564919224|FG001|Overall Study|Withdrawal by Subject|20|||
156498082|NCT00129935|564919223|FG000|Overall Study|Protocol Violation|0|||
156498083|NCT00129935|564919224|FG001|Overall Study|Protocol Violation|4|||
156498084|NCT00129935|564919223|FG000|Overall Study|Physician Decision|3|||
156498085|NCT00129935|564919224|FG001|Overall Study|Physician Decision|4|||
156498086|NCT00129935|564919223|FG000|Overall Study|Recurrence|1|||
156498087|NCT00129935|564919224|FG001|Overall Study|Recurrence|3|||
156498088|NCT00129935|564919223|FG000|Overall Study|Second primary|0|||
156498089|NCT00129935|564919224|FG001|Overall Study|Second primary|1|||
156498090|NCT00129935|564919223|FG000|Overall Study|Other|3|||
156498091|NCT00129935|564919224|FG001|Overall Study|Other|2|||
156498092|NCT00129935|564919223|FG000|Overall Study|Crossed to the other arm|2|||
156498093|NCT00129935|564919224|FG001|Overall Study|Crossed to the other arm|1|||
156498094|NCT00129935|564919223|FG000|Overall Study|Incorrect study treatment|1|||
156498095|NCT00129935|564919224|FG001|Overall Study|Incorrect study treatment|0|||
156498096|NCT04090528|564919230|FG000|Overall Study|participants still on study|9|||
156498097|NCT04090528|564919231|FG001|Overall Study|participants still on study|13|||
156498098|NCT02056626|564919232|FG000|Overall Study|patient did not follow directions|3|||
156498099|NCT02056626|564919233|FG001|Overall Study|patient did not follow directions|1|||
156498100|NCT02056626|564919234|FG002|Overall Study|patient did not follow directions|0|||
156498101|NCT02056626|564919235|FG003|Overall Study|patient did not follow directions|0|||
156498102|NCT04916002|564919239|FG000|Overall Study|Adverse Event|0|||
156498103|NCT04916002|564919240|FG001|Overall Study|Adverse Event|1|||
156498104|NCT04916002|564919241|FG002|Overall Study|Adverse Event|0|||
156498105|NCT04916002|564919242|FG003|Overall Study|Adverse Event|1|||
156498106|NCT04916002|564919243|FG004|Overall Study|Adverse Event|0|||
156498107|NCT04916002|564919239|FG000|Overall Study|Withdrawal by Subject|3|||
156498108|NCT04916002|564919240|FG001|Overall Study|Withdrawal by Subject|1|||
156498109|NCT04916002|564919241|FG002|Overall Study|Withdrawal by Subject|0|||
156498110|NCT04916002|564919242|FG003|Overall Study|Withdrawal by Subject|1|||
156498111|NCT04916002|564919243|FG004|Overall Study|Withdrawal by Subject|0|||
156498112|NCT04916002|564919239|FG000|Overall Study|Death|8|||
156498113|NCT04916002|564919240|FG001|Overall Study|Death|7|||
156498114|NCT04916002|564919241|FG002|Overall Study|Death|4|||
156498115|NCT04916002|564919242|FG003|Overall Study|Death|9|||
156498116|NCT04916002|564919243|FG004|Overall Study|Death|0|||
156498117|NCT04916002|564919239|FG000|Overall Study|Study Terminated by Sponsor|11|||
156498118|NCT04916002|564919240|FG001|Overall Study|Study Terminated by Sponsor|10|||
156498119|NCT04916002|564919241|FG002|Overall Study|Study Terminated by Sponsor|8|||
156498120|NCT04916002|564919242|FG003|Overall Study|Study Terminated by Sponsor|5|||
156498121|NCT04916002|564919243|FG004|Overall Study|Study Terminated by Sponsor|4|||
156498122|NCT04916002|564919239|FG000|Overall Study|End of trial|1|||
156498123|NCT04916002|564919240|FG001|Overall Study|End of trial|0|||
156498124|NCT04916002|564919241|FG002|Overall Study|End of trial|0|||
156376434|NCT02460224|564472310|FG021|Overall Study|Subject/guardian decision|1|||
156498125|NCT04916002|564919242|FG003|Overall Study|End of trial|0|||
156498126|NCT04916002|564919243|FG004|Overall Study|End of trial|0|||
156498127|NCT04916002|564919239|FG000|Overall Study|Progressive disease|0|||
156498128|NCT04916002|564919240|FG001|Overall Study|Progressive disease|0|||
156498129|NCT04916002|564919241|FG002|Overall Study|Progressive disease|1|||
156498130|NCT04916002|564919242|FG003|Overall Study|Progressive disease|0|||
156498131|NCT04916002|564919243|FG004|Overall Study|Progressive disease|0|||
156498132|NCT04916002|564919239|FG000|Overall Study|Participant non-compliance|2|||
156498133|NCT04916002|564919240|FG001|Overall Study|Participant non-compliance|0|||
156498134|NCT04916002|564919241|FG002|Overall Study|Participant non-compliance|0|||
156498135|NCT04916002|564919242|FG003|Overall Study|Participant non-compliance|0|||
156498136|NCT04916002|564919243|FG004|Overall Study|Participant non-compliance|0|||
156376435|NCT02460224|564472311|FG022|Overall Study|Subject/guardian decision|0|||
156376436|NCT02460224|564472312|FG023|Overall Study|Subject/guardian decision|0|||
156376437|NCT02460224|564472313|FG024|Overall Study|Subject/guardian decision|0|||
156376438|NCT02460224|564472314|FG025|Overall Study|Subject/guardian decision|0|||
156376439|NCT02460224|564472315|FG026|Overall Study|Subject/guardian decision|6|||
156376440|NCT02460224|564472316|FG027|Overall Study|Subject/guardian decision|2|||
156376441|NCT02460224|564472317|FG028|Overall Study|Subject/guardian decision|3|||
156376442|NCT02797262|564472318|FG000|Overall Study|Withdrawal by Subject|5|||
156376443|NCT02797262|564472319|FG001|Overall Study|Withdrawal by Subject|1|||
156376444|NCT02797262|564472318|FG000|Overall Study|Lost to Follow-up|10|||
156376445|NCT02797262|564472319|FG001|Overall Study|Lost to Follow-up|7|||
156376446|NCT02797262|564472318|FG000|Overall Study|Death|1|||
156376447|NCT02797262|564472319|FG001|Overall Study|Death|2|||
156376448|NCT02797262|564472318|FG000|Overall Study|Adverse Event|1|||
156376449|NCT02797262|564472319|FG001|Overall Study|Adverse Event|0|||
156376450|NCT02797262|564472318|FG000|Overall Study|COVID-19|2|||
156376451|NCT02797262|564472319|FG001|Overall Study|COVID-19|1|||
156376452|NCT02797262|564472318|FG000|Overall Study|Out-of-country|1|||
156376453|NCT02797262|564472319|FG001|Overall Study|Out-of-country|0|||
156376454|NCT00586469|564472320|FG000|Overall Study|Adverse Event|0|||
156376455|NCT00586469|564472321|FG001|Overall Study|Adverse Event|1|||
156376456|NCT01600586|564472322|FG000|Overall Study|Physician Decision|3|||
156376457|NCT01600586|564472323|FG001|Overall Study|Physician Decision|3|||
156376458|NCT01978184|564472326|FG000|Overall Study|Progressive disease|5|||
156376459|NCT01978184|564472327|FG001|Overall Study|Progressive disease|5|||
156376460|NCT01978184|564472326|FG000|Overall Study|Other than PDA|2|||
156376461|NCT01978184|564472327|FG001|Overall Study|Other than PDA|2|||
156376462|NCT01978184|564472326|FG000|Overall Study|Physician Decision|0|||
156376463|NCT01978184|564472327|FG001|Overall Study|Physician Decision|3|||
156376464|NCT01978184|564472326|FG000|Overall Study|Noncompliance|1|||
156376465|NCT01978184|564472327|FG001|Overall Study|Noncompliance|2|||
156376466|NCT01978184|564472326|FG000|Overall Study|Death|1|||
156376467|NCT01978184|564472327|FG001|Overall Study|Death|0|||
156376468|NCT01978184|564472326|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
156376469|NCT01978184|564472327|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
156376470|NCT04055116|564472328|FG000|First Intervention|Physician Decision|2|||
156376471|NCT04055116|564472329|FG001|First Intervention|Physician Decision|7|||
156376472|NCT03146650|564472332|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
156376473|NCT03146650|564472332|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
156376474|NCT03146650|564472332|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
156376475|NCT03146650|564472332|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
156376476|NCT03146650|564472332|FG000|2 Year Follow-up|Death|11|||
156376477|NCT03146650|564472332|FG000|2 Year Follow-up|Still in follow-up|7|||
156376478|NCT03146650|564472332|FG000|2 Year Follow-up|Lost to Follow-up|1|||
156376479|NCT02460198|564472335|FG000|Overall Study|Adverse Event|1|||
156376480|NCT02460198|564472336|FG001|Overall Study|Adverse Event|3|||
156376481|NCT02460198|564472335|FG000|Overall Study|Death|36|||
156376482|NCT02460198|564472336|FG001|Overall Study|Death|28|||
156376483|NCT02460198|564472335|FG000|Overall Study|Lost to Follow-up|1|||
156376484|NCT02460198|564472336|FG001|Overall Study|Lost to Follow-up|1|||
156376485|NCT02460198|564472335|FG000|Overall Study|Transferred to Extension Study|15|||
156376486|NCT02460198|564472336|FG001|Overall Study|Transferred to Extension Study|15|||
156376487|NCT02460198|564472335|FG000|Overall Study|Withdrawal by Subject|2|||
156376488|NCT02460198|564472336|FG001|Overall Study|Withdrawal by Subject|4|||
156376489|NCT02460198|564472335|FG000|Overall Study|Site Terminated By Sponsor|0|||
156376490|NCT02460198|564472336|FG001|Overall Study|Site Terminated By Sponsor|1|||
156376491|NCT02460198|564472335|FG000|Overall Study|Did Not Continue on Extension Study|6|||
156376492|NCT02460198|564472336|FG001|Overall Study|Did Not Continue on Extension Study|11|||
156376493|NCT00931307|564472337|FG000|Overall Study|Lack of Efficacy|12|||
156376494|NCT00931307|564472337|FG000|Overall Study|Biomicroscopy|1|||
156376495|NCT00965848|564472340|FG000|Overall Study|Protocol Violation|3|||
156376496|NCT00965848|564472341|FG001|Overall Study|Protocol Violation|0|||
156376497|NCT00965848|564472342|FG002|Overall Study|Protocol Violation|1|||
156376498|NCT00965848|564472340|FG000|Overall Study|Death|11|||
156376499|NCT00965848|564472341|FG001|Overall Study|Death|1|||
156376500|NCT00965848|564472342|FG002|Overall Study|Death|5|||
156376501|NCT00965848|564472340|FG000|Overall Study|Lost to Follow-up|0|||
156376502|NCT00965848|564472341|FG001|Overall Study|Lost to Follow-up|0|||
156376503|NCT00965848|564472342|FG002|Overall Study|Lost to Follow-up|1|||
156376504|NCT00965848|564472340|FG000|Overall Study|Withdrawal by Subject|1|||
156376505|NCT00965848|564472341|FG001|Overall Study|Withdrawal by Subject|0|||
156376506|NCT00965848|564472342|FG002|Overall Study|Withdrawal by Subject|0|||
156376507|NCT00965848|564472340|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
156376508|NCT00965848|564472341|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
156376509|NCT00965848|564472342|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
156376510|NCT00965848|564472340|FG000|Overall Study|Not Clinically Evaluable|7|||
156376511|NCT00965848|564472341|FG001|Overall Study|Not Clinically Evaluable|1|||
156498137|NCT05923112|564919244|FG000|Overall Study|Protocol Violation|4|||
156498138|NCT05923112|564919244|FG000|Overall Study|No informed consent on publication of study results|243|||
156498139|NCT04351269|564919245|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
156498140|NCT04351269|564919246|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
156498141|NCT04351269|564919247|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
156498142|NCT04351269|564919245|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
156498143|NCT04351269|564919246|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
156498144|NCT04351269|564919247|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
156498145|NCT04351269|564919245|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
156498146|NCT04351269|564919246|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
156498147|NCT04351269|564919247|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
156498148|NCT04351269|564919245|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
156498149|NCT04351269|564919246|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
156498150|NCT04351269|564919247|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
156498151|NCT04351269|564919245|FG000|Overall Study|Lost to Follow-up|1|||
156498152|NCT04351269|564919246|FG001|Overall Study|Lost to Follow-up|3|||
156498153|NCT04351269|564919247|FG002|Overall Study|Lost to Follow-up|0|||
156498154|NCT04486313|564919248|FG000|Overall Study|Lost to Follow-up|7|||
156498155|NCT04486313|564919249|FG001|Overall Study|Lost to Follow-up|9|||
156498156|NCT04486313|564919248|FG000|Overall Study|Withdrawal by Subject|8|||
156498157|NCT04486313|564919249|FG001|Overall Study|Withdrawal by Subject|6|||
156498158|NCT04486313|564919248|FG000|Overall Study|Physician Decision|1|||
156498159|NCT04486313|564919249|FG001|Overall Study|Physician Decision|1|||
156498160|NCT04486313|564919248|FG000|Overall Study|Death|2|||
156498161|NCT04486313|564919249|FG001|Overall Study|Death|0|||
156498162|NCT04486313|564919248|FG000|Overall Study|Protocol Violation|1|||
156498163|NCT04486313|564919249|FG001|Overall Study|Protocol Violation|1|||
156498164|NCT01013961|564919253|FG000|Overall Study|Adverse Event|2|||
156498165|NCT01013961|564919254|FG001|Overall Study|Adverse Event|2|||
156498166|NCT01013961|564919253|FG000|Overall Study|Withdrawal by Subject|1|||
156498167|NCT01013961|564919254|FG001|Overall Study|Withdrawal by Subject|0|||
156498168|NCT01013961|564919253|FG000|Overall Study|Physician Decision|0|||
156498169|NCT01013961|564919254|FG001|Overall Study|Physician Decision|1|||
156498170|NCT01271504|564919255|FG000|Overall Study|Death|7|||
156498171|NCT01271504|564919256|FG001|Overall Study|Death|6|||
156498172|NCT01271504|564919257|FG002|Overall Study|Death|32|||
156498173|NCT01271504|564919258|FG003|Overall Study|Death|32|||
156498174|NCT01271504|564919255|FG000|Overall Study|Lost to Follow-up|0|||
156498175|NCT01271504|564919256|FG001|Overall Study|Lost to Follow-up|1|||
156498176|NCT01271504|564919257|FG002|Overall Study|Lost to Follow-up|3|||
156498177|NCT01271504|564919258|FG003|Overall Study|Lost to Follow-up|1|||
156498178|NCT01271504|564919255|FG000|Overall Study|Protocol Violation|0|||
156498179|NCT01271504|564919256|FG001|Overall Study|Protocol Violation|0|||
156498180|NCT01271504|564919257|FG002|Overall Study|Protocol Violation|0|||
156498181|NCT01271504|564919258|FG003|Overall Study|Protocol Violation|2|||
156498182|NCT01271504|564919255|FG000|Overall Study|Administrative Reasons|0|||
156498183|NCT01271504|564919256|FG001|Overall Study|Administrative Reasons|0|||
156498184|NCT01271504|564919257|FG002|Overall Study|Administrative Reasons|6|||
156498185|NCT01271504|564919258|FG003|Overall Study|Administrative Reasons|5|||
156498186|NCT01271504|564919255|FG000|Overall Study|Withdrawal by Subject|0|||
156498187|NCT01271504|564919256|FG001|Overall Study|Withdrawal by Subject|0|||
156498188|NCT01271504|564919257|FG002|Overall Study|Withdrawal by Subject|1|||
156498189|NCT01271504|564919258|FG003|Overall Study|Withdrawal by Subject|3|||
156498190|NCT01271504|564919255|FG000|Overall Study|Other|0|||
156498191|NCT01271504|564919256|FG001|Overall Study|Other|1|||
156498192|NCT01271504|564919257|FG002|Overall Study|Other|2|||
156498193|NCT01271504|564919258|FG003|Overall Study|Other|0|||
156498194|NCT01162135|564919267|FG000|Overall Study|Withdrawal by Subject|1|||
156498195|NCT01162135|564919267|FG000|Overall Study|Severe back pain|1|||
156498196|NCT01162135|564919267|FG000|Overall Study|Ineligible|1|||
156498197|NCT01777334|564919268|FG000|Overall Study|Adverse Event|18|||
156498198|NCT01777334|564919269|FG001|Overall Study|Adverse Event|14|||
156498199|NCT01777334|564919268|FG000|Overall Study|Lack of Efficacy|15|||
156498200|NCT01777334|564919269|FG001|Overall Study|Lack of Efficacy|29|||
156498201|NCT01777334|564919268|FG000|Overall Study|Protocol Violation|3|||
156498202|NCT01777334|564919269|FG001|Overall Study|Protocol Violation|7|||
156498203|NCT01777334|564919268|FG000|Overall Study|Lost to Follow-up|3|||
156498204|NCT01777334|564919269|FG001|Overall Study|Lost to Follow-up|2|||
156498205|NCT01777334|564919268|FG000|Overall Study|Withdrawal by Subject|14|||
156498206|NCT01777334|564919269|FG001|Overall Study|Withdrawal by Subject|11|||
156498207|NCT06136897|564919276|FG000|Overall Study|Ineligible|3|||
156498208|NCT06136897|564919276|FG000|Overall Study|Mutation status not confirmed|7|||
156498209|NCT06136897|564919276|FG000|Overall Study|Adverse Event|2|||
156498210|NCT06136897|564919276|FG000|Overall Study|Death|1|||
156498211|NCT06136897|564919276|FG000|Overall Study|Disease progression|18|||
156376512|NCT00965848|564472342|FG002|Overall Study|Not Clinically Evaluable|1|||
156376513|NCT00965848|564472340|FG000|Overall Study|Other|5|||
156376514|NCT00965848|564472341|FG001|Overall Study|Other|0|||
156376515|NCT00965848|564472342|FG002|Overall Study|Other|1|||
156376516|NCT00813761|564472343|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
156376517|NCT00813761|564472344|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
156376518|NCT00813761|564472345|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
156376519|NCT00813761|564472346|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
156376520|NCT00813761|564472343|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
156376521|NCT00813761|564472344|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
156376522|NCT00813761|564472345|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
156376523|NCT00813761|564472346|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
156376524|NCT00813761|564472343|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
156376525|NCT00813761|564472344|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
156376526|NCT00813761|564472345|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
156376527|NCT00813761|564472346|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
156376528|NCT00813761|564472343|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
156376529|NCT00813761|564472344|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
156376530|NCT00813761|564472345|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
156376531|NCT00813761|564472346|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
156376532|NCT00813761|564472343|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
156376533|NCT00813761|564472344|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
156498212|NCT06136897|564919276|FG000|Overall Study|Other complicating disease|1|||
156546731|NCT02915523|565094962|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
156546732|NCT02915523|565094959|FG000|Expansion Phase (Phase 2)|Death|0|||
156546733|NCT02915523|565094960|FG001|Expansion Phase (Phase 2)|Death|0|||
156546734|NCT02915523|565094961|FG002|Expansion Phase (Phase 2)|Death|26|||
156546735|NCT02915523|565094962|FG003|Expansion Phase (Phase 2)|Death|53|||
156498213|NCT06136897|564919276|FG000|Overall Study|Withdrawal by Subject|1|||
156498214|NCT06136897|564919276|FG000|Overall Study|Still on treatment|1|||
156498215|NCT06136897|564919276|FG000|Overall Study|Lost to Follow-up|1|||
156498216|NCT00756457|564919277|FG000|Overall Study|Lost to Follow-up|1|||
156498217|NCT00756457|564919278|FG001|Overall Study|Lost to Follow-up|2|||
156498218|NCT02947100|564919279|FG000|Overall Study|study terminated early|3|||
156498219|NCT02947100|564919279|FG000|Overall Study|did not meet inclusion criteria|1|||
156498220|NCT00822770|564919280|FG000|Overall Study|Not treated|1|||
156498221|NCT00822770|564919281|FG001|Overall Study|Not treated|0|||
156498222|NCT00822770|564919280|FG000|Overall Study|Complication/Incomplete treatment|1|||
156498223|NCT00822770|564919281|FG001|Overall Study|Complication/Incomplete treatment|0|||
156498224|NCT00822770|564919280|FG000|Overall Study|Death|1|||
156498225|NCT00822770|564919281|FG001|Overall Study|Death|1|||
156498226|NCT02402322|564919282|FG000|Pretreatment|Withdrawal by Subject|3|||
156498227|NCT02402322|564919283|FG001|Pretreatment|Withdrawal by Subject|1|||
156498228|NCT02402322|564919284|FG002|Pretreatment|Withdrawal by Subject|1|||
156498229|NCT02402322|564919282|FG000|Follow-up|Withdrawal by Subject|6|||
156498230|NCT02402322|564919283|FG001|Follow-up|Withdrawal by Subject|3|||
156498231|NCT02402322|564919284|FG002|Follow-up|Withdrawal by Subject|24|||
156498232|NCT02818998|564919285|FG000|Overall Study|Adverse Event|3|||
156498233|NCT02818998|564919286|FG001|Overall Study|Adverse Event|2|||
156498234|NCT02818998|564919287|FG002|Overall Study|Adverse Event|1|||
156498235|NCT02818998|564919285|FG000|Overall Study|Lost to Follow-up|4|||
156498236|NCT02818998|564919286|FG001|Overall Study|Lost to Follow-up|1|||
156376534|NCT00813761|564472345|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
156376535|NCT00813761|564472346|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
156498237|NCT02818998|564919287|FG002|Overall Study|Lost to Follow-up|2|||
156498238|NCT02818998|564919285|FG000|Overall Study|Withdrawal by sponsor|0|||
156498239|NCT02818998|564919286|FG001|Overall Study|Withdrawal by sponsor|1|||
156498240|NCT02818998|564919287|FG002|Overall Study|Withdrawal by sponsor|1|||
156498241|NCT02818998|564919285|FG000|Overall Study|Death|3|||
156498242|NCT02818998|564919286|FG001|Overall Study|Death|6|||
156376536|NCT00813761|564472343|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
156376537|NCT00813761|564472344|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
156498243|NCT02818998|564919287|FG002|Overall Study|Death|8|||
156498244|NCT02818998|564919285|FG000|Overall Study|Withdrawal by Subject|7|||
156546736|NCT02915523|565094959|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
156376538|NCT00813761|564472345|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
156498245|NCT02818998|564919286|FG001|Overall Study|Withdrawal by Subject|6|||
156498246|NCT02818998|564919287|FG002|Overall Study|Withdrawal by Subject|6|||
156498247|NCT02818998|564919285|FG000|Overall Study|Physician Decision|1|||
156498248|NCT02818998|564919286|FG001|Overall Study|Physician Decision|0|||
156498249|NCT02818998|564919287|FG002|Overall Study|Physician Decision|0|||
156498250|NCT00632021|564919292|FG000|Overall Study|Withdrawal/death|4|||
156498251|NCT00632021|564919293|FG001|Overall Study|Withdrawal/death|7|||
156498252|NCT01296555|564919294|FG000|Overall Study|Adverse Event|0|||
156498253|NCT01296555|564919295|FG001|Overall Study|Adverse Event|0|||
156546737|NCT02915523|565094960|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
156498254|NCT01296555|564919296|FG002|Overall Study|Adverse Event|1|||
156498255|NCT01296555|564919297|FG003|Overall Study|Adverse Event|1|||
156498256|NCT01296555|564919298|FG004|Overall Study|Adverse Event|2|||
156498257|NCT01296555|564919299|FG005|Overall Study|Adverse Event|4|||
156498258|NCT01296555|564919300|FG006|Overall Study|Adverse Event|1|||
156498259|NCT01296555|564919301|FG007|Overall Study|Adverse Event|4|||
156498260|NCT01296555|564919302|FG008|Overall Study|Adverse Event|3|||
156498261|NCT01296555|564919303|FG009|Overall Study|Adverse Event|1|||
156498262|NCT01296555|564919304|FG010|Overall Study|Adverse Event|0|||
156376539|NCT00813761|564472346|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
156376540|NCT00813761|564472343|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
156498263|NCT01296555|564919305|FG011|Overall Study|Adverse Event|4|||
156498264|NCT01296555|564919306|FG012|Overall Study|Adverse Event|1|||
156498265|NCT01296555|564919307|FG013|Overall Study|Adverse Event|4|||
156498266|NCT01296555|564919308|FG014|Overall Study|Adverse Event|0|||
156498267|NCT01296555|564919309|FG015|Overall Study|Adverse Event|0|||
156498268|NCT01296555|564919310|FG016|Overall Study|Adverse Event|0|||
156498269|NCT01296555|564919311|FG017|Overall Study|Adverse Event|0|||
156498270|NCT01296555|564919312|FG018|Overall Study|Adverse Event|0|||
156498271|NCT01296555|564919313|FG019|Overall Study|Adverse Event|1|||
156498272|NCT01296555|564919314|FG020|Overall Study|Adverse Event|0|||
156376541|NCT00813761|564472344|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
156376542|NCT00813761|564472345|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
156376543|NCT00813761|564472346|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
156376544|NCT00813761|564472343|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
156376545|NCT00813761|564472344|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
156376546|NCT00813761|564472345|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
156376547|NCT00813761|564472346|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
156376548|NCT00813761|564472343|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
156376549|NCT00813761|564472344|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
156376550|NCT00813761|564472345|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
156376551|NCT00813761|564472346|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
156376552|NCT00813761|564472343|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
156376553|NCT00813761|564472344|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
156376554|NCT00813761|564472345|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
156376555|NCT00813761|564472346|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
156376556|NCT00813761|564472343|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
156376557|NCT00813761|564472344|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
156376558|NCT00813761|564472345|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
156376559|NCT00813761|564472346|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
156376560|NCT00813761|564472343|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
156376561|NCT00813761|564472344|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
156376562|NCT00813761|564472345|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
156376563|NCT00813761|564472346|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
156376564|NCT00691210|564472347|FG000|Overall Study|Progression of Disease|0|||
156376565|NCT00691210|564472348|FG001|Overall Study|Progression of Disease|0|||
156376566|NCT00691210|564472349|FG002|Overall Study|Progression of Disease|0|||
156376567|NCT00691210|564472350|FG003|Overall Study|Progression of Disease|2|||
156376568|NCT00691210|564472351|FG004|Overall Study|Progression of Disease|0|||
156376569|NCT00691210|564472352|FG005|Overall Study|Progression of Disease|0|||
156376570|NCT00691210|564472353|FG006|Overall Study|Progression of Disease|0|||
156376571|NCT00691210|564472354|FG007|Overall Study|Progression of Disease|0|||
156376572|NCT00691210|564472347|FG000|Overall Study|Lack of Efficacy|0|||
156498273|NCT01296555|564919315|FG021|Overall Study|Adverse Event|0|||
156498274|NCT01296555|564919316|FG022|Overall Study|Adverse Event|0|||
156498275|NCT01296555|564919317|FG023|Overall Study|Adverse Event|0|||
156498276|NCT01296555|564919318|FG024|Overall Study|Adverse Event|0|||
156498277|NCT01296555|564919319|FG025|Overall Study|Adverse Event|0|||
156498278|NCT01296555|564919320|FG026|Overall Study|Adverse Event|0|||
156376573|NCT00691210|564472348|FG001|Overall Study|Lack of Efficacy|0|||
156376574|NCT00691210|564472349|FG002|Overall Study|Lack of Efficacy|0|||
156376575|NCT00691210|564472350|FG003|Overall Study|Lack of Efficacy|1|||
156376576|NCT00691210|564472351|FG004|Overall Study|Lack of Efficacy|0|||
156376577|NCT00691210|564472352|FG005|Overall Study|Lack of Efficacy|1|||
156376578|NCT00691210|564472353|FG006|Overall Study|Lack of Efficacy|0|||
156376579|NCT00691210|564472354|FG007|Overall Study|Lack of Efficacy|0|||
156376580|NCT00441337|564472360|FG000|Overall Study|Disease Progression|6|||
156376581|NCT00441337|564472361|FG001|Overall Study|Disease Progression|6|||
156498279|NCT01296555|564919321|FG027|Overall Study|Adverse Event|0|||
156498280|NCT01296555|564919322|FG028|Overall Study|Adverse Event|0|||
156376582|NCT00441337|564472362|FG002|Overall Study|Disease Progression|4|||
156376583|NCT00441337|564472363|FG003|Overall Study|Disease Progression|18|||
156498281|NCT01296555|564919294|FG000|Overall Study|Reason Not Specified|0|||
156498282|NCT01296555|564919295|FG001|Overall Study|Reason Not Specified|0|||
156498283|NCT01296555|564919296|FG002|Overall Study|Reason Not Specified|0|||
156498284|NCT01296555|564919297|FG003|Overall Study|Reason Not Specified|0|||
156498285|NCT01296555|564919298|FG004|Overall Study|Reason Not Specified|0|||
156498286|NCT01296555|564919299|FG005|Overall Study|Reason Not Specified|0|||
156498287|NCT01296555|564919300|FG006|Overall Study|Reason Not Specified|0|||
156498288|NCT01296555|564919301|FG007|Overall Study|Reason Not Specified|0|||
156498289|NCT01296555|564919302|FG008|Overall Study|Reason Not Specified|0|||
156498290|NCT01296555|564919303|FG009|Overall Study|Reason Not Specified|0|||
156498291|NCT01296555|564919304|FG010|Overall Study|Reason Not Specified|0|||
156498292|NCT01296555|564919305|FG011|Overall Study|Reason Not Specified|0|||
156498293|NCT01296555|564919306|FG012|Overall Study|Reason Not Specified|0|||
156498294|NCT01296555|564919307|FG013|Overall Study|Reason Not Specified|1|||
156498295|NCT01296555|564919308|FG014|Overall Study|Reason Not Specified|2|||
156498296|NCT01296555|564919309|FG015|Overall Study|Reason Not Specified|3|||
156498297|NCT01296555|564919310|FG016|Overall Study|Reason Not Specified|7|||
156498298|NCT01296555|564919311|FG017|Overall Study|Reason Not Specified|4|||
156498299|NCT01296555|564919312|FG018|Overall Study|Reason Not Specified|3|||
156498300|NCT01296555|564919313|FG019|Overall Study|Reason Not Specified|7|||
156498301|NCT01296555|564919314|FG020|Overall Study|Reason Not Specified|11|||
156498302|NCT01296555|564919315|FG021|Overall Study|Reason Not Specified|5|||
156498303|NCT01296555|564919316|FG022|Overall Study|Reason Not Specified|5|||
156498304|NCT01296555|564919317|FG023|Overall Study|Reason Not Specified|7|||
156498305|NCT01296555|564919318|FG024|Overall Study|Reason Not Specified|2|||
156498306|NCT01296555|564919319|FG025|Overall Study|Reason Not Specified|2|||
156498307|NCT01296555|564919320|FG026|Overall Study|Reason Not Specified|19|||
156498308|NCT01296555|564919321|FG027|Overall Study|Reason Not Specified|11|||
156498309|NCT01296555|564919322|FG028|Overall Study|Reason Not Specified|9|||
156498310|NCT01296555|564919294|FG000|Overall Study|Physician Decision|0|||
156498311|NCT01296555|564919295|FG001|Overall Study|Physician Decision|0|||
156498312|NCT01296555|564919296|FG002|Overall Study|Physician Decision|0|||
156498313|NCT01296555|564919297|FG003|Overall Study|Physician Decision|0|||
156498314|NCT01296555|564919298|FG004|Overall Study|Physician Decision|1|||
156498315|NCT01296555|564919299|FG005|Overall Study|Physician Decision|0|||
156498316|NCT01296555|564919300|FG006|Overall Study|Physician Decision|0|||
156498317|NCT01296555|564919301|FG007|Overall Study|Physician Decision|0|||
156498318|NCT01296555|564919302|FG008|Overall Study|Physician Decision|0|||
156498319|NCT01296555|564919303|FG009|Overall Study|Physician Decision|0|||
156498320|NCT01296555|564919304|FG010|Overall Study|Physician Decision|0|||
156498321|NCT01296555|564919305|FG011|Overall Study|Physician Decision|0|||
156498322|NCT01296555|564919306|FG012|Overall Study|Physician Decision|0|||
156498323|NCT01296555|564919307|FG013|Overall Study|Physician Decision|1|||
156498324|NCT01296555|564919308|FG014|Overall Study|Physician Decision|0|||
156498325|NCT01296555|564919309|FG015|Overall Study|Physician Decision|0|||
156498326|NCT01296555|564919310|FG016|Overall Study|Physician Decision|0|||
156498327|NCT01296555|564919311|FG017|Overall Study|Physician Decision|0|||
156498328|NCT01296555|564919312|FG018|Overall Study|Physician Decision|0|||
156498329|NCT01296555|564919313|FG019|Overall Study|Physician Decision|1|||
156498330|NCT01296555|564919314|FG020|Overall Study|Physician Decision|0|||
156498331|NCT01296555|564919315|FG021|Overall Study|Physician Decision|0|||
156498332|NCT01296555|564919316|FG022|Overall Study|Physician Decision|0|||
156498333|NCT01296555|564919317|FG023|Overall Study|Physician Decision|0|||
156498334|NCT01296555|564919318|FG024|Overall Study|Physician Decision|0|||
156498335|NCT01296555|564919319|FG025|Overall Study|Physician Decision|0|||
156498336|NCT01296555|564919320|FG026|Overall Study|Physician Decision|0|||
156498337|NCT01296555|564919321|FG027|Overall Study|Physician Decision|0|||
156498338|NCT01296555|564919322|FG028|Overall Study|Physician Decision|0|||
156498339|NCT01296555|564919294|FG000|Overall Study|Progressive Disease|6|||
156498340|NCT01296555|564919295|FG001|Overall Study|Progressive Disease|3|||
156498341|NCT01296555|564919296|FG002|Overall Study|Progressive Disease|3|||
156498342|NCT01296555|564919297|FG003|Overall Study|Progressive Disease|7|||
156498343|NCT01296555|564919298|FG004|Overall Study|Progressive Disease|6|||
156498344|NCT01296555|564919299|FG005|Overall Study|Progressive Disease|16|||
156498345|NCT01296555|564919300|FG006|Overall Study|Progressive Disease|16|||
156498346|NCT01296555|564919301|FG007|Overall Study|Progressive Disease|8|||
156546738|NCT02915523|565094961|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
156546739|NCT02915523|565094962|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
156498347|NCT01296555|564919302|FG008|Overall Study|Progressive Disease|7|||
156498348|NCT01296555|564919303|FG009|Overall Study|Progressive Disease|18|||
156498349|NCT01296555|564919304|FG010|Overall Study|Progressive Disease|7|||
156498350|NCT01296555|564919305|FG011|Overall Study|Progressive Disease|14|||
156498351|NCT01296555|564919306|FG012|Overall Study|Progressive Disease|5|||
156498352|NCT01296555|564919307|FG013|Overall Study|Progressive Disease|12|||
156498353|NCT01296555|564919308|FG014|Overall Study|Progressive Disease|1|||
156498354|NCT01296555|564919309|FG015|Overall Study|Progressive Disease|1|||
156498355|NCT01296555|564919310|FG016|Overall Study|Progressive Disease|0|||
156498356|NCT01296555|564919311|FG017|Overall Study|Progressive Disease|0|||
156498357|NCT01296555|564919312|FG018|Overall Study|Progressive Disease|0|||
156498358|NCT01296555|564919313|FG019|Overall Study|Progressive Disease|1|||
156498359|NCT01296555|564919314|FG020|Overall Study|Progressive Disease|0|||
156498360|NCT01296555|564919315|FG021|Overall Study|Progressive Disease|0|||
156498361|NCT01296555|564919316|FG022|Overall Study|Progressive Disease|0|||
156498362|NCT01296555|564919317|FG023|Overall Study|Progressive Disease|0|||
156498363|NCT01296555|564919318|FG024|Overall Study|Progressive Disease|1|||
156498364|NCT01296555|564919319|FG025|Overall Study|Progressive Disease|0|||
156498365|NCT01296555|564919320|FG026|Overall Study|Progressive Disease|5|||
156498366|NCT01296555|564919321|FG027|Overall Study|Progressive Disease|1|||
156498367|NCT01296555|564919322|FG028|Overall Study|Progressive Disease|0|||
156498368|NCT01296555|564919294|FG000|Overall Study|Protocol Violation|0|||
156498369|NCT01296555|564919295|FG001|Overall Study|Protocol Violation|0|||
156498370|NCT01296555|564919296|FG002|Overall Study|Protocol Violation|0|||
156498371|NCT01296555|564919297|FG003|Overall Study|Protocol Violation|0|||
156498372|NCT01296555|564919298|FG004|Overall Study|Protocol Violation|0|||
156498373|NCT01296555|564919299|FG005|Overall Study|Protocol Violation|0|||
156498374|NCT01296555|564919300|FG006|Overall Study|Protocol Violation|0|||
156498375|NCT01296555|564919301|FG007|Overall Study|Protocol Violation|0|||
156498376|NCT01296555|564919302|FG008|Overall Study|Protocol Violation|0|||
156498377|NCT01296555|564919303|FG009|Overall Study|Protocol Violation|0|||
156498378|NCT01296555|564919304|FG010|Overall Study|Protocol Violation|0|||
156498379|NCT01296555|564919305|FG011|Overall Study|Protocol Violation|0|||
156498380|NCT01296555|564919306|FG012|Overall Study|Protocol Violation|0|||
156498381|NCT01296555|564919307|FG013|Overall Study|Protocol Violation|1|||
156498382|NCT01296555|564919308|FG014|Overall Study|Protocol Violation|0|||
156498383|NCT01296555|564919309|FG015|Overall Study|Protocol Violation|0|||
156376584|NCT00441337|564472360|FG000|Overall Study|Lost to Follow-up|0|||
156376585|NCT00441337|564472361|FG001|Overall Study|Lost to Follow-up|0|||
156376586|NCT00441337|564472362|FG002|Overall Study|Lost to Follow-up|0|||
156376587|NCT00441337|564472363|FG003|Overall Study|Lost to Follow-up|1|||
156376588|NCT00441337|564472360|FG000|Overall Study|Sponsor Decision|0|||
156376589|NCT00441337|564472361|FG001|Overall Study|Sponsor Decision|0|||
156376590|NCT00441337|564472362|FG002|Overall Study|Sponsor Decision|1|||
156376591|NCT00441337|564472363|FG003|Overall Study|Sponsor Decision|2|||
156376592|NCT00441337|564472360|FG000|Overall Study|Did not meet inclusion criteria|0|||
156376593|NCT00441337|564472361|FG001|Overall Study|Did not meet inclusion criteria|0|||
156376594|NCT00441337|564472362|FG002|Overall Study|Did not meet inclusion criteria|1|||
156376595|NCT00441337|564472363|FG003|Overall Study|Did not meet inclusion criteria|0|||
156376596|NCT01818336|564473728|FG000|Overall Study|Declined retest visit|0|||
156376597|NCT01818336|564473729|FG001|Overall Study|Declined retest visit|11|||
156376598|NCT01818336|564473728|FG000|Overall Study|Lost to Follow-up|0|||
156376599|NCT01818336|564473729|FG001|Overall Study|Lost to Follow-up|1|||
156376600|NCT00608829|564473732|FG000|Overall Study|Death|6|||
156376601|NCT00608829|564473732|FG000|Overall Study|Withdrawal by Subject|4|||
156376602|NCT00608829|564473732|FG000|Overall Study|Subject refuses to follow up or return.|5|||
156376603|NCT00672477|564473735|FG000|Overall Study|Adverse Event|10|||
156376604|NCT00672477|564473736|FG001|Overall Study|Adverse Event|7|||
156376605|NCT00672477|564473735|FG000|Overall Study|Death|7|||
156376606|NCT00672477|564473736|FG001|Overall Study|Death|11|||
156376607|NCT00672477|564473735|FG000|Overall Study|Physician Decision|2|||
156376608|NCT00672477|564473736|FG001|Overall Study|Physician Decision|0|||
156376609|NCT00672477|564473735|FG000|Overall Study|Protocol Violation|1|||
156376610|NCT00672477|564473736|FG001|Overall Study|Protocol Violation|1|||
156376611|NCT00672477|564473735|FG000|Overall Study|Withdrawal by Subject|5|||
156376612|NCT00672477|564473736|FG001|Overall Study|Withdrawal by Subject|3|||
156376613|NCT00672477|564473735|FG000|Overall Study|Lack of Efficacy|1|||
156376614|NCT00672477|564473736|FG001|Overall Study|Lack of Efficacy|1|||
156376615|NCT00672477|564473735|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
156376616|NCT00672477|564473736|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
156376617|NCT00982319|564473738|FG000|Overall Study|Surgery date change|1|||
156376618|NCT00982319|564473739|FG001|Overall Study|Surgery date change|0|||
156376619|NCT00982319|564473738|FG000|Overall Study|Preop values out of acceptable range|1|||
156376620|NCT00982319|564473739|FG001|Overall Study|Preop values out of acceptable range|1|||
156376621|NCT00982319|564473738|FG000|Overall Study|Pregnancy|0|||
156498384|NCT01296555|564919310|FG016|Overall Study|Protocol Violation|0|||
156376622|NCT00982319|564473739|FG001|Overall Study|Pregnancy|1|||
156376623|NCT00975975|564473740|FG000|Overall Study|Death|6|||
156498385|NCT01296555|564919311|FG017|Overall Study|Protocol Violation|0|||
156376624|NCT01731171|564473747|FG000|Overall Study|Withdrawal by Subject|4|||
156376625|NCT01731171|564473748|FG001|Overall Study|Withdrawal by Subject|1|||
156376626|NCT01731171|564473747|FG000|Overall Study|Lost to Follow-up|3|||
156376627|NCT01731171|564473748|FG001|Overall Study|Lost to Follow-up|2|||
156498386|NCT01296555|564919312|FG018|Overall Study|Protocol Violation|0|||
156498387|NCT01296555|564919313|FG019|Overall Study|Protocol Violation|0|||
156498388|NCT01296555|564919314|FG020|Overall Study|Protocol Violation|0|||
156498389|NCT01296555|564919315|FG021|Overall Study|Protocol Violation|0|||
156546740|NCT02915523|565094959|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
156376628|NCT01731171|564473747|FG000|Overall Study|Moved out of Area|0|||
156376629|NCT01731171|564473748|FG001|Overall Study|Moved out of Area|2|||
156376630|NCT01731171|564473747|FG000|Overall Study|Terminated for Lack of Adherence|0|||
156498390|NCT01296555|564919316|FG022|Overall Study|Protocol Violation|0|||
156498391|NCT01296555|564919317|FG023|Overall Study|Protocol Violation|0|||
156498392|NCT01296555|564919318|FG024|Overall Study|Protocol Violation|0|||
156498393|NCT01296555|564919319|FG025|Overall Study|Protocol Violation|0|||
156498394|NCT01296555|564919320|FG026|Overall Study|Protocol Violation|0|||
156498395|NCT01296555|564919321|FG027|Overall Study|Protocol Violation|0|||
156498396|NCT01296555|564919322|FG028|Overall Study|Protocol Violation|0|||
156498397|NCT01296555|564919294|FG000|Overall Study|Study Terminated By Sponsor|0|||
156498398|NCT01296555|564919295|FG001|Overall Study|Study Terminated By Sponsor|0|||
156498399|NCT01296555|564919296|FG002|Overall Study|Study Terminated By Sponsor|0|||
156498400|NCT01296555|564919297|FG003|Overall Study|Study Terminated By Sponsor|0|||
156498401|NCT01296555|564919298|FG004|Overall Study|Study Terminated By Sponsor|0|||
156498402|NCT01296555|564919299|FG005|Overall Study|Study Terminated By Sponsor|0|||
156498403|NCT01296555|564919300|FG006|Overall Study|Study Terminated By Sponsor|0|||
156498404|NCT01296555|564919301|FG007|Overall Study|Study Terminated By Sponsor|0|||
156498405|NCT01296555|564919302|FG008|Overall Study|Study Terminated By Sponsor|0|||
156498406|NCT01296555|564919303|FG009|Overall Study|Study Terminated By Sponsor|0|||
156498407|NCT01296555|564919304|FG010|Overall Study|Study Terminated By Sponsor|0|||
156498408|NCT01296555|564919305|FG011|Overall Study|Study Terminated By Sponsor|0|||
156498409|NCT01296555|564919306|FG012|Overall Study|Study Terminated By Sponsor|0|||
156498410|NCT01296555|564919307|FG013|Overall Study|Study Terminated By Sponsor|0|||
156498411|NCT01296555|564919308|FG014|Overall Study|Study Terminated By Sponsor|0|||
156498412|NCT01296555|564919309|FG015|Overall Study|Study Terminated By Sponsor|0|||
156498413|NCT01296555|564919310|FG016|Overall Study|Study Terminated By Sponsor|0|||
156498414|NCT01296555|564919311|FG017|Overall Study|Study Terminated By Sponsor|0|||
156498415|NCT01296555|564919312|FG018|Overall Study|Study Terminated By Sponsor|0|||
156498416|NCT01296555|564919313|FG019|Overall Study|Study Terminated By Sponsor|0|||
156498417|NCT01296555|564919314|FG020|Overall Study|Study Terminated By Sponsor|0|||
156498418|NCT01296555|564919315|FG021|Overall Study|Study Terminated By Sponsor|0|||
156498419|NCT01296555|564919316|FG022|Overall Study|Study Terminated By Sponsor|0|||
156498420|NCT01296555|564919317|FG023|Overall Study|Study Terminated By Sponsor|0|||
156498421|NCT01296555|564919318|FG024|Overall Study|Study Terminated By Sponsor|0|||
156498422|NCT01296555|564919319|FG025|Overall Study|Study Terminated By Sponsor|1|||
156498423|NCT01296555|564919320|FG026|Overall Study|Study Terminated By Sponsor|0|||
156498424|NCT01296555|564919321|FG027|Overall Study|Study Terminated By Sponsor|0|||
156498425|NCT01296555|564919322|FG028|Overall Study|Study Terminated By Sponsor|0|||
156498426|NCT01296555|564919294|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498427|NCT01296555|564919295|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498428|NCT01296555|564919296|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498429|NCT01296555|564919297|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498430|NCT01296555|564919298|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498431|NCT01296555|564919299|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498432|NCT01296555|564919300|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498433|NCT01296555|564919301|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498434|NCT01296555|564919302|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498435|NCT01296555|564919303|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498436|NCT01296555|564919304|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498437|NCT01296555|564919305|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498438|NCT01296555|564919306|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498439|NCT01296555|564919307|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498440|NCT01296555|564919308|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498441|NCT01296555|564919309|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498442|NCT01296555|564919310|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498443|NCT01296555|564919311|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498444|NCT01296555|564919312|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498445|NCT01296555|564919313|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
156498446|NCT01296555|564919314|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498447|NCT01296555|564919315|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498448|NCT01296555|564919316|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498449|NCT01296555|564919317|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498450|NCT01296555|564919318|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498451|NCT01296555|564919319|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498452|NCT01296555|564919320|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498453|NCT01296555|564919321|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498454|NCT01296555|564919322|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
156498455|NCT01296555|564919294|FG000|Overall Study|Death|0|||
156498456|NCT01296555|564919295|FG001|Overall Study|Death|0|||
156498457|NCT01296555|564919296|FG002|Overall Study|Death|0|||
156498458|NCT01296555|564919297|FG003|Overall Study|Death|2|||
156498459|NCT01296555|564919298|FG004|Overall Study|Death|1|||
156498460|NCT01296555|564919299|FG005|Overall Study|Death|0|||
156498461|NCT01296555|564919300|FG006|Overall Study|Death|2|||
156498462|NCT01296555|564919301|FG007|Overall Study|Death|0|||
156498463|NCT01296555|564919302|FG008|Overall Study|Death|0|||
156498464|NCT01296555|564919303|FG009|Overall Study|Death|1|||
156498465|NCT01296555|564919304|FG010|Overall Study|Death|0|||
156498466|NCT01296555|564919305|FG011|Overall Study|Death|1|||
156546741|NCT02915523|565094960|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
156498467|NCT01296555|564919306|FG012|Overall Study|Death|0|||
156498468|NCT01296555|564919307|FG013|Overall Study|Death|2|||
156498469|NCT01296555|564919308|FG014|Overall Study|Death|27|||
156498470|NCT01296555|564919309|FG015|Overall Study|Death|15|||
156498471|NCT01296555|564919310|FG016|Overall Study|Death|11|||
156498472|NCT01296555|564919311|FG017|Overall Study|Death|11|||
156498473|NCT01296555|564919312|FG018|Overall Study|Death|17|||
156498474|NCT01296555|564919313|FG019|Overall Study|Death|12|||
156498475|NCT01296555|564919314|FG020|Overall Study|Death|13|||
156498476|NCT01296555|564919315|FG021|Overall Study|Death|12|||
156498477|NCT01296555|564919316|FG022|Overall Study|Death|12|||
156498478|NCT01296555|564919317|FG023|Overall Study|Death|13|||
156498479|NCT01296555|564919318|FG024|Overall Study|Death|7|||
156498480|NCT01296555|564919319|FG025|Overall Study|Death|7|||
156498481|NCT01296555|564919320|FG026|Overall Study|Death|35|||
156498482|NCT01296555|564919321|FG027|Overall Study|Death|92|||
156498483|NCT01296555|564919322|FG028|Overall Study|Death|44|||
156498484|NCT01296555|564919294|FG000|Overall Study|Lost to Follow-up|0|||
156498485|NCT01296555|564919295|FG001|Overall Study|Lost to Follow-up|0|||
156498486|NCT01296555|564919296|FG002|Overall Study|Lost to Follow-up|0|||
156498487|NCT01296555|564919297|FG003|Overall Study|Lost to Follow-up|0|||
156498488|NCT01296555|564919298|FG004|Overall Study|Lost to Follow-up|0|||
156498489|NCT01296555|564919299|FG005|Overall Study|Lost to Follow-up|0|||
156498490|NCT01296555|564919300|FG006|Overall Study|Lost to Follow-up|0|||
156498491|NCT01296555|564919301|FG007|Overall Study|Lost to Follow-up|0|||
156498492|NCT01296555|564919302|FG008|Overall Study|Lost to Follow-up|0|||
156498493|NCT01296555|564919303|FG009|Overall Study|Lost to Follow-up|0|||
156498494|NCT01296555|564919304|FG010|Overall Study|Lost to Follow-up|0|||
156498495|NCT01296555|564919305|FG011|Overall Study|Lost to Follow-up|0|||
156498496|NCT01296555|564919306|FG012|Overall Study|Lost to Follow-up|0|||
156498497|NCT01296555|564919307|FG013|Overall Study|Lost to Follow-up|0|||
156498498|NCT01296555|564919308|FG014|Overall Study|Lost to Follow-up|2|||
156498499|NCT01296555|564919309|FG015|Overall Study|Lost to Follow-up|1|||
156498500|NCT01296555|564919310|FG016|Overall Study|Lost to Follow-up|0|||
156498501|NCT01296555|564919311|FG017|Overall Study|Lost to Follow-up|2|||
156498502|NCT01296555|564919312|FG018|Overall Study|Lost to Follow-up|0|||
156498503|NCT01296555|564919313|FG019|Overall Study|Lost to Follow-up|2|||
156498504|NCT01296555|564919314|FG020|Overall Study|Lost to Follow-up|3|||
156498505|NCT01296555|564919315|FG021|Overall Study|Lost to Follow-up|2|||
156498506|NCT01296555|564919316|FG022|Overall Study|Lost to Follow-up|0|||
156498507|NCT01296555|564919317|FG023|Overall Study|Lost to Follow-up|0|||
156498508|NCT01296555|564919318|FG024|Overall Study|Lost to Follow-up|0|||
156498509|NCT01296555|564919319|FG025|Overall Study|Lost to Follow-up|0|||
156498510|NCT01296555|564919320|FG026|Overall Study|Lost to Follow-up|3|||
156498511|NCT01296555|564919321|FG027|Overall Study|Lost to Follow-up|13|||
156498512|NCT01296555|564919322|FG028|Overall Study|Lost to Follow-up|5|||
156498513|NCT01296555|564919294|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156498514|NCT01296555|564919295|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156498515|NCT01296555|564919296|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156498516|NCT01296555|564919297|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156498517|NCT01296555|564919298|FG004|Overall Study|Non-Compliance With Study Drug|0|||
156498518|NCT01296555|564919299|FG005|Overall Study|Non-Compliance With Study Drug|0|||
156498519|NCT01296555|564919300|FG006|Overall Study|Non-Compliance With Study Drug|0|||
156498520|NCT01296555|564919301|FG007|Overall Study|Non-Compliance With Study Drug|1|||
156498521|NCT01296555|564919302|FG008|Overall Study|Non-Compliance With Study Drug|0|||
156498522|NCT01296555|564919303|FG009|Overall Study|Non-Compliance With Study Drug|0|||
156498523|NCT01296555|564919304|FG010|Overall Study|Non-Compliance With Study Drug|0|||
156498524|NCT01296555|564919305|FG011|Overall Study|Non-Compliance With Study Drug|0|||
156376631|NCT01731171|564473748|FG001|Overall Study|Terminated for Lack of Adherence|1|||
156376632|NCT01731171|564473747|FG000|Overall Study|Terminated for Safety Reasons|0|||
156376633|NCT01731171|564473748|FG001|Overall Study|Terminated for Safety Reasons|1|||
156376634|NCT02604589|564473754|FG000|Overall Study|catheter dislodgement|0|||
156376635|NCT02604589|564473755|FG001|Overall Study|catheter dislodgement|0|||
156498525|NCT01296555|564919306|FG012|Overall Study|Non-Compliance With Study Drug|0|||
156498526|NCT01296555|564919307|FG013|Overall Study|Non-Compliance With Study Drug|0|||
156498527|NCT01296555|564919308|FG014|Overall Study|Non-Compliance With Study Drug|0|||
156498528|NCT01296555|564919309|FG015|Overall Study|Non-Compliance With Study Drug|0|||
156498529|NCT01296555|564919310|FG016|Overall Study|Non-Compliance With Study Drug|0|||
156498530|NCT01296555|564919311|FG017|Overall Study|Non-Compliance With Study Drug|0|||
156498531|NCT01296555|564919312|FG018|Overall Study|Non-Compliance With Study Drug|0|||
156498532|NCT01296555|564919313|FG019|Overall Study|Non-Compliance With Study Drug|0|||
156498533|NCT01296555|564919314|FG020|Overall Study|Non-Compliance With Study Drug|0|||
156498534|NCT01296555|564919315|FG021|Overall Study|Non-Compliance With Study Drug|0|||
156498535|NCT01296555|564919316|FG022|Overall Study|Non-Compliance With Study Drug|0|||
156498536|NCT01296555|564919317|FG023|Overall Study|Non-Compliance With Study Drug|0|||
156498537|NCT01296555|564919318|FG024|Overall Study|Non-Compliance With Study Drug|0|||
156498538|NCT01296555|564919319|FG025|Overall Study|Non-Compliance With Study Drug|0|||
156498539|NCT01296555|564919320|FG026|Overall Study|Non-Compliance With Study Drug|0|||
156376636|NCT02604589|564473756|FG002|Overall Study|catheter dislodgement|1|||
156376637|NCT04632940|564473760|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
156376638|NCT04632940|564473761|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
156376639|NCT04632940|564473760|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
156376640|NCT04632940|564473761|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
156376641|NCT04632940|564473760|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
156376642|NCT04632940|564473761|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
156376643|NCT04632940|564473760|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
156376644|NCT04632940|564473761|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
156376645|NCT04632940|564473760|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
156376646|NCT04632940|564473761|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
156376647|NCT04632940|564473760|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
156376648|NCT04632940|564473761|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
156376649|NCT04632940|564473760|FG000|OLE Period (52 Weeks)|Other than specified|0|||
156376650|NCT04632940|564473761|FG001|OLE Period (52 Weeks)|Other than specified|1|||
156376651|NCT04632940|564473760|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
156376652|NCT04632940|564473761|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
156376653|NCT02520531|564473766|FG000|Overall Study|Revision of study device components|2|||
156376654|NCT02520531|564473767|FG001|Overall Study|Revision of study device components|2|||
156376655|NCT02520531|564473766|FG000|Overall Study|Death|1|||
156376656|NCT02520531|564473767|FG001|Overall Study|Death|2|||
156376657|NCT02520531|564473766|FG000|Overall Study|Lost to Follow-up|1|||
156376658|NCT02520531|564473767|FG001|Overall Study|Lost to Follow-up|1|||
156376659|NCT02520531|564473766|FG000|Overall Study|Meet exclusion criterion|0|||
156376660|NCT02520531|564473767|FG001|Overall Study|Meet exclusion criterion|1|||
156376661|NCT02520531|564473766|FG000|Overall Study|Withdrawal by Subject|1|||
156376662|NCT02520531|564473767|FG001|Overall Study|Withdrawal by Subject|0|||
156376663|NCT02520531|564473766|FG000|Overall Study|Not study device|1|||
156376664|NCT02520531|564473767|FG001|Overall Study|Not study device|0|||
156376665|NCT00622635|564473771|FG000|Treatment Period 1|Adverse Event|0|||
156376666|NCT00622635|564473772|FG001|Treatment Period 1|Adverse Event|0|||
156376667|NCT00622635|564473773|FG002|Treatment Period 1|Adverse Event|1|||
156376668|NCT00622635|564473774|FG003|Treatment Period 1|Adverse Event|0|||
156376669|NCT00622635|564473775|FG004|Treatment Period 1|Adverse Event|0|||
156376670|NCT00622635|564473776|FG005|Treatment Period 1|Adverse Event|0|||
156376671|NCT00622635|564473771|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156376672|NCT00622635|564473772|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156376673|NCT00622635|564473773|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156376674|NCT00622635|564473774|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156376675|NCT00622635|564473775|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156376676|NCT00622635|564473776|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156376677|NCT00622635|564473771|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
156376678|NCT00622635|564473772|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
156376679|NCT00622635|564473773|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
156376680|NCT00622635|564473774|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
156376681|NCT00622635|564473775|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
156376682|NCT00622635|564473776|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
156376683|NCT00622635|564473771|FG000|Treatment Period 2|Adverse Event|1|||
156376684|NCT00622635|564473772|FG001|Treatment Period 2|Adverse Event|0|||
156376685|NCT00622635|564473773|FG002|Treatment Period 2|Adverse Event|0|||
156376686|NCT00622635|564473774|FG003|Treatment Period 2|Adverse Event|0|||
156376687|NCT00622635|564473775|FG004|Treatment Period 2|Adverse Event|0|||
156376688|NCT00622635|564473776|FG005|Treatment Period 2|Adverse Event|0|||
156376689|NCT00622635|564473771|FG000|Treatment Period 3|Adverse Event|0|||
156376690|NCT00622635|564473772|FG001|Treatment Period 3|Adverse Event|0|||
156376691|NCT00622635|564473773|FG002|Treatment Period 3|Adverse Event|0|||
156376692|NCT00622635|564473774|FG003|Treatment Period 3|Adverse Event|2|||
156376693|NCT00622635|564473775|FG004|Treatment Period 3|Adverse Event|0|||
156376694|NCT00622635|564473776|FG005|Treatment Period 3|Adverse Event|0|||
156376695|NCT00622635|564473771|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156376696|NCT00622635|564473772|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156376697|NCT00622635|564473773|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156376698|NCT00622635|564473774|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156376699|NCT00622635|564473775|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156376700|NCT00622635|564473776|FG005|Treatment Period 3|Withdrawal by Subject|0|||
156376701|NCT00835406|564473777|FG000|Period: First Intervention|Adverse Event|0|||
156376702|NCT00835406|564473778|FG001|Period: First Intervention|Adverse Event|1|||
156376703|NCT00835406|564473777|FG000|Period: First Intervention|Withdrawal by Subject|2|||
156376704|NCT00835406|564473778|FG001|Period: First Intervention|Withdrawal by Subject|0|||
156376705|NCT00835406|564473777|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
156376706|NCT00835406|564473778|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
156376707|NCT00281840|564473779|FG000|Overall Study|Adverse Event|12|||
156376708|NCT00281840|564473779|FG000|Overall Study|Physician Decision|6|||
156376709|NCT00281840|564473779|FG000|Overall Study|Withdrawal by Subject|3|||
156376710|NCT00281840|564473779|FG000|Overall Study|Disease Progression|2|||
156498540|NCT01296555|564919321|FG027|Overall Study|Non-Compliance With Study Drug|0|||
156498541|NCT01296555|564919322|FG028|Overall Study|Non-Compliance With Study Drug|0|||
156498542|NCT01296555|564919294|FG000|Overall Study|Withdrawal by Subject|0|||
156498543|NCT01296555|564919295|FG001|Overall Study|Withdrawal by Subject|0|||
156498544|NCT01296555|564919296|FG002|Overall Study|Withdrawal by Subject|0|||
156498545|NCT01296555|564919297|FG003|Overall Study|Withdrawal by Subject|0|||
156498546|NCT01296555|564919298|FG004|Overall Study|Withdrawal by Subject|1|||
156498547|NCT01296555|564919299|FG005|Overall Study|Withdrawal by Subject|0|||
156498548|NCT01296555|564919300|FG006|Overall Study|Withdrawal by Subject|1|||
156498549|NCT01296555|564919301|FG007|Overall Study|Withdrawal by Subject|0|||
156498550|NCT01296555|564919302|FG008|Overall Study|Withdrawal by Subject|0|||
156498551|NCT01296555|564919303|FG009|Overall Study|Withdrawal by Subject|0|||
156498552|NCT01296555|564919304|FG010|Overall Study|Withdrawal by Subject|1|||
156498553|NCT01296555|564919305|FG011|Overall Study|Withdrawal by Subject|1|||
156498554|NCT01296555|564919306|FG012|Overall Study|Withdrawal by Subject|0|||
156498555|NCT01296555|564919307|FG013|Overall Study|Withdrawal by Subject|0|||
156498556|NCT01296555|564919308|FG014|Overall Study|Withdrawal by Subject|3|||
156498557|NCT01296555|564919309|FG015|Overall Study|Withdrawal by Subject|0|||
156498558|NCT01296555|564919310|FG016|Overall Study|Withdrawal by Subject|2|||
156498559|NCT01296555|564919311|FG017|Overall Study|Withdrawal by Subject|1|||
156498560|NCT01296555|564919312|FG018|Overall Study|Withdrawal by Subject|0|||
156498561|NCT01296555|564919313|FG019|Overall Study|Withdrawal by Subject|1|||
156498562|NCT01296555|564919314|FG020|Overall Study|Withdrawal by Subject|1|||
156498563|NCT01296555|564919315|FG021|Overall Study|Withdrawal by Subject|1|||
156498564|NCT01296555|564919316|FG022|Overall Study|Withdrawal by Subject|3|||
156498565|NCT01296555|564919317|FG023|Overall Study|Withdrawal by Subject|0|||
156498566|NCT01296555|564919318|FG024|Overall Study|Withdrawal by Subject|0|||
156498567|NCT01296555|564919319|FG025|Overall Study|Withdrawal by Subject|0|||
156498568|NCT01296555|564919320|FG026|Overall Study|Withdrawal by Subject|8|||
156498569|NCT01296555|564919321|FG027|Overall Study|Withdrawal by Subject|4|||
156498570|NCT01296555|564919322|FG028|Overall Study|Withdrawal by Subject|2|||
156498571|NCT02250534|564919323|FG000|Overall Study|Lost to Follow-up|18|||
156498572|NCT02250534|564919324|FG001|Overall Study|Lost to Follow-up|28|||
156498573|NCT02250534|564919325|FG002|Overall Study|Lost to Follow-up|33|||
156498574|NCT02250534|564919323|FG000|Overall Study|Personal reasons|7|||
156498575|NCT02250534|564919324|FG001|Overall Study|Personal reasons|8|||
156498576|NCT02250534|564919325|FG002|Overall Study|Personal reasons|14|||
156498577|NCT02250534|564919323|FG000|Overall Study|Adverse Event|6|||
156498578|NCT02250534|564919324|FG001|Overall Study|Adverse Event|3|||
156498579|NCT02250534|564919325|FG002|Overall Study|Adverse Event|8|||
156498580|NCT02250534|564919323|FG000|Overall Study|incarcerated|2|||
156498581|NCT02250534|564919324|FG001|Overall Study|incarcerated|1|||
156498582|NCT02250534|564919325|FG002|Overall Study|incarcerated|2|||
156498583|NCT02250534|564919323|FG000|Overall Study|Withdrawal by Subject|0|||
156498584|NCT02250534|564919324|FG001|Overall Study|Withdrawal by Subject|1|||
156498585|NCT02250534|564919325|FG002|Overall Study|Withdrawal by Subject|2|||
156498586|NCT02250534|564919323|FG000|Overall Study|Death|0|||
156498587|NCT02250534|564919324|FG001|Overall Study|Death|1|||
156498588|NCT02250534|564919325|FG002|Overall Study|Death|1|||
156498589|NCT02250534|564919323|FG000|Overall Study|Physician Decision|1|||
156498590|NCT02250534|564919324|FG001|Overall Study|Physician Decision|3|||
156498591|NCT02250534|564919325|FG002|Overall Study|Physician Decision|1|||
156498592|NCT02250534|564919323|FG000|Overall Study|Protocol Violation|1|||
156498593|NCT02250534|564919324|FG001|Overall Study|Protocol Violation|0|||
156498594|NCT02250534|564919325|FG002|Overall Study|Protocol Violation|1|||
156498595|NCT02250534|564919323|FG000|Overall Study|Reason unknown|1|||
156498596|NCT02250534|564919324|FG001|Overall Study|Reason unknown|0|||
156498597|NCT02250534|564919325|FG002|Overall Study|Reason unknown|0|||
156498598|NCT01101061|564919328|FG000|Overall Study|Adverse Event|0|||
156498599|NCT01101061|564919329|FG001|Overall Study|Adverse Event|0|||
156498600|NCT01101061|564919330|FG002|Overall Study|Adverse Event|1|||
156498601|NCT01101061|564919331|FG003|Overall Study|Adverse Event|0|||
156498602|NCT01101061|564919332|FG004|Overall Study|Adverse Event|0|||
156498603|NCT01101061|564919333|FG005|Overall Study|Adverse Event|0|||
156498604|NCT01587118|564919334|FG000|Overall Study|Adverse Event|3|||
156498605|NCT01587118|564919334|FG000|Overall Study|Lost to Follow-up|2|||
156498606|NCT01587118|564919334|FG000|Overall Study|Relocation|1|||
156498607|NCT01587118|564919334|FG000|Overall Study|nonresponse|1|||
156498608|NCT00537329|564919335|FG000|Overall Study|Death|10|||
156498609|NCT00537329|564919335|FG000|Overall Study|Adverse Event|3|||
156498610|NCT00537329|564919335|FG000|Overall Study|Lack of Efficacy|2|||
156498611|NCT00537329|564919335|FG000|Overall Study|Lost to Follow-up|6|||
156498612|NCT00537329|564919335|FG000|Overall Study|Withdrawal by Subject|4|||
156498613|NCT00537329|564919335|FG000|Overall Study|Other|1|||
156498614|NCT00778921|564919336|FG000|Overall Study|Adverse Event|9|||
156498615|NCT00778921|564919337|FG001|Overall Study|Adverse Event|10|||
156498616|NCT00778921|564919338|FG002|Overall Study|Adverse Event|14|||
156498617|NCT00778921|564919336|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
156376711|NCT00281840|564473779|FG000|Overall Study|exceed maximum delay in treatment|1|||
156376712|NCT00281840|564473779|FG000|Overall Study|Complicating Disease|1|||
156376713|NCT02138214|564473782|FG000|Overall Study|Withdrawal by Subject|0|||
156376714|NCT02138214|564473783|FG001|Overall Study|Withdrawal by Subject|1|||
156376715|NCT02138214|564473784|FG002|Overall Study|Withdrawal by Subject|0|||
156376716|NCT02138214|564473782|FG000|Overall Study|Lost to Follow-up|0|||
156376717|NCT02138214|564473783|FG001|Overall Study|Lost to Follow-up|2|||
156376718|NCT02138214|564473784|FG002|Overall Study|Lost to Follow-up|4|||
156376719|NCT02138214|564473782|FG000|Overall Study|Screen Failure|0|||
156376720|NCT02138214|564473783|FG001|Overall Study|Screen Failure|1|||
156376721|NCT02138214|564473784|FG002|Overall Study|Screen Failure|0|||
156376722|NCT02185768|564473785|FG000|Overall Study|Patients were not treated|2|||
156376723|NCT02486406|564473787|FG000|Overall Study|Withdrew consent|1|||
156376724|NCT02486406|564473788|FG001|Overall Study|Withdrew consent|0|||
156376725|NCT02486406|564473789|FG002|Overall Study|Withdrew consent|0|||
156376726|NCT02486406|564473790|FG003|Overall Study|Withdrew consent|1|||
156376727|NCT02486406|564473787|FG000|Overall Study|Lost to Follow-up|1|||
156376728|NCT02486406|564473788|FG001|Overall Study|Lost to Follow-up|3|||
156376729|NCT02486406|564473789|FG002|Overall Study|Lost to Follow-up|1|||
156376730|NCT02486406|564473790|FG003|Overall Study|Lost to Follow-up|3|||
156376731|NCT02486406|564473787|FG000|Overall Study|Other, not specified|0|||
156376732|NCT02486406|564473788|FG001|Overall Study|Other, not specified|0|||
156376733|NCT02486406|564473789|FG002|Overall Study|Other, not specified|1|||
156376734|NCT02486406|564473790|FG003|Overall Study|Other, not specified|0|||
156376735|NCT01079234|564473793|FG000|Main: Week 0 to 26|Adverse Event|5|||
156376736|NCT01079234|564473794|FG001|Main: Week 0 to 26|Adverse Event|4|||
156376737|NCT01079234|564473795|FG002|Main: Week 0 to 26|Adverse Event|1|||
156376738|NCT01079234|564473796|FG003|Main: Week 0 to 26|Adverse Event|0|||
156376739|NCT01079234|564473793|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
156376740|NCT01079234|564473794|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
156376741|NCT01079234|564473795|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
156376742|NCT01079234|564473796|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
156376743|NCT01079234|564473793|FG000|Main: Week 0 to 26|Protocol Violation|6|||
156376744|NCT01079234|564473794|FG001|Main: Week 0 to 26|Protocol Violation|2|||
156376745|NCT01079234|564473795|FG002|Main: Week 0 to 26|Protocol Violation|4|||
156376746|NCT01079234|564473796|FG003|Main: Week 0 to 26|Protocol Violation|0|||
156376747|NCT01079234|564473793|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
156376748|NCT01079234|564473794|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
156376749|NCT01079234|564473795|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
156376750|NCT01079234|564473796|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
156376751|NCT01079234|564473793|FG000|Main: Week 0 to 26|Unclassified|7|||
156376752|NCT01079234|564473794|FG001|Main: Week 0 to 26|Unclassified|13|||
156376753|NCT01079234|564473795|FG002|Main: Week 0 to 26|Unclassified|4|||
156376754|NCT01079234|564473796|FG003|Main: Week 0 to 26|Unclassified|0|||
156376755|NCT01079234|564473793|FG000|Extension: Week 27 to 52|Adverse Event|0|||
156376756|NCT01079234|564473794|FG001|Extension: Week 27 to 52|Adverse Event|0|||
156376757|NCT01079234|564473795|FG002|Extension: Week 27 to 52|Adverse Event|1|||
156376758|NCT01079234|564473796|FG003|Extension: Week 27 to 52|Adverse Event|0|||
156376759|NCT01079234|564473793|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
156376760|NCT01079234|564473794|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
156376761|NCT01079234|564473795|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
156376762|NCT01079234|564473796|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
156376763|NCT01079234|564473793|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
156376764|NCT01079234|564473794|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
156376765|NCT01079234|564473795|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
156376766|NCT01079234|564473796|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
156376767|NCT01079234|564473793|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
156498618|NCT00778921|564919337|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
156498619|NCT00778921|564919338|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
156498620|NCT00778921|564919336|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
156498621|NCT00778921|564919337|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156498622|NCT00778921|564919338|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
156376768|NCT01079234|564473794|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
156376769|NCT01079234|564473795|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
156376770|NCT01079234|564473796|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
156376771|NCT01079234|564473793|FG000|Extension: Week 27 to 52|Unclassified|0|||
156376772|NCT01079234|564473794|FG001|Extension: Week 27 to 52|Unclassified|0|||
156376773|NCT01079234|564473795|FG002|Extension: Week 27 to 52|Unclassified|4|||
156498623|NCT00778921|564919336|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
156498624|NCT00778921|564919337|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
156498625|NCT00778921|564919338|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
156376774|NCT01079234|564473796|FG003|Extension: Week 27 to 52|Unclassified|7|||
156376775|NCT05402995|564473806|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
156376776|NCT05402995|564473807|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
156376777|NCT05402995|564473808|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
156376778|NCT05402995|564473809|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
156376779|NCT01071512|564473810|FG000|Overall Study|Adverse Event|1|||
156376780|NCT01071512|564473810|FG000|Overall Study|Development of antibodies to drug|2|||
156376781|NCT01071512|564473810|FG000|Overall Study|positive anti-JC virus antibody test|2|||
156376782|NCT02316717|564473815|FG000|Overall Study|Adverse Event|2|||
156376783|NCT02316717|564473816|FG001|Overall Study|Adverse Event|2|||
156376784|NCT02316717|564473817|FG002|Overall Study|Adverse Event|0|||
156376785|NCT02316717|564473815|FG000|Overall Study|Lost to Follow-up|1|||
156376786|NCT02316717|564473816|FG001|Overall Study|Lost to Follow-up|2|||
156376787|NCT02316717|564473817|FG002|Overall Study|Lost to Follow-up|1|||
156376788|NCT02316717|564473815|FG000|Overall Study|Non compliance|3|||
156376789|NCT02316717|564473816|FG001|Overall Study|Non compliance|1|||
156376790|NCT02316717|564473817|FG002|Overall Study|Non compliance|0|||
156376791|NCT02316717|564473815|FG000|Overall Study|Protocol Violation|2|||
156376792|NCT02316717|564473816|FG001|Overall Study|Protocol Violation|0|||
156376793|NCT02316717|564473817|FG002|Overall Study|Protocol Violation|0|||
156376794|NCT02316717|564473815|FG000|Overall Study|Withdrawal by Subject|2|||
156376795|NCT02316717|564473816|FG001|Overall Study|Withdrawal by Subject|1|||
156376796|NCT02316717|564473817|FG002|Overall Study|Withdrawal by Subject|1|||
156376797|NCT02316717|564473815|FG000|Overall Study|Death|0|||
156376798|NCT02316717|564473816|FG001|Overall Study|Death|0|||
156376799|NCT02316717|564473817|FG002|Overall Study|Death|1|||
156376800|NCT02316717|564473815|FG000|Overall Study|Physician Decision|0|||
156376801|NCT02316717|564473816|FG001|Overall Study|Physician Decision|1|||
156376802|NCT02316717|564473817|FG002|Overall Study|Physician Decision|0|||
156376803|NCT02316717|564473815|FG000|Overall Study|TBC|1|||
156376804|NCT02316717|564473816|FG001|Overall Study|TBC|0|||
156376805|NCT02316717|564473817|FG002|Overall Study|TBC|0|||
156376806|NCT00183872|564473818|FG000|Overall Study|Death|3|||
156376807|NCT00183872|564473818|FG000|Overall Study|Adverse Event|9|||
156376808|NCT00183872|564473818|FG000|Overall Study|Withdrawal by Subject|2|||
156376809|NCT00183872|564473818|FG000|Overall Study|Drug delayed more than 28 days|2|||
156376810|NCT02047604|564473821|FG000|Overall Study|Withdrawal by Subject|0|||
156376811|NCT02047604|564473822|FG001|Overall Study|Withdrawal by Subject|0|||
156376812|NCT02047604|564473823|FG002|Overall Study|Withdrawal by Subject|0|||
156376813|NCT02047604|564473824|FG003|Overall Study|Withdrawal by Subject|0|||
156376814|NCT02047604|564473825|FG004|Overall Study|Withdrawal by Subject|1|||
156376815|NCT02047604|564473826|FG005|Overall Study|Withdrawal by Subject|1|||
156376816|NCT01208233|564473827|FG000|Overall Study|Adverse Event|0|||
156376817|NCT01208233|564473828|FG001|Overall Study|Adverse Event|1|||
156376818|NCT01208233|564473829|FG002|Overall Study|Adverse Event|2|||
156376819|NCT01208233|564473830|FG003|Overall Study|Adverse Event|0|||
156376820|NCT01208233|564473831|FG004|Overall Study|Adverse Event|3|||
156376821|NCT01208233|564473832|FG005|Overall Study|Adverse Event|5|||
156376822|NCT01208233|564473827|FG000|Overall Study|Death|0|||
156376823|NCT01208233|564473828|FG001|Overall Study|Death|0|||
156376824|NCT01208233|564473829|FG002|Overall Study|Death|0|||
156376825|NCT01208233|564473830|FG003|Overall Study|Death|0|||
156376826|NCT01208233|564473831|FG004|Overall Study|Death|3|||
156376827|NCT01208233|564473832|FG005|Overall Study|Death|5|||
156376828|NCT01208233|564473827|FG000|Overall Study|Did not meet entrance criteria|2|||
156376829|NCT01208233|564473828|FG001|Overall Study|Did not meet entrance criteria|1|||
156376830|NCT01208233|564473829|FG002|Overall Study|Did not meet entrance criteria|1|||
156376831|NCT01208233|564473830|FG003|Overall Study|Did not meet entrance criteria|0|||
156376832|NCT01208233|564473831|FG004|Overall Study|Did not meet entrance criteria|1|||
156376833|NCT01208233|564473832|FG005|Overall Study|Did not meet entrance criteria|0|||
156376834|NCT01208233|564473827|FG000|Overall Study|Medication error without adverse event|0|||
156376835|NCT01208233|564473828|FG001|Overall Study|Medication error without adverse event|0|||
156376836|NCT01208233|564473829|FG002|Overall Study|Medication error without adverse event|0|||
156376837|NCT01208233|564473830|FG003|Overall Study|Medication error without adverse event|0|||
156376838|NCT01208233|564473831|FG004|Overall Study|Medication error without adverse event|0|||
156376839|NCT01208233|564473832|FG005|Overall Study|Medication error without adverse event|1|||
156376840|NCT01208233|564473827|FG000|Overall Study|Study terminated by sponsor|0|||
156376841|NCT01208233|564473828|FG001|Overall Study|Study terminated by sponsor|0|||
156376842|NCT01208233|564473829|FG002|Overall Study|Study terminated by sponsor|0|||
156376843|NCT01208233|564473830|FG003|Overall Study|Study terminated by sponsor|0|||
156376844|NCT01208233|564473831|FG004|Overall Study|Study terminated by sponsor|10|||
156376845|NCT01208233|564473832|FG005|Overall Study|Study terminated by sponsor|7|||
156376846|NCT01208233|564473827|FG000|Overall Study|Protocol Violation|0|||
156376847|NCT01208233|564473828|FG001|Overall Study|Protocol Violation|0|||
156376848|NCT01208233|564473829|FG002|Overall Study|Protocol Violation|0|||
156376849|NCT01208233|564473830|FG003|Overall Study|Protocol Violation|0|||
156376850|NCT01208233|564473831|FG004|Overall Study|Protocol Violation|3|||
156376851|NCT01208233|564473832|FG005|Overall Study|Protocol Violation|0|||
156376852|NCT01208233|564473827|FG000|Overall Study|Other|2|||
156376853|NCT01208233|564473828|FG001|Overall Study|Other|1|||
156376854|NCT01208233|564473829|FG002|Overall Study|Other|0|||
156376855|NCT01208233|564473830|FG003|Overall Study|Other|0|||
156498626|NCT00778921|564919336|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
156498627|NCT00778921|564919337|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
156498628|NCT00778921|564919338|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
156498629|NCT00778921|564919336|FG000|Overall Study|Patient withdrew request|3|||
156498630|NCT00778921|564919337|FG001|Overall Study|Patient withdrew request|1|||
156498631|NCT00778921|564919338|FG002|Overall Study|Patient withdrew request|6|||
156498632|NCT00778921|564919336|FG000|Overall Study|Lost to Follow-up|0|||
156498633|NCT00778921|564919337|FG001|Overall Study|Lost to Follow-up|2|||
156498634|NCT00778921|564919338|FG002|Overall Study|Lost to Follow-up|1|||
156498635|NCT00778921|564919336|FG000|Overall Study|Administrative Problems|1|||
156498636|NCT00778921|564919337|FG001|Overall Study|Administrative Problems|2|||
156498637|NCT00778921|564919338|FG002|Overall Study|Administrative Problems|0|||
156498638|NCT00778921|564919336|FG000|Overall Study|Protocol Violation|3|||
156498639|NCT00778921|564919337|FG001|Overall Study|Protocol Violation|0|||
156498640|NCT00778921|564919338|FG002|Overall Study|Protocol Violation|2|||
156498641|NCT00778921|564919336|FG000|Overall Study|Not treated|0|||
156498642|NCT00778921|564919337|FG001|Overall Study|Not treated|2|||
156498643|NCT00778921|564919338|FG002|Overall Study|Not treated|2|||
156498644|NCT00572533|564919339|FG000|Overall Study|Death|4|||
156498645|NCT00572533|564919340|FG001|Overall Study|Death|1|||
156498646|NCT00572533|564919339|FG000|Overall Study|Received Kidney Transplant|2|||
156498647|NCT00572533|564919340|FG001|Overall Study|Received Kidney Transplant|1|||
156498648|NCT00572533|564919339|FG000|Overall Study|Social Issues|1|||
156498649|NCT00572533|564919340|FG001|Overall Study|Social Issues|0|||
156498650|NCT00572533|564919339|FG000|Overall Study|Transfer out of Facility|0|||
156498651|NCT00572533|564919340|FG001|Overall Study|Transfer out of Facility|1|||
156498652|NCT00003477|564919341|FG000|Overall Study|Not evalauable|4|||
156498653|NCT00267098|564919342|FG000|Overall Study|Death|0|||
156498654|NCT00267098|564919343|FG001|Overall Study|Death|0|||
156498655|NCT00267098|564919344|FG002|Overall Study|Death|57|||
156498656|NCT00267098|564919345|FG003|Overall Study|Death|66|||
156498657|NCT00267098|564919346|FG004|Overall Study|Death|14|||
156498658|NCT00267098|564919347|FG005|Overall Study|Death|23|||
156498659|NCT00267098|564919348|FG006|Overall Study|Death|28|||
156498660|NCT00267098|564919349|FG007|Overall Study|Death|9|||
156498661|NCT00267098|564919342|FG000|Overall Study|Lost to Follow-up|0|||
156498662|NCT00267098|564919343|FG001|Overall Study|Lost to Follow-up|0|||
156498663|NCT00267098|564919344|FG002|Overall Study|Lost to Follow-up|6|||
156498664|NCT00267098|564919345|FG003|Overall Study|Lost to Follow-up|5|||
156498665|NCT00267098|564919346|FG004|Overall Study|Lost to Follow-up|2|||
156498666|NCT00267098|564919347|FG005|Overall Study|Lost to Follow-up|3|||
156498667|NCT00267098|564919348|FG006|Overall Study|Lost to Follow-up|1|||
156498668|NCT00267098|564919349|FG007|Overall Study|Lost to Follow-up|1|||
156498669|NCT00267098|564919342|FG000|Overall Study|Withdrawal by Subject|8|||
156498670|NCT00267098|564919343|FG001|Overall Study|Withdrawal by Subject|0|||
156498671|NCT00267098|564919344|FG002|Overall Study|Withdrawal by Subject|24|||
156498672|NCT00267098|564919345|FG003|Overall Study|Withdrawal by Subject|21|||
156498673|NCT00267098|564919346|FG004|Overall Study|Withdrawal by Subject|12|||
156498674|NCT00267098|564919347|FG005|Overall Study|Withdrawal by Subject|9|||
156498675|NCT00267098|564919348|FG006|Overall Study|Withdrawal by Subject|12|||
156498676|NCT00267098|564919349|FG007|Overall Study|Withdrawal by Subject|5|||
156498677|NCT00267098|564919342|FG000|Overall Study|Physician Decision|5|||
156498678|NCT00267098|564919343|FG001|Overall Study|Physician Decision|0|||
156498679|NCT00267098|564919344|FG002|Overall Study|Physician Decision|7|||
156498680|NCT00267098|564919345|FG003|Overall Study|Physician Decision|11|||
156498681|NCT00267098|564919346|FG004|Overall Study|Physician Decision|5|||
156498682|NCT00267098|564919347|FG005|Overall Study|Physician Decision|4|||
156498683|NCT00267098|564919348|FG006|Overall Study|Physician Decision|3|||
156498684|NCT00267098|564919349|FG007|Overall Study|Physician Decision|0|||
156498685|NCT00267098|564919342|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
156498686|NCT00267098|564919343|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156376856|NCT01208233|564473831|FG004|Overall Study|Other|0|||
156376857|NCT01208233|564473832|FG005|Overall Study|Other|1|||
156376858|NCT01208233|564473827|FG000|Overall Study|Withdrawal by Subject|1|||
156498687|NCT00267098|564919344|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156498688|NCT00267098|564919345|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156498689|NCT00267098|564919346|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
156498690|NCT00267098|564919347|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156498691|NCT00267098|564919348|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156498692|NCT00267098|564919349|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156498693|NCT00267098|564919342|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
156498694|NCT00267098|564919343|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
156498695|NCT00267098|564919344|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
156498696|NCT00267098|564919345|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
156498697|NCT00267098|564919346|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
156376859|NCT01208233|564473828|FG001|Overall Study|Withdrawal by Subject|0|||
156498698|NCT00267098|564919347|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
156376860|NCT01208233|564473829|FG002|Overall Study|Withdrawal by Subject|1|||
156376861|NCT01208233|564473830|FG003|Overall Study|Withdrawal by Subject|1|||
156376862|NCT01208233|564473831|FG004|Overall Study|Withdrawal by Subject|4|||
156376863|NCT01208233|564473832|FG005|Overall Study|Withdrawal by Subject|2|||
156376864|NCT00983814|564473834|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
156376865|NCT00983814|564473835|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
156376866|NCT00983814|564473836|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
156376867|NCT00983814|564473834|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
156376868|NCT00983814|564473835|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
156376869|NCT00983814|564473836|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
156376870|NCT00983814|564473834|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
156376871|NCT00983814|564473835|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
156376872|NCT00983814|564473836|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
156376873|NCT00983814|564473834|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
156376874|NCT00983814|564473835|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
156376875|NCT00983814|564473836|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
156376876|NCT00983814|564473834|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
156376877|NCT00983814|564473835|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
156376878|NCT00983814|564473836|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
156376879|NCT01181895|564473837|FG000|Overall Study|Adverse Event|3|||
156376880|NCT01181895|564473838|FG001|Overall Study|Adverse Event|1|||
156376881|NCT01181895|564473839|FG002|Overall Study|Adverse Event|1|||
156376882|NCT01181895|564473837|FG000|Overall Study|Lack of Efficacy|8|||
156376883|NCT01181895|564473838|FG001|Overall Study|Lack of Efficacy|9|||
156376884|NCT01181895|564473839|FG002|Overall Study|Lack of Efficacy|9|||
156376885|NCT01181895|564473837|FG000|Overall Study|Protocol Violation|2|||
156376886|NCT01181895|564473838|FG001|Overall Study|Protocol Violation|1|||
156376887|NCT01181895|564473839|FG002|Overall Study|Protocol Violation|0|||
156376888|NCT01181895|564473837|FG000|Overall Study|Lost to Follow-up|0|||
156376889|NCT01181895|564473838|FG001|Overall Study|Lost to Follow-up|1|||
156376890|NCT01181895|564473839|FG002|Overall Study|Lost to Follow-up|2|||
156376891|NCT01181895|564473837|FG000|Overall Study|Investigator Discretion|1|||
156376892|NCT01181895|564473838|FG001|Overall Study|Investigator Discretion|2|||
156376893|NCT01181895|564473839|FG002|Overall Study|Investigator Discretion|1|||
156376894|NCT01181895|564473837|FG000|Overall Study|Withdrawal by Subject|3|||
156376895|NCT01181895|564473838|FG001|Overall Study|Withdrawal by Subject|0|||
156376896|NCT01181895|564473839|FG002|Overall Study|Withdrawal by Subject|5|||
156376897|NCT02707640|564473842|FG000|Overall Study|Adverse Event|4|||
156376898|NCT02707640|564473843|FG001|Overall Study|Adverse Event|2|||
156376899|NCT02707640|564473842|FG000|Overall Study|Death|1|||
156376900|NCT02707640|564473843|FG001|Overall Study|Death|2|||
156376901|NCT02707640|564473842|FG000|Overall Study|Physician Decision|2|||
156376902|NCT02707640|564473843|FG001|Overall Study|Physician Decision|0|||
156376903|NCT02707640|564473842|FG000|Overall Study|Withdrawal by Subject|0|||
156376904|NCT02707640|564473843|FG001|Overall Study|Withdrawal by Subject|1|||
156376905|NCT02707640|564473842|FG000|Overall Study|Participant's Personal Decision|1|||
156376906|NCT02707640|564473843|FG001|Overall Study|Participant's Personal Decision|2|||
156376907|NCT02707640|564473842|FG000|Overall Study|Sponsor Discretion|1|||
156376908|NCT02707640|564473843|FG001|Overall Study|Sponsor Discretion|0|||
156376909|NCT00555438|564473844|FG000|10 Days Post-operative|Death|4|||
156376910|NCT00555438|564473844|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
156376911|NCT02517905|564473845|FG000|Overall Study|Lost to Follow-up|4|||
156376912|NCT02517905|564473846|FG001|Overall Study|Lost to Follow-up|0|||
156376913|NCT02517905|564473845|FG000|Overall Study|Withdrawal by Subject|4|||
156376914|NCT02517905|564473846|FG001|Overall Study|Withdrawal by Subject|0|||
156376915|NCT02517905|564473845|FG000|Overall Study|Screen failure|2|||
156376916|NCT02517905|564473846|FG001|Overall Study|Screen failure|2|||
156376917|NCT02758236|564473851|FG000|Overall Study|Investigator discretion|43|||
156376918|NCT05789875|564473852|FG000|Overall Study|Lost to Follow-up|6|||
156376919|NCT00023452|564473853|FG000|Overall Study|Ineligible for Study|163|||
156376920|NCT00023452|564473854|FG001|Overall Study|Ineligible for Study|159|||
156376921|NCT00023452|564473853|FG000|Overall Study|Out of Window|129|||
156376922|NCT00023452|564473854|FG001|Overall Study|Out of Window|69|||
156376923|NCT00023452|564473853|FG000|Overall Study|Death|2|||
156376924|NCT00023452|564473854|FG001|Overall Study|Death|0|||
156376925|NCT00023452|564473853|FG000|Overall Study|Withdrawal by Subject|66|||
156376926|NCT00023452|564473854|FG001|Overall Study|Withdrawal by Subject|54|||
156376927|NCT00023452|564473853|FG000|Overall Study|Adverse Event|139|||
156376928|NCT00023452|564473854|FG001|Overall Study|Adverse Event|196|||
156376929|NCT00023452|564473853|FG000|Overall Study|Lost to Follow-up|293|||
156376930|NCT00023452|564473854|FG001|Overall Study|Lost to Follow-up|60|||
156376931|NCT00023452|564473853|FG000|Overall Study|Physician Decision|49|||
156376932|NCT00023452|564473854|FG001|Overall Study|Physician Decision|21|||
156376933|NCT00023452|564473853|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
156376934|NCT00023452|564473854|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
156376935|NCT00023452|564473853|FG000|Overall Study|Pregnant|53|||
156376936|NCT00023452|564473854|FG001|Overall Study|Pregnant|20|||
156376937|NCT00023452|564473853|FG000|Overall Study|Other|204|||
156376938|NCT00023452|564473854|FG001|Overall Study|Other|69|||
156376939|NCT01994395|564473856|FG000|Overall Study|Withdrawal by Subject|1|||
156376940|NCT01994395|564473857|FG001|Overall Study|Withdrawal by Subject|2|||
156376941|NCT00459134|564473864|FG000|Overall Study|Physician Decision|1|||
156376942|NCT00459134|564473865|FG001|Overall Study|Physician Decision|1|||
156376943|NCT00459134|564473864|FG000|Overall Study|Withdrawal by Subject|8|||
156376944|NCT00459134|564473865|FG001|Overall Study|Withdrawal by Subject|7|||
156376945|NCT00459134|564473864|FG000|Overall Study|Lost to Follow-up|6|||
156376946|NCT00459134|564473865|FG001|Overall Study|Lost to Follow-up|7|||
156376947|NCT00459134|564473864|FG000|Overall Study|Surgery|1|||
156376948|NCT00459134|564473865|FG001|Overall Study|Surgery|2|||
156376949|NCT00459134|564473864|FG000|Overall Study|Toxicity|4|||
156376950|NCT00459134|564473865|FG001|Overall Study|Toxicity|5|||
156376951|NCT00459134|564473864|FG000|Overall Study|Progression|1|||
156376952|NCT00459134|564473865|FG001|Overall Study|Progression|0|||
156376953|NCT00459134|564473864|FG000|Overall Study|Multiple Reasons|2|||
156376954|NCT00459134|564473865|FG001|Overall Study|Multiple Reasons|3|||
156376955|NCT03333486|564473868|FG000|Overall Study|Withdrawal by Subject|1|||
156376956|NCT03333486|564473868|FG000|Overall Study|Lost to Follow-up|1|||
156376957|NCT01755416|564473873|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
156376958|NCT01755416|564473874|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
156376959|NCT03246529|564473875|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
156376960|NCT03246529|564473876|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
156376961|NCT03246529|564473877|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
156376962|NCT03246529|564473875|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
156376963|NCT03246529|564473876|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
156376964|NCT03246529|564473877|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
156376965|NCT03246529|564473875|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
156376966|NCT03246529|564473876|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
156376967|NCT03246529|564473877|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
156376968|NCT03246529|564473875|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
156376969|NCT03246529|564473876|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
156376970|NCT03246529|564473877|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
156376971|NCT03246529|564473875|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
156376972|NCT03246529|564473876|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
156376973|NCT03246529|564473877|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
156376974|NCT03246529|564473875|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
156376975|NCT03246529|564473876|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
156376976|NCT03246529|564473877|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
156376977|NCT03246529|564473875|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
156376978|NCT03246529|564473876|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
156376979|NCT03246529|564473877|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
156376980|NCT03246529|564473875|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
156376981|NCT03246529|564473876|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
156376982|NCT03246529|564473877|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
156376983|NCT03246529|564473875|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
156376984|NCT03246529|564473876|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
156376985|NCT03246529|564473877|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
156376986|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
156376987|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
156376988|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
156376989|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Death|1|||
156376990|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Death|0|||
156376991|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Death|0|||
156376992|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
156376993|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
156376994|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
156376995|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
156376996|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
156376997|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
156376998|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
156376999|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
156377000|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
156377001|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
156377002|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
156377003|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
156377004|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
156377005|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
156498699|NCT00267098|564919348|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
156498700|NCT00267098|564919349|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
156498701|NCT00267098|564919342|FG000|Overall Study|Site closure|0|||
156498702|NCT00267098|564919343|FG001|Overall Study|Site closure|0|||
156498703|NCT00267098|564919344|FG002|Overall Study|Site closure|0|||
156498704|NCT00267098|564919345|FG003|Overall Study|Site closure|1|||
156498705|NCT00267098|564919346|FG004|Overall Study|Site closure|0|||
156498706|NCT00267098|564919347|FG005|Overall Study|Site closure|1|||
156498707|NCT00267098|564919348|FG006|Overall Study|Site closure|1|||
156498708|NCT00267098|564919349|FG007|Overall Study|Site closure|0|||
156498709|NCT00267098|564919342|FG000|Overall Study|Explanted Medtronic device|0|||
156498710|NCT00267098|564919343|FG001|Overall Study|Explanted Medtronic device|0|||
156498711|NCT00267098|564919344|FG002|Overall Study|Explanted Medtronic device|0|||
156498712|NCT00267098|564919345|FG003|Overall Study|Explanted Medtronic device|1|||
156498713|NCT00267098|564919346|FG004|Overall Study|Explanted Medtronic device|0|||
156498714|NCT00267098|564919347|FG005|Overall Study|Explanted Medtronic device|0|||
156498715|NCT00267098|564919348|FG006|Overall Study|Explanted Medtronic device|0|||
156498716|NCT00267098|564919349|FG007|Overall Study|Explanted Medtronic device|0|||
156498717|NCT00267098|564919342|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
156498718|NCT00267098|564919343|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
156498719|NCT00267098|564919344|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
156498720|NCT00267098|564919345|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
156498721|NCT00267098|564919346|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
156498722|NCT00267098|564919347|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
156498723|NCT00267098|564919348|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
156498724|NCT00267098|564919349|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
156498725|NCT00267098|564919342|FG000|Overall Study|Subject listed for heart transplant|0|||
156498726|NCT00267098|564919343|FG001|Overall Study|Subject listed for heart transplant|0|||
156498727|NCT00267098|564919344|FG002|Overall Study|Subject listed for heart transplant|0|||
156498728|NCT00267098|564919345|FG003|Overall Study|Subject listed for heart transplant|0|||
156498729|NCT00267098|564919346|FG004|Overall Study|Subject listed for heart transplant|0|||
156498730|NCT00267098|564919347|FG005|Overall Study|Subject listed for heart transplant|0|||
156498731|NCT00267098|564919348|FG006|Overall Study|Subject listed for heart transplant|1|||
156498732|NCT00267098|564919349|FG007|Overall Study|Subject listed for heart transplant|0|||
156498733|NCT00267098|564919342|FG000|Overall Study|Sponsor withdrew subject|0|||
156498734|NCT00267098|564919343|FG001|Overall Study|Sponsor withdrew subject|0|||
156498735|NCT00267098|564919344|FG002|Overall Study|Sponsor withdrew subject|0|||
156498736|NCT00267098|564919345|FG003|Overall Study|Sponsor withdrew subject|1|||
156498737|NCT00267098|564919346|FG004|Overall Study|Sponsor withdrew subject|0|||
156498738|NCT00267098|564919347|FG005|Overall Study|Sponsor withdrew subject|0|||
156377006|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
156377007|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
156377008|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
156377009|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
156377010|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
156377011|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
156377012|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
156377013|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
156377014|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
156377015|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
156377016|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
156377017|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
156377018|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
156377019|NCT03655236|564473878|FG000|Subject Disposition in Part 1 Period|Other|0|||
156377020|NCT03655236|564473879|FG001|Subject Disposition in Part 1 Period|Other|2|||
156377021|NCT03655236|564473880|FG002|Subject Disposition in Part 1 Period|Other|2|||
156377022|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
156377023|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
156377024|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
156377025|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
156377026|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
156377027|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
156377028|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
156377029|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
156498739|NCT00267098|564919348|FG006|Overall Study|Sponsor withdrew subject|0|||
156498740|NCT00267098|564919349|FG007|Overall Study|Sponsor withdrew subject|0|||
156498741|NCT02031536|564919351|FG000|Overall Study|ineligible|1|||
156498742|NCT02031536|564919352|FG001|Overall Study|ineligible|0|||
156498743|NCT04211389|564919353|FG000|Overall Study|Adverse Event|1|||
156498744|NCT04211389|564919354|FG001|Overall Study|Adverse Event|2|||
156377030|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
156377031|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
156377032|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
156377033|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
156377034|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
156377035|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
156377036|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
156377037|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
156377038|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
156377039|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
156377040|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
156377041|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
156377042|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
156377043|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
156377044|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
156377045|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
156377046|NCT03655236|564473878|FG000|Subject Disposition in Part 2 Period|Other|1|||
156377047|NCT03655236|564473879|FG001|Subject Disposition in Part 2 Period|Other|0|||
156377048|NCT03655236|564473880|FG002|Subject Disposition in Part 2 Period|Other|0|||
156377049|NCT00432380|564475238|FG000|Overall Study|Migrated/moved from study area|3|||
156377050|NCT00432380|564475239|FG001|Overall Study|Migrated/moved from study area|4|||
156377051|NCT00432380|564475240|FG002|Overall Study|Migrated/moved from study area|1|||
156377052|NCT00432380|564475238|FG000|Overall Study|Adverse Event|1|||
156377053|NCT00432380|564475239|FG001|Overall Study|Adverse Event|0|||
156377054|NCT00432380|564475240|FG002|Overall Study|Adverse Event|0|||
156377055|NCT02805257|564475241|FG000|Overall Study|Lost to Follow-up|7|||
156377056|NCT02805257|564475242|FG001|Overall Study|Lost to Follow-up|6|||
156377057|NCT02805257|564475241|FG000|Overall Study|Death|0|||
156377058|NCT02805257|564475242|FG001|Overall Study|Death|1|||
156377059|NCT00524134|564475243|FG000|Overall Study|Withdrawal by Subject|1|||
156377060|NCT00524134|564475243|FG000|Overall Study|Physician Decision|1|||
156377061|NCT02627677|564475244|FG000|Overall Study|Adverse event (not progressive disease)|1|||
156377062|NCT02627677|564475245|FG001|Overall Study|Adverse event (not progressive disease)|4|||
156377063|NCT02627677|564475246|FG002|Overall Study|Adverse event (not progressive disease)|1|||
156377064|NCT02627677|564475244|FG000|Overall Study|Progressive disease|1|||
156377065|NCT02627677|564475245|FG001|Overall Study|Progressive disease|3|||
156377066|NCT02627677|564475246|FG002|Overall Study|Progressive disease|0|||
156377067|NCT02627677|564475244|FG000|Overall Study|Lack of Efficacy|1|||
156377068|NCT02627677|564475245|FG001|Overall Study|Lack of Efficacy|2|||
156377069|NCT02627677|564475246|FG002|Overall Study|Lack of Efficacy|0|||
156377070|NCT02627677|564475244|FG000|Overall Study|Lost to Follow-up|0|||
156377071|NCT02627677|564475245|FG001|Overall Study|Lost to Follow-up|0|||
156377072|NCT02627677|564475246|FG002|Overall Study|Lost to Follow-up|1|||
156377073|NCT02627677|564475244|FG000|Overall Study|Pregnancy|0|||
156377074|NCT02627677|564475245|FG001|Overall Study|Pregnancy|1|||
156377075|NCT02627677|564475246|FG002|Overall Study|Pregnancy|0|||
156377076|NCT02627677|564475244|FG000|Overall Study|Study Terminated by Sponsor|5|||
156377077|NCT02627677|564475245|FG001|Overall Study|Study Terminated by Sponsor|10|||
156377078|NCT02627677|564475246|FG002|Overall Study|Study Terminated by Sponsor|6|||
156377079|NCT02627677|564475244|FG000|Overall Study|Physician Decision|0|||
156377080|NCT02627677|564475245|FG001|Overall Study|Physician Decision|0|||
156377081|NCT02627677|564475246|FG002|Overall Study|Physician Decision|2|||
156377082|NCT02627677|564475244|FG000|Overall Study|Withdrawal by Subject|2|||
156377083|NCT02627677|564475245|FG001|Overall Study|Withdrawal by Subject|1|||
156377084|NCT02627677|564475246|FG002|Overall Study|Withdrawal by Subject|1|||
156377085|NCT02627677|564475244|FG000|Overall Study|Reason not Specified|0|||
156377086|NCT02627677|564475245|FG001|Overall Study|Reason not Specified|0|||
156377087|NCT02627677|564475246|FG002|Overall Study|Reason not Specified|1|||
156377088|NCT02627677|564475244|FG000|Overall Study|Randomized but not Treated|1|||
156377089|NCT02627677|564475245|FG001|Overall Study|Randomized but not Treated|0|||
156377090|NCT02627677|564475246|FG002|Overall Study|Randomized but not Treated|0|||
156377091|NCT03087591|564475249|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
156377092|NCT03087591|564475249|FG000|Overall Study|Withdrawal by Subject|1|||
156377093|NCT01073618|564475252|FG000|Overall Study|Death|208|||
156377094|NCT01073618|564475252|FG000|Overall Study|Adverse Event|19|||
156377095|NCT01073618|564475252|FG000|Overall Study|Other|80|||
156377096|NCT02696850|564475253|FG000|Overall Study|Withdrawal by Subject|3|||
156377097|NCT02696850|564475254|FG001|Overall Study|Withdrawal by Subject|3|||
156377098|NCT02696850|564475253|FG000|Overall Study|Lost to Follow-up|8|||
156377099|NCT02696850|564475254|FG001|Overall Study|Lost to Follow-up|5|||
156377100|NCT00097591|564475257|FG000|Overall Study|Withdrawal of consent|342|||
156377101|NCT00097591|564475258|FG001|Overall Study|Withdrawal of consent|323|||
156377102|NCT00097591|564475257|FG000|Overall Study|Less than 6 months on study drug|9|||
156498745|NCT04211389|564919353|FG000|Overall Study|Lost to Follow-up|15|||
156498746|NCT04211389|564919354|FG001|Overall Study|Lost to Follow-up|7|||
156498747|NCT04211389|564919353|FG000|Overall Study|Protocol Violation|0|||
156498748|NCT04211389|564919354|FG001|Overall Study|Protocol Violation|1|||
156498749|NCT04211389|564919353|FG000|Overall Study|Withdrawal by Subject|10|||
156498750|NCT04211389|564919354|FG001|Overall Study|Withdrawal by Subject|11|||
156498751|NCT04206085|564919356|FG000|Overall Study|Lost to Follow-up|0|||
156498752|NCT04206085|564919357|FG001|Overall Study|Lost to Follow-up|1|||
156498753|NCT04206085|564919358|FG002|Overall Study|Lost to Follow-up|0|||
156498754|NCT04206085|564919356|FG000|Overall Study|Lost to Follow-up|0|||
156498755|NCT04206085|564919357|FG001|Overall Study|Lost to Follow-up|0|||
156498756|NCT04206085|564919358|FG002|Overall Study|Lost to Follow-up|1|||
156498757|NCT01530087|564919359|FG000|Overall Study|Physician Decision|2|||
156498758|NCT02353871|564919360|FG000|Overall Study|Protocol deviation|0|||
156498759|NCT02353871|564919361|FG001|Overall Study|Protocol deviation|1|||
156498760|NCT02353871|564919360|FG000|Overall Study|Consent withdrawn|1|||
156498761|NCT02353871|564919361|FG001|Overall Study|Consent withdrawn|8|||
156498762|NCT02353871|564919360|FG000|Overall Study|Lost to Follow-up|2|||
156498763|NCT02353871|564919361|FG001|Overall Study|Lost to Follow-up|0|||
156498764|NCT05314374|564919362|FG000|Overall Study|Adverse Event|2|||
156498765|NCT05314374|564919363|FG001|Overall Study|Adverse Event|2|||
156498766|NCT02658175|564919366|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
156498767|NCT02658175|564919367|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
156498768|NCT02658175|564919368|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
156498769|NCT02658175|564919366|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
156498770|NCT02658175|564919367|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
156498771|NCT02658175|564919368|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
156498772|NCT02658175|564919366|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
156498773|NCT02658175|564919367|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
156498774|NCT02658175|564919368|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
156498775|NCT02658175|564919366|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
156498776|NCT02658175|564919367|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
156498777|NCT02658175|564919368|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
156498778|NCT02658175|564919366|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
156498779|NCT02658175|564919367|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
156498780|NCT02658175|564919368|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
156498781|NCT02658175|564919366|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
156498782|NCT02658175|564919367|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
156498783|NCT02658175|564919368|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
156498784|NCT02658175|564919366|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
156498785|NCT02658175|564919367|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
156498786|NCT02658175|564919368|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
156498787|NCT02658175|564919366|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
156498788|NCT02658175|564919367|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
156498789|NCT02658175|564919368|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
156498790|NCT02658175|564919366|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
156498791|NCT02658175|564919367|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
156498792|NCT02658175|564919368|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
156498793|NCT02658175|564919366|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
156498794|NCT02658175|564919367|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
156498795|NCT02658175|564919368|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
156498796|NCT05739994|564919376|FG000|Overall Study|Withdrawal by Subject|2|||
156498797|NCT05739994|564919377|FG001|Overall Study|Withdrawal by Subject|2|||
156498798|NCT05739994|564919378|FG002|Overall Study|Withdrawal by Subject|4|||
156498799|NCT02647645|564919379|FG000|Overall Study|Lost to Follow-up|2|||
156498800|NCT02647645|564919380|FG001|Overall Study|Lost to Follow-up|1|||
156498801|NCT04599907|564919383|FG000|Overall Study|Withdrawal by Subject|1|||
156498802|NCT04599907|564919384|FG001|Overall Study|Withdrawal by Subject|7|||
156498803|NCT04599907|564919385|FG002|Overall Study|Withdrawal by Subject|6|||
156498804|NCT04599907|564919383|FG000|Overall Study|Lost to Follow-up|0|||
156498805|NCT04599907|564919384|FG001|Overall Study|Lost to Follow-up|1|||
156498806|NCT04599907|564919385|FG002|Overall Study|Lost to Follow-up|0|||
156498807|NCT01466790|564919386|FG000|Overall Study|Adverse Event|1|||
156498808|NCT01466790|564919387|FG001|Overall Study|Adverse Event|0|||
156498809|NCT01466790|564919388|FG002|Overall Study|Adverse Event|0|||
156498810|NCT01466790|564919389|FG003|Overall Study|Adverse Event|0|||
156498811|NCT01466790|564919390|FG004|Overall Study|Adverse Event|2|||
156498812|NCT01466790|564919391|FG005|Overall Study|Adverse Event|0|||
156498813|NCT01466790|564919392|FG006|Overall Study|Adverse Event|0|||
156498814|NCT01466790|564919393|FG007|Overall Study|Adverse Event|0|||
156498815|NCT01466790|564919386|FG000|Overall Study|Lost to Follow-up|2|||
156498816|NCT01466790|564919387|FG001|Overall Study|Lost to Follow-up|0|||
156498817|NCT01466790|564919388|FG002|Overall Study|Lost to Follow-up|0|||
156498818|NCT01466790|564919389|FG003|Overall Study|Lost to Follow-up|0|||
156498819|NCT01466790|564919390|FG004|Overall Study|Lost to Follow-up|0|||
156498820|NCT01466790|564919391|FG005|Overall Study|Lost to Follow-up|0|||
156498821|NCT01466790|564919392|FG006|Overall Study|Lost to Follow-up|0|||
156498822|NCT01466790|564919393|FG007|Overall Study|Lost to Follow-up|0|||
156498823|NCT01466790|564919386|FG000|Overall Study|Withdrawal by Subject|1|||
156498824|NCT01466790|564919387|FG001|Overall Study|Withdrawal by Subject|1|||
156498825|NCT01466790|564919388|FG002|Overall Study|Withdrawal by Subject|0|||
156546742|NCT02915523|565094961|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
156546743|NCT02915523|565094962|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
156546744|NCT02915523|565094959|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
156546745|NCT02915523|565094960|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
156546746|NCT02915523|565094961|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
156377103|NCT00097591|564475258|FG001|Overall Study|Less than 6 months on study drug|7|||
156377104|NCT00097591|564475257|FG000|Overall Study|Unable to attend termination visit|53|||
156377105|NCT00097591|564475258|FG001|Overall Study|Unable to attend termination visit|51|||
156377106|NCT00097591|564475257|FG000|Overall Study|Lost to follow up|6|||
156377107|NCT00097591|564475258|FG001|Overall Study|Lost to follow up|10|||
156377108|NCT00097591|564475257|FG000|Overall Study|Other|0|||
156377109|NCT00097591|564475258|FG001|Overall Study|Other|3|||
156377110|NCT00807092|564475261|FG000|Overall Study|Adverse Event|0|||
156377111|NCT00807092|564475262|FG001|Overall Study|Adverse Event|1|||
156377112|NCT00807092|564475261|FG000|Overall Study|Protocol Violation|0|||
156377113|NCT00807092|564475262|FG001|Overall Study|Protocol Violation|2|||
156377114|NCT00807092|564475261|FG000|Overall Study|Withdrawal by Subject|1|||
156377115|NCT00807092|564475262|FG001|Overall Study|Withdrawal by Subject|0|||
156377116|NCT00807092|564475261|FG000|Overall Study|CGMS data collection failed|0|||
156377117|NCT00807092|564475262|FG001|Overall Study|CGMS data collection failed|1|||
156377118|NCT02114892|564475268|FG000|Overall Study|Lost to Follow-up|1|||
156377119|NCT02114892|564475269|FG001|Overall Study|Lost to Follow-up|2|||
156377120|NCT02013765|564475270|FG000|Overall Study|Trial was terminated by sponsor|1|||
156377121|NCT00718042|564475276|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156377122|NCT00718042|564475277|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156377123|NCT00718042|564475278|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156377124|NCT00718042|564475279|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156377125|NCT00718042|564475280|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
156377126|NCT00718042|564475281|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156377127|NCT00718042|564475276|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
156377128|NCT00718042|564475277|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
156377129|NCT00718042|564475278|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
156377130|NCT00718042|564475279|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
156377131|NCT00718042|564475280|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
156377132|NCT00718042|564475281|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
156377133|NCT00718042|564475276|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
156377134|NCT00718042|564475277|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
156377135|NCT00718042|564475278|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
156377136|NCT00718042|564475279|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
156377137|NCT00718042|564475280|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
156377138|NCT00718042|564475281|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
156377139|NCT00718042|564475276|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156377140|NCT00718042|564475277|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
156377141|NCT00718042|564475278|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156498826|NCT01466790|564919389|FG003|Overall Study|Withdrawal by Subject|0|||
156377142|NCT00718042|564475279|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156377143|NCT00718042|564475280|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156377144|NCT00718042|564475281|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156377145|NCT00718042|564475276|FG000|Donor Follow-up|Lost to Follow-up|13|||
156377146|NCT00718042|564475277|FG001|Donor Follow-up|Lost to Follow-up|0|||
156377147|NCT00718042|564475278|FG002|Donor Follow-up|Lost to Follow-up|0|||
156377148|NCT00718042|564475279|FG003|Donor Follow-up|Lost to Follow-up|0|||
156377149|NCT00718042|564475280|FG004|Donor Follow-up|Lost to Follow-up|19|||
156377150|NCT00718042|564475281|FG005|Donor Follow-up|Lost to Follow-up|0|||
156498827|NCT01466790|564919390|FG004|Overall Study|Withdrawal by Subject|1|||
156498828|NCT01466790|564919391|FG005|Overall Study|Withdrawal by Subject|0|||
156498829|NCT01466790|564919392|FG006|Overall Study|Withdrawal by Subject|1|||
156498830|NCT01466790|564919393|FG007|Overall Study|Withdrawal by Subject|1|||
156546747|NCT02915523|565094962|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
156377151|NCT04327934|564475282|FG000|Overall Study|Did not qualify|7|||
156377152|NCT04327934|564475283|FG001|Overall Study|Did not qualify|4|||
156377153|NCT04327934|564475282|FG000|Overall Study|Physician Decision|0|||
156377154|NCT04327934|564475283|FG001|Overall Study|Physician Decision|1|||
156377155|NCT02443298|564475284|FG000|Overall Study|Adverse Event|3|||
156377156|NCT02443298|564475285|FG001|Overall Study|Adverse Event|3|||
156377157|NCT02443298|564475284|FG000|Overall Study|Withdrawal by Subject|1|||
156377158|NCT02443298|564475285|FG001|Overall Study|Withdrawal by Subject|2|||
156377159|NCT03095417|564475286|FG000|Overall Study|missed|1|||
156377160|NCT03095417|564475287|FG001|Overall Study|missed|2|||
156377161|NCT03095417|564475288|FG002|Overall Study|missed|0|||
156377162|NCT03095417|564475289|FG003|Overall Study|missed|1|||
156377163|NCT03095417|564475286|FG000|Overall Study|Lost to Follow-up|2|||
156377164|NCT03095417|564475287|FG001|Overall Study|Lost to Follow-up|2|||
156377165|NCT03095417|564475288|FG002|Overall Study|Lost to Follow-up|1|||
156377166|NCT03095417|564475289|FG003|Overall Study|Lost to Follow-up|0|||
156377167|NCT03095417|564475286|FG000|Overall Study|refusal|0|||
156377168|NCT03095417|564475287|FG001|Overall Study|refusal|1|||
156377169|NCT03095417|564475288|FG002|Overall Study|refusal|0|||
156377170|NCT03095417|564475289|FG003|Overall Study|refusal|1|||
156377171|NCT03095417|564475286|FG000|Overall Study|Withdrawal by Subject|8|||
156377172|NCT03095417|564475287|FG001|Overall Study|Withdrawal by Subject|2|||
156377173|NCT03095417|564475288|FG002|Overall Study|Withdrawal by Subject|5|||
156377174|NCT03095417|564475289|FG003|Overall Study|Withdrawal by Subject|4|||
156377175|NCT03095417|564475286|FG000|Overall Study|Physician Decision|1|||
156377176|NCT03095417|564475287|FG001|Overall Study|Physician Decision|2|||
156377177|NCT03095417|564475288|FG002|Overall Study|Physician Decision|2|||
156377178|NCT03095417|564475289|FG003|Overall Study|Physician Decision|2|||
156377179|NCT03095417|564475286|FG000|Overall Study|Death|1|||
156377180|NCT03095417|564475287|FG001|Overall Study|Death|2|||
156377181|NCT03095417|564475288|FG002|Overall Study|Death|1|||
156377182|NCT03095417|564475289|FG003|Overall Study|Death|3|||
156377183|NCT01877421|564475290|FG000|Phase 2|Lost to Follow-up|0|||
156377184|NCT01877421|564475291|FG001|Phase 2|Lost to Follow-up|0|||
156377185|NCT01877421|564475292|FG002|Phase 2|Lost to Follow-up|0|||
156377186|NCT01877421|564475293|FG003|Phase 2|Lost to Follow-up|0|||
156377187|NCT01877421|564475294|FG004|Phase 2|Lost to Follow-up|0|||
156377188|NCT01877421|564475295|FG005|Phase 2|Lost to Follow-up|0|||
156377189|NCT01877421|564475296|FG006|Phase 2|Lost to Follow-up|1|||
156377190|NCT01877421|564475297|FG007|Phase 2|Lost to Follow-up|0|||
156377191|NCT01877421|564475298|FG008|Phase 2|Lost to Follow-up|0|||
156377192|NCT01877421|564475299|FG009|Phase 2|Lost to Follow-up|0|||
156377193|NCT01877421|564475300|FG010|Phase 2|Lost to Follow-up|0|||
156377194|NCT01877421|564475301|FG011|Phase 2|Lost to Follow-up|0|||
156377195|NCT01877421|564475302|FG012|Phase 2|Lost to Follow-up|0|||
156377196|NCT01877421|564475303|FG013|Phase 2|Lost to Follow-up|0|||
156377197|NCT01877421|564475304|FG014|Phase 2|Lost to Follow-up|0|||
156377198|NCT01877421|564475305|FG015|Phase 2|Lost to Follow-up|0|||
156377199|NCT01877421|564475306|FG016|Phase 2|Lost to Follow-up|0|||
156377200|NCT01877421|564475307|FG017|Phase 2|Lost to Follow-up|0|||
156377201|NCT01877421|564475290|FG000|Phase 2|Withdrawal by Subject|0|||
156377202|NCT01877421|564475291|FG001|Phase 2|Withdrawal by Subject|0|||
156377203|NCT01877421|564475292|FG002|Phase 2|Withdrawal by Subject|0|||
156377204|NCT01877421|564475293|FG003|Phase 2|Withdrawal by Subject|0|||
156377205|NCT01877421|564475294|FG004|Phase 2|Withdrawal by Subject|0|||
156377206|NCT01877421|564475295|FG005|Phase 2|Withdrawal by Subject|0|||
156377207|NCT01877421|564475296|FG006|Phase 2|Withdrawal by Subject|0|||
156377208|NCT01877421|564475297|FG007|Phase 2|Withdrawal by Subject|0|||
156377209|NCT01877421|564475298|FG008|Phase 2|Withdrawal by Subject|1|||
156377210|NCT01877421|564475299|FG009|Phase 2|Withdrawal by Subject|0|||
156377211|NCT01877421|564475300|FG010|Phase 2|Withdrawal by Subject|1|||
156377212|NCT01877421|564475301|FG011|Phase 2|Withdrawal by Subject|0|||
156377213|NCT01877421|564475302|FG012|Phase 2|Withdrawal by Subject|1|||
156377214|NCT01877421|564475303|FG013|Phase 2|Withdrawal by Subject|0|||
156377215|NCT01877421|564475304|FG014|Phase 2|Withdrawal by Subject|0|||
156377216|NCT01877421|564475305|FG015|Phase 2|Withdrawal by Subject|1|||
156377217|NCT01877421|564475306|FG016|Phase 2|Withdrawal by Subject|0|||
156377218|NCT01877421|564475307|FG017|Phase 2|Withdrawal by Subject|0|||
156377219|NCT01877421|564475290|FG000|Phase 2|Protocol Violation|0|||
156498831|NCT00356811|564919394|FG000|Overall Study|Death|35|||
156377220|NCT01877421|564475291|FG001|Phase 2|Protocol Violation|0|||
156377221|NCT01877421|564475292|FG002|Phase 2|Protocol Violation|0|||
156377222|NCT01877421|564475293|FG003|Phase 2|Protocol Violation|0|||
156377223|NCT01877421|564475294|FG004|Phase 2|Protocol Violation|0|||
156377224|NCT01877421|564475295|FG005|Phase 2|Protocol Violation|0|||
156377225|NCT01877421|564475296|FG006|Phase 2|Protocol Violation|0|||
156377226|NCT01877421|564475297|FG007|Phase 2|Protocol Violation|0|||
156377227|NCT01877421|564475298|FG008|Phase 2|Protocol Violation|0|||
156377228|NCT01877421|564475299|FG009|Phase 2|Protocol Violation|0|||
156377229|NCT01877421|564475300|FG010|Phase 2|Protocol Violation|1|||
156377230|NCT01877421|564475301|FG011|Phase 2|Protocol Violation|0|||
156377231|NCT01877421|564475302|FG012|Phase 2|Protocol Violation|0|||
156377232|NCT01877421|564475303|FG013|Phase 2|Protocol Violation|0|||
156377233|NCT01877421|564475304|FG014|Phase 2|Protocol Violation|0|||
156377234|NCT01877421|564475305|FG015|Phase 2|Protocol Violation|0|||
156377235|NCT01877421|564475306|FG016|Phase 2|Protocol Violation|0|||
156377236|NCT01877421|564475307|FG017|Phase 2|Protocol Violation|0|||
156498832|NCT00356811|564919394|FG000|Overall Study|Lost to Follow-up|2|||
156498833|NCT00356811|564919394|FG000|Overall Study|Withdrawal by Subject|6|||
156498834|NCT00356811|564919394|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
156498835|NCT00356811|564919394|FG000|Overall Study|Study Is Terminating|3|||
156498836|NCT00356811|564919394|FG000|Overall Study|Site Closed during Follow-up|2|||
156498837|NCT03668223|564919395|FG000|Overall Study|Death|10|||
156498838|NCT03668223|564919396|FG001|Overall Study|Death|5|||
156498839|NCT03668223|564919395|FG000|Overall Study|Lost to Follow-up|12|||
156498840|NCT03668223|564919396|FG001|Overall Study|Lost to Follow-up|12|||
156498841|NCT03668223|564919395|FG000|Overall Study|Withdrawal by Subject|8|||
156498842|NCT03668223|564919396|FG001|Overall Study|Withdrawal by Subject|3|||
156498843|NCT05502783|564919397|FG000|Overall Study|Lack of Efficacy|1|||
156498844|NCT04340843|564919398|FG000|Overall Study|Adverse Event|0|||
156498845|NCT04340843|564919399|FG001|Overall Study|Adverse Event|2|||
156498846|NCT04340843|564919398|FG000|Overall Study|Withdrawal by Subject|0|||
156498847|NCT04340843|564919399|FG001|Overall Study|Withdrawal by Subject|2|||
156498848|NCT03733899|564919400|FG000|Period 1|Protocol Violation|0|||
156498849|NCT03733899|564919401|FG001|Period 1|Protocol Violation|0|||
156498850|NCT03733899|564919402|FG002|Period 1|Protocol Violation|0|||
156498851|NCT03733899|564919403|FG003|Period 1|Protocol Violation|0|||
156498852|NCT03733899|564919404|FG004|Period 1|Protocol Violation|0|||
156498853|NCT03733899|564919405|FG005|Period 1|Protocol Violation|1|||
156498854|NCT03733899|564919400|FG000|Period 2|Unscuccessful Treatment|0|||
156498855|NCT03733899|564919401|FG001|Period 2|Unscuccessful Treatment|1|||
156498856|NCT03733899|564919402|FG002|Period 2|Unscuccessful Treatment|0|||
156498857|NCT03733899|564919403|FG003|Period 2|Unscuccessful Treatment|0|||
156498858|NCT03733899|564919404|FG004|Period 2|Unscuccessful Treatment|0|||
156498859|NCT03733899|564919405|FG005|Period 2|Unscuccessful Treatment|0|||
156498860|NCT03733899|564919400|FG000|Period 3|Withdrawal by Subject|1|||
156498861|NCT03733899|564919401|FG001|Period 3|Withdrawal by Subject|0|||
156498862|NCT03733899|564919402|FG002|Period 3|Withdrawal by Subject|0|||
156498863|NCT03733899|564919403|FG003|Period 3|Withdrawal by Subject|0|||
156498864|NCT03733899|564919404|FG004|Period 3|Withdrawal by Subject|0|||
156498865|NCT03733899|564919405|FG005|Period 3|Withdrawal by Subject|0|||
156377237|NCT01260922|564475309|FG000|First Intervention|Withdrawal by Subject|0|||
156377238|NCT01260922|564475310|FG001|First Intervention|Withdrawal by Subject|1|||
156377239|NCT01260922|564475309|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
156377240|NCT01260922|564475310|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
156377241|NCT01260922|564475309|FG000|Second Intervention|Emesis|0|||
156377242|NCT01260922|564475310|FG001|Second Intervention|Emesis|2|||
156377243|NCT01599650|564475311|FG000|Overall Study|Administrative issue|1|||
156377244|NCT01599650|564475312|FG001|Overall Study|Administrative issue|0|||
156377245|NCT01599650|564475313|FG002|Overall Study|Administrative issue|1|||
156377246|NCT01599650|564475311|FG000|Overall Study|Physician Decision|2|||
156377247|NCT01599650|564475312|FG001|Overall Study|Physician Decision|0|||
156377248|NCT01599650|564475313|FG002|Overall Study|Physician Decision|7|||
156377249|NCT01599650|564475311|FG000|Overall Study|Protocol Violation|0|||
156377250|NCT01599650|564475312|FG001|Overall Study|Protocol Violation|3|||
156377251|NCT01599650|564475313|FG002|Overall Study|Protocol Violation|0|||
156377252|NCT01599650|564475311|FG000|Overall Study|Death|2|||
156377253|NCT01599650|564475312|FG001|Overall Study|Death|1|||
156377254|NCT01599650|564475313|FG002|Overall Study|Death|2|||
156377255|NCT01599650|564475311|FG000|Overall Study|Lost to Follow-up|3|||
156377256|NCT01599650|564475312|FG001|Overall Study|Lost to Follow-up|3|||
156377257|NCT01599650|564475313|FG002|Overall Study|Lost to Follow-up|3|||
156377258|NCT01599650|564475311|FG000|Overall Study|Withdrawal by Subject|11|||
156377259|NCT01599650|564475312|FG001|Overall Study|Withdrawal by Subject|11|||
156377260|NCT01599650|564475313|FG002|Overall Study|Withdrawal by Subject|10|||
156377261|NCT01599650|564475311|FG000|Overall Study|Adverse Event|3|||
156377262|NCT01599650|564475312|FG001|Overall Study|Adverse Event|8|||
156377263|NCT01599650|564475313|FG002|Overall Study|Adverse Event|4|||
156377264|NCT01410110|564475314|FG000|Overall Study|Withdrawal by Subject|4|||
156377265|NCT01410110|564475315|FG001|Overall Study|Withdrawal by Subject|2|||
156377266|NCT01416805|564475316|FG000|Overall Study|Lost to Follow-up|4|||
156377267|NCT01416805|564475317|FG001|Overall Study|Lost to Follow-up|4|||
156377268|NCT01700946|564475324|FG000|Overall Study|Lost to Follow-up|1|||
156377269|NCT01700946|564475325|FG001|Overall Study|Lost to Follow-up|0|||
156377270|NCT01700946|564475324|FG000|Overall Study|Physician Decision|7|||
156377271|NCT01700946|564475325|FG001|Overall Study|Physician Decision|12|||
156377272|NCT01700946|564475324|FG000|Overall Study|Withdrawal by Subject|0|||
156377273|NCT01700946|564475325|FG001|Overall Study|Withdrawal by Subject|2|||
156377274|NCT01700946|564475324|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
156377275|NCT01700946|564475325|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
156377276|NCT01700946|564475324|FG000|Overall Study|Relapse|2|||
156377277|NCT01700946|564475325|FG001|Overall Study|Relapse|1|||
156377278|NCT01700946|564475324|FG000|Overall Study|Unacceptable toxicity|1|||
156377279|NCT01700946|564475325|FG001|Overall Study|Unacceptable toxicity|0|||
156377280|NCT00684424|564475330|FG000|Overall Study|Adverse Event|1|||
156377281|NCT00684424|564475330|FG000|Overall Study|Lost to Follow-up|2|||
156377282|NCT00684424|564475330|FG000|Overall Study|Other|2|||
156377283|NCT01723904|564475335|FG000|Overall Study|Noncompliant|3|||
156377284|NCT01723904|564475335|FG000|Overall Study|Adverse Event|5|||
156377285|NCT01723904|564475335|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
156377286|NCT00887341|564475346|FG000|Overall Study|Refused treatment|1|||
156377287|NCT00887341|564475347|FG001|Overall Study|Refused treatment|0|||
156377288|NCT00887341|564475346|FG000|Overall Study|Withdrawal by Subject|1|||
156377289|NCT00887341|564475347|FG001|Overall Study|Withdrawal by Subject|1|||
156377290|NCT00887341|564475346|FG000|Overall Study|Adverse Event|0|||
156377291|NCT00887341|564475347|FG001|Overall Study|Adverse Event|1|||
156377292|NCT00887341|564475346|FG000|Overall Study|Lost to Follow-up|0|||
156377293|NCT00887341|564475347|FG001|Overall Study|Lost to Follow-up|1|||
156377294|NCT03062891|564475348|FG000|Overall Study|Withdrawal by Subject|2|||
156377295|NCT03062891|564475349|FG001|Overall Study|Withdrawal by Subject|0|||
156377296|NCT03062891|564475348|FG000|Overall Study|Lost to Follow-up|50|||
156377297|NCT03062891|564475349|FG001|Overall Study|Lost to Follow-up|38|||
156377298|NCT03509948|564475353|FG000|Overall Study|Protocol Violation|0|||
156377299|NCT03509948|564475354|FG001|Overall Study|Protocol Violation|1|||
156377300|NCT03221257|564475355|FG000|Overall Study|Lost to Follow-up|0|||
156377301|NCT03221257|564475356|FG001|Overall Study|Lost to Follow-up|1|||
156377302|NCT03221257|564475355|FG000|Overall Study|Withdrawal by Subject|1|||
156377303|NCT03221257|564475356|FG001|Overall Study|Withdrawal by Subject|1|||
156377304|NCT01334866|564475365|FG000|Overall Study|Withdrawal by Subject|10|||
156377305|NCT01334866|564475365|FG000|Overall Study|Lost to Follow-up|3|||
156377306|NCT01334866|564475365|FG000|Overall Study|Physician Decision|3|||
156377307|NCT01334866|564475365|FG000|Overall Study|medically necessary prior to procedure|2|||
156377308|NCT01334866|564475365|FG000|Overall Study|medically necessary post-procedure|1|||
156377309|NCT00958880|564475377|FG000|Overall Study|Lost to Follow-up|2|||
156377310|NCT00958880|564475378|FG001|Overall Study|Lost to Follow-up|2|||
156377311|NCT01971346|564475379|FG000|Overall Study|Protocol Violation|3|||
156377312|NCT01971346|564475379|FG000|Overall Study|Lost to Follow-up|2|||
156377313|NCT01971346|564475379|FG000|Overall Study|Withdrawal by Subject|2|||
156377314|NCT01971346|564475379|FG000|Overall Study|Physician Decision|1|||
156377315|NCT04187196|564475382|FG000|Overall Study|Screen Failure|2|||
156377316|NCT04187196|564475383|FG001|Overall Study|Screen Failure|0|||
156377317|NCT01687166|564475384|FG000|Overall Study|Attempt subject|2|||
156377318|NCT01687166|564475385|FG001|Overall Study|Attempt subject|3|||
156377319|NCT01687166|564475386|FG002|Overall Study|Attempt subject|2|||
156377320|NCT01687166|564475387|FG003|Overall Study|Attempt subject|0|||
156377321|NCT01687166|564475384|FG000|Overall Study|Did not meet eligibility criteria|4|||
156377322|NCT01687166|564475385|FG001|Overall Study|Did not meet eligibility criteria|6|||
156377323|NCT01687166|564475386|FG002|Overall Study|Did not meet eligibility criteria|1|||
156377324|NCT01687166|564475387|FG003|Overall Study|Did not meet eligibility criteria|1|||
156377325|NCT01687166|564475384|FG000|Overall Study|Adverse Event|2|||
156377326|NCT01687166|564475385|FG001|Overall Study|Adverse Event|1|||
156377327|NCT01687166|564475386|FG002|Overall Study|Adverse Event|0|||
156377328|NCT01687166|564475387|FG003|Overall Study|Adverse Event|0|||
156377329|NCT01687166|564475384|FG000|Overall Study|Physician Decision|3|||
156377330|NCT01687166|564475385|FG001|Overall Study|Physician Decision|2|||
156377331|NCT01687166|564475386|FG002|Overall Study|Physician Decision|1|||
156377332|NCT01687166|564475387|FG003|Overall Study|Physician Decision|0|||
156377333|NCT01687166|564475384|FG000|Overall Study|Withdrawal by Subject|11|||
156377334|NCT01687166|564475385|FG001|Overall Study|Withdrawal by Subject|4|||
156377335|NCT01687166|564475386|FG002|Overall Study|Withdrawal by Subject|3|||
156377336|NCT01687166|564475387|FG003|Overall Study|Withdrawal by Subject|0|||
156377337|NCT01687166|564475384|FG000|Overall Study|Lost to Follow-up|2|||
156546748|NCT00708500|565094966|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
156377338|NCT01687166|564475385|FG001|Overall Study|Lost to Follow-up|5|||
156377339|NCT01687166|564475386|FG002|Overall Study|Lost to Follow-up|1|||
156377340|NCT01687166|564475387|FG003|Overall Study|Lost to Follow-up|0|||
156377341|NCT01687166|564475384|FG000|Overall Study|Equipment/Device Availability|0|||
156377342|NCT01687166|564475385|FG001|Overall Study|Equipment/Device Availability|1|||
156377343|NCT01687166|564475386|FG002|Overall Study|Equipment/Device Availability|0|||
156377344|NCT01687166|564475387|FG003|Overall Study|Equipment/Device Availability|0|||
156377345|NCT01687166|564475384|FG000|Overall Study|Death|1|||
156377346|NCT01687166|564475385|FG001|Overall Study|Death|1|||
156377347|NCT01687166|564475386|FG002|Overall Study|Death|0|||
156377348|NCT01687166|564475387|FG003|Overall Study|Death|0|||
156377349|NCT01687166|564475384|FG000|Overall Study|Protocol Violation|1|||
156377350|NCT01687166|564475385|FG001|Overall Study|Protocol Violation|1|||
156377351|NCT01687166|564475386|FG002|Overall Study|Protocol Violation|1|||
156377352|NCT01687166|564475387|FG003|Overall Study|Protocol Violation|0|||
156377353|NCT01687166|564475384|FG000|Overall Study|Subject moved out of state|0|||
156377354|NCT01687166|564475385|FG001|Overall Study|Subject moved out of state|1|||
156377355|NCT01687166|564475386|FG002|Overall Study|Subject moved out of state|0|||
156377356|NCT01687166|564475387|FG003|Overall Study|Subject moved out of state|0|||
156377357|NCT01687166|564475384|FG000|Overall Study|Patient unable to be compliant|1|||
156377358|NCT01687166|564475385|FG001|Overall Study|Patient unable to be compliant|0|||
156377359|NCT01687166|564475386|FG002|Overall Study|Patient unable to be compliant|0|||
156377360|NCT01687166|564475387|FG003|Overall Study|Patient unable to be compliant|0|||
156377361|NCT01687166|564475384|FG000|Overall Study|Physician choice to use different device|1|||
156377362|NCT01687166|564475385|FG001|Overall Study|Physician choice to use different device|2|||
156377363|NCT01687166|564475386|FG002|Overall Study|Physician choice to use different device|4|||
156377364|NCT01687166|564475387|FG003|Overall Study|Physician choice to use different device|0|||
156377365|NCT01687166|564475384|FG000|Overall Study|Insurance|0|||
156377366|NCT01687166|564475385|FG001|Overall Study|Insurance|0|||
156377367|NCT01687166|564475386|FG002|Overall Study|Insurance|1|||
156377368|NCT01687166|564475387|FG003|Overall Study|Insurance|1|||
156377369|NCT02755831|564475388|FG000|Overall Study|Lost to Follow-up|3|||
156377370|NCT02755831|564475389|FG001|Overall Study|Lost to Follow-up|3|||
156377371|NCT02296112|564475390|FG000|Overall Study|Disease progression|7|||
156377372|NCT02296112|564475390|FG000|Overall Study|Toxicity|1|||
156377373|NCT02296112|564475390|FG000|Overall Study|Began an alternate therapy|1|||
156377374|NCT00298831|564475391|FG000|Overall Study|Adverse Event|1|||
156377375|NCT00298831|564475391|FG000|Overall Study|Lost to Follow-up|3|||
156377376|NCT00298831|564475391|FG000|Overall Study|Withdrawal by Subject|1|||
156377377|NCT00298831|564475391|FG000|Overall Study|Participants did not receive treatment|27|||
156377378|NCT01516879|564475392|FG000|Overall Study|Withdrawal by Subject|9|||
156377379|NCT01516879|564475393|FG001|Overall Study|Withdrawal by Subject|11|||
156377380|NCT01516879|564475392|FG000|Overall Study|Death|0|||
156377381|NCT01516879|564475393|FG001|Overall Study|Death|2|||
156377382|NCT01516879|564475392|FG000|Overall Study|Lost to Follow-up|2|||
156377383|NCT01516879|564475393|FG001|Overall Study|Lost to Follow-up|11|||
156377384|NCT01516879|564475392|FG000|Overall Study|Other|5|||
156377385|NCT01516879|564475393|FG001|Overall Study|Other|10|||
156377386|NCT01720069|564475394|FG000|Overall Study|Could not use e-diary correctly|0|||
156377387|NCT01720069|564475395|FG001|Overall Study|Could not use e-diary correctly|1|||
156377388|NCT01720069|564475396|FG002|Overall Study|Could not use e-diary correctly|1|||
156377389|NCT01720069|564475394|FG000|Overall Study|Randomised without baseline values|0|||
156377390|NCT01720069|564475395|FG001|Overall Study|Randomised without baseline values|0|||
156377391|NCT01720069|564475396|FG002|Overall Study|Randomised without baseline values|1|||
156546749|NCT00708500|565094967|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
156377392|NCT01720069|564475394|FG000|Overall Study|Adverse Event|0|||
156377393|NCT01720069|564475395|FG001|Overall Study|Adverse Event|0|||
156377394|NCT01720069|564475396|FG002|Overall Study|Adverse Event|1|||
156377395|NCT01720069|564475394|FG000|Overall Study|Lack of Efficacy|0|||
156377396|NCT01720069|564475395|FG001|Overall Study|Lack of Efficacy|4|||
156377397|NCT01720069|564475396|FG002|Overall Study|Lack of Efficacy|0|||
156377398|NCT01720069|564475394|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
156377399|NCT01720069|564475395|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
156377400|NCT01720069|564475396|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
156377401|NCT01720069|564475394|FG000|Overall Study|Withdrawal by Subject|0|||
156377402|NCT01720069|564475395|FG001|Overall Study|Withdrawal by Subject|2|||
156377403|NCT01720069|564475396|FG002|Overall Study|Withdrawal by Subject|1|||
156377404|NCT01720069|564475394|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
156546750|NCT00708500|565094968|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
156377405|NCT01720069|564475395|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
156377406|NCT01720069|564475396|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
156377407|NCT01720069|564475394|FG000|Overall Study|Non-compliance on using e-diary|0|||
156377408|NCT01720069|564475395|FG001|Overall Study|Non-compliance on using e-diary|0|||
156377409|NCT01720069|564475396|FG002|Overall Study|Non-compliance on using e-diary|1|||
156546751|NCT00708500|565094966|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
156377410|NCT01720069|564475394|FG000|Overall Study|Lost to Follow-up|0|||
156377411|NCT01720069|564475395|FG001|Overall Study|Lost to Follow-up|0|||
156377412|NCT01720069|564475396|FG002|Overall Study|Lost to Follow-up|1|||
156377413|NCT04568122|564475397|FG000|Overall Study|Lost to Follow-up|48|||
156377414|NCT04568122|564475398|FG001|Overall Study|Lost to Follow-up|44|||
156377415|NCT04568122|564475399|FG002|Overall Study|Lost to Follow-up|4|||
156377416|NCT04568122|564475400|FG003|Overall Study|Lost to Follow-up|0|||
156377417|NCT04568122|564475401|FG004|Overall Study|Lost to Follow-up|0|||
156377418|NCT06748040|564475411|FG000|Overall Study|Death|3|||
156377419|NCT06748040|564475412|FG001|Overall Study|Death|4|||
156377420|NCT06748040|564475411|FG000|Overall Study|Lost to Follow-up|134|||
156377421|NCT06748040|564475412|FG001|Overall Study|Lost to Follow-up|132|||
156377422|NCT06748040|564475411|FG000|Overall Study|Withdrawal by Subject|3|||
156377423|NCT06748040|564475412|FG001|Overall Study|Withdrawal by Subject|5|||
156377424|NCT03136068|564477272|FG000|Overall Study|Lost to Follow-up|1|||
156377425|NCT03136068|564477273|FG001|Overall Study|Lost to Follow-up|1|||
156377426|NCT03136068|564477272|FG000|Overall Study|Protocol Violation|1|||
156377427|NCT03136068|564477273|FG001|Overall Study|Protocol Violation|0|||
156377428|NCT01071395|564477284|FG000|Overall Study|Withdrawal by Subject|2|||
156377429|NCT01071395|564477285|FG001|Overall Study|Withdrawal by Subject|1|||
156377430|NCT01071395|564477284|FG000|Overall Study|Adverse Event|3|||
156377431|NCT01071395|564477285|FG001|Overall Study|Adverse Event|1|||
156377432|NCT00612066|564477286|FG000|Overall Study|Adverse Event|1|||
156377433|NCT01043874|564477290|FG000|Overall Study|Adverse Event|3|||
156377434|NCT01043874|564477290|FG000|Overall Study|Withdrawal by Subject|1|||
156377435|NCT01043874|564477290|FG000|Overall Study|Lack of Efficacy|1|||
156377436|NCT01043874|564477290|FG000|Overall Study|Administrative Problems|1|||
156377437|NCT03422003|564477291|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
156377438|NCT03422003|564477292|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
156377439|NCT03422003|564477291|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
156377440|NCT03422003|564477292|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
156377441|NCT01337089|564477293|FG000|Overall Study|Adverse Event|237|||
156377442|NCT01337089|564477293|FG000|Overall Study|Withdrawal by Subject|129|||
156377443|NCT01337089|564477293|FG000|Overall Study|Withdrawal by Investigator|33|||
156377444|NCT01337089|564477293|FG000|Overall Study|Met Withdrawal Criteria|3|||
156377445|NCT01337089|564477293|FG000|Overall Study|Lost to Follow-up|2|||
156377446|NCT01404312|564477294|FG000|Overall Study|Death|21|||
156377447|NCT01404312|564477295|FG001|Overall Study|Death|27|||
156377448|NCT01404312|564477294|FG000|Overall Study|Withdrawal by Subject|15|||
156377449|NCT01404312|564477295|FG001|Overall Study|Withdrawal by Subject|18|||
156377450|NCT01404312|564477294|FG000|Overall Study|Participant Unable to get to clinic|93|||
156546752|NCT00708500|565094967|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
156377451|NCT01404312|564477295|FG001|Overall Study|Participant Unable to get to clinic|103|||
156377452|NCT01404312|564477294|FG000|Overall Study|Lost to Follow-up|115|||
156377453|NCT01404312|564477295|FG001|Overall Study|Lost to Follow-up|111|||
156377454|NCT01404312|564477294|FG000|Overall Study|Site closed|22|||
156377455|NCT01404312|564477295|FG001|Overall Study|Site closed|21|||
156377456|NCT01404312|564477294|FG000|Overall Study|Participant not willing to adhere to req|31|||
156377457|NCT01404312|564477295|FG001|Overall Study|Participant not willing to adhere to req|29|||
156546753|NCT00708500|565094968|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
156546754|NCT00708500|565094966|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
156377458|NCT01404312|564477294|FG000|Overall Study|Severe debilitation, unable to continue|1|||
156377459|NCT01404312|564477295|FG001|Overall Study|Severe debilitation, unable to continue|2|||
156377460|NCT04419493|564477296|FG000|Wash-out After Period 1|Adverse Event|1|||
156377461|NCT04419493|564477297|FG001|Wash-out After Period 1|Adverse Event|2|||
156377462|NCT04419493|564477298|FG002|Wash-out After Period 1|Adverse Event|1|||
156377463|NCT04419493|564477299|FG003|Wash-out After Period 1|Adverse Event|0|||
156377464|NCT03266588|564477300|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
156377465|NCT03266588|564477301|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
156377466|NCT03266588|564477302|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
156377467|NCT03266588|564477300|FG000|Observational Period|Withdrawal by Subject|44|||
156377468|NCT03266588|564477301|FG001|Observational Period|Withdrawal by Subject|22|||
156377469|NCT03266588|564477302|FG002|Observational Period|Withdrawal by Subject|13|||
156377470|NCT03266588|564477300|FG000|Observational Period|Non-compliance|18|||
156377471|NCT03266588|564477301|FG001|Observational Period|Non-compliance|12|||
156377472|NCT03266588|564477302|FG002|Observational Period|Non-compliance|10|||
156377473|NCT03266588|564477300|FG000|Observational Period|Lost to Follow-up|8|||
156377474|NCT03266588|564477301|FG001|Observational Period|Lost to Follow-up|12|||
156377475|NCT03266588|564477302|FG002|Observational Period|Lost to Follow-up|4|||
156377476|NCT03266588|564477300|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
156377477|NCT03266588|564477301|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
156377478|NCT03266588|564477302|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
156377479|NCT03266588|564477300|FG000|Observational Period|Protocol Deviation|1|||
156377480|NCT03266588|564477301|FG001|Observational Period|Protocol Deviation|0|||
156377481|NCT03266588|564477302|FG002|Observational Period|Protocol Deviation|0|||
156377482|NCT03266588|564477300|FG000|Observational Period|Other Reasons|3|||
156377483|NCT03266588|564477301|FG001|Observational Period|Other Reasons|0|||
156377484|NCT03266588|564477302|FG002|Observational Period|Other Reasons|1|||
156377485|NCT03266588|564477300|FG000|Long-term Treatment Period|Adverse Event|33|||
156377486|NCT03266588|564477301|FG001|Long-term Treatment Period|Adverse Event|17|||
156377487|NCT03266588|564477302|FG002|Long-term Treatment Period|Adverse Event|8|||
156377488|NCT03266588|564477300|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
156377489|NCT03266588|564477301|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
156377490|NCT03266588|564477302|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
156377491|NCT03266588|564477300|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
156377492|NCT03266588|564477301|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
156377493|NCT03266588|564477302|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
156377494|NCT03266588|564477300|FG000|Long-term Treatment Period|Non-Compliance|126|||
156377495|NCT03266588|564477301|FG001|Long-term Treatment Period|Non-Compliance|57|||
156377496|NCT03266588|564477302|FG002|Long-term Treatment Period|Non-Compliance|7|||
156377497|NCT03266588|564477300|FG000|Long-term Treatment Period|Pregnancy|11|||
156377498|NCT03266588|564477301|FG001|Long-term Treatment Period|Pregnancy|5|||
156377499|NCT03266588|564477302|FG002|Long-term Treatment Period|Pregnancy|0|||
156377500|NCT03266588|564477300|FG000|Long-term Treatment Period|Protocol Deviation|17|||
156377501|NCT03266588|564477301|FG001|Long-term Treatment Period|Protocol Deviation|10|||
156377502|NCT03266588|564477302|FG002|Long-term Treatment Period|Protocol Deviation|4|||
156377503|NCT03266588|564477300|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
156377504|NCT03266588|564477301|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
156377505|NCT03266588|564477302|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
156377506|NCT03266588|564477300|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
156377507|NCT03266588|564477301|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
156377508|NCT03266588|564477302|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
156377509|NCT03266588|564477300|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
156377510|NCT03266588|564477301|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
156377511|NCT03266588|564477302|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
156377512|NCT03266588|564477300|FG000|Long-term Treatment Period|Other Reasons|5|||
156377513|NCT03266588|564477301|FG001|Long-term Treatment Period|Other Reasons|0|||
156377514|NCT03266588|564477302|FG002|Long-term Treatment Period|Other Reasons|0|||
156377515|NCT03266588|564477300|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
156377516|NCT03266588|564477301|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
156377517|NCT03266588|564477302|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
156377518|NCT00673049|564477306|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
156377519|NCT00673049|564477307|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
156377520|NCT00673049|564477308|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
156377521|NCT00673049|564477309|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
156377522|NCT00673049|564477306|FG000|Before Progression on Erlotinib|Death|235|||
156377523|NCT00673049|564477307|FG001|Before Progression on Erlotinib|Death|167|||
156377524|NCT00673049|564477308|FG002|Before Progression on Erlotinib|Death|1|||
156377525|NCT00673049|564477309|FG003|Before Progression on Erlotinib|Death|0|||
156377526|NCT00673049|564477306|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
156377527|NCT00673049|564477307|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
156546755|NCT00708500|565094967|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
156546756|NCT00708500|565094968|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
156377528|NCT00673049|564477308|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
156377529|NCT00673049|564477309|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
156377530|NCT00673049|564477306|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
156377531|NCT00673049|564477307|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
156546757|NCT00708500|565094966|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
156377532|NCT00673049|564477308|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
156377533|NCT00673049|564477309|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
156377534|NCT00673049|564477306|FG000|Before Progression on Erlotinib|Other|1|||
156377535|NCT00673049|564477307|FG001|Before Progression on Erlotinib|Other|2|||
156377536|NCT00673049|564477308|FG002|Before Progression on Erlotinib|Other|0|||
156377537|NCT00673049|564477309|FG003|Before Progression on Erlotinib|Other|0|||
156377538|NCT00673049|564477306|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
156377539|NCT00673049|564477307|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
156377540|NCT00673049|564477308|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
156377541|NCT00673049|564477309|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
156377542|NCT00673049|564477306|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
156377543|NCT00673049|564477307|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
156377544|NCT00673049|564477308|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
156377545|NCT00673049|564477309|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
156377546|NCT00673049|564477306|FG000|After Progression on Erlotinib|Death|0|||
156377547|NCT00673049|564477307|FG001|After Progression on Erlotinib|Death|0|||
156377548|NCT00673049|564477308|FG002|After Progression on Erlotinib|Death|0|||
156377549|NCT00673049|564477309|FG003|After Progression on Erlotinib|Death|71|||
156377550|NCT00673049|564477306|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
156377551|NCT00673049|564477307|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
156377552|NCT00673049|564477308|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
156377553|NCT00673049|564477309|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
156377554|NCT00673049|564477306|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
156377555|NCT00673049|564477307|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
156377556|NCT00673049|564477308|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
156377557|NCT00673049|564477309|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
156377558|NCT00673049|564477306|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
156377559|NCT00673049|564477307|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
156377560|NCT00673049|564477308|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
156377561|NCT00673049|564477309|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
156377562|NCT01933334|564477316|FG000|Overall Study|Adverse Event|5|||
156377563|NCT01933334|564477317|FG001|Overall Study|Adverse Event|1|||
156377564|NCT01933334|564477316|FG000|Overall Study|Withdrawal by Subject|0|||
156377565|NCT01933334|564477317|FG001|Overall Study|Withdrawal by Subject|1|||
156377566|NCT00767000|564477318|FG000|54-week Study|Adverse Event|4|||
156377567|NCT00767000|564477319|FG001|54-week Study|Adverse Event|6|||
156377568|NCT00767000|564477320|FG002|54-week Study|Adverse Event|6|||
156377569|NCT00767000|564477321|FG003|54-week Study|Adverse Event|8|||
156377570|NCT00767000|564477322|FG004|54-week Study|Adverse Event|4|||
156377571|NCT00767000|564477318|FG000|54-week Study|Creaninine/creatinine clearance|2|||
156377572|NCT00767000|564477319|FG001|54-week Study|Creaninine/creatinine clearance|1|||
156377573|NCT00767000|564477320|FG002|54-week Study|Creaninine/creatinine clearance|2|||
156377574|NCT00767000|564477321|FG003|54-week Study|Creaninine/creatinine clearance|2|||
156377575|NCT00767000|564477322|FG004|54-week Study|Creaninine/creatinine clearance|4|||
156377576|NCT00767000|564477318|FG000|54-week Study|Hyperglycemia|0|||
156377577|NCT00767000|564477319|FG001|54-week Study|Hyperglycemia|0|||
156377578|NCT00767000|564477320|FG002|54-week Study|Hyperglycemia|1|||
156377579|NCT00767000|564477321|FG003|54-week Study|Hyperglycemia|0|||
156377580|NCT00767000|564477322|FG004|54-week Study|Hyperglycemia|1|||
156377581|NCT00767000|564477318|FG000|54-week Study|Hypoglycemia|0|||
156377582|NCT00767000|564477319|FG001|54-week Study|Hypoglycemia|1|||
156377583|NCT00767000|564477320|FG002|54-week Study|Hypoglycemia|0|||
156377584|NCT00767000|564477321|FG003|54-week Study|Hypoglycemia|0|||
156377585|NCT00767000|564477322|FG004|54-week Study|Hypoglycemia|0|||
156377586|NCT00767000|564477318|FG000|54-week Study|Interruption of study medication|0|||
156377587|NCT00767000|564477319|FG001|54-week Study|Interruption of study medication|0|||
156377588|NCT00767000|564477320|FG002|54-week Study|Interruption of study medication|1|||
156377589|NCT00767000|564477321|FG003|54-week Study|Interruption of study medication|0|||
156377590|NCT00767000|564477322|FG004|54-week Study|Interruption of study medication|0|||
156377591|NCT00767000|564477318|FG000|54-week Study|Lack of Efficacy|2|||
156377592|NCT00767000|564477319|FG001|54-week Study|Lack of Efficacy|0|||
156377593|NCT00767000|564477320|FG002|54-week Study|Lack of Efficacy|1|||
156377594|NCT00767000|564477321|FG003|54-week Study|Lack of Efficacy|0|||
156377595|NCT00767000|564477322|FG004|54-week Study|Lack of Efficacy|5|||
156377596|NCT00767000|564477318|FG000|54-week Study|Lost to Follow-up|4|||
156377597|NCT00767000|564477319|FG001|54-week Study|Lost to Follow-up|0|||
156377598|NCT00767000|564477320|FG002|54-week Study|Lost to Follow-up|1|||
156377599|NCT00767000|564477321|FG003|54-week Study|Lost to Follow-up|4|||
156377600|NCT00767000|564477322|FG004|54-week Study|Lost to Follow-up|2|||
156377601|NCT00767000|564477318|FG000|54-week Study|Physician Decision|4|||
156377602|NCT00767000|564477319|FG001|54-week Study|Physician Decision|0|||
156546758|NCT00708500|565094967|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
156377603|NCT00767000|564477320|FG002|54-week Study|Physician Decision|1|||
156546759|NCT00708500|565094968|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
156377604|NCT00767000|564477321|FG003|54-week Study|Physician Decision|1|||
156377605|NCT00767000|564477322|FG004|54-week Study|Physician Decision|1|||
156377606|NCT00767000|564477318|FG000|54-week Study|Progressive disease|0|||
156377607|NCT00767000|564477319|FG001|54-week Study|Progressive disease|0|||
156377608|NCT00767000|564477320|FG002|54-week Study|Progressive disease|1|||
156377609|NCT00767000|564477321|FG003|54-week Study|Progressive disease|0|||
156377610|NCT00767000|564477322|FG004|54-week Study|Progressive disease|0|||
156377611|NCT00767000|564477318|FG000|54-week Study|Protocol Violation|0|||
156377612|NCT00767000|564477319|FG001|54-week Study|Protocol Violation|0|||
156377613|NCT00767000|564477320|FG002|54-week Study|Protocol Violation|1|||
156377614|NCT00767000|564477321|FG003|54-week Study|Protocol Violation|2|||
156377615|NCT00767000|564477322|FG004|54-week Study|Protocol Violation|0|||
156377616|NCT00767000|564477318|FG000|54-week Study|Withdrawal by Subject|2|||
156377617|NCT00767000|564477319|FG001|54-week Study|Withdrawal by Subject|3|||
156377618|NCT00767000|564477320|FG002|54-week Study|Withdrawal by Subject|5|||
156377619|NCT00767000|564477321|FG003|54-week Study|Withdrawal by Subject|11|||
156377620|NCT00767000|564477322|FG004|54-week Study|Withdrawal by Subject|13|||
156377621|NCT00767000|564477318|FG000|54-week Study|Study terminated by sponsor|90|||
156377622|NCT00767000|564477319|FG001|54-week Study|Study terminated by sponsor|102|||
156377623|NCT00767000|564477320|FG002|54-week Study|Study terminated by sponsor|89|||
156377624|NCT00767000|564477321|FG003|54-week Study|Study terminated by sponsor|196|||
156377625|NCT00767000|564477322|FG004|54-week Study|Study terminated by sponsor|194|||
156377626|NCT00767000|564477318|FG000|54-week Study|Reason not reported|0|||
156377627|NCT00767000|564477319|FG001|54-week Study|Reason not reported|0|||
156377628|NCT00767000|564477320|FG002|54-week Study|Reason not reported|0|||
156377629|NCT00767000|564477321|FG003|54-week Study|Reason not reported|1|||
156377630|NCT00767000|564477322|FG004|54-week Study|Reason not reported|0|||
156377631|NCT00767000|564477318|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
156377632|NCT00767000|564477319|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
156377633|NCT00767000|564477320|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
156377634|NCT00767000|564477321|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
156377635|NCT00767000|564477322|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
156377636|NCT02039505|564477324|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
156377637|NCT02039505|564477325|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
156377638|NCT02039505|564477326|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
156377639|NCT02039505|564477327|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
156377640|NCT02039505|564477328|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
156377641|NCT02039505|564477329|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
156377642|NCT02039505|564477330|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
156377643|NCT02039505|564477324|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
156377644|NCT02039505|564477325|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
156377645|NCT02039505|564477326|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
156377646|NCT02039505|564477327|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
156377647|NCT02039505|564477328|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
156377648|NCT02039505|564477329|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
156377649|NCT02039505|564477330|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
156377650|NCT02039505|564477324|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
156377651|NCT02039505|564477325|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156377652|NCT02039505|564477326|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156377653|NCT02039505|564477327|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156377654|NCT02039505|564477328|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156377655|NCT02039505|564477329|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156377656|NCT02039505|564477330|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156377657|NCT02039505|564477324|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
156377658|NCT02039505|564477325|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
156377659|NCT02039505|564477326|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
156377660|NCT02039505|564477327|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
156377661|NCT02039505|564477328|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
156377662|NCT02039505|564477329|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
156377663|NCT02039505|564477330|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
156377664|NCT02039505|564477324|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
156377665|NCT02039505|564477325|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
156377666|NCT02039505|564477326|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
156377667|NCT02039505|564477327|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
156377668|NCT02039505|564477328|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
156377669|NCT02039505|564477329|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
156377670|NCT02039505|564477330|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
156377671|NCT02039505|564477324|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
156377672|NCT02039505|564477325|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
156377673|NCT02039505|564477326|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
156377674|NCT02039505|564477327|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
156377675|NCT02039505|564477328|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
156377676|NCT02039505|564477329|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
156377677|NCT02039505|564477330|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
156377678|NCT02039505|564477324|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156377679|NCT02039505|564477325|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156377680|NCT02039505|564477326|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156377681|NCT02039505|564477327|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
156377682|NCT02039505|564477328|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156377683|NCT02039505|564477329|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156377684|NCT02039505|564477330|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156377685|NCT02039505|564477324|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156377686|NCT02039505|564477325|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156377687|NCT02039505|564477326|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156377688|NCT02039505|564477327|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156377689|NCT02039505|564477328|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156377690|NCT02039505|564477329|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156377691|NCT02039505|564477330|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
156377692|NCT02039505|564477324|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156377693|NCT02039505|564477325|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156377694|NCT02039505|564477326|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156377695|NCT02039505|564477327|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156377696|NCT02039505|564477328|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156377697|NCT02039505|564477329|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156377698|NCT02039505|564477330|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
156377699|NCT02039505|564477324|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156377700|NCT02039505|564477325|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156377701|NCT02039505|564477326|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156377702|NCT02039505|564477327|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156377703|NCT02039505|564477328|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156377704|NCT02039505|564477329|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156377705|NCT02039505|564477330|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
156377706|NCT02039505|564477324|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156377707|NCT02039505|564477325|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156377708|NCT02039505|564477326|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156377709|NCT02039505|564477327|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156377710|NCT02039505|564477328|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156377711|NCT02039505|564477329|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156377712|NCT02039505|564477330|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
156377713|NCT01722331|564477331|FG000|Part 1|Adverse Event|5|||
156377714|NCT01722331|564477332|FG001|Part 1|Adverse Event|0|||
156377715|NCT01722331|564477333|FG002|Part 1|Adverse Event|0|||
156377716|NCT01722331|564477334|FG003|Part 1|Adverse Event|0|||
156377717|NCT01722331|564477335|FG004|Part 1|Adverse Event|0|||
156377718|NCT01722331|564477336|FG005|Part 1|Adverse Event|0|||
156377719|NCT01722331|564477337|FG006|Part 1|Adverse Event|0|||
156377720|NCT01722331|564477331|FG000|Part 1|Lack of Efficacy|0|||
156377721|NCT01722331|564477332|FG001|Part 1|Lack of Efficacy|0|||
156377722|NCT01722331|564477333|FG002|Part 1|Lack of Efficacy|1|||
156377723|NCT01722331|564477334|FG003|Part 1|Lack of Efficacy|0|||
156377724|NCT01722331|564477335|FG004|Part 1|Lack of Efficacy|2|||
156377725|NCT01722331|564477336|FG005|Part 1|Lack of Efficacy|0|||
156377726|NCT01722331|564477337|FG006|Part 1|Lack of Efficacy|0|||
156377727|NCT01722331|564477331|FG000|Part 1|Lost to Follow-up|1|||
156377728|NCT01722331|564477332|FG001|Part 1|Lost to Follow-up|0|||
156377729|NCT01722331|564477333|FG002|Part 1|Lost to Follow-up|2|||
156377730|NCT01722331|564477334|FG003|Part 1|Lost to Follow-up|0|||
156377731|NCT01722331|564477335|FG004|Part 1|Lost to Follow-up|1|||
156377732|NCT01722331|564477336|FG005|Part 1|Lost to Follow-up|0|||
156377733|NCT01722331|564477337|FG006|Part 1|Lost to Follow-up|0|||
156377734|NCT01722331|564477331|FG000|Part 1|Physician Decision|0|||
156377735|NCT01722331|564477332|FG001|Part 1|Physician Decision|0|||
156377736|NCT01722331|564477333|FG002|Part 1|Physician Decision|3|||
156377737|NCT01722331|564477334|FG003|Part 1|Physician Decision|0|||
156377738|NCT01722331|564477335|FG004|Part 1|Physician Decision|1|||
156377739|NCT01722331|564477336|FG005|Part 1|Physician Decision|0|||
156377740|NCT01722331|564477337|FG006|Part 1|Physician Decision|0|||
156377741|NCT01722331|564477331|FG000|Part 1|Pregnancy|1|||
156377742|NCT01722331|564477332|FG001|Part 1|Pregnancy|0|||
156377743|NCT01722331|564477333|FG002|Part 1|Pregnancy|0|||
156377744|NCT01722331|564477334|FG003|Part 1|Pregnancy|0|||
156377745|NCT01722331|564477335|FG004|Part 1|Pregnancy|0|||
156377746|NCT01722331|564477336|FG005|Part 1|Pregnancy|0|||
156377747|NCT01722331|564477337|FG006|Part 1|Pregnancy|0|||
156377748|NCT01722331|564477331|FG000|Part 1|Progressive Disease|0|||
156377749|NCT01722331|564477332|FG001|Part 1|Progressive Disease|0|||
156377750|NCT01722331|564477333|FG002|Part 1|Progressive Disease|0|||
156377751|NCT01722331|564477334|FG003|Part 1|Progressive Disease|0|||
156377752|NCT01722331|564477335|FG004|Part 1|Progressive Disease|1|||
156377753|NCT01722331|564477336|FG005|Part 1|Progressive Disease|0|||
156377754|NCT01722331|564477337|FG006|Part 1|Progressive Disease|0|||
156377755|NCT01722331|564477331|FG000|Part 1|Protocol Violation|1|||
156377756|NCT01722331|564477332|FG001|Part 1|Protocol Violation|0|||
156377757|NCT01722331|564477333|FG002|Part 1|Protocol Violation|0|||
156377758|NCT01722331|564477334|FG003|Part 1|Protocol Violation|0|||
156377759|NCT01722331|564477335|FG004|Part 1|Protocol Violation|1|||
156377760|NCT01722331|564477336|FG005|Part 1|Protocol Violation|0|||
156377761|NCT01722331|564477337|FG006|Part 1|Protocol Violation|0|||
156377762|NCT01722331|564477331|FG000|Part 1|Withdrawal by Subject|2|||
156377763|NCT01722331|564477332|FG001|Part 1|Withdrawal by Subject|0|||
156377764|NCT01722331|564477333|FG002|Part 1|Withdrawal by Subject|3|||
156377765|NCT01722331|564477334|FG003|Part 1|Withdrawal by Subject|0|||
156377766|NCT01722331|564477335|FG004|Part 1|Withdrawal by Subject|3|||
156377767|NCT01722331|564477336|FG005|Part 1|Withdrawal by Subject|0|||
156377768|NCT01722331|564477337|FG006|Part 1|Withdrawal by Subject|0|||
156377769|NCT01722331|564477331|FG000|Part 2|Adverse Event|3|||
156377770|NCT01722331|564477332|FG001|Part 2|Adverse Event|0|||
156377771|NCT01722331|564477333|FG002|Part 2|Adverse Event|0|||
156377772|NCT01722331|564477334|FG003|Part 2|Adverse Event|0|||
156377773|NCT01722331|564477335|FG004|Part 2|Adverse Event|0|||
156377774|NCT01722331|564477336|FG005|Part 2|Adverse Event|1|||
156377775|NCT01722331|564477337|FG006|Part 2|Adverse Event|0|||
156377776|NCT01722331|564477331|FG000|Part 2|Lack of Efficacy|3|||
156377777|NCT01722331|564477332|FG001|Part 2|Lack of Efficacy|0|||
156377778|NCT01722331|564477333|FG002|Part 2|Lack of Efficacy|11|||
156377779|NCT01722331|564477334|FG003|Part 2|Lack of Efficacy|0|||
156377780|NCT01722331|564477335|FG004|Part 2|Lack of Efficacy|0|||
156377781|NCT01722331|564477336|FG005|Part 2|Lack of Efficacy|3|||
156377782|NCT01722331|564477337|FG006|Part 2|Lack of Efficacy|3|||
156377783|NCT01722331|564477331|FG000|Part 2|Lost to Follow-up|0|||
156377784|NCT01722331|564477332|FG001|Part 2|Lost to Follow-up|0|||
156377785|NCT01722331|564477333|FG002|Part 2|Lost to Follow-up|3|||
156377786|NCT01722331|564477334|FG003|Part 2|Lost to Follow-up|0|||
156377787|NCT01722331|564477335|FG004|Part 2|Lost to Follow-up|0|||
156377788|NCT01722331|564477336|FG005|Part 2|Lost to Follow-up|1|||
156377789|NCT01722331|564477337|FG006|Part 2|Lost to Follow-up|1|||
156377790|NCT01722331|564477331|FG000|Part 2|Non-Compliance with Study Drug|1|||
156377791|NCT01722331|564477332|FG001|Part 2|Non-Compliance with Study Drug|0|||
156377792|NCT01722331|564477333|FG002|Part 2|Non-Compliance with Study Drug|1|||
156377793|NCT01722331|564477334|FG003|Part 2|Non-Compliance with Study Drug|0|||
156377794|NCT01722331|564477335|FG004|Part 2|Non-Compliance with Study Drug|0|||
156377795|NCT01722331|564477336|FG005|Part 2|Non-Compliance with Study Drug|0|||
156377796|NCT01722331|564477337|FG006|Part 2|Non-Compliance with Study Drug|0|||
156377797|NCT01722331|564477331|FG000|Part 2|Physician Decision|0|||
156377798|NCT01722331|564477332|FG001|Part 2|Physician Decision|0|||
156377799|NCT01722331|564477333|FG002|Part 2|Physician Decision|2|||
156377800|NCT01722331|564477334|FG003|Part 2|Physician Decision|0|||
156377801|NCT01722331|564477335|FG004|Part 2|Physician Decision|0|||
156377802|NCT01722331|564477336|FG005|Part 2|Physician Decision|0|||
156377803|NCT01722331|564477337|FG006|Part 2|Physician Decision|0|||
156377804|NCT01722331|564477331|FG000|Part 2|Pregnancy|0|||
156377805|NCT01722331|564477332|FG001|Part 2|Pregnancy|0|||
156546760|NCT00708500|565094966|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
156546761|NCT00708500|565094967|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
156377806|NCT01722331|564477333|FG002|Part 2|Pregnancy|0|||
156377807|NCT01722331|564477334|FG003|Part 2|Pregnancy|0|||
156377808|NCT01722331|564477335|FG004|Part 2|Pregnancy|0|||
156377809|NCT01722331|564477336|FG005|Part 2|Pregnancy|1|||
156377810|NCT01722331|564477337|FG006|Part 2|Pregnancy|0|||
156377811|NCT01722331|564477331|FG000|Part 2|Progressive Disease|0|||
156377812|NCT01722331|564477332|FG001|Part 2|Progressive Disease|0|||
156377813|NCT01722331|564477333|FG002|Part 2|Progressive Disease|1|||
156377814|NCT01722331|564477334|FG003|Part 2|Progressive Disease|0|||
156377815|NCT01722331|564477335|FG004|Part 2|Progressive Disease|0|||
156377816|NCT01722331|564477336|FG005|Part 2|Progressive Disease|0|||
156377817|NCT01722331|564477337|FG006|Part 2|Progressive Disease|0|||
156377818|NCT01722331|564477331|FG000|Part 2|Protocol Violation|1|||
156377819|NCT01722331|564477332|FG001|Part 2|Protocol Violation|0|||
156377820|NCT01722331|564477333|FG002|Part 2|Protocol Violation|0|||
156377821|NCT01722331|564477334|FG003|Part 2|Protocol Violation|0|||
156377822|NCT01722331|564477335|FG004|Part 2|Protocol Violation|0|||
156377823|NCT01722331|564477336|FG005|Part 2|Protocol Violation|0|||
156377824|NCT01722331|564477337|FG006|Part 2|Protocol Violation|0|||
156377825|NCT01722331|564477331|FG000|Part 2|Withdrawal by Subject|5|||
156377826|NCT01722331|564477332|FG001|Part 2|Withdrawal by Subject|0|||
156377827|NCT01722331|564477333|FG002|Part 2|Withdrawal by Subject|3|||
156377828|NCT01722331|564477334|FG003|Part 2|Withdrawal by Subject|0|||
156377829|NCT01722331|564477335|FG004|Part 2|Withdrawal by Subject|0|||
156377830|NCT01722331|564477336|FG005|Part 2|Withdrawal by Subject|2|||
156377831|NCT01722331|564477337|FG006|Part 2|Withdrawal by Subject|2|||
156377832|NCT01722331|564477331|FG000|Part 2|Other Protocol Specified Criteria|6|||
156377833|NCT01722331|564477332|FG001|Part 2|Other Protocol Specified Criteria|0|||
156377834|NCT01722331|564477333|FG002|Part 2|Other Protocol Specified Criteria|10|||
156377835|NCT01722331|564477334|FG003|Part 2|Other Protocol Specified Criteria|0|||
156377836|NCT01722331|564477335|FG004|Part 2|Other Protocol Specified Criteria|0|||
156377837|NCT01722331|564477336|FG005|Part 2|Other Protocol Specified Criteria|2|||
156377838|NCT01722331|564477337|FG006|Part 2|Other Protocol Specified Criteria|1|||
156377839|NCT01722331|564477331|FG000|Part 3|Adverse Event|2|||
156377840|NCT01722331|564477332|FG001|Part 3|Adverse Event|2|||
156377841|NCT01722331|564477333|FG002|Part 3|Adverse Event|0|||
156377842|NCT01722331|564477334|FG003|Part 3|Adverse Event|1|||
156377843|NCT01722331|564477335|FG004|Part 3|Adverse Event|0|||
156377844|NCT01722331|564477336|FG005|Part 3|Adverse Event|0|||
156377845|NCT01722331|564477337|FG006|Part 3|Adverse Event|0|||
156377846|NCT01722331|564477331|FG000|Part 3|Death|1|||
156377847|NCT01722331|564477332|FG001|Part 3|Death|0|||
156377848|NCT01722331|564477333|FG002|Part 3|Death|0|||
156377849|NCT01722331|564477334|FG003|Part 3|Death|0|||
156377850|NCT01722331|564477335|FG004|Part 3|Death|0|||
156377851|NCT01722331|564477336|FG005|Part 3|Death|0|||
156377852|NCT01722331|564477337|FG006|Part 3|Death|0|||
156377853|NCT01722331|564477331|FG000|Part 3|Lack of Efficacy|1|||
156377854|NCT01722331|564477332|FG001|Part 3|Lack of Efficacy|0|||
156377855|NCT01722331|564477333|FG002|Part 3|Lack of Efficacy|0|||
156377856|NCT01722331|564477334|FG003|Part 3|Lack of Efficacy|0|||
156377857|NCT01722331|564477335|FG004|Part 3|Lack of Efficacy|0|||
156377858|NCT01722331|564477336|FG005|Part 3|Lack of Efficacy|0|||
156377859|NCT01722331|564477337|FG006|Part 3|Lack of Efficacy|0|||
156377860|NCT01722331|564477331|FG000|Part 3|Lost to Follow-up|3|||
156377861|NCT01722331|564477332|FG001|Part 3|Lost to Follow-up|4|||
156377862|NCT01722331|564477333|FG002|Part 3|Lost to Follow-up|0|||
156377863|NCT01722331|564477334|FG003|Part 3|Lost to Follow-up|0|||
156377864|NCT01722331|564477335|FG004|Part 3|Lost to Follow-up|0|||
156377865|NCT01722331|564477336|FG005|Part 3|Lost to Follow-up|1|||
156377866|NCT01722331|564477337|FG006|Part 3|Lost to Follow-up|0|||
156377867|NCT01722331|564477331|FG000|Part 3|Non-Compliance with Study Drug|0|||
156377868|NCT01722331|564477332|FG001|Part 3|Non-Compliance with Study Drug|1|||
156377869|NCT01722331|564477333|FG002|Part 3|Non-Compliance with Study Drug|0|||
156377870|NCT01722331|564477334|FG003|Part 3|Non-Compliance with Study Drug|0|||
156377871|NCT01722331|564477335|FG004|Part 3|Non-Compliance with Study Drug|0|||
156377872|NCT01722331|564477336|FG005|Part 3|Non-Compliance with Study Drug|0|||
156377873|NCT01722331|564477337|FG006|Part 3|Non-Compliance with Study Drug|0|||
156377874|NCT01722331|564477331|FG000|Part 3|Physician Decision|1|||
156377875|NCT01722331|564477332|FG001|Part 3|Physician Decision|1|||
156377876|NCT01722331|564477333|FG002|Part 3|Physician Decision|0|||
156377877|NCT01722331|564477334|FG003|Part 3|Physician Decision|0|||
156377878|NCT01722331|564477335|FG004|Part 3|Physician Decision|0|||
156377879|NCT01722331|564477336|FG005|Part 3|Physician Decision|0|||
156377880|NCT01722331|564477337|FG006|Part 3|Physician Decision|1|||
156377881|NCT01722331|564477331|FG000|Part 3|Protocol Violation|2|||
156377882|NCT01722331|564477332|FG001|Part 3|Protocol Violation|1|||
156377883|NCT01722331|564477333|FG002|Part 3|Protocol Violation|0|||
156377884|NCT01722331|564477334|FG003|Part 3|Protocol Violation|0|||
156377885|NCT01722331|564477335|FG004|Part 3|Protocol Violation|0|||
156377886|NCT01722331|564477336|FG005|Part 3|Protocol Violation|0|||
156377887|NCT01722331|564477337|FG006|Part 3|Protocol Violation|0|||
156377888|NCT01722331|564477331|FG000|Part 3|Withdrawal by Subject|4|||
156377889|NCT01722331|564477332|FG001|Part 3|Withdrawal by Subject|7|||
156377890|NCT01722331|564477333|FG002|Part 3|Withdrawal by Subject|0|||
156377891|NCT01722331|564477334|FG003|Part 3|Withdrawal by Subject|0|||
156377892|NCT01722331|564477335|FG004|Part 3|Withdrawal by Subject|0|||
156377893|NCT01722331|564477336|FG005|Part 3|Withdrawal by Subject|2|||
156377894|NCT01722331|564477337|FG006|Part 3|Withdrawal by Subject|1|||
156377895|NCT01722331|564477331|FG000|Part 3|Other Protocol Specified Criteria|1|||
156377896|NCT01722331|564477332|FG001|Part 3|Other Protocol Specified Criteria|1|||
156377897|NCT01722331|564477333|FG002|Part 3|Other Protocol Specified Criteria|0|||
156377898|NCT01722331|564477334|FG003|Part 3|Other Protocol Specified Criteria|0|||
156377899|NCT01722331|564477335|FG004|Part 3|Other Protocol Specified Criteria|0|||
156377900|NCT01722331|564477336|FG005|Part 3|Other Protocol Specified Criteria|0|||
156377901|NCT01722331|564477337|FG006|Part 3|Other Protocol Specified Criteria|0|||
156377902|NCT04265755|564477347|FG000|Overall Study|Withdrawal by Subject|39|||
156377903|NCT04265755|564477347|FG000|Overall Study|Decision by sponsor|2|||
156377904|NCT04265755|564477347|FG000|Overall Study|Lost to Follow-up|11|||
156377905|NCT04265755|564477347|FG000|Overall Study|Death|1|||
156377906|NCT01863446|564477350|FG000|Overall Study|Withdrawal by Subject|1|||
156377907|NCT01863446|564477351|FG001|Overall Study|Withdrawal by Subject|0|||
156377908|NCT01863446|564477352|FG002|Overall Study|Withdrawal by Subject|1|||
156377909|NCT01863446|564477353|FG003|Overall Study|Withdrawal by Subject|2|||
156377910|NCT01863446|564477350|FG000|Overall Study|Physician Decision|0|||
156377911|NCT01863446|564477351|FG001|Overall Study|Physician Decision|0|||
156377912|NCT01863446|564477352|FG002|Overall Study|Physician Decision|1|||
156377913|NCT01863446|564477353|FG003|Overall Study|Physician Decision|0|||
156377914|NCT02554773|564477354|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
156377915|NCT02554773|564477355|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
156377916|NCT02554773|564477354|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
156377917|NCT02554773|564477355|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
156377918|NCT02554773|564477354|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
156377919|NCT02554773|564477355|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
156377920|NCT02554773|564477354|FG000|Original Dose Regimen (SAS 1)|Death|1|||
156377921|NCT02554773|564477355|FG001|Original Dose Regimen (SAS 1)|Death|0|||
156377922|NCT02554773|564477354|FG000|Original Dose Regimen (SAS 1)|Other|4|||
156377923|NCT02554773|564477355|FG001|Original Dose Regimen (SAS 1)|Other|0|||
156377924|NCT02554773|564477354|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
156377925|NCT02554773|564477355|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
156377926|NCT02554773|564477354|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
156377927|NCT02554773|564477355|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
156377928|NCT02554773|564477354|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
156377929|NCT02554773|564477355|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
156377930|NCT02554773|564477354|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
156377931|NCT02554773|564477355|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
156377932|NCT02496884|564477356|FG000|Overall Study|Counted twice as enrolled|2|||
156377933|NCT02496884|564477357|FG001|Overall Study|Counted twice as enrolled|0|||
156377934|NCT02496884|564477358|FG002|Overall Study|Counted twice as enrolled|0|||
156377935|NCT02496884|564477359|FG003|Overall Study|Counted twice as enrolled|0|||
156377936|NCT02496884|564477356|FG000|Overall Study|Withdrawal by Subject|0|||
156377937|NCT02496884|564477357|FG001|Overall Study|Withdrawal by Subject|3|||
156377938|NCT02496884|564477358|FG002|Overall Study|Withdrawal by Subject|0|||
156377939|NCT02496884|564477359|FG003|Overall Study|Withdrawal by Subject|0|||
156377940|NCT01794949|564477364|FG000|Overall Study|Lost to Follow-up|1|||
156377941|NCT01794949|564477365|FG001|Overall Study|Lost to Follow-up|0|||
156377942|NCT02956629|564477368|FG000|Overall Study|Adverse Event|0|||
156377943|NCT02956629|564477369|FG001|Overall Study|Adverse Event|0|||
156377944|NCT02956629|564477370|FG002|Overall Study|Adverse Event|1|||
156377945|NCT02956629|564477371|FG003|Overall Study|Adverse Event|0|||
156377946|NCT02956629|564477372|FG004|Overall Study|Adverse Event|0|||
156377947|NCT02956629|564477373|FG005|Overall Study|Adverse Event|0|||
156377948|NCT02956629|564477368|FG000|Overall Study|Lost to Follow-up|2|||
156377949|NCT02956629|564477369|FG001|Overall Study|Lost to Follow-up|5|||
156377950|NCT02956629|564477370|FG002|Overall Study|Lost to Follow-up|3|||
156377951|NCT02956629|564477371|FG003|Overall Study|Lost to Follow-up|1|||
156377952|NCT02956629|564477372|FG004|Overall Study|Lost to Follow-up|0|||
156377953|NCT02956629|564477373|FG005|Overall Study|Lost to Follow-up|1|||
156377954|NCT02956629|564477368|FG000|Overall Study|Withdrawal by Subject|3|||
156377955|NCT02956629|564477369|FG001|Overall Study|Withdrawal by Subject|1|||
156377956|NCT02956629|564477370|FG002|Overall Study|Withdrawal by Subject|0|||
156377957|NCT02956629|564477371|FG003|Overall Study|Withdrawal by Subject|0|||
156377958|NCT02956629|564477372|FG004|Overall Study|Withdrawal by Subject|0|||
156377959|NCT02956629|564477373|FG005|Overall Study|Withdrawal by Subject|0|||
156377960|NCT00003498|564477374|FG000|Overall Study|Not evaluable.|4|||
156377961|NCT04713748|564477387|FG000|Overall Study|Not enough kits allocated|35|||
156377962|NCT01557946|564477392|FG000|Overall Study|Adverse Event|3|||
156377963|NCT01557946|564477393|FG001|Overall Study|Adverse Event|0|||
156377964|NCT04067141|564477394|FG000|First Intervention|Withdrawal by Subject|0|||
156377965|NCT04067141|564477395|FG001|First Intervention|Withdrawal by Subject|1|||
156377966|NCT04067141|564477394|FG000|Second Intervention|Adverse Event|0|||
156377967|NCT04067141|564477395|FG001|Second Intervention|Adverse Event|2|||
156377968|NCT00406029|564477396|FG000|Overall Study|Adverse Event|12|||
156377969|NCT00406029|564477397|FG001|Overall Study|Adverse Event|2|||
156377970|NCT00406029|564477398|FG002|Overall Study|Adverse Event|5|||
156377971|NCT00406029|564477399|FG003|Overall Study|Adverse Event|10|||
156377972|NCT00406029|564477400|FG004|Overall Study|Adverse Event|7|||
156377973|NCT00406029|564477396|FG000|Overall Study|Withdrawal by Subject|3|||
156377974|NCT00406029|564477397|FG001|Overall Study|Withdrawal by Subject|4|||
156377975|NCT00406029|564477398|FG002|Overall Study|Withdrawal by Subject|2|||
156377976|NCT00406029|564477399|FG003|Overall Study|Withdrawal by Subject|2|||
156377977|NCT00406029|564477400|FG004|Overall Study|Withdrawal by Subject|0|||
156377978|NCT00406029|564477396|FG000|Overall Study|Protocol Violation|1|||
156377979|NCT00406029|564477397|FG001|Overall Study|Protocol Violation|2|||
156377980|NCT00406029|564477398|FG002|Overall Study|Protocol Violation|0|||
156377981|NCT00406029|564477399|FG003|Overall Study|Protocol Violation|2|||
156377982|NCT00406029|564477400|FG004|Overall Study|Protocol Violation|0|||
156377983|NCT00406029|564477396|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156377984|NCT00406029|564477397|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
156377985|NCT00406029|564477398|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
156377986|NCT00406029|564477399|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
156377987|NCT00406029|564477400|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
156377988|NCT00406029|564477396|FG000|Overall Study|Randomized in Error|0|||
156377989|NCT00406029|564477397|FG001|Overall Study|Randomized in Error|0|||
156377990|NCT00406029|564477398|FG002|Overall Study|Randomized in Error|2|||
156377991|NCT00406029|564477399|FG003|Overall Study|Randomized in Error|3|||
156377992|NCT00406029|564477400|FG004|Overall Study|Randomized in Error|1|||
156377993|NCT01978119|564477402|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
156377994|NCT01978119|564477403|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
156377995|NCT01978119|564477402|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156377996|NCT01978119|564477403|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156377997|NCT01978119|564477402|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156377998|NCT01978119|564477403|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
156377999|NCT00812812|564477405|FG000|Overall Study|Adverse Event|2|||
156378000|NCT00812812|564477406|FG001|Overall Study|Adverse Event|1|||
156378001|NCT00812812|564477405|FG000|Overall Study|Lack of Efficacy|1|||
156378002|NCT00812812|564477406|FG001|Overall Study|Lack of Efficacy|0|||
156378003|NCT00812812|564477405|FG000|Overall Study|Lost to Follow-up|0|||
156378004|NCT00812812|564477406|FG001|Overall Study|Lost to Follow-up|1|||
156378005|NCT00812812|564477405|FG000|Overall Study|Withdrawal by Subject|0|||
156378006|NCT00812812|564477406|FG001|Overall Study|Withdrawal by Subject|2|||
156378007|NCT00889421|564477407|FG000|Overall Study|Lack of Efficacy|3|||
156378008|NCT01958918|564477408|FG000|Overall Study|Death|1|||
156378009|NCT01958918|564477409|FG001|Overall Study|Death|3|||
156378010|NCT01958918|564477408|FG000|Overall Study|Lost to Follow-up|4|||
156378011|NCT01958918|564477409|FG001|Overall Study|Lost to Follow-up|7|||
156378012|NCT01958918|564477408|FG000|Overall Study|Withdrawal by Subject|13|||
156378013|NCT01958918|564477409|FG001|Overall Study|Withdrawal by Subject|8|||
156378014|NCT01958918|564477408|FG000|Overall Study|Lack of Efficacy|13|||
156378015|NCT01958918|564477409|FG001|Overall Study|Lack of Efficacy|10|||
156378016|NCT01958918|564477408|FG000|Overall Study|Adverse Event|12|||
156378017|NCT01958918|564477409|FG001|Overall Study|Adverse Event|12|||
156378018|NCT01958918|564477408|FG000|Overall Study|administrative problems|0|||
156378019|NCT01958918|564477409|FG001|Overall Study|administrative problems|2|||
156378020|NCT04479618|564477416|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
156378021|NCT04479618|564477417|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
156378022|NCT04479618|564477418|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
156378023|NCT04479618|564477416|FG000|Overall Study|Lack of Efficacy|1|||
156378024|NCT04479618|564477417|FG001|Overall Study|Lack of Efficacy|0|||
156378025|NCT04479618|564477418|FG002|Overall Study|Lack of Efficacy|0|||
156378026|NCT04479618|564477416|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
156378027|NCT04479618|564477417|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
156378028|NCT04479618|564477418|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
156378029|NCT04479618|564477416|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
156546762|NCT00708500|565094968|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
156546763|NCT00708500|565094966|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
156546764|NCT00708500|565094967|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
156546765|NCT00708500|565094968|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
156546766|NCT00708500|565094966|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
156546767|NCT00708500|565094967|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
156546768|NCT00708500|565094968|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
156546769|NCT00708500|565094966|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
156546770|NCT00708500|565094967|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
156546771|NCT00708500|565094968|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
156546772|NCT00708500|565094966|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
156546773|NCT00708500|565094967|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
156546774|NCT00708500|565094968|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
156546775|NCT00708500|565094966|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
156546776|NCT00708500|565094967|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
156546777|NCT00708500|565094968|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
156546778|NCT00708500|565094966|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
156546779|NCT00708500|565094967|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
156546780|NCT00708500|565094968|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
156546781|NCT00708500|565094966|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
156546782|NCT00708500|565094967|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
156546783|NCT00708500|565094968|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
156546784|NCT00708500|565094966|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
156546785|NCT00708500|565094967|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
156546786|NCT00708500|565094968|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
156546787|NCT00708500|565094966|FG000|FOLLOWUP|Adverse Event|0|||
156546788|NCT00708500|565094967|FG001|FOLLOWUP|Adverse Event|1|||
156546789|NCT00708500|565094968|FG002|FOLLOWUP|Adverse Event|0|||
156546790|NCT00708500|565094966|FG000|FOLLOWUP|Lost to Follow-up|1|||
156546791|NCT00708500|565094967|FG001|FOLLOWUP|Lost to Follow-up|6|||
156546792|NCT00708500|565094968|FG002|FOLLOWUP|Lost to Follow-up|4|||
156499845|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
156499846|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
156499847|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
156499848|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Death|4|||
156499849|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Death|2|||
156499850|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Death|3|||
156499851|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
156499852|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
156499853|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
156499854|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
156499855|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
156499856|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
156499857|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
156499858|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
156499859|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
156499860|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
156499861|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
156499862|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
156499863|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
156499864|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
156499865|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
156499866|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
156499867|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
156499868|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
156499869|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
156499870|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
156499871|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
156499872|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
156499873|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
156499874|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
156499875|NCT02783573|564923656|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
156378030|NCT04479618|564477417|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
156378031|NCT04479618|564477418|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
156378032|NCT04479618|564477416|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
156378033|NCT04479618|564477417|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
156378034|NCT04479618|564477418|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
156378035|NCT04479618|564477416|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
156378036|NCT04479618|564477417|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
156378037|NCT04479618|564477418|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
156378038|NCT00659269|564477421|FG000|Overall Study|Physician Decision|1|||
156378039|NCT00659269|564477422|FG001|Overall Study|Physician Decision|1|||
156378040|NCT01047683|564477423|FG000|Overall Study|Adverse Event|3|||
156378041|NCT01047683|564477424|FG001|Overall Study|Adverse Event|1|||
156378042|NCT01047683|564477425|FG002|Overall Study|Adverse Event|0|||
156378043|NCT01047683|564477423|FG000|Overall Study|Withdrew Consent|1|||
156378044|NCT01047683|564477424|FG001|Overall Study|Withdrew Consent|4|||
156378045|NCT01047683|564477425|FG002|Overall Study|Withdrew Consent|2|||
156378046|NCT01047683|564477423|FG000|Overall Study|Lost to Follow-up|0|||
156378047|NCT01047683|564477424|FG001|Overall Study|Lost to Follow-up|1|||
156378048|NCT01047683|564477425|FG002|Overall Study|Lost to Follow-up|0|||
156378049|NCT01047683|564477423|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
156378050|NCT01047683|564477424|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
156378051|NCT01047683|564477425|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
156378052|NCT00908960|564477438|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
156378053|NCT00908960|564477439|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
156378054|NCT00908960|564477440|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
156378055|NCT01158924|564477441|FG000|Overall Study|Withdrawal by Subject|1|||
156378056|NCT01158924|564477442|FG001|Overall Study|Withdrawal by Subject|2|||
156378057|NCT01158924|564477441|FG000|Overall Study|Lost to Follow-up|0|||
156378058|NCT01158924|564477442|FG001|Overall Study|Lost to Follow-up|1|||
156378059|NCT03795922|564477443|FG000|Overall Study|Adverse Event|2|||
156378060|NCT03795922|564477444|FG001|Overall Study|Adverse Event|1|||
156378061|NCT03795922|564477443|FG000|Overall Study|Withdrawal by Subject|5|||
156378062|NCT03795922|564477444|FG001|Overall Study|Withdrawal by Subject|13|||
156499876|NCT02783573|564923657|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
156378063|NCT03795922|564477443|FG000|Overall Study|Lost to Follow-up|2|||
156378064|NCT03795922|564477444|FG001|Overall Study|Lost to Follow-up|3|||
156378065|NCT03795922|564477443|FG000|Overall Study|Pregnancy|0|||
156378066|NCT03795922|564477444|FG001|Overall Study|Pregnancy|1|||
156378067|NCT03795922|564477443|FG000|Overall Study|Physician Decision|1|||
156378068|NCT03795922|564477444|FG001|Overall Study|Physician Decision|2|||
156378069|NCT03795922|564477443|FG000|Overall Study|Protocol Violation|0|||
156378070|NCT03795922|564477444|FG001|Overall Study|Protocol Violation|1|||
156378071|NCT03795922|564477443|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
156378072|NCT03795922|564477444|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
156378073|NCT02822794|564477445|FG000|Overall Study|Withdrew Consent|1|||
156378074|NCT02822794|564477446|FG001|Overall Study|Withdrew Consent|0|||
156378075|NCT04788147|564477447|FG000|Overall Study|Screen Failure|3|||
156378076|NCT04788147|564477448|FG001|Overall Study|Screen Failure|10|||
156378077|NCT04788147|564477447|FG000|Overall Study|Incomplete RMRS image session|2|||
156378078|NCT04788147|564477448|FG001|Overall Study|Incomplete RMRS image session|0|||
156378079|NCT00781326|564477451|FG000|Phase I|Adverse Event|1|||
156378080|NCT00781326|564477451|FG000|Phase I|Withdrawal by Subject|1|||
156378081|NCT00781326|564477451|FG000|Phase I|Physician Decision|2|||
156378082|NCT03732248|564477452|FG000|Overall Study|Withdrawal by Subject|1|||
156378083|NCT03732248|564477453|FG001|Overall Study|Withdrawal by Subject|0|||
156378084|NCT05101252|564477454|FG000|Overall Study|Unsatisfactory Test Article|1|||
156378085|NCT05101252|564477455|FG001|Overall Study|Unsatisfactory Test Article|0|||
156378086|NCT05101252|564477454|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156378087|NCT05101252|564477455|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
156378088|NCT05101252|564477454|FG000|Overall Study|Withdrew Consent during study|0|||
156378089|NCT05101252|564477455|FG001|Overall Study|Withdrew Consent during study|1|||
156378090|NCT05101252|564477454|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
156378091|NCT05101252|564477455|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
156378092|NCT02266381|564477456|FG000|Overall Study|Physician Decision|3|||
156378093|NCT02266381|564477457|FG001|Overall Study|Physician Decision|5|||
156378094|NCT02266381|564477458|FG002|Overall Study|Physician Decision|4|||
156378095|NCT03653429|564477461|FG000|Overall Study|Physician Decision|4|||
156378096|NCT03653429|564477462|FG001|Overall Study|Physician Decision|10|||
156378097|NCT00403546|564477463|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
156378098|NCT00403546|564477464|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
156378099|NCT00403546|564477465|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
156378100|NCT00403546|564477463|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
156378101|NCT00403546|564477464|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
156378102|NCT00403546|564477465|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
156378103|NCT00403546|564477463|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
156378104|NCT00403546|564477464|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
156378105|NCT00403546|564477465|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
156378106|NCT00403546|564477463|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
156378107|NCT00403546|564477464|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
156378108|NCT00403546|564477465|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
156378109|NCT00403546|564477463|FG000|Screening Phase|Screening Failure|22|||
156378110|NCT00403546|564477464|FG001|Screening Phase|Screening Failure|0|||
156378111|NCT00403546|564477465|FG002|Screening Phase|Screening Failure|0|||
156378112|NCT00403546|564477463|FG000|Screening Phase|Adverse Event|1|||
156378113|NCT00403546|564477464|FG001|Screening Phase|Adverse Event|0|||
156378114|NCT00403546|564477465|FG002|Screening Phase|Adverse Event|0|||
156378115|NCT00403546|564477463|FG000|Screening Phase|Terminated Prior to Randomization|5|||
156378116|NCT00403546|564477464|FG001|Screening Phase|Terminated Prior to Randomization|0|||
156378117|NCT00403546|564477465|FG002|Screening Phase|Terminated Prior to Randomization|0|||
156378118|NCT00403546|564477463|FG000|Randomized Trial|Early Terminations|0|||
156378119|NCT00403546|564477464|FG001|Randomized Trial|Early Terminations|17|||
156378120|NCT00403546|564477465|FG002|Randomized Trial|Early Terminations|16|||
156378121|NCT00793910|564477466|FG000|Overall Study|discarded study pills|0|||
156378122|NCT00793910|564477467|FG001|Overall Study|discarded study pills|1|||
156378123|NCT00793910|564477466|FG000|Overall Study|did not pick up medications|1|||
156378124|NCT00793910|564477467|FG001|Overall Study|did not pick up medications|1|||
156378125|NCT00793910|564477466|FG000|Overall Study|ineligible based on entry criteria|2|||
156378126|NCT00793910|564477467|FG001|Overall Study|ineligible based on entry criteria|3|||
156378127|NCT00793910|564477466|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
156378128|NCT00793910|564477467|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
156378129|NCT00793910|564477466|FG000|Overall Study|Withdrawal by Subject|0|||
156378130|NCT00793910|564477467|FG001|Overall Study|Withdrawal by Subject|1|||
156378131|NCT03634579|564477470|FG000|Overall Study|study termination|9|||
156378132|NCT02480621|564477471|FG000|Randomization|Withdrawal by Subject|1|||
156378133|NCT02480621|564477472|FG001|Randomization|Withdrawal by Subject|0|||
156378134|NCT02480621|564477471|FG000|Randomization|Surgeon did not give intervention|0|||
156378135|NCT02480621|564477472|FG001|Randomization|Surgeon did not give intervention|1|||
156378136|NCT02480621|564477471|FG000|Follow Up|Lost to Follow-up|4|||
156499877|NCT02783573|564923658|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
156499878|NCT02783573|564923656|FG000|Delayed-Start Period|Sponsor Decision|0|||
156499879|NCT02783573|564923657|FG001|Delayed-Start Period|Sponsor Decision|17|||
156499880|NCT02783573|564923658|FG002|Delayed-Start Period|Sponsor Decision|12|||
156499881|NCT01434680|564923659|FG000|Overall Study|Withdrawal by Subject|1|||
156499882|NCT01434680|564923660|FG001|Overall Study|Withdrawal by Subject|0|||
156499883|NCT01434680|564923661|FG002|Overall Study|Withdrawal by Subject|2|||
156499884|NCT01434680|564923662|FG003|Overall Study|Withdrawal by Subject|0|||
156499885|NCT01434680|564923659|FG000|Overall Study|Lost to Follow-up|1|||
156499886|NCT01434680|564923660|FG001|Overall Study|Lost to Follow-up|1|||
156499887|NCT01434680|564923661|FG002|Overall Study|Lost to Follow-up|0|||
156499888|NCT01434680|564923662|FG003|Overall Study|Lost to Follow-up|0|||
156499889|NCT01434680|564923659|FG000|Overall Study|Protocol Violation|1|||
156499890|NCT01434680|564923660|FG001|Overall Study|Protocol Violation|1|||
156499891|NCT01434680|564923661|FG002|Overall Study|Protocol Violation|0|||
156499892|NCT01434680|564923662|FG003|Overall Study|Protocol Violation|0|||
156499893|NCT02684123|564923663|FG000|Phase 1|Lack of Efficacy|5|||
156499894|NCT02684123|564923664|FG001|Phase 1|Lack of Efficacy|0|||
156499895|NCT02684123|564923663|FG000|Phase 1|Adverse Event|3|||
156499896|NCT02684123|564923664|FG001|Phase 1|Adverse Event|0|||
156499897|NCT02684123|564923663|FG000|Phase 1|Lost to Follow-up|0|||
156499898|NCT02684123|564923664|FG001|Phase 1|Lost to Follow-up|1|||
156499899|NCT02684123|564923663|FG000|Phase 2|Lack of Efficacy|1|||
156499900|NCT02684123|564923664|FG001|Phase 2|Lack of Efficacy|8|||
156499901|NCT04991766|564923667|FG000|Overall Study|Withdrawal by Subject|2|||
156499902|NCT04991766|564923668|FG001|Overall Study|Withdrawal by Subject|0|||
156499903|NCT05765435|564923676|FG000|Overall Study|Lost to Follow-up|0|||
156499904|NCT05765435|564923677|FG001|Overall Study|Lost to Follow-up|1|||
156499905|NCT05765435|564923678|FG002|Overall Study|Lost to Follow-up|0|||
156499906|NCT05765435|564923676|FG000|Overall Study|Withdrawal by Subject|0|||
156499907|NCT05765435|564923677|FG001|Overall Study|Withdrawal by Subject|0|||
156499908|NCT05765435|564923678|FG002|Overall Study|Withdrawal by Subject|1|||
156499909|NCT01952847|564923679|FG000|Overall Study|Ineligible|1|||
156499910|NCT01952847|564923680|FG001|Overall Study|Ineligible|0|||
156499911|NCT01952847|564923681|FG002|Overall Study|Ineligible|0|||
156499912|NCT01952847|564923682|FG003|Overall Study|Ineligible|0|||
156499913|NCT01952847|564923679|FG000|Overall Study|Lack of Insurance Coverage|0|||
156499914|NCT01952847|564923680|FG001|Overall Study|Lack of Insurance Coverage|1|||
156499915|NCT01952847|564923681|FG002|Overall Study|Lack of Insurance Coverage|0|||
156499916|NCT01952847|564923682|FG003|Overall Study|Lack of Insurance Coverage|0|||
156499917|NCT01952847|564923679|FG000|Overall Study|Withdrawal by Subject|1|||
156499918|NCT01952847|564923680|FG001|Overall Study|Withdrawal by Subject|1|||
156499919|NCT01952847|564923681|FG002|Overall Study|Withdrawal by Subject|0|||
156499920|NCT01952847|564923682|FG003|Overall Study|Withdrawal by Subject|1|||
156499921|NCT00940875|564923687|FG000|Treatment Phase|Adverse Event|9|||
156499922|NCT00940875|564923688|FG001|Treatment Phase|Adverse Event|3|||
156499923|NCT00940875|564923687|FG000|Treatment Phase|Death|3|||
156499924|NCT00940875|564923688|FG001|Treatment Phase|Death|5|||
156499925|NCT00940875|564923687|FG000|Treatment Phase|Lack of Efficacy|1|||
156499926|NCT00940875|564923688|FG001|Treatment Phase|Lack of Efficacy|0|||
156499927|NCT00940875|564923687|FG000|Treatment Phase|Withdrawal by Subject|3|||
156499928|NCT00940875|564923688|FG001|Treatment Phase|Withdrawal by Subject|0|||
156499929|NCT00940875|564923687|FG000|Treatment Phase|Disease progression|9|||
156499930|NCT00940875|564923688|FG001|Treatment Phase|Disease progression|11|||
156499931|NCT00940875|564923687|FG000|Treatment Phase|Physician Decision|1|||
156499932|NCT00940875|564923688|FG001|Treatment Phase|Physician Decision|0|||
156499933|NCT00940875|564923687|FG000|Post-Study Treatment|Death|0|||
156499934|NCT00940875|564923688|FG001|Post-Study Treatment|Death|1|||
156378137|NCT02480621|564477472|FG001|Follow Up|Lost to Follow-up|2|||
156378138|NCT02610140|564477473|FG000|Randomization and Treatment Period|Radiological progression|23|||
156378139|NCT02610140|564477474|FG001|Randomization and Treatment Period|Radiological progression|15|||
156378140|NCT02610140|564477473|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
156378141|NCT02610140|564477474|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
156499935|NCT00940875|564923687|FG000|Post-Study Treatment|Disease Progression|0|||
156499936|NCT00940875|564923688|FG001|Post-Study Treatment|Disease Progression|2|||
156499937|NCT00943787|564923689|FG000|Overall Study|Physician Decision|4|||
156499938|NCT00943787|564923689|FG000|Overall Study|Withdrawal by Subject|3|||
156499939|NCT01850589|564923690|FG000|Overall Study|Withdrawal by Subject|8|||
156499940|NCT01850589|564923691|FG001|Overall Study|Withdrawal by Subject|0|||
156499941|NCT03721705|564923692|FG000|Overall Study|Adverse Event|2|||
156499942|NCT03721705|564923693|FG001|Overall Study|Adverse Event|0|||
156499943|NCT03721705|564923692|FG000|Overall Study|Withdrawal by Subject|4|||
156499944|NCT03721705|564923693|FG001|Overall Study|Withdrawal by Subject|10|||
156378142|NCT02610140|564477473|FG000|Randomization and Treatment Period|Protocol Violation|1|||
156499945|NCT03721705|564923692|FG000|Overall Study|No Suitable Study Partner|1|||
156499946|NCT03721705|564923693|FG001|Overall Study|No Suitable Study Partner|0|||
156499947|NCT03721705|564923692|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
156378143|NCT02610140|564477474|FG001|Randomization and Treatment Period|Protocol Violation|0|||
156378144|NCT02610140|564477473|FG000|Randomization and Treatment Period|Physician Decision|0|||
156378145|NCT02610140|564477474|FG001|Randomization and Treatment Period|Physician Decision|1|||
156378146|NCT02610140|564477473|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
156378147|NCT02610140|564477474|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
156378148|NCT02610140|564477473|FG000|Randomization and Treatment Period|Death|7|||
156378149|NCT02610140|564477474|FG001|Randomization and Treatment Period|Death|1|||
156378150|NCT02610140|564477473|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
156378151|NCT02610140|564477474|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
156378152|NCT02610140|564477473|FG000|Randomization and Treatment Period|Adverse Event|44|||
156378153|NCT02610140|564477474|FG001|Randomization and Treatment Period|Adverse Event|13|||
156378154|NCT02610140|564477473|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
156378155|NCT02610140|564477474|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
156378156|NCT02610140|564477473|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
156378157|NCT02610140|564477474|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
156378158|NCT02610140|564477473|FG000|Randomization and Treatment Period|Not treated|3|||
156378159|NCT02610140|564477474|FG001|Randomization and Treatment Period|Not treated|10|||
156378160|NCT02610140|564477473|FG000|Safety Follow-up|Other|0|||
156378161|NCT02610140|564477474|FG001|Safety Follow-up|Other|2|||
156378162|NCT02610140|564477473|FG000|Safety Follow-up|Lost to Follow-up|1|||
156378163|NCT02610140|564477474|FG001|Safety Follow-up|Lost to Follow-up|0|||
156378164|NCT02610140|564477473|FG000|Safety Follow-up|No follow-up|5|||
156378165|NCT02610140|564477474|FG001|Safety Follow-up|No follow-up|3|||
156378166|NCT02610140|564477473|FG000|Safety Follow-up|Death|12|||
156378167|NCT02610140|564477474|FG001|Safety Follow-up|Death|2|||
156378168|NCT02610140|564477473|FG000|Safety Follow-up|Deterioration of general conditions|15|||
156378169|NCT02610140|564477474|FG001|Safety Follow-up|Deterioration of general conditions|5|||
156378170|NCT02610140|564477473|FG000|Safety Follow-up|Withdrawal by Subject|12|||
156378171|NCT02610140|564477474|FG001|Safety Follow-up|Withdrawal by Subject|12|||
156378172|NCT02610140|564477473|FG000|Active Follow-up|Progressive disease - radiological|30|||
156378173|NCT02610140|564477474|FG001|Active Follow-up|Progressive disease - radiological|22|||
156378174|NCT02610140|564477473|FG000|Active Follow-up|Death|8|||
156378175|NCT02610140|564477474|FG001|Active Follow-up|Death|1|||
156378176|NCT02610140|564477473|FG000|Active Follow-up|Withdrawal by Subject|4|||
156378177|NCT02610140|564477474|FG001|Active Follow-up|Withdrawal by Subject|0|||
156378178|NCT02610140|564477473|FG000|Active Follow-up|Progressive disease - clinical|1|||
156378179|NCT02610140|564477474|FG001|Active Follow-up|Progressive disease - clinical|2|||
156378180|NCT02610140|564477473|FG000|Active Follow-up|Deterioration of general conditions|1|||
156378181|NCT02610140|564477474|FG001|Active Follow-up|Deterioration of general conditions|0|||
156378182|NCT02610140|564477473|FG000|Active Follow-up|Ongoing but not completed|4|||
156378183|NCT02610140|564477474|FG001|Active Follow-up|Ongoing but not completed|1|||
156378184|NCT02610140|564477473|FG000|Long-term Follow-up|Death|86|||
156378185|NCT02610140|564477474|FG001|Long-term Follow-up|Death|44|||
156378186|NCT02610140|564477473|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
156378187|NCT02610140|564477474|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
156378188|NCT02610140|564477473|FG000|Long-term Follow-up|Lost to Follow-up|1|||
156378189|NCT02610140|564477474|FG001|Long-term Follow-up|Lost to Follow-up|2|||
156378190|NCT02610140|564477473|FG000|Long-term Follow-up|Ongoing but not completed|30|||
156378191|NCT02610140|564477474|FG001|Long-term Follow-up|Ongoing but not completed|17|||
156378192|NCT02617589|564477475|FG000|Randomization|Request to Discontinue Study Treatment|1|||
156378193|NCT02617589|564477476|FG001|Randomization|Request to Discontinue Study Treatment|3|||
156378194|NCT02617589|564477475|FG000|Randomization|Participant Withdrew Consent|1|||
156378195|NCT02617589|564477476|FG001|Randomization|Participant Withdrew Consent|2|||
156378196|NCT02617589|564477475|FG000|Treatment|Other Reasons|3|||
156378197|NCT02617589|564477476|FG001|Treatment|Other Reasons|3|||
156378198|NCT02617589|564477475|FG000|Treatment|Poor/Non Compliance|1|||
156378199|NCT02617589|564477476|FG001|Treatment|Poor/Non Compliance|1|||
156378200|NCT02617589|564477475|FG000|Treatment|Maximum Clinical Benefit|0|||
156378201|NCT02617589|564477476|FG001|Treatment|Maximum Clinical Benefit|2|||
156378202|NCT02617589|564477475|FG000|Treatment|Participant Withdrew Consent|2|||
156378203|NCT02617589|564477476|FG001|Treatment|Participant Withdrew Consent|6|||
156378204|NCT02617589|564477475|FG000|Treatment|Participant Request to Discontinue|12|||
156378205|NCT02617589|564477476|FG001|Treatment|Participant Request to Discontinue|21|||
156378206|NCT02617589|564477475|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
156378207|NCT02617589|564477476|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
156378208|NCT02617589|564477475|FG000|Treatment|Death|1|||
156378209|NCT02617589|564477476|FG001|Treatment|Death|1|||
156378210|NCT02617589|564477475|FG000|Treatment|Study Drug Toxicity|27|||
156378211|NCT02617589|564477476|FG001|Treatment|Study Drug Toxicity|20|||
156378212|NCT02617589|564477475|FG000|Treatment|Disease Progression|216|||
156378213|NCT02617589|564477476|FG001|Treatment|Disease Progression|136|||
156378214|NCT01752933|564477479|FG000|Treatment|Disease Progression|3|||
156378215|NCT01752933|564477480|FG001|Treatment|Disease Progression|29|||
156378216|NCT01752933|564477479|FG000|Treatment|Withdrawal by Subject|0|||
156378217|NCT01752933|564477480|FG001|Treatment|Withdrawal by Subject|5|||
156378218|NCT01752933|564477479|FG000|Treatment|Adverse Event|1|||
156378219|NCT01752933|564477480|FG001|Treatment|Adverse Event|4|||
156378220|NCT01752933|564477479|FG000|Treatment|Physician Decision|0|||
156378221|NCT01752933|564477480|FG001|Treatment|Physician Decision|3|||
156378222|NCT01752933|564477479|FG000|Treatment|Death|0|||
156378223|NCT01752933|564477480|FG001|Treatment|Death|2|||
156499948|NCT03721705|564923693|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
156499949|NCT03721705|564923692|FG000|Overall Study|Death|0|||
156499950|NCT03721705|564923693|FG001|Overall Study|Death|1|||
156499951|NCT01843777|564923694|FG000|Overall Study|Withdrawal by Subject|1|||
156499952|NCT01843777|564923695|FG001|Overall Study|Withdrawal by Subject|0|||
156499953|NCT05147350|564923697|FG000|Overall Study|Death|2|||
156499954|NCT05147350|564923698|FG001|Overall Study|Death|3|||
156499955|NCT05147350|564923699|FG002|Overall Study|Death|3|||
156499956|NCT05147350|564923700|FG003|Overall Study|Death|2|||
156499957|NCT05147350|564923701|FG004|Overall Study|Death|2|||
156499958|NCT05147350|564923702|FG005|Overall Study|Death|1|||
156499959|NCT05147350|564923703|FG006|Overall Study|Death|1|||
156499960|NCT05147350|564923704|FG007|Overall Study|Death|3|||
156499961|NCT05147350|564923697|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
156499962|NCT05147350|564923698|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
156499963|NCT05147350|564923699|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
156499964|NCT05147350|564923700|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
156499965|NCT05147350|564923701|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
156499966|NCT05147350|564923702|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
156499967|NCT05147350|564923703|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
156499968|NCT05147350|564923704|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
156499969|NCT05147350|564923697|FG000|Overall Study|Withdrawal by Subject|0|||
156499970|NCT05147350|564923698|FG001|Overall Study|Withdrawal by Subject|0|||
156499971|NCT05147350|564923699|FG002|Overall Study|Withdrawal by Subject|3|||
156499972|NCT05147350|564923700|FG003|Overall Study|Withdrawal by Subject|1|||
156499973|NCT05147350|564923701|FG004|Overall Study|Withdrawal by Subject|1|||
156499974|NCT05147350|564923702|FG005|Overall Study|Withdrawal by Subject|0|||
156499975|NCT05147350|564923703|FG006|Overall Study|Withdrawal by Subject|1|||
156499976|NCT05147350|564923704|FG007|Overall Study|Withdrawal by Subject|0|||
156499977|NCT05147350|564923697|FG000|Overall Study|Other Reasons|0|||
156499978|NCT05147350|564923698|FG001|Overall Study|Other Reasons|0|||
156378224|NCT01752933|564477479|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
156378225|NCT01752933|564477480|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
156378226|NCT01752933|564477479|FG000|Treatment|Patient noncompliant|0|||
156378227|NCT01752933|564477480|FG001|Treatment|Patient noncompliant|1|||
156378228|NCT01752933|564477479|FG000|Treatment|Patient unable to travel to appointments|0|||
156378229|NCT01752933|564477480|FG001|Treatment|Patient unable to travel to appointments|1|||
156378230|NCT01752933|564477479|FG000|Overall Study and Follow-up|Death|4|||
156378231|NCT01752933|564477480|FG001|Overall Study and Follow-up|Death|34|||
156378232|NCT01752933|564477479|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
156378233|NCT01752933|564477480|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
156378234|NCT01752933|564477479|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
156378235|NCT01752933|564477480|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
156378236|NCT01752933|564477479|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
156378237|NCT01752933|564477480|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
156378238|NCT01591681|564477481|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
156378239|NCT01591681|564477481|FG000|Overall Study|Failed to use system during run-in|1|||
156378240|NCT03794089|564479780|FG000|Overall Study|Lost to Follow-up|4|||
156378241|NCT03794089|564479781|FG001|Overall Study|Lost to Follow-up|1|||
156378242|NCT03794089|564479780|FG000|Overall Study|Withdrawal by Subject|2|||
156378243|NCT03794089|564479781|FG001|Overall Study|Withdrawal by Subject|0|||
156378244|NCT03985423|564479782|FG000|Overall Study|Adverse Event|1|||
156378245|NCT03985423|564479782|FG000|Overall Study|Death|2|||
156378246|NCT03985423|564479782|FG000|Overall Study|Physician Decision|1|||
156378247|NCT03985423|564479782|FG000|Overall Study|Withdrawal by Subject|2|||
156378248|NCT03985423|564479782|FG000|Overall Study|Lack of insurance and citizenship|1|||
156378249|NCT01782131|564479786|FG000|Overall Study|Death|93|||
156378250|NCT01782131|564479787|FG001|Overall Study|Death|96|||
156378251|NCT01782131|564479786|FG000|Overall Study|Lost to Follow-up|1|||
156378252|NCT01782131|564479787|FG001|Overall Study|Lost to Follow-up|3|||
156378253|NCT01782131|564479786|FG000|Overall Study|Withdrawal by Subject|10|||
156378254|NCT01782131|564479787|FG001|Overall Study|Withdrawal by Subject|10|||
156499979|NCT05147350|564923699|FG002|Overall Study|Other Reasons|2|||
156499980|NCT05147350|564923700|FG003|Overall Study|Other Reasons|0|||
156499981|NCT05147350|564923701|FG004|Overall Study|Other Reasons|0|||
156499982|NCT05147350|564923702|FG005|Overall Study|Other Reasons|2|||
156499983|NCT05147350|564923703|FG006|Overall Study|Other Reasons|1|||
156499984|NCT05147350|564923704|FG007|Overall Study|Other Reasons|1|||
156499985|NCT01080326|564923705|FG000|Overall Study|Patient deterioration prior to procedure|3|||
156499986|NCT01080326|564923705|FG000|Overall Study|Surgeon decision|1|||
156499987|NCT01628692|564923708|FG000|Overall Study|Lack of Efficacy|4|||
156499988|NCT01628692|564923709|FG001|Overall Study|Lack of Efficacy|4|||
156499989|NCT01628692|564923710|FG002|Overall Study|Lack of Efficacy|5|||
156499990|NCT01628692|564923711|FG003|Overall Study|Lack of Efficacy|1|||
156499991|NCT01628692|564923712|FG004|Overall Study|Lack of Efficacy|4|||
156499992|NCT01628692|564923713|FG005|Overall Study|Lack of Efficacy|7|||
156499993|NCT01628692|564923708|FG000|Overall Study|Adverse Event|2|||
156499994|NCT01628692|564923709|FG001|Overall Study|Adverse Event|0|||
156499995|NCT01628692|564923710|FG002|Overall Study|Adverse Event|2|||
156499996|NCT01628692|564923711|FG003|Overall Study|Adverse Event|0|||
156499997|NCT01628692|564923712|FG004|Overall Study|Adverse Event|0|||
156499998|NCT01628692|564923713|FG005|Overall Study|Adverse Event|0|||
156499999|NCT01628692|564923708|FG000|Overall Study|Withdrawal by Subject|0|||
156500000|NCT01628692|564923709|FG001|Overall Study|Withdrawal by Subject|1|||
156500001|NCT01628692|564923710|FG002|Overall Study|Withdrawal by Subject|1|||
156500002|NCT01628692|564923711|FG003|Overall Study|Withdrawal by Subject|0|||
156500003|NCT01628692|564923712|FG004|Overall Study|Withdrawal by Subject|0|||
156500004|NCT01628692|564923713|FG005|Overall Study|Withdrawal by Subject|0|||
156500005|NCT01628692|564923708|FG000|Overall Study|Death|0|||
156500006|NCT01628692|564923709|FG001|Overall Study|Death|1|||
156500007|NCT01628692|564923710|FG002|Overall Study|Death|0|||
156500008|NCT01628692|564923711|FG003|Overall Study|Death|0|||
156500009|NCT01628692|564923712|FG004|Overall Study|Death|0|||
156500010|NCT01628692|564923713|FG005|Overall Study|Death|0|||
156500011|NCT01628692|564923708|FG000|Overall Study|Poor compliance/noncompliance|1|||
156500012|NCT01628692|564923709|FG001|Overall Study|Poor compliance/noncompliance|0|||
156500013|NCT01628692|564923710|FG002|Overall Study|Poor compliance/noncompliance|0|||
156500014|NCT01628692|564923711|FG003|Overall Study|Poor compliance/noncompliance|0|||
156500015|NCT01628692|564923712|FG004|Overall Study|Poor compliance/noncompliance|0|||
156500016|NCT01628692|564923713|FG005|Overall Study|Poor compliance/noncompliance|0|||
156500017|NCT01628692|564923708|FG000|Overall Study|Administrative reason by sponsor|0|||
156500018|NCT01628692|564923709|FG001|Overall Study|Administrative reason by sponsor|0|||
156500019|NCT01628692|564923710|FG002|Overall Study|Administrative reason by sponsor|0|||
156500020|NCT01628692|564923711|FG003|Overall Study|Administrative reason by sponsor|0|||
156500021|NCT01628692|564923712|FG004|Overall Study|Administrative reason by sponsor|0|||
156500022|NCT01628692|564923713|FG005|Overall Study|Administrative reason by sponsor|1|||
156500023|NCT01628692|564923708|FG000|Overall Study|Completed 12 Week only|0|||
156500024|NCT01628692|564923709|FG001|Overall Study|Completed 12 Week only|0|||
156500025|NCT01628692|564923710|FG002|Overall Study|Completed 12 Week only|0|||
156500026|NCT01628692|564923711|FG003|Overall Study|Completed 12 Week only|0|||
156500027|NCT01628692|564923712|FG004|Overall Study|Completed 12 Week only|0|||
156500028|NCT01628692|564923713|FG005|Overall Study|Completed 12 Week only|1|||
156500029|NCT02437071|564923714|FG000|Overall Study|Withdrawal by Subject|1|||
156500030|NCT02437071|564923715|FG001|Overall Study|Withdrawal by Subject|0|||
156500031|NCT03513068|564923720|FG000|Overall Study|Death|1|||
156500032|NCT03513068|564923721|FG001|Overall Study|Death|0|||
156500033|NCT03513068|564923720|FG000|Overall Study|Withdrawal by Subject|4|||
156500034|NCT03513068|564923721|FG001|Overall Study|Withdrawal by Subject|6|||
156500035|NCT04788511|564923722|FG000|Overall Study|Withdrawal by Subject|2|||
156500036|NCT04788511|564923723|FG001|Overall Study|Withdrawal by Subject|1|||
156500037|NCT04788511|564923722|FG000|Overall Study|Lost to Follow-up|2|||
156500038|NCT04788511|564923723|FG001|Overall Study|Lost to Follow-up|7|||
156500039|NCT04788511|564923722|FG000|Overall Study|Death|3|||
156500040|NCT04788511|564923723|FG001|Overall Study|Death|4|||
156500041|NCT03636373|564923724|FG000|Overall Study|Study closure due to Covid-19|1|||
156500042|NCT03636373|564923725|FG001|Overall Study|Study closure due to Covid-19|0|||
156500043|NCT02353468|564923726|FG000|Overall Study|Study terminated|3|||
156500044|NCT01236352|564923727|FG000|Overall Study|Death|0|||
156500045|NCT01236352|564923728|FG001|Overall Study|Death|0|||
156500046|NCT01236352|564923729|FG002|Overall Study|Death|0|||
156546793|NCT00708500|565094966|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
156546794|NCT00708500|565094967|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
156546795|NCT00708500|565094968|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
156500047|NCT01236352|564923730|FG003|Overall Study|Death|0|||
156500048|NCT01236352|564923731|FG004|Overall Study|Death|0|||
156500049|NCT01236352|564923732|FG005|Overall Study|Death|0|||
156500050|NCT01236352|564923733|FG006|Overall Study|Death|0|||
156546796|NCT00708500|565094966|FG000|FOLLOWUP|Subject withdrew consent|31|||
156500051|NCT01236352|564923734|FG007|Overall Study|Death|1|||
156500052|NCT01236352|564923735|FG008|Overall Study|Death|0|||
156500053|NCT01236352|564923736|FG009|Overall Study|Death|0|||
156500054|NCT01236352|564923737|FG010|Overall Study|Death|0|||
156500055|NCT01236352|564923727|FG000|Overall Study|Withdrawal by Subject|0|||
156500056|NCT01236352|564923728|FG001|Overall Study|Withdrawal by Subject|0|||
156500057|NCT01236352|564923729|FG002|Overall Study|Withdrawal by Subject|0|||
156500058|NCT01236352|564923730|FG003|Overall Study|Withdrawal by Subject|0|||
156500059|NCT01236352|564923731|FG004|Overall Study|Withdrawal by Subject|0|||
156500060|NCT01236352|564923732|FG005|Overall Study|Withdrawal by Subject|0|||
156500061|NCT01236352|564923733|FG006|Overall Study|Withdrawal by Subject|0|||
156500062|NCT01236352|564923734|FG007|Overall Study|Withdrawal by Subject|0|||
156500063|NCT01236352|564923735|FG008|Overall Study|Withdrawal by Subject|0|||
156500064|NCT01236352|564923736|FG009|Overall Study|Withdrawal by Subject|2|||
156500065|NCT01236352|564923737|FG010|Overall Study|Withdrawal by Subject|1|||
156500066|NCT01236352|564923727|FG000|Overall Study|Adverse Event|0|||
156500067|NCT01236352|564923728|FG001|Overall Study|Adverse Event|0|||
156500068|NCT01236352|564923729|FG002|Overall Study|Adverse Event|0|||
156500069|NCT01236352|564923730|FG003|Overall Study|Adverse Event|0|||
156500070|NCT01236352|564923731|FG004|Overall Study|Adverse Event|0|||
156500071|NCT01236352|564923732|FG005|Overall Study|Adverse Event|0|||
156500072|NCT01236352|564923733|FG006|Overall Study|Adverse Event|2|||
156500073|NCT01236352|564923734|FG007|Overall Study|Adverse Event|0|||
156500074|NCT01236352|564923735|FG008|Overall Study|Adverse Event|0|||
156500075|NCT01236352|564923736|FG009|Overall Study|Adverse Event|4|||
156500076|NCT01236352|564923737|FG010|Overall Study|Adverse Event|1|||
156500077|NCT01236352|564923727|FG000|Overall Study|Study drug toxicity|0|||
156500078|NCT01236352|564923728|FG001|Overall Study|Study drug toxicity|0|||
156500079|NCT01236352|564923729|FG002|Overall Study|Study drug toxicity|0|||
156500080|NCT01236352|564923730|FG003|Overall Study|Study drug toxicity|0|||
156500081|NCT01236352|564923731|FG004|Overall Study|Study drug toxicity|0|||
156500082|NCT01236352|564923732|FG005|Overall Study|Study drug toxicity|1|||
156500083|NCT01236352|564923733|FG006|Overall Study|Study drug toxicity|1|||
156500084|NCT01236352|564923734|FG007|Overall Study|Study drug toxicity|0|||
156500085|NCT01236352|564923735|FG008|Overall Study|Study drug toxicity|0|||
156500086|NCT01236352|564923736|FG009|Overall Study|Study drug toxicity|2|||
156500087|NCT01236352|564923737|FG010|Overall Study|Study drug toxicity|2|||
156500088|NCT01236352|564923727|FG000|Overall Study|Disease progression|1|||
156500089|NCT01236352|564923728|FG001|Overall Study|Disease progression|2|||
156500090|NCT01236352|564923729|FG002|Overall Study|Disease progression|1|||
156500091|NCT01236352|564923730|FG003|Overall Study|Disease progression|2|||
156500092|NCT01236352|564923731|FG004|Overall Study|Disease progression|2|||
156500093|NCT01236352|564923732|FG005|Overall Study|Disease progression|2|||
156500094|NCT01236352|564923733|FG006|Overall Study|Disease progression|1|||
156500095|NCT01236352|564923734|FG007|Overall Study|Disease progression|3|||
156500096|NCT01236352|564923735|FG008|Overall Study|Disease progression|2|||
156500097|NCT01236352|564923736|FG009|Overall Study|Disease progression|2|||
156500098|NCT01236352|564923737|FG010|Overall Study|Disease progression|2|||
156500099|NCT01236352|564923727|FG000|Overall Study|Poor/Non-compliance|1|||
156500100|NCT01236352|564923728|FG001|Overall Study|Poor/Non-compliance|0|||
156500101|NCT01236352|564923729|FG002|Overall Study|Poor/Non-compliance|0|||
156500102|NCT01236352|564923730|FG003|Overall Study|Poor/Non-compliance|0|||
156500103|NCT01236352|564923731|FG004|Overall Study|Poor/Non-compliance|0|||
156500104|NCT01236352|564923732|FG005|Overall Study|Poor/Non-compliance|0|||
156500105|NCT01236352|564923733|FG006|Overall Study|Poor/Non-compliance|0|||
156500106|NCT01236352|564923734|FG007|Overall Study|Poor/Non-compliance|0|||
156500107|NCT01236352|564923735|FG008|Overall Study|Poor/Non-compliance|0|||
156500108|NCT01236352|564923736|FG009|Overall Study|Poor/Non-compliance|0|||
156500109|NCT01236352|564923737|FG010|Overall Study|Poor/Non-compliance|0|||
156500110|NCT01236352|564923727|FG000|Overall Study|Maximum clinical benefit|1|||
156500111|NCT01236352|564923728|FG001|Overall Study|Maximum clinical benefit|1|||
156500112|NCT01236352|564923729|FG002|Overall Study|Maximum clinical benefit|1|||
156500113|NCT01236352|564923730|FG003|Overall Study|Maximum clinical benefit|0|||
156500114|NCT01236352|564923731|FG004|Overall Study|Maximum clinical benefit|2|||
156500115|NCT01236352|564923732|FG005|Overall Study|Maximum clinical benefit|0|||
156500116|NCT01236352|564923733|FG006|Overall Study|Maximum clinical benefit|3|||
156500117|NCT01236352|564923734|FG007|Overall Study|Maximum clinical benefit|1|||
156500118|NCT01236352|564923735|FG008|Overall Study|Maximum clinical benefit|1|||
156500119|NCT01236352|564923736|FG009|Overall Study|Maximum clinical benefit|4|||
156500120|NCT01236352|564923737|FG010|Overall Study|Maximum clinical benefit|2|||
156500121|NCT01236352|564923727|FG000|Overall Study|Subject request to discontinue treatment|0|||
156500122|NCT01236352|564923728|FG001|Overall Study|Subject request to discontinue treatment|0|||
156546797|NCT00708500|565094967|FG001|FOLLOWUP|Subject withdrew consent|4|||
156546798|NCT00708500|565094968|FG002|FOLLOWUP|Subject withdrew consent|5|||
156546799|NCT00708500|565094966|FG000|FOLLOWUP|Non-compliance with protocol|5|||
156546800|NCT00708500|565094967|FG001|FOLLOWUP|Non-compliance with protocol|0|||
156500123|NCT01236352|564923729|FG002|Overall Study|Subject request to discontinue treatment|1|||
156500124|NCT01236352|564923730|FG003|Overall Study|Subject request to discontinue treatment|1|||
156500125|NCT01236352|564923731|FG004|Overall Study|Subject request to discontinue treatment|0|||
156500126|NCT01236352|564923732|FG005|Overall Study|Subject request to discontinue treatment|1|||
156500127|NCT01236352|564923733|FG006|Overall Study|Subject request to discontinue treatment|0|||
156500128|NCT01236352|564923734|FG007|Overall Study|Subject request to discontinue treatment|0|||
156500129|NCT01236352|564923735|FG008|Overall Study|Subject request to discontinue treatment|0|||
156500130|NCT01236352|564923736|FG009|Overall Study|Subject request to discontinue treatment|1|||
156500131|NCT01236352|564923737|FG010|Overall Study|Subject request to discontinue treatment|4|||
156500132|NCT01236352|564923727|FG000|Overall Study|Subject to receive drug via EAP|1|||
156546801|NCT00708500|565094968|FG002|FOLLOWUP|Non-compliance with protocol|1|||
156500133|NCT01236352|564923728|FG001|Overall Study|Subject to receive drug via EAP|1|||
156500134|NCT01236352|564923729|FG002|Overall Study|Subject to receive drug via EAP|1|||
156500135|NCT01236352|564923730|FG003|Overall Study|Subject to receive drug via EAP|0|||
156500136|NCT01236352|564923731|FG004|Overall Study|Subject to receive drug via EAP|0|||
156500137|NCT01236352|564923732|FG005|Overall Study|Subject to receive drug via EAP|0|||
156500138|NCT01236352|564923733|FG006|Overall Study|Subject to receive drug via EAP|0|||
156500139|NCT01236352|564923734|FG007|Overall Study|Subject to receive drug via EAP|2|||
156500140|NCT01236352|564923735|FG008|Overall Study|Subject to receive drug via EAP|0|||
156500141|NCT01236352|564923736|FG009|Overall Study|Subject to receive drug via EAP|4|||
156500142|NCT01236352|564923737|FG010|Overall Study|Subject to receive drug via EAP|0|||
156500143|NCT01236352|564923727|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
156500144|NCT01236352|564923728|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
156500145|NCT01236352|564923729|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
156500146|NCT01236352|564923730|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
156500147|NCT01236352|564923731|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
156500148|NCT01236352|564923732|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
156500149|NCT01236352|564923733|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
156500150|NCT01236352|564923734|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
156500151|NCT01236352|564923735|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
156500152|NCT01236352|564923736|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
156500153|NCT01236352|564923737|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
156500154|NCT01236352|564923727|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500155|NCT01236352|564923728|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500156|NCT01236352|564923729|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500157|NCT01236352|564923730|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500158|NCT01236352|564923731|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500159|NCT01236352|564923732|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500160|NCT01236352|564923733|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500161|NCT01236352|564923734|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500162|NCT01236352|564923735|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500163|NCT01236352|564923736|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
156500164|NCT01236352|564923737|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
156500165|NCT01236352|564923727|FG000|Overall Study|Lack of response to drug|0|||
156500166|NCT01236352|564923728|FG001|Overall Study|Lack of response to drug|0|||
156500167|NCT01236352|564923729|FG002|Overall Study|Lack of response to drug|0|||
156500168|NCT01236352|564923730|FG003|Overall Study|Lack of response to drug|0|||
156500169|NCT01236352|564923731|FG004|Overall Study|Lack of response to drug|0|||
156500170|NCT01236352|564923732|FG005|Overall Study|Lack of response to drug|0|||
156500171|NCT01236352|564923733|FG006|Overall Study|Lack of response to drug|0|||
156500172|NCT01236352|564923734|FG007|Overall Study|Lack of response to drug|0|||
156500173|NCT01236352|564923735|FG008|Overall Study|Lack of response to drug|0|||
156500174|NCT01236352|564923736|FG009|Overall Study|Lack of response to drug|1|||
156500175|NCT01236352|564923737|FG010|Overall Study|Lack of response to drug|1|||
156500176|NCT01236352|564923727|FG000|Overall Study|Patient transferred to IST|0|||
156500177|NCT01236352|564923728|FG001|Overall Study|Patient transferred to IST|0|||
156500178|NCT01236352|564923729|FG002|Overall Study|Patient transferred to IST|0|||
156500179|NCT01236352|564923730|FG003|Overall Study|Patient transferred to IST|0|||
156500180|NCT01236352|564923731|FG004|Overall Study|Patient transferred to IST|0|||
156500181|NCT01236352|564923732|FG005|Overall Study|Patient transferred to IST|0|||
156500182|NCT01236352|564923733|FG006|Overall Study|Patient transferred to IST|0|||
156500183|NCT01236352|564923734|FG007|Overall Study|Patient transferred to IST|0|||
156500184|NCT01236352|564923735|FG008|Overall Study|Patient transferred to IST|0|||
156500185|NCT01236352|564923736|FG009|Overall Study|Patient transferred to IST|2|||
156500186|NCT01236352|564923737|FG010|Overall Study|Patient transferred to IST|6|||
156500187|NCT01575873|564923738|FG000|Overall Study|Withdrawal by Subject|15|||
156378255|NCT01782131|564479786|FG000|Overall Study|Randomized but not treated|5|||
156378256|NCT01782131|564479787|FG001|Overall Study|Randomized but not treated|5|||
156546802|NCT00794677|565094978|FG000|First Intervention|Withdrawal by Subject|2|||
156378257|NCT01782131|564479786|FG000|Overall Study|Reason not provided|0|||
156500188|NCT01575873|564923739|FG001|Overall Study|Withdrawal by Subject|20|||
156500189|NCT01575873|564923740|FG002|Overall Study|Withdrawal by Subject|34|||
156500190|NCT01575873|564923741|FG003|Overall Study|Withdrawal by Subject|34|||
156500191|NCT01575873|564923738|FG000|Overall Study|Adverse Event|7|||
156500192|NCT01575873|564923739|FG001|Overall Study|Adverse Event|7|||
156500193|NCT01575873|564923740|FG002|Overall Study|Adverse Event|9|||
156500194|NCT01575873|564923741|FG003|Overall Study|Adverse Event|12|||
156378258|NCT01782131|564479787|FG001|Overall Study|Reason not provided|1|||
156500195|NCT01575873|564923738|FG000|Overall Study|Lost to Follow-up|1|||
156500196|NCT01575873|564923739|FG001|Overall Study|Lost to Follow-up|3|||
156500197|NCT01575873|564923740|FG002|Overall Study|Lost to Follow-up|13|||
156500198|NCT01575873|564923741|FG003|Overall Study|Lost to Follow-up|5|||
156500199|NCT01575873|564923738|FG000|Overall Study|Death|3|||
156500200|NCT01575873|564923739|FG001|Overall Study|Death|2|||
156500201|NCT01575873|564923740|FG002|Overall Study|Death|8|||
156500202|NCT01575873|564923741|FG003|Overall Study|Death|9|||
156500203|NCT01575873|564923738|FG000|Overall Study|Noncompliance|1|||
156500204|NCT01575873|564923739|FG001|Overall Study|Noncompliance|2|||
156500205|NCT01575873|564923740|FG002|Overall Study|Noncompliance|4|||
156500206|NCT01575873|564923741|FG003|Overall Study|Noncompliance|3|||
156500207|NCT01575873|564923738|FG000|Overall Study|Administrative decision|1|||
156500208|NCT01575873|564923739|FG001|Overall Study|Administrative decision|1|||
156500209|NCT01575873|564923740|FG002|Overall Study|Administrative decision|1|||
156500210|NCT01575873|564923741|FG003|Overall Study|Administrative decision|0|||
156500211|NCT01575873|564923738|FG000|Overall Study|Protocol deviation|0|||
156500212|NCT01575873|564923739|FG001|Overall Study|Protocol deviation|1|||
156500213|NCT01575873|564923740|FG002|Overall Study|Protocol deviation|0|||
156500214|NCT01575873|564923741|FG003|Overall Study|Protocol deviation|1|||
156500215|NCT01575873|564923738|FG000|Overall Study|Requirement for Alternative Therapy|0|||
156500216|NCT01575873|564923739|FG001|Overall Study|Requirement for Alternative Therapy|0|||
156500217|NCT01575873|564923740|FG002|Overall Study|Requirement for Alternative Therapy|1|||
156500218|NCT01575873|564923741|FG003|Overall Study|Requirement for Alternative Therapy|1|||
156500219|NCT01575873|564923738|FG000|Overall Study|Other|0|||
156500220|NCT01575873|564923739|FG001|Overall Study|Other|0|||
156500221|NCT01575873|564923740|FG002|Overall Study|Other|4|||
156500222|NCT01575873|564923741|FG003|Overall Study|Other|2|||
156500223|NCT00246090|564923743|FG000|Overall Study|Adverse Event|25|||
156500224|NCT00246090|564923743|FG000|Overall Study|Withdrawal by Subject|7|||
156500225|NCT00246090|564923743|FG000|Overall Study|Progressive Disease|212|||
156500226|NCT00246090|564923743|FG000|Overall Study|Clinical Progression|30|||
156500227|NCT00246090|564923743|FG000|Overall Study|Physician Decision|11|||
156500228|NCT00246090|564923743|FG000|Overall Study|Not Otherwise Specified|10|||
156500229|NCT02688530|564923747|FG000|Overall Study|Withdrawal by Subject|0|||
156500230|NCT02688530|564923748|FG001|Overall Study|Withdrawal by Subject|1|||
156500231|NCT02688530|564923749|FG002|Overall Study|Withdrawal by Subject|0|||
156500232|NCT02688530|564923750|FG003|Overall Study|Withdrawal by Subject|0|||
156500233|NCT02688530|564923747|FG000|Overall Study|Lost to Follow-up|0|||
156500234|NCT02688530|564923748|FG001|Overall Study|Lost to Follow-up|0|||
156500235|NCT02688530|564923749|FG002|Overall Study|Lost to Follow-up|2|||
156500236|NCT02688530|564923750|FG003|Overall Study|Lost to Follow-up|0|||
156500237|NCT01658020|564923751|FG000|Overall Study|Adverse Event|3|||
156500238|NCT01658020|564923752|FG001|Overall Study|Adverse Event|3|||
156500239|NCT01658020|564923751|FG000|Overall Study|Lost to Follow-up|1|||
156500240|NCT01658020|564923752|FG001|Overall Study|Lost to Follow-up|0|||
156500241|NCT01658020|564923751|FG000|Overall Study|Withdrawal by Subject|4|||
156500242|NCT01658020|564923752|FG001|Overall Study|Withdrawal by Subject|5|||
156500243|NCT01658020|564923751|FG000|Overall Study|Protocol Violation|0|||
156500244|NCT01658020|564923752|FG001|Overall Study|Protocol Violation|1|||
156500245|NCT02554383|564923758|FG000|Overall Study|Ineligible|3|||
156500246|NCT02554383|564923759|FG001|Overall Study|Ineligible|2|||
156500247|NCT02554383|564923758|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
156500248|NCT02554383|564923759|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
156500249|NCT02554383|564923758|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
156500250|NCT02554383|564923759|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
156500251|NCT02554383|564923758|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
156500252|NCT02554383|564923759|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
156500253|NCT02165826|564923760|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
156500254|NCT02165826|564923761|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
156500255|NCT02165826|564923762|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
156500256|NCT02165826|564923760|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
156500257|NCT02165826|564923761|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
156500258|NCT02165826|564923762|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
156500259|NCT02165826|564923760|FG000|Main Treatment Period|Lost to Follow-up|4|||
156500260|NCT02165826|564923761|FG001|Main Treatment Period|Lost to Follow-up|2|||
156500261|NCT02165826|564923762|FG002|Main Treatment Period|Lost to Follow-up|1|||
156500262|NCT02165826|564923760|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
156500263|NCT02165826|564923761|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
156500264|NCT02165826|564923762|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
156500265|NCT02165826|564923760|FG000|Main Treatment Period|Lack of Efficacy|2|||
156500266|NCT02165826|564923761|FG001|Main Treatment Period|Lack of Efficacy|0|||
156500267|NCT02165826|564923762|FG002|Main Treatment Period|Lack of Efficacy|0|||
156500268|NCT02165826|564923760|FG000|Main Treatment Period|Reason Not Specified|8|||
156500269|NCT02165826|564923761|FG001|Main Treatment Period|Reason Not Specified|5|||
156500270|NCT02165826|564923762|FG002|Main Treatment Period|Reason Not Specified|16|||
156500271|NCT02165826|564923760|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
156500272|NCT02165826|564923761|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
156500273|NCT02165826|564923762|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
156378259|NCT01627249|564479788|FG000|Overall Study|Death|3|||
156378260|NCT01627249|564479789|FG001|Overall Study|Death|5|||
156378261|NCT01627249|564479790|FG002|Overall Study|Death|3|||
156378262|NCT01627249|564479788|FG000|Overall Study|Withdrawal by Subject|12|||
156378263|NCT01627249|564479789|FG001|Overall Study|Withdrawal by Subject|6|||
156378264|NCT01627249|564479790|FG002|Overall Study|Withdrawal by Subject|9|||
156378265|NCT01627249|564479788|FG000|Overall Study|Missed Visit|1|||
156378266|NCT01627249|564479789|FG001|Overall Study|Missed Visit|1|||
156378267|NCT01627249|564479790|FG002|Overall Study|Missed Visit|0|||
156378268|NCT00796718|564479791|FG000|Overall Study|Adverse Event|2|||
156378269|NCT00796718|564479791|FG000|Overall Study|Exclusion Criteria|1|||
156378270|NCT00796718|564479791|FG000|Overall Study|Lost to Follow-up|5|||
156378271|NCT00796718|564479791|FG000|Overall Study|Withdrawal by Informed Consent|1|||
156378272|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Adverse Event|5|||
156378273|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Adverse Event|8|||
156378274|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Adverse Event|4|||
156378275|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Adverse Event|8|||
156378276|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
156378277|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
156378278|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
156378279|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
156378280|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
156378281|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
156378282|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
156378283|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
156378284|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Physician Decision|1|||
156378285|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Physician Decision|0|||
156378286|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Physician Decision|0|||
156378287|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Physician Decision|0|||
156378288|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
156378289|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
156378290|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
156378291|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
156378292|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Pregnancy|0|||
156378293|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Pregnancy|1|||
156378294|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Pregnancy|0|||
156378295|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Pregnancy|0|||
156378296|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
156378297|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
156378298|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
156378299|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
156378300|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Death|0|||
156378301|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Death|1|||
156378302|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Death|0|||
156378303|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Death|0|||
156378304|NCT00071487|564479797|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
156378305|NCT00071487|564479798|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
156378306|NCT00071487|564479799|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
156378307|NCT00071487|564479800|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
156378308|NCT00071487|564479797|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
156378309|NCT00071487|564479798|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
156378310|NCT00071487|564479799|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
156378311|NCT00071487|564479800|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
156378312|NCT00071487|564479797|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156378313|NCT00071487|564479798|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156378314|NCT00071487|564479799|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156378315|NCT00071487|564479800|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
156378316|NCT00071487|564479797|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156378317|NCT00071487|564479798|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156378318|NCT00071487|564479799|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156378319|NCT00071487|564479800|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
156378320|NCT00071487|564479797|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
156378321|NCT00071487|564479798|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
156378322|NCT00071487|564479799|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
156378323|NCT00071487|564479800|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
156378324|NCT00071487|564479797|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156378325|NCT00071487|564479798|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156378326|NCT00071487|564479799|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156378327|NCT00071487|564479800|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
156378328|NCT00071487|564479797|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156500274|NCT02165826|564923760|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
156378329|NCT00071487|564479798|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156500275|NCT02165826|564923761|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
156500276|NCT02165826|564923762|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
156500277|NCT02165826|564923760|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
156500278|NCT02165826|564923761|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
156500279|NCT02165826|564923762|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
156500280|NCT02165826|564923760|FG000|Down-Titration Period|Reason Not Specified|1|||
156500281|NCT02165826|564923761|FG001|Down-Titration Period|Reason Not Specified|0|||
156500282|NCT02165826|564923762|FG002|Down-Titration Period|Reason Not Specified|2|||
156500283|NCT02581059|564923763|FG000|Study Treatment|Disease Progression|1|||
156500284|NCT02581059|564923764|FG001|Study Treatment|Disease Progression|1|||
156500285|NCT02581059|564923763|FG000|Study Treatment|Adverse Event|2|||
156500286|NCT02581059|564923764|FG001|Study Treatment|Adverse Event|1|||
156500287|NCT02581059|564923763|FG000|Study Treatment|Death|1|||
156500288|NCT02581059|564923764|FG001|Study Treatment|Death|1|||
156500289|NCT02581059|564923763|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
156500290|NCT02581059|564923764|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
156378330|NCT00071487|564479799|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156378331|NCT00071487|564479800|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
156378332|NCT02044510|564479803|FG000|Overall Study|Adverse Event|1|||
156378333|NCT02044510|564479804|FG001|Overall Study|Adverse Event|2|||
156378334|NCT01154166|564479805|FG000|Overall Study|Adverse Event|14|||
156378335|NCT01154166|564479806|FG001|Overall Study|Adverse Event|9|||
156378336|NCT01154166|564479805|FG000|Overall Study|Lost to Follow-up|1|||
156378337|NCT01154166|564479806|FG001|Overall Study|Lost to Follow-up|1|||
156378338|NCT01154166|564479805|FG000|Overall Study|Protocol Violation|4|||
156378339|NCT01154166|564479806|FG001|Overall Study|Protocol Violation|1|||
156378340|NCT01154166|564479805|FG000|Overall Study|Withdrawal by Subject|10|||
156378341|NCT01154166|564479806|FG001|Overall Study|Withdrawal by Subject|1|||
156378342|NCT01154166|564479805|FG000|Overall Study|Lack of Efficacy|3|||
156378343|NCT01154166|564479806|FG001|Overall Study|Lack of Efficacy|0|||
156378344|NCT01154166|564479805|FG000|Overall Study|Disease Progression|1|||
156378345|NCT01154166|564479806|FG001|Overall Study|Disease Progression|0|||
156378346|NCT01154166|564479805|FG000|Overall Study|Poor Compliance|1|||
156378347|NCT01154166|564479806|FG001|Overall Study|Poor Compliance|0|||
156378348|NCT01375049|564479807|FG000|Overall Study|Adverse Event|2|||
156378349|NCT01375049|564479807|FG000|Overall Study|Lost to Follow-up|1|||
156378350|NCT01375049|564479807|FG000|Overall Study|Withdrawal by Subject|2|||
156378351|NCT01375049|564479807|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
156378352|NCT03614793|564479808|FG000|Overall Study|Lost to Follow-up|1|||
156378353|NCT03614793|564479809|FG001|Overall Study|Lost to Follow-up|2|||
156378354|NCT03614793|564479808|FG000|Overall Study|Lack of Efficacy|0|||
156378355|NCT03614793|564479809|FG001|Overall Study|Lack of Efficacy|5|||
156378356|NCT03614793|564479808|FG000|Overall Study|Withdrawal by Subject|0|||
156378357|NCT03614793|564479809|FG001|Overall Study|Withdrawal by Subject|1|||
156378358|NCT03614793|564479808|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
156378359|NCT03614793|564479809|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
156378360|NCT02082522|564479810|FG000|Overall Study|Sponsor termination|5|||
156378361|NCT02082522|564479811|FG001|Overall Study|Sponsor termination|3|||
156378362|NCT02082522|564479810|FG000|Overall Study|Withdrawal by Subject|2|||
156378363|NCT02082522|564479811|FG001|Overall Study|Withdrawal by Subject|4|||
156378364|NCT02082522|564479810|FG000|Overall Study|Death|1|||
156378365|NCT02082522|564479811|FG001|Overall Study|Death|0|||
156378366|NCT02082522|564479810|FG000|Overall Study|Lost to Follow-up|1|||
156378367|NCT02082522|564479811|FG001|Overall Study|Lost to Follow-up|0|||
156378368|NCT02082522|564479810|FG000|Overall Study|Physician Decision|3|||
156378369|NCT02082522|564479811|FG001|Overall Study|Physician Decision|1|||
156378370|NCT02082522|564479810|FG000|Overall Study|Disease progression|2|||
156378371|NCT02082522|564479811|FG001|Overall Study|Disease progression|2|||
156500291|NCT02581059|564923763|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
156500292|NCT02581059|564923764|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
156500293|NCT02581059|564923763|FG000|Follow up|Death|1|||
156500294|NCT02581059|564923764|FG001|Follow up|Death|3|||
156500295|NCT02581059|564923763|FG000|Follow up|study terminated|1|||
156378372|NCT02082522|564479810|FG000|Overall Study|Chemotherapy change|1|||
156378373|NCT02082522|564479811|FG001|Overall Study|Chemotherapy change|3|||
156378374|NCT01575561|564479812|FG000|Overall Study|Adverse Event|9|||
156378375|NCT01575561|564479812|FG000|Overall Study|Lack of Efficacy|8|||
156500296|NCT02581059|564923764|FG001|Follow up|study terminated|1|||
156500297|NCT02581059|564923763|FG000|Follow up|screen failure|0|||
156378376|NCT01575561|564479812|FG000|Overall Study|Lost to Follow-up|6|||
156378377|NCT01575561|564479812|FG000|Overall Study|Protocol Violation|4|||
156378378|NCT01575561|564479812|FG000|Overall Study|Withdrawal by Subject|11|||
156378379|NCT01575561|564479812|FG000|Overall Study|administration|1|||
156378380|NCT00633984|564479813|FG000|Overall Study|Lost to Follow-up|0|||
156500298|NCT02581059|564923764|FG001|Follow up|screen failure|1|||
156500299|NCT02581059|564923763|FG000|Follow up|Patient started new clinical trial|1|||
156378381|NCT00633984|564479814|FG001|Overall Study|Lost to Follow-up|6|||
156500300|NCT02581059|564923764|FG001|Follow up|Patient started new clinical trial|0|||
156500301|NCT04590404|564923766|FG000|Overall Study|Death|16|||
156500302|NCT04590404|564923767|FG001|Overall Study|Death|17|||
156500303|NCT04590404|564923766|FG000|Overall Study|Withdrawal by Subject|7|||
156500304|NCT04590404|564923767|FG001|Overall Study|Withdrawal by Subject|2|||
156500305|NCT05903183|564923768|FG000|Main Trial Part (365 Days)|Death|1|||
156500306|NCT05903183|564923769|FG001|Main Trial Part (365 Days)|Death|0|||
156500307|NCT05903183|564923770|FG002|Main Trial Part (365 Days)|Death|0|||
156500308|NCT05903183|564923771|FG003|Main Trial Part (365 Days)|Death|0|||
156500309|NCT05903183|564923772|FG004|Main Trial Part (365 Days)|Death|0|||
156500310|NCT05903183|564923768|FG000|Main Trial Part (365 Days)|Other|1|||
156500311|NCT05903183|564923769|FG001|Main Trial Part (365 Days)|Other|2|||
156500312|NCT05903183|564923770|FG002|Main Trial Part (365 Days)|Other|1|||
156500313|NCT05903183|564923771|FG003|Main Trial Part (365 Days)|Other|0|||
156500314|NCT05903183|564923772|FG004|Main Trial Part (365 Days)|Other|0|||
156500315|NCT05903183|564923768|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
156500316|NCT05903183|564923769|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
156500317|NCT05903183|564923770|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
156500318|NCT05903183|564923771|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
156500319|NCT05903183|564923772|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
156500320|NCT05903183|564923768|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
156500321|NCT05903183|564923769|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
156500322|NCT05903183|564923770|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
156500323|NCT05903183|564923771|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
156500324|NCT05903183|564923772|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
156500325|NCT05903183|564923768|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
156500326|NCT05903183|564923769|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
156500327|NCT05903183|564923770|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
156500328|NCT05903183|564923771|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
156500329|NCT05903183|564923772|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
156500330|NCT03735121|564923773|FG000|Overall Study|Death|3|||
156500331|NCT03735121|564923774|FG001|Overall Study|Death|6|||
156500332|NCT03735121|564923775|FG002|Overall Study|Death|19|||
156500333|NCT03735121|564923776|FG003|Overall Study|Death|97|||
156500334|NCT03735121|564923777|FG004|Overall Study|Death|205|||
156500335|NCT03735121|564923773|FG000|Overall Study|Lost to Follow-up|0|||
156500336|NCT03735121|564923774|FG001|Overall Study|Lost to Follow-up|0|||
156500337|NCT03735121|564923775|FG002|Overall Study|Lost to Follow-up|0|||
156500338|NCT03735121|564923776|FG003|Overall Study|Lost to Follow-up|2|||
156500339|NCT03735121|564923777|FG004|Overall Study|Lost to Follow-up|3|||
156500340|NCT03735121|564923773|FG000|Overall Study|New Therapy|0|||
156500341|NCT03735121|564923774|FG001|Overall Study|New Therapy|1|||
156500342|NCT03735121|564923775|FG002|Overall Study|New Therapy|0|||
156500343|NCT03735121|564923776|FG003|Overall Study|New Therapy|0|||
156500344|NCT03735121|564923777|FG004|Overall Study|New Therapy|0|||
156500345|NCT03735121|564923773|FG000|Overall Study|Study Ended by Sponsor|1|||
156500346|NCT03735121|564923774|FG001|Overall Study|Study Ended by Sponsor|0|||
156500347|NCT03735121|564923775|FG002|Overall Study|Study Ended by Sponsor|1|||
156500348|NCT03735121|564923776|FG003|Overall Study|Study Ended by Sponsor|17|||
156500349|NCT03735121|564923777|FG004|Overall Study|Study Ended by Sponsor|28|||
156500350|NCT03735121|564923773|FG000|Overall Study|Withdrawal by Subject|1|||
156500351|NCT03735121|564923774|FG001|Overall Study|Withdrawal by Subject|1|||
156500352|NCT03735121|564923775|FG002|Overall Study|Withdrawal by Subject|6|||
156500353|NCT03735121|564923776|FG003|Overall Study|Withdrawal by Subject|8|||
156500354|NCT03735121|564923777|FG004|Overall Study|Withdrawal by Subject|11|||
156500355|NCT04750577|564923778|FG000|Overall Study|Adverse Event|2|||
156500356|NCT04750577|564923779|FG001|Overall Study|Adverse Event|10|||
156500357|NCT04750577|564923780|FG002|Overall Study|Adverse Event|8|||
156500358|NCT04750577|564923781|FG003|Overall Study|Adverse Event|1|||
156500359|NCT04750577|564923778|FG000|Overall Study|Change of residence|0|||
156500360|NCT04750577|564923779|FG001|Overall Study|Change of residence|0|||
156500361|NCT04750577|564923780|FG002|Overall Study|Change of residence|1|||
156500362|NCT04750577|564923781|FG003|Overall Study|Change of residence|0|||
156500363|NCT04750577|564923778|FG000|Overall Study|Burden of study procedures|0|||
156500364|NCT04750577|564923779|FG001|Overall Study|Burden of study procedures|2|||
156500365|NCT04750577|564923780|FG002|Overall Study|Burden of study procedures|2|||
156500366|NCT04750577|564923781|FG003|Overall Study|Burden of study procedures|0|||
156500367|NCT04750577|564923778|FG000|Overall Study|Prematurely discontinued|0|||
156500368|NCT04750577|564923779|FG001|Overall Study|Prematurely discontinued|0|||
156500369|NCT04750577|564923780|FG002|Overall Study|Prematurely discontinued|0|||
156546803|NCT00794677|565094979|FG001|First Intervention|Withdrawal by Subject|0|||
156500370|NCT04750577|564923781|FG003|Overall Study|Prematurely discontinued|2|||
156500371|NCT04750577|564923778|FG000|Overall Study|Protocol deviation|1|||
156546804|NCT01029366|565094992|FG000|Overall Study|Withdrawal by Subject|1|||
156500372|NCT04750577|564923779|FG001|Overall Study|Protocol deviation|1|||
156500373|NCT04750577|564923780|FG002|Overall Study|Protocol deviation|1|||
156500374|NCT04750577|564923781|FG003|Overall Study|Protocol deviation|1|||
156500375|NCT04750577|564923778|FG000|Overall Study|Other than listed|3|||
156500376|NCT04750577|564923779|FG001|Overall Study|Other than listed|2|||
156500377|NCT04750577|564923780|FG002|Overall Study|Other than listed|2|||
156500378|NCT04750577|564923781|FG003|Overall Study|Other than listed|1|||
156378382|NCT00633984|564479813|FG000|Overall Study|Withdrawal by Subject|8|||
156378383|NCT00633984|564479814|FG001|Overall Study|Withdrawal by Subject|7|||
156378384|NCT00633984|564479813|FG000|Overall Study|Hospitalized|1|||
156378385|NCT00633984|564479814|FG001|Overall Study|Hospitalized|0|||
156378386|NCT02840877|564479815|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
156378387|NCT02840877|564479815|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
156378388|NCT02840877|564479815|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
156378389|NCT02840877|564479815|FG000|Baseline to 12 Weeks|Death|1|||
156378390|NCT02840877|564479815|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
156378391|NCT02840877|564479815|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
156378392|NCT02840877|564479815|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
156378393|NCT02840877|564479815|FG000|12 Weeks to 6 Months|Treatment failure|1|||
156378394|NCT02840877|564479815|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
156378395|NCT02840877|564479815|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
156378396|NCT02840877|564479815|FG000|12 Weeks to 6 Months|Death|1|||
156378397|NCT02840877|564479815|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
156378398|NCT02840877|564479815|FG000|6 Months to 18 Months|Treatment failure|7|||
156378399|NCT02840877|564479815|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
156378400|NCT02840877|564479815|FG000|6 Months to 18 Months|Moved/transferred out|6|||
156378401|NCT02840877|564479815|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
156378402|NCT02840877|564479815|FG000|6 Months to 18 Months|Death|4|||
156378403|NCT02840877|564479815|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
156378404|NCT02840877|564479815|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
156378405|NCT02840877|564479815|FG000|6 Months to 18 Months|Still in study.|14|||
156378406|NCT01168999|564479816|FG000|Overall Study|Lost to Follow-up|2|||
156378407|NCT01168999|564479817|FG001|Overall Study|Lost to Follow-up|1|||
156378408|NCT01168999|564479818|FG002|Overall Study|Lost to Follow-up|0|||
156378409|NCT01168999|564479819|FG003|Overall Study|Lost to Follow-up|0|||
156378410|NCT01276327|564479820|FG000|Overall Study|Adverse Event|1|||
156378411|NCT01276327|564479821|FG001|Overall Study|Adverse Event|3|||
156378412|NCT01276327|564479820|FG000|Overall Study|Withdrawal by Subject|1|||
156378413|NCT01276327|564479821|FG001|Overall Study|Withdrawal by Subject|0|||
156378414|NCT03003676|564479822|FG000|Overall Study|Lack of Efficacy|5|||
156378415|NCT03003676|564479823|FG001|Overall Study|Lack of Efficacy|7|||
156378416|NCT03003676|564479822|FG000|Overall Study|Withdrawal by Subject|0|||
156378417|NCT03003676|564479823|FG001|Overall Study|Withdrawal by Subject|1|||
156378418|NCT03003676|564479822|FG000|Overall Study|Hepatitis B infection|1|||
156378419|NCT03003676|564479823|FG001|Overall Study|Hepatitis B infection|0|||
156378420|NCT03766646|564479825|FG000|Overall Study|Withdrawal by Subject|1|||
156378421|NCT03766646|564479826|FG001|Overall Study|Withdrawal by Subject|0|||
156378422|NCT03766646|564479825|FG000|Overall Study|Protocol Violation|0|||
156378423|NCT03766646|564479826|FG001|Overall Study|Protocol Violation|3|||
156378424|NCT02530619|564479836|FG000|Registered for Study|Withdrawal by Subject|2|||
156378425|NCT02530619|564479836|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
156378426|NCT02530619|564479836|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
156378427|NCT02530619|564479836|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
156378428|NCT02530619|564479836|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
156378429|NCT02530619|564479836|FG000|Follow-up Period (6 Months)|Death|4|||
156378430|NCT02530619|564479836|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
156378431|NCT02530619|564479836|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
156378432|NCT01854554|564479844|FG000|Overall Study|Denial of Insurance Coverage|12|||
156378433|NCT01854554|564479845|FG001|Overall Study|Denial of Insurance Coverage|0|||
156378434|NCT01854554|564479844|FG000|Overall Study|Decided to get treatment locally|1|||
156500379|NCT04750577|564923778|FG000|Overall Study|Not treated|0|||
156500380|NCT04750577|564923779|FG001|Overall Study|Not treated|0|||
156500381|NCT04750577|564923780|FG002|Overall Study|Not treated|0|||
156378435|NCT01854554|564479845|FG001|Overall Study|Decided to get treatment locally|5|||
156378436|NCT01854554|564479844|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
156378437|NCT01854554|564479845|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
156378438|NCT01854554|564479844|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156378439|NCT01854554|564479845|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
156378440|NCT01854554|564479844|FG000|Overall Study|Progression|0|||
156378441|NCT01854554|564479845|FG001|Overall Study|Progression|1|||
156378442|NCT01854554|564479844|FG000|Overall Study|Lost to Follow-up|0|||
156378443|NCT01854554|564479845|FG001|Overall Study|Lost to Follow-up|1|||
156378444|NCT02819726|564479846|FG000|Part A (All Participants)|Lost to Follow-up|0|||
156378445|NCT02819726|564479847|FG001|Part A (All Participants)|Lost to Follow-up|1|||
156378446|NCT02819726|564479848|FG002|Part A (All Participants)|Lost to Follow-up|0|||
156500382|NCT04750577|564923781|FG003|Overall Study|Not treated|2|||
156500383|NCT02473042|564923782|FG000|Overall Study|Withdrawal by Subject|1|||
156378447|NCT02819726|564479849|FG003|Part A (All Participants)|Lost to Follow-up|0|||
156378448|NCT02819726|564479846|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
156378449|NCT02819726|564479847|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
156378450|NCT02819726|564479848|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
156378451|NCT02819726|564479849|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
156378452|NCT02819726|564479846|FG000|Part A (All Participants)|Protocol non-compliance|3|||
156378453|NCT02819726|564479847|FG001|Part A (All Participants)|Protocol non-compliance|4|||
156378454|NCT02819726|564479848|FG002|Part A (All Participants)|Protocol non-compliance|5|||
156378455|NCT02819726|564479849|FG003|Part A (All Participants)|Protocol non-compliance|0|||
156378456|NCT02819726|564479846|FG000|Part B (All Participants)|Lost to Follow-up|1|||
156378457|NCT02819726|564479847|FG001|Part B (All Participants)|Lost to Follow-up|1|||
156378458|NCT02819726|564479848|FG002|Part B (All Participants)|Lost to Follow-up|2|||
156378459|NCT02819726|564479849|FG003|Part B (All Participants)|Lost to Follow-up|2|||
156378460|NCT02819726|564479846|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
156378461|NCT02819726|564479847|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
156378462|NCT02819726|564479848|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
156378463|NCT02819726|564479849|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
156378464|NCT02819726|564479846|FG000|Part B (All Participants)|Protocol non-compliance|0|||
156378465|NCT02819726|564479847|FG001|Part B (All Participants)|Protocol non-compliance|0|||
156378466|NCT02819726|564479848|FG002|Part B (All Participants)|Protocol non-compliance|1|||
156378467|NCT02819726|564479849|FG003|Part B (All Participants)|Protocol non-compliance|0|||
156378468|NCT00359762|564479850|FG000|Period II|Adverse Event|17|||
156378469|NCT00359762|564479851|FG001|Period II|Adverse Event|0|||
156378470|NCT00359762|564479852|FG002|Period II|Adverse Event|0|||
156378471|NCT00359762|564479853|FG003|Period II|Adverse Event|0|||
156378472|NCT00359762|564479854|FG004|Period II|Adverse Event|49|||
156378473|NCT00359762|564479850|FG000|Period II|Protocol Violation|18|||
156378474|NCT00359762|564479851|FG001|Period II|Protocol Violation|0|||
156378475|NCT00359762|564479852|FG002|Period II|Protocol Violation|0|||
156378476|NCT00359762|564479853|FG003|Period II|Protocol Violation|0|||
156378477|NCT00359762|564479854|FG004|Period II|Protocol Violation|11|||
156378478|NCT00359762|564479850|FG000|Period II|Physician Decision|17|||
156378479|NCT00359762|564479851|FG001|Period II|Physician Decision|0|||
156378480|NCT00359762|564479852|FG002|Period II|Physician Decision|0|||
156378481|NCT00359762|564479853|FG003|Period II|Physician Decision|0|||
156378482|NCT00359762|564479854|FG004|Period II|Physician Decision|23|||
156378483|NCT00359762|564479850|FG000|Period II|Death|2|||
156378484|NCT00359762|564479851|FG001|Period II|Death|0|||
156378485|NCT00359762|564479852|FG002|Period II|Death|0|||
156378486|NCT00359762|564479853|FG003|Period II|Death|0|||
156378487|NCT00359762|564479854|FG004|Period II|Death|4|||
156378488|NCT00359762|564479850|FG000|Period II|Lack of Efficacy|11|||
156378489|NCT00359762|564479851|FG001|Period II|Lack of Efficacy|0|||
156378490|NCT00359762|564479852|FG002|Period II|Lack of Efficacy|0|||
156378491|NCT00359762|564479853|FG003|Period II|Lack of Efficacy|0|||
156378492|NCT00359762|564479854|FG004|Period II|Lack of Efficacy|8|||
156378493|NCT00359762|564479850|FG000|Period II|Lost to follow up|5|||
156378494|NCT00359762|564479851|FG001|Period II|Lost to follow up|0|||
156378495|NCT00359762|564479852|FG002|Period II|Lost to follow up|0|||
156378496|NCT00359762|564479853|FG003|Period II|Lost to follow up|0|||
156378497|NCT00359762|564479854|FG004|Period II|Lost to follow up|5|||
156378498|NCT00359762|564479850|FG000|Period II|Entry Criteria Not Met|8|||
156378499|NCT00359762|564479851|FG001|Period II|Entry Criteria Not Met|0|||
156378500|NCT00359762|564479852|FG002|Period II|Entry Criteria Not Met|0|||
156378501|NCT00359762|564479853|FG003|Period II|Entry Criteria Not Met|0|||
156378502|NCT00359762|564479854|FG004|Period II|Entry Criteria Not Met|4|||
156378503|NCT00359762|564479850|FG000|Period II|Subject Decision|50|||
156378504|NCT00359762|564479851|FG001|Period II|Subject Decision|0|||
156378505|NCT00359762|564479852|FG002|Period II|Subject Decision|0|||
156378506|NCT00359762|564479853|FG003|Period II|Subject Decision|0|||
156500384|NCT02473042|564923783|FG001|Overall Study|Withdrawal by Subject|0|||
156500385|NCT02473042|564923782|FG000|Overall Study|Patient became ineligible after enrollment|2|||
156500386|NCT02473042|564923783|FG001|Overall Study|Patient became ineligible after enrollment|5|||
156500387|NCT02473042|564923782|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
156378507|NCT00359762|564479854|FG004|Period II|Subject Decision|70|||
156378508|NCT00359762|564479850|FG000|Period III|Protocol Violation|0|||
156378509|NCT00359762|564479851|FG001|Period III|Protocol Violation|5|||
156378510|NCT00359762|564479852|FG002|Period III|Protocol Violation|3|||
156378511|NCT00359762|564479853|FG003|Period III|Protocol Violation|8|||
156378512|NCT00359762|564479854|FG004|Period III|Protocol Violation|0|||
156378513|NCT00359762|564479850|FG000|Period III|Adverse Event|0|||
156378514|NCT00359762|564479851|FG001|Period III|Adverse Event|3|||
156378515|NCT00359762|564479852|FG002|Period III|Adverse Event|4|||
156378516|NCT00359762|564479853|FG003|Period III|Adverse Event|10|||
156378517|NCT00359762|564479854|FG004|Period III|Adverse Event|0|||
156378518|NCT00359762|564479850|FG000|Period III|Physician Decision|0|||
156378519|NCT00359762|564479851|FG001|Period III|Physician Decision|5|||
156378520|NCT00359762|564479852|FG002|Period III|Physician Decision|9|||
156378521|NCT00359762|564479853|FG003|Period III|Physician Decision|15|||
156378522|NCT00359762|564479854|FG004|Period III|Physician Decision|0|||
156378523|NCT00359762|564479850|FG000|Period III|Lack of Efficacy|0|||
156378524|NCT00359762|564479851|FG001|Period III|Lack of Efficacy|7|||
156378525|NCT00359762|564479852|FG002|Period III|Lack of Efficacy|5|||
156378526|NCT00359762|564479853|FG003|Period III|Lack of Efficacy|9|||
156378527|NCT00359762|564479854|FG004|Period III|Lack of Efficacy|0|||
156378528|NCT00359762|564479850|FG000|Period III|Lost to follow up|0|||
156378529|NCT00359762|564479851|FG001|Period III|Lost to follow up|1|||
156378530|NCT00359762|564479852|FG002|Period III|Lost to follow up|1|||
156378531|NCT00359762|564479853|FG003|Period III|Lost to follow up|2|||
156378532|NCT00359762|564479854|FG004|Period III|Lost to follow up|0|||
156378533|NCT00359762|564479850|FG000|Period III|Entry Criteria Not Met|0|||
156378534|NCT00359762|564479851|FG001|Period III|Entry Criteria Not Met|1|||
156378535|NCT00359762|564479852|FG002|Period III|Entry Criteria Not Met|0|||
156378536|NCT00359762|564479853|FG003|Period III|Entry Criteria Not Met|1|||
156378537|NCT00359762|564479854|FG004|Period III|Entry Criteria Not Met|0|||
156378538|NCT00359762|564479850|FG000|Period III|Subject Decision|0|||
156378539|NCT00359762|564479851|FG001|Period III|Subject Decision|7|||
156378540|NCT00359762|564479852|FG002|Period III|Subject Decision|8|||
156378541|NCT00359762|564479853|FG003|Period III|Subject Decision|20|||
156378542|NCT00359762|564479854|FG004|Period III|Subject Decision|0|||
156378543|NCT01172938|564479858|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
156378544|NCT01172938|564479859|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
156378545|NCT01172938|564479860|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
156378546|NCT01172938|564479861|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156378547|NCT01172938|564479862|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156378548|NCT01172938|564479863|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156378549|NCT01172938|564479864|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156378550|NCT01172938|564479865|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156378551|NCT01172938|564479866|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156378552|NCT01172938|564479858|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
156378553|NCT01172938|564479859|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
156378554|NCT01172938|564479860|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
156378555|NCT01172938|564479861|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156378556|NCT01172938|564479862|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156378557|NCT01172938|564479863|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156378558|NCT01172938|564479864|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156378559|NCT01172938|564479865|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156378560|NCT01172938|564479866|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156378561|NCT01172938|564479858|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156378562|NCT01172938|564479859|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
156378563|NCT01172938|564479860|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
156378564|NCT01172938|564479861|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156378565|NCT01172938|564479862|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156378566|NCT01172938|564479863|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156378567|NCT01172938|564479864|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156378568|NCT01172938|564479865|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156378569|NCT01172938|564479866|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156378570|NCT01172938|564479858|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
156378571|NCT01172938|564479859|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
156378572|NCT01172938|564479860|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
156378573|NCT01172938|564479861|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156378574|NCT01172938|564479862|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156378575|NCT01172938|564479863|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156378576|NCT01172938|564479864|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156378577|NCT01172938|564479865|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156378578|NCT01172938|564479866|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156378579|NCT01172938|564479858|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
156378580|NCT01172938|564479859|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
156378581|NCT01172938|564479860|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
156378582|NCT01172938|564479861|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
156378583|NCT01172938|564479862|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
156378584|NCT01172938|564479863|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
156378585|NCT01172938|564479864|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
156378586|NCT01172938|564479865|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
156378587|NCT01172938|564479866|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
156378588|NCT01172938|564479858|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
156378589|NCT01172938|564479859|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156378590|NCT01172938|564479860|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156378591|NCT01172938|564479861|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156378592|NCT01172938|564479862|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156378593|NCT01172938|564479863|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156378594|NCT01172938|564479864|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156378595|NCT01172938|564479865|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156378596|NCT01172938|564479866|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156378597|NCT01172938|564479858|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
156378598|NCT01172938|564479859|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
156378599|NCT01172938|564479860|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
156378600|NCT01172938|564479861|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
156378601|NCT01172938|564479862|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
156378602|NCT01172938|564479863|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
156378603|NCT01172938|564479864|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
156378604|NCT01172938|564479865|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
156378605|NCT01172938|564479866|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
156378606|NCT01172938|564479858|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
156378607|NCT01172938|564479859|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
156378608|NCT01172938|564479860|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
156378609|NCT01172938|564479861|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
156378610|NCT01172938|564479862|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
156378611|NCT01172938|564479863|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
156378612|NCT01172938|564479864|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
156378613|NCT01172938|564479865|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
156378614|NCT01172938|564479866|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
156378615|NCT01172938|564479858|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
156378616|NCT01172938|564479859|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
156378617|NCT01172938|564479860|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
156378618|NCT01172938|564479861|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
156378619|NCT01172938|564479862|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
156378620|NCT01172938|564479863|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
156378621|NCT01172938|564479864|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
156378622|NCT01172938|564479865|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
156378623|NCT01172938|564479866|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
156378624|NCT01172938|564479858|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156378625|NCT01172938|564479859|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156378626|NCT01172938|564479860|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
156378627|NCT01172938|564479861|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156378628|NCT01172938|564479862|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156378629|NCT01172938|564479863|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156378630|NCT01172938|564479864|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156378631|NCT01172938|564479865|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156378632|NCT01172938|564479866|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156378633|NCT01172938|564479858|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
156378634|NCT01172938|564479859|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
156378635|NCT01172938|564479860|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
156378636|NCT01172938|564479861|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
156378637|NCT01172938|564479862|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
156378638|NCT01172938|564479863|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
156378639|NCT01172938|564479864|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
156378640|NCT01172938|564479865|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
156378641|NCT01172938|564479866|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
156378642|NCT01172938|564479858|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156378643|NCT01172938|564479859|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
156378644|NCT01172938|564479860|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
156500388|NCT02473042|564923783|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
156500389|NCT02473042|564923782|FG000|Overall Study|PACU data unable to be collected|3|||
156500390|NCT02473042|564923783|FG001|Overall Study|PACU data unable to be collected|0|||
156500391|NCT03371823|564923786|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
156500392|NCT03371823|564923787|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
156500393|NCT04870957|564923788|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
156500394|NCT04870957|564923789|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
156500395|NCT04870957|564923790|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
156378645|NCT01172938|564479861|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
156378646|NCT01172938|564479862|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156378647|NCT01172938|564479863|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156378648|NCT01172938|564479864|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156378649|NCT01172938|564479865|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156378650|NCT01172938|564479866|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156378651|NCT01172938|564479858|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
156378652|NCT01172938|564479859|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
156378653|NCT01172938|564479860|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
156378654|NCT01172938|564479861|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
156378655|NCT01172938|564479862|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
156378656|NCT01172938|564479863|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
156378657|NCT01172938|564479864|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
156378658|NCT01172938|564479865|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
156378659|NCT01172938|564479866|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
156378660|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156378661|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
156378662|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
156378663|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156378664|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156378665|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156378666|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156378667|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
156378668|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
156378669|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156378670|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
156378671|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
156378672|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156378673|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156378674|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156378675|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156378676|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
156378677|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156378678|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156378679|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156378680|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
156378681|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156378682|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156378683|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156378684|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156378685|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156378686|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156378687|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156378688|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
156378689|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
156378690|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156378691|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156378692|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156378693|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156378694|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
156378695|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
156378696|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156378697|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156378698|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
156378699|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156378700|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156378701|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156378702|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156378703|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156378704|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156378705|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156378706|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
156500396|NCT04870957|564923791|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
156500397|NCT04870957|564923792|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
156500398|NCT04870957|564923793|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
156378707|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
156378708|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156378709|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156378710|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156378711|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156378712|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
156378713|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156378714|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156378715|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
156378716|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156378717|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156378718|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156378719|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156378720|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156378721|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156378722|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
156378723|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156378724|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
156378725|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156378726|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156378727|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156378728|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156378729|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156378730|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156378731|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156378732|NCT01172938|564479858|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156378733|NCT01172938|564479859|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156378734|NCT01172938|564479860|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156378735|NCT01172938|564479861|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156378736|NCT01172938|564479862|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156378737|NCT01172938|564479863|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156378738|NCT01172938|564479864|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156378739|NCT01172938|564479865|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156378740|NCT01172938|564479866|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
156378741|NCT01172938|564479858|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156378742|NCT01172938|564479859|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
156378743|NCT01172938|564479860|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
156378744|NCT01172938|564479861|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156378745|NCT01172938|564479862|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156378746|NCT01172938|564479863|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156378747|NCT01172938|564479864|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156378748|NCT01172938|564479865|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
156378749|NCT01172938|564479866|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
156378750|NCT01172938|564479858|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156378751|NCT01172938|564479859|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
156378752|NCT01172938|564479860|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
156378753|NCT01172938|564479861|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156378754|NCT01172938|564479862|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156378755|NCT01172938|564479863|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156378756|NCT01172938|564479864|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156378757|NCT01172938|564479865|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
156378758|NCT01172938|564479866|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
156378759|NCT01172938|564479858|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
156378760|NCT01172938|564479859|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
156378761|NCT01172938|564479860|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
156378762|NCT01172938|564479861|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
156378763|NCT01172938|564479862|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
156378764|NCT01172938|564479863|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
156378765|NCT01172938|564479864|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
156378766|NCT01172938|564479865|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
156378767|NCT01172938|564479866|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
156378768|NCT01172938|564479858|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156378769|NCT01172938|564479859|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
156378770|NCT01172938|564479860|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156500399|NCT04870957|564923788|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
156500400|NCT04870957|564923789|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
156378771|NCT01172938|564479861|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156378772|NCT01172938|564479862|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156378773|NCT01172938|564479863|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156378774|NCT01172938|564479864|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156378775|NCT01172938|564479865|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156378776|NCT01172938|564479866|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156378777|NCT01172938|564479858|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156378778|NCT01172938|564479859|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156378779|NCT01172938|564479860|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
156378780|NCT01172938|564479861|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156378781|NCT01172938|564479862|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156378782|NCT01172938|564479863|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156378783|NCT01172938|564479864|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156378784|NCT01172938|564479865|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156378785|NCT01172938|564479866|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156378786|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156378787|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
156378788|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
156378789|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156378790|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156378791|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156378792|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156378793|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
156378794|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156378795|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156378796|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
156378797|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
156378798|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156378799|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156378800|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156378801|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156378802|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
156500401|NCT04870957|564923790|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
156500402|NCT04870957|564923791|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
156500403|NCT04870957|564923792|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
156500404|NCT04870957|564923793|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
156500405|NCT04870957|564923788|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
156500406|NCT04870957|564923789|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
156500407|NCT04870957|564923790|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
156500408|NCT04870957|564923791|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
156500409|NCT04870957|564923792|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
156500410|NCT04870957|564923793|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
156500411|NCT04870957|564923788|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
156500412|NCT04870957|564923789|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
156500413|NCT04870957|564923790|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
156500414|NCT04870957|564923791|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
156500415|NCT04870957|564923792|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
156500416|NCT04870957|564923793|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
156500417|NCT04870957|564923788|FG000|T2 (Randomization) - T3|Adverse Event|1|||
156500418|NCT04870957|564923789|FG001|T2 (Randomization) - T3|Adverse Event|1|||
156500419|NCT04870957|564923790|FG002|T2 (Randomization) - T3|Adverse Event|0|||
156500420|NCT04870957|564923791|FG003|T2 (Randomization) - T3|Adverse Event|0|||
156500421|NCT04870957|564923792|FG004|T2 (Randomization) - T3|Adverse Event|0|||
156500422|NCT04870957|564923793|FG005|T2 (Randomization) - T3|Adverse Event|0|||
156500423|NCT04870957|564923788|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
156546805|NCT01029366|565094993|FG001|Overall Study|Withdrawal by Subject|0|||
156546806|NCT01029366|565094992|FG000|Overall Study|Death|1|||
156378803|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
156378804|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156378805|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
156378806|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
156378807|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156500424|NCT04870957|564923789|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
156546807|NCT01029366|565094993|FG001|Overall Study|Death|1|||
156546808|NCT01029366|565094992|FG000|Overall Study|disease progression|2|||
156500425|NCT04870957|564923790|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
156546809|NCT01029366|565094993|FG001|Overall Study|disease progression|0|||
156378808|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156378809|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156378810|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156378811|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
156378812|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
156378813|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156378814|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156546810|NCT01029366|565094992|FG000|Overall Study|manufacturing failure|0|||
156378815|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
156378816|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156378817|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156378818|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156378819|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156378820|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156378821|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
156378822|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156378823|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156378824|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156378825|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156378826|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156378827|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156378828|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156378829|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
156378830|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156378831|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156378832|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156378833|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
156378834|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156378835|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156378836|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156378837|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156378838|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
156378839|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
156378840|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156378841|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156546811|NCT01029366|565094993|FG001|Overall Study|manufacturing failure|1|||
156546812|NCT00607386|565094994|FG000|Overall Study|Physician Decision|1|||
156546813|NCT00440947|565094995|FG000|36-Week Induction Phase|Adverse Event|16|||
156546814|NCT00440947|565094996|FG001|36-Week Induction Phase|Adverse Event|0|||
156546815|NCT00440947|565094997|FG002|36-Week Induction Phase|Adverse Event|0|||
156378842|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
156378843|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156378844|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156378845|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156378846|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156378847|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156378848|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156378849|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156378850|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
156378851|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156500426|NCT04870957|564923791|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
156500427|NCT04870957|564923792|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
156500428|NCT04870957|564923793|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
156500429|NCT04870957|564923788|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
156500430|NCT04870957|564923789|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
156500431|NCT04870957|564923790|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
156500432|NCT04870957|564923791|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
156378852|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156378853|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156378854|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156378855|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156500433|NCT04870957|564923792|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
156500434|NCT04870957|564923793|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
156500435|NCT04870957|564923788|FG000|T2 (Randomization) - T3|Physician Decision|0|||
156500436|NCT04870957|564923789|FG001|T2 (Randomization) - T3|Physician Decision|0|||
156546816|NCT00440947|565094998|FG003|36-Week Induction Phase|Adverse Event|0|||
156378856|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
156378857|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156378858|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156378859|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
156378860|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
156378861|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156378862|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156378863|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156378864|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156378865|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
156378866|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156378867|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156378868|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156378869|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
156378870|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156378871|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156378872|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156378873|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156378874|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156378875|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156378876|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156378877|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156378878|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
156378879|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156378880|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156378881|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156378882|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156378883|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156378884|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156378885|NCT01172938|564479858|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156378886|NCT01172938|564479859|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156378887|NCT01172938|564479860|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156378888|NCT01172938|564479861|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156378889|NCT01172938|564479862|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156378890|NCT01172938|564479863|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156378891|NCT01172938|564479864|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156378892|NCT01172938|564479865|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156378893|NCT01172938|564479866|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
156378894|NCT01033747|564479867|FG000|Overall Study|Adverse Event|9|||
156378895|NCT01033747|564479868|FG001|Overall Study|Adverse Event|4|||
156378896|NCT01033747|564479867|FG000|Overall Study|Abnormal Laboratory Value|1|||
156378897|NCT01033747|564479868|FG001|Overall Study|Abnormal Laboratory Value|0|||
156378898|NCT01033747|564479867|FG000|Overall Study|Abnormal test procedure|0|||
156378899|NCT01033747|564479868|FG001|Overall Study|Abnormal test procedure|1|||
156378900|NCT01033747|564479867|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
156378901|NCT01033747|564479868|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156378902|NCT01033747|564479867|FG000|Overall Study|Protocol Violation|1|||
156378903|NCT01033747|564479868|FG001|Overall Study|Protocol Violation|0|||
156378904|NCT01033747|564479867|FG000|Overall Study|Withdrawal by Subject|9|||
156378905|NCT01033747|564479868|FG001|Overall Study|Withdrawal by Subject|6|||
156378906|NCT01033747|564479867|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
156378907|NCT01033747|564479868|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
156378908|NCT01033747|564479867|FG000|Overall Study|Stopped at end of Extension 1|2|||
156378909|NCT01033747|564479868|FG001|Overall Study|Stopped at end of Extension 1|0|||
156378910|NCT02613481|564479869|FG000|Overall Study|Lost to Follow-up|7|||
156378911|NCT02613481|564479869|FG000|Overall Study|Withdrawal by Subject|2|||
156378912|NCT04382326|564479870|FG000|Overall Study|Adverse Event, not serious|1|||
156378913|NCT04382326|564479871|FG001|Overall Study|Adverse Event, not serious|2|||
156378914|NCT04382326|564479870|FG000|Overall Study|Other|1|||
156378915|NCT04382326|564479871|FG001|Overall Study|Other|0|||
156378916|NCT04382326|564479870|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
156378917|NCT04382326|564479871|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
156378918|NCT04382326|564479870|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
156378919|NCT04382326|564479871|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
156378920|NCT04382326|564479870|FG000|Overall Study|Protocol Violation|29|||
156378921|NCT04382326|564479871|FG001|Overall Study|Protocol Violation|23|||
156378922|NCT04382326|564479870|FG000|Overall Study|Physician Decision|0|||
156378923|NCT04382326|564479871|FG001|Overall Study|Physician Decision|1|||
156378924|NCT04382326|564479870|FG000|Overall Study|Lost to Follow-up|48|||
156378925|NCT04382326|564479871|FG001|Overall Study|Lost to Follow-up|63|||
156378926|NCT04382326|564479870|FG000|Overall Study|Adverse Event, non-fatal|1|||
156378927|NCT04382326|564479871|FG001|Overall Study|Adverse Event, non-fatal|1|||
156378928|NCT01038921|564479877|FG000|Overall Study|Withdrawal by Subject|1|||
156378929|NCT01038921|564479878|FG001|Overall Study|Withdrawal by Subject|0|||
156378930|NCT01038921|564479877|FG000|Overall Study|Physician Decision|1|||
156378931|NCT01038921|564479878|FG001|Overall Study|Physician Decision|0|||
156378932|NCT02519504|564479880|FG000|Overall Study|Protocol Violation|6|||
156378933|NCT02519504|564479881|FG001|Overall Study|Protocol Violation|5|||
156378934|NCT02519504|564479880|FG000|Overall Study|Ineligible for direct testing|12|||
156378935|NCT02519504|564479881|FG001|Overall Study|Ineligible for direct testing|12|||
156378936|NCT02519504|564479880|FG000|Overall Study|Did not participate in direct testing|95|||
156378937|NCT02519504|564479881|FG001|Overall Study|Did not participate in direct testing|86|||
156378938|NCT05061446|564479884|FG000|Overall Study|Adverse Event|2|||
156378939|NCT05061446|564479885|FG001|Overall Study|Adverse Event|0|||
156378940|NCT05061446|564479886|FG002|Overall Study|Adverse Event|0|||
156378941|NCT05061446|564479884|FG000|Overall Study|Participant no longer available due to personal reason|0|||
156378942|NCT05061446|564479885|FG001|Overall Study|Participant no longer available due to personal reason|1|||
156378943|NCT05061446|564479886|FG002|Overall Study|Participant no longer available due to personal reason|0|||
156378944|NCT01440946|564479892|FG000|Overall Study|Lost to Follow-up|1|||
156378945|NCT01440946|564479893|FG001|Overall Study|Lost to Follow-up|1|||
156378946|NCT01440946|564479892|FG000|Overall Study|Physician Decision|1|||
156378947|NCT01440946|564479893|FG001|Overall Study|Physician Decision|0|||
156378948|NCT01975389|564479894|FG000|Overall Study|Adverse Event|10|||
156378949|NCT01975389|564479895|FG001|Overall Study|Adverse Event|6|||
156378950|NCT01975389|564479894|FG000|Overall Study|Death|61|||
156378951|NCT01975389|564479895|FG001|Overall Study|Death|54|||
156378952|NCT01975389|564479894|FG000|Overall Study|Lost to Follow-up|81|||
156378953|NCT01975389|564479895|FG001|Overall Study|Lost to Follow-up|86|||
156378954|NCT01975389|564479894|FG000|Overall Study|Withdrawal by Subject|90|||
156378955|NCT01975389|564479895|FG001|Overall Study|Withdrawal by Subject|76|||
156378956|NCT01975389|564479894|FG000|Overall Study|Other|6|||
156378957|NCT01975389|564479895|FG001|Overall Study|Other|9|||
156378958|NCT01975389|564479894|FG000|Overall Study|Randomized, not treated|4|||
156378959|NCT01975389|564479895|FG001|Overall Study|Randomized, not treated|5|||
156378960|NCT01312961|564479897|FG000|Overall Study|Adverse Event|3|||
156378961|NCT01312961|564479898|FG001|Overall Study|Adverse Event|3|||
156378962|NCT01312961|564479897|FG000|Overall Study|Lack of Efficacy|11|||
156378963|NCT01312961|564479898|FG001|Overall Study|Lack of Efficacy|1|||
156378964|NCT01312961|564479897|FG000|Overall Study|Poor compliance to protocol|1|||
156378965|NCT01312961|564479898|FG001|Overall Study|Poor compliance to protocol|0|||
156378966|NCT01312961|564479897|FG000|Overall Study|Other than specified above|2|||
156378967|NCT01312961|564479898|FG001|Overall Study|Other than specified above|3|||
156378968|NCT00235989|564479899|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
156378969|NCT00235989|564479900|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
156378970|NCT00235989|564479901|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
156378971|NCT00235989|564479902|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
156378972|NCT00235989|564479903|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
156378973|NCT00235989|564479904|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
156378974|NCT00235989|564479899|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
156378975|NCT00235989|564479900|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
156378976|NCT00235989|564479901|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
156378977|NCT00235989|564479902|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
156378978|NCT00235989|564479903|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
156378979|NCT00235989|564479904|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
156378980|NCT00235989|564479899|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
156378981|NCT00235989|564479900|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
156378982|NCT00235989|564479901|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
156378983|NCT00235989|564479902|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
156378984|NCT00235989|564479903|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
156378985|NCT00235989|564479904|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
156378986|NCT00235989|564479899|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
156378987|NCT00235989|564479900|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
156378988|NCT00235989|564479901|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
156378989|NCT00235989|564479902|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
156378990|NCT00235989|564479903|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
156378991|NCT00235989|564479904|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
156378992|NCT00235989|564479899|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
156378993|NCT00235989|564479900|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
156378994|NCT00235989|564479901|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
156378995|NCT00235989|564479902|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
156378996|NCT00235989|564479903|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
156378997|NCT00235989|564479904|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
156378998|NCT00360334|564479912|FG000|Overall Study|Adverse Event|7|||
156378999|NCT00360334|564479913|FG001|Overall Study|Adverse Event|4|||
156379000|NCT00360334|564479912|FG000|Overall Study|Protocol Violation|1|||
156379001|NCT00360334|564479913|FG001|Overall Study|Protocol Violation|1|||
156379002|NCT00360334|564479912|FG000|Overall Study|Physician Decision|2|||
156379003|NCT00360334|564479913|FG001|Overall Study|Physician Decision|3|||
156379004|NCT00360334|564479912|FG000|Overall Study|Lack of Efficacy|0|||
156379005|NCT00360334|564479913|FG001|Overall Study|Lack of Efficacy|1|||
156379006|NCT00360334|564479912|FG000|Overall Study|Entry criterion not met|1|||
156379007|NCT00360334|564479913|FG001|Overall Study|Entry criterion not met|2|||
156379008|NCT00360334|564479912|FG000|Overall Study|Subject decision|8|||
156379009|NCT00360334|564479913|FG001|Overall Study|Subject decision|2|||
156379010|NCT01916304|564479915|FG000|Overall Study|Screening failure|17|||
156379011|NCT01898793|564479916|FG000|Overall Study|Death|2|||
156379012|NCT01898793|564479917|FG001|Overall Study|Death|1|||
156379013|NCT01898793|564479918|FG002|Overall Study|Death|4|||
156379014|NCT01898793|564479919|FG003|Overall Study|Death|0|||
156379015|NCT01898793|564479920|FG004|Overall Study|Death|0|||
156379016|NCT01898793|564479921|FG005|Overall Study|Death|0|||
156379017|NCT01898793|564479922|FG006|Overall Study|Death|0|||
156379018|NCT04666441|564479925|FG000|Overall Study|Lost to Follow-up|1|||
156379019|NCT04666441|564479926|FG001|Overall Study|Lost to Follow-up|4|||
156379020|NCT04666441|564479927|FG002|Overall Study|Lost to Follow-up|1|||
156379021|NCT04666441|564479928|FG003|Overall Study|Lost to Follow-up|3|||
156379022|NCT04666441|564479929|FG004|Overall Study|Lost to Follow-up|0|||
156379023|NCT04666441|564479930|FG005|Overall Study|Lost to Follow-up|2|||
156379024|NCT04666441|564479931|FG006|Overall Study|Lost to Follow-up|2|||
156379025|NCT04666441|564479932|FG007|Overall Study|Lost to Follow-up|2|||
156379026|NCT04666441|564479925|FG000|Overall Study|Subject Decision|1|||
156379027|NCT04666441|564479926|FG001|Overall Study|Subject Decision|1|||
156379028|NCT04666441|564479927|FG002|Overall Study|Subject Decision|3|||
156379029|NCT04666441|564479928|FG003|Overall Study|Subject Decision|1|||
156379030|NCT04666441|564479929|FG004|Overall Study|Subject Decision|0|||
156379031|NCT04666441|564479930|FG005|Overall Study|Subject Decision|1|||
156379032|NCT04666441|564479931|FG006|Overall Study|Subject Decision|3|||
156379033|NCT04666441|564479932|FG007|Overall Study|Subject Decision|2|||
156379034|NCT01306617|564479936|FG000|Overall Study|Adverse Event|1|||
156379035|NCT01306617|564479937|FG001|Overall Study|Adverse Event|0|||
156379036|NCT01306617|564479938|FG002|Overall Study|Adverse Event|0|||
156379037|NCT01306617|564479936|FG000|Overall Study|Virologic Failure|0|||
156379038|NCT01306617|564479937|FG001|Overall Study|Virologic Failure|0|||
156500437|NCT04870957|564923790|FG002|T2 (Randomization) - T3|Physician Decision|2|||
156379039|NCT01306617|564479938|FG002|Overall Study|Virologic Failure|5|||
156379040|NCT01306617|564479936|FG000|Overall Study|Non-compliance|0|||
156379041|NCT01306617|564479937|FG001|Overall Study|Non-compliance|1|||
156379042|NCT01306617|564479938|FG002|Overall Study|Non-compliance|0|||
156379043|NCT04028388|564479946|FG000|Overall Study|Evaluations missing|3|||
156379044|NCT04028388|564479947|FG001|Overall Study|Evaluations missing|6|||
156379045|NCT04028388|564479946|FG000|Overall Study|Not started|2|||
156500438|NCT04870957|564923791|FG003|T2 (Randomization) - T3|Physician Decision|1|||
156379046|NCT04028388|564479947|FG001|Overall Study|Not started|0|||
156379047|NCT00766415|564479952|FG000|Overall Study|Withdrawal by Subject|0|||
156379048|NCT00766415|564479953|FG001|Overall Study|Withdrawal by Subject|1|||
156379049|NCT01114516|564479954|FG000|Overall Study|Lost to Follow-up|2|||
156379050|NCT01114516|564479955|FG001|Overall Study|Lost to Follow-up|1|||
156379051|NCT01431508|564479958|FG000|Overall Study|Lack of Efficacy|1|||
156379052|NCT01431508|564479958|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
156379053|NCT00132769|564479959|FG000|Overall Study|Withdrawal by Subject|1|||
156500439|NCT04870957|564923792|FG004|T2 (Randomization) - T3|Physician Decision|0|||
156500440|NCT04870957|564923793|FG005|T2 (Randomization) - T3|Physician Decision|0|||
156500441|NCT04870957|564923788|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
156500442|NCT04870957|564923789|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
156500443|NCT04870957|564923790|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
156500444|NCT04870957|564923791|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
156500445|NCT04870957|564923792|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
156500446|NCT04870957|564923793|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
156500447|NCT04870957|564923788|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
156500448|NCT04870957|564923789|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
156500449|NCT04870957|564923790|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
156500450|NCT04870957|564923791|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
156500451|NCT04870957|564923792|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
156500452|NCT04870957|564923793|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
156500453|NCT04870957|564923788|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
156500454|NCT04870957|564923789|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
156500455|NCT04870957|564923790|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
156500456|NCT04870957|564923791|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
156500457|NCT04870957|564923792|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
156379054|NCT00132769|564479960|FG001|Overall Study|Withdrawal by Subject|3|||
156379055|NCT00132769|564479959|FG000|Overall Study|Lack of Efficacy|7|||
156379056|NCT00132769|564479960|FG001|Overall Study|Lack of Efficacy|6|||
156379057|NCT00132769|564479959|FG000|Overall Study|Adverse Event|2|||
156379058|NCT00132769|564479960|FG001|Overall Study|Adverse Event|1|||
156379059|NCT00132769|564479959|FG000|Overall Study|Protocol Violation|1|||
156379060|NCT00132769|564479960|FG001|Overall Study|Protocol Violation|1|||
156379061|NCT00129259|564479961|FG000|Overall Study|Lost to Follow-up|1|||
156379062|NCT00129259|564479962|FG001|Overall Study|Lost to Follow-up|1|||
156379063|NCT00129259|564479961|FG000|Overall Study|Withdrawal by Subject|2|||
156379064|NCT00129259|564479962|FG001|Overall Study|Withdrawal by Subject|1|||
156379065|NCT00129259|564479961|FG000|Overall Study|Only available minimal phone assessments|0|||
156379066|NCT00129259|564479962|FG001|Overall Study|Only available minimal phone assessments|1|||
156379067|NCT01609556|564479964|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379068|NCT01609556|564479965|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379069|NCT01609556|564479966|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379070|NCT01609556|564479967|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379071|NCT01609556|564479968|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156379072|NCT01609556|564479969|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379073|NCT01609556|564479970|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379074|NCT01609556|564479971|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156379075|NCT01609556|564479972|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156379076|NCT01609556|564479973|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379077|NCT01609556|564479974|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156379078|NCT01609556|564479975|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156379079|NCT01609556|564479976|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379080|NCT01609556|564479977|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379081|NCT01609556|564479978|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379082|NCT01609556|564479979|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156379083|NCT01609556|564479964|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156379084|NCT01609556|564479965|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
156379085|NCT01609556|564479966|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
156500458|NCT04870957|564923793|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
156500459|NCT04870957|564923788|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
156500460|NCT04870957|564923789|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
156500461|NCT04870957|564923790|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
156500462|NCT04870957|564923791|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
156379086|NCT01609556|564479967|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
156500463|NCT04870957|564923792|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
156500464|NCT04870957|564923793|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
156379087|NCT01609556|564479968|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
156500465|NCT04870957|564923788|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
156500466|NCT04870957|564923789|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
156500467|NCT04870957|564923790|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
156379088|NCT01609556|564479969|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
156379089|NCT01609556|564479970|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
156379090|NCT01609556|564479971|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
156379091|NCT01609556|564479972|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
156379092|NCT01609556|564479973|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
156379093|NCT01609556|564479974|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
156379094|NCT01609556|564479975|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
156379095|NCT01609556|564479976|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156379096|NCT01609556|564479977|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156379097|NCT01609556|564479978|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156379098|NCT01609556|564479979|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156379099|NCT01609556|564479964|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379100|NCT01609556|564479965|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379101|NCT01609556|564479966|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379102|NCT01609556|564479967|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379103|NCT01609556|564479968|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379104|NCT01609556|564479969|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
156379105|NCT01609556|564479970|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
156379106|NCT01609556|564479971|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379107|NCT01609556|564479972|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379108|NCT01609556|564479973|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
156379109|NCT01609556|564479974|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
156379110|NCT01609556|564479975|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
156379111|NCT01609556|564479976|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379112|NCT01609556|564479977|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379113|NCT01609556|564479978|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379114|NCT01609556|564479979|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156379115|NCT01609556|564479964|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379116|NCT01609556|564479965|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379117|NCT01609556|564479966|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379118|NCT01609556|564479967|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379119|NCT01609556|564479968|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379120|NCT01609556|564479969|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
156379121|NCT01609556|564479970|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379122|NCT01609556|564479971|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379123|NCT01609556|564479972|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379124|NCT01609556|564479973|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379125|NCT01609556|564479974|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379126|NCT01609556|564479975|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
156379127|NCT01609556|564479976|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379128|NCT01609556|564479977|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379129|NCT01609556|564479978|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379130|NCT01609556|564479979|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156379131|NCT01609556|564479964|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379132|NCT01609556|564479965|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379133|NCT01609556|564479966|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379134|NCT01609556|564479967|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379135|NCT01609556|564479968|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379136|NCT01609556|564479969|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
156379137|NCT01609556|564479970|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379138|NCT01609556|564479971|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379139|NCT01609556|564479972|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379140|NCT01609556|564479973|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379141|NCT01609556|564479974|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379142|NCT01609556|564479975|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379143|NCT01609556|564479976|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379144|NCT01609556|564479977|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379145|NCT01609556|564479978|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379146|NCT01609556|564479979|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156379147|NCT01609556|564479964|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379148|NCT01609556|564479965|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379149|NCT01609556|564479966|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379150|NCT01609556|564479967|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379151|NCT01609556|564479968|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379152|NCT01609556|564479969|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379153|NCT01609556|564479970|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379154|NCT01609556|564479971|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379155|NCT01609556|564479972|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
156379156|NCT01609556|564479973|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379157|NCT01609556|564479974|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379158|NCT01609556|564479975|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379159|NCT01609556|564479976|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379160|NCT01609556|564479977|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379161|NCT01609556|564479978|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379162|NCT01609556|564479979|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156379163|NCT01609556|564479964|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
156379164|NCT01609556|564479965|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379165|NCT01609556|564479966|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379166|NCT01609556|564479967|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379167|NCT01609556|564479968|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379168|NCT01609556|564479969|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
156379169|NCT01609556|564479970|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379170|NCT01609556|564479971|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379171|NCT01609556|564479972|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379172|NCT01609556|564479973|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379173|NCT01609556|564479974|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
156379174|NCT01609556|564479975|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379175|NCT01609556|564479976|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379176|NCT01609556|564479977|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379177|NCT01609556|564479978|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379178|NCT01609556|564479979|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156379179|NCT01609556|564479964|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379180|NCT01609556|564479965|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379181|NCT01609556|564479966|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379182|NCT01609556|564479967|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379183|NCT01609556|564479968|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379184|NCT01609556|564479969|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379185|NCT01609556|564479970|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379186|NCT01609556|564479971|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379187|NCT01609556|564479972|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379188|NCT01609556|564479973|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379189|NCT01609556|564479974|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379190|NCT01609556|564479975|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156379191|NCT01609556|564479976|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
156379192|NCT01609556|564479977|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
156379193|NCT01609556|564479978|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
156379194|NCT01609556|564479979|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
156379195|NCT01609556|564479964|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379196|NCT01609556|564479965|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379197|NCT01609556|564479966|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379198|NCT01609556|564479967|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379199|NCT01609556|564479968|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379200|NCT01609556|564479969|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379201|NCT01609556|564479970|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379202|NCT01609556|564479971|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379203|NCT01609556|564479972|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379204|NCT01609556|564479973|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379205|NCT01609556|564479974|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379206|NCT01609556|564479975|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156379207|NCT01609556|564479976|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
156379208|NCT01609556|564479977|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
156379209|NCT01609556|564479978|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
156379210|NCT01609556|564479979|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
156379211|NCT01609556|564479964|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379212|NCT01609556|564479965|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379213|NCT01609556|564479966|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379214|NCT01609556|564479967|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379215|NCT01609556|564479968|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379216|NCT01609556|564479969|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379217|NCT01609556|564479970|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379218|NCT01609556|564479971|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379219|NCT01609556|564479972|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379220|NCT01609556|564479973|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379221|NCT01609556|564479974|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379222|NCT01609556|564479975|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156379223|NCT01609556|564479976|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
156379224|NCT01609556|564479977|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
156379225|NCT01609556|564479978|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
156379226|NCT01609556|564479979|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
156379227|NCT01609556|564479964|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379228|NCT01609556|564479965|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379229|NCT01609556|564479966|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379230|NCT01609556|564479967|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379231|NCT01609556|564479968|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379232|NCT01609556|564479969|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379233|NCT01609556|564479970|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379234|NCT01609556|564479971|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379235|NCT01609556|564479972|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379236|NCT01609556|564479973|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379237|NCT01609556|564479974|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379238|NCT01609556|564479975|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379239|NCT01609556|564479976|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
156379240|NCT01609556|564479977|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379241|NCT01609556|564479978|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379242|NCT01609556|564479979|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156379243|NCT01609556|564479964|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379244|NCT01609556|564479965|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379245|NCT01609556|564479966|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379246|NCT01609556|564479967|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379247|NCT01609556|564479968|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379248|NCT01609556|564479969|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379249|NCT01609556|564479970|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379250|NCT01609556|564479971|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379251|NCT01609556|564479972|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379252|NCT01609556|564479973|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379253|NCT01609556|564479974|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379254|NCT01609556|564479975|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156379255|NCT01609556|564479976|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
156379256|NCT01609556|564479977|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
156379257|NCT01609556|564479978|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
156379258|NCT01609556|564479979|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
156379259|NCT01609556|564479964|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379260|NCT01609556|564479965|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379261|NCT01609556|564479966|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379262|NCT01609556|564479967|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379263|NCT01609556|564479968|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379264|NCT01609556|564479969|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379265|NCT01609556|564479970|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379266|NCT01609556|564479971|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379267|NCT01609556|564479972|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379268|NCT01609556|564479973|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379269|NCT01609556|564479974|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379270|NCT01609556|564479975|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379271|NCT01609556|564479976|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379272|NCT01609556|564479977|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379273|NCT01609556|564479978|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156379274|NCT01609556|564479979|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
156379275|NCT01609556|564479964|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379276|NCT01609556|564479965|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379277|NCT01609556|564479966|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379278|NCT01609556|564479967|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379279|NCT01609556|564479968|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379280|NCT01609556|564479969|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379281|NCT01609556|564479970|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379282|NCT01609556|564479971|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379283|NCT01609556|564479972|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379284|NCT01609556|564479973|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379285|NCT01609556|564479974|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379286|NCT01609556|564479975|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379287|NCT01609556|564479976|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
156379288|NCT01609556|564479977|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
156379289|NCT01609556|564479978|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
156379290|NCT01609556|564479979|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
156379291|NCT01609556|564479964|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379292|NCT01609556|564479965|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379293|NCT01609556|564479966|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379294|NCT01609556|564479967|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379295|NCT01609556|564479968|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379296|NCT01609556|564479969|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379297|NCT01609556|564479970|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379298|NCT01609556|564479971|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379299|NCT01609556|564479972|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379300|NCT01609556|564479973|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379301|NCT01609556|564479974|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379302|NCT01609556|564479975|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379303|NCT01609556|564479976|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
156379304|NCT01609556|564479977|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379305|NCT01609556|564479978|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379306|NCT01609556|564479979|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156379307|NCT01632579|564479982|FG000|Washout Period|Adverse Event|1|||
156379308|NCT01632579|564479983|FG001|Washout Period|Adverse Event|0|||
156379309|NCT01632579|564479984|FG002|Washout Period|Adverse Event|0|||
156379310|NCT01632579|564479985|FG003|Washout Period|Adverse Event|0|||
156379311|NCT01632579|564479986|FG004|Washout Period|Adverse Event|0|||
156379312|NCT01632579|564479987|FG005|Washout Period|Adverse Event|0|||
156379313|NCT01632579|564479988|FG006|Washout Period|Adverse Event|0|||
156379314|NCT01632579|564479989|FG007|Washout Period|Adverse Event|0|||
156379315|NCT01632579|564479990|FG008|Washout Period|Adverse Event|0|||
156379316|NCT01632579|564479982|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
156500468|NCT04870957|564923791|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
156500469|NCT04870957|564923792|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
156500470|NCT04870957|564923793|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
156500471|NCT04870957|564923788|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
156500472|NCT04870957|564923789|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
156500473|NCT04870957|564923790|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
156500474|NCT04870957|564923791|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
156500475|NCT04870957|564923792|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
156500476|NCT04870957|564923793|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
156500477|NCT04870957|564923788|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
156500478|NCT04870957|564923789|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
156379317|NCT01632579|564479983|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
156379318|NCT01632579|564479984|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
156379319|NCT01632579|564479985|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
156379320|NCT01632579|564479986|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
156379321|NCT01632579|564479987|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
156379322|NCT01632579|564479988|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
156379323|NCT01632579|564479989|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
156379324|NCT01632579|564479990|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
156500479|NCT04870957|564923790|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
156500480|NCT04870957|564923791|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
156500481|NCT04870957|564923792|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
156500482|NCT04870957|564923793|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
156500483|NCT04870957|564923788|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
156500484|NCT04870957|564923789|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
156500485|NCT04870957|564923790|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
156500486|NCT04870957|564923791|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
156500487|NCT04870957|564923792|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
156500488|NCT04870957|564923793|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
156500489|NCT04870957|564923788|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
156500490|NCT04870957|564923789|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
156500491|NCT04870957|564923790|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
156500492|NCT04870957|564923791|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
156500493|NCT04870957|564923792|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
156500494|NCT04870957|564923793|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
156500495|NCT05970640|564923794|FG000|Overall Study|Adverse Event|1|||
156500496|NCT05970640|564923795|FG001|Overall Study|Adverse Event|3|||
156500497|NCT05970640|564923796|FG002|Overall Study|Adverse Event|1|||
156500498|NCT05970640|564923797|FG003|Overall Study|Adverse Event|0|||
156500499|NCT05970640|564923794|FG000|Overall Study|Withdrawal by Subject|0|||
156379325|NCT01539291|564481534|FG000|Study GS-US-312-0116|Adverse Event|9|||
156379326|NCT01539291|564481535|FG001|Study GS-US-312-0116|Adverse Event|0|||
156379327|NCT01539291|564481536|FG002|Study GS-US-312-0116|Adverse Event|0|||
156379328|NCT01539291|564481537|FG003|Study GS-US-312-0116|Adverse Event|0|||
156379329|NCT01539291|564481534|FG000|Study GS-US-312-0116|Physician Decision|1|||
156379330|NCT01539291|564481535|FG001|Study GS-US-312-0116|Physician Decision|0|||
156379331|NCT01539291|564481536|FG002|Study GS-US-312-0116|Physician Decision|0|||
156379332|NCT01539291|564481537|FG003|Study GS-US-312-0116|Physician Decision|0|||
156379333|NCT01539291|564481534|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
156379334|NCT01539291|564481535|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
156379335|NCT01539291|564481536|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
156379336|NCT01539291|564481537|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
156379337|NCT01539291|564481534|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
156379338|NCT01539291|564481535|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
156379339|NCT01539291|564481536|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
156379340|NCT01539291|564481537|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
156379341|NCT01539291|564481534|FG000|Study GS-US-312-0116|Other|1|||
156379342|NCT01539291|564481535|FG001|Study GS-US-312-0116|Other|0|||
156379343|NCT01539291|564481536|FG002|Study GS-US-312-0116|Other|0|||
156379344|NCT01539291|564481537|FG003|Study GS-US-312-0116|Other|0|||
156379345|NCT01539291|564481534|FG000|Study GS-US-312-0117|Adverse Event|22|||
156379346|NCT01539291|564481535|FG001|Study GS-US-312-0117|Adverse Event|1|||
156379347|NCT01539291|564481536|FG002|Study GS-US-312-0117|Adverse Event|9|||
156379348|NCT01539291|564481537|FG003|Study GS-US-312-0117|Adverse Event|12|||
156379349|NCT01539291|564481534|FG000|Study GS-US-312-0117|Physician Decision|9|||
156379350|NCT01539291|564481535|FG001|Study GS-US-312-0117|Physician Decision|0|||
156379351|NCT01539291|564481536|FG002|Study GS-US-312-0117|Physician Decision|6|||
156379352|NCT01539291|564481537|FG003|Study GS-US-312-0117|Physician Decision|4|||
156379353|NCT01539291|564481534|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
156379354|NCT01539291|564481535|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
156379355|NCT01539291|564481536|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
156379356|NCT01539291|564481537|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
156379357|NCT01539291|564481534|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
156379358|NCT01539291|564481535|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
156379359|NCT01539291|564481536|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
156379360|NCT01539291|564481537|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
156379361|NCT01539291|564481534|FG000|Study GS-US-312-0117|Other|2|||
156379362|NCT01539291|564481535|FG001|Study GS-US-312-0117|Other|1|||
156379363|NCT01539291|564481536|FG002|Study GS-US-312-0117|Other|1|||
156379364|NCT01539291|564481537|FG003|Study GS-US-312-0117|Other|1|||
156379365|NCT01045447|564481548|FG000|Overall Study|Adverse Event|0|||
156379366|NCT01045447|564481549|FG001|Overall Study|Adverse Event|1|||
156379367|NCT01045447|564481548|FG000|Overall Study|Lack of Efficacy|3|||
156379368|NCT01045447|564481549|FG001|Overall Study|Lack of Efficacy|1|||
156379369|NCT01045447|564481548|FG000|Overall Study|Protocol Violation|6|||
156379370|NCT01045447|564481549|FG001|Overall Study|Protocol Violation|3|||
156379371|NCT01045447|564481548|FG000|Overall Study|Withdrawal Criteria|10|||
156379372|NCT01045447|564481549|FG001|Overall Study|Withdrawal Criteria|10|||
156379373|NCT01045447|564481548|FG000|Overall Study|Unclassified|17|||
156379374|NCT01045447|564481549|FG001|Overall Study|Unclassified|13|||
156379375|NCT02318329|564481550|FG000|Overall Study|Progressive Disease|2|||
156379376|NCT02318329|564481551|FG001|Overall Study|Progressive Disease|3|||
156379377|NCT02318329|564481552|FG002|Overall Study|Progressive Disease|2|||
156379378|NCT02318329|564481553|FG003|Overall Study|Progressive Disease|3|||
156379379|NCT02318329|564481554|FG004|Overall Study|Progressive Disease|3|||
156379380|NCT02318329|564481555|FG005|Overall Study|Progressive Disease|3|||
156379381|NCT02318329|564481556|FG006|Overall Study|Progressive Disease|1|||
156379382|NCT02318329|564481557|FG007|Overall Study|Progressive Disease|1|||
156379383|NCT02318329|564481558|FG008|Overall Study|Progressive Disease|5|||
156379384|NCT02318329|564481559|FG009|Overall Study|Progressive Disease|39|||
156379385|NCT02318329|564481550|FG000|Overall Study|Death|0|||
156379386|NCT02318329|564481551|FG001|Overall Study|Death|0|||
156379387|NCT02318329|564481552|FG002|Overall Study|Death|0|||
156379388|NCT02318329|564481553|FG003|Overall Study|Death|0|||
156379389|NCT02318329|564481554|FG004|Overall Study|Death|0|||
156379390|NCT02318329|564481555|FG005|Overall Study|Death|0|||
156379391|NCT02318329|564481556|FG006|Overall Study|Death|0|||
156379392|NCT02318329|564481557|FG007|Overall Study|Death|0|||
156379393|NCT02318329|564481558|FG008|Overall Study|Death|0|||
156379394|NCT02318329|564481559|FG009|Overall Study|Death|5|||
156379395|NCT02318329|564481550|FG000|Overall Study|Lost to Follow-up|0|||
156379396|NCT02318329|564481551|FG001|Overall Study|Lost to Follow-up|0|||
156379397|NCT02318329|564481552|FG002|Overall Study|Lost to Follow-up|0|||
156379398|NCT02318329|564481553|FG003|Overall Study|Lost to Follow-up|0|||
156379399|NCT02318329|564481554|FG004|Overall Study|Lost to Follow-up|0|||
156379400|NCT02318329|564481555|FG005|Overall Study|Lost to Follow-up|0|||
156379401|NCT02318329|564481556|FG006|Overall Study|Lost to Follow-up|0|||
156379402|NCT02318329|564481557|FG007|Overall Study|Lost to Follow-up|0|||
156379403|NCT02318329|564481558|FG008|Overall Study|Lost to Follow-up|0|||
156379404|NCT02318329|564481559|FG009|Overall Study|Lost to Follow-up|1|||
156379405|NCT02318329|564481550|FG000|Overall Study|Withdrawal by Subject|0|||
156379406|NCT02318329|564481551|FG001|Overall Study|Withdrawal by Subject|0|||
156379407|NCT02318329|564481552|FG002|Overall Study|Withdrawal by Subject|0|||
156379408|NCT02318329|564481553|FG003|Overall Study|Withdrawal by Subject|0|||
156379409|NCT02318329|564481554|FG004|Overall Study|Withdrawal by Subject|0|||
156379410|NCT02318329|564481555|FG005|Overall Study|Withdrawal by Subject|0|||
156379411|NCT02318329|564481556|FG006|Overall Study|Withdrawal by Subject|0|||
156379412|NCT02318329|564481557|FG007|Overall Study|Withdrawal by Subject|0|||
156379413|NCT02318329|564481558|FG008|Overall Study|Withdrawal by Subject|0|||
156379414|NCT02318329|564481559|FG009|Overall Study|Withdrawal by Subject|6|||
156379415|NCT02318329|564481550|FG000|Overall Study|Other|1|||
156379416|NCT02318329|564481551|FG001|Overall Study|Other|1|||
156379417|NCT02318329|564481552|FG002|Overall Study|Other|1|||
156379418|NCT02318329|564481553|FG003|Overall Study|Other|0|||
156379419|NCT02318329|564481554|FG004|Overall Study|Other|0|||
156379420|NCT02318329|564481555|FG005|Overall Study|Other|0|||
156379421|NCT02318329|564481556|FG006|Overall Study|Other|0|||
156379422|NCT02318329|564481557|FG007|Overall Study|Other|0|||
156379423|NCT02318329|564481558|FG008|Overall Study|Other|1|||
156379424|NCT02318329|564481559|FG009|Overall Study|Other|1|||
156379425|NCT00581945|564481562|FG000|Overall Study|Adverse Event|4|||
156379426|NCT00581945|564481563|FG001|Overall Study|Adverse Event|4|||
156379427|NCT00581945|564481562|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156379428|NCT00581945|564481563|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156379429|NCT00581945|564481562|FG000|Overall Study|Withdrawal by Subject|2|||
156379430|NCT00581945|564481563|FG001|Overall Study|Withdrawal by Subject|6|||
156379431|NCT00581945|564481562|FG000|Overall Study|Death|1|||
156379432|NCT00581945|564481563|FG001|Overall Study|Death|0|||
156379433|NCT02979535|564481564|FG000|Overall Study|Non compliance with the protocol|78|||
156379434|NCT02979535|564481565|FG001|Overall Study|Non compliance with the protocol|82|||
156379435|NCT02979535|564481564|FG000|Overall Study|Consent withdrawn by participant|11|||
156379436|NCT02979535|564481565|FG001|Overall Study|Consent withdrawn by participant|18|||
156379437|NCT02979535|564481564|FG000|Overall Study|Lost to Follow-up|6|||
156379438|NCT02979535|564481565|FG001|Overall Study|Lost to Follow-up|1|||
156379439|NCT02032901|564481571|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
156379440|NCT02032901|564481572|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
156379441|NCT02032901|564481571|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
156379442|NCT02032901|564481572|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
156379443|NCT00982020|564481573|FG000|Overall Study|Adverse Event|19|||
156379444|NCT00982020|564481574|FG001|Overall Study|Adverse Event|15|||
156379445|NCT00982020|564481573|FG000|Overall Study|Withdrawal by Subject|11|||
156379446|NCT00982020|564481574|FG001|Overall Study|Withdrawal by Subject|14|||
156379447|NCT00982020|564481573|FG000|Overall Study|Lost to Follow-up|5|||
156379448|NCT00982020|564481574|FG001|Overall Study|Lost to Follow-up|11|||
156379449|NCT00982020|564481573|FG000|Overall Study|Lack of Efficacy|10|||
156379450|NCT00982020|564481574|FG001|Overall Study|Lack of Efficacy|4|||
156379451|NCT00982020|564481573|FG000|Overall Study|Parent/Caregiver Decision|5|||
156379452|NCT00982020|564481574|FG001|Overall Study|Parent/Caregiver Decision|5|||
156379453|NCT00982020|564481573|FG000|Overall Study|Treatment Non-compliance|3|||
156379454|NCT00982020|564481574|FG001|Overall Study|Treatment Non-compliance|6|||
156379455|NCT00982020|564481573|FG000|Overall Study|Physician Decision|2|||
156379456|NCT00982020|564481574|FG001|Overall Study|Physician Decision|5|||
156379457|NCT00982020|564481573|FG000|Overall Study|Entry Criteria Not Met|2|||
156379458|NCT00982020|564481574|FG001|Overall Study|Entry Criteria Not Met|1|||
156379459|NCT00982020|564481573|FG000|Overall Study|Protocol Violation|0|||
156379460|NCT00982020|564481574|FG001|Overall Study|Protocol Violation|2|||
156379461|NCT00982020|564481573|FG000|Overall Study|Clinical Relapse|0|||
156379462|NCT00982020|564481574|FG001|Overall Study|Clinical Relapse|1|||
156379463|NCT00353704|564481578|FG000|Overall Study|Protocol Violation|3|||
156379464|NCT00353704|564481579|FG001|Overall Study|Protocol Violation|1|||
156379465|NCT02525133|564481580|FG000|Overall Study|Adverse Event|0|||
156379466|NCT02525133|564481581|FG001|Overall Study|Adverse Event|1|||
156379467|NCT02525133|564481580|FG000|Overall Study|Death|0|||
156379468|NCT02525133|564481581|FG001|Overall Study|Death|1|||
156379469|NCT02525133|564481580|FG000|Overall Study|did not meet randomization criteria|1|||
156379470|NCT02525133|564481581|FG001|Overall Study|did not meet randomization criteria|0|||
156379471|NCT02525133|564481580|FG000|Overall Study|Lost to Follow-up|5|||
156379472|NCT02525133|564481581|FG001|Overall Study|Lost to Follow-up|1|||
156379473|NCT02525133|564481580|FG000|Overall Study|randomized not enrolled|3|||
156379474|NCT02525133|564481581|FG001|Overall Study|randomized not enrolled|0|||
156379475|NCT02525133|564481580|FG000|Overall Study|Withdrawal by Subject|1|||
156379476|NCT02525133|564481581|FG001|Overall Study|Withdrawal by Subject|0|||
156379477|NCT01343082|564481582|FG000|The run-in Period|Not meeting criteria|3|||
156379478|NCT01343082|564481583|FG001|The run-in Period|Not meeting criteria|4|||
156379479|NCT01343082|564481584|FG002|The run-in Period|Not meeting criteria|5|||
156379480|NCT01343082|564481582|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
156379481|NCT01343082|564481583|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
156379482|NCT01343082|564481584|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
156379483|NCT01343082|564481582|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
156379484|NCT01343082|564481583|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
156379485|NCT01343082|564481584|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
156379486|NCT01343082|564481582|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
156379487|NCT01343082|564481583|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
156379488|NCT01343082|564481584|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
156379489|NCT01343082|564481582|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
156379490|NCT01343082|564481583|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
156379491|NCT01343082|564481584|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
156379492|NCT04317586|564481585|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
156379493|NCT04317586|564481585|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
156379494|NCT00803023|564481597|FG000|Overall Study|Adverse Event|5|||
156379495|NCT00803023|564481598|FG001|Overall Study|Adverse Event|4|||
156379496|NCT00803023|564481599|FG002|Overall Study|Adverse Event|8|||
156379497|NCT00803023|564481600|FG003|Overall Study|Adverse Event|6|||
156379498|NCT00803023|564481597|FG000|Overall Study|Withdrawal by Subject|0|||
156379499|NCT00803023|564481598|FG001|Overall Study|Withdrawal by Subject|2|||
156379500|NCT00803023|564481599|FG002|Overall Study|Withdrawal by Subject|0|||
156379501|NCT00803023|564481600|FG003|Overall Study|Withdrawal by Subject|0|||
156379502|NCT00803023|564481597|FG000|Overall Study|Lost to Follow-up|0|||
156379503|NCT00803023|564481598|FG001|Overall Study|Lost to Follow-up|1|||
156379504|NCT00803023|564481599|FG002|Overall Study|Lost to Follow-up|2|||
156379505|NCT00803023|564481600|FG003|Overall Study|Lost to Follow-up|1|||
156379506|NCT00803023|564481597|FG000|Overall Study|Lack of Efficacy|0|||
156379507|NCT00803023|564481598|FG001|Overall Study|Lack of Efficacy|1|||
156379508|NCT00803023|564481599|FG002|Overall Study|Lack of Efficacy|1|||
156379509|NCT00803023|564481600|FG003|Overall Study|Lack of Efficacy|1|||
156379510|NCT02647658|564481601|FG000|Overall Study|Consent refusal|15|||
156379511|NCT02647658|564481602|FG001|Overall Study|Consent refusal|24|||
156379512|NCT01542528|564481603|FG000|Overall Study|Lost to Follow-up|2|||
156379513|NCT01542528|564481604|FG001|Overall Study|Lost to Follow-up|1|||
156379514|NCT01542528|564481603|FG000|Overall Study|Physician Decision|1|||
156379515|NCT01542528|564481604|FG001|Overall Study|Physician Decision|0|||
156379516|NCT01542528|564481603|FG000|Overall Study|Withdrawal by Subject|9|||
156379517|NCT01542528|564481604|FG001|Overall Study|Withdrawal by Subject|6|||
156379518|NCT05282004|564481605|FG000|Overall Study|Adverse Event|2|||
156379519|NCT04808609|564481606|FG000|Overall Study|Lost to Follow-up|0|||
156379520|NCT04808609|564481607|FG001|Overall Study|Lost to Follow-up|2|||
156379521|NCT04808609|564481606|FG000|Overall Study|Administrative Withdrawal|0|||
156379522|NCT04808609|564481607|FG001|Overall Study|Administrative Withdrawal|1|||
156379523|NCT00562159|564481609|FG000|Overall Study|Adverse Event|11|||
156379524|NCT00562159|564481610|FG001|Overall Study|Adverse Event|8|||
156379525|NCT00562159|564481609|FG000|Overall Study|Lost to Follow-up|5|||
156379526|NCT00562159|564481610|FG001|Overall Study|Lost to Follow-up|4|||
156379527|NCT00562159|564481609|FG000|Overall Study|Withdrawal by Subject|9|||
156379528|NCT00562159|564481610|FG001|Overall Study|Withdrawal by Subject|8|||
156379529|NCT00562159|564481609|FG000|Overall Study|Protocol Violation|12|||
156379530|NCT00562159|564481610|FG001|Overall Study|Protocol Violation|12|||
156379531|NCT00562159|564481609|FG000|Overall Study|Did not meet protocol eligibility|1|||
156379532|NCT00562159|564481610|FG001|Overall Study|Did not meet protocol eligibility|1|||
156379533|NCT01181921|564481613|FG000|Overall Study|Lost to Follow-up|1|||
156379534|NCT02461589|564481614|FG000|Overall Study|Withdrawal by Subject|5|||
156379535|NCT02461589|564481615|FG001|Overall Study|Withdrawal by Subject|1|||
156379536|NCT02461589|564481616|FG002|Overall Study|Withdrawal by Subject|3|||
156379537|NCT02461589|564481617|FG003|Overall Study|Withdrawal by Subject|2|||
156379538|NCT02461589|564481618|FG004|Overall Study|Withdrawal by Subject|1|||
156379539|NCT02461589|564481619|FG005|Overall Study|Withdrawal by Subject|2|||
156379540|NCT02461589|564481620|FG006|Overall Study|Withdrawal by Subject|1|||
156379541|NCT02461589|564481621|FG007|Overall Study|Withdrawal by Subject|3|||
156379542|NCT02461589|564481622|FG008|Overall Study|Withdrawal by Subject|3|||
156379543|NCT02461589|564481623|FG009|Overall Study|Withdrawal by Subject|1|||
156379544|NCT02461589|564481614|FG000|Overall Study|Lost to Follow-up|0|||
156379545|NCT02461589|564481615|FG001|Overall Study|Lost to Follow-up|0|||
156379546|NCT02461589|564481616|FG002|Overall Study|Lost to Follow-up|2|||
156379547|NCT02461589|564481617|FG003|Overall Study|Lost to Follow-up|3|||
156379548|NCT02461589|564481618|FG004|Overall Study|Lost to Follow-up|1|||
156379549|NCT02461589|564481619|FG005|Overall Study|Lost to Follow-up|1|||
156379550|NCT02461589|564481620|FG006|Overall Study|Lost to Follow-up|3|||
156379551|NCT02461589|564481621|FG007|Overall Study|Lost to Follow-up|1|||
156379552|NCT02461589|564481622|FG008|Overall Study|Lost to Follow-up|3|||
156379553|NCT02461589|564481623|FG009|Overall Study|Lost to Follow-up|1|||
156379554|NCT02461589|564481614|FG000|Overall Study|Death|0|||
156379555|NCT02461589|564481615|FG001|Overall Study|Death|0|||
156379556|NCT02461589|564481616|FG002|Overall Study|Death|0|||
156379557|NCT02461589|564481617|FG003|Overall Study|Death|0|||
156379558|NCT02461589|564481618|FG004|Overall Study|Death|0|||
156379559|NCT02461589|564481619|FG005|Overall Study|Death|0|||
156379560|NCT02461589|564481620|FG006|Overall Study|Death|0|||
156379561|NCT02461589|564481621|FG007|Overall Study|Death|1|||
156379562|NCT02461589|564481622|FG008|Overall Study|Death|0|||
156379563|NCT02461589|564481623|FG009|Overall Study|Death|0|||
156379564|NCT02461589|564481614|FG000|Overall Study|Unclassified|0|||
156379565|NCT02461589|564481615|FG001|Overall Study|Unclassified|0|||
156379566|NCT02461589|564481616|FG002|Overall Study|Unclassified|0|||
156379567|NCT02461589|564481617|FG003|Overall Study|Unclassified|0|||
156379568|NCT02461589|564481618|FG004|Overall Study|Unclassified|0|||
156379569|NCT02461589|564481619|FG005|Overall Study|Unclassified|0|||
156379570|NCT02461589|564481620|FG006|Overall Study|Unclassified|1|||
156379571|NCT02461589|564481621|FG007|Overall Study|Unclassified|0|||
156379572|NCT02461589|564481622|FG008|Overall Study|Unclassified|0|||
156379573|NCT02461589|564481623|FG009|Overall Study|Unclassified|2|||
156379574|NCT02461589|564481614|FG000|Overall Study|Missing follow-up information|1|||
156379575|NCT02461589|564481615|FG001|Overall Study|Missing follow-up information|1|||
156379576|NCT02461589|564481616|FG002|Overall Study|Missing follow-up information|0|||
156379577|NCT02461589|564481617|FG003|Overall Study|Missing follow-up information|0|||
156379578|NCT02461589|564481618|FG004|Overall Study|Missing follow-up information|0|||
156379579|NCT02461589|564481619|FG005|Overall Study|Missing follow-up information|0|||
156379580|NCT02461589|564481620|FG006|Overall Study|Missing follow-up information|1|||
156379581|NCT02461589|564481621|FG007|Overall Study|Missing follow-up information|0|||
156379582|NCT02461589|564481622|FG008|Overall Study|Missing follow-up information|0|||
156379583|NCT02461589|564481623|FG009|Overall Study|Missing follow-up information|0|||
156379584|NCT02461589|564481614|FG000|Overall Study|Withdrawal from trial before exposure|0|||
156379585|NCT02461589|564481615|FG001|Overall Study|Withdrawal from trial before exposure|0|||
156379586|NCT02461589|564481616|FG002|Overall Study|Withdrawal from trial before exposure|0|||
156379587|NCT02461589|564481617|FG003|Overall Study|Withdrawal from trial before exposure|0|||
156379588|NCT02461589|564481618|FG004|Overall Study|Withdrawal from trial before exposure|0|||
156379589|NCT02461589|564481619|FG005|Overall Study|Withdrawal from trial before exposure|0|||
156379590|NCT02461589|564481620|FG006|Overall Study|Withdrawal from trial before exposure|0|||
156379591|NCT02461589|564481621|FG007|Overall Study|Withdrawal from trial before exposure|0|||
156379592|NCT02461589|564481622|FG008|Overall Study|Withdrawal from trial before exposure|0|||
156379593|NCT02461589|564481623|FG009|Overall Study|Withdrawal from trial before exposure|1|||
156379594|NCT03295201|564481625|FG000|Overall Study|Lost to Follow-up|1|||
156379595|NCT03295201|564481626|FG001|Overall Study|Lost to Follow-up|1|||
156379596|NCT03295201|564481625|FG000|Overall Study|Hospital admission|0|||
156379597|NCT03295201|564481626|FG001|Overall Study|Hospital admission|1|||
156379598|NCT00572572|564481627|FG000|Overall Study|Withdrawal by Subject|3|||
156379599|NCT00572572|564481628|FG001|Overall Study|Withdrawal by Subject|6|||
156379600|NCT01831089|564481629|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
156379601|NCT01831089|564481630|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
156379602|NCT01831089|564481631|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
156379603|NCT01831089|564481632|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
156379604|NCT01831089|564481633|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
156379605|NCT01831089|564481634|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
156379606|NCT01831089|564481629|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
156379607|NCT01831089|564481630|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
156379608|NCT01831089|564481631|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
156379609|NCT01831089|564481632|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
156379610|NCT01831089|564481633|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
156379611|NCT01831089|564481634|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
156500500|NCT05970640|564923795|FG001|Overall Study|Withdrawal by Subject|0|||
156379612|NCT01831089|564481629|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156379613|NCT01831089|564481630|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
156379614|NCT01831089|564481631|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156379615|NCT01831089|564481632|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156379616|NCT01831089|564481633|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156379617|NCT01831089|564481634|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156379618|NCT01831089|564481629|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
156379619|NCT01831089|564481630|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
156379620|NCT01831089|564481631|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
156379621|NCT01831089|564481632|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
156379622|NCT01831089|564481633|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
156379623|NCT01831089|564481634|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
156379624|NCT01831089|564481629|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156379625|NCT01831089|564481630|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156379626|NCT01831089|564481631|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
156500501|NCT05970640|564923796|FG002|Overall Study|Withdrawal by Subject|1|||
156500502|NCT05970640|564923797|FG003|Overall Study|Withdrawal by Subject|1|||
156379627|NCT01831089|564481632|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156379628|NCT01831089|564481633|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156379629|NCT01831089|564481634|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156379630|NCT01831089|564481629|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
156379631|NCT01831089|564481630|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
156379632|NCT01831089|564481631|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
156379633|NCT01831089|564481632|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
156379634|NCT01831089|564481633|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
156379635|NCT01831089|564481634|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
156379636|NCT01831089|564481629|FG000|Cohort III: Dose Level 3|Global end of study|0|||
156379637|NCT01831089|564481630|FG001|Cohort III: Dose Level 3|Global end of study|0|||
156379638|NCT01831089|564481631|FG002|Cohort III: Dose Level 3|Global end of study|1|||
156379639|NCT01831089|564481632|FG003|Cohort III: Dose Level 3|Global end of study|0|||
156379640|NCT01831089|564481633|FG004|Cohort III: Dose Level 3|Global end of study|0|||
156379641|NCT01831089|564481634|FG005|Cohort III: Dose Level 3|Global end of study|0|||
156379642|NCT01831089|564481629|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
156379643|NCT01831089|564481630|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
156379644|NCT01831089|564481631|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
156379645|NCT01831089|564481632|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
156379646|NCT01831089|564481633|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
156379647|NCT01831089|564481634|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
156379648|NCT01831089|564481629|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
156379649|NCT01831089|564481630|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
156379650|NCT01831089|564481631|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
156379651|NCT01831089|564481632|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
156379652|NCT01831089|564481633|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
156379653|NCT01831089|564481634|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
156379654|NCT01831089|564481629|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156379655|NCT01831089|564481630|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156379656|NCT01831089|564481631|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156379657|NCT01831089|564481632|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156379658|NCT01831089|564481633|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
156379659|NCT01831089|564481634|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156379660|NCT01831089|564481629|FG000|Cohort V: Dose Level 5|Death|0|||
156379661|NCT01831089|564481630|FG001|Cohort V: Dose Level 5|Death|0|||
156379662|NCT01831089|564481631|FG002|Cohort V: Dose Level 5|Death|0|||
156379663|NCT01831089|564481632|FG003|Cohort V: Dose Level 5|Death|0|||
156379664|NCT01831089|564481633|FG004|Cohort V: Dose Level 5|Death|1|||
156379665|NCT01831089|564481634|FG005|Cohort V: Dose Level 5|Death|0|||
156379666|NCT01831089|564481629|FG000|Cohort V: Dose Level 5|Global end of study|0|||
156379667|NCT01831089|564481630|FG001|Cohort V: Dose Level 5|Global end of study|0|||
156379668|NCT01831089|564481631|FG002|Cohort V: Dose Level 5|Global end of study|0|||
156379669|NCT01831089|564481632|FG003|Cohort V: Dose Level 5|Global end of study|0|||
156379670|NCT01831089|564481633|FG004|Cohort V: Dose Level 5|Global end of study|2|||
156379671|NCT01831089|564481634|FG005|Cohort V: Dose Level 5|Global end of study|0|||
156379672|NCT01831089|564481629|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156379673|NCT01831089|564481630|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156379674|NCT01831089|564481631|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156379675|NCT01831089|564481632|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156379676|NCT01831089|564481633|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
156379677|NCT01831089|564481634|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156379678|NCT01831089|564481629|FG000|Cohort B: Arm B|Progressive disease|0|||
156379679|NCT01831089|564481630|FG001|Cohort B: Arm B|Progressive disease|0|||
156379680|NCT01831089|564481631|FG002|Cohort B: Arm B|Progressive disease|0|||
156379681|NCT01831089|564481632|FG003|Cohort B: Arm B|Progressive disease|0|||
156379682|NCT01831089|564481633|FG004|Cohort B: Arm B|Progressive disease|0|||
156379683|NCT01831089|564481634|FG005|Cohort B: Arm B|Progressive disease|8|||
156379684|NCT01831089|564481629|FG000|Cohort B: Arm B|Physician Decision|0|||
156379685|NCT01831089|564481630|FG001|Cohort B: Arm B|Physician Decision|0|||
156379686|NCT01831089|564481631|FG002|Cohort B: Arm B|Physician Decision|0|||
156379687|NCT01831089|564481632|FG003|Cohort B: Arm B|Physician Decision|0|||
156379688|NCT01831089|564481633|FG004|Cohort B: Arm B|Physician Decision|0|||
156379689|NCT01831089|564481634|FG005|Cohort B: Arm B|Physician Decision|2|||
156379690|NCT01831089|564481629|FG000|Cohort B: Arm B|Never treated|0|||
156379691|NCT01831089|564481630|FG001|Cohort B: Arm B|Never treated|0|||
156379692|NCT01831089|564481631|FG002|Cohort B: Arm B|Never treated|0|||
156379693|NCT01831089|564481632|FG003|Cohort B: Arm B|Never treated|0|||
156379694|NCT01831089|564481633|FG004|Cohort B: Arm B|Never treated|0|||
156500503|NCT05970640|564923794|FG000|Overall Study|Sponsor decision|0|||
156500504|NCT05970640|564923795|FG001|Overall Study|Sponsor decision|0|||
156379695|NCT01831089|564481634|FG005|Cohort B: Arm B|Never treated|2|||
156379696|NCT01831089|564481629|FG000|Cohort B: Arm B|Adverse Event|0|||
156379697|NCT01831089|564481630|FG001|Cohort B: Arm B|Adverse Event|0|||
156379698|NCT01831089|564481631|FG002|Cohort B: Arm B|Adverse Event|0|||
156379699|NCT01831089|564481632|FG003|Cohort B: Arm B|Adverse Event|0|||
156379700|NCT01831089|564481633|FG004|Cohort B: Arm B|Adverse Event|0|||
156379701|NCT01831089|564481634|FG005|Cohort B: Arm B|Adverse Event|1|||
156379702|NCT01831089|564481629|FG000|Cohort B: Arm B|Global end of study|0|||
156379703|NCT01831089|564481630|FG001|Cohort B: Arm B|Global end of study|0|||
156379704|NCT01831089|564481631|FG002|Cohort B: Arm B|Global end of study|0|||
156379705|NCT01831089|564481632|FG003|Cohort B: Arm B|Global end of study|0|||
156379706|NCT01831089|564481633|FG004|Cohort B: Arm B|Global end of study|0|||
156379707|NCT01831089|564481634|FG005|Cohort B: Arm B|Global end of study|1|||
156379708|NCT02548962|564481635|FG000|Overall Study|Withdrawal by Subject|1|||
156379709|NCT02548962|564481636|FG001|Overall Study|Withdrawal by Subject|0|||
156379710|NCT01485861|564481639|FG000|Phase Ib|Death|1|||
156379711|NCT01485861|564481640|FG001|Phase Ib|Death|0|||
156379712|NCT01485861|564481641|FG002|Phase Ib|Death|0|||
156379713|NCT01485861|564481642|FG003|Phase Ib|Death|0|||
156379714|NCT01485861|564481643|FG004|Phase Ib|Death|0|||
156379715|NCT01485861|564481644|FG005|Phase Ib|Death|0|||
156379716|NCT01485861|564481639|FG000|Phase Ib|Physician Decision|1|||
156379717|NCT01485861|564481640|FG001|Phase Ib|Physician Decision|1|||
156379718|NCT01485861|564481641|FG002|Phase Ib|Physician Decision|0|||
156379719|NCT01485861|564481642|FG003|Phase Ib|Physician Decision|0|||
156379720|NCT01485861|564481643|FG004|Phase Ib|Physician Decision|0|||
156379721|NCT01485861|564481644|FG005|Phase Ib|Physician Decision|0|||
156379722|NCT01485861|564481639|FG000|Phase Ib|Adverse Event|0|||
156379723|NCT01485861|564481640|FG001|Phase Ib|Adverse Event|4|||
156379724|NCT01485861|564481641|FG002|Phase Ib|Adverse Event|0|||
156379725|NCT01485861|564481642|FG003|Phase Ib|Adverse Event|0|||
156379726|NCT01485861|564481643|FG004|Phase Ib|Adverse Event|0|||
156379727|NCT01485861|564481644|FG005|Phase Ib|Adverse Event|0|||
156379728|NCT01485861|564481639|FG000|Phase Ib|Progression of disease|5|||
156379729|NCT01485861|564481640|FG001|Phase Ib|Progression of disease|0|||
156379730|NCT01485861|564481641|FG002|Phase Ib|Progression of disease|0|||
156379731|NCT01485861|564481642|FG003|Phase Ib|Progression of disease|0|||
156379732|NCT01485861|564481643|FG004|Phase Ib|Progression of disease|0|||
156379733|NCT01485861|564481644|FG005|Phase Ib|Progression of disease|0|||
156379734|NCT01485861|564481639|FG000|Phase Ib|Other|3|||
156379735|NCT01485861|564481640|FG001|Phase Ib|Other|0|||
156379736|NCT01485861|564481641|FG002|Phase Ib|Other|0|||
156379737|NCT01485861|564481642|FG003|Phase Ib|Other|0|||
156379738|NCT01485861|564481643|FG004|Phase Ib|Other|0|||
156379739|NCT01485861|564481644|FG005|Phase Ib|Other|0|||
156379740|NCT01485861|564481639|FG000|Phase Ib|Withdrawal by Subject|4|||
156379741|NCT01485861|564481640|FG001|Phase Ib|Withdrawal by Subject|1|||
156379742|NCT01485861|564481641|FG002|Phase Ib|Withdrawal by Subject|0|||
156379743|NCT01485861|564481642|FG003|Phase Ib|Withdrawal by Subject|0|||
156379744|NCT01485861|564481643|FG004|Phase Ib|Withdrawal by Subject|0|||
156379745|NCT01485861|564481644|FG005|Phase Ib|Withdrawal by Subject|0|||
156379746|NCT01485861|564481639|FG000|Phase II|Death|0|||
156379747|NCT01485861|564481640|FG001|Phase II|Death|0|||
156379748|NCT01485861|564481641|FG002|Phase II|Death|67|||
156379749|NCT01485861|564481642|FG003|Phase II|Death|71|||
156379750|NCT01485861|564481643|FG004|Phase II|Death|68|||
156379751|NCT01485861|564481644|FG005|Phase II|Death|0|||
156379752|NCT01485861|564481639|FG000|Phase II|Progression of Disease|0|||
156379753|NCT01485861|564481640|FG001|Phase II|Progression of Disease|0|||
156379754|NCT01485861|564481641|FG002|Phase II|Progression of Disease|1|||
156379755|NCT01485861|564481642|FG003|Phase II|Progression of Disease|0|||
156379756|NCT01485861|564481643|FG004|Phase II|Progression of Disease|0|||
156379757|NCT01485861|564481644|FG005|Phase II|Progression of Disease|0|||
156379758|NCT01485861|564481639|FG000|Phase II|Other|0|||
156379759|NCT01485861|564481640|FG001|Phase II|Other|0|||
156379760|NCT01485861|564481641|FG002|Phase II|Other|0|||
156379761|NCT01485861|564481642|FG003|Phase II|Other|1|||
156546817|NCT00440947|565094999|FG004|36-Week Induction Phase|Adverse Event|0|||
156546818|NCT00440947|565094995|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
156379762|NCT01485861|564481643|FG004|Phase II|Other|0|||
156379763|NCT01485861|564481644|FG005|Phase II|Other|0|||
156379764|NCT01485861|564481639|FG000|Phase II|Withdrawal by Subject|0|||
156379765|NCT01485861|564481640|FG001|Phase II|Withdrawal by Subject|0|||
156379766|NCT01485861|564481641|FG002|Phase II|Withdrawal by Subject|6|||
156379767|NCT01485861|564481642|FG003|Phase II|Withdrawal by Subject|3|||
156546819|NCT00440947|565094996|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
156379768|NCT01485861|564481643|FG004|Phase II|Withdrawal by Subject|4|||
156379769|NCT01485861|564481644|FG005|Phase II|Withdrawal by Subject|0|||
156379770|NCT01485861|564481639|FG000|Phase II|Lost to Follow-up|0|||
156379771|NCT01485861|564481640|FG001|Phase II|Lost to Follow-up|0|||
156379772|NCT01485861|564481641|FG002|Phase II|Lost to Follow-up|2|||
156379773|NCT01485861|564481642|FG003|Phase II|Lost to Follow-up|3|||
156379774|NCT01485861|564481643|FG004|Phase II|Lost to Follow-up|5|||
156379775|NCT01485861|564481644|FG005|Phase II|Lost to Follow-up|0|||
156379776|NCT01485861|564481639|FG000|Phase II|Study Ended|0|||
156379777|NCT01485861|564481640|FG001|Phase II|Study Ended|0|||
156379778|NCT01485861|564481641|FG002|Phase II|Study Ended|7|||
156379779|NCT01485861|564481642|FG003|Phase II|Study Ended|8|||
156379780|NCT01485861|564481643|FG004|Phase II|Study Ended|6|||
156379781|NCT01485861|564481644|FG005|Phase II|Study Ended|0|||
156379782|NCT01485861|564481639|FG000|Safety Phase|Death|0|||
156379783|NCT01485861|564481640|FG001|Safety Phase|Death|0|||
156379784|NCT01485861|564481641|FG002|Safety Phase|Death|0|||
156379785|NCT01485861|564481642|FG003|Safety Phase|Death|0|||
156379786|NCT01485861|564481643|FG004|Safety Phase|Death|0|||
156379787|NCT01485861|564481644|FG005|Safety Phase|Death|2|||
156379788|NCT01485861|564481639|FG000|Safety Phase|Adverse Event|0|||
156379789|NCT01485861|564481640|FG001|Safety Phase|Adverse Event|0|||
156379790|NCT01485861|564481641|FG002|Safety Phase|Adverse Event|0|||
156379791|NCT01485861|564481642|FG003|Safety Phase|Adverse Event|0|||
156379792|NCT01485861|564481643|FG004|Safety Phase|Adverse Event|0|||
156379793|NCT01485861|564481644|FG005|Safety Phase|Adverse Event|1|||
156379794|NCT01485861|564481639|FG000|Safety Phase|Other|0|||
156379795|NCT01485861|564481640|FG001|Safety Phase|Other|0|||
156379796|NCT01485861|564481641|FG002|Safety Phase|Other|0|||
156379797|NCT01485861|564481642|FG003|Safety Phase|Other|0|||
156379798|NCT01485861|564481643|FG004|Safety Phase|Other|0|||
156379799|NCT01485861|564481644|FG005|Safety Phase|Other|5|||
156379800|NCT01485861|564481639|FG000|Safety Phase|Progression of Disease|0|||
156379801|NCT01485861|564481640|FG001|Safety Phase|Progression of Disease|0|||
156379802|NCT01485861|564481641|FG002|Safety Phase|Progression of Disease|0|||
156379803|NCT01485861|564481642|FG003|Safety Phase|Progression of Disease|0|||
156379804|NCT01485861|564481643|FG004|Safety Phase|Progression of Disease|0|||
156379805|NCT01485861|564481644|FG005|Safety Phase|Progression of Disease|9|||
156379806|NCT01485861|564481639|FG000|Safety Phase|Withdrawal by Subject|0|||
156379807|NCT01485861|564481640|FG001|Safety Phase|Withdrawal by Subject|0|||
156379808|NCT01485861|564481641|FG002|Safety Phase|Withdrawal by Subject|0|||
156379809|NCT01485861|564481642|FG003|Safety Phase|Withdrawal by Subject|0|||
156379810|NCT01485861|564481643|FG004|Safety Phase|Withdrawal by Subject|0|||
156379811|NCT01485861|564481644|FG005|Safety Phase|Withdrawal by Subject|6|||
156379812|NCT01485861|564481639|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
156379813|NCT01485861|564481640|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
156379814|NCT01485861|564481641|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
156379815|NCT01485861|564481642|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
156379816|NCT01485861|564481643|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
156379817|NCT01485861|564481644|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
156379818|NCT00096941|564481645|FG000|Overall Study|disease progression|3|||
156379819|NCT02401672|564481646|FG000|Overall Study|Withdrawal by Subject|1|||
156379820|NCT02401672|564481647|FG001|Overall Study|Withdrawal by Subject|3|||
156379821|NCT04111497|564481653|FG000|Overall Study|relapse of primary disease|1|||
156379822|NCT04111497|564481653|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
156379823|NCT03056690|564481654|FG000|Overall Study|Adverse Event|3|||
156379824|NCT03056690|564481655|FG001|Overall Study|Adverse Event|2|||
156379825|NCT03056690|564481654|FG000|Overall Study|Lack of Efficacy|1|||
156379826|NCT03056690|564481655|FG001|Overall Study|Lack of Efficacy|2|||
156379827|NCT03056690|564481654|FG000|Overall Study|Lost to Follow-up|3|||
156379828|NCT03056690|564481655|FG001|Overall Study|Lost to Follow-up|2|||
156379829|NCT03056690|564481654|FG000|Overall Study|Protocol Violation|2|||
156379830|NCT03056690|564481655|FG001|Overall Study|Protocol Violation|2|||
156379831|NCT03056690|564481654|FG000|Overall Study|Withdrawal by Subject|3|||
156379832|NCT03056690|564481655|FG001|Overall Study|Withdrawal by Subject|6|||
156379833|NCT03056690|564481654|FG000|Overall Study|Non-compliance with Study Drug|1|||
156379834|NCT03056690|564481655|FG001|Overall Study|Non-compliance with Study Drug|0|||
156379835|NCT03056690|564481654|FG000|Overall Study|Miscellaneous|1|||
156379836|NCT03056690|564481655|FG001|Overall Study|Miscellaneous|2|||
156379837|NCT01993719|564481656|FG000|First Drug Administration|Not treated|1|||
156379838|NCT01993719|564481657|FG001|First Drug Administration|Not treated|0|||
156379839|NCT01993719|564481658|FG002|First Drug Administration|Not treated|0|||
156379840|NCT01993719|564481659|FG003|First Drug Administration|Not treated|0|||
156379841|NCT01993719|564481660|FG004|First Drug Administration|Not treated|0|||
156379842|NCT05857527|564481663|FG000|Overall Study|Withdrawal by Subject|0|||
156379843|NCT05857527|564481664|FG001|Overall Study|Withdrawal by Subject|1|||
156379844|NCT02799082|564481666|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
156379845|NCT02799082|564481667|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
156379846|NCT02799082|564481666|FG000|Overall Study|Protocol Violation|0|||
156500505|NCT05970640|564923796|FG002|Overall Study|Sponsor decision|1|||
156379847|NCT02799082|564481667|FG001|Overall Study|Protocol Violation|1|||
156379848|NCT01592708|564481668|FG000|Overall Study|Protocol Violation|3|||
156379849|NCT01592708|564481669|FG001|Overall Study|Protocol Violation|0|||
156379850|NCT02056301|564481672|FG000|Overall Study|Protocol Violation|1|||
156379851|NCT02056301|564481673|FG001|Overall Study|Protocol Violation|2|||
156379852|NCT02056301|564481672|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
156379853|NCT02056301|564481673|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
156379854|NCT02056301|564481672|FG000|Overall Study|Withdrawal by Subject|0|||
156379855|NCT02056301|564481673|FG001|Overall Study|Withdrawal by Subject|1|||
156379856|NCT02056301|564481672|FG000|Overall Study|Issues with epidural|0|||
156379857|NCT02056301|564481673|FG001|Overall Study|Issues with epidural|3|||
156379858|NCT02328326|564481674|FG000|Overall Study|Withdrawal by Subject|10|||
156379859|NCT02328326|564481675|FG001|Overall Study|Withdrawal by Subject|3|||
156379860|NCT02328326|564481674|FG000|Overall Study|Death|2|||
156379861|NCT02328326|564481675|FG001|Overall Study|Death|1|||
156379862|NCT02328326|564481674|FG000|Overall Study|Lost to Follow-up|10|||
156379863|NCT02328326|564481675|FG001|Overall Study|Lost to Follow-up|4|||
156379864|NCT02543346|564481676|FG000|Second Priming Visit|Withdrawal by Subject|0|||
156379865|NCT02543346|564481677|FG001|Second Priming Visit|Withdrawal by Subject|2|||
156379866|NCT02543346|564481678|FG002|Second Priming Visit|Withdrawal by Subject|2|||
156379867|NCT02543346|564481679|FG003|Second Priming Visit|Withdrawal by Subject|2|||
156379868|NCT02543346|564481676|FG000|Second Priming Visit|Adverse Event|1|||
156379869|NCT02543346|564481677|FG001|Second Priming Visit|Adverse Event|0|||
156379870|NCT02543346|564481678|FG002|Second Priming Visit|Adverse Event|0|||
156379871|NCT02543346|564481679|FG003|Second Priming Visit|Adverse Event|0|||
156379872|NCT01748994|564481681|FG000|Overall Study|Lost to Follow-up|8|||
156379873|NCT01748994|564481682|FG001|Overall Study|Lost to Follow-up|6|||
156379874|NCT03433456|564481683|FG000|Overall Study|Death|1|||
156379875|NCT03433456|564481684|FG001|Overall Study|Death|1|||
156379876|NCT03433456|564481683|FG000|Overall Study|Lost to Follow-up|14|||
156379877|NCT03433456|564481684|FG001|Overall Study|Lost to Follow-up|11|||
156379878|NCT03433456|564481683|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
156379879|NCT03433456|564481684|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
156379880|NCT03105362|564481685|FG000|Overall Study|Withdrawal by Subject|1|||
156379881|NCT03105362|564481685|FG000|Overall Study|Lost to Follow-up|1|||
156379882|NCT01198600|564481686|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
156379883|NCT01198600|564481687|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
156379884|NCT01198600|564481688|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
156379885|NCT01198600|564481689|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
156379886|NCT01198600|564481686|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
156379887|NCT01198600|564481687|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
156379888|NCT01198600|564481688|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
156379889|NCT01198600|564481689|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
156379890|NCT01198600|564481686|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
156379891|NCT01198600|564481687|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
156379892|NCT01198600|564481688|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
156379893|NCT01198600|564481689|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
156379894|NCT01198600|564481686|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
156379895|NCT01198600|564481687|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
156379896|NCT01198600|564481688|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
156379897|NCT01198600|564481689|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
156379898|NCT01198600|564481686|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
156379899|NCT01198600|564481687|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
156379900|NCT01198600|564481688|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
156379901|NCT01198600|564481689|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
156379902|NCT01198600|564481686|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
156379903|NCT01198600|564481687|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
156379904|NCT01198600|564481688|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
156379905|NCT01198600|564481689|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
156379906|NCT01198600|564481686|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
156379907|NCT01198600|564481687|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
156379908|NCT01198600|564481688|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
156379909|NCT01198600|564481689|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
156379910|NCT02141516|564481691|FG000|Overall Study|Adverse Event|0|||
156379911|NCT02141516|564481692|FG001|Overall Study|Adverse Event|1|||
156379912|NCT02141516|564481693|FG002|Overall Study|Adverse Event|0|||
156379913|NCT02141516|564481691|FG000|Overall Study|Lost to Follow-up|0|||
156500506|NCT05970640|564923797|FG003|Overall Study|Sponsor decision|1|||
156500507|NCT04021043|564926409|FG000|Overall Study|Adverse Event|3|||
156500508|NCT04021043|564926410|FG001|Overall Study|Adverse Event|1|||
156500509|NCT04021043|564926411|FG002|Overall Study|Adverse Event|1|||
156500510|NCT04021043|564926412|FG003|Overall Study|Adverse Event|0|||
156500511|NCT04021043|564926409|FG000|Overall Study|Death|2|||
156379914|NCT02141516|564481692|FG001|Overall Study|Lost to Follow-up|1|||
156379915|NCT02141516|564481693|FG002|Overall Study|Lost to Follow-up|0|||
156379916|NCT02141516|564481691|FG000|Overall Study|Other|0|||
156379917|NCT02141516|564481692|FG001|Overall Study|Other|3|||
156379918|NCT02141516|564481693|FG002|Overall Study|Other|0|||
156379919|NCT00861341|564481694|FG000|Overall Study|Withdrawal by Subject|2|||
156379920|NCT02127307|564481697|FG000|Overall Study|Protocol Violation|36|||
156379921|NCT02127307|564481697|FG000|Overall Study|Lost to Follow-up|2|||
156379922|NCT02127307|564481697|FG000|Overall Study|Death|101|||
156379923|NCT02127307|564481697|FG000|Overall Study|Other than specified above|169|||
156379924|NCT01337297|564481700|FG000|Overall Study|They entered to single anodal tDCS|4|||
156379925|NCT01337297|564481701|FG001|Overall Study|They entered to single anodal tDCS|3|||
156379926|NCT01337297|564481700|FG000|Overall Study|Lost to Follow-up|1|||
156379927|NCT01337297|564481701|FG001|Overall Study|Lost to Follow-up|3|||
156379928|NCT04122443|564481702|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
156379929|NCT04122443|564481703|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
156379930|NCT04122443|564481704|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
156379931|NCT04122443|564481702|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
156379932|NCT04122443|564481703|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
156379933|NCT04122443|564481704|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
156379934|NCT01072201|564481705|FG000|Overall Study|Lost to Follow-up|0|||
156379935|NCT01072201|564481706|FG001|Overall Study|Lost to Follow-up|1|||
156379936|NCT00162136|564481707|FG000|Overall Study|Adverse Event|1|||
156379937|NCT00162136|564481707|FG000|Overall Study|Death|1|||
156379938|NCT00162136|564481707|FG000|Overall Study|Disease Progression/Relapse|23|||
156379939|NCT00162136|564481707|FG000|Overall Study|Investigator Request|5|||
156379940|NCT00162136|564481707|FG000|Overall Study|Study Drug Toxicity|4|||
156379941|NCT00162136|564481707|FG000|Overall Study|Withdrawal by Subject|1|||
156379942|NCT00836875|564481711|FG000|Overall Study|Death|3|||
156379943|NCT00836875|564481712|FG001|Overall Study|Death|2|||
156379944|NCT00836875|564481711|FG000|Overall Study|Withdrawal by Subject|0|||
156379945|NCT00836875|564481712|FG001|Overall Study|Withdrawal by Subject|1|||
156379946|NCT00129987|564483616|FG000|1st Educational Session|Withdrawal by Subject|141|||
156379947|NCT00129987|564483617|FG001|1st Educational Session|Withdrawal by Subject|109|||
156379948|NCT00129987|564483616|FG000|1 Year|Withdrawal by Subject|32|||
156379949|NCT00129987|564483617|FG001|1 Year|Withdrawal by Subject|21|||
156379950|NCT00116805|564483618|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
156500512|NCT04021043|564926410|FG001|Overall Study|Death|3|||
156500513|NCT04021043|564926411|FG002|Overall Study|Death|1|||
156500514|NCT04021043|564926412|FG003|Overall Study|Death|3|||
156500515|NCT04021043|564926409|FG000|Overall Study|Withdrawal by Subject|1|||
156500516|NCT04021043|564926410|FG001|Overall Study|Withdrawal by Subject|1|||
156500517|NCT04021043|564926411|FG002|Overall Study|Withdrawal by Subject|1|||
156500518|NCT04021043|564926412|FG003|Overall Study|Withdrawal by Subject|6|||
156500519|NCT04021043|564926409|FG000|Overall Study|Discontinued due to disease progression|4|||
156500520|NCT04021043|564926410|FG001|Overall Study|Discontinued due to disease progression|5|||
156500521|NCT04021043|564926411|FG002|Overall Study|Discontinued due to disease progression|7|||
156500522|NCT04021043|564926412|FG003|Overall Study|Discontinued due to disease progression|10|||
156500523|NCT00826228|564926413|FG000|Overall Study|Withdrawal by Subject|1|||
156500524|NCT01246999|564926414|FG000|Overall Study|Lost to Follow-up|0|||
156500525|NCT01246999|564926415|FG001|Overall Study|Lost to Follow-up|1|||
156500526|NCT01246999|564926416|FG002|Overall Study|Lost to Follow-up|0|||
156500527|NCT01246999|564926417|FG003|Overall Study|Lost to Follow-up|0|||
156500528|NCT01246999|564926414|FG000|Overall Study|Withdrawal by Subject|0|||
156500529|NCT01246999|564926415|FG001|Overall Study|Withdrawal by Subject|0|||
156500530|NCT01246999|564926416|FG002|Overall Study|Withdrawal by Subject|0|||
156500531|NCT01246999|564926417|FG003|Overall Study|Withdrawal by Subject|2|||
156500532|NCT01867047|564926418|FG000|Overall Study|Lost to Follow-up|3|||
156500533|NCT01867047|564926419|FG001|Overall Study|Lost to Follow-up|3|||
156500534|NCT01867047|564926418|FG000|Overall Study|Withdrawal by Subject|2|||
156500535|NCT01867047|564926419|FG001|Overall Study|Withdrawal by Subject|0|||
156500536|NCT01867047|564926418|FG000|Overall Study|Physician Decision|2|||
156500537|NCT01867047|564926419|FG001|Overall Study|Physician Decision|0|||
156500538|NCT01867047|564926418|FG000|Overall Study|surgery not indicated in protocol|1|||
156500539|NCT01867047|564926419|FG001|Overall Study|surgery not indicated in protocol|2|||
156500540|NCT00307047|564926420|FG000|Overall Study|Lost to Follow-up|35|||
156500541|NCT00307047|564926421|FG001|Overall Study|Lost to Follow-up|24|||
156500542|NCT00307047|564926420|FG000|Overall Study|Withdrawal by Subject|6|||
156500543|NCT00307047|564926421|FG001|Overall Study|Withdrawal by Subject|6|||
156500544|NCT00307047|564926420|FG000|Overall Study|Physician Decision|1|||
156500545|NCT00307047|564926421|FG001|Overall Study|Physician Decision|2|||
156500546|NCT00307047|564926420|FG000|Overall Study|Lost to follow-up for other reasons|0|||
156500547|NCT00307047|564926421|FG001|Overall Study|Lost to follow-up for other reasons|1|||
156500548|NCT00307047|564926420|FG000|Overall Study|All death, all MI, all Revascularization|27|||
156500549|NCT00307047|564926421|FG001|Overall Study|All death, all MI, all Revascularization|16|||
156500550|NCT00379769|564926422|FG000|Main Study|Death|57|||
156500551|NCT00379769|564926423|FG001|Main Study|Death|67|||
156500552|NCT00379769|564926424|FG002|Main Study|Death|54|||
156500553|NCT00379769|564926425|FG003|Main Study|Death|72|||
156500554|NCT00379769|564926426|FG004|Main Study|Death|0|||
156546820|NCT00440947|565094997|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
156379951|NCT00116805|564483619|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
156500555|NCT00379769|564926427|FG005|Main Study|Death|0|||
156500556|NCT00379769|564926422|FG000|Main Study|Adverse Event|5|||
156500557|NCT00379769|564926423|FG001|Main Study|Adverse Event|8|||
156500558|NCT00379769|564926424|FG002|Main Study|Adverse Event|10|||
156379952|NCT00116805|564483618|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
156379953|NCT00116805|564483619|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
156379954|NCT00116805|564483618|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
156379955|NCT00116805|564483619|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
156379956|NCT00116805|564483618|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
156379957|NCT00116805|564483619|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
156379958|NCT00116805|564483618|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
156379959|NCT00116805|564483619|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
156379960|NCT00116805|564483618|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
156379961|NCT00116805|564483619|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
156379962|NCT00116805|564483618|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
156379963|NCT00116805|564483619|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
156379964|NCT00116805|564483618|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
156379965|NCT00116805|564483619|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
156379966|NCT00116805|564483618|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
156379967|NCT00116805|564483619|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
156379968|NCT00116805|564483618|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
156379969|NCT00116805|564483619|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
156379970|NCT00116805|564483618|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
156379971|NCT00116805|564483619|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
156379972|NCT00116805|564483618|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
156379973|NCT00116805|564483619|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
156379974|NCT00116805|564483618|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
156379975|NCT00116805|564483619|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
156379976|NCT00116805|564483618|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
156379977|NCT00116805|564483619|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
156379978|NCT00116805|564483618|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
156379979|NCT00116805|564483619|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
156379980|NCT00116805|564483618|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
156379981|NCT00116805|564483619|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
156379982|NCT00116805|564483618|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
156379983|NCT00116805|564483619|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
156379984|NCT00116805|564483618|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
156379985|NCT00116805|564483619|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
156379986|NCT00116805|564483618|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
156379987|NCT00116805|564483619|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
156379988|NCT00116805|564483618|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
156379989|NCT00116805|564483619|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
156379990|NCT00116805|564483618|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
156379991|NCT00116805|564483619|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
156379992|NCT00116805|564483618|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
156379993|NCT00116805|564483619|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
156379994|NCT00116805|564483618|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
156379995|NCT00116805|564483619|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
156379996|NCT00116805|564483618|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
156379997|NCT00116805|564483619|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
156379998|NCT00116805|564483618|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
156379999|NCT00116805|564483619|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
156380000|NCT00116805|564483618|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
156380001|NCT00116805|564483619|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
156380002|NCT00116805|564483618|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
156380003|NCT00116805|564483619|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
156380004|NCT00116805|564483618|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
156380005|NCT00116805|564483619|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
156380006|NCT00116805|564483618|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
156380007|NCT00116805|564483619|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
156380008|NCT00116805|564483618|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
156380009|NCT00116805|564483619|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
156380010|NCT00116805|564483618|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
156380011|NCT00116805|564483619|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
156380012|NCT00116805|564483618|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
156380013|NCT00116805|564483619|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
156500559|NCT00379769|564926425|FG003|Main Study|Adverse Event|11|||
156500560|NCT00379769|564926426|FG004|Main Study|Adverse Event|0|||
156380014|NCT00116805|564483618|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
156500561|NCT00379769|564926427|FG005|Main Study|Adverse Event|0|||
156380015|NCT00116805|564483619|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
156380016|NCT00116805|564483618|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
156380017|NCT00116805|564483619|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
156380018|NCT00116805|564483618|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
156380019|NCT00116805|564483619|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
156380020|NCT00116805|564483618|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
156380021|NCT00116805|564483619|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
156380022|NCT00116805|564483618|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
156380023|NCT00116805|564483619|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
156380024|NCT00116805|564483618|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
156380025|NCT00116805|564483619|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
156380026|NCT00116805|564483618|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
156380027|NCT00116805|564483619|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
156380028|NCT00116805|564483618|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
156380029|NCT00116805|564483619|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
156380030|NCT00116805|564483618|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
156380031|NCT00116805|564483619|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
156380032|NCT00116805|564483618|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
156380033|NCT00116805|564483619|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
156380034|NCT00116805|564483618|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
156380035|NCT00116805|564483619|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
156380036|NCT00116805|564483618|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
156380037|NCT00116805|564483619|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
156380038|NCT00116805|564483618|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
156380039|NCT00116805|564483619|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
156380040|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
156380041|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
156380042|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
156380043|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
156380044|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Adverse Event|5|||
156380045|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Adverse Event|3|||
156380046|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Adverse Event|4|||
156380047|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Adverse Event|10|||
156380048|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
156380049|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
156380050|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
156380051|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
156380052|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
156380053|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
156380054|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
156380055|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
156380056|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Pregnancy|5|||
156380057|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Pregnancy|0|||
156380058|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Pregnancy|3|||
156380059|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Pregnancy|2|||
156380060|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Non-compliance|1|||
156380061|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Non-compliance|4|||
156380062|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Non-compliance|0|||
156380063|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Non-compliance|3|||
156380064|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Other|0|||
156380065|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Other|3|||
156380066|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Other|3|||
156380067|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Other|1|||
156380068|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
156380069|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
156380070|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
156380071|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
156380072|NCT01760954|564483620|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
156380073|NCT01760954|564483621|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
156380074|NCT01760954|564483622|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
156380075|NCT01760954|564483623|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
156380076|NCT01760954|564483620|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
156380077|NCT01760954|564483621|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
156380078|NCT01760954|564483622|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
156380079|NCT01760954|564483623|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
156380080|NCT01760954|564483620|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
156380081|NCT01760954|564483621|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
156380082|NCT01760954|564483622|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
156380083|NCT01760954|564483623|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
156380084|NCT01760954|564483620|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
156380085|NCT01760954|564483621|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
156380086|NCT01760954|564483622|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
156380087|NCT01760954|564483623|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
156380088|NCT01760954|564483620|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
156380089|NCT01760954|564483621|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
156380090|NCT01760954|564483622|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
156380091|NCT01760954|564483623|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
156380092|NCT01760954|564483620|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
156380093|NCT01760954|564483621|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
156380094|NCT01760954|564483622|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
156380095|NCT01760954|564483623|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
156380096|NCT01760954|564483620|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
156380097|NCT01760954|564483621|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
156380098|NCT01760954|564483622|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
156380099|NCT01760954|564483623|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
156380100|NCT01159938|564483624|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
156380101|NCT01159938|564483625|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
156380102|NCT01159938|564483626|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
156380103|NCT01159938|564483627|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
156380104|NCT01159938|564483628|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
156500562|NCT00379769|564926422|FG000|Main Study|Lost to Follow-up|29|||
156500563|NCT00379769|564926423|FG001|Main Study|Lost to Follow-up|29|||
156500564|NCT00379769|564926424|FG002|Main Study|Lost to Follow-up|25|||
156500565|NCT00379769|564926425|FG003|Main Study|Lost to Follow-up|26|||
156500566|NCT00379769|564926426|FG004|Main Study|Lost to Follow-up|0|||
156500567|NCT00379769|564926427|FG005|Main Study|Lost to Follow-up|0|||
156500568|NCT00379769|564926422|FG000|Main Study|Withdrawal by Subject|46|||
156500569|NCT00379769|564926423|FG001|Main Study|Withdrawal by Subject|56|||
156500570|NCT00379769|564926424|FG002|Main Study|Withdrawal by Subject|72|||
156500571|NCT00379769|564926425|FG003|Main Study|Withdrawal by Subject|70|||
156500572|NCT00379769|564926426|FG004|Main Study|Withdrawal by Subject|0|||
156500573|NCT00379769|564926427|FG005|Main Study|Withdrawal by Subject|0|||
156500574|NCT00379769|564926422|FG000|Main Study|Moved to survival status follow-up only|27|||
156500575|NCT00379769|564926423|FG001|Main Study|Moved to survival status follow-up only|25|||
156500576|NCT00379769|564926424|FG002|Main Study|Moved to survival status follow-up only|32|||
156500577|NCT00379769|564926425|FG003|Main Study|Moved to survival status follow-up only|36|||
156500578|NCT00379769|564926426|FG004|Main Study|Moved to survival status follow-up only|0|||
156500579|NCT00379769|564926427|FG005|Main Study|Moved to survival status follow-up only|0|||
156500580|NCT00379769|564926422|FG000|Main Study|Participant moved|3|||
156500581|NCT00379769|564926423|FG001|Main Study|Participant moved|2|||
156500582|NCT00379769|564926424|FG002|Main Study|Participant moved|3|||
156500583|NCT00379769|564926425|FG003|Main Study|Participant moved|3|||
156500584|NCT00379769|564926426|FG004|Main Study|Participant moved|0|||
156500585|NCT00379769|564926427|FG005|Main Study|Participant moved|0|||
156500586|NCT00379769|564926422|FG000|Main Study|Poor compliance|3|||
156500587|NCT00379769|564926423|FG001|Main Study|Poor compliance|2|||
156500588|NCT00379769|564926424|FG002|Main Study|Poor compliance|2|||
156500589|NCT00379769|564926425|FG003|Main Study|Poor compliance|1|||
156500590|NCT00379769|564926426|FG004|Main Study|Poor compliance|0|||
156500591|NCT00379769|564926427|FG005|Main Study|Poor compliance|0|||
156500592|NCT00379769|564926422|FG000|Main Study|Prohibited glucose lowering medication|0|||
156500593|NCT00379769|564926423|FG001|Main Study|Prohibited glucose lowering medication|3|||
156500594|NCT00379769|564926424|FG002|Main Study|Prohibited glucose lowering medication|0|||
156500595|NCT00379769|564926425|FG003|Main Study|Prohibited glucose lowering medication|1|||
156500596|NCT00379769|564926426|FG004|Main Study|Prohibited glucose lowering medication|0|||
156500597|NCT00379769|564926427|FG005|Main Study|Prohibited glucose lowering medication|0|||
156500598|NCT00379769|564926422|FG000|Main Study|Site closed|4|||
156500599|NCT00379769|564926423|FG001|Main Study|Site closed|4|||
156500600|NCT00379769|564926424|FG002|Main Study|Site closed|4|||
156500601|NCT00379769|564926425|FG003|Main Study|Site closed|8|||
156500602|NCT00379769|564926426|FG004|Main Study|Site closed|0|||
156500603|NCT00379769|564926427|FG005|Main Study|Site closed|0|||
156500604|NCT00379769|564926422|FG000|Main Study|Entry criteria violation|0|||
156500605|NCT00379769|564926423|FG001|Main Study|Entry criteria violation|0|||
156500606|NCT00379769|564926424|FG002|Main Study|Entry criteria violation|1|||
156500607|NCT00379769|564926425|FG003|Main Study|Entry criteria violation|1|||
156500608|NCT00379769|564926426|FG004|Main Study|Entry criteria violation|0|||
156546821|NCT00440947|565094998|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
156546822|NCT00440947|565094999|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
156546823|NCT00440947|565094995|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
156546824|NCT00440947|565094996|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
156380105|NCT04837482|564483629|FG000|Period 2|Withdrawal by Subject|0|||
156380106|NCT04837482|564483630|FG001|Period 2|Withdrawal by Subject|1|||
156380107|NCT04820673|564483631|FG000|Overall Study|Adverse Event|6|||
156380108|NCT04820673|564483631|FG000|Overall Study|Due to Lack of Effectiveness|1|||
156380109|NCT04820673|564483631|FG000|Overall Study|Pregnancy|1|||
156380110|NCT04820673|564483631|FG000|Overall Study|Voluntary Withdrawal|20|||
156380111|NCT04820673|564483631|FG000|Overall Study|Lost to Follow-up|10|||
156380112|NCT00587587|564483632|FG000|Overall Study|Lost to Follow-up|6|||
156380113|NCT00587587|564483633|FG001|Overall Study|Lost to Follow-up|1|||
156380114|NCT01762761|564483638|FG000|Overall Study|Adverse Event|15|||
156380115|NCT01762761|564483639|FG001|Overall Study|Adverse Event|17|||
156380116|NCT01762761|564483638|FG000|Overall Study|Lack of Efficacy|9|||
156380117|NCT01762761|564483639|FG001|Overall Study|Lack of Efficacy|25|||
156380118|NCT01762761|564483638|FG000|Overall Study|Protocol Violation|1|||
156380119|NCT01762761|564483639|FG001|Overall Study|Protocol Violation|1|||
156380120|NCT01762761|564483638|FG000|Overall Study|Study closed/terminated|0|||
156380121|NCT01762761|564483639|FG001|Overall Study|Study closed/terminated|2|||
156380122|NCT01762761|564483638|FG000|Overall Study|Lost to Follow-up|3|||
156380123|NCT01762761|564483639|FG001|Overall Study|Lost to Follow-up|6|||
156380124|NCT01762761|564483638|FG000|Overall Study|Physician Decision|4|||
156500609|NCT00379769|564926427|FG005|Main Study|Entry criteria violation|0|||
156500610|NCT00379769|564926422|FG000|Main Study|Participant did not take study drug|0|||
156500611|NCT00379769|564926423|FG001|Main Study|Participant did not take study drug|0|||
156500612|NCT00379769|564926424|FG002|Main Study|Participant did not take study drug|1|||
156500613|NCT00379769|564926425|FG003|Main Study|Participant did not take study drug|0|||
156500614|NCT00379769|564926426|FG004|Main Study|Participant did not take study drug|0|||
156500615|NCT00379769|564926427|FG005|Main Study|Participant did not take study drug|0|||
156500616|NCT00379769|564926422|FG000|Main Study|Physician Decision|2|||
156500617|NCT00379769|564926423|FG001|Main Study|Physician Decision|2|||
156500618|NCT00379769|564926424|FG002|Main Study|Physician Decision|1|||
156500619|NCT00379769|564926425|FG003|Main Study|Physician Decision|1|||
156500620|NCT00379769|564926426|FG004|Main Study|Physician Decision|0|||
156500621|NCT00379769|564926427|FG005|Main Study|Physician Decision|0|||
156500622|NCT00379769|564926422|FG000|Main Study|Participant completed study at visit 27|1|||
156500623|NCT00379769|564926423|FG001|Main Study|Participant completed study at visit 27|0|||
156500624|NCT00379769|564926424|FG002|Main Study|Participant completed study at visit 27|0|||
156500625|NCT00379769|564926425|FG003|Main Study|Participant completed study at visit 27|0|||
156500626|NCT00379769|564926426|FG004|Main Study|Participant completed study at visit 27|0|||
156500627|NCT00379769|564926427|FG005|Main Study|Participant completed study at visit 27|0|||
156500628|NCT00379769|564926422|FG000|Main Study|Personal reasons|1|||
156500629|NCT00379769|564926423|FG001|Main Study|Personal reasons|0|||
156500630|NCT00379769|564926424|FG002|Main Study|Personal reasons|0|||
156500631|NCT00379769|564926425|FG003|Main Study|Personal reasons|0|||
156500632|NCT00379769|564926426|FG004|Main Study|Personal reasons|0|||
156500633|NCT00379769|564926427|FG005|Main Study|Personal reasons|0|||
156500634|NCT00379769|564926422|FG000|Main Study|Risk of heart failure|0|||
156500635|NCT00379769|564926423|FG001|Main Study|Risk of heart failure|1|||
156500636|NCT00379769|564926424|FG002|Main Study|Risk of heart failure|0|||
156500637|NCT00379769|564926425|FG003|Main Study|Risk of heart failure|0|||
156500638|NCT00379769|564926426|FG004|Main Study|Risk of heart failure|0|||
156500639|NCT00379769|564926427|FG005|Main Study|Risk of heart failure|0|||
156500640|NCT00379769|564926422|FG000|Main Study|Investigator refused to log temperature|0|||
156500641|NCT00379769|564926423|FG001|Main Study|Investigator refused to log temperature|0|||
156500642|NCT00379769|564926424|FG002|Main Study|Investigator refused to log temperature|1|||
156500643|NCT00379769|564926425|FG003|Main Study|Investigator refused to log temperature|0|||
156500644|NCT00379769|564926426|FG004|Main Study|Investigator refused to log temperature|0|||
156500645|NCT00379769|564926427|FG005|Main Study|Investigator refused to log temperature|0|||
156500646|NCT00379769|564926422|FG000|Main Study|Reason unspecified|0|||
156500647|NCT00379769|564926423|FG001|Main Study|Reason unspecified|0|||
156500648|NCT00379769|564926424|FG002|Main Study|Reason unspecified|1|||
156500649|NCT00379769|564926425|FG003|Main Study|Reason unspecified|0|||
156500650|NCT00379769|564926426|FG004|Main Study|Reason unspecified|0|||
156500651|NCT00379769|564926427|FG005|Main Study|Reason unspecified|0|||
156500652|NCT00379769|564926422|FG000|Observational Follow-up|Death|0|||
156380125|NCT01762761|564483639|FG001|Overall Study|Physician Decision|6|||
156380126|NCT01762761|564483638|FG000|Overall Study|Withdrawal by Subject|7|||
156500653|NCT00379769|564926423|FG001|Observational Follow-up|Death|0|||
156500654|NCT00379769|564926424|FG002|Observational Follow-up|Death|0|||
156500655|NCT00379769|564926425|FG003|Observational Follow-up|Death|0|||
156500656|NCT00379769|564926426|FG004|Observational Follow-up|Death|78|||
156500657|NCT00379769|564926427|FG005|Observational Follow-up|Death|70|||
156380127|NCT01762761|564483639|FG001|Overall Study|Withdrawal by Subject|8|||
156380128|NCT01709227|564483640|FG000|Overall Study|Physician Decision|1|||
156380129|NCT01709227|564483641|FG001|Overall Study|Physician Decision|0|||
156380130|NCT01709227|564483640|FG000|Overall Study|Pleural Peritoneal communication|0|||
156380131|NCT01709227|564483641|FG001|Overall Study|Pleural Peritoneal communication|9|||
156380132|NCT02162810|564483642|FG000|Overall Study|Protocol Violation|1|||
156380133|NCT02162810|564483643|FG001|Overall Study|Protocol Violation|0|||
156380134|NCT02162810|564483642|FG000|Overall Study|patients did not report compliance|4|||
156380135|NCT02162810|564483643|FG001|Overall Study|patients did not report compliance|1|||
156380136|NCT02317575|564483644|FG000|Period 1|Difficulty with venous cannulation|0|||
156380137|NCT02317575|564483645|FG001|Period 1|Difficulty with venous cannulation|1|||
156380138|NCT02317575|564483646|FG002|Period 1|Difficulty with venous cannulation|0|||
156380139|NCT02317575|564483647|FG003|Period 1|Difficulty with venous cannulation|0|||
156380140|NCT02317575|564483648|FG004|Period 1|Difficulty with venous cannulation|0|||
156380141|NCT02317575|564483644|FG000|Period 1|Withdrawal by Subject|1|||
156380142|NCT02317575|564483645|FG001|Period 1|Withdrawal by Subject|0|||
156380143|NCT02317575|564483646|FG002|Period 1|Withdrawal by Subject|0|||
156380144|NCT02317575|564483647|FG003|Period 1|Withdrawal by Subject|0|||
156380145|NCT02317575|564483648|FG004|Period 1|Withdrawal by Subject|0|||
156380146|NCT01465334|564483649|FG000|Overall Study|Disease Progression|1|||
156380147|NCT01465334|564483650|FG001|Overall Study|Disease Progression|0|||
156380148|NCT01465334|564483649|FG000|Overall Study|Adverse Event|1|||
156380149|NCT01465334|564483650|FG001|Overall Study|Adverse Event|0|||
156380150|NCT01465334|564483649|FG000|Overall Study|Richter's transformation|0|||
156380151|NCT01465334|564483650|FG001|Overall Study|Richter's transformation|3|||
156380152|NCT01465334|564483649|FG000|Overall Study|Refractory Disease|0|||
156380153|NCT01465334|564483650|FG001|Overall Study|Refractory Disease|3|||
156380154|NCT01659021|564483656|FG000|Main Study|Adverse Event|2|||
156380155|NCT01659021|564483657|FG001|Main Study|Adverse Event|3|||
156380156|NCT01659021|564483656|FG000|Main Study|Lost to Follow-up|1|||
156380157|NCT01659021|564483657|FG001|Main Study|Lost to Follow-up|0|||
156380158|NCT01659021|564483656|FG000|Main Study|Unknown Reasons|2|||
156380159|NCT01659021|564483657|FG001|Main Study|Unknown Reasons|1|||
156380160|NCT01659021|564483656|FG000|Main Study|Physician Decision|34|||
156380161|NCT01659021|564483657|FG001|Main Study|Physician Decision|16|||
156380162|NCT01659021|564483656|FG000|Main Study|Withdrawal by Subject|19|||
156380163|NCT01659021|564483657|FG001|Main Study|Withdrawal by Subject|16|||
156380164|NCT01659021|564483656|FG000|Main Study|Study Terminated by Sponsor|16|||
156380165|NCT01659021|564483657|FG001|Main Study|Study Terminated by Sponsor|1|||
156380166|NCT01659021|564483656|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
156380167|NCT01659021|564483657|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
156380168|NCT01659021|564483656|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
156380169|NCT01659021|564483657|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
156380170|NCT01925183|564483663|FG000|Overall Study|Adverse Event|1|||
156380171|NCT01925183|564483664|FG001|Overall Study|Adverse Event|0|||
156380172|NCT01114646|564483665|FG000|Overall Study|Withdrawal by Subject|3|||
156380173|NCT01114646|564483666|FG001|Overall Study|Withdrawal by Subject|2|||
156380174|NCT01046110|564483667|FG000|Overall Study|Adverse Event|9|||
156500658|NCT00379769|564926422|FG000|Observational Follow-up|Adverse Event|0|||
156500659|NCT00379769|564926423|FG001|Observational Follow-up|Adverse Event|0|||
156500660|NCT00379769|564926424|FG002|Observational Follow-up|Adverse Event|0|||
156500661|NCT00379769|564926425|FG003|Observational Follow-up|Adverse Event|0|||
156500662|NCT00379769|564926426|FG004|Observational Follow-up|Adverse Event|1|||
156380175|NCT01046110|564483668|FG001|Overall Study|Adverse Event|2|||
156380176|NCT01046110|564483667|FG000|Overall Study|Lack of Efficacy|0|||
156380177|NCT01046110|564483668|FG001|Overall Study|Lack of Efficacy|1|||
156380178|NCT01046110|564483667|FG000|Overall Study|Protocol Violation|7|||
156380179|NCT01046110|564483668|FG001|Overall Study|Protocol Violation|12|||
156380180|NCT01046110|564483667|FG000|Overall Study|Withdrawal Criteria|3|||
156380181|NCT01046110|564483668|FG001|Overall Study|Withdrawal Criteria|5|||
156380182|NCT01046110|564483667|FG000|Overall Study|Unclassified|36|||
156380183|NCT01046110|564483668|FG001|Overall Study|Unclassified|35|||
156500663|NCT00379769|564926427|FG005|Observational Follow-up|Adverse Event|0|||
156500664|NCT00379769|564926422|FG000|Observational Follow-up|Lost to Follow-up|0|||
156500665|NCT00379769|564926423|FG001|Observational Follow-up|Lost to Follow-up|0|||
156500666|NCT00379769|564926424|FG002|Observational Follow-up|Lost to Follow-up|0|||
156500667|NCT00379769|564926425|FG003|Observational Follow-up|Lost to Follow-up|0|||
156500668|NCT00379769|564926426|FG004|Observational Follow-up|Lost to Follow-up|25|||
156546825|NCT00440947|565094997|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
156380184|NCT01248884|564483673|FG000|Overall Study|Withdrawal by Subject|1|||
156380185|NCT01248884|564483674|FG001|Overall Study|Withdrawal by Subject|3|||
156380186|NCT01248884|564483675|FG002|Overall Study|Withdrawal by Subject|1|||
156546826|NCT00440947|565094998|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
156380187|NCT01248884|564483673|FG000|Overall Study|Adverse Event|1|||
156380188|NCT01248884|564483674|FG001|Overall Study|Adverse Event|0|||
156380189|NCT01248884|564483675|FG002|Overall Study|Adverse Event|0|||
156500669|NCT00379769|564926427|FG005|Observational Follow-up|Lost to Follow-up|27|||
156380190|NCT03465540|564483680|FG000|Overall Study|Withdrawal by Subject|0|||
156380191|NCT03465540|564483681|FG001|Overall Study|Withdrawal by Subject|0|||
156380192|NCT03465540|564483682|FG002|Overall Study|Withdrawal by Subject|1|||
156380193|NCT03465540|564483683|FG003|Overall Study|Withdrawal by Subject|1|||
156546827|NCT00440947|565094999|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
156546828|NCT00440947|565094995|FG000|36-Week Induction Phase|Non-compliance|10|||
156546829|NCT00440947|565094996|FG001|36-Week Induction Phase|Non-compliance|0|||
156546830|NCT00440947|565094997|FG002|36-Week Induction Phase|Non-compliance|0|||
156546831|NCT00440947|565094998|FG003|36-Week Induction Phase|Non-compliance|0|||
156546832|NCT00440947|565094999|FG004|36-Week Induction Phase|Non-compliance|0|||
156546833|NCT00440947|565094995|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
156546834|NCT00440947|565094996|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
156546835|NCT00440947|565094997|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
156380194|NCT03465540|564483684|FG004|Overall Study|Withdrawal by Subject|1|||
156380195|NCT03465540|564483685|FG005|Overall Study|Withdrawal by Subject|0|||
156380196|NCT03465540|564483680|FG000|Overall Study|Lost to Follow-up|0|||
156380197|NCT03465540|564483681|FG001|Overall Study|Lost to Follow-up|1|||
156380198|NCT03465540|564483682|FG002|Overall Study|Lost to Follow-up|0|||
156380199|NCT03465540|564483683|FG003|Overall Study|Lost to Follow-up|0|||
156380200|NCT03465540|564483684|FG004|Overall Study|Lost to Follow-up|1|||
156380201|NCT03465540|564483685|FG005|Overall Study|Lost to Follow-up|0|||
156380202|NCT03465540|564483680|FG000|Overall Study|Death|1|||
156380203|NCT03465540|564483681|FG001|Overall Study|Death|1|||
156380204|NCT03465540|564483682|FG002|Overall Study|Death|0|||
156380205|NCT03465540|564483683|FG003|Overall Study|Death|2|||
156380206|NCT03465540|564483684|FG004|Overall Study|Death|0|||
156380207|NCT03465540|564483685|FG005|Overall Study|Death|2|||
156380208|NCT03465540|564483680|FG000|Overall Study|Protocol specified criteria|0|||
156380209|NCT03465540|564483681|FG001|Overall Study|Protocol specified criteria|2|||
156380210|NCT03465540|564483682|FG002|Overall Study|Protocol specified criteria|2|||
156380211|NCT03465540|564483683|FG003|Overall Study|Protocol specified criteria|0|||
156380212|NCT03465540|564483684|FG004|Overall Study|Protocol specified criteria|2|||
156380213|NCT03465540|564483685|FG005|Overall Study|Protocol specified criteria|0|||
156380214|NCT04096560|564483686|FG000|Overall Study|Reason not Specified|1|||
156380215|NCT04096560|564483687|FG001|Overall Study|Reason not Specified|0|||
156380216|NCT04096560|564483688|FG002|Overall Study|Reason not Specified|0|||
156380217|NCT04096560|564483689|FG003|Overall Study|Reason not Specified|0|||
156380218|NCT04096560|564483690|FG004|Overall Study|Reason not Specified|1|||
156380219|NCT04096560|564483691|FG005|Overall Study|Reason not Specified|1|||
156380220|NCT04096560|564483692|FG006|Overall Study|Reason not Specified|1|||
156380221|NCT04096560|564483693|FG007|Overall Study|Reason not Specified|0|||
156380222|NCT04096560|564483686|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156380223|NCT04096560|564483687|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156380224|NCT04096560|564483688|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156380225|NCT04096560|564483689|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156380226|NCT04096560|564483690|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156380227|NCT04096560|564483691|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
156380228|NCT04096560|564483692|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
156380229|NCT04096560|564483693|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156380230|NCT04096560|564483686|FG000|Overall Study|Study Terminated by Sponsor|0|||
156500670|NCT00379769|564926422|FG000|Observational Follow-up|Withdrawal by Subject|0|||
156500671|NCT00379769|564926423|FG001|Observational Follow-up|Withdrawal by Subject|0|||
156500672|NCT00379769|564926424|FG002|Observational Follow-up|Withdrawal by Subject|0|||
156500673|NCT00379769|564926425|FG003|Observational Follow-up|Withdrawal by Subject|0|||
156500674|NCT00379769|564926426|FG004|Observational Follow-up|Withdrawal by Subject|12|||
156500675|NCT00379769|564926427|FG005|Observational Follow-up|Withdrawal by Subject|12|||
156500676|NCT00379769|564926422|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
156500677|NCT00379769|564926423|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
156500678|NCT00379769|564926424|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
156500679|NCT00379769|564926425|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
156500680|NCT00379769|564926426|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
156500681|NCT00379769|564926427|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
156500682|NCT00379769|564926422|FG000|Observational Follow-up|Physician Decision|0|||
156500683|NCT00379769|564926423|FG001|Observational Follow-up|Physician Decision|0|||
156500684|NCT00379769|564926424|FG002|Observational Follow-up|Physician Decision|0|||
156380231|NCT04096560|564483687|FG001|Overall Study|Study Terminated by Sponsor|0|||
156500685|NCT00379769|564926425|FG003|Observational Follow-up|Physician Decision|0|||
156500686|NCT00379769|564926426|FG004|Observational Follow-up|Physician Decision|8|||
156500687|NCT00379769|564926427|FG005|Observational Follow-up|Physician Decision|8|||
156546836|NCT00440947|565094998|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
156546837|NCT00440947|565094999|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
156546838|NCT00440947|565094995|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
156380232|NCT04096560|564483688|FG002|Overall Study|Study Terminated by Sponsor|0|||
156380233|NCT04096560|564483689|FG003|Overall Study|Study Terminated by Sponsor|5|||
156380234|NCT04096560|564483690|FG004|Overall Study|Study Terminated by Sponsor|6|||
156380235|NCT04096560|564483691|FG005|Overall Study|Study Terminated by Sponsor|4|||
156380236|NCT04096560|564483692|FG006|Overall Study|Study Terminated by Sponsor|6|||
156380237|NCT04096560|564483693|FG007|Overall Study|Study Terminated by Sponsor|1|||
156380238|NCT04096560|564483686|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156380239|NCT04096560|564483687|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156380240|NCT04096560|564483688|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156380241|NCT04096560|564483689|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156380242|NCT04096560|564483690|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156380243|NCT04096560|564483691|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156380244|NCT04096560|564483692|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156380245|NCT04096560|564483693|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
156380246|NCT01459796|564483696|FG000|Overall Study|Non compliance with protocol|2|||
156380247|NCT01459796|564483697|FG001|Overall Study|Non compliance with protocol|4|||
156380248|NCT01459796|564483696|FG000|Overall Study|Adverse Event|5|||
156380249|NCT01459796|564483697|FG001|Overall Study|Adverse Event|5|||
156380250|NCT01459796|564483696|FG000|Overall Study|Withdrawal by Subject|6|||
156380251|NCT01459796|564483697|FG001|Overall Study|Withdrawal by Subject|3|||
156380252|NCT01459796|564483696|FG000|Overall Study|Lost to Follow-up|5|||
156380253|NCT01459796|564483697|FG001|Overall Study|Lost to Follow-up|4|||
156500688|NCT00379769|564926422|FG000|Observational Follow-up|Site Closed Early|0|||
156500689|NCT00379769|564926423|FG001|Observational Follow-up|Site Closed Early|0|||
156500690|NCT00379769|564926424|FG002|Observational Follow-up|Site Closed Early|0|||
156500691|NCT00379769|564926425|FG003|Observational Follow-up|Site Closed Early|0|||
156500692|NCT00379769|564926426|FG004|Observational Follow-up|Site Closed Early|6|||
156500693|NCT00379769|564926427|FG005|Observational Follow-up|Site Closed Early|7|||
156500694|NCT00379769|564926422|FG000|Observational Follow-up|Participant Moved|0|||
156500695|NCT00379769|564926423|FG001|Observational Follow-up|Participant Moved|0|||
156500696|NCT00379769|564926424|FG002|Observational Follow-up|Participant Moved|0|||
156500697|NCT00379769|564926425|FG003|Observational Follow-up|Participant Moved|0|||
156500698|NCT00379769|564926426|FG004|Observational Follow-up|Participant Moved|0|||
156500699|NCT00379769|564926427|FG005|Observational Follow-up|Participant Moved|1|||
156500700|NCT00379769|564926422|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
156500701|NCT00379769|564926423|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
156500702|NCT00379769|564926424|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
156500703|NCT00379769|564926425|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
156500704|NCT00379769|564926426|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
156500705|NCT00379769|564926427|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
156500706|NCT02825251|564926428|FG000|Overall Study|Adverse Event|0|||
156500707|NCT02825251|564926429|FG001|Overall Study|Adverse Event|1|||
156500708|NCT02825251|564926428|FG000|Overall Study|Lost to Follow-up|0|||
156500709|NCT02825251|564926429|FG001|Overall Study|Lost to Follow-up|1|||
156500710|NCT02825251|564926428|FG000|Overall Study|Withdrawal by Subject|1|||
156500711|NCT02825251|564926429|FG001|Overall Study|Withdrawal by Subject|4|||
156500712|NCT02825251|564926428|FG000|Overall Study|Unclassified|2|||
156500713|NCT02825251|564926429|FG001|Overall Study|Unclassified|0|||
156500714|NCT01689363|564926436|FG000|Overall Study|Protocol Violation|0|||
156500715|NCT01689363|564926437|FG001|Overall Study|Protocol Violation|1|||
156500716|NCT01689363|564926438|FG002|Overall Study|Protocol Violation|0|||
156500717|NCT01689363|564926439|FG003|Overall Study|Protocol Violation|0|||
156500718|NCT01689363|564926440|FG004|Overall Study|Protocol Violation|0|||
156500719|NCT01689363|564926441|FG005|Overall Study|Protocol Violation|0|||
156500720|NCT01689363|564926442|FG006|Overall Study|Protocol Violation|0|||
156500721|NCT01689363|564926443|FG007|Overall Study|Protocol Violation|0|||
156500722|NCT00321685|564926444|FG000|Overall Study|Adverse Event|18|||
156500723|NCT00321685|564926444|FG000|Overall Study|Death|2|||
156500724|NCT00321685|564926444|FG000|Overall Study|Withdrawal by Subject|8|||
156500725|NCT00321685|564926444|FG000|Overall Study|Alternative therapy|1|||
156500726|NCT00321685|564926444|FG000|Overall Study|Complicating disese|1|||
156500727|NCT00321685|564926444|FG000|Overall Study|Other|5|||
156500728|NCT00321685|564926444|FG000|Overall Study|Not start protocol therapy|2|||
156500729|NCT00321685|564926444|FG000|Overall Study|Ineligible|2|||
156500730|NCT05064488|564926448|FG000|Overall Study|Withdrawal by Subject|2|||
156500731|NCT05064488|564926449|FG001|Overall Study|Withdrawal by Subject|0|||
156500732|NCT03023722|564926450|FG000|Overall Study|No follow-up assessment|4|||
156500733|NCT00590564|564926451|FG000|Overall Study|Withdrawal by Subject|4|||
156500734|NCT00590564|564926451|FG000|Overall Study|Lost to Follow-up|6|||
156500735|NCT00590564|564926451|FG000|Overall Study|Protocol Violation|1|||
156500736|NCT00590564|564926451|FG000|Overall Study|Patient Found to be Ineligible|1|||
156500737|NCT00590564|564926451|FG000|Overall Study|Patient Non-compliance|6|||
156500738|NCT02037477|564926453|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
156500739|NCT02037477|564926454|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
156380254|NCT01459796|564483696|FG000|Overall Study|Reason unspecified|1|||
156380255|NCT01459796|564483697|FG001|Overall Study|Reason unspecified|2|||
156380256|NCT01459796|564483696|FG000|Overall Study|Decision by the sponsor|75|||
156380257|NCT01459796|564483697|FG001|Overall Study|Decision by the sponsor|108|||
156380258|NCT00701051|564483698|FG000|Screening|Failed Screening|40|||
156380259|NCT00701051|564483699|FG001|Screening|Failed Screening|0|||
156380260|NCT00701051|564483700|FG002|Screening|Failed Screening|0|||
156380261|NCT00701051|564483698|FG000|Screening|Time conflicts|19|||
156380262|NCT00701051|564483699|FG001|Screening|Time conflicts|0|||
156380263|NCT00701051|564483700|FG002|Screening|Time conflicts|0|||
156380264|NCT00701051|564483698|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
156380265|NCT00701051|564483699|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
156380266|NCT00701051|564483700|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
156380267|NCT03321019|564483711|FG000|Overall Study|Withdrawal by Subject|0|||
156380268|NCT03321019|564483712|FG001|Overall Study|Withdrawal by Subject|6|||
156380269|NCT03321019|564483711|FG000|Overall Study|Lost to Follow-up|0|||
156380270|NCT03321019|564483712|FG001|Overall Study|Lost to Follow-up|22|||
156380271|NCT03880578|564483713|FG000|Overall Study|Withdrawal by Subject|0|||
156380272|NCT03880578|564483714|FG001|Overall Study|Withdrawal by Subject|3|||
156380273|NCT03880578|564483715|FG002|Overall Study|Withdrawal by Subject|1|||
156380274|NCT03880578|564483713|FG000|Overall Study|Death|0|||
156380275|NCT03880578|564483714|FG001|Overall Study|Death|1|||
156380276|NCT03880578|564483715|FG002|Overall Study|Death|0|||
156380277|NCT04934670|564483716|FG000|Overall Study|Death|4|||
156380278|NCT04934670|564483717|FG001|Overall Study|Death|0|||
156380279|NCT04934670|564483716|FG000|Overall Study|Lost to Follow-up|1|||
156380280|NCT04934670|564483717|FG001|Overall Study|Lost to Follow-up|4|||
156380281|NCT00153101|564483720|FG000|Overall Study|Lost to Follow-up|14|||
156380282|NCT00153101|564483721|FG001|Overall Study|Lost to Follow-up|14|||
156380283|NCT00153101|564483722|FG002|Overall Study|Lost to Follow-up|12|||
156380284|NCT00153101|564483723|FG003|Overall Study|Lost to Follow-up|5|||
156380285|NCT00153101|564483724|FG004|Overall Study|Lost to Follow-up|5|||
156380286|NCT00153101|564483720|FG000|Overall Study|Withdrawal by Subject|3|||
156380287|NCT00153101|564483721|FG001|Overall Study|Withdrawal by Subject|4|||
156380288|NCT00153101|564483722|FG002|Overall Study|Withdrawal by Subject|3|||
156380289|NCT00153101|564483723|FG003|Overall Study|Withdrawal by Subject|3|||
156380290|NCT00153101|564483724|FG004|Overall Study|Withdrawal by Subject|5|||
156380291|NCT03169153|564483725|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
156380292|NCT03169153|564483726|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
156380293|NCT03169153|564483725|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
156380294|NCT03169153|564483726|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
156380295|NCT03169153|564483725|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
156380296|NCT03169153|564483726|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
156380297|NCT03169153|564483725|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
156380298|NCT03169153|564483726|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
156380299|NCT00439777|564483727|FG000|Treatment Period|Death|29|||
156380300|NCT00439777|564483728|FG001|Treatment Period|Death|21|||
156380301|NCT00439777|564483727|FG000|Treatment Period|Study terminated by sponsor|125|||
156380302|NCT00439777|564483728|FG001|Treatment Period|Study terminated by sponsor|132|||
156380303|NCT00439777|564483727|FG000|Treatment Period|Site closed by investigator|0|||
156380304|NCT00439777|564483728|FG001|Treatment Period|Site closed by investigator|1|||
156380305|NCT00439777|564483727|FG000|Treatment Period|Did not take study treatment|7|||
156380306|NCT00439777|564483728|FG001|Treatment Period|Did not take study treatment|8|||
156380307|NCT00439777|564483727|FG000|Treatment Period|Adverse Event|111|||
156380308|NCT00439777|564483728|FG001|Treatment Period|Adverse Event|92|||
156380309|NCT00439777|564483727|FG000|Treatment Period|Protocol Violation|23|||
156380310|NCT00439777|564483728|FG001|Treatment Period|Protocol Violation|30|||
156500740|NCT02037477|564926455|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
156500741|NCT02037477|564926456|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
156500742|NCT01245140|564926457|FG000|Overall Study|Adverse Event|1|||
156500743|NCT01245140|564926458|FG001|Overall Study|Adverse Event|3|||
156500744|NCT01245140|564926457|FG000|Overall Study|Lack of Efficacy|2|||
156380311|NCT00439777|564483727|FG000|Treatment Period|Withdrawal by Subject|66|||
156380312|NCT00439777|564483728|FG001|Treatment Period|Withdrawal by Subject|118|||
156380313|NCT00439777|564483727|FG000|Treatment Period|Lack of Efficacy|1|||
156380314|NCT00439777|564483728|FG001|Treatment Period|Lack of Efficacy|4|||
156380315|NCT00439777|564483727|FG000|Treatment Period|Lost to Follow-up|8|||
156380316|NCT00439777|564483728|FG001|Treatment Period|Lost to Follow-up|10|||
156380317|NCT00439777|564483727|FG000|Treatment Period|Protocol driven decision point|1|||
156380318|NCT00439777|564483728|FG001|Treatment Period|Protocol driven decision point|3|||
156380319|NCT00439777|564483727|FG000|Treatment Period|Physician Decision|7|||
156380320|NCT00439777|564483728|FG001|Treatment Period|Physician Decision|18|||
156380321|NCT00439777|564483727|FG000|Treatment Period|Clinical endpoint reached|26|||
156380322|NCT00439777|564483728|FG001|Treatment Period|Clinical endpoint reached|13|||
156380323|NCT00439777|564483727|FG000|Treatment Period|Technical problems|3|||
156500745|NCT01245140|564926458|FG001|Overall Study|Lack of Efficacy|4|||
156380324|NCT00439777|564483728|FG001|Treatment Period|Technical problems|1|||
156380325|NCT00439777|564483727|FG000|Treatment Period|Participant convenience|12|||
156380326|NCT00439777|564483728|FG001|Treatment Period|Participant convenience|8|||
156380327|NCT00439777|564483727|FG000|Observational Period|Protocol Violation|0|||
156380328|NCT00439777|564483728|FG001|Observational Period|Protocol Violation|2|||
156380329|NCT00439777|564483727|FG000|Observational Period|Withdrawal by Subject|9|||
156380330|NCT00439777|564483728|FG001|Observational Period|Withdrawal by Subject|5|||
156380331|NCT00439777|564483727|FG000|Observational Period|Lost to Follow-up|1|||
156380332|NCT00439777|564483728|FG001|Observational Period|Lost to Follow-up|11|||
156380333|NCT00439777|564483727|FG000|Observational Period|Death|27|||
156380334|NCT00439777|564483728|FG001|Observational Period|Death|20|||
156380335|NCT00439777|564483727|FG000|Observational Period|Study terminated by sponsor|3|||
156380336|NCT00439777|564483728|FG001|Observational Period|Study terminated by sponsor|1|||
156380337|NCT00439777|564483727|FG000|Observational Period|Protocol driven decision point|0|||
156380338|NCT00439777|564483728|FG001|Observational Period|Protocol driven decision point|1|||
156380339|NCT00439777|564483727|FG000|Observational Period|Lack of Efficacy|1|||
156380340|NCT00439777|564483728|FG001|Observational Period|Lack of Efficacy|0|||
156380341|NCT00439777|564483727|FG000|Observational Period|Technical problems|0|||
156380342|NCT00439777|564483728|FG001|Observational Period|Technical problems|1|||
156380343|NCT00784043|564483729|FG000|Overall Study|Withdrawal by Subject|8|||
156380344|NCT00784043|564483730|FG001|Overall Study|Withdrawal by Subject|5|||
156380345|NCT00784043|564483729|FG000|Overall Study|Protocol Terminated|23|||
156380346|NCT00784043|564483730|FG001|Overall Study|Protocol Terminated|1|||
156380347|NCT03791398|564483737|FG000|Overall Study|Progression of Disease Under Study|2|||
156380348|NCT03791398|564483738|FG001|Overall Study|Progression of Disease Under Study|0|||
156380349|NCT03791398|564483739|FG002|Overall Study|Progression of Disease Under Study|0|||
156380350|NCT02207829|564483740|FG000|Overall Study|Adverse Event|10|||
156380351|NCT02207829|564483741|FG001|Overall Study|Adverse Event|9|||
156380352|NCT02207829|564483740|FG000|Overall Study|Lack of Efficacy|7|||
156380353|NCT02207829|564483741|FG001|Overall Study|Lack of Efficacy|5|||
156380354|NCT02207829|564483740|FG000|Overall Study|Lost to Follow-up|2|||
156380355|NCT02207829|564483741|FG001|Overall Study|Lost to Follow-up|2|||
156380356|NCT02207829|564483740|FG000|Overall Study|Protocol deviation|5|||
156380357|NCT02207829|564483741|FG001|Overall Study|Protocol deviation|4|||
156380358|NCT02207829|564483740|FG000|Overall Study|Withdrew consent|18|||
156380359|NCT02207829|564483741|FG001|Overall Study|Withdrew consent|14|||
156380360|NCT03299192|564483742|FG000|Overall Study|Fell before classes started|1|||
156380361|NCT03299192|564483743|FG001|Overall Study|Fell before classes started|0|||
156380362|NCT03299192|564483744|FG002|Overall Study|Fell before classes started|0|||
156380363|NCT03299192|564483742|FG000|Overall Study|Other|0|||
156380364|NCT03299192|564483743|FG001|Overall Study|Other|2|||
156380365|NCT03299192|564483744|FG002|Overall Study|Other|1|||
156380366|NCT01418209|564483750|FG000|Overall Study|Withdrawal by Subject|1|||
156380367|NCT01418209|564483751|FG001|Overall Study|Withdrawal by Subject|0|||
156380368|NCT01418209|564483752|FG002|Overall Study|Withdrawal by Subject|1|||
156380369|NCT01418209|564483750|FG000|Overall Study|Did not provide hot flash diary data|1|||
156380370|NCT01418209|564483751|FG001|Overall Study|Did not provide hot flash diary data|3|||
156380371|NCT01418209|564483752|FG002|Overall Study|Did not provide hot flash diary data|3|||
156380372|NCT00101101|564483753|FG000|Overall Study|never received vaccine|20|||
156380373|NCT00983580|564483754|FG000|Overall Study|Cancel Prior to treatment|1|||
156380374|NCT00983580|564483755|FG001|Overall Study|Cancel Prior to treatment|3|||
156380375|NCT00983580|564483754|FG000|Overall Study|Protocol Violation|1|||
156380376|NCT00983580|564483755|FG001|Overall Study|Protocol Violation|1|||
156380377|NCT00983580|564483754|FG000|Overall Study|Ineligible|3|||
156380378|NCT00983580|564483755|FG001|Overall Study|Ineligible|0|||
156380379|NCT01603875|564483756|FG000|Overall Study|Preexisting rabies antibody|3|||
156380380|NCT01603875|564483757|FG001|Overall Study|Preexisting rabies antibody|4|||
156380381|NCT01603875|564483758|FG002|Overall Study|Preexisting rabies antibody|3|||
156380382|NCT01603875|564483756|FG000|Overall Study|Lost to Follow-up|4|||
156380383|NCT01603875|564483757|FG001|Overall Study|Lost to Follow-up|3|||
156380384|NCT01603875|564483758|FG002|Overall Study|Lost to Follow-up|6|||
156380385|NCT01603875|564483756|FG000|Overall Study|Protocol Violation|0|||
156380386|NCT01603875|564483757|FG001|Overall Study|Protocol Violation|1|||
156380387|NCT01603875|564483758|FG002|Overall Study|Protocol Violation|0|||
156380388|NCT01652716|564483762|FG000|Overall Study|Loss of glucose control|1|||
156380389|NCT01652716|564483763|FG001|Overall Study|Loss of glucose control|0|||
156380390|NCT01652716|564483762|FG000|Overall Study|Administrative|0|||
156380391|NCT01652716|564483763|FG001|Overall Study|Administrative|2|||
156380392|NCT01652716|564483762|FG000|Overall Study|Investigator decision|1|||
156380393|NCT01652716|564483763|FG001|Overall Study|Investigator decision|4|||
156380394|NCT01652716|564483762|FG000|Overall Study|Lost to Follow-up|12|||
156380395|NCT01652716|564483763|FG001|Overall Study|Lost to Follow-up|11|||
156380396|NCT01652716|564483762|FG000|Overall Study|Protocol Violation|2|||
156380397|NCT01652716|564483763|FG001|Overall Study|Protocol Violation|1|||
156380398|NCT01652716|564483762|FG000|Overall Study|Adverse Event|7|||
156380399|NCT01652716|564483763|FG001|Overall Study|Adverse Event|10|||
156380400|NCT01652716|564483762|FG000|Overall Study|Withdrawal by Subject|33|||
156380401|NCT01652716|564483763|FG001|Overall Study|Withdrawal by Subject|18|||
156380402|NCT01800903|564483764|FG000|Second Test Period|unable to catheterise|1|||
156380403|NCT01800903|564483765|FG001|Second Test Period|unable to catheterise|0|||
156380404|NCT01800903|564483766|FG002|Second Test Period|unable to catheterise|0|||
156380405|NCT01800903|564483767|FG003|Second Test Period|unable to catheterise|0|||
156380406|NCT01800903|564483768|FG004|Second Test Period|unable to catheterise|0|||
156380407|NCT01800903|564483769|FG005|Second Test Period|unable to catheterise|0|||
156380408|NCT02778204|564483770|FG000|Overall Study|Adverse Event|1|||
156380409|NCT02778204|564483771|FG001|Overall Study|Adverse Event|0|||
156380410|NCT02778204|564483772|FG002|Overall Study|Adverse Event|0|||
156380411|NCT02778204|564483773|FG003|Overall Study|Adverse Event|0|||
156380412|NCT02778204|564483770|FG000|Overall Study|Withdrawal by Subject|0|||
156380413|NCT02778204|564483771|FG001|Overall Study|Withdrawal by Subject|0|||
156380414|NCT02778204|564483772|FG002|Overall Study|Withdrawal by Subject|1|||
156380415|NCT02778204|564483773|FG003|Overall Study|Withdrawal by Subject|2|||
156380416|NCT02778204|564483770|FG000|Overall Study|Lost to Follow-up|1|||
156380417|NCT02778204|564483771|FG001|Overall Study|Lost to Follow-up|0|||
156380418|NCT02778204|564483772|FG002|Overall Study|Lost to Follow-up|2|||
156380419|NCT02778204|564483773|FG003|Overall Study|Lost to Follow-up|1|||
156380420|NCT02778204|564483770|FG000|Overall Study|Protocol Violation|0|||
156380421|NCT02778204|564483771|FG001|Overall Study|Protocol Violation|0|||
156380422|NCT02778204|564483772|FG002|Overall Study|Protocol Violation|1|||
156380423|NCT02778204|564483773|FG003|Overall Study|Protocol Violation|0|||
156380424|NCT02778204|564483770|FG000|Overall Study|Eligibility Violation|0|||
156380425|NCT02778204|564483771|FG001|Overall Study|Eligibility Violation|0|||
156380426|NCT02778204|564483772|FG002|Overall Study|Eligibility Violation|0|||
156380427|NCT02778204|564483773|FG003|Overall Study|Eligibility Violation|1|||
156380428|NCT04382612|564483774|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
156380429|NCT01328002|564483776|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
156380430|NCT01328002|564483777|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
156380431|NCT01328002|564483776|FG000|Open-Label Period|Adverse Event|8|||
156380432|NCT01328002|564483777|FG001|Open-Label Period|Adverse Event|0|||
156380433|NCT01328002|564483776|FG000|Open-Label Period|Lack of Efficacy|3|||
156380434|NCT01328002|564483777|FG001|Open-Label Period|Lack of Efficacy|0|||
156380435|NCT01328002|564483776|FG000|Open-Label Period|Protocol Violation|2|||
156380436|NCT01328002|564483777|FG001|Open-Label Period|Protocol Violation|0|||
156380437|NCT01328002|564483776|FG000|Open-Label Period|Withdrawal by Subject|9|||
156380438|NCT01328002|564483777|FG001|Open-Label Period|Withdrawal by Subject|0|||
156380439|NCT01328002|564483776|FG000|Open-Label Period|Lost to Follow-up|6|||
156380440|NCT01328002|564483777|FG001|Open-Label Period|Lost to Follow-up|0|||
156380441|NCT01328002|564483776|FG000|Open-Label Period|Other Reason|2|||
156380442|NCT01328002|564483777|FG001|Open-Label Period|Other Reason|0|||
156380443|NCT01328002|564483776|FG000|Double-Blind Period|Adverse Event|1|||
156380444|NCT01328002|564483777|FG001|Double-Blind Period|Adverse Event|0|||
156380445|NCT01328002|564483776|FG000|Double-Blind Period|Lack of Efficacy|1|||
156380446|NCT01328002|564483777|FG001|Double-Blind Period|Lack of Efficacy|0|||
156500746|NCT01245140|564926457|FG000|Overall Study|Protocol Violation|0|||
156380447|NCT01578551|564483778|FG000|Overall Study|Adverse Event|1|||
156380448|NCT01578551|564483779|FG001|Overall Study|Adverse Event|0|||
156380449|NCT05204134|564483780|FG000|Overall Study|Withdrawal by Subject|3|||
156380450|NCT05204134|564483780|FG000|Overall Study|Physician Decision|1|||
156380451|NCT01312467|564483782|FG000|Overall Study|Adverse Event|4|||
156380452|NCT01312467|564483782|FG000|Overall Study|Lost to Follow-up|1|||
156380453|NCT01312467|564483782|FG000|Overall Study|Withdrawal by Subject|2|||
156380454|NCT01312467|564483782|FG000|Overall Study|Deported to country of origin|1|||
156380455|NCT01312467|564483782|FG000|Overall Study|Another medical condition|1|||
156380456|NCT01312467|564483782|FG000|Overall Study|Ineligible|4|||
156380457|NCT02752048|564483783|FG000|Overall Study|Withdrawal by Subject|0|||
156380458|NCT02752048|564483784|FG001|Overall Study|Withdrawal by Subject|0|||
156380459|NCT02752048|564483785|FG002|Overall Study|Withdrawal by Subject|3|||
156380460|NCT00061048|564483786|FG000|Overall Study|Adverse Event|2|||
156380461|NCT00061048|564483786|FG000|Overall Study|disease progression|20|||
156380462|NCT03779841|564483790|FG000|Randomized Population|Did Not Receive Treatment|3|||
156380463|NCT03779841|564483791|FG001|Randomized Population|Did Not Receive Treatment|1|||
156380464|NCT03779841|564483792|FG002|Randomized Population|Did Not Receive Treatment|0|||
156380465|NCT03779841|564483790|FG000|Treated (Safety) Population|Adverse Event|1|||
156380466|NCT03779841|564483791|FG001|Treated (Safety) Population|Adverse Event|1|||
156380467|NCT03779841|564483792|FG002|Treated (Safety) Population|Adverse Event|0|||
156380468|NCT03779841|564483790|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
156380469|NCT03779841|564483791|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
156380470|NCT03779841|564483792|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
156380471|NCT03779841|564483790|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
156380472|NCT03779841|564483791|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
156380473|NCT03779841|564483792|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
156380474|NCT03779841|564483790|FG000|Treated (Safety) Population|Death|1|||
156380475|NCT03779841|564483791|FG001|Treated (Safety) Population|Death|0|||
156380476|NCT03779841|564483792|FG002|Treated (Safety) Population|Death|2|||
156380477|NCT02788175|564483793|FG000|Overall Study|Protocol Violation|3|||
156380478|NCT02788175|564483793|FG000|Overall Study|Withdrawal by Subject|4|||
156380479|NCT02788175|564483793|FG000|Overall Study|Ineligible prior to study agent|6|||
156380480|NCT00818441|564483794|FG000|Overall Study|Death|69|||
156380481|NCT00818441|564483795|FG001|Overall Study|Death|26|||
156380482|NCT00818441|564483794|FG000|Overall Study|Other|5|||
156380483|NCT00818441|564483795|FG001|Overall Study|Other|0|||
156380484|NCT00818441|564483794|FG000|Overall Study|Lost to Follow-up|2|||
156380485|NCT00818441|564483795|FG001|Overall Study|Lost to Follow-up|1|||
156380486|NCT00818441|564483794|FG000|Overall Study|Withdrawal by Subject|2|||
156380487|NCT00818441|564483795|FG001|Overall Study|Withdrawal by Subject|0|||
156380488|NCT00818441|564483794|FG000|Overall Study|Adverse Event|0|||
156380489|NCT00818441|564483795|FG001|Overall Study|Adverse Event|1|||
156380490|NCT00818441|564483794|FG000|Overall Study|Study terminated by sponsor|11|||
156380491|NCT00818441|564483795|FG001|Overall Study|Study terminated by sponsor|2|||
156380492|NCT00898677|564483796|FG000|Overall Study|Adverse Event|0|||
156380493|NCT00898677|564483797|FG001|Overall Study|Adverse Event|0|||
156380494|NCT00898677|564483798|FG002|Overall Study|Adverse Event|1|||
156380495|NCT00898677|564483799|FG003|Overall Study|Adverse Event|0|||
156380496|NCT00898677|564483796|FG000|Overall Study|Lost to Follow-up|0|||
156380497|NCT00898677|564483797|FG001|Overall Study|Lost to Follow-up|0|||
156380498|NCT00898677|564483798|FG002|Overall Study|Lost to Follow-up|2|||
156380499|NCT00898677|564483799|FG003|Overall Study|Lost to Follow-up|0|||
156380500|NCT00898677|564483796|FG000|Overall Study|Protocol Violation|1|||
156380501|NCT00898677|564483797|FG001|Overall Study|Protocol Violation|1|||
156380502|NCT00898677|564483798|FG002|Overall Study|Protocol Violation|2|||
156380503|NCT00898677|564483799|FG003|Overall Study|Protocol Violation|0|||
156380504|NCT00898677|564483796|FG000|Overall Study|Withdrawal by Subject|0|||
156380505|NCT00898677|564483797|FG001|Overall Study|Withdrawal by Subject|0|||
156380506|NCT00898677|564483798|FG002|Overall Study|Withdrawal by Subject|0|||
156380507|NCT00898677|564483799|FG003|Overall Study|Withdrawal by Subject|1|||
156380508|NCT00898677|564483796|FG000|Overall Study|Not Treated: Adverse Event|0|||
156380509|NCT00898677|564483797|FG001|Overall Study|Not Treated: Adverse Event|2|||
156380510|NCT00898677|564483798|FG002|Overall Study|Not Treated: Adverse Event|1|||
156380511|NCT00898677|564483799|FG003|Overall Study|Not Treated: Adverse Event|0|||
156380512|NCT00898677|564483796|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
156380513|NCT00898677|564483797|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
156380514|NCT00898677|564483798|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
156380515|NCT00898677|564483799|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
156380516|NCT00898677|564483796|FG000|Overall Study|Not Treated: Pregnancy|0|||
156380517|NCT00898677|564483797|FG001|Overall Study|Not Treated: Pregnancy|0|||
156380518|NCT00898677|564483798|FG002|Overall Study|Not Treated: Pregnancy|1|||
156380519|NCT00898677|564483799|FG003|Overall Study|Not Treated: Pregnancy|0|||
156380520|NCT00898677|564483796|FG000|Overall Study|Not Treated: Protocol Violation|2|||
156380521|NCT00898677|564483797|FG001|Overall Study|Not Treated: Protocol Violation|0|||
156380522|NCT00898677|564483798|FG002|Overall Study|Not Treated: Protocol Violation|2|||
156380523|NCT00898677|564483799|FG003|Overall Study|Not Treated: Protocol Violation|0|||
156380524|NCT00898677|564483796|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
156380525|NCT00898677|564483797|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
156380526|NCT00898677|564483798|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
156380527|NCT00898677|564483799|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
156380528|NCT00898677|564483796|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
156380529|NCT00898677|564483797|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
156380530|NCT00898677|564483798|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
156380531|NCT00898677|564483799|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
156380532|NCT00898677|564483796|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
156380533|NCT00898677|564483797|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
156380534|NCT00898677|564483798|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
156380535|NCT00898677|564483799|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
156380536|NCT00898677|564483796|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
156380537|NCT00898677|564483797|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
156380538|NCT00898677|564483798|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
156380539|NCT00898677|564483799|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
156380540|NCT00898677|564483796|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
156380541|NCT00898677|564483797|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
156380542|NCT00898677|564483798|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
156380543|NCT00898677|564483799|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
156380544|NCT00898677|564483796|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
156380545|NCT00898677|564483797|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
156546839|NCT00440947|565094996|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
156546840|NCT00440947|565094997|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
156546841|NCT00440947|565094998|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
156380546|NCT00898677|564483798|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
156380547|NCT00898677|564483799|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
156380548|NCT00898677|564483796|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
156380549|NCT00898677|564483797|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
156380550|NCT00898677|564483798|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
156380551|NCT00898677|564483799|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
156380552|NCT04450264|564486158|FG000|Overall Study|Incomplete survey|13|||
156380553|NCT04450264|564486159|FG001|Overall Study|Incomplete survey|19|||
156380554|NCT02055352|564486160|FG000|Overall Study|Adverse Event|0|||
156380555|NCT02055352|564486161|FG001|Overall Study|Adverse Event|1|||
156380556|NCT02055352|564486160|FG000|Overall Study|Non-eligible|0|||
156380557|NCT02055352|564486161|FG001|Overall Study|Non-eligible|1|||
156380558|NCT02055352|564486160|FG000|Overall Study|Poor compliance|1|||
156380559|NCT02055352|564486161|FG001|Overall Study|Poor compliance|1|||
156380560|NCT02055352|564486160|FG000|Overall Study|Death|1|||
156380561|NCT02055352|564486161|FG001|Overall Study|Death|2|||
156380562|NCT02055352|564486160|FG000|Overall Study|Patient decision|1|||
156380563|NCT02055352|564486161|FG001|Overall Study|Patient decision|1|||
156380564|NCT02055352|564486160|FG000|Overall Study|Use of prohibited treatment|0|||
156380565|NCT02055352|564486161|FG001|Overall Study|Use of prohibited treatment|3|||
156380566|NCT02055352|564486160|FG000|Overall Study|AE, study drug would be detrimental|1|||
156380567|NCT02055352|564486161|FG001|Overall Study|AE, study drug would be detrimental|3|||
156380568|NCT02055352|564486160|FG000|Overall Study|Withdrawal of informed consent|1|||
156380569|NCT02055352|564486161|FG001|Overall Study|Withdrawal of informed consent|0|||
156380570|NCT02055352|564486160|FG000|Overall Study|Reason unknown|1|||
156380571|NCT02055352|564486161|FG001|Overall Study|Reason unknown|5|||
156380572|NCT00970502|564486163|FG000|Overall Study|Withdrawal by Subject|1|||
156380573|NCT02707055|564486164|FG000|Phase 1|Withdrawal by Subject|1|||
156380574|NCT02707055|564486165|FG001|Phase 1|Withdrawal by Subject|2|||
156380575|NCT02707055|564486164|FG000|Phase 1|Physician Decision|0|||
156380576|NCT02707055|564486165|FG001|Phase 1|Physician Decision|1|||
156380577|NCT02707055|564486164|FG000|Phase 2|Adverse Event|1|||
156380578|NCT02707055|564486165|FG001|Phase 2|Adverse Event|2|||
156380579|NCT01880424|564486166|FG000|Overall Study|Adverse Event|7|||
156380580|NCT01880424|564486167|FG001|Overall Study|Adverse Event|6|||
156380581|NCT01880424|564486166|FG000|Overall Study|Lack of Efficacy|1|||
156380582|NCT01880424|564486167|FG001|Overall Study|Lack of Efficacy|4|||
156380583|NCT01880424|564486166|FG000|Overall Study|Lost to Follow-up|3|||
156380584|NCT01880424|564486167|FG001|Overall Study|Lost to Follow-up|2|||
156380585|NCT01880424|564486166|FG000|Overall Study|Protocol Violation|11|||
156380586|NCT01880424|564486167|FG001|Overall Study|Protocol Violation|13|||
156380587|NCT01880424|564486166|FG000|Overall Study|Withdrawal by Subject|10|||
156380588|NCT01880424|564486167|FG001|Overall Study|Withdrawal by Subject|30|||
156380589|NCT01880424|564486166|FG000|Overall Study|Other|1|||
156380590|NCT01880424|564486167|FG001|Overall Study|Other|0|||
156380591|NCT02280044|564486170|FG000|Overall Study|Planned alternate|0|||
156380592|NCT02280044|564486171|FG001|Overall Study|Planned alternate|2|||
156380593|NCT00466193|564486174|FG000|Overall Study|Adverse Event|0|||
156380594|NCT00466193|564486175|FG001|Overall Study|Adverse Event|1|||
156380595|NCT00466193|564486174|FG000|Overall Study|Lost to Follow-up|2|||
156380596|NCT00466193|564486175|FG001|Overall Study|Lost to Follow-up|4|||
156380597|NCT00466193|564486174|FG000|Overall Study|Physician Decision|1|||
156380598|NCT00466193|564486175|FG001|Overall Study|Physician Decision|0|||
156380599|NCT00466193|564486174|FG000|Overall Study|Protocol Violation|1|||
156380600|NCT00466193|564486175|FG001|Overall Study|Protocol Violation|1|||
156380601|NCT00466193|564486174|FG000|Overall Study|Withdrawal by Subject|7|||
156380602|NCT00466193|564486175|FG001|Overall Study|Withdrawal by Subject|2|||
156380603|NCT00466193|564486174|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
156380604|NCT00466193|564486175|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
156380605|NCT00086346|564486176|FG000|Randomization|Did not receive test article|4|||
156380606|NCT00086346|564486177|FG001|Randomization|Did not receive test article|4|||
156380607|NCT00086346|564486176|FG000|Patients Dosed With Test Article|Adverse Event|94|||
156380608|NCT00086346|564486177|FG001|Patients Dosed With Test Article|Adverse Event|11|||
156380609|NCT00086346|564486176|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
156380610|NCT00086346|564486177|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
156380611|NCT00086346|564486176|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
156380612|NCT00086346|564486177|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
156380613|NCT00086346|564486176|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
156380614|NCT00086346|564486177|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
156380615|NCT00086346|564486176|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
156380616|NCT00086346|564486177|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
156380617|NCT00086346|564486176|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
156380618|NCT00086346|564486177|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
156380619|NCT04495374|564486178|FG000|Overall Study|Protocol Violation|2|||
156380620|NCT04495374|564486179|FG001|Overall Study|Protocol Violation|1|||
156380621|NCT02807948|564486180|FG000|Overall Study|Physician Decision|1|||
156380622|NCT02807948|564486181|FG001|Overall Study|Physician Decision|0|||
156380623|NCT03727750|564486182|FG000|Overall Study|Death|45|||
156380624|NCT03727750|564486182|FG000|Overall Study|Withdrawal by Subject|2|||
156500747|NCT01245140|564926458|FG001|Overall Study|Protocol Violation|1|||
156500748|NCT01245140|564926457|FG000|Overall Study|Withdrawal by Subject|0|||
156500749|NCT01245140|564926458|FG001|Overall Study|Withdrawal by Subject|1|||
156500750|NCT01245140|564926457|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
156500751|NCT01245140|564926458|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
156500752|NCT02635360|564926459|FG000|Overall Study|Adverse Event|0|||
156500753|NCT02635360|564926460|FG001|Overall Study|Adverse Event|3|||
156500754|NCT02635360|564926459|FG000|Overall Study|Withdrawal by Subject|2|||
156500755|NCT02635360|564926460|FG001|Overall Study|Withdrawal by Subject|0|||
156500756|NCT02635360|564926459|FG000|Overall Study|Non-Compliance|3|||
156500757|NCT02635360|564926460|FG001|Overall Study|Non-Compliance|1|||
156500758|NCT02635360|564926459|FG000|Overall Study|Disease Progression|0|||
156500759|NCT02635360|564926460|FG001|Overall Study|Disease Progression|2|||
156500760|NCT02635360|564926459|FG000|Overall Study|Lost to Follow-up|1|||
156500761|NCT02635360|564926460|FG001|Overall Study|Lost to Follow-up|1|||
156500762|NCT04082429|564926461|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
156500763|NCT04082429|564926462|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
156500764|NCT04082429|564926463|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
156500765|NCT04082429|564926464|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
156500766|NCT04082429|564926465|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
156500767|NCT04082429|564926466|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
156500768|NCT04082429|564926467|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
156500769|NCT04082429|564926468|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
156500770|NCT04082429|564926469|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
156500771|NCT04082429|564926461|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
156500772|NCT04082429|564926462|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
156500773|NCT04082429|564926463|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
156500774|NCT04082429|564926464|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
156500775|NCT04082429|564926465|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
156500776|NCT04082429|564926466|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
156500777|NCT04082429|564926467|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
156500778|NCT04082429|564926468|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
156500779|NCT04082429|564926469|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
156500780|NCT04082429|564926461|FG000|Main Part (After the Treatment Pause)|Death|0|||
156500781|NCT04082429|564926462|FG001|Main Part (After the Treatment Pause)|Death|0|||
156500782|NCT04082429|564926463|FG002|Main Part (After the Treatment Pause)|Death|0|||
156500783|NCT04082429|564926464|FG003|Main Part (After the Treatment Pause)|Death|0|||
156500784|NCT04082429|564926465|FG004|Main Part (After the Treatment Pause)|Death|1|||
156500785|NCT04082429|564926466|FG005|Main Part (After the Treatment Pause)|Death|0|||
156500786|NCT04082429|564926467|FG006|Main Part (After the Treatment Pause)|Death|0|||
156500787|NCT04082429|564926468|FG007|Main Part (After the Treatment Pause)|Death|0|||
156500788|NCT04082429|564926469|FG008|Main Part (After the Treatment Pause)|Death|0|||
156500789|NCT04082429|564926461|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
156500790|NCT04082429|564926462|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
156500791|NCT04082429|564926463|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
156500792|NCT04082429|564926464|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
156500793|NCT04082429|564926465|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
156500794|NCT04082429|564926466|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
156500795|NCT04082429|564926467|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
156500796|NCT04082429|564926468|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
156500797|NCT04082429|564926469|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
156500798|NCT04082429|564926461|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
156500799|NCT04082429|564926462|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
156500800|NCT04082429|564926463|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
156500801|NCT04082429|564926464|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
156500802|NCT04082429|564926465|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
156500803|NCT04082429|564926466|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
156500804|NCT04082429|564926467|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
156500805|NCT04082429|564926468|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
156500806|NCT04082429|564926469|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
156500807|NCT04082429|564926461|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
156500808|NCT04082429|564926462|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
156500809|NCT04082429|564926463|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
156500810|NCT04082429|564926464|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
156500811|NCT04082429|564926465|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
156500812|NCT04082429|564926466|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
156546842|NCT00440947|565094999|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
156546843|NCT00440947|565094995|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
156500813|NCT04082429|564926467|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
156500814|NCT04082429|564926468|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
156500815|NCT04082429|564926469|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
156546844|NCT00440947|565094996|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
156546845|NCT00440947|565094997|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
156546846|NCT00440947|565094998|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
156546847|NCT00440947|565094999|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
156546848|NCT00440947|565094995|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
156546849|NCT00440947|565094996|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
156546850|NCT00440947|565094997|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
156500816|NCT04082429|564926461|FG000|Extension Part|Ongoing|0|||
156500817|NCT04082429|564926462|FG001|Extension Part|Ongoing|7|||
156500818|NCT04082429|564926463|FG002|Extension Part|Ongoing|17|||
156500819|NCT04082429|564926464|FG003|Extension Part|Ongoing|6|||
156500820|NCT04082429|564926465|FG004|Extension Part|Ongoing|45|||
156500821|NCT04082429|564926466|FG005|Extension Part|Ongoing|0|||
156500822|NCT04082429|564926467|FG006|Extension Part|Ongoing|10|||
156500823|NCT04082429|564926468|FG007|Extension Part|Ongoing|23|||
156546851|NCT00440947|565094998|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
156546852|NCT00440947|565094999|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
156546853|NCT00440947|565094995|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
156380625|NCT03727750|564486182|FG000|Overall Study|Lost to Follow-up|1|||
156500824|NCT04082429|564926469|FG008|Extension Part|Ongoing|25|||
156546854|NCT00440947|565094996|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
156380626|NCT03727750|564486182|FG000|Overall Study|Other|1|||
156500825|NCT00334542|564926470|FG000|Overall Study|Adverse Event|3|||
156500826|NCT00334542|564926470|FG000|Overall Study|Withdrawal by Subject|1|||
156380627|NCT02473614|564486183|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
156380628|NCT02473614|564486184|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
156380629|NCT01075074|564486187|FG000|Overall Study|Surgeon changed to open incisional case|1|||
156380630|NCT01075074|564486188|FG001|Overall Study|Surgeon changed to open incisional case|2|||
156380631|NCT01075074|564486189|FG002|Overall Study|Surgeon changed to open incisional case|2|||
156380632|NCT01054729|564486190|FG000|Overall Study|Randomized but Not Treated|0|||
156380633|NCT01054729|564486191|FG001|Overall Study|Randomized but Not Treated|1|||
156380634|NCT01054729|564486192|FG002|Overall Study|Randomized but Not Treated|0|||
156380635|NCT01054729|564486193|FG003|Overall Study|Randomized but Not Treated|0|||
156380636|NCT01054729|564486190|FG000|Overall Study|Adverse Event|1|||
156380637|NCT01054729|564486191|FG001|Overall Study|Adverse Event|1|||
156380638|NCT01054729|564486192|FG002|Overall Study|Adverse Event|2|||
156380639|NCT01054729|564486193|FG003|Overall Study|Adverse Event|1|||
156380640|NCT01054729|564486190|FG000|Overall Study|Withdrawal by Subject|1|||
156380641|NCT01054729|564486191|FG001|Overall Study|Withdrawal by Subject|0|||
156380642|NCT01054729|564486192|FG002|Overall Study|Withdrawal by Subject|1|||
156380643|NCT01054729|564486193|FG003|Overall Study|Withdrawal by Subject|0|||
156380644|NCT01054729|564486190|FG000|Overall Study|Lost to Follow-up|0|||
156380645|NCT01054729|564486191|FG001|Overall Study|Lost to Follow-up|1|||
156380646|NCT01054729|564486192|FG002|Overall Study|Lost to Follow-up|0|||
156380647|NCT01054729|564486193|FG003|Overall Study|Lost to Follow-up|0|||
156380648|NCT01054729|564486190|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
156380649|NCT01054729|564486191|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
156380650|NCT01054729|564486192|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
156380651|NCT01054729|564486193|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
156380652|NCT01054729|564486190|FG000|Overall Study|Non-responder|1|||
156380653|NCT01054729|564486191|FG001|Overall Study|Non-responder|0|||
156380654|NCT01054729|564486192|FG002|Overall Study|Non-responder|1|||
156380655|NCT01054729|564486193|FG003|Overall Study|Non-responder|1|||
156380656|NCT01054729|564486190|FG000|Overall Study|PEG/RBV Non-responder|1|||
156380657|NCT01054729|564486191|FG001|Overall Study|PEG/RBV Non-responder|0|||
156380658|NCT01054729|564486192|FG002|Overall Study|PEG/RBV Non-responder|1|||
156380659|NCT01054729|564486193|FG003|Overall Study|PEG/RBV Non-responder|0|||
156380660|NCT01054729|564486190|FG000|Overall Study|Personal/Obligations|0|||
156380661|NCT01054729|564486191|FG001|Overall Study|Personal/Obligations|1|||
156380662|NCT01054729|564486192|FG002|Overall Study|Personal/Obligations|0|||
156380663|NCT01054729|564486193|FG003|Overall Study|Personal/Obligations|0|||
156380664|NCT01054729|564486190|FG000|Overall Study|Subject moved|0|||
156380665|NCT01054729|564486191|FG001|Overall Study|Subject moved|0|||
156380666|NCT01054729|564486192|FG002|Overall Study|Subject moved|1|||
156380667|NCT01054729|564486193|FG003|Overall Study|Subject moved|0|||
156380668|NCT01054729|564486190|FG000|Overall Study|Lack of Efficacy|0|||
156380669|NCT01054729|564486191|FG001|Overall Study|Lack of Efficacy|0|||
156380670|NCT01054729|564486192|FG002|Overall Study|Lack of Efficacy|0|||
156380671|NCT01054729|564486193|FG003|Overall Study|Lack of Efficacy|1|||
156380672|NCT00844194|564486196|FG000|Overall Study|Adverse Event|17|||
156380673|NCT00844194|564486197|FG001|Overall Study|Adverse Event|5|||
156380674|NCT00844194|564486196|FG000|Overall Study|Protocol Violation|1|||
156380675|NCT00844194|564486197|FG001|Overall Study|Protocol Violation|1|||
156380676|NCT00844194|564486196|FG000|Overall Study|Lost to Follow-up|1|||
156380677|NCT00844194|564486197|FG001|Overall Study|Lost to Follow-up|1|||
156380678|NCT00844194|564486196|FG000|Overall Study|Withdrawal by Subject|2|||
156380679|NCT00844194|564486197|FG001|Overall Study|Withdrawal by Subject|1|||
156380680|NCT00844194|564486196|FG000|Overall Study|Lack of Efficacy|3|||
156380681|NCT00844194|564486197|FG001|Overall Study|Lack of Efficacy|0|||
156380682|NCT00844194|564486196|FG000|Overall Study|Other reason (not specified)|1|||
156380683|NCT00844194|564486197|FG001|Overall Study|Other reason (not specified)|0|||
156380684|NCT01992536|564486203|FG000|Overall Study|Administrative Reason|0|||
156380685|NCT01992536|564486204|FG001|Overall Study|Administrative Reason|0|||
156380686|NCT01992536|564486205|FG002|Overall Study|Administrative Reason|0|||
156380687|NCT01992536|564486206|FG003|Overall Study|Administrative Reason|0|||
156380688|NCT01992536|564486207|FG004|Overall Study|Administrative Reason|0|||
156380689|NCT01992536|564486208|FG005|Overall Study|Administrative Reason|0|||
156380690|NCT01992536|564486209|FG006|Overall Study|Administrative Reason|7|||
156380691|NCT01992536|564486210|FG007|Overall Study|Administrative Reason|0|||
156380692|NCT01992536|564486211|FG008|Overall Study|Administrative Reason|0|||
156380693|NCT01992536|564486212|FG009|Overall Study|Administrative Reason|0|||
156380694|NCT01992536|564486203|FG000|Overall Study|Lost to Follow-up|4|||
156380695|NCT01992536|564486204|FG001|Overall Study|Lost to Follow-up|2|||
156380696|NCT01992536|564486205|FG002|Overall Study|Lost to Follow-up|1|||
156380697|NCT01992536|564486206|FG003|Overall Study|Lost to Follow-up|0|||
156380698|NCT01992536|564486207|FG004|Overall Study|Lost to Follow-up|0|||
156380699|NCT01992536|564486208|FG005|Overall Study|Lost to Follow-up|1|||
156380700|NCT01992536|564486209|FG006|Overall Study|Lost to Follow-up|0|||
156380701|NCT01992536|564486210|FG007|Overall Study|Lost to Follow-up|0|||
156380702|NCT01992536|564486211|FG008|Overall Study|Lost to Follow-up|1|||
156380703|NCT01992536|564486212|FG009|Overall Study|Lost to Follow-up|1|||
156380704|NCT01992536|564486203|FG000|Overall Study|Withdrawal by Subject|0|||
156380705|NCT01992536|564486204|FG001|Overall Study|Withdrawal by Subject|1|||
156380706|NCT01992536|564486205|FG002|Overall Study|Withdrawal by Subject|0|||
156380707|NCT01992536|564486206|FG003|Overall Study|Withdrawal by Subject|2|||
156380708|NCT01992536|564486207|FG004|Overall Study|Withdrawal by Subject|0|||
156380709|NCT01992536|564486208|FG005|Overall Study|Withdrawal by Subject|0|||
156380710|NCT01992536|564486209|FG006|Overall Study|Withdrawal by Subject|0|||
156380711|NCT01992536|564486210|FG007|Overall Study|Withdrawal by Subject|0|||
156380712|NCT01992536|564486211|FG008|Overall Study|Withdrawal by Subject|0|||
156380713|NCT01992536|564486212|FG009|Overall Study|Withdrawal by Subject|0|||
156380714|NCT02352493|564486218|FG000|Overall Study|Pregnancy|0|||
156380715|NCT02352493|564486219|FG001|Overall Study|Pregnancy|0|||
156380716|NCT02352493|564486220|FG002|Overall Study|Pregnancy|0|||
156380717|NCT02352493|564486221|FG003|Overall Study|Pregnancy|0|||
156380718|NCT02352493|564486222|FG004|Overall Study|Pregnancy|0|||
156380719|NCT02352493|564486223|FG005|Overall Study|Pregnancy|0|||
156380720|NCT02352493|564486224|FG006|Overall Study|Pregnancy|1|||
156380721|NCT02352493|564486225|FG007|Overall Study|Pregnancy|0|||
156380722|NCT02352493|564486226|FG008|Overall Study|Pregnancy|1|||
156380723|NCT02352493|564486227|FG009|Overall Study|Pregnancy|0|||
156380724|NCT02352493|564486228|FG010|Overall Study|Pregnancy|0|||
156380725|NCT02352493|564486229|FG011|Overall Study|Pregnancy|0|||
156380726|NCT02352493|564486230|FG012|Overall Study|Pregnancy|0|||
156380727|NCT02352493|564486231|FG013|Overall Study|Pregnancy|0|||
156380728|NCT02352493|564486232|FG014|Overall Study|Pregnancy|0|||
156380729|NCT02352493|564486233|FG015|Overall Study|Pregnancy|0|||
156380730|NCT02352493|564486234|FG016|Overall Study|Pregnancy|0|||
156380731|NCT02352493|564486235|FG017|Overall Study|Pregnancy|0|||
156380732|NCT02352493|564486218|FG000|Overall Study|Withdrawal by Subject|0|||
156380733|NCT02352493|564486219|FG001|Overall Study|Withdrawal by Subject|0|||
156380734|NCT02352493|564486220|FG002|Overall Study|Withdrawal by Subject|0|||
156380735|NCT02352493|564486221|FG003|Overall Study|Withdrawal by Subject|0|||
156380736|NCT02352493|564486222|FG004|Overall Study|Withdrawal by Subject|0|||
156380737|NCT02352493|564486223|FG005|Overall Study|Withdrawal by Subject|0|||
156380738|NCT02352493|564486224|FG006|Overall Study|Withdrawal by Subject|0|||
156380739|NCT02352493|564486225|FG007|Overall Study|Withdrawal by Subject|0|||
156380740|NCT02352493|564486226|FG008|Overall Study|Withdrawal by Subject|1|||
156380741|NCT02352493|564486227|FG009|Overall Study|Withdrawal by Subject|0|||
156380742|NCT02352493|564486228|FG010|Overall Study|Withdrawal by Subject|0|||
156380743|NCT02352493|564486229|FG011|Overall Study|Withdrawal by Subject|0|||
156380744|NCT02352493|564486230|FG012|Overall Study|Withdrawal by Subject|0|||
156380745|NCT02352493|564486231|FG013|Overall Study|Withdrawal by Subject|0|||
156380746|NCT02352493|564486232|FG014|Overall Study|Withdrawal by Subject|1|||
156380747|NCT02352493|564486233|FG015|Overall Study|Withdrawal by Subject|0|||
156380748|NCT02352493|564486234|FG016|Overall Study|Withdrawal by Subject|0|||
156380749|NCT02352493|564486235|FG017|Overall Study|Withdrawal by Subject|0|||
156380750|NCT02352493|564486218|FG000|Overall Study|Lost to Follow-up|0|||
156380751|NCT02352493|564486219|FG001|Overall Study|Lost to Follow-up|0|||
156380752|NCT02352493|564486220|FG002|Overall Study|Lost to Follow-up|0|||
156380753|NCT02352493|564486221|FG003|Overall Study|Lost to Follow-up|0|||
156380754|NCT02352493|564486222|FG004|Overall Study|Lost to Follow-up|0|||
156380755|NCT02352493|564486223|FG005|Overall Study|Lost to Follow-up|0|||
156380756|NCT02352493|564486224|FG006|Overall Study|Lost to Follow-up|0|||
156380757|NCT02352493|564486225|FG007|Overall Study|Lost to Follow-up|0|||
156380758|NCT02352493|564486226|FG008|Overall Study|Lost to Follow-up|0|||
156380759|NCT02352493|564486227|FG009|Overall Study|Lost to Follow-up|1|||
156500827|NCT00334542|564926470|FG000|Overall Study|New cancer diagnosis|1|||
156380760|NCT02352493|564486228|FG010|Overall Study|Lost to Follow-up|0|||
156380761|NCT02352493|564486229|FG011|Overall Study|Lost to Follow-up|0|||
156380762|NCT02352493|564486230|FG012|Overall Study|Lost to Follow-up|1|||
156380763|NCT02352493|564486231|FG013|Overall Study|Lost to Follow-up|2|||
156380764|NCT02352493|564486232|FG014|Overall Study|Lost to Follow-up|0|||
156380765|NCT02352493|564486233|FG015|Overall Study|Lost to Follow-up|0|||
156380766|NCT02352493|564486234|FG016|Overall Study|Lost to Follow-up|0|||
156380767|NCT02352493|564486235|FG017|Overall Study|Lost to Follow-up|0|||
156380768|NCT03669081|564486236|FG000|Overall Study|Data could not be validated|1|||
156380769|NCT03669081|564486237|FG001|Overall Study|Data could not be validated|1|||
156380770|NCT00389324|564486238|FG000|Run-In Phase|Adverse Event|1|||
156380771|NCT00389324|564486238|FG000|Run-In Phase|Lost to Follow-up|1|||
156500828|NCT03118050|564926471|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
156500829|NCT03118050|564926472|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
156380772|NCT00389324|564486238|FG000|Run-In Phase|Withdrawal by Subject|1|||
156380773|NCT00389324|564486238|FG000|Subcutaneous Phase|Adverse Event|2|||
156380774|NCT00389324|564486238|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
156380775|NCT00389324|564486238|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
156380776|NCT00389324|564486238|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
156380777|NCT04831736|564486243|FG000|Overall Study|Withdrawal by Subject|0|||
156380778|NCT04831736|564486244|FG001|Overall Study|Withdrawal by Subject|1|||
156380779|NCT00795600|564486245|FG000|Overall Study|Adverse Event|1|||
156380780|NCT00795600|564486246|FG001|Overall Study|Adverse Event|1|||
156380781|NCT00795600|564486245|FG000|Overall Study|Protocol Violation|1|||
156380782|NCT00795600|564486246|FG001|Overall Study|Protocol Violation|2|||
156380783|NCT00795600|564486245|FG000|Overall Study|Withdrawal by Subject|1|||
156380784|NCT00795600|564486246|FG001|Overall Study|Withdrawal by Subject|0|||
156380785|NCT00795600|564486245|FG000|Overall Study|Unclassified|1|||
156380786|NCT00795600|564486246|FG001|Overall Study|Unclassified|1|||
156380787|NCT03936244|564486247|FG000|Overall Study|Lost to Follow-up|5|||
156380788|NCT03936244|564486248|FG001|Overall Study|Lost to Follow-up|1|||
156380789|NCT03936244|564486247|FG000|Overall Study|Physician Decision|7|||
156380790|NCT03936244|564486248|FG001|Overall Study|Physician Decision|3|||
156380791|NCT03551938|564486249|FG000|3-Month Follow Up|Lost to Follow-up|39|||
156380792|NCT03551938|564486250|FG001|3-Month Follow Up|Lost to Follow-up|38|||
156380793|NCT03551938|564486249|FG000|6-Month Follow Up|Lost to Follow-up|46|||
156380794|NCT03551938|564486250|FG001|6-Month Follow Up|Lost to Follow-up|42|||
156380795|NCT03551938|564486249|FG000|9-Month Follow Up|Lost to Follow-up|44|||
156380796|NCT03551938|564486250|FG001|9-Month Follow Up|Lost to Follow-up|43|||
156380797|NCT01233817|564486253|FG000|Overall Study|Lost to Follow-up|1|||
156380798|NCT01233817|564486253|FG000|Overall Study|Withdrawal by Subject|2|||
156380799|NCT02159482|564486254|FG000|Overall Study|Withdrawal by Subject|2|||
156380800|NCT02159482|564486254|FG000|Overall Study|Physician Decision|3|||
156380801|NCT01202773|564486257|FG000|Overall Study|Adverse Event|4|||
156380802|NCT01202773|564486258|FG001|Overall Study|Adverse Event|5|||
156380803|NCT01202773|564486259|FG002|Overall Study|Adverse Event|5|||
156380804|NCT01202773|564486257|FG000|Overall Study|Lack of Efficacy|5|||
156380805|NCT01202773|564486258|FG001|Overall Study|Lack of Efficacy|4|||
156380806|NCT01202773|564486259|FG002|Overall Study|Lack of Efficacy|9|||
156380807|NCT01202773|564486257|FG000|Overall Study|Entry Criteria Not Met|2|||
156380808|NCT01202773|564486258|FG001|Overall Study|Entry Criteria Not Met|0|||
156380809|NCT01202773|564486259|FG002|Overall Study|Entry Criteria Not Met|1|||
156380810|NCT01202773|564486257|FG000|Overall Study|Lost to Follow-up|1|||
156380811|NCT01202773|564486258|FG001|Overall Study|Lost to Follow-up|2|||
156380812|NCT01202773|564486259|FG002|Overall Study|Lost to Follow-up|2|||
156380813|NCT01202773|564486257|FG000|Overall Study|Withdrawal by Subject|13|||
156380814|NCT01202773|564486258|FG001|Overall Study|Withdrawal by Subject|6|||
156380815|NCT01202773|564486259|FG002|Overall Study|Withdrawal by Subject|5|||
156380816|NCT01202773|564486257|FG000|Overall Study|Physician Decision|2|||
156380817|NCT01202773|564486258|FG001|Overall Study|Physician Decision|0|||
156380818|NCT01202773|564486259|FG002|Overall Study|Physician Decision|0|||
156380819|NCT01202773|564486257|FG000|Overall Study|Protocol Violation|11|||
156380820|NCT01202773|564486258|FG001|Overall Study|Protocol Violation|6|||
156380821|NCT01202773|564486259|FG002|Overall Study|Protocol Violation|10|||
156380822|NCT01202773|564486257|FG000|Overall Study|Sponsor Decision|19|||
156380823|NCT01202773|564486258|FG001|Overall Study|Sponsor Decision|20|||
156380824|NCT01202773|564486259|FG002|Overall Study|Sponsor Decision|23|||
156380825|NCT00575588|564486260|FG000|Overall Study|Adverse Event|11|||
156380826|NCT00575588|564486261|FG001|Overall Study|Adverse Event|13|||
156380827|NCT00575588|564486260|FG000|Overall Study|Withdrawal by Subject|27|||
156380828|NCT00575588|564486261|FG001|Overall Study|Withdrawal by Subject|31|||
156380829|NCT00575588|564486260|FG000|Overall Study|Lost to Follow-up|1|||
156380830|NCT00575588|564486261|FG001|Overall Study|Lost to Follow-up|3|||
156380831|NCT00575588|564486260|FG000|Overall Study|Death|4|||
156380832|NCT00575588|564486261|FG001|Overall Study|Death|2|||
156380833|NCT00575588|564486260|FG000|Overall Study|Incorrect enrollment|8|||
156380834|NCT00575588|564486261|FG001|Overall Study|Incorrect enrollment|4|||
156380835|NCT00575588|564486260|FG000|Overall Study|Study specific discontinuation criteria|203|||
156380836|NCT00575588|564486261|FG001|Overall Study|Study specific discontinuation criteria|218|||
156380837|NCT00575588|564486260|FG000|Overall Study|Severe non-compliance to protocol|5|||
156380838|NCT00575588|564486261|FG001|Overall Study|Severe non-compliance to protocol|7|||
156380839|NCT00575588|564486260|FG000|Overall Study|Safety reasons|2|||
156380840|NCT00575588|564486261|FG001|Overall Study|Safety reasons|1|||
156380841|NCT00575588|564486260|FG000|Overall Study|Elevated triglyceride|1|||
156380842|NCT00575588|564486261|FG001|Overall Study|Elevated triglyceride|0|||
156380843|NCT00575588|564486260|FG000|Overall Study|Patient moved|1|||
156380844|NCT00575588|564486261|FG001|Overall Study|Patient moved|3|||
156380845|NCT00575588|564486260|FG000|Overall Study|Impossible to determine HbA1c|0|||
156380846|NCT00575588|564486261|FG001|Overall Study|Impossible to determine HbA1c|1|||
156380847|NCT01430130|564486262|FG000|Overall Study|Lost to Follow-up|1|||
156380848|NCT01430130|564486262|FG000|Overall Study|Infection on Control Side of Incision|1|||
156380849|NCT02828111|564486264|FG000|Overall Study|Withdrawal by Subject|0|||
156380850|NCT02828111|564486265|FG001|Overall Study|Withdrawal by Subject|0|||
156380851|NCT02828111|564486266|FG002|Overall Study|Withdrawal by Subject|2|||
156380852|NCT02828111|564486267|FG003|Overall Study|Withdrawal by Subject|0|||
156380853|NCT02828111|564486268|FG004|Overall Study|Withdrawal by Subject|0|||
156380854|NCT02828111|564486264|FG000|Overall Study|Lost to Follow-up|0|||
156380855|NCT02828111|564486265|FG001|Overall Study|Lost to Follow-up|0|||
156500830|NCT03118050|564926473|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
156500831|NCT03118050|564926474|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
156500832|NCT03118050|564926475|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
156500833|NCT03118050|564926476|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
156500834|NCT03118050|564926477|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
156500835|NCT02125279|564926483|FG000|Overall Study|Lack of Efficacy|2|||
156500836|NCT02125279|564926483|FG000|Overall Study|Withdrawal by Subject|6|||
156500837|NCT02125279|564926483|FG000|Overall Study|Protocol Violation|1|||
156500838|NCT02125279|564926483|FG000|Overall Study|Lost to Follow-up|4|||
156500839|NCT01607879|564926484|FG000|Overall Study|Death|1|||
156500840|NCT01607879|564926485|FG001|Overall Study|Death|0|||
156500841|NCT03845140|564926486|FG000|Overall Study|Participant travelled outside study area|0|||
156500842|NCT03845140|564926487|FG001|Overall Study|Participant travelled outside study area|1|||
156500843|NCT03845140|564926488|FG002|Overall Study|Participant travelled outside study area|0|||
156500844|NCT03845140|564926489|FG003|Overall Study|Participant travelled outside study area|0|||
156500845|NCT03845140|564926490|FG004|Overall Study|Participant travelled outside study area|0|||
156500846|NCT03845140|564926491|FG005|Overall Study|Participant travelled outside study area|0|||
156500847|NCT01592045|564926494|FG000|Overall Study|Disease Progression|1|||
156500848|NCT01592045|564926495|FG001|Overall Study|Disease Progression|1|||
156500849|NCT01592045|564926494|FG000|Overall Study|Adverse Event|1|||
156500850|NCT01592045|564926495|FG001|Overall Study|Adverse Event|1|||
156500851|NCT01592045|564926494|FG000|Overall Study|Withdrawal by Subject|1|||
156500852|NCT01592045|564926495|FG001|Overall Study|Withdrawal by Subject|0|||
156500853|NCT01592045|564926494|FG000|Overall Study|Moved out of country|2|||
156500854|NCT01592045|564926495|FG001|Overall Study|Moved out of country|0|||
156500855|NCT02472145|564926498|FG000|Overall Study|Death|10|||
156500856|NCT02472145|564926499|FG001|Overall Study|Death|101|||
156500857|NCT02472145|564926500|FG002|Overall Study|Death|99|||
156500858|NCT02472145|564926498|FG000|Overall Study|Lost to Follow-up|0|||
156500859|NCT02472145|564926499|FG001|Overall Study|Lost to Follow-up|1|||
156500860|NCT02472145|564926500|FG002|Overall Study|Lost to Follow-up|0|||
156500861|NCT02472145|564926498|FG000|Overall Study|Withdrawal by Subject|0|||
156500862|NCT02472145|564926499|FG001|Overall Study|Withdrawal by Subject|9|||
156500863|NCT02472145|564926500|FG002|Overall Study|Withdrawal by Subject|13|||
156500864|NCT02472145|564926498|FG000|Overall Study|Sponsor decision|0|||
156500865|NCT02472145|564926499|FG001|Overall Study|Sponsor decision|3|||
156500866|NCT02472145|564926500|FG002|Overall Study|Sponsor decision|2|||
156500867|NCT02472145|564926498|FG000|Overall Study|Other|0|||
156500868|NCT02472145|564926499|FG001|Overall Study|Other|45|||
156500869|NCT02472145|564926500|FG002|Overall Study|Other|43|||
156500870|NCT02049515|564926501|FG000|Overall Study|Adverse Event|46|||
156500871|NCT02049515|564926502|FG001|Overall Study|Adverse Event|2|||
156500872|NCT02049515|564926501|FG000|Overall Study|Protocol-specified Disease Progression|23|||
156500873|NCT02049515|564926502|FG001|Overall Study|Protocol-specified Disease Progression|2|||
156500874|NCT02049515|564926501|FG000|Overall Study|Death|6|||
156500875|NCT02049515|564926502|FG001|Overall Study|Death|0|||
156500876|NCT02049515|564926501|FG000|Overall Study|Physician Decision|5|||
156500877|NCT02049515|564926502|FG001|Overall Study|Physician Decision|1|||
156500878|NCT02049515|564926501|FG000|Overall Study|Withdrawal by Subject|3|||
156500879|NCT02049515|564926502|FG001|Overall Study|Withdrawal by Subject|0|||
156500880|NCT02049515|564926501|FG000|Overall Study|Termination of the Study by Sponsor|2|||
156500881|NCT02049515|564926502|FG001|Overall Study|Termination of the Study by Sponsor|0|||
156500882|NCT02049515|564926501|FG000|Overall Study|Protocol Violation|1|||
156500883|NCT02049515|564926502|FG001|Overall Study|Protocol Violation|1|||
156500884|NCT02049515|564926501|FG000|Overall Study|Clinical Deterioration|1|||
156500885|NCT02049515|564926502|FG001|Overall Study|Clinical Deterioration|0|||
156500886|NCT02049515|564926501|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
156500887|NCT02049515|564926502|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
156500888|NCT02049515|564926501|FG000|Overall Study|Treatment Interruption >42 Days|1|||
156500889|NCT02049515|564926502|FG001|Overall Study|Treatment Interruption >42 Days|0|||
156500890|NCT02049515|564926501|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
156500891|NCT02049515|564926502|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
156500892|NCT00224029|564926504|FG000|Overall Study|Lost to Follow-up|1|||
156500893|NCT00224029|564926504|FG000|Overall Study|Withdrawal by Subject|4|||
156500894|NCT00224029|564926504|FG000|Overall Study|Other|1|||
156500895|NCT04016272|564926520|FG000|Overall Study|Withdrawal by Subject|1|||
156500896|NCT04016272|564926521|FG001|Overall Study|Withdrawal by Subject|2|||
156500897|NCT00825305|564926522|FG000|Overall Study|Adverse Event|1|||
156500898|NCT00825305|564926523|FG001|Overall Study|Adverse Event|1|||
156500899|NCT00825305|564926522|FG000|Overall Study|Withdrawal by Subject|6|||
156500900|NCT00825305|564926523|FG001|Overall Study|Withdrawal by Subject|12|||
156500901|NCT00825305|564926522|FG000|Overall Study|Inappropriate inclusion|1|||
156500902|NCT00825305|564926523|FG001|Overall Study|Inappropriate inclusion|0|||
156500903|NCT00825305|564926522|FG000|Overall Study|Protocol Violation|9|||
156500904|NCT00825305|564926523|FG001|Overall Study|Protocol Violation|9|||
156380856|NCT02828111|564486266|FG002|Overall Study|Lost to Follow-up|0|||
156380857|NCT02828111|564486267|FG003|Overall Study|Lost to Follow-up|1|||
156380858|NCT02828111|564486268|FG004|Overall Study|Lost to Follow-up|1|||
156380859|NCT00840970|564486269|FG000|Overall Study|Adverse Event|0|||
156380860|NCT00840970|564486270|FG001|Overall Study|Adverse Event|0|||
156380861|NCT00840970|564486271|FG002|Overall Study|Adverse Event|1|||
156380862|NCT01854827|564486272|FG000|Overall Study|Death|1|||
156380863|NCT02667912|564486273|FG000|Overall Study|Death|3|||
156380864|NCT02667912|564486274|FG001|Overall Study|Death|1|||
156380865|NCT02667912|564486273|FG000|Overall Study|Withdrawal by Subject|1|||
156380866|NCT02667912|564486274|FG001|Overall Study|Withdrawal by Subject|2|||
156380867|NCT02667912|564486273|FG000|Overall Study|Withdrawal by Subject|1|||
156380868|NCT02667912|564486274|FG001|Overall Study|Withdrawal by Subject|0|||
156380869|NCT04443218|564486275|FG000|Overall Study|Exited study for other reasons|9|||
156380870|NCT04443218|564486275|FG000|Overall Study|Withdrawal by Subject|1|||
156380871|NCT04443218|564486275|FG000|Overall Study|Lost to Follow-up|4|||
156380872|NCT04443218|564486275|FG000|Overall Study|Death|19|||
156380873|NCT00534352|564486276|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
156380874|NCT00534352|564486276|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
156380875|NCT00534352|564486276|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
156380876|NCT00534352|564486276|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
156380877|NCT00534352|564486276|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
156380878|NCT00534352|564486276|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
156380879|NCT00833924|564486277|FG000|Overall Study|Death|21|||
156380880|NCT00833924|564486277|FG000|Overall Study|Conversion|2|||
156380881|NCT00833924|564486277|FG000|Overall Study|Lost to Follow-up|2|||
156380882|NCT00833924|564486277|FG000|Overall Study|Withdrawal by Subject|13|||
156380883|NCT00833924|564486277|FG000|Overall Study|In study follow-up|71|||
156380884|NCT04796610|564486282|FG000|Overall Study|Withdrawal by Subject|1|||
156380885|NCT04796610|564486283|FG001|Overall Study|Withdrawal by Subject|0|||
156380886|NCT04796610|564486284|FG002|Overall Study|Withdrawal by Subject|0|||
156380887|NCT04796610|564486285|FG003|Overall Study|Withdrawal by Subject|0|||
156380888|NCT04796610|564486282|FG000|Overall Study|Lost to Follow-up|2|||
156380889|NCT04796610|564486283|FG001|Overall Study|Lost to Follow-up|0|||
156380890|NCT04796610|564486284|FG002|Overall Study|Lost to Follow-up|1|||
156380891|NCT04796610|564486285|FG003|Overall Study|Lost to Follow-up|1|||
156380892|NCT00733824|564486286|FG000|Phase I|Withdrawal by Subject|1|||
156380893|NCT00733824|564486287|FG001|Phase I|Withdrawal by Subject|0|||
156380894|NCT00733824|564486288|FG002|Phase I|Withdrawal by Subject|0|||
156380895|NCT00733824|564486289|FG003|Phase I|Withdrawal by Subject|0|||
156380896|NCT00733824|564486290|FG004|Phase I|Withdrawal by Subject|0|||
156380897|NCT01243944|564486292|FG000|Overall Study|Adverse Event|15|||
156380898|NCT01243944|564486293|FG001|Overall Study|Adverse Event|13|||
156380899|NCT01243944|564486292|FG000|Overall Study|Lost to Follow-up|2|||
156380900|NCT01243944|564486293|FG001|Overall Study|Lost to Follow-up|1|||
156380901|NCT01243944|564486292|FG000|Overall Study|Physician Decision|2|||
156380902|NCT01243944|564486293|FG001|Overall Study|Physician Decision|7|||
156380903|NCT01243944|564486292|FG000|Overall Study|Disease progression|12|||
156380904|NCT01243944|564486293|FG001|Overall Study|Disease progression|11|||
156380905|NCT01243944|564486292|FG000|Overall Study|Protocol deviation|1|||
156380906|NCT01243944|564486293|FG001|Overall Study|Protocol deviation|1|||
156380907|NCT01243944|564486292|FG000|Overall Study|Participant decision|10|||
156380908|NCT01243944|564486293|FG001|Overall Study|Participant decision|15|||
156380909|NCT01243944|564486292|FG000|Overall Study|Death|2|||
156380910|NCT01243944|564486293|FG001|Overall Study|Death|3|||
156380911|NCT01243944|564486292|FG000|Overall Study|Non-compliance with study treatment|1|||
156380912|NCT01243944|564486293|FG001|Overall Study|Non-compliance with study treatment|0|||
156380913|NCT02673697|564486299|FG000|Overall Study|Adverse Event|2|||
156380914|NCT02673697|564486300|FG001|Overall Study|Adverse Event|0|||
156380915|NCT02673697|564486299|FG000|Overall Study|Death|32|||
156380916|NCT02673697|564486300|FG001|Overall Study|Death|24|||
156380917|NCT02673697|564486299|FG000|Overall Study|Lost to Follow-up|5|||
156380918|NCT02673697|564486300|FG001|Overall Study|Lost to Follow-up|2|||
156380919|NCT02673697|564486299|FG000|Overall Study|Physician Decision|2|||
156380920|NCT02673697|564486300|FG001|Overall Study|Physician Decision|1|||
156380921|NCT02673697|564486299|FG000|Overall Study|Withdrawal by Subject|10|||
156380922|NCT02673697|564486300|FG001|Overall Study|Withdrawal by Subject|7|||
156380923|NCT02673697|564486299|FG000|Overall Study|Change subj medical status|1|||
156380924|NCT02673697|564486300|FG001|Overall Study|Change subj medical status|2|||
156380925|NCT02673697|564486299|FG000|Overall Study|Explant|10|||
156380926|NCT02673697|564486300|FG001|Overall Study|Explant|5|||
156380927|NCT02673697|564486299|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
156380928|NCT02673697|564486300|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
156380929|NCT01525082|564486302|FG000|Overall Study|Death|1|||
156380930|NCT03067441|564486304|FG000|Overall Study|Withdrawal by Subject|16|||
156380931|NCT03067441|564486305|FG001|Overall Study|Withdrawal by Subject|34|||
156380932|NCT03067441|564486304|FG000|Overall Study|Lost to Follow-up|7|||
156380933|NCT03067441|564486305|FG001|Overall Study|Lost to Follow-up|5|||
156380934|NCT03067441|564486304|FG000|Overall Study|Adverse Event|7|||
156500905|NCT00825305|564926522|FG000|Overall Study|Can not be classified|0|||
156500906|NCT00825305|564926523|FG001|Overall Study|Can not be classified|1|||
156500907|NCT01850030|564926529|FG000|Overall Study|Adverse Event|64|||
156500908|NCT01850030|564926530|FG001|Overall Study|Adverse Event|82|||
156500909|NCT01850030|564926529|FG000|Overall Study|Lack of Efficacy|3|||
156500910|NCT01850030|564926530|FG001|Overall Study|Lack of Efficacy|1|||
156500911|NCT01850030|564926529|FG000|Overall Study|Lost to Follow-up|5|||
156500912|NCT01850030|564926530|FG001|Overall Study|Lost to Follow-up|5|||
156500913|NCT01850030|564926529|FG000|Overall Study|Withdrawal by Subject|3|||
156500914|NCT01850030|564926530|FG001|Overall Study|Withdrawal by Subject|4|||
156500915|NCT01850030|564926529|FG000|Overall Study|Protocol Violation|24|||
156500916|NCT01850030|564926530|FG001|Overall Study|Protocol Violation|28|||
156500917|NCT01850030|564926529|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
156500918|NCT01850030|564926530|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
156500919|NCT03332784|564926533|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500920|NCT03332784|564926534|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
156500921|NCT03332784|564926535|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500922|NCT03332784|564926536|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500923|NCT03332784|564926537|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500924|NCT03332784|564926538|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500925|NCT03332784|564926539|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500926|NCT03332784|564926540|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500927|NCT03332784|564926541|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500928|NCT03332784|564926542|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500929|NCT03332784|564926543|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500930|NCT03332784|564926544|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500931|NCT03332784|564926545|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500932|NCT03332784|564926546|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500933|NCT03332784|564926547|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
156500934|NCT03332784|564926548|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500935|NCT03332784|564926549|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500936|NCT03332784|564926550|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500937|NCT03332784|564926551|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500938|NCT03332784|564926552|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
156500939|NCT00763451|564926558|FG000|Overall Study|Adverse Event|4|||
156500940|NCT00763451|564926559|FG001|Overall Study|Adverse Event|6|||
156500941|NCT00763451|564926560|FG002|Overall Study|Adverse Event|19|||
156500942|NCT00763451|564926561|FG003|Overall Study|Adverse Event|14|||
156500943|NCT00763451|564926558|FG000|Overall Study|Lack of Efficacy|1|||
156500944|NCT00763451|564926559|FG001|Overall Study|Lack of Efficacy|4|||
156500945|NCT00763451|564926560|FG002|Overall Study|Lack of Efficacy|3|||
156500946|NCT00763451|564926561|FG003|Overall Study|Lack of Efficacy|2|||
156500947|NCT00763451|564926558|FG000|Overall Study|Withdrawal by Subject|1|||
156500948|NCT00763451|564926559|FG001|Overall Study|Withdrawal by Subject|6|||
156500949|NCT00763451|564926560|FG002|Overall Study|Withdrawal by Subject|9|||
156500950|NCT00763451|564926561|FG003|Overall Study|Withdrawal by Subject|7|||
156500951|NCT00763451|564926558|FG000|Overall Study|Protocol Violation|0|||
156500952|NCT00763451|564926559|FG001|Overall Study|Protocol Violation|0|||
156500953|NCT00763451|564926560|FG002|Overall Study|Protocol Violation|1|||
156500954|NCT00763451|564926561|FG003|Overall Study|Protocol Violation|0|||
156500955|NCT00763451|564926558|FG000|Overall Study|Poor Compliance to Protocol|1|||
156500956|NCT00763451|564926559|FG001|Overall Study|Poor Compliance to Protocol|1|||
156500957|NCT00763451|564926560|FG002|Overall Study|Poor Compliance to Protocol|2|||
156500958|NCT00763451|564926561|FG003|Overall Study|Poor Compliance to Protocol|2|||
156500959|NCT00763451|564926558|FG000|Overall Study|Familial and Personal Reasons|5|||
156500960|NCT00763451|564926559|FG001|Overall Study|Familial and Personal Reasons|3|||
156500961|NCT00763451|564926560|FG002|Overall Study|Familial and Personal Reasons|5|||
156500962|NCT00763451|564926561|FG003|Overall Study|Familial and Personal Reasons|4|||
156500963|NCT00763451|564926558|FG000|Overall Study|Randomized but not Treated|1|||
156546855|NCT00440947|565094997|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
156500964|NCT00763451|564926559|FG001|Overall Study|Randomized but not Treated|1|||
156500965|NCT00763451|564926560|FG002|Overall Study|Randomized but not Treated|0|||
156500966|NCT00763451|564926561|FG003|Overall Study|Randomized but not Treated|0|||
156500967|NCT00763451|564926558|FG000|Overall Study|Study Site Reason|0|||
156500968|NCT00763451|564926559|FG001|Overall Study|Study Site Reason|1|||
156500969|NCT00763451|564926560|FG002|Overall Study|Study Site Reason|1|||
156500970|NCT00763451|564926561|FG003|Overall Study|Study Site Reason|1|||
156500971|NCT01827046|564926562|FG000|Overall Study|Lost to Follow-up|1|||
156500972|NCT01827046|564926563|FG001|Overall Study|Lost to Follow-up|5|||
156500973|NCT01827046|564926562|FG000|Overall Study|Withdrawal by Subject|0|||
156500974|NCT01827046|564926563|FG001|Overall Study|Withdrawal by Subject|4|||
156500975|NCT00115336|564926568|FG000|Overall Study|Hospital discharge before study drug|0|||
156500976|NCT00115336|564926569|FG001|Overall Study|Hospital discharge before study drug|1|||
156500977|NCT00715117|564926580|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
156500978|NCT00715117|564926581|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
156500979|NCT02394665|564926587|FG000|Overall Study|Physician Decision|1|||
156500980|NCT02394665|564926588|FG001|Overall Study|Physician Decision|0|||
156500981|NCT02394665|564926589|FG002|Overall Study|Physician Decision|0|||
156500982|NCT03698019|564926590|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
156500983|NCT03698019|564926591|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
156500984|NCT03698019|564926590|FG000|Step 1: Registration|Withdrawal by Subject|7|||
156500985|NCT03698019|564926591|FG001|Step 1: Registration|Withdrawal by Subject|2|||
156500986|NCT03698019|564926590|FG000|Step 1: Registration|Toxicity|0|||
156500987|NCT03698019|564926591|FG001|Step 1: Registration|Toxicity|1|||
156500988|NCT03698019|564926590|FG000|Step 1: Registration|Disease Progression|0|||
156500989|NCT03698019|564926591|FG001|Step 1: Registration|Disease Progression|12|||
156500990|NCT03698019|564926590|FG000|Step 1: Registration|Co-morbidities|0|||
156500991|NCT03698019|564926591|FG001|Step 1: Registration|Co-morbidities|1|||
156500992|NCT03698019|564926590|FG000|Step 1: Registration|Scheduling Issues|1|||
156500993|NCT03698019|564926591|FG001|Step 1: Registration|Scheduling Issues|0|||
156500994|NCT03698019|564926590|FG000|Step 1: Registration|Participant Refusal|0|||
156500995|NCT03698019|564926591|FG001|Step 1: Registration|Participant Refusal|1|||
156500996|NCT03698019|564926590|FG000|Step 2: Surgery|Participant Refusal|2|||
156500997|NCT03698019|564926591|FG001|Step 2: Surgery|Participant Refusal|1|||
156500998|NCT03698019|564926590|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
156500999|NCT03698019|564926591|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
156501000|NCT03698019|564926590|FG000|Step 2: Surgery|Metastatic Disease|16|||
156501001|NCT03698019|564926591|FG001|Step 2: Surgery|Metastatic Disease|9|||
156501002|NCT03698019|564926590|FG000|Step 2: Surgery|Residual Disease|2|||
156501003|NCT03698019|564926591|FG001|Step 2: Surgery|Residual Disease|1|||
156501004|NCT03698019|564926590|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
156501005|NCT03698019|564926591|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
156501006|NCT03698019|564926590|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
156501007|NCT03698019|564926591|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
156501008|NCT03698019|564926590|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
156501009|NCT03698019|564926591|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
156501010|NCT03698019|564926590|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
156501011|NCT03698019|564926591|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
156501012|NCT03698019|564926590|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
156501013|NCT03698019|564926591|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
156380935|NCT03067441|564486305|FG001|Overall Study|Adverse Event|14|||
156380936|NCT03067441|564486304|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
156380937|NCT03067441|564486305|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
156380938|NCT03067441|564486304|FG000|Overall Study|Physician Decision|1|||
156501014|NCT03698019|564926590|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
156501015|NCT03698019|564926591|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
156380939|NCT03067441|564486305|FG001|Overall Study|Physician Decision|3|||
156380940|NCT03067441|564486304|FG000|Overall Study|Other|1|||
156380941|NCT03067441|564486305|FG001|Overall Study|Other|1|||
156501016|NCT03698019|564926590|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
156501017|NCT03698019|564926591|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
156501018|NCT03698019|564926590|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
156501019|NCT03698019|564926591|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
156380942|NCT01985126|564486308|FG000|Overall Study|Death|15|||
156380943|NCT01985126|564486309|FG001|Overall Study|Death|69|||
156380944|NCT01985126|564486308|FG000|Overall Study|Lost to Follow-up|0|||
156380945|NCT01985126|564486309|FG001|Overall Study|Lost to Follow-up|8|||
156380946|NCT01985126|564486308|FG000|Overall Study|Study Terminated By Sponsor|1|||
156380947|NCT01985126|564486309|FG001|Overall Study|Study Terminated By Sponsor|22|||
156380948|NCT01985126|564486308|FG000|Overall Study|Withdrawal by Subject|2|||
156380949|NCT01985126|564486309|FG001|Overall Study|Withdrawal by Subject|7|||
156380950|NCT01785602|564486316|FG000|Overall Study|Withdrawal by Subject|2|||
156380951|NCT01785602|564486317|FG001|Overall Study|Withdrawal by Subject|0|||
156380952|NCT01785602|564486316|FG000|Overall Study|Lost to Follow-up|1|||
156380953|NCT01785602|564486317|FG001|Overall Study|Lost to Follow-up|1|||
156380954|NCT01785602|564486316|FG000|Overall Study|Adverse Event|3|||
156380955|NCT01785602|564486317|FG001|Overall Study|Adverse Event|5|||
156380956|NCT01785602|564486316|FG000|Overall Study|Administrative problems|7|||
156380957|NCT01785602|564486317|FG001|Overall Study|Administrative problems|3|||
156380958|NCT02041429|564486318|FG000|Overall Study|Progressive Disease|2|||
156380959|NCT02041429|564486319|FG001|Overall Study|Progressive Disease|2|||
156380960|NCT02041429|564486320|FG002|Overall Study|Progressive Disease|3|||
156380961|NCT02041429|564486321|FG003|Overall Study|Progressive Disease|2|||
156380962|NCT02041429|564486318|FG000|Overall Study|Toxicity|0|||
156380963|NCT02041429|564486319|FG001|Overall Study|Toxicity|1|||
156380964|NCT02041429|564486320|FG002|Overall Study|Toxicity|4|||
156380965|NCT02041429|564486321|FG003|Overall Study|Toxicity|2|||
156380966|NCT02041429|564486318|FG000|Overall Study|Withdrawal by Subject|0|||
156380967|NCT02041429|564486319|FG001|Overall Study|Withdrawal by Subject|1|||
156380968|NCT02041429|564486320|FG002|Overall Study|Withdrawal by Subject|0|||
156380969|NCT02041429|564486321|FG003|Overall Study|Withdrawal by Subject|0|||
156380970|NCT02041429|564486318|FG000|Overall Study|On Maintenance Therapy|1|||
156380971|NCT02041429|564486319|FG001|Overall Study|On Maintenance Therapy|0|||
156380972|NCT02041429|564486320|FG002|Overall Study|On Maintenance Therapy|0|||
156380973|NCT02041429|564486321|FG003|Overall Study|On Maintenance Therapy|2|||
156380974|NCT03251924|564486322|FG000|Overall Study|Disease Progression|6|||
156380975|NCT03251924|564486323|FG001|Overall Study|Disease Progression|6|||
156380976|NCT03251924|564486324|FG002|Overall Study|Disease Progression|7|||
156380977|NCT03251924|564486325|FG003|Overall Study|Disease Progression|8|||
156380978|NCT03251924|564486326|FG004|Overall Study|Disease Progression|8|||
156380979|NCT03251924|564486327|FG005|Overall Study|Disease Progression|7|||
156380980|NCT03251924|564486328|FG006|Overall Study|Disease Progression|6|||
156380981|NCT03251924|564486329|FG007|Overall Study|Disease Progression|10|||
156380982|NCT03251924|564486330|FG008|Overall Study|Disease Progression|6|||
156380983|NCT03251924|564486322|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
156380984|NCT03251924|564486323|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
156380985|NCT03251924|564486324|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
156380986|NCT03251924|564486325|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
156380987|NCT03251924|564486326|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
156380988|NCT03251924|564486327|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
156380989|NCT03251924|564486328|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
156380990|NCT03251924|564486329|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
156380991|NCT03251924|564486330|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
156380992|NCT03251924|564486322|FG000|Overall Study|Death|0|||
156501020|NCT00569127|564926592|FG000|Overall Study|Adverse Event|57|||
156501021|NCT00569127|564926593|FG001|Overall Study|Adverse Event|47|||
156501022|NCT00569127|564926592|FG000|Overall Study|Withdrawal by Subject|13|||
156380993|NCT03251924|564486323|FG001|Overall Study|Death|1|||
156380994|NCT03251924|564486324|FG002|Overall Study|Death|0|||
156380995|NCT03251924|564486325|FG003|Overall Study|Death|1|||
156501023|NCT00569127|564926593|FG001|Overall Study|Withdrawal by Subject|27|||
156380996|NCT03251924|564486326|FG004|Overall Study|Death|1|||
156380997|NCT03251924|564486327|FG005|Overall Study|Death|1|||
156501024|NCT00569127|564926592|FG000|Overall Study|Progression|99|||
156501025|NCT00569127|564926593|FG001|Overall Study|Progression|100|||
156501026|NCT00569127|564926592|FG000|Overall Study|Death|4|||
156380998|NCT03251924|564486328|FG006|Overall Study|Death|0|||
156380999|NCT03251924|564486329|FG007|Overall Study|Death|0|||
156381000|NCT03251924|564486330|FG008|Overall Study|Death|0|||
156381001|NCT03251924|564486322|FG000|Overall Study|Study Drug Toxicity|0|||
156381002|NCT03251924|564486323|FG001|Overall Study|Study Drug Toxicity|0|||
156381003|NCT03251924|564486324|FG002|Overall Study|Study Drug Toxicity|0|||
156381004|NCT03251924|564486325|FG003|Overall Study|Study Drug Toxicity|1|||
156381005|NCT03251924|564486326|FG004|Overall Study|Study Drug Toxicity|0|||
156501027|NCT00569127|564926593|FG001|Overall Study|Death|3|||
156381006|NCT03251924|564486327|FG005|Overall Study|Study Drug Toxicity|0|||
156381007|NCT03251924|564486328|FG006|Overall Study|Study Drug Toxicity|0|||
156381008|NCT03251924|564486329|FG007|Overall Study|Study Drug Toxicity|0|||
156381009|NCT03251924|564486330|FG008|Overall Study|Study Drug Toxicity|1|||
156381010|NCT03251924|564486322|FG000|Overall Study|Other Reasons|0|||
156381011|NCT03251924|564486323|FG001|Overall Study|Other Reasons|0|||
156381012|NCT03251924|564486324|FG002|Overall Study|Other Reasons|0|||
156381013|NCT03251924|564486325|FG003|Overall Study|Other Reasons|0|||
156381014|NCT03251924|564486326|FG004|Overall Study|Other Reasons|0|||
156381015|NCT03251924|564486327|FG005|Overall Study|Other Reasons|0|||
156381016|NCT03251924|564486328|FG006|Overall Study|Other Reasons|0|||
156381017|NCT03251924|564486329|FG007|Overall Study|Other Reasons|0|||
156381018|NCT03251924|564486330|FG008|Overall Study|Other Reasons|1|||
156381019|NCT03251924|564486322|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156381020|NCT03251924|564486323|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156381021|NCT03251924|564486324|FG002|Overall Study|Participant request to discontinue study treatment|0|||
156381022|NCT03251924|564486325|FG003|Overall Study|Participant request to discontinue study treatment|0|||
156381023|NCT03251924|564486326|FG004|Overall Study|Participant request to discontinue study treatment|0|||
156381024|NCT03251924|564486327|FG005|Overall Study|Participant request to discontinue study treatment|0|||
156381025|NCT03251924|564486328|FG006|Overall Study|Participant request to discontinue study treatment|0|||
156381026|NCT03251924|564486329|FG007|Overall Study|Participant request to discontinue study treatment|1|||
156381027|NCT03251924|564486330|FG008|Overall Study|Participant request to discontinue study treatment|0|||
156381028|NCT00774995|564486334|FG000|Overall Study|Protocol Violation|0|||
156381029|NCT00774995|564486335|FG001|Overall Study|Protocol Violation|0|||
156381030|NCT00774995|564486336|FG002|Overall Study|Protocol Violation|1|||
156381031|NCT00774995|564486337|FG003|Overall Study|Protocol Violation|0|||
156381032|NCT03964454|564486342|FG000|Overall Study|Lost to Follow-up|13|||
156381033|NCT03964454|564486343|FG001|Overall Study|Lost to Follow-up|7|||
156381034|NCT03964454|564486342|FG000|Overall Study|Withdrawal by Subject|4|||
156381035|NCT03964454|564486343|FG001|Overall Study|Withdrawal by Subject|11|||
156381036|NCT02239510|564487875|FG000|Overall Study|Lost to Follow-up|2|||
156381037|NCT02239510|564487876|FG001|Overall Study|Lost to Follow-up|1|||
156381038|NCT00074282|564487880|FG000|Step 1|Adverse Event|32|||
156381039|NCT00074282|564487881|FG001|Step 1|Adverse Event|0|||
156381040|NCT00074282|564487882|FG002|Step 1|Adverse Event|0|||
156381041|NCT00074282|564487880|FG000|Step 1|Death|6|||
156381042|NCT00074282|564487881|FG001|Step 1|Death|0|||
156381043|NCT00074282|564487882|FG002|Step 1|Death|0|||
156381044|NCT00074282|564487880|FG000|Step 1|Withdrawal by Subject|7|||
156381045|NCT00074282|564487881|FG001|Step 1|Withdrawal by Subject|0|||
156381046|NCT00074282|564487882|FG002|Step 1|Withdrawal by Subject|0|||
156381047|NCT00074282|564487880|FG000|Step 1|Disease progression|2|||
156381048|NCT00074282|564487881|FG001|Step 1|Disease progression|0|||
156381049|NCT00074282|564487882|FG002|Step 1|Disease progression|0|||
156381050|NCT00074282|564487880|FG000|Step 1|Alternative therapy|2|||
156381051|NCT00074282|564487881|FG001|Step 1|Alternative therapy|0|||
156381052|NCT00074282|564487882|FG002|Step 1|Alternative therapy|0|||
156381053|NCT00074282|564487880|FG000|Step 1|Other complicating disease|2|||
156381054|NCT00074282|564487881|FG001|Step 1|Other complicating disease|0|||
156381055|NCT00074282|564487882|FG002|Step 1|Other complicating disease|0|||
156381056|NCT00074282|564487880|FG000|Step 1|Physician Decision|1|||
156381057|NCT00074282|564487881|FG001|Step 1|Physician Decision|0|||
156381058|NCT00074282|564487882|FG002|Step 1|Physician Decision|0|||
156381059|NCT00074282|564487880|FG000|Step 1|Ineligible|4|||
156381060|NCT00074282|564487881|FG001|Step 1|Ineligible|0|||
156381061|NCT00074282|564487882|FG002|Step 1|Ineligible|0|||
156381062|NCT00074282|564487880|FG000|Step 1|Never started treatment|2|||
156381063|NCT00074282|564487881|FG001|Step 1|Never started treatment|0|||
156381064|NCT00074282|564487882|FG002|Step 1|Never started treatment|0|||
156381065|NCT00074282|564487880|FG000|Step 2|Adverse Event|0|||
156381066|NCT00074282|564487881|FG001|Step 2|Adverse Event|2|||
156381067|NCT00074282|564487882|FG002|Step 2|Adverse Event|12|||
156381068|NCT00074282|564487880|FG000|Step 2|Disease progression|0|||
156381069|NCT00074282|564487881|FG001|Step 2|Disease progression|0|||
156381070|NCT00074282|564487882|FG002|Step 2|Disease progression|5|||
156381071|NCT00074282|564487880|FG000|Step 2|Death|0|||
156381072|NCT00074282|564487881|FG001|Step 2|Death|0|||
156381073|NCT00074282|564487882|FG002|Step 2|Death|3|||
156381074|NCT00074282|564487880|FG000|Step 2|Withdrawal by Subject|0|||
156381075|NCT00074282|564487881|FG001|Step 2|Withdrawal by Subject|0|||
156381076|NCT00074282|564487882|FG002|Step 2|Withdrawal by Subject|2|||
156381077|NCT00074282|564487880|FG000|Step 2|Physician Decision|0|||
156381078|NCT00074282|564487881|FG001|Step 2|Physician Decision|0|||
156381079|NCT00074282|564487882|FG002|Step 2|Physician Decision|1|||
156381080|NCT00074282|564487880|FG000|Step 2|Ineligible|0|||
156381081|NCT00074282|564487881|FG001|Step 2|Ineligible|0|||
156381082|NCT00074282|564487882|FG002|Step 2|Ineligible|1|||
156381083|NCT00464542|564487883|FG000|Pre-treatment|Withdrawal by Subject|2|||
156381084|NCT02105116|564487887|FG000|Overall Study|not eligible for step 2 of trial|5|||
156381085|NCT02105116|564487887|FG000|Overall Study|Death|1|||
156381086|NCT05706506|564487888|FG000|Overall Study|Adverse Event|1|||
156381087|NCT05706506|564487888|FG000|Overall Study|Withdrawal by Subject|4|||
156381088|NCT05706506|564487888|FG000|Overall Study|Lost to Follow-up|2|||
156381089|NCT05706506|564487888|FG000|Overall Study|Inadvertent Enrolment|12|||
156381090|NCT05706506|564487888|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
156381091|NCT05706506|564487888|FG000|Overall Study|Participant Moved Out of State|1|||
156381092|NCT01075321|564487892|FG000|Overall Study|Withdrawal by Subject|0|||
156381093|NCT01075321|564487893|FG001|Overall Study|Withdrawal by Subject|0|||
156381094|NCT01075321|564487894|FG002|Overall Study|Withdrawal by Subject|1|||
156381095|NCT01075321|564487895|FG003|Overall Study|Withdrawal by Subject|1|||
156381096|NCT01075321|564487892|FG000|Overall Study|Protocol Violation|0|||
156381097|NCT01075321|564487893|FG001|Overall Study|Protocol Violation|0|||
156381098|NCT01075321|564487894|FG002|Overall Study|Protocol Violation|1|||
156381099|NCT01075321|564487895|FG003|Overall Study|Protocol Violation|0|||
156381100|NCT01075321|564487892|FG000|Overall Study|Treatment Incomplete due to progression|1|||
156381101|NCT01075321|564487893|FG001|Overall Study|Treatment Incomplete due to progression|0|||
156381102|NCT01075321|564487894|FG002|Overall Study|Treatment Incomplete due to progression|0|||
156381103|NCT01075321|564487895|FG003|Overall Study|Treatment Incomplete due to progression|0|||
156381104|NCT01075321|564487892|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
156381105|NCT01075321|564487893|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
156381106|NCT01075321|564487894|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
156381107|NCT01075321|564487895|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
156381108|NCT02246998|564487896|FG000|Overall Study|Adverse Event|0|||
156381109|NCT02246998|564487897|FG001|Overall Study|Adverse Event|1|||
156381110|NCT02246998|564487898|FG002|Overall Study|Adverse Event|1|||
156381111|NCT02246998|564487899|FG003|Overall Study|Adverse Event|0|||
156381112|NCT02246998|564487896|FG000|Overall Study|Lost to Follow-up|1|||
156381113|NCT02246998|564487897|FG001|Overall Study|Lost to Follow-up|0|||
156381114|NCT02246998|564487898|FG002|Overall Study|Lost to Follow-up|0|||
156381115|NCT02246998|564487899|FG003|Overall Study|Lost to Follow-up|1|||
156381116|NCT02246998|564487896|FG000|Overall Study|Randomized but Never Dosed|1|||
156381117|NCT02246998|564487897|FG001|Overall Study|Randomized but Never Dosed|2|||
156381118|NCT02246998|564487898|FG002|Overall Study|Randomized but Never Dosed|2|||
156381119|NCT02246998|564487899|FG003|Overall Study|Randomized but Never Dosed|1|||
156381120|NCT01303627|564487900|FG000|Overall Study|the failure while performing URS|0|||
156381121|NCT01303627|564487901|FG001|Overall Study|the failure while performing URS|1|||
156381122|NCT00321919|564487903|FG000|Overall Study|Adverse Event|17|||
156381123|NCT00321919|564487904|FG001|Overall Study|Adverse Event|10|||
156381124|NCT00321919|564487903|FG000|Overall Study|Death|21|||
156381125|NCT00321919|564487904|FG001|Overall Study|Death|17|||
156381126|NCT00321919|564487903|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156381127|NCT00321919|564487904|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156381128|NCT00321919|564487903|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
156381129|NCT00321919|564487904|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156381130|NCT00321919|564487903|FG000|Overall Study|Refused Treatment|23|||
156381131|NCT00321919|564487904|FG001|Overall Study|Refused Treatment|14|||
156381132|NCT00321919|564487903|FG000|Overall Study|Other Protocol Violation|2|||
156381133|NCT00321919|564487904|FG001|Overall Study|Other Protocol Violation|3|||
156381134|NCT00321919|564487903|FG000|Overall Study|Failure to Return|3|||
156381135|NCT00321919|564487904|FG001|Overall Study|Failure to Return|1|||
156381136|NCT00321919|564487903|FG000|Overall Study|Other withdrawal reason|7|||
156381137|NCT00321919|564487904|FG001|Overall Study|Other withdrawal reason|6|||
156381138|NCT02590354|564487905|FG000|Phase 1|Active hepatitis B or C infection|1|||
156381139|NCT02590354|564487905|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
156381140|NCT02590354|564487905|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
156381141|NCT02590354|564487905|FG000|Phase 1|Subject does not want to participate|20|||
156381142|NCT02590354|564487905|FG000|Phase 1|Lost to Follow-up|1|||
156381143|NCT02590354|564487905|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
156381144|NCT00996996|564487906|FG000|Overall Study|Progressive Disease|10|||
156381145|NCT00996996|564487906|FG000|Overall Study|Non-compliance|8|||
156381146|NCT00996996|564487906|FG000|Overall Study|Lost to Follow-up|9|||
156381147|NCT00996996|564487906|FG000|Overall Study|Death|5|||
156381148|NCT00996996|564487906|FG000|Overall Study|Did Not Receive Study Medications|1|||
156381149|NCT02019719|564487907|FG000|Overall Study|Adverse Event|1|||
156381150|NCT02019719|564487908|FG001|Overall Study|Adverse Event|0|||
156381151|NCT02019719|564487909|FG002|Overall Study|Adverse Event|0|||
156381152|NCT02019719|564487910|FG003|Overall Study|Adverse Event|1|||
156381153|NCT02019719|564487911|FG004|Overall Study|Adverse Event|1|||
156381154|NCT02019719|564487907|FG000|Overall Study|Protocol Violation|1|||
156381155|NCT02019719|564487908|FG001|Overall Study|Protocol Violation|1|||
156381156|NCT02019719|564487909|FG002|Overall Study|Protocol Violation|0|||
156381157|NCT02019719|564487910|FG003|Overall Study|Protocol Violation|0|||
156381158|NCT02019719|564487911|FG004|Overall Study|Protocol Violation|0|||
156381159|NCT02019719|564487907|FG000|Overall Study|Protocol defined stopping criteria|2|||
156381160|NCT02019719|564487908|FG001|Overall Study|Protocol defined stopping criteria|0|||
156381161|NCT02019719|564487909|FG002|Overall Study|Protocol defined stopping criteria|0|||
156501028|NCT00569127|564926592|FG000|Overall Study|Other|20|||
156501029|NCT00569127|564926593|FG001|Overall Study|Other|19|||
156501030|NCT00569127|564926592|FG000|Overall Study|Lost to Follow-up|0|||
156501031|NCT00569127|564926593|FG001|Overall Study|Lost to Follow-up|3|||
156501032|NCT00569127|564926592|FG000|Overall Study|Not Eligible|14|||
156501033|NCT00569127|564926593|FG001|Overall Study|Not Eligible|11|||
156501034|NCT00569127|564926592|FG000|Overall Study|Still on Treatment|7|||
156501035|NCT00569127|564926593|FG001|Overall Study|Still on Treatment|3|||
156501036|NCT03149029|564926608|FG000|Overall Study|Adverse Event|2|||
156501037|NCT03149029|564926609|FG001|Overall Study|Adverse Event|0|||
156501038|NCT02037256|564926616|FG000|Overall Study|Protocol Violation|0|||
156501039|NCT02037256|564926617|FG001|Overall Study|Protocol Violation|1|||
156501040|NCT02037256|564926616|FG000|Overall Study|Withdrawn prior to Velcade|0|||
156501041|NCT02037256|564926617|FG001|Overall Study|Withdrawn prior to Velcade|2|||
156501042|NCT03007732|564926618|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
156381162|NCT02019719|564487910|FG003|Overall Study|Protocol defined stopping criteria|1|||
156381163|NCT02019719|564487911|FG004|Overall Study|Protocol defined stopping criteria|1|||
156381164|NCT02019719|564487907|FG000|Overall Study|Physician Decision|2|||
156381165|NCT02019719|564487908|FG001|Overall Study|Physician Decision|0|||
156381166|NCT02019719|564487909|FG002|Overall Study|Physician Decision|0|||
156381167|NCT02019719|564487910|FG003|Overall Study|Physician Decision|0|||
156381168|NCT02019719|564487911|FG004|Overall Study|Physician Decision|0|||
156381169|NCT01055639|564487913|FG000|Overall Study|Adverse Event|0|||
156381170|NCT01055639|564487914|FG001|Overall Study|Adverse Event|1|||
156381171|NCT01055639|564487913|FG000|Overall Study|Lack of Efficacy|0|||
156381172|NCT01055639|564487914|FG001|Overall Study|Lack of Efficacy|1|||
156381173|NCT01055639|564487913|FG000|Overall Study|Lost to Follow-up|8|||
156381174|NCT01055639|564487914|FG001|Overall Study|Lost to Follow-up|11|||
156381175|NCT01055639|564487913|FG000|Overall Study|Protocol Violation|5|||
156381176|NCT01055639|564487914|FG001|Overall Study|Protocol Violation|5|||
156381177|NCT01055639|564487913|FG000|Overall Study|Withdrawal by Subject|8|||
156381178|NCT01055639|564487914|FG001|Overall Study|Withdrawal by Subject|11|||
156381179|NCT01921348|564487918|FG000|Overall Study|Withdrawal by Subject|1|||
156381180|NCT01921348|564487919|FG001|Overall Study|Withdrawal by Subject|0|||
156381181|NCT01921348|564487918|FG000|Overall Study|Lost to Follow-up|0|||
156381182|NCT01921348|564487919|FG001|Overall Study|Lost to Follow-up|2|||
156381183|NCT02223390|564487920|FG000|Overall Study|Lost to Follow-up|9|||
156381184|NCT02223390|564487921|FG001|Overall Study|Lost to Follow-up|4|||
156381185|NCT02896855|564487923|FG000|Overall Study|Death|50|||
156381186|NCT02896855|564487924|FG001|Overall Study|Death|40|||
156381187|NCT02896855|564487923|FG000|Overall Study|Lost to Follow-up|15|||
156381188|NCT02896855|564487924|FG001|Overall Study|Lost to Follow-up|9|||
156381189|NCT02896855|564487923|FG000|Overall Study|Withdrawal by Subject|7|||
156381190|NCT02896855|564487924|FG001|Overall Study|Withdrawal by Subject|4|||
156381191|NCT02169674|564487925|FG000|Overall Study|Withdrawal by Subject|2|||
156381192|NCT02169674|564487926|FG001|Overall Study|Withdrawal by Subject|1|||
156381193|NCT02169674|564487925|FG000|Overall Study|Seroprotected|30|||
156381194|NCT02169674|564487926|FG001|Overall Study|Seroprotected|76|||
156381195|NCT02169674|564487925|FG000|Overall Study|Lost to Follow-up|0|||
156381196|NCT02169674|564487926|FG001|Overall Study|Lost to Follow-up|1|||
156381197|NCT03525834|564487927|FG000|Overall Study|Progressive disease|1|||
156381198|NCT00504829|564487930|FG000|Overall Study|Protocol Violation|6|||
156381199|NCT00504829|564487931|FG001|Overall Study|Protocol Violation|4|||
156381200|NCT00504829|564487932|FG002|Overall Study|Protocol Violation|10|||
156381201|NCT01131312|564487933|FG000|Overall Study|Lost to Follow-up|425|||
156381202|NCT01131312|564487934|FG001|Overall Study|Lost to Follow-up|229|||
156381203|NCT01131312|564487935|FG002|Overall Study|Lost to Follow-up|351|||
156381204|NCT02660944|564487940|FG000|Overall Study|Adverse Event|3|||
156381205|NCT02660944|564487941|FG001|Overall Study|Adverse Event|4|||
156381206|NCT02660944|564487940|FG000|Overall Study|Physician Decision|3|||
156381207|NCT02660944|564487941|FG001|Overall Study|Physician Decision|1|||
156381208|NCT02660944|564487940|FG000|Overall Study|Withdrawal by Subject|5|||
156381209|NCT02660944|564487941|FG001|Overall Study|Withdrawal by Subject|3|||
156381210|NCT02660944|564487940|FG000|Overall Study|Lost to Follow-up|4|||
156381211|NCT02660944|564487941|FG001|Overall Study|Lost to Follow-up|1|||
156381212|NCT02660944|564487940|FG000|Overall Study|Subject schedule|0|||
156381213|NCT02660944|564487941|FG001|Overall Study|Subject schedule|1|||
156381214|NCT02660944|564487940|FG000|Overall Study|Exclusion criteria met|2|||
156381215|NCT02660944|564487941|FG001|Overall Study|Exclusion criteria met|0|||
156381216|NCT02843568|564487942|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
156381217|NCT02843568|564487943|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
156381218|NCT02843568|564487942|FG000|Overall Study|Death|3|||
156546856|NCT00440947|565094998|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
156381219|NCT02843568|564487943|FG001|Overall Study|Death|3|||
156381220|NCT02843568|564487942|FG000|Overall Study|Withdrawal by Subject|1|||
156381221|NCT02843568|564487943|FG001|Overall Study|Withdrawal by Subject|1|||
156381222|NCT02843568|564487942|FG000|Overall Study|Lost to Follow-up|2|||
156381223|NCT02843568|564487943|FG001|Overall Study|Lost to Follow-up|0|||
156381224|NCT03586999|564487944|FG000|Overall Study|Lack of Efficacy|2|||
156381225|NCT03447769|564487945|FG000|Overall Study|Progressive disease|138|||
156381226|NCT03447769|564487946|FG001|Overall Study|Progressive disease|148|||
156381227|NCT03447769|564487945|FG000|Overall Study|Study terminated by Sponsor|60|||
156381228|NCT03447769|564487946|FG001|Overall Study|Study terminated by Sponsor|44|||
156381229|NCT03447769|564487945|FG000|Overall Study|Adverse Event|34|||
156381230|NCT03447769|564487946|FG001|Overall Study|Adverse Event|31|||
156381231|NCT03447769|564487945|FG000|Overall Study|Patient decision|27|||
156381232|NCT03447769|564487946|FG001|Overall Study|Patient decision|27|||
156381233|NCT03447769|564487945|FG000|Overall Study|Protocol deviation|4|||
156381234|NCT03447769|564487946|FG001|Overall Study|Protocol deviation|6|||
156381235|NCT03447769|564487945|FG000|Overall Study|Death|2|||
156381236|NCT03447769|564487946|FG001|Overall Study|Death|7|||
156546857|NCT00440947|565094999|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
156381237|NCT03447769|564487945|FG000|Overall Study|Technical problems|1|||
156381238|NCT03447769|564487946|FG001|Overall Study|Technical problems|0|||
156381239|NCT03447769|564487945|FG000|Overall Study|Lost to Follow-up|0|||
156381240|NCT03447769|564487946|FG001|Overall Study|Lost to Follow-up|1|||
156381241|NCT03447769|564487945|FG000|Overall Study|Physician Decision|13|||
156381242|NCT03447769|564487946|FG001|Overall Study|Physician Decision|5|||
156381243|NCT03264989|564487951|FG000|Overall Study|Lost to Follow-up|1|||
156381244|NCT03264989|564487952|FG001|Overall Study|Lost to Follow-up|0|||
156381245|NCT03264989|564487951|FG000|Overall Study|New Therapy for study Indication|1|||
156381246|NCT03264989|564487952|FG001|Overall Study|New Therapy for study Indication|0|||
156381247|NCT03264989|564487951|FG000|Overall Study|Protocol Violation|0|||
156381248|NCT03264989|564487952|FG001|Overall Study|Protocol Violation|1|||
156381249|NCT03264989|564487951|FG000|Overall Study|Patient decision|13|||
156381250|NCT03264989|564487952|FG001|Overall Study|Patient decision|0|||
156381251|NCT03264989|564487951|FG000|Overall Study|Physician Decision|6|||
156381252|NCT03264989|564487952|FG001|Overall Study|Physician Decision|4|||
156381253|NCT03264989|564487951|FG000|Overall Study|Adverse Event|2|||
156381254|NCT03264989|564487952|FG001|Overall Study|Adverse Event|1|||
156381255|NCT03264989|564487951|FG000|Overall Study|Death|1|||
156381256|NCT03264989|564487952|FG001|Overall Study|Death|1|||
156381257|NCT03264989|564487951|FG000|Overall Study|Pregnancy|2|||
156381258|NCT03264989|564487952|FG001|Overall Study|Pregnancy|0|||
156381259|NCT03264989|564487951|FG000|Overall Study|End of Study|19|||
156381260|NCT03264989|564487952|FG001|Overall Study|End of Study|5|||
156381261|NCT00797667|564487958|FG000|Overall Study|Lack of Efficacy|0|||
156381262|NCT00797667|564487959|FG001|Overall Study|Lack of Efficacy|1|||
156381263|NCT00797667|564487960|FG002|Overall Study|Lack of Efficacy|0|||
156381264|NCT00797667|564487958|FG000|Overall Study|Lost to Follow-up|8|||
156381265|NCT00797667|564487959|FG001|Overall Study|Lost to Follow-up|12|||
156381266|NCT00797667|564487960|FG002|Overall Study|Lost to Follow-up|2|||
156381267|NCT00797667|564487958|FG000|Overall Study|Physician Decision|3|||
156381268|NCT00797667|564487959|FG001|Overall Study|Physician Decision|1|||
156381269|NCT00797667|564487960|FG002|Overall Study|Physician Decision|0|||
156381270|NCT00797667|564487958|FG000|Overall Study|Pregnancy|2|||
156381271|NCT00797667|564487959|FG001|Overall Study|Pregnancy|0|||
156381272|NCT00797667|564487960|FG002|Overall Study|Pregnancy|0|||
156381273|NCT00797667|564487958|FG000|Overall Study|Protocol Violation|2|||
156381274|NCT00797667|564487959|FG001|Overall Study|Protocol Violation|7|||
156381275|NCT00797667|564487960|FG002|Overall Study|Protocol Violation|0|||
156381276|NCT00797667|564487958|FG000|Overall Study|Study Terminated by Sponsor|217|||
156381277|NCT00797667|564487959|FG001|Overall Study|Study Terminated by Sponsor|216|||
156381278|NCT00797667|564487960|FG002|Overall Study|Study Terminated by Sponsor|115|||
156381279|NCT00797667|564487958|FG000|Overall Study|Withdrawal by Subject|9|||
156381280|NCT00797667|564487959|FG001|Overall Study|Withdrawal by Subject|14|||
156381281|NCT00797667|564487960|FG002|Overall Study|Withdrawal by Subject|2|||
156381282|NCT00797667|564487958|FG000|Overall Study|Adverse Event|19|||
156381283|NCT00797667|564487959|FG001|Overall Study|Adverse Event|8|||
156381284|NCT00797667|564487960|FG002|Overall Study|Adverse Event|8|||
156381285|NCT01986829|564487965|FG000|Overall Study|Death|1|||
156381286|NCT02059148|564487966|FG000|Treatment 1|Protocol Violation|0|||
156381287|NCT02059148|564487967|FG001|Treatment 1|Protocol Violation|0|||
156381288|NCT02059148|564487968|FG002|Treatment 1|Protocol Violation|0|||
156381289|NCT02059148|564487969|FG003|Treatment 1|Protocol Violation|0|||
156381290|NCT02059148|564487970|FG004|Treatment 1|Protocol Violation|0|||
156381291|NCT02059148|564487971|FG005|Treatment 1|Protocol Violation|1|||
156381292|NCT00437489|564487972|FG000|Overall Study|Study terminated by sponsor|23|||
156381293|NCT00437489|564487973|FG001|Overall Study|Study terminated by sponsor|21|||
156381294|NCT00437489|564487972|FG000|Overall Study|Lost to Follow-up|0|||
156381295|NCT00437489|564487973|FG001|Overall Study|Lost to Follow-up|1|||
156381296|NCT03321981|564487980|FG000|Overall Study|Progressive Disease (PD)|15|||
156381297|NCT03321981|564487981|FG001|Overall Study|Progressive Disease (PD)|30|||
156381298|NCT03321981|564487982|FG002|Overall Study|Progressive Disease (PD)|47|||
156381299|NCT03321981|564487980|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
156381300|NCT03321981|564487981|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
156381301|NCT03321981|564487982|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
156381302|NCT03321981|564487980|FG000|Overall Study|Adverse Event|0|||
156381303|NCT03321981|564487981|FG001|Overall Study|Adverse Event|0|||
156381304|NCT03321981|564487982|FG002|Overall Study|Adverse Event|2|||
156381305|NCT03321981|564487980|FG000|Overall Study|symptomatic deterioration|0|||
156381306|NCT03321981|564487981|FG001|Overall Study|symptomatic deterioration|1|||
156381307|NCT03321981|564487982|FG002|Overall Study|symptomatic deterioration|1|||
156381308|NCT03321981|564487980|FG000|Overall Study|Lack of compliance|0|||
156381309|NCT03321981|564487981|FG001|Overall Study|Lack of compliance|1|||
156381310|NCT03321981|564487982|FG002|Overall Study|Lack of compliance|0|||
156381311|NCT03321981|564487980|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
156381312|NCT03321981|564487981|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
156381313|NCT03321981|564487982|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
156381314|NCT03321981|564487980|FG000|Overall Study|Death|0|||
156381315|NCT03321981|564487981|FG001|Overall Study|Death|1|||
156381316|NCT03321981|564487982|FG002|Overall Study|Death|0|||
156381317|NCT03321981|564487980|FG000|Overall Study|Subject withdrawal of investigational product|0|||
156381318|NCT03321981|564487981|FG001|Overall Study|Subject withdrawal of investigational product|1|||
156381319|NCT03321981|564487982|FG002|Overall Study|Subject withdrawal of investigational product|0|||
156381320|NCT03321981|564487980|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
156381321|NCT03321981|564487981|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
156381322|NCT03321981|564487982|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
156381323|NCT03321981|564487980|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
156381324|NCT03321981|564487981|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
156381325|NCT03321981|564487982|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
156381326|NCT00022516|564487990|FG000|Overall Study|Adverse Event|0|||
156381327|NCT00022516|564487991|FG001|Overall Study|Adverse Event|59|||
156381328|NCT00022516|564487990|FG000|Overall Study|Lack of Efficacy|0|||
156381329|NCT00022516|564487991|FG001|Overall Study|Lack of Efficacy|27|||
156381330|NCT00022516|564487990|FG000|Overall Study|Physician Decision|0|||
156381331|NCT00022516|564487991|FG001|Overall Study|Physician Decision|1|||
156381332|NCT00022516|564487990|FG000|Overall Study|Protocol Violation|1|||
156381333|NCT00022516|564487991|FG001|Overall Study|Protocol Violation|3|||
156381334|NCT00022516|564487990|FG000|Overall Study|Withdrawal by Subject|2|||
156381335|NCT00022516|564487991|FG001|Overall Study|Withdrawal by Subject|113|||
156381336|NCT00022516|564487990|FG000|Overall Study|Incomplete documentation|0|||
156381337|NCT00022516|564487991|FG001|Overall Study|Incomplete documentation|27|||
156381338|NCT01568047|564487993|FG000|Overall Study|Ineligibility|1|||
156381339|NCT01568047|564487994|FG001|Overall Study|Ineligibility|0|||
156381340|NCT01568047|564487995|FG002|Overall Study|Ineligibility|0|||
156381341|NCT01568047|564487996|FG003|Overall Study|Ineligibility|0|||
156381342|NCT01568047|564487993|FG000|Overall Study|Withdrawal by Subject|0|||
156381343|NCT01568047|564487994|FG001|Overall Study|Withdrawal by Subject|1|||
156381344|NCT01568047|564487995|FG002|Overall Study|Withdrawal by Subject|0|||
156381345|NCT01568047|564487996|FG003|Overall Study|Withdrawal by Subject|0|||
156381346|NCT01568047|564487993|FG000|Overall Study|Adverse Event|0|||
156381347|NCT01568047|564487994|FG001|Overall Study|Adverse Event|0|||
156381348|NCT01568047|564487995|FG002|Overall Study|Adverse Event|1|||
156381349|NCT01568047|564487996|FG003|Overall Study|Adverse Event|1|||
156381350|NCT03783923|564487997|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
156381351|NCT03783923|564487998|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
156381352|NCT03783923|564487997|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
156381353|NCT03783923|564487998|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
156381354|NCT03783923|564487997|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
156381355|NCT03783923|564487998|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
156381356|NCT03783923|564487997|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
156381357|NCT03783923|564487998|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
156381358|NCT03783923|564487997|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
156381359|NCT03783923|564487998|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
156381360|NCT02209324|564488011|FG000|Overall Study|Adverse Event|2|||
156381361|NCT02209324|564488011|FG000|Overall Study|Lack of Efficacy|1|||
156381362|NCT02209324|564488011|FG000|Overall Study|Lost to Follow-up|1|||
156381363|NCT02209324|564488011|FG000|Overall Study|Physician Decision|3|||
156381364|NCT02209324|564488011|FG000|Overall Study|Protocol Violation|14|||
156381365|NCT02209324|564488011|FG000|Overall Study|Withdrawal by Subject|8|||
156381366|NCT02209324|564488011|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
156381367|NCT02209324|564488011|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
156381368|NCT02209324|564488011|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
156381369|NCT04177108|564488015|FG000|Overall Study|Withdrawal by Subject|4|||
156381370|NCT04177108|564488016|FG001|Overall Study|Withdrawal by Subject|8|||
156381371|NCT04177108|564488017|FG002|Overall Study|Withdrawal by Subject|9|||
156381372|NCT04177108|564488018|FG003|Overall Study|Withdrawal by Subject|11|||
156501043|NCT03007732|564926619|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
156501044|NCT03007732|564926620|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
156501045|NCT03007732|564926621|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
156501046|NCT02386839|564926623|FG000|Overall Study|Death|1|||
156381373|NCT04177108|564488019|FG004|Overall Study|Withdrawal by Subject|13|||
156381374|NCT04177108|564488015|FG000|Overall Study|Physician Decision|23|||
156381375|NCT04177108|564488016|FG001|Overall Study|Physician Decision|15|||
156381376|NCT04177108|564488017|FG002|Overall Study|Physician Decision|18|||
156381377|NCT04177108|564488018|FG003|Overall Study|Physician Decision|29|||
156381378|NCT04177108|564488019|FG004|Overall Study|Physician Decision|23|||
156381379|NCT04177108|564488015|FG000|Overall Study|Reason Not Specified|0|||
156381380|NCT04177108|564488016|FG001|Overall Study|Reason Not Specified|1|||
156381381|NCT04177108|564488017|FG002|Overall Study|Reason Not Specified|0|||
156381382|NCT04177108|564488018|FG003|Overall Study|Reason Not Specified|0|||
156381383|NCT04177108|564488019|FG004|Overall Study|Reason Not Specified|2|||
156381384|NCT04177108|564488015|FG000|Overall Study|Lost to Follow-up|0|||
156381385|NCT04177108|564488016|FG001|Overall Study|Lost to Follow-up|0|||
156381386|NCT04177108|564488017|FG002|Overall Study|Lost to Follow-up|1|||
156381387|NCT04177108|564488018|FG003|Overall Study|Lost to Follow-up|1|||
156381388|NCT04177108|564488019|FG004|Overall Study|Lost to Follow-up|1|||
156381389|NCT04177108|564488015|FG000|Overall Study|Death|16|||
156381390|NCT04177108|564488016|FG001|Overall Study|Death|19|||
156381391|NCT04177108|564488017|FG002|Overall Study|Death|13|||
156381392|NCT04177108|564488018|FG003|Overall Study|Death|17|||
156381393|NCT04177108|564488019|FG004|Overall Study|Death|18|||
156381394|NCT04496258|564488020|FG000|Overall Study|Withdrawal by Subject|2|||
156381395|NCT04496258|564488021|FG001|Overall Study|Withdrawal by Subject|1|||
156381396|NCT01427712|564488022|FG000|Overall Study|Transfer to a different hospital|2|||
156381397|NCT01427712|564488022|FG000|Overall Study|Lost to Follow-up|1|||
156381398|NCT01427712|564488022|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
156381399|NCT01427712|564488022|FG000|Overall Study|Failure to visit|1|||
156381400|NCT00661492|564488023|FG000|Overall Study|Adverse Event|16|||
156381401|NCT00661492|564488024|FG001|Overall Study|Adverse Event|13|||
156381402|NCT00661492|564488023|FG000|Overall Study|Disease Progression|44|||
156381403|NCT00661492|564488024|FG001|Overall Study|Disease Progression|14|||
156381404|NCT00661492|564488023|FG000|Overall Study|Patient Request|6|||
156381405|NCT00661492|564488024|FG001|Overall Study|Patient Request|1|||
156381406|NCT00661492|564488023|FG000|Overall Study|Investigator Request|1|||
156381407|NCT00661492|564488024|FG001|Overall Study|Investigator Request|0|||
156381408|NCT00661492|564488023|FG000|Overall Study|Lost to Follow-up|0|||
156381409|NCT00661492|564488024|FG001|Overall Study|Lost to Follow-up|1|||
156381410|NCT00661492|564488023|FG000|Overall Study|Other|1|||
156381411|NCT00661492|564488024|FG001|Overall Study|Other|0|||
156381412|NCT01143259|564488025|FG000|Overall Study|Withdrawal by Subject|3|||
156381413|NCT01143259|564488026|FG001|Overall Study|Withdrawal by Subject|2|||
156381414|NCT01143259|564488025|FG000|Overall Study|Protocol Violation|13|||
156381415|NCT01143259|564488026|FG001|Overall Study|Protocol Violation|9|||
156381416|NCT01143259|564488025|FG000|Overall Study|Screen Failure|7|||
156381417|NCT01143259|564488026|FG001|Overall Study|Screen Failure|9|||
156381418|NCT00099983|564488027|FG000|Overall Study|Lost to Follow-up|2|||
156381419|NCT00099983|564488028|FG001|Overall Study|Lost to Follow-up|3|||
156381420|NCT00099983|564488027|FG000|Overall Study|Missing Source Documents|14|||
156381421|NCT00099983|564488028|FG001|Overall Study|Missing Source Documents|15|||
156381422|NCT00099983|564488027|FG000|Overall Study|Withdrawal by Subject|3|||
156381423|NCT00099983|564488028|FG001|Overall Study|Withdrawal by Subject|2|||
156381424|NCT00099983|564488027|FG000|Overall Study|Adverse Event|1|||
156381425|NCT00099983|564488028|FG001|Overall Study|Adverse Event|1|||
156381426|NCT00099983|564488027|FG000|Overall Study|Lack of Efficacy|0|||
156381427|NCT00099983|564488028|FG001|Overall Study|Lack of Efficacy|1|||
156381428|NCT00099983|564488027|FG000|Overall Study|Unable to return for appointments|1|||
156381429|NCT00099983|564488028|FG001|Overall Study|Unable to return for appointments|1|||
156381430|NCT00099983|564488027|FG000|Overall Study|Moved|1|||
156381431|NCT00099983|564488028|FG001|Overall Study|Moved|0|||
156381432|NCT00099983|564488027|FG000|Overall Study|Other psychiatric problem|1|||
156381433|NCT00099983|564488028|FG001|Overall Study|Other psychiatric problem|0|||
156381434|NCT00099983|564488027|FG000|Overall Study|Incarcerated|0|||
156381435|NCT00099983|564488028|FG001|Overall Study|Incarcerated|1|||
156381436|NCT00099983|564488027|FG000|Overall Study|Intolerant of burden of visits|0|||
156381437|NCT00099983|564488028|FG001|Overall Study|Intolerant of burden of visits|1|||
156381438|NCT00099983|564488027|FG000|Overall Study|Other issue|1|||
156381439|NCT00099983|564488028|FG001|Overall Study|Other issue|0|||
156381440|NCT02641080|564488029|FG000|Overall Study|Physician Decision|2|||
156381441|NCT02641080|564488030|FG001|Overall Study|Physician Decision|0|||
156381442|NCT02641080|564488029|FG000|Overall Study|Withdrawal by Subject|0|||
156546858|NCT00440947|565094995|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
156546859|NCT00440947|565094996|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
156546860|NCT00440947|565094997|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
156381443|NCT02641080|564488030|FG001|Overall Study|Withdrawal by Subject|1|||
156381444|NCT02641080|564488029|FG000|Overall Study|Rehab Center denied use of pumps|0|||
156381445|NCT02641080|564488030|FG001|Overall Study|Rehab Center denied use of pumps|3|||
156381446|NCT02641080|564488029|FG000|Overall Study|Lost to Follow-up|0|||
156381447|NCT02641080|564488030|FG001|Overall Study|Lost to Follow-up|3|||
156381448|NCT00803634|564488031|FG000|Overall Study|Withdrew Consent|1|||
156381449|NCT00803634|564488032|FG001|Overall Study|Withdrew Consent|0|||
156381450|NCT00803634|564488031|FG000|Overall Study|Lost to Follow-up|2|||
156381451|NCT00803634|564488032|FG001|Overall Study|Lost to Follow-up|3|||
156381452|NCT00803634|564488031|FG000|Overall Study|Death|3|||
156381453|NCT00803634|564488032|FG001|Overall Study|Death|2|||
156381454|NCT03835533|564488033|FG000|Overall Study|Death|5|||
156381455|NCT03835533|564488034|FG001|Overall Study|Death|10|||
156381456|NCT03835533|564488035|FG002|Overall Study|Death|9|||
156501047|NCT02386839|564926624|FG001|Overall Study|Death|0|||
156501048|NCT02386839|564926623|FG000|Overall Study|Withdrawal by Subject|9|||
156501049|NCT02386839|564926624|FG001|Overall Study|Withdrawal by Subject|10|||
156501050|NCT02386839|564926623|FG000|Overall Study|Lost to Follow-up|4|||
156501051|NCT02386839|564926624|FG001|Overall Study|Lost to Follow-up|4|||
156501052|NCT02386839|564926623|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
156501053|NCT02386839|564926624|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
156501054|NCT02386839|564926623|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
156501055|NCT02386839|564926624|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
156501056|NCT02386839|564926623|FG000|Overall Study|Other (unspecified)|1|||
156501057|NCT02386839|564926624|FG001|Overall Study|Other (unspecified)|0|||
156501058|NCT02101983|564926628|FG000|Overall Study|Physician Decision|1|||
156501059|NCT02101983|564926629|FG001|Overall Study|Physician Decision|0|||
156501060|NCT03725605|564926630|FG000|Overall Study|Unsuccessful TIL expansion|2|||
156501061|NCT01503086|564926631|FG000|Overall Study|Lost to Follow-up|0|||
156501062|NCT01503086|564926632|FG001|Overall Study|Lost to Follow-up|1|||
156381457|NCT03835533|564488033|FG000|Overall Study|Withdrawal by Subject|2|||
156381458|NCT03835533|564488034|FG001|Overall Study|Withdrawal by Subject|2|||
156381459|NCT03835533|564488035|FG002|Overall Study|Withdrawal by Subject|2|||
156381460|NCT03835533|564488033|FG000|Overall Study|Lost to Follow-up|1|||
156381461|NCT03835533|564488034|FG001|Overall Study|Lost to Follow-up|0|||
156381462|NCT03835533|564488035|FG002|Overall Study|Lost to Follow-up|0|||
156381463|NCT00499889|564488042|FG000|Overall Study|Infection prior to treatment|1|||
156381464|NCT00766376|564488046|FG000|Overall Study|Withdrawal by Subject|27|||
156381465|NCT03149328|564488049|FG000|Overall Study|Withdrawal by Subject|30|||
156381466|NCT03149328|564488050|FG001|Overall Study|Withdrawal by Subject|26|||
156381467|NCT03149328|564488049|FG000|Overall Study|Changed Dialysis Modality|18|||
156381468|NCT03149328|564488050|FG001|Overall Study|Changed Dialysis Modality|1|||
156381469|NCT03149328|564488049|FG000|Overall Study|Transplant|9|||
156381470|NCT03149328|564488050|FG001|Overall Study|Transplant|1|||
156381471|NCT03149328|564488049|FG000|Overall Study|Lost to Follow-up|25|||
156381472|NCT03149328|564488050|FG001|Overall Study|Lost to Follow-up|16|||
156381473|NCT03149328|564488049|FG000|Overall Study|Left Study Site|1|||
156381474|NCT03149328|564488050|FG001|Overall Study|Left Study Site|2|||
156381475|NCT03149328|564488049|FG000|Overall Study|Language Barrier|1|||
156381476|NCT03149328|564488050|FG001|Overall Study|Language Barrier|0|||
156381477|NCT00852397|564488051|FG000|Overall Study|Adverse Event|4|||
156381478|NCT00852397|564488052|FG001|Overall Study|Adverse Event|6|||
156381479|NCT00852397|564488053|FG002|Overall Study|Adverse Event|4|||
156381480|NCT00852397|564488051|FG000|Overall Study|Death|0|||
156381481|NCT00852397|564488052|FG001|Overall Study|Death|0|||
156381482|NCT00852397|564488053|FG002|Overall Study|Death|1|||
156381483|NCT00852397|564488051|FG000|Overall Study|Withdrawal by Subject|4|||
156381484|NCT00852397|564488052|FG001|Overall Study|Withdrawal by Subject|1|||
156381485|NCT00852397|564488053|FG002|Overall Study|Withdrawal by Subject|2|||
156381486|NCT00852397|564488051|FG000|Overall Study|Study terminated by sponsor|2|||
156381487|NCT00852397|564488052|FG001|Overall Study|Study terminated by sponsor|1|||
156381488|NCT00852397|564488053|FG002|Overall Study|Study terminated by sponsor|6|||
156381489|NCT00852397|564488051|FG000|Overall Study|Difficulty in study site visit|1|||
156381490|NCT00852397|564488052|FG001|Overall Study|Difficulty in study site visit|0|||
156381491|NCT00852397|564488053|FG002|Overall Study|Difficulty in study site visit|0|||
156381492|NCT00852397|564488051|FG000|Overall Study|Protocol Violation|0|||
156381493|NCT00852397|564488052|FG001|Overall Study|Protocol Violation|0|||
156381494|NCT00852397|564488053|FG002|Overall Study|Protocol Violation|1|||
156381495|NCT01968434|564488059|FG000|Overall Study|Lost to Follow-up|3|||
156381496|NCT01968434|564488060|FG001|Overall Study|Lost to Follow-up|6|||
156381497|NCT02199691|564488061|FG000|Overall Study|Protocol Violation|3|||
156381498|NCT02199691|564488062|FG001|Overall Study|Protocol Violation|3|||
156381499|NCT02199691|564488063|FG002|Overall Study|Protocol Violation|6|||
156381500|NCT02199691|564488064|FG003|Overall Study|Protocol Violation|7|||
156381501|NCT02199691|564488061|FG000|Overall Study|Withdrawal by Subject|5|||
156381502|NCT02199691|564488062|FG001|Overall Study|Withdrawal by Subject|3|||
156381503|NCT02199691|564488063|FG002|Overall Study|Withdrawal by Subject|12|||
156381504|NCT02199691|564488064|FG003|Overall Study|Withdrawal by Subject|13|||
156381505|NCT02199691|564488061|FG000|Overall Study|Lost to Follow-up|2|||
156381506|NCT02199691|564488062|FG001|Overall Study|Lost to Follow-up|1|||
156381507|NCT02199691|564488063|FG002|Overall Study|Lost to Follow-up|9|||
156381508|NCT02199691|564488064|FG003|Overall Study|Lost to Follow-up|10|||
156381509|NCT00136955|564490142|FG000|Overall Study|Adverse Event|8|||
156381510|NCT00136955|564490142|FG000|Overall Study|Lost to Follow-up|1|||
156381511|NCT00136955|564490142|FG000|Overall Study|Withdrawal by Subject|2|||
156381512|NCT00136955|564490142|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
156381513|NCT01773226|564490143|FG000|Overall Study|Withdrawal by Subject|1|||
156381514|NCT05349617|564490147|FG000|Overall Study|Death|1|||
156381515|NCT05349617|564490148|FG001|Overall Study|Death|1|||
156381516|NCT05349617|564490147|FG000|Overall Study|Lost to Follow-up|3|||
156381517|NCT05349617|564490148|FG001|Overall Study|Lost to Follow-up|8|||
156381518|NCT05349617|564490147|FG000|Overall Study|Withdrawal by Subject|2|||
156381519|NCT05349617|564490148|FG001|Overall Study|Withdrawal by Subject|10|||
156381520|NCT00566228|564490149|FG000|Overall Study|Withdrawal by Subject|1|||
156381521|NCT00566228|564490150|FG001|Overall Study|Withdrawal by Subject|0|||
156381522|NCT00566228|564490149|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
156381523|NCT00566228|564490150|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
156381524|NCT00566228|564490149|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
156381525|NCT00566228|564490150|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
156381526|NCT00566228|564490149|FG000|Overall Study|progressed before infusion could occur|0|||
156381527|NCT00566228|564490150|FG001|Overall Study|progressed before infusion could occur|1|||
156381528|NCT00987467|564490155|FG000|Overall Study|Lost to Follow-up|2|||
156381529|NCT00262834|564490156|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
156381530|NCT00262834|564490157|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
156381531|NCT02646423|564490158|FG000|Overall Study|Adverse Event|5|||
156381532|NCT02646423|564490159|FG001|Overall Study|Adverse Event|7|||
156381533|NCT02646423|564490158|FG000|Overall Study|Ineligible|2|||
156381534|NCT02646423|564490159|FG001|Overall Study|Ineligible|1|||
156381535|NCT00003457|564490160|FG000|Overall Study|Not evaluable|9|||
156381536|NCT02416791|564490165|FG000|6 Months|Lost to Follow-up|0|||
156381537|NCT02416791|564490166|FG001|6 Months|Lost to Follow-up|0|||
156381538|NCT02416791|564490167|FG002|6 Months|Lost to Follow-up|1|||
156381539|NCT01054820|564490168|FG000|Overall Study|Withdrawal by Subject|2|||
156381540|NCT02624804|564490169|FG000|Overall Study|Screen Failure|5|||
156381541|NCT00760929|564490170|FG000|Overall Study|Adverse Event|2|||
156381542|NCT00760929|564490171|FG001|Overall Study|Adverse Event|0|||
156381543|NCT00760929|564490172|FG002|Overall Study|Adverse Event|6|||
156381544|NCT00760929|564490173|FG003|Overall Study|Adverse Event|10|||
156381545|NCT00760929|564490170|FG000|Overall Study|Lack of Efficacy|0|||
156381546|NCT00760929|564490171|FG001|Overall Study|Lack of Efficacy|2|||
156381547|NCT00760929|564490172|FG002|Overall Study|Lack of Efficacy|1|||
156381548|NCT00760929|564490173|FG003|Overall Study|Lack of Efficacy|0|||
156381549|NCT00760929|564490170|FG000|Overall Study|Withdrawal by Subject|1|||
156381550|NCT00760929|564490171|FG001|Overall Study|Withdrawal by Subject|0|||
156381551|NCT00760929|564490172|FG002|Overall Study|Withdrawal by Subject|9|||
156381552|NCT00760929|564490173|FG003|Overall Study|Withdrawal by Subject|1|||
156381553|NCT00760929|564490170|FG000|Overall Study|Lost to Follow-up|0|||
156381554|NCT00760929|564490171|FG001|Overall Study|Lost to Follow-up|0|||
156381555|NCT00760929|564490172|FG002|Overall Study|Lost to Follow-up|1|||
156381556|NCT00760929|564490173|FG003|Overall Study|Lost to Follow-up|0|||
156381557|NCT00760929|564490170|FG000|Overall Study|Progression of Disease|21|||
156381558|NCT00760929|564490171|FG001|Overall Study|Progression of Disease|26|||
156381559|NCT00760929|564490172|FG002|Overall Study|Progression of Disease|38|||
156381560|NCT00760929|564490173|FG003|Overall Study|Progression of Disease|42|||
156381561|NCT00760929|564490170|FG000|Overall Study|Other|2|||
156381562|NCT00760929|564490171|FG001|Overall Study|Other|0|||
156381563|NCT00760929|564490172|FG002|Overall Study|Other|2|||
156381564|NCT00760929|564490173|FG003|Overall Study|Other|1|||
156381565|NCT00760929|564490170|FG000|Overall Study|Death|0|||
156381566|NCT00760929|564490171|FG001|Overall Study|Death|0|||
156381567|NCT00760929|564490172|FG002|Overall Study|Death|1|||
156381568|NCT00760929|564490173|FG003|Overall Study|Death|0|||
156381569|NCT00760929|564490170|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
156381570|NCT00760929|564490171|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
156381571|NCT00760929|564490172|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
156381572|NCT00760929|564490173|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
156381573|NCT02348216|564490174|FG000|Overall Study|Death|5|||
156381574|NCT02348216|564490175|FG001|Overall Study|Death|53|||
156381575|NCT02348216|564490176|FG002|Overall Study|Death|11|||
156381576|NCT02348216|564490177|FG003|Overall Study|Death|20|||
156381577|NCT02348216|564490178|FG004|Overall Study|Death|16|||
156381578|NCT02348216|564490179|FG005|Overall Study|Death|32|||
156381579|NCT02348216|564490180|FG006|Overall Study|Death|17|||
156381580|NCT02348216|564490174|FG000|Overall Study|Full consent withdrawal|0|||
156381581|NCT02348216|564490175|FG001|Overall Study|Full consent withdrawal|0|||
156381582|NCT02348216|564490176|FG002|Overall Study|Full consent withdrawal|0|||
156381583|NCT02348216|564490177|FG003|Overall Study|Full consent withdrawal|1|||
156381584|NCT02348216|564490178|FG004|Overall Study|Full consent withdrawal|3|||
156381585|NCT02348216|564490179|FG005|Overall Study|Full consent withdrawal|0|||
156381586|NCT02348216|564490180|FG006|Overall Study|Full consent withdrawal|3|||
156381587|NCT02348216|564490174|FG000|Overall Study|Lost to Follow-up|0|||
156381588|NCT02348216|564490175|FG001|Overall Study|Lost to Follow-up|5|||
156381589|NCT02348216|564490176|FG002|Overall Study|Lost to Follow-up|2|||
156381590|NCT02348216|564490177|FG003|Overall Study|Lost to Follow-up|0|||
156381591|NCT02348216|564490178|FG004|Overall Study|Lost to Follow-up|1|||
156381592|NCT02348216|564490179|FG005|Overall Study|Lost to Follow-up|1|||
156381593|NCT02348216|564490180|FG006|Overall Study|Lost to Follow-up|1|||
156381594|NCT02348216|564490174|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
156381595|NCT02348216|564490175|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
156381596|NCT02348216|564490176|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
156546861|NCT00440947|565094998|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
156546862|NCT00440947|565094999|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
156381597|NCT02348216|564490177|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
156381598|NCT02348216|564490178|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
156381599|NCT02348216|564490179|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
156381600|NCT02348216|564490180|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
156381601|NCT02348216|564490174|FG000|Overall Study|Reason not specified|2|||
156381602|NCT02348216|564490175|FG001|Overall Study|Reason not specified|19|||
156381603|NCT02348216|564490176|FG002|Overall Study|Reason not specified|11|||
156381604|NCT02348216|564490177|FG003|Overall Study|Reason not specified|17|||
156381605|NCT02348216|564490178|FG004|Overall Study|Reason not specified|21|||
156381606|NCT02348216|564490179|FG005|Overall Study|Reason not specified|17|||
156381607|NCT02348216|564490180|FG006|Overall Study|Reason not specified|19|||
156381608|NCT00765245|564490181|FG000|Overall Study|disease progression|3|||
156381609|NCT00765245|564490182|FG001|Overall Study|disease progression|2|||
156381610|NCT00765245|564490181|FG000|Overall Study|Withdrawal by Subject|3|||
156381611|NCT00765245|564490182|FG001|Overall Study|Withdrawal by Subject|0|||
156381612|NCT00765245|564490181|FG000|Overall Study|Adverse Event|5|||
156381613|NCT00765245|564490182|FG001|Overall Study|Adverse Event|0|||
156381614|NCT00765245|564490181|FG000|Overall Study|Physician Decision|1|||
156381615|NCT00765245|564490182|FG001|Overall Study|Physician Decision|0|||
156381616|NCT00765245|564490181|FG000|Overall Study|Death|1|||
156381617|NCT00765245|564490182|FG001|Overall Study|Death|0|||
156381618|NCT02546544|564490183|FG000|Overall Study|Disease Progression|14|||
156381619|NCT02546544|564490183|FG000|Overall Study|Adverse Event|1|||
156381620|NCT02546544|564490183|FG000|Overall Study|Withdrawal by Subject|1|||
156381621|NCT02511431|564490184|FG000|Treatment|Lost to Follow-up|0|||
156381622|NCT02511431|564490185|FG001|Treatment|Lost to Follow-up|0|||
156381623|NCT02511431|564490186|FG002|Treatment|Lost to Follow-up|1|||
156381624|NCT02511431|564490187|FG003|Treatment|Lost to Follow-up|0|||
156381625|NCT02511431|564490188|FG004|Treatment|Lost to Follow-up|0|||
156381626|NCT02511431|564490189|FG005|Treatment|Lost to Follow-up|1|||
156381627|NCT00614939|564490192|FG000|Overall Study|Withdrawal by Subject|10|||
156381628|NCT00614939|564490193|FG001|Overall Study|Withdrawal by Subject|17|||
156381629|NCT00614939|564490192|FG000|Overall Study|Study specific discontinuation criteris|13|||
156381630|NCT00614939|564490193|FG001|Overall Study|Study specific discontinuation criteris|16|||
156381631|NCT00614939|564490192|FG000|Overall Study|Adverse Event|2|||
156381632|NCT00614939|564490193|FG001|Overall Study|Adverse Event|5|||
156381633|NCT00614939|564490192|FG000|Overall Study|Incorrect enrollment|1|||
156381634|NCT00614939|564490193|FG001|Overall Study|Incorrect enrollment|2|||
156381635|NCT00614939|564490192|FG000|Overall Study|Death|4|||
156381636|NCT00614939|564490193|FG001|Overall Study|Death|3|||
156381637|NCT00614939|564490192|FG000|Overall Study|Poor/non-compliance|4|||
156381638|NCT00614939|564490193|FG001|Overall Study|Poor/non-compliance|0|||
156381639|NCT00614939|564490192|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
156381640|NCT00614939|564490193|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
156381641|NCT00736996|564490194|FG000|Overall Study|Lost to Follow-up|1|||
156381642|NCT00736996|564490195|FG001|Overall Study|Lost to Follow-up|9|||
156381643|NCT00736996|564490196|FG002|Overall Study|Lost to Follow-up|2|||
156381644|NCT00462384|564490197|FG000|Overall Study|Adverse Event|2|||
156381645|NCT00462384|564490197|FG000|Overall Study|Death|2|||
156381646|NCT00462384|564490197|FG000|Overall Study|Withdrawal by Subject|1|||
156381647|NCT00462384|564490197|FG000|Overall Study|Other|4|||
156381648|NCT04000165|564490198|FG000|Overall Study|Physician Decision|1|||
156381649|NCT04000165|564490198|FG000|Overall Study|Withdrawal by Subject|1|||
156381650|NCT01753193|564490199|FG000|Overall Study|Withdrawal by Subject|23|||
156381651|NCT01753193|564490199|FG000|Overall Study|Lost to Follow-up|6|||
156381652|NCT01753193|564490199|FG000|Overall Study|Death|1|||
156381653|NCT01753193|564490199|FG000|Overall Study|Other|16|||
156381654|NCT02682264|564490200|FG000|Overall Study|Withdrawal by Subject|56|||
156381655|NCT02682264|564490201|FG001|Overall Study|Withdrawal by Subject|45|||
156381656|NCT02682264|564490200|FG000|Overall Study|Lost to Follow-up|49|||
156381657|NCT02682264|564490201|FG001|Overall Study|Lost to Follow-up|41|||
156381658|NCT02682264|564490200|FG000|Overall Study|Lack of Efficacy|14|||
156381659|NCT02682264|564490201|FG001|Overall Study|Lack of Efficacy|16|||
156501063|NCT01503086|564926633|FG002|Overall Study|Lost to Follow-up|0|||
156501064|NCT01503086|564926631|FG000|Overall Study|Did Not Start Treatment|4|||
156501065|NCT01503086|564926632|FG001|Overall Study|Did Not Start Treatment|3|||
156501066|NCT01503086|564926633|FG002|Overall Study|Did Not Start Treatment|3|||
156501067|NCT01503086|564926631|FG000|Overall Study|Progressive disease|3|||
156501068|NCT01503086|564926632|FG001|Overall Study|Progressive disease|1|||
156381660|NCT02682264|564490200|FG000|Overall Study|Withdrawal by Parent|6|||
156381661|NCT02682264|564490201|FG001|Overall Study|Withdrawal by Parent|7|||
156381662|NCT02682264|564490200|FG000|Overall Study|Adverse Event|9|||
156381663|NCT02682264|564490201|FG001|Overall Study|Adverse Event|0|||
156381664|NCT02682264|564490200|FG000|Overall Study|Noncompliance with study drug|1|||
156381665|NCT02682264|564490201|FG001|Overall Study|Noncompliance with study drug|4|||
156501069|NCT01503086|564926633|FG002|Overall Study|Progressive disease|0|||
156501070|NCT01503086|564926631|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
156501071|NCT01503086|564926632|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
156501072|NCT01503086|564926633|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
156501073|NCT01503086|564926631|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
156381666|NCT02682264|564490200|FG000|Overall Study|Pregnancy|1|||
156381667|NCT02682264|564490201|FG001|Overall Study|Pregnancy|2|||
156381668|NCT02682264|564490200|FG000|Overall Study|Recovery|1|||
156381669|NCT02682264|564490201|FG001|Overall Study|Recovery|2|||
156381670|NCT02682264|564490200|FG000|Overall Study|Progressive Disease|1|||
156381671|NCT02682264|564490201|FG001|Overall Study|Progressive Disease|0|||
156381672|NCT02682264|564490200|FG000|Overall Study|Technical Problems|0|||
156381673|NCT02682264|564490201|FG001|Overall Study|Technical Problems|1|||
156381674|NCT02682264|564490200|FG000|Overall Study|Moved abroad and unable to continue|0|||
156381675|NCT02682264|564490201|FG001|Overall Study|Moved abroad and unable to continue|3|||
156381676|NCT02682264|564490200|FG000|Overall Study|Stopped test article application|0|||
156381677|NCT02682264|564490201|FG001|Overall Study|Stopped test article application|1|||
156381678|NCT01751568|564490202|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
156381679|NCT01751568|564490203|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
156381680|NCT01751568|564490204|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
156381681|NCT03879798|564490214|FG000|Overall Study|Adverse Event|0|||
156381682|NCT03879798|564490215|FG001|Overall Study|Adverse Event|0|||
156381683|NCT03879798|564490216|FG002|Overall Study|Adverse Event|0|||
156381684|NCT03879798|564490217|FG003|Overall Study|Adverse Event|0|||
156381685|NCT03879798|564490218|FG004|Overall Study|Adverse Event|0|||
156381686|NCT03879798|564490219|FG005|Overall Study|Adverse Event|1|||
156381687|NCT03879798|564490214|FG000|Overall Study|Lack of Efficacy|0|||
156381688|NCT03879798|564490215|FG001|Overall Study|Lack of Efficacy|0|||
156381689|NCT03879798|564490216|FG002|Overall Study|Lack of Efficacy|0|||
156381690|NCT03879798|564490217|FG003|Overall Study|Lack of Efficacy|0|||
156381691|NCT03879798|564490218|FG004|Overall Study|Lack of Efficacy|0|||
156381692|NCT03879798|564490219|FG005|Overall Study|Lack of Efficacy|1|||
156381693|NCT03879798|564490214|FG000|Overall Study|Withdrawal by Subject|0|||
156381694|NCT03879798|564490215|FG001|Overall Study|Withdrawal by Subject|0|||
156381695|NCT03879798|564490216|FG002|Overall Study|Withdrawal by Subject|0|||
156381696|NCT03879798|564490217|FG003|Overall Study|Withdrawal by Subject|0|||
156381697|NCT03879798|564490218|FG004|Overall Study|Withdrawal by Subject|0|||
156381698|NCT03879798|564490219|FG005|Overall Study|Withdrawal by Subject|1|||
156381699|NCT01343407|564490220|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
156381700|NCT01343407|564490221|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
156381701|NCT01343407|564490222|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
156381702|NCT01343407|564490223|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
156381703|NCT01343407|564490224|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
156381704|NCT01343407|564490225|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
156381705|NCT01343407|564490220|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
156381706|NCT01343407|564490221|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
156381707|NCT01343407|564490222|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
156381708|NCT01343407|564490223|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
156381709|NCT01343407|564490224|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
156381710|NCT01343407|564490225|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
156381711|NCT04079933|564490228|FG000|Overall Study|Withdrawal by Subject|3|||
156381712|NCT04079933|564490229|FG001|Overall Study|Withdrawal by Subject|4|||
156381713|NCT04079933|564490228|FG000|Overall Study|Lost to Follow-up|0|||
156381714|NCT04079933|564490229|FG001|Overall Study|Lost to Follow-up|1|||
156381715|NCT02504866|564490230|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
156381716|NCT02504866|564490231|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
156381717|NCT02504866|564490232|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
156381718|NCT01229436|564490233|FG000|Overall Study|Withdrawal by Subject|2|||
156381719|NCT01229436|564490233|FG000|Overall Study|Lost to Follow-up|3|||
156381720|NCT01775137|564490234|FG000|Overall Study|Death|1|||
156381721|NCT01775137|564490234|FG000|Overall Study|Protocol deviation|2|||
156381722|NCT01775137|564490234|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156381723|NCT01775137|564490234|FG000|Overall Study|Adverse Event|1|||
156501074|NCT01503086|564926632|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
156501075|NCT01503086|564926633|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
156501076|NCT02035696|564928016|FG000|Overall Study|Lost to Follow-up|0|||
156501077|NCT02035696|564928017|FG001|Overall Study|Lost to Follow-up|3|||
156381724|NCT01775137|564490234|FG000|Overall Study|Withdrawal by participants|5|||
156381725|NCT01343056|564490235|FG000|Overall Study|Lost to Follow-up|7|||
156381726|NCT01343056|564490236|FG001|Overall Study|Lost to Follow-up|5|||
156381727|NCT01343056|564490237|FG002|Overall Study|Lost to Follow-up|3|||
156381728|NCT01343056|564490238|FG003|Overall Study|Lost to Follow-up|9|||
156381729|NCT03893448|564490239|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
156381730|NCT03893448|564490240|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
156381731|NCT03893448|564490239|FG000|Overall Study|Physician Decision|8|||
156381732|NCT03893448|564490240|FG001|Overall Study|Physician Decision|14|||
156501078|NCT02035696|564928018|FG002|Overall Study|Lost to Follow-up|1|||
156381733|NCT03893448|564490239|FG000|Overall Study|Lost to Follow-up|34|||
156381734|NCT03893448|564490240|FG001|Overall Study|Lost to Follow-up|27|||
156381735|NCT03893448|564490239|FG000|Overall Study|Death|1|||
156381736|NCT03893448|564490240|FG001|Overall Study|Death|0|||
156381737|NCT01944046|564490241|FG000|Randomized to DB|Adverse Event|5|||
156381738|NCT01944046|564490242|FG001|Randomized to DB|Adverse Event|2|||
156381739|NCT01944046|564490241|FG000|Randomized to DB|Clinical Worsening|3|||
156381740|NCT01944046|564490242|FG001|Randomized to DB|Clinical Worsening|2|||
156381741|NCT01944046|564490241|FG000|Randomized to DB|Lost to Follow-up|3|||
156381742|NCT01944046|564490242|FG001|Randomized to DB|Lost to Follow-up|3|||
156546863|NCT00440947|565094995|FG000|36-Week Induction Phase|Incarceration|3|||
156546864|NCT00440947|565094996|FG001|36-Week Induction Phase|Incarceration|0|||
156546865|NCT00440947|565094997|FG002|36-Week Induction Phase|Incarceration|0|||
156546866|NCT00440947|565094998|FG003|36-Week Induction Phase|Incarceration|0|||
156546867|NCT00440947|565094999|FG004|36-Week Induction Phase|Incarceration|0|||
156546868|NCT00440947|565094995|FG000|36-Week Induction Phase|Pregnancy|1|||
156546869|NCT00440947|565094996|FG001|36-Week Induction Phase|Pregnancy|0|||
156546870|NCT00440947|565094997|FG002|36-Week Induction Phase|Pregnancy|0|||
156546871|NCT00440947|565094998|FG003|36-Week Induction Phase|Pregnancy|0|||
156546872|NCT00440947|565094999|FG004|36-Week Induction Phase|Pregnancy|0|||
156546873|NCT00440947|565094995|FG000|48-Week Randomization Phase|Adverse Event|0|||
156546874|NCT00440947|565094996|FG001|48-Week Randomization Phase|Adverse Event|2|||
156546875|NCT00440947|565094997|FG002|48-Week Randomization Phase|Adverse Event|5|||
156546876|NCT00440947|565094998|FG003|48-Week Randomization Phase|Adverse Event|0|||
156546877|NCT00440947|565094999|FG004|48-Week Randomization Phase|Adverse Event|0|||
156546878|NCT00440947|565094995|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
156546879|NCT00440947|565094996|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
156546880|NCT00440947|565094997|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
156546881|NCT00440947|565094998|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
156546882|NCT00440947|565094999|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
156546883|NCT00440947|565094995|FG000|48-Week Randomization Phase|Non-compliance|0|||
156546884|NCT00440947|565094996|FG001|48-Week Randomization Phase|Non-compliance|3|||
156546885|NCT00440947|565094997|FG002|48-Week Randomization Phase|Non-compliance|4|||
156546886|NCT00440947|565094998|FG003|48-Week Randomization Phase|Non-compliance|0|||
156546887|NCT00440947|565094999|FG004|48-Week Randomization Phase|Non-compliance|0|||
156546888|NCT00440947|565094995|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
156501079|NCT02035696|564928019|FG003|Overall Study|Lost to Follow-up|2|||
156501080|NCT02035696|564928016|FG000|Overall Study|Withdrawal by Subject|3|||
156501081|NCT02035696|564928017|FG001|Overall Study|Withdrawal by Subject|0|||
156501082|NCT02035696|564928018|FG002|Overall Study|Withdrawal by Subject|2|||
156501083|NCT02035696|564928019|FG003|Overall Study|Withdrawal by Subject|1|||
156501084|NCT04650698|564928020|FG000|Overall Study|Protocol Violation|2|||
156501085|NCT04650698|564928021|FG001|Overall Study|Protocol Violation|1|||
156501086|NCT04650698|564928020|FG000|Overall Study|Withdrawal by Subject|0|||
156501087|NCT04650698|564928021|FG001|Overall Study|Withdrawal by Subject|1|||
156501088|NCT01090011|564928022|FG000|Overall Study|Progressive disease|128|||
156501089|NCT01090011|564928022|FG000|Overall Study|Adverse Event|32|||
156501090|NCT01090011|564928022|FG000|Overall Study|Protocol Violation|1|||
156501091|NCT01090011|564928022|FG000|Overall Study|Refusal to start/continue medication|5|||
156501092|NCT01090011|564928022|FG000|Overall Study|Other reason not defined above|5|||
156501093|NCT03778294|564928023|FG000|Overall Study|Death|1|||
156501094|NCT03778294|564928023|FG000|Overall Study|Issues with insurance|1|||
156501095|NCT03778294|564928023|FG000|Overall Study|disease progression before treatment|2|||
156501096|NCT02859064|564928025|FG000|Overall Study|Progressive Disease|3|||
156501097|NCT02859064|564928025|FG000|Overall Study|Physician Decision|1|||
156501098|NCT02859064|564928025|FG000|Overall Study|Withdrawal by Subject|1|||
156501099|NCT02859064|564928025|FG000|Overall Study|Death|1|||
156501100|NCT01730950|564928031|FG000|Overall Study|Protocol Violation|6|||
156501101|NCT01730950|564928032|FG001|Overall Study|Protocol Violation|6|||
156501102|NCT02737826|564928033|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
156501103|NCT02737826|564928034|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
156501104|NCT02737826|564928035|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
156501105|NCT00667459|564928036|FG000|Overall Study|Death|0|||
156501106|NCT00667459|564928037|FG001|Overall Study|Death|2|||
156501107|NCT00667459|564928036|FG000|Overall Study|Lost to Follow-up|8|||
156501108|NCT00667459|564928037|FG001|Overall Study|Lost to Follow-up|43|||
156501109|NCT00078377|564928038|FG000|Overall Study|Adverse Event|2|||
156501110|NCT00078377|564928039|FG001|Overall Study|Adverse Event|5|||
156501111|NCT00078377|564928040|FG002|Overall Study|Adverse Event|1|||
156501112|NCT00078377|564928038|FG000|Overall Study|Lack of Efficacy|2|||
156501113|NCT00078377|564928039|FG001|Overall Study|Lack of Efficacy|0|||
156501114|NCT00078377|564928040|FG002|Overall Study|Lack of Efficacy|2|||
156546889|NCT00440947|565094996|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
156501115|NCT00078377|564928038|FG000|Overall Study|Lost to Follow-up|0|||
156546890|NCT00440947|565094997|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
156546891|NCT00440947|565094998|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
156546892|NCT00440947|565094999|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
156546893|NCT00440947|565094995|FG000|48-Week Randomization Phase|Protocol Violation|0|||
156501116|NCT00078377|564928039|FG001|Overall Study|Lost to Follow-up|1|||
156501117|NCT00078377|564928040|FG002|Overall Study|Lost to Follow-up|1|||
156501118|NCT00078377|564928038|FG000|Overall Study|Physician Decision|2|||
156501119|NCT00078377|564928039|FG001|Overall Study|Physician Decision|0|||
156501120|NCT00078377|564928040|FG002|Overall Study|Physician Decision|0|||
156501121|NCT00078377|564928038|FG000|Overall Study|Withdrawal by Subject|3|||
156501122|NCT00078377|564928039|FG001|Overall Study|Withdrawal by Subject|4|||
156546894|NCT00440947|565094996|FG001|48-Week Randomization Phase|Protocol Violation|0|||
156546895|NCT00440947|565094997|FG002|48-Week Randomization Phase|Protocol Violation|1|||
156546896|NCT00440947|565094998|FG003|48-Week Randomization Phase|Protocol Violation|0|||
156546897|NCT00440947|565094999|FG004|48-Week Randomization Phase|Protocol Violation|0|||
156381743|NCT01944046|564490241|FG000|Randomized to DB|Withdrawal by Subject|2|||
156381744|NCT01944046|564490242|FG001|Randomized to DB|Withdrawal by Subject|4|||
156381745|NCT01944046|564490241|FG000|Randomized to DB|Physician Decision|1|||
156381746|NCT01944046|564490242|FG001|Randomized to DB|Physician Decision|2|||
156381747|NCT01944046|564490241|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
156381748|NCT01944046|564490242|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
156381749|NCT01944046|564490241|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
156381750|NCT01944046|564490242|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
156381751|NCT01944046|564490241|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
156381752|NCT01944046|564490242|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
156381753|NCT01944046|564490241|FG000|Open Label Eligible and Consented|Adverse Event|6|||
156381754|NCT01944046|564490242|FG001|Open Label Eligible and Consented|Adverse Event|1|||
156381755|NCT01944046|564490241|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
156381756|NCT01944046|564490242|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
156381757|NCT01944046|564490241|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
156381758|NCT01944046|564490242|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
156381759|NCT02007577|564490245|FG000|Overall Study|Adverse Event|1|||
156381760|NCT02007577|564490246|FG001|Overall Study|Adverse Event|0|||
156381761|NCT02007577|564490245|FG000|Overall Study|Withdrawal by Subject|0|||
156381762|NCT02007577|564490246|FG001|Overall Study|Withdrawal by Subject|1|||
156381763|NCT02504294|564490249|FG000|Overall Study|Adverse Event|15|||
156381764|NCT02504294|564490250|FG001|Overall Study|Adverse Event|12|||
156381765|NCT02504294|564490249|FG000|Overall Study|Withdrawal by Subject|7|||
156381766|NCT02504294|564490250|FG001|Overall Study|Withdrawal by Subject|1|||
156381767|NCT02504294|564490249|FG000|Overall Study|Protocol Violation|27|||
156381768|NCT02504294|564490250|FG001|Overall Study|Protocol Violation|26|||
156381769|NCT02504294|564490249|FG000|Overall Study|Physician Decision|1|||
156381770|NCT02504294|564490250|FG001|Overall Study|Physician Decision|2|||
156381771|NCT02504294|564490249|FG000|Overall Study|Lost to Follow-up|6|||
156381772|NCT02504294|564490250|FG001|Overall Study|Lost to Follow-up|7|||
156381773|NCT02252211|564490254|FG000|Overall Study|Adverse Event|0|||
156381774|NCT02252211|564490255|FG001|Overall Study|Adverse Event|1|||
156381775|NCT02252211|564490256|FG002|Overall Study|Adverse Event|0|||
156381776|NCT02252211|564490254|FG000|Overall Study|Progressive disease|3|||
156381777|NCT02252211|564490255|FG001|Overall Study|Progressive disease|2|||
156381778|NCT02252211|564490256|FG002|Overall Study|Progressive disease|0|||
156381779|NCT02252211|564490254|FG000|Overall Study|Withdrawal by Subject|1|||
156381780|NCT02252211|564490255|FG001|Overall Study|Withdrawal by Subject|0|||
156381781|NCT02252211|564490256|FG002|Overall Study|Withdrawal by Subject|0|||
156381782|NCT02252211|564490254|FG000|Overall Study|Serious Adverse Event During Screening|1|||
156381783|NCT02252211|564490255|FG001|Overall Study|Serious Adverse Event During Screening|0|||
156381784|NCT02252211|564490256|FG002|Overall Study|Serious Adverse Event During Screening|1|||
156381785|NCT03694548|564490259|FG000|Part A Survey|Protocol Violation|3|||
156381786|NCT03694548|564490260|FG001|Part A Survey|Protocol Violation|3|||
156381787|NCT03694548|564490261|FG002|Part A Survey|Protocol Violation|0|||
156381788|NCT03694548|564490259|FG000|Part B Yoga Program|Protocol Violation|0|||
156381789|NCT03694548|564490260|FG001|Part B Yoga Program|Protocol Violation|0|||
156381790|NCT03694548|564490261|FG002|Part B Yoga Program|Protocol Violation|3|||
156381791|NCT03694548|564490259|FG000|Part B Yoga Program|Did not attend intervention|0|||
156381792|NCT03694548|564490260|FG001|Part B Yoga Program|Did not attend intervention|0|||
156381793|NCT03694548|564490261|FG002|Part B Yoga Program|Did not attend intervention|8|||
156381794|NCT04307186|564490262|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
156381795|NCT04307186|564490262|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
156381796|NCT04307186|564490262|FG000|Washout 3-14 Days|Progressive disease|1|||
156381797|NCT04307186|564490262|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
156381798|NCT04307186|564490262|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
156381799|NCT06281548|564490265|FG000|Overall Study|Lost to Follow-up|3|||
156381800|NCT01618838|564490266|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
156381801|NCT01587651|564490267|FG000|Overall Study|Adverse Event|0|||
156381802|NCT01587651|564490268|FG001|Overall Study|Adverse Event|1|||
156381803|NCT01587651|564490269|FG002|Overall Study|Adverse Event|0|||
156381804|NCT01587651|564490267|FG000|Overall Study|Protocol Violation|0|||
156546898|NCT00440947|565094995|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
156546899|NCT00440947|565094996|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
156381805|NCT01587651|564490268|FG001|Overall Study|Protocol Violation|1|||
156381806|NCT01587651|564490269|FG002|Overall Study|Protocol Violation|1|||
156381807|NCT01587651|564490267|FG000|Overall Study|Withdrawal by Subject|0|||
156381808|NCT01587651|564490268|FG001|Overall Study|Withdrawal by Subject|1|||
156381809|NCT01587651|564490269|FG002|Overall Study|Withdrawal by Subject|0|||
156381810|NCT01866709|564490270|FG000|Overall Study|Adverse Event|1|||
156501123|NCT00078377|564928040|FG002|Overall Study|Withdrawal by Subject|4|||
156501124|NCT00078377|564928038|FG000|Overall Study|Miscellaneous|2|||
156501125|NCT00078377|564928039|FG001|Overall Study|Miscellaneous|6|||
156501126|NCT00078377|564928040|FG002|Overall Study|Miscellaneous|1|||
156501127|NCT02568397|564928041|FG000|Period 2|Withdrawal by Subject|0|||
156501128|NCT02568397|564928042|FG001|Period 2|Withdrawal by Subject|1|||
156501129|NCT02568397|564928041|FG000|Period 2|Physician Decision|0|||
156501130|NCT02568397|564928042|FG001|Period 2|Physician Decision|1|||
156501131|NCT02354651|564928043|FG000|Overall Study|Withdrawal by Subject|2|||
156501132|NCT02354651|564928043|FG000|Overall Study|Physician Decision|1|||
156501133|NCT00581893|564928044|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
156501134|NCT00581893|564928045|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
156501135|NCT02550938|564928046|FG000|Overall Study|Lost to Follow-up|8|||
156501136|NCT02550938|564928047|FG001|Overall Study|Lost to Follow-up|7|||
156501137|NCT02550938|564928048|FG002|Overall Study|Lost to Follow-up|12|||
156501138|NCT02550938|564928049|FG003|Overall Study|Lost to Follow-up|11|||
156381811|NCT01866709|564490271|FG001|Overall Study|Adverse Event|0|||
156381812|NCT03285477|564490285|FG000|Treatment and Response Assessment Period|Death|1|||
156381813|NCT03285477|564490286|FG001|Treatment and Response Assessment Period|Death|0|||
156381814|NCT03285477|564490285|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
156381815|NCT03285477|564490286|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
156381816|NCT03285477|564490285|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
156381817|NCT03285477|564490286|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
156381818|NCT03285477|564490285|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
156381819|NCT03285477|564490286|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
156381820|NCT03285477|564490285|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
156381821|NCT03285477|564490286|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
156381822|NCT00560833|564490287|FG000|Overall Study|Adverse Event|16|||
156381823|NCT00560833|564490288|FG001|Overall Study|Adverse Event|10|||
156381824|NCT00560833|564490289|FG002|Overall Study|Adverse Event|25|||
156381825|NCT00560833|564490290|FG003|Overall Study|Adverse Event|23|||
156381826|NCT00560833|564490291|FG004|Overall Study|Adverse Event|35|||
156381827|NCT00560833|564490287|FG000|Overall Study|Lost to Follow-up|0|||
156381828|NCT00560833|564490288|FG001|Overall Study|Lost to Follow-up|0|||
156381829|NCT00560833|564490289|FG002|Overall Study|Lost to Follow-up|1|||
156381830|NCT00560833|564490290|FG003|Overall Study|Lost to Follow-up|0|||
156381831|NCT00560833|564490291|FG004|Overall Study|Lost to Follow-up|0|||
156381832|NCT00560833|564490287|FG000|Overall Study|Lack of Efficacy|22|||
156381833|NCT00560833|564490288|FG001|Overall Study|Lack of Efficacy|9|||
156381834|NCT00560833|564490289|FG002|Overall Study|Lack of Efficacy|6|||
156381835|NCT00560833|564490290|FG003|Overall Study|Lack of Efficacy|4|||
156381836|NCT00560833|564490291|FG004|Overall Study|Lack of Efficacy|4|||
156381837|NCT00560833|564490287|FG000|Overall Study|Participant uncooperative|5|||
156381838|NCT00560833|564490288|FG001|Overall Study|Participant uncooperative|5|||
156381839|NCT00560833|564490289|FG002|Overall Study|Participant uncooperative|4|||
156381840|NCT00560833|564490290|FG003|Overall Study|Participant uncooperative|4|||
156381841|NCT00560833|564490291|FG004|Overall Study|Participant uncooperative|2|||
156381842|NCT00560833|564490287|FG000|Overall Study|Other|1|||
156381843|NCT00560833|564490288|FG001|Overall Study|Other|1|||
156381844|NCT00560833|564490289|FG002|Overall Study|Other|3|||
156381845|NCT00560833|564490290|FG003|Overall Study|Other|0|||
156381846|NCT00560833|564490291|FG004|Overall Study|Other|0|||
156381847|NCT00560833|564490287|FG000|Overall Study|Never received drug|0|||
156381848|NCT00560833|564490288|FG001|Overall Study|Never received drug|1|||
156381849|NCT00560833|564490289|FG002|Overall Study|Never received drug|0|||
156381850|NCT00560833|564490290|FG003|Overall Study|Never received drug|0|||
156381851|NCT00560833|564490291|FG004|Overall Study|Never received drug|1|||
156381852|NCT03283670|564490292|FG000|Placebo Gas|Withdrawal by Subject|2|||
156381853|NCT03283670|564490292|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
156381854|NCT03283670|564490292|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
156501139|NCT01367847|564928050|FG000|Overall Study|Withdrawal by Subject|2|||
156381855|NCT01059617|564490295|FG000|Overall Study|Other|7|||
156501140|NCT01367847|564928051|FG001|Overall Study|Withdrawal by Subject|2|||
156381856|NCT01059617|564490296|FG001|Overall Study|Other|1|||
156381857|NCT01059617|564490297|FG002|Overall Study|Other|8|||
156381858|NCT01059617|564490298|FG003|Overall Study|Other|6|||
156381859|NCT01307501|564490299|FG000|Overall Study|Treatment Failure|1|||
156381860|NCT01307501|564490299|FG000|Overall Study|Death|20|||
156501141|NCT01454739|564928052|FG000|Overall Study|Protocol Violation|2|||
156501142|NCT01454739|564928053|FG001|Overall Study|Protocol Violation|3|||
156501143|NCT01454739|564928052|FG000|Overall Study|Withdrawal by Subject|2|||
156501144|NCT01454739|564928053|FG001|Overall Study|Withdrawal by Subject|6|||
156381861|NCT01307501|564490299|FG000|Overall Study|Lost to Follow-up|1|||
156501145|NCT01454739|564928052|FG000|Overall Study|Other|3|||
156381862|NCT01307501|564490299|FG000|Overall Study|Starting Hospice|1|||
156381863|NCT00612313|564490306|FG000|Overall Study|Withdrawal by Subject|6|||
156381864|NCT00612313|564490307|FG001|Overall Study|Withdrawal by Subject|9|||
156501146|NCT01454739|564928053|FG001|Overall Study|Other|5|||
156381865|NCT00612313|564490306|FG000|Overall Study|Lost to Follow-up|11|||
156381866|NCT00612313|564490307|FG001|Overall Study|Lost to Follow-up|4|||
156381867|NCT01209624|564490313|FG000|Overall Study|Death|2|||
156381868|NCT01209624|564490313|FG000|Overall Study|Adverse Event|13|||
156381869|NCT01209624|564490313|FG000|Overall Study|Lack of Efficacy|17|||
156381870|NCT01209624|564490313|FG000|Overall Study|Lost to Follow-up|290|||
156381871|NCT01209624|564490313|FG000|Overall Study|Other|4|||
156381872|NCT03403634|564490314|FG000|Overall Study|Disease progression|3|||
156381873|NCT03403634|564490314|FG000|Overall Study|Did not meet eligibility criteria|4|||
156381874|NCT00428610|564490315|FG000|Overall Study|Death Due to Adverse Event|3|||
156381875|NCT00428610|564490316|FG001|Overall Study|Death Due to Adverse Event|0|||
156381876|NCT00428610|564490317|FG002|Overall Study|Death Due to Adverse Event|5|||
156381877|NCT00428610|564490315|FG000|Overall Study|Death Due to Progressive Disease|0|||
156381878|NCT00428610|564490316|FG001|Overall Study|Death Due to Progressive Disease|0|||
156381879|NCT00428610|564490317|FG002|Overall Study|Death Due to Progressive Disease|2|||
156381880|NCT00428610|564490315|FG000|Overall Study|Adverse Event|2|||
156381881|NCT00428610|564490316|FG001|Overall Study|Adverse Event|3|||
156381882|NCT00428610|564490317|FG002|Overall Study|Adverse Event|2|||
156381883|NCT00428610|564490315|FG000|Overall Study|Investigator Decision|2|||
156381884|NCT00428610|564490316|FG001|Overall Study|Investigator Decision|1|||
156381885|NCT00428610|564490317|FG002|Overall Study|Investigator Decision|1|||
156381886|NCT00428610|564490315|FG000|Overall Study|Progressive Disease|42|||
156381887|NCT00428610|564490316|FG001|Overall Study|Progressive Disease|14|||
156381888|NCT00428610|564490317|FG002|Overall Study|Progressive Disease|22|||
156381889|NCT00428610|564490315|FG000|Overall Study|Withdrawal by Subject|4|||
156381890|NCT00428610|564490316|FG001|Overall Study|Withdrawal by Subject|0|||
156381891|NCT00428610|564490317|FG002|Overall Study|Withdrawal by Subject|0|||
156381892|NCT03859323|564492417|FG000|Overall Study|Lost to Follow-up|0|||
156381893|NCT03859323|564492418|FG001|Overall Study|Lost to Follow-up|0|||
156381894|NCT03859323|564492419|FG002|Overall Study|Lost to Follow-up|0|||
156381895|NCT03859323|564492420|FG003|Overall Study|Lost to Follow-up|0|||
156381896|NCT03859323|564492421|FG004|Overall Study|Lost to Follow-up|0|||
156381897|NCT03859323|564492422|FG005|Overall Study|Lost to Follow-up|0|||
156381898|NCT03859323|564492423|FG006|Overall Study|Lost to Follow-up|1|||
156381899|NCT03859323|564492424|FG007|Overall Study|Lost to Follow-up|0|||
156381900|NCT03859323|564492425|FG008|Overall Study|Lost to Follow-up|0|||
156381901|NCT03859323|564492426|FG009|Overall Study|Lost to Follow-up|0|||
156381902|NCT03859323|564492427|FG010|Overall Study|Lost to Follow-up|0|||
156381903|NCT03859323|564492428|FG011|Overall Study|Lost to Follow-up|0|||
156381904|NCT03859323|564492429|FG012|Overall Study|Lost to Follow-up|0|||
156381905|NCT03859323|564492417|FG000|Overall Study|Withdrawal by Subject|0|||
156381906|NCT03859323|564492418|FG001|Overall Study|Withdrawal by Subject|0|||
156381907|NCT03859323|564492419|FG002|Overall Study|Withdrawal by Subject|1|||
156381908|NCT03859323|564492420|FG003|Overall Study|Withdrawal by Subject|0|||
156381909|NCT03859323|564492421|FG004|Overall Study|Withdrawal by Subject|0|||
156381910|NCT03859323|564492422|FG005|Overall Study|Withdrawal by Subject|1|||
156381911|NCT03859323|564492423|FG006|Overall Study|Withdrawal by Subject|0|||
156381912|NCT03859323|564492424|FG007|Overall Study|Withdrawal by Subject|0|||
156381913|NCT03859323|564492425|FG008|Overall Study|Withdrawal by Subject|0|||
156381914|NCT03859323|564492426|FG009|Overall Study|Withdrawal by Subject|1|||
156381915|NCT03859323|564492427|FG010|Overall Study|Withdrawal by Subject|1|||
156381916|NCT03859323|564492428|FG011|Overall Study|Withdrawal by Subject|2|||
156381917|NCT03859323|564492429|FG012|Overall Study|Withdrawal by Subject|1|||
156381918|NCT03859323|564492417|FG000|Overall Study|Pregnancy|0|||
156381919|NCT03859323|564492418|FG001|Overall Study|Pregnancy|0|||
156381920|NCT03859323|564492419|FG002|Overall Study|Pregnancy|0|||
156381921|NCT03859323|564492420|FG003|Overall Study|Pregnancy|0|||
156381922|NCT03859323|564492421|FG004|Overall Study|Pregnancy|0|||
156381923|NCT03859323|564492422|FG005|Overall Study|Pregnancy|0|||
156381924|NCT03859323|564492423|FG006|Overall Study|Pregnancy|0|||
156381925|NCT03859323|564492424|FG007|Overall Study|Pregnancy|0|||
156381926|NCT03859323|564492425|FG008|Overall Study|Pregnancy|0|||
156381927|NCT03859323|564492426|FG009|Overall Study|Pregnancy|1|||
156381928|NCT03859323|564492427|FG010|Overall Study|Pregnancy|0|||
156381929|NCT03859323|564492428|FG011|Overall Study|Pregnancy|0|||
156381930|NCT03859323|564492429|FG012|Overall Study|Pregnancy|0|||
156381931|NCT04745169|564492430|FG000|Overall Study|Kidney transplantation|1|||
156381932|NCT04745169|564492430|FG000|Overall Study|Participant health problems|3|||
156381933|NCT04745169|564492430|FG000|Overall Study|Physician Decision|2|||
156381934|NCT00993447|564492439|FG000|Overall Study|Withdrawal by Subject|23|||
156381935|NCT00993447|564492440|FG001|Overall Study|Withdrawal by Subject|8|||
156381936|NCT00993447|564492439|FG000|Overall Study|Protocol Violation|12|||
156381937|NCT00993447|564492440|FG001|Overall Study|Protocol Violation|8|||
156381938|NCT00993447|564492439|FG000|Overall Study|Lost to Follow-up|1|||
156381939|NCT00993447|564492440|FG001|Overall Study|Lost to Follow-up|3|||
156381940|NCT00993447|564492439|FG000|Overall Study|Adverse Event|1|||
156381941|NCT00993447|564492440|FG001|Overall Study|Adverse Event|0|||
156381942|NCT04401579|564492442|FG000|Overall Study|Death|23|||
156381943|NCT04401579|564492443|FG001|Overall Study|Death|36|||
156501147|NCT01454739|564928052|FG000|Overall Study|Physician Decision|0|||
156501148|NCT01454739|564928053|FG001|Overall Study|Physician Decision|5|||
156501149|NCT01454739|564928052|FG000|Overall Study|Lost to Follow-up|0|||
156501150|NCT01454739|564928053|FG001|Overall Study|Lost to Follow-up|1|||
156501151|NCT01454739|564928052|FG000|Overall Study|Adverse Event|0|||
156501152|NCT01454739|564928053|FG001|Overall Study|Adverse Event|1|||
156501153|NCT01375751|564928054|FG000|Overall Study|Other|0|||
156501154|NCT01375751|564928055|FG001|Overall Study|Other|1|||
156501155|NCT01375751|564928056|FG002|Overall Study|Other|0|||
156501156|NCT02980523|564928057|FG000|Overall Study|Lost to Follow-up|1|||
156501157|NCT02980523|564928058|FG001|Overall Study|Lost to Follow-up|4|||
156501158|NCT02980523|564928059|FG002|Overall Study|Lost to Follow-up|1|||
156501159|NCT02980523|564928060|FG003|Overall Study|Lost to Follow-up|2|||
156501160|NCT02980523|564928061|FG004|Overall Study|Lost to Follow-up|1|||
156501161|NCT02980523|564928057|FG000|Overall Study|Excluded from analysis|1|||
156501162|NCT02980523|564928058|FG001|Overall Study|Excluded from analysis|3|||
156501163|NCT02980523|564928059|FG002|Overall Study|Excluded from analysis|1|||
156501164|NCT02980523|564928060|FG003|Overall Study|Excluded from analysis|1|||
156501165|NCT02980523|564928061|FG004|Overall Study|Excluded from analysis|1|||
156501166|NCT02980523|564928057|FG000|Overall Study|Lack of Efficacy|1|||
156501167|NCT02980523|564928058|FG001|Overall Study|Lack of Efficacy|4|||
156501168|NCT02980523|564928059|FG002|Overall Study|Lack of Efficacy|4|||
156501169|NCT02980523|564928060|FG003|Overall Study|Lack of Efficacy|5|||
156501170|NCT02980523|564928061|FG004|Overall Study|Lack of Efficacy|8|||
156501171|NCT02980523|564928057|FG000|Overall Study|Did not receive intervention|0|||
156501172|NCT02980523|564928058|FG001|Overall Study|Did not receive intervention|0|||
156501173|NCT02980523|564928059|FG002|Overall Study|Did not receive intervention|0|||
156501174|NCT02980523|564928060|FG003|Overall Study|Did not receive intervention|1|||
156501175|NCT02980523|564928061|FG004|Overall Study|Did not receive intervention|0|||
156501176|NCT00633945|564928062|FG000|Overall Study|Physician Decision|2|||
156501177|NCT00882115|564928063|FG000|Overall Study|Withdrawal by Subject|3|||
156501178|NCT00882115|564928063|FG000|Overall Study|did not respond to DEP challe|6|||
156501179|NCT02552147|564928064|FG000|First Intervention (7 Days)|Protocol Violation|1|||
156501180|NCT02552147|564928065|FG001|First Intervention (7 Days)|Protocol Violation|0|||
156501181|NCT02552147|564928064|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
156501182|NCT02552147|564928065|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
156501183|NCT01547598|564928066|FG000|Overall Study|Withdrew consent|1|||
156501184|NCT01547598|564928067|FG001|Overall Study|Withdrew consent|1|||
156501185|NCT01547598|564928066|FG000|Overall Study|Lost to Follow-up|1|||
156501186|NCT01547598|564928067|FG001|Overall Study|Lost to Follow-up|1|||
156501187|NCT01547598|564928066|FG000|Overall Study|Adverse Event|1|||
156501188|NCT01547598|564928067|FG001|Overall Study|Adverse Event|1|||
156501189|NCT01547598|564928066|FG000|Overall Study|Protocol Violation|1|||
156501190|NCT01547598|564928067|FG001|Overall Study|Protocol Violation|1|||
156501191|NCT01547598|564928066|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156501192|NCT01547598|564928067|FG001|Overall Study|Other Miscellaneous Reasons|1|||
156501193|NCT00872001|564928071|FG000|Overall Study|Adverse Event|34|||
156501194|NCT00872001|564928072|FG001|Overall Study|Adverse Event|23|||
156501195|NCT00872001|564928071|FG000|Overall Study|Protocol Defined Clinical Event|5|||
156501196|NCT00872001|564928072|FG001|Overall Study|Protocol Defined Clinical Event|7|||
156501197|NCT00872001|564928071|FG000|Overall Study|Lost to Follow-up|13|||
156501198|NCT00872001|564928072|FG001|Overall Study|Lost to Follow-up|12|||
156501199|NCT00872001|564928071|FG000|Overall Study|Withdrawal by Subject|18|||
156501200|NCT00872001|564928072|FG001|Overall Study|Withdrawal by Subject|30|||
156501201|NCT00872001|564928071|FG000|Overall Study|Protocol Violation|5|||
156501202|NCT00872001|564928072|FG001|Overall Study|Protocol Violation|8|||
156501203|NCT00872001|564928071|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
156501204|NCT00872001|564928072|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
156501205|NCT00872001|564928071|FG000|Overall Study|Administrative|23|||
156501206|NCT00872001|564928072|FG001|Overall Study|Administrative|15|||
156501207|NCT04071301|564928073|FG000|Overall Study|Withdrawal by Subject|6|||
156501208|NCT04071301|564928073|FG000|Overall Study|Death|1|||
156501209|NCT00121667|564928074|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
156501210|NCT00121667|564928075|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
156501211|NCT00121667|564928076|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
156501212|NCT00121667|564928077|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
156501213|NCT00121667|564928074|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
156501214|NCT00121667|564928075|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
156501215|NCT00121667|564928076|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
156501216|NCT00121667|564928077|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
156501217|NCT00121667|564928074|FG000|Short Term (ST) Period|Adverse Event|5|||
156501218|NCT00121667|564928075|FG001|Short Term (ST) Period|Adverse Event|6|||
156501219|NCT00121667|564928076|FG002|Short Term (ST) Period|Adverse Event|5|||
156501220|NCT00121667|564928077|FG003|Short Term (ST) Period|Adverse Event|3|||
156501221|NCT00121667|564928074|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
156501222|NCT00121667|564928075|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
156501223|NCT00121667|564928076|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
156381944|NCT04401579|564492442|FG000|Overall Study|Lost to Follow-up|40|||
156381945|NCT04401579|564492443|FG001|Overall Study|Lost to Follow-up|41|||
156381946|NCT04401579|564492442|FG000|Overall Study|Withdrawal by Subject|8|||
156381947|NCT04401579|564492443|FG001|Overall Study|Withdrawal by Subject|16|||
156381948|NCT04401579|564492442|FG000|Overall Study|Physician Decision|1|||
156381949|NCT04401579|564492443|FG001|Overall Study|Physician Decision|2|||
156381950|NCT04401579|564492442|FG000|Overall Study|Became ineligible after enrollment|1|||
156381951|NCT04401579|564492443|FG001|Overall Study|Became ineligible after enrollment|1|||
156381952|NCT04401579|564492442|FG000|Overall Study|Enrolled but treatment not administered|7|||
156381953|NCT04401579|564492443|FG001|Overall Study|Enrolled but treatment not administered|9|||
156381954|NCT04401579|564492442|FG000|Overall Study|Adverse Event|2|||
156381955|NCT04401579|564492443|FG001|Overall Study|Adverse Event|1|||
156381956|NCT04401579|564492442|FG000|Overall Study|Scheduling error|1|||
156381957|NCT04401579|564492443|FG001|Overall Study|Scheduling error|2|||
156381958|NCT04401579|564492442|FG000|Overall Study|Transferred to another hospital|1|||
156381959|NCT04401579|564492443|FG001|Overall Study|Transferred to another hospital|2|||
156381960|NCT00489970|564492444|FG000|Persistence Year 9|Lost to Follow-up|2|||
156381961|NCT00489970|564492445|FG001|Persistence Year 9|Lost to Follow-up|2|||
156381962|NCT00489970|564492446|FG002|Persistence Year 9|Lost to Follow-up|3|||
156381963|NCT00489970|564492444|FG000|Persistence Year 9|Other|1|||
156381964|NCT00489970|564492445|FG001|Persistence Year 9|Other|0|||
156381965|NCT00489970|564492446|FG002|Persistence Year 9|Other|2|||
156381966|NCT01438411|564492447|FG000|Overall Study|Adverse Event|8|||
156381967|NCT01438411|564492447|FG000|Overall Study|Lost to Follow-up|1|||
156381968|NCT01438411|564492447|FG000|Overall Study|Lack of Efficacy|1|||
156381969|NCT01438411|564492447|FG000|Overall Study|Withdrawal by Subject|3|||
156381970|NCT01863680|564492448|FG000|Overall Study|Adverse Event|17|||
156381971|NCT01863680|564492448|FG000|Overall Study|Risk of OHSS|17|||
156381972|NCT01863680|564492448|FG000|Overall Study|Spontaneous pregnancy|2|||
156381973|NCT01863680|564492448|FG000|Overall Study|Withdrawal by Subject|1|||
156381974|NCT01863680|564492448|FG000|Overall Study|Did not undergo IVF/ET|14|||
156381975|NCT01863680|564492448|FG000|Overall Study|Other|6|||
156381976|NCT00618514|564492449|FG000|Overall Study|Lost to Follow-up|11|||
156381977|NCT00618514|564492450|FG001|Overall Study|Lost to Follow-up|12|||
156381978|NCT00618514|564492451|FG002|Overall Study|Lost to Follow-up|4|||
156381979|NCT03320070|564492458|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
156381980|NCT03320070|564492459|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
156381981|NCT03320070|564492458|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
156381982|NCT03320070|564492459|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
156381983|NCT03320070|564492458|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
156381984|NCT03320070|564492459|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
156381985|NCT03320070|564492458|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
156381986|NCT03320070|564492459|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
156381987|NCT03320070|564492458|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
156381988|NCT03320070|564492459|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
156381989|NCT03320070|564492458|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
156381990|NCT03320070|564492459|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
156381991|NCT02041195|564492460|FG000|Overall Study|Adverse Event|1|||
156381992|NCT02041195|564492461|FG001|Overall Study|Adverse Event|2|||
156381993|NCT02041195|564492462|FG002|Overall Study|Adverse Event|0|||
156381994|NCT02041195|564492463|FG003|Overall Study|Adverse Event|0|||
156381995|NCT02041195|564492464|FG004|Overall Study|Adverse Event|0|||
156381996|NCT02041195|564492465|FG005|Overall Study|Adverse Event|0|||
156381997|NCT02041195|564492466|FG006|Overall Study|Adverse Event|3|||
156381998|NCT02041195|564492467|FG007|Overall Study|Adverse Event|0|||
156381999|NCT02041195|564492460|FG000|Overall Study|Withdrawal by Subject|1|||
156382000|NCT02041195|564492461|FG001|Overall Study|Withdrawal by Subject|0|||
156382001|NCT02041195|564492462|FG002|Overall Study|Withdrawal by Subject|0|||
156382002|NCT02041195|564492463|FG003|Overall Study|Withdrawal by Subject|0|||
156382003|NCT02041195|564492464|FG004|Overall Study|Withdrawal by Subject|0|||
156382004|NCT02041195|564492465|FG005|Overall Study|Withdrawal by Subject|0|||
156382005|NCT02041195|564492466|FG006|Overall Study|Withdrawal by Subject|4|||
156382006|NCT02041195|564492467|FG007|Overall Study|Withdrawal by Subject|3|||
156501224|NCT00121667|564928077|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
156382007|NCT02041195|564492460|FG000|Overall Study|Unable to comply with study visits|0|||
156382008|NCT02041195|564492461|FG001|Overall Study|Unable to comply with study visits|1|||
156382009|NCT02041195|564492462|FG002|Overall Study|Unable to comply with study visits|0|||
156382010|NCT02041195|564492463|FG003|Overall Study|Unable to comply with study visits|0|||
156382011|NCT02041195|564492464|FG004|Overall Study|Unable to comply with study visits|1|||
156382012|NCT02041195|564492465|FG005|Overall Study|Unable to comply with study visits|0|||
156382013|NCT02041195|564492466|FG006|Overall Study|Unable to comply with study visits|0|||
156382014|NCT02041195|564492467|FG007|Overall Study|Unable to comply with study visits|0|||
156382015|NCT03564496|564492468|FG000|Overall Study|Withdrawal by Subject|1|||
156382016|NCT03564496|564492469|FG001|Overall Study|Withdrawal by Subject|1|||
156382017|NCT03564496|564492470|FG002|Overall Study|Withdrawal by Subject|0|||
156382018|NCT03564496|564492468|FG000|Overall Study|Screen failure|0|||
156382019|NCT03564496|564492469|FG001|Overall Study|Screen failure|3|||
156382020|NCT03564496|564492470|FG002|Overall Study|Screen failure|0|||
156382021|NCT00674986|564492471|FG000|Overall Study|Adverse Event|2|||
156382022|NCT00674986|564492472|FG001|Overall Study|Adverse Event|1|||
156382023|NCT00674986|564492471|FG000|Overall Study|Subject withdrew consent|12|||
156382024|NCT00674986|564492472|FG001|Overall Study|Subject withdrew consent|19|||
156382025|NCT00674986|564492471|FG000|Overall Study|Lost to Follow-up|25|||
156382026|NCT00674986|564492472|FG001|Overall Study|Lost to Follow-up|53|||
156382027|NCT00674986|564492471|FG000|Overall Study|Other reasons|4|||
156382028|NCT00674986|564492472|FG001|Overall Study|Other reasons|8|||
156382029|NCT02053350|564492477|FG000|Overall Study|Withdrawal by Subject|1|||
156382030|NCT02053350|564492477|FG000|Overall Study|Adverse Event|4|||
156382031|NCT03521635|564492478|FG000|Overall Study|Adverse Event|1|||
156382032|NCT03521635|564492479|FG001|Overall Study|Adverse Event|1|||
156382033|NCT03521635|564492478|FG000|Overall Study|Refused to complete study visit|1|||
156382034|NCT03521635|564492479|FG001|Overall Study|Refused to complete study visit|0|||
156382035|NCT03521635|564492478|FG000|Overall Study|Refused to continue trial medication|2|||
156382036|NCT03521635|564492479|FG001|Overall Study|Refused to continue trial medication|2|||
156382037|NCT03521635|564492478|FG000|Overall Study|Lost to Follow-up|0|||
156382038|NCT03521635|564492479|FG001|Overall Study|Lost to Follow-up|1|||
156382039|NCT03521635|564492478|FG000|Overall Study|Meet exclusion criteria|0|||
156382040|NCT03521635|564492479|FG001|Overall Study|Meet exclusion criteria|1|||
156382041|NCT03521635|564492478|FG000|Overall Study|Patient not taken study medicine|0|||
156382042|NCT03521635|564492479|FG001|Overall Study|Patient not taken study medicine|1|||
156382043|NCT02244944|564492480|FG000|Overall Study|Withdrawal by Subject|1|||
156382044|NCT02244944|564492480|FG000|Overall Study|Study Terminated|1|||
156382045|NCT01747772|564492481|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
156382046|NCT00896168|564492482|FG000|Overall Study|Adverse Event|4|||
156382047|NCT00896168|564492483|FG001|Overall Study|Adverse Event|7|||
156382048|NCT00896168|564492482|FG000|Overall Study|Treatment failure|8|||
156382049|NCT00896168|564492483|FG001|Overall Study|Treatment failure|10|||
156382050|NCT00896168|564492482|FG000|Overall Study|Lost to Follow-up|1|||
156382051|NCT00896168|564492483|FG001|Overall Study|Lost to Follow-up|1|||
156382052|NCT00896168|564492482|FG000|Overall Study|Other|1|||
156382053|NCT00896168|564492483|FG001|Overall Study|Other|1|||
156382054|NCT02492100|564492484|FG000|Overall Study|Death|1|||
156382055|NCT03832010|564492485|FG000|Overall Study|Withdrawal by Subject|2|||
156382056|NCT03832010|564492486|FG001|Overall Study|Withdrawal by Subject|1|||
156382057|NCT03832010|564492487|FG002|Overall Study|Withdrawal by Subject|0|||
156382058|NCT03832010|564492485|FG000|Overall Study|Lost to Follow-up|2|||
156382059|NCT03832010|564492486|FG001|Overall Study|Lost to Follow-up|1|||
156382060|NCT03832010|564492487|FG002|Overall Study|Lost to Follow-up|1|||
156382061|NCT01227889|564492488|FG000|Randomized Phase (RP)|Adverse Event|13|||
156382062|NCT01227889|564492489|FG001|Randomized Phase (RP)|Adverse Event|0|||
156382063|NCT01227889|564492488|FG000|Randomized Phase (RP)|Physician Decision|13|||
156382064|NCT01227889|564492489|FG001|Randomized Phase (RP)|Physician Decision|5|||
156382065|NCT01227889|564492488|FG000|Randomized Phase (RP)|Progressive Disease|135|||
156382066|NCT01227889|564492489|FG001|Randomized Phase (RP)|Progressive Disease|52|||
156382067|NCT01227889|564492488|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
156382068|NCT01227889|564492489|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
156382069|NCT01227889|564492488|FG000|Randomized Phase (RP)|Missing|1|||
156382070|NCT01227889|564492489|FG001|Randomized Phase (RP)|Missing|3|||
156382071|NCT01227889|564492488|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
156382072|NCT01227889|564492489|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
156382073|NCT01227889|564492488|FG000|Crossover Phase|Adverse Event|0|||
156382074|NCT01227889|564492489|FG001|Crossover Phase|Adverse Event|1|||
156382075|NCT01227889|564492488|FG000|Crossover Phase|Physician Decision|0|||
156382076|NCT01227889|564492489|FG001|Crossover Phase|Physician Decision|3|||
156382077|NCT01227889|564492488|FG000|Crossover Phase|Progressive Disease|0|||
156382078|NCT01227889|564492489|FG001|Crossover Phase|Progressive Disease|31|||
156382079|NCT01227889|564492488|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
156382080|NCT01227889|564492489|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
156382081|NCT01227889|564492488|FG000|Crossover Phase|Withdrawal by Subject|0|||
156382082|NCT01227889|564492489|FG001|Crossover Phase|Withdrawal by Subject|1|||
156501225|NCT00121667|564928074|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
156382083|NCT04121962|564492490|FG000|Overall Study|Lost to Follow-up|42|||
156382084|NCT04121962|564492491|FG001|Overall Study|Lost to Follow-up|39|||
156382085|NCT02417246|564492496|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
156382086|NCT02417246|564492497|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
156382087|NCT02417246|564492496|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
156501226|NCT00121667|564928075|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
156382088|NCT02417246|564492497|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
156382089|NCT02417246|564492496|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
156382090|NCT02417246|564492497|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
156382091|NCT02417246|564492496|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
156382092|NCT02417246|564492497|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
156382093|NCT04408469|564492501|FG000|Overall Study|Lost to Follow-up|6|||
156382094|NCT04408469|564492502|FG001|Overall Study|Lost to Follow-up|9|||
156382095|NCT04408469|564492501|FG000|Overall Study|Withdrawal by Subject|6|||
156382096|NCT04408469|564492502|FG001|Overall Study|Withdrawal by Subject|1|||
156382097|NCT04408469|564492501|FG000|Overall Study|Dismissal due to ineligibility|0|||
156382098|NCT04408469|564492502|FG001|Overall Study|Dismissal due to ineligibility|1|||
156382099|NCT04321460|564492503|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
156382100|NCT04321460|564492504|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
156382101|NCT01308749|564492505|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
156382102|NCT01308749|564492506|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
156382103|NCT01308749|564492505|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
156382104|NCT01308749|564492506|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
156382105|NCT01308749|564492505|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
156382106|NCT01308749|564492506|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
156382107|NCT01197950|564492511|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
156382108|NCT01197950|564492512|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
156382109|NCT01197950|564492513|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
156382110|NCT02553330|564492514|FG000|Overall Study|Study Terminated by Sponsor|2|||
156382111|NCT02553330|564492515|FG001|Overall Study|Study Terminated by Sponsor|13|||
156382112|NCT02553330|564492516|FG002|Overall Study|Study Terminated by Sponsor|12|||
156382113|NCT02553330|564492514|FG000|Overall Study|Withdrawal by Subject|3|||
156382114|NCT02553330|564492515|FG001|Overall Study|Withdrawal by Subject|19|||
156382115|NCT02553330|564492516|FG002|Overall Study|Withdrawal by Subject|21|||
156382116|NCT02553330|564492514|FG000|Overall Study|Other|0|||
156382117|NCT02553330|564492515|FG001|Overall Study|Other|1|||
156382118|NCT02553330|564492516|FG002|Overall Study|Other|0|||
156382119|NCT02553330|564492514|FG000|Overall Study|Non compliance to study treatment|0|||
156382120|NCT02553330|564492515|FG001|Overall Study|Non compliance to study treatment|1|||
156382121|NCT02553330|564492516|FG002|Overall Study|Non compliance to study treatment|0|||
156382122|NCT02553330|564492514|FG000|Overall Study|Adverse Event|0|||
156382123|NCT02553330|564492515|FG001|Overall Study|Adverse Event|1|||
156382124|NCT02553330|564492516|FG002|Overall Study|Adverse Event|0|||
156382125|NCT02553330|564492514|FG000|Overall Study|Lost to Follow-up|0|||
156382126|NCT02553330|564492515|FG001|Overall Study|Lost to Follow-up|4|||
156382127|NCT02553330|564492516|FG002|Overall Study|Lost to Follow-up|4|||
156382128|NCT01205685|564492517|FG000|Overall Study|Disease Progression|10|||
156382129|NCT01205685|564492517|FG000|Overall Study|Withdrawal by Subject|1|||
156382130|NCT01666002|564492518|FG000|Overall Study|Lost to Follow-up|5|||
156382131|NCT01666002|564492519|FG001|Overall Study|Lost to Follow-up|0|||
156382132|NCT03058679|564492532|FG000|Baseline to Week 6|Lost to Follow-up|3|||
156382133|NCT03058679|564492533|FG001|Baseline to Week 6|Lost to Follow-up|2|||
156382134|NCT03058679|564492532|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
156382135|NCT03058679|564492533|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
156382136|NCT03058679|564492532|FG000|Baseline to Week 6|Adverse Event|6|||
156382137|NCT03058679|564492533|FG001|Baseline to Week 6|Adverse Event|6|||
156382138|NCT03058679|564492532|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
156382139|NCT03058679|564492533|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
156382140|NCT03058679|564492532|FG000|Baseline to Week 6|Difficulty following the diet|0|||
156382141|NCT03058679|564492533|FG001|Baseline to Week 6|Difficulty following the diet|2|||
156382142|NCT03058679|564492532|FG000|Baseline to Week 6|Physician Decision|1|||
156382143|NCT03058679|564492533|FG001|Baseline to Week 6|Physician Decision|0|||
156382144|NCT03058679|564492532|FG000|Week 6 to Week 12|Change in medication|5|||
156382145|NCT03058679|564492533|FG001|Week 6 to Week 12|Change in medication|7|||
156382146|NCT03058679|564492532|FG000|Week 6 to Week 12|Adverse Event|4|||
156382147|NCT03058679|564492533|FG001|Week 6 to Week 12|Adverse Event|3|||
156382148|NCT03058679|564492532|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
156382149|NCT03058679|564492533|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
156382150|NCT03058679|564492532|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
156382151|NCT03058679|564492533|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
156382152|NCT02265705|564492543|FG000|Treatment Period Week 0-24|Adverse Event|3|||
156501227|NCT00121667|564928076|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
156382153|NCT02265705|564492544|FG001|Treatment Period Week 0-24|Adverse Event|2|||
156382154|NCT02265705|564492545|FG002|Treatment Period Week 0-24|Adverse Event|0|||
156501228|NCT00121667|564928077|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
156382155|NCT02265705|564492546|FG003|Treatment Period Week 0-24|Adverse Event|0|||
156501229|NCT00121667|564928074|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
156501230|NCT00121667|564928075|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
156382156|NCT02265705|564492547|FG004|Treatment Period Week 0-24|Adverse Event|0|||
156382157|NCT02265705|564492548|FG005|Treatment Period Week 0-24|Adverse Event|0|||
156382158|NCT02265705|564492549|FG006|Treatment Period Week 0-24|Adverse Event|0|||
156501231|NCT00121667|564928076|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
156501232|NCT00121667|564928077|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
156501233|NCT00121667|564928074|FG000|Short Term (ST) Period|Other Reason|3|||
156501234|NCT00121667|564928075|FG001|Short Term (ST) Period|Other Reason|0|||
156501235|NCT00121667|564928076|FG002|Short Term (ST) Period|Other Reason|0|||
156501236|NCT00121667|564928077|FG003|Short Term (ST) Period|Other Reason|0|||
156501237|NCT00121667|564928074|FG000|Short Term (ST) Period|Death|0|||
156501238|NCT00121667|564928075|FG001|Short Term (ST) Period|Death|0|||
156501239|NCT00121667|564928076|FG002|Short Term (ST) Period|Death|0|||
156501240|NCT00121667|564928077|FG003|Short Term (ST) Period|Death|1|||
156501241|NCT00121667|564928074|FG000|Short Term (ST) Period|Pregnancy|0|||
156501242|NCT00121667|564928075|FG001|Short Term (ST) Period|Pregnancy|0|||
156501243|NCT00121667|564928076|FG002|Short Term (ST) Period|Pregnancy|0|||
156501244|NCT00121667|564928077|FG003|Short Term (ST) Period|Pregnancy|1|||
156501245|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
156501246|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
156501247|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
156501248|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
156501249|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
156501250|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
156501251|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
156501252|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
156501253|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
156501254|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
156501255|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
156501256|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
156501257|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
156501258|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
156501259|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
156501260|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
156501261|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
156501262|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
156501263|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
156501264|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
156501265|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
156501266|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
156501267|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
156501268|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
156501269|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
156501270|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
156501271|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
156501272|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
156501273|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
156501274|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
156501275|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
156501276|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
156501277|NCT00121667|564928074|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
156501278|NCT00121667|564928075|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
156501279|NCT00121667|564928076|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
156501280|NCT00121667|564928077|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
156501281|NCT02879383|564928078|FG000|First 24 Weeks|Physician Decision|0|||
156501282|NCT02879383|564928079|FG001|First 24 Weeks|Physician Decision|1|||
156501283|NCT02879383|564928080|FG002|First 24 Weeks|Physician Decision|0|||
156501284|NCT02879383|564928081|FG003|First 24 Weeks|Physician Decision|0|||
156501285|NCT05186311|564928082|FG000|Part A: Serum|Withdrawal by Subject|1|||
156501286|NCT04468230|564928089|FG000|Overall Study|Adverse Event|2|||
156501287|NCT03912662|564928091|FG000|Overall Study|Adverse Event|3|||
156501288|NCT03912662|564928091|FG000|Overall Study|Adverse Event and Death|1|||
156501289|NCT03912662|564928091|FG000|Overall Study|Death|1|||
156501290|NCT03912662|564928091|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
156501291|NCT03912662|564928091|FG000|Overall Study|Mesh Removal|1|||
156501292|NCT03912662|564928091|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
156501293|NCT03912662|564928091|FG000|Overall Study|Early study termination|20|||
156501294|NCT01790295|564928102|FG000|Overall Study|Adverse Event|1|||
156501295|NCT01790295|564928102|FG000|Overall Study|Death|4|||
156501296|NCT01790295|564928102|FG000|Overall Study|Lack of Efficacy|2|||
156501297|NCT01790295|564928102|FG000|Overall Study|Study closure|4|||
156501298|NCT00420784|564928107|FG000|Overall Study|Adverse Event|11|||
156501299|NCT00420784|564928108|FG001|Overall Study|Adverse Event|29|||
156546900|NCT00440947|565094997|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
156546901|NCT00440947|565094998|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
156546902|NCT00440947|565094999|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
156546903|NCT00440947|565094995|FG000|48-Week Randomization Phase|Pregnancy|0|||
156546904|NCT00440947|565094996|FG001|48-Week Randomization Phase|Pregnancy|0|||
156382159|NCT02265705|564492543|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
156382160|NCT02265705|564492544|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
156382161|NCT02265705|564492545|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156382162|NCT02265705|564492546|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156382163|NCT02265705|564492547|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156382164|NCT02265705|564492548|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156382165|NCT02265705|564492549|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156382166|NCT02265705|564492543|FG000|Treatment Period Week 0-24|Physician Decision|1|||
156382167|NCT02265705|564492544|FG001|Treatment Period Week 0-24|Physician Decision|0|||
156382168|NCT02265705|564492545|FG002|Treatment Period Week 0-24|Physician Decision|0|||
156382169|NCT02265705|564492546|FG003|Treatment Period Week 0-24|Physician Decision|0|||
156382170|NCT02265705|564492547|FG004|Treatment Period Week 0-24|Physician Decision|0|||
156382171|NCT02265705|564492548|FG005|Treatment Period Week 0-24|Physician Decision|0|||
156382172|NCT02265705|564492549|FG006|Treatment Period Week 0-24|Physician Decision|0|||
156382173|NCT02265705|564492543|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
156382174|NCT02265705|564492544|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
156382175|NCT02265705|564492545|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156382176|NCT02265705|564492546|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156382177|NCT02265705|564492547|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156382178|NCT02265705|564492548|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156382179|NCT02265705|564492549|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156382180|NCT02265705|564492543|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
156382181|NCT02265705|564492544|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
156382182|NCT02265705|564492545|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
156382183|NCT02265705|564492546|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
156382184|NCT02265705|564492547|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
156382185|NCT02265705|564492548|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
156382186|NCT02265705|564492549|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
156382187|NCT02265705|564492543|FG000|Rescue Period|Withdrawal by Subject|0|||
156382188|NCT02265705|564492544|FG001|Rescue Period|Withdrawal by Subject|0|||
156382189|NCT02265705|564492545|FG002|Rescue Period|Withdrawal by Subject|1|||
156382190|NCT02265705|564492546|FG003|Rescue Period|Withdrawal by Subject|0|||
156382191|NCT02265705|564492547|FG004|Rescue Period|Withdrawal by Subject|0|||
156382192|NCT02265705|564492548|FG005|Rescue Period|Withdrawal by Subject|0|||
156382193|NCT02265705|564492549|FG006|Rescue Period|Withdrawal by Subject|0|||
156382194|NCT02265705|564492543|FG000|Rescue Period|Death|0|||
156382195|NCT02265705|564492544|FG001|Rescue Period|Death|0|||
156382196|NCT02265705|564492545|FG002|Rescue Period|Death|1|||
156382197|NCT02265705|564492546|FG003|Rescue Period|Death|0|||
156382198|NCT02265705|564492547|FG004|Rescue Period|Death|0|||
156382199|NCT02265705|564492548|FG005|Rescue Period|Death|0|||
156382200|NCT02265705|564492549|FG006|Rescue Period|Death|0|||
156382201|NCT02265705|564492543|FG000|Rescue Period|Lack of Efficacy|0|||
156382202|NCT02265705|564492544|FG001|Rescue Period|Lack of Efficacy|0|||
156382203|NCT02265705|564492545|FG002|Rescue Period|Lack of Efficacy|1|||
156382204|NCT02265705|564492546|FG003|Rescue Period|Lack of Efficacy|0|||
156382205|NCT02265705|564492547|FG004|Rescue Period|Lack of Efficacy|0|||
156382206|NCT02265705|564492548|FG005|Rescue Period|Lack of Efficacy|0|||
156382207|NCT02265705|564492549|FG006|Rescue Period|Lack of Efficacy|0|||
156382208|NCT02265705|564492543|FG000|Open Label Period|Adverse Event|0|||
156382209|NCT02265705|564492544|FG001|Open Label Period|Adverse Event|0|||
156382210|NCT02265705|564492545|FG002|Open Label Period|Adverse Event|0|||
156382211|NCT02265705|564492546|FG003|Open Label Period|Adverse Event|2|||
156382212|NCT02265705|564492547|FG004|Open Label Period|Adverse Event|2|||
156382213|NCT02265705|564492548|FG005|Open Label Period|Adverse Event|0|||
156382214|NCT02265705|564492549|FG006|Open Label Period|Adverse Event|0|||
156382215|NCT02265705|564492543|FG000|Open Label Period|Physician Decision|0|||
156382216|NCT02265705|564492544|FG001|Open Label Period|Physician Decision|0|||
156382217|NCT02265705|564492545|FG002|Open Label Period|Physician Decision|0|||
156382218|NCT02265705|564492546|FG003|Open Label Period|Physician Decision|0|||
156382219|NCT02265705|564492547|FG004|Open Label Period|Physician Decision|1|||
156382220|NCT02265705|564492548|FG005|Open Label Period|Physician Decision|0|||
156382221|NCT02265705|564492549|FG006|Open Label Period|Physician Decision|0|||
156382222|NCT02265705|564492543|FG000|Open Label Period|Withdrawal by Subject|0|||
156382223|NCT02265705|564492544|FG001|Open Label Period|Withdrawal by Subject|0|||
156382224|NCT02265705|564492545|FG002|Open Label Period|Withdrawal by Subject|0|||
156382225|NCT02265705|564492546|FG003|Open Label Period|Withdrawal by Subject|0|||
156546905|NCT00440947|565094997|FG002|48-Week Randomization Phase|Pregnancy|1|||
156382226|NCT02265705|564492547|FG004|Open Label Period|Withdrawal by Subject|2|||
156546906|NCT00440947|565094998|FG003|48-Week Randomization Phase|Pregnancy|0|||
156382227|NCT02265705|564492548|FG005|Open Label Period|Withdrawal by Subject|0|||
156382228|NCT02265705|564492549|FG006|Open Label Period|Withdrawal by Subject|0|||
156382229|NCT02265705|564492543|FG000|Follow-up Period|Sponsor Decision|0|||
156382230|NCT02265705|564492544|FG001|Follow-up Period|Sponsor Decision|0|||
156382231|NCT02265705|564492545|FG002|Follow-up Period|Sponsor Decision|0|||
156382232|NCT02265705|564492546|FG003|Follow-up Period|Sponsor Decision|0|||
156382233|NCT02265705|564492547|FG004|Follow-up Period|Sponsor Decision|0|||
156382234|NCT02265705|564492548|FG005|Follow-up Period|Sponsor Decision|1|||
156382235|NCT02265705|564492549|FG006|Follow-up Period|Sponsor Decision|6|||
156382236|NCT02265705|564492543|FG000|Follow-up Period|Adverse Event|0|||
156382237|NCT02265705|564492544|FG001|Follow-up Period|Adverse Event|0|||
156382238|NCT02265705|564492545|FG002|Follow-up Period|Adverse Event|0|||
156382239|NCT02265705|564492546|FG003|Follow-up Period|Adverse Event|0|||
156382240|NCT02265705|564492547|FG004|Follow-up Period|Adverse Event|0|||
156382241|NCT02265705|564492548|FG005|Follow-up Period|Adverse Event|0|||
156382242|NCT02265705|564492549|FG006|Follow-up Period|Adverse Event|3|||
156382243|NCT02265705|564492543|FG000|Follow-up Period|Physician Decision|0|||
156382244|NCT02265705|564492544|FG001|Follow-up Period|Physician Decision|0|||
156382245|NCT02265705|564492545|FG002|Follow-up Period|Physician Decision|0|||
156382246|NCT02265705|564492546|FG003|Follow-up Period|Physician Decision|0|||
156382247|NCT02265705|564492547|FG004|Follow-up Period|Physician Decision|0|||
156382248|NCT02265705|564492548|FG005|Follow-up Period|Physician Decision|0|||
156382249|NCT02265705|564492549|FG006|Follow-up Period|Physician Decision|1|||
156382250|NCT02265705|564492543|FG000|Follow-up Period|Withdrawal by Subject|0|||
156382251|NCT02265705|564492544|FG001|Follow-up Period|Withdrawal by Subject|0|||
156382252|NCT02265705|564492545|FG002|Follow-up Period|Withdrawal by Subject|0|||
156382253|NCT02265705|564492546|FG003|Follow-up Period|Withdrawal by Subject|0|||
156382254|NCT02265705|564492547|FG004|Follow-up Period|Withdrawal by Subject|0|||
156382255|NCT02265705|564492548|FG005|Follow-up Period|Withdrawal by Subject|0|||
156382256|NCT02265705|564492549|FG006|Follow-up Period|Withdrawal by Subject|1|||
156382257|NCT01255358|564492554|FG000|Overall Study|Adverse Event|2|||
156382258|NCT01255358|564492554|FG000|Overall Study|Protocol Violation|2|||
156382259|NCT06027216|564492555|FG000|Overall Study|Did not qualify|8|||
156382260|NCT03231371|564492556|FG000|Overall Study|Withdrawal by Subject|1|||
156382261|NCT03231371|564492556|FG000|Overall Study|chose or were ineligible to have MRI|12|||
156382262|NCT00345579|564492560|FG000|Overall Study|Adverse Event|9|||
156382263|NCT00345579|564492561|FG001|Overall Study|Adverse Event|6|||
156382264|NCT00345579|564492560|FG000|Overall Study|Protocol Violation|14|||
156382265|NCT00345579|564492561|FG001|Overall Study|Protocol Violation|5|||
156382266|NCT00345579|564492560|FG000|Overall Study|Withdrawal by Subject|50|||
156382267|NCT00345579|564492561|FG001|Overall Study|Withdrawal by Subject|17|||
156382268|NCT00345579|564492560|FG000|Overall Study|Lost to Follow-up|82|||
156382269|NCT00345579|564492561|FG001|Overall Study|Lost to Follow-up|36|||
156382270|NCT00345579|564492560|FG000|Overall Study|Other|9|||
156382271|NCT00345579|564492561|FG001|Overall Study|Other|1|||
156382272|NCT03029208|564492562|FG000|Overall Study|Withdrawal by Subject|2|||
156382273|NCT03029208|564492563|FG001|Overall Study|Withdrawal by Subject|3|||
156382274|NCT03029208|564492562|FG000|Overall Study|Lost to Follow-up|0|||
156382275|NCT03029208|564492563|FG001|Overall Study|Lost to Follow-up|1|||
156382276|NCT03207750|564492566|FG000|Overall Study|Adverse Event|3|||
156382277|NCT03207750|564492567|FG001|Overall Study|Adverse Event|2|||
156382278|NCT03207750|564492566|FG000|Overall Study|Lost to Follow-up|21|||
156382279|NCT03207750|564492567|FG001|Overall Study|Lost to Follow-up|29|||
156382280|NCT03207750|564492566|FG000|Overall Study|Protocol Violation|0|||
156382281|NCT03207750|564492567|FG001|Overall Study|Protocol Violation|1|||
156382282|NCT03207750|564492566|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
156382283|NCT03207750|564492567|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
156382284|NCT03207750|564492566|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
156382285|NCT03207750|564492567|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
156382286|NCT03207750|564492566|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
156382287|NCT03207750|564492567|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
156382288|NCT03207750|564492566|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
156382289|NCT03207750|564492567|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
156382290|NCT03207750|564492566|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
156382291|NCT03207750|564492567|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
156382292|NCT02493361|564492568|FG000|Overall Study|Withdrawal by Subject|3|||
156382293|NCT00856583|564492571|FG000|Overall Study|Lack of Efficacy|389|||
156382294|NCT00856583|564492572|FG001|Overall Study|Lack of Efficacy|377|||
156382295|NCT00856583|564492571|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
156382296|NCT00856583|564492572|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
156382297|NCT00856583|564492571|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
156382298|NCT00856583|564492572|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
156382299|NCT00856583|564492571|FG000|Overall Study|Non-compliance|305|||
156382300|NCT00856583|564492572|FG001|Overall Study|Non-compliance|262|||
156382301|NCT00856583|564492571|FG000|Overall Study|Withdrawal by Subject|1092|||
156382302|NCT00856583|564492572|FG001|Overall Study|Withdrawal by Subject|919|||
156501300|NCT00420784|564928109|FG002|Overall Study|Adverse Event|10|||
156501301|NCT00420784|564928110|FG003|Overall Study|Adverse Event|5|||
156501302|NCT00420784|564928107|FG000|Overall Study|Withdrawal by Subject|0|||
156501303|NCT00420784|564928108|FG001|Overall Study|Withdrawal by Subject|1|||
156501304|NCT00420784|564928109|FG002|Overall Study|Withdrawal by Subject|0|||
156501305|NCT00420784|564928110|FG003|Overall Study|Withdrawal by Subject|0|||
156501306|NCT00420784|564928107|FG000|Overall Study|Lost to Follow-up|0|||
156501307|NCT00420784|564928108|FG001|Overall Study|Lost to Follow-up|0|||
156501308|NCT00420784|564928109|FG002|Overall Study|Lost to Follow-up|2|||
156501309|NCT00420784|564928110|FG003|Overall Study|Lost to Follow-up|1|||
156501310|NCT00420784|564928107|FG000|Overall Study|Virologic Stopping Rule|17|||
156501311|NCT00420784|564928108|FG001|Overall Study|Virologic Stopping Rule|26|||
156501312|NCT00420784|564928109|FG002|Overall Study|Virologic Stopping Rule|41|||
156501313|NCT00420784|564928110|FG003|Overall Study|Virologic Stopping Rule|67|||
156501314|NCT00420784|564928107|FG000|Overall Study|Other|1|||
156501315|NCT00420784|564928108|FG001|Overall Study|Other|2|||
156501316|NCT00420784|564928109|FG002|Overall Study|Other|0|||
156501317|NCT00420784|564928110|FG003|Overall Study|Other|5|||
156501318|NCT00983853|564928113|FG000|Overall Study|Lost to Follow-up|1|||
156501319|NCT00983853|564928114|FG001|Overall Study|Lost to Follow-up|1|||
156501320|NCT00983853|564928115|FG002|Overall Study|Lost to Follow-up|2|||
156501321|NCT00983853|564928116|FG003|Overall Study|Lost to Follow-up|2|||
156501322|NCT00983853|564928117|FG004|Overall Study|Lost to Follow-up|2|||
156501323|NCT00983853|564928118|FG005|Overall Study|Lost to Follow-up|1|||
156501324|NCT00983853|564928113|FG000|Overall Study|Withdrawal by Subject|0|||
156501325|NCT00983853|564928114|FG001|Overall Study|Withdrawal by Subject|0|||
156501326|NCT00983853|564928115|FG002|Overall Study|Withdrawal by Subject|1|||
156501327|NCT00983853|564928116|FG003|Overall Study|Withdrawal by Subject|0|||
156501328|NCT00983853|564928117|FG004|Overall Study|Withdrawal by Subject|1|||
156501329|NCT00983853|564928118|FG005|Overall Study|Withdrawal by Subject|0|||
156501330|NCT00983853|564928113|FG000|Overall Study|Unable to come to study follow-up visits|0|||
156501331|NCT00983853|564928114|FG001|Overall Study|Unable to come to study follow-up visits|1|||
156501332|NCT00983853|564928115|FG002|Overall Study|Unable to come to study follow-up visits|0|||
156501333|NCT00983853|564928116|FG003|Overall Study|Unable to come to study follow-up visits|0|||
156501334|NCT00983853|564928117|FG004|Overall Study|Unable to come to study follow-up visits|0|||
156501335|NCT00983853|564928118|FG005|Overall Study|Unable to come to study follow-up visits|0|||
156501336|NCT02599688|564928119|FG000|Overall Study|Lack of Efficacy|1|||
156501337|NCT02599688|564928119|FG000|Overall Study|Withdrawal by Subject|1|||
156501338|NCT02599688|564928119|FG000|Overall Study|Termination by Sponsor|2|||
156501339|NCT01318876|564928123|FG000|Day 8 Survey|email address invalid|96|||
156501340|NCT01318876|564928123|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
156501341|NCT01318876|564928123|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
156501342|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
156501343|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
156501344|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
156501345|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
156501346|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
156501347|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
156501348|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
156501349|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
156501350|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
156501351|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
156501352|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
156501353|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
156501354|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
156501355|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
156501356|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
156501357|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
156501358|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
156382303|NCT00856583|564492571|FG000|Overall Study|Physician Decision|59|||
156382304|NCT00856583|564492572|FG001|Overall Study|Physician Decision|82|||
156501359|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
156501360|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Missing|2|||
156501361|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Missing|1|||
156382305|NCT00856583|564492571|FG000|Overall Study|Pregnancy|14|||
156501362|NCT00443209|564928124|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
156501363|NCT00443209|564928125|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
156501364|NCT00443209|564928124|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
156501365|NCT00443209|564928125|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
156501366|NCT00443209|564928124|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
156501367|NCT00443209|564928125|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
156501368|NCT00443209|564928124|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
156382306|NCT00856583|564492572|FG001|Overall Study|Pregnancy|5|||
156501369|NCT00443209|564928125|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
156501370|NCT00443209|564928124|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
156501371|NCT00443209|564928125|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
156501372|NCT00443209|564928124|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
156501373|NCT00443209|564928125|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
156501374|NCT00443209|564928124|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
156501375|NCT00443209|564928125|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
156501376|NCT00478205|564928128|FG000|Overall Study|Adverse Event|182|||
156501377|NCT00478205|564928129|FG001|Overall Study|Adverse Event|39|||
156501378|NCT00478205|564928128|FG000|Overall Study|Medication Non-compliance|9|||
156501379|NCT00478205|564928129|FG001|Overall Study|Medication Non-compliance|4|||
156501380|NCT00478205|564928128|FG000|Overall Study|Protocol Violation|15|||
156501381|NCT00478205|564928129|FG001|Overall Study|Protocol Violation|5|||
156501382|NCT00478205|564928128|FG000|Overall Study|Request of Investigator or Sponsor|4|||
156501383|NCT00478205|564928129|FG001|Overall Study|Request of Investigator or Sponsor|5|||
156501384|NCT00478205|564928128|FG000|Overall Study|Withdrawal by Subject|61|||
156501385|NCT00478205|564928129|FG001|Overall Study|Withdrawal by Subject|22|||
156501386|NCT00478205|564928128|FG000|Overall Study|Lack of Efficacy|1|||
156501387|NCT00478205|564928129|FG001|Overall Study|Lack of Efficacy|0|||
156501388|NCT00478205|564928128|FG000|Overall Study|Other|24|||
156501389|NCT00478205|564928129|FG001|Overall Study|Other|12|||
156501390|NCT01012947|564928130|FG000|Overall Study|Lost to Follow-up|131|||
156501391|NCT01012947|564928131|FG001|Overall Study|Lost to Follow-up|135|||
156501392|NCT01012947|564928132|FG002|Overall Study|Lost to Follow-up|130|||
156501393|NCT01012947|564928133|FG003|Overall Study|Lost to Follow-up|118|||
156501394|NCT01012947|564928134|FG004|Overall Study|Lost to Follow-up|142|||
156501395|NCT02127125|564928135|FG000|Overall Study|Lost to Follow-up|0|||
156501396|NCT02127125|564928136|FG001|Overall Study|Lost to Follow-up|0|||
156501397|NCT02127125|564928137|FG002|Overall Study|Lost to Follow-up|0|||
156501398|NCT02127125|564928138|FG003|Overall Study|Lost to Follow-up|0|||
156501399|NCT02127125|564928139|FG004|Overall Study|Lost to Follow-up|2|||
156501400|NCT02127125|564928140|FG005|Overall Study|Lost to Follow-up|1|||
156382307|NCT00856583|564492571|FG000|Overall Study|Other|92|||
156382308|NCT00856583|564492572|FG001|Overall Study|Other|104|||
156382309|NCT00856583|564492571|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
156382310|NCT00856583|564492572|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
156382311|NCT02937545|564492573|FG000|Overall Study|Withdrawal by Subject|1|||
156382312|NCT02937545|564492574|FG001|Overall Study|Withdrawal by Subject|2|||
156382313|NCT02937545|564492575|FG002|Overall Study|Withdrawal by Subject|6|||
156382314|NCT02937545|564492576|FG003|Overall Study|Withdrawal by Subject|7|||
156382315|NCT02937545|564492573|FG000|Overall Study|Lost to Follow-up|1|||
156382316|NCT02937545|564492574|FG001|Overall Study|Lost to Follow-up|0|||
156382317|NCT02937545|564492575|FG002|Overall Study|Lost to Follow-up|0|||
156501401|NCT02127125|564928141|FG006|Overall Study|Lost to Follow-up|0|||
156501402|NCT02127125|564928142|FG007|Overall Study|Lost to Follow-up|0|||
156501403|NCT02127125|564928143|FG008|Overall Study|Lost to Follow-up|0|||
156501404|NCT02127125|564928135|FG000|Overall Study|Withdrawal by Subject|0|||
156382318|NCT02937545|564492576|FG003|Overall Study|Lost to Follow-up|0|||
156382319|NCT01767116|564492577|FG000|Overall Study|Lost to Follow-up|2|||
156501405|NCT02127125|564928136|FG001|Overall Study|Withdrawal by Subject|0|||
156501406|NCT02127125|564928137|FG002|Overall Study|Withdrawal by Subject|0|||
156501407|NCT02127125|564928138|FG003|Overall Study|Withdrawal by Subject|1|||
156501408|NCT02127125|564928139|FG004|Overall Study|Withdrawal by Subject|0|||
156501409|NCT02127125|564928140|FG005|Overall Study|Withdrawal by Subject|0|||
156501410|NCT02127125|564928141|FG006|Overall Study|Withdrawal by Subject|0|||
156501411|NCT02127125|564928142|FG007|Overall Study|Withdrawal by Subject|0|||
156501412|NCT02127125|564928143|FG008|Overall Study|Withdrawal by Subject|0|||
156501413|NCT02127125|564928135|FG000|Overall Study|Physician Decision|0|||
156501414|NCT02127125|564928136|FG001|Overall Study|Physician Decision|0|||
156501415|NCT02127125|564928137|FG002|Overall Study|Physician Decision|1|||
156501416|NCT02127125|564928138|FG003|Overall Study|Physician Decision|0|||
156501417|NCT02127125|564928139|FG004|Overall Study|Physician Decision|1|||
156501418|NCT02127125|564928140|FG005|Overall Study|Physician Decision|2|||
156501419|NCT02127125|564928141|FG006|Overall Study|Physician Decision|0|||
156501420|NCT02127125|564928142|FG007|Overall Study|Physician Decision|0|||
156501421|NCT02127125|564928143|FG008|Overall Study|Physician Decision|0|||
156501422|NCT02282917|564928144|FG000|Overall Study|Withdrawal by Subject|1|||
156501423|NCT02282917|564928144|FG000|Overall Study|Screen Failure/Not Eligible|1|||
156501424|NCT01018732|564928145|FG000|Overall Study|Lost to Follow-up|0|||
156501425|NCT01018732|564928146|FG001|Overall Study|Lost to Follow-up|0|||
156501426|NCT01018732|564928147|FG002|Overall Study|Lost to Follow-up|3|||
156501427|NCT01018732|564928145|FG000|Overall Study|Protocol Violation|1|||
156501428|NCT01018732|564928146|FG001|Overall Study|Protocol Violation|1|||
156501429|NCT01018732|564928147|FG002|Overall Study|Protocol Violation|0|||
156501430|NCT01018732|564928145|FG000|Overall Study|Inappropriate Enrollment|0|||
156501431|NCT01018732|564928146|FG001|Overall Study|Inappropriate Enrollment|1|||
156501432|NCT01018732|564928147|FG002|Overall Study|Inappropriate Enrollment|0|||
156501433|NCT01018732|564928145|FG000|Overall Study|Unable to Classify|0|||
156501434|NCT01018732|564928146|FG001|Overall Study|Unable to Classify|0|||
156501435|NCT01018732|564928147|FG002|Overall Study|Unable to Classify|1|||
156501436|NCT00978562|564928148|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
156501437|NCT03569891|564928149|FG000|Lead-in|Ineligible during lead-in|8|||
156501438|NCT03569891|564928149|FG000|Lead-in|Withdrawal by Subject|3|||
156501439|NCT03569891|564928149|FG000|Lead-in|Risks related to COVID-19|2|||
156501440|NCT03569891|564928149|FG000|AMT-061|Adverse Event|1|||
156501441|NCT02176863|564928150|FG000|Overall Study|Physician Decision|1|||
156501442|NCT02176863|564928151|FG001|Overall Study|Physician Decision|0|||
156501443|NCT02176863|564928152|FG002|Overall Study|Physician Decision|0|||
156501444|NCT02176863|564928153|FG003|Overall Study|Physician Decision|0|||
156501445|NCT02176863|564928154|FG004|Overall Study|Physician Decision|0|||
156501446|NCT02176863|564928150|FG000|Overall Study|Adverse Event|10|||
156501447|NCT02176863|564928151|FG001|Overall Study|Adverse Event|4|||
156501448|NCT02176863|564928152|FG002|Overall Study|Adverse Event|4|||
156501449|NCT02176863|564928153|FG003|Overall Study|Adverse Event|1|||
156501450|NCT02176863|564928154|FG004|Overall Study|Adverse Event|1|||
156501451|NCT02176863|564928150|FG000|Overall Study|Protocol Violation|2|||
156501452|NCT02176863|564928151|FG001|Overall Study|Protocol Violation|0|||
156501453|NCT02176863|564928152|FG002|Overall Study|Protocol Violation|1|||
156501454|NCT02176863|564928153|FG003|Overall Study|Protocol Violation|1|||
156501455|NCT02176863|564928154|FG004|Overall Study|Protocol Violation|0|||
156501456|NCT02176863|564928150|FG000|Overall Study|Withdrawal by Subject|4|||
156501457|NCT02176863|564928151|FG001|Overall Study|Withdrawal by Subject|2|||
156501458|NCT02176863|564928152|FG002|Overall Study|Withdrawal by Subject|2|||
156501459|NCT02176863|564928153|FG003|Overall Study|Withdrawal by Subject|3|||
156501460|NCT02176863|564928154|FG004|Overall Study|Withdrawal by Subject|4|||
156501461|NCT02176863|564928150|FG000|Overall Study|Reason not specified|0|||
156501462|NCT02176863|564928151|FG001|Overall Study|Reason not specified|1|||
156501463|NCT02176863|564928152|FG002|Overall Study|Reason not specified|1|||
156501464|NCT02176863|564928153|FG003|Overall Study|Reason not specified|2|||
156501465|NCT02176863|564928154|FG004|Overall Study|Reason not specified|1|||
156501466|NCT02176863|564928150|FG000|Overall Study|Lost to Follow-up|0|||
156501467|NCT02176863|564928151|FG001|Overall Study|Lost to Follow-up|1|||
156501468|NCT02176863|564928152|FG002|Overall Study|Lost to Follow-up|1|||
156501469|NCT02176863|564928153|FG003|Overall Study|Lost to Follow-up|0|||
156501470|NCT02176863|564928154|FG004|Overall Study|Lost to Follow-up|0|||
156501471|NCT02358668|564929754|FG000|Overall Study|Adverse Event|2|||
156501472|NCT02358668|564929755|FG001|Overall Study|Adverse Event|0|||
156501473|NCT02358668|564929756|FG002|Overall Study|Adverse Event|0|||
156501474|NCT02358668|564929754|FG000|Overall Study|Withdrawal by Subject|0|||
156501475|NCT02358668|564929755|FG001|Overall Study|Withdrawal by Subject|1|||
156501476|NCT02358668|564929756|FG002|Overall Study|Withdrawal by Subject|0|||
156501477|NCT02104505|564929757|FG000|First Intervention (14 Days)|Adverse Event|2|||
156501478|NCT02104505|564929758|FG001|First Intervention (14 Days)|Adverse Event|0|||
156501479|NCT02104505|564929757|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
156501480|NCT02104505|564929758|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
156501481|NCT02104505|564929757|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
156501482|NCT02104505|564929758|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
156501483|NCT02104505|564929757|FG000|First Intervention (14 Days)|exclusionary condition|0|||
156501484|NCT02104505|564929758|FG001|First Intervention (14 Days)|exclusionary condition|1|||
156501485|NCT02104505|564929757|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
156501486|NCT02104505|564929758|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
156501487|NCT02104505|564929757|FG000|Second Intervention (14 Days)|Adverse Event|2|||
156501488|NCT02104505|564929758|FG001|Second Intervention (14 Days)|Adverse Event|0|||
156501489|NCT01845805|564929759|FG000|Overall Study|Withdrawal by Subject|1|||
156501490|NCT01845805|564929760|FG001|Overall Study|Withdrawal by Subject|2|||
156501491|NCT01845805|564929759|FG000|Overall Study|Disease Progression|13|||
156501492|NCT01845805|564929760|FG001|Overall Study|Disease Progression|14|||
156501493|NCT01845805|564929759|FG000|Overall Study|Drug-related Toxicity|4|||
156501494|NCT01845805|564929760|FG001|Overall Study|Drug-related Toxicity|0|||
156501495|NCT02419417|564929761|FG000|Overall Study|Disease progression|5|||
156501496|NCT02419417|564929762|FG001|Overall Study|Disease progression|4|||
156501497|NCT02419417|564929763|FG002|Overall Study|Disease progression|13|||
156501498|NCT02419417|564929764|FG003|Overall Study|Disease progression|10|||
156501499|NCT02419417|564929765|FG004|Overall Study|Disease progression|10|||
156501500|NCT02419417|564929766|FG005|Overall Study|Disease progression|3|||
156501501|NCT02419417|564929767|FG006|Overall Study|Disease progression|4|||
156501502|NCT02419417|564929768|FG007|Overall Study|Disease progression|5|||
156501503|NCT02419417|564929769|FG008|Overall Study|Disease progression|13|||
156501504|NCT02419417|564929770|FG009|Overall Study|Disease progression|9|||
156501505|NCT02419417|564929771|FG010|Overall Study|Disease progression|0|||
156501506|NCT02419417|564929761|FG000|Overall Study|Study drug toxicity|0|||
156501507|NCT02419417|564929762|FG001|Overall Study|Study drug toxicity|0|||
156501508|NCT02419417|564929763|FG002|Overall Study|Study drug toxicity|0|||
156501509|NCT02419417|564929764|FG003|Overall Study|Study drug toxicity|0|||
156501510|NCT02419417|564929765|FG004|Overall Study|Study drug toxicity|1|||
156501511|NCT02419417|564929766|FG005|Overall Study|Study drug toxicity|0|||
156501512|NCT02419417|564929767|FG006|Overall Study|Study drug toxicity|0|||
156501513|NCT02419417|564929768|FG007|Overall Study|Study drug toxicity|0|||
156501514|NCT02419417|564929769|FG008|Overall Study|Study drug toxicity|0|||
156501515|NCT02419417|564929770|FG009|Overall Study|Study drug toxicity|0|||
156501516|NCT02419417|564929771|FG010|Overall Study|Study drug toxicity|0|||
156501517|NCT02419417|564929761|FG000|Overall Study|Adverse event unrelated to study drug|0|||
156501518|NCT02419417|564929762|FG001|Overall Study|Adverse event unrelated to study drug|0|||
156501519|NCT02419417|564929763|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156501520|NCT02419417|564929764|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156501521|NCT02419417|564929765|FG004|Overall Study|Adverse event unrelated to study drug|2|||
156501522|NCT02419417|564929766|FG005|Overall Study|Adverse event unrelated to study drug|1|||
156501523|NCT02419417|564929767|FG006|Overall Study|Adverse event unrelated to study drug|0|||
156501524|NCT02419417|564929768|FG007|Overall Study|Adverse event unrelated to study drug|1|||
156501525|NCT02419417|564929769|FG008|Overall Study|Adverse event unrelated to study drug|0|||
156501526|NCT02419417|564929770|FG009|Overall Study|Adverse event unrelated to study drug|0|||
156501527|NCT02419417|564929771|FG010|Overall Study|Adverse event unrelated to study drug|0|||
156501528|NCT02419417|564929761|FG000|Overall Study|Participant request to discontinue|0|||
156501529|NCT02419417|564929762|FG001|Overall Study|Participant request to discontinue|0|||
156501530|NCT02419417|564929763|FG002|Overall Study|Participant request to discontinue|0|||
156501531|NCT02419417|564929764|FG003|Overall Study|Participant request to discontinue|0|||
156501532|NCT02419417|564929765|FG004|Overall Study|Participant request to discontinue|0|||
156501533|NCT02419417|564929766|FG005|Overall Study|Participant request to discontinue|0|||
156501534|NCT02419417|564929767|FG006|Overall Study|Participant request to discontinue|0|||
156501535|NCT02419417|564929768|FG007|Overall Study|Participant request to discontinue|0|||
156501536|NCT02419417|564929769|FG008|Overall Study|Participant request to discontinue|0|||
156501537|NCT02419417|564929770|FG009|Overall Study|Participant request to discontinue|1|||
156501538|NCT02419417|564929771|FG010|Overall Study|Participant request to discontinue|0|||
156501539|NCT02419417|564929761|FG000|Overall Study|Withdrawal by Subject|0|||
156501540|NCT02419417|564929762|FG001|Overall Study|Withdrawal by Subject|0|||
156501541|NCT02419417|564929763|FG002|Overall Study|Withdrawal by Subject|0|||
156501542|NCT02419417|564929764|FG003|Overall Study|Withdrawal by Subject|0|||
156501543|NCT02419417|564929765|FG004|Overall Study|Withdrawal by Subject|0|||
156501544|NCT02419417|564929766|FG005|Overall Study|Withdrawal by Subject|0|||
156501545|NCT02419417|564929767|FG006|Overall Study|Withdrawal by Subject|0|||
156501546|NCT02419417|564929768|FG007|Overall Study|Withdrawal by Subject|0|||
156501547|NCT02419417|564929769|FG008|Overall Study|Withdrawal by Subject|0|||
156501548|NCT02419417|564929770|FG009|Overall Study|Withdrawal by Subject|0|||
156501549|NCT02419417|564929771|FG010|Overall Study|Withdrawal by Subject|1|||
156501550|NCT01240551|564929772|FG000|Overall Study|Refused further treatment|3|||
156501551|NCT01240551|564929773|FG001|Overall Study|Refused further treatment|2|||
156501552|NCT01240551|564929772|FG000|Overall Study|Lost to Follow-up|1|||
156501553|NCT01240551|564929773|FG001|Overall Study|Lost to Follow-up|1|||
156382320|NCT01767116|564492578|FG001|Overall Study|Lost to Follow-up|2|||
156382321|NCT00968669|564492580|FG000|Overall Study|Lost to Follow-up|5|||
156382322|NCT00968669|564492581|FG001|Overall Study|Lost to Follow-up|2|||
156382323|NCT00968669|564492582|FG002|Overall Study|Lost to Follow-up|1|||
156382324|NCT00968669|564492583|FG003|Overall Study|Lost to Follow-up|4|||
156382325|NCT00968669|564492580|FG000|Overall Study|Withdrawal by Subject|9|||
156382326|NCT00968669|564492581|FG001|Overall Study|Withdrawal by Subject|7|||
156382327|NCT00968669|564492582|FG002|Overall Study|Withdrawal by Subject|5|||
156382328|NCT00968669|564492583|FG003|Overall Study|Withdrawal by Subject|3|||
156382329|NCT00968669|564492580|FG000|Overall Study|Pregnancy|0|||
156382330|NCT00968669|564492581|FG001|Overall Study|Pregnancy|0|||
156382331|NCT00968669|564492582|FG002|Overall Study|Pregnancy|2|||
156382332|NCT00968669|564492583|FG003|Overall Study|Pregnancy|0|||
156382333|NCT00968669|564492580|FG000|Overall Study|AE|1|||
156382334|NCT00968669|564492581|FG001|Overall Study|AE|0|||
156382335|NCT00968669|564492582|FG002|Overall Study|AE|0|||
156382336|NCT00968669|564492583|FG003|Overall Study|AE|0|||
156382337|NCT00968669|564492580|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
156382338|NCT00968669|564492581|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
156382339|NCT00968669|564492582|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
156382340|NCT00968669|564492583|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
156382341|NCT00968669|564492580|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
156382342|NCT00968669|564492581|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
156382343|NCT00968669|564492582|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
156382344|NCT00968669|564492583|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
156382345|NCT00968669|564492580|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
156382346|NCT00968669|564492581|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
156382347|NCT00968669|564492582|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
156382348|NCT00968669|564492583|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
156382349|NCT00968669|564492580|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
156382350|NCT00968669|564492581|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
156382351|NCT00968669|564492582|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
156382352|NCT00968669|564492583|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
156382353|NCT00968669|564492580|FG000|Overall Study|EARLY WITHDRAWAL|0|||
156382354|NCT00968669|564492581|FG001|Overall Study|EARLY WITHDRAWAL|1|||
156382355|NCT00968669|564492582|FG002|Overall Study|EARLY WITHDRAWAL|0|||
156382356|NCT00968669|564492583|FG003|Overall Study|EARLY WITHDRAWAL|0|||
156382357|NCT00968669|564492580|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
156382358|NCT00968669|564492581|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
156382359|NCT00968669|564492582|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
156382360|NCT00968669|564492583|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
156382361|NCT00968669|564492580|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
156382362|NCT00968669|564492581|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
156382363|NCT00968669|564492582|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
156382364|NCT00968669|564492583|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
156382365|NCT00968669|564492580|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
156382366|NCT00968669|564492581|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
156382367|NCT00968669|564492582|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
156382368|NCT00968669|564492583|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
156382369|NCT00968669|564492580|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
156382370|NCT00968669|564492581|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
156382371|NCT00968669|564492582|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
156382372|NCT00968669|564492583|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
156382373|NCT00968669|564492580|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
156382374|NCT00968669|564492581|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
156382375|NCT00968669|564492582|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
156382376|NCT00968669|564492583|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
156382377|NCT00968669|564492580|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
156382378|NCT00968669|564492581|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
156382379|NCT00968669|564492582|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
156382380|NCT00968669|564492583|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
156382381|NCT00968669|564492580|FG000|Overall Study|SPONSOR DECISION|0|||
156382382|NCT00968669|564492581|FG001|Overall Study|SPONSOR DECISION|1|||
156382383|NCT00968669|564492582|FG002|Overall Study|SPONSOR DECISION|0|||
156382384|NCT00968669|564492583|FG003|Overall Study|SPONSOR DECISION|0|||
156382385|NCT00968669|564492580|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
156382386|NCT00968669|564492581|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
156382387|NCT00968669|564492582|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
156382388|NCT00968669|564492583|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
156382389|NCT00968669|564492580|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
156382390|NCT00968669|564492581|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
156382391|NCT00968669|564492582|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
156382392|NCT00968669|564492583|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
156501554|NCT01317875|564929774|FG000|Overall Study|Other|0|||
156501555|NCT01317875|564929775|FG001|Overall Study|Other|0|||
156501556|NCT01317875|564929776|FG002|Overall Study|Other|1|||
156501557|NCT01317875|564929777|FG003|Overall Study|Other|0|||
156501558|NCT01317875|564929778|FG004|Overall Study|Other|0|||
156501559|NCT01317875|564929779|FG005|Overall Study|Other|0|||
156501560|NCT01317875|564929780|FG006|Overall Study|Other|0|||
156501561|NCT01317875|564929781|FG007|Overall Study|Other|0|||
156501562|NCT01317875|564929782|FG008|Overall Study|Other|0|||
156501563|NCT01317875|564929783|FG009|Overall Study|Other|0|||
156501564|NCT01317875|564929774|FG000|Overall Study|Noncompliance with study drug|0|||
156501565|NCT01317875|564929775|FG001|Overall Study|Noncompliance with study drug|0|||
156501566|NCT01317875|564929776|FG002|Overall Study|Noncompliance with study drug|1|||
156501567|NCT01317875|564929777|FG003|Overall Study|Noncompliance with study drug|0|||
156501568|NCT01317875|564929778|FG004|Overall Study|Noncompliance with study drug|0|||
156501569|NCT01317875|564929779|FG005|Overall Study|Noncompliance with study drug|0|||
156501570|NCT01317875|564929780|FG006|Overall Study|Noncompliance with study drug|0|||
156501571|NCT01317875|564929781|FG007|Overall Study|Noncompliance with study drug|0|||
156501572|NCT01317875|564929782|FG008|Overall Study|Noncompliance with study drug|0|||
156501573|NCT01317875|564929783|FG009|Overall Study|Noncompliance with study drug|0|||
156501574|NCT01317875|564929774|FG000|Overall Study|Progressive Disease|1|||
156501575|NCT01317875|564929775|FG001|Overall Study|Progressive Disease|0|||
156501576|NCT01317875|564929776|FG002|Overall Study|Progressive Disease|2|||
156501577|NCT01317875|564929777|FG003|Overall Study|Progressive Disease|0|||
156501578|NCT01317875|564929778|FG004|Overall Study|Progressive Disease|1|||
156501579|NCT01317875|564929779|FG005|Overall Study|Progressive Disease|0|||
156501580|NCT01317875|564929780|FG006|Overall Study|Progressive Disease|0|||
156501581|NCT01317875|564929781|FG007|Overall Study|Progressive Disease|1|||
156501582|NCT01317875|564929782|FG008|Overall Study|Progressive Disease|0|||
156501583|NCT01317875|564929783|FG009|Overall Study|Progressive Disease|0|||
156501584|NCT01317875|564929774|FG000|Overall Study|Withdrawal by Subject|0|||
156501585|NCT01317875|564929775|FG001|Overall Study|Withdrawal by Subject|0|||
156501586|NCT01317875|564929776|FG002|Overall Study|Withdrawal by Subject|0|||
156501587|NCT01317875|564929777|FG003|Overall Study|Withdrawal by Subject|0|||
156501588|NCT01317875|564929778|FG004|Overall Study|Withdrawal by Subject|1|||
156501589|NCT01317875|564929779|FG005|Overall Study|Withdrawal by Subject|0|||
156501590|NCT01317875|564929780|FG006|Overall Study|Withdrawal by Subject|0|||
156501591|NCT01317875|564929781|FG007|Overall Study|Withdrawal by Subject|3|||
156501592|NCT01317875|564929782|FG008|Overall Study|Withdrawal by Subject|0|||
156501593|NCT01317875|564929783|FG009|Overall Study|Withdrawal by Subject|0|||
156501594|NCT01317875|564929774|FG000|Overall Study|Physician Decision|0|||
156501595|NCT01317875|564929775|FG001|Overall Study|Physician Decision|1|||
156501596|NCT01317875|564929776|FG002|Overall Study|Physician Decision|1|||
156501597|NCT01317875|564929777|FG003|Overall Study|Physician Decision|0|||
156501598|NCT01317875|564929778|FG004|Overall Study|Physician Decision|2|||
156501599|NCT01317875|564929779|FG005|Overall Study|Physician Decision|0|||
156501600|NCT01317875|564929780|FG006|Overall Study|Physician Decision|0|||
156501601|NCT01317875|564929781|FG007|Overall Study|Physician Decision|2|||
156501602|NCT01317875|564929782|FG008|Overall Study|Physician Decision|0|||
156501603|NCT01317875|564929783|FG009|Overall Study|Physician Decision|0|||
156501604|NCT01317875|564929774|FG000|Overall Study|Death|0|||
156501605|NCT01317875|564929775|FG001|Overall Study|Death|0|||
156501606|NCT01317875|564929776|FG002|Overall Study|Death|2|||
156501607|NCT01317875|564929777|FG003|Overall Study|Death|1|||
156501608|NCT01317875|564929778|FG004|Overall Study|Death|0|||
156501609|NCT01317875|564929779|FG005|Overall Study|Death|1|||
156501610|NCT01317875|564929780|FG006|Overall Study|Death|0|||
156501611|NCT01317875|564929781|FG007|Overall Study|Death|4|||
156501612|NCT01317875|564929782|FG008|Overall Study|Death|0|||
156501613|NCT01317875|564929783|FG009|Overall Study|Death|0|||
156501614|NCT01317875|564929774|FG000|Overall Study|Adverse Event|2|||
156382393|NCT00968669|564492580|FG000|Overall Study|SUBJECT INCARCERATED|0|||
156382394|NCT00968669|564492581|FG001|Overall Study|SUBJECT INCARCERATED|1|||
156382395|NCT00968669|564492582|FG002|Overall Study|SUBJECT INCARCERATED|0|||
156501615|NCT01317875|564929775|FG001|Overall Study|Adverse Event|1|||
156501616|NCT01317875|564929776|FG002|Overall Study|Adverse Event|2|||
156382396|NCT00968669|564492583|FG003|Overall Study|SUBJECT INCARCERATED|0|||
156382397|NCT00968669|564492580|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
156382398|NCT00968669|564492581|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
156382399|NCT00968669|564492582|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
156501617|NCT01317875|564929777|FG003|Overall Study|Adverse Event|1|||
156501618|NCT01317875|564929778|FG004|Overall Study|Adverse Event|5|||
156501619|NCT01317875|564929779|FG005|Overall Study|Adverse Event|1|||
156501620|NCT01317875|564929780|FG006|Overall Study|Adverse Event|2|||
156501621|NCT01317875|564929781|FG007|Overall Study|Adverse Event|5|||
156501622|NCT01317875|564929782|FG008|Overall Study|Adverse Event|0|||
156501623|NCT01317875|564929783|FG009|Overall Study|Adverse Event|0|||
156501624|NCT01381575|564929784|FG000|Overall Study|Serious Adverse Event|1|||
156501625|NCT01381575|564929785|FG001|Overall Study|Serious Adverse Event|0|||
156382400|NCT00968669|564492583|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
156382401|NCT00968669|564492580|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
156382402|NCT00968669|564492581|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
156382403|NCT00968669|564492582|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
156382404|NCT00968669|564492583|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
156382405|NCT05799495|564492589|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
156382406|NCT05799495|564492590|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
156382407|NCT05799495|564492591|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
156382408|NCT05799495|564492592|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
156382409|NCT05799495|564492589|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
156382410|NCT05799495|564492590|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
156382411|NCT05799495|564492591|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
156382412|NCT05799495|564492592|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
156382413|NCT05799495|564492589|FG000|Treatment (Up to 5 Days)|Other|0|||
156382414|NCT05799495|564492590|FG001|Treatment (Up to 5 Days)|Other|1|||
156382415|NCT05799495|564492591|FG002|Treatment (Up to 5 Days)|Other|0|||
156382416|NCT05799495|564492592|FG003|Treatment (Up to 5 Days)|Other|0|||
156382417|NCT05799495|564492589|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
156382418|NCT05799495|564492590|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
156382419|NCT05799495|564492591|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
156382420|NCT05799495|564492592|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
156382421|NCT05799495|564492589|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
156382422|NCT05799495|564492590|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
156382423|NCT05799495|564492591|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
156382424|NCT05799495|564492592|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
156382425|NCT05799495|564492589|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156382426|NCT05799495|564492590|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156382427|NCT05799495|564492591|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
156382428|NCT05799495|564492592|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156382429|NCT04102501|564492596|FG000|Overall Study|Withdrawal by Subject|7|||
156382430|NCT04102501|564492597|FG001|Overall Study|Withdrawal by Subject|9|||
156382431|NCT04102501|564492596|FG000|Overall Study|Adverse Event|1|||
156382432|NCT04102501|564492597|FG001|Overall Study|Adverse Event|3|||
156382433|NCT02338362|564492598|FG000|Overall Study|Withdrawal by Subject|1|||
156382434|NCT02338362|564492599|FG001|Overall Study|Withdrawal by Subject|1|||
156382435|NCT04798586|564492601|FG000|Overall Study|Death|2|||
156382436|NCT01669343|564492602|FG000|Part A: All Patients|Withdrawal by Subject|7|||
156382437|NCT01669343|564492602|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
156382438|NCT01669343|564492602|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
156382439|NCT01669343|564492602|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
156382440|NCT01669343|564492602|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
156382441|NCT00968617|564492603|FG000|Overall Study|Study terminated by sponsor|6|||
156382442|NCT02371369|564492608|FG000|Part 1|Physician Decision|0|||
156382443|NCT02371369|564492609|FG001|Part 1|Physician Decision|3|||
156382444|NCT02371369|564492608|FG000|Part 1|Adverse Event|8|||
156382445|NCT02371369|564492609|FG001|Part 1|Adverse Event|0|||
156382446|NCT02371369|564492608|FG000|Part 1|Withdrawal by Subject|1|||
156382447|NCT02371369|564492609|FG001|Part 1|Withdrawal by Subject|6|||
156382448|NCT02371369|564492608|FG000|Part 1|Disease progression|0|||
156382449|NCT02371369|564492609|FG001|Part 1|Disease progression|1|||
156382450|NCT02371369|564492608|FG000|Part 1|Protocol Violation|0|||
156382451|NCT02371369|564492609|FG001|Part 1|Protocol Violation|1|||
156382452|NCT02371369|564492608|FG000|Part 2|Adverse Event|6|||
156382453|NCT02371369|564492609|FG001|Part 2|Adverse Event|5|||
156382454|NCT02371369|564492608|FG000|Part 2|Withdrawal by Subject|16|||
156382455|NCT02371369|564492609|FG001|Part 2|Withdrawal by Subject|6|||
156382456|NCT02371369|564492608|FG000|Part 2|Investigator decision|1|||
156382457|NCT02371369|564492609|FG001|Part 2|Investigator decision|2|||
156382458|NCT02371369|564492608|FG000|Part 2|Death|0|||
156382459|NCT02371369|564492609|FG001|Part 2|Death|1|||
156382460|NCT02371369|564492608|FG000|Part 2|Disease progression|1|||
156382461|NCT02371369|564492609|FG001|Part 2|Disease progression|0|||
156382462|NCT02371369|564492608|FG000|Part 2|Subject Noncompliance|1|||
156382463|NCT02371369|564492609|FG001|Part 2|Subject Noncompliance|0|||
156382464|NCT02371369|564492608|FG000|Part 2|Lost to Follow-up|1|||
156382465|NCT02371369|564492609|FG001|Part 2|Lost to Follow-up|1|||
156382466|NCT02371369|564492608|FG000|Part 2|Subject transitioned to commercial supply|6|||
156382467|NCT02371369|564492609|FG001|Part 2|Subject transitioned to commercial supply|4|||
156382468|NCT02371369|564492608|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
156382469|NCT02371369|564492609|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
156382470|NCT02371369|564492608|FG000|Part 2|Surgical resection of tumor|1|||
156382471|NCT02371369|564492609|FG001|Part 2|Surgical resection of tumor|1|||
156382472|NCT02371369|564492608|FG000|Part 2|Other|0|||
156382473|NCT02371369|564492609|FG001|Part 2|Other|1|||
156382474|NCT01682460|564494250|FG000|Overall Study|Withdrawal by Subject|2|||
156382475|NCT01682460|564494250|FG000|Overall Study|Did not meet inclusion criteria|2|||
156501626|NCT01381575|564929786|FG002|Overall Study|Serious Adverse Event|0|||
156501627|NCT01381575|564929784|FG000|Overall Study|Non-Serious Adverse Event|0|||
156501628|NCT01381575|564929785|FG001|Overall Study|Non-Serious Adverse Event|0|||
156501629|NCT01381575|564929786|FG002|Overall Study|Non-Serious Adverse Event|1|||
156501630|NCT01381575|564929784|FG000|Overall Study|Protocol Violation|0|||
156501631|NCT01381575|564929785|FG001|Overall Study|Protocol Violation|1|||
156501632|NCT01381575|564929786|FG002|Overall Study|Protocol Violation|1|||
156501633|NCT01381575|564929784|FG000|Overall Study|Withdrawal by Subject|15|||
156501634|NCT01381575|564929785|FG001|Overall Study|Withdrawal by Subject|9|||
156501635|NCT01381575|564929786|FG002|Overall Study|Withdrawal by Subject|7|||
156501636|NCT01381575|564929784|FG000|Overall Study|Migrated/moved from study area|2|||
156501637|NCT01381575|564929785|FG001|Overall Study|Migrated/moved from study area|12|||
156501638|NCT01381575|564929786|FG002|Overall Study|Migrated/moved from study area|2|||
156501639|NCT01381575|564929784|FG000|Overall Study|Lost to Follow-up|8|||
156501640|NCT01381575|564929785|FG001|Overall Study|Lost to Follow-up|17|||
156501641|NCT01381575|564929786|FG002|Overall Study|Lost to Follow-up|9|||
156501642|NCT01377389|564929787|FG000|Overall Study|Withdrawal by Subject|1|||
156501643|NCT01377389|564929787|FG000|Overall Study|Screen failure|2|||
156501644|NCT03945773|564929794|FG000|Overall Study|Consent Withdrawn|1|||
156501645|NCT03945773|564929795|FG001|Overall Study|Consent Withdrawn|1|||
156501646|NCT03945773|564929794|FG000|Overall Study|Lost to Follow-up|1|||
156501647|NCT03945773|564929795|FG001|Overall Study|Lost to Follow-up|0|||
156501648|NCT03945773|564929794|FG000|Overall Study|Death|46|||
156501649|NCT03945773|564929795|FG001|Overall Study|Death|22|||
156501650|NCT03945773|564929794|FG000|Overall Study|Physician Decision|1|||
156501651|NCT03945773|564929795|FG001|Overall Study|Physician Decision|0|||
156501652|NCT03945773|564929794|FG000|Overall Study|Other|1|||
156501653|NCT03945773|564929795|FG001|Overall Study|Other|0|||
156501654|NCT03945773|564929794|FG000|Overall Study|Ongoing at the time of DCO|4|||
156501655|NCT03945773|564929795|FG001|Overall Study|Ongoing at the time of DCO|3|||
156501656|NCT04546217|564929796|FG000|Overall Study|Withdrawal by Subject|2|||
156501657|NCT04546217|564929797|FG001|Overall Study|Withdrawal by Subject|0|||
156501658|NCT04546217|564929796|FG000|Overall Study|Uncontrolled hypertension|1|||
156501659|NCT04546217|564929797|FG001|Overall Study|Uncontrolled hypertension|0|||
156501660|NCT00725712|564929798|FG000|Overall Study|Withdrawal by Subject|2|||
156501661|NCT00725712|564929799|FG001|Overall Study|Withdrawal by Subject|1|||
156501662|NCT00725712|564929798|FG000|Overall Study|Protocol Violation|1|||
156501663|NCT00725712|564929799|FG001|Overall Study|Protocol Violation|0|||
156501664|NCT00725712|564929798|FG000|Overall Study|Progressive disease|37|||
156501665|NCT00725712|564929799|FG001|Overall Study|Progressive disease|16|||
156501666|NCT00725712|564929798|FG000|Overall Study|Clinical progression not based on RECIST|0|||
156501667|NCT00725712|564929799|FG001|Overall Study|Clinical progression not based on RECIST|3|||
156501668|NCT00725712|564929798|FG000|Overall Study|Adverse Event|5|||
156501669|NCT00725712|564929799|FG001|Overall Study|Adverse Event|5|||
156501670|NCT00725712|564929798|FG000|Overall Study|Death|2|||
156501671|NCT00725712|564929799|FG001|Overall Study|Death|0|||
156501672|NCT00725712|564929798|FG000|Overall Study|Other: Death|1|||
156501673|NCT00725712|564929799|FG001|Overall Study|Other: Death|0|||
156501674|NCT00725712|564929798|FG000|Overall Study|Hospitalized, unable to continue|0|||
156501675|NCT00725712|564929799|FG001|Overall Study|Hospitalized, unable to continue|1|||
156501676|NCT03020069|564929803|FG000|Overall Study|Lost to Follow-up|0|||
156501677|NCT03020069|564929804|FG001|Overall Study|Lost to Follow-up|1|||
156501678|NCT01439867|564929808|FG000|Overall Study|Non-compliance|0|||
156501679|NCT01439867|564929809|FG001|Overall Study|Non-compliance|1|||
156501680|NCT01439867|564929808|FG000|Overall Study|Withdrawal by Subject|1|||
156501681|NCT01439867|564929809|FG001|Overall Study|Withdrawal by Subject|2|||
156501682|NCT01439867|564929808|FG000|Overall Study|Administrative Decision|4|||
156501683|NCT01439867|564929809|FG001|Overall Study|Administrative Decision|5|||
156501684|NCT01439867|564929808|FG000|Overall Study|Protocol-specified Criteria|1|||
156501685|NCT01439867|564929809|FG001|Overall Study|Protocol-specified Criteria|0|||
156501686|NCT00863512|564929810|FG000|Overall Study|Adverse Event|2|||
156501687|NCT00863512|564929811|FG001|Overall Study|Adverse Event|0|||
156501688|NCT00863512|564929810|FG000|Overall Study|Withdrawal by Subject|11|||
156501689|NCT00863512|564929811|FG001|Overall Study|Withdrawal by Subject|0|||
156501690|NCT00863512|564929810|FG000|Overall Study|Physician Decision|1|||
156501691|NCT00863512|564929811|FG001|Overall Study|Physician Decision|0|||
156501692|NCT04024462|564929816|FG000|Overall Study|Withdrawal by Subject|6|||
156501693|NCT04024462|564929817|FG001|Overall Study|Withdrawal by Subject|7|||
156501694|NCT04024462|564929816|FG000|Overall Study|Progressive Disease|0|||
156501695|NCT04024462|564929817|FG001|Overall Study|Progressive Disease|1|||
156501696|NCT04024462|564929816|FG000|Overall Study|Adverse Event|0|||
156501697|NCT04024462|564929817|FG001|Overall Study|Adverse Event|1|||
156501698|NCT04024462|564929816|FG000|Overall Study|Death|0|||
156501699|NCT04024462|564929817|FG001|Overall Study|Death|1|||
156501700|NCT04024462|564929816|FG000|Overall Study|Lost to Follow-up|1|||
156501701|NCT04024462|564929817|FG001|Overall Study|Lost to Follow-up|0|||
156501702|NCT04024462|564929816|FG000|Overall Study|Ongoing in the Study|94|||
156501703|NCT04024462|564929817|FG001|Overall Study|Ongoing in the Study|89|||
156501704|NCT05687032|564929821|FG000|Treatment Phase|Adverse Event|13|||
156501705|NCT05687032|564929821|FG000|Treatment Phase|Death|1|||
156501706|NCT05687032|564929821|FG000|Treatment Phase|Physician Decision|3|||
156501707|NCT05687032|564929821|FG000|Treatment Phase|Progressive disease|9|||
156501708|NCT05687032|564929821|FG000|Treatment Phase|Withdrawal by Subject|5|||
156501709|NCT05687032|564929821|FG000|Follow-Up Phase|Death|16|||
156501710|NCT05687032|564929821|FG000|Follow-Up Phase|Ongoing|26|||
156501711|NCT01437423|564929830|FG000|Overall Study|Lost to Follow-up|12|||
156501712|NCT01437423|564929830|FG000|Overall Study|Off label usage|3|||
156501713|NCT03934099|564929836|FG000|Overall Study|Adverse Event|0|||
156501714|NCT03934099|564929837|FG001|Overall Study|Adverse Event|3|||
156501715|NCT03934099|564929838|FG002|Overall Study|Adverse Event|1|||
156501716|NCT03934099|564929839|FG003|Overall Study|Adverse Event|0|||
156501717|NCT03934099|564929836|FG000|Overall Study|Lost to Follow-up|1|||
156501718|NCT03934099|564929837|FG001|Overall Study|Lost to Follow-up|2|||
156501719|NCT03934099|564929838|FG002|Overall Study|Lost to Follow-up|1|||
156501720|NCT03934099|564929839|FG003|Overall Study|Lost to Follow-up|1|||
156501721|NCT03934099|564929836|FG000|Overall Study|Protocol Violation|1|||
156501722|NCT03934099|564929837|FG001|Overall Study|Protocol Violation|0|||
156501723|NCT03934099|564929838|FG002|Overall Study|Protocol Violation|0|||
156501724|NCT03934099|564929839|FG003|Overall Study|Protocol Violation|0|||
156501725|NCT03934099|564929836|FG000|Overall Study|Withdrawal by Subject|2|||
156501726|NCT03934099|564929837|FG001|Overall Study|Withdrawal by Subject|0|||
156501727|NCT03934099|564929838|FG002|Overall Study|Withdrawal by Subject|1|||
156501728|NCT03934099|564929839|FG003|Overall Study|Withdrawal by Subject|1|||
156501729|NCT03934099|564929836|FG000|Overall Study|Other reasons|0|||
156501730|NCT03934099|564929837|FG001|Overall Study|Other reasons|1|||
156501731|NCT03934099|564929838|FG002|Overall Study|Other reasons|0|||
156501732|NCT03934099|564929839|FG003|Overall Study|Other reasons|0|||
156501733|NCT02872012|564929853|FG000|Overall Study|Withdrawal by Subject|1|||
156501734|NCT02872012|564929854|FG001|Overall Study|Withdrawal by Subject|0|||
156501735|NCT02872012|564929855|FG002|Overall Study|Withdrawal by Subject|0|||
156501736|NCT02872012|564929856|FG003|Overall Study|Withdrawal by Subject|0|||
156501737|NCT02872012|564929857|FG004|Overall Study|Withdrawal by Subject|0|||
156501738|NCT03000348|564929858|FG000|Overall Study|Adverse Event|1|||
156501739|NCT03000348|564929859|FG001|Overall Study|Adverse Event|1|||
156501740|NCT03000348|564929860|FG002|Overall Study|Adverse Event|1|||
156501741|NCT03000348|564929861|FG003|Overall Study|Adverse Event|1|||
156501742|NCT03000348|564929862|FG004|Overall Study|Adverse Event|1|||
156501743|NCT03000348|564929863|FG005|Overall Study|Adverse Event|1|||
156501744|NCT03000348|564929858|FG000|Overall Study|Lost to Follow-up|0|||
156501745|NCT03000348|564929859|FG001|Overall Study|Lost to Follow-up|0|||
156501746|NCT03000348|564929860|FG002|Overall Study|Lost to Follow-up|1|||
156501747|NCT03000348|564929861|FG003|Overall Study|Lost to Follow-up|0|||
156501748|NCT03000348|564929862|FG004|Overall Study|Lost to Follow-up|0|||
156501749|NCT03000348|564929863|FG005|Overall Study|Lost to Follow-up|0|||
156501750|NCT03000348|564929858|FG000|Overall Study|Withdrawal by Subject|0|||
156501751|NCT03000348|564929859|FG001|Overall Study|Withdrawal by Subject|1|||
156501752|NCT03000348|564929860|FG002|Overall Study|Withdrawal by Subject|0|||
156501753|NCT03000348|564929861|FG003|Overall Study|Withdrawal by Subject|0|||
156501754|NCT03000348|564929862|FG004|Overall Study|Withdrawal by Subject|0|||
156501755|NCT03000348|564929863|FG005|Overall Study|Withdrawal by Subject|0|||
156501756|NCT03000348|564929858|FG000|Overall Study|Consent|0|||
156501757|NCT03000348|564929859|FG001|Overall Study|Consent|0|||
156501758|NCT03000348|564929860|FG002|Overall Study|Consent|0|||
156501759|NCT03000348|564929861|FG003|Overall Study|Consent|0|||
156501760|NCT03000348|564929862|FG004|Overall Study|Consent|1|||
156546907|NCT00440947|565094999|FG004|48-Week Randomization Phase|Pregnancy|0|||
156546908|NCT00440947|565094995|FG000|48-Week Randomization Phase|Incarceration|0|||
156546909|NCT00440947|565094996|FG001|48-Week Randomization Phase|Incarceration|3|||
156546910|NCT00440947|565094997|FG002|48-Week Randomization Phase|Incarceration|0|||
156546911|NCT00440947|565094998|FG003|48-Week Randomization Phase|Incarceration|0|||
156501761|NCT03000348|564929863|FG005|Overall Study|Consent|0|||
156501762|NCT03000348|564929858|FG000|Overall Study|Failure to expectorate sputum|1|||
156501763|NCT03000348|564929859|FG001|Overall Study|Failure to expectorate sputum|0|||
156501764|NCT03000348|564929860|FG002|Overall Study|Failure to expectorate sputum|1|||
156501765|NCT03000348|564929861|FG003|Overall Study|Failure to expectorate sputum|0|||
156501766|NCT03000348|564929862|FG004|Overall Study|Failure to expectorate sputum|1|||
156501767|NCT03000348|564929863|FG005|Overall Study|Failure to expectorate sputum|0|||
156501768|NCT03000348|564929858|FG000|Overall Study|No gram negative|1|||
156501769|NCT03000348|564929859|FG001|Overall Study|No gram negative|2|||
156501770|NCT03000348|564929860|FG002|Overall Study|No gram negative|1|||
156501771|NCT03000348|564929861|FG003|Overall Study|No gram negative|1|||
156546912|NCT00440947|565094999|FG004|48-Week Randomization Phase|Incarceration|0|||
156501772|NCT03000348|564929862|FG004|Overall Study|No gram negative|1|||
156501773|NCT03000348|564929863|FG005|Overall Study|No gram negative|1|||
156501774|NCT03000348|564929858|FG000|Overall Study|Patient had no transport|0|||
156501775|NCT03000348|564929859|FG001|Overall Study|Patient had no transport|0|||
156546913|NCT00440947|565094995|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
156501776|NCT03000348|564929860|FG002|Overall Study|Patient had no transport|0|||
156501777|NCT03000348|564929861|FG003|Overall Study|Patient had no transport|1|||
156501778|NCT03000348|564929862|FG004|Overall Study|Patient had no transport|0|||
156501779|NCT03000348|564929863|FG005|Overall Study|Patient had no transport|0|||
156501780|NCT03000348|564929858|FG000|Overall Study|Dosing|0|||
156501781|NCT03000348|564929859|FG001|Overall Study|Dosing|0|||
156501782|NCT03000348|564929860|FG002|Overall Study|Dosing|0|||
156501783|NCT03000348|564929861|FG003|Overall Study|Dosing|0|||
156501784|NCT03000348|564929862|FG004|Overall Study|Dosing|1|||
156501785|NCT03000348|564929863|FG005|Overall Study|Dosing|0|||
156501786|NCT00723125|564929864|FG000|Overall Study|Met Dx|1|||
156501787|NCT00723125|564929865|FG001|Overall Study|Met Dx|0|||
156501788|NCT00723125|564929864|FG000|Overall Study|Withdrawal by Subject|15|||
156501789|NCT00723125|564929865|FG001|Overall Study|Withdrawal by Subject|6|||
156501790|NCT00723125|564929864|FG000|Overall Study|Adverse Event|2|||
156501791|NCT00723125|564929865|FG001|Overall Study|Adverse Event|0|||
156501792|NCT01807182|564929866|FG000|Overall Study|Death|1|||
156501793|NCT01807182|564929866|FG000|Overall Study|New therapy|1|||
156501794|NCT01807182|564929866|FG000|Overall Study|Moved to hospice care|1|||
156501795|NCT01262092|564929869|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
156501796|NCT01262092|564929870|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
156501797|NCT01262092|564929869|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
156501798|NCT01262092|564929870|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
156501799|NCT01262092|564929869|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
156501800|NCT01262092|564929870|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
156501801|NCT01262092|564929869|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
156501802|NCT01262092|564929870|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
156501803|NCT03784820|564929871|FG000|Overall Study|Lost to Follow-up|5|||
156501804|NCT03784820|564929872|FG001|Overall Study|Lost to Follow-up|5|||
156501805|NCT03784820|564929873|FG002|Overall Study|Lost to Follow-up|3|||
156501806|NCT03784820|564929874|FG003|Overall Study|Lost to Follow-up|3|||
156501807|NCT02336425|564929875|FG000|Overall Study|Study terminated.|2|||
156501808|NCT02336425|564929876|FG001|Overall Study|Study terminated.|2|||
156501809|NCT02336425|564929877|FG002|Overall Study|Study terminated.|3|||
156501810|NCT02336425|564929878|FG003|Overall Study|Study terminated.|3|||
156501811|NCT01191008|564929879|FG000|Overall Study|Protocol Violation|7|||
156501812|NCT01191008|564929879|FG000|Overall Study|Lost to Follow-up|8|||
156501813|NCT03299959|564929882|FG000|Overall Study|Lost to Follow-up|7|||
156501814|NCT03299959|564929883|FG001|Overall Study|Lost to Follow-up|9|||
156501815|NCT03299959|564929882|FG000|Overall Study|Death|1|||
156501816|NCT03299959|564929883|FG001|Overall Study|Death|0|||
156501817|NCT03299959|564929882|FG000|Overall Study|Withdrawal by Subject|13|||
156501818|NCT03299959|564929883|FG001|Overall Study|Withdrawal by Subject|9|||
156501819|NCT03299959|564929882|FG000|Overall Study|Changes in study team and government regulations|1|||
156501820|NCT03299959|564929883|FG001|Overall Study|Changes in study team and government regulations|1|||
156501821|NCT03299959|564929882|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
156501822|NCT03299959|564929883|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
156501823|NCT01310699|564929884|FG000|Overall Study|Patients did not complete tandem.|4|||
156501824|NCT01310699|564929885|FG001|Overall Study|Patients did not complete tandem.|6|||
156501825|NCT00926575|564929886|FG000|Overall Study|Adverse Event|1|||
156501826|NCT00926575|564929887|FG001|Overall Study|Adverse Event|1|||
156501827|NCT00926575|564929886|FG000|Overall Study|Death|4|||
156501828|NCT00926575|564929887|FG001|Overall Study|Death|4|||
156501829|NCT00926575|564929886|FG000|Overall Study|Lost to Follow-up|1|||
156501830|NCT00926575|564929887|FG001|Overall Study|Lost to Follow-up|1|||
156501831|NCT00926575|564929886|FG000|Overall Study|Physician Decision|1|||
156501832|NCT00926575|564929887|FG001|Overall Study|Physician Decision|2|||
156501833|NCT00926575|564929886|FG000|Overall Study|Protocol Violation|1|||
156501834|NCT00926575|564929887|FG001|Overall Study|Protocol Violation|0|||
156382476|NCT00724282|564494251|FG000|Overall Study|Withdrawal by Subject|3|||
156382477|NCT00724282|564494251|FG000|Overall Study|Physician Decision|1|||
156382478|NCT03811912|564494252|FG000|Overall Study|Withdrew Consent|4|||
156382479|NCT03811912|564494253|FG001|Overall Study|Withdrew Consent|2|||
156382480|NCT03586648|564494256|FG000|Period 1|Withdrawal by Subject|0|||
156382481|NCT03586648|564494257|FG001|Period 1|Withdrawal by Subject|1|||
156382482|NCT03586648|564494256|FG000|Period 1|Lost to Follow-up|1|||
156501835|NCT00926575|564929886|FG000|Overall Study|Withdrawal by Subject|8|||
156501836|NCT00926575|564929887|FG001|Overall Study|Withdrawal by Subject|9|||
156501837|NCT00490698|564929888|FG000|Overall Study|Withdrawal by Subject|1|||
156501838|NCT00490698|564929888|FG000|Overall Study|Disease Progression|7|||
156501839|NCT00490698|564929888|FG000|Overall Study|Physician Decision|2|||
156501840|NCT00469859|564929890|FG000|Overall Study|Inevaluable|0|||
156501841|NCT00469859|564929891|FG001|Overall Study|Inevaluable|2|||
156501842|NCT04124471|564929892|FG000|Overall Study|screen failure|1|||
156501843|NCT02394925|564929895|FG000|Overall Study|Adverse Event|1|||
156501844|NCT02394925|564929895|FG000|Overall Study|Lens Discomfort|3|||
156382483|NCT03586648|564494257|FG001|Period 1|Lost to Follow-up|1|||
156501845|NCT02394925|564929895|FG000|Overall Study|Lens handling difficulities|5|||
156501846|NCT02394925|564929895|FG000|Overall Study|Lost to Follow-up|9|||
156501847|NCT02394925|564929895|FG000|Overall Study|Protocol Violation|5|||
156501848|NCT02394925|564929895|FG000|Overall Study|No longer meet eligibility criteria|1|||
156501849|NCT02394925|564929895|FG000|Overall Study|Unsatisfactory Visual Response|5|||
156501850|NCT03459846|564929899|FG000|Overall Study|Death|52|||
156501851|NCT03459846|564929900|FG001|Overall Study|Death|46|||
156501852|NCT03459846|564929899|FG000|Overall Study|Study terminated by sponsor|24|||
156501853|NCT03459846|564929900|FG001|Overall Study|Study terminated by sponsor|28|||
156501854|NCT03459846|564929899|FG000|Overall Study|Withdrawal by Subject|2|||
156501855|NCT03459846|564929900|FG001|Overall Study|Withdrawal by Subject|2|||
156501856|NCT03595124|564931440|FG000|Overall Study|Physician Decision|1|||
156501857|NCT03595124|564931441|FG001|Overall Study|Physician Decision|1|||
156501858|NCT03595124|564931442|FG002|Overall Study|Physician Decision|1|||
156501859|NCT03595124|564931440|FG000|Overall Study|Ineligible|1|||
156501860|NCT03595124|564931441|FG001|Overall Study|Ineligible|1|||
156501861|NCT03595124|564931442|FG002|Overall Study|Ineligible|0|||
156501862|NCT03595124|564931440|FG000|Overall Study|Disease Progression|4|||
156501863|NCT03595124|564931441|FG001|Overall Study|Disease Progression|1|||
156501864|NCT03595124|564931442|FG002|Overall Study|Disease Progression|4|||
156382484|NCT03586648|564494256|FG000|Period 1|Adverse Event|1|||
156382485|NCT03586648|564494257|FG001|Period 1|Adverse Event|0|||
156382486|NCT03586648|564494256|FG000|Period 1|Study related symptoms or complaints|2|||
156382487|NCT03586648|564494257|FG001|Period 1|Study related symptoms or complaints|1|||
156382488|NCT03586648|564494256|FG000|Period 1|Physician Decision|0|||
156382489|NCT03586648|564494257|FG001|Period 1|Physician Decision|1|||
156382490|NCT03586648|564494256|FG000|Period 2|Adverse Event|1|||
156382491|NCT03586648|564494257|FG001|Period 2|Adverse Event|0|||
156382492|NCT00377234|564494258|FG000|Overall Study|Adverse Event|14|||
156382493|NCT00377234|564494259|FG001|Overall Study|Adverse Event|17|||
156382494|NCT00377234|564494258|FG000|Overall Study|Withdrawal by Subject|11|||
156382495|NCT00377234|564494259|FG001|Overall Study|Withdrawal by Subject|9|||
156382496|NCT00377234|564494258|FG000|Overall Study|Lost to Follow-up|4|||
156382497|NCT00377234|564494259|FG001|Overall Study|Lost to Follow-up|2|||
156382498|NCT00377234|564494258|FG000|Overall Study|Administrative|2|||
156382499|NCT00377234|564494259|FG001|Overall Study|Administrative|1|||
156382500|NCT00377234|564494258|FG000|Overall Study|Not assigned|3|||
156382501|NCT00377234|564494259|FG001|Overall Study|Not assigned|2|||
156382502|NCT00626522|564494264|FG000|Overall Study|Protocol Violation|0|||
156382503|NCT00626522|564494265|FG001|Overall Study|Protocol Violation|0|||
156382504|NCT00626522|564494266|FG002|Overall Study|Protocol Violation|0|||
156382505|NCT00626522|564494267|FG003|Overall Study|Protocol Violation|0|||
156382506|NCT00626522|564494268|FG004|Overall Study|Protocol Violation|1|||
156382507|NCT00626522|564494269|FG005|Overall Study|Protocol Violation|0|||
156382508|NCT00626522|564494264|FG000|Overall Study|Adverse Event|2|||
156382509|NCT00626522|564494265|FG001|Overall Study|Adverse Event|1|||
156382510|NCT00626522|564494266|FG002|Overall Study|Adverse Event|2|||
156382511|NCT00626522|564494267|FG003|Overall Study|Adverse Event|0|||
156382512|NCT00626522|564494268|FG004|Overall Study|Adverse Event|1|||
156382513|NCT00626522|564494269|FG005|Overall Study|Adverse Event|1|||
156382514|NCT00626522|564494264|FG000|Overall Study|Withdrawal by Subject|2|||
156382515|NCT00626522|564494265|FG001|Overall Study|Withdrawal by Subject|5|||
156382516|NCT00626522|564494266|FG002|Overall Study|Withdrawal by Subject|5|||
156382517|NCT00626522|564494267|FG003|Overall Study|Withdrawal by Subject|0|||
156382518|NCT00626522|564494268|FG004|Overall Study|Withdrawal by Subject|4|||
156382519|NCT00626522|564494269|FG005|Overall Study|Withdrawal by Subject|1|||
156382520|NCT00626522|564494264|FG000|Overall Study|COPD exacerbation|0|||
156382521|NCT00626522|564494265|FG001|Overall Study|COPD exacerbation|0|||
156382522|NCT00626522|564494266|FG002|Overall Study|COPD exacerbation|0|||
156382523|NCT00626522|564494267|FG003|Overall Study|COPD exacerbation|1|||
156501865|NCT03607422|564931443|FG000|Overall Study|Adverse Event|7|||
156501866|NCT03607422|564931444|FG001|Overall Study|Adverse Event|3|||
156501867|NCT03607422|564931445|FG002|Overall Study|Adverse Event|2|||
156382524|NCT00626522|564494268|FG004|Overall Study|COPD exacerbation|1|||
156382525|NCT00626522|564494269|FG005|Overall Study|COPD exacerbation|0|||
156382526|NCT00626522|564494264|FG000|Overall Study|Lost to Follow-up|0|||
156382527|NCT00626522|564494265|FG001|Overall Study|Lost to Follow-up|1|||
156382528|NCT00626522|564494266|FG002|Overall Study|Lost to Follow-up|0|||
156382529|NCT00626522|564494267|FG003|Overall Study|Lost to Follow-up|0|||
156382530|NCT00626522|564494268|FG004|Overall Study|Lost to Follow-up|0|||
156501868|NCT03607422|564931446|FG003|Overall Study|Adverse Event|0|||
156501869|NCT03607422|564931447|FG004|Overall Study|Adverse Event|2|||
156501870|NCT03607422|564931448|FG005|Overall Study|Adverse Event|0|||
156501871|NCT03607422|564931443|FG000|Overall Study|Withdrawal by Subject|11|||
156382531|NCT00626522|564494269|FG005|Overall Study|Lost to Follow-up|0|||
156382532|NCT00626522|564494264|FG000|Overall Study|Inconsistent reason reported|1|||
156382533|NCT00626522|564494265|FG001|Overall Study|Inconsistent reason reported|0|||
156382534|NCT00626522|564494266|FG002|Overall Study|Inconsistent reason reported|0|||
156382535|NCT00626522|564494267|FG003|Overall Study|Inconsistent reason reported|0|||
156382536|NCT00626522|564494268|FG004|Overall Study|Inconsistent reason reported|0|||
156382537|NCT00626522|564494269|FG005|Overall Study|Inconsistent reason reported|0|||
156382538|NCT00626522|564494264|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
156382539|NCT00626522|564494265|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
156382540|NCT00626522|564494266|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
156382541|NCT00626522|564494267|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
156382542|NCT00626522|564494268|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
156382543|NCT00626522|564494269|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
156382544|NCT01928719|564494270|FG000|Overall Study|Lost to Follow-up|26|||
156382545|NCT01928719|564494271|FG001|Overall Study|Lost to Follow-up|11|||
156382546|NCT01928719|564494270|FG000|Overall Study|Withdrawal by Subject|22|||
156382547|NCT01928719|564494271|FG001|Overall Study|Withdrawal by Subject|7|||
156382548|NCT01928719|564494270|FG000|Overall Study|Protocol Violation|3|||
156382549|NCT01928719|564494271|FG001|Overall Study|Protocol Violation|1|||
156382550|NCT01928719|564494270|FG000|Overall Study|Adverse Event|1|||
156382551|NCT01928719|564494271|FG001|Overall Study|Adverse Event|0|||
156382552|NCT02367911|564494274|FG000|Overall Study|Withdrawal by Subject|3|||
156382553|NCT02367911|564494275|FG001|Overall Study|Withdrawal by Subject|2|||
156382554|NCT02367911|564494274|FG000|Overall Study|Lost to Follow-up|2|||
156382555|NCT02367911|564494275|FG001|Overall Study|Lost to Follow-up|2|||
156382556|NCT00263666|564494276|FG000|Overall Study|Adverse Event|6|||
156382557|NCT00263666|564494277|FG001|Overall Study|Adverse Event|8|||
156382558|NCT00263666|564494276|FG000|Overall Study|Lost to Follow-up|1|||
156382559|NCT00263666|564494277|FG001|Overall Study|Lost to Follow-up|2|||
156382560|NCT00263666|564494276|FG000|Overall Study|Withdrawal by Subject|0|||
156382561|NCT00263666|564494277|FG001|Overall Study|Withdrawal by Subject|1|||
156382562|NCT00902304|564494278|FG000|Overall Study|Adverse Event|4|||
156382563|NCT00902304|564494279|FG001|Overall Study|Adverse Event|10|||
156382564|NCT00902304|564494280|FG002|Overall Study|Adverse Event|25|||
156382565|NCT00902304|564494278|FG000|Overall Study|Investigator discretion|3|||
156382566|NCT00902304|564494279|FG001|Overall Study|Investigator discretion|5|||
156382567|NCT00902304|564494280|FG002|Overall Study|Investigator discretion|13|||
156382568|NCT00902304|564494278|FG000|Overall Study|Lost to Follow-up|7|||
156382569|NCT00902304|564494279|FG001|Overall Study|Lost to Follow-up|7|||
156382570|NCT00902304|564494280|FG002|Overall Study|Lost to Follow-up|7|||
156382571|NCT00902304|564494278|FG000|Overall Study|Protocol Violation|9|||
156382572|NCT00902304|564494279|FG001|Overall Study|Protocol Violation|18|||
156382573|NCT00902304|564494280|FG002|Overall Study|Protocol Violation|20|||
156382574|NCT00902304|564494278|FG000|Overall Study|Withdrawal by Subject|32|||
156382575|NCT00902304|564494279|FG001|Overall Study|Withdrawal by Subject|22|||
156382576|NCT00902304|564494280|FG002|Overall Study|Withdrawal by Subject|43|||
156382577|NCT00902304|564494278|FG000|Overall Study|includes pregnancy|3|||
156382578|NCT00902304|564494279|FG001|Overall Study|includes pregnancy|9|||
156382579|NCT00902304|564494280|FG002|Overall Study|includes pregnancy|2|||
156382580|NCT00838110|564494281|FG000|Overall Study|Death|0|||
156382581|NCT00838110|564494282|FG001|Overall Study|Death|0|||
156382582|NCT00838110|564494283|FG002|Overall Study|Death|1|||
156382583|NCT00838110|564494284|FG003|Overall Study|Death|2|||
156382584|NCT00838110|564494281|FG000|Overall Study|Adverse Event|11|||
156382585|NCT00838110|564494282|FG001|Overall Study|Adverse Event|10|||
156382586|NCT00838110|564494283|FG002|Overall Study|Adverse Event|8|||
156382587|NCT00838110|564494284|FG003|Overall Study|Adverse Event|7|||
156382588|NCT00838110|564494281|FG000|Overall Study|Withdrawal by Subject|5|||
156382589|NCT00838110|564494282|FG001|Overall Study|Withdrawal by Subject|6|||
156382590|NCT00838110|564494283|FG002|Overall Study|Withdrawal by Subject|3|||
156382591|NCT00838110|564494284|FG003|Overall Study|Withdrawal by Subject|4|||
156382592|NCT00838110|564494281|FG000|Overall Study|Other|3|||
156382593|NCT00838110|564494282|FG001|Overall Study|Other|3|||
156382594|NCT00838110|564494283|FG002|Overall Study|Other|3|||
156382595|NCT00838110|564494284|FG003|Overall Study|Other|2|||
156382596|NCT00838110|564494281|FG000|Overall Study|Protocol Violation|0|||
156382597|NCT00838110|564494282|FG001|Overall Study|Protocol Violation|2|||
156382598|NCT00838110|564494283|FG002|Overall Study|Protocol Violation|1|||
156382599|NCT00838110|564494284|FG003|Overall Study|Protocol Violation|1|||
156382600|NCT00838110|564494281|FG000|Overall Study|Lost to Follow-up|3|||
156382601|NCT00838110|564494282|FG001|Overall Study|Lost to Follow-up|0|||
156382602|NCT00838110|564494283|FG002|Overall Study|Lost to Follow-up|0|||
156382603|NCT00838110|564494284|FG003|Overall Study|Lost to Follow-up|0|||
156382604|NCT00838110|564494281|FG000|Overall Study|Did not meet eligibility criteria|0|||
156382605|NCT00838110|564494282|FG001|Overall Study|Did not meet eligibility criteria|0|||
156382606|NCT00838110|564494283|FG002|Overall Study|Did not meet eligibility criteria|1|||
156382607|NCT00838110|564494284|FG003|Overall Study|Did not meet eligibility criteria|2|||
156382608|NCT00838110|564494281|FG000|Overall Study|Randomized but not treated|0|||
156382609|NCT00838110|564494282|FG001|Overall Study|Randomized but not treated|1|||
156382610|NCT00838110|564494283|FG002|Overall Study|Randomized but not treated|0|||
156382611|NCT00838110|564494284|FG003|Overall Study|Randomized but not treated|0|||
156382612|NCT01003899|564494285|FG000|Overall Study|Other Adverse Event|8|||
156501872|NCT03607422|564931444|FG001|Overall Study|Withdrawal by Subject|3|||
156501873|NCT03607422|564931445|FG002|Overall Study|Withdrawal by Subject|6|||
156501874|NCT03607422|564931446|FG003|Overall Study|Withdrawal by Subject|2|||
156501875|NCT03607422|564931447|FG004|Overall Study|Withdrawal by Subject|0|||
156501876|NCT03607422|564931448|FG005|Overall Study|Withdrawal by Subject|0|||
156501877|NCT03607422|564931443|FG000|Overall Study|Lost to Follow-up|0|||
156501878|NCT03607422|564931444|FG001|Overall Study|Lost to Follow-up|0|||
156501879|NCT03607422|564931445|FG002|Overall Study|Lost to Follow-up|1|||
156501880|NCT03607422|564931446|FG003|Overall Study|Lost to Follow-up|0|||
156501881|NCT03607422|564931447|FG004|Overall Study|Lost to Follow-up|0|||
156501882|NCT03607422|564931448|FG005|Overall Study|Lost to Follow-up|0|||
156501883|NCT03607422|564931443|FG000|Overall Study|Other|12|||
156501884|NCT03607422|564931444|FG001|Overall Study|Other|4|||
156501885|NCT03607422|564931445|FG002|Overall Study|Other|1|||
156501886|NCT03607422|564931446|FG003|Overall Study|Other|2|||
156501887|NCT03607422|564931447|FG004|Overall Study|Other|0|||
156501888|NCT03607422|564931448|FG005|Overall Study|Other|2|||
156501889|NCT03607422|564931443|FG000|Overall Study|Ongoing at Time of Analysis|8|||
156501890|NCT03607422|564931444|FG001|Overall Study|Ongoing at Time of Analysis|0|||
156501891|NCT03607422|564931445|FG002|Overall Study|Ongoing at Time of Analysis|2|||
156501892|NCT03607422|564931446|FG003|Overall Study|Ongoing at Time of Analysis|1|||
156501893|NCT03607422|564931447|FG004|Overall Study|Ongoing at Time of Analysis|1|||
156501894|NCT03607422|564931448|FG005|Overall Study|Ongoing at Time of Analysis|1|||
156501895|NCT01920932|564931449|FG000|Overall Study|Death|1|||
156501896|NCT01920932|564931449|FG000|Overall Study|Withdrawal of consent|1|||
156501897|NCT01107899|564931450|FG000|Overall Study|Physician Decision|5|||
156501898|NCT01107899|564931451|FG001|Overall Study|Physician Decision|0|||
156501899|NCT01107899|564931452|FG002|Overall Study|Physician Decision|3|||
156501900|NCT01107899|564931450|FG000|Overall Study|Withdrawal by Subject|0|||
156501901|NCT01107899|564931451|FG001|Overall Study|Withdrawal by Subject|0|||
156501902|NCT01107899|564931452|FG002|Overall Study|Withdrawal by Subject|1|||
156501903|NCT03584152|564931453|FG000|Overall Study|Discontinued intervention|7|||
156501904|NCT03584152|564931454|FG001|Overall Study|Discontinued intervention|4|||
156501905|NCT05274750|564931459|FG000|Overall Study|Adverse Event|0|||
156501906|NCT05274750|564931460|FG001|Overall Study|Adverse Event|1|||
156501907|NCT05274750|564931459|FG000|Overall Study|Lost to Follow-up|2|||
156501908|NCT05274750|564931460|FG001|Overall Study|Lost to Follow-up|3|||
156501909|NCT05274750|564931459|FG000|Overall Study|Physician Decision|3|||
156501910|NCT05274750|564931460|FG001|Overall Study|Physician Decision|0|||
156501911|NCT05274750|564931459|FG000|Overall Study|Withdrawal by Subject|10|||
156501912|NCT05274750|564931460|FG001|Overall Study|Withdrawal by Subject|9|||
156501913|NCT05274750|564931459|FG000|Overall Study|GCP Violation|0|||
156501914|NCT05274750|564931460|FG001|Overall Study|GCP Violation|4|||
156382613|NCT01003899|564494285|FG000|Overall Study|Not entered|4|||
156382614|NCT01003899|564494285|FG000|Overall Study|Not treated|1|||
156382615|NCT01003899|564494285|FG000|Overall Study|Progressive disease|34|||
156382616|NCT00352365|564494286|FG000|Induction Therapy|Adverse Event|7|||
156382617|NCT00352365|564494286|FG000|Induction Therapy|Progression/Relapse|8|||
156382618|NCT00352365|564494286|FG000|Induction Therapy|Death|7|||
156382619|NCT00352365|564494286|FG000|Induction Therapy|Not protocol specified|1|||
156382620|NCT00352365|564494286|FG000|Induction Therapy|Not eligible|3|||
156382621|NCT00352365|564494286|FG000|Induction Therapy|Death before starting protocol therapy|1|||
156382622|NCT00352365|564494286|FG000|Maintenance Therapy|Progression/Relapse|3|||
156382623|NCT00352365|564494286|FG000|Maintenance Therapy|Death|2|||
156382624|NCT00352365|564494286|FG000|Maintenance Therapy|Not protocol specified|3|||
156382625|NCT00352365|564494286|FG000|Maintenance Therapy|Not eligible|4|||
156382626|NCT02811861|564494287|FG000|Overall Study|Radiological Disease Progression|123|||
156382627|NCT02811861|564494288|FG001|Overall Study|Radiological Disease Progression|97|||
156382628|NCT02811861|564494289|FG002|Overall Study|Radiological Disease Progression|174|||
156382629|NCT02811861|564494287|FG000|Overall Study|Clinical Disease Progression|20|||
156382630|NCT02811861|564494288|FG001|Overall Study|Clinical Disease Progression|19|||
156382631|NCT02811861|564494289|FG002|Overall Study|Clinical Disease Progression|22|||
156382632|NCT02811861|564494287|FG000|Overall Study|Adverse Event|63|||
156382633|NCT02811861|564494288|FG001|Overall Study|Adverse Event|60|||
156382634|NCT02811861|564494289|FG002|Overall Study|Adverse Event|41|||
156382635|NCT02811861|564494287|FG000|Overall Study|Lost to Follow-up|0|||
156382636|NCT02811861|564494288|FG001|Overall Study|Lost to Follow-up|0|||
156382637|NCT02811861|564494289|FG002|Overall Study|Lost to Follow-up|1|||
156382638|NCT02811861|564494287|FG000|Overall Study|Subject Choice|29|||
156382639|NCT02811861|564494288|FG001|Overall Study|Subject Choice|17|||
156382640|NCT02811861|564494289|FG002|Overall Study|Subject Choice|23|||
156382641|NCT02811861|564494287|FG000|Overall Study|Withdrawal by Subject|4|||
156382642|NCT02811861|564494288|FG001|Overall Study|Withdrawal by Subject|4|||
156382643|NCT02811861|564494289|FG002|Overall Study|Withdrawal by Subject|9|||
156382644|NCT02811861|564494287|FG000|Overall Study|Other|4|||
156382645|NCT02811861|564494288|FG001|Overall Study|Other|13|||
156382646|NCT02811861|564494289|FG002|Overall Study|Other|3|||
156382647|NCT02811861|564494287|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
156382648|NCT02811861|564494288|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
156382649|NCT02811861|564494289|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
156382650|NCT02811861|564494287|FG000|Overall Study|Randomized but not treated|2|||
156382651|NCT02811861|564494288|FG001|Overall Study|Randomized but not treated|3|||
156382652|NCT02811861|564494289|FG002|Overall Study|Randomized but not treated|17|||
156382653|NCT04743908|564494290|FG000|Overall Study|Death|1|||
156382654|NCT04743908|564494291|FG001|Overall Study|Death|0|||
156382655|NCT04743908|564494290|FG000|Overall Study|Lost to Follow-up|181|||
156382656|NCT04743908|564494291|FG001|Overall Study|Lost to Follow-up|180|||
156382657|NCT04743908|564494290|FG000|Overall Study|Withdrawal by Subject|1|||
156382658|NCT04743908|564494291|FG001|Overall Study|Withdrawal by Subject|2|||
156382659|NCT03822533|564494292|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
156382660|NCT03822533|564494293|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
156382661|NCT03822533|564494292|FG000|3 Month Follow-up|Lost to Follow-up|2|||
156382662|NCT03822533|564494293|FG001|3 Month Follow-up|Lost to Follow-up|2|||
156382663|NCT03822533|564494292|FG000|6 Month Follow-up|Lost to Follow-up|3|||
156382664|NCT03822533|564494293|FG001|6 Month Follow-up|Lost to Follow-up|0|||
156382665|NCT03822533|564494292|FG000|12 Month Follow-up|Lost to Follow-up|2|||
156382666|NCT03822533|564494293|FG001|12 Month Follow-up|Lost to Follow-up|3|||
156382667|NCT03822533|564494292|FG000|12 Month Follow-up|Pregnancy|0|||
156382668|NCT03822533|564494293|FG001|12 Month Follow-up|Pregnancy|1|||
156382669|NCT03822533|564494292|FG000|12 Month Follow-up|Surgery|2|||
156382670|NCT03822533|564494293|FG001|12 Month Follow-up|Surgery|0|||
156382671|NCT03822533|564494292|FG000|12 Month Follow-up|Wrong address|1|||
156382672|NCT03822533|564494293|FG001|12 Month Follow-up|Wrong address|0|||
156382673|NCT03822533|564494292|FG000|12 Month Follow-up|No symptoms|1|||
156382674|NCT03822533|564494293|FG001|12 Month Follow-up|No symptoms|0|||
156501915|NCT05274750|564931459|FG000|Overall Study|Randomized, not treated|0|||
156501916|NCT05274750|564931460|FG001|Overall Study|Randomized, not treated|1|||
156501917|NCT00983749|564931461|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
156501918|NCT00983749|564931462|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
156382675|NCT03822533|564494292|FG000|12 Month Follow-up|Changed primary care center|0|||
156382676|NCT03822533|564494293|FG001|12 Month Follow-up|Changed primary care center|1|||
156382677|NCT04969783|564494296|FG000|Overall Study|Lost to Follow-up|2|||
156382678|NCT04969783|564494297|FG001|Overall Study|Lost to Follow-up|0|||
156382679|NCT04969783|564494296|FG000|Overall Study|Withdrawal by Subject|4|||
156382680|NCT04969783|564494297|FG001|Overall Study|Withdrawal by Subject|0|||
156382681|NCT04969783|564494296|FG000|Overall Study|Physician Decision|6|||
156382682|NCT04969783|564494297|FG001|Overall Study|Physician Decision|0|||
156382683|NCT02489500|564494298|FG000|Overall Study|Death|1|||
156382684|NCT02489500|564494299|FG001|Overall Study|Death|1|||
156382685|NCT00512135|564494300|FG000|Overall Study|Not Treated|5|||
156501919|NCT02906020|564931463|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
156501920|NCT02906020|564931464|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
156501921|NCT02906020|564931465|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
156501922|NCT02906020|564931466|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
156501923|NCT02906020|564931467|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
156501924|NCT02906020|564931468|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
156501925|NCT02906020|564931469|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
156501926|NCT02906020|564931470|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
156501927|NCT02906020|564931471|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
156501928|NCT02906020|564931472|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
156501929|NCT02906020|564931473|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
156501930|NCT02906020|564931474|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
156501931|NCT02906020|564931475|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
156501932|NCT02906020|564931476|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
156501933|NCT02906020|564931477|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
156501934|NCT02906020|564931478|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
156501935|NCT02906020|564931463|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501936|NCT02906020|564931464|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501937|NCT02906020|564931465|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501938|NCT02906020|564931466|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501939|NCT02906020|564931467|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501940|NCT02906020|564931468|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501941|NCT02906020|564931469|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501942|NCT02906020|564931470|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501943|NCT02906020|564931471|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
156501944|NCT02906020|564931472|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
156501945|NCT02906020|564931473|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501946|NCT02906020|564931474|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501947|NCT02906020|564931475|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501948|NCT02906020|564931476|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501949|NCT02906020|564931477|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501950|NCT02906020|564931478|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
156501951|NCT02906020|564931463|FG000|Part 2: Double-blind Treatment Period|Other|0|||
156501952|NCT02906020|564931464|FG001|Part 2: Double-blind Treatment Period|Other|0|||
156501953|NCT02906020|564931465|FG002|Part 2: Double-blind Treatment Period|Other|0|||
156501954|NCT02906020|564931466|FG003|Part 2: Double-blind Treatment Period|Other|0|||
156501955|NCT02906020|564931467|FG004|Part 2: Double-blind Treatment Period|Other|0|||
156501956|NCT02906020|564931468|FG005|Part 2: Double-blind Treatment Period|Other|0|||
156501957|NCT02906020|564931469|FG006|Part 2: Double-blind Treatment Period|Other|0|||
156501958|NCT02906020|564931470|FG007|Part 2: Double-blind Treatment Period|Other|0|||
156501959|NCT02906020|564931471|FG008|Part 2: Double-blind Treatment Period|Other|6|||
156501960|NCT02906020|564931472|FG009|Part 2: Double-blind Treatment Period|Other|10|||
156501961|NCT02906020|564931473|FG010|Part 2: Double-blind Treatment Period|Other|0|||
156501962|NCT02906020|564931474|FG011|Part 2: Double-blind Treatment Period|Other|0|||
156501963|NCT02906020|564931475|FG012|Part 2: Double-blind Treatment Period|Other|0|||
156501964|NCT02906020|564931476|FG013|Part 2: Double-blind Treatment Period|Other|0|||
156501965|NCT02906020|564931477|FG014|Part 2: Double-blind Treatment Period|Other|0|||
156501966|NCT02906020|564931478|FG015|Part 2: Double-blind Treatment Period|Other|0|||
156501967|NCT02906020|564931463|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501968|NCT02906020|564931464|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501969|NCT02906020|564931465|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501970|NCT02906020|564931466|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501971|NCT02906020|564931467|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501972|NCT02906020|564931468|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501973|NCT02906020|564931469|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501974|NCT02906020|564931470|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501975|NCT02906020|564931471|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501976|NCT02906020|564931472|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501977|NCT02906020|564931473|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501978|NCT02906020|564931474|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501979|NCT02906020|564931475|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
156501980|NCT02906020|564931476|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
156501981|NCT02906020|564931477|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501982|NCT02906020|564931478|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
156501983|NCT02906020|564931463|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501984|NCT02906020|564931464|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501985|NCT02906020|564931465|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156382686|NCT00512135|564494300|FG000|Overall Study|Lack of Efficacy|2|||
156501986|NCT02906020|564931466|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156382687|NCT00512135|564494300|FG000|Overall Study|Adverse Event|6|||
156382688|NCT00512135|564494300|FG000|Overall Study|Withdrawal by Subject|22|||
156382689|NCT00512135|564494300|FG000|Overall Study|Lost to Follow-up|27|||
156382690|NCT00512135|564494300|FG000|Overall Study|Other|22|||
156382691|NCT03422250|564494301|FG000|Intervention|Adverse Event|0|||
156382692|NCT03422250|564494302|FG001|Intervention|Adverse Event|1|||
156382693|NCT03422250|564494303|FG002|Intervention|Adverse Event|0|||
156382694|NCT03422250|564494304|FG003|Intervention|Adverse Event|1|||
156382695|NCT03422250|564494301|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
156382696|NCT03422250|564494302|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
156382697|NCT03422250|564494303|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
156382698|NCT03422250|564494304|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
156382699|NCT03422250|564494301|FG000|Follow-up|Withdrawal by Subject|0|||
156382700|NCT03422250|564494302|FG001|Follow-up|Withdrawal by Subject|0|||
156382701|NCT03422250|564494303|FG002|Follow-up|Withdrawal by Subject|0|||
156382702|NCT03422250|564494304|FG003|Follow-up|Withdrawal by Subject|1|||
156382703|NCT03422250|564494301|FG000|Follow-up|Adverse Event|0|||
156382704|NCT03422250|564494302|FG001|Follow-up|Adverse Event|0|||
156382705|NCT03422250|564494303|FG002|Follow-up|Adverse Event|0|||
156382706|NCT03422250|564494304|FG003|Follow-up|Adverse Event|1|||
156382707|NCT00377819|564494307|FG000|Overall Study|Adverse Event|2|||
156382708|NCT00377819|564494308|FG001|Overall Study|Adverse Event|3|||
156382709|NCT00377819|564494307|FG000|Overall Study|Withdrawal by Subject|10|||
156382710|NCT00377819|564494308|FG001|Overall Study|Withdrawal by Subject|4|||
156382711|NCT00377819|564494307|FG000|Overall Study|Death|0|||
156382712|NCT00377819|564494308|FG001|Overall Study|Death|1|||
156382713|NCT00377819|564494307|FG000|Overall Study|Lost to Follow-up|0|||
156382714|NCT00377819|564494308|FG001|Overall Study|Lost to Follow-up|1|||
156382715|NCT00377819|564494307|FG000|Overall Study|Protocol Violation|1|||
156382716|NCT00377819|564494308|FG001|Overall Study|Protocol Violation|1|||
156382717|NCT01917526|564494309|FG000|Overall Study|Protocol Violation|1|||
156382718|NCT01917526|564494310|FG001|Overall Study|Protocol Violation|1|||
156382719|NCT02099838|564494311|FG000|Overall Study|Death|1|||
156382720|NCT02099838|564494312|FG001|Overall Study|Death|0|||
156382721|NCT02099838|564494311|FG000|Overall Study|Lost to Follow-up|3|||
156382722|NCT02099838|564494312|FG001|Overall Study|Lost to Follow-up|1|||
156382723|NCT02099838|564494311|FG000|Overall Study|Withdrawal by Subject|0|||
156382724|NCT02099838|564494312|FG001|Overall Study|Withdrawal by Subject|1|||
156382725|NCT00774787|564494313|FG000|Overall Study|Lost to Follow-up|1|||
156382726|NCT04535037|564494314|FG000|Overall Study|Protocol Violation|1|||
156382727|NCT04535037|564494315|FG001|Overall Study|Protocol Violation|0|||
156382728|NCT04535037|564494314|FG000|Overall Study|Withdrawal by Subject|8|||
156382729|NCT04535037|564494315|FG001|Overall Study|Withdrawal by Subject|9|||
156382730|NCT04535037|564494314|FG000|Overall Study|Migrated / moved from the study area|1|||
156382731|NCT04535037|564494315|FG001|Overall Study|Migrated / moved from the study area|4|||
156382732|NCT04535037|564494314|FG000|Overall Study|Other|2|||
156382733|NCT04535037|564494315|FG001|Overall Study|Other|5|||
156382734|NCT02031276|564494316|FG000|Period 1 Double-blind IV|Adverse Event|6|||
156382735|NCT02031276|564494317|FG001|Period 1 Double-blind IV|Adverse Event|5|||
156382736|NCT02031276|564494318|FG002|Period 1 Double-blind IV|Adverse Event|1|||
156382737|NCT02031276|564494316|FG000|Period 1 Double-blind IV|Other|0|||
156382738|NCT02031276|564494317|FG001|Period 1 Double-blind IV|Other|1|||
156382739|NCT02031276|564494318|FG002|Period 1 Double-blind IV|Other|0|||
156382740|NCT02031276|564494316|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
156382741|NCT02031276|564494317|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
156382742|NCT02031276|564494318|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
156382743|NCT02031276|564494316|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
156382744|NCT02031276|564494317|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
156382745|NCT02031276|564494318|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
156382746|NCT02031276|564494316|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
156382747|NCT02031276|564494317|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
156382748|NCT02031276|564494318|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
156382749|NCT02031276|564494316|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
156382750|NCT02031276|564494317|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
156382751|NCT02031276|564494318|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
156382752|NCT02031276|564494316|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
156382753|NCT02031276|564494317|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
156382754|NCT02031276|564494318|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
156382755|NCT02031276|564494316|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
156382756|NCT02031276|564494317|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
156382757|NCT02031276|564494318|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
156382758|NCT02031276|564494316|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
156382759|NCT02031276|564494317|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
156382760|NCT02031276|564494318|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
156382761|NCT01148810|564494319|FG000|Overall Study|Adverse Event|0|||
156382762|NCT01148810|564494320|FG001|Overall Study|Adverse Event|2|||
156501987|NCT02906020|564931467|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501988|NCT02906020|564931468|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501989|NCT02906020|564931469|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501990|NCT02906020|564931470|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501991|NCT02906020|564931471|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501992|NCT02906020|564931472|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501993|NCT02906020|564931473|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501994|NCT02906020|564931474|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501995|NCT02906020|564931475|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
156501996|NCT02906020|564931476|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
156501997|NCT02906020|564931477|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
156501998|NCT02906020|564931478|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
156501999|NCT02906020|564931463|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502000|NCT02906020|564931464|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502001|NCT02906020|564931465|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502002|NCT02906020|564931466|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502003|NCT02906020|564931467|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502004|NCT02906020|564931468|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502005|NCT02906020|564931469|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502006|NCT02906020|564931470|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502007|NCT02906020|564931471|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502008|NCT02906020|564931472|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502009|NCT02906020|564931473|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502010|NCT02906020|564931474|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502011|NCT02906020|564931475|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
156502012|NCT02906020|564931476|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
156502013|NCT02906020|564931477|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502014|NCT02906020|564931478|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
156502015|NCT02906020|564931463|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502016|NCT02906020|564931464|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502017|NCT02906020|564931465|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502018|NCT02906020|564931466|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502019|NCT02906020|564931467|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502020|NCT02906020|564931468|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502021|NCT02906020|564931469|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502022|NCT02906020|564931470|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502023|NCT02906020|564931471|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502024|NCT02906020|564931472|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502025|NCT02906020|564931473|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502026|NCT02906020|564931474|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502027|NCT02906020|564931475|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
156502028|NCT02906020|564931476|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
156546914|NCT00440947|565094996|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
156382763|NCT01148810|564494319|FG000|Overall Study|Lack of Efficacy|0|||
156382764|NCT01148810|564494320|FG001|Overall Study|Lack of Efficacy|1|||
156382765|NCT01148810|564494319|FG000|Overall Study|Withdrawal by Subject|0|||
156382766|NCT01148810|564494320|FG001|Overall Study|Withdrawal by Subject|2|||
156382767|NCT01148810|564494319|FG000|Overall Study|Protocol Violation|1|||
156382768|NCT01148810|564494320|FG001|Overall Study|Protocol Violation|0|||
156382769|NCT02731131|564494324|FG000|Overall Study|Psychiatric Disorder|0|||
156382770|NCT02731131|564494325|FG001|Overall Study|Psychiatric Disorder|1|||
156382771|NCT02731131|564494324|FG000|Overall Study|Refused Therapy|0|||
156502029|NCT02906020|564931477|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502030|NCT02906020|564931478|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
156502031|NCT02906020|564931463|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502032|NCT02906020|564931464|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502033|NCT02906020|564931465|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502034|NCT02906020|564931466|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502035|NCT02906020|564931467|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502036|NCT02906020|564931468|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502037|NCT02906020|564931469|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502038|NCT02906020|564931470|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502039|NCT02906020|564931471|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502040|NCT02906020|564931472|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502041|NCT02906020|564931473|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502042|NCT02906020|564931474|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
156502043|NCT02906020|564931475|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
156502044|NCT02906020|564931476|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
156502045|NCT02906020|564931477|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
156502046|NCT02906020|564931478|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
156502047|NCT02906020|564931463|FG000|Part 2: Long-term Follow-up Period|Other|0|||
156502048|NCT02906020|564931464|FG001|Part 2: Long-term Follow-up Period|Other|0|||
156502049|NCT02906020|564931465|FG002|Part 2: Long-term Follow-up Period|Other|0|||
156502050|NCT02906020|564931466|FG003|Part 2: Long-term Follow-up Period|Other|0|||
156502051|NCT02906020|564931467|FG004|Part 2: Long-term Follow-up Period|Other|0|||
156502052|NCT02906020|564931468|FG005|Part 2: Long-term Follow-up Period|Other|0|||
156502053|NCT02906020|564931469|FG006|Part 2: Long-term Follow-up Period|Other|0|||
156502054|NCT02906020|564931470|FG007|Part 2: Long-term Follow-up Period|Other|0|||
156502055|NCT02906020|564931471|FG008|Part 2: Long-term Follow-up Period|Other|0|||
156502056|NCT02906020|564931472|FG009|Part 2: Long-term Follow-up Period|Other|0|||
156502057|NCT02906020|564931473|FG010|Part 2: Long-term Follow-up Period|Other|0|||
156502058|NCT02906020|564931474|FG011|Part 2: Long-term Follow-up Period|Other|0|||
156502059|NCT02906020|564931475|FG012|Part 2: Long-term Follow-up Period|Other|13|||
156502060|NCT02906020|564931476|FG013|Part 2: Long-term Follow-up Period|Other|8|||
156502061|NCT02906020|564931477|FG014|Part 2: Long-term Follow-up Period|Other|3|||
156502062|NCT02906020|564931478|FG015|Part 2: Long-term Follow-up Period|Other|2|||
156502063|NCT04698915|564931479|FG000|Overall Study|Adverse Event|2|||
156502064|NCT04698915|564931480|FG001|Overall Study|Adverse Event|0|||
156502065|NCT04698915|564931479|FG000|Overall Study|Death|23|||
156502066|NCT04698915|564931480|FG001|Overall Study|Death|20|||
156502067|NCT04698915|564931479|FG000|Overall Study|Physician Decision|1|||
156502068|NCT04698915|564931480|FG001|Overall Study|Physician Decision|1|||
156502069|NCT04698915|564931479|FG000|Overall Study|Lost to Follow-up|1|||
156502070|NCT04698915|564931480|FG001|Overall Study|Lost to Follow-up|0|||
156502071|NCT04698915|564931479|FG000|Overall Study|Study Terminated by Sponsor|55|||
156502072|NCT04698915|564931480|FG001|Overall Study|Study Terminated by Sponsor|60|||
156382772|NCT02731131|564494325|FG001|Overall Study|Refused Therapy|1|||
156382773|NCT04137380|564494330|FG000|Overall Study|Physician Decision|0|||
156382774|NCT04137380|564494331|FG001|Overall Study|Physician Decision|0|||
156382775|NCT04137380|564494332|FG002|Overall Study|Physician Decision|0|||
156382776|NCT04137380|564494333|FG003|Overall Study|Physician Decision|1|||
156382777|NCT04137380|564494334|FG004|Overall Study|Physician Decision|0|||
156382778|NCT04137380|564494335|FG005|Overall Study|Physician Decision|0|||
156382779|NCT04137380|564494336|FG006|Overall Study|Physician Decision|0|||
156382780|NCT00346034|564494339|FG000|Overall Study|Adverse Event|34|||
156382781|NCT00346034|564494339|FG000|Overall Study|Lack of Efficacy|8|||
156502073|NCT04698915|564931479|FG000|Overall Study|Withdrawal by Subject|2|||
156502074|NCT04698915|564931480|FG001|Overall Study|Withdrawal by Subject|3|||
156502075|NCT02312557|564931481|FG000|Overall Study|Survival follow-up|4|||
156502076|NCT01124097|564931482|FG000|Overall Study|Withdrawal by Subject|4|||
156502077|NCT01124097|564931483|FG001|Overall Study|Withdrawal by Subject|3|||
156502078|NCT01124097|564931484|FG002|Overall Study|Withdrawal by Subject|2|||
156502079|NCT01124097|564931485|FG003|Overall Study|Withdrawal by Subject|3|||
156502080|NCT01124097|564931482|FG000|Overall Study|Lack of Efficacy|2|||
156502081|NCT01124097|564931483|FG001|Overall Study|Lack of Efficacy|3|||
156502082|NCT01124097|564931484|FG002|Overall Study|Lack of Efficacy|1|||
156502083|NCT01124097|564931485|FG003|Overall Study|Lack of Efficacy|3|||
156502084|NCT01124097|564931482|FG000|Overall Study|Adverse Event|24|||
156502085|NCT01124097|564931483|FG001|Overall Study|Adverse Event|15|||
156502086|NCT01124097|564931484|FG002|Overall Study|Adverse Event|15|||
156502087|NCT01124097|564931485|FG003|Overall Study|Adverse Event|7|||
156502088|NCT01124097|564931482|FG000|Overall Study|Protocol Violation|2|||
156502089|NCT01124097|564931483|FG001|Overall Study|Protocol Violation|0|||
156382782|NCT00346034|564494339|FG000|Overall Study|Withdrawal by Subject|13|||
156382783|NCT00346034|564494339|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
156382784|NCT00346034|564494339|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
156382785|NCT02079805|564494343|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156382786|NCT02079805|564494344|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
156382787|NCT02079805|564494343|FG000|Overall Study|Voluntary Withdrawal|0|||
156382788|NCT02079805|564494344|FG001|Overall Study|Voluntary Withdrawal|1|||
156382789|NCT00583557|564494345|FG000|Overall Study|Withdrawal by Subject|18|||
156382790|NCT00583557|564494345|FG000|Overall Study|Adverse Event|9|||
156382791|NCT00583557|564494345|FG000|Overall Study|Lack of Efficacy|31|||
156382792|NCT00583557|564494345|FG000|Overall Study|Lack of Compliance|5|||
156382793|NCT00583557|564494345|FG000|Overall Study|Other|5|||
156382794|NCT00583557|564494345|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
156382795|NCT02334748|564494346|FG000|Overall Study|Adverse Event|1|||
156382796|NCT02334748|564494346|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
156382797|NCT02334748|564494346|FG000|Overall Study|Patient no longer required study drug|2|||
156382798|NCT02334748|564494346|FG000|Overall Study|Lack of Efficacy|4|||
156382799|NCT01046643|564494347|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
156382800|NCT01046643|564494348|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
156382801|NCT01046643|564494349|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
156382802|NCT01046643|564494350|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
156382803|NCT02043782|564494353|FG000|Period 1|Adverse Event|0|||
156382804|NCT02043782|564494354|FG001|Period 1|Adverse Event|0|||
156382805|NCT02043782|564494355|FG002|Period 1|Adverse Event|1|||
156382806|NCT02043782|564494356|FG003|Period 1|Adverse Event|0|||
156382807|NCT02043782|564494357|FG004|Period 1|Adverse Event|0|||
156382808|NCT02043782|564494358|FG005|Period 1|Adverse Event|0|||
156382809|NCT00874029|564494359|FG000|Overall Study|Withdrawal by Subject|10|||
156382810|NCT00874029|564494359|FG000|Overall Study|Pregnancy|4|||
156382811|NCT00874029|564494359|FG000|Overall Study|Physician Decision|1|||
156382812|NCT00874029|564494359|FG000|Overall Study|Adverse Event|1|||
156382813|NCT00874029|564494359|FG000|Overall Study|Lost to Follow-up|5|||
156382814|NCT01024387|564494363|FG000|Overall Study|Radiographic Progression|29|||
156382815|NCT01024387|564494363|FG000|Overall Study|Symptomatic Progression|10|||
156382816|NCT01024387|564494363|FG000|Overall Study|Physician Decision|5|||
156382817|NCT01024387|564494363|FG000|Overall Study|Withdrawal by Subject|5|||
156382818|NCT01024387|564494363|FG000|Overall Study|Death|2|||
156382819|NCT01024387|564494363|FG000|Overall Study|Prolonged Treatment Delay|1|||
156382820|NCT01024387|564494363|FG000|Overall Study|Adverse Event|3|||
156382821|NCT01024387|564494363|FG000|Overall Study|Other|5|||
156382822|NCT03855189|564494364|FG000|Overall Study|Adverse Event|5|||
156382823|NCT03855189|564494365|FG001|Overall Study|Adverse Event|2|||
156382824|NCT03855189|564494366|FG002|Overall Study|Adverse Event|4|||
156382825|NCT03855189|564494364|FG000|Overall Study|Treatment Failure|1|||
156382826|NCT03855189|564494365|FG001|Overall Study|Treatment Failure|1|||
156382827|NCT03855189|564494366|FG002|Overall Study|Treatment Failure|2|||
156382828|NCT03855189|564494364|FG000|Overall Study|Noncompliance with Protocol|0|||
156382829|NCT03855189|564494365|FG001|Overall Study|Noncompliance with Protocol|1|||
156382830|NCT03855189|564494366|FG002|Overall Study|Noncompliance with Protocol|0|||
156382831|NCT03855189|564494364|FG000|Overall Study|Did Not Return|4|||
156382832|NCT03855189|564494365|FG001|Overall Study|Did Not Return|3|||
156382833|NCT03855189|564494366|FG002|Overall Study|Did Not Return|0|||
156382834|NCT00586105|564494368|FG000|Overall Study|Adverse Event|4|||
156382835|NCT00586105|564494368|FG000|Overall Study|Death|2|||
156382836|NCT00586105|564494368|FG000|Overall Study|Protocol Violation|1|||
156382837|NCT00586105|564494368|FG000|Overall Study|Withdrawal by Subject|3|||
156382838|NCT00586105|564494368|FG000|Overall Study|Disease progression|19|||
156382839|NCT00586105|564494368|FG000|Overall Study|Switched to commercial drug|9|||
156382840|NCT00586105|564494368|FG000|Overall Study|Reason not reported|1|||
156382841|NCT03191903|564494372|FG000|Overall Study|Withdrawal by Subject|6|||
156382842|NCT03191903|564494373|FG001|Overall Study|Withdrawal by Subject|5|||
156382843|NCT03191903|564494374|FG002|Overall Study|Withdrawal by Subject|4|||
156382844|NCT03191903|564494372|FG000|Overall Study|Adverse Event|1|||
156382845|NCT03191903|564494373|FG001|Overall Study|Adverse Event|0|||
156382846|NCT03191903|564494374|FG002|Overall Study|Adverse Event|0|||
156382847|NCT00503685|564494378|FG000|Overall Study|Adverse Event|0|||
156382848|NCT00503685|564494379|FG001|Overall Study|Adverse Event|0|||
156382849|NCT00503685|564494380|FG002|Overall Study|Adverse Event|2|||
156382850|NCT00503685|564494378|FG000|Overall Study|Withdrawal by Subject|0|||
156382851|NCT00503685|564494379|FG001|Overall Study|Withdrawal by Subject|1|||
156382852|NCT00503685|564494380|FG002|Overall Study|Withdrawal by Subject|0|||
156382853|NCT00503685|564494378|FG000|Overall Study|Protocol Violation|0|||
156382854|NCT00503685|564494379|FG001|Overall Study|Protocol Violation|1|||
156382855|NCT00503685|564494380|FG002|Overall Study|Protocol Violation|0|||
156382856|NCT00503685|564494378|FG000|Overall Study|Eligibility Criteria Not Met|0|||
156382857|NCT00503685|564494379|FG001|Overall Study|Eligibility Criteria Not Met|1|||
156382858|NCT00503685|564494380|FG002|Overall Study|Eligibility Criteria Not Met|0|||
156382859|NCT00927927|564494383|FG000|Overall Study|Withdrawal by Subject|0|||
156382860|NCT00927927|564494384|FG001|Overall Study|Withdrawal by Subject|0|||
156382861|NCT00927927|564494385|FG002|Overall Study|Withdrawal by Subject|0|||
156502090|NCT01124097|564931484|FG002|Overall Study|Protocol Violation|2|||
156502091|NCT01124097|564931485|FG003|Overall Study|Protocol Violation|1|||
156502092|NCT01124097|564931482|FG000|Overall Study|Physician Decision|2|||
156502093|NCT01124097|564931483|FG001|Overall Study|Physician Decision|1|||
156502094|NCT01124097|564931484|FG002|Overall Study|Physician Decision|0|||
156502095|NCT01124097|564931485|FG003|Overall Study|Physician Decision|0|||
156502096|NCT00425607|564931488|FG000|Overall Study|Death|1|||
156502097|NCT00425607|564931488|FG000|Overall Study|Withdrawal by Subject|1|||
156502098|NCT00193479|564931489|FG000|Induction Chemotherapy|Adverse Event|2|||
156502099|NCT00193479|564931489|FG000|Induction Chemotherapy|Disease Progression|1|||
156502100|NCT00193479|564931489|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
156502101|NCT00193479|564931489|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
156502102|NCT00079339|564931490|FG000|Overall Study|Adverse Event|1|||
156502103|NCT00079339|564931491|FG001|Overall Study|Adverse Event|7|||
156502104|NCT00079339|564931492|FG002|Overall Study|Adverse Event|2|||
156502105|NCT00079339|564931490|FG000|Overall Study|Death|1|||
156502106|NCT00079339|564931491|FG001|Overall Study|Death|0|||
156502107|NCT00079339|564931492|FG002|Overall Study|Death|0|||
156502108|NCT00079339|564931490|FG000|Overall Study|Non-compliance|0|||
156502109|NCT00079339|564931491|FG001|Overall Study|Non-compliance|0|||
156502110|NCT00079339|564931492|FG002|Overall Study|Non-compliance|1|||
156502111|NCT00079339|564931490|FG000|Overall Study|Withdrawal by Subject|0|||
156502112|NCT00079339|564931491|FG001|Overall Study|Withdrawal by Subject|4|||
156502113|NCT00079339|564931492|FG002|Overall Study|Withdrawal by Subject|1|||
156502114|NCT00079339|564931490|FG000|Overall Study|Disease progression|3|||
156502115|NCT00079339|564931491|FG001|Overall Study|Disease progression|28|||
156502116|NCT00079339|564931492|FG002|Overall Study|Disease progression|2|||
156502117|NCT00559377|564931493|FG000|Overall Study|Withdrawal by Subject|9|||
156502118|NCT02563548|564931495|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
156502119|NCT02563548|564931496|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
156502120|NCT02563548|564931497|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
156502121|NCT02563548|564931498|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
156502122|NCT02563548|564931499|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
156502123|NCT02563548|564931500|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
156502124|NCT02563548|564931495|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
156502125|NCT02563548|564931496|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
156502126|NCT02563548|564931497|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
156502127|NCT02563548|564931498|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
156502128|NCT02563548|564931499|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
156502129|NCT02563548|564931500|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
156502130|NCT02563548|564931495|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
156502131|NCT02563548|564931496|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
156502132|NCT02563548|564931497|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
156502133|NCT02563548|564931498|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
156502134|NCT02563548|564931499|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
156502135|NCT02563548|564931500|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
156502136|NCT02563548|564931495|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
156502137|NCT02563548|564931496|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
156502138|NCT02563548|564931497|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
156502139|NCT02563548|564931498|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
156502140|NCT02563548|564931499|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
156502141|NCT02563548|564931500|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
156502142|NCT02563548|564931495|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
156502143|NCT02563548|564931496|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
156502144|NCT02563548|564931497|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
156502145|NCT02563548|564931498|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
156502146|NCT02563548|564931499|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
156502147|NCT02563548|564931500|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
156502148|NCT02563548|564931495|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
156502149|NCT02563548|564931496|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
156502150|NCT02563548|564931497|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
156502151|NCT02563548|564931498|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
156502152|NCT02563548|564931499|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
156502153|NCT02563548|564931500|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
156502154|NCT02563548|564931495|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
156502155|NCT02563548|564931496|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
156502156|NCT02563548|564931497|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
156502157|NCT02563548|564931498|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
156502158|NCT02563548|564931499|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
156502159|NCT02563548|564931500|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
156546915|NCT00440947|565094997|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
156502160|NCT02563548|564931495|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
156502161|NCT02563548|564931496|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
156502162|NCT02563548|564931497|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
156502163|NCT02563548|564931498|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
156502164|NCT02563548|564931499|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
156502165|NCT02563548|564931500|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
156502166|NCT02563548|564931495|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
156502167|NCT02563548|564931496|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
156502168|NCT02563548|564931497|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
156502169|NCT02563548|564931498|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
156502170|NCT02563548|564931499|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
156502171|NCT02563548|564931500|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
156502172|NCT02563548|564931495|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
156502173|NCT02563548|564931496|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
156502174|NCT02563548|564931497|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
156502175|NCT02563548|564931498|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
156502176|NCT02563548|564931499|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
156502177|NCT02563548|564931500|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
156502178|NCT02563548|564931495|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
156502179|NCT02563548|564931496|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
156502180|NCT02563548|564931497|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
156502181|NCT02563548|564931498|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
156502182|NCT02563548|564931499|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
156502183|NCT02563548|564931500|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
156502184|NCT02563548|564931495|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
156502185|NCT02563548|564931496|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
156502186|NCT02563548|564931497|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
156502187|NCT02563548|564931498|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
156502188|NCT02563548|564931499|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
156502189|NCT02563548|564931500|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
156502190|NCT00203047|564931505|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
156502191|NCT00203047|564931506|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
156502192|NCT00203047|564931505|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
156502193|NCT00203047|564931506|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
156502194|NCT00203047|564931505|FG000|Overall Study|Withdrawal by Subject|13|||
156502195|NCT00203047|564931506|FG001|Overall Study|Withdrawal by Subject|47|||
156502196|NCT00203047|564931505|FG000|Overall Study|Teva requested participant withdrawal|1|||
156502197|NCT00203047|564931506|FG001|Overall Study|Teva requested participant withdrawal|1|||
156502198|NCT00203047|564931505|FG000|Overall Study|Physician Decision|8|||
156502199|NCT00203047|564931506|FG001|Overall Study|Physician Decision|7|||
156502200|NCT00203047|564931505|FG000|Overall Study|Non-compliance|4|||
156502201|NCT00203047|564931506|FG001|Overall Study|Non-compliance|8|||
156502202|NCT00203047|564931505|FG000|Overall Study|Protocol Violation|1|||
156502203|NCT00203047|564931506|FG001|Overall Study|Protocol Violation|0|||
156502204|NCT00203047|564931505|FG000|Overall Study|Lost to Follow-up|11|||
156502205|NCT00203047|564931506|FG001|Overall Study|Lost to Follow-up|5|||
156502206|NCT00203047|564931505|FG000|Overall Study|Adverse Event|8|||
156502207|NCT00203047|564931506|FG001|Overall Study|Adverse Event|18|||
156502208|NCT00203047|564931505|FG000|Overall Study|Death|1|||
156502209|NCT00203047|564931506|FG001|Overall Study|Death|2|||
156502210|NCT00203047|564931505|FG000|Overall Study|Pregnancy|3|||
156502211|NCT00203047|564931506|FG001|Overall Study|Pregnancy|0|||
156502212|NCT00203047|564931505|FG000|Overall Study|Other|5|||
156502213|NCT00203047|564931506|FG001|Overall Study|Other|5|||
156502214|NCT01453023|564931509|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
156502215|NCT01453023|564931510|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
156502216|NCT01453023|564931509|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
156502217|NCT01453023|564931510|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
156502218|NCT01453023|564931509|FG000|Treatment Period 2|Protocol Violation|0|||
156502219|NCT01453023|564931510|FG001|Treatment Period 2|Protocol Violation|1|||
156502220|NCT03721172|564931511|FG000|Placebo-controlled Phase|Adverse Event|7|||
156502221|NCT03721172|564931512|FG001|Placebo-controlled Phase|Adverse Event|7|||
156502222|NCT03721172|564931513|FG002|Placebo-controlled Phase|Adverse Event|0|||
156502223|NCT03721172|564931511|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
156502224|NCT03721172|564931512|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
156502225|NCT03721172|564931513|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
156502226|NCT03721172|564931511|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
156502227|NCT03721172|564931512|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
156502228|NCT03721172|564931513|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
156502229|NCT03721172|564931511|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
156382862|NCT00927927|564494386|FG003|Overall Study|Withdrawal by Subject|0|||
156382863|NCT00927927|564494387|FG004|Overall Study|Withdrawal by Subject|0|||
156382864|NCT00927927|564494388|FG005|Overall Study|Withdrawal by Subject|0|||
156382865|NCT00927927|564494389|FG006|Overall Study|Withdrawal by Subject|0|||
156382866|NCT00927927|564494390|FG007|Overall Study|Withdrawal by Subject|2|||
156382867|NCT00927927|564494391|FG008|Overall Study|Withdrawal by Subject|0|||
156382868|NCT00927927|564494392|FG009|Overall Study|Withdrawal by Subject|0|||
156382869|NCT00927927|564494393|FG010|Overall Study|Withdrawal by Subject|0|||
156382870|NCT00927927|564494394|FG011|Overall Study|Withdrawal by Subject|2|||
156382871|NCT00927927|564494395|FG012|Overall Study|Withdrawal by Subject|0|||
156382872|NCT00927927|564494396|FG013|Overall Study|Withdrawal by Subject|0|||
156382873|NCT00927927|564494397|FG014|Overall Study|Withdrawal by Subject|0|||
156382874|NCT01110239|564494402|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
156382875|NCT01110239|564494403|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
156382876|NCT01110239|564494404|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
156382877|NCT01110239|564494405|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
156382878|NCT01110239|564494402|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
156382879|NCT01110239|564494403|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
156382880|NCT01110239|564494404|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
156382881|NCT01110239|564494405|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
156382882|NCT00080223|564494410|FG000|Overall Study|Adverse Event|23|||
156382883|NCT00080223|564494410|FG000|Overall Study|Death|21|||
156382884|NCT00080223|564494410|FG000|Overall Study|Withdrawal by Subject|13|||
156382885|NCT00080223|564494410|FG000|Overall Study|Lung Transplantation|9|||
156382886|NCT00080223|564494410|FG000|Overall Study|Non-compliance With Study Treatment|7|||
156382887|NCT00080223|564494410|FG000|Overall Study|Participant unwilling to continue|2|||
156382888|NCT00080223|564494410|FG000|Overall Study|Physician Decision|1|||
156382889|NCT03099382|564494417|FG000|Overall Study|Protocol Violation|2|||
156382890|NCT03099382|564494418|FG001|Overall Study|Protocol Violation|3|||
156382891|NCT00499369|564494419|FG000|Overall Study|Adverse Event|2|||
156382892|NCT00499369|564494420|FG001|Overall Study|Adverse Event|2|||
156382893|NCT00499369|564494421|FG002|Overall Study|Adverse Event|3|||
156382894|NCT00499369|564494422|FG003|Overall Study|Adverse Event|1|||
156382895|NCT00499369|564494423|FG004|Overall Study|Adverse Event|2|||
156382896|NCT00499369|564494419|FG000|Overall Study|Withdrawal by Subject|0|||
156382897|NCT00499369|564494420|FG001|Overall Study|Withdrawal by Subject|1|||
156382898|NCT00499369|564494421|FG002|Overall Study|Withdrawal by Subject|1|||
156382899|NCT00499369|564494422|FG003|Overall Study|Withdrawal by Subject|0|||
156382900|NCT00499369|564494423|FG004|Overall Study|Withdrawal by Subject|0|||
156382901|NCT00499369|564494419|FG000|Overall Study|Progression|10|||
156382902|NCT00499369|564494420|FG001|Overall Study|Progression|12|||
156382903|NCT00499369|564494421|FG002|Overall Study|Progression|9|||
156382904|NCT00499369|564494422|FG003|Overall Study|Progression|6|||
156382905|NCT00499369|564494423|FG004|Overall Study|Progression|10|||
156382906|NCT00499369|564494419|FG000|Overall Study|Death|0|||
156382907|NCT00499369|564494420|FG001|Overall Study|Death|1|||
156382908|NCT00499369|564494421|FG002|Overall Study|Death|0|||
156382909|NCT00499369|564494422|FG003|Overall Study|Death|0|||
156382910|NCT00499369|564494423|FG004|Overall Study|Death|0|||
156382911|NCT00499369|564494419|FG000|Overall Study|Not protocol specified|2|||
156382912|NCT00499369|564494420|FG001|Overall Study|Not protocol specified|0|||
156382913|NCT00499369|564494421|FG002|Overall Study|Not protocol specified|3|||
156382914|NCT00499369|564494422|FG003|Overall Study|Not protocol specified|1|||
156382915|NCT00499369|564494423|FG004|Overall Study|Not protocol specified|0|||
156546916|NCT00440947|565094998|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
156546917|NCT00440947|565094999|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
156546918|NCT00440947|565094995|FG000|48-Week Randomization Phase|Physician Decision|0|||
156382916|NCT00499369|564494419|FG000|Overall Study|Ineligible|2|||
156382917|NCT00499369|564494420|FG001|Overall Study|Ineligible|2|||
156382918|NCT00499369|564494421|FG002|Overall Study|Ineligible|1|||
156382919|NCT00499369|564494422|FG003|Overall Study|Ineligible|1|||
156382920|NCT00499369|564494423|FG004|Overall Study|Ineligible|0|||
156382921|NCT01898195|564494425|FG000|Smoking Abstinence|Did not have good measurements|35|||
156382922|NCT01898195|564494426|FG001|Smoking Abstinence|Did not have good measurements|38|||
156382923|NCT01898195|564494427|FG002|Smoking Abstinence|Did not have good measurements|36|||
156382924|NCT01802411|564494428|FG000|Overall Study|Death|2|||
156382925|NCT01802411|564494429|FG001|Overall Study|Death|1|||
156382926|NCT01802411|564494428|FG000|Overall Study|Adverse Event|2|||
156382927|NCT01802411|564494429|FG001|Overall Study|Adverse Event|7|||
156382928|NCT01802411|564494428|FG000|Overall Study|Lack of Efficacy|8|||
156382929|NCT01802411|564494429|FG001|Overall Study|Lack of Efficacy|10|||
156382930|NCT01802411|564494428|FG000|Overall Study|Withdrawal by Subject|0|||
156382931|NCT01802411|564494429|FG001|Overall Study|Withdrawal by Subject|2|||
156382932|NCT01802411|564494428|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
156382933|NCT01802411|564494429|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
156382934|NCT01802411|564494428|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
156382935|NCT01802411|564494429|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
156502230|NCT03721172|564931512|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
156502231|NCT03721172|564931513|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
156502232|NCT03721172|564931511|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
156502233|NCT03721172|564931512|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
156502234|NCT03721172|564931513|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
156502235|NCT03721172|564931511|FG000|Placebo-controlled Phase|Other|3|||
156502236|NCT03721172|564931512|FG001|Placebo-controlled Phase|Other|0|||
156502237|NCT03721172|564931513|FG002|Placebo-controlled Phase|Other|0|||
156502238|NCT03721172|564931511|FG000|Apremilast Extension Phase|Adverse Event|0|||
156502239|NCT03721172|564931512|FG001|Apremilast Extension Phase|Adverse Event|0|||
156502240|NCT03721172|564931513|FG002|Apremilast Extension Phase|Adverse Event|10|||
156502241|NCT03721172|564931511|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
156502242|NCT03721172|564931512|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
156502243|NCT03721172|564931513|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
156502244|NCT03721172|564931511|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
156502245|NCT03721172|564931512|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
156502246|NCT03721172|564931513|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
156502247|NCT03721172|564931511|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
156502248|NCT03721172|564931512|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
156502249|NCT03721172|564931513|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
156502250|NCT03721172|564931511|FG000|Apremilast Extension Phase|Protocol Violation|0|||
156502251|NCT03721172|564931512|FG001|Apremilast Extension Phase|Protocol Violation|0|||
156502252|NCT03721172|564931513|FG002|Apremilast Extension Phase|Protocol Violation|1|||
156502253|NCT03721172|564931511|FG000|Apremilast Extension Phase|Physician Decision|0|||
156502254|NCT03721172|564931512|FG001|Apremilast Extension Phase|Physician Decision|0|||
156502255|NCT03721172|564931513|FG002|Apremilast Extension Phase|Physician Decision|1|||
156502256|NCT03721172|564931511|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
156502257|NCT03721172|564931512|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
156502258|NCT03721172|564931513|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
156502259|NCT03721172|564931511|FG000|Apremilast Extension Phase|Other|0|||
156502260|NCT03721172|564931512|FG001|Apremilast Extension Phase|Other|0|||
156502261|NCT03721172|564931513|FG002|Apremilast Extension Phase|Other|3|||
156502262|NCT03721172|564931511|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
156502263|NCT03721172|564931512|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
156502264|NCT03721172|564931513|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
156502265|NCT02417441|564931516|FG000|Overall Study|Inconclusive due to missing data|52|||
156502266|NCT02417441|564931517|FG001|Overall Study|Inconclusive due to missing data|19|||
156502267|NCT05628285|564931518|FG000|Overall Study|Lost to Follow-up|1|||
156502268|NCT02339506|564931519|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
156502269|NCT02339506|564931520|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
156502270|NCT02339506|564931519|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
156502271|NCT02339506|564931520|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
156502272|NCT02869867|564931521|FG000|Overall Study|Protocol Violation|1|||
156502273|NCT02869867|564931522|FG001|Overall Study|Protocol Violation|0|||
156502274|NCT02869867|564931521|FG000|Overall Study|Lost to Follow-up|5|||
156502275|NCT02869867|564931522|FG001|Overall Study|Lost to Follow-up|5|||
156502276|NCT05218499|564931523|FG000|Overall Study|Not treated|1|||
156502277|NCT05218499|564931524|FG001|Overall Study|Not treated|1|||
156502278|NCT05218499|564931525|FG002|Overall Study|Not treated|8|||
156502279|NCT05218499|564931523|FG000|Overall Study|Death|2|||
156502280|NCT05218499|564931524|FG001|Overall Study|Death|0|||
156502281|NCT05218499|564931525|FG002|Overall Study|Death|0|||
156502282|NCT05218499|564931523|FG000|Overall Study|Other than listed|3|||
156502283|NCT05218499|564931524|FG001|Overall Study|Other than listed|7|||
156502284|NCT05218499|564931525|FG002|Overall Study|Other than listed|10|||
156502285|NCT05218499|564931523|FG000|Overall Study|Protocol deviation|5|||
156502286|NCT05218499|564931524|FG001|Overall Study|Protocol deviation|6|||
156502287|NCT05218499|564931525|FG002|Overall Study|Protocol deviation|4|||
156502288|NCT05218499|564931523|FG000|Overall Study|Technical problems|0|||
156502289|NCT05218499|564931524|FG001|Overall Study|Technical problems|1|||
156502290|NCT05218499|564931525|FG002|Overall Study|Technical problems|0|||
156502291|NCT05218499|564931523|FG000|Overall Study|Burden of trial procedures|0|||
156502292|NCT05218499|564931524|FG001|Overall Study|Burden of trial procedures|1|||
156502293|NCT05218499|564931525|FG002|Overall Study|Burden of trial procedures|2|||
156502294|NCT05218499|564931523|FG000|Overall Study|Clinical disease progression|6|||
156502295|NCT05218499|564931524|FG001|Overall Study|Clinical disease progression|6|||
156502296|NCT05218499|564931525|FG002|Overall Study|Clinical disease progression|11|||
156502297|NCT05218499|564931523|FG000|Overall Study|Objective disease progression|44|||
156502298|NCT05218499|564931524|FG001|Overall Study|Objective disease progression|61|||
156502299|NCT05218499|564931525|FG002|Overall Study|Objective disease progression|42|||
156502300|NCT05218499|564931523|FG000|Overall Study|Adverse Event|11|||
156502301|NCT05218499|564931524|FG001|Overall Study|Adverse Event|36|||
156502302|NCT05218499|564931525|FG002|Overall Study|Adverse Event|9|||
156502303|NCT05218499|564931523|FG000|Overall Study|On treatment at time of snapshot|18|||
156546919|NCT00440947|565094996|FG001|48-Week Randomization Phase|Physician Decision|2|||
156546920|NCT00440947|565094997|FG002|48-Week Randomization Phase|Physician Decision|0|||
156546921|NCT00440947|565094998|FG003|48-Week Randomization Phase|Physician Decision|0|||
156546922|NCT00440947|565094999|FG004|48-Week Randomization Phase|Physician Decision|0|||
156546923|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
156546924|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
156546925|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
156546926|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
156546927|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
156546928|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
156546929|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
156546930|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
156546931|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
156546932|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
156546933|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
156546934|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
156546935|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
156546936|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
156382936|NCT01802411|564494428|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
156382937|NCT01802411|564494429|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
156382938|NCT03930745|564494430|FG000|Overall Study|Lost to Follow-up|10|||
156382939|NCT03930745|564494431|FG001|Overall Study|Lost to Follow-up|5|||
156382940|NCT03930745|564494430|FG000|Overall Study|Withdrawal by Subject|1|||
156382941|NCT03930745|564494431|FG001|Overall Study|Withdrawal by Subject|2|||
156382942|NCT03930745|564494430|FG000|Overall Study|Protocol Violation|2|||
156382943|NCT03930745|564494431|FG001|Overall Study|Protocol Violation|2|||
156382944|NCT03930745|564494430|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
156382945|NCT03930745|564494431|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
156382946|NCT03930745|564494430|FG000|Overall Study|Adverse Event|0|||
156382947|NCT03930745|564494431|FG001|Overall Study|Adverse Event|1|||
156382948|NCT03930745|564494430|FG000|Overall Study|Pregnancy|0|||
156382949|NCT03930745|564494431|FG001|Overall Study|Pregnancy|1|||
156382950|NCT01337245|564494432|FG000|Overall Study|Lost to Follow-up|1|||
156382951|NCT04095858|564494435|FG000|Overall Study|Death|1|||
156382952|NCT04095858|564494436|FG001|Overall Study|Death|0|||
156382953|NCT04095858|564494435|FG000|Overall Study|Study terminated by Sponsor|2|||
156382954|NCT04095858|564494436|FG001|Overall Study|Study terminated by Sponsor|4|||
156382955|NCT01344460|564494437|FG000|Overall Study|Withdrawal by Subject|1|||
156382956|NCT01344460|564494437|FG000|Overall Study|Lost to Follow-up|2|||
156382957|NCT00558285|564494438|FG000|Overall Study|Adverse Event|1|||
156382958|NCT00558285|564494439|FG001|Overall Study|Adverse Event|1|||
156382959|NCT00558285|564494440|FG002|Overall Study|Adverse Event|4|||
156382960|NCT00558285|564494441|FG003|Overall Study|Adverse Event|1|||
156382961|NCT00558285|564494442|FG004|Overall Study|Adverse Event|2|||
156382962|NCT00558285|564494438|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156382963|NCT00558285|564494439|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156382964|NCT00558285|564494440|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156382965|NCT00558285|564494441|FG003|Overall Study|Abnormal test procedure result(s)|0|||
156382966|NCT00558285|564494442|FG004|Overall Study|Abnormal test procedure result(s)|0|||
156382967|NCT00558285|564494438|FG000|Overall Study|Subject withdrew consent|2|||
156382968|NCT00558285|564494439|FG001|Overall Study|Subject withdrew consent|0|||
156382969|NCT00558285|564494440|FG002|Overall Study|Subject withdrew consent|1|||
156382970|NCT00558285|564494441|FG003|Overall Study|Subject withdrew consent|1|||
156382971|NCT00558285|564494442|FG004|Overall Study|Subject withdrew consent|1|||
156382972|NCT00558285|564494438|FG000|Overall Study|Lost to Follow-up|1|||
156382973|NCT00558285|564494439|FG001|Overall Study|Lost to Follow-up|1|||
156382974|NCT00558285|564494440|FG002|Overall Study|Lost to Follow-up|0|||
156382975|NCT00558285|564494441|FG003|Overall Study|Lost to Follow-up|0|||
156382976|NCT00558285|564494442|FG004|Overall Study|Lost to Follow-up|0|||
156382977|NCT00558285|564494438|FG000|Overall Study|Administrative problems|0|||
156382978|NCT00558285|564494439|FG001|Overall Study|Administrative problems|0|||
156382979|NCT00558285|564494440|FG002|Overall Study|Administrative problems|0|||
156382980|NCT00558285|564494441|FG003|Overall Study|Administrative problems|1|||
156382981|NCT00558285|564494442|FG004|Overall Study|Administrative problems|1|||
156382982|NCT00558285|564494438|FG000|Overall Study|Protocol deviation|1|||
156382983|NCT00558285|564494439|FG001|Overall Study|Protocol deviation|1|||
156382984|NCT00558285|564494440|FG002|Overall Study|Protocol deviation|0|||
156382985|NCT00558285|564494441|FG003|Overall Study|Protocol deviation|1|||
156382986|NCT00558285|564494442|FG004|Overall Study|Protocol deviation|0|||
156382987|NCT04827576|564496778|FG000|Overall Study|Death|5|||
156382988|NCT04827576|564496779|FG001|Overall Study|Death|17|||
156382989|NCT04827576|564496780|FG002|Overall Study|Death|17|||
156382990|NCT04827576|564496781|FG003|Overall Study|Death|32|||
156382991|NCT04827576|564496778|FG000|Overall Study|Study Terminated by Sponsor|2|||
156382992|NCT04827576|564496779|FG001|Overall Study|Study Terminated by Sponsor|9|||
156382993|NCT04827576|564496780|FG002|Overall Study|Study Terminated by Sponsor|7|||
156502304|NCT05218499|564931524|FG001|Overall Study|On treatment at time of snapshot|29|||
156502305|NCT05218499|564931525|FG002|Overall Study|On treatment at time of snapshot|0|||
156502306|NCT05555615|564931530|FG000|Overall Study|Adverse Event|7|||
156502307|NCT05555615|564931530|FG000|Overall Study|Lack of Efficacy|12|||
156502308|NCT05555615|564931530|FG000|Overall Study|Lost to Follow-up|10|||
156502309|NCT05555615|564931530|FG000|Overall Study|Noncompliance with study drug|5|||
156502310|NCT05555615|564931530|FG000|Overall Study|Physician Decision|2|||
156502311|NCT05555615|564931530|FG000|Overall Study|Study terminated by sponsor|80|||
156502312|NCT05555615|564931530|FG000|Overall Study|Prohibited medication use|2|||
156502313|NCT05555615|564931530|FG000|Overall Study|Withdrawal by Subject|20|||
156502314|NCT05555615|564931530|FG000|Overall Study|Not further specified|4|||
156502315|NCT03016598|564931531|FG000|Overall Study|Lost to Follow-up|0|||
156502316|NCT03016598|564931532|FG001|Overall Study|Lost to Follow-up|2|||
156502317|NCT01728623|564931536|FG000|Overall Study|Disease progression|26|||
156502318|NCT01728623|564931536|FG000|Overall Study|Adverse Event|1|||
156502319|NCT01728623|564931536|FG000|Overall Study|Withdrawal by Subject|1|||
156502320|NCT01667549|564931537|FG000|Overall Study|Withdrawal by Subject|3|||
156502321|NCT01667549|564931538|FG001|Overall Study|Withdrawal by Subject|5|||
156502322|NCT01667549|564931539|FG002|Overall Study|Withdrawal by Subject|7|||
156502323|NCT01667549|564931540|FG003|Overall Study|Withdrawal by Subject|6|||
156502324|NCT01667549|564931541|FG004|Overall Study|Withdrawal by Subject|1|||
156502325|NCT01407276|564931542|FG000|Overall Study|Withdrawal by Subject|0|||
156502326|NCT01407276|564931543|FG001|Overall Study|Withdrawal by Subject|0|||
156502327|NCT01407276|564931544|FG002|Overall Study|Withdrawal by Subject|0|||
156502328|NCT01407276|564931545|FG003|Overall Study|Withdrawal by Subject|0|||
156502329|NCT01407276|564931546|FG004|Overall Study|Withdrawal by Subject|0|||
156502330|NCT01407276|564931547|FG005|Overall Study|Withdrawal by Subject|0|||
156502331|NCT01407276|564931548|FG006|Overall Study|Withdrawal by Subject|0|||
156502332|NCT01407276|564931549|FG007|Overall Study|Withdrawal by Subject|1|||
156502333|NCT04092452|564931551|FG000|Overall Study|Adverse Event|1|||
156502334|NCT04092452|564931552|FG001|Overall Study|Adverse Event|3|||
156502335|NCT04092452|564931553|FG002|Overall Study|Adverse Event|3|||
156502336|NCT04092452|564931554|FG003|Overall Study|Adverse Event|7|||
156502337|NCT04092452|564931551|FG000|Overall Study|Lack of Efficacy|1|||
156502338|NCT04092452|564931552|FG001|Overall Study|Lack of Efficacy|1|||
156502339|NCT04092452|564931553|FG002|Overall Study|Lack of Efficacy|1|||
156502340|NCT04092452|564931554|FG003|Overall Study|Lack of Efficacy|0|||
156502341|NCT04092452|564931551|FG000|Overall Study|Lost to Follow-up|4|||
156502342|NCT04092452|564931552|FG001|Overall Study|Lost to Follow-up|3|||
156502343|NCT04092452|564931553|FG002|Overall Study|Lost to Follow-up|5|||
156502344|NCT04092452|564931554|FG003|Overall Study|Lost to Follow-up|1|||
156502345|NCT04092452|564931551|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156502346|NCT04092452|564931552|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156502347|NCT04092452|564931553|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156502348|NCT04092452|564931554|FG003|Overall Study|Non-Compliance With Study Drug|1|||
156502349|NCT04092452|564931551|FG000|Overall Study|Physician Decision|1|||
156502350|NCT04092452|564931552|FG001|Overall Study|Physician Decision|0|||
156502351|NCT04092452|564931553|FG002|Overall Study|Physician Decision|1|||
156502352|NCT04092452|564931554|FG003|Overall Study|Physician Decision|0|||
156502353|NCT04092452|564931551|FG000|Overall Study|Pregnancy|2|||
156502354|NCT04092452|564931552|FG001|Overall Study|Pregnancy|0|||
156502355|NCT04092452|564931553|FG002|Overall Study|Pregnancy|0|||
156502356|NCT04092452|564931554|FG003|Overall Study|Pregnancy|0|||
156502357|NCT04092452|564931551|FG000|Overall Study|Protocol Deviation|1|||
156502358|NCT04092452|564931552|FG001|Overall Study|Protocol Deviation|0|||
156502359|NCT04092452|564931553|FG002|Overall Study|Protocol Deviation|0|||
156502360|NCT04092452|564931554|FG003|Overall Study|Protocol Deviation|0|||
156502361|NCT04092452|564931551|FG000|Overall Study|Withdrawal by Subject|3|||
156502362|NCT04092452|564931552|FG001|Overall Study|Withdrawal by Subject|10|||
156502363|NCT04092452|564931553|FG002|Overall Study|Withdrawal by Subject|3|||
156502364|NCT04092452|564931554|FG003|Overall Study|Withdrawal by Subject|5|||
156382994|NCT04827576|564496781|FG003|Overall Study|Study Terminated by Sponsor|5|||
156502365|NCT04092452|564931551|FG000|Overall Study|Other|0|||
156502366|NCT04092452|564931552|FG001|Overall Study|Other|0|||
156502367|NCT04092452|564931553|FG002|Overall Study|Other|1|||
156546937|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
156546938|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
156546939|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
156502368|NCT04092452|564931554|FG003|Overall Study|Other|2|||
156502369|NCT01791413|564931563|FG000|Overall Study|Lost to Follow-up|5|||
156382995|NCT04827576|564496778|FG000|Overall Study|Investigator's Discretion|1|||
156502370|NCT01791413|564931564|FG001|Overall Study|Lost to Follow-up|1|||
156502371|NCT05594589|564931567|FG000|Overall Study|Other|0|||
156502372|NCT05594589|564931568|FG001|Overall Study|Other|1|||
156502373|NCT05594589|564931569|FG002|Overall Study|Other|0|||
156502374|NCT01536171|564931570|FG000|Overall Study|Withdrawal by Subject|1|||
156382996|NCT04827576|564496779|FG001|Overall Study|Investigator's Discretion|0|||
156502375|NCT02201901|564931574|FG000|Overall Study|Randomized but never treated|0|||
156502376|NCT02201901|564931575|FG001|Overall Study|Randomized but never treated|1|||
156502377|NCT02201901|564931576|FG002|Overall Study|Randomized but never treated|0|||
156502378|NCT02201901|564931574|FG000|Overall Study|Lack of Efficacy|7|||
156502379|NCT02201901|564931575|FG001|Overall Study|Lack of Efficacy|1|||
156502380|NCT02201901|564931576|FG002|Overall Study|Lack of Efficacy|6|||
156502381|NCT02201901|564931574|FG000|Overall Study|Death|3|||
156502382|NCT02201901|564931575|FG001|Overall Study|Death|3|||
156502383|NCT02201901|564931576|FG002|Overall Study|Death|3|||
156502384|NCT02201901|564931574|FG000|Overall Study|Lost to Follow-up|2|||
156502385|NCT02201901|564931575|FG001|Overall Study|Lost to Follow-up|3|||
156502386|NCT02201901|564931576|FG002|Overall Study|Lost to Follow-up|2|||
156502387|NCT02201901|564931574|FG000|Overall Study|Withdrew Consent|2|||
156502388|NCT02201901|564931575|FG001|Overall Study|Withdrew Consent|0|||
156502389|NCT02201901|564931576|FG002|Overall Study|Withdrew Consent|2|||
156502390|NCT02201901|564931574|FG000|Overall Study|Adverse Event|1|||
156502391|NCT02201901|564931575|FG001|Overall Study|Adverse Event|1|||
156502392|NCT02201901|564931576|FG002|Overall Study|Adverse Event|0|||
156502393|NCT01431950|564931577|FG000|Overall Study|Study Site Closed/Terminated|7|||
156502394|NCT01431950|564931578|FG001|Overall Study|Study Site Closed/Terminated|3|||
156502395|NCT01431950|564931577|FG000|Overall Study|Withdrawal by Subject|4|||
156502396|NCT01431950|564931578|FG001|Overall Study|Withdrawal by Subject|3|||
156502397|NCT01431950|564931577|FG000|Overall Study|Protocol Violation|2|||
156502398|NCT01431950|564931578|FG001|Overall Study|Protocol Violation|3|||
156502399|NCT01431950|564931577|FG000|Overall Study|Adverse Event|2|||
156502400|NCT01431950|564931578|FG001|Overall Study|Adverse Event|2|||
156502401|NCT01431950|564931577|FG000|Overall Study|Physician Decision|2|||
156502402|NCT01431950|564931578|FG001|Overall Study|Physician Decision|1|||
156502403|NCT01431950|564931577|FG000|Overall Study|Lack of Efficacy|2|||
156502404|NCT01431950|564931578|FG001|Overall Study|Lack of Efficacy|1|||
156502405|NCT01431950|564931577|FG000|Overall Study|Lost to Follow-up|0|||
156502406|NCT01431950|564931578|FG001|Overall Study|Lost to Follow-up|1|||
156502407|NCT01431950|564931577|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
156502408|NCT01431950|564931578|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156502409|NCT00738283|564931581|FG000|Overall Study|Death|1|||
156502410|NCT00738283|564931581|FG000|Overall Study|Transfer to another facility|2|||
156502411|NCT00738283|564931581|FG000|Overall Study|Discharge home prior to end of study|1|||
156502412|NCT01210651|564931582|FG000|Overall Study|Lost to Follow-up|1|||
156502413|NCT01210651|564931583|FG001|Overall Study|Lost to Follow-up|1|||
156502414|NCT01210651|564931582|FG000|Overall Study|schedule conflicts|1|||
156502415|NCT01210651|564931583|FG001|Overall Study|schedule conflicts|5|||
156502416|NCT01210651|564931582|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
156502417|NCT01210651|564931583|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
156502418|NCT01210651|564931582|FG000|Overall Study|Withdrawal by Subject|1|||
156502419|NCT01210651|564931583|FG001|Overall Study|Withdrawal by Subject|1|||
156502420|NCT01210651|564931582|FG000|Overall Study|Injury outside study|2|||
156502421|NCT01210651|564931583|FG001|Overall Study|Injury outside study|0|||
156502422|NCT03494985|564931584|FG000|Overall Study|Adverse Event|3|||
156502423|NCT03494985|564931585|FG001|Overall Study|Adverse Event|2|||
156502424|NCT03494985|564931586|FG002|Overall Study|Adverse Event|3|||
156502425|NCT03494985|564931587|FG003|Overall Study|Adverse Event|0|||
156502426|NCT03494985|564931584|FG000|Overall Study|Other (Withdrawal of consent)|2|||
156502427|NCT03494985|564931585|FG001|Overall Study|Other (Withdrawal of consent)|3|||
156502428|NCT03494985|564931586|FG002|Overall Study|Other (Withdrawal of consent)|2|||
156502429|NCT03494985|564931587|FG003|Overall Study|Other (Withdrawal of consent)|5|||
156502430|NCT03494985|564931584|FG000|Overall Study|Other (Not specified)|0|||
156502431|NCT03494985|564931585|FG001|Overall Study|Other (Not specified)|1|||
156502432|NCT03494985|564931586|FG002|Overall Study|Other (Not specified)|1|||
156502433|NCT03494985|564931587|FG003|Overall Study|Other (Not specified)|0|||
156502434|NCT04886518|564931588|FG000|Overall Study|Noncompliance with study drug|1|||
156502435|NCT04886518|564931589|FG001|Overall Study|Noncompliance with study drug|0|||
156502436|NCT04886518|564931590|FG002|Overall Study|Noncompliance with study drug|0|||
156502437|NCT04886518|564931588|FG000|Overall Study|Adverse Event|0|||
156502438|NCT04886518|564931589|FG001|Overall Study|Adverse Event|1|||
156502439|NCT04886518|564931590|FG002|Overall Study|Adverse Event|0|||
156502440|NCT04886518|564931588|FG000|Overall Study|Withdrawal by Subject|1|||
156502441|NCT04886518|564931589|FG001|Overall Study|Withdrawal by Subject|0|||
156502442|NCT04886518|564931590|FG002|Overall Study|Withdrawal by Subject|0|||
156502443|NCT04441905|564933770|FG000|Overall Study|Lost to Follow-up|1|||
156502444|NCT04441905|564933771|FG001|Overall Study|Lost to Follow-up|0|||
156502445|NCT04441905|564933772|FG002|Overall Study|Lost to Follow-up|0|||
156502446|NCT04441905|564933773|FG003|Overall Study|Lost to Follow-up|0|||
156502447|NCT04441905|564933774|FG004|Overall Study|Lost to Follow-up|0|||
156502448|NCT04441905|564933775|FG005|Overall Study|Lost to Follow-up|0|||
156502449|NCT04441905|564933770|FG000|Overall Study|Enrolled but treatment not administered|0|||
156502450|NCT04441905|564933771|FG001|Overall Study|Enrolled but treatment not administered|1|||
156502451|NCT04441905|564933772|FG002|Overall Study|Enrolled but treatment not administered|0|||
156502452|NCT04441905|564933773|FG003|Overall Study|Enrolled but treatment not administered|0|||
156502453|NCT04441905|564933774|FG004|Overall Study|Enrolled but treatment not administered|0|||
156502454|NCT04441905|564933775|FG005|Overall Study|Enrolled but treatment not administered|0|||
156502455|NCT04441905|564933770|FG000|Overall Study|Became ineligible after enrollment|0|||
156502456|NCT04441905|564933771|FG001|Overall Study|Became ineligible after enrollment|0|||
156502457|NCT04441905|564933772|FG002|Overall Study|Became ineligible after enrollment|0|||
156502458|NCT04441905|564933773|FG003|Overall Study|Became ineligible after enrollment|0|||
156502459|NCT04441905|564933774|FG004|Overall Study|Became ineligible after enrollment|1|||
156502460|NCT04441905|564933775|FG005|Overall Study|Became ineligible after enrollment|0|||
156502461|NCT00127842|564933776|FG000|Overall Study|Adverse Event|15|||
156502462|NCT00127842|564933776|FG000|Overall Study|Withdrawal by Subject|3|||
156502463|NCT00127842|564933776|FG000|Overall Study|Lost to Follow-up|1|||
156502464|NCT00127842|564933776|FG000|Overall Study|Lack of Efficacy|12|||
156502465|NCT00127842|564933776|FG000|Overall Study|Noncompliance|2|||
156502466|NCT00127842|564933776|FG000|Overall Study|Protocol Violation|1|||
156502467|NCT00127842|564933776|FG000|Overall Study|Other|5|||
156502468|NCT01385748|564933777|FG000|Overall Study|Withdrawal by Subject|7|||
156502469|NCT01385748|564933778|FG001|Overall Study|Withdrawal by Subject|4|||
156502470|NCT01385748|564933779|FG002|Overall Study|Withdrawal by Subject|5|||
156502471|NCT01385748|564933777|FG000|Overall Study|Noncompliance|3|||
156502472|NCT01385748|564933778|FG001|Overall Study|Noncompliance|1|||
156502473|NCT01385748|564933779|FG002|Overall Study|Noncompliance|6|||
156502474|NCT01385748|564933777|FG000|Overall Study|Other|1|||
156502475|NCT01385748|564933778|FG001|Overall Study|Other|7|||
156502476|NCT01385748|564933779|FG002|Overall Study|Other|1|||
156502477|NCT01385748|564933777|FG000|Overall Study|Adverse Event|4|||
156502478|NCT01385748|564933778|FG001|Overall Study|Adverse Event|2|||
156502479|NCT01385748|564933779|FG002|Overall Study|Adverse Event|1|||
156502480|NCT01443403|564933780|FG000|Overall Study|Adverse Event|1|||
156502481|NCT01443403|564933781|FG001|Overall Study|Adverse Event|1|||
156502482|NCT01443403|564933782|FG002|Overall Study|Adverse Event|4|||
156502483|NCT01443403|564933783|FG003|Overall Study|Adverse Event|5|||
156502484|NCT01443403|564933780|FG000|Overall Study|Withdrawal by Subject|0|||
156502485|NCT01443403|564933781|FG001|Overall Study|Withdrawal by Subject|1|||
156502486|NCT01443403|564933782|FG002|Overall Study|Withdrawal by Subject|2|||
156502487|NCT01443403|564933783|FG003|Overall Study|Withdrawal by Subject|1|||
156502488|NCT01443403|564933780|FG000|Overall Study|Lost to Follow-up|0|||
156502489|NCT01443403|564933781|FG001|Overall Study|Lost to Follow-up|0|||
156502490|NCT01443403|564933782|FG002|Overall Study|Lost to Follow-up|0|||
156502491|NCT01443403|564933783|FG003|Overall Study|Lost to Follow-up|1|||
156502492|NCT01443403|564933780|FG000|Overall Study|Protocol Violation|2|||
156502493|NCT01443403|564933781|FG001|Overall Study|Protocol Violation|1|||
156382997|NCT04827576|564496780|FG002|Overall Study|Investigator's Discretion|2|||
156382998|NCT04827576|564496781|FG003|Overall Study|Investigator's Discretion|5|||
156382999|NCT04827576|564496778|FG000|Overall Study|Withdrew Consent|0|||
156383000|NCT04827576|564496779|FG001|Overall Study|Withdrew Consent|3|||
156383001|NCT04827576|564496780|FG002|Overall Study|Withdrew Consent|0|||
156383002|NCT04827576|564496781|FG003|Overall Study|Withdrew Consent|0|||
156383003|NCT04827576|564496778|FG000|Overall Study|Lost to Follow-up|1|||
156383004|NCT04827576|564496779|FG001|Overall Study|Lost to Follow-up|0|||
156383005|NCT04827576|564496780|FG002|Overall Study|Lost to Follow-up|0|||
156383006|NCT04827576|564496781|FG003|Overall Study|Lost to Follow-up|0|||
156383007|NCT04295564|564496782|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
156383008|NCT04295564|564496783|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
156383009|NCT04537923|564496784|FG000|Overall Study|Adverse Event|2|||
156383010|NCT04537923|564496785|FG001|Overall Study|Adverse Event|1|||
156383011|NCT04537923|564496786|FG002|Overall Study|Adverse Event|2|||
156383012|NCT04537923|564496787|FG003|Overall Study|Adverse Event|4|||
156383013|NCT04537923|564496784|FG000|Overall Study|Death|3|||
156383014|NCT04537923|564496785|FG001|Overall Study|Death|3|||
156383015|NCT04537923|564496786|FG002|Overall Study|Death|1|||
156383016|NCT04537923|564496787|FG003|Overall Study|Death|11|||
156383017|NCT04537923|564496784|FG000|Overall Study|Lost to Follow-up|1|||
156383018|NCT04537923|564496785|FG001|Overall Study|Lost to Follow-up|2|||
156383019|NCT04537923|564496786|FG002|Overall Study|Lost to Follow-up|1|||
156383020|NCT04537923|564496787|FG003|Overall Study|Lost to Follow-up|6|||
156383021|NCT04537923|564496784|FG000|Overall Study|Physician Decision|1|||
156383022|NCT04537923|564496785|FG001|Overall Study|Physician Decision|0|||
156383023|NCT04537923|564496786|FG002|Overall Study|Physician Decision|2|||
156383024|NCT04537923|564496787|FG003|Overall Study|Physician Decision|5|||
156383025|NCT04537923|564496784|FG000|Overall Study|Pregnancy|1|||
156502494|NCT01443403|564933782|FG002|Overall Study|Protocol Violation|1|||
156502495|NCT01443403|564933783|FG003|Overall Study|Protocol Violation|1|||
156502496|NCT01443403|564933780|FG000|Overall Study|Use of Prohibited Treatment|2|||
156502497|NCT01443403|564933781|FG001|Overall Study|Use of Prohibited Treatment|3|||
156383026|NCT04537923|564496785|FG001|Overall Study|Pregnancy|0|||
156383027|NCT04537923|564496786|FG002|Overall Study|Pregnancy|0|||
156502498|NCT01443403|564933782|FG002|Overall Study|Use of Prohibited Treatment|0|||
156502499|NCT01443403|564933783|FG003|Overall Study|Use of Prohibited Treatment|0|||
156502500|NCT01443403|564933780|FG000|Overall Study|Other - Miscellaneous|1|||
156502501|NCT01443403|564933781|FG001|Overall Study|Other - Miscellaneous|0|||
156502502|NCT01443403|564933782|FG002|Overall Study|Other - Miscellaneous|0|||
156502503|NCT01443403|564933783|FG003|Overall Study|Other - Miscellaneous|1|||
156383028|NCT04537923|564496787|FG003|Overall Study|Pregnancy|0|||
156383029|NCT04537923|564496784|FG000|Overall Study|Withdrawal by Subject|4|||
156383030|NCT04537923|564496785|FG001|Overall Study|Withdrawal by Subject|4|||
156383031|NCT04537923|564496786|FG002|Overall Study|Withdrawal by Subject|4|||
156383032|NCT04537923|564496787|FG003|Overall Study|Withdrawal by Subject|58|||
156383033|NCT04537923|564496784|FG000|Overall Study|Missed study visits|2|||
156383034|NCT04537923|564496785|FG001|Overall Study|Missed study visits|0|||
156383035|NCT04537923|564496786|FG002|Overall Study|Missed study visits|0|||
156383036|NCT04537923|564496787|FG003|Overall Study|Missed study visits|3|||
156383037|NCT04537923|564496784|FG000|Overall Study|Sponsor's decision|0|||
156383038|NCT04537923|564496785|FG001|Overall Study|Sponsor's decision|0|||
156383039|NCT04537923|564496786|FG002|Overall Study|Sponsor's decision|1|||
156383040|NCT04537923|564496787|FG003|Overall Study|Sponsor's decision|1|||
156383041|NCT04537923|564496784|FG000|Overall Study|Safety reasons|1|||
156383042|NCT04537923|564496785|FG001|Overall Study|Safety reasons|0|||
156383043|NCT04537923|564496786|FG002|Overall Study|Safety reasons|0|||
156383044|NCT04537923|564496787|FG003|Overall Study|Safety reasons|0|||
156383045|NCT02527798|564496788|FG000|Overall Study|Physician Decision|1|||
156383046|NCT02527798|564496789|FG001|Overall Study|Physician Decision|0|||
156383047|NCT02527798|564496790|FG002|Overall Study|Physician Decision|1|||
156383048|NCT02527798|564496791|FG003|Overall Study|Physician Decision|1|||
156383049|NCT02527798|564496792|FG004|Overall Study|Physician Decision|0|||
156383050|NCT02527798|564496793|FG005|Overall Study|Physician Decision|0|||
156383051|NCT02527798|564496788|FG000|Overall Study|Death|0|||
156383052|NCT02527798|564496789|FG001|Overall Study|Death|0|||
156383053|NCT02527798|564496790|FG002|Overall Study|Death|1|||
156383054|NCT02527798|564496791|FG003|Overall Study|Death|0|||
156383055|NCT02527798|564496792|FG004|Overall Study|Death|0|||
156383056|NCT02527798|564496793|FG005|Overall Study|Death|0|||
156383057|NCT02527798|564496788|FG000|Overall Study|Withdrawal by Subject|0|||
156383058|NCT02527798|564496789|FG001|Overall Study|Withdrawal by Subject|1|||
156383059|NCT02527798|564496790|FG002|Overall Study|Withdrawal by Subject|2|||
156383060|NCT02527798|564496791|FG003|Overall Study|Withdrawal by Subject|0|||
156383061|NCT02527798|564496792|FG004|Overall Study|Withdrawal by Subject|0|||
156383062|NCT02527798|564496793|FG005|Overall Study|Withdrawal by Subject|0|||
156383063|NCT02527798|564496788|FG000|Overall Study|Reason undisclosed|1|||
156383064|NCT02527798|564496789|FG001|Overall Study|Reason undisclosed|0|||
156383065|NCT02527798|564496790|FG002|Overall Study|Reason undisclosed|1|||
156383066|NCT02527798|564496791|FG003|Overall Study|Reason undisclosed|0|||
156383067|NCT02527798|564496792|FG004|Overall Study|Reason undisclosed|0|||
156383068|NCT02527798|564496793|FG005|Overall Study|Reason undisclosed|0|||
156383069|NCT02527798|564496788|FG000|Overall Study|Did not receive intervention|1|||
156383070|NCT02527798|564496789|FG001|Overall Study|Did not receive intervention|1|||
156383071|NCT02527798|564496790|FG002|Overall Study|Did not receive intervention|0|||
156383072|NCT02527798|564496791|FG003|Overall Study|Did not receive intervention|0|||
156383073|NCT02527798|564496792|FG004|Overall Study|Did not receive intervention|0|||
156383074|NCT02527798|564496793|FG005|Overall Study|Did not receive intervention|0|||
156383075|NCT01275625|564496794|FG000|Overall Study|Death|1|||
156383076|NCT01275625|564496794|FG000|Overall Study|Lack of Efficacy|2|||
156383077|NCT01275625|564496794|FG000|Overall Study|Lost to Follow-up|1|||
156383078|NCT01275625|564496794|FG000|Overall Study|Withdrawal by Subject|3|||
156383079|NCT01275625|564496794|FG000|Overall Study|Protocol Violation|1|||
156383080|NCT01275625|564496794|FG000|Overall Study|Adverse Event|4|||
156383081|NCT01275625|564496794|FG000|Overall Study|Other|1|||
156383082|NCT05732454|564496795|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
156383083|NCT05732454|564496796|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
156383084|NCT05732454|564496795|FG000|Part 1: DB Period|Adverse Event|1|||
156383085|NCT05732454|564496796|FG001|Part 1: DB Period|Adverse Event|0|||
156383086|NCT05732454|564496795|FG000|Part 1: DB Period|Lost to Follow-up|1|||
156383087|NCT05732454|564496796|FG001|Part 1: DB Period|Lost to Follow-up|0|||
156502504|NCT02562235|564933784|FG000|Overall Study|Adverse Event|3|||
156383088|NCT05732454|564496795|FG000|Part 1: DB Period|Protocol Violation|0|||
156383089|NCT05732454|564496796|FG001|Part 1: DB Period|Protocol Violation|1|||
156383090|NCT05732454|564496795|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
156383091|NCT05732454|564496796|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
156383092|NCT05732454|564496795|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
156383093|NCT05732454|564496796|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
156383094|NCT05732454|564496795|FG000|Part 1: OLE Period|Adverse Event|0|||
156383095|NCT05732454|564496796|FG001|Part 1: OLE Period|Adverse Event|1|||
156383096|NCT05732454|564496795|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
156383097|NCT05732454|564496796|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
156383098|NCT03725982|564496799|FG000|First Intervention|Withdrawal by Subject|0|||
156502505|NCT01200342|564933785|FG000|Overall Study|Disease Progression|1|||
156502506|NCT03258723|564933790|FG000|Overall Study|COVID Interruption of study|54|||
156502507|NCT03258723|564933790|FG000|Overall Study|Lost to Follow-up|8|||
156502508|NCT04832971|564933791|FG000|Double-Blind (DB) Treatment Period|Death|1|||
156502509|NCT04832971|564933792|FG001|Double-Blind (DB) Treatment Period|Death|0|||
156502510|NCT04832971|564933793|FG002|Double-Blind (DB) Treatment Period|Death|0|||
156502511|NCT04832971|564933794|FG003|Double-Blind (DB) Treatment Period|Death|0|||
156502512|NCT04832971|564933795|FG004|Double-Blind (DB) Treatment Period|Death|0|||
156502513|NCT04832971|564933796|FG005|Double-Blind (DB) Treatment Period|Death|0|||
156502514|NCT04832971|564933797|FG006|Double-Blind (DB) Treatment Period|Death|0|||
156502515|NCT04832971|564933798|FG007|Double-Blind (DB) Treatment Period|Death|0|||
156502516|NCT04832971|564933799|FG008|Double-Blind (DB) Treatment Period|Death|0|||
156502517|NCT04832971|564933800|FG009|Double-Blind (DB) Treatment Period|Death|0|||
156502518|NCT04832971|564933791|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
156502519|NCT04832971|564933792|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
156502520|NCT04832971|564933793|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
156502521|NCT04832971|564933794|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156502522|NCT04832971|564933795|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156502523|NCT04832971|564933796|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156502524|NCT04832971|564933797|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156502525|NCT04832971|564933798|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156502526|NCT04832971|564933799|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156502527|NCT04832971|564933800|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
156502528|NCT04832971|564933791|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
156502529|NCT04832971|564933792|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
156502530|NCT04832971|564933793|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
156502531|NCT04832971|564933794|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
156502532|NCT04832971|564933795|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156502533|NCT04832971|564933796|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156502534|NCT04832971|564933797|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156502535|NCT04832971|564933798|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156502536|NCT04832971|564933799|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156502537|NCT04832971|564933800|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
156502538|NCT04832971|564933791|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502539|NCT04832971|564933792|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
156502540|NCT04832971|564933793|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502541|NCT04832971|564933794|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502542|NCT04832971|564933795|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502543|NCT04832971|564933796|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502544|NCT04832971|564933797|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502545|NCT04832971|564933798|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502546|NCT04832971|564933799|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502547|NCT04832971|564933800|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
156502548|NCT04832971|564933791|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
156502549|NCT04832971|564933792|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
156502550|NCT04832971|564933793|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
156502551|NCT04832971|564933794|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
156502552|NCT04832971|564933795|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
156502553|NCT04832971|564933796|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
156502554|NCT04832971|564933797|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
156502555|NCT04832971|564933798|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
156502556|NCT04832971|564933799|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
156502557|NCT04832971|564933800|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
156502558|NCT04832971|564933791|FG000|Open-Label Extension (OLE) Period|Death|0|||
156502559|NCT04832971|564933792|FG001|Open-Label Extension (OLE) Period|Death|0|||
156502560|NCT04832971|564933793|FG002|Open-Label Extension (OLE) Period|Death|0|||
156502561|NCT04832971|564933794|FG003|Open-Label Extension (OLE) Period|Death|0|||
156502562|NCT04832971|564933795|FG004|Open-Label Extension (OLE) Period|Death|0|||
156502563|NCT04832971|564933796|FG005|Open-Label Extension (OLE) Period|Death|0|||
156502564|NCT04832971|564933797|FG006|Open-Label Extension (OLE) Period|Death|0|||
156502565|NCT04832971|564933798|FG007|Open-Label Extension (OLE) Period|Death|1|||
156502566|NCT04832971|564933799|FG008|Open-Label Extension (OLE) Period|Death|0|||
156502567|NCT04832971|564933800|FG009|Open-Label Extension (OLE) Period|Death|0|||
156502568|NCT04832971|564933791|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156383099|NCT03725982|564496800|FG001|First Intervention|Withdrawal by Subject|1|||
156383100|NCT03725982|564496799|FG000|First Intervention|Physician Decision|1|||
156383101|NCT03725982|564496800|FG001|First Intervention|Physician Decision|1|||
156546940|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
156546941|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
156546942|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
156383102|NCT01262651|564496801|FG000|Overall Study|Adverse Event|40|||
156383103|NCT01262651|564496802|FG001|Overall Study|Adverse Event|35|||
156383104|NCT01262651|564496801|FG000|Overall Study|Withdrawal by Subject|15|||
156383105|NCT01262651|564496802|FG001|Overall Study|Withdrawal by Subject|11|||
156383106|NCT01262651|564496801|FG000|Overall Study|Withdrawal by Investigator|2|||
156383107|NCT01262651|564496802|FG001|Overall Study|Withdrawal by Investigator|2|||
156383108|NCT01262651|564496801|FG000|Overall Study|Met Withdrawal Criteria|1|||
156383109|NCT01262651|564496802|FG001|Overall Study|Met Withdrawal Criteria|0|||
156383110|NCT01175382|564496808|FG000|Overall Study|Lost to Follow-up|4|||
156383111|NCT01175382|564496809|FG001|Overall Study|Lost to Follow-up|3|||
156383112|NCT01175382|564496810|FG002|Overall Study|Lost to Follow-up|1|||
156383113|NCT01175382|564496808|FG000|Overall Study|Physician Decision|0|||
156383114|NCT01175382|564496809|FG001|Overall Study|Physician Decision|1|||
156383115|NCT01175382|564496810|FG002|Overall Study|Physician Decision|0|||
156383116|NCT01175382|564496808|FG000|Overall Study|Withdrawal by Subject|0|||
156383117|NCT01175382|564496809|FG001|Overall Study|Withdrawal by Subject|0|||
156383118|NCT01175382|564496810|FG002|Overall Study|Withdrawal by Subject|1|||
156383119|NCT01175382|564496808|FG000|Overall Study|No longer having problem|1|||
156383120|NCT01175382|564496809|FG001|Overall Study|No longer having problem|0|||
156383121|NCT01175382|564496810|FG002|Overall Study|No longer having problem|1|||
156383122|NCT01175382|564496808|FG000|Overall Study|Unable/unwilling to attend visits|3|||
156383123|NCT01175382|564496809|FG001|Overall Study|Unable/unwilling to attend visits|1|||
156383124|NCT01175382|564496810|FG002|Overall Study|Unable/unwilling to attend visits|2|||
156383125|NCT01175382|564496808|FG000|Overall Study|Unwilling to follow protocol|0|||
156383126|NCT01175382|564496809|FG001|Overall Study|Unwilling to follow protocol|1|||
156383127|NCT01175382|564496810|FG002|Overall Study|Unwilling to follow protocol|0|||
156383128|NCT01175382|564496808|FG000|Overall Study|Unable to tolerate study meds|0|||
156383129|NCT01175382|564496809|FG001|Overall Study|Unable to tolerate study meds|1|||
156383130|NCT01175382|564496810|FG002|Overall Study|Unable to tolerate study meds|1|||
156383131|NCT00941603|564496811|FG000|Overall Study|Adverse Event|10|||
156383132|NCT00941603|564496812|FG001|Overall Study|Adverse Event|15|||
156383133|NCT00941603|564496813|FG002|Overall Study|Adverse Event|5|||
156383134|NCT00941603|564496814|FG003|Overall Study|Adverse Event|1|||
156383135|NCT00941603|564496815|FG004|Overall Study|Adverse Event|4|||
156383136|NCT00941603|564496816|FG005|Overall Study|Adverse Event|0|||
156383137|NCT00941603|564496811|FG000|Overall Study|Lost to Follow-up|0|||
156383138|NCT00941603|564496812|FG001|Overall Study|Lost to Follow-up|0|||
156383139|NCT00941603|564496813|FG002|Overall Study|Lost to Follow-up|0|||
156383140|NCT00941603|564496814|FG003|Overall Study|Lost to Follow-up|1|||
156383141|NCT00941603|564496815|FG004|Overall Study|Lost to Follow-up|0|||
156383142|NCT00941603|564496816|FG005|Overall Study|Lost to Follow-up|2|||
156383143|NCT00941603|564496811|FG000|Overall Study|Withdrawal by Subject|0|||
156383144|NCT00941603|564496812|FG001|Overall Study|Withdrawal by Subject|0|||
156383145|NCT00941603|564496813|FG002|Overall Study|Withdrawal by Subject|0|||
156383146|NCT00941603|564496814|FG003|Overall Study|Withdrawal by Subject|2|||
156383147|NCT00941603|564496815|FG004|Overall Study|Withdrawal by Subject|0|||
156383148|NCT00941603|564496816|FG005|Overall Study|Withdrawal by Subject|1|||
156383149|NCT00941603|564496811|FG000|Overall Study|Protocol Violation|0|||
156383150|NCT00941603|564496812|FG001|Overall Study|Protocol Violation|1|||
156383151|NCT00941603|564496813|FG002|Overall Study|Protocol Violation|0|||
156383152|NCT00941603|564496814|FG003|Overall Study|Protocol Violation|0|||
156383153|NCT00941603|564496815|FG004|Overall Study|Protocol Violation|0|||
156383154|NCT00941603|564496816|FG005|Overall Study|Protocol Violation|0|||
156383155|NCT00941603|564496811|FG000|Overall Study|Did not meet protocol eligibility|1|||
156383156|NCT00941603|564496812|FG001|Overall Study|Did not meet protocol eligibility|0|||
156383157|NCT00941603|564496813|FG002|Overall Study|Did not meet protocol eligibility|0|||
156383158|NCT00941603|564496814|FG003|Overall Study|Did not meet protocol eligibility|0|||
156383159|NCT00941603|564496815|FG004|Overall Study|Did not meet protocol eligibility|0|||
156383160|NCT00941603|564496816|FG005|Overall Study|Did not meet protocol eligibility|0|||
156383161|NCT00383435|564496817|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
156383162|NCT00383435|564496818|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
156502569|NCT04832971|564933792|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156502570|NCT04832971|564933793|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156383163|NCT00383435|564496819|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
156383164|NCT00383435|564496820|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
156383165|NCT00383435|564496821|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
156383166|NCT00383435|564496817|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
156383167|NCT00383435|564496818|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
156383168|NCT00383435|564496819|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
156383169|NCT00383435|564496820|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
156383170|NCT00383435|564496821|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
156383171|NCT00383435|564496817|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
156383172|NCT00383435|564496818|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
156502571|NCT04832971|564933794|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156502572|NCT04832971|564933795|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156502573|NCT04832971|564933796|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156502574|NCT04832971|564933797|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
156502575|NCT04832971|564933798|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
156502576|NCT04832971|564933799|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156502577|NCT04832971|564933800|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156502578|NCT04832971|564933791|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
156502579|NCT04832971|564933792|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
156502580|NCT04832971|564933793|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
156502581|NCT04832971|564933794|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
156502582|NCT04832971|564933795|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
156502583|NCT04832971|564933796|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
156502584|NCT04832971|564933797|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
156502585|NCT04832971|564933798|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
156502586|NCT04832971|564933799|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
156502587|NCT04832971|564933800|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
156502588|NCT04832971|564933791|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156502589|NCT04832971|564933792|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156502590|NCT04832971|564933793|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156502591|NCT04832971|564933794|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156502592|NCT04832971|564933795|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
156502593|NCT04832971|564933796|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
156502594|NCT04832971|564933797|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156502595|NCT04832971|564933798|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
156502596|NCT04832971|564933799|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
156502597|NCT04832971|564933800|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
156502598|NCT04832971|564933791|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
156502599|NCT04832971|564933792|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
156502600|NCT04832971|564933793|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
156502601|NCT04832971|564933794|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
156502602|NCT04832971|564933795|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
156502603|NCT04832971|564933796|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
156502604|NCT04832971|564933797|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
156502605|NCT04832971|564933798|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
156502606|NCT04832971|564933799|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
156502607|NCT04832971|564933800|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
156502608|NCT00433511|564933801|FG000|Step 1|Adverse Event|50|||
156502609|NCT00433511|564933802|FG001|Step 1|Adverse Event|157|||
156502610|NCT00433511|564933803|FG002|Step 1|Adverse Event|153|||
156502611|NCT00433511|564933801|FG000|Step 1|Withdrawal by Subject|45|||
156502612|NCT00433511|564933802|FG001|Step 1|Withdrawal by Subject|143|||
156502613|NCT00433511|564933803|FG002|Step 1|Withdrawal by Subject|154|||
156502614|NCT00433511|564933801|FG000|Step 1|Death|3|||
156502615|NCT00433511|564933802|FG001|Step 1|Death|1|||
156502616|NCT00433511|564933803|FG002|Step 1|Death|1|||
156502617|NCT00433511|564933801|FG000|Step 1|Physician Decision|1|||
156502618|NCT00433511|564933802|FG001|Step 1|Physician Decision|4|||
156502619|NCT00433511|564933803|FG002|Step 1|Physician Decision|3|||
156502620|NCT00433511|564933801|FG000|Step 1|Never started protocol therapy|28|||
156502621|NCT00433511|564933802|FG001|Step 1|Never started protocol therapy|64|||
156502622|NCT00433511|564933803|FG002|Step 1|Never started protocol therapy|66|||
156502623|NCT00433511|564933801|FG000|Step 1|Alternative therapy|2|||
156502624|NCT00433511|564933802|FG001|Step 1|Alternative therapy|1|||
156502625|NCT00433511|564933803|FG002|Step 1|Alternative therapy|3|||
156502626|NCT00433511|564933801|FG000|Step 1|Disease progression, relapse|5|||
156502627|NCT00433511|564933802|FG001|Step 1|Disease progression, relapse|3|||
156502628|NCT00433511|564933803|FG002|Step 1|Disease progression, relapse|3|||
156502629|NCT00433511|564933801|FG000|Step 1|Other complicating disease|2|||
156502630|NCT00433511|564933802|FG001|Step 1|Other complicating disease|6|||
156502631|NCT00433511|564933803|FG002|Step 1|Other complicating disease|3|||
156502632|NCT00433511|564933801|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
156502633|NCT00433511|564933802|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
156502634|NCT00433511|564933803|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
156502635|NCT00433511|564933801|FG000|Step 1|Suspected recurrence|0|||
156502636|NCT00433511|564933802|FG001|Step 1|Suspected recurrence|1|||
156502637|NCT00433511|564933803|FG002|Step 1|Suspected recurrence|0|||
156502638|NCT00433511|564933801|FG000|Step 1|Insurance/drug distribution issues|0|||
156502639|NCT00433511|564933802|FG001|Step 1|Insurance/drug distribution issues|1|||
156502640|NCT00433511|564933803|FG002|Step 1|Insurance/drug distribution issues|2|||
156383173|NCT00383435|564496819|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
156502641|NCT00433511|564933801|FG000|Step 1|Patient moved|0|||
156502642|NCT00433511|564933802|FG001|Step 1|Patient moved|0|||
156502643|NCT00433511|564933803|FG002|Step 1|Patient moved|1|||
156502644|NCT00433511|564933801|FG000|Step 2 (Arm D)|Adverse Event|0|||
156502645|NCT00433511|564933802|FG001|Step 2 (Arm D)|Adverse Event|0|||
156502646|NCT00433511|564933803|FG002|Step 2 (Arm D)|Adverse Event|135|||
156502647|NCT00433511|564933801|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
156502648|NCT00433511|564933802|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
156502649|NCT00433511|564933803|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
156502650|NCT00433511|564933801|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
156502651|NCT00433511|564933802|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
156502652|NCT00433511|564933803|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
156502653|NCT00433511|564933801|FG000|Step 2 (Arm D)|Physician Decision|0|||
156502654|NCT00433511|564933802|FG001|Step 2 (Arm D)|Physician Decision|0|||
156502655|NCT00433511|564933803|FG002|Step 2 (Arm D)|Physician Decision|9|||
156502656|NCT00433511|564933801|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
156502657|NCT00433511|564933802|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
156502658|NCT00433511|564933803|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
156502659|NCT00433511|564933801|FG000|Step 2 (Arm D)|Other complicating disease|0|||
156502660|NCT00433511|564933802|FG001|Step 2 (Arm D)|Other complicating disease|0|||
156502661|NCT00433511|564933803|FG002|Step 2 (Arm D)|Other complicating disease|3|||
156502662|NCT00433511|564933801|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
156502663|NCT00433511|564933802|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
156502664|NCT00433511|564933803|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
156502665|NCT00433511|564933801|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
156502666|NCT00433511|564933802|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
156502667|NCT00433511|564933803|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
156502668|NCT00433511|564933801|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
156502669|NCT00433511|564933802|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
156502670|NCT00433511|564933803|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
156502671|NCT00433511|564933801|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
156502672|NCT00433511|564933802|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
156502673|NCT00433511|564933803|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
156502674|NCT04292470|564933804|FG000|Overall Study|Withdrawal by Subject|0|||
156502675|NCT04292470|564933805|FG001|Overall Study|Withdrawal by Subject|1|||
156502676|NCT01375673|564933828|FG000|Overall Study|Withdrawal by Subject|0|||
156502677|NCT01375673|564933829|FG001|Overall Study|Withdrawal by Subject|1|||
156502678|NCT04328623|564933834|FG000|Overall Study|Protocol Violation|0|||
156502679|NCT04328623|564933835|FG001|Overall Study|Protocol Violation|1|||
156502680|NCT04340947|564933836|FG000|7-day Washout Period|Lost to Follow-up|5|||
156502681|NCT04340947|564933837|FG001|7-day Washout Period|Lost to Follow-up|4|||
156502682|NCT01907906|564933838|FG000|Overall Study|Withdrawal by Subject|1|||
156502683|NCT01907906|564933839|FG001|Overall Study|Withdrawal by Subject|0|||
156502684|NCT01907906|564933838|FG000|Overall Study|Physician Decision|3|||
156502685|NCT01907906|564933839|FG001|Overall Study|Physician Decision|1|||
156502686|NCT00979953|564933840|FG000|Overall Study|Adverse Event|5|||
156502687|NCT00979953|564933841|FG001|Overall Study|Adverse Event|2|||
156502688|NCT00979953|564933842|FG002|Overall Study|Adverse Event|17|||
156502689|NCT00979953|564933843|FG003|Overall Study|Adverse Event|4|||
156502690|NCT00979953|564933840|FG000|Overall Study|Lack of Efficacy|1|||
156502691|NCT00979953|564933841|FG001|Overall Study|Lack of Efficacy|2|||
156502692|NCT00979953|564933842|FG002|Overall Study|Lack of Efficacy|0|||
156502693|NCT00979953|564933843|FG003|Overall Study|Lack of Efficacy|0|||
156502694|NCT00979953|564933840|FG000|Overall Study|Lost to Follow-up|1|||
156502695|NCT00979953|564933841|FG001|Overall Study|Lost to Follow-up|1|||
156502696|NCT00979953|564933842|FG002|Overall Study|Lost to Follow-up|1|||
156502697|NCT00979953|564933843|FG003|Overall Study|Lost to Follow-up|0|||
156502698|NCT00979953|564933840|FG000|Overall Study|Withdrawal by Subject|0|||
156502699|NCT00979953|564933841|FG001|Overall Study|Withdrawal by Subject|0|||
156502700|NCT00979953|564933842|FG002|Overall Study|Withdrawal by Subject|2|||
156502701|NCT00979953|564933843|FG003|Overall Study|Withdrawal by Subject|1|||
156502702|NCT00979953|564933840|FG000|Overall Study|Protocol Violation|1|||
156502703|NCT00979953|564933841|FG001|Overall Study|Protocol Violation|0|||
156502704|NCT00979953|564933842|FG002|Overall Study|Protocol Violation|2|||
156502705|NCT00979953|564933843|FG003|Overall Study|Protocol Violation|2|||
156502706|NCT04829747|564933847|FG000|Overall Study|Protocol Violation|1|||
156502707|NCT02367352|564933850|FG000|Overall Study|Progressive disease|7|||
156502708|NCT02367352|564933851|FG001|Overall Study|Progressive disease|0|||
156502709|NCT02367352|564933852|FG002|Overall Study|Progressive disease|0|||
156502710|NCT02367352|564933850|FG000|Overall Study|Participant Received Alternative Therapy|1|||
156502711|NCT02367352|564933851|FG001|Overall Study|Participant Received Alternative Therapy|0|||
156502712|NCT02367352|564933852|FG002|Overall Study|Participant Received Alternative Therapy|0|||
156502713|NCT02367352|564933850|FG000|Overall Study|Adverse Event|1|||
156502714|NCT02367352|564933851|FG001|Overall Study|Adverse Event|0|||
156502715|NCT02367352|564933852|FG002|Overall Study|Adverse Event|0|||
156502716|NCT05878873|564933853|FG000|Overall Study|Lost to Follow-up|2|||
156502717|NCT05878873|564933854|FG001|Overall Study|Lost to Follow-up|0|||
156502718|NCT02375347|564933861|FG000|Overall Study|Protocol Violation|1|||
156502719|NCT02229227|564933862|FG000|Overall Study|Adverse Event|14|||
156502720|NCT02229227|564933863|FG001|Overall Study|Adverse Event|9|||
156502721|NCT02229227|564933862|FG000|Overall Study|Lack of Efficacy|3|||
156502722|NCT02229227|564933863|FG001|Overall Study|Lack of Efficacy|3|||
156502723|NCT02229227|564933862|FG000|Overall Study|Protocol Violation|6|||
156502724|NCT02229227|564933863|FG001|Overall Study|Protocol Violation|8|||
156502725|NCT02229227|564933862|FG000|Overall Study|Protocol defined stopping criteria|1|||
156502726|NCT02229227|564933863|FG001|Overall Study|Protocol defined stopping criteria|3|||
156502727|NCT02229227|564933862|FG000|Overall Study|Lost to Follow-up|3|||
156502728|NCT02229227|564933863|FG001|Overall Study|Lost to Follow-up|3|||
156502729|NCT02229227|564933862|FG000|Overall Study|Study terminated by sponsor|11|||
156502730|NCT02229227|564933863|FG001|Overall Study|Study terminated by sponsor|11|||
156502731|NCT02229227|564933862|FG000|Overall Study|Withdrawal by Subject|8|||
156502732|NCT02229227|564933863|FG001|Overall Study|Withdrawal by Subject|12|||
156502733|NCT02229227|564933862|FG000|Overall Study|Other|0|||
156502734|NCT02229227|564933863|FG001|Overall Study|Other|1|||
156502735|NCT02229227|564933862|FG000|Overall Study|Physician Decision|5|||
156502736|NCT02229227|564933863|FG001|Overall Study|Physician Decision|12|||
156502737|NCT00340704|564933864|FG000|PK Study|Adverse Event|0|||
156502738|NCT00340704|564933865|FG001|PK Study|Adverse Event|1|||
156502739|NCT00340704|564933866|FG002|PK Study|Adverse Event|0|||
156502740|NCT00340704|564933867|FG003|PK Study|Adverse Event|0|||
156502741|NCT00340704|564933868|FG004|PK Study|Adverse Event|0|||
156502742|NCT00340704|564933869|FG005|PK Study|Adverse Event|0|||
156502743|NCT00340704|564933870|FG006|PK Study|Adverse Event|0|||
156502744|NCT00340704|564933871|FG007|PK Study|Adverse Event|0|||
156502745|NCT00340704|564933872|FG008|PK Study|Adverse Event|0|||
156502746|NCT00340704|564933864|FG000|PK Study|Not treated|0|||
156502747|NCT00340704|564933865|FG001|PK Study|Not treated|0|||
156502748|NCT00340704|564933866|FG002|PK Study|Not treated|1|||
156502749|NCT00340704|564933867|FG003|PK Study|Not treated|0|||
156502750|NCT00340704|564933868|FG004|PK Study|Not treated|0|||
156502751|NCT00340704|564933869|FG005|PK Study|Not treated|0|||
156502752|NCT00340704|564933870|FG006|PK Study|Not treated|0|||
156502753|NCT00340704|564933871|FG007|PK Study|Not treated|0|||
156502754|NCT00340704|564933872|FG008|PK Study|Not treated|0|||
156502755|NCT00340704|564933864|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
156502756|NCT00340704|564933865|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
156502757|NCT00340704|564933866|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
156502758|NCT00340704|564933867|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
156502759|NCT00340704|564933868|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
156502760|NCT00340704|564933869|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
156502761|NCT00340704|564933870|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
156502762|NCT00340704|564933871|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
156502763|NCT00340704|564933872|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
156502764|NCT00340704|564933864|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
156502765|NCT00340704|564933865|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
156502766|NCT00340704|564933866|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
156502767|NCT00340704|564933867|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
156502768|NCT00340704|564933868|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
156502769|NCT00340704|564933869|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
156502770|NCT00340704|564933870|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
156502771|NCT00340704|564933871|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
156502772|NCT00340704|564933872|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
156502773|NCT00340704|564933864|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
156502774|NCT00340704|564933865|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
156502775|NCT00340704|564933866|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
156502776|NCT00340704|564933867|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
156502777|NCT00340704|564933868|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
156502778|NCT00340704|564933869|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
156502779|NCT00340704|564933870|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
156502780|NCT00340704|564933871|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
156502781|NCT00340704|564933872|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
156502782|NCT00340704|564933864|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
156502783|NCT00340704|564933865|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
156502784|NCT00340704|564933866|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
156502785|NCT00340704|564933867|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
156502786|NCT00340704|564933868|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
156502787|NCT00340704|564933869|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
156502788|NCT00340704|564933870|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
156502789|NCT00340704|564933871|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
156502790|NCT00340704|564933872|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
156502791|NCT03880019|564933877|FG000|Overall Study|Competing disease|1|||
156502792|NCT03635086|564933883|FG000|Overall Study|Withdrawal of consent|0|||
156502793|NCT03635086|564933884|FG001|Overall Study|Withdrawal of consent|0|||
156502794|NCT03635086|564933885|FG002|Overall Study|Withdrawal of consent|1|||
156383174|NCT00383435|564496820|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
156383175|NCT00383435|564496821|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
156383176|NCT00383435|564496817|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
156383177|NCT00383435|564496818|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
156383178|NCT00383435|564496819|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
156383179|NCT00383435|564496820|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
156383180|NCT00383435|564496821|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
156383181|NCT00383435|564496817|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
156383182|NCT00383435|564496818|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
156383183|NCT00383435|564496819|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
156383184|NCT00383435|564496820|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
156383185|NCT00383435|564496821|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
156383186|NCT00383435|564496817|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
156383187|NCT00383435|564496818|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
156383188|NCT00383435|564496819|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
156383189|NCT00383435|564496820|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
156383190|NCT00383435|564496821|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
156383191|NCT00383435|564496817|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
156383192|NCT00383435|564496818|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
156383193|NCT00383435|564496819|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
156383194|NCT00383435|564496820|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
156383195|NCT00383435|564496821|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
156383196|NCT00383435|564496817|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
156383197|NCT00383435|564496818|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
156383198|NCT00383435|564496819|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
156383199|NCT00383435|564496820|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
156383200|NCT00383435|564496821|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
156383201|NCT00383435|564496817|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
156383202|NCT00383435|564496818|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
156383203|NCT00383435|564496819|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
156383204|NCT00383435|564496820|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
156383205|NCT00383435|564496821|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
156383206|NCT00383435|564496817|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156383207|NCT00383435|564496818|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156383208|NCT00383435|564496819|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156383209|NCT00383435|564496820|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156383210|NCT00383435|564496821|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
156383211|NCT00383435|564496817|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
156383212|NCT00383435|564496818|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
156383213|NCT00383435|564496819|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
156383214|NCT00383435|564496820|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
156383215|NCT00383435|564496821|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
156383216|NCT00383435|564496817|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
156383217|NCT00383435|564496818|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
156383218|NCT00383435|564496819|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
156383219|NCT00383435|564496820|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
156383220|NCT00383435|564496821|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
156383221|NCT00383435|564496817|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
156383222|NCT00383435|564496818|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
156383223|NCT00383435|564496819|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
156383224|NCT00383435|564496820|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
156502795|NCT03635086|564933886|FG003|Overall Study|Withdrawal of consent|0|||
156502796|NCT03635086|564933887|FG004|Overall Study|Withdrawal of consent|0|||
156502797|NCT03635086|564933883|FG000|Overall Study|Adverse Event|0|||
156502798|NCT03635086|564933884|FG001|Overall Study|Adverse Event|1|||
156502799|NCT03635086|564933885|FG002|Overall Study|Adverse Event|0|||
156502800|NCT03635086|564933886|FG003|Overall Study|Adverse Event|0|||
156502801|NCT03635086|564933887|FG004|Overall Study|Adverse Event|0|||
156502802|NCT03635086|564933883|FG000|Overall Study|Lost to Follow-up|1|||
156502803|NCT03635086|564933884|FG001|Overall Study|Lost to Follow-up|0|||
156502804|NCT03635086|564933885|FG002|Overall Study|Lost to Follow-up|0|||
156502805|NCT03635086|564933886|FG003|Overall Study|Lost to Follow-up|0|||
156502806|NCT03635086|564933887|FG004|Overall Study|Lost to Follow-up|0|||
156502807|NCT02196077|564933888|FG000|Overall Study|Adverse Event|4|||
156502808|NCT02196077|564933888|FG000|Overall Study|Lack of Efficacy|1|||
156502809|NCT02196077|564933888|FG000|Overall Study|Withdrawal by Subject|14|||
156502810|NCT02196077|564933888|FG000|Overall Study|Physician Decision|1|||
156502811|NCT02196077|564933888|FG000|Overall Study|Lost to Follow-up|3|||
156502812|NCT02196077|564933888|FG000|Overall Study|Protocol Violation|24|||
156502813|NCT03482752|564933893|FG000|Overall Study|Withdrawal by Subject|2|||
156502814|NCT03482752|564933893|FG000|Overall Study|Lost to Follow-up|1|||
156502815|NCT03482752|564933893|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
156502816|NCT02689453|564933894|FG000|Overall Study|Progressive disease|0|||
156502817|NCT02689453|564933895|FG001|Overall Study|Progressive disease|1|||
156502818|NCT02689453|564933896|FG002|Overall Study|Progressive disease|1|||
156502819|NCT03566979|564933900|FG000|Overall Study|Withdrawal by Subject|2|||
156502820|NCT03566979|564933901|FG001|Overall Study|Withdrawal by Subject|0|||
156502821|NCT03566979|564933902|FG002|Overall Study|Withdrawal by Subject|1|||
156502822|NCT03566979|564933903|FG003|Overall Study|Withdrawal by Subject|1|||
156502823|NCT03566979|564933900|FG000|Overall Study|Lost to Follow-up|2|||
156502824|NCT03566979|564933901|FG001|Overall Study|Lost to Follow-up|7|||
156502825|NCT03566979|564933902|FG002|Overall Study|Lost to Follow-up|9|||
156502826|NCT03566979|564933903|FG003|Overall Study|Lost to Follow-up|5|||
156502827|NCT03566979|564933900|FG000|Overall Study|Adverse Event|1|||
156502828|NCT03566979|564933901|FG001|Overall Study|Adverse Event|0|||
156502829|NCT03566979|564933902|FG002|Overall Study|Adverse Event|0|||
156502830|NCT03566979|564933903|FG003|Overall Study|Adverse Event|0|||
156502831|NCT00658606|564933904|FG000|Overall Study|Adverse Event|2|||
156502832|NCT00658606|564933905|FG001|Overall Study|Adverse Event|1|||
156502833|NCT00658606|564933904|FG000|Overall Study|Lack of Efficacy|6|||
156502834|NCT00658606|564933905|FG001|Overall Study|Lack of Efficacy|3|||
156502835|NCT00658606|564933904|FG000|Overall Study|Lost to Follow-up|1|||
156502836|NCT00658606|564933905|FG001|Overall Study|Lost to Follow-up|0|||
156502837|NCT00658606|564933904|FG000|Overall Study|Withdrawal by Subject|7|||
156502838|NCT00658606|564933905|FG001|Overall Study|Withdrawal by Subject|16|||
156502839|NCT00658606|564933904|FG000|Overall Study|Lack of Compliance|0|||
156502840|NCT00658606|564933905|FG001|Overall Study|Lack of Compliance|3|||
156502841|NCT01056263|564933906|FG000|Overall Study|Adverse Event|12|||
156502842|NCT01056263|564933906|FG000|Overall Study|Death|1|||
156502843|NCT01056263|564933906|FG000|Overall Study|Withdrawal by Subject|1|||
156502844|NCT01056263|564933906|FG000|Overall Study|Lack of Efficacy|29|||
156502845|NCT01056263|564933906|FG000|Overall Study|Progressive disease|2|||
156502846|NCT01056263|564933906|FG000|Overall Study|Neoplasm progression|1|||
156502847|NCT01056263|564933906|FG000|Overall Study|Objective progression or relapse|1|||
156502848|NCT01056263|564933906|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
156502849|NCT03348631|564933907|FG000|Overall Study|Not Eligible, No treatment|0|||
156502850|NCT03348631|564933908|FG001|Overall Study|Not Eligible, No treatment|1|||
156502851|NCT03348631|564933907|FG000|Overall Study|Not Eligible, Treated|2|||
156502852|NCT03348631|564933908|FG001|Overall Study|Not Eligible, Treated|0|||
156502853|NCT03348631|564933907|FG000|Overall Study|Eligible, No Treatment|1|||
156502854|NCT03348631|564933908|FG001|Overall Study|Eligible, No Treatment|0|||
156502855|NCT01068210|564933909|FG000|Overall Study|Lost to Follow-up|1|||
156502856|NCT01068210|564933910|FG001|Overall Study|Lost to Follow-up|2|||
156502857|NCT01068210|564933911|FG002|Overall Study|Lost to Follow-up|2|||
156502858|NCT01068210|564933912|FG003|Overall Study|Lost to Follow-up|1|||
156502859|NCT01068210|564933909|FG000|Overall Study|Second cancer|0|||
156502860|NCT01068210|564933910|FG001|Overall Study|Second cancer|1|||
156502861|NCT01068210|564933911|FG002|Overall Study|Second cancer|0|||
156502862|NCT01068210|564933912|FG003|Overall Study|Second cancer|0|||
156502863|NCT01068210|564933909|FG000|Overall Study|Disease progression|0|||
156502864|NCT01068210|564933910|FG001|Overall Study|Disease progression|0|||
156502865|NCT01068210|564933911|FG002|Overall Study|Disease progression|0|||
156546943|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
156383225|NCT00383435|564496821|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
156383226|NCT00383435|564496817|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
156383227|NCT00383435|564496818|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
156383228|NCT00383435|564496819|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
156502866|NCT01068210|564933912|FG003|Overall Study|Disease progression|2|||
156502867|NCT01358331|564933917|FG000|Overall Study|Lost to Follow-up|0|||
156502868|NCT01358331|564933918|FG001|Overall Study|Lost to Follow-up|0|||
156502869|NCT01358331|564933919|FG002|Overall Study|Lost to Follow-up|0|||
156502870|NCT01358331|564933920|FG003|Overall Study|Lost to Follow-up|1|||
156502871|NCT01358331|564933921|FG004|Overall Study|Lost to Follow-up|0|||
156502872|NCT01358331|564933922|FG005|Overall Study|Lost to Follow-up|0|||
156502873|NCT01358331|564933917|FG000|Overall Study|Withdrawal by Subject|0|||
156383229|NCT00383435|564496820|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
156383230|NCT00383435|564496821|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
156383231|NCT00383435|564496817|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
156383232|NCT00383435|564496818|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
156383233|NCT00383435|564496819|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
156383234|NCT00383435|564496820|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
156383235|NCT00383435|564496821|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
156383236|NCT00383435|564496817|FG000|26-Week Treatment Safety Extension|Administrative|1|||
156383237|NCT00383435|564496818|FG001|26-Week Treatment Safety Extension|Administrative|1|||
156383238|NCT00383435|564496819|FG002|26-Week Treatment Safety Extension|Administrative|0|||
156383239|NCT00383435|564496820|FG003|26-Week Treatment Safety Extension|Administrative|1|||
156383240|NCT00383435|564496821|FG004|26-Week Treatment Safety Extension|Administrative|0|||
156383241|NCT02347761|564496822|FG000|All Collected|Death|1|||
156383242|NCT02347761|564496823|FG001|All Collected|Death|0|||
156383243|NCT02347761|564496824|FG002|All Collected|Death|0|||
156383244|NCT02347761|564496822|FG000|All Collected|Lost to Follow-up|3|||
156383245|NCT02347761|564496823|FG001|All Collected|Lost to Follow-up|2|||
156383246|NCT02347761|564496824|FG002|All Collected|Lost to Follow-up|3|||
156383247|NCT02347761|564496822|FG000|All Collected|Withdrawal by Subject|11|||
156383248|NCT02347761|564496823|FG001|All Collected|Withdrawal by Subject|11|||
156383249|NCT02347761|564496824|FG002|All Collected|Withdrawal by Subject|22|||
156383250|NCT02347761|564496822|FG000|All Collected|invetigator disretion|2|||
156383251|NCT02347761|564496823|FG001|All Collected|invetigator disretion|0|||
156383252|NCT02347761|564496824|FG002|All Collected|invetigator disretion|0|||
156383253|NCT02347761|564496822|FG000|All Collected|instillation site pain|0|||
156383254|NCT02347761|564496823|FG001|All Collected|instillation site pain|0|||
156383255|NCT02347761|564496824|FG002|All Collected|instillation site pain|1|||
156383256|NCT02347761|564496822|FG000|All Collected|exacerbation of COPD|0|||
156383257|NCT02347761|564496823|FG001|All Collected|exacerbation of COPD|0|||
156383258|NCT02347761|564496824|FG002|All Collected|exacerbation of COPD|1|||
156383259|NCT02347761|564496822|FG000|All Collected|moved/travel|0|||
156383260|NCT02347761|564496823|FG001|All Collected|moved/travel|1|||
156383261|NCT02347761|564496824|FG002|All Collected|moved/travel|0|||
156383262|NCT02347761|564496822|FG000|On Study Treatment|Lack of Efficacy|2|||
156383263|NCT02347761|564496823|FG001|On Study Treatment|Lack of Efficacy|3|||
156383264|NCT02347761|564496824|FG002|On Study Treatment|Lack of Efficacy|4|||
156383265|NCT02347761|564496822|FG000|On Study Treatment|non-compliance with study medication|0|||
156383266|NCT02347761|564496823|FG001|On Study Treatment|non-compliance with study medication|0|||
156383267|NCT02347761|564496824|FG002|On Study Treatment|non-compliance with study medication|2|||
156383268|NCT02347761|564496822|FG000|On Study Treatment|Withdrawal by Subject|7|||
156383269|NCT02347761|564496823|FG001|On Study Treatment|Withdrawal by Subject|3|||
156383270|NCT02347761|564496824|FG002|On Study Treatment|Withdrawal by Subject|5|||
156383271|NCT02347761|564496822|FG000|On Study Treatment|move/travel|2|||
156383272|NCT02347761|564496823|FG001|On Study Treatment|move/travel|6|||
156383273|NCT02347761|564496824|FG002|On Study Treatment|move/travel|5|||
156383274|NCT02347761|564496822|FG000|On Study Treatment|dissastisfaction with device|2|||
156383275|NCT02347761|564496823|FG001|On Study Treatment|dissastisfaction with device|1|||
156383276|NCT02347761|564496824|FG002|On Study Treatment|dissastisfaction with device|4|||
156383277|NCT02347761|564496822|FG000|On Study Treatment|Lost to Follow-up|2|||
156383278|NCT02347761|564496823|FG001|On Study Treatment|Lost to Follow-up|1|||
156383279|NCT02347761|564496824|FG002|On Study Treatment|Lost to Follow-up|1|||
156383280|NCT02347761|564496822|FG000|On Study Treatment|investigator discretion|2|||
156383281|NCT02347761|564496823|FG001|On Study Treatment|investigator discretion|0|||
156383282|NCT02347761|564496824|FG002|On Study Treatment|investigator discretion|0|||
156383283|NCT02347761|564496822|FG000|On Study Treatment|durg not working|0|||
156383284|NCT02347761|564496823|FG001|On Study Treatment|durg not working|1|||
156383285|NCT02347761|564496824|FG002|On Study Treatment|durg not working|1|||
156383286|NCT02347761|564496822|FG000|On Study Treatment|Adverse Event|10|||
156383287|NCT02347761|564496823|FG001|On Study Treatment|Adverse Event|8|||
156383288|NCT02347761|564496824|FG002|On Study Treatment|Adverse Event|20|||
156383289|NCT03950739|564496825|FG000|Treatment Phase|Adverse Event|2|||
156383290|NCT03950739|564496825|FG000|Optional Extension Phase|Death|1|||
156383291|NCT03950739|564496825|FG000|Optional Extension Phase|Progressive Disease|5|||
156383292|NCT03950739|564496825|FG000|Optional Extension Phase|Adverse Event|7|||
156383293|NCT03950739|564496825|FG000|Optional Extension Phase|Lost to Follow-up|2|||
156383294|NCT03950739|564496825|FG000|Optional Extension Phase|Site Closure|2|||
156383295|NCT03950739|564496825|FG000|Optional Extension Phase|Pregnancy|1|||
156383296|NCT03625570|564496826|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
156383297|NCT03625570|564496827|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
156383298|NCT03625570|564496826|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
156383299|NCT03625570|564496827|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
156383300|NCT03625570|564496826|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
156502874|NCT01358331|564933918|FG001|Overall Study|Withdrawal by Subject|0|||
156502875|NCT01358331|564933919|FG002|Overall Study|Withdrawal by Subject|0|||
156502876|NCT01358331|564933920|FG003|Overall Study|Withdrawal by Subject|1|||
156502877|NCT01358331|564933921|FG004|Overall Study|Withdrawal by Subject|1|||
156502878|NCT01358331|564933922|FG005|Overall Study|Withdrawal by Subject|1|||
156502879|NCT01358331|564933917|FG000|Overall Study|Adverse Events|1|||
156502880|NCT01358331|564933918|FG001|Overall Study|Adverse Events|1|||
156502881|NCT01358331|564933919|FG002|Overall Study|Adverse Events|1|||
156502882|NCT01358331|564933920|FG003|Overall Study|Adverse Events|0|||
156502883|NCT01358331|564933921|FG004|Overall Study|Adverse Events|1|||
156502884|NCT01358331|564933922|FG005|Overall Study|Adverse Events|5|||
156502885|NCT01358331|564933917|FG000|Overall Study|Symptomatic Deterioration|0|||
156502886|NCT01358331|564933918|FG001|Overall Study|Symptomatic Deterioration|0|||
156502887|NCT01358331|564933919|FG002|Overall Study|Symptomatic Deterioration|0|||
156502888|NCT01358331|564933920|FG003|Overall Study|Symptomatic Deterioration|0|||
156502889|NCT01358331|564933921|FG004|Overall Study|Symptomatic Deterioration|1|||
156502890|NCT01358331|564933922|FG005|Overall Study|Symptomatic Deterioration|0|||
156502891|NCT01358331|564933917|FG000|Overall Study|Participants did not wish to continue|0|||
156502892|NCT01358331|564933918|FG001|Overall Study|Participants did not wish to continue|0|||
156502893|NCT01358331|564933919|FG002|Overall Study|Participants did not wish to continue|0|||
156502894|NCT01358331|564933920|FG003|Overall Study|Participants did not wish to continue|0|||
156502895|NCT01358331|564933921|FG004|Overall Study|Participants did not wish to continue|1|||
156502896|NCT01358331|564933922|FG005|Overall Study|Participants did not wish to continue|0|||
156502897|NCT01358331|564933917|FG000|Overall Study|Progress of disease under investigation|1|||
156502898|NCT01358331|564933918|FG001|Overall Study|Progress of disease under investigation|2|||
156502899|NCT01358331|564933919|FG002|Overall Study|Progress of disease under investigation|3|||
156502900|NCT01358331|564933920|FG003|Overall Study|Progress of disease under investigation|1|||
156502901|NCT01358331|564933921|FG004|Overall Study|Progress of disease under investigation|3|||
156502902|NCT01358331|564933922|FG005|Overall Study|Progress of disease under investigation|0|||
156502903|NCT03170518|564933925|FG000|Overall Study|Lost to Follow-up|4|||
156502904|NCT03170518|564933926|FG001|Overall Study|Lost to Follow-up|1|||
156502905|NCT03170518|564933927|FG002|Overall Study|Lost to Follow-up|0|||
156502906|NCT03170518|564933925|FG000|Overall Study|Physician Decision|1|||
156502907|NCT03170518|564933926|FG001|Overall Study|Physician Decision|0|||
156502908|NCT03170518|564933927|FG002|Overall Study|Physician Decision|0|||
156502909|NCT03170518|564933925|FG000|Overall Study|Withdrawal by Subject|4|||
156502910|NCT03170518|564933926|FG001|Overall Study|Withdrawal by Subject|5|||
156502911|NCT03170518|564933927|FG002|Overall Study|Withdrawal by Subject|2|||
156502912|NCT03170518|564933925|FG000|Overall Study|Site terminated by sponsor|0|||
156502913|NCT03170518|564933926|FG001|Overall Study|Site terminated by sponsor|1|||
156502914|NCT03170518|564933927|FG002|Overall Study|Site terminated by sponsor|0|||
156502915|NCT03170518|564933925|FG000|Overall Study|Non-compliance with study drug|1|||
156502916|NCT03170518|564933926|FG001|Overall Study|Non-compliance with study drug|0|||
156502917|NCT03170518|564933927|FG002|Overall Study|Non-compliance with study drug|1|||
156502918|NCT03170518|564933925|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156502919|NCT03170518|564933926|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156502920|NCT03170518|564933927|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156502921|NCT00546078|564933928|FG000|Overall Study|Lost to Follow-up|1|||
156502922|NCT00546078|564933929|FG001|Overall Study|Lost to Follow-up|3|||
156502923|NCT00546078|564933928|FG000|Overall Study|Withdrawal by Subject|2|||
156502924|NCT00546078|564933929|FG001|Overall Study|Withdrawal by Subject|3|||
156502925|NCT00546078|564933928|FG000|Overall Study|Other reason|1|||
156502926|NCT00546078|564933929|FG001|Overall Study|Other reason|1|||
156502927|NCT02559310|564933934|FG000|Overall Study|Death|4|||
156502928|NCT02559310|564933935|FG001|Overall Study|Death|3|||
156502929|NCT02559310|564933934|FG000|Overall Study|Lost to Follow-up|5|||
156502930|NCT02559310|564933935|FG001|Overall Study|Lost to Follow-up|3|||
156502931|NCT02559310|564933934|FG000|Overall Study|Physician Decision|2|||
156502932|NCT02559310|564933935|FG001|Overall Study|Physician Decision|1|||
156502933|NCT02559310|564933934|FG000|Overall Study|Withdrawal by Subject|13|||
156502934|NCT02559310|564933935|FG001|Overall Study|Withdrawal by Subject|9|||
156502935|NCT02559310|564933934|FG000|Overall Study|Sponsor Decision|0|||
156502936|NCT02559310|564933935|FG001|Overall Study|Sponsor Decision|1|||
156502937|NCT02559310|564933934|FG000|Overall Study|Randomized but not treated|3|||
156502938|NCT02559310|564933935|FG001|Overall Study|Randomized but not treated|2|||
156502939|NCT03595878|564933936|FG000|Overall Study|Death|2|||
156502940|NCT03595878|564933937|FG001|Overall Study|Death|1|||
156502941|NCT03595878|564933938|FG002|Overall Study|Death|0|||
156502942|NCT03595878|564933936|FG000|Overall Study|Disease progression|2|||
156502943|NCT03595878|564933937|FG001|Overall Study|Disease progression|1|||
156383301|NCT03625570|564496827|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
156383302|NCT03646513|564496828|FG000|Overall Study|Premature study termination|4|||
156502944|NCT03595878|564933938|FG002|Overall Study|Disease progression|2|||
156502945|NCT03036124|564933939|FG000|Overall Study|Lost to Follow-up|0|||
156502946|NCT03036124|564933940|FG001|Overall Study|Lost to Follow-up|2|||
156383303|NCT01732835|564496829|FG000|6-month Primary Endpoint|Did not receive device|19|||
156383304|NCT01732835|564496829|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
156383305|NCT01732835|564496829|FG000|6-month Primary Endpoint|Adverse Event|3|||
156383306|NCT01732835|564496829|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
156383307|NCT01732835|564496829|FG000|2-year Extended Follow-up|Adverse Event|3|||
156383308|NCT01732835|564496829|FG000|2-year Extended Follow-up|Death|1|||
156383309|NCT00093145|564496832|FG000|Overall Study|Unacceptable Toxicity Only|2|||
156383310|NCT00093145|564496832|FG000|Overall Study|Physician Decision|5|||
156383311|NCT00093145|564496832|FG000|Overall Study|Withdrawal by Subject|9|||
156383312|NCT00093145|564496832|FG000|Overall Study|Other|1|||
156383313|NCT01175668|564496833|FG000|Overall Study|Withdrawal by Subject|2|||
156383314|NCT01175668|564496834|FG001|Overall Study|Withdrawal by Subject|0|||
156383315|NCT00817089|564496835|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
156383316|NCT00817089|564496836|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
156383317|NCT00817089|564496837|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
156383318|NCT00817089|564496838|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
156383319|NCT00817089|564496835|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
156383320|NCT00817089|564496836|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
156383321|NCT00817089|564496837|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
156383322|NCT00817089|564496838|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
156383323|NCT01953926|564496846|FG000|Overall Study|Withdrawal by Subject|23|||
156383324|NCT01953926|564496847|FG001|Overall Study|Withdrawal by Subject|3|||
156383325|NCT01953926|564496848|FG002|Overall Study|Withdrawal by Subject|3|||
156383326|NCT01953926|564496849|FG003|Overall Study|Withdrawal by Subject|5|||
156383327|NCT01953926|564496850|FG004|Overall Study|Withdrawal by Subject|6|||
156383328|NCT01953926|564496851|FG005|Overall Study|Withdrawal by Subject|0|||
156383329|NCT01953926|564496852|FG006|Overall Study|Withdrawal by Subject|1|||
156383330|NCT01953926|564496846|FG000|Overall Study|Physician Decision|1|||
156383331|NCT01953926|564496847|FG001|Overall Study|Physician Decision|0|||
156383332|NCT01953926|564496848|FG002|Overall Study|Physician Decision|0|||
156383333|NCT01953926|564496849|FG003|Overall Study|Physician Decision|0|||
156383334|NCT01953926|564496850|FG004|Overall Study|Physician Decision|2|||
156383335|NCT01953926|564496851|FG005|Overall Study|Physician Decision|0|||
156383336|NCT01953926|564496852|FG006|Overall Study|Physician Decision|0|||
156383337|NCT01953926|564496846|FG000|Overall Study|Lost to Follow-up|18|||
156383338|NCT01953926|564496847|FG001|Overall Study|Lost to Follow-up|3|||
156383339|NCT01953926|564496848|FG002|Overall Study|Lost to Follow-up|0|||
156383340|NCT01953926|564496849|FG003|Overall Study|Lost to Follow-up|5|||
156383341|NCT01953926|564496850|FG004|Overall Study|Lost to Follow-up|3|||
156383342|NCT01953926|564496851|FG005|Overall Study|Lost to Follow-up|0|||
156383343|NCT01953926|564496852|FG006|Overall Study|Lost to Follow-up|0|||
156383344|NCT01953926|564496846|FG000|Overall Study|Protocol Violation|1|||
156383345|NCT01953926|564496847|FG001|Overall Study|Protocol Violation|0|||
156383346|NCT01953926|564496848|FG002|Overall Study|Protocol Violation|0|||
156383347|NCT01953926|564496849|FG003|Overall Study|Protocol Violation|0|||
156383348|NCT01953926|564496850|FG004|Overall Study|Protocol Violation|0|||
156383349|NCT01953926|564496851|FG005|Overall Study|Protocol Violation|0|||
156383350|NCT01953926|564496852|FG006|Overall Study|Protocol Violation|0|||
156383351|NCT01953926|564496846|FG000|Overall Study|Other, Disease progression|2|||
156383352|NCT01953926|564496847|FG001|Overall Study|Other, Disease progression|1|||
156383353|NCT01953926|564496848|FG002|Overall Study|Other, Disease progression|0|||
156383354|NCT01953926|564496849|FG003|Overall Study|Other, Disease progression|0|||
156383355|NCT01953926|564496850|FG004|Overall Study|Other, Disease progression|1|||
156383356|NCT01953926|564496851|FG005|Overall Study|Other, Disease progression|0|||
156383357|NCT01953926|564496852|FG006|Overall Study|Other, Disease progression|0|||
156383358|NCT01953926|564496846|FG000|Overall Study|Discontinuation of study by sponsor|41|||
156383359|NCT01953926|564496847|FG001|Overall Study|Discontinuation of study by sponsor|7|||
156383360|NCT01953926|564496848|FG002|Overall Study|Discontinuation of study by sponsor|5|||
156383361|NCT01953926|564496849|FG003|Overall Study|Discontinuation of study by sponsor|12|||
156383362|NCT01953926|564496850|FG004|Overall Study|Discontinuation of study by sponsor|46|||
156383363|NCT01953926|564496851|FG005|Overall Study|Discontinuation of study by sponsor|5|||
156383364|NCT01953926|564496852|FG006|Overall Study|Discontinuation of study by sponsor|6|||
156383365|NCT01953926|564496846|FG000|Overall Study|Not Treated|1|||
156383366|NCT01953926|564496847|FG001|Overall Study|Not Treated|0|||
156383367|NCT01953926|564496848|FG002|Overall Study|Not Treated|1|||
156383368|NCT01953926|564496849|FG003|Overall Study|Not Treated|0|||
156383369|NCT01953926|564496850|FG004|Overall Study|Not Treated|0|||
156383370|NCT01953926|564496851|FG005|Overall Study|Not Treated|0|||
156383371|NCT01953926|564496852|FG006|Overall Study|Not Treated|0|||
156383372|NCT01949480|564496854|FG000|Overall Study|Physician Decision|5|||
156383373|NCT01949480|564496855|FG001|Overall Study|Physician Decision|8|||
156383374|NCT00144339|564496856|FG000|Overall Study|Adverse Event|746|||
156383375|NCT00144339|564496857|FG001|Overall Study|Adverse Event|627|||
156383376|NCT00144339|564496856|FG000|Overall Study|Protocol Violation|75|||
156383377|NCT00144339|564496857|FG001|Overall Study|Protocol Violation|48|||
156383378|NCT00144339|564496856|FG000|Overall Study|Withdrawal by Subject|403|||
156383379|NCT00144339|564496857|FG001|Overall Study|Withdrawal by Subject|300|||
156383380|NCT00144339|564496856|FG000|Overall Study|Lost to Follow-up|76|||
156502947|NCT03036124|564933939|FG000|Overall Study|Withdrawal by Subject|5|||
156502948|NCT03036124|564933940|FG001|Overall Study|Withdrawal by Subject|4|||
156502949|NCT02282059|564933941|FG000|Overall Study|Other|15|||
156502950|NCT02282059|564933942|FG001|Overall Study|Other|3|||
156502951|NCT02282059|564933941|FG000|Overall Study|Participant refused further follow-up|8|||
156502952|NCT02282059|564933942|FG001|Overall Study|Participant refused further follow-up|4|||
156502953|NCT02282059|564933941|FG000|Overall Study|Lost to Follow-up|19|||
156502954|NCT02282059|564933942|FG001|Overall Study|Lost to Follow-up|3|||
156502955|NCT02282059|564933941|FG000|Overall Study|Death|40|||
156502956|NCT02282059|564933942|FG001|Overall Study|Death|8|||
156502957|NCT01340014|564933943|FG000|Period 1, First 7 Days|Adverse Event|1|||
156502958|NCT01340014|564933944|FG001|Period 1, First 7 Days|Adverse Event|0|||
156502959|NCT01340014|564933943|FG000|Period 1, First 7 Days|Personal Reasons|1|||
156502960|NCT01340014|564933944|FG001|Period 1, First 7 Days|Personal Reasons|0|||
156502961|NCT01340014|564933943|FG000|Period 2, Second 7 Days|Adverse Event|0|||
156502962|NCT01340014|564933944|FG001|Period 2, Second 7 Days|Adverse Event|1|||
156502963|NCT04526665|564933947|FG000|Overall Study|Withdrawal by Subject|6|||
156502964|NCT04526665|564933948|FG001|Overall Study|Withdrawal by Subject|3|||
156502965|NCT04526665|564933947|FG000|Overall Study|Adverse Event|4|||
156502966|NCT04526665|564933948|FG001|Overall Study|Adverse Event|1|||
156502967|NCT04526665|564933947|FG000|Overall Study|Physician Decision|2|||
156502968|NCT04526665|564933948|FG001|Overall Study|Physician Decision|2|||
156502969|NCT04526665|564933947|FG000|Overall Study|Death|2|||
156502970|NCT04526665|564933948|FG001|Overall Study|Death|0|||
156502971|NCT04526665|564933947|FG000|Overall Study|Other|0|||
156502972|NCT04526665|564933948|FG001|Overall Study|Other|1|||
156502973|NCT02065882|564933950|FG000|Part I: PK/PD|Screening failure|5|||
156502974|NCT02065882|564933950|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
156502975|NCT02065882|564933950|FG000|Part I: PK/PD|Adverse Event|1|||
156502976|NCT02065882|564933950|FG000|Part II: Clinical Efficacy|Screening failure|7|||
156502977|NCT02065882|564933950|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
156502978|NCT02065882|564933950|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
156502979|NCT02065882|564933950|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
156502980|NCT02065882|564933950|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
156502981|NCT02065882|564933950|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
156502982|NCT00742326|564935755|FG000|Overall Study|Physician Decision|0|||
156502983|NCT00742326|564935756|FG001|Overall Study|Physician Decision|1|||
156502984|NCT00150618|564935758|FG000|Overall Study|Adverse Event|2|||
156502985|NCT00150618|564935759|FG001|Overall Study|Adverse Event|2|||
156502986|NCT00150618|564935760|FG002|Overall Study|Adverse Event|6|||
156502987|NCT00150618|564935761|FG003|Overall Study|Adverse Event|9|||
156502988|NCT00150618|564935762|FG004|Overall Study|Adverse Event|5|||
156502989|NCT00150618|564935758|FG000|Overall Study|Withdrawal by Subject|6|||
156502990|NCT00150618|564935759|FG001|Overall Study|Withdrawal by Subject|8|||
156502991|NCT00150618|564935760|FG002|Overall Study|Withdrawal by Subject|8|||
156502992|NCT00150618|564935761|FG003|Overall Study|Withdrawal by Subject|4|||
156502993|NCT00150618|564935762|FG004|Overall Study|Withdrawal by Subject|5|||
156502994|NCT00150618|564935758|FG000|Overall Study|Lost to Follow-up|4|||
156502995|NCT00150618|564935759|FG001|Overall Study|Lost to Follow-up|1|||
156502996|NCT00150618|564935760|FG002|Overall Study|Lost to Follow-up|5|||
156502997|NCT00150618|564935761|FG003|Overall Study|Lost to Follow-up|8|||
156502998|NCT00150618|564935762|FG004|Overall Study|Lost to Follow-up|4|||
156502999|NCT00150618|564935758|FG000|Overall Study|Protocol Violation|1|||
156503000|NCT00150618|564935759|FG001|Overall Study|Protocol Violation|0|||
156503001|NCT00150618|564935760|FG002|Overall Study|Protocol Violation|0|||
156503002|NCT00150618|564935761|FG003|Overall Study|Protocol Violation|0|||
156383381|NCT00144339|564496857|FG001|Overall Study|Lost to Follow-up|64|||
156383382|NCT00144339|564496856|FG000|Overall Study|Other|58|||
156383383|NCT00144339|564496857|FG001|Overall Study|Other|60|||
156383384|NCT00305058|564496858|FG000|Overall Study|Participant too young|1|||
156383385|NCT00305058|564496859|FG001|Overall Study|Participant too young|0|||
156383386|NCT00305058|564496858|FG000|Overall Study|Missing data collection instrument|3|||
156383387|NCT00305058|564496859|FG001|Overall Study|Missing data collection instrument|2|||
156383388|NCT00305058|564496858|FG000|Overall Study|Missing outcome data|3|||
156383389|NCT00305058|564496859|FG001|Overall Study|Missing outcome data|2|||
156383390|NCT00288587|564496862|FG000|Overall Study|Death|4|||
156383391|NCT00288587|564496863|FG001|Overall Study|Death|4|||
156503003|NCT00150618|564935762|FG004|Overall Study|Protocol Violation|1|||
156503004|NCT00150618|564935758|FG000|Overall Study|Lack of Efficacy|1|||
156503005|NCT00150618|564935759|FG001|Overall Study|Lack of Efficacy|4|||
156503006|NCT00150618|564935760|FG002|Overall Study|Lack of Efficacy|7|||
156503007|NCT00150618|564935761|FG003|Overall Study|Lack of Efficacy|4|||
156503008|NCT00150618|564935762|FG004|Overall Study|Lack of Efficacy|6|||
156503009|NCT00150618|564935758|FG000|Overall Study|No study meds|0|||
156503010|NCT00150618|564935759|FG001|Overall Study|No study meds|0|||
156503011|NCT00150618|564935760|FG002|Overall Study|No study meds|0|||
156383392|NCT00288587|564496862|FG000|Overall Study|Transplant|0|||
156383393|NCT00288587|564496863|FG001|Overall Study|Transplant|3|||
156383394|NCT00288587|564496862|FG000|Overall Study|Adverse Event|0|||
156503012|NCT00150618|564935761|FG003|Overall Study|No study meds|0|||
156503013|NCT00150618|564935762|FG004|Overall Study|No study meds|2|||
156503014|NCT00150618|564935758|FG000|Overall Study|Physician Decision|0|||
156503015|NCT00150618|564935759|FG001|Overall Study|Physician Decision|2|||
156503016|NCT00150618|564935760|FG002|Overall Study|Physician Decision|0|||
156503017|NCT00150618|564935761|FG003|Overall Study|Physician Decision|0|||
156503018|NCT00150618|564935762|FG004|Overall Study|Physician Decision|1|||
156503019|NCT00150618|564935758|FG000|Overall Study|Lack of compliance|2|||
156503020|NCT00150618|564935759|FG001|Overall Study|Lack of compliance|1|||
156503021|NCT00150618|564935760|FG002|Overall Study|Lack of compliance|1|||
156503022|NCT00150618|564935761|FG003|Overall Study|Lack of compliance|0|||
156503023|NCT00150618|564935762|FG004|Overall Study|Lack of compliance|1|||
156503024|NCT00150618|564935758|FG000|Overall Study|Abnormal ECG|1|||
156503025|NCT00150618|564935759|FG001|Overall Study|Abnormal ECG|0|||
156503026|NCT00150618|564935760|FG002|Overall Study|Abnormal ECG|0|||
156503027|NCT00150618|564935761|FG003|Overall Study|Abnormal ECG|0|||
156503028|NCT00150618|564935762|FG004|Overall Study|Abnormal ECG|0|||
156503029|NCT00150618|564935758|FG000|Overall Study|Sponsor's decision|0|||
156503030|NCT00150618|564935759|FG001|Overall Study|Sponsor's decision|0|||
156503031|NCT00150618|564935760|FG002|Overall Study|Sponsor's decision|0|||
156503032|NCT00150618|564935761|FG003|Overall Study|Sponsor's decision|1|||
156503033|NCT00150618|564935762|FG004|Overall Study|Sponsor's decision|0|||
156503034|NCT02493946|564935763|FG000|DB Period|Withdrawal by Subject|8|||
156503035|NCT02493946|564935764|FG001|DB Period|Withdrawal by Subject|5|||
156503036|NCT02493946|564935765|FG002|DB Period|Withdrawal by Subject|0|||
156503037|NCT02493946|564935763|FG000|Open Label Period|Withdrawal by Subject|0|||
156503038|NCT02493946|564935764|FG001|Open Label Period|Withdrawal by Subject|0|||
156503039|NCT02493946|564935765|FG002|Open Label Period|Withdrawal by Subject|74|||
156503040|NCT02493946|564935763|FG000|Open Label Period|Adverse Event|0|||
156503041|NCT02493946|564935764|FG001|Open Label Period|Adverse Event|0|||
156503042|NCT02493946|564935765|FG002|Open Label Period|Adverse Event|4|||
156503043|NCT02493946|564935763|FG000|Open Label Period|Lost to Follow-up|0|||
156503044|NCT02493946|564935764|FG001|Open Label Period|Lost to Follow-up|0|||
156503045|NCT02493946|564935765|FG002|Open Label Period|Lost to Follow-up|1|||
156503046|NCT02493946|564935763|FG000|Open Label Period|Investigator decision, non-compliance|0|||
156503047|NCT02493946|564935764|FG001|Open Label Period|Investigator decision, non-compliance|0|||
156503048|NCT02493946|564935765|FG002|Open Label Period|Investigator decision, non-compliance|2|||
156503049|NCT02493946|564935763|FG000|Open Label Period|Investigator decision, non-availability|0|||
156503050|NCT02493946|564935764|FG001|Open Label Period|Investigator decision, non-availability|0|||
156503051|NCT02493946|564935765|FG002|Open Label Period|Investigator decision, non-availability|1|||
156503052|NCT02493946|564935763|FG000|Open Label Period|Pregnancy|0|||
156503053|NCT02493946|564935764|FG001|Open Label Period|Pregnancy|0|||
156503054|NCT02493946|564935765|FG002|Open Label Period|Pregnancy|3|||
156503055|NCT02493946|564935763|FG000|Open Label Period|Site error|0|||
156503056|NCT02493946|564935764|FG001|Open Label Period|Site error|0|||
156503057|NCT02493946|564935765|FG002|Open Label Period|Site error|1|||
156503058|NCT00965497|564935766|FG000|Overall Study|Physician Decision|1|||
156503059|NCT02878603|564935767|FG000|Overall Study|Lost to Follow-up|4|||
156503060|NCT02878603|564935768|FG001|Overall Study|Lost to Follow-up|1|||
156503061|NCT02878603|564935767|FG000|Overall Study|Withdrawal by Subject|1|||
156503062|NCT02878603|564935768|FG001|Overall Study|Withdrawal by Subject|1|||
156503063|NCT02878603|564935767|FG000|Overall Study|Death|1|||
156503064|NCT02878603|564935768|FG001|Overall Study|Death|0|||
156503065|NCT02878603|564935767|FG000|Overall Study|Physician Decision|0|||
156503066|NCT02878603|564935768|FG001|Overall Study|Physician Decision|3|||
156503067|NCT01162486|564935769|FG000|Overall Study|low ANC|1|||
156503068|NCT01162486|564935770|FG001|Overall Study|low ANC|0|||
156503069|NCT01162486|564935771|FG002|Overall Study|low ANC|0|||
156503070|NCT01162486|564935772|FG003|Overall Study|low ANC|0|||
156503071|NCT01162486|564935773|FG004|Overall Study|low ANC|0|||
156503072|NCT01162486|564935769|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
156503073|NCT01162486|564935770|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
156503074|NCT01162486|564935771|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
156503075|NCT01162486|564935772|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
156383395|NCT00288587|564496863|FG001|Overall Study|Adverse Event|1|||
156383396|NCT00288587|564496862|FG000|Overall Study|Physician Decision|0|||
156503076|NCT01162486|564935773|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
156503077|NCT01162486|564935769|FG000|Overall Study|elevated LFTs|0|||
156503078|NCT01162486|564935770|FG001|Overall Study|elevated LFTs|0|||
156503079|NCT01162486|564935771|FG002|Overall Study|elevated LFTs|1|||
156503080|NCT01162486|564935772|FG003|Overall Study|elevated LFTs|0|||
156503081|NCT01162486|564935773|FG004|Overall Study|elevated LFTs|0|||
156503082|NCT01162486|564935769|FG000|Overall Study|Pregnancy|0|||
156503083|NCT01162486|564935770|FG001|Overall Study|Pregnancy|0|||
156503084|NCT01162486|564935771|FG002|Overall Study|Pregnancy|0|||
156503085|NCT01162486|564935772|FG003|Overall Study|Pregnancy|1|||
156503086|NCT01162486|564935773|FG004|Overall Study|Pregnancy|0|||
156503087|NCT00794924|564935774|FG000|Overall Study|Lost to Follow-up|6|||
156503088|NCT00794924|564935775|FG001|Overall Study|Lost to Follow-up|8|||
156503089|NCT00794924|564935774|FG000|Overall Study|Withdrawal by Subject|48|||
156503090|NCT00794924|564935775|FG001|Overall Study|Withdrawal by Subject|60|||
156503091|NCT00794924|564935774|FG000|Overall Study|Adverse Event|6|||
156503092|NCT00794924|564935775|FG001|Overall Study|Adverse Event|2|||
156503093|NCT00953615|564935776|FG000|Overall Study|Adverse Event|1|||
156503094|NCT03274895|564935777|FG000|Overall Study|Lack of Efficacy|1|||
156503095|NCT03274895|564935778|FG001|Overall Study|Lack of Efficacy|0|||
156503096|NCT03274895|564935777|FG000|Overall Study|Adverse Event|8|||
156503097|NCT03274895|564935778|FG001|Overall Study|Adverse Event|7|||
156503098|NCT03274895|564935777|FG000|Overall Study|Lost to Follow-up|1|||
156503099|NCT03274895|564935778|FG001|Overall Study|Lost to Follow-up|0|||
156503100|NCT03274895|564935777|FG000|Overall Study|Diagnosis not confirmed|3|||
156503101|NCT03274895|564935778|FG001|Overall Study|Diagnosis not confirmed|4|||
156503102|NCT01969851|564935783|FG000|Overall Study|Adverse Event|0|||
156503103|NCT01969851|564935784|FG001|Overall Study|Adverse Event|0|||
156503104|NCT01969851|564935785|FG002|Overall Study|Adverse Event|3|||
156503105|NCT01969851|564935783|FG000|Overall Study|Lack of Efficacy|0|||
156503106|NCT01969851|564935784|FG001|Overall Study|Lack of Efficacy|3|||
156503107|NCT01969851|564935785|FG002|Overall Study|Lack of Efficacy|1|||
156503108|NCT01969851|564935783|FG000|Overall Study|Withdrawal by Subject|1|||
156503109|NCT01969851|564935784|FG001|Overall Study|Withdrawal by Subject|0|||
156503110|NCT01969851|564935785|FG002|Overall Study|Withdrawal by Subject|1|||
156503111|NCT01969851|564935783|FG000|Overall Study|No effective dose in Titration period|0|||
156503112|NCT01969851|564935784|FG001|Overall Study|No effective dose in Titration period|0|||
156503113|NCT01969851|564935785|FG002|Overall Study|No effective dose in Titration period|1|||
156503114|NCT01969851|564935783|FG000|Overall Study|Sponsor decision|0|||
156503115|NCT01969851|564935784|FG001|Overall Study|Sponsor decision|0|||
156503116|NCT01969851|564935785|FG002|Overall Study|Sponsor decision|1|||
156503117|NCT01294436|564935786|FG000|Overall Study|Adverse Event|10|||
156503118|NCT01294436|564935787|FG001|Overall Study|Adverse Event|17|||
156503119|NCT01294436|564935786|FG000|Overall Study|Withdrawal by Subject|11|||
156503120|NCT01294436|564935787|FG001|Overall Study|Withdrawal by Subject|28|||
156503121|NCT01294436|564935786|FG000|Overall Study|subject no longer meets study criteria|5|||
156503122|NCT01294436|564935787|FG001|Overall Study|subject no longer meets study criteria|20|||
156503123|NCT01294436|564935786|FG000|Overall Study|poor/non-compliance|2|||
156503124|NCT01294436|564935787|FG001|Overall Study|poor/non-compliance|5|||
156503125|NCT02389764|564935788|FG000|Overall Study|Lack of Efficacy|9|||
156503126|NCT02498236|564935795|FG000|Overall Study|Did not show for testing|1|||
156503127|NCT02498236|564935796|FG001|Overall Study|Did not show for testing|0|||
156503128|NCT02498236|564935797|FG002|Overall Study|Did not show for testing|0|||
156503129|NCT02498236|564935798|FG003|Overall Study|Did not show for testing|0|||
156503130|NCT02498236|564935799|FG004|Overall Study|Did not show for testing|0|||
156503131|NCT02498236|564935800|FG005|Overall Study|Did not show for testing|0|||
156503132|NCT02498236|564935801|FG006|Overall Study|Did not show for testing|0|||
156503133|NCT02498236|564935802|FG007|Overall Study|Did not show for testing|1|||
156503134|NCT02498236|564935795|FG000|Overall Study|Equipment failure|0|||
156503135|NCT02498236|564935796|FG001|Overall Study|Equipment failure|0|||
156503136|NCT02498236|564935797|FG002|Overall Study|Equipment failure|0|||
156503137|NCT02498236|564935798|FG003|Overall Study|Equipment failure|0|||
156503138|NCT02498236|564935799|FG004|Overall Study|Equipment failure|0|||
156503139|NCT02498236|564935800|FG005|Overall Study|Equipment failure|0|||
156503140|NCT02498236|564935801|FG006|Overall Study|Equipment failure|1|||
156503141|NCT02498236|564935802|FG007|Overall Study|Equipment failure|0|||
156503142|NCT02498236|564935795|FG000|Overall Study|Withdrawal by Subject|0|||
156503143|NCT02498236|564935796|FG001|Overall Study|Withdrawal by Subject|0|||
156503144|NCT02498236|564935797|FG002|Overall Study|Withdrawal by Subject|0|||
156503145|NCT02498236|564935798|FG003|Overall Study|Withdrawal by Subject|0|||
156503146|NCT02498236|564935799|FG004|Overall Study|Withdrawal by Subject|1|||
156503147|NCT02498236|564935800|FG005|Overall Study|Withdrawal by Subject|0|||
156503148|NCT02498236|564935801|FG006|Overall Study|Withdrawal by Subject|0|||
156503149|NCT02498236|564935802|FG007|Overall Study|Withdrawal by Subject|0|||
156503150|NCT02296892|564935803|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
156503151|NCT02296892|564935804|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
156503152|NCT02296892|564935805|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
156503153|NCT02296892|564935803|FG000|Overall Study|Lost to Follow-up|5|||
156503154|NCT02296892|564935804|FG001|Overall Study|Lost to Follow-up|0|||
156503155|NCT02296892|564935805|FG002|Overall Study|Lost to Follow-up|1|||
156503156|NCT00585078|564935806|FG000|Overall Study|Withdrawal by Subject|4|||
156503157|NCT00585078|564935806|FG000|Overall Study|Poor performance status|1|||
156503158|NCT00585078|564935806|FG000|Overall Study|Disease Progression|24|||
156503159|NCT00585078|564935806|FG000|Overall Study|Adverse Event|10|||
156503160|NCT00585078|564935806|FG000|Overall Study|Death|1|||
156503161|NCT01814072|564935811|FG000|Overall Study|Lost to Follow-up|2|||
156503162|NCT01814072|564935812|FG001|Overall Study|Lost to Follow-up|2|||
156503163|NCT01814072|564935813|FG002|Overall Study|Lost to Follow-up|2|||
156503164|NCT01814072|564935814|FG003|Overall Study|Lost to Follow-up|0|||
156503165|NCT01814072|564935815|FG004|Overall Study|Lost to Follow-up|2|||
156503166|NCT01814072|564935816|FG005|Overall Study|Lost to Follow-up|3|||
156503167|NCT01814072|564935817|FG006|Overall Study|Lost to Follow-up|3|||
156503168|NCT01814072|564935818|FG007|Overall Study|Lost to Follow-up|1|||
156503169|NCT01814072|564935819|FG008|Overall Study|Lost to Follow-up|2|||
156503170|NCT01814072|564935820|FG009|Overall Study|Lost to Follow-up|3|||
156503171|NCT01814072|564935821|FG010|Overall Study|Lost to Follow-up|1|||
156503172|NCT01814072|564935822|FG011|Overall Study|Lost to Follow-up|2|||
156503173|NCT01814072|564935823|FG012|Overall Study|Lost to Follow-up|2|||
156503174|NCT01814072|564935824|FG013|Overall Study|Lost to Follow-up|1|||
156503175|NCT01814072|564935825|FG014|Overall Study|Lost to Follow-up|2|||
156503176|NCT01814072|564935826|FG015|Overall Study|Lost to Follow-up|1|||
156503177|NCT01814072|564935827|FG016|Overall Study|Lost to Follow-up|3|||
156503178|NCT01814072|564935828|FG017|Overall Study|Lost to Follow-up|1|||
156503179|NCT01814072|564935829|FG018|Overall Study|Lost to Follow-up|3|||
156503180|NCT01814072|564935830|FG019|Overall Study|Lost to Follow-up|3|||
156503181|NCT01814072|564935831|FG020|Overall Study|Lost to Follow-up|2|||
156503182|NCT01814072|564935832|FG021|Overall Study|Lost to Follow-up|1|||
156503183|NCT01814072|564935833|FG022|Overall Study|Lost to Follow-up|3|||
156503184|NCT01814072|564935834|FG023|Overall Study|Lost to Follow-up|1|||
156503185|NCT01814072|564935835|FG024|Overall Study|Lost to Follow-up|4|||
156503186|NCT01814072|564935836|FG025|Overall Study|Lost to Follow-up|1|||
156503187|NCT01814072|564935837|FG026|Overall Study|Lost to Follow-up|1|||
156503188|NCT01814072|564935838|FG027|Overall Study|Lost to Follow-up|2|||
156503189|NCT01814072|564935839|FG028|Overall Study|Lost to Follow-up|3|||
156503190|NCT01814072|564935840|FG029|Overall Study|Lost to Follow-up|3|||
156503191|NCT01814072|564935841|FG030|Overall Study|Lost to Follow-up|2|||
156503192|NCT01814072|564935842|FG031|Overall Study|Lost to Follow-up|0|||
156503193|NCT01814072|564935811|FG000|Overall Study|Withdrawal by Subject|2|||
156503194|NCT01814072|564935812|FG001|Overall Study|Withdrawal by Subject|0|||
156503195|NCT01814072|564935813|FG002|Overall Study|Withdrawal by Subject|1|||
156503196|NCT01814072|564935814|FG003|Overall Study|Withdrawal by Subject|0|||
156503197|NCT01814072|564935815|FG004|Overall Study|Withdrawal by Subject|2|||
156503198|NCT01814072|564935816|FG005|Overall Study|Withdrawal by Subject|3|||
156503199|NCT01814072|564935817|FG006|Overall Study|Withdrawal by Subject|1|||
156503200|NCT01814072|564935818|FG007|Overall Study|Withdrawal by Subject|0|||
156503201|NCT01814072|564935819|FG008|Overall Study|Withdrawal by Subject|1|||
156503202|NCT01814072|564935820|FG009|Overall Study|Withdrawal by Subject|2|||
156503203|NCT01814072|564935821|FG010|Overall Study|Withdrawal by Subject|0|||
156503204|NCT01814072|564935822|FG011|Overall Study|Withdrawal by Subject|0|||
156503205|NCT01814072|564935823|FG012|Overall Study|Withdrawal by Subject|1|||
156503206|NCT01814072|564935824|FG013|Overall Study|Withdrawal by Subject|1|||
156503207|NCT01814072|564935825|FG014|Overall Study|Withdrawal by Subject|1|||
156503208|NCT01814072|564935826|FG015|Overall Study|Withdrawal by Subject|1|||
156503209|NCT01814072|564935827|FG016|Overall Study|Withdrawal by Subject|0|||
156503210|NCT01814072|564935828|FG017|Overall Study|Withdrawal by Subject|0|||
156503211|NCT01814072|564935829|FG018|Overall Study|Withdrawal by Subject|0|||
156503212|NCT01814072|564935830|FG019|Overall Study|Withdrawal by Subject|2|||
156503213|NCT01814072|564935831|FG020|Overall Study|Withdrawal by Subject|0|||
156503214|NCT01814072|564935832|FG021|Overall Study|Withdrawal by Subject|0|||
156503215|NCT01814072|564935833|FG022|Overall Study|Withdrawal by Subject|1|||
156503216|NCT01814072|564935834|FG023|Overall Study|Withdrawal by Subject|0|||
156503217|NCT01814072|564935835|FG024|Overall Study|Withdrawal by Subject|2|||
156503218|NCT01814072|564935836|FG025|Overall Study|Withdrawal by Subject|1|||
156503219|NCT01814072|564935837|FG026|Overall Study|Withdrawal by Subject|1|||
156503220|NCT01814072|564935838|FG027|Overall Study|Withdrawal by Subject|2|||
156503221|NCT01814072|564935839|FG028|Overall Study|Withdrawal by Subject|1|||
156503222|NCT01814072|564935840|FG029|Overall Study|Withdrawal by Subject|0|||
156503223|NCT01814072|564935841|FG030|Overall Study|Withdrawal by Subject|0|||
156503224|NCT01814072|564935842|FG031|Overall Study|Withdrawal by Subject|0|||
156503225|NCT00250432|564935848|FG000|Overall Study|Adverse Event|25|||
156503226|NCT00250432|564935849|FG001|Overall Study|Adverse Event|29|||
156503227|NCT00250432|564935848|FG000|Overall Study|Lack of Efficacy|2|||
156503228|NCT00250432|564935849|FG001|Overall Study|Lack of Efficacy|1|||
156503229|NCT00250432|564935848|FG000|Overall Study|Lost to Follow-up|6|||
156503230|NCT00250432|564935849|FG001|Overall Study|Lost to Follow-up|5|||
156503231|NCT00250432|564935848|FG000|Overall Study|Patient Moved|0|||
156503232|NCT00250432|564935849|FG001|Overall Study|Patient Moved|1|||
156503233|NCT00250432|564935848|FG000|Overall Study|Protocol Violation|0|||
156503234|NCT00250432|564935849|FG001|Overall Study|Protocol Violation|3|||
156503235|NCT00250432|564935848|FG000|Overall Study|Withdrawal by Subject|6|||
156503236|NCT00250432|564935849|FG001|Overall Study|Withdrawal by Subject|2|||
156503237|NCT00250432|564935848|FG000|Overall Study|Pt died out of posttherapy report period|6|||
156503238|NCT00250432|564935849|FG001|Overall Study|Pt died out of posttherapy report period|5|||
156503239|NCT00250432|564935848|FG000|Overall Study|Pt was considered untreatable|0|||
156503240|NCT00250432|564935849|FG001|Overall Study|Pt was considered untreatable|1|||
156503241|NCT01011868|564935850|FG000|After Week 18 Follow-up|Adverse Event|8|||
156503242|NCT01011868|564935851|FG001|After Week 18 Follow-up|Adverse Event|6|||
156503243|NCT01011868|564935852|FG002|After Week 18 Follow-up|Adverse Event|13|||
156503244|NCT01011868|564935850|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
156503245|NCT01011868|564935851|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
156503246|NCT01011868|564935852|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
156503247|NCT01011868|564935850|FG000|After Week 18 Follow-up|Protocol Violation|1|||
156503248|NCT01011868|564935851|FG001|After Week 18 Follow-up|Protocol Violation|1|||
156503249|NCT01011868|564935852|FG002|After Week 18 Follow-up|Protocol Violation|1|||
156503250|NCT01011868|564935850|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
156503251|NCT01011868|564935851|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
156503252|NCT01011868|564935852|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
156503253|NCT01011868|564935850|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
156503254|NCT01011868|564935851|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
156503255|NCT01011868|564935852|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
156503256|NCT01011868|564935850|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
156503257|NCT01011868|564935851|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
156503258|NCT01011868|564935852|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
156503259|NCT01011868|564935850|FG000|After Week 78 Follow-up|Adverse Event|14|||
156503260|NCT01011868|564935851|FG001|After Week 78 Follow-up|Adverse Event|18|||
156503261|NCT01011868|564935852|FG002|After Week 78 Follow-up|Adverse Event|21|||
156503262|NCT01011868|564935850|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
156503263|NCT01011868|564935851|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
156503264|NCT01011868|564935852|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
156503265|NCT01011868|564935850|FG000|After Week 78 Follow-up|Protocol Violation|9|||
156503266|NCT01011868|564935851|FG001|After Week 78 Follow-up|Protocol Violation|1|||
156503267|NCT01011868|564935852|FG002|After Week 78 Follow-up|Protocol Violation|2|||
156503268|NCT01011868|564935850|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
156503269|NCT01011868|564935851|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
156503270|NCT01011868|564935852|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
156503271|NCT01011868|564935850|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
156503272|NCT01011868|564935851|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
156503273|NCT01011868|564935852|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
156503274|NCT01011868|564935850|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
156503275|NCT01011868|564935851|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
156503276|NCT01011868|564935852|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
156503277|NCT01255761|564935853|FG000|Overall Study|Adverse Event|29|||
156383397|NCT00288587|564496863|FG001|Overall Study|Physician Decision|2|||
156383398|NCT00288587|564496862|FG000|Overall Study|Severe Aortic Stenosis|1|||
156383399|NCT00288587|564496863|FG001|Overall Study|Severe Aortic Stenosis|0|||
156383400|NCT01764945|564496868|FG000|Overall Study|Adverse Event|0|||
156383401|NCT01764945|564496869|FG001|Overall Study|Adverse Event|1|||
156383402|NCT01764945|564496870|FG002|Overall Study|Adverse Event|0|||
156383403|NCT01764945|564496871|FG003|Overall Study|Adverse Event|0|||
156383404|NCT01764945|564496872|FG004|Overall Study|Adverse Event|0|||
156383405|NCT01764945|564496873|FG005|Overall Study|Adverse Event|0|||
156383406|NCT01764945|564496874|FG006|Overall Study|Adverse Event|1|||
156383407|NCT01764945|564496875|FG007|Overall Study|Adverse Event|0|||
156383408|NCT02911948|564496879|FG000|Overall Study|Protocol Violation|0|||
156383409|NCT02911948|564496880|FG001|Overall Study|Protocol Violation|1|||
156383410|NCT02911948|564496879|FG000|Overall Study|Withdrawal by Subject|0|||
156383411|NCT02911948|564496880|FG001|Overall Study|Withdrawal by Subject|2|||
156383412|NCT02911948|564496879|FG000|Overall Study|Lack of Efficacy|0|||
156383413|NCT02911948|564496880|FG001|Overall Study|Lack of Efficacy|1|||
156383414|NCT02911948|564496879|FG000|Overall Study|Unclassified|0|||
156383415|NCT02911948|564496880|FG001|Overall Study|Unclassified|3|||
156383416|NCT01136291|564496884|FG000|Overall Study|Lost to Follow-up|1|||
156383417|NCT01136291|564496885|FG001|Overall Study|Lost to Follow-up|1|||
156383418|NCT03864900|564496891|FG000|Overall Study|Withdrawal by Subject|1|||
156383419|NCT03864900|564496892|FG001|Overall Study|Withdrawal by Subject|1|||
156383420|NCT03864900|564496891|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
156383421|NCT03864900|564496892|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
156383422|NCT03165045|564496896|FG000|Visit 1|No registration after visit 1|9|||
156383423|NCT03165045|564496896|FG000|Visit 1|No treatment documented|10|||
156383424|NCT03165045|564496896|FG000|Visit 1|No visit 1|10|||
156383425|NCT03165045|564496896|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
156503278|NCT01255761|564935854|FG001|Overall Study|Adverse Event|43|||
156503279|NCT01255761|564935853|FG000|Overall Study|Lack of Efficacy|86|||
156383426|NCT03165045|564496896|FG000|Visit 2|No available total CCQ score at all|29|||
156383427|NCT03165045|564496896|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
156383428|NCT03238001|564496897|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
156383429|NCT03238001|564496897|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
156503280|NCT01255761|564935854|FG001|Overall Study|Lack of Efficacy|74|||
156503281|NCT01255761|564935853|FG000|Overall Study|Protocol Violation|9|||
156503282|NCT01255761|564935854|FG001|Overall Study|Protocol Violation|5|||
156503283|NCT01255761|564935853|FG000|Overall Study|Lost to Follow-up|10|||
156503284|NCT01255761|564935854|FG001|Overall Study|Lost to Follow-up|8|||
156503285|NCT01255761|564935853|FG000|Overall Study|Withdrawal by Subject|11|||
156503286|NCT01255761|564935854|FG001|Overall Study|Withdrawal by Subject|27|||
156503287|NCT01255761|564935853|FG000|Overall Study|Other Reasons|37|||
156503288|NCT01255761|564935854|FG001|Overall Study|Other Reasons|18|||
156503289|NCT04147858|564935855|FG000|Overall Study|Adverse Event|6|||
156503290|NCT04147858|564935856|FG001|Overall Study|Adverse Event|6|||
156503291|NCT04147858|564935857|FG002|Overall Study|Adverse Event|6|||
156503292|NCT04147858|564935855|FG000|Overall Study|Lack of Efficacy|3|||
156503293|NCT04147858|564935856|FG001|Overall Study|Lack of Efficacy|3|||
156503294|NCT04147858|564935857|FG002|Overall Study|Lack of Efficacy|1|||
156503295|NCT04147858|564935855|FG000|Overall Study|Lost to Follow-up|1|||
156503296|NCT04147858|564935856|FG001|Overall Study|Lost to Follow-up|6|||
156503297|NCT04147858|564935857|FG002|Overall Study|Lost to Follow-up|2|||
156503298|NCT04147858|564935855|FG000|Overall Study|Withdrawal by Subject|3|||
156503299|NCT04147858|564935856|FG001|Overall Study|Withdrawal by Subject|4|||
156503300|NCT04147858|564935857|FG002|Overall Study|Withdrawal by Subject|10|||
156503301|NCT04147858|564935855|FG000|Overall Study|Subject Noncompliance, Other|4|||
156503302|NCT04147858|564935856|FG001|Overall Study|Subject Noncompliance, Other|3|||
156503303|NCT04147858|564935857|FG002|Overall Study|Subject Noncompliance, Other|1|||
156503304|NCT02615938|564935860|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
156503305|NCT02615938|564935861|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
156503306|NCT02615938|564935862|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
156503307|NCT02615938|564935863|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
156503308|NCT02615938|564935860|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
156503309|NCT02615938|564935861|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
156383430|NCT03238001|564496897|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
156383431|NCT03238001|564496897|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
156383432|NCT03238001|564496897|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
156383433|NCT03238001|564496897|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
156383434|NCT03238001|564496897|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
156503310|NCT02615938|564935862|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
156503311|NCT02615938|564935863|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
156503312|NCT02615938|564935860|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
156503313|NCT02615938|564935861|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
156503314|NCT02615938|564935862|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
156503315|NCT02615938|564935863|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
156503316|NCT04905849|564935865|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
156503317|NCT04905849|564935866|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
156503318|NCT00838929|564935876|FG000|Overall Study|Protocol Violation|0|||
156503319|NCT00838929|564935877|FG001|Overall Study|Protocol Violation|1|||
156503320|NCT00838929|564935878|FG002|Overall Study|Protocol Violation|0|||
156503321|NCT00838929|564935876|FG000|Overall Study|Disease progression|0|||
156383435|NCT03238001|564496897|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
156383436|NCT03325712|564496898|FG000|Overall Study|Protocol Violation|0|||
156383437|NCT03325712|564496899|FG001|Overall Study|Protocol Violation|0|||
156383438|NCT03325712|564496900|FG002|Overall Study|Protocol Violation|0|||
156383439|NCT03325712|564496901|FG003|Overall Study|Protocol Violation|0|||
156383440|NCT03325712|564496902|FG004|Overall Study|Protocol Violation|1|||
156503322|NCT00838929|564935877|FG001|Overall Study|Disease progression|2|||
156503323|NCT00838929|564935878|FG002|Overall Study|Disease progression|1|||
156503324|NCT03375320|564935885|FG000|Overall Study|Adverse Event|34|||
156503325|NCT03375320|564935886|FG001|Overall Study|Adverse Event|9|||
156503326|NCT03375320|564935887|FG002|Overall Study|Adverse Event|10|||
156503327|NCT03375320|564935888|FG003|Overall Study|Adverse Event|0|||
156503328|NCT03375320|564935885|FG000|Overall Study|Death|6|||
156503329|NCT03375320|564935886|FG001|Overall Study|Death|3|||
156503330|NCT03375320|564935887|FG002|Overall Study|Death|0|||
156546944|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
156546945|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
156546946|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
156546947|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
156383441|NCT03325712|564496903|FG005|Overall Study|Protocol Violation|0|||
156383442|NCT03325712|564496904|FG006|Overall Study|Protocol Violation|0|||
156383443|NCT03325712|564496905|FG007|Overall Study|Protocol Violation|0|||
156383444|NCT03325712|564496898|FG000|Overall Study|Adverse Event|0|||
156503331|NCT03375320|564935888|FG003|Overall Study|Death|0|||
156503332|NCT03375320|564935885|FG000|Overall Study|Withdrawal by Subject|7|||
156503333|NCT03375320|564935886|FG001|Overall Study|Withdrawal by Subject|4|||
156503334|NCT03375320|564935887|FG002|Overall Study|Withdrawal by Subject|5|||
156503335|NCT03375320|564935888|FG003|Overall Study|Withdrawal by Subject|4|||
156503336|NCT03375320|564935885|FG000|Overall Study|Progressive disease|55|||
156503337|NCT03375320|564935886|FG001|Overall Study|Progressive disease|41|||
156383445|NCT03325712|564496899|FG001|Overall Study|Adverse Event|0|||
156383446|NCT03325712|564496900|FG002|Overall Study|Adverse Event|0|||
156383447|NCT03325712|564496901|FG003|Overall Study|Adverse Event|0|||
156383448|NCT03325712|564496902|FG004|Overall Study|Adverse Event|1|||
156383449|NCT03325712|564496903|FG005|Overall Study|Adverse Event|0|||
156383450|NCT03325712|564496904|FG006|Overall Study|Adverse Event|0|||
156383451|NCT03325712|564496905|FG007|Overall Study|Adverse Event|0|||
156383452|NCT02265237|564496907|FG000|As Treated (Overall Study)|Adverse Event|1|||
156383453|NCT02265237|564496908|FG001|As Treated (Overall Study)|Adverse Event|1|||
156383454|NCT02265237|564496909|FG002|As Treated (Overall Study)|Adverse Event|0|||
156383455|NCT02265237|564496910|FG003|As Treated (Overall Study)|Adverse Event|0|||
156383456|NCT02265237|564496907|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
156383457|NCT02265237|564496908|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
156383458|NCT02265237|564496909|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
156383459|NCT02265237|564496910|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
156383460|NCT02265237|564496907|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
156383461|NCT02265237|564496908|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
156383462|NCT02265237|564496909|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
156383463|NCT02265237|564496910|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
156383464|NCT02265237|564496907|FG000|As Treated (Overall Study)|Other|2|||
156383465|NCT02265237|564496908|FG001|As Treated (Overall Study)|Other|0|||
156383466|NCT02265237|564496909|FG002|As Treated (Overall Study)|Other|3|||
156383467|NCT02265237|564496910|FG003|As Treated (Overall Study)|Other|1|||
156383468|NCT01178853|564496912|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
156383469|NCT01178853|564496913|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
156383470|NCT01178853|564496912|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
156383471|NCT01178853|564496913|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
156383472|NCT01178853|564496912|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
156383473|NCT01178853|564496913|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
156383474|NCT01178853|564496912|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
156383475|NCT01178853|564496913|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
156383476|NCT01178853|564496912|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
156383477|NCT01178853|564496913|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
156383478|NCT03550313|564496914|FG000|Overall Study|Adverse Event|0|||
156383479|NCT03550313|564496915|FG001|Overall Study|Adverse Event|1|||
156383480|NCT03550313|564496916|FG002|Overall Study|Adverse Event|0|||
156383481|NCT03550313|564496914|FG000|Overall Study|Lost to Follow-up|5|||
156383482|NCT03550313|564496915|FG001|Overall Study|Lost to Follow-up|7|||
156383483|NCT03550313|564496916|FG002|Overall Study|Lost to Follow-up|12|||
156383484|NCT03550313|564496914|FG000|Overall Study|Study terminated by sponsor|44|||
156383485|NCT03550313|564496915|FG001|Overall Study|Study terminated by sponsor|37|||
156383486|NCT03550313|564496916|FG002|Overall Study|Study terminated by sponsor|48|||
156383487|NCT03550313|564496914|FG000|Overall Study|No longer met eligibility criteria|3|||
156383488|NCT03550313|564496915|FG001|Overall Study|No longer met eligibility criteria|5|||
156383489|NCT03550313|564496916|FG002|Overall Study|No longer met eligibility criteria|6|||
156383490|NCT03550313|564496914|FG000|Overall Study|Withdrawal by parent/guardian|20|||
156383491|NCT03550313|564496915|FG001|Overall Study|Withdrawal by parent/guardian|18|||
156383492|NCT03550313|564496916|FG002|Overall Study|Withdrawal by parent/guardian|26|||
156383493|NCT03550313|564496914|FG000|Overall Study|Other|4|||
156383494|NCT03550313|564496915|FG001|Overall Study|Other|2|||
156383495|NCT03550313|564496916|FG002|Overall Study|Other|2|||
156383496|NCT03550313|564496914|FG000|Overall Study|Randomized but not vaccinated|3|||
156383497|NCT03550313|564496915|FG001|Overall Study|Randomized but not vaccinated|23|||
156383498|NCT03550313|564496916|FG002|Overall Study|Randomized but not vaccinated|2|||
156383499|NCT03550313|564496914|FG000|Overall Study|Sites terminated due to quality issues|18|||
156383500|NCT03550313|564496915|FG001|Overall Study|Sites terminated due to quality issues|17|||
156383501|NCT03550313|564496916|FG002|Overall Study|Sites terminated due to quality issues|18|||
156383502|NCT00839072|564496917|FG000|First Intervention Period|Withdrawal by Subject|1|||
156383503|NCT00839072|564496918|FG001|First Intervention Period|Withdrawal by Subject|0|||
156383504|NCT00839072|564496917|FG000|First Intervention Period|Adverse Event|1|||
156383505|NCT00839072|564496918|FG001|First Intervention Period|Adverse Event|1|||
156383506|NCT00839072|564496917|FG000|Second Intervention Period|Withdrawal by Subject|1|||
156383507|NCT00839072|564496918|FG001|Second Intervention Period|Withdrawal by Subject|0|||
156383508|NCT00380068|564496919|FG000|Overall Study|Adverse Event|40|||
156383509|NCT00380068|564496919|FG000|Overall Study|Withdrawal by Subject|10|||
156383510|NCT00380068|564496919|FG000|Overall Study|Not compliant|6|||
156383511|NCT00380068|564496919|FG000|Overall Study|Lost to Follow-up|1|||
156383512|NCT00380068|564496919|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
156383513|NCT00380068|564496919|FG000|Overall Study|Lung transplant|3|||
156383514|NCT00380068|564496919|FG000|Overall Study|Physician Decision|2|||
156383515|NCT00380068|564496919|FG000|Overall Study|Partipant moved away|1|||
156383516|NCT00380068|564496919|FG000|Overall Study|Lack of Efficacy|5|||
156383517|NCT01297062|564496920|FG000|Overall Study|Adverse Event|2|||
156383518|NCT01297062|564496921|FG001|Overall Study|Adverse Event|0|||
156503338|NCT03375320|564935887|FG002|Overall Study|Progressive disease|29|||
156503339|NCT03375320|564935888|FG003|Overall Study|Progressive disease|24|||
156503340|NCT03375320|564935885|FG000|Overall Study|Alternative treatment|6|||
156503341|NCT03375320|564935886|FG001|Overall Study|Alternative treatment|1|||
156503342|NCT03375320|564935887|FG002|Overall Study|Alternative treatment|1|||
156503343|NCT03375320|564935888|FG003|Overall Study|Alternative treatment|0|||
156503344|NCT03375320|564935885|FG000|Overall Study|Other disease|1|||
156503345|NCT03375320|564935886|FG001|Overall Study|Other disease|1|||
156383519|NCT01297062|564496922|FG002|Overall Study|Adverse Event|1|||
156503346|NCT03375320|564935887|FG002|Overall Study|Other disease|3|||
156503347|NCT03375320|564935888|FG003|Overall Study|Other disease|0|||
156503348|NCT03375320|564935885|FG000|Overall Study|Withdrawal prior to initiation|2|||
156503349|NCT03375320|564935886|FG001|Overall Study|Withdrawal prior to initiation|2|||
156503350|NCT03375320|564935887|FG002|Overall Study|Withdrawal prior to initiation|1|||
156503351|NCT03375320|564935888|FG003|Overall Study|Withdrawal prior to initiation|0|||
156503352|NCT03375320|564935885|FG000|Overall Study|Physician Decision|1|||
156503353|NCT03375320|564935886|FG001|Overall Study|Physician Decision|1|||
156503354|NCT03375320|564935887|FG002|Overall Study|Physician Decision|1|||
156503355|NCT03375320|564935888|FG003|Overall Study|Physician Decision|1|||
156503356|NCT03375320|564935885|FG000|Overall Study|Non-compliance|1|||
156503357|NCT03375320|564935886|FG001|Overall Study|Non-compliance|0|||
156503358|NCT03375320|564935887|FG002|Overall Study|Non-compliance|0|||
156503359|NCT03375320|564935888|FG003|Overall Study|Non-compliance|0|||
156503360|NCT04199052|564935891|FG000|Overall Study|Lost to Follow-up|11|||
156503361|NCT04199052|564935892|FG001|Overall Study|Lost to Follow-up|18|||
156503362|NCT00699842|564935893|FG000|Overall Study|Death|0|||
156503363|NCT00699842|564935894|FG001|Overall Study|Death|1|||
156503364|NCT00699842|564935895|FG002|Overall Study|Death|0|||
156503365|NCT04907357|564935896|FG000|Overall Study|Death|0|||
156503366|NCT04907357|564935897|FG001|Overall Study|Death|1|||
156503367|NCT04907357|564935896|FG000|Overall Study|Lost to Follow-up|9|||
156503368|NCT04907357|564935897|FG001|Overall Study|Lost to Follow-up|18|||
156503369|NCT04907357|564935896|FG000|Overall Study|Physician Decision|1|||
156503370|NCT04907357|564935897|FG001|Overall Study|Physician Decision|0|||
156503371|NCT04907357|564935896|FG000|Overall Study|Withdrawal by Subject|0|||
156503372|NCT04907357|564935897|FG001|Overall Study|Withdrawal by Subject|1|||
156503373|NCT04907357|564935896|FG000|Overall Study|Unable to attend visits|1|||
156503374|NCT04907357|564935897|FG001|Overall Study|Unable to attend visits|0|||
156503375|NCT04907357|564935896|FG000|Overall Study|Incarcerated|1|||
156503376|NCT04907357|564935897|FG001|Overall Study|Incarcerated|1|||
156503377|NCT03342196|564935898|FG000|Overall Study|Physician Decision|1|||
156503378|NCT03512197|564935901|FG000|Overall Study|Guardian decision|1|||
156503379|NCT03512197|564935902|FG001|Overall Study|Guardian decision|1|||
156503380|NCT03512197|564935901|FG000|Overall Study|Lack of Efficacy|19|||
156503381|NCT03512197|564935902|FG001|Overall Study|Lack of Efficacy|11|||
156503382|NCT03512197|564935901|FG000|Overall Study|New Therapy for Study Indication|16|||
156503383|NCT03512197|564935902|FG001|Overall Study|New Therapy for Study Indication|16|||
156503384|NCT03512197|564935901|FG000|Overall Study|Physician Decision|60|||
156503385|NCT03512197|564935902|FG001|Overall Study|Physician Decision|60|||
156503386|NCT03512197|564935901|FG000|Overall Study|Protocol Violation|0|||
156503387|NCT03512197|564935902|FG001|Overall Study|Protocol Violation|2|||
156503388|NCT03512197|564935901|FG000|Overall Study|Terminated by Sponsored|46|||
156503389|NCT03512197|564935902|FG001|Overall Study|Terminated by Sponsored|50|||
156383520|NCT01297062|564496923|FG003|Overall Study|Adverse Event|0|||
156503390|NCT03512197|564935901|FG000|Overall Study|Subject Decision|15|||
156503391|NCT03512197|564935902|FG001|Overall Study|Subject Decision|12|||
156503392|NCT03512197|564935901|FG000|Overall Study|Withdrawal of informed consent|20|||
156503393|NCT03512197|564935902|FG001|Overall Study|Withdrawal of informed consent|14|||
156503394|NCT03512197|564935901|FG000|Overall Study|Adverse Event|30|||
156503395|NCT03512197|564935902|FG001|Overall Study|Adverse Event|34|||
156503396|NCT03512197|564935901|FG000|Overall Study|Death|14|||
156503397|NCT03512197|564935902|FG001|Overall Study|Death|9|||
156503398|NCT03512197|564935901|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
156546948|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
156383521|NCT01297062|564496924|FG004|Overall Study|Adverse Event|0|||
156503399|NCT03512197|564935902|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
156503400|NCT03512197|564935901|FG000|Overall Study|Missing|3|||
156503401|NCT03512197|564935902|FG001|Overall Study|Missing|13|||
156503402|NCT01806389|564935903|FG000|Overall Study|Withdrawal by Subject|4|||
156503403|NCT03842436|564935904|FG000|Overall Study|Lost to Follow-up|1|||
156503404|NCT01948076|564935905|FG000|Overall Study|Withdrawal by Subject|0|||
156503405|NCT01948076|564935906|FG001|Overall Study|Withdrawal by Subject|1|||
156503406|NCT01151423|564935909|FG000|Overall Study|Study terminated by Sponsor|9|||
156503407|NCT01151423|564935910|FG001|Overall Study|Study terminated by Sponsor|10|||
156503408|NCT01151423|564935909|FG000|Overall Study|Protocol Violation|0|||
156503409|NCT01151423|564935910|FG001|Overall Study|Protocol Violation|1|||
156503410|NCT01151423|564935909|FG000|Overall Study|Physician Decision|1|||
156503411|NCT01151423|564935910|FG001|Overall Study|Physician Decision|1|||
156503412|NCT01151423|564935909|FG000|Overall Study|Pregnancy|0|||
156383522|NCT01297062|564496925|FG005|Overall Study|Adverse Event|0|||
156383523|NCT01297062|564496926|FG006|Overall Study|Adverse Event|0|||
156383524|NCT01297062|564496920|FG000|Overall Study|Physician Decision|1|||
156383525|NCT01297062|564496921|FG001|Overall Study|Physician Decision|0|||
156383526|NCT01297062|564496922|FG002|Overall Study|Physician Decision|1|||
156383527|NCT01297062|564496923|FG003|Overall Study|Physician Decision|0|||
156383528|NCT01297062|564496924|FG004|Overall Study|Physician Decision|0|||
156383529|NCT01297062|564496925|FG005|Overall Study|Physician Decision|0|||
156383530|NCT01297062|564496926|FG006|Overall Study|Physician Decision|6|||
156383531|NCT01297062|564496920|FG000|Overall Study|Protocol Violation|0|||
156383532|NCT01297062|564496921|FG001|Overall Study|Protocol Violation|0|||
156383533|NCT01297062|564496922|FG002|Overall Study|Protocol Violation|0|||
156383534|NCT01297062|564496923|FG003|Overall Study|Protocol Violation|0|||
156383535|NCT01297062|564496924|FG004|Overall Study|Protocol Violation|1|||
156383536|NCT01297062|564496925|FG005|Overall Study|Protocol Violation|0|||
156383537|NCT01297062|564496926|FG006|Overall Study|Protocol Violation|0|||
156383538|NCT01297062|564496920|FG000|Overall Study|Subject Decision|1|||
156383539|NCT01297062|564496921|FG001|Overall Study|Subject Decision|1|||
156383540|NCT01297062|564496922|FG002|Overall Study|Subject Decision|0|||
156383541|NCT01297062|564496923|FG003|Overall Study|Subject Decision|1|||
156383542|NCT01297062|564496924|FG004|Overall Study|Subject Decision|1|||
156383543|NCT01297062|564496925|FG005|Overall Study|Subject Decision|1|||
156383544|NCT01297062|564496926|FG006|Overall Study|Subject Decision|2|||
156383545|NCT04964089|564496929|FG000|Overall Study|Adverse Event|8|||
156383546|NCT04964089|564496930|FG001|Overall Study|Adverse Event|6|||
156383547|NCT04964089|564496929|FG000|Overall Study|Non-compliance with study schedule|1|||
156383548|NCT04964089|564496930|FG001|Overall Study|Non-compliance with study schedule|0|||
156383549|NCT04964089|564496929|FG000|Overall Study|Withdrawal by Subject|6|||
156383550|NCT04964089|564496930|FG001|Overall Study|Withdrawal by Subject|5|||
156383551|NCT04964089|564496929|FG000|Overall Study|Lost to Follow-up|1|||
156383552|NCT04964089|564496930|FG001|Overall Study|Lost to Follow-up|1|||
156383553|NCT04964089|564496929|FG000|Overall Study|Progressive disease|4|||
156383554|NCT04964089|564496930|FG001|Overall Study|Progressive disease|0|||
156383555|NCT04964089|564496929|FG000|Overall Study|Physician Decision|1|||
156383556|NCT04964089|564496930|FG001|Overall Study|Physician Decision|0|||
156383557|NCT04964089|564496929|FG000|Overall Study|Participant did not want to continue study treatment|1|||
156383558|NCT04964089|564496930|FG001|Overall Study|Participant did not want to continue study treatment|0|||
156383559|NCT04964089|564496929|FG000|Overall Study|Participant moved to different state|1|||
156383560|NCT04964089|564496930|FG001|Overall Study|Participant moved to different state|0|||
156383561|NCT04964089|564496929|FG000|Overall Study|Participant decided to discontinue|0|||
156383562|NCT04964089|564496930|FG001|Overall Study|Participant decided to discontinue|1|||
156383563|NCT01682837|564496931|FG000|Baseline|Withdrawal by Subject|5|||
156383564|NCT03021187|564496934|FG000|Overall Study|Death|0|||
156383565|NCT03021187|564496935|FG001|Overall Study|Death|0|||
156383566|NCT03021187|564496936|FG002|Overall Study|Death|3|||
156383567|NCT03021187|564496937|FG003|Overall Study|Death|0|||
156383568|NCT03021187|564496934|FG000|Overall Study|Withdrawal by Subject|0|||
156383569|NCT03021187|564496935|FG001|Overall Study|Withdrawal by Subject|6|||
156383570|NCT03021187|564496936|FG002|Overall Study|Withdrawal by Subject|2|||
156383571|NCT03021187|564496937|FG003|Overall Study|Withdrawal by Subject|5|||
156383572|NCT03021187|564496934|FG000|Overall Study|Lost to Follow-up|10|||
156383573|NCT03021187|564496935|FG001|Overall Study|Lost to Follow-up|3|||
156383574|NCT03021187|564496936|FG002|Overall Study|Lost to Follow-up|1|||
156383575|NCT03021187|564496937|FG003|Overall Study|Lost to Follow-up|4|||
156383576|NCT01664078|564496938|FG000|Overall Study|Death|9|||
156546949|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
156546950|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
156383577|NCT01664078|564496938|FG000|Overall Study|Withdrawal by Subject|4|||
156383578|NCT01664078|564496938|FG000|Overall Study|Lost to Follow-up|2|||
156383579|NCT01664078|564496938|FG000|Overall Study|missed 5 year visit|1|||
156383580|NCT01664078|564496938|FG000|Overall Study|Other|53|||
156383581|NCT04782323|564496939|FG000|Overall Study|Death|1|||
156383582|NCT04782323|564496940|FG001|Overall Study|Death|0|||
156383583|NCT04782323|564496941|FG002|Overall Study|Death|0|||
156383584|NCT04782323|564496942|FG003|Overall Study|Death|0|||
156383585|NCT04782323|564496943|FG004|Overall Study|Death|1|||
156383586|NCT04782323|564496944|FG005|Overall Study|Death|1|||
156383587|NCT04782323|564496945|FG006|Overall Study|Death|1|||
156383588|NCT04782323|564496946|FG007|Overall Study|Death|0|||
156383589|NCT04782323|564496939|FG000|Overall Study|Withdrawal by Subject|0|||
156383590|NCT04782323|564496940|FG001|Overall Study|Withdrawal by Subject|0|||
156383591|NCT04782323|564496941|FG002|Overall Study|Withdrawal by Subject|1|||
156383592|NCT04782323|564496942|FG003|Overall Study|Withdrawal by Subject|0|||
156383593|NCT04782323|564496943|FG004|Overall Study|Withdrawal by Subject|0|||
156383594|NCT04782323|564496944|FG005|Overall Study|Withdrawal by Subject|1|||
156383595|NCT04782323|564496945|FG006|Overall Study|Withdrawal by Subject|0|||
156383596|NCT04782323|564496946|FG007|Overall Study|Withdrawal by Subject|1|||
156383597|NCT04782323|564496939|FG000|Overall Study|Lost to Follow-up|0|||
156383598|NCT04782323|564496940|FG001|Overall Study|Lost to Follow-up|1|||
156383599|NCT04782323|564496941|FG002|Overall Study|Lost to Follow-up|1|||
156383600|NCT04782323|564496942|FG003|Overall Study|Lost to Follow-up|0|||
156383601|NCT04782323|564496943|FG004|Overall Study|Lost to Follow-up|0|||
156383602|NCT04782323|564496944|FG005|Overall Study|Lost to Follow-up|1|||
156383603|NCT04782323|564496945|FG006|Overall Study|Lost to Follow-up|1|||
156383604|NCT04782323|564496946|FG007|Overall Study|Lost to Follow-up|2|||
156383605|NCT04782323|564496939|FG000|Overall Study|randomization in error|1|||
156383606|NCT04782323|564496940|FG001|Overall Study|randomization in error|0|||
156383607|NCT04782323|564496941|FG002|Overall Study|randomization in error|0|||
156383608|NCT04782323|564496942|FG003|Overall Study|randomization in error|0|||
156383609|NCT04782323|564496943|FG004|Overall Study|randomization in error|0|||
156383610|NCT04782323|564496944|FG005|Overall Study|randomization in error|0|||
156383611|NCT04782323|564496945|FG006|Overall Study|randomization in error|0|||
156383612|NCT04782323|564496946|FG007|Overall Study|randomization in error|0|||
156383613|NCT03351049|564496947|FG000|Overall Study|Withdrawal|26|||
156383614|NCT03351049|564496948|FG001|Overall Study|Withdrawal|22|||
156383615|NCT04369469|564496951|FG000|Overall Study|Lost to Follow-up|2|||
156383616|NCT04369469|564496952|FG001|Overall Study|Lost to Follow-up|4|||
156383617|NCT04369469|564496951|FG000|Overall Study|Physician Decision|2|||
156383618|NCT04369469|564496952|FG001|Overall Study|Physician Decision|1|||
156383619|NCT04369469|564496951|FG000|Overall Study|Withdrawal by Subject|2|||
156383620|NCT04369469|564496952|FG001|Overall Study|Withdrawal by Subject|3|||
156383621|NCT04369469|564496951|FG000|Overall Study|Adverse Event|1|||
156383622|NCT04369469|564496952|FG001|Overall Study|Adverse Event|0|||
156383623|NCT04369469|564496951|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
156383624|NCT04369469|564496952|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
156383625|NCT04369469|564496951|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
156383626|NCT04369469|564496952|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
156383627|NCT04369469|564496951|FG000|Overall Study|Unable to Provide Consent|0|||
156383628|NCT04369469|564496952|FG001|Overall Study|Unable to Provide Consent|1|||
156383629|NCT03135522|564496953|FG000|Overall Study|Adverse Event|1|||
156383630|NCT03135522|564496954|FG001|Overall Study|Adverse Event|0|||
156383631|NCT03832192|564496957|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
156383632|NCT03832192|564496958|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
156383633|NCT03483623|564496962|FG000|Overall Study|43 complete sets achieved|1|||
156383634|NCT01165281|564496963|FG000|Overall Study|Adverse Event|12|||
156383635|NCT01165281|564496964|FG001|Overall Study|Adverse Event|14|||
156383636|NCT01165281|564496963|FG000|Overall Study|Death|3|||
156383637|NCT01165281|564496964|FG001|Overall Study|Death|4|||
156383638|NCT01165281|564496963|FG000|Overall Study|Lack of Efficacy|4|||
156383639|NCT01165281|564496964|FG001|Overall Study|Lack of Efficacy|1|||
156383640|NCT01165281|564496963|FG000|Overall Study|Lost to Follow-up|0|||
156383641|NCT01165281|564496964|FG001|Overall Study|Lost to Follow-up|1|||
156383642|NCT01165281|564496963|FG000|Overall Study|Physician Decision|8|||
156383643|NCT01165281|564496964|FG001|Overall Study|Physician Decision|1|||
156383644|NCT01165281|564496963|FG000|Overall Study|Protocol Violation|6|||
156383645|NCT01165281|564496964|FG001|Overall Study|Protocol Violation|5|||
156383646|NCT01165281|564496963|FG000|Overall Study|Withdrawal by Subject|8|||
156383647|NCT01165281|564496964|FG001|Overall Study|Withdrawal by Subject|7|||
156383648|NCT01165281|564496963|FG000|Overall Study|Noncompliance with Study Drug|1|||
156383649|NCT01165281|564496964|FG001|Overall Study|Noncompliance with Study Drug|4|||
156383650|NCT01165281|564496963|FG000|Overall Study|Progressive Disease|10|||
156383651|NCT01165281|564496964|FG001|Overall Study|Progressive Disease|14|||
156383652|NCT01165281|564496963|FG000|Overall Study|Other|6|||
156546951|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
156546952|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
156383653|NCT01165281|564496964|FG001|Overall Study|Other|0|||
156383654|NCT02863991|564496965|FG000|Overall Study|Death|0|||
156383655|NCT02863991|564496966|FG001|Overall Study|Death|3|||
156383656|NCT02863991|564496965|FG000|Overall Study|Lack of Efficacy|0|||
156383657|NCT02863991|564496966|FG001|Overall Study|Lack of Efficacy|1|||
156383658|NCT02863991|564496965|FG000|Overall Study|Study Terminated|2|||
156383659|NCT02863991|564496966|FG001|Overall Study|Study Terminated|8|||
156383660|NCT01261611|564498892|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
156383661|NCT01261611|564498893|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
156383662|NCT01261611|564498894|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
156383663|NCT01261611|564498892|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
156383664|NCT01261611|564498893|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
156383665|NCT01261611|564498894|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
156383666|NCT01261611|564498892|FG000|Treatment Cycle 1|Adverse Event|0|||
156383667|NCT01261611|564498893|FG001|Treatment Cycle 1|Adverse Event|1|||
156383668|NCT01261611|564498894|FG002|Treatment Cycle 1|Adverse Event|0|||
156383669|NCT01261611|564498892|FG000|Treatment Cycle 1|Protocol Violation|0|||
156383670|NCT01261611|564498893|FG001|Treatment Cycle 1|Protocol Violation|0|||
156383671|NCT01261611|564498894|FG002|Treatment Cycle 1|Protocol Violation|2|||
156383672|NCT01261611|564498892|FG000|Treatment Cycle 2|Completed study|4|||
156503413|NCT01151423|564935910|FG001|Overall Study|Pregnancy|1|||
156503414|NCT01151423|564935909|FG000|Overall Study|Death|0|||
156503415|NCT01151423|564935910|FG001|Overall Study|Death|1|||
156503416|NCT01151423|564935909|FG000|Overall Study|Adverse Event|3|||
156503417|NCT01151423|564935910|FG001|Overall Study|Adverse Event|0|||
156503418|NCT01151423|564935909|FG000|Overall Study|Withdrawal by Subject|1|||
156503419|NCT01151423|564935910|FG001|Overall Study|Withdrawal by Subject|3|||
156503420|NCT01151423|564935909|FG000|Overall Study|Lost to Follow-up|1|||
156503421|NCT01151423|564935910|FG001|Overall Study|Lost to Follow-up|0|||
156503422|NCT01151423|564935909|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
156503423|NCT01151423|564935910|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
156503424|NCT01151423|564935909|FG000|Overall Study|Participated in other clinical trial|1|||
156503425|NCT01151423|564935910|FG001|Overall Study|Participated in other clinical trial|0|||
156503426|NCT01263054|564935912|FG000|Overall Study|Death|1|||
156503427|NCT01263054|564935913|FG001|Overall Study|Death|0|||
156503428|NCT01263054|564935912|FG000|Overall Study|Lost to Follow-up|2|||
156503429|NCT01263054|564935913|FG001|Overall Study|Lost to Follow-up|2|||
156503430|NCT01263054|564935912|FG000|Overall Study|Withdrawal by Subject|1|||
156503431|NCT01263054|564935913|FG001|Overall Study|Withdrawal by Subject|3|||
156503432|NCT01263054|564935912|FG000|Overall Study|Qualification Violation|1|||
156503433|NCT01263054|564935913|FG001|Overall Study|Qualification Violation|0|||
156503434|NCT01263054|564935912|FG000|Overall Study|Other|0|||
156503435|NCT01263054|564935913|FG001|Overall Study|Other|1|||
156503436|NCT03358238|564935914|FG000|Overall Study|Withdrawal by Subject|0|||
156503437|NCT03358238|564935915|FG001|Overall Study|Withdrawal by Subject|1|||
156503438|NCT00486252|564935921|FG000|Overall Study|Adverse Event|7|||
156503439|NCT00486252|564935921|FG000|Overall Study|Lack of Efficacy|9|||
156503440|NCT00486252|564935921|FG000|Overall Study|Lost to Follow-up|24|||
156503441|NCT00486252|564935921|FG000|Overall Study|Other|18|||
156503442|NCT01261247|564935922|FG000|Overall Study|Ineligible|2|||
156503443|NCT04596540|564935923|FG000|Overall Study|Withdrawal by Subject|9|||
156503444|NCT04596540|564935924|FG001|Overall Study|Withdrawal by Subject|8|||
156503445|NCT04596540|564935925|FG002|Overall Study|Withdrawal by Subject|5|||
156503446|NCT04596540|564935923|FG000|Overall Study|Lost to Follow-up|1|||
156503447|NCT04596540|564935924|FG001|Overall Study|Lost to Follow-up|2|||
156503448|NCT04596540|564935925|FG002|Overall Study|Lost to Follow-up|1|||
156503449|NCT04596540|564935923|FG000|Overall Study|Sponsor Decision|2|||
156503450|NCT04596540|564935924|FG001|Overall Study|Sponsor Decision|0|||
156503451|NCT04596540|564935925|FG002|Overall Study|Sponsor Decision|0|||
156503452|NCT04596540|564935923|FG000|Overall Study|Physician Decision|0|||
156503453|NCT04596540|564935924|FG001|Overall Study|Physician Decision|1|||
156503454|NCT04596540|564935925|FG002|Overall Study|Physician Decision|1|||
156503455|NCT04596540|564935923|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
156503456|NCT04596540|564935924|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
156503457|NCT04596540|564935925|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
156503458|NCT04596540|564935923|FG000|Overall Study|Other Than Specified|5|||
156503459|NCT04596540|564935924|FG001|Overall Study|Other Than Specified|5|||
156503460|NCT04596540|564935925|FG002|Overall Study|Other Than Specified|2|||
156503461|NCT02633397|564935926|FG000|Overall Study|Adverse Event|8|||
156503462|NCT02633397|564935927|FG001|Overall Study|Adverse Event|8|||
156503463|NCT02633397|564935926|FG000|Overall Study|Study Burden|4|||
156503464|NCT02633397|564935927|FG001|Overall Study|Study Burden|1|||
156503465|NCT02633397|564935926|FG000|Overall Study|Treatment interruption|2|||
156503466|NCT02633397|564935927|FG001|Overall Study|Treatment interruption|5|||
156503467|NCT02633397|564935926|FG000|Overall Study|Death|2|||
156503468|NCT02633397|564935927|FG001|Overall Study|Death|2|||
156503469|NCT02633397|564935926|FG000|Overall Study|Physician Decision|0|||
156503470|NCT02633397|564935927|FG001|Overall Study|Physician Decision|1|||
156503471|NCT02520310|564935930|FG000|At 6 Months Clinical Follow-up|Death|1|||
156503472|NCT02520310|564935930|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
156503473|NCT02520310|564935930|FG000|AT 3 Year Clinical Follow-up|Death|2|||
156503474|NCT02520310|564935930|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
156503475|NCT02520310|564935930|FG000|AT 4 Year Clinical Follow-up|Death|1|||
156503476|NCT02520310|564935930|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
156503477|NCT05101993|564935933|FG000|Overall Study|Withdrawal by Subject|1|||
156503478|NCT04577573|564935934|FG000|Overall Study|Technical - invalid protocol|0|||
156503479|NCT04577573|564935935|FG001|Overall Study|Technical - invalid protocol|2|||
156503480|NCT04577573|564935936|FG002|Overall Study|Technical - invalid protocol|0|||
156503481|NCT01124838|564935937|FG000|Overall Study|Miscellaneous|4|||
156503482|NCT01124838|564935938|FG001|Overall Study|Miscellaneous|2|||
156503483|NCT01124838|564935937|FG000|Overall Study|Adverse Event|7|||
156546953|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
156546954|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
156503484|NCT01124838|564935938|FG001|Overall Study|Adverse Event|11|||
156503485|NCT01124838|564935937|FG000|Overall Study|Lack of Efficacy|2|||
156503486|NCT01124838|564935938|FG001|Overall Study|Lack of Efficacy|0|||
156503487|NCT01124838|564935937|FG000|Overall Study|Withdrawal by Subject|3|||
156503488|NCT01124838|564935938|FG001|Overall Study|Withdrawal by Subject|2|||
156503489|NCT01124838|564935937|FG000|Overall Study|Lost to Follow-up|2|||
156503490|NCT01124838|564935938|FG001|Overall Study|Lost to Follow-up|0|||
156503491|NCT04949802|564937383|FG000|Overall Study|Lost to Follow-up|3|||
156503492|NCT01020877|564937386|FG000|Second Intervention|Withdrawal by Subject|1|||
156503493|NCT01020877|564937387|FG001|Second Intervention|Withdrawal by Subject|0|||
156503494|NCT01784523|564937388|FG000|Overall Study|Study closed early|7|||
156503495|NCT01784523|564937389|FG001|Overall Study|Study closed early|4|||
156503496|NCT00709228|564937390|FG000|Overall Study|Not treated|14|||
156503497|NCT00709228|564937390|FG000|Overall Study|Eligibility criteria not met|281|||
156503498|NCT00709228|564937390|FG000|Overall Study|Adverse events|2|||
156503499|NCT00709228|564937390|FG000|Overall Study|Discontinued treatment|14|||
156503500|NCT00709228|564937390|FG000|Overall Study|Did not enter follow-up|4|||
156503501|NCT00709228|564937390|FG000|Overall Study|Discontinued follow-up|5|||
156503502|NCT00709228|564937390|FG000|Overall Study|Disease progression|1|||
156503503|NCT00709228|564937390|FG000|Overall Study|Lost to Follow-up|6|||
156503504|NCT00709228|564937390|FG000|Overall Study|Non-compliance|5|||
156503505|NCT02179177|564937393|FG000|Overall Study|Lost to Follow-up|1|||
156503506|NCT02179177|564937394|FG001|Overall Study|Lost to Follow-up|1|||
156503507|NCT02179177|564937393|FG000|Overall Study|Withdrawal by Subject|1|||
156503508|NCT02179177|564937394|FG001|Overall Study|Withdrawal by Subject|1|||
156503509|NCT00022659|564937395|FG000|Overall Study|Ineligible: wrong primary|1|||
156503510|NCT00022659|564937395|FG000|Overall Study|Never treated|1|||
156503511|NCT00884650|564937398|FG000|Overall Study|Did not return complete pain diaries|7|||
156503512|NCT00884650|564937399|FG001|Overall Study|Did not return complete pain diaries|7|||
156503513|NCT00884650|564937398|FG000|Overall Study|Admitted Post-Op|1|||
156503514|NCT00884650|564937399|FG001|Overall Study|Admitted Post-Op|0|||
156503515|NCT00884650|564937398|FG000|Overall Study|Femoral Stress Fracture|1|||
156503516|NCT00884650|564937399|FG001|Overall Study|Femoral Stress Fracture|0|||
156503517|NCT00884650|564937398|FG000|Overall Study|Pain Pump Complication|0|||
156503518|NCT00884650|564937399|FG001|Overall Study|Pain Pump Complication|1|||
156503519|NCT04052425|564937400|FG000|24-Week Double-blind Period|Adverse Event|0|||
156503520|NCT04052425|564937401|FG001|24-Week Double-blind Period|Adverse Event|1|||
156503521|NCT04052425|564937402|FG002|24-Week Double-blind Period|Adverse Event|0|||
156503522|NCT04052425|564937403|FG003|24-Week Double-blind Period|Adverse Event|0|||
156503523|NCT04052425|564937400|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
156503524|NCT04052425|564937401|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
156503525|NCT04052425|564937402|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
156503526|NCT04052425|564937403|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
156503527|NCT04052425|564937400|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
156503528|NCT04052425|564937401|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
156503529|NCT04052425|564937402|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
156503530|NCT04052425|564937403|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
156503531|NCT04052425|564937400|FG000|24-Week Double-blind Period|Physician Decision|1|||
156503532|NCT04052425|564937401|FG001|24-Week Double-blind Period|Physician Decision|0|||
156503533|NCT04052425|564937402|FG002|24-Week Double-blind Period|Physician Decision|0|||
156503534|NCT04052425|564937403|FG003|24-Week Double-blind Period|Physician Decision|0|||
156503535|NCT04052425|564937400|FG000|24-Week Double-blind Period|Protocol Violation|1|||
156503536|NCT04052425|564937401|FG001|24-Week Double-blind Period|Protocol Violation|0|||
156503537|NCT04052425|564937402|FG002|24-Week Double-blind Period|Protocol Violation|0|||
156503538|NCT04052425|564937403|FG003|24-Week Double-blind Period|Protocol Violation|0|||
156503539|NCT04052425|564937400|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
156503540|NCT04052425|564937401|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
156503541|NCT04052425|564937402|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
156503542|NCT04052425|564937403|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
156503543|NCT04052425|564937400|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
156503544|NCT04052425|564937401|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
156503545|NCT04052425|564937402|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
156546955|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
156546956|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
156546957|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
156546958|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
156546959|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
156546960|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
156503546|NCT04052425|564937403|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
156503547|NCT04052425|564937400|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
156503548|NCT04052425|564937401|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
156503549|NCT04052425|564937402|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
156546961|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
156546962|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
156503550|NCT04052425|564937403|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
156503551|NCT04052425|564937400|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
156503552|NCT04052425|564937401|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
156503553|NCT04052425|564937402|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
156503554|NCT04052425|564937403|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
156503555|NCT04052425|564937400|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
156503556|NCT04052425|564937401|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
156503557|NCT04052425|564937402|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
156503558|NCT04052425|564937403|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
156503559|NCT04052425|564937400|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
156503560|NCT04052425|564937401|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
156503561|NCT04052425|564937402|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
156503562|NCT04052425|564937403|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
156503563|NCT04052425|564937400|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
156503564|NCT04052425|564937401|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
156503565|NCT04052425|564937402|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
156503566|NCT04052425|564937403|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
156503567|NCT04052425|564937400|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
156503568|NCT04052425|564937401|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
156503569|NCT04052425|564937402|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
156503570|NCT04052425|564937403|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
156503571|NCT04052425|564937400|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
156503572|NCT04052425|564937401|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
156503573|NCT04052425|564937402|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
156503574|NCT04052425|564937403|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
156503575|NCT04334278|564937404|FG000|Overall Study|Lost to Follow-up|0|||
156503576|NCT04334278|564937405|FG001|Overall Study|Lost to Follow-up|3|||
156503577|NCT04334278|564937404|FG000|Overall Study|Withdrawal by Subject|4|||
156503578|NCT04334278|564937405|FG001|Overall Study|Withdrawal by Subject|2|||
156503579|NCT01732549|564937408|FG000|Overall Study|Adverse Event|13|||
156503580|NCT01732549|564937409|FG001|Overall Study|Adverse Event|3|||
156503581|NCT01732549|564937408|FG000|Overall Study|Consent withdrawn|13|||
156503582|NCT01732549|564937409|FG001|Overall Study|Consent withdrawn|6|||
156503583|NCT01732549|564937408|FG000|Overall Study|Disease progression|37|||
156503584|NCT01732549|564937409|FG001|Overall Study|Disease progression|50|||
156503585|NCT01732549|564937408|FG000|Overall Study|Other|8|||
156503586|NCT01732549|564937409|FG001|Overall Study|Other|14|||
156503587|NCT01516749|564937410|FG000|Active Therapy|Lost to Follow-up|1|||
156503588|NCT01516749|564937410|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
156503589|NCT03994731|564937412|FG000|Pegloticase + IMM Period|Death|2|||
156503590|NCT03994731|564937413|FG001|Pegloticase + IMM Period|Death|0|||
156503591|NCT03994731|564937412|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
156503592|NCT03994731|564937413|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
156503593|NCT03994731|564937412|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
156503594|NCT03994731|564937413|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
156503595|NCT01681992|564937418|FG000|Overall Study|Adverse Event|3|||
156503596|NCT01681992|564937419|FG001|Overall Study|Adverse Event|2|||
156503597|NCT01681992|564937420|FG002|Overall Study|Adverse Event|3|||
156503598|NCT01681992|564937418|FG000|Overall Study|Lost to Follow-up|36|||
156503599|NCT01681992|564937419|FG001|Overall Study|Lost to Follow-up|38|||
156503600|NCT01681992|564937420|FG002|Overall Study|Lost to Follow-up|53|||
156546963|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
156546964|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
156383673|NCT01261611|564498893|FG001|Treatment Cycle 2|Completed study|0|||
156383674|NCT01261611|564498894|FG002|Treatment Cycle 2|Completed study|0|||
156383675|NCT01261611|564498892|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
156383676|NCT01261611|564498893|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
156383677|NCT01261611|564498894|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
156383678|NCT01261611|564498892|FG000|Treatment Cycle 2|Adverse Event|1|||
156383679|NCT01261611|564498893|FG001|Treatment Cycle 2|Adverse Event|0|||
156383680|NCT01261611|564498894|FG002|Treatment Cycle 2|Adverse Event|0|||
156383681|NCT01261611|564498892|FG000|Treatment Cycle 2|Protocol Violation|2|||
156383682|NCT01261611|564498893|FG001|Treatment Cycle 2|Protocol Violation|0|||
156383683|NCT01261611|564498894|FG002|Treatment Cycle 2|Protocol Violation|0|||
156503601|NCT01681992|564937418|FG000|Overall Study|As Per Sponsor Decision|0|||
156503602|NCT01681992|564937419|FG001|Overall Study|As Per Sponsor Decision|0|||
156503603|NCT01681992|564937420|FG002|Overall Study|As Per Sponsor Decision|1|||
156503604|NCT01681992|564937418|FG000|Overall Study|Protocol Violation|0|||
156503605|NCT01681992|564937419|FG001|Overall Study|Protocol Violation|0|||
156503606|NCT01681992|564937420|FG002|Overall Study|Protocol Violation|1|||
156503607|NCT01681992|564937418|FG000|Overall Study|Withdrawal by Subject|27|||
156503608|NCT01681992|564937419|FG001|Overall Study|Withdrawal by Subject|30|||
156503609|NCT01681992|564937420|FG002|Overall Study|Withdrawal by Subject|25|||
156383684|NCT01261611|564498892|FG000|Treatment Cycle 2|Not otherwise specified|2|||
156383685|NCT01261611|564498893|FG001|Treatment Cycle 2|Not otherwise specified|0|||
156383686|NCT01261611|564498894|FG002|Treatment Cycle 2|Not otherwise specified|0|||
156383687|NCT01261611|564498892|FG000|Treatment Cycle 3|Completed study|24|||
156383688|NCT01261611|564498893|FG001|Treatment Cycle 3|Completed study|0|||
156503610|NCT00447590|564937423|FG000|Overall Study|Withdrawal by Subject|26|||
156503611|NCT00447590|564937423|FG000|Overall Study|Lost to Follow-up|24|||
156503612|NCT00447590|564937423|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
156503613|NCT03377361|564937424|FG000|Pre-Treatment|Subject withdrew consent|0|||
156503614|NCT03377361|564937425|FG001|Pre-Treatment|Subject withdrew consent|0|||
156503615|NCT03377361|564937426|FG002|Pre-Treatment|Subject withdrew consent|0|||
156503616|NCT03377361|564937427|FG003|Pre-Treatment|Subject withdrew consent|0|||
156503617|NCT03377361|564937428|FG004|Pre-Treatment|Subject withdrew consent|0|||
156503618|NCT03377361|564937429|FG005|Pre-Treatment|Subject withdrew consent|0|||
156503619|NCT03377361|564937430|FG006|Pre-Treatment|Subject withdrew consent|0|||
156503620|NCT03377361|564937431|FG007|Pre-Treatment|Subject withdrew consent|3|||
156503621|NCT03377361|564937432|FG008|Pre-Treatment|Subject withdrew consent|1|||
156503622|NCT03377361|564937433|FG009|Pre-Treatment|Subject withdrew consent|0|||
156503623|NCT03377361|564937424|FG000|Pre-Treatment|Not Reported|0|||
156503624|NCT03377361|564937425|FG001|Pre-Treatment|Not Reported|0|||
156503625|NCT03377361|564937426|FG002|Pre-Treatment|Not Reported|0|||
156503626|NCT03377361|564937427|FG003|Pre-Treatment|Not Reported|0|||
156503627|NCT03377361|564937428|FG004|Pre-Treatment|Not Reported|0|||
156503628|NCT03377361|564937429|FG005|Pre-Treatment|Not Reported|0|||
156503629|NCT03377361|564937430|FG006|Pre-Treatment|Not Reported|0|||
156503630|NCT03377361|564937431|FG007|Pre-Treatment|Not Reported|0|||
156503631|NCT03377361|564937432|FG008|Pre-Treatment|Not Reported|3|||
156503632|NCT03377361|564937433|FG009|Pre-Treatment|Not Reported|0|||
156503633|NCT03377361|564937424|FG000|Treatment Period|Disease Progression|3|||
156503634|NCT03377361|564937425|FG001|Treatment Period|Disease Progression|2|||
156503635|NCT03377361|564937426|FG002|Treatment Period|Disease Progression|5|||
156503636|NCT03377361|564937427|FG003|Treatment Period|Disease Progression|3|||
156503637|NCT03377361|564937428|FG004|Treatment Period|Disease Progression|3|||
156503638|NCT03377361|564937429|FG005|Treatment Period|Disease Progression|3|||
156503639|NCT03377361|564937430|FG006|Treatment Period|Disease Progression|6|||
156503640|NCT03377361|564937431|FG007|Treatment Period|Disease Progression|106|||
156503641|NCT03377361|564937432|FG008|Treatment Period|Disease Progression|48|||
156503642|NCT03377361|564937433|FG009|Treatment Period|Disease Progression|59|||
156503643|NCT03377361|564937424|FG000|Treatment Period|Study Drug Toxicity|0|||
156503644|NCT03377361|564937425|FG001|Treatment Period|Study Drug Toxicity|0|||
156503645|NCT03377361|564937426|FG002|Treatment Period|Study Drug Toxicity|0|||
156503646|NCT03377361|564937427|FG003|Treatment Period|Study Drug Toxicity|1|||
156503647|NCT03377361|564937428|FG004|Treatment Period|Study Drug Toxicity|0|||
156503648|NCT03377361|564937429|FG005|Treatment Period|Study Drug Toxicity|0|||
156503649|NCT03377361|564937430|FG006|Treatment Period|Study Drug Toxicity|0|||
156503650|NCT03377361|564937431|FG007|Treatment Period|Study Drug Toxicity|7|||
156503651|NCT03377361|564937432|FG008|Treatment Period|Study Drug Toxicity|2|||
156503652|NCT03377361|564937433|FG009|Treatment Period|Study Drug Toxicity|16|||
156503653|NCT03377361|564937424|FG000|Treatment Period|Death|0|||
156503654|NCT03377361|564937425|FG001|Treatment Period|Death|0|||
156383689|NCT01261611|564498894|FG002|Treatment Cycle 3|Completed study|0|||
156383690|NCT01261611|564498892|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
156383691|NCT01261611|564498893|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
156383692|NCT01261611|564498894|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
156383693|NCT01261611|564498892|FG000|Treatment Cycle 3|Adverse Event|1|||
156383694|NCT01261611|564498893|FG001|Treatment Cycle 3|Adverse Event|0|||
156383695|NCT01261611|564498894|FG002|Treatment Cycle 3|Adverse Event|0|||
156383696|NCT01261611|564498892|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
156383697|NCT01261611|564498893|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
156383698|NCT01261611|564498894|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
156383699|NCT01261611|564498892|FG000|Treatment Cycle 4|Completed study|87|||
156383700|NCT01261611|564498893|FG001|Treatment Cycle 4|Completed study|0|||
156383701|NCT01261611|564498894|FG002|Treatment Cycle 4|Completed study|0|||
156383702|NCT01261611|564498892|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
156383703|NCT01261611|564498893|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
156383704|NCT01261611|564498894|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
156383705|NCT01261611|564498892|FG000|Treatment Cycle 4|Adverse Event|1|||
156503655|NCT03377361|564937426|FG002|Treatment Period|Death|1|||
156503656|NCT03377361|564937427|FG003|Treatment Period|Death|0|||
156503657|NCT03377361|564937428|FG004|Treatment Period|Death|0|||
156383706|NCT01261611|564498893|FG001|Treatment Cycle 4|Adverse Event|0|||
156383707|NCT01261611|564498894|FG002|Treatment Cycle 4|Adverse Event|0|||
156383708|NCT01261611|564498892|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
156383709|NCT01261611|564498893|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
156383710|NCT01261611|564498894|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
156503658|NCT03377361|564937429|FG005|Treatment Period|Death|0|||
156503659|NCT03377361|564937430|FG006|Treatment Period|Death|0|||
156503660|NCT03377361|564937431|FG007|Treatment Period|Death|2|||
156503661|NCT03377361|564937432|FG008|Treatment Period|Death|1|||
156503662|NCT03377361|564937433|FG009|Treatment Period|Death|3|||
156503663|NCT03377361|564937424|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
156503664|NCT03377361|564937425|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
156503665|NCT03377361|564937426|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
156503666|NCT03377361|564937427|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
156503667|NCT03377361|564937428|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
156503668|NCT03377361|564937429|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
156503669|NCT03377361|564937430|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
156503670|NCT03377361|564937431|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
156503671|NCT03377361|564937432|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
156503672|NCT03377361|564937433|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
156503673|NCT03377361|564937424|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
156503674|NCT03377361|564937425|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
156503675|NCT03377361|564937426|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
156503676|NCT03377361|564937427|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
156503677|NCT03377361|564937428|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
156503678|NCT03377361|564937429|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
156503679|NCT03377361|564937430|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
156503680|NCT03377361|564937431|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
156383711|NCT01261611|564498892|FG000|Treatment Cycle 4|Not otherwise specified|3|||
156383712|NCT01261611|564498893|FG001|Treatment Cycle 4|Not otherwise specified|0|||
156383713|NCT01261611|564498894|FG002|Treatment Cycle 4|Not otherwise specified|0|||
156383714|NCT01261611|564498892|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
156383715|NCT01261611|564498893|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
156383716|NCT01261611|564498894|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
156383717|NCT01261611|564498892|FG000|Treatment Cycle 5|Adverse Event|1|||
156383718|NCT01261611|564498893|FG001|Treatment Cycle 5|Adverse Event|0|||
156383719|NCT01261611|564498894|FG002|Treatment Cycle 5|Adverse Event|0|||
156383720|NCT01261611|564498892|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
156383721|NCT01261611|564498893|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
156383722|NCT01261611|564498894|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
156383723|NCT00156065|564498896|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
156383724|NCT00156065|564498897|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
156383725|NCT00156065|564498898|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
156383726|NCT00156065|564498896|FG000|Overall Study|Adverse Event|8|||
156383727|NCT00156065|564498897|FG001|Overall Study|Adverse Event|11|||
156383728|NCT00156065|564498898|FG002|Overall Study|Adverse Event|4|||
156383729|NCT00156065|564498896|FG000|Overall Study|Lack of Efficacy|2|||
156383730|NCT00156065|564498897|FG001|Overall Study|Lack of Efficacy|9|||
156383731|NCT00156065|564498898|FG002|Overall Study|Lack of Efficacy|3|||
156383732|NCT00156065|564498896|FG000|Overall Study|Withdrawal by Subject|13|||
156383733|NCT00156065|564498897|FG001|Overall Study|Withdrawal by Subject|26|||
156383734|NCT00156065|564498898|FG002|Overall Study|Withdrawal by Subject|16|||
156383735|NCT00156065|564498896|FG000|Overall Study|Lost to Follow-up|5|||
156383736|NCT00156065|564498897|FG001|Overall Study|Lost to Follow-up|7|||
156383737|NCT00156065|564498898|FG002|Overall Study|Lost to Follow-up|1|||
156383738|NCT00156065|564498896|FG000|Overall Study|Other|2|||
156503681|NCT03377361|564937432|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
156503682|NCT03377361|564937433|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
156383739|NCT00156065|564498897|FG001|Overall Study|Other|9|||
156383740|NCT00156065|564498898|FG002|Overall Study|Other|3|||
156383741|NCT01808690|564498899|FG000|Overall Study|Withdrawal by Subject|1|||
156383742|NCT01808690|564498900|FG001|Overall Study|Withdrawal by Subject|2|||
156383743|NCT02891187|564498901|FG000|Overall Study|Lost to Follow-up|1|||
156383744|NCT02891187|564498902|FG001|Overall Study|Lost to Follow-up|2|||
156383745|NCT02395120|564498903|FG000|Overall Study|Missed follow-up dental exam|57|||
156383746|NCT02395120|564498904|FG001|Overall Study|Missed follow-up dental exam|62|||
156383747|NCT02395120|564498905|FG002|Overall Study|Missed follow-up dental exam|6|||
156383748|NCT02395120|564498906|FG003|Overall Study|Missed follow-up dental exam|6|||
156383749|NCT02395120|564498907|FG004|Overall Study|Missed follow-up dental exam|51|||
156383750|NCT01490632|564498908|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
156383751|NCT01490632|564498909|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
156383752|NCT01490632|564498910|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
156383753|NCT01490632|564498911|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
156383754|NCT01490632|564498912|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
156383755|NCT01490632|564498913|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
156383756|NCT01490632|564498914|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
156383757|NCT01490632|564498915|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
156383758|NCT01490632|564498916|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
156383759|NCT01490632|564498917|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
156383760|NCT01490632|564498918|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
156383761|NCT01490632|564498919|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
156383762|NCT01490632|564498920|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
156383763|NCT01490632|564498921|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
156383764|NCT01490632|564498922|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
156383765|NCT01490632|564498923|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
156383766|NCT01490632|564498924|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
156383767|NCT01490632|564498925|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
156383768|NCT01490632|564498926|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
156383769|NCT01490632|564498927|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
156383770|NCT01490632|564498908|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
156383771|NCT01490632|564498909|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
156383772|NCT01490632|564498910|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
156383773|NCT01490632|564498911|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
156383774|NCT01490632|564498912|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383775|NCT01490632|564498913|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383776|NCT01490632|564498914|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383777|NCT01490632|564498915|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383778|NCT01490632|564498916|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383779|NCT01490632|564498917|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383780|NCT01490632|564498918|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383781|NCT01490632|564498919|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383782|NCT01490632|564498920|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383783|NCT01490632|564498921|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383784|NCT01490632|564498922|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383785|NCT01490632|564498923|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383786|NCT01490632|564498924|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383787|NCT01490632|564498925|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383788|NCT01490632|564498926|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383789|NCT01490632|564498927|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156383790|NCT01490632|564498908|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383791|NCT01490632|564498909|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383792|NCT01490632|564498910|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
156383793|NCT01490632|564498911|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
156383794|NCT01490632|564498912|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
156383795|NCT01490632|564498913|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383796|NCT01490632|564498914|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383797|NCT01490632|564498915|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383798|NCT01490632|564498916|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383799|NCT01490632|564498917|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383800|NCT01490632|564498918|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383801|NCT01490632|564498919|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383802|NCT01490632|564498920|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383803|NCT01490632|564498921|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383804|NCT01490632|564498922|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383805|NCT01490632|564498923|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383806|NCT01490632|564498924|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383807|NCT01490632|564498925|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383808|NCT01490632|564498926|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383809|NCT01490632|564498927|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156383810|NCT01490632|564498908|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
156383811|NCT01490632|564498909|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
156383812|NCT01490632|564498910|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
156383813|NCT01490632|564498911|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
156383814|NCT01490632|564498912|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
156503683|NCT03377361|564937424|FG000|Treatment Period|Subject Withdrew Consent|0|||
156503684|NCT03377361|564937425|FG001|Treatment Period|Subject Withdrew Consent|0|||
156503685|NCT03377361|564937426|FG002|Treatment Period|Subject Withdrew Consent|0|||
156503686|NCT03377361|564937427|FG003|Treatment Period|Subject Withdrew Consent|0|||
156503687|NCT03377361|564937428|FG004|Treatment Period|Subject Withdrew Consent|0|||
156503688|NCT03377361|564937429|FG005|Treatment Period|Subject Withdrew Consent|0|||
156503689|NCT03377361|564937430|FG006|Treatment Period|Subject Withdrew Consent|0|||
156503690|NCT03377361|564937431|FG007|Treatment Period|Subject Withdrew Consent|0|||
156503691|NCT03377361|564937432|FG008|Treatment Period|Subject Withdrew Consent|2|||
156503692|NCT03377361|564937433|FG009|Treatment Period|Subject Withdrew Consent|1|||
156383815|NCT01490632|564498913|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
156383816|NCT01490632|564498914|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
156383817|NCT01490632|564498915|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
156383818|NCT01490632|564498916|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
156383819|NCT01490632|564498917|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
156503693|NCT03377361|564937424|FG000|Treatment Period|No longer meets study criteria|0|||
156503694|NCT03377361|564937425|FG001|Treatment Period|No longer meets study criteria|1|||
156383820|NCT01490632|564498918|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
156383821|NCT01490632|564498919|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
156503695|NCT03377361|564937426|FG002|Treatment Period|No longer meets study criteria|0|||
156503696|NCT03377361|564937427|FG003|Treatment Period|No longer meets study criteria|0|||
156503697|NCT03377361|564937428|FG004|Treatment Period|No longer meets study criteria|0|||
156503698|NCT03377361|564937429|FG005|Treatment Period|No longer meets study criteria|0|||
156503699|NCT03377361|564937430|FG006|Treatment Period|No longer meets study criteria|0|||
156503700|NCT03377361|564937431|FG007|Treatment Period|No longer meets study criteria|1|||
156503701|NCT03377361|564937432|FG008|Treatment Period|No longer meets study criteria|0|||
156503702|NCT03377361|564937433|FG009|Treatment Period|No longer meets study criteria|0|||
156503703|NCT03377361|564937424|FG000|Treatment Period|Other Reasons|0|||
156503704|NCT03377361|564937425|FG001|Treatment Period|Other Reasons|0|||
156503705|NCT03377361|564937426|FG002|Treatment Period|Other Reasons|0|||
156503706|NCT03377361|564937427|FG003|Treatment Period|Other Reasons|3|||
156503707|NCT03377361|564937428|FG004|Treatment Period|Other Reasons|0|||
156503708|NCT03377361|564937429|FG005|Treatment Period|Other Reasons|0|||
156503709|NCT03377361|564937430|FG006|Treatment Period|Other Reasons|0|||
156503710|NCT03377361|564937431|FG007|Treatment Period|Other Reasons|2|||
156503711|NCT03377361|564937432|FG008|Treatment Period|Other Reasons|0|||
156503712|NCT03377361|564937433|FG009|Treatment Period|Other Reasons|1|||
156503713|NCT03698994|564937434|FG000|Overall Study|Adverse Event|2|||
156503714|NCT03698994|564937434|FG000|Overall Study|Death|1|||
156503715|NCT03698994|564937434|FG000|Overall Study|Physician Decision|1|||
156503716|NCT03698994|564937434|FG000|Overall Study|Withdrawal by Subject|3|||
156503717|NCT03698994|564937434|FG000|Overall Study|Progressive Disease|12|||
156503718|NCT04042077|564937435|FG000|Overall Study|Adverse Event|0|||
156503719|NCT04042077|564937436|FG001|Overall Study|Adverse Event|1|||
156503720|NCT04042077|564937435|FG000|Overall Study|Death|2|||
156503721|NCT04042077|564937436|FG001|Overall Study|Death|1|||
156503722|NCT04042077|564937435|FG000|Overall Study|Physician Decision|2|||
156503723|NCT04042077|564937436|FG001|Overall Study|Physician Decision|0|||
156503724|NCT04042077|564937435|FG000|Overall Study|Withdrawal by Subject|3|||
156503725|NCT04042077|564937436|FG001|Overall Study|Withdrawal by Subject|2|||
156503726|NCT04042077|564937435|FG000|Overall Study|Lack of Efficacy|0|||
156503727|NCT04042077|564937436|FG001|Overall Study|Lack of Efficacy|1|||
156503728|NCT01080300|564937437|FG000|Overall Study|Adverse Event|49|||
156503729|NCT01080300|564937438|FG001|Overall Study|Adverse Event|35|||
156503730|NCT01080300|564937437|FG000|Overall Study|Lack of Efficacy|12|||
156503731|NCT01080300|564937438|FG001|Overall Study|Lack of Efficacy|15|||
156503732|NCT01080300|564937437|FG000|Overall Study|Protocol Violation|7|||
156503733|NCT01080300|564937438|FG001|Overall Study|Protocol Violation|13|||
156503734|NCT01080300|564937437|FG000|Overall Study|Lost to Follow-up|10|||
156503735|NCT01080300|564937438|FG001|Overall Study|Lost to Follow-up|6|||
156503736|NCT01080300|564937437|FG000|Overall Study|Death|0|||
156503737|NCT01080300|564937438|FG001|Overall Study|Death|1|||
156503738|NCT01080300|564937437|FG000|Overall Study|Withdrawal by Subject|12|||
156503739|NCT01080300|564937438|FG001|Overall Study|Withdrawal by Subject|28|||
156503740|NCT01080300|564937437|FG000|Overall Study|Reasons not specified|4|||
156503741|NCT01080300|564937438|FG001|Overall Study|Reasons not specified|6|||
156503742|NCT02844777|564937439|FG000|Overall Study|Withdrawal by Subject|2|||
156503743|NCT02844777|564937440|FG001|Overall Study|Withdrawal by Subject|0|||
156503744|NCT02844777|564937441|FG002|Overall Study|Withdrawal by Subject|0|||
156503745|NCT01776008|564937442|FG000|Overall Study|ineligible|2|||
156503746|NCT01163474|564937443|FG000|Overall Study|Withdrawal by Subject|1|||
156503747|NCT01163474|564937443|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
156503748|NCT01163474|564937443|FG000|Overall Study|Lost to Follow-up|3|||
156503749|NCT02838134|564937444|FG000|Overall Study|Lost to Follow-up|1|||
156503750|NCT02838134|564937445|FG001|Overall Study|Lost to Follow-up|2|||
156503751|NCT02838134|564937444|FG000|Overall Study|logistic problems|1|||
156503752|NCT02838134|564937445|FG001|Overall Study|logistic problems|1|||
156503753|NCT00383123|564937446|FG000|Overall Study|Adverse Event|1|||
156383822|NCT01490632|564498920|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
156383823|NCT01490632|564498921|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
156383824|NCT01490632|564498922|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
156503754|NCT00383123|564937447|FG001|Overall Study|Adverse Event|0|||
156503755|NCT00383123|564937446|FG000|Overall Study|Lost to Follow-up|68|||
156503756|NCT00383123|564937447|FG001|Overall Study|Lost to Follow-up|61|||
156503757|NCT00383123|564937446|FG000|Overall Study|Protocol Violation|5|||
156503758|NCT00383123|564937447|FG001|Overall Study|Protocol Violation|1|||
156503759|NCT00383123|564937446|FG000|Overall Study|Withdrawal by Subject|27|||
156503760|NCT00383123|564937447|FG001|Overall Study|Withdrawal by Subject|18|||
156503761|NCT00383123|564937446|FG000|Overall Study|Other reason|10|||
156503762|NCT00383123|564937447|FG001|Overall Study|Other reason|6|||
156383825|NCT01490632|564498923|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
156503763|NCT02781311|564937448|FG000|Overall Study|Adverse Event|2|||
156503764|NCT02781311|564937449|FG001|Overall Study|Adverse Event|6|||
156503765|NCT02781311|564937450|FG002|Overall Study|Adverse Event|1|||
156383826|NCT01490632|564498924|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
156503766|NCT02781311|564937448|FG000|Overall Study|Withdrawal of Consent|11|||
156383827|NCT01490632|564498925|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
156383828|NCT01490632|564498926|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
156383829|NCT01490632|564498927|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
156383830|NCT01490632|564498908|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
156383831|NCT01490632|564498909|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383832|NCT01490632|564498910|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383833|NCT01490632|564498911|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383834|NCT01490632|564498912|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383835|NCT01490632|564498913|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383836|NCT01490632|564498914|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383837|NCT01490632|564498915|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383838|NCT01490632|564498916|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383839|NCT01490632|564498917|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383840|NCT01490632|564498918|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383841|NCT01490632|564498919|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383842|NCT01490632|564498920|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383843|NCT01490632|564498921|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383844|NCT01490632|564498922|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383845|NCT01490632|564498923|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383846|NCT01490632|564498924|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383847|NCT01490632|564498925|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383848|NCT01490632|564498926|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383849|NCT01490632|564498927|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
156383850|NCT01490632|564498908|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
156383851|NCT01490632|564498909|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
156383852|NCT01490632|564498910|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383853|NCT01490632|564498911|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
156383854|NCT01490632|564498912|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
156383855|NCT01490632|564498913|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383856|NCT01490632|564498914|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383857|NCT01490632|564498915|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383858|NCT01490632|564498916|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383859|NCT01490632|564498917|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383860|NCT01490632|564498918|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383861|NCT01490632|564498919|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383862|NCT01490632|564498920|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383863|NCT01490632|564498921|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383864|NCT01490632|564498922|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383865|NCT01490632|564498923|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383866|NCT01490632|564498924|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383867|NCT01490632|564498925|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383868|NCT01490632|564498926|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383869|NCT01490632|564498927|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156383870|NCT01490632|564498908|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383871|NCT01490632|564498909|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383872|NCT01490632|564498910|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383873|NCT01490632|564498911|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383874|NCT01490632|564498912|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
156383875|NCT01490632|564498913|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383876|NCT01490632|564498914|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383877|NCT01490632|564498915|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383878|NCT01490632|564498916|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383879|NCT01490632|564498917|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383880|NCT01490632|564498918|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383881|NCT01490632|564498919|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383882|NCT01490632|564498920|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383883|NCT01490632|564498921|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383884|NCT01490632|564498922|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383885|NCT01490632|564498923|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383886|NCT01490632|564498924|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383887|NCT01490632|564498925|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383888|NCT01490632|564498926|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156503767|NCT02781311|564937449|FG001|Overall Study|Withdrawal of Consent|12|||
156503768|NCT02781311|564937450|FG002|Overall Study|Withdrawal of Consent|2|||
156503769|NCT02781311|564937448|FG000|Overall Study|Lost to Follow-up|11|||
156503770|NCT02781311|564937449|FG001|Overall Study|Lost to Follow-up|8|||
156503771|NCT02781311|564937450|FG002|Overall Study|Lost to Follow-up|1|||
156503772|NCT02781311|564937448|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156503773|NCT02781311|564937449|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156503774|NCT02781311|564937450|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156503775|NCT04547023|564937453|FG000|Overall Study|Did Not Receive Intervention|3|||
156503776|NCT04547023|564937454|FG001|Overall Study|Did Not Receive Intervention|2|||
156503777|NCT04547023|564937453|FG000|Overall Study|Lost to Follow-up|1|||
156503778|NCT04547023|564937454|FG001|Overall Study|Lost to Follow-up|1|||
156503779|NCT01637077|564937455|FG000|Overall Study|Cancel|1|||
156503780|NCT01637077|564937456|FG001|Overall Study|Cancel|1|||
156503781|NCT01637077|564937455|FG000|Overall Study|Withdrawal by Subject|1|||
156503782|NCT01637077|564937456|FG001|Overall Study|Withdrawal by Subject|0|||
156503783|NCT01637077|564937455|FG000|Overall Study|No cycle 1 questionnaire data|2|||
156503784|NCT01637077|564937456|FG001|Overall Study|No cycle 1 questionnaire data|0|||
156503785|NCT02638103|564937457|FG000|Overall Study|Adverse Event|13|||
156503786|NCT02638103|564937458|FG001|Overall Study|Adverse Event|12|||
156503787|NCT02638103|564937459|FG002|Overall Study|Adverse Event|19|||
156503788|NCT02638103|564937460|FG003|Overall Study|Adverse Event|12|||
156503789|NCT02638103|564937457|FG000|Overall Study|Withdrawal by Subject|43|||
156503790|NCT02638103|564937458|FG001|Overall Study|Withdrawal by Subject|53|||
156503791|NCT02638103|564937459|FG002|Overall Study|Withdrawal by Subject|30|||
156503792|NCT02638103|564937460|FG003|Overall Study|Withdrawal by Subject|61|||
156503793|NCT02638103|564937457|FG000|Overall Study|Protocol Violation|1|||
156503794|NCT02638103|564937458|FG001|Overall Study|Protocol Violation|2|||
156503795|NCT02638103|564937459|FG002|Overall Study|Protocol Violation|1|||
156503796|NCT02638103|564937460|FG003|Overall Study|Protocol Violation|4|||
156503797|NCT02638103|564937457|FG000|Overall Study|Pregnancy|2|||
156503798|NCT02638103|564937458|FG001|Overall Study|Pregnancy|3|||
156503799|NCT02638103|564937459|FG002|Overall Study|Pregnancy|0|||
156503800|NCT02638103|564937460|FG003|Overall Study|Pregnancy|1|||
156503801|NCT02638103|564937457|FG000|Overall Study|Non-compliance to Study Procedures|2|||
156503802|NCT02638103|564937458|FG001|Overall Study|Non-compliance to Study Procedures|1|||
156503803|NCT02638103|564937459|FG002|Overall Study|Non-compliance to Study Procedures|1|||
156503804|NCT02638103|564937460|FG003|Overall Study|Non-compliance to Study Procedures|1|||
156503805|NCT02638103|564937457|FG000|Overall Study|Lost to Follow-up|26|||
156503806|NCT02638103|564937458|FG001|Overall Study|Lost to Follow-up|33|||
156503807|NCT02638103|564937459|FG002|Overall Study|Lost to Follow-up|20|||
156503808|NCT02638103|564937460|FG003|Overall Study|Lost to Follow-up|37|||
156503809|NCT02638103|564937457|FG000|Overall Study|Lack of Efficacy|14|||
156503810|NCT02638103|564937458|FG001|Overall Study|Lack of Efficacy|10|||
156503811|NCT02638103|564937459|FG002|Overall Study|Lack of Efficacy|12|||
156503812|NCT02638103|564937460|FG003|Overall Study|Lack of Efficacy|22|||
156503813|NCT02638103|564937457|FG000|Overall Study|Other than specified|5|||
156503814|NCT02638103|564937458|FG001|Overall Study|Other than specified|4|||
156503815|NCT02638103|564937459|FG002|Overall Study|Other than specified|2|||
156503816|NCT02638103|564937460|FG003|Overall Study|Other than specified|4|||
156503817|NCT00365547|564937464|FG000|Overall Study|Insurance did not cover Avastin|1|||
156503818|NCT00365547|564937464|FG000|Overall Study|Screen failure|1|||
156503819|NCT00365547|564937464|FG000|Overall Study|Withdrawal by Subject|1|||
156503820|NCT03692052|564937465|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
156503821|NCT03692052|564937465|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
156503822|NCT03692052|564937465|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
156503823|NCT03692052|564937465|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
156503824|NCT02257918|564937466|FG000|Overall Study|Lost to Follow-up|4|||
156503825|NCT02257918|564937467|FG001|Overall Study|Lost to Follow-up|1|||
156503826|NCT02257918|564937468|FG002|Overall Study|Lost to Follow-up|0|||
156503827|NCT02257918|564937466|FG000|Overall Study|Withdrawal by Subject|0|||
156503828|NCT02257918|564937467|FG001|Overall Study|Withdrawal by Subject|0|||
156503829|NCT02257918|564937468|FG002|Overall Study|Withdrawal by Subject|1|||
156503830|NCT02257918|564937466|FG000|Overall Study|Pregnancy|0|||
156503831|NCT02257918|564937467|FG001|Overall Study|Pregnancy|0|||
156503832|NCT02257918|564937468|FG002|Overall Study|Pregnancy|1|||
156503833|NCT00936598|564937469|FG000|Overall Study|Withdrawal by Subject|1|||
156503834|NCT00936598|564937470|FG001|Overall Study|Withdrawal by Subject|0|||
156503835|NCT00936598|564937469|FG000|Overall Study|Ineligible after consent|1|||
156503836|NCT00936598|564937470|FG001|Overall Study|Ineligible after consent|0|||
156503837|NCT01740154|564937472|FG000|Overall Study|Adverse Event|1|||
156503838|NCT03358472|564937476|FG000|Overall Study|Death|6|||
156503839|NCT03358472|564937477|FG001|Overall Study|Death|3|||
156503840|NCT03358472|564937478|FG002|Overall Study|Death|10|||
156503841|NCT03358472|564937476|FG000|Overall Study|Physician Decision|0|||
156503842|NCT03358472|564937477|FG001|Overall Study|Physician Decision|1|||
156503843|NCT03358472|564937478|FG002|Overall Study|Physician Decision|0|||
156503844|NCT03358472|564937476|FG000|Overall Study|Withdrawal by Subject|0|||
156383889|NCT01490632|564498927|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156383890|NCT01490632|564498908|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383891|NCT01490632|564498909|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383892|NCT01490632|564498910|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383893|NCT01490632|564498911|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383894|NCT01490632|564498912|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383895|NCT01490632|564498913|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
156383896|NCT01490632|564498914|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
156383897|NCT01490632|564498915|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383898|NCT01490632|564498916|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383899|NCT01490632|564498917|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
156383900|NCT01490632|564498918|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
156383901|NCT01490632|564498919|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
156383902|NCT01490632|564498920|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
156503845|NCT03358472|564937477|FG001|Overall Study|Withdrawal by Subject|0|||
156503846|NCT03358472|564937478|FG002|Overall Study|Withdrawal by Subject|1|||
156503847|NCT03358472|564937476|FG000|Overall Study|On-going at clinical cut off date|9|||
156503848|NCT03358472|564937477|FG001|Overall Study|On-going at clinical cut off date|6|||
156503849|NCT03358472|564937478|FG002|Overall Study|On-going at clinical cut off date|5|||
156503850|NCT04013971|564937481|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
156503851|NCT04013971|564937482|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
156503852|NCT04013971|564937481|FG000|Overall Study|Missing biomechanical data|0|||
156503853|NCT04013971|564937482|FG001|Overall Study|Missing biomechanical data|1|||
156503854|NCT06719986|564937487|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
156503855|NCT06719986|564937488|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
156503856|NCT06719986|564937489|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
156503857|NCT06719986|564937487|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
156503858|NCT06719986|564937488|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
156503859|NCT06719986|564937489|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
156503860|NCT04704219|564937490|FG000|Overall Study|Screen Failure|1|||
156503861|NCT04704219|564937490|FG000|Overall Study|Withdrawal by Subject|1|||
156503862|NCT04704219|564937490|FG000|Overall Study|Death|78|||
156503863|NCT04704219|564937490|FG000|Overall Study|Participants Ongoing|80|||
156503864|NCT02600897|564937491|FG000|Overall Study|Death|1|||
156503865|NCT02600897|564937492|FG001|Overall Study|Death|2|||
156503866|NCT02600897|564937493|FG002|Overall Study|Death|1|||
156503867|NCT02600897|564937494|FG003|Overall Study|Death|2|||
156503868|NCT02600897|564937495|FG004|Overall Study|Death|3|||
156503869|NCT02600897|564937496|FG005|Overall Study|Death|2|||
156503870|NCT02600897|564937497|FG006|Overall Study|Death|10|||
156503871|NCT02600897|564937498|FG007|Overall Study|Death|7|||
156503872|NCT02600897|564937499|FG008|Overall Study|Death|20|||
156503873|NCT02600897|564937491|FG000|Overall Study|Lost to Follow-up|1|||
156503874|NCT02600897|564937492|FG001|Overall Study|Lost to Follow-up|0|||
156503875|NCT02600897|564937493|FG002|Overall Study|Lost to Follow-up|0|||
156503876|NCT02600897|564937494|FG003|Overall Study|Lost to Follow-up|0|||
156503877|NCT02600897|564937495|FG004|Overall Study|Lost to Follow-up|0|||
156503878|NCT02600897|564937496|FG005|Overall Study|Lost to Follow-up|0|||
156503879|NCT02600897|564937497|FG006|Overall Study|Lost to Follow-up|0|||
156503880|NCT02600897|564937498|FG007|Overall Study|Lost to Follow-up|1|||
156503881|NCT02600897|564937499|FG008|Overall Study|Lost to Follow-up|0|||
156503882|NCT02600897|564937491|FG000|Overall Study|Withdrawal by Subject|0|||
156503883|NCT02600897|564937492|FG001|Overall Study|Withdrawal by Subject|0|||
156503884|NCT02600897|564937493|FG002|Overall Study|Withdrawal by Subject|0|||
156503885|NCT02600897|564937494|FG003|Overall Study|Withdrawal by Subject|0|||
156503886|NCT02600897|564937495|FG004|Overall Study|Withdrawal by Subject|0|||
156503887|NCT02600897|564937496|FG005|Overall Study|Withdrawal by Subject|0|||
156503888|NCT02600897|564937497|FG006|Overall Study|Withdrawal by Subject|0|||
156503889|NCT02600897|564937498|FG007|Overall Study|Withdrawal by Subject|4|||
156503890|NCT02600897|564937499|FG008|Overall Study|Withdrawal by Subject|2|||
156503891|NCT02600897|564937491|FG000|Overall Study|Reason Not Specified|0|||
156503892|NCT02600897|564937492|FG001|Overall Study|Reason Not Specified|0|||
156503893|NCT02600897|564937493|FG002|Overall Study|Reason Not Specified|0|||
156503894|NCT02600897|564937494|FG003|Overall Study|Reason Not Specified|0|||
156546965|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
156503895|NCT02600897|564937495|FG004|Overall Study|Reason Not Specified|0|||
156503896|NCT02600897|564937496|FG005|Overall Study|Reason Not Specified|0|||
156503897|NCT02600897|564937497|FG006|Overall Study|Reason Not Specified|0|||
156503898|NCT02600897|564937498|FG007|Overall Study|Reason Not Specified|0|||
156503899|NCT02600897|564937499|FG008|Overall Study|Reason Not Specified|1|||
156503900|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
156503901|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
156503902|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
156383903|NCT01490632|564498921|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383904|NCT01490632|564498922|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383905|NCT01490632|564498923|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383906|NCT01490632|564498924|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383907|NCT01490632|564498925|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383908|NCT01490632|564498926|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383909|NCT01490632|564498927|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
156383910|NCT01490632|564498908|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383911|NCT01490632|564498909|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383912|NCT01490632|564498910|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383913|NCT01490632|564498911|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383914|NCT01490632|564498912|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383915|NCT01490632|564498913|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383916|NCT01490632|564498914|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
156383917|NCT01490632|564498915|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383918|NCT01490632|564498916|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
156383919|NCT01490632|564498917|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
156383920|NCT01490632|564498918|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
156383921|NCT01490632|564498919|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383922|NCT01490632|564498920|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383923|NCT01490632|564498921|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383924|NCT01490632|564498922|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383925|NCT01490632|564498923|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383926|NCT01490632|564498924|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383927|NCT01490632|564498925|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383928|NCT01490632|564498926|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383929|NCT01490632|564498927|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156383930|NCT01490632|564498908|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383931|NCT01490632|564498909|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383932|NCT01490632|564498910|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383933|NCT01490632|564498911|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383934|NCT01490632|564498912|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383935|NCT01490632|564498913|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383936|NCT01490632|564498914|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
156383937|NCT01490632|564498915|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383938|NCT01490632|564498916|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383939|NCT01490632|564498917|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
156383940|NCT01490632|564498918|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383941|NCT01490632|564498919|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383942|NCT01490632|564498920|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383943|NCT01490632|564498921|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383944|NCT01490632|564498922|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383945|NCT01490632|564498923|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383946|NCT01490632|564498924|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383947|NCT01490632|564498925|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383948|NCT01490632|564498926|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383949|NCT01490632|564498927|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156383950|NCT01490632|564498908|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383951|NCT01490632|564498909|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383952|NCT01490632|564498910|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383953|NCT01490632|564498911|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383954|NCT01490632|564498912|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383955|NCT01490632|564498913|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383956|NCT01490632|564498914|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
156383957|NCT01490632|564498915|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383958|NCT01490632|564498916|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383959|NCT01490632|564498917|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383960|NCT01490632|564498918|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383961|NCT01490632|564498919|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383962|NCT01490632|564498920|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383963|NCT01490632|564498921|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383964|NCT01490632|564498922|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383965|NCT01490632|564498923|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383966|NCT01490632|564498924|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383967|NCT01490632|564498925|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383968|NCT01490632|564498926|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
156503903|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
156503904|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
156503905|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
156503906|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
156503907|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
156503908|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
156503909|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
156503910|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
156503911|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
156503912|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
156503913|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
156503914|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
156503915|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
156503916|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
156503917|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
156503918|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
156503919|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
156503920|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
156503921|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
156503922|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
156503923|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
156503924|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
156503925|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
156503926|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
156503927|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
156503928|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
156503929|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
156503930|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
156503931|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
156503932|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
156503933|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
156503934|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
156503935|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
156503936|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
156503937|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
156503938|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
156503939|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
156503940|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
156503941|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
156503942|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
156503943|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
156503944|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
156503945|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
156503946|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
156503947|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
156503948|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
156503949|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
156503950|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
156503951|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
156503952|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
156503953|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
156503954|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
156503955|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
156503956|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
156503957|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
156503958|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
156503959|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
156503960|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
156503961|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
156503962|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
156503963|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
156503964|NCT00217737|564937500|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
156503965|NCT00217737|564937501|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
156503966|NCT00217737|564937502|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
156503967|NCT00217737|564937503|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
156503968|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
156503969|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
156503970|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
156503971|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
156503972|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
156503973|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
156503974|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
156503975|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
156503976|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Study suspension|0|||
156503977|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Study suspension|45|||
156503978|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Study suspension|0|||
156503979|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Study suspension|0|||
156503980|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
156503981|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
156503982|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
156503983|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
156503984|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Death|2|||
156503985|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Death|3|||
156503986|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Death|0|||
156503987|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Death|0|||
156503988|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
156503989|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
156503990|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
156503991|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
156503992|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
156503993|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
156503994|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
156503995|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
156503996|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
156503997|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
156503998|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
156503999|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
156504000|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
156504001|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
156504002|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
156504003|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
156504004|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
156504005|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
156504006|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
156504007|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
156504008|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
156504009|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
156504010|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
156504011|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
156504012|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
156504013|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
156504014|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
156504015|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
156504016|NCT00217737|564937500|FG000|Step 2 Randomization/Registration|Other|1|||
156504017|NCT00217737|564937501|FG001|Step 2 Randomization/Registration|Other|2|||
156504018|NCT00217737|564937502|FG002|Step 2 Randomization/Registration|Other|0|||
156504019|NCT00217737|564937503|FG003|Step 2 Randomization/Registration|Other|0|||
156504020|NCT03213704|564937505|FG000|Overall Study|Physician Decision|3|||
156504021|NCT03213704|564937505|FG000|Overall Study|Protocol Violation|1|||
156504022|NCT03213704|564937505|FG000|Overall Study|Progressive disease|4|||
156504023|NCT01183390|564938544|FG000|First Intervention|Adverse Event|0|||
156504024|NCT01183390|564938545|FG001|First Intervention|Adverse Event|1|||
156504025|NCT00233480|564938548|FG000|Overall Study|Underwent status II heart transplant|0|||
156504026|NCT00233480|564938549|FG001|Overall Study|Underwent status II heart transplant|1|||
156504027|NCT00474526|564938550|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
156504028|NCT00474526|564938551|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
156504029|NCT00474526|564938552|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
156504030|NCT00474526|564938553|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
156504031|NCT00474526|564938554|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
156504032|NCT00474526|564938555|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
156546966|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
156546967|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
156504033|NCT00474526|564938556|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
156504034|NCT00474526|564938557|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
156504035|NCT00474526|564938558|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
156504036|NCT00474526|564938559|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
156504037|NCT00474526|564938560|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
156504038|NCT00474526|564938561|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
156504039|NCT00474526|564938562|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
156504040|NCT00474526|564938563|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
156504041|NCT00474526|564938564|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
156504042|NCT00474526|564938565|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
156504043|NCT00474526|564938566|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
156504044|NCT00474526|564938550|FG000|Overall Study|Adverse Event|2|||
156504045|NCT00474526|564938551|FG001|Overall Study|Adverse Event|0|||
156504046|NCT00474526|564938552|FG002|Overall Study|Adverse Event|2|||
156504047|NCT00474526|564938553|FG003|Overall Study|Adverse Event|4|||
156504048|NCT00474526|564938554|FG004|Overall Study|Adverse Event|2|||
156504049|NCT00474526|564938555|FG005|Overall Study|Adverse Event|1|||
156504050|NCT00474526|564938556|FG006|Overall Study|Adverse Event|1|||
156504051|NCT00474526|564938557|FG007|Overall Study|Adverse Event|0|||
156504052|NCT00474526|564938558|FG008|Overall Study|Adverse Event|0|||
156504053|NCT00474526|564938559|FG009|Overall Study|Adverse Event|0|||
156504054|NCT00474526|564938560|FG010|Overall Study|Adverse Event|0|||
156504055|NCT00474526|564938561|FG011|Overall Study|Adverse Event|0|||
156504056|NCT00474526|564938562|FG012|Overall Study|Adverse Event|0|||
156504057|NCT00474526|564938563|FG013|Overall Study|Adverse Event|0|||
156504058|NCT00474526|564938564|FG014|Overall Study|Adverse Event|1|||
156504059|NCT00474526|564938565|FG015|Overall Study|Adverse Event|1|||
156504060|NCT00474526|564938566|FG016|Overall Study|Adverse Event|0|||
156504061|NCT00474526|564938550|FG000|Overall Study|Death|0|||
156383969|NCT01490632|564498927|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
156383970|NCT01490632|564498908|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383971|NCT01490632|564498909|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383972|NCT01490632|564498910|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383973|NCT01490632|564498911|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383974|NCT01490632|564498912|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383975|NCT01490632|564498913|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
156383976|NCT01490632|564498914|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383977|NCT01490632|564498915|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383978|NCT01490632|564498916|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383979|NCT01490632|564498917|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383980|NCT01490632|564498918|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383981|NCT01490632|564498919|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383982|NCT01490632|564498920|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383983|NCT01490632|564498921|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383984|NCT01490632|564498922|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383985|NCT01490632|564498923|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383986|NCT01490632|564498924|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383987|NCT01490632|564498925|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383988|NCT01490632|564498926|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383989|NCT01490632|564498927|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156383990|NCT01490632|564498908|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156383991|NCT01490632|564498909|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156383992|NCT01490632|564498910|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156383993|NCT01490632|564498911|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156383994|NCT01490632|564498912|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156383995|NCT01490632|564498913|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156383996|NCT01490632|564498914|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
156383997|NCT01490632|564498915|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156383998|NCT01490632|564498916|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
156383999|NCT01490632|564498917|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156384000|NCT01490632|564498918|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
156384001|NCT01490632|564498919|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
156384002|NCT01490632|564498920|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156384003|NCT01490632|564498921|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156504062|NCT00474526|564938551|FG001|Overall Study|Death|0|||
156504063|NCT00474526|564938552|FG002|Overall Study|Death|0|||
156504064|NCT00474526|564938553|FG003|Overall Study|Death|0|||
156504065|NCT00474526|564938554|FG004|Overall Study|Death|0|||
156504066|NCT00474526|564938555|FG005|Overall Study|Death|0|||
156504067|NCT00474526|564938556|FG006|Overall Study|Death|0|||
156504068|NCT00474526|564938557|FG007|Overall Study|Death|0|||
156504069|NCT00474526|564938558|FG008|Overall Study|Death|0|||
156504070|NCT00474526|564938559|FG009|Overall Study|Death|0|||
156384004|NCT01490632|564498922|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156384005|NCT01490632|564498923|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156384006|NCT01490632|564498924|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156384007|NCT01490632|564498925|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156384008|NCT01490632|564498926|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156384009|NCT01490632|564498927|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156384010|NCT01490632|564498908|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384011|NCT01490632|564498909|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384012|NCT01490632|564498910|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384013|NCT01490632|564498911|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384014|NCT01490632|564498912|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384015|NCT01490632|564498913|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
156384016|NCT01490632|564498914|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
156384017|NCT01490632|564498915|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
156384018|NCT01490632|564498916|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
156384019|NCT01490632|564498917|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
156384020|NCT01490632|564498918|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
156384021|NCT01490632|564498919|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
156384022|NCT01490632|564498920|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384023|NCT01490632|564498921|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384024|NCT01490632|564498922|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384025|NCT01490632|564498923|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384026|NCT01490632|564498924|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384027|NCT01490632|564498925|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384028|NCT01490632|564498926|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384029|NCT01490632|564498927|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156384030|NCT01490632|564498908|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384031|NCT01490632|564498909|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384032|NCT01490632|564498910|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384033|NCT01490632|564498911|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384034|NCT01490632|564498912|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384035|NCT01490632|564498913|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384036|NCT01490632|564498914|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384037|NCT01490632|564498915|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384038|NCT01490632|564498916|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384039|NCT01490632|564498917|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384040|NCT01490632|564498918|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384041|NCT01490632|564498919|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384042|NCT01490632|564498920|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384043|NCT01490632|564498921|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384044|NCT01490632|564498922|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
156384045|NCT01490632|564498923|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
156384046|NCT01490632|564498924|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384047|NCT01490632|564498925|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384048|NCT01490632|564498926|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384049|NCT01490632|564498927|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
156384050|NCT01490632|564498908|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384051|NCT01490632|564498909|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384052|NCT01490632|564498910|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384053|NCT01490632|564498911|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384054|NCT01490632|564498912|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384055|NCT01490632|564498913|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384056|NCT01490632|564498914|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384057|NCT01490632|564498915|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384058|NCT01490632|564498916|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384059|NCT01490632|564498917|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384060|NCT01490632|564498918|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384061|NCT01490632|564498919|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384062|NCT01490632|564498920|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384063|NCT01490632|564498921|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
156384064|NCT01490632|564498922|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384065|NCT01490632|564498923|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384066|NCT01490632|564498924|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384067|NCT01490632|564498925|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384068|NCT01490632|564498926|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384069|NCT01490632|564498927|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156384070|NCT01490632|564498908|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384071|NCT01490632|564498909|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384072|NCT01490632|564498910|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384073|NCT01490632|564498911|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384074|NCT01490632|564498912|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384075|NCT01490632|564498913|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384076|NCT01490632|564498914|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384077|NCT01490632|564498915|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384078|NCT01490632|564498916|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384079|NCT01490632|564498917|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384080|NCT01490632|564498918|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384081|NCT01490632|564498919|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384082|NCT01490632|564498920|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384083|NCT01490632|564498921|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384084|NCT01490632|564498922|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
156384085|NCT01490632|564498923|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
156384086|NCT01490632|564498924|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384087|NCT01490632|564498925|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384088|NCT01490632|564498926|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384089|NCT01490632|564498927|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156384090|NCT01490632|564498908|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384091|NCT01490632|564498909|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384092|NCT01490632|564498910|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384093|NCT01490632|564498911|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384094|NCT01490632|564498912|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384095|NCT01490632|564498913|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384096|NCT01490632|564498914|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384097|NCT01490632|564498915|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384098|NCT01490632|564498916|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384099|NCT01490632|564498917|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384100|NCT01490632|564498918|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384101|NCT01490632|564498919|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384102|NCT01490632|564498920|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
156384103|NCT01490632|564498921|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
156384104|NCT01490632|564498922|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
156384105|NCT01490632|564498923|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
156384106|NCT01490632|564498924|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384107|NCT01490632|564498925|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384108|NCT01490632|564498926|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384109|NCT01490632|564498927|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156384110|NCT01490632|564498908|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
156384111|NCT01490632|564498909|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
156384112|NCT01490632|564498910|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
156384113|NCT01490632|564498911|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
156384114|NCT01490632|564498912|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
156384115|NCT01490632|564498913|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
156384116|NCT01490632|564498914|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
156384117|NCT01490632|564498915|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
156384118|NCT01490632|564498916|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
156384119|NCT01490632|564498917|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
156384120|NCT01490632|564498918|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
156384121|NCT01490632|564498919|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
156384122|NCT01490632|564498920|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
156384123|NCT01490632|564498921|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
156384124|NCT01490632|564498922|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
156384125|NCT01490632|564498923|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
156384126|NCT01490632|564498924|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
156384127|NCT01490632|564498925|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
156384128|NCT01490632|564498926|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
156504071|NCT00474526|564938560|FG010|Overall Study|Death|0|||
156504072|NCT00474526|564938561|FG011|Overall Study|Death|0|||
156504073|NCT00474526|564938562|FG012|Overall Study|Death|0|||
156504074|NCT00474526|564938563|FG013|Overall Study|Death|3|||
156504075|NCT00474526|564938564|FG014|Overall Study|Death|0|||
156504076|NCT00474526|564938565|FG015|Overall Study|Death|0|||
156504077|NCT00474526|564938566|FG016|Overall Study|Death|0|||
156504078|NCT00474526|564938550|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504079|NCT00474526|564938551|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
156504080|NCT00474526|564938552|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504081|NCT00474526|564938553|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
156504082|NCT00474526|564938554|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
156504083|NCT00474526|564938555|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504084|NCT00474526|564938556|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504085|NCT00474526|564938557|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504086|NCT00474526|564938558|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504087|NCT00474526|564938559|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504088|NCT00474526|564938560|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504089|NCT00474526|564938561|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504090|NCT00474526|564938562|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504091|NCT00474526|564938563|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
156504092|NCT00474526|564938564|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
156504093|NCT00474526|564938565|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504094|NCT00474526|564938566|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
156504095|NCT00474526|564938550|FG000|Overall Study|Lost to Follow-up|8|||
156504096|NCT00474526|564938551|FG001|Overall Study|Lost to Follow-up|6|||
156504097|NCT00474526|564938552|FG002|Overall Study|Lost to Follow-up|13|||
156504098|NCT00474526|564938553|FG003|Overall Study|Lost to Follow-up|29|||
156504099|NCT00474526|564938554|FG004|Overall Study|Lost to Follow-up|11|||
156504100|NCT00474526|564938555|FG005|Overall Study|Lost to Follow-up|5|||
156504101|NCT00474526|564938556|FG006|Overall Study|Lost to Follow-up|8|||
156504102|NCT00474526|564938557|FG007|Overall Study|Lost to Follow-up|1|||
156504103|NCT00474526|564938558|FG008|Overall Study|Lost to Follow-up|0|||
156504104|NCT00474526|564938559|FG009|Overall Study|Lost to Follow-up|6|||
156504105|NCT00474526|564938560|FG010|Overall Study|Lost to Follow-up|2|||
156504106|NCT00474526|564938561|FG011|Overall Study|Lost to Follow-up|4|||
156504107|NCT00474526|564938562|FG012|Overall Study|Lost to Follow-up|6|||
156504108|NCT00474526|564938563|FG013|Overall Study|Lost to Follow-up|74|||
156504109|NCT00474526|564938564|FG014|Overall Study|Lost to Follow-up|29|||
156504110|NCT00474526|564938565|FG015|Overall Study|Lost to Follow-up|4|||
156504111|NCT00474526|564938566|FG016|Overall Study|Lost to Follow-up|5|||
156504112|NCT00474526|564938550|FG000|Overall Study|Protocol Violation|2|||
156504113|NCT00474526|564938551|FG001|Overall Study|Protocol Violation|6|||
156504114|NCT00474526|564938552|FG002|Overall Study|Protocol Violation|4|||
156504115|NCT00474526|564938553|FG003|Overall Study|Protocol Violation|12|||
156504116|NCT00474526|564938554|FG004|Overall Study|Protocol Violation|3|||
156504117|NCT00474526|564938555|FG005|Overall Study|Protocol Violation|1|||
156504118|NCT00474526|564938556|FG006|Overall Study|Protocol Violation|3|||
156504119|NCT00474526|564938557|FG007|Overall Study|Protocol Violation|0|||
156504120|NCT00474526|564938558|FG008|Overall Study|Protocol Violation|0|||
156504121|NCT00474526|564938559|FG009|Overall Study|Protocol Violation|4|||
156504122|NCT00474526|564938560|FG010|Overall Study|Protocol Violation|2|||
156504123|NCT00474526|564938561|FG011|Overall Study|Protocol Violation|2|||
156504124|NCT00474526|564938562|FG012|Overall Study|Protocol Violation|4|||
156504125|NCT00474526|564938563|FG013|Overall Study|Protocol Violation|19|||
156504126|NCT00474526|564938564|FG014|Overall Study|Protocol Violation|9|||
156504127|NCT00474526|564938565|FG015|Overall Study|Protocol Violation|6|||
156504128|NCT00474526|564938566|FG016|Overall Study|Protocol Violation|2|||
156504129|NCT00474526|564938550|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
156504130|NCT00474526|564938551|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
156504131|NCT00474526|564938552|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
156504132|NCT00474526|564938553|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
156504133|NCT00474526|564938554|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
156504134|NCT00474526|564938555|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
156504135|NCT00474526|564938556|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
156384129|NCT01490632|564498927|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
156504136|NCT00474526|564938557|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
156504137|NCT00474526|564938558|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
156504138|NCT00474526|564938559|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
156504139|NCT00474526|564938560|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
156504140|NCT00474526|564938561|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
156504141|NCT00474526|564938562|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
156504142|NCT00474526|564938563|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
156504143|NCT00474526|564938564|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
156504144|NCT00474526|564938565|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
156504145|NCT00474526|564938566|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
156384130|NCT01490632|564498908|FG000|Part D: Re-Treatment Period|Death|0|||
156504146|NCT00474526|564938550|FG000|Overall Study|Withdrawal by Subject|9|||
156504147|NCT00474526|564938551|FG001|Overall Study|Withdrawal by Subject|24|||
156504148|NCT00474526|564938552|FG002|Overall Study|Withdrawal by Subject|21|||
156504149|NCT00474526|564938553|FG003|Overall Study|Withdrawal by Subject|52|||
156504150|NCT00474526|564938554|FG004|Overall Study|Withdrawal by Subject|38|||
156504151|NCT00474526|564938555|FG005|Overall Study|Withdrawal by Subject|6|||
156504152|NCT00474526|564938556|FG006|Overall Study|Withdrawal by Subject|12|||
156504153|NCT00474526|564938557|FG007|Overall Study|Withdrawal by Subject|4|||
156504154|NCT00474526|564938558|FG008|Overall Study|Withdrawal by Subject|4|||
156504155|NCT00474526|564938559|FG009|Overall Study|Withdrawal by Subject|13|||
156504156|NCT00474526|564938560|FG010|Overall Study|Withdrawal by Subject|5|||
156504157|NCT00474526|564938561|FG011|Overall Study|Withdrawal by Subject|4|||
156504158|NCT00474526|564938562|FG012|Overall Study|Withdrawal by Subject|4|||
156504159|NCT00474526|564938563|FG013|Overall Study|Withdrawal by Subject|37|||
156504160|NCT00474526|564938564|FG014|Overall Study|Withdrawal by Subject|22|||
156504161|NCT00474526|564938565|FG015|Overall Study|Withdrawal by Subject|1|||
156504162|NCT00474526|564938566|FG016|Overall Study|Withdrawal by Subject|1|||
156504163|NCT00953147|564938567|FG000|Overall Study|Adverse Event|8|||
156504164|NCT00953147|564938568|FG001|Overall Study|Adverse Event|16|||
156504165|NCT00953147|564938569|FG002|Overall Study|Adverse Event|6|||
156504166|NCT00953147|564938567|FG000|Overall Study|Protocol Violation|2|||
156504167|NCT00953147|564938568|FG001|Overall Study|Protocol Violation|8|||
156504168|NCT00953147|564938569|FG002|Overall Study|Protocol Violation|4|||
156504169|NCT00953147|564938567|FG000|Overall Study|Withdrawal by Subject|13|||
156504170|NCT00953147|564938568|FG001|Overall Study|Withdrawal by Subject|15|||
156504171|NCT00953147|564938569|FG002|Overall Study|Withdrawal by Subject|12|||
156504172|NCT00953147|564938567|FG000|Overall Study|Lost to Follow-up|8|||
156504173|NCT00953147|564938568|FG001|Overall Study|Lost to Follow-up|9|||
156504174|NCT00953147|564938569|FG002|Overall Study|Lost to Follow-up|4|||
156504175|NCT00953147|564938567|FG000|Overall Study|Physician Decision|2|||
156504176|NCT00953147|564938568|FG001|Overall Study|Physician Decision|7|||
156504177|NCT00953147|564938569|FG002|Overall Study|Physician Decision|3|||
156504178|NCT00953147|564938567|FG000|Overall Study|Other|4|||
156504179|NCT00953147|564938568|FG001|Overall Study|Other|11|||
156504180|NCT00953147|564938569|FG002|Overall Study|Other|13|||
156504181|NCT01484431|564938571|FG000|Period 1: High Dose|Physician Decision|0|||
156504182|NCT01484431|564938572|FG001|Period 1: High Dose|Physician Decision|1|||
156504183|NCT01484431|564938573|FG002|Period 1: High Dose|Physician Decision|0|||
156504184|NCT01484431|564938571|FG000|Period 2|Death|0|||
156504185|NCT01484431|564938572|FG001|Period 2|Death|1|||
156504186|NCT01484431|564938573|FG002|Period 2|Death|1|||
156504187|NCT01484431|564938571|FG000|Period 2|Physician Decision|0|||
156504188|NCT01484431|564938572|FG001|Period 2|Physician Decision|0|||
156504189|NCT01484431|564938573|FG002|Period 2|Physician Decision|1|||
156504190|NCT01484431|564938571|FG000|Period 2|Non-Compliance with Study Drug|1|||
156504191|NCT01484431|564938572|FG001|Period 2|Non-Compliance with Study Drug|0|||
156504192|NCT01484431|564938573|FG002|Period 2|Non-Compliance with Study Drug|0|||
156504193|NCT01251770|564938574|FG000|Overall Study|Protocol Violation|13|||
156504194|NCT01251770|564938575|FG001|Overall Study|Protocol Violation|7|||
156504195|NCT02113124|564938576|FG000|Overall Study|Unable to retrieve blood sample|1|||
156504196|NCT02113124|564938577|FG001|Overall Study|Unable to retrieve blood sample|1|||
156504197|NCT02763215|564938578|FG000|Overall Study|Participants withdrew from study|3|||
156504198|NCT02763215|564938578|FG000|Overall Study|Missed visit|1|||
156504199|NCT02763215|564938578|FG000|Overall Study|Visit outside visit-window|1|||
156504200|NCT02763215|564938578|FG000|Overall Study|Death|1|||
156504201|NCT02763215|564938578|FG000|Overall Study|Lost to Follow-up|1|||
156504202|NCT02521363|564938581|FG000|Overall Study|Withdrawal by Subject|1|||
156504203|NCT02521363|564938582|FG001|Overall Study|Withdrawal by Subject|2|||
156504204|NCT00953771|564938586|FG000|Overall Study|Death|1|||
156504205|NCT00953771|564938587|FG001|Overall Study|Death|0|||
156504206|NCT00974259|564938588|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
156504207|NCT00974259|564938589|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
156504208|NCT00944229|564938590|FG000|Overall Study|Withdrawal by Subject|11|||
156504209|NCT00944229|564938590|FG000|Overall Study|Physician Decision|14|||
156504210|NCT02963090|564938591|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
156504211|NCT02963090|564938592|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
156504212|NCT00732992|564938604|FG000|Overall Study|Adverse Event|1|||
156504213|NCT00732992|564938605|FG001|Overall Study|Adverse Event|1|||
156504214|NCT00732992|564938604|FG000|Overall Study|Objective Progression or Relapse|3|||
156504215|NCT00732992|564938605|FG001|Overall Study|Objective Progression or Relapse|5|||
156504216|NCT00732992|564938604|FG000|Overall Study|Global Deterioration of Health Status|1|||
156504217|NCT00732992|564938605|FG001|Overall Study|Global Deterioration of Health Status|0|||
156504218|NCT00732992|564938604|FG000|Overall Study|Withdrawal by Subject|1|||
156504219|NCT00732992|564938605|FG001|Overall Study|Withdrawal by Subject|0|||
156504220|NCT00762476|564938614|FG000|Overall Study|Adverse Event|7|||
156504221|NCT00762476|564938615|FG001|Overall Study|Adverse Event|1|||
156504222|NCT00762476|564938614|FG000|Overall Study|Lost to Follow-up|2|||
156504223|NCT00762476|564938615|FG001|Overall Study|Lost to Follow-up|0|||
156504224|NCT00762476|564938614|FG000|Overall Study|Protocol Violation|5|||
156504225|NCT00762476|564938615|FG001|Overall Study|Protocol Violation|6|||
156504226|NCT00762476|564938614|FG000|Overall Study|Physician Decision|2|||
156504227|NCT00762476|564938615|FG001|Overall Study|Physician Decision|14|||
156504228|NCT00762476|564938614|FG000|Overall Study|Withdrawal by Subject|6|||
156384131|NCT01490632|564498909|FG001|Part D: Re-Treatment Period|Death|0|||
156384132|NCT01490632|564498910|FG002|Part D: Re-Treatment Period|Death|0|||
156384133|NCT01490632|564498911|FG003|Part D: Re-Treatment Period|Death|0|||
156384134|NCT01490632|564498912|FG004|Part D: Re-Treatment Period|Death|0|||
156384135|NCT01490632|564498913|FG005|Part D: Re-Treatment Period|Death|0|||
156384136|NCT01490632|564498914|FG006|Part D: Re-Treatment Period|Death|0|||
156384137|NCT01490632|564498915|FG007|Part D: Re-Treatment Period|Death|0|||
156384138|NCT01490632|564498916|FG008|Part D: Re-Treatment Period|Death|0|||
156384139|NCT01490632|564498917|FG009|Part D: Re-Treatment Period|Death|0|||
156384140|NCT01490632|564498918|FG010|Part D: Re-Treatment Period|Death|0|||
156384141|NCT01490632|564498919|FG011|Part D: Re-Treatment Period|Death|0|||
156384142|NCT01490632|564498920|FG012|Part D: Re-Treatment Period|Death|0|||
156384143|NCT01490632|564498921|FG013|Part D: Re-Treatment Period|Death|0|||
156384144|NCT01490632|564498922|FG014|Part D: Re-Treatment Period|Death|0|||
156384145|NCT01490632|564498923|FG015|Part D: Re-Treatment Period|Death|0|||
156384146|NCT01490632|564498924|FG016|Part D: Re-Treatment Period|Death|0|||
156384147|NCT01490632|564498925|FG017|Part D: Re-Treatment Period|Death|0|||
156384148|NCT01490632|564498926|FG018|Part D: Re-Treatment Period|Death|1|||
156384149|NCT01490632|564498927|FG019|Part D: Re-Treatment Period|Death|0|||
156384150|NCT01490632|564498908|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384151|NCT01490632|564498909|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384152|NCT01490632|564498910|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384153|NCT01490632|564498911|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384154|NCT01490632|564498912|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384155|NCT01490632|564498913|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384156|NCT01490632|564498914|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384157|NCT01490632|564498915|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384158|NCT01490632|564498916|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384159|NCT01490632|564498917|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384160|NCT01490632|564498918|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384161|NCT01490632|564498919|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384162|NCT01490632|564498920|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384163|NCT01490632|564498921|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384164|NCT01490632|564498922|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384165|NCT01490632|564498923|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384166|NCT01490632|564498924|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156384167|NCT01490632|564498925|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
156384168|NCT01490632|564498926|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
156384169|NCT01490632|564498927|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
156384170|NCT01490632|564498908|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384171|NCT01490632|564498909|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384172|NCT01490632|564498910|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384173|NCT01490632|564498911|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384174|NCT01490632|564498912|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384175|NCT01490632|564498913|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384176|NCT01490632|564498914|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384177|NCT01490632|564498915|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384178|NCT01490632|564498916|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384179|NCT01490632|564498917|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384180|NCT01490632|564498918|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384181|NCT01490632|564498919|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384182|NCT01490632|564498920|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384183|NCT01490632|564498921|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384184|NCT01490632|564498922|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384185|NCT01490632|564498923|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384186|NCT01490632|564498924|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384187|NCT01490632|564498925|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384188|NCT01490632|564498926|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
156384189|NCT01490632|564498927|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156384190|NCT01490632|564498908|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
156384191|NCT01490632|564498909|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
156384192|NCT01490632|564498910|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
156384193|NCT01490632|564498911|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
156384194|NCT01490632|564498912|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
156384195|NCT01490632|564498913|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
156384196|NCT01490632|564498914|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
156384197|NCT01490632|564498915|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
156384198|NCT01490632|564498916|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
156384199|NCT01490632|564498917|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
156384200|NCT01490632|564498918|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
156384201|NCT01490632|564498919|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
156384202|NCT01490632|564498920|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
156384203|NCT01490632|564498921|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
156504229|NCT00762476|564938615|FG001|Overall Study|Withdrawal by Subject|12|||
156504230|NCT00762476|564938614|FG000|Overall Study|antibiotic use|0|||
156504231|NCT00762476|564938615|FG001|Overall Study|antibiotic use|1|||
156504232|NCT00762476|564938614|FG000|Overall Study|non-compliance with study visits|0|||
156504233|NCT00762476|564938615|FG001|Overall Study|non-compliance with study visits|2|||
156504234|NCT00762476|564938614|FG000|Overall Study|Seasonal allergies|1|||
156504235|NCT00762476|564938615|FG001|Overall Study|Seasonal allergies|0|||
156504236|NCT00856245|564938617|FG000|Overall Study|Was not transplanted|5|||
156504237|NCT04674189|564938622|FG000|Overall Study|Adverse Event|0|||
156504238|NCT04674189|564938623|FG001|Overall Study|Adverse Event|0|||
156504239|NCT04674189|564938624|FG002|Overall Study|Adverse Event|1|||
156504240|NCT04674189|564938622|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
156504241|NCT04674189|564938623|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
156504242|NCT04674189|564938624|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
156504243|NCT04674189|564938622|FG000|Overall Study|Physician Decision|1|||
156504244|NCT04674189|564938623|FG001|Overall Study|Physician Decision|0|||
156504245|NCT04674189|564938624|FG002|Overall Study|Physician Decision|0|||
156504246|NCT04674189|564938622|FG000|Overall Study|Withdrawal by Participant|83|||
156504247|NCT04674189|564938623|FG001|Overall Study|Withdrawal by Participant|71|||
156504248|NCT04674189|564938624|FG002|Overall Study|Withdrawal by Participant|142|||
156504249|NCT04674189|564938622|FG000|Overall Study|Lost to Follow-up|55|||
156504250|NCT04674189|564938623|FG001|Overall Study|Lost to Follow-up|53|||
156504251|NCT04674189|564938624|FG002|Overall Study|Lost to Follow-up|44|||
156504252|NCT04674189|564938622|FG000|Overall Study|Miscellaneous|27|||
156504253|NCT04674189|564938623|FG001|Overall Study|Miscellaneous|23|||
156504254|NCT04674189|564938624|FG002|Overall Study|Miscellaneous|207|||
156504255|NCT04674189|564938622|FG000|Overall Study|Did Not Receive Treatment|3|||
156504256|NCT04674189|564938623|FG001|Overall Study|Did Not Receive Treatment|1|||
156504257|NCT04674189|564938624|FG002|Overall Study|Did Not Receive Treatment|2|||
156504258|NCT04946942|564938626|FG000|Overall Study|Lost to Follow-up|6|||
156504259|NCT04946942|564938627|FG001|Overall Study|Lost to Follow-up|2|||
156504260|NCT04946942|564938628|FG002|Overall Study|Lost to Follow-up|0|||
156504261|NCT03023423|564938629|FG000|Overall Study|Death|5|||
156504262|NCT03023423|564938630|FG001|Overall Study|Death|12|||
156504263|NCT03023423|564938631|FG002|Overall Study|Death|20|||
156504264|NCT03023423|564938629|FG000|Overall Study|Other|0|||
156504265|NCT03023423|564938630|FG001|Overall Study|Other|2|||
156504266|NCT03023423|564938631|FG002|Overall Study|Other|2|||
156504267|NCT03023423|564938629|FG000|Overall Study|Ongoing|2|||
156504268|NCT03023423|564938630|FG001|Overall Study|Ongoing|32|||
156504269|NCT03023423|564938631|FG002|Overall Study|Ongoing|24|||
156504270|NCT00681668|564938632|FG000|Overall Study|Protocol Violation|1|||
156504271|NCT00681668|564938632|FG000|Overall Study|Withdrawal by Subject|1|||
156504272|NCT04277507|564938633|FG000|Overall Study|Lost to Follow-up|17|||
156504273|NCT04277507|564938633|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
156504274|NCT04277507|564938633|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
156504275|NCT04277507|564938633|FG000|Overall Study|Withdrawal by Subject|3|||
156504276|NCT04277507|564938633|FG000|Overall Study|Death due to COVID-19|1|||
156504277|NCT04277507|564938633|FG000|Overall Study|Data missing for full evaluation|5|||
156504278|NCT00583947|564938636|FG000|Cross-over Period|Adverse Event|2|||
156504279|NCT00583947|564938637|FG001|Cross-over Period|Adverse Event|0|||
156504280|NCT00583947|564938636|FG000|Cross-over Period|Withdrawal by Subject|2|||
156504281|NCT00583947|564938637|FG001|Cross-over Period|Withdrawal by Subject|0|||
156504282|NCT00583947|564938636|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
156504283|NCT00583947|564938637|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
156504284|NCT00583947|564938636|FG000|Cross-over Period|Other|1|||
156504285|NCT00583947|564938637|FG001|Cross-over Period|Other|1|||
156504286|NCT05226130|564938638|FG000|Overall Study|Lost to Follow-up|0|||
156504287|NCT05226130|564938639|FG001|Overall Study|Lost to Follow-up|1|||
156504288|NCT05226130|564938638|FG000|Overall Study|Not treatment adherent|0|||
156504289|NCT05226130|564938639|FG001|Overall Study|Not treatment adherent|2|||
156504290|NCT03974022|564938640|FG000|Overall Study|Death|0|||
156504291|NCT03974022|564938641|FG001|Overall Study|Death|1|||
156504292|NCT03974022|564938642|FG002|Overall Study|Death|0|||
156504293|NCT03974022|564938643|FG003|Overall Study|Death|2|||
156504294|NCT03974022|564938644|FG004|Overall Study|Death|0|||
156546968|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
156504295|NCT03974022|564938645|FG005|Overall Study|Death|1|||
156504296|NCT03974022|564938646|FG006|Overall Study|Death|0|||
156504297|NCT03974022|564938647|FG007|Overall Study|Death|2|||
156504298|NCT03974022|564938648|FG008|Overall Study|Death|1|||
156504299|NCT03974022|564938649|FG009|Overall Study|Death|4|||
156504300|NCT03974022|564938650|FG010|Overall Study|Death|0|||
156504301|NCT03974022|564938651|FG011|Overall Study|Death|0|||
156504302|NCT03974022|564938652|FG012|Overall Study|Death|0|||
156504303|NCT03974022|564938653|FG013|Overall Study|Death|33|||
156504304|NCT03974022|564938654|FG014|Overall Study|Death|40|||
156504305|NCT03974022|564938640|FG000|Overall Study|Withdrawal by Subject|0|||
156504306|NCT03974022|564938641|FG001|Overall Study|Withdrawal by Subject|0|||
156504307|NCT03974022|564938642|FG002|Overall Study|Withdrawal by Subject|0|||
156504308|NCT03974022|564938643|FG003|Overall Study|Withdrawal by Subject|0|||
156504309|NCT03974022|564938644|FG004|Overall Study|Withdrawal by Subject|0|||
156504310|NCT03974022|564938645|FG005|Overall Study|Withdrawal by Subject|4|||
156504311|NCT03974022|564938646|FG006|Overall Study|Withdrawal by Subject|4|||
156504312|NCT03974022|564938647|FG007|Overall Study|Withdrawal by Subject|2|||
156504313|NCT03974022|564938648|FG008|Overall Study|Withdrawal by Subject|2|||
156504314|NCT03974022|564938649|FG009|Overall Study|Withdrawal by Subject|3|||
156504315|NCT03974022|564938650|FG010|Overall Study|Withdrawal by Subject|0|||
156504316|NCT03974022|564938651|FG011|Overall Study|Withdrawal by Subject|1|||
156504317|NCT03974022|564938652|FG012|Overall Study|Withdrawal by Subject|0|||
156504318|NCT03974022|564938653|FG013|Overall Study|Withdrawal by Subject|3|||
156504319|NCT03974022|564938654|FG014|Overall Study|Withdrawal by Subject|9|||
156504320|NCT03974022|564938640|FG000|Overall Study|Lost to Follow-up|0|||
156504321|NCT03974022|564938641|FG001|Overall Study|Lost to Follow-up|0|||
156504322|NCT03974022|564938642|FG002|Overall Study|Lost to Follow-up|0|||
156504323|NCT03974022|564938643|FG003|Overall Study|Lost to Follow-up|0|||
156504324|NCT03974022|564938644|FG004|Overall Study|Lost to Follow-up|0|||
156504325|NCT03974022|564938645|FG005|Overall Study|Lost to Follow-up|0|||
156504326|NCT03974022|564938646|FG006|Overall Study|Lost to Follow-up|1|||
156504327|NCT03974022|564938647|FG007|Overall Study|Lost to Follow-up|0|||
156504328|NCT03974022|564938648|FG008|Overall Study|Lost to Follow-up|0|||
156504329|NCT03974022|564938649|FG009|Overall Study|Lost to Follow-up|0|||
156504330|NCT03974022|564938650|FG010|Overall Study|Lost to Follow-up|0|||
156504331|NCT03974022|564938651|FG011|Overall Study|Lost to Follow-up|0|||
156504332|NCT03974022|564938652|FG012|Overall Study|Lost to Follow-up|0|||
156504333|NCT03974022|564938653|FG013|Overall Study|Lost to Follow-up|1|||
156384204|NCT01490632|564498922|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
156384205|NCT01490632|564498923|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
156384206|NCT01490632|564498924|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
156504334|NCT03974022|564938654|FG014|Overall Study|Lost to Follow-up|1|||
156504335|NCT03974022|564938640|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
156504336|NCT03974022|564938641|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
156504337|NCT03974022|564938642|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
156504338|NCT03974022|564938643|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
156504339|NCT03974022|564938644|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
156504340|NCT03974022|564938645|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
156504341|NCT03974022|564938646|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
156504342|NCT03974022|564938647|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
156504343|NCT03974022|564938648|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
156504344|NCT03974022|564938649|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
156504345|NCT03974022|564938650|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
156504346|NCT03974022|564938651|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
156504347|NCT03974022|564938652|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
156504348|NCT03974022|564938653|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
156504349|NCT03974022|564938654|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
156504350|NCT04680533|564938667|FG000|Overall Study|Screen failure|1|||
156504351|NCT04991753|564940736|FG000|Overall Study|Withdrawal by Subject|0|||
156504352|NCT04991753|564940737|FG001|Overall Study|Withdrawal by Subject|1|||
156504353|NCT02514239|564940742|FG000|Overall Study|Refused to continue trial medication|0|||
156504354|NCT02514239|564940743|FG001|Overall Study|Refused to continue trial medication|0|||
156504355|NCT02514239|564940744|FG002|Overall Study|Refused to continue trial medication|0|||
156504356|NCT02514239|564940745|FG003|Overall Study|Refused to continue trial medication|0|||
156504357|NCT02514239|564940746|FG004|Overall Study|Refused to continue trial medication|0|||
156504358|NCT02514239|564940747|FG005|Overall Study|Refused to continue trial medication|0|||
156546969|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
156546970|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
156384207|NCT01490632|564498925|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
156384208|NCT01490632|564498926|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
156384209|NCT01490632|564498927|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
156384210|NCT01490632|564498908|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
156384211|NCT01490632|564498909|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
156384212|NCT01490632|564498910|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
156384213|NCT01490632|564498911|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
156504359|NCT02514239|564940748|FG006|Overall Study|Refused to continue trial medication|0|||
156504360|NCT02514239|564940749|FG007|Overall Study|Refused to continue trial medication|0|||
156504361|NCT02514239|564940750|FG008|Overall Study|Refused to continue trial medication|0|||
156504362|NCT02514239|564940751|FG009|Overall Study|Refused to continue trial medication|1|||
156384214|NCT01490632|564498912|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
156384215|NCT01490632|564498913|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
156504363|NCT02514239|564940742|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
156504364|NCT02514239|564940743|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
156504365|NCT02514239|564940744|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
156504366|NCT02514239|564940745|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
156504367|NCT02514239|564940746|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
156504368|NCT02514239|564940747|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
156504369|NCT02514239|564940748|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
156504370|NCT02514239|564940749|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
156504371|NCT02514239|564940750|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
156504372|NCT02514239|564940751|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
156504373|NCT02514239|564940742|FG000|Overall Study|Not treated|0|||
156504374|NCT02514239|564940743|FG001|Overall Study|Not treated|1|||
156504375|NCT02514239|564940744|FG002|Overall Study|Not treated|0|||
156504376|NCT02514239|564940745|FG003|Overall Study|Not treated|0|||
156504377|NCT02514239|564940746|FG004|Overall Study|Not treated|0|||
156504378|NCT02514239|564940747|FG005|Overall Study|Not treated|0|||
156504379|NCT02514239|564940748|FG006|Overall Study|Not treated|0|||
156504380|NCT02514239|564940749|FG007|Overall Study|Not treated|0|||
156504381|NCT02514239|564940750|FG008|Overall Study|Not treated|0|||
156504382|NCT02514239|564940751|FG009|Overall Study|Not treated|0|||
156504383|NCT02514239|564940742|FG000|Overall Study|Other Adverse Events|2|||
156504384|NCT02514239|564940743|FG001|Overall Study|Other Adverse Events|0|||
156504385|NCT02514239|564940744|FG002|Overall Study|Other Adverse Events|0|||
156504386|NCT02514239|564940745|FG003|Overall Study|Other Adverse Events|1|||
156504387|NCT02514239|564940746|FG004|Overall Study|Other Adverse Events|0|||
156504388|NCT02514239|564940747|FG005|Overall Study|Other Adverse Events|1|||
156504389|NCT02514239|564940748|FG006|Overall Study|Other Adverse Events|0|||
156504390|NCT02514239|564940749|FG007|Overall Study|Other Adverse Events|1|||
156504391|NCT02514239|564940750|FG008|Overall Study|Other Adverse Events|2|||
156504392|NCT02514239|564940751|FG009|Overall Study|Other Adverse Events|0|||
156504393|NCT02514239|564940742|FG000|Overall Study|Progressive disease|3|||
156504394|NCT02514239|564940743|FG001|Overall Study|Progressive disease|3|||
156504395|NCT02514239|564940744|FG002|Overall Study|Progressive disease|2|||
156504396|NCT02514239|564940745|FG003|Overall Study|Progressive disease|2|||
156504397|NCT02514239|564940746|FG004|Overall Study|Progressive disease|3|||
156504398|NCT02514239|564940747|FG005|Overall Study|Progressive disease|3|||
156504399|NCT02514239|564940748|FG006|Overall Study|Progressive disease|4|||
156504400|NCT02514239|564940749|FG007|Overall Study|Progressive disease|2|||
156504401|NCT02514239|564940750|FG008|Overall Study|Progressive disease|5|||
156504402|NCT02514239|564940751|FG009|Overall Study|Progressive disease|0|||
156504403|NCT03299049|564940752|FG000|Overall Study|On-going|486|||
156504404|NCT03299049|564940753|FG001|Overall Study|On-going|481|||
156504405|NCT03299049|564940752|FG000|Overall Study|Withdrawal by Subject|6|||
156504406|NCT03299049|564940753|FG001|Overall Study|Withdrawal by Subject|21|||
156504407|NCT03299049|564940752|FG000|Overall Study|Physician Decision|5|||
156504408|NCT03299049|564940753|FG001|Overall Study|Physician Decision|1|||
156504409|NCT03299049|564940752|FG000|Overall Study|Lost to Follow-up|2|||
156504410|NCT03299049|564940753|FG001|Overall Study|Lost to Follow-up|0|||
156504411|NCT03299049|564940752|FG000|Overall Study|Pregnancy|1|||
156504412|NCT03299049|564940753|FG001|Overall Study|Pregnancy|3|||
156504413|NCT03299049|564940752|FG000|Overall Study|Protocol Violation|1|||
156504414|NCT03299049|564940753|FG001|Overall Study|Protocol Violation|1|||
156504415|NCT03299049|564940752|FG000|Overall Study|Lack of Efficacy|9|||
156504416|NCT03299049|564940753|FG001|Overall Study|Lack of Efficacy|3|||
156504417|NCT03299049|564940752|FG000|Overall Study|Adverse Event|12|||
156504418|NCT03299049|564940753|FG001|Overall Study|Adverse Event|13|||
156504419|NCT02980042|564940754|FG000|Overall Study|Lost to Follow-up|5|||
156504420|NCT02980042|564940755|FG001|Overall Study|Lost to Follow-up|0|||
156504421|NCT02980042|564940754|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
156504422|NCT02980042|564940755|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
156504423|NCT00790400|564940760|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
156504424|NCT00790400|564940761|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
156504425|NCT00790400|564940760|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
156504426|NCT00790400|564940761|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
156504427|NCT00790400|564940760|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
156504428|NCT00790400|564940761|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
156504429|NCT00790400|564940760|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
156504430|NCT00790400|564940761|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
156504431|NCT00790400|564940760|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
156504432|NCT00790400|564940761|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
156504433|NCT00790400|564940760|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
156504434|NCT00790400|564940761|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
156504435|NCT00790400|564940760|FG000|Double-blind Period (Core Phase)|Death|1|||
156504436|NCT00790400|564940761|FG001|Double-blind Period (Core Phase)|Death|0|||
156504437|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
156504438|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
156384216|NCT01490632|564498914|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
156384217|NCT01490632|564498915|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
156384218|NCT01490632|564498916|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
156384219|NCT01490632|564498917|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
156384220|NCT01490632|564498918|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
156384221|NCT01490632|564498919|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
156384222|NCT01490632|564498920|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
156384223|NCT01490632|564498921|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
156384224|NCT01490632|564498922|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
156384225|NCT01490632|564498923|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
156384226|NCT01490632|564498924|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
156384227|NCT01490632|564498925|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
156384228|NCT01490632|564498926|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
156384229|NCT01490632|564498927|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
156384230|NCT01490632|564498908|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384231|NCT01490632|564498909|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384232|NCT01490632|564498910|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384233|NCT01490632|564498911|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384234|NCT01490632|564498912|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156504439|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
156384235|NCT01490632|564498913|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384236|NCT01490632|564498914|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156504440|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
156504441|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
156504442|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
156504443|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
156504444|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
156504445|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
156504446|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
156504447|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|Death|1|||
156546971|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
156546972|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
156546973|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
156546974|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
156546975|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
156546976|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
156546977|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
156546978|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Other|0|||
156546979|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Other|0|||
156546980|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Other|0|||
156546981|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Other|1|||
156546982|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Other|0|||
156546983|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
156546984|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
156546985|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
156546986|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
156546987|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
156546988|NCT00440947|565094995|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
156546989|NCT00440947|565094996|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
156546990|NCT00440947|565094997|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
156546991|NCT00440947|565094998|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
156546992|NCT00440947|565094999|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
156546993|NCT01827670|565095000|FG000|Overall Study|Withdrawal of Consent|3|||
156546994|NCT01827670|565095001|FG001|Overall Study|Withdrawal of Consent|2|||
156546995|NCT01827670|565095000|FG000|Overall Study|Lost to Follow-up|0|||
156546996|NCT01827670|565095001|FG001|Overall Study|Lost to Follow-up|1|||
156546997|NCT02813694|565095007|FG000|Overall Study|Physician Decision|0|||
156546998|NCT02813694|565095008|FG001|Overall Study|Physician Decision|1|||
156546999|NCT02813694|565095007|FG000|Overall Study|Withdrawal by Subject|10|||
156547000|NCT02813694|565095008|FG001|Overall Study|Withdrawal by Subject|9|||
156547001|NCT02813694|565095007|FG000|Overall Study|Lost to Follow-up|1|||
156547002|NCT02813694|565095008|FG001|Overall Study|Lost to Follow-up|1|||
156547003|NCT02813694|565095007|FG000|Overall Study|Death|3|||
156547004|NCT02813694|565095008|FG001|Overall Study|Death|3|||
156547005|NCT02813694|565095007|FG000|Overall Study|Randomized- did not receive study drug|2|||
156547006|NCT02813694|565095008|FG001|Overall Study|Randomized- did not receive study drug|0|||
156547007|NCT02813694|565095007|FG000|Overall Study|Patient hospitalized|1|||
156547008|NCT02813694|565095008|FG001|Overall Study|Patient hospitalized|0|||
156547009|NCT00513500|565095018|FG000|Overall Study|Lost to Follow-up|35|||
156547010|NCT00513500|565095019|FG001|Overall Study|Lost to Follow-up|39|||
156547011|NCT00513500|565095018|FG000|Overall Study|Death|2|||
156547012|NCT00513500|565095019|FG001|Overall Study|Death|1|||
156547013|NCT00513500|565095018|FG000|Overall Study|Hospitalized|4|||
156547014|NCT00513500|565095019|FG001|Overall Study|Hospitalized|14|||
156547015|NCT01136655|565095021|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
156547016|NCT01136655|565095021|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
156547017|NCT01136655|565095021|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
156547018|NCT01136655|565095021|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
156547019|NCT01265550|565095022|FG000|Pre Randomization|Withdrawal by Subject|0|||
156547020|NCT01265550|565095023|FG001|Pre Randomization|Withdrawal by Subject|0|||
156547021|NCT01265550|565095024|FG002|Pre Randomization|Withdrawal by Subject|0|||
156547022|NCT01265550|565095025|FG003|Pre Randomization|Withdrawal by Subject|70|||
156547023|NCT01265550|565095022|FG000|Pre Randomization|Technical Exclusions|0|||
156547024|NCT01265550|565095023|FG001|Pre Randomization|Technical Exclusions|0|||
156547025|NCT01265550|565095024|FG002|Pre Randomization|Technical Exclusions|0|||
156547026|NCT01265550|565095025|FG003|Pre Randomization|Technical Exclusions|54|||
156547027|NCT01265550|565095022|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
156547028|NCT01265550|565095023|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
156547029|NCT01265550|565095024|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
156504448|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|Death|0|||
156504449|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
156504450|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
156504451|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
156504452|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
156504453|NCT00790400|564940760|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
156504454|NCT00790400|564940761|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
156504455|NCT02412735|564940763|FG000|Overall Study|Adverse Event|0|||
156504456|NCT02412735|564940764|FG001|Overall Study|Adverse Event|1|||
156547030|NCT01265550|565095025|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
156547031|NCT01265550|565095022|FG000|Pre Randomization|Non-GERD organic disorders|0|||
156547032|NCT01265550|565095023|FG001|Pre Randomization|Non-GERD organic disorders|0|||
156504457|NCT02412735|564940765|FG002|Overall Study|Adverse Event|2|||
156504458|NCT02412735|564940763|FG000|Overall Study|Withdrawal by Subject|23|||
156504459|NCT02412735|564940764|FG001|Overall Study|Withdrawal by Subject|27|||
156504460|NCT02412735|564940765|FG002|Overall Study|Withdrawal by Subject|22|||
156504461|NCT02412735|564940763|FG000|Overall Study|Investigator Decision|3|||
156504462|NCT02412735|564940764|FG001|Overall Study|Investigator Decision|3|||
156504463|NCT02412735|564940765|FG002|Overall Study|Investigator Decision|2|||
156504464|NCT02412735|564940763|FG000|Overall Study|Lost to Follow-up|17|||
156504465|NCT02412735|564940764|FG001|Overall Study|Lost to Follow-up|11|||
156504466|NCT02412735|564940765|FG002|Overall Study|Lost to Follow-up|18|||
156504467|NCT02412735|564940763|FG000|Overall Study|Reason not Specified|3|||
156504468|NCT02412735|564940764|FG001|Overall Study|Reason not Specified|2|||
156504469|NCT02412735|564940765|FG002|Overall Study|Reason not Specified|2|||
156504470|NCT02460575|564940766|FG000|Overall Study|Lost to Follow-up|1|||
156504471|NCT02460575|564940767|FG001|Overall Study|Lost to Follow-up|0|||
156504472|NCT00592293|564940768|FG000|Overall Study|Withdrawal by Subject|1|||
156504473|NCT01606319|564940771|FG000|Overall Study|Lost to Follow-up|17|||
156504474|NCT01606319|564940772|FG001|Overall Study|Lost to Follow-up|14|||
156504475|NCT01606319|564940771|FG000|Overall Study|Withdrawal by Subject|9|||
156504476|NCT01606319|564940772|FG001|Overall Study|Withdrawal by Subject|12|||
156504477|NCT01606319|564940771|FG000|Overall Study|Physician Decision|1|||
156504478|NCT01606319|564940772|FG001|Overall Study|Physician Decision|2|||
156504479|NCT01606319|564940771|FG000|Overall Study|Lack of Efficacy|6|||
156504480|NCT01606319|564940772|FG001|Overall Study|Lack of Efficacy|8|||
156504481|NCT01606319|564940771|FG000|Overall Study|Adverse Event|1|||
156504482|NCT01606319|564940772|FG001|Overall Study|Adverse Event|4|||
156504483|NCT01270828|564940773|FG000|Pregabalin CR SB|Reason Unspecified|0|||
156504484|NCT01270828|564940774|FG001|Pregabalin CR SB|Reason Unspecified|0|||
156504485|NCT01270828|564940775|FG002|Pregabalin CR SB|Reason Unspecified|8|||
156504486|NCT01270828|564940773|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
156504487|NCT01270828|564940774|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
156504488|NCT01270828|564940775|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
156504489|NCT01270828|564940773|FG000|Pregabalin CR SB|Related adverse event|0|||
156504490|NCT01270828|564940774|FG001|Pregabalin CR SB|Related adverse event|0|||
156504491|NCT01270828|564940775|FG002|Pregabalin CR SB|Related adverse event|46|||
156504492|NCT01270828|564940773|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
156504493|NCT01270828|564940774|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
156504494|NCT01270828|564940775|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
156504495|NCT01270828|564940773|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
156504496|NCT01270828|564940774|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
156504497|NCT01270828|564940775|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
156504498|NCT01270828|564940773|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
156504499|NCT01270828|564940774|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
156504500|NCT01270828|564940775|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
156504501|NCT01270828|564940773|FG000|Pregabalin CR SB|Unrelated AE|0|||
156504502|NCT01270828|564940774|FG001|Pregabalin CR SB|Unrelated AE|0|||
156504503|NCT01270828|564940775|FG002|Pregabalin CR SB|Unrelated AE|8|||
156504504|NCT01270828|564940773|FG000|Pregabalin CR SB|Protocol Violation|0|||
156504505|NCT01270828|564940774|FG001|Pregabalin CR SB|Protocol Violation|0|||
156504506|NCT01270828|564940775|FG002|Pregabalin CR SB|Protocol Violation|8|||
156504507|NCT01270828|564940773|FG000|Double Blind Phase|Death|0|||
156504508|NCT01270828|564940774|FG001|Double Blind Phase|Death|1|||
156504509|NCT01270828|564940775|FG002|Double Blind Phase|Death|0|||
156504510|NCT01270828|564940773|FG000|Double Blind Phase|Protocol Violation|0|||
156504511|NCT01270828|564940774|FG001|Double Blind Phase|Protocol Violation|1|||
156504512|NCT01270828|564940775|FG002|Double Blind Phase|Protocol Violation|0|||
156504513|NCT01270828|564940773|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
156504514|NCT01270828|564940774|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
156504515|NCT01270828|564940775|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
156504516|NCT01270828|564940773|FG000|Double Blind Phase|Reason Unspecified|7|||
156504517|NCT01270828|564940774|FG001|Double Blind Phase|Reason Unspecified|4|||
156504518|NCT01270828|564940775|FG002|Double Blind Phase|Reason Unspecified|0|||
156504519|NCT01270828|564940773|FG000|Double Blind Phase|Withdrawal by Subject|6|||
156504520|NCT01270828|564940774|FG001|Double Blind Phase|Withdrawal by Subject|15|||
156504521|NCT01270828|564940775|FG002|Double Blind Phase|Withdrawal by Subject|0|||
156504522|NCT01270828|564940773|FG000|Double Blind Phase|Lost to Follow-up|1|||
156504523|NCT01270828|564940774|FG001|Double Blind Phase|Lost to Follow-up|2|||
156504524|NCT01270828|564940775|FG002|Double Blind Phase|Lost to Follow-up|0|||
156504525|NCT01270828|564940773|FG000|Double Blind Phase|Lack of Efficacy|2|||
156504526|NCT01270828|564940774|FG001|Double Blind Phase|Lack of Efficacy|11|||
156504527|NCT01270828|564940775|FG002|Double Blind Phase|Lack of Efficacy|0|||
156504528|NCT01270828|564940773|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
156504529|NCT01270828|564940774|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
156504530|NCT01270828|564940775|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
156504531|NCT01270828|564940773|FG000|Double Blind Phase|Adverse event related to study drug|5|||
156504532|NCT01270828|564940774|FG001|Double Blind Phase|Adverse event related to study drug|7|||
156504533|NCT01270828|564940775|FG002|Double Blind Phase|Adverse event related to study drug|0|||
156504534|NCT01810939|564940776|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
156504535|NCT01810939|564940777|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
156504536|NCT01810939|564940778|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
156504537|NCT01810939|564940776|FG000|Part A Treatment Period|Protocol Violation|2|||
156504538|NCT01810939|564940777|FG001|Part A Treatment Period|Protocol Violation|0|||
156504539|NCT01810939|564940778|FG002|Part A Treatment Period|Protocol Violation|0|||
156504540|NCT01810939|564940776|FG000|Part A Treatment Period|Adverse Event|10|||
156504541|NCT01810939|564940777|FG001|Part A Treatment Period|Adverse Event|0|||
156504542|NCT01810939|564940778|FG002|Part A Treatment Period|Adverse Event|0|||
156504543|NCT01810939|564940776|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
156504544|NCT01810939|564940777|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
156504545|NCT01810939|564940778|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
156504546|NCT01810939|564940776|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
156504547|NCT01810939|564940777|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
156504548|NCT01810939|564940778|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
156504549|NCT01810939|564940776|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
156504550|NCT01810939|564940777|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
156504551|NCT01810939|564940778|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
156504552|NCT01810939|564940776|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
156504553|NCT01810939|564940777|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
156504554|NCT01810939|564940778|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
156504555|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
156504556|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
156504557|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
156504558|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
156504559|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
156504560|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
156504561|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
156504562|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
156504563|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
156504564|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
156504565|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
156504566|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
156504567|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
156504568|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
156504569|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
156504570|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
156504571|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
156504572|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
156504573|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
156504574|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
156504575|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
156504576|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
156504577|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
156504578|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
156504579|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
156504580|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
156504581|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
156504582|NCT01810939|564940776|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
156504583|NCT01810939|564940777|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
156504584|NCT01810939|564940778|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
156504585|NCT02870972|564940781|FG000|Overall Study|Adverse Event|1|||
156504586|NCT02870972|564940782|FG001|Overall Study|Adverse Event|0|||
156504587|NCT02870972|564940783|FG002|Overall Study|Adverse Event|0|||
156504588|NCT02870972|564940784|FG003|Overall Study|Adverse Event|0|||
156504589|NCT02870972|564940785|FG004|Overall Study|Adverse Event|0|||
156504590|NCT04497389|564940786|FG000|Overall Study|Withdrawal by Subject|1|||
156504591|NCT04497389|564940787|FG001|Overall Study|Withdrawal by Subject|0|||
156504592|NCT04400487|564940788|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
156504593|NCT04400487|564940788|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
156504594|NCT04400487|564940788|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
156384237|NCT01490632|564498915|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384238|NCT01490632|564498916|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384239|NCT01490632|564498917|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156504595|NCT01821937|564940789|FG000|Overall Study|Adverse Event|0|||
156547033|NCT01265550|565095024|FG002|Pre Randomization|Non-GERD organic disorders|0|||
156504596|NCT01821937|564940790|FG001|Overall Study|Adverse Event|3|||
156504597|NCT01677299|564940791|FG000|Overall Study|Adverse Event|0|||
156504598|NCT01677299|564940792|FG001|Overall Study|Adverse Event|2|||
156504599|NCT01677299|564940793|FG002|Overall Study|Adverse Event|1|||
156504600|NCT01677299|564940794|FG003|Overall Study|Adverse Event|0|||
156504601|NCT01677299|564940791|FG000|Overall Study|Withdrawal by Subject|0|||
156504602|NCT01677299|564940792|FG001|Overall Study|Withdrawal by Subject|1|||
156504603|NCT01677299|564940793|FG002|Overall Study|Withdrawal by Subject|0|||
156504604|NCT01677299|564940794|FG003|Overall Study|Withdrawal by Subject|1|||
156504605|NCT03445533|564940795|FG000|Overall Study|Progressive Disease|48|||
156504606|NCT03445533|564940796|FG001|Overall Study|Progressive Disease|81|||
156504607|NCT03445533|564940795|FG000|Overall Study|Adverse Event|60|||
156504608|NCT03445533|564940796|FG001|Overall Study|Adverse Event|64|||
156504609|NCT03445533|564940795|FG000|Overall Study|Death|9|||
156504610|NCT03445533|564940796|FG001|Overall Study|Death|19|||
156504611|NCT03445533|564940795|FG000|Overall Study|Miscellaneous|0|||
156504612|NCT03445533|564940796|FG001|Overall Study|Miscellaneous|16|||
156504613|NCT03445533|564940795|FG000|Overall Study|Withdrawal by Subject|3|||
156504614|NCT03445533|564940796|FG001|Overall Study|Withdrawal by Subject|4|||
156504615|NCT03445533|564940795|FG000|Overall Study|Physician Decision|1|||
156504616|NCT03445533|564940796|FG001|Overall Study|Physician Decision|3|||
156504617|NCT03445533|564940795|FG000|Overall Study|Sponsor Decision|0|||
156504618|NCT03445533|564940796|FG001|Overall Study|Sponsor Decision|1|||
156504619|NCT03445533|564940795|FG000|Overall Study|Lost to Follow-up|0|||
156504620|NCT03445533|564940796|FG001|Overall Study|Lost to Follow-up|1|||
156504621|NCT03445533|564940795|FG000|Overall Study|Never Received any Study Treatment|7|||
156504622|NCT03445533|564940796|FG001|Overall Study|Never Received any Study Treatment|4|||
156504623|NCT02615509|564940797|FG000|Overall Study|Lost to Follow-up|134|||
156504624|NCT02615509|564940797|FG000|Overall Study|Death|4|||
156504625|NCT02615509|564940797|FG000|Overall Study|Withdrawal by Subject|8|||
156504626|NCT03334253|564940798|FG000|Overall Study|Withdrawal by Subject|1|||
156504627|NCT03334253|564940799|FG001|Overall Study|Withdrawal by Subject|0|||
156504628|NCT03334253|564940798|FG000|Overall Study|Lost to Follow-up|4|||
156504629|NCT03334253|564940799|FG001|Overall Study|Lost to Follow-up|3|||
156504630|NCT03334253|564940798|FG000|Overall Study|Moved residence|2|||
156504631|NCT03334253|564940799|FG001|Overall Study|Moved residence|2|||
156504632|NCT03274453|564940800|FG000|Overall Study|Lost to Follow-up|2|||
156504633|NCT03274453|564940801|FG001|Overall Study|Lost to Follow-up|5|||
156504634|NCT03274453|564940802|FG002|Overall Study|Lost to Follow-up|4|||
156504635|NCT03274453|564940803|FG003|Overall Study|Lost to Follow-up|1|||
156504636|NCT03274453|564940800|FG000|Overall Study|Physician Decision|2|||
156504637|NCT03274453|564940801|FG001|Overall Study|Physician Decision|0|||
156504638|NCT03274453|564940802|FG002|Overall Study|Physician Decision|0|||
156504639|NCT03274453|564940803|FG003|Overall Study|Physician Decision|3|||
156504640|NCT03274453|564940800|FG000|Overall Study|Surgery Cancelled|0|||
156504641|NCT03274453|564940801|FG001|Overall Study|Surgery Cancelled|1|||
156504642|NCT03274453|564940802|FG002|Overall Study|Surgery Cancelled|0|||
156504643|NCT03274453|564940803|FG003|Overall Study|Surgery Cancelled|0|||
156504644|NCT00968526|564940804|FG000|Overall Study|Adverse Event|2|||
156504645|NCT00968526|564940805|FG001|Overall Study|Adverse Event|0|||
156504646|NCT00968526|564940804|FG000|Overall Study|Migrated/moved from study area|1|||
156504647|NCT00968526|564940805|FG001|Overall Study|Migrated/moved from study area|0|||
156504648|NCT00945672|564940806|FG000|Overall Study|Withdrawal by Subject|0|||
156504649|NCT00945672|564940807|FG001|Overall Study|Withdrawal by Subject|0|||
156504650|NCT00945672|564940808|FG002|Overall Study|Withdrawal by Subject|0|||
156504651|NCT00945672|564940809|FG003|Overall Study|Withdrawal by Subject|1|||
156504652|NCT02030002|564940813|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
156504653|NCT02030002|564940813|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
156504654|NCT02030002|564940813|FG000|Follow-up|Lost to Follow-up|2|||
156504655|NCT00609947|564940814|FG000|Overall Study|Death|1|||
156504656|NCT00504075|564940815|FG000|Overall Study|Adverse Event|1|||
156504657|NCT00504075|564940815|FG000|Overall Study|Lost to Follow-up|5|||
156504658|NCT00504075|564940815|FG000|Overall Study|Withdrawal by Subject|1|||
156504659|NCT00504075|564940815|FG000|Overall Study|Required other therapeutic intervention|1|||
156504660|NCT02406248|564940816|FG000|Overall Study|Death|7|||
156504661|NCT02406248|564940816|FG000|Overall Study|Withdrawal by Subject|2|||
156504662|NCT01689857|564940818|FG000|Overall Study|Lost to Follow-up|5|||
156504663|NCT01689857|564940819|FG001|Overall Study|Lost to Follow-up|2|||
156547034|NCT01265550|565095025|FG003|Pre Randomization|Non-GERD organic disorders|23|||
156547035|NCT01265550|565095022|FG000|Pre Randomization|Functional heartburn|0|||
156547036|NCT01265550|565095023|FG001|Pre Randomization|Functional heartburn|0|||
156504664|NCT02643628|564940826|FG000|Overall Study|Lost to Follow-up|1|||
156547037|NCT01265550|565095024|FG002|Pre Randomization|Functional heartburn|0|||
156504665|NCT02643628|564940827|FG001|Overall Study|Lost to Follow-up|4|||
156504666|NCT02643628|564940826|FG000|Overall Study|Withdrawal by Subject|0|||
156504667|NCT02643628|564940827|FG001|Overall Study|Withdrawal by Subject|1|||
156504668|NCT02643628|564940826|FG000|Overall Study|Relocated out of state|0|||
156384240|NCT01490632|564498918|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384241|NCT01490632|564498919|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384242|NCT01490632|564498920|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384243|NCT01490632|564498921|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384244|NCT01490632|564498922|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384245|NCT01490632|564498923|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384246|NCT01490632|564498924|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156384247|NCT01490632|564498925|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
156384248|NCT01490632|564498926|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
156384249|NCT01490632|564498927|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
156384250|NCT02332720|564498929|FG000|Part A and Part B|Lost to Follow-up|1|||
156384251|NCT02332720|564498930|FG001|Part A and Part B|Lost to Follow-up|0|||
156384252|NCT02332720|564498931|FG002|Part A and Part B|Lost to Follow-up|0|||
156384253|NCT02332720|564498932|FG003|Part A and Part B|Lost to Follow-up|0|||
156384254|NCT02332720|564498933|FG004|Part A and Part B|Lost to Follow-up|0|||
156384255|NCT02332720|564498934|FG005|Part A and Part B|Lost to Follow-up|2|||
156384256|NCT02332720|564498935|FG006|Part A and Part B|Lost to Follow-up|1|||
156384257|NCT02332720|564498936|FG007|Part A and Part B|Lost to Follow-up|1|||
156384258|NCT02332720|564498937|FG008|Part A and Part B|Lost to Follow-up|0|||
156384259|NCT02332720|564498938|FG009|Part A and Part B|Lost to Follow-up|0|||
156384260|NCT02332720|564498939|FG010|Part A and Part B|Lost to Follow-up|0|||
156384261|NCT02332720|564498940|FG011|Part A and Part B|Lost to Follow-up|0|||
156384262|NCT02332720|564498941|FG012|Part A and Part B|Lost to Follow-up|0|||
156384263|NCT02332720|564498942|FG013|Part A and Part B|Lost to Follow-up|0|||
156384264|NCT02332720|564498943|FG014|Part A and Part B|Lost to Follow-up|0|||
156384265|NCT02332720|564498944|FG015|Part A and Part B|Lost to Follow-up|1|||
156384266|NCT02332720|564498945|FG016|Part A and Part B|Lost to Follow-up|0|||
156384267|NCT02332720|564498946|FG017|Part A and Part B|Lost to Follow-up|0|||
156384268|NCT02332720|564498947|FG018|Part A and Part B|Lost to Follow-up|0|||
156384269|NCT02332720|564498948|FG019|Part A and Part B|Lost to Follow-up|0|||
156384270|NCT02332720|564498949|FG020|Part A and Part B|Lost to Follow-up|0|||
156384271|NCT02332720|564498950|FG021|Part A and Part B|Lost to Follow-up|0|||
156384272|NCT02332720|564498951|FG022|Part A and Part B|Lost to Follow-up|0|||
156384273|NCT02332720|564498929|FG000|Part A and Part B|Adverse Event|0|||
156384274|NCT02332720|564498930|FG001|Part A and Part B|Adverse Event|0|||
156384275|NCT02332720|564498931|FG002|Part A and Part B|Adverse Event|0|||
156384276|NCT02332720|564498932|FG003|Part A and Part B|Adverse Event|0|||
156384277|NCT02332720|564498933|FG004|Part A and Part B|Adverse Event|0|||
156384278|NCT02332720|564498934|FG005|Part A and Part B|Adverse Event|0|||
156384279|NCT02332720|564498935|FG006|Part A and Part B|Adverse Event|0|||
156384280|NCT02332720|564498936|FG007|Part A and Part B|Adverse Event|0|||
156384281|NCT02332720|564498937|FG008|Part A and Part B|Adverse Event|0|||
156384282|NCT02332720|564498938|FG009|Part A and Part B|Adverse Event|0|||
156384283|NCT02332720|564498939|FG010|Part A and Part B|Adverse Event|0|||
156384284|NCT02332720|564498940|FG011|Part A and Part B|Adverse Event|0|||
156384285|NCT02332720|564498941|FG012|Part A and Part B|Adverse Event|0|||
156384286|NCT02332720|564498942|FG013|Part A and Part B|Adverse Event|0|||
156384287|NCT02332720|564498943|FG014|Part A and Part B|Adverse Event|0|||
156384288|NCT02332720|564498944|FG015|Part A and Part B|Adverse Event|0|||
156384289|NCT02332720|564498945|FG016|Part A and Part B|Adverse Event|0|||
156384290|NCT02332720|564498946|FG017|Part A and Part B|Adverse Event|1|||
156384291|NCT02332720|564498947|FG018|Part A and Part B|Adverse Event|0|||
156384292|NCT02332720|564498948|FG019|Part A and Part B|Adverse Event|0|||
156384293|NCT02332720|564498949|FG020|Part A and Part B|Adverse Event|0|||
156384294|NCT02332720|564498950|FG021|Part A and Part B|Adverse Event|0|||
156384295|NCT02332720|564498951|FG022|Part A and Part B|Adverse Event|0|||
156384296|NCT02332720|564498929|FG000|Part A and Part B|Physician Decision|0|||
156384297|NCT02332720|564498930|FG001|Part A and Part B|Physician Decision|0|||
156384298|NCT02332720|564498931|FG002|Part A and Part B|Physician Decision|0|||
156384299|NCT02332720|564498932|FG003|Part A and Part B|Physician Decision|0|||
156384300|NCT02332720|564498933|FG004|Part A and Part B|Physician Decision|0|||
156384301|NCT02332720|564498934|FG005|Part A and Part B|Physician Decision|0|||
156384302|NCT02332720|564498935|FG006|Part A and Part B|Physician Decision|0|||
156384303|NCT02332720|564498936|FG007|Part A and Part B|Physician Decision|0|||
156384304|NCT02332720|564498937|FG008|Part A and Part B|Physician Decision|0|||
156384305|NCT02332720|564498938|FG009|Part A and Part B|Physician Decision|0|||
156384306|NCT02332720|564498939|FG010|Part A and Part B|Physician Decision|0|||
156384307|NCT02332720|564498940|FG011|Part A and Part B|Physician Decision|0|||
156384308|NCT02332720|564498941|FG012|Part A and Part B|Physician Decision|0|||
156384309|NCT02332720|564498942|FG013|Part A and Part B|Physician Decision|0|||
156384310|NCT02332720|564498943|FG014|Part A and Part B|Physician Decision|0|||
156384311|NCT02332720|564498944|FG015|Part A and Part B|Physician Decision|0|||
156384312|NCT02332720|564498945|FG016|Part A and Part B|Physician Decision|0|||
156384313|NCT02332720|564498946|FG017|Part A and Part B|Physician Decision|0|||
156384314|NCT02332720|564498947|FG018|Part A and Part B|Physician Decision|1|||
156384315|NCT02332720|564498948|FG019|Part A and Part B|Physician Decision|0|||
156384316|NCT02332720|564498949|FG020|Part A and Part B|Physician Decision|0|||
156384317|NCT02332720|564498950|FG021|Part A and Part B|Physician Decision|0|||
156384318|NCT02332720|564498951|FG022|Part A and Part B|Physician Decision|0|||
156384319|NCT02332720|564498929|FG000|Part A and Part B|Withdrawal by Subject|0|||
156504669|NCT02643628|564940827|FG001|Overall Study|Relocated out of state|1|||
156504670|NCT02362503|564940828|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
156504671|NCT02362503|564940829|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
156504672|NCT02362503|564940830|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
156504673|NCT02362503|564940828|FG000|Double-blind Period-Up to 8 Days|Death|1|||
156504674|NCT02362503|564940829|FG001|Double-blind Period-Up to 8 Days|Death|0|||
156504675|NCT02362503|564940830|FG002|Double-blind Period-Up to 8 Days|Death|0|||
156504676|NCT02362503|564940828|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
156504677|NCT02362503|564940829|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
156504678|NCT02362503|564940830|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
156504679|NCT02362503|564940828|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
156504680|NCT02362503|564940829|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
156504681|NCT02362503|564940830|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
156504682|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
156504683|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
156504684|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
156504685|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
156504686|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
156504687|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
156504688|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
156504689|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
156504690|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
156504691|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
156504692|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
156504693|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
156504694|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
156504695|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
156504696|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
156504697|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
156504698|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
156504699|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
156504700|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
156504701|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
156504702|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
156504703|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
156504704|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
156504705|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
156504706|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
156504707|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
156504708|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
156504709|NCT02362503|564940828|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
156504710|NCT02362503|564940829|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
156504711|NCT02362503|564940830|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
156504712|NCT04148651|564940834|FG000|Overall Study|Lost to Follow-up|2|||
156504713|NCT03392168|564940837|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
156504714|NCT03392168|564940838|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
156504715|NCT03392168|564940839|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
156504716|NCT03392168|564940840|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
156504717|NCT03392168|564940837|FG000|Period 2: Cohort 2|Other|0|||
156504718|NCT03392168|564940838|FG001|Period 2: Cohort 2|Other|1|||
156504719|NCT03392168|564940839|FG002|Period 2: Cohort 2|Other|0|||
156504720|NCT03392168|564940840|FG003|Period 2: Cohort 2|Other|0|||
156504721|NCT02609672|564940842|FG000|Overall Study|Lost to Follow-up|3|||
156504722|NCT02609672|564940843|FG001|Overall Study|Lost to Follow-up|1|||
156504723|NCT01441635|564940844|FG000|Overall Study|Adverse Event|4|||
156384320|NCT02332720|564498930|FG001|Part A and Part B|Withdrawal by Subject|0|||
156384321|NCT02332720|564498931|FG002|Part A and Part B|Withdrawal by Subject|0|||
156504724|NCT01441635|564940845|FG001|Overall Study|Adverse Event|3|||
156504725|NCT01441635|564940846|FG002|Overall Study|Adverse Event|1|||
156504726|NCT01441635|564940847|FG003|Overall Study|Adverse Event|5|||
156384322|NCT02332720|564498932|FG003|Part A and Part B|Withdrawal by Subject|0|||
156384323|NCT02332720|564498933|FG004|Part A and Part B|Withdrawal by Subject|0|||
156384324|NCT02332720|564498934|FG005|Part A and Part B|Withdrawal by Subject|1|||
156504727|NCT01441635|564940848|FG004|Overall Study|Adverse Event|1|||
156504728|NCT01441635|564940849|FG005|Overall Study|Adverse Event|2|||
156384325|NCT02332720|564498935|FG006|Part A and Part B|Withdrawal by Subject|0|||
156384326|NCT02332720|564498936|FG007|Part A and Part B|Withdrawal by Subject|0|||
156504729|NCT01441635|564940850|FG006|Overall Study|Adverse Event|2|||
156504730|NCT01441635|564940851|FG007|Overall Study|Adverse Event|2|||
156504731|NCT01441635|564940852|FG008|Overall Study|Adverse Event|1|||
156504732|NCT01441635|564940853|FG009|Overall Study|Adverse Event|0|||
156504733|NCT01441635|564940844|FG000|Overall Study|Withdrawal by Subject|1|||
156504734|NCT01441635|564940845|FG001|Overall Study|Withdrawal by Subject|1|||
156504735|NCT01441635|564940846|FG002|Overall Study|Withdrawal by Subject|0|||
156504736|NCT01441635|564940847|FG003|Overall Study|Withdrawal by Subject|1|||
156504737|NCT01441635|564940848|FG004|Overall Study|Withdrawal by Subject|0|||
156504738|NCT01441635|564940849|FG005|Overall Study|Withdrawal by Subject|0|||
156504739|NCT01441635|564940850|FG006|Overall Study|Withdrawal by Subject|2|||
156504740|NCT01441635|564940851|FG007|Overall Study|Withdrawal by Subject|0|||
156504741|NCT01441635|564940852|FG008|Overall Study|Withdrawal by Subject|1|||
156504742|NCT01441635|564940853|FG009|Overall Study|Withdrawal by Subject|1|||
156504743|NCT01441635|564940844|FG000|Overall Study|Lost to Follow-up|0|||
156504744|NCT01441635|564940845|FG001|Overall Study|Lost to Follow-up|1|||
156504745|NCT01441635|564940846|FG002|Overall Study|Lost to Follow-up|1|||
156504746|NCT01441635|564940847|FG003|Overall Study|Lost to Follow-up|1|||
156504747|NCT01441635|564940848|FG004|Overall Study|Lost to Follow-up|1|||
156504748|NCT01441635|564940849|FG005|Overall Study|Lost to Follow-up|3|||
156504749|NCT01441635|564940850|FG006|Overall Study|Lost to Follow-up|1|||
156504750|NCT01441635|564940851|FG007|Overall Study|Lost to Follow-up|1|||
156504751|NCT01441635|564940852|FG008|Overall Study|Lost to Follow-up|0|||
156504752|NCT01441635|564940853|FG009|Overall Study|Lost to Follow-up|1|||
156504753|NCT01441635|564940844|FG000|Overall Study|Noncompliance|0|||
156504754|NCT01441635|564940845|FG001|Overall Study|Noncompliance|1|||
156504755|NCT01441635|564940846|FG002|Overall Study|Noncompliance|0|||
156504756|NCT01441635|564940847|FG003|Overall Study|Noncompliance|0|||
156504757|NCT01441635|564940848|FG004|Overall Study|Noncompliance|0|||
156504758|NCT01441635|564940849|FG005|Overall Study|Noncompliance|0|||
156504759|NCT01441635|564940850|FG006|Overall Study|Noncompliance|1|||
156504760|NCT01441635|564940851|FG007|Overall Study|Noncompliance|0|||
156504761|NCT01441635|564940852|FG008|Overall Study|Noncompliance|0|||
156504762|NCT01441635|564940853|FG009|Overall Study|Noncompliance|0|||
156504763|NCT01441635|564940844|FG000|Overall Study|Surgery or Invasive Intervention|0|||
156504764|NCT01441635|564940845|FG001|Overall Study|Surgery or Invasive Intervention|0|||
156504765|NCT01441635|564940846|FG002|Overall Study|Surgery or Invasive Intervention|1|||
156504766|NCT01441635|564940847|FG003|Overall Study|Surgery or Invasive Intervention|0|||
156504767|NCT01441635|564940848|FG004|Overall Study|Surgery or Invasive Intervention|0|||
156504768|NCT01441635|564940849|FG005|Overall Study|Surgery or Invasive Intervention|0|||
156504769|NCT01441635|564940850|FG006|Overall Study|Surgery or Invasive Intervention|0|||
156504770|NCT01441635|564940851|FG007|Overall Study|Surgery or Invasive Intervention|0|||
156504771|NCT01441635|564940852|FG008|Overall Study|Surgery or Invasive Intervention|0|||
156504772|NCT01441635|564940853|FG009|Overall Study|Surgery or Invasive Intervention|0|||
156504773|NCT01441635|564940844|FG000|Overall Study|Received Exclusionary Medication|1|||
156504774|NCT01441635|564940845|FG001|Overall Study|Received Exclusionary Medication|0|||
156504775|NCT01441635|564940846|FG002|Overall Study|Received Exclusionary Medication|0|||
156504776|NCT01441635|564940847|FG003|Overall Study|Received Exclusionary Medication|0|||
156504777|NCT01441635|564940848|FG004|Overall Study|Received Exclusionary Medication|0|||
156504778|NCT01441635|564940849|FG005|Overall Study|Received Exclusionary Medication|0|||
156504779|NCT01441635|564940850|FG006|Overall Study|Received Exclusionary Medication|0|||
156504780|NCT01441635|564940851|FG007|Overall Study|Received Exclusionary Medication|0|||
156504781|NCT01441635|564940852|FG008|Overall Study|Received Exclusionary Medication|0|||
156504782|NCT01441635|564940853|FG009|Overall Study|Received Exclusionary Medication|0|||
156504783|NCT01441635|564940844|FG000|Overall Study|Other|0|||
156504784|NCT01441635|564940845|FG001|Overall Study|Other|0|||
156504785|NCT01441635|564940846|FG002|Overall Study|Other|0|||
156504786|NCT01441635|564940847|FG003|Overall Study|Other|0|||
156504787|NCT01441635|564940848|FG004|Overall Study|Other|0|||
156504788|NCT01441635|564940849|FG005|Overall Study|Other|0|||
156504789|NCT01441635|564940850|FG006|Overall Study|Other|0|||
156504790|NCT01441635|564940851|FG007|Overall Study|Other|1|||
156504791|NCT01441635|564940852|FG008|Overall Study|Other|0|||
156504792|NCT01441635|564940853|FG009|Overall Study|Other|0|||
156504793|NCT01912404|564940857|FG000|Overall Study|Due to personal reasons|1|||
156504794|NCT01912404|564940858|FG001|Overall Study|Due to personal reasons|0|||
156504795|NCT02269423|564940865|FG000|Overall Study|Discontinued due to change in residence|0|||
156504796|NCT02269423|564940866|FG001|Overall Study|Discontinued due to change in residence|1|||
156504797|NCT02269423|564940867|FG002|Overall Study|Discontinued due to change in residence|0|||
156504798|NCT02269423|564940868|FG003|Overall Study|Discontinued due to change in residence|1|||
156504799|NCT01430468|564940869|FG000|Overall Study|Physician Decision|2|||
156504800|NCT01430468|564940870|FG001|Overall Study|Physician Decision|1|||
156504801|NCT01430468|564940869|FG000|Overall Study|Withdrawal by Subject|5|||
156504802|NCT01430468|564940870|FG001|Overall Study|Withdrawal by Subject|5|||
156504803|NCT01281839|564940871|FG000|Overall Study|Lost to Follow-up|6|||
156504804|NCT01281839|564940872|FG001|Overall Study|Lost to Follow-up|3|||
156504805|NCT01281839|564940871|FG000|Overall Study|Withdrawal by Subject|4|||
156504806|NCT01281839|564940872|FG001|Overall Study|Withdrawal by Subject|10|||
156504807|NCT01281839|564940871|FG000|Overall Study|Reason not specified|0|||
156504808|NCT01281839|564940872|FG001|Overall Study|Reason not specified|1|||
156504809|NCT01305239|564940873|FG000|Overall Study|Adverse Event|22|||
156504810|NCT01305239|564940873|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
156504811|NCT01754753|564940875|FG000|Overall Study|Study close|43|||
156504812|NCT01754753|564940876|FG001|Overall Study|Study close|44|||
156504813|NCT01754753|564940875|FG000|Overall Study|Lost to Follow-up|9|||
156504814|NCT01754753|564940876|FG001|Overall Study|Lost to Follow-up|5|||
156504815|NCT03229486|564940877|FG000|Overall Study|Protocol Violation|0|||
156504816|NCT03229486|564940878|FG001|Overall Study|Protocol Violation|1|||
156504817|NCT01443923|564940879|FG000|Overall Study|Adverse Event|1|||
156504818|NCT01443923|564940880|FG001|Overall Study|Adverse Event|0|||
156504819|NCT01245374|564940883|FG000|Overall Study|Protocol Violation|1|||
156504820|NCT01245374|564940883|FG000|Overall Study|Withdrawal by Subject|3|||
156504821|NCT01782690|564940885|FG000|Overall Study|Not reported|7|||
156504822|NCT01782690|564940885|FG000|Overall Study|Toxicity of gemcitabine|1|||
156504823|NCT01782690|564940885|FG000|Overall Study|Toxicity of erlotinib|1|||
156504824|NCT01782690|564940885|FG000|Overall Study|Lost to Follow-up|31|||
156504825|NCT01782690|564940885|FG000|Overall Study|Withdrawal of informed consent|2|||
156504826|NCT01782690|564940885|FG000|Overall Study|Absent rash|9|||
156504827|NCT01782690|564940885|FG000|Overall Study|Physician Decision|13|||
156504828|NCT01782690|564940885|FG000|Overall Study|Patient's wish|21|||
156504829|NCT01782690|564940885|FG000|Overall Study|Tumor progression|74|||
156504830|NCT01782690|564940885|FG000|Overall Study|Death|133|||
156504831|NCT01782690|564940885|FG000|Overall Study|Study completion unknown|7|||
156504832|NCT05032066|564940893|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
156504833|NCT05032066|564940894|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
156504834|NCT05032066|564940895|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
156504835|NCT05032066|564940893|FG000|Part 1: Core Phase|Physician Decision|0|||
156504836|NCT05032066|564940894|FG001|Part 1: Core Phase|Physician Decision|1|||
156504837|NCT05032066|564940895|FG002|Part 1: Core Phase|Physician Decision|1|||
156504838|NCT05032066|564940893|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
156504839|NCT05032066|564940894|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
156504840|NCT05032066|564940895|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
156504841|NCT05032066|564940893|FG000|Part 1: Core Phase|Death|3|||
156504842|NCT05032066|564940894|FG001|Part 1: Core Phase|Death|4|||
156504843|NCT05032066|564940895|FG002|Part 1: Core Phase|Death|2|||
156504844|NCT05032066|564940893|FG000|Part 1: Core Phase|Adverse Event|2|||
156504845|NCT05032066|564940894|FG001|Part 1: Core Phase|Adverse Event|3|||
156504846|NCT05032066|564940895|FG002|Part 1: Core Phase|Adverse Event|0|||
156504847|NCT05032066|564940893|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
156504848|NCT05032066|564940894|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
156504849|NCT05032066|564940895|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
156504850|NCT05032066|564940893|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
156504851|NCT05032066|564940894|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
156504852|NCT05032066|564940895|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
156504853|NCT05032066|564940893|FG000|Part 2: Extension Phase|Physician Decision|1|||
156504854|NCT05032066|564940894|FG001|Part 2: Extension Phase|Physician Decision|2|||
156504855|NCT05032066|564940895|FG002|Part 2: Extension Phase|Physician Decision|0|||
156504856|NCT05032066|564940893|FG000|Part 2: Extension Phase|Death|2|||
156504857|NCT05032066|564940894|FG001|Part 2: Extension Phase|Death|4|||
156504858|NCT05032066|564940895|FG002|Part 2: Extension Phase|Death|5|||
156504859|NCT04297618|564940896|FG000|Overall Study|Adverse Event|1|||
156504860|NCT04297618|564940896|FG000|Overall Study|Withdrawal by Subject|1|||
156504861|NCT02614183|564940899|FG000|Double Blind Treatment Phase|Adverse Event|10|||
156504862|NCT02614183|564940900|FG001|Double Blind Treatment Phase|Adverse Event|9|||
156504863|NCT02614183|564940901|FG002|Double Blind Treatment Phase|Adverse Event|7|||
156504864|NCT02614183|564940899|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
156504865|NCT02614183|564940900|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
156504866|NCT02614183|564940901|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
156504867|NCT02614183|564940899|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
156504868|NCT02614183|564940900|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
156504869|NCT02614183|564940901|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
156504870|NCT02614183|564940899|FG000|Double Blind Treatment Phase|Physician Decision|7|||
156504871|NCT02614183|564940900|FG001|Double Blind Treatment Phase|Physician Decision|3|||
156504872|NCT02614183|564940901|FG002|Double Blind Treatment Phase|Physician Decision|2|||
156504873|NCT02614183|564940899|FG000|Double Blind Treatment Phase|Pregnancy|2|||
156504874|NCT02614183|564940900|FG001|Double Blind Treatment Phase|Pregnancy|1|||
156504875|NCT02614183|564940901|FG002|Double Blind Treatment Phase|Pregnancy|3|||
156504876|NCT02614183|564940899|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
156504877|NCT02614183|564940900|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
156504878|NCT02614183|564940901|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
156504879|NCT02614183|564940899|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
156504880|NCT02614183|564940900|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
156384327|NCT02332720|564498937|FG008|Part A and Part B|Withdrawal by Subject|0|||
156384328|NCT02332720|564498938|FG009|Part A and Part B|Withdrawal by Subject|0|||
156384329|NCT02332720|564498939|FG010|Part A and Part B|Withdrawal by Subject|0|||
156384330|NCT02332720|564498940|FG011|Part A and Part B|Withdrawal by Subject|0|||
156384331|NCT02332720|564498941|FG012|Part A and Part B|Withdrawal by Subject|0|||
156384332|NCT02332720|564498942|FG013|Part A and Part B|Withdrawal by Subject|0|||
156384333|NCT02332720|564498943|FG014|Part A and Part B|Withdrawal by Subject|0|||
156384334|NCT02332720|564498944|FG015|Part A and Part B|Withdrawal by Subject|0|||
156384335|NCT02332720|564498945|FG016|Part A and Part B|Withdrawal by Subject|0|||
156384336|NCT02332720|564498946|FG017|Part A and Part B|Withdrawal by Subject|0|||
156384337|NCT02332720|564498947|FG018|Part A and Part B|Withdrawal by Subject|0|||
156384338|NCT02332720|564498948|FG019|Part A and Part B|Withdrawal by Subject|1|||
156384339|NCT02332720|564498949|FG020|Part A and Part B|Withdrawal by Subject|0|||
156384340|NCT02332720|564498950|FG021|Part A and Part B|Withdrawal by Subject|0|||
156384341|NCT02332720|564498951|FG022|Part A and Part B|Withdrawal by Subject|0|||
156384342|NCT01153633|564498952|FG000|Overall Study|Protocol Violation|1|||
156384343|NCT01153633|564498953|FG001|Overall Study|Protocol Violation|1|||
156384344|NCT01153633|564498952|FG000|Overall Study|Therapeutic failure|3|||
156384345|NCT01153633|564498953|FG001|Overall Study|Therapeutic failure|3|||
156384346|NCT00384085|564498954|FG000|Overall Study|Adverse Event|5|||
156384347|NCT00384085|564498955|FG001|Overall Study|Adverse Event|5|||
156384348|NCT00384085|564498956|FG002|Overall Study|Adverse Event|4|||
156384349|NCT00384085|564498954|FG000|Overall Study|Lack of Efficacy|0|||
156384350|NCT00384085|564498955|FG001|Overall Study|Lack of Efficacy|3|||
156384351|NCT00384085|564498956|FG002|Overall Study|Lack of Efficacy|2|||
156384352|NCT00384085|564498954|FG000|Overall Study|No longer Requires Study Treatment|1|||
156384353|NCT00384085|564498955|FG001|Overall Study|No longer Requires Study Treatment|0|||
156384354|NCT00384085|564498956|FG002|Overall Study|No longer Requires Study Treatment|1|||
156384355|NCT00384085|564498954|FG000|Overall Study|Protocol Violation|2|||
156384356|NCT00384085|564498955|FG001|Overall Study|Protocol Violation|2|||
156384357|NCT00384085|564498956|FG002|Overall Study|Protocol Violation|2|||
156384358|NCT00384085|564498954|FG000|Overall Study|Lost to Follow-up|9|||
156384359|NCT00384085|564498955|FG001|Overall Study|Lost to Follow-up|9|||
156384360|NCT00384085|564498956|FG002|Overall Study|Lost to Follow-up|10|||
156384361|NCT00384085|564498954|FG000|Overall Study|Progressive Disease|0|||
156384362|NCT00384085|564498955|FG001|Overall Study|Progressive Disease|1|||
156384363|NCT00384085|564498956|FG002|Overall Study|Progressive Disease|0|||
156384364|NCT00384085|564498954|FG000|Overall Study|Withdrawal by Subject|14|||
156384365|NCT00384085|564498955|FG001|Overall Study|Withdrawal by Subject|19|||
156384366|NCT00384085|564498956|FG002|Overall Study|Withdrawal by Subject|29|||
156384367|NCT00384085|564498954|FG000|Overall Study|Patient non-compliant|4|||
156384368|NCT00384085|564498955|FG001|Overall Study|Patient non-compliant|4|||
156384369|NCT00384085|564498956|FG002|Overall Study|Patient non-compliant|5|||
156384370|NCT00384085|564498954|FG000|Overall Study|Physician Decision|1|||
156384371|NCT00384085|564498955|FG001|Overall Study|Physician Decision|0|||
156384372|NCT00384085|564498956|FG002|Overall Study|Physician Decision|0|||
156384373|NCT00384085|564498954|FG000|Overall Study|Loss of site personnel|1|||
156384374|NCT00384085|564498955|FG001|Overall Study|Loss of site personnel|0|||
156384375|NCT00384085|564498956|FG002|Overall Study|Loss of site personnel|1|||
156384376|NCT00384085|564498954|FG000|Overall Study|Sponsor decision|1|||
156384377|NCT00384085|564498955|FG001|Overall Study|Sponsor decision|2|||
156384378|NCT00384085|564498956|FG002|Overall Study|Sponsor decision|1|||
156384379|NCT00384085|564498954|FG000|Overall Study|Patient moved|1|||
156384380|NCT00384085|564498955|FG001|Overall Study|Patient moved|0|||
156384381|NCT00384085|564498956|FG002|Overall Study|Patient moved|1|||
156384382|NCT00384085|564498954|FG000|Overall Study|Patient required surgery|0|||
156384383|NCT00384085|564498955|FG001|Overall Study|Patient required surgery|1|||
156384384|NCT00384085|564498956|FG002|Overall Study|Patient required surgery|0|||
156384385|NCT00467870|564498966|FG000|Overall Study|Adverse Event|13|||
156384386|NCT00467870|564498967|FG001|Overall Study|Adverse Event|9|||
156384387|NCT00467870|564498968|FG002|Overall Study|Adverse Event|1|||
156384388|NCT00467870|564498969|FG003|Overall Study|Adverse Event|15|||
156384389|NCT00467870|564498970|FG004|Overall Study|Adverse Event|15|||
156384390|NCT00467870|564498971|FG005|Overall Study|Adverse Event|1|||
156384391|NCT00467870|564498966|FG000|Overall Study|Protocol Violation|2|||
156384392|NCT00467870|564498967|FG001|Overall Study|Protocol Violation|1|||
156504881|NCT02614183|564940901|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
156504882|NCT02614183|564940899|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
156384393|NCT00467870|564498968|FG002|Overall Study|Protocol Violation|1|||
156384394|NCT00467870|564498969|FG003|Overall Study|Protocol Violation|2|||
156384395|NCT00467870|564498970|FG004|Overall Study|Protocol Violation|0|||
156384396|NCT00467870|564498971|FG005|Overall Study|Protocol Violation|0|||
156384397|NCT00467870|564498966|FG000|Overall Study|Withdrawal by Subject|14|||
156384398|NCT00467870|564498967|FG001|Overall Study|Withdrawal by Subject|21|||
156384399|NCT00467870|564498968|FG002|Overall Study|Withdrawal by Subject|0|||
156384400|NCT00467870|564498969|FG003|Overall Study|Withdrawal by Subject|9|||
156384401|NCT00467870|564498970|FG004|Overall Study|Withdrawal by Subject|10|||
156504883|NCT02614183|564940900|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
156504884|NCT02614183|564940901|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
156504885|NCT02614183|564940899|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
156504886|NCT02614183|564940900|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
156504887|NCT02614183|564940901|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
156504888|NCT02614183|564940899|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
156504889|NCT02614183|564940900|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
156504890|NCT02614183|564940901|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
156504891|NCT02614183|564940899|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
156504892|NCT02614183|564940900|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
156504893|NCT02614183|564940901|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
156504894|NCT02614183|564940899|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
156504895|NCT02614183|564940900|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
156504896|NCT02614183|564940901|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
156504897|NCT05992922|564940902|FG000|Overall Study|Adverse Event|6|||
156504898|NCT05992922|564940903|FG001|Overall Study|Adverse Event|0|||
156504899|NCT05992922|564940902|FG000|Overall Study|Sponsor Termination of Study|14|||
156504900|NCT05992922|564940903|FG001|Overall Study|Sponsor Termination of Study|20|||
156504901|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Adverse Event|2|||
156504902|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Adverse Event|0|||
156504903|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Adverse Event|0|||
156504904|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Adverse Event|0|||
156504905|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
156504906|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
156504907|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
156504908|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
156504909|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
156504910|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
156504911|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
156504912|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
156504913|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Physician Decision|1|||
156504914|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Physician Decision|0|||
156504915|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Physician Decision|0|||
156504916|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Physician Decision|0|||
156504917|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Pregnancy|1|||
156504918|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Pregnancy|0|||
156504919|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Pregnancy|0|||
156504920|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Pregnancy|0|||
156504921|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
156504922|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
156504923|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
156504924|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
156504925|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
156504926|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
156504927|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
156504928|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
156504929|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
156504930|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
156504931|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
156504932|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
156504933|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
156504934|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
156504935|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
156504936|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
156504937|NCT04057573|564943136|FG000|24-Week Double-Blind Period|Not Treated|1|||
156504938|NCT04057573|564943137|FG001|24-Week Double-Blind Period|Not Treated|0|||
156504939|NCT04057573|564943138|FG002|24-Week Double-Blind Period|Not Treated|0|||
156504940|NCT04057573|564943139|FG003|24-Week Double-Blind Period|Not Treated|0|||
156504941|NCT04057573|564943136|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
156504942|NCT04057573|564943137|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
156504943|NCT04057573|564943138|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
156504944|NCT04057573|564943139|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
156504945|NCT04057573|564943136|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
156504946|NCT04057573|564943137|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
156504947|NCT04057573|564943138|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
156547038|NCT01265550|565095025|FG003|Pre Randomization|Functional heartburn|99|||
156547039|NCT00794157|565095031|FG000|Overall Study|Adverse Event|4|||
156547040|NCT00794157|565095032|FG001|Overall Study|Adverse Event|1|||
156384402|NCT00467870|564498971|FG005|Overall Study|Withdrawal by Subject|1|||
156384403|NCT00467870|564498966|FG000|Overall Study|Lost to Follow-up|5|||
156384404|NCT00467870|564498967|FG001|Overall Study|Lost to Follow-up|3|||
156384405|NCT00467870|564498968|FG002|Overall Study|Lost to Follow-up|1|||
156384406|NCT00467870|564498969|FG003|Overall Study|Lost to Follow-up|1|||
156384407|NCT00467870|564498970|FG004|Overall Study|Lost to Follow-up|3|||
156384408|NCT00467870|564498971|FG005|Overall Study|Lost to Follow-up|0|||
156384409|NCT00467870|564498966|FG000|Overall Study|Subject Non-compliance|3|||
156384410|NCT00467870|564498967|FG001|Overall Study|Subject Non-compliance|4|||
156384411|NCT00467870|564498968|FG002|Overall Study|Subject Non-compliance|0|||
156384412|NCT00467870|564498969|FG003|Overall Study|Subject Non-compliance|1|||
156384413|NCT00467870|564498970|FG004|Overall Study|Subject Non-compliance|5|||
156384414|NCT00467870|564498971|FG005|Overall Study|Subject Non-compliance|0|||
156384415|NCT00467870|564498966|FG000|Overall Study|Other/Unknown|8|||
156384416|NCT00467870|564498967|FG001|Overall Study|Other/Unknown|5|||
156547041|NCT00794157|565095033|FG002|Overall Study|Adverse Event|8|||
156547042|NCT00794157|565095031|FG000|Overall Study|Subject withdrew consent|2|||
156547043|NCT00794157|565095032|FG001|Overall Study|Subject withdrew consent|0|||
156547044|NCT00794157|565095033|FG002|Overall Study|Subject withdrew consent|3|||
156547045|NCT00794157|565095031|FG000|Overall Study|Lost to Follow-up|2|||
156547046|NCT00794157|565095032|FG001|Overall Study|Lost to Follow-up|0|||
156547047|NCT00794157|565095033|FG002|Overall Study|Lost to Follow-up|1|||
156547048|NCT00794157|565095031|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156547049|NCT00794157|565095032|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156547050|NCT00794157|565095033|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156547051|NCT00794157|565095031|FG000|Overall Study|Administrative problems|1|||
156547052|NCT00794157|565095032|FG001|Overall Study|Administrative problems|7|||
156547053|NCT00794157|565095033|FG002|Overall Study|Administrative problems|4|||
156547054|NCT00794157|565095031|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156547055|NCT00794157|565095032|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156547056|NCT00794157|565095033|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156384417|NCT00467870|564498968|FG002|Overall Study|Other/Unknown|1|||
156384418|NCT00467870|564498969|FG003|Overall Study|Other/Unknown|5|||
156504948|NCT04057573|564943139|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
156504949|NCT04057573|564943136|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
156504950|NCT04057573|564943137|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
156504951|NCT04057573|564943138|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
156504952|NCT04057573|564943139|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
156504953|NCT04057573|564943136|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
156504954|NCT04057573|564943137|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
156504955|NCT04057573|564943138|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
156504956|NCT04057573|564943139|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
156504957|NCT04057573|564943136|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
156504958|NCT04057573|564943137|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
156504959|NCT04057573|564943138|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
156504960|NCT04057573|564943139|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
156504961|NCT02797522|564943142|FG000|Overall Study|Study Terminated by Sponsor|0|||
156504962|NCT02797522|564943143|FG001|Overall Study|Study Terminated by Sponsor|0|||
156504963|NCT02797522|564943144|FG002|Overall Study|Study Terminated by Sponsor|0|||
156504964|NCT02797522|564943145|FG003|Overall Study|Study Terminated by Sponsor|0|||
156504965|NCT02797522|564943146|FG004|Overall Study|Study Terminated by Sponsor|0|||
156504966|NCT02797522|564943147|FG005|Overall Study|Study Terminated by Sponsor|0|||
156504967|NCT02797522|564943148|FG006|Overall Study|Study Terminated by Sponsor|0|||
156504968|NCT02797522|564943149|FG007|Overall Study|Study Terminated by Sponsor|4|||
156504969|NCT02797522|564943150|FG008|Overall Study|Study Terminated by Sponsor|2|||
156504970|NCT02797522|564943151|FG009|Overall Study|Study Terminated by Sponsor|4|||
156504971|NCT02797522|564943152|FG010|Overall Study|Study Terminated by Sponsor|1|||
156504972|NCT00132678|564943155|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
156504973|NCT00132678|564943156|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
156504974|NCT00132678|564943157|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
156504975|NCT00132678|564943155|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
156504976|NCT00132678|564943156|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
156504977|NCT00132678|564943157|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
156504978|NCT00132678|564943155|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
156384419|NCT00467870|564498970|FG004|Overall Study|Other/Unknown|4|||
156384420|NCT00467870|564498971|FG005|Overall Study|Other/Unknown|0|||
156384421|NCT03489304|564498972|FG000|Overall Study|Lost to Follow-up|4|||
156384422|NCT02239679|564498973|FG000|Overall Study|Lost to Follow-up|1|||
156504979|NCT00132678|564943156|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
156384423|NCT02239679|564498974|FG001|Overall Study|Lost to Follow-up|0|||
156384424|NCT02239679|564498975|FG002|Overall Study|Lost to Follow-up|0|||
156384425|NCT02239679|564498973|FG000|Overall Study|Withdrawal by Subject|2|||
156504980|NCT00132678|564943157|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
156504981|NCT00132678|564943155|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
156504982|NCT00132678|564943156|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
156504983|NCT00132678|564943157|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
156504984|NCT00132678|564943155|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
156504985|NCT00132678|564943156|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
156504986|NCT00132678|564943157|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
156504987|NCT00132678|564943155|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
156504988|NCT00132678|564943156|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
156504989|NCT00132678|564943157|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
156504990|NCT00132678|564943155|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
156504991|NCT00132678|564943156|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
156504992|NCT00132678|564943157|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
156504993|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Death|2|||
156504994|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Death|0|||
156504995|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Death|0|||
156504996|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
156504997|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
156504998|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
156504999|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
156505000|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
156505001|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
156505002|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
156505003|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
156505004|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
156505005|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
156505006|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
156505007|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
156505008|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
156505009|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
156505010|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
156505011|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
156505012|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
156505013|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
156505014|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
156505015|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
156505016|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
156505017|NCT00132678|564943155|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
156505018|NCT00132678|564943156|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
156505019|NCT00132678|564943157|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
156505020|NCT00132678|564943155|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
156505021|NCT00132678|564943156|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
156505022|NCT00132678|564943157|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
156505023|NCT00132678|564943155|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
156505024|NCT00132678|564943156|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
156505025|NCT00132678|564943157|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
156505026|NCT00132678|564943155|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
156505027|NCT00132678|564943156|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
156505028|NCT00132678|564943157|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
156505029|NCT00132678|564943155|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
156505030|NCT00132678|564943156|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
156505031|NCT00132678|564943157|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
156505032|NCT00132678|564943155|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
156505033|NCT00132678|564943156|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
156505034|NCT00132678|564943157|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
156505035|NCT00132678|564943155|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
156505036|NCT00132678|564943156|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
156505037|NCT00132678|564943157|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
156505038|NCT00132678|564943155|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
156505039|NCT00132678|564943156|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
156505040|NCT00132678|564943157|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
156505041|NCT01901419|564943158|FG000|Overall Study|Protocol Violation|2|||
156505042|NCT01901419|564943159|FG001|Overall Study|Protocol Violation|6|||
156505043|NCT01901419|564943158|FG000|Overall Study|unavailable researchers|6|||
156505044|NCT01901419|564943159|FG001|Overall Study|unavailable researchers|3|||
156505045|NCT01888874|564943160|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
156505046|NCT01888874|564943161|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
156505047|NCT01888874|564943162|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
156505048|NCT01888874|564943163|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
156505049|NCT01888874|564943164|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
156505050|NCT01888874|564943165|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
156505051|NCT01888874|564943166|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
156505052|NCT01888874|564943160|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
156505053|NCT01888874|564943161|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
156505054|NCT01888874|564943162|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
156505055|NCT01888874|564943163|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
156505056|NCT01888874|564943164|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
156505057|NCT01888874|564943165|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
156505058|NCT01888874|564943166|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
156505059|NCT01888874|564943160|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
156505060|NCT01888874|564943161|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
156505061|NCT01888874|564943162|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
156505062|NCT01888874|564943163|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
156505063|NCT01888874|564943164|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
156505064|NCT01888874|564943165|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
156505065|NCT01888874|564943166|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
156505066|NCT01888874|564943160|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
156505067|NCT01888874|564943161|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
156505068|NCT01888874|564943162|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
156505069|NCT01888874|564943163|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
156505070|NCT01888874|564943164|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
156505071|NCT01888874|564943165|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
156505072|NCT01888874|564943166|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
156505073|NCT01888874|564943160|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156505074|NCT01888874|564943161|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156505075|NCT01888874|564943162|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156505076|NCT01888874|564943163|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156505077|NCT01888874|564943164|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
156505078|NCT01888874|564943165|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156505079|NCT01888874|564943166|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156505080|NCT01888874|564943160|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
156505081|NCT01888874|564943161|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
156505082|NCT01888874|564943162|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
156505083|NCT01888874|564943163|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
156505084|NCT01888874|564943164|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
156505085|NCT01888874|564943165|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
156505086|NCT01888874|564943166|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
156505087|NCT01888874|564943160|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
156505088|NCT01888874|564943161|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
156505089|NCT01888874|564943162|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
156505090|NCT01888874|564943163|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
156505091|NCT01888874|564943164|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
156505092|NCT01888874|564943165|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
156505093|NCT01888874|564943166|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
156505094|NCT01888874|564943160|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
156505095|NCT01888874|564943161|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
156505096|NCT01888874|564943162|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
156505097|NCT01888874|564943163|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
156505098|NCT01888874|564943164|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
156505099|NCT01888874|564943165|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
156505100|NCT01888874|564943166|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
156505101|NCT01888874|564943160|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
156505102|NCT01888874|564943161|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
156505103|NCT01888874|564943162|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
156505104|NCT01888874|564943163|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
156505105|NCT01888874|564943164|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
156505106|NCT01888874|564943165|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
156505107|NCT01888874|564943166|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
156505108|NCT01888874|564943160|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
156384426|NCT02239679|564498974|FG001|Overall Study|Withdrawal by Subject|3|||
156384427|NCT02239679|564498975|FG002|Overall Study|Withdrawal by Subject|1|||
156384428|NCT02261363|564498976|FG000|Overall Study|Lost to Follow-up|21|||
156384429|NCT01517802|564498977|FG000|Overall Study|Death|1|||
156384430|NCT02605954|564498978|FG000|Overall Study|Adverse Event|5|||
156384431|NCT02605954|564498979|FG001|Overall Study|Adverse Event|1|||
156384432|NCT02605954|564498978|FG000|Overall Study|Investigator's Discretion|1|||
156384433|NCT02605954|564498979|FG001|Overall Study|Investigator's Discretion|0|||
156384434|NCT02605954|564498978|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156384435|NCT02605954|564498979|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156384436|NCT02605954|564498978|FG000|Overall Study|Withdrew Consent|2|||
156384437|NCT02605954|564498979|FG001|Overall Study|Withdrew Consent|2|||
156384438|NCT02605954|564498978|FG000|Overall Study|Lost to Follow-up|3|||
156384439|NCT02605954|564498979|FG001|Overall Study|Lost to Follow-up|0|||
156384440|NCT02605954|564498978|FG000|Overall Study|Randomized but not treated|0|||
156384441|NCT02605954|564498979|FG001|Overall Study|Randomized but not treated|1|||
156384442|NCT01310036|564498980|FG000|Overall Study|Administrative/other|10|||
156384443|NCT01310036|564498980|FG000|Overall Study|Withdrew Consent|11|||
156384444|NCT01310036|564498980|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
156384445|NCT01310036|564498980|FG000|Overall Study|Progression of Disease|164|||
156384446|NCT01310036|564498980|FG000|Overall Study|Death|1|||
156384447|NCT01310036|564498980|FG000|Overall Study|Adverse event or intercurrent illness|12|||
156384448|NCT00709722|564498981|FG000|Overall Study|Adverse Event|1|||
156384449|NCT04667117|564498982|FG000|Investigational Period|Lost to Follow-up|0|||
156384450|NCT04667117|564498983|FG001|Investigational Period|Lost to Follow-up|0|||
156384451|NCT04667117|564498984|FG002|Investigational Period|Lost to Follow-up|1|||
156384452|NCT04667117|564498982|FG000|Investigational Period|Protocol Deviation|0|||
156384453|NCT04667117|564498983|FG001|Investigational Period|Protocol Deviation|1|||
156384454|NCT04667117|564498984|FG002|Investigational Period|Protocol Deviation|0|||
156384455|NCT04667117|564498982|FG000|Extension Period|Lost to Follow-up|1|||
156384456|NCT04667117|564498983|FG001|Extension Period|Lost to Follow-up|0|||
156384457|NCT04667117|564498984|FG002|Extension Period|Lost to Follow-up|0|||
156384458|NCT03359096|564498985|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
156384459|NCT03359096|564498986|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
156384460|NCT03359096|564498985|FG000|First Intervention (4 Weeks)|Death|1|||
156384461|NCT03359096|564498986|FG001|First Intervention (4 Weeks)|Death|0|||
156384462|NCT03359096|564498985|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
156384463|NCT03359096|564498986|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
156384464|NCT04433767|564498987|FG000|Overall Study|Adverse Event|1|||
156384465|NCT03538626|564498994|FG000|Overall Study|Withdrawal by Subject|0|||
156384466|NCT03538626|564498995|FG001|Overall Study|Withdrawal by Subject|1|||
156384467|NCT03538626|564498996|FG002|Overall Study|Withdrawal by Subject|0|||
156384468|NCT03538626|564498997|FG003|Overall Study|Withdrawal by Subject|0|||
156384469|NCT03538626|564498998|FG004|Overall Study|Withdrawal by Subject|0|||
156384470|NCT03538626|564498999|FG005|Overall Study|Withdrawal by Subject|0|||
156384471|NCT03538626|564499000|FG006|Overall Study|Withdrawal by Subject|0|||
156384472|NCT03538626|564499001|FG007|Overall Study|Withdrawal by Subject|0|||
156384473|NCT03538626|564498994|FG000|Overall Study|Lost to Follow-up|0|||
156384474|NCT03538626|564498995|FG001|Overall Study|Lost to Follow-up|0|||
156384475|NCT03538626|564498996|FG002|Overall Study|Lost to Follow-up|0|||
156384476|NCT03538626|564498997|FG003|Overall Study|Lost to Follow-up|0|||
156384477|NCT03538626|564498998|FG004|Overall Study|Lost to Follow-up|0|||
156384478|NCT03538626|564498999|FG005|Overall Study|Lost to Follow-up|0|||
156384479|NCT03538626|564499000|FG006|Overall Study|Lost to Follow-up|1|||
156384480|NCT03538626|564499001|FG007|Overall Study|Lost to Follow-up|0|||
156384481|NCT01434602|564499006|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
156384482|NCT01434602|564499007|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
156384483|NCT01434602|564499008|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
156384484|NCT01434602|564499009|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
156384485|NCT01434602|564499010|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
156384486|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
156384487|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
156384488|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
156384489|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
156384490|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
156384491|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
156505109|NCT01888874|564943161|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
156505110|NCT01888874|564943162|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
156505111|NCT01888874|564943163|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
156384492|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
156384493|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
156384494|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
156384495|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
156384496|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
156384497|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
156384498|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
156384499|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
156384500|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
156384501|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
156384502|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
156384503|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
156384504|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
156384505|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
156384506|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
156384507|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
156384508|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
156384509|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
156384510|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
156384511|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
156384512|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
156384513|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
156384514|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
156384515|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
156384516|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
156384517|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
156384518|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
156384519|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
156384520|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
156384521|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
156384522|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
156384523|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
156384524|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
156384525|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
156384526|NCT01434602|564499006|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
156384527|NCT01434602|564499007|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
156384528|NCT01434602|564499008|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
156384529|NCT01434602|564499009|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
156384530|NCT01434602|564499010|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
156384531|NCT02232893|564499012|FG000|Overall Study|Withdrawal by Subject|4|||
156384532|NCT02232893|564499013|FG001|Overall Study|Withdrawal by Subject|1|||
156384533|NCT02232893|564499012|FG000|Overall Study|Adverse Event|0|||
156384534|NCT02232893|564499013|FG001|Overall Study|Adverse Event|1|||
156384535|NCT02232893|564499012|FG000|Overall Study|Sponsor request early termination|0|||
156384536|NCT02232893|564499013|FG001|Overall Study|Sponsor request early termination|1|||
156384537|NCT02232893|564499012|FG000|Overall Study|Developed exclusion criteria|0|||
156384538|NCT02232893|564499013|FG001|Overall Study|Developed exclusion criteria|1|||
156384539|NCT02232893|564499012|FG000|Overall Study|Other|0|||
156384540|NCT02232893|564499013|FG001|Overall Study|Other|3|||
156384541|NCT05077267|564499015|FG000|Treatment Period|Lost to Follow-up|0|||
156384542|NCT05077267|564499016|FG001|Treatment Period|Lost to Follow-up|1|||
156384543|NCT05077267|564499017|FG002|Treatment Period|Lost to Follow-up|0|||
156384544|NCT05077267|564499015|FG000|Treatment Period|Withdrawal by Subject|0|||
156384545|NCT05077267|564499016|FG001|Treatment Period|Withdrawal by Subject|1|||
156384546|NCT05077267|564499017|FG002|Treatment Period|Withdrawal by Subject|0|||
156384547|NCT05077267|564499015|FG000|Follow-up Period|Lost to Follow-up|0|||
156384548|NCT05077267|564499016|FG001|Follow-up Period|Lost to Follow-up|5|||
156384549|NCT05077267|564499017|FG002|Follow-up Period|Lost to Follow-up|7|||
156505112|NCT01888874|564943164|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
156505113|NCT01888874|564943165|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
156505114|NCT01888874|564943166|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
156505115|NCT01888874|564943160|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
156505116|NCT01888874|564943161|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
156505117|NCT01888874|564943162|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
156505118|NCT01888874|564943163|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
156505119|NCT01888874|564943164|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
156505120|NCT01888874|564943165|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
156505121|NCT01888874|564943166|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
156505122|NCT01888874|564943160|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
156505123|NCT01888874|564943161|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
156505124|NCT01888874|564943162|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
156505125|NCT01888874|564943163|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
156505126|NCT01888874|564943164|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
156505127|NCT01888874|564943165|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
156505128|NCT01888874|564943166|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
156505129|NCT01888874|564943160|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
156505130|NCT01888874|564943161|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
156505131|NCT01888874|564943162|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
156505132|NCT01888874|564943163|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
156505133|NCT01888874|564943164|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
156505134|NCT01888874|564943165|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
156505135|NCT01888874|564943166|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
156505136|NCT00475644|564943168|FG000|Overall Study|Protocol Violation|13|||
156505137|NCT01411241|564943171|FG000|Overall Study|Protocol Violation|0|||
156505138|NCT01411241|564943172|FG001|Overall Study|Protocol Violation|5|||
156505139|NCT01411241|564943171|FG000|Overall Study|Withdrawal by Subject|9|||
156505140|NCT01411241|564943172|FG001|Overall Study|Withdrawal by Subject|10|||
156505141|NCT01411241|564943171|FG000|Overall Study|Serious Adverse Event|0|||
156505142|NCT01411241|564943172|FG001|Overall Study|Serious Adverse Event|3|||
156505143|NCT01411241|564943171|FG000|Overall Study|Lost to Follow-up|2|||
156505144|NCT01411241|564943172|FG001|Overall Study|Lost to Follow-up|4|||
156505145|NCT00699153|564943175|FG000|Overall Study|Lost to Follow-up|1|||
156505146|NCT00699153|564943176|FG001|Overall Study|Lost to Follow-up|0|||
156505147|NCT00699153|564943175|FG000|Overall Study|Adverse Event|0|||
156505148|NCT00699153|564943176|FG001|Overall Study|Adverse Event|2|||
156505149|NCT00699153|564943175|FG000|Overall Study|Protocol Violation|1|||
156505150|NCT00699153|564943176|FG001|Overall Study|Protocol Violation|0|||
156505151|NCT00699153|564943175|FG000|Overall Study|Travel Problem|1|||
156505152|NCT00699153|564943176|FG001|Overall Study|Travel Problem|0|||
156505153|NCT01006980|564943180|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
156505154|NCT01006980|564943181|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
156505155|NCT01006980|564943180|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
156505156|NCT01006980|564943181|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
156505157|NCT01006980|564943180|FG000|Vemurafenib and Dacarbazine|Death|13|||
156505158|NCT01006980|564943181|FG001|Vemurafenib and Dacarbazine|Death|12|||
156505159|NCT01006980|564943180|FG000|Vemurafenib and Dacarbazine|Progression|257|||
156505160|NCT01006980|564943181|FG001|Vemurafenib and Dacarbazine|Progression|218|||
156505161|NCT01006980|564943180|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
156505162|NCT01006980|564943181|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
156505163|NCT01006980|564943180|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
156505164|NCT01006980|564943181|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
156505165|NCT01006980|564943180|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
156505166|NCT01006980|564943181|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
156505167|NCT01006980|564943180|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
156505168|NCT01006980|564943181|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
156505169|NCT01006980|564943180|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
156505170|NCT01006980|564943181|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
156505171|NCT01006980|564943180|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
156505172|NCT01006980|564943181|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
156505173|NCT01006980|564943180|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
156505174|NCT01006980|564943181|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
156505175|NCT01006980|564943180|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
156505176|NCT01006980|564943181|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
156505177|NCT01006980|564943180|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
156505178|NCT01006980|564943181|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
156505179|NCT00078338|564943182|FG000|Overall Study|Adverse Event|31|||
156505180|NCT00078338|564943183|FG001|Overall Study|Adverse Event|24|||
156505181|NCT00078338|564943182|FG000|Overall Study|Lost to Follow-up|17|||
156505182|NCT00078338|564943183|FG001|Overall Study|Lost to Follow-up|2|||
156505183|NCT00078338|564943182|FG000|Overall Study|Protocol Violation|2|||
156505184|NCT00078338|564943183|FG001|Overall Study|Protocol Violation|2|||
156505185|NCT00078338|564943182|FG000|Overall Study|Disease Progression|4|||
156505186|NCT00078338|564943183|FG001|Overall Study|Disease Progression|7|||
156505187|NCT00078338|564943182|FG000|Overall Study|Other|28|||
156547057|NCT00794157|565095031|FG000|Overall Study|Protocol deviation|0|||
156505188|NCT00078338|564943183|FG001|Overall Study|Other|16|||
156505189|NCT00078338|564943182|FG000|Overall Study|Subjects randomized, but not treated|3|||
156505190|NCT00078338|564943183|FG001|Overall Study|Subjects randomized, but not treated|3|||
156505191|NCT00603525|564943184|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
156505192|NCT00603525|564943185|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
156505193|NCT00603525|564943186|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156505194|NCT00603525|564943184|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
156505195|NCT00603525|564943185|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
156505196|NCT00603525|564943186|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
156505197|NCT00603525|564943184|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
156505198|NCT00603525|564943185|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
156505199|NCT00603525|564943186|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156505200|NCT00603525|564943184|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156505201|NCT00603525|564943185|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
156505202|NCT00603525|564943186|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156505203|NCT00603525|564943184|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
156505204|NCT00603525|564943185|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
156505205|NCT00603525|564943186|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156505206|NCT00603525|564943184|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
156505207|NCT00603525|564943185|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
156505208|NCT00603525|564943186|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
156505209|NCT00603525|564943184|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
156505210|NCT00603525|564943185|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
156505211|NCT00603525|564943186|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
156505212|NCT00603525|564943184|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
156505213|NCT00603525|564943185|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
156505214|NCT00603525|564943186|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
156505215|NCT00603525|564943184|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
156505216|NCT00603525|564943185|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
156505217|NCT00603525|564943186|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
156505218|NCT00603525|564943184|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
156505219|NCT00603525|564943185|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
156505220|NCT00603525|564943186|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
156505221|NCT00603525|564943184|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
156505222|NCT00603525|564943185|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
156505223|NCT00603525|564943186|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
156505224|NCT00603525|564943184|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
156505225|NCT00603525|564943185|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
156505226|NCT00603525|564943186|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
156505227|NCT00603525|564943184|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
156505228|NCT00603525|564943185|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
156505229|NCT00603525|564943186|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
156505230|NCT00603525|564943184|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
156505231|NCT00603525|564943185|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
156505232|NCT00603525|564943186|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
156505233|NCT00603525|564943184|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
156505234|NCT00603525|564943185|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
156505235|NCT00603525|564943186|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
156505236|NCT01483144|564943187|FG000|Overall Study|Adverse Event|9|||
156505237|NCT01483144|564943188|FG001|Overall Study|Adverse Event|4|||
156505238|NCT01483144|564943189|FG002|Overall Study|Adverse Event|6|||
156505239|NCT01483144|564943187|FG000|Overall Study|Withdrawal by Subject|0|||
156505240|NCT01483144|564943188|FG001|Overall Study|Withdrawal by Subject|2|||
156505241|NCT01483144|564943189|FG002|Overall Study|Withdrawal by Subject|5|||
156505242|NCT01483144|564943187|FG000|Overall Study|Physician Decision|1|||
156505243|NCT01483144|564943188|FG001|Overall Study|Physician Decision|0|||
156505244|NCT01483144|564943189|FG002|Overall Study|Physician Decision|0|||
156547058|NCT00794157|565095032|FG001|Overall Study|Protocol deviation|1|||
156505245|NCT01483144|564943187|FG000|Overall Study|Lost to Follow-up|2|||
156505246|NCT01483144|564943188|FG001|Overall Study|Lost to Follow-up|4|||
156547059|NCT00794157|565095033|FG002|Overall Study|Protocol deviation|1|||
156547060|NCT01970501|565095034|FG000|Overall Study|Discontinuation of study by sponsor|16|||
156384550|NCT05077267|564499015|FG000|Follow-up Period|Withdrawal by Subject|0|||
156384551|NCT05077267|564499016|FG001|Follow-up Period|Withdrawal by Subject|2|||
156384552|NCT05077267|564499017|FG002|Follow-up Period|Withdrawal by Subject|5|||
156384553|NCT05077267|564499015|FG000|Follow-up Period|Study terminated by sponsor|0|||
156384554|NCT05077267|564499016|FG001|Follow-up Period|Study terminated by sponsor|27|||
156384555|NCT05077267|564499017|FG002|Follow-up Period|Study terminated by sponsor|23|||
156505247|NCT01483144|564943189|FG002|Overall Study|Lost to Follow-up|1|||
156505248|NCT01483144|564943187|FG000|Overall Study|Protocol Violation|3|||
156547061|NCT01970501|565095035|FG001|Overall Study|Discontinuation of study by sponsor|14|||
156384556|NCT05077267|564499015|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
156384557|NCT05077267|564499016|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
156384558|NCT05077267|564499017|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
156384559|NCT05077267|564499015|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
156384560|NCT05077267|564499016|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
156384561|NCT05077267|564499017|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
156384562|NCT03965052|564499022|FG000|Overall Study|Protocol Violation|1|||
156384563|NCT03965052|564499023|FG001|Overall Study|Protocol Violation|0|||
156384564|NCT00759109|564499029|FG000|Overall Study|Adverse Event|17|||
156384565|NCT00759109|564499030|FG001|Overall Study|Adverse Event|12|||
156384566|NCT00759109|564499029|FG000|Overall Study|Inability to comply|1|||
156384567|NCT00759109|564499030|FG001|Overall Study|Inability to comply|1|||
156384568|NCT00759109|564499029|FG000|Overall Study|Withdrawal by Subject|9|||
156384569|NCT00759109|564499030|FG001|Overall Study|Withdrawal by Subject|5|||
156384570|NCT00759109|564499029|FG000|Overall Study|Death|4|||
156384571|NCT00759109|564499030|FG001|Overall Study|Death|3|||
156384572|NCT00759109|564499029|FG000|Overall Study|Lost to Follow-up|4|||
156384573|NCT00759109|564499030|FG001|Overall Study|Lost to Follow-up|6|||
156384574|NCT00759109|564499029|FG000|Overall Study|Started new therapy|2|||
156384575|NCT00759109|564499030|FG001|Overall Study|Started new therapy|6|||
156384576|NCT00759109|564499029|FG000|Overall Study|HCV RNA negative|1|||
156384577|NCT00759109|564499030|FG001|Overall Study|HCV RNA negative|0|||
156384578|NCT00759109|564499029|FG000|Overall Study|Participant moved to a different city|0|||
156384579|NCT00759109|564499030|FG001|Overall Study|Participant moved to a different city|1|||
156384580|NCT00759109|564499029|FG000|Overall Study|Participant had a liver transplant|0|||
156384581|NCT00759109|564499030|FG001|Overall Study|Participant had a liver transplant|1|||
156384582|NCT00759109|564499029|FG000|Overall Study|Lost during study|1|||
156384583|NCT00759109|564499030|FG001|Overall Study|Lost during study|0|||
156384584|NCT02308033|564499031|FG000|Overall Study|Normal Gram stain at Baseline|13|||
156384585|NCT02308033|564499032|FG001|Overall Study|Normal Gram stain at Baseline|10|||
156384586|NCT02308033|564499031|FG000|Overall Study|Positive for STD at Baseline|7|||
156384587|NCT02308033|564499032|FG001|Overall Study|Positive for STD at Baseline|4|||
156384588|NCT02308033|564499031|FG000|Overall Study|Lost to Follow-up|6|||
156384589|NCT02308033|564499032|FG001|Overall Study|Lost to Follow-up|5|||
156384590|NCT01827904|564499033|FG000|Main Study|Withdrawal by Subject|1|||
156384591|NCT01827904|564499034|FG001|Main Study|Withdrawal by Subject|0|||
156384592|NCT01827904|564499035|FG002|Main Study|Withdrawal by Subject|0|||
156384593|NCT01827904|564499033|FG000|Main Study|Adverse Event|1|||
156384594|NCT01827904|564499034|FG001|Main Study|Adverse Event|0|||
156384595|NCT01827904|564499035|FG002|Main Study|Adverse Event|0|||
156384596|NCT01827904|564499033|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
156384597|NCT01827904|564499034|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
156384598|NCT01827904|564499035|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
156384599|NCT01827904|564499033|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
156384600|NCT01827904|564499034|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
156384601|NCT01827904|564499035|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
156384602|NCT01827904|564499033|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
156384603|NCT01827904|564499034|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
156384604|NCT01827904|564499035|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
156384605|NCT01827904|564499033|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
156384606|NCT01827904|564499034|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
156384607|NCT01827904|564499035|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
156384608|NCT01827904|564499033|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
156384609|NCT01827904|564499034|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
156505249|NCT01483144|564943188|FG001|Overall Study|Protocol Violation|3|||
156505250|NCT01483144|564943189|FG002|Overall Study|Protocol Violation|3|||
156505251|NCT02124811|564943190|FG000|Overall Study|Early termination|2|||
156505252|NCT02124811|564943191|FG001|Overall Study|Early termination|2|||
156505253|NCT02124811|564943190|FG000|Overall Study|Withdrawal by Subject|1|||
156505254|NCT02124811|564943191|FG001|Overall Study|Withdrawal by Subject|0|||
156505255|NCT04043143|564943192|FG000|Overall Study|Lost to Follow-up|5|||
156505256|NCT04043143|564943193|FG001|Overall Study|Lost to Follow-up|5|||
156505257|NCT04043143|564943192|FG000|Overall Study|screen failure|1|||
156384610|NCT01827904|564499035|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
156384611|NCT01827904|564499033|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
156384612|NCT01827904|564499034|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
156384613|NCT01827904|564499035|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
156384614|NCT01827904|564499033|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
156384615|NCT01827904|564499034|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
156384616|NCT01827904|564499035|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
156384617|NCT01827904|564499033|FG000|Long-term Annual Follow-up|Physician Decision|1|||
156384618|NCT01827904|564499034|FG001|Long-term Annual Follow-up|Physician Decision|0|||
156505258|NCT04043143|564943193|FG001|Overall Study|screen failure|0|||
156384619|NCT01827904|564499035|FG002|Long-term Annual Follow-up|Physician Decision|0|||
156384620|NCT01827904|564499033|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
156384621|NCT01827904|564499034|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
156384622|NCT01827904|564499035|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
156384623|NCT01827904|564499033|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
156384624|NCT01827904|564499034|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
156384625|NCT01827904|564499035|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
156384626|NCT04323436|564499046|FG000|Overall Study|Adverse Event|7|||
156384627|NCT04323436|564499047|FG001|Overall Study|Adverse Event|0|||
156384628|NCT04323436|564499048|FG002|Overall Study|Adverse Event|0|||
156384629|NCT04323436|564499046|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
156384630|NCT04323436|564499047|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
156384631|NCT04323436|564499048|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
156384632|NCT04323436|564499046|FG000|Overall Study|Death|1|||
156384633|NCT04323436|564499047|FG001|Overall Study|Death|0|||
156384634|NCT04323436|564499048|FG002|Overall Study|Death|0|||
156384635|NCT04323436|564499046|FG000|Overall Study|Physician Decision|2|||
156384636|NCT04323436|564499047|FG001|Overall Study|Physician Decision|0|||
156384637|NCT04323436|564499048|FG002|Overall Study|Physician Decision|0|||
156384638|NCT04323436|564499046|FG000|Overall Study|Progressive disease|10|||
156384639|NCT04323436|564499047|FG001|Overall Study|Progressive disease|0|||
156384640|NCT04323436|564499048|FG002|Overall Study|Progressive disease|0|||
156384641|NCT04323436|564499046|FG000|Overall Study|Subject decision|3|||
156384642|NCT04323436|564499047|FG001|Overall Study|Subject decision|0|||
156384643|NCT04323436|564499048|FG002|Overall Study|Subject decision|0|||
156384644|NCT00142909|564499049|FG000|Randomization|Various Reasons|7|||
156384645|NCT00142909|564499050|FG001|Randomization|Various Reasons|10|||
156384646|NCT00142909|564499049|FG000|Medications Begin|Protocol Violation|2|||
156384647|NCT00142909|564499050|FG001|Medications Begin|Protocol Violation|0|||
156384648|NCT00142909|564499049|FG000|Medications Begin|Withdrawal by Subject|5|||
156384649|NCT00142909|564499050|FG001|Medications Begin|Withdrawal by Subject|3|||
156384650|NCT00142909|564499049|FG000|Medications Begin|Withdrawal by Subject|2|||
156384651|NCT00142909|564499050|FG001|Medications Begin|Withdrawal by Subject|0|||
156384652|NCT01660763|564499054|FG000|Overall Study|Lack of Efficacy|45|||
156384653|NCT01660763|564499055|FG001|Overall Study|Lack of Efficacy|50|||
156384654|NCT01660763|564499054|FG000|Overall Study|Adverse Event|22|||
156384655|NCT01660763|564499055|FG001|Overall Study|Adverse Event|7|||
156384656|NCT01660763|564499054|FG000|Overall Study|Protocol Violation|1|||
156384657|NCT01660763|564499055|FG001|Overall Study|Protocol Violation|0|||
156384658|NCT01660763|564499054|FG000|Overall Study|Withdrawal by Subject|4|||
156384659|NCT01660763|564499055|FG001|Overall Study|Withdrawal by Subject|0|||
156384660|NCT01660763|564499054|FG000|Overall Study|Patient ready for early discharge|28|||
156384661|NCT01660763|564499055|FG001|Overall Study|Patient ready for early discharge|4|||
156384662|NCT01870843|564499056|FG000|Overall Study|Adverse Event|10|||
156384663|NCT01870843|564499056|FG000|Overall Study|Lost to Follow-up|24|||
156384664|NCT01870843|564499056|FG000|Overall Study|Death|1|||
156384665|NCT01870843|564499056|FG000|Overall Study|Withdrawal by Subject|18|||
156384666|NCT00345397|564499057|FG000|Overall Study|Death|1|||
156384667|NCT00364858|564499062|FG000|Overall Study|Adverse Event|1|||
156384668|NCT00364858|564499063|FG001|Overall Study|Adverse Event|5|||
156384669|NCT00364858|564499062|FG000|Overall Study|Withdrawal by Subject|1|||
156384670|NCT00364858|564499063|FG001|Overall Study|Withdrawal by Subject|1|||
156384671|NCT00364858|564499062|FG000|Overall Study|Pregnancy|1|||
156384672|NCT00364858|564499063|FG001|Overall Study|Pregnancy|1|||
156384673|NCT00364858|564499062|FG000|Overall Study|Clinical failure|2|||
156384674|NCT00364858|564499063|FG001|Overall Study|Clinical failure|13|||
156384675|NCT00364858|564499062|FG000|Overall Study|Discontinuation at baseline|1|||
156384676|NCT00364858|564499063|FG001|Overall Study|Discontinuation at baseline|0|||
156384677|NCT00364858|564499062|FG000|Overall Study|Non-compliant|1|||
156505259|NCT04896008|564943199|FG000|Overall Study|Ongoing|70|||
156505260|NCT04896008|564943200|FG001|Overall Study|Ongoing|38|||
156505261|NCT04896008|564943199|FG000|Overall Study|Adverse Event|0|||
156384678|NCT00364858|564499063|FG001|Overall Study|Non-compliant|0|||
156384679|NCT00364858|564499062|FG000|Overall Study|Return to Q2 regimen|0|||
156384680|NCT00364858|564499063|FG001|Overall Study|Return to Q2 regimen|1|||
156384681|NCT00364858|564499062|FG000|Overall Study|Clinical baseline issue|0|||
156384682|NCT00364858|564499063|FG001|Overall Study|Clinical baseline issue|1|||
156384683|NCT00363766|564499064|FG000|Overall Study|Progressive Disease|15|||
156384684|NCT00363766|564499065|FG001|Overall Study|Progressive Disease|9|||
156384685|NCT00363766|564499064|FG000|Overall Study|Adverse Event|10|||
156384686|NCT00363766|564499065|FG001|Overall Study|Adverse Event|2|||
156384687|NCT00363766|564499064|FG000|Overall Study|Disease Related Death|1|||
156384688|NCT00363766|564499065|FG001|Overall Study|Disease Related Death|3|||
156384689|NCT00363766|564499064|FG000|Overall Study|Not Disease Related Death|3|||
156384690|NCT00363766|564499065|FG001|Overall Study|Not Disease Related Death|4|||
156384691|NCT00363766|564499064|FG000|Overall Study|Withdrawal by Subject|2|||
156384692|NCT00363766|564499065|FG001|Overall Study|Withdrawal by Subject|0|||
156384693|NCT00363766|564499064|FG000|Overall Study|Physician Decision|1|||
156384694|NCT00363766|564499065|FG001|Overall Study|Physician Decision|2|||
156384695|NCT02730819|564499072|FG000|Overall Study|Lost to Follow-up|9|||
156384696|NCT02345512|564499073|FG000|Overall Study|Adverse Event|1|||
156384697|NCT02345512|564499073|FG000|Overall Study|Withdrawal by Subject|1|||
156384698|NCT01660906|564499074|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
156384699|NCT02121847|564499075|FG000|Overall Study|Administrative Reasons|1|||
156384700|NCT02121847|564499075|FG000|Overall Study|Adverse Event|2|||
156384701|NCT03478891|564499081|FG000|Overall Study|Enrolled, but product never administered|0|||
156384702|NCT03478891|564499082|FG001|Overall Study|Enrolled, but product never administered|0|||
156384703|NCT03478891|564499083|FG002|Overall Study|Enrolled, but product never administered|1|||
156384704|NCT03478891|564499081|FG000|Overall Study|Moved from area|0|||
156384705|NCT03478891|564499082|FG001|Overall Study|Moved from area|0|||
156384706|NCT03478891|564499083|FG002|Overall Study|Moved from area|1|||
156384707|NCT03478891|564499081|FG000|Overall Study|Lost to Follow-up|1|||
156384708|NCT03478891|564499082|FG001|Overall Study|Lost to Follow-up|0|||
156384709|NCT03478891|564499083|FG002|Overall Study|Lost to Follow-up|1|||
156384710|NCT03864614|564499088|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
156384711|NCT03864614|564499089|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
156384712|NCT03864614|564499090|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
156384713|NCT03864614|564499091|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
156384714|NCT03864614|564499088|FG000|Overall Study|Withdrawal by Subject|72|||
156384715|NCT03864614|564499089|FG001|Overall Study|Withdrawal by Subject|100|||
156384716|NCT03864614|564499090|FG002|Overall Study|Withdrawal by Subject|1|||
156384717|NCT03864614|564499091|FG003|Overall Study|Withdrawal by Subject|21|||
156384718|NCT03864614|564499088|FG000|Overall Study|Lost to Follow-up|45|||
156384719|NCT03864614|564499089|FG001|Overall Study|Lost to Follow-up|54|||
156384720|NCT03864614|564499090|FG002|Overall Study|Lost to Follow-up|0|||
156384721|NCT03864614|564499091|FG003|Overall Study|Lost to Follow-up|9|||
156384722|NCT03864614|564499088|FG000|Overall Study|Adverse Event|42|||
156384723|NCT03864614|564499089|FG001|Overall Study|Adverse Event|30|||
156384724|NCT03864614|564499090|FG002|Overall Study|Adverse Event|1|||
156384725|NCT03864614|564499091|FG003|Overall Study|Adverse Event|9|||
156384726|NCT03864614|564499088|FG000|Overall Study|Protocol Deviation|6|||
156384727|NCT03864614|564499089|FG001|Overall Study|Protocol Deviation|26|||
156384728|NCT03864614|564499090|FG002|Overall Study|Protocol Deviation|0|||
156384729|NCT03864614|564499091|FG003|Overall Study|Protocol Deviation|1|||
156384730|NCT03864614|564499088|FG000|Overall Study|Physician Decision|7|||
156384731|NCT03864614|564499089|FG001|Overall Study|Physician Decision|10|||
156384732|NCT03864614|564499090|FG002|Overall Study|Physician Decision|1|||
156384733|NCT03864614|564499091|FG003|Overall Study|Physician Decision|5|||
156384734|NCT03864614|564499088|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
156384735|NCT03864614|564499089|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
156384736|NCT03864614|564499090|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
156384737|NCT03864614|564499091|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
156384738|NCT03864614|564499088|FG000|Overall Study|Sponsor Decision|1|||
156384739|NCT03864614|564499089|FG001|Overall Study|Sponsor Decision|2|||
156384740|NCT03864614|564499090|FG002|Overall Study|Sponsor Decision|0|||
156384741|NCT03864614|564499091|FG003|Overall Study|Sponsor Decision|0|||
156384742|NCT03864614|564499088|FG000|Overall Study|Pregnancy|0|||
156384743|NCT03864614|564499089|FG001|Overall Study|Pregnancy|1|||
156384744|NCT03864614|564499090|FG002|Overall Study|Pregnancy|0|||
156384745|NCT03864614|564499091|FG003|Overall Study|Pregnancy|0|||
156384746|NCT03864614|564499088|FG000|Overall Study|Other|7|||
156384747|NCT03864614|564499089|FG001|Overall Study|Other|9|||
156384748|NCT03864614|564499090|FG002|Overall Study|Other|1|||
156384749|NCT03864614|564499091|FG003|Overall Study|Other|4|||
156384750|NCT03864614|564499088|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
156384751|NCT03864614|564499089|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
156384752|NCT03864614|564499090|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
156384753|NCT03864614|564499091|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
156384754|NCT01850004|564499092|FG000|Overall Study|Poor/Non-compliance|1|||
156384755|NCT01850004|564499092|FG000|Overall Study|Participant Withdrew Consent|9|||
156384756|NCT01850004|564499092|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
156384757|NCT01850004|564499092|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
156384758|NCT01850004|564499092|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
156384759|NCT01850004|564499092|FG000|Overall Study|Other Reasons|2|||
156384760|NCT01850004|564499092|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
156384761|NCT01850004|564499092|FG000|Overall Study|Maximum Clinical Benefit|4|||
156384762|NCT01625897|564500989|FG000|Overall Study|Adverse Event|27|||
156384763|NCT01625897|564500990|FG001|Overall Study|Adverse Event|10|||
156384764|NCT01625897|564500989|FG000|Overall Study|Physician Decision|0|||
156384765|NCT01625897|564500990|FG001|Overall Study|Physician Decision|1|||
156384766|NCT01625897|564500989|FG000|Overall Study|Withdrawal by Subject|25|||
156384767|NCT01625897|564500990|FG001|Overall Study|Withdrawal by Subject|3|||
156384768|NCT01432366|564500991|FG000|Overall Study|Non-Responder|7|||
156384769|NCT01432366|564500991|FG000|Overall Study|Adverse Event|8|||
156384770|NCT01432366|564500991|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
156384771|NCT01432366|564500991|FG000|Overall Study|Pregnancy|1|||
156384772|NCT01432366|564500991|FG000|Overall Study|Lost to Follow-up|13|||
156384773|NCT01432366|564500991|FG000|Overall Study|Lack of Efficacy|1|||
156384774|NCT01432366|564500991|FG000|Overall Study|Site Closed|20|||
156384775|NCT01432366|564500991|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
156384776|NCT01432366|564500991|FG000|Overall Study|Other|14|||
156384777|NCT04546581|564500993|FG000|Overall Study|Adverse Event|9|||
156384778|NCT04546581|564500994|FG001|Overall Study|Adverse Event|3|||
156384779|NCT04546581|564500993|FG000|Overall Study|Physician Decision|0|||
156384780|NCT04546581|564500994|FG001|Overall Study|Physician Decision|1|||
156384781|NCT04546581|564500993|FG000|Overall Study|Protocol Violation|1|||
156384782|NCT04546581|564500994|FG001|Overall Study|Protocol Violation|2|||
156384783|NCT04546581|564500993|FG000|Overall Study|Withdrawal by Subject|3|||
156384784|NCT04546581|564500994|FG001|Overall Study|Withdrawal by Subject|7|||
156384785|NCT02526693|564500995|FG000|Overall Study|Physician Decision|3|||
156384786|NCT02526693|564500996|FG001|Overall Study|Physician Decision|1|||
156384787|NCT01585103|564500998|FG000|Overall Study|Unable to swallow Cytosponge|6|||
156384788|NCT01349569|564500999|FG000|Overall Study|Lack of Efficacy|4|||
156384789|NCT03581305|564501000|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
156384790|NCT03581305|564501001|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
156384791|NCT03581305|564501000|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
156384792|NCT03581305|564501001|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
156384793|NCT03581305|564501000|FG000|Serotonergic Study|Withdrawal by Subject|5|||
156384794|NCT03581305|564501001|FG001|Serotonergic Study|Withdrawal by Subject|1|||
156384795|NCT01798927|564501002|FG000|Overall Study|Withdrawal by Subject|1|||
156384796|NCT01159691|564501003|FG000|Overall Study|Lost to Follow-up|2|||
156384797|NCT01159691|564501003|FG000|Overall Study|Unknown reasons|1|||
156384798|NCT01159691|564501003|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
156384799|NCT01159691|564501003|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
156384800|NCT01159691|564501003|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
156505262|NCT04896008|564943200|FG001|Overall Study|Adverse Event|2|||
156505263|NCT04896008|564943199|FG000|Overall Study|Death|5|||
156505264|NCT04896008|564943200|FG001|Overall Study|Death|10|||
156505265|NCT04896008|564943199|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
156505266|NCT04896008|564943200|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
156505267|NCT04896008|564943199|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
156505268|NCT04896008|564943200|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
156505269|NCT04896008|564943199|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
156505270|NCT04896008|564943200|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
156505271|NCT04896008|564943199|FG000|Overall Study|Withdrawal by Subject|1|||
156505272|NCT04896008|564943200|FG001|Overall Study|Withdrawal by Subject|4|||
156505273|NCT04896008|564943199|FG000|Overall Study|Investigator Decision|2|||
156505274|NCT04896008|564943200|FG001|Overall Study|Investigator Decision|0|||
156505275|NCT04896008|564943199|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
156505276|NCT04896008|564943200|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
156505277|NCT04201288|564943203|FG000|Overall Study|Death|1|||
156505278|NCT04201288|564943204|FG001|Overall Study|Death|1|||
156505279|NCT04201288|564943203|FG000|Overall Study|Lost to Follow-up|5|||
156505280|NCT04201288|564943204|FG001|Overall Study|Lost to Follow-up|3|||
156505281|NCT04201288|564943203|FG000|Overall Study|Withdrawal by Subject|1|||
156505282|NCT04201288|564943204|FG001|Overall Study|Withdrawal by Subject|0|||
156505283|NCT03322540|564943212|FG000|Overall Study|Death|21|||
156505284|NCT03322540|564943213|FG001|Overall Study|Death|28|||
156505285|NCT03322540|564943212|FG000|Overall Study|Lost to Follow-up|0|||
156505286|NCT03322540|564943213|FG001|Overall Study|Lost to Follow-up|1|||
156505287|NCT03322540|564943212|FG000|Overall Study|Physician Decision|7|||
156505288|NCT03322540|564943213|FG001|Overall Study|Physician Decision|6|||
156505289|NCT03322540|564943212|FG000|Overall Study|Withdrawal by Subject|3|||
156505290|NCT03322540|564943213|FG001|Overall Study|Withdrawal by Subject|1|||
156505291|NCT03322540|564943212|FG000|Overall Study|Study terminated by sponsor|0|||
156505292|NCT03322540|564943213|FG001|Overall Study|Study terminated by sponsor|1|||
156505293|NCT01594827|564943214|FG000|Overall Study|Adverse Event|1|||
156384801|NCT01159691|564501003|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
156384802|NCT01159691|564501003|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
156384803|NCT01159691|564501003|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
156384804|NCT01944631|564501009|FG000|Overall Study|Adverse Event|1|||
156384805|NCT01944631|564501010|FG001|Overall Study|Adverse Event|0|||
156505294|NCT01594827|564943215|FG001|Overall Study|Adverse Event|0|||
156505295|NCT01594827|564943214|FG000|Overall Study|Physician Decision|3|||
156505296|NCT01594827|564943215|FG001|Overall Study|Physician Decision|0|||
156384806|NCT01944631|564501009|FG000|Overall Study|Lost to Follow-up|3|||
156384807|NCT01944631|564501010|FG001|Overall Study|Lost to Follow-up|1|||
156384808|NCT01944631|564501009|FG000|Overall Study|Withdrawal by Subject|0|||
156505297|NCT02153905|564943216|FG000|Overall Study|Death|1|||
156505298|NCT02153905|564943217|FG001|Overall Study|Death|0|||
156505299|NCT00520845|564943218|FG000|Overall Study|Death|3|||
156505300|NCT00520845|564943218|FG000|Overall Study|Adverse Event|4|||
156505301|NCT00520845|564943218|FG000|Overall Study|Disease Progression, relapse|13|||
156505302|NCT00520845|564943218|FG000|Overall Study|Withdrawal by Subject|1|||
156505303|NCT00520845|564943218|FG000|Overall Study|Alternative Therapy|1|||
156505304|NCT00351377|564943219|FG000|Overall Study|Adverse Event|5|||
156505305|NCT00351377|564943219|FG000|Overall Study|Death|1|||
156505306|NCT00351377|564943219|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156505307|NCT02493062|564943221|FG000|Overall Study|Physician Decision|12|||
156505308|NCT01327612|564943222|FG000|Overall Study|Withdrawal by Subject|0|||
156505309|NCT01327612|564943223|FG001|Overall Study|Withdrawal by Subject|0|||
156505310|NCT01327612|564943224|FG002|Overall Study|Withdrawal by Subject|0|||
156505311|NCT01327612|564943225|FG003|Overall Study|Withdrawal by Subject|0|||
156505312|NCT01327612|564943226|FG004|Overall Study|Withdrawal by Subject|0|||
156505313|NCT01327612|564943227|FG005|Overall Study|Withdrawal by Subject|1|||
156505314|NCT01327612|564943228|FG006|Overall Study|Withdrawal by Subject|0|||
156505315|NCT01327612|564943222|FG000|Overall Study|Disease Progression|1|||
156505316|NCT01327612|564943223|FG001|Overall Study|Disease Progression|1|||
156505317|NCT01327612|564943224|FG002|Overall Study|Disease Progression|1|||
156505318|NCT01327612|564943225|FG003|Overall Study|Disease Progression|0|||
156505319|NCT01327612|564943226|FG004|Overall Study|Disease Progression|1|||
156505320|NCT01327612|564943227|FG005|Overall Study|Disease Progression|2|||
156505321|NCT01327612|564943228|FG006|Overall Study|Disease Progression|2|||
156505322|NCT01327612|564943222|FG000|Overall Study|Administrative Decision|0|||
156505323|NCT01327612|564943223|FG001|Overall Study|Administrative Decision|0|||
156505324|NCT01327612|564943224|FG002|Overall Study|Administrative Decision|0|||
156505325|NCT01327612|564943225|FG003|Overall Study|Administrative Decision|1|||
156505326|NCT01327612|564943226|FG004|Overall Study|Administrative Decision|0|||
156505327|NCT01327612|564943227|FG005|Overall Study|Administrative Decision|0|||
156505328|NCT01327612|564943228|FG006|Overall Study|Administrative Decision|0|||
156505329|NCT01327612|564943222|FG000|Overall Study|Death|0|||
156505330|NCT01327612|564943223|FG001|Overall Study|Death|0|||
156505331|NCT01327612|564943224|FG002|Overall Study|Death|0|||
156505332|NCT01327612|564943225|FG003|Overall Study|Death|0|||
156505333|NCT01327612|564943226|FG004|Overall Study|Death|1|||
156505334|NCT01327612|564943227|FG005|Overall Study|Death|0|||
156505335|NCT01327612|564943228|FG006|Overall Study|Death|0|||
156505336|NCT01294397|564943230|FG000|Overall Study|Withdrawal by Subject|1|||
156505337|NCT01294397|564943230|FG000|Overall Study|Administrative Decision|1|||
156505338|NCT01967069|564943231|FG000|Overall Study|Adverse Event|2|||
156505339|NCT01967069|564943232|FG001|Overall Study|Adverse Event|2|||
156505340|NCT01967069|564943231|FG000|Overall Study|Lost to Follow-up|5|||
156505341|NCT01967069|564943232|FG001|Overall Study|Lost to Follow-up|2|||
156505342|NCT01967069|564943231|FG000|Overall Study|Withdrawal by Subject|1|||
156505343|NCT01967069|564943232|FG001|Overall Study|Withdrawal by Subject|3|||
156505344|NCT01967069|564943231|FG000|Overall Study|Lack of Efficacy|0|||
156505345|NCT01967069|564943232|FG001|Overall Study|Lack of Efficacy|1|||
156505346|NCT05569421|564943233|FG000|Overall Study|Withdrawal by Subject|1|||
156505347|NCT05569421|564943234|FG001|Overall Study|Withdrawal by Subject|0|||
156505348|NCT05569421|564943235|FG002|Overall Study|Withdrawal by Subject|0|||
156505349|NCT00479882|564943237|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
156505350|NCT00479882|564943238|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
156505351|NCT00479882|564943239|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
156505352|NCT00479882|564943240|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
156505353|NCT00479882|564943237|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
156505354|NCT00479882|564943238|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
156505355|NCT00479882|564943239|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
156505356|NCT00479882|564943240|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
156505357|NCT00479882|564943237|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
156505358|NCT00479882|564943238|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
156505359|NCT00479882|564943239|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
156505360|NCT00479882|564943240|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
156505361|NCT00479882|564943237|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
156505362|NCT00479882|564943238|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
156384809|NCT01944631|564501010|FG001|Overall Study|Withdrawal by Subject|1|||
156505363|NCT00479882|564943239|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
156505364|NCT00479882|564943240|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
156505365|NCT00479882|564943237|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
156505366|NCT00479882|564943238|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
156505367|NCT00479882|564943239|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
156505368|NCT00479882|564943240|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
156505369|NCT00479882|564943237|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
156505370|NCT00479882|564943238|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
156505371|NCT00479882|564943239|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
156505372|NCT00479882|564943240|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
156505373|NCT00479882|564943237|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
156505374|NCT00479882|564943238|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
156505375|NCT00479882|564943239|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
156505376|NCT00479882|564943240|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
156505377|NCT00479882|564943237|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
156505378|NCT00479882|564943238|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
156505379|NCT00479882|564943239|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
156505380|NCT00479882|564943240|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
156505381|NCT00479882|564943237|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
156505382|NCT00479882|564943238|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
156505383|NCT00479882|564943239|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
156505384|NCT00479882|564943240|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
156505385|NCT00479882|564943237|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
156505386|NCT00479882|564943238|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
156505387|NCT00479882|564943239|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
156505388|NCT00479882|564943240|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
156505389|NCT00479882|564943237|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
156505390|NCT00479882|564943238|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
156505391|NCT00479882|564943239|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
156505392|NCT00479882|564943240|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
156505393|NCT00479882|564943237|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
156505394|NCT00479882|564943238|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
156505395|NCT00479882|564943239|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
156505396|NCT00479882|564943240|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
156505397|NCT00479882|564943237|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
156505398|NCT00479882|564943238|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
156505399|NCT00479882|564943239|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
156505400|NCT00479882|564943240|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
156505401|NCT00479882|564943237|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
156505402|NCT00479882|564943238|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
156505403|NCT00479882|564943239|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
156505404|NCT00479882|564943240|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
156505405|NCT03812029|564943241|FG000|Overall Study|Protocol Violation|1|||
156505406|NCT03812029|564943242|FG001|Overall Study|Protocol Violation|0|||
156505407|NCT03812029|564943243|FG002|Overall Study|Protocol Violation|0|||
156505408|NCT03812029|564943244|FG003|Overall Study|Protocol Violation|1|||
156505409|NCT03812029|564943245|FG004|Overall Study|Protocol Violation|0|||
156505410|NCT03812029|564943241|FG000|Overall Study|Withdrawal by Subject|1|||
156505411|NCT03812029|564943242|FG001|Overall Study|Withdrawal by Subject|0|||
156505412|NCT03812029|564943243|FG002|Overall Study|Withdrawal by Subject|0|||
156505413|NCT03812029|564943244|FG003|Overall Study|Withdrawal by Subject|2|||
156505414|NCT03812029|564943245|FG004|Overall Study|Withdrawal by Subject|2|||
156505415|NCT03812029|564943241|FG000|Overall Study|Stopping rules|0|||
156505416|NCT03812029|564943242|FG001|Overall Study|Stopping rules|1|||
156505417|NCT03812029|564943243|FG002|Overall Study|Stopping rules|0|||
156505418|NCT03812029|564943244|FG003|Overall Study|Stopping rules|0|||
156505419|NCT03812029|564943245|FG004|Overall Study|Stopping rules|0|||
156505420|NCT03812029|564943241|FG000|Overall Study|Adverse Event|0|||
156505421|NCT03812029|564943242|FG001|Overall Study|Adverse Event|9|||
156505422|NCT03812029|564943243|FG002|Overall Study|Adverse Event|0|||
156505423|NCT03812029|564943244|FG003|Overall Study|Adverse Event|3|||
156505424|NCT03812029|564943245|FG004|Overall Study|Adverse Event|5|||
156505425|NCT03812029|564943241|FG000|Overall Study|Lost to Follow-up|0|||
156505426|NCT03812029|564943242|FG001|Overall Study|Lost to Follow-up|0|||
156505427|NCT03812029|564943243|FG002|Overall Study|Lost to Follow-up|0|||
156505428|NCT03812029|564943244|FG003|Overall Study|Lost to Follow-up|0|||
156505429|NCT03812029|564943245|FG004|Overall Study|Lost to Follow-up|3|||
156505430|NCT03106753|564943246|FG000|Overall Study|Withdrawal by Subject|0|||
156505431|NCT03106753|564943247|FG001|Overall Study|Withdrawal by Subject|1|||
156505432|NCT01643044|564943249|FG000|Overall Study|Lost to Follow-up|1|||
156505433|NCT01643044|564943250|FG001|Overall Study|Lost to Follow-up|1|||
156505434|NCT01643044|564943249|FG000|Overall Study|Miscarried baby|2|||
156505435|NCT01643044|564943250|FG001|Overall Study|Miscarried baby|2|||
156505436|NCT01643044|564943249|FG000|Overall Study|Delivered outside of hospital|1|||
156505437|NCT01643044|564943250|FG001|Overall Study|Delivered outside of hospital|2|||
156505438|NCT03149042|564943251|FG000|Overall Study|Invasive FFR not performed|21|||
156505439|NCT03149042|564943251|FG000|Overall Study|Poor CT Image Quality|1|||
156505440|NCT03149042|564943251|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
156505441|NCT01023958|564943258|FG000|Overall Study|Progressive disease|48|||
156505442|NCT01023958|564943258|FG000|Overall Study|Other adverse event|1|||
156505443|NCT01023958|564943258|FG000|Overall Study|Refused to continue medication|1|||
156505444|NCT00790205|564943262|FG000|Overall Study|Lost to Follow-up|61|||
156505445|NCT00790205|564943263|FG001|Overall Study|Lost to Follow-up|71|||
156505446|NCT00790205|564943262|FG000|Overall Study|Withdrawal by Subject|299|||
156505447|NCT00790205|564943263|FG001|Overall Study|Withdrawal by Subject|363|||
156505448|NCT03933462|564943264|FG000|Overall Study|Adverse Event|2|||
156505449|NCT03933462|564943265|FG001|Overall Study|Adverse Event|0|||
156505450|NCT04805073|564943272|FG000|Overall Study|study personnel not available|2|||
156505451|NCT04805073|564943273|FG001|Overall Study|study personnel not available|0|||
156505452|NCT04805073|564943272|FG000|Overall Study|spinal anesthesia failure|0|||
156505453|NCT04805073|564943273|FG001|Overall Study|spinal anesthesia failure|1|||
156505454|NCT04805073|564943272|FG000|Overall Study|Lost to Follow-up|0|||
156505455|NCT04805073|564943273|FG001|Overall Study|Lost to Follow-up|2|||
156505456|NCT02975102|564943275|FG000|Overall Study|Adverse Event|2|||
156505457|NCT02975102|564943276|FG001|Overall Study|Adverse Event|1|||
156505458|NCT00243074|564943279|FG000|Overall Study|Ineligible|6|||
156505459|NCT00243074|564943279|FG000|Overall Study|Adverse Event|6|||
156505460|NCT00243074|564943279|FG000|Overall Study|Withdrawal by Subject|2|||
156505461|NCT00243074|564943279|FG000|Overall Study|Lack of Efficacy|36|||
156505462|NCT00243074|564943279|FG000|Overall Study|Death|2|||
156505463|NCT00243074|564943279|FG000|Overall Study|not protocol specified|1|||
156505464|NCT00243074|564943279|FG000|Overall Study|Did not receive any treatment|1|||
156505465|NCT00344032|564943280|FG000|Overall Study|Adverse Event|0|||
156505466|NCT00344032|564943281|FG001|Overall Study|Adverse Event|1|||
156505467|NCT00344032|564943280|FG000|Overall Study|Withdrawal by Subject|6|||
156505468|NCT00344032|564943281|FG001|Overall Study|Withdrawal by Subject|2|||
156505469|NCT00344032|564943280|FG000|Overall Study|Lost to Follow-up|4|||
156505470|NCT00344032|564943281|FG001|Overall Study|Lost to Follow-up|6|||
156505471|NCT00344032|564943280|FG000|Overall Study|Physician Decision|4|||
156505472|NCT00344032|564943281|FG001|Overall Study|Physician Decision|1|||
156505473|NCT05131477|564943284|FG000|PART 1|Withdrawal by Subject|2|||
156505474|NCT05131477|564943285|FG001|PART 1|Withdrawal by Subject|9|||
156505475|NCT05131477|564943286|FG002|PART 1|Withdrawal by Subject|6|||
156505476|NCT05131477|564943287|FG003|PART 1|Withdrawal by Subject|2|||
156505477|NCT05131477|564943288|FG004|PART 1|Withdrawal by Subject|8|||
156505478|NCT05131477|564943289|FG005|PART 1|Withdrawal by Subject|0|||
156505479|NCT05131477|564943290|FG006|PART 1|Withdrawal by Subject|0|||
156505480|NCT05131477|564943291|FG007|PART 1|Withdrawal by Subject|0|||
156505481|NCT05131477|564943292|FG008|PART 1|Withdrawal by Subject|0|||
156505482|NCT05131477|564943293|FG009|PART 1|Withdrawal by Subject|0|||
156505483|NCT05131477|564943294|FG010|PART 1|Withdrawal by Subject|0|||
156505484|NCT05131477|564943295|FG011|PART 1|Withdrawal by Subject|0|||
156505485|NCT05131477|564943296|FG012|PART 1|Withdrawal by Subject|0|||
156505486|NCT05131477|564943297|FG013|PART 1|Withdrawal by Subject|0|||
156505487|NCT05131477|564943284|FG000|PART 1|Physician Decision|1|||
156505488|NCT05131477|564943285|FG001|PART 1|Physician Decision|0|||
156505489|NCT05131477|564943286|FG002|PART 1|Physician Decision|0|||
156505490|NCT05131477|564943287|FG003|PART 1|Physician Decision|0|||
156505491|NCT05131477|564943288|FG004|PART 1|Physician Decision|0|||
156505492|NCT05131477|564943289|FG005|PART 1|Physician Decision|0|||
156505493|NCT05131477|564943290|FG006|PART 1|Physician Decision|0|||
156505494|NCT05131477|564943291|FG007|PART 1|Physician Decision|0|||
156505495|NCT05131477|564943292|FG008|PART 1|Physician Decision|0|||
156505496|NCT05131477|564943293|FG009|PART 1|Physician Decision|0|||
156505497|NCT05131477|564943294|FG010|PART 1|Physician Decision|0|||
156505498|NCT05131477|564943295|FG011|PART 1|Physician Decision|0|||
156505499|NCT05131477|564943296|FG012|PART 1|Physician Decision|0|||
156505500|NCT05131477|564943297|FG013|PART 1|Physician Decision|0|||
156505501|NCT05131477|564943284|FG000|PART 1|Adverse Event|3|||
156505502|NCT05131477|564943285|FG001|PART 1|Adverse Event|5|||
156505503|NCT05131477|564943286|FG002|PART 1|Adverse Event|1|||
156505504|NCT05131477|564943287|FG003|PART 1|Adverse Event|6|||
156505505|NCT05131477|564943288|FG004|PART 1|Adverse Event|4|||
156505506|NCT05131477|564943289|FG005|PART 1|Adverse Event|0|||
156505507|NCT05131477|564943290|FG006|PART 1|Adverse Event|0|||
156505508|NCT05131477|564943291|FG007|PART 1|Adverse Event|0|||
156505509|NCT05131477|564943292|FG008|PART 1|Adverse Event|0|||
156505510|NCT05131477|564943293|FG009|PART 1|Adverse Event|0|||
156505511|NCT05131477|564943294|FG010|PART 1|Adverse Event|0|||
156505512|NCT05131477|564943295|FG011|PART 1|Adverse Event|0|||
156505513|NCT05131477|564943296|FG012|PART 1|Adverse Event|0|||
156505514|NCT05131477|564943297|FG013|PART 1|Adverse Event|0|||
156505515|NCT05131477|564943284|FG000|PART 1|unclassified|1|||
156505516|NCT05131477|564943285|FG001|PART 1|unclassified|1|||
156505517|NCT05131477|564943286|FG002|PART 1|unclassified|0|||
156505518|NCT05131477|564943287|FG003|PART 1|unclassified|0|||
156505519|NCT05131477|564943288|FG004|PART 1|unclassified|4|||
156505520|NCT05131477|564943289|FG005|PART 1|unclassified|0|||
156505521|NCT05131477|564943290|FG006|PART 1|unclassified|0|||
156505522|NCT05131477|564943291|FG007|PART 1|unclassified|0|||
156505523|NCT05131477|564943292|FG008|PART 1|unclassified|0|||
156384810|NCT00328510|564501013|FG000|Overall Study|Gag disorder, could not use frame|4|||
156384811|NCT00328510|564501014|FG001|Overall Study|Gag disorder, could not use frame|0|||
156384812|NCT00328510|564501013|FG000|Overall Study|Dentition problems, could not use frame|1|||
156384813|NCT00328510|564501014|FG001|Overall Study|Dentition problems, could not use frame|0|||
156384814|NCT00328510|564501013|FG000|Overall Study|Withdrawal by Subject|4|||
156384815|NCT00328510|564501014|FG001|Overall Study|Withdrawal by Subject|2|||
156384816|NCT00328510|564501013|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
156384817|NCT00328510|564501014|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
156384818|NCT00328510|564501013|FG000|Overall Study|Treatment changed to a single fraction|1|||
156384819|NCT00328510|564501014|FG001|Overall Study|Treatment changed to a single fraction|1|||
156505524|NCT05131477|564943293|FG009|PART 1|unclassified|0|||
156505525|NCT05131477|564943294|FG010|PART 1|unclassified|0|||
156505526|NCT05131477|564943295|FG011|PART 1|unclassified|0|||
156505527|NCT05131477|564943296|FG012|PART 1|unclassified|0|||
156384820|NCT01412944|564501015|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156384821|NCT01412944|564501016|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156384822|NCT01412944|564501017|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
156384823|NCT01412944|564501018|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156384824|NCT01412944|564501019|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156384825|NCT01412944|564501020|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156384826|NCT01412944|564501015|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156384827|NCT01412944|564501016|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156384828|NCT01412944|564501017|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156384829|NCT01412944|564501018|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156384830|NCT01412944|564501019|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156384831|NCT01412944|564501020|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
156384832|NCT01412944|564501015|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156384833|NCT01412944|564501016|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156384834|NCT01412944|564501017|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156384835|NCT01412944|564501018|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156384836|NCT01412944|564501019|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156384837|NCT01412944|564501020|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
156384838|NCT01412944|564501015|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
156384839|NCT01412944|564501016|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156384840|NCT01412944|564501017|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156384841|NCT01412944|564501018|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156384842|NCT01412944|564501019|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156384843|NCT01412944|564501020|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156384844|NCT01412944|564501015|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
156384845|NCT01412944|564501016|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
156384846|NCT01412944|564501017|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
156384847|NCT01412944|564501018|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
156384848|NCT01412944|564501019|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
156384849|NCT01412944|564501020|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
156384850|NCT01412944|564501015|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156384851|NCT01412944|564501016|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
156384852|NCT01412944|564501017|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156384853|NCT01412944|564501018|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156384854|NCT01412944|564501019|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156384855|NCT01412944|564501020|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156384856|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156384857|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156384858|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
156384859|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
156384860|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
156384861|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156384862|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Adverse Event|0|||
156384863|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Adverse Event|0|||
156384864|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Adverse Event|0|||
156384865|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Adverse Event|0|||
156384866|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Adverse Event|1|||
156384867|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Adverse Event|0|||
156384868|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
156384869|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
156505528|NCT05131477|564943297|FG013|PART 1|unclassified|0|||
156384870|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
156505529|NCT05131477|564943284|FG000|PART 1|Randomized and not treated|0|||
156505530|NCT05131477|564943285|FG001|PART 1|Randomized and not treated|0|||
156384871|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
156384872|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
156505531|NCT05131477|564943286|FG002|PART 1|Randomized and not treated|0|||
156505532|NCT05131477|564943287|FG003|PART 1|Randomized and not treated|1|||
156505533|NCT05131477|564943288|FG004|PART 1|Randomized and not treated|1|||
156505534|NCT05131477|564943289|FG005|PART 1|Randomized and not treated|0|||
156505535|NCT05131477|564943290|FG006|PART 1|Randomized and not treated|0|||
156505536|NCT05131477|564943291|FG007|PART 1|Randomized and not treated|0|||
156505537|NCT05131477|564943292|FG008|PART 1|Randomized and not treated|0|||
156505538|NCT05131477|564943293|FG009|PART 1|Randomized and not treated|0|||
156505539|NCT05131477|564943294|FG010|PART 1|Randomized and not treated|0|||
156505540|NCT05131477|564943295|FG011|PART 1|Randomized and not treated|0|||
156505541|NCT05131477|564943296|FG012|PART 1|Randomized and not treated|0|||
156505542|NCT05131477|564943297|FG013|PART 1|Randomized and not treated|0|||
156505543|NCT05131477|564943284|FG000|PART 1|Protocol Violation|2|||
156505544|NCT05131477|564943285|FG001|PART 1|Protocol Violation|0|||
156505545|NCT05131477|564943286|FG002|PART 1|Protocol Violation|0|||
156505546|NCT05131477|564943287|FG003|PART 1|Protocol Violation|1|||
156505547|NCT05131477|564943288|FG004|PART 1|Protocol Violation|0|||
156505548|NCT05131477|564943289|FG005|PART 1|Protocol Violation|0|||
156505549|NCT05131477|564943290|FG006|PART 1|Protocol Violation|0|||
156505550|NCT05131477|564943291|FG007|PART 1|Protocol Violation|0|||
156505551|NCT05131477|564943292|FG008|PART 1|Protocol Violation|0|||
156505552|NCT05131477|564943293|FG009|PART 1|Protocol Violation|0|||
156505553|NCT05131477|564943294|FG010|PART 1|Protocol Violation|0|||
156505554|NCT05131477|564943295|FG011|PART 1|Protocol Violation|0|||
156505555|NCT05131477|564943296|FG012|PART 1|Protocol Violation|0|||
156505556|NCT05131477|564943297|FG013|PART 1|Protocol Violation|0|||
156505557|NCT05131477|564943284|FG000|PART 1|Lack of Efficacy|0|||
156505558|NCT05131477|564943285|FG001|PART 1|Lack of Efficacy|1|||
156505559|NCT05131477|564943286|FG002|PART 1|Lack of Efficacy|1|||
156505560|NCT05131477|564943287|FG003|PART 1|Lack of Efficacy|2|||
156505561|NCT05131477|564943288|FG004|PART 1|Lack of Efficacy|5|||
156505562|NCT05131477|564943289|FG005|PART 1|Lack of Efficacy|0|||
156505563|NCT05131477|564943290|FG006|PART 1|Lack of Efficacy|0|||
156505564|NCT05131477|564943291|FG007|PART 1|Lack of Efficacy|0|||
156505565|NCT05131477|564943292|FG008|PART 1|Lack of Efficacy|0|||
156505566|NCT05131477|564943293|FG009|PART 1|Lack of Efficacy|0|||
156505567|NCT05131477|564943294|FG010|PART 1|Lack of Efficacy|0|||
156505568|NCT05131477|564943295|FG011|PART 1|Lack of Efficacy|0|||
156505569|NCT05131477|564943296|FG012|PART 1|Lack of Efficacy|0|||
156505570|NCT05131477|564943297|FG013|PART 1|Lack of Efficacy|0|||
156505571|NCT05131477|564943284|FG000|PART 2|Withdrawal by Subject|0|||
156505572|NCT05131477|564943285|FG001|PART 2|Withdrawal by Subject|0|||
156505573|NCT05131477|564943286|FG002|PART 2|Withdrawal by Subject|0|||
156505574|NCT05131477|564943287|FG003|PART 2|Withdrawal by Subject|0|||
156505575|NCT05131477|564943288|FG004|PART 2|Withdrawal by Subject|0|||
156505576|NCT05131477|564943289|FG005|PART 2|Withdrawal by Subject|0|||
156505577|NCT05131477|564943290|FG006|PART 2|Withdrawal by Subject|2|||
156505578|NCT05131477|564943291|FG007|PART 2|Withdrawal by Subject|0|||
156505579|NCT05131477|564943292|FG008|PART 2|Withdrawal by Subject|0|||
156505580|NCT05131477|564943293|FG009|PART 2|Withdrawal by Subject|0|||
156505581|NCT05131477|564943294|FG010|PART 2|Withdrawal by Subject|2|||
156505582|NCT05131477|564943295|FG011|PART 2|Withdrawal by Subject|0|||
156505583|NCT05131477|564943296|FG012|PART 2|Withdrawal by Subject|2|||
156505584|NCT05131477|564943297|FG013|PART 2|Withdrawal by Subject|2|||
156505585|NCT05131477|564943284|FG000|PART 2|Other|0|||
156505586|NCT05131477|564943285|FG001|PART 2|Other|0|||
156505587|NCT05131477|564943286|FG002|PART 2|Other|0|||
156505588|NCT05131477|564943287|FG003|PART 2|Other|0|||
156505589|NCT05131477|564943288|FG004|PART 2|Other|0|||
156505590|NCT05131477|564943289|FG005|PART 2|Other|0|||
156505591|NCT05131477|564943290|FG006|PART 2|Other|0|||
156505592|NCT05131477|564943291|FG007|PART 2|Other|0|||
156505593|NCT05131477|564943292|FG008|PART 2|Other|1|||
156505594|NCT05131477|564943293|FG009|PART 2|Other|1|||
156505595|NCT05131477|564943294|FG010|PART 2|Other|0|||
156505596|NCT05131477|564943295|FG011|PART 2|Other|0|||
156505597|NCT05131477|564943296|FG012|PART 2|Other|1|||
156505598|NCT05131477|564943297|FG013|PART 2|Other|0|||
156505599|NCT05131477|564943284|FG000|PART 2|Lack of Efficacy|0|||
156505600|NCT05131477|564943285|FG001|PART 2|Lack of Efficacy|0|||
156505601|NCT05131477|564943286|FG002|PART 2|Lack of Efficacy|0|||
156505602|NCT05131477|564943287|FG003|PART 2|Lack of Efficacy|0|||
156505603|NCT05131477|564943288|FG004|PART 2|Lack of Efficacy|0|||
156505604|NCT05131477|564943289|FG005|PART 2|Lack of Efficacy|1|||
156505605|NCT05131477|564943290|FG006|PART 2|Lack of Efficacy|1|||
156505606|NCT05131477|564943291|FG007|PART 2|Lack of Efficacy|0|||
156505607|NCT05131477|564943292|FG008|PART 2|Lack of Efficacy|3|||
156505608|NCT05131477|564943293|FG009|PART 2|Lack of Efficacy|0|||
156505609|NCT05131477|564943294|FG010|PART 2|Lack of Efficacy|1|||
156505610|NCT05131477|564943295|FG011|PART 2|Lack of Efficacy|0|||
156505611|NCT05131477|564943296|FG012|PART 2|Lack of Efficacy|2|||
156505612|NCT05131477|564943297|FG013|PART 2|Lack of Efficacy|0|||
156505613|NCT05131477|564943284|FG000|PART 2|Unclassified|0|||
156505614|NCT05131477|564943285|FG001|PART 2|Unclassified|0|||
156505615|NCT05131477|564943286|FG002|PART 2|Unclassified|0|||
156505616|NCT05131477|564943287|FG003|PART 2|Unclassified|0|||
156505617|NCT05131477|564943288|FG004|PART 2|Unclassified|0|||
156505618|NCT05131477|564943289|FG005|PART 2|Unclassified|0|||
156505619|NCT05131477|564943290|FG006|PART 2|Unclassified|0|||
156505620|NCT05131477|564943291|FG007|PART 2|Unclassified|0|||
156505621|NCT05131477|564943292|FG008|PART 2|Unclassified|0|||
156505622|NCT05131477|564943293|FG009|PART 2|Unclassified|0|||
156505623|NCT05131477|564943294|FG010|PART 2|Unclassified|1|||
156505624|NCT05131477|564943295|FG011|PART 2|Unclassified|0|||
156505625|NCT05131477|564943296|FG012|PART 2|Unclassified|0|||
156505626|NCT05131477|564943297|FG013|PART 2|Unclassified|0|||
156505627|NCT05131477|564943284|FG000|PART 2|Re-randomized and not treated|0|||
156505628|NCT05131477|564943285|FG001|PART 2|Re-randomized and not treated|0|||
156505629|NCT05131477|564943286|FG002|PART 2|Re-randomized and not treated|0|||
156505630|NCT05131477|564943287|FG003|PART 2|Re-randomized and not treated|0|||
156505631|NCT05131477|564943288|FG004|PART 2|Re-randomized and not treated|0|||
156505632|NCT05131477|564943289|FG005|PART 2|Re-randomized and not treated|0|||
156505633|NCT05131477|564943290|FG006|PART 2|Re-randomized and not treated|0|||
156505634|NCT05131477|564943291|FG007|PART 2|Re-randomized and not treated|1|||
156505635|NCT05131477|564943292|FG008|PART 2|Re-randomized and not treated|0|||
156505636|NCT05131477|564943293|FG009|PART 2|Re-randomized and not treated|0|||
156505637|NCT05131477|564943294|FG010|PART 2|Re-randomized and not treated|1|||
156505638|NCT05131477|564943295|FG011|PART 2|Re-randomized and not treated|0|||
156505639|NCT05131477|564943296|FG012|PART 2|Re-randomized and not treated|1|||
156505640|NCT05131477|564943297|FG013|PART 2|Re-randomized and not treated|1|||
156505641|NCT02194829|564943298|FG000|Overall Study|Adverse Event|2|||
156505642|NCT02194829|564943299|FG001|Overall Study|Adverse Event|2|||
156505643|NCT02194829|564943298|FG000|Overall Study|Death|0|||
156505644|NCT02194829|564943299|FG001|Overall Study|Death|1|||
156505645|NCT02194829|564943298|FG000|Overall Study|Disease progression|0|||
156505646|NCT02194829|564943299|FG001|Overall Study|Disease progression|1|||
156505647|NCT02194829|564943298|FG000|Overall Study|Withdrawal by Subject|0|||
156505648|NCT02194829|564943299|FG001|Overall Study|Withdrawal by Subject|1|||
156505649|NCT02194829|564943298|FG000|Overall Study|Never started protocol therapy|0|||
156505650|NCT02194829|564943299|FG001|Overall Study|Never started protocol therapy|1|||
156505651|NCT03939689|564945156|FG000|Overall Study|Radiographic progression|14|||
156505652|NCT03939689|564945157|FG001|Overall Study|Radiographic progression|17|||
156505653|NCT03939689|564945156|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
156505654|NCT03939689|564945157|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
156505655|NCT03939689|564945156|FG000|Overall Study|Adverse Event|1|||
156505656|NCT03939689|564945157|FG001|Overall Study|Adverse Event|8|||
156505657|NCT03939689|564945156|FG000|Overall Study|Unequivocal clinical progression|2|||
156505658|NCT03939689|564945157|FG001|Overall Study|Unequivocal clinical progression|5|||
156505659|NCT03939689|564945156|FG000|Overall Study|Other|1|||
156505660|NCT03939689|564945157|FG001|Overall Study|Other|4|||
156505661|NCT03939689|564945156|FG000|Overall Study|Death|0|||
156505662|NCT03939689|564945157|FG001|Overall Study|Death|3|||
156505663|NCT03939689|564945156|FG000|Overall Study|Participant decision|0|||
156505664|NCT03939689|564945157|FG001|Overall Study|Participant decision|3|||
156505665|NCT03939689|564945156|FG000|Overall Study|Withdrawal of consent|2|||
156505666|NCT03939689|564945157|FG001|Overall Study|Withdrawal of consent|1|||
156505667|NCT03939689|564945156|FG000|Overall Study|Investigator decision|1|||
156505668|NCT03939689|564945157|FG001|Overall Study|Investigator decision|0|||
156505669|NCT04427280|564945158|FG000|Overall Study|Withdrawal by Subject|0|||
156505670|NCT04427280|564945159|FG001|Overall Study|Withdrawal by Subject|2|||
156505671|NCT01667926|564945173|FG000|Overall Study|Withdrawal by Subject|1|||
156505672|NCT01667926|564945174|FG001|Overall Study|Withdrawal by Subject|2|||
156505673|NCT01667926|564945175|FG002|Overall Study|Withdrawal by Subject|2|||
156505674|NCT01667926|564945173|FG000|Overall Study|Physician Decision|0|||
156505675|NCT01667926|564945174|FG001|Overall Study|Physician Decision|0|||
156505676|NCT01667926|564945175|FG002|Overall Study|Physician Decision|1|||
156505677|NCT01667926|564945173|FG000|Overall Study|Time committment|0|||
156505678|NCT01667926|564945174|FG001|Overall Study|Time committment|0|||
156505679|NCT01667926|564945175|FG002|Overall Study|Time committment|2|||
156505680|NCT01667926|564945173|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
156505681|NCT01667926|564945174|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
156505682|NCT01667926|564945175|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
156505683|NCT01667926|564945173|FG000|Overall Study|Lost to Follow-up|1|||
156505684|NCT01667926|564945174|FG001|Overall Study|Lost to Follow-up|2|||
156505685|NCT01667926|564945175|FG002|Overall Study|Lost to Follow-up|1|||
156505686|NCT01667926|564945173|FG000|Overall Study|Side effects|3|||
156505687|NCT01667926|564945174|FG001|Overall Study|Side effects|0|||
156505688|NCT01667926|564945175|FG002|Overall Study|Side effects|0|||
156505689|NCT04307940|564945176|FG000|Overall Study|Adverse Event|1|||
156505690|NCT04307940|564945177|FG001|Overall Study|Adverse Event|0|||
156505691|NCT04307940|564945178|FG002|Overall Study|Adverse Event|0|||
156505692|NCT04307940|564945176|FG000|Overall Study|Withdrawal by Subject|2|||
156505693|NCT04307940|564945177|FG001|Overall Study|Withdrawal by Subject|3|||
156505694|NCT04307940|564945178|FG002|Overall Study|Withdrawal by Subject|1|||
156505695|NCT04307940|564945176|FG000|Overall Study|Lost to Follow-up|2|||
156505696|NCT04307940|564945177|FG001|Overall Study|Lost to Follow-up|0|||
156505697|NCT04307940|564945178|FG002|Overall Study|Lost to Follow-up|1|||
156505698|NCT04624243|564945182|FG000|Overall Study|Death|0|||
156505699|NCT04624243|564945183|FG001|Overall Study|Death|1|||
156505700|NCT04624243|564945184|FG002|Overall Study|Death|0|||
156505701|NCT04624243|564945185|FG003|Overall Study|Death|0|||
156505702|NCT04624243|564945186|FG004|Overall Study|Death|0|||
156505703|NCT04624243|564945182|FG000|Overall Study|Lost to Follow-up|2|||
156505704|NCT04624243|564945183|FG001|Overall Study|Lost to Follow-up|3|||
156505705|NCT04624243|564945184|FG002|Overall Study|Lost to Follow-up|7|||
156505706|NCT04624243|564945185|FG003|Overall Study|Lost to Follow-up|1|||
156505707|NCT04624243|564945186|FG004|Overall Study|Lost to Follow-up|3|||
156505708|NCT04624243|564945182|FG000|Overall Study|Physician Decision|3|||
156505709|NCT04624243|564945183|FG001|Overall Study|Physician Decision|8|||
156505710|NCT04624243|564945184|FG002|Overall Study|Physician Decision|15|||
156505711|NCT04624243|564945185|FG003|Overall Study|Physician Decision|2|||
156505712|NCT04624243|564945186|FG004|Overall Study|Physician Decision|11|||
156505713|NCT04624243|564945182|FG000|Overall Study|Withdrawal by Subject|19|||
156505714|NCT04624243|564945183|FG001|Overall Study|Withdrawal by Subject|44|||
156505715|NCT04624243|564945184|FG002|Overall Study|Withdrawal by Subject|40|||
156505716|NCT04624243|564945185|FG003|Overall Study|Withdrawal by Subject|21|||
156505717|NCT04624243|564945186|FG004|Overall Study|Withdrawal by Subject|39|||
156505718|NCT04624243|564945182|FG000|Overall Study|Miscellaneous|3|||
156505719|NCT04624243|564945183|FG001|Overall Study|Miscellaneous|12|||
156505720|NCT04624243|564945184|FG002|Overall Study|Miscellaneous|9|||
156505721|NCT04624243|564945185|FG003|Overall Study|Miscellaneous|4|||
156505722|NCT04624243|564945186|FG004|Overall Study|Miscellaneous|6|||
156505723|NCT04996004|564945187|FG000|Phase I|Death|1|||
156505724|NCT04996004|564945188|FG001|Phase I|Death|2|||
156505725|NCT04996004|564945189|FG002|Phase I|Death|1|||
156505726|NCT04996004|564945190|FG003|Phase I|Death|0|||
156505727|NCT04996004|564945191|FG004|Phase I|Death|0|||
156505728|NCT04996004|564945192|FG005|Phase I|Death|0|||
156505729|NCT04996004|564945187|FG000|Phase I|Study terminated by sponsor|2|||
156505730|NCT04996004|564945188|FG001|Phase I|Study terminated by sponsor|1|||
156505731|NCT04996004|564945189|FG002|Phase I|Study terminated by sponsor|2|||
156505732|NCT04996004|564945190|FG003|Phase I|Study terminated by sponsor|0|||
156505733|NCT04996004|564945191|FG004|Phase I|Study terminated by sponsor|0|||
156505734|NCT04996004|564945192|FG005|Phase I|Study terminated by sponsor|0|||
156505735|NCT04996004|564945187|FG000|Phase II|Study terminated by sponsor|0|||
156505736|NCT04996004|564945188|FG001|Phase II|Study terminated by sponsor|0|||
156505737|NCT04996004|564945189|FG002|Phase II|Study terminated by sponsor|0|||
156505738|NCT04996004|564945190|FG003|Phase II|Study terminated by sponsor|20|||
156505739|NCT04996004|564945191|FG004|Phase II|Study terminated by sponsor|10|||
156505740|NCT04996004|564945192|FG005|Phase II|Study terminated by sponsor|10|||
156505741|NCT04996004|564945187|FG000|Phase II|Withdrawal by Subject|0|||
156505742|NCT04996004|564945188|FG001|Phase II|Withdrawal by Subject|0|||
156505743|NCT04996004|564945189|FG002|Phase II|Withdrawal by Subject|0|||
156505744|NCT04996004|564945190|FG003|Phase II|Withdrawal by Subject|0|||
156505745|NCT04996004|564945191|FG004|Phase II|Withdrawal by Subject|1|||
156505746|NCT04996004|564945192|FG005|Phase II|Withdrawal by Subject|2|||
156505747|NCT04996004|564945187|FG000|Phase II|Death|0|||
156505748|NCT04996004|564945188|FG001|Phase II|Death|0|||
156505749|NCT04996004|564945189|FG002|Phase II|Death|0|||
156505750|NCT04996004|564945190|FG003|Phase II|Death|12|||
156505751|NCT04996004|564945191|FG004|Phase II|Death|2|||
156505752|NCT04996004|564945192|FG005|Phase II|Death|9|||
156505753|NCT04996004|564945187|FG000|Phase II|Other|0|||
156505754|NCT04996004|564945188|FG001|Phase II|Other|0|||
156505755|NCT04996004|564945189|FG002|Phase II|Other|0|||
156505756|NCT04996004|564945190|FG003|Phase II|Other|0|||
156505757|NCT04996004|564945191|FG004|Phase II|Other|0|||
156505758|NCT04996004|564945192|FG005|Phase II|Other|1|||
156505759|NCT05543174|564945193|FG000|Overall Study|Ongoing|7|||
156505760|NCT03374488|564945195|FG000|Overall Study|Death|13|||
156505761|NCT03374488|564945196|FG001|Overall Study|Death|13|||
156505762|NCT03374488|564945195|FG000|Overall Study|Withdrawal by Subject|3|||
156505763|NCT03374488|564945196|FG001|Overall Study|Withdrawal by Subject|1|||
156505764|NCT03374488|564945195|FG000|Overall Study|Physician Decision|3|||
156505765|NCT03374488|564945196|FG001|Overall Study|Physician Decision|0|||
156505766|NCT03104075|564945197|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
156505767|NCT03104075|564945198|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
156505768|NCT00789360|564945201|FG000|Overall Study|Protocol Violation|3|||
156505769|NCT00789360|564945202|FG001|Overall Study|Protocol Violation|1|||
156505770|NCT03559062|564945203|FG000|Overall Study|Other|0|||
156505771|NCT03559062|564945204|FG001|Overall Study|Other|1|||
156505772|NCT03559062|564945205|FG002|Overall Study|Other|0|||
156505773|NCT01757197|564945206|FG000|Overall Study|Death|2|||
156505774|NCT00874731|564945207|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
156505775|NCT00874731|564945208|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
156505776|NCT00874731|564945209|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
156384873|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
156384874|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384875|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384876|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384877|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384878|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384879|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
156384880|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384881|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384882|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384883|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384884|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
156384885|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384886|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
156384887|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
156384888|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156384889|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156384890|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156384891|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156384892|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
156384893|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
156384894|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
156384895|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
156384896|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
156384897|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
156384898|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384899|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
156384900|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384901|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384902|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384903|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
156384904|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384905|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
156384906|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384907|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384908|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384909|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
156384910|NCT01412944|564501015|FG000|Entire: IV + Maintenance|Adverse Event|0|||
156384911|NCT01412944|564501016|FG001|Entire: IV + Maintenance|Adverse Event|1|||
156384912|NCT01412944|564501017|FG002|Entire: IV + Maintenance|Adverse Event|0|||
156384913|NCT01412944|564501018|FG003|Entire: IV + Maintenance|Adverse Event|0|||
156384914|NCT01412944|564501019|FG004|Entire: IV + Maintenance|Adverse Event|0|||
156384915|NCT01412944|564501020|FG005|Entire: IV + Maintenance|Adverse Event|0|||
156384916|NCT01990950|564501021|FG000|Overall Study|Death|3|||
156384917|NCT01990950|564501021|FG000|Overall Study|Lost to Follow-up|2|||
156384918|NCT01990950|564501021|FG000|Overall Study|Withdrawal by Subject|6|||
156384919|NCT02863926|564501022|FG000|Overall Study|Physician Decision|1|||
156384920|NCT02863926|564501023|FG001|Overall Study|Physician Decision|0|||
156384921|NCT02863926|564501022|FG000|Overall Study|Lost to Follow-up|1|||
156384922|NCT02863926|564501023|FG001|Overall Study|Lost to Follow-up|1|||
156384923|NCT02301143|564501028|FG000|Induction Period|Enrolled But Not Treated|1|||
156384924|NCT02301143|564501029|FG001|Induction Period|Enrolled But Not Treated|0|||
156384925|NCT02301143|564501028|FG000|Induction Period|Death|1|||
156384926|NCT02301143|564501029|FG001|Induction Period|Death|0|||
156384927|NCT02301143|564501028|FG000|Induction Period|Adverse Event|22|||
156384928|NCT02301143|564501029|FG001|Induction Period|Adverse Event|0|||
156384929|NCT02301143|564501028|FG000|Induction Period|Progressive Disease|8|||
156384930|NCT02301143|564501029|FG001|Induction Period|Progressive Disease|0|||
156505777|NCT00874731|564945207|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
156505778|NCT00874731|564945208|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
156505779|NCT00874731|564945209|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
156505780|NCT00874731|564945207|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
156505781|NCT00874731|564945208|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
156384931|NCT02301143|564501028|FG000|Induction Period|Withdrawal by Subject|3|||
156384932|NCT02301143|564501029|FG001|Induction Period|Withdrawal by Subject|0|||
156384933|NCT02301143|564501028|FG000|Induction Period|Noncompliance with Study Drug|1|||
156384934|NCT02301143|564501029|FG001|Induction Period|Noncompliance with Study Drug|0|||
156384935|NCT02301143|564501028|FG000|Induction Period|Physician Decision|4|||
156505782|NCT00874731|564945209|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
156384936|NCT02301143|564501029|FG001|Induction Period|Physician Decision|0|||
156384937|NCT02301143|564501028|FG000|Induction Period|Symptomatic Deterioration|2|||
156384938|NCT02301143|564501029|FG001|Induction Period|Symptomatic Deterioration|0|||
156384939|NCT02301143|564501028|FG000|Induction Period|Protocol Violation|2|||
156384940|NCT02301143|564501029|FG001|Induction Period|Protocol Violation|0|||
156505783|NCT05105087|564945210|FG000|Overall Study|Withdrawal by Subject|2|||
156505784|NCT05105087|564945210|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
156505785|NCT00581477|564945215|FG000|Overall Study|Physician Decision|2|||
156505786|NCT03443414|564945218|FG000|Overall Study|Adverse Event|6|||
156505787|NCT03443414|564945219|FG001|Overall Study|Adverse Event|0|||
156505788|NCT03443414|564945220|FG002|Overall Study|Adverse Event|4|||
156505789|NCT03443414|564945221|FG003|Overall Study|Adverse Event|2|||
156505790|NCT03443414|564945222|FG004|Overall Study|Adverse Event|3|||
156505791|NCT03443414|564945218|FG000|Overall Study|Withdrawal by Subject|3|||
156505792|NCT03443414|564945219|FG001|Overall Study|Withdrawal by Subject|2|||
156505793|NCT03443414|564945220|FG002|Overall Study|Withdrawal by Subject|2|||
156505794|NCT03443414|564945221|FG003|Overall Study|Withdrawal by Subject|2|||
156505795|NCT03443414|564945222|FG004|Overall Study|Withdrawal by Subject|1|||
156505796|NCT03443414|564945218|FG000|Overall Study|Death|0|||
156505797|NCT03443414|564945219|FG001|Overall Study|Death|1|||
156505798|NCT03443414|564945220|FG002|Overall Study|Death|0|||
156505799|NCT03443414|564945221|FG003|Overall Study|Death|1|||
156505800|NCT03443414|564945222|FG004|Overall Study|Death|0|||
156505801|NCT03443414|564945218|FG000|Overall Study|Reason not specified|2|||
156505802|NCT03443414|564945219|FG001|Overall Study|Reason not specified|0|||
156505803|NCT03443414|564945220|FG002|Overall Study|Reason not specified|0|||
156505804|NCT03443414|564945221|FG003|Overall Study|Reason not specified|0|||
156505805|NCT03443414|564945222|FG004|Overall Study|Reason not specified|1|||
156505806|NCT01266161|564945223|FG000|Overall Study|Ineligible|1|||
156505807|NCT01266161|564945224|FG001|Overall Study|Ineligible|0|||
156505808|NCT01266161|564945223|FG000|Overall Study|Lack of Efficacy|0|||
156505809|NCT01266161|564945224|FG001|Overall Study|Lack of Efficacy|1|||
156505810|NCT01266161|564945223|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
156505811|NCT01266161|564945224|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
156505812|NCT01485120|564945233|FG000|Overall Study|Withdrawal by Subject|2|||
156505813|NCT00422734|564945234|FG000|Overall Study|Physician Decision|1|||
156505814|NCT00422734|564945235|FG001|Overall Study|Physician Decision|1|||
156505815|NCT00422734|564945234|FG000|Overall Study|Protocol Violation|1|||
156505816|NCT00422734|564945235|FG001|Overall Study|Protocol Violation|6|||
156505817|NCT00422734|564945234|FG000|Overall Study|Withdrawal by Subject|12|||
156505818|NCT00422734|564945235|FG001|Overall Study|Withdrawal by Subject|8|||
156505819|NCT00422734|564945234|FG000|Overall Study|Adverse Event|0|||
156384941|NCT02301143|564501028|FG000|Induction Period|Other|1|||
156384942|NCT02301143|564501029|FG001|Induction Period|Other|0|||
156384943|NCT02301143|564501028|FG000|Investigator's Choice|Adverse Event|0|||
156384944|NCT02301143|564501029|FG001|Investigator's Choice|Adverse Event|3|||
156384945|NCT02301143|564501028|FG000|Investigator's Choice|Progressive Disease|0|||
156384946|NCT02301143|564501029|FG001|Investigator's Choice|Progressive Disease|3|||
156384947|NCT02301143|564501028|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
156505820|NCT00422734|564945235|FG001|Overall Study|Adverse Event|3|||
156505821|NCT00422734|564945234|FG000|Overall Study|Partner Decision|0|||
156505822|NCT00422734|564945235|FG001|Overall Study|Partner Decision|3|||
156505823|NCT02344342|564945236|FG000|Overall Study|Industry partner dropped out|11|||
156505824|NCT02344342|564945237|FG001|Overall Study|Industry partner dropped out|9|||
156505825|NCT02344342|564945238|FG002|Overall Study|Industry partner dropped out|14|||
156505826|NCT02344342|564945239|FG003|Overall Study|Industry partner dropped out|10|||
156505827|NCT00848484|564945240|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
156505828|NCT00848484|564945241|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
156505829|NCT00848484|564945240|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
156505830|NCT00848484|564945241|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
156505831|NCT00848484|564945240|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
156505832|NCT00848484|564945241|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
156505833|NCT00848484|564945240|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
156505834|NCT00848484|564945241|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
156505835|NCT00848484|564945240|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
156505836|NCT00848484|564945241|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
156505837|NCT03355209|564945242|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
156505838|NCT03355209|564945243|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
156505839|NCT03355209|564945244|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
156505840|NCT03355209|564945245|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
156505841|NCT03355209|564945246|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
156505842|NCT03355209|564945247|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
156505843|NCT03355209|564945242|FG000|Part 1: Double-Blind Period|Death|0|||
156505844|NCT03355209|564945243|FG001|Part 1: Double-Blind Period|Death|0|||
156505845|NCT03355209|564945244|FG002|Part 1: Double-Blind Period|Death|1|||
156505846|NCT03355209|564945245|FG003|Part 1: Double-Blind Period|Death|0|||
156505847|NCT03355209|564945246|FG004|Part 1: Double-Blind Period|Death|0|||
156384948|NCT02301143|564501029|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
156505848|NCT03355209|564945247|FG005|Part 1: Double-Blind Period|Death|0|||
156505849|NCT03355209|564945242|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
156505850|NCT03355209|564945243|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
156505851|NCT03355209|564945244|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
156505852|NCT03355209|564945245|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
156505853|NCT03355209|564945246|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
156505854|NCT03355209|564945247|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
156505855|NCT03355209|564945242|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
156505856|NCT03355209|564945243|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
156505857|NCT03355209|564945244|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
156505858|NCT03355209|564945245|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156505859|NCT03355209|564945246|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156505860|NCT03355209|564945247|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156505861|NCT03355209|564945242|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
156505862|NCT03355209|564945243|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
156505863|NCT03355209|564945244|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
156505864|NCT03355209|564945245|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
156505865|NCT03355209|564945246|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
156505866|NCT03355209|564945247|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
156505867|NCT03355209|564945242|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
156505868|NCT03355209|564945243|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
156505869|NCT03355209|564945244|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
156505870|NCT03355209|564945245|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
156505871|NCT03355209|564945246|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
156505872|NCT03355209|564945247|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
156505873|NCT03355209|564945242|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
156505874|NCT03355209|564945243|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
156505875|NCT03355209|564945244|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
156505876|NCT03355209|564945245|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
156505877|NCT03355209|564945246|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
156505878|NCT03355209|564945247|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
156505879|NCT03355209|564945242|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
156505880|NCT03355209|564945243|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
156505881|NCT03355209|564945244|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
156505882|NCT03355209|564945245|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
156505883|NCT03355209|564945246|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
156505884|NCT03355209|564945247|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
156505885|NCT03355209|564945242|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
156505886|NCT03355209|564945243|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
156505887|NCT03355209|564945244|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
156505888|NCT03355209|564945245|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156505889|NCT03355209|564945246|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
156505890|NCT03355209|564945247|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156505891|NCT03355209|564945242|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
156505892|NCT03355209|564945243|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
156505893|NCT03355209|564945244|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
156505894|NCT03355209|564945245|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
156505895|NCT03355209|564945246|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
156505896|NCT03355209|564945247|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
156505897|NCT03355209|564945242|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
156505898|NCT03355209|564945243|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
156505899|NCT03355209|564945244|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
156505900|NCT03355209|564945245|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
156505901|NCT03355209|564945246|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
156505902|NCT03355209|564945247|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
156505903|NCT01081886|564945248|FG000|Overall Study|Study termination|11|||
156505904|NCT01081886|564945249|FG001|Overall Study|Study termination|13|||
156505905|NCT03017742|564945251|FG000|Overall Study|Protocol Violation|36|||
156505906|NCT03017742|564945251|FG000|Overall Study|Withdrawal by Subject|37|||
156505907|NCT05262751|564945254|FG000|Washout Period 2|Adverse Event|1|||
156505908|NCT05262751|564945255|FG001|Washout Period 2|Adverse Event|0|||
156505909|NCT05262751|564945256|FG002|Washout Period 2|Adverse Event|0|||
156505910|NCT05262751|564945257|FG003|Washout Period 2|Adverse Event|0|||
156505911|NCT05262751|564945258|FG004|Washout Period 2|Adverse Event|0|||
156505912|NCT05262751|564945259|FG005|Washout Period 2|Adverse Event|0|||
156505913|NCT05262751|564945254|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
156547062|NCT01970501|565095034|FG000|Overall Study|Withdrawal by Subject|6|||
156505914|NCT05262751|564945255|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
156547063|NCT01970501|565095035|FG001|Overall Study|Withdrawal by Subject|7|||
156505915|NCT05262751|564945256|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
156505916|NCT05262751|564945257|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
156505917|NCT05262751|564945258|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
156505918|NCT05262751|564945259|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
156505919|NCT03690427|564945260|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
156505920|NCT03690427|564945261|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
156505921|NCT03519204|564945262|FG000|Overall Study|Lost to Follow-up|3|||
156505922|NCT03519204|564945263|FG001|Overall Study|Lost to Follow-up|8|||
156547064|NCT01970501|565095034|FG000|Overall Study|Adverse Event|2|||
156505923|NCT03519204|564945262|FG000|Overall Study|Withdrawal by Subject|9|||
156505924|NCT03519204|564945263|FG001|Overall Study|Withdrawal by Subject|7|||
156505925|NCT03519204|564945262|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156505926|NCT03519204|564945263|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156505927|NCT02956837|564945266|FG000|Overall Study|Serious Adverse Events|0|||
156505928|NCT02956837|564945267|FG001|Overall Study|Serious Adverse Events|1|||
156505929|NCT02956837|564945268|FG002|Overall Study|Serious Adverse Events|0|||
156505930|NCT02956837|564945269|FG003|Overall Study|Serious Adverse Events|0|||
156505931|NCT02956837|564945266|FG000|Overall Study|Withdrawal by Subject|0|||
156505932|NCT02956837|564945267|FG001|Overall Study|Withdrawal by Subject|1|||
156505933|NCT02956837|564945268|FG002|Overall Study|Withdrawal by Subject|0|||
156505934|NCT02956837|564945269|FG003|Overall Study|Withdrawal by Subject|3|||
156505935|NCT02956837|564945266|FG000|Overall Study|Lost to Follow-up|0|||
156505936|NCT02956837|564945267|FG001|Overall Study|Lost to Follow-up|1|||
156505937|NCT02956837|564945268|FG002|Overall Study|Lost to Follow-up|2|||
156505938|NCT02956837|564945269|FG003|Overall Study|Lost to Follow-up|0|||
156505939|NCT02597712|564945270|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
156505940|NCT02597712|564945271|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
156505941|NCT02597712|564945270|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
156505942|NCT02597712|564945271|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
156505943|NCT02597712|564945270|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
156505944|NCT02597712|564945271|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
156505945|NCT01727505|564945279|FG000|First 24 Hours|Adverse Event|0|||
156505946|NCT01727505|564945280|FG001|First 24 Hours|Adverse Event|1|||
156505947|NCT01727505|564945279|FG000|Second 24 Hours|Missing data|0|||
156505948|NCT01727505|564945280|FG001|Second 24 Hours|Missing data|1|||
156505949|NCT02637323|564945282|FG000|Overall Study|Lost to Follow-up|2|||
156505950|NCT02637323|564945283|FG001|Overall Study|Lost to Follow-up|0|||
156505951|NCT02637323|564945282|FG000|Overall Study|Protocol Violation|0|||
156505952|NCT02637323|564945283|FG001|Overall Study|Protocol Violation|1|||
156505953|NCT01154140|564945284|FG000|Overall Study|Death|71|||
156505954|NCT01154140|564945285|FG001|Overall Study|Death|81|||
156505955|NCT01154140|564945284|FG000|Overall Study|Lost to Follow-up|4|||
156505956|NCT01154140|564945285|FG001|Overall Study|Lost to Follow-up|5|||
156505957|NCT01154140|564945284|FG000|Overall Study|Withdrawal by Subject|12|||
156505958|NCT01154140|564945285|FG001|Overall Study|Withdrawal by Subject|13|||
156505959|NCT01154140|564945284|FG000|Overall Study|Other|3|||
156505960|NCT01154140|564945285|FG001|Overall Study|Other|1|||
156505961|NCT01154140|564945284|FG000|Overall Study|Randomized but not treated|1|||
156505962|NCT01154140|564945285|FG001|Overall Study|Randomized but not treated|2|||
156505963|NCT00358644|564945286|FG000|Overall Study|Progressive Disease|21|||
156505964|NCT00358644|564945286|FG000|Overall Study|Adverse Event|7|||
156505965|NCT00358644|564945286|FG000|Overall Study|Death|11|||
156505966|NCT00358644|564945286|FG000|Overall Study|Withdrawal by Subject|4|||
156505967|NCT00358644|564945286|FG000|Overall Study|Physician Decision|6|||
156505968|NCT00358644|564945286|FG000|Overall Study|Patient not eligible for study|1|||
156505969|NCT00513708|564945287|FG000|Overall Study|Lost to Follow-up|4|||
156505970|NCT00513708|564945288|FG001|Overall Study|Lost to Follow-up|4|||
156505971|NCT00513708|564945289|FG002|Overall Study|Lost to Follow-up|4|||
156505972|NCT00368875|564945290|FG000|Overall Study|Adverse Event|0|||
156505973|NCT00368875|564945291|FG001|Overall Study|Adverse Event|12|||
156505974|NCT00368875|564945290|FG000|Overall Study|Progressive disease|3|||
156505975|NCT00368875|564945291|FG001|Overall Study|Progressive disease|27|||
156505976|NCT00368875|564945290|FG000|Overall Study|Withdrawal by Subject|2|||
156505977|NCT00368875|564945291|FG001|Overall Study|Withdrawal by Subject|6|||
156505978|NCT00368875|564945290|FG000|Overall Study|Other Reason|0|||
156505979|NCT00368875|564945291|FG001|Overall Study|Other Reason|2|||
156505980|NCT00368875|564945290|FG000|Overall Study|Alternative Therapy|1|||
156505981|NCT00368875|564945291|FG001|Overall Study|Alternative Therapy|1|||
156505982|NCT03327831|564945292|FG000|Overall Study|Lost to Follow-up|2|||
156505983|NCT01564277|564945293|FG000|Overall Study|Protocol Violation|0|||
156505984|NCT01564277|564945294|FG001|Overall Study|Protocol Violation|1|||
156505985|NCT01564277|564945293|FG000|Overall Study|Physician Decision|1|||
156505986|NCT01564277|564945294|FG001|Overall Study|Physician Decision|0|||
156505987|NCT02595372|564945295|FG000|Overall Study|Adverse Event|6|||
156505988|NCT02595372|564945295|FG000|Overall Study|Physician Decision|2|||
156505989|NCT02595372|564945295|FG000|Overall Study|Disease Progression|1|||
156505990|NCT01594970|564945298|FG000|Overall Study|Non-Adverse Event Related|4|||
156505991|NCT01594970|564945299|FG001|Overall Study|Non-Adverse Event Related|5|||
156505992|NCT01594970|564945300|FG002|Overall Study|Non-Adverse Event Related|6|||
156505993|NCT01594970|564945298|FG000|Overall Study|Adverse Event|17|||
156505994|NCT01594970|564945299|FG001|Overall Study|Adverse Event|23|||
156505995|NCT01594970|564945300|FG002|Overall Study|Adverse Event|23|||
156505996|NCT01594970|564945298|FG000|Overall Study|Lost to Follow-up|54|||
156505997|NCT01594970|564945299|FG001|Overall Study|Lost to Follow-up|54|||
156505998|NCT01594970|564945300|FG002|Overall Study|Lost to Follow-up|37|||
156505999|NCT00401258|564945301|FG000|Overall Study|Adverse Event|7|||
156506000|NCT04276051|564945306|FG000|Overall Study|Lost to Follow-up|0|||
156506001|NCT04276051|564945307|FG001|Overall Study|Lost to Follow-up|1|||
156506002|NCT04276051|564945306|FG000|Overall Study|Physician Decision|0|||
156506003|NCT04276051|564945307|FG001|Overall Study|Physician Decision|1|||
156506004|NCT04276051|564945306|FG000|Overall Study|Withdrawal by Subject|1|||
156506005|NCT04276051|564945307|FG001|Overall Study|Withdrawal by Subject|1|||
156506006|NCT01374568|564945308|FG000|Overall Study|Lab unable to analyze BTM|0|||
156506007|NCT01374568|564945309|FG001|Overall Study|Lab unable to analyze BTM|2|||
156506008|NCT01299480|564945310|FG000|Overall Study|No longer willing to participate|19|||
156506009|NCT01299480|564945311|FG001|Overall Study|No longer willing to participate|17|||
156506010|NCT01299480|564945312|FG002|Overall Study|No longer willing to participate|14|||
156506011|NCT01299480|564945313|FG003|Overall Study|No longer willing to participate|13|||
156506012|NCT01299480|564945314|FG004|Overall Study|No longer willing to participate|10|||
156506013|NCT01299480|564945310|FG000|Overall Study|Protocol Violation|7|||
156506014|NCT01299480|564945311|FG001|Overall Study|Protocol Violation|5|||
156506015|NCT01299480|564945312|FG002|Overall Study|Protocol Violation|8|||
156506016|NCT01299480|564945313|FG003|Overall Study|Protocol Violation|1|||
156506017|NCT01299480|564945314|FG004|Overall Study|Protocol Violation|1|||
156506018|NCT01299480|564945310|FG000|Overall Study|Withdrawal by Subject|3|||
156506019|NCT01299480|564945311|FG001|Overall Study|Withdrawal by Subject|4|||
156506020|NCT01299480|564945312|FG002|Overall Study|Withdrawal by Subject|7|||
156506021|NCT01299480|564945313|FG003|Overall Study|Withdrawal by Subject|3|||
156506022|NCT01299480|564945314|FG004|Overall Study|Withdrawal by Subject|4|||
156506023|NCT01299480|564945310|FG000|Overall Study|Adverse Event|6|||
156506024|NCT01299480|564945311|FG001|Overall Study|Adverse Event|4|||
156506025|NCT01299480|564945312|FG002|Overall Study|Adverse Event|5|||
156506026|NCT01299480|564945313|FG003|Overall Study|Adverse Event|4|||
156506027|NCT01299480|564945314|FG004|Overall Study|Adverse Event|0|||
156506028|NCT01299480|564945310|FG000|Overall Study|Withdrawal due to pregnancy|0|||
156506029|NCT01299480|564945311|FG001|Overall Study|Withdrawal due to pregnancy|1|||
156506030|NCT01299480|564945312|FG002|Overall Study|Withdrawal due to pregnancy|1|||
156506031|NCT01299480|564945313|FG003|Overall Study|Withdrawal due to pregnancy|0|||
156506032|NCT01299480|564945314|FG004|Overall Study|Withdrawal due to pregnancy|0|||
156506033|NCT01299480|564945310|FG000|Overall Study|Physician Decision|1|||
156506034|NCT01299480|564945311|FG001|Overall Study|Physician Decision|1|||
156506035|NCT01299480|564945312|FG002|Overall Study|Physician Decision|0|||
156506036|NCT01299480|564945313|FG003|Overall Study|Physician Decision|2|||
156506037|NCT01299480|564945314|FG004|Overall Study|Physician Decision|0|||
156506038|NCT01299480|564945310|FG000|Overall Study|Lost to Follow-up|3|||
156506039|NCT01299480|564945311|FG001|Overall Study|Lost to Follow-up|1|||
156506040|NCT01299480|564945312|FG002|Overall Study|Lost to Follow-up|2|||
156506041|NCT01299480|564945313|FG003|Overall Study|Lost to Follow-up|1|||
156506042|NCT01299480|564945314|FG004|Overall Study|Lost to Follow-up|2|||
156506043|NCT01299480|564945310|FG000|Overall Study|Other|3|||
156506044|NCT01299480|564945311|FG001|Overall Study|Other|2|||
156506045|NCT01299480|564945312|FG002|Overall Study|Other|3|||
156506046|NCT01299480|564945313|FG003|Overall Study|Other|0|||
156506047|NCT01299480|564945314|FG004|Overall Study|Other|3|||
156506048|NCT01299480|564945310|FG000|Overall Study|Started, but not vaccinated|0|||
156506049|NCT01299480|564945311|FG001|Overall Study|Started, but not vaccinated|0|||
156506050|NCT01299480|564945312|FG002|Overall Study|Started, but not vaccinated|1|||
156506051|NCT01299480|564945313|FG003|Overall Study|Started, but not vaccinated|1|||
156506052|NCT01299480|564945314|FG004|Overall Study|Started, but not vaccinated|0|||
156506053|NCT00617929|564945315|FG000|Overall Study|Physician Decision|1|||
156506054|NCT00844597|564945316|FG000|Overall Study|Adverse Event|0|||
156506055|NCT00844597|564945317|FG001|Overall Study|Adverse Event|0|||
156506056|NCT00844597|564945318|FG002|Overall Study|Adverse Event|0|||
156506057|NCT00844597|564945319|FG003|Overall Study|Adverse Event|1|||
156506058|NCT00844597|564945320|FG004|Overall Study|Adverse Event|0|||
156506059|NCT00844597|564945321|FG005|Overall Study|Adverse Event|0|||
156506060|NCT04160988|564945322|FG000|Overall Study|poor image quality|28|||
156547065|NCT01970501|565095035|FG001|Overall Study|Adverse Event|4|||
156506061|NCT01250509|564945323|FG000|Overall Study|Lost to Follow-up|5|||
156506062|NCT01250509|564945324|FG001|Overall Study|Lost to Follow-up|2|||
156506063|NCT06840769|564945327|FG000|Overall Study|Withdrawal by Subject|1|||
156506064|NCT06840769|564945328|FG001|Overall Study|Withdrawal by Subject|0|||
156506065|NCT06840769|564945329|FG002|Overall Study|Withdrawal by Subject|0|||
156506066|NCT06840769|564945330|FG003|Overall Study|Withdrawal by Subject|0|||
156506067|NCT06840769|564945331|FG004|Overall Study|Withdrawal by Subject|0|||
156384949|NCT02301143|564501028|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
156384950|NCT02301143|564501029|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
156384951|NCT02301143|564501028|FG000|Investigator's Choice|Other|0|||
156384952|NCT02301143|564501029|FG001|Investigator's Choice|Other|1|||
156384953|NCT02301143|564501028|FG000|Investigator's Choice|Unresectable Surgery|0|||
156384954|NCT02301143|564501029|FG001|Investigator's Choice|Unresectable Surgery|1|||
156384955|NCT03214367|564501032|FG000|Lead-in Period|Withdrawal by Subject|50|||
156384956|NCT03214367|564501033|FG001|Lead-in Period|Withdrawal by Subject|0|||
156384957|NCT03214367|564501034|FG002|Lead-in Period|Withdrawal by Subject|0|||
156384958|NCT03214367|564501035|FG003|Lead-in Period|Withdrawal by Subject|0|||
156384959|NCT03214367|564501036|FG004|Lead-in Period|Withdrawal by Subject|2|||
156384960|NCT03214367|564501037|FG005|Lead-in Period|Withdrawal by Subject|0|||
156384961|NCT03214367|564501038|FG006|Lead-in Period|Withdrawal by Subject|0|||
156384962|NCT03214367|564501039|FG007|Lead-in Period|Withdrawal by Subject|0|||
156384963|NCT03214367|564501032|FG000|Lead-in Period|Adverse Event|3|||
156384964|NCT03214367|564501033|FG001|Lead-in Period|Adverse Event|0|||
156384965|NCT03214367|564501034|FG002|Lead-in Period|Adverse Event|0|||
156384966|NCT03214367|564501035|FG003|Lead-in Period|Adverse Event|0|||
156384967|NCT03214367|564501036|FG004|Lead-in Period|Adverse Event|0|||
156384968|NCT03214367|564501037|FG005|Lead-in Period|Adverse Event|0|||
156384969|NCT03214367|564501038|FG006|Lead-in Period|Adverse Event|0|||
156384970|NCT03214367|564501039|FG007|Lead-in Period|Adverse Event|0|||
156384971|NCT03214367|564501032|FG000|Lead-in Period|Lost to Follow-up|12|||
156384972|NCT03214367|564501033|FG001|Lead-in Period|Lost to Follow-up|0|||
156384973|NCT03214367|564501034|FG002|Lead-in Period|Lost to Follow-up|0|||
156384974|NCT03214367|564501035|FG003|Lead-in Period|Lost to Follow-up|0|||
156384975|NCT03214367|564501036|FG004|Lead-in Period|Lost to Follow-up|0|||
156384976|NCT03214367|564501037|FG005|Lead-in Period|Lost to Follow-up|0|||
156384977|NCT03214367|564501038|FG006|Lead-in Period|Lost to Follow-up|0|||
156384978|NCT03214367|564501039|FG007|Lead-in Period|Lost to Follow-up|0|||
156384979|NCT03214367|564501032|FG000|Lead-in Period|Sponsor Decision|11|||
156384980|NCT03214367|564501033|FG001|Lead-in Period|Sponsor Decision|0|||
156384981|NCT03214367|564501034|FG002|Lead-in Period|Sponsor Decision|0|||
156384982|NCT03214367|564501035|FG003|Lead-in Period|Sponsor Decision|0|||
156384983|NCT03214367|564501036|FG004|Lead-in Period|Sponsor Decision|0|||
156384984|NCT03214367|564501037|FG005|Lead-in Period|Sponsor Decision|0|||
156384985|NCT03214367|564501038|FG006|Lead-in Period|Sponsor Decision|0|||
156384986|NCT03214367|564501039|FG007|Lead-in Period|Sponsor Decision|0|||
156384987|NCT03214367|564501032|FG000|Lead-in Period|Physician Decision|12|||
156384988|NCT03214367|564501033|FG001|Lead-in Period|Physician Decision|0|||
156384989|NCT03214367|564501034|FG002|Lead-in Period|Physician Decision|0|||
156384990|NCT03214367|564501035|FG003|Lead-in Period|Physician Decision|0|||
156384991|NCT03214367|564501036|FG004|Lead-in Period|Physician Decision|0|||
156384992|NCT03214367|564501037|FG005|Lead-in Period|Physician Decision|0|||
156384993|NCT03214367|564501038|FG006|Lead-in Period|Physician Decision|0|||
156384994|NCT03214367|564501039|FG007|Lead-in Period|Physician Decision|0|||
156384995|NCT03214367|564501032|FG000|Lead-in Period|Protocol Violation|5|||
156384996|NCT03214367|564501033|FG001|Lead-in Period|Protocol Violation|0|||
156384997|NCT03214367|564501034|FG002|Lead-in Period|Protocol Violation|0|||
156384998|NCT03214367|564501035|FG003|Lead-in Period|Protocol Violation|0|||
156384999|NCT03214367|564501036|FG004|Lead-in Period|Protocol Violation|0|||
156385000|NCT03214367|564501037|FG005|Lead-in Period|Protocol Violation|0|||
156385001|NCT03214367|564501038|FG006|Lead-in Period|Protocol Violation|0|||
156385002|NCT03214367|564501039|FG007|Lead-in Period|Protocol Violation|0|||
156385003|NCT03214367|564501032|FG000|Lead-in Period|Treatment Interruption|1|||
156385004|NCT03214367|564501033|FG001|Lead-in Period|Treatment Interruption|0|||
156385005|NCT03214367|564501034|FG002|Lead-in Period|Treatment Interruption|0|||
156385006|NCT03214367|564501035|FG003|Lead-in Period|Treatment Interruption|0|||
156385007|NCT03214367|564501036|FG004|Lead-in Period|Treatment Interruption|0|||
156385008|NCT03214367|564501037|FG005|Lead-in Period|Treatment Interruption|0|||
156385009|NCT03214367|564501038|FG006|Lead-in Period|Treatment Interruption|0|||
156385010|NCT03214367|564501039|FG007|Lead-in Period|Treatment Interruption|0|||
156385011|NCT03214367|564501032|FG000|Treatment Period|Adverse Event|0|||
156385012|NCT03214367|564501033|FG001|Treatment Period|Adverse Event|1|||
156385013|NCT03214367|564501034|FG002|Treatment Period|Adverse Event|4|||
156385014|NCT03214367|564501035|FG003|Treatment Period|Adverse Event|2|||
156385015|NCT03214367|564501036|FG004|Treatment Period|Adverse Event|0|||
156385016|NCT03214367|564501037|FG005|Treatment Period|Adverse Event|0|||
156385017|NCT03214367|564501038|FG006|Treatment Period|Adverse Event|0|||
156385018|NCT03214367|564501039|FG007|Treatment Period|Adverse Event|0|||
156385019|NCT03214367|564501032|FG000|Treatment Period|Death|0|||
156385020|NCT03214367|564501033|FG001|Treatment Period|Death|1|||
156385021|NCT03214367|564501034|FG002|Treatment Period|Death|1|||
156385022|NCT03214367|564501035|FG003|Treatment Period|Death|1|||
156385023|NCT03214367|564501036|FG004|Treatment Period|Death|0|||
156385024|NCT03214367|564501037|FG005|Treatment Period|Death|0|||
156385025|NCT03214367|564501038|FG006|Treatment Period|Death|0|||
156385026|NCT03214367|564501039|FG007|Treatment Period|Death|0|||
156385027|NCT03214367|564501032|FG000|Treatment Period|Lost to Follow-up|0|||
156385028|NCT03214367|564501033|FG001|Treatment Period|Lost to Follow-up|5|||
156385029|NCT03214367|564501034|FG002|Treatment Period|Lost to Follow-up|3|||
156385030|NCT03214367|564501035|FG003|Treatment Period|Lost to Follow-up|2|||
156385031|NCT03214367|564501036|FG004|Treatment Period|Lost to Follow-up|0|||
156385032|NCT03214367|564501037|FG005|Treatment Period|Lost to Follow-up|2|||
156385033|NCT03214367|564501038|FG006|Treatment Period|Lost to Follow-up|1|||
156385034|NCT03214367|564501039|FG007|Treatment Period|Lost to Follow-up|0|||
156385035|NCT03214367|564501032|FG000|Treatment Period|Sponsor Decision|0|||
156385036|NCT03214367|564501033|FG001|Treatment Period|Sponsor Decision|3|||
156385037|NCT03214367|564501034|FG002|Treatment Period|Sponsor Decision|0|||
156385038|NCT03214367|564501035|FG003|Treatment Period|Sponsor Decision|0|||
156385039|NCT03214367|564501036|FG004|Treatment Period|Sponsor Decision|0|||
156385040|NCT03214367|564501037|FG005|Treatment Period|Sponsor Decision|0|||
156385041|NCT03214367|564501038|FG006|Treatment Period|Sponsor Decision|0|||
156385042|NCT03214367|564501039|FG007|Treatment Period|Sponsor Decision|0|||
156385043|NCT03214367|564501032|FG000|Treatment Period|Physician Decision|0|||
156385044|NCT03214367|564501033|FG001|Treatment Period|Physician Decision|1|||
156385045|NCT03214367|564501034|FG002|Treatment Period|Physician Decision|2|||
156385046|NCT03214367|564501035|FG003|Treatment Period|Physician Decision|0|||
156385047|NCT03214367|564501036|FG004|Treatment Period|Physician Decision|0|||
156385048|NCT03214367|564501037|FG005|Treatment Period|Physician Decision|0|||
156385049|NCT03214367|564501038|FG006|Treatment Period|Physician Decision|0|||
156385050|NCT03214367|564501039|FG007|Treatment Period|Physician Decision|0|||
156385051|NCT03214367|564501032|FG000|Treatment Period|Protocol Violation|0|||
156385052|NCT03214367|564501033|FG001|Treatment Period|Protocol Violation|3|||
156385053|NCT03214367|564501034|FG002|Treatment Period|Protocol Violation|0|||
156385054|NCT03214367|564501035|FG003|Treatment Period|Protocol Violation|0|||
156385055|NCT03214367|564501036|FG004|Treatment Period|Protocol Violation|0|||
156385056|NCT03214367|564501037|FG005|Treatment Period|Protocol Violation|0|||
156385057|NCT03214367|564501038|FG006|Treatment Period|Protocol Violation|0|||
156385058|NCT03214367|564501039|FG007|Treatment Period|Protocol Violation|0|||
156385059|NCT03214367|564501032|FG000|Treatment Period|Withdrawal by Subject|0|||
156385060|NCT03214367|564501033|FG001|Treatment Period|Withdrawal by Subject|20|||
156385061|NCT03214367|564501034|FG002|Treatment Period|Withdrawal by Subject|23|||
156385062|NCT03214367|564501035|FG003|Treatment Period|Withdrawal by Subject|14|||
156385063|NCT03214367|564501036|FG004|Treatment Period|Withdrawal by Subject|0|||
156385064|NCT03214367|564501037|FG005|Treatment Period|Withdrawal by Subject|1|||
156385065|NCT03214367|564501038|FG006|Treatment Period|Withdrawal by Subject|1|||
156385066|NCT03214367|564501039|FG007|Treatment Period|Withdrawal by Subject|1|||
156385067|NCT03268811|564501042|FG000|Overall Study|Adverse Event|0|||
156385068|NCT03268811|564501043|FG001|Overall Study|Adverse Event|1|||
156385069|NCT04726709|564501047|FG000|Overall Study|Withdrawal by Subject|2|||
156385070|NCT04726709|564501048|FG001|Overall Study|Withdrawal by Subject|2|||
156385071|NCT02473952|564501051|FG000|Overall Study|Adverse Event|2|||
156385072|NCT02473952|564501052|FG001|Overall Study|Adverse Event|2|||
156385073|NCT02473952|564501051|FG000|Overall Study|Withdrawal by Subject|0|||
156385074|NCT02473952|564501052|FG001|Overall Study|Withdrawal by Subject|6|||
156385075|NCT00455195|564501053|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
156385076|NCT00455195|564501054|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
156385077|NCT00455195|564501053|FG000|Double-blind Study AGLU02704|Death|1|||
156385078|NCT00455195|564501054|FG001|Double-blind Study AGLU02704|Death|0|||
156385079|NCT00455195|564501053|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
156385080|NCT00455195|564501054|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
156385081|NCT00455195|564501053|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
156385082|NCT00455195|564501054|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
156385083|NCT00823719|564501055|FG000|Overall Study|Adverse Event|1|||
156385084|NCT00823719|564501056|FG001|Overall Study|Adverse Event|2|||
156385085|NCT00823719|564501055|FG000|Overall Study|Physician Decision|1|||
156385086|NCT00823719|564501056|FG001|Overall Study|Physician Decision|4|||
156385087|NCT00823719|564501055|FG000|Overall Study|Withdrawal by Subject|0|||
156385088|NCT00823719|564501056|FG001|Overall Study|Withdrawal by Subject|1|||
156385089|NCT00823719|564501055|FG000|Overall Study|Disease Progression|4|||
156385090|NCT00823719|564501056|FG001|Overall Study|Disease Progression|4|||
156385091|NCT02117570|564501057|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
156385092|NCT02117570|564501058|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
156385093|NCT02117570|564501059|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
156385094|NCT02117570|564501057|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
156385095|NCT02117570|564501058|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
156385096|NCT02117570|564501059|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
156385097|NCT02117570|564501057|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
156385098|NCT02117570|564501058|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
156385099|NCT02117570|564501059|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
156385100|NCT02117570|564501057|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
156385101|NCT02117570|564501058|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
156547066|NCT01970501|565095034|FG000|Overall Study|Death|1|||
156506068|NCT02726945|564945332|FG000|Overall Study|Withdrawal by Subject|0|||
156506069|NCT02726945|564945333|FG001|Overall Study|Withdrawal by Subject|0|||
156506070|NCT02726945|564945334|FG002|Overall Study|Withdrawal by Subject|1|||
156506071|NCT02726945|564945332|FG000|Overall Study|Elected to have total knee replacement|0|||
156506072|NCT02726945|564945333|FG001|Overall Study|Elected to have total knee replacement|1|||
156506073|NCT02726945|564945334|FG002|Overall Study|Elected to have total knee replacement|0|||
156506074|NCT02473965|564946789|FG000|Overall Study|Adverse Event|6|||
156506075|NCT02473965|564946790|FG001|Overall Study|Adverse Event|4|||
156506076|NCT02473965|564946789|FG000|Overall Study|MG worsening|4|||
156506077|NCT02473965|564946790|FG001|Overall Study|MG worsening|1|||
156506078|NCT02473965|564946789|FG000|Overall Study|Withdrawal by Subject|2|||
156506079|NCT02473965|564946790|FG001|Overall Study|Withdrawal by Subject|3|||
156506080|NCT02473965|564946789|FG000|Overall Study|Physician Decision|0|||
156506081|NCT02473965|564946790|FG001|Overall Study|Physician Decision|2|||
156506082|NCT03816761|564946791|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
156506083|NCT03816761|564946792|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
156506084|NCT03816761|564946793|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
156506085|NCT03816761|564946794|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
156506086|NCT03816761|564946795|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
156506087|NCT03816761|564946796|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
156506088|NCT03816761|564946791|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
156506089|NCT03816761|564946792|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
156506090|NCT03816761|564946793|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
156506091|NCT03816761|564946794|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
156506092|NCT03816761|564946795|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
156506093|NCT03816761|564946796|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
156506094|NCT01920477|564946797|FG000|Overall Study|Adverse Event|0|||
156506095|NCT01920477|564946798|FG001|Overall Study|Adverse Event|1|||
156506096|NCT01920477|564946797|FG000|Overall Study|Lack of Efficacy|1|||
156506097|NCT01920477|564946798|FG001|Overall Study|Lack of Efficacy|0|||
156506098|NCT01920477|564946797|FG000|Overall Study|Study closed/terminated|14|||
156506099|NCT01920477|564946798|FG001|Overall Study|Study closed/terminated|15|||
156506100|NCT01920477|564946797|FG000|Overall Study|Withdrawal by Subject|0|||
156506101|NCT01920477|564946798|FG001|Overall Study|Withdrawal by Subject|1|||
156506102|NCT03926195|564946807|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
156506103|NCT03926195|564946808|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
156506104|NCT03926195|564946807|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
156506105|NCT03926195|564946808|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
156506106|NCT03926195|564946807|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
156506107|NCT03926195|564946808|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
156506108|NCT03926195|564946807|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
156506109|NCT03926195|564946808|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
156506110|NCT03926195|564946807|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
156506111|NCT03926195|564946808|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
156506112|NCT03926195|564946807|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
156506113|NCT03926195|564946808|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
156506114|NCT03054337|564946809|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
156506115|NCT03054337|564946810|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
156506116|NCT03054337|564946811|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
156506117|NCT03054337|564946812|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
156506118|NCT03054337|564946813|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
156506119|NCT03054337|564946814|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
156506120|NCT01661205|564946817|FG000|Overall Study|Physician Decision|2|||
156506121|NCT00955708|564946819|FG000|Overall Study|Death|269|||
156506122|NCT00955708|564946819|FG000|Overall Study|Lost to Follow-up|72|||
156506123|NCT00955708|564946819|FG000|Overall Study|Physician Decision|36|||
156506124|NCT00955708|564946819|FG000|Overall Study|Protocol Violation|134|||
156506125|NCT00955708|564946819|FG000|Overall Study|Registry Conclusion|186|||
156506126|NCT00955708|564946819|FG000|Overall Study|Product removed from service|94|||
156506127|NCT00955708|564946819|FG000|Overall Study|Patient Refused to participate further|116|||
156506128|NCT00955708|564946819|FG000|Overall Study|Closure of study location|60|||
156506129|NCT00955708|564946819|FG000|Overall Study|Patient changed care provider/moved|91|||
156506130|NCT01736540|564946820|FG000|Overall Study|Did not complete scan within 45 days|2|||
156385102|NCT02117570|564501059|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
156385103|NCT02117570|564501057|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
156506131|NCT01736540|564946820|FG000|Overall Study|Death|1|||
156506132|NCT01736540|564946820|FG000|Overall Study|Abnormal test procedure|1|||
156506133|NCT01736540|564946820|FG000|Overall Study|Withdrawal by Subject|5|||
156506134|NCT01736540|564946820|FG000|Overall Study|Protocol Violation|1|||
156547067|NCT01970501|565095035|FG001|Overall Study|Death|3|||
156385104|NCT02117570|564501058|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
156385105|NCT02117570|564501059|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
156385106|NCT02117570|564501057|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
156385107|NCT02117570|564501058|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
156385108|NCT02117570|564501059|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
156385109|NCT02117570|564501057|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
156385110|NCT02117570|564501058|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
156506135|NCT01736540|564946820|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
156506136|NCT01736540|564946820|FG000|Overall Study|No show for MRI appointment|1|||
156506137|NCT01736540|564946820|FG000|Overall Study|Unable to make MRI appointment|3|||
156506138|NCT01735175|564946821|FG000|Overall Study|Withdrawal by Subject|9|||
156506139|NCT01735175|564946822|FG001|Overall Study|Withdrawal by Subject|2|||
156506140|NCT01735175|564946821|FG000|Overall Study|Lost to Follow-up|4|||
156506141|NCT01735175|564946822|FG001|Overall Study|Lost to Follow-up|2|||
156506142|NCT01735175|564946821|FG000|Overall Study|Death|3|||
156506143|NCT01735175|564946822|FG001|Overall Study|Death|2|||
156506144|NCT01735175|564946821|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
156506145|NCT01735175|564946822|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
156506146|NCT01031628|564946823|FG000|Overall Study|Study terminated early|0|||
156506147|NCT01031628|564946824|FG001|Overall Study|Study terminated early|1|||
156506148|NCT01031628|564946825|FG002|Overall Study|Study terminated early|3|||
156506149|NCT01031628|564946826|FG003|Overall Study|Study terminated early|0|||
156506150|NCT00755417|564946829|FG000|Overall Study|Adverse Event|28|||
156506151|NCT00755417|564946830|FG001|Overall Study|Adverse Event|20|||
156506152|NCT00755417|564946831|FG002|Overall Study|Adverse Event|7|||
156506153|NCT00755417|564946829|FG000|Overall Study|Lack of Efficacy|8|||
156506154|NCT00755417|564946830|FG001|Overall Study|Lack of Efficacy|4|||
156506155|NCT00755417|564946831|FG002|Overall Study|Lack of Efficacy|9|||
156506156|NCT00755417|564946829|FG000|Overall Study|Protocol Violation|2|||
156506157|NCT00755417|564946830|FG001|Overall Study|Protocol Violation|1|||
156506158|NCT00755417|564946831|FG002|Overall Study|Protocol Violation|1|||
156506159|NCT00755417|564946829|FG000|Overall Study|Lost to Follow-up|3|||
156506160|NCT00755417|564946830|FG001|Overall Study|Lost to Follow-up|0|||
156506161|NCT00755417|564946831|FG002|Overall Study|Lost to Follow-up|1|||
156506162|NCT00755417|564946829|FG000|Overall Study|Withdrawal by Subject|12|||
156506163|NCT00755417|564946830|FG001|Overall Study|Withdrawal by Subject|12|||
156506164|NCT00755417|564946831|FG002|Overall Study|Withdrawal by Subject|12|||
156506165|NCT00755417|564946829|FG000|Overall Study|Not specified or missing data|9|||
156506166|NCT00755417|564946830|FG001|Overall Study|Not specified or missing data|18|||
156506167|NCT00755417|564946831|FG002|Overall Study|Not specified or missing data|12|||
156506168|NCT02803593|564946832|FG000|Overall Study|Lost to Follow-up|17|||
156506169|NCT02803593|564946833|FG001|Overall Study|Lost to Follow-up|35|||
156506170|NCT05143138|564946834|FG000|Overall Study|Death|5|||
156506171|NCT05143138|564946835|FG001|Overall Study|Death|35|||
156506172|NCT05143138|564946836|FG002|Overall Study|Death|1|||
156506173|NCT05143138|564946834|FG000|Overall Study|Lost to Follow-up|2|||
156506174|NCT05143138|564946835|FG001|Overall Study|Lost to Follow-up|4|||
156506175|NCT05143138|564946836|FG002|Overall Study|Lost to Follow-up|0|||
156506176|NCT05143138|564946834|FG000|Overall Study|withdrawal|1|||
156506177|NCT05143138|564946835|FG001|Overall Study|withdrawal|1|||
156506178|NCT05143138|564946836|FG002|Overall Study|withdrawal|0|||
156506179|NCT04245345|564946839|FG000|Overall Study|Death|1|||
156506180|NCT04245345|564946839|FG000|Overall Study|Exited prior to implant|5|||
156506181|NCT04245345|564946839|FG000|Overall Study|Exited prior to 1-month|9|||
156506182|NCT04245345|564946839|FG000|Overall Study|Missed 1-month visit|3|||
156506183|NCT04245345|564946839|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
156506184|NCT04245345|564946839|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
156506185|NCT02522728|564946843|FG000|Overall Study|Withdrawal by Subject|6|||
156506186|NCT02522728|564946844|FG001|Overall Study|Withdrawal by Subject|6|||
156506187|NCT02522728|564946843|FG000|Overall Study|Death|4|||
156506188|NCT02522728|564946844|FG001|Overall Study|Death|3|||
156506189|NCT02522728|564946843|FG000|Overall Study|Adverse Event|2|||
156506190|NCT02522728|564946844|FG001|Overall Study|Adverse Event|1|||
156506191|NCT02522728|564946843|FG000|Overall Study|Did not receive randomized study device|0|||
156506192|NCT02522728|564946844|FG001|Overall Study|Did not receive randomized study device|1|||
156506193|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
156506194|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
156506195|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
156506196|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
156506197|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
156506198|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
156506199|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
156506200|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
156506201|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
156506202|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
156385111|NCT02117570|564501059|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
156385112|NCT02148250|564501060|FG000|Screening|Withdrawal by Subject|5|||
156385113|NCT02148250|564501061|FG001|Screening|Withdrawal by Subject|0|||
156385114|NCT01286779|564501065|FG000|Overall Study|Withdrawal by Subject|9|||
156385115|NCT01286779|564501065|FG000|Overall Study|Protocol Violation|5|||
156385116|NCT01286779|564501065|FG000|Overall Study|Physician Decision|2|||
156385117|NCT01286779|564501065|FG000|Overall Study|Participant had scheduled surgery|1|||
156385118|NCT01286779|564501065|FG000|Overall Study|Participant moved to another country|1|||
156385119|NCT01286779|564501065|FG000|Overall Study|Discontinued by sponsor|1|||
156385120|NCT04827212|564501066|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
156385121|NCT04827212|564501067|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
156385122|NCT04827212|564501066|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
156385123|NCT04827212|564501067|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
156385124|NCT00574080|564501068|FG000|Overall Study|Death|10|||
156385125|NCT00574080|564501069|FG001|Overall Study|Death|10|||
156385126|NCT00599326|564501070|FG000|Overall Study|Lost to Follow-up|1|||
156385127|NCT00599326|564501070|FG000|Overall Study|Noncompliant|1|||
156385128|NCT00784810|564501071|FG000|Overall Study|Adverse Event|32|||
156385129|NCT00784810|564501072|FG001|Overall Study|Adverse Event|20|||
156385130|NCT00784810|564501071|FG000|Overall Study|Lack of Efficacy|14|||
156385131|NCT00784810|564501072|FG001|Overall Study|Lack of Efficacy|11|||
156385132|NCT00784810|564501071|FG000|Overall Study|Withdrawal by Subject|11|||
156385133|NCT00784810|564501072|FG001|Overall Study|Withdrawal by Subject|9|||
156385134|NCT00784810|564501071|FG000|Overall Study|Administrative|5|||
156385135|NCT00784810|564501072|FG001|Overall Study|Administrative|8|||
156385136|NCT00784810|564501071|FG000|Overall Study|Lost to Follow-up|1|||
156385137|NCT00784810|564501072|FG001|Overall Study|Lost to Follow-up|1|||
156385138|NCT04969250|564501075|FG000|Overall Study|Protocol Violation|0|||
156385139|NCT04969250|564501076|FG001|Overall Study|Protocol Violation|2|||
156385140|NCT04969250|564501077|FG002|Overall Study|Protocol Violation|3|||
156385141|NCT04969250|564501078|FG003|Overall Study|Protocol Violation|8|||
156385142|NCT04969250|564501075|FG000|Overall Study|Withdrawal by Subject|0|||
156385143|NCT04969250|564501076|FG001|Overall Study|Withdrawal by Subject|1|||
156385144|NCT04969250|564501077|FG002|Overall Study|Withdrawal by Subject|0|||
156385145|NCT04969250|564501078|FG003|Overall Study|Withdrawal by Subject|0|||
156385146|NCT00563784|564501079|FG000|Overall Study|Withdrawal by Subject|2|||
156385147|NCT00563784|564501079|FG000|Overall Study|Screen Failures|20|||
156385148|NCT02119416|564501080|FG000|Overall Study|Protocol Violation|1|||
156385149|NCT02119416|564501081|FG001|Overall Study|Protocol Violation|1|||
156385150|NCT02119416|564501082|FG002|Overall Study|Protocol Violation|1|||
156385151|NCT02119416|564501080|FG000|Overall Study|wrong pubertal stage|1|||
156385152|NCT02119416|564501081|FG001|Overall Study|wrong pubertal stage|0|||
156385153|NCT02119416|564501082|FG002|Overall Study|wrong pubertal stage|1|||
156385154|NCT04004611|564501083|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156385155|NCT04004611|564501084|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156385156|NCT04004611|564501085|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156385157|NCT04004611|564501086|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156385158|NCT04004611|564501087|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156385159|NCT04004611|564501088|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156385160|NCT04004611|564501089|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156385161|NCT04004611|564501090|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156385162|NCT04004611|564501091|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
156385163|NCT04004611|564501083|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156506203|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
156506204|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
156506205|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
156506206|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
156506207|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
156506208|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
156506209|NCT04210843|564946845|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
156506210|NCT04210843|564946846|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
156506211|NCT04210843|564946845|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
156506212|NCT04210843|564946846|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
156506213|NCT04210843|564946845|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
156506214|NCT04210843|564946846|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
156385164|NCT04004611|564501084|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156385165|NCT04004611|564501085|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156385166|NCT04004611|564501086|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156385167|NCT04004611|564501087|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156506215|NCT04210843|564946845|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
156547068|NCT01970501|565095034|FG000|Overall Study|Physician Decision|2|||
156385168|NCT04004611|564501088|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
156385169|NCT04004611|564501089|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
156385170|NCT04004611|564501090|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156506216|NCT04210843|564946846|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
156506217|NCT04210843|564946845|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
156506218|NCT04210843|564946846|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
156506219|NCT04210843|564946845|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
156506220|NCT04210843|564946846|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
156506221|NCT04210843|564946845|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
156506222|NCT04210843|564946846|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
156506223|NCT04210843|564946845|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
156506224|NCT04210843|564946846|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
156506225|NCT04210843|564946845|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
156506226|NCT04210843|564946846|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
156506227|NCT04210843|564946845|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
156506228|NCT04210843|564946846|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
156506229|NCT04210843|564946845|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
156506230|NCT04210843|564946846|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
156506231|NCT04210843|564946845|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
156506232|NCT04210843|564946846|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
156506233|NCT04210843|564946845|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
156506234|NCT04210843|564946846|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
156506235|NCT04210843|564946845|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
156506236|NCT04210843|564946846|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
156506237|NCT04210843|564946845|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
156506238|NCT04210843|564946846|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
156506239|NCT04210843|564946845|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
156506240|NCT04210843|564946846|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
156506241|NCT02990468|564946847|FG000|Phase 2: MTD|Change in treatment|0|||
156506242|NCT02990468|564946848|FG001|Phase 2: MTD|Change in treatment|0|||
156506243|NCT02990468|564946849|FG002|Phase 2: MTD|Change in treatment|1|||
156506244|NCT01436305|564946850|FG000|Overall Study|Death|1|||
156506245|NCT01436305|564946851|FG001|Overall Study|Death|0|||
156506246|NCT01436305|564946852|FG002|Overall Study|Death|0|||
156506247|NCT01436305|564946850|FG000|Overall Study|Lost to Follow-up|0|||
156506248|NCT01436305|564946851|FG001|Overall Study|Lost to Follow-up|1|||
156506249|NCT01436305|564946852|FG002|Overall Study|Lost to Follow-up|0|||
156506250|NCT01436305|564946850|FG000|Overall Study|Withdrawal by Subject|1|||
156506251|NCT01436305|564946851|FG001|Overall Study|Withdrawal by Subject|3|||
156506252|NCT01436305|564946852|FG002|Overall Study|Withdrawal by Subject|0|||
156506253|NCT02567708|564946853|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
156506254|NCT02567708|564946854|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
156506255|NCT02567708|564946853|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
156506256|NCT02567708|564946854|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
156506257|NCT02567708|564946853|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
156506258|NCT02567708|564946854|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
156506259|NCT02567708|564946853|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
156506260|NCT02567708|564946854|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
156506261|NCT00706654|564946855|FG000|Conversion Phase|Lost to Follow-up|4|||
156506262|NCT00706654|564946856|FG001|Conversion Phase|Lost to Follow-up|0|||
156506263|NCT00706654|564946857|FG002|Conversion Phase|Lost to Follow-up|0|||
156506264|NCT00706654|564946858|FG003|Conversion Phase|Lost to Follow-up|0|||
156506265|NCT00706654|564946855|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
156506266|NCT00706654|564946856|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
156506267|NCT00706654|564946857|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
156506268|NCT00706654|564946858|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
156506269|NCT00706654|564946855|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
156506270|NCT00706654|564946856|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
156506271|NCT00706654|564946857|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
156506272|NCT00706654|564946858|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
156506273|NCT00706654|564946855|FG000|Conversion Phase|Withdrawn by Investigator|14|||
156506274|NCT00706654|564946856|FG001|Conversion Phase|Withdrawn by Investigator|0|||
156506275|NCT00706654|564946857|FG002|Conversion Phase|Withdrawn by Investigator|0|||
156506276|NCT00706654|564946858|FG003|Conversion Phase|Withdrawn by Investigator|0|||
156506277|NCT00706654|564946855|FG000|Conversion Phase|Withdrew Consent|38|||
156506278|NCT00706654|564946856|FG001|Conversion Phase|Withdrew Consent|0|||
156506279|NCT00706654|564946857|FG002|Conversion Phase|Withdrew Consent|0|||
156506280|NCT00706654|564946858|FG003|Conversion Phase|Withdrew Consent|0|||
156506281|NCT00706654|564946855|FG000|Conversion Phase|Adverse Event|18|||
156506282|NCT00706654|564946856|FG001|Conversion Phase|Adverse Event|0|||
156506283|NCT00706654|564946857|FG002|Conversion Phase|Adverse Event|0|||
156506284|NCT00706654|564946858|FG003|Conversion Phase|Adverse Event|0|||
156506285|NCT00706654|564946855|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
156547069|NCT01970501|565095035|FG001|Overall Study|Physician Decision|0|||
156547070|NCT00708123|565095036|FG000|Period 1|Protocol Violation|0|||
156547071|NCT00708123|565095037|FG001|Period 1|Protocol Violation|1|||
156547072|NCT00708123|565095038|FG002|Period 1|Protocol Violation|0|||
156547073|NCT00708123|565095039|FG003|Period 1|Protocol Violation|1|||
156547074|NCT00708123|565095040|FG004|Period 1|Protocol Violation|0|||
156547075|NCT00708123|565095036|FG000|Period 1|Adverse Event|0|||
156547076|NCT00708123|565095037|FG001|Period 1|Adverse Event|0|||
156547077|NCT00708123|565095038|FG002|Period 1|Adverse Event|1|||
156547078|NCT00708123|565095039|FG003|Period 1|Adverse Event|0|||
156547079|NCT00708123|565095040|FG004|Period 1|Adverse Event|0|||
156547080|NCT00708123|565095036|FG000|Period 2|Protocol Violation|0|||
156547081|NCT00708123|565095037|FG001|Period 2|Protocol Violation|0|||
156547082|NCT00708123|565095038|FG002|Period 2|Protocol Violation|0|||
156547083|NCT00708123|565095039|FG003|Period 2|Protocol Violation|1|||
156547084|NCT00708123|565095040|FG004|Period 2|Protocol Violation|0|||
156547085|NCT00708123|565095036|FG000|Period 2|Other Reason|1|||
156547086|NCT00708123|565095037|FG001|Period 2|Other Reason|0|||
156385171|NCT04004611|564501091|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
156385172|NCT04004611|564501083|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156385173|NCT04004611|564501084|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156385174|NCT04004611|564501085|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156385175|NCT04004611|564501086|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156385176|NCT04004611|564501087|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
156385177|NCT04004611|564501088|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156385178|NCT04004611|564501089|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156385179|NCT04004611|564501090|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156385180|NCT04004611|564501091|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156385181|NCT04004611|564501083|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
156385182|NCT04004611|564501084|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
156385183|NCT04004611|564501085|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
156385184|NCT04004611|564501086|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
156385185|NCT04004611|564501087|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
156385186|NCT04004611|564501088|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
156385187|NCT04004611|564501089|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
156385188|NCT04004611|564501090|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
156385189|NCT04004611|564501091|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
156385190|NCT04004611|564501083|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
156385191|NCT04004611|564501084|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156385192|NCT04004611|564501085|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
156385193|NCT04004611|564501086|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156385194|NCT04004611|564501087|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156385195|NCT04004611|564501088|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156506286|NCT00706654|564946856|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
156506287|NCT00706654|564946857|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
156506288|NCT00706654|564946858|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
156506289|NCT00706654|564946855|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
156506290|NCT00706654|564946856|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
156506291|NCT00706654|564946857|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
156506292|NCT00706654|564946858|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
156506293|NCT00706654|564946855|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
156506294|NCT00706654|564946856|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
156506295|NCT00706654|564946857|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
156506296|NCT00706654|564946858|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
156506297|NCT00706654|564946855|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
156506298|NCT00706654|564946856|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
156506299|NCT00706654|564946857|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
156506300|NCT00706654|564946858|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
156506301|NCT00706654|564946855|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
156506302|NCT00706654|564946856|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
156506303|NCT00706654|564946857|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
156506304|NCT00706654|564946858|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
156506305|NCT00706654|564946855|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
156506306|NCT00706654|564946856|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
156506307|NCT00706654|564946857|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
156506308|NCT00706654|564946858|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
156506309|NCT00706654|564946855|FG000|Oral Stabilization Phase|Withdrew consent|55|||
156547087|NCT00708123|565095038|FG002|Period 2|Other Reason|0|||
156547088|NCT00708123|565095039|FG003|Period 2|Other Reason|0|||
156547089|NCT00708123|565095040|FG004|Period 2|Other Reason|0|||
156547090|NCT00708123|565095036|FG000|Period 3|Lost to Follow-up|0|||
156506310|NCT00706654|564946856|FG001|Oral Stabilization Phase|Withdrew consent|0|||
156506311|NCT00706654|564946857|FG002|Oral Stabilization Phase|Withdrew consent|0|||
156506312|NCT00706654|564946858|FG003|Oral Stabilization Phase|Withdrew consent|0|||
156506313|NCT00706654|564946855|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
156506314|NCT00706654|564946856|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
156506315|NCT00706654|564946857|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
156506316|NCT00706654|564946858|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
156506317|NCT00706654|564946855|FG000|Oral Stabilization Phase|Adverse Event|21|||
156506318|NCT00706654|564946856|FG001|Oral Stabilization Phase|Adverse Event|0|||
156506319|NCT00706654|564946857|FG002|Oral Stabilization Phase|Adverse Event|0|||
156506320|NCT00706654|564946858|FG003|Oral Stabilization Phase|Adverse Event|0|||
156506321|NCT00706654|564946855|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
156506322|NCT00706654|564946856|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
156506323|NCT00706654|564946857|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
156506324|NCT00706654|564946858|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
156506325|NCT00706654|564946855|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
156506326|NCT00706654|564946856|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
156506327|NCT00706654|564946857|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
156506328|NCT00706654|564946858|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
156506329|NCT00706654|564946855|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
156506330|NCT00706654|564946856|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
156506331|NCT00706654|564946857|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
156506332|NCT00706654|564946858|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
156506333|NCT00706654|564946855|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
156506334|NCT00706654|564946856|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
156506335|NCT00706654|564946857|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
156506336|NCT00706654|564946858|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
156506337|NCT00706654|564946855|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
156506338|NCT00706654|564946856|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
156506339|NCT00706654|564946857|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
156506340|NCT00706654|564946858|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
156506341|NCT00706654|564946855|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
156506342|NCT00706654|564946856|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
156506343|NCT00706654|564946857|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
156506344|NCT00706654|564946858|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
156506345|NCT00706654|564946855|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
156506346|NCT00706654|564946856|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
156506347|NCT00706654|564946857|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
156506348|NCT00706654|564946858|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
156506349|NCT00706654|564946855|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
156506350|NCT00706654|564946856|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
156506351|NCT00706654|564946857|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
156506352|NCT00706654|564946858|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
156506353|NCT00706654|564946855|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
156506354|NCT00706654|564946856|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
156506355|NCT00706654|564946857|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
156506356|NCT00706654|564946858|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
156506357|NCT00706654|564946855|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
156506358|NCT00706654|564946856|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
156506359|NCT00706654|564946857|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
156506360|NCT00706654|564946858|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
156506361|NCT01261000|564946859|FG000|Overall Study|Screen failure|1|||
156506362|NCT01151215|564946863|FG000|Overall Study|Worsening of condition under study|1|||
156506363|NCT01151215|564946864|FG001|Overall Study|Worsening of condition under study|1|||
156506364|NCT01151215|564946865|FG002|Overall Study|Worsening of condition under study|1|||
156506365|NCT01151215|564946863|FG000|Overall Study|Death|16|||
156506366|NCT01151215|564946864|FG001|Overall Study|Death|20|||
156506367|NCT01151215|564946865|FG002|Overall Study|Death|11|||
156506368|NCT01151215|564946863|FG000|Overall Study|Lost to Follow-up|0|||
156506369|NCT01151215|564946864|FG001|Overall Study|Lost to Follow-up|0|||
156506370|NCT01151215|564946865|FG002|Overall Study|Lost to Follow-up|3|||
156506371|NCT01151215|564946863|FG000|Overall Study|Withdrawal by Subject|3|||
156506372|NCT01151215|564946864|FG001|Overall Study|Withdrawal by Subject|1|||
156506373|NCT01151215|564946865|FG002|Overall Study|Withdrawal by Subject|2|||
156506374|NCT01151215|564946863|FG000|Overall Study|Disease progression|0|||
156506375|NCT01151215|564946864|FG001|Overall Study|Disease progression|1|||
156506376|NCT01151215|564946865|FG002|Overall Study|Disease progression|1|||
156506377|NCT01151215|564946863|FG000|Overall Study|Safety as judged by the investigator|0|||
156506378|NCT01151215|564946864|FG001|Overall Study|Safety as judged by the investigator|0|||
156506379|NCT01151215|564946865|FG002|Overall Study|Safety as judged by the investigator|1|||
156547091|NCT00708123|565095037|FG001|Period 3|Lost to Follow-up|0|||
156547092|NCT00708123|565095038|FG002|Period 3|Lost to Follow-up|1|||
156547093|NCT00708123|565095039|FG003|Period 3|Lost to Follow-up|1|||
156547094|NCT00708123|565095040|FG004|Period 3|Lost to Follow-up|0|||
156547095|NCT00708123|565095036|FG000|Period 4|Protocol Violation|0|||
156547096|NCT00708123|565095037|FG001|Period 4|Protocol Violation|1|||
156547097|NCT00708123|565095038|FG002|Period 4|Protocol Violation|0|||
156547098|NCT00708123|565095039|FG003|Period 4|Protocol Violation|0|||
156547099|NCT00708123|565095040|FG004|Period 4|Protocol Violation|0|||
156547100|NCT02970292|565095041|FG000|Overall Study|Physician Decision|1|||
156547101|NCT02970292|565095042|FG001|Overall Study|Physician Decision|1|||
156547102|NCT02970292|565095041|FG000|Overall Study|Withdrawal by Subject|11|||
156547103|NCT02970292|565095042|FG001|Overall Study|Withdrawal by Subject|5|||
156547104|NCT02970292|565095041|FG000|Overall Study|Noncompliance with study drug|2|||
156547105|NCT02970292|565095042|FG001|Overall Study|Noncompliance with study drug|2|||
156547106|NCT02970292|565095041|FG000|Overall Study|Adverse Event|5|||
156547107|NCT02970292|565095042|FG001|Overall Study|Adverse Event|0|||
156547108|NCT02970292|565095041|FG000|Overall Study|Lack of Efficacy|1|||
156547109|NCT02970292|565095042|FG001|Overall Study|Lack of Efficacy|0|||
156547110|NCT02970292|565095041|FG000|Overall Study|Lost to Follow-up|1|||
156547111|NCT02970292|565095042|FG001|Overall Study|Lost to Follow-up|0|||
156547112|NCT02970292|565095041|FG000|Overall Study|Protocol Violation|2|||
156547113|NCT02970292|565095042|FG001|Overall Study|Protocol Violation|0|||
156547114|NCT02970292|565095041|FG000|Overall Study|Other|1|||
156547115|NCT02970292|565095042|FG001|Overall Study|Other|0|||
156547116|NCT04486950|565095044|FG000|Overall Study|Lost to Follow-up|0|||
156547117|NCT04486950|565095045|FG001|Overall Study|Lost to Follow-up|0|||
156547118|NCT04486950|565095046|FG002|Overall Study|Lost to Follow-up|0|||
156547119|NCT04486950|565095047|FG003|Overall Study|Lost to Follow-up|0|||
156547120|NCT04486950|565095048|FG004|Overall Study|Lost to Follow-up|0|||
156547121|NCT04486950|565095049|FG005|Overall Study|Lost to Follow-up|1|||
156547122|NCT04486950|565095050|FG006|Overall Study|Lost to Follow-up|0|||
156547123|NCT00401375|565095051|FG000|Overall Study|Protocol Violation|2|||
156547124|NCT00401375|565095052|FG001|Overall Study|Protocol Violation|2|||
156547125|NCT00401375|565095053|FG002|Overall Study|Protocol Violation|1|||
156547126|NCT00401375|565095051|FG000|Overall Study|Adverse Event|6|||
156547127|NCT00401375|565095052|FG001|Overall Study|Adverse Event|11|||
156547128|NCT00401375|565095053|FG002|Overall Study|Adverse Event|10|||
156547129|NCT00401375|565095051|FG000|Overall Study|Withdrawal by Subject|9|||
156547130|NCT00401375|565095052|FG001|Overall Study|Withdrawal by Subject|7|||
156385196|NCT04004611|564501089|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156385197|NCT04004611|564501090|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156506380|NCT01721954|564946866|FG000|Overall Study|Death|58|||
156506381|NCT01721954|564946867|FG001|Overall Study|Death|64|||
156506382|NCT01721954|564946866|FG000|Overall Study|Withdrawal by Subject|8|||
156506383|NCT01721954|564946867|FG001|Overall Study|Withdrawal by Subject|4|||
156506384|NCT01721954|564946866|FG000|Overall Study|Adverse Event|2|||
156506385|NCT01721954|564946867|FG001|Overall Study|Adverse Event|0|||
156506386|NCT01721954|564946866|FG000|Overall Study|Lost to Follow-up|2|||
156506387|NCT01721954|564946867|FG001|Overall Study|Lost to Follow-up|1|||
156506388|NCT01427725|564946868|FG000|Overall Study|Lost to Follow-up|17|||
156506389|NCT01427725|564946868|FG000|Overall Study|Protocol Violation|1|||
156506390|NCT01427725|564946868|FG000|Overall Study|Drug not administered|1|||
156506391|NCT01427725|564946868|FG000|Overall Study|Failure to visit|7|||
156506392|NCT01427725|564946868|FG000|Overall Study|Adverse Event|46|||
156506393|NCT01427725|564946868|FG000|Overall Study|Failure to visit after administration|40|||
156506394|NCT01427725|564946868|FG000|Overall Study|Patient's rejection|27|||
156506395|NCT01427725|564946868|FG000|Overall Study|Transfer to a different hospital|17|||
156506396|NCT01427725|564946868|FG000|Overall Study|Lack of Efficacy|8|||
156506397|NCT01427725|564946868|FG000|Overall Study|Death|7|||
156506398|NCT01427725|564946868|FG000|Overall Study|Symptom improvement|6|||
156506399|NCT01427725|564946868|FG000|Overall Study|AE and Patient's rejection|5|||
156506400|NCT01427725|564946868|FG000|Overall Study|Physician Decision|5|||
156506401|NCT01427725|564946868|FG000|Overall Study|Exacerbation of underlying disease|5|||
156506402|NCT01427725|564946868|FG000|Overall Study|Oral feeding difficulty|5|||
156506403|NCT01427725|564946868|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
156506404|NCT01427725|564946868|FG000|Overall Study|Forgetting prescription|1|||
156506405|NCT01427725|564946868|FG000|Overall Study|Other|2|||
156547131|NCT00401375|565095053|FG002|Overall Study|Withdrawal by Subject|7|||
156547132|NCT00401375|565095051|FG000|Overall Study|Lost to Follow-up|0|||
156547133|NCT00401375|565095052|FG001|Overall Study|Lost to Follow-up|1|||
156547134|NCT00401375|565095053|FG002|Overall Study|Lost to Follow-up|1|||
156547135|NCT00401375|565095051|FG000|Overall Study|Other than specified|2|||
156506406|NCT04230122|564946869|FG000|Overall Study|Lost to Follow-up|1|||
156506407|NCT04230122|564946870|FG001|Overall Study|Lost to Follow-up|0|||
156506408|NCT00760747|564946881|FG000|Study Period II|Adverse Event|3|||
156506409|NCT00760747|564946882|FG001|Study Period II|Adverse Event|4|||
156547136|NCT00401375|565095052|FG001|Overall Study|Other than specified|1|||
156547137|NCT00401375|565095053|FG002|Overall Study|Other than specified|3|||
156506410|NCT00760747|564946881|FG000|Study Period II|Lack of Efficacy|0|||
156506411|NCT00760747|564946882|FG001|Study Period II|Lack of Efficacy|6|||
156506412|NCT00760747|564946881|FG000|Study Period II|Parent/Caregiver Decision|3|||
156506413|NCT00760747|564946882|FG001|Study Period II|Parent/Caregiver Decision|0|||
156506414|NCT00760747|564946881|FG000|Study Period II|Protocol Violation|6|||
156506415|NCT00760747|564946882|FG001|Study Period II|Protocol Violation|3|||
156506416|NCT00760747|564946881|FG000|Study Period II|Withdrawal by Subject|1|||
156506417|NCT00760747|564946882|FG001|Study Period II|Withdrawal by Subject|0|||
156506418|NCT00760747|564946881|FG000|Study Period II|No drug administered|0|||
156506419|NCT00760747|564946882|FG001|Study Period II|No drug administered|1|||
156506420|NCT00760747|564946881|FG000|Study Period III|Adverse Event|1|||
156506421|NCT00760747|564946882|FG001|Study Period III|Adverse Event|0|||
156506422|NCT00760747|564946881|FG000|Study Period III|Lack of Efficacy|1|||
156506423|NCT00760747|564946882|FG001|Study Period III|Lack of Efficacy|0|||
156506424|NCT00760747|564946881|FG000|Study Period III|Parent/Caregiver Decision|0|||
156506425|NCT00760747|564946882|FG001|Study Period III|Parent/Caregiver Decision|1|||
156506426|NCT00760747|564946881|FG000|Study Period III|Protocol Violation|1|||
156506427|NCT00760747|564946882|FG001|Study Period III|Protocol Violation|1|||
156506428|NCT00760747|564946881|FG000|Study Period III|Physician Decision|0|||
156506429|NCT00760747|564946882|FG001|Study Period III|Physician Decision|1|||
156506430|NCT00108745|564946884|FG000|Overall Study|Withdrawal by Subject|19|||
156506431|NCT00108745|564946885|FG001|Overall Study|Withdrawal by Subject|12|||
156506432|NCT00108745|564946886|FG002|Overall Study|Withdrawal by Subject|12|||
156506433|NCT00108745|564946884|FG000|Overall Study|Never Treated|8|||
156506434|NCT00108745|564946885|FG001|Overall Study|Never Treated|10|||
156506435|NCT00108745|564946886|FG002|Overall Study|Never Treated|12|||
156506436|NCT00108745|564946884|FG000|Overall Study|Ineligible|7|||
156506437|NCT00108745|564946885|FG001|Overall Study|Ineligible|13|||
156506438|NCT00108745|564946886|FG002|Overall Study|Ineligible|13|||
156506439|NCT01228175|564946887|FG000|Overall Study|Lost to Follow-up|64|||
156506440|NCT01228175|564946888|FG001|Overall Study|Lost to Follow-up|50|||
156506441|NCT01228175|564946887|FG000|Overall Study|Withdrawal by Subject|1|||
156506442|NCT01228175|564946888|FG001|Overall Study|Withdrawal by Subject|2|||
156506443|NCT01228175|564946887|FG000|Overall Study|Physician Decision|1|||
156506444|NCT01228175|564946888|FG001|Overall Study|Physician Decision|1|||
156506445|NCT00402051|564946890|FG000|Overall Study|Progressive Disease|13|||
156506446|NCT00402051|564946891|FG001|Overall Study|Progressive Disease|20|||
156506447|NCT00402051|564946890|FG000|Overall Study|Adverse Event|11|||
156506448|NCT00402051|564946891|FG001|Overall Study|Adverse Event|4|||
156506449|NCT00402051|564946890|FG000|Overall Study|Physician Decision|7|||
156506450|NCT00402051|564946891|FG001|Overall Study|Physician Decision|3|||
156506451|NCT00402051|564946890|FG000|Overall Study|Withdrawal by Subject|3|||
156506452|NCT00402051|564946891|FG001|Overall Study|Withdrawal by Subject|3|||
156506453|NCT00402051|564946890|FG000|Overall Study|Death - Related to Study Drug|1|||
156506454|NCT00402051|564946891|FG001|Overall Study|Death - Related to Study Drug|2|||
156506455|NCT00402051|564946890|FG000|Overall Study|Death Due to Study Disease|2|||
156506456|NCT00402051|564946891|FG001|Overall Study|Death Due to Study Disease|1|||
156506457|NCT00402051|564946890|FG000|Overall Study|Death Due to Adverse Event|0|||
156506458|NCT00402051|564946891|FG001|Overall Study|Death Due to Adverse Event|2|||
156506459|NCT00402051|564946890|FG000|Overall Study|Lost to Follow-up|1|||
156506460|NCT00402051|564946891|FG001|Overall Study|Lost to Follow-up|0|||
156506461|NCT00277095|564946892|FG000|Overall Study|Death|2|||
156506462|NCT00277095|564946892|FG000|Overall Study|Explanted|7|||
156506463|NCT00277095|564946892|FG000|Overall Study|Lost to Follow-up|2|||
156506464|NCT00277095|564946892|FG000|Overall Study|Missed Follow-up|9|||
156506465|NCT00277095|564946892|FG000|Overall Study|Physician Decision|1|||
156506466|NCT05415748|564946896|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
156506467|NCT05415748|564946897|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
156506468|NCT05415748|564946898|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
156506469|NCT05415748|564946899|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
156506470|NCT05415748|564946896|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
156506471|NCT05415748|564946897|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
156506472|NCT05415748|564946898|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
156506473|NCT05415748|564946899|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
156506474|NCT03075527|564946900|FG000|Overall Study|Death|1|||
156506475|NCT03075527|564946900|FG000|Overall Study|Withdrawal by Subject|1|||
156506476|NCT03075527|564946900|FG000|Overall Study|Physician Decision|3|||
156506477|NCT03075527|564946900|FG000|Overall Study|Progression/Relapse|14|||
156506478|NCT01447576|564946901|FG000|Overall Study|Lost to Follow-up|52|||
156506479|NCT01447576|564946901|FG000|Overall Study|Adverse Event|127|||
156506480|NCT01447576|564946901|FG000|Overall Study|Participant met withdrawal criteria|40|||
156506481|NCT01447576|564946901|FG000|Overall Study|Withdrawal by Subject|100|||
156506482|NCT01447576|564946901|FG000|Overall Study|Protocol deviation|83|||
156506483|NCT01447576|564946901|FG000|Overall Study|Lack of Efficacy|68|||
156506484|NCT01447576|564946901|FG000|Overall Study|Physician Decision|6|||
156547138|NCT00401375|565095051|FG000|Overall Study|Randomized but not treated|3|||
156506485|NCT03128671|564946902|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
156506486|NCT03128671|564946903|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
156506487|NCT03128671|564946902|FG000|Allocation|Death|1|||
156506488|NCT03128671|564946903|FG001|Allocation|Death|0|||
156506489|NCT03128671|564946902|FG000|Allocation|Withdrawal by Subject|4|||
156506490|NCT03128671|564946903|FG001|Allocation|Withdrawal by Subject|0|||
156506491|NCT03128671|564946902|FG000|Intervention|Withdrawal by Subject|11|||
156506492|NCT03128671|564946903|FG001|Intervention|Withdrawal by Subject|10|||
156506493|NCT03128671|564946902|FG000|Intervention|Palliative/hospice care initiated|9|||
156506494|NCT03128671|564946903|FG001|Intervention|Palliative/hospice care initiated|10|||
156506495|NCT03128671|564946902|FG000|Intervention|Death|13|||
156506496|NCT03128671|564946903|FG001|Intervention|Death|11|||
156506497|NCT03128671|564946902|FG000|Intervention|Interrupted by hurricane|1|||
156506498|NCT03128671|564946903|FG001|Intervention|Interrupted by hurricane|0|||
156506499|NCT03128671|564946902|FG000|Intervention|Physician Decision|2|||
156506500|NCT03128671|564946903|FG001|Intervention|Physician Decision|3|||
156506501|NCT04463680|564946909|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
156506502|NCT04463680|564946909|FG000|Overall Study|Not eligible due to implant duration of use|1|||
156506503|NCT04463680|564946909|FG000|Overall Study|Withdrawal by Subject|3|||
156506504|NCT02592707|564946910|FG000|Overall Study|Consent Withdrawn|0|||
156506505|NCT02592707|564946911|FG001|Overall Study|Consent Withdrawn|1|||
156506506|NCT02592707|564946912|FG002|Overall Study|Consent Withdrawn|2|||
156506507|NCT02592707|564946913|FG003|Overall Study|Consent Withdrawn|0|||
156506508|NCT02592707|564946910|FG000|Overall Study|Death|1|||
156506509|NCT02592707|564946911|FG001|Overall Study|Death|0|||
156506510|NCT02592707|564946912|FG002|Overall Study|Death|0|||
156506511|NCT02592707|564946913|FG003|Overall Study|Death|0|||
156506512|NCT02592707|564946910|FG000|Overall Study|Progressive Disease|4|||
156506513|NCT02592707|564946911|FG001|Overall Study|Progressive Disease|4|||
156506514|NCT02592707|564946912|FG002|Overall Study|Progressive Disease|3|||
156506515|NCT02592707|564946913|FG003|Overall Study|Progressive Disease|3|||
156506516|NCT02592707|564946910|FG000|Overall Study|Other|0|||
156506517|NCT02592707|564946911|FG001|Overall Study|Other|0|||
156506518|NCT02592707|564946912|FG002|Overall Study|Other|1|||
156506519|NCT02592707|564946913|FG003|Overall Study|Other|2|||
156506520|NCT02592707|564946910|FG000|Overall Study|Never entered LTFU period|1|||
156506521|NCT02592707|564946911|FG001|Overall Study|Never entered LTFU period|0|||
156506522|NCT02592707|564946912|FG002|Overall Study|Never entered LTFU period|0|||
156506523|NCT02592707|564946913|FG003|Overall Study|Never entered LTFU period|2|||
156506524|NCT02998476|564946916|FG000|Overall Study|Lost to Follow-up|1|||
156506525|NCT02998476|564946917|FG001|Overall Study|Lost to Follow-up|0|||
156506526|NCT02998476|564946916|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
156506527|NCT02998476|564946917|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
156506528|NCT02998476|564946916|FG000|Overall Study|Withdrawal by Subject|1|||
156506529|NCT02998476|564946917|FG001|Overall Study|Withdrawal by Subject|2|||
156506530|NCT02998476|564946916|FG000|Overall Study|Death|45|||
156506531|NCT02998476|564946917|FG001|Overall Study|Death|2|||
156506532|NCT02998476|564946916|FG000|Overall Study|Other|6|||
156506533|NCT02998476|564946917|FG001|Overall Study|Other|1|||
156506534|NCT04855734|564946918|FG000|Overall Study|Lost to Follow-up|2|||
156506535|NCT04855734|564946919|FG001|Overall Study|Lost to Follow-up|2|||
156506536|NCT03832595|564946920|FG000|Overall Study|Death|142|||
156506537|NCT03832595|564946921|FG001|Overall Study|Death|130|||
156506538|NCT03832595|564946920|FG000|Overall Study|Medical management without dialysis|37|||
156506539|NCT03832595|564946921|FG001|Overall Study|Medical management without dialysis|1|||
156506540|NCT03277352|564946922|FG000|Overall Study|Study Terminated By Sponsor|2|||
156506541|NCT03277352|564946922|FG000|Overall Study|Withdrawal by Subject|4|||
156506542|NCT03277352|564946922|FG000|Overall Study|Death|4|||
156506543|NCT01681277|564948795|FG000|Overall Study|Adverse Event|1|||
156506544|NCT01681277|564948796|FG001|Overall Study|Adverse Event|0|||
156506545|NCT01681277|564948797|FG002|Overall Study|Adverse Event|0|||
156506546|NCT01681277|564948798|FG003|Overall Study|Adverse Event|0|||
156506547|NCT01681277|564948799|FG004|Overall Study|Adverse Event|0|||
156506548|NCT03838731|564948800|FG000|Overall Study|Pregnancy|0|||
156506549|NCT03838731|564948801|FG001|Overall Study|Pregnancy|1|||
156506550|NCT03838731|564948800|FG000|Overall Study|Withdrawal of consent|1|||
156506551|NCT03838731|564948801|FG001|Overall Study|Withdrawal of consent|0|||
156506552|NCT02271984|564948804|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506553|NCT02271984|564948805|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506554|NCT02271984|564948806|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506555|NCT02271984|564948807|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506556|NCT02271984|564948808|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506557|NCT02271984|564948809|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
156506558|NCT02271984|564948810|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506559|NCT02271984|564948811|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
156547139|NCT00401375|565095052|FG001|Overall Study|Randomized but not treated|3|||
156506560|NCT02271984|564948812|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506561|NCT02271984|564948813|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506562|NCT02271984|564948814|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156385198|NCT04004611|564501091|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156385199|NCT04004611|564501083|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156385200|NCT04004611|564501084|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
156385201|NCT04004611|564501085|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156385202|NCT04004611|564501086|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156385203|NCT04004611|564501087|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156385204|NCT04004611|564501088|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156385205|NCT04004611|564501089|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156385206|NCT04004611|564501090|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156385207|NCT04004611|564501091|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156385208|NCT03434119|564501092|FG000|Overall Study|Randomized but not treated|1|||
156385209|NCT03434119|564501093|FG001|Overall Study|Randomized but not treated|0|||
156385210|NCT03434119|564501092|FG000|Overall Study|Adverse Event|1|||
156385211|NCT03434119|564501093|FG001|Overall Study|Adverse Event|0|||
156385212|NCT03434119|564501092|FG000|Overall Study|Poor Compliance to Protocol|0|||
156385213|NCT03434119|564501093|FG001|Overall Study|Poor Compliance to Protocol|1|||
156385214|NCT03434119|564501092|FG000|Overall Study|Study Terminated by Sponsor|91|||
156385215|NCT03434119|564501093|FG001|Overall Study|Study Terminated by Sponsor|102|||
156385216|NCT03434119|564501092|FG000|Overall Study|Withdrawal by Subject|7|||
156385217|NCT03434119|564501093|FG001|Overall Study|Withdrawal by Subject|5|||
156385218|NCT03434119|564501092|FG000|Overall Study|Other than specified|7|||
156385219|NCT03434119|564501093|FG001|Overall Study|Other than specified|5|||
156385220|NCT04360824|564501094|FG000|Overall Study|Withdrawal by Subject|2|||
156385221|NCT04360824|564501095|FG001|Overall Study|Withdrawal by Subject|1|||
156385222|NCT04360824|564501094|FG000|Overall Study|Did not receive assigned treatment|1|||
156385223|NCT04360824|564501095|FG001|Overall Study|Did not receive assigned treatment|3|||
156385224|NCT00304070|564501096|FG000|Overall Study|Death|0|||
156385225|NCT00304070|564501097|FG001|Overall Study|Death|0|||
156385226|NCT00304070|564501098|FG002|Overall Study|Death|3|||
156385227|NCT00304070|564501096|FG000|Overall Study|Lost to Follow-up|0|||
156385228|NCT00304070|564501097|FG001|Overall Study|Lost to Follow-up|0|||
156385229|NCT00304070|564501098|FG002|Overall Study|Lost to Follow-up|1|||
156385230|NCT00304070|564501096|FG000|Overall Study|Physician Decision|0|||
156385231|NCT00304070|564501097|FG001|Overall Study|Physician Decision|0|||
156385232|NCT00304070|564501098|FG002|Overall Study|Physician Decision|3|||
156385233|NCT00304070|564501096|FG000|Overall Study|Withdrawal by Subject|0|||
156385234|NCT00304070|564501097|FG001|Overall Study|Withdrawal by Subject|0|||
156385235|NCT00304070|564501098|FG002|Overall Study|Withdrawal by Subject|1|||
156385236|NCT00304070|564501096|FG000|Overall Study|Progressive Disease|3|||
156385237|NCT00304070|564501097|FG001|Overall Study|Progressive Disease|7|||
156385238|NCT00304070|564501098|FG002|Overall Study|Progressive Disease|4|||
156385239|NCT00320216|564501099|FG000|Overall Study|Adverse Event|0|||
156385240|NCT00320216|564501100|FG001|Overall Study|Adverse Event|6|||
156385241|NCT00320216|564501101|FG002|Overall Study|Adverse Event|0|||
156385242|NCT00320216|564501102|FG003|Overall Study|Adverse Event|2|||
156385243|NCT00320216|564501103|FG004|Overall Study|Adverse Event|2|||
156385244|NCT00320216|564501099|FG000|Overall Study|Lack of Efficacy|6|||
156385245|NCT00320216|564501100|FG001|Overall Study|Lack of Efficacy|2|||
156385246|NCT00320216|564501101|FG002|Overall Study|Lack of Efficacy|1|||
156385247|NCT00320216|564501102|FG003|Overall Study|Lack of Efficacy|0|||
156385248|NCT00320216|564501103|FG004|Overall Study|Lack of Efficacy|1|||
156385249|NCT00320216|564501099|FG000|Overall Study|Lost to Follow-up|3|||
156385250|NCT00320216|564501100|FG001|Overall Study|Lost to Follow-up|0|||
156385251|NCT00320216|564501101|FG002|Overall Study|Lost to Follow-up|0|||
156506563|NCT02271984|564948815|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156506564|NCT01088984|564948816|FG000|Phase 1|Death|2|||
156506565|NCT01088984|564948817|FG001|Phase 1|Death|1|||
156506566|NCT01088984|564948816|FG000|Phase 1|Disease Progression|2|||
156385252|NCT00320216|564501102|FG003|Overall Study|Lost to Follow-up|0|||
156385253|NCT00320216|564501103|FG004|Overall Study|Lost to Follow-up|0|||
156385254|NCT00320216|564501099|FG000|Overall Study|Other|7|||
156385255|NCT00320216|564501100|FG001|Overall Study|Other|2|||
156385256|NCT00320216|564501101|FG002|Overall Study|Other|5|||
156385257|NCT00320216|564501102|FG003|Overall Study|Other|1|||
156385258|NCT00320216|564501103|FG004|Overall Study|Other|3|||
156385259|NCT00779246|564501112|FG000|Overall Study|Missing sufficient data for analysis|33|||
156385260|NCT00779246|564501113|FG001|Overall Study|Missing sufficient data for analysis|53|||
156385261|NCT03579459|564501114|FG000|Overall Study|Adverse Event|7|||
156385262|NCT03579459|564501115|FG001|Overall Study|Adverse Event|6|||
156385263|NCT03579459|564501116|FG002|Overall Study|Adverse Event|2|||
156385264|NCT03579459|564501117|FG003|Overall Study|Adverse Event|6|||
156385265|NCT03579459|564501114|FG000|Overall Study|Death|1|||
156385266|NCT03579459|564501115|FG001|Overall Study|Death|0|||
156385267|NCT03579459|564501116|FG002|Overall Study|Death|1|||
156385268|NCT03579459|564501117|FG003|Overall Study|Death|2|||
156506567|NCT01088984|564948817|FG001|Phase 1|Disease Progression|4|||
156506568|NCT01088984|564948816|FG000|Phase 1|Other|1|||
156506569|NCT01088984|564948817|FG001|Phase 1|Other|1|||
156506570|NCT01088984|564948816|FG000|Phase 2|Death|0|||
156506571|NCT01088984|564948817|FG001|Phase 2|Death|5|||
156506572|NCT01088984|564948816|FG000|Phase 2|Withdrawal by Subject|0|||
156506573|NCT01088984|564948817|FG001|Phase 2|Withdrawal by Subject|1|||
156506574|NCT01088984|564948816|FG000|Phase 2|DIsease Progression|0|||
156506575|NCT01088984|564948817|FG001|Phase 2|DIsease Progression|25|||
156506576|NCT01088984|564948816|FG000|Phase 2|Other|0|||
156506577|NCT01088984|564948817|FG001|Phase 2|Other|1|||
156506578|NCT01228318|564948818|FG000|Overall Study|Clinic no show to receive intervention|1|||
156506579|NCT01228318|564948819|FG001|Overall Study|Clinic no show to receive intervention|0|||
156506580|NCT01228318|564948818|FG000|Overall Study|Unable to contact|2|||
156506581|NCT01228318|564948819|FG001|Overall Study|Unable to contact|5|||
156506582|NCT01228318|564948818|FG000|Overall Study|Moved|0|||
156506583|NCT01228318|564948819|FG001|Overall Study|Moved|2|||
156506584|NCT01228318|564948818|FG000|Overall Study|Incarcerated|1|||
156506585|NCT01228318|564948819|FG001|Overall Study|Incarcerated|0|||
156506586|NCT00770029|564948824|FG000|Overall Study|Lost to Follow-up|2|||
156506587|NCT00770029|564948825|FG001|Overall Study|Lost to Follow-up|0|||
156506588|NCT00770029|564948824|FG000|Overall Study|Withdrawal by Subject|3|||
156506589|NCT00770029|564948825|FG001|Overall Study|Withdrawal by Subject|3|||
156506590|NCT00770029|564948824|FG000|Overall Study|Adverse Event|1|||
156506591|NCT00770029|564948825|FG001|Overall Study|Adverse Event|0|||
156506592|NCT03480932|564948826|FG000|Overall Study|Death|1|||
156506593|NCT03480932|564948827|FG001|Overall Study|Death|1|||
156506594|NCT03480932|564948828|FG002|Overall Study|Death|0|||
156506595|NCT03480932|564948826|FG000|Overall Study|Lost to Follow-up|0|||
156506596|NCT03480932|564948827|FG001|Overall Study|Lost to Follow-up|2|||
156506597|NCT03480932|564948828|FG002|Overall Study|Lost to Follow-up|3|||
156506598|NCT03480932|564948826|FG000|Overall Study|Incarcerated|2|||
156506599|NCT03480932|564948827|FG001|Overall Study|Incarcerated|2|||
156506600|NCT03480932|564948828|FG002|Overall Study|Incarcerated|2|||
156506601|NCT03412773|564948831|FG000|Overall Study|Lost to Follow-up|0|||
156506602|NCT03412773|564948832|FG001|Overall Study|Lost to Follow-up|7|||
156506603|NCT03412773|564948833|FG002|Overall Study|Lost to Follow-up|6|||
156506604|NCT03412773|564948831|FG000|Overall Study|Withdrawal by Subject|0|||
156506605|NCT03412773|564948832|FG001|Overall Study|Withdrawal by Subject|15|||
156506606|NCT03412773|564948833|FG002|Overall Study|Withdrawal by Subject|19|||
156506607|NCT03412773|564948831|FG000|Overall Study|Study Closed By Sponsor|3|||
156506608|NCT03412773|564948832|FG001|Overall Study|Study Closed By Sponsor|46|||
156506609|NCT03412773|564948833|FG002|Overall Study|Study Closed By Sponsor|33|||
156506610|NCT03412773|564948831|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
156506611|NCT03412773|564948832|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
156506612|NCT03412773|564948833|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
156506613|NCT03412773|564948831|FG000|Overall Study|Death|7|||
156506614|NCT03412773|564948832|FG001|Overall Study|Death|259|||
156506615|NCT03412773|564948833|FG002|Overall Study|Death|273|||
156506616|NCT03412773|564948831|FG000|Overall Study|Physician Decision|0|||
156506617|NCT03412773|564948832|FG001|Overall Study|Physician Decision|0|||
156506618|NCT03412773|564948833|FG002|Overall Study|Physician Decision|1|||
156506619|NCT03057847|564948836|FG000|Overall Study|Lost to Follow-up|16|||
156506620|NCT02138786|564948840|FG000|Overall Study|Adverse Event|0|||
156506621|NCT02138786|564948841|FG001|Overall Study|Adverse Event|2|||
156506622|NCT02138786|564948842|FG002|Overall Study|Adverse Event|1|||
156506623|NCT02138786|564948840|FG000|Overall Study|Death|1|||
156506624|NCT02138786|564948841|FG001|Overall Study|Death|7|||
156506625|NCT02138786|564948842|FG002|Overall Study|Death|2|||
156506626|NCT02138786|564948840|FG000|Overall Study|Disease Progression|1|||
156506627|NCT02138786|564948841|FG001|Overall Study|Disease Progression|1|||
156506628|NCT02138786|564948842|FG002|Overall Study|Disease Progression|3|||
156506629|NCT02138786|564948840|FG000|Overall Study|Withdrawal by Subject|1|||
156506630|NCT02138786|564948841|FG001|Overall Study|Withdrawal by Subject|2|||
156506631|NCT02138786|564948842|FG002|Overall Study|Withdrawal by Subject|0|||
156506632|NCT02138786|564948840|FG000|Overall Study|Patient's Wish|0|||
156506633|NCT02138786|564948841|FG001|Overall Study|Patient's Wish|2|||
156506634|NCT02138786|564948842|FG002|Overall Study|Patient's Wish|0|||
156506635|NCT02138786|564948840|FG000|Overall Study|Sponsor Terminated Study|0|||
156506636|NCT02138786|564948841|FG001|Overall Study|Sponsor Terminated Study|1|||
156506637|NCT02138786|564948842|FG002|Overall Study|Sponsor Terminated Study|1|||
156506638|NCT02138786|564948840|FG000|Overall Study|Non-Compliance|0|||
156506639|NCT02138786|564948841|FG001|Overall Study|Non-Compliance|0|||
156506640|NCT02138786|564948842|FG002|Overall Study|Non-Compliance|1|||
156506641|NCT02088957|564948843|FG000|Overall Study|Lack of Efficacy|1|||
156506642|NCT02088957|564948844|FG001|Overall Study|Lack of Efficacy|0|||
156506643|NCT00426127|564948848|FG000|Overall Study|Adverse Event|1|||
156506644|NCT00426127|564948848|FG000|Overall Study|Removed due to disease progression|1|||
156506645|NCT03111095|564948851|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
156506646|NCT03111095|564948852|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
156506647|NCT03111095|564948851|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
156547140|NCT00401375|565095053|FG002|Overall Study|Randomized but not treated|3|||
156547141|NCT01883635|565095057|FG000|Overall Study|Withdrawal by Subject|4|||
156547142|NCT01883635|565095058|FG001|Overall Study|Withdrawal by Subject|0|||
156547143|NCT01187953|565095059|FG000|Overall Study|Death|11|||
156547144|NCT01187953|565095060|FG001|Overall Study|Death|13|||
156547145|NCT01187953|565095059|FG000|Overall Study|Adverse Event|1|||
156547146|NCT01187953|565095060|FG001|Overall Study|Adverse Event|2|||
156547147|NCT01187953|565095059|FG000|Overall Study|Lost to Follow-up|0|||
156547148|NCT01187953|565095060|FG001|Overall Study|Lost to Follow-up|3|||
156547149|NCT01187953|565095059|FG000|Overall Study|Withdrawal by Subject|3|||
156547150|NCT01187953|565095060|FG001|Overall Study|Withdrawal by Subject|3|||
156547151|NCT01464307|565095061|FG000|Main Period|Death|0|||
156547152|NCT01464307|565095062|FG001|Main Period|Death|1|||
156547153|NCT01464307|565095061|FG000|Main Period|Adverse Event|6|||
156547154|NCT01464307|565095062|FG001|Main Period|Adverse Event|1|||
156547155|NCT01464307|565095061|FG000|Main Period|Lack of Efficacy|2|||
156547156|NCT01464307|565095062|FG001|Main Period|Lack of Efficacy|0|||
156547157|NCT01464307|565095061|FG000|Main Period|Withdrawal by Subject|5|||
156547158|NCT01464307|565095062|FG001|Main Period|Withdrawal by Subject|2|||
156547159|NCT01464307|565095061|FG000|Main Period|Predefined discontinuation criteria|2|||
156547160|NCT01464307|565095062|FG001|Main Period|Predefined discontinuation criteria|1|||
156547161|NCT01464307|565095061|FG000|Open-Label Extension Period|Adverse Event|15|||
156547162|NCT01464307|565095062|FG001|Open-Label Extension Period|Adverse Event|0|||
156547163|NCT01464307|565095061|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
156547164|NCT01464307|565095062|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
156547165|NCT01464307|565095061|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
156547166|NCT01464307|565095062|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
156547167|NCT01464307|565095061|FG000|Open-Label Extension Period|Death|1|||
156547168|NCT01464307|565095062|FG001|Open-Label Extension Period|Death|0|||
156547169|NCT01464307|565095061|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
156547170|NCT01464307|565095062|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
156547171|NCT01464307|565095061|FG000|Open-Label Extension Period|Non-compliance|9|||
156547172|NCT01464307|565095062|FG001|Open-Label Extension Period|Non-compliance|0|||
156547173|NCT01464307|565095061|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
156547174|NCT01464307|565095062|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
156547175|NCT00761514|565095065|FG000|Overall Study|Adverse Event|1|||
156547176|NCT00761514|565095065|FG000|Overall Study|Withdrawal by Subject|2|||
156547177|NCT00761514|565095065|FG000|Overall Study|Lost to Follow-up|1|||
156547178|NCT00761514|565095065|FG000|Overall Study|Health insurance didn't cover study drug|1|||
156547179|NCT00761514|565095065|FG000|Overall Study|Problem complying with study visit|1|||
156547180|NCT00761514|565095065|FG000|Overall Study|Unable to pay for medications|1|||
156547181|NCT00894556|565095066|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
156547182|NCT00894556|565095067|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
156547183|NCT00894556|565095068|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
156547184|NCT00894556|565095069|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
156547185|NCT00894556|565095066|FG000|Treatment Phase|Lost to Follow-up|2|||
156547186|NCT00894556|565095067|FG001|Treatment Phase|Lost to Follow-up|3|||
156547187|NCT00894556|565095068|FG002|Treatment Phase|Lost to Follow-up|1|||
156547188|NCT00894556|565095069|FG003|Treatment Phase|Lost to Follow-up|0|||
156547189|NCT00894556|565095066|FG000|Treatment Phase|Lack of Qualifying Event|2|||
156547190|NCT00894556|565095067|FG001|Treatment Phase|Lack of Qualifying Event|1|||
156547191|NCT00894556|565095068|FG002|Treatment Phase|Lack of Qualifying Event|0|||
156547192|NCT00894556|565095069|FG003|Treatment Phase|Lack of Qualifying Event|0|||
156547193|NCT05054114|565095070|FG000|Overall Study|Protocol Violation|13|||
156547194|NCT05054114|565095071|FG001|Overall Study|Protocol Violation|1|||
156547195|NCT05054114|565095070|FG000|Overall Study|Pregnancy|0|||
156547196|NCT05054114|565095071|FG001|Overall Study|Pregnancy|1|||
156547197|NCT01806779|565095072|FG000|Overall Study|Physician Decision|2|||
156547198|NCT01806779|565095073|FG001|Overall Study|Physician Decision|0|||
156385269|NCT03579459|564501114|FG000|Overall Study|Lost to Follow-up|6|||
156385270|NCT03579459|564501115|FG001|Overall Study|Lost to Follow-up|2|||
156385271|NCT03579459|564501116|FG002|Overall Study|Lost to Follow-up|4|||
156385272|NCT03579459|564501117|FG003|Overall Study|Lost to Follow-up|1|||
156385273|NCT03579459|564501114|FG000|Overall Study|Physician Decision|0|||
156385274|NCT03579459|564501115|FG001|Overall Study|Physician Decision|1|||
156547199|NCT01806779|565095074|FG002|Overall Study|Physician Decision|1|||
156547200|NCT01806779|565095072|FG000|Overall Study|Lack of Efficacy|1|||
156547201|NCT01806779|565095073|FG001|Overall Study|Lack of Efficacy|1|||
156547202|NCT01806779|565095074|FG002|Overall Study|Lack of Efficacy|0|||
156547203|NCT01806779|565095072|FG000|Overall Study|Lost to Follow-up|19|||
156547204|NCT01806779|565095073|FG001|Overall Study|Lost to Follow-up|20|||
156385275|NCT03579459|564501116|FG002|Overall Study|Physician Decision|0|||
156385276|NCT03579459|564501117|FG003|Overall Study|Physician Decision|1|||
156547205|NCT01806779|565095074|FG002|Overall Study|Lost to Follow-up|0|||
156547206|NCT01806779|565095072|FG000|Overall Study|Withdrawal by Subject|20|||
156547207|NCT01806779|565095073|FG001|Overall Study|Withdrawal by Subject|23|||
156547208|NCT01806779|565095074|FG002|Overall Study|Withdrawal by Subject|22|||
156506648|NCT03111095|564948852|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
156506649|NCT01016262|564948859|FG000|Double-blind Phase|Adverse Event|0|||
156506650|NCT01016262|564948860|FG001|Double-blind Phase|Adverse Event|0|||
156506651|NCT01016262|564948861|FG002|Double-blind Phase|Adverse Event|1|||
156506652|NCT01016262|564948862|FG003|Double-blind Phase|Adverse Event|0|||
156506653|NCT01016262|564948863|FG004|Double-blind Phase|Adverse Event|0|||
156506654|NCT01016262|564948864|FG005|Double-blind Phase|Adverse Event|0|||
156506655|NCT01016262|564948859|FG000|Double-blind Phase|Lack of Efficacy|1|||
156506656|NCT01016262|564948860|FG001|Double-blind Phase|Lack of Efficacy|0|||
156506657|NCT01016262|564948861|FG002|Double-blind Phase|Lack of Efficacy|5|||
156506658|NCT01016262|564948862|FG003|Double-blind Phase|Lack of Efficacy|0|||
156506659|NCT01016262|564948863|FG004|Double-blind Phase|Lack of Efficacy|0|||
156506660|NCT01016262|564948864|FG005|Double-blind Phase|Lack of Efficacy|0|||
156506661|NCT01016262|564948859|FG000|Double-blind Phase|Disease Progression|0|||
156506662|NCT01016262|564948860|FG001|Double-blind Phase|Disease Progression|1|||
156506663|NCT01016262|564948861|FG002|Double-blind Phase|Disease Progression|2|||
156506664|NCT01016262|564948862|FG003|Double-blind Phase|Disease Progression|0|||
156506665|NCT01016262|564948863|FG004|Double-blind Phase|Disease Progression|0|||
156506666|NCT01016262|564948864|FG005|Double-blind Phase|Disease Progression|0|||
156506667|NCT01016262|564948859|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
156506668|NCT01016262|564948860|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
156506669|NCT01016262|564948861|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
156506670|NCT01016262|564948862|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
156506671|NCT01016262|564948863|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
156506672|NCT01016262|564948864|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
156506673|NCT01016262|564948859|FG000|Open-Label Phase|Adverse Event|0|||
156506674|NCT01016262|564948860|FG001|Open-Label Phase|Adverse Event|0|||
156506675|NCT01016262|564948861|FG002|Open-Label Phase|Adverse Event|0|||
156506676|NCT01016262|564948862|FG003|Open-Label Phase|Adverse Event|1|||
156506677|NCT01016262|564948863|FG004|Open-Label Phase|Adverse Event|0|||
156506678|NCT01016262|564948864|FG005|Open-Label Phase|Adverse Event|0|||
156506679|NCT01016262|564948859|FG000|Open-Label Phase|Lost to Follow-up|0|||
156506680|NCT01016262|564948860|FG001|Open-Label Phase|Lost to Follow-up|0|||
156506681|NCT01016262|564948861|FG002|Open-Label Phase|Lost to Follow-up|0|||
156506682|NCT01016262|564948862|FG003|Open-Label Phase|Lost to Follow-up|0|||
156506683|NCT01016262|564948863|FG004|Open-Label Phase|Lost to Follow-up|1|||
156506684|NCT01016262|564948864|FG005|Open-Label Phase|Lost to Follow-up|0|||
156506685|NCT01016262|564948859|FG000|Open-Label Phase|Lack of Efficacy|0|||
156506686|NCT01016262|564948860|FG001|Open-Label Phase|Lack of Efficacy|0|||
156506687|NCT01016262|564948861|FG002|Open-Label Phase|Lack of Efficacy|0|||
156506688|NCT01016262|564948862|FG003|Open-Label Phase|Lack of Efficacy|1|||
156506689|NCT01016262|564948863|FG004|Open-Label Phase|Lack of Efficacy|0|||
156506690|NCT01016262|564948864|FG005|Open-Label Phase|Lack of Efficacy|0|||
156506691|NCT01016262|564948859|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
156506692|NCT01016262|564948860|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
156506693|NCT01016262|564948861|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
156506694|NCT01016262|564948862|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
156506695|NCT01016262|564948863|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
156506696|NCT01016262|564948864|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
156506697|NCT03738475|564948866|FG000|Overall Study|Participant Non-Compliance|1|||
156506698|NCT03738475|564948867|FG001|Overall Study|Participant Non-Compliance|0|||
156506699|NCT00677534|564948868|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
156506700|NCT00677534|564948868|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
156506701|NCT00677534|564948868|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
156506702|NCT01730378|564948869|FG000|Overall Study|Lost to Follow-up|1|||
156506703|NCT01730378|564948870|FG001|Overall Study|Lost to Follow-up|0|||
156506704|NCT02687035|564948871|FG000|Overall Study|Withdrawal by Subject|1|||
156506705|NCT02687035|564948871|FG000|Overall Study|Death|87|||
156506706|NCT02687035|564948871|FG000|Overall Study|Lost to Follow-up|1|||
156506707|NCT02687035|564948871|FG000|Overall Study|Missed Visit|87|||
156506708|NCT02687035|564948871|FG000|Overall Study|Did not receive Study Device|8|||
156506709|NCT05000216|564948873|FG000|Stage 1|Lost to Follow-up|0|||
156506710|NCT05000216|564948874|FG001|Stage 1|Lost to Follow-up|0|||
156506711|NCT05000216|564948875|FG002|Stage 1|Lost to Follow-up|0|||
156506712|NCT05000216|564948876|FG003|Stage 1|Lost to Follow-up|0|||
156506713|NCT05000216|564948877|FG004|Stage 1|Lost to Follow-up|0|||
156506714|NCT05000216|564948878|FG005|Stage 1|Lost to Follow-up|0|||
156506715|NCT05000216|564948879|FG006|Stage 1|Lost to Follow-up|1|||
156506716|NCT05000216|564948880|FG007|Stage 1|Lost to Follow-up|1|||
156506717|NCT05000216|564948881|FG008|Stage 1|Lost to Follow-up|0|||
156506718|NCT05000216|564948882|FG009|Stage 1|Lost to Follow-up|2|||
156506719|NCT05000216|564948883|FG010|Stage 1|Lost to Follow-up|3|||
156506720|NCT05000216|564948884|FG011|Stage 1|Lost to Follow-up|0|||
156506721|NCT05000216|564948885|FG012|Stage 1|Lost to Follow-up|0|||
156506722|NCT05000216|564948886|FG013|Stage 1|Lost to Follow-up|0|||
156506723|NCT05000216|564948887|FG014|Stage 1|Lost to Follow-up|0|||
156506724|NCT05000216|564948888|FG015|Stage 1|Lost to Follow-up|0|||
156506725|NCT05000216|564948889|FG016|Stage 1|Lost to Follow-up|0|||
156506726|NCT05000216|564948890|FG017|Stage 1|Lost to Follow-up|0|||
156506727|NCT05000216|564948891|FG018|Stage 1|Lost to Follow-up|0|||
156506728|NCT05000216|564948892|FG019|Stage 1|Lost to Follow-up|0|||
156506729|NCT05000216|564948893|FG020|Stage 1|Lost to Follow-up|0|||
156506730|NCT05000216|564948894|FG021|Stage 1|Lost to Follow-up|0|||
156506731|NCT05000216|564948873|FG000|Stage 1|Physician Decision|0|||
156506732|NCT05000216|564948874|FG001|Stage 1|Physician Decision|0|||
156506733|NCT05000216|564948875|FG002|Stage 1|Physician Decision|0|||
156506734|NCT05000216|564948876|FG003|Stage 1|Physician Decision|0|||
156506735|NCT05000216|564948877|FG004|Stage 1|Physician Decision|0|||
156506736|NCT05000216|564948878|FG005|Stage 1|Physician Decision|0|||
156506737|NCT05000216|564948879|FG006|Stage 1|Physician Decision|0|||
156506738|NCT05000216|564948880|FG007|Stage 1|Physician Decision|1|||
156506739|NCT05000216|564948881|FG008|Stage 1|Physician Decision|1|||
156506740|NCT05000216|564948882|FG009|Stage 1|Physician Decision|0|||
156506741|NCT05000216|564948883|FG010|Stage 1|Physician Decision|0|||
156506742|NCT05000216|564948884|FG011|Stage 1|Physician Decision|0|||
156506743|NCT05000216|564948885|FG012|Stage 1|Physician Decision|0|||
156506744|NCT05000216|564948886|FG013|Stage 1|Physician Decision|0|||
156506745|NCT05000216|564948887|FG014|Stage 1|Physician Decision|0|||
156506746|NCT05000216|564948888|FG015|Stage 1|Physician Decision|0|||
156506747|NCT05000216|564948889|FG016|Stage 1|Physician Decision|0|||
156506748|NCT05000216|564948890|FG017|Stage 1|Physician Decision|0|||
156506749|NCT05000216|564948891|FG018|Stage 1|Physician Decision|0|||
156506750|NCT05000216|564948892|FG019|Stage 1|Physician Decision|0|||
156506751|NCT05000216|564948893|FG020|Stage 1|Physician Decision|0|||
156506752|NCT05000216|564948894|FG021|Stage 1|Physician Decision|0|||
156506753|NCT05000216|564948873|FG000|Stage 1|Withdrawal by Subject|0|||
156506754|NCT05000216|564948874|FG001|Stage 1|Withdrawal by Subject|1|||
156506755|NCT05000216|564948875|FG002|Stage 1|Withdrawal by Subject|0|||
156506756|NCT05000216|564948876|FG003|Stage 1|Withdrawal by Subject|0|||
156506757|NCT05000216|564948877|FG004|Stage 1|Withdrawal by Subject|0|||
156506758|NCT05000216|564948878|FG005|Stage 1|Withdrawal by Subject|0|||
156506759|NCT05000216|564948879|FG006|Stage 1|Withdrawal by Subject|0|||
156506760|NCT05000216|564948880|FG007|Stage 1|Withdrawal by Subject|0|||
156506761|NCT05000216|564948881|FG008|Stage 1|Withdrawal by Subject|0|||
156506762|NCT05000216|564948882|FG009|Stage 1|Withdrawal by Subject|3|||
156506763|NCT05000216|564948883|FG010|Stage 1|Withdrawal by Subject|10|||
156506764|NCT05000216|564948884|FG011|Stage 1|Withdrawal by Subject|0|||
156506765|NCT05000216|564948885|FG012|Stage 1|Withdrawal by Subject|0|||
156506766|NCT05000216|564948886|FG013|Stage 1|Withdrawal by Subject|0|||
156506767|NCT05000216|564948887|FG014|Stage 1|Withdrawal by Subject|0|||
156506768|NCT05000216|564948888|FG015|Stage 1|Withdrawal by Subject|0|||
156506769|NCT05000216|564948889|FG016|Stage 1|Withdrawal by Subject|0|||
156506770|NCT05000216|564948890|FG017|Stage 1|Withdrawal by Subject|0|||
156506771|NCT05000216|564948891|FG018|Stage 1|Withdrawal by Subject|0|||
156506772|NCT05000216|564948892|FG019|Stage 1|Withdrawal by Subject|0|||
156506773|NCT05000216|564948893|FG020|Stage 1|Withdrawal by Subject|0|||
156506774|NCT05000216|564948894|FG021|Stage 1|Withdrawal by Subject|0|||
156506775|NCT05000216|564948873|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
156506776|NCT05000216|564948874|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
156506777|NCT05000216|564948875|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
156506778|NCT05000216|564948876|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
156506779|NCT05000216|564948877|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
156506780|NCT05000216|564948878|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
156506781|NCT05000216|564948879|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
156506782|NCT05000216|564948880|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
156506783|NCT05000216|564948881|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
156506784|NCT05000216|564948882|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
156506785|NCT05000216|564948883|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
156506786|NCT05000216|564948884|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
156506787|NCT05000216|564948885|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
156506788|NCT05000216|564948886|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
156506789|NCT05000216|564948887|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
156506790|NCT05000216|564948888|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
156506791|NCT05000216|564948889|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
156506792|NCT05000216|564948890|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
156506793|NCT05000216|564948891|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
156506794|NCT05000216|564948892|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
156506795|NCT05000216|564948893|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
156506796|NCT05000216|564948894|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
156506797|NCT05000216|564948873|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156547209|NCT04294901|565095075|FG000|Overall Study|Death|86|||
156385277|NCT03579459|564501114|FG000|Overall Study|Protocol Violation|1|||
156506798|NCT05000216|564948874|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156385278|NCT03579459|564501115|FG001|Overall Study|Protocol Violation|2|||
156506799|NCT05000216|564948875|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506800|NCT05000216|564948876|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506801|NCT05000216|564948877|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506802|NCT05000216|564948878|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506803|NCT05000216|564948879|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506804|NCT05000216|564948880|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506805|NCT05000216|564948881|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
156506806|NCT05000216|564948882|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506807|NCT05000216|564948883|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506808|NCT05000216|564948884|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506809|NCT05000216|564948885|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506810|NCT05000216|564948886|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506811|NCT05000216|564948887|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506812|NCT05000216|564948888|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506813|NCT05000216|564948889|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506814|NCT05000216|564948890|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506815|NCT05000216|564948891|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506816|NCT05000216|564948892|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506817|NCT05000216|564948893|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506818|NCT05000216|564948894|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
156506819|NCT05000216|564948873|FG000|Stage 1|Other|0|||
156506820|NCT05000216|564948874|FG001|Stage 1|Other|0|||
156506821|NCT05000216|564948875|FG002|Stage 1|Other|0|||
156506822|NCT05000216|564948876|FG003|Stage 1|Other|0|||
156506823|NCT05000216|564948877|FG004|Stage 1|Other|1|||
156506824|NCT05000216|564948878|FG005|Stage 1|Other|0|||
156506825|NCT05000216|564948879|FG006|Stage 1|Other|0|||
156506826|NCT05000216|564948880|FG007|Stage 1|Other|2|||
156506827|NCT05000216|564948881|FG008|Stage 1|Other|0|||
156506828|NCT05000216|564948882|FG009|Stage 1|Other|0|||
156506829|NCT05000216|564948883|FG010|Stage 1|Other|1|||
156506830|NCT05000216|564948884|FG011|Stage 1|Other|1|||
156506831|NCT05000216|564948885|FG012|Stage 1|Other|0|||
156506832|NCT05000216|564948886|FG013|Stage 1|Other|0|||
156506833|NCT05000216|564948887|FG014|Stage 1|Other|0|||
156506834|NCT05000216|564948888|FG015|Stage 1|Other|0|||
156506835|NCT05000216|564948889|FG016|Stage 1|Other|0|||
156506836|NCT05000216|564948890|FG017|Stage 1|Other|0|||
156506837|NCT05000216|564948891|FG018|Stage 1|Other|0|||
156506838|NCT05000216|564948892|FG019|Stage 1|Other|0|||
156506839|NCT05000216|564948893|FG020|Stage 1|Other|0|||
156506840|NCT05000216|564948894|FG021|Stage 1|Other|0|||
156506841|NCT05000216|564948873|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
156506842|NCT05000216|564948874|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
156506843|NCT05000216|564948875|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
156506844|NCT05000216|564948876|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
156506845|NCT05000216|564948877|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
156506846|NCT05000216|564948878|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
156506847|NCT05000216|564948879|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
156506848|NCT05000216|564948880|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
156506849|NCT05000216|564948881|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
156506850|NCT05000216|564948882|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
156506851|NCT05000216|564948883|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
156506852|NCT05000216|564948884|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
156506853|NCT05000216|564948885|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
156506854|NCT05000216|564948886|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
156506855|NCT05000216|564948887|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
156385279|NCT03579459|564501116|FG002|Overall Study|Protocol Violation|3|||
156506856|NCT05000216|564948888|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
156506857|NCT05000216|564948889|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
156506858|NCT05000216|564948890|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
156506859|NCT05000216|564948891|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
156506860|NCT05000216|564948892|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
156506861|NCT05000216|564948893|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
156506862|NCT05000216|564948894|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
156506863|NCT05000216|564948873|FG000|Stage 2|Lost to Follow-up|0|||
156506864|NCT05000216|564948874|FG001|Stage 2|Lost to Follow-up|0|||
156506865|NCT05000216|564948875|FG002|Stage 2|Lost to Follow-up|0|||
156506866|NCT05000216|564948876|FG003|Stage 2|Lost to Follow-up|0|||
156506867|NCT05000216|564948877|FG004|Stage 2|Lost to Follow-up|0|||
156506868|NCT05000216|564948878|FG005|Stage 2|Lost to Follow-up|0|||
156506869|NCT05000216|564948879|FG006|Stage 2|Lost to Follow-up|0|||
156506870|NCT05000216|564948880|FG007|Stage 2|Lost to Follow-up|0|||
156506871|NCT05000216|564948881|FG008|Stage 2|Lost to Follow-up|0|||
156506872|NCT05000216|564948882|FG009|Stage 2|Lost to Follow-up|0|||
156506873|NCT05000216|564948883|FG010|Stage 2|Lost to Follow-up|0|||
156506874|NCT05000216|564948884|FG011|Stage 2|Lost to Follow-up|0|||
156506875|NCT05000216|564948885|FG012|Stage 2|Lost to Follow-up|0|||
156506876|NCT05000216|564948886|FG013|Stage 2|Lost to Follow-up|0|||
156506877|NCT05000216|564948887|FG014|Stage 2|Lost to Follow-up|0|||
156506878|NCT05000216|564948888|FG015|Stage 2|Lost to Follow-up|0|||
156506879|NCT05000216|564948889|FG016|Stage 2|Lost to Follow-up|4|||
156506880|NCT05000216|564948890|FG017|Stage 2|Lost to Follow-up|0|||
156385280|NCT03579459|564501117|FG003|Overall Study|Protocol Violation|5|||
156506881|NCT05000216|564948891|FG018|Stage 2|Lost to Follow-up|0|||
156506882|NCT05000216|564948892|FG019|Stage 2|Lost to Follow-up|0|||
156506883|NCT05000216|564948893|FG020|Stage 2|Lost to Follow-up|0|||
156506884|NCT05000216|564948894|FG021|Stage 2|Lost to Follow-up|0|||
156506885|NCT05000216|564948873|FG000|Stage 2|Physician Decision|0|||
156506886|NCT05000216|564948874|FG001|Stage 2|Physician Decision|0|||
156506887|NCT05000216|564948875|FG002|Stage 2|Physician Decision|0|||
156506888|NCT05000216|564948876|FG003|Stage 2|Physician Decision|0|||
156506889|NCT05000216|564948877|FG004|Stage 2|Physician Decision|0|||
156506890|NCT05000216|564948878|FG005|Stage 2|Physician Decision|0|||
156506891|NCT05000216|564948879|FG006|Stage 2|Physician Decision|0|||
156506892|NCT05000216|564948880|FG007|Stage 2|Physician Decision|0|||
156506893|NCT05000216|564948881|FG008|Stage 2|Physician Decision|0|||
156506894|NCT05000216|564948882|FG009|Stage 2|Physician Decision|0|||
156506895|NCT05000216|564948883|FG010|Stage 2|Physician Decision|0|||
156506896|NCT05000216|564948884|FG011|Stage 2|Physician Decision|0|||
156506897|NCT05000216|564948885|FG012|Stage 2|Physician Decision|1|||
156506898|NCT05000216|564948886|FG013|Stage 2|Physician Decision|0|||
156506899|NCT05000216|564948887|FG014|Stage 2|Physician Decision|0|||
156506900|NCT05000216|564948888|FG015|Stage 2|Physician Decision|0|||
156506901|NCT05000216|564948889|FG016|Stage 2|Physician Decision|0|||
156506902|NCT05000216|564948890|FG017|Stage 2|Physician Decision|0|||
156506903|NCT05000216|564948891|FG018|Stage 2|Physician Decision|0|||
156506904|NCT05000216|564948892|FG019|Stage 2|Physician Decision|0|||
156506905|NCT05000216|564948893|FG020|Stage 2|Physician Decision|0|||
156506906|NCT05000216|564948894|FG021|Stage 2|Physician Decision|0|||
156506907|NCT05000216|564948873|FG000|Stage 2|Withdrawal by Subject|0|||
156506908|NCT05000216|564948874|FG001|Stage 2|Withdrawal by Subject|0|||
156506909|NCT05000216|564948875|FG002|Stage 2|Withdrawal by Subject|0|||
156506910|NCT05000216|564948876|FG003|Stage 2|Withdrawal by Subject|0|||
156506911|NCT05000216|564948877|FG004|Stage 2|Withdrawal by Subject|0|||
156506912|NCT05000216|564948878|FG005|Stage 2|Withdrawal by Subject|0|||
156506913|NCT05000216|564948879|FG006|Stage 2|Withdrawal by Subject|0|||
156506914|NCT05000216|564948880|FG007|Stage 2|Withdrawal by Subject|0|||
156506915|NCT05000216|564948881|FG008|Stage 2|Withdrawal by Subject|0|||
156506916|NCT05000216|564948882|FG009|Stage 2|Withdrawal by Subject|0|||
156506917|NCT05000216|564948883|FG010|Stage 2|Withdrawal by Subject|0|||
156506918|NCT05000216|564948884|FG011|Stage 2|Withdrawal by Subject|0|||
156506919|NCT05000216|564948885|FG012|Stage 2|Withdrawal by Subject|0|||
156506920|NCT05000216|564948886|FG013|Stage 2|Withdrawal by Subject|0|||
156506921|NCT05000216|564948887|FG014|Stage 2|Withdrawal by Subject|2|||
156506922|NCT05000216|564948888|FG015|Stage 2|Withdrawal by Subject|0|||
156506923|NCT05000216|564948889|FG016|Stage 2|Withdrawal by Subject|9|||
156506924|NCT05000216|564948890|FG017|Stage 2|Withdrawal by Subject|0|||
156506925|NCT05000216|564948891|FG018|Stage 2|Withdrawal by Subject|0|||
156506926|NCT05000216|564948892|FG019|Stage 2|Withdrawal by Subject|0|||
156506927|NCT05000216|564948893|FG020|Stage 2|Withdrawal by Subject|0|||
156506928|NCT05000216|564948894|FG021|Stage 2|Withdrawal by Subject|0|||
156506929|NCT05000216|564948873|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
156506930|NCT05000216|564948874|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
156506931|NCT05000216|564948875|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
156506932|NCT05000216|564948876|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
156506933|NCT05000216|564948877|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
156506934|NCT05000216|564948878|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
156506935|NCT05000216|564948879|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
156506936|NCT05000216|564948880|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
156506937|NCT05000216|564948881|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
156506938|NCT05000216|564948882|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
156506939|NCT05000216|564948883|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
156385281|NCT03579459|564501114|FG000|Overall Study|Withdrawal by Subject|12|||
156385282|NCT03579459|564501115|FG001|Overall Study|Withdrawal by Subject|8|||
156385283|NCT03579459|564501116|FG002|Overall Study|Withdrawal by Subject|11|||
156506940|NCT05000216|564948884|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
156506941|NCT05000216|564948885|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
156506942|NCT05000216|564948886|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
156506943|NCT05000216|564948887|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
156506944|NCT05000216|564948888|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
156506945|NCT05000216|564948889|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
156506946|NCT05000216|564948890|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
156506947|NCT05000216|564948891|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
156506948|NCT05000216|564948892|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
156506949|NCT05000216|564948893|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
156506950|NCT05000216|564948894|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
156506951|NCT05000216|564948873|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506952|NCT05000216|564948874|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506953|NCT05000216|564948875|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506954|NCT05000216|564948876|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506955|NCT05000216|564948877|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506956|NCT05000216|564948878|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506957|NCT05000216|564948879|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506958|NCT05000216|564948880|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506959|NCT05000216|564948881|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506960|NCT05000216|564948882|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506961|NCT05000216|564948883|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506962|NCT05000216|564948884|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506963|NCT05000216|564948885|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506964|NCT05000216|564948886|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506965|NCT05000216|564948887|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
156506966|NCT05000216|564948888|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506967|NCT05000216|564948889|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
156506968|NCT05000216|564948890|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506969|NCT05000216|564948891|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506970|NCT05000216|564948892|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506971|NCT05000216|564948893|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506972|NCT05000216|564948894|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
156506973|NCT05000216|564948873|FG000|Stage 2|Other reason|0|||
156506974|NCT05000216|564948874|FG001|Stage 2|Other reason|0|||
156506975|NCT05000216|564948875|FG002|Stage 2|Other reason|0|||
156506976|NCT05000216|564948876|FG003|Stage 2|Other reason|0|||
156506977|NCT05000216|564948877|FG004|Stage 2|Other reason|0|||
156506978|NCT05000216|564948878|FG005|Stage 2|Other reason|0|||
156506979|NCT05000216|564948879|FG006|Stage 2|Other reason|0|||
156506980|NCT05000216|564948880|FG007|Stage 2|Other reason|0|||
156506981|NCT05000216|564948881|FG008|Stage 2|Other reason|0|||
156506982|NCT05000216|564948882|FG009|Stage 2|Other reason|0|||
156506983|NCT05000216|564948883|FG010|Stage 2|Other reason|0|||
156506984|NCT05000216|564948884|FG011|Stage 2|Other reason|0|||
156506985|NCT05000216|564948885|FG012|Stage 2|Other reason|0|||
156506986|NCT05000216|564948886|FG013|Stage 2|Other reason|0|||
156506987|NCT05000216|564948887|FG014|Stage 2|Other reason|0|||
156506988|NCT05000216|564948888|FG015|Stage 2|Other reason|0|||
156506989|NCT05000216|564948889|FG016|Stage 2|Other reason|1|||
156506990|NCT05000216|564948890|FG017|Stage 2|Other reason|0|||
156506991|NCT05000216|564948891|FG018|Stage 2|Other reason|0|||
156506992|NCT05000216|564948892|FG019|Stage 2|Other reason|0|||
156506993|NCT05000216|564948893|FG020|Stage 2|Other reason|0|||
156506994|NCT05000216|564948894|FG021|Stage 2|Other reason|0|||
156506995|NCT05000216|564948873|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
156506996|NCT05000216|564948874|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
156506997|NCT05000216|564948875|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
156506998|NCT05000216|564948876|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
156506999|NCT05000216|564948877|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
156507000|NCT05000216|564948878|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
156507001|NCT05000216|564948879|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
156507002|NCT05000216|564948880|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
156507003|NCT05000216|564948881|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
156507004|NCT05000216|564948882|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
156507005|NCT05000216|564948883|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
156507006|NCT05000216|564948884|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
156507007|NCT05000216|564948885|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
156507008|NCT05000216|564948886|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
156507009|NCT05000216|564948887|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
156507010|NCT05000216|564948888|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
156507011|NCT05000216|564948889|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
156507012|NCT05000216|564948890|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
156507013|NCT05000216|564948891|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
156507014|NCT05000216|564948892|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
156507015|NCT05000216|564948893|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
156507016|NCT05000216|564948894|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
156507017|NCT05000216|564948873|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507018|NCT05000216|564948874|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507019|NCT05000216|564948875|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507020|NCT05000216|564948876|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507021|NCT05000216|564948877|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507022|NCT05000216|564948878|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507023|NCT05000216|564948879|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507024|NCT05000216|564948880|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507025|NCT05000216|564948881|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507026|NCT05000216|564948882|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507027|NCT05000216|564948883|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507028|NCT05000216|564948884|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507029|NCT05000216|564948885|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
156547210|NCT04294901|565095076|FG001|Overall Study|Death|110|||
156507030|NCT05000216|564948886|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507031|NCT05000216|564948887|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507032|NCT05000216|564948888|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
156507033|NCT05000216|564948889|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
156547211|NCT04294901|565095075|FG000|Overall Study|Provider did not have historical control patients|581|||
156547212|NCT04294901|565095076|FG001|Overall Study|Provider did not have historical control patients|0|||
156547213|NCT04294901|565095075|FG000|Overall Study|Provider did not have intervention patients|0|||
156547214|NCT04294901|565095076|FG001|Overall Study|Provider did not have intervention patients|98|||
156547215|NCT03657043|565096698|FG000|Overall Study|Withdrawal by Subject|1|||
156547216|NCT03657043|565096699|FG001|Overall Study|Withdrawal by Subject|1|||
156547217|NCT03657043|565096700|FG002|Overall Study|Withdrawal by Subject|0|||
156547218|NCT03657043|565096701|FG003|Overall Study|Withdrawal by Subject|0|||
156547219|NCT03657043|565096702|FG004|Overall Study|Withdrawal by Subject|4|||
156547220|NCT03657043|565096698|FG000|Overall Study|Study closure by Sponsor|0|||
156547221|NCT03657043|565096699|FG001|Overall Study|Study closure by Sponsor|2|||
156547222|NCT03657043|565096700|FG002|Overall Study|Study closure by Sponsor|0|||
156547223|NCT03657043|565096701|FG003|Overall Study|Study closure by Sponsor|0|||
156547224|NCT03657043|565096702|FG004|Overall Study|Study closure by Sponsor|17|||
156547225|NCT03657043|565096698|FG000|Overall Study|Lost to Follow-up|0|||
156547226|NCT03657043|565096699|FG001|Overall Study|Lost to Follow-up|0|||
156547227|NCT03657043|565096700|FG002|Overall Study|Lost to Follow-up|0|||
156547228|NCT03657043|565096701|FG003|Overall Study|Lost to Follow-up|0|||
156547229|NCT03657043|565096702|FG004|Overall Study|Lost to Follow-up|4|||
156547230|NCT03657043|565096698|FG000|Overall Study|Death|6|||
156547231|NCT03657043|565096699|FG001|Overall Study|Death|5|||
156547232|NCT03657043|565096700|FG002|Overall Study|Death|0|||
156547233|NCT03657043|565096701|FG003|Overall Study|Death|0|||
156547234|NCT03657043|565096702|FG004|Overall Study|Death|53|||
156547235|NCT03657043|565096698|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
156507034|NCT05000216|564948890|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507035|NCT05000216|564948891|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507036|NCT05000216|564948892|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507037|NCT05000216|564948893|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507038|NCT05000216|564948894|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
156507039|NCT05000216|564948873|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507040|NCT05000216|564948874|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507041|NCT05000216|564948875|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507042|NCT05000216|564948876|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507043|NCT05000216|564948877|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507044|NCT05000216|564948878|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507045|NCT05000216|564948879|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507046|NCT05000216|564948880|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507047|NCT05000216|564948881|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507048|NCT05000216|564948882|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507049|NCT05000216|564948883|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507050|NCT05000216|564948884|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507051|NCT05000216|564948885|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507052|NCT05000216|564948886|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
156507053|NCT05000216|564948887|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507054|NCT05000216|564948888|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
156507055|NCT05000216|564948889|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507056|NCT05000216|564948890|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507057|NCT05000216|564948891|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
156507058|NCT05000216|564948892|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507059|NCT05000216|564948893|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507060|NCT05000216|564948894|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
156507061|NCT04638660|564948895|FG000|Overall Study|Withdrawal by Subject|2|||
156507062|NCT04638660|564948896|FG001|Overall Study|Withdrawal by Subject|0|||
156507063|NCT04638660|564948895|FG000|Overall Study|Lost to Follow-up|1|||
156547236|NCT03657043|565096699|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
156547237|NCT03657043|565096700|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
156547238|NCT03657043|565096701|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
156547239|NCT03657043|565096702|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
156547240|NCT03657043|565096698|FG000|Overall Study|Adverse Event|0|||
156547241|NCT03657043|565096699|FG001|Overall Study|Adverse Event|0|||
156547242|NCT03657043|565096700|FG002|Overall Study|Adverse Event|0|||
156547243|NCT03657043|565096701|FG003|Overall Study|Adverse Event|0|||
156507064|NCT04638660|564948896|FG001|Overall Study|Lost to Follow-up|0|||
156547244|NCT03657043|565096702|FG004|Overall Study|Adverse Event|2|||
156507065|NCT00863681|564948903|FG000|Overall Study|Other|2|||
156507066|NCT00863681|564948904|FG001|Overall Study|Other|0|||
156507067|NCT00863681|564948905|FG002|Overall Study|Other|0|||
156507068|NCT00863681|564948903|FG000|Overall Study|Missing|1|||
156507069|NCT00863681|564948904|FG001|Overall Study|Missing|0|||
156547245|NCT03657043|565096698|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
156547246|NCT03657043|565096699|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
156385284|NCT03579459|564501117|FG003|Overall Study|Withdrawal by Subject|8|||
156507070|NCT00863681|564948905|FG002|Overall Study|Missing|0|||
156507071|NCT00863681|564948903|FG000|Overall Study|Death|40|||
156507072|NCT00863681|564948904|FG001|Overall Study|Death|23|||
156507073|NCT00863681|564948905|FG002|Overall Study|Death|6|||
156507074|NCT00863681|564948903|FG000|Overall Study|Withdrawal by Subject|12|||
156507075|NCT00863681|564948904|FG001|Overall Study|Withdrawal by Subject|5|||
156507076|NCT00863681|564948905|FG002|Overall Study|Withdrawal by Subject|2|||
156507077|NCT00863681|564948903|FG000|Overall Study|Protocol Violation|2|||
156507078|NCT00863681|564948904|FG001|Overall Study|Protocol Violation|0|||
156507079|NCT00863681|564948905|FG002|Overall Study|Protocol Violation|0|||
156507080|NCT00863681|564948903|FG000|Overall Study|Lost to Follow-up|3|||
156507081|NCT00863681|564948904|FG001|Overall Study|Lost to Follow-up|0|||
156507082|NCT00863681|564948905|FG002|Overall Study|Lost to Follow-up|3|||
156507083|NCT00863681|564948903|FG000|Overall Study|Adverse Event|28|||
156507084|NCT00863681|564948904|FG001|Overall Study|Adverse Event|10|||
156507085|NCT00863681|564948905|FG002|Overall Study|Adverse Event|6|||
156507086|NCT00863681|564948903|FG000|Overall Study|Lack of Efficacy|2|||
156507087|NCT00863681|564948904|FG001|Overall Study|Lack of Efficacy|2|||
156507088|NCT00863681|564948905|FG002|Overall Study|Lack of Efficacy|1|||
156507089|NCT00863681|564948903|FG000|Overall Study|Non-compliance with study drug|1|||
156507090|NCT00863681|564948904|FG001|Overall Study|Non-compliance with study drug|3|||
156507091|NCT00863681|564948905|FG002|Overall Study|Non-compliance with study drug|0|||
156507092|NCT01853475|564948907|FG000|Overall Study|Withdrawal by Subject|0|||
156507093|NCT01853475|564948908|FG001|Overall Study|Withdrawal by Subject|1|||
156507094|NCT01853475|564948909|FG002|Overall Study|Withdrawal by Subject|0|||
156507095|NCT00659880|564948910|FG000|Overall Study|Lost to Follow-up|5|||
156507096|NCT03199469|564948911|FG000|Overall Study|Randomized, not treated|0|||
156507097|NCT03199469|564948912|FG001|Overall Study|Randomized, not treated|3|||
156507098|NCT03199469|564948911|FG000|Overall Study|Withdrawal by Subject|1|||
156507099|NCT03199469|564948912|FG001|Overall Study|Withdrawal by Subject|0|||
156507100|NCT03199469|564948911|FG000|Overall Study|Death|1|||
156507101|NCT03199469|564948912|FG001|Overall Study|Death|3|||
156507102|NCT03199469|564948911|FG000|Overall Study|Ongoing|5|||
156507103|NCT03199469|564948912|FG001|Overall Study|Ongoing|14|||
156507104|NCT03080493|564948913|FG000|Overall Study|Did not provide NRS pain results|1|||
156507105|NCT03080493|564948914|FG001|Overall Study|Did not provide NRS pain results|0|||
156507106|NCT03080493|564948913|FG000|Overall Study|Adverse Event|0|||
156507107|NCT03080493|564948914|FG001|Overall Study|Adverse Event|1|||
156507108|NCT03080493|564948913|FG000|Overall Study|Randomization error (parity group)|0|||
156507109|NCT03080493|564948914|FG001|Overall Study|Randomization error (parity group)|1|||
156507110|NCT01304498|564948915|FG000|Overall Study|Adverse Event|1|||
156507111|NCT01304498|564948916|FG001|Overall Study|Adverse Event|1|||
156507112|NCT01304498|564948915|FG000|Overall Study|Withdrawal by Subject|2|||
156507113|NCT01304498|564948916|FG001|Overall Study|Withdrawal by Subject|3|||
156507114|NCT01304498|564948915|FG000|Overall Study|Protocol Violation|1|||
156507115|NCT01304498|564948916|FG001|Overall Study|Protocol Violation|0|||
156507116|NCT01304498|564948915|FG000|Overall Study|Lost to Follow-up|2|||
156507117|NCT01304498|564948916|FG001|Overall Study|Lost to Follow-up|1|||
156507118|NCT01834586|564948925|FG000|Overall Study|Adverse Event|1|||
156507119|NCT03325777|564948928|FG000|Overall Study|Lost to Follow-up|9|||
156507120|NCT03325777|564948929|FG001|Overall Study|Lost to Follow-up|12|||
156507121|NCT03004404|564948930|FG000|Period 2|Adverse Event|0|||
156507122|NCT03004404|564948931|FG001|Period 2|Adverse Event|0|||
156507123|NCT03004404|564948932|FG002|Period 2|Adverse Event|0|||
156507124|NCT03004404|564948933|FG003|Period 2|Adverse Event|0|||
156547247|NCT03657043|565096700|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
156507125|NCT03004404|564948934|FG004|Period 2|Adverse Event|0|||
156507126|NCT03004404|564948935|FG005|Period 2|Adverse Event|0|||
156507127|NCT03004404|564948936|FG006|Period 2|Adverse Event|0|||
156507128|NCT03004404|564948937|FG007|Period 2|Adverse Event|0|||
156507129|NCT03004404|564948938|FG008|Period 2|Adverse Event|1|||
156507130|NCT03004404|564948939|FG009|Period 2|Adverse Event|0|||
156507131|NCT03004404|564948940|FG010|Period 2|Adverse Event|0|||
156507132|NCT03004404|564948941|FG011|Period 2|Adverse Event|0|||
156507133|NCT03004404|564948942|FG012|Period 2|Adverse Event|0|||
156507134|NCT03004404|564948943|FG013|Period 2|Adverse Event|0|||
156507135|NCT03004404|564948944|FG014|Period 2|Adverse Event|0|||
156507136|NCT03004404|564948945|FG015|Period 2|Adverse Event|1|||
156507137|NCT01099917|564948950|FG000|Overall Study|Adverse Event|3|||
156507138|NCT01099917|564948950|FG000|Overall Study|Not Treated|24|||
156547248|NCT03657043|565096701|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
156547249|NCT03657043|565096702|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
156547250|NCT03657043|565096698|FG000|Overall Study|Withdrawal - declined follow-up|0|||
156507139|NCT01001390|564948952|FG000|Overall Study|Failure to wear AFO device|2|||
156507140|NCT01001390|564948953|FG001|Overall Study|Failure to wear AFO device|0|||
156507141|NCT01825577|564948954|FG000|Overall Study|Physician Decision|2|||
156507142|NCT01825577|564948954|FG000|Overall Study|Withdrawal by Subject|1|||
156507143|NCT01825577|564948954|FG000|Overall Study|Withdrawn by family members|2|||
156507144|NCT01825577|564948954|FG000|Overall Study|Lack of Efficacy|3|||
156507145|NCT00604708|564948962|FG000|Overall Study|Withdrawal by Subject|9|||
156385285|NCT03579459|564501114|FG000|Overall Study|Medication error without associated adverse event|2|||
156385286|NCT03579459|564501115|FG001|Overall Study|Medication error without associated adverse event|1|||
156385287|NCT03579459|564501116|FG002|Overall Study|Medication error without associated adverse event|1|||
156385288|NCT03579459|564501117|FG003|Overall Study|Medication error without associated adverse event|0|||
156385289|NCT03579459|564501114|FG000|Overall Study|Other|0|||
156385290|NCT03579459|564501115|FG001|Overall Study|Other|1|||
156385291|NCT03579459|564501116|FG002|Overall Study|Other|1|||
156385292|NCT03579459|564501117|FG003|Overall Study|Other|0|||
156507146|NCT00604708|564948963|FG001|Overall Study|Withdrawal by Subject|10|||
156507147|NCT00604708|564948962|FG000|Overall Study|Protocol Violation|2|||
156507148|NCT00604708|564948963|FG001|Overall Study|Protocol Violation|8|||
156507149|NCT00604708|564948962|FG000|Overall Study|Lost to Follow-up|5|||
156507150|NCT00604708|564948963|FG001|Overall Study|Lost to Follow-up|5|||
156507151|NCT00604708|564948962|FG000|Overall Study|administrative reasons|9|||
156507152|NCT00604708|564948963|FG001|Overall Study|administrative reasons|11|||
156507153|NCT00604708|564948962|FG000|Overall Study|Adverse Event|6|||
156507154|NCT00604708|564948963|FG001|Overall Study|Adverse Event|6|||
156507155|NCT01277887|564948964|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
156507156|NCT01277887|564948965|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
156507157|NCT01277887|564948964|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
156507158|NCT01277887|564948965|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
156507159|NCT01277887|564948964|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
156507160|NCT01277887|564948965|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
156507161|NCT00415051|564948966|FG000|Overall Study|Protocol Violation|1|||
156507162|NCT04916730|564948969|FG000|Overall Study|Withdrawal by Subject|4|||
156507163|NCT04916730|564948970|FG001|Overall Study|Withdrawal by Subject|2|||
156507164|NCT04916730|564948969|FG000|Overall Study|Lost to Follow-up|0|||
156507165|NCT04916730|564948970|FG001|Overall Study|Lost to Follow-up|2|||
156507166|NCT04916730|564948969|FG000|Overall Study|Physician Decision|1|||
156507167|NCT04916730|564948970|FG001|Overall Study|Physician Decision|0|||
156507168|NCT02670122|564948974|FG000|Overall Study|Lost to Follow-up|4|||
156507169|NCT02762903|564948978|FG000|Overall Study|Lost to Follow-up|0|||
156507170|NCT02762903|564948979|FG001|Overall Study|Lost to Follow-up|1|||
156507171|NCT03041792|564948982|FG000|Overall Study|Adverse Event|4|||
156507172|NCT03041792|564948983|FG001|Overall Study|Adverse Event|0|||
156507173|NCT03041792|564948982|FG000|Overall Study|Death in the family|0|||
156507174|NCT03041792|564948983|FG001|Overall Study|Death in the family|2|||
156507175|NCT03041792|564948982|FG000|Overall Study|Randomized but not treated|0|||
156507176|NCT03041792|564948983|FG001|Overall Study|Randomized but not treated|1|||
156507177|NCT04641962|564948987|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
156507178|NCT04641962|564948988|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
156507179|NCT04641962|564948989|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
156507180|NCT04641962|564948990|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
156507181|NCT04641962|564948991|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
156507182|NCT04641962|564948987|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
156507183|NCT04641962|564948988|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
156507184|NCT04641962|564948989|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
156507185|NCT04641962|564948990|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
156507186|NCT04641962|564948991|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
156507187|NCT04641962|564948987|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
156507188|NCT04641962|564948988|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
156507189|NCT04641962|564948989|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
156507190|NCT04641962|564948990|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
156507191|NCT04641962|564948991|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
156507192|NCT04641962|564948987|FG000|DBT Period: Up to 52 Weeks|Death|1|||
156507193|NCT04641962|564948988|FG001|DBT Period: Up to 52 Weeks|Death|0|||
156507194|NCT04641962|564948989|FG002|DBT Period: Up to 52 Weeks|Death|0|||
156507195|NCT04641962|564948990|FG003|DBT Period: Up to 52 Weeks|Death|0|||
156507196|NCT04641962|564948991|FG004|DBT Period: Up to 52 Weeks|Death|0|||
156507197|NCT04641962|564948987|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
156507198|NCT04641962|564948988|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
156507199|NCT04641962|564948989|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
156507200|NCT04641962|564948990|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
156507201|NCT04641962|564948991|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
156385293|NCT03579459|564501114|FG000|Overall Study|Randomized not vaccinated|0|||
156385294|NCT03579459|564501115|FG001|Overall Study|Randomized not vaccinated|2|||
156385295|NCT03579459|564501116|FG002|Overall Study|Randomized not vaccinated|0|||
156507202|NCT04641962|564948987|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
156507203|NCT04641962|564948988|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
156507204|NCT04641962|564948989|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
156507205|NCT04641962|564948990|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
156507206|NCT04641962|564948991|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
156507207|NCT04641962|564948987|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
156507208|NCT04641962|564948988|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
156507209|NCT04641962|564948989|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
156507210|NCT04641962|564948990|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
156507211|NCT04641962|564948991|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
156507212|NCT05239598|564948995|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
156507213|NCT05239598|564948996|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
156507214|NCT05239598|564948995|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
156507215|NCT05239598|564948996|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
156507216|NCT04535544|564948999|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
156507217|NCT04535544|564949000|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
156507218|NCT04535544|564949001|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
156507219|NCT04535544|564949002|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
156507220|NCT04535544|564948999|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
156507221|NCT04535544|564949000|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
156507222|NCT04535544|564949001|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
156507223|NCT04535544|564949002|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
156507224|NCT04535544|564948999|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
156507225|NCT04535544|564949000|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
156507226|NCT04535544|564949001|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
156507227|NCT04535544|564949002|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
156507228|NCT04535544|564948999|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
156507229|NCT04535544|564949000|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
156507230|NCT04535544|564949001|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
156507231|NCT04535544|564949002|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
156507232|NCT04535544|564948999|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
156507233|NCT04535544|564949000|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
156507234|NCT04535544|564949001|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
156507235|NCT04535544|564949002|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
156507236|NCT04535544|564948999|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
156507237|NCT04535544|564949000|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
156507238|NCT04535544|564949001|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
156507239|NCT04535544|564949002|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
156507240|NCT04535544|564948999|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
156507241|NCT04535544|564949000|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
156507242|NCT04535544|564949001|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
156507243|NCT04535544|564949002|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
156507244|NCT04535544|564948999|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
156507245|NCT04535544|564949000|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
156507246|NCT04535544|564949001|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
156507247|NCT04535544|564949002|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
156507248|NCT02706405|564950892|FG000|Overall Study|Death|3|||
156507249|NCT02706405|564950893|FG001|Overall Study|Death|2|||
156507250|NCT02706405|564950894|FG002|Overall Study|Death|0|||
156507251|NCT02706405|564950895|FG003|Overall Study|Death|1|||
156507252|NCT02706405|564950896|FG004|Overall Study|Death|0|||
156507253|NCT02706405|564950897|FG005|Overall Study|Death|0|||
156507254|NCT02706405|564950898|FG006|Overall Study|Death|3|||
156507255|NCT02706405|564950899|FG007|Overall Study|Death|4|||
156507256|NCT02706405|564950892|FG000|Overall Study|Disease progression|0|||
156507257|NCT02706405|564950893|FG001|Overall Study|Disease progression|0|||
156507258|NCT02706405|564950894|FG002|Overall Study|Disease progression|0|||
156507259|NCT02706405|564950895|FG003|Overall Study|Disease progression|0|||
156507260|NCT02706405|564950896|FG004|Overall Study|Disease progression|0|||
156507261|NCT02706405|564950897|FG005|Overall Study|Disease progression|0|||
156507262|NCT02706405|564950898|FG006|Overall Study|Disease progression|0|||
156507263|NCT02706405|564950899|FG007|Overall Study|Disease progression|1|||
156507264|NCT02706405|564950892|FG000|Overall Study|Pt moved to new therapy|0|||
156507265|NCT02706405|564950893|FG001|Overall Study|Pt moved to new therapy|0|||
156507266|NCT02706405|564950894|FG002|Overall Study|Pt moved to new therapy|0|||
156507267|NCT02706405|564950895|FG003|Overall Study|Pt moved to new therapy|0|||
156507268|NCT02706405|564950896|FG004|Overall Study|Pt moved to new therapy|0|||
156507269|NCT02706405|564950897|FG005|Overall Study|Pt moved to new therapy|1|||
156507270|NCT02706405|564950898|FG006|Overall Study|Pt moved to new therapy|0|||
156507271|NCT02706405|564950899|FG007|Overall Study|Pt moved to new therapy|1|||
156507272|NCT02706405|564950892|FG000|Overall Study|Physician Decision|1|||
156507273|NCT02706405|564950893|FG001|Overall Study|Physician Decision|0|||
156507274|NCT02706405|564950894|FG002|Overall Study|Physician Decision|0|||
156507275|NCT02706405|564950895|FG003|Overall Study|Physician Decision|0|||
156507276|NCT02706405|564950896|FG004|Overall Study|Physician Decision|0|||
156507277|NCT02706405|564950897|FG005|Overall Study|Physician Decision|0|||
156507278|NCT02706405|564950898|FG006|Overall Study|Physician Decision|0|||
156507279|NCT02706405|564950899|FG007|Overall Study|Physician Decision|0|||
156507280|NCT02304705|564950900|FG000|Overall Study|Withdrawal by Subject|2|||
156507281|NCT02304705|564950901|FG001|Overall Study|Withdrawal by Subject|0|||
156507282|NCT02304705|564950900|FG000|Overall Study|Physician Decision|2|||
156507283|NCT02304705|564950901|FG001|Overall Study|Physician Decision|4|||
156507284|NCT02304705|564950900|FG000|Overall Study|Death|0|||
156507285|NCT02304705|564950901|FG001|Overall Study|Death|1|||
156507286|NCT02304705|564950900|FG000|Overall Study|Lost to Follow-up|0|||
156507287|NCT02304705|564950901|FG001|Overall Study|Lost to Follow-up|2|||
156507288|NCT03140280|564950902|FG000|Overall Study|Physician Decision|5|||
156507289|NCT05602727|564950913|FG000|Overall Study|Physician Decision|0|||
156507290|NCT05602727|564950914|FG001|Overall Study|Physician Decision|1|||
156507291|NCT05602727|564950915|FG002|Overall Study|Physician Decision|0|||
156507292|NCT05602727|564950913|FG000|Overall Study|Randomized by mistake without study medication|1|||
156507293|NCT05602727|564950914|FG001|Overall Study|Randomized by mistake without study medication|0|||
156507294|NCT05602727|564950915|FG002|Overall Study|Randomized by mistake without study medication|0|||
156507295|NCT05602727|564950913|FG000|Overall Study|Study termination by Sponsor|18|||
156507296|NCT05602727|564950914|FG001|Overall Study|Study termination by Sponsor|15|||
156507297|NCT05602727|564950915|FG002|Overall Study|Study termination by Sponsor|19|||
156507298|NCT05602727|564950913|FG000|Overall Study|Withdrawal by Subject|2|||
156507299|NCT05602727|564950914|FG001|Overall Study|Withdrawal by Subject|1|||
156507300|NCT05602727|564950915|FG002|Overall Study|Withdrawal by Subject|1|||
156507301|NCT05602727|564950913|FG000|Overall Study|Various reasons|1|||
156507302|NCT05602727|564950914|FG001|Overall Study|Various reasons|6|||
156507303|NCT05602727|564950915|FG002|Overall Study|Various reasons|1|||
156507304|NCT02038842|564950916|FG000|Overall Study|Withdrawal by Subject|2|||
156507305|NCT02038842|564950917|FG001|Overall Study|Withdrawal by Subject|2|||
156507306|NCT02038842|564950918|FG002|Overall Study|Withdrawal by Subject|0|||
156507307|NCT02038842|564950919|FG003|Overall Study|Withdrawal by Subject|0|||
156507308|NCT02038842|564950916|FG000|Overall Study|Participant decision|0|||
156507309|NCT02038842|564950917|FG001|Overall Study|Participant decision|0|||
156507310|NCT02038842|564950918|FG002|Overall Study|Participant decision|2|||
156507311|NCT02038842|564950919|FG003|Overall Study|Participant decision|1|||
156507312|NCT02038842|564950916|FG000|Overall Study|Adverse Event|0|||
156507313|NCT02038842|564950917|FG001|Overall Study|Adverse Event|0|||
156507314|NCT02038842|564950918|FG002|Overall Study|Adverse Event|3|||
156507315|NCT02038842|564950919|FG003|Overall Study|Adverse Event|1|||
156507316|NCT02038842|564950916|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
156507317|NCT02038842|564950917|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
156507318|NCT02038842|564950918|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
156507319|NCT02038842|564950919|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
156507320|NCT02643303|564950922|FG000|Overall Study|Progressive Disease|4|||
156507321|NCT02643303|564950923|FG001|Overall Study|Progressive Disease|4|||
156507322|NCT02643303|564950924|FG002|Overall Study|Progressive Disease|1|||
156507323|NCT02643303|564950925|FG003|Overall Study|Progressive Disease|12|||
156507324|NCT02643303|564950926|FG004|Overall Study|Progressive Disease|6|||
156507325|NCT02643303|564950927|FG005|Overall Study|Progressive Disease|4|||
156507326|NCT02643303|564950928|FG006|Overall Study|Progressive Disease|8|||
156507327|NCT02643303|564950929|FG007|Overall Study|Progressive Disease|2|||
156507328|NCT02643303|564950930|FG008|Overall Study|Progressive Disease|6|||
156507329|NCT02643303|564950922|FG000|Overall Study|Adverse Event|0|||
156507330|NCT02643303|564950923|FG001|Overall Study|Adverse Event|1|||
156507331|NCT02643303|564950924|FG002|Overall Study|Adverse Event|0|||
156507332|NCT02643303|564950925|FG003|Overall Study|Adverse Event|0|||
156507333|NCT02643303|564950926|FG004|Overall Study|Adverse Event|1|||
156507334|NCT02643303|564950927|FG005|Overall Study|Adverse Event|0|||
156507335|NCT02643303|564950928|FG006|Overall Study|Adverse Event|0|||
156507336|NCT02643303|564950929|FG007|Overall Study|Adverse Event|0|||
156507337|NCT02643303|564950930|FG008|Overall Study|Adverse Event|0|||
156507338|NCT02643303|564950922|FG000|Overall Study|Withdrawal by Subject|0|||
156507339|NCT02643303|564950923|FG001|Overall Study|Withdrawal by Subject|0|||
156507340|NCT02643303|564950924|FG002|Overall Study|Withdrawal by Subject|0|||
156507341|NCT02643303|564950925|FG003|Overall Study|Withdrawal by Subject|1|||
156507342|NCT02643303|564950926|FG004|Overall Study|Withdrawal by Subject|0|||
156507343|NCT02643303|564950927|FG005|Overall Study|Withdrawal by Subject|0|||
156507344|NCT02643303|564950928|FG006|Overall Study|Withdrawal by Subject|1|||
156507345|NCT02643303|564950929|FG007|Overall Study|Withdrawal by Subject|1|||
156507346|NCT02643303|564950930|FG008|Overall Study|Withdrawal by Subject|1|||
156507347|NCT05332912|564950931|FG000|Overall Study|Withdrawal by Subject|0|||
156507348|NCT05332912|564950932|FG001|Overall Study|Withdrawal by Subject|1|||
156507349|NCT05332912|564950933|FG002|Overall Study|Withdrawal by Subject|2|||
156507350|NCT05332912|564950934|FG003|Overall Study|Withdrawal by Subject|0|||
156507351|NCT05332912|564950931|FG000|Overall Study|Lost to Follow-up|0|||
156507352|NCT05332912|564950932|FG001|Overall Study|Lost to Follow-up|0|||
156507353|NCT05332912|564950933|FG002|Overall Study|Lost to Follow-up|1|||
156507354|NCT05332912|564950934|FG003|Overall Study|Lost to Follow-up|0|||
156507355|NCT01174446|564950935|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
156507356|NCT01174446|564950936|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
156507357|NCT01174446|564950937|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
156507358|NCT01174446|564950938|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
156385296|NCT03579459|564501117|FG003|Overall Study|Randomized not vaccinated|1|||
156385297|NCT00148343|564501120|FG000|Overall Study|Withdrawal by Subject|12|||
156385298|NCT00148343|564501121|FG001|Overall Study|Withdrawal by Subject|7|||
156385299|NCT00148343|564501120|FG000|Overall Study|Physician Decision|3|||
156385300|NCT00148343|564501121|FG001|Overall Study|Physician Decision|4|||
156385301|NCT02844946|564501125|FG000|Overall Study|Lost to Follow-up|7|||
156385302|NCT02844946|564501126|FG001|Overall Study|Lost to Follow-up|0|||
156385303|NCT02806986|564501127|FG000|Treatment Stage 1|Adverse Event|1|||
156385304|NCT02806986|564501127|FG000|Treatment Stage 2|Adverse Event|3|||
156385305|NCT02806986|564501127|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
156385306|NCT02528214|564501133|FG000|Overall Study|Protocol Violation|0|||
156385307|NCT02528214|564501134|FG001|Overall Study|Protocol Violation|1|||
156385308|NCT02528214|564501133|FG000|Overall Study|Adverse Event|0|||
156385309|NCT02528214|564501134|FG001|Overall Study|Adverse Event|1|||
156385310|NCT02528214|564501133|FG000|Overall Study|Other than specified above|0|||
156385311|NCT02528214|564501134|FG001|Overall Study|Other than specified above|1|||
156385312|NCT00407537|564501135|FG000|Overall Study|Death|5|||
156385313|NCT00407537|564501136|FG001|Overall Study|Death|2|||
156385314|NCT00407537|564501135|FG000|Overall Study|Adverse Event|36|||
156385315|NCT00407537|564501136|FG001|Overall Study|Adverse Event|0|||
156385316|NCT00407537|564501135|FG000|Overall Study|Lost to Follow-up|12|||
156385317|NCT00407537|564501136|FG001|Overall Study|Lost to Follow-up|19|||
156385318|NCT00407537|564501135|FG000|Overall Study|Other|6|||
156385319|NCT00407537|564501136|FG001|Overall Study|Other|7|||
156385320|NCT00407537|564501135|FG000|Overall Study|Withdrawal by Subject|34|||
156385321|NCT00407537|564501136|FG001|Overall Study|Withdrawal by Subject|16|||
156385322|NCT02384759|564501137|FG000|Overall Study|Patients not treated|3|||
156385323|NCT02384759|564501138|FG001|Overall Study|Patients not treated|2|||
156385324|NCT01605617|564501139|FG000|First Intervention|Adverse Event|0|||
156385325|NCT01605617|564501140|FG001|First Intervention|Adverse Event|1|||
156385326|NCT01605617|564501139|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
156385327|NCT01605617|564501140|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
156385328|NCT00121238|564501142|FG000|Overall Study|disease progression before intervention|1|||
156385329|NCT00121238|564501142|FG000|Overall Study|Protocol Violation|2|||
156385330|NCT01380327|564501143|FG000|Overall Study|Lost to Follow-up|0|||
156385331|NCT01380327|564501144|FG001|Overall Study|Lost to Follow-up|1|||
156385332|NCT01380327|564501145|FG002|Overall Study|Lost to Follow-up|1|||
156385333|NCT01380327|564501143|FG000|Overall Study|Protocol Violation|3|||
156385334|NCT01380327|564501144|FG001|Overall Study|Protocol Violation|2|||
156385335|NCT01380327|564501145|FG002|Overall Study|Protocol Violation|3|||
156385336|NCT01380327|564501143|FG000|Overall Study|Withdrawal by Subject|0|||
156385337|NCT01380327|564501144|FG001|Overall Study|Withdrawal by Subject|0|||
156385338|NCT01380327|564501145|FG002|Overall Study|Withdrawal by Subject|1|||
156385339|NCT01380327|564501143|FG000|Overall Study|Housing situation precluded ability to k|0|||
156385340|NCT01380327|564501144|FG001|Overall Study|Housing situation precluded ability to k|0|||
156385341|NCT01380327|564501145|FG002|Overall Study|Housing situation precluded ability to k|1|||
156385342|NCT01380327|564501143|FG000|Overall Study|Questionable onset of epilepsy|0|||
156385343|NCT01380327|564501144|FG001|Overall Study|Questionable onset of epilepsy|0|||
156385344|NCT01380327|564501145|FG002|Overall Study|Questionable onset of epilepsy|1|||
156385345|NCT03043664|564501146|FG000|Overall Study|Lost to Follow-up|1|||
156385346|NCT01540851|564501147|FG000|Overall Study|Lost to Follow-up|14|||
156385347|NCT01540851|564501148|FG001|Overall Study|Lost to Follow-up|15|||
156385348|NCT01540851|564501147|FG000|Overall Study|Withdrawal by Subject|7|||
156385349|NCT01540851|564501148|FG001|Overall Study|Withdrawal by Subject|3|||
156385350|NCT00325468|564501149|FG000|Overall Study|Adverse Event|1|||
156385351|NCT00325468|564501150|FG001|Overall Study|Adverse Event|1|||
156385352|NCT00325468|564501151|FG002|Overall Study|Adverse Event|0|||
156385353|NCT00325468|564501152|FG003|Overall Study|Adverse Event|5|||
156385354|NCT00325468|564501153|FG004|Overall Study|Adverse Event|1|||
156385355|NCT00325468|564501149|FG000|Overall Study|Death|2|||
156385356|NCT00325468|564501150|FG001|Overall Study|Death|0|||
156385357|NCT00325468|564501151|FG002|Overall Study|Death|2|||
156385358|NCT00325468|564501152|FG003|Overall Study|Death|4|||
156385359|NCT00325468|564501153|FG004|Overall Study|Death|0|||
156385360|NCT00325468|564501149|FG000|Overall Study|Lost to Follow-up|0|||
156385361|NCT00325468|564501150|FG001|Overall Study|Lost to Follow-up|0|||
156385362|NCT00325468|564501151|FG002|Overall Study|Lost to Follow-up|1|||
156385363|NCT00325468|564501152|FG003|Overall Study|Lost to Follow-up|2|||
156547251|NCT03657043|565096699|FG001|Overall Study|Withdrawal - declined follow-up|0|||
156385364|NCT00325468|564501153|FG004|Overall Study|Lost to Follow-up|2|||
156385365|NCT00325468|564501149|FG000|Overall Study|Physician Decision|1|||
156385366|NCT00325468|564501150|FG001|Overall Study|Physician Decision|1|||
156385367|NCT00325468|564501151|FG002|Overall Study|Physician Decision|0|||
156385368|NCT00325468|564501152|FG003|Overall Study|Physician Decision|1|||
156385369|NCT00325468|564501153|FG004|Overall Study|Physician Decision|0|||
156385370|NCT00325468|564501149|FG000|Overall Study|Withdrawal by Subject|3|||
156385371|NCT00325468|564501150|FG001|Overall Study|Withdrawal by Subject|1|||
156385372|NCT00325468|564501151|FG002|Overall Study|Withdrawal by Subject|0|||
156385373|NCT00325468|564501152|FG003|Overall Study|Withdrawal by Subject|14|||
156385374|NCT00325468|564501153|FG004|Overall Study|Withdrawal by Subject|4|||
156385375|NCT00325468|564501149|FG000|Overall Study|site closure etc|4|||
156385376|NCT00325468|564501150|FG001|Overall Study|site closure etc|2|||
156385377|NCT00325468|564501151|FG002|Overall Study|site closure etc|1|||
156385378|NCT00325468|564501152|FG003|Overall Study|site closure etc|8|||
156385379|NCT00325468|564501153|FG004|Overall Study|site closure etc|1|||
156385380|NCT03593655|564501154|FG000|First Product Use Period|Withdrawal by Subject|1|||
156385381|NCT03593655|564501155|FG001|First Product Use Period|Withdrawal by Subject|1|||
156385382|NCT03593655|564501154|FG000|First Product Use Period|Lost to Follow-up|1|||
156385383|NCT03593655|564501155|FG001|First Product Use Period|Lost to Follow-up|3|||
156507359|NCT01174446|564950935|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
156507360|NCT01174446|564950936|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
156507361|NCT01174446|564950937|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
156507362|NCT01174446|564950938|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
156507363|NCT01174446|564950935|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
156507364|NCT01174446|564950936|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
156507365|NCT01174446|564950937|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
156507366|NCT01174446|564950938|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
156507367|NCT01174446|564950935|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
156507368|NCT01174446|564950936|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
156507369|NCT01174446|564950937|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
156507370|NCT01174446|564950938|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
156507371|NCT00847626|564950941|FG000|Overall Study|Adverse Event|10|||
156507372|NCT00847626|564950942|FG001|Overall Study|Adverse Event|10|||
156507373|NCT00847626|564950943|FG002|Overall Study|Adverse Event|6|||
156507374|NCT00847626|564950944|FG003|Overall Study|Adverse Event|19|||
156507375|NCT00847626|564950945|FG004|Overall Study|Adverse Event|11|||
156507376|NCT00847626|564950946|FG005|Overall Study|Adverse Event|22|||
156507377|NCT00847626|564950947|FG006|Overall Study|Adverse Event|4|||
156507378|NCT00847626|564950948|FG007|Overall Study|Adverse Event|6|||
156507379|NCT00847626|564950949|FG008|Overall Study|Adverse Event|3|||
156507380|NCT00847626|564950950|FG009|Overall Study|Adverse Event|6|||
156507381|NCT00847626|564950951|FG010|Overall Study|Adverse Event|6|||
156507382|NCT00847626|564950941|FG000|Overall Study|Protocol Violation|2|||
156507383|NCT00847626|564950942|FG001|Overall Study|Protocol Violation|1|||
156507384|NCT00847626|564950943|FG002|Overall Study|Protocol Violation|2|||
156507385|NCT00847626|564950944|FG003|Overall Study|Protocol Violation|1|||
156507386|NCT00847626|564950945|FG004|Overall Study|Protocol Violation|1|||
156507387|NCT00847626|564950946|FG005|Overall Study|Protocol Violation|1|||
156507388|NCT00847626|564950947|FG006|Overall Study|Protocol Violation|1|||
156507389|NCT00847626|564950948|FG007|Overall Study|Protocol Violation|1|||
156507390|NCT00847626|564950949|FG008|Overall Study|Protocol Violation|0|||
156507391|NCT00847626|564950950|FG009|Overall Study|Protocol Violation|1|||
156507392|NCT00847626|564950951|FG010|Overall Study|Protocol Violation|1|||
156507393|NCT00847626|564950941|FG000|Overall Study|Lost to Follow-up|0|||
156507394|NCT00847626|564950942|FG001|Overall Study|Lost to Follow-up|1|||
156507395|NCT00847626|564950943|FG002|Overall Study|Lost to Follow-up|1|||
156507396|NCT00847626|564950944|FG003|Overall Study|Lost to Follow-up|1|||
156507397|NCT00847626|564950945|FG004|Overall Study|Lost to Follow-up|0|||
156507398|NCT00847626|564950946|FG005|Overall Study|Lost to Follow-up|3|||
156507399|NCT00847626|564950947|FG006|Overall Study|Lost to Follow-up|1|||
156507400|NCT00847626|564950948|FG007|Overall Study|Lost to Follow-up|3|||
156507401|NCT00847626|564950949|FG008|Overall Study|Lost to Follow-up|1|||
156507402|NCT00847626|564950950|FG009|Overall Study|Lost to Follow-up|0|||
156507403|NCT00847626|564950951|FG010|Overall Study|Lost to Follow-up|1|||
156507404|NCT00847626|564950941|FG000|Overall Study|Withdrawal by Subject|5|||
156507405|NCT00847626|564950942|FG001|Overall Study|Withdrawal by Subject|5|||
156507406|NCT00847626|564950943|FG002|Overall Study|Withdrawal by Subject|3|||
156507407|NCT00847626|564950944|FG003|Overall Study|Withdrawal by Subject|8|||
156507408|NCT00847626|564950945|FG004|Overall Study|Withdrawal by Subject|12|||
156507409|NCT00847626|564950946|FG005|Overall Study|Withdrawal by Subject|9|||
156507410|NCT00847626|564950947|FG006|Overall Study|Withdrawal by Subject|8|||
156507411|NCT00847626|564950948|FG007|Overall Study|Withdrawal by Subject|4|||
156507412|NCT00847626|564950949|FG008|Overall Study|Withdrawal by Subject|4|||
156507413|NCT00847626|564950950|FG009|Overall Study|Withdrawal by Subject|5|||
156507414|NCT00847626|564950951|FG010|Overall Study|Withdrawal by Subject|2|||
156507415|NCT00847626|564950941|FG000|Overall Study|Lack of Efficacy|3|||
156385384|NCT03593655|564501154|FG000|Second Product Use Period|Withdrawal by Subject|1|||
156385385|NCT03593655|564501155|FG001|Second Product Use Period|Withdrawal by Subject|1|||
156507416|NCT00847626|564950942|FG001|Overall Study|Lack of Efficacy|1|||
156507417|NCT00847626|564950943|FG002|Overall Study|Lack of Efficacy|0|||
156507418|NCT00847626|564950944|FG003|Overall Study|Lack of Efficacy|1|||
156507419|NCT00847626|564950945|FG004|Overall Study|Lack of Efficacy|2|||
156507420|NCT00847626|564950946|FG005|Overall Study|Lack of Efficacy|0|||
156507421|NCT00847626|564950947|FG006|Overall Study|Lack of Efficacy|6|||
156547252|NCT03657043|565096700|FG002|Overall Study|Withdrawal - declined follow-up|0|||
156547253|NCT03657043|565096701|FG003|Overall Study|Withdrawal - declined follow-up|0|||
156547254|NCT03657043|565096702|FG004|Overall Study|Withdrawal - declined follow-up|1|||
156547255|NCT02239939|565096707|FG000|Overall Study|Adverse Event|1|||
156547256|NCT02239939|565096708|FG001|Overall Study|Adverse Event|0|||
156547257|NCT02239939|565096707|FG000|Overall Study|Withdrawal by Subject|1|||
156547258|NCT02239939|565096708|FG001|Overall Study|Withdrawal by Subject|1|||
156547259|NCT02239939|565096707|FG000|Overall Study|Lost to Follow-up|0|||
156547260|NCT02239939|565096708|FG001|Overall Study|Lost to Follow-up|1|||
156547261|NCT05634577|565096709|FG000|Overall Study|Lost to Follow-up|1|||
156547262|NCT05634577|565096709|FG000|Overall Study|Withdrawal by Subject|1|||
156547263|NCT02631200|565096712|FG000|First Period|Death|1|||
156547264|NCT02631200|565096713|FG001|First Period|Death|2|||
156547265|NCT02631200|565096712|FG000|First Period|Patient ill-health|2|||
156385386|NCT03593655|564501154|FG000|Second Product Use Period|Lost to Follow-up|1|||
156507422|NCT00847626|564950948|FG007|Overall Study|Lack of Efficacy|2|||
156507423|NCT00847626|564950949|FG008|Overall Study|Lack of Efficacy|5|||
156507424|NCT00847626|564950950|FG009|Overall Study|Lack of Efficacy|1|||
156507425|NCT00847626|564950951|FG010|Overall Study|Lack of Efficacy|7|||
156507426|NCT00847626|564950941|FG000|Overall Study|Other|1|||
156507427|NCT00847626|564950942|FG001|Overall Study|Other|5|||
156507428|NCT00847626|564950943|FG002|Overall Study|Other|4|||
156507429|NCT00847626|564950944|FG003|Overall Study|Other|1|||
156507430|NCT00847626|564950945|FG004|Overall Study|Other|2|||
156507431|NCT00847626|564950946|FG005|Overall Study|Other|2|||
156507432|NCT00847626|564950947|FG006|Overall Study|Other|2|||
156507433|NCT00847626|564950948|FG007|Overall Study|Other|3|||
156507434|NCT00847626|564950949|FG008|Overall Study|Other|1|||
156507435|NCT00847626|564950950|FG009|Overall Study|Other|1|||
156507436|NCT00847626|564950951|FG010|Overall Study|Other|3|||
156507437|NCT00335140|564950954|FG000|Overall Study|Ineligible|1|||
156507438|NCT00737477|564950955|FG000|Overall Study|Adverse Event|9|||
156507439|NCT00737477|564950955|FG000|Overall Study|Death|9|||
156507440|NCT00737477|564950955|FG000|Overall Study|Treatment Refusal|1|||
156507441|NCT00737477|564950955|FG000|Overall Study|Withdrawal by Subject|1|||
156507442|NCT00737477|564950955|FG000|Overall Study|Renal Transplantation|10|||
156507443|NCT00737477|564950955|FG000|Overall Study|Other|4|||
156507444|NCT01132820|564950956|FG000|Overall Study|Ineligible: wrong cell type|1|||
156507445|NCT01132820|564950956|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
156507446|NCT01132820|564950956|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
156507447|NCT01132820|564950956|FG000|Overall Study|Never treated|1|||
156507448|NCT01132820|564950956|FG000|Overall Study|Inadequate data|1|||
156507449|NCT01370655|564950957|FG000|Period 1|Adverse Event|2|||
156507450|NCT01370655|564950958|FG001|Period 1|Adverse Event|0|||
156507451|NCT01370655|564950959|FG002|Period 1|Adverse Event|0|||
156507452|NCT01370655|564950960|FG003|Period 1|Adverse Event|0|||
156507453|NCT01370655|564950961|FG004|Period 1|Adverse Event|0|||
156507454|NCT01370655|564950962|FG005|Period 1|Adverse Event|0|||
156507455|NCT01370655|564950963|FG006|Period 1|Adverse Event|1|||
156507456|NCT01370655|564950964|FG007|Period 1|Adverse Event|0|||
156507457|NCT01370655|564950965|FG008|Period 1|Adverse Event|0|||
156507458|NCT01370655|564950966|FG009|Period 1|Adverse Event|0|||
156507459|NCT01370655|564950967|FG010|Period 1|Adverse Event|0|||
156507460|NCT01370655|564950968|FG011|Period 1|Adverse Event|0|||
156507461|NCT01370655|564950957|FG000|Period 2|Adverse Event|0|||
156507462|NCT01370655|564950958|FG001|Period 2|Adverse Event|0|||
156507463|NCT01370655|564950959|FG002|Period 2|Adverse Event|1|||
156507464|NCT01370655|564950960|FG003|Period 2|Adverse Event|0|||
156507465|NCT01370655|564950961|FG004|Period 2|Adverse Event|1|||
156507466|NCT01370655|564950962|FG005|Period 2|Adverse Event|0|||
156507467|NCT01370655|564950963|FG006|Period 2|Adverse Event|0|||
156507468|NCT01370655|564950964|FG007|Period 2|Adverse Event|1|||
156507469|NCT01370655|564950965|FG008|Period 2|Adverse Event|0|||
156507470|NCT01370655|564950966|FG009|Period 2|Adverse Event|0|||
156507471|NCT01370655|564950967|FG010|Period 2|Adverse Event|0|||
156507472|NCT01370655|564950968|FG011|Period 2|Adverse Event|0|||
156507473|NCT01370655|564950957|FG000|Period 2|met protocol specified stopping criteria|0|||
156507474|NCT01370655|564950958|FG001|Period 2|met protocol specified stopping criteria|0|||
156507475|NCT01370655|564950959|FG002|Period 2|met protocol specified stopping criteria|1|||
156507476|NCT01370655|564950960|FG003|Period 2|met protocol specified stopping criteria|0|||
156507477|NCT01370655|564950961|FG004|Period 2|met protocol specified stopping criteria|0|||
156507478|NCT01370655|564950962|FG005|Period 2|met protocol specified stopping criteria|0|||
156507479|NCT01370655|564950963|FG006|Period 2|met protocol specified stopping criteria|1|||
156507480|NCT01370655|564950964|FG007|Period 2|met protocol specified stopping criteria|0|||
156507481|NCT01370655|564950965|FG008|Period 2|met protocol specified stopping criteria|1|||
156507482|NCT01370655|564950966|FG009|Period 2|met protocol specified stopping criteria|0|||
156507483|NCT01370655|564950967|FG010|Period 2|met protocol specified stopping criteria|1|||
156507484|NCT01370655|564950968|FG011|Period 2|met protocol specified stopping criteria|0|||
156507485|NCT01370655|564950957|FG000|Period 2|Withdrawal by Subject|0|||
156507486|NCT01370655|564950958|FG001|Period 2|Withdrawal by Subject|0|||
156547266|NCT02631200|565096713|FG001|First Period|Patient ill-health|4|||
156547267|NCT02631200|565096712|FG000|First Period|Withdrawal by Subject|4|||
156547268|NCT02631200|565096713|FG001|First Period|Withdrawal by Subject|1|||
156547269|NCT02631200|565096712|FG000|Deferred Period|Death|0|||
156547270|NCT02631200|565096713|FG001|Deferred Period|Death|1|||
156547271|NCT02631200|565096712|FG000|Deferred Period|Received kidney transplant|0|||
156547272|NCT02631200|565096713|FG001|Deferred Period|Received kidney transplant|1|||
156547273|NCT02631200|565096712|FG000|Deferred Period|Withdrawal by Subject|0|||
156547274|NCT02631200|565096713|FG001|Deferred Period|Withdrawal by Subject|2|||
156547275|NCT02631200|565096712|FG000|Deferred Period|Lost to Follow-up|0|||
156547276|NCT02631200|565096713|FG001|Deferred Period|Lost to Follow-up|1|||
156547277|NCT04091087|565096716|FG000|Overall Study|Not treated|1|||
156547278|NCT04091087|565096717|FG001|Overall Study|Not treated|0|||
156547279|NCT04091087|565096716|FG000|Overall Study|Adverse Event|4|||
156547280|NCT04091087|565096717|FG001|Overall Study|Adverse Event|4|||
156547281|NCT04091087|565096716|FG000|Overall Study|Protocol Violation|0|||
156547282|NCT04091087|565096717|FG001|Overall Study|Protocol Violation|1|||
156547283|NCT04091087|565096716|FG000|Overall Study|Withdrawal by Subject|5|||
156547284|NCT04091087|565096717|FG001|Overall Study|Withdrawal by Subject|2|||
156547285|NCT04152161|565096718|FG000|Overall Study|Death|0|||
156547286|NCT04152161|565096719|FG001|Overall Study|Death|1|||
156547287|NCT04152161|565096718|FG000|Overall Study|Physician Decision|0|||
156547288|NCT04152161|565096719|FG001|Overall Study|Physician Decision|1|||
156547289|NCT04152161|565096718|FG000|Overall Study|Lost to Follow-up|9|||
156547290|NCT04152161|565096719|FG001|Overall Study|Lost to Follow-up|3|||
156547291|NCT04152161|565096718|FG000|Overall Study|Protocol Violation|1|||
156547292|NCT04152161|565096719|FG001|Overall Study|Protocol Violation|0|||
156547293|NCT04152161|565096718|FG000|Overall Study|Withdrawal by Subject|29|||
156547294|NCT04152161|565096719|FG001|Overall Study|Withdrawal by Subject|28|||
156547295|NCT04152161|565096718|FG000|Overall Study|Sponsor termination of study|750|||
156547296|NCT04152161|565096719|FG001|Overall Study|Sponsor termination of study|755|||
156547297|NCT04152161|565096718|FG000|Overall Study|Other|20|||
156547298|NCT04152161|565096719|FG001|Overall Study|Other|18|||
156547299|NCT03363321|565096720|FG000|Overall Study|Withdrawal by Subject|0|||
156547300|NCT03363321|565096721|FG001|Overall Study|Withdrawal by Subject|1|||
156547301|NCT03363321|565096722|FG002|Overall Study|Withdrawal by Subject|0|||
156547302|NCT03363321|565096723|FG003|Overall Study|Withdrawal by Subject|1|||
156547303|NCT03363321|565096724|FG004|Overall Study|Withdrawal by Subject|0|||
156547304|NCT02590588|565096727|FG000|Overall Study|Adverse Event|1|||
156547305|NCT01780831|565096735|FG000|Overall Study|Withdrawal by Subject|0|||
156547306|NCT01780831|565096736|FG001|Overall Study|Withdrawal by Subject|0|||
156547307|NCT01780831|565096737|FG002|Overall Study|Withdrawal by Subject|4|||
156547308|NCT01780831|565096738|FG003|Overall Study|Withdrawal by Subject|0|||
156547309|NCT01780831|565096735|FG000|Overall Study|Lost to Follow-up|0|||
156547310|NCT01780831|565096736|FG001|Overall Study|Lost to Follow-up|0|||
156547311|NCT01780831|565096737|FG002|Overall Study|Lost to Follow-up|0|||
156547312|NCT01780831|565096738|FG003|Overall Study|Lost to Follow-up|1|||
156547313|NCT01784861|565096741|FG000|Overall Study|Adverse Event|0|||
156547314|NCT01784861|565096742|FG001|Overall Study|Adverse Event|0|||
156547315|NCT01784861|565096743|FG002|Overall Study|Adverse Event|1|||
156547316|NCT01784861|565096744|FG003|Overall Study|Adverse Event|2|||
156547317|NCT01784861|565096745|FG004|Overall Study|Adverse Event|1|||
156547318|NCT01784861|565096746|FG005|Overall Study|Adverse Event|0|||
156547319|NCT01784861|565096741|FG000|Overall Study|Withdrawal by Subject|0|||
156547320|NCT01784861|565096742|FG001|Overall Study|Withdrawal by Subject|0|||
156547321|NCT01784861|565096743|FG002|Overall Study|Withdrawal by Subject|0|||
156547322|NCT01784861|565096744|FG003|Overall Study|Withdrawal by Subject|1|||
156547323|NCT01784861|565096745|FG004|Overall Study|Withdrawal by Subject|0|||
156547324|NCT01784861|565096746|FG005|Overall Study|Withdrawal by Subject|0|||
156547325|NCT01784861|565096741|FG000|Overall Study|Physician Decision|0|||
156547326|NCT01784861|565096742|FG001|Overall Study|Physician Decision|0|||
156547327|NCT01784861|565096743|FG002|Overall Study|Physician Decision|0|||
156547328|NCT01784861|565096744|FG003|Overall Study|Physician Decision|2|||
156547329|NCT01784861|565096745|FG004|Overall Study|Physician Decision|0|||
156547330|NCT01784861|565096746|FG005|Overall Study|Physician Decision|1|||
156547331|NCT01965262|565096760|FG000|Second Intervention (7 Days)|Discontinued|0|||
156547332|NCT01965262|565096761|FG001|Second Intervention (7 Days)|Discontinued|1|||
156547333|NCT01965262|565096760|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
156547334|NCT01965262|565096761|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
156547335|NCT01965262|565096760|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
156547336|NCT01965262|565096761|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
156547337|NCT00143312|565096762|FG000|Overall Study|Death|11|||
156547338|NCT00143312|565096762|FG000|Overall Study|Adverse Event|2|||
156547339|NCT00143312|565096762|FG000|Overall Study|Lost to Follow-up|1|||
156547340|NCT00143312|565096762|FG000|Overall Study|Other|1|||
156547341|NCT00143312|565096762|FG000|Overall Study|Withdrawal by Subject|1|||
156547342|NCT00906087|565096763|FG000|Initial Washout|Withdrawal by Subject|1|||
156547343|NCT00906087|565096763|FG000|Initial Washout|Physician Decision|1|||
156547344|NCT01046877|565096775|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
156507487|NCT01370655|564950959|FG002|Period 2|Withdrawal by Subject|0|||
156507488|NCT01370655|564950960|FG003|Period 2|Withdrawal by Subject|0|||
156507489|NCT01370655|564950961|FG004|Period 2|Withdrawal by Subject|0|||
156507490|NCT01370655|564950962|FG005|Period 2|Withdrawal by Subject|0|||
156507491|NCT01370655|564950963|FG006|Period 2|Withdrawal by Subject|0|||
156507492|NCT01370655|564950964|FG007|Period 2|Withdrawal by Subject|0|||
156507493|NCT01370655|564950965|FG008|Period 2|Withdrawal by Subject|1|||
156507494|NCT01370655|564950966|FG009|Period 2|Withdrawal by Subject|0|||
156507495|NCT01370655|564950967|FG010|Period 2|Withdrawal by Subject|0|||
156507496|NCT01370655|564950968|FG011|Period 2|Withdrawal by Subject|0|||
156507497|NCT00667394|564950972|FG000|Overall Study|Adverse Event|3|||
156507498|NCT00667394|564950973|FG001|Overall Study|Adverse Event|0|||
156507499|NCT00667394|564950972|FG000|Overall Study|Progressive disease|1|||
156507500|NCT00667394|564950973|FG001|Overall Study|Progressive disease|0|||
156507501|NCT04076943|564950977|FG000|Overall Study|Withdrawal by Subject|12|||
156507502|NCT04076943|564950977|FG000|Overall Study|Adverse Event|1|||
156507503|NCT04076943|564950977|FG000|Overall Study|Progressive Disease|2|||
156507504|NCT04076943|564950977|FG000|Overall Study|Death|13|||
156507505|NCT04076943|564950977|FG000|Overall Study|Other than specified|6|||
156507506|NCT02224703|564950980|FG000|Overall Study|Adverse Event|0|||
156507507|NCT02224703|564950981|FG001|Overall Study|Adverse Event|5|||
156507508|NCT02224703|564950982|FG002|Overall Study|Adverse Event|0|||
156507509|NCT02224703|564950980|FG000|Overall Study|Withdrawn by investigator|1|||
156507510|NCT02224703|564950981|FG001|Overall Study|Withdrawn by investigator|0|||
156507511|NCT02224703|564950982|FG002|Overall Study|Withdrawn by investigator|0|||
156507512|NCT02224703|564950980|FG000|Overall Study|Advised by medical monitor|1|||
156507513|NCT02224703|564950981|FG001|Overall Study|Advised by medical monitor|0|||
156507514|NCT02224703|564950982|FG002|Overall Study|Advised by medical monitor|0|||
156507515|NCT02224703|564950980|FG000|Overall Study|Withdrawn by parent/guardian|0|||
156507516|NCT02224703|564950981|FG001|Overall Study|Withdrawn by parent/guardian|1|||
156507517|NCT02224703|564950982|FG002|Overall Study|Withdrawn by parent/guardian|0|||
156507518|NCT02224703|564950980|FG000|Overall Study|Lack of Efficacy|1|||
156507519|NCT02224703|564950981|FG001|Overall Study|Lack of Efficacy|0|||
156507520|NCT02224703|564950982|FG002|Overall Study|Lack of Efficacy|0|||
156507521|NCT00332462|564950983|FG000|Overall Study|Adverse Event|5|||
156507522|NCT00332462|564950983|FG000|Overall Study|Abnormal Lab Value|1|||
156507523|NCT00332462|564950983|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156507524|NCT00332462|564950983|FG000|Overall Study|no longer requires study drug|1|||
156507525|NCT00332462|564950983|FG000|Overall Study|Death|3|||
156507526|NCT00332462|564950983|FG000|Overall Study|Graft Loss|2|||
156507527|NCT02922023|564950986|FG000|Overall Study|Lost to Follow-up|2|||
156507528|NCT02922023|564950987|FG001|Overall Study|Lost to Follow-up|0|||
156507529|NCT02159040|564950993|FG000|Overall Study|Death|1|||
156507530|NCT02766777|564950997|FG000|Overall Study|Adverse Event|12|||
156507531|NCT02766777|564950997|FG000|Overall Study|Lost to Follow-up|16|||
156507532|NCT02766777|564950997|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156507533|NCT02766777|564950997|FG000|Overall Study|Protocol Violation|1|||
156507534|NCT02766777|564950997|FG000|Overall Study|Withdrawal by Subject|4|||
156507535|NCT01886287|564950998|FG000|Overall Study|Radiographic disease progression|1|||
156507536|NCT01886287|564950998|FG000|Overall Study|Clinical progression due to disease|1|||
156507537|NCT01602510|564951001|FG000|Open Label Phase|Adverse Event|46|||
156507538|NCT01602510|564951002|FG001|Open Label Phase|Adverse Event|0|||
156507539|NCT01602510|564951003|FG002|Open Label Phase|Adverse Event|0|||
156507540|NCT01602510|564951001|FG000|Open Label Phase|Lack of Efficacy|22|||
156507541|NCT01602510|564951002|FG001|Open Label Phase|Lack of Efficacy|0|||
156507542|NCT01602510|564951003|FG002|Open Label Phase|Lack of Efficacy|0|||
156507543|NCT01602510|564951001|FG000|Open Label Phase|Protocol Violation|15|||
156507544|NCT01602510|564951002|FG001|Open Label Phase|Protocol Violation|0|||
156507545|NCT01602510|564951003|FG002|Open Label Phase|Protocol Violation|0|||
156507546|NCT01602510|564951001|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
156507547|NCT01602510|564951002|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
156507548|NCT01602510|564951003|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
156507549|NCT01602510|564951001|FG000|Open Label Phase|Lost to Follow-up|22|||
156507550|NCT01602510|564951002|FG001|Open Label Phase|Lost to Follow-up|0|||
156507551|NCT01602510|564951003|FG002|Open Label Phase|Lost to Follow-up|0|||
156507552|NCT01602510|564951001|FG000|Open Label Phase|Physician Decision|19|||
156507553|NCT01602510|564951002|FG001|Open Label Phase|Physician Decision|0|||
156507554|NCT01602510|564951003|FG002|Open Label Phase|Physician Decision|0|||
156507555|NCT01602510|564951001|FG000|Open Label Phase|Withdrawal by Subject|57|||
156507556|NCT01602510|564951002|FG001|Open Label Phase|Withdrawal by Subject|0|||
156507557|NCT01602510|564951003|FG002|Open Label Phase|Withdrawal by Subject|0|||
156507558|NCT01602510|564951001|FG000|Randomized Phase|Adverse Event|0|||
156507559|NCT01602510|564951002|FG001|Randomized Phase|Adverse Event|2|||
156507560|NCT01602510|564951003|FG002|Randomized Phase|Adverse Event|6|||
156507561|NCT01602510|564951001|FG000|Randomized Phase|Lack of Efficacy|0|||
156507562|NCT01602510|564951002|FG001|Randomized Phase|Lack of Efficacy|4|||
156507563|NCT01602510|564951003|FG002|Randomized Phase|Lack of Efficacy|4|||
156507564|NCT01602510|564951001|FG000|Randomized Phase|Protocol Violation|0|||
156385387|NCT03593655|564501155|FG001|Second Product Use Period|Lost to Follow-up|0|||
156385388|NCT03593655|564501154|FG000|Third Product Use Period|Lost to Follow-up|1|||
156385389|NCT03593655|564501155|FG001|Third Product Use Period|Lost to Follow-up|2|||
156385390|NCT03593655|564501154|FG000|Third Product Use Period|Physician Decision|0|||
156385391|NCT03593655|564501155|FG001|Third Product Use Period|Physician Decision|1|||
156385392|NCT03593655|564501154|FG000|Third Product Use Period|Withdrawal by Subject|0|||
156385393|NCT03593655|564501155|FG001|Third Product Use Period|Withdrawal by Subject|1|||
156385394|NCT03732209|564501156|FG000|Overall Study|Lost to Follow-up|4|||
156385395|NCT03732209|564501157|FG001|Overall Study|Lost to Follow-up|4|||
156385396|NCT03732209|564501156|FG000|Overall Study|Withdrawal by Subject|8|||
156385397|NCT03732209|564501157|FG001|Overall Study|Withdrawal by Subject|9|||
156385398|NCT05046795|564501158|FG000|Overall Study|Adverse Event|13|||
156507565|NCT01602510|564951002|FG001|Randomized Phase|Protocol Violation|3|||
156507566|NCT01602510|564951003|FG002|Randomized Phase|Protocol Violation|3|||
156507567|NCT01602510|564951001|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
156507568|NCT01602510|564951002|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
156507569|NCT01602510|564951003|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
156507570|NCT01602510|564951001|FG000|Randomized Phase|Lost to Follow-up|0|||
156507571|NCT01602510|564951002|FG001|Randomized Phase|Lost to Follow-up|1|||
156507572|NCT01602510|564951003|FG002|Randomized Phase|Lost to Follow-up|3|||
156507573|NCT01602510|564951001|FG000|Randomized Phase|Physician Decision|0|||
156507574|NCT01602510|564951002|FG001|Randomized Phase|Physician Decision|0|||
156507575|NCT01602510|564951003|FG002|Randomized Phase|Physician Decision|2|||
156507576|NCT01602510|564951001|FG000|Randomized Phase|Withdrawal by Subject|0|||
156507577|NCT01602510|564951002|FG001|Randomized Phase|Withdrawal by Subject|6|||
156507578|NCT01602510|564951003|FG002|Randomized Phase|Withdrawal by Subject|7|||
156507579|NCT01195623|564951004|FG000|Overall Study|Lost to Follow-up|35|||
156507580|NCT01195623|564951005|FG001|Overall Study|Lost to Follow-up|37|||
156507581|NCT00534495|564951006|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
156507582|NCT00534495|564951007|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
156507583|NCT00534495|564951008|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
156507584|NCT00534495|564951006|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
156507585|NCT00534495|564951007|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
156507586|NCT00534495|564951008|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
156507587|NCT00534495|564951006|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
156507588|NCT00534495|564951007|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
156507589|NCT00534495|564951008|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
156507590|NCT00534495|564951006|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
156507591|NCT00534495|564951007|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
156507592|NCT00534495|564951008|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
156507593|NCT00534495|564951006|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
156507594|NCT00534495|564951007|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
156507595|NCT00534495|564951008|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
156507596|NCT00534495|564951006|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
156507597|NCT00534495|564951007|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
156507598|NCT00534495|564951008|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
156507599|NCT00534495|564951006|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
156507600|NCT00534495|564951007|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
156507601|NCT00534495|564951008|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
156507602|NCT00534495|564951006|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
156507603|NCT00534495|564951007|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
156507604|NCT00534495|564951008|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
156507605|NCT00534495|564951006|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
156507606|NCT00534495|564951007|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
156507607|NCT00534495|564951008|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
156507608|NCT02920970|564951012|FG000|First Intervention|Protocol Violation|0|||
156507609|NCT02920970|564951013|FG001|First Intervention|Protocol Violation|1|||
156507610|NCT02920970|564951012|FG000|First Intervention|Adverse Event|0|||
156507611|NCT02920970|564951013|FG001|First Intervention|Adverse Event|1|||
156507612|NCT02920970|564951012|FG000|Second Intervention|Poor Lens Fit|1|||
156507613|NCT02920970|564951013|FG001|Second Intervention|Poor Lens Fit|0|||
156507614|NCT01711853|564951014|FG000|Overall Study|Not treated|3|||
156507615|NCT04191616|564951015|FG000|Pre-assignment Period|Did not receive study treatment|2|||
156507616|NCT04191616|564951015|FG000|Treatment Period|Death|37|||
156507617|NCT04191616|564951015|FG000|Treatment Period|Sponsor decision|11|||
156385399|NCT05046795|564501159|FG001|Overall Study|Adverse Event|15|||
156385400|NCT05046795|564501158|FG000|Overall Study|Withdrawal by Subject|4|||
156385401|NCT05046795|564501159|FG001|Overall Study|Withdrawal by Subject|7|||
156385402|NCT05046795|564501158|FG000|Overall Study|Physician Decision|1|||
156507618|NCT04191616|564951015|FG000|Treatment Period|Withdrawal by Subject|4|||
156507619|NCT01361594|564951016|FG000|Overall Study|Withdrawal by Subject|1|||
156547345|NCT01046877|565096775|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
156547346|NCT01152021|565096785|FG000|Overall Study|Adverse Event|4|||
156547347|NCT01152021|565096786|FG001|Overall Study|Adverse Event|4|||
156547348|NCT01152021|565096785|FG000|Overall Study|Study drug had expired|1|||
156547349|NCT01152021|565096786|FG001|Overall Study|Study drug had expired|0|||
156547350|NCT01152021|565096785|FG000|Overall Study|Physician Decision|1|||
156547351|NCT01152021|565096786|FG001|Overall Study|Physician Decision|1|||
156547352|NCT01152021|565096785|FG000|Overall Study|No access to study drug in Pharmacy|0|||
156547353|NCT01152021|565096786|FG001|Overall Study|No access to study drug in Pharmacy|1|||
156547354|NCT00563186|565096787|FG000|Overall Study|LOS<48 hours|97|||
156547355|NCT00563186|565096788|FG001|Overall Study|LOS<48 hours|74|||
156547356|NCT00563186|565096787|FG000|Overall Study|Incomplete data|1|||
156547357|NCT00563186|565096788|FG001|Overall Study|Incomplete data|1|||
156547358|NCT04288154|565096789|FG000|Overall Study|Withdrawal by Subject|9|||
156547359|NCT04288154|565096790|FG001|Overall Study|Withdrawal by Subject|9|||
156547360|NCT01902290|565096796|FG000|Overall Study|Withdrawal by Subject|19|||
156547361|NCT01902290|565096797|FG001|Overall Study|Withdrawal by Subject|27|||
156547362|NCT01902290|565096796|FG000|Overall Study|Lost to Follow-up|2|||
156547363|NCT01902290|565096797|FG001|Overall Study|Lost to Follow-up|2|||
156547364|NCT01902290|565096796|FG000|Overall Study|Death|1|||
156547365|NCT01902290|565096797|FG001|Overall Study|Death|0|||
156547366|NCT01902290|565096796|FG000|Overall Study|Sponsor Decision|26|||
156547367|NCT01902290|565096797|FG001|Overall Study|Sponsor Decision|24|||
156547368|NCT00769184|565096798|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
156547369|NCT00769184|565096799|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
156547370|NCT00769184|565096798|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
156547371|NCT00769184|565096799|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
156547372|NCT00769184|565096798|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
156547373|NCT00769184|565096799|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
156547374|NCT00517829|565096800|FG000|Overall Study|Adverse Event|22|||
156547375|NCT00517829|565096801|FG001|Overall Study|Adverse Event|34|||
156547376|NCT00517829|565096800|FG000|Overall Study|Disease Progression|39|||
156547377|NCT00517829|565096801|FG001|Overall Study|Disease Progression|32|||
156547378|NCT00517829|565096800|FG000|Overall Study|Patient Request|6|||
156547379|NCT00517829|565096801|FG001|Overall Study|Patient Request|5|||
156547380|NCT00517829|565096800|FG000|Overall Study|Investigator Request|5|||
156547381|NCT00517829|565096801|FG001|Overall Study|Investigator Request|3|||
156547382|NCT00517829|565096800|FG000|Overall Study|Other|3|||
156547383|NCT00517829|565096801|FG001|Overall Study|Other|1|||
156547384|NCT00446511|565096802|FG000|Overall Study|Adverse Event|7|||
156547385|NCT00446511|565096803|FG001|Overall Study|Adverse Event|2|||
156547386|NCT00446511|565096804|FG002|Overall Study|Adverse Event|3|||
156547387|NCT00446511|565096805|FG003|Overall Study|Adverse Event|1|||
156547388|NCT00446511|565096802|FG000|Overall Study|Protocol Violation|0|||
156547389|NCT00446511|565096803|FG001|Overall Study|Protocol Violation|0|||
156547390|NCT00446511|565096804|FG002|Overall Study|Protocol Violation|0|||
156547391|NCT00446511|565096805|FG003|Overall Study|Protocol Violation|1|||
156547392|NCT00446511|565096802|FG000|Overall Study|Withdrawal by Subject|0|||
156547393|NCT00446511|565096803|FG001|Overall Study|Withdrawal by Subject|0|||
156547394|NCT00446511|565096804|FG002|Overall Study|Withdrawal by Subject|0|||
156547395|NCT00446511|565096805|FG003|Overall Study|Withdrawal by Subject|3|||
156547396|NCT00446511|565096802|FG000|Overall Study|Administrative Problems|3|||
156547397|NCT00446511|565096803|FG001|Overall Study|Administrative Problems|0|||
156547398|NCT00446511|565096804|FG002|Overall Study|Administrative Problems|4|||
156547399|NCT00446511|565096805|FG003|Overall Study|Administrative Problems|1|||
156547400|NCT03873714|565096813|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
156547401|NCT00845650|565096814|FG000|Overall Study|Withdrawal by Subject|0|||
156547402|NCT00845650|565096815|FG001|Overall Study|Withdrawal by Subject|0|||
156547403|NCT00845650|565096816|FG002|Overall Study|Withdrawal by Subject|0|||
156547404|NCT00845650|565096817|FG003|Overall Study|Withdrawal by Subject|0|||
156547405|NCT00845650|565096818|FG004|Overall Study|Withdrawal by Subject|2|||
156547406|NCT00845650|565096819|FG005|Overall Study|Withdrawal by Subject|0|||
156547407|NCT00845650|565096814|FG000|Overall Study|Lost to Follow-up|0|||
156547408|NCT00845650|565096815|FG001|Overall Study|Lost to Follow-up|0|||
156547409|NCT00845650|565096816|FG002|Overall Study|Lost to Follow-up|3|||
156547410|NCT00845650|565096817|FG003|Overall Study|Lost to Follow-up|1|||
156547411|NCT00845650|565096818|FG004|Overall Study|Lost to Follow-up|0|||
156547412|NCT00845650|565096819|FG005|Overall Study|Lost to Follow-up|1|||
156547413|NCT00845650|565096814|FG000|Overall Study|Sponsor hold on dosing|0|||
156547414|NCT00845650|565096815|FG001|Overall Study|Sponsor hold on dosing|0|||
156547415|NCT00845650|565096816|FG002|Overall Study|Sponsor hold on dosing|0|||
156547416|NCT00845650|565096817|FG003|Overall Study|Sponsor hold on dosing|0|||
156547417|NCT00845650|565096818|FG004|Overall Study|Sponsor hold on dosing|1|||
156547418|NCT00845650|565096819|FG005|Overall Study|Sponsor hold on dosing|1|||
156547419|NCT00845650|565096814|FG000|Overall Study|Unable to access IV line|1|||
156547420|NCT00845650|565096815|FG001|Overall Study|Unable to access IV line|0|||
156547421|NCT00845650|565096816|FG002|Overall Study|Unable to access IV line|0|||
156385403|NCT05046795|564501159|FG001|Overall Study|Physician Decision|2|||
156385404|NCT05046795|564501158|FG000|Overall Study|Protocol Violation|1|||
156385405|NCT05046795|564501159|FG001|Overall Study|Protocol Violation|2|||
156385406|NCT05046795|564501158|FG000|Overall Study|Death|1|||
156385407|NCT05046795|564501159|FG001|Overall Study|Death|0|||
156385408|NCT05046795|564501158|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
156385409|NCT05046795|564501159|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
156385410|NCT01910519|564501160|FG000|Overall Study|Withdrawal by Subject|2|||
156385411|NCT01910519|564501161|FG001|Overall Study|Withdrawal by Subject|0|||
156385412|NCT01910519|564501160|FG000|Overall Study|Adverse Event|2|||
156385413|NCT01910519|564501161|FG001|Overall Study|Adverse Event|0|||
156385414|NCT04266028|564501162|FG000|Overall Study|Adverse Event|0|||
156385415|NCT04266028|564501163|FG001|Overall Study|Adverse Event|0|||
156385416|NCT04266028|564501164|FG002|Overall Study|Adverse Event|1|||
156385417|NCT04266028|564501165|FG003|Overall Study|Adverse Event|0|||
156385418|NCT04266028|564501166|FG004|Overall Study|Adverse Event|1|||
156385419|NCT04266028|564501167|FG005|Overall Study|Adverse Event|0|||
156385420|NCT04266028|564501168|FG006|Overall Study|Adverse Event|2|||
156385421|NCT04266028|564501169|FG007|Overall Study|Adverse Event|0|||
156385422|NCT04266028|564501162|FG000|Overall Study|temporary halt of the study|0|||
156385423|NCT04266028|564501163|FG001|Overall Study|temporary halt of the study|0|||
156385424|NCT04266028|564501164|FG002|Overall Study|temporary halt of the study|0|||
156385425|NCT04266028|564501165|FG003|Overall Study|temporary halt of the study|0|||
156385426|NCT04266028|564501166|FG004|Overall Study|temporary halt of the study|0|||
156385427|NCT04266028|564501167|FG005|Overall Study|temporary halt of the study|0|||
156385428|NCT04266028|564501168|FG006|Overall Study|temporary halt of the study|2|||
156385429|NCT04266028|564501169|FG007|Overall Study|temporary halt of the study|1|||
156385430|NCT04266028|564501162|FG000|Overall Study|Onset of birch pollen season|0|||
156385431|NCT04266028|564501163|FG001|Overall Study|Onset of birch pollen season|0|||
156385432|NCT04266028|564501164|FG002|Overall Study|Onset of birch pollen season|0|||
156385433|NCT04266028|564501165|FG003|Overall Study|Onset of birch pollen season|0|||
156385434|NCT04266028|564501166|FG004|Overall Study|Onset of birch pollen season|1|||
156385435|NCT04266028|564501167|FG005|Overall Study|Onset of birch pollen season|0|||
156385436|NCT04266028|564501168|FG006|Overall Study|Onset of birch pollen season|0|||
156385437|NCT04266028|564501169|FG007|Overall Study|Onset of birch pollen season|0|||
156385438|NCT02720484|564501170|FG000|Treatment on Study|Adverse Event|1|||
156385439|NCT02720484|564501170|FG000|Treatment on Study|Withdrawal by Subject|1|||
156385440|NCT02720484|564501170|FG000|Treatment on Study|Progressive Disease|4|||
156385441|NCT02720484|564501170|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
156385442|NCT02720484|564501170|FG000|Follow Up for 2 Years|Death|3|||
156385443|NCT02720484|564501170|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
156385444|NCT01617629|564501173|FG000|Overall Study|Death|2|||
156385445|NCT01617629|564501173|FG000|Overall Study|Investigator's Clinical Judgement|1|||
156385446|NCT01617629|564501173|FG000|Overall Study|Reason Not Specified|1|||
156385447|NCT01617629|564501173|FG000|Overall Study|Participant Withdrew Consent|2|||
156385448|NCT01663636|564501176|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
156385449|NCT01663636|564501177|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
156385450|NCT02715765|564501178|FG000|Overall Study|Study Termination|3|||
156385451|NCT02715765|564501179|FG001|Overall Study|Study Termination|0|||
156385452|NCT02715765|564501180|FG002|Overall Study|Study Termination|0|||
156385453|NCT02838017|564501182|FG000|Overall Study|Lost to Follow-up|14|||
156385454|NCT02838017|564501183|FG001|Overall Study|Lost to Follow-up|11|||
156385455|NCT01692197|564501184|FG000|Overall Study|Failed Screening|3|||
156385456|NCT02120924|564501185|FG000|Overall Study|Lack of Efficacy|1|||
156385457|NCT02120924|564501186|FG001|Overall Study|Lack of Efficacy|2|||
156385458|NCT02120924|564501187|FG002|Overall Study|Lack of Efficacy|3|||
156547422|NCT00845650|565096817|FG003|Overall Study|Unable to access IV line|0|||
156547423|NCT00845650|565096818|FG004|Overall Study|Unable to access IV line|0|||
156547424|NCT00845650|565096819|FG005|Overall Study|Unable to access IV line|0|||
156547425|NCT00814892|565096820|FG000|Overall Study|Disease Progression|1|||
156547426|NCT00814892|565096820|FG000|Overall Study|Study Termination|1|||
156385459|NCT02120924|564501185|FG000|Overall Study|Adverse Event|0|||
156385460|NCT02120924|564501186|FG001|Overall Study|Adverse Event|1|||
156385461|NCT02120924|564501187|FG002|Overall Study|Adverse Event|3|||
156385462|NCT02120924|564501185|FG000|Overall Study|Withdrawal by Subject|16|||
156385463|NCT02120924|564501186|FG001|Overall Study|Withdrawal by Subject|20|||
156385464|NCT02120924|564501187|FG002|Overall Study|Withdrawal by Subject|8|||
156385465|NCT02120924|564501185|FG000|Overall Study|Lost to Follow-up|14|||
156385466|NCT02120924|564501186|FG001|Overall Study|Lost to Follow-up|14|||
156385467|NCT02120924|564501187|FG002|Overall Study|Lost to Follow-up|11|||
156385468|NCT02120924|564501185|FG000|Overall Study|Pregnancy|2|||
156385469|NCT02120924|564501186|FG001|Overall Study|Pregnancy|0|||
156385470|NCT02120924|564501187|FG002|Overall Study|Pregnancy|0|||
156385471|NCT02120924|564501185|FG000|Overall Study|Protocol Violation|3|||
156385472|NCT02120924|564501186|FG001|Overall Study|Protocol Violation|7|||
156385473|NCT02120924|564501187|FG002|Overall Study|Protocol Violation|2|||
156385474|NCT02120924|564501185|FG000|Overall Study|Physician Decision|0|||
156385475|NCT02120924|564501186|FG001|Overall Study|Physician Decision|1|||
156385476|NCT02120924|564501187|FG002|Overall Study|Physician Decision|1|||
156385477|NCT02120924|564501185|FG000|Overall Study|Death|1|||
156385478|NCT02120924|564501186|FG001|Overall Study|Death|0|||
156385479|NCT02120924|564501187|FG002|Overall Study|Death|0|||
156385480|NCT02120924|564501185|FG000|Overall Study|Compliance with IP|5|||
156385481|NCT02120924|564501186|FG001|Overall Study|Compliance with IP|1|||
156385482|NCT02120924|564501187|FG002|Overall Study|Compliance with IP|1|||
156385483|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
156385484|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
156385485|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
156385486|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
156385487|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
156385488|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
156385489|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
156385490|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
156385491|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
156385492|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
156385493|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
156385494|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
156385495|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
156385496|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
156385497|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
156385498|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
156385499|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
156385500|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
156385501|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
156385502|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
156385503|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
156385504|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
156385505|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
156385506|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
156385507|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
156385508|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
156385509|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
156385510|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
156385511|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
156385512|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
156385513|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
156385514|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
156385515|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
156385516|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
156385517|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
156385518|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
156385519|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
156385520|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
156385521|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
156385522|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
156385523|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
156385524|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
156385525|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
156385526|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
156385527|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
156385528|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
156385529|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
156385530|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
156385531|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
156385532|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
156385533|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
156385534|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
156385535|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
156385536|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
156507620|NCT01361594|564951017|FG001|Overall Study|Withdrawal by Subject|2|||
156507621|NCT03651700|564951019|FG000|Overall Study|Withdrawal by Subject|1|||
156385537|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
156385538|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
156385539|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
156385540|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
156385541|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
156385542|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
156385543|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
156385544|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
156385545|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
156385546|NCT01884350|564501188|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
156385547|NCT01884350|564501189|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
156385548|NCT01884350|564501190|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
156385549|NCT03588572|564501197|FG000|Visitation 1|Lack of Efficacy|1|||
156385550|NCT03588572|564501198|FG001|Visitation 1|Lack of Efficacy|1|||
156385551|NCT03588572|564501197|FG000|Visitation 2|Lost to Follow-up|1|||
156385552|NCT03588572|564501198|FG001|Visitation 2|Lost to Follow-up|1|||
156385553|NCT03588572|564501197|FG000|Visitation 2|Lack of Efficacy|0|||
156385554|NCT03588572|564501198|FG001|Visitation 2|Lack of Efficacy|1|||
156385555|NCT03588572|564501197|FG000|Visitation 2|Withdrawal by Subject|1|||
156385556|NCT03588572|564501198|FG001|Visitation 2|Withdrawal by Subject|0|||
156385557|NCT03588572|564501197|FG000|Visitation 3|Lost to Follow-up|1|||
156385558|NCT03588572|564501198|FG001|Visitation 3|Lost to Follow-up|1|||
156385559|NCT03588572|564501197|FG000|Visitation 3|Physician Decision|1|||
156385560|NCT03588572|564501198|FG001|Visitation 3|Physician Decision|1|||
156385561|NCT03588572|564501197|FG000|Visitation 3|Withdrawal by Subject|1|||
156385562|NCT03588572|564501198|FG001|Visitation 3|Withdrawal by Subject|0|||
156385563|NCT01308580|564501204|FG000|Overall Study|Lost to Follow-up|12|||
156385564|NCT01308580|564501205|FG001|Overall Study|Lost to Follow-up|7|||
156385565|NCT03823651|564501206|FG000|Overall Study|Death|5|||
156507622|NCT03651700|564951020|FG001|Overall Study|Withdrawal by Subject|0|||
156507623|NCT04978090|564951024|FG000|Overall Study|unable to adequately fit device|2|||
156507624|NCT00935532|564951027|FG000|Overall Study|Adverse Event|11|||
156507625|NCT00935532|564951028|FG001|Overall Study|Adverse Event|6|||
156507626|NCT00935532|564951027|FG000|Overall Study|Death|1|||
156507627|NCT00935532|564951028|FG001|Overall Study|Death|0|||
156507628|NCT00935532|564951027|FG000|Overall Study|Lost to Follow-up|1|||
156507629|NCT00935532|564951028|FG001|Overall Study|Lost to Follow-up|0|||
156507630|NCT00935532|564951027|FG000|Overall Study|Physician Decision|1|||
156507631|NCT00935532|564951028|FG001|Overall Study|Physician Decision|2|||
156507632|NCT00935532|564951027|FG000|Overall Study|Protocol Violation|2|||
156507633|NCT00935532|564951028|FG001|Overall Study|Protocol Violation|1|||
156507634|NCT00935532|564951027|FG000|Overall Study|Subject Decision|2|||
156507635|NCT00935532|564951028|FG001|Overall Study|Subject Decision|1|||
156507636|NCT00935532|564951027|FG000|Overall Study|Sponsor Decision|0|||
156507637|NCT00935532|564951028|FG001|Overall Study|Sponsor Decision|1|||
156507638|NCT00935532|564951027|FG000|Overall Study|Loss Glucose Control|4|||
156507639|NCT00935532|564951028|FG001|Overall Study|Loss Glucose Control|0|||
156507640|NCT02227992|564951029|FG000|Overall Study|Lost to Follow-up|1|||
156507641|NCT02227992|564951030|FG001|Overall Study|Lost to Follow-up|1|||
156507642|NCT01371708|564951035|FG000|Overall Study|Insufficient clinical response|3|||
156507643|NCT01371708|564951036|FG001|Overall Study|Insufficient clinical response|2|||
156507644|NCT01371708|564951037|FG002|Overall Study|Insufficient clinical response|0|||
156507645|NCT01371708|564951035|FG000|Overall Study|Lost to Follow-up|5|||
156507646|NCT01371708|564951036|FG001|Overall Study|Lost to Follow-up|9|||
156507647|NCT01371708|564951037|FG002|Overall Study|Lost to Follow-up|7|||
156507648|NCT01371708|564951035|FG000|Overall Study|Protocol Violation|2|||
156507649|NCT01371708|564951036|FG001|Overall Study|Protocol Violation|1|||
156507650|NCT01371708|564951037|FG002|Overall Study|Protocol Violation|2|||
156507651|NCT01371708|564951035|FG000|Overall Study|No longer willing to participate|7|||
156507652|NCT01371708|564951036|FG001|Overall Study|No longer willing to participate|7|||
156507653|NCT01371708|564951037|FG002|Overall Study|No longer willing to participate|13|||
156507654|NCT01371708|564951035|FG000|Overall Study|Medication error/not related to AE|0|||
156507655|NCT01371708|564951036|FG001|Overall Study|Medication error/not related to AE|1|||
156507656|NCT01371708|564951037|FG002|Overall Study|Medication error/not related to AE|0|||
156507657|NCT01371708|564951035|FG000|Overall Study|Other|3|||
156507658|NCT01371708|564951036|FG001|Overall Study|Other|2|||
156507659|NCT01371708|564951037|FG002|Overall Study|Other|4|||
156507660|NCT01371708|564951035|FG000|Overall Study|Adverse Event|5|||
156507661|NCT01371708|564951036|FG001|Overall Study|Adverse Event|8|||
156507662|NCT01371708|564951037|FG002|Overall Study|Adverse Event|12|||
156547427|NCT00531752|565096824|FG000|First Double-blind Intervention Period|Adverse Event|2|||
156547428|NCT00531752|565096825|FG001|First Double-blind Intervention Period|Adverse Event|0|||
156385566|NCT03823651|564501207|FG001|Overall Study|Death|0|||
156385567|NCT03823651|564501206|FG000|Overall Study|Physician Decision|1|||
156507663|NCT01371708|564951035|FG000|Overall Study|Started but did not receive treatment|1|||
156385568|NCT03823651|564501207|FG001|Overall Study|Physician Decision|0|||
156385569|NCT03823651|564501206|FG000|Overall Study|Caregiver to patient who died|0|||
156385570|NCT03823651|564501207|FG001|Overall Study|Caregiver to patient who died|5|||
156385571|NCT03823651|564501206|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
156385572|NCT03823651|564501207|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
156385573|NCT00791765|564502578|FG000|Weeks 1 to 12|Adverse Event|0|||
156385574|NCT00791765|564502579|FG001|Weeks 1 to 12|Adverse Event|1|||
156385575|NCT00791765|564502578|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
156385576|NCT00791765|564502579|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
156385577|NCT00791765|564502578|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
156385578|NCT00791765|564502579|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
156385579|NCT00791765|564502578|FG000|Weeks 1 to 12|Physician Decision|1|||
156385580|NCT00791765|564502579|FG001|Weeks 1 to 12|Physician Decision|0|||
156385581|NCT00791765|564502578|FG000|Weeks 1 to 12|Disease progression|3|||
156385582|NCT00791765|564502579|FG001|Weeks 1 to 12|Disease progression|0|||
156385583|NCT00791765|564502578|FG000|Weeks 1 to 12|Ineligibility determined|0|||
156385584|NCT00791765|564502579|FG001|Weeks 1 to 12|Ineligibility determined|3|||
156385585|NCT00791765|564502578|FG000|Weeks 13 to 24|Protocol deviation|2|||
156385586|NCT00791765|564502579|FG001|Weeks 13 to 24|Protocol deviation|0|||
156385587|NCT00791765|564502578|FG000|Weeks 13 to 24|Adverse Event|0|||
156385588|NCT00791765|564502579|FG001|Weeks 13 to 24|Adverse Event|3|||
156385589|NCT00791765|564502578|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
156385590|NCT00791765|564502579|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
156385591|NCT00791765|564502578|FG000|Weeks 13 to 24|Disease progression|0|||
156385592|NCT00791765|564502579|FG001|Weeks 13 to 24|Disease progression|1|||
156385593|NCT00791765|564502578|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
156385594|NCT00791765|564502579|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
156385595|NCT00791765|564502578|FG000|Weeks 13 to 24|Other|0|||
156385596|NCT00791765|564502579|FG001|Weeks 13 to 24|Other|1|||
156385597|NCT00924287|564502581|FG000|Overall Study|Death|1|||
156385598|NCT04579757|564502592|FG000|Overall Study|Adverse Event|0|||
156385599|NCT04579757|564502593|FG001|Overall Study|Adverse Event|0|||
156385600|NCT04579757|564502594|FG002|Overall Study|Adverse Event|0|||
156385601|NCT04579757|564502595|FG003|Overall Study|Adverse Event|2|||
156385602|NCT04579757|564502596|FG004|Overall Study|Adverse Event|1|||
156385603|NCT04579757|564502597|FG005|Overall Study|Adverse Event|1|||
156385604|NCT04579757|564502598|FG006|Overall Study|Adverse Event|0|||
156385605|NCT04579757|564502599|FG007|Overall Study|Adverse Event|0|||
156385606|NCT04579757|564502600|FG008|Overall Study|Adverse Event|0|||
156385607|NCT04579757|564502592|FG000|Overall Study|Death|4|||
156385608|NCT04579757|564502593|FG001|Overall Study|Death|1|||
156385609|NCT04579757|564502594|FG002|Overall Study|Death|14|||
156385610|NCT04579757|564502595|FG003|Overall Study|Death|3|||
156385611|NCT04579757|564502596|FG004|Overall Study|Death|2|||
156385612|NCT04579757|564502597|FG005|Overall Study|Death|7|||
156385613|NCT04579757|564502598|FG006|Overall Study|Death|0|||
156385614|NCT04579757|564502599|FG007|Overall Study|Death|1|||
156385615|NCT04579757|564502600|FG008|Overall Study|Death|3|||
156385616|NCT04579757|564502592|FG000|Overall Study|Physician Decision|0|||
156385617|NCT04579757|564502593|FG001|Overall Study|Physician Decision|0|||
156385618|NCT04579757|564502594|FG002|Overall Study|Physician Decision|0|||
156385619|NCT04579757|564502595|FG003|Overall Study|Physician Decision|2|||
156385620|NCT04579757|564502596|FG004|Overall Study|Physician Decision|1|||
156385621|NCT04579757|564502597|FG005|Overall Study|Physician Decision|1|||
156385622|NCT04579757|564502598|FG006|Overall Study|Physician Decision|1|||
156385623|NCT04579757|564502599|FG007|Overall Study|Physician Decision|0|||
156385624|NCT04579757|564502600|FG008|Overall Study|Physician Decision|0|||
156385625|NCT04579757|564502592|FG000|Overall Study|Study Terminated By Sponsor|0|||
156385626|NCT04579757|564502593|FG001|Overall Study|Study Terminated By Sponsor|0|||
156385627|NCT04579757|564502594|FG002|Overall Study|Study Terminated By Sponsor|0|||
156385628|NCT04579757|564502595|FG003|Overall Study|Study Terminated By Sponsor|0|||
156385629|NCT04579757|564502596|FG004|Overall Study|Study Terminated By Sponsor|2|||
156385630|NCT04579757|564502597|FG005|Overall Study|Study Terminated By Sponsor|0|||
156507664|NCT01371708|564951036|FG001|Overall Study|Started but did not receive treatment|0|||
156385631|NCT04579757|564502598|FG006|Overall Study|Study Terminated By Sponsor|0|||
156385632|NCT04579757|564502599|FG007|Overall Study|Study Terminated By Sponsor|2|||
156385633|NCT04579757|564502600|FG008|Overall Study|Study Terminated By Sponsor|0|||
156385634|NCT04579757|564502592|FG000|Overall Study|Withdrawal by Subject|1|||
156385635|NCT04579757|564502593|FG001|Overall Study|Withdrawal by Subject|1|||
156385636|NCT04579757|564502594|FG002|Overall Study|Withdrawal by Subject|0|||
156385637|NCT04579757|564502595|FG003|Overall Study|Withdrawal by Subject|0|||
156385638|NCT04579757|564502596|FG004|Overall Study|Withdrawal by Subject|2|||
156385639|NCT04579757|564502597|FG005|Overall Study|Withdrawal by Subject|1|||
156385640|NCT04579757|564502598|FG006|Overall Study|Withdrawal by Subject|0|||
156385641|NCT04579757|564502599|FG007|Overall Study|Withdrawal by Subject|3|||
156385642|NCT04579757|564502600|FG008|Overall Study|Withdrawal by Subject|0|||
156385643|NCT04579757|564502592|FG000|Overall Study|Radiological or Clinical PD|1|||
156385644|NCT04579757|564502593|FG001|Overall Study|Radiological or Clinical PD|4|||
156385645|NCT04579757|564502594|FG002|Overall Study|Radiological or Clinical PD|1|||
156385646|NCT04579757|564502595|FG003|Overall Study|Radiological or Clinical PD|3|||
156547429|NCT00531752|565096826|FG002|First Double-blind Intervention Period|Adverse Event|1|||
156547430|NCT00531752|565096827|FG003|First Double-blind Intervention Period|Adverse Event|1|||
156547431|NCT00531752|565096824|FG000|First Double-blind Intervention Period|Other|1|||
156547432|NCT00531752|565096825|FG001|First Double-blind Intervention Period|Other|4|||
156547433|NCT00531752|565096826|FG002|First Double-blind Intervention Period|Other|4|||
156547434|NCT00531752|565096827|FG003|First Double-blind Intervention Period|Other|0|||
156547435|NCT00531752|565096824|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
156547436|NCT00531752|565096825|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
156547437|NCT00531752|565096826|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
156547438|NCT00531752|565096827|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
156547439|NCT00531752|565096824|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
156547440|NCT00531752|565096825|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
156547441|NCT00531752|565096826|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
156547442|NCT00531752|565096827|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
156547443|NCT00531752|565096824|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
156547444|NCT00531752|565096825|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
156547445|NCT00531752|565096826|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
156547446|NCT00531752|565096827|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
156547447|NCT00531752|565096824|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
156385647|NCT04579757|564502596|FG004|Overall Study|Radiological or Clinical PD|9|||
156385648|NCT04579757|564502597|FG005|Overall Study|Radiological or Clinical PD|4|||
156385649|NCT04579757|564502598|FG006|Overall Study|Radiological or Clinical PD|2|||
156385650|NCT04579757|564502599|FG007|Overall Study|Radiological or Clinical PD|2|||
156385651|NCT04579757|564502600|FG008|Overall Study|Radiological or Clinical PD|0|||
156385652|NCT04579757|564502592|FG000|Overall Study|Start of New Therapy|0|||
156385653|NCT04579757|564502593|FG001|Overall Study|Start of New Therapy|0|||
156385654|NCT04579757|564502594|FG002|Overall Study|Start of New Therapy|0|||
156385655|NCT04579757|564502595|FG003|Overall Study|Start of New Therapy|0|||
156385656|NCT04579757|564502596|FG004|Overall Study|Start of New Therapy|2|||
156385657|NCT04579757|564502597|FG005|Overall Study|Start of New Therapy|1|||
156385658|NCT04579757|564502598|FG006|Overall Study|Start of New Therapy|0|||
156385659|NCT04579757|564502599|FG007|Overall Study|Start of New Therapy|0|||
156385660|NCT04579757|564502600|FG008|Overall Study|Start of New Therapy|0|||
156385661|NCT01843192|564502601|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
156385662|NCT01843192|564502602|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
156385663|NCT01843192|564502603|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
156385664|NCT01127178|564502605|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
156385665|NCT01127178|564502606|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
156385666|NCT01127178|564502605|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
156385667|NCT01127178|564502606|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
156385668|NCT01127178|564502605|FG000|Dose Escalation: Treatment Phase|Other|2|||
156385669|NCT01127178|564502606|FG001|Dose Escalation: Treatment Phase|Other|0|||
156385670|NCT01127178|564502605|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
156385671|NCT01127178|564502606|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
156385672|NCT01127178|564502605|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
156385673|NCT01127178|564502606|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
156385674|NCT01127178|564502605|FG000|Dose Escalation: Extension Phase|Other|1|||
156385675|NCT01127178|564502606|FG001|Dose Escalation: Extension Phase|Other|0|||
156385676|NCT04139317|564502607|FG000|Overall Study|Adverse Event|10|||
156385677|NCT04139317|564502608|FG001|Overall Study|Adverse Event|2|||
156547448|NCT00531752|565096825|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
156547449|NCT00531752|565096826|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
156547450|NCT00531752|565096827|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
156547451|NCT00531752|565096824|FG000|Second Double-blind Intervention Period|Other|1|||
156547452|NCT00531752|565096825|FG001|Second Double-blind Intervention Period|Other|1|||
156547453|NCT00531752|565096826|FG002|Second Double-blind Intervention Period|Other|0|||
156547454|NCT00531752|565096827|FG003|Second Double-blind Intervention Period|Other|0|||
156547455|NCT00531752|565096824|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
156547456|NCT00531752|565096825|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
156547457|NCT00531752|565096826|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
156547458|NCT00531752|565096827|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
156547459|NCT00531752|565096824|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
156385678|NCT04139317|564502607|FG000|Overall Study|Death|6|||
156385679|NCT04139317|564502608|FG001|Overall Study|Death|4|||
156385680|NCT04139317|564502607|FG000|Overall Study|Lost to Follow-up|1|||
156385681|NCT04139317|564502608|FG001|Overall Study|Lost to Follow-up|0|||
156385682|NCT04139317|564502607|FG000|Overall Study|Physician Decision|3|||
156385683|NCT04139317|564502608|FG001|Overall Study|Physician Decision|1|||
156385684|NCT04139317|564502607|FG000|Overall Study|Progressive Disease|19|||
156385685|NCT04139317|564502608|FG001|Overall Study|Progressive Disease|9|||
156385686|NCT04139317|564502607|FG000|Overall Study|Subject Decision|2|||
156385687|NCT04139317|564502608|FG001|Overall Study|Subject Decision|2|||
156385688|NCT03621696|564502611|FG000|Overall Study|Not eligible|0|||
156385689|NCT03621696|564502612|FG001|Overall Study|Not eligible|0|||
156385690|NCT03621696|564502613|FG002|Overall Study|Not eligible|0|||
156385691|NCT03621696|564502614|FG003|Overall Study|Not eligible|5|||
156385692|NCT03621696|564502611|FG000|Overall Study|Withdrawal by Subject|1|||
156385693|NCT03621696|564502612|FG001|Overall Study|Withdrawal by Subject|1|||
156385694|NCT03621696|564502613|FG002|Overall Study|Withdrawal by Subject|1|||
156385695|NCT03621696|564502614|FG003|Overall Study|Withdrawal by Subject|0|||
156385696|NCT03621696|564502611|FG000|Overall Study|Physician Decision|0|||
156385697|NCT03621696|564502612|FG001|Overall Study|Physician Decision|0|||
156385698|NCT03621696|564502613|FG002|Overall Study|Physician Decision|1|||
156385699|NCT03621696|564502614|FG003|Overall Study|Physician Decision|0|||
156385700|NCT00413413|564502615|FG000|Single-Blind|Adverse Event|0|||
156385701|NCT00413413|564502616|FG001|Single-Blind|Adverse Event|9|||
156385702|NCT00413413|564502617|FG002|Single-Blind|Adverse Event|0|||
156385703|NCT00413413|564502615|FG000|Single-Blind|Lack of Efficacy|0|||
156385704|NCT00413413|564502616|FG001|Single-Blind|Lack of Efficacy|5|||
156385705|NCT00413413|564502617|FG002|Single-Blind|Lack of Efficacy|0|||
156385706|NCT00413413|564502615|FG000|Single-Blind|Subject no longer requires study drug|0|||
156385707|NCT00413413|564502616|FG001|Single-Blind|Subject no longer requires study drug|151|||
156385708|NCT00413413|564502617|FG002|Single-Blind|Subject no longer requires study drug|0|||
156385709|NCT00413413|564502615|FG000|Single-Blind|Protocol Violation|0|||
156385710|NCT00413413|564502616|FG001|Single-Blind|Protocol Violation|16|||
156385711|NCT00413413|564502617|FG002|Single-Blind|Protocol Violation|0|||
156385712|NCT00413413|564502615|FG000|Single-Blind|Withdrawal by Subject|0|||
156385713|NCT00413413|564502616|FG001|Single-Blind|Withdrawal by Subject|27|||
156385714|NCT00413413|564502617|FG002|Single-Blind|Withdrawal by Subject|0|||
156385715|NCT00413413|564502615|FG000|Single-Blind|Lost to Follow-up|0|||
156385716|NCT00413413|564502616|FG001|Single-Blind|Lost to Follow-up|8|||
156385717|NCT00413413|564502617|FG002|Single-Blind|Lost to Follow-up|0|||
156385718|NCT00413413|564502615|FG000|Double-Blind|Adverse Event|6|||
156385719|NCT00413413|564502616|FG001|Double-Blind|Adverse Event|0|||
156385720|NCT00413413|564502617|FG002|Double-Blind|Adverse Event|5|||
156385721|NCT00413413|564502615|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
156385722|NCT00413413|564502616|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
156385723|NCT00413413|564502617|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
156385724|NCT00413413|564502615|FG000|Double-Blind|Protocol deviation|1|||
156385725|NCT00413413|564502616|FG001|Double-Blind|Protocol deviation|2|||
156385726|NCT00413413|564502617|FG002|Double-Blind|Protocol deviation|1|||
156385727|NCT00413413|564502615|FG000|Double-Blind|Subject withdrew consent|4|||
156385728|NCT00413413|564502616|FG001|Double-Blind|Subject withdrew consent|6|||
156385729|NCT00413413|564502617|FG002|Double-Blind|Subject withdrew consent|9|||
156385730|NCT00413413|564502615|FG000|Double-Blind|Lost to Follow-up|3|||
156385731|NCT00413413|564502616|FG001|Double-Blind|Lost to Follow-up|4|||
156385732|NCT00413413|564502617|FG002|Double-Blind|Lost to Follow-up|2|||
156385733|NCT05348681|564502618|FG000|Overall Study|Study terminated by Sponsor|8|||
156385734|NCT05348681|564502619|FG001|Overall Study|Study terminated by Sponsor|3|||
156385735|NCT05348681|564502618|FG000|Overall Study|Withdrawal by Subject|1|||
156385736|NCT05348681|564502619|FG001|Overall Study|Withdrawal by Subject|1|||
156385737|NCT05348681|564502618|FG000|Overall Study|Lost to Follow-up|1|||
156385738|NCT05348681|564502619|FG001|Overall Study|Lost to Follow-up|1|||
156385739|NCT05348681|564502618|FG000|Overall Study|Adverse Event|1|||
156385740|NCT05348681|564502619|FG001|Overall Study|Adverse Event|0|||
156385741|NCT05348681|564502618|FG000|Overall Study|Other|2|||
156385742|NCT05348681|564502619|FG001|Overall Study|Other|1|||
156385743|NCT00782340|564502620|FG000|Open Label Titration|Adverse Event|12|||
156385744|NCT00782340|564502621|FG001|Open Label Titration|Adverse Event|0|||
156385745|NCT00782340|564502622|FG002|Open Label Titration|Adverse Event|0|||
156385746|NCT00782340|564502620|FG000|Open Label Titration|Treatment failure|50|||
156385747|NCT00782340|564502621|FG001|Open Label Titration|Treatment failure|0|||
156385748|NCT00782340|564502622|FG002|Open Label Titration|Treatment failure|0|||
156385749|NCT00782340|564502620|FG000|Open Label Titration|Protocol Violation|5|||
156507665|NCT01371708|564951037|FG002|Overall Study|Started but did not receive treatment|1|||
156507666|NCT00996606|564951038|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
156507667|NCT00996606|564951038|FG000|Overall Study|Insufficient Therapeutic Response|2|||
156385750|NCT00782340|564502621|FG001|Open Label Titration|Protocol Violation|0|||
156385751|NCT00782340|564502622|FG002|Open Label Titration|Protocol Violation|0|||
156385752|NCT00782340|564502620|FG000|Open Label Titration|Withdrawal by Subject|5|||
156385753|NCT00782340|564502621|FG001|Open Label Titration|Withdrawal by Subject|0|||
156385754|NCT00782340|564502622|FG002|Open Label Titration|Withdrawal by Subject|0|||
156385755|NCT00782340|564502620|FG000|Open Label Titration|Enrollment capped|16|||
156385756|NCT00782340|564502621|FG001|Open Label Titration|Enrollment capped|0|||
156385757|NCT00782340|564502622|FG002|Open Label Titration|Enrollment capped|0|||
156547460|NCT00531752|565096825|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
156547461|NCT00531752|565096826|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
156547462|NCT00531752|565096827|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
156547463|NCT01181011|565096828|FG000|Overall Study|Adverse Event|2|||
156385758|NCT00782340|564502620|FG000|Open Label Titration|Did not meet responder criteria|2|||
156385759|NCT00782340|564502621|FG001|Open Label Titration|Did not meet responder criteria|0|||
156385760|NCT00782340|564502622|FG002|Open Label Titration|Did not meet responder criteria|0|||
156385761|NCT00782340|564502620|FG000|Open Label Titration|Lost to Follow-up|5|||
156385762|NCT00782340|564502621|FG001|Open Label Titration|Lost to Follow-up|0|||
156385763|NCT00782340|564502622|FG002|Open Label Titration|Lost to Follow-up|0|||
156385764|NCT00782340|564502620|FG000|Open Label Titration|Randomized in error|6|||
156385765|NCT00782340|564502621|FG001|Open Label Titration|Randomized in error|0|||
156385766|NCT00782340|564502622|FG002|Open Label Titration|Randomized in error|0|||
156385767|NCT00553267|564502627|FG000|Overall Study|Adverse Event|8|||
156385768|NCT00553267|564502628|FG001|Overall Study|Adverse Event|10|||
156385769|NCT00553267|564502629|FG002|Overall Study|Adverse Event|5|||
156385770|NCT00553267|564502627|FG000|Overall Study|Non compliant with protocol|3|||
156385771|NCT00553267|564502628|FG001|Overall Study|Non compliant with protocol|3|||
156385772|NCT00553267|564502629|FG002|Overall Study|Non compliant with protocol|2|||
156385773|NCT00553267|564502627|FG000|Overall Study|Lost to Follow-up|0|||
156385774|NCT00553267|564502628|FG001|Overall Study|Lost to Follow-up|0|||
156385775|NCT00553267|564502629|FG002|Overall Study|Lost to Follow-up|1|||
156385776|NCT00553267|564502627|FG000|Overall Study|Consent withdrawn|2|||
156385777|NCT00553267|564502628|FG001|Overall Study|Consent withdrawn|3|||
156385778|NCT00553267|564502629|FG002|Overall Study|Consent withdrawn|1|||
156385779|NCT00553267|564502627|FG000|Overall Study|Specified category|1|||
156385780|NCT00553267|564502628|FG001|Overall Study|Specified category|2|||
156385781|NCT00553267|564502629|FG002|Overall Study|Specified category|1|||
156385782|NCT04389840|564502630|FG000|Overall Study|Adverse Event|0|||
156385783|NCT04389840|564502631|FG001|Overall Study|Adverse Event|0|||
156385784|NCT04389840|564502632|FG002|Overall Study|Adverse Event|0|||
156385785|NCT04389840|564502633|FG003|Overall Study|Adverse Event|1|||
156385786|NCT04389840|564502634|FG004|Overall Study|Adverse Event|0|||
156385787|NCT04389840|564502635|FG005|Overall Study|Adverse Event|0|||
156385788|NCT04389840|564502630|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
156385789|NCT04389840|564502631|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
156385790|NCT04389840|564502632|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
156385791|NCT04389840|564502633|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
156385792|NCT04389840|564502634|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
156385793|NCT04389840|564502635|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
156385794|NCT04389840|564502630|FG000|Overall Study|Death|0|||
156385795|NCT04389840|564502631|FG001|Overall Study|Death|1|||
156385796|NCT04389840|564502632|FG002|Overall Study|Death|0|||
156385797|NCT04389840|564502633|FG003|Overall Study|Death|0|||
156385798|NCT04389840|564502634|FG004|Overall Study|Death|0|||
156385799|NCT04389840|564502635|FG005|Overall Study|Death|0|||
156385800|NCT02365467|564502636|FG000|Overall Study|Death|3|||
156385801|NCT01306162|564502637|FG000|Period 1|Adverse Event|0|||
156385802|NCT01306162|564502638|FG001|Period 1|Adverse Event|0|||
156385803|NCT01306162|564502639|FG002|Period 1|Adverse Event|0|||
156385804|NCT01306162|564502640|FG003|Period 1|Adverse Event|1|||
156385805|NCT01306162|564502637|FG000|Washout 1|Non-compliance to protocol|0|||
156385806|NCT01306162|564502638|FG001|Washout 1|Non-compliance to protocol|1|||
156385807|NCT01306162|564502639|FG002|Washout 1|Non-compliance to protocol|0|||
156385808|NCT01306162|564502640|FG003|Washout 1|Non-compliance to protocol|0|||
156385809|NCT01109992|564502641|FG000|Overall Study|Withdrawal by Subject|0|||
156385810|NCT01109992|564502642|FG001|Overall Study|Withdrawal by Subject|1|||
156385811|NCT01109992|564502641|FG000|Overall Study|Movement during rest scan.|0|||
156385812|NCT01109992|564502642|FG001|Overall Study|Movement during rest scan.|1|||
156385813|NCT00690755|564502643|FG000|Overall Study|Physician Decision|2|||
156385814|NCT00690755|564502644|FG001|Overall Study|Physician Decision|0|||
156385815|NCT00690755|564502645|FG002|Overall Study|Physician Decision|46|||
156385816|NCT00690755|564502646|FG003|Overall Study|Physician Decision|5|||
156547464|NCT01181011|565096828|FG000|Overall Study|Lost to Follow-up|1|||
156547465|NCT00950664|565096829|FG000|First Intervention|Lost to Follow-up|1|||
156547466|NCT00950664|565096830|FG001|First Intervention|Lost to Follow-up|3|||
156385817|NCT00690755|564502647|FG004|Overall Study|Physician Decision|0|||
156385818|NCT00690755|564502648|FG005|Overall Study|Physician Decision|4|||
156385819|NCT00690755|564502649|FG006|Overall Study|Physician Decision|0|||
156385820|NCT04287920|564502650|FG000|Overall Study|Lost to Follow-up|1|||
156385821|NCT04287920|564502651|FG001|Overall Study|Lost to Follow-up|1|||
156385822|NCT04287920|564502650|FG000|Overall Study|Withdrawal by Subject|0|||
156385823|NCT04287920|564502651|FG001|Overall Study|Withdrawal by Subject|3|||
156385824|NCT01435577|564502654|FG000|Overall Study|Adverse Event|10|||
156385825|NCT01435577|564502655|FG001|Overall Study|Adverse Event|0|||
156385826|NCT01435577|564502654|FG000|Overall Study|Lack of Efficacy|7|||
156385827|NCT01435577|564502655|FG001|Overall Study|Lack of Efficacy|51|||
156385828|NCT01435577|564502654|FG000|Overall Study|Alternative treatment started|0|||
156385829|NCT01435577|564502655|FG001|Overall Study|Alternative treatment started|1|||
156385830|NCT03273946|564502656|FG000|Overall Study|Withdrawal by Subject|5|||
156385831|NCT03273946|564502656|FG000|Overall Study|Unwillingness of the guardian|1|||
156385832|NCT03273946|564502656|FG000|Overall Study|Participant refused to use the drug|2|||
156385833|NCT03273946|564502656|FG000|Overall Study|Participant relative refused to use drug|1|||
156385834|NCT02199028|564502658|FG000|Week 1|Adverse Event|1|||
156385835|NCT02199028|564502659|FG001|Week 1|Adverse Event|0|||
156385836|NCT02199028|564502658|FG000|Week 3|Adverse Event|1|||
156385837|NCT02199028|564502659|FG001|Week 3|Adverse Event|0|||
156385838|NCT01881126|564502660|FG000|Overall Study|Non-compliance|1|||
156385839|NCT01881126|564502661|FG001|Overall Study|Non-compliance|1|||
156385840|NCT01881126|564502660|FG000|Overall Study|Adverse Event|0|||
156385841|NCT01881126|564502661|FG001|Overall Study|Adverse Event|1|||
156385842|NCT01458574|564502664|FG000|Overall Study|Adverse Event|5|||
156385843|NCT01458574|564502665|FG001|Overall Study|Adverse Event|9|||
156385844|NCT01458574|564502666|FG002|Overall Study|Adverse Event|7|||
156385845|NCT01458574|564502664|FG000|Overall Study|Lack of Efficacy|70|||
156385846|NCT01458574|564502665|FG001|Overall Study|Lack of Efficacy|53|||
156385847|NCT01458574|564502666|FG002|Overall Study|Lack of Efficacy|132|||
156385848|NCT01458574|564502664|FG000|Overall Study|Lost to Follow-up|3|||
156385849|NCT01458574|564502665|FG001|Overall Study|Lost to Follow-up|2|||
156385850|NCT01458574|564502666|FG002|Overall Study|Lost to Follow-up|1|||
156385851|NCT01458574|564502664|FG000|Overall Study|Pregnancy|1|||
156385852|NCT01458574|564502665|FG001|Overall Study|Pregnancy|1|||
156385853|NCT01458574|564502666|FG002|Overall Study|Pregnancy|0|||
156385854|NCT01458574|564502664|FG000|Overall Study|Protocol Violation|0|||
156385855|NCT01458574|564502665|FG001|Overall Study|Protocol Violation|1|||
156385856|NCT01458574|564502666|FG002|Overall Study|Protocol Violation|0|||
156385857|NCT01458574|564502664|FG000|Overall Study|Withdrawal by Subject|6|||
156385858|NCT01458574|564502665|FG001|Overall Study|Withdrawal by Subject|3|||
156385859|NCT01458574|564502666|FG002|Overall Study|Withdrawal by Subject|5|||
156385860|NCT01458574|564502664|FG000|Overall Study|Other|2|||
156385861|NCT01458574|564502665|FG001|Overall Study|Other|1|||
156385862|NCT01458574|564502666|FG002|Overall Study|Other|0|||
156385863|NCT01458574|564502664|FG000|Overall Study|Randomized but not treated|0|||
156385864|NCT01458574|564502665|FG001|Overall Study|Randomized but not treated|1|||
156385865|NCT01458574|564502666|FG002|Overall Study|Randomized but not treated|0|||
156385866|NCT02125786|564502667|FG000|Overall Study|Still in Follow-up|3|||
156385867|NCT02125786|564502667|FG000|Overall Study|Screen Failure|2|||
156385868|NCT02125786|564502667|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
156385869|NCT02125786|564502667|FG000|Overall Study|Progressive Disease|44|||
156385870|NCT02125786|564502667|FG000|Overall Study|Death|8|||
156385871|NCT01365494|564502668|FG000|Overall Study|Adverse Event|1|||
156385872|NCT01365494|564502669|FG001|Overall Study|Adverse Event|0|||
156385873|NCT01365494|564502668|FG000|Overall Study|Withdrawal by Subject|0|||
156385874|NCT01365494|564502669|FG001|Overall Study|Withdrawal by Subject|1|||
156385875|NCT01365494|564502668|FG000|Overall Study|Lost to Follow-up|1|||
156385876|NCT01365494|564502669|FG001|Overall Study|Lost to Follow-up|2|||
156385877|NCT02663128|564502670|FG000|Period 2|Physician Decision|0|||
156385878|NCT02663128|564502671|FG001|Period 2|Physician Decision|0|||
156385879|NCT02663128|564502672|FG002|Period 2|Physician Decision|0|||
156385880|NCT02663128|564502673|FG003|Period 2|Physician Decision|0|||
156385881|NCT02663128|564502674|FG004|Period 2|Physician Decision|1|||
156385882|NCT02663128|564502675|FG005|Period 2|Physician Decision|0|||
156385883|NCT05070897|564502679|FG000|Overall Study|Protocol Violation|123|||
156385884|NCT05070897|564502680|FG001|Overall Study|Protocol Violation|68|||
156385885|NCT03832946|564502681|FG000|Overall Study|Adverse Event|3|||
156385886|NCT03832946|564502682|FG001|Overall Study|Adverse Event|1|||
156507668|NCT00996606|564951038|FG000|Overall Study|Protocol Violation|1|||
156507669|NCT00996606|564951038|FG000|Overall Study|Withdrawal by Subject|3|||
156507670|NCT00281320|564951048|FG000|Overall Study|Adverse Event|12|||
156385887|NCT03832946|564502681|FG000|Overall Study|Lost to Follow-up|1|||
156507671|NCT00281320|564951049|FG001|Overall Study|Adverse Event|9|||
156507672|NCT00281320|564951048|FG000|Overall Study|Lack of Efficacy|4|||
156507673|NCT00281320|564951049|FG001|Overall Study|Lack of Efficacy|3|||
156507674|NCT00281320|564951048|FG000|Overall Study|Withdrawal by Subject|5|||
156385888|NCT03832946|564502682|FG001|Overall Study|Lost to Follow-up|0|||
156385889|NCT03832946|564502681|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
156385890|NCT03832946|564502682|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
156385891|NCT03832946|564502681|FG000|Overall Study|Lack of Efficacy|1|||
156385892|NCT03832946|564502682|FG001|Overall Study|Lack of Efficacy|0|||
156385893|NCT03832946|564502681|FG000|Overall Study|Withdrawal by Subject|12|||
156385894|NCT03832946|564502682|FG001|Overall Study|Withdrawal by Subject|9|||
156385895|NCT03394924|564502683|FG000|Overall Study|Adverse Event|0|||
156385896|NCT03394924|564502684|FG001|Overall Study|Adverse Event|5|||
156385897|NCT03394924|564502685|FG002|Overall Study|Adverse Event|0|||
156507675|NCT00281320|564951049|FG001|Overall Study|Withdrawal by Subject|6|||
156385898|NCT03394924|564502683|FG000|Overall Study|Withdrawal by Subject|2|||
156385899|NCT03394924|564502684|FG001|Overall Study|Withdrawal by Subject|0|||
156385900|NCT03394924|564502685|FG002|Overall Study|Withdrawal by Subject|0|||
156385901|NCT03394924|564502683|FG000|Overall Study|Lost to Follow-up|0|||
156385902|NCT03394924|564502684|FG001|Overall Study|Lost to Follow-up|1|||
156385903|NCT03394924|564502685|FG002|Overall Study|Lost to Follow-up|0|||
156385904|NCT03394924|564502683|FG000|Overall Study|Did not meet all inclusion criteria|1|||
156385905|NCT03394924|564502684|FG001|Overall Study|Did not meet all inclusion criteria|0|||
156385906|NCT03394924|564502685|FG002|Overall Study|Did not meet all inclusion criteria|0|||
156385907|NCT03277313|564502692|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
156385908|NCT03277313|564502693|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
156385909|NCT03277313|564502692|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
156385910|NCT03277313|564502693|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
156385911|NCT03277313|564502692|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
156385912|NCT03277313|564502693|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
156385913|NCT03277313|564502692|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
156385914|NCT03277313|564502693|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
156385915|NCT03277313|564502692|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
156385916|NCT03277313|564502693|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
156385917|NCT02005471|564502694|FG000|Main Study|Adverse Event|0|||
156385918|NCT02005471|564502695|FG001|Main Study|Adverse Event|1|||
156385919|NCT02005471|564502696|FG002|Main Study|Adverse Event|0|||
156385920|NCT02005471|564502697|FG003|Main Study|Adverse Event|0|||
156385921|NCT02005471|564502694|FG000|Main Study|Death|83|||
156385922|NCT02005471|564502695|FG001|Main Study|Death|52|||
156385923|NCT02005471|564502696|FG002|Main Study|Death|0|||
156385924|NCT02005471|564502697|FG003|Main Study|Death|0|||
156385925|NCT02005471|564502694|FG000|Main Study|Lost to Follow-up|4|||
156385926|NCT02005471|564502695|FG001|Main Study|Lost to Follow-up|5|||
156385927|NCT02005471|564502696|FG002|Main Study|Lost to Follow-up|0|||
156385928|NCT02005471|564502697|FG003|Main Study|Lost to Follow-up|0|||
156385929|NCT02005471|564502694|FG000|Main Study|Physician Decision|3|||
156385930|NCT02005471|564502695|FG001|Main Study|Physician Decision|1|||
156385931|NCT02005471|564502696|FG002|Main Study|Physician Decision|0|||
156385932|NCT02005471|564502697|FG003|Main Study|Physician Decision|0|||
156385933|NCT02005471|564502694|FG000|Main Study|Withdrawal by Subject|26|||
156385934|NCT02005471|564502695|FG001|Main Study|Withdrawal by Subject|11|||
156385935|NCT02005471|564502696|FG002|Main Study|Withdrawal by Subject|0|||
156385936|NCT02005471|564502697|FG003|Main Study|Withdrawal by Subject|0|||
156385937|NCT02005471|564502694|FG000|Main Study|Reason not Specified|0|||
156385938|NCT02005471|564502695|FG001|Main Study|Reason not Specified|6|||
156385939|NCT02005471|564502696|FG002|Main Study|Reason not Specified|0|||
156385940|NCT02005471|564502697|FG003|Main Study|Reason not Specified|0|||
156385941|NCT02005471|564502694|FG000|Main Study|Randomized but not Dosed|8|||
156385942|NCT02005471|564502695|FG001|Main Study|Randomized but not Dosed|0|||
156385943|NCT02005471|564502696|FG002|Main Study|Randomized but not Dosed|0|||
156385944|NCT02005471|564502697|FG003|Main Study|Randomized but not Dosed|0|||
156385945|NCT02005471|564502694|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
156385946|NCT02005471|564502695|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
156385947|NCT02005471|564502696|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
156385948|NCT02005471|564502697|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
156385949|NCT02005471|564502694|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
156385950|NCT02005471|564502695|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
156385951|NCT02005471|564502696|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
156385952|NCT02005471|564502697|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
156385953|NCT02005471|564502694|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
156385954|NCT02005471|564502695|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
156385955|NCT02005471|564502696|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
156385956|NCT02005471|564502697|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
156507676|NCT00281320|564951048|FG000|Overall Study|Lost to Follow-up|1|||
156507677|NCT00281320|564951049|FG001|Overall Study|Lost to Follow-up|2|||
156507678|NCT00281320|564951048|FG000|Overall Study|Other|3|||
156385957|NCT00627705|564502699|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
156385958|NCT00627705|564502700|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
156507679|NCT00281320|564951049|FG001|Overall Study|Other|1|||
156385959|NCT00627705|564502699|FG000|Overall Study|Adverse Event|1|||
156385960|NCT00627705|564502700|FG001|Overall Study|Adverse Event|0|||
156385961|NCT00627705|564502699|FG000|Overall Study|Withdrawal by Subject|0|||
156385962|NCT00627705|564502700|FG001|Overall Study|Withdrawal by Subject|2|||
156385963|NCT00627705|564502699|FG000|Overall Study|Lost to Follow-up|0|||
156385964|NCT00627705|564502700|FG001|Overall Study|Lost to Follow-up|1|||
156385965|NCT02663817|564502701|FG000|Overall Study|Screen failure|2|||
156385966|NCT01410448|564502704|FG000|Overall Study|No conversion to everolimus|0|||
156385967|NCT01410448|564502705|FG001|Overall Study|No conversion to everolimus|24|||
156385968|NCT01410448|564502704|FG000|Overall Study|Graft loss|4|||
156385969|NCT01410448|564502705|FG001|Overall Study|Graft loss|1|||
156385970|NCT01410448|564502704|FG000|Overall Study|Administrative issues|2|||
156385971|NCT01410448|564502705|FG001|Overall Study|Administrative issues|1|||
156385972|NCT01410448|564502704|FG000|Overall Study|Lost to Follow-up|1|||
156385973|NCT01410448|564502705|FG001|Overall Study|Lost to Follow-up|0|||
156385974|NCT01410448|564502704|FG000|Overall Study|Withdrawal by Subject|3|||
156385975|NCT01410448|564502705|FG001|Overall Study|Withdrawal by Subject|2|||
156385976|NCT01410448|564502704|FG000|Overall Study|Protocol Violation|0|||
156385977|NCT01410448|564502705|FG001|Overall Study|Protocol Violation|4|||
156385978|NCT01410448|564502704|FG000|Overall Study|Death|2|||
156385979|NCT01410448|564502705|FG001|Overall Study|Death|3|||
156385980|NCT02535065|564502706|FG000|Overall Study|Death|13|||
156385981|NCT02535065|564502706|FG000|Overall Study|Lost to Follow-up|1|||
156385982|NCT02535065|564502706|FG000|Overall Study|Withdrawal by Subject|6|||
156385983|NCT03712917|564502707|FG000|Overall Study|Pregnancy|0|||
156385984|NCT03712917|564502708|FG001|Overall Study|Pregnancy|0|||
156385985|NCT03712917|564502709|FG002|Overall Study|Pregnancy|1|||
156385986|NCT03712917|564502707|FG000|Overall Study|Adverse Event|0|||
156385987|NCT03712917|564502708|FG001|Overall Study|Adverse Event|4|||
156547467|NCT00950664|565096829|FG000|First Intervention|Withdrawal by Subject|2|||
156547468|NCT00950664|565096830|FG001|First Intervention|Withdrawal by Subject|2|||
156547469|NCT00677014|565096831|FG000|Overall Study|Lost to Follow-up|20|||
156547470|NCT00677014|565096832|FG001|Overall Study|Lost to Follow-up|12|||
156547471|NCT00677014|565096833|FG002|Overall Study|Lost to Follow-up|24|||
156547472|NCT00677014|565096831|FG000|Overall Study|Death|6|||
156547473|NCT00677014|565096832|FG001|Overall Study|Death|15|||
156547474|NCT00677014|565096833|FG002|Overall Study|Death|7|||
156547475|NCT00677014|565096831|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
156547476|NCT00677014|565096832|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
156547477|NCT00677014|565096833|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
156547478|NCT01326546|565096834|FG000|Overall Study|Lost to Follow-up|8|||
156547479|NCT01326546|565096835|FG001|Overall Study|Lost to Follow-up|7|||
156547480|NCT01326546|565096834|FG000|Overall Study|Protocol Violation|3|||
156547481|NCT01326546|565096835|FG001|Overall Study|Protocol Violation|4|||
156547482|NCT01326546|565096834|FG000|Overall Study|Pregnancy|0|||
156547483|NCT01326546|565096835|FG001|Overall Study|Pregnancy|1|||
156547484|NCT01326546|565096834|FG000|Overall Study|Adverse Event|1|||
156547485|NCT01326546|565096835|FG001|Overall Study|Adverse Event|0|||
156547486|NCT01326546|565096834|FG000|Overall Study|Withdrawal by Subject|5|||
156547487|NCT01326546|565096835|FG001|Overall Study|Withdrawal by Subject|1|||
156547488|NCT03152019|565096836|FG000|Overall Study|Adverse Event|0|||
156547489|NCT03152019|565096837|FG001|Overall Study|Adverse Event|1|||
156547490|NCT00081159|565096841|FG000|Overall Study|Withdrawal by Subject|0|||
156547491|NCT00081159|565096842|FG001|Overall Study|Withdrawal by Subject|3|||
156547492|NCT00081159|565096841|FG000|Overall Study|Myelosuppression prior to treatment|0|||
156547493|NCT00081159|565096842|FG001|Overall Study|Myelosuppression prior to treatment|1|||
156547494|NCT00081159|565096841|FG000|Overall Study|Lost to Follow-up|2|||
156547495|NCT00081159|565096842|FG001|Overall Study|Lost to Follow-up|1|||
156547496|NCT00923130|565096845|FG000|Overall Study|Stopped treatment due to progression|17|||
156547497|NCT00923130|565096845|FG000|Overall Study|Death|1|||
156547498|NCT00923130|565096845|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
156547499|NCT00923130|565096845|FG000|Overall Study|Switched to alternative treatment|2|||
156547500|NCT00923130|565096845|FG000|Overall Study|Refused further treatment|2|||
156547501|NCT03693625|565096846|FG000|Overall Study|Adverse Event|2|||
156547502|NCT03693625|565096847|FG001|Overall Study|Adverse Event|0|||
156547503|NCT03693625|565096846|FG000|Overall Study|Study Terminated By Sponsor|20|||
156547504|NCT03693625|565096847|FG001|Overall Study|Study Terminated By Sponsor|7|||
156547505|NCT03693625|565096846|FG000|Overall Study|Withdrawal by Subject|1|||
156547506|NCT03693625|565096847|FG001|Overall Study|Withdrawal by Subject|1|||
156547507|NCT02457637|565096850|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
156547508|NCT01035905|565096852|FG000|Overall Study|Lack of Efficacy|1|||
156547509|NCT01035905|565096853|FG001|Overall Study|Lack of Efficacy|1|||
156547510|NCT01273883|565096854|FG000|First Intervention|Adverse Event|2|||
156547511|NCT01273883|565096855|FG001|First Intervention|Adverse Event|1|||
156547512|NCT01273883|565096854|FG000|Second Intervention|Lost to Follow-up|1|||
156547513|NCT01273883|565096855|FG001|Second Intervention|Lost to Follow-up|1|||
156547514|NCT01273883|565096854|FG000|Second Intervention|Lack of Efficacy|1|||
156547515|NCT01273883|565096855|FG001|Second Intervention|Lack of Efficacy|0|||
156547516|NCT00159861|565096856|FG000|Core Study - 16 Weeks|Death|3|||
156547517|NCT00159861|565096857|FG001|Core Study - 16 Weeks|Death|0|||
156547518|NCT00159861|565096856|FG000|Core Study - 16 Weeks|Adverse Event|12|||
156385988|NCT03712917|564502709|FG002|Overall Study|Adverse Event|3|||
156385989|NCT03712917|564502707|FG000|Overall Study|Lost to Follow-up|9|||
156385990|NCT03712917|564502708|FG001|Overall Study|Lost to Follow-up|4|||
156385991|NCT03712917|564502709|FG002|Overall Study|Lost to Follow-up|5|||
156385992|NCT00932893|564502714|FG000|Overall Study|Death|115|||
156385993|NCT00932893|564502715|FG001|Overall Study|Death|24|||
156547519|NCT00159861|565096857|FG001|Core Study - 16 Weeks|Adverse Event|6|||
156547520|NCT00159861|565096856|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
156547521|NCT00159861|565096857|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
156385994|NCT00932893|564502714|FG000|Overall Study|Lost to Follow-up|8|||
156385995|NCT00932893|564502715|FG001|Overall Study|Lost to Follow-up|0|||
156385996|NCT00932893|564502714|FG000|Overall Study|Withdrawal by Subject|5|||
156385997|NCT00932893|564502715|FG001|Overall Study|Withdrawal by Subject|2|||
156385998|NCT00932893|564502714|FG000|Overall Study|Other|5|||
156385999|NCT00932893|564502715|FG001|Overall Study|Other|144|||
156386000|NCT05350449|564502720|FG000|Overall Study|Withdrawal by Subject|4|||
156386001|NCT05350449|564502721|FG001|Overall Study|Withdrawal by Subject|8|||
156386002|NCT03750552|564505998|FG000|Overall Study|Adverse Event|5|||
156386003|NCT03750552|564505999|FG001|Overall Study|Adverse Event|1|||
156386004|NCT03750552|564505998|FG000|Overall Study|Withdrawal by Subject|1|||
156386005|NCT03750552|564505999|FG001|Overall Study|Withdrawal by Subject|1|||
156386006|NCT03750552|564505998|FG000|Overall Study|Other|2|||
156386007|NCT03750552|564505999|FG001|Overall Study|Other|0|||
156386008|NCT02062632|564506000|FG000|Overall Study|No treatment data|1|||
156386009|NCT02008890|564506002|FG000|Period 1|Withdrawal by Subject|7|||
156386010|NCT02008890|564506003|FG001|Period 1|Withdrawal by Subject|7|||
156386011|NCT02008890|564506004|FG002|Period 1|Withdrawal by Subject|5|||
156386012|NCT02008890|564506005|FG003|Period 1|Withdrawal by Subject|0|||
156386013|NCT02008890|564506006|FG004|Period 1|Withdrawal by Subject|0|||
156386014|NCT02008890|564506002|FG000|Period 1|Pregnancy|1|||
156386015|NCT02008890|564506003|FG001|Period 1|Pregnancy|0|||
156386016|NCT02008890|564506004|FG002|Period 1|Pregnancy|0|||
156386017|NCT02008890|564506005|FG003|Period 1|Pregnancy|0|||
156386018|NCT02008890|564506006|FG004|Period 1|Pregnancy|0|||
156386019|NCT02008890|564506002|FG000|Period 1|Physician Decision|1|||
156386020|NCT02008890|564506003|FG001|Period 1|Physician Decision|0|||
156386021|NCT02008890|564506004|FG002|Period 1|Physician Decision|1|||
156386022|NCT02008890|564506005|FG003|Period 1|Physician Decision|0|||
156386023|NCT02008890|564506006|FG004|Period 1|Physician Decision|0|||
156386024|NCT02008890|564506002|FG000|Period 1|Adverse Event|6|||
156386025|NCT02008890|564506003|FG001|Period 1|Adverse Event|8|||
156386026|NCT02008890|564506004|FG002|Period 1|Adverse Event|6|||
156386027|NCT02008890|564506005|FG003|Period 1|Adverse Event|0|||
156386028|NCT02008890|564506006|FG004|Period 1|Adverse Event|0|||
156386029|NCT02008890|564506002|FG000|Period 2|Adverse Event|12|||
156386030|NCT02008890|564506003|FG001|Period 2|Adverse Event|7|||
156386031|NCT02008890|564506004|FG002|Period 2|Adverse Event|0|||
156386032|NCT02008890|564506005|FG003|Period 2|Adverse Event|5|||
156386033|NCT02008890|564506006|FG004|Period 2|Adverse Event|5|||
156386034|NCT02008890|564506002|FG000|Period 2|Withdrawal by Subject|11|||
156386035|NCT02008890|564506003|FG001|Period 2|Withdrawal by Subject|8|||
156386036|NCT02008890|564506004|FG002|Period 2|Withdrawal by Subject|0|||
156386037|NCT02008890|564506005|FG003|Period 2|Withdrawal by Subject|7|||
156386038|NCT02008890|564506006|FG004|Period 2|Withdrawal by Subject|2|||
156386039|NCT02008890|564506002|FG000|Period 2|Physician Decision|4|||
156386040|NCT02008890|564506003|FG001|Period 2|Physician Decision|0|||
156386041|NCT02008890|564506004|FG002|Period 2|Physician Decision|0|||
156386042|NCT02008890|564506005|FG003|Period 2|Physician Decision|2|||
156386043|NCT02008890|564506006|FG004|Period 2|Physician Decision|1|||
156386044|NCT02008890|564506002|FG000|Period 2|Lost to Follow-up|0|||
156386045|NCT02008890|564506003|FG001|Period 2|Lost to Follow-up|0|||
156386046|NCT02008890|564506004|FG002|Period 2|Lost to Follow-up|1|||
156386047|NCT02008890|564506005|FG003|Period 2|Lost to Follow-up|0|||
156386048|NCT02008890|564506006|FG004|Period 2|Lost to Follow-up|0|||
156386049|NCT02008890|564506002|FG000|Extension Period|Withdrawal by Subject|3|||
156386050|NCT02008890|564506003|FG001|Extension Period|Withdrawal by Subject|2|||
156386051|NCT02008890|564506004|FG002|Extension Period|Withdrawal by Subject|0|||
156386052|NCT02008890|564506005|FG003|Extension Period|Withdrawal by Subject|4|||
156386053|NCT02008890|564506006|FG004|Extension Period|Withdrawal by Subject|2|||
156386054|NCT02008890|564506002|FG000|Extension Period|Lost to Follow-up|1|||
156386055|NCT02008890|564506003|FG001|Extension Period|Lost to Follow-up|0|||
156386056|NCT02008890|564506004|FG002|Extension Period|Lost to Follow-up|0|||
156386057|NCT02008890|564506005|FG003|Extension Period|Lost to Follow-up|0|||
156386058|NCT02008890|564506006|FG004|Extension Period|Lost to Follow-up|0|||
156386059|NCT02008890|564506002|FG000|Extension Period|Adverse Event|1|||
156386060|NCT02008890|564506003|FG001|Extension Period|Adverse Event|3|||
156386061|NCT02008890|564506004|FG002|Extension Period|Adverse Event|0|||
156386062|NCT02008890|564506005|FG003|Extension Period|Adverse Event|0|||
156386063|NCT02008890|564506006|FG004|Extension Period|Adverse Event|2|||
156386064|NCT02207816|564506007|FG000|Overall Study|Serious Adverse Event|0|||
156386065|NCT02207816|564506008|FG001|Overall Study|Serious Adverse Event|5|||
156386066|NCT02207816|564506009|FG002|Overall Study|Serious Adverse Event|2|||
156386067|NCT02207816|564506007|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
156507680|NCT00475228|564951052|FG000|Overall Study|Lost to Follow-up|17|||
156507681|NCT00475228|564951053|FG001|Overall Study|Lost to Follow-up|17|||
156386068|NCT02207816|564506008|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
156386069|NCT02207816|564506009|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
156386070|NCT02207816|564506007|FG000|Overall Study|Withdrawal by Subject|4|||
156386071|NCT02207816|564506008|FG001|Overall Study|Withdrawal by Subject|9|||
156507682|NCT02209181|564951055|FG000|Overall Study|Adverse Event|1|||
156386072|NCT02207816|564506009|FG002|Overall Study|Withdrawal by Subject|7|||
156386073|NCT02207816|564506007|FG000|Overall Study|Migrated/Moved From Study Area|41|||
156386074|NCT02207816|564506008|FG001|Overall Study|Migrated/Moved From Study Area|60|||
156386075|NCT02207816|564506009|FG002|Overall Study|Migrated/Moved From Study Area|51|||
156386076|NCT02207816|564506007|FG000|Overall Study|Lost to Follow-up|3|||
156386077|NCT02207816|564506008|FG001|Overall Study|Lost to Follow-up|9|||
156386078|NCT02207816|564506009|FG002|Overall Study|Lost to Follow-up|1|||
156386079|NCT02207816|564506007|FG000|Overall Study|Other|1|||
156386080|NCT02207816|564506008|FG001|Overall Study|Other|2|||
156386081|NCT02207816|564506009|FG002|Overall Study|Other|4|||
156386082|NCT05912400|564506010|FG000|Overall Study|Lost to Follow-up|1|||
156386083|NCT05912400|564506011|FG001|Overall Study|Lost to Follow-up|0|||
156386084|NCT05912400|564506010|FG000|Overall Study|Physician Decision|6|||
156386085|NCT05912400|564506011|FG001|Overall Study|Physician Decision|0|||
156386086|NCT05912400|564506010|FG000|Overall Study|Withdrawal by Subject|1|||
156386087|NCT05912400|564506011|FG001|Overall Study|Withdrawal by Subject|0|||
156386088|NCT02522494|564506012|FG000|Overall Study|Lost to Follow-up|6|||
156386089|NCT02522494|564506013|FG001|Overall Study|Lost to Follow-up|2|||
156386090|NCT02522494|564506012|FG000|Overall Study|Withdrawal by Subject|1|||
156386091|NCT02522494|564506013|FG001|Overall Study|Withdrawal by Subject|0|||
156386092|NCT02522494|564506012|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
156386093|NCT02522494|564506013|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
156386094|NCT02522494|564506012|FG000|Overall Study|Participant did not watch the video|1|||
156386095|NCT02522494|564506013|FG001|Overall Study|Participant did not watch the video|0|||
156386096|NCT02522494|564506012|FG000|Overall Study|Death|0|||
156386097|NCT02522494|564506013|FG001|Overall Study|Death|1|||
156507683|NCT02209181|564951056|FG001|Overall Study|Adverse Event|0|||
156507684|NCT02209181|564951057|FG002|Overall Study|Adverse Event|1|||
156507685|NCT02209181|564951058|FG003|Overall Study|Adverse Event|0|||
156507686|NCT02209181|564951055|FG000|Overall Study|Withdrawal by Subject|0|||
156507687|NCT02209181|564951056|FG001|Overall Study|Withdrawal by Subject|1|||
156507688|NCT02209181|564951057|FG002|Overall Study|Withdrawal by Subject|0|||
156507689|NCT02209181|564951058|FG003|Overall Study|Withdrawal by Subject|0|||
156507690|NCT02579772|564951059|FG000|Overall Study|Withdrawal by Subject|0|||
156507691|NCT02579772|564951060|FG001|Overall Study|Withdrawal by Subject|1|||
156507692|NCT02579772|564951059|FG000|Overall Study|Usage of additional antioxidants|1|||
156507693|NCT02579772|564951060|FG001|Overall Study|Usage of additional antioxidants|0|||
156507694|NCT02579772|564951059|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
156507695|NCT02579772|564951060|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
156507696|NCT01182441|564952912|FG000|Overall Study|Patient Still in Follow-up|152|||
156507697|NCT01182441|564952913|FG001|Overall Study|Patient Still in Follow-up|72|||
156507698|NCT01182441|564952912|FG000|Overall Study|Death|37|||
156507699|NCT01182441|564952913|FG001|Overall Study|Death|25|||
156507700|NCT01182441|564952912|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
156507701|NCT01182441|564952913|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
156507702|NCT01182441|564952912|FG000|Overall Study|Lost to Follow-up|5|||
156507703|NCT01182441|564952913|FG001|Overall Study|Lost to Follow-up|8|||
156507704|NCT01182441|564952912|FG000|Overall Study|Withdrawal by Subject|6|||
156507705|NCT01182441|564952913|FG001|Overall Study|Withdrawal by Subject|13|||
156507706|NCT01182441|564952912|FG000|Overall Study|Implant Not Attempted|4|||
156507707|NCT01182441|564952913|FG001|Overall Study|Implant Not Attempted|0|||
156507708|NCT01182441|564952912|FG000|Overall Study|Adverse Event|2|||
156507709|NCT01182441|564952913|FG001|Overall Study|Adverse Event|0|||
156507710|NCT01182441|564952912|FG000|Overall Study|Physician Decision|1|||
156507711|NCT01182441|564952913|FG001|Overall Study|Physician Decision|1|||
156507712|NCT00663702|564952914|FG000|Overall Study|Adverse Event|8|||
156507713|NCT00663702|564952915|FG001|Overall Study|Adverse Event|4|||
156507714|NCT00663702|564952914|FG000|Overall Study|Withdrawal by Subject|3|||
156507715|NCT00663702|564952915|FG001|Overall Study|Withdrawal by Subject|1|||
156507716|NCT00663702|564952914|FG000|Overall Study|Pregnancy|0|||
156507717|NCT00663702|564952915|FG001|Overall Study|Pregnancy|1|||
156507718|NCT00663702|564952914|FG000|Overall Study|Lost to Follow-up|3|||
156507719|NCT00663702|564952915|FG001|Overall Study|Lost to Follow-up|0|||
156507720|NCT00663702|564952914|FG000|Overall Study|Death|1|||
156507721|NCT00663702|564952915|FG001|Overall Study|Death|1|||
156507722|NCT00663702|564952914|FG000|Overall Study|Lack of Efficacy|3|||
156507723|NCT00663702|564952915|FG001|Overall Study|Lack of Efficacy|3|||
156507724|NCT03056300|564952916|FG000|Overall Study|Surgical reason per study protocol|3|||
156507725|NCT04079868|564952923|FG000|Overall Study|Lost to Follow-up|100|||
156507726|NCT04079868|564952924|FG001|Overall Study|Lost to Follow-up|200|||
156386098|NCT01914926|564506014|FG000|Overall Study|Adverse Event|1|||
156386099|NCT01914926|564506015|FG001|Overall Study|Adverse Event|0|||
156386100|NCT01914926|564506014|FG000|Overall Study|uncooperative, agitated and removed|0|||
156386101|NCT01914926|564506015|FG001|Overall Study|uncooperative, agitated and removed|1|||
156386102|NCT00856856|564506017|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
156386103|NCT00856856|564506017|FG000|4-year Clinical Follow-up|Missed visit|1|||
156386104|NCT00434057|564506020|FG000|Overall Study|Withdrawal by Subject|1|||
156386105|NCT03073603|564506022|FG000|Overall Study|Noncompliance|3|||
156386106|NCT03073603|564506023|FG001|Overall Study|Noncompliance|1|||
156386107|NCT03073603|564506022|FG000|Overall Study|Adverse Event|5|||
156386108|NCT03073603|564506023|FG001|Overall Study|Adverse Event|3|||
156386109|NCT03073603|564506022|FG000|Overall Study|Physician Decision|1|||
156386110|NCT03073603|564506023|FG001|Overall Study|Physician Decision|2|||
156386111|NCT03073603|564506022|FG000|Overall Study|Required treatment not allowed by protocol|1|||
156386112|NCT03073603|564506023|FG001|Overall Study|Required treatment not allowed by protocol|0|||
156386113|NCT03073603|564506022|FG000|Overall Study|Financial or insurance-related|8|||
156386114|NCT03073603|564506023|FG001|Overall Study|Financial or insurance-related|0|||
156386115|NCT03073603|564506022|FG000|Overall Study|Withdrawal by Subject|0|||
156386116|NCT03073603|564506023|FG001|Overall Study|Withdrawal by Subject|1|||
156386117|NCT03073603|564506022|FG000|Overall Study|Discontinued DMT|4|||
156386118|NCT03073603|564506023|FG001|Overall Study|Discontinued DMT|0|||
156386119|NCT03073603|564506022|FG000|Overall Study|Restarted DMT|0|||
156386120|NCT03073603|564506023|FG001|Overall Study|Restarted DMT|1|||
156386121|NCT00922428|564506026|FG000|Overall Study|retrospective/extremely implausible data|2|||
156386122|NCT00922428|564506026|FG000|Overall Study|no medication use or questionable use|13|||
156386123|NCT03701555|564506038|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
156386124|NCT03701555|564506039|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
156386125|NCT03701555|564506040|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
156386126|NCT03701555|564506041|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
156386127|NCT03701555|564506042|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
156386128|NCT03701555|564506043|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
156386129|NCT03701555|564506044|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
156386130|NCT03701555|564506045|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
156386131|NCT03701555|564506046|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
156386132|NCT03701555|564506047|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
156386133|NCT03701555|564506048|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
156386134|NCT03701555|564506049|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
156386135|NCT03701555|564506050|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
156386136|NCT03701555|564506051|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
156386137|NCT03701555|564506052|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
156386138|NCT03701555|564506053|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
156386139|NCT03701555|564506054|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
156386140|NCT03701555|564506055|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
156386141|NCT03701555|564506056|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
156386142|NCT03701555|564506057|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
156386143|NCT03701555|564506058|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
156386144|NCT03701555|564506059|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
156386145|NCT03701555|564506060|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
156386146|NCT03701555|564506061|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
156386147|NCT03701555|564506062|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
156386148|NCT03701555|564506063|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
156386149|NCT03701555|564506064|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
156386150|NCT03701555|564506065|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
156386151|NCT03701555|564506066|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
156386152|NCT03701555|564506067|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
156386153|NCT03701555|564506068|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
156386154|NCT03701555|564506069|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
156386155|NCT03701555|564506070|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
156386156|NCT03701555|564506071|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
156386157|NCT03701555|564506072|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
156386158|NCT03701555|564506073|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
156386159|NCT03701555|564506038|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
156386160|NCT03701555|564506039|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
156386161|NCT03701555|564506040|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
156386162|NCT03701555|564506041|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
156386163|NCT03701555|564506042|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
156386164|NCT03701555|564506043|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
156386165|NCT03701555|564506044|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
156386166|NCT03701555|564506045|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
156386167|NCT03701555|564506046|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
156386168|NCT03701555|564506047|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
156386169|NCT03701555|564506048|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
156386170|NCT03701555|564506049|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
156386171|NCT03701555|564506050|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
156386172|NCT03701555|564506051|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
156386173|NCT03701555|564506052|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
156386174|NCT03701555|564506053|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
156386175|NCT03701555|564506054|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
156386176|NCT03701555|564506055|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
156386177|NCT03701555|564506056|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
156386178|NCT03701555|564506057|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
156386179|NCT03701555|564506058|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
156386180|NCT03701555|564506059|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
156386181|NCT03701555|564506060|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
156386182|NCT03701555|564506061|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
156386183|NCT03701555|564506062|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
156386184|NCT03701555|564506063|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
156386185|NCT03701555|564506064|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
156386186|NCT03701555|564506065|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
156386187|NCT03701555|564506066|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
156386188|NCT03701555|564506067|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
156386189|NCT03701555|564506068|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
156386190|NCT03701555|564506069|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
156386191|NCT03701555|564506070|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
156386192|NCT03701555|564506071|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
156386193|NCT03701555|564506072|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
156386194|NCT03701555|564506073|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
156386195|NCT03701555|564506038|FG000|Part 2 (Day 1)|Other|0|||
156386196|NCT03701555|564506039|FG001|Part 2 (Day 1)|Other|0|||
156507727|NCT04079868|564952923|FG000|Overall Study|Physician Decision|100|||
156507728|NCT04079868|564952924|FG001|Overall Study|Physician Decision|0|||
156507729|NCT05262517|564952925|FG000|Overall Study|Randomized but not treated|5|||
156507730|NCT05262517|564952926|FG001|Overall Study|Randomized but not treated|11|||
156507731|NCT05620108|564952927|FG000|Overall Study|Physician Decision|1|||
156507732|NCT05620108|564952928|FG001|Overall Study|Physician Decision|2|||
156507733|NCT00626197|564952934|FG000|Overall Study|Did not cooperate|2|||
156507734|NCT00626197|564952935|FG001|Overall Study|Did not cooperate|6|||
156507735|NCT00626197|564952936|FG002|Overall Study|Did not cooperate|1|||
156507736|NCT00626197|564952934|FG000|Overall Study|Failure to return|6|||
156507737|NCT00626197|564952935|FG001|Overall Study|Failure to return|5|||
156507738|NCT00626197|564952936|FG002|Overall Study|Failure to return|6|||
156507739|NCT00626197|564952934|FG000|Overall Study|Adverse event, serious fatal|3|||
156507740|NCT00626197|564952935|FG001|Overall Study|Adverse event, serious fatal|6|||
156507741|NCT00626197|564952936|FG002|Overall Study|Adverse event, serious fatal|6|||
156507742|NCT00626197|564952934|FG000|Overall Study|Adverse Event|1|||
156507743|NCT00626197|564952935|FG001|Overall Study|Adverse Event|1|||
156507744|NCT00626197|564952936|FG002|Overall Study|Adverse Event|2|||
156507745|NCT00626197|564952934|FG000|Overall Study|Withdrawal by Subject|17|||
156507746|NCT00626197|564952935|FG001|Overall Study|Withdrawal by Subject|17|||
156507747|NCT00626197|564952936|FG002|Overall Study|Withdrawal by Subject|7|||
156507748|NCT00626197|564952934|FG000|Overall Study|Administrative reasons|15|||
156507749|NCT00626197|564952935|FG001|Overall Study|Administrative reasons|19|||
156507750|NCT00626197|564952936|FG002|Overall Study|Administrative reasons|55|||
156507751|NCT03301155|564952938|FG000|Overall Study|Сompliance with exclusion criteria|8|||
156507752|NCT03301155|564952939|FG001|Overall Study|Сompliance with exclusion criteria|7|||
156507753|NCT03510455|564952940|FG000|Overall Study|Physician Decision|1|||
156507754|NCT00384189|564952941|FG000|Overall Study|Reason Not Specified|50|||
156507755|NCT00384189|564952942|FG001|Overall Study|Reason Not Specified|57|||
156507756|NCT00384189|564952943|FG002|Overall Study|Reason Not Specified|58|||
156507757|NCT00384189|564952944|FG003|Overall Study|Reason Not Specified|40|||
156507758|NCT04958642|564952945|FG000|Overall Study|Transferred to OLEX program|3|||
156507759|NCT04958642|564952946|FG001|Overall Study|Transferred to OLEX program|0|||
156507760|NCT04958642|564952947|FG002|Overall Study|Transferred to OLEX program|5|||
156507761|NCT04958642|564952945|FG000|Overall Study|Death|0|||
156507762|NCT04958642|564952946|FG001|Overall Study|Death|0|||
156507763|NCT04958642|564952947|FG002|Overall Study|Death|1|||
156507764|NCT04958642|564952945|FG000|Overall Study|Withdrawal by Subject|4|||
156507765|NCT04958642|564952946|FG001|Overall Study|Withdrawal by Subject|9|||
156507766|NCT04958642|564952947|FG002|Overall Study|Withdrawal by Subject|13|||
156507767|NCT04958642|564952945|FG000|Overall Study|Investigator's Decision|0|||
156507768|NCT04958642|564952946|FG001|Overall Study|Investigator's Decision|0|||
156507769|NCT04958642|564952947|FG002|Overall Study|Investigator's Decision|1|||
156507770|NCT04958642|564952945|FG000|Overall Study|Adverse Event|1|||
156507771|NCT04958642|564952946|FG001|Overall Study|Adverse Event|0|||
156507772|NCT04958642|564952947|FG002|Overall Study|Adverse Event|1|||
156507773|NCT04958642|564952945|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
156507774|NCT04958642|564952946|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
156507775|NCT04958642|564952947|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
156507776|NCT04958642|564952945|FG000|Overall Study|Lost to Follow-up|1|||
156386197|NCT03701555|564506040|FG002|Part 2 (Day 1)|Other|0|||
156386198|NCT03701555|564506041|FG003|Part 2 (Day 1)|Other|0|||
156507777|NCT04958642|564952946|FG001|Overall Study|Lost to Follow-up|0|||
156507778|NCT04958642|564952947|FG002|Overall Study|Lost to Follow-up|0|||
156507779|NCT04958642|564952945|FG000|Overall Study|Transferred to EAP following study termination|0|||
156507780|NCT04958642|564952946|FG001|Overall Study|Transferred to EAP following study termination|0|||
156386199|NCT03701555|564506042|FG004|Part 2 (Day 1)|Other|0|||
156386200|NCT03701555|564506043|FG005|Part 2 (Day 1)|Other|0|||
156386201|NCT03701555|564506044|FG006|Part 2 (Day 1)|Other|0|||
156386202|NCT03701555|564506045|FG007|Part 2 (Day 1)|Other|0|||
156386203|NCT03701555|564506046|FG008|Part 2 (Day 1)|Other|0|||
156507781|NCT04958642|564952947|FG002|Overall Study|Transferred to EAP following study termination|1|||
156507782|NCT04958642|564952945|FG000|Overall Study|Transferred to Expanded Access Program|1|||
156386204|NCT03701555|564506047|FG009|Part 2 (Day 1)|Other|0|||
156547522|NCT00159861|565096856|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
156547523|NCT00159861|565096857|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
156386205|NCT03701555|564506048|FG010|Part 2 (Day 1)|Other|3|||
156386206|NCT03701555|564506049|FG011|Part 2 (Day 1)|Other|1|||
156386207|NCT03701555|564506050|FG012|Part 2 (Day 1)|Other|0|||
156386208|NCT03701555|564506051|FG013|Part 2 (Day 1)|Other|1|||
156386209|NCT03701555|564506052|FG014|Part 2 (Day 1)|Other|0|||
156386210|NCT03701555|564506053|FG015|Part 2 (Day 1)|Other|2|||
156386211|NCT03701555|564506054|FG016|Part 2 (Day 1)|Other|2|||
156386212|NCT03701555|564506055|FG017|Part 2 (Day 1)|Other|0|||
156386213|NCT03701555|564506056|FG018|Part 2 (Day 1)|Other|0|||
156386214|NCT03701555|564506057|FG019|Part 2 (Day 1)|Other|0|||
156386215|NCT03701555|564506058|FG020|Part 2 (Day 1)|Other|0|||
156386216|NCT03701555|564506059|FG021|Part 2 (Day 1)|Other|0|||
156386217|NCT03701555|564506060|FG022|Part 2 (Day 1)|Other|0|||
156386218|NCT03701555|564506061|FG023|Part 2 (Day 1)|Other|0|||
156386219|NCT03701555|564506062|FG024|Part 2 (Day 1)|Other|0|||
156386220|NCT03701555|564506063|FG025|Part 2 (Day 1)|Other|0|||
156386221|NCT03701555|564506064|FG026|Part 2 (Day 1)|Other|0|||
156386222|NCT03701555|564506065|FG027|Part 2 (Day 1)|Other|0|||
156386223|NCT03701555|564506066|FG028|Part 2 (Day 1)|Other|0|||
156386224|NCT03701555|564506067|FG029|Part 2 (Day 1)|Other|0|||
156386225|NCT03701555|564506068|FG030|Part 2 (Day 1)|Other|0|||
156386226|NCT03701555|564506069|FG031|Part 2 (Day 1)|Other|0|||
156386227|NCT03701555|564506070|FG032|Part 2 (Day 1)|Other|0|||
156386228|NCT03701555|564506071|FG033|Part 2 (Day 1)|Other|0|||
156386229|NCT03701555|564506072|FG034|Part 2 (Day 1)|Other|0|||
156386230|NCT03701555|564506073|FG035|Part 2 (Day 1)|Other|0|||
156386231|NCT03701555|564506038|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
156386232|NCT03701555|564506039|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
156386233|NCT03701555|564506040|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
156386234|NCT03701555|564506041|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
156386235|NCT03701555|564506042|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
156386236|NCT03701555|564506043|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
156386237|NCT03701555|564506044|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
156386238|NCT03701555|564506045|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
156386239|NCT03701555|564506046|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
156386240|NCT03701555|564506047|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
156386241|NCT03701555|564506048|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
156386242|NCT03701555|564506049|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
156386243|NCT03701555|564506050|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
156386244|NCT03701555|564506051|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
156386245|NCT03701555|564506052|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
156386246|NCT03701555|564506053|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
156547524|NCT00159861|565096856|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
156547525|NCT00159861|565096857|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
156547526|NCT00159861|565096856|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
156547527|NCT00159861|565096857|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
156547528|NCT00159861|565096856|FG000|Extension Study - up to 3 Years|Death|24|||
156547529|NCT00159861|565096857|FG001|Extension Study - up to 3 Years|Death|28|||
156547530|NCT00159861|565096856|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
156547531|NCT00159861|565096857|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
156547532|NCT00159861|565096856|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
156547533|NCT00159861|565096857|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
156547534|NCT00159861|565096856|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
156386247|NCT03701555|564506054|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
156386248|NCT03701555|564506055|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
156386249|NCT03701555|564506056|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
156386250|NCT03701555|564506057|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
156547535|NCT00159861|565096857|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
156547536|NCT00159861|565096856|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
156547537|NCT00159861|565096857|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
156547538|NCT01553136|565096859|FG000|Overall Study|Adverse Event|3|||
156547539|NCT01553136|565096860|FG001|Overall Study|Adverse Event|2|||
156547540|NCT01553136|565096859|FG000|Overall Study|Withdrawal by Subject|2|||
156386251|NCT03701555|564506058|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
156386252|NCT03701555|564506059|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
156386253|NCT03701555|564506060|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
156386254|NCT03701555|564506061|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
156386255|NCT03701555|564506062|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
156386256|NCT03701555|564506063|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
156547541|NCT01553136|565096860|FG001|Overall Study|Withdrawal by Subject|3|||
156547542|NCT01553136|565096859|FG000|Overall Study|Lost to Follow-up|4|||
156386257|NCT03701555|564506064|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
156386258|NCT03701555|564506065|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
156386259|NCT03701555|564506066|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
156386260|NCT03701555|564506067|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
156386261|NCT03701555|564506068|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
156386262|NCT03701555|564506069|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
156386263|NCT03701555|564506070|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
156386264|NCT03701555|564506071|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
156386265|NCT03701555|564506072|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
156386266|NCT03701555|564506073|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
156386267|NCT03701555|564506038|FG000|Part 3 (Day 1)|Subject Decision|0|||
156386268|NCT03701555|564506039|FG001|Part 3 (Day 1)|Subject Decision|0|||
156386269|NCT03701555|564506040|FG002|Part 3 (Day 1)|Subject Decision|0|||
156386270|NCT03701555|564506041|FG003|Part 3 (Day 1)|Subject Decision|0|||
156386271|NCT03701555|564506042|FG004|Part 3 (Day 1)|Subject Decision|0|||
156386272|NCT03701555|564506043|FG005|Part 3 (Day 1)|Subject Decision|0|||
156386273|NCT03701555|564506044|FG006|Part 3 (Day 1)|Subject Decision|0|||
156386274|NCT03701555|564506045|FG007|Part 3 (Day 1)|Subject Decision|0|||
156386275|NCT03701555|564506046|FG008|Part 3 (Day 1)|Subject Decision|0|||
156386276|NCT03701555|564506047|FG009|Part 3 (Day 1)|Subject Decision|0|||
156386277|NCT03701555|564506048|FG010|Part 3 (Day 1)|Subject Decision|0|||
156386278|NCT03701555|564506049|FG011|Part 3 (Day 1)|Subject Decision|0|||
156386279|NCT03701555|564506050|FG012|Part 3 (Day 1)|Subject Decision|0|||
156386280|NCT03701555|564506051|FG013|Part 3 (Day 1)|Subject Decision|0|||
156386281|NCT03701555|564506052|FG014|Part 3 (Day 1)|Subject Decision|0|||
156386282|NCT03701555|564506053|FG015|Part 3 (Day 1)|Subject Decision|0|||
156386283|NCT03701555|564506054|FG016|Part 3 (Day 1)|Subject Decision|0|||
156386284|NCT03701555|564506055|FG017|Part 3 (Day 1)|Subject Decision|0|||
156386285|NCT03701555|564506056|FG018|Part 3 (Day 1)|Subject Decision|0|||
156386286|NCT03701555|564506057|FG019|Part 3 (Day 1)|Subject Decision|0|||
156386287|NCT03701555|564506058|FG020|Part 3 (Day 1)|Subject Decision|0|||
156386288|NCT03701555|564506059|FG021|Part 3 (Day 1)|Subject Decision|0|||
156386289|NCT03701555|564506060|FG022|Part 3 (Day 1)|Subject Decision|0|||
156386290|NCT03701555|564506061|FG023|Part 3 (Day 1)|Subject Decision|0|||
156386291|NCT03701555|564506062|FG024|Part 3 (Day 1)|Subject Decision|0|||
156386292|NCT03701555|564506063|FG025|Part 3 (Day 1)|Subject Decision|0|||
156386293|NCT03701555|564506064|FG026|Part 3 (Day 1)|Subject Decision|1|||
156386294|NCT03701555|564506065|FG027|Part 3 (Day 1)|Subject Decision|0|||
156386295|NCT03701555|564506066|FG028|Part 3 (Day 1)|Subject Decision|0|||
156386296|NCT03701555|564506067|FG029|Part 3 (Day 1)|Subject Decision|0|||
156386297|NCT03701555|564506068|FG030|Part 3 (Day 1)|Subject Decision|0|||
156386298|NCT03701555|564506069|FG031|Part 3 (Day 1)|Subject Decision|2|||
156386299|NCT03701555|564506070|FG032|Part 3 (Day 1)|Subject Decision|1|||
156386300|NCT03701555|564506071|FG033|Part 3 (Day 1)|Subject Decision|1|||
156386301|NCT03701555|564506072|FG034|Part 3 (Day 1)|Subject Decision|0|||
156386302|NCT03701555|564506073|FG035|Part 3 (Day 1)|Subject Decision|0|||
156386303|NCT03701555|564506038|FG000|Part 3 (Day 1)|Other|0|||
156386304|NCT03701555|564506039|FG001|Part 3 (Day 1)|Other|0|||
156386305|NCT03701555|564506040|FG002|Part 3 (Day 1)|Other|0|||
156386306|NCT03701555|564506041|FG003|Part 3 (Day 1)|Other|0|||
156386307|NCT03701555|564506042|FG004|Part 3 (Day 1)|Other|0|||
156386308|NCT03701555|564506043|FG005|Part 3 (Day 1)|Other|0|||
156386309|NCT03701555|564506044|FG006|Part 3 (Day 1)|Other|0|||
156386310|NCT03701555|564506045|FG007|Part 3 (Day 1)|Other|0|||
156386311|NCT03701555|564506046|FG008|Part 3 (Day 1)|Other|0|||
156386312|NCT03701555|564506047|FG009|Part 3 (Day 1)|Other|0|||
156386313|NCT03701555|564506048|FG010|Part 3 (Day 1)|Other|0|||
156386314|NCT03701555|564506049|FG011|Part 3 (Day 1)|Other|0|||
156386315|NCT03701555|564506050|FG012|Part 3 (Day 1)|Other|0|||
156386316|NCT03701555|564506051|FG013|Part 3 (Day 1)|Other|0|||
156386317|NCT03701555|564506052|FG014|Part 3 (Day 1)|Other|0|||
156386318|NCT03701555|564506053|FG015|Part 3 (Day 1)|Other|0|||
156507783|NCT04958642|564952946|FG001|Overall Study|Transferred to Expanded Access Program|0|||
156507784|NCT04958642|564952947|FG002|Overall Study|Transferred to Expanded Access Program|0|||
156507785|NCT02942004|564952948|FG000|Overall Study|Withdrawal by Subject|0|||
156507786|NCT02942004|564952949|FG001|Overall Study|Withdrawal by Subject|2|||
156507787|NCT02942004|564952950|FG002|Overall Study|Withdrawal by Subject|3|||
156507788|NCT02942004|564952948|FG000|Overall Study|Lost to Follow-up|1|||
156507789|NCT02942004|564952949|FG001|Overall Study|Lost to Follow-up|1|||
156386319|NCT03701555|564506054|FG016|Part 3 (Day 1)|Other|0|||
156386320|NCT03701555|564506055|FG017|Part 3 (Day 1)|Other|0|||
156386321|NCT03701555|564506056|FG018|Part 3 (Day 1)|Other|0|||
156386322|NCT03701555|564506057|FG019|Part 3 (Day 1)|Other|0|||
156386323|NCT03701555|564506058|FG020|Part 3 (Day 1)|Other|0|||
156386324|NCT03701555|564506059|FG021|Part 3 (Day 1)|Other|0|||
156386325|NCT03701555|564506060|FG022|Part 3 (Day 1)|Other|0|||
156386326|NCT03701555|564506061|FG023|Part 3 (Day 1)|Other|0|||
156386327|NCT03701555|564506062|FG024|Part 3 (Day 1)|Other|1|||
156386328|NCT03701555|564506063|FG025|Part 3 (Day 1)|Other|1|||
156386329|NCT03701555|564506064|FG026|Part 3 (Day 1)|Other|0|||
156386330|NCT03701555|564506065|FG027|Part 3 (Day 1)|Other|0|||
156386331|NCT03701555|564506066|FG028|Part 3 (Day 1)|Other|0|||
156386332|NCT03701555|564506067|FG029|Part 3 (Day 1)|Other|1|||
156386333|NCT03701555|564506068|FG030|Part 3 (Day 1)|Other|1|||
156386334|NCT03701555|564506069|FG031|Part 3 (Day 1)|Other|0|||
156386335|NCT03701555|564506070|FG032|Part 3 (Day 1)|Other|1|||
156386336|NCT03701555|564506071|FG033|Part 3 (Day 1)|Other|1|||
156386337|NCT03701555|564506072|FG034|Part 3 (Day 1)|Other|0|||
156386338|NCT03701555|564506073|FG035|Part 3 (Day 1)|Other|0|||
156386339|NCT04757649|564506074|FG000|Overall Study|Withdrawal by Subject|1|||
156386340|NCT04757649|564506074|FG000|Overall Study|Adverse Event|1|||
156386341|NCT02508311|564506082|FG000|Overall Study|Withdrawal by Subject|1|||
156386342|NCT02508311|564506083|FG001|Overall Study|Withdrawal by Subject|0|||
156386343|NCT04862143|564506084|FG000|Overall Study|Adverse Event|1|||
156386344|NCT04862143|564506084|FG000|Overall Study|Study terminated by sponsor|1|||
156386345|NCT02370602|564506086|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156386346|NCT02370602|564506087|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
156386347|NCT02370602|564506088|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156386348|NCT02370602|564506089|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
156386349|NCT02370602|564506090|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
156386350|NCT02370602|564506091|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
156386351|NCT02103439|564506092|FG000|Overall Study|Adverse Event|0|||
156386352|NCT02103439|564506093|FG001|Overall Study|Adverse Event|2|||
156386353|NCT02103439|564506092|FG000|Overall Study|Withdrawal by Subject|3|||
156386354|NCT02103439|564506093|FG001|Overall Study|Withdrawal by Subject|1|||
156386355|NCT04955639|564506094|FG000|Overall Study|Withdrawal by Subject|2|||
156386356|NCT04955639|564506095|FG001|Overall Study|Withdrawal by Subject|2|||
156386357|NCT04955639|564506094|FG000|Overall Study|Week 26 survey not completed|2|||
156386358|NCT04955639|564506095|FG001|Overall Study|Week 26 survey not completed|2|||
156386359|NCT04447404|564506096|FG000|Overall Study|Death|2|||
156386360|NCT04447404|564506097|FG001|Overall Study|Death|0|||
156386361|NCT00413153|564506098|FG000|Overall Study|Withdrawal by Subject|1|||
156386362|NCT00413153|564506099|FG001|Overall Study|Withdrawal by Subject|1|||
156386363|NCT00413153|564506098|FG000|Overall Study|Adverse Event|1|||
156386364|NCT00413153|564506099|FG001|Overall Study|Adverse Event|0|||
156386365|NCT00454051|564506102|FG000|Overall Study|Adverse Event|1|||
156386366|NCT00454051|564506103|FG001|Overall Study|Adverse Event|2|||
156386367|NCT00454051|564506102|FG000|Overall Study|Withdrawal by Subject|1|||
156386368|NCT00454051|564506103|FG001|Overall Study|Withdrawal by Subject|0|||
156386369|NCT00454051|564506102|FG000|Overall Study|Protocol Violation|1|||
156386370|NCT00454051|564506103|FG001|Overall Study|Protocol Violation|1|||
156386371|NCT02097472|564506106|FG000|Received Vaccination 2|Adverse Event|0|||
156386372|NCT02097472|564506107|FG001|Received Vaccination 2|Adverse Event|0|||
156386373|NCT02097472|564506108|FG002|Received Vaccination 2|Adverse Event|0|||
156386374|NCT02097472|564506109|FG003|Received Vaccination 2|Adverse Event|0|||
156386375|NCT02097472|564506110|FG004|Received Vaccination 2|Adverse Event|0|||
156386376|NCT02097472|564506111|FG005|Received Vaccination 2|Adverse Event|0|||
156386377|NCT02097472|564506112|FG006|Received Vaccination 2|Adverse Event|1|||
156386378|NCT02097472|564506113|FG007|Received Vaccination 2|Adverse Event|0|||
156386379|NCT02862106|564506114|FG000|Overall Study|Adverse Event|4|||
156386380|NCT02862106|564506115|FG001|Overall Study|Adverse Event|0|||
156386381|NCT02862106|564506114|FG000|Overall Study|Protocol Violation|16|||
156386382|NCT02862106|564506115|FG001|Overall Study|Protocol Violation|1|||
156386383|NCT02862106|564506114|FG000|Overall Study|Lost to Follow-up|15|||
156386384|NCT02862106|564506115|FG001|Overall Study|Lost to Follow-up|5|||
156386385|NCT02862106|564506114|FG000|Overall Study|Withdrawal by Subject|2|||
156386386|NCT02862106|564506115|FG001|Overall Study|Withdrawal by Subject|0|||
156386387|NCT02862106|564506114|FG000|Overall Study|Subjects moved to other city|1|||
156386388|NCT02862106|564506115|FG001|Overall Study|Subjects moved to other city|0|||
156386389|NCT03966157|564506116|FG000|Overall Study|Physician Decision|1|||
156386390|NCT03966157|564506117|FG001|Overall Study|Physician Decision|0|||
156386391|NCT03305016|564506120|FG000|Overall Study|Withdrawal by Subject|2|||
156386392|NCT01221597|564506121|FG000|Overall Study|Adverse Event|4|||
156386393|NCT01221597|564506122|FG001|Overall Study|Adverse Event|1|||
156386394|NCT01221597|564506121|FG000|Overall Study|Withdrawal by Subject|20|||
156386395|NCT01221597|564506122|FG001|Overall Study|Withdrawal by Subject|6|||
156386396|NCT01221597|564506121|FG000|Overall Study|Lost to Follow-up|6|||
156386397|NCT01221597|564506122|FG001|Overall Study|Lost to Follow-up|5|||
156386398|NCT01221597|564506121|FG000|Overall Study|Protocol Violation|1|||
156386399|NCT01221597|564506122|FG001|Overall Study|Protocol Violation|0|||
156386400|NCT01221597|564506121|FG000|Overall Study|Other|3|||
156386401|NCT01221597|564506122|FG001|Overall Study|Other|4|||
156386402|NCT01221597|564506121|FG000|Overall Study|Death|2|||
156386403|NCT01221597|564506122|FG001|Overall Study|Death|0|||
156386404|NCT04420689|564506124|FG000|Overall Study|COVID-19 related hospitalization|0|||
156386405|NCT04420689|564506125|FG001|Overall Study|COVID-19 related hospitalization|0|||
156386406|NCT04420689|564506126|FG002|Overall Study|COVID-19 related hospitalization|0|||
156386407|NCT04420689|564506127|FG003|Overall Study|COVID-19 related hospitalization|0|||
156386408|NCT04420689|564506128|FG004|Overall Study|COVID-19 related hospitalization|1|||
156386409|NCT04420689|564506129|FG005|Overall Study|COVID-19 related hospitalization|0|||
156386410|NCT04420689|564506130|FG006|Overall Study|COVID-19 related hospitalization|0|||
156386411|NCT04420689|564506124|FG000|Overall Study|Physician Decision|0|||
156386412|NCT04420689|564506125|FG001|Overall Study|Physician Decision|0|||
156386413|NCT04420689|564506126|FG002|Overall Study|Physician Decision|0|||
156386414|NCT04420689|564506127|FG003|Overall Study|Physician Decision|0|||
156386415|NCT04420689|564506128|FG004|Overall Study|Physician Decision|0|||
156386416|NCT04420689|564506129|FG005|Overall Study|Physician Decision|1|||
156386417|NCT04420689|564506130|FG006|Overall Study|Physician Decision|0|||
156386418|NCT02278328|564506136|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
156386419|NCT02278328|564506137|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
156386420|NCT02278328|564506138|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
156386421|NCT02278328|564506136|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
156386422|NCT02278328|564506137|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
156386423|NCT02278328|564506138|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
156386424|NCT02278328|564506136|FG000|Neuropsych Screening|incomplete consent|0|||
156386425|NCT02278328|564506137|FG001|Neuropsych Screening|incomplete consent|0|||
156386426|NCT02278328|564506138|FG002|Neuropsych Screening|incomplete consent|2|||
156386427|NCT00377676|564506139|FG000|Overall Study|Adverse Event|498|||
156386428|NCT00377676|564506140|FG001|Overall Study|Adverse Event|107|||
156386429|NCT00377676|564506139|FG000|Overall Study|Protocol Violation|33|||
156386430|NCT00377676|564506140|FG001|Overall Study|Protocol Violation|27|||
156386431|NCT00377676|564506139|FG000|Overall Study|Death|5|||
156386432|NCT00377676|564506140|FG001|Overall Study|Death|2|||
156386433|NCT00377676|564506139|FG000|Overall Study|Withdrawal by Subject|187|||
156386434|NCT00377676|564506140|FG001|Overall Study|Withdrawal by Subject|72|||
156386435|NCT00377676|564506139|FG000|Overall Study|Lost to Follow-up|120|||
156386436|NCT00377676|564506140|FG001|Overall Study|Lost to Follow-up|56|||
156386437|NCT00377676|564506139|FG000|Overall Study|Other|118|||
156386438|NCT00377676|564506140|FG001|Overall Study|Other|58|||
156386439|NCT03834779|564506141|FG000|Overall Study|Death|1|||
156386440|NCT03834779|564506142|FG001|Overall Study|Death|2|||
156386441|NCT03834779|564506141|FG000|Overall Study|Lost to Follow-up|6|||
156386442|NCT03834779|564506142|FG001|Overall Study|Lost to Follow-up|4|||
156386443|NCT01519206|564506148|FG000|Overall Study|Lost to Follow-up|3|||
156386444|NCT01519206|564506148|FG000|Overall Study|Missed Visit|2|||
156386445|NCT02014116|564506149|FG000|Overall Study|Progressive Disease|3|||
156386446|NCT02014116|564506150|FG001|Overall Study|Progressive Disease|4|||
156386447|NCT02014116|564506151|FG002|Overall Study|Progressive Disease|2|||
156386448|NCT02014116|564506152|FG003|Overall Study|Progressive Disease|6|||
156386449|NCT02014116|564506153|FG004|Overall Study|Progressive Disease|1|||
156386450|NCT02014116|564506154|FG005|Overall Study|Progressive Disease|13|||
156386451|NCT02014116|564506155|FG006|Overall Study|Progressive Disease|1|||
156386452|NCT02014116|564506156|FG007|Overall Study|Progressive Disease|3|||
156386453|NCT02014116|564506157|FG008|Overall Study|Progressive Disease|7|||
156386454|NCT02014116|564506149|FG000|Overall Study|Adverse Event|0|||
156386455|NCT02014116|564506150|FG001|Overall Study|Adverse Event|0|||
156386456|NCT02014116|564506151|FG002|Overall Study|Adverse Event|0|||
156386457|NCT02014116|564506152|FG003|Overall Study|Adverse Event|0|||
156386458|NCT02014116|564506153|FG004|Overall Study|Adverse Event|1|||
156386459|NCT02014116|564506154|FG005|Overall Study|Adverse Event|0|||
156507790|NCT02942004|564952950|FG002|Overall Study|Lost to Follow-up|2|||
156507791|NCT02942004|564952948|FG000|Overall Study|Randomized but not dosed|3|||
156507792|NCT02942004|564952949|FG001|Overall Study|Randomized but not dosed|9|||
156507793|NCT02942004|564952950|FG002|Overall Study|Randomized but not dosed|4|||
156507794|NCT05627258|564952951|FG000|Overall Study|Lost to Follow-up|1|||
156507795|NCT05627258|564952952|FG001|Overall Study|Lost to Follow-up|0|||
156507796|NCT05627258|564952953|FG002|Overall Study|Lost to Follow-up|0|||
156507797|NCT05627258|564952954|FG003|Overall Study|Lost to Follow-up|0|||
156507798|NCT05627258|564952955|FG004|Overall Study|Lost to Follow-up|0|||
156507799|NCT05627258|564952956|FG005|Overall Study|Lost to Follow-up|0|||
156507800|NCT05627258|564952951|FG000|Overall Study|Withdrawal by Subject|0|||
156507801|NCT05627258|564952952|FG001|Overall Study|Withdrawal by Subject|0|||
156507802|NCT05627258|564952953|FG002|Overall Study|Withdrawal by Subject|0|||
156507803|NCT05627258|564952954|FG003|Overall Study|Withdrawal by Subject|0|||
156507804|NCT05627258|564952955|FG004|Overall Study|Withdrawal by Subject|2|||
156507805|NCT05627258|564952956|FG005|Overall Study|Withdrawal by Subject|0|||
156507806|NCT05627258|564952951|FG000|Overall Study|Enrolled, but product not administered|1|||
156507807|NCT05627258|564952952|FG001|Overall Study|Enrolled, but product not administered|0|||
156507808|NCT05627258|564952953|FG002|Overall Study|Enrolled, but product not administered|0|||
156507809|NCT05627258|564952954|FG003|Overall Study|Enrolled, but product not administered|0|||
156507810|NCT05627258|564952955|FG004|Overall Study|Enrolled, but product not administered|0|||
156386460|NCT02014116|564506155|FG006|Overall Study|Adverse Event|0|||
156386461|NCT02014116|564506156|FG007|Overall Study|Adverse Event|1|||
156386462|NCT02014116|564506157|FG008|Overall Study|Adverse Event|0|||
156386463|NCT02014116|564506149|FG000|Overall Study|Lost to Follow-up|0|||
156386464|NCT02014116|564506150|FG001|Overall Study|Lost to Follow-up|0|||
156507811|NCT05627258|564952956|FG005|Overall Study|Enrolled, but product not administered|0|||
156386465|NCT02014116|564506151|FG002|Overall Study|Lost to Follow-up|0|||
156386466|NCT02014116|564506152|FG003|Overall Study|Lost to Follow-up|0|||
156507812|NCT05627258|564952951|FG000|Overall Study|Other subject illness/injury|1|||
156386467|NCT02014116|564506153|FG004|Overall Study|Lost to Follow-up|0|||
156386468|NCT02014116|564506154|FG005|Overall Study|Lost to Follow-up|1|||
156386469|NCT02014116|564506155|FG006|Overall Study|Lost to Follow-up|0|||
156386470|NCT02014116|564506156|FG007|Overall Study|Lost to Follow-up|0|||
156386471|NCT02014116|564506157|FG008|Overall Study|Lost to Follow-up|1|||
156386472|NCT02014116|564506149|FG000|Overall Study|Death|0|||
156386473|NCT02014116|564506150|FG001|Overall Study|Death|0|||
156386474|NCT02014116|564506151|FG002|Overall Study|Death|0|||
156386475|NCT02014116|564506152|FG003|Overall Study|Death|0|||
156386476|NCT02014116|564506153|FG004|Overall Study|Death|0|||
156386477|NCT02014116|564506154|FG005|Overall Study|Death|0|||
156386478|NCT02014116|564506155|FG006|Overall Study|Death|0|||
156386479|NCT02014116|564506156|FG007|Overall Study|Death|1|||
156386480|NCT02014116|564506157|FG008|Overall Study|Death|1|||
156386481|NCT02014116|564506149|FG000|Overall Study|Withdrawal by Subject|0|||
156386482|NCT02014116|564506150|FG001|Overall Study|Withdrawal by Subject|0|||
156386483|NCT02014116|564506151|FG002|Overall Study|Withdrawal by Subject|1|||
156386484|NCT02014116|564506152|FG003|Overall Study|Withdrawal by Subject|1|||
156386485|NCT02014116|564506153|FG004|Overall Study|Withdrawal by Subject|0|||
156386486|NCT02014116|564506154|FG005|Overall Study|Withdrawal by Subject|1|||
156386487|NCT02014116|564506155|FG006|Overall Study|Withdrawal by Subject|0|||
156386488|NCT02014116|564506156|FG007|Overall Study|Withdrawal by Subject|0|||
156386489|NCT02014116|564506157|FG008|Overall Study|Withdrawal by Subject|0|||
156386490|NCT02014116|564506149|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
156386491|NCT02014116|564506150|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
156386492|NCT02014116|564506151|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
156386493|NCT02014116|564506152|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
156386494|NCT02014116|564506153|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
156386495|NCT02014116|564506154|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
156386496|NCT02014116|564506155|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
156386497|NCT02014116|564506156|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
156386498|NCT02014116|564506157|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
156386499|NCT02014116|564506149|FG000|Overall Study|Physician Decision|0|||
156386500|NCT02014116|564506150|FG001|Overall Study|Physician Decision|0|||
156386501|NCT02014116|564506151|FG002|Overall Study|Physician Decision|0|||
156386502|NCT02014116|564506152|FG003|Overall Study|Physician Decision|0|||
156386503|NCT02014116|564506153|FG004|Overall Study|Physician Decision|0|||
156386504|NCT02014116|564506154|FG005|Overall Study|Physician Decision|0|||
156386505|NCT02014116|564506155|FG006|Overall Study|Physician Decision|0|||
156386506|NCT02014116|564506156|FG007|Overall Study|Physician Decision|0|||
156386507|NCT02014116|564506157|FG008|Overall Study|Physician Decision|1|||
156386508|NCT02864082|564506158|FG000|Overall Study|Adverse Event|1|||
156386509|NCT02864082|564506159|FG001|Overall Study|Adverse Event|1|||
156386510|NCT02864082|564506158|FG000|Overall Study|Lost to Follow-up|0|||
156386511|NCT02864082|564506159|FG001|Overall Study|Lost to Follow-up|1|||
156386512|NCT02864082|564506158|FG000|Overall Study|Withdrawal by Subject|2|||
156386513|NCT02864082|564506159|FG001|Overall Study|Withdrawal by Subject|2|||
156386514|NCT00096135|564506168|FG000|Overall Study|Physician Decision|20|||
156386515|NCT00096135|564506169|FG001|Overall Study|Physician Decision|4|||
156386516|NCT00096135|564506168|FG000|Overall Study|Refusal of further protocol therapy|4|||
156386517|NCT00096135|564506169|FG001|Overall Study|Refusal of further protocol therapy|1|||
156386518|NCT00096135|564506168|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
156386519|NCT00096135|564506169|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
156386520|NCT00096135|564506168|FG000|Overall Study|Other, specify|15|||
156386521|NCT00096135|564506169|FG001|Overall Study|Other, specify|3|||
156386522|NCT00096135|564506168|FG000|Overall Study|Ineligible|2|||
156386523|NCT00096135|564506169|FG001|Overall Study|Ineligible|0|||
156386524|NCT00833989|564506173|FG000|Overall Study|Physician Decision|0|||
156386525|NCT00833989|564506174|FG001|Overall Study|Physician Decision|0|||
156386526|NCT00833989|564506175|FG002|Overall Study|Physician Decision|0|||
156386527|NCT00833989|564506176|FG003|Overall Study|Physician Decision|1|||
156386528|NCT00833989|564506173|FG000|Overall Study|Withdrawal by Subject|3|||
156386529|NCT00833989|564506174|FG001|Overall Study|Withdrawal by Subject|0|||
156386530|NCT00833989|564506175|FG002|Overall Study|Withdrawal by Subject|1|||
156386531|NCT00833989|564506176|FG003|Overall Study|Withdrawal by Subject|1|||
156386532|NCT02310750|564506179|FG000|HP Period 1|Lost to Follow-up|0|||
156386533|NCT02310750|564506180|FG001|HP Period 1|Lost to Follow-up|0|||
156386534|NCT02310750|564506181|FG002|HP Period 1|Lost to Follow-up|0|||
156386535|NCT02310750|564506182|FG003|HP Period 1|Lost to Follow-up|0|||
156386536|NCT02310750|564506183|FG004|HP Period 1|Lost to Follow-up|0|||
156386537|NCT02310750|564506184|FG005|HP Period 1|Lost to Follow-up|0|||
156386538|NCT02310750|564506185|FG006|HP Period 1|Lost to Follow-up|1|||
156386539|NCT02310750|564506186|FG007|HP Period 1|Lost to Follow-up|0|||
156386540|NCT02310750|564506187|FG008|HP Period 1|Lost to Follow-up|0|||
156386541|NCT02310750|564506188|FG009|HP Period 1|Lost to Follow-up|0|||
156386542|NCT02310750|564506189|FG010|HP Period 1|Lost to Follow-up|0|||
156386543|NCT02310750|564506190|FG011|HP Period 1|Lost to Follow-up|0|||
156386544|NCT02310750|564506191|FG012|HP Period 1|Lost to Follow-up|0|||
156386545|NCT02310750|564506192|FG013|HP Period 1|Lost to Follow-up|0|||
156386546|NCT02310750|564506193|FG014|HP Period 1|Lost to Follow-up|0|||
156386547|NCT02310750|564506194|FG015|HP Period 1|Lost to Follow-up|0|||
156386548|NCT02310750|564506179|FG000|HP Period 1|Withdrawal by Subject|1|||
156386549|NCT02310750|564506180|FG001|HP Period 1|Withdrawal by Subject|0|||
156386550|NCT02310750|564506181|FG002|HP Period 1|Withdrawal by Subject|0|||
156386551|NCT02310750|564506182|FG003|HP Period 1|Withdrawal by Subject|1|||
156386552|NCT02310750|564506183|FG004|HP Period 1|Withdrawal by Subject|0|||
156386553|NCT02310750|564506184|FG005|HP Period 1|Withdrawal by Subject|0|||
156386554|NCT02310750|564506185|FG006|HP Period 1|Withdrawal by Subject|0|||
156386555|NCT02310750|564506186|FG007|HP Period 1|Withdrawal by Subject|0|||
156386556|NCT02310750|564506187|FG008|HP Period 1|Withdrawal by Subject|0|||
156386557|NCT02310750|564506188|FG009|HP Period 1|Withdrawal by Subject|0|||
156386558|NCT02310750|564506189|FG010|HP Period 1|Withdrawal by Subject|0|||
156386559|NCT02310750|564506190|FG011|HP Period 1|Withdrawal by Subject|0|||
156386560|NCT02310750|564506191|FG012|HP Period 1|Withdrawal by Subject|0|||
156386561|NCT02310750|564506192|FG013|HP Period 1|Withdrawal by Subject|0|||
156386562|NCT02310750|564506193|FG014|HP Period 1|Withdrawal by Subject|0|||
156386563|NCT02310750|564506194|FG015|HP Period 1|Withdrawal by Subject|0|||
156386564|NCT02310750|564506179|FG000|HP Washout 1|Lost to Follow-up|0|||
156386565|NCT02310750|564506180|FG001|HP Washout 1|Lost to Follow-up|0|||
156386566|NCT02310750|564506181|FG002|HP Washout 1|Lost to Follow-up|1|||
156386567|NCT02310750|564506182|FG003|HP Washout 1|Lost to Follow-up|1|||
156386568|NCT02310750|564506183|FG004|HP Washout 1|Lost to Follow-up|2|||
156386569|NCT02310750|564506184|FG005|HP Washout 1|Lost to Follow-up|2|||
156386570|NCT02310750|564506185|FG006|HP Washout 1|Lost to Follow-up|3|||
156386571|NCT02310750|564506186|FG007|HP Washout 1|Lost to Follow-up|0|||
156386572|NCT02310750|564506187|FG008|HP Washout 1|Lost to Follow-up|0|||
156386573|NCT02310750|564506188|FG009|HP Washout 1|Lost to Follow-up|0|||
156386574|NCT02310750|564506189|FG010|HP Washout 1|Lost to Follow-up|0|||
156386575|NCT02310750|564506190|FG011|HP Washout 1|Lost to Follow-up|0|||
156386576|NCT02310750|564506191|FG012|HP Washout 1|Lost to Follow-up|0|||
156386577|NCT02310750|564506192|FG013|HP Washout 1|Lost to Follow-up|0|||
156386578|NCT02310750|564506193|FG014|HP Washout 1|Lost to Follow-up|0|||
156386579|NCT02310750|564506194|FG015|HP Washout 1|Lost to Follow-up|0|||
156386580|NCT02310750|564506179|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386581|NCT02310750|564506180|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386582|NCT02310750|564506181|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386583|NCT02310750|564506182|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
156386584|NCT02310750|564506183|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386585|NCT02310750|564506184|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
156386586|NCT02310750|564506185|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386587|NCT02310750|564506186|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386588|NCT02310750|564506187|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
156386589|NCT02310750|564506188|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
156386590|NCT02310750|564506189|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386591|NCT02310750|564506190|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386592|NCT02310750|564506191|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386593|NCT02310750|564506192|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386594|NCT02310750|564506193|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386595|NCT02310750|564506194|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156386596|NCT02310750|564506179|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386597|NCT02310750|564506180|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386598|NCT02310750|564506181|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386599|NCT02310750|564506182|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386600|NCT02310750|564506183|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386601|NCT02310750|564506184|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386602|NCT02310750|564506185|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386603|NCT02310750|564506186|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386604|NCT02310750|564506187|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386605|NCT02310750|564506188|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
156386606|NCT02310750|564506189|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386607|NCT02310750|564506190|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386608|NCT02310750|564506191|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386609|NCT02310750|564506192|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386610|NCT02310750|564506193|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386611|NCT02310750|564506194|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156386612|NCT02310750|564506179|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386613|NCT02310750|564506180|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386614|NCT02310750|564506181|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386615|NCT02310750|564506182|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386616|NCT02310750|564506183|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386617|NCT02310750|564506184|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386618|NCT02310750|564506185|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386619|NCT02310750|564506186|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
156386620|NCT02310750|564506187|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
156386621|NCT02310750|564506188|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
156386622|NCT02310750|564506189|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386623|NCT02310750|564506190|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386624|NCT02310750|564506191|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386625|NCT02310750|564506192|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386626|NCT02310750|564506193|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386627|NCT02310750|564506194|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156386628|NCT02310750|564506179|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386629|NCT02310750|564506180|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386630|NCT02310750|564506181|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386631|NCT02310750|564506182|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386632|NCT02310750|564506183|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386633|NCT02310750|564506184|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386634|NCT02310750|564506185|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386635|NCT02310750|564506186|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
156386636|NCT02310750|564506187|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
156386637|NCT02310750|564506188|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386638|NCT02310750|564506189|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386639|NCT02310750|564506190|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386640|NCT02310750|564506191|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386641|NCT02310750|564506192|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386642|NCT02310750|564506193|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386643|NCT02310750|564506194|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156386644|NCT02310750|564506179|FG000|HP Washout 2|Lost to Follow-up|0|||
156386645|NCT02310750|564506180|FG001|HP Washout 2|Lost to Follow-up|0|||
156386646|NCT02310750|564506181|FG002|HP Washout 2|Lost to Follow-up|0|||
156386647|NCT02310750|564506182|FG003|HP Washout 2|Lost to Follow-up|0|||
156386648|NCT02310750|564506183|FG004|HP Washout 2|Lost to Follow-up|1|||
156386649|NCT02310750|564506184|FG005|HP Washout 2|Lost to Follow-up|0|||
156386650|NCT02310750|564506185|FG006|HP Washout 2|Lost to Follow-up|7|||
156386651|NCT02310750|564506186|FG007|HP Washout 2|Lost to Follow-up|0|||
156386652|NCT02310750|564506187|FG008|HP Washout 2|Lost to Follow-up|0|||
156386653|NCT02310750|564506188|FG009|HP Washout 2|Lost to Follow-up|0|||
156386654|NCT02310750|564506189|FG010|HP Washout 2|Lost to Follow-up|0|||
156386655|NCT02310750|564506190|FG011|HP Washout 2|Lost to Follow-up|0|||
156386656|NCT02310750|564506191|FG012|HP Washout 2|Lost to Follow-up|0|||
156386657|NCT02310750|564506192|FG013|HP Washout 2|Lost to Follow-up|0|||
156386658|NCT02310750|564506193|FG014|HP Washout 2|Lost to Follow-up|0|||
156386659|NCT02310750|564506194|FG015|HP Washout 2|Lost to Follow-up|0|||
156386660|NCT02952924|564506197|FG000|Overall Study|Protocol Violation|0|||
156386661|NCT02952924|564506198|FG001|Overall Study|Protocol Violation|0|||
156386662|NCT02952924|564506199|FG002|Overall Study|Protocol Violation|0|||
156386663|NCT02952924|564506200|FG003|Overall Study|Protocol Violation|0|||
156386664|NCT02952924|564506201|FG004|Overall Study|Protocol Violation|0|||
156386665|NCT02952924|564506202|FG005|Overall Study|Protocol Violation|0|||
156386666|NCT02952924|564506203|FG006|Overall Study|Protocol Violation|0|||
156386667|NCT02952924|564506204|FG007|Overall Study|Protocol Violation|0|||
156386668|NCT02952924|564506205|FG008|Overall Study|Protocol Violation|0|||
156386669|NCT02952924|564506206|FG009|Overall Study|Protocol Violation|0|||
156386670|NCT02952924|564506207|FG010|Overall Study|Protocol Violation|0|||
156386671|NCT02952924|564506208|FG011|Overall Study|Protocol Violation|0|||
156386672|NCT02952924|564506209|FG012|Overall Study|Protocol Violation|0|||
156386673|NCT02952924|564506210|FG013|Overall Study|Protocol Violation|0|||
156386674|NCT02952924|564506211|FG014|Overall Study|Protocol Violation|0|||
156386675|NCT02952924|564506212|FG015|Overall Study|Protocol Violation|0|||
156386676|NCT02952924|564506213|FG016|Overall Study|Protocol Violation|0|||
156386677|NCT02952924|564506214|FG017|Overall Study|Protocol Violation|0|||
156386678|NCT02952924|564506215|FG018|Overall Study|Protocol Violation|0|||
156386679|NCT02952924|564506216|FG019|Overall Study|Protocol Violation|1|||
156386680|NCT02952924|564506217|FG020|Overall Study|Protocol Violation|0|||
156386681|NCT02952924|564506218|FG021|Overall Study|Protocol Violation|0|||
156386682|NCT02952924|564506197|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
156547543|NCT01553136|565096860|FG001|Overall Study|Lost to Follow-up|10|||
156547544|NCT01553136|565096859|FG000|Overall Study|Physician Decision|2|||
156386683|NCT02952924|564506198|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
156386684|NCT02952924|564506199|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
156386685|NCT02952924|564506200|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
156386686|NCT02952924|564506201|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
156386687|NCT02952924|564506202|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
156386688|NCT02952924|564506203|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
156386689|NCT02952924|564506204|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
156386690|NCT02952924|564506205|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
156547545|NCT01553136|565096860|FG001|Overall Study|Physician Decision|3|||
156386691|NCT02952924|564506206|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
156386692|NCT02952924|564506207|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
156386693|NCT02952924|564506208|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
156386694|NCT02952924|564506209|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
156386695|NCT02952924|564506210|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
156386696|NCT02952924|564506211|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
156386697|NCT02952924|564506212|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
156386698|NCT02952924|564506213|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
156386699|NCT02952924|564506214|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
156386700|NCT02952924|564506215|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
156386701|NCT02952924|564506216|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
156386702|NCT02952924|564506217|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
156386703|NCT02952924|564506218|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
156386704|NCT02952924|564506197|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386705|NCT02952924|564506198|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386706|NCT02952924|564506199|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386707|NCT02952924|564506200|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386708|NCT02952924|564506201|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386709|NCT02952924|564506202|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386710|NCT02952924|564506203|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386711|NCT02952924|564506204|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386712|NCT02952924|564506205|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386713|NCT02952924|564506206|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386714|NCT02952924|564506207|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386715|NCT02952924|564506208|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386716|NCT02952924|564506209|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386717|NCT02952924|564506210|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386718|NCT02952924|564506211|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386719|NCT02952924|564506212|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386720|NCT02952924|564506213|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386721|NCT02952924|564506214|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386722|NCT02952924|564506215|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386723|NCT02952924|564506216|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386724|NCT02952924|564506217|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
156386725|NCT02952924|564506218|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
156386726|NCT02952924|564506197|FG000|Overall Study|Noncompliance with study drug|0|||
156386727|NCT02952924|564506198|FG001|Overall Study|Noncompliance with study drug|0|||
156386728|NCT02952924|564506199|FG002|Overall Study|Noncompliance with study drug|0|||
156386729|NCT02952924|564506200|FG003|Overall Study|Noncompliance with study drug|0|||
156386730|NCT02952924|564506201|FG004|Overall Study|Noncompliance with study drug|0|||
156386731|NCT02952924|564506202|FG005|Overall Study|Noncompliance with study drug|0|||
156386732|NCT02952924|564506203|FG006|Overall Study|Noncompliance with study drug|0|||
156386733|NCT02952924|564506204|FG007|Overall Study|Noncompliance with study drug|0|||
156386734|NCT02952924|564506205|FG008|Overall Study|Noncompliance with study drug|0|||
156386735|NCT02952924|564506206|FG009|Overall Study|Noncompliance with study drug|0|||
156386736|NCT02952924|564506207|FG010|Overall Study|Noncompliance with study drug|0|||
156386737|NCT02952924|564506208|FG011|Overall Study|Noncompliance with study drug|0|||
156386738|NCT02952924|564506209|FG012|Overall Study|Noncompliance with study drug|0|||
156386739|NCT02952924|564506210|FG013|Overall Study|Noncompliance with study drug|0|||
156386740|NCT02952924|564506211|FG014|Overall Study|Noncompliance with study drug|0|||
156386741|NCT02952924|564506212|FG015|Overall Study|Noncompliance with study drug|0|||
156386742|NCT02952924|564506213|FG016|Overall Study|Noncompliance with study drug|0|||
156386743|NCT02952924|564506214|FG017|Overall Study|Noncompliance with study drug|0|||
156386744|NCT02952924|564506215|FG018|Overall Study|Noncompliance with study drug|0|||
156507813|NCT05627258|564952952|FG001|Overall Study|Other subject illness/injury|0|||
156507814|NCT05627258|564952953|FG002|Overall Study|Other subject illness/injury|0|||
156507815|NCT05627258|564952954|FG003|Overall Study|Other subject illness/injury|0|||
156507816|NCT05627258|564952955|FG004|Overall Study|Other subject illness/injury|0|||
156507817|NCT05627258|564952956|FG005|Overall Study|Other subject illness/injury|0|||
156507818|NCT05627258|564952951|FG000|Overall Study|Subject moved from area|0|||
156507819|NCT05627258|564952952|FG001|Overall Study|Subject moved from area|0|||
156507820|NCT05627258|564952953|FG002|Overall Study|Subject moved from area|1|||
156507821|NCT05627258|564952954|FG003|Overall Study|Subject moved from area|0|||
156547546|NCT01553136|565096859|FG000|Overall Study|Scheduling Difficulties|5|||
156386745|NCT02952924|564506216|FG019|Overall Study|Noncompliance with study drug|0|||
156386746|NCT02952924|564506217|FG020|Overall Study|Noncompliance with study drug|0|||
156386747|NCT02952924|564506218|FG021|Overall Study|Noncompliance with study drug|1|||
156386748|NCT03585244|564506219|FG000|Overall Study|Withdrawal by Subject|15|||
156386749|NCT01934218|564506221|FG000|Double-blind Phase|Adverse Event|8|||
156386750|NCT01934218|564506222|FG001|Double-blind Phase|Adverse Event|8|||
156386751|NCT01934218|564506221|FG000|Double-blind Phase|Lack of Efficacy|6|||
156386752|NCT01934218|564506222|FG001|Double-blind Phase|Lack of Efficacy|7|||
156386753|NCT01934218|564506221|FG000|Double-blind Phase|Lost to Follow-up|7|||
156386754|NCT01934218|564506222|FG001|Double-blind Phase|Lost to Follow-up|14|||
156386755|NCT01934218|564506221|FG000|Double-blind Phase|Physician Decision|1|||
156386756|NCT01934218|564506222|FG001|Double-blind Phase|Physician Decision|2|||
156386757|NCT01934218|564506221|FG000|Double-blind Phase|Protocol Violation|4|||
156386758|NCT01934218|564506222|FG001|Double-blind Phase|Protocol Violation|0|||
156386759|NCT01934218|564506221|FG000|Double-blind Phase|Withdrawal by Subject|16|||
156386760|NCT01934218|564506222|FG001|Double-blind Phase|Withdrawal by Subject|13|||
156386761|NCT01934218|564506221|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
156386762|NCT01934218|564506222|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
156386763|NCT01934218|564506221|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
156386764|NCT01934218|564506222|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
156386765|NCT01934218|564506221|FG000|Open-Label Phase|Adverse Event|2|||
156386766|NCT01934218|564506222|FG001|Open-Label Phase|Adverse Event|4|||
156386767|NCT01934218|564506221|FG000|Open-Label Phase|Lack of Efficacy|1|||
156386768|NCT01934218|564506222|FG001|Open-Label Phase|Lack of Efficacy|4|||
156386769|NCT01934218|564506221|FG000|Open-Label Phase|Lost to Follow-up|4|||
156386770|NCT01934218|564506222|FG001|Open-Label Phase|Lost to Follow-up|2|||
156386771|NCT01934218|564506221|FG000|Open-Label Phase|Physician Decision|1|||
156386772|NCT01934218|564506222|FG001|Open-Label Phase|Physician Decision|0|||
156386773|NCT01934218|564506221|FG000|Open-Label Phase|Protocol Violation|1|||
156386774|NCT01934218|564506222|FG001|Open-Label Phase|Protocol Violation|0|||
156386775|NCT01934218|564506221|FG000|Open-Label Phase|Withdrawal by Subject|13|||
156386776|NCT01934218|564506222|FG001|Open-Label Phase|Withdrawal by Subject|11|||
156386777|NCT01934218|564506221|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
156386778|NCT01934218|564506222|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
156386779|NCT01934218|564506221|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
156386780|NCT01934218|564506222|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
156386781|NCT01220557|564506227|FG000|Overall Study|Lost to Follow-up|5|||
156386782|NCT01220557|564506228|FG001|Overall Study|Lost to Follow-up|3|||
156386783|NCT01220557|564506227|FG000|Overall Study|attended less than 6 lessons|1|||
156386784|NCT01220557|564506228|FG001|Overall Study|attended less than 6 lessons|2|||
156386785|NCT05045625|564506229|FG000|Overall Study|Lost to Follow-up|3|||
156386786|NCT00110617|564506230|FG000|Overall Study|Adverse Event|2|||
156386787|NCT00110617|564506231|FG001|Overall Study|Adverse Event|4|||
156386788|NCT00110617|564506230|FG000|Overall Study|Abnormal Laboratory Value|4|||
156386789|NCT00110617|564506231|FG001|Overall Study|Abnormal Laboratory Value|2|||
156386790|NCT00110617|564506230|FG000|Overall Study|Lack of Efficacy|1|||
156386791|NCT00110617|564506231|FG001|Overall Study|Lack of Efficacy|0|||
156386792|NCT00110617|564506230|FG000|Overall Study|Patient no longer requires study drug|1|||
156386793|NCT00110617|564506231|FG001|Overall Study|Patient no longer requires study drug|0|||
156386794|NCT00110617|564506230|FG000|Overall Study|Protocol Violation|5|||
156386795|NCT00110617|564506231|FG001|Overall Study|Protocol Violation|0|||
156386796|NCT00110617|564506230|FG000|Overall Study|Withdrawal by Subject|10|||
156386797|NCT00110617|564506231|FG001|Overall Study|Withdrawal by Subject|4|||
156386798|NCT00110617|564506230|FG000|Overall Study|Lost to Follow-up|9|||
156386799|NCT00110617|564506231|FG001|Overall Study|Lost to Follow-up|1|||
156386800|NCT00110617|564506230|FG000|Overall Study|Administrative problems|6|||
156386801|NCT00110617|564506231|FG001|Overall Study|Administrative problems|5|||
156386802|NCT00110617|564506230|FG000|Overall Study|Death|1|||
156386803|NCT00110617|564506231|FG001|Overall Study|Death|1|||
156386804|NCT00110617|564506230|FG000|Overall Study|Did not receive study drug|0|||
156386805|NCT00110617|564506231|FG001|Overall Study|Did not receive study drug|12|||
156386806|NCT04764396|564506232|FG000|Overall Study|Physician Decision|1|||
156386807|NCT04764396|564506233|FG001|Overall Study|Physician Decision|0|||
156386808|NCT03230916|564506234|FG000|Overall Study|Withdrawal by Subject|0|||
156386809|NCT03230916|564506235|FG001|Overall Study|Withdrawal by Subject|0|||
156386810|NCT03230916|564506236|FG002|Overall Study|Withdrawal by Subject|0|||
156386811|NCT03230916|564506237|FG003|Overall Study|Withdrawal by Subject|0|||
156386812|NCT03230916|564506238|FG004|Overall Study|Withdrawal by Subject|0|||
156386813|NCT03230916|564506239|FG005|Overall Study|Withdrawal by Subject|1|||
156386814|NCT03230916|564506240|FG006|Overall Study|Withdrawal by Subject|0|||
156386815|NCT03230916|564506241|FG007|Overall Study|Withdrawal by Subject|0|||
156386816|NCT03230916|564506242|FG008|Overall Study|Withdrawal by Subject|0|||
156386817|NCT03230916|564506243|FG009|Overall Study|Withdrawal by Subject|0|||
156386818|NCT03230916|564506244|FG010|Overall Study|Withdrawal by Subject|0|||
156386819|NCT01983293|564508518|FG000|Overall Study|Withdrawal by Subject|29|||
156386820|NCT01983293|564508519|FG001|Overall Study|Withdrawal by Subject|15|||
156386821|NCT01983293|564508518|FG000|Overall Study|Missing 12-month visit|3|||
156386822|NCT01983293|564508519|FG001|Overall Study|Missing 12-month visit|3|||
156386823|NCT01983293|564508518|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
156386824|NCT01983293|564508519|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
156386825|NCT03147248|564508520|FG000|Overall Study|Adverse Event|0|||
156386826|NCT03147248|564508521|FG001|Overall Study|Adverse Event|2|||
156386827|NCT03147248|564508522|FG002|Overall Study|Adverse Event|2|||
156386828|NCT03147248|564508523|FG003|Overall Study|Adverse Event|2|||
156386829|NCT03147248|564508524|FG004|Overall Study|Adverse Event|6|||
156386830|NCT03147248|564508525|FG005|Overall Study|Adverse Event|11|||
156386831|NCT03147248|564508520|FG000|Overall Study|Disease progression|1|||
156386832|NCT03147248|564508521|FG001|Overall Study|Disease progression|0|||
156386833|NCT03147248|564508522|FG002|Overall Study|Disease progression|0|||
156386834|NCT03147248|564508523|FG003|Overall Study|Disease progression|0|||
156386835|NCT03147248|564508524|FG004|Overall Study|Disease progression|0|||
156386836|NCT03147248|564508525|FG005|Overall Study|Disease progression|2|||
156386837|NCT03147248|564508520|FG000|Overall Study|Withdrawal by Subject|0|||
156386838|NCT03147248|564508521|FG001|Overall Study|Withdrawal by Subject|0|||
156386839|NCT03147248|564508522|FG002|Overall Study|Withdrawal by Subject|0|||
156386840|NCT03147248|564508523|FG003|Overall Study|Withdrawal by Subject|0|||
156386841|NCT03147248|564508524|FG004|Overall Study|Withdrawal by Subject|12|||
156386842|NCT03147248|564508525|FG005|Overall Study|Withdrawal by Subject|9|||
156386843|NCT03147248|564508520|FG000|Overall Study|Protocol Violation|0|||
156386844|NCT03147248|564508521|FG001|Overall Study|Protocol Violation|0|||
156386845|NCT03147248|564508522|FG002|Overall Study|Protocol Violation|0|||
156386846|NCT03147248|564508523|FG003|Overall Study|Protocol Violation|0|||
156386847|NCT03147248|564508524|FG004|Overall Study|Protocol Violation|2|||
156386848|NCT03147248|564508525|FG005|Overall Study|Protocol Violation|0|||
156386849|NCT03147248|564508520|FG000|Overall Study|Lost to Follow-up|0|||
156386850|NCT03147248|564508521|FG001|Overall Study|Lost to Follow-up|0|||
156386851|NCT03147248|564508522|FG002|Overall Study|Lost to Follow-up|0|||
156386852|NCT03147248|564508523|FG003|Overall Study|Lost to Follow-up|0|||
156386853|NCT03147248|564508524|FG004|Overall Study|Lost to Follow-up|2|||
156386854|NCT03147248|564508525|FG005|Overall Study|Lost to Follow-up|0|||
156386855|NCT03147248|564508520|FG000|Overall Study|Pregnancy|0|||
156386856|NCT03147248|564508521|FG001|Overall Study|Pregnancy|0|||
156386857|NCT03147248|564508522|FG002|Overall Study|Pregnancy|0|||
156386858|NCT03147248|564508523|FG003|Overall Study|Pregnancy|0|||
156386859|NCT03147248|564508524|FG004|Overall Study|Pregnancy|1|||
156386860|NCT03147248|564508525|FG005|Overall Study|Pregnancy|0|||
156386861|NCT03147248|564508520|FG000|Overall Study|Death|0|||
156386862|NCT03147248|564508521|FG001|Overall Study|Death|0|||
156386863|NCT03147248|564508522|FG002|Overall Study|Death|0|||
156386864|NCT03147248|564508523|FG003|Overall Study|Death|0|||
156507822|NCT05627258|564952955|FG004|Overall Study|Subject moved from area|0|||
156507823|NCT05627258|564952956|FG005|Overall Study|Subject moved from area|0|||
156507824|NCT04517669|564952957|FG000|Overall Study|Lost to Follow-up|2|||
156507825|NCT04517669|564952957|FG000|Overall Study|Withdrawal by Subject|3|||
156507826|NCT04517669|564952957|FG000|Overall Study|Drug withdrawn|44|||
156507827|NCT04517669|564952957|FG000|Overall Study|Other|1|||
156507828|NCT04517669|564952957|FG000|Overall Study|Eligibility criteria not met|4|||
156507829|NCT04517669|564952957|FG000|Overall Study|Did not receive treatment|3|||
156507830|NCT01923662|564952958|FG000|Overall Study|Withdrawal by Subject|1|||
156507831|NCT01199068|564952959|FG000|Overall Study|Unacceptable toxicity|0|||
156507832|NCT01199068|564952960|FG001|Overall Study|Unacceptable toxicity|0|||
156507833|NCT01199068|564952961|FG002|Overall Study|Unacceptable toxicity|2|||
156507834|NCT01199068|564952959|FG000|Overall Study|Progressive disease|3|||
156507835|NCT01199068|564952960|FG001|Overall Study|Progressive disease|3|||
156507836|NCT01199068|564952961|FG002|Overall Study|Progressive disease|6|||
156507837|NCT01199068|564952959|FG000|Overall Study|Withdrawal by Subject|0|||
156507838|NCT01199068|564952960|FG001|Overall Study|Withdrawal by Subject|0|||
156507839|NCT01199068|564952961|FG002|Overall Study|Withdrawal by Subject|1|||
156507840|NCT01250925|564952962|FG000|Overall Study|Lost to Follow-up|1|||
156507841|NCT01250925|564952963|FG001|Overall Study|Lost to Follow-up|1|||
156507842|NCT01250925|564952964|FG002|Overall Study|Lost to Follow-up|0|||
156386865|NCT03147248|564508524|FG004|Overall Study|Death|0|||
156386866|NCT03147248|564508525|FG005|Overall Study|Death|4|||
156507843|NCT01250925|564952962|FG000|Overall Study|Withdrawal by Subject|2|||
156507844|NCT01250925|564952963|FG001|Overall Study|Withdrawal by Subject|0|||
156386867|NCT03147248|564508520|FG000|Overall Study|Physician Decision|0|||
156386868|NCT03147248|564508521|FG001|Overall Study|Physician Decision|0|||
156386869|NCT03147248|564508522|FG002|Overall Study|Physician Decision|0|||
156386870|NCT03147248|564508523|FG003|Overall Study|Physician Decision|0|||
156386871|NCT03147248|564508524|FG004|Overall Study|Physician Decision|2|||
156507845|NCT01250925|564952964|FG002|Overall Study|Withdrawal by Subject|0|||
156507846|NCT01250925|564952962|FG000|Overall Study|Protocol Violation|2|||
156507847|NCT01250925|564952963|FG001|Overall Study|Protocol Violation|0|||
156507848|NCT01250925|564952964|FG002|Overall Study|Protocol Violation|0|||
156386872|NCT03147248|564508525|FG005|Overall Study|Physician Decision|4|||
156386873|NCT03147248|564508520|FG000|Overall Study|Prolonged Dosing Interval|0|||
156386874|NCT03147248|564508521|FG001|Overall Study|Prolonged Dosing Interval|0|||
156386875|NCT03147248|564508522|FG002|Overall Study|Prolonged Dosing Interval|0|||
156386876|NCT03147248|564508523|FG003|Overall Study|Prolonged Dosing Interval|0|||
156386877|NCT03147248|564508524|FG004|Overall Study|Prolonged Dosing Interval|1|||
156386878|NCT03147248|564508525|FG005|Overall Study|Prolonged Dosing Interval|1|||
156386879|NCT00773968|564508526|FG000|Overall Study|Adverse Event|2|||
156386880|NCT00773968|564508526|FG000|Overall Study|Death|1|||
156386881|NCT00773968|564508526|FG000|Overall Study|Failure to Return|2|||
156386882|NCT00773968|564508526|FG000|Overall Study|Lack of Efficacy|3|||
156386883|NCT00773968|564508526|FG000|Overall Study|Protocol Violation|1|||
156386884|NCT00773968|564508526|FG000|Overall Study|Withdrawal by Subject|11|||
156386885|NCT00773968|564508526|FG000|Overall Study|Screen Failure|17|||
156386886|NCT00773968|564508526|FG000|Overall Study|Other|8|||
156386887|NCT03240588|564508530|FG000|Overall Study|Death|3|||
156386888|NCT03240588|564508531|FG001|Overall Study|Death|0|||
156386889|NCT03240588|564508532|FG002|Overall Study|Death|0|||
156386890|NCT03240588|564508530|FG000|Overall Study|Adverse Event|5|||
156386891|NCT03240588|564508531|FG001|Overall Study|Adverse Event|4|||
156386892|NCT03240588|564508532|FG002|Overall Study|Adverse Event|0|||
156386893|NCT03240588|564508530|FG000|Overall Study|Lost to Follow-up|9|||
156386894|NCT03240588|564508531|FG001|Overall Study|Lost to Follow-up|4|||
156386895|NCT03240588|564508532|FG002|Overall Study|Lost to Follow-up|0|||
156386896|NCT03240588|564508530|FG000|Overall Study|Physician Decision|3|||
156386897|NCT03240588|564508531|FG001|Overall Study|Physician Decision|2|||
156386898|NCT03240588|564508532|FG002|Overall Study|Physician Decision|0|||
156386899|NCT03240588|564508530|FG000|Overall Study|Did not meet eligibility criteria|0|||
156386900|NCT03240588|564508531|FG001|Overall Study|Did not meet eligibility criteria|6|||
156386901|NCT03240588|564508532|FG002|Overall Study|Did not meet eligibility criteria|0|||
156386902|NCT03240588|564508530|FG000|Overall Study|No longer meets protocol criteria|12|||
156386903|NCT03240588|564508531|FG001|Overall Study|No longer meets protocol criteria|7|||
156386904|NCT03240588|564508532|FG002|Overall Study|No longer meets protocol criteria|0|||
156386905|NCT03240588|564508530|FG000|Overall Study|Withdrawal by Subject|60|||
156386906|NCT03240588|564508531|FG001|Overall Study|Withdrawal by Subject|52|||
156386907|NCT03240588|564508532|FG002|Overall Study|Withdrawal by Subject|7|||
156386908|NCT03240588|564508530|FG000|Overall Study|Other, additional details not available.|0|||
156386909|NCT03240588|564508531|FG001|Overall Study|Other, additional details not available.|12|||
156386910|NCT03240588|564508532|FG002|Overall Study|Other, additional details not available.|1|||
156386911|NCT03240588|564508530|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
156386912|NCT03240588|564508531|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
156386913|NCT03240588|564508532|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
156386914|NCT03240588|564508530|FG000|Overall Study|Closure of study|55|||
156386915|NCT03240588|564508531|FG001|Overall Study|Closure of study|3|||
156386916|NCT03240588|564508532|FG002|Overall Study|Closure of study|0|||
156386917|NCT03240588|564508530|FG000|Overall Study|Subject non-compliance|23|||
156386918|NCT03240588|564508531|FG001|Overall Study|Subject non-compliance|2|||
156386919|NCT03240588|564508532|FG002|Overall Study|Subject non-compliance|1|||
156386920|NCT03240588|564508530|FG000|Overall Study|Device Deficiency|1|||
156386921|NCT03240588|564508531|FG001|Overall Study|Device Deficiency|0|||
156386922|NCT03240588|564508532|FG002|Overall Study|Device Deficiency|0|||
156386923|NCT03240588|564508530|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
156386924|NCT03240588|564508531|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
156386925|NCT03240588|564508532|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
156386926|NCT01259713|564508534|FG000|Overall Study|Adverse Event|54|||
156386927|NCT01259713|564508535|FG001|Overall Study|Adverse Event|23|||
156386928|NCT01259713|564508534|FG000|Overall Study|Death Not Related to IFI|8|||
156386929|NCT01259713|564508535|FG001|Overall Study|Death Not Related to IFI|1|||
156386930|NCT01259713|564508534|FG000|Overall Study|Investigators Discretion|14|||
156386931|NCT01259713|564508535|FG001|Overall Study|Investigators Discretion|6|||
156386932|NCT01259713|564508534|FG000|Overall Study|Lack of Efficacy|2|||
156386933|NCT01259713|564508535|FG001|Overall Study|Lack of Efficacy|0|||
156386934|NCT01259713|564508534|FG000|Overall Study|Protocol Violation|5|||
156386935|NCT01259713|564508535|FG001|Overall Study|Protocol Violation|4|||
156386936|NCT01259713|564508534|FG000|Overall Study|Subject Withdrew Consent|12|||
156386937|NCT01259713|564508535|FG001|Overall Study|Subject Withdrew Consent|7|||
156386938|NCT02091726|564508536|FG000|Overall Study|Lost to Follow-up|6|||
156386939|NCT06111742|564508537|FG000|Overall Study|Did not receive intervention|1|||
156386940|NCT06111742|564508538|FG001|Overall Study|Did not receive intervention|0|||
156386941|NCT06111742|564508539|FG002|Overall Study|Did not receive intervention|0|||
156386942|NCT06111742|564508537|FG000|Overall Study|Withdrawal by Subject|2|||
156386943|NCT06111742|564508538|FG001|Overall Study|Withdrawal by Subject|0|||
156386944|NCT06111742|564508539|FG002|Overall Study|Withdrawal by Subject|0|||
156386945|NCT03461003|564508540|FG000|Overall Study|Lost to Follow-up|2|||
156386946|NCT03461003|564508541|FG001|Overall Study|Lost to Follow-up|2|||
156386947|NCT03461003|564508540|FG000|Overall Study|Withdrawal by Subject|3|||
156386948|NCT03461003|564508541|FG001|Overall Study|Withdrawal by Subject|1|||
156386949|NCT02047045|564508545|FG000|Baseline|Withdrawal by Subject|3|||
156386950|NCT02047045|564508546|FG001|Baseline|Withdrawal by Subject|2|||
156386951|NCT02047045|564508545|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
156386952|NCT02047045|564508546|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
156386953|NCT02047045|564508545|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
156386954|NCT02047045|564508546|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
156386955|NCT02047045|564508545|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
156386956|NCT02047045|564508546|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
156386957|NCT02047045|564508545|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
156386958|NCT02047045|564508546|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
156386959|NCT02047045|564508545|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
156386960|NCT02047045|564508546|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
156386961|NCT02047045|564508545|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
156386962|NCT02047045|564508546|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
156386963|NCT02047045|564508545|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
156386964|NCT02047045|564508546|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
156386965|NCT02047045|564508545|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
156386966|NCT02047045|564508546|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
156386967|NCT03508843|564508547|FG000|Overall Study|Withdrawal by Subject|1|||
156386968|NCT03508843|564508547|FG000|Overall Study|technical difficulties|2|||
156386969|NCT03555396|564508548|FG000|Overall Study|Death|3|||
156386970|NCT03555396|564508549|FG001|Overall Study|Death|1|||
156386971|NCT03555396|564508548|FG000|Overall Study|Lost to Follow-up|0|||
156386972|NCT03555396|564508549|FG001|Overall Study|Lost to Follow-up|2|||
156386973|NCT02536508|564508550|FG000|Overall Study|Withdrawal by Subject|18|||
156386974|NCT02536508|564508551|FG001|Overall Study|Withdrawal by Subject|13|||
156386975|NCT02536508|564508552|FG002|Overall Study|Withdrawal by Subject|7|||
156386976|NCT02536508|564508550|FG000|Overall Study|Adverse Event|14|||
156386977|NCT02536508|564508551|FG001|Overall Study|Adverse Event|13|||
156386978|NCT02536508|564508552|FG002|Overall Study|Adverse Event|6|||
156386979|NCT02536508|564508550|FG000|Overall Study|Lost to Follow-up|12|||
156386980|NCT02536508|564508551|FG001|Overall Study|Lost to Follow-up|4|||
156386981|NCT02536508|564508552|FG002|Overall Study|Lost to Follow-up|0|||
156386982|NCT02536508|564508550|FG000|Overall Study|Lack of Efficacy|3|||
156386983|NCT02536508|564508551|FG001|Overall Study|Lack of Efficacy|5|||
156386984|NCT02536508|564508552|FG002|Overall Study|Lack of Efficacy|4|||
156386985|NCT02536508|564508550|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
156386986|NCT02536508|564508551|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
156386987|NCT02536508|564508552|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
156386988|NCT02536508|564508550|FG000|Overall Study|Physician Decision|0|||
156386989|NCT02536508|564508551|FG001|Overall Study|Physician Decision|4|||
156386990|NCT02536508|564508552|FG002|Overall Study|Physician Decision|2|||
156386991|NCT02536508|564508550|FG000|Overall Study|Major Protocol Deviation|2|||
156386992|NCT02536508|564508551|FG001|Overall Study|Major Protocol Deviation|2|||
156386993|NCT02536508|564508552|FG002|Overall Study|Major Protocol Deviation|2|||
156386994|NCT02536508|564508550|FG000|Overall Study|Administrative Reasons|0|||
156386995|NCT02536508|564508551|FG001|Overall Study|Administrative Reasons|1|||
156386996|NCT02536508|564508552|FG002|Overall Study|Administrative Reasons|0|||
156386997|NCT01369342|564508557|FG000|Overall Study|Withdrawal by Subject|7|||
156386998|NCT01369342|564508558|FG001|Overall Study|Withdrawal by Subject|7|||
156386999|NCT01369342|564508559|FG002|Overall Study|Withdrawal by Subject|2|||
156387000|NCT01369342|564508557|FG000|Overall Study|Lost to Follow-up|5|||
156387001|NCT01369342|564508558|FG001|Overall Study|Lost to Follow-up|2|||
156507849|NCT01250925|564952962|FG000|Overall Study|Physician Decision|0|||
156507850|NCT01250925|564952963|FG001|Overall Study|Physician Decision|2|||
156507851|NCT01250925|564952964|FG002|Overall Study|Physician Decision|1|||
156507852|NCT01250925|564952962|FG000|Overall Study|Adverse Event|0|||
156507853|NCT01250925|564952963|FG001|Overall Study|Adverse Event|0|||
156507854|NCT01250925|564952964|FG002|Overall Study|Adverse Event|1|||
156387002|NCT01369342|564508559|FG002|Overall Study|Lost to Follow-up|1|||
156387003|NCT01369342|564508557|FG000|Overall Study|Not Treated|1|||
156387004|NCT01369342|564508558|FG001|Overall Study|Not Treated|0|||
156387005|NCT01369342|564508559|FG002|Overall Study|Not Treated|0|||
156387006|NCT01816594|564508560|FG000|Overall Study|Local Progress|0|||
156387007|NCT01816594|564508561|FG001|Overall Study|Local Progress|2|||
156507855|NCT00678301|564952965|FG000|Overall Study|Non-compliance with study procedures|0|||
156387008|NCT01816594|564508560|FG000|Overall Study|Adverse Event|9|||
156387009|NCT01816594|564508561|FG001|Overall Study|Adverse Event|0|||
156507856|NCT00678301|564952966|FG001|Overall Study|Non-compliance with study procedures|1|||
156507857|NCT00678301|564952965|FG000|Overall Study|Adverse Event|1|||
156387010|NCT01816594|564508560|FG000|Overall Study|Withdrawal by Subject|1|||
156387011|NCT01816594|564508561|FG001|Overall Study|Withdrawal by Subject|0|||
156387012|NCT01816594|564508560|FG000|Overall Study|Physician Decision|1|||
156387013|NCT01816594|564508561|FG001|Overall Study|Physician Decision|0|||
156387014|NCT04723576|564508562|FG000|Overall Study|Withdrawal by Subject|2133|||
156387015|NCT04723576|564508563|FG001|Overall Study|Withdrawal by Subject|3234|||
156387016|NCT03204279|564508567|FG000|Overall Study|Withdrawal by Subject|0|||
156387017|NCT03204279|564508568|FG001|Overall Study|Withdrawal by Subject|1|||
156387018|NCT01064739|564508569|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
156387019|NCT01571362|564508570|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
156387020|NCT01571362|564508571|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
156387021|NCT01571362|564508572|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
156387022|NCT01571362|564508570|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
156387023|NCT01571362|564508571|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
156387024|NCT01571362|564508572|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
156387025|NCT01571362|564508570|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
156387026|NCT01571362|564508571|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
156387027|NCT01571362|564508572|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
156387028|NCT01571362|564508570|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
156387029|NCT01571362|564508571|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
156387030|NCT01571362|564508572|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
156387031|NCT01571362|564508570|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
156387032|NCT01571362|564508571|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
156387033|NCT01571362|564508572|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
156387034|NCT01571362|564508570|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
156387035|NCT01571362|564508571|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
156387036|NCT01571362|564508572|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
156387037|NCT01571362|564508570|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156387038|NCT01571362|564508571|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
156387039|NCT01571362|564508572|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
156387040|NCT01571362|564508570|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156387041|NCT01571362|564508571|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
156387042|NCT01571362|564508572|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
156387043|NCT01571362|564508570|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156387044|NCT01571362|564508571|FG001|Double-Blind Treatment Period|Adverse Event|9|||
156387045|NCT01571362|564508572|FG002|Double-Blind Treatment Period|Adverse Event|14|||
156387046|NCT01571362|564508570|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156387047|NCT01571362|564508571|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
156387048|NCT01571362|564508572|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
156387049|NCT01571362|564508570|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
156387050|NCT01571362|564508571|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
156387051|NCT01571362|564508572|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
156387052|NCT01571362|564508570|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
156387053|NCT01571362|564508571|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
156387054|NCT01571362|564508572|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
156387055|NCT04258020|564508573|FG000|Overall Study|Withdrawal by Subject|1|||
156387056|NCT04258020|564508574|FG001|Overall Study|Withdrawal by Subject|0|||
156387057|NCT00130533|564508580|FG000|Overall Study|Withdrawal by Subject|33|||
156507858|NCT00678301|564952966|FG001|Overall Study|Adverse Event|0|||
156507859|NCT00678301|564952965|FG000|Overall Study|Withdrawal by Subject|4|||
156507860|NCT00678301|564952966|FG001|Overall Study|Withdrawal by Subject|0|||
156507861|NCT00678301|564952965|FG000|Overall Study|Lost to Follow-up|3|||
156507862|NCT00678301|564952966|FG001|Overall Study|Lost to Follow-up|1|||
156507863|NCT03338296|564952967|FG000|Overall Study|Adverse Event|0|||
156507864|NCT03338296|564952968|FG001|Overall Study|Adverse Event|1|||
156507865|NCT03338296|564952967|FG000|Overall Study|Withdrawal by Subject|14|||
156507866|NCT03338296|564952968|FG001|Overall Study|Withdrawal by Subject|13|||
156507867|NCT03338296|564952967|FG000|Overall Study|Lost to Follow-up|10|||
156507868|NCT03338296|564952968|FG001|Overall Study|Lost to Follow-up|10|||
156507869|NCT03338296|564952967|FG000|Overall Study|Study Terminated by Sponsor|77|||
156507870|NCT03338296|564952968|FG001|Overall Study|Study Terminated by Sponsor|76|||
156507871|NCT03338296|564952967|FG000|Overall Study|Other|2|||
156507872|NCT03338296|564952968|FG001|Overall Study|Other|7|||
156507873|NCT03338296|564952967|FG000|Overall Study|Missing|0|||
156507874|NCT03338296|564952968|FG001|Overall Study|Missing|1|||
156507875|NCT01939353|564952969|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
156387058|NCT00130533|564508581|FG001|Overall Study|Withdrawal by Subject|6|||
156507876|NCT01939353|564952969|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
156507877|NCT01939353|564952969|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
156507878|NCT01939353|564952969|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
156507879|NCT01939353|564952969|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
156507880|NCT05048238|564952971|FG000|Overall Study|Withdrawal by Subject|1|||
156387059|NCT00130533|564508580|FG000|Overall Study|Adverse Event|34|||
156387060|NCT00130533|564508581|FG001|Overall Study|Adverse Event|1|||
156387061|NCT00130533|564508580|FG000|Overall Study|Disease relapse|9|||
156387062|NCT00130533|564508581|FG001|Overall Study|Disease relapse|13|||
156387063|NCT00130533|564508580|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
156387064|NCT00130533|564508581|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
156387065|NCT00130533|564508580|FG000|Overall Study|Death|4|||
156387066|NCT00130533|564508581|FG001|Overall Study|Death|2|||
156387067|NCT00130533|564508580|FG000|Overall Study|Protocol Violation|5|||
156387068|NCT00130533|564508581|FG001|Overall Study|Protocol Violation|1|||
156387069|NCT00130533|564508580|FG000|Overall Study|Lost to Follow-up|1|||
156387070|NCT00130533|564508581|FG001|Overall Study|Lost to Follow-up|1|||
156387071|NCT00130533|564508580|FG000|Overall Study|Sponsor´s decision|2|||
156387072|NCT00130533|564508581|FG001|Overall Study|Sponsor´s decision|0|||
156387073|NCT00130533|564508580|FG000|Overall Study|Second Primary Malignancy|0|||
156387074|NCT00130533|564508581|FG001|Overall Study|Second Primary Malignancy|1|||
156387075|NCT00130533|564508580|FG000|Overall Study|Other|12|||
156387076|NCT00130533|564508581|FG001|Overall Study|Other|5|||
156387077|NCT03927950|564508582|FG000|Overall Study|Adverse Event|9|||
156387078|NCT01491854|564508583|FG000|Overall Study|mainly due to premature termination|93|||
156387079|NCT01491854|564508583|FG000|Overall Study|Death|1|||
156387080|NCT01491854|564508583|FG000|Overall Study|Withdrawal by Subject|3|||
156387081|NCT01491854|564508583|FG000|Overall Study|Lost to Follow-up|33|||
156387082|NCT01026974|564508584|FG000|Overall Study|Withdrawal by Subject|0|||
156387083|NCT01026974|564508585|FG001|Overall Study|Withdrawal by Subject|1|||
156387084|NCT01026974|564508586|FG002|Overall Study|Withdrawal by Subject|7|||
156387085|NCT01026974|564508587|FG003|Overall Study|Withdrawal by Subject|2|||
156387086|NCT01026974|564508584|FG000|Overall Study|Lost to Follow-up|1|||
156387087|NCT01026974|564508585|FG001|Overall Study|Lost to Follow-up|1|||
156387088|NCT01026974|564508586|FG002|Overall Study|Lost to Follow-up|4|||
156387089|NCT01026974|564508587|FG003|Overall Study|Lost to Follow-up|0|||
156387090|NCT01026974|564508584|FG000|Overall Study|Adverse Event|0|||
156387091|NCT01026974|564508585|FG001|Overall Study|Adverse Event|0|||
156387092|NCT01026974|564508586|FG002|Overall Study|Adverse Event|0|||
156387093|NCT01026974|564508587|FG003|Overall Study|Adverse Event|1|||
156387094|NCT01026974|564508584|FG000|Overall Study|Inappropriate enrollment|0|||
156387095|NCT01026974|564508585|FG001|Overall Study|Inappropriate enrollment|0|||
156387096|NCT01026974|564508586|FG002|Overall Study|Inappropriate enrollment|1|||
156387097|NCT01026974|564508587|FG003|Overall Study|Inappropriate enrollment|0|||
156387098|NCT03638141|564508588|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
156387099|NCT03526250|564508591|FG000|Overall Study|Adverse Event|4|||
156387100|NCT03526250|564508591|FG000|Overall Study|Progressive Disease|16|||
156387101|NCT03526250|564508591|FG000|Overall Study|No Treatment|3|||
156387102|NCT04420221|564508592|FG000|Overall Study|Withdrawal by Subject|0|||
156387103|NCT04420221|564508593|FG001|Overall Study|Withdrawal by Subject|0|||
156387104|NCT04420221|564508594|FG002|Overall Study|Withdrawal by Subject|0|||
156387105|NCT04420221|564508595|FG003|Overall Study|Withdrawal by Subject|0|||
156387106|NCT04420221|564508596|FG004|Overall Study|Withdrawal by Subject|0|||
156387107|NCT04420221|564508597|FG005|Overall Study|Withdrawal by Subject|20|||
156387108|NCT04420221|564508598|FG006|Overall Study|Withdrawal by Subject|5|||
156387109|NCT04420221|564508592|FG000|Overall Study|Other|0|||
156387110|NCT04420221|564508593|FG001|Overall Study|Other|0|||
156387111|NCT04420221|564508594|FG002|Overall Study|Other|0|||
156387112|NCT04420221|564508595|FG003|Overall Study|Other|0|||
156387113|NCT04420221|564508596|FG004|Overall Study|Other|0|||
156387114|NCT04420221|564508597|FG005|Overall Study|Other|1|||
156387115|NCT04420221|564508598|FG006|Overall Study|Other|1|||
156387116|NCT04420221|564508592|FG000|Overall Study|Lost to Follow-up|0|||
156387117|NCT04420221|564508593|FG001|Overall Study|Lost to Follow-up|0|||
156387118|NCT04420221|564508594|FG002|Overall Study|Lost to Follow-up|0|||
156387119|NCT04420221|564508595|FG003|Overall Study|Lost to Follow-up|0|||
156387120|NCT04420221|564508596|FG004|Overall Study|Lost to Follow-up|0|||
156387121|NCT04420221|564508597|FG005|Overall Study|Lost to Follow-up|3|||
156387122|NCT04420221|564508598|FG006|Overall Study|Lost to Follow-up|2|||
156387123|NCT04420221|564508592|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
156387124|NCT04420221|564508593|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
156387125|NCT04420221|564508594|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
156387126|NCT04420221|564508595|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
156387127|NCT04420221|564508596|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
156387128|NCT04420221|564508597|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
156387129|NCT04420221|564508598|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
156547547|NCT01553136|565096860|FG001|Overall Study|Scheduling Difficulties|4|||
156387130|NCT01040130|564508602|FG000|Overall Study|Adverse Event|1|||
156387131|NCT01040130|564508603|FG001|Overall Study|Adverse Event|1|||
156387132|NCT01040130|564508604|FG002|Overall Study|Adverse Event|0|||
156387133|NCT01040130|564508605|FG003|Overall Study|Adverse Event|5|||
156387134|NCT01040130|564508606|FG004|Overall Study|Adverse Event|0|||
156387135|NCT01040130|564508607|FG005|Overall Study|Adverse Event|3|||
156387136|NCT01040130|564508602|FG000|Overall Study|Protocol Violation|0|||
156387137|NCT01040130|564508603|FG001|Overall Study|Protocol Violation|0|||
156387138|NCT01040130|564508604|FG002|Overall Study|Protocol Violation|2|||
156387139|NCT01040130|564508605|FG003|Overall Study|Protocol Violation|0|||
156387140|NCT01040130|564508606|FG004|Overall Study|Protocol Violation|0|||
156387141|NCT01040130|564508607|FG005|Overall Study|Protocol Violation|0|||
156387142|NCT01040130|564508602|FG000|Overall Study|Withdrawal by Subject|0|||
156387143|NCT01040130|564508603|FG001|Overall Study|Withdrawal by Subject|2|||
156387144|NCT01040130|564508604|FG002|Overall Study|Withdrawal by Subject|0|||
156387145|NCT01040130|564508605|FG003|Overall Study|Withdrawal by Subject|0|||
156387146|NCT01040130|564508606|FG004|Overall Study|Withdrawal by Subject|0|||
156387147|NCT01040130|564508607|FG005|Overall Study|Withdrawal by Subject|1|||
156387148|NCT01040130|564508602|FG000|Overall Study|Other reasons not listed above|2|||
156387149|NCT01040130|564508603|FG001|Overall Study|Other reasons not listed above|0|||
156387150|NCT01040130|564508604|FG002|Overall Study|Other reasons not listed above|0|||
156387151|NCT01040130|564508605|FG003|Overall Study|Other reasons not listed above|0|||
156387152|NCT01040130|564508606|FG004|Overall Study|Other reasons not listed above|0|||
156387153|NCT01040130|564508607|FG005|Overall Study|Other reasons not listed above|0|||
156387154|NCT01618864|564508610|FG000|Overall Study|Withdrawal by Subject|2|||
156387155|NCT01618864|564508610|FG000|Overall Study|Lost to Follow-up|2|||
156387156|NCT01090453|564508618|FG000|Overall Study|Withdrawal by Subject|1|||
156387157|NCT01090453|564508619|FG001|Overall Study|Withdrawal by Subject|2|||
156387158|NCT01090453|564508618|FG000|Overall Study|Lost to Follow-up|7|||
156387159|NCT01090453|564508619|FG001|Overall Study|Lost to Follow-up|7|||
156387160|NCT01090453|564508618|FG000|Overall Study|Non serious AEs|1|||
156387161|NCT01090453|564508619|FG001|Overall Study|Non serious AEs|0|||
156387162|NCT01090453|564508618|FG000|Overall Study|Protocol Violation|2|||
156387163|NCT01090453|564508619|FG001|Overall Study|Protocol Violation|0|||
156387164|NCT01090453|564508618|FG000|Overall Study|Other|2|||
156387165|NCT01090453|564508619|FG001|Overall Study|Other|4|||
156387166|NCT01090453|564508618|FG000|Overall Study|Eligibility Criteria|0|||
156387167|NCT01090453|564508619|FG001|Overall Study|Eligibility Criteria|1|||
156387168|NCT03867734|564508620|FG000|Overall Study|Lost to Follow-up|2|||
156387169|NCT00718718|564508622|FG000|Prior to Week 12|Adverse Event|0|||
156387170|NCT00718718|564508623|FG001|Prior to Week 12|Adverse Event|0|||
156387171|NCT00718718|564508624|FG002|Prior to Week 12|Adverse Event|0|||
156387172|NCT00718718|564508625|FG003|Prior to Week 12|Adverse Event|0|||
156387173|NCT00718718|564508626|FG004|Prior to Week 12|Adverse Event|0|||
156387174|NCT00718718|564508627|FG005|Prior to Week 12|Adverse Event|0|||
156387175|NCT00718718|564508628|FG006|Prior to Week 12|Adverse Event|0|||
156387176|NCT00718718|564508629|FG007|Prior to Week 12|Adverse Event|1|||
156387177|NCT00718718|564508630|FG008|Prior to Week 12|Adverse Event|1|||
156387178|NCT00718718|564508631|FG009|Prior to Week 12|Adverse Event|0|||
156387179|NCT00718718|564508622|FG000|Prior to Week 12|Withdrawal by Subject|0|||
156387180|NCT00718718|564508623|FG001|Prior to Week 12|Withdrawal by Subject|0|||
156387181|NCT00718718|564508624|FG002|Prior to Week 12|Withdrawal by Subject|0|||
156387182|NCT00718718|564508625|FG003|Prior to Week 12|Withdrawal by Subject|0|||
156387183|NCT00718718|564508626|FG004|Prior to Week 12|Withdrawal by Subject|3|||
156387184|NCT00718718|564508627|FG005|Prior to Week 12|Withdrawal by Subject|0|||
156387185|NCT00718718|564508628|FG006|Prior to Week 12|Withdrawal by Subject|1|||
156387186|NCT00718718|564508629|FG007|Prior to Week 12|Withdrawal by Subject|1|||
156387187|NCT00718718|564508630|FG008|Prior to Week 12|Withdrawal by Subject|1|||
156387188|NCT00718718|564508631|FG009|Prior to Week 12|Withdrawal by Subject|0|||
156387189|NCT00718718|564508622|FG000|Prior to Week 12|Other|1|||
156387190|NCT00718718|564508623|FG001|Prior to Week 12|Other|0|||
156387191|NCT00718718|564508624|FG002|Prior to Week 12|Other|1|||
156387192|NCT00718718|564508625|FG003|Prior to Week 12|Other|0|||
156387193|NCT00718718|564508626|FG004|Prior to Week 12|Other|0|||
156387194|NCT00718718|564508627|FG005|Prior to Week 12|Other|0|||
156387195|NCT00718718|564508628|FG006|Prior to Week 12|Other|0|||
156387196|NCT00718718|564508629|FG007|Prior to Week 12|Other|0|||
156387197|NCT00718718|564508630|FG008|Prior to Week 12|Other|0|||
156387198|NCT00718718|564508631|FG009|Prior to Week 12|Other|0|||
156387199|NCT00718718|564508622|FG000|Week 12 to End of Study|Adverse Event|0|||
156387200|NCT00718718|564508623|FG001|Week 12 to End of Study|Adverse Event|0|||
156387201|NCT00718718|564508624|FG002|Week 12 to End of Study|Adverse Event|0|||
156387202|NCT00718718|564508625|FG003|Week 12 to End of Study|Adverse Event|0|||
156387203|NCT00718718|564508626|FG004|Week 12 to End of Study|Adverse Event|0|||
156387204|NCT00718718|564508627|FG005|Week 12 to End of Study|Adverse Event|0|||
156387205|NCT00718718|564508628|FG006|Week 12 to End of Study|Adverse Event|0|||
156387206|NCT00718718|564508629|FG007|Week 12 to End of Study|Adverse Event|1|||
156387207|NCT00718718|564508630|FG008|Week 12 to End of Study|Adverse Event|0|||
156387208|NCT00718718|564508631|FG009|Week 12 to End of Study|Adverse Event|0|||
156387209|NCT00718718|564508622|FG000|Week 12 to End of Study|Death|0|||
156387210|NCT00718718|564508623|FG001|Week 12 to End of Study|Death|0|||
156387211|NCT00718718|564508624|FG002|Week 12 to End of Study|Death|0|||
156387212|NCT00718718|564508625|FG003|Week 12 to End of Study|Death|0|||
156387213|NCT00718718|564508626|FG004|Week 12 to End of Study|Death|0|||
156387214|NCT00718718|564508627|FG005|Week 12 to End of Study|Death|1|||
156507881|NCT04481373|564952977|FG000|Overall Study|Protocol Violation|1|||
156507882|NCT04481373|564952978|FG001|Overall Study|Protocol Violation|0|||
156507883|NCT04481373|564952977|FG000|Overall Study|Viral load in hospital not over 1000|2|||
156507884|NCT04481373|564952978|FG001|Overall Study|Viral load in hospital not over 1000|1|||
156507885|NCT04481373|564952977|FG000|Overall Study|Death before hospital discharge|1|||
156507886|NCT04481373|564952978|FG001|Overall Study|Death before hospital discharge|0|||
156387215|NCT00718718|564508628|FG006|Week 12 to End of Study|Death|0|||
156387216|NCT00718718|564508629|FG007|Week 12 to End of Study|Death|0|||
156387217|NCT00718718|564508630|FG008|Week 12 to End of Study|Death|0|||
156387218|NCT00718718|564508631|FG009|Week 12 to End of Study|Death|0|||
156387219|NCT00718718|564508622|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
156387220|NCT00718718|564508623|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
156387221|NCT00718718|564508624|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
156387222|NCT00718718|564508625|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
156387223|NCT00718718|564508626|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
156387224|NCT00718718|564508627|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
156387225|NCT00718718|564508628|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
156387226|NCT00718718|564508629|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
156387227|NCT00718718|564508630|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
156387228|NCT00718718|564508631|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
156387229|NCT00718718|564508622|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
156387230|NCT00718718|564508623|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
156387231|NCT00718718|564508624|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
156387232|NCT00718718|564508625|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
156387233|NCT00718718|564508626|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
156387234|NCT00718718|564508627|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
156387235|NCT00718718|564508628|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
156387236|NCT00718718|564508629|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
156387237|NCT00718718|564508630|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
156387238|NCT00718718|564508631|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
156387239|NCT00718718|564508622|FG000|Week 12 to End of Study|Other|0|||
156387240|NCT00718718|564508623|FG001|Week 12 to End of Study|Other|1|||
156387241|NCT00718718|564508624|FG002|Week 12 to End of Study|Other|0|||
156387242|NCT00718718|564508625|FG003|Week 12 to End of Study|Other|1|||
156387243|NCT00718718|564508626|FG004|Week 12 to End of Study|Other|0|||
156387244|NCT00718718|564508627|FG005|Week 12 to End of Study|Other|0|||
156387245|NCT00718718|564508628|FG006|Week 12 to End of Study|Other|1|||
156387246|NCT00718718|564508629|FG007|Week 12 to End of Study|Other|0|||
156387247|NCT00718718|564508630|FG008|Week 12 to End of Study|Other|0|||
156387248|NCT00718718|564508631|FG009|Week 12 to End of Study|Other|0|||
156387249|NCT02276482|564508634|FG000|Overall Study|Adverse Event|1|||
156387250|NCT02276482|564508635|FG001|Overall Study|Adverse Event|0|||
156387251|NCT02276482|564508634|FG000|Overall Study|Withdrawal by Subject|1|||
156387252|NCT02276482|564508635|FG001|Overall Study|Withdrawal by Subject|0|||
156387253|NCT02276482|564508634|FG000|Overall Study|Gram-negative infection|1|||
156387254|NCT02276482|564508635|FG001|Overall Study|Gram-negative infection|0|||
156387255|NCT02276482|564508634|FG000|Overall Study|Reason not specified|0|||
156387256|NCT02276482|564508635|FG001|Overall Study|Reason not specified|1|||
156387257|NCT00360529|564508639|FG000|Overall Study|Adverse Event|10|||
156387258|NCT00360529|564508640|FG001|Overall Study|Adverse Event|23|||
156387259|NCT00360529|564508641|FG002|Overall Study|Adverse Event|33|||
156387260|NCT00360529|564508639|FG000|Overall Study|Protocol Violation|3|||
156387261|NCT00360529|564508640|FG001|Overall Study|Protocol Violation|3|||
156387262|NCT00360529|564508641|FG002|Overall Study|Protocol Violation|11|||
156387263|NCT00360529|564508639|FG000|Overall Study|Lost to Follow-up|14|||
156387264|NCT00360529|564508640|FG001|Overall Study|Lost to Follow-up|10|||
156387265|NCT00360529|564508641|FG002|Overall Study|Lost to Follow-up|13|||
156387266|NCT00360529|564508639|FG000|Overall Study|Withdrawal by Subject|22|||
156387267|NCT00360529|564508640|FG001|Overall Study|Withdrawal by Subject|14|||
156387268|NCT00360529|564508641|FG002|Overall Study|Withdrawal by Subject|18|||
156387269|NCT00360529|564508639|FG000|Overall Study|Lack of Efficacy|8|||
156387270|NCT00360529|564508640|FG001|Overall Study|Lack of Efficacy|6|||
156387271|NCT00360529|564508641|FG002|Overall Study|Lack of Efficacy|5|||
156387272|NCT00360529|564508639|FG000|Overall Study|Reason discontinued not explained above|4|||
156387273|NCT00360529|564508640|FG001|Overall Study|Reason discontinued not explained above|9|||
156387274|NCT00360529|564508641|FG002|Overall Study|Reason discontinued not explained above|11|||
156387275|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
156387276|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
156387277|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
156387278|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
156387279|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
156387280|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
156387281|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
156387282|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
156507887|NCT02057575|564952983|FG000|Overall Study|Adverse Event|0|||
156387283|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
156387284|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
156387285|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
156387286|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
156387287|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
156387288|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
156387289|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
156387290|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
156387291|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
156387292|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
156387293|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
156387294|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
156387295|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
156387296|NCT01781572|564508647|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
156387297|NCT01781572|564508648|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
156387298|NCT01781572|564508649|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
156387299|NCT01781572|564508647|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
156387300|NCT01781572|564508648|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
156387301|NCT01781572|564508649|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
156387302|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
156387303|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
156387304|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
156387305|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
156387306|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
156387307|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
156387308|NCT01781572|564508647|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
156387309|NCT01781572|564508648|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
156387310|NCT01781572|564508649|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
156387311|NCT01781572|564508647|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
156387312|NCT01781572|564508648|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
156387313|NCT01781572|564508649|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
156387314|NCT01781572|564508647|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
156387315|NCT01781572|564508648|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
156387316|NCT01781572|564508649|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
156387317|NCT01781572|564508647|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
156387318|NCT01781572|564508648|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
156387319|NCT01781572|564508649|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
156387320|NCT01781572|564508647|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
156387321|NCT01781572|564508648|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
156387322|NCT01781572|564508649|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
156387323|NCT01781572|564508647|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
156387324|NCT01781572|564508648|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
156387325|NCT01781572|564508649|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
156387326|NCT01781572|564508647|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
156387327|NCT01781572|564508648|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
156387328|NCT01781572|564508649|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
156387329|NCT01218438|564508650|FG000|Epoch 1|Physician Decision|2|||
156387330|NCT01218438|564508650|FG000|Epoch 1|Adverse Event|1|||
156387331|NCT01218438|564508650|FG000|Epoch 3|Withdrawal by Subject|3|||
156387332|NCT01218438|564508650|FG000|Epoch 3|Adverse Event|1|||
156387333|NCT01218438|564508650|FG000|Epoch 4|Physician Decision|1|||
156387334|NCT01218438|564508650|FG000|Epoch 4|Withdrawal by Subject|2|||
156387335|NCT01438541|564508654|FG000|Overall Study|Physician Decision|1|||
156387336|NCT01438541|564508654|FG000|Overall Study|Withdrawal by Subject|1|||
156387337|NCT01438541|564508654|FG000|Overall Study|discharge from the hospital|5|||
156387338|NCT02091167|564508655|FG000|Overall Study|Lost to Follow-up|0|||
156387339|NCT02091167|564508656|FG001|Overall Study|Lost to Follow-up|2|||
156387340|NCT01218646|564508657|FG000|Overall Study|Adverse Event|0|||
156387341|NCT01218646|564508658|FG001|Overall Study|Adverse Event|0|||
156387342|NCT01218646|564508659|FG002|Overall Study|Adverse Event|1|||
156387343|NCT01218646|564508660|FG003|Overall Study|Adverse Event|0|||
156387344|NCT01218646|564508657|FG000|Overall Study|Lost to Follow-up|1|||
156387345|NCT01218646|564508658|FG001|Overall Study|Lost to Follow-up|0|||
156387346|NCT01218646|564508659|FG002|Overall Study|Lost to Follow-up|0|||
156387347|NCT01218646|564508660|FG003|Overall Study|Lost to Follow-up|0|||
156387348|NCT01218646|564508657|FG000|Overall Study|Protocol Violation|0|||
156387349|NCT01218646|564508658|FG001|Overall Study|Protocol Violation|0|||
156387350|NCT01218646|564508659|FG002|Overall Study|Protocol Violation|1|||
156387351|NCT01218646|564508660|FG003|Overall Study|Protocol Violation|1|||
156387352|NCT00722761|564508661|FG000|Overall Study|Lost to Follow-up|1|||
156387353|NCT00722761|564508662|FG001|Overall Study|Lost to Follow-up|4|||
156387354|NCT00722761|564508661|FG000|Overall Study|Withdrawal by Subject|5|||
156387355|NCT00722761|564508662|FG001|Overall Study|Withdrawal by Subject|2|||
156387356|NCT02693665|564508668|FG000|Overall Study|Death|3|||
156387357|NCT02693665|564508669|FG001|Overall Study|Death|2|||
156387358|NCT02693665|564508668|FG000|Overall Study|Lost to Follow-up|7|||
156387359|NCT02693665|564508669|FG001|Overall Study|Lost to Follow-up|3|||
156387360|NCT02693665|564508668|FG000|Overall Study|Protocol Violation|1|||
156387361|NCT02693665|564508669|FG001|Overall Study|Protocol Violation|0|||
156387362|NCT02693665|564508668|FG000|Overall Study|Withdrawal by Subject|2|||
156387363|NCT02693665|564508669|FG001|Overall Study|Withdrawal by Subject|0|||
156387364|NCT02693665|564508668|FG000|Overall Study|patient wanted to leave it behind|1|||
156387365|NCT02693665|564508669|FG001|Overall Study|patient wanted to leave it behind|0|||
156387366|NCT02693665|564508668|FG000|Overall Study|anxiety|1|||
156387367|NCT02693665|564508669|FG001|Overall Study|anxiety|0|||
156387368|NCT02693665|564508668|FG000|Overall Study|family issues|1|||
156387369|NCT02693665|564508669|FG001|Overall Study|family issues|0|||
156387370|NCT02693665|564508668|FG000|Overall Study|no reason given|1|||
156387371|NCT02693665|564508669|FG001|Overall Study|no reason given|0|||
156387372|NCT03096782|564508670|FG000|Overall Study|Death|1|||
156387373|NCT03096782|564508670|FG000|Overall Study|Participant Relapsed|1|||
156387374|NCT02075593|564508671|FG000|Overall Study|Withdrawal by Subject|1|||
156387375|NCT03156023|564508672|FG000|Overall Study|Withdrawal by Subject|1|||
156387376|NCT03156023|564508673|FG001|Overall Study|Withdrawal by Subject|0|||
156387377|NCT03156023|564508674|FG002|Overall Study|Withdrawal by Subject|2|||
156387378|NCT03156023|564508675|FG003|Overall Study|Withdrawal by Subject|1|||
156387379|NCT03156023|564508676|FG004|Overall Study|Withdrawal by Subject|1|||
156387380|NCT03156023|564508672|FG000|Overall Study|Lost to Follow-up|0|||
156387381|NCT03156023|564508673|FG001|Overall Study|Lost to Follow-up|0|||
156387382|NCT03156023|564508674|FG002|Overall Study|Lost to Follow-up|0|||
156387383|NCT03156023|564508675|FG003|Overall Study|Lost to Follow-up|0|||
156387384|NCT03156023|564508676|FG004|Overall Study|Lost to Follow-up|1|||
156387385|NCT05819749|564508681|FG000|Overall Study|Lost to Follow-up|1|||
156387386|NCT00844857|564511185|FG000|Overall Study|Adverse Event|24|||
156387387|NCT00844857|564511186|FG001|Overall Study|Adverse Event|5|||
156387388|NCT00844857|564511185|FG000|Overall Study|Sponsor Decision|1|||
156387389|NCT00844857|564511186|FG001|Overall Study|Sponsor Decision|1|||
156387390|NCT00844857|564511185|FG000|Overall Study|Physician Decision|2|||
156387391|NCT00844857|564511186|FG001|Overall Study|Physician Decision|0|||
156387392|NCT00844857|564511185|FG000|Overall Study|Parent/Caregiver Decision|6|||
156387393|NCT00844857|564511186|FG001|Overall Study|Parent/Caregiver Decision|2|||
156387394|NCT00844857|564511185|FG000|Overall Study|Withdrawal by Subject|8|||
156387395|NCT00844857|564511186|FG001|Overall Study|Withdrawal by Subject|7|||
156387396|NCT00844857|564511185|FG000|Overall Study|Protocol Violation|6|||
156387397|NCT00844857|564511186|FG001|Overall Study|Protocol Violation|0|||
156387398|NCT00844857|564511185|FG000|Overall Study|Lack of Efficacy|5|||
156387399|NCT00844857|564511186|FG001|Overall Study|Lack of Efficacy|5|||
156387400|NCT00844857|564511185|FG000|Overall Study|Clinical Relapse|0|||
156387401|NCT00844857|564511186|FG001|Overall Study|Clinical Relapse|1|||
156387402|NCT00844857|564511185|FG000|Overall Study|Entry Criteria Not Met|0|||
156387403|NCT00844857|564511186|FG001|Overall Study|Entry Criteria Not Met|1|||
156387404|NCT00844857|564511185|FG000|Overall Study|Lost to Follow-up|2|||
156387405|NCT00844857|564511186|FG001|Overall Study|Lost to Follow-up|3|||
156387406|NCT00844857|564511185|FG000|Overall Study|Did Not Take Study Drug|3|||
156387407|NCT00844857|564511186|FG001|Overall Study|Did Not Take Study Drug|1|||
156387408|NCT00844857|564511185|FG000|Overall Study|Good Clinical Practice Violations|21|||
156387409|NCT00844857|564511186|FG001|Overall Study|Good Clinical Practice Violations|11|||
156387410|NCT00570674|564511187|FG000|Overall Study|Withdrawal by Subject|0|||
156387411|NCT00570674|564511188|FG001|Overall Study|Withdrawal by Subject|0|||
156387412|NCT00570674|564511189|FG002|Overall Study|Withdrawal by Subject|1|||
156387413|NCT00570674|564511190|FG003|Overall Study|Withdrawal by Subject|0|||
156387414|NCT00570674|564511191|FG004|Overall Study|Withdrawal by Subject|0|||
156387415|NCT00570674|564511192|FG005|Overall Study|Withdrawal by Subject|0|||
156387416|NCT00570674|564511193|FG006|Overall Study|Withdrawal by Subject|0|||
156387417|NCT03069482|564511194|FG000|Overall Study|Lost to Follow-up|0|||
156387418|NCT03069482|564511195|FG001|Overall Study|Lost to Follow-up|1|||
156387419|NCT03069482|564511194|FG000|Overall Study|Physician Decision|1|||
156387420|NCT03069482|564511195|FG001|Overall Study|Physician Decision|0|||
156547548|NCT03040999|565098340|FG000|Overall Study|Lost to Follow-up|2|||
156387421|NCT01912612|564511204|FG000|Overall Study|Adverse Event|4|||
156387422|NCT01912612|564511205|FG001|Overall Study|Adverse Event|0|||
156387423|NCT01912612|564511206|FG002|Overall Study|Adverse Event|0|||
156387424|NCT01912612|564511204|FG000|Overall Study|Withdrew consent|1|||
156387425|NCT01912612|564511205|FG001|Overall Study|Withdrew consent|0|||
156387426|NCT01912612|564511206|FG002|Overall Study|Withdrew consent|0|||
156387427|NCT01912612|564511204|FG000|Overall Study|Study design change|0|||
156387428|NCT01912612|564511205|FG001|Overall Study|Study design change|0|||
156387429|NCT01912612|564511206|FG002|Overall Study|Study design change|3|||
156387430|NCT02349295|564511211|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
156387431|NCT02349295|564511212|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
156387432|NCT02349295|564511213|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
156387433|NCT02349295|564511214|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387434|NCT02349295|564511215|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387435|NCT02349295|564511216|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387436|NCT02349295|564511217|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387437|NCT02349295|564511218|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387438|NCT02349295|564511219|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387439|NCT02349295|564511220|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387440|NCT02349295|564511221|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387441|NCT02349295|564511222|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387442|NCT02349295|564511223|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387443|NCT02349295|564511224|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156387444|NCT02349295|564511211|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
156387445|NCT02349295|564511212|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
156387446|NCT02349295|564511213|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
156387447|NCT02349295|564511214|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387448|NCT02349295|564511215|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387449|NCT02349295|564511216|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387450|NCT02349295|564511217|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387451|NCT02349295|564511218|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387452|NCT02349295|564511219|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387453|NCT02349295|564511220|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387454|NCT02349295|564511221|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387455|NCT02349295|564511222|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387456|NCT02349295|564511223|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387457|NCT02349295|564511224|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156387458|NCT02349295|564511211|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
156387459|NCT02349295|564511212|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
156387460|NCT02349295|564511213|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
156387461|NCT02349295|564511214|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387462|NCT02349295|564511215|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387463|NCT02349295|564511216|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387464|NCT02349295|564511217|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387465|NCT02349295|564511218|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387466|NCT02349295|564511219|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387467|NCT02349295|564511220|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387468|NCT02349295|564511221|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387469|NCT02349295|564511222|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387470|NCT02349295|564511223|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387471|NCT02349295|564511224|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156387472|NCT02349295|564511211|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
156387473|NCT02349295|564511212|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
156387474|NCT02349295|564511213|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
156387475|NCT02349295|564511214|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387476|NCT02349295|564511215|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387477|NCT02349295|564511216|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387478|NCT02349295|564511217|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387479|NCT02349295|564511218|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387480|NCT02349295|564511219|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387481|NCT02349295|564511220|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387482|NCT02349295|564511221|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387483|NCT02349295|564511222|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387484|NCT02349295|564511223|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387485|NCT02349295|564511224|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156387486|NCT02349295|564511211|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387487|NCT02349295|564511212|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
156387488|NCT02349295|564511213|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
156387489|NCT02349295|564511214|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387490|NCT02349295|564511215|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387491|NCT02349295|564511216|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387492|NCT02349295|564511217|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387493|NCT02349295|564511218|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387494|NCT02349295|564511219|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156507888|NCT02057575|564952984|FG001|Overall Study|Adverse Event|2|||
156507889|NCT02057575|564952985|FG002|Overall Study|Adverse Event|0|||
156507890|NCT02057575|564952986|FG003|Overall Study|Adverse Event|1|||
156387495|NCT02349295|564511220|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156507891|NCT02057575|564952983|FG000|Overall Study|Withdrawal by Subject|1|||
156547549|NCT03040999|565098341|FG001|Overall Study|Lost to Follow-up|2|||
156547550|NCT03040999|565098340|FG000|Overall Study|Withdrawal by Subject|12|||
156547551|NCT03040999|565098341|FG001|Overall Study|Withdrawal by Subject|13|||
156547552|NCT03040999|565098340|FG000|Overall Study|Death|155|||
156547553|NCT03040999|565098341|FG001|Overall Study|Death|171|||
156547554|NCT03040999|565098340|FG000|Overall Study|Physician Decision|0|||
156547555|NCT03040999|565098341|FG001|Overall Study|Physician Decision|3|||
156547556|NCT03451773|565098343|FG000|Overall Study|Death on study|1|||
156547557|NCT03451773|565098344|FG001|Overall Study|Death on study|5|||
156547558|NCT03451773|565098343|FG000|Overall Study|Death during follow-up period|0|||
156547559|NCT03451773|565098344|FG001|Overall Study|Death during follow-up period|1|||
156547560|NCT02068547|565098345|FG000|Overall Study|Lost to Follow-up|3|||
156547561|NCT02068547|565098346|FG001|Overall Study|Lost to Follow-up|3|||
156547562|NCT02068547|565098345|FG000|Overall Study|Physician Decision|1|||
156547563|NCT02068547|565098346|FG001|Overall Study|Physician Decision|0|||
156547564|NCT01783678|565098347|FG000|Overall Study|Randomized but Not Treated|0|||
156547565|NCT01783678|565098348|FG001|Overall Study|Randomized but Not Treated|0|||
156547566|NCT01783678|565098349|FG002|Overall Study|Randomized but Not Treated|0|||
156547567|NCT01783678|565098350|FG003|Overall Study|Randomized but Not Treated|1|||
156547568|NCT01783678|565098351|FG004|Overall Study|Randomized but Not Treated|0|||
156547569|NCT01783678|565098352|FG005|Overall Study|Randomized but Not Treated|0|||
156547570|NCT01783678|565098347|FG000|Overall Study|Lack of Efficacy|1|||
156547571|NCT01783678|565098348|FG001|Overall Study|Lack of Efficacy|13|||
156547572|NCT01783678|565098349|FG002|Overall Study|Lack of Efficacy|1|||
156547573|NCT01783678|565098350|FG003|Overall Study|Lack of Efficacy|3|||
156547574|NCT01783678|565098351|FG004|Overall Study|Lack of Efficacy|6|||
156547575|NCT01783678|565098352|FG005|Overall Study|Lack of Efficacy|5|||
156547576|NCT01783678|565098347|FG000|Overall Study|Lost to Follow-up|0|||
156547577|NCT01783678|565098348|FG001|Overall Study|Lost to Follow-up|4|||
156547578|NCT01783678|565098349|FG002|Overall Study|Lost to Follow-up|0|||
156547579|NCT01783678|565098350|FG003|Overall Study|Lost to Follow-up|2|||
156547580|NCT01783678|565098351|FG004|Overall Study|Lost to Follow-up|1|||
156547581|NCT01783678|565098352|FG005|Overall Study|Lost to Follow-up|0|||
156547582|NCT01783678|565098347|FG000|Overall Study|Withdrew Consent|1|||
156547583|NCT01783678|565098348|FG001|Overall Study|Withdrew Consent|1|||
156547584|NCT01783678|565098349|FG002|Overall Study|Withdrew Consent|0|||
156547585|NCT01783678|565098350|FG003|Overall Study|Withdrew Consent|2|||
156547586|NCT01783678|565098351|FG004|Overall Study|Withdrew Consent|0|||
156547587|NCT01783678|565098352|FG005|Overall Study|Withdrew Consent|0|||
156547588|NCT01995071|565098353|FG000|Overall Study|Adverse Event|0|||
156547589|NCT01995071|565098354|FG001|Overall Study|Adverse Event|0|||
156547590|NCT01995071|565098355|FG002|Overall Study|Adverse Event|0|||
156547591|NCT01995071|565098356|FG003|Overall Study|Adverse Event|0|||
156547592|NCT01995071|565098357|FG004|Overall Study|Adverse Event|0|||
156547593|NCT01995071|565098358|FG005|Overall Study|Adverse Event|0|||
156547594|NCT01995071|565098359|FG006|Overall Study|Adverse Event|1|||
156547595|NCT01995071|565098360|FG007|Overall Study|Adverse Event|0|||
156547596|NCT01995071|565098361|FG008|Overall Study|Adverse Event|0|||
156547597|NCT01995071|565098362|FG009|Overall Study|Adverse Event|0|||
156547598|NCT01995071|565098363|FG010|Overall Study|Adverse Event|0|||
156547599|NCT01995071|565098364|FG011|Overall Study|Adverse Event|0|||
156547600|NCT01995071|565098353|FG000|Overall Study|Moved|0|||
156547601|NCT01995071|565098354|FG001|Overall Study|Moved|0|||
156547602|NCT01995071|565098355|FG002|Overall Study|Moved|1|||
156547603|NCT01995071|565098356|FG003|Overall Study|Moved|0|||
156547604|NCT01995071|565098357|FG004|Overall Study|Moved|1|||
156547605|NCT01995071|565098358|FG005|Overall Study|Moved|0|||
156547606|NCT01995071|565098359|FG006|Overall Study|Moved|0|||
156547607|NCT01995071|565098360|FG007|Overall Study|Moved|0|||
156547608|NCT01995071|565098361|FG008|Overall Study|Moved|0|||
156547609|NCT01995071|565098362|FG009|Overall Study|Moved|0|||
156547610|NCT01995071|565098363|FG010|Overall Study|Moved|1|||
156547611|NCT01995071|565098364|FG011|Overall Study|Moved|0|||
156547612|NCT01995071|565098353|FG000|Overall Study|Lost to Follow-up|1|||
156547613|NCT01995071|565098354|FG001|Overall Study|Lost to Follow-up|0|||
156547614|NCT01995071|565098355|FG002|Overall Study|Lost to Follow-up|0|||
156547615|NCT01995071|565098356|FG003|Overall Study|Lost to Follow-up|0|||
156547616|NCT01995071|565098357|FG004|Overall Study|Lost to Follow-up|0|||
156547617|NCT01995071|565098358|FG005|Overall Study|Lost to Follow-up|0|||
156547618|NCT01995071|565098359|FG006|Overall Study|Lost to Follow-up|0|||
156547619|NCT01995071|565098360|FG007|Overall Study|Lost to Follow-up|1|||
156547620|NCT01995071|565098361|FG008|Overall Study|Lost to Follow-up|1|||
156547621|NCT01995071|565098362|FG009|Overall Study|Lost to Follow-up|0|||
156547622|NCT01995071|565098363|FG010|Overall Study|Lost to Follow-up|0|||
156547623|NCT01995071|565098364|FG011|Overall Study|Lost to Follow-up|0|||
156547624|NCT01995071|565098353|FG000|Overall Study|Incarcerated|0|||
156547625|NCT01995071|565098354|FG001|Overall Study|Incarcerated|0|||
156547626|NCT01995071|565098355|FG002|Overall Study|Incarcerated|0|||
156547627|NCT01995071|565098356|FG003|Overall Study|Incarcerated|0|||
156547628|NCT01995071|565098357|FG004|Overall Study|Incarcerated|0|||
156547629|NCT01995071|565098358|FG005|Overall Study|Incarcerated|0|||
156387496|NCT02349295|564511221|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387497|NCT02349295|564511222|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387498|NCT02349295|564511223|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387499|NCT02349295|564511224|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156387500|NCT02349295|564511211|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
156387501|NCT02349295|564511212|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
156387502|NCT02349295|564511213|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
156387503|NCT02349295|564511214|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
156387504|NCT02349295|564511215|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
156387505|NCT02349295|564511216|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
156387506|NCT02349295|564511217|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
156387507|NCT02349295|564511218|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
156387508|NCT02349295|564511219|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
156387509|NCT02349295|564511220|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
156387510|NCT02349295|564511221|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
156387511|NCT02349295|564511222|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
156387512|NCT02349295|564511223|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
156387513|NCT02349295|564511224|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
156387514|NCT02349295|564511211|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387515|NCT02349295|564511212|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387516|NCT02349295|564511213|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387517|NCT02349295|564511214|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387518|NCT02349295|564511215|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387519|NCT02349295|564511216|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387520|NCT02349295|564511217|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387521|NCT02349295|564511218|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
156387522|NCT02349295|564511219|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
156387523|NCT02349295|564511220|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
156387524|NCT02349295|564511221|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
156387525|NCT02349295|564511222|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387526|NCT02349295|564511223|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387527|NCT02349295|564511224|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156387528|NCT02349295|564511211|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387529|NCT02349295|564511212|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387530|NCT02349295|564511213|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387531|NCT02349295|564511214|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387532|NCT02349295|564511215|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387533|NCT02349295|564511216|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387534|NCT02349295|564511217|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387535|NCT02349295|564511218|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
156387536|NCT02349295|564511219|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
156387537|NCT02349295|564511220|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
156387538|NCT02349295|564511221|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
156387539|NCT02349295|564511222|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387540|NCT02349295|564511223|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387541|NCT02349295|564511224|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156387542|NCT02349295|564511211|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387543|NCT02349295|564511212|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387544|NCT02349295|564511213|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387545|NCT02349295|564511214|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387546|NCT02349295|564511215|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387547|NCT02349295|564511216|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387548|NCT02349295|564511217|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387549|NCT02349295|564511218|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
156387550|NCT02349295|564511219|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387551|NCT02349295|564511220|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
156387552|NCT02349295|564511221|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387553|NCT02349295|564511222|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387554|NCT02349295|564511223|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387555|NCT02349295|564511224|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156387556|NCT02349295|564511211|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
156387557|NCT02349295|564511212|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
156387558|NCT02349295|564511213|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
156387559|NCT02349295|564511214|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
156387560|NCT02349295|564511215|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
156387561|NCT02349295|564511216|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
156507892|NCT02057575|564952984|FG001|Overall Study|Withdrawal by Subject|0|||
156507893|NCT02057575|564952985|FG002|Overall Study|Withdrawal by Subject|0|||
156507894|NCT02057575|564952986|FG003|Overall Study|Withdrawal by Subject|0|||
156547630|NCT01995071|565098359|FG006|Overall Study|Incarcerated|0|||
156547631|NCT01995071|565098360|FG007|Overall Study|Incarcerated|1|||
156547632|NCT01995071|565098361|FG008|Overall Study|Incarcerated|0|||
156547633|NCT01995071|565098362|FG009|Overall Study|Incarcerated|0|||
156547634|NCT01995071|565098363|FG010|Overall Study|Incarcerated|0|||
156547635|NCT01995071|565098364|FG011|Overall Study|Incarcerated|0|||
156547636|NCT02404103|565098365|FG000|Overall Study|Adverse Event|1|||
156547637|NCT02404103|565098366|FG001|Overall Study|Adverse Event|0|||
156547638|NCT02404103|565098365|FG000|Overall Study|Lost to Follow-up|3|||
156547639|NCT02404103|565098366|FG001|Overall Study|Lost to Follow-up|3|||
156547640|NCT00631371|565098374|FG000|Overall Study|Lost to Follow-up|24|||
156547641|NCT00631371|565098375|FG001|Overall Study|Lost to Follow-up|19|||
156547642|NCT00631371|565098374|FG000|Overall Study|Other reason|5|||
156547643|NCT00631371|565098375|FG001|Overall Study|Other reason|12|||
156547644|NCT00631371|565098374|FG000|Overall Study|subject request|38|||
156547645|NCT00631371|565098375|FG001|Overall Study|subject request|45|||
156547646|NCT00631371|565098374|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
156547647|NCT00631371|565098375|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
156547648|NCT00631371|565098374|FG000|Overall Study|Death|263|||
156547649|NCT00631371|565098375|FG001|Overall Study|Death|239|||
156547650|NCT03354663|565098376|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
156547651|NCT03354663|565098376|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
156547652|NCT03354663|565098376|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
156547653|NCT03354663|565098376|FG000|Completed 30-day Visit|Missed Visit|1|||
156547654|NCT01661140|565098379|FG000|Open-Label Period|Adverse Event|44|||
156547655|NCT01661140|565098380|FG001|Open-Label Period|Adverse Event|0|||
156547656|NCT01661140|565098381|FG002|Open-Label Period|Adverse Event|0|||
156547657|NCT01661140|565098379|FG000|Open-Label Period|Protocol Violation|3|||
156547658|NCT01661140|565098380|FG001|Open-Label Period|Protocol Violation|0|||
156547659|NCT01661140|565098381|FG002|Open-Label Period|Protocol Violation|0|||
156547660|NCT01661140|565098379|FG000|Open-Label Period|Withdrawal by Subject|5|||
156547661|NCT01661140|565098380|FG001|Open-Label Period|Withdrawal by Subject|0|||
156547662|NCT01661140|565098381|FG002|Open-Label Period|Withdrawal by Subject|0|||
156547663|NCT01661140|565098379|FG000|Open-Label Period|Investigator Decision|3|||
156547664|NCT01661140|565098380|FG001|Open-Label Period|Investigator Decision|0|||
156547665|NCT01661140|565098381|FG002|Open-Label Period|Investigator Decision|0|||
156547666|NCT01661140|565098379|FG000|Open-Label Period|Death|1|||
156387562|NCT02349295|564511217|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
156387563|NCT02349295|564511218|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
156387564|NCT02349295|564511219|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
156387565|NCT02349295|564511220|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
156387566|NCT02349295|564511221|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
156387567|NCT02349295|564511222|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
156387568|NCT02349295|564511223|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
156387569|NCT02349295|564511224|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
156387570|NCT02349295|564511211|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387571|NCT02349295|564511212|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387572|NCT02349295|564511213|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387573|NCT02349295|564511214|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387574|NCT02349295|564511215|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387575|NCT02349295|564511216|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387576|NCT02349295|564511217|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387577|NCT02349295|564511218|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
156387578|NCT02349295|564511219|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
156387579|NCT02349295|564511220|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
156387580|NCT02349295|564511221|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
156387581|NCT02349295|564511222|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387582|NCT02349295|564511223|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387583|NCT02349295|564511224|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156387584|NCT02349295|564511211|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387585|NCT02349295|564511212|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387586|NCT02349295|564511213|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387587|NCT02349295|564511214|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387588|NCT02349295|564511215|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156547667|NCT01661140|565098380|FG001|Open-Label Period|Death|0|||
156547668|NCT01661140|565098381|FG002|Open-Label Period|Death|0|||
156547669|NCT01661140|565098379|FG000|Open-Label Period|Administrative/Other|1|||
156547670|NCT01661140|565098380|FG001|Open-Label Period|Administrative/Other|0|||
156547671|NCT01661140|565098381|FG002|Open-Label Period|Administrative/Other|0|||
156547672|NCT01661140|565098379|FG000|Open-Label Period|Sponsor termination|16|||
156547673|NCT01661140|565098380|FG001|Open-Label Period|Sponsor termination|0|||
156547674|NCT01661140|565098381|FG002|Open-Label Period|Sponsor termination|0|||
156387589|NCT02349295|564511216|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387590|NCT02349295|564511217|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387591|NCT02349295|564511218|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
156387592|NCT02349295|564511219|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
156387593|NCT02349295|564511220|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387594|NCT02349295|564511221|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387595|NCT02349295|564511222|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387596|NCT02349295|564511223|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387597|NCT02349295|564511224|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156387598|NCT02349295|564511211|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387599|NCT02349295|564511212|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387600|NCT02349295|564511213|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387601|NCT02349295|564511214|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387602|NCT02349295|564511215|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387603|NCT02349295|564511216|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387604|NCT02349295|564511217|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387605|NCT02349295|564511218|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
156387606|NCT02349295|564511219|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
156387607|NCT02349295|564511220|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387608|NCT02349295|564511221|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387609|NCT02349295|564511222|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387610|NCT02349295|564511223|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387611|NCT02349295|564511224|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156387612|NCT02349295|564511211|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387613|NCT02349295|564511212|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387614|NCT02349295|564511213|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387615|NCT02349295|564511214|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387616|NCT02349295|564511215|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387617|NCT02349295|564511216|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387618|NCT02349295|564511217|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387619|NCT02349295|564511218|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387620|NCT02349295|564511219|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387621|NCT02349295|564511220|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387622|NCT02349295|564511221|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156387623|NCT02349295|564511222|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
156387624|NCT02349295|564511223|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
156387625|NCT02349295|564511224|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
156387626|NCT02349295|564511211|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387627|NCT02349295|564511212|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387628|NCT02349295|564511213|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387629|NCT02349295|564511214|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387630|NCT02349295|564511215|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387631|NCT02349295|564511216|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387632|NCT02349295|564511217|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387633|NCT02349295|564511218|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387634|NCT02349295|564511219|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387635|NCT02349295|564511220|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387636|NCT02349295|564511221|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156387637|NCT02349295|564511222|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
156387638|NCT02349295|564511223|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
156387639|NCT02349295|564511224|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156507895|NCT02057575|564952983|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
156507896|NCT02057575|564952984|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
156507897|NCT02057575|564952985|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
156387640|NCT02349295|564511211|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387641|NCT02349295|564511212|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387642|NCT02349295|564511213|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387643|NCT02349295|564511214|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387644|NCT02349295|564511215|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387645|NCT02349295|564511216|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387646|NCT02349295|564511217|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387647|NCT02349295|564511218|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387648|NCT02349295|564511219|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387649|NCT02349295|564511220|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387650|NCT02349295|564511221|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387651|NCT02349295|564511222|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
156387652|NCT02349295|564511223|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
156387653|NCT02349295|564511224|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156387654|NCT02349295|564511211|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387655|NCT02349295|564511212|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387656|NCT02349295|564511213|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387657|NCT02349295|564511214|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387658|NCT02349295|564511215|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387659|NCT02349295|564511216|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387660|NCT02349295|564511217|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387661|NCT02349295|564511218|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387662|NCT02349295|564511219|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387663|NCT02349295|564511220|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387664|NCT02349295|564511221|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387665|NCT02349295|564511222|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
156387666|NCT02349295|564511223|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387667|NCT02349295|564511224|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156387668|NCT02349295|564511211|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387669|NCT02349295|564511212|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387670|NCT02349295|564511213|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387671|NCT02349295|564511214|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387672|NCT02349295|564511215|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387673|NCT02349295|564511216|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387674|NCT02349295|564511217|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387675|NCT02349295|564511218|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387676|NCT02349295|564511219|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387677|NCT02349295|564511220|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387678|NCT02349295|564511221|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387679|NCT02349295|564511222|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
156387680|NCT02349295|564511223|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387681|NCT02349295|564511224|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156387682|NCT00620750|564511235|FG000|Overall Study|Lost to Follow-up|25|||
156387683|NCT04477187|564511236|FG000|Overall Study|Lost to Follow-up|2|||
156387684|NCT04717596|564511238|FG000|Overall Study|Withdrawal by Subject|4|||
156387685|NCT00765843|564511239|FG000|Overall Study|Lost to Follow-up|1|||
156387686|NCT00765843|564511240|FG001|Overall Study|Lost to Follow-up|3|||
156387687|NCT00765843|564511241|FG002|Overall Study|Lost to Follow-up|2|||
156387688|NCT00765843|564511239|FG000|Overall Study|did not return to receive intervention|0|||
156387689|NCT00765843|564511240|FG001|Overall Study|did not return to receive intervention|1|||
156387690|NCT00765843|564511241|FG002|Overall Study|did not return to receive intervention|0|||
156387691|NCT00765843|564511239|FG000|Overall Study|Adverse Event|0|||
156387692|NCT00765843|564511240|FG001|Overall Study|Adverse Event|0|||
156387693|NCT00765843|564511241|FG002|Overall Study|Adverse Event|1|||
156387694|NCT04066114|564511242|FG000|Overall Study|Adverse Event|1|||
156387695|NCT04066114|564511243|FG001|Overall Study|Adverse Event|0|||
156387696|NCT04066114|564511244|FG002|Overall Study|Adverse Event|0|||
156387697|NCT04066114|564511242|FG000|Overall Study|Withdrawal by Subject|1|||
156387698|NCT04066114|564511243|FG001|Overall Study|Withdrawal by Subject|0|||
156387699|NCT04066114|564511244|FG002|Overall Study|Withdrawal by Subject|0|||
156387700|NCT04066114|564511242|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156387701|NCT04066114|564511243|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
156387702|NCT04066114|564511244|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
156387703|NCT02460991|564511245|FG000|Overall Study|Withdrawal by Subject|0|||
156387704|NCT02460991|564511246|FG001|Overall Study|Withdrawal by Subject|2|||
156387705|NCT02564523|564511247|FG000|Overall Study|Withdrawal by Subject|3|||
156387706|NCT02564523|564511248|FG001|Overall Study|Withdrawal by Subject|0|||
156387707|NCT02564523|564511249|FG002|Overall Study|Withdrawal by Subject|1|||
156387708|NCT02564523|564511250|FG003|Overall Study|Withdrawal by Subject|0|||
156387709|NCT02564523|564511251|FG004|Overall Study|Withdrawal by Subject|1|||
156547675|NCT01661140|565098379|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
156387710|NCT02564523|564511252|FG005|Overall Study|Withdrawal by Subject|0|||
156387711|NCT02564523|564511253|FG006|Overall Study|Withdrawal by Subject|1|||
156387712|NCT02564523|564511254|FG007|Overall Study|Withdrawal by Subject|0|||
156387713|NCT02564523|564511255|FG008|Overall Study|Withdrawal by Subject|0|||
156387714|NCT02564523|564511256|FG009|Overall Study|Withdrawal by Subject|0|||
156387715|NCT02564523|564511257|FG010|Overall Study|Withdrawal by Subject|1|||
156387716|NCT02564523|564511258|FG011|Overall Study|Withdrawal by Subject|0|||
156387717|NCT02564523|564511259|FG012|Overall Study|Withdrawal by Subject|1|||
156387718|NCT02564523|564511260|FG013|Overall Study|Withdrawal by Subject|0|||
156387719|NCT02564523|564511261|FG014|Overall Study|Withdrawal by Subject|0|||
156387720|NCT02564523|564511262|FG015|Overall Study|Withdrawal by Subject|0|||
156387721|NCT02564523|564511263|FG016|Overall Study|Withdrawal by Subject|0|||
156387722|NCT02564523|564511264|FG017|Overall Study|Withdrawal by Subject|0|||
156387723|NCT02564523|564511247|FG000|Overall Study|Adverse Event|0|||
156387724|NCT02564523|564511248|FG001|Overall Study|Adverse Event|0|||
156387725|NCT02564523|564511249|FG002|Overall Study|Adverse Event|0|||
156387726|NCT02564523|564511250|FG003|Overall Study|Adverse Event|0|||
156387727|NCT02564523|564511251|FG004|Overall Study|Adverse Event|0|||
156387728|NCT02564523|564511252|FG005|Overall Study|Adverse Event|0|||
156387729|NCT02564523|564511253|FG006|Overall Study|Adverse Event|0|||
156387730|NCT02564523|564511254|FG007|Overall Study|Adverse Event|0|||
156387731|NCT02564523|564511255|FG008|Overall Study|Adverse Event|0|||
156387732|NCT02564523|564511256|FG009|Overall Study|Adverse Event|0|||
156387733|NCT02564523|564511257|FG010|Overall Study|Adverse Event|0|||
156387734|NCT02564523|564511258|FG011|Overall Study|Adverse Event|0|||
156387735|NCT02564523|564511259|FG012|Overall Study|Adverse Event|0|||
156387736|NCT02564523|564511260|FG013|Overall Study|Adverse Event|0|||
156387737|NCT02564523|564511261|FG014|Overall Study|Adverse Event|0|||
156387738|NCT02564523|564511262|FG015|Overall Study|Adverse Event|0|||
156387739|NCT02564523|564511263|FG016|Overall Study|Adverse Event|0|||
156387740|NCT02564523|564511264|FG017|Overall Study|Adverse Event|1|||
156387741|NCT02564523|564511247|FG000|Overall Study|Death|0|||
156387742|NCT02564523|564511248|FG001|Overall Study|Death|0|||
156387743|NCT02564523|564511249|FG002|Overall Study|Death|0|||
156387744|NCT02564523|564511250|FG003|Overall Study|Death|0|||
156387745|NCT02564523|564511251|FG004|Overall Study|Death|0|||
156387746|NCT02564523|564511252|FG005|Overall Study|Death|0|||
156387747|NCT02564523|564511253|FG006|Overall Study|Death|1|||
156387748|NCT02564523|564511254|FG007|Overall Study|Death|0|||
156387749|NCT02564523|564511255|FG008|Overall Study|Death|0|||
156387750|NCT02564523|564511256|FG009|Overall Study|Death|0|||
156387751|NCT02564523|564511257|FG010|Overall Study|Death|1|||
156387752|NCT02564523|564511258|FG011|Overall Study|Death|0|||
156387753|NCT02564523|564511259|FG012|Overall Study|Death|0|||
156387754|NCT02564523|564511260|FG013|Overall Study|Death|0|||
156387755|NCT02564523|564511261|FG014|Overall Study|Death|0|||
156387756|NCT02564523|564511262|FG015|Overall Study|Death|0|||
156387757|NCT02564523|564511263|FG016|Overall Study|Death|0|||
156387758|NCT02564523|564511264|FG017|Overall Study|Death|0|||
156387759|NCT02564523|564511247|FG000|Overall Study|Lost to Follow-up|2|||
156387760|NCT02564523|564511248|FG001|Overall Study|Lost to Follow-up|1|||
156387761|NCT02564523|564511249|FG002|Overall Study|Lost to Follow-up|4|||
156387762|NCT02564523|564511250|FG003|Overall Study|Lost to Follow-up|0|||
156387763|NCT02564523|564511251|FG004|Overall Study|Lost to Follow-up|1|||
156387764|NCT02564523|564511252|FG005|Overall Study|Lost to Follow-up|0|||
156387765|NCT02564523|564511253|FG006|Overall Study|Lost to Follow-up|1|||
156387766|NCT02564523|564511254|FG007|Overall Study|Lost to Follow-up|0|||
156387767|NCT02564523|564511255|FG008|Overall Study|Lost to Follow-up|0|||
156387768|NCT02564523|564511256|FG009|Overall Study|Lost to Follow-up|0|||
156387769|NCT02564523|564511257|FG010|Overall Study|Lost to Follow-up|0|||
156387770|NCT02564523|564511258|FG011|Overall Study|Lost to Follow-up|1|||
156387771|NCT02564523|564511259|FG012|Overall Study|Lost to Follow-up|1|||
156387772|NCT02564523|564511260|FG013|Overall Study|Lost to Follow-up|0|||
156387773|NCT02564523|564511261|FG014|Overall Study|Lost to Follow-up|0|||
156387774|NCT02564523|564511262|FG015|Overall Study|Lost to Follow-up|0|||
156387775|NCT02564523|564511263|FG016|Overall Study|Lost to Follow-up|0|||
156387776|NCT02564523|564511264|FG017|Overall Study|Lost to Follow-up|0|||
156387777|NCT02564523|564511247|FG000|Overall Study|Physician Decision|0|||
156387778|NCT02564523|564511248|FG001|Overall Study|Physician Decision|0|||
156387779|NCT02564523|564511249|FG002|Overall Study|Physician Decision|0|||
156387780|NCT02564523|564511250|FG003|Overall Study|Physician Decision|0|||
156387781|NCT02564523|564511251|FG004|Overall Study|Physician Decision|1|||
156387782|NCT02564523|564511252|FG005|Overall Study|Physician Decision|0|||
156387783|NCT02564523|564511253|FG006|Overall Study|Physician Decision|0|||
156387784|NCT02564523|564511254|FG007|Overall Study|Physician Decision|0|||
156387785|NCT02564523|564511255|FG008|Overall Study|Physician Decision|0|||
156387786|NCT02564523|564511256|FG009|Overall Study|Physician Decision|0|||
156387787|NCT02564523|564511257|FG010|Overall Study|Physician Decision|1|||
156387788|NCT02564523|564511258|FG011|Overall Study|Physician Decision|0|||
156387789|NCT02564523|564511259|FG012|Overall Study|Physician Decision|0|||
156387790|NCT02564523|564511260|FG013|Overall Study|Physician Decision|0|||
156387791|NCT02564523|564511261|FG014|Overall Study|Physician Decision|0|||
156387792|NCT02564523|564511262|FG015|Overall Study|Physician Decision|0|||
156387793|NCT02564523|564511263|FG016|Overall Study|Physician Decision|0|||
156387794|NCT02564523|564511264|FG017|Overall Study|Physician Decision|0|||
156387795|NCT02564523|564511247|FG000|Overall Study|Protocol Violation|2|||
156387796|NCT02564523|564511248|FG001|Overall Study|Protocol Violation|2|||
156387797|NCT02564523|564511249|FG002|Overall Study|Protocol Violation|5|||
156387798|NCT02564523|564511250|FG003|Overall Study|Protocol Violation|0|||
156387799|NCT02564523|564511251|FG004|Overall Study|Protocol Violation|1|||
156387800|NCT02564523|564511252|FG005|Overall Study|Protocol Violation|0|||
156387801|NCT02564523|564511253|FG006|Overall Study|Protocol Violation|0|||
156387802|NCT02564523|564511254|FG007|Overall Study|Protocol Violation|0|||
156387803|NCT02564523|564511255|FG008|Overall Study|Protocol Violation|0|||
156387804|NCT02564523|564511256|FG009|Overall Study|Protocol Violation|0|||
156387805|NCT02564523|564511257|FG010|Overall Study|Protocol Violation|0|||
156387806|NCT02564523|564511258|FG011|Overall Study|Protocol Violation|0|||
156387807|NCT02564523|564511259|FG012|Overall Study|Protocol Violation|0|||
156387808|NCT02564523|564511260|FG013|Overall Study|Protocol Violation|0|||
156387809|NCT02564523|564511261|FG014|Overall Study|Protocol Violation|0|||
156387810|NCT02564523|564511262|FG015|Overall Study|Protocol Violation|0|||
156387811|NCT02564523|564511263|FG016|Overall Study|Protocol Violation|0|||
156387812|NCT02564523|564511264|FG017|Overall Study|Protocol Violation|0|||
156387813|NCT02564523|564511247|FG000|Overall Study|Other|3|||
156387814|NCT02564523|564511248|FG001|Overall Study|Other|0|||
156387815|NCT02564523|564511249|FG002|Overall Study|Other|0|||
156387816|NCT02564523|564511250|FG003|Overall Study|Other|1|||
156387817|NCT02564523|564511251|FG004|Overall Study|Other|0|||
156387818|NCT02564523|564511252|FG005|Overall Study|Other|0|||
156387819|NCT02564523|564511253|FG006|Overall Study|Other|0|||
156387820|NCT02564523|564511254|FG007|Overall Study|Other|0|||
156387821|NCT02564523|564511255|FG008|Overall Study|Other|0|||
156387822|NCT02564523|564511256|FG009|Overall Study|Other|0|||
156387823|NCT02564523|564511257|FG010|Overall Study|Other|0|||
156387824|NCT02564523|564511258|FG011|Overall Study|Other|0|||
156387825|NCT02564523|564511259|FG012|Overall Study|Other|0|||
156387826|NCT02564523|564511260|FG013|Overall Study|Other|0|||
156387827|NCT02564523|564511261|FG014|Overall Study|Other|0|||
156387828|NCT02564523|564511262|FG015|Overall Study|Other|0|||
156387829|NCT02564523|564511263|FG016|Overall Study|Other|0|||
156387830|NCT02564523|564511264|FG017|Overall Study|Other|0|||
156387831|NCT00448539|564511265|FG000|Overall Study|Medication non-compliance|4|||
156387832|NCT00448539|564511266|FG001|Overall Study|Medication non-compliance|1|||
156387833|NCT00448539|564511265|FG000|Overall Study|Protocol Violation|1|||
156387834|NCT00448539|564511266|FG001|Overall Study|Protocol Violation|0|||
156387835|NCT00448539|564511265|FG000|Overall Study|Request of the investigator or sponsor|67|||
156387836|NCT00448539|564511266|FG001|Overall Study|Request of the investigator or sponsor|54|||
156387837|NCT00448539|564511265|FG000|Overall Study|Withdrawal by Subject|20|||
156387838|NCT00448539|564511266|FG001|Overall Study|Withdrawal by Subject|24|||
156387839|NCT00448539|564511265|FG000|Overall Study|Diary non-compliance|1|||
156387840|NCT00448539|564511266|FG001|Overall Study|Diary non-compliance|0|||
156387841|NCT00448539|564511265|FG000|Overall Study|Adverse Event|9|||
156387842|NCT00448539|564511266|FG001|Overall Study|Adverse Event|26|||
156387843|NCT00448539|564511265|FG000|Overall Study|Lack of Efficacy|27|||
156387844|NCT00448539|564511266|FG001|Overall Study|Lack of Efficacy|40|||
156387845|NCT00448539|564511265|FG000|Overall Study|Miscellaneous|2|||
156387846|NCT00448539|564511266|FG001|Overall Study|Miscellaneous|1|||
156387847|NCT00448539|564511265|FG000|Overall Study|Change of meds|2|||
156387848|NCT00448539|564511266|FG001|Overall Study|Change of meds|3|||
156387849|NCT00448539|564511265|FG000|Overall Study|Lost to Follow-up|1|||
156387850|NCT00448539|564511266|FG001|Overall Study|Lost to Follow-up|3|||
156387851|NCT03349710|564511267|FG000|Treatment Period|Death|0|||
156387852|NCT03349710|564511268|FG001|Treatment Period|Death|0|||
156387853|NCT03349710|564511269|FG002|Treatment Period|Death|1|||
156387854|NCT03349710|564511270|FG003|Treatment Period|Death|0|||
156387855|NCT03349710|564511267|FG000|Treatment Period|Disease Progression|0|||
156387856|NCT03349710|564511268|FG001|Treatment Period|Disease Progression|2|||
156387857|NCT03349710|564511269|FG002|Treatment Period|Disease Progression|0|||
156387858|NCT03349710|564511270|FG003|Treatment Period|Disease Progression|1|||
156387859|NCT03349710|564511267|FG000|Treatment Period|Study Drug Toxicity|1|||
156387860|NCT03349710|564511268|FG001|Treatment Period|Study Drug Toxicity|0|||
156387861|NCT03349710|564511269|FG002|Treatment Period|Study Drug Toxicity|1|||
156387862|NCT03349710|564511270|FG003|Treatment Period|Study Drug Toxicity|1|||
156387863|NCT03349710|564511267|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
156387864|NCT03349710|564511268|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
156387865|NCT03349710|564511269|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
156387866|NCT03349710|564511270|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
156387867|NCT03349710|564511267|FG000|Treatment Period|admin reason by sponsor|0|||
156387868|NCT03349710|564511268|FG001|Treatment Period|admin reason by sponsor|7|||
156387869|NCT03349710|564511269|FG002|Treatment Period|admin reason by sponsor|0|||
156387870|NCT03349710|564511270|FG003|Treatment Period|admin reason by sponsor|19|||
156387871|NCT03349710|564511267|FG000|Treatment Period|Other Reason|2|||
156387872|NCT03349710|564511268|FG001|Treatment Period|Other Reason|0|||
156387873|NCT03349710|564511269|FG002|Treatment Period|Other Reason|2|||
156387874|NCT03349710|564511270|FG003|Treatment Period|Other Reason|1|||
156387875|NCT03349710|564511267|FG000|Treatment Period|completed|6|||
156387876|NCT03349710|564511268|FG001|Treatment Period|completed|0|||
156387877|NCT03349710|564511269|FG002|Treatment Period|completed|18|||
156387878|NCT03349710|564511270|FG003|Treatment Period|completed|1|||
156387879|NCT03349710|564511267|FG000|Treatment Period|participant request to discontinue|0|||
156387880|NCT03349710|564511268|FG001|Treatment Period|participant request to discontinue|0|||
156387881|NCT03349710|564511269|FG002|Treatment Period|participant request to discontinue|4|||
156387882|NCT03349710|564511270|FG003|Treatment Period|participant request to discontinue|0|||
156387883|NCT03349710|564511267|FG000|Treatment Period|participant withdrew consent|1|||
156387884|NCT03349710|564511268|FG001|Treatment Period|participant withdrew consent|0|||
156387885|NCT03349710|564511269|FG002|Treatment Period|participant withdrew consent|0|||
156387886|NCT03349710|564511270|FG003|Treatment Period|participant withdrew consent|0|||
156387887|NCT00695903|564511271|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
156387888|NCT00695903|564511272|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
156387889|NCT00695903|564511271|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
156387890|NCT00695903|564511272|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
156387891|NCT00695903|564511271|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
156387892|NCT00695903|564511272|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
156387893|NCT00695903|564511271|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
156387894|NCT00695903|564511272|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
156387895|NCT00695903|564511271|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
156387896|NCT00695903|564511272|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
156387897|NCT00695903|564511271|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
156387898|NCT00695903|564511272|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
156387899|NCT00695903|564511271|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
156387900|NCT00695903|564511272|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
156387901|NCT00695903|564511271|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
156387902|NCT00695903|564511272|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
156387903|NCT00695903|564511271|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
156387904|NCT00695903|564511272|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
156387905|NCT02696317|564511273|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
156387906|NCT02696317|564511274|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
156387907|NCT02696317|564511273|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
156387908|NCT02696317|564511274|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
156387909|NCT01343368|564511275|FG000|Overall Study|Death|1|||
156387910|NCT01343368|564511276|FG001|Overall Study|Death|0|||
156387911|NCT01343368|564511275|FG000|Overall Study|Lost to Follow-up|1|||
156387912|NCT01343368|564511276|FG001|Overall Study|Lost to Follow-up|0|||
156387913|NCT01296568|564511282|FG000|Continued Access Phase|Lost to Follow-up|1|||
156387914|NCT01296568|564511282|FG000|Continued Access Phase|Withdrawal by Subject|1|||
156387915|NCT01296568|564511282|FG000|Continued Access Phase|Disease Progression|1|||
156387916|NCT00237744|564511283|FG000|Overall Study|Withdrawal by Subject|3|||
156387917|NCT00237744|564511284|FG001|Overall Study|Withdrawal by Subject|1|||
156387918|NCT00237744|564511285|FG002|Overall Study|Withdrawal by Subject|0|||
156387919|NCT00321854|564511288|FG000|Overall Study|Adverse Event|41|||
156387920|NCT00321854|564511289|FG001|Overall Study|Adverse Event|43|||
156387921|NCT00321854|564511288|FG000|Overall Study|Lack of Efficacy|9|||
156387922|NCT00321854|564511289|FG001|Overall Study|Lack of Efficacy|14|||
156387923|NCT00321854|564511288|FG000|Overall Study|Protocol Violation|6|||
156387924|NCT00321854|564511289|FG001|Overall Study|Protocol Violation|5|||
156387925|NCT00321854|564511288|FG000|Overall Study|Lost to Follow-up|0|||
156387926|NCT00321854|564511289|FG001|Overall Study|Lost to Follow-up|2|||
156387927|NCT00321854|564511288|FG000|Overall Study|Withdrawal by Subject|6|||
156387928|NCT00321854|564511289|FG001|Overall Study|Withdrawal by Subject|17|||
156387929|NCT00321854|564511288|FG000|Overall Study|Other|1|||
156387930|NCT00321854|564511289|FG001|Overall Study|Other|1|||
156387931|NCT03905655|564511290|FG000|Overall Study|Adverse Event|1|||
156387932|NCT03905655|564511291|FG001|Overall Study|Adverse Event|0|||
156387933|NCT03905655|564511292|FG002|Overall Study|Adverse Event|1|||
156387934|NCT03905655|564511293|FG003|Overall Study|Adverse Event|1|||
156387935|NCT02277106|564511294|FG000|Stage 2|Adverse Event|0|||
156387936|NCT02277106|564511295|FG001|Stage 2|Adverse Event|0|||
156547676|NCT01661140|565098380|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
156547677|NCT01661140|565098381|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
156547678|NCT01661140|565098379|FG000|Open-Label Period|Lost to Follow-up|2|||
156547679|NCT01661140|565098380|FG001|Open-Label Period|Lost to Follow-up|0|||
156547680|NCT01661140|565098381|FG002|Open-Label Period|Lost to Follow-up|0|||
156547681|NCT01661140|565098379|FG000|Double-Blind Period|Refused Treatment|0|||
156387937|NCT02277106|564511296|FG002|Stage 2|Adverse Event|1|||
156387938|NCT03117738|564511297|FG000|Overall Study|Withdrawal by Subject|3|||
156547682|NCT01661140|565098380|FG001|Double-Blind Period|Refused Treatment|0|||
156547683|NCT01661140|565098381|FG002|Double-Blind Period|Refused Treatment|1|||
156387939|NCT03117738|564511298|FG001|Overall Study|Withdrawal by Subject|1|||
156387940|NCT03117738|564511297|FG000|Overall Study|Lost to Follow-up|1|||
156387941|NCT03117738|564511298|FG001|Overall Study|Lost to Follow-up|4|||
156387942|NCT01669629|564511299|FG000|Period 1|protocol deviation|1|||
156387943|NCT01669629|564511300|FG001|Period 1|protocol deviation|2|||
156387944|NCT01292928|564511301|FG000|Overall Study|Death|8|||
156387945|NCT01292928|564511301|FG000|Overall Study|Withdrawal by Subject|8|||
156387946|NCT01292928|564511301|FG000|Overall Study|Lost to Follow-up|6|||
156387947|NCT01292928|564511301|FG000|Overall Study|Physician Decision|2|||
156387948|NCT01059565|564511302|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
156387949|NCT01059565|564511303|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
156387950|NCT01059565|564511302|FG000|24-Week Randomized Phase|Adverse Event|5|||
156387951|NCT01059565|564511303|FG001|24-Week Randomized Phase|Adverse Event|0|||
156387952|NCT01059565|564511302|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
156387953|NCT01059565|564511303|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
156387954|NCT01059565|564511302|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
156387955|NCT01059565|564511303|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
156387956|NCT01059565|564511302|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
156387957|NCT01059565|564511303|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
156387958|NCT01059565|564511302|FG000|24-Week Open-Label Phase|Adverse Event|2|||
156387959|NCT01059565|564511303|FG001|24-Week Open-Label Phase|Adverse Event|0|||
156387960|NCT01059565|564511302|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
156387961|NCT01059565|564511303|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
156387962|NCT01059565|564511302|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
156387963|NCT01059565|564511303|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
156387964|NCT01059565|564511302|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
156387965|NCT01059565|564511303|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
156387966|NCT01059565|564511302|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
156387967|NCT01059565|564511303|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
156387968|NCT01059565|564511302|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
156387969|NCT01059565|564511303|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
156387970|NCT03263429|564511304|FG000|Overall Study|Withdrawal by Subject|0|||
156387971|NCT03263429|564511305|FG001|Overall Study|Withdrawal by Subject|1|||
156387972|NCT03263429|564511306|FG002|Overall Study|Withdrawal by Subject|0|||
156387973|NCT03263429|564511304|FG000|Overall Study|Follow-Up Period Completed|0|||
156387974|NCT03263429|564511305|FG001|Overall Study|Follow-Up Period Completed|2|||
156387975|NCT03263429|564511306|FG002|Overall Study|Follow-Up Period Completed|0|||
156387976|NCT03263429|564511304|FG000|Overall Study|Death|3|||
156387977|NCT03263429|564511305|FG001|Overall Study|Death|5|||
156387978|NCT03263429|564511306|FG002|Overall Study|Death|16|||
156387979|NCT03263429|564511304|FG000|Overall Study|Participant unable to return|0|||
156387980|NCT03263429|564511305|FG001|Overall Study|Participant unable to return|0|||
156387981|NCT03263429|564511306|FG002|Overall Study|Participant unable to return|1|||
156387982|NCT03263429|564511304|FG000|Overall Study|Study Closed|0|||
156387983|NCT03263429|564511305|FG001|Overall Study|Study Closed|0|||
156387984|NCT03263429|564511306|FG002|Overall Study|Study Closed|1|||
156387985|NCT04530448|564511307|FG000|Overall Study|Physician Decision|3|||
156387986|NCT04530448|564511308|FG001|Overall Study|Physician Decision|0|||
156387987|NCT03579563|564511322|FG000|Overall Study|Lost to Follow-up|0|||
156387988|NCT03579563|564511323|FG001|Overall Study|Lost to Follow-up|0|||
156387989|NCT03579563|564511324|FG002|Overall Study|Lost to Follow-up|0|||
156387990|NCT03579563|564511325|FG003|Overall Study|Lost to Follow-up|0|||
156387991|NCT03579563|564511326|FG004|Overall Study|Lost to Follow-up|1|||
156387992|NCT03579563|564511327|FG005|Overall Study|Lost to Follow-up|0|||
156387993|NCT03579563|564511322|FG000|Overall Study|Lack of Efficacy|1|||
156387994|NCT03579563|564511323|FG001|Overall Study|Lack of Efficacy|1|||
156387995|NCT03579563|564511324|FG002|Overall Study|Lack of Efficacy|4|||
156387996|NCT03579563|564511325|FG003|Overall Study|Lack of Efficacy|1|||
156387997|NCT03579563|564511326|FG004|Overall Study|Lack of Efficacy|2|||
156507898|NCT02057575|564952986|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
156507899|NCT02057575|564952983|FG000|Overall Study|Protocol Violation|0|||
156507900|NCT02057575|564952984|FG001|Overall Study|Protocol Violation|1|||
156507901|NCT02057575|564952985|FG002|Overall Study|Protocol Violation|0|||
156507902|NCT02057575|564952986|FG003|Overall Study|Protocol Violation|0|||
156507903|NCT02979249|564952988|FG000|Overall Study|Lost to Follow-up|2|||
156507904|NCT02979249|564952988|FG000|Overall Study|Withdrawal by Subject|4|||
156507905|NCT01125046|564952989|FG000|First 6 Months of Treatment|Death|1|||
156507906|NCT01125046|564952989|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
156507907|NCT01125046|564952989|FG000|First 6 Months of Treatment|Non-compliance|1|||
156507908|NCT01125046|564952989|FG000|First 6 Months of Treatment|Surgery|1|||
156547684|NCT01661140|565098379|FG000|Double-Blind Period|Adverse Event|0|||
156387998|NCT03579563|564511327|FG005|Overall Study|Lack of Efficacy|3|||
156387999|NCT03579563|564511322|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
156388000|NCT03579563|564511323|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
156388001|NCT03579563|564511324|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
156388002|NCT03579563|564511325|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
156388003|NCT03579563|564511326|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
156388004|NCT03579563|564511327|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
156507909|NCT01125046|564952989|FG000|First 6 Months of Treatment|Progressive Disease|7|||
156547685|NCT01661140|565098380|FG001|Double-Blind Period|Adverse Event|16|||
156388005|NCT03579563|564511322|FG000|Overall Study|Time/distance concern|0|||
156388006|NCT03579563|564511323|FG001|Overall Study|Time/distance concern|0|||
156388007|NCT03579563|564511324|FG002|Overall Study|Time/distance concern|1|||
156388008|NCT03579563|564511325|FG003|Overall Study|Time/distance concern|0|||
156388009|NCT03579563|564511326|FG004|Overall Study|Time/distance concern|0|||
156388010|NCT03579563|564511327|FG005|Overall Study|Time/distance concern|1|||
156388011|NCT03579563|564511322|FG000|Overall Study|COVID shutdown|2|||
156388012|NCT03579563|564511323|FG001|Overall Study|COVID shutdown|3|||
156388013|NCT03579563|564511324|FG002|Overall Study|COVID shutdown|4|||
156388014|NCT03579563|564511325|FG003|Overall Study|COVID shutdown|3|||
156388015|NCT03579563|564511326|FG004|Overall Study|COVID shutdown|1|||
156388016|NCT03579563|564511327|FG005|Overall Study|COVID shutdown|2|||
156388017|NCT03579563|564511322|FG000|Overall Study|Protocol administration error|1|||
156388018|NCT03579563|564511323|FG001|Overall Study|Protocol administration error|0|||
156388019|NCT03579563|564511324|FG002|Overall Study|Protocol administration error|1|||
156388020|NCT03579563|564511325|FG003|Overall Study|Protocol administration error|0|||
156388021|NCT03579563|564511326|FG004|Overall Study|Protocol administration error|1|||
156388022|NCT03579563|564511327|FG005|Overall Study|Protocol administration error|5|||
156388023|NCT01715805|564511328|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
156388024|NCT01715805|564511329|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
156388025|NCT01715805|564511330|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
156388026|NCT01715805|564511331|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
156388027|NCT01715805|564511328|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
156388028|NCT01715805|564511329|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
156388029|NCT01715805|564511330|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
156388030|NCT01715805|564511331|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
156388031|NCT01715805|564511328|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
156388032|NCT01715805|564511329|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
156388033|NCT01715805|564511330|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
156388034|NCT01715805|564511331|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
156388035|NCT01715805|564511328|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
156388036|NCT01715805|564511329|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
156388037|NCT01715805|564511330|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
156388038|NCT01715805|564511331|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
156388039|NCT01715805|564511328|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
156388040|NCT01715805|564511329|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
156388041|NCT01715805|564511330|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
156388042|NCT01715805|564511331|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
156388043|NCT01715805|564511328|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
156388044|NCT01715805|564511329|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
156388045|NCT01715805|564511330|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
156388046|NCT01715805|564511331|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
156388047|NCT01715805|564511328|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
156388048|NCT01715805|564511329|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
156388049|NCT01715805|564511330|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
156388050|NCT01715805|564511331|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
156388051|NCT01715805|564511328|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
156388052|NCT01715805|564511329|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
156388053|NCT01715805|564511330|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
156388054|NCT01715805|564511331|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
156388055|NCT01715805|564511328|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
156388056|NCT01715805|564511329|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
156388057|NCT01715805|564511330|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
156388058|NCT01715805|564511331|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
156388059|NCT01715805|564511328|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
156388060|NCT01715805|564511329|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
156388061|NCT01715805|564511330|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
156388062|NCT01715805|564511331|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
156388063|NCT01715805|564511328|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
156388064|NCT01715805|564511329|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
156388065|NCT01715805|564511330|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
156388066|NCT01715805|564511331|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
156388067|NCT01715805|564511328|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
156388068|NCT01715805|564511329|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
156507910|NCT01125046|564952989|FG000|First 6 Months of Treatment|Adverse Event|2|||
156507911|NCT01125046|564952989|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
156507912|NCT01125046|564952989|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
156507913|NCT01125046|564952989|FG000|Follow-up/Data Cut Off Point|Death|29|||
156388069|NCT01715805|564511330|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
156388070|NCT01715805|564511331|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
156388071|NCT01715805|564511328|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
156388072|NCT01715805|564511329|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
156388073|NCT01715805|564511330|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
156388074|NCT01715805|564511331|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
156388075|NCT01715805|564511328|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
156388076|NCT01715805|564511329|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
156388077|NCT01715805|564511330|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
156388078|NCT01715805|564511331|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
156388079|NCT02219932|564511334|FG000|Overall Study|Other|5|||
156388080|NCT02219932|564511335|FG001|Overall Study|Other|11|||
156388081|NCT02219932|564511334|FG000|Overall Study|Death|1|||
156388082|NCT02219932|564511335|FG001|Overall Study|Death|1|||
156388083|NCT02219932|564511334|FG000|Overall Study|Investigator Decision|0|||
156388084|NCT02219932|564511335|FG001|Overall Study|Investigator Decision|1|||
156388085|NCT02219932|564511334|FG000|Overall Study|Consent Withdrawn|11|||
156388086|NCT02219932|564511335|FG001|Overall Study|Consent Withdrawn|7|||
156388087|NCT02219932|564511334|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
156388088|NCT02219932|564511335|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
156388089|NCT02219932|564511334|FG000|Overall Study|Protocol Violation|10|||
156388090|NCT02219932|564511335|FG001|Overall Study|Protocol Violation|6|||
156388091|NCT02219932|564511334|FG000|Overall Study|Pregnancy|1|||
156388092|NCT02219932|564511335|FG001|Overall Study|Pregnancy|0|||
156388093|NCT02219932|564511334|FG000|Overall Study|Lost to Follow-up|4|||
156388094|NCT02219932|564511335|FG001|Overall Study|Lost to Follow-up|2|||
156388095|NCT02219932|564511334|FG000|Overall Study|Adverse Event|23|||
156388096|NCT02219932|564511335|FG001|Overall Study|Adverse Event|21|||
156388097|NCT00511004|564511336|FG000|Overall Study|Lost to Follow-up|0|||
156388098|NCT00511004|564511337|FG001|Overall Study|Lost to Follow-up|0|||
156388099|NCT00511004|564511338|FG002|Overall Study|Lost to Follow-up|4|||
156388100|NCT00990652|564511339|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
156388101|NCT00990652|564511339|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
156388102|NCT05177770|564511340|FG000|Overall Study|Death|4|||
156388103|NCT05177770|564511340|FG000|Overall Study|Withdrawal by Subject|1|||
156388104|NCT05177770|564511340|FG000|Overall Study|Adverse Event prior to dosing|1|||
156388105|NCT01672801|564511345|FG000|Overall Study|Screen Failure|0|||
156388106|NCT01672801|564511346|FG001|Overall Study|Screen Failure|1|||
156388107|NCT02384954|564511354|FG000|Phase 1|Progressive Disease|2|||
156388108|NCT02384954|564511355|FG001|Phase 1|Progressive Disease|0|||
156388109|NCT02384954|564511356|FG002|Phase 1|Progressive Disease|1|||
156388110|NCT02384954|564511357|FG003|Phase 1|Progressive Disease|1|||
156388111|NCT02384954|564511358|FG004|Phase 1|Progressive Disease|0|||
156388112|NCT02384954|564511359|FG005|Phase 1|Progressive Disease|0|||
156388113|NCT02384954|564511360|FG006|Phase 1|Progressive Disease|0|||
156388114|NCT02384954|564511361|FG007|Phase 1|Progressive Disease|0|||
156388115|NCT02384954|564511362|FG008|Phase 1|Progressive Disease|0|||
156388116|NCT02384954|564511354|FG000|Phase 1|Adverse Event|0|||
156388117|NCT02384954|564511355|FG001|Phase 1|Adverse Event|0|||
156388118|NCT02384954|564511356|FG002|Phase 1|Adverse Event|1|||
156388119|NCT02384954|564511357|FG003|Phase 1|Adverse Event|0|||
156388120|NCT02384954|564511358|FG004|Phase 1|Adverse Event|0|||
156388121|NCT02384954|564511359|FG005|Phase 1|Adverse Event|0|||
156507914|NCT01125046|564952989|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
156507915|NCT01685229|564952990|FG000|Overall Study|Subjects missing Study Exit form|3|||
156507916|NCT01685229|564952991|FG001|Overall Study|Subjects missing Study Exit form|1|||
156507917|NCT01685229|564952990|FG000|Overall Study|Lost to Follow-up|16|||
156507918|NCT01685229|564952991|FG001|Overall Study|Lost to Follow-up|10|||
156507919|NCT01685229|564952990|FG000|Overall Study|Withdrawal by Subject|6|||
156388122|NCT02384954|564511360|FG006|Phase 1|Adverse Event|0|||
156388123|NCT02384954|564511361|FG007|Phase 1|Adverse Event|0|||
156388124|NCT02384954|564511362|FG008|Phase 1|Adverse Event|0|||
156388125|NCT02384954|564511354|FG000|Phase 2|Progressive Disease|0|||
156388126|NCT02384954|564511355|FG001|Phase 2|Progressive Disease|0|||
156388127|NCT02384954|564511356|FG002|Phase 2|Progressive Disease|0|||
156388128|NCT02384954|564511357|FG003|Phase 2|Progressive Disease|0|||
156507920|NCT01685229|564952991|FG001|Overall Study|Withdrawal by Subject|5|||
156507921|NCT01685229|564952990|FG000|Overall Study|Death|1|||
156388129|NCT02384954|564511358|FG004|Phase 2|Progressive Disease|0|||
156388130|NCT02384954|564511359|FG005|Phase 2|Progressive Disease|0|||
156388131|NCT02384954|564511360|FG006|Phase 2|Progressive Disease|0|||
156388132|NCT02384954|564511361|FG007|Phase 2|Progressive Disease|1|||
156388133|NCT02384954|564511362|FG008|Phase 2|Progressive Disease|2|||
156388134|NCT02384954|564511354|FG000|Phase 2|Adverse Event|0|||
156507922|NCT01685229|564952991|FG001|Overall Study|Death|0|||
156388135|NCT02384954|564511355|FG001|Phase 2|Adverse Event|0|||
156388136|NCT02384954|564511356|FG002|Phase 2|Adverse Event|0|||
156388137|NCT02384954|564511357|FG003|Phase 2|Adverse Event|0|||
156388138|NCT02384954|564511358|FG004|Phase 2|Adverse Event|0|||
156388139|NCT02384954|564511359|FG005|Phase 2|Adverse Event|0|||
156388140|NCT02384954|564511360|FG006|Phase 2|Adverse Event|0|||
156388141|NCT02384954|564511361|FG007|Phase 2|Adverse Event|1|||
156388142|NCT02384954|564511362|FG008|Phase 2|Adverse Event|1|||
156388143|NCT02384954|564511354|FG000|Phase 2|Failure to meet continuation criteria|0|||
156388144|NCT02384954|564511355|FG001|Phase 2|Failure to meet continuation criteria|0|||
156388145|NCT02384954|564511356|FG002|Phase 2|Failure to meet continuation criteria|0|||
156388146|NCT02384954|564511357|FG003|Phase 2|Failure to meet continuation criteria|0|||
156388147|NCT02384954|564511358|FG004|Phase 2|Failure to meet continuation criteria|0|||
156388148|NCT02384954|564511359|FG005|Phase 2|Failure to meet continuation criteria|0|||
156388149|NCT02384954|564511360|FG006|Phase 2|Failure to meet continuation criteria|0|||
156388150|NCT02384954|564511361|FG007|Phase 2|Failure to meet continuation criteria|1|||
156388151|NCT02384954|564511362|FG008|Phase 2|Failure to meet continuation criteria|0|||
156388152|NCT02372396|564511363|FG000|Overall Study|Lost to Follow-up|7|||
156388153|NCT02372396|564511364|FG001|Overall Study|Lost to Follow-up|9|||
156388154|NCT00214136|564511365|FG000|Overall Study|Death|5|||
156388155|NCT04313634|564511366|FG000|Overall Study|Adverse Event|2|||
156388156|NCT04313634|564511367|FG001|Overall Study|Adverse Event|2|||
156388157|NCT04313634|564511368|FG002|Overall Study|Adverse Event|0|||
156388158|NCT04313634|564511366|FG000|Overall Study|Withdrawal by Subject|1|||
156388159|NCT04313634|564511367|FG001|Overall Study|Withdrawal by Subject|0|||
156388160|NCT04313634|564511368|FG002|Overall Study|Withdrawal by Subject|1|||
156388161|NCT04313634|564511366|FG000|Overall Study|Protocol Violation|0|||
156388162|NCT04313634|564511367|FG001|Overall Study|Protocol Violation|0|||
156388163|NCT04313634|564511368|FG002|Overall Study|Protocol Violation|1|||
156388164|NCT01226745|564511369|FG000|Overall Study|Did not complete schedule of assessments|8|||
156388165|NCT01226745|564511370|FG001|Overall Study|Did not complete schedule of assessments|3|||
156388166|NCT01226745|564511371|FG002|Overall Study|Did not complete schedule of assessments|6|||
156388167|NCT01226745|564511372|FG003|Overall Study|Did not complete schedule of assessments|0|||
156388168|NCT01226745|564511373|FG004|Overall Study|Did not complete schedule of assessments|0|||
156388169|NCT01226745|564511374|FG005|Overall Study|Did not complete schedule of assessments|1|||
156388170|NCT01226745|564511369|FG000|Overall Study|Lost to Follow-up|2|||
156388171|NCT01226745|564511370|FG001|Overall Study|Lost to Follow-up|6|||
156388172|NCT01226745|564511371|FG002|Overall Study|Lost to Follow-up|6|||
156388173|NCT01226745|564511372|FG003|Overall Study|Lost to Follow-up|1|||
156388174|NCT01226745|564511373|FG004|Overall Study|Lost to Follow-up|1|||
156388175|NCT01226745|564511374|FG005|Overall Study|Lost to Follow-up|2|||
156388176|NCT01226745|564511369|FG000|Overall Study|Death|1|||
156388177|NCT01226745|564511370|FG001|Overall Study|Death|0|||
156388178|NCT01226745|564511371|FG002|Overall Study|Death|0|||
156388179|NCT01226745|564511372|FG003|Overall Study|Death|0|||
156388180|NCT01226745|564511373|FG004|Overall Study|Death|0|||
156388181|NCT01226745|564511374|FG005|Overall Study|Death|1|||
156388182|NCT01226745|564511369|FG000|Overall Study|Other|6|||
156388183|NCT01226745|564511370|FG001|Overall Study|Other|7|||
156388184|NCT01226745|564511371|FG002|Overall Study|Other|8|||
156388185|NCT01226745|564511372|FG003|Overall Study|Other|4|||
156388186|NCT01226745|564511373|FG004|Overall Study|Other|3|||
156388187|NCT01226745|564511374|FG005|Overall Study|Other|1|||
156388188|NCT02105948|564511375|FG000|Overall Study|Adverse Event|10|||
156388189|NCT02105948|564511376|FG001|Overall Study|Adverse Event|7|||
156388190|NCT02105948|564511377|FG002|Overall Study|Adverse Event|11|||
156388191|NCT02105948|564511378|FG003|Overall Study|Adverse Event|11|||
156388192|NCT02105948|564511375|FG000|Overall Study|Lack of Efficacy|0|||
156388193|NCT02105948|564511376|FG001|Overall Study|Lack of Efficacy|1|||
156388194|NCT02105948|564511377|FG002|Overall Study|Lack of Efficacy|3|||
156388195|NCT02105948|564511378|FG003|Overall Study|Lack of Efficacy|2|||
156388196|NCT02105948|564511375|FG000|Overall Study|Lost to Follow-up|0|||
156388197|NCT02105948|564511376|FG001|Overall Study|Lost to Follow-up|0|||
156547686|NCT01661140|565098381|FG002|Double-Blind Period|Adverse Event|18|||
156547687|NCT01661140|565098379|FG000|Double-Blind Period|Protocol Violation|0|||
156388198|NCT02105948|564511377|FG002|Overall Study|Lost to Follow-up|2|||
156388199|NCT02105948|564511378|FG003|Overall Study|Lost to Follow-up|1|||
156388200|NCT02105948|564511375|FG000|Overall Study|Physician Decision|2|||
156388201|NCT02105948|564511376|FG001|Overall Study|Physician Decision|2|||
156388202|NCT02105948|564511377|FG002|Overall Study|Physician Decision|2|||
156388203|NCT02105948|564511378|FG003|Overall Study|Physician Decision|2|||
156388204|NCT02105948|564511375|FG000|Overall Study|Withdrawal by Subject|15|||
156388205|NCT02105948|564511376|FG001|Overall Study|Withdrawal by Subject|10|||
156388206|NCT02105948|564511377|FG002|Overall Study|Withdrawal by Subject|10|||
156388207|NCT02105948|564511378|FG003|Overall Study|Withdrawal by Subject|11|||
156388208|NCT01581281|564511379|FG000|Overall Study|Early Study Closure|15|||
156388209|NCT01581281|564511380|FG001|Overall Study|Early Study Closure|6|||
156388210|NCT01581281|564511381|FG002|Overall Study|Early Study Closure|12|||
156388211|NCT02187991|564511383|FG000|Overall Study|Adverse Event|13|||
156388212|NCT02187991|564511384|FG001|Overall Study|Adverse Event|14|||
156388213|NCT02187991|564511385|FG002|Overall Study|Adverse Event|3|||
156388214|NCT02187991|564511386|FG003|Overall Study|Adverse Event|2|||
156388215|NCT02187991|564511383|FG000|Overall Study|Withdrawal by Subject|9|||
156388216|NCT02187991|564511384|FG001|Overall Study|Withdrawal by Subject|6|||
156388217|NCT02187991|564511385|FG002|Overall Study|Withdrawal by Subject|3|||
156388218|NCT02187991|564511386|FG003|Overall Study|Withdrawal by Subject|2|||
156388219|NCT02187991|564511383|FG000|Overall Study|Physician Decision|4|||
156388220|NCT02187991|564511384|FG001|Overall Study|Physician Decision|4|||
156388221|NCT02187991|564511385|FG002|Overall Study|Physician Decision|0|||
156388222|NCT02187991|564511386|FG003|Overall Study|Physician Decision|2|||
156388223|NCT02187991|564511383|FG000|Overall Study|Other, unrelated complication|7|||
156388224|NCT02187991|564511384|FG001|Overall Study|Other, unrelated complication|1|||
156388225|NCT02187991|564511385|FG002|Overall Study|Other, unrelated complication|1|||
156388226|NCT02187991|564511386|FG003|Overall Study|Other, unrelated complication|2|||
156388227|NCT02187991|564511383|FG000|Overall Study|Death|1|||
156388228|NCT02187991|564511384|FG001|Overall Study|Death|3|||
156388229|NCT02187991|564511385|FG002|Overall Study|Death|0|||
156388230|NCT02187991|564511386|FG003|Overall Study|Death|0|||
156388231|NCT04072159|564511392|FG000|Overall Study|Lost to Follow-up|6|||
156388232|NCT04072159|564511393|FG001|Overall Study|Lost to Follow-up|6|||
156388233|NCT04072159|564511392|FG000|Overall Study|Withdrawal by Subject|2|||
156388234|NCT04072159|564511393|FG001|Overall Study|Withdrawal by Subject|0|||
156388235|NCT00522275|564511394|FG000|Overall Study|Adverse Event|35|||
156388236|NCT00522275|564511394|FG000|Overall Study|Lack of Efficacy|80|||
156388237|NCT00522275|564511394|FG000|Overall Study|Subject withdrew consent|16|||
156388238|NCT00522275|564511394|FG000|Overall Study|Protocol deviation|1|||
156388239|NCT00522275|564511394|FG000|Overall Study|Unsatisfactory compliance|11|||
156388240|NCT00522275|564511394|FG000|Overall Study|Lost to Follow-up|8|||
156388241|NCT00522275|564511394|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
156388242|NCT00522275|564511394|FG000|Overall Study|Other: Subject is pregnant|2|||
156388243|NCT00522275|564511394|FG000|Overall Study|Other: Subject relocated|2|||
156388244|NCT00522275|564511394|FG000|Overall Study|Other: Subject arrested|1|||
156388245|NCT00522275|564511394|FG000|Overall Study|Other: Site / clinic closed|4|||
156388246|NCT00522275|564511394|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
156388247|NCT00522275|564511394|FG000|Overall Study|Other: Sponsor request|2|||
156388248|NCT00522275|564511394|FG000|Overall Study|Other: Subject ran out of medication|1|||
156388249|NCT00522275|564511394|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
156388250|NCT01196975|564511395|FG000|Overall Study|Adverse Event|2|||
156388251|NCT01196975|564511396|FG001|Overall Study|Adverse Event|2|||
156388252|NCT01196975|564511397|FG002|Overall Study|Adverse Event|0|||
156388253|NCT01196975|564511398|FG003|Overall Study|Adverse Event|0|||
156388254|NCT01196975|564511399|FG004|Overall Study|Adverse Event|2|||
156388255|NCT01196975|564511395|FG000|Overall Study|Withdrawal by Subject|2|||
156388256|NCT01196975|564511396|FG001|Overall Study|Withdrawal by Subject|1|||
156388257|NCT01196975|564511397|FG002|Overall Study|Withdrawal by Subject|0|||
156388258|NCT01196975|564511398|FG003|Overall Study|Withdrawal by Subject|1|||
156388259|NCT01196975|564511399|FG004|Overall Study|Withdrawal by Subject|0|||
156388260|NCT01196975|564511395|FG000|Overall Study|Lost to Follow-up|11|||
156388261|NCT01196975|564511396|FG001|Overall Study|Lost to Follow-up|6|||
156388262|NCT01196975|564511397|FG002|Overall Study|Lost to Follow-up|5|||
156388263|NCT01196975|564511398|FG003|Overall Study|Lost to Follow-up|5|||
156388264|NCT01196975|564511399|FG004|Overall Study|Lost to Follow-up|11|||
156388265|NCT01462344|564511404|FG000|Overall Study|Withdrawal by Subject|245|||
156388266|NCT01462344|564511405|FG001|Overall Study|Withdrawal by Subject|226|||
156388267|NCT01462344|564511404|FG000|Overall Study|Adverse Event|24|||
156388268|NCT01462344|564511405|FG001|Overall Study|Adverse Event|23|||
156388269|NCT01462344|564511404|FG000|Overall Study|Asthma Exacerbation|34|||
156547688|NCT01661140|565098380|FG001|Double-Blind Period|Protocol Violation|2|||
156547689|NCT01661140|565098381|FG002|Double-Blind Period|Protocol Violation|3|||
156547690|NCT01661140|565098379|FG000|Double-Blind Period|Withdrawal by Subject|0|||
156547691|NCT01661140|565098380|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156547692|NCT01661140|565098381|FG002|Double-Blind Period|Withdrawal by Subject|3|||
156388270|NCT01462344|564511405|FG001|Overall Study|Asthma Exacerbation|35|||
156388271|NCT01462344|564511404|FG000|Overall Study|Lack of Efficacy|5|||
156388272|NCT01462344|564511405|FG001|Overall Study|Lack of Efficacy|6|||
156388273|NCT01462344|564511404|FG000|Overall Study|Protocol Violation|68|||
156388274|NCT01462344|564511405|FG001|Overall Study|Protocol Violation|53|||
156388275|NCT01462344|564511404|FG000|Overall Study|Lost to Follow-up|7|||
156388276|NCT01462344|564511405|FG001|Overall Study|Lost to Follow-up|7|||
156388277|NCT03086447|564511408|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156388278|NCT03086447|564511409|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
156388279|NCT03086447|564511408|FG000|Overall Study|Lost Lens|2|||
156388280|NCT03086447|564511409|FG001|Overall Study|Lost Lens|5|||
156388281|NCT03086447|564511408|FG000|Overall Study|Product quality complaint|0|||
156388282|NCT03086447|564511409|FG001|Overall Study|Product quality complaint|1|||
156388283|NCT03086447|564511408|FG000|Overall Study|Lens Damage|1|||
156388284|NCT03086447|564511409|FG001|Overall Study|Lens Damage|6|||
156388285|NCT03086447|564511408|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
156388286|NCT03086447|564511409|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
156388287|NCT03086447|564511408|FG000|Overall Study|Test Article No Longer Available|1|||
156388288|NCT03086447|564511409|FG001|Overall Study|Test Article No Longer Available|0|||
156388289|NCT03086447|564511408|FG000|Overall Study|Protocol Violation|2|||
156388290|NCT03086447|564511409|FG001|Overall Study|Protocol Violation|4|||
156388291|NCT03086447|564511408|FG000|Overall Study|Lost to Follow-up|0|||
156388292|NCT03086447|564511409|FG001|Overall Study|Lost to Follow-up|1|||
156388293|NCT03086447|564511408|FG000|Overall Study|Adverse Event|3|||
156388294|NCT03086447|564511409|FG001|Overall Study|Adverse Event|0|||
156388295|NCT03086447|564511408|FG000|Overall Study|Lens Discomfort|2|||
156388296|NCT03086447|564511409|FG001|Overall Study|Lens Discomfort|1|||
156388297|NCT00253864|564511411|FG000|Overall Study|Lost to Follow-up|5|||
156388298|NCT00253864|564511412|FG001|Overall Study|Lost to Follow-up|8|||
156388299|NCT01128413|564511413|FG000|Overall Study|Withdrawal by Subject|1|||
156388300|NCT01128413|564511414|FG001|Overall Study|Withdrawal by Subject|0|||
156388301|NCT01128413|564511413|FG000|Overall Study|NICOM Monitor Problems|2|||
156388302|NCT01128413|564511414|FG001|Overall Study|NICOM Monitor Problems|1|||
156388303|NCT01128413|564511413|FG000|Overall Study|Pt made DNR|1|||
156388304|NCT01128413|564511414|FG001|Overall Study|Pt made DNR|0|||
156388305|NCT00045110|564511415|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
156388306|NCT00045110|564511416|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
156388307|NCT00045110|564511417|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
156388308|NCT00045110|564511415|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
156388309|NCT00045110|564511416|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
156388310|NCT00045110|564511417|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
156388311|NCT00045110|564511415|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
156388312|NCT00045110|564511416|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
156388313|NCT00045110|564511417|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
156388314|NCT03662750|564511418|FG000|Overall Study|Withdrawal by Subject|1|||
156388315|NCT01588184|564512920|FG000|Overall Study|Death|1|||
156388316|NCT01588184|564512921|FG001|Overall Study|Death|0|||
156388317|NCT01588184|564512922|FG002|Overall Study|Death|0|||
156388318|NCT01588184|564512923|FG003|Overall Study|Death|1|||
156388319|NCT01588184|564512924|FG004|Overall Study|Death|1|||
156388320|NCT01588184|564512925|FG005|Overall Study|Death|1|||
156388321|NCT01588184|564512920|FG000|Overall Study|Withdrawal by Subject|2|||
156388322|NCT01588184|564512921|FG001|Overall Study|Withdrawal by Subject|4|||
156388323|NCT01588184|564512922|FG002|Overall Study|Withdrawal by Subject|0|||
156388324|NCT01588184|564512923|FG003|Overall Study|Withdrawal by Subject|1|||
156388325|NCT01588184|564512924|FG004|Overall Study|Withdrawal by Subject|0|||
156388326|NCT01588184|564512925|FG005|Overall Study|Withdrawal by Subject|0|||
156388327|NCT01588184|564512920|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
156388328|NCT01588184|564512921|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
156388329|NCT01588184|564512922|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
156388330|NCT01588184|564512923|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
156388331|NCT01588184|564512924|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
156388332|NCT01588184|564512925|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
156388333|NCT01588184|564512920|FG000|Overall Study|multiple reasons|0|||
156388334|NCT01588184|564512921|FG001|Overall Study|multiple reasons|3|||
156388335|NCT01588184|564512922|FG002|Overall Study|multiple reasons|0|||
156388336|NCT01588184|564512923|FG003|Overall Study|multiple reasons|1|||
156388337|NCT01588184|564512924|FG004|Overall Study|multiple reasons|0|||
156388338|NCT01588184|564512925|FG005|Overall Study|multiple reasons|0|||
156388339|NCT00907153|564512931|FG000|Overall Study|Lost to Follow-up|1|||
156388340|NCT00907153|564512932|FG001|Overall Study|Lost to Follow-up|1|||
156388341|NCT00907153|564512931|FG000|Overall Study|Withdrawal by Subject|1|||
156388342|NCT00907153|564512932|FG001|Overall Study|Withdrawal by Subject|3|||
156388343|NCT02338154|564512940|FG000|Overall Study|Death|46|||
156388344|NCT02338154|564512940|FG000|Overall Study|Valve Implant Failure|17|||
156388345|NCT02338154|564512940|FG000|Overall Study|Valve Explant|11|||
156388346|NCT02338154|564512940|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
156388347|NCT02338154|564512940|FG000|Overall Study|Lost to Follow-up|8|||
156388348|NCT02338154|564512940|FG000|Overall Study|Other Reason|3|||
156388349|NCT02338154|564512940|FG000|Overall Study|Patients Without Exit Form|47|||
156388350|NCT02338154|564512940|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
156388351|NCT03393000|564512943|FG000|Overall Study|Death|11|||
156507923|NCT03842228|564952994|FG000|Overall Study|Adverse Event|1|||
156507924|NCT03842228|564952995|FG001|Overall Study|Adverse Event|1|||
156507925|NCT03842228|564952996|FG002|Overall Study|Adverse Event|1|||
156507926|NCT03842228|564952997|FG003|Overall Study|Adverse Event|0|||
156388352|NCT03393000|564512943|FG000|Overall Study|Withdrawal by Subject|2|||
156388353|NCT03393000|564512943|FG000|Overall Study|Physician Decision|1|||
156388354|NCT01773070|564512944|FG000|Overall Study|Withdrawal by Subject|24|||
156388355|NCT01773070|564512944|FG000|Overall Study|Lost to Follow-up|39|||
156388356|NCT01773070|564512944|FG000|Overall Study|Other|15|||
156388357|NCT01773070|564512944|FG000|Overall Study|Death (unrelated to study procedures)|3|||
156388358|NCT01559844|564512945|FG000|Overall Study|Consent Withdrawn|7|||
156388359|NCT01559844|564512945|FG000|Overall Study|Death|5|||
156388360|NCT01559844|564512945|FG000|Overall Study|Efficacy Failure|10|||
156388361|NCT01559844|564512945|FG000|Overall Study|No Longer A Transplant Candidate|3|||
156388362|NCT02181803|564512946|FG000|Overall Study|Withdrawal by Subject|0|||
156388363|NCT02181803|564512947|FG001|Overall Study|Withdrawal by Subject|2|||
156388364|NCT02181803|564512948|FG002|Overall Study|Withdrawal by Subject|0|||
156388365|NCT02181803|564512949|FG003|Overall Study|Withdrawal by Subject|0|||
156388366|NCT02181803|564512950|FG004|Overall Study|Withdrawal by Subject|0|||
156388367|NCT02181803|564512951|FG005|Overall Study|Withdrawal by Subject|0|||
156388368|NCT02181803|564512952|FG006|Overall Study|Withdrawal by Subject|0|||
156388369|NCT02181803|564512953|FG007|Overall Study|Withdrawal by Subject|0|||
156388370|NCT02181803|564512954|FG008|Overall Study|Withdrawal by Subject|0|||
156388371|NCT02181803|564512946|FG000|Overall Study|Physician Decision|0|||
156388372|NCT02181803|564512947|FG001|Overall Study|Physician Decision|0|||
156388373|NCT02181803|564512948|FG002|Overall Study|Physician Decision|0|||
156388374|NCT02181803|564512949|FG003|Overall Study|Physician Decision|1|||
156388375|NCT02181803|564512950|FG004|Overall Study|Physician Decision|0|||
156388376|NCT02181803|564512951|FG005|Overall Study|Physician Decision|0|||
156388377|NCT02181803|564512952|FG006|Overall Study|Physician Decision|0|||
156388378|NCT02181803|564512953|FG007|Overall Study|Physician Decision|1|||
156388379|NCT02181803|564512954|FG008|Overall Study|Physician Decision|0|||
156388380|NCT02181803|564512946|FG000|Overall Study|Adverse Event|0|||
156388381|NCT02181803|564512947|FG001|Overall Study|Adverse Event|2|||
156388382|NCT02181803|564512948|FG002|Overall Study|Adverse Event|0|||
156388383|NCT02181803|564512949|FG003|Overall Study|Adverse Event|1|||
156388384|NCT02181803|564512950|FG004|Overall Study|Adverse Event|0|||
156388385|NCT02181803|564512951|FG005|Overall Study|Adverse Event|0|||
156388386|NCT02181803|564512952|FG006|Overall Study|Adverse Event|1|||
156388387|NCT02181803|564512953|FG007|Overall Study|Adverse Event|0|||
156388388|NCT02181803|564512954|FG008|Overall Study|Adverse Event|0|||
156388389|NCT00951041|564512956|FG000|Overall Study|Withdrawal by Subject|1|||
156388390|NCT00951041|564512957|FG001|Overall Study|Withdrawal by Subject|1|||
156388391|NCT00951041|564512956|FG000|Overall Study|Lost to Follow-up|1|||
156388392|NCT00951041|564512957|FG001|Overall Study|Lost to Follow-up|0|||
156388393|NCT00951041|564512956|FG000|Overall Study|Other|3|||
156388394|NCT00951041|564512957|FG001|Overall Study|Other|0|||
156388395|NCT02388724|564512961|FG000|Overall Study|Reason not Specified|0|||
156388396|NCT02388724|564512962|FG001|Overall Study|Reason not Specified|1|||
156388397|NCT02388724|564512961|FG000|Overall Study|Major Protocol Deviation|3|||
156388398|NCT02388724|564512962|FG001|Overall Study|Major Protocol Deviation|3|||
156388399|NCT02388724|564512961|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
156388400|NCT02388724|564512962|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
156388401|NCT02388724|564512961|FG000|Overall Study|Voluntary Withdrawal|6|||
156388402|NCT02388724|564512962|FG001|Overall Study|Voluntary Withdrawal|5|||
156547693|NCT01661140|565098379|FG000|Double-Blind Period|Investigator's Decision|0|||
156547694|NCT01661140|565098380|FG001|Double-Blind Period|Investigator's Decision|1|||
156547695|NCT01661140|565098381|FG002|Double-Blind Period|Investigator's Decision|2|||
156547696|NCT01661140|565098379|FG000|Double-Blind Period|Sponsor Termination|0|||
156547697|NCT01661140|565098380|FG001|Double-Blind Period|Sponsor Termination|14|||
156547698|NCT01661140|565098381|FG002|Double-Blind Period|Sponsor Termination|17|||
156547699|NCT01661140|565098379|FG000|Double-Blind Period|Administrative/Other|0|||
156547700|NCT01661140|565098380|FG001|Double-Blind Period|Administrative/Other|7|||
156547701|NCT01661140|565098381|FG002|Double-Blind Period|Administrative/Other|6|||
156547702|NCT00781456|565098382|FG000|Overall Study|Adverse Event|3|||
156547703|NCT00781456|565098383|FG001|Overall Study|Adverse Event|3|||
156547704|NCT00781456|565098382|FG000|Overall Study|Withdrawal by Subject|3|||
156547705|NCT00781456|565098383|FG001|Overall Study|Withdrawal by Subject|5|||
156547706|NCT00781456|565098382|FG000|Overall Study|Protocol Violation|4|||
156547707|NCT00781456|565098383|FG001|Overall Study|Protocol Violation|1|||
156547708|NCT00781456|565098382|FG000|Overall Study|Noncompliance With Protocol|1|||
156547709|NCT00781456|565098383|FG001|Overall Study|Noncompliance With Protocol|1|||
156547710|NCT00781456|565098382|FG000|Overall Study|Lost to Follow-up|10|||
156388403|NCT02388724|564512961|FG000|Overall Study|Randomized but not Treated|0|||
156388404|NCT02388724|564512962|FG001|Overall Study|Randomized but not Treated|2|||
156388405|NCT01217073|564512963|FG000|Base Period|Adverse Event|1|||
156388406|NCT01217073|564512964|FG001|Base Period|Adverse Event|0|||
156388407|NCT01217073|564512965|FG002|Base Period|Adverse Event|1|||
156388408|NCT01217073|564512966|FG003|Base Period|Adverse Event|0|||
156388409|NCT01217073|564512967|FG004|Base Period|Adverse Event|4|||
156388410|NCT01217073|564512968|FG005|Base Period|Adverse Event|1|||
156388411|NCT01217073|564512969|FG006|Base Period|Adverse Event|0|||
156547711|NCT00781456|565098383|FG001|Overall Study|Lost to Follow-up|5|||
156388412|NCT01217073|564512970|FG007|Base Period|Adverse Event|0|||
156547712|NCT00781456|565098382|FG000|Overall Study|Other Reason, Unknown|0|||
156547713|NCT00781456|565098383|FG001|Overall Study|Other Reason, Unknown|1|||
156388413|NCT01217073|564512963|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
156388414|NCT01217073|564512964|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156388415|NCT01217073|564512965|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156388416|NCT01217073|564512966|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156388417|NCT01217073|564512967|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156388418|NCT01217073|564512968|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156388419|NCT01217073|564512969|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156388420|NCT01217073|564512970|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156388421|NCT01217073|564512963|FG000|Base Period|Excluded medication|0|||
156388422|NCT01217073|564512964|FG001|Base Period|Excluded medication|0|||
156388423|NCT01217073|564512965|FG002|Base Period|Excluded medication|0|||
156388424|NCT01217073|564512966|FG003|Base Period|Excluded medication|0|||
156388425|NCT01217073|564512967|FG004|Base Period|Excluded medication|1|||
156388426|NCT01217073|564512968|FG005|Base Period|Excluded medication|0|||
156388427|NCT01217073|564512969|FG006|Base Period|Excluded medication|0|||
156388428|NCT01217073|564512970|FG007|Base Period|Excluded medication|0|||
156388429|NCT01217073|564512963|FG000|Base Period|Lack of Efficacy|0|||
156388430|NCT01217073|564512964|FG001|Base Period|Lack of Efficacy|0|||
156388431|NCT01217073|564512965|FG002|Base Period|Lack of Efficacy|0|||
156388432|NCT01217073|564512966|FG003|Base Period|Lack of Efficacy|0|||
156388433|NCT01217073|564512967|FG004|Base Period|Lack of Efficacy|0|||
156388434|NCT01217073|564512968|FG005|Base Period|Lack of Efficacy|1|||
156388435|NCT01217073|564512969|FG006|Base Period|Lack of Efficacy|0|||
156388436|NCT01217073|564512970|FG007|Base Period|Lack of Efficacy|0|||
156388437|NCT01217073|564512963|FG000|Base Period|Lost to Follow-up|0|||
156388438|NCT01217073|564512964|FG001|Base Period|Lost to Follow-up|0|||
156388439|NCT01217073|564512965|FG002|Base Period|Lost to Follow-up|1|||
156388440|NCT01217073|564512966|FG003|Base Period|Lost to Follow-up|1|||
156388441|NCT01217073|564512967|FG004|Base Period|Lost to Follow-up|3|||
156388442|NCT01217073|564512968|FG005|Base Period|Lost to Follow-up|0|||
156388443|NCT01217073|564512969|FG006|Base Period|Lost to Follow-up|0|||
156388444|NCT01217073|564512970|FG007|Base Period|Lost to Follow-up|0|||
156388445|NCT01217073|564512963|FG000|Base Period|Physician Decision|0|||
156388446|NCT01217073|564512964|FG001|Base Period|Physician Decision|0|||
156388447|NCT01217073|564512965|FG002|Base Period|Physician Decision|0|||
156388448|NCT01217073|564512966|FG003|Base Period|Physician Decision|0|||
156388449|NCT01217073|564512967|FG004|Base Period|Physician Decision|1|||
156388450|NCT01217073|564512968|FG005|Base Period|Physician Decision|0|||
156388451|NCT01217073|564512969|FG006|Base Period|Physician Decision|0|||
156388452|NCT01217073|564512970|FG007|Base Period|Physician Decision|0|||
156388453|NCT01217073|564512963|FG000|Base Period|Protocol Violation|1|||
156388454|NCT01217073|564512964|FG001|Base Period|Protocol Violation|0|||
156388455|NCT01217073|564512965|FG002|Base Period|Protocol Violation|0|||
156388456|NCT01217073|564512966|FG003|Base Period|Protocol Violation|0|||
156388457|NCT01217073|564512967|FG004|Base Period|Protocol Violation|1|||
156388458|NCT01217073|564512968|FG005|Base Period|Protocol Violation|2|||
156388459|NCT01217073|564512969|FG006|Base Period|Protocol Violation|0|||
156388460|NCT01217073|564512970|FG007|Base Period|Protocol Violation|0|||
156388461|NCT01217073|564512963|FG000|Base Period|Withdrawal by Subject|4|||
156388462|NCT01217073|564512964|FG001|Base Period|Withdrawal by Subject|5|||
156388463|NCT01217073|564512965|FG002|Base Period|Withdrawal by Subject|5|||
156388464|NCT01217073|564512966|FG003|Base Period|Withdrawal by Subject|1|||
156388465|NCT01217073|564512967|FG004|Base Period|Withdrawal by Subject|5|||
156388466|NCT01217073|564512968|FG005|Base Period|Withdrawal by Subject|5|||
156388467|NCT01217073|564512969|FG006|Base Period|Withdrawal by Subject|0|||
156388468|NCT01217073|564512970|FG007|Base Period|Withdrawal by Subject|0|||
156388469|NCT01217073|564512963|FG000|Extension Period|Adverse Event|0|||
156388470|NCT01217073|564512964|FG001|Extension Period|Adverse Event|0|||
156388471|NCT01217073|564512965|FG002|Extension Period|Adverse Event|0|||
156388472|NCT01217073|564512966|FG003|Extension Period|Adverse Event|0|||
156388473|NCT01217073|564512967|FG004|Extension Period|Adverse Event|0|||
156388474|NCT01217073|564512968|FG005|Extension Period|Adverse Event|0|||
156388475|NCT01217073|564512969|FG006|Extension Period|Adverse Event|19|||
156388476|NCT01217073|564512970|FG007|Extension Period|Adverse Event|5|||
156507927|NCT03842228|564952998|FG004|Overall Study|Adverse Event|0|||
156388477|NCT01217073|564512963|FG000|Extension Period|ALT/AST|0|||
156388478|NCT01217073|564512964|FG001|Extension Period|ALT/AST|0|||
156388479|NCT01217073|564512965|FG002|Extension Period|ALT/AST|0|||
156388480|NCT01217073|564512966|FG003|Extension Period|ALT/AST|0|||
156388481|NCT01217073|564512967|FG004|Extension Period|ALT/AST|0|||
156507928|NCT03842228|564952999|FG005|Overall Study|Adverse Event|0|||
156507929|NCT03842228|564953000|FG006|Overall Study|Adverse Event|0|||
156388482|NCT01217073|564512968|FG005|Extension Period|ALT/AST|0|||
156388483|NCT01217073|564512969|FG006|Extension Period|ALT/AST|2|||
156388484|NCT01217073|564512970|FG007|Extension Period|ALT/AST|0|||
156388485|NCT01217073|564512963|FG000|Extension Period|Contraindication to study medication|0|||
156388486|NCT01217073|564512964|FG001|Extension Period|Contraindication to study medication|0|||
156388487|NCT01217073|564512965|FG002|Extension Period|Contraindication to study medication|0|||
156388488|NCT01217073|564512966|FG003|Extension Period|Contraindication to study medication|0|||
156388489|NCT01217073|564512967|FG004|Extension Period|Contraindication to study medication|0|||
156388490|NCT01217073|564512968|FG005|Extension Period|Contraindication to study medication|0|||
156388491|NCT01217073|564512969|FG006|Extension Period|Contraindication to study medication|1|||
156388492|NCT01217073|564512970|FG007|Extension Period|Contraindication to study medication|0|||
156388493|NCT01217073|564512963|FG000|Extension Period|Creatinine/eGFR|0|||
156388494|NCT01217073|564512964|FG001|Extension Period|Creatinine/eGFR|0|||
156388495|NCT01217073|564512965|FG002|Extension Period|Creatinine/eGFR|0|||
156388496|NCT01217073|564512966|FG003|Extension Period|Creatinine/eGFR|0|||
156388497|NCT01217073|564512967|FG004|Extension Period|Creatinine/eGFR|0|||
156388498|NCT01217073|564512968|FG005|Extension Period|Creatinine/eGFR|0|||
156388499|NCT01217073|564512969|FG006|Extension Period|Creatinine/eGFR|11|||
156388500|NCT01217073|564512970|FG007|Extension Period|Creatinine/eGFR|1|||
156388501|NCT01217073|564512963|FG000|Extension Period|Death|0|||
156388502|NCT01217073|564512964|FG001|Extension Period|Death|0|||
156388503|NCT01217073|564512965|FG002|Extension Period|Death|0|||
156388504|NCT01217073|564512966|FG003|Extension Period|Death|0|||
156388505|NCT01217073|564512967|FG004|Extension Period|Death|0|||
156388506|NCT01217073|564512968|FG005|Extension Period|Death|0|||
156388507|NCT01217073|564512969|FG006|Extension Period|Death|1|||
156388508|NCT01217073|564512970|FG007|Extension Period|Death|0|||
156388509|NCT01217073|564512963|FG000|Extension Period|Excluded medication|0|||
156388510|NCT01217073|564512964|FG001|Extension Period|Excluded medication|0|||
156388511|NCT01217073|564512965|FG002|Extension Period|Excluded medication|0|||
156388512|NCT01217073|564512966|FG003|Extension Period|Excluded medication|0|||
156388513|NCT01217073|564512967|FG004|Extension Period|Excluded medication|0|||
156388514|NCT01217073|564512968|FG005|Extension Period|Excluded medication|0|||
156388515|NCT01217073|564512969|FG006|Extension Period|Excluded medication|2|||
156388516|NCT01217073|564512970|FG007|Extension Period|Excluded medication|0|||
156388517|NCT01217073|564512963|FG000|Extension Period|Lack of Efficacy|0|||
156388518|NCT01217073|564512964|FG001|Extension Period|Lack of Efficacy|0|||
156388519|NCT01217073|564512965|FG002|Extension Period|Lack of Efficacy|0|||
156388520|NCT01217073|564512966|FG003|Extension Period|Lack of Efficacy|0|||
156388521|NCT01217073|564512967|FG004|Extension Period|Lack of Efficacy|0|||
156388522|NCT01217073|564512968|FG005|Extension Period|Lack of Efficacy|0|||
156388523|NCT01217073|564512969|FG006|Extension Period|Lack of Efficacy|3|||
156388524|NCT01217073|564512970|FG007|Extension Period|Lack of Efficacy|0|||
156388525|NCT01217073|564512963|FG000|Extension Period|Lost to Follow-up|0|||
156388526|NCT01217073|564512964|FG001|Extension Period|Lost to Follow-up|0|||
156388527|NCT01217073|564512965|FG002|Extension Period|Lost to Follow-up|0|||
156388528|NCT01217073|564512966|FG003|Extension Period|Lost to Follow-up|0|||
156388529|NCT01217073|564512967|FG004|Extension Period|Lost to Follow-up|0|||
156388530|NCT01217073|564512968|FG005|Extension Period|Lost to Follow-up|0|||
156388531|NCT01217073|564512969|FG006|Extension Period|Lost to Follow-up|9|||
156388532|NCT01217073|564512970|FG007|Extension Period|Lost to Follow-up|1|||
156388533|NCT01217073|564512963|FG000|Extension Period|Non-compliance with study drug|0|||
156388534|NCT01217073|564512964|FG001|Extension Period|Non-compliance with study drug|0|||
156388535|NCT01217073|564512965|FG002|Extension Period|Non-compliance with study drug|0|||
156388536|NCT01217073|564512966|FG003|Extension Period|Non-compliance with study drug|0|||
156388537|NCT01217073|564512967|FG004|Extension Period|Non-compliance with study drug|0|||
156388538|NCT01217073|564512968|FG005|Extension Period|Non-compliance with study drug|0|||
156388539|NCT01217073|564512969|FG006|Extension Period|Non-compliance with study drug|0|||
156388540|NCT01217073|564512970|FG007|Extension Period|Non-compliance with study drug|1|||
156388541|NCT01217073|564512963|FG000|Extension Period|Physician Decision|0|||
156388542|NCT01217073|564512964|FG001|Extension Period|Physician Decision|0|||
156388543|NCT01217073|564512965|FG002|Extension Period|Physician Decision|0|||
156388544|NCT01217073|564512966|FG003|Extension Period|Physician Decision|0|||
156388545|NCT01217073|564512967|FG004|Extension Period|Physician Decision|0|||
156388546|NCT01217073|564512968|FG005|Extension Period|Physician Decision|0|||
156388547|NCT01217073|564512969|FG006|Extension Period|Physician Decision|4|||
156388548|NCT01217073|564512970|FG007|Extension Period|Physician Decision|1|||
156388549|NCT01217073|564512963|FG000|Extension Period|Protocol Violation|0|||
156388550|NCT01217073|564512964|FG001|Extension Period|Protocol Violation|0|||
156388551|NCT01217073|564512965|FG002|Extension Period|Protocol Violation|0|||
156388552|NCT01217073|564512966|FG003|Extension Period|Protocol Violation|0|||
156388553|NCT01217073|564512967|FG004|Extension Period|Protocol Violation|0|||
156507930|NCT03842228|564952994|FG000|Overall Study|Death|0|||
156507931|NCT03842228|564952995|FG001|Overall Study|Death|1|||
156388554|NCT01217073|564512968|FG005|Extension Period|Protocol Violation|0|||
156388555|NCT01217073|564512969|FG006|Extension Period|Protocol Violation|2|||
156388556|NCT01217073|564512970|FG007|Extension Period|Protocol Violation|1|||
156388557|NCT01217073|564512963|FG000|Extension Period|Site discontinued study participation|0|||
156388558|NCT01217073|564512964|FG001|Extension Period|Site discontinued study participation|0|||
156388559|NCT01217073|564512965|FG002|Extension Period|Site discontinued study participation|0|||
156388560|NCT01217073|564512966|FG003|Extension Period|Site discontinued study participation|0|||
156388561|NCT01217073|564512967|FG004|Extension Period|Site discontinued study participation|0|||
156388562|NCT01217073|564512968|FG005|Extension Period|Site discontinued study participation|0|||
156388563|NCT01217073|564512969|FG006|Extension Period|Site discontinued study participation|7|||
156507932|NCT03842228|564952996|FG002|Overall Study|Death|0|||
156388564|NCT01217073|564512970|FG007|Extension Period|Site discontinued study participation|2|||
156388565|NCT01217073|564512963|FG000|Extension Period|Withdrawal by Subject|0|||
156388566|NCT01217073|564512964|FG001|Extension Period|Withdrawal by Subject|0|||
156388567|NCT01217073|564512965|FG002|Extension Period|Withdrawal by Subject|0|||
156388568|NCT01217073|564512966|FG003|Extension Period|Withdrawal by Subject|0|||
156388569|NCT01217073|564512967|FG004|Extension Period|Withdrawal by Subject|0|||
156388570|NCT01217073|564512968|FG005|Extension Period|Withdrawal by Subject|0|||
156388571|NCT01217073|564512969|FG006|Extension Period|Withdrawal by Subject|30|||
156388572|NCT01217073|564512970|FG007|Extension Period|Withdrawal by Subject|8|||
156388573|NCT01272934|564512993|FG000|Overall Study|Adverse Event|0|||
156388574|NCT01272934|564512994|FG001|Overall Study|Adverse Event|1|||
156388575|NCT01272934|564512993|FG000|Overall Study|Abnormal Laboratory Value|0|||
156388576|NCT01272934|564512994|FG001|Overall Study|Abnormal Laboratory Value|1|||
156388577|NCT03595904|564513000|FG000|Overall Study|Protocol Violation|3|||
156388578|NCT03595904|564513001|FG001|Overall Study|Protocol Violation|1|||
156388579|NCT03595904|564513000|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
156388580|NCT03595904|564513001|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
156388581|NCT03595904|564513000|FG000|Overall Study|Insurance complications|1|||
156388582|NCT03595904|564513001|FG001|Overall Study|Insurance complications|0|||
156388583|NCT03595904|564513000|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
156388584|NCT03595904|564513001|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
156388585|NCT04656847|564513005|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
156388586|NCT03301051|564513006|FG000|Overall Study|Adverse Event|0|||
156388587|NCT03301051|564513007|FG001|Overall Study|Adverse Event|4|||
156388588|NCT03301051|564513006|FG000|Overall Study|Withdrawal by Subject|59|||
156388589|NCT03301051|564513007|FG001|Overall Study|Withdrawal by Subject|65|||
156388590|NCT03301051|564513006|FG000|Overall Study|Lost to Follow-up|263|||
156388591|NCT03301051|564513007|FG001|Overall Study|Lost to Follow-up|282|||
156388592|NCT03301051|564513006|FG000|Overall Study|Protocol Violation|1|||
156388593|NCT03301051|564513007|FG001|Overall Study|Protocol Violation|3|||
156388594|NCT03301051|564513006|FG000|Overall Study|Physician Decision|1|||
156388595|NCT03301051|564513007|FG001|Overall Study|Physician Decision|3|||
156388596|NCT03301051|564513006|FG000|Overall Study|Death|1|||
156388597|NCT03301051|564513007|FG001|Overall Study|Death|1|||
156388598|NCT03301051|564513006|FG000|Overall Study|Miscellaneous|8|||
156388599|NCT03301051|564513007|FG001|Overall Study|Miscellaneous|4|||
156388600|NCT03301051|564513006|FG000|Overall Study|Randomized, not vaccinated|13|||
156388601|NCT03301051|564513007|FG001|Overall Study|Randomized, not vaccinated|10|||
156388602|NCT00047879|564513008|FG000|Overall Study|Progressive disease|4|||
156388603|NCT00047879|564513009|FG001|Overall Study|Progressive disease|3|||
156388604|NCT04558346|564513023|FG000|Overall Study|Withdrawal by Subject|2|||
156388605|NCT04558346|564513024|FG001|Overall Study|Withdrawal by Subject|0|||
156388606|NCT04558346|564513023|FG000|Overall Study|Lost to Follow-up|0|||
156388607|NCT04558346|564513024|FG001|Overall Study|Lost to Follow-up|1|||
156388608|NCT04558346|564513023|FG000|Overall Study|Adverse Event|0|||
156388609|NCT04558346|564513024|FG001|Overall Study|Adverse Event|1|||
156388610|NCT00724971|564513027|FG000|Overall Study|Adverse Event|5|||
156388611|NCT00724971|564513027|FG000|Overall Study|Withdrawal by Subject|1|||
156388612|NCT01003249|564513028|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156388613|NCT01003249|564513029|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156388614|NCT01003249|564513028|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
156388615|NCT01003249|564513029|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
156388616|NCT01003249|564513028|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156388617|NCT01003249|564513029|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156388618|NCT01003249|564513028|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
156388619|NCT01003249|564513029|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
156547714|NCT01877187|565098384|FG000|Overall Study|Death|2|||
156388620|NCT01962974|564513030|FG000|Overall Study|Study termination|7|||
156388621|NCT04598152|564513031|FG000|Overall Study|Lost to Follow-up|0|||
156388622|NCT04598152|564513032|FG001|Overall Study|Lost to Follow-up|1|||
156388623|NCT01965834|564513036|FG000|Overall Study|Lack of Efficacy|4|||
156388624|NCT03674177|564513039|FG000|Overall Study|Lost to Follow-up|2|||
156388625|NCT03674177|564513040|FG001|Overall Study|Lost to Follow-up|1|||
156388626|NCT03674177|564513041|FG002|Overall Study|Lost to Follow-up|0|||
156388627|NCT03674177|564513042|FG003|Overall Study|Lost to Follow-up|2|||
156388628|NCT03387852|564513043|FG000|Overall Study|Adverse event (AE)|3|||
156388629|NCT03387852|564513044|FG001|Overall Study|Adverse event (AE)|0|||
156388630|NCT03387852|564513045|FG002|Overall Study|Adverse event (AE)|2|||
156388631|NCT03387852|564513046|FG003|Overall Study|Adverse event (AE)|0|||
156388632|NCT03387852|564513043|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
156388633|NCT03387852|564513044|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
156388634|NCT03387852|564513045|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
156388635|NCT03387852|564513046|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
156388636|NCT03387852|564513043|FG000|Overall Study|Withdrawal by participant|1|||
156388637|NCT03387852|564513044|FG001|Overall Study|Withdrawal by participant|1|||
156388638|NCT03387852|564513045|FG002|Overall Study|Withdrawal by participant|3|||
156388639|NCT03387852|564513046|FG003|Overall Study|Withdrawal by participant|2|||
156388640|NCT03387852|564513043|FG000|Overall Study|Other- Unspecified|1|||
156388641|NCT03387852|564513044|FG001|Overall Study|Other- Unspecified|1|||
156388642|NCT03387852|564513045|FG002|Overall Study|Other- Unspecified|2|||
156388643|NCT03387852|564513046|FG003|Overall Study|Other- Unspecified|1|||
156388644|NCT03387852|564513043|FG000|Overall Study|Poor compliance to protocol|0|||
156388645|NCT03387852|564513044|FG001|Overall Study|Poor compliance to protocol|0|||
156388646|NCT03387852|564513045|FG002|Overall Study|Poor compliance to protocol|0|||
156388647|NCT03387852|564513046|FG003|Overall Study|Poor compliance to protocol|1|||
156388648|NCT03387852|564513043|FG000|Overall Study|Randomized and not treated|0|||
156388649|NCT03387852|564513044|FG001|Overall Study|Randomized and not treated|0|||
156388650|NCT03387852|564513045|FG002|Overall Study|Randomized and not treated|0|||
156388651|NCT03387852|564513046|FG003|Overall Study|Randomized and not treated|1|||
156388652|NCT02194621|564513054|FG000|Overall Study|6 withdrew prior to randomization|2|||
156388653|NCT02194621|564513055|FG001|Overall Study|6 withdrew prior to randomization|2|||
156388654|NCT02194621|564513056|FG002|Overall Study|6 withdrew prior to randomization|2|||
156388655|NCT02194621|564513054|FG000|Overall Study|Withdrawal by Subject|4|||
156388656|NCT02194621|564513055|FG001|Overall Study|Withdrawal by Subject|4|||
156388657|NCT02194621|564513056|FG002|Overall Study|Withdrawal by Subject|7|||
156388658|NCT00659334|564513061|FG000|Overall Study|Screen Failure|8|||
156388659|NCT00659334|564513062|FG001|Overall Study|Screen Failure|5|||
156388660|NCT00659334|564513063|FG002|Overall Study|Screen Failure|0|||
156388661|NCT00659334|564513064|FG003|Overall Study|Screen Failure|0|||
156388662|NCT00659334|564513065|FG004|Overall Study|Screen Failure|0|||
156388663|NCT00659334|564513066|FG005|Overall Study|Screen Failure|0|||
156388664|NCT00659334|564513067|FG006|Overall Study|Screen Failure|1|||
156388665|NCT03034577|564513068|FG000|Overall Study|Withdrawal by Subject|6|||
156388666|NCT03034577|564513069|FG001|Overall Study|Withdrawal by Subject|9|||
156547715|NCT01877187|565098384|FG000|Overall Study|Withdrawal by Subject|4|||
156547716|NCT01877187|565098384|FG000|Overall Study|Lost to Follow-up|3|||
156547717|NCT01877187|565098384|FG000|Overall Study|Declining clinical status|11|||
156547718|NCT01877187|565098384|FG000|Overall Study|Liver transplant|2|||
156547719|NCT05098041|565098391|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
156547720|NCT02599961|565098392|FG000|Overall Study|Withdrawal by Subject|1|||
156547721|NCT02599961|565098392|FG000|Overall Study|Subject Non-Compliance|2|||
156547722|NCT02599961|565098392|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
156547723|NCT02599961|565098392|FG000|Overall Study|Other, Not Specified|3|||
156547724|NCT00618410|565098393|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
156547725|NCT00618410|565098394|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
156547726|NCT01297270|565098395|FG000|Overall Study|Adverse Event|19|||
156547727|NCT01297270|565098396|FG001|Overall Study|Adverse Event|32|||
156547728|NCT01297270|565098397|FG002|Overall Study|Adverse Event|5|||
156547729|NCT01297270|565098395|FG000|Overall Study|Lack of Efficacy|15|||
156547730|NCT01297270|565098396|FG001|Overall Study|Lack of Efficacy|17|||
156547731|NCT01297270|565098397|FG002|Overall Study|Lack of Efficacy|15|||
156547732|NCT01297270|565098395|FG000|Overall Study|Lost to Follow-up|1|||
156547733|NCT01297270|565098396|FG001|Overall Study|Lost to Follow-up|2|||
156547734|NCT01297270|565098397|FG002|Overall Study|Lost to Follow-up|1|||
156547735|NCT01297270|565098395|FG000|Overall Study|Protocol Violation|0|||
156547736|NCT01297270|565098396|FG001|Overall Study|Protocol Violation|2|||
156547737|NCT01297270|565098397|FG002|Overall Study|Protocol Violation|0|||
156547738|NCT01297270|565098395|FG000|Overall Study|Withdrawal by Subject|7|||
156547739|NCT01297270|565098396|FG001|Overall Study|Withdrawal by Subject|15|||
156547740|NCT01297270|565098397|FG002|Overall Study|Withdrawal by Subject|7|||
156547741|NCT01297270|565098395|FG000|Overall Study|Other reason not defined above|3|||
156547742|NCT01297270|565098396|FG001|Overall Study|Other reason not defined above|3|||
156547743|NCT01297270|565098397|FG002|Overall Study|Other reason not defined above|1|||
156547744|NCT01297270|565098395|FG000|Overall Study|Not treated|0|||
156547745|NCT01297270|565098396|FG001|Overall Study|Not treated|1|||
156547746|NCT01297270|565098397|FG002|Overall Study|Not treated|0|||
156547747|NCT00382993|565098398|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
156547748|NCT00382993|565098399|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
156547749|NCT00382993|565098398|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
156547750|NCT00382993|565098399|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
156547751|NCT00382993|565098398|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
156547752|NCT00382993|565098399|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
156388667|NCT03034577|564513068|FG000|Overall Study|Lost to Follow-up|25|||
156388668|NCT03034577|564513069|FG001|Overall Study|Lost to Follow-up|26|||
156547753|NCT00382993|565098398|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
156547754|NCT00382993|565098399|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
156388669|NCT01174342|564513070|FG000|Overall Study|Conversion to cesarean section|4|||
156388670|NCT02625623|564513071|FG000|Overall Study|Participants randomized but not treated|9|||
156388671|NCT02625623|564513072|FG001|Overall Study|Participants randomized but not treated|1|||
156388672|NCT00726752|564513074|FG000|Overall Study|Lack of Efficacy|6|||
156388673|NCT01949311|564515150|FG000|Overall Study|Lost to Follow-up|73|||
156507933|NCT03842228|564952997|FG003|Overall Study|Death|0|||
156507934|NCT03842228|564952998|FG004|Overall Study|Death|0|||
156507935|NCT03842228|564952999|FG005|Overall Study|Death|0|||
156388674|NCT01949311|564515150|FG000|Overall Study|Terminated by Sponsor|708|||
156388675|NCT01949311|564515150|FG000|Overall Study|Withdrawal by Subject|375|||
156388676|NCT01949311|564515150|FG000|Overall Study|Lack of Efficacy|50|||
156388677|NCT01949311|564515150|FG000|Overall Study|Protocol Deviation|34|||
156388678|NCT01949311|564515150|FG000|Overall Study|Pregnancy|20|||
156388679|NCT01949311|564515150|FG000|Overall Study|Physician Decision|9|||
156388680|NCT01949311|564515150|FG000|Overall Study|Other|4|||
156388681|NCT01949311|564515150|FG000|Overall Study|Adverse Event|107|||
156388682|NCT02732938|564515155|FG000|Overall Study|Death|0|||
156388683|NCT02732938|564515156|FG001|Overall Study|Death|11|||
156388684|NCT02732938|564515157|FG002|Overall Study|Death|0|||
156388685|NCT02732938|564515155|FG000|Overall Study|Randomized but did not receive treatment|0|||
156388686|NCT02732938|564515156|FG001|Overall Study|Randomized but did not receive treatment|1|||
156388687|NCT02732938|564515157|FG002|Overall Study|Randomized but did not receive treatment|0|||
156388688|NCT02732938|564515155|FG000|Overall Study|Refused further follow-up|1|||
156388689|NCT02732938|564515156|FG001|Overall Study|Refused further follow-up|0|||
156388690|NCT02732938|564515157|FG002|Overall Study|Refused further follow-up|0|||
156388691|NCT02732938|564515155|FG000|Overall Study|Study terminated by sponsor|3|||
156388692|NCT02732938|564515156|FG001|Overall Study|Study terminated by sponsor|6|||
156388693|NCT02732938|564515157|FG002|Overall Study|Study terminated by sponsor|0|||
156388694|NCT02015676|564515158|FG000|Overall Study|Adverse Event|2|||
156388695|NCT02015676|564515159|FG001|Overall Study|Adverse Event|18|||
156388696|NCT02015676|564515160|FG002|Overall Study|Adverse Event|0|||
156388697|NCT02015676|564515158|FG000|Overall Study|Lack of Efficacy|2|||
156388698|NCT02015676|564515159|FG001|Overall Study|Lack of Efficacy|4|||
156388699|NCT02015676|564515160|FG002|Overall Study|Lack of Efficacy|0|||
156388700|NCT02015676|564515158|FG000|Overall Study|Protocol Violation|1|||
156388701|NCT02015676|564515159|FG001|Overall Study|Protocol Violation|0|||
156388702|NCT02015676|564515160|FG002|Overall Study|Protocol Violation|0|||
156388703|NCT02015676|564515158|FG000|Overall Study|Withdrawal by Subject|1|||
156388704|NCT02015676|564515159|FG001|Overall Study|Withdrawal by Subject|7|||
156388705|NCT02015676|564515160|FG002|Overall Study|Withdrawal by Subject|1|||
156388706|NCT02015676|564515158|FG000|Overall Study|Administrative reasons|0|||
156388707|NCT02015676|564515159|FG001|Overall Study|Administrative reasons|3|||
156388708|NCT02015676|564515160|FG002|Overall Study|Administrative reasons|1|||
156388709|NCT02015676|564515158|FG000|Overall Study|Death|0|||
156388710|NCT02015676|564515159|FG001|Overall Study|Death|1|||
156388711|NCT02015676|564515160|FG002|Overall Study|Death|0|||
156388712|NCT02015676|564515158|FG000|Overall Study|Disease progression|3|||
156388713|NCT02015676|564515159|FG001|Overall Study|Disease progression|1|||
156388714|NCT02015676|564515160|FG002|Overall Study|Disease progression|1|||
156388715|NCT00476476|564515161|FG000|Overall Study|Adverse Event|2|||
156388716|NCT00476476|564515162|FG001|Overall Study|Adverse Event|7|||
156388717|NCT00476476|564515161|FG000|Overall Study|Progressive Disease|0|||
156388718|NCT00476476|564515162|FG001|Overall Study|Progressive Disease|17|||
156388719|NCT00971048|564515167|FG000|Overall Study|Protocol Violation|1|||
156388720|NCT00971048|564515168|FG001|Overall Study|Protocol Violation|2|||
156388721|NCT00971048|564515169|FG002|Overall Study|Protocol Violation|0|||
156388722|NCT00971048|564515170|FG003|Overall Study|Protocol Violation|1|||
156388723|NCT00971048|564515167|FG000|Overall Study|Adverse Event|0|||
156388724|NCT00971048|564515168|FG001|Overall Study|Adverse Event|0|||
156388725|NCT00971048|564515169|FG002|Overall Study|Adverse Event|1|||
156388726|NCT00971048|564515170|FG003|Overall Study|Adverse Event|0|||
156388727|NCT00971048|564515167|FG000|Overall Study|Physician Decision|0|||
156388728|NCT00971048|564515168|FG001|Overall Study|Physician Decision|0|||
156388729|NCT00971048|564515169|FG002|Overall Study|Physician Decision|0|||
156388730|NCT00971048|564515170|FG003|Overall Study|Physician Decision|1|||
156388731|NCT03321396|564515171|FG000|Overall Study|Physician Decision|1|||
156388732|NCT03280121|564515172|FG000|Overall Study|Physician Decision|1|||
156388733|NCT03280121|564515172|FG000|Overall Study|Lost to Follow-up|1|||
156388734|NCT03280121|564515172|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
156388735|NCT02633137|564515177|FG000|Overall Study|Adverse Event|1|||
156388736|NCT02633137|564515177|FG000|Overall Study|Lack of Efficacy|2|||
156388737|NCT02633137|564515177|FG000|Overall Study|Withdrawal by Subject|1|||
156388738|NCT04307004|564515178|FG000|Randomization 1|Withdrawal by Subject|25|||
156388739|NCT04307004|564515179|FG001|Randomization 1|Withdrawal by Subject|26|||
156388740|NCT04307004|564515180|FG002|Randomization 1|Withdrawal by Subject|0|||
156388741|NCT04307004|564515181|FG003|Randomization 1|Withdrawal by Subject|0|||
156388742|NCT04307004|564515178|FG000|Randomization 2|Withdrawal by Subject|0|||
156388743|NCT04307004|564515179|FG001|Randomization 2|Withdrawal by Subject|0|||
156388744|NCT04307004|564515180|FG002|Randomization 2|Withdrawal by Subject|28|||
156388745|NCT04307004|564515181|FG003|Randomization 2|Withdrawal by Subject|23|||
156388746|NCT05545072|564515184|FG000|Overall Study|Lost to Follow-up|1|||
156388747|NCT05545072|564515185|FG001|Overall Study|Lost to Follow-up|0|||
156507936|NCT03842228|564953000|FG006|Overall Study|Death|0|||
156388748|NCT05545072|564515184|FG000|Overall Study|Study ended prematurely due to funding|2|||
156388749|NCT05545072|564515185|FG001|Overall Study|Study ended prematurely due to funding|2|||
156388750|NCT02395042|564515186|FG000|Treatment 1 Period|Adverse Event|1|||
156388751|NCT02395042|564515187|FG001|Treatment 1 Period|Adverse Event|3|||
156388752|NCT02395042|564515188|FG002|Treatment 1 Period|Adverse Event|1|||
156388753|NCT02395042|564515186|FG000|Treatment 1 Period|Lack of Efficacy|1|||
156388754|NCT02395042|564515187|FG001|Treatment 1 Period|Lack of Efficacy|1|||
156388755|NCT02395042|564515188|FG002|Treatment 1 Period|Lack of Efficacy|0|||
156388756|NCT02395042|564515186|FG000|Treatment 1 Period|Lost to Follow-up|1|||
156388757|NCT02395042|564515187|FG001|Treatment 1 Period|Lost to Follow-up|0|||
156388758|NCT02395042|564515188|FG002|Treatment 1 Period|Lost to Follow-up|0|||
156388759|NCT02395042|564515186|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
156388760|NCT02395042|564515187|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
156388761|NCT02395042|564515188|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
156388762|NCT02395042|564515186|FG000|Treatment 2 Period|Lack of Efficacy|1|||
156388763|NCT02395042|564515187|FG001|Treatment 2 Period|Lack of Efficacy|1|||
156388764|NCT02395042|564515188|FG002|Treatment 2 Period|Lack of Efficacy|0|||
156388765|NCT03996473|564515189|FG000|Treatment Assignment|Withdrawal by Subject|1|||
156388766|NCT03996473|564515189|FG000|Treatment Assignment|Progressive disease|6|||
156388767|NCT03996473|564515189|FG000|Treatment Assignment|Study drug never administered|1|||
156388768|NCT03996473|564515189|FG000|Active Follow-up|Death|1|||
156388769|NCT03996473|564515189|FG000|Long-term Follow-up|Death|5|||
156388770|NCT03759873|564515190|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
156388771|NCT03759873|564515191|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
156388772|NCT03759873|564515192|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
156388773|NCT03759873|564515193|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
156388774|NCT03759873|564515190|FG000|Overall Study|Moved outside eligible area|0|||
156388775|NCT03759873|564515191|FG001|Overall Study|Moved outside eligible area|2|||
156388776|NCT03759873|564515192|FG002|Overall Study|Moved outside eligible area|0|||
156388777|NCT03759873|564515193|FG003|Overall Study|Moved outside eligible area|0|||
156388778|NCT03759873|564515190|FG000|Overall Study|Withdrawal by Subject|0|||
156388779|NCT03759873|564515191|FG001|Overall Study|Withdrawal by Subject|0|||
156388780|NCT03759873|564515192|FG002|Overall Study|Withdrawal by Subject|1|||
156388781|NCT03759873|564515193|FG003|Overall Study|Withdrawal by Subject|0|||
156388782|NCT04349553|564515197|FG000|Overall Study|Withdrawal by Subject|1|||
156388783|NCT04349553|564515198|FG001|Overall Study|Withdrawal by Subject|0|||
156388784|NCT04349553|564515199|FG002|Overall Study|Withdrawal by Subject|1|||
156388785|NCT04349553|564515200|FG003|Overall Study|Withdrawal by Subject|0|||
156388786|NCT02647359|564515201|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
156388787|NCT02647359|564515202|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
156388788|NCT02647359|564515201|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
156388789|NCT02647359|564515202|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
156388790|NCT02647359|564515201|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
156388791|NCT02647359|564515202|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
156388792|NCT02647359|564515201|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
156388793|NCT02647359|564515202|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
156388794|NCT02647359|564515201|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
156388795|NCT02647359|564515202|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
156388796|NCT02647359|564515201|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
156388797|NCT02647359|564515202|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
156388798|NCT04642638|564515203|FG000|Overall Study|Withdrawal by Subject|23|||
156388799|NCT04642638|564515204|FG001|Overall Study|Withdrawal by Subject|29|||
156388800|NCT04642638|564515205|FG002|Overall Study|Withdrawal by Subject|9|||
156388801|NCT04642638|564515206|FG003|Overall Study|Withdrawal by Subject|7|||
156388802|NCT04642638|564515207|FG004|Overall Study|Withdrawal by Subject|61|||
156388803|NCT04642638|564515208|FG005|Overall Study|Withdrawal by Subject|27|||
156388804|NCT04642638|564515203|FG000|Overall Study|Lost to Follow-up|17|||
156388805|NCT04642638|564515204|FG001|Overall Study|Lost to Follow-up|18|||
156388806|NCT04642638|564515205|FG002|Overall Study|Lost to Follow-up|5|||
156388807|NCT04642638|564515206|FG003|Overall Study|Lost to Follow-up|5|||
156388808|NCT04642638|564515207|FG004|Overall Study|Lost to Follow-up|6|||
156388809|NCT04642638|564515208|FG005|Overall Study|Lost to Follow-up|3|||
156388810|NCT04642638|564515203|FG000|Overall Study|Adverse Event|0|||
156388811|NCT04642638|564515204|FG001|Overall Study|Adverse Event|0|||
156388812|NCT04642638|564515205|FG002|Overall Study|Adverse Event|1|||
156388813|NCT04642638|564515206|FG003|Overall Study|Adverse Event|0|||
156388814|NCT04642638|564515207|FG004|Overall Study|Adverse Event|10|||
156388815|NCT04642638|564515208|FG005|Overall Study|Adverse Event|3|||
156388816|NCT04642638|564515203|FG000|Overall Study|Reason Not Specified|1|||
156388817|NCT04642638|564515204|FG001|Overall Study|Reason Not Specified|4|||
156388818|NCT04642638|564515205|FG002|Overall Study|Reason Not Specified|0|||
156388819|NCT04642638|564515206|FG003|Overall Study|Reason Not Specified|0|||
156388820|NCT04642638|564515207|FG004|Overall Study|Reason Not Specified|38|||
156388821|NCT04642638|564515208|FG005|Overall Study|Reason Not Specified|16|||
156388822|NCT04642638|564515203|FG000|Overall Study|Physician Decision|0|||
156388823|NCT04642638|564515204|FG001|Overall Study|Physician Decision|0|||
156388824|NCT04642638|564515205|FG002|Overall Study|Physician Decision|0|||
156388825|NCT04642638|564515206|FG003|Overall Study|Physician Decision|0|||
156388826|NCT04642638|564515207|FG004|Overall Study|Physician Decision|2|||
156388827|NCT04642638|564515208|FG005|Overall Study|Physician Decision|1|||
156388828|NCT04642638|564515203|FG000|Overall Study|Protocol Deviation|0|||
156507937|NCT03842228|564952994|FG000|Overall Study|Withdrawal by Subject|0|||
156507938|NCT03842228|564952995|FG001|Overall Study|Withdrawal by Subject|0|||
156507939|NCT03842228|564952996|FG002|Overall Study|Withdrawal by Subject|2|||
156507940|NCT03842228|564952997|FG003|Overall Study|Withdrawal by Subject|1|||
156507941|NCT03842228|564952998|FG004|Overall Study|Withdrawal by Subject|0|||
156507942|NCT03842228|564952999|FG005|Overall Study|Withdrawal by Subject|0|||
156507943|NCT03842228|564953000|FG006|Overall Study|Withdrawal by Subject|2|||
156507944|NCT03842228|564952994|FG000|Overall Study|Progression|8|||
156507945|NCT03842228|564952995|FG001|Overall Study|Progression|1|||
156507946|NCT03842228|564952996|FG002|Overall Study|Progression|7|||
156507947|NCT03842228|564952997|FG003|Overall Study|Progression|5|||
156507948|NCT03842228|564952998|FG004|Overall Study|Progression|4|||
156507949|NCT03842228|564952999|FG005|Overall Study|Progression|2|||
156507950|NCT03842228|564953000|FG006|Overall Study|Progression|3|||
156507951|NCT01371825|564953007|FG000|Overall Study|Death|4|||
156507952|NCT00895895|564953008|FG000|Period 1|Adverse Event|7|||
156507953|NCT00895895|564953009|FG001|Period 1|Adverse Event|6|||
156388829|NCT04642638|564515204|FG001|Overall Study|Protocol Deviation|0|||
156388830|NCT04642638|564515205|FG002|Overall Study|Protocol Deviation|0|||
156388831|NCT04642638|564515206|FG003|Overall Study|Protocol Deviation|0|||
156388832|NCT04642638|564515207|FG004|Overall Study|Protocol Deviation|1|||
156388833|NCT04642638|564515208|FG005|Overall Study|Protocol Deviation|3|||
156388834|NCT04642638|564515203|FG000|Overall Study|Study Terminated|0|||
156388835|NCT04642638|564515204|FG001|Overall Study|Study Terminated|0|||
156388836|NCT04642638|564515205|FG002|Overall Study|Study Terminated|0|||
156388837|NCT04642638|564515206|FG003|Overall Study|Study Terminated|0|||
156388838|NCT04642638|564515207|FG004|Overall Study|Study Terminated|484|||
156388839|NCT04642638|564515208|FG005|Overall Study|Study Terminated|250|||
156388840|NCT04642638|564515203|FG000|Overall Study|Pregnancy|0|||
156388841|NCT04642638|564515204|FG001|Overall Study|Pregnancy|0|||
156388842|NCT04642638|564515205|FG002|Overall Study|Pregnancy|0|||
156388843|NCT04642638|564515206|FG003|Overall Study|Pregnancy|0|||
156388844|NCT04642638|564515207|FG004|Overall Study|Pregnancy|1|||
156388845|NCT04642638|564515208|FG005|Overall Study|Pregnancy|0|||
156388846|NCT01869491|564515211|FG000|Overall Study|Adverse Event|3|||
156388847|NCT01869491|564515212|FG001|Overall Study|Adverse Event|5|||
156388848|NCT01869491|564515211|FG000|Overall Study|Lack of Efficacy|0|||
156388849|NCT01869491|564515212|FG001|Overall Study|Lack of Efficacy|3|||
156388850|NCT01869491|564515211|FG000|Overall Study|Withdrawal by Subject|6|||
156388851|NCT01869491|564515212|FG001|Overall Study|Withdrawal by Subject|7|||
156388852|NCT01869491|564515211|FG000|Overall Study|Lost to Follow-up|11|||
156388853|NCT01869491|564515212|FG001|Overall Study|Lost to Follow-up|9|||
156388854|NCT01869491|564515211|FG000|Overall Study|No further need of investigational product|1|||
156388855|NCT01869491|564515212|FG001|Overall Study|No further need of investigational product|0|||
156388856|NCT06476366|564515213|FG000|Overall Study|Lost to Follow-up|1|||
156388857|NCT06476366|564515214|FG001|Overall Study|Lost to Follow-up|3|||
156388858|NCT06476366|564515213|FG000|Overall Study|Adverse Event|1|||
156388859|NCT06476366|564515214|FG001|Overall Study|Adverse Event|0|||
156388860|NCT04313881|564515215|FG000|Overall Study|Death|138|||
156388861|NCT04313881|564515216|FG001|Overall Study|Death|126|||
156388862|NCT04313881|564515215|FG000|Overall Study|Study terminated by sponsor|108|||
156388863|NCT04313881|564515216|FG001|Overall Study|Study terminated by sponsor|129|||
156388864|NCT04313881|564515215|FG000|Overall Study|Consent withdrawn|19|||
156388865|NCT04313881|564515216|FG001|Overall Study|Consent withdrawn|15|||
156388866|NCT04313881|564515215|FG000|Overall Study|Reason not Specified|3|||
156388867|NCT04313881|564515216|FG001|Overall Study|Reason not Specified|1|||
156388868|NCT00727272|564515217|FG000|Washout Period A|Adverse Event|0|||
156388869|NCT00727272|564515218|FG001|Washout Period A|Adverse Event|0|||
156388870|NCT00727272|564515219|FG002|Washout Period A|Adverse Event|1|||
156388871|NCT00727272|564515217|FG000|Washout Period B|Withdrawal by Subject|0|||
156507954|NCT00895895|564953010|FG002|Period 1|Adverse Event|4|||
156507955|NCT00895895|564953011|FG003|Period 1|Adverse Event|6|||
156507956|NCT00895895|564953012|FG004|Period 1|Adverse Event|7|||
156507957|NCT00895895|564953008|FG000|Period 1|Death|0|||
156507958|NCT00895895|564953009|FG001|Period 1|Death|0|||
156507959|NCT00895895|564953010|FG002|Period 1|Death|0|||
156388872|NCT00727272|564515218|FG001|Washout Period B|Withdrawal by Subject|0|||
156388873|NCT00727272|564515219|FG002|Washout Period B|Withdrawal by Subject|1|||
156388874|NCT00651664|564515220|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
156388875|NCT00651664|564515221|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
156388876|NCT00651664|564515222|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
156388877|NCT00651664|564515223|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
156388878|NCT00651664|564515224|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
156507960|NCT00895895|564953011|FG003|Period 1|Death|0|||
156507961|NCT00895895|564953012|FG004|Period 1|Death|1|||
156388879|NCT00651664|564515225|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
156388880|NCT00651664|564515226|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
156507962|NCT00895895|564953008|FG000|Period 1|discontinued by sponsor|2|||
156547755|NCT00382993|565098398|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
156547756|NCT00382993|565098399|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
156547757|NCT00382993|565098398|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
156547758|NCT00382993|565098399|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
156547759|NCT00382993|565098398|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
156547760|NCT00382993|565098399|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
156547761|NCT00382993|565098398|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
156547762|NCT00382993|565098399|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
156547763|NCT00382993|565098398|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
156547764|NCT00382993|565098399|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
156547765|NCT00382993|565098398|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
156547766|NCT00382993|565098399|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
156547767|NCT02898259|565098411|FG000|Overall Study|Adverse Event|0|||
156547768|NCT02898259|565098412|FG001|Overall Study|Adverse Event|0|||
156547769|NCT02898259|565098413|FG002|Overall Study|Adverse Event|1|||
156547770|NCT02898259|565098414|FG003|Overall Study|Adverse Event|0|||
156547771|NCT02898259|565098415|FG004|Overall Study|Adverse Event|0|||
156547772|NCT02898259|565098411|FG000|Overall Study|Lack of Efficacy|1|||
156547773|NCT02898259|565098412|FG001|Overall Study|Lack of Efficacy|1|||
156547774|NCT02898259|565098413|FG002|Overall Study|Lack of Efficacy|3|||
156547775|NCT02898259|565098414|FG003|Overall Study|Lack of Efficacy|0|||
156547776|NCT02898259|565098415|FG004|Overall Study|Lack of Efficacy|0|||
156547777|NCT02898259|565098411|FG000|Overall Study|Lost to Follow-up|0|||
156547778|NCT02898259|565098412|FG001|Overall Study|Lost to Follow-up|0|||
156547779|NCT02898259|565098413|FG002|Overall Study|Lost to Follow-up|1|||
156547780|NCT02898259|565098414|FG003|Overall Study|Lost to Follow-up|0|||
156547781|NCT02898259|565098415|FG004|Overall Study|Lost to Follow-up|0|||
156547782|NCT02898259|565098411|FG000|Overall Study|Transformation before study began|0|||
156547783|NCT02898259|565098412|FG001|Overall Study|Transformation before study began|0|||
156547784|NCT02898259|565098413|FG002|Overall Study|Transformation before study began|0|||
156547785|NCT02898259|565098414|FG003|Overall Study|Transformation before study began|1|||
156547786|NCT02898259|565098415|FG004|Overall Study|Transformation before study began|0|||
156547787|NCT01834274|565098418|FG000|Overall Study|Study Termination|41|||
156547788|NCT01834274|565098419|FG001|Overall Study|Study Termination|38|||
156547789|NCT01834274|565098418|FG000|Overall Study|Withdrawal by Subject|1|||
156547790|NCT01834274|565098419|FG001|Overall Study|Withdrawal by Subject|1|||
156547791|NCT01834274|565098418|FG000|Overall Study|Lost to Follow-up|3|||
156547792|NCT01834274|565098419|FG001|Overall Study|Lost to Follow-up|1|||
156547793|NCT01834274|565098418|FG000|Overall Study|Other|2|||
156547794|NCT01834274|565098419|FG001|Overall Study|Other|1|||
156547795|NCT03681119|565098422|FG000|Overall Study|No specific reason|4|||
156547796|NCT03681119|565098423|FG001|Overall Study|No specific reason|0|||
156547797|NCT03681119|565098422|FG000|Overall Study|Sickness|2|||
156547798|NCT03681119|565098423|FG001|Overall Study|Sickness|0|||
156547799|NCT03016325|565098424|FG000|Treatment Period|Participant withdrew consent|0|||
156547800|NCT03016325|565098425|FG001|Treatment Period|Participant withdrew consent|1|||
156547801|NCT03016325|565098426|FG002|Treatment Period|Participant withdrew consent|0|||
156507963|NCT00895895|564953009|FG001|Period 1|discontinued by sponsor|1|||
156507964|NCT00895895|564953010|FG002|Period 1|discontinued by sponsor|2|||
156507965|NCT00895895|564953011|FG003|Period 1|discontinued by sponsor|1|||
156507966|NCT00895895|564953012|FG004|Period 1|discontinued by sponsor|1|||
156507967|NCT00895895|564953008|FG000|Period 1|failed to return|0|||
156507968|NCT00895895|564953009|FG001|Period 1|failed to return|0|||
156507969|NCT00895895|564953010|FG002|Period 1|failed to return|1|||
156507970|NCT00895895|564953011|FG003|Period 1|failed to return|0|||
156507971|NCT00895895|564953012|FG004|Period 1|failed to return|1|||
156507972|NCT00895895|564953008|FG000|Period 1|investigator request|0|||
156507973|NCT00895895|564953009|FG001|Period 1|investigator request|1|||
156507974|NCT00895895|564953010|FG002|Period 1|investigator request|0|||
156507975|NCT00895895|564953011|FG003|Period 1|investigator request|0|||
156507976|NCT00895895|564953012|FG004|Period 1|investigator request|0|||
156507977|NCT00895895|564953008|FG000|Period 1|Lost to Follow-up|2|||
156507978|NCT00895895|564953009|FG001|Period 1|Lost to Follow-up|1|||
156507979|NCT00895895|564953010|FG002|Period 1|Lost to Follow-up|3|||
156507980|NCT00895895|564953011|FG003|Period 1|Lost to Follow-up|2|||
156507981|NCT00895895|564953012|FG004|Period 1|Lost to Follow-up|3|||
156507982|NCT00895895|564953008|FG000|Period 1|Other|1|||
156507983|NCT00895895|564953009|FG001|Period 1|Other|2|||
156507984|NCT00895895|564953010|FG002|Period 1|Other|1|||
156507985|NCT00895895|564953011|FG003|Period 1|Other|1|||
156507986|NCT00895895|564953012|FG004|Period 1|Other|1|||
156507987|NCT00895895|564953008|FG000|Period 1|Protocol Violation|0|||
156507988|NCT00895895|564953009|FG001|Period 1|Protocol Violation|1|||
156507989|NCT00895895|564953010|FG002|Period 1|Protocol Violation|0|||
156388881|NCT00651664|564515227|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
156388882|NCT00651664|564515228|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
156388883|NCT00651664|564515229|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
156388884|NCT00651664|564515220|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
156388885|NCT00651664|564515221|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
156388886|NCT00651664|564515222|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
156388887|NCT00651664|564515223|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
156388888|NCT00651664|564515224|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
156388889|NCT00651664|564515225|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
156388890|NCT00651664|564515226|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
156388891|NCT00651664|564515227|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
156388892|NCT00651664|564515228|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
156388893|NCT00651664|564515229|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
156388894|NCT00651664|564515220|FG000|Overall Study|Progressive Disease|3|||
156388895|NCT00651664|564515221|FG001|Overall Study|Progressive Disease|3|||
156388896|NCT00651664|564515222|FG002|Overall Study|Progressive Disease|3|||
156388897|NCT00651664|564515223|FG003|Overall Study|Progressive Disease|12|||
156388898|NCT00651664|564515224|FG004|Overall Study|Progressive Disease|4|||
156388899|NCT00651664|564515225|FG005|Overall Study|Progressive Disease|1|||
156388900|NCT00651664|564515226|FG006|Overall Study|Progressive Disease|3|||
156388901|NCT00651664|564515227|FG007|Overall Study|Progressive Disease|6|||
156388902|NCT00651664|564515228|FG008|Overall Study|Progressive Disease|5|||
156388903|NCT00651664|564515229|FG009|Overall Study|Progressive Disease|5|||
156388904|NCT00651664|564515220|FG000|Overall Study|Patient Declined Further Treatment|0|||
156388905|NCT00651664|564515221|FG001|Overall Study|Patient Declined Further Treatment|0|||
156388906|NCT00651664|564515222|FG002|Overall Study|Patient Declined Further Treatment|0|||
156388907|NCT00651664|564515223|FG003|Overall Study|Patient Declined Further Treatment|1|||
156388908|NCT00651664|564515224|FG004|Overall Study|Patient Declined Further Treatment|1|||
156388909|NCT00651664|564515225|FG005|Overall Study|Patient Declined Further Treatment|1|||
156388910|NCT00651664|564515226|FG006|Overall Study|Patient Declined Further Treatment|0|||
156388911|NCT00651664|564515227|FG007|Overall Study|Patient Declined Further Treatment|0|||
156388912|NCT00651664|564515228|FG008|Overall Study|Patient Declined Further Treatment|0|||
156388913|NCT00651664|564515229|FG009|Overall Study|Patient Declined Further Treatment|1|||
156388914|NCT00651664|564515220|FG000|Overall Study|Symptomatic Deterioration|0|||
156388915|NCT00651664|564515221|FG001|Overall Study|Symptomatic Deterioration|0|||
156388916|NCT00651664|564515222|FG002|Overall Study|Symptomatic Deterioration|0|||
156388917|NCT00651664|564515223|FG003|Overall Study|Symptomatic Deterioration|1|||
156388918|NCT00651664|564515224|FG004|Overall Study|Symptomatic Deterioration|0|||
156388919|NCT00651664|564515225|FG005|Overall Study|Symptomatic Deterioration|0|||
156388920|NCT00651664|564515226|FG006|Overall Study|Symptomatic Deterioration|1|||
156388921|NCT00651664|564515227|FG007|Overall Study|Symptomatic Deterioration|0|||
156388922|NCT00651664|564515228|FG008|Overall Study|Symptomatic Deterioration|1|||
156388923|NCT00651664|564515229|FG009|Overall Study|Symptomatic Deterioration|0|||
156388924|NCT00651664|564515220|FG000|Overall Study|Reason not Specified|0|||
156388925|NCT00651664|564515221|FG001|Overall Study|Reason not Specified|0|||
156388926|NCT00651664|564515222|FG002|Overall Study|Reason not Specified|0|||
156388927|NCT00651664|564515223|FG003|Overall Study|Reason not Specified|0|||
156388928|NCT00651664|564515224|FG004|Overall Study|Reason not Specified|0|||
156388929|NCT00651664|564515225|FG005|Overall Study|Reason not Specified|0|||
156388930|NCT00651664|564515226|FG006|Overall Study|Reason not Specified|1|||
156388931|NCT00651664|564515227|FG007|Overall Study|Reason not Specified|0|||
156388932|NCT00651664|564515228|FG008|Overall Study|Reason not Specified|0|||
156388933|NCT00651664|564515229|FG009|Overall Study|Reason not Specified|0|||
156388934|NCT04053764|564515230|FG000|Overall Study|Withdrawal by Subject|6|||
156388935|NCT04053764|564515231|FG001|Overall Study|Withdrawal by Subject|2|||
156388936|NCT04053764|564515230|FG000|Overall Study|Physician Decision|2|||
156388937|NCT04053764|564515231|FG001|Overall Study|Physician Decision|1|||
156388938|NCT04053764|564515230|FG000|Overall Study|Adverse Event|1|||
156388939|NCT04053764|564515231|FG001|Overall Study|Adverse Event|0|||
156388940|NCT04053764|564515230|FG000|Overall Study|Pregnancy|1|||
156388941|NCT04053764|564515231|FG001|Overall Study|Pregnancy|0|||
156388942|NCT04732286|564515235|FG000|Overall Study|Progressive Disease|2|||
156388943|NCT04732286|564515235|FG000|Overall Study|Physician Decision|1|||
156388944|NCT04732286|564515235|FG000|Overall Study|Study Terminated by Sponsor|31|||
156388945|NCT04732286|564515235|FG000|Overall Study|Withdrawal by Subject|10|||
156388946|NCT04732286|564515235|FG000|Overall Study|Non-compliance With Study Drug|1|||
156388947|NCT04732286|564515235|FG000|Overall Study|Lost to Follow-up|4|||
156388948|NCT04732286|564515235|FG000|Overall Study|Death|51|||
156388949|NCT01910129|564515244|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
156388950|NCT01910129|564515245|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
156388951|NCT01910129|564515246|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
156388952|NCT01910129|564515244|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
156388953|NCT01910129|564515245|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
156388954|NCT01910129|564515246|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
156388955|NCT00319098|564515247|FG000|Overall Study|Serious adverse event|3|||
156547802|NCT03016325|565098427|FG003|Treatment Period|Participant withdrew consent|0|||
156547803|NCT03016325|565098428|FG004|Treatment Period|Participant withdrew consent|0|||
156547804|NCT03016325|565098429|FG005|Treatment Period|Participant withdrew consent|0|||
156547805|NCT03016325|565098430|FG006|Treatment Period|Participant withdrew consent|0|||
156547806|NCT03016325|565098431|FG007|Treatment Period|Participant withdrew consent|0|||
156547807|NCT03016325|565098424|FG000|Treatment Period|Death|0|||
156547808|NCT03016325|565098425|FG001|Treatment Period|Death|0|||
156547809|NCT03016325|565098426|FG002|Treatment Period|Death|0|||
156388956|NCT00319098|564515248|FG001|Overall Study|Serious adverse event|0|||
156388957|NCT00319098|564515247|FG000|Overall Study|Adverse Event|20|||
156388958|NCT00319098|564515248|FG001|Overall Study|Adverse Event|1|||
156388959|NCT00319098|564515247|FG000|Overall Study|Withdrawal by Subject|37|||
156388960|NCT00319098|564515248|FG001|Overall Study|Withdrawal by Subject|8|||
156388961|NCT00319098|564515247|FG000|Overall Study|Migrated/moved from study area|2|||
156388962|NCT00319098|564515248|FG001|Overall Study|Migrated/moved from study area|1|||
156388963|NCT00319098|564515247|FG000|Overall Study|Lost to Follow-up|37|||
156388964|NCT00319098|564515248|FG001|Overall Study|Lost to Follow-up|13|||
156388965|NCT00319098|564515247|FG000|Overall Study|Others|33|||
156388966|NCT00319098|564515248|FG001|Overall Study|Others|8|||
156388967|NCT00319098|564515247|FG000|Overall Study|Protocol Violation|3|||
156388968|NCT00319098|564515248|FG001|Overall Study|Protocol Violation|1|||
156388969|NCT03449030|564515249|FG000|Overall Study|Withdrawal by Subject|0|||
156388970|NCT03449030|564515250|FG001|Overall Study|Withdrawal by Subject|0|||
156388971|NCT03449030|564515251|FG002|Overall Study|Withdrawal by Subject|0|||
156388972|NCT03449030|564515252|FG003|Overall Study|Withdrawal by Subject|1|||
156388973|NCT03449030|564515253|FG004|Overall Study|Withdrawal by Subject|1|||
156388974|NCT03449030|564515254|FG005|Overall Study|Withdrawal by Subject|1|||
156388975|NCT03449030|564515255|FG006|Overall Study|Withdrawal by Subject|1|||
156388976|NCT03449030|564515256|FG007|Overall Study|Withdrawal by Subject|2|||
156388977|NCT03449030|564515257|FG008|Overall Study|Withdrawal by Subject|0|||
156388978|NCT03449030|564515258|FG009|Overall Study|Withdrawal by Subject|0|||
156388979|NCT03449030|564515249|FG000|Overall Study|Symptomatic Deterioration|0|||
156388980|NCT03449030|564515250|FG001|Overall Study|Symptomatic Deterioration|1|||
156388981|NCT03449030|564515251|FG002|Overall Study|Symptomatic Deterioration|0|||
156388982|NCT03449030|564515252|FG003|Overall Study|Symptomatic Deterioration|0|||
156388983|NCT03449030|564515253|FG004|Overall Study|Symptomatic Deterioration|0|||
156388984|NCT03449030|564515254|FG005|Overall Study|Symptomatic Deterioration|1|||
156388985|NCT03449030|564515255|FG006|Overall Study|Symptomatic Deterioration|1|||
156388986|NCT03449030|564515256|FG007|Overall Study|Symptomatic Deterioration|0|||
156388987|NCT03449030|564515257|FG008|Overall Study|Symptomatic Deterioration|2|||
156388988|NCT03449030|564515258|FG009|Overall Study|Symptomatic Deterioration|0|||
156388989|NCT03449030|564515249|FG000|Overall Study|Progressive Disease|1|||
156388990|NCT03449030|564515250|FG001|Overall Study|Progressive Disease|0|||
156388991|NCT03449030|564515251|FG002|Overall Study|Progressive Disease|1|||
156388992|NCT03449030|564515252|FG003|Overall Study|Progressive Disease|4|||
156388993|NCT03449030|564515253|FG004|Overall Study|Progressive Disease|5|||
156388994|NCT03449030|564515254|FG005|Overall Study|Progressive Disease|3|||
156388995|NCT03449030|564515255|FG006|Overall Study|Progressive Disease|0|||
156388996|NCT03449030|564515256|FG007|Overall Study|Progressive Disease|1|||
156388997|NCT03449030|564515257|FG008|Overall Study|Progressive Disease|1|||
156388998|NCT03449030|564515258|FG009|Overall Study|Progressive Disease|1|||
156388999|NCT03449030|564515249|FG000|Overall Study|Adverse Event|0|||
156389000|NCT03449030|564515250|FG001|Overall Study|Adverse Event|0|||
156389001|NCT03449030|564515251|FG002|Overall Study|Adverse Event|0|||
156389002|NCT03449030|564515252|FG003|Overall Study|Adverse Event|0|||
156389003|NCT03449030|564515253|FG004|Overall Study|Adverse Event|0|||
156389004|NCT03449030|564515254|FG005|Overall Study|Adverse Event|2|||
156389005|NCT03449030|564515255|FG006|Overall Study|Adverse Event|0|||
156389006|NCT03449030|564515256|FG007|Overall Study|Adverse Event|0|||
156389007|NCT03449030|564515257|FG008|Overall Study|Adverse Event|0|||
156389008|NCT03449030|564515258|FG009|Overall Study|Adverse Event|0|||
156389009|NCT03449030|564515249|FG000|Overall Study|Death|0|||
156389010|NCT03449030|564515250|FG001|Overall Study|Death|0|||
156389011|NCT03449030|564515251|FG002|Overall Study|Death|0|||
156389012|NCT03449030|564515252|FG003|Overall Study|Death|0|||
156389013|NCT03449030|564515253|FG004|Overall Study|Death|1|||
156389014|NCT03449030|564515254|FG005|Overall Study|Death|0|||
156389015|NCT03449030|564515255|FG006|Overall Study|Death|0|||
156389016|NCT03449030|564515256|FG007|Overall Study|Death|0|||
156389017|NCT03449030|564515257|FG008|Overall Study|Death|0|||
156389018|NCT03449030|564515258|FG009|Overall Study|Death|0|||
156389019|NCT00965523|564515259|FG000|Study 221|Progressive Disease|4|||
156389020|NCT00965523|564515259|FG000|Study 221|Physician Decision|3|||
156389021|NCT00965523|564515259|FG000|Study 224|Progressive Disease|5|||
156389022|NCT00965523|564515259|FG000|Study 224|Physician Decision|1|||
156389023|NCT02415400|564515262|FG000|Overall Study|Adverse Event|0|||
156389024|NCT02415400|564515263|FG001|Overall Study|Adverse Event|1|||
156389025|NCT02415400|564515264|FG002|Overall Study|Adverse Event|1|||
156547810|NCT03016325|565098427|FG003|Treatment Period|Death|0|||
156547811|NCT03016325|565098428|FG004|Treatment Period|Death|2|||
156389026|NCT02415400|564515265|FG003|Overall Study|Adverse Event|2|||
156389027|NCT02415400|564515262|FG000|Overall Study|Participant request to stop therapy|4|||
156389028|NCT02415400|564515263|FG001|Overall Study|Participant request to stop therapy|3|||
156389029|NCT02415400|564515264|FG002|Overall Study|Participant request to stop therapy|8|||
156389030|NCT02415400|564515265|FG003|Overall Study|Participant request to stop therapy|6|||
156389031|NCT02415400|564515262|FG000|Overall Study|Participant withdrew consent|14|||
156389032|NCT02415400|564515263|FG001|Overall Study|Participant withdrew consent|12|||
156389033|NCT02415400|564515264|FG002|Overall Study|Participant withdrew consent|30|||
156389034|NCT02415400|564515265|FG003|Overall Study|Participant withdrew consent|21|||
156389035|NCT02415400|564515262|FG000|Overall Study|Death|39|||
156389036|NCT02415400|564515263|FG001|Overall Study|Death|41|||
156389037|NCT02415400|564515264|FG002|Overall Study|Death|35|||
156389038|NCT02415400|564515265|FG003|Overall Study|Death|42|||
156389039|NCT02415400|564515262|FG000|Overall Study|Lost to Follow-up|3|||
156389040|NCT02415400|564515263|FG001|Overall Study|Lost to Follow-up|3|||
156389041|NCT02415400|564515264|FG002|Overall Study|Lost to Follow-up|2|||
156389042|NCT02415400|564515265|FG003|Overall Study|Lost to Follow-up|5|||
156389043|NCT02415400|564515262|FG000|Overall Study|Poor/Non-Compliance|0|||
156389044|NCT02415400|564515263|FG001|Overall Study|Poor/Non-Compliance|1|||
156389045|NCT02415400|564515264|FG002|Overall Study|Poor/Non-Compliance|3|||
156389046|NCT02415400|564515265|FG003|Overall Study|Poor/Non-Compliance|4|||
156389047|NCT02415400|564515262|FG000|Overall Study|Participant no longer meets criteria|2|||
156389048|NCT02415400|564515263|FG001|Overall Study|Participant no longer meets criteria|0|||
156389049|NCT02415400|564515264|FG002|Overall Study|Participant no longer meets criteria|0|||
156389050|NCT02415400|564515265|FG003|Overall Study|Participant no longer meets criteria|1|||
156389051|NCT02415400|564515262|FG000|Overall Study|Participant doesn't answer phone|1|||
156389052|NCT02415400|564515263|FG001|Overall Study|Participant doesn't answer phone|0|||
156389053|NCT02415400|564515264|FG002|Overall Study|Participant doesn't answer phone|0|||
156389054|NCT02415400|564515265|FG003|Overall Study|Participant doesn't answer phone|0|||
156389055|NCT02415400|564515262|FG000|Overall Study|Participant wanted home visits|1|||
156389056|NCT02415400|564515263|FG001|Overall Study|Participant wanted home visits|0|||
156389057|NCT02415400|564515264|FG002|Overall Study|Participant wanted home visits|0|||
156389058|NCT02415400|564515265|FG003|Overall Study|Participant wanted home visits|0|||
156389059|NCT02415400|564515262|FG000|Overall Study|Randomized in error|2|||
156389060|NCT02415400|564515263|FG001|Overall Study|Randomized in error|0|||
156389061|NCT02415400|564515264|FG002|Overall Study|Randomized in error|0|||
156389062|NCT02415400|564515265|FG003|Overall Study|Randomized in error|0|||
156389063|NCT02415400|564515262|FG000|Overall Study|No study drug on site|0|||
156389064|NCT02415400|564515263|FG001|Overall Study|No study drug on site|1|||
156389065|NCT02415400|564515264|FG002|Overall Study|No study drug on site|0|||
156389066|NCT02415400|564515265|FG003|Overall Study|No study drug on site|0|||
156389067|NCT02415400|564515262|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
156389068|NCT02415400|564515263|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
156389069|NCT02415400|564515264|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
156389070|NCT02415400|564515265|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
156389071|NCT02415400|564515262|FG000|Overall Study|Coagulation values cannot be set|0|||
156389072|NCT02415400|564515263|FG001|Overall Study|Coagulation values cannot be set|0|||
156389073|NCT02415400|564515264|FG002|Overall Study|Coagulation values cannot be set|1|||
156389074|NCT02415400|564515265|FG003|Overall Study|Coagulation values cannot be set|0|||
156389075|NCT02415400|564515262|FG000|Overall Study|State regulations prevent participation|0|||
156389076|NCT02415400|564515263|FG001|Overall Study|State regulations prevent participation|0|||
156389077|NCT02415400|564515264|FG002|Overall Study|State regulations prevent participation|1|||
156389078|NCT02415400|564515265|FG003|Overall Study|State regulations prevent participation|0|||
156389079|NCT02415400|564515262|FG000|Overall Study|Poor treatment monitoring|0|||
156389080|NCT02415400|564515263|FG001|Overall Study|Poor treatment monitoring|0|||
156389081|NCT02415400|564515264|FG002|Overall Study|Poor treatment monitoring|1|||
156389082|NCT02415400|564515265|FG003|Overall Study|Poor treatment monitoring|0|||
156389083|NCT02415400|564515262|FG000|Overall Study|Participant in jail|0|||
156389084|NCT02415400|564515263|FG001|Overall Study|Participant in jail|0|||
156389085|NCT02415400|564515264|FG002|Overall Study|Participant in jail|1|||
156389086|NCT02415400|564515265|FG003|Overall Study|Participant in jail|0|||
156389087|NCT02415400|564515262|FG000|Overall Study|Investigator decision|0|||
156389088|NCT02415400|564515263|FG001|Overall Study|Investigator decision|0|||
156389089|NCT02415400|564515264|FG002|Overall Study|Investigator decision|1|||
156389090|NCT02415400|564515265|FG003|Overall Study|Investigator decision|1|||
156389091|NCT02415400|564515262|FG000|Overall Study|Site closure; participant won't transfer|0|||
156389092|NCT02415400|564515263|FG001|Overall Study|Site closure; participant won't transfer|0|||
156389093|NCT02415400|564515264|FG002|Overall Study|Site closure; participant won't transfer|0|||
156389094|NCT02415400|564515265|FG003|Overall Study|Site closure; participant won't transfer|1|||
156389095|NCT01392560|564515271|FG000|Overall Study|Adverse Event|2|||
156389096|NCT01392560|564515271|FG000|Overall Study|not entered|8|||
156389097|NCT01392560|564515271|FG000|Overall Study|discontinued during placebo run-in|2|||
156389098|NCT02081846|564515276|FG000|Overall Study|Withdrawal by Subject|1|||
156389099|NCT02081846|564515277|FG001|Overall Study|Withdrawal by Subject|0|||
156389100|NCT02081846|564515276|FG000|Overall Study|invalid consent|1|||
156389101|NCT02081846|564515277|FG001|Overall Study|invalid consent|0|||
156389102|NCT01939028|564515278|FG000|Overall Study|Withdrawal by Subject|5|||
156389103|NCT01939028|564515278|FG000|Overall Study|Physician Decision|7|||
156389104|NCT00295750|564515282|FG000|Overall Study|Adverse Event|19|||
156389105|NCT00295750|564515283|FG001|Overall Study|Adverse Event|15|||
156389106|NCT00295750|564515284|FG002|Overall Study|Adverse Event|12|||
156389107|NCT00295750|564515282|FG000|Overall Study|Lack of Efficacy|1|||
156389108|NCT00295750|564515283|FG001|Overall Study|Lack of Efficacy|1|||
156389109|NCT00295750|564515284|FG002|Overall Study|Lack of Efficacy|0|||
156389110|NCT00295750|564515282|FG000|Overall Study|Lost to Follow-up|1|||
156389111|NCT00295750|564515283|FG001|Overall Study|Lost to Follow-up|4|||
156389112|NCT00295750|564515284|FG002|Overall Study|Lost to Follow-up|1|||
156389113|NCT00295750|564515282|FG000|Overall Study|Taking prohibited therapy|2|||
156389114|NCT00295750|564515283|FG001|Overall Study|Taking prohibited therapy|3|||
156389115|NCT00295750|564515284|FG002|Overall Study|Taking prohibited therapy|2|||
156507990|NCT00895895|564953011|FG003|Period 1|Protocol Violation|0|||
156507991|NCT00895895|564953012|FG004|Period 1|Protocol Violation|0|||
156507992|NCT00895895|564953008|FG000|Period 1|Withdrawal by Subject|6|||
156507993|NCT00895895|564953009|FG001|Period 1|Withdrawal by Subject|6|||
156507994|NCT00895895|564953010|FG002|Period 1|Withdrawal by Subject|8|||
156507995|NCT00895895|564953011|FG003|Period 1|Withdrawal by Subject|2|||
156507996|NCT00895895|564953012|FG004|Period 1|Withdrawal by Subject|4|||
156507997|NCT00895895|564953008|FG000|Period 1|unsatisfactory response-efficacy|2|||
156507998|NCT00895895|564953009|FG001|Period 1|unsatisfactory response-efficacy|0|||
156507999|NCT00895895|564953010|FG002|Period 1|unsatisfactory response-efficacy|0|||
156508000|NCT00895895|564953011|FG003|Period 1|unsatisfactory response-efficacy|0|||
156508001|NCT00895895|564953012|FG004|Period 1|unsatisfactory response-efficacy|0|||
156508002|NCT00895895|564953008|FG000|Period 1|randomized and not treated|1|||
156508003|NCT00895895|564953009|FG001|Period 1|randomized and not treated|3|||
156508004|NCT00895895|564953010|FG002|Period 1|randomized and not treated|1|||
156508005|NCT00895895|564953011|FG003|Period 1|randomized and not treated|1|||
156508006|NCT00895895|564953012|FG004|Period 1|randomized and not treated|2|||
156508007|NCT00895895|564953008|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
156508008|NCT00895895|564953009|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
156508009|NCT00895895|564953010|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
156508010|NCT00895895|564953011|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
156508011|NCT00895895|564953012|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
156508012|NCT00895895|564953008|FG000|After Period 1, Prior to Period 2|Other|0|||
156508013|NCT00895895|564953009|FG001|After Period 1, Prior to Period 2|Other|0|||
156508014|NCT00895895|564953010|FG002|After Period 1, Prior to Period 2|Other|1|||
156508015|NCT00895895|564953011|FG003|After Period 1, Prior to Period 2|Other|0|||
156508016|NCT00895895|564953012|FG004|After Period 1, Prior to Period 2|Other|0|||
156508017|NCT00895895|564953008|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
156508018|NCT00895895|564953009|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
156508019|NCT00895895|564953010|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
156508020|NCT00895895|564953011|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
156508021|NCT00895895|564953012|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
156508022|NCT00895895|564953008|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
156508023|NCT00895895|564953009|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
156508024|NCT00895895|564953010|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
156508025|NCT00895895|564953011|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
156508026|NCT00895895|564953012|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
156508027|NCT00895895|564953008|FG000|Period 2|Adverse Event|3|||
156508028|NCT00895895|564953009|FG001|Period 2|Adverse Event|3|||
156508029|NCT00895895|564953010|FG002|Period 2|Adverse Event|5|||
156508030|NCT00895895|564953011|FG003|Period 2|Adverse Event|2|||
156508031|NCT00895895|564953012|FG004|Period 2|Adverse Event|5|||
156508032|NCT00895895|564953008|FG000|Period 2|Death|0|||
156508033|NCT00895895|564953009|FG001|Period 2|Death|0|||
156508034|NCT00895895|564953010|FG002|Period 2|Death|1|||
156508035|NCT00895895|564953011|FG003|Period 2|Death|0|||
156508036|NCT00895895|564953012|FG004|Period 2|Death|0|||
156508037|NCT00895895|564953008|FG000|Period 2|discontinued by sponsor|44|||
156508038|NCT00895895|564953009|FG001|Period 2|discontinued by sponsor|44|||
156389116|NCT00295750|564515282|FG000|Overall Study|Administrative errors|2|||
156389117|NCT00295750|564515283|FG001|Overall Study|Administrative errors|4|||
156508039|NCT00895895|564953010|FG002|Period 2|discontinued by sponsor|38|||
156508040|NCT00895895|564953011|FG003|Period 2|discontinued by sponsor|46|||
156508041|NCT00895895|564953012|FG004|Period 2|discontinued by sponsor|37|||
156508042|NCT00895895|564953008|FG000|Period 2|failed to return|2|||
156508043|NCT00895895|564953009|FG001|Period 2|failed to return|0|||
156508044|NCT00895895|564953010|FG002|Period 2|failed to return|0|||
156508045|NCT00895895|564953011|FG003|Period 2|failed to return|0|||
156508046|NCT00895895|564953012|FG004|Period 2|failed to return|0|||
156508047|NCT00895895|564953008|FG000|Period 2|investigator request|2|||
156508048|NCT00895895|564953009|FG001|Period 2|investigator request|0|||
156508049|NCT00895895|564953010|FG002|Period 2|investigator request|0|||
156389118|NCT00295750|564515284|FG002|Overall Study|Administrative errors|5|||
156389119|NCT00295750|564515282|FG000|Overall Study|Trial drug errors|1|||
156389120|NCT00295750|564515283|FG001|Overall Study|Trial drug errors|1|||
156389121|NCT00295750|564515284|FG002|Overall Study|Trial drug errors|0|||
156389122|NCT00295750|564515282|FG000|Overall Study|Disease progression|2|||
156389123|NCT00295750|564515283|FG001|Overall Study|Disease progression|1|||
156389124|NCT00295750|564515284|FG002|Overall Study|Disease progression|0|||
156389125|NCT00295750|564515282|FG000|Overall Study|Personal reasons|0|||
156389126|NCT00295750|564515283|FG001|Overall Study|Personal reasons|1|||
156389127|NCT00295750|564515284|FG002|Overall Study|Personal reasons|0|||
156389128|NCT00295750|564515282|FG000|Overall Study|Randomized but never received trial drug|4|||
156389129|NCT00295750|564515283|FG001|Overall Study|Randomized but never received trial drug|3|||
156389130|NCT00295750|564515284|FG002|Overall Study|Randomized but never received trial drug|3|||
156389131|NCT00295750|564515282|FG000|Overall Study|Withdrawal by Subject|9|||
156389132|NCT00295750|564515283|FG001|Overall Study|Withdrawal by Subject|4|||
156389133|NCT00295750|564515284|FG002|Overall Study|Withdrawal by Subject|7|||
156389134|NCT00295750|564515282|FG000|Overall Study|Protocol Violation|2|||
156389135|NCT00295750|564515283|FG001|Overall Study|Protocol Violation|4|||
156389136|NCT00295750|564515284|FG002|Overall Study|Protocol Violation|2|||
156389137|NCT00322348|564515285|FG000|Overall Study|Adverse Event|0|||
156389138|NCT00322348|564515286|FG001|Overall Study|Adverse Event|1|||
156389139|NCT00322348|564515285|FG000|Overall Study|Withdrawal by Subject|1|||
156389140|NCT00322348|564515286|FG001|Overall Study|Withdrawal by Subject|4|||
156389141|NCT00322348|564515285|FG000|Overall Study|Lost to Follow-up|1|||
156389142|NCT00322348|564515286|FG001|Overall Study|Lost to Follow-up|0|||
156389143|NCT00322348|564515285|FG000|Overall Study|Death|0|||
156389144|NCT00322348|564515286|FG001|Overall Study|Death|2|||
156389145|NCT00322348|564515285|FG000|Overall Study|Disease Progression|30|||
156389146|NCT00322348|564515286|FG001|Overall Study|Disease Progression|25|||
156389147|NCT00322348|564515285|FG000|Overall Study|Reasons not specified|5|||
156389148|NCT00322348|564515286|FG001|Overall Study|Reasons not specified|1|||
156389149|NCT01650259|564515287|FG000|Overall Study|Improvement|105|||
156389150|NCT01650259|564515288|FG001|Overall Study|Improvement|0|||
156389151|NCT01650259|564515287|FG000|Overall Study|Adverse Event|127|||
156389152|NCT01650259|564515288|FG001|Overall Study|Adverse Event|0|||
156389153|NCT01650259|564515287|FG000|Overall Study|Lack of Efficacy|143|||
156389154|NCT01650259|564515288|FG001|Overall Study|Lack of Efficacy|0|||
156389155|NCT01650259|564515287|FG000|Overall Study|Lost to Follow-up|435|||
156389156|NCT01650259|564515288|FG001|Overall Study|Lost to Follow-up|0|||
156389157|NCT01650259|564515287|FG000|Overall Study|Patients had no visit after entry|70|||
156508050|NCT00895895|564953011|FG003|Period 2|investigator request|0|||
156508051|NCT00895895|564953012|FG004|Period 2|investigator request|0|||
156508052|NCT00895895|564953008|FG000|Period 2|Lost to Follow-up|1|||
156508053|NCT00895895|564953009|FG001|Period 2|Lost to Follow-up|2|||
156508054|NCT00895895|564953010|FG002|Period 2|Lost to Follow-up|1|||
156508055|NCT00895895|564953011|FG003|Period 2|Lost to Follow-up|1|||
156508056|NCT00895895|564953012|FG004|Period 2|Lost to Follow-up|0|||
156508057|NCT00895895|564953008|FG000|Period 2|Other|1|||
156508058|NCT00895895|564953009|FG001|Period 2|Other|1|||
156508059|NCT00895895|564953010|FG002|Period 2|Other|3|||
156508060|NCT00895895|564953011|FG003|Period 2|Other|1|||
156508061|NCT00895895|564953012|FG004|Period 2|Other|1|||
156508062|NCT00895895|564953008|FG000|Period 2|Protocol Violation|1|||
156508063|NCT00895895|564953009|FG001|Period 2|Protocol Violation|0|||
156508064|NCT00895895|564953010|FG002|Period 2|Protocol Violation|1|||
156508065|NCT00895895|564953011|FG003|Period 2|Protocol Violation|1|||
156508066|NCT00895895|564953012|FG004|Period 2|Protocol Violation|1|||
156508067|NCT00895895|564953008|FG000|Period 2|Withdrawal by Subject|0|||
156508068|NCT00895895|564953009|FG001|Period 2|Withdrawal by Subject|2|||
156508069|NCT00895895|564953010|FG002|Period 2|Withdrawal by Subject|0|||
156508070|NCT00895895|564953011|FG003|Period 2|Withdrawal by Subject|3|||
156508071|NCT00895895|564953012|FG004|Period 2|Withdrawal by Subject|5|||
156508072|NCT00895895|564953008|FG000|Period 2|unsatisfactory response-efficacy|2|||
156508073|NCT00895895|564953009|FG001|Period 2|unsatisfactory response-efficacy|1|||
156508074|NCT00895895|564953010|FG002|Period 2|unsatisfactory response-efficacy|0|||
156508075|NCT00895895|564953011|FG003|Period 2|unsatisfactory response-efficacy|0|||
156508076|NCT00895895|564953012|FG004|Period 2|unsatisfactory response-efficacy|0|||
156508077|NCT03019640|564953013|FG000|Overall Study|Screen Failures|4|||
156508078|NCT03019640|564953013|FG000|Overall Study|Adverse Event|3|||
156508079|NCT03019640|564953013|FG000|Overall Study|Participant Relapsed|1|||
156508080|NCT01889069|564953014|FG000|Overall Study|Death|18|||
156508081|NCT01889069|564953014|FG000|Overall Study|Progression of Disease|14|||
156508082|NCT01889069|564953014|FG000|Overall Study|Lost to Follow-up|6|||
156508083|NCT01889069|564953014|FG000|Overall Study|Other|4|||
156508084|NCT01889069|564953014|FG000|Overall Study|Consent Withdrawal|3|||
156508085|NCT01426347|564953018|FG000|Overall Study|Lost to Follow-up|0|||
156389158|NCT01650259|564515288|FG001|Overall Study|Patients had no visit after entry|0|||
156508086|NCT01426347|564953019|FG001|Overall Study|Lost to Follow-up|3|||
156508087|NCT01426347|564953018|FG000|Overall Study|Protocol Violation|2|||
156508088|NCT01426347|564953019|FG001|Overall Study|Protocol Violation|0|||
156389159|NCT01650259|564515287|FG000|Overall Study|CRF not collected|98|||
156389160|NCT01650259|564515288|FG001|Overall Study|CRF not collected|82|||
156389161|NCT01650259|564515287|FG000|Overall Study|Not treated|1|||
156389162|NCT01650259|564515288|FG001|Overall Study|Not treated|7|||
156389163|NCT01650259|564515287|FG000|Overall Study|Other than listed|64|||
156389164|NCT01650259|564515288|FG001|Overall Study|Other than listed|146|||
156389165|NCT00936858|564515289|FG000|Overall Study|Death|3|||
156389166|NCT00936858|564515289|FG000|Overall Study|Progression|29|||
156389167|NCT00936858|564515289|FG000|Overall Study|Withdrawal by Subject|5|||
156389168|NCT00936858|564515289|FG000|Overall Study|Adverse Event|1|||
156389169|NCT00936858|564515289|FG000|Overall Study|Physician Decision|7|||
156389170|NCT00936858|564515289|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
156389171|NCT00936858|564515289|FG000|Overall Study|Lost to Follow-up|1|||
156389172|NCT00584727|564515298|FG000|First Intervention|Discontinuation|0|||
156389173|NCT00584727|564515299|FG001|First Intervention|Discontinuation|0|||
156389174|NCT00584727|564515300|FG002|First Intervention|Discontinuation|1|||
156389175|NCT00584727|564515301|FG003|First Intervention|Discontinuation|0|||
156389176|NCT00584727|564515302|FG004|First Intervention|Discontinuation|0|||
156389177|NCT00584727|564515303|FG005|First Intervention|Discontinuation|0|||
156389178|NCT00584727|564515298|FG000|Third Intervention|Protocol Violation|0|||
156389179|NCT00584727|564515299|FG001|Third Intervention|Protocol Violation|0|||
156389180|NCT00584727|564515300|FG002|Third Intervention|Protocol Violation|1|||
156389181|NCT00584727|564515301|FG003|Third Intervention|Protocol Violation|0|||
156389182|NCT00584727|564515302|FG004|Third Intervention|Protocol Violation|4|||
156389183|NCT00584727|564515303|FG005|Third Intervention|Protocol Violation|2|||
156389184|NCT00989287|564515307|FG000|Overall Study|Adverse Event|1|||
156389185|NCT00989287|564515308|FG001|Overall Study|Adverse Event|0|||
156389186|NCT00989287|564515307|FG000|Overall Study|Lost to Follow-up|0|||
156389187|NCT00989287|564515308|FG001|Overall Study|Lost to Follow-up|1|||
156389188|NCT00695669|564515309|FG000|Overall Study|Adverse Event|0|||
156389189|NCT00695669|564515310|FG001|Overall Study|Adverse Event|0|||
156389190|NCT00695669|564515311|FG002|Overall Study|Adverse Event|2|||
156389191|NCT00695669|564515312|FG003|Overall Study|Adverse Event|0|||
156389192|NCT00695669|564515309|FG000|Overall Study|Lost to Follow-up|4|||
156389193|NCT00695669|564515310|FG001|Overall Study|Lost to Follow-up|4|||
156389194|NCT00695669|564515311|FG002|Overall Study|Lost to Follow-up|1|||
156389195|NCT00695669|564515312|FG003|Overall Study|Lost to Follow-up|4|||
156389196|NCT00092131|564515313|FG000|Treatment Period I|Adverse Event|1|||
156389197|NCT00092131|564515314|FG001|Treatment Period I|Adverse Event|0|||
156389198|NCT00092131|564515313|FG000|Treatment Period II|Adverse Event|0|||
156389199|NCT00092131|564515314|FG001|Treatment Period II|Adverse Event|1|||
156389200|NCT02341417|564515315|FG000|Overall Study|Withdrawal by Subject|0|||
156389201|NCT02341417|564515316|FG001|Overall Study|Withdrawal by Subject|2|||
156389202|NCT02341417|564515317|FG002|Overall Study|Withdrawal by Subject|0|||
156389203|NCT02341417|564515315|FG000|Overall Study|Decision by sponsor|2|||
156389204|NCT02341417|564515316|FG001|Overall Study|Decision by sponsor|0|||
156389205|NCT02341417|564515317|FG002|Overall Study|Decision by sponsor|0|||
156389206|NCT02341417|564515315|FG000|Overall Study|Death|0|||
156389207|NCT02341417|564515316|FG001|Overall Study|Death|0|||
156389208|NCT02341417|564515317|FG002|Overall Study|Death|1|||
156389209|NCT03738150|564515339|FG000|Base Study|Withdrawal by Subject|1|||
156389210|NCT03738150|564515339|FG000|Extension Study|Withdrawal by Subject|1|||
156389211|NCT01358526|564515342|FG000|Open-label Titration Period|Adverse Event|95|||
156389212|NCT01358526|564515343|FG001|Open-label Titration Period|Adverse Event|0|||
156389213|NCT01358526|564515344|FG002|Open-label Titration Period|Adverse Event|0|||
156389214|NCT01358526|564515342|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
156389215|NCT01358526|564515343|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
156389216|NCT01358526|564515344|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
156389217|NCT01358526|564515342|FG000|Open-label Titration Period|Lost to Follow-up|25|||
156389218|NCT01358526|564515343|FG001|Open-label Titration Period|Lost to Follow-up|0|||
156389219|NCT01358526|564515344|FG002|Open-label Titration Period|Lost to Follow-up|0|||
156389220|NCT01358526|564515342|FG000|Open-label Titration Period|Lack of Efficacy|107|||
156508089|NCT01426347|564953018|FG000|Overall Study|Withdrawal by Subject|5|||
156508090|NCT01426347|564953019|FG001|Overall Study|Withdrawal by Subject|0|||
156508091|NCT00455741|564953020|FG000|Overall Study|Physician Decision|0|||
156508092|NCT00455741|564953021|FG001|Overall Study|Physician Decision|1|||
156389221|NCT01358526|564515343|FG001|Open-label Titration Period|Lack of Efficacy|0|||
156389222|NCT01358526|564515344|FG002|Open-label Titration Period|Lack of Efficacy|0|||
156389223|NCT01358526|564515342|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
156389224|NCT01358526|564515343|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
156389225|NCT01358526|564515344|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
156389226|NCT01358526|564515342|FG000|Open-label Titration Period|Administrative|8|||
156389227|NCT01358526|564515343|FG001|Open-label Titration Period|Administrative|0|||
156508093|NCT01509547|564953022|FG000|Overall Study|Lost to Follow-up|24|||
156389228|NCT01358526|564515344|FG002|Open-label Titration Period|Administrative|0|||
156389229|NCT01358526|564515342|FG000|Open-label Titration Period|Did not qualify|178|||
156389230|NCT01358526|564515343|FG001|Open-label Titration Period|Did not qualify|0|||
156389231|NCT01358526|564515344|FG002|Open-label Titration Period|Did not qualify|0|||
156389232|NCT01358526|564515342|FG000|Double-blind Phase|Adverse Event|0|||
156389233|NCT01358526|564515343|FG001|Double-blind Phase|Adverse Event|24|||
156389234|NCT01358526|564515344|FG002|Double-blind Phase|Adverse Event|23|||
156389235|NCT01358526|564515342|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156389236|NCT01358526|564515343|FG001|Double-blind Phase|Withdrawal by Subject|10|||
156389237|NCT01358526|564515344|FG002|Double-blind Phase|Withdrawal by Subject|8|||
156389238|NCT01358526|564515342|FG000|Double-blind Phase|Lost to Follow-up|0|||
156389239|NCT01358526|564515343|FG001|Double-blind Phase|Lost to Follow-up|4|||
156389240|NCT01358526|564515344|FG002|Double-blind Phase|Lost to Follow-up|1|||
156389241|NCT01358526|564515342|FG000|Double-blind Phase|Lack of Efficacy|0|||
156389242|NCT01358526|564515343|FG001|Double-blind Phase|Lack of Efficacy|31|||
156389243|NCT01358526|564515344|FG002|Double-blind Phase|Lack of Efficacy|73|||
156389244|NCT01358526|564515342|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
156389245|NCT01358526|564515343|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
156389246|NCT01358526|564515344|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
156389247|NCT01358526|564515342|FG000|Double-blind Phase|Administrative|0|||
156389248|NCT01358526|564515343|FG001|Double-blind Phase|Administrative|6|||
156389249|NCT01358526|564515344|FG002|Double-blind Phase|Administrative|10|||
156389250|NCT02493127|564515347|FG000|Overall Study|Lost to Follow-up|1|||
156389251|NCT02493127|564515348|FG001|Overall Study|Lost to Follow-up|1|||
156389252|NCT00714168|564515349|FG000|Overall Study|Pregnancy|5|||
156389253|NCT00714168|564515350|FG001|Overall Study|Pregnancy|4|||
156389254|NCT00714168|564515349|FG000|Overall Study|Lost to Follow-up|32|||
156389255|NCT00714168|564515350|FG001|Overall Study|Lost to Follow-up|50|||
156389256|NCT00714168|564515349|FG000|Overall Study|Relocation|4|||
156389257|NCT00714168|564515350|FG001|Overall Study|Relocation|3|||
156389258|NCT00714168|564515349|FG000|Overall Study|Non-study medical condition|3|||
156389259|NCT00714168|564515350|FG001|Overall Study|Non-study medical condition|2|||
156389260|NCT04988308|564515352|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
156389261|NCT04988308|564515353|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
156389262|NCT04988308|564515354|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
156389263|NCT04988308|564515355|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156389264|NCT04988308|564515356|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156389265|NCT04988308|564515357|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156389266|NCT04988308|564515352|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156389267|NCT04988308|564515353|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156389268|NCT04988308|564515354|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
156389269|NCT04988308|564515355|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156389270|NCT04988308|564515356|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156389271|NCT04988308|564515357|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156389272|NCT04988308|564515352|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
156389273|NCT04988308|564515353|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
156389274|NCT04988308|564515354|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
156389275|NCT04988308|564515355|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
156389276|NCT04988308|564515356|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
156389277|NCT04988308|564515357|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
156389278|NCT04988308|564515352|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
156389279|NCT04988308|564515353|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
156389280|NCT04988308|564515354|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
156389281|NCT04988308|564515355|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156389282|NCT04988308|564515356|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156389283|NCT04988308|564515357|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156389284|NCT04988308|564515352|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
156389285|NCT04988308|564515353|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
156389286|NCT04988308|564515354|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
156389287|NCT04988308|564515355|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
156389288|NCT04988308|564515356|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
156389289|NCT04988308|564515357|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
156389290|NCT04988308|564515352|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156389291|NCT04988308|564515353|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156389292|NCT04988308|564515354|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156389293|NCT04988308|564515355|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
156389294|NCT04988308|564515356|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
156389295|NCT04988308|564515357|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
156389296|NCT04988308|564515352|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156389297|NCT04988308|564515353|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156547812|NCT03016325|565098429|FG005|Treatment Period|Death|0|||
156547813|NCT03016325|565098430|FG006|Treatment Period|Death|0|||
156389298|NCT04988308|564515354|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156389299|NCT04988308|564515355|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
156389300|NCT04988308|564515356|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
156389301|NCT04988308|564515357|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
156389302|NCT04988308|564515352|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156389303|NCT04988308|564515353|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156389304|NCT04988308|564515354|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156389305|NCT04988308|564515355|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
156389306|NCT04988308|564515356|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
156389307|NCT04988308|564515357|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
156389308|NCT04988308|564515352|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
156389309|NCT04988308|564515353|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
156389310|NCT04988308|564515354|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
156389311|NCT04988308|564515355|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
156389312|NCT04988308|564515356|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
156389313|NCT04988308|564515357|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
156389314|NCT00809757|564515358|FG000|Overall Study|Adverse Event|2|||
156389315|NCT00809757|564515359|FG001|Overall Study|Adverse Event|3|||
156389316|NCT00809757|564515360|FG002|Overall Study|Adverse Event|3|||
156389317|NCT00809757|564515358|FG000|Overall Study|Lost to Follow-up|0|||
156389318|NCT00809757|564515359|FG001|Overall Study|Lost to Follow-up|0|||
156389319|NCT00809757|564515360|FG002|Overall Study|Lost to Follow-up|1|||
156389320|NCT00809757|564515358|FG000|Overall Study|Protocol Violation|1|||
156389321|NCT00809757|564515359|FG001|Overall Study|Protocol Violation|1|||
156389322|NCT00809757|564515360|FG002|Overall Study|Protocol Violation|1|||
156389323|NCT00809757|564515358|FG000|Overall Study|Withdrawal by Subject|2|||
156389324|NCT00809757|564515359|FG001|Overall Study|Withdrawal by Subject|1|||
156389325|NCT00809757|564515360|FG002|Overall Study|Withdrawal by Subject|3|||
156389326|NCT00809757|564515358|FG000|Overall Study|Subject Uncooperative|1|||
156389327|NCT00809757|564515359|FG001|Overall Study|Subject Uncooperative|0|||
156389328|NCT00809757|564515360|FG002|Overall Study|Subject Uncooperative|2|||
156389329|NCT00809757|564515358|FG000|Overall Study|Noncompliance with Medication|0|||
156389330|NCT00809757|564515359|FG001|Overall Study|Noncompliance with Medication|0|||
156389331|NCT00809757|564515360|FG002|Overall Study|Noncompliance with Medication|1|||
156389332|NCT02979639|564518053|FG000|Overall Study|Withdrawal based on medical judgement|1|||
156389333|NCT02979639|564518053|FG000|Overall Study|Lost to Follow-up|8|||
156389334|NCT02979639|564518053|FG000|Overall Study|Withdrawal by Subject|3|||
156389335|NCT02979639|564518053|FG000|Overall Study|Adverse Event|2|||
156389336|NCT01877408|564518057|FG000|Overall Study|Lost to Follow-up|0|||
156389337|NCT01877408|564518058|FG001|Overall Study|Lost to Follow-up|2|||
156389338|NCT02621931|564518059|FG000|Overall Study|Death|0|||
156389339|NCT02621931|564518060|FG001|Overall Study|Death|1|||
156389340|NCT02621931|564518061|FG002|Overall Study|Death|0|||
156389341|NCT02621931|564518059|FG000|Overall Study|Adverse Event|8|||
156389342|NCT02621931|564518060|FG001|Overall Study|Adverse Event|5|||
156389343|NCT02621931|564518061|FG002|Overall Study|Adverse Event|7|||
156389344|NCT02621931|564518059|FG000|Overall Study|Withdrawal by Subject|12|||
156389345|NCT02621931|564518060|FG001|Overall Study|Withdrawal by Subject|10|||
156389346|NCT02621931|564518061|FG002|Overall Study|Withdrawal by Subject|11|||
156389347|NCT02621931|564518059|FG000|Overall Study|Protocol Violation|2|||
156389348|NCT02621931|564518060|FG001|Overall Study|Protocol Violation|2|||
156389349|NCT02621931|564518061|FG002|Overall Study|Protocol Violation|2|||
156389350|NCT02621931|564518059|FG000|Overall Study|Pregnancy|2|||
156389351|NCT02621931|564518060|FG001|Overall Study|Pregnancy|0|||
156389352|NCT02621931|564518061|FG002|Overall Study|Pregnancy|0|||
156389353|NCT02621931|564518059|FG000|Overall Study|Noncompliance to study procedures|0|||
156389354|NCT02621931|564518060|FG001|Overall Study|Noncompliance to study procedures|1|||
156389355|NCT02621931|564518061|FG002|Overall Study|Noncompliance to study procedures|2|||
156389356|NCT02621931|564518059|FG000|Overall Study|Lost to Follow-up|8|||
156389357|NCT02621931|564518060|FG001|Overall Study|Lost to Follow-up|7|||
156389358|NCT02621931|564518061|FG002|Overall Study|Lost to Follow-up|10|||
156389359|NCT02621931|564518059|FG000|Overall Study|Lack of Efficacy|0|||
156547814|NCT03016325|565098431|FG007|Treatment Period|Death|0|||
156389360|NCT02621931|564518060|FG001|Overall Study|Lack of Efficacy|0|||
156389361|NCT02621931|564518061|FG002|Overall Study|Lack of Efficacy|1|||
156389362|NCT02621931|564518059|FG000|Overall Study|Other|1|||
156389363|NCT02621931|564518060|FG001|Overall Study|Other|1|||
156389364|NCT02621931|564518061|FG002|Overall Study|Other|3|||
156389365|NCT01292603|564518062|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156389366|NCT01292603|564518063|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156389367|NCT01292603|564518064|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156389368|NCT01292603|564518065|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
156389369|NCT01292603|564518066|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156389370|NCT01292603|564518067|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156389371|NCT01292603|564518062|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
156389372|NCT01292603|564518063|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
156389373|NCT01292603|564518064|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
156389374|NCT01292603|564518065|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
156389375|NCT01292603|564518066|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
156389376|NCT01292603|564518067|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
156389377|NCT01292603|564518062|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156389378|NCT01292603|564518063|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156389379|NCT01292603|564518064|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156389380|NCT01292603|564518065|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
156389381|NCT01292603|564518066|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156389382|NCT01292603|564518067|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156389383|NCT01292603|564518062|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156389384|NCT01292603|564518063|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156389385|NCT01292603|564518064|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156389386|NCT01292603|564518065|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
156389387|NCT01292603|564518066|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156389388|NCT01292603|564518067|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156389389|NCT01292603|564518062|FG000|Part 1: Regular Follow-Up Period|Death|3|||
156389390|NCT01292603|564518063|FG001|Part 1: Regular Follow-Up Period|Death|1|||
156389391|NCT01292603|564518064|FG002|Part 1: Regular Follow-Up Period|Death|3|||
156389392|NCT01292603|564518065|FG003|Part 1: Regular Follow-Up Period|Death|1|||
156389393|NCT01292603|564518066|FG004|Part 1: Regular Follow-Up Period|Death|0|||
156389394|NCT01292603|564518067|FG005|Part 1: Regular Follow-Up Period|Death|0|||
156389395|NCT01292603|564518062|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
156389396|NCT01292603|564518063|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
156389397|NCT01292603|564518064|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
156389398|NCT01292603|564518065|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
156389399|NCT01292603|564518066|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
156389400|NCT01292603|564518067|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
156389401|NCT01292603|564518062|FG000|Part 2: Dose Confirmation Period|Death|0|||
156389402|NCT01292603|564518063|FG001|Part 2: Dose Confirmation Period|Death|0|||
156389403|NCT01292603|564518064|FG002|Part 2: Dose Confirmation Period|Death|0|||
156389404|NCT01292603|564518065|FG003|Part 2: Dose Confirmation Period|Death|0|||
156389405|NCT01292603|564518066|FG004|Part 2: Dose Confirmation Period|Death|1|||
156389406|NCT01292603|564518067|FG005|Part 2: Dose Confirmation Period|Death|0|||
156389407|NCT01292603|564518062|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
156389408|NCT01292603|564518063|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
156389409|NCT01292603|564518064|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
156389410|NCT01292603|564518065|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
156389411|NCT01292603|564518066|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
156389412|NCT01292603|564518067|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
156389413|NCT01292603|564518062|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
156389414|NCT01292603|564518063|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
156389415|NCT01292603|564518064|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
156389416|NCT01292603|564518065|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
156389417|NCT01292603|564518066|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
156389418|NCT01292603|564518067|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
156389419|NCT01292603|564518062|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
156389420|NCT01292603|564518063|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
156389421|NCT01292603|564518064|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
156389422|NCT01292603|564518065|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
156389423|NCT01292603|564518066|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
156389424|NCT01292603|564518067|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
156389425|NCT01292603|564518062|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
156389426|NCT01292603|564518063|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
156389427|NCT01292603|564518064|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
156389428|NCT01292603|564518065|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
156389429|NCT01292603|564518066|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
156389430|NCT01292603|564518067|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
156389431|NCT01292603|564518062|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156389432|NCT01292603|564518063|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156508094|NCT01509547|564953023|FG001|Overall Study|Lost to Follow-up|14|||
156508095|NCT01509547|564953022|FG000|Overall Study|Withdrawal by Subject|11|||
156389433|NCT01292603|564518064|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156389434|NCT01292603|564518065|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156508096|NCT01509547|564953023|FG001|Overall Study|Withdrawal by Subject|24|||
156508097|NCT01509547|564953022|FG000|Overall Study|Physician Decision|0|||
156508098|NCT01509547|564953023|FG001|Overall Study|Physician Decision|1|||
156389435|NCT01292603|564518066|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156389436|NCT01292603|564518067|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
156389437|NCT01292603|564518062|FG000|Part 2: Regular Follow-Up|Death|0|||
156389438|NCT01292603|564518063|FG001|Part 2: Regular Follow-Up|Death|0|||
156389439|NCT01292603|564518064|FG002|Part 2: Regular Follow-Up|Death|0|||
156389440|NCT01292603|564518065|FG003|Part 2: Regular Follow-Up|Death|0|||
156389441|NCT01292603|564518066|FG004|Part 2: Regular Follow-Up|Death|6|||
156389442|NCT01292603|564518067|FG005|Part 2: Regular Follow-Up|Death|3|||
156389443|NCT01292603|564518062|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
156389444|NCT01292603|564518063|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
156389445|NCT01292603|564518064|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
156389446|NCT01292603|564518065|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
156389447|NCT01292603|564518066|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
156389448|NCT01292603|564518067|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
156389449|NCT01292603|564518062|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
156389450|NCT01292603|564518063|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
156389451|NCT01292603|564518064|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
156389452|NCT01292603|564518065|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
156389453|NCT01292603|564518066|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
156389454|NCT01292603|564518067|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
156389455|NCT01292603|564518062|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156389456|NCT01292603|564518063|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156389457|NCT01292603|564518064|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156389458|NCT01292603|564518065|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156389459|NCT01292603|564518066|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156389460|NCT01292603|564518067|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
156389461|NCT01292603|564518062|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
156389462|NCT01292603|564518063|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
156389463|NCT01292603|564518064|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
156389464|NCT01292603|564518065|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
156389465|NCT01292603|564518066|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
156389466|NCT01292603|564518067|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
156389467|NCT01292603|564518062|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
156389468|NCT01292603|564518063|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
156389469|NCT01292603|564518064|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
156389470|NCT01292603|564518065|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
156389471|NCT01292603|564518066|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
156389472|NCT01292603|564518067|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
156389473|NCT01292603|564518062|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
156389474|NCT01292603|564518063|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
156389475|NCT01292603|564518064|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
156389476|NCT01292603|564518065|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
156389477|NCT01292603|564518066|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
156389478|NCT01292603|564518067|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
156389479|NCT01292603|564518062|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
156389480|NCT01292603|564518063|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
156389481|NCT01292603|564518064|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
156389482|NCT01292603|564518065|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
156389483|NCT01292603|564518066|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
156389484|NCT01292603|564518067|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
156389485|NCT01292603|564518062|FG000|Overall Survival Status|Death|3|||
156389486|NCT01292603|564518063|FG001|Overall Survival Status|Death|1|||
156389487|NCT01292603|564518064|FG002|Overall Survival Status|Death|3|||
156389488|NCT01292603|564518065|FG003|Overall Survival Status|Death|1|||
156389489|NCT01292603|564518066|FG004|Overall Survival Status|Death|16|||
156389490|NCT01292603|564518067|FG005|Overall Survival Status|Death|10|||
156389491|NCT03870763|564518070|FG000|Overall Study|Study terminated by sponsor|0|||
156389492|NCT03870763|564518071|FG001|Overall Study|Study terminated by sponsor|2|||
156389493|NCT03870763|564518072|FG002|Overall Study|Study terminated by sponsor|0|||
156389494|NCT03870763|564518070|FG000|Overall Study|Withdrawal by Subject|0|||
156389495|NCT03870763|564518071|FG001|Overall Study|Withdrawal by Subject|1|||
156508099|NCT02514551|564953024|FG000|Overall Study|Lost to Follow-up|0|||
156389496|NCT03870763|564518072|FG002|Overall Study|Withdrawal by Subject|0|||
156389497|NCT03870763|564518070|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
156389498|NCT03870763|564518071|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
156508100|NCT02514551|564953025|FG001|Overall Study|Lost to Follow-up|1|||
156508101|NCT02514551|564953024|FG000|Overall Study|Participant Never Treated|0|||
156389499|NCT03870763|564518072|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
156389500|NCT02985866|564518073|FG000|Overall Study|Poor CGM data|1|||
156389501|NCT02985866|564518074|FG001|Overall Study|Poor CGM data|1|||
156389502|NCT04279314|564518075|FG000|Overall Study|Adverse Event|55|||
156389503|NCT04279314|564518075|FG000|Overall Study|Withdrawal by Subject|5|||
156389504|NCT04279314|564518075|FG000|Overall Study|Lack of Efficacy|5|||
156389505|NCT04279314|564518075|FG000|Overall Study|Protocol Violation|3|||
156389506|NCT04279314|564518075|FG000|Overall Study|Other (not COVID-19 related)|2|||
156389507|NCT02120027|564518076|FG000|Overall Study|Adverse Event|4|||
156389508|NCT02120027|564518077|FG001|Overall Study|Adverse Event|5|||
156389509|NCT02120027|564518076|FG000|Overall Study|Lack of Efficacy|3|||
156389510|NCT02120027|564518077|FG001|Overall Study|Lack of Efficacy|5|||
156389511|NCT02120027|564518076|FG000|Overall Study|Lost to Follow-up|5|||
156389512|NCT02120027|564518077|FG001|Overall Study|Lost to Follow-up|13|||
156389513|NCT02120027|564518076|FG000|Overall Study|Other|4|||
156389514|NCT02120027|564518077|FG001|Overall Study|Other|0|||
156389515|NCT02120027|564518076|FG000|Overall Study|Physician Decision|4|||
156389516|NCT02120027|564518077|FG001|Overall Study|Physician Decision|3|||
156389517|NCT02120027|564518076|FG000|Overall Study|Protocol Violation|18|||
156389518|NCT02120027|564518077|FG001|Overall Study|Protocol Violation|21|||
156389519|NCT02120027|564518076|FG000|Overall Study|Study terminated by Sponsor|45|||
156389520|NCT02120027|564518077|FG001|Overall Study|Study terminated by Sponsor|47|||
156389521|NCT02120027|564518076|FG000|Overall Study|Withdrawal by Subject|33|||
156389522|NCT02120027|564518077|FG001|Overall Study|Withdrawal by Subject|25|||
156389523|NCT01471054|564518082|FG000|Overall Study|Study terminated prematurely|4|||
156389524|NCT01471054|564518083|FG001|Overall Study|Study terminated prematurely|0|||
156389525|NCT00360308|564518084|FG000|Overall Study|Adverse Event|15|||
156389526|NCT00360308|564518085|FG001|Overall Study|Adverse Event|14|||
156389527|NCT00360308|564518086|FG002|Overall Study|Adverse Event|25|||
156389528|NCT00360308|564518084|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
156389529|NCT00360308|564518085|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
156389530|NCT00360308|564518086|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
156389531|NCT00360308|564518084|FG000|Overall Study|Protocol Violation|2|||
156389532|NCT00360308|564518085|FG001|Overall Study|Protocol Violation|1|||
156389533|NCT00360308|564518086|FG002|Overall Study|Protocol Violation|2|||
156389534|NCT00360308|564518084|FG000|Overall Study|Withdrawal by Subject|11|||
156389535|NCT00360308|564518085|FG001|Overall Study|Withdrawal by Subject|7|||
156389536|NCT00360308|564518086|FG002|Overall Study|Withdrawal by Subject|14|||
156389537|NCT00360308|564518084|FG000|Overall Study|Lack of Efficacy|3|||
156389538|NCT00360308|564518085|FG001|Overall Study|Lack of Efficacy|0|||
156389539|NCT00360308|564518086|FG002|Overall Study|Lack of Efficacy|2|||
156389540|NCT00360308|564518084|FG000|Overall Study|Other|2|||
156389541|NCT00360308|564518085|FG001|Overall Study|Other|1|||
156389542|NCT00360308|564518086|FG002|Overall Study|Other|1|||
156389543|NCT00360308|564518084|FG000|Overall Study|Study termination by sponsor|43|||
156389544|NCT00360308|564518085|FG001|Overall Study|Study termination by sponsor|55|||
156389545|NCT00360308|564518086|FG002|Overall Study|Study termination by sponsor|44|||
156389546|NCT04786444|564518087|FG000|Overall Study|Withdrawal by Subject|4|||
156389547|NCT04786444|564518088|FG001|Overall Study|Withdrawal by Subject|7|||
156389548|NCT04786444|564518089|FG002|Overall Study|Withdrawal by Subject|2|||
156389549|NCT04786444|564518087|FG000|Overall Study|Lost to Follow-up|11|||
156389550|NCT04786444|564518088|FG001|Overall Study|Lost to Follow-up|9|||
156389551|NCT04786444|564518089|FG002|Overall Study|Lost to Follow-up|10|||
156389552|NCT04786444|564518087|FG000|Overall Study|Subject would like to become pregnant|0|||
156389553|NCT04786444|564518088|FG001|Overall Study|Subject would like to become pregnant|1|||
156389554|NCT04786444|564518089|FG002|Overall Study|Subject would like to become pregnant|0|||
156389555|NCT03166618|564518090|FG000|Overall Study|Study was Terminated|0|||
156389556|NCT03166618|564518091|FG001|Overall Study|Study was Terminated|1|||
156389557|NCT03137303|564518093|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
156389558|NCT03137303|564518094|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
156389559|NCT03137303|564518093|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
156389560|NCT03137303|564518094|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
156389561|NCT03137303|564518093|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
156389562|NCT03137303|564518094|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
156389563|NCT03137303|564518093|FG000|T3: 9-month Follow-up|Death|1|||
156389564|NCT03137303|564518094|FG001|T3: 9-month Follow-up|Death|0|||
156389565|NCT03137303|564518093|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
156389566|NCT03137303|564518094|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
156389567|NCT03137303|564518093|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
156389568|NCT03137303|564518094|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
156389569|NCT03137303|564518093|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
156389570|NCT03137303|564518094|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
156508102|NCT02514551|564953025|FG001|Overall Study|Participant Never Treated|2|||
156508103|NCT01399918|564953036|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
156389571|NCT03561090|564518095|FG000|Overall Study|Adverse Event|11|||
156508104|NCT03197766|564953037|FG000|Overall Study|Withdrawal by Subject|2|||
156508105|NCT03197766|564953038|FG001|Overall Study|Withdrawal by Subject|0|||
156389572|NCT03561090|564518096|FG001|Overall Study|Adverse Event|7|||
156389573|NCT03561090|564518095|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156389574|NCT03561090|564518096|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156389575|NCT03561090|564518095|FG000|Overall Study|Protocol Violation|2|||
156389576|NCT03561090|564518096|FG001|Overall Study|Protocol Violation|2|||
156389577|NCT03561090|564518095|FG000|Overall Study|Withdrawal by Subject|7|||
156389578|NCT03561090|564518096|FG001|Overall Study|Withdrawal by Subject|7|||
156389579|NCT03561090|564518095|FG000|Overall Study|Lost to Follow-up|7|||
156389580|NCT03561090|564518096|FG001|Overall Study|Lost to Follow-up|2|||
156389581|NCT03561090|564518095|FG000|Overall Study|Study Terminated by Sponsor|10|||
156389582|NCT03561090|564518096|FG001|Overall Study|Study Terminated by Sponsor|15|||
156389583|NCT03561090|564518095|FG000|Overall Study|Randomized by Mistake|1|||
156389584|NCT03561090|564518096|FG001|Overall Study|Randomized by Mistake|1|||
156389585|NCT03561090|564518095|FG000|Overall Study|Other Not Specified|0|||
156389586|NCT03561090|564518096|FG001|Overall Study|Other Not Specified|2|||
156389587|NCT00725452|564518106|FG000|Overall Study|Adverse Event|3|||
156389588|NCT00725452|564518106|FG000|Overall Study|Lack of Efficacy|2|||
156389589|NCT00725452|564518106|FG000|Overall Study|Reason not specified|1|||
156389590|NCT00725452|564518106|FG000|Overall Study|Physician Decision|1|||
156389591|NCT00725452|564518106|FG000|Overall Study|Withdrawal by Subject|3|||
156389592|NCT00725452|564518106|FG000|Overall Study|Lost to Follow-up|1|||
156389593|NCT00713648|564518107|FG000|Overall Study|Adverse Event|1|||
156389594|NCT00713648|564518107|FG000|Overall Study|Unclassified|2|||
156389595|NCT00713648|564518107|FG000|Overall Study|According to Protocol|2|||
156389596|NCT00713648|564518107|FG000|Overall Study|Development of antibodies|3|||
156389597|NCT01733732|564518108|FG000|Overall Study|Adverse Event|1|||
156389598|NCT01733732|564518109|FG001|Overall Study|Adverse Event|0|||
156389599|NCT01733732|564518108|FG000|Overall Study|Did not attend all study visits|1|||
156389600|NCT01733732|564518109|FG001|Overall Study|Did not attend all study visits|0|||
156389601|NCT00464815|564518110|FG000|Overall Study|Withdrawal by Subject|6|||
156389602|NCT00464815|564518111|FG001|Overall Study|Withdrawal by Subject|3|||
156389603|NCT02566031|564518114|FG000|Overall Study|Patient/guardian decision|14|||
156389604|NCT02566031|564518115|FG001|Overall Study|Patient/guardian decision|7|||
156389605|NCT02566031|564518114|FG000|Overall Study|Protocol deviation|2|||
156389606|NCT02566031|564518115|FG001|Overall Study|Protocol deviation|3|||
156389607|NCT02566031|564518114|FG000|Overall Study|Adverse Event|3|||
156389608|NCT02566031|564518115|FG001|Overall Study|Adverse Event|1|||
156389609|NCT02566031|564518114|FG000|Overall Study|Lost to Follow-up|1|||
156389610|NCT02566031|564518115|FG001|Overall Study|Lost to Follow-up|1|||
156389611|NCT03031938|564518116|FG000|Overall Study|Death|1|||
156389612|NCT03031938|564518117|FG001|Overall Study|Death|0|||
156389613|NCT02479412|564518122|FG000|Overall Study|Adverse Event|0|||
156389614|NCT02479412|564518123|FG001|Overall Study|Adverse Event|0|||
156389615|NCT02479412|564518124|FG002|Overall Study|Adverse Event|1|||
156389616|NCT02479412|564518125|FG003|Overall Study|Adverse Event|0|||
156389617|NCT02479412|564518126|FG004|Overall Study|Adverse Event|0|||
156389618|NCT02479412|564518127|FG005|Overall Study|Adverse Event|0|||
156389619|NCT02479412|564518128|FG006|Overall Study|Adverse Event|0|||
156389620|NCT02479412|564518129|FG007|Overall Study|Adverse Event|0|||
156389621|NCT02479412|564518130|FG008|Overall Study|Adverse Event|0|||
156389622|NCT02479412|564518122|FG000|Overall Study|Study-specific withdrawal criteria|0|||
156389623|NCT02479412|564518123|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156389624|NCT02479412|564518124|FG002|Overall Study|Study-specific withdrawal criteria|1|||
156389625|NCT02479412|564518125|FG003|Overall Study|Study-specific withdrawal criteria|1|||
156389626|NCT02479412|564518126|FG004|Overall Study|Study-specific withdrawal criteria|0|||
156389627|NCT02479412|564518127|FG005|Overall Study|Study-specific withdrawal criteria|0|||
156389628|NCT02479412|564518128|FG006|Overall Study|Study-specific withdrawal criteria|0|||
156389629|NCT02479412|564518129|FG007|Overall Study|Study-specific withdrawal criteria|1|||
156389630|NCT02479412|564518130|FG008|Overall Study|Study-specific withdrawal criteria|1|||
156389631|NCT02479412|564518122|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
156389632|NCT02479412|564518123|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
156389633|NCT02479412|564518124|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
156389634|NCT02479412|564518125|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
156389635|NCT02479412|564518126|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
156389636|NCT02479412|564518127|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
156389637|NCT02479412|564518128|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
156389638|NCT02479412|564518129|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
156389639|NCT02479412|564518130|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
156389640|NCT04402866|564518135|FG000|Overall Study|Discontinued Prior to Treatment|0|||
156389641|NCT04402866|564518136|FG001|Overall Study|Discontinued Prior to Treatment|0|||
156389642|NCT04402866|564518137|FG002|Overall Study|Discontinued Prior to Treatment|0|||
156389643|NCT04402866|564518138|FG003|Overall Study|Discontinued Prior to Treatment|0|||
156389644|NCT04402866|564518139|FG004|Overall Study|Discontinued Prior to Treatment|2|||
156389645|NCT04402866|564518140|FG005|Overall Study|Discontinued Prior to Treatment|3|||
156389646|NCT04402866|564518135|FG000|Overall Study|Adverse Event|2|||
156389647|NCT04402866|564518136|FG001|Overall Study|Adverse Event|1|||
156389648|NCT04402866|564518137|FG002|Overall Study|Adverse Event|0|||
156389649|NCT04402866|564518138|FG003|Overall Study|Adverse Event|0|||
156389650|NCT04402866|564518139|FG004|Overall Study|Adverse Event|13|||
156389651|NCT04402866|564518140|FG005|Overall Study|Adverse Event|8|||
156389652|NCT04402866|564518135|FG000|Overall Study|Miscellaneous|0|||
156389653|NCT04402866|564518136|FG001|Overall Study|Miscellaneous|0|||
156389654|NCT04402866|564518137|FG002|Overall Study|Miscellaneous|1|||
156389655|NCT04402866|564518138|FG003|Overall Study|Miscellaneous|0|||
156389656|NCT04402866|564518139|FG004|Overall Study|Miscellaneous|0|||
156389657|NCT04402866|564518140|FG005|Overall Study|Miscellaneous|0|||
156389658|NCT04402866|564518135|FG000|Overall Study|Lost to Follow-up|0|||
156389659|NCT04402866|564518136|FG001|Overall Study|Lost to Follow-up|0|||
156389660|NCT04402866|564518137|FG002|Overall Study|Lost to Follow-up|0|||
156389661|NCT04402866|564518138|FG003|Overall Study|Lost to Follow-up|0|||
156389662|NCT04402866|564518139|FG004|Overall Study|Lost to Follow-up|0|||
156389663|NCT04402866|564518140|FG005|Overall Study|Lost to Follow-up|1|||
156389664|NCT04402866|564518135|FG000|Overall Study|Withdrawal by Subject|0|||
156389665|NCT04402866|564518136|FG001|Overall Study|Withdrawal by Subject|0|||
156389666|NCT04402866|564518137|FG002|Overall Study|Withdrawal by Subject|0|||
156389667|NCT04402866|564518138|FG003|Overall Study|Withdrawal by Subject|0|||
156389668|NCT04402866|564518139|FG004|Overall Study|Withdrawal by Subject|0|||
156389669|NCT04402866|564518140|FG005|Overall Study|Withdrawal by Subject|2|||
156389670|NCT03667053|564518141|FG000|Overall Study|Withdrawal by Subject|1|||
156389671|NCT03667053|564518142|FG001|Overall Study|Withdrawal by Subject|0|||
156389672|NCT03667053|564518143|FG002|Overall Study|Withdrawal by Subject|0|||
156389673|NCT00515502|564518145|FG000|Treatment Period 1|Adverse Event|0|||
156389674|NCT00515502|564518146|FG001|Treatment Period 1|Adverse Event|0|||
156389675|NCT00515502|564518147|FG002|Treatment Period 1|Adverse Event|0|||
156389676|NCT00515502|564518148|FG003|Treatment Period 1|Adverse Event|0|||
156389677|NCT00515502|564518149|FG004|Treatment Period 1|Adverse Event|0|||
156389678|NCT00515502|564518150|FG005|Treatment Period 1|Adverse Event|0|||
156389679|NCT00515502|564518151|FG006|Treatment Period 1|Adverse Event|1|||
156389680|NCT00515502|564518152|FG007|Treatment Period 1|Adverse Event|0|||
156389681|NCT00515502|564518153|FG008|Treatment Period 1|Adverse Event|1|||
156389682|NCT00515502|564518154|FG009|Treatment Period 1|Adverse Event|0|||
156389683|NCT00515502|564518155|FG010|Treatment Period 1|Adverse Event|0|||
156389684|NCT00515502|564518156|FG011|Treatment Period 1|Adverse Event|1|||
156389685|NCT00515502|564518145|FG000|Treatment Period 2|Adverse Event|0|||
156389686|NCT00515502|564518146|FG001|Treatment Period 2|Adverse Event|1|||
156389687|NCT00515502|564518147|FG002|Treatment Period 2|Adverse Event|0|||
156389688|NCT00515502|564518148|FG003|Treatment Period 2|Adverse Event|0|||
156389689|NCT00515502|564518149|FG004|Treatment Period 2|Adverse Event|0|||
156389690|NCT00515502|564518150|FG005|Treatment Period 2|Adverse Event|0|||
156389691|NCT00515502|564518151|FG006|Treatment Period 2|Adverse Event|0|||
156389692|NCT00515502|564518152|FG007|Treatment Period 2|Adverse Event|0|||
156389693|NCT00515502|564518153|FG008|Treatment Period 2|Adverse Event|0|||
156389694|NCT00515502|564518154|FG009|Treatment Period 2|Adverse Event|0|||
156389695|NCT00515502|564518155|FG010|Treatment Period 2|Adverse Event|0|||
156389696|NCT00515502|564518156|FG011|Treatment Period 2|Adverse Event|0|||
156389697|NCT03647501|564518157|FG000|Overall Study|Lost to Follow-up|1|||
156389698|NCT03647501|564518158|FG001|Overall Study|Lost to Follow-up|1|||
156389699|NCT03647501|564518157|FG000|Overall Study|Withdrawal by Subject|0|||
156389700|NCT03647501|564518158|FG001|Overall Study|Withdrawal by Subject|1|||
156389701|NCT01324271|564518163|FG000|Overall Study|Lost to Follow-up|3|||
156389702|NCT01324271|564518164|FG001|Overall Study|Lost to Follow-up|0|||
156389703|NCT01324271|564518163|FG000|Overall Study|Physician Decision|1|||
156389704|NCT01324271|564518164|FG001|Overall Study|Physician Decision|0|||
156389705|NCT02807558|564518165|FG000|Overall Study|Consent withdrawn by participant|4|||
156389706|NCT02807558|564518166|FG001|Overall Study|Consent withdrawn by participant|0|||
156389707|NCT02807558|564518167|FG002|Overall Study|Consent withdrawn by participant|4|||
156389708|NCT02807558|564518168|FG003|Overall Study|Consent withdrawn by participant|2|||
156389709|NCT02807558|564518169|FG004|Overall Study|Consent withdrawn by participant|1|||
156389710|NCT02807558|564518170|FG005|Overall Study|Consent withdrawn by participant|0|||
156389711|NCT02807558|564518165|FG000|Overall Study|Non-compliance with Study Drug|0|||
156389712|NCT02807558|564518166|FG001|Overall Study|Non-compliance with Study Drug|0|||
156389713|NCT02807558|564518167|FG002|Overall Study|Non-compliance with Study Drug|1|||
156389714|NCT02807558|564518168|FG003|Overall Study|Non-compliance with Study Drug|0|||
156508106|NCT00570908|564953041|FG000|Overall Study|Adverse Event|5|||
156508107|NCT00570908|564953041|FG000|Overall Study|Withdrawal by Subject|2|||
156508108|NCT00632502|564953042|FG000|Overall Study|Adverse Event|0|||
156508109|NCT00632502|564953043|FG001|Overall Study|Adverse Event|1|||
156389715|NCT02807558|564518169|FG004|Overall Study|Non-compliance with Study Drug|0|||
156389716|NCT02807558|564518170|FG005|Overall Study|Non-compliance with Study Drug|0|||
156389717|NCT02807558|564518165|FG000|Overall Study|Adverse Event|0|||
156389718|NCT02807558|564518166|FG001|Overall Study|Adverse Event|0|||
156389719|NCT02807558|564518167|FG002|Overall Study|Adverse Event|9|||
156508110|NCT00632502|564953042|FG000|Overall Study|Randomized not treated|3|||
156389720|NCT02807558|564518168|FG003|Overall Study|Adverse Event|0|||
156389721|NCT02807558|564518169|FG004|Overall Study|Adverse Event|0|||
156389722|NCT02807558|564518170|FG005|Overall Study|Adverse Event|0|||
156389723|NCT02807558|564518165|FG000|Overall Study|Death|23|||
156389724|NCT02807558|564518166|FG001|Overall Study|Death|2|||
156389725|NCT02807558|564518167|FG002|Overall Study|Death|3|||
156389726|NCT02807558|564518168|FG003|Overall Study|Death|43|||
156389727|NCT02807558|564518169|FG004|Overall Study|Death|24|||
156389728|NCT02807558|564518170|FG005|Overall Study|Death|15|||
156389729|NCT02807558|564518165|FG000|Overall Study|Progressive Disease|0|||
156389730|NCT02807558|564518166|FG001|Overall Study|Progressive Disease|0|||
156389731|NCT02807558|564518167|FG002|Overall Study|Progressive Disease|1|||
156389732|NCT02807558|564518168|FG003|Overall Study|Progressive Disease|0|||
156389733|NCT02807558|564518169|FG004|Overall Study|Progressive Disease|0|||
156389734|NCT02807558|564518170|FG005|Overall Study|Progressive Disease|0|||
156389735|NCT02807558|564518165|FG000|Overall Study|Other than specified|1|||
156389736|NCT02807558|564518166|FG001|Overall Study|Other than specified|0|||
156389737|NCT02807558|564518167|FG002|Overall Study|Other than specified|2|||
156389738|NCT02807558|564518168|FG003|Overall Study|Other than specified|0|||
156389739|NCT02807558|564518169|FG004|Overall Study|Other than specified|1|||
156389740|NCT02807558|564518170|FG005|Overall Study|Other than specified|1|||
156389741|NCT02807558|564518165|FG000|Overall Study|Lack of Efficacy|0|||
156389742|NCT02807558|564518166|FG001|Overall Study|Lack of Efficacy|0|||
156389743|NCT02807558|564518167|FG002|Overall Study|Lack of Efficacy|9|||
156389744|NCT02807558|564518168|FG003|Overall Study|Lack of Efficacy|0|||
156389745|NCT02807558|564518169|FG004|Overall Study|Lack of Efficacy|0|||
156389746|NCT02807558|564518170|FG005|Overall Study|Lack of Efficacy|0|||
156389747|NCT01972841|564518171|FG000|Overall Study|Randomized but Never Received Treatment|2|||
156389748|NCT01972841|564518172|FG001|Overall Study|Randomized but Never Received Treatment|5|||
156389749|NCT01972841|564518173|FG002|Overall Study|Randomized but Never Received Treatment|4|||
156389750|NCT01972841|564518174|FG003|Overall Study|Randomized but Never Received Treatment|2|||
156389751|NCT01972841|564518175|FG004|Overall Study|Randomized but Never Received Treatment|6|||
156389752|NCT01972841|564518176|FG005|Overall Study|Randomized but Never Received Treatment|13|||
156389753|NCT01972841|564518171|FG000|Overall Study|Adverse Event|13|||
156389754|NCT01972841|564518172|FG001|Overall Study|Adverse Event|8|||
156389755|NCT01972841|564518173|FG002|Overall Study|Adverse Event|12|||
156389756|NCT01972841|564518174|FG003|Overall Study|Adverse Event|9|||
156508111|NCT00632502|564953043|FG001|Overall Study|Randomized not treated|0|||
156508112|NCT01213524|564953044|FG000|Baseline|Withdrawal by Subject|5|||
156508113|NCT01213524|564953044|FG000|Baseline|high breath alcohol levels|1|||
156508114|NCT01213524|564953044|FG000|Baseline|Physician Decision|1|||
156508115|NCT01213524|564953044|FG000|Session 2|Withdrawal by Subject|5|||
156508116|NCT01213524|564953044|FG000|Session 3|Withdrawal by Subject|4|||
156508117|NCT01213524|564953044|FG000|Session 4|Physician Decision|1|||
156508118|NCT01213524|564953044|FG000|Session 4|Withdrawal by Subject|2|||
156508119|NCT02519348|564953047|FG000|Overall Study|Death|31|||
156508120|NCT02519348|564953048|FG001|Overall Study|Death|74|||
156508121|NCT02519348|564953049|FG002|Overall Study|Death|47|||
156508122|NCT02519348|564953050|FG003|Overall Study|Death|54|||
156508123|NCT02519348|564953051|FG004|Overall Study|Death|63|||
156508124|NCT02519348|564953052|FG005|Overall Study|Death|18|||
156508125|NCT02519348|564953053|FG006|Overall Study|Death|2|||
156508126|NCT02519348|564953054|FG007|Overall Study|Death|5|||
156508127|NCT02519348|564953055|FG008|Overall Study|Death|5|||
156508128|NCT02519348|564953047|FG000|Overall Study|Withdrawal by Subject|4|||
156508129|NCT02519348|564953048|FG001|Overall Study|Withdrawal by Subject|7|||
156508130|NCT02519348|564953049|FG002|Overall Study|Withdrawal by Subject|4|||
156508131|NCT02519348|564953050|FG003|Overall Study|Withdrawal by Subject|3|||
156508132|NCT02519348|564953051|FG004|Overall Study|Withdrawal by Subject|3|||
156508133|NCT02519348|564953052|FG005|Overall Study|Withdrawal by Subject|2|||
156508134|NCT02519348|564953053|FG006|Overall Study|Withdrawal by Subject|0|||
156508135|NCT02519348|564953054|FG007|Overall Study|Withdrawal by Subject|0|||
156508136|NCT02519348|564953055|FG008|Overall Study|Withdrawal by Subject|1|||
156508137|NCT02519348|564953047|FG000|Overall Study|Lost to Follow-up|0|||
156508138|NCT02519348|564953048|FG001|Overall Study|Lost to Follow-up|0|||
156508139|NCT02519348|564953049|FG002|Overall Study|Lost to Follow-up|1|||
156508140|NCT02519348|564953050|FG003|Overall Study|Lost to Follow-up|0|||
156508141|NCT02519348|564953051|FG004|Overall Study|Lost to Follow-up|2|||
156508142|NCT02519348|564953052|FG005|Overall Study|Lost to Follow-up|1|||
156508143|NCT02519348|564953053|FG006|Overall Study|Lost to Follow-up|1|||
156508144|NCT02519348|564953054|FG007|Overall Study|Lost to Follow-up|0|||
156508145|NCT02519348|564953055|FG008|Overall Study|Lost to Follow-up|0|||
156389757|NCT01972841|564518175|FG004|Overall Study|Adverse Event|21|||
156389758|NCT01972841|564518176|FG005|Overall Study|Adverse Event|26|||
156389759|NCT01972841|564518171|FG000|Overall Study|Lack of Efficacy|1|||
156389760|NCT01972841|564518172|FG001|Overall Study|Lack of Efficacy|0|||
156389761|NCT01972841|564518173|FG002|Overall Study|Lack of Efficacy|0|||
156389762|NCT01972841|564518174|FG003|Overall Study|Lack of Efficacy|2|||
156389763|NCT01972841|564518175|FG004|Overall Study|Lack of Efficacy|4|||
156508146|NCT02519348|564953047|FG000|Overall Study|Other|0|||
156508147|NCT02519348|564953048|FG001|Overall Study|Other|3|||
156508148|NCT02519348|564953049|FG002|Overall Study|Other|0|||
156389764|NCT01972841|564518176|FG005|Overall Study|Lack of Efficacy|1|||
156508149|NCT02519348|564953050|FG003|Overall Study|Other|0|||
156508150|NCT02519348|564953051|FG004|Overall Study|Other|1|||
156508151|NCT02519348|564953052|FG005|Overall Study|Other|0|||
156389765|NCT01972841|564518171|FG000|Overall Study|Lost to Follow-up|4|||
156389766|NCT01972841|564518172|FG001|Overall Study|Lost to Follow-up|2|||
156389767|NCT01972841|564518173|FG002|Overall Study|Lost to Follow-up|4|||
156389768|NCT01972841|564518174|FG003|Overall Study|Lost to Follow-up|2|||
156389769|NCT01972841|564518175|FG004|Overall Study|Lost to Follow-up|9|||
156389770|NCT01972841|564518176|FG005|Overall Study|Lost to Follow-up|3|||
156389771|NCT01972841|564518171|FG000|Overall Study|Protocol Violation|2|||
156389772|NCT01972841|564518172|FG001|Overall Study|Protocol Violation|2|||
156389773|NCT01972841|564518173|FG002|Overall Study|Protocol Violation|3|||
156389774|NCT01972841|564518174|FG003|Overall Study|Protocol Violation|5|||
156389775|NCT01972841|564518175|FG004|Overall Study|Protocol Violation|9|||
156389776|NCT01972841|564518176|FG005|Overall Study|Protocol Violation|4|||
156389777|NCT01972841|564518171|FG000|Overall Study|Withdrawal by participants|21|||
156389778|NCT01972841|564518172|FG001|Overall Study|Withdrawal by participants|27|||
156389779|NCT01972841|564518173|FG002|Overall Study|Withdrawal by participants|23|||
156389780|NCT01972841|564518174|FG003|Overall Study|Withdrawal by participants|16|||
156389781|NCT01972841|564518175|FG004|Overall Study|Withdrawal by participants|33|||
156389782|NCT01972841|564518176|FG005|Overall Study|Withdrawal by participants|34|||
156389783|NCT01972841|564518171|FG000|Overall Study|Miscellaneous|0|||
156389784|NCT01972841|564518172|FG001|Overall Study|Miscellaneous|0|||
156389785|NCT01972841|564518173|FG002|Overall Study|Miscellaneous|4|||
156389786|NCT01972841|564518174|FG003|Overall Study|Miscellaneous|1|||
156389787|NCT01972841|564518175|FG004|Overall Study|Miscellaneous|0|||
156389788|NCT01972841|564518176|FG005|Overall Study|Miscellaneous|4|||
156389789|NCT01972841|564518171|FG000|Overall Study|Did not have end of treatment page|0|||
156389790|NCT01972841|564518172|FG001|Overall Study|Did not have end of treatment page|0|||
156389791|NCT01972841|564518173|FG002|Overall Study|Did not have end of treatment page|0|||
156389792|NCT01972841|564518174|FG003|Overall Study|Did not have end of treatment page|0|||
156389793|NCT01972841|564518175|FG004|Overall Study|Did not have end of treatment page|1|||
156389794|NCT01972841|564518176|FG005|Overall Study|Did not have end of treatment page|0|||
156389795|NCT02734212|564518177|FG000|Overall Study|Lost to Follow-up|5|||
156389796|NCT02734212|564518178|FG001|Overall Study|Lost to Follow-up|10|||
156389797|NCT00688636|564518179|FG000|Overall Study|Adverse Event|2|||
156389798|NCT00688636|564518180|FG001|Overall Study|Adverse Event|1|||
156389799|NCT01572727|564518181|FG000|Overall Study|Adverse Event|43|||
156389800|NCT01572727|564518182|FG001|Overall Study|Adverse Event|15|||
156389801|NCT01572727|564518181|FG000|Overall Study|Lost to Follow-up|1|||
156389802|NCT01572727|564518182|FG001|Overall Study|Lost to Follow-up|1|||
156389803|NCT01572727|564518181|FG000|Overall Study|Physician Decision|23|||
156389804|NCT01572727|564518182|FG001|Overall Study|Physician Decision|9|||
156389805|NCT01572727|564518181|FG000|Overall Study|Progressive disease|59|||
156389806|NCT01572727|564518182|FG001|Overall Study|Progressive disease|82|||
156389807|NCT01572727|564518181|FG000|Overall Study|Protocol Violation|0|||
156389808|NCT01572727|564518182|FG001|Overall Study|Protocol Violation|1|||
156389809|NCT01572727|564518181|FG000|Overall Study|Study terminated by sponsor|61|||
156389810|NCT01572727|564518182|FG001|Overall Study|Study terminated by sponsor|83|||
156389811|NCT01572727|564518181|FG000|Overall Study|Parent/guardian decision|14|||
156389812|NCT01572727|564518182|FG001|Overall Study|Parent/guardian decision|9|||
156389813|NCT01572727|564518181|FG000|Overall Study|Death|2|||
156389814|NCT01572727|564518182|FG001|Overall Study|Death|2|||
156389815|NCT01572727|564518181|FG000|Overall Study|Untreated|4|||
156389816|NCT01572727|564518182|FG001|Overall Study|Untreated|7|||
156389817|NCT02195986|564518183|FG000|Overall Study|Adverse Event|3|||
156389818|NCT02195986|564518184|FG001|Overall Study|Adverse Event|0|||
156389819|NCT02195986|564518185|FG002|Overall Study|Adverse Event|0|||
156389820|NCT02195986|564518183|FG000|Overall Study|Withdrawal by Subject|0|||
156389821|NCT02195986|564518184|FG001|Overall Study|Withdrawal by Subject|3|||
156389822|NCT02195986|564518185|FG002|Overall Study|Withdrawal by Subject|0|||
156389823|NCT02195986|564518183|FG000|Overall Study|Family Emergency|0|||
156389824|NCT02195986|564518184|FG001|Overall Study|Family Emergency|0|||
156389825|NCT02195986|564518185|FG002|Overall Study|Family Emergency|1|||
156389826|NCT02195986|564518183|FG000|Overall Study|Protocol Violation|0|||
156389827|NCT02195986|564518184|FG001|Overall Study|Protocol Violation|1|||
156389828|NCT02195986|564518185|FG002|Overall Study|Protocol Violation|1|||
156389829|NCT02195986|564518183|FG000|Overall Study|Non-compliance|0|||
156389830|NCT02195986|564518184|FG001|Overall Study|Non-compliance|1|||
156389831|NCT02195986|564518185|FG002|Overall Study|Non-compliance|0|||
156508152|NCT02519348|564953053|FG006|Overall Study|Other|0|||
156389832|NCT02834780|564518186|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
156389833|NCT02834780|564518187|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
156389834|NCT02834780|564518188|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
156389835|NCT02834780|564518189|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
156508153|NCT02519348|564953054|FG007|Overall Study|Other|0|||
156389836|NCT02834780|564518190|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
156389837|NCT02834780|564518191|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
156389838|NCT02834780|564518192|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
156389839|NCT02834780|564518193|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
156389840|NCT02834780|564518194|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
156389841|NCT02834780|564518195|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
156389842|NCT02834780|564518196|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
156389843|NCT02834780|564518197|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
156389844|NCT02834780|564518198|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
156389845|NCT02834780|564518186|FG000|Overall Study|Withdrawal by Subject|0|||
156389846|NCT02834780|564518187|FG001|Overall Study|Withdrawal by Subject|0|||
156389847|NCT02834780|564518188|FG002|Overall Study|Withdrawal by Subject|1|||
156389848|NCT02834780|564518189|FG003|Overall Study|Withdrawal by Subject|0|||
156389849|NCT02834780|564518190|FG004|Overall Study|Withdrawal by Subject|0|||
156389850|NCT02834780|564518191|FG005|Overall Study|Withdrawal by Subject|0|||
156389851|NCT02834780|564518192|FG006|Overall Study|Withdrawal by Subject|0|||
156389852|NCT02834780|564518193|FG007|Overall Study|Withdrawal by Subject|0|||
156389853|NCT02834780|564518194|FG008|Overall Study|Withdrawal by Subject|0|||
156389854|NCT02834780|564518195|FG009|Overall Study|Withdrawal by Subject|0|||
156389855|NCT02834780|564518196|FG010|Overall Study|Withdrawal by Subject|1|||
156389856|NCT02834780|564518197|FG011|Overall Study|Withdrawal by Subject|0|||
156389857|NCT02834780|564518198|FG012|Overall Study|Withdrawal by Subject|0|||
156389858|NCT02834780|564518186|FG000|Overall Study|Adverse Event|0|||
156389859|NCT02834780|564518187|FG001|Overall Study|Adverse Event|0|||
156389860|NCT02834780|564518188|FG002|Overall Study|Adverse Event|0|||
156389861|NCT02834780|564518189|FG003|Overall Study|Adverse Event|0|||
156389862|NCT02834780|564518190|FG004|Overall Study|Adverse Event|1|||
156389863|NCT02834780|564518191|FG005|Overall Study|Adverse Event|0|||
156389864|NCT02834780|564518192|FG006|Overall Study|Adverse Event|1|||
156389865|NCT02834780|564518193|FG007|Overall Study|Adverse Event|1|||
156389866|NCT02834780|564518194|FG008|Overall Study|Adverse Event|0|||
156389867|NCT02834780|564518195|FG009|Overall Study|Adverse Event|2|||
156389868|NCT02834780|564518196|FG010|Overall Study|Adverse Event|0|||
156389869|NCT02834780|564518197|FG011|Overall Study|Adverse Event|3|||
156389870|NCT02834780|564518198|FG012|Overall Study|Adverse Event|2|||
156389871|NCT02834780|564518186|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
156389872|NCT02834780|564518187|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
156389873|NCT02834780|564518188|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
156389874|NCT02834780|564518189|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
156389875|NCT02834780|564518190|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
156389876|NCT02834780|564518191|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
156389877|NCT02834780|564518192|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
156389878|NCT02834780|564518193|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
156389879|NCT02834780|564518194|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
156389880|NCT02834780|564518195|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
156389881|NCT02834780|564518196|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
156389882|NCT02834780|564518197|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
156389883|NCT02834780|564518198|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
156389884|NCT02834780|564518186|FG000|Overall Study|Other|1|||
156389885|NCT02834780|564518187|FG001|Overall Study|Other|0|||
156389886|NCT02834780|564518188|FG002|Overall Study|Other|1|||
156389887|NCT02834780|564518189|FG003|Overall Study|Other|2|||
156389888|NCT02834780|564518190|FG004|Overall Study|Other|0|||
156389889|NCT02834780|564518191|FG005|Overall Study|Other|0|||
156389890|NCT02834780|564518192|FG006|Overall Study|Other|0|||
156389891|NCT02834780|564518193|FG007|Overall Study|Other|0|||
156389892|NCT02834780|564518194|FG008|Overall Study|Other|0|||
156389893|NCT02834780|564518195|FG009|Overall Study|Other|0|||
156389894|NCT02834780|564518196|FG010|Overall Study|Other|0|||
156389895|NCT02834780|564518197|FG011|Overall Study|Other|0|||
156389896|NCT02834780|564518198|FG012|Overall Study|Other|1|||
156389897|NCT03150056|564518199|FG000|Overall Study|Withdrawal by Subject|0|||
156508154|NCT02519348|564953055|FG008|Overall Study|Other|0|||
156508155|NCT02519348|564953047|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
156389898|NCT03150056|564518200|FG001|Overall Study|Withdrawal by Subject|0|||
156389899|NCT03150056|564518201|FG002|Overall Study|Withdrawal by Subject|0|||
156389900|NCT03150056|564518202|FG003|Overall Study|Withdrawal by Subject|0|||
156389901|NCT03150056|564518203|FG004|Overall Study|Withdrawal by Subject|0|||
156389902|NCT03150056|564518204|FG005|Overall Study|Withdrawal by Subject|2|||
156389903|NCT03150056|564518199|FG000|Overall Study|Study terminated by Sponsor|1|||
156389904|NCT03150056|564518200|FG001|Overall Study|Study terminated by Sponsor|3|||
156389905|NCT03150056|564518201|FG002|Overall Study|Study terminated by Sponsor|1|||
156389906|NCT03150056|564518202|FG003|Overall Study|Study terminated by Sponsor|1|||
156389907|NCT03150056|564518203|FG004|Overall Study|Study terminated by Sponsor|5|||
156389908|NCT03150056|564518204|FG005|Overall Study|Study terminated by Sponsor|6|||
156389909|NCT03150056|564518199|FG000|Overall Study|Death|9|||
156389910|NCT03150056|564518200|FG001|Overall Study|Death|2|||
156389911|NCT03150056|564518201|FG002|Overall Study|Death|2|||
156389912|NCT03150056|564518202|FG003|Overall Study|Death|7|||
156389913|NCT03150056|564518203|FG004|Overall Study|Death|8|||
156389914|NCT03150056|564518204|FG005|Overall Study|Death|10|||
156389915|NCT01857531|564518209|FG000|Overall Study|Withdrawal by Subject|4|||
156389916|NCT02576067|564518210|FG000|Overall Study|Death|0|||
156389917|NCT02576067|564518211|FG001|Overall Study|Death|1|||
156389918|NCT02576067|564518210|FG000|Overall Study|Lack of Efficacy|1|||
156389919|NCT02576067|564518211|FG001|Overall Study|Lack of Efficacy|0|||
156389920|NCT02576067|564518210|FG000|Overall Study|Lost to Follow-up|11|||
156389921|NCT02576067|564518211|FG001|Overall Study|Lost to Follow-up|0|||
156389922|NCT02576067|564518210|FG000|Overall Study|Withdrawal by Subject|11|||
156389923|NCT02576067|564518211|FG001|Overall Study|Withdrawal by Subject|2|||
156389924|NCT02576067|564518210|FG000|Overall Study|study closure of main CIRT trial)|0|||
156389925|NCT02576067|564518211|FG001|Overall Study|study closure of main CIRT trial)|8|||
156389926|NCT02576067|564518210|FG000|Overall Study|not randomized, failed run-in|7|||
156389927|NCT02576067|564518211|FG001|Overall Study|not randomized, failed run-in|0|||
156389928|NCT02576067|564518210|FG000|Overall Study|screen failure/ re-enrolled|0|||
156389929|NCT02576067|564518211|FG001|Overall Study|screen failure/ re-enrolled|25|||
156389930|NCT02576067|564518210|FG000|Overall Study|Physician Decision|4|||
156389931|NCT02576067|564518211|FG001|Overall Study|Physician Decision|0|||
156389932|NCT03570619|564518214|FG000|Overall Study|Adverse Event|2|||
156389933|NCT03570619|564518215|FG001|Overall Study|Adverse Event|0|||
156389934|NCT03570619|564518216|FG002|Overall Study|Adverse Event|1|||
156389935|NCT03570619|564518214|FG000|Overall Study|new diagnosis of new malignancy|1|||
156389936|NCT03570619|564518215|FG001|Overall Study|new diagnosis of new malignancy|0|||
156389937|NCT03570619|564518216|FG002|Overall Study|new diagnosis of new malignancy|0|||
156389938|NCT03570619|564518214|FG000|Overall Study|Physician Decision|1|||
156389939|NCT03570619|564518215|FG001|Overall Study|Physician Decision|1|||
156389940|NCT03570619|564518216|FG002|Overall Study|Physician Decision|0|||
156389941|NCT03570619|564518214|FG000|Overall Study|Withdrawal by Subject|0|||
156389942|NCT03570619|564518215|FG001|Overall Study|Withdrawal by Subject|2|||
156389943|NCT03570619|564518216|FG002|Overall Study|Withdrawal by Subject|0|||
156389944|NCT04773587|564518217|FG000|Overall Study|Lost to Follow-up|11|||
156389945|NCT04773587|564518218|FG001|Overall Study|Lost to Follow-up|3|||
156389946|NCT04773587|564518217|FG000|Overall Study|Adverse Event|6|||
156389947|NCT04773587|564518218|FG001|Overall Study|Adverse Event|3|||
156389948|NCT04773587|564518217|FG000|Overall Study|Lack of Efficacy|5|||
156389949|NCT04773587|564518218|FG001|Overall Study|Lack of Efficacy|2|||
156389950|NCT04773587|564518217|FG000|Overall Study|Withdrawal by Subject|4|||
156389951|NCT04773587|564518218|FG001|Overall Study|Withdrawal by Subject|5|||
156389952|NCT04773587|564518217|FG000|Overall Study|Noncompliance|1|||
156389953|NCT04773587|564518218|FG001|Overall Study|Noncompliance|0|||
156389954|NCT04773587|564518217|FG000|Overall Study|Protocol Violation|1|||
156389955|NCT04773587|564518218|FG001|Overall Study|Protocol Violation|0|||
156389956|NCT04773587|564518217|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
156389957|NCT04773587|564518218|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
156389958|NCT01808313|564518221|FG000|Overall Study|Adverse Event|5|||
156389959|NCT01808313|564518221|FG000|Overall Study|Protocol Violation|2|||
156389960|NCT01808313|564518221|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156389961|NCT01808313|564518221|FG000|Overall Study|Lost to Follow-up|1|||
156389962|NCT01808313|564518221|FG000|Overall Study|Physician Decision|1|||
156389963|NCT03346759|564518224|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
156389964|NCT03346759|564518225|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
156508156|NCT02519348|564953048|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
156508157|NCT02519348|564953049|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
156508158|NCT02519348|564953050|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
156389965|NCT03346759|564518224|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
156389966|NCT03346759|564518225|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
156389967|NCT03346759|564518224|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
156389968|NCT03346759|564518225|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
156389969|NCT00435370|564518226|FG000|Overall Study|Adverse Event|8|||
156389970|NCT00435370|564518227|FG001|Overall Study|Adverse Event|8|||
156389971|NCT00435370|564518226|FG000|Overall Study|Withdrawal by Subject|10|||
156389972|NCT00435370|564518227|FG001|Overall Study|Withdrawal by Subject|10|||
156389973|NCT00435370|564518226|FG000|Overall Study|Antipsychotic medication changed|4|||
156389974|NCT00435370|564518227|FG001|Overall Study|Antipsychotic medication changed|2|||
156389975|NCT02132611|564518228|FG000|Overall Study|Death|2|||
156389976|NCT03943095|564518229|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
156389977|NCT03943095|564518230|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
156389978|NCT03943095|564518229|FG000|Overall Study|Withdrawal by Subject|1|||
156389979|NCT03943095|564518230|FG001|Overall Study|Withdrawal by Subject|0|||
156389980|NCT00744653|564518231|FG000|Overall Study|antineoplastic treatment|11|||
156389981|NCT00744653|564518231|FG000|Overall Study|Death|1|||
156389982|NCT00744653|564518231|FG000|Overall Study|Lost to Follow-up|1|||
156389983|NCT00744653|564518231|FG000|Overall Study|Physician Decision|3|||
156389984|NCT02298192|564518235|FG000|Overall Study|Unclassified|3|||
156389985|NCT02298192|564518236|FG001|Overall Study|Unclassified|2|||
156389986|NCT02298192|564518235|FG000|Overall Study|Withdrawal criteria|2|||
156389987|NCT02298192|564518236|FG001|Overall Study|Withdrawal criteria|0|||
156389988|NCT02298192|564518235|FG000|Overall Study|Withdrawal by Subject|6|||
156389989|NCT02298192|564518236|FG001|Overall Study|Withdrawal by Subject|1|||
156389990|NCT02298192|564518235|FG000|Overall Study|Lost to Follow-up|2|||
156389991|NCT02298192|564518236|FG001|Overall Study|Lost to Follow-up|1|||
156389992|NCT02298192|564518235|FG000|Overall Study|Adverse Event|6|||
156389993|NCT02298192|564518236|FG001|Overall Study|Adverse Event|2|||
156389994|NCT02352948|564518240|FG000|Overall Study|Death|47|||
156389995|NCT02352948|564518241|FG001|Overall Study|Death|48|||
156389996|NCT02352948|564518242|FG002|Overall Study|Death|114|||
156389997|NCT02352948|564518243|FG003|Overall Study|Death|74|||
156389998|NCT02352948|564518244|FG004|Overall Study|Death|77|||
156389999|NCT02352948|564518245|FG005|Overall Study|Death|44|||
156390000|NCT02352948|564518240|FG000|Overall Study|Lost to Follow-up|1|||
156390001|NCT02352948|564518241|FG001|Overall Study|Lost to Follow-up|0|||
156390002|NCT02352948|564518242|FG002|Overall Study|Lost to Follow-up|2|||
156390003|NCT02352948|564518243|FG003|Overall Study|Lost to Follow-up|1|||
156390004|NCT02352948|564518244|FG004|Overall Study|Lost to Follow-up|2|||
156390005|NCT02352948|564518245|FG005|Overall Study|Lost to Follow-up|1|||
156390006|NCT02352948|564518240|FG000|Overall Study|Withdrawal by Subject|1|||
156390007|NCT02352948|564518241|FG001|Overall Study|Withdrawal by Subject|10|||
156390008|NCT02352948|564518242|FG002|Overall Study|Withdrawal by Subject|11|||
156390009|NCT02352948|564518243|FG003|Overall Study|Withdrawal by Subject|23|||
156390010|NCT02352948|564518244|FG004|Overall Study|Withdrawal by Subject|9|||
156390011|NCT02352948|564518245|FG005|Overall Study|Withdrawal by Subject|4|||
156390012|NCT02352948|564518240|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156390013|NCT02352948|564518241|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156390014|NCT02352948|564518242|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
156390015|NCT02352948|564518243|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156390016|NCT02352948|564518244|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
156390017|NCT02352948|564518245|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
156390018|NCT02352948|564518240|FG000|Overall Study|Other|0|||
156390019|NCT02352948|564518241|FG001|Overall Study|Other|0|||
156390020|NCT02352948|564518242|FG002|Overall Study|Other|2|||
156390021|NCT02352948|564518243|FG003|Overall Study|Other|0|||
156390022|NCT02352948|564518244|FG004|Overall Study|Other|0|||
156390023|NCT02352948|564518245|FG005|Overall Study|Other|0|||
156390024|NCT02763384|564518251|FG000|Overall Study|Physician Decision|1|||
156390025|NCT02763384|564518251|FG000|Overall Study|Rapid decline - went on hospice|1|||
156390026|NCT02096900|564518252|FG000|Overall Study|Did not receive medication|3|||
156390027|NCT02096900|564518253|FG001|Overall Study|Did not receive medication|1|||
156390028|NCT02096900|564518252|FG000|Overall Study|Surgery cancelled- medication received|1|||
156390029|NCT02096900|564518253|FG001|Overall Study|Surgery cancelled- medication received|1|||
156390030|NCT04657211|564518254|FG000|Overall Study|Withdrawal by Subject|21|||
156390031|NCT04657211|564518254|FG000|Overall Study|Lost to Follow-up|113|||
156390032|NCT04657211|564518254|FG000|Overall Study|Death|47|||
156390033|NCT04657211|564518254|FG000|Overall Study|Transfer to another institution|21|||
156547815|NCT03016325|565098424|FG000|Treatment Period|Participant refuses assessments|0|||
156547816|NCT03016325|565098425|FG001|Treatment Period|Participant refuses assessments|0|||
156547817|NCT03016325|565098426|FG002|Treatment Period|Participant refuses assessments|1|||
156547818|NCT03016325|565098427|FG003|Treatment Period|Participant refuses assessments|0|||
156547819|NCT03016325|565098428|FG004|Treatment Period|Participant refuses assessments|0|||
156547820|NCT03016325|565098429|FG005|Treatment Period|Participant refuses assessments|0|||
156547821|NCT03016325|565098430|FG006|Treatment Period|Participant refuses assessments|0|||
156547822|NCT03016325|565098431|FG007|Treatment Period|Participant refuses assessments|0|||
156390034|NCT04657211|564518254|FG000|Overall Study|Other|29|||
156390035|NCT06273774|564518257|FG000|Overall Study|Participant was out of state.|0|||
156390036|NCT06273774|564518258|FG001|Overall Study|Participant was out of state.|0|||
156390037|NCT06273774|564518259|FG002|Overall Study|Participant was out of state.|0|||
156390038|NCT06273774|564518260|FG003|Overall Study|Participant was out of state.|0|||
156390039|NCT06273774|564518261|FG004|Overall Study|Participant was out of state.|0|||
156390040|NCT06273774|564518262|FG005|Overall Study|Participant was out of state.|1|||
156390041|NCT06273774|564518257|FG000|Overall Study|Lost to Follow-up|0|||
156547823|NCT03016325|565098424|FG000|32-Day Follow-Up Period|Death|2|||
156547824|NCT03016325|565098425|FG001|32-Day Follow-Up Period|Death|0|||
156547825|NCT03016325|565098426|FG002|32-Day Follow-Up Period|Death|5|||
156547826|NCT03016325|565098427|FG003|32-Day Follow-Up Period|Death|6|||
156547827|NCT03016325|565098428|FG004|32-Day Follow-Up Period|Death|3|||
156547828|NCT03016325|565098429|FG005|32-Day Follow-Up Period|Death|0|||
156390042|NCT06273774|564518258|FG001|Overall Study|Lost to Follow-up|0|||
156390043|NCT06273774|564518259|FG002|Overall Study|Lost to Follow-up|0|||
156390044|NCT06273774|564518260|FG003|Overall Study|Lost to Follow-up|0|||
156390045|NCT06273774|564518261|FG004|Overall Study|Lost to Follow-up|1|||
156390046|NCT06273774|564518262|FG005|Overall Study|Lost to Follow-up|0|||
156390047|NCT02010060|564518263|FG000|Overall Study|Lost to Follow-up|1|||
156390048|NCT02010060|564518264|FG001|Overall Study|Lost to Follow-up|2|||
156390049|NCT02010060|564518265|FG002|Overall Study|Lost to Follow-up|2|||
156390050|NCT02010060|564518263|FG000|Overall Study|Injury|0|||
156390051|NCT02010060|564518264|FG001|Overall Study|Injury|1|||
156390052|NCT02010060|564518265|FG002|Overall Study|Injury|0|||
156390053|NCT04414696|564518266|FG000|3-month Follow up|Withdrawal by Subject|1|||
156390054|NCT04414696|564518267|FG001|3-month Follow up|Withdrawal by Subject|0|||
156390055|NCT04414696|564518266|FG000|3-month Follow up|Lost to Follow-up|22|||
156390056|NCT04414696|564518267|FG001|3-month Follow up|Lost to Follow-up|23|||
156390057|NCT04414696|564518266|FG000|6-month Follow up|Withdrawal by Subject|1|||
156390058|NCT04414696|564518267|FG001|6-month Follow up|Withdrawal by Subject|2|||
156390059|NCT04414696|564518266|FG000|6-month Follow up|Lost to Follow-up|5|||
156390060|NCT04414696|564518267|FG001|6-month Follow up|Lost to Follow-up|2|||
156390061|NCT00660010|564518270|FG000|Overall Study|Withdrawal by Subject|2|||
156390062|NCT00660010|564518270|FG000|Overall Study|Lost to Follow-up|3|||
156390063|NCT00660010|564518270|FG000|Overall Study|Adverse Event|1|||
156390064|NCT00660010|564518270|FG000|Overall Study|Noncompliance with visit schedule|3|||
156390065|NCT06167031|564518273|FG000|Overall Study|Lost to Follow-up|5|||
156508159|NCT02519348|564953051|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
156508160|NCT02519348|564953052|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
156508161|NCT02519348|564953053|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
156508162|NCT02519348|564953054|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
156508163|NCT02519348|564953055|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
156508164|NCT01110408|564953056|FG000|Overall Study|Protocol Violation|1|||
156508165|NCT01110408|564953057|FG001|Overall Study|Protocol Violation|0|||
156508166|NCT00669877|564953058|FG000|Overall Study|Disease Progression/Death|4|||
156508167|NCT04103892|564953059|FG000|Overall Study|Adverse Event|0|||
156508168|NCT04103892|564953060|FG001|Overall Study|Adverse Event|0|||
156508169|NCT04103892|564953061|FG002|Overall Study|Adverse Event|0|||
156508170|NCT04103892|564953062|FG003|Overall Study|Adverse Event|3|||
156508171|NCT04103892|564953059|FG000|Overall Study|Lost to Follow-up|0|||
156508172|NCT04103892|564953060|FG001|Overall Study|Lost to Follow-up|0|||
156508173|NCT04103892|564953061|FG002|Overall Study|Lost to Follow-up|2|||
156508174|NCT04103892|564953062|FG003|Overall Study|Lost to Follow-up|0|||
156508175|NCT04103892|564953059|FG000|Overall Study|Protocol Violation|0|||
156508176|NCT04103892|564953060|FG001|Overall Study|Protocol Violation|0|||
156508177|NCT04103892|564953061|FG002|Overall Study|Protocol Violation|1|||
156508178|NCT04103892|564953062|FG003|Overall Study|Protocol Violation|1|||
156508179|NCT04103892|564953059|FG000|Overall Study|Withdrawal by Subject|1|||
156508180|NCT04103892|564953060|FG001|Overall Study|Withdrawal by Subject|0|||
156508181|NCT04103892|564953061|FG002|Overall Study|Withdrawal by Subject|2|||
156508182|NCT04103892|564953062|FG003|Overall Study|Withdrawal by Subject|5|||
156508183|NCT04103892|564953059|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
156508184|NCT04103892|564953060|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
156508185|NCT04103892|564953061|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
156508186|NCT04103892|564953062|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
156508187|NCT03008005|564953063|FG000|Overall Study|Physician Decision|1|||
156508188|NCT03008005|564953064|FG001|Overall Study|Physician Decision|0|||
156508189|NCT03008005|564953065|FG002|Overall Study|Physician Decision|0|||
156508190|NCT03008005|564953063|FG000|Overall Study|Withdrawal by Subject|1|||
156508191|NCT03008005|564953064|FG001|Overall Study|Withdrawal by Subject|0|||
156508192|NCT03008005|564953065|FG002|Overall Study|Withdrawal by Subject|0|||
156508193|NCT03008005|564953063|FG000|Overall Study|Ineligible|0|||
156508194|NCT03008005|564953064|FG001|Overall Study|Ineligible|1|||
156508195|NCT03008005|564953065|FG002|Overall Study|Ineligible|0|||
156508196|NCT00975676|564953066|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
156508197|NCT00975676|564953067|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
156508198|NCT02548078|564953068|FG000|Overall Study|Serious adverse event/Adverse event|1|||
156508199|NCT02548078|564953069|FG001|Overall Study|Serious adverse event/Adverse event|0|||
156508200|NCT02548078|564953068|FG000|Overall Study|Moved from study area|3|||
156508201|NCT02548078|564953069|FG001|Overall Study|Moved from study area|3|||
156508202|NCT02548078|564953068|FG000|Overall Study|Lost to Follow-up|1|||
156508203|NCT02548078|564953069|FG001|Overall Study|Lost to Follow-up|3|||
156508204|NCT00862836|564953070|FG000|Overall Study|Withdrawal by Subject|1|||
156508205|NCT05855967|564953071|FG000|Overall Study|Withdrawal by Subject|7|||
156508206|NCT05855967|564953072|FG001|Overall Study|Withdrawal by Subject|5|||
156508207|NCT05855967|564953071|FG000|Overall Study|Lost to Follow-up|2|||
156508208|NCT05855967|564953072|FG001|Overall Study|Lost to Follow-up|1|||
156390066|NCT06167031|564518274|FG001|Overall Study|Lost to Follow-up|1|||
156390067|NCT00003508|564520399|FG000|Overall Study|Not evaluable|5|||
156508209|NCT04147195|564953073|FG000|Overall Study|Adverse Event|0|||
156390068|NCT02160314|564520400|FG000|Overall Study|Adverse Event|0|||
156390069|NCT02160314|564520401|FG001|Overall Study|Adverse Event|6|||
156508210|NCT04147195|564953074|FG001|Overall Study|Adverse Event|3|||
156390070|NCT02160314|564520400|FG000|Overall Study|Protocol Violation|0|||
156390071|NCT02160314|564520401|FG001|Overall Study|Protocol Violation|4|||
156390072|NCT02160314|564520400|FG000|Overall Study|Withdrawal by Subject|1|||
156390073|NCT02160314|564520401|FG001|Overall Study|Withdrawal by Subject|2|||
156390074|NCT02160314|564520400|FG000|Overall Study|Lost to Follow-up|0|||
156390075|NCT02160314|564520401|FG001|Overall Study|Lost to Follow-up|1|||
156390076|NCT00593567|564520402|FG000|Overall Study|Adverse Event|2|||
156390077|NCT00593567|564520403|FG001|Overall Study|Adverse Event|0|||
156390078|NCT00593567|564520402|FG000|Overall Study|Physician Decision|2|||
156390079|NCT00593567|564520403|FG001|Overall Study|Physician Decision|0|||
156390080|NCT00593567|564520402|FG000|Overall Study|Protocol Violation|13|||
156390081|NCT00593567|564520403|FG001|Overall Study|Protocol Violation|7|||
156390082|NCT00593567|564520402|FG000|Overall Study|Lack of Efficacy|2|||
156390083|NCT00593567|564520403|FG001|Overall Study|Lack of Efficacy|1|||
156390084|NCT00593567|564520402|FG000|Overall Study|Withdrawal by Subject|1|||
156390085|NCT00593567|564520403|FG001|Overall Study|Withdrawal by Subject|2|||
156390086|NCT03576768|564520409|FG000|Overall Study|Lost to Follow-up|3|||
156390087|NCT03576768|564520410|FG001|Overall Study|Lost to Follow-up|3|||
156390088|NCT03576768|564520411|FG002|Overall Study|Lost to Follow-up|0|||
156390089|NCT03576768|564520412|FG003|Overall Study|Lost to Follow-up|0|||
156390090|NCT00590902|564520413|FG000|Overall Study|Death|1|||
156390091|NCT00785291|564520414|FG000|Overall Study|Never began treatment|8|||
156390092|NCT00785291|564520415|FG001|Overall Study|Never began treatment|4|||
156390093|NCT00785291|564520416|FG002|Overall Study|Never began treatment|4|||
156390094|NCT00785291|564520414|FG000|Overall Study|Adverse Event|39|||
156390095|NCT00785291|564520415|FG001|Overall Study|Adverse Event|70|||
156390096|NCT00785291|564520416|FG002|Overall Study|Adverse Event|56|||
156390097|NCT00785291|564520414|FG000|Overall Study|Death|7|||
156390098|NCT00785291|564520415|FG001|Overall Study|Death|4|||
156390099|NCT00785291|564520416|FG002|Overall Study|Death|3|||
156390100|NCT00785291|564520414|FG000|Overall Study|Withdrawal by Subject|35|||
156390101|NCT00785291|564520415|FG001|Overall Study|Withdrawal by Subject|36|||
156390102|NCT00785291|564520416|FG002|Overall Study|Withdrawal by Subject|17|||
156390103|NCT00785291|564520414|FG000|Overall Study|Alternative Therapy|12|||
156390104|NCT00785291|564520415|FG001|Overall Study|Alternative Therapy|6|||
156390105|NCT00785291|564520416|FG002|Overall Study|Alternative Therapy|7|||
156390106|NCT00785291|564520414|FG000|Overall Study|Complicating illness|6|||
156390107|NCT00785291|564520415|FG001|Overall Study|Complicating illness|4|||
156390108|NCT00785291|564520416|FG002|Overall Study|Complicating illness|4|||
156390109|NCT00785291|564520414|FG000|Overall Study|Other Medical Reasons|29|||
156390110|NCT00785291|564520415|FG001|Overall Study|Other Medical Reasons|25|||
156390111|NCT00785291|564520416|FG002|Overall Study|Other Medical Reasons|15|||
156390112|NCT02119260|564520417|FG000|Overall Study|Adverse Event|1|||
156390113|NCT02119260|564520418|FG001|Overall Study|Adverse Event|0|||
156390114|NCT02119260|564520419|FG002|Overall Study|Adverse Event|0|||
156390115|NCT02119260|564520420|FG003|Overall Study|Adverse Event|0|||
156390116|NCT02119260|564520421|FG004|Overall Study|Adverse Event|0|||
156390117|NCT02119260|564520422|FG005|Overall Study|Adverse Event|0|||
156390118|NCT02119260|564520423|FG006|Overall Study|Adverse Event|0|||
156390119|NCT02119260|564520417|FG000|Overall Study|Withdrew consent|0|||
156390120|NCT02119260|564520418|FG001|Overall Study|Withdrew consent|1|||
156390121|NCT02119260|564520419|FG002|Overall Study|Withdrew consent|1|||
156390122|NCT02119260|564520420|FG003|Overall Study|Withdrew consent|0|||
156390123|NCT02119260|564520421|FG004|Overall Study|Withdrew consent|0|||
156390124|NCT02119260|564520422|FG005|Overall Study|Withdrew consent|0|||
156390125|NCT02119260|564520423|FG006|Overall Study|Withdrew consent|0|||
156390126|NCT02057874|564520425|FG000|Overall Study|participant did not return for scan|1|||
156390127|NCT01738984|564520428|FG000|Overall Study|Pregnancy|4|||
156390128|NCT01738984|564520429|FG001|Overall Study|Pregnancy|0|||
156390129|NCT01738984|564520428|FG000|Overall Study|Withdrawal by Subject|1|||
156390130|NCT01738984|564520429|FG001|Overall Study|Withdrawal by Subject|0|||
156390131|NCT01738984|564520428|FG000|Overall Study|Lost to Follow-up|59|||
156508211|NCT04147195|564953073|FG000|Overall Study|Study Terminated by Sponsor|4|||
156508212|NCT04147195|564953074|FG001|Overall Study|Study Terminated by Sponsor|2|||
156508213|NCT04147195|564953073|FG000|Overall Study|Withdrawal by Subject|0|||
156390132|NCT01738984|564520429|FG001|Overall Study|Lost to Follow-up|39|||
156390133|NCT00920426|564520430|FG000|ITZ111451|Adverse Event|1|||
156390134|NCT00920426|564520431|FG001|ITZ111451|Adverse Event|0|||
156390135|NCT00920426|564520432|FG002|ITZ111451|Adverse Event|0|||
156390136|NCT00920426|564520433|FG003|ITZ111451|Adverse Event|0|||
156390137|NCT02925455|564520434|FG000|Overall Study|Withdrawal by Subject|2|||
156390138|NCT02925455|564520435|FG001|Overall Study|Withdrawal by Subject|0|||
156390139|NCT00686166|564520441|FG000|Overall Study|Adverse Event|7|||
156390140|NCT00686166|564520441|FG000|Overall Study|Withdrawal by Subject|1|||
156390141|NCT00686166|564520441|FG000|Overall Study|Progression/Relapse|1|||
156390142|NCT00686166|564520441|FG000|Overall Study|Death|1|||
156390143|NCT00686166|564520441|FG000|Overall Study|Not Protocol Specified|1|||
156390144|NCT00686166|564520441|FG000|Overall Study|Ineligible|5|||
156390145|NCT00686166|564520441|FG000|Overall Study|Did not begin protocol therapy|4|||
156390146|NCT00985725|564520442|FG000|Overall Study|Adverse Event|4|||
156390147|NCT00985725|564520443|FG001|Overall Study|Adverse Event|1|||
156508214|NCT04147195|564953074|FG001|Overall Study|Withdrawal by Subject|1|||
156390148|NCT00985725|564520442|FG000|Overall Study|Protocol Violation|1|||
156390149|NCT00985725|564520443|FG001|Overall Study|Protocol Violation|3|||
156390150|NCT00985725|564520442|FG000|Overall Study|Withdrawal by Subject|4|||
156390151|NCT00985725|564520443|FG001|Overall Study|Withdrawal by Subject|4|||
156390152|NCT00985725|564520442|FG000|Overall Study|Lost to Follow-up|1|||
156390153|NCT00985725|564520443|FG001|Overall Study|Lost to Follow-up|1|||
156390154|NCT00985725|564520442|FG000|Overall Study|Lack of Efficacy|0|||
156390155|NCT00985725|564520443|FG001|Overall Study|Lack of Efficacy|1|||
156390156|NCT00985725|564520442|FG000|Overall Study|Non-compliance|1|||
156390157|NCT00985725|564520443|FG001|Overall Study|Non-compliance|2|||
156390158|NCT00985725|564520442|FG000|Overall Study|Out-of-window visits|0|||
156390159|NCT00985725|564520443|FG001|Overall Study|Out-of-window visits|1|||
156390160|NCT01514448|564520444|FG000|Overall Study|Death|7|||
156390161|NCT01514448|564520445|FG001|Overall Study|Death|8|||
156390162|NCT01514448|564520444|FG000|Overall Study|Withdrawal by Subject|2|||
156390163|NCT01514448|564520445|FG001|Overall Study|Withdrawal by Subject|0|||
156390164|NCT01514448|564520444|FG000|Overall Study|Lost to Follow-up|2|||
156390165|NCT01514448|564520445|FG001|Overall Study|Lost to Follow-up|0|||
156390166|NCT01514448|564520444|FG000|Overall Study|New Cancer Therapy|1|||
156390167|NCT01514448|564520445|FG001|Overall Study|New Cancer Therapy|0|||
156390168|NCT03912259|564520449|FG000|Overall Study|Adverse Event (AE)|2|||
156390169|NCT03912259|564520450|FG001|Overall Study|Adverse Event (AE)|4|||
156390170|NCT03912259|564520449|FG000|Overall Study|Lack of Efficacy|4|||
156390171|NCT03912259|564520450|FG001|Overall Study|Lack of Efficacy|1|||
156390172|NCT03912259|564520449|FG000|Overall Study|Withdrawal by Subject|11|||
156390173|NCT03912259|564520450|FG001|Overall Study|Withdrawal by Subject|1|||
156390174|NCT01549613|564520451|FG000|Overall Study|Lost to Follow-up|11|||
156390175|NCT01549613|564520452|FG001|Overall Study|Lost to Follow-up|11|||
156390176|NCT02131272|564520453|FG000|Overall Study|Withdrawal by parent|0|||
156390177|NCT02131272|564520454|FG001|Overall Study|Withdrawal by parent|1|||
156390178|NCT02131272|564520453|FG000|Overall Study|Withdrawal by Subject|0|||
156390179|NCT02131272|564520454|FG001|Overall Study|Withdrawal by Subject|1|||
156390180|NCT02131272|564520453|FG000|Overall Study|Withdrawal Criteria|1|||
156390181|NCT02131272|564520454|FG001|Overall Study|Withdrawal Criteria|0|||
156390182|NCT01925950|564520455|FG000|Part 2|Withdrawal by Subject|1|||
156390183|NCT01925950|564520456|FG001|Part 2|Withdrawal by Subject|0|||
156390184|NCT00381940|564520457|FG000|Overall Study|Lack of Efficacy|3|||
156390185|NCT00381940|564520457|FG000|Overall Study|Protocol Violation|1|||
156390186|NCT00381940|564520457|FG000|Overall Study|Ineligible|1|||
156390187|NCT03162224|564520458|FG000|Overall Study|Death|4|||
156390188|NCT03162224|564520459|FG001|Overall Study|Death|5|||
156390189|NCT03162224|564520460|FG002|Overall Study|Death|8|||
156390190|NCT03162224|564520458|FG000|Overall Study|Withdrawal by Subject|1|||
156390191|NCT03162224|564520459|FG001|Overall Study|Withdrawal by Subject|0|||
156390192|NCT03162224|564520460|FG002|Overall Study|Withdrawal by Subject|1|||
156390193|NCT03162224|564520458|FG000|Overall Study|Lost to Follow-up|0|||
156390194|NCT03162224|564520459|FG001|Overall Study|Lost to Follow-up|1|||
156390195|NCT03162224|564520460|FG002|Overall Study|Lost to Follow-up|0|||
156390196|NCT03162224|564520458|FG000|Overall Study|Other|6|||
156390197|NCT03162224|564520459|FG001|Overall Study|Other|2|||
156390198|NCT03162224|564520460|FG002|Overall Study|Other|1|||
156390199|NCT04162769|564520461|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
156390200|NCT04162769|564520462|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
156390201|NCT04162769|564520463|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
156390202|NCT04162769|564520464|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
156390203|NCT04162769|564520461|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
156390204|NCT04162769|564520462|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
156390205|NCT04162769|564520463|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
156390206|NCT04162769|564520464|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
156390207|NCT04162769|564520461|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
156390208|NCT04162769|564520462|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
156390209|NCT04162769|564520463|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
156390210|NCT04162769|564520464|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
156508215|NCT05823012|564953075|FG000|Titration Period|Adverse Event|1|||
156508216|NCT05823012|564953075|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
156508217|NCT05823012|564953075|FG000|Maintenance Period|Adverse Event|1|||
156508218|NCT05823012|564953075|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
156390211|NCT04162769|564520461|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
156390212|NCT04162769|564520462|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
156390213|NCT04162769|564520463|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
156390214|NCT04162769|564520464|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
156390215|NCT04162769|564520461|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
156390216|NCT04162769|564520462|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
156390217|NCT04162769|564520463|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
156390218|NCT04162769|564520464|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
156390219|NCT04162769|564520461|FG000|Double-blind Treatment (12-Week)|Other|0|||
156547829|NCT03016325|565098430|FG006|32-Day Follow-Up Period|Death|0|||
156547830|NCT03016325|565098431|FG007|32-Day Follow-Up Period|Death|0|||
156547831|NCT03016325|565098424|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
156547832|NCT03016325|565098425|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
156547833|NCT03016325|565098426|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
156547834|NCT03016325|565098427|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
156547835|NCT03016325|565098428|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
156547836|NCT03016325|565098429|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
156547837|NCT03016325|565098430|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
156547838|NCT03016325|565098431|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
156547839|NCT03016325|565098424|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
156547840|NCT03016325|565098425|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
156547841|NCT03016325|565098426|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
156547842|NCT03016325|565098427|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
156547843|NCT03016325|565098428|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
156547844|NCT03016325|565098429|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
156547845|NCT03016325|565098430|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
156547846|NCT03016325|565098431|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
156547847|NCT03016325|565098424|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
156547848|NCT03016325|565098425|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
156547849|NCT03016325|565098426|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
156547850|NCT03016325|565098427|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
156547851|NCT03016325|565098428|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
156547852|NCT03016325|565098429|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
156547853|NCT03016325|565098430|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
156547854|NCT03016325|565098431|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
156547855|NCT03016325|565098424|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
156547856|NCT03016325|565098425|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
156547857|NCT03016325|565098426|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
156547858|NCT03016325|565098427|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
156547859|NCT03016325|565098428|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
156547860|NCT03016325|565098429|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
156547861|NCT03016325|565098430|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
156547862|NCT03016325|565098431|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
156547863|NCT03016325|565098424|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
156547864|NCT03016325|565098425|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
156547865|NCT03016325|565098426|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
156547866|NCT03016325|565098427|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
156547867|NCT03016325|565098428|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
156547868|NCT03016325|565098429|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
156547869|NCT03016325|565098430|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
156547870|NCT03016325|565098431|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
156547871|NCT03016325|565098424|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
156547872|NCT03016325|565098425|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
156547873|NCT03016325|565098426|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
156547874|NCT03016325|565098427|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
156547875|NCT03016325|565098428|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
156547876|NCT03016325|565098429|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
156547877|NCT03016325|565098430|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
156547878|NCT03016325|565098431|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
156547879|NCT03016325|565098424|FG000|182-Day Follow-Up Period|Death|3|||
156547880|NCT03016325|565098425|FG001|182-Day Follow-Up Period|Death|3|||
156547881|NCT03016325|565098426|FG002|182-Day Follow-Up Period|Death|11|||
156547882|NCT03016325|565098427|FG003|182-Day Follow-Up Period|Death|12|||
156547883|NCT03016325|565098428|FG004|182-Day Follow-Up Period|Death|9|||
156547884|NCT03016325|565098429|FG005|182-Day Follow-Up Period|Death|0|||
156547885|NCT03016325|565098430|FG006|182-Day Follow-Up Period|Death|0|||
156547886|NCT03016325|565098431|FG007|182-Day Follow-Up Period|Death|1|||
156547887|NCT03016325|565098424|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
156547888|NCT03016325|565098425|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
156547889|NCT03016325|565098426|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
156547890|NCT03016325|565098427|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
156547891|NCT03016325|565098428|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
156547892|NCT03016325|565098429|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
156547893|NCT03016325|565098430|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
156547894|NCT03016325|565098431|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
156547895|NCT03016325|565098424|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
156390220|NCT04162769|564520462|FG001|Double-blind Treatment (12-Week)|Other|1|||
156390221|NCT04162769|564520463|FG002|Double-blind Treatment (12-Week)|Other|1|||
156390222|NCT04162769|564520464|FG003|Double-blind Treatment (12-Week)|Other|0|||
156390223|NCT04162769|564520461|FG000|OLE Period (52-Week)|Adverse Event|0|||
156390224|NCT04162769|564520462|FG001|OLE Period (52-Week)|Adverse Event|0|||
156390225|NCT04162769|564520463|FG002|OLE Period (52-Week)|Adverse Event|0|||
156390226|NCT04162769|564520464|FG003|OLE Period (52-Week)|Adverse Event|5|||
156390227|NCT04162769|564520461|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
156390228|NCT04162769|564520462|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
156390229|NCT04162769|564520463|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
156390230|NCT04162769|564520464|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
156390231|NCT04162769|564520461|FG000|OLE Period (52-Week)|Physician Decision|0|||
156390232|NCT04162769|564520462|FG001|OLE Period (52-Week)|Physician Decision|0|||
156390233|NCT04162769|564520463|FG002|OLE Period (52-Week)|Physician Decision|0|||
156390234|NCT04162769|564520464|FG003|OLE Period (52-Week)|Physician Decision|1|||
156390235|NCT04162769|564520461|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
156390236|NCT04162769|564520462|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
156390237|NCT04162769|564520463|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
156390238|NCT04162769|564520464|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
156390239|NCT04162769|564520461|FG000|OLE Period (52-Week)|Protocol deviation|0|||
156390240|NCT04162769|564520462|FG001|OLE Period (52-Week)|Protocol deviation|0|||
156390241|NCT04162769|564520463|FG002|OLE Period (52-Week)|Protocol deviation|0|||
156390242|NCT04162769|564520464|FG003|OLE Period (52-Week)|Protocol deviation|2|||
156390243|NCT01613248|564520467|FG000|Overall Study|Adverse Event|0|||
156390244|NCT01613248|564520468|FG001|Overall Study|Adverse Event|0|||
156390245|NCT01613248|564520469|FG002|Overall Study|Adverse Event|0|||
156390246|NCT01613248|564520470|FG003|Overall Study|Adverse Event|1|||
156390247|NCT01613248|564520471|FG004|Overall Study|Adverse Event|0|||
156390248|NCT01613248|564520472|FG005|Overall Study|Adverse Event|0|||
156390249|NCT01613248|564520467|FG000|Overall Study|Withdrawal by Subject|3|||
156390250|NCT01613248|564520468|FG001|Overall Study|Withdrawal by Subject|2|||
156390251|NCT01613248|564520469|FG002|Overall Study|Withdrawal by Subject|2|||
156390252|NCT01613248|564520470|FG003|Overall Study|Withdrawal by Subject|5|||
156390253|NCT01613248|564520471|FG004|Overall Study|Withdrawal by Subject|0|||
156390254|NCT01613248|564520472|FG005|Overall Study|Withdrawal by Subject|1|||
156390255|NCT01613248|564520467|FG000|Overall Study|Lost to Follow-up|5|||
156390256|NCT01613248|564520468|FG001|Overall Study|Lost to Follow-up|7|||
156390257|NCT01613248|564520469|FG002|Overall Study|Lost to Follow-up|4|||
156390258|NCT01613248|564520470|FG003|Overall Study|Lost to Follow-up|8|||
156390259|NCT01613248|564520471|FG004|Overall Study|Lost to Follow-up|4|||
156390260|NCT01613248|564520472|FG005|Overall Study|Lost to Follow-up|2|||
156390261|NCT01613248|564520467|FG000|Overall Study|Study Terminated by Sponsor|4|||
156390262|NCT01613248|564520468|FG001|Overall Study|Study Terminated by Sponsor|6|||
156390263|NCT01613248|564520469|FG002|Overall Study|Study Terminated by Sponsor|8|||
156390264|NCT01613248|564520470|FG003|Overall Study|Study Terminated by Sponsor|8|||
156390265|NCT01613248|564520471|FG004|Overall Study|Study Terminated by Sponsor|9|||
156390266|NCT01613248|564520472|FG005|Overall Study|Study Terminated by Sponsor|11|||
156390267|NCT01613248|564520467|FG000|Overall Study|Physician Decision|8|||
156390268|NCT01613248|564520468|FG001|Overall Study|Physician Decision|8|||
156390269|NCT01613248|564520469|FG002|Overall Study|Physician Decision|9|||
156390270|NCT01613248|564520470|FG003|Overall Study|Physician Decision|4|||
156390271|NCT01613248|564520471|FG004|Overall Study|Physician Decision|7|||
156390272|NCT01613248|564520472|FG005|Overall Study|Physician Decision|6|||
156390273|NCT01613248|564520467|FG000|Overall Study|Lack of Qualifying Event|9|||
156390274|NCT01613248|564520468|FG001|Overall Study|Lack of Qualifying Event|11|||
156390275|NCT01613248|564520469|FG002|Overall Study|Lack of Qualifying Event|10|||
156390276|NCT01613248|564520470|FG003|Overall Study|Lack of Qualifying Event|11|||
156390277|NCT01613248|564520471|FG004|Overall Study|Lack of Qualifying Event|15|||
156390278|NCT01613248|564520472|FG005|Overall Study|Lack of Qualifying Event|18|||
156508219|NCT05823012|564953075|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
156508220|NCT01424813|564953076|FG000|Overall Study|Withdrawal by Subject|3|||
156508221|NCT01424813|564953077|FG001|Overall Study|Withdrawal by Subject|0|||
156390279|NCT01613248|564520467|FG000|Overall Study|Pregnancy|0|||
156508222|NCT01424813|564953076|FG000|Overall Study|Protocol Violation|1|||
156508223|NCT01424813|564953077|FG001|Overall Study|Protocol Violation|0|||
156508224|NCT01424813|564953076|FG000|Overall Study|Other|1|||
156390280|NCT01613248|564520468|FG001|Overall Study|Pregnancy|0|||
156390281|NCT01613248|564520469|FG002|Overall Study|Pregnancy|0|||
156390282|NCT01613248|564520470|FG003|Overall Study|Pregnancy|1|||
156390283|NCT01613248|564520471|FG004|Overall Study|Pregnancy|0|||
156390284|NCT01613248|564520472|FG005|Overall Study|Pregnancy|0|||
156390285|NCT06116591|564520477|FG000|Overall Study|No longer met eligibility criteria|0|||
156390286|NCT06116591|564520478|FG001|Overall Study|No longer met eligibility criteria|1|||
156390287|NCT06116591|564520477|FG000|Overall Study|Other: Change in life situation|0|||
156390288|NCT06116591|564520478|FG001|Overall Study|Other: Change in life situation|1|||
156390289|NCT05585307|564520479|FG000|Overall Study|Lost to Follow-up|0|||
156390290|NCT05585307|564520480|FG001|Overall Study|Lost to Follow-up|0|||
156390291|NCT05585307|564520481|FG002|Overall Study|Lost to Follow-up|0|||
156390292|NCT05585307|564520482|FG003|Overall Study|Lost to Follow-up|0|||
156390293|NCT05585307|564520483|FG004|Overall Study|Lost to Follow-up|0|||
156390294|NCT05585307|564520484|FG005|Overall Study|Lost to Follow-up|0|||
156390295|NCT05585307|564520485|FG006|Overall Study|Lost to Follow-up|1|||
156390296|NCT05585307|564520486|FG007|Overall Study|Lost to Follow-up|0|||
156390297|NCT02270450|564520495|FG000|Overall Study|Refusal unrelated to adverse event|3|||
156390298|NCT02270450|564520496|FG001|Overall Study|Refusal unrelated to adverse event|1|||
156547896|NCT03016325|565098425|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
156547897|NCT03016325|565098426|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
156547898|NCT03016325|565098427|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
156547899|NCT03016325|565098428|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
156547900|NCT03016325|565098429|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
156547901|NCT03016325|565098430|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
156547902|NCT03016325|565098431|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
156547903|NCT03016325|565098424|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
156547904|NCT03016325|565098425|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
156547905|NCT03016325|565098426|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
156547906|NCT03016325|565098427|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
156547907|NCT03016325|565098428|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
156547908|NCT03016325|565098429|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
156547909|NCT03016325|565098430|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
156547910|NCT03016325|565098431|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
156547911|NCT03016325|565098424|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
156547912|NCT03016325|565098425|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
156547913|NCT03016325|565098426|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
156547914|NCT03016325|565098427|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
156547915|NCT03016325|565098428|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
156547916|NCT03016325|565098429|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
156547917|NCT03016325|565098430|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
156547918|NCT03016325|565098431|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
156547919|NCT03016325|565098424|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
156547920|NCT03016325|565098425|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
156547921|NCT03016325|565098426|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
156547922|NCT03016325|565098427|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
156547923|NCT03016325|565098428|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
156547924|NCT03016325|565098429|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
156547925|NCT03016325|565098430|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
156547926|NCT03016325|565098431|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
156547927|NCT03016325|565098424|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
156547928|NCT03016325|565098425|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
156547929|NCT03016325|565098426|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
156547930|NCT03016325|565098427|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
156547931|NCT03016325|565098428|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
156547932|NCT03016325|565098429|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
156547933|NCT03016325|565098430|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
156547934|NCT03016325|565098431|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
156547935|NCT03016325|565098424|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
156547936|NCT03016325|565098425|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
156547937|NCT03016325|565098426|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
156547938|NCT03016325|565098427|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
156547939|NCT03016325|565098428|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
156547940|NCT03016325|565098429|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
156547941|NCT03016325|565098430|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
156547942|NCT03016325|565098431|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
156547943|NCT02941627|565098435|FG000|Overall Study|Death|1|||
156547944|NCT02941627|565098435|FG000|Overall Study|Surgical failure|1|||
156547945|NCT02941627|565098435|FG000|Overall Study|cholesteatoma prevented implantation|1|||
156547946|NCT02595723|565098436|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
156547947|NCT02595723|565098437|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
156547948|NCT02595723|565098438|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
156547949|NCT02595723|565098436|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
156547950|NCT02595723|565098437|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
156547951|NCT02595723|565098438|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
156547952|NCT01087905|565098439|FG000|Overall Study|Lost to Follow-up|24|||
156547953|NCT01087905|565098440|FG001|Overall Study|Lost to Follow-up|28|||
156390299|NCT02270450|564520497|FG002|Overall Study|Refusal unrelated to adverse event|5|||
156390300|NCT02270450|564520498|FG003|Overall Study|Refusal unrelated to adverse event|14|||
156390301|NCT02270450|564520495|FG000|Overall Study|Progression/relapse|1|||
156390302|NCT02270450|564520496|FG001|Overall Study|Progression/relapse|2|||
156390303|NCT02270450|564520497|FG002|Overall Study|Progression/relapse|4|||
156390304|NCT02270450|564520498|FG003|Overall Study|Progression/relapse|9|||
156390305|NCT02270450|564520495|FG000|Overall Study|Death|19|||
156390306|NCT02270450|564520496|FG001|Overall Study|Death|19|||
156390307|NCT02270450|564520497|FG002|Overall Study|Death|31|||
156390308|NCT02270450|564520498|FG003|Overall Study|Death|59|||
156390309|NCT02363738|564520499|FG000|Overall Study|Adverse Event|5|||
156390310|NCT02363738|564520500|FG001|Overall Study|Adverse Event|2|||
156390311|NCT02363738|564520499|FG000|Overall Study|Lack of Efficacy|1|||
156390312|NCT02363738|564520500|FG001|Overall Study|Lack of Efficacy|2|||
156390313|NCT02363738|564520499|FG000|Overall Study|Lost to Follow-up|2|||
156390314|NCT02363738|564520500|FG001|Overall Study|Lost to Follow-up|1|||
156390315|NCT03282227|564520501|FG000|Overall Study|Exposure Goals Achieved|60|||
156390316|NCT03282227|564520501|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
156390317|NCT03282227|564520501|FG000|Overall Study|Adverse Event|15|||
156390318|NCT03282227|564520501|FG000|Overall Study|Lost to Follow-up|21|||
156390319|NCT03282227|564520501|FG000|Overall Study|Withdrawal by Subject|20|||
156390320|NCT03282227|564520501|FG000|Overall Study|Lack of Efficacy|12|||
156390321|NCT03282227|564520501|FG000|Overall Study|Sponsor decision|3|||
156390322|NCT03282227|564520501|FG000|Overall Study|Physician Decision|2|||
156390323|NCT03282227|564520501|FG000|Overall Study|Pregnancy|2|||
156390324|NCT03282227|564520501|FG000|Overall Study|Other|1|||
156390325|NCT00700401|564520509|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
156390326|NCT00700401|564520509|FG000|Overall Study|Adverse Event|5|||
156390327|NCT00700401|564520509|FG000|Overall Study|Refused Treatment|2|||
156390328|NCT00700401|564520509|FG000|Overall Study|Lost to Follow-up|1|||
156390329|NCT00700401|564520509|FG000|Overall Study|Treatment never started|1|||
156390330|NCT00700401|564520509|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
156390331|NCT00700401|564520509|FG000|Overall Study|Withdrawal by Subject|2|||
156390332|NCT02491671|564520510|FG000|Overall Study|Adverse Event|6|||
156390333|NCT02491671|564520511|FG001|Overall Study|Adverse Event|8|||
156390334|NCT02491671|564520510|FG000|Overall Study|Death|0|||
156390335|NCT02491671|564520511|FG001|Overall Study|Death|2|||
156390336|NCT02491671|564520510|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
156390337|NCT02491671|564520511|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
156390338|NCT02251990|564520515|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
156390339|NCT02251990|564520516|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
156390340|NCT02251990|564520515|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
156390341|NCT02251990|564520516|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
156390342|NCT02251990|564520515|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
156390343|NCT02251990|564520516|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
156390344|NCT02251990|564520515|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
156390345|NCT02251990|564520516|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
156390346|NCT02251990|564520515|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
156390347|NCT02251990|564520516|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
156390348|NCT02251990|564520515|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
156390349|NCT02251990|564520516|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
156390350|NCT03265600|564520517|FG000|Overall Study|Lost to Follow-up|17|||
156390351|NCT03265600|564520518|FG001|Overall Study|Lost to Follow-up|5|||
156390352|NCT03265600|564520517|FG000|Overall Study|Withdrawal by Subject|4|||
156390353|NCT03265600|564520518|FG001|Overall Study|Withdrawal by Subject|2|||
156390354|NCT03265600|564520517|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
156390355|NCT03265600|564520518|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
156390356|NCT00535730|564520519|FG000|Overall Study|Adverse Event|1|||
156390357|NCT00535730|564520520|FG001|Overall Study|Adverse Event|1|||
156390358|NCT00535730|564520519|FG000|Overall Study|Lost to Follow-up|0|||
156508225|NCT01424813|564953077|FG001|Overall Study|Other|2|||
156508226|NCT03554629|564955441|FG000|Overall Study|Inadequate data|6|||
156508227|NCT01195948|564955444|FG000|Overall Study|Lost to Follow-up|0|||
156508228|NCT01195948|564955445|FG001|Overall Study|Lost to Follow-up|1|||
156508229|NCT01195948|564955446|FG002|Overall Study|Lost to Follow-up|2|||
156508230|NCT05577715|564955447|FG000|Overall Study|Withdrawal by Subject|1|||
156508231|NCT05577715|564955447|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
156508232|NCT05577715|564955447|FG000|Overall Study|Lost to Follow-up|1|||
156508233|NCT05577715|564955447|FG000|Overall Study|Death|6|||
156547954|NCT01087905|565098441|FG002|Overall Study|Lost to Follow-up|18|||
156547955|NCT01087905|565098442|FG003|Overall Study|Lost to Follow-up|31|||
156390359|NCT00535730|564520520|FG001|Overall Study|Lost to Follow-up|1|||
156390360|NCT00535730|564520519|FG000|Overall Study|Physician Decision|0|||
156390361|NCT00535730|564520520|FG001|Overall Study|Physician Decision|1|||
156390362|NCT00535730|564520519|FG000|Overall Study|Protocol Violation|1|||
156390363|NCT00535730|564520520|FG001|Overall Study|Protocol Violation|0|||
156390364|NCT00535730|564520519|FG000|Overall Study|Withdrawal by Subject|0|||
156390365|NCT00535730|564520520|FG001|Overall Study|Withdrawal by Subject|4|||
156390366|NCT03152552|564520522|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
156390367|NCT03152552|564520523|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
156390368|NCT03152552|564520524|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
156390369|NCT03152552|564520525|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
156390370|NCT03152552|564520526|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
156390371|NCT03152552|564520522|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
156390372|NCT03152552|564520523|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
156390373|NCT03152552|564520524|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
156390374|NCT03152552|564520525|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
156390375|NCT03152552|564520526|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
156390376|NCT03152552|564520522|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
156390377|NCT03152552|564520523|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
156390378|NCT03152552|564520524|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
156390379|NCT03152552|564520525|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
156390380|NCT03152552|564520526|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
156390381|NCT03152552|564520522|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156390382|NCT03152552|564520523|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156390383|NCT03152552|564520524|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156390384|NCT03152552|564520525|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156390385|NCT03152552|564520526|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156390386|NCT03152552|564520522|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
156390387|NCT03152552|564520523|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
156390388|NCT03152552|564520524|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
156390389|NCT03152552|564520525|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
156390390|NCT03152552|564520526|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
156390391|NCT03152552|564520522|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
156390392|NCT03152552|564520523|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
156390393|NCT03152552|564520524|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
156390394|NCT03152552|564520525|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
156390395|NCT03152552|564520526|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
156390396|NCT03152552|564520522|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
156390397|NCT03152552|564520523|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
156390398|NCT03152552|564520524|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
156390399|NCT03152552|564520525|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
156390400|NCT03152552|564520526|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
156390401|NCT00355082|564520529|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
156390402|NCT00355082|564520530|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
156390403|NCT00355082|564520531|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
156390404|NCT00355082|564520529|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
156390405|NCT00355082|564520530|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
156508234|NCT05282121|564955452|FG000|Overall Study|Adverse Event|1|||
156508235|NCT05282121|564955453|FG001|Overall Study|Adverse Event|1|||
156508236|NCT05282121|564955454|FG002|Overall Study|Adverse Event|4|||
156508237|NCT05282121|564955455|FG003|Overall Study|Adverse Event|1|||
156508238|NCT05282121|564955452|FG000|Overall Study|Study Terminated by Sponsor|1|||
156508239|NCT05282121|564955453|FG001|Overall Study|Study Terminated by Sponsor|2|||
156508240|NCT05282121|564955454|FG002|Overall Study|Study Terminated by Sponsor|2|||
156508241|NCT05282121|564955455|FG003|Overall Study|Study Terminated by Sponsor|2|||
156508242|NCT05282121|564955452|FG000|Overall Study|Other than listed|0|||
156508243|NCT05282121|564955453|FG001|Overall Study|Other than listed|0|||
156508244|NCT05282121|564955454|FG002|Overall Study|Other than listed|1|||
156508245|NCT05282121|564955455|FG003|Overall Study|Other than listed|0|||
156508246|NCT05282121|564955452|FG000|Overall Study|No reason available|0|||
156508247|NCT05282121|564955453|FG001|Overall Study|No reason available|0|||
156508248|NCT05282121|564955454|FG002|Overall Study|No reason available|1|||
156508249|NCT05282121|564955455|FG003|Overall Study|No reason available|0|||
156508250|NCT01077128|564955462|FG000|Overall Study|Adverse Event|8|||
156508251|NCT01077128|564955462|FG000|Overall Study|Lack of Efficacy|1|||
156508252|NCT01077128|564955462|FG000|Overall Study|Disease exacerbation|1|||
156508253|NCT01077128|564955462|FG000|Overall Study|Adverse event and consent withdrawal|1|||
156508254|NCT01077128|564955462|FG000|Overall Study|Adverse event and disease exacerbation|1|||
156508255|NCT01077128|564955462|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
156508256|NCT01077128|564955462|FG000|Overall Study|Other|54|||
156508257|NCT02175641|564955468|FG000|Overall Study|Death|3|||
156508258|NCT02175641|564955469|FG001|Overall Study|Death|4|||
156508259|NCT02175641|564955468|FG000|Overall Study|Lost to Follow-up|4|||
156508260|NCT02175641|564955469|FG001|Overall Study|Lost to Follow-up|4|||
156508261|NCT02175641|564955468|FG000|Overall Study|Withdrawal by Subject|7|||
156547956|NCT01087905|565098443|FG004|Overall Study|Lost to Follow-up|27|||
156508262|NCT02175641|564955469|FG001|Overall Study|Withdrawal by Subject|4|||
156508263|NCT02175641|564955468|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
156508264|NCT02175641|564955469|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
156390406|NCT00355082|564520531|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
156390407|NCT00355082|564520529|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
156390408|NCT00355082|564520530|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
156390409|NCT00355082|564520531|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
156390410|NCT00355082|564520529|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
156390411|NCT00355082|564520530|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
156390412|NCT00355082|564520531|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
156390413|NCT00355082|564520529|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
156390414|NCT00355082|564520530|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
156390415|NCT00355082|564520531|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
156390416|NCT00355082|564520529|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
156390417|NCT00355082|564520530|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
156390418|NCT00355082|564520531|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
156390419|NCT00355082|564520529|FG000|Continuation Phase|Adverse Event|2|||
156390420|NCT00355082|564520530|FG001|Continuation Phase|Adverse Event|0|||
156390421|NCT00355082|564520531|FG002|Continuation Phase|Adverse Event|1|||
156390422|NCT00355082|564520529|FG000|Continuation Phase|Lost to Follow-up|2|||
156390423|NCT00355082|564520530|FG001|Continuation Phase|Lost to Follow-up|0|||
156390424|NCT00355082|564520531|FG002|Continuation Phase|Lost to Follow-up|1|||
156390425|NCT00355082|564520529|FG000|Continuation Phase|Protocol Violation|1|||
156390426|NCT00355082|564520530|FG001|Continuation Phase|Protocol Violation|0|||
156390427|NCT00355082|564520531|FG002|Continuation Phase|Protocol Violation|1|||
156390428|NCT00355082|564520529|FG000|Continuation Phase|Withdrawal by Subject|4|||
156390429|NCT00355082|564520530|FG001|Continuation Phase|Withdrawal by Subject|0|||
156390430|NCT00355082|564520531|FG002|Continuation Phase|Withdrawal by Subject|0|||
156390431|NCT00355082|564520529|FG000|Continuation Phase|Lack of Efficacy|5|||
156390432|NCT00355082|564520530|FG001|Continuation Phase|Lack of Efficacy|0|||
156390433|NCT00355082|564520531|FG002|Continuation Phase|Lack of Efficacy|0|||
156390434|NCT00355082|564520529|FG000|Continuation Phase|Site Closed by Sponsor|8|||
156390435|NCT00355082|564520530|FG001|Continuation Phase|Site Closed by Sponsor|0|||
156390436|NCT00355082|564520531|FG002|Continuation Phase|Site Closed by Sponsor|0|||
156390437|NCT00355082|564520529|FG000|Continuation Phase|Scheduling Error|1|||
156390438|NCT00355082|564520530|FG001|Continuation Phase|Scheduling Error|0|||
156390439|NCT00355082|564520531|FG002|Continuation Phase|Scheduling Error|0|||
156390440|NCT00355082|564520529|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
156390441|NCT00355082|564520530|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
156390442|NCT00355082|564520531|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
156390443|NCT02372409|564520532|FG000|Overall Study|Lost to Follow-up|1|||
156390444|NCT02372409|564520533|FG001|Overall Study|Lost to Follow-up|0|||
156390445|NCT02372409|564520532|FG000|Overall Study|Disease progression|1|||
156390446|NCT02372409|564520533|FG001|Overall Study|Disease progression|1|||
156390447|NCT04084314|564520534|FG000|Overall Study|Subject/guardian decision|91|||
156390448|NCT04084314|564520534|FG000|Overall Study|Adverse Event|24|||
156390449|NCT04084314|564520534|FG000|Overall Study|Lost to Follow-up|19|||
156390450|NCT04084314|564520534|FG000|Overall Study|New therapy for study indication|9|||
156390451|NCT04084314|564520534|FG000|Overall Study|Pregnancy|9|||
156390452|NCT04084314|564520534|FG000|Overall Study|Withdrawal of informed consent|8|||
156390453|NCT04084314|564520534|FG000|Overall Study|Physician Decision|4|||
156390454|NCT04084314|564520534|FG000|Overall Study|Protocol Deviation|3|||
156390455|NCT00622167|564520535|FG000|Overall Study|Did not meet angiographic criteria|20|||
156390456|NCT01954017|564520536|FG000|Overall Study|Adverse Event|0|||
156390457|NCT01954017|564520537|FG001|Overall Study|Adverse Event|0|||
156390458|NCT01954017|564520538|FG002|Overall Study|Adverse Event|1|||
156390459|NCT01954017|564520536|FG000|Overall Study|Death|2|||
156390460|NCT01954017|564520537|FG001|Overall Study|Death|1|||
156390461|NCT01954017|564520538|FG002|Overall Study|Death|1|||
156390462|NCT01954017|564520536|FG000|Overall Study|Withdrawal by Subject|0|||
156390463|NCT01954017|564520537|FG001|Overall Study|Withdrawal by Subject|1|||
156390464|NCT01954017|564520538|FG002|Overall Study|Withdrawal by Subject|0|||
156390465|NCT01954017|564520536|FG000|Overall Study|Protocol Violation|0|||
156390466|NCT01954017|564520537|FG001|Overall Study|Protocol Violation|3|||
156508265|NCT02175641|564955468|FG000|Overall Study|Developed Contraindicated Condition|8|||
156390467|NCT01954017|564520538|FG002|Overall Study|Protocol Violation|2|||
156390468|NCT01954017|564520536|FG000|Overall Study|Necrotizing enterocolitis|1|||
156390469|NCT01954017|564520537|FG001|Overall Study|Necrotizing enterocolitis|0|||
156390470|NCT01954017|564520538|FG002|Overall Study|Necrotizing enterocolitis|1|||
156390471|NCT01954017|564520536|FG000|Overall Study|Enteral intake stopped >7 days|0|||
156390472|NCT01954017|564520537|FG001|Overall Study|Enteral intake stopped >7 days|1|||
156390473|NCT01954017|564520538|FG002|Overall Study|Enteral intake stopped >7 days|1|||
156508266|NCT02175641|564955469|FG001|Overall Study|Developed Contraindicated Condition|0|||
156508267|NCT03596762|564955475|FG000|Overall Study|Protocol Violation|0|||
156390474|NCT01954017|564520536|FG000|Overall Study|All other reasons|2|||
156390475|NCT01954017|564520537|FG001|Overall Study|All other reasons|2|||
156390476|NCT01954017|564520538|FG002|Overall Study|All other reasons|7|||
156390477|NCT04177758|564520548|FG000|Overall Study|Lost to Follow-up|19|||
156508268|NCT03596762|564955476|FG001|Overall Study|Protocol Violation|0|||
156390478|NCT04177758|564520549|FG001|Overall Study|Lost to Follow-up|11|||
156390479|NCT03826667|564520550|FG000|Overall Study|Protocol deviation|21|||
156390480|NCT00808808|564520551|FG000|Overall Study|Vaccinated; survey not completed|131|||
156390481|NCT00808808|564520552|FG001|Overall Study|Vaccinated; survey not completed|169|||
156390482|NCT00808808|564520553|FG002|Overall Study|Vaccinated; survey not completed|302|||
156390483|NCT00808808|564520551|FG000|Overall Study|Employee was not vaccinated.|2686|||
156390484|NCT00808808|564520552|FG001|Overall Study|Employee was not vaccinated.|2268|||
156390485|NCT00808808|564520553|FG002|Overall Study|Employee was not vaccinated.|2255|||
156390486|NCT00679939|564520554|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
156390487|NCT00679939|564520555|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
156390488|NCT00679939|564520554|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
156390489|NCT00679939|564520555|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
156390490|NCT00679939|564520554|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
156390491|NCT00679939|564520555|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
156390492|NCT00679939|564520554|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
156390493|NCT00679939|564520555|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
156390494|NCT00679939|564520554|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
156390495|NCT00679939|564520555|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
156390496|NCT00679939|564520554|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
156390497|NCT00679939|564520555|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
156390498|NCT00679939|564520554|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
156390499|NCT00679939|564520555|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
156390500|NCT00679939|564520554|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
156390501|NCT00679939|564520555|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
156390502|NCT00679939|564520554|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
156390503|NCT00679939|564520555|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
156390504|NCT00679939|564520554|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
156390505|NCT00679939|564520555|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
156390506|NCT01453595|564520558|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156390507|NCT01453595|564520559|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156390508|NCT01453595|564520560|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156390509|NCT02653482|564520563|FG000|Overall Study|Death|1|||
156390510|NCT02653482|564520564|FG001|Overall Study|Death|1|||
156390511|NCT01864564|564520567|FG000|Overall Study|Lost to Follow-up|17|||
156390512|NCT01864564|564520568|FG001|Overall Study|Lost to Follow-up|23|||
156390513|NCT01864564|564520567|FG000|Overall Study|Withdrawal by Subject|20|||
156390514|NCT01864564|564520568|FG001|Overall Study|Withdrawal by Subject|11|||
156390515|NCT01864564|564520567|FG000|Overall Study|Protocol Violation|0|||
156390516|NCT01864564|564520568|FG001|Overall Study|Protocol Violation|27|||
156390517|NCT01864564|564520567|FG000|Overall Study|not reported|0|||
156390518|NCT01864564|564520568|FG001|Overall Study|not reported|34|||
156390519|NCT03077724|564520569|FG000|Overall Study|Lost to Follow-up|5|||
156390520|NCT03077724|564520570|FG001|Overall Study|Lost to Follow-up|1|||
156390521|NCT03077724|564520569|FG000|Overall Study|Withdrawal by Subject|3|||
156390522|NCT03077724|564520570|FG001|Overall Study|Withdrawal by Subject|1|||
156390523|NCT02269670|564520571|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
156390524|NCT00234065|564520572|FG000|Overall Study|Adverse Event|268|||
156390525|NCT00234065|564520573|FG001|Overall Study|Adverse Event|166|||
156390526|NCT00234065|564520572|FG000|Overall Study|Withdrawal by Subject|73|||
156390527|NCT00234065|564520573|FG001|Overall Study|Withdrawal by Subject|56|||
156390528|NCT00234065|564520572|FG000|Overall Study|Physician Decision|23|||
156390529|NCT00234065|564520573|FG001|Overall Study|Physician Decision|22|||
156390530|NCT00234065|564520572|FG000|Overall Study|Not Classified|111|||
156390531|NCT00234065|564520573|FG001|Overall Study|Not Classified|112|||
156390532|NCT00955357|564521628|FG000|Titration Phase|Adverse Event|9|||
156390533|NCT00955357|564521629|FG001|Titration Phase|Adverse Event|46|||
156390534|NCT00955357|564521628|FG000|Titration Phase|Lack of Efficacy|0|||
156390535|NCT00955357|564521629|FG001|Titration Phase|Lack of Efficacy|2|||
156390536|NCT00955357|564521628|FG000|Titration Phase|Protocol Violation|3|||
156390537|NCT00955357|564521629|FG001|Titration Phase|Protocol Violation|7|||
156390538|NCT00955357|564521628|FG000|Titration Phase|Lost to Follow-up|1|||
156390539|NCT00955357|564521629|FG001|Titration Phase|Lost to Follow-up|3|||
156390540|NCT00955357|564521628|FG000|Titration Phase|Withdrawal by Subject|3|||
156390541|NCT00955357|564521629|FG001|Titration Phase|Withdrawal by Subject|5|||
156390542|NCT00955357|564521628|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
156390543|NCT00955357|564521629|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
156390544|NCT00955357|564521628|FG000|Titration Phase|Study medication not tolerated|0|||
156390545|NCT00955357|564521629|FG001|Titration Phase|Study medication not tolerated|1|||
156390546|NCT00955357|564521628|FG000|Titration Phase|Non compliance to study procedures|0|||
156390547|NCT00955357|564521629|FG001|Titration Phase|Non compliance to study procedures|1|||
156390548|NCT00955357|564521628|FG000|Maintenance Phase|Adverse Event|3|||
156390549|NCT00955357|564521629|FG001|Maintenance Phase|Adverse Event|23|||
156508269|NCT03596762|564955477|FG002|Overall Study|Protocol Violation|0|||
156390550|NCT00955357|564521628|FG000|Maintenance Phase|Lack of Efficacy|0|||
156390551|NCT00955357|564521629|FG001|Maintenance Phase|Lack of Efficacy|4|||
156390552|NCT00955357|564521628|FG000|Maintenance Phase|Protocol Violation|2|||
156390553|NCT00955357|564521629|FG001|Maintenance Phase|Protocol Violation|6|||
156390554|NCT00955357|564521628|FG000|Maintenance Phase|Lost to Follow-up|2|||
156390555|NCT00955357|564521629|FG001|Maintenance Phase|Lost to Follow-up|7|||
156390556|NCT00955357|564521628|FG000|Maintenance Phase|Withdrawal by Subject|4|||
156390557|NCT00955357|564521629|FG001|Maintenance Phase|Withdrawal by Subject|4|||
156390558|NCT00955357|564521628|FG000|Maintenance Phase|Patient moving out of area|0|||
156390559|NCT00955357|564521629|FG001|Maintenance Phase|Patient moving out of area|1|||
156390560|NCT00955357|564521628|FG000|Maintenance Phase|Non compliance to study procedures|1|||
156390561|NCT00955357|564521629|FG001|Maintenance Phase|Non compliance to study procedures|0|||
156390562|NCT02481310|564521630|FG000|Follow up|Still in follow up|0|||
156390563|NCT02481310|564521631|FG001|Follow up|Still in follow up|3|||
156390564|NCT02481310|564521632|FG002|Follow up|Still in follow up|0|||
156390565|NCT00643916|564521634|FG000|Overall Study|Protocol Violation|0|||
156390566|NCT00643916|564521635|FG001|Overall Study|Protocol Violation|1|||
156390567|NCT00643916|564521636|FG002|Overall Study|Protocol Violation|1|||
156390568|NCT00643916|564521637|FG003|Overall Study|Protocol Violation|1|||
156390569|NCT00643916|564521638|FG004|Overall Study|Protocol Violation|0|||
156390570|NCT00643916|564521639|FG005|Overall Study|Protocol Violation|0|||
156390571|NCT00643916|564521634|FG000|Overall Study|Lost to Follow-up|0|||
156390572|NCT00643916|564521635|FG001|Overall Study|Lost to Follow-up|1|||
156390573|NCT00643916|564521636|FG002|Overall Study|Lost to Follow-up|0|||
156390574|NCT00643916|564521637|FG003|Overall Study|Lost to Follow-up|0|||
156390575|NCT00643916|564521638|FG004|Overall Study|Lost to Follow-up|0|||
156390576|NCT00643916|564521639|FG005|Overall Study|Lost to Follow-up|0|||
156390577|NCT00643916|564521634|FG000|Overall Study|Withdrawal by Subject|2|||
156390578|NCT00643916|564521635|FG001|Overall Study|Withdrawal by Subject|2|||
156390579|NCT00643916|564521636|FG002|Overall Study|Withdrawal by Subject|2|||
156390580|NCT00643916|564521637|FG003|Overall Study|Withdrawal by Subject|1|||
156390581|NCT00643916|564521638|FG004|Overall Study|Withdrawal by Subject|0|||
156390582|NCT00643916|564521639|FG005|Overall Study|Withdrawal by Subject|1|||
156390583|NCT00643916|564521634|FG000|Overall Study|Not Vaccinated|2|||
156390584|NCT00643916|564521635|FG001|Overall Study|Not Vaccinated|2|||
156390585|NCT00643916|564521636|FG002|Overall Study|Not Vaccinated|3|||
156390586|NCT00643916|564521637|FG003|Overall Study|Not Vaccinated|0|||
156390587|NCT00643916|564521638|FG004|Overall Study|Not Vaccinated|2|||
156390588|NCT00643916|564521639|FG005|Overall Study|Not Vaccinated|0|||
156390589|NCT03151005|564521644|FG000|Overall Study|Lost to Follow-up|5|||
156390590|NCT03151005|564521645|FG001|Overall Study|Lost to Follow-up|5|||
156390591|NCT05159622|564521646|FG000|Overall Study|Lost to Follow-up|4|||
156390592|NCT05159622|564521647|FG001|Overall Study|Lost to Follow-up|5|||
156390593|NCT00082173|564521648|FG000|Overall Study|Withdrawal by Subject|3|||
156390594|NCT00082173|564521649|FG001|Overall Study|Withdrawal by Subject|5|||
156390595|NCT00082173|564521648|FG000|Overall Study|Lost to Follow-up|1|||
156390596|NCT00082173|564521649|FG001|Overall Study|Lost to Follow-up|0|||
156390597|NCT00082173|564521648|FG000|Overall Study|Adverse Event|1|||
156390598|NCT00082173|564521649|FG001|Overall Study|Adverse Event|0|||
156390599|NCT00082173|564521648|FG000|Overall Study|Culture negative or resistant at baselin|5|||
156390600|NCT00082173|564521649|FG001|Overall Study|Culture negative or resistant at baselin|6|||
156390601|NCT04052204|564521657|FG000|Overall Study|Death|1|||
156390602|NCT04052204|564521658|FG001|Overall Study|Death|0|||
156390603|NCT04052204|564521659|FG002|Overall Study|Death|0|||
156390604|NCT04052204|564521657|FG000|Overall Study|Progressive disease|1|||
156390605|NCT04052204|564521658|FG001|Overall Study|Progressive disease|0|||
156390606|NCT04052204|564521659|FG002|Overall Study|Progressive disease|0|||
156390607|NCT04052204|564521657|FG000|Overall Study|Other|1|||
156508270|NCT03596762|564955478|FG003|Overall Study|Protocol Violation|0|||
156508271|NCT03596762|564955479|FG004|Overall Study|Protocol Violation|1|||
156508272|NCT03596762|564955475|FG000|Overall Study|Adverse Event|2|||
156508273|NCT03596762|564955476|FG001|Overall Study|Adverse Event|0|||
156508274|NCT03596762|564955477|FG002|Overall Study|Adverse Event|1|||
156390608|NCT04052204|564521658|FG001|Overall Study|Other|0|||
156390609|NCT04052204|564521659|FG002|Overall Study|Other|0|||
156390610|NCT01433354|564521660|FG000|Overall Study|Adverse Event|6|||
156390611|NCT01433354|564521660|FG000|Overall Study|Lost to Follow-up|1|||
156390612|NCT01433354|564521660|FG000|Overall Study|Administrative problems|90|||
156390613|NCT01433354|564521660|FG000|Overall Study|Protocol Violation|2|||
156390614|NCT01433354|564521660|FG000|Overall Study|Lack of Efficacy|17|||
156390615|NCT01433354|564521660|FG000|Overall Study|Subject Withdrew Consent|3|||
156508275|NCT03596762|564955478|FG003|Overall Study|Adverse Event|0|||
156508276|NCT03596762|564955479|FG004|Overall Study|Adverse Event|5|||
156390616|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
156390617|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
156390618|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
156390619|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
156390620|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
156390621|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
156390622|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
156390623|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
156390624|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
156390625|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
156390626|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
156390627|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
156390628|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
156390629|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
156390630|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
156390631|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
156390632|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
156390633|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
156390634|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
156390635|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
156390636|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
156390637|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
156390638|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
156390639|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
156390640|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
156390641|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
156390642|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
156390643|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
156390644|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
156390645|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
156390646|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
156390647|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
156390648|NCT04818346|564521671|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
156390649|NCT04818346|564521672|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
156390650|NCT04818346|564521673|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
156390651|NCT04818346|564521674|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
156390652|NCT04818346|564521671|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
156390653|NCT04818346|564521672|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
156390654|NCT04818346|564521673|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
156390655|NCT04818346|564521674|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
156390656|NCT04818346|564521671|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
156390657|NCT04818346|564521672|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
156390658|NCT04818346|564521673|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
156390659|NCT04818346|564521674|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
156390660|NCT04818346|564521671|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
156390661|NCT04818346|564521672|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
156390662|NCT04818346|564521673|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
156390663|NCT04818346|564521674|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
156390664|NCT04818346|564521671|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
156390665|NCT04818346|564521672|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
156390666|NCT04818346|564521673|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
156390667|NCT04818346|564521674|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
156390668|NCT04818346|564521671|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
156390669|NCT04818346|564521672|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
156390670|NCT04818346|564521673|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
156390671|NCT04818346|564521674|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
156390672|NCT04818346|564521671|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
156390673|NCT04818346|564521672|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
156390674|NCT04818346|564521673|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
156508277|NCT03596762|564955475|FG000|Overall Study|Withdrawal by Subject|2|||
156508278|NCT03596762|564955476|FG001|Overall Study|Withdrawal by Subject|1|||
156508279|NCT03596762|564955477|FG002|Overall Study|Withdrawal by Subject|0|||
156508280|NCT03596762|564955478|FG003|Overall Study|Withdrawal by Subject|1|||
156508281|NCT03596762|564955479|FG004|Overall Study|Withdrawal by Subject|1|||
156508282|NCT00504777|564955480|FG000|Overall Study|Adverse Event|1|||
156508283|NCT01572740|564955481|FG000|Overall Study|Adverse Event|1|||
156508284|NCT01572740|564955482|FG001|Overall Study|Adverse Event|1|||
156390675|NCT04818346|564521674|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
156390676|NCT01362140|564521675|FG000|Overall Study|Noncompliance|1|||
156390677|NCT01362140|564521676|FG001|Overall Study|Noncompliance|0|||
156390678|NCT01362140|564521675|FG000|Overall Study|Adverse Event|2|||
156390679|NCT01362140|564521676|FG001|Overall Study|Adverse Event|2|||
156390680|NCT01362140|564521675|FG000|Overall Study|Withdrawal by Subject|3|||
156390681|NCT01362140|564521676|FG001|Overall Study|Withdrawal by Subject|3|||
156390682|NCT01362140|564521675|FG000|Overall Study|Administrative Decision|0|||
156390683|NCT01362140|564521676|FG001|Overall Study|Administrative Decision|1|||
156390684|NCT01362140|564521675|FG000|Overall Study|Death|2|||
156390685|NCT01362140|564521676|FG001|Overall Study|Death|1|||
156390686|NCT01362140|564521675|FG000|Overall Study|Other|1|||
156390687|NCT01362140|564521676|FG001|Overall Study|Other|1|||
156390688|NCT01362140|564521675|FG000|Overall Study|Protocol-specified Criteria|1|||
156390689|NCT01362140|564521676|FG001|Overall Study|Protocol-specified Criteria|2|||
156390690|NCT01362140|564521675|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
156390691|NCT01362140|564521676|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
156390692|NCT05553808|564521677|FG000|Overall Study|Death|25|||
156390693|NCT05553808|564521678|FG001|Overall Study|Death|62|||
156390694|NCT05553808|564521677|FG000|Overall Study|Site Closed|6|||
156390695|NCT05553808|564521678|FG001|Overall Study|Site Closed|6|||
156390696|NCT05553808|564521677|FG000|Overall Study|Lost to Follow-up|1|||
156390697|NCT05553808|564521678|FG001|Overall Study|Lost to Follow-up|0|||
156390698|NCT05553808|564521677|FG000|Overall Study|Withdrawal by Subject|3|||
156390699|NCT05553808|564521678|FG001|Overall Study|Withdrawal by Subject|2|||
156390700|NCT02273141|564521679|FG000|Overall Study|Adverse Event|0|||
156390701|NCT02273141|564521680|FG001|Overall Study|Adverse Event|1|||
156390702|NCT02273141|564521679|FG000|Overall Study|Lost to Follow-up|1|||
156390703|NCT02273141|564521680|FG001|Overall Study|Lost to Follow-up|3|||
156547957|NCT01087905|565098444|FG005|Overall Study|Lost to Follow-up|25|||
156547958|NCT01087905|565098445|FG006|Overall Study|Lost to Follow-up|20|||
156547959|NCT01087905|565098446|FG007|Overall Study|Lost to Follow-up|24|||
156547960|NCT01087905|565098439|FG000|Overall Study|Withdrawal by Subject|5|||
156547961|NCT01087905|565098440|FG001|Overall Study|Withdrawal by Subject|4|||
156547962|NCT01087905|565098441|FG002|Overall Study|Withdrawal by Subject|4|||
156547963|NCT01087905|565098442|FG003|Overall Study|Withdrawal by Subject|5|||
156547964|NCT01087905|565098443|FG004|Overall Study|Withdrawal by Subject|4|||
156547965|NCT01087905|565098444|FG005|Overall Study|Withdrawal by Subject|3|||
156547966|NCT01087905|565098445|FG006|Overall Study|Withdrawal by Subject|3|||
156547967|NCT01087905|565098446|FG007|Overall Study|Withdrawal by Subject|5|||
156547968|NCT00385255|565098447|FG000|Overall Study|Serious Adverse Event|1|||
156547969|NCT00385255|565098448|FG001|Overall Study|Serious Adverse Event|2|||
156547970|NCT00385255|565098447|FG000|Overall Study|Protocol Violation|0|||
156547971|NCT00385255|565098448|FG001|Overall Study|Protocol Violation|4|||
156547972|NCT00385255|565098447|FG000|Overall Study|Withdrawal by Subject|0|||
156547973|NCT00385255|565098448|FG001|Overall Study|Withdrawal by Subject|8|||
156547974|NCT00385255|565098447|FG000|Overall Study|Migrated/moved from study area|0|||
156547975|NCT00385255|565098448|FG001|Overall Study|Migrated/moved from study area|1|||
156547976|NCT00385255|565098447|FG000|Overall Study|Lost to Follow-up|20|||
156547977|NCT00385255|565098448|FG001|Overall Study|Lost to Follow-up|58|||
156547978|NCT00835237|565098449|FG000|Overall Study|Lost to Follow-up|4|||
156547979|NCT00835237|565098450|FG001|Overall Study|Lost to Follow-up|0|||
156547980|NCT00835237|565098449|FG000|Overall Study|Withdrawal by Subject|2|||
156547981|NCT00835237|565098450|FG001|Overall Study|Withdrawal by Subject|0|||
156547982|NCT00606086|565098454|FG000|Overall Study|Adverse Event|1|||
156547983|NCT00606086|565098455|FG001|Overall Study|Adverse Event|1|||
156547984|NCT00606086|565098454|FG000|Overall Study|Lost to Follow-up|4|||
156547985|NCT00606086|565098455|FG001|Overall Study|Lost to Follow-up|8|||
156547986|NCT00606086|565098454|FG000|Overall Study|Protocol Violation|1|||
156547987|NCT00606086|565098455|FG001|Overall Study|Protocol Violation|0|||
156390704|NCT02273141|564521679|FG000|Overall Study|Withdrawal by Subject|10|||
156390705|NCT02273141|564521680|FG001|Overall Study|Withdrawal by Subject|15|||
156390706|NCT02273141|564521679|FG000|Overall Study|Various|6|||
156390707|NCT02273141|564521680|FG001|Overall Study|Various|6|||
156547988|NCT00606086|565098454|FG000|Overall Study|Withdrawal by Subject|5|||
156547989|NCT00606086|565098455|FG001|Overall Study|Withdrawal by Subject|3|||
156390708|NCT00492284|564521681|FG000|Overall Study|Adverse Event|0|||
156390709|NCT00492284|564521682|FG001|Overall Study|Adverse Event|1|||
156547990|NCT00606086|565098454|FG000|Overall Study|Non-compliance|0|||
156547991|NCT00606086|565098455|FG001|Overall Study|Non-compliance|1|||
156547992|NCT00606086|565098454|FG000|Overall Study|Randomized, not treated|1|||
156547993|NCT00606086|565098455|FG001|Overall Study|Randomized, not treated|2|||
156547994|NCT01929408|565098456|FG000|Overall Study|received HCT as initial treatment|8|||
156390710|NCT00492284|564521683|FG002|Overall Study|Adverse Event|1|||
156390711|NCT00492284|564521684|FG003|Overall Study|Adverse Event|2|||
156390712|NCT00492284|564521681|FG000|Overall Study|Lost to Follow-up|0|||
156390713|NCT00492284|564521682|FG001|Overall Study|Lost to Follow-up|0|||
156390714|NCT00492284|564521683|FG002|Overall Study|Lost to Follow-up|3|||
156390715|NCT00492284|564521684|FG003|Overall Study|Lost to Follow-up|1|||
156390716|NCT00492284|564521681|FG000|Overall Study|Death|0|||
156390717|NCT00492284|564521682|FG001|Overall Study|Death|3|||
156390718|NCT00492284|564521683|FG002|Overall Study|Death|2|||
156390719|NCT00492284|564521684|FG003|Overall Study|Death|5|||
156390720|NCT00492284|564521681|FG000|Overall Study|Withdrawal by Subject|1|||
156390721|NCT00492284|564521682|FG001|Overall Study|Withdrawal by Subject|0|||
156390722|NCT00492284|564521683|FG002|Overall Study|Withdrawal by Subject|0|||
156390723|NCT00492284|564521684|FG003|Overall Study|Withdrawal by Subject|2|||
156390724|NCT02293538|564521689|FG000|Overall Study|Adverse Event|0|||
156390725|NCT02293538|564521690|FG001|Overall Study|Adverse Event|1|||
156390726|NCT02293538|564521689|FG000|Overall Study|Lost to Follow-up|1|||
156390727|NCT02293538|564521690|FG001|Overall Study|Lost to Follow-up|0|||
156390728|NCT02293538|564521689|FG000|Overall Study|Withdrawal by Subject|0|||
156390729|NCT02293538|564521690|FG001|Overall Study|Withdrawal by Subject|1|||
156390730|NCT00729833|564521703|FG000|Overall Study|Death|5|||
156390731|NCT00729833|564521704|FG001|Overall Study|Death|1|||
156390732|NCT00729833|564521705|FG002|Overall Study|Death|3|||
156390733|NCT00729833|564521706|FG003|Overall Study|Death|5|||
156390734|NCT00729833|564521703|FG000|Overall Study|Study Terminated by Sponsor|0|||
156390735|NCT00729833|564521704|FG001|Overall Study|Study Terminated by Sponsor|0|||
156390736|NCT00729833|564521705|FG002|Overall Study|Study Terminated by Sponsor|1|||
156390737|NCT00729833|564521706|FG003|Overall Study|Study Terminated by Sponsor|0|||
156390738|NCT00729833|564521703|FG000|Overall Study|Lost to Follow-up|1|||
156390739|NCT00729833|564521704|FG001|Overall Study|Lost to Follow-up|0|||
156390740|NCT00729833|564521705|FG002|Overall Study|Lost to Follow-up|0|||
156390741|NCT00729833|564521706|FG003|Overall Study|Lost to Follow-up|0|||
156390742|NCT00729833|564521703|FG000|Overall Study|Withdrawal by Subject|3|||
156390743|NCT00729833|564521704|FG001|Overall Study|Withdrawal by Subject|1|||
156390744|NCT00729833|564521705|FG002|Overall Study|Withdrawal by Subject|3|||
156390745|NCT00729833|564521706|FG003|Overall Study|Withdrawal by Subject|0|||
156390746|NCT00729833|564521703|FG000|Overall Study|Unspecified Reasons|11|||
156390747|NCT00729833|564521704|FG001|Overall Study|Unspecified Reasons|5|||
156390748|NCT00729833|564521705|FG002|Overall Study|Unspecified Reasons|5|||
156390749|NCT00729833|564521706|FG003|Overall Study|Unspecified Reasons|1|||
156390750|NCT01041638|564521707|FG000|Overall Study|Adverse Event|4|||
156390751|NCT01041638|564521707|FG000|Overall Study|Death|1|||
156390752|NCT01041638|564521707|FG000|Overall Study|Lack of Efficacy|7|||
156390753|NCT01041638|564521707|FG000|Overall Study|Physician Decision|4|||
156390754|NCT01041638|564521707|FG000|Overall Study|Withdrawal by Subject|11|||
156390755|NCT03336619|564521708|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
156390756|NCT03336619|564521709|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
156390757|NCT03336619|564521708|FG000|Overall Study|Withdrawal by Subject|17|||
156390758|NCT03336619|564521709|FG001|Overall Study|Withdrawal by Subject|16|||
156390759|NCT03336619|564521708|FG000|Overall Study|Adverse Event|2|||
156390760|NCT03336619|564521709|FG001|Overall Study|Adverse Event|5|||
156390761|NCT03336619|564521708|FG000|Overall Study|Physician Decision|3|||
156390762|NCT03336619|564521709|FG001|Overall Study|Physician Decision|0|||
156390763|NCT01300546|564521710|FG000|Overall Study|Withdrawal by Subject|1|||
156390764|NCT01300546|564521711|FG001|Overall Study|Withdrawal by Subject|0|||
156390765|NCT01300546|564521710|FG000|Overall Study|Lost to Follow-up|0|||
156390766|NCT01300546|564521711|FG001|Overall Study|Lost to Follow-up|2|||
156390767|NCT01300546|564521710|FG000|Overall Study|Lack of Efficacy|0|||
156390768|NCT01300546|564521711|FG001|Overall Study|Lack of Efficacy|3|||
156390769|NCT01300546|564521710|FG000|Overall Study|Adverse Event|0|||
156547995|NCT01015768|565098461|FG000|Overall Study|Some subject data unuseable|4|||
156547996|NCT01015768|565098462|FG001|Overall Study|Some subject data unuseable|4|||
156547997|NCT01225731|565098463|FG000|Part 1|Did not meet eligibility criteria|1|||
156547998|NCT01225731|565098464|FG001|Part 1|Did not meet eligibility criteria|0|||
156547999|NCT01225731|565098465|FG002|Part 1|Did not meet eligibility criteria|0|||
156548000|NCT01225731|565098466|FG003|Part 1|Did not meet eligibility criteria|0|||
156548001|NCT01225731|565098467|FG004|Part 1|Did not meet eligibility criteria|1|||
156390770|NCT01300546|564521711|FG001|Overall Study|Adverse Event|1|||
156390771|NCT02820623|564521712|FG000|Overall Study|Withdrawal by Subject|1|||
156390772|NCT02820623|564521713|FG001|Overall Study|Withdrawal by Subject|3|||
156390773|NCT02820623|564521714|FG002|Overall Study|Withdrawal by Subject|3|||
156390774|NCT02820623|564521712|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
156390775|NCT02820623|564521713|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
156390776|NCT02820623|564521714|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
156548002|NCT01225731|565098468|FG005|Part 1|Did not meet eligibility criteria|0|||
156548003|NCT01225731|565098469|FG006|Part 1|Did not meet eligibility criteria|0|||
156390777|NCT02820623|564521712|FG000|Overall Study|Therapist unable to enroll clients|1|||
156390778|NCT02820623|564521713|FG001|Overall Study|Therapist unable to enroll clients|1|||
156390779|NCT02820623|564521714|FG002|Overall Study|Therapist unable to enroll clients|3|||
156390780|NCT02820623|564521712|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
156390781|NCT02820623|564521713|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
156548004|NCT01225731|565098470|FG007|Part 1|Did not meet eligibility criteria|0|||
156548005|NCT01225731|565098471|FG008|Part 1|Did not meet eligibility criteria|0|||
156548006|NCT01225731|565098472|FG009|Part 1|Did not meet eligibility criteria|0|||
156548007|NCT01225731|565098473|FG010|Part 1|Did not meet eligibility criteria|0|||
156548008|NCT01225731|565098474|FG011|Part 1|Did not meet eligibility criteria|0|||
156548009|NCT01225731|565098475|FG012|Part 1|Did not meet eligibility criteria|0|||
156548010|NCT01225731|565098463|FG000|Part 1|Adverse Event|1|||
156548011|NCT01225731|565098464|FG001|Part 1|Adverse Event|2|||
156548012|NCT01225731|565098465|FG002|Part 1|Adverse Event|1|||
156548013|NCT01225731|565098466|FG003|Part 1|Adverse Event|1|||
156548014|NCT01225731|565098467|FG004|Part 1|Adverse Event|1|||
156548015|NCT01225731|565098468|FG005|Part 1|Adverse Event|0|||
156548016|NCT01225731|565098469|FG006|Part 1|Adverse Event|0|||
156548017|NCT01225731|565098470|FG007|Part 1|Adverse Event|0|||
156548018|NCT01225731|565098471|FG008|Part 1|Adverse Event|0|||
156548019|NCT01225731|565098472|FG009|Part 1|Adverse Event|0|||
156548020|NCT01225731|565098473|FG010|Part 1|Adverse Event|0|||
156548021|NCT01225731|565098474|FG011|Part 1|Adverse Event|0|||
156548022|NCT01225731|565098475|FG012|Part 1|Adverse Event|0|||
156548023|NCT01225731|565098463|FG000|Part 1|Withdrawal by Subject|0|||
156548024|NCT01225731|565098464|FG001|Part 1|Withdrawal by Subject|3|||
156548025|NCT01225731|565098465|FG002|Part 1|Withdrawal by Subject|0|||
156548026|NCT01225731|565098466|FG003|Part 1|Withdrawal by Subject|0|||
156548027|NCT01225731|565098467|FG004|Part 1|Withdrawal by Subject|4|||
156548028|NCT01225731|565098468|FG005|Part 1|Withdrawal by Subject|0|||
156548029|NCT01225731|565098469|FG006|Part 1|Withdrawal by Subject|0|||
156548030|NCT01225731|565098470|FG007|Part 1|Withdrawal by Subject|0|||
156548031|NCT01225731|565098471|FG008|Part 1|Withdrawal by Subject|0|||
156548032|NCT01225731|565098472|FG009|Part 1|Withdrawal by Subject|0|||
156548033|NCT01225731|565098473|FG010|Part 1|Withdrawal by Subject|0|||
156548034|NCT01225731|565098474|FG011|Part 1|Withdrawal by Subject|0|||
156548035|NCT01225731|565098475|FG012|Part 1|Withdrawal by Subject|0|||
156548036|NCT01225731|565098463|FG000|Part 1|Protocol Violation|0|||
156548037|NCT01225731|565098464|FG001|Part 1|Protocol Violation|0|||
156548038|NCT01225731|565098465|FG002|Part 1|Protocol Violation|0|||
156548039|NCT01225731|565098466|FG003|Part 1|Protocol Violation|1|||
156548040|NCT01225731|565098467|FG004|Part 1|Protocol Violation|0|||
156548041|NCT01225731|565098468|FG005|Part 1|Protocol Violation|0|||
156548042|NCT01225731|565098469|FG006|Part 1|Protocol Violation|0|||
156548043|NCT01225731|565098470|FG007|Part 1|Protocol Violation|0|||
156548044|NCT01225731|565098471|FG008|Part 1|Protocol Violation|0|||
156548045|NCT01225731|565098472|FG009|Part 1|Protocol Violation|0|||
156548046|NCT01225731|565098473|FG010|Part 1|Protocol Violation|0|||
156548047|NCT01225731|565098474|FG011|Part 1|Protocol Violation|0|||
156548048|NCT01225731|565098475|FG012|Part 1|Protocol Violation|0|||
156548049|NCT01225731|565098463|FG000|Part 2|Protocol Violation|0|||
156548050|NCT01225731|565098464|FG001|Part 2|Protocol Violation|0|||
156548051|NCT01225731|565098465|FG002|Part 2|Protocol Violation|0|||
156548052|NCT01225731|565098466|FG003|Part 2|Protocol Violation|0|||
156548053|NCT01225731|565098467|FG004|Part 2|Protocol Violation|0|||
156548054|NCT01225731|565098468|FG005|Part 2|Protocol Violation|1|||
156548055|NCT01225731|565098469|FG006|Part 2|Protocol Violation|0|||
156548056|NCT01225731|565098470|FG007|Part 2|Protocol Violation|0|||
156548057|NCT01225731|565098471|FG008|Part 2|Protocol Violation|1|||
156548058|NCT01225731|565098472|FG009|Part 2|Protocol Violation|0|||
156548059|NCT01225731|565098473|FG010|Part 2|Protocol Violation|0|||
156548060|NCT01225731|565098474|FG011|Part 2|Protocol Violation|0|||
156548061|NCT01225731|565098475|FG012|Part 2|Protocol Violation|0|||
156548062|NCT01225731|565098463|FG000|Part 2|Adverse Event|0|||
156548063|NCT01225731|565098464|FG001|Part 2|Adverse Event|0|||
156548064|NCT01225731|565098465|FG002|Part 2|Adverse Event|0|||
156548065|NCT01225731|565098466|FG003|Part 2|Adverse Event|0|||
156548066|NCT01225731|565098467|FG004|Part 2|Adverse Event|0|||
156548067|NCT01225731|565098468|FG005|Part 2|Adverse Event|0|||
156548068|NCT01225731|565098469|FG006|Part 2|Adverse Event|4|||
156548069|NCT01225731|565098470|FG007|Part 2|Adverse Event|4|||
156390782|NCT02820623|564521714|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
156548070|NCT01225731|565098471|FG008|Part 2|Adverse Event|2|||
156548071|NCT01225731|565098472|FG009|Part 2|Adverse Event|0|||
156548072|NCT01225731|565098473|FG010|Part 2|Adverse Event|0|||
156548073|NCT01225731|565098474|FG011|Part 2|Adverse Event|0|||
156548074|NCT01225731|565098475|FG012|Part 2|Adverse Event|0|||
156548075|NCT01225731|565098463|FG000|Part 2|Lack of Efficacy|0|||
156548076|NCT01225731|565098464|FG001|Part 2|Lack of Efficacy|0|||
156548077|NCT01225731|565098465|FG002|Part 2|Lack of Efficacy|0|||
156548078|NCT01225731|565098466|FG003|Part 2|Lack of Efficacy|0|||
156548079|NCT01225731|565098467|FG004|Part 2|Lack of Efficacy|0|||
156548080|NCT01225731|565098468|FG005|Part 2|Lack of Efficacy|1|||
156548081|NCT01225731|565098469|FG006|Part 2|Lack of Efficacy|0|||
156548082|NCT01225731|565098470|FG007|Part 2|Lack of Efficacy|12|||
156548083|NCT01225731|565098471|FG008|Part 2|Lack of Efficacy|3|||
156548084|NCT01225731|565098472|FG009|Part 2|Lack of Efficacy|0|||
156548085|NCT01225731|565098473|FG010|Part 2|Lack of Efficacy|0|||
156548086|NCT01225731|565098474|FG011|Part 2|Lack of Efficacy|0|||
156548087|NCT01225731|565098475|FG012|Part 2|Lack of Efficacy|0|||
156548088|NCT01225731|565098463|FG000|Part 2|Pregnancy|0|||
156390783|NCT05207813|564521715|FG000|Overall Study|Lost to Follow-up|2|||
156390784|NCT03762473|564521723|FG000|Overall Study|Death|1|||
156390785|NCT03762473|564521724|FG001|Overall Study|Death|0|||
156390786|NCT00126438|564521726|FG000|Overall Study|Withdrawal due to adverse event|1|||
156390787|NCT00126438|564521727|FG001|Overall Study|Withdrawal due to adverse event|0|||
156390788|NCT00126438|564521726|FG000|Overall Study|Lost to Follow-up|22|||
156390789|NCT00126438|564521727|FG001|Overall Study|Lost to Follow-up|0|||
156390790|NCT00126438|564521726|FG000|Overall Study|Protocol Violation|8|||
156390791|NCT00126438|564521727|FG001|Overall Study|Protocol Violation|8|||
156390792|NCT00126438|564521726|FG000|Overall Study|Withdrawal by Subject|3|||
156390793|NCT00126438|564521727|FG001|Overall Study|Withdrawal by Subject|2|||
156390794|NCT02313428|564521728|FG000|Overall Study|Lost to Follow-up|1|||
156390795|NCT02313428|564521729|FG001|Overall Study|Lost to Follow-up|1|||
156390796|NCT05374421|564521730|FG000|Overall Study|Withdrawal by Subject|3|||
156390797|NCT05374421|564521731|FG001|Overall Study|Withdrawal by Subject|4|||
156390798|NCT05132699|564521732|FG000|Overall Study|Withdrawal by Subject|3|||
156390799|NCT05132699|564521733|FG001|Overall Study|Withdrawal by Subject|0|||
156390800|NCT04370054|564521734|FG000|Treatment Phase|Lost to Follow-up|1|||
156390801|NCT04370054|564521734|FG000|Treatment Phase|Withdrawal by Subject|1|||
156390802|NCT04370054|564521734|FG000|Follow-Up Phase|Ongoing|75|||
156390803|NCT00710424|564521737|FG000|Overall Study|Adverse Event|30|||
156390804|NCT00710424|564521738|FG001|Overall Study|Adverse Event|12|||
156390805|NCT00710424|564521737|FG000|Overall Study|Lack of Efficacy|4|||
156548089|NCT01225731|565098464|FG001|Part 2|Pregnancy|0|||
156548090|NCT01225731|565098465|FG002|Part 2|Pregnancy|0|||
156548091|NCT01225731|565098466|FG003|Part 2|Pregnancy|0|||
156548092|NCT01225731|565098467|FG004|Part 2|Pregnancy|0|||
156548093|NCT01225731|565098468|FG005|Part 2|Pregnancy|0|||
156548094|NCT01225731|565098469|FG006|Part 2|Pregnancy|1|||
156548095|NCT01225731|565098470|FG007|Part 2|Pregnancy|0|||
156548096|NCT01225731|565098471|FG008|Part 2|Pregnancy|1|||
156548097|NCT01225731|565098472|FG009|Part 2|Pregnancy|0|||
156548098|NCT01225731|565098473|FG010|Part 2|Pregnancy|0|||
156548099|NCT01225731|565098474|FG011|Part 2|Pregnancy|0|||
156548100|NCT01225731|565098475|FG012|Part 2|Pregnancy|0|||
156548101|NCT01225731|565098463|FG000|Part 2|Lost to Follow-up|0|||
156548102|NCT01225731|565098464|FG001|Part 2|Lost to Follow-up|0|||
156548103|NCT01225731|565098465|FG002|Part 2|Lost to Follow-up|0|||
156548104|NCT01225731|565098466|FG003|Part 2|Lost to Follow-up|0|||
156548105|NCT01225731|565098467|FG004|Part 2|Lost to Follow-up|0|||
156548106|NCT01225731|565098468|FG005|Part 2|Lost to Follow-up|0|||
156548107|NCT01225731|565098469|FG006|Part 2|Lost to Follow-up|0|||
156548108|NCT01225731|565098470|FG007|Part 2|Lost to Follow-up|3|||
156548109|NCT01225731|565098471|FG008|Part 2|Lost to Follow-up|1|||
156548110|NCT01225731|565098472|FG009|Part 2|Lost to Follow-up|0|||
156548111|NCT01225731|565098473|FG010|Part 2|Lost to Follow-up|0|||
156548112|NCT01225731|565098474|FG011|Part 2|Lost to Follow-up|0|||
156548113|NCT01225731|565098475|FG012|Part 2|Lost to Follow-up|0|||
156548114|NCT01225731|565098463|FG000|Part 2|Physician Decision|0|||
156548115|NCT01225731|565098464|FG001|Part 2|Physician Decision|0|||
156548116|NCT01225731|565098465|FG002|Part 2|Physician Decision|0|||
156548117|NCT01225731|565098466|FG003|Part 2|Physician Decision|0|||
156548118|NCT01225731|565098467|FG004|Part 2|Physician Decision|0|||
156548119|NCT01225731|565098468|FG005|Part 2|Physician Decision|0|||
156548120|NCT01225731|565098469|FG006|Part 2|Physician Decision|0|||
156548121|NCT01225731|565098470|FG007|Part 2|Physician Decision|2|||
156548122|NCT01225731|565098471|FG008|Part 2|Physician Decision|2|||
156548123|NCT01225731|565098472|FG009|Part 2|Physician Decision|0|||
156548124|NCT01225731|565098473|FG010|Part 2|Physician Decision|0|||
156548125|NCT01225731|565098474|FG011|Part 2|Physician Decision|0|||
156390806|NCT00710424|564521738|FG001|Overall Study|Lack of Efficacy|5|||
156390807|NCT00710424|564521737|FG000|Overall Study|Withdrawal by Subject|5|||
156390808|NCT00710424|564521738|FG001|Overall Study|Withdrawal by Subject|3|||
156390809|NCT00710424|564521737|FG000|Overall Study|Lost to Follow-up|0|||
156390810|NCT00710424|564521738|FG001|Overall Study|Lost to Follow-up|1|||
156390811|NCT00710424|564521737|FG000|Overall Study|Refused medication, no side effects|1|||
156390812|NCT00710424|564521738|FG001|Overall Study|Refused medication, no side effects|0|||
156390813|NCT00710424|564521737|FG000|Overall Study|Non-compliance with stable analgesia|1|||
156390814|NCT00710424|564521738|FG001|Overall Study|Non-compliance with stable analgesia|0|||
156390815|NCT00710424|564521737|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
156390816|NCT00710424|564521738|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
156548126|NCT01225731|565098475|FG012|Part 2|Physician Decision|0|||
156548127|NCT01225731|565098463|FG000|Part 2|Withdrawal by Subject|0|||
156548128|NCT01225731|565098464|FG001|Part 2|Withdrawal by Subject|0|||
156548129|NCT01225731|565098465|FG002|Part 2|Withdrawal by Subject|0|||
156548130|NCT01225731|565098466|FG003|Part 2|Withdrawal by Subject|0|||
156548131|NCT01225731|565098467|FG004|Part 2|Withdrawal by Subject|0|||
156548132|NCT01225731|565098468|FG005|Part 2|Withdrawal by Subject|1|||
156548133|NCT01225731|565098469|FG006|Part 2|Withdrawal by Subject|3|||
156548134|NCT01225731|565098470|FG007|Part 2|Withdrawal by Subject|4|||
156548135|NCT01225731|565098471|FG008|Part 2|Withdrawal by Subject|1|||
156548136|NCT01225731|565098472|FG009|Part 2|Withdrawal by Subject|0|||
156548137|NCT01225731|565098473|FG010|Part 2|Withdrawal by Subject|0|||
156548138|NCT01225731|565098474|FG011|Part 2|Withdrawal by Subject|0|||
156548139|NCT01225731|565098475|FG012|Part 2|Withdrawal by Subject|0|||
156548140|NCT01225731|565098463|FG000|Part 3|Adverse Event|0|||
156548141|NCT01225731|565098464|FG001|Part 3|Adverse Event|0|||
156548142|NCT01225731|565098465|FG002|Part 3|Adverse Event|0|||
156548143|NCT01225731|565098466|FG003|Part 3|Adverse Event|0|||
156548144|NCT01225731|565098467|FG004|Part 3|Adverse Event|0|||
156548145|NCT01225731|565098468|FG005|Part 3|Adverse Event|0|||
156548146|NCT01225731|565098469|FG006|Part 3|Adverse Event|0|||
156548147|NCT01225731|565098470|FG007|Part 3|Adverse Event|0|||
156548148|NCT01225731|565098471|FG008|Part 3|Adverse Event|0|||
156548149|NCT01225731|565098472|FG009|Part 3|Adverse Event|0|||
156548150|NCT01225731|565098473|FG010|Part 3|Adverse Event|1|||
156548151|NCT01225731|565098474|FG011|Part 3|Adverse Event|1|||
156548152|NCT01225731|565098475|FG012|Part 3|Adverse Event|0|||
156548153|NCT01225731|565098463|FG000|Part 3|Lost to Follow-up|0|||
156548154|NCT01225731|565098464|FG001|Part 3|Lost to Follow-up|0|||
156548155|NCT01225731|565098465|FG002|Part 3|Lost to Follow-up|0|||
156548156|NCT01225731|565098466|FG003|Part 3|Lost to Follow-up|0|||
156548157|NCT01225731|565098467|FG004|Part 3|Lost to Follow-up|0|||
156548158|NCT01225731|565098468|FG005|Part 3|Lost to Follow-up|0|||
156548159|NCT01225731|565098469|FG006|Part 3|Lost to Follow-up|0|||
156548160|NCT01225731|565098470|FG007|Part 3|Lost to Follow-up|0|||
156548161|NCT01225731|565098471|FG008|Part 3|Lost to Follow-up|0|||
156548162|NCT01225731|565098472|FG009|Part 3|Lost to Follow-up|0|||
156548163|NCT01225731|565098473|FG010|Part 3|Lost to Follow-up|1|||
156548164|NCT01225731|565098474|FG011|Part 3|Lost to Follow-up|2|||
156548165|NCT01225731|565098475|FG012|Part 3|Lost to Follow-up|1|||
156548166|NCT01225731|565098463|FG000|Part 3|Physician Decision|0|||
156548167|NCT01225731|565098464|FG001|Part 3|Physician Decision|0|||
156548168|NCT01225731|565098465|FG002|Part 3|Physician Decision|0|||
156548169|NCT01225731|565098466|FG003|Part 3|Physician Decision|0|||
156548170|NCT01225731|565098467|FG004|Part 3|Physician Decision|0|||
156548171|NCT01225731|565098468|FG005|Part 3|Physician Decision|0|||
156548172|NCT01225731|565098469|FG006|Part 3|Physician Decision|0|||
156548173|NCT01225731|565098470|FG007|Part 3|Physician Decision|0|||
156548174|NCT01225731|565098471|FG008|Part 3|Physician Decision|0|||
156548175|NCT01225731|565098472|FG009|Part 3|Physician Decision|0|||
156548176|NCT01225731|565098473|FG010|Part 3|Physician Decision|0|||
156548177|NCT01225731|565098474|FG011|Part 3|Physician Decision|1|||
156548178|NCT01225731|565098475|FG012|Part 3|Physician Decision|2|||
156548179|NCT01225731|565098463|FG000|Part 3|Withdrawal by Subject|0|||
156548180|NCT01225731|565098464|FG001|Part 3|Withdrawal by Subject|0|||
156548181|NCT01225731|565098465|FG002|Part 3|Withdrawal by Subject|0|||
156548182|NCT01225731|565098466|FG003|Part 3|Withdrawal by Subject|0|||
156548183|NCT01225731|565098467|FG004|Part 3|Withdrawal by Subject|0|||
156548184|NCT01225731|565098468|FG005|Part 3|Withdrawal by Subject|0|||
156548185|NCT01225731|565098469|FG006|Part 3|Withdrawal by Subject|0|||
156548186|NCT01225731|565098470|FG007|Part 3|Withdrawal by Subject|0|||
156548187|NCT01225731|565098471|FG008|Part 3|Withdrawal by Subject|0|||
156548188|NCT01225731|565098472|FG009|Part 3|Withdrawal by Subject|0|||
156548189|NCT01225731|565098473|FG010|Part 3|Withdrawal by Subject|4|||
156548190|NCT01225731|565098474|FG011|Part 3|Withdrawal by Subject|6|||
156548191|NCT01225731|565098475|FG012|Part 3|Withdrawal by Subject|4|||
156548192|NCT01073267|565098476|FG000|Overall Study|Disease Progression|3|||
156548193|NCT00577642|565098477|FG000|Overall Study|Clinical Disease Progression|1|||
156548194|NCT01505634|565098485|FG000|Overall Study|Withdrawal by Subject|2|||
156548195|NCT01505634|565098486|FG001|Overall Study|Withdrawal by Subject|5|||
156548196|NCT01505634|565098487|FG002|Overall Study|Withdrawal by Subject|1|||
156548197|NCT01505634|565098485|FG000|Overall Study|Physician Decision|1|||
156548198|NCT01505634|565098486|FG001|Overall Study|Physician Decision|1|||
156548199|NCT01505634|565098487|FG002|Overall Study|Physician Decision|0|||
156548200|NCT01505634|565098485|FG000|Overall Study|Adverse Event|1|||
156548201|NCT01505634|565098486|FG001|Overall Study|Adverse Event|0|||
156548202|NCT01505634|565098487|FG002|Overall Study|Adverse Event|0|||
156548203|NCT01505634|565098485|FG000|Overall Study|Insufficient supply of drug at site|1|||
156548204|NCT01505634|565098486|FG001|Overall Study|Insufficient supply of drug at site|0|||
156548205|NCT01505634|565098487|FG002|Overall Study|Insufficient supply of drug at site|0|||
156548206|NCT01505634|565098485|FG000|Overall Study|Protocol Violation|2|||
156548207|NCT01505634|565098486|FG001|Overall Study|Protocol Violation|0|||
156548208|NCT01505634|565098487|FG002|Overall Study|Protocol Violation|0|||
156548209|NCT01505634|565098485|FG000|Overall Study|Lost to Follow-up|1|||
156548210|NCT01505634|565098486|FG001|Overall Study|Lost to Follow-up|4|||
156548211|NCT01505634|565098487|FG002|Overall Study|Lost to Follow-up|4|||
156548212|NCT01505634|565098485|FG000|Overall Study|Death|1|||
156548213|NCT01505634|565098486|FG001|Overall Study|Death|0|||
156548214|NCT01505634|565098487|FG002|Overall Study|Death|0|||
156548215|NCT01505634|565098485|FG000|Overall Study|In a conflict zone|0|||
156548216|NCT01505634|565098486|FG001|Overall Study|In a conflict zone|0|||
156548217|NCT01505634|565098487|FG002|Overall Study|In a conflict zone|1|||
156548218|NCT00542269|565098488|FG000|Overall Study|Adverse Event|10|||
156548219|NCT00542269|565098489|FG001|Overall Study|Adverse Event|4|||
156548220|NCT00542269|565098490|FG002|Overall Study|Adverse Event|5|||
156548221|NCT00542269|565098488|FG000|Overall Study|Protocol Violation|1|||
156508285|NCT01572740|564955481|FG000|Overall Study|Withdrawal by Subject|1|||
156508286|NCT01572740|564955482|FG001|Overall Study|Withdrawal by Subject|1|||
156508287|NCT01572740|564955481|FG000|Overall Study|unclassified|4|||
156508288|NCT01572740|564955482|FG001|Overall Study|unclassified|3|||
156508289|NCT01818531|564955488|FG000|Overall Study|Withdrawn for case delay after block|1|||
156508290|NCT01818531|564955489|FG001|Overall Study|Withdrawn for case delay after block|0|||
156508291|NCT01818531|564955488|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
156508292|NCT01818531|564955489|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
156508293|NCT01818531|564955488|FG000|Overall Study|Withdrawn for failure to place block|0|||
156508294|NCT01818531|564955489|FG001|Overall Study|Withdrawn for failure to place block|1|||
156508295|NCT00214019|564955490|FG000|Overall Study|Lost to Follow-up|11|||
156508296|NCT00214019|564955490|FG000|Overall Study|Withdrawal by Subject|2|||
156508297|NCT00214019|564955490|FG000|Overall Study|Screen Failed prior to randomization|17|||
156508298|NCT00477490|564955491|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
156508299|NCT00477490|564955492|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
156508300|NCT00477490|564955493|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
156508301|NCT00477490|564955494|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
156508302|NCT00477490|564955495|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
156508303|NCT00477490|564955496|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
156508304|NCT00477490|564955497|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
156508305|NCT00477490|564955498|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
156508306|NCT00477490|564955499|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
156508307|NCT00477490|564955491|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
156508308|NCT00477490|564955492|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
156508309|NCT00477490|564955493|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
156508310|NCT00477490|564955494|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
156508311|NCT00477490|564955495|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
156508312|NCT00477490|564955496|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
156508313|NCT00477490|564955497|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
156508314|NCT00477490|564955498|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
156508315|NCT00477490|564955499|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
156508316|NCT00477490|564955491|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
156508317|NCT00477490|564955492|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
156508318|NCT00477490|564955493|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
156508319|NCT00477490|564955494|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
156508320|NCT00477490|564955495|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
156508321|NCT00477490|564955496|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
156508322|NCT00477490|564955497|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
156508323|NCT00477490|564955498|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
156508324|NCT00477490|564955499|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
156508325|NCT00477490|564955491|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
156508326|NCT00477490|564955492|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
156508327|NCT00477490|564955493|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
156508328|NCT00477490|564955494|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
156508329|NCT00477490|564955495|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
156508330|NCT00477490|564955496|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
156508331|NCT00477490|564955497|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
156508332|NCT00477490|564955498|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
156508333|NCT00477490|564955499|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
156508334|NCT00477490|564955491|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
156508335|NCT00477490|564955492|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
156508336|NCT00477490|564955493|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
156508337|NCT00477490|564955494|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
156508338|NCT00477490|564955495|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
156508339|NCT00477490|564955496|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
156508340|NCT00477490|564955497|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
156508341|NCT00477490|564955498|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
156508342|NCT00477490|564955499|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
156508343|NCT00477490|564955491|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
156508344|NCT00477490|564955492|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
156508345|NCT00477490|564955493|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
156508346|NCT00477490|564955494|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
156508347|NCT00477490|564955495|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
156508348|NCT00477490|564955496|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
156508349|NCT00477490|564955497|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
156508350|NCT00477490|564955498|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
156508351|NCT00477490|564955499|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
156508352|NCT00477490|564955491|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
156508353|NCT00477490|564955492|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
156508354|NCT00477490|564955493|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
156508355|NCT00477490|564955494|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
156508356|NCT00477490|564955495|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
156390817|NCT00710424|564521737|FG000|Overall Study|Subject thought medication changed|1|||
156390818|NCT00710424|564521738|FG001|Overall Study|Subject thought medication changed|0|||
156390819|NCT00710424|564521737|FG000|Overall Study|Ceased treatment due to travel|1|||
156390820|NCT00710424|564521738|FG001|Overall Study|Ceased treatment due to travel|0|||
156390821|NCT00710424|564521737|FG000|Overall Study|Subject preferred paracetamol|0|||
156390822|NCT00710424|564521738|FG001|Overall Study|Subject preferred paracetamol|1|||
156390823|NCT00710424|564521737|FG000|Overall Study|Felt good so stopped treatment|0|||
156390824|NCT00710424|564521738|FG001|Overall Study|Felt good so stopped treatment|1|||
156390825|NCT02314624|564523479|FG000|Overall Study|No participating patient|16|||
156390826|NCT02314624|564523480|FG001|Overall Study|No participating patient|13|||
156390827|NCT02314624|564523479|FG000|Overall Study|Participant withdrew|7|||
156390828|NCT02314624|564523480|FG001|Overall Study|Participant withdrew|2|||
156390829|NCT02314624|564523479|FG000|Overall Study|Lost to Follow-up|2|||
156390830|NCT02314624|564523480|FG001|Overall Study|Lost to Follow-up|5|||
156390831|NCT02314624|564523479|FG000|Overall Study|Dropped/Excluded by PI|6|||
156390832|NCT02314624|564523480|FG001|Overall Study|Dropped/Excluded by PI|6|||
156390833|NCT02163733|564523481|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
156390834|NCT02163733|564523482|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
156390835|NCT02163733|564523483|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
156390836|NCT02163733|564523481|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
156390837|NCT02163733|564523482|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
156390838|NCT02163733|564523483|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
156390839|NCT02723864|564523484|FG000|Overall Study|Refused further treatment|1|||
156390840|NCT02723864|564523485|FG001|Overall Study|Refused further treatment|0|||
156390841|NCT02723864|564523486|FG002|Overall Study|Refused further treatment|0|||
156390842|NCT02723864|564523487|FG003|Overall Study|Refused further treatment|0|||
156390843|NCT02723864|564523488|FG004|Overall Study|Refused further treatment|1|||
156508357|NCT00477490|564955496|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
156508358|NCT00477490|564955497|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
156508359|NCT00477490|564955498|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
156508360|NCT00477490|564955499|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
156508361|NCT00477490|564955491|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
156508362|NCT00477490|564955492|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
156508363|NCT00477490|564955493|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
156508364|NCT00477490|564955494|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
156508365|NCT00477490|564955495|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
156508366|NCT00477490|564955496|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
156508367|NCT00477490|564955497|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
156508368|NCT00477490|564955498|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
156508369|NCT00477490|564955499|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
156508370|NCT00477490|564955491|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
156508371|NCT00477490|564955492|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
156508372|NCT00477490|564955493|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
156508373|NCT00477490|564955494|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
156508374|NCT00477490|564955495|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
156508375|NCT00477490|564955496|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
156508376|NCT00477490|564955497|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
156508377|NCT00477490|564955498|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
156508378|NCT00477490|564955499|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
156508379|NCT00477490|564955491|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
156508380|NCT00477490|564955492|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
156508381|NCT00477490|564955493|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
156508382|NCT00477490|564955494|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
156508383|NCT00477490|564955495|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
156508384|NCT00477490|564955496|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
156508385|NCT00477490|564955497|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
156508386|NCT00477490|564955498|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
156508387|NCT00477490|564955499|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
156508388|NCT00477490|564955491|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
156508389|NCT00477490|564955492|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
156508390|NCT00477490|564955493|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
156508391|NCT00477490|564955494|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
156508392|NCT00477490|564955495|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
156508393|NCT00477490|564955496|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
156508394|NCT00477490|564955497|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
156390844|NCT02723864|564523489|FG005|Overall Study|Refused further treatment|2|||
156390845|NCT02723864|564523490|FG006|Overall Study|Refused further treatment|0|||
156390846|NCT02723864|564523484|FG000|Overall Study|Exceed treatment hold time|0|||
156548222|NCT00542269|565098489|FG001|Overall Study|Protocol Violation|1|||
156548223|NCT00542269|565098490|FG002|Overall Study|Protocol Violation|0|||
156548224|NCT00542269|565098488|FG000|Overall Study|Withdrawal by Subject|1|||
156548225|NCT00542269|565098489|FG001|Overall Study|Withdrawal by Subject|0|||
156548226|NCT00542269|565098490|FG002|Overall Study|Withdrawal by Subject|0|||
156548227|NCT00542269|565098488|FG000|Overall Study|Administrative problems|1|||
156548228|NCT00542269|565098489|FG001|Overall Study|Administrative problems|1|||
156548229|NCT00542269|565098490|FG002|Overall Study|Administrative problems|1|||
156548230|NCT00333359|565098496|FG000|Overall Study|Adverse Event|29|||
156548231|NCT00333359|565098497|FG001|Overall Study|Adverse Event|35|||
156548232|NCT00333359|565098496|FG000|Overall Study|Withdrawal by Subject|19|||
156548233|NCT00333359|565098497|FG001|Overall Study|Withdrawal by Subject|37|||
156548234|NCT00333359|565098496|FG000|Overall Study|Physician Decision|2|||
156548235|NCT00333359|565098497|FG001|Overall Study|Physician Decision|2|||
156548236|NCT00333359|565098496|FG000|Overall Study|Protocol Non-compliance|2|||
156548237|NCT00333359|565098497|FG001|Overall Study|Protocol Non-compliance|8|||
156548238|NCT00333359|565098496|FG000|Overall Study|Lost to Follow-up|15|||
156548239|NCT00333359|565098497|FG001|Overall Study|Lost to Follow-up|25|||
156548240|NCT00333359|565098496|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
156390847|NCT02723864|564523485|FG001|Overall Study|Exceed treatment hold time|1|||
156390848|NCT02723864|564523486|FG002|Overall Study|Exceed treatment hold time|0|||
156390849|NCT02723864|564523487|FG003|Overall Study|Exceed treatment hold time|0|||
156390850|NCT02723864|564523488|FG004|Overall Study|Exceed treatment hold time|0|||
156390851|NCT02723864|564523489|FG005|Overall Study|Exceed treatment hold time|0|||
156390852|NCT02723864|564523490|FG006|Overall Study|Exceed treatment hold time|0|||
156390853|NCT02723864|564523484|FG000|Overall Study|Clinical progression|0|||
156390854|NCT02723864|564523485|FG001|Overall Study|Clinical progression|0|||
156390855|NCT02723864|564523486|FG002|Overall Study|Clinical progression|1|||
156390856|NCT02723864|564523487|FG003|Overall Study|Clinical progression|0|||
156390857|NCT02723864|564523488|FG004|Overall Study|Clinical progression|0|||
156390858|NCT02723864|564523489|FG005|Overall Study|Clinical progression|3|||
156390859|NCT02723864|564523490|FG006|Overall Study|Clinical progression|1|||
156390860|NCT02723864|564523484|FG000|Overall Study|Physician Decision|0|||
156390861|NCT02723864|564523485|FG001|Overall Study|Physician Decision|0|||
156390862|NCT02723864|564523486|FG002|Overall Study|Physician Decision|0|||
156548241|NCT00333359|565098497|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
156548242|NCT00333359|565098496|FG000|Overall Study|Treatment Failure|3|||
156548243|NCT00333359|565098497|FG001|Overall Study|Treatment Failure|8|||
156548244|NCT00333359|565098496|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
156548245|NCT00333359|565098497|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
156548246|NCT01534533|565098501|FG000|Overall Study|Lost to Follow-up|3|||
156390863|NCT02723864|564523487|FG003|Overall Study|Physician Decision|0|||
156390864|NCT02723864|564523488|FG004|Overall Study|Physician Decision|0|||
156390865|NCT02723864|564523489|FG005|Overall Study|Physician Decision|0|||
156390866|NCT02723864|564523490|FG006|Overall Study|Physician Decision|1|||
156390867|NCT02723864|564523484|FG000|Overall Study|Changes in patient condition|0|||
156390868|NCT02723864|564523485|FG001|Overall Study|Changes in patient condition|0|||
156390869|NCT02723864|564523486|FG002|Overall Study|Changes in patient condition|0|||
156390870|NCT02723864|564523487|FG003|Overall Study|Changes in patient condition|0|||
156390871|NCT02723864|564523488|FG004|Overall Study|Changes in patient condition|0|||
156390872|NCT02723864|564523489|FG005|Overall Study|Changes in patient condition|1|||
156390873|NCT02723864|564523490|FG006|Overall Study|Changes in patient condition|0|||
156390874|NCT02723864|564523484|FG000|Overall Study|Patient choice|0|||
156390875|NCT02723864|564523485|FG001|Overall Study|Patient choice|0|||
156390876|NCT02723864|564523486|FG002|Overall Study|Patient choice|0|||
156548247|NCT01534533|565098502|FG001|Overall Study|Lost to Follow-up|0|||
156548248|NCT01534533|565098503|FG002|Overall Study|Lost to Follow-up|4|||
156548249|NCT01534533|565098504|FG003|Overall Study|Lost to Follow-up|3|||
156548250|NCT01534533|565098501|FG000|Overall Study|Withdrawal by Subject|5|||
156548251|NCT01534533|565098502|FG001|Overall Study|Withdrawal by Subject|3|||
156548252|NCT01534533|565098503|FG002|Overall Study|Withdrawal by Subject|4|||
156548253|NCT01534533|565098504|FG003|Overall Study|Withdrawal by Subject|1|||
156548254|NCT04311502|565100278|FG000|Overall Study|Death|1|||
156548255|NCT04311502|565100279|FG001|Overall Study|Death|1|||
156390877|NCT02723864|564523487|FG003|Overall Study|Patient choice|0|||
156390878|NCT02723864|564523488|FG004|Overall Study|Patient choice|0|||
156390879|NCT02723864|564523489|FG005|Overall Study|Patient choice|1|||
156548256|NCT04311502|565100280|FG002|Overall Study|Death|1|||
156548257|NCT04311502|565100278|FG000|Overall Study|Lost to Follow-up|2|||
156390880|NCT02723864|564523490|FG006|Overall Study|Patient choice|0|||
156390881|NCT02723864|564523484|FG000|Overall Study|Adverse Event|0|||
156390882|NCT02723864|564523485|FG001|Overall Study|Adverse Event|0|||
156548258|NCT04311502|565100279|FG001|Overall Study|Lost to Follow-up|3|||
156548259|NCT04311502|565100280|FG002|Overall Study|Lost to Follow-up|0|||
156548260|NCT04311502|565100278|FG000|Overall Study|Participant is in prison|1|||
156548261|NCT04311502|565100279|FG001|Overall Study|Participant is in prison|0|||
156548262|NCT04311502|565100280|FG002|Overall Study|Participant is in prison|0|||
156548263|NCT04311502|565100278|FG000|Overall Study|Participant moved out of country|1|||
156548264|NCT04311502|565100279|FG001|Overall Study|Participant moved out of country|0|||
156548265|NCT04311502|565100280|FG002|Overall Study|Participant moved out of country|0|||
156548266|NCT04311502|565100278|FG000|Overall Study|Withdrawal by Subject|2|||
156548267|NCT04311502|565100279|FG001|Overall Study|Withdrawal by Subject|0|||
156548268|NCT04311502|565100280|FG002|Overall Study|Withdrawal by Subject|0|||
156548269|NCT04311502|565100278|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
156548270|NCT04311502|565100279|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
156548271|NCT04311502|565100280|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
156548272|NCT05032157|565100281|FG000|Overall Study|Adverse Event|12|||
156548273|NCT05032157|565100282|FG001|Overall Study|Adverse Event|7|||
156548274|NCT05032157|565100281|FG000|Overall Study|Pregnancy|0|||
156548275|NCT05032157|565100282|FG001|Overall Study|Pregnancy|2|||
156548276|NCT05032157|565100281|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156390883|NCT02723864|564523486|FG002|Overall Study|Adverse Event|0|||
156390884|NCT02723864|564523487|FG003|Overall Study|Adverse Event|0|||
156390885|NCT02723864|564523488|FG004|Overall Study|Adverse Event|0|||
156390886|NCT02723864|564523489|FG005|Overall Study|Adverse Event|1|||
156390887|NCT02723864|564523490|FG006|Overall Study|Adverse Event|0|||
156390888|NCT02723864|564523484|FG000|Overall Study|Started new treatment|0|||
156390889|NCT02723864|564523485|FG001|Overall Study|Started new treatment|0|||
156390890|NCT02723864|564523486|FG002|Overall Study|Started new treatment|0|||
156390891|NCT02723864|564523487|FG003|Overall Study|Started new treatment|0|||
156390892|NCT02723864|564523488|FG004|Overall Study|Started new treatment|0|||
156390893|NCT02723864|564523489|FG005|Overall Study|Started new treatment|1|||
156548277|NCT05032157|565100282|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
156548278|NCT05032157|565100281|FG000|Overall Study|Protocol Deviation|8|||
156548279|NCT05032157|565100282|FG001|Overall Study|Protocol Deviation|4|||
156548280|NCT05032157|565100281|FG000|Overall Study|Lost to Follow-up|1|||
156548281|NCT05032157|565100282|FG001|Overall Study|Lost to Follow-up|3|||
156548282|NCT05032157|565100281|FG000|Overall Study|Physician Decision|7|||
156548283|NCT05032157|565100282|FG001|Overall Study|Physician Decision|2|||
156548284|NCT05032157|565100281|FG000|Overall Study|Patient Decision|38|||
156548285|NCT05032157|565100282|FG001|Overall Study|Patient Decision|19|||
156548286|NCT03468855|565100283|FG000|Overall Study|Adverse Event|2|||
156390894|NCT02723864|564523490|FG006|Overall Study|Started new treatment|0|||
156390895|NCT02723864|564523484|FG000|Overall Study|Switched to alternative treatment|0|||
156390896|NCT02723864|564523485|FG001|Overall Study|Switched to alternative treatment|0|||
156390897|NCT02723864|564523486|FG002|Overall Study|Switched to alternative treatment|0|||
156390898|NCT02723864|564523487|FG003|Overall Study|Switched to alternative treatment|0|||
156390899|NCT02723864|564523488|FG004|Overall Study|Switched to alternative treatment|0|||
156390900|NCT02723864|564523489|FG005|Overall Study|Switched to alternative treatment|1|||
156390901|NCT02723864|564523490|FG006|Overall Study|Switched to alternative treatment|0|||
156390902|NCT02723864|564523484|FG000|Overall Study|Late determination of ineligibility|0|||
156390903|NCT02723864|564523485|FG001|Overall Study|Late determination of ineligibility|0|||
156390904|NCT02723864|564523486|FG002|Overall Study|Late determination of ineligibility|0|||
156390905|NCT02723864|564523487|FG003|Overall Study|Late determination of ineligibility|0|||
156390906|NCT02723864|564523488|FG004|Overall Study|Late determination of ineligibility|0|||
156390907|NCT02723864|564523489|FG005|Overall Study|Late determination of ineligibility|1|||
156390908|NCT02723864|564523490|FG006|Overall Study|Late determination of ineligibility|0|||
156390909|NCT00746590|564523491|FG000|Overall Study|Death|1|||
156390910|NCT02633800|564523494|FG000|Overall Study|Death|3|||
156390911|NCT02633800|564523495|FG001|Overall Study|Death|3|||
156390912|NCT02633800|564523494|FG000|Overall Study|Reason not provided|1|||
156390913|NCT02633800|564523495|FG001|Overall Study|Reason not provided|0|||
156390914|NCT02633800|564523494|FG000|Overall Study|Radiologic(al) progression|23|||
156390915|NCT02633800|564523495|FG001|Overall Study|Radiologic(al) progression|23|||
156390916|NCT02633800|564523494|FG000|Overall Study|Clinical progression|3|||
156390917|NCT02633800|564523495|FG001|Overall Study|Clinical progression|6|||
156390918|NCT02633800|564523494|FG000|Overall Study|Study terminated by sponsor|6|||
156390919|NCT02633800|564523495|FG001|Overall Study|Study terminated by sponsor|5|||
156390920|NCT02633800|564523494|FG000|Overall Study|Adverse event, non-fatal|7|||
156390921|NCT02633800|564523495|FG001|Overall Study|Adverse event, non-fatal|2|||
156390922|NCT02633800|564523494|FG000|Overall Study|Withdrawal by Subject|0|||
156390923|NCT02633800|564523495|FG001|Overall Study|Withdrawal by Subject|3|||
156548287|NCT03468855|565100283|FG000|Overall Study|Lost to Follow-up|5|||
156548288|NCT03468855|565100283|FG000|Overall Study|Withdrawal by Subject|3|||
156390924|NCT02633800|564523494|FG000|Overall Study|Patient Request|1|||
156390925|NCT02633800|564523495|FG001|Overall Study|Patient Request|1|||
156390926|NCT03643952|564523499|FG000|Overall Study|Lack of Efficacy|1|||
156390927|NCT01358968|564523500|FG000|Period 2|Adverse Event|0|||
156390928|NCT01358968|564523501|FG001|Period 2|Adverse Event|1|||
156548289|NCT03468855|565100283|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
156548290|NCT02627495|565100286|FG000|Overall Study|Withdrawal by Subject|4|||
156548291|NCT00880893|565100287|FG000|Overall Study|Protocol Violation|13|||
156548292|NCT00880893|565100288|FG001|Overall Study|Protocol Violation|1|||
156390929|NCT01358968|564523502|FG002|Period 2|Adverse Event|0|||
156390930|NCT01358968|564523503|FG003|Period 2|Adverse Event|0|||
156390931|NCT01358968|564523500|FG000|Continued Access Phase|Progression of Disease|0|||
156390932|NCT01358968|564523501|FG001|Continued Access Phase|Progression of Disease|0|||
156390933|NCT01358968|564523502|FG002|Continued Access Phase|Progression of Disease|8|||
156390934|NCT01358968|564523503|FG003|Continued Access Phase|Progression of Disease|4|||
156390935|NCT01358968|564523500|FG000|Continued Access Phase|Protocol Violation|0|||
156390936|NCT01358968|564523501|FG001|Continued Access Phase|Protocol Violation|0|||
156390937|NCT01358968|564523502|FG002|Continued Access Phase|Protocol Violation|0|||
156390938|NCT01358968|564523503|FG003|Continued Access Phase|Protocol Violation|2|||
156390939|NCT01358968|564523500|FG000|Continued Access Phase|Withdrawal by Subject|0|||
156390940|NCT01358968|564523501|FG001|Continued Access Phase|Withdrawal by Subject|0|||
156390941|NCT01358968|564523502|FG002|Continued Access Phase|Withdrawal by Subject|3|||
156390942|NCT01358968|564523503|FG003|Continued Access Phase|Withdrawal by Subject|0|||
156390943|NCT01358968|564523500|FG000|Continued Access Phase|Death|0|||
156390944|NCT01358968|564523501|FG001|Continued Access Phase|Death|0|||
156390945|NCT01358968|564523502|FG002|Continued Access Phase|Death|1|||
156390946|NCT01358968|564523503|FG003|Continued Access Phase|Death|1|||
156390947|NCT03252587|564523511|FG000|Overall Study|Adverse Event|3|||
156390948|NCT03252587|564523512|FG001|Overall Study|Adverse Event|8|||
156390949|NCT03252587|564523513|FG002|Overall Study|Adverse Event|6|||
156390950|NCT03252587|564523514|FG003|Overall Study|Adverse Event|12|||
156390951|NCT03252587|564523511|FG000|Overall Study|Lack of Efficacy|7|||
156390952|NCT03252587|564523512|FG001|Overall Study|Lack of Efficacy|2|||
156390953|NCT03252587|564523513|FG002|Overall Study|Lack of Efficacy|2|||
156390954|NCT03252587|564523514|FG003|Overall Study|Lack of Efficacy|4|||
156390955|NCT03252587|564523511|FG000|Overall Study|Lost to Follow-up|2|||
156390956|NCT03252587|564523512|FG001|Overall Study|Lost to Follow-up|0|||
156390957|NCT03252587|564523513|FG002|Overall Study|Lost to Follow-up|0|||
156390958|NCT03252587|564523514|FG003|Overall Study|Lost to Follow-up|2|||
156390959|NCT03252587|564523511|FG000|Overall Study|Pregnancy|2|||
156390960|NCT03252587|564523512|FG001|Overall Study|Pregnancy|1|||
156390961|NCT03252587|564523513|FG002|Overall Study|Pregnancy|0|||
156390962|NCT03252587|564523514|FG003|Overall Study|Pregnancy|1|||
156390963|NCT03252587|564523511|FG000|Overall Study|Withdrawal by Subject|8|||
156390964|NCT03252587|564523512|FG001|Overall Study|Withdrawal by Subject|4|||
156390965|NCT03252587|564523513|FG002|Overall Study|Withdrawal by Subject|4|||
156390966|NCT03252587|564523514|FG003|Overall Study|Withdrawal by Subject|4|||
156390967|NCT03252587|564523511|FG000|Overall Study|Other Reasons|2|||
156390968|NCT03252587|564523512|FG001|Overall Study|Other Reasons|5|||
156390969|NCT03252587|564523513|FG002|Overall Study|Other Reasons|5|||
156390970|NCT03252587|564523514|FG003|Overall Study|Other Reasons|4|||
156390971|NCT03945188|564523515|FG000|Overall Study|Protocol Violation|1|||
156390972|NCT03945188|564523516|FG001|Overall Study|Protocol Violation|0|||
156390973|NCT03945188|564523515|FG000|Overall Study|Disease worsening|79|||
156390974|NCT03945188|564523516|FG001|Overall Study|Disease worsening|73|||
156390975|NCT03945188|564523515|FG000|Overall Study|Physician Decision|2|||
156390976|NCT03945188|564523516|FG001|Overall Study|Physician Decision|2|||
156390977|NCT03945188|564523515|FG000|Overall Study|Lack of Efficacy|7|||
156390978|NCT03945188|564523516|FG001|Overall Study|Lack of Efficacy|4|||
156390979|NCT03945188|564523515|FG000|Overall Study|Pregnancy|2|||
156390980|NCT03945188|564523516|FG001|Overall Study|Pregnancy|0|||
156390981|NCT03945188|564523515|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
156390982|NCT03945188|564523516|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
156390983|NCT03945188|564523515|FG000|Overall Study|Adverse Event|10|||
156390984|NCT03945188|564523516|FG001|Overall Study|Adverse Event|5|||
156390985|NCT03945188|564523515|FG000|Overall Study|Other|2|||
156390986|NCT03945188|564523516|FG001|Overall Study|Other|2|||
156390987|NCT03945188|564523515|FG000|Overall Study|Lost to Follow-up|1|||
156390988|NCT03945188|564523516|FG001|Overall Study|Lost to Follow-up|2|||
156390989|NCT01618162|564523536|FG000|Overall Study|Protocol Violation|13|||
156390990|NCT01618162|564523537|FG001|Overall Study|Protocol Violation|10|||
156390991|NCT01618162|564523536|FG000|Overall Study|Adverse Event|9|||
156390992|NCT01618162|564523537|FG001|Overall Study|Adverse Event|2|||
156390993|NCT01618162|564523536|FG000|Overall Study|Withdrawal Criteria|2|||
156390994|NCT01618162|564523537|FG001|Overall Study|Withdrawal Criteria|10|||
156390995|NCT01618162|564523536|FG000|Overall Study|Unclassified|14|||
156390996|NCT01618162|564523537|FG001|Overall Study|Unclassified|13|||
156390997|NCT04794803|564523538|FG000|Overall Study|Death|1|||
156390998|NCT04794803|564523539|FG001|Overall Study|Death|3|||
156390999|NCT04794803|564523538|FG000|Overall Study|Lost to Follow-up|2|||
156391000|NCT04794803|564523539|FG001|Overall Study|Lost to Follow-up|2|||
156391001|NCT04794803|564523538|FG000|Overall Study|Withdrawal by Subject|1|||
156391002|NCT04794803|564523539|FG001|Overall Study|Withdrawal by Subject|0|||
156391003|NCT04794803|564523538|FG000|Overall Study|Physician Decision|1|||
156391004|NCT04794803|564523539|FG001|Overall Study|Physician Decision|1|||
156391005|NCT04794803|564523538|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
156391006|NCT04794803|564523539|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
156508395|NCT00477490|564955498|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
156508396|NCT00477490|564955499|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
156508397|NCT00477490|564955491|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
156508398|NCT00477490|564955492|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
156508399|NCT00477490|564955493|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
156508400|NCT00477490|564955494|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
156508401|NCT00477490|564955495|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
156508402|NCT00477490|564955496|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
156508403|NCT00477490|564955497|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
156508404|NCT00477490|564955498|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
156508405|NCT00477490|564955499|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
156508406|NCT00477490|564955491|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
156508407|NCT00477490|564955492|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
156508408|NCT00477490|564955493|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
156508409|NCT00477490|564955494|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
156508410|NCT00477490|564955495|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
156508411|NCT00477490|564955496|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
156508412|NCT00477490|564955497|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
156508413|NCT00477490|564955498|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
156508414|NCT00477490|564955499|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
156508415|NCT00477490|564955491|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
156508416|NCT00477490|564955492|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
156508417|NCT00477490|564955493|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
156508418|NCT00477490|564955494|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
156508419|NCT00477490|564955495|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
156508420|NCT00477490|564955496|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
156508421|NCT00477490|564955497|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
156508422|NCT00477490|564955498|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
156508423|NCT00477490|564955499|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
156508424|NCT01465763|564955502|FG000|Overall Study|Withdrawal by Subject|4|||
156508425|NCT01465763|564955503|FG001|Overall Study|Withdrawal by Subject|0|||
156508426|NCT01465763|564955504|FG002|Overall Study|Withdrawal by Subject|1|||
156508427|NCT01465763|564955502|FG000|Overall Study|Insufficient Clinical Response|11|||
156508428|NCT01465763|564955503|FG001|Overall Study|Insufficient Clinical Response|0|||
156508429|NCT01465763|564955504|FG002|Overall Study|Insufficient Clinical Response|1|||
156508430|NCT01465763|564955502|FG000|Overall Study|Adverse Event|9|||
156508431|NCT01465763|564955503|FG001|Overall Study|Adverse Event|0|||
156508432|NCT01465763|564955504|FG002|Overall Study|Adverse Event|1|||
156508433|NCT01465763|564955502|FG000|Overall Study|Other|2|||
156508434|NCT01465763|564955503|FG001|Overall Study|Other|0|||
156508435|NCT01465763|564955504|FG002|Overall Study|Other|0|||
156508436|NCT01465763|564955502|FG000|Overall Study|Protocol Violation|4|||
156508437|NCT01465763|564955503|FG001|Overall Study|Protocol Violation|1|||
156508438|NCT01465763|564955504|FG002|Overall Study|Protocol Violation|1|||
156508439|NCT01465763|564955502|FG000|Overall Study|Death|1|||
156508440|NCT01465763|564955503|FG001|Overall Study|Death|0|||
156508441|NCT01465763|564955504|FG002|Overall Study|Death|0|||
156508442|NCT01646177|564955505|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
156508443|NCT01646177|564955506|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
156508444|NCT01646177|564955507|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
156508445|NCT01646177|564955508|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
156508446|NCT01646177|564955509|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
156508447|NCT01646177|564955510|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
156508448|NCT01646177|564955511|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
156508449|NCT01646177|564955512|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
156508450|NCT01646177|564955513|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
156508451|NCT01646177|564955514|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
156508452|NCT01646177|564955515|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
156508453|NCT01646177|564955516|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
156508454|NCT01646177|564955505|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
156508455|NCT01646177|564955506|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
156508456|NCT01646177|564955507|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
156508457|NCT01646177|564955508|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
156508458|NCT01646177|564955509|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
156508459|NCT01646177|564955510|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
156508460|NCT01646177|564955511|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
156508461|NCT01646177|564955512|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
156508462|NCT01646177|564955513|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
156391007|NCT04794803|564523538|FG000|Overall Study|Refused to continue the treatment|1|||
156391008|NCT04794803|564523539|FG001|Overall Study|Refused to continue the treatment|0|||
156391009|NCT04794803|564523538|FG000|Overall Study|Patient admitted to ICU|0|||
156391010|NCT04794803|564523539|FG001|Overall Study|Patient admitted to ICU|1|||
156391011|NCT01654549|564523542|FG000|Overall Study|H.pylori eradication not successful|0|||
156391012|NCT01654549|564523543|FG001|Overall Study|H.pylori eradication not successful|1|||
156391013|NCT00937924|564523546|FG000|Overall Study|Lost to Follow-up|44|||
156391014|NCT00937924|564523547|FG001|Overall Study|Lost to Follow-up|44|||
156391015|NCT00937924|564523548|FG002|Overall Study|Lost to Follow-up|41|||
156391016|NCT03152526|564523556|FG000|Overall Study|Withdrawal by Subject|0|||
156391017|NCT03152526|564523557|FG001|Overall Study|Withdrawal by Subject|1|||
156391018|NCT04391023|564523558|FG000|Overall Study|Withdrawal by Subject|2|||
156391019|NCT04391023|564523559|FG001|Overall Study|Withdrawal by Subject|2|||
156391020|NCT04009291|564523561|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
156391021|NCT04009291|564523562|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
156391022|NCT04009291|564523563|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
156391023|NCT04009291|564523564|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
156391024|NCT04009291|564523565|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
156391025|NCT04009291|564523561|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
156391026|NCT04009291|564523562|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
156548293|NCT00880893|565100287|FG000|Overall Study|Withdrawal by Subject|15|||
156391027|NCT04009291|564523563|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
156391028|NCT04009291|564523564|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
156391029|NCT04009291|564523565|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
156391030|NCT01270347|564523566|FG000|Core Phase|Adverse Event|1|||
156391031|NCT01270347|564523567|FG001|Core Phase|Adverse Event|6|||
156391032|NCT01270347|564523566|FG000|Core Phase|Withdrawal by Subject|1|||
156391033|NCT01270347|564523567|FG001|Core Phase|Withdrawal by Subject|2|||
156391034|NCT01270347|564523566|FG000|Core Phase|Lost to Follow-up|0|||
156391035|NCT01270347|564523567|FG001|Core Phase|Lost to Follow-up|1|||
156391036|NCT01270347|564523566|FG000|Core Phase|Miscellaneous|8|||
156391037|NCT01270347|564523567|FG001|Core Phase|Miscellaneous|14|||
156391038|NCT01270347|564523566|FG000|Extension Phase|Adverse Event|1|||
156391039|NCT01270347|564523567|FG001|Extension Phase|Adverse Event|3|||
156391040|NCT01270347|564523566|FG000|Extension Phase|Withdrawal by Subject|3|||
156391041|NCT01270347|564523567|FG001|Extension Phase|Withdrawal by Subject|4|||
156391042|NCT01270347|564523566|FG000|Extension Phase|Miscellaneous|2|||
156391043|NCT01270347|564523567|FG001|Extension Phase|Miscellaneous|2|||
156391044|NCT02085408|564523568|FG000|Step 1: Induction|Disease Progression|19|||
156391045|NCT02085408|564523569|FG001|Step 1: Induction|Disease Progression|19|||
156391046|NCT02085408|564523568|FG000|Step 1: Induction|Adverse Event|18|||
156391047|NCT02085408|564523569|FG001|Step 1: Induction|Adverse Event|17|||
156391048|NCT02085408|564523568|FG000|Step 1: Induction|Death|33|||
156391049|NCT02085408|564523569|FG001|Step 1: Induction|Death|30|||
156391050|NCT02085408|564523568|FG000|Step 1: Induction|Withdrawal by Subject|16|||
156391051|NCT02085408|564523569|FG001|Step 1: Induction|Withdrawal by Subject|8|||
156391052|NCT02085408|564523568|FG000|Step 1: Induction|Alternative Therapy|15|||
156391053|NCT02085408|564523569|FG001|Step 1: Induction|Alternative Therapy|19|||
156391054|NCT02085408|564523568|FG000|Step 1: Induction|Complicating Disease|2|||
156391055|NCT02085408|564523569|FG001|Step 1: Induction|Complicating Disease|3|||
156391056|NCT02085408|564523568|FG000|Step 1: Induction|Other|27|||
156391057|NCT02085408|564523569|FG001|Step 1: Induction|Other|39|||
156391058|NCT02085408|564523568|FG000|Step 1: Induction|Never started treatment|6|||
156391059|NCT02085408|564523569|FG001|Step 1: Induction|Never started treatment|4|||
156391060|NCT02085408|564523568|FG000|Step 2: Consolidation|Disease Progression|5|||
156391061|NCT02085408|564523569|FG001|Step 2: Consolidation|Disease Progression|20|||
156391062|NCT02085408|564523568|FG000|Step 2: Consolidation|Adverse Event|9|||
156391063|NCT02085408|564523569|FG001|Step 2: Consolidation|Adverse Event|8|||
156508463|NCT01646177|564955514|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
156508464|NCT01646177|564955515|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
156508465|NCT01646177|564955516|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
156508466|NCT01646177|564955505|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
156508467|NCT01646177|564955506|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
156508468|NCT01646177|564955507|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
156508469|NCT01646177|564955508|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
156508470|NCT01646177|564955509|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
156508471|NCT01646177|564955510|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
156508472|NCT01646177|564955511|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
156508473|NCT01646177|564955512|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
156508474|NCT01646177|564955513|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
156508475|NCT01646177|564955514|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
156548294|NCT00880893|565100288|FG001|Overall Study|Withdrawal by Subject|11|||
156391064|NCT02085408|564523568|FG000|Step 2: Consolidation|Death|4|||
156508476|NCT01646177|564955515|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
156508477|NCT01646177|564955516|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
156508478|NCT01646177|564955505|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
156508479|NCT01646177|564955506|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
156508480|NCT01646177|564955507|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
156508481|NCT01646177|564955508|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
156508482|NCT01646177|564955509|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
156508483|NCT01646177|564955510|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
156508484|NCT01646177|564955511|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
156508485|NCT01646177|564955512|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
156508486|NCT01646177|564955513|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
156508487|NCT01646177|564955514|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
156508488|NCT01646177|564955515|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
156508489|NCT01646177|564955516|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
156508490|NCT01646177|564955505|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508491|NCT01646177|564955506|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508492|NCT01646177|564955507|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
156508493|NCT01646177|564955508|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
156508494|NCT01646177|564955509|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508495|NCT01646177|564955510|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508496|NCT01646177|564955511|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508497|NCT01646177|564955512|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508498|NCT01646177|564955513|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508499|NCT01646177|564955514|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508500|NCT01646177|564955515|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508501|NCT01646177|564955516|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
156508502|NCT01646177|564955505|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
156508503|NCT01646177|564955506|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
156508504|NCT01646177|564955507|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
156508505|NCT01646177|564955508|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508506|NCT01646177|564955509|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508507|NCT01646177|564955510|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508508|NCT01646177|564955511|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508509|NCT01646177|564955512|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508510|NCT01646177|564955513|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508511|NCT01646177|564955514|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508512|NCT01646177|564955515|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508513|NCT01646177|564955516|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
156508514|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
156508515|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
156508516|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
156508517|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
156508518|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
156508519|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
156508520|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
156508521|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
156508522|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
156508523|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
156508524|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
156508525|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
156508526|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
156508527|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
156508528|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
156548295|NCT00880893|565100287|FG000|Overall Study|Lost to Follow-up|76|||
156391065|NCT02085408|564523569|FG001|Step 2: Consolidation|Death|3|||
156391066|NCT02085408|564523568|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
156391067|NCT02085408|564523569|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
156391068|NCT02085408|564523568|FG000|Step 2: Consolidation|Alternative Therapy|9|||
156391069|NCT02085408|564523569|FG001|Step 2: Consolidation|Alternative Therapy|3|||
156391070|NCT02085408|564523568|FG000|Step 2: Consolidation|Complicating Disease|0|||
156391071|NCT02085408|564523569|FG001|Step 2: Consolidation|Complicating Disease|2|||
156391072|NCT02085408|564523568|FG000|Step 2: Consolidation|Other|6|||
156391073|NCT02085408|564523569|FG001|Step 2: Consolidation|Other|6|||
156391074|NCT02085408|564523568|FG000|Step 2: Consolidation|Never started treatment|4|||
156391075|NCT02085408|564523569|FG001|Step 2: Consolidation|Never started treatment|3|||
156391076|NCT02085408|564523568|FG000|Step 3: Maintenance|Disease Progression|13|||
156391077|NCT02085408|564523569|FG001|Step 3: Maintenance|Disease Progression|11|||
156548296|NCT00880893|565100288|FG001|Overall Study|Lost to Follow-up|33|||
156548297|NCT00880893|565100287|FG000|Overall Study|Serious adverse event|3|||
156548298|NCT00880893|565100288|FG001|Overall Study|Serious adverse event|0|||
156548299|NCT01736579|565100292|FG000|Overall Study|Termination of Study by Sponsor|2|||
156548300|NCT01736579|565100293|FG001|Overall Study|Termination of Study by Sponsor|2|||
156548301|NCT02543528|565100300|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
156548302|NCT02543528|565100301|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
156548303|NCT02543528|565100302|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
156548304|NCT02543528|565100303|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
156548305|NCT02543528|565100304|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
156548306|NCT02543528|565100300|FG000|Adaptation Period|Lens Handling Difficultes|0|||
156548307|NCT02543528|565100301|FG001|Adaptation Period|Lens Handling Difficultes|0|||
156548308|NCT02543528|565100302|FG002|Adaptation Period|Lens Handling Difficultes|0|||
156548309|NCT02543528|565100303|FG003|Adaptation Period|Lens Handling Difficultes|0|||
156548310|NCT02543528|565100304|FG004|Adaptation Period|Lens Handling Difficultes|8|||
156548311|NCT02543528|565100300|FG000|Adaptation Period|Lost to Follow-up|0|||
156548312|NCT02543528|565100301|FG001|Adaptation Period|Lost to Follow-up|0|||
156548313|NCT02543528|565100302|FG002|Adaptation Period|Lost to Follow-up|0|||
156548314|NCT02543528|565100303|FG003|Adaptation Period|Lost to Follow-up|0|||
156548315|NCT02543528|565100304|FG004|Adaptation Period|Lost to Follow-up|14|||
156548316|NCT02543528|565100300|FG000|Adaptation Period|Adverse Event|0|||
156548317|NCT02543528|565100301|FG001|Adaptation Period|Adverse Event|0|||
156548318|NCT02543528|565100302|FG002|Adaptation Period|Adverse Event|0|||
156548319|NCT02543528|565100303|FG003|Adaptation Period|Adverse Event|0|||
156548320|NCT02543528|565100304|FG004|Adaptation Period|Adverse Event|2|||
156548321|NCT02543528|565100300|FG000|Extended Wear Period|Adverse Event|17|||
156548322|NCT02543528|565100301|FG001|Extended Wear Period|Adverse Event|11|||
156548323|NCT02543528|565100302|FG002|Extended Wear Period|Adverse Event|16|||
156548324|NCT02543528|565100303|FG003|Extended Wear Period|Adverse Event|3|||
156548325|NCT02543528|565100304|FG004|Extended Wear Period|Adverse Event|0|||
156548326|NCT02543528|565100300|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
156548327|NCT02543528|565100301|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
156548328|NCT02543528|565100302|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
156548329|NCT02543528|565100303|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
156548330|NCT02543528|565100304|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
156548331|NCT02543528|565100300|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
156548332|NCT02543528|565100301|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
156548333|NCT02543528|565100302|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
156548334|NCT02543528|565100303|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
156548335|NCT02543528|565100304|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
156548336|NCT02543528|565100300|FG000|Extended Wear Period|Lost to Follow-up|0|||
156548337|NCT02543528|565100301|FG001|Extended Wear Period|Lost to Follow-up|1|||
156548338|NCT02543528|565100302|FG002|Extended Wear Period|Lost to Follow-up|2|||
156548339|NCT02543528|565100303|FG003|Extended Wear Period|Lost to Follow-up|1|||
156548340|NCT02543528|565100304|FG004|Extended Wear Period|Lost to Follow-up|0|||
156548341|NCT02543528|565100300|FG000|Extended Wear Period|Withdrawal by Subject|10|||
156548342|NCT02543528|565100301|FG001|Extended Wear Period|Withdrawal by Subject|9|||
156548343|NCT02543528|565100302|FG002|Extended Wear Period|Withdrawal by Subject|4|||
156548344|NCT02543528|565100303|FG003|Extended Wear Period|Withdrawal by Subject|5|||
156548345|NCT02543528|565100304|FG004|Extended Wear Period|Withdrawal by Subject|0|||
156548346|NCT01979523|565100308|FG000|Overall Study|Withdrawal by Subject|1|||
156548347|NCT01979523|565100309|FG001|Overall Study|Withdrawal by Subject|0|||
156548348|NCT01339559|565100316|FG000|Overall Study|Adverse Event|92|||
156548349|NCT01339559|565100316|FG000|Overall Study|Death|5|||
156548350|NCT01339559|565100316|FG000|Overall Study|Lack of Efficacy|164|||
156548351|NCT01339559|565100316|FG000|Overall Study|Lost to Follow-up|22|||
156548352|NCT01339559|565100316|FG000|Overall Study|Subject choice|89|||
156548353|NCT01339559|565100316|FG000|Overall Study|Protocol Violation|15|||
156548354|NCT01339559|565100316|FG000|Overall Study|Study closure at site|1|||
156548355|NCT01339559|565100316|FG000|Overall Study|Incarcerated|2|||
156548356|NCT01339559|565100316|FG000|Overall Study|Epilepsy surgery|1|||
156391078|NCT02085408|564523568|FG000|Step 3: Maintenance|Adverse Event|2|||
156391079|NCT02085408|564523569|FG001|Step 3: Maintenance|Adverse Event|4|||
156391080|NCT02085408|564523568|FG000|Step 3: Maintenance|Death|1|||
156548357|NCT01339559|565100316|FG000|Overall Study|Pregnancy planned|2|||
156548358|NCT01339559|565100316|FG000|Overall Study|Left the country|1|||
156548359|NCT01339559|565100316|FG000|Overall Study|Investigator decision|2|||
156548360|NCT01339559|565100316|FG000|Overall Study|Patient didn't wish to continue|1|||
156548361|NCT01339559|565100316|FG000|Overall Study|PI decision|1|||
156548362|NCT00971945|565100317|FG000|Overall Study|Progressive Disease|3|||
156548363|NCT00971945|565100317|FG000|Overall Study|Change in treatment policy|1|||
156548364|NCT00971945|565100317|FG000|Overall Study|Other reasons|2|||
156548365|NCT00513409|565100321|FG000|Overall Study|Adverse Event|0|||
156548366|NCT00513409|565100322|FG001|Overall Study|Adverse Event|1|||
156548367|NCT00513409|565100321|FG000|Overall Study|Withdrawal by Subject|0|||
156508529|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
156508530|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
156508531|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
156508532|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
156508533|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
156508534|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
156508535|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
156508536|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
156508537|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
156508538|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
156508539|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
156508540|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
156508541|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
156508542|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
156508543|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
156508544|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
156508545|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
156508546|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
156508547|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
156508548|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
156508549|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
156508550|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
156508551|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
156508552|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
156508553|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
156508554|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
156508555|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
156508556|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
156508557|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
156508558|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
156508559|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
156508560|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
156508561|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
156508562|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
156508563|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
156508564|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
156508565|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
156508566|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
156508567|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
156508568|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
156508569|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
156508570|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
156508571|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
156508572|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
156508573|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
156508574|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508575|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508576|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508577|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508578|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
156508579|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
156508580|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508581|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
156508582|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508583|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508584|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508585|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
156508586|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
156508587|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
156508588|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
156508589|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
156508590|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
156548368|NCT00513409|565100322|FG001|Overall Study|Withdrawal by Subject|2|||
156548369|NCT00513409|565100321|FG000|Overall Study|Lost to Follow-up|0|||
156548370|NCT00513409|565100322|FG001|Overall Study|Lost to Follow-up|1|||
156548371|NCT00513409|565100321|FG000|Overall Study|Physician Decision|1|||
156548372|NCT00513409|565100322|FG001|Overall Study|Physician Decision|0|||
156548373|NCT00513409|565100321|FG000|Overall Study|Visit 3 not done|1|||
156548374|NCT00513409|565100322|FG001|Overall Study|Visit 3 not done|2|||
156548375|NCT00746252|565100323|FG000|Overall Study|weight gain >7.5 %|1|||
156548376|NCT00746252|565100324|FG001|Overall Study|weight gain >7.5 %|2|||
156548377|NCT01049035|565100325|FG000|Overall Study|Serious adverse event|0|||
156548378|NCT01049035|565100326|FG001|Overall Study|Serious adverse event|1|||
156548379|NCT01049035|565100327|FG002|Overall Study|Serious adverse event|1|||
156548380|NCT01049035|565100328|FG003|Overall Study|Serious adverse event|2|||
156548381|NCT01049035|565100329|FG004|Overall Study|Serious adverse event|0|||
156548382|NCT01049035|565100330|FG005|Overall Study|Serious adverse event|0|||
156548383|NCT01049035|565100331|FG006|Overall Study|Serious adverse event|0|||
156548384|NCT01049035|565100325|FG000|Overall Study|Other adverse event (AE)|0|||
156548385|NCT01049035|565100326|FG001|Overall Study|Other adverse event (AE)|0|||
156548386|NCT01049035|565100327|FG002|Overall Study|Other adverse event (AE)|0|||
156548387|NCT01049035|565100328|FG003|Overall Study|Other adverse event (AE)|1|||
156548388|NCT01049035|565100329|FG004|Overall Study|Other adverse event (AE)|0|||
156548389|NCT01049035|565100330|FG005|Overall Study|Other adverse event (AE)|0|||
156548390|NCT01049035|565100331|FG006|Overall Study|Other adverse event (AE)|0|||
156548391|NCT01049035|565100325|FG000|Overall Study|Non-compliance with the protocol|12|||
156548392|NCT01049035|565100326|FG001|Overall Study|Non-compliance with the protocol|6|||
156548393|NCT01049035|565100327|FG002|Overall Study|Non-compliance with the protocol|14|||
156548394|NCT01049035|565100328|FG003|Overall Study|Non-compliance with the protocol|5|||
156548395|NCT01049035|565100329|FG004|Overall Study|Non-compliance with the protocol|3|||
156548396|NCT01049035|565100330|FG005|Overall Study|Non-compliance with the protocol|4|||
156548397|NCT01049035|565100331|FG006|Overall Study|Non-compliance with the protocol|10|||
156548398|NCT01049035|565100325|FG000|Overall Study|Lost to Follow-up|5|||
156548399|NCT01049035|565100326|FG001|Overall Study|Lost to Follow-up|4|||
156548400|NCT01049035|565100327|FG002|Overall Study|Lost to Follow-up|4|||
156548401|NCT01049035|565100328|FG003|Overall Study|Lost to Follow-up|1|||
156548402|NCT01049035|565100329|FG004|Overall Study|Lost to Follow-up|0|||
156548403|NCT01049035|565100330|FG005|Overall Study|Lost to Follow-up|3|||
156548404|NCT01049035|565100331|FG006|Overall Study|Lost to Follow-up|3|||
156548405|NCT01049035|565100325|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
156548406|NCT01049035|565100326|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
156548407|NCT01049035|565100327|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
156548408|NCT01049035|565100328|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
156548409|NCT01049035|565100329|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
156548410|NCT01049035|565100330|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
156548411|NCT01049035|565100331|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
156548412|NCT03548051|565100333|FG000|Overall Study|Death|1|||
156548413|NCT03548051|565100334|FG001|Overall Study|Death|1|||
156548414|NCT03548051|565100333|FG000|Overall Study|Withdrawal by Subject|1|||
156548415|NCT03548051|565100334|FG001|Overall Study|Withdrawal by Subject|0|||
156548416|NCT00817531|565100336|FG000|Overall Study|Adverse Event|1|||
156548417|NCT00817531|565100336|FG000|Overall Study|Lack of Efficacy|1|||
156548418|NCT00812214|565100337|FG000|Overall Study|Lost to Follow-up|3|||
156548419|NCT00812214|565100338|FG001|Overall Study|Lost to Follow-up|1|||
156548420|NCT03325673|565100339|FG000|Overall Study|Adverse Event|4|||
156548421|NCT03325673|565100340|FG001|Overall Study|Adverse Event|0|||
156548422|NCT03189446|565100341|FG000|Overall Study|Adverse Event|2|||
156548423|NCT03189446|565100341|FG000|Overall Study|Withdrawal by Subject|2|||
156548424|NCT03189446|565100341|FG000|Overall Study|Physician Decision|1|||
156548425|NCT05594173|565100342|FG000|Overall Study|Adverse Event|1|||
156548426|NCT05594173|565100342|FG000|Overall Study|COVID-19 Pandemic|2|||
156548427|NCT00883337|565100343|FG000|Core Treatment Period|Adverse Event|9|||
156548428|NCT00883337|565100344|FG001|Core Treatment Period|Adverse Event|12|||
156391081|NCT02085408|564523569|FG001|Step 3: Maintenance|Death|2|||
156391082|NCT02085408|564523568|FG000|Step 3: Maintenance|Alternative Therapy|1|||
156391083|NCT02085408|564523569|FG001|Step 3: Maintenance|Alternative Therapy|1|||
156391084|NCT02085408|564523568|FG000|Step 3: Maintenance|Complicating Disease|0|||
156548429|NCT00883337|565100345|FG002|Core Treatment Period|Adverse Event|22|||
156548430|NCT00883337|565100343|FG000|Core Treatment Period|Lack of Efficacy|7|||
156548431|NCT00883337|565100344|FG001|Core Treatment Period|Lack of Efficacy|4|||
156548432|NCT00883337|565100345|FG002|Core Treatment Period|Lack of Efficacy|2|||
156548433|NCT00883337|565100343|FG000|Core Treatment Period|Lost to Follow-up|1|||
156548434|NCT00883337|565100344|FG001|Core Treatment Period|Lost to Follow-up|1|||
156548435|NCT00883337|565100345|FG002|Core Treatment Period|Lost to Follow-up|0|||
156548436|NCT00883337|565100343|FG000|Core Treatment Period|Withdrawal by Subject|2|||
156548437|NCT00883337|565100344|FG001|Core Treatment Period|Withdrawal by Subject|2|||
156548438|NCT00883337|565100345|FG002|Core Treatment Period|Withdrawal by Subject|6|||
156548439|NCT00883337|565100343|FG000|Core Treatment Period|Wish to be pregnant|1|||
156548440|NCT00883337|565100344|FG001|Core Treatment Period|Wish to be pregnant|2|||
156548441|NCT00883337|565100345|FG002|Core Treatment Period|Wish to be pregnant|1|||
156548442|NCT00883337|565100343|FG000|Core Treatment Period|Poor compliance to protocol|0|||
156548443|NCT00883337|565100344|FG001|Core Treatment Period|Poor compliance to protocol|0|||
156548444|NCT00883337|565100345|FG002|Core Treatment Period|Poor compliance to protocol|1|||
156548445|NCT00883337|565100343|FG000|Core Treatment Period|Other than above|0|||
156548446|NCT00883337|565100344|FG001|Core Treatment Period|Other than above|1|||
156548447|NCT00883337|565100345|FG002|Core Treatment Period|Other than above|1|||
156548448|NCT00883337|565100343|FG000|Extension Treatment Period|Adverse Event|8|||
156548449|NCT00883337|565100344|FG001|Extension Treatment Period|Adverse Event|5|||
156548450|NCT00883337|565100345|FG002|Extension Treatment Period|Adverse Event|5|||
156548451|NCT00883337|565100343|FG000|Extension Treatment Period|Lack of Efficacy|8|||
156548452|NCT00883337|565100344|FG001|Extension Treatment Period|Lack of Efficacy|8|||
156548453|NCT00883337|565100345|FG002|Extension Treatment Period|Lack of Efficacy|8|||
156548454|NCT00883337|565100343|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
156548455|NCT00883337|565100344|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
156548456|NCT00883337|565100345|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
156548457|NCT00883337|565100343|FG000|Extension Treatment Period|Lost to Follow-up|1|||
156548458|NCT00883337|565100344|FG001|Extension Treatment Period|Lost to Follow-up|0|||
156548459|NCT00883337|565100345|FG002|Extension Treatment Period|Lost to Follow-up|0|||
156548460|NCT00883337|565100343|FG000|Extension Treatment Period|Other than above|10|||
156548461|NCT00883337|565100344|FG001|Extension Treatment Period|Other than above|9|||
156548462|NCT00883337|565100345|FG002|Extension Treatment Period|Other than above|5|||
156548463|NCT00763139|565100346|FG000|Overall Study|Adverse Event|4|||
156548464|NCT00763139|565100347|FG001|Overall Study|Adverse Event|2|||
156548465|NCT00763139|565100346|FG000|Overall Study|Withdrawal by Subject|0|||
156548466|NCT00763139|565100347|FG001|Overall Study|Withdrawal by Subject|1|||
156548467|NCT00763139|565100346|FG000|Overall Study|med change not allowed by protocol|1|||
156548468|NCT00763139|565100347|FG001|Overall Study|med change not allowed by protocol|0|||
156548469|NCT03468309|565100348|FG000|Overall Study|Lost to Follow-up|4|||
156548470|NCT03468309|565100348|FG000|Overall Study|Withdrawal by Subject|2|||
156548471|NCT00713700|565100349|FG000|Overall Study|Lost to Follow-up|3|||
156548472|NCT00713700|565100349|FG000|Overall Study|Withdrawal by Subject|1|||
156548473|NCT02669017|565100350|FG000|Overall Study|Death|1|||
156548474|NCT02669017|565100351|FG001|Overall Study|Death|2|||
156548475|NCT02669017|565100352|FG002|Overall Study|Death|2|||
156548476|NCT02669017|565100353|FG003|Overall Study|Death|3|||
156548477|NCT02669017|565100354|FG004|Overall Study|Death|8|||
156548478|NCT02669017|565100355|FG005|Overall Study|Death|18|||
156548479|NCT02669017|565100356|FG006|Overall Study|Death|10|||
156548480|NCT02669017|565100357|FG007|Overall Study|Death|47|||
156548481|NCT02669017|565100358|FG008|Overall Study|Death|20|||
156548482|NCT02669017|565100350|FG000|Overall Study|Withdrawal by Subject|0|||
156548483|NCT02669017|565100351|FG001|Overall Study|Withdrawal by Subject|0|||
156391085|NCT02085408|564523569|FG001|Step 3: Maintenance|Complicating Disease|1|||
156391086|NCT02085408|564523568|FG000|Step 3: Maintenance|Other|3|||
156391087|NCT02085408|564523569|FG001|Step 3: Maintenance|Other|2|||
156391088|NCT02085408|564523568|FG000|Step 3: Maintenance|Never started treatment|5|||
156391089|NCT02085408|564523569|FG001|Step 3: Maintenance|Never started treatment|1|||
156391090|NCT02189798|564523570|FG000|Extended Use Phase|Withdrawal by Subject|0|||
156548484|NCT02669017|565100352|FG002|Overall Study|Withdrawal by Subject|0|||
156548485|NCT02669017|565100353|FG003|Overall Study|Withdrawal by Subject|1|||
156548486|NCT02669017|565100354|FG004|Overall Study|Withdrawal by Subject|2|||
156391091|NCT02189798|564523571|FG001|Extended Use Phase|Withdrawal by Subject|4|||
156391092|NCT02189798|564523570|FG000|Extended Use Phase|Physician Decision|1|||
156391093|NCT02189798|564523571|FG001|Extended Use Phase|Physician Decision|0|||
156391094|NCT02189798|564523570|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
156391095|NCT02189798|564523571|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
156391096|NCT02189798|564523570|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
156391097|NCT02189798|564523571|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
156391098|NCT02189798|564523570|FG000|Extended Use Phase|Travel Issues|2|||
156391099|NCT02189798|564523571|FG001|Extended Use Phase|Travel Issues|1|||
156391100|NCT02189798|564523570|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
156391101|NCT02189798|564523571|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
156391102|NCT00529399|564523576|FG000|Overall Study|Lost to Follow-up|1|||
156391103|NCT00529399|564523577|FG001|Overall Study|Lost to Follow-up|0|||
156391104|NCT00529399|564523578|FG002|Overall Study|Lost to Follow-up|1|||
156391105|NCT00529399|564523576|FG000|Overall Study|Withdrawal by Subject|1|||
156391106|NCT00529399|564523577|FG001|Overall Study|Withdrawal by Subject|0|||
156391107|NCT00529399|564523578|FG002|Overall Study|Withdrawal by Subject|1|||
156548487|NCT02669017|565100355|FG005|Overall Study|Withdrawal by Subject|0|||
156391108|NCT00529399|564523576|FG000|Overall Study|Non-compliant|0|||
156391109|NCT00529399|564523577|FG001|Overall Study|Non-compliant|1|||
156391110|NCT00529399|564523578|FG002|Overall Study|Non-compliant|0|||
156508591|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
156508592|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
156508593|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
156508594|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
156508595|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
156508596|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
156508597|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
156508598|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
156508599|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
156508600|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
156508601|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
156508602|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
156508603|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
156508604|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
156508605|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
156508606|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
156508607|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
156508608|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
156508609|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
156508610|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
156508611|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
156508612|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
156508613|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
156508614|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
156508615|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
156508616|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
156508617|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
156508618|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
156508619|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
156508620|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
156508621|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
156508622|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508623|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508624|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508625|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508626|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508627|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508628|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508629|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
156508630|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508631|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508632|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508633|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
156508634|NCT01646177|564955505|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508635|NCT01646177|564955506|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508636|NCT01646177|564955507|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508637|NCT01646177|564955508|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508638|NCT01646177|564955509|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508639|NCT01646177|564955510|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
156508640|NCT01646177|564955511|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
156508641|NCT01646177|564955512|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
156508642|NCT01646177|564955513|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508643|NCT01646177|564955514|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508644|NCT01646177|564955515|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508645|NCT01646177|564955516|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
156508646|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
156508647|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
156508648|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
156508649|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
156508650|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
156508651|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
156508652|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
156508653|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
156508654|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
156391111|NCT03695172|564523579|FG000|Overall Study|Withdrawal by Subject|1|||
156391112|NCT03695172|564523580|FG001|Overall Study|Withdrawal by Subject|1|||
156391113|NCT03695172|564523581|FG002|Overall Study|Withdrawal by Subject|0|||
156391114|NCT01474681|564523596|FG000|Overall Study|Death|0|||
156391115|NCT01474681|564523597|FG001|Overall Study|Death|3|||
156391116|NCT01474681|564523598|FG002|Overall Study|Death|2|||
156391117|NCT01474681|564523599|FG003|Overall Study|Death|6|||
156391118|NCT03998618|564523602|FG000|Overall Study|Death|7|||
156391119|NCT03998618|564523603|FG001|Overall Study|Death|11|||
156391120|NCT03998618|564523602|FG000|Overall Study|hospice enrollment|3|||
156391121|NCT03998618|564523603|FG001|Overall Study|hospice enrollment|3|||
156391122|NCT03998618|564523602|FG000|Overall Study|Not feeling well/health problems|3|||
156391123|NCT03998618|564523603|FG001|Overall Study|Not feeling well/health problems|5|||
156391124|NCT03998618|564523602|FG000|Overall Study|Lost to Follow-up|6|||
156391125|NCT03998618|564523603|FG001|Overall Study|Lost to Follow-up|6|||
156391126|NCT03998618|564523602|FG000|Overall Study|Withdrawal by Subject|0|||
156391127|NCT03998618|564523603|FG001|Overall Study|Withdrawal by Subject|4|||
156391128|NCT01483924|564523604|FG000|Overall Study|Withdrawal by Subject|2|||
156391129|NCT01483924|564523605|FG001|Overall Study|Withdrawal by Subject|0|||
156391130|NCT01483924|564523606|FG002|Overall Study|Withdrawal by Subject|0|||
156391131|NCT01483924|564523607|FG003|Overall Study|Withdrawal by Subject|1|||
156391132|NCT01483924|564523608|FG004|Overall Study|Withdrawal by Subject|1|||
156391133|NCT01483924|564523604|FG000|Overall Study|Adverse Event|0|||
156391134|NCT01483924|564523605|FG001|Overall Study|Adverse Event|0|||
156391135|NCT01483924|564523606|FG002|Overall Study|Adverse Event|1|||
156391136|NCT01483924|564523607|FG003|Overall Study|Adverse Event|1|||
156391137|NCT01483924|564523608|FG004|Overall Study|Adverse Event|0|||
156391138|NCT01483924|564523604|FG000|Overall Study|Non-compliance|0|||
156391139|NCT01483924|564523605|FG001|Overall Study|Non-compliance|0|||
156391140|NCT01483924|564523606|FG002|Overall Study|Non-compliance|0|||
156391141|NCT01483924|564523607|FG003|Overall Study|Non-compliance|1|||
156391142|NCT01483924|564523608|FG004|Overall Study|Non-compliance|1|||
156391143|NCT01483924|564523604|FG000|Overall Study|Sponsor concern over ECG result|0|||
156391144|NCT01483924|564523605|FG001|Overall Study|Sponsor concern over ECG result|0|||
156391145|NCT01483924|564523606|FG002|Overall Study|Sponsor concern over ECG result|0|||
156391146|NCT01483924|564523607|FG003|Overall Study|Sponsor concern over ECG result|1|||
156391147|NCT01483924|564523608|FG004|Overall Study|Sponsor concern over ECG result|0|||
156391148|NCT00003298|564523609|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
156391149|NCT00003298|564523609|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
156391150|NCT00003298|564523609|FG000|Surgery|Unresectable at surgery|3|||
156391151|NCT00003298|564523609|FG000|Surgery|Progression before surgery|2|||
156391152|NCT00003298|564523609|FG000|Surgery|Unevaluable and off study|2|||
156391153|NCT00003298|564523609|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
156391154|NCT00003298|564523609|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
156391155|NCT00003298|564523609|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
156391156|NCT00003298|564523609|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
156391157|NCT00003298|564523609|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
156391158|NCT00003298|564523609|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
156391159|NCT00003298|564523609|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
156391160|NCT00003298|564523609|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
156391161|NCT00003298|564523609|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
156391162|NCT00003298|564523609|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
156391163|NCT00335322|564523611|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
156391164|NCT00335322|564523612|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
156391165|NCT00335322|564523613|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
156391166|NCT02576678|564523618|FG000|Overall Study|Adverse Event|0|||
156391167|NCT02576678|564523619|FG001|Overall Study|Adverse Event|0|||
156391168|NCT02576678|564523620|FG002|Overall Study|Adverse Event|2|||
156391169|NCT02576678|564523618|FG000|Overall Study|Withdrawal by Subject|3|||
156391170|NCT02576678|564523619|FG001|Overall Study|Withdrawal by Subject|1|||
156391171|NCT02576678|564523620|FG002|Overall Study|Withdrawal by Subject|2|||
156391172|NCT02576678|564523618|FG000|Overall Study|Lost to Follow-up|0|||
156391173|NCT02576678|564523619|FG001|Overall Study|Lost to Follow-up|0|||
156391174|NCT02576678|564523620|FG002|Overall Study|Lost to Follow-up|1|||
156391175|NCT02576678|564523618|FG000|Overall Study|Miscellaneous|2|||
156391176|NCT02576678|564523619|FG001|Overall Study|Miscellaneous|0|||
156391177|NCT02576678|564523620|FG002|Overall Study|Miscellaneous|0|||
156508655|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
156508656|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
156391178|NCT04330638|564523623|FG000|Overall Study|Adverse Event|9|||
156391179|NCT04330638|564523624|FG001|Overall Study|Adverse Event|10|||
156391180|NCT04330638|564523625|FG002|Overall Study|Adverse Event|15|||
156391181|NCT04330638|564523626|FG003|Overall Study|Adverse Event|6|||
156391182|NCT04330638|564523627|FG004|Overall Study|Adverse Event|10|||
156391183|NCT04330638|564523628|FG005|Overall Study|Adverse Event|5|||
156391184|NCT04330638|564523623|FG000|Overall Study|Other|2|||
156391185|NCT04330638|564523624|FG001|Overall Study|Other|2|||
156391186|NCT04330638|564523625|FG002|Overall Study|Other|5|||
156391187|NCT04330638|564523626|FG003|Overall Study|Other|1|||
156391188|NCT04330638|564523627|FG004|Overall Study|Other|3|||
156391189|NCT04330638|564523628|FG005|Overall Study|Other|2|||
156391190|NCT04330638|564523623|FG000|Overall Study|Withdrawal by Subject|4|||
156391191|NCT04330638|564523624|FG001|Overall Study|Withdrawal by Subject|0|||
156391192|NCT04330638|564523625|FG002|Overall Study|Withdrawal by Subject|0|||
156391193|NCT04330638|564523626|FG003|Overall Study|Withdrawal by Subject|0|||
156391194|NCT04330638|564523627|FG004|Overall Study|Withdrawal by Subject|0|||
156391195|NCT04330638|564523628|FG005|Overall Study|Withdrawal by Subject|0|||
156391196|NCT04330638|564523623|FG000|Overall Study|Lost to Follow-up|3|||
156391197|NCT04330638|564523624|FG001|Overall Study|Lost to Follow-up|2|||
156391198|NCT04330638|564523625|FG002|Overall Study|Lost to Follow-up|3|||
156391199|NCT04330638|564523626|FG003|Overall Study|Lost to Follow-up|2|||
156391200|NCT04330638|564523627|FG004|Overall Study|Lost to Follow-up|3|||
156391201|NCT04330638|564523628|FG005|Overall Study|Lost to Follow-up|0|||
156391202|NCT01988779|564523630|FG000|Overall Study|Withdrawal by Subject|2|||
156391203|NCT01988779|564523631|FG001|Overall Study|Withdrawal by Subject|2|||
156391204|NCT01988779|564523630|FG000|Overall Study|Protocol Violation|1|||
156391205|NCT01988779|564523631|FG001|Overall Study|Protocol Violation|0|||
156391206|NCT02275065|564523632|FG000|Overall Study|Randomized but not treated|1|||
156391207|NCT02275065|564523633|FG001|Overall Study|Randomized but not treated|0|||
156391208|NCT02275065|564523634|FG002|Overall Study|Randomized but not treated|1|||
156391209|NCT02275065|564523635|FG003|Overall Study|Randomized but not treated|1|||
156391210|NCT02275065|564523636|FG004|Overall Study|Randomized but not treated|0|||
156391211|NCT00417079|564523638|FG000|Overall Study|Disease progression|267|||
156391212|NCT00417079|564523639|FG001|Overall Study|Disease progression|180|||
156391213|NCT00417079|564523638|FG000|Overall Study|Adverse Event|32|||
156391214|NCT00417079|564523639|FG001|Overall Study|Adverse Event|67|||
156391215|NCT00417079|564523638|FG000|Overall Study|Non-compliance to protocol|0|||
156391216|NCT00417079|564523639|FG001|Overall Study|Non-compliance to protocol|1|||
156391217|NCT00417079|564523638|FG000|Overall Study|Lost to Follow-up|2|||
156391218|NCT00417079|564523639|FG001|Overall Study|Lost to Follow-up|0|||
156391219|NCT00417079|564523638|FG000|Overall Study|Withdrawal by Subject|17|||
156391220|NCT00417079|564523639|FG001|Overall Study|Withdrawal by Subject|8|||
156391221|NCT00417079|564523638|FG000|Overall Study|Not treated|6|||
156391222|NCT00417079|564523639|FG001|Overall Study|Not treated|7|||
156391223|NCT00417079|564523638|FG000|Overall Study|Screened failure|2|||
156391224|NCT00417079|564523639|FG001|Overall Study|Screened failure|1|||
156391225|NCT00417079|564523638|FG000|Overall Study|Investigator's decision|1|||
156391226|NCT00417079|564523639|FG001|Overall Study|Investigator's decision|4|||
156391227|NCT00417079|564523638|FG000|Overall Study|Non-confirmed Disease progression|1|||
156391228|NCT00417079|564523639|FG001|Overall Study|Non-confirmed Disease progression|1|||
156391229|NCT00417079|564523638|FG000|Overall Study|Clinical deterioration|1|||
156391230|NCT00417079|564523639|FG001|Overall Study|Clinical deterioration|0|||
156391231|NCT00417079|564523638|FG000|Overall Study|Screening error|2|||
156391232|NCT00417079|564523639|FG001|Overall Study|Screening error|1|||
156391233|NCT00417079|564523638|FG000|Overall Study|Withdrawal by subject's family|0|||
156391234|NCT00417079|564523639|FG001|Overall Study|Withdrawal by subject's family|1|||
156391235|NCT00417079|564523638|FG000|Overall Study|Patient unable to come to the clinic|0|||
156391236|NCT00417079|564523639|FG001|Overall Study|Patient unable to come to the clinic|1|||
156391237|NCT00417079|564523638|FG000|Overall Study|abnormal liver function tests|0|||
156391238|NCT00417079|564523639|FG001|Overall Study|abnormal liver function tests|1|||
156391239|NCT01687257|564523641|FG000|Overall Study|Efficacy Failure|6|||
156391240|NCT01687257|564523642|FG001|Overall Study|Efficacy Failure|0|||
156391241|NCT01687257|564523643|FG002|Overall Study|Efficacy Failure|5|||
156391242|NCT01687257|564523641|FG000|Overall Study|Subject Withdrew Consent|1|||
156391243|NCT01687257|564523642|FG001|Overall Study|Subject Withdrew Consent|1|||
156391244|NCT01687257|564523643|FG002|Overall Study|Subject Withdrew Consent|1|||
156391245|NCT01687257|564523641|FG000|Overall Study|Adverse Event|1|||
156391246|NCT01687257|564523642|FG001|Overall Study|Adverse Event|0|||
156391247|NCT01687257|564523643|FG002|Overall Study|Adverse Event|0|||
156391248|NCT01687257|564523641|FG000|Overall Study|Investigator's Discretion|0|||
156391249|NCT01687257|564523642|FG001|Overall Study|Investigator's Discretion|3|||
156391250|NCT01687257|564523643|FG002|Overall Study|Investigator's Discretion|0|||
156391251|NCT01922076|564523644|FG000|Overall Study|Adverse Event|0|||
156391252|NCT01922076|564523645|FG001|Overall Study|Adverse Event|0|||
156391253|NCT01922076|564523646|FG002|Overall Study|Adverse Event|0|||
156391254|NCT01922076|564523647|FG003|Overall Study|Adverse Event|0|||
156391255|NCT01922076|564523648|FG004|Overall Study|Adverse Event|1|||
156391256|NCT01922076|564523649|FG005|Overall Study|Adverse Event|0|||
156391257|NCT01922076|564523650|FG006|Overall Study|Adverse Event|0|||
156391258|NCT01922076|564523644|FG000|Overall Study|Physician Decision|0|||
156391259|NCT01922076|564523645|FG001|Overall Study|Physician Decision|0|||
156391260|NCT01922076|564523646|FG002|Overall Study|Physician Decision|1|||
156391261|NCT01922076|564523647|FG003|Overall Study|Physician Decision|0|||
156391262|NCT01922076|564523648|FG004|Overall Study|Physician Decision|0|||
156391263|NCT01922076|564523649|FG005|Overall Study|Physician Decision|0|||
156391264|NCT01922076|564523650|FG006|Overall Study|Physician Decision|0|||
156391265|NCT01922076|564523644|FG000|Overall Study|Withdrawal by Subject|0|||
156391266|NCT01922076|564523645|FG001|Overall Study|Withdrawal by Subject|0|||
156391267|NCT01922076|564523646|FG002|Overall Study|Withdrawal by Subject|0|||
156391268|NCT01922076|564523647|FG003|Overall Study|Withdrawal by Subject|1|||
156391269|NCT01922076|564523648|FG004|Overall Study|Withdrawal by Subject|0|||
156391270|NCT01922076|564523649|FG005|Overall Study|Withdrawal by Subject|1|||
156391271|NCT01922076|564523650|FG006|Overall Study|Withdrawal by Subject|1|||
156391272|NCT04899349|564523658|FG000|Overall Study|Study terminated by Sponsor|2|||
156391273|NCT04899349|564523659|FG001|Overall Study|Study terminated by Sponsor|0|||
156391274|NCT01018394|564523660|FG000|Overall Study|Withdrawal by Subject|5|||
156391275|NCT01018394|564523661|FG001|Overall Study|Withdrawal by Subject|5|||
156391276|NCT01018394|564523660|FG000|Overall Study|Lost to Follow-up|4|||
156391277|NCT01018394|564523661|FG001|Overall Study|Lost to Follow-up|3|||
156391278|NCT00683644|564523662|FG000|Overall Study|Withdrawal by Subject|4|||
156391279|NCT00683644|564523663|FG001|Overall Study|Withdrawal by Subject|2|||
156391280|NCT00683644|564523662|FG000|Overall Study|Lost to Follow-up|1|||
156391281|NCT00683644|564523663|FG001|Overall Study|Lost to Follow-up|4|||
156391282|NCT00683644|564523662|FG000|Overall Study|Adverse Event|1|||
156391283|NCT00683644|564523663|FG001|Overall Study|Adverse Event|2|||
156391284|NCT00683644|564523662|FG000|Overall Study|Low copper, other health problems,|7|||
156391285|NCT00683644|564523663|FG001|Overall Study|Low copper, other health problems,|6|||
156391286|NCT03240692|564523664|FG000|Overall Study|Physician Decision|1|||
156391287|NCT03240692|564523664|FG000|Overall Study|Withdrawal by Subject|1|||
156391288|NCT00617344|564523666|FG000|Overall Study|Serious adverse event|1|||
156391289|NCT00617344|564523667|FG001|Overall Study|Serious adverse event|0|||
156391290|NCT00617344|564523668|FG002|Overall Study|Serious adverse event|0|||
156391291|NCT00617344|564523666|FG000|Overall Study|Other Adverse Event|1|||
156391292|NCT00617344|564523667|FG001|Overall Study|Other Adverse Event|1|||
156391293|NCT00617344|564523668|FG002|Overall Study|Other Adverse Event|0|||
156391294|NCT00617344|564523666|FG000|Overall Study|Protocol Violation|10|||
156391295|NCT00617344|564523667|FG001|Overall Study|Protocol Violation|8|||
156391296|NCT00617344|564523668|FG002|Overall Study|Protocol Violation|5|||
156391297|NCT00617344|564523666|FG000|Overall Study|Lost to Follow-up|5|||
156391298|NCT00617344|564523667|FG001|Overall Study|Lost to Follow-up|4|||
156391299|NCT00617344|564523668|FG002|Overall Study|Lost to Follow-up|1|||
156391300|NCT00617344|564523666|FG000|Overall Study|Withdrawal by Subject|8|||
156391301|NCT00617344|564523667|FG001|Overall Study|Withdrawal by Subject|9|||
156391302|NCT00617344|564523668|FG002|Overall Study|Withdrawal by Subject|2|||
156391303|NCT01986881|564525635|FG000|Overall Study|Death|228|||
156391304|NCT01986881|564525636|FG001|Overall Study|Death|233|||
156391305|NCT01986881|564525637|FG002|Overall Study|Death|247|||
156391306|NCT01986881|564525635|FG000|Overall Study|Lost to Follow-up|51|||
156391307|NCT01986881|564525636|FG001|Overall Study|Lost to Follow-up|44|||
156391308|NCT01986881|564525637|FG002|Overall Study|Lost to Follow-up|55|||
156391309|NCT01986881|564525635|FG000|Overall Study|Physician Decision|7|||
156391310|NCT01986881|564525636|FG001|Overall Study|Physician Decision|4|||
156391311|NCT01986881|564525637|FG002|Overall Study|Physician Decision|6|||
156391312|NCT01986881|564525635|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
156391313|NCT01986881|564525636|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
156391314|NCT01986881|564525637|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
156391315|NCT01986881|564525635|FG000|Overall Study|Withdrawal by Subject|41|||
156391316|NCT01986881|564525636|FG001|Overall Study|Withdrawal by Subject|60|||
156391317|NCT01986881|564525637|FG002|Overall Study|Withdrawal by Subject|45|||
156391318|NCT01986881|564525635|FG000|Overall Study|Subject Moved|0|||
156391319|NCT01986881|564525636|FG001|Overall Study|Subject Moved|1|||
156391320|NCT01986881|564525637|FG002|Overall Study|Subject Moved|0|||
156391321|NCT01986881|564525635|FG000|Overall Study|Other|1|||
156391322|NCT01986881|564525636|FG001|Overall Study|Other|2|||
156391323|NCT01986881|564525637|FG002|Overall Study|Other|2|||
156391324|NCT01258608|564525638|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
156391325|NCT01258608|564525639|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
156391326|NCT01258608|564525638|FG000|Overall Study|Clinical progression|1|||
156391327|NCT01258608|564525639|FG001|Overall Study|Clinical progression|0|||
156391328|NCT01258608|564525638|FG000|Overall Study|Sponsor decision|0|||
156391329|NCT01258608|564525639|FG001|Overall Study|Sponsor decision|1|||
156391330|NCT01258608|564525638|FG000|Overall Study|Physician Decision|6|||
156391331|NCT01258608|564525639|FG001|Overall Study|Physician Decision|1|||
156391332|NCT01258608|564525638|FG000|Overall Study|Lost to Follow-up|0|||
156391333|NCT01258608|564525639|FG001|Overall Study|Lost to Follow-up|1|||
156391334|NCT01258608|564525638|FG000|Overall Study|Lack of compliance|1|||
156391335|NCT01258608|564525639|FG001|Overall Study|Lack of compliance|0|||
156391336|NCT01258608|564525638|FG000|Overall Study|Lack of Efficacy|0|||
156391337|NCT01258608|564525639|FG001|Overall Study|Lack of Efficacy|1|||
156391338|NCT01258608|564525638|FG000|Overall Study|Adverse Event|6|||
156391339|NCT01258608|564525639|FG001|Overall Study|Adverse Event|10|||
156391340|NCT01258608|564525638|FG000|Overall Study|Withdrawal by Subject|6|||
156391341|NCT01258608|564525639|FG001|Overall Study|Withdrawal by Subject|5|||
156391342|NCT04205630|564525640|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
156391343|NCT04205630|564525640|FG000|Overall Study|Disease clinical progression|7|||
156391344|NCT04205630|564525640|FG000|Overall Study|Withdrawal by Subject|2|||
156391345|NCT04205630|564525640|FG000|Overall Study|Adverse Event|17|||
156391346|NCT04205630|564525640|FG000|Overall Study|Other|1|||
156391347|NCT02943408|564525646|FG000|Overall Study|Lost to Follow-up|7|||
156391348|NCT02943408|564525647|FG001|Overall Study|Lost to Follow-up|1|||
156391349|NCT02943408|564525646|FG000|Overall Study|Withdrawal by Subject|0|||
156391350|NCT02943408|564525647|FG001|Overall Study|Withdrawal by Subject|1|||
156391351|NCT01621126|564525650|FG000|Overall Study|Physician Decision|6|||
156391352|NCT00886340|564525651|FG000|Overall Study|Withdrawal by Subject|0|||
156391353|NCT00886340|564525652|FG001|Overall Study|Withdrawal by Subject|7|||
156391354|NCT03751631|564525653|FG000|Overall Study|Withdrawal by Subject|0|||
156391355|NCT03751631|564525654|FG001|Overall Study|Withdrawal by Subject|0|||
156391356|NCT03751631|564525655|FG002|Overall Study|Withdrawal by Subject|1|||
156391357|NCT03751631|564525656|FG003|Overall Study|Withdrawal by Subject|1|||
156391358|NCT03751631|564525657|FG004|Overall Study|Withdrawal by Subject|0|||
156391359|NCT03751631|564525658|FG005|Overall Study|Withdrawal by Subject|0|||
156391360|NCT03224182|564525659|FG000|Overall Study|Study Drug Not Instilled|6|||
156391361|NCT03224182|564525660|FG001|Overall Study|Study Drug Not Instilled|1|||
156391362|NCT03224182|564525659|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
156391363|NCT03224182|564525660|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
156391364|NCT03224182|564525659|FG000|Overall Study|Withdrew of Consent|4|||
156391365|NCT03224182|564525660|FG001|Overall Study|Withdrew of Consent|2|||
156391366|NCT03224182|564525659|FG000|Overall Study|Investigator Decision|3|||
156391367|NCT03224182|564525660|FG001|Overall Study|Investigator Decision|1|||
156391368|NCT03224182|564525659|FG000|Overall Study|Sponsor Decision|26|||
156391369|NCT03224182|564525660|FG001|Overall Study|Sponsor Decision|12|||
156391370|NCT03224182|564525659|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
156391371|NCT03224182|564525660|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
156391372|NCT03224182|564525659|FG000|Overall Study|Lost to Follow-up|1|||
156391373|NCT03224182|564525660|FG001|Overall Study|Lost to Follow-up|0|||
156391374|NCT03224182|564525659|FG000|Overall Study|Participant Had Recurrence|11|||
156391375|NCT03224182|564525660|FG001|Overall Study|Participant Had Recurrence|5|||
156391376|NCT03224182|564525659|FG000|Overall Study|Death|0|||
156391377|NCT03224182|564525660|FG001|Overall Study|Death|1|||
156391378|NCT03224182|564525659|FG000|Overall Study|Reason not Specified|3|||
156391379|NCT03224182|564525660|FG001|Overall Study|Reason not Specified|3|||
156391380|NCT03224182|564525659|FG000|Overall Study|Other|1|||
156391381|NCT03224182|564525660|FG001|Overall Study|Other|0|||
156391382|NCT00447057|564525663|FG000|Overall Study|Adverse Event|4|||
156391383|NCT00447057|564525664|FG001|Overall Study|Adverse Event|10|||
156391384|NCT00447057|564525665|FG002|Overall Study|Adverse Event|0|||
156391385|NCT00447057|564525666|FG003|Overall Study|Adverse Event|3|||
156391386|NCT00447057|564525663|FG000|Overall Study|Death due to study disease|6|||
156391387|NCT00447057|564525664|FG001|Overall Study|Death due to study disease|4|||
156391388|NCT00447057|564525665|FG002|Overall Study|Death due to study disease|1|||
156391389|NCT00447057|564525666|FG003|Overall Study|Death due to study disease|1|||
156391390|NCT00447057|564525663|FG000|Overall Study|Lost to Follow-up|0|||
156391391|NCT00447057|564525664|FG001|Overall Study|Lost to Follow-up|1|||
156391392|NCT00447057|564525665|FG002|Overall Study|Lost to Follow-up|0|||
156391393|NCT00447057|564525666|FG003|Overall Study|Lost to Follow-up|0|||
156391394|NCT00447057|564525663|FG000|Overall Study|Entry criteria not met|1|||
156391395|NCT00447057|564525664|FG001|Overall Study|Entry criteria not met|1|||
156391396|NCT00447057|564525665|FG002|Overall Study|Entry criteria not met|0|||
156391397|NCT00447057|564525666|FG003|Overall Study|Entry criteria not met|0|||
156391398|NCT00447057|564525663|FG000|Overall Study|Protocol Violation|0|||
156391399|NCT00447057|564525664|FG001|Overall Study|Protocol Violation|1|||
156391400|NCT00447057|564525665|FG002|Overall Study|Protocol Violation|0|||
156391401|NCT00447057|564525666|FG003|Overall Study|Protocol Violation|0|||
156391402|NCT00447057|564525663|FG000|Overall Study|Withdrawal by Subject|4|||
156391403|NCT00447057|564525664|FG001|Overall Study|Withdrawal by Subject|5|||
156391404|NCT00447057|564525665|FG002|Overall Study|Withdrawal by Subject|1|||
156391405|NCT00447057|564525666|FG003|Overall Study|Withdrawal by Subject|1|||
156391406|NCT00447057|564525663|FG000|Overall Study|Physician Decision|9|||
156391407|NCT00447057|564525664|FG001|Overall Study|Physician Decision|6|||
156391408|NCT00447057|564525665|FG002|Overall Study|Physician Decision|3|||
156391409|NCT00447057|564525666|FG003|Overall Study|Physician Decision|1|||
156391410|NCT00447057|564525663|FG000|Overall Study|Sponsor decision|1|||
156391411|NCT00447057|564525664|FG001|Overall Study|Sponsor decision|1|||
156391412|NCT00447057|564525665|FG002|Overall Study|Sponsor decision|0|||
156391413|NCT00447057|564525666|FG003|Overall Study|Sponsor decision|0|||
156391414|NCT00447057|564525663|FG000|Overall Study|Progressive disease|58|||
156391415|NCT00447057|564525664|FG001|Overall Study|Progressive disease|43|||
156391416|NCT00447057|564525665|FG002|Overall Study|Progressive disease|13|||
156391417|NCT00447057|564525666|FG003|Overall Study|Progressive disease|18|||
156391418|NCT00447057|564525663|FG000|Overall Study|Death due to adverse event|0|||
156391419|NCT00447057|564525664|FG001|Overall Study|Death due to adverse event|0|||
156391420|NCT00447057|564525665|FG002|Overall Study|Death due to adverse event|1|||
156391421|NCT00447057|564525666|FG003|Overall Study|Death due to adverse event|2|||
156391422|NCT00447057|564525663|FG000|Overall Study|Death, study drug related|0|||
156391423|NCT00447057|564525664|FG001|Overall Study|Death, study drug related|1|||
156391424|NCT00447057|564525665|FG002|Overall Study|Death, study drug related|0|||
156391425|NCT00447057|564525666|FG003|Overall Study|Death, study drug related|0|||
156391426|NCT00677833|564525667|FG000|Overall Study|Withdrawal by Subject|4|||
156391427|NCT00677833|564525668|FG001|Overall Study|Withdrawal by Subject|0|||
156391428|NCT00677833|564525669|FG002|Overall Study|Withdrawal by Subject|1|||
156391429|NCT00677833|564525670|FG003|Overall Study|Withdrawal by Subject|3|||
156391430|NCT00677833|564525667|FG000|Overall Study|Lost to Follow-up|0|||
156391431|NCT00677833|564525668|FG001|Overall Study|Lost to Follow-up|0|||
156391432|NCT00677833|564525669|FG002|Overall Study|Lost to Follow-up|1|||
156391433|NCT00677833|564525670|FG003|Overall Study|Lost to Follow-up|0|||
156391434|NCT02606279|564525675|FG000|Overall Study|Lost to Follow-up|0|||
156391435|NCT02606279|564525676|FG001|Overall Study|Lost to Follow-up|1|||
156391436|NCT02184611|564525679|FG000|Overall Study|Lack of Efficacy|11|||
156391437|NCT02184611|564525680|FG001|Overall Study|Lack of Efficacy|15|||
156391438|NCT02184611|564525679|FG000|Overall Study|Withdrawal by Subject|5|||
156391439|NCT02184611|564525680|FG001|Overall Study|Withdrawal by Subject|6|||
156391440|NCT02184611|564525679|FG000|Overall Study|Adverse Event|4|||
156391441|NCT02184611|564525680|FG001|Overall Study|Adverse Event|5|||
156391442|NCT02184611|564525679|FG000|Overall Study|Protocol Violation|1|||
156391443|NCT02184611|564525680|FG001|Overall Study|Protocol Violation|1|||
156391444|NCT02184611|564525679|FG000|Overall Study|Protocol defined stopping criteria|0|||
156391445|NCT02184611|564525680|FG001|Overall Study|Protocol defined stopping criteria|1|||
156391446|NCT00160680|564525681|FG000|Overall Study|Adverse Event|0|||
156391447|NCT00160680|564525682|FG001|Overall Study|Adverse Event|1|||
156391448|NCT00160680|564525681|FG000|Overall Study|Lack of Efficacy|2|||
156391449|NCT00160680|564525682|FG001|Overall Study|Lack of Efficacy|1|||
156391450|NCT00160680|564525681|FG000|Overall Study|Lost to Follow-up|3|||
156391451|NCT00160680|564525682|FG001|Overall Study|Lost to Follow-up|2|||
156391452|NCT00160680|564525681|FG000|Overall Study|Withdrawal by Subject|4|||
156391453|NCT00160680|564525682|FG001|Overall Study|Withdrawal by Subject|9|||
156391454|NCT04493216|564525683|FG000|Overall Study|Study terminated by sponsor|30|||
156391455|NCT04493216|564525684|FG001|Overall Study|Study terminated by sponsor|33|||
156391456|NCT04493216|564525685|FG002|Overall Study|Study terminated by sponsor|28|||
156391457|NCT04493216|564525686|FG003|Overall Study|Study terminated by sponsor|27|||
156391458|NCT04493216|564525683|FG000|Overall Study|Withdrawal by Subject|2|||
156391459|NCT04493216|564525684|FG001|Overall Study|Withdrawal by Subject|1|||
156391460|NCT04493216|564525685|FG002|Overall Study|Withdrawal by Subject|1|||
156391461|NCT04493216|564525686|FG003|Overall Study|Withdrawal by Subject|2|||
156391462|NCT04493216|564525683|FG000|Overall Study|Protocol Violation|1|||
156391463|NCT04493216|564525684|FG001|Overall Study|Protocol Violation|2|||
156391464|NCT04493216|564525685|FG002|Overall Study|Protocol Violation|0|||
156391465|NCT04493216|564525686|FG003|Overall Study|Protocol Violation|2|||
156391466|NCT04493216|564525683|FG000|Overall Study|Physician Decision|0|||
156391467|NCT04493216|564525684|FG001|Overall Study|Physician Decision|0|||
156391468|NCT04493216|564525685|FG002|Overall Study|Physician Decision|1|||
156391469|NCT04493216|564525686|FG003|Overall Study|Physician Decision|0|||
156391470|NCT04493216|564525683|FG000|Overall Study|Lost to Follow-up|2|||
156391471|NCT04493216|564525684|FG001|Overall Study|Lost to Follow-up|1|||
156391472|NCT04493216|564525685|FG002|Overall Study|Lost to Follow-up|0|||
156391473|NCT04493216|564525686|FG003|Overall Study|Lost to Follow-up|1|||
156391474|NCT04493216|564525683|FG000|Overall Study|Adverse Event|1|||
156391475|NCT04493216|564525684|FG001|Overall Study|Adverse Event|4|||
156391476|NCT04493216|564525685|FG002|Overall Study|Adverse Event|5|||
156391477|NCT04493216|564525686|FG003|Overall Study|Adverse Event|2|||
156391478|NCT04493216|564525683|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
156391479|NCT04493216|564525684|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
156391480|NCT04493216|564525685|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
156391481|NCT04493216|564525686|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
156391482|NCT02583425|564525691|FG000|Screening|Did not meet entry criteria|12|||
156391483|NCT02583425|564525691|FG000|Baseline|Did not meet continued criteria|5|||
156391484|NCT02583425|564525691|FG000|Treatment Period|Adverse Event|1|||
156391485|NCT02216123|564525694|FG000|Overall Study|Lost to Follow-up|4|||
156391486|NCT02216123|564525695|FG001|Overall Study|Lost to Follow-up|2|||
156391487|NCT02216123|564525694|FG000|Overall Study|Withdrawal by Subject|2|||
156391488|NCT02216123|564525695|FG001|Overall Study|Withdrawal by Subject|0|||
156391489|NCT03232983|564525696|FG000|Period 1|Physician Decision|0|||
156391490|NCT03232983|564525697|FG001|Period 1|Physician Decision|0|||
156391491|NCT03232983|564525698|FG002|Period 1|Physician Decision|1|||
156391492|NCT03232983|564525699|FG003|Period 1|Physician Decision|0|||
156391493|NCT03232983|564525696|FG000|Washout Period 2|Physician Decision|0|||
156391494|NCT03232983|564525697|FG001|Washout Period 2|Physician Decision|0|||
156391495|NCT03232983|564525698|FG002|Washout Period 2|Physician Decision|1|||
156391496|NCT03232983|564525699|FG003|Washout Period 2|Physician Decision|0|||
156391497|NCT03232983|564525696|FG000|Washout Period 2|Withdrawal by Subject|0|||
156391498|NCT03232983|564525697|FG001|Washout Period 2|Withdrawal by Subject|0|||
156391499|NCT03232983|564525698|FG002|Washout Period 2|Withdrawal by Subject|0|||
156391500|NCT03232983|564525699|FG003|Washout Period 2|Withdrawal by Subject|1|||
156391501|NCT03232983|564525696|FG000|Period 4|Withdrawal by Subject|1|||
156391502|NCT03232983|564525697|FG001|Period 4|Withdrawal by Subject|0|||
156391503|NCT03232983|564525698|FG002|Period 4|Withdrawal by Subject|0|||
156391504|NCT03232983|564525699|FG003|Period 4|Withdrawal by Subject|0|||
156391505|NCT02261493|564525700|FG000|Overall Study|Noncompliance|0|||
156391506|NCT02261493|564525701|FG001|Overall Study|Noncompliance|0|||
156391507|NCT02261493|564525702|FG002|Overall Study|Noncompliance|2|||
156391508|NCT02261493|564525700|FG000|Overall Study|Physician Decision|0|||
156391509|NCT02261493|564525701|FG001|Overall Study|Physician Decision|1|||
156391510|NCT02261493|564525702|FG002|Overall Study|Physician Decision|0|||
156391511|NCT02261493|564525700|FG000|Overall Study|Undisclosed alcohol abuse|0|||
156391512|NCT02261493|564525701|FG001|Overall Study|Undisclosed alcohol abuse|1|||
156391513|NCT02261493|564525702|FG002|Overall Study|Undisclosed alcohol abuse|0|||
156391514|NCT02261493|564525700|FG000|Overall Study|Protocol Violation|1|||
156391515|NCT02261493|564525701|FG001|Overall Study|Protocol Violation|0|||
156391516|NCT02261493|564525702|FG002|Overall Study|Protocol Violation|0|||
156391517|NCT02261493|564525700|FG000|Overall Study|Personal Reasons|14|||
156391518|NCT02261493|564525701|FG001|Overall Study|Personal Reasons|14|||
156391519|NCT02261493|564525702|FG002|Overall Study|Personal Reasons|16|||
156391520|NCT02261493|564525700|FG000|Overall Study|Lost to Follow-up|14|||
156391521|NCT02261493|564525701|FG001|Overall Study|Lost to Follow-up|27|||
156391522|NCT02261493|564525702|FG002|Overall Study|Lost to Follow-up|8|||
156391523|NCT02261493|564525700|FG000|Overall Study|Pregnancy|1|||
156391524|NCT02261493|564525701|FG001|Overall Study|Pregnancy|2|||
156391525|NCT02261493|564525702|FG002|Overall Study|Pregnancy|0|||
156391526|NCT02261493|564525700|FG000|Overall Study|Lack of Efficacy|0|||
156391527|NCT02261493|564525701|FG001|Overall Study|Lack of Efficacy|1|||
156391528|NCT02261493|564525702|FG002|Overall Study|Lack of Efficacy|0|||
156391529|NCT02261493|564525700|FG000|Overall Study|Adverse Event|0|||
156391530|NCT02261493|564525701|FG001|Overall Study|Adverse Event|1|||
156391531|NCT02261493|564525702|FG002|Overall Study|Adverse Event|0|||
156391532|NCT01597050|564525703|FG000|Overall Study|Withdrawal by Subject|1|||
156391533|NCT01597050|564525704|FG001|Overall Study|Withdrawal by Subject|0|||
156391534|NCT00483184|564525705|FG000|Overall Study|Withdrawal by Subject|2|||
156391535|NCT00483184|564525706|FG001|Overall Study|Withdrawal by Subject|2|||
156391536|NCT00483184|564525707|FG002|Overall Study|Withdrawal by Subject|0|||
156391537|NCT00483184|564525705|FG000|Overall Study|Lost to Follow-up|1|||
156391538|NCT00483184|564525706|FG001|Overall Study|Lost to Follow-up|0|||
156391539|NCT00483184|564525707|FG002|Overall Study|Lost to Follow-up|0|||
156391540|NCT00483184|564525705|FG000|Overall Study|Adverse Event|1|||
156391541|NCT00483184|564525706|FG001|Overall Study|Adverse Event|2|||
156391542|NCT00483184|564525707|FG002|Overall Study|Adverse Event|2|||
156391543|NCT00483184|564525705|FG000|Overall Study|Protocol Violation|1|||
156391544|NCT00483184|564525706|FG001|Overall Study|Protocol Violation|0|||
156391545|NCT00483184|564525707|FG002|Overall Study|Protocol Violation|1|||
156391546|NCT02065336|564525708|FG000|Extension Phase|Study Terminated by Sponsor|0|||
156391547|NCT02065336|564525709|FG001|Extension Phase|Study Terminated by Sponsor|0|||
156391548|NCT02065336|564525710|FG002|Extension Phase|Study Terminated by Sponsor|0|||
156391549|NCT02065336|564525711|FG003|Extension Phase|Study Terminated by Sponsor|0|||
156391550|NCT02065336|564525712|FG004|Extension Phase|Study Terminated by Sponsor|0|||
156391551|NCT02065336|564525713|FG005|Extension Phase|Study Terminated by Sponsor|0|||
156391552|NCT02065336|564525714|FG006|Extension Phase|Study Terminated by Sponsor|0|||
156391553|NCT02065336|564525715|FG007|Extension Phase|Study Terminated by Sponsor|0|||
156391554|NCT02065336|564525716|FG008|Extension Phase|Study Terminated by Sponsor|2|||
156391555|NCT02065336|564525717|FG009|Extension Phase|Study Terminated by Sponsor|8|||
156391556|NCT00530855|564525718|FG000|Overall Study|Lack of Efficacy|20|||
156391557|NCT00530855|564525718|FG000|Overall Study|Withdrawal by Subject|30|||
156391558|NCT00530855|564525718|FG000|Overall Study|Fatal Serious AE|3|||
156391559|NCT00530855|564525718|FG000|Overall Study|Non Fatal Serious AE|7|||
156391560|NCT00530855|564525718|FG000|Overall Study|Non Fatal Non Serious AE|12|||
156391561|NCT00530855|564525718|FG000|Overall Study|Protocol Violation|3|||
156391562|NCT00530855|564525718|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
156391563|NCT00530855|564525718|FG000|Overall Study|Lost to Follow-up|9|||
156391564|NCT00530855|564525718|FG000|Overall Study|Other reason for premature termination|17|||
156391565|NCT00815295|564525719|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
156391566|NCT00815295|564525720|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
156391567|NCT00815295|564525721|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
156391568|NCT02794285|564525722|FG000|Overall Study|Adverse Event|11|||
156391569|NCT02794285|564525723|FG001|Overall Study|Adverse Event|4|||
156391570|NCT02794285|564525724|FG002|Overall Study|Adverse Event|5|||
156391571|NCT02794285|564525725|FG003|Overall Study|Adverse Event|8|||
156391572|NCT02794285|564525722|FG000|Overall Study|Condition Under Investigation Improved|1|||
156391573|NCT02794285|564525723|FG001|Overall Study|Condition Under Investigation Improved|0|||
156391574|NCT02794285|564525724|FG002|Overall Study|Condition Under Investigation Improved|0|||
156391575|NCT02794285|564525725|FG003|Overall Study|Condition Under Investigation Improved|0|||
156391576|NCT02794285|564525722|FG000|Overall Study|Condition Under Investigation Worsened|0|||
156391577|NCT02794285|564525723|FG001|Overall Study|Condition Under Investigation Worsened|2|||
156391578|NCT02794285|564525724|FG002|Overall Study|Condition Under Investigation Worsened|1|||
156391579|NCT02794285|564525725|FG003|Overall Study|Condition Under Investigation Worsened|0|||
156391580|NCT02794285|564525722|FG000|Overall Study|Death|2|||
156391581|NCT02794285|564525723|FG001|Overall Study|Death|1|||
156391582|NCT02794285|564525724|FG002|Overall Study|Death|2|||
156391583|NCT02794285|564525725|FG003|Overall Study|Death|0|||
156391584|NCT02794285|564525722|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
156391585|NCT02794285|564525723|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
156391586|NCT02794285|564525724|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
156391587|NCT02794285|564525725|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
156391588|NCT02794285|564525722|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
156391589|NCT02794285|564525723|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
156391590|NCT02794285|564525724|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
156391591|NCT02794285|564525725|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
156391592|NCT02794285|564525722|FG000|Overall Study|Lack of Efficacy|10|||
156391593|NCT02794285|564525723|FG001|Overall Study|Lack of Efficacy|6|||
156391594|NCT02794285|564525724|FG002|Overall Study|Lack of Efficacy|3|||
156391595|NCT02794285|564525725|FG003|Overall Study|Lack of Efficacy|3|||
156391596|NCT02794285|564525722|FG000|Overall Study|Lost to Follow-up|5|||
156391597|NCT02794285|564525723|FG001|Overall Study|Lost to Follow-up|6|||
156391598|NCT02794285|564525724|FG002|Overall Study|Lost to Follow-up|3|||
156391599|NCT02794285|564525725|FG003|Overall Study|Lost to Follow-up|1|||
156391600|NCT02794285|564525722|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
156391601|NCT02794285|564525723|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
156391602|NCT02794285|564525724|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
156391603|NCT02794285|564525725|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
156391604|NCT02794285|564525722|FG000|Overall Study|Withdrawal by Subject|38|||
156391605|NCT02794285|564525723|FG001|Overall Study|Withdrawal by Subject|29|||
156391606|NCT02794285|564525724|FG002|Overall Study|Withdrawal by Subject|20|||
156391607|NCT02794285|564525725|FG003|Overall Study|Withdrawal by Subject|12|||
156391608|NCT02794285|564525722|FG000|Overall Study|Missing|1|||
156391609|NCT02794285|564525723|FG001|Overall Study|Missing|0|||
156391610|NCT02794285|564525724|FG002|Overall Study|Missing|0|||
156391611|NCT02794285|564525725|FG003|Overall Study|Missing|0|||
156391612|NCT02794285|564525722|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
156391613|NCT02794285|564525723|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
156391614|NCT02794285|564525724|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
156391615|NCT02794285|564525725|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
156391616|NCT02794285|564525722|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
156391617|NCT02794285|564525723|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
156391618|NCT02794285|564525724|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
156391619|NCT02794285|564525725|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
156391620|NCT04124926|564525729|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
156391621|NCT04124926|564525730|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
156391622|NCT04124926|564525731|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
156391623|NCT04124926|564525732|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
156391624|NCT04124926|564525733|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
156391625|NCT04124926|564525729|FG000|Healing Phase|Protocol Violation|0|||
156391626|NCT04124926|564525730|FG001|Healing Phase|Protocol Violation|1|||
156391627|NCT04124926|564525731|FG002|Healing Phase|Protocol Violation|0|||
156391628|NCT04124926|564525732|FG003|Healing Phase|Protocol Violation|0|||
156391629|NCT04124926|564525733|FG004|Healing Phase|Protocol Violation|0|||
156391630|NCT04124926|564525729|FG000|Healing Phase|Lost to Follow-up|5|||
156391631|NCT04124926|564525730|FG001|Healing Phase|Lost to Follow-up|4|||
156391632|NCT04124926|564525731|FG002|Healing Phase|Lost to Follow-up|0|||
156391633|NCT04124926|564525732|FG003|Healing Phase|Lost to Follow-up|0|||
156391634|NCT04124926|564525733|FG004|Healing Phase|Lost to Follow-up|0|||
156391635|NCT04124926|564525729|FG000|Healing Phase|Voluntary Withdrawal|10|||
156391636|NCT04124926|564525730|FG001|Healing Phase|Voluntary Withdrawal|7|||
156391637|NCT04124926|564525731|FG002|Healing Phase|Voluntary Withdrawal|0|||
156391638|NCT04124926|564525732|FG003|Healing Phase|Voluntary Withdrawal|0|||
156391639|NCT04124926|564525733|FG004|Healing Phase|Voluntary Withdrawal|0|||
156391640|NCT04124926|564525729|FG000|Healing Phase|Withdrawal of Consent|5|||
156391641|NCT04124926|564525730|FG001|Healing Phase|Withdrawal of Consent|3|||
156548488|NCT02669017|565100356|FG006|Overall Study|Withdrawal by Subject|0|||
156548489|NCT02669017|565100357|FG007|Overall Study|Withdrawal by Subject|2|||
156391642|NCT04124926|564525731|FG002|Healing Phase|Withdrawal of Consent|0|||
156391643|NCT04124926|564525732|FG003|Healing Phase|Withdrawal of Consent|0|||
156391644|NCT04124926|564525733|FG004|Healing Phase|Withdrawal of Consent|0|||
156391645|NCT04124926|564525729|FG000|Healing Phase|Miscellaneous|8|||
156391646|NCT04124926|564525730|FG001|Healing Phase|Miscellaneous|7|||
156391647|NCT04124926|564525731|FG002|Healing Phase|Miscellaneous|0|||
156391648|NCT04124926|564525732|FG003|Healing Phase|Miscellaneous|0|||
156391649|NCT04124926|564525733|FG004|Healing Phase|Miscellaneous|0|||
156391650|NCT04124926|564525729|FG000|Healing Phase|Randomized but not Treated|0|||
156391651|NCT04124926|564525730|FG001|Healing Phase|Randomized but not Treated|3|||
156391652|NCT04124926|564525731|FG002|Healing Phase|Randomized but not Treated|0|||
156391653|NCT04124926|564525732|FG003|Healing Phase|Randomized but not Treated|0|||
156391654|NCT04124926|564525733|FG004|Healing Phase|Randomized but not Treated|0|||
156391655|NCT04124926|564525729|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
156391656|NCT04124926|564525730|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
156391657|NCT04124926|564525731|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
156391658|NCT04124926|564525732|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
156391659|NCT04124926|564525733|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
156391660|NCT04124926|564525729|FG000|Maintenance Phase|Protocol Violation|0|||
156391661|NCT04124926|564525730|FG001|Maintenance Phase|Protocol Violation|0|||
156391662|NCT04124926|564525731|FG002|Maintenance Phase|Protocol Violation|3|||
156391663|NCT04124926|564525732|FG003|Maintenance Phase|Protocol Violation|0|||
156391664|NCT04124926|564525733|FG004|Maintenance Phase|Protocol Violation|0|||
156391665|NCT04124926|564525729|FG000|Maintenance Phase|Lost to Follow-up|0|||
156391666|NCT04124926|564525730|FG001|Maintenance Phase|Lost to Follow-up|0|||
156391667|NCT04124926|564525731|FG002|Maintenance Phase|Lost to Follow-up|7|||
156391668|NCT04124926|564525732|FG003|Maintenance Phase|Lost to Follow-up|8|||
156391669|NCT04124926|564525733|FG004|Maintenance Phase|Lost to Follow-up|9|||
156391670|NCT04124926|564525729|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
156391671|NCT04124926|564525730|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
156391672|NCT04124926|564525731|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
156391673|NCT04124926|564525732|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
156391674|NCT04124926|564525733|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
156391675|NCT04124926|564525729|FG000|Maintenance Phase|Pregnancy|0|||
156391676|NCT04124926|564525730|FG001|Maintenance Phase|Pregnancy|0|||
156391677|NCT04124926|564525731|FG002|Maintenance Phase|Pregnancy|0|||
156391678|NCT04124926|564525732|FG003|Maintenance Phase|Pregnancy|1|||
156391679|NCT04124926|564525733|FG004|Maintenance Phase|Pregnancy|0|||
156391680|NCT04124926|564525729|FG000|Maintenance Phase|Lack of Efficacy|0|||
156391681|NCT04124926|564525730|FG001|Maintenance Phase|Lack of Efficacy|0|||
156391682|NCT04124926|564525731|FG002|Maintenance Phase|Lack of Efficacy|0|||
156391683|NCT04124926|564525732|FG003|Maintenance Phase|Lack of Efficacy|0|||
156391684|NCT04124926|564525733|FG004|Maintenance Phase|Lack of Efficacy|1|||
156391685|NCT04124926|564525729|FG000|Maintenance Phase|Withdrawal of Consent|0|||
156391686|NCT04124926|564525730|FG001|Maintenance Phase|Withdrawal of Consent|0|||
156391687|NCT04124926|564525731|FG002|Maintenance Phase|Withdrawal of Consent|5|||
156391688|NCT04124926|564525732|FG003|Maintenance Phase|Withdrawal of Consent|5|||
156391689|NCT04124926|564525733|FG004|Maintenance Phase|Withdrawal of Consent|5|||
156391690|NCT04124926|564525729|FG000|Maintenance Phase|Miscellaneous|0|||
156391691|NCT04124926|564525730|FG001|Maintenance Phase|Miscellaneous|0|||
156391692|NCT04124926|564525731|FG002|Maintenance Phase|Miscellaneous|1|||
156391693|NCT04124926|564525732|FG003|Maintenance Phase|Miscellaneous|2|||
156391694|NCT04124926|564525733|FG004|Maintenance Phase|Miscellaneous|4|||
156391695|NCT04124926|564525729|FG000|Maintenance Phase|Randomized but not Treated|0|||
156391696|NCT04124926|564525730|FG001|Maintenance Phase|Randomized but not Treated|0|||
156391697|NCT04124926|564525731|FG002|Maintenance Phase|Randomized but not Treated|2|||
156391698|NCT04124926|564525732|FG003|Maintenance Phase|Randomized but not Treated|2|||
156391699|NCT04124926|564525733|FG004|Maintenance Phase|Randomized but not Treated|0|||
156391700|NCT01207102|564525737|FG000|Overall Study|Withdrawal by Subject|5|||
156391701|NCT01207102|564525737|FG000|Overall Study|Adverse Event|2|||
156391702|NCT01207102|564525737|FG000|Overall Study|progression|2|||
156391703|NCT01207102|564525737|FG000|Overall Study|Withdrawal by Treating Physician|1|||
156391704|NCT03792126|564525738|FG000|Overall Study|Adverse Event|1|||
156391705|NCT03792126|564525739|FG001|Overall Study|Adverse Event|2|||
156391706|NCT03792126|564525738|FG000|Overall Study|Death|0|||
156391707|NCT03792126|564525739|FG001|Overall Study|Death|1|||
156391708|NCT03792126|564525738|FG000|Overall Study|Lost to Follow-up|1|||
156391709|NCT03792126|564525739|FG001|Overall Study|Lost to Follow-up|0|||
156391710|NCT03792126|564525738|FG000|Overall Study|Withdrawal by Subject|0|||
156391711|NCT03792126|564525739|FG001|Overall Study|Withdrawal by Subject|1|||
156391712|NCT03792126|564525738|FG000|Overall Study|COVID-19 Restrictions|1|||
156391713|NCT03792126|564525739|FG001|Overall Study|COVID-19 Restrictions|3|||
156391714|NCT03792126|564525738|FG000|Overall Study|Symptoms resolved|0|||
156391715|NCT03792126|564525739|FG001|Overall Study|Symptoms resolved|3|||
156391716|NCT00833638|564525740|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
156391717|NCT00833638|564525741|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
156391718|NCT00833638|564525742|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
156391719|NCT00833638|564525740|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
156391720|NCT00833638|564525741|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
156391721|NCT00833638|564525742|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
156391722|NCT00833638|564525740|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
156391723|NCT00833638|564525741|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
156391724|NCT00833638|564525742|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
156391725|NCT00833638|564525740|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
156391726|NCT00833638|564525741|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
156391727|NCT00833638|564525742|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
156391728|NCT00833638|564525740|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
156391729|NCT00833638|564525741|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
156391730|NCT00833638|564525742|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
156391731|NCT00833638|564525740|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
156391732|NCT00833638|564525741|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
156391733|NCT00833638|564525742|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
156391734|NCT00833638|564525740|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
156391735|NCT00833638|564525741|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
156391736|NCT00833638|564525742|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
156391737|NCT00833638|564525740|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
156391738|NCT00833638|564525741|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
156391739|NCT00833638|564525742|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
156391740|NCT00833638|564525740|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
156391741|NCT00833638|564525741|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
156391742|NCT00833638|564525742|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
156391743|NCT00490646|564525743|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
156391744|NCT00490646|564525744|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
156391745|NCT00490646|564525743|FG000|Overall Study|Never Treated (had an adverse event)|1|||
156391746|NCT00490646|564525744|FG001|Overall Study|Never Treated (had an adverse event)|0|||
156391747|NCT00490646|564525743|FG000|Overall Study|Never Treated (withdrew consent)|0|||
156391748|NCT00490646|564525744|FG001|Overall Study|Never Treated (withdrew consent)|1|||
156391749|NCT01178086|564525745|FG000|Overall Study|Participant refusal|7|||
156391750|NCT01178086|564525745|FG000|Overall Study|Physician Decision|44|||
156508657|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
156508658|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
156508659|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
156508660|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
156508661|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
156508662|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
156508663|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
156508664|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
156508665|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
156508666|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
156508667|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
156508668|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
156508669|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
156508670|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
156508671|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
156508672|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
156508673|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
156508674|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
156508675|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
156508676|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
156508677|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
156508678|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
156508679|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
156508680|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
156508681|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
156508682|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
156508683|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
156508684|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
156548490|NCT02669017|565100358|FG008|Overall Study|Withdrawal by Subject|2|||
156548491|NCT02669017|565100350|FG000|Overall Study|Lost to Follow-up|0|||
156548492|NCT02669017|565100351|FG001|Overall Study|Lost to Follow-up|0|||
156391751|NCT01178086|564525745|FG000|Overall Study|Switch to other CLL therapy|113|||
156391752|NCT01178086|564525745|FG000|Overall Study|Death|59|||
156391753|NCT01178086|564525745|FG000|Overall Study|Other unspecified|89|||
156391754|NCT01178086|564525745|FG000|Overall Study|Excluded from EAS|20|||
156391755|NCT00983073|564525747|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
156391756|NCT00983073|564525747|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
156391757|NCT00983073|564525747|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
156391758|NCT00983073|564525747|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
156391759|NCT00983073|564525747|FG000|Titration and Optimal Dose Period|Other reason|4|||
156391760|NCT00983073|564525747|FG000|Maintenance Period|Adverse Event|5|||
156391761|NCT00983073|564525747|FG000|Maintenance Period|Withdrawal by Subject|2|||
156391762|NCT00983073|564525747|FG000|Maintenance Period|Lack of Efficacy|2|||
156391763|NCT00983073|564525747|FG000|Maintenance Period|Other Reason|7|||
156391764|NCT01400503|564525748|FG000|Overall Study|Withdrawal by Subject|1|||
156391765|NCT01400503|564525748|FG000|Overall Study|Study Terminated by Sponsor|58|||
156391766|NCT01400503|564525748|FG000|Overall Study|Other|1|||
156391767|NCT01669122|564525751|FG000|Period I|Lost to Follow-up|1|||
156391768|NCT01669122|564525751|FG000|Washout Period II|Protocol Violation|2|||
156391769|NCT02962908|564525754|FG000|Overall Study|Lost to Follow-up|0|||
156391770|NCT02962908|564525755|FG001|Overall Study|Lost to Follow-up|3|||
156391771|NCT02962908|564525756|FG002|Overall Study|Lost to Follow-up|0|||
156391772|NCT02962908|564525757|FG003|Overall Study|Lost to Follow-up|1|||
156391773|NCT02962908|564525754|FG000|Overall Study|Withdrawal by Subject|0|||
156391774|NCT02962908|564525755|FG001|Overall Study|Withdrawal by Subject|3|||
156391775|NCT02962908|564525756|FG002|Overall Study|Withdrawal by Subject|0|||
156391776|NCT02962908|564525757|FG003|Overall Study|Withdrawal by Subject|2|||
156391777|NCT02962908|564525754|FG000|Overall Study|Protocol Violation|0|||
156391778|NCT02962908|564525755|FG001|Overall Study|Protocol Violation|1|||
156391779|NCT02962908|564525756|FG002|Overall Study|Protocol Violation|0|||
156391780|NCT02962908|564525757|FG003|Overall Study|Protocol Violation|0|||
156391781|NCT02962908|564525754|FG000|Overall Study|Physician Decision|0|||
156391782|NCT02962908|564525755|FG001|Overall Study|Physician Decision|1|||
156391783|NCT02962908|564525756|FG002|Overall Study|Physician Decision|0|||
156391784|NCT02962908|564525757|FG003|Overall Study|Physician Decision|0|||
156391785|NCT03543254|564525758|FG000|Overall Study|Lost to Follow-up|1|||
156391786|NCT02077166|564525759|FG000|Overall Study|Death|6|||
156391787|NCT02077166|564525760|FG001|Overall Study|Death|7|||
156391788|NCT02077166|564525761|FG002|Overall Study|Death|5|||
156391789|NCT02077166|564525762|FG003|Overall Study|Death|6|||
156391790|NCT02077166|564525763|FG004|Overall Study|Death|4|||
156391791|NCT02077166|564525764|FG005|Overall Study|Death|32|||
156391792|NCT02077166|564525765|FG006|Overall Study|Death|22|||
156391793|NCT02077166|564525759|FG000|Overall Study|Study Closure by Sponsor|3|||
156391794|NCT02077166|564525760|FG001|Overall Study|Study Closure by Sponsor|0|||
156391795|NCT02077166|564525761|FG002|Overall Study|Study Closure by Sponsor|2|||
156391796|NCT02077166|564525762|FG003|Overall Study|Study Closure by Sponsor|2|||
156391797|NCT02077166|564525763|FG004|Overall Study|Study Closure by Sponsor|2|||
156391798|NCT02077166|564525764|FG005|Overall Study|Study Closure by Sponsor|12|||
156391799|NCT02077166|564525765|FG006|Overall Study|Study Closure by Sponsor|4|||
156391800|NCT02077166|564525759|FG000|Overall Study|Lost to Follow-up|0|||
156391801|NCT02077166|564525760|FG001|Overall Study|Lost to Follow-up|0|||
156391802|NCT02077166|564525761|FG002|Overall Study|Lost to Follow-up|0|||
156391803|NCT02077166|564525762|FG003|Overall Study|Lost to Follow-up|0|||
156391804|NCT02077166|564525763|FG004|Overall Study|Lost to Follow-up|0|||
156391805|NCT02077166|564525764|FG005|Overall Study|Lost to Follow-up|1|||
156391806|NCT02077166|564525765|FG006|Overall Study|Lost to Follow-up|0|||
156391807|NCT02077166|564525759|FG000|Overall Study|Withdrawal by Subject|3|||
156391808|NCT02077166|564525760|FG001|Overall Study|Withdrawal by Subject|0|||
156508685|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
156508686|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
156508687|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
156508688|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
156508689|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
156508690|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
156508691|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
156508692|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
156508693|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
156391809|NCT02077166|564525761|FG002|Overall Study|Withdrawal by Subject|1|||
156391810|NCT02077166|564525762|FG003|Overall Study|Withdrawal by Subject|1|||
156391811|NCT02077166|564525763|FG004|Overall Study|Withdrawal by Subject|1|||
156391812|NCT02077166|564525764|FG005|Overall Study|Withdrawal by Subject|3|||
156391813|NCT02077166|564525765|FG006|Overall Study|Withdrawal by Subject|0|||
156391814|NCT02077166|564525759|FG000|Overall Study|Other, Not Specified|0|||
156391815|NCT02077166|564525760|FG001|Overall Study|Other, Not Specified|0|||
156391816|NCT02077166|564525761|FG002|Overall Study|Other, Not Specified|1|||
156391817|NCT02077166|564525762|FG003|Overall Study|Other, Not Specified|0|||
156391818|NCT02077166|564525763|FG004|Overall Study|Other, Not Specified|1|||
156391819|NCT02077166|564525764|FG005|Overall Study|Other, Not Specified|7|||
156391820|NCT02077166|564525765|FG006|Overall Study|Other, Not Specified|8|||
156391821|NCT01261338|564525766|FG000|Overall Study|Withdrawal by Subject|3|||
156391822|NCT01261338|564525767|FG001|Overall Study|Withdrawal by Subject|2|||
156391823|NCT02899728|564525768|FG000|Overall Study|Withdrawal by Subject|1|||
156391824|NCT02899728|564525769|FG001|Overall Study|Withdrawal by Subject|1|||
156391825|NCT05557942|564525770|FG000|Overall Study|Death|0|||
156391826|NCT05557942|564525771|FG001|Overall Study|Death|0|||
156391827|NCT05557942|564525772|FG002|Overall Study|Death|0|||
156391828|NCT05557942|564525773|FG003|Overall Study|Death|2|||
156391829|NCT05557942|564525774|FG004|Overall Study|Death|1|||
156391830|NCT05557942|564525775|FG005|Overall Study|Death|1|||
156391831|NCT05557942|564525770|FG000|Overall Study|Physician Decision|1|||
156391832|NCT05557942|564525771|FG001|Overall Study|Physician Decision|1|||
156391833|NCT05557942|564525772|FG002|Overall Study|Physician Decision|2|||
156391834|NCT05557942|564525773|FG003|Overall Study|Physician Decision|3|||
156391835|NCT05557942|564525774|FG004|Overall Study|Physician Decision|0|||
156391836|NCT05557942|564525775|FG005|Overall Study|Physician Decision|2|||
156391837|NCT05557942|564525770|FG000|Overall Study|Study terminated by sponsor|17|||
156391838|NCT05557942|564525771|FG001|Overall Study|Study terminated by sponsor|17|||
156391839|NCT05557942|564525772|FG002|Overall Study|Study terminated by sponsor|14|||
156391840|NCT05557942|564525773|FG003|Overall Study|Study terminated by sponsor|40|||
156391841|NCT05557942|564525774|FG004|Overall Study|Study terminated by sponsor|45|||
156391842|NCT05557942|564525775|FG005|Overall Study|Study terminated by sponsor|37|||
156391843|NCT05557942|564525770|FG000|Overall Study|Protocol Violation|0|||
156391844|NCT05557942|564525771|FG001|Overall Study|Protocol Violation|0|||
156391845|NCT05557942|564525772|FG002|Overall Study|Protocol Violation|0|||
156391846|NCT05557942|564525773|FG003|Overall Study|Protocol Violation|0|||
156391847|NCT05557942|564525774|FG004|Overall Study|Protocol Violation|0|||
156391848|NCT05557942|564525775|FG005|Overall Study|Protocol Violation|1|||
156391849|NCT05557942|564525770|FG000|Overall Study|Withdrawal by Subject|0|||
156391850|NCT05557942|564525771|FG001|Overall Study|Withdrawal by Subject|0|||
156391851|NCT05557942|564525772|FG002|Overall Study|Withdrawal by Subject|0|||
156391852|NCT05557942|564525773|FG003|Overall Study|Withdrawal by Subject|0|||
156391853|NCT05557942|564525774|FG004|Overall Study|Withdrawal by Subject|2|||
156391854|NCT05557942|564525775|FG005|Overall Study|Withdrawal by Subject|0|||
156391855|NCT01962493|564525776|FG000|Overall Study|Adverse Event|1|||
156391856|NCT01962493|564525777|FG001|Overall Study|Adverse Event|2|||
156391857|NCT01962493|564525776|FG000|Overall Study|Protocol Violation|0|||
156391858|NCT01962493|564525777|FG001|Overall Study|Protocol Violation|1|||
156391859|NCT01962493|564525776|FG000|Overall Study|Withdrawal by Subject|4|||
156391860|NCT01962493|564525777|FG001|Overall Study|Withdrawal by Subject|2|||
156391861|NCT03776136|564525778|FG000|Overall Study|Death|85|||
156391862|NCT03776136|564525778|FG000|Overall Study|Withdrawal by Subject|3|||
156391863|NCT03776136|564525778|FG000|Overall Study|Sponsor Decision|15|||
156391864|NCT03754803|564525785|FG000|Overall Study|Withdrawal by Subject|2|||
156391865|NCT04348604|564525788|FG000|Week 8|Withdrawal by Subject|1|||
156391866|NCT04348604|564525789|FG001|Week 8|Withdrawal by Subject|1|||
156391867|NCT04348604|564525788|FG000|Week 8|Lost to Follow-up|1|||
156391868|NCT04348604|564525789|FG001|Week 8|Lost to Follow-up|2|||
156391869|NCT04348604|564525788|FG000|Week 8|Suspended|0|||
156391870|NCT04348604|564525789|FG001|Week 8|Suspended|1|||
156391871|NCT04348604|564525788|FG000|Week 12|Lost to Follow-up|1|||
156391872|NCT04348604|564525789|FG001|Week 12|Lost to Follow-up|2|||
156508694|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
156508695|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
156508696|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
156508697|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
156508698|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
156508699|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
156508700|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
156508701|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
156508702|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
156508703|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
156508704|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
156508705|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
156508706|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
156391873|NCT04348604|564525788|FG000|Week 12|Withdrawal by Subject|1|||
156391874|NCT04348604|564525789|FG001|Week 12|Withdrawal by Subject|0|||
156391875|NCT04348604|564525788|FG000|Week 24|Lost to Follow-up|2|||
156391876|NCT04348604|564525789|FG001|Week 24|Lost to Follow-up|1|||
156391877|NCT02097108|564525790|FG000|Overall Study|Adverse Event|1|||
156391878|NCT02097108|564525790|FG000|Overall Study|patient was abroad for 6 months|1|||
156391879|NCT00127608|564525793|FG000|Overall Study|VZV DNA negative|1|||
156391880|NCT05245864|564525794|FG000|Overall Study|Withdrawal by Subject|1|||
156391881|NCT05245864|564525795|FG001|Overall Study|Withdrawal by Subject|1|||
156391882|NCT01475136|564525798|FG000|Overall Study|Sponsor Decision|0|||
156391883|NCT01475136|564525799|FG001|Overall Study|Sponsor Decision|1|||
156391884|NCT01475136|564525800|FG002|Overall Study|Sponsor Decision|0|||
156391885|NCT01475136|564525801|FG003|Overall Study|Sponsor Decision|0|||
156391886|NCT01475136|564525798|FG000|Overall Study|Entry Criteria Not Met|0|||
156391887|NCT01475136|564525799|FG001|Overall Study|Entry Criteria Not Met|2|||
156391888|NCT01475136|564525800|FG002|Overall Study|Entry Criteria Not Met|3|||
156391889|NCT01475136|564525801|FG003|Overall Study|Entry Criteria Not Met|1|||
156391890|NCT01475136|564525798|FG000|Overall Study|Withdrawal by Subject|0|||
156391891|NCT01475136|564525799|FG001|Overall Study|Withdrawal by Subject|0|||
156391892|NCT01475136|564525800|FG002|Overall Study|Withdrawal by Subject|0|||
156391893|NCT01475136|564525801|FG003|Overall Study|Withdrawal by Subject|2|||
156391894|NCT01475136|564525798|FG000|Overall Study|Adverse Event|1|||
156391895|NCT01475136|564525799|FG001|Overall Study|Adverse Event|0|||
156391896|NCT01475136|564525800|FG002|Overall Study|Adverse Event|0|||
156391897|NCT01475136|564525801|FG003|Overall Study|Adverse Event|1|||
156391898|NCT01475136|564525798|FG000|Overall Study|Death|0|||
156391899|NCT01475136|564525799|FG001|Overall Study|Death|0|||
156391900|NCT01475136|564525800|FG002|Overall Study|Death|0|||
156391901|NCT01475136|564525801|FG003|Overall Study|Death|1|||
156391902|NCT01329029|564525802|FG000|Overall Study|Withdrawal by Subject|117|||
156391903|NCT01329029|564525803|FG001|Overall Study|Withdrawal by Subject|87|||
156391904|NCT01329029|564525802|FG000|Overall Study|Adverse Event|82|||
156391905|NCT01329029|564525803|FG001|Overall Study|Adverse Event|29|||
156391906|NCT01329029|564525802|FG000|Overall Study|Death|16|||
156391907|NCT01329029|564525803|FG001|Overall Study|Death|19|||
156391908|NCT01329029|564525802|FG000|Overall Study|Other|14|||
156391909|NCT01329029|564525803|FG001|Overall Study|Other|20|||
156391910|NCT01329029|564525802|FG000|Overall Study|COPD Exacerbation|11|||
156391911|NCT01329029|564525803|FG001|Overall Study|COPD Exacerbation|18|||
156391912|NCT01329029|564525802|FG000|Overall Study|Physician Decision|16|||
156391913|NCT01329029|564525803|FG001|Overall Study|Physician Decision|13|||
156391914|NCT01329029|564525802|FG000|Overall Study|Lost to Follow-up|8|||
156391915|NCT01329029|564525803|FG001|Overall Study|Lost to Follow-up|5|||
156391916|NCT01329029|564525802|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
156391917|NCT01329029|564525803|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
156391918|NCT01323530|564527728|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
156391919|NCT01323530|564527729|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156391920|NCT01323530|564527730|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156391921|NCT01323530|564527731|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156391922|NCT01323530|564527732|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156391923|NCT01323530|564527733|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
156391924|NCT01323530|564527734|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156391925|NCT01323530|564527728|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
156391926|NCT01323530|564527729|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
156391927|NCT01323530|564527730|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
156391928|NCT01323530|564527731|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156391929|NCT01323530|564527732|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
156391930|NCT01323530|564527733|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156391931|NCT01323530|564527734|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156391932|NCT01323530|564527728|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
156391933|NCT01323530|564527729|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
156391934|NCT01323530|564527730|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
156391935|NCT01323530|564527731|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
156391936|NCT01323530|564527732|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
156391937|NCT01323530|564527733|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
156391938|NCT01323530|564527734|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
156391939|NCT01323530|564527728|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156391940|NCT01323530|564527729|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156391941|NCT01323530|564527730|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156391942|NCT01323530|564527731|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156391943|NCT01323530|564527732|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156391944|NCT01323530|564527733|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156391945|NCT01323530|564527734|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
156391946|NCT01323530|564527728|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156391947|NCT01323530|564527729|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156391948|NCT01323530|564527730|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156391949|NCT01323530|564527731|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156391950|NCT01323530|564527732|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156391951|NCT01323530|564527733|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156391952|NCT01323530|564527734|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
156391953|NCT01323530|564527728|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156391954|NCT01323530|564527729|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156508707|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
156548493|NCT02669017|565100352|FG002|Overall Study|Lost to Follow-up|0|||
156391955|NCT01323530|564527730|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156391956|NCT01323530|564527731|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156391957|NCT01323530|564527732|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156391958|NCT01323530|564527733|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156391959|NCT01323530|564527734|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
156391960|NCT01323530|564527728|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156391961|NCT01323530|564527729|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156391962|NCT01323530|564527730|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156391963|NCT01323530|564527731|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156391964|NCT01323530|564527732|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156391965|NCT01323530|564527733|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156391966|NCT01323530|564527734|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
156391967|NCT01323530|564527728|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156391968|NCT01323530|564527729|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156391969|NCT01323530|564527730|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156391970|NCT01323530|564527731|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156391971|NCT01323530|564527732|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156391972|NCT01323530|564527733|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156391973|NCT01323530|564527734|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
156391974|NCT01194570|564527735|FG000|Overall Study|Adverse Event|22|||
156391975|NCT01194570|564527736|FG001|Overall Study|Adverse Event|40|||
156391976|NCT01194570|564527735|FG000|Overall Study|Death|6|||
156391977|NCT01194570|564527736|FG001|Overall Study|Death|20|||
156391978|NCT01194570|564527735|FG000|Overall Study|Lack of Efficacy|32|||
156391979|NCT01194570|564527736|FG001|Overall Study|Lack of Efficacy|33|||
156391980|NCT01194570|564527735|FG000|Overall Study|Lost to Follow-up|4|||
156391981|NCT01194570|564527736|FG001|Overall Study|Lost to Follow-up|15|||
156391982|NCT01194570|564527735|FG000|Overall Study|Non-Compliance|2|||
156391983|NCT01194570|564527736|FG001|Overall Study|Non-Compliance|2|||
156391984|NCT01194570|564527735|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156391985|NCT01194570|564527736|FG001|Overall Study|Non-Compliance With Study Drug|2|||
156391986|NCT01194570|564527735|FG000|Overall Study|Other|18|||
156391987|NCT01194570|564527736|FG001|Overall Study|Other|47|||
156391988|NCT01194570|564527735|FG000|Overall Study|Physician Decision|10|||
156391989|NCT01194570|564527736|FG001|Overall Study|Physician Decision|25|||
156391990|NCT01194570|564527735|FG000|Overall Study|Protocol Violation|1|||
156391991|NCT01194570|564527736|FG001|Overall Study|Protocol Violation|2|||
156391992|NCT01194570|564527735|FG000|Overall Study|Study Terminated By Sponsor|0|||
156391993|NCT01194570|564527736|FG001|Overall Study|Study Terminated By Sponsor|1|||
156391994|NCT01194570|564527735|FG000|Overall Study|Withdrawal by Subject|57|||
156391995|NCT01194570|564527736|FG001|Overall Study|Withdrawal by Subject|82|||
156391996|NCT01194570|564527735|FG000|Overall Study|Pregnancy|1|||
156391997|NCT01194570|564527736|FG001|Overall Study|Pregnancy|1|||
156391998|NCT04918784|564527740|FG000|Overall Study|Amputation - no longer eligible|1|||
156391999|NCT04918784|564527741|FG001|Overall Study|Amputation - no longer eligible|2|||
156392000|NCT04918784|564527740|FG000|Overall Study|Death|1|||
156392001|NCT04918784|564527741|FG001|Overall Study|Death|0|||
156392002|NCT04918784|564527740|FG000|Overall Study|patient non-compliance|3|||
156392003|NCT04918784|564527741|FG001|Overall Study|patient non-compliance|1|||
156392004|NCT04918784|564527740|FG000|Overall Study|Adverse Event|1|||
156392005|NCT04918784|564527741|FG001|Overall Study|Adverse Event|0|||
156392006|NCT01712009|564527742|FG000|Overall Study|Withdrawal by Subject|24|||
156392007|NCT01712009|564527743|FG001|Overall Study|Withdrawal by Subject|15|||
156392008|NCT01712009|564527744|FG002|Overall Study|Withdrawal by Subject|8|||
156392009|NCT01712009|564527742|FG000|Overall Study|Lost to Follow-up|2|||
156392010|NCT01712009|564527743|FG001|Overall Study|Lost to Follow-up|0|||
156392011|NCT01712009|564527744|FG002|Overall Study|Lost to Follow-up|1|||
156392012|NCT01712009|564527742|FG000|Overall Study|Decision by Sponsor|12|||
156392013|NCT01712009|564527743|FG001|Overall Study|Decision by Sponsor|14|||
156392014|NCT01712009|564527744|FG002|Overall Study|Decision by Sponsor|12|||
156392015|NCT01111123|564527746|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
156392016|NCT01111123|564527747|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
156548494|NCT02669017|565100353|FG003|Overall Study|Lost to Follow-up|0|||
156392017|NCT01111123|564527746|FG000|Maintenance Phase|Lost to Follow-up|0|||
156392018|NCT01111123|564527747|FG001|Maintenance Phase|Lost to Follow-up|2|||
156392019|NCT01203930|564527753|FG000|Overall Study|Disease Progression|0|||
156392020|NCT01203930|564527754|FG001|Overall Study|Disease Progression|4|||
156392021|NCT01203930|564527753|FG000|Overall Study|Death|3|||
156392022|NCT01203930|564527754|FG001|Overall Study|Death|1|||
156392023|NCT01203930|564527753|FG000|Overall Study|Withdrew Consent|1|||
156392024|NCT01203930|564527754|FG001|Overall Study|Withdrew Consent|10|||
156392025|NCT01203930|564527753|FG000|Overall Study|Investigator Request|0|||
156392026|NCT01203930|564527754|FG001|Overall Study|Investigator Request|8|||
156548495|NCT02669017|565100354|FG004|Overall Study|Lost to Follow-up|0|||
156548496|NCT02669017|565100355|FG005|Overall Study|Lost to Follow-up|0|||
156392027|NCT01203930|564527753|FG000|Overall Study|Study Terminated by Sponsor|0|||
156392028|NCT01203930|564527754|FG001|Overall Study|Study Terminated by Sponsor|12|||
156392029|NCT01203930|564527753|FG000|Overall Study|Poor tolerance of study drug|0|||
156392030|NCT01203930|564527754|FG001|Overall Study|Poor tolerance of study drug|1|||
156392031|NCT01203930|564527753|FG000|Overall Study|Adverse Event|17|||
156392032|NCT01203930|564527754|FG001|Overall Study|Adverse Event|5|||
156392033|NCT01332227|564527755|FG000|Overall Study|Adverse Event|4|||
156392034|NCT01332227|564527756|FG001|Overall Study|Adverse Event|1|||
156392035|NCT01332227|564527755|FG000|Overall Study|Withdrawal by Subject|5|||
156392036|NCT01332227|564527756|FG001|Overall Study|Withdrawal by Subject|1|||
156392037|NCT01332227|564527755|FG000|Overall Study|Lost to Follow-up|2|||
156392038|NCT01332227|564527756|FG001|Overall Study|Lost to Follow-up|0|||
156392039|NCT01332227|564527755|FG000|Overall Study|Lack of Efficacy|3|||
156392040|NCT01332227|564527756|FG001|Overall Study|Lack of Efficacy|1|||
156392041|NCT01332227|564527755|FG000|Overall Study|Poor compliance/noncompliance|1|||
156392042|NCT01332227|564527756|FG001|Overall Study|Poor compliance/noncompliance|1|||
156392043|NCT01332227|564527755|FG000|Overall Study|Patient moved from area|1|||
156392044|NCT01332227|564527756|FG001|Overall Study|Patient moved from area|0|||
156392045|NCT01332227|564527755|FG000|Overall Study|Patient began prohibited medication|0|||
156392046|NCT01332227|564527756|FG001|Overall Study|Patient began prohibited medication|1|||
156392047|NCT02822222|564527757|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
156392048|NCT02822222|564527758|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
156392049|NCT00428090|564527760|FG000|Overall Study|Adverse Event|10|||
156392050|NCT00428090|564527761|FG001|Overall Study|Adverse Event|8|||
156392051|NCT00428090|564527762|FG002|Overall Study|Adverse Event|10|||
156392052|NCT00428090|564527763|FG003|Overall Study|Adverse Event|11|||
156392053|NCT00428090|564527760|FG000|Overall Study|Lost to Follow-up|3|||
156392054|NCT00428090|564527761|FG001|Overall Study|Lost to Follow-up|6|||
156392055|NCT00428090|564527762|FG002|Overall Study|Lost to Follow-up|1|||
156392056|NCT00428090|564527763|FG003|Overall Study|Lost to Follow-up|4|||
156392057|NCT00428090|564527760|FG000|Overall Study|Protocol Violation|3|||
156392058|NCT00428090|564527761|FG001|Overall Study|Protocol Violation|1|||
156392059|NCT00428090|564527762|FG002|Overall Study|Protocol Violation|3|||
156392060|NCT00428090|564527763|FG003|Overall Study|Protocol Violation|3|||
156392061|NCT00428090|564527760|FG000|Overall Study|Withdrawal by Subject|10|||
156392062|NCT00428090|564527761|FG001|Overall Study|Withdrawal by Subject|12|||
156392063|NCT00428090|564527762|FG002|Overall Study|Withdrawal by Subject|15|||
156392064|NCT00428090|564527763|FG003|Overall Study|Withdrawal by Subject|5|||
156392065|NCT00428090|564527760|FG000|Overall Study|Sponsor terminated study|0|||
156392066|NCT00428090|564527761|FG001|Overall Study|Sponsor terminated study|1|||
156392067|NCT00428090|564527762|FG002|Overall Study|Sponsor terminated study|0|||
156392068|NCT00428090|564527763|FG003|Overall Study|Sponsor terminated study|0|||
156392069|NCT00428090|564527760|FG000|Overall Study|Non-compliance|4|||
156392070|NCT00428090|564527761|FG001|Overall Study|Non-compliance|0|||
156392071|NCT00428090|564527762|FG002|Overall Study|Non-compliance|1|||
156392072|NCT00428090|564527763|FG003|Overall Study|Non-compliance|3|||
156392073|NCT00428090|564527760|FG000|Overall Study|Par. did not returned to visit|1|||
156392074|NCT00428090|564527761|FG001|Overall Study|Par. did not returned to visit|0|||
156392075|NCT00428090|564527762|FG002|Overall Study|Par. did not returned to visit|0|||
156392076|NCT00428090|564527763|FG003|Overall Study|Par. did not returned to visit|1|||
156392077|NCT00428090|564527760|FG000|Overall Study|Follow-Up visit not possible|1|||
156392078|NCT00428090|564527761|FG001|Overall Study|Follow-Up visit not possible|0|||
156392079|NCT00428090|564527762|FG002|Overall Study|Follow-Up visit not possible|0|||
156392080|NCT00428090|564527763|FG003|Overall Study|Follow-Up visit not possible|0|||
156392081|NCT00428090|564527760|FG000|Overall Study|Prohibited medication used for SAE|1|||
156392082|NCT00428090|564527761|FG001|Overall Study|Prohibited medication used for SAE|0|||
156392083|NCT00428090|564527762|FG002|Overall Study|Prohibited medication used for SAE|0|||
156392084|NCT00428090|564527763|FG003|Overall Study|Prohibited medication used for SAE|0|||
156392085|NCT00428090|564527760|FG000|Overall Study|Death of par.|1|||
156392086|NCT00428090|564527761|FG001|Overall Study|Death of par.|0|||
156392087|NCT00428090|564527762|FG002|Overall Study|Death of par.|1|||
156392088|NCT00428090|564527763|FG003|Overall Study|Death of par.|0|||
156392089|NCT00428090|564527760|FG000|Overall Study|Visit 7 exceed the visit window|0|||
156392090|NCT00428090|564527761|FG001|Overall Study|Visit 7 exceed the visit window|1|||
156392091|NCT00428090|564527762|FG002|Overall Study|Visit 7 exceed the visit window|0|||
156392092|NCT00428090|564527763|FG003|Overall Study|Visit 7 exceed the visit window|0|||
156392093|NCT00428090|564527760|FG000|Overall Study|Medical monitor terminated par.|0|||
156392094|NCT00428090|564527761|FG001|Overall Study|Medical monitor terminated par.|1|||
156392095|NCT00428090|564527762|FG002|Overall Study|Medical monitor terminated par.|0|||
156392096|NCT00428090|564527763|FG003|Overall Study|Medical monitor terminated par.|0|||
156392097|NCT00428090|564527760|FG000|Overall Study|Mental status of par. was|0|||
156392098|NCT00428090|564527761|FG001|Overall Study|Mental status of par. was|1|||
156392099|NCT00428090|564527762|FG002|Overall Study|Mental status of par. was|0|||
156392100|NCT00428090|564527763|FG003|Overall Study|Mental status of par. was|0|||
156392101|NCT00428090|564527760|FG000|Overall Study|Worsening of AD|0|||
156392102|NCT00428090|564527761|FG001|Overall Study|Worsening of AD|0|||
156392103|NCT00428090|564527762|FG002|Overall Study|Worsening of AD|1|||
156392104|NCT00428090|564527763|FG003|Overall Study|Worsening of AD|0|||
156392105|NCT00428090|564527760|FG000|Overall Study|Excluded for concerning QTc value|0|||
156392106|NCT00428090|564527761|FG001|Overall Study|Excluded for concerning QTc value|0|||
156392107|NCT00428090|564527762|FG002|Overall Study|Excluded for concerning QTc value|1|||
156392108|NCT00428090|564527763|FG003|Overall Study|Excluded for concerning QTc value|0|||
156392109|NCT00428090|564527760|FG000|Overall Study|Insufficient AD documentation|0|||
156392110|NCT00428090|564527761|FG001|Overall Study|Insufficient AD documentation|0|||
156392111|NCT00428090|564527762|FG002|Overall Study|Insufficient AD documentation|1|||
156392112|NCT00428090|564527763|FG003|Overall Study|Insufficient AD documentation|0|||
156392113|NCT00428090|564527760|FG000|Overall Study|High MMSE scores|0|||
156392114|NCT00428090|564527761|FG001|Overall Study|High MMSE scores|0|||
156392115|NCT00428090|564527762|FG002|Overall Study|High MMSE scores|1|||
156392116|NCT00428090|564527763|FG003|Overall Study|High MMSE scores|0|||
156392117|NCT00428090|564527760|FG000|Overall Study|Deterioration of cognitive status|0|||
156392118|NCT00428090|564527761|FG001|Overall Study|Deterioration of cognitive status|0|||
156392119|NCT00428090|564527762|FG002|Overall Study|Deterioration of cognitive status|1|||
156392120|NCT00428090|564527763|FG003|Overall Study|Deterioration of cognitive status|0|||
156392121|NCT00428090|564527760|FG000|Overall Study|Serious adverse event|0|||
156392122|NCT00428090|564527761|FG001|Overall Study|Serious adverse event|0|||
156392123|NCT00428090|564527762|FG002|Overall Study|Serious adverse event|1|||
156392124|NCT00428090|564527763|FG003|Overall Study|Serious adverse event|0|||
156392125|NCT00428090|564527760|FG000|Overall Study|Excluded for heart insufficiency|0|||
156392126|NCT00428090|564527761|FG001|Overall Study|Excluded for heart insufficiency|0|||
156392127|NCT00428090|564527762|FG002|Overall Study|Excluded for heart insufficiency|1|||
156392128|NCT00428090|564527763|FG003|Overall Study|Excluded for heart insufficiency|0|||
156392129|NCT00428090|564527760|FG000|Overall Study|Raised Creatinine Value|0|||
156392130|NCT00428090|564527761|FG001|Overall Study|Raised Creatinine Value|0|||
156392131|NCT00428090|564527762|FG002|Overall Study|Raised Creatinine Value|0|||
156392132|NCT00428090|564527763|FG003|Overall Study|Raised Creatinine Value|1|||
156392133|NCT00440531|564527764|FG000|Overall Study|Adverse Event|1|||
156392134|NCT00440531|564527765|FG001|Overall Study|Adverse Event|0|||
156392135|NCT00440531|564527766|FG002|Overall Study|Adverse Event|2|||
156392136|NCT00440531|564527764|FG000|Overall Study|Withdrawal by Subject|2|||
156392137|NCT00440531|564527765|FG001|Overall Study|Withdrawal by Subject|0|||
156392138|NCT00440531|564527766|FG002|Overall Study|Withdrawal by Subject|0|||
156392139|NCT00440531|564527764|FG000|Overall Study|Protocol Violation|1|||
156392140|NCT00440531|564527765|FG001|Overall Study|Protocol Violation|2|||
156392141|NCT00440531|564527766|FG002|Overall Study|Protocol Violation|0|||
156392142|NCT00440531|564527764|FG000|Overall Study|Lost to Follow-up|4|||
156392143|NCT00440531|564527765|FG001|Overall Study|Lost to Follow-up|3|||
156392144|NCT00440531|564527766|FG002|Overall Study|Lost to Follow-up|5|||
156392145|NCT00440531|564527764|FG000|Overall Study|see pre-assignment details|2|||
156392146|NCT00440531|564527765|FG001|Overall Study|see pre-assignment details|0|||
156392147|NCT00440531|564527766|FG002|Overall Study|see pre-assignment details|0|||
156392148|NCT03318523|564527769|FG000|PC Period: Up to Year 1|Adverse Event|1|||
156392149|NCT03318523|564527770|FG001|PC Period: Up to Year 1|Adverse Event|0|||
156392150|NCT03318523|564527771|FG002|PC Period: Up to Year 1|Adverse Event|2|||
156392151|NCT03318523|564527772|FG003|PC Period: Up to Year 1|Adverse Event|0|||
156392152|NCT03318523|564527773|FG004|PC Period: Up to Year 1|Adverse Event|0|||
156392153|NCT03318523|564527774|FG005|PC Period: Up to Year 1|Adverse Event|0|||
156392154|NCT03318523|564527775|FG006|PC Period: Up to Year 1|Adverse Event|0|||
156392155|NCT03318523|564527776|FG007|PC Period: Up to Year 1|Adverse Event|0|||
156392156|NCT03318523|564527777|FG008|PC Period: Up to Year 1|Adverse Event|0|||
156392157|NCT03318523|564527778|FG009|PC Period: Up to Year 1|Adverse Event|0|||
156392158|NCT03318523|564527769|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
156392159|NCT03318523|564527770|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
156392160|NCT03318523|564527771|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
156392161|NCT03318523|564527772|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
156392162|NCT03318523|564527773|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
156392163|NCT03318523|564527774|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
156392164|NCT03318523|564527775|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
156392165|NCT03318523|564527776|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
156392166|NCT03318523|564527777|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
156392167|NCT03318523|564527778|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
156392168|NCT03318523|564527769|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156392169|NCT03318523|564527770|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156392170|NCT03318523|564527771|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156392171|NCT03318523|564527772|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156392172|NCT03318523|564527773|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
156508708|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
156392173|NCT03318523|564527774|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156392174|NCT03318523|564527775|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156392175|NCT03318523|564527776|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
156392176|NCT03318523|564527777|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156392177|NCT03318523|564527778|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
156392178|NCT03318523|564527769|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156392179|NCT03318523|564527770|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156392180|NCT03318523|564527771|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156392181|NCT03318523|564527772|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156392182|NCT03318523|564527773|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
156392183|NCT03318523|564527774|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156392184|NCT03318523|564527775|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156392185|NCT03318523|564527776|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
156392186|NCT03318523|564527777|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
156392187|NCT03318523|564527778|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
156392188|NCT03318523|564527769|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392189|NCT03318523|564527770|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392190|NCT03318523|564527771|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392191|NCT03318523|564527772|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392192|NCT03318523|564527773|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392193|NCT03318523|564527774|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
156392194|NCT03318523|564527775|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392195|NCT03318523|564527776|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392196|NCT03318523|564527777|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392197|NCT03318523|564527778|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156392198|NCT03318523|564527769|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392199|NCT03318523|564527770|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392200|NCT03318523|564527771|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392201|NCT03318523|564527772|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392202|NCT03318523|564527773|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392203|NCT03318523|564527774|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392204|NCT03318523|564527775|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392205|NCT03318523|564527776|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392206|NCT03318523|564527777|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156392207|NCT03318523|564527778|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
156392208|NCT03318523|564527769|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
156392209|NCT03318523|564527770|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
156392210|NCT03318523|564527771|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
156392211|NCT03318523|564527772|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
156392212|NCT03318523|564527773|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
156392213|NCT03318523|564527774|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
156392214|NCT03318523|564527775|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
156392215|NCT03318523|564527776|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
156392216|NCT03318523|564527777|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
156392217|NCT03318523|564527778|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
156392218|NCT03318523|564527769|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156392219|NCT03318523|564527770|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156392220|NCT03318523|564527771|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156392221|NCT03318523|564527772|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156392222|NCT03318523|564527773|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
156392223|NCT03318523|564527774|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156392224|NCT03318523|564527775|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156392225|NCT03318523|564527776|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
156392226|NCT03318523|564527777|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
156392227|NCT03318523|564527778|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156392228|NCT01615328|564527783|FG000|Overall Study|Lost to Follow-up|3|||
156392229|NCT01615328|564527784|FG001|Overall Study|Lost to Follow-up|5|||
156392230|NCT02548455|564527785|FG000|Overall Study|Withdrawal by Subject|27|||
156392231|NCT02548455|564527785|FG000|Overall Study|Death|26|||
156392232|NCT02548455|564527785|FG000|Overall Study|Lost to Follow-up|14|||
156392233|NCT02548455|564527785|FG000|Overall Study|Visit not completed|173|||
156392234|NCT00254982|564527786|FG000|Overall Study|Other|2|||
156392235|NCT00254982|564527787|FG001|Overall Study|Other|1|||
156392236|NCT00254982|564527786|FG000|Overall Study|Lack of Efficacy|5|||
156392237|NCT00254982|564527787|FG001|Overall Study|Lack of Efficacy|3|||
156392238|NCT00254982|564527786|FG000|Overall Study|Lost to Follow-up|5|||
156392239|NCT00254982|564527787|FG001|Overall Study|Lost to Follow-up|3|||
156392240|NCT00254982|564527786|FG000|Overall Study|Adverse Event|18|||
156392241|NCT00254982|564527787|FG001|Overall Study|Adverse Event|16|||
156548497|NCT02669017|565100356|FG006|Overall Study|Lost to Follow-up|0|||
156548498|NCT02669017|565100357|FG007|Overall Study|Lost to Follow-up|0|||
156548499|NCT02669017|565100358|FG008|Overall Study|Lost to Follow-up|1|||
156548500|NCT02669017|565100350|FG000|Overall Study|Miscellaneous|0|||
156548501|NCT02669017|565100351|FG001|Overall Study|Miscellaneous|0|||
156392242|NCT00254982|564527786|FG000|Overall Study|Withdrawal by Subject|1|||
156392243|NCT00254982|564527787|FG001|Overall Study|Withdrawal by Subject|1|||
156392244|NCT00254982|564527786|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
156392245|NCT00254982|564527787|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
156392246|NCT00254982|564527786|FG000|Overall Study|Protocol deviation|1|||
156392247|NCT00254982|564527787|FG001|Overall Study|Protocol deviation|1|||
156548502|NCT02669017|565100352|FG002|Overall Study|Miscellaneous|0|||
156548503|NCT02669017|565100353|FG003|Overall Study|Miscellaneous|0|||
156548504|NCT02669017|565100354|FG004|Overall Study|Miscellaneous|2|||
156548505|NCT02669017|565100355|FG005|Overall Study|Miscellaneous|1|||
156548506|NCT02669017|565100356|FG006|Overall Study|Miscellaneous|1|||
156548507|NCT02669017|565100357|FG007|Overall Study|Miscellaneous|13|||
156392248|NCT00254982|564527786|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
156392249|NCT00254982|564527787|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
156392250|NCT00254982|564527786|FG000|Overall Study|Malignancy|0|||
156392251|NCT00254982|564527787|FG001|Overall Study|Malignancy|2|||
156392252|NCT00254982|564527786|FG000|Overall Study|Opportunistic infection|1|||
156392253|NCT00254982|564527787|FG001|Overall Study|Opportunistic infection|0|||
156392254|NCT00254982|564527786|FG000|Overall Study|Abnormal liver function tests|2|||
156392255|NCT00254982|564527787|FG001|Overall Study|Abnormal liver function tests|1|||
156392256|NCT01292876|564527788|FG000|Overall Study|Physician Decision|4|||
156392257|NCT01137474|564527794|FG000|Overall Study|Adverse Event|3|||
156392258|NCT01137474|564527795|FG001|Overall Study|Adverse Event|5|||
156392259|NCT01137474|564527796|FG002|Overall Study|Adverse Event|1|||
156392260|NCT01137474|564527797|FG003|Overall Study|Adverse Event|3|||
156392261|NCT01137474|564527794|FG000|Overall Study|Withdrawal by Subject|7|||
156392262|NCT01137474|564527795|FG001|Overall Study|Withdrawal by Subject|2|||
156392263|NCT01137474|564527796|FG002|Overall Study|Withdrawal by Subject|6|||
156392264|NCT01137474|564527797|FG003|Overall Study|Withdrawal by Subject|9|||
156392265|NCT01137474|564527794|FG000|Overall Study|No longer met study criteria|6|||
156392266|NCT01137474|564527795|FG001|Overall Study|No longer met study criteria|1|||
156392267|NCT01137474|564527796|FG002|Overall Study|No longer met study criteria|0|||
156392268|NCT01137474|564527797|FG003|Overall Study|No longer met study criteria|5|||
156392269|NCT01137474|564527794|FG000|Overall Study|Lost to Follow-up|5|||
156392270|NCT01137474|564527795|FG001|Overall Study|Lost to Follow-up|1|||
156392271|NCT01137474|564527796|FG002|Overall Study|Lost to Follow-up|0|||
156392272|NCT01137474|564527797|FG003|Overall Study|Lost to Follow-up|2|||
156392273|NCT01137474|564527794|FG000|Overall Study|Lack of Efficacy|0|||
156392274|NCT01137474|564527795|FG001|Overall Study|Lack of Efficacy|0|||
156392275|NCT01137474|564527796|FG002|Overall Study|Lack of Efficacy|0|||
156392276|NCT01137474|564527797|FG003|Overall Study|Lack of Efficacy|2|||
156392277|NCT01137474|564527794|FG000|Overall Study|Other|3|||
156392278|NCT01137474|564527795|FG001|Overall Study|Other|1|||
156392279|NCT01137474|564527796|FG002|Overall Study|Other|0|||
156392280|NCT01137474|564527797|FG003|Overall Study|Other|0|||
156392281|NCT01137474|564527794|FG000|Overall Study|Pregnancy|0|||
156392282|NCT01137474|564527795|FG001|Overall Study|Pregnancy|1|||
156392283|NCT01137474|564527796|FG002|Overall Study|Pregnancy|0|||
156392284|NCT01137474|564527797|FG003|Overall Study|Pregnancy|0|||
156392285|NCT01137474|564527794|FG000|Overall Study|Administrative reason by sponsor|0|||
156392286|NCT01137474|564527795|FG001|Overall Study|Administrative reason by sponsor|1|||
156392287|NCT01137474|564527796|FG002|Overall Study|Administrative reason by sponsor|0|||
156392288|NCT01137474|564527797|FG003|Overall Study|Administrative reason by sponsor|0|||
156392289|NCT02013622|564527803|FG000|Overall Study|Lost to Follow-up|10|||
156392290|NCT02013622|564527803|FG000|Overall Study|Adverse Event|3|||
156392291|NCT02013622|564527803|FG000|Overall Study|Met Withdrawal Criteria|3|||
156392292|NCT02013622|564527803|FG000|Overall Study|Withdrawal by Subject|6|||
156392293|NCT02013622|564527803|FG000|Overall Study|Protocol Deviation|1|||
156392294|NCT02013622|564527803|FG000|Overall Study|Lack of Efficacy|1|||
156392295|NCT00224874|564527804|FG000|Overall Study|Withdrawal by Subject|0|||
156392296|NCT00224874|564527805|FG001|Overall Study|Withdrawal by Subject|0|||
156548508|NCT02669017|565100358|FG008|Overall Study|Miscellaneous|2|||
156548509|NCT00915681|565100363|FG000|Overall Study|Screening failures|46|||
156392297|NCT00224874|564527806|FG002|Overall Study|Withdrawal by Subject|1|||
156392298|NCT00224874|564527807|FG003|Overall Study|Withdrawal by Subject|0|||
156392299|NCT02355002|564527808|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
156392300|NCT02355002|564527809|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
156392301|NCT02355002|564527808|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
156392302|NCT02355002|564527809|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
156392303|NCT02355002|564527808|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
156392304|NCT02355002|564527809|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
156548510|NCT03221751|565100366|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
156548511|NCT03221751|565100367|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
156548512|NCT02559687|565100368|FG000|Overall Study|Death|112|||
156548513|NCT02559687|565100368|FG000|Overall Study|Sponsor Decision|5|||
156548514|NCT02559687|565100368|FG000|Overall Study|Withdrawal by Subject|4|||
156548515|NCT03245450|565100370|FG000|Overall Study|Radiological disease progression|3|||
156548516|NCT03245450|565100371|FG001|Overall Study|Radiological disease progression|3|||
156548517|NCT03245450|565100372|FG002|Overall Study|Radiological disease progression|2|||
156392305|NCT02355002|564527808|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
156392306|NCT02355002|564527809|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
156392307|NCT02355002|564527808|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
156392308|NCT02355002|564527809|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
156392309|NCT02355002|564527808|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
156392310|NCT02355002|564527809|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
156392311|NCT02355002|564527808|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
156392312|NCT02355002|564527809|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
156392313|NCT05554237|564527810|FG000|Part 2 (7 Days)|Adverse Event|0|||
156392314|NCT05554237|564527811|FG001|Part 2 (7 Days)|Adverse Event|0|||
156392315|NCT05554237|564527812|FG002|Part 2 (7 Days)|Adverse Event|0|||
156392316|NCT05554237|564527813|FG003|Part 2 (7 Days)|Adverse Event|0|||
156392317|NCT05554237|564527814|FG004|Part 2 (7 Days)|Adverse Event|2|||
156392318|NCT05554237|564527815|FG005|Part 2 (7 Days)|Adverse Event|0|||
156392319|NCT05554237|564527816|FG006|Part 2 (7 Days)|Adverse Event|0|||
156392320|NCT05554237|564527817|FG007|Part 2 (7 Days)|Adverse Event|0|||
156392321|NCT05554237|564527818|FG008|Part 2 (7 Days)|Adverse Event|0|||
156392322|NCT05554237|564527819|FG009|Part 2 (7 Days)|Adverse Event|1|||
156392323|NCT05554237|564527820|FG010|Part 2 (7 Days)|Adverse Event|0|||
156392324|NCT05554237|564527821|FG011|Part 2 (7 Days)|Adverse Event|0|||
156392325|NCT05554237|564527822|FG012|Part 2 (7 Days)|Adverse Event|1|||
156392326|NCT05554237|564527823|FG013|Part 2 (7 Days)|Adverse Event|0|||
156392327|NCT05130970|564527826|FG000|Overall Study|Adverse Event|1|||
156392328|NCT05130970|564527827|FG001|Overall Study|Adverse Event|1|||
156392329|NCT05130970|564527826|FG000|Overall Study|Death|0|||
156392330|NCT05130970|564527827|FG001|Overall Study|Death|1|||
156392331|NCT05130970|564527826|FG000|Overall Study|Lost to Follow-up|0|||
156392332|NCT05130970|564527827|FG001|Overall Study|Lost to Follow-up|1|||
156392333|NCT05130970|564527826|FG000|Overall Study|Physician Decision|0|||
156392334|NCT05130970|564527827|FG001|Overall Study|Physician Decision|1|||
156392335|NCT05130970|564527826|FG000|Overall Study|Withdrawal by Subject|1|||
156392336|NCT05130970|564527827|FG001|Overall Study|Withdrawal by Subject|1|||
156392337|NCT03644186|564527828|FG000|Overall Study|Withdrawal by Subject|1|||
156392338|NCT03644186|564527829|FG001|Overall Study|Withdrawal by Subject|1|||
156392339|NCT04969198|564527832|FG000|Overall Study|Withdrawal by Subject|20|||
156392340|NCT04969198|564527832|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
156392341|NCT04969198|564527832|FG000|Overall Study|Lost to Follow-up|20|||
156392342|NCT02701985|564527833|FG000|Overall Study|Withdrawal by Subject|1|||
156392343|NCT02701985|564527834|FG001|Overall Study|Withdrawal by Subject|1|||
156392344|NCT02701985|564527833|FG000|Overall Study|Lost to Follow-up|1|||
156392345|NCT02701985|564527834|FG001|Overall Study|Lost to Follow-up|0|||
156392346|NCT02701985|564527833|FG000|Overall Study|Death|1|||
156392347|NCT02701985|564527834|FG001|Overall Study|Death|0|||
156392348|NCT02701985|564527833|FG000|Overall Study|Adverse Event|0|||
156392349|NCT02701985|564527834|FG001|Overall Study|Adverse Event|5|||
156392350|NCT01640808|564527836|FG000|Overall Study|Unable to continue dynamic CT|14|||
156392351|NCT01640808|564527837|FG001|Overall Study|Unable to continue dynamic CT|4|||
156392352|NCT01640808|564527836|FG000|Overall Study|Withdrawal by Subject|12|||
156392353|NCT01640808|564527837|FG001|Overall Study|Withdrawal by Subject|4|||
156392354|NCT01640808|564527836|FG000|Overall Study|Lost to Follow-up|4|||
156392355|NCT01640808|564527837|FG001|Overall Study|Lost to Follow-up|0|||
156392356|NCT01640808|564527836|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
156392357|NCT01640808|564527837|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
156392358|NCT01640808|564527836|FG000|Overall Study|Administration of anticancer drugs|2|||
156392359|NCT01640808|564527837|FG001|Overall Study|Administration of anticancer drugs|1|||
156392360|NCT01640808|564527836|FG000|Overall Study|Physician Decision|19|||
156392361|NCT01640808|564527837|FG001|Overall Study|Physician Decision|5|||
156392362|NCT01640808|564527836|FG000|Overall Study|Randomized but not treated|4|||
156392363|NCT01640808|564527837|FG001|Overall Study|Randomized but not treated|2|||
156392364|NCT02477111|564527838|FG000|Overall Study|Death|28|||
156392365|NCT02477111|564527838|FG000|Overall Study|Withdrawal by Subject|19|||
156392366|NCT02477111|564527838|FG000|Overall Study|Lost to Follow-up|4|||
156392367|NCT02192502|564527840|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
156548518|NCT03245450|565100373|FG003|Overall Study|Radiological disease progression|2|||
156392368|NCT02192502|564527841|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
156392369|NCT02192502|564527840|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
156392370|NCT02192502|564527841|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
156392371|NCT02192502|564527840|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
156392372|NCT02192502|564527841|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
156392373|NCT01381692|564527842|FG000|Overall Study|Adverse Event|1|||
156392374|NCT01381692|564527843|FG001|Overall Study|Adverse Event|0|||
156392375|NCT01381692|564527844|FG002|Overall Study|Adverse Event|0|||
156392376|NCT01381692|564527845|FG003|Overall Study|Adverse Event|0|||
156392377|NCT01381692|564527846|FG004|Overall Study|Adverse Event|0|||
156392378|NCT01381692|564527847|FG005|Overall Study|Adverse Event|0|||
156392379|NCT03896035|564527852|FG000|Overall Study|Lost to Follow-up|2|||
156392380|NCT03896035|564527853|FG001|Overall Study|Lost to Follow-up|6|||
156392381|NCT03896035|564527852|FG000|Overall Study|Withdrawal by Subject|0|||
156392382|NCT03896035|564527853|FG001|Overall Study|Withdrawal by Subject|1|||
156392383|NCT03896035|564527852|FG000|Overall Study|Health/family health issues during COVID|0|||
156392384|NCT03896035|564527853|FG001|Overall Study|Health/family health issues during COVID|4|||
156392385|NCT01556438|564527854|FG000|Overall Study|Adverse Event|4|||
156392386|NCT01556438|564527855|FG001|Overall Study|Adverse Event|2|||
156392387|NCT01556438|564527854|FG000|Overall Study|Sponsor Decision|0|||
156392388|NCT01556438|564527855|FG001|Overall Study|Sponsor Decision|2|||
156392389|NCT01556438|564527854|FG000|Overall Study|Progressive Disease|0|||
156392390|NCT01556438|564527855|FG001|Overall Study|Progressive Disease|6|||
156392391|NCT01556438|564527854|FG000|Overall Study|Death|0|||
156392392|NCT01556438|564527855|FG001|Overall Study|Death|1|||
156392393|NCT01506193|564527858|FG000|Overall Study|Protocol Violation|1|||
156392394|NCT01506193|564527859|FG001|Overall Study|Protocol Violation|0|||
156392395|NCT01506193|564527860|FG002|Overall Study|Protocol Violation|1|||
156392396|NCT01506193|564527858|FG000|Overall Study|Migrated/moved from study area|0|||
156392397|NCT01506193|564527859|FG001|Overall Study|Migrated/moved from study area|0|||
156392398|NCT01506193|564527860|FG002|Overall Study|Migrated/moved from study area|1|||
156392399|NCT01506193|564527858|FG000|Overall Study|Adverse event, non-fatal|0|||
156392400|NCT01506193|564527859|FG001|Overall Study|Adverse event, non-fatal|0|||
156392401|NCT01506193|564527860|FG002|Overall Study|Adverse event, non-fatal|1|||
156392402|NCT01506193|564527858|FG000|Overall Study|Withdrawal by Subject|5|||
156392403|NCT01506193|564527859|FG001|Overall Study|Withdrawal by Subject|1|||
156392404|NCT01506193|564527860|FG002|Overall Study|Withdrawal by Subject|8|||
156392405|NCT01506193|564527858|FG000|Overall Study|Lost to Follow-up|8|||
156392406|NCT01506193|564527859|FG001|Overall Study|Lost to Follow-up|3|||
156392407|NCT01506193|564527860|FG002|Overall Study|Lost to Follow-up|3|||
156392408|NCT01388816|564527864|FG000|Overall Study|Adverse Event|0|||
156392409|NCT01388816|564527865|FG001|Overall Study|Adverse Event|2|||
156392410|NCT01388816|564527866|FG002|Overall Study|Adverse Event|0|||
156392411|NCT01388816|564527867|FG003|Overall Study|Adverse Event|0|||
156392412|NCT01388816|564527864|FG000|Overall Study|Lost to Follow-up|0|||
156392413|NCT01388816|564527865|FG001|Overall Study|Lost to Follow-up|1|||
156392414|NCT01388816|564527866|FG002|Overall Study|Lost to Follow-up|0|||
156392415|NCT01388816|564527867|FG003|Overall Study|Lost to Follow-up|0|||
156392416|NCT01388816|564527864|FG000|Overall Study|Withdrawal by Subject|2|||
156392417|NCT01388816|564527865|FG001|Overall Study|Withdrawal by Subject|1|||
156392418|NCT01388816|564527866|FG002|Overall Study|Withdrawal by Subject|1|||
156392419|NCT01388816|564527867|FG003|Overall Study|Withdrawal by Subject|0|||
156392420|NCT01388816|564527864|FG000|Overall Study|Protocol Violation|0|||
156392421|NCT01388816|564527865|FG001|Overall Study|Protocol Violation|0|||
156392422|NCT01388816|564527866|FG002|Overall Study|Protocol Violation|2|||
156392423|NCT01388816|564527867|FG003|Overall Study|Protocol Violation|0|||
156392424|NCT04575467|564527868|FG000|Overall Study|Adverse Event|0|||
156392425|NCT04575467|564527869|FG001|Overall Study|Adverse Event|1|||
156392426|NCT04575467|564527870|FG002|Overall Study|Adverse Event|0|||
156392427|NCT04575467|564527871|FG003|Overall Study|Adverse Event|0|||
156392428|NCT00743366|564527872|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
156392429|NCT00743366|564527873|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
156392430|NCT01328574|564527874|FG000|Overall Study|Refused further treatment|1|||
156392431|NCT03206203|564527875|FG000|Treatment|Death|38|||
156392432|NCT03206203|564527876|FG001|Treatment|Death|26|||
156392433|NCT03206203|564527877|FG002|Treatment|Death|0|||
156392434|NCT03206203|564527875|FG000|Treatment|Withdrawal by Subject|1|||
156392435|NCT03206203|564527876|FG001|Treatment|Withdrawal by Subject|0|||
156392436|NCT03206203|564527877|FG002|Treatment|Withdrawal by Subject|0|||
156392437|NCT03206203|564527875|FG000|Treatment|Lost to Follow-up|4|||
156392438|NCT03206203|564527876|FG001|Treatment|Lost to Follow-up|0|||
156508709|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
156392439|NCT03206203|564527877|FG002|Treatment|Lost to Follow-up|0|||
156392440|NCT03206203|564527875|FG000|Treatment|N/A in Follow-Up|8|||
156392441|NCT03206203|564527876|FG001|Treatment|N/A in Follow-Up|1|||
156392442|NCT03206203|564527877|FG002|Treatment|N/A in Follow-Up|0|||
156392443|NCT03206203|564527875|FG000|Treatment|Disease progression|0|||
156392444|NCT03206203|564527876|FG001|Treatment|Disease progression|1|||
156392445|NCT03206203|564527877|FG002|Treatment|Disease progression|0|||
156392446|NCT03206203|564527875|FG000|Treatment|Refused follow-up|0|||
156548519|NCT03245450|565100374|FG004|Overall Study|Radiological disease progression|7|||
156548520|NCT03245450|565100375|FG005|Overall Study|Radiological disease progression|6|||
156548521|NCT03245450|565100376|FG006|Overall Study|Radiological disease progression|6|||
156392447|NCT03206203|564527876|FG001|Treatment|Refused follow-up|1|||
156392448|NCT03206203|564527877|FG002|Treatment|Refused follow-up|0|||
156392449|NCT03206203|564527875|FG000|Treatment|Cross over to Arm 1|0|||
156392450|NCT03206203|564527876|FG001|Treatment|Cross over to Arm 1|19|||
156392451|NCT03206203|564527877|FG002|Treatment|Cross over to Arm 1|0|||
156548522|NCT03245450|565100370|FG000|Overall Study|Clinical disease progression|0|||
156548523|NCT03245450|565100371|FG001|Overall Study|Clinical disease progression|0|||
156548524|NCT03245450|565100372|FG002|Overall Study|Clinical disease progression|1|||
156548525|NCT03245450|565100373|FG003|Overall Study|Clinical disease progression|0|||
156548526|NCT03245450|565100374|FG004|Overall Study|Clinical disease progression|0|||
156548527|NCT03245450|565100375|FG005|Overall Study|Clinical disease progression|2|||
156548528|NCT03245450|565100376|FG006|Overall Study|Clinical disease progression|0|||
156548529|NCT03245450|565100370|FG000|Overall Study|Other|0|||
156548530|NCT03245450|565100371|FG001|Overall Study|Other|0|||
156548531|NCT03245450|565100372|FG002|Overall Study|Other|0|||
156548532|NCT03245450|565100373|FG003|Overall Study|Other|1|||
156548533|NCT03245450|565100374|FG004|Overall Study|Other|1|||
156548534|NCT03245450|565100375|FG005|Overall Study|Other|1|||
156548535|NCT03245450|565100376|FG006|Overall Study|Other|1|||
156548536|NCT03245450|565100370|FG000|Overall Study|Withdrawal by Subject|0|||
156392452|NCT03206203|564527875|FG000|Optional Cross-Over|Death|0|||
156392453|NCT03206203|564527876|FG001|Optional Cross-Over|Death|0|||
156392454|NCT03206203|564527877|FG002|Optional Cross-Over|Death|14|||
156392455|NCT03206203|564527875|FG000|Optional Cross-Over|Refused follow-up|0|||
156392456|NCT03206203|564527876|FG001|Optional Cross-Over|Refused follow-up|0|||
156392457|NCT03206203|564527877|FG002|Optional Cross-Over|Refused follow-up|2|||
156392458|NCT01152580|564527886|FG000|Overall Study|Withdrawal by Subject|0|||
156392459|NCT01152580|564527887|FG001|Overall Study|Withdrawal by Subject|1|||
156392460|NCT02308748|564527888|FG000|Period 1|Withdrawal by Subject|0|||
156392461|NCT02308748|564527889|FG001|Period 1|Withdrawal by Subject|0|||
156392462|NCT02308748|564527890|FG002|Period 1|Withdrawal by Subject|1|||
156392463|NCT02308748|564527891|FG003|Period 1|Withdrawal by Subject|0|||
156392464|NCT02308748|564527892|FG004|Period 1|Withdrawal by Subject|0|||
156392465|NCT02308748|564527893|FG005|Period 1|Withdrawal by Subject|0|||
156392466|NCT02308748|564527894|FG006|Period 1|Withdrawal by Subject|0|||
156392467|NCT02308748|564527895|FG007|Period 1|Withdrawal by Subject|0|||
156392468|NCT02308748|564527896|FG008|Period 1|Withdrawal by Subject|0|||
156392469|NCT02308748|564527897|FG009|Period 1|Withdrawal by Subject|0|||
156392470|NCT02308748|564527888|FG000|Period 2|Adverse Event|0|||
156392471|NCT02308748|564527889|FG001|Period 2|Adverse Event|0|||
156392472|NCT02308748|564527890|FG002|Period 2|Adverse Event|0|||
156392473|NCT02308748|564527891|FG003|Period 2|Adverse Event|0|||
156392474|NCT02308748|564527892|FG004|Period 2|Adverse Event|0|||
156392475|NCT02308748|564527893|FG005|Period 2|Adverse Event|0|||
156392476|NCT02308748|564527894|FG006|Period 2|Adverse Event|0|||
156392477|NCT02308748|564527895|FG007|Period 2|Adverse Event|1|||
156392478|NCT02308748|564527896|FG008|Period 2|Adverse Event|0|||
156392479|NCT02308748|564527897|FG009|Period 2|Adverse Event|0|||
156392480|NCT02308748|564527888|FG000|Period 3|Protocol Violation|0|||
156392481|NCT02308748|564527889|FG001|Period 3|Protocol Violation|0|||
156392482|NCT02308748|564527890|FG002|Period 3|Protocol Violation|0|||
156392483|NCT02308748|564527891|FG003|Period 3|Protocol Violation|0|||
156392484|NCT02308748|564527892|FG004|Period 3|Protocol Violation|0|||
156392485|NCT02308748|564527893|FG005|Period 3|Protocol Violation|0|||
156392486|NCT02308748|564527894|FG006|Period 3|Protocol Violation|0|||
156392487|NCT02308748|564527895|FG007|Period 3|Protocol Violation|0|||
156392488|NCT02308748|564527896|FG008|Period 3|Protocol Violation|0|||
156392489|NCT02308748|564527897|FG009|Period 3|Protocol Violation|1|||
156392490|NCT02308748|564527888|FG000|Period 5|Adverse Event|1|||
156392491|NCT02308748|564527889|FG001|Period 5|Adverse Event|0|||
156392492|NCT02308748|564527890|FG002|Period 5|Adverse Event|0|||
156392493|NCT02308748|564527891|FG003|Period 5|Adverse Event|0|||
156392494|NCT02308748|564527892|FG004|Period 5|Adverse Event|0|||
156392495|NCT02308748|564527893|FG005|Period 5|Adverse Event|0|||
156392496|NCT02308748|564527894|FG006|Period 5|Adverse Event|0|||
156392497|NCT02308748|564527895|FG007|Period 5|Adverse Event|0|||
156392498|NCT02308748|564527896|FG008|Period 5|Adverse Event|1|||
156392499|NCT02308748|564527897|FG009|Period 5|Adverse Event|0|||
156392500|NCT01994954|564527898|FG000|Overall Study|Death|1|||
156392501|NCT01994954|564527899|FG001|Overall Study|Death|0|||
156392502|NCT01994954|564527898|FG000|Overall Study|Withdrawal by Subject|9|||
156392503|NCT01994954|564527899|FG001|Overall Study|Withdrawal by Subject|14|||
156392504|NCT01994954|564527898|FG000|Overall Study|Physician Decision|2|||
156392505|NCT01994954|564527899|FG001|Overall Study|Physician Decision|2|||
156392506|NCT01994954|564527898|FG000|Overall Study|Lost to Follow-up|8|||
156392507|NCT01994954|564527899|FG001|Overall Study|Lost to Follow-up|10|||
156392508|NCT01994954|564527898|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
156548537|NCT03245450|565100371|FG001|Overall Study|Withdrawal by Subject|1|||
156548538|NCT03245450|565100372|FG002|Overall Study|Withdrawal by Subject|0|||
156548539|NCT03245450|565100373|FG003|Overall Study|Withdrawal by Subject|0|||
156548540|NCT03245450|565100374|FG004|Overall Study|Withdrawal by Subject|0|||
156548541|NCT03245450|565100375|FG005|Overall Study|Withdrawal by Subject|0|||
156548542|NCT03245450|565100376|FG006|Overall Study|Withdrawal by Subject|0|||
156548543|NCT03245450|565100370|FG000|Overall Study|Adverse Event|0|||
156548544|NCT03245450|565100371|FG001|Overall Study|Adverse Event|0|||
156548545|NCT03245450|565100372|FG002|Overall Study|Adverse Event|0|||
156548546|NCT03245450|565100373|FG003|Overall Study|Adverse Event|0|||
156548547|NCT03245450|565100374|FG004|Overall Study|Adverse Event|1|||
156548548|NCT03245450|565100375|FG005|Overall Study|Adverse Event|0|||
156548549|NCT03245450|565100376|FG006|Overall Study|Adverse Event|2|||
156548550|NCT00705939|565100379|FG000|Overall Study|Protocol Violation|0|||
156548551|NCT00705939|565100380|FG001|Overall Study|Protocol Violation|0|||
156548552|NCT00705939|565100381|FG002|Overall Study|Protocol Violation|1|||
156392509|NCT01994954|564527899|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
156392510|NCT00449176|564527900|FG000|Overall Study|Withdrawal by Subject|39|||
156548553|NCT00705939|565100379|FG000|Overall Study|Withdrawal by Subject|0|||
156548554|NCT00705939|565100380|FG001|Overall Study|Withdrawal by Subject|1|||
156548555|NCT00705939|565100381|FG002|Overall Study|Withdrawal by Subject|3|||
156392511|NCT00449176|564527901|FG001|Overall Study|Withdrawal by Subject|43|||
156392512|NCT00449176|564527902|FG002|Overall Study|Withdrawal by Subject|59|||
156392513|NCT00449176|564527900|FG000|Overall Study|Lost to Follow-up|13|||
156392514|NCT00449176|564527901|FG001|Overall Study|Lost to Follow-up|8|||
156548556|NCT00705939|565100379|FG000|Overall Study|Physician Decision|0|||
156548557|NCT00705939|565100380|FG001|Overall Study|Physician Decision|1|||
156548558|NCT00705939|565100381|FG002|Overall Study|Physician Decision|0|||
156548559|NCT00464334|565100387|FG000|Overall Study|Adverse Event|0|||
156548560|NCT00464334|565100388|FG001|Overall Study|Adverse Event|0|||
156548561|NCT00464334|565100389|FG002|Overall Study|Adverse Event|0|||
156548562|NCT00464334|565100390|FG003|Overall Study|Adverse Event|1|||
156548563|NCT00464334|565100391|FG004|Overall Study|Adverse Event|1|||
156392515|NCT00449176|564527902|FG002|Overall Study|Lost to Follow-up|12|||
156392516|NCT00449176|564527900|FG000|Overall Study|Adverse Event|51|||
156392517|NCT00449176|564527901|FG001|Overall Study|Adverse Event|107|||
156392518|NCT00449176|564527902|FG002|Overall Study|Adverse Event|15|||
156392519|NCT00449176|564527900|FG000|Overall Study|Lack of Efficacy|13|||
156392520|NCT00449176|564527901|FG001|Overall Study|Lack of Efficacy|7|||
156392521|NCT00449176|564527902|FG002|Overall Study|Lack of Efficacy|50|||
156392522|NCT00449176|564527900|FG000|Overall Study|Study drug non-compliant|14|||
156392523|NCT00449176|564527901|FG001|Overall Study|Study drug non-compliant|11|||
156392524|NCT00449176|564527902|FG002|Overall Study|Study drug non-compliant|11|||
156392525|NCT00449176|564527900|FG000|Overall Study|all other|22|||
156392526|NCT00449176|564527901|FG001|Overall Study|all other|19|||
156392527|NCT00449176|564527902|FG002|Overall Study|all other|20|||
156392528|NCT00675766|564527903|FG000|Overall Study|Lost to Follow-up|6|||
156392529|NCT00675766|564527904|FG001|Overall Study|Lost to Follow-up|5|||
156392530|NCT00675766|564527905|FG002|Overall Study|Lost to Follow-up|21|||
156392531|NCT00675766|564527906|FG003|Overall Study|Lost to Follow-up|26|||
156392532|NCT02472964|564527907|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
156392533|NCT02472964|564527908|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
156392534|NCT02472964|564527907|FG000|Part 1 (up to Week 24)|disease progression|58|||
156392535|NCT02472964|564527908|FG001|Part 1 (up to Week 24)|disease progression|47|||
156392536|NCT02472964|564527907|FG000|Part 1 (up to Week 24)|Death|3|||
156392537|NCT02472964|564527908|FG001|Part 1 (up to Week 24)|Death|6|||
156392538|NCT02472964|564527907|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
156392539|NCT02472964|564527908|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
156392540|NCT02472964|564527907|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
156392541|NCT02472964|564527908|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
156392542|NCT02472964|564527907|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
156392543|NCT02472964|564527908|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
156392544|NCT02472964|564527907|FG000|Part 1 (up to Week 24)|Other|2|||
156392545|NCT02472964|564527908|FG001|Part 1 (up to Week 24)|Other|1|||
156392546|NCT02472964|564527907|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
156392547|NCT02472964|564527908|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
156392548|NCT02472964|564527907|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
156548564|NCT00464334|565100392|FG005|Overall Study|Adverse Event|1|||
156548565|NCT00464334|565100393|FG006|Overall Study|Adverse Event|0|||
156548566|NCT00464334|565100394|FG007|Overall Study|Adverse Event|0|||
156548567|NCT00464334|565100395|FG008|Overall Study|Adverse Event|2|||
156392549|NCT02472964|564527908|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
156392550|NCT02472964|564527907|FG000|Part 2 (Week 24-week 48)|Death|0|||
156392551|NCT02472964|564527908|FG001|Part 2 (Week 24-week 48)|Death|1|||
156392552|NCT02472964|564527907|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
156548568|NCT00464334|565100396|FG009|Overall Study|Adverse Event|1|||
156548569|NCT00464334|565100397|FG010|Overall Study|Adverse Event|2|||
156548570|NCT00464334|565100387|FG000|Overall Study|Lack of Efficacy|0|||
156548571|NCT00464334|565100388|FG001|Overall Study|Lack of Efficacy|1|||
156392553|NCT02472964|564527908|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
156392554|NCT02472964|564527907|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
156392555|NCT02472964|564527908|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
156392556|NCT02472964|564527907|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
156392557|NCT02472964|564527908|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
156392558|NCT02472964|564527907|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
156392559|NCT02472964|564527908|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
156392560|NCT01454583|564527909|FG000|1st Year|Lost to Follow-up|1057|||
156392561|NCT01454583|564527910|FG001|1st Year|Lost to Follow-up|318|||
156392562|NCT01454583|564527911|FG002|1st Year|Lost to Follow-up|180|||
156392563|NCT01454583|564527909|FG000|2nd Year|Lost to Follow-up|3965|||
156392564|NCT01454583|564527910|FG001|2nd Year|Lost to Follow-up|1049|||
156392565|NCT01454583|564527911|FG002|2nd Year|Lost to Follow-up|737|||
156392566|NCT01454583|564527909|FG000|3rd Year|Lost to Follow-up|1959|||
156392567|NCT01454583|564527910|FG001|3rd Year|Lost to Follow-up|512|||
156392568|NCT01454583|564527911|FG002|3rd Year|Lost to Follow-up|297|||
156392569|NCT01749982|564527912|FG000|Overall Study|Physician Decision|0|||
156392570|NCT01749982|564527913|FG001|Overall Study|Physician Decision|0|||
156392571|NCT01749982|564527914|FG002|Overall Study|Physician Decision|0|||
156392572|NCT01749982|564527915|FG003|Overall Study|Physician Decision|1|||
156392573|NCT01749982|564527912|FG000|Overall Study|Lost to Follow-up|0|||
156392574|NCT01749982|564527913|FG001|Overall Study|Lost to Follow-up|0|||
156392575|NCT01749982|564527914|FG002|Overall Study|Lost to Follow-up|0|||
156392576|NCT01749982|564527915|FG003|Overall Study|Lost to Follow-up|1|||
156392577|NCT01749982|564527912|FG000|Overall Study|Withdrawal by Subject|0|||
156392578|NCT01749982|564527913|FG001|Overall Study|Withdrawal by Subject|0|||
156392579|NCT01749982|564527914|FG002|Overall Study|Withdrawal by Subject|0|||
156392580|NCT01749982|564527915|FG003|Overall Study|Withdrawal by Subject|1|||
156392581|NCT01967732|564527916|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
156392582|NCT01967732|564527917|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
156392583|NCT01967732|564527918|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
156392584|NCT01967732|564527919|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
156392585|NCT01967732|564527916|FG000|First Intervention (Day 1)|Poor venous access|0|||
156392586|NCT01967732|564527917|FG001|First Intervention (Day 1)|Poor venous access|1|||
156392587|NCT01967732|564527918|FG002|First Intervention (Day 1)|Poor venous access|0|||
156392588|NCT01967732|564527919|FG003|First Intervention (Day 1)|Poor venous access|0|||
156392589|NCT00113568|564527931|FG000|Overall Study|Adverse Event|97|||
156392590|NCT00113568|564527931|FG000|Overall Study|Death|1|||
156392591|NCT00113568|564527931|FG000|Overall Study|Lack of Efficacy|30|||
156392592|NCT00113568|564527931|FG000|Overall Study|Lost to Follow-up|156|||
156392593|NCT00113568|564527931|FG000|Overall Study|Protocol Violation|32|||
156392594|NCT00113568|564527931|FG000|Overall Study|Withdrawal by Subject|117|||
156392595|NCT00113568|564527931|FG000|Overall Study|Other|112|||
156392596|NCT00377403|564527934|FG000|Overall Study|Unable to contact for telephone intervie|4|||
156392597|NCT00377403|564527935|FG001|Overall Study|Unable to contact for telephone intervie|7|||
156392598|NCT01569438|564527942|FG000|Overall Study|Lack of Efficacy|1|||
156392599|NCT01569438|564527943|FG001|Overall Study|Lack of Efficacy|2|||
156392600|NCT01569438|564527942|FG000|Overall Study|Withdrawal by Subject|0|||
156392601|NCT01569438|564527943|FG001|Overall Study|Withdrawal by Subject|3|||
156392602|NCT01569438|564527942|FG000|Overall Study|Adverse Event|2|||
156392603|NCT01569438|564527943|FG001|Overall Study|Adverse Event|15|||
156392604|NCT01569438|564527942|FG000|Overall Study|Protocol Violation|2|||
156392605|NCT01569438|564527943|FG001|Overall Study|Protocol Violation|0|||
156392606|NCT01569438|564527942|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
156392607|NCT01569438|564527943|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
156392608|NCT01569438|564527942|FG000|Overall Study|Sponsor/Physician decision|1|||
156392609|NCT01569438|564527943|FG001|Overall Study|Sponsor/Physician decision|1|||
156392610|NCT01569438|564527942|FG000|Overall Study|Unable to adhere to study schedule|0|||
156392611|NCT01569438|564527943|FG001|Overall Study|Unable to adhere to study schedule|1|||
156392612|NCT00736645|564527946|FG000|Overall Study|Adverse Event|0|||
156392613|NCT00736645|564527947|FG001|Overall Study|Adverse Event|2|||
156392614|NCT00736645|564527948|FG002|Overall Study|Adverse Event|0|||
156392615|NCT00736645|564527949|FG003|Overall Study|Adverse Event|0|||
156392616|NCT04050865|564530022|FG000|Overall Study|Adverse Event|1|||
156392617|NCT04050865|564530023|FG001|Overall Study|Adverse Event|0|||
156392618|NCT04050865|564530022|FG000|Overall Study|no insert|1|||
156392619|NCT04050865|564530023|FG001|Overall Study|no insert|0|||
156392620|NCT04050865|564530022|FG000|Overall Study|Only 1 insert|2|||
156392621|NCT04050865|564530023|FG001|Overall Study|Only 1 insert|3|||
156392622|NCT04050865|564530022|FG000|Overall Study|Physician Decision|0|||
156392623|NCT04050865|564530023|FG001|Overall Study|Physician Decision|1|||
156392624|NCT04050865|564530022|FG000|Overall Study|Withdrawal by Subject|0|||
156392625|NCT04050865|564530023|FG001|Overall Study|Withdrawal by Subject|1|||
156392626|NCT01266850|564530024|FG000|Overall Study|Lost to Follow-up|19|||
156392627|NCT01266850|564530025|FG001|Overall Study|Lost to Follow-up|19|||
156392628|NCT01266850|564530026|FG002|Overall Study|Lost to Follow-up|13|||
156392629|NCT01266850|564530027|FG003|Overall Study|Lost to Follow-up|13|||
156392630|NCT01266850|564530028|FG004|Overall Study|Lost to Follow-up|12|||
156392631|NCT01266850|564530024|FG000|Overall Study|Withdrawal by Subject|8|||
156392632|NCT01266850|564530025|FG001|Overall Study|Withdrawal by Subject|9|||
156392633|NCT01266850|564530026|FG002|Overall Study|Withdrawal by Subject|6|||
156392634|NCT01266850|564530027|FG003|Overall Study|Withdrawal by Subject|9|||
156392635|NCT01266850|564530028|FG004|Overall Study|Withdrawal by Subject|12|||
156392636|NCT01266850|564530024|FG000|Overall Study|Physician Decision|3|||
156392637|NCT01266850|564530025|FG001|Overall Study|Physician Decision|6|||
156392638|NCT01266850|564530026|FG002|Overall Study|Physician Decision|4|||
156392639|NCT01266850|564530027|FG003|Overall Study|Physician Decision|4|||
156392640|NCT01266850|564530028|FG004|Overall Study|Physician Decision|3|||
156392641|NCT01266850|564530024|FG000|Overall Study|Protocol Violation|0|||
156392642|NCT01266850|564530025|FG001|Overall Study|Protocol Violation|1|||
156392643|NCT01266850|564530026|FG002|Overall Study|Protocol Violation|0|||
156392644|NCT01266850|564530027|FG003|Overall Study|Protocol Violation|1|||
156392645|NCT01266850|564530028|FG004|Overall Study|Protocol Violation|2|||
156392646|NCT01266850|564530024|FG000|Overall Study|Adverse Event|0|||
156392647|NCT01266850|564530025|FG001|Overall Study|Adverse Event|0|||
156392648|NCT01266850|564530026|FG002|Overall Study|Adverse Event|0|||
156392649|NCT01266850|564530027|FG003|Overall Study|Adverse Event|0|||
156392650|NCT01266850|564530028|FG004|Overall Study|Adverse Event|1|||
156392651|NCT01266850|564530024|FG000|Overall Study|Site Closure|0|||
156392652|NCT01266850|564530025|FG001|Overall Study|Site Closure|1|||
156392653|NCT01266850|564530026|FG002|Overall Study|Site Closure|1|||
156392654|NCT01266850|564530027|FG003|Overall Study|Site Closure|1|||
156392655|NCT01266850|564530028|FG004|Overall Study|Site Closure|0|||
156392656|NCT02035332|564530030|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
156392657|NCT00857207|564530031|FG000|Overall Study|Withdrawal by Subject|13|||
156392658|NCT00857207|564530032|FG001|Overall Study|Withdrawal by Subject|0|||
156392659|NCT00857207|564530031|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
156392660|NCT00857207|564530032|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
156392661|NCT00857207|564530031|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
156392662|NCT00857207|564530032|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
156392663|NCT01791725|564530043|FG000|Overall Study|Withdrawal by Subject|0|||
156392664|NCT01791725|564530044|FG001|Overall Study|Withdrawal by Subject|1|||
156392665|NCT01791725|564530045|FG002|Overall Study|Withdrawal by Subject|0|||
156392666|NCT02690974|564530046|FG000|Overall Study|Adverse Event|16|||
156392667|NCT02690974|564530046|FG000|Overall Study|Death|9|||
156392668|NCT02690974|564530046|FG000|Overall Study|Subject/guardian decision|4|||
156392669|NCT02690974|564530046|FG000|Overall Study|Lost to Follow-up|3|||
156392670|NCT02690974|564530046|FG000|Overall Study|Withdrawal of Informed Consent|3|||
156392671|NCT02690974|564530046|FG000|Overall Study|Physician Decision|2|||
156392672|NCT02690974|564530046|FG000|Overall Study|Non-compliance with study treatment|1|||
156392673|NCT02690974|564530046|FG000|Overall Study|Protocol-defined stopping criteria|1|||
156392674|NCT02690974|564530046|FG000|Overall Study|Protocol Deviation|1|||
156392675|NCT01644734|564530052|FG000|Overall Study|Adverse Event|4|||
156392676|NCT01644734|564530052|FG000|Overall Study|Lost to Follow-up|17|||
156392677|NCT01644734|564530052|FG000|Overall Study|Reasons other than stated above|7|||
156392678|NCT01644734|564530052|FG000|Overall Study|Missing documentation|238|||
156392679|NCT02157779|564530057|FG000|Overall Study|Logistical|9|||
156392680|NCT02157779|564530058|FG001|Overall Study|Logistical|3|||
156392681|NCT02157779|564530057|FG000|Overall Study|Stopped attending, reason unknown|11|||
156392682|NCT02157779|564530058|FG001|Overall Study|Stopped attending, reason unknown|7|||
156392683|NCT02157779|564530057|FG000|Overall Study|No response to outreach after Baseline|1|||
156392684|NCT02157779|564530058|FG001|Overall Study|No response to outreach after Baseline|1|||
156392685|NCT02157779|564530057|FG000|Overall Study|Moved|1|||
156392686|NCT02157779|564530058|FG001|Overall Study|Moved|0|||
156392687|NCT02157779|564530057|FG000|Overall Study|Medical|1|||
156392688|NCT02157779|564530058|FG001|Overall Study|Medical|0|||
156392689|NCT02157779|564530057|FG000|Overall Study|Legal issue|1|||
156392690|NCT02157779|564530058|FG001|Overall Study|Legal issue|0|||
156392691|NCT00487162|564530060|FG000|Overall Study|Adverse Event|0|||
156392692|NCT00487162|564530061|FG001|Overall Study|Adverse Event|1|||
156392693|NCT00487162|564530060|FG000|Overall Study|Physician Decision|0|||
156392694|NCT00487162|564530061|FG001|Overall Study|Physician Decision|1|||
156392695|NCT00487162|564530060|FG000|Overall Study|Withdrawal by Subject|2|||
156392696|NCT00487162|564530061|FG001|Overall Study|Withdrawal by Subject|3|||
156392697|NCT01627327|564530062|FG000|Overall Study|Adverse Event|6|||
156392698|NCT01627327|564530063|FG001|Overall Study|Adverse Event|12|||
156392699|NCT01627327|564530062|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
156392700|NCT01627327|564530063|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
156392701|NCT01627327|564530062|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
156392702|NCT01627327|564530063|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
156392703|NCT01627327|564530062|FG000|Overall Study|Protocol Violation|4|||
156392704|NCT01627327|564530063|FG001|Overall Study|Protocol Violation|10|||
156392705|NCT01627327|564530062|FG000|Overall Study|Lost to Follow-up|1|||
156392706|NCT01627327|564530063|FG001|Overall Study|Lost to Follow-up|3|||
156392707|NCT01627327|564530062|FG000|Overall Study|Physician Decision|1|||
156392708|NCT01627327|564530063|FG001|Overall Study|Physician Decision|0|||
156392709|NCT01627327|564530062|FG000|Overall Study|Withdrawal by Subject|3|||
156392710|NCT01627327|564530063|FG001|Overall Study|Withdrawal by Subject|3|||
156392711|NCT02525874|564530064|FG000|Overall Study|Other|1|||
156392712|NCT02525874|564530064|FG000|Overall Study|Investigator Decision|1|||
156392713|NCT02525874|564530064|FG000|Overall Study|Consent withdrawn|22|||
156392714|NCT02525874|564530064|FG000|Overall Study|Non-compliance with study drug|3|||
156392715|NCT02525874|564530064|FG000|Overall Study|Adverse Event|17|||
156392716|NCT02525874|564530064|FG000|Overall Study|Lost to Follow-up|7|||
156392717|NCT02525874|564530064|FG000|Overall Study|Disease progression, defined by protocol|2|||
156392718|NCT02525874|564530064|FG000|Overall Study|Disease relapse|4|||
156392719|NCT02525874|564530064|FG000|Overall Study|Alternative Treatment for MS|2|||
156392720|NCT02525874|564530064|FG000|Overall Study|New lesions in Brain|1|||
156392721|NCT01692782|564530065|FG000|Overall Study|Adverse Event|12|||
156392722|NCT01692782|564530066|FG001|Overall Study|Adverse Event|32|||
156392723|NCT01692782|564530067|FG002|Overall Study|Adverse Event|2|||
156392724|NCT01692782|564530065|FG000|Overall Study|Lack of Efficacy|1|||
156392725|NCT01692782|564530066|FG001|Overall Study|Lack of Efficacy|2|||
156392726|NCT01692782|564530067|FG002|Overall Study|Lack of Efficacy|0|||
156392727|NCT01692782|564530065|FG000|Overall Study|Lost to Follow-up|2|||
156392728|NCT01692782|564530066|FG001|Overall Study|Lost to Follow-up|7|||
156392729|NCT01692782|564530067|FG002|Overall Study|Lost to Follow-up|1|||
156392730|NCT01692782|564530065|FG000|Overall Study|Pregnancy|1|||
156392731|NCT01692782|564530066|FG001|Overall Study|Pregnancy|0|||
156392732|NCT01692782|564530067|FG002|Overall Study|Pregnancy|0|||
156392733|NCT01692782|564530065|FG000|Overall Study|Protocol Violation|1|||
156392734|NCT01692782|564530066|FG001|Overall Study|Protocol Violation|0|||
156392735|NCT01692782|564530067|FG002|Overall Study|Protocol Violation|2|||
156392736|NCT01692782|564530065|FG000|Overall Study|Non-complance with study drug|0|||
156392737|NCT01692782|564530066|FG001|Overall Study|Non-complance with study drug|4|||
156392738|NCT01692782|564530067|FG002|Overall Study|Non-complance with study drug|1|||
156392739|NCT01692782|564530065|FG000|Overall Study|Non-compliant with study visits|0|||
156392740|NCT01692782|564530066|FG001|Overall Study|Non-compliant with study visits|0|||
156392741|NCT01692782|564530067|FG002|Overall Study|Non-compliant with study visits|1|||
156392742|NCT01692782|564530065|FG000|Overall Study|SAE not related to study drug|0|||
156392743|NCT01692782|564530066|FG001|Overall Study|SAE not related to study drug|1|||
156392744|NCT01692782|564530067|FG002|Overall Study|SAE not related to study drug|0|||
156392745|NCT01692782|564530065|FG000|Overall Study|Withdrawal by Subject|3|||
156392746|NCT01692782|564530066|FG001|Overall Study|Withdrawal by Subject|10|||
156392747|NCT01692782|564530067|FG002|Overall Study|Withdrawal by Subject|3|||
156392748|NCT00338884|564530079|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
156392749|NCT00338884|564530079|FG000|Overall Study|Adverse Event|14|||
156392750|NCT00338884|564530079|FG000|Overall Study|Death|8|||
156392751|NCT00338884|564530079|FG000|Overall Study|Other|4|||
156392752|NCT00338884|564530079|FG000|Overall Study|Global Deterioration of Health Status|3|||
156392753|NCT00338884|564530079|FG000|Overall Study|Withdrawal by Subject|3|||
156392754|NCT00338884|564530079|FG000|Overall Study|Lost to Follow-up|1|||
156392755|NCT00338884|564530079|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
156392756|NCT00423176|564530080|FG000|Overall Study|Adverse Event|4|||
156392757|NCT00423176|564530081|FG001|Overall Study|Adverse Event|6|||
156392758|NCT00423176|564530080|FG000|Overall Study|Treatment Failure|1|||
156392759|NCT00423176|564530081|FG001|Overall Study|Treatment Failure|6|||
156392760|NCT00423176|564530080|FG000|Overall Study|Lost to Follow-up|4|||
156392761|NCT00423176|564530081|FG001|Overall Study|Lost to Follow-up|7|||
156392762|NCT00423176|564530080|FG000|Overall Study|Withdrawal by Subject|4|||
156392763|NCT00423176|564530081|FG001|Overall Study|Withdrawal by Subject|3|||
156392764|NCT00423176|564530080|FG000|Overall Study|Protocol Violation|1|||
156392765|NCT00423176|564530081|FG001|Overall Study|Protocol Violation|3|||
156392766|NCT00423176|564530080|FG000|Overall Study|Did not meet protocol eligibility|2|||
156392767|NCT00423176|564530081|FG001|Overall Study|Did not meet protocol eligibility|4|||
156392768|NCT00911534|564530082|FG000|Overall Study|Adverse Event|4|||
156392769|NCT00911534|564530083|FG001|Overall Study|Adverse Event|4|||
156392770|NCT00911534|564530082|FG000|Overall Study|Lost to Follow-up|2|||
156392771|NCT00911534|564530083|FG001|Overall Study|Lost to Follow-up|4|||
156392772|NCT00911534|564530082|FG000|Overall Study|Withdrawal by Subject|2|||
156392773|NCT00911534|564530083|FG001|Overall Study|Withdrawal by Subject|1|||
156392774|NCT00911534|564530082|FG000|Overall Study|Lack of Efficacy|4|||
156392775|NCT00911534|564530083|FG001|Overall Study|Lack of Efficacy|1|||
156392776|NCT00911534|564530082|FG000|Overall Study|Withdrawal of consent|1|||
156392777|NCT00911534|564530083|FG001|Overall Study|Withdrawal of consent|4|||
156392778|NCT00911534|564530082|FG000|Overall Study|Other|2|||
156392779|NCT00911534|564530083|FG001|Overall Study|Other|2|||
156392780|NCT02677116|564530091|FG000|Overall Study|Adverse Event|0|||
156392781|NCT02677116|564530092|FG001|Overall Study|Adverse Event|1|||
156392782|NCT02677116|564530093|FG002|Overall Study|Adverse Event|0|||
156392783|NCT02677116|564530094|FG003|Overall Study|Adverse Event|0|||
156392784|NCT02677116|564530095|FG004|Overall Study|Adverse Event|0|||
156392785|NCT02677116|564530096|FG005|Overall Study|Adverse Event|1|||
156392786|NCT02677116|564530097|FG006|Overall Study|Adverse Event|1|||
156392787|NCT02677116|564530098|FG007|Overall Study|Adverse Event|0|||
156392788|NCT02677116|564530099|FG008|Overall Study|Adverse Event|0|||
156548572|NCT00464334|565100389|FG002|Overall Study|Lack of Efficacy|0|||
156548573|NCT00464334|565100390|FG003|Overall Study|Lack of Efficacy|0|||
156548574|NCT00464334|565100391|FG004|Overall Study|Lack of Efficacy|0|||
156548575|NCT00464334|565100392|FG005|Overall Study|Lack of Efficacy|0|||
156548576|NCT00464334|565100393|FG006|Overall Study|Lack of Efficacy|0|||
156548577|NCT00464334|565100394|FG007|Overall Study|Lack of Efficacy|0|||
156548578|NCT00464334|565100395|FG008|Overall Study|Lack of Efficacy|0|||
156548579|NCT00464334|565100396|FG009|Overall Study|Lack of Efficacy|0|||
156548580|NCT00464334|565100397|FG010|Overall Study|Lack of Efficacy|0|||
156548581|NCT00464334|565100387|FG000|Overall Study|Lost to Follow-up|0|||
156548582|NCT00464334|565100388|FG001|Overall Study|Lost to Follow-up|0|||
156392789|NCT02677116|564530091|FG000|Overall Study|Physician Decision|0|||
156392790|NCT02677116|564530092|FG001|Overall Study|Physician Decision|2|||
156392791|NCT02677116|564530093|FG002|Overall Study|Physician Decision|3|||
156392792|NCT02677116|564530094|FG003|Overall Study|Physician Decision|2|||
156392793|NCT02677116|564530095|FG004|Overall Study|Physician Decision|1|||
156392794|NCT02677116|564530096|FG005|Overall Study|Physician Decision|3|||
156392795|NCT02677116|564530097|FG006|Overall Study|Physician Decision|1|||
156392796|NCT02677116|564530098|FG007|Overall Study|Physician Decision|1|||
156392797|NCT02677116|564530099|FG008|Overall Study|Physician Decision|2|||
156392798|NCT02677116|564530091|FG000|Overall Study|Withdrawal by parent or guardian|2|||
156392799|NCT02677116|564530092|FG001|Overall Study|Withdrawal by parent or guardian|1|||
156392800|NCT02677116|564530093|FG002|Overall Study|Withdrawal by parent or guardian|0|||
156392801|NCT02677116|564530094|FG003|Overall Study|Withdrawal by parent or guardian|1|||
156548583|NCT00464334|565100389|FG002|Overall Study|Lost to Follow-up|1|||
156548584|NCT00464334|565100390|FG003|Overall Study|Lost to Follow-up|0|||
156392802|NCT02677116|564530095|FG004|Overall Study|Withdrawal by parent or guardian|0|||
156392803|NCT02677116|564530096|FG005|Overall Study|Withdrawal by parent or guardian|0|||
156392804|NCT02677116|564530097|FG006|Overall Study|Withdrawal by parent or guardian|2|||
156392805|NCT02677116|564530098|FG007|Overall Study|Withdrawal by parent or guardian|1|||
156392806|NCT02677116|564530099|FG008|Overall Study|Withdrawal by parent or guardian|0|||
156392807|NCT02677116|564530091|FG000|Overall Study|Withdrawal by Subject|1|||
156392808|NCT02677116|564530092|FG001|Overall Study|Withdrawal by Subject|0|||
156392809|NCT02677116|564530093|FG002|Overall Study|Withdrawal by Subject|0|||
156392810|NCT02677116|564530094|FG003|Overall Study|Withdrawal by Subject|0|||
156392811|NCT02677116|564530095|FG004|Overall Study|Withdrawal by Subject|0|||
156392812|NCT02677116|564530096|FG005|Overall Study|Withdrawal by Subject|0|||
156392813|NCT02677116|564530097|FG006|Overall Study|Withdrawal by Subject|0|||
156392814|NCT02677116|564530098|FG007|Overall Study|Withdrawal by Subject|0|||
156392815|NCT02677116|564530099|FG008|Overall Study|Withdrawal by Subject|0|||
156392816|NCT04403698|564530100|FG000|Overall Study|Adverse Event|1|||
156392817|NCT04403698|564530101|FG001|Overall Study|Adverse Event|1|||
156392818|NCT04403698|564530100|FG000|Overall Study|Lost to Follow-up|1|||
156392819|NCT04403698|564530101|FG001|Overall Study|Lost to Follow-up|0|||
156392820|NCT04403698|564530100|FG000|Overall Study|Protocol Violation|0|||
156392821|NCT04403698|564530101|FG001|Overall Study|Protocol Violation|1|||
156392822|NCT00977665|564530102|FG000|Overall Study|Withdrawal by Subject|1|||
156392823|NCT00977665|564530103|FG001|Overall Study|Withdrawal by Subject|3|||
156392824|NCT00977665|564530102|FG000|Overall Study|Physician Decision|2|||
156392825|NCT00977665|564530103|FG001|Overall Study|Physician Decision|1|||
156392826|NCT00977665|564530102|FG000|Overall Study|Sponsor requested withdrawal|0|||
156392827|NCT00977665|564530103|FG001|Overall Study|Sponsor requested withdrawal|1|||
156392828|NCT00977665|564530102|FG000|Overall Study|Lost to Follow-up|1|||
156392829|NCT00977665|564530103|FG001|Overall Study|Lost to Follow-up|0|||
156392830|NCT00977665|564530102|FG000|Overall Study|Death|3|||
156392831|NCT00977665|564530103|FG001|Overall Study|Death|2|||
156392832|NCT00977665|564530102|FG000|Overall Study|Adverse Event|14|||
156392833|NCT00977665|564530103|FG001|Overall Study|Adverse Event|7|||
156392834|NCT00977665|564530102|FG000|Overall Study|Treatment failure|0|||
156392835|NCT00977665|564530103|FG001|Overall Study|Treatment failure|1|||
156392836|NCT01330433|564530104|FG000|Overall Study|Death|1|||
156392837|NCT01330433|564530105|FG001|Overall Study|Death|3|||
156392838|NCT01330433|564530104|FG000|Overall Study|Lost to Follow-up|1|||
156392839|NCT01330433|564530105|FG001|Overall Study|Lost to Follow-up|0|||
156392840|NCT02300220|564530108|FG000|Overall Study|Lost to Follow-up|1|||
156392841|NCT02300220|564530109|FG001|Overall Study|Lost to Follow-up|2|||
156392842|NCT02300220|564530108|FG000|Overall Study|Death|1|||
156548585|NCT00464334|565100391|FG004|Overall Study|Lost to Follow-up|1|||
156392843|NCT02300220|564530109|FG001|Overall Study|Death|1|||
156392844|NCT02300220|564530108|FG000|Overall Study|Adverse Event|1|||
156392845|NCT02300220|564530109|FG001|Overall Study|Adverse Event|1|||
156392846|NCT02300220|564530108|FG000|Overall Study|Protocol Violation|1|||
156392847|NCT02300220|564530109|FG001|Overall Study|Protocol Violation|0|||
156392848|NCT02300220|564530108|FG000|Overall Study|Withdrawal by Subject|0|||
156548586|NCT00464334|565100392|FG005|Overall Study|Lost to Follow-up|0|||
156548587|NCT00464334|565100393|FG006|Overall Study|Lost to Follow-up|1|||
156392849|NCT02300220|564530109|FG001|Overall Study|Withdrawal by Subject|2|||
156392850|NCT02300220|564530108|FG000|Overall Study|Did not tolerate IMP|0|||
156392851|NCT02300220|564530109|FG001|Overall Study|Did not tolerate IMP|1|||
156392852|NCT04123067|564530110|FG000|Overall Study|Lost to Follow-up|0|||
156392853|NCT04123067|564530111|FG001|Overall Study|Lost to Follow-up|1|||
156392854|NCT02238379|564530112|FG000|Overall Study|Lost to Follow-up|1|||
156392855|NCT02238379|564530113|FG001|Overall Study|Lost to Follow-up|0|||
156392856|NCT00441090|564530114|FG000|Overall Study|Adverse Event|0|||
156392857|NCT00441090|564530115|FG001|Overall Study|Adverse Event|1|||
156392858|NCT00441090|564530116|FG002|Overall Study|Adverse Event|1|||
156392859|NCT00441090|564530117|FG003|Overall Study|Adverse Event|0|||
156392860|NCT00441090|564530118|FG004|Overall Study|Adverse Event|0|||
156392861|NCT00441090|564530114|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
156392862|NCT00441090|564530115|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
156392863|NCT00441090|564530116|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
156392864|NCT00441090|564530117|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
156392865|NCT00441090|564530118|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
156392866|NCT00441090|564530114|FG000|Overall Study|Withdrawal by Subject|1|||
156392867|NCT00441090|564530115|FG001|Overall Study|Withdrawal by Subject|0|||
156392868|NCT00441090|564530116|FG002|Overall Study|Withdrawal by Subject|1|||
156392869|NCT00441090|564530117|FG003|Overall Study|Withdrawal by Subject|0|||
156392870|NCT00441090|564530118|FG004|Overall Study|Withdrawal by Subject|0|||
156392871|NCT00441090|564530114|FG000|Overall Study|Lack of Efficacy|1|||
156392872|NCT00441090|564530115|FG001|Overall Study|Lack of Efficacy|0|||
156392873|NCT00441090|564530116|FG002|Overall Study|Lack of Efficacy|0|||
156548588|NCT00464334|565100394|FG007|Overall Study|Lost to Follow-up|0|||
156548589|NCT00464334|565100395|FG008|Overall Study|Lost to Follow-up|0|||
156548590|NCT00464334|565100396|FG009|Overall Study|Lost to Follow-up|0|||
156548591|NCT00464334|565100397|FG010|Overall Study|Lost to Follow-up|2|||
156548592|NCT00464334|565100387|FG000|Overall Study|Progressive Disease|0|||
156548593|NCT00464334|565100388|FG001|Overall Study|Progressive Disease|0|||
156548594|NCT00464334|565100389|FG002|Overall Study|Progressive Disease|0|||
156392874|NCT00441090|564530117|FG003|Overall Study|Lack of Efficacy|0|||
156392875|NCT00441090|564530118|FG004|Overall Study|Lack of Efficacy|0|||
156392876|NCT03085485|564530119|FG000|Overall Study|Death|1|||
156392877|NCT03085485|564530120|FG001|Overall Study|Death|0|||
156392878|NCT03085485|564530119|FG000|Overall Study|Lost to Follow-up|1|||
156392879|NCT03085485|564530120|FG001|Overall Study|Lost to Follow-up|0|||
156392880|NCT01022762|564530121|FG000|Overall Study|Adverse Event|3|||
156548595|NCT00464334|565100390|FG003|Overall Study|Progressive Disease|0|||
156548596|NCT00464334|565100391|FG004|Overall Study|Progressive Disease|0|||
156392881|NCT01022762|564530122|FG001|Overall Study|Adverse Event|1|||
156392882|NCT01022762|564530121|FG000|Overall Study|Lack of Efficacy|0|||
156548597|NCT00464334|565100392|FG005|Overall Study|Progressive Disease|1|||
156548598|NCT00464334|565100393|FG006|Overall Study|Progressive Disease|0|||
156548599|NCT00464334|565100394|FG007|Overall Study|Progressive Disease|0|||
156548600|NCT00464334|565100395|FG008|Overall Study|Progressive Disease|1|||
156548601|NCT00464334|565100396|FG009|Overall Study|Progressive Disease|0|||
156548602|NCT00464334|565100397|FG010|Overall Study|Progressive Disease|0|||
156392883|NCT01022762|564530122|FG001|Overall Study|Lack of Efficacy|1|||
156392884|NCT01022762|564530121|FG000|Overall Study|Protocol Violation|7|||
156392885|NCT01022762|564530122|FG001|Overall Study|Protocol Violation|6|||
156392886|NCT01022762|564530121|FG000|Overall Study|Unclassified|12|||
156392887|NCT01022762|564530122|FG001|Overall Study|Unclassified|20|||
156392888|NCT00605280|564530123|FG000|Year 1|Protocol Violation|0|||
156392889|NCT00605280|564530124|FG001|Year 1|Protocol Violation|0|||
156392890|NCT00605280|564530125|FG002|Year 1|Protocol Violation|0|||
156392891|NCT00605280|564530126|FG003|Year 1|Protocol Violation|1|||
156392892|NCT00605280|564530123|FG000|Year 1|Adverse Event|3|||
156548603|NCT00464334|565100387|FG000|Overall Study|Study Terminated by Sponsor|0|||
156548604|NCT00464334|565100388|FG001|Overall Study|Study Terminated by Sponsor|0|||
156548605|NCT00464334|565100389|FG002|Overall Study|Study Terminated by Sponsor|0|||
156548606|NCT00464334|565100390|FG003|Overall Study|Study Terminated by Sponsor|1|||
156548607|NCT00464334|565100391|FG004|Overall Study|Study Terminated by Sponsor|0|||
156548608|NCT00464334|565100392|FG005|Overall Study|Study Terminated by Sponsor|0|||
156548609|NCT00464334|565100393|FG006|Overall Study|Study Terminated by Sponsor|0|||
156548610|NCT00464334|565100394|FG007|Overall Study|Study Terminated by Sponsor|0|||
156548611|NCT00464334|565100395|FG008|Overall Study|Study Terminated by Sponsor|0|||
156548612|NCT00464334|565100396|FG009|Overall Study|Study Terminated by Sponsor|0|||
156548613|NCT00464334|565100397|FG010|Overall Study|Study Terminated by Sponsor|0|||
156392893|NCT00605280|564530124|FG001|Year 1|Adverse Event|1|||
156392894|NCT00605280|564530125|FG002|Year 1|Adverse Event|1|||
156392895|NCT00605280|564530126|FG003|Year 1|Adverse Event|5|||
156548614|NCT00464334|565100387|FG000|Overall Study|Withdrawal by Subject|1|||
156548615|NCT00464334|565100388|FG001|Overall Study|Withdrawal by Subject|7|||
156548616|NCT00464334|565100389|FG002|Overall Study|Withdrawal by Subject|4|||
156548617|NCT00464334|565100390|FG003|Overall Study|Withdrawal by Subject|2|||
156548618|NCT00464334|565100391|FG004|Overall Study|Withdrawal by Subject|2|||
156548619|NCT00464334|565100392|FG005|Overall Study|Withdrawal by Subject|2|||
156548620|NCT00464334|565100393|FG006|Overall Study|Withdrawal by Subject|2|||
156548621|NCT00464334|565100394|FG007|Overall Study|Withdrawal by Subject|1|||
156548622|NCT00464334|565100395|FG008|Overall Study|Withdrawal by Subject|3|||
156548623|NCT00464334|565100396|FG009|Overall Study|Withdrawal by Subject|0|||
156548624|NCT00464334|565100397|FG010|Overall Study|Withdrawal by Subject|0|||
156548625|NCT03948178|565100398|FG000|Overall Study|Protocol Violation|1|||
156548626|NCT03948178|565100398|FG000|Overall Study|Lost to Follow-up|2|||
156548627|NCT03948178|565100398|FG000|Overall Study|Withdrawal by Subject|2|||
156548628|NCT03948178|565100398|FG000|Overall Study|Reason not known|2|||
156548629|NCT03948178|565100398|FG000|Overall Study|Personal reason|14|||
156548630|NCT03948178|565100398|FG000|Overall Study|Disease progression|30|||
156548631|NCT03948178|565100398|FG000|Overall Study|Adverse Event|12|||
156548632|NCT03948178|565100398|FG000|Overall Study|Sponsor terminated study|164|||
156548633|NCT00401752|565100401|FG000|Overall Study|Adverse Event|2|||
156548634|NCT00401752|565100402|FG001|Overall Study|Adverse Event|5|||
156548635|NCT00401752|565100401|FG000|Overall Study|Withdrawal by Subject|2|||
156548636|NCT00401752|565100402|FG001|Overall Study|Withdrawal by Subject|6|||
156548637|NCT00401752|565100401|FG000|Overall Study|Lost to Follow-up|1|||
156548638|NCT00401752|565100402|FG001|Overall Study|Lost to Follow-up|4|||
156548639|NCT00401752|565100401|FG000|Overall Study|Development of any exclusion criteria|4|||
156548640|NCT00401752|565100402|FG001|Overall Study|Development of any exclusion criteria|2|||
156548641|NCT00401752|565100401|FG000|Overall Study|Physician Decision|1|||
156548642|NCT00401752|565100402|FG001|Overall Study|Physician Decision|1|||
156548643|NCT02432235|565100403|FG000|Overall Study|Death|1|||
156548644|NCT02432235|565100404|FG001|Overall Study|Death|1|||
156548645|NCT02432235|565100405|FG002|Overall Study|Death|2|||
156548646|NCT02432235|565100406|FG003|Overall Study|Death|2|||
156548647|NCT02432235|565100407|FG004|Overall Study|Death|1|||
156548648|NCT02432235|565100408|FG005|Overall Study|Death|3|||
156548649|NCT02432235|565100409|FG006|Overall Study|Death|11|||
156548650|NCT02432235|565100410|FG007|Overall Study|Death|15|||
156548651|NCT02432235|565100411|FG008|Overall Study|Death|15|||
156548652|NCT02432235|565100412|FG009|Overall Study|Death|3|||
156548653|NCT02432235|565100413|FG010|Overall Study|Death|1|||
156548654|NCT02432235|565100414|FG011|Overall Study|Death|0|||
156548655|NCT02432235|565100403|FG000|Overall Study|Withdrawal by Subject|0|||
156548656|NCT02432235|565100404|FG001|Overall Study|Withdrawal by Subject|1|||
156548657|NCT02432235|565100405|FG002|Overall Study|Withdrawal by Subject|0|||
156548658|NCT02432235|565100406|FG003|Overall Study|Withdrawal by Subject|0|||
156548659|NCT02432235|565100407|FG004|Overall Study|Withdrawal by Subject|0|||
156548660|NCT02432235|565100408|FG005|Overall Study|Withdrawal by Subject|2|||
156548661|NCT02432235|565100409|FG006|Overall Study|Withdrawal by Subject|5|||
156548662|NCT02432235|565100410|FG007|Overall Study|Withdrawal by Subject|3|||
156548663|NCT02432235|565100411|FG008|Overall Study|Withdrawal by Subject|1|||
156548664|NCT02432235|565100412|FG009|Overall Study|Withdrawal by Subject|0|||
156548665|NCT02432235|565100413|FG010|Overall Study|Withdrawal by Subject|0|||
156548666|NCT02432235|565100414|FG011|Overall Study|Withdrawal by Subject|0|||
156548667|NCT02432235|565100403|FG000|Overall Study|Lost to Follow-up|0|||
156548668|NCT02432235|565100404|FG001|Overall Study|Lost to Follow-up|0|||
156548669|NCT02432235|565100405|FG002|Overall Study|Lost to Follow-up|0|||
156548670|NCT02432235|565100406|FG003|Overall Study|Lost to Follow-up|0|||
156548671|NCT02432235|565100407|FG004|Overall Study|Lost to Follow-up|0|||
156548672|NCT02432235|565100408|FG005|Overall Study|Lost to Follow-up|1|||
156548673|NCT02432235|565100409|FG006|Overall Study|Lost to Follow-up|0|||
156548674|NCT02432235|565100410|FG007|Overall Study|Lost to Follow-up|0|||
156548675|NCT02432235|565100411|FG008|Overall Study|Lost to Follow-up|1|||
156548676|NCT02432235|565100412|FG009|Overall Study|Lost to Follow-up|0|||
156548677|NCT02432235|565100413|FG010|Overall Study|Lost to Follow-up|0|||
156548678|NCT02432235|565100414|FG011|Overall Study|Lost to Follow-up|0|||
156548679|NCT02432235|565100403|FG000|Overall Study|Miscellaneous|0|||
156548680|NCT02432235|565100404|FG001|Overall Study|Miscellaneous|0|||
156548681|NCT02432235|565100405|FG002|Overall Study|Miscellaneous|0|||
156548682|NCT02432235|565100406|FG003|Overall Study|Miscellaneous|0|||
156392896|NCT00605280|564530123|FG000|Year 1|Physician Decision|7|||
156548683|NCT02432235|565100407|FG004|Overall Study|Miscellaneous|1|||
156548684|NCT02432235|565100408|FG005|Overall Study|Miscellaneous|6|||
156548685|NCT02432235|565100409|FG006|Overall Study|Miscellaneous|2|||
156548686|NCT02432235|565100410|FG007|Overall Study|Miscellaneous|2|||
156392897|NCT00605280|564530124|FG001|Year 1|Physician Decision|4|||
156392898|NCT00605280|564530125|FG002|Year 1|Physician Decision|0|||
156548687|NCT02432235|565100411|FG008|Overall Study|Miscellaneous|4|||
156548688|NCT02432235|565100412|FG009|Overall Study|Miscellaneous|0|||
156548689|NCT02432235|565100413|FG010|Overall Study|Miscellaneous|0|||
156548690|NCT02432235|565100414|FG011|Overall Study|Miscellaneous|1|||
156548691|NCT01895322|565100415|FG000|Overall Study|Adverse Event|1|||
156548692|NCT01895322|565100415|FG000|Overall Study|Withdrawal by Subject|2|||
156548693|NCT01895322|565100415|FG000|Overall Study|Protocol Violation|10|||
156548694|NCT03436862|565100418|FG000|Overall Study|Adverse Event|4|||
156548695|NCT03436862|565100418|FG000|Overall Study|Progressive Disease|2|||
156548696|NCT00391222|565100424|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
156548697|NCT00391222|565100425|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
156548698|NCT00391222|565100426|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
156548699|NCT00391222|565100427|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
156548700|NCT00391222|565100424|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
156548701|NCT00391222|565100425|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
156548702|NCT00391222|565100426|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
156548703|NCT00391222|565100427|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
156548704|NCT00391222|565100424|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
156548705|NCT00391222|565100425|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
156548706|NCT00391222|565100426|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
156548707|NCT00391222|565100427|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
156548708|NCT00391222|565100424|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
156548709|NCT00391222|565100425|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
156548710|NCT00391222|565100426|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
156548711|NCT00391222|565100427|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
156548712|NCT00391222|565100424|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
156548713|NCT00391222|565100425|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
156548714|NCT00391222|565100426|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
156548715|NCT00391222|565100427|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
156548716|NCT00391222|565100424|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
156548717|NCT00391222|565100425|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
156548718|NCT00391222|565100426|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
156548719|NCT00391222|565100427|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
156548720|NCT00391222|565100424|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
156548721|NCT00391222|565100425|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
156548722|NCT00391222|565100426|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
156548723|NCT00391222|565100427|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
156548724|NCT00391222|565100424|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
156548725|NCT00391222|565100425|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
156548726|NCT00391222|565100426|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
156548727|NCT00391222|565100427|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
156548728|NCT00391222|565100424|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
156548729|NCT00391222|565100425|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
156548730|NCT00391222|565100426|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
156548731|NCT00391222|565100427|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
156548732|NCT00391222|565100424|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
156548733|NCT00391222|565100425|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
156548734|NCT00391222|565100426|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
156548735|NCT00391222|565100427|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
156548736|NCT00391222|565100424|FG000|Period III (Double-Blind Treatment)|Other|6|||
156548737|NCT00391222|565100425|FG001|Period III (Double-Blind Treatment)|Other|1|||
156548738|NCT00391222|565100426|FG002|Period III (Double-Blind Treatment)|Other|6|||
156548739|NCT00391222|565100427|FG003|Period III (Double-Blind Treatment)|Other|0|||
156548740|NCT01627860|565100428|FG000|Overall Study|Adverse Event|9|||
156548741|NCT01627860|565100429|FG001|Overall Study|Adverse Event|4|||
156548742|NCT01627860|565100428|FG000|Overall Study|Withdrawal by Subject|2|||
156548743|NCT01627860|565100429|FG001|Overall Study|Withdrawal by Subject|1|||
156548744|NCT01627860|565100428|FG000|Overall Study|Seizure frequency doubled|0|||
156548745|NCT01627860|565100429|FG001|Overall Study|Seizure frequency doubled|1|||
156548746|NCT01627860|565100428|FG000|Overall Study|Protocol Violation|1|||
156548747|NCT01627860|565100429|FG001|Overall Study|Protocol Violation|0|||
156548748|NCT02054897|565100431|FG000|Overall Study|Withdrawal by Subject|2|||
156548749|NCT02054897|565100432|FG001|Overall Study|Withdrawal by Subject|0|||
156548750|NCT02054897|565100433|FG002|Overall Study|Withdrawal by Subject|2|||
156548751|NCT02054897|565100431|FG000|Overall Study|Missing follow-up information|3|||
156548752|NCT02054897|565100432|FG001|Overall Study|Missing follow-up information|5|||
156548753|NCT02054897|565100433|FG002|Overall Study|Missing follow-up information|3|||
156548754|NCT02054897|565100431|FG000|Overall Study|Lost to Follow-up|4|||
156548755|NCT02054897|565100432|FG001|Overall Study|Lost to Follow-up|2|||
156548756|NCT02054897|565100433|FG002|Overall Study|Lost to Follow-up|7|||
156548757|NCT02054897|565100431|FG000|Overall Study|Randomized but not exposed|1|||
156548758|NCT02054897|565100432|FG001|Overall Study|Randomized but not exposed|0|||
156548759|NCT02054897|565100433|FG002|Overall Study|Randomized but not exposed|0|||
156548760|NCT00960843|565100434|FG000|Overall Study|Lost to Follow-up|2|||
156548761|NCT00960843|565100435|FG001|Overall Study|Lost to Follow-up|0|||
156392899|NCT00605280|564530126|FG003|Year 1|Physician Decision|6|||
156392900|NCT00605280|564530123|FG000|Year 1|Withdrawal by Subject|2|||
156392901|NCT00605280|564530124|FG001|Year 1|Withdrawal by Subject|4|||
156392902|NCT00605280|564530125|FG002|Year 1|Withdrawal by Subject|0|||
156392903|NCT00605280|564530126|FG003|Year 1|Withdrawal by Subject|4|||
156392904|NCT00605280|564530123|FG000|Year 1|Other|2|||
156392905|NCT00605280|564530124|FG001|Year 1|Other|1|||
156392906|NCT00605280|564530125|FG002|Year 1|Other|0|||
156392907|NCT00605280|564530126|FG003|Year 1|Other|1|||
156392908|NCT00605280|564530123|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
156392909|NCT00605280|564530124|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
156392910|NCT00605280|564530125|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
156392911|NCT00605280|564530126|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
156392912|NCT00605280|564530123|FG000|Year 2|Adverse Event|4|||
156392913|NCT00605280|564530124|FG001|Year 2|Adverse Event|0|||
156392914|NCT00605280|564530125|FG002|Year 2|Adverse Event|2|||
156392915|NCT00605280|564530126|FG003|Year 2|Adverse Event|4|||
156392916|NCT00605280|564530123|FG000|Year 2|Physician Decision|11|||
156392917|NCT00605280|564530124|FG001|Year 2|Physician Decision|6|||
156392918|NCT00605280|564530125|FG002|Year 2|Physician Decision|4|||
156392919|NCT00605280|564530126|FG003|Year 2|Physician Decision|11|||
156392920|NCT00605280|564530123|FG000|Year 2|Withdrawal by Subject|4|||
156392921|NCT00605280|564530124|FG001|Year 2|Withdrawal by Subject|0|||
156392922|NCT00605280|564530125|FG002|Year 2|Withdrawal by Subject|0|||
156392923|NCT00605280|564530126|FG003|Year 2|Withdrawal by Subject|4|||
156392924|NCT00605280|564530123|FG000|Year 2|Other|1|||
156392925|NCT00605280|564530124|FG001|Year 2|Other|0|||
156392926|NCT00605280|564530125|FG002|Year 2|Other|0|||
156392927|NCT00605280|564530126|FG003|Year 2|Other|1|||
156392928|NCT00605280|564530123|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
156392929|NCT00605280|564530124|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
156392930|NCT00605280|564530125|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
156392931|NCT00605280|564530126|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
156392932|NCT00605280|564530123|FG000|Year 3 Extension|Adverse Event|2|||
156392933|NCT00605280|564530124|FG001|Year 3 Extension|Adverse Event|0|||
156392934|NCT00605280|564530125|FG002|Year 3 Extension|Adverse Event|0|||
156508710|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
156508711|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
156508712|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
156508713|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
156508714|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
156508715|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
156508716|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
156508717|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
156508718|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508719|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508720|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508721|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508722|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508723|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508724|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508725|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508726|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
156508727|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
156508728|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
156508729|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
156508730|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508731|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508732|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508733|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508734|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508735|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508736|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508737|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508738|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
156508739|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
156508740|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
156508741|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
156508742|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156548762|NCT00960843|565100434|FG000|Overall Study|Protocol Violation|0|||
156548763|NCT00960843|565100435|FG001|Overall Study|Protocol Violation|4|||
156392935|NCT00605280|564530126|FG003|Year 3 Extension|Adverse Event|2|||
156392936|NCT00605280|564530123|FG000|Year 3 Extension|Physician Decision|0|||
156392937|NCT00605280|564530124|FG001|Year 3 Extension|Physician Decision|0|||
156392938|NCT00605280|564530125|FG002|Year 3 Extension|Physician Decision|0|||
156392939|NCT00605280|564530126|FG003|Year 3 Extension|Physician Decision|2|||
156392940|NCT00605280|564530123|FG000|Year 3 Extension|Withdrawal by Subject|2|||
156392941|NCT00605280|564530124|FG001|Year 3 Extension|Withdrawal by Subject|0|||
156392942|NCT00605280|564530125|FG002|Year 3 Extension|Withdrawal by Subject|0|||
156392943|NCT00605280|564530126|FG003|Year 3 Extension|Withdrawal by Subject|5|||
156392944|NCT00605280|564530123|FG000|Year 3 Extension|Other|2|||
156392945|NCT00605280|564530124|FG001|Year 3 Extension|Other|0|||
156392946|NCT00605280|564530125|FG002|Year 3 Extension|Other|0|||
156392947|NCT00605280|564530126|FG003|Year 3 Extension|Other|0|||
156392948|NCT00605280|564530123|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
156392949|NCT00605280|564530124|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
156392950|NCT00605280|564530125|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
156392951|NCT00605280|564530126|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
156392952|NCT01302119|564530127|FG000|Overall Study|Withdrawal by Subject|30|||
156392953|NCT01302119|564530128|FG001|Overall Study|Withdrawal by Subject|20|||
156392954|NCT01302119|564530127|FG000|Overall Study|Lost to Follow-up|10|||
156392955|NCT01302119|564530128|FG001|Overall Study|Lost to Follow-up|4|||
156392956|NCT01302119|564530127|FG000|Overall Study|Adverse Event|2|||
156392957|NCT01302119|564530128|FG001|Overall Study|Adverse Event|1|||
156392958|NCT01302119|564530127|FG000|Overall Study|Non-compliance|4|||
156392959|NCT01302119|564530128|FG001|Overall Study|Non-compliance|2|||
156392960|NCT01302119|564530127|FG000|Overall Study|Non-specific|4|||
156392961|NCT01302119|564530128|FG001|Overall Study|Non-specific|1|||
156392962|NCT01775904|564530132|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
156392963|NCT01775904|564530132|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
156392964|NCT00518115|564530133|FG000|Overall Study|Adverse Event|6|||
156392965|NCT00518115|564530134|FG001|Overall Study|Adverse Event|1|||
156392966|NCT00518115|564530135|FG002|Overall Study|Adverse Event|5|||
156392967|NCT00518115|564530136|FG003|Overall Study|Adverse Event|6|||
156392968|NCT00518115|564530137|FG004|Overall Study|Adverse Event|5|||
156392969|NCT00518115|564530138|FG005|Overall Study|Adverse Event|5|||
156392970|NCT00518115|564530139|FG006|Overall Study|Adverse Event|5|||
156392971|NCT00518115|564530140|FG007|Overall Study|Adverse Event|10|||
156392972|NCT00518115|564530141|FG008|Overall Study|Adverse Event|2|||
156392973|NCT00518115|564530142|FG009|Overall Study|Adverse Event|9|||
156392974|NCT00518115|564530133|FG000|Overall Study|Lost to Follow-up|0|||
156392975|NCT00518115|564530134|FG001|Overall Study|Lost to Follow-up|0|||
156392976|NCT00518115|564530135|FG002|Overall Study|Lost to Follow-up|2|||
156392977|NCT00518115|564530136|FG003|Overall Study|Lost to Follow-up|3|||
156392978|NCT00518115|564530137|FG004|Overall Study|Lost to Follow-up|1|||
156392979|NCT00518115|564530138|FG005|Overall Study|Lost to Follow-up|3|||
156392980|NCT00518115|564530139|FG006|Overall Study|Lost to Follow-up|0|||
156392981|NCT00518115|564530140|FG007|Overall Study|Lost to Follow-up|1|||
156392982|NCT00518115|564530141|FG008|Overall Study|Lost to Follow-up|1|||
156392983|NCT00518115|564530142|FG009|Overall Study|Lost to Follow-up|1|||
156392984|NCT00518115|564530133|FG000|Overall Study|Protocol Violation|1|||
156392985|NCT00518115|564530134|FG001|Overall Study|Protocol Violation|3|||
156392986|NCT00518115|564530135|FG002|Overall Study|Protocol Violation|1|||
156392987|NCT00518115|564530136|FG003|Overall Study|Protocol Violation|0|||
156392988|NCT00518115|564530137|FG004|Overall Study|Protocol Violation|0|||
156392989|NCT00518115|564530138|FG005|Overall Study|Protocol Violation|0|||
156392990|NCT00518115|564530139|FG006|Overall Study|Protocol Violation|0|||
156392991|NCT00518115|564530140|FG007|Overall Study|Protocol Violation|0|||
156392992|NCT00518115|564530141|FG008|Overall Study|Protocol Violation|0|||
156392993|NCT00518115|564530142|FG009|Overall Study|Protocol Violation|0|||
156392994|NCT00518115|564530133|FG000|Overall Study|Withdrawal by Subject|1|||
156392995|NCT00518115|564530134|FG001|Overall Study|Withdrawal by Subject|1|||
156392996|NCT00518115|564530135|FG002|Overall Study|Withdrawal by Subject|5|||
156548764|NCT00960843|565100434|FG000|Overall Study|Repeated needle dislodgment|0|||
156548765|NCT00960843|565100435|FG001|Overall Study|Repeated needle dislodgment|1|||
156548766|NCT00652366|565100436|FG000|Overall Study|Adverse Event|8|||
156548767|NCT00652366|565100437|FG001|Overall Study|Adverse Event|4|||
156548768|NCT00652366|565100438|FG002|Overall Study|Adverse Event|7|||
156548769|NCT00652366|565100439|FG003|Overall Study|Adverse Event|17|||
156548770|NCT00652366|565100440|FG004|Overall Study|Adverse Event|13|||
156392997|NCT00518115|564530136|FG003|Overall Study|Withdrawal by Subject|0|||
156392998|NCT00518115|564530137|FG004|Overall Study|Withdrawal by Subject|2|||
156392999|NCT00518115|564530138|FG005|Overall Study|Withdrawal by Subject|1|||
156393000|NCT00518115|564530139|FG006|Overall Study|Withdrawal by Subject|0|||
156393001|NCT00518115|564530140|FG007|Overall Study|Withdrawal by Subject|2|||
156548771|NCT00652366|565100436|FG000|Overall Study|Death|5|||
156548772|NCT00652366|565100437|FG001|Overall Study|Death|4|||
156393002|NCT00518115|564530141|FG008|Overall Study|Withdrawal by Subject|1|||
156393003|NCT00518115|564530142|FG009|Overall Study|Withdrawal by Subject|3|||
156393004|NCT00518115|564530133|FG000|Overall Study|Lack of Efficacy|1|||
156548773|NCT00652366|565100438|FG002|Overall Study|Death|1|||
156548774|NCT00652366|565100439|FG003|Overall Study|Death|8|||
156393005|NCT00518115|564530134|FG001|Overall Study|Lack of Efficacy|0|||
156393006|NCT00518115|564530135|FG002|Overall Study|Lack of Efficacy|1|||
156393007|NCT00518115|564530136|FG003|Overall Study|Lack of Efficacy|1|||
156393008|NCT00518115|564530137|FG004|Overall Study|Lack of Efficacy|0|||
156393009|NCT00518115|564530138|FG005|Overall Study|Lack of Efficacy|0|||
156393010|NCT00518115|564530139|FG006|Overall Study|Lack of Efficacy|0|||
156393011|NCT00518115|564530140|FG007|Overall Study|Lack of Efficacy|1|||
156393012|NCT00518115|564530141|FG008|Overall Study|Lack of Efficacy|0|||
156393013|NCT00518115|564530142|FG009|Overall Study|Lack of Efficacy|0|||
156393014|NCT00518115|564530133|FG000|Overall Study|Non-Compliance|1|||
156393015|NCT00518115|564530134|FG001|Overall Study|Non-Compliance|0|||
156393016|NCT00518115|564530135|FG002|Overall Study|Non-Compliance|1|||
156393017|NCT00518115|564530136|FG003|Overall Study|Non-Compliance|0|||
156393018|NCT00518115|564530137|FG004|Overall Study|Non-Compliance|1|||
156393019|NCT00518115|564530138|FG005|Overall Study|Non-Compliance|1|||
156393020|NCT00518115|564530139|FG006|Overall Study|Non-Compliance|1|||
156393021|NCT00518115|564530140|FG007|Overall Study|Non-Compliance|1|||
156393022|NCT00518115|564530141|FG008|Overall Study|Non-Compliance|0|||
156393023|NCT00518115|564530142|FG009|Overall Study|Non-Compliance|1|||
156393024|NCT00518115|564530133|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
156393025|NCT00518115|564530134|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
156393026|NCT00518115|564530135|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156393027|NCT00518115|564530136|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156393028|NCT00518115|564530137|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156393029|NCT00518115|564530138|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
156393030|NCT00518115|564530139|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156393031|NCT00518115|564530140|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156393032|NCT00518115|564530141|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156393033|NCT00518115|564530142|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156393034|NCT00518115|564530133|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
156393035|NCT00518115|564530134|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393036|NCT00518115|564530135|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393037|NCT00518115|564530136|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393038|NCT00518115|564530137|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393039|NCT00518115|564530138|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393040|NCT00518115|564530139|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393041|NCT00518115|564530140|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393042|NCT00518115|564530141|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393043|NCT00518115|564530142|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156393044|NCT00518115|564530133|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
156393045|NCT00518115|564530134|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
156393046|NCT00518115|564530135|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
156393047|NCT00518115|564530136|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
156393048|NCT00518115|564530137|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
156393049|NCT00518115|564530138|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
156393050|NCT00518115|564530139|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
156393051|NCT00518115|564530140|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
156393052|NCT00518115|564530141|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
156393053|NCT00518115|564530142|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
156393054|NCT00518115|564530133|FG000|Overall Study|Wrong Monotherapy Administered|0|||
156393055|NCT00518115|564530134|FG001|Overall Study|Wrong Monotherapy Administered|0|||
156393056|NCT00518115|564530135|FG002|Overall Study|Wrong Monotherapy Administered|1|||
156393057|NCT00518115|564530136|FG003|Overall Study|Wrong Monotherapy Administered|0|||
156393058|NCT00518115|564530137|FG004|Overall Study|Wrong Monotherapy Administered|0|||
156393059|NCT00518115|564530138|FG005|Overall Study|Wrong Monotherapy Administered|0|||
156393060|NCT00518115|564530139|FG006|Overall Study|Wrong Monotherapy Administered|1|||
156393061|NCT00518115|564530140|FG007|Overall Study|Wrong Monotherapy Administered|0|||
156393062|NCT00518115|564530141|FG008|Overall Study|Wrong Monotherapy Administered|0|||
156393063|NCT00518115|564530142|FG009|Overall Study|Wrong Monotherapy Administered|0|||
156393064|NCT00518115|564530133|FG000|Overall Study|Violation of Exclusion Criteria|0|||
156393065|NCT00518115|564530134|FG001|Overall Study|Violation of Exclusion Criteria|0|||
156393066|NCT00518115|564530135|FG002|Overall Study|Violation of Exclusion Criteria|0|||
156393067|NCT00518115|564530136|FG003|Overall Study|Violation of Exclusion Criteria|1|||
156393068|NCT00518115|564530137|FG004|Overall Study|Violation of Exclusion Criteria|0|||
156393069|NCT00518115|564530138|FG005|Overall Study|Violation of Exclusion Criteria|0|||
156393070|NCT00518115|564530139|FG006|Overall Study|Violation of Exclusion Criteria|1|||
156393071|NCT00518115|564530140|FG007|Overall Study|Violation of Exclusion Criteria|0|||
156393072|NCT00518115|564530141|FG008|Overall Study|Violation of Exclusion Criteria|0|||
156393073|NCT00518115|564530142|FG009|Overall Study|Violation of Exclusion Criteria|0|||
156508743|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156393074|NCT00518115|564530133|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
156393075|NCT00518115|564530134|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
156393076|NCT00518115|564530135|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
156393077|NCT00518115|564530136|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
156393078|NCT00518115|564530137|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
156393079|NCT00518115|564530138|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
156393080|NCT00518115|564530139|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
156393081|NCT00518115|564530140|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
156393082|NCT00518115|564530141|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
156393083|NCT00518115|564530142|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
156393084|NCT00518115|564530133|FG000|Overall Study|Withdrew Consent|0|||
156393085|NCT00518115|564530134|FG001|Overall Study|Withdrew Consent|0|||
156393086|NCT00518115|564530135|FG002|Overall Study|Withdrew Consent|0|||
156393087|NCT00518115|564530136|FG003|Overall Study|Withdrew Consent|0|||
156393088|NCT00518115|564530137|FG004|Overall Study|Withdrew Consent|0|||
156393089|NCT00518115|564530138|FG005|Overall Study|Withdrew Consent|1|||
156393090|NCT00518115|564530139|FG006|Overall Study|Withdrew Consent|0|||
156393091|NCT00518115|564530140|FG007|Overall Study|Withdrew Consent|0|||
156393092|NCT00518115|564530141|FG008|Overall Study|Withdrew Consent|0|||
156393093|NCT00518115|564530142|FG009|Overall Study|Withdrew Consent|0|||
156393094|NCT00518115|564530133|FG000|Overall Study|Moved Out of State|0|||
156393095|NCT00518115|564530134|FG001|Overall Study|Moved Out of State|0|||
156393096|NCT00518115|564530135|FG002|Overall Study|Moved Out of State|0|||
156393097|NCT00518115|564530136|FG003|Overall Study|Moved Out of State|0|||
156393098|NCT00518115|564530137|FG004|Overall Study|Moved Out of State|0|||
156393099|NCT00518115|564530138|FG005|Overall Study|Moved Out of State|0|||
156393100|NCT00518115|564530139|FG006|Overall Study|Moved Out of State|0|||
156393101|NCT00518115|564530140|FG007|Overall Study|Moved Out of State|0|||
156393102|NCT00518115|564530141|FG008|Overall Study|Moved Out of State|0|||
156393103|NCT00518115|564530142|FG009|Overall Study|Moved Out of State|1|||
156393104|NCT04891419|564530143|FG000|Overall Study|Withdrawal by Subject|4|||
156393105|NCT04891419|564530144|FG001|Overall Study|Withdrawal by Subject|0|||
156393106|NCT04891419|564530143|FG000|Overall Study|Lost to Follow-up|1|||
156393107|NCT04891419|564530144|FG001|Overall Study|Lost to Follow-up|3|||
156393108|NCT00843167|564530147|FG000|Treatment Period|Adverse Event|1|||
156393109|NCT00843167|564530148|FG001|Treatment Period|Adverse Event|5|||
156393110|NCT00843167|564530147|FG000|Treatment Period|Withdrawal by Subject|2|||
156393111|NCT00843167|564530148|FG001|Treatment Period|Withdrawal by Subject|3|||
156393112|NCT02291614|564530149|FG000|Overall Study|Lost to Follow-up|0|||
156393113|NCT02291614|564530150|FG001|Overall Study|Lost to Follow-up|0|||
156393114|NCT02291614|564530151|FG002|Overall Study|Lost to Follow-up|0|||
156393115|NCT02291614|564530152|FG003|Overall Study|Lost to Follow-up|0|||
156393116|NCT02291614|564530153|FG004|Overall Study|Lost to Follow-up|0|||
156393117|NCT02291614|564530154|FG005|Overall Study|Lost to Follow-up|0|||
156393118|NCT02291614|564530155|FG006|Overall Study|Lost to Follow-up|0|||
156393119|NCT02291614|564530156|FG007|Overall Study|Lost to Follow-up|1|||
156393120|NCT02291614|564530157|FG008|Overall Study|Lost to Follow-up|0|||
156393121|NCT02291614|564530158|FG009|Overall Study|Lost to Follow-up|0|||
156393122|NCT02291614|564530159|FG010|Overall Study|Lost to Follow-up|0|||
156393123|NCT02291614|564530149|FG000|Overall Study|Withdrawal by Subject|0|||
156393124|NCT02291614|564530150|FG001|Overall Study|Withdrawal by Subject|1|||
156393125|NCT02291614|564530151|FG002|Overall Study|Withdrawal by Subject|0|||
156393126|NCT02291614|564530152|FG003|Overall Study|Withdrawal by Subject|0|||
156393127|NCT02291614|564530153|FG004|Overall Study|Withdrawal by Subject|0|||
156393128|NCT02291614|564530154|FG005|Overall Study|Withdrawal by Subject|0|||
156393129|NCT02291614|564530155|FG006|Overall Study|Withdrawal by Subject|0|||
156393130|NCT02291614|564530156|FG007|Overall Study|Withdrawal by Subject|0|||
156393131|NCT02291614|564530157|FG008|Overall Study|Withdrawal by Subject|0|||
156393132|NCT02291614|564530158|FG009|Overall Study|Withdrawal by Subject|2|||
156393133|NCT02291614|564530159|FG010|Overall Study|Withdrawal by Subject|2|||
156393134|NCT02291614|564530149|FG000|Overall Study|Decision by sponsor|0|||
156393135|NCT02291614|564530150|FG001|Overall Study|Decision by sponsor|0|||
156393136|NCT02291614|564530151|FG002|Overall Study|Decision by sponsor|0|||
156393137|NCT02291614|564530152|FG003|Overall Study|Decision by sponsor|1|||
156393138|NCT02291614|564530153|FG004|Overall Study|Decision by sponsor|0|||
156393139|NCT02291614|564530154|FG005|Overall Study|Decision by sponsor|0|||
156393140|NCT02291614|564530155|FG006|Overall Study|Decision by sponsor|0|||
156393141|NCT02291614|564530156|FG007|Overall Study|Decision by sponsor|0|||
156393142|NCT02291614|564530157|FG008|Overall Study|Decision by sponsor|0|||
156393143|NCT02291614|564530158|FG009|Overall Study|Decision by sponsor|0|||
156393144|NCT02291614|564530159|FG010|Overall Study|Decision by sponsor|0|||
156393145|NCT02291614|564530149|FG000|Overall Study|Death|0|||
156393146|NCT02291614|564530150|FG001|Overall Study|Death|0|||
156393147|NCT02291614|564530151|FG002|Overall Study|Death|1|||
156393148|NCT02291614|564530152|FG003|Overall Study|Death|0|||
156393149|NCT02291614|564530153|FG004|Overall Study|Death|1|||
156393150|NCT02291614|564530154|FG005|Overall Study|Death|1|||
156393151|NCT02291614|564530155|FG006|Overall Study|Death|1|||
156393152|NCT02291614|564530156|FG007|Overall Study|Death|0|||
156393153|NCT02291614|564530157|FG008|Overall Study|Death|0|||
156393154|NCT02291614|564530158|FG009|Overall Study|Death|0|||
156393155|NCT02291614|564530159|FG010|Overall Study|Death|0|||
156393156|NCT03743038|564530160|FG000|Overall Study|Physician Decision|1|||
156393157|NCT02432105|564530163|FG000|Overall Study|Lost to Follow-up|1|||
156393158|NCT02432105|564530164|FG001|Overall Study|Lost to Follow-up|1|||
156393159|NCT02432105|564530165|FG002|Overall Study|Lost to Follow-up|0|||
156393160|NCT02432105|564530163|FG000|Overall Study|Withdrawal by Subject|1|||
156393161|NCT02432105|564530164|FG001|Overall Study|Withdrawal by Subject|0|||
156393162|NCT02432105|564530165|FG002|Overall Study|Withdrawal by Subject|1|||
156393163|NCT02432105|564530163|FG000|Overall Study|Culture positive for yeast|0|||
156393164|NCT02432105|564530164|FG001|Overall Study|Culture positive for yeast|1|||
156393165|NCT02432105|564530165|FG002|Overall Study|Culture positive for yeast|0|||
156393166|NCT02432105|564530163|FG000|Overall Study|Randomized in error|0|||
156393167|NCT02432105|564530164|FG001|Overall Study|Randomized in error|0|||
156393168|NCT02432105|564530165|FG002|Overall Study|Randomized in error|2|||
156393169|NCT01302847|564530166|FG000|Overall Study|Death|0|||
156548775|NCT00652366|565100440|FG004|Overall Study|Death|5|||
156548776|NCT00652366|565100436|FG000|Overall Study|Lack of Efficacy|84|||
156393170|NCT01302847|564530167|FG001|Overall Study|Death|1|||
156393171|NCT01302847|564530168|FG002|Overall Study|Death|0|||
156393172|NCT01302847|564530169|FG003|Overall Study|Death|0|||
156393173|NCT01302847|564530170|FG004|Overall Study|Death|0|||
156393174|NCT01302847|564530171|FG005|Overall Study|Death|1|||
156393175|NCT01302847|564530172|FG006|Overall Study|Death|1|||
156393176|NCT01302847|564530173|FG007|Overall Study|Death|0|||
156393177|NCT01302847|564530166|FG000|Overall Study|Pregnancy|2|||
156393178|NCT01302847|564530167|FG001|Overall Study|Pregnancy|0|||
156393179|NCT01302847|564530168|FG002|Overall Study|Pregnancy|0|||
156393180|NCT01302847|564530169|FG003|Overall Study|Pregnancy|0|||
156393181|NCT01302847|564530170|FG004|Overall Study|Pregnancy|0|||
156393182|NCT01302847|564530171|FG005|Overall Study|Pregnancy|0|||
156393183|NCT01302847|564530172|FG006|Overall Study|Pregnancy|0|||
156393184|NCT01302847|564530173|FG007|Overall Study|Pregnancy|0|||
156393185|NCT01302847|564530166|FG000|Overall Study|Virologic failure|0|||
156393186|NCT01302847|564530167|FG001|Overall Study|Virologic failure|2|||
156393187|NCT01302847|564530168|FG002|Overall Study|Virologic failure|0|||
156393188|NCT01302847|564530169|FG003|Overall Study|Virologic failure|2|||
156393189|NCT01302847|564530170|FG004|Overall Study|Virologic failure|1|||
156393190|NCT01302847|564530171|FG005|Overall Study|Virologic failure|3|||
156393191|NCT01302847|564530172|FG006|Overall Study|Virologic failure|1|||
156393192|NCT01302847|564530173|FG007|Overall Study|Virologic failure|2|||
156393193|NCT01302847|564530166|FG000|Overall Study|Severe debilitation, unable to continue|0|||
156393194|NCT01302847|564530167|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156393195|NCT01302847|564530168|FG002|Overall Study|Severe debilitation, unable to continue|0|||
156393196|NCT01302847|564530169|FG003|Overall Study|Severe debilitation, unable to continue|0|||
156393197|NCT01302847|564530170|FG004|Overall Study|Severe debilitation, unable to continue|0|||
156393198|NCT01302847|564530171|FG005|Overall Study|Severe debilitation, unable to continue|1|||
156393199|NCT01302847|564530172|FG006|Overall Study|Severe debilitation, unable to continue|1|||
156393200|NCT01302847|564530173|FG007|Overall Study|Severe debilitation, unable to continue|0|||
156393201|NCT01302847|564530166|FG000|Overall Study|Not able to get to clinic|1|||
156393202|NCT01302847|564530167|FG001|Overall Study|Not able to get to clinic|1|||
156393203|NCT01302847|564530168|FG002|Overall Study|Not able to get to clinic|0|||
156393204|NCT01302847|564530169|FG003|Overall Study|Not able to get to clinic|0|||
156393205|NCT01302847|564530170|FG004|Overall Study|Not able to get to clinic|0|||
156393206|NCT01302847|564530171|FG005|Overall Study|Not able to get to clinic|0|||
156393207|NCT01302847|564530172|FG006|Overall Study|Not able to get to clinic|0|||
156393208|NCT01302847|564530173|FG007|Overall Study|Not able to get to clinic|0|||
156393209|NCT01302847|564530166|FG000|Overall Study|Site closing|2|||
156393210|NCT01302847|564530167|FG001|Overall Study|Site closing|2|||
156393211|NCT01302847|564530168|FG002|Overall Study|Site closing|0|||
156393212|NCT01302847|564530169|FG003|Overall Study|Site closing|0|||
156393213|NCT01302847|564530170|FG004|Overall Study|Site closing|0|||
156393214|NCT01302847|564530171|FG005|Overall Study|Site closing|0|||
156393215|NCT01302847|564530172|FG006|Overall Study|Site closing|0|||
156548777|NCT00652366|565100437|FG001|Overall Study|Lack of Efficacy|58|||
156393216|NCT01302847|564530173|FG007|Overall Study|Site closing|0|||
156393217|NCT01302847|564530166|FG000|Overall Study|Withdrawal by Subject|1|||
156393218|NCT01302847|564530167|FG001|Overall Study|Withdrawal by Subject|0|||
156393219|NCT01302847|564530168|FG002|Overall Study|Withdrawal by Subject|0|||
156393220|NCT01302847|564530169|FG003|Overall Study|Withdrawal by Subject|0|||
156393221|NCT01302847|564530170|FG004|Overall Study|Withdrawal by Subject|1|||
156393222|NCT01302847|564530171|FG005|Overall Study|Withdrawal by Subject|0|||
156393223|NCT01302847|564530172|FG006|Overall Study|Withdrawal by Subject|0|||
156393224|NCT01302847|564530173|FG007|Overall Study|Withdrawal by Subject|1|||
156393225|NCT01302847|564530166|FG000|Overall Study|Not willing to adhere to requirements|5|||
156393226|NCT01302847|564530167|FG001|Overall Study|Not willing to adhere to requirements|0|||
156393227|NCT01302847|564530168|FG002|Overall Study|Not willing to adhere to requirements|1|||
156393228|NCT01302847|564530169|FG003|Overall Study|Not willing to adhere to requirements|0|||
156393229|NCT01302847|564530170|FG004|Overall Study|Not willing to adhere to requirements|0|||
156548778|NCT00652366|565100438|FG002|Overall Study|Lack of Efficacy|53|||
156393230|NCT01302847|564530171|FG005|Overall Study|Not willing to adhere to requirements|0|||
156393231|NCT01302847|564530172|FG006|Overall Study|Not willing to adhere to requirements|0|||
156393232|NCT01302847|564530173|FG007|Overall Study|Not willing to adhere to requirements|2|||
156393233|NCT01302847|564530166|FG000|Overall Study|Site unable to contact participant|2|||
156393234|NCT01302847|564530167|FG001|Overall Study|Site unable to contact participant|1|||
156393235|NCT01302847|564530168|FG002|Overall Study|Site unable to contact participant|0|||
156393236|NCT01302847|564530169|FG003|Overall Study|Site unable to contact participant|0|||
156393237|NCT01302847|564530170|FG004|Overall Study|Site unable to contact participant|0|||
156393238|NCT01302847|564530171|FG005|Overall Study|Site unable to contact participant|0|||
156393239|NCT01302847|564530172|FG006|Overall Study|Site unable to contact participant|2|||
156393240|NCT01302847|564530173|FG007|Overall Study|Site unable to contact participant|0|||
156393241|NCT04302350|564530175|FG000|Overall Study|Physician Decision|1|||
156393242|NCT04302350|564530176|FG001|Overall Study|Physician Decision|1|||
156393243|NCT04302350|564530177|FG002|Overall Study|Physician Decision|2|||
156393244|NCT04302350|564530175|FG000|Overall Study|Lack of Efficacy|1|||
156393245|NCT04302350|564530176|FG001|Overall Study|Lack of Efficacy|1|||
156393246|NCT04302350|564530177|FG002|Overall Study|Lack of Efficacy|4|||
156393247|NCT04302350|564530175|FG000|Overall Study|Adverse Event|0|||
156393248|NCT04302350|564530176|FG001|Overall Study|Adverse Event|1|||
156393249|NCT04302350|564530177|FG002|Overall Study|Adverse Event|2|||
156393250|NCT02137369|564530180|FG000|Overall Study|Withdrawal by Subject|3|||
156393251|NCT02137369|564530181|FG001|Overall Study|Withdrawal by Subject|2|||
156393252|NCT02137369|564530180|FG000|Overall Study|Adverse Event|2|||
156393253|NCT02137369|564530181|FG001|Overall Study|Adverse Event|0|||
156393254|NCT02137369|564530180|FG000|Overall Study|Lost to Follow-up|1|||
156393255|NCT02137369|564530181|FG001|Overall Study|Lost to Follow-up|0|||
156393256|NCT02137369|564530180|FG000|Overall Study|Moved away|2|||
156393257|NCT02137369|564530181|FG001|Overall Study|Moved away|0|||
156393258|NCT00707031|564530182|FG000|Overall Study|Adverse Event|45|||
156393259|NCT00707031|564530183|FG001|Overall Study|Adverse Event|45|||
156393260|NCT00707031|564530182|FG000|Overall Study|Lack of Efficacy|19|||
156393261|NCT00707031|564530183|FG001|Overall Study|Lack of Efficacy|6|||
156393262|NCT00707031|564530182|FG000|Overall Study|Lost to Follow-up|2|||
156393263|NCT00707031|564530183|FG001|Overall Study|Lost to Follow-up|1|||
156393264|NCT00707031|564530182|FG000|Overall Study|Protocol Violation|1|||
156393265|NCT00707031|564530183|FG001|Overall Study|Protocol Violation|0|||
156393266|NCT00707031|564530182|FG000|Overall Study|Withdrawal by Subject|7|||
156393267|NCT00707031|564530183|FG001|Overall Study|Withdrawal by Subject|8|||
156393268|NCT00707031|564530182|FG000|Overall Study|Poor Compliance to Protocol|7|||
156393269|NCT00707031|564530183|FG001|Overall Study|Poor Compliance to Protocol|13|||
156393270|NCT00707031|564530182|FG000|Overall Study|Familial or Personal Reasons|12|||
156393271|NCT00707031|564530183|FG001|Overall Study|Familial or Personal Reasons|15|||
156393272|NCT00707031|564530182|FG000|Overall Study|Serious Noncompliance|2|||
156393273|NCT00707031|564530183|FG001|Overall Study|Serious Noncompliance|3|||
156393274|NCT00707031|564530182|FG000|Overall Study|Sponsor Decision|9|||
156393275|NCT00707031|564530183|FG001|Overall Study|Sponsor Decision|8|||
156393276|NCT03519854|564530184|FG000|Overall Study|Technical Error|0|||
156393277|NCT03519854|564530185|FG001|Overall Study|Technical Error|0|||
156393278|NCT03519854|564530186|FG002|Overall Study|Technical Error|1|||
156393279|NCT03519854|564530187|FG003|Overall Study|Technical Error|0|||
156393280|NCT03519854|564530188|FG004|Overall Study|Technical Error|0|||
156393281|NCT03519854|564530189|FG005|Overall Study|Technical Error|0|||
156393282|NCT03519854|564530190|FG006|Overall Study|Technical Error|0|||
156393283|NCT03519854|564530191|FG007|Overall Study|Technical Error|0|||
156393284|NCT03519854|564530192|FG008|Overall Study|Technical Error|0|||
156393285|NCT03519854|564530193|FG009|Overall Study|Technical Error|0|||
156393286|NCT03519854|564530194|FG010|Overall Study|Technical Error|0|||
156393287|NCT03519854|564530195|FG011|Overall Study|Technical Error|0|||
156393288|NCT03519854|564530196|FG012|Overall Study|Technical Error|0|||
156393289|NCT03519854|564530197|FG013|Overall Study|Technical Error|0|||
156393290|NCT03519854|564530198|FG014|Overall Study|Technical Error|0|||
156393291|NCT03519854|564530199|FG015|Overall Study|Technical Error|0|||
156393292|NCT03519854|564530200|FG016|Overall Study|Technical Error|0|||
156393293|NCT03519854|564530201|FG017|Overall Study|Technical Error|0|||
156393294|NCT02747238|564530202|FG000|Overall Study|Lack of Efficacy|0|||
156393295|NCT02747238|564530203|FG001|Overall Study|Lack of Efficacy|1|||
156393296|NCT02747238|564530202|FG000|Overall Study|Data lost|3|||
156393297|NCT02747238|564530203|FG001|Overall Study|Data lost|5|||
156393298|NCT01951625|564530208|FG000|Treatment Period|Protocol Violation|2|||
156393299|NCT01951625|564530209|FG001|Treatment Period|Protocol Violation|0|||
156393300|NCT01951625|564530210|FG002|Treatment Period|Protocol Violation|1|||
156393301|NCT01951625|564530211|FG003|Treatment Period|Protocol Violation|3|||
156393302|NCT01951625|564530212|FG004|Treatment Period|Protocol Violation|2|||
156393303|NCT01951625|564530208|FG000|Treatment Period|Physician Decision|0|||
156393304|NCT01951625|564530209|FG001|Treatment Period|Physician Decision|0|||
156393305|NCT01951625|564530210|FG002|Treatment Period|Physician Decision|0|||
156393306|NCT01951625|564530211|FG003|Treatment Period|Physician Decision|0|||
156393307|NCT01951625|564530212|FG004|Treatment Period|Physician Decision|1|||
156393308|NCT01951625|564530208|FG000|Treatment Period|Protocol driven decision point|0|||
156393309|NCT01951625|564530209|FG001|Treatment Period|Protocol driven decision point|5|||
156393310|NCT01951625|564530210|FG002|Treatment Period|Protocol driven decision point|0|||
156393311|NCT01951625|564530211|FG003|Treatment Period|Protocol driven decision point|2|||
156393312|NCT01951625|564530212|FG004|Treatment Period|Protocol driven decision point|1|||
156393313|NCT01951625|564530208|FG000|Treatment Period|Non compliance with study drug|1|||
156393314|NCT01951625|564530209|FG001|Treatment Period|Non compliance with study drug|2|||
156393315|NCT01951625|564530210|FG002|Treatment Period|Non compliance with study drug|2|||
156393316|NCT01951625|564530211|FG003|Treatment Period|Non compliance with study drug|0|||
156393317|NCT01951625|564530212|FG004|Treatment Period|Non compliance with study drug|0|||
156393318|NCT01951625|564530208|FG000|Treatment Period|Death|3|||
156393319|NCT01951625|564530209|FG001|Treatment Period|Death|2|||
156393320|NCT01951625|564530210|FG002|Treatment Period|Death|2|||
156393321|NCT01951625|564530211|FG003|Treatment Period|Death|1|||
156393322|NCT01951625|564530212|FG004|Treatment Period|Death|2|||
156393323|NCT01951625|564530208|FG000|Treatment Period|Adverse Event|7|||
156393324|NCT01951625|564530209|FG001|Treatment Period|Adverse Event|10|||
156393325|NCT01951625|564530210|FG002|Treatment Period|Adverse Event|9|||
156393326|NCT01951625|564530211|FG003|Treatment Period|Adverse Event|8|||
156393327|NCT01951625|564530212|FG004|Treatment Period|Adverse Event|8|||
156393328|NCT01951625|564530208|FG000|Treatment Period|Withdrawal by Subject|5|||
156393329|NCT01951625|564530209|FG001|Treatment Period|Withdrawal by Subject|2|||
156393330|NCT01951625|564530210|FG002|Treatment Period|Withdrawal by Subject|1|||
156393331|NCT01951625|564530211|FG003|Treatment Period|Withdrawal by Subject|7|||
156393332|NCT01951625|564530212|FG004|Treatment Period|Withdrawal by Subject|3|||
156393333|NCT01951625|564530208|FG000|Treatment Period|Lost to Follow-up|1|||
156393334|NCT01951625|564530209|FG001|Treatment Period|Lost to Follow-up|0|||
156393335|NCT01951625|564530210|FG002|Treatment Period|Lost to Follow-up|0|||
156548779|NCT00652366|565100439|FG003|Overall Study|Lack of Efficacy|133|||
156548780|NCT00652366|565100440|FG004|Overall Study|Lack of Efficacy|13|||
156548781|NCT00652366|565100436|FG000|Overall Study|Violation of Selection Criteria|0|||
156548782|NCT00652366|565100437|FG001|Overall Study|Violation of Selection Criteria|0|||
156548783|NCT00652366|565100438|FG002|Overall Study|Violation of Selection Criteria|1|||
156548784|NCT00652366|565100439|FG003|Overall Study|Violation of Selection Criteria|0|||
156548785|NCT00652366|565100440|FG004|Overall Study|Violation of Selection Criteria|0|||
156548786|NCT00652366|565100436|FG000|Overall Study|Protocol Violation|1|||
156548787|NCT00652366|565100437|FG001|Overall Study|Protocol Violation|0|||
156548788|NCT00652366|565100438|FG002|Overall Study|Protocol Violation|0|||
156548789|NCT00652366|565100439|FG003|Overall Study|Protocol Violation|0|||
156548790|NCT00652366|565100440|FG004|Overall Study|Protocol Violation|0|||
156548791|NCT00652366|565100436|FG000|Overall Study|Refused treatment|3|||
156548792|NCT00652366|565100437|FG001|Overall Study|Refused treatment|7|||
156548793|NCT00652366|565100438|FG002|Overall Study|Refused treatment|6|||
156548794|NCT00652366|565100439|FG003|Overall Study|Refused treatment|17|||
156548795|NCT00652366|565100440|FG004|Overall Study|Refused treatment|5|||
156548796|NCT00652366|565100436|FG000|Overall Study|Other|5|||
156548797|NCT00652366|565100437|FG001|Overall Study|Other|2|||
156548798|NCT00652366|565100438|FG002|Overall Study|Other|3|||
156393336|NCT01951625|564530211|FG003|Treatment Period|Lost to Follow-up|1|||
156393337|NCT01951625|564530212|FG004|Treatment Period|Lost to Follow-up|0|||
156393338|NCT01951625|564530208|FG000|Follow Up Period|Non-compliance with study drug|1|||
156393339|NCT01951625|564530209|FG001|Follow Up Period|Non-compliance with study drug|0|||
156393340|NCT01951625|564530210|FG002|Follow Up Period|Non-compliance with study drug|0|||
156393341|NCT01951625|564530211|FG003|Follow Up Period|Non-compliance with study drug|0|||
156393342|NCT01951625|564530212|FG004|Follow Up Period|Non-compliance with study drug|0|||
156393343|NCT01951625|564530208|FG000|Follow Up Period|Death|1|||
156393344|NCT01951625|564530209|FG001|Follow Up Period|Death|3|||
156393345|NCT01951625|564530210|FG002|Follow Up Period|Death|2|||
156393346|NCT01951625|564530211|FG003|Follow Up Period|Death|2|||
156393347|NCT01951625|564530212|FG004|Follow Up Period|Death|1|||
156393348|NCT01951625|564530208|FG000|Follow Up Period|Logistical difficulties|1|||
156393349|NCT01951625|564530209|FG001|Follow Up Period|Logistical difficulties|2|||
156393350|NCT01951625|564530210|FG002|Follow Up Period|Logistical difficulties|0|||
156393351|NCT01951625|564530211|FG003|Follow Up Period|Logistical difficulties|0|||
156548799|NCT00652366|565100439|FG003|Overall Study|Other|4|||
156548800|NCT00652366|565100440|FG004|Overall Study|Other|0|||
156548801|NCT02069899|565100441|FG000|Overall Study|Adverse Event|6|||
156393352|NCT01951625|564530212|FG004|Follow Up Period|Logistical difficulties|0|||
156393353|NCT01951625|564530208|FG000|Follow Up Period|Adverse Event|0|||
156393354|NCT01951625|564530209|FG001|Follow Up Period|Adverse Event|3|||
156393355|NCT01951625|564530210|FG002|Follow Up Period|Adverse Event|2|||
156393356|NCT01951625|564530211|FG003|Follow Up Period|Adverse Event|3|||
156393357|NCT01951625|564530212|FG004|Follow Up Period|Adverse Event|5|||
156393358|NCT01951625|564530208|FG000|Follow Up Period|Withdrawal by Subject|4|||
156393359|NCT01951625|564530209|FG001|Follow Up Period|Withdrawal by Subject|1|||
156548802|NCT02069899|565100442|FG001|Overall Study|Adverse Event|0|||
156393360|NCT01951625|564530210|FG002|Follow Up Period|Withdrawal by Subject|0|||
156393361|NCT01951625|564530211|FG003|Follow Up Period|Withdrawal by Subject|5|||
156393362|NCT01951625|564530212|FG004|Follow Up Period|Withdrawal by Subject|3|||
156393363|NCT01951625|564530208|FG000|Follow Up Period|Lost to Follow-up|1|||
156393364|NCT01951625|564530209|FG001|Follow Up Period|Lost to Follow-up|0|||
156393365|NCT01951625|564530210|FG002|Follow Up Period|Lost to Follow-up|0|||
156393366|NCT01951625|564530211|FG003|Follow Up Period|Lost to Follow-up|1|||
156393367|NCT01951625|564530212|FG004|Follow Up Period|Lost to Follow-up|1|||
156393368|NCT00680407|564530225|FG000|Overall Study|Lost to Follow-up|3|||
156393369|NCT00680407|564530226|FG001|Overall Study|Lost to Follow-up|3|||
156393370|NCT00680407|564530227|FG002|Overall Study|Lost to Follow-up|1|||
156548803|NCT02069899|565100443|FG002|Overall Study|Adverse Event|1|||
156548804|NCT02069899|565100441|FG000|Overall Study|Withdrawal by Participant|2|||
156548805|NCT02069899|565100442|FG001|Overall Study|Withdrawal by Participant|0|||
156548806|NCT02069899|565100443|FG002|Overall Study|Withdrawal by Participant|0|||
156548807|NCT02069899|565100441|FG000|Overall Study|Lost to Follow-up|1|||
156548808|NCT02069899|565100442|FG001|Overall Study|Lost to Follow-up|0|||
156548809|NCT02069899|565100443|FG002|Overall Study|Lost to Follow-up|1|||
156548810|NCT02069899|565100441|FG000|Overall Study|Other|4|||
156548811|NCT02069899|565100442|FG001|Overall Study|Other|0|||
156548812|NCT02069899|565100443|FG002|Overall Study|Other|0|||
156393371|NCT00680407|564530225|FG000|Overall Study|Withdrawal by Subject|5|||
156393372|NCT00680407|564530226|FG001|Overall Study|Withdrawal by Subject|2|||
156393373|NCT00680407|564530227|FG002|Overall Study|Withdrawal by Subject|2|||
156393374|NCT04128293|564532406|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
156393375|NCT04128293|564532407|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
156393376|NCT04128293|564532408|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
156548813|NCT02069899|565100441|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
156548814|NCT02069899|565100442|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
156548815|NCT02069899|565100443|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
156548816|NCT02069899|565100441|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
156548817|NCT02069899|565100442|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
156548818|NCT02069899|565100443|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
156548819|NCT00490451|565100444|FG000|Overall Study|Adverse Event|3|||
156548820|NCT00490451|565100445|FG001|Overall Study|Adverse Event|3|||
156548821|NCT00490451|565100444|FG000|Overall Study|Death|3|||
156548822|NCT00490451|565100445|FG001|Overall Study|Death|1|||
156548823|NCT00490451|565100444|FG000|Overall Study|Withdrawal by Subject|2|||
156548824|NCT00490451|565100445|FG001|Overall Study|Withdrawal by Subject|0|||
156548825|NCT00490451|565100444|FG000|Overall Study|Investigator Decision|1|||
156548826|NCT00490451|565100445|FG001|Overall Study|Investigator Decision|0|||
156548827|NCT00490451|565100444|FG000|Overall Study|Protocol Violation|1|||
156393377|NCT04128293|564532409|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
156393378|NCT02030015|564532412|FG000|Overall Study|Withdrawal by Subject|3|||
156393379|NCT02030015|564532412|FG000|Overall Study|Death|13|||
156393380|NCT03014674|564532414|FG000|Overall Study|Withdrawal by Subject|1|||
156393381|NCT03014674|564532415|FG001|Overall Study|Withdrawal by Subject|0|||
156393382|NCT03014674|564532416|FG002|Overall Study|Withdrawal by Subject|0|||
156548828|NCT00490451|565100445|FG001|Overall Study|Protocol Violation|0|||
156548829|NCT00490451|565100444|FG000|Overall Study|Progressive Disease|53|||
156548830|NCT00490451|565100445|FG001|Overall Study|Progressive Disease|34|||
156548831|NCT04703075|565100448|FG000|Overall Study|Adverse Event|11|||
156548832|NCT04703075|565100449|FG001|Overall Study|Adverse Event|7|||
156548833|NCT04703075|565100448|FG000|Overall Study|Lost to Follow-up|6|||
156548834|NCT04703075|565100449|FG001|Overall Study|Lost to Follow-up|12|||
156548835|NCT04703075|565100448|FG000|Overall Study|Physician Decision|3|||
156548836|NCT04703075|565100449|FG001|Overall Study|Physician Decision|0|||
156548837|NCT04703075|565100448|FG000|Overall Study|Moved|0|||
156548838|NCT04703075|565100449|FG001|Overall Study|Moved|2|||
156548839|NCT04703075|565100448|FG000|Overall Study|Index INH Resistant|0|||
156548840|NCT04703075|565100449|FG001|Overall Study|Index INH Resistant|1|||
156393383|NCT00514943|564532417|FG000|Stage 1|Progressive disease|4|||
156393384|NCT00514943|564532418|FG001|Stage 1|Progressive disease|8|||
156393385|NCT00514943|564532417|FG000|Stage 1|Other Adverse Event|16|||
156393386|NCT00514943|564532418|FG001|Stage 1|Other Adverse Event|6|||
156393387|NCT00514943|564532417|FG000|Stage 1|Not treated|1|||
156393388|NCT00514943|564532418|FG001|Stage 1|Not treated|2|||
156548841|NCT04703075|565100448|FG000|Overall Study|Lack of Efficacy|6|||
156548842|NCT04703075|565100449|FG001|Overall Study|Lack of Efficacy|18|||
156548843|NCT00254501|565100452|FG000|Overall Study|Lost to Follow-up|1|||
156548844|NCT00254501|565100453|FG001|Overall Study|Lost to Follow-up|1|||
156548845|NCT00550680|565100454|FG000|Overall Study|Administrative Reasons|1|||
156548846|NCT00550680|565100454|FG000|Overall Study|Adverse Event|5|||
156393389|NCT00514943|564532417|FG000|Stage 1|Patient refused to continue study meds|8|||
156393390|NCT00514943|564532418|FG001|Stage 1|Patient refused to continue study meds|3|||
156393391|NCT00514943|564532417|FG000|Stage 1|Other than stated above|1|||
156393392|NCT00514943|564532418|FG001|Stage 1|Other than stated above|7|||
156393393|NCT00514943|564532417|FG000|Stage 2|Progressive disease|27|||
156393394|NCT00514943|564532418|FG001|Stage 2|Progressive disease|24|||
156393395|NCT00514943|564532417|FG000|Stage 2|Other Adverse Event|3|||
156393396|NCT00514943|564532418|FG001|Stage 2|Other Adverse Event|10|||
156393397|NCT00514943|564532417|FG000|Stage 2|Patient refused to continue study meds|2|||
156393398|NCT00514943|564532418|FG001|Stage 2|Patient refused to continue study meds|0|||
156393399|NCT00514943|564532417|FG000|Stage 2|Other than stated above|0|||
156393400|NCT00514943|564532418|FG001|Stage 2|Other than stated above|2|||
156393401|NCT00833560|564532422|FG000|Overall Study|Toxicity|13|||
156393402|NCT00833560|564532422|FG000|Overall Study|Adverse Event|11|||
156393403|NCT00833560|564532422|FG000|Overall Study|Protocol Violation|6|||
156393404|NCT00833560|564532422|FG000|Overall Study|Lack of Efficacy|4|||
156393405|NCT00833560|564532422|FG000|Overall Study|Death|2|||
156393406|NCT00833560|564532422|FG000|Overall Study|Pregression of other disease|1|||
156393407|NCT00833560|564532422|FG000|Overall Study|Other|5|||
156393408|NCT03382782|564532425|FG000|Cohort 1|Withdrawal by Subject|11|||
156393409|NCT03382782|564532426|FG001|Cohort 1|Withdrawal by Subject|5|||
156393410|NCT03382782|564532427|FG002|Cohort 1|Withdrawal by Subject|0|||
156393411|NCT03382782|564532425|FG000|Cohort 2|Withdrawal by Subject|1|||
156393412|NCT03382782|564532426|FG001|Cohort 2|Withdrawal by Subject|1|||
156393413|NCT03382782|564532427|FG002|Cohort 2|Withdrawal by Subject|0|||
156393414|NCT03382782|564532425|FG000|Cohort 3|Withdrawal by Subject|1|||
156393415|NCT03382782|564532426|FG001|Cohort 3|Withdrawal by Subject|2|||
156393416|NCT03382782|564532427|FG002|Cohort 3|Withdrawal by Subject|0|||
156393417|NCT02623322|564532432|FG000|Overall Study|Lost to Follow-up|2|||
156393418|NCT02623322|564532433|FG001|Overall Study|Lost to Follow-up|1|||
156393419|NCT02623322|564532434|FG002|Overall Study|Lost to Follow-up|0|||
156393420|NCT02450331|564532438|FG000|Overall Study|Death|162|||
156393421|NCT02450331|564532439|FG001|Overall Study|Death|171|||
156393422|NCT02450331|564532438|FG000|Overall Study|Lost to Follow-up|14|||
156393423|NCT02450331|564532439|FG001|Overall Study|Lost to Follow-up|12|||
156393424|NCT02450331|564532438|FG000|Overall Study|Withdrawal by Subject|55|||
156393425|NCT02450331|564532439|FG001|Overall Study|Withdrawal by Subject|44|||
156393426|NCT02450331|564532438|FG000|Overall Study|Non-specified other|1|||
156393427|NCT02450331|564532439|FG001|Overall Study|Non-specified other|1|||
156393428|NCT02080871|564532440|FG000|Overall Study|Death|1|||
156393429|NCT02080871|564532440|FG000|Overall Study|Lost to Follow-up|1|||
156393430|NCT02428296|564532441|FG000|Overall Study|Adverse Event|7|||
156393431|NCT02428296|564532441|FG000|Overall Study|Withdrawal by Subject|2|||
156393432|NCT00868439|564532443|FG000|Overall Study|Adverse Event|4|||
156393433|NCT00868439|564532444|FG001|Overall Study|Adverse Event|3|||
156393434|NCT00868439|564532443|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
156393435|NCT00868439|564532444|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
156393436|NCT00868439|564532443|FG000|Overall Study|Death|0|||
156393437|NCT00868439|564532444|FG001|Overall Study|Death|1|||
156393438|NCT00868439|564532443|FG000|Overall Study|Protocol Violation|1|||
156393439|NCT00868439|564532444|FG001|Overall Study|Protocol Violation|1|||
156393440|NCT00868439|564532443|FG000|Overall Study|Physician Decision|1|||
156393441|NCT00868439|564532444|FG001|Overall Study|Physician Decision|0|||
156393442|NCT00868439|564532443|FG000|Overall Study|Withdrawal by Subject|0|||
156393443|NCT00868439|564532444|FG001|Overall Study|Withdrawal by Subject|1|||
156393444|NCT01132326|564532445|FG000|Overall Study|Lack of Efficacy|25|||
156393445|NCT01132326|564532445|FG000|Overall Study|Adverse Event|37|||
156393446|NCT01132326|564532445|FG000|Overall Study|Protocol Violation|1|||
156393447|NCT01132326|564532445|FG000|Overall Study|Lost to Follow-up|16|||
156393448|NCT01132326|564532445|FG000|Overall Study|Withdrawal by Subject|40|||
156393449|NCT01132326|564532445|FG000|Overall Study|Physician Decision|10|||
156393450|NCT01132326|564532445|FG000|Overall Study|Study Termination|80|||
156393451|NCT01132326|564532445|FG000|Overall Study|Declining Health|1|||
156548847|NCT00550680|565100454|FG000|Overall Study|Death|3|||
156548848|NCT00550680|565100454|FG000|Overall Study|Early Improvement|1|||
156548849|NCT00550680|565100454|FG000|Overall Study|Lost to Follow-up|3|||
156548850|NCT00550680|565100454|FG000|Overall Study|Lack of Efficacy|1|||
156548851|NCT00550680|565100454|FG000|Overall Study|Other|10|||
156393452|NCT01132326|564532445|FG000|Overall Study|Pregnancy|1|||
156393453|NCT01132326|564532445|FG000|Overall Study|Caregiver Withdrew Consent|1|||
156393454|NCT01132326|564532445|FG000|Overall Study|Death|5|||
156393455|NCT01132326|564532445|FG000|Overall Study|Subject Unable to Come To Visits|1|||
156393456|NCT04535947|564532446|FG000|Overall Study|Adverse Event|1|||
156393457|NCT04535947|564532447|FG001|Overall Study|Adverse Event|4|||
156393458|NCT04535947|564532446|FG000|Overall Study|Other reasons not specified|2|||
156393459|NCT04535947|564532447|FG001|Overall Study|Other reasons not specified|0|||
156393460|NCT04535947|564532446|FG000|Overall Study|Withdrawal by Subject|1|||
156393461|NCT04535947|564532447|FG001|Overall Study|Withdrawal by Subject|1|||
156393462|NCT04867369|564532454|FG000|Overall Study|Withdrawal by Subject|1|||
156393463|NCT04867369|564532455|FG001|Overall Study|Withdrawal by Subject|0|||
156393464|NCT03492281|564532456|FG000|Overall Study|Withdrawal by Subject|21|||
156393465|NCT03492281|564532457|FG001|Overall Study|Withdrawal by Subject|14|||
156393466|NCT03492281|564532458|FG002|Overall Study|Withdrawal by Subject|13|||
156548852|NCT00550680|565100454|FG000|Overall Study|Protocol Violation|7|||
156548853|NCT00550680|565100454|FG000|Overall Study|Refused Treatment|19|||
156548854|NCT00550680|565100454|FG000|Overall Study|Screen Failure|6|||
156548855|NCT01119248|565100455|FG000|Overall Study|Physician Decision|5|||
156548856|NCT01967550|565100456|FG000|Overall Study|Withdrawal by Subject|1|||
156548857|NCT01967550|565100457|FG001|Overall Study|Withdrawal by Subject|0|||
156548858|NCT01967550|565100456|FG000|Overall Study|Adverse Event|2|||
156393467|NCT03492281|564532456|FG000|Overall Study|Lost to Follow-up|14|||
156393468|NCT03492281|564532457|FG001|Overall Study|Lost to Follow-up|15|||
156548859|NCT01967550|565100457|FG001|Overall Study|Adverse Event|0|||
156548860|NCT01967550|565100456|FG000|Overall Study|Protocol Violation|2|||
156548861|NCT01967550|565100457|FG001|Overall Study|Protocol Violation|1|||
156548862|NCT01967550|565100456|FG000|Overall Study|Non Compliance|0|||
156393469|NCT03492281|564532458|FG002|Overall Study|Lost to Follow-up|10|||
156393470|NCT03492281|564532456|FG000|Overall Study|Adverse Event|6|||
156393471|NCT03492281|564532457|FG001|Overall Study|Adverse Event|8|||
156393472|NCT03492281|564532458|FG002|Overall Study|Adverse Event|13|||
156393473|NCT03492281|564532456|FG000|Overall Study|Lack of Efficacy|3|||
156393474|NCT03492281|564532457|FG001|Overall Study|Lack of Efficacy|0|||
156393475|NCT03492281|564532458|FG002|Overall Study|Lack of Efficacy|1|||
156393476|NCT03492281|564532456|FG000|Overall Study|Physician Decision|1|||
156393477|NCT03492281|564532457|FG001|Overall Study|Physician Decision|0|||
156393478|NCT03492281|564532458|FG002|Overall Study|Physician Decision|3|||
156393479|NCT03492281|564532456|FG000|Overall Study|Protocol Violation|0|||
156393480|NCT03492281|564532457|FG001|Overall Study|Protocol Violation|2|||
156393481|NCT03492281|564532458|FG002|Overall Study|Protocol Violation|1|||
156393482|NCT03492281|564532456|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
156393483|NCT03492281|564532457|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
156393484|NCT03492281|564532458|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
156393485|NCT03492281|564532456|FG000|Overall Study|Death|0|||
156393486|NCT03492281|564532457|FG001|Overall Study|Death|0|||
156393487|NCT03492281|564532458|FG002|Overall Study|Death|1|||
156393488|NCT03492281|564532456|FG000|Overall Study|Captured as Other in Database|8|||
156393489|NCT03492281|564532457|FG001|Overall Study|Captured as Other in Database|6|||
156393490|NCT03492281|564532458|FG002|Overall Study|Captured as Other in Database|3|||
156393491|NCT03342638|564532459|FG000|Overall Study|Withdrawal by Subject|1|||
156393492|NCT03342638|564532460|FG001|Overall Study|Withdrawal by Subject|0|||
156393493|NCT03342638|564532459|FG000|Overall Study|Physician Decision|0|||
156393494|NCT03342638|564532460|FG001|Overall Study|Physician Decision|1|||
156393495|NCT01292239|564532465|FG000|Overall Study|Other|1|||
156393496|NCT01292239|564532466|FG001|Overall Study|Other|1|||
156393497|NCT01292239|564532465|FG000|Overall Study|Withdrawal by Subject|3|||
156393498|NCT01292239|564532466|FG001|Overall Study|Withdrawal by Subject|6|||
156393499|NCT03213158|564532467|FG000|Overall Study|Withdrawal by Subject|1|||
156548863|NCT01967550|565100457|FG001|Overall Study|Non Compliance|1|||
156548864|NCT00250835|565100458|FG000|Overall Study|Withdrawal by Subject|1|||
156548865|NCT01100437|565100460|FG000|Titration/Stabilization|Adverse Event|0|||
156548866|NCT01100437|565100461|FG001|Titration/Stabilization|Adverse Event|0|||
156393500|NCT03213158|564532467|FG000|Overall Study|Physician Decision|2|||
156393501|NCT03649230|564532469|FG000|Overall Study|Adverse Event|12|||
156393502|NCT03649230|564532469|FG000|Overall Study|Death|8|||
156393503|NCT03649230|564532469|FG000|Overall Study|Withdrawal by Subject|6|||
156393504|NCT03649230|564532469|FG000|Overall Study|Physician Decision|5|||
156393505|NCT03649230|564532469|FG000|Overall Study|Disease progression|5|||
156393506|NCT03649230|564532469|FG000|Overall Study|Switched to non-HEC|5|||
156393507|NCT03649230|564532469|FG000|Overall Study|Chemotherapy discontinued|4|||
156393508|NCT03649230|564532469|FG000|Overall Study|Received only 3 HEC cycles|4|||
156393509|NCT03649230|564532469|FG000|Overall Study|Screen Failure|3|||
156548867|NCT01100437|565100462|FG002|Titration/Stabilization|Adverse Event|4|||
156548868|NCT01100437|565100460|FG000|Titration/Stabilization|Non-compliance|0|||
156393510|NCT03649230|564532469|FG000|Overall Study|Patient stopped treatment|2|||
156393511|NCT03649230|564532469|FG000|Overall Study|Protocol Violation|1|||
156393512|NCT03649230|564532469|FG000|Overall Study|Non-compliance|1|||
156393513|NCT03649230|564532469|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
156393514|NCT01693068|564532473|FG000|Randomization Period|On-study|2|||
156393515|NCT01693068|564532474|FG001|Randomization Period|On-study|5|||
156393516|NCT01693068|564532475|FG002|Randomization Period|On-study|0|||
156393517|NCT01693068|564532473|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
156393518|NCT01693068|564532474|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
156393519|NCT01693068|564532475|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
156393520|NCT00295022|564532478|FG000|Overall Study|Adverse Event|1|||
156548869|NCT01100437|565100461|FG001|Titration/Stabilization|Non-compliance|0|||
156393521|NCT00295022|564532479|FG001|Overall Study|Adverse Event|1|||
156393522|NCT00295022|564532480|FG002|Overall Study|Adverse Event|2|||
156393523|NCT00295022|564532478|FG000|Overall Study|Lost to Follow-up|0|||
156548870|NCT01100437|565100462|FG002|Titration/Stabilization|Non-compliance|1|||
156548871|NCT01100437|565100460|FG000|Titration/Stabilization|Sponsor canceled study|0|||
156548872|NCT01100437|565100461|FG001|Titration/Stabilization|Sponsor canceled study|0|||
156393524|NCT00295022|564532479|FG001|Overall Study|Lost to Follow-up|0|||
156393525|NCT00295022|564532480|FG002|Overall Study|Lost to Follow-up|1|||
156393526|NCT00295022|564532478|FG000|Overall Study|Withdrawal by Subject|0|||
156393527|NCT00295022|564532479|FG001|Overall Study|Withdrawal by Subject|0|||
156393528|NCT00295022|564532480|FG002|Overall Study|Withdrawal by Subject|2|||
156393529|NCT00734630|564532482|FG000|Overall Study|Lack of Efficacy|4|||
156393530|NCT00734630|564532483|FG001|Overall Study|Lack of Efficacy|4|||
156393531|NCT00734630|564532482|FG000|Overall Study|Withdrawal by Subject|7|||
156393532|NCT00734630|564532483|FG001|Overall Study|Withdrawal by Subject|9|||
156393533|NCT00734630|564532482|FG000|Overall Study|Lost to Follow-up|13|||
156393534|NCT00734630|564532483|FG001|Overall Study|Lost to Follow-up|7|||
156393535|NCT00734630|564532482|FG000|Overall Study|Protocol Violation|0|||
156393536|NCT00734630|564532483|FG001|Overall Study|Protocol Violation|3|||
156393537|NCT00734630|564532482|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
156393538|NCT00734630|564532483|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
156548873|NCT01100437|565100462|FG002|Titration/Stabilization|Sponsor canceled study|1|||
156548874|NCT01100437|565100460|FG000|Maintenance|Withdrawal by Subject|0|||
156548875|NCT01100437|565100461|FG001|Maintenance|Withdrawal by Subject|0|||
156548876|NCT01100437|565100462|FG002|Maintenance|Withdrawal by Subject|1|||
156548877|NCT01100437|565100460|FG000|Maintenance|Sponsor termination of study|0|||
156548878|NCT01100437|565100461|FG001|Maintenance|Sponsor termination of study|0|||
156393539|NCT00734630|564532482|FG000|Overall Study|Adverse Event|3|||
156393540|NCT00734630|564532483|FG001|Overall Study|Adverse Event|6|||
156393541|NCT00734630|564532482|FG000|Overall Study|Randomized in Error|0|||
156393542|NCT00734630|564532483|FG001|Overall Study|Randomized in Error|1|||
156393543|NCT00734630|564532482|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
156393544|NCT00734630|564532483|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
156393545|NCT00734630|564532482|FG000|Overall Study|Poor Compliance|1|||
156393546|NCT00734630|564532483|FG001|Overall Study|Poor Compliance|1|||
156393547|NCT01239030|564532484|FG000|Double Blind|Adverse Event|0|||
156393548|NCT01239030|564532485|FG001|Double Blind|Adverse Event|1|||
156393549|NCT01239030|564532486|FG002|Double Blind|Adverse Event|0|||
156393550|NCT01239030|564532487|FG003|Double Blind|Adverse Event|2|||
156393551|NCT01239030|564532488|FG004|Double Blind|Adverse Event|0|||
156393552|NCT01239030|564532484|FG000|Double Blind|Withdrawal by Subject|0|||
156393553|NCT01239030|564532485|FG001|Double Blind|Withdrawal by Subject|1|||
156393554|NCT01239030|564532486|FG002|Double Blind|Withdrawal by Subject|1|||
156393555|NCT01239030|564532487|FG003|Double Blind|Withdrawal by Subject|0|||
156393556|NCT01239030|564532488|FG004|Double Blind|Withdrawal by Subject|1|||
156393557|NCT01239030|564532484|FG000|Double Blind|Lost to Follow-up|1|||
156393558|NCT01239030|564532485|FG001|Double Blind|Lost to Follow-up|1|||
156393559|NCT01239030|564532486|FG002|Double Blind|Lost to Follow-up|0|||
156393560|NCT01239030|564532487|FG003|Double Blind|Lost to Follow-up|0|||
156393561|NCT01239030|564532488|FG004|Double Blind|Lost to Follow-up|0|||
156393562|NCT01239030|564532484|FG000|Double Blind|Physician Decision|0|||
156393563|NCT01239030|564532485|FG001|Double Blind|Physician Decision|1|||
156393564|NCT01239030|564532486|FG002|Double Blind|Physician Decision|0|||
156393565|NCT01239030|564532487|FG003|Double Blind|Physician Decision|0|||
156393566|NCT01239030|564532488|FG004|Double Blind|Physician Decision|0|||
156393567|NCT01239030|564532484|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
156393568|NCT01239030|564532485|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
156393569|NCT01239030|564532486|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
156393570|NCT01239030|564532487|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
156393571|NCT01239030|564532488|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
156393572|NCT01239030|564532484|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
156393573|NCT01239030|564532485|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
156393574|NCT01239030|564532486|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
156393575|NCT01239030|564532487|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
156393576|NCT01239030|564532488|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
156393577|NCT01239030|564532484|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
156393578|NCT01239030|564532485|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
156393579|NCT01239030|564532486|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
156393580|NCT01239030|564532487|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
156393581|NCT01239030|564532488|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
156393582|NCT01239030|564532484|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
156548879|NCT01100437|565100462|FG002|Maintenance|Sponsor termination of study|1|||
156393583|NCT01239030|564532485|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
156393584|NCT01239030|564532486|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
156393585|NCT01239030|564532487|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
156393586|NCT01239030|564532488|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
156393587|NCT04322682|564532489|FG000|Overall Study|Withdrawal by Subject|33|||
156393588|NCT04322682|564532490|FG001|Overall Study|Withdrawal by Subject|47|||
156393589|NCT04322682|564532489|FG000|Overall Study|Death|5|||
156393590|NCT04322682|564532490|FG001|Overall Study|Death|9|||
156393591|NCT04322682|564532489|FG000|Overall Study|Lost to Follow-up|4|||
156393592|NCT04322682|564532490|FG001|Overall Study|Lost to Follow-up|8|||
156393593|NCT04322682|564532489|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
156393594|NCT04322682|564532490|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
156393595|NCT01441102|564532491|FG000|Overall Study|Adverse Event|1|||
156393596|NCT01441102|564532491|FG000|Overall Study|Withdrawal by Subject|2|||
156393597|NCT00802074|564532493|FG000|Overall Study|Adverse Event|1|||
156393598|NCT00802074|564532494|FG001|Overall Study|Adverse Event|1|||
156393599|NCT00802074|564532495|FG002|Overall Study|Adverse Event|1|||
156393600|NCT00802074|564532496|FG003|Overall Study|Adverse Event|0|||
156393601|NCT00802074|564532497|FG004|Overall Study|Adverse Event|0|||
156393602|NCT00802074|564532498|FG005|Overall Study|Adverse Event|0|||
156393603|NCT00802074|564532493|FG000|Overall Study|Withdrawal by Subject|1|||
156393604|NCT00802074|564532494|FG001|Overall Study|Withdrawal by Subject|0|||
156393605|NCT00802074|564532495|FG002|Overall Study|Withdrawal by Subject|0|||
156393606|NCT00802074|564532496|FG003|Overall Study|Withdrawal by Subject|0|||
156393607|NCT00802074|564532497|FG004|Overall Study|Withdrawal by Subject|0|||
156393608|NCT00802074|564532498|FG005|Overall Study|Withdrawal by Subject|0|||
156393609|NCT00827918|564532499|FG000|Overall Study|Adverse Event|4|||
156393610|NCT00827918|564532500|FG001|Overall Study|Adverse Event|0|||
156393611|NCT00827918|564532501|FG002|Overall Study|Adverse Event|0|||
156393612|NCT00827918|564532499|FG000|Overall Study|Lack of Efficacy|16|||
156393613|NCT00827918|564532500|FG001|Overall Study|Lack of Efficacy|4|||
156393614|NCT00827918|564532501|FG002|Overall Study|Lack of Efficacy|15|||
156393615|NCT00827918|564532499|FG000|Overall Study|Physician Decision|1|||
156393616|NCT00827918|564532500|FG001|Overall Study|Physician Decision|0|||
156393617|NCT00827918|564532501|FG002|Overall Study|Physician Decision|0|||
156393618|NCT00827918|564532499|FG000|Overall Study|Pregnancy|0|||
156393619|NCT00827918|564532500|FG001|Overall Study|Pregnancy|1|||
156393620|NCT00827918|564532501|FG002|Overall Study|Pregnancy|0|||
156393621|NCT00827918|564532499|FG000|Overall Study|Progressive Disease|1|||
156393622|NCT00827918|564532500|FG001|Overall Study|Progressive Disease|1|||
156393623|NCT00827918|564532501|FG002|Overall Study|Progressive Disease|0|||
156393624|NCT00827918|564532499|FG000|Overall Study|Protocol Violation|0|||
156393625|NCT00827918|564532500|FG001|Overall Study|Protocol Violation|1|||
156393626|NCT00827918|564532501|FG002|Overall Study|Protocol Violation|0|||
156393627|NCT00827918|564532499|FG000|Overall Study|Withdrawal by Subject|6|||
156393628|NCT00827918|564532500|FG001|Overall Study|Withdrawal by Subject|2|||
156393629|NCT00827918|564532501|FG002|Overall Study|Withdrawal by Subject|6|||
156393630|NCT00127101|564532504|FG000|Base Protocol|Adverse Event|0|||
156393631|NCT00127101|564532505|FG001|Base Protocol|Adverse Event|2|||
156393632|NCT00127101|564532506|FG002|Base Protocol|Adverse Event|1|||
156393633|NCT00127101|564532507|FG003|Base Protocol|Adverse Event|0|||
156393634|NCT00127101|564532508|FG004|Base Protocol|Adverse Event|0|||
156393635|NCT00127101|564532509|FG005|Base Protocol|Adverse Event|0|||
156393636|NCT00127101|564532504|FG000|Base Protocol|Lack of Efficacy|1|||
156393637|NCT00127101|564532505|FG001|Base Protocol|Lack of Efficacy|0|||
156393638|NCT00127101|564532506|FG002|Base Protocol|Lack of Efficacy|0|||
156393639|NCT00127101|564532507|FG003|Base Protocol|Lack of Efficacy|0|||
156393640|NCT00127101|564532508|FG004|Base Protocol|Lack of Efficacy|2|||
156393641|NCT00127101|564532509|FG005|Base Protocol|Lack of Efficacy|0|||
156393642|NCT00127101|564532504|FG000|Base Protocol|Withdrawal by Subject|1|||
156393643|NCT00127101|564532505|FG001|Base Protocol|Withdrawal by Subject|2|||
156393644|NCT00127101|564532506|FG002|Base Protocol|Withdrawal by Subject|1|||
156393645|NCT00127101|564532507|FG003|Base Protocol|Withdrawal by Subject|0|||
156393646|NCT00127101|564532508|FG004|Base Protocol|Withdrawal by Subject|0|||
156393647|NCT00127101|564532509|FG005|Base Protocol|Withdrawal by Subject|1|||
156393648|NCT00127101|564532504|FG000|Continuation Phase|Adverse Event|0|||
156393649|NCT00127101|564532505|FG001|Continuation Phase|Adverse Event|0|||
156393650|NCT00127101|564532506|FG002|Continuation Phase|Adverse Event|0|||
156393651|NCT00127101|564532507|FG003|Continuation Phase|Adverse Event|0|||
156393652|NCT00127101|564532508|FG004|Continuation Phase|Adverse Event|1|||
156393653|NCT00127101|564532509|FG005|Continuation Phase|Adverse Event|1|||
156393654|NCT00127101|564532504|FG000|Continuation Phase|Lack of Efficacy|0|||
156393655|NCT00127101|564532505|FG001|Continuation Phase|Lack of Efficacy|0|||
156393656|NCT00127101|564532506|FG002|Continuation Phase|Lack of Efficacy|0|||
156393657|NCT00127101|564532507|FG003|Continuation Phase|Lack of Efficacy|0|||
156393658|NCT00127101|564532508|FG004|Continuation Phase|Lack of Efficacy|0|||
156393659|NCT00127101|564532509|FG005|Continuation Phase|Lack of Efficacy|1|||
156393660|NCT00127101|564532504|FG000|Continuation Phase|Withdrawal by Subject|0|||
156393661|NCT00127101|564532505|FG001|Continuation Phase|Withdrawal by Subject|0|||
156393662|NCT00127101|564532506|FG002|Continuation Phase|Withdrawal by Subject|1|||
156393663|NCT00127101|564532507|FG003|Continuation Phase|Withdrawal by Subject|0|||
156393664|NCT00127101|564532508|FG004|Continuation Phase|Withdrawal by Subject|2|||
156393665|NCT00127101|564532509|FG005|Continuation Phase|Withdrawal by Subject|1|||
156393666|NCT01662310|564532511|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
156393667|NCT01662310|564532512|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
156393668|NCT01662310|564532513|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
156393669|NCT01662310|564532514|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
156393670|NCT01662310|564532515|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
156393671|NCT01662310|564532511|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
156393672|NCT01662310|564532512|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
156393673|NCT01662310|564532513|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
156393674|NCT01662310|564532514|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
156393675|NCT01662310|564532515|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
156548880|NCT01014689|565100463|FG000|Overall Study|Lack of Efficacy|0|||
156548881|NCT01014689|565100464|FG001|Overall Study|Lack of Efficacy|1|||
156548882|NCT01014689|565100463|FG000|Overall Study|Adverse Event|3|||
156548883|NCT01014689|565100464|FG001|Overall Study|Adverse Event|0|||
156548884|NCT01014689|565100463|FG000|Overall Study|Withdrawal by Subject|5|||
156548885|NCT01014689|565100464|FG001|Overall Study|Withdrawal by Subject|4|||
156548886|NCT01014689|565100463|FG000|Overall Study|Protocol Violation|1|||
156548887|NCT01014689|565100464|FG001|Overall Study|Protocol Violation|1|||
156548888|NCT01014689|565100463|FG000|Overall Study|Lost to Follow-up|3|||
156548889|NCT01014689|565100464|FG001|Overall Study|Lost to Follow-up|7|||
156548890|NCT01014689|565100463|FG000|Overall Study|Pregnancy|1|||
156548891|NCT01014689|565100464|FG001|Overall Study|Pregnancy|0|||
156548892|NCT01042600|565102416|FG000|Overall Study|Ineligible|1|||
156548893|NCT01042600|565102417|FG001|Overall Study|Ineligible|0|||
156548894|NCT00621504|565102418|FG000|Overall Study|Adverse Event|1|||
156548895|NCT00621504|565102419|FG001|Overall Study|Adverse Event|3|||
156548896|NCT00621504|565102418|FG000|Overall Study|At the request of sponsor/investigator|1|||
156548897|NCT00621504|565102419|FG001|Overall Study|At the request of sponsor/investigator|0|||
156548898|NCT00621504|565102418|FG000|Overall Study|Withdrew consent|9|||
156548899|NCT00621504|565102419|FG001|Overall Study|Withdrew consent|6|||
156548900|NCT00621504|565102418|FG000|Overall Study|Lost to Follow-up|8|||
156548901|NCT00621504|565102419|FG001|Overall Study|Lost to Follow-up|10|||
156548902|NCT00621504|565102418|FG000|Overall Study|Other|1|||
156548903|NCT00621504|565102419|FG001|Overall Study|Other|0|||
156548904|NCT00621504|565102418|FG000|Overall Study|Death|6|||
156548905|NCT00621504|565102419|FG001|Overall Study|Death|6|||
156548906|NCT03311711|565102420|FG000|Overall Study|Death|1|||
156548907|NCT03311711|565102421|FG001|Overall Study|Death|0|||
156548908|NCT03311711|565102422|FG002|Overall Study|Death|0|||
156548909|NCT03311711|565102423|FG003|Overall Study|Death|0|||
156548910|NCT03311711|565102424|FG004|Overall Study|Death|0|||
156548911|NCT03311711|565102425|FG005|Overall Study|Death|0|||
156548912|NCT03311711|565102426|FG006|Overall Study|Death|1|||
156548913|NCT03311711|565102427|FG007|Overall Study|Death|0|||
156548914|NCT03311711|565102428|FG008|Overall Study|Death|1|||
156548915|NCT03311711|565102429|FG009|Overall Study|Death|0|||
156548916|NCT03311711|565102420|FG000|Overall Study|Death of dyad partner|0|||
156548917|NCT03311711|565102421|FG001|Overall Study|Death of dyad partner|1|||
156548918|NCT03311711|565102422|FG002|Overall Study|Death of dyad partner|0|||
156548919|NCT03311711|565102423|FG003|Overall Study|Death of dyad partner|0|||
156548920|NCT03311711|565102424|FG004|Overall Study|Death of dyad partner|0|||
156548921|NCT03311711|565102425|FG005|Overall Study|Death of dyad partner|0|||
156548922|NCT03311711|565102426|FG006|Overall Study|Death of dyad partner|0|||
156548923|NCT03311711|565102427|FG007|Overall Study|Death of dyad partner|1|||
156548924|NCT03311711|565102428|FG008|Overall Study|Death of dyad partner|0|||
156548925|NCT03311711|565102429|FG009|Overall Study|Death of dyad partner|1|||
156548926|NCT03311711|565102420|FG000|Overall Study|Lost to Follow-up|2|||
156548927|NCT03311711|565102421|FG001|Overall Study|Lost to Follow-up|2|||
156548928|NCT03311711|565102422|FG002|Overall Study|Lost to Follow-up|0|||
156548929|NCT03311711|565102423|FG003|Overall Study|Lost to Follow-up|0|||
156548930|NCT03311711|565102424|FG004|Overall Study|Lost to Follow-up|0|||
156548931|NCT03311711|565102425|FG005|Overall Study|Lost to Follow-up|0|||
156548932|NCT03311711|565102426|FG006|Overall Study|Lost to Follow-up|1|||
156548933|NCT03311711|565102427|FG007|Overall Study|Lost to Follow-up|1|||
156548934|NCT03311711|565102428|FG008|Overall Study|Lost to Follow-up|0|||
156548935|NCT03311711|565102429|FG009|Overall Study|Lost to Follow-up|0|||
156548936|NCT03311711|565102420|FG000|Overall Study|Withdrawal by Subject|1|||
156548937|NCT03311711|565102421|FG001|Overall Study|Withdrawal by Subject|1|||
156548938|NCT03311711|565102422|FG002|Overall Study|Withdrawal by Subject|0|||
156548939|NCT03311711|565102423|FG003|Overall Study|Withdrawal by Subject|0|||
156548940|NCT03311711|565102424|FG004|Overall Study|Withdrawal by Subject|0|||
156393676|NCT01662310|564532511|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
156393677|NCT01662310|564532512|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
156548941|NCT03311711|565102425|FG005|Overall Study|Withdrawal by Subject|0|||
156393678|NCT01662310|564532513|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
156548942|NCT03311711|565102426|FG006|Overall Study|Withdrawal by Subject|3|||
156548943|NCT03311711|565102427|FG007|Overall Study|Withdrawal by Subject|3|||
156548944|NCT03311711|565102428|FG008|Overall Study|Withdrawal by Subject|0|||
156548945|NCT03311711|565102429|FG009|Overall Study|Withdrawal by Subject|0|||
156548946|NCT00706134|565102430|FG000|Overall Study|Adverse Event|8|||
156548947|NCT00706134|565102431|FG001|Overall Study|Adverse Event|7|||
156548948|NCT00706134|565102432|FG002|Overall Study|Adverse Event|2|||
156548949|NCT00706134|565102433|FG003|Overall Study|Adverse Event|3|||
156548950|NCT00706134|565102430|FG000|Overall Study|Lost to Follow-up|0|||
156548951|NCT00706134|565102431|FG001|Overall Study|Lost to Follow-up|1|||
156548952|NCT00706134|565102432|FG002|Overall Study|Lost to Follow-up|0|||
156548953|NCT00706134|565102433|FG003|Overall Study|Lost to Follow-up|0|||
156393679|NCT01662310|564532514|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
156393680|NCT01662310|564532515|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
156393681|NCT01662310|564532511|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
156393682|NCT01662310|564532512|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
156393683|NCT01662310|564532513|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
156393684|NCT01662310|564532514|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
156393685|NCT01662310|564532515|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
156393686|NCT01662310|564532511|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
156508744|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156508745|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156508746|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156508747|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156508748|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156508749|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156508750|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
156508751|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
156508752|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
156508753|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
156508754|NCT01646177|564955505|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508755|NCT01646177|564955506|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508756|NCT01646177|564955507|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508757|NCT01646177|564955508|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156393687|NCT01662310|564532512|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
156393688|NCT01662310|564532513|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
156393689|NCT01662310|564532514|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
156393690|NCT01662310|564532515|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
156393691|NCT01662310|564532511|FG000|Run-In or Stabilization Phase|Other|1|||
156393692|NCT01662310|564532512|FG001|Run-In or Stabilization Phase|Other|0|||
156393693|NCT01662310|564532513|FG002|Run-In or Stabilization Phase|Other|0|||
156393694|NCT01662310|564532514|FG003|Run-In or Stabilization Phase|Other|0|||
156393695|NCT01662310|564532515|FG004|Run-In or Stabilization Phase|Other|0|||
156393696|NCT01662310|564532511|FG000|Double-Blind Phase|Adverse Event|0|||
156393697|NCT01662310|564532512|FG001|Double-Blind Phase|Adverse Event|0|||
156393698|NCT01662310|564532513|FG002|Double-Blind Phase|Adverse Event|1|||
156508758|NCT01646177|564955509|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508759|NCT01646177|564955510|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508760|NCT01646177|564955511|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508761|NCT01646177|564955512|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508762|NCT01646177|564955513|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508763|NCT01646177|564955514|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
156508764|NCT01646177|564955515|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
156508765|NCT01646177|564955516|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
156508766|NCT01038427|564955519|FG000|Overall Study|Lost to follow up|1|||
156508767|NCT01038427|564955520|FG001|Overall Study|Lost to follow up|1|||
156508768|NCT01038427|564955521|FG002|Overall Study|Lost to follow up|0|||
156508769|NCT01038427|564955519|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
156508770|NCT01038427|564955520|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
156508771|NCT01038427|564955521|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
156508772|NCT01038427|564955519|FG000|Overall Study|Withdrew consent|0|||
156508773|NCT01038427|564955520|FG001|Overall Study|Withdrew consent|0|||
156508774|NCT01038427|564955521|FG002|Overall Study|Withdrew consent|1|||
156508775|NCT01038427|564955519|FG000|Overall Study|Adverse Event|2|||
156508776|NCT01038427|564955520|FG001|Overall Study|Adverse Event|2|||
156508777|NCT01038427|564955521|FG002|Overall Study|Adverse Event|1|||
156508778|NCT01038427|564955519|FG000|Overall Study|Enrolled in error|0|||
156508779|NCT01038427|564955520|FG001|Overall Study|Enrolled in error|1|||
156508780|NCT01038427|564955521|FG002|Overall Study|Enrolled in error|1|||
156508781|NCT01038427|564955519|FG000|Overall Study|Other|0|||
156508782|NCT01038427|564955520|FG001|Overall Study|Other|2|||
156508783|NCT01038427|564955521|FG002|Overall Study|Other|0|||
156508784|NCT00820170|564955522|FG000|Overall Study|Adverse Event|0|||
156548954|NCT00706134|565102430|FG000|Overall Study|Protocol Violation|0|||
156393699|NCT01662310|564532514|FG003|Double-Blind Phase|Adverse Event|0|||
156393700|NCT01662310|564532515|FG004|Double-Blind Phase|Adverse Event|0|||
156508785|NCT00820170|564955523|FG001|Overall Study|Adverse Event|0|||
156508786|NCT00820170|564955524|FG002|Overall Study|Adverse Event|0|||
156508787|NCT00820170|564955525|FG003|Overall Study|Adverse Event|0|||
156508788|NCT00820170|564955526|FG004|Overall Study|Adverse Event|2|||
156548955|NCT00706134|565102431|FG001|Overall Study|Protocol Violation|6|||
156393701|NCT01662310|564532511|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156393702|NCT01662310|564532512|FG001|Double-Blind Phase|Lost to Follow-up|3|||
156393703|NCT01662310|564532513|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156393704|NCT01662310|564532514|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156393705|NCT01662310|564532515|FG004|Double-Blind Phase|Lost to Follow-up|0|||
156393706|NCT01662310|564532511|FG000|Double-Blind Phase|Pregnancy|0|||
156393707|NCT01662310|564532512|FG001|Double-Blind Phase|Pregnancy|2|||
156393708|NCT01662310|564532513|FG002|Double-Blind Phase|Pregnancy|0|||
156393709|NCT01662310|564532514|FG003|Double-Blind Phase|Pregnancy|0|||
156393710|NCT01662310|564532515|FG004|Double-Blind Phase|Pregnancy|0|||
156393711|NCT01662310|564532511|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156393712|NCT01662310|564532512|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
156393713|NCT01662310|564532513|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
156393714|NCT01662310|564532514|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156393715|NCT01662310|564532515|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156393716|NCT01662310|564532511|FG000|Double-Blind Phase|Other|0|||
156393717|NCT01662310|564532512|FG001|Double-Blind Phase|Other|0|||
156393718|NCT01662310|564532513|FG002|Double-Blind Phase|Other|1|||
156393719|NCT01662310|564532514|FG003|Double-Blind Phase|Other|0|||
156393720|NCT01662310|564532515|FG004|Double-Blind Phase|Other|0|||
156393721|NCT01662310|564532511|FG000|Double-Blind Phase|Randomized but not treated|0|||
156393722|NCT01662310|564532512|FG001|Double-Blind Phase|Randomized but not treated|1|||
156393723|NCT01662310|564532513|FG002|Double-Blind Phase|Randomized but not treated|0|||
156393724|NCT01662310|564532514|FG003|Double-Blind Phase|Randomized but not treated|0|||
156393725|NCT01662310|564532515|FG004|Double-Blind Phase|Randomized but not treated|0|||
156393726|NCT01662310|564532511|FG000|Open-Label Extension Phase|Adverse Event|0|||
156393727|NCT01662310|564532512|FG001|Open-Label Extension Phase|Adverse Event|0|||
156393728|NCT01662310|564532513|FG002|Open-Label Extension Phase|Adverse Event|0|||
156393729|NCT01662310|564532514|FG003|Open-Label Extension Phase|Adverse Event|3|||
156393730|NCT01662310|564532515|FG004|Open-Label Extension Phase|Adverse Event|0|||
156393731|NCT01662310|564532511|FG000|Open-Label Extension Phase|Death|0|||
156393732|NCT01662310|564532512|FG001|Open-Label Extension Phase|Death|0|||
156393733|NCT01662310|564532513|FG002|Open-Label Extension Phase|Death|0|||
156393734|NCT01662310|564532514|FG003|Open-Label Extension Phase|Death|1|||
156393735|NCT01662310|564532515|FG004|Open-Label Extension Phase|Death|0|||
156393736|NCT01662310|564532511|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
156393737|NCT01662310|564532512|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
156393738|NCT01662310|564532513|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
156393739|NCT01662310|564532514|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
156393740|NCT01662310|564532515|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
156393741|NCT01662310|564532511|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
156393742|NCT01662310|564532512|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
156393743|NCT01662310|564532513|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
156393744|NCT01662310|564532514|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
156393745|NCT01662310|564532515|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
156393746|NCT01662310|564532511|FG000|Open-Label Extension Phase|Pregnancy|0|||
156393747|NCT01662310|564532512|FG001|Open-Label Extension Phase|Pregnancy|0|||
156393748|NCT01662310|564532513|FG002|Open-Label Extension Phase|Pregnancy|0|||
156393749|NCT01662310|564532514|FG003|Open-Label Extension Phase|Pregnancy|1|||
156393750|NCT01662310|564532515|FG004|Open-Label Extension Phase|Pregnancy|0|||
156393751|NCT01662310|564532511|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
156393752|NCT01662310|564532512|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
156393753|NCT01662310|564532513|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
156393754|NCT01662310|564532514|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
156393755|NCT01662310|564532515|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
156393756|NCT01565707|564532520|FG000|Overall Study|Adverse Event|1|||
156393757|NCT01565707|564532521|FG001|Overall Study|Adverse Event|6|||
156393758|NCT01565707|564532522|FG002|Overall Study|Adverse Event|2|||
156393759|NCT01565707|564532523|FG003|Overall Study|Adverse Event|1|||
156393760|NCT01565707|564532520|FG000|Overall Study|Lost to Follow-up|1|||
156393761|NCT01565707|564532521|FG001|Overall Study|Lost to Follow-up|0|||
156393762|NCT01565707|564532522|FG002|Overall Study|Lost to Follow-up|0|||
156393763|NCT01565707|564532523|FG003|Overall Study|Lost to Follow-up|0|||
156393764|NCT01565707|564532520|FG000|Overall Study|Protocol Violation|1|||
156393765|NCT01565707|564532521|FG001|Overall Study|Protocol Violation|0|||
156393766|NCT01565707|564532522|FG002|Overall Study|Protocol Violation|0|||
156393767|NCT01565707|564532523|FG003|Overall Study|Protocol Violation|1|||
156393768|NCT01565707|564532520|FG000|Overall Study|Withdrawal by Subject|3|||
156393769|NCT01565707|564532521|FG001|Overall Study|Withdrawal by Subject|1|||
156393770|NCT01565707|564532522|FG002|Overall Study|Withdrawal by Subject|1|||
156393771|NCT01565707|564532523|FG003|Overall Study|Withdrawal by Subject|1|||
156393772|NCT01565707|564532520|FG000|Overall Study|Randomized but not evaluable|2|||
156393773|NCT01565707|564532521|FG001|Overall Study|Randomized but not evaluable|0|||
156393774|NCT01565707|564532522|FG002|Overall Study|Randomized but not evaluable|0|||
156393775|NCT01565707|564532523|FG003|Overall Study|Randomized but not evaluable|0|||
156393776|NCT01565707|564532520|FG000|Overall Study|Miscellaneous|1|||
156393777|NCT01565707|564532521|FG001|Overall Study|Miscellaneous|1|||
156393778|NCT01565707|564532522|FG002|Overall Study|Miscellaneous|0|||
156393779|NCT01565707|564532523|FG003|Overall Study|Miscellaneous|2|||
156393780|NCT01371851|564532524|FG000|Overall Study|Lost to Follow-up|5|||
156393781|NCT01371851|564532525|FG001|Overall Study|Lost to Follow-up|8|||
156393782|NCT01371851|564532524|FG000|Overall Study|was arrested and put in jail|0|||
156393783|NCT01371851|564532525|FG001|Overall Study|was arrested and put in jail|1|||
156393784|NCT01371851|564532524|FG000|Overall Study|non study related adverse event|1|||
156393785|NCT01371851|564532525|FG001|Overall Study|non study related adverse event|0|||
156393786|NCT01371851|564532524|FG000|Overall Study|Blood Pressure outside study parameters|2|||
156393787|NCT01371851|564532525|FG001|Overall Study|Blood Pressure outside study parameters|0|||
156393788|NCT02012491|564532526|FG000|Overall Study|Lost to Follow-up|1|||
156393789|NCT02012491|564532527|FG001|Overall Study|Lost to Follow-up|0|||
156393790|NCT02012491|564532526|FG000|Overall Study|Protocol Violation|0|||
156393791|NCT02012491|564532527|FG001|Overall Study|Protocol Violation|1|||
156393792|NCT02012491|564532526|FG000|Overall Study|Withdrawal by Subject|1|||
156393793|NCT02012491|564532527|FG001|Overall Study|Withdrawal by Subject|0|||
156393794|NCT00450411|564532528|FG000|Overall Study|Protocol Violation|6|||
156393795|NCT00450411|564532528|FG000|Overall Study|No protocol treatment|2|||
156393796|NCT05608629|564532539|FG000|Overall Study|Lost to Follow-up|2|||
156393797|NCT03969719|564532540|FG000|Overall Study|Other reasons not specified|1|||
156393798|NCT03969719|564532541|FG001|Overall Study|Other reasons not specified|1|||
156393799|NCT03969719|564532542|FG002|Overall Study|Other reasons not specified|3|||
156393800|NCT03969719|564532540|FG000|Overall Study|Withdrawal by Subject|2|||
156393801|NCT03969719|564532541|FG001|Overall Study|Withdrawal by Subject|3|||
156393802|NCT03969719|564532542|FG002|Overall Study|Withdrawal by Subject|2|||
156393803|NCT03969719|564532540|FG000|Overall Study|Protocol Violation|1|||
156393804|NCT03969719|564532541|FG001|Overall Study|Protocol Violation|2|||
156393805|NCT03969719|564532542|FG002|Overall Study|Protocol Violation|0|||
156393806|NCT03969719|564532540|FG000|Overall Study|Adverse Event|0|||
156393807|NCT03969719|564532541|FG001|Overall Study|Adverse Event|2|||
156393808|NCT03969719|564532542|FG002|Overall Study|Adverse Event|0|||
156393809|NCT03969719|564532540|FG000|Overall Study|Lost to Follow-up|0|||
156393810|NCT03969719|564532541|FG001|Overall Study|Lost to Follow-up|1|||
156393811|NCT03969719|564532542|FG002|Overall Study|Lost to Follow-up|0|||
156393812|NCT02130193|564532543|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
156393813|NCT02130193|564532544|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
156393814|NCT02130193|564532545|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
156393815|NCT02130193|564532543|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
156393816|NCT02130193|564532544|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
156393817|NCT02130193|564532545|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
156393818|NCT02130193|564532543|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
156393819|NCT02130193|564532544|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
156393820|NCT02130193|564532545|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
156393821|NCT02130193|564532543|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
156393822|NCT02130193|564532544|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
156393823|NCT02130193|564532545|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
156393824|NCT01212770|564532546|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
156393825|NCT01212770|564532547|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
156393826|NCT01212770|564532548|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
156393827|NCT01212770|564532549|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156393828|NCT01212770|564532550|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156393829|NCT01212770|564532551|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156393830|NCT01212770|564532552|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156393831|NCT01212770|564532553|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156393832|NCT01212770|564532554|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156393833|NCT01212770|564532546|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
156393834|NCT01212770|564532547|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
156393835|NCT01212770|564532548|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
156393836|NCT01212770|564532549|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156393837|NCT01212770|564532550|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156393838|NCT01212770|564532551|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156393839|NCT01212770|564532552|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156393840|NCT01212770|564532553|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156393841|NCT01212770|564532554|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156393842|NCT01212770|564532546|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
156393843|NCT01212770|564532547|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
156393844|NCT01212770|564532548|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
156393845|NCT01212770|564532549|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156393846|NCT01212770|564532550|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156508789|NCT00820170|564955522|FG000|Overall Study|Progressive Disease|0|||
156393847|NCT01212770|564532551|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156393848|NCT01212770|564532552|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156393849|NCT01212770|564532553|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156393850|NCT01212770|564532554|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156393851|NCT01212770|564532546|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
156393852|NCT01212770|564532547|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156393853|NCT01212770|564532548|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
156393854|NCT01212770|564532549|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156393855|NCT01212770|564532550|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156393856|NCT01212770|564532551|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156548956|NCT00706134|565102432|FG002|Overall Study|Protocol Violation|0|||
156548957|NCT00706134|565102433|FG003|Overall Study|Protocol Violation|3|||
156393857|NCT01212770|564532552|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156548958|NCT00706134|565102430|FG000|Overall Study|Withdrawal by Subject|1|||
156548959|NCT00706134|565102431|FG001|Overall Study|Withdrawal by Subject|2|||
156548960|NCT00706134|565102432|FG002|Overall Study|Withdrawal by Subject|1|||
156548961|NCT00706134|565102433|FG003|Overall Study|Withdrawal by Subject|0|||
156548962|NCT00706134|565102430|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
156548963|NCT00706134|565102431|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156548964|NCT00706134|565102432|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
156548965|NCT00706134|565102433|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
156548966|NCT00706134|565102430|FG000|Overall Study|Did not meet study criteria|2|||
156548967|NCT00706134|565102431|FG001|Overall Study|Did not meet study criteria|0|||
156548968|NCT00706134|565102432|FG002|Overall Study|Did not meet study criteria|0|||
156548969|NCT00706134|565102433|FG003|Overall Study|Did not meet study criteria|0|||
156548970|NCT03691974|565102434|FG000|Overall Study|Physician Decision|1|||
156548971|NCT03691974|565102435|FG001|Overall Study|Physician Decision|0|||
156548972|NCT03691974|565102434|FG000|Overall Study|Adverse Event|1|||
156548973|NCT03691974|565102435|FG001|Overall Study|Adverse Event|0|||
156548974|NCT03691974|565102434|FG000|Overall Study|Withdrawal by Subject|11|||
156548975|NCT03691974|565102435|FG001|Overall Study|Withdrawal by Subject|9|||
156548976|NCT03691974|565102434|FG000|Overall Study|Protocol Violation|1|||
156548977|NCT03691974|565102435|FG001|Overall Study|Protocol Violation|0|||
156548978|NCT03691974|565102434|FG000|Overall Study|Lost to Follow-up|8|||
156548979|NCT03691974|565102435|FG001|Overall Study|Lost to Follow-up|7|||
156548980|NCT00691483|565102436|FG000|Overall Study|Adverse Event|14|||
156548981|NCT00691483|565102437|FG001|Overall Study|Adverse Event|6|||
156548982|NCT00691483|565102436|FG000|Overall Study|Lost to Follow-up|17|||
156548983|NCT00691483|565102437|FG001|Overall Study|Lost to Follow-up|10|||
156548984|NCT00691483|565102436|FG000|Overall Study|Withdrawal by Subject|24|||
156548985|NCT00691483|565102437|FG001|Overall Study|Withdrawal by Subject|7|||
156548986|NCT00691483|565102436|FG000|Overall Study|Other known cause|6|||
156393858|NCT01212770|564532553|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156393859|NCT01212770|564532554|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156393860|NCT01212770|564532546|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156393861|NCT01212770|564532547|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156393862|NCT01212770|564532548|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
156393863|NCT01212770|564532549|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156393864|NCT01212770|564532550|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156393865|NCT01212770|564532551|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156393866|NCT01212770|564532552|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156393867|NCT01212770|564532553|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156393868|NCT01212770|564532554|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156393869|NCT01212770|564532546|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
156393870|NCT01212770|564532547|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
156393871|NCT01212770|564532548|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
156393872|NCT01212770|564532549|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156393873|NCT01212770|564532550|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156393874|NCT01212770|564532551|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156393875|NCT01212770|564532552|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156393876|NCT01212770|564532553|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156393877|NCT01212770|564532554|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156393878|NCT01212770|564532546|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156393879|NCT01212770|564532547|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
156393880|NCT01212770|564532548|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
156393881|NCT01212770|564532549|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
156548987|NCT00691483|565102437|FG001|Overall Study|Other known cause|1|||
156548988|NCT00691483|565102436|FG000|Overall Study|Randomized by not treated|7|||
156548989|NCT00691483|565102437|FG001|Overall Study|Randomized by not treated|1|||
156548990|NCT01137773|565102438|FG000|Overall Study|Death|3|||
156548991|NCT01137773|565102439|FG001|Overall Study|Death|3|||
156393882|NCT01212770|564532550|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156393883|NCT01212770|564532551|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156393884|NCT01212770|564532552|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
156393885|NCT01212770|564532553|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156393886|NCT01212770|564532554|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156393887|NCT01212770|564532546|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
156393888|NCT01212770|564532547|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
156393889|NCT01212770|564532548|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
156393890|NCT01212770|564532549|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
156393891|NCT01212770|564532550|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
156393892|NCT01212770|564532551|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
156393893|NCT01212770|564532552|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
156393894|NCT01212770|564532553|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
156393895|NCT01212770|564532554|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
156393896|NCT01212770|564532546|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
156393897|NCT01212770|564532547|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
156393898|NCT01212770|564532548|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
156393899|NCT01212770|564532549|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
156393900|NCT01212770|564532550|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
156393901|NCT01212770|564532551|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
156393902|NCT01212770|564532552|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
156393903|NCT01212770|564532553|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
156393904|NCT01212770|564532554|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
156393905|NCT01212770|564532546|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156393906|NCT01212770|564532547|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156393907|NCT01212770|564532548|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
156393908|NCT01212770|564532549|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156393909|NCT01212770|564532550|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156393910|NCT01212770|564532551|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156393911|NCT01212770|564532552|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156393912|NCT01212770|564532553|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156393913|NCT01212770|564532554|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156393914|NCT01212770|564532546|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156393915|NCT01212770|564532547|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156393916|NCT01212770|564532548|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156393917|NCT01212770|564532549|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
156393918|NCT01212770|564532550|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156393919|NCT01212770|564532551|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156393920|NCT01212770|564532552|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156393921|NCT01212770|564532553|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156393922|NCT01212770|564532554|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156393923|NCT01212770|564532546|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156393924|NCT01212770|564532547|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156393925|NCT01212770|564532548|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
156393926|NCT01212770|564532549|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
156393927|NCT01212770|564532550|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156393928|NCT01212770|564532551|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156393929|NCT01212770|564532552|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156393930|NCT01212770|564532553|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156393931|NCT01212770|564532554|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156393932|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156393933|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
156393934|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
156393935|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156393936|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156393937|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156393938|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156393939|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156393940|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
156393941|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156393942|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
156508790|NCT00820170|564955523|FG001|Overall Study|Progressive Disease|0|||
156508791|NCT00820170|564955524|FG002|Overall Study|Progressive Disease|0|||
156393943|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
156393944|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156508792|NCT00820170|564955525|FG003|Overall Study|Progressive Disease|0|||
156393945|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156393946|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156393947|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156393948|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
156393949|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
156393950|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156393951|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
156393952|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156393953|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156393954|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156393955|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156393956|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156393957|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156393958|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156393959|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156393960|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
156393961|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
156393962|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156548992|NCT01137773|565102438|FG000|Overall Study|Lost to Follow-up|6|||
156548993|NCT01137773|565102439|FG001|Overall Study|Lost to Follow-up|0|||
156393963|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156393964|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156393965|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156393966|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
156393967|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
156393968|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156393969|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
156393970|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
156393971|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156393972|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156393973|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156393974|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156393975|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
156393976|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
156393977|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156393978|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
156393979|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
156393980|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156393981|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156393982|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156393983|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156393984|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156393985|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
156393986|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156393987|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
156393988|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
156393989|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156393990|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156393991|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156393992|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156393993|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
156393994|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
156393995|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156393996|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
156393997|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
156393998|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156393999|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156394000|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156394001|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156394002|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
156394003|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
156508793|NCT00820170|564955526|FG004|Overall Study|Progressive Disease|2|||
156508794|NCT03995316|564955527|FG000|Overall Study|Lost to Follow-up|10|||
156508795|NCT03995316|564955528|FG001|Overall Study|Lost to Follow-up|3|||
156508796|NCT02180243|564955529|FG000|Overall Study|Withdrawal by Subject|12|||
156508797|NCT02180243|564955530|FG001|Overall Study|Withdrawal by Subject|12|||
156508798|NCT02180243|564955529|FG000|Overall Study|Lost to Follow-up|12|||
156508799|NCT02180243|564955530|FG001|Overall Study|Lost to Follow-up|2|||
156508800|NCT05479734|564955531|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
156394004|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156394005|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
156394006|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
156394007|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156394008|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156394009|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156394010|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156394011|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
156394012|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
156394013|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156394014|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
156394015|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156394016|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156394017|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156394018|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156394019|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156394020|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156394021|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156394022|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156394023|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156394024|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156394025|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156394026|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156394027|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156394028|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156394029|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
156394030|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156394031|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156394032|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
156394033|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
156394034|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156394035|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156394036|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156394037|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156394038|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
156394039|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
156394040|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156394041|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
156394042|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
156394043|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156394044|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156394045|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156394046|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156394047|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156394048|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
156394049|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156394050|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
156394051|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
156394052|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156394053|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156394054|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156394055|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156394056|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
156394057|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156394058|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156394059|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
156394060|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
156394061|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156394062|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156394063|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156394064|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156394065|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
156394066|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156394067|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156394068|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
156394069|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
156394070|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156394071|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156394072|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156394073|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156394074|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156394075|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156394076|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156394077|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156394078|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
156394079|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156394080|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156394081|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156394082|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156394083|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156394084|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156394085|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156394086|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
156394087|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156394088|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156394089|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156394090|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156394091|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156394092|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156394093|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
156394094|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
156394095|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
156394096|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
156394097|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
156394098|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
156394099|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
156394100|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
156394101|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
156394102|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
156394103|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156394104|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156394105|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
156394106|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156394107|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156394108|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156394109|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156394110|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156394111|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156394112|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156394113|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156394114|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
156394115|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156394116|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156394117|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156394118|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156394119|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156394120|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
156394121|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156394122|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156394123|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
156394124|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156394125|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156394126|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156394127|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156394128|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156394129|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156394130|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156394131|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
156394132|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
156394133|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156394134|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156394135|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156394136|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156394137|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
156394138|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156394139|NCT01212770|564532546|FG000|Long-term Safety Phase (Year 5)|Death|0|||
156394140|NCT01212770|564532547|FG001|Long-term Safety Phase (Year 5)|Death|0|||
156394141|NCT01212770|564532548|FG002|Long-term Safety Phase (Year 5)|Death|0|||
156394142|NCT01212770|564532549|FG003|Long-term Safety Phase (Year 5)|Death|0|||
156394143|NCT01212770|564532550|FG004|Long-term Safety Phase (Year 5)|Death|0|||
156394144|NCT01212770|564532551|FG005|Long-term Safety Phase (Year 5)|Death|0|||
156394145|NCT01212770|564532552|FG006|Long-term Safety Phase (Year 5)|Death|0|||
156394146|NCT01212770|564532553|FG007|Long-term Safety Phase (Year 5)|Death|1|||
156394147|NCT01212770|564532554|FG008|Long-term Safety Phase (Year 5)|Death|0|||
156394148|NCT00829387|564532557|FG000|Overall Study|Withdrawal by Subject|2|||
156394149|NCT00829387|564532558|FG001|Overall Study|Withdrawal by Subject|3|||
156394150|NCT00829387|564532557|FG000|Overall Study|Disqualified by PI|1|||
156394151|NCT00829387|564532558|FG001|Overall Study|Disqualified by PI|0|||
156394152|NCT02693743|564532568|FG000|Overall Study|Physician Decision|1|||
156394153|NCT02693743|564532569|FG001|Overall Study|Physician Decision|0|||
156394154|NCT02626780|564532570|FG000|Overall Study|Withdrawal by Subject|3|||
156394155|NCT04304833|564532571|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
156394156|NCT04304833|564532572|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
156394157|NCT02858895|564532573|FG000|Overall Study|Disease progression|31|||
156394158|NCT02858895|564532573|FG000|Overall Study|Death|2|||
156394159|NCT02858895|564532573|FG000|Overall Study|Adverse Event|1|||
156394160|NCT02858895|564532573|FG000|Overall Study|Withdrawal by Subject|3|||
156394161|NCT02858895|564532573|FG000|Overall Study|hospice,|1|||
156394162|NCT02858895|564532573|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
156394163|NCT05338333|564532578|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
156394164|NCT05338333|564532579|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
156394165|NCT01377480|564534443|FG000|Overall Study|Protocol Violation|0|||
156394166|NCT01377480|564534444|FG001|Overall Study|Protocol Violation|0|||
156394167|NCT01377480|564534445|FG002|Overall Study|Protocol Violation|0|||
156394168|NCT01377480|564534446|FG003|Overall Study|Protocol Violation|4|||
156394169|NCT01377480|564534443|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
156394170|NCT01377480|564534444|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
156394171|NCT01377480|564534445|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
156394172|NCT01377480|564534446|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
156394173|NCT01377480|564534443|FG000|Overall Study|Withdrawal by Subject|0|||
156394174|NCT01377480|564534444|FG001|Overall Study|Withdrawal by Subject|0|||
156394175|NCT01377480|564534445|FG002|Overall Study|Withdrawal by Subject|1|||
156394176|NCT01377480|564534446|FG003|Overall Study|Withdrawal by Subject|0|||
156394177|NCT01377480|564534443|FG000|Overall Study|Serious adverse event|0|||
156394178|NCT01377480|564534444|FG001|Overall Study|Serious adverse event|0|||
156394179|NCT01377480|564534445|FG002|Overall Study|Serious adverse event|1|||
156394180|NCT01377480|564534446|FG003|Overall Study|Serious adverse event|1|||
156394181|NCT01377480|564534443|FG000|Overall Study|Other|0|||
156394182|NCT01377480|564534444|FG001|Overall Study|Other|0|||
156394183|NCT01377480|564534445|FG002|Overall Study|Other|7|||
156394184|NCT01377480|564534446|FG003|Overall Study|Other|6|||
156394185|NCT00499031|564534452|FG000|Overall Study|Improper pre-protocol treatment|1|||
156394186|NCT00499031|564534452|FG000|Overall Study|Required test not done|1|||
156394187|NCT00499031|564534452|FG000|Overall Study|Never treated|1|||
156394188|NCT03409666|564534453|FG000|Overall Study|Physician Decision|0|||
156394189|NCT03409666|564534454|FG001|Overall Study|Physician Decision|1|||
156394190|NCT03409666|564534453|FG000|Overall Study|Protocol Violation|0|||
156394191|NCT03409666|564534454|FG001|Overall Study|Protocol Violation|3|||
156394192|NCT00512148|564534455|FG000|Primay Study Period|Withdrawal by Subject|1|||
156394193|NCT01666951|564534462|FG000|Overall Study|Not dosed|1|||
156394194|NCT01666951|564534463|FG001|Overall Study|Not dosed|1|||
156394195|NCT02366910|564534464|FG000|Overall Study|Withdrawal by Subject|2|||
156394196|NCT02366910|564534464|FG000|Overall Study|Screen Failure|3|||
156394197|NCT03284788|564534465|FG000|Overall Study|Withdrawal by Subject|2|||
156394198|NCT03563716|564534466|FG000|Overall Study|Death|20|||
156394199|NCT03563716|564534467|FG001|Overall Study|Death|14|||
156394200|NCT03563716|564534466|FG000|Overall Study|Withdrawal by Subject|3|||
156394201|NCT03563716|564534467|FG001|Overall Study|Withdrawal by Subject|3|||
156394202|NCT03563716|564534466|FG000|Overall Study|Still on Study|45|||
156394203|NCT03563716|564534467|FG001|Overall Study|Still on Study|50|||
156394204|NCT04605978|564534468|FG000|Overall Study|Adverse Event|2|||
156394205|NCT04605978|564534469|FG001|Overall Study|Adverse Event|1|||
156508801|NCT05479734|564955532|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
156394206|NCT04605978|564534468|FG000|Overall Study|Withdrawal nonmedical reason|1|||
156394207|NCT04605978|564534469|FG001|Overall Study|Withdrawal nonmedical reason|1|||
156394208|NCT03813238|564534470|FG000|Overall Study|Adverse Event|0|||
156394209|NCT03813238|564534471|FG001|Overall Study|Adverse Event|6|||
156394210|NCT03813238|564534470|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156394211|NCT03813238|564534471|FG001|Overall Study|Withdrawal by parent/guardian|2|||
156508802|NCT05479734|564955531|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
156508803|NCT05479734|564955532|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
156548994|NCT01391000|565102440|FG000|Overall Study|Lost to Follow-up|2|||
156394212|NCT03813238|564534470|FG000|Overall Study|Lost to Follow-up|0|||
156394213|NCT03813238|564534471|FG001|Overall Study|Lost to Follow-up|1|||
156394214|NCT03813238|564534470|FG000|Overall Study|Other than specified|1|||
156394215|NCT03813238|564534471|FG001|Overall Study|Other than specified|2|||
156394216|NCT03104699|564534472|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
156394217|NCT03104699|564534473|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
156394218|NCT03104699|564534474|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
156394219|NCT03104699|564534475|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
156394220|NCT03104699|564534476|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
156394221|NCT03104699|564534477|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156394222|NCT03104699|564534472|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
156394223|NCT03104699|564534473|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
156394224|NCT03104699|564534474|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
156394225|NCT03104699|564534475|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
156394226|NCT03104699|564534476|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
156394227|NCT03104699|564534477|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
156394228|NCT03104699|564534472|FG000|Phase 1: Dose Escalation|Death|6|||
156394229|NCT03104699|564534473|FG001|Phase 1: Dose Escalation|Death|3|||
156394230|NCT03104699|564534474|FG002|Phase 1: Dose Escalation|Death|0|||
156394231|NCT03104699|564534475|FG003|Phase 1: Dose Escalation|Death|1|||
156394232|NCT03104699|564534476|FG004|Phase 1: Dose Escalation|Death|1|||
156394233|NCT03104699|564534477|FG005|Phase 1: Dose Escalation|Death|0|||
156394234|NCT03104699|564534472|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
156394235|NCT03104699|564534473|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
156394236|NCT03104699|564534474|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
156394237|NCT03104699|564534475|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
156394238|NCT03104699|564534476|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
156394239|NCT03104699|564534477|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
156394240|NCT03104699|564534472|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
156394241|NCT03104699|564534473|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
156394242|NCT03104699|564534474|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
156394243|NCT03104699|564534475|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
156394244|NCT03104699|564534476|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
156394245|NCT03104699|564534477|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
156394246|NCT03104699|564534472|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
156394247|NCT03104699|564534473|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
156394248|NCT03104699|564534474|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
156394249|NCT03104699|564534475|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
156394250|NCT03104699|564534476|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
156394251|NCT03104699|564534477|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
156394252|NCT03104699|564534472|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
156394253|NCT03104699|564534473|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
156394254|NCT03104699|564534474|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
156394255|NCT03104699|564534475|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
156394256|NCT03104699|564534476|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
156394257|NCT03104699|564534477|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
156394258|NCT03104699|564534472|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
156394259|NCT03104699|564534473|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
156394260|NCT03104699|564534474|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
156394261|NCT03104699|564534475|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
156394262|NCT03104699|564534476|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
156394263|NCT03104699|564534477|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
156394264|NCT03104699|564534472|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156394265|NCT03104699|564534473|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156394266|NCT03104699|564534474|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156394267|NCT03104699|564534475|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156394268|NCT03104699|564534476|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156394269|NCT03104699|564534477|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
156394270|NCT03104699|564534472|FG000|Phase 2: Dose Expansion|Death|0|||
156394271|NCT03104699|564534473|FG001|Phase 2: Dose Expansion|Death|0|||
156394272|NCT03104699|564534474|FG002|Phase 2: Dose Expansion|Death|0|||
156394273|NCT03104699|564534475|FG003|Phase 2: Dose Expansion|Death|0|||
156394274|NCT03104699|564534476|FG004|Phase 2: Dose Expansion|Death|0|||
156394275|NCT03104699|564534477|FG005|Phase 2: Dose Expansion|Death|107|||
156548995|NCT01391000|565102441|FG001|Overall Study|Lost to Follow-up|0|||
156394276|NCT03104699|564534472|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156394277|NCT03104699|564534473|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156394278|NCT03104699|564534474|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156394279|NCT03104699|564534475|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156394280|NCT03104699|564534476|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156394281|NCT03104699|564534477|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
156548996|NCT00082888|565102445|FG000|Overall Study|Ineligible|1|||
156394282|NCT03104699|564534472|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156394283|NCT03104699|564534473|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156394284|NCT03104699|564534474|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156394285|NCT03104699|564534475|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156394286|NCT03104699|564534476|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156394287|NCT03104699|564534477|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
156394288|NCT03104699|564534472|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156394289|NCT03104699|564534473|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156394290|NCT03104699|564534474|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156394291|NCT03104699|564534475|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156394292|NCT03104699|564534476|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156394293|NCT03104699|564534477|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
156394294|NCT03104699|564534472|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
156394295|NCT03104699|564534473|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
156394296|NCT03104699|564534474|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
156394297|NCT03104699|564534475|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
156394298|NCT03104699|564534476|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
156394299|NCT03104699|564534477|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
156394300|NCT01690130|564534478|FG000|Overall Study|Subject have cancelled visit.|1|||
156394301|NCT01690130|564534479|FG001|Overall Study|Subject have cancelled visit.|0|||
156394302|NCT01786512|564534480|FG000|Overall Study|Lost to Follow-up|0|||
156394303|NCT01786512|564534481|FG001|Overall Study|Lost to Follow-up|0|||
156394304|NCT01786512|564534482|FG002|Overall Study|Lost to Follow-up|0|||
156394305|NCT01786512|564534483|FG003|Overall Study|Lost to Follow-up|0|||
156394306|NCT01786512|564534484|FG004|Overall Study|Lost to Follow-up|0|||
156394307|NCT01786512|564534485|FG005|Overall Study|Lost to Follow-up|0|||
156394308|NCT01786512|564534486|FG006|Overall Study|Lost to Follow-up|0|||
156394309|NCT01786512|564534487|FG007|Overall Study|Lost to Follow-up|0|||
156394310|NCT01786512|564534488|FG008|Overall Study|Lost to Follow-up|0|||
156394311|NCT01786512|564534489|FG009|Overall Study|Lost to Follow-up|1|||
156394312|NCT01786512|564534490|FG010|Overall Study|Lost to Follow-up|0|||
156394313|NCT01786512|564534480|FG000|Overall Study|Decision by sponsor|0|||
156394314|NCT01786512|564534481|FG001|Overall Study|Decision by sponsor|0|||
156394315|NCT01786512|564534482|FG002|Overall Study|Decision by sponsor|0|||
156394316|NCT01786512|564534483|FG003|Overall Study|Decision by sponsor|0|||
156394317|NCT01786512|564534484|FG004|Overall Study|Decision by sponsor|0|||
156394318|NCT01786512|564534485|FG005|Overall Study|Decision by sponsor|0|||
156394319|NCT01786512|564534486|FG006|Overall Study|Decision by sponsor|0|||
156394320|NCT01786512|564534487|FG007|Overall Study|Decision by sponsor|0|||
156394321|NCT01786512|564534488|FG008|Overall Study|Decision by sponsor|0|||
156394322|NCT01786512|564534489|FG009|Overall Study|Decision by sponsor|0|||
156394323|NCT01786512|564534490|FG010|Overall Study|Decision by sponsor|2|||
156394324|NCT01786512|564534480|FG000|Overall Study|Withdrawal by Subject|0|||
156394325|NCT01786512|564534481|FG001|Overall Study|Withdrawal by Subject|1|||
156394326|NCT01786512|564534482|FG002|Overall Study|Withdrawal by Subject|0|||
156394327|NCT01786512|564534483|FG003|Overall Study|Withdrawal by Subject|0|||
156394328|NCT01786512|564534484|FG004|Overall Study|Withdrawal by Subject|0|||
156394329|NCT01786512|564534485|FG005|Overall Study|Withdrawal by Subject|0|||
156394330|NCT01786512|564534486|FG006|Overall Study|Withdrawal by Subject|1|||
156394331|NCT01786512|564534487|FG007|Overall Study|Withdrawal by Subject|0|||
156394332|NCT01786512|564534488|FG008|Overall Study|Withdrawal by Subject|0|||
156394333|NCT01786512|564534489|FG009|Overall Study|Withdrawal by Subject|3|||
156394334|NCT01786512|564534490|FG010|Overall Study|Withdrawal by Subject|7|||
156394335|NCT01786512|564534480|FG000|Overall Study|Death|0|||
156394336|NCT01786512|564534481|FG001|Overall Study|Death|0|||
156394337|NCT01786512|564534482|FG002|Overall Study|Death|0|||
156394338|NCT01786512|564534483|FG003|Overall Study|Death|0|||
156394339|NCT01786512|564534484|FG004|Overall Study|Death|0|||
156394340|NCT01786512|564534485|FG005|Overall Study|Death|0|||
156394341|NCT01786512|564534486|FG006|Overall Study|Death|0|||
156394342|NCT01786512|564534487|FG007|Overall Study|Death|0|||
156394343|NCT01786512|564534488|FG008|Overall Study|Death|4|||
156394344|NCT01786512|564534489|FG009|Overall Study|Death|1|||
156394345|NCT01786512|564534490|FG010|Overall Study|Death|3|||
156394346|NCT00234052|564534494|FG000|Treatment|Withdrawal by Subject|3|||
156394347|NCT00234052|564534494|FG000|Treatment|Adverse Event|5|||
156394348|NCT00234052|564534494|FG000|Treatment|Death|2|||
156394349|NCT00234052|564534494|FG000|Treatment|Progressive Disease|11|||
156394350|NCT00234052|564534494|FG000|Follow-up for 5 Years|Death|41|||
156394351|NCT00234052|564534494|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
156508804|NCT05479734|564955531|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
156508805|NCT05479734|564955532|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
156394352|NCT00234052|564534494|FG000|Follow-up for 5 Years|Other|7|||
156394353|NCT01410474|564534495|FG000|Overall Study|Withdrawal by Subject|0|||
156394354|NCT01410474|564534496|FG001|Overall Study|Withdrawal by Subject|1|||
156394355|NCT00828984|564534498|FG000|Overall Study|Adverse Event|2|||
156394356|NCT00828984|564534499|FG001|Overall Study|Adverse Event|3|||
156394357|NCT00828984|564534500|FG002|Overall Study|Adverse Event|0|||
156394358|NCT00828984|564534498|FG000|Overall Study|Lost to Follow-up|5|||
156394359|NCT00828984|564534499|FG001|Overall Study|Lost to Follow-up|3|||
156394360|NCT00828984|564534500|FG002|Overall Study|Lost to Follow-up|1|||
156394361|NCT00828984|564534498|FG000|Overall Study|Withdrawal by Subject|4|||
156394362|NCT00828984|564534499|FG001|Overall Study|Withdrawal by Subject|4|||
156394363|NCT00828984|564534500|FG002|Overall Study|Withdrawal by Subject|4|||
156394364|NCT00828984|564534498|FG000|Overall Study|Ineligable|1|||
156394365|NCT00828984|564534499|FG001|Overall Study|Ineligable|2|||
156394366|NCT00828984|564534500|FG002|Overall Study|Ineligable|0|||
156394367|NCT00828984|564534498|FG000|Overall Study|Medical Contraindication|0|||
156394368|NCT00828984|564534499|FG001|Overall Study|Medical Contraindication|1|||
156394369|NCT00828984|564534500|FG002|Overall Study|Medical Contraindication|0|||
156394370|NCT00828984|564534498|FG000|Overall Study|Noncompliant|1|||
156394371|NCT00828984|564534499|FG001|Overall Study|Noncompliant|2|||
156394372|NCT00828984|564534500|FG002|Overall Study|Noncompliant|3|||
156394373|NCT00828984|564534498|FG000|Overall Study|ConMed|1|||
156394374|NCT00828984|564534499|FG001|Overall Study|ConMed|1|||
156394375|NCT00828984|564534500|FG002|Overall Study|ConMed|1|||
156394376|NCT04493931|564534505|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
156394377|NCT04493931|564534506|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156394378|NCT04493931|564534507|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156394379|NCT04493931|564534508|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156394380|NCT04493931|564534509|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156394381|NCT04493931|564534510|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156394382|NCT04493931|564534511|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156394383|NCT04493931|564534505|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156394384|NCT04493931|564534506|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
156394385|NCT04493931|564534507|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156394386|NCT04493931|564534508|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156394387|NCT04493931|564534509|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156394388|NCT04493931|564534510|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156394389|NCT04493931|564534511|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156394390|NCT04493931|564534505|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156394391|NCT04493931|564534506|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
156394392|NCT04493931|564534507|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156394393|NCT04493931|564534508|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156394394|NCT04493931|564534509|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156394395|NCT04493931|564534510|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156394396|NCT04493931|564534511|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156394397|NCT04493931|564534505|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156394398|NCT04493931|564534506|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156394399|NCT04493931|564534507|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
156394400|NCT04493931|564534508|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156394401|NCT04493931|564534509|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156394402|NCT04493931|564534510|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156394403|NCT04493931|564534511|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156394404|NCT00863655|564534512|FG000|Overall Study|Protocol Violation|4|||
156394405|NCT00863655|564534513|FG001|Overall Study|Protocol Violation|0|||
156394406|NCT00863655|564534512|FG000|Overall Study|Adverse Event|52|||
156394407|NCT00863655|564534513|FG001|Overall Study|Adverse Event|8|||
156394408|NCT00863655|564534512|FG000|Overall Study|Withdrawal by Subject|47|||
156394409|NCT00863655|564534513|FG001|Overall Study|Withdrawal by Subject|7|||
156394410|NCT00863655|564534512|FG000|Overall Study|Administrative problems|1|||
156394411|NCT00863655|564534513|FG001|Overall Study|Administrative problems|0|||
156394412|NCT00863655|564534512|FG000|Overall Study|Death|7|||
156394413|NCT00863655|564534513|FG001|Overall Study|Death|1|||
156394414|NCT00863655|564534512|FG000|Overall Study|New cancer therapy|5|||
156394415|NCT00863655|564534513|FG001|Overall Study|New cancer therapy|1|||
156394416|NCT00863655|564534512|FG000|Overall Study|Disease progression|364|||
156394417|NCT00863655|564534513|FG001|Overall Study|Disease progression|221|||
156394418|NCT00863655|564534512|FG000|Overall Study|Treatment completed as per protocol|5|||
156394419|NCT00863655|564534513|FG001|Overall Study|Treatment completed as per protocol|1|||
156394420|NCT00002558|564534519|FG000|Overall Study|Withdrawal by Subject|0|||
156394421|NCT00002558|564534520|FG001|Overall Study|Withdrawal by Subject|1|||
156394422|NCT00558428|564534521|FG000|Overall Study|Adverse Event|6|||
156394423|NCT00558428|564534522|FG001|Overall Study|Adverse Event|22|||
156394424|NCT00558428|564534523|FG002|Overall Study|Adverse Event|3|||
156394425|NCT00558428|564534524|FG003|Overall Study|Adverse Event|4|||
156394426|NCT00558428|564534521|FG000|Overall Study|Lost to Follow-up|0|||
156394427|NCT00558428|564534522|FG001|Overall Study|Lost to Follow-up|1|||
156394428|NCT00558428|564534523|FG002|Overall Study|Lost to Follow-up|0|||
156394429|NCT00558428|564534524|FG003|Overall Study|Lost to Follow-up|0|||
156394430|NCT00558428|564534521|FG000|Overall Study|Lack of Efficacy|0|||
156394431|NCT00558428|564534522|FG001|Overall Study|Lack of Efficacy|0|||
156394432|NCT00558428|564534523|FG002|Overall Study|Lack of Efficacy|1|||
156394433|NCT00558428|564534524|FG003|Overall Study|Lack of Efficacy|2|||
156394434|NCT00558428|564534521|FG000|Overall Study|Non compliant with protocol|1|||
156394435|NCT00558428|564534522|FG001|Overall Study|Non compliant with protocol|0|||
156394436|NCT00558428|564534523|FG002|Overall Study|Non compliant with protocol|0|||
156394437|NCT00558428|564534524|FG003|Overall Study|Non compliant with protocol|3|||
156394438|NCT00558428|564534521|FG000|Overall Study|Consent withdrawn|2|||
156394439|NCT00558428|564534522|FG001|Overall Study|Consent withdrawn|1|||
156394440|NCT00558428|564534523|FG002|Overall Study|Consent withdrawn|0|||
156394441|NCT00558428|564534524|FG003|Overall Study|Consent withdrawn|1|||
156394442|NCT00558428|564534521|FG000|Overall Study|Other|3|||
156394443|NCT00558428|564534522|FG001|Overall Study|Other|0|||
156394444|NCT00558428|564534523|FG002|Overall Study|Other|0|||
156394445|NCT00558428|564534524|FG003|Overall Study|Other|1|||
156394446|NCT02570126|564534525|FG000|Overall Study|Lost to Follow-up|2|||
156394447|NCT02570126|564534526|FG001|Overall Study|Lost to Follow-up|0|||
156394448|NCT02570126|564534525|FG000|Overall Study|Unable To Arrange Visit 3|1|||
156394449|NCT02570126|564534526|FG001|Overall Study|Unable To Arrange Visit 3|0|||
156394450|NCT02570126|564534525|FG000|Overall Study|Violation Of Procedures GSK|0|||
156394451|NCT02570126|564534526|FG001|Overall Study|Violation Of Procedures GSK|1|||
156394452|NCT02570126|564534525|FG000|Overall Study|Protocol Violation|0|||
156394453|NCT02570126|564534526|FG001|Overall Study|Protocol Violation|1|||
156394454|NCT02570126|564534525|FG000|Overall Study|Withdrawal by Subject|3|||
156394455|NCT02570126|564534526|FG001|Overall Study|Withdrawal by Subject|7|||
156394456|NCT00626028|564534527|FG000|Overall Study|Adverse Event|1|||
156394457|NCT00626028|564534528|FG001|Overall Study|Adverse Event|1|||
156394458|NCT00626028|564534527|FG000|Overall Study|Device Failure|0|||
156394459|NCT00626028|564534528|FG001|Overall Study|Device Failure|1|||
156394460|NCT00626028|564534527|FG000|Overall Study|Physician Decision|2|||
156394461|NCT00626028|564534528|FG001|Overall Study|Physician Decision|1|||
156394462|NCT00626028|564534527|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
156394463|NCT00626028|564534528|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
156394464|NCT05224050|564534529|FG000|Overall Study|Withdrawal by Subject|9|||
156394465|NCT05224050|564534529|FG000|Overall Study|Lost to Follow-up|3|||
156394466|NCT00917579|564534531|FG000|Washout >= 2 Weeks|Adverse Event|1|||
156394467|NCT00917579|564534532|FG001|Washout >= 2 Weeks|Adverse Event|0|||
156394468|NCT00917579|564534531|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
156394469|NCT00917579|564534532|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
156394470|NCT00754338|564534533|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
156394471|NCT00754338|564534534|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
156394472|NCT00754338|564534535|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
156394473|NCT00754338|564534536|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
156394474|NCT00754338|564534533|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
156394475|NCT00754338|564534534|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
156394476|NCT00754338|564534535|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
156394477|NCT00754338|564534536|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
156394478|NCT00831779|564534539|FG000|Overall Study|Lost to Follow-up|1|||
156394479|NCT00831779|564534540|FG001|Overall Study|Lost to Follow-up|0|||
156394480|NCT00831779|564534539|FG000|Overall Study|No longer met criteria|0|||
156394481|NCT00831779|564534540|FG001|Overall Study|No longer met criteria|1|||
156394482|NCT04020341|564534541|FG000|Overall Study|Adverse Event|8|||
156394483|NCT04020341|564534542|FG001|Overall Study|Adverse Event|6|||
156394484|NCT04020341|564534541|FG000|Overall Study|Lost to Follow-up|8|||
156394485|NCT04020341|564534542|FG001|Overall Study|Lost to Follow-up|2|||
156394486|NCT04020341|564534541|FG000|Overall Study|Withdrawal by Subject|16|||
156394487|NCT04020341|564534542|FG001|Overall Study|Withdrawal by Subject|16|||
156394488|NCT04020341|564534541|FG000|Overall Study|Participant not able to swallow the tablet|1|||
156394489|NCT04020341|564534542|FG001|Overall Study|Participant not able to swallow the tablet|0|||
156394490|NCT04020341|564534541|FG000|Overall Study|Physician Decision|0|||
156394491|NCT04020341|564534542|FG001|Overall Study|Physician Decision|2|||
156394492|NCT04020341|564534541|FG000|Overall Study|Protocol Deviation|0|||
156508806|NCT05479734|564955531|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
156394493|NCT04020341|564534542|FG001|Overall Study|Protocol Deviation|2|||
156394494|NCT05763628|564534543|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
156394495|NCT05763628|564534544|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
156394496|NCT05763628|564534543|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
156394497|NCT05763628|564534544|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
156394498|NCT05763628|564534543|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
156394499|NCT05763628|564534544|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
156394500|NCT04528069|564534545|FG000|Overall Study|Adverse Event|1|||
156394501|NCT04528069|564534545|FG000|Overall Study|Lost to Follow-up|1|||
156508807|NCT05479734|564955532|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
156394502|NCT04528069|564534545|FG000|Overall Study|Patient Unable to Come|1|||
156394503|NCT04528069|564534545|FG000|Overall Study|Patient Unable to Attend|1|||
156394504|NCT01814371|564534553|FG000|Overall Study|Lost to Follow-up|30|||
156394505|NCT01814371|564534554|FG001|Overall Study|Lost to Follow-up|27|||
156394506|NCT04683926|564534555|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
156394507|NCT04683926|564534556|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
156394508|NCT04683926|564534557|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
156394509|NCT04683926|564534558|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
156394510|NCT02123108|564534565|FG000|Overall Study|Death|2|||
156394511|NCT02123108|564534566|FG001|Overall Study|Death|3|||
156394512|NCT00716092|564534570|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
156394513|NCT00716092|564534571|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
156394514|NCT00716092|564534572|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
156394515|NCT02219048|564534573|FG000|Overall Study|Adverse Event|2|||
156394516|NCT02219048|564534574|FG001|Overall Study|Adverse Event|5|||
156394517|NCT02219048|564534573|FG000|Overall Study|No longer meets eligibility criteria|1|||
156394518|NCT02219048|564534574|FG001|Overall Study|No longer meets eligibility criteria|0|||
156394519|NCT02219048|564534573|FG000|Overall Study|Study terminated by sponsor|16|||
156394520|NCT02219048|564534574|FG001|Overall Study|Study terminated by sponsor|15|||
156394521|NCT02219048|564534573|FG000|Overall Study|Withdrawal by Subject|2|||
156394522|NCT02219048|564534574|FG001|Overall Study|Withdrawal by Subject|0|||
156394523|NCT02219048|564534573|FG000|Overall Study|Other|0|||
156394524|NCT02219048|564534574|FG001|Overall Study|Other|1|||
156394525|NCT02436330|564534575|FG000|Cohort 1|Lost to Follow-up|5|||
156394526|NCT02436330|564534576|FG001|Cohort 1|Lost to Follow-up|2|||
156394527|NCT02436330|564534575|FG000|Cohort 1|Withdrawal by Subject|0|||
156394528|NCT02436330|564534576|FG001|Cohort 1|Withdrawal by Subject|1|||
156394529|NCT02436330|564534575|FG000|Cohort 2|Lost to Follow-up|2|||
156394530|NCT02436330|564534576|FG001|Cohort 2|Lost to Follow-up|0|||
156394531|NCT02436330|564534575|FG000|Cohort 2|Withdrawal by Subject|2|||
156394532|NCT02436330|564534576|FG001|Cohort 2|Withdrawal by Subject|3|||
156394533|NCT02436330|564534575|FG000|Cohort 3|Lost to Follow-up|1|||
156394534|NCT02436330|564534576|FG001|Cohort 3|Lost to Follow-up|0|||
156394535|NCT02436330|564534575|FG000|Cohort 3|Withdrawal by Subject|4|||
156394536|NCT02436330|564534576|FG001|Cohort 3|Withdrawal by Subject|0|||
156394537|NCT02436330|564534575|FG000|Cohort 4|Lost to Follow-up|1|||
156394538|NCT02436330|564534576|FG001|Cohort 4|Lost to Follow-up|0|||
156394539|NCT02436330|564534575|FG000|Cohort 4|Withdrawal by Subject|1|||
156394540|NCT02436330|564534576|FG001|Cohort 4|Withdrawal by Subject|0|||
156394541|NCT02436330|564534575|FG000|Cohort 5|Lost to Follow-up|3|||
156394542|NCT02436330|564534576|FG001|Cohort 5|Lost to Follow-up|2|||
156394543|NCT02436330|564534575|FG000|Cohort 5|Withdrawal by Subject|3|||
156394544|NCT02436330|564534576|FG001|Cohort 5|Withdrawal by Subject|2|||
156394545|NCT02436330|564534575|FG000|Cohort 6|Lost to Follow-up|2|||
156394546|NCT02436330|564534576|FG001|Cohort 6|Lost to Follow-up|0|||
156394547|NCT02436330|564534575|FG000|Cohort 6|Withdrawal by Subject|1|||
156394548|NCT02436330|564534576|FG001|Cohort 6|Withdrawal by Subject|1|||
156394549|NCT02054806|564534577|FG000|Overall Study|Sponsor Decision|31|||
156394550|NCT02054806|564534577|FG000|Overall Study|Withdrawal by Subject|43|||
156394551|NCT02054806|564534577|FG000|Overall Study|Protocol Violation|2|||
156394552|NCT02054806|564534577|FG000|Overall Study|Lost to Follow-up|10|||
156394553|NCT02054806|564534577|FG000|Overall Study|Death|391|||
156394554|NCT04721925|564534578|FG000|2-Month Assessment|Lost to Follow-up|5|||
156548997|NCT00082888|565102446|FG001|Overall Study|Ineligible|0|||
156548998|NCT00082888|565102447|FG002|Overall Study|Ineligible|0|||
156548999|NCT03860961|565102448|FG000|Overall Study|Withdrawal by Subject|6|||
156549000|NCT03860961|565102449|FG001|Overall Study|Withdrawal by Subject|11|||
156394555|NCT04721925|564534579|FG001|2-Month Assessment|Lost to Follow-up|3|||
156394556|NCT04721925|564534578|FG000|4-Month Assessment|Lost to Follow-up|3|||
156394557|NCT04721925|564534579|FG001|4-Month Assessment|Lost to Follow-up|6|||
156394558|NCT05072080|564534582|FG000|Overall Study|Death|0|||
156394559|NCT05072080|564534583|FG001|Overall Study|Death|0|||
156394560|NCT05072080|564534584|FG002|Overall Study|Death|1|||
156394561|NCT05072080|564534585|FG003|Overall Study|Death|0|||
156394562|NCT05072080|564534582|FG000|Overall Study|Lost to Follow-up|65|||
156394563|NCT05072080|564534583|FG001|Overall Study|Lost to Follow-up|70|||
156394564|NCT05072080|564534584|FG002|Overall Study|Lost to Follow-up|58|||
156394565|NCT05072080|564534585|FG003|Overall Study|Lost to Follow-up|23|||
156394566|NCT05072080|564534582|FG000|Overall Study|Physician Decision|2|||
156394567|NCT05072080|564534583|FG001|Overall Study|Physician Decision|1|||
156394568|NCT05072080|564534584|FG002|Overall Study|Physician Decision|1|||
156394569|NCT05072080|564534585|FG003|Overall Study|Physician Decision|0|||
156394570|NCT05072080|564534582|FG000|Overall Study|Withdrawal by Subject|45|||
156394571|NCT05072080|564534583|FG001|Overall Study|Withdrawal by Subject|30|||
156394572|NCT05072080|564534584|FG002|Overall Study|Withdrawal by Subject|27|||
156394573|NCT05072080|564534585|FG003|Overall Study|Withdrawal by Subject|7|||
156394574|NCT05072080|564534582|FG000|Overall Study|Sponsor Decision|0|||
156394575|NCT05072080|564534583|FG001|Overall Study|Sponsor Decision|1|||
156549001|NCT03860961|565102448|FG000|Overall Study|Death|10|||
156549002|NCT03860961|565102449|FG001|Overall Study|Death|6|||
156394576|NCT05072080|564534584|FG002|Overall Study|Sponsor Decision|0|||
156394577|NCT05072080|564534585|FG003|Overall Study|Sponsor Decision|0|||
156394578|NCT05072080|564534582|FG000|Overall Study|Subject moved|1|||
156394579|NCT05072080|564534583|FG001|Overall Study|Subject moved|3|||
156394580|NCT05072080|564534584|FG002|Overall Study|Subject moved|5|||
156394581|NCT05072080|564534585|FG003|Overall Study|Subject moved|2|||
156394582|NCT05072080|564534582|FG000|Overall Study|Withdrawal by parent|0|||
156394583|NCT05072080|564534583|FG001|Overall Study|Withdrawal by parent|0|||
156394584|NCT05072080|564534584|FG002|Overall Study|Withdrawal by parent|1|||
156394585|NCT05072080|564534585|FG003|Overall Study|Withdrawal by parent|0|||
156394586|NCT05072080|564534582|FG000|Overall Study|Subject was deployed|0|||
156394587|NCT05072080|564534583|FG001|Overall Study|Subject was deployed|1|||
156394588|NCT05072080|564534584|FG002|Overall Study|Subject was deployed|0|||
156394589|NCT05072080|564534585|FG003|Overall Study|Subject was deployed|0|||
156394590|NCT05072080|564534582|FG000|Overall Study|Subject left site without receiving dose|0|||
156394591|NCT05072080|564534583|FG001|Overall Study|Subject left site without receiving dose|1|||
156394592|NCT05072080|564534584|FG002|Overall Study|Subject left site without receiving dose|0|||
156394593|NCT05072080|564534585|FG003|Overall Study|Subject left site without receiving dose|0|||
156394594|NCT05072080|564534582|FG000|Overall Study|Subject incarcerated|0|||
156394595|NCT05072080|564534583|FG001|Overall Study|Subject incarcerated|1|||
156394596|NCT05072080|564534584|FG002|Overall Study|Subject incarcerated|0|||
156394597|NCT05072080|564534585|FG003|Overall Study|Subject incarcerated|1|||
156394598|NCT05072080|564534582|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
156394599|NCT05072080|564534583|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
156394600|NCT05072080|564534584|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
156394601|NCT05072080|564534585|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
156394602|NCT05072080|564534582|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
156394603|NCT05072080|564534583|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
156394604|NCT05072080|564534584|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
156394605|NCT05072080|564534585|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
156394606|NCT04212091|564534587|FG000|Overall Study|Lost to Follow-up|0|||
156394607|NCT04212091|564534588|FG001|Overall Study|Lost to Follow-up|0|||
156394608|NCT04212091|564534589|FG002|Overall Study|Lost to Follow-up|0|||
156394609|NCT04212091|564534590|FG003|Overall Study|Lost to Follow-up|0|||
156394610|NCT04212091|564534591|FG004|Overall Study|Lost to Follow-up|1|||
156394611|NCT04212091|564534592|FG005|Overall Study|Lost to Follow-up|1|||
156394612|NCT04212091|564534587|FG000|Overall Study|Participant unable to adhere to visit|0|||
156394613|NCT04212091|564534588|FG001|Overall Study|Participant unable to adhere to visit|0|||
156394614|NCT04212091|564534589|FG002|Overall Study|Participant unable to adhere to visit|0|||
156394615|NCT04212091|564534590|FG003|Overall Study|Participant unable to adhere to visit|0|||
156394616|NCT04212091|564534591|FG004|Overall Study|Participant unable to adhere to visit|1|||
156394617|NCT04212091|564534592|FG005|Overall Study|Participant unable to adhere to visit|0|||
156394618|NCT03182868|564534593|FG000|Overall Study|Protocol Violation|3|||
156394619|NCT03182868|564534594|FG001|Overall Study|Protocol Violation|0|||
156394620|NCT03182868|564534595|FG002|Overall Study|Protocol Violation|4|||
156394621|NCT03182868|564534596|FG003|Overall Study|Protocol Violation|1|||
156394622|NCT03182868|564534597|FG004|Overall Study|Protocol Violation|8|||
156394623|NCT02191267|564534599|FG000|Overall Study|Withdrawal by Subject|1|||
156394624|NCT02191267|564534600|FG001|Overall Study|Withdrawal by Subject|0|||
156394625|NCT02191267|564534601|FG002|Overall Study|Withdrawal by Subject|0|||
156394626|NCT00587964|564534602|FG000|Overall Study|Withdrawal by Subject|1|||
156394627|NCT00587964|564534602|FG000|Overall Study|Lost to Follow-up|1|||
156394628|NCT00587964|564534602|FG000|Overall Study|Patient found to be ineligible|1|||
156394629|NCT00587964|564534602|FG000|Overall Study|Patient did not receive intervention|5|||
156394630|NCT00587964|564534602|FG000|Overall Study|Progression of Disease|4|||
156394631|NCT01830127|564534608|FG000|Overall Study|Adverse Event|1|||
156394632|NCT01830127|564534609|FG001|Overall Study|Adverse Event|6|||
156394633|NCT01830127|564534608|FG000|Overall Study|Lack of Efficacy|3|||
156394634|NCT01830127|564534609|FG001|Overall Study|Lack of Efficacy|0|||
156394635|NCT01830127|564534608|FG000|Overall Study|Withdrawal by Subject|1|||
156394636|NCT01830127|564534609|FG001|Overall Study|Withdrawal by Subject|1|||
156394637|NCT01830127|564534608|FG000|Overall Study|Other reason not defined above|0|||
156394638|NCT01830127|564534609|FG001|Overall Study|Other reason not defined above|2|||
156394639|NCT00251745|564534612|FG000|Overall Study|Adverse Event|7|||
156394640|NCT00251745|564534613|FG001|Overall Study|Adverse Event|9|||
156394641|NCT00251745|564534614|FG002|Overall Study|Adverse Event|11|||
156394642|NCT00251745|564534612|FG000|Overall Study|Lost to Follow-up|4|||
156394643|NCT00251745|564534613|FG001|Overall Study|Lost to Follow-up|2|||
156394644|NCT00251745|564534614|FG002|Overall Study|Lost to Follow-up|5|||
156394645|NCT00251745|564534612|FG000|Overall Study|Withdrawal by Subject|13|||
156394646|NCT00251745|564534613|FG001|Overall Study|Withdrawal by Subject|7|||
156394647|NCT00251745|564534614|FG002|Overall Study|Withdrawal by Subject|3|||
156394648|NCT00251745|564534612|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
156394649|NCT00251745|564534613|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
156394650|NCT00251745|564534614|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
156394651|NCT00251745|564534612|FG000|Overall Study|Lack of Efficacy|3|||
156394652|NCT00251745|564534613|FG001|Overall Study|Lack of Efficacy|0|||
156394653|NCT00251745|564534614|FG002|Overall Study|Lack of Efficacy|0|||
156394654|NCT00251745|564534612|FG000|Overall Study|Noncompliant|0|||
156394655|NCT00251745|564534613|FG001|Overall Study|Noncompliant|2|||
156394656|NCT00251745|564534614|FG002|Overall Study|Noncompliant|2|||
156394657|NCT00251745|564534612|FG000|Overall Study|Pregnancy|0|||
156394658|NCT00251745|564534613|FG001|Overall Study|Pregnancy|1|||
156394659|NCT00251745|564534614|FG002|Overall Study|Pregnancy|0|||
156394660|NCT00251745|564534612|FG000|Overall Study|Per Subject Request|0|||
156394661|NCT00251745|564534613|FG001|Overall Study|Per Subject Request|0|||
156394662|NCT00251745|564534614|FG002|Overall Study|Per Subject Request|1|||
156394663|NCT00251745|564534612|FG000|Overall Study|Per Investigator Request|1|||
156394664|NCT00251745|564534613|FG001|Overall Study|Per Investigator Request|0|||
156394665|NCT00251745|564534614|FG002|Overall Study|Per Investigator Request|0|||
156394666|NCT00175825|564536624|FG000|Overall Study|Adverse Event|3|||
156394667|NCT00175825|564536625|FG001|Overall Study|Adverse Event|2|||
156394668|NCT00175825|564536626|FG002|Overall Study|Adverse Event|1|||
156394669|NCT00175825|564536627|FG003|Overall Study|Adverse Event|1|||
156394670|NCT00175825|564536624|FG000|Overall Study|Lost to Follow-up|1|||
156394671|NCT00175825|564536625|FG001|Overall Study|Lost to Follow-up|2|||
156394672|NCT00175825|564536626|FG002|Overall Study|Lost to Follow-up|0|||
156394673|NCT00175825|564536627|FG003|Overall Study|Lost to Follow-up|0|||
156394674|NCT00175825|564536624|FG000|Overall Study|Withdrawal by Subject|1|||
156394675|NCT00175825|564536625|FG001|Overall Study|Withdrawal by Subject|0|||
156394676|NCT00175825|564536626|FG002|Overall Study|Withdrawal by Subject|0|||
156394677|NCT00175825|564536627|FG003|Overall Study|Withdrawal by Subject|0|||
156394678|NCT04098406|564536628|FG000|Overall Study|Adverse Event|2|||
156394679|NCT04098406|564536629|FG001|Overall Study|Adverse Event|1|||
156394680|NCT04098406|564536628|FG000|Overall Study|Withdrawal by Subject|1|||
156394681|NCT04098406|564536629|FG001|Overall Study|Withdrawal by Subject|0|||
156394682|NCT00605293|564536630|FG000|Overall Study|Death|2|||
156394683|NCT00605293|564536631|FG001|Overall Study|Death|1|||
156394684|NCT00605293|564536630|FG000|Overall Study|Insufficient Therapeutic Response|2|||
156394685|NCT00605293|564536631|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156394686|NCT00605293|564536630|FG000|Overall Study|Adverse Event|1|||
156394687|NCT00605293|564536631|FG001|Overall Study|Adverse Event|0|||
156394688|NCT00605293|564536630|FG000|Overall Study|Holidays Dialysis Out|1|||
156394689|NCT00605293|564536631|FG001|Overall Study|Holidays Dialysis Out|0|||
156394690|NCT00605293|564536630|FG000|Overall Study|Blood Transfusion|7|||
156394691|NCT00605293|564536631|FG001|Overall Study|Blood Transfusion|1|||
156394692|NCT00605293|564536630|FG000|Overall Study|Renal Transplantation|3|||
156394693|NCT00605293|564536631|FG001|Overall Study|Renal Transplantation|1|||
156394694|NCT00605293|564536630|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
156394695|NCT00605293|564536631|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
156394696|NCT00605293|564536630|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
156394697|NCT00605293|564536631|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
156394698|NCT00605293|564536630|FG000|Overall Study|Principal Investigator Decision|0|||
156394699|NCT00605293|564536631|FG001|Overall Study|Principal Investigator Decision|1|||
156394700|NCT03581981|564536632|FG000|Overall Study|Withdrawal by Subject|12|||
156394701|NCT03581981|564536633|FG001|Overall Study|Withdrawal by Subject|13|||
156394702|NCT03581981|564536632|FG000|Overall Study|Physician Decision|1|||
156394703|NCT03581981|564536633|FG001|Overall Study|Physician Decision|2|||
156394704|NCT03581981|564536632|FG000|Overall Study|Lost to Follow-up|0|||
156394705|NCT03581981|564536633|FG001|Overall Study|Lost to Follow-up|4|||
156394706|NCT03338894|564536634|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
156394707|NCT00420199|564536637|FG000|Overall Study|Participant no longer met study criteria|1|||
156394708|NCT00420199|564536638|FG001|Overall Study|Participant no longer met study criteria|0|||
156394709|NCT01260350|564536650|FG000|Overall Study|Lack of Efficacy|0|||
156394710|NCT01260350|564536651|FG001|Overall Study|Lack of Efficacy|0|||
156394711|NCT01260350|564536652|FG002|Overall Study|Lack of Efficacy|0|||
156394712|NCT01260350|564536653|FG003|Overall Study|Lack of Efficacy|0|||
156394713|NCT01260350|564536654|FG004|Overall Study|Lack of Efficacy|0|||
156394714|NCT01260350|564536655|FG005|Overall Study|Lack of Efficacy|0|||
156394715|NCT01260350|564536656|FG006|Overall Study|Lack of Efficacy|0|||
156394716|NCT01260350|564536657|FG007|Overall Study|Lack of Efficacy|0|||
156394717|NCT01260350|564536658|FG008|Overall Study|Lack of Efficacy|0|||
156394718|NCT01260350|564536659|FG009|Overall Study|Lack of Efficacy|0|||
156394719|NCT01260350|564536660|FG010|Overall Study|Lack of Efficacy|0|||
156394720|NCT01260350|564536661|FG011|Overall Study|Lack of Efficacy|0|||
156394721|NCT01260350|564536662|FG012|Overall Study|Lack of Efficacy|0|||
156394722|NCT01260350|564536663|FG013|Overall Study|Lack of Efficacy|0|||
156394723|NCT01260350|564536664|FG014|Overall Study|Lack of Efficacy|0|||
156394724|NCT01260350|564536665|FG015|Overall Study|Lack of Efficacy|0|||
156394725|NCT01260350|564536666|FG016|Overall Study|Lack of Efficacy|0|||
156394726|NCT01260350|564536667|FG017|Overall Study|Lack of Efficacy|1|||
156394727|NCT01260350|564536668|FG018|Overall Study|Lack of Efficacy|0|||
156394728|NCT01260350|564536669|FG019|Overall Study|Lack of Efficacy|0|||
156394729|NCT01260350|564536670|FG020|Overall Study|Lack of Efficacy|3|||
156394730|NCT01260350|564536671|FG021|Overall Study|Lack of Efficacy|0|||
156394731|NCT01260350|564536650|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394732|NCT01260350|564536651|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394733|NCT01260350|564536652|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394734|NCT01260350|564536653|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394735|NCT01260350|564536654|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394736|NCT01260350|564536655|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394737|NCT01260350|564536656|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394738|NCT01260350|564536657|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394739|NCT01260350|564536658|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
156394740|NCT01260350|564536659|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394741|NCT01260350|564536660|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394742|NCT01260350|564536661|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394743|NCT01260350|564536662|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394744|NCT01260350|564536663|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394745|NCT01260350|564536664|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394746|NCT01260350|564536665|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394747|NCT01260350|564536666|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394748|NCT01260350|564536667|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394749|NCT01260350|564536668|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394750|NCT01260350|564536669|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394751|NCT01260350|564536670|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394752|NCT01260350|564536671|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156394753|NCT04385368|564536672|FG000|Overall Study|Death|5|||
156394754|NCT04385368|564536673|FG001|Overall Study|Death|5|||
156394755|NCT04385368|564536672|FG000|Overall Study|Physician Decision|3|||
156394756|NCT04385368|564536673|FG001|Overall Study|Physician Decision|0|||
156394757|NCT04385368|564536672|FG000|Overall Study|Withdrawal by Subject|4|||
156394758|NCT04385368|564536673|FG001|Overall Study|Withdrawal by Subject|3|||
156394759|NCT00677235|564536675|FG000|Overall Study|Withdrawal by Subject|1|||
156394760|NCT00677235|564536676|FG001|Overall Study|Withdrawal by Subject|1|||
156394761|NCT00677235|564536675|FG000|Overall Study|Lost to Follow-up|2|||
156394762|NCT00677235|564536676|FG001|Overall Study|Lost to Follow-up|1|||
156394763|NCT00677235|564536675|FG000|Overall Study|Death|37|||
156394764|NCT00677235|564536676|FG001|Overall Study|Death|36|||
156394765|NCT00677235|564536675|FG000|Overall Study|Adverse Experience|1|||
156394766|NCT00677235|564536676|FG001|Overall Study|Adverse Experience|0|||
156394767|NCT00952367|564536677|FG000|Overall Study|Withdrawal by Subject|2|||
156394768|NCT00952367|564536677|FG000|Overall Study|Noncoordination|1|||
156394769|NCT00952367|564536677|FG000|Overall Study|Protocol Violation|3|||
156394770|NCT03205371|564536689|FG000|Overall Study|Withdrawal by Subject|4|||
156394771|NCT03205371|564536690|FG001|Overall Study|Withdrawal by Subject|1|||
156394772|NCT03205371|564536691|FG002|Overall Study|Withdrawal by Subject|0|||
156394773|NCT03205371|564536692|FG003|Overall Study|Withdrawal by Subject|0|||
156394774|NCT03205371|564536693|FG004|Overall Study|Withdrawal by Subject|0|||
156394775|NCT03205371|564536694|FG005|Overall Study|Withdrawal by Subject|0|||
156394776|NCT03205371|564536695|FG006|Overall Study|Withdrawal by Subject|4|||
156394777|NCT03205371|564536696|FG007|Overall Study|Withdrawal by Subject|0|||
156394778|NCT03205371|564536697|FG008|Overall Study|Withdrawal by Subject|2|||
156394779|NCT03205371|564536698|FG009|Overall Study|Withdrawal by Subject|0|||
156394780|NCT03205371|564536699|FG010|Overall Study|Withdrawal by Subject|0|||
156394781|NCT03205371|564536700|FG011|Overall Study|Withdrawal by Subject|1|||
156394782|NCT03205371|564536689|FG000|Overall Study|Lost to Follow-up|0|||
156394783|NCT03205371|564536690|FG001|Overall Study|Lost to Follow-up|0|||
156394784|NCT03205371|564536691|FG002|Overall Study|Lost to Follow-up|0|||
156394785|NCT03205371|564536692|FG003|Overall Study|Lost to Follow-up|0|||
156394786|NCT03205371|564536693|FG004|Overall Study|Lost to Follow-up|0|||
156394787|NCT03205371|564536694|FG005|Overall Study|Lost to Follow-up|0|||
156394788|NCT03205371|564536695|FG006|Overall Study|Lost to Follow-up|5|||
156394789|NCT03205371|564536696|FG007|Overall Study|Lost to Follow-up|2|||
156394790|NCT03205371|564536697|FG008|Overall Study|Lost to Follow-up|3|||
156394791|NCT03205371|564536698|FG009|Overall Study|Lost to Follow-up|0|||
156394792|NCT03205371|564536699|FG010|Overall Study|Lost to Follow-up|0|||
156394793|NCT03205371|564536700|FG011|Overall Study|Lost to Follow-up|0|||
156394794|NCT03205371|564536689|FG000|Overall Study|Protocol Violation|0|||
156394795|NCT03205371|564536690|FG001|Overall Study|Protocol Violation|0|||
156394796|NCT03205371|564536691|FG002|Overall Study|Protocol Violation|0|||
156394797|NCT03205371|564536692|FG003|Overall Study|Protocol Violation|0|||
156394798|NCT03205371|564536693|FG004|Overall Study|Protocol Violation|0|||
156394799|NCT03205371|564536694|FG005|Overall Study|Protocol Violation|0|||
156394800|NCT03205371|564536695|FG006|Overall Study|Protocol Violation|1|||
156394801|NCT03205371|564536696|FG007|Overall Study|Protocol Violation|0|||
156394802|NCT03205371|564536697|FG008|Overall Study|Protocol Violation|0|||
156394803|NCT03205371|564536698|FG009|Overall Study|Protocol Violation|0|||
156394804|NCT03205371|564536699|FG010|Overall Study|Protocol Violation|0|||
156394805|NCT03205371|564536700|FG011|Overall Study|Protocol Violation|0|||
156394806|NCT03205371|564536689|FG000|Overall Study|Adverse Event|0|||
156394807|NCT03205371|564536690|FG001|Overall Study|Adverse Event|0|||
156394808|NCT03205371|564536691|FG002|Overall Study|Adverse Event|0|||
156394809|NCT03205371|564536692|FG003|Overall Study|Adverse Event|0|||
156394810|NCT03205371|564536693|FG004|Overall Study|Adverse Event|0|||
156394811|NCT03205371|564536694|FG005|Overall Study|Adverse Event|0|||
156394812|NCT03205371|564536695|FG006|Overall Study|Adverse Event|0|||
156394813|NCT03205371|564536696|FG007|Overall Study|Adverse Event|1|||
156394814|NCT03205371|564536697|FG008|Overall Study|Adverse Event|0|||
156394815|NCT03205371|564536698|FG009|Overall Study|Adverse Event|0|||
156394816|NCT03205371|564536699|FG010|Overall Study|Adverse Event|0|||
156394817|NCT03205371|564536700|FG011|Overall Study|Adverse Event|0|||
156394818|NCT02835339|564536702|FG000|Overall Study|Did not receive allocated intervention|13|||
156394819|NCT02835339|564536703|FG001|Overall Study|Did not receive allocated intervention|16|||
156394820|NCT01077544|564536704|FG000|Overall Study|New Cancer Therapy|3|||
156394821|NCT01077544|564536705|FG001|Overall Study|New Cancer Therapy|3|||
156394822|NCT01077544|564536704|FG000|Overall Study|Adverse Event|0|||
156394823|NCT01077544|564536705|FG001|Overall Study|Adverse Event|1|||
156394824|NCT01077544|564536704|FG000|Overall Study|Disease Progression|0|||
156394825|NCT01077544|564536705|FG001|Overall Study|Disease Progression|1|||
156394826|NCT04918147|564536714|FG000|Overall Study|Disease flare as defined in protocol|0|||
156394827|NCT04918147|564536715|FG001|Overall Study|Disease flare as defined in protocol|2|||
156394828|NCT04575051|564536717|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
156394829|NCT04575051|564536718|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
156394830|NCT04575051|564536719|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
156394831|NCT04575051|564536720|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
156394832|NCT04575051|564536721|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
156394833|NCT04575051|564536717|FG000|Time Period 1|Missing follow up|1|||
156394834|NCT04575051|564536718|FG001|Time Period 1|Missing follow up|3|||
156394835|NCT04575051|564536719|FG002|Time Period 1|Missing follow up|1|||
156394836|NCT04575051|564536720|FG003|Time Period 1|Missing follow up|3|||
156394837|NCT04575051|564536721|FG004|Time Period 1|Missing follow up|2|||
156394838|NCT04575051|564536717|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
156394839|NCT04575051|564536718|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
156394840|NCT04575051|564536719|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
156394841|NCT04575051|564536720|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
156394842|NCT04575051|564536721|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
156394843|NCT04575051|564536717|FG000|Time Period 2|Missing follow up|1|||
156394844|NCT04575051|564536718|FG001|Time Period 2|Missing follow up|8|||
156394845|NCT04575051|564536719|FG002|Time Period 2|Missing follow up|7|||
156394846|NCT04575051|564536720|FG003|Time Period 2|Missing follow up|0|||
156394847|NCT04575051|564536721|FG004|Time Period 2|Missing follow up|1|||
156394848|NCT04575051|564536717|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
156394849|NCT04575051|564536718|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
156394850|NCT04575051|564536719|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
156394851|NCT04575051|564536720|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
156394852|NCT04575051|564536721|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
156394853|NCT04575051|564536717|FG000|Time Period 3|Missing follow up|8|||
156394854|NCT04575051|564536718|FG001|Time Period 3|Missing follow up|6|||
156394855|NCT04575051|564536719|FG002|Time Period 3|Missing follow up|4|||
156394856|NCT04575051|564536720|FG003|Time Period 3|Missing follow up|3|||
156394857|NCT04575051|564536721|FG004|Time Period 3|Missing follow up|0|||
156394858|NCT04575051|564536717|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
156394859|NCT04575051|564536718|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
156394860|NCT04575051|564536719|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
156394861|NCT04575051|564536720|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
156508808|NCT01461005|564955533|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
156508809|NCT00600613|564955534|FG000|Overall Study|Protocol Deviation|1|||
156508810|NCT00664534|564955535|FG000|Overall Study|Adverse Event|2|||
156508811|NCT00664534|564955536|FG001|Overall Study|Adverse Event|3|||
156508812|NCT00664534|564955535|FG000|Overall Study|Lost to Follow-up|6|||
156508813|NCT00664534|564955536|FG001|Overall Study|Lost to Follow-up|10|||
156508814|NCT00664534|564955535|FG000|Overall Study|Protocol Violation|10|||
156508815|NCT00664534|564955536|FG001|Overall Study|Protocol Violation|8|||
156394862|NCT04575051|564536721|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
156394863|NCT04575051|564536717|FG000|Time Period 4|Missing follow up|17|||
156394864|NCT04575051|564536718|FG001|Time Period 4|Missing follow up|3|||
156394865|NCT04575051|564536719|FG002|Time Period 4|Missing follow up|4|||
156394866|NCT04575051|564536720|FG003|Time Period 4|Missing follow up|2|||
156508816|NCT00664534|564955535|FG000|Overall Study|Withdrawal by Subject|7|||
156394867|NCT04575051|564536721|FG004|Time Period 4|Missing follow up|1|||
156394868|NCT04575051|564536717|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
156549003|NCT03860961|565102448|FG000|Overall Study|Incomplete two-year data|4|||
156549004|NCT03860961|565102449|FG001|Overall Study|Incomplete two-year data|0|||
156549005|NCT02684981|565102450|FG000|Overall Study|Permanently discontinued the treatment|157|||
156549006|NCT02684981|565102451|FG001|Overall Study|Permanently discontinued the treatment|161|||
156549007|NCT02684981|565102452|FG002|Overall Study|Permanently discontinued the treatment|110|||
156549008|NCT02684981|565102450|FG000|Overall Study|Other|83|||
156549009|NCT02684981|565102451|FG001|Overall Study|Other|49|||
156549010|NCT02684981|565102452|FG002|Overall Study|Other|17|||
156549011|NCT04623242|565102453|FG000|Overall Study|Withdrawal by Subject|7|||
156549012|NCT04623242|565102454|FG001|Overall Study|Withdrawal by Subject|12|||
156549013|NCT04623242|565102455|FG002|Overall Study|Withdrawal by Subject|5|||
156549014|NCT04623242|565102456|FG003|Overall Study|Withdrawal by Subject|7|||
156549015|NCT04623242|565102457|FG004|Overall Study|Withdrawal by Subject|0|||
156549016|NCT04623242|565102453|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
156549017|NCT04623242|565102454|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
156549018|NCT04623242|565102455|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
156549019|NCT04623242|565102456|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
156549020|NCT04623242|565102457|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
156549021|NCT04623242|565102453|FG000|Overall Study|Subject unblinded to mutation status|0|||
156549022|NCT04623242|565102454|FG001|Overall Study|Subject unblinded to mutation status|0|||
156549023|NCT04623242|565102455|FG002|Overall Study|Subject unblinded to mutation status|0|||
156549024|NCT04623242|565102456|FG003|Overall Study|Subject unblinded to mutation status|13|||
156549025|NCT04623242|565102457|FG004|Overall Study|Subject unblinded to mutation status|0|||
156394869|NCT04575051|564536718|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
156394870|NCT04575051|564536719|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
156394871|NCT04575051|564536720|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
156394872|NCT04575051|564536721|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
156394873|NCT04575051|564536717|FG000|Time Period 5|Missing follow up|11|||
156394874|NCT04575051|564536718|FG001|Time Period 5|Missing follow up|8|||
156394875|NCT04575051|564536719|FG002|Time Period 5|Missing follow up|12|||
156394876|NCT04575051|564536720|FG003|Time Period 5|Missing follow up|3|||
156394877|NCT04575051|564536721|FG004|Time Period 5|Missing follow up|11|||
156394878|NCT02862457|564536722|FG000|Overall Study|Death|1|||
156394879|NCT02862457|564536723|FG001|Overall Study|Death|3|||
156394880|NCT02862457|564536724|FG002|Overall Study|Death|2|||
156394881|NCT02862457|564536725|FG003|Overall Study|Death|3|||
156549026|NCT00493870|565102462|FG000|Overall Study|Lost to Follow-up|12|||
156549027|NCT00493870|565102463|FG001|Overall Study|Lost to Follow-up|15|||
156549028|NCT00272038|565102464|FG000|Overall Study|withdrew before they received 2 cycles|7|||
156549029|NCT00356278|565102467|FG000|Overall Study|Withdrawal by Subject|25|||
156549030|NCT00356278|565102468|FG001|Overall Study|Withdrawal by Subject|15|||
156549031|NCT00356278|565102469|FG002|Overall Study|Withdrawal by Subject|19|||
156549032|NCT01363986|565102470|FG000|Overall Study|Disease progression|1|||
156549033|NCT01637142|565102471|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
156549034|NCT02111564|565102472|FG000|Overall Study|Death|109|||
156549035|NCT02111564|565102473|FG001|Overall Study|Death|120|||
156394882|NCT02862457|564536726|FG004|Overall Study|Death|0|||
156394883|NCT02862457|564536727|FG005|Overall Study|Death|2|||
156394884|NCT02862457|564536728|FG006|Overall Study|Death|1|||
156394885|NCT02862457|564536722|FG000|Overall Study|Lost to Follow-up|1|||
156394886|NCT02862457|564536723|FG001|Overall Study|Lost to Follow-up|0|||
156394887|NCT02862457|564536724|FG002|Overall Study|Lost to Follow-up|0|||
156394888|NCT02862457|564536725|FG003|Overall Study|Lost to Follow-up|1|||
156394889|NCT02862457|564536726|FG004|Overall Study|Lost to Follow-up|0|||
156394890|NCT02862457|564536727|FG005|Overall Study|Lost to Follow-up|0|||
156394891|NCT02862457|564536728|FG006|Overall Study|Lost to Follow-up|0|||
156394892|NCT02862457|564536722|FG000|Overall Study|Withdrawal by Subject|0|||
156394893|NCT02862457|564536723|FG001|Overall Study|Withdrawal by Subject|0|||
156394894|NCT02862457|564536724|FG002|Overall Study|Withdrawal by Subject|1|||
156394895|NCT02862457|564536725|FG003|Overall Study|Withdrawal by Subject|0|||
156394896|NCT02862457|564536726|FG004|Overall Study|Withdrawal by Subject|0|||
156394897|NCT02862457|564536727|FG005|Overall Study|Withdrawal by Subject|1|||
156394898|NCT02862457|564536728|FG006|Overall Study|Withdrawal by Subject|0|||
156394899|NCT00951483|564536729|FG000|Overall Study|Physician Decision|4|||
156394900|NCT00951483|564536730|FG001|Overall Study|Physician Decision|0|||
156394901|NCT00951483|564536729|FG000|Overall Study|Withdrawal by Subject|15|||
156394902|NCT00951483|564536730|FG001|Overall Study|Withdrawal by Subject|0|||
156394903|NCT03565887|564536731|FG000|Overall Study|Adverse Event|1|||
156394904|NCT03565887|564536732|FG001|Overall Study|Adverse Event|0|||
156549036|NCT02111564|565102472|FG000|Overall Study|Lost to Follow-up|2|||
156549037|NCT02111564|565102473|FG001|Overall Study|Lost to Follow-up|3|||
156549038|NCT02111564|565102472|FG000|Overall Study|Withdrawal by Subject|20|||
156394905|NCT03565887|564536731|FG000|Overall Study|Withdrawal by Subject|0|||
156394906|NCT03565887|564536732|FG001|Overall Study|Withdrawal by Subject|2|||
156394907|NCT02975973|564536733|FG000|Overall Study|Adverse Event|1|||
156394908|NCT02975973|564536734|FG001|Overall Study|Adverse Event|1|||
156394909|NCT02975973|564536735|FG002|Overall Study|Adverse Event|1|||
156394910|NCT02975973|564536736|FG003|Overall Study|Adverse Event|0|||
156394911|NCT03804710|564536737|FG000|Overall Study|Adverse Event|0|||
156394912|NCT03804710|564536738|FG001|Overall Study|Adverse Event|3|||
156394913|NCT03804710|564536737|FG000|Overall Study|Withdrawal by Subject|2|||
156394914|NCT03804710|564536738|FG001|Overall Study|Withdrawal by Subject|1|||
156394915|NCT03804710|564536737|FG000|Overall Study|Other|0|||
156394916|NCT03804710|564536738|FG001|Overall Study|Other|1|||
156394917|NCT00689221|564536744|FG000|Overall Study|Ongoing at cut-off date|39|||
156394918|NCT00689221|564536745|FG001|Overall Study|Ongoing at cut-off date|36|||
156394919|NCT01939548|564536747|FG000|Overall Study|Non compliance|0|||
156394920|NCT01939548|564536748|FG001|Overall Study|Non compliance|2|||
156394921|NCT01939548|564536749|FG002|Overall Study|Non compliance|0|||
156394922|NCT01939548|564536747|FG000|Overall Study|Study Terminated by Sponsor|17|||
156394923|NCT01939548|564536748|FG001|Overall Study|Study Terminated by Sponsor|19|||
156394924|NCT01939548|564536749|FG002|Overall Study|Study Terminated by Sponsor|12|||
156394925|NCT01939548|564536747|FG000|Overall Study|Insufficient Clinical Response|1|||
156394926|NCT01939548|564536748|FG001|Overall Study|Insufficient Clinical Response|0|||
156394927|NCT01939548|564536749|FG002|Overall Study|Insufficient Clinical Response|0|||
156394928|NCT01939548|564536747|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
156394929|NCT01939548|564536748|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
156394930|NCT01939548|564536749|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
156394931|NCT01939548|564536747|FG000|Overall Study|Withdrawal by Subject|4|||
156394932|NCT01939548|564536748|FG001|Overall Study|Withdrawal by Subject|4|||
156394933|NCT01939548|564536749|FG002|Overall Study|Withdrawal by Subject|1|||
156394934|NCT01939548|564536747|FG000|Overall Study|Protocol Violation|7|||
156394935|NCT01939548|564536748|FG001|Overall Study|Protocol Violation|6|||
156394936|NCT01939548|564536749|FG002|Overall Study|Protocol Violation|5|||
156394937|NCT01939548|564536747|FG000|Overall Study|Lost to Follow-up|5|||
156394938|NCT01939548|564536748|FG001|Overall Study|Lost to Follow-up|5|||
156394939|NCT01939548|564536749|FG002|Overall Study|Lost to Follow-up|3|||
156394940|NCT01939548|564536747|FG000|Overall Study|Adverse Event|2|||
156394941|NCT01939548|564536748|FG001|Overall Study|Adverse Event|9|||
156394942|NCT01939548|564536749|FG002|Overall Study|Adverse Event|7|||
156394943|NCT01939548|564536747|FG000|Overall Study|Death|0|||
156394944|NCT01939548|564536748|FG001|Overall Study|Death|0|||
156394945|NCT01939548|564536749|FG002|Overall Study|Death|1|||
156394946|NCT01939548|564536747|FG000|Overall Study|Participant dropped|0|||
156394947|NCT01939548|564536748|FG001|Overall Study|Participant dropped|0|||
156394948|NCT01939548|564536749|FG002|Overall Study|Participant dropped|1|||
156394949|NCT01939548|564536747|FG000|Overall Study|Participant unwilling to continue|0|||
156394950|NCT01939548|564536748|FG001|Overall Study|Participant unwilling to continue|1|||
156394951|NCT01939548|564536749|FG002|Overall Study|Participant unwilling to continue|0|||
156394952|NCT01939548|564536747|FG000|Overall Study|Participant withdrew consent|0|||
156394953|NCT01939548|564536748|FG001|Overall Study|Participant withdrew consent|2|||
156394954|NCT01939548|564536749|FG002|Overall Study|Participant withdrew consent|0|||
156394955|NCT01939548|564536747|FG000|Overall Study|Did not complete follow-up|0|||
156394956|NCT01939548|564536748|FG001|Overall Study|Did not complete follow-up|1|||
156394957|NCT01939548|564536749|FG002|Overall Study|Did not complete follow-up|0|||
156394958|NCT03311373|564536750|FG000|Overall Study|Adverse Event|1|||
156394959|NCT03311373|564536750|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
156394960|NCT03311373|564536750|FG000|Overall Study|Lost to Follow-up|1|||
156394961|NCT03311373|564536750|FG000|Overall Study|Physician Decision|1|||
156394962|NCT03311373|564536750|FG000|Overall Study|Withdrawal by Subject|3|||
156394963|NCT01297959|564536755|FG000|Overall Study|Adverse Event|0|||
156394964|NCT01297959|564536756|FG001|Overall Study|Adverse Event|1|||
156394965|NCT01297959|564536755|FG000|Overall Study|Protocol Violation|2|||
156394966|NCT01297959|564536756|FG001|Overall Study|Protocol Violation|1|||
156394967|NCT01297959|564536755|FG000|Overall Study|Withdrawal by Subject|5|||
156394968|NCT01297959|564536756|FG001|Overall Study|Withdrawal by Subject|4|||
156394969|NCT01297959|564536755|FG000|Overall Study|Physician Decision|0|||
156394970|NCT01297959|564536756|FG001|Overall Study|Physician Decision|1|||
156394971|NCT01297959|564536755|FG000|Overall Study|Unrelated medical illness / complication|0|||
156508817|NCT00664534|564955536|FG001|Overall Study|Withdrawal by Subject|6|||
156508818|NCT00664534|564955535|FG000|Overall Study|Physician Decision|8|||
156394972|NCT01297959|564536756|FG001|Overall Study|Unrelated medical illness / complication|2|||
156394973|NCT01297959|564536755|FG000|Overall Study|Other|13|||
156508819|NCT00664534|564955536|FG001|Overall Study|Physician Decision|0|||
156394974|NCT01297959|564536756|FG001|Overall Study|Other|7|||
156394975|NCT00344461|564536757|FG000|Overall Study|Adverse Event|6|||
156394976|NCT00344461|564536757|FG000|Overall Study|Death|1|||
156394977|NCT00344461|564536757|FG000|Overall Study|Lack of Efficacy|2|||
156394978|NCT00344461|564536757|FG000|Overall Study|Lost to Follow-up|2|||
156508820|NCT00664534|564955535|FG000|Overall Study|Sponsor decision|8|||
156394979|NCT00344461|564536757|FG000|Overall Study|Physician Decision|2|||
156394980|NCT00344461|564536757|FG000|Overall Study|Protocol Violation|6|||
156394981|NCT00344461|564536757|FG000|Overall Study|Withdrawal by Subject|2|||
156394982|NCT00941330|564536764|FG000|Overall Study|Other|1|||
156394983|NCT00941330|564536765|FG001|Overall Study|Other|0|||
156394984|NCT00941330|564536764|FG000|Overall Study|Physician Decision|0|||
156394985|NCT00941330|564536765|FG001|Overall Study|Physician Decision|2|||
156394986|NCT00686881|564536766|FG000|Overall Study|Withdrawal by Subject|11|||
156394987|NCT00686881|564536767|FG001|Overall Study|Withdrawal by Subject|18|||
156394988|NCT00686881|564536766|FG000|Overall Study|Lost to Follow-up|0|||
156394989|NCT00686881|564536767|FG001|Overall Study|Lost to Follow-up|1|||
156394990|NCT00686881|564536766|FG000|Overall Study|Treatment-related adverse event|10|||
156394991|NCT00686881|564536767|FG001|Overall Study|Treatment-related adverse event|9|||
156394992|NCT00686881|564536766|FG000|Overall Study|Met discontinuation criteria|5|||
156394993|NCT00686881|564536767|FG001|Overall Study|Met discontinuation criteria|0|||
156394994|NCT00686881|564536766|FG000|Overall Study|Onset of malignant tumor|11|||
156394995|NCT00686881|564536767|FG001|Overall Study|Onset of malignant tumor|11|||
156394996|NCT00686881|564536766|FG000|Overall Study|Lack of Efficacy|4|||
156394997|NCT00686881|564536767|FG001|Overall Study|Lack of Efficacy|3|||
156394998|NCT00686881|564536766|FG000|Overall Study|Physician Decision|1|||
156394999|NCT00686881|564536767|FG001|Overall Study|Physician Decision|0|||
156395000|NCT00686881|564536766|FG000|Overall Study|Circumstances of site|1|||
156395001|NCT00686881|564536767|FG001|Overall Study|Circumstances of site|1|||
156395002|NCT00686881|564536766|FG000|Overall Study|Did not meet protocol eligibility|1|||
156395003|NCT00686881|564536767|FG001|Overall Study|Did not meet protocol eligibility|0|||
156395004|NCT00686881|564536766|FG000|Overall Study|Irregular visits|1|||
156395005|NCT00686881|564536767|FG001|Overall Study|Irregular visits|0|||
156395006|NCT00686881|564536766|FG000|Overall Study|Study discontinuation|35|||
156395007|NCT00686881|564536767|FG001|Overall Study|Study discontinuation|32|||
156395008|NCT00686881|564536766|FG000|Overall Study|Never received study drug|2|||
156395009|NCT00686881|564536767|FG001|Overall Study|Never received study drug|6|||
156395010|NCT02085252|564536770|FG000|Overall Study|Withdrawal of Consent|1|||
156395011|NCT02085252|564536771|FG001|Overall Study|Withdrawal of Consent|0|||
156395012|NCT02085252|564536770|FG000|Overall Study|Adverse Event|0|||
156395013|NCT02085252|564536771|FG001|Overall Study|Adverse Event|1|||
156395014|NCT02085252|564536770|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
156395015|NCT02085252|564536771|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
156395016|NCT02085252|564536770|FG000|Overall Study|Reason Not Specified|0|||
156395017|NCT02085252|564536771|FG001|Overall Study|Reason Not Specified|1|||
156395018|NCT02085252|564536770|FG000|Overall Study|Reason Unknown|0|||
156395019|NCT02085252|564536771|FG001|Overall Study|Reason Unknown|1|||
156395020|NCT00951275|564536772|FG000|Overall Study|Administrative Reason|1|||
156395021|NCT00951275|564536772|FG000|Overall Study|Adverse Event|7|||
156395022|NCT00951275|564536772|FG000|Overall Study|Withdrawal by Subject|4|||
156395023|NCT00951275|564536772|FG000|Overall Study|Protocol Violation|1|||
156395024|NCT03260868|564536774|FG000|Overall Study|Poor Compliance to Protocol|0|||
156395025|NCT03260868|564536775|FG001|Overall Study|Poor Compliance to Protocol|2|||
156395026|NCT03260868|564536774|FG000|Overall Study|Study Terminated By Sponsor|2|||
156395027|NCT03260868|564536775|FG001|Overall Study|Study Terminated By Sponsor|1|||
156395028|NCT03260868|564536774|FG000|Overall Study|Other than specified above|1|||
156395029|NCT03260868|564536775|FG001|Overall Study|Other than specified above|0|||
156395030|NCT00541450|564536776|FG000|Phase A|Adverse Event|3|||
156395031|NCT00541450|564536777|FG001|Phase A|Adverse Event|0|||
156395032|NCT00541450|564536776|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
156395033|NCT00541450|564536777|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
156395034|NCT00541450|564536776|FG000|Phase A|Hyperglycemia|0|||
156395035|NCT00541450|564536777|FG001|Phase A|Hyperglycemia|1|||
156395036|NCT00541450|564536776|FG000|Phase A|Lost to Follow-up|6|||
156395037|NCT00541450|564536777|FG001|Phase A|Lost to Follow-up|4|||
156395038|NCT00541450|564536776|FG000|Phase A|Physician Decision|2|||
156395039|NCT00541450|564536777|FG001|Phase A|Physician Decision|0|||
156395040|NCT00541450|564536776|FG000|Phase A|Protocol Violation|2|||
156395041|NCT00541450|564536777|FG001|Phase A|Protocol Violation|3|||
156395042|NCT00541450|564536776|FG000|Phase A|Withdrawal by Subject|7|||
156395043|NCT00541450|564536777|FG001|Phase A|Withdrawal by Subject|7|||
156395044|NCT00541450|564536776|FG000|Phase B|Adverse Event|6|||
156395045|NCT00541450|564536777|FG001|Phase B|Adverse Event|6|||
156395046|NCT00541450|564536776|FG000|Phase B|Hyperglycemia|10|||
156508821|NCT00664534|564955536|FG001|Overall Study|Sponsor decision|6|||
156508822|NCT01436253|564955542|FG000|Overall Study|Lost to Follow-up|182|||
156395047|NCT00541450|564536777|FG001|Phase B|Hyperglycemia|9|||
156395048|NCT00541450|564536776|FG000|Phase B|Lost to Follow-up|6|||
156395049|NCT00541450|564536777|FG001|Phase B|Lost to Follow-up|4|||
156395050|NCT00541450|564536776|FG000|Phase B|Physician Decision|4|||
156395051|NCT00541450|564536777|FG001|Phase B|Physician Decision|2|||
156395052|NCT00541450|564536776|FG000|Phase B|Pregnancy|0|||
156395053|NCT00541450|564536777|FG001|Phase B|Pregnancy|1|||
156395054|NCT00541450|564536776|FG000|Phase B|Protocol Violation|3|||
156395055|NCT00541450|564536777|FG001|Phase B|Protocol Violation|3|||
156395056|NCT00541450|564536776|FG000|Phase B|Withdrawal by Subject|8|||
156395057|NCT00541450|564536777|FG001|Phase B|Withdrawal by Subject|6|||
156395058|NCT02048072|564536778|FG000|Overall Study|Adverse Event|3|||
156395059|NCT02048072|564536778|FG000|Overall Study|Lost to Follow-up|1|||
156395060|NCT01112579|564536779|FG000|Overall Study|Missed Visit|1|||
156395061|NCT01112579|564536780|FG001|Overall Study|Missed Visit|1|||
156395062|NCT01112579|564536779|FG000|Overall Study|Death|0|||
156395063|NCT01112579|564536780|FG001|Overall Study|Death|2|||
156395064|NCT03645759|564536784|FG000|Overall Study|Lost to Follow-up|3|||
156395065|NCT03645759|564536785|FG001|Overall Study|Lost to Follow-up|2|||
156395066|NCT01648270|564536786|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
156395067|NCT00818753|564536787|FG000|Overall Study|Protocol Violation|1|||
156395068|NCT00818753|564536788|FG001|Overall Study|Protocol Violation|0|||
156395069|NCT00818753|564536789|FG002|Overall Study|Protocol Violation|0|||
156395070|NCT00818753|564536787|FG000|Overall Study|Other reason (not specified)|0|||
156395071|NCT00818753|564536788|FG001|Overall Study|Other reason (not specified)|0|||
156395072|NCT00818753|564536789|FG002|Overall Study|Other reason (not specified)|1|||
156395073|NCT00818753|564536787|FG000|Overall Study|Randomised and not treated|2|||
156395074|NCT00818753|564536788|FG001|Overall Study|Randomised and not treated|0|||
156395075|NCT00818753|564536789|FG002|Overall Study|Randomised and not treated|0|||
156395076|NCT01389973|564536790|FG000|Overall Study|Lost to Follow-up|1|||
156395077|NCT01389973|564536790|FG000|Overall Study|Trial Stopped by Sponsor|9|||
156395078|NCT01389973|564536790|FG000|Overall Study|Other|10|||
156395079|NCT02459574|564536792|FG000|Overall Study|Withdrawal by Subject|6|||
156395080|NCT02459574|564536793|FG001|Overall Study|Withdrawal by Subject|6|||
156395081|NCT02459574|564536794|FG002|Overall Study|Withdrawal by Subject|2|||
156395082|NCT02459574|564536792|FG000|Overall Study|Lost to Follow-up|1|||
156395083|NCT02459574|564536793|FG001|Overall Study|Lost to Follow-up|1|||
156395084|NCT02459574|564536794|FG002|Overall Study|Lost to Follow-up|0|||
156395085|NCT02459574|564536792|FG000|Overall Study|Death|0|||
156395086|NCT02459574|564536793|FG001|Overall Study|Death|1|||
156395087|NCT02459574|564536794|FG002|Overall Study|Death|0|||
156395088|NCT04508699|564536800|FG000|Overall Study|Lack of Efficacy|2|||
156395089|NCT04508699|564536801|FG001|Overall Study|Lack of Efficacy|15|||
156395090|NCT04508699|564536800|FG000|Overall Study|Withdrawal by Subject|0|||
156395091|NCT04508699|564536801|FG001|Overall Study|Withdrawal by Subject|2|||
156395092|NCT04866017|564536802|FG000|Overall Study|Study Terminated by Sponsor|13|||
156395093|NCT04866017|564536803|FG001|Overall Study|Study Terminated by Sponsor|14|||
156395094|NCT04866017|564536804|FG002|Overall Study|Study Terminated by Sponsor|13|||
156395095|NCT04866017|564536802|FG000|Overall Study|Death|8|||
156395096|NCT04866017|564536803|FG001|Overall Study|Death|4|||
156395097|NCT04866017|564536804|FG002|Overall Study|Death|8|||
156395098|NCT04866017|564536802|FG000|Overall Study|Withdrawal by Subject|1|||
156395099|NCT04866017|564536803|FG001|Overall Study|Withdrawal by Subject|0|||
156395100|NCT04866017|564536804|FG002|Overall Study|Withdrawal by Subject|1|||
156395101|NCT04866017|564536802|FG000|Overall Study|Physician Decision|0|||
156395102|NCT04866017|564536803|FG001|Overall Study|Physician Decision|1|||
156395103|NCT04866017|564536804|FG002|Overall Study|Physician Decision|0|||
156395104|NCT01735201|564538259|FG000|Overall Study|Adverse Event|1|||
156395105|NCT01735201|564538260|FG001|Overall Study|Adverse Event|1|||
156395106|NCT01735201|564538261|FG002|Overall Study|Adverse Event|0|||
156395107|NCT01735201|564538262|FG003|Overall Study|Adverse Event|1|||
156395108|NCT01735201|564538263|FG004|Overall Study|Adverse Event|1|||
156395109|NCT01735201|564538264|FG005|Overall Study|Adverse Event|3|||
156395110|NCT01735201|564538265|FG006|Overall Study|Adverse Event|2|||
156395111|NCT01735201|564538266|FG007|Overall Study|Adverse Event|1|||
156395112|NCT01735201|564538259|FG000|Overall Study|Personal Reasons|1|||
156395113|NCT01735201|564538260|FG001|Overall Study|Personal Reasons|0|||
156395114|NCT01735201|564538261|FG002|Overall Study|Personal Reasons|0|||
156395115|NCT01735201|564538262|FG003|Overall Study|Personal Reasons|0|||
156395116|NCT01735201|564538263|FG004|Overall Study|Personal Reasons|0|||
156395117|NCT01735201|564538264|FG005|Overall Study|Personal Reasons|0|||
156395118|NCT01735201|564538265|FG006|Overall Study|Personal Reasons|0|||
156395119|NCT01735201|564538266|FG007|Overall Study|Personal Reasons|0|||
156395120|NCT01735201|564538259|FG000|Overall Study|Protocol Violation|1|||
156395121|NCT01735201|564538260|FG001|Overall Study|Protocol Violation|0|||
156395122|NCT01735201|564538261|FG002|Overall Study|Protocol Violation|0|||
156395123|NCT01735201|564538262|FG003|Overall Study|Protocol Violation|0|||
156395124|NCT01735201|564538263|FG004|Overall Study|Protocol Violation|0|||
156395125|NCT01735201|564538264|FG005|Overall Study|Protocol Violation|0|||
156395126|NCT01735201|564538265|FG006|Overall Study|Protocol Violation|0|||
156395127|NCT01735201|564538266|FG007|Overall Study|Protocol Violation|0|||
156395128|NCT01735201|564538259|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156395129|NCT01735201|564538260|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156395130|NCT01735201|564538261|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156395131|NCT01735201|564538262|FG003|Overall Study|Other Miscellaneous Reasons|1|||
156395132|NCT01735201|564538263|FG004|Overall Study|Other Miscellaneous Reasons|0|||
156395133|NCT01735201|564538264|FG005|Overall Study|Other Miscellaneous Reasons|2|||
156395134|NCT01735201|564538265|FG006|Overall Study|Other Miscellaneous Reasons|1|||
156395135|NCT01735201|564538266|FG007|Overall Study|Other Miscellaneous Reasons|1|||
156395136|NCT02178059|564538272|FG000|Washout|Physician Decision|1|||
156395137|NCT02178059|564538273|FG001|Washout|Physician Decision|0|||
156395138|NCT00289887|564538274|FG000|Overall Study|Adverse Event|3|||
156395139|NCT00289887|564538275|FG001|Overall Study|Adverse Event|3|||
156395140|NCT00289887|564538274|FG000|Overall Study|Lack of Efficacy|3|||
156395141|NCT00289887|564538275|FG001|Overall Study|Lack of Efficacy|11|||
156395142|NCT00289887|564538274|FG000|Overall Study|Lost to Follow-up|3|||
156395143|NCT00289887|564538275|FG001|Overall Study|Lost to Follow-up|3|||
156395144|NCT00289887|564538274|FG000|Overall Study|Protocol Violation|3|||
156395145|NCT00289887|564538275|FG001|Overall Study|Protocol Violation|1|||
156395146|NCT00289887|564538274|FG000|Overall Study|Withdrawal by Subject|3|||
156395147|NCT00289887|564538275|FG001|Overall Study|Withdrawal by Subject|8|||
156395148|NCT00289887|564538274|FG000|Overall Study|Other|7|||
156395149|NCT00289887|564538275|FG001|Overall Study|Other|3|||
156395150|NCT03255824|564538283|FG000|Overall Study|Under-sedation|2|||
156395151|NCT03255824|564538284|FG001|Overall Study|Under-sedation|1|||
156395152|NCT02001194|564538287|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
156395153|NCT02001194|564538288|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
156395154|NCT02001194|564538289|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
156395155|NCT02001194|564538290|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
156395156|NCT02001194|564538287|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
156395157|NCT02001194|564538288|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
156395158|NCT02001194|564538289|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
156395159|NCT02001194|564538290|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
156395160|NCT03432364|564538292|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
156395161|NCT00522301|564538293|FG000|Overall Study|Withdrawal by Subject|1|||
156395162|NCT00522301|564538293|FG000|Overall Study|Adverse Event|5|||
156395163|NCT03040713|564538294|FG000|Overall Study|Positive amyloid scan|3|||
156395164|NCT01699022|564538301|FG000|Overall Study|Early discontinuation from the study|3|||
156395165|NCT04539821|564538302|FG000|Overall Study|Withdrawal by Subject|2|||
156395166|NCT04539821|564538302|FG000|Overall Study|continued care with their physician|20|||
156395167|NCT04539821|564538302|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
156395168|NCT02066402|564538305|FG000|Overall Study|Adverse Event|1|||
156395169|NCT02066402|564538306|FG001|Overall Study|Adverse Event|2|||
156395170|NCT02066402|564538305|FG000|Overall Study|Lost to Follow-up|11|||
156395171|NCT02066402|564538306|FG001|Overall Study|Lost to Follow-up|8|||
156395172|NCT02066402|564538305|FG000|Overall Study|Withdrawal by Subject|14|||
156395173|NCT02066402|564538306|FG001|Overall Study|Withdrawal by Subject|11|||
156395174|NCT02066402|564538305|FG000|Overall Study|Progressive disease-clinical progression|0|||
156395175|NCT02066402|564538306|FG001|Overall Study|Progressive disease-clinical progression|1|||
156395176|NCT02066402|564538305|FG000|Overall Study|Protocol driven decision point|0|||
156395177|NCT02066402|564538306|FG001|Overall Study|Protocol driven decision point|1|||
156395178|NCT00152464|564538307|FG000|Overall Study|Adverse Event|3|||
156395179|NCT00152464|564538308|FG001|Overall Study|Adverse Event|6|||
156395180|NCT00152464|564538307|FG000|Overall Study|Lost to Follow-up|8|||
156395181|NCT00152464|564538308|FG001|Overall Study|Lost to Follow-up|4|||
156395182|NCT00152464|564538307|FG000|Overall Study|Protocol Violation|3|||
156395183|NCT00152464|564538308|FG001|Overall Study|Protocol Violation|1|||
156395184|NCT00152464|564538307|FG000|Overall Study|Withdrawal by Subject|21|||
156395185|NCT00152464|564538308|FG001|Overall Study|Withdrawal by Subject|22|||
156395186|NCT00152464|564538307|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
156395187|NCT00152464|564538308|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
156395188|NCT00152464|564538307|FG000|Overall Study|Eczema deterioration|0|||
156395189|NCT00152464|564538308|FG001|Overall Study|Eczema deterioration|1|||
156395190|NCT00152464|564538307|FG000|Overall Study|Parent decision|1|||
156395191|NCT00152464|564538308|FG001|Overall Study|Parent decision|1|||
156395192|NCT00152464|564538307|FG000|Overall Study|Investigator decision|1|||
156395193|NCT00152464|564538308|FG001|Overall Study|Investigator decision|0|||
156395194|NCT00152464|564538307|FG000|Overall Study|Lack of Efficacy|1|||
156395195|NCT00152464|564538308|FG001|Overall Study|Lack of Efficacy|0|||
156395196|NCT00152464|564538307|FG000|Overall Study|Eczema poorly controlled|1|||
156395197|NCT00152464|564538308|FG001|Overall Study|Eczema poorly controlled|0|||
156395198|NCT00152464|564538307|FG000|Overall Study|Patient relocated|1|||
156395199|NCT00152464|564538308|FG001|Overall Study|Patient relocated|0|||
156395200|NCT02462876|564538309|FG000|Overall Study|Death|3|||
156395201|NCT02462876|564538309|FG000|Overall Study|Lost to Follow-up|7|||
156508823|NCT01436253|564955542|FG000|Overall Study|Not meeting all eligibility criteria|117|||
156508824|NCT01495598|564955544|FG000|Overall Study|Death during follow up period|2|||
156508825|NCT01495598|564955544|FG000|Overall Study|Death on study|1|||
156395202|NCT02462876|564538309|FG000|Overall Study|Surgical Bypass|9|||
156395203|NCT02462876|564538309|FG000|Overall Study|Amputation Above the Metatarsals|1|||
156395204|NCT02462876|564538309|FG000|Overall Study|36 months follow-up visit missed|1|||
156395205|NCT02462876|564538309|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
156508826|NCT01495598|564955544|FG000|Overall Study|Lost to Follow-up|3|||
156395206|NCT02462876|564538309|FG000|Overall Study|Patient did not come back to the vascular department|1|||
156395207|NCT02462876|564538309|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
156395208|NCT02462876|564538309|FG000|Overall Study|Patient refused to come back|1|||
156395209|NCT02462876|564538309|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
156395210|NCT02462876|564538309|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
156395211|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
156395212|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
156395213|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
156395214|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
156395215|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
156395216|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
156395217|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
156395218|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
156395219|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Other|18|||
156395220|NCT02565914|564538310|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
156395221|NCT02565914|564538310|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
156395222|NCT02565914|564538310|FG000|Part B (Up to 96 Weeks)|Other|1|||
156395223|NCT02565914|564538310|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
156395224|NCT02565914|564538310|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
156395225|NCT02565914|564538310|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
156395226|NCT02565914|564538310|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
156395227|NCT02565914|564538310|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
156395228|NCT02565914|564538310|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
156395229|NCT02565914|564538310|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
156395230|NCT02565914|564538310|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
156395231|NCT02565914|564538310|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
156395232|NCT02565914|564538310|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
156395233|NCT02565914|564538310|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
156395234|NCT02565914|564538310|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
156395235|NCT04465357|564538311|FG000|Overall Study|Adverse Event|2|||
156395236|NCT04465357|564538311|FG000|Overall Study|Lack of Efficacy|1|||
156395237|NCT04465357|564538311|FG000|Overall Study|Lost to Follow-up|2|||
156395238|NCT04465357|564538311|FG000|Overall Study|Withdrawal by Subject|6|||
156395239|NCT04465357|564538311|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
156395240|NCT01040260|564538313|FG000|Overall Study|Withdrawal by Subject|12|||
156395241|NCT01040260|564538314|FG001|Overall Study|Withdrawal by Subject|6|||
156395242|NCT01040260|564538313|FG000|Overall Study|Lost to Follow-up|3|||
156395243|NCT01040260|564538314|FG001|Overall Study|Lost to Follow-up|5|||
156395244|NCT01113502|564538317|FG000|Overall Study|Withdrawal by Subject|1|||
156395245|NCT01113502|564538318|FG001|Overall Study|Withdrawal by Subject|0|||
156395246|NCT01113502|564538319|FG002|Overall Study|Withdrawal by Subject|1|||
156395247|NCT01113502|564538320|FG003|Overall Study|Withdrawal by Subject|1|||
156395248|NCT01113502|564538321|FG004|Overall Study|Withdrawal by Subject|0|||
156395249|NCT01113502|564538317|FG000|Overall Study|Adverse Event|0|||
156395250|NCT01113502|564538318|FG001|Overall Study|Adverse Event|0|||
156395251|NCT01113502|564538319|FG002|Overall Study|Adverse Event|3|||
156395252|NCT01113502|564538320|FG003|Overall Study|Adverse Event|2|||
156395253|NCT01113502|564538321|FG004|Overall Study|Adverse Event|0|||
156395254|NCT00781391|564538324|FG000|Overall Study|never received study drug|24|||
156395255|NCT00781391|564538325|FG001|Overall Study|never received study drug|23|||
156395256|NCT00781391|564538326|FG002|Overall Study|never received study drug|32|||
156395257|NCT00781391|564538324|FG000|Overall Study|Protocol Violation|19|||
156395258|NCT00781391|564538325|FG001|Overall Study|Protocol Violation|17|||
156395259|NCT00781391|564538326|FG002|Overall Study|Protocol Violation|20|||
156395260|NCT00781391|564538324|FG000|Overall Study|Death|789|||
156395261|NCT00781391|564538325|FG001|Overall Study|Death|730|||
156395262|NCT00781391|564538326|FG002|Overall Study|Death|706|||
156395263|NCT00781391|564538324|FG000|Overall Study|Withdrawal by Subject|47|||
156395264|NCT00781391|564538325|FG001|Overall Study|Withdrawal by Subject|37|||
156395265|NCT00781391|564538326|FG002|Overall Study|Withdrawal by Subject|25|||
156395266|NCT00781391|564538324|FG000|Overall Study|Lost to Follow-up|0|||
156395267|NCT00781391|564538325|FG001|Overall Study|Lost to Follow-up|0|||
156395268|NCT00781391|564538326|FG002|Overall Study|Lost to Follow-up|1|||
156395269|NCT00708916|564538328|FG000|Overall Study|Subject Noncompliance|2|||
156395270|NCT00708916|564538328|FG000|Overall Study|Adverse Event|2|||
156395271|NCT01984684|564538330|FG000|Overall Study|Lost to Follow-up|25|||
156395272|NCT01984684|564538331|FG001|Overall Study|Lost to Follow-up|24|||
156395273|NCT01984684|564538330|FG000|Overall Study|Adverse Event|8|||
156395274|NCT01984684|564538331|FG001|Overall Study|Adverse Event|12|||
156395275|NCT01984684|564538330|FG000|Overall Study|Withdrawal by Subject|9|||
156395276|NCT01984684|564538331|FG001|Overall Study|Withdrawal by Subject|9|||
156395277|NCT01984684|564538330|FG000|Overall Study|Lack of Efficacy|3|||
156395278|NCT01984684|564538331|FG001|Overall Study|Lack of Efficacy|6|||
156395279|NCT01984684|564538330|FG000|Overall Study|Physician Decision|4|||
156395280|NCT01984684|564538331|FG001|Overall Study|Physician Decision|2|||
156395281|NCT01984684|564538330|FG000|Overall Study|Protocol Violation|4|||
156395282|NCT01984684|564538331|FG001|Overall Study|Protocol Violation|2|||
156395283|NCT01984684|564538330|FG000|Overall Study|Death|0|||
156395284|NCT01984684|564538331|FG001|Overall Study|Death|1|||
156395285|NCT01984684|564538330|FG000|Overall Study|Noncompliance with study drug|2|||
156395286|NCT01984684|564538331|FG001|Overall Study|Noncompliance with study drug|1|||
156395287|NCT01984684|564538330|FG000|Overall Study|Subject incarcerated|1|||
156395288|NCT01984684|564538331|FG001|Overall Study|Subject incarcerated|0|||
156395289|NCT01984684|564538330|FG000|Overall Study|Study drug not available at site|1|||
156395290|NCT01984684|564538331|FG001|Overall Study|Study drug not available at site|1|||
156395291|NCT01984684|564538330|FG000|Overall Study|Subject had inadequate IV access|0|||
156395292|NCT01984684|564538331|FG001|Overall Study|Subject had inadequate IV access|1|||
156395293|NCT04555096|564538337|FG000|Overall Study|Death|4|||
156395294|NCT04555096|564538338|FG001|Overall Study|Death|4|||
156395295|NCT04555096|564538337|FG000|Overall Study|Withdrawal by Subject|1|||
156395296|NCT04555096|564538338|FG001|Overall Study|Withdrawal by Subject|0|||
156395297|NCT04555096|564538337|FG000|Overall Study|Other|0|||
156395298|NCT04555096|564538338|FG001|Overall Study|Other|1|||
156395299|NCT03923959|564538341|FG000|Overall Study|Death|16|||
156395300|NCT03923959|564538342|FG001|Overall Study|Death|12|||
156395301|NCT03923959|564538341|FG000|Overall Study|Lost to Follow-up|56|||
156395302|NCT03923959|564538342|FG001|Overall Study|Lost to Follow-up|56|||
156395303|NCT03923959|564538341|FG000|Overall Study|Withdrawal by Subject|1|||
156395304|NCT03923959|564538342|FG001|Overall Study|Withdrawal by Subject|1|||
156395305|NCT03923959|564538341|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
156395306|NCT03923959|564538342|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
156395307|NCT05711641|564538343|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
156395308|NCT05711641|564538344|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
156395309|NCT05711641|564538343|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
156395310|NCT05711641|564538344|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
156395311|NCT03574597|564538345|FG000|Overall Study|Withdrawal by Subject|67|||
156395312|NCT03574597|564538346|FG001|Overall Study|Withdrawal by Subject|96|||
156395313|NCT03574597|564538345|FG000|Overall Study|Lost to Follow-up|192|||
156395314|NCT03574597|564538346|FG001|Overall Study|Lost to Follow-up|188|||
156395315|NCT04040751|564538347|FG000|Overall Study|Withdrawal by Subject|2|||
156395316|NCT04040751|564538348|FG001|Overall Study|Withdrawal by Subject|0|||
156395317|NCT04040751|564538349|FG002|Overall Study|Withdrawal by Subject|2|||
156395318|NCT04040751|564538350|FG003|Overall Study|Withdrawal by Subject|0|||
156395319|NCT03624504|564538351|FG000|Overall Study|Unsuccessful Implant|1|||
156395320|NCT03364751|564538352|FG000|Overall Study|Withdrawal by Subject|1|||
156395321|NCT03364751|564538353|FG001|Overall Study|Withdrawal by Subject|0|||
156395322|NCT03364751|564538354|FG002|Overall Study|Withdrawal by Subject|0|||
156395323|NCT03364751|564538355|FG003|Overall Study|Withdrawal by Subject|0|||
156395324|NCT03364751|564538352|FG000|Overall Study|Lost to Follow-up|0|||
156395325|NCT03364751|564538353|FG001|Overall Study|Lost to Follow-up|1|||
156395326|NCT03364751|564538354|FG002|Overall Study|Lost to Follow-up|0|||
156395327|NCT03364751|564538355|FG003|Overall Study|Lost to Follow-up|0|||
156395328|NCT04542018|564538357|FG000|Overall Study|Withdrawal by Subject|0|||
156395329|NCT04542018|564538358|FG001|Overall Study|Withdrawal by Subject|0|||
156395330|NCT04542018|564538359|FG002|Overall Study|Withdrawal by Subject|4|||
156395331|NCT04542018|564538357|FG000|Overall Study|Protocol Violation|0|||
156395332|NCT04542018|564538358|FG001|Overall Study|Protocol Violation|0|||
156395333|NCT04542018|564538359|FG002|Overall Study|Protocol Violation|2|||
156395334|NCT01596582|564538366|FG000|Overall Study|Deemed ineligible after study visit|3|||
156395335|NCT01596582|564538367|FG001|Overall Study|Deemed ineligible after study visit|6|||
156395336|NCT01596582|564538366|FG000|Overall Study|Missing all outcome data|1|||
156395337|NCT01596582|564538367|FG001|Overall Study|Missing all outcome data|1|||
156395338|NCT01667432|564538370|FG000|Overall Study|Premature Study Termination|26|||
156395339|NCT01667432|564538370|FG000|Overall Study|Failure to Return|10|||
156395340|NCT01667432|564538370|FG000|Overall Study|Moved to Another Center|3|||
156395341|NCT01667432|564538370|FG000|Overall Study|Lost to Follow-up|3|||
156395342|NCT01667432|564538370|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
156395343|NCT01667432|564538370|FG000|Overall Study|Insufficient Therapeutic Response|4|||
156395344|NCT01667432|564538370|FG000|Overall Study|Adverse Event|1|||
156395345|NCT01667432|564538370|FG000|Overall Study|Protocol Deviation|2|||
156395346|NCT01667432|564538370|FG000|Overall Study|Principal Investigator Decision|1|||
156395347|NCT01667432|564538370|FG000|Overall Study|Reason Not Specified|2|||
156395348|NCT01667432|564538370|FG000|Overall Study|Missing Information|4|||
156395349|NCT00553696|564538371|FG000|Overall Study|Adverse Event|2|||
156395350|NCT00553696|564538372|FG001|Overall Study|Adverse Event|4|||
156395351|NCT00553696|564538373|FG002|Overall Study|Adverse Event|0|||
156395352|NCT00553696|564538374|FG003|Overall Study|Adverse Event|1|||
156395353|NCT00553696|564538371|FG000|Overall Study|Global deterioration of health status|0|||
156395354|NCT00553696|564538372|FG001|Overall Study|Global deterioration of health status|2|||
156395355|NCT00553696|564538373|FG002|Overall Study|Global deterioration of health status|0|||
156395356|NCT00553696|564538374|FG003|Overall Study|Global deterioration of health status|0|||
156395357|NCT00553696|564538371|FG000|Overall Study|Objective progression or relapse|2|||
156395358|NCT00553696|564538372|FG001|Overall Study|Objective progression or relapse|9|||
156395359|NCT00553696|564538373|FG002|Overall Study|Objective progression or relapse|6|||
156395360|NCT00553696|564538374|FG003|Overall Study|Objective progression or relapse|0|||
156395361|NCT00553696|564538371|FG000|Overall Study|Withdrawal by Subject|0|||
156395362|NCT00553696|564538372|FG001|Overall Study|Withdrawal by Subject|1|||
156395363|NCT00553696|564538373|FG002|Overall Study|Withdrawal by Subject|0|||
156395364|NCT00553696|564538374|FG003|Overall Study|Withdrawal by Subject|0|||
156395365|NCT00671931|564538375|FG000|Overall Study|Physician Decision|1|||
156395366|NCT00671931|564538376|FG001|Overall Study|Physician Decision|0|||
156395367|NCT00671931|564538377|FG002|Overall Study|Physician Decision|0|||
156395368|NCT00671931|564538378|FG003|Overall Study|Physician Decision|2|||
156395369|NCT00671931|564538379|FG004|Overall Study|Physician Decision|1|||
156395370|NCT02925676|564538380|FG000|Overall Study|Withdrawal by Subject|1|||
156395371|NCT00981084|564538381|FG000|Post Intervention (Data Analysis)|poor effort|1|||
156395372|NCT00981084|564538382|FG001|Post Intervention (Data Analysis)|poor effort|1|||
156395373|NCT00981084|564538381|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
156395374|NCT00981084|564538382|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
156395375|NCT00902694|564538383|FG000|Overall Study|Death|1|||
156395376|NCT00902694|564538384|FG001|Overall Study|Death|3|||
156395377|NCT00902694|564538383|FG000|Overall Study|Lost to Follow-up|1|||
156395378|NCT00902694|564538384|FG001|Overall Study|Lost to Follow-up|0|||
156395379|NCT00902694|564538383|FG000|Overall Study|Censored per protocol|3|||
156395380|NCT00902694|564538384|FG001|Overall Study|Censored per protocol|1|||
156395381|NCT00902694|564538383|FG000|Overall Study|Pregnancy|1|||
156395382|NCT00902694|564538384|FG001|Overall Study|Pregnancy|1|||
156395383|NCT00902694|564538383|FG000|Overall Study|Incarceration|1|||
156395384|NCT00902694|564538384|FG001|Overall Study|Incarceration|0|||
156395385|NCT04969263|564538385|FG000|Overall Study|Death|1|||
156395386|NCT04969263|564538385|FG000|Overall Study|Lost to Follow-up|2|||
156395387|NCT04969263|564538385|FG000|Overall Study|Withdrawal by Subject|5|||
156395388|NCT04969263|564538385|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
156395389|NCT00725296|564538386|FG000|Overall Study|Adverse Event|11|||
156395390|NCT00725296|564538386|FG000|Overall Study|Lack of Efficacy|7|||
156395391|NCT00725296|564538386|FG000|Overall Study|Withdrawal by Subject|3|||
156395392|NCT00725296|564538386|FG000|Overall Study|Non-Compliance|2|||
156395393|NCT00725296|564538386|FG000|Overall Study|Lost to Follow-up|1|||
156395394|NCT00725296|564538386|FG000|Overall Study|Other|38|||
156395395|NCT03360942|564538387|FG000|Overall Study|Device explanted|2|||
156395396|NCT03360942|564538387|FG000|Overall Study|Study closure|1|||
156395397|NCT03360942|564538387|FG000|Overall Study|Withdrawal by Subject|2|||
156395398|NCT03456700|564538388|FG000|Overall Study|Withdrawal by Subject|1|||
156395399|NCT04154787|564538389|FG000|Overall Study|Adverse Event|0|||
156395400|NCT04154787|564538390|FG001|Overall Study|Adverse Event|1|||
156395401|NCT04154787|564538391|FG002|Overall Study|Adverse Event|0|||
156395402|NCT04154787|564538389|FG000|Overall Study|Patient Requires Other Treatment|0|||
156395403|NCT04154787|564538390|FG001|Overall Study|Patient Requires Other Treatment|1|||
156395404|NCT04154787|564538391|FG002|Overall Study|Patient Requires Other Treatment|0|||
156395405|NCT04154787|564538389|FG000|Overall Study|Study Terminated By Sponsor|0|||
156395406|NCT04154787|564538390|FG001|Overall Study|Study Terminated By Sponsor|6|||
156395407|NCT04154787|564538391|FG002|Overall Study|Study Terminated By Sponsor|1|||
156395408|NCT04154787|564538389|FG000|Overall Study|Subject Decision|0|||
156395409|NCT04154787|564538390|FG001|Overall Study|Subject Decision|1|||
156395410|NCT04154787|564538391|FG002|Overall Study|Subject Decision|0|||
156395411|NCT04154787|564538389|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
156395412|NCT04154787|564538390|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
156395413|NCT04154787|564538391|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
156395414|NCT00613951|564538395|FG000|Overall Study|Adverse Event|1|||
156395415|NCT00613951|564538396|FG001|Overall Study|Adverse Event|0|||
156395416|NCT00613951|564538397|FG002|Overall Study|Adverse Event|1|||
156395417|NCT00613951|564538395|FG000|Overall Study|Lack of Efficacy|0|||
156395418|NCT00613951|564538396|FG001|Overall Study|Lack of Efficacy|1|||
156395419|NCT00613951|564538397|FG002|Overall Study|Lack of Efficacy|1|||
156395420|NCT00613951|564538395|FG000|Overall Study|Protocol Violation|1|||
156395421|NCT00613951|564538396|FG001|Overall Study|Protocol Violation|1|||
156395422|NCT00613951|564538397|FG002|Overall Study|Protocol Violation|1|||
156395423|NCT00613951|564538395|FG000|Overall Study|Unclassified|5|||
156395424|NCT00613951|564538396|FG001|Overall Study|Unclassified|3|||
156395425|NCT00613951|564538397|FG002|Overall Study|Unclassified|2|||
156395426|NCT03053050|564538398|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
156395427|NCT03053050|564538399|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
156395428|NCT03053050|564538400|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
156395429|NCT03053050|564538401|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
156395430|NCT03053050|564538398|FG000|Randomized Phase|Withdrew Consent|16|||
156395431|NCT03053050|564538399|FG001|Randomized Phase|Withdrew Consent|8|||
156395432|NCT03053050|564538400|FG002|Randomized Phase|Withdrew Consent|9|||
156395433|NCT03053050|564538401|FG003|Randomized Phase|Withdrew Consent|0|||
156395434|NCT03053050|564538398|FG000|Randomized Phase|Investigator's Discretion|6|||
156395435|NCT03053050|564538399|FG001|Randomized Phase|Investigator's Discretion|6|||
156395436|NCT03053050|564538400|FG002|Randomized Phase|Investigator's Discretion|3|||
156395437|NCT03053050|564538401|FG003|Randomized Phase|Investigator's Discretion|0|||
156395438|NCT03053050|564538398|FG000|Randomized Phase|Lost to Follow-up|5|||
156395439|NCT03053050|564538399|FG001|Randomized Phase|Lost to Follow-up|1|||
156395440|NCT03053050|564538400|FG002|Randomized Phase|Lost to Follow-up|1|||
156395441|NCT03053050|564538401|FG003|Randomized Phase|Lost to Follow-up|0|||
156395442|NCT03053050|564538398|FG000|Randomized Phase|Adverse Event|0|||
156395443|NCT03053050|564538399|FG001|Randomized Phase|Adverse Event|1|||
156395444|NCT03053050|564538400|FG002|Randomized Phase|Adverse Event|0|||
156395445|NCT03053050|564538401|FG003|Randomized Phase|Adverse Event|0|||
156395446|NCT03053050|564538398|FG000|Randomized Phase|Randomized but Never Treated|2|||
156395447|NCT03053050|564538399|FG001|Randomized Phase|Randomized but Never Treated|2|||
156395448|NCT03053050|564538400|FG002|Randomized Phase|Randomized but Never Treated|2|||
156395449|NCT03053050|564538401|FG003|Randomized Phase|Randomized but Never Treated|0|||
156395450|NCT03053050|564538398|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
156395451|NCT03053050|564538399|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
156395452|NCT03053050|564538400|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
156395453|NCT03053050|564538401|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
156395454|NCT03053050|564538398|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
156395455|NCT03053050|564538399|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
156395456|NCT03053050|564538400|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
156395457|NCT03053050|564538401|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
156395458|NCT03053050|564538398|FG000|Open-label Phase|Withdrew Consent|0|||
156395459|NCT03053050|564538399|FG001|Open-label Phase|Withdrew Consent|0|||
156395460|NCT03053050|564538400|FG002|Open-label Phase|Withdrew Consent|0|||
156395461|NCT03053050|564538401|FG003|Open-label Phase|Withdrew Consent|6|||
156395462|NCT03053050|564538398|FG000|Open-label Phase|Investigator's Discretion|0|||
156395463|NCT03053050|564538399|FG001|Open-label Phase|Investigator's Discretion|0|||
156395464|NCT03053050|564538400|FG002|Open-label Phase|Investigator's Discretion|0|||
156395465|NCT03053050|564538401|FG003|Open-label Phase|Investigator's Discretion|4|||
156395466|NCT00655980|564538402|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
156395467|NCT00655980|564538403|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
156395468|NCT00655980|564538404|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
156395469|NCT05540522|564538405|FG000|Overall Study|Adverse Event|1|||
156395470|NCT05540522|564538406|FG001|Overall Study|Adverse Event|0|||
156395471|NCT05540522|564538407|FG002|Overall Study|Adverse Event|2|||
156395472|NCT05540522|564538408|FG003|Overall Study|Adverse Event|5|||
156395473|NCT05540522|564538405|FG000|Overall Study|Lost to Follow-up|487|||
156395474|NCT05540522|564538406|FG001|Overall Study|Lost to Follow-up|427|||
156395475|NCT05540522|564538407|FG002|Overall Study|Lost to Follow-up|146|||
156395476|NCT05540522|564538408|FG003|Overall Study|Lost to Follow-up|166|||
156395477|NCT05540522|564538405|FG000|Overall Study|Physician Decision|11|||
156395478|NCT05540522|564538406|FG001|Overall Study|Physician Decision|19|||
156395479|NCT05540522|564538407|FG002|Overall Study|Physician Decision|8|||
156395480|NCT05540522|564538408|FG003|Overall Study|Physician Decision|13|||
156395481|NCT05540522|564538405|FG000|Overall Study|Pregnancy|1|||
156395482|NCT05540522|564538406|FG001|Overall Study|Pregnancy|0|||
156395483|NCT05540522|564538407|FG002|Overall Study|Pregnancy|0|||
156395484|NCT05540522|564538408|FG003|Overall Study|Pregnancy|0|||
156395485|NCT05540522|564538405|FG000|Overall Study|Protocol Violation|3|||
156395486|NCT05540522|564538406|FG001|Overall Study|Protocol Violation|1|||
156395487|NCT05540522|564538407|FG002|Overall Study|Protocol Violation|9|||
156395488|NCT05540522|564538408|FG003|Overall Study|Protocol Violation|7|||
156395489|NCT05540522|564538405|FG000|Overall Study|Withdrawal by Subject|168|||
156395490|NCT05540522|564538406|FG001|Overall Study|Withdrawal by Subject|134|||
156395491|NCT05540522|564538407|FG002|Overall Study|Withdrawal by Subject|331|||
156395492|NCT05540522|564538408|FG003|Overall Study|Withdrawal by Subject|322|||
156395493|NCT05540522|564538405|FG000|Overall Study|Death|7|||
156395494|NCT05540522|564538406|FG001|Overall Study|Death|9|||
156395495|NCT05540522|564538407|FG002|Overall Study|Death|49|||
156395496|NCT05540522|564538408|FG003|Overall Study|Death|46|||
156395497|NCT05540522|564538405|FG000|Overall Study|Not vaccinated|34|||
156395498|NCT05540522|564538406|FG001|Overall Study|Not vaccinated|53|||
156395499|NCT05540522|564538407|FG002|Overall Study|Not vaccinated|57|||
156395500|NCT05540522|564538408|FG003|Overall Study|Not vaccinated|50|||
156395501|NCT05540522|564538405|FG000|Overall Study|No longer meets eligibility criteria|0|||
156395502|NCT05540522|564538406|FG001|Overall Study|No longer meets eligibility criteria|0|||
156395503|NCT05540522|564538407|FG002|Overall Study|No longer meets eligibility criteria|3|||
156395504|NCT05540522|564538408|FG003|Overall Study|No longer meets eligibility criteria|2|||
156508827|NCT01495598|564955544|FG000|Overall Study|Physician Decision|8|||
156395505|NCT05540522|564538405|FG000|Overall Study|Other (Unspecified)|8|||
156395506|NCT05540522|564538406|FG001|Overall Study|Other (Unspecified)|10|||
156395507|NCT05540522|564538407|FG002|Overall Study|Other (Unspecified)|4|||
156395508|NCT05540522|564538408|FG003|Overall Study|Other (Unspecified)|2|||
156395509|NCT00506493|564538412|FG000|Overall Study|Death|6|||
156395510|NCT00506493|564538412|FG000|Overall Study|Withdrawal by Subject|5|||
156395511|NCT01266642|564538413|FG000|Overall Study|Protocol Violation|0|||
156395512|NCT01266642|564538414|FG001|Overall Study|Protocol Violation|1|||
156395513|NCT02543658|564539785|FG000|Overall Study|Lack of Efficacy|0|||
156395514|NCT02543658|564539786|FG001|Overall Study|Lack of Efficacy|4|||
156395515|NCT00789815|564539787|FG000|Overall Study|Protocol Violation|6|||
156395516|NCT00789815|564539788|FG001|Overall Study|Protocol Violation|1|||
156395517|NCT00789815|564539787|FG000|Overall Study|Intubation due to massive bleeding|1|||
156395518|NCT00789815|564539788|FG001|Overall Study|Intubation due to massive bleeding|0|||
156395519|NCT01553318|564539796|FG000|Overall Study|Protocol Violation|3|||
156395520|NCT01553318|564539797|FG001|Overall Study|Protocol Violation|2|||
156395521|NCT01787097|564539799|FG000|Overall Study|Withdrawal by Subject|1|||
156395522|NCT01787097|564539800|FG001|Overall Study|Withdrawal by Subject|0|||
156395523|NCT01787097|564539801|FG002|Overall Study|Withdrawal by Subject|0|||
156395524|NCT01787097|564539802|FG003|Overall Study|Withdrawal by Subject|0|||
156395525|NCT02127372|564539807|FG000|Overall Study|Withdrawal by Subject|1|||
156395526|NCT02127372|564539808|FG001|Overall Study|Withdrawal by Subject|0|||
156395527|NCT02173548|564539809|FG000|Overall Study|Lost to Follow-up|0|||
156395528|NCT02173548|564539810|FG001|Overall Study|Lost to Follow-up|2|||
156395529|NCT02173548|564539809|FG000|Overall Study|Withdrawal by Subject|1|||
156395530|NCT02173548|564539810|FG001|Overall Study|Withdrawal by Subject|0|||
156395531|NCT03597568|564539811|FG000|Overall Study|Withdrawal by Subject|1|||
156395532|NCT03597568|564539812|FG001|Overall Study|Withdrawal by Subject|1|||
156395533|NCT03597568|564539811|FG000|Overall Study|Unable to analyze vascular data|1|||
156395534|NCT03597568|564539812|FG001|Overall Study|Unable to analyze vascular data|1|||
156395535|NCT03822117|564539815|FG000|Overall Study|Death|18|||
156395536|NCT03822117|564539816|FG001|Overall Study|Death|17|||
156395537|NCT03822117|564539817|FG002|Overall Study|Death|12|||
156395538|NCT03822117|564539818|FG003|Overall Study|Death|4|||
156395539|NCT03822117|564539815|FG000|Overall Study|Lost to Follow-up|1|||
156395540|NCT03822117|564539816|FG001|Overall Study|Lost to Follow-up|2|||
156395541|NCT03822117|564539817|FG002|Overall Study|Lost to Follow-up|3|||
156395542|NCT03822117|564539818|FG003|Overall Study|Lost to Follow-up|0|||
156395543|NCT03822117|564539815|FG000|Overall Study|Study Terminated by Sponsor|25|||
156395544|NCT03822117|564539816|FG001|Overall Study|Study Terminated by Sponsor|11|||
156395545|NCT03822117|564539817|FG002|Overall Study|Study Terminated by Sponsor|6|||
156395546|NCT03822117|564539818|FG003|Overall Study|Study Terminated by Sponsor|0|||
156395547|NCT03822117|564539815|FG000|Overall Study|Withdrawal by Subject|4|||
156395548|NCT03822117|564539816|FG001|Overall Study|Withdrawal by Subject|0|||
156395549|NCT03822117|564539817|FG002|Overall Study|Withdrawal by Subject|3|||
156395550|NCT03822117|564539818|FG003|Overall Study|Withdrawal by Subject|0|||
156395551|NCT03822117|564539815|FG000|Overall Study|Disease Progression|1|||
156395552|NCT03822117|564539816|FG001|Overall Study|Disease Progression|2|||
156395553|NCT03822117|564539817|FG002|Overall Study|Disease Progression|1|||
156395554|NCT03822117|564539818|FG003|Overall Study|Disease Progression|0|||
156395555|NCT03822117|564539815|FG000|Overall Study|Never Returned to Hospital|0|||
156395556|NCT03822117|564539816|FG001|Overall Study|Never Returned to Hospital|0|||
156395557|NCT03822117|564539817|FG002|Overall Study|Never Returned to Hospital|1|||
156395558|NCT03822117|564539818|FG003|Overall Study|Never Returned to Hospital|0|||
156395559|NCT00999466|564539823|FG000|Main Part|Withdrawal by Subject|0|||
156395560|NCT00999466|564539824|FG001|Main Part|Withdrawal by Subject|0|||
156395561|NCT00999466|564539825|FG002|Main Part|Withdrawal by Subject|2|||
156395562|NCT00999466|564539823|FG000|Main Part|Adverse Event|0|||
156395563|NCT00999466|564539824|FG001|Main Part|Adverse Event|4|||
156395564|NCT00999466|564539825|FG002|Main Part|Adverse Event|2|||
156395565|NCT01357616|564539826|FG000|Overall Study|Adverse Event|1|||
156395566|NCT01357616|564539827|FG001|Overall Study|Adverse Event|1|||
156395567|NCT01357616|564539826|FG000|Overall Study|Lost to Follow-up|4|||
156395568|NCT01357616|564539827|FG001|Overall Study|Lost to Follow-up|3|||
156395569|NCT01357616|564539826|FG000|Overall Study|Protocol Violation|0|||
156395570|NCT01357616|564539827|FG001|Overall Study|Protocol Violation|2|||
156395571|NCT01357616|564539826|FG000|Overall Study|Inadequate Control of IOP|1|||
156395572|NCT01357616|564539827|FG001|Overall Study|Inadequate Control of IOP|2|||
156395573|NCT01357616|564539826|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
156395574|NCT01357616|564539827|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
156395575|NCT01357616|564539826|FG000|Overall Study|Withdrawal by Subject|1|||
156395576|NCT01357616|564539827|FG001|Overall Study|Withdrawal by Subject|0|||
156395577|NCT05131165|564539829|FG000|Overall Study|Death|1|||
156395578|NCT05131165|564539830|FG001|Overall Study|Death|1|||
156395579|NCT05131165|564539831|FG002|Overall Study|Death|0|||
156395580|NCT05131165|564539829|FG000|Overall Study|Lost to Follow-up|2|||
156395581|NCT05131165|564539830|FG001|Overall Study|Lost to Follow-up|2|||
156395582|NCT05131165|564539831|FG002|Overall Study|Lost to Follow-up|5|||
156395583|NCT05131165|564539829|FG000|Overall Study|Transferred out of clinic|1|||
156395584|NCT05131165|564539830|FG001|Overall Study|Transferred out of clinic|0|||
156395585|NCT05131165|564539831|FG002|Overall Study|Transferred out of clinic|3|||
156395586|NCT05131165|564539829|FG000|Overall Study|Dropped out|1|||
156395587|NCT05131165|564539830|FG001|Overall Study|Dropped out|2|||
156395588|NCT05131165|564539831|FG002|Overall Study|Dropped out|0|||
156395589|NCT00430248|564539840|FG000|Overall Study|Adverse Event|49|||
156395590|NCT00430248|564539841|FG001|Overall Study|Adverse Event|61|||
156395591|NCT00430248|564539842|FG002|Overall Study|Adverse Event|64|||
156395592|NCT00430248|564539840|FG000|Overall Study|Protocol Violation|10|||
156395593|NCT00430248|564539841|FG001|Overall Study|Protocol Violation|2|||
156395594|NCT00430248|564539842|FG002|Overall Study|Protocol Violation|4|||
156395595|NCT00430248|564539840|FG000|Overall Study|Personal Reasons|12|||
156395596|NCT00430248|564539841|FG001|Overall Study|Personal Reasons|24|||
156395597|NCT00430248|564539842|FG002|Overall Study|Personal Reasons|9|||
156395598|NCT00430248|564539840|FG000|Overall Study|Lost to Follow-up|28|||
156395599|NCT00430248|564539841|FG001|Overall Study|Lost to Follow-up|33|||
156395600|NCT00430248|564539842|FG002|Overall Study|Lost to Follow-up|28|||
156395601|NCT00430248|564539840|FG000|Overall Study|Therapeutic Failure|1|||
156395602|NCT00430248|564539841|FG001|Overall Study|Therapeutic Failure|1|||
156395603|NCT00430248|564539842|FG002|Overall Study|Therapeutic Failure|1|||
156395604|NCT00430248|564539840|FG000|Overall Study|Withdrawal by Subject|14|||
156395605|NCT00430248|564539841|FG001|Overall Study|Withdrawal by Subject|20|||
156395606|NCT00430248|564539842|FG002|Overall Study|Withdrawal by Subject|16|||
156395607|NCT00430248|564539840|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156395608|NCT00430248|564539841|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
156395609|NCT00430248|564539842|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156395610|NCT00430248|564539840|FG000|Overall Study|Gout Flare|3|||
156395611|NCT00430248|564539841|FG001|Overall Study|Gout Flare|7|||
156395612|NCT00430248|564539842|FG002|Overall Study|Gout Flare|2|||
156395613|NCT00430248|564539840|FG000|Overall Study|Reason Not Specified|8|||
156395614|NCT00430248|564539841|FG001|Overall Study|Reason Not Specified|8|||
156395615|NCT00430248|564539842|FG002|Overall Study|Reason Not Specified|11|||
156395616|NCT02230956|564539843|FG000|Overall Study|Adverse Event|1|||
156395617|NCT02230956|564539844|FG001|Overall Study|Adverse Event|1|||
156395618|NCT02230956|564539845|FG002|Overall Study|Adverse Event|0|||
156395619|NCT02230956|564539843|FG000|Overall Study|Lack of Efficacy|1|||
156508828|NCT03083665|564955545|FG000|Double-Blind Period|Adverse Event|5|||
156508829|NCT03083665|564955546|FG001|Double-Blind Period|Adverse Event|4|||
156508830|NCT03083665|564955547|FG002|Double-Blind Period|Adverse Event|5|||
156508831|NCT03083665|564955548|FG003|Double-Blind Period|Adverse Event|0|||
156508832|NCT03083665|564955549|FG004|Double-Blind Period|Adverse Event|0|||
156508833|NCT03083665|564955550|FG005|Double-Blind Period|Adverse Event|0|||
156508834|NCT03083665|564955545|FG000|Double-Blind Period|Lack of Efficacy|0|||
156508835|NCT03083665|564955546|FG001|Double-Blind Period|Lack of Efficacy|0|||
156508836|NCT03083665|564955547|FG002|Double-Blind Period|Lack of Efficacy|1|||
156508837|NCT03083665|564955548|FG003|Double-Blind Period|Lack of Efficacy|0|||
156508838|NCT03083665|564955549|FG004|Double-Blind Period|Lack of Efficacy|0|||
156508839|NCT03083665|564955550|FG005|Double-Blind Period|Lack of Efficacy|0|||
156508840|NCT03083665|564955545|FG000|Double-Blind Period|Protocol Violation|1|||
156508841|NCT03083665|564955546|FG001|Double-Blind Period|Protocol Violation|0|||
156508842|NCT03083665|564955547|FG002|Double-Blind Period|Protocol Violation|1|||
156508843|NCT03083665|564955548|FG003|Double-Blind Period|Protocol Violation|0|||
156508844|NCT03083665|564955549|FG004|Double-Blind Period|Protocol Violation|0|||
156508845|NCT03083665|564955550|FG005|Double-Blind Period|Protocol Violation|0|||
156508846|NCT03083665|564955545|FG000|Double-Blind Period|Lost to Follow-up|1|||
156508847|NCT03083665|564955546|FG001|Double-Blind Period|Lost to Follow-up|0|||
156508848|NCT03083665|564955547|FG002|Double-Blind Period|Lost to Follow-up|1|||
156508849|NCT03083665|564955548|FG003|Double-Blind Period|Lost to Follow-up|0|||
156508850|NCT03083665|564955549|FG004|Double-Blind Period|Lost to Follow-up|0|||
156508851|NCT03083665|564955550|FG005|Double-Blind Period|Lost to Follow-up|0|||
156508852|NCT03083665|564955545|FG000|Double-Blind Period|Withdrawal by Subject|3|||
156508853|NCT03083665|564955546|FG001|Double-Blind Period|Withdrawal by Subject|0|||
156508854|NCT03083665|564955547|FG002|Double-Blind Period|Withdrawal by Subject|0|||
156508855|NCT03083665|564955548|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156508856|NCT03083665|564955549|FG004|Double-Blind Period|Withdrawal by Subject|0|||
156508857|NCT03083665|564955550|FG005|Double-Blind Period|Withdrawal by Subject|0|||
156508858|NCT03083665|564955545|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
156508859|NCT03083665|564955546|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
156508860|NCT03083665|564955547|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
156508861|NCT03083665|564955548|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
156508862|NCT03083665|564955549|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
156508863|NCT03083665|564955550|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
156508864|NCT03083665|564955545|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
156395620|NCT02230956|564539844|FG001|Overall Study|Lack of Efficacy|1|||
156395621|NCT02230956|564539845|FG002|Overall Study|Lack of Efficacy|1|||
156395622|NCT02230956|564539843|FG000|Overall Study|Lost to Follow-up|1|||
156395623|NCT02230956|564539844|FG001|Overall Study|Lost to Follow-up|1|||
156395624|NCT02230956|564539845|FG002|Overall Study|Lost to Follow-up|2|||
156395625|NCT02230956|564539843|FG000|Overall Study|Personal Reasons|2|||
156395626|NCT02230956|564539844|FG001|Overall Study|Personal Reasons|1|||
156395627|NCT02230956|564539845|FG002|Overall Study|Personal Reasons|1|||
156395628|NCT02230956|564539843|FG000|Overall Study|Protocol Violation|0|||
156395629|NCT02230956|564539844|FG001|Overall Study|Protocol Violation|1|||
156395630|NCT02230956|564539845|FG002|Overall Study|Protocol Violation|1|||
156395631|NCT02230956|564539843|FG000|Overall Study|Other Miscellaneous Reason|0|||
156395632|NCT02230956|564539844|FG001|Overall Study|Other Miscellaneous Reason|1|||
156395633|NCT02230956|564539845|FG002|Overall Study|Other Miscellaneous Reason|2|||
156395634|NCT00117676|564539848|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
156395635|NCT00117676|564539849|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
156395636|NCT00117676|564539848|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
156395637|NCT00117676|564539849|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
156395638|NCT00117676|564539848|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
156395639|NCT00117676|564539849|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
156395640|NCT00117676|564539848|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
156395641|NCT00117676|564539849|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
156395642|NCT00117676|564539848|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
156395643|NCT00117676|564539849|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
156395644|NCT00117676|564539848|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
156395645|NCT00117676|564539849|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
156395646|NCT00117676|564539848|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
156395647|NCT00117676|564539849|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
156395648|NCT00117676|564539848|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
156549039|NCT02111564|565102473|FG001|Overall Study|Withdrawal by Subject|20|||
156549040|NCT01268293|565102474|FG000|Overall Study|Disease progression|7|||
156549041|NCT01268293|565102474|FG000|Overall Study|Adverse Event|1|||
156549042|NCT01268293|565102474|FG000|Overall Study|Subject choice|1|||
156549043|NCT00925015|565102475|FG000|Overall Study|Adverse Event|1|||
156549044|NCT00925015|565102476|FG001|Overall Study|Adverse Event|2|||
156549045|NCT00925015|565102477|FG002|Overall Study|Adverse Event|1|||
156549046|NCT00925015|565102475|FG000|Overall Study|Physician Decision|0|||
156549047|NCT00925015|565102476|FG001|Overall Study|Physician Decision|1|||
156549048|NCT00925015|565102477|FG002|Overall Study|Physician Decision|0|||
156549049|NCT00925015|565102475|FG000|Overall Study|Progressive Disease|7|||
156549050|NCT00925015|565102476|FG001|Overall Study|Progressive Disease|3|||
156549051|NCT00925015|565102477|FG002|Overall Study|Progressive Disease|4|||
156395649|NCT00117676|564539849|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
156395650|NCT00117676|564539848|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
156395651|NCT00117676|564539849|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
156395652|NCT00117676|564539848|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
156395653|NCT00117676|564539849|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
156395654|NCT00117676|564539848|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
156395655|NCT00117676|564539849|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
156395656|NCT00117676|564539848|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
156395657|NCT00117676|564539849|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
156395658|NCT00117676|564539848|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
156395659|NCT00117676|564539849|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
156395660|NCT00117676|564539848|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
156395661|NCT00117676|564539849|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
156395662|NCT00117676|564539848|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
156395663|NCT00117676|564539849|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
156395664|NCT00117676|564539848|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
156395665|NCT00117676|564539849|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
156395666|NCT00117676|564539848|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
156549052|NCT00925015|565102475|FG000|Overall Study|Withdrawal by Subject|0|||
156395667|NCT00117676|564539849|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
156395668|NCT00117676|564539848|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
156549053|NCT00925015|565102476|FG001|Overall Study|Withdrawal by Subject|0|||
156549054|NCT00925015|565102477|FG002|Overall Study|Withdrawal by Subject|1|||
156395669|NCT00117676|564539849|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
156395670|NCT00117676|564539848|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
156395671|NCT00117676|564539849|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
156549055|NCT04986202|565102480|FG000|Overall Study|Death|10|||
156549056|NCT04986202|565102481|FG001|Overall Study|Death|3|||
156549057|NCT04986202|565102482|FG002|Overall Study|Death|10|||
156549058|NCT04986202|565102480|FG000|Overall Study|Physician Decision|3|||
156395672|NCT00117676|564539848|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
156395673|NCT00117676|564539849|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
156395674|NCT00117676|564539848|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
156395675|NCT00117676|564539849|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
156395676|NCT00117676|564539848|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
156395677|NCT00117676|564539849|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
156395678|NCT00117676|564539848|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
156395679|NCT00117676|564539849|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
156395680|NCT00117676|564539848|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
156395681|NCT00117676|564539849|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
156395682|NCT00117676|564539848|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
156395683|NCT00117676|564539849|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
156395684|NCT00117676|564539848|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
156395685|NCT00117676|564539849|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
156395686|NCT00117676|564539848|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
156395687|NCT00117676|564539849|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
156395688|NCT00117676|564539848|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
156395689|NCT00117676|564539849|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
156395690|NCT00117676|564539848|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
156395691|NCT00117676|564539849|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
156395692|NCT00117676|564539848|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
156395693|NCT00117676|564539849|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
156395694|NCT00117676|564539848|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
156395695|NCT00117676|564539849|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
156395696|NCT00117676|564539848|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
156395697|NCT00117676|564539849|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
156395698|NCT00117676|564539848|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
156395699|NCT00117676|564539849|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
156395700|NCT00117676|564539848|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
156395701|NCT00117676|564539849|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
156395702|NCT00117676|564539848|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
156395703|NCT00117676|564539849|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
156395704|NCT00952822|564539850|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
156395705|NCT00952822|564539851|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
156395706|NCT00952822|564539852|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
156395707|NCT00952822|564539853|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
156395708|NCT00952822|564539850|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
156395709|NCT00952822|564539851|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
156395710|NCT00952822|564539852|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
156395711|NCT00952822|564539853|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
156395712|NCT01362439|564539855|FG000|Overall Study|Adverse Event|1|||
156395713|NCT01362439|564539855|FG000|Overall Study|Lack of Efficacy|3|||
156395714|NCT01362439|564539855|FG000|Overall Study|Lost to Follow-up|2|||
156395715|NCT01362439|564539855|FG000|Overall Study|Study medication non-compliant|1|||
156395716|NCT01362439|564539855|FG000|Overall Study|Participant who withdrew consent|8|||
156395717|NCT02355743|564539856|FG000|Overall Study|Withdrawal by Subject|1|||
156395718|NCT02355743|564539856|FG000|Overall Study|Lost to Follow-up|1|||
156395719|NCT03583554|564539857|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
156395720|NCT03583554|564539858|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
156395721|NCT03583554|564539859|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
156395722|NCT01428076|564539860|FG000|Overall Study|Adverse Event|0|||
156395723|NCT01428076|564539861|FG001|Overall Study|Adverse Event|1|||
156395724|NCT00262821|564539862|FG000|Overall Study|Ineligible - wrong stage|0|||
156395725|NCT00262821|564539863|FG001|Overall Study|Ineligible - wrong stage|3|||
156395726|NCT00262821|564539862|FG000|Overall Study|Ineligible - wrong cell type|2|||
156395727|NCT00262821|564539863|FG001|Overall Study|Ineligible - wrong cell type|2|||
156395728|NCT00262821|564539862|FG000|Overall Study|Ineligible - wrong primary|0|||
156395729|NCT00262821|564539863|FG001|Overall Study|Ineligible - wrong primary|1|||
156395730|NCT00262821|564539862|FG000|Overall Study|Ineligible - inadequate pathology|1|||
156395731|NCT00262821|564539863|FG001|Overall Study|Ineligible - inadequate pathology|3|||
156395732|NCT00262821|564539862|FG000|Overall Study|Ineligible - elevated creatinine|0|||
156395733|NCT00262821|564539863|FG001|Overall Study|Ineligible - elevated creatinine|2|||
156395734|NCT00262821|564539862|FG000|Overall Study|Ineligible - required test not done|1|||
156395735|NCT00262821|564539863|FG001|Overall Study|Ineligible - required test not done|4|||
156395736|NCT00262821|564539862|FG000|Overall Study|Inevaluable - inadequate data|0|||
156395737|NCT00262821|564539863|FG001|Overall Study|Inevaluable - inadequate data|4|||
156549059|NCT04986202|565102481|FG001|Overall Study|Physician Decision|1|||
156395738|NCT00765388|564539864|FG000|Period 1|Lack of Efficacy|1|||
156395739|NCT00765388|564539865|FG001|Period 1|Lack of Efficacy|2|||
156395740|NCT00765388|564539864|FG000|Period 1|Lost to Follow-up|0|||
156395741|NCT00765388|564539865|FG001|Period 1|Lost to Follow-up|1|||
156395742|NCT00765388|564539864|FG000|Period 1|Herpes Zoster|0|||
156395743|NCT00765388|564539865|FG001|Period 1|Herpes Zoster|1|||
156395744|NCT00765388|564539864|FG000|Period 1|Hip operation|0|||
156395745|NCT00765388|564539865|FG001|Period 1|Hip operation|1|||
156395746|NCT03923933|564539869|FG000|Overall Study|Lost to Follow-up|1|||
156395747|NCT03923933|564539870|FG001|Overall Study|Lost to Follow-up|0|||
156395748|NCT03923933|564539869|FG000|Overall Study|Withdrawal by Subject|0|||
156395749|NCT03923933|564539870|FG001|Overall Study|Withdrawal by Subject|1|||
156395750|NCT02454101|564539871|FG000|Overall Study|Adverse Event|2|||
156395751|NCT02454101|564539872|FG001|Overall Study|Adverse Event|3|||
156395752|NCT02454101|564539871|FG000|Overall Study|Lost to Follow-up|3|||
156395753|NCT02454101|564539872|FG001|Overall Study|Lost to Follow-up|4|||
156395754|NCT01813474|564539873|FG000|Overall Study|Withdrawal by Subject|0|||
156395755|NCT01813474|564539874|FG001|Overall Study|Withdrawal by Subject|0|||
156395756|NCT01813474|564539875|FG002|Overall Study|Withdrawal by Subject|1|||
156395757|NCT01813474|564539873|FG000|Overall Study|Adverse Event|1|||
156395758|NCT01813474|564539874|FG001|Overall Study|Adverse Event|1|||
156395759|NCT01813474|564539875|FG002|Overall Study|Adverse Event|0|||
156395760|NCT01813474|564539873|FG000|Overall Study|Lack of Efficacy|2|||
156395761|NCT01813474|564539874|FG001|Overall Study|Lack of Efficacy|6|||
156395762|NCT01813474|564539875|FG002|Overall Study|Lack of Efficacy|9|||
156395763|NCT01813474|564539873|FG000|Overall Study|Death|0|||
156395764|NCT01813474|564539874|FG001|Overall Study|Death|0|||
156395765|NCT01813474|564539875|FG002|Overall Study|Death|1|||
156395766|NCT01995461|564539883|FG000|Overall Study|Death|1|||
156395767|NCT01995461|564539883|FG000|Overall Study|Lost to Follow-up|2|||
156395768|NCT01995461|564539883|FG000|Overall Study|Withdrawal by Subject|2|||
156395769|NCT01777854|564539891|FG000|Overall Study|Physician Decision|3|||
156395770|NCT01777854|564539892|FG001|Overall Study|Physician Decision|3|||
156395771|NCT02124265|564539895|FG000|Overall Study|Adverse Event|1|||
156395772|NCT01298999|564539902|FG000|Overall Study|Physician Decision|0|||
156395773|NCT01298999|564539903|FG001|Overall Study|Physician Decision|1|||
156395774|NCT01298999|564539902|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
156395775|NCT01298999|564539903|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
156395776|NCT02291679|564539904|FG000|Overall Study|Adverse Event|2|||
156395777|NCT02291679|564539905|FG001|Overall Study|Adverse Event|12|||
156395778|NCT02291679|564539906|FG002|Overall Study|Adverse Event|19|||
156395779|NCT02291679|564539904|FG000|Overall Study|Protocol Violation|5|||
156395780|NCT02291679|564539905|FG001|Overall Study|Protocol Violation|1|||
156395781|NCT02291679|564539906|FG002|Overall Study|Protocol Violation|7|||
156395782|NCT02291679|564539904|FG000|Overall Study|Withdrew Consent|18|||
156395783|NCT02291679|564539905|FG001|Overall Study|Withdrew Consent|10|||
156395784|NCT02291679|564539906|FG002|Overall Study|Withdrew Consent|15|||
156395785|NCT02291679|564539904|FG000|Overall Study|Lost to Follow-up|12|||
156395786|NCT02291679|564539905|FG001|Overall Study|Lost to Follow-up|10|||
156395787|NCT02291679|564539906|FG002|Overall Study|Lost to Follow-up|9|||
156395788|NCT02291679|564539904|FG000|Overall Study|Insufficient Therapeutic Response|5|||
156395789|NCT02291679|564539905|FG001|Overall Study|Insufficient Therapeutic Response|5|||
156395790|NCT02291679|564539906|FG002|Overall Study|Insufficient Therapeutic Response|7|||
156395791|NCT02291679|564539904|FG000|Overall Study|Other|2|||
156395792|NCT02291679|564539905|FG001|Overall Study|Other|4|||
156395793|NCT02291679|564539906|FG002|Overall Study|Other|2|||
156395794|NCT00989092|564541633|FG000|Overall Study|Physician Decision|9|||
156395795|NCT00989092|564541634|FG001|Overall Study|Physician Decision|6|||
156395796|NCT00989092|564541633|FG000|Overall Study|Adverse Event|20|||
156395797|NCT00989092|564541634|FG001|Overall Study|Adverse Event|1|||
156395798|NCT00989092|564541633|FG000|Overall Study|Chemotherapy initiated|12|||
156395799|NCT00989092|564541634|FG001|Overall Study|Chemotherapy initiated|4|||
156395800|NCT00989092|564541633|FG000|Overall Study|Withdrawal by Subject|17|||
156395801|NCT00989092|564541634|FG001|Overall Study|Withdrawal by Subject|9|||
156395802|NCT00989092|564541633|FG000|Overall Study|Death|14|||
156395803|NCT00989092|564541634|FG001|Overall Study|Death|2|||
156395804|NCT00989092|564541633|FG000|Overall Study|Ineligibility determined|3|||
156395805|NCT00989092|564541634|FG001|Overall Study|Ineligibility determined|3|||
156395806|NCT00989092|564541633|FG000|Overall Study|Lost to Follow-up|6|||
156395807|NCT00989092|564541634|FG001|Overall Study|Lost to Follow-up|2|||
156508865|NCT03083665|564955546|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
156508866|NCT03083665|564955547|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
156508867|NCT03083665|564955548|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
156395808|NCT00989092|564541633|FG000|Overall Study|Other|3|||
156395809|NCT00989092|564541634|FG001|Overall Study|Other|1|||
156395810|NCT00989092|564541633|FG000|Overall Study|Protocol deviation|2|||
156395811|NCT00989092|564541634|FG001|Overall Study|Protocol deviation|0|||
156395812|NCT00989092|564541633|FG000|Overall Study|Erythropoietin therapy initiated|2|||
156395813|NCT00989092|564541634|FG001|Overall Study|Erythropoietin therapy initiated|0|||
156395814|NCT00989092|564541633|FG000|Overall Study|Did not receive study drug|2|||
156395815|NCT00989092|564541634|FG001|Overall Study|Did not receive study drug|0|||
156395816|NCT02586025|564541638|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
156395817|NCT02586025|564541639|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
156395818|NCT02586025|564541638|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
156395819|NCT02586025|564541639|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
156395820|NCT02586025|564541638|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
156395821|NCT02586025|564541639|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
156395822|NCT02586025|564541638|FG000|Neoadjuvant Treatment|Death|1|||
156395823|NCT02586025|564541639|FG001|Neoadjuvant Treatment|Death|0|||
156395824|NCT02586025|564541638|FG000|Neoadjuvant Treatment|Adverse Event|1|||
156395825|NCT02586025|564541639|FG001|Neoadjuvant Treatment|Adverse Event|0|||
156395826|NCT02586025|564541638|FG000|Neoadjuvant Treatment|Physician Decision|2|||
156395827|NCT02586025|564541639|FG001|Neoadjuvant Treatment|Physician Decision|1|||
156395828|NCT02586025|564541638|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
156395829|NCT02586025|564541639|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
156395830|NCT02586025|564541638|FG000|Adjuvant Treatment|Recurrent Disease|4|||
156395831|NCT02586025|564541639|FG001|Adjuvant Treatment|Recurrent Disease|5|||
156395832|NCT02586025|564541638|FG000|Adjuvant Treatment|Physician Decision|0|||
156395833|NCT02586025|564541639|FG001|Adjuvant Treatment|Physician Decision|1|||
156395834|NCT02586025|564541638|FG000|Adjuvant Treatment|Pregnancy|1|||
156395835|NCT02586025|564541639|FG001|Adjuvant Treatment|Pregnancy|0|||
156395836|NCT02586025|564541638|FG000|Treatment-Free Follow-Up|Death|11|||
156395837|NCT02586025|564541639|FG001|Treatment-Free Follow-Up|Death|11|||
156395838|NCT02586025|564541638|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
156395839|NCT02586025|564541639|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
156395840|NCT02586025|564541638|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
156395841|NCT02586025|564541639|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
156395842|NCT02586025|564541638|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
156395843|NCT02586025|564541639|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
156395844|NCT02586025|564541638|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
156395845|NCT02586025|564541639|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
156395846|NCT02472652|564541640|FG000|Overall Study|Lost to Follow-up|1|||
156395847|NCT04586569|564541645|FG000|Overall Study|Withdrawal by Subject|0|||
156395848|NCT04586569|564541646|FG001|Overall Study|Withdrawal by Subject|2|||
156395849|NCT04586569|564541645|FG000|Overall Study|No longer eligible|2|||
156395850|NCT04586569|564541646|FG001|Overall Study|No longer eligible|3|||
156395851|NCT04586569|564541645|FG000|Overall Study|Physician Decision|1|||
156395852|NCT04586569|564541646|FG001|Overall Study|Physician Decision|0|||
156395853|NCT00998400|564541647|FG000|Overall Study|Lack of interest/motivation|1|||
156395854|NCT00998400|564541648|FG001|Overall Study|Lack of interest/motivation|2|||
156395855|NCT00998400|564541647|FG000|Overall Study|Logistical problems|1|||
156395856|NCT00998400|564541648|FG001|Overall Study|Logistical problems|0|||
156395857|NCT03704584|564541649|FG000|Overall Study|Withdrawal by Subject|1|||
156395858|NCT03704584|564541650|FG001|Overall Study|Withdrawal by Subject|0|||
156395859|NCT03185832|564541651|FG000|Overall Study|Death|9|||
156395860|NCT03185832|564541652|FG001|Overall Study|Death|14|||
156395861|NCT03185832|564541653|FG002|Overall Study|Death|9|||
156395862|NCT03185832|564541654|FG003|Overall Study|Death|7|||
156395863|NCT03185832|564541651|FG000|Overall Study|Withdrawn - vital status available|0|||
156395864|NCT03185832|564541652|FG001|Overall Study|Withdrawn - vital status available|1|||
156395865|NCT03185832|564541653|FG002|Overall Study|Withdrawn - vital status available|1|||
156395866|NCT03185832|564541654|FG003|Overall Study|Withdrawn - vital status available|4|||
156395867|NCT01083641|564541656|FG000|Overall Study|Withdrawal by Subject|2|||
156395868|NCT03439189|564541657|FG000|Overall Study|Protocol Violation|19|||
156395869|NCT03439189|564541657|FG000|Overall Study|Lack of Efficacy|63|||
156395870|NCT03412812|564541658|FG000|Level 1|Death|3|||
156395871|NCT03412812|564541659|FG001|Level 1|Death|0|||
156395872|NCT03412812|564541658|FG000|Level 1|Adverse Event|0|||
156395873|NCT03412812|564541659|FG001|Level 1|Adverse Event|1|||
156395874|NCT01777321|564541660|FG000|Overall Study|Withdrawal by Subject|0|||
156395875|NCT01777321|564541661|FG001|Overall Study|Withdrawal by Subject|1|||
156395876|NCT02641392|564541662|FG000|Overall Study|Lost to Follow-up|0|||
156395877|NCT02641392|564541663|FG001|Overall Study|Lost to Follow-up|0|||
156395878|NCT02641392|564541664|FG002|Overall Study|Lost to Follow-up|2|||
156395879|NCT02641392|564541662|FG000|Overall Study|Withdrawal by Subject|0|||
156395880|NCT02641392|564541663|FG001|Overall Study|Withdrawal by Subject|0|||
156395881|NCT02641392|564541664|FG002|Overall Study|Withdrawal by Subject|17|||
156395882|NCT02641392|564541662|FG000|Overall Study|Adverse Event|0|||
156395883|NCT02641392|564541663|FG001|Overall Study|Adverse Event|1|||
156395884|NCT02641392|564541664|FG002|Overall Study|Adverse Event|25|||
156395885|NCT02641392|564541662|FG000|Overall Study|Study Terminated by Sponsor|4|||
156395886|NCT02641392|564541663|FG001|Overall Study|Study Terminated by Sponsor|12|||
156395887|NCT02641392|564541664|FG002|Overall Study|Study Terminated by Sponsor|144|||
156395888|NCT02641392|564541662|FG000|Overall Study|Lack of Efficacy|0|||
156395889|NCT02641392|564541663|FG001|Overall Study|Lack of Efficacy|0|||
156395890|NCT02641392|564541664|FG002|Overall Study|Lack of Efficacy|101|||
156395891|NCT02641392|564541662|FG000|Overall Study|Miscellaneous|0|||
156395892|NCT02641392|564541663|FG001|Overall Study|Miscellaneous|0|||
156395893|NCT02641392|564541664|FG002|Overall Study|Miscellaneous|3|||
156395894|NCT02641392|564541662|FG000|Overall Study|Death|0|||
156395895|NCT02641392|564541663|FG001|Overall Study|Death|0|||
156395896|NCT02641392|564541664|FG002|Overall Study|Death|1|||
156395897|NCT02691182|564541665|FG000|Overall Study|Withdrawal by Subject|4|||
156549060|NCT04986202|565102482|FG002|Overall Study|Physician Decision|2|||
156549061|NCT04986202|565102480|FG000|Overall Study|Withdrawal by Subject|4|||
156549062|NCT04986202|565102481|FG001|Overall Study|Withdrawal by Subject|2|||
156549063|NCT04986202|565102482|FG002|Overall Study|Withdrawal by Subject|4|||
156549064|NCT03548558|565102485|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
156549065|NCT03548558|565102486|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
156549066|NCT03548558|565102487|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
156395898|NCT02691182|564541666|FG001|Overall Study|Withdrawal by Subject|7|||
156395899|NCT02691182|564541667|FG002|Overall Study|Withdrawal by Subject|6|||
156395900|NCT02691182|564541668|FG003|Overall Study|Withdrawal by Subject|8|||
156395901|NCT02691182|564541665|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
156395902|NCT02691182|564541666|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
156395903|NCT02691182|564541667|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
156395904|NCT02691182|564541668|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
156395905|NCT02691182|564541665|FG000|Overall Study|Lost to Follow-up|8|||
156395906|NCT02691182|564541666|FG001|Overall Study|Lost to Follow-up|33|||
156395907|NCT02691182|564541667|FG002|Overall Study|Lost to Follow-up|19|||
156395908|NCT02691182|564541668|FG003|Overall Study|Lost to Follow-up|22|||
156395909|NCT02691182|564541665|FG000|Overall Study|Adverse Event|3|||
156395910|NCT02691182|564541666|FG001|Overall Study|Adverse Event|10|||
156395911|NCT02691182|564541667|FG002|Overall Study|Adverse Event|10|||
156395912|NCT02691182|564541668|FG003|Overall Study|Adverse Event|11|||
156395913|NCT02691182|564541665|FG000|Overall Study|Physician Decision|3|||
156395914|NCT02691182|564541666|FG001|Overall Study|Physician Decision|7|||
156395915|NCT02691182|564541667|FG002|Overall Study|Physician Decision|14|||
156395916|NCT02691182|564541668|FG003|Overall Study|Physician Decision|8|||
156395917|NCT02691182|564541665|FG000|Overall Study|Lack of Efficacy|0|||
156395918|NCT02691182|564541666|FG001|Overall Study|Lack of Efficacy|0|||
156395919|NCT02691182|564541667|FG002|Overall Study|Lack of Efficacy|0|||
156395920|NCT02691182|564541668|FG003|Overall Study|Lack of Efficacy|4|||
156395921|NCT02691182|564541665|FG000|Overall Study|Protocol Violation|2|||
156395922|NCT02691182|564541666|FG001|Overall Study|Protocol Violation|6|||
156395923|NCT02691182|564541667|FG002|Overall Study|Protocol Violation|6|||
156395924|NCT02691182|564541668|FG003|Overall Study|Protocol Violation|8|||
156395925|NCT02691182|564541665|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
156395926|NCT02691182|564541666|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
156395927|NCT02691182|564541667|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
156395928|NCT02691182|564541668|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
156395929|NCT02691182|564541665|FG000|Overall Study|Missing|0|||
156395930|NCT02691182|564541666|FG001|Overall Study|Missing|5|||
156395931|NCT02691182|564541667|FG002|Overall Study|Missing|1|||
156395932|NCT02691182|564541668|FG003|Overall Study|Missing|5|||
156395933|NCT00266825|564541675|FG000|Completed Follow-Up|Lost to Follow-up|14|||
156395934|NCT00266825|564541676|FG001|Completed Follow-Up|Lost to Follow-up|19|||
156395935|NCT00266825|564541675|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
156395936|NCT00266825|564541676|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
156395937|NCT02799784|564541677|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
156395938|NCT02799784|564541678|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
156395939|NCT02799784|564541677|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
156395940|NCT02799784|564541678|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
156395941|NCT02799784|564541677|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
156395942|NCT02799784|564541678|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
156395943|NCT02799784|564541677|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
156395944|NCT02799784|564541678|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
156395945|NCT02799784|564541677|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
156395946|NCT02799784|564541678|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
156549067|NCT03548558|565102488|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
156395947|NCT02799784|564541677|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
156395948|NCT02799784|564541678|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
156395949|NCT01127646|564541679|FG000|Overall Study|Entry Criteria Not Met|1|||
156395950|NCT01127646|564541680|FG001|Overall Study|Entry Criteria Not Met|0|||
156395951|NCT01127646|564541679|FG000|Overall Study|Protocol Violation|0|||
156395952|NCT01127646|564541680|FG001|Overall Study|Protocol Violation|1|||
156395953|NCT03466086|564541681|FG000|Period 1|Sponsor decision due to study timeline|1|||
156395954|NCT03466086|564541682|FG001|Period 1|Sponsor decision due to study timeline|0|||
156549068|NCT03548558|565102489|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
156395955|NCT03466086|564541681|FG000|Period 1|Withdrawal by Subject|1|||
156395956|NCT03466086|564541682|FG001|Period 1|Withdrawal by Subject|0|||
156395957|NCT01754467|564541686|FG000|Overall Study|Lost to Follow-up|1|||
156395958|NCT01970462|564541687|FG000|Overall Study|Lost to Follow-up|0|||
156395959|NCT01970462|564541688|FG001|Overall Study|Lost to Follow-up|2|||
156395960|NCT03002610|564541689|FG000|Overall Study|Withdrawal by Subject|6|||
156395961|NCT03002610|564541690|FG001|Overall Study|Withdrawal by Subject|25|||
156395962|NCT03002610|564541691|FG002|Overall Study|Withdrawal by Subject|13|||
156395963|NCT03802123|564541692|FG000|Overall Study|Withdrawal by Subject|3|||
156395964|NCT03802123|564541692|FG000|Overall Study|Physician Decision|1|||
156395965|NCT03802123|564541692|FG000|Overall Study|Subject moved to hospice care|1|||
156395966|NCT03802123|564541692|FG000|Overall Study|technician error|1|||
156395967|NCT03802123|564541692|FG000|Overall Study|Death|3|||
156395968|NCT01274182|564541693|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
156395969|NCT01274182|564541694|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156395970|NCT01274182|564541695|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
156395971|NCT01274182|564541693|FG000|Overall Study|Adverse Event|4|||
156395972|NCT01274182|564541694|FG001|Overall Study|Adverse Event|5|||
156395973|NCT01274182|564541695|FG002|Overall Study|Adverse Event|3|||
156395974|NCT01274182|564541693|FG000|Overall Study|Withdrawal by Subject|5|||
156395975|NCT01274182|564541694|FG001|Overall Study|Withdrawal by Subject|5|||
156395976|NCT01274182|564541695|FG002|Overall Study|Withdrawal by Subject|3|||
156395977|NCT01274182|564541693|FG000|Overall Study|Lost to Follow-up|2|||
156395978|NCT01274182|564541694|FG001|Overall Study|Lost to Follow-up|3|||
156395979|NCT01274182|564541695|FG002|Overall Study|Lost to Follow-up|1|||
156395980|NCT01274182|564541693|FG000|Overall Study|Protocol Violation|3|||
156395981|NCT01274182|564541694|FG001|Overall Study|Protocol Violation|2|||
156395982|NCT01274182|564541695|FG002|Overall Study|Protocol Violation|0|||
156395983|NCT01274182|564541693|FG000|Overall Study|Death|1|||
156395984|NCT01274182|564541694|FG001|Overall Study|Death|0|||
156395985|NCT01274182|564541695|FG002|Overall Study|Death|1|||
156395986|NCT01822587|564541696|FG000|Overall Study|Lost to Follow-up|7|||
156395987|NCT01822587|564541697|FG001|Overall Study|Lost to Follow-up|9|||
156395988|NCT01822587|564541698|FG002|Overall Study|Lost to Follow-up|12|||
156395989|NCT01822587|564541696|FG000|Overall Study|Physician Decision|9|||
156395990|NCT01822587|564541697|FG001|Overall Study|Physician Decision|6|||
156395991|NCT01822587|564541698|FG002|Overall Study|Physician Decision|6|||
156395992|NCT01970982|564541699|FG000|Overall Study|Withdrawal by Subject|0|||
156395993|NCT01970982|564541700|FG001|Overall Study|Withdrawal by Subject|0|||
156395994|NCT01970982|564541701|FG002|Overall Study|Withdrawal by Subject|2|||
156395995|NCT03575325|564541707|FG000|Overall Study|Death|1|||
156395996|NCT02712905|564541710|FG000|Monotherapy|Death|2|||
156395997|NCT02712905|564541711|FG001|Monotherapy|Death|5|||
156395998|NCT02712905|564541712|FG002|Monotherapy|Death|0|||
156395999|NCT02712905|564541713|FG003|Monotherapy|Death|3|||
156396000|NCT02712905|564541714|FG004|Monotherapy|Death|15|||
156396001|NCT02712905|564541715|FG005|Monotherapy|Death|1|||
156396002|NCT02712905|564541716|FG006|Monotherapy|Death|3|||
156396003|NCT02712905|564541717|FG007|Monotherapy|Death|3|||
156549069|NCT03548558|565102490|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
156549070|NCT03548558|565102491|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
156549071|NCT03548558|565102485|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
156396004|NCT02712905|564541718|FG008|Monotherapy|Death|0|||
156396005|NCT02712905|564541719|FG009|Monotherapy|Death|27|||
156396006|NCT02712905|564541720|FG010|Monotherapy|Death|2|||
156396007|NCT02712905|564541721|FG011|Monotherapy|Death|5|||
156396008|NCT02712905|564541722|FG012|Monotherapy|Death|0|||
156396009|NCT02712905|564541723|FG013|Monotherapy|Death|0|||
156396010|NCT02712905|564541724|FG014|Monotherapy|Death|0|||
156396011|NCT02712905|564541725|FG015|Monotherapy|Death|0|||
156396012|NCT02712905|564541726|FG016|Monotherapy|Death|0|||
156549072|NCT03548558|565102486|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
156396013|NCT02712905|564541727|FG017|Monotherapy|Death|0|||
156396014|NCT02712905|564541710|FG000|Monotherapy|Lost to Follow-up|0|||
156396015|NCT02712905|564541711|FG001|Monotherapy|Lost to Follow-up|1|||
156396016|NCT02712905|564541712|FG002|Monotherapy|Lost to Follow-up|0|||
156396017|NCT02712905|564541713|FG003|Monotherapy|Lost to Follow-up|1|||
156396018|NCT02712905|564541714|FG004|Monotherapy|Lost to Follow-up|0|||
156396019|NCT02712905|564541715|FG005|Monotherapy|Lost to Follow-up|0|||
156396020|NCT02712905|564541716|FG006|Monotherapy|Lost to Follow-up|0|||
156396021|NCT02712905|564541717|FG007|Monotherapy|Lost to Follow-up|0|||
156396022|NCT02712905|564541718|FG008|Monotherapy|Lost to Follow-up|0|||
156396023|NCT02712905|564541719|FG009|Monotherapy|Lost to Follow-up|2|||
156396024|NCT02712905|564541720|FG010|Monotherapy|Lost to Follow-up|0|||
156396025|NCT02712905|564541721|FG011|Monotherapy|Lost to Follow-up|0|||
156396026|NCT02712905|564541722|FG012|Monotherapy|Lost to Follow-up|0|||
156396027|NCT02712905|564541723|FG013|Monotherapy|Lost to Follow-up|0|||
156396028|NCT02712905|564541724|FG014|Monotherapy|Lost to Follow-up|0|||
156396029|NCT02712905|564541725|FG015|Monotherapy|Lost to Follow-up|0|||
156396030|NCT02712905|564541726|FG016|Monotherapy|Lost to Follow-up|0|||
156396031|NCT02712905|564541727|FG017|Monotherapy|Lost to Follow-up|0|||
156396032|NCT02712905|564541710|FG000|Monotherapy|Physician Decision|1|||
156396033|NCT02712905|564541711|FG001|Monotherapy|Physician Decision|0|||
156396034|NCT02712905|564541712|FG002|Monotherapy|Physician Decision|0|||
156396035|NCT02712905|564541713|FG003|Monotherapy|Physician Decision|1|||
156396036|NCT02712905|564541714|FG004|Monotherapy|Physician Decision|0|||
156396037|NCT02712905|564541715|FG005|Monotherapy|Physician Decision|0|||
156396038|NCT02712905|564541716|FG006|Monotherapy|Physician Decision|0|||
156396039|NCT02712905|564541717|FG007|Monotherapy|Physician Decision|0|||
156396040|NCT02712905|564541718|FG008|Monotherapy|Physician Decision|0|||
156396041|NCT02712905|564541719|FG009|Monotherapy|Physician Decision|1|||
156549073|NCT03548558|565102487|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
156549074|NCT03548558|565102488|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
156549075|NCT03548558|565102489|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
156549076|NCT03548558|565102490|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
156549077|NCT03548558|565102491|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
156549078|NCT03548558|565102485|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
156549079|NCT03548558|565102486|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
156549080|NCT03548558|565102487|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
156549081|NCT03548558|565102488|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
156549082|NCT03548558|565102489|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
156549083|NCT03548558|565102490|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
156549084|NCT03548558|565102491|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
156549085|NCT03548558|565102485|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
156549086|NCT03548558|565102486|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
156549087|NCT03548558|565102487|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
156549088|NCT03548558|565102488|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
156549089|NCT03548558|565102489|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
156549090|NCT03548558|565102490|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
156549091|NCT03548558|565102491|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
156549092|NCT03548558|565102485|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
156549093|NCT03548558|565102486|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
156549094|NCT03548558|565102487|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
156549095|NCT03548558|565102488|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
156549096|NCT03548558|565102489|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
156549097|NCT03548558|565102490|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
156549098|NCT03548558|565102491|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
156549099|NCT03548558|565102485|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
156549100|NCT03548558|565102486|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
156549101|NCT03548558|565102487|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
156549102|NCT03548558|565102488|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
156549103|NCT03548558|565102489|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
156396042|NCT02712905|564541720|FG010|Monotherapy|Physician Decision|0|||
156508868|NCT03083665|564955549|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
156508869|NCT03083665|564955550|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
156508870|NCT03083665|564955545|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
156508871|NCT03083665|564955546|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
156508872|NCT03083665|564955547|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
156508873|NCT03083665|564955548|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
156508874|NCT03083665|564955549|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
156508875|NCT03083665|564955550|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
156508876|NCT03083665|564955545|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
156508877|NCT03083665|564955546|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
156508878|NCT03083665|564955547|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
156508879|NCT03083665|564955548|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
156508880|NCT03083665|564955549|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
156508881|NCT03083665|564955550|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
156508882|NCT03083665|564955545|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
156508883|NCT03083665|564955546|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
156508884|NCT03083665|564955547|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
156508885|NCT03083665|564955548|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
156508886|NCT03083665|564955549|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
156508887|NCT03083665|564955550|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
156508888|NCT03083665|564955545|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
156508889|NCT03083665|564955546|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
156508890|NCT03083665|564955547|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
156508891|NCT03083665|564955548|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
156396043|NCT02712905|564541721|FG011|Monotherapy|Physician Decision|0|||
156396044|NCT02712905|564541722|FG012|Monotherapy|Physician Decision|0|||
156549104|NCT03548558|565102490|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
156549105|NCT03548558|565102491|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
156549106|NCT01485627|565102493|FG000|Overall Study|Patient withdrew|6|||
156549107|NCT01485627|565102494|FG001|Overall Study|Patient withdrew|5|||
156549108|NCT01485627|565102493|FG000|Overall Study|Patient died|3|||
156549109|NCT01485627|565102494|FG001|Overall Study|Patient died|1|||
156549110|NCT01485627|565102493|FG000|Overall Study|Patient lost to followup|0|||
156549111|NCT01485627|565102494|FG001|Overall Study|Patient lost to followup|1|||
156549112|NCT01485627|565102493|FG000|Overall Study|Caregiver withdrew|3|||
156549113|NCT01485627|565102494|FG001|Overall Study|Caregiver withdrew|3|||
156549114|NCT01485627|565102493|FG000|Overall Study|Caregiver lost to follow up|11|||
156549115|NCT01485627|565102494|FG001|Overall Study|Caregiver lost to follow up|12|||
156549116|NCT01485627|565102493|FG000|Overall Study|Caregiver died|1|||
156549117|NCT01485627|565102494|FG001|Overall Study|Caregiver died|0|||
156549118|NCT01485627|565102493|FG000|Overall Study|caregiver was not bereaved|42|||
156549119|NCT01485627|565102494|FG001|Overall Study|caregiver was not bereaved|35|||
156549120|NCT01709149|565102495|FG000|Open-label Lead-in Phase|Adverse Event|109|||
156549121|NCT01709149|565102496|FG001|Open-label Lead-in Phase|Adverse Event|0|||
156549122|NCT01709149|565102497|FG002|Open-label Lead-in Phase|Adverse Event|0|||
156549123|NCT01709149|565102495|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
156549124|NCT01709149|565102496|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
156549125|NCT01709149|565102497|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
156549126|NCT01709149|565102495|FG000|Open-label Lead-in Phase|Death|1|||
156549127|NCT01709149|565102496|FG001|Open-label Lead-in Phase|Death|0|||
156549128|NCT01709149|565102497|FG002|Open-label Lead-in Phase|Death|0|||
156549129|NCT01709149|565102495|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
156549130|NCT01709149|565102496|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
156549131|NCT01709149|565102497|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
156549132|NCT01709149|565102495|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
156549133|NCT01709149|565102496|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
156549134|NCT01709149|565102497|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
156549135|NCT01709149|565102495|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156549136|NCT01709149|565102496|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
156549137|NCT01709149|565102497|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
156549138|NCT01709149|565102495|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156549139|NCT01709149|565102496|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
156549140|NCT01709149|565102497|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
156549141|NCT01709149|565102495|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
156549142|NCT01709149|565102496|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
156549143|NCT01709149|565102497|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
156549144|NCT01709149|565102495|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
156549145|NCT01709149|565102496|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
156549146|NCT01709149|565102497|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
156549147|NCT01709149|565102495|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156549148|NCT01709149|565102496|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
156549149|NCT01709149|565102497|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156549150|NCT00763815|565102498|FG000|Overall Study|Adverse Event|14|||
156549151|NCT00763815|565102499|FG001|Overall Study|Adverse Event|29|||
156549152|NCT00763815|565102498|FG000|Overall Study|Lack of Efficacy|10|||
156549153|NCT00763815|565102499|FG001|Overall Study|Lack of Efficacy|11|||
156549154|NCT00763815|565102498|FG000|Overall Study|Poor Compliance to Protocol|6|||
156549155|NCT00763815|565102499|FG001|Overall Study|Poor Compliance to Protocol|6|||
156549156|NCT00763815|565102498|FG000|Overall Study|Lost to Follow-up|2|||
156549157|NCT00763815|565102499|FG001|Overall Study|Lost to Follow-up|4|||
156549158|NCT00763815|565102498|FG000|Overall Study|Early Termination|1|||
156549159|NCT00763815|565102499|FG001|Overall Study|Early Termination|0|||
156549160|NCT00763815|565102498|FG000|Overall Study|Familial and Personal Reasons|9|||
156549161|NCT00763815|565102499|FG001|Overall Study|Familial and Personal Reasons|16|||
156549162|NCT00763815|565102498|FG000|Overall Study|Physician Decision|1|||
156549163|NCT00763815|565102499|FG001|Overall Study|Physician Decision|0|||
156549164|NCT00763815|565102498|FG000|Overall Study|Withdrawal by Subject|7|||
156549165|NCT00763815|565102499|FG001|Overall Study|Withdrawal by Subject|12|||
156549166|NCT00763815|565102498|FG000|Overall Study|Protocol Violation|2|||
156549167|NCT00763815|565102499|FG001|Overall Study|Protocol Violation|5|||
156549168|NCT00763815|565102498|FG000|Overall Study|Sponsor's Decision|0|||
156549169|NCT00763815|565102499|FG001|Overall Study|Sponsor's Decision|1|||
156549170|NCT04951037|565102500|FG000|Overall Study|Lost to Follow-up|16|||
156549171|NCT04951037|565102500|FG000|Overall Study|Withdrawal by Subject|5|||
156549172|NCT04951037|565102500|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
156549173|NCT05630937|565102503|FG000|Overall Study|Study terminated by sponsor|1|||
156549174|NCT05630937|565102504|FG001|Overall Study|Study terminated by sponsor|1|||
156549175|NCT05630937|565102505|FG002|Overall Study|Study terminated by sponsor|8|||
156549176|NCT05630937|565102506|FG003|Overall Study|Study terminated by sponsor|0|||
156549177|NCT05630937|565102503|FG000|Overall Study|Lost to Follow-up|0|||
156549178|NCT05630937|565102504|FG001|Overall Study|Lost to Follow-up|0|||
156549179|NCT05630937|565102505|FG002|Overall Study|Lost to Follow-up|1|||
156549180|NCT05630937|565102506|FG003|Overall Study|Lost to Follow-up|0|||
156549181|NCT05630937|565102503|FG000|Overall Study|Enrolled but not treated|0|||
156549182|NCT05630937|565102504|FG001|Overall Study|Enrolled but not treated|0|||
156549183|NCT05630937|565102505|FG002|Overall Study|Enrolled but not treated|0|||
156549184|NCT05630937|565102506|FG003|Overall Study|Enrolled but not treated|1|||
156549185|NCT02429414|565102508|FG000|Overall Study|Physician Decision|0|||
156549186|NCT02429414|565102509|FG001|Overall Study|Physician Decision|1|||
156549187|NCT00267748|565102510|FG000|Non-randomized Period|Progressive disease|10|||
156549188|NCT00267748|565102511|FG001|Non-randomized Period|Progressive disease|0|||
156549189|NCT00267748|565102512|FG002|Non-randomized Period|Progressive disease|0|||
156549190|NCT00267748|565102510|FG000|Non-randomized Period|Adverse Event|8|||
156549191|NCT00267748|565102511|FG001|Non-randomized Period|Adverse Event|0|||
156549192|NCT00267748|565102512|FG002|Non-randomized Period|Adverse Event|0|||
156549193|NCT00267748|565102510|FG000|Non-randomized Period|Death|1|||
156549194|NCT00267748|565102511|FG001|Non-randomized Period|Death|0|||
156549195|NCT00267748|565102512|FG002|Non-randomized Period|Death|0|||
156549196|NCT00267748|565102510|FG000|Non-randomized Period|Participant not willing to participate|1|||
156549197|NCT00267748|565102511|FG001|Non-randomized Period|Participant not willing to participate|0|||
156549198|NCT00267748|565102512|FG002|Non-randomized Period|Participant not willing to participate|0|||
156549199|NCT00267748|565102510|FG000|Non-randomized Period|Other|3|||
156549200|NCT00267748|565102511|FG001|Non-randomized Period|Other|0|||
156549201|NCT00267748|565102512|FG002|Non-randomized Period|Other|0|||
156549202|NCT00267748|565102510|FG000|Randomized Period|Death|0|||
156549203|NCT00267748|565102511|FG001|Randomized Period|Death|2|||
156549204|NCT00267748|565102512|FG002|Randomized Period|Death|3|||
156549205|NCT00267748|565102510|FG000|Randomized Period|Adverse Event|0|||
156549206|NCT00267748|565102511|FG001|Randomized Period|Adverse Event|23|||
156549207|NCT00267748|565102512|FG002|Randomized Period|Adverse Event|25|||
156549208|NCT00267748|565102510|FG000|Randomized Period|Global deterioration of health status|0|||
156549209|NCT00267748|565102511|FG001|Randomized Period|Global deterioration of health status|6|||
156549210|NCT00267748|565102512|FG002|Randomized Period|Global deterioration of health status|7|||
156549211|NCT00267748|565102510|FG000|Randomized Period|Lost to Follow-up|0|||
156549212|NCT00267748|565102511|FG001|Randomized Period|Lost to Follow-up|1|||
156549213|NCT00267748|565102512|FG002|Randomized Period|Lost to Follow-up|0|||
156549214|NCT00267748|565102510|FG000|Randomized Period|Objective progression or relapse|0|||
156549215|NCT00267748|565102511|FG001|Randomized Period|Objective progression or relapse|77|||
156549216|NCT00267748|565102512|FG002|Randomized Period|Objective progression or relapse|86|||
156549217|NCT00267748|565102510|FG000|Randomized Period|Withdrawal by Subject|0|||
156549218|NCT00267748|565102511|FG001|Randomized Period|Withdrawal by Subject|9|||
156549219|NCT00267748|565102512|FG002|Randomized Period|Withdrawal by Subject|2|||
156549220|NCT00267748|565102510|FG000|Randomized Period|Other|0|||
156549221|NCT00267748|565102511|FG001|Randomized Period|Other|9|||
156549222|NCT00267748|565102512|FG002|Randomized Period|Other|6|||
156549223|NCT00267748|565102510|FG000|Randomized Period|randomized but not treated|0|||
156549224|NCT00267748|565102511|FG001|Randomized Period|randomized but not treated|0|||
156549225|NCT00267748|565102512|FG002|Randomized Period|randomized but not treated|3|||
156549226|NCT01098071|565102522|FG000|Overall Study|Surgery (adenoidectomy)|2|||
156549227|NCT01098071|565102522|FG000|Overall Study|Lost to Follow-up|13|||
156549228|NCT01604265|565102526|FG000|Overall Study|Adverse Event|1|||
156549229|NCT01604265|565102527|FG001|Overall Study|Adverse Event|0|||
156549230|NCT01604265|565102526|FG000|Overall Study|Withdrawal by Subject|1|||
156549231|NCT01604265|565102527|FG001|Overall Study|Withdrawal by Subject|0|||
156549232|NCT01903837|565102528|FG000|Part A|Withdrawal by Subject|4|||
156549233|NCT01903837|565102529|FG001|Part A|Withdrawal by Subject|9|||
156549234|NCT01903837|565102530|FG002|Part A|Withdrawal by Subject|8|||
156549235|NCT01903837|565102531|FG003|Part A|Withdrawal by Subject|5|||
156549236|NCT01903837|565102528|FG000|Part A|Adverse Event|3|||
156549237|NCT01903837|565102529|FG001|Part A|Adverse Event|6|||
156549238|NCT01903837|565102530|FG002|Part A|Adverse Event|9|||
156549239|NCT01903837|565102531|FG003|Part A|Adverse Event|6|||
156549240|NCT01903837|565102528|FG000|Part A|Lost to Follow-up|9|||
156549241|NCT01903837|565102529|FG001|Part A|Lost to Follow-up|7|||
156549242|NCT01903837|565102530|FG002|Part A|Lost to Follow-up|7|||
156549243|NCT01903837|565102531|FG003|Part A|Lost to Follow-up|2|||
156549244|NCT01903837|565102528|FG000|Part A|Non-compliance with study drug|1|||
156549245|NCT01903837|565102529|FG001|Part A|Non-compliance with study drug|4|||
156549246|NCT01903837|565102530|FG002|Part A|Non-compliance with study drug|4|||
156549247|NCT01903837|565102531|FG003|Part A|Non-compliance with study drug|0|||
156549248|NCT01903837|565102528|FG000|Part A|Physician Decision|1|||
156549249|NCT01903837|565102529|FG001|Part A|Physician Decision|1|||
156549250|NCT01903837|565102530|FG002|Part A|Physician Decision|0|||
156549251|NCT01903837|565102531|FG003|Part A|Physician Decision|0|||
156549252|NCT01903837|565102528|FG000|Part A|Protocol Violation|1|||
156549253|NCT01903837|565102529|FG001|Part A|Protocol Violation|1|||
156549254|NCT01903837|565102530|FG002|Part A|Protocol Violation|0|||
156549255|NCT01903837|565102531|FG003|Part A|Protocol Violation|0|||
156549256|NCT01903837|565102528|FG000|Part B|Lost to Follow-up|0|||
156549257|NCT01903837|565102529|FG001|Part B|Lost to Follow-up|3|||
156549258|NCT01903837|565102530|FG002|Part B|Lost to Follow-up|3|||
156549259|NCT01903837|565102531|FG003|Part B|Lost to Follow-up|4|||
156549260|NCT01903837|565102528|FG000|Part B|Withdrawal by Subject|1|||
156549261|NCT01903837|565102529|FG001|Part B|Withdrawal by Subject|2|||
156549262|NCT01903837|565102530|FG002|Part B|Withdrawal by Subject|0|||
156549263|NCT01903837|565102531|FG003|Part B|Withdrawal by Subject|3|||
156549264|NCT01903837|565102528|FG000|Part B|Adverse Event|3|||
156549265|NCT01903837|565102529|FG001|Part B|Adverse Event|0|||
156549266|NCT01903837|565102530|FG002|Part B|Adverse Event|2|||
156549267|NCT01903837|565102531|FG003|Part B|Adverse Event|0|||
156549268|NCT01903837|565102528|FG000|Part B|Non-compliance with study drug|2|||
156549269|NCT01903837|565102529|FG001|Part B|Non-compliance with study drug|0|||
156549270|NCT01903837|565102530|FG002|Part B|Non-compliance with study drug|0|||
156549271|NCT01903837|565102531|FG003|Part B|Non-compliance with study drug|1|||
156549272|NCT01903837|565102528|FG000|Part B|Incarceration|2|||
156549273|NCT01903837|565102529|FG001|Part B|Incarceration|0|||
156549274|NCT01903837|565102530|FG002|Part B|Incarceration|0|||
156549275|NCT01903837|565102531|FG003|Part B|Incarceration|1|||
156549276|NCT01903837|565102528|FG000|Part B|Physician Decision|1|||
156549277|NCT01903837|565102529|FG001|Part B|Physician Decision|0|||
156549278|NCT01903837|565102530|FG002|Part B|Physician Decision|0|||
156549279|NCT01903837|565102531|FG003|Part B|Physician Decision|2|||
156549280|NCT01903837|565102528|FG000|Part B|Lack of Efficacy|0|||
156549281|NCT01903837|565102529|FG001|Part B|Lack of Efficacy|1|||
156549282|NCT01903837|565102530|FG002|Part B|Lack of Efficacy|0|||
156549283|NCT01903837|565102531|FG003|Part B|Lack of Efficacy|0|||
156549284|NCT02706873|565102532|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
156549285|NCT02706873|565102533|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
156549286|NCT02706873|565102534|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
156549287|NCT02706873|565102535|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
156549288|NCT02706873|565102532|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
156549289|NCT02706873|565102533|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
156549290|NCT02706873|565102534|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
156549291|NCT02706873|565102535|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
156549292|NCT02706873|565102532|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
156549293|NCT02706873|565102533|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
156549294|NCT02706873|565102534|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
156549295|NCT02706873|565102535|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
156549296|NCT02706873|565102532|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
156549297|NCT02706873|565102533|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
156549298|NCT02706873|565102534|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
156549299|NCT02706873|565102535|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
156549300|NCT02706873|565102532|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
156549301|NCT02706873|565102533|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
156549302|NCT02706873|565102534|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
156549303|NCT02706873|565102535|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
156549304|NCT02706873|565102532|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
156549305|NCT02706873|565102533|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
156549306|NCT02706873|565102534|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
156549307|NCT02706873|565102535|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
156549308|NCT02706873|565102532|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
156549309|NCT02706873|565102533|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
156549310|NCT02706873|565102534|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
156549311|NCT02706873|565102535|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
156549312|NCT02706873|565102532|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
156549313|NCT02706873|565102533|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
156549314|NCT02706873|565102534|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
156549315|NCT02706873|565102535|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
156549316|NCT02706873|565102532|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
156549317|NCT02706873|565102533|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
156549318|NCT02706873|565102534|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
156549319|NCT02706873|565102535|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
156549320|NCT02706873|565102532|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
156549321|NCT02706873|565102533|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
156549322|NCT02706873|565102534|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
156549323|NCT02706873|565102535|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
156549324|NCT02706873|565102532|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
156549325|NCT02706873|565102533|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
156549326|NCT02706873|565102534|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
156549327|NCT02706873|565102535|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
156549328|NCT02706873|565102532|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
156549329|NCT02706873|565102533|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
156549330|NCT02706873|565102534|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
156549331|NCT02706873|565102535|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
156549332|NCT02706873|565102532|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
156549333|NCT02706873|565102533|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
156549334|NCT02706873|565102534|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
156549335|NCT02706873|565102535|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
156549336|NCT00797732|565102536|FG000|Overall Study|Withdrawal by Subject|3|||
156549337|NCT00797732|565102537|FG001|Overall Study|Withdrawal by Subject|3|||
156549338|NCT00797732|565102538|FG002|Overall Study|Withdrawal by Subject|0|||
156549339|NCT00797732|565102536|FG000|Overall Study|Lost to Follow-up|1|||
156549340|NCT00797732|565102537|FG001|Overall Study|Lost to Follow-up|0|||
156549341|NCT00797732|565102538|FG002|Overall Study|Lost to Follow-up|0|||
156549342|NCT00797732|565102536|FG000|Overall Study|Death|1|||
156549343|NCT00797732|565102537|FG001|Overall Study|Death|0|||
156549344|NCT00797732|565102538|FG002|Overall Study|Death|0|||
156549345|NCT00797732|565102536|FG000|Overall Study|Not meet inclusion criteria|0|||
156549346|NCT00797732|565102537|FG001|Overall Study|Not meet inclusion criteria|0|||
156549347|NCT00797732|565102538|FG002|Overall Study|Not meet inclusion criteria|7|||
156549348|NCT00797732|565102536|FG000|Overall Study|Excluded due to time constraints|0|||
156549349|NCT00797732|565102537|FG001|Overall Study|Excluded due to time constraints|0|||
156549350|NCT00797732|565102538|FG002|Overall Study|Excluded due to time constraints|24|||
156549351|NCT00797732|565102536|FG000|Overall Study|Refused to Participate|0|||
156549352|NCT00797732|565102537|FG001|Overall Study|Refused to Participate|0|||
156549353|NCT00797732|565102538|FG002|Overall Study|Refused to Participate|123|||
156549354|NCT01857869|565102539|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
156549355|NCT01857869|565102540|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
156549356|NCT01857869|565102541|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
156549357|NCT01857869|565102542|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
156549358|NCT01857869|565102543|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
156549359|NCT01857869|565102544|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
156549360|NCT01857869|565102545|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
156549361|NCT01857869|565102546|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
156549362|NCT01857869|565102547|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
156508892|NCT03083665|564955549|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
156508893|NCT03083665|564955550|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
156508894|NCT03083665|564955545|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
156508895|NCT03083665|564955546|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
156508896|NCT03083665|564955547|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
156508897|NCT03083665|564955548|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
156508898|NCT03083665|564955549|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
156508899|NCT03083665|564955550|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
156508900|NCT03083665|564955545|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
156508901|NCT03083665|564955546|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
156508902|NCT03083665|564955547|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
156508903|NCT03083665|564955548|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
156508904|NCT03083665|564955549|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
156508905|NCT03083665|564955550|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
156508906|NCT03083665|564955545|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
156508907|NCT03083665|564955546|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
156508908|NCT03083665|564955547|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
156508909|NCT03083665|564955548|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
156508910|NCT03083665|564955549|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
156508911|NCT03083665|564955550|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
156508912|NCT03635099|564955551|FG000|Period 1|Adverse Event|1|||
156508913|NCT03635099|564955552|FG001|Period 1|Adverse Event|0|||
156508914|NCT03635099|564955553|FG002|Period 1|Adverse Event|0|||
156508915|NCT03635099|564955554|FG003|Period 1|Adverse Event|1|||
156508916|NCT03635099|564955555|FG004|Period 1|Adverse Event|0|||
156508917|NCT03635099|564955556|FG005|Period 1|Adverse Event|0|||
156508918|NCT03635099|564955557|FG006|Period 1|Adverse Event|0|||
156508919|NCT03635099|564955558|FG007|Period 1|Adverse Event|0|||
156508920|NCT03635099|564955551|FG000|Period 1|Protocol Violation|0|||
156508921|NCT03635099|564955552|FG001|Period 1|Protocol Violation|0|||
156508922|NCT03635099|564955553|FG002|Period 1|Protocol Violation|1|||
156549363|NCT01857869|565102548|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
156549364|NCT01857869|565102539|FG000|Primary/Challenge Phase|Pregnancy|1|||
156549365|NCT01857869|565102540|FG001|Primary/Challenge Phase|Pregnancy|0|||
156549366|NCT01857869|565102541|FG002|Primary/Challenge Phase|Pregnancy|0|||
156549367|NCT01857869|565102542|FG003|Primary/Challenge Phase|Pregnancy|0|||
156549368|NCT01857869|565102543|FG004|Primary/Challenge Phase|Pregnancy|0|||
156549369|NCT01857869|565102544|FG005|Primary/Challenge Phase|Pregnancy|0|||
156549370|NCT01857869|565102545|FG006|Primary/Challenge Phase|Pregnancy|0|||
156549371|NCT01857869|565102546|FG007|Primary/Challenge Phase|Pregnancy|0|||
156549372|NCT01857869|565102547|FG008|Primary/Challenge Phase|Pregnancy|0|||
156549373|NCT01857869|565102548|FG009|Primary/Challenge Phase|Pregnancy|0|||
156396045|NCT02712905|564541723|FG013|Monotherapy|Physician Decision|0|||
156549374|NCT01857869|565102539|FG000|Primary/Challenge Phase|Protocol Violation|1|||
156549375|NCT01857869|565102540|FG001|Primary/Challenge Phase|Protocol Violation|0|||
156549376|NCT01857869|565102541|FG002|Primary/Challenge Phase|Protocol Violation|0|||
156549377|NCT01857869|565102542|FG003|Primary/Challenge Phase|Protocol Violation|0|||
156549378|NCT01857869|565102543|FG004|Primary/Challenge Phase|Protocol Violation|0|||
156549379|NCT01857869|565102544|FG005|Primary/Challenge Phase|Protocol Violation|0|||
156549380|NCT01857869|565102545|FG006|Primary/Challenge Phase|Protocol Violation|0|||
156549381|NCT01857869|565102546|FG007|Primary/Challenge Phase|Protocol Violation|0|||
156549382|NCT01857869|565102547|FG008|Primary/Challenge Phase|Protocol Violation|0|||
156549383|NCT01857869|565102548|FG009|Primary/Challenge Phase|Protocol Violation|0|||
156549384|NCT01857869|565102539|FG000|Primary/Challenge Phase|Other|1|||
156549385|NCT01857869|565102540|FG001|Primary/Challenge Phase|Other|1|||
156549386|NCT01857869|565102541|FG002|Primary/Challenge Phase|Other|0|||
156549387|NCT01857869|565102542|FG003|Primary/Challenge Phase|Other|0|||
156549388|NCT01857869|565102543|FG004|Primary/Challenge Phase|Other|0|||
156549389|NCT01857869|565102544|FG005|Primary/Challenge Phase|Other|0|||
156549390|NCT01857869|565102545|FG006|Primary/Challenge Phase|Other|0|||
156549391|NCT01857869|565102546|FG007|Primary/Challenge Phase|Other|0|||
156549392|NCT01857869|565102547|FG008|Primary/Challenge Phase|Other|0|||
156549393|NCT01857869|565102548|FG009|Primary/Challenge Phase|Other|0|||
156549394|NCT01857869|565102539|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549395|NCT01857869|565102540|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549396|NCT01857869|565102541|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549397|NCT01857869|565102542|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
156549398|NCT01857869|565102543|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549399|NCT01857869|565102544|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549400|NCT01857869|565102545|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549401|NCT01857869|565102546|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549402|NCT01857869|565102547|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549403|NCT01857869|565102548|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
156549404|NCT01857869|565102539|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549405|NCT01857869|565102540|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549406|NCT01857869|565102541|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549407|NCT01857869|565102542|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
156549408|NCT01857869|565102543|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549409|NCT01857869|565102544|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549410|NCT01857869|565102545|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549411|NCT01857869|565102546|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549412|NCT01857869|565102547|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549413|NCT01857869|565102548|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
156549414|NCT02728830|565102559|FG000|Overall Study|Exclusionary Surgery|9|||
156549415|NCT02728830|565102559|FG000|Overall Study|Exclusionary Pathology|6|||
156549416|NCT02728830|565102559|FG000|Overall Study|Physician Decision|3|||
156549417|NCT02728830|565102559|FG000|Overall Study|Withdrawal by Subject|2|||
156549418|NCT02728830|565102559|FG000|Overall Study|Lost to Follow-up|1|||
156549419|NCT02728830|565102559|FG000|Overall Study|Exclusionary Lab Values|1|||
156549420|NCT02728830|565102559|FG000|Overall Study|Contraindicated Illness|1|||
156549421|NCT02728830|565102559|FG000|Overall Study|Language Barrier|1|||
156549422|NCT01347554|565102560|FG000|Overall Study|Lack of Efficacy|7|||
156549423|NCT01347554|565102561|FG001|Overall Study|Lack of Efficacy|11|||
156549424|NCT03603496|565102562|FG000|Overall Study|Death|19|||
156549425|NCT03603496|565102563|FG001|Overall Study|Death|24|||
156549426|NCT03603496|565102562|FG000|Overall Study|Lost to Follow-up|141|||
156549427|NCT03603496|565102563|FG001|Overall Study|Lost to Follow-up|141|||
156549428|NCT03603496|565102562|FG000|Overall Study|Withdrawal by Subject|26|||
156549429|NCT03603496|565102563|FG001|Overall Study|Withdrawal by Subject|20|||
156549430|NCT00004259|565102566|FG000|Overall Study|Protocol Violation|1|||
156549431|NCT00004259|565102567|FG001|Overall Study|Protocol Violation|2|||
156396046|NCT02712905|564541724|FG014|Monotherapy|Physician Decision|0|||
156396047|NCT02712905|564541725|FG015|Monotherapy|Physician Decision|0|||
156396048|NCT02712905|564541726|FG016|Monotherapy|Physician Decision|0|||
156549432|NCT00004259|565102568|FG002|Overall Study|Protocol Violation|0|||
156396049|NCT02712905|564541727|FG017|Monotherapy|Physician Decision|0|||
156549433|NCT00004259|565102569|FG003|Overall Study|Protocol Violation|0|||
156549434|NCT00004259|565102566|FG000|Overall Study|Withdrawal by Subject|0|||
156549435|NCT00004259|565102567|FG001|Overall Study|Withdrawal by Subject|2|||
156396050|NCT02712905|564541710|FG000|Monotherapy|Study Terminated by Sponsor|0|||
156396051|NCT02712905|564541711|FG001|Monotherapy|Study Terminated by Sponsor|0|||
156396052|NCT02712905|564541712|FG002|Monotherapy|Study Terminated by Sponsor|0|||
156396053|NCT02712905|564541713|FG003|Monotherapy|Study Terminated by Sponsor|0|||
156396054|NCT02712905|564541714|FG004|Monotherapy|Study Terminated by Sponsor|1|||
156396055|NCT02712905|564541715|FG005|Monotherapy|Study Terminated by Sponsor|0|||
156396056|NCT02712905|564541716|FG006|Monotherapy|Study Terminated by Sponsor|0|||
156396057|NCT02712905|564541717|FG007|Monotherapy|Study Terminated by Sponsor|0|||
156396058|NCT02712905|564541718|FG008|Monotherapy|Study Terminated by Sponsor|0|||
156396059|NCT02712905|564541719|FG009|Monotherapy|Study Terminated by Sponsor|2|||
156396060|NCT02712905|564541720|FG010|Monotherapy|Study Terminated by Sponsor|0|||
156396061|NCT02712905|564541721|FG011|Monotherapy|Study Terminated by Sponsor|0|||
156396062|NCT02712905|564541722|FG012|Monotherapy|Study Terminated by Sponsor|0|||
156396063|NCT02712905|564541723|FG013|Monotherapy|Study Terminated by Sponsor|0|||
156396064|NCT02712905|564541724|FG014|Monotherapy|Study Terminated by Sponsor|0|||
156396065|NCT02712905|564541725|FG015|Monotherapy|Study Terminated by Sponsor|0|||
156396066|NCT02712905|564541726|FG016|Monotherapy|Study Terminated by Sponsor|0|||
156396067|NCT02712905|564541727|FG017|Monotherapy|Study Terminated by Sponsor|0|||
156396068|NCT02712905|564541710|FG000|Monotherapy|Withdrawal by Subject|0|||
156396069|NCT02712905|564541711|FG001|Monotherapy|Withdrawal by Subject|0|||
156396070|NCT02712905|564541712|FG002|Monotherapy|Withdrawal by Subject|1|||
156396071|NCT02712905|564541713|FG003|Monotherapy|Withdrawal by Subject|0|||
156396072|NCT02712905|564541714|FG004|Monotherapy|Withdrawal by Subject|2|||
156396073|NCT02712905|564541715|FG005|Monotherapy|Withdrawal by Subject|0|||
156396074|NCT02712905|564541716|FG006|Monotherapy|Withdrawal by Subject|0|||
156396075|NCT02712905|564541717|FG007|Monotherapy|Withdrawal by Subject|0|||
156396076|NCT02712905|564541718|FG008|Monotherapy|Withdrawal by Subject|0|||
156396077|NCT02712905|564541719|FG009|Monotherapy|Withdrawal by Subject|4|||
156396078|NCT02712905|564541720|FG010|Monotherapy|Withdrawal by Subject|1|||
156396079|NCT02712905|564541721|FG011|Monotherapy|Withdrawal by Subject|2|||
156396080|NCT02712905|564541722|FG012|Monotherapy|Withdrawal by Subject|0|||
156396081|NCT02712905|564541723|FG013|Monotherapy|Withdrawal by Subject|0|||
156396082|NCT02712905|564541724|FG014|Monotherapy|Withdrawal by Subject|0|||
156396083|NCT02712905|564541725|FG015|Monotherapy|Withdrawal by Subject|0|||
156396084|NCT02712905|564541726|FG016|Monotherapy|Withdrawal by Subject|0|||
156396085|NCT02712905|564541727|FG017|Monotherapy|Withdrawal by Subject|0|||
156396086|NCT02712905|564541710|FG000|Monotherapy|Started New Cancer Drug|0|||
156396087|NCT02712905|564541711|FG001|Monotherapy|Started New Cancer Drug|0|||
156396088|NCT02712905|564541712|FG002|Monotherapy|Started New Cancer Drug|0|||
156396089|NCT02712905|564541713|FG003|Monotherapy|Started New Cancer Drug|0|||
156396090|NCT02712905|564541714|FG004|Monotherapy|Started New Cancer Drug|0|||
156396091|NCT02712905|564541715|FG005|Monotherapy|Started New Cancer Drug|1|||
156396092|NCT02712905|564541716|FG006|Monotherapy|Started New Cancer Drug|0|||
156396093|NCT02712905|564541717|FG007|Monotherapy|Started New Cancer Drug|0|||
156396094|NCT02712905|564541718|FG008|Monotherapy|Started New Cancer Drug|0|||
156396095|NCT02712905|564541719|FG009|Monotherapy|Started New Cancer Drug|0|||
156396096|NCT02712905|564541720|FG010|Monotherapy|Started New Cancer Drug|0|||
156396097|NCT02712905|564541721|FG011|Monotherapy|Started New Cancer Drug|0|||
156396098|NCT02712905|564541722|FG012|Monotherapy|Started New Cancer Drug|0|||
156396099|NCT02712905|564541723|FG013|Monotherapy|Started New Cancer Drug|0|||
156396100|NCT02712905|564541724|FG014|Monotherapy|Started New Cancer Drug|0|||
156396101|NCT02712905|564541725|FG015|Monotherapy|Started New Cancer Drug|0|||
156396102|NCT02712905|564541726|FG016|Monotherapy|Started New Cancer Drug|0|||
156396103|NCT02712905|564541727|FG017|Monotherapy|Started New Cancer Drug|0|||
156396104|NCT02712905|564541710|FG000|Monotherapy|Adverse Event|0|||
156396105|NCT02712905|564541711|FG001|Monotherapy|Adverse Event|0|||
156396106|NCT02712905|564541712|FG002|Monotherapy|Adverse Event|0|||
156396107|NCT02712905|564541713|FG003|Monotherapy|Adverse Event|0|||
156396108|NCT02712905|564541714|FG004|Monotherapy|Adverse Event|0|||
156396109|NCT02712905|564541715|FG005|Monotherapy|Adverse Event|0|||
156396110|NCT02712905|564541716|FG006|Monotherapy|Adverse Event|0|||
156396111|NCT02712905|564541717|FG007|Monotherapy|Adverse Event|0|||
156396112|NCT02712905|564541718|FG008|Monotherapy|Adverse Event|1|||
156396113|NCT02712905|564541719|FG009|Monotherapy|Adverse Event|0|||
156396114|NCT02712905|564541720|FG010|Monotherapy|Adverse Event|0|||
156396115|NCT02712905|564541721|FG011|Monotherapy|Adverse Event|0|||
156396116|NCT02712905|564541722|FG012|Monotherapy|Adverse Event|0|||
156396117|NCT02712905|564541723|FG013|Monotherapy|Adverse Event|0|||
156396118|NCT02712905|564541724|FG014|Monotherapy|Adverse Event|0|||
156396119|NCT02712905|564541725|FG015|Monotherapy|Adverse Event|0|||
156396120|NCT02712905|564541726|FG016|Monotherapy|Adverse Event|0|||
156396121|NCT02712905|564541727|FG017|Monotherapy|Adverse Event|0|||
156396122|NCT02712905|564541710|FG000|Combination Therapy|Death|0|||
156396123|NCT02712905|564541711|FG001|Combination Therapy|Death|0|||
156396124|NCT02712905|564541712|FG002|Combination Therapy|Death|0|||
156396125|NCT02712905|564541713|FG003|Combination Therapy|Death|0|||
156396126|NCT02712905|564541714|FG004|Combination Therapy|Death|0|||
156396127|NCT02712905|564541715|FG005|Combination Therapy|Death|0|||
156396128|NCT02712905|564541716|FG006|Combination Therapy|Death|0|||
156396129|NCT02712905|564541717|FG007|Combination Therapy|Death|0|||
156396130|NCT02712905|564541718|FG008|Combination Therapy|Death|0|||
156396131|NCT02712905|564541719|FG009|Combination Therapy|Death|0|||
156396132|NCT02712905|564541720|FG010|Combination Therapy|Death|0|||
156396133|NCT02712905|564541721|FG011|Combination Therapy|Death|0|||
156396134|NCT02712905|564541722|FG012|Combination Therapy|Death|5|||
156396135|NCT02712905|564541723|FG013|Combination Therapy|Death|6|||
156396136|NCT02712905|564541724|FG014|Combination Therapy|Death|1|||
156396137|NCT02712905|564541725|FG015|Combination Therapy|Death|3|||
156396138|NCT02712905|564541726|FG016|Combination Therapy|Death|1|||
156396139|NCT02712905|564541727|FG017|Combination Therapy|Death|3|||
156396140|NCT02712905|564541710|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
156396141|NCT02712905|564541711|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
156396142|NCT02712905|564541712|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
156396143|NCT02712905|564541713|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
156396144|NCT02712905|564541714|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
156396145|NCT02712905|564541715|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
156396146|NCT02712905|564541716|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
156396147|NCT02712905|564541717|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
156396148|NCT02712905|564541718|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
156396149|NCT02712905|564541719|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
156396150|NCT02712905|564541720|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
156396151|NCT02712905|564541721|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
156396152|NCT02712905|564541722|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
156396153|NCT02712905|564541723|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
156396154|NCT02712905|564541724|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
156396155|NCT02712905|564541725|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
156396156|NCT02712905|564541726|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
156396157|NCT02712905|564541727|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
156396158|NCT02712905|564541710|FG000|Combination Therapy|Withdrawal by Subject|0|||
156396159|NCT02712905|564541711|FG001|Combination Therapy|Withdrawal by Subject|0|||
156396160|NCT02712905|564541712|FG002|Combination Therapy|Withdrawal by Subject|0|||
156396161|NCT02712905|564541713|FG003|Combination Therapy|Withdrawal by Subject|0|||
156396162|NCT02712905|564541714|FG004|Combination Therapy|Withdrawal by Subject|0|||
156396163|NCT02712905|564541715|FG005|Combination Therapy|Withdrawal by Subject|0|||
156396164|NCT02712905|564541716|FG006|Combination Therapy|Withdrawal by Subject|0|||
156396165|NCT02712905|564541717|FG007|Combination Therapy|Withdrawal by Subject|0|||
156396166|NCT02712905|564541718|FG008|Combination Therapy|Withdrawal by Subject|0|||
156396167|NCT02712905|564541719|FG009|Combination Therapy|Withdrawal by Subject|0|||
156396168|NCT02712905|564541720|FG010|Combination Therapy|Withdrawal by Subject|0|||
156396169|NCT02712905|564541721|FG011|Combination Therapy|Withdrawal by Subject|0|||
156396170|NCT02712905|564541722|FG012|Combination Therapy|Withdrawal by Subject|0|||
156396171|NCT02712905|564541723|FG013|Combination Therapy|Withdrawal by Subject|0|||
156396172|NCT02712905|564541724|FG014|Combination Therapy|Withdrawal by Subject|0|||
156396173|NCT02712905|564541725|FG015|Combination Therapy|Withdrawal by Subject|1|||
156396174|NCT02712905|564541726|FG016|Combination Therapy|Withdrawal by Subject|0|||
156396175|NCT02712905|564541727|FG017|Combination Therapy|Withdrawal by Subject|2|||
156396176|NCT02712905|564541710|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396177|NCT02712905|564541711|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396178|NCT02712905|564541712|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396179|NCT02712905|564541713|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396180|NCT02712905|564541714|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396181|NCT02712905|564541715|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396182|NCT02712905|564541716|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396183|NCT02712905|564541717|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396184|NCT02712905|564541718|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396185|NCT02712905|564541719|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396186|NCT02712905|564541720|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396187|NCT02712905|564541721|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396188|NCT02712905|564541722|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396189|NCT02712905|564541723|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156508923|NCT03635099|564955554|FG003|Period 1|Protocol Violation|0|||
156508924|NCT03635099|564955555|FG004|Period 1|Protocol Violation|0|||
156508925|NCT03635099|564955556|FG005|Period 1|Protocol Violation|0|||
156508926|NCT03635099|564955557|FG006|Period 1|Protocol Violation|0|||
156508927|NCT03635099|564955558|FG007|Period 1|Protocol Violation|0|||
156508928|NCT03635099|564955551|FG000|Period 1|Lost to Follow-up|0|||
156508929|NCT03635099|564955552|FG001|Period 1|Lost to Follow-up|0|||
156508930|NCT03635099|564955553|FG002|Period 1|Lost to Follow-up|1|||
156508931|NCT03635099|564955554|FG003|Period 1|Lost to Follow-up|2|||
156508932|NCT03635099|564955555|FG004|Period 1|Lost to Follow-up|1|||
156508933|NCT03635099|564955556|FG005|Period 1|Lost to Follow-up|0|||
156549436|NCT00004259|565102568|FG002|Overall Study|Withdrawal by Subject|0|||
156549437|NCT00004259|565102569|FG003|Overall Study|Withdrawal by Subject|0|||
156549438|NCT03594227|565102570|FG000|Overall Study|Adverse Event|2|||
156549439|NCT03594227|565102571|FG001|Overall Study|Adverse Event|1|||
156549440|NCT03594227|565102572|FG002|Overall Study|Adverse Event|0|||
156549441|NCT03594227|565102573|FG003|Overall Study|Adverse Event|2|||
156549442|NCT03594227|565102570|FG000|Overall Study|Lost to Follow-up|1|||
156549443|NCT03594227|565102571|FG001|Overall Study|Lost to Follow-up|1|||
156549444|NCT03594227|565102572|FG002|Overall Study|Lost to Follow-up|1|||
156549445|NCT03594227|565102573|FG003|Overall Study|Lost to Follow-up|0|||
156549446|NCT03594227|565102570|FG000|Overall Study|Withdrawal by Subject|1|||
156549447|NCT03594227|565102571|FG001|Overall Study|Withdrawal by Subject|1|||
156549448|NCT03594227|565102572|FG002|Overall Study|Withdrawal by Subject|1|||
156549449|NCT03594227|565102573|FG003|Overall Study|Withdrawal by Subject|1|||
156549450|NCT03594227|565102570|FG000|Overall Study|Pregnancy|0|||
156549451|NCT03594227|565102571|FG001|Overall Study|Pregnancy|1|||
156549452|NCT03594227|565102572|FG002|Overall Study|Pregnancy|0|||
156549453|NCT03594227|565102573|FG003|Overall Study|Pregnancy|0|||
156549454|NCT03594227|565102570|FG000|Overall Study|Sponsor Decision|0|||
156549455|NCT03594227|565102571|FG001|Overall Study|Sponsor Decision|0|||
156549456|NCT03594227|565102572|FG002|Overall Study|Sponsor Decision|0|||
156549457|NCT03594227|565102573|FG003|Overall Study|Sponsor Decision|1|||
156549458|NCT03594227|565102570|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
156549459|NCT03594227|565102571|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
156549460|NCT03594227|565102572|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
156549461|NCT03594227|565102573|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
156549462|NCT00790907|565102574|FG000|Overall Study|Adverse Event|9|||
156549463|NCT00790907|565102575|FG001|Overall Study|Adverse Event|7|||
156549464|NCT00790907|565102576|FG002|Overall Study|Adverse Event|6|||
156549465|NCT00790907|565102574|FG000|Overall Study|Physician Decision|304|||
156549466|NCT00790907|565102575|FG001|Overall Study|Physician Decision|271|||
156549467|NCT00790907|565102576|FG002|Overall Study|Physician Decision|255|||
156549468|NCT00790907|565102574|FG000|Overall Study|Withdrawal by Subject|1|||
156549469|NCT00790907|565102575|FG001|Overall Study|Withdrawal by Subject|7|||
156549470|NCT00790907|565102576|FG002|Overall Study|Withdrawal by Subject|5|||
156549471|NCT00790907|565102574|FG000|Overall Study|Bleeding Event|11|||
156549472|NCT00790907|565102575|FG001|Overall Study|Bleeding Event|16|||
156549473|NCT00790907|565102576|FG002|Overall Study|Bleeding Event|21|||
156549474|NCT00790907|565102574|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
156549475|NCT00790907|565102575|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
156549476|NCT00790907|565102576|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
156549477|NCT00790907|565102574|FG000|Overall Study|Qualifying Condition Not Present|29|||
156549478|NCT00790907|565102575|FG001|Overall Study|Qualifying Condition Not Present|14|||
156549479|NCT00790907|565102576|FG002|Overall Study|Qualifying Condition Not Present|16|||
156549480|NCT00790907|565102574|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
156549481|NCT00790907|565102575|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
156549482|NCT00790907|565102576|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
156549483|NCT00790907|565102574|FG000|Overall Study|Did Not Receive Study Drug|10|||
156549484|NCT00790907|565102575|FG001|Overall Study|Did Not Receive Study Drug|0|||
156549485|NCT00790907|565102576|FG002|Overall Study|Did Not Receive Study Drug|0|||
156549486|NCT00774345|565102577|FG000|Pre-treatment|Other reasons|2|||
156549487|NCT00774345|565102578|FG001|Pre-treatment|Other reasons|0|||
156549488|NCT00774345|565102577|FG000|Treatment|Adverse Event|61|||
156549489|NCT00774345|565102578|FG001|Treatment|Adverse Event|15|||
156549490|NCT00774345|565102577|FG000|Treatment|Progressive Disease without histologic transformation|51|||
156549491|NCT00774345|565102578|FG001|Treatment|Progressive Disease without histologic transformation|111|||
156549492|NCT00774345|565102577|FG000|Treatment|Progressive Disease with histologic transformation|4|||
156549493|NCT00774345|565102578|FG001|Treatment|Progressive Disease with histologic transformation|2|||
156549494|NCT00774345|565102577|FG000|Treatment|Withdrawal by Subject|5|||
156549495|NCT00774345|565102578|FG001|Treatment|Withdrawal by Subject|2|||
156549496|NCT00774345|565102577|FG000|Treatment|Lost to Follow-up|1|||
156549497|NCT00774345|565102578|FG001|Treatment|Lost to Follow-up|1|||
156549498|NCT00774345|565102577|FG000|Treatment|Death|4|||
156549499|NCT00774345|565102578|FG001|Treatment|Death|0|||
156396190|NCT02712905|564541724|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396191|NCT02712905|564541725|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
156396192|NCT02712905|564541726|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156549500|NCT00774345|565102577|FG000|Treatment|Other Reasons|32|||
156549501|NCT00774345|565102578|FG001|Treatment|Other Reasons|26|||
156549502|NCT02873936|565102586|FG000|Overall Study|Withdrew Consent|4|||
156549503|NCT02873936|565102587|FG001|Overall Study|Withdrew Consent|11|||
156549504|NCT02873936|565102588|FG002|Overall Study|Withdrew Consent|20|||
156549505|NCT02873936|565102586|FG000|Overall Study|Investigator's Discretion|3|||
156549506|NCT02873936|565102587|FG001|Overall Study|Investigator's Discretion|5|||
156549507|NCT02873936|565102588|FG002|Overall Study|Investigator's Discretion|4|||
156549508|NCT02873936|565102586|FG000|Overall Study|Adverse Event|3|||
156549509|NCT02873936|565102587|FG001|Overall Study|Adverse Event|5|||
156549510|NCT02873936|565102588|FG002|Overall Study|Adverse Event|3|||
156549511|NCT02873936|565102586|FG000|Overall Study|Protocol Violation|0|||
156549512|NCT02873936|565102587|FG001|Overall Study|Protocol Violation|1|||
156549513|NCT02873936|565102588|FG002|Overall Study|Protocol Violation|3|||
156549514|NCT02873936|565102586|FG000|Overall Study|Lost to Follow-up|1|||
156549515|NCT02873936|565102587|FG001|Overall Study|Lost to Follow-up|1|||
156549516|NCT02873936|565102588|FG002|Overall Study|Lost to Follow-up|1|||
156549517|NCT02873936|565102586|FG000|Overall Study|Non-compliance With Study Drug|1|||
156549518|NCT02873936|565102587|FG001|Overall Study|Non-compliance With Study Drug|0|||
156549519|NCT02873936|565102588|FG002|Overall Study|Non-compliance With Study Drug|1|||
156549520|NCT02873936|565102586|FG000|Overall Study|Randomized but not Dosed|1|||
156549521|NCT02873936|565102587|FG001|Overall Study|Randomized but not Dosed|0|||
156549522|NCT02873936|565102588|FG002|Overall Study|Randomized but not Dosed|0|||
156549523|NCT01967537|565102589|FG000|Overall Study|Withdrawal by Subject|52|||
156549524|NCT01967537|565102589|FG000|Overall Study|Refuse treatment|2|||
156549525|NCT01967537|565102589|FG000|Overall Study|Lost to Follow-up|6|||
156549526|NCT01836783|565102594|FG000|Overall Study|Withdrawal by Subject|0|||
156549527|NCT01836783|565102595|FG001|Overall Study|Withdrawal by Subject|2|||
156549528|NCT01452152|565102601|FG000|Overall Study|Study termination by sponsor|5|||
156549529|NCT01452152|565102602|FG001|Overall Study|Study termination by sponsor|0|||
156549530|NCT01452152|565102603|FG002|Overall Study|Study termination by sponsor|4|||
156549531|NCT02867995|565102605|FG000|Overall Study|Withdrawal by Subject|0|||
156549532|NCT02867995|565102606|FG001|Overall Study|Withdrawal by Subject|1|||
156549533|NCT02867995|565102605|FG000|Overall Study|Lost to Follow-up|0|||
156549534|NCT02867995|565102606|FG001|Overall Study|Lost to Follow-up|2|||
156549535|NCT03315871|565102607|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
156549536|NCT03315871|565102608|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
156549537|NCT03315871|565102609|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
156549538|NCT03315871|565102607|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
156549539|NCT03315871|565102608|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
156549540|NCT03315871|565102609|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
156549541|NCT03315871|565102607|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
156549542|NCT03315871|565102608|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
156549543|NCT03315871|565102609|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
156549544|NCT03315871|565102607|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
156549545|NCT03315871|565102608|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
156549546|NCT03315871|565102609|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
156549547|NCT03315871|565102607|FG000|PROSTVAC + CV301|Progressive disease|0|||
156549548|NCT03315871|565102608|FG001|PROSTVAC + CV301|Progressive disease|0|||
156549549|NCT03315871|565102609|FG002|PROSTVAC + CV301|Progressive disease|1|||
156549550|NCT03315871|565102607|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
156549551|NCT03315871|565102608|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
156549552|NCT03315871|565102609|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
156549553|NCT04099251|565103678|FG000|Pre-Treatment|Other reasons|1|||
156549554|NCT04099251|565103679|FG001|Pre-Treatment|Other reasons|0|||
156549555|NCT04099251|565103678|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
156549556|NCT04099251|565103679|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
156549557|NCT04099251|565103678|FG000|Blinded Treatment Phase|Other reasons|16|||
156549558|NCT04099251|565103679|FG001|Blinded Treatment Phase|Other reasons|7|||
156549559|NCT04099251|565103678|FG000|Blinded Treatment Phase|Disease recurrence|26|||
156549560|NCT04099251|565103679|FG001|Blinded Treatment Phase|Disease recurrence|41|||
156549561|NCT04099251|565103678|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
156549562|NCT04099251|565103679|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
156549563|NCT04099251|565103678|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
156549564|NCT04099251|565103679|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
156549565|NCT04099251|565103678|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
156549566|NCT04099251|565103679|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
156549567|NCT04099251|565103678|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
156549568|NCT04099251|565103679|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
156549569|NCT04099251|565103678|FG000|Blinded Treatment Phase|Death|6|||
156549570|NCT04099251|565103679|FG001|Blinded Treatment Phase|Death|2|||
156549571|NCT04099251|565103678|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
156549572|NCT04099251|565103679|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
156549573|NCT04099251|565103678|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
156549574|NCT04099251|565103679|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
156549575|NCT04099251|565103678|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
156549576|NCT04099251|565103679|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
156549577|NCT04099251|565103678|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
156549578|NCT04099251|565103679|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
156508934|NCT03635099|564955557|FG006|Period 1|Lost to Follow-up|1|||
156508935|NCT03635099|564955558|FG007|Period 1|Lost to Follow-up|2|||
156508936|NCT03635099|564955551|FG000|Period 1|Withdrawal by Subject|3|||
156508937|NCT03635099|564955552|FG001|Period 1|Withdrawal by Subject|3|||
156508938|NCT03635099|564955553|FG002|Period 1|Withdrawal by Subject|5|||
156508939|NCT03635099|564955554|FG003|Period 1|Withdrawal by Subject|2|||
156508940|NCT03635099|564955555|FG004|Period 1|Withdrawal by Subject|2|||
156508941|NCT03635099|564955556|FG005|Period 1|Withdrawal by Subject|0|||
156508942|NCT03635099|564955557|FG006|Period 1|Withdrawal by Subject|3|||
156508943|NCT03635099|564955558|FG007|Period 1|Withdrawal by Subject|0|||
156508944|NCT03635099|564955551|FG000|Period 1|History of suicidal ideation|0|||
156508945|NCT03635099|564955552|FG001|Period 1|History of suicidal ideation|0|||
156508946|NCT03635099|564955553|FG002|Period 1|History of suicidal ideation|1|||
156508947|NCT03635099|564955554|FG003|Period 1|History of suicidal ideation|0|||
156508948|NCT03635099|564955555|FG004|Period 1|History of suicidal ideation|0|||
156508949|NCT03635099|564955556|FG005|Period 1|History of suicidal ideation|0|||
156508950|NCT03635099|564955557|FG006|Period 1|History of suicidal ideation|0|||
156508951|NCT03635099|564955558|FG007|Period 1|History of suicidal ideation|0|||
156508952|NCT03635099|564955551|FG000|Period 1|pursue other treatment options|0|||
156508953|NCT03635099|564955552|FG001|Period 1|pursue other treatment options|0|||
156508954|NCT03635099|564955553|FG002|Period 1|pursue other treatment options|0|||
156508955|NCT03635099|564955554|FG003|Period 1|pursue other treatment options|0|||
156508956|NCT03635099|564955555|FG004|Period 1|pursue other treatment options|0|||
156508957|NCT03635099|564955556|FG005|Period 1|pursue other treatment options|1|||
156508958|NCT03635099|564955557|FG006|Period 1|pursue other treatment options|0|||
156508959|NCT03635099|564955558|FG007|Period 1|pursue other treatment options|0|||
156508960|NCT03635099|564955551|FG000|Not Eligible for Period 2|Pregnancy|0|||
156508961|NCT03635099|564955552|FG001|Not Eligible for Period 2|Pregnancy|0|||
156508962|NCT03635099|564955553|FG002|Not Eligible for Period 2|Pregnancy|0|||
156508963|NCT03635099|564955554|FG003|Not Eligible for Period 2|Pregnancy|1|||
156508964|NCT03635099|564955555|FG004|Not Eligible for Period 2|Pregnancy|0|||
156508965|NCT03635099|564955556|FG005|Not Eligible for Period 2|Pregnancy|0|||
156508966|NCT03635099|564955557|FG006|Not Eligible for Period 2|Pregnancy|0|||
156508967|NCT03635099|564955558|FG007|Not Eligible for Period 2|Pregnancy|0|||
156508968|NCT03635099|564955551|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
156508969|NCT03635099|564955552|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
156508970|NCT03635099|564955553|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
156508971|NCT03635099|564955554|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
156508972|NCT03635099|564955555|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
156508973|NCT03635099|564955556|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
156508974|NCT03635099|564955557|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
156508975|NCT03635099|564955558|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
156508976|NCT03635099|564955551|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
156508977|NCT03635099|564955552|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
156508978|NCT03635099|564955553|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
156508979|NCT03635099|564955554|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
156508980|NCT03635099|564955555|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
156508981|NCT03635099|564955556|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
156508982|NCT03635099|564955557|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
156508983|NCT03635099|564955558|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
156508984|NCT03635099|564955551|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
156508985|NCT03635099|564955552|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
156508986|NCT03635099|564955553|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
156508987|NCT03635099|564955554|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
156508988|NCT03635099|564955555|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
156508989|NCT03635099|564955556|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
156508990|NCT03635099|564955557|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
156508991|NCT03635099|564955558|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
156508992|NCT03635099|564955551|FG000|Period 2|Adverse Event|0|||
156508993|NCT03635099|564955552|FG001|Period 2|Adverse Event|0|||
156508994|NCT03635099|564955553|FG002|Period 2|Adverse Event|1|||
156508995|NCT03635099|564955554|FG003|Period 2|Adverse Event|0|||
156508996|NCT03635099|564955555|FG004|Period 2|Adverse Event|1|||
156508997|NCT03635099|564955556|FG005|Period 2|Adverse Event|0|||
156508998|NCT03635099|564955557|FG006|Period 2|Adverse Event|0|||
156508999|NCT03635099|564955558|FG007|Period 2|Adverse Event|0|||
156509000|NCT03635099|564955551|FG000|Period 2|Lost to Follow-up|0|||
156509001|NCT03635099|564955552|FG001|Period 2|Lost to Follow-up|0|||
156509002|NCT03635099|564955553|FG002|Period 2|Lost to Follow-up|1|||
156509003|NCT03635099|564955554|FG003|Period 2|Lost to Follow-up|0|||
156549579|NCT04099251|565103678|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
156549580|NCT04099251|565103679|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
156549581|NCT04099251|565103678|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
156549582|NCT04099251|565103679|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
156549583|NCT04099251|565103678|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
156549584|NCT04099251|565103679|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
156396193|NCT02712905|564541727|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156396194|NCT03178266|564541730|FG000|Overall Study|Death|0|||
156396195|NCT03178266|564541731|FG001|Overall Study|Death|1|||
156396196|NCT03178266|564541730|FG000|Overall Study|Disont. Early|0|||
156396197|NCT03178266|564541731|FG001|Overall Study|Disont. Early|1|||
156396198|NCT03178266|564541730|FG000|Overall Study|Withdrawal by Subject|0|||
156396199|NCT03178266|564541731|FG001|Overall Study|Withdrawal by Subject|2|||
156396200|NCT01812655|564541732|FG000|Overall Study|Protocol Violation|1|||
156396201|NCT01812655|564541733|FG001|Overall Study|Protocol Violation|1|||
156396202|NCT01812655|564541734|FG002|Overall Study|Protocol Violation|0|||
156396203|NCT02363946|564541735|FG000|Overall Study|Lost to Follow-up|0|||
156396204|NCT02363946|564541736|FG001|Overall Study|Lost to Follow-up|0|||
156396205|NCT02363946|564541737|FG002|Overall Study|Lost to Follow-up|0|||
156396206|NCT02363946|564541738|FG003|Overall Study|Lost to Follow-up|0|||
156396207|NCT02363946|564541739|FG004|Overall Study|Lost to Follow-up|0|||
156396208|NCT02363946|564541740|FG005|Overall Study|Lost to Follow-up|0|||
156396209|NCT02363946|564541741|FG006|Overall Study|Lost to Follow-up|0|||
156396210|NCT02363946|564541742|FG007|Overall Study|Lost to Follow-up|1|||
156396211|NCT02363946|564541743|FG008|Overall Study|Lost to Follow-up|0|||
156396212|NCT02363946|564541744|FG009|Overall Study|Lost to Follow-up|0|||
156396213|NCT02363946|564541745|FG010|Overall Study|Lost to Follow-up|0|||
156396214|NCT02363946|564541746|FG011|Overall Study|Lost to Follow-up|0|||
156396215|NCT02363946|564541747|FG012|Overall Study|Lost to Follow-up|0|||
156396216|NCT04435665|564541748|FG000|Overall Study|Lost to Follow-up|0|||
156396217|NCT04435665|564541749|FG001|Overall Study|Lost to Follow-up|0|||
156396218|NCT04435665|564541750|FG002|Overall Study|Lost to Follow-up|0|||
156396219|NCT04435665|564541751|FG003|Overall Study|Lost to Follow-up|1|||
156396220|NCT00419263|564541752|FG000|Overall Study|Lost to Follow-up|2|||
156396221|NCT00419263|564541753|FG001|Overall Study|Lost to Follow-up|1|||
156396222|NCT00419263|564541754|FG002|Overall Study|Lost to Follow-up|1|||
156396223|NCT00419263|564541752|FG000|Overall Study|Randomized in Error, Not Treated|1|||
156396224|NCT00419263|564541753|FG001|Overall Study|Randomized in Error, Not Treated|1|||
156396225|NCT00419263|564541754|FG002|Overall Study|Randomized in Error, Not Treated|0|||
156396226|NCT00419263|564541752|FG000|Overall Study|Adverse Event|0|||
156396227|NCT00419263|564541753|FG001|Overall Study|Adverse Event|0|||
156396228|NCT00419263|564541754|FG002|Overall Study|Adverse Event|1|||
156396229|NCT00419263|564541752|FG000|Overall Study|Withdrawal by Subject|0|||
156396230|NCT00419263|564541753|FG001|Overall Study|Withdrawal by Subject|0|||
156396231|NCT00419263|564541754|FG002|Overall Study|Withdrawal by Subject|1|||
156396232|NCT02342886|564541755|FG000|Overall Study|Treatment non-compliance|1|||
156396233|NCT02342886|564541756|FG001|Overall Study|Treatment non-compliance|0|||
156396234|NCT02342886|564541757|FG002|Overall Study|Treatment non-compliance|0|||
156396235|NCT02342886|564541758|FG003|Overall Study|Treatment non-compliance|1|||
156396236|NCT02342886|564541759|FG004|Overall Study|Treatment non-compliance|0|||
156396237|NCT02342886|564541755|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
156396238|NCT02342886|564541756|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
156396239|NCT02342886|564541757|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
156396240|NCT02342886|564541758|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
156396241|NCT02342886|564541759|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
156396242|NCT02342886|564541755|FG000|Overall Study|Adverse event/specific toxicity|4|||
156396243|NCT02342886|564541756|FG001|Overall Study|Adverse event/specific toxicity|3|||
156396244|NCT02342886|564541757|FG002|Overall Study|Adverse event/specific toxicity|11|||
156396245|NCT02342886|564541758|FG003|Overall Study|Adverse event/specific toxicity|2|||
156396246|NCT02342886|564541759|FG004|Overall Study|Adverse event/specific toxicity|1|||
156396247|NCT02342886|564541755|FG000|Overall Study|Lost to Follow-up|1|||
156396248|NCT02342886|564541756|FG001|Overall Study|Lost to Follow-up|0|||
156396249|NCT02342886|564541757|FG002|Overall Study|Lost to Follow-up|0|||
156396250|NCT02342886|564541758|FG003|Overall Study|Lost to Follow-up|0|||
156396251|NCT02342886|564541759|FG004|Overall Study|Lost to Follow-up|0|||
156396252|NCT02342886|564541755|FG000|Overall Study|Death|1|||
156396253|NCT02342886|564541756|FG001|Overall Study|Death|2|||
156396254|NCT02342886|564541757|FG002|Overall Study|Death|1|||
156396255|NCT02342886|564541758|FG003|Overall Study|Death|0|||
156396256|NCT02342886|564541759|FG004|Overall Study|Death|1|||
156396257|NCT02342886|564541755|FG000|Overall Study|Withdrawal by Subject|0|||
156396258|NCT02342886|564541756|FG001|Overall Study|Withdrawal by Subject|1|||
156396259|NCT02342886|564541757|FG002|Overall Study|Withdrawal by Subject|0|||
156396260|NCT02342886|564541758|FG003|Overall Study|Withdrawal by Subject|1|||
156396261|NCT02342886|564541759|FG004|Overall Study|Withdrawal by Subject|0|||
156396262|NCT02342886|564541755|FG000|Overall Study|Investigator/sponsor decision|0|||
156396263|NCT02342886|564541756|FG001|Overall Study|Investigator/sponsor decision|2|||
156396264|NCT02342886|564541757|FG002|Overall Study|Investigator/sponsor decision|0|||
156396265|NCT02342886|564541758|FG003|Overall Study|Investigator/sponsor decision|3|||
156396266|NCT02342886|564541759|FG004|Overall Study|Investigator/sponsor decision|1|||
156396267|NCT02342886|564541755|FG000|Overall Study|Pregnancy|0|||
156396268|NCT02342886|564541756|FG001|Overall Study|Pregnancy|0|||
156396269|NCT02342886|564541757|FG002|Overall Study|Pregnancy|2|||
156396270|NCT02342886|564541758|FG003|Overall Study|Pregnancy|0|||
156396271|NCT02342886|564541759|FG004|Overall Study|Pregnancy|0|||
156396272|NCT02342886|564541755|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
156396273|NCT02342886|564541756|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
156396274|NCT02342886|564541757|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
156396275|NCT02342886|564541758|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
156396276|NCT02342886|564541759|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
156396277|NCT02342886|564541755|FG000|Overall Study|Protocol Violation|0|||
156396278|NCT02342886|564541756|FG001|Overall Study|Protocol Violation|0|||
156396279|NCT02342886|564541757|FG002|Overall Study|Protocol Violation|0|||
156396280|NCT02342886|564541758|FG003|Overall Study|Protocol Violation|2|||
156396281|NCT02342886|564541759|FG004|Overall Study|Protocol Violation|0|||
156396282|NCT00862134|564541763|FG000|Overall Study|Death|1|||
156396283|NCT00862134|564541764|FG001|Overall Study|Death|0|||
156396284|NCT00862134|564541763|FG000|Overall Study|Physician Decision|0|||
156396285|NCT00862134|564541764|FG001|Overall Study|Physician Decision|1|||
156396286|NCT00862134|564541763|FG000|Overall Study|Withdrawal by Subject|1|||
156396287|NCT00862134|564541764|FG001|Overall Study|Withdrawal by Subject|2|||
156396288|NCT00862134|564541763|FG000|Overall Study|Sponsor terminated study|5|||
156396289|NCT00862134|564541764|FG001|Overall Study|Sponsor terminated study|7|||
156396290|NCT00862134|564541763|FG000|Overall Study|Adverse Event|2|||
156396291|NCT00862134|564541764|FG001|Overall Study|Adverse Event|2|||
156396292|NCT00862134|564541763|FG000|Overall Study|Withdrew prior to dosing|2|||
156396293|NCT00862134|564541764|FG001|Overall Study|Withdrew prior to dosing|0|||
156396294|NCT00765674|564541765|FG000|Overall Study|Adverse Event|7|||
156396295|NCT00765674|564541766|FG001|Overall Study|Adverse Event|2|||
156396296|NCT00765674|564541767|FG002|Overall Study|Adverse Event|8|||
156396297|NCT00765674|564541768|FG003|Overall Study|Adverse Event|11|||
156396298|NCT00765674|564541765|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
156396299|NCT00765674|564541766|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
156396300|NCT00765674|564541767|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
156396301|NCT00765674|564541768|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
156396302|NCT00765674|564541765|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
156396303|NCT00765674|564541766|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
156396304|NCT00765674|564541767|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
156396305|NCT00765674|564541768|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
156396306|NCT00765674|564541765|FG000|Overall Study|Lack of Efficacy|2|||
156396307|NCT00765674|564541766|FG001|Overall Study|Lack of Efficacy|3|||
156396308|NCT00765674|564541767|FG002|Overall Study|Lack of Efficacy|1|||
156396309|NCT00765674|564541768|FG003|Overall Study|Lack of Efficacy|2|||
156396310|NCT00765674|564541765|FG000|Overall Study|Protocol Violation|2|||
156396311|NCT00765674|564541766|FG001|Overall Study|Protocol Violation|0|||
156396312|NCT00765674|564541767|FG002|Overall Study|Protocol Violation|1|||
156396313|NCT00765674|564541768|FG003|Overall Study|Protocol Violation|0|||
156396314|NCT00765674|564541765|FG000|Overall Study|Withdrawal by Subject|5|||
156396315|NCT00765674|564541766|FG001|Overall Study|Withdrawal by Subject|7|||
156396316|NCT00765674|564541767|FG002|Overall Study|Withdrawal by Subject|3|||
156396317|NCT00765674|564541768|FG003|Overall Study|Withdrawal by Subject|8|||
156396318|NCT00765674|564541765|FG000|Overall Study|Lost to Follow-up|4|||
156396319|NCT00765674|564541766|FG001|Overall Study|Lost to Follow-up|6|||
156396320|NCT00765674|564541767|FG002|Overall Study|Lost to Follow-up|2|||
156396321|NCT00765674|564541768|FG003|Overall Study|Lost to Follow-up|1|||
156396322|NCT00765674|564541765|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
156396323|NCT00765674|564541766|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
156396324|NCT00765674|564541767|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
156396325|NCT00765674|564541768|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
156396326|NCT03015402|564541769|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
156396327|NCT03015402|564541770|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
156396328|NCT03015402|564541769|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
156396329|NCT03015402|564541770|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
156396330|NCT00316082|564541771|FG000|Overall Study|Lack of Efficacy|2|||
156396331|NCT00316082|564541772|FG001|Overall Study|Lack of Efficacy|3|||
156396332|NCT00316082|564541773|FG002|Overall Study|Lack of Efficacy|3|||
156396333|NCT00316082|564541774|FG003|Overall Study|Lack of Efficacy|4|||
156396334|NCT00316082|564541775|FG004|Overall Study|Lack of Efficacy|6|||
156396335|NCT00316082|564541771|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
156396336|NCT00316082|564541772|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
156396337|NCT00316082|564541773|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
156396338|NCT00316082|564541774|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
156396339|NCT00316082|564541775|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
156396340|NCT00316082|564541771|FG000|Overall Study|Lost to Follow-up|7|||
156396341|NCT00316082|564541772|FG001|Overall Study|Lost to Follow-up|6|||
156396342|NCT00316082|564541773|FG002|Overall Study|Lost to Follow-up|7|||
156396343|NCT00316082|564541774|FG003|Overall Study|Lost to Follow-up|8|||
156396344|NCT00316082|564541775|FG004|Overall Study|Lost to Follow-up|6|||
156396345|NCT00316082|564541771|FG000|Overall Study|Poor/noncompliance|6|||
156396346|NCT00316082|564541772|FG001|Overall Study|Poor/noncompliance|1|||
156396347|NCT00316082|564541773|FG002|Overall Study|Poor/noncompliance|4|||
156396348|NCT00316082|564541774|FG003|Overall Study|Poor/noncompliance|1|||
156396349|NCT00316082|564541775|FG004|Overall Study|Poor/noncompliance|4|||
156396350|NCT00316082|564541771|FG000|Overall Study|Adverse Event|4|||
156396351|NCT00316082|564541772|FG001|Overall Study|Adverse Event|2|||
156396352|NCT00316082|564541773|FG002|Overall Study|Adverse Event|5|||
156396353|NCT00316082|564541774|FG003|Overall Study|Adverse Event|1|||
156396354|NCT00316082|564541775|FG004|Overall Study|Adverse Event|3|||
156396355|NCT00316082|564541771|FG000|Overall Study|Subject no longer meets study criteria|3|||
156396356|NCT00316082|564541772|FG001|Overall Study|Subject no longer meets study criteria|1|||
156396357|NCT00316082|564541773|FG002|Overall Study|Subject no longer meets study criteria|2|||
156396358|NCT00316082|564541774|FG003|Overall Study|Subject no longer meets study criteria|2|||
156396359|NCT00316082|564541775|FG004|Overall Study|Subject no longer meets study criteria|1|||
156396360|NCT00316082|564541771|FG000|Overall Study|Physician Decision|1|||
156396361|NCT00316082|564541772|FG001|Overall Study|Physician Decision|1|||
156396362|NCT00316082|564541773|FG002|Overall Study|Physician Decision|2|||
156396363|NCT00316082|564541774|FG003|Overall Study|Physician Decision|1|||
156396364|NCT00316082|564541775|FG004|Overall Study|Physician Decision|1|||
156396365|NCT00316082|564541771|FG000|Overall Study|Death|0|||
156396366|NCT00316082|564541772|FG001|Overall Study|Death|0|||
156396367|NCT00316082|564541773|FG002|Overall Study|Death|1|||
156396368|NCT00316082|564541774|FG003|Overall Study|Death|0|||
156396369|NCT00316082|564541775|FG004|Overall Study|Death|0|||
156396370|NCT00316082|564541771|FG000|Overall Study|Administrative reason by sponsor|0|||
156396371|NCT00316082|564541772|FG001|Overall Study|Administrative reason by sponsor|0|||
156396372|NCT00316082|564541773|FG002|Overall Study|Administrative reason by sponsor|1|||
156396373|NCT00316082|564541774|FG003|Overall Study|Administrative reason by sponsor|0|||
156396374|NCT00316082|564541775|FG004|Overall Study|Administrative reason by sponsor|0|||
156396375|NCT02216773|564541776|FG000|Overall Study|Disease progression|4|||
156396376|NCT02216773|564541777|FG001|Overall Study|Disease progression|2|||
156396377|NCT02216773|564541776|FG000|Overall Study|Insufficient FLRV|4|||
156396378|NCT02216773|564541777|FG001|Overall Study|Insufficient FLRV|0|||
156396379|NCT02216773|564541776|FG000|Overall Study|Abandoned|4|||
156396380|NCT02216773|564541777|FG001|Overall Study|Abandoned|3|||
156396381|NCT00528775|564541778|FG000|Overall Study|Other not specified|1|||
156396382|NCT00540124|564541779|FG000|Overall Study|Adverse Event|0|||
156396383|NCT00540124|564541780|FG001|Overall Study|Adverse Event|2|||
156396384|NCT00540124|564541781|FG002|Overall Study|Adverse Event|1|||
156396385|NCT00540124|564541779|FG000|Overall Study|Entry Criteria Not Met|2|||
156396386|NCT00540124|564541780|FG001|Overall Study|Entry Criteria Not Met|0|||
156396387|NCT00540124|564541781|FG002|Overall Study|Entry Criteria Not Met|0|||
156396388|NCT00540124|564541779|FG000|Overall Study|Lack of Efficacy|1|||
156396389|NCT00540124|564541780|FG001|Overall Study|Lack of Efficacy|0|||
156396390|NCT00540124|564541781|FG002|Overall Study|Lack of Efficacy|0|||
156396391|NCT00540124|564541779|FG000|Overall Study|Withdrawal by Subject|1|||
156396392|NCT00540124|564541780|FG001|Overall Study|Withdrawal by Subject|1|||
156396393|NCT00540124|564541781|FG002|Overall Study|Withdrawal by Subject|0|||
156396394|NCT01494584|564541783|FG000|Overall Study|Study Closed/Terminated|1|||
156396395|NCT00374322|564541788|FG000|Overall Study|Lost to Follow-up|92|||
156396396|NCT00374322|564541789|FG001|Overall Study|Lost to Follow-up|90|||
156396397|NCT00374322|564541788|FG000|Overall Study|Protocol Violation|8|||
156396398|NCT00374322|564541789|FG001|Overall Study|Protocol Violation|3|||
156396399|NCT00374322|564541788|FG000|Overall Study|Withdrawal by Subject|235|||
156396400|NCT00374322|564541789|FG001|Overall Study|Withdrawal by Subject|167|||
156396401|NCT00374322|564541788|FG000|Overall Study|Sponsor Terminated Study|866|||
156396402|NCT00374322|564541789|FG001|Overall Study|Sponsor Terminated Study|990|||
156396403|NCT00374322|564541788|FG000|Overall Study|Physician Decision|36|||
156396404|NCT00374322|564541789|FG001|Overall Study|Physician Decision|32|||
156396405|NCT00374322|564541788|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
156396406|NCT00374322|564541789|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
156396407|NCT00374322|564541788|FG000|Overall Study|Sponsor Decision|2|||
156396408|NCT00374322|564541789|FG001|Overall Study|Sponsor Decision|3|||
156396409|NCT00374322|564541788|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
156396410|NCT00374322|564541789|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
156396411|NCT00374322|564541788|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
156396412|NCT00374322|564541789|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
156396413|NCT00374322|564541788|FG000|Overall Study|Severe Toxicity|1|||
156396414|NCT00374322|564541789|FG001|Overall Study|Severe Toxicity|0|||
156396415|NCT00374322|564541788|FG000|Overall Study|Site Closed|2|||
156396416|NCT00374322|564541789|FG001|Overall Study|Site Closed|2|||
156396417|NCT00374322|564541788|FG000|Overall Study|Participant Changed Physician|1|||
156396418|NCT00374322|564541789|FG001|Overall Study|Participant Changed Physician|0|||
156396419|NCT00374322|564541788|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
156396420|NCT00374322|564541789|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
156396421|NCT00374322|564541788|FG000|Overall Study|Noncompliance with Study Requirements|0|||
156396422|NCT00374322|564541789|FG001|Overall Study|Noncompliance with Study Requirements|1|||
156396423|NCT00374322|564541788|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
156396424|NCT00374322|564541789|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
156396425|NCT00374322|564541788|FG000|Overall Study|Did Not Receive Study Medication|8|||
156396426|NCT00374322|564541789|FG001|Overall Study|Did Not Receive Study Medication|6|||
156396427|NCT00058123|564541794|FG000|Overall Study|Wrong histology|9|||
156396428|NCT00058123|564541794|FG000|Overall Study|Received >3 prior treatments|1|||
156396429|NCT02151266|564541795|FG000|Overall Study|Lost to Follow-up|1|||
156396430|NCT02151266|564541796|FG001|Overall Study|Lost to Follow-up|4|||
156396431|NCT02151266|564541797|FG002|Overall Study|Lost to Follow-up|1|||
156396432|NCT02151266|564541795|FG000|Overall Study|Did NOT receive intervention|3|||
156396433|NCT02151266|564541796|FG001|Overall Study|Did NOT receive intervention|6|||
156396434|NCT02151266|564541797|FG002|Overall Study|Did NOT receive intervention|2|||
156396435|NCT02151266|564541795|FG000|Overall Study|Not able to exercise|4|||
156396436|NCT02151266|564541796|FG001|Overall Study|Not able to exercise|5|||
156396437|NCT02151266|564541797|FG002|Overall Study|Not able to exercise|4|||
156396438|NCT01169675|564541800|FG000|Overall Study|Progressive disease|13|||
156396439|NCT01169675|564541801|FG001|Overall Study|Progressive disease|2|||
156396440|NCT01169675|564541802|FG002|Overall Study|Progressive disease|5|||
156396441|NCT01169675|564541803|FG003|Overall Study|Progressive disease|15|||
156396442|NCT01169675|564541804|FG004|Overall Study|Progressive disease|1|||
156396443|NCT01169675|564541800|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156396444|NCT01169675|564541801|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156396445|NCT01169675|564541802|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156396446|NCT01169675|564541803|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156396447|NCT01169675|564541804|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156396448|NCT01169675|564541800|FG000|Overall Study|Adverse Event|5|||
156396449|NCT01169675|564541801|FG001|Overall Study|Adverse Event|1|||
156396450|NCT01169675|564541802|FG002|Overall Study|Adverse Event|2|||
156396451|NCT01169675|564541803|FG003|Overall Study|Adverse Event|0|||
156396452|NCT01169675|564541804|FG004|Overall Study|Adverse Event|0|||
156396453|NCT01169675|564541800|FG000|Overall Study|Withdrawal by Subject|1|||
156396454|NCT01169675|564541801|FG001|Overall Study|Withdrawal by Subject|0|||
156396455|NCT01169675|564541802|FG002|Overall Study|Withdrawal by Subject|0|||
156396456|NCT01169675|564541803|FG003|Overall Study|Withdrawal by Subject|1|||
156396457|NCT01169675|564541804|FG004|Overall Study|Withdrawal by Subject|2|||
156396458|NCT01169675|564541800|FG000|Overall Study|Other Reason Not Defined Above|0|||
156396459|NCT01169675|564541801|FG001|Overall Study|Other Reason Not Defined Above|0|||
156396460|NCT01169675|564541802|FG002|Overall Study|Other Reason Not Defined Above|0|||
156396461|NCT01169675|564541803|FG003|Overall Study|Other Reason Not Defined Above|1|||
156396462|NCT01169675|564541804|FG004|Overall Study|Other Reason Not Defined Above|1|||
156396463|NCT04839965|564541807|FG000|Overall Study|Death|6|||
156396464|NCT04839965|564541808|FG001|Overall Study|Death|6|||
156396465|NCT04839965|564541807|FG000|Overall Study|Lost to Follow-up|1|||
156396466|NCT04839965|564541808|FG001|Overall Study|Lost to Follow-up|0|||
156396467|NCT02816138|564541809|FG000|Overall Study|Adverse Event|1|||
156396468|NCT02355028|564541810|FG000|Overall Study|Adverse Event|2|||
156396469|NCT02355028|564541811|FG001|Overall Study|Adverse Event|0|||
156396470|NCT02355028|564541810|FG000|Overall Study|Withdrawal by Subject|1|||
156396471|NCT02355028|564541811|FG001|Overall Study|Withdrawal by Subject|1|||
156396472|NCT02355028|564541810|FG000|Overall Study|Deemed ineligible after randomization|8|||
156396473|NCT02355028|564541811|FG001|Overall Study|Deemed ineligible after randomization|4|||
156396474|NCT02276222|564541812|FG000|Overall Study|Adverse Event|62|||
156396475|NCT02276222|564541813|FG001|Overall Study|Adverse Event|11|||
156396476|NCT02276222|564541812|FG000|Overall Study|Death|3|||
156549585|NCT04099251|565103678|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
156549586|NCT04099251|565103679|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
156549587|NCT04099251|565103678|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
156396477|NCT02276222|564541813|FG001|Overall Study|Death|4|||
156396478|NCT02276222|564541812|FG000|Overall Study|Lack of Efficacy|13|||
156396479|NCT02276222|564541813|FG001|Overall Study|Lack of Efficacy|3|||
156396480|NCT02276222|564541812|FG000|Overall Study|Protocol Violation|3|||
156396481|NCT02276222|564541813|FG001|Overall Study|Protocol Violation|2|||
156396482|NCT02276222|564541812|FG000|Overall Study|Withdrawal by Subject|79|||
156396483|NCT02276222|564541813|FG001|Overall Study|Withdrawal by Subject|33|||
156396484|NCT02276222|564541812|FG000|Overall Study|non compliance with study medication|6|||
156396485|NCT02276222|564541813|FG001|Overall Study|non compliance with study medication|2|||
156396486|NCT02276222|564541812|FG000|Overall Study|sponsor decision|0|||
156396487|NCT02276222|564541813|FG001|Overall Study|sponsor decision|3|||
156396488|NCT02276222|564541812|FG000|Overall Study|Lost to Follow-up|15|||
156396489|NCT02276222|564541813|FG001|Overall Study|Lost to Follow-up|5|||
156396490|NCT02276222|564541812|FG000|Overall Study|Physician Decision|2|||
156396491|NCT02276222|564541813|FG001|Overall Study|Physician Decision|1|||
156396492|NCT02276222|564541812|FG000|Overall Study|sheduling conflict|1|||
156396493|NCT02276222|564541813|FG001|Overall Study|sheduling conflict|0|||
156396494|NCT02276222|564541812|FG000|Overall Study|subject withdrew after randomization|1|||
156396495|NCT02276222|564541813|FG001|Overall Study|subject withdrew after randomization|0|||
156396496|NCT04102579|564541814|FG000|Overall Study|Withdrawal by Subject|3|||
156396497|NCT04102579|564541815|FG001|Overall Study|Withdrawal by Subject|4|||
156396498|NCT04102579|564541814|FG000|Overall Study|Lost to Follow-up|0|||
156396499|NCT04102579|564541815|FG001|Overall Study|Lost to Follow-up|1|||
156396500|NCT04102579|564541814|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
156396501|NCT04102579|564541815|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
156396502|NCT04102579|564541814|FG000|Overall Study|Other than Specified|1|||
156396503|NCT04102579|564541815|FG001|Overall Study|Other than Specified|0|||
156396504|NCT04102579|564541814|FG000|Overall Study|Not Dosed with Study Drug|0|||
156396505|NCT04102579|564541815|FG001|Overall Study|Not Dosed with Study Drug|1|||
156396506|NCT02532179|564543419|FG000|Overall Study|Lost to Follow-up|1|||
156396507|NCT02532179|564543419|FG000|Overall Study|Pregnancy|1|||
156396508|NCT02532179|564543419|FG000|Overall Study|Subject received depot steroid injection|1|||
156396509|NCT01337674|564543423|FG000|Treatment Period 1|Adverse Event|0|||
156396510|NCT01337674|564543424|FG001|Treatment Period 1|Adverse Event|1|||
156396511|NCT01337674|564543425|FG002|Treatment Period 1|Adverse Event|0|||
156396512|NCT01337674|564543426|FG003|Treatment Period 1|Adverse Event|0|||
156396513|NCT01337674|564543423|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
156396514|NCT01337674|564543424|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
156396515|NCT01337674|564543425|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
156396516|NCT01337674|564543426|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
156396517|NCT01337674|564543423|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156396518|NCT01337674|564543424|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156396519|NCT01337674|564543425|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156396520|NCT01337674|564543426|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156396521|NCT00119405|564543427|FG000|Overall Study|Withdrawal by Subject|1|||
156396522|NCT00939484|564543428|FG000|Overall Study|Progression/Relapse|8|||
156396523|NCT00939484|564543429|FG001|Overall Study|Progression/Relapse|20|||
156396524|NCT00939484|564543430|FG002|Overall Study|Progression/Relapse|3|||
156396525|NCT04233372|564543431|FG000|Overall Study|Lost to Follow-up|104|||
156396526|NCT04233372|564543431|FG000|Overall Study|Adverse Event|8|||
156396527|NCT04233372|564543431|FG000|Overall Study|Withdrawal by Subject|2|||
156396528|NCT04958785|564543432|FG000|Overall Study|Study Terminated by Sponsor|4|||
156396529|NCT04958785|564543433|FG001|Overall Study|Study Terminated by Sponsor|10|||
156396530|NCT04958785|564543434|FG002|Overall Study|Study Terminated by Sponsor|7|||
156396531|NCT04958785|564543435|FG003|Overall Study|Study Terminated by Sponsor|6|||
156396532|NCT04958785|564543436|FG004|Overall Study|Study Terminated by Sponsor|34|||
156396533|NCT04958785|564543432|FG000|Overall Study|Death|2|||
156396534|NCT04958785|564543433|FG001|Overall Study|Death|3|||
156396535|NCT04958785|564543434|FG002|Overall Study|Death|4|||
156396536|NCT04958785|564543435|FG003|Overall Study|Death|5|||
156396537|NCT04958785|564543436|FG004|Overall Study|Death|5|||
156396538|NCT04958785|564543432|FG000|Overall Study|Withdrew consent|2|||
156396539|NCT04958785|564543433|FG001|Overall Study|Withdrew consent|0|||
156396540|NCT04958785|564543434|FG002|Overall Study|Withdrew consent|3|||
156396541|NCT04958785|564543435|FG003|Overall Study|Withdrew consent|1|||
156396542|NCT04958785|564543436|FG004|Overall Study|Withdrew consent|0|||
156396543|NCT04958785|564543432|FG000|Overall Study|Investigator's discretion|0|||
156396544|NCT04958785|564543433|FG001|Overall Study|Investigator's discretion|1|||
156396545|NCT04958785|564543434|FG002|Overall Study|Investigator's discretion|0|||
156396546|NCT04958785|564543435|FG003|Overall Study|Investigator's discretion|1|||
156396547|NCT04958785|564543436|FG004|Overall Study|Investigator's discretion|2|||
156396548|NCT04958785|564543432|FG000|Overall Study|Adverse Event|0|||
156396549|NCT04958785|564543433|FG001|Overall Study|Adverse Event|0|||
156396550|NCT04958785|564543434|FG002|Overall Study|Adverse Event|0|||
156396551|NCT04958785|564543435|FG003|Overall Study|Adverse Event|0|||
156396552|NCT04958785|564543436|FG004|Overall Study|Adverse Event|1|||
156396553|NCT04958785|564543432|FG000|Overall Study|Lost to Follow-up|0|||
156396554|NCT04958785|564543433|FG001|Overall Study|Lost to Follow-up|0|||
156396555|NCT04958785|564543434|FG002|Overall Study|Lost to Follow-up|0|||
156396556|NCT04958785|564543435|FG003|Overall Study|Lost to Follow-up|0|||
156396557|NCT04958785|564543436|FG004|Overall Study|Lost to Follow-up|1|||
156396558|NCT03938454|564543437|FG000|Overall Study|Protocol Violation|1|||
156396559|NCT03938454|564543437|FG000|Overall Study|Withdrawal by Subject|2|||
156396560|NCT03938454|564543437|FG000|Overall Study|Lost to Follow-up|3|||
156396561|NCT01090310|564543438|FG000|Core Study|Adverse Event|2|||
156396562|NCT01090310|564543439|FG001|Core Study|Adverse Event|2|||
156396563|NCT01090310|564543440|FG002|Core Study|Adverse Event|1|||
156396564|NCT01090310|564543441|FG003|Core Study|Adverse Event|1|||
156396565|NCT01090310|564543438|FG000|Core Study|Subject withdrew consent|0|||
156396566|NCT01090310|564543439|FG001|Core Study|Subject withdrew consent|3|||
156396567|NCT01090310|564543440|FG002|Core Study|Subject withdrew consent|1|||
156396568|NCT01090310|564543441|FG003|Core Study|Subject withdrew consent|1|||
156396569|NCT01090310|564543438|FG000|Core Study|Abnormal test procedure result|0|||
156396570|NCT01090310|564543439|FG001|Core Study|Abnormal test procedure result|0|||
156396571|NCT01090310|564543440|FG002|Core Study|Abnormal test procedure result|1|||
156396572|NCT01090310|564543441|FG003|Core Study|Abnormal test procedure result|0|||
156396573|NCT01090310|564543438|FG000|Core Study|Administrative reasons|5|||
156396574|NCT01090310|564543439|FG001|Core Study|Administrative reasons|6|||
156396575|NCT01090310|564543440|FG002|Core Study|Administrative reasons|4|||
156396576|NCT01090310|564543441|FG003|Core Study|Administrative reasons|4|||
156396577|NCT01090310|564543438|FG000|Core Study|Protocol deviation|1|||
156396578|NCT01090310|564543439|FG001|Core Study|Protocol deviation|0|||
156396579|NCT01090310|564543440|FG002|Core Study|Protocol deviation|0|||
156396580|NCT01090310|564543441|FG003|Core Study|Protocol deviation|1|||
156396581|NCT01090310|564543438|FG000|Extension Study|Aministrative problems|13|||
156396582|NCT01090310|564543439|FG001|Extension Study|Aministrative problems|15|||
156396583|NCT01090310|564543440|FG002|Extension Study|Aministrative problems|14|||
156396584|NCT01090310|564543441|FG003|Extension Study|Aministrative problems|18|||
156396585|NCT01090310|564543438|FG000|Extension Study|Adverse Event|0|||
156396586|NCT01090310|564543439|FG001|Extension Study|Adverse Event|0|||
156396587|NCT01090310|564543440|FG002|Extension Study|Adverse Event|0|||
156396588|NCT01090310|564543441|FG003|Extension Study|Adverse Event|1|||
156396589|NCT01090310|564543438|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
156396590|NCT01090310|564543439|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
156396591|NCT01090310|564543440|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
156396592|NCT01090310|564543441|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
156396593|NCT01090310|564543438|FG000|Extension Study|Subject withdrew consent|0|||
156396594|NCT01090310|564543439|FG001|Extension Study|Subject withdrew consent|1|||
156396595|NCT01090310|564543440|FG002|Extension Study|Subject withdrew consent|0|||
156396596|NCT01090310|564543441|FG003|Extension Study|Subject withdrew consent|0|||
156396597|NCT00695786|564543442|FG000|Overall Study|Adverse Event|0|||
156396598|NCT00695786|564543443|FG001|Overall Study|Adverse Event|3|||
156396599|NCT00695786|564543444|FG002|Overall Study|Adverse Event|4|||
156396600|NCT00695786|564543445|FG003|Overall Study|Adverse Event|2|||
156396601|NCT00695786|564543442|FG000|Overall Study|Lost to Follow-up|0|||
156396602|NCT00695786|564543443|FG001|Overall Study|Lost to Follow-up|5|||
156396603|NCT00695786|564543444|FG002|Overall Study|Lost to Follow-up|1|||
156396604|NCT00695786|564543445|FG003|Overall Study|Lost to Follow-up|1|||
156396605|NCT00695786|564543442|FG000|Overall Study|Withdrawal by Subject|0|||
156396606|NCT00695786|564543443|FG001|Overall Study|Withdrawal by Subject|4|||
156396607|NCT00695786|564543444|FG002|Overall Study|Withdrawal by Subject|3|||
156396608|NCT00695786|564543445|FG003|Overall Study|Withdrawal by Subject|1|||
156396609|NCT00695786|564543442|FG000|Overall Study|Deemed Ineligible|1|||
156396610|NCT00695786|564543443|FG001|Overall Study|Deemed Ineligible|0|||
156396611|NCT00695786|564543444|FG002|Overall Study|Deemed Ineligible|0|||
156396612|NCT00695786|564543445|FG003|Overall Study|Deemed Ineligible|0|||
156396613|NCT00695786|564543442|FG000|Overall Study|Lack of Efficacy|0|||
156396614|NCT00695786|564543443|FG001|Overall Study|Lack of Efficacy|0|||
156396615|NCT00695786|564543444|FG002|Overall Study|Lack of Efficacy|0|||
156396616|NCT00695786|564543445|FG003|Overall Study|Lack of Efficacy|4|||
156396617|NCT01224925|564543446|FG000|Overall Study|Lost to Follow-up|3|||
156396618|NCT01224925|564543447|FG001|Overall Study|Lost to Follow-up|2|||
156396619|NCT04244396|564543451|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
156396620|NCT04244396|564543451|FG000|Overall Study|Withdrawal by Subject|2|||
156396621|NCT04244396|564543451|FG000|Overall Study|Study termination|37|||
156396622|NCT00949884|564543452|FG000|Overall Study|Adverse Event|14|||
156396623|NCT00949884|564543453|FG001|Overall Study|Adverse Event|3|||
156396624|NCT00949884|564543454|FG002|Overall Study|Adverse Event|12|||
156396625|NCT00949884|564543452|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
156396626|NCT00949884|564543453|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
156396627|NCT00949884|564543454|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
156396628|NCT00949884|564543452|FG000|Overall Study|Lost to Follow-up|7|||
156396629|NCT00949884|564543453|FG001|Overall Study|Lost to Follow-up|5|||
156396630|NCT00949884|564543454|FG002|Overall Study|Lost to Follow-up|5|||
156396631|NCT00949884|564543452|FG000|Overall Study|Physician Decision|5|||
156396632|NCT00949884|564543453|FG001|Overall Study|Physician Decision|0|||
156396633|NCT00949884|564543454|FG002|Overall Study|Physician Decision|6|||
156396634|NCT00949884|564543452|FG000|Overall Study|Treatment non-compliance|5|||
156396635|NCT00949884|564543453|FG001|Overall Study|Treatment non-compliance|0|||
156396636|NCT00949884|564543454|FG002|Overall Study|Treatment non-compliance|8|||
156396637|NCT00949884|564543452|FG000|Overall Study|Withdrawal by Subject|13|||
156396638|NCT00949884|564543453|FG001|Overall Study|Withdrawal by Subject|4|||
156396639|NCT00949884|564543454|FG002|Overall Study|Withdrawal by Subject|16|||
156396640|NCT00949884|564543452|FG000|Overall Study|Lack of Efficacy|4|||
156396641|NCT00949884|564543453|FG001|Overall Study|Lack of Efficacy|2|||
156396642|NCT00949884|564543454|FG002|Overall Study|Lack of Efficacy|7|||
156396643|NCT00949884|564543452|FG000|Overall Study|Study terminated by sponsor|0|||
156396644|NCT00949884|564543453|FG001|Overall Study|Study terminated by sponsor|0|||
156396645|NCT00949884|564543454|FG002|Overall Study|Study terminated by sponsor|1|||
156396646|NCT00245102|564543455|FG000|Overall Study|Not Treated|1|||
156396647|NCT00245102|564543456|FG001|Overall Study|Not Treated|0|||
156396648|NCT00245102|564543457|FG002|Overall Study|Not Treated|1|||
156396649|NCT00245102|564543458|FG003|Overall Study|Not Treated|0|||
156396650|NCT00245102|564543459|FG004|Overall Study|Not Treated|0|||
156396651|NCT00245102|564543460|FG005|Overall Study|Not Treated|0|||
156396652|NCT00245102|564543455|FG000|Overall Study|Protocol Violation|1|||
156396653|NCT00245102|564543456|FG001|Overall Study|Protocol Violation|0|||
156396654|NCT00245102|564543457|FG002|Overall Study|Protocol Violation|0|||
156396655|NCT00245102|564543458|FG003|Overall Study|Protocol Violation|0|||
156396656|NCT00245102|564543459|FG004|Overall Study|Protocol Violation|0|||
156396657|NCT00245102|564543460|FG005|Overall Study|Protocol Violation|0|||
156396658|NCT00245102|564543455|FG000|Overall Study|Death|0|||
156396659|NCT00245102|564543456|FG001|Overall Study|Death|0|||
156396660|NCT00245102|564543457|FG002|Overall Study|Death|0|||
156396661|NCT00245102|564543458|FG003|Overall Study|Death|1|||
156396662|NCT00245102|564543459|FG004|Overall Study|Death|0|||
156396663|NCT00245102|564543460|FG005|Overall Study|Death|0|||
156396664|NCT00245102|564543455|FG000|Overall Study|Adverse Event|4|||
156396665|NCT00245102|564543456|FG001|Overall Study|Adverse Event|2|||
156396666|NCT00245102|564543457|FG002|Overall Study|Adverse Event|5|||
156396667|NCT00245102|564543458|FG003|Overall Study|Adverse Event|1|||
156396668|NCT00245102|564543459|FG004|Overall Study|Adverse Event|0|||
156396669|NCT00245102|564543460|FG005|Overall Study|Adverse Event|2|||
156396670|NCT00245102|564543455|FG000|Overall Study|Decline in performance|0|||
156396671|NCT00245102|564543456|FG001|Overall Study|Decline in performance|2|||
156396672|NCT00245102|564543457|FG002|Overall Study|Decline in performance|0|||
156396673|NCT00245102|564543458|FG003|Overall Study|Decline in performance|1|||
156396674|NCT00245102|564543459|FG004|Overall Study|Decline in performance|0|||
156396675|NCT00245102|564543460|FG005|Overall Study|Decline in performance|2|||
156396676|NCT00245102|564543455|FG000|Overall Study|Participant needed surgery|0|||
156396677|NCT00245102|564543456|FG001|Overall Study|Participant needed surgery|0|||
156396678|NCT00245102|564543457|FG002|Overall Study|Participant needed surgery|1|||
156396679|NCT00245102|564543458|FG003|Overall Study|Participant needed surgery|0|||
156396680|NCT00245102|564543459|FG004|Overall Study|Participant needed surgery|0|||
156396681|NCT00245102|564543460|FG005|Overall Study|Participant needed surgery|0|||
156396682|NCT00245102|564543455|FG000|Overall Study|Clinical progression|1|||
156396683|NCT00245102|564543456|FG001|Overall Study|Clinical progression|0|||
156396684|NCT00245102|564543457|FG002|Overall Study|Clinical progression|0|||
156396685|NCT00245102|564543458|FG003|Overall Study|Clinical progression|0|||
156396686|NCT00245102|564543459|FG004|Overall Study|Clinical progression|0|||
156396687|NCT00245102|564543460|FG005|Overall Study|Clinical progression|0|||
156396688|NCT02293395|564543465|FG000|Overall Study|Lost to Follow-up|1|||
156396689|NCT02293395|564543466|FG001|Overall Study|Lost to Follow-up|0|||
156396690|NCT02293395|564543465|FG000|Overall Study|Withdrawal by Subject|8|||
156396691|NCT02293395|564543466|FG001|Overall Study|Withdrawal by Subject|7|||
156396692|NCT00224770|564543472|FG000|Overall Study|Lost to Follow-up|4|||
156396693|NCT00224770|564543473|FG001|Overall Study|Lost to Follow-up|2|||
156396694|NCT00224770|564543474|FG002|Overall Study|Lost to Follow-up|0|||
156396695|NCT01106430|564543475|FG000|Overall Study|Adverse Event|8|||
156396696|NCT01106430|564543476|FG001|Overall Study|Adverse Event|10|||
156396697|NCT01106430|564543475|FG000|Overall Study|Lack of Efficacy|2|||
156396698|NCT01106430|564543476|FG001|Overall Study|Lack of Efficacy|13|||
156396699|NCT01106430|564543475|FG000|Overall Study|Lost to Follow-up|5|||
156396700|NCT01106430|564543476|FG001|Overall Study|Lost to Follow-up|1|||
156396701|NCT01106430|564543475|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
156396702|NCT01106430|564543476|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
156396703|NCT01106430|564543475|FG000|Overall Study|Moved Out Of State|0|||
156396704|NCT01106430|564543476|FG001|Overall Study|Moved Out Of State|1|||
156396705|NCT01106430|564543475|FG000|Overall Study|Refused To Take Medication|0|||
156396706|NCT01106430|564543476|FG001|Overall Study|Refused To Take Medication|1|||
156396707|NCT01106430|564543475|FG000|Overall Study|Noncompliance|0|||
156396708|NCT01106430|564543476|FG001|Overall Study|Noncompliance|1|||
156396709|NCT01106430|564543475|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
156396710|NCT01106430|564543476|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
156396711|NCT01106430|564543475|FG000|Overall Study|Previous Use Of Marijuana|1|||
156396712|NCT01106430|564543476|FG001|Overall Study|Previous Use Of Marijuana|0|||
156396713|NCT01106430|564543475|FG000|Overall Study|Protocol Violation|7|||
156396714|NCT01106430|564543476|FG001|Overall Study|Protocol Violation|2|||
156509004|NCT03635099|564955555|FG004|Period 2|Lost to Follow-up|4|||
156396715|NCT01106430|564543475|FG000|Overall Study|Withdrawal by Subject|8|||
156396716|NCT01106430|564543476|FG001|Overall Study|Withdrawal by Subject|4|||
156396717|NCT00437645|564543483|FG000|Overall Study|Adverse Event|15|||
156396718|NCT00437645|564543484|FG001|Overall Study|Adverse Event|84|||
156396719|NCT00437645|564543483|FG000|Overall Study|Withdrawal by Subject|10|||
156396720|NCT00437645|564543484|FG001|Overall Study|Withdrawal by Subject|22|||
156396721|NCT00437645|564543483|FG000|Overall Study|Protocol Violation|3|||
156396722|NCT00437645|564543484|FG001|Overall Study|Protocol Violation|3|||
156396723|NCT00437645|564543483|FG000|Overall Study|Lost to Follow-up|2|||
156396724|NCT00437645|564543484|FG001|Overall Study|Lost to Follow-up|3|||
156396725|NCT00437645|564543483|FG000|Overall Study|Administrative problems|2|||
156396726|NCT00437645|564543484|FG001|Overall Study|Administrative problems|1|||
156396727|NCT00437645|564543483|FG000|Overall Study|Lack of Efficacy|2|||
156396728|NCT00437645|564543484|FG001|Overall Study|Lack of Efficacy|1|||
156396729|NCT00437645|564543483|FG000|Overall Study|Condition no longer requires study drug|1|||
156396730|NCT00437645|564543484|FG001|Overall Study|Condition no longer requires study drug|1|||
156396731|NCT00662857|564543485|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
156396732|NCT00662857|564543486|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
156396733|NCT00662857|564543485|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
156396734|NCT00662857|564543486|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
156396735|NCT00662857|564543485|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
156396736|NCT00662857|564543486|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
156396737|NCT03966053|564543487|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
156396738|NCT02832622|564543492|FG000|Overall Study|MPP not programmed|1259|||
156396739|NCT02832622|564543492|FG000|Overall Study|Withdrawal by Subject|123|||
156396740|NCT02832622|564543492|FG000|Overall Study|Death|119|||
156396741|NCT02832622|564543492|FG000|Overall Study|Unsuccessful CRT implant|93|||
156396742|NCT02832622|564543492|FG000|Overall Study|Lost to Follow-up|45|||
156396743|NCT02832622|564543492|FG000|Overall Study|Patient non-compliance|42|||
156396744|NCT02832622|564543492|FG000|Overall Study|Withdrawal by other reasons|25|||
156396745|NCT02832622|564543492|FG000|Overall Study|System explant|24|||
156396746|NCT02832622|564543492|FG000|Overall Study|Physician Decision|6|||
156396747|NCT03837509|564543494|FG000|Phase 1|Death|5|||
156396748|NCT03837509|564543495|FG001|Phase 1|Death|2|||
156396749|NCT03837509|564543496|FG002|Phase 1|Death|0|||
156396750|NCT03837509|564543497|FG003|Phase 1|Death|0|||
156396751|NCT03837509|564543498|FG004|Phase 1|Death|0|||
156396752|NCT03837509|564543494|FG000|Phase 2|Death|0|||
156396753|NCT03837509|564543495|FG001|Phase 2|Death|0|||
156396754|NCT03837509|564543496|FG002|Phase 2|Death|0|||
156396755|NCT03837509|564543497|FG003|Phase 2|Death|1|||
156396756|NCT03837509|564543498|FG004|Phase 2|Death|1|||
156396757|NCT03548207|564543503|FG000|Overall Study|Death|10|||
156396758|NCT03548207|564543504|FG001|Overall Study|Death|23|||
156396759|NCT03548207|564543505|FG002|Overall Study|Death|3|||
156396760|NCT03548207|564543503|FG000|Overall Study|Lost to Follow-up|0|||
156396761|NCT03548207|564543504|FG001|Overall Study|Lost to Follow-up|2|||
156396762|NCT03548207|564543505|FG002|Overall Study|Lost to Follow-up|0|||
156396763|NCT03548207|564543503|FG000|Overall Study|Withdrawal by Subject|0|||
156396764|NCT03548207|564543504|FG001|Overall Study|Withdrawal by Subject|3|||
156396765|NCT03548207|564543505|FG002|Overall Study|Withdrawal by Subject|0|||
156396766|NCT03548207|564543503|FG000|Overall Study|Sponsor decision|19|||
156396767|NCT03548207|564543504|FG001|Overall Study|Sponsor decision|40|||
156396768|NCT03548207|564543505|FG002|Overall Study|Sponsor decision|6|||
156396769|NCT03548207|564543503|FG000|Overall Study|Randomized but not treated|6|||
156396770|NCT03548207|564543504|FG001|Overall Study|Randomized but not treated|10|||
156396771|NCT03548207|564543505|FG002|Overall Study|Randomized but not treated|4|||
156396772|NCT01756352|564543506|FG000|Overall Study|moved away and lost to followup|1|||
156396773|NCT00415610|564543507|FG000|Overall Study|Death|3|||
156396774|NCT00415610|564543508|FG001|Overall Study|Death|2|||
156396775|NCT00415610|564543509|FG002|Overall Study|Death|5|||
156396776|NCT00526630|564543510|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
156396777|NCT00526630|564543511|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
156396778|NCT00526630|564543510|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
156396779|NCT00526630|564543511|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
156396780|NCT00337272|564543512|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
156509005|NCT03635099|564955556|FG005|Period 2|Lost to Follow-up|0|||
156509006|NCT03635099|564955557|FG006|Period 2|Lost to Follow-up|0|||
156509007|NCT03635099|564955558|FG007|Period 2|Lost to Follow-up|0|||
156396781|NCT00337272|564543513|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
156396782|NCT00337272|564543512|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
156396783|NCT00337272|564543513|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
156396784|NCT00337272|564543512|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
156396785|NCT00337272|564543513|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
156396786|NCT00337272|564543512|FG000|Treatment Period|Non-compliance|1|||
156396787|NCT00337272|564543513|FG001|Treatment Period|Non-compliance|1|||
156396788|NCT00337272|564543512|FG000|Treatment Period|Withdrawal by Subject|0|||
156396789|NCT00337272|564543513|FG001|Treatment Period|Withdrawal by Subject|1|||
156396790|NCT00337272|564543512|FG000|Withdrawal Period|Non-compliance|0|||
156396791|NCT00337272|564543513|FG001|Withdrawal Period|Non-compliance|1|||
156396792|NCT03320018|564543514|FG000|Treatment Period|Withdrawal by Subject|1|||
156396793|NCT03320018|564543515|FG001|Treatment Period|Withdrawal by Subject|0|||
156509008|NCT03635099|564955551|FG000|Period 2|Withdrawal by Subject|0|||
156396794|NCT03320018|564543514|FG000|Day 90 Follow up|Death|0|||
156396795|NCT03320018|564543515|FG001|Day 90 Follow up|Death|1|||
156396796|NCT01662063|564543519|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
156396797|NCT01662063|564543520|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
156396798|NCT01662063|564543521|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
156396799|NCT01662063|564543519|FG000|Overall Study|Lack of Efficacy|1|||
156396800|NCT01662063|564543520|FG001|Overall Study|Lack of Efficacy|6|||
156396801|NCT01662063|564543521|FG002|Overall Study|Lack of Efficacy|0|||
156396802|NCT01662063|564543519|FG000|Overall Study|Lost to Follow-up|0|||
156396803|NCT01662063|564543520|FG001|Overall Study|Lost to Follow-up|4|||
156396804|NCT01662063|564543521|FG002|Overall Study|Lost to Follow-up|0|||
156396805|NCT01662063|564543519|FG000|Overall Study|Protocol Violation|1|||
156396806|NCT01662063|564543520|FG001|Overall Study|Protocol Violation|0|||
156396807|NCT01662063|564543521|FG002|Overall Study|Protocol Violation|0|||
156396808|NCT01662063|564543519|FG000|Overall Study|Withdrawal by Subject|2|||
156396809|NCT01662063|564543520|FG001|Overall Study|Withdrawal by Subject|4|||
156396810|NCT01662063|564543521|FG002|Overall Study|Withdrawal by Subject|1|||
156396811|NCT01662063|564543519|FG000|Overall Study|Physician Decision|0|||
156396812|NCT01662063|564543520|FG001|Overall Study|Physician Decision|2|||
156396813|NCT01662063|564543521|FG002|Overall Study|Physician Decision|0|||
156396814|NCT01662063|564543519|FG000|Overall Study|Other|0|||
156396815|NCT01662063|564543520|FG001|Overall Study|Other|1|||
156396816|NCT01662063|564543521|FG002|Overall Study|Other|0|||
156396817|NCT00293267|564543522|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
156396818|NCT00293267|564543523|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
156396819|NCT00293267|564543522|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
156396820|NCT00293267|564543523|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
156396821|NCT00293267|564543522|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
156396822|NCT00293267|564543523|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
156396823|NCT00293267|564543522|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
156396824|NCT00293267|564543523|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
156396825|NCT00293267|564543522|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
156396826|NCT00293267|564543523|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
156396827|NCT00293267|564543522|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
156396828|NCT00293267|564543523|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
156396829|NCT00293267|564543522|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
156396830|NCT00293267|564543523|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
156396831|NCT00293267|564543522|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
156396832|NCT00293267|564543523|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
156396833|NCT00293267|564543522|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
156396834|NCT00293267|564543523|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
156396835|NCT00293267|564543522|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
156396836|NCT00293267|564543523|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
156396837|NCT00293267|564543522|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
156396838|NCT00293267|564543523|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
156396839|NCT00293267|564543522|FG000|Extension - Double-Blind Week 49-156|Death|3|||
156396840|NCT00293267|564543523|FG001|Extension - Double-Blind Week 49-156|Death|0|||
156396841|NCT00293267|564543522|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
156396842|NCT00293267|564543523|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
156396843|NCT00293267|564543522|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
156396844|NCT00293267|564543523|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
156396845|NCT00293267|564543522|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
156396846|NCT00293267|564543523|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
156396847|NCT00293267|564543522|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
156396848|NCT00293267|564543523|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
156396849|NCT00293267|564543522|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
156396850|NCT00293267|564543523|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
156396851|NCT00293267|564543522|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
156396852|NCT00293267|564543523|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
156396853|NCT00293267|564543522|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
156396854|NCT00293267|564543523|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
156396855|NCT00293267|564543522|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
156396856|NCT00293267|564543523|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
156396857|NCT00293267|564543522|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
156509009|NCT03635099|564955552|FG001|Period 2|Withdrawal by Subject|0|||
156509010|NCT03635099|564955553|FG002|Period 2|Withdrawal by Subject|7|||
156509011|NCT03635099|564955554|FG003|Period 2|Withdrawal by Subject|4|||
156509012|NCT03635099|564955555|FG004|Period 2|Withdrawal by Subject|7|||
156509013|NCT03635099|564955556|FG005|Period 2|Withdrawal by Subject|0|||
156509014|NCT03635099|564955557|FG006|Period 2|Withdrawal by Subject|0|||
156396858|NCT00293267|564543523|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
156396859|NCT00293267|564543522|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
156396860|NCT00293267|564543523|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
156396861|NCT00293267|564543522|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
156396862|NCT00293267|564543523|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
156396863|NCT00293267|564543522|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
156396864|NCT00293267|564543523|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
156396865|NCT00293267|564543522|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
156396866|NCT00293267|564543523|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
156396867|NCT00293267|564543522|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
156396868|NCT00293267|564543523|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
156396869|NCT00293267|564543522|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
156396870|NCT00293267|564543523|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
156396871|NCT00293267|564543522|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
156396872|NCT00293267|564543523|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
156396873|NCT01050816|564543524|FG000|Overall Study|Lost to Follow-up|2|||
156396874|NCT01050816|564543524|FG000|Overall Study|patient's refusal|2|||
156396875|NCT01123382|564543525|FG000|Overall Study|Withdrawal by Subject|1|||
156396876|NCT01123382|564543526|FG001|Overall Study|Withdrawal by Subject|4|||
156396877|NCT01123382|564543525|FG000|Overall Study|Lost to Follow-up|1|||
156396878|NCT01123382|564543526|FG001|Overall Study|Lost to Follow-up|2|||
156396879|NCT02740049|564543527|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
156396880|NCT02274857|564543528|FG000|Overall Study|Adverse Event|1|||
156396881|NCT02274857|564543529|FG001|Overall Study|Adverse Event|0|||
156396882|NCT02274857|564543528|FG000|Overall Study|Death|1|||
156396883|NCT02274857|564543529|FG001|Overall Study|Death|2|||
156396884|NCT02274857|564543528|FG000|Overall Study|Lost to Follow-up|3|||
156396885|NCT02274857|564543529|FG001|Overall Study|Lost to Follow-up|0|||
156396886|NCT02274857|564543528|FG000|Overall Study|Physician Decision|2|||
156396887|NCT02274857|564543529|FG001|Overall Study|Physician Decision|0|||
156396888|NCT02274857|564543528|FG000|Overall Study|Trial screen failure|0|||
156396889|NCT02274857|564543529|FG001|Overall Study|Trial screen failure|2|||
156396890|NCT02274857|564543528|FG000|Overall Study|Withdrawal by Subject|11|||
156396891|NCT02274857|564543529|FG001|Overall Study|Withdrawal by Subject|2|||
156396892|NCT02274857|564543528|FG000|Overall Study|Other|2|||
156396893|NCT02274857|564543529|FG001|Overall Study|Other|0|||
156396894|NCT02403180|564543532|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
156396895|NCT02403180|564543533|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
156396896|NCT02403180|564543532|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
156396897|NCT02403180|564543533|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
156396898|NCT04570436|564543539|FG000|Overall Study|Adverse Event|0|||
156396899|NCT04570436|564543540|FG001|Overall Study|Adverse Event|0|||
156396900|NCT04570436|564543541|FG002|Overall Study|Adverse Event|1|||
156396901|NCT04570436|564543542|FG003|Overall Study|Adverse Event|0|||
156396902|NCT04570436|564543543|FG004|Overall Study|Adverse Event|0|||
156396903|NCT04570436|564543544|FG005|Overall Study|Adverse Event|0|||
156396904|NCT04570436|564543545|FG006|Overall Study|Adverse Event|0|||
156396905|NCT04570436|564543546|FG007|Overall Study|Adverse Event|0|||
156396906|NCT04570436|564543547|FG008|Overall Study|Adverse Event|0|||
156396907|NCT04570436|564543548|FG009|Overall Study|Adverse Event|0|||
156396908|NCT04570436|564543539|FG000|Overall Study|Physician Decision|1|||
156396909|NCT04570436|564543540|FG001|Overall Study|Physician Decision|0|||
156396910|NCT04570436|564543541|FG002|Overall Study|Physician Decision|0|||
156396911|NCT04570436|564543542|FG003|Overall Study|Physician Decision|0|||
156396912|NCT04570436|564543543|FG004|Overall Study|Physician Decision|0|||
156396913|NCT04570436|564543544|FG005|Overall Study|Physician Decision|0|||
156396914|NCT04570436|564543545|FG006|Overall Study|Physician Decision|0|||
156396915|NCT04570436|564543546|FG007|Overall Study|Physician Decision|0|||
156396916|NCT04570436|564543547|FG008|Overall Study|Physician Decision|0|||
156396917|NCT04570436|564543548|FG009|Overall Study|Physician Decision|0|||
156396918|NCT03440372|564543549|FG000|Treatment|Adverse Event|16|||
156396919|NCT03440372|564543550|FG001|Treatment|Adverse Event|8|||
156396920|NCT03440372|564543549|FG000|Treatment|Lack of Efficacy|4|||
156396921|NCT03440372|564543550|FG001|Treatment|Lack of Efficacy|2|||
156396922|NCT03440372|564543549|FG000|Treatment|Withdrawal by Subject|12|||
156396923|NCT03440372|564543550|FG001|Treatment|Withdrawal by Subject|8|||
156396924|NCT03440372|564543549|FG000|Treatment|Lost to Follow-up|1|||
156396925|NCT03440372|564543550|FG001|Treatment|Lost to Follow-up|0|||
156396926|NCT03440372|564543549|FG000|Treatment|Pregnancy|1|||
156396927|NCT03440372|564543550|FG001|Treatment|Pregnancy|0|||
156396928|NCT03440372|564543549|FG000|Treatment|Study Terminated by Sponsor|2|||
156396929|NCT03440372|564543550|FG001|Treatment|Study Terminated by Sponsor|1|||
156396930|NCT03440372|564543549|FG000|Treatment|Other Reason|2|||
156396931|NCT03440372|564543550|FG001|Treatment|Other Reason|3|||
156396932|NCT04642898|564543551|FG000|Overall Study|Withdrawal by Subject|2|||
156396933|NCT04642898|564543552|FG001|Overall Study|Withdrawal by Subject|4|||
156396934|NCT04642898|564543553|FG002|Overall Study|Withdrawal by Subject|4|||
156396935|NCT04642898|564543554|FG003|Overall Study|Withdrawal by Subject|6|||
156396936|NCT04642898|564543555|FG004|Overall Study|Withdrawal by Subject|2|||
156396937|NCT04642898|564543556|FG005|Overall Study|Withdrawal by Subject|6|||
156396938|NCT04642898|564543551|FG000|Overall Study|Lost to Follow-up|0|||
156396939|NCT04642898|564543552|FG001|Overall Study|Lost to Follow-up|0|||
156396940|NCT04642898|564543553|FG002|Overall Study|Lost to Follow-up|0|||
156396941|NCT04642898|564543554|FG003|Overall Study|Lost to Follow-up|2|||
156396942|NCT04642898|564543555|FG004|Overall Study|Lost to Follow-up|0|||
156396943|NCT04642898|564543556|FG005|Overall Study|Lost to Follow-up|1|||
156396944|NCT04642898|564543551|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
156396945|NCT04642898|564543552|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
156396946|NCT04642898|564543553|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
156396947|NCT04642898|564543554|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
156396948|NCT04642898|564543555|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
156396949|NCT04642898|564543556|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
156396950|NCT04642898|564543551|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156396951|NCT04642898|564543552|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156396952|NCT04642898|564543553|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156396953|NCT04642898|564543554|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156396954|NCT04642898|564543555|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
156396955|NCT04642898|564543556|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156396956|NCT04495179|564543557|FG000|Overall Study|Lost to Follow-up|0|||
156396957|NCT04495179|564543558|FG001|Overall Study|Lost to Follow-up|1|||
156396958|NCT04495179|564543557|FG000|Overall Study|Withdrawal by Subject|2|||
156396959|NCT04495179|564543558|FG001|Overall Study|Withdrawal by Subject|4|||
156396960|NCT04495179|564543557|FG000|Overall Study|Study terminated by sponsor|0|||
156396961|NCT04495179|564543558|FG001|Overall Study|Study terminated by sponsor|18|||
156396962|NCT04495179|564543557|FG000|Overall Study|Death|0|||
156396963|NCT04495179|564543558|FG001|Overall Study|Death|4|||
156396964|NCT04495179|564543557|FG000|Overall Study|Adverse Event|0|||
156396965|NCT04495179|564543558|FG001|Overall Study|Adverse Event|1|||
156396966|NCT04280562|564543559|FG000|Study|Adverse Event|2|||
156396967|NCT04280562|564543560|FG001|Study|Adverse Event|0|||
156396968|NCT04280562|564543559|FG000|Study|Lost to Follow-up|3|||
156396969|NCT04280562|564543560|FG001|Study|Lost to Follow-up|3|||
156396970|NCT00162370|564543564|FG000|Efficacy Population|Lost to Follow-up|51|||
156396971|NCT00569582|564543565|FG000|Overall Study|Withdrawal by Subject|5|||
156396972|NCT00569582|564543565|FG000|Overall Study|Death|2|||
156396973|NCT00569582|564543565|FG000|Overall Study|Adverse Event|7|||
156396974|NCT00569582|564543565|FG000|Overall Study|Subject was too ill to travel.|1|||
156396975|NCT00569582|564543565|FG000|Overall Study|Subject was non-compliant.|1|||
156396976|NCT01328080|564543570|FG000|Overall Study|Lost to Follow-up|5|||
156396977|NCT03266770|564543571|FG000|Overall Study|Physician Decision|3|||
156396978|NCT03266770|564543571|FG000|Overall Study|Insufficient study supplies|1|||
156396979|NCT03266770|564543571|FG000|Overall Study|Adverse Event|1|||
156396980|NCT01936857|564543572|FG000|Overall Study|Sent to prison or 06 center|11|||
156396981|NCT01936857|564543573|FG001|Overall Study|Sent to prison or 06 center|12|||
156396982|NCT01936857|564543572|FG000|Overall Study|Lost to Follow-up|10|||
156396983|NCT01936857|564543573|FG001|Overall Study|Lost to Follow-up|7|||
156396984|NCT01936857|564543572|FG000|Overall Study|Death|7|||
156396985|NCT01936857|564543573|FG001|Overall Study|Death|3|||
156396986|NCT01936857|564543572|FG000|Overall Study|Moved|2|||
156396987|NCT01936857|564543573|FG001|Overall Study|Moved|1|||
156396988|NCT01936857|564543572|FG000|Overall Study|Withdrawal by Subject|1|||
156396989|NCT01936857|564543573|FG001|Overall Study|Withdrawal by Subject|0|||
156396990|NCT01936857|564543572|FG000|Overall Study|Side effect of medication|1|||
156396991|NCT01936857|564543573|FG001|Overall Study|Side effect of medication|0|||
156396992|NCT01936857|564543572|FG000|Overall Study|Other|2|||
156396993|NCT01936857|564543573|FG001|Overall Study|Other|2|||
156396994|NCT00490282|564543574|FG000|Overall Study|Withdrawal by Subject|3|||
156396995|NCT05380947|564543579|FG000|Washout Period 1|Not attend visit|1|||
156549588|NCT04099251|565103679|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
156549589|NCT01408147|565103680|FG000|Overall Study|Withdrawal by Subject|0|||
156549590|NCT01408147|565103681|FG001|Overall Study|Withdrawal by Subject|1|||
156549591|NCT03445000|565103683|FG000|Overall Study|Disease progression|8|||
156396996|NCT05380947|564543580|FG001|Washout Period 1|Not attend visit|0|||
156396997|NCT05380947|564543581|FG002|Washout Period 1|Not attend visit|0|||
156396998|NCT05380947|564543582|FG003|Washout Period 1|Not attend visit|0|||
156396999|NCT05380947|564543579|FG000|Washout Period 2|Adverse Event|1|||
156397000|NCT05380947|564543580|FG001|Washout Period 2|Adverse Event|0|||
156397001|NCT05380947|564543581|FG002|Washout Period 2|Adverse Event|0|||
156397002|NCT05380947|564543582|FG003|Washout Period 2|Adverse Event|0|||
156549592|NCT03445000|565103683|FG000|Overall Study|Adverse Event|3|||
156549593|NCT03445000|565103683|FG000|Overall Study|Death|2|||
156397003|NCT05380947|564543579|FG000|Washout Period 3|Adverse Event|0|||
156397004|NCT05380947|564543580|FG001|Washout Period 3|Adverse Event|1|||
156397005|NCT05380947|564543581|FG002|Washout Period 3|Adverse Event|0|||
156397006|NCT05380947|564543582|FG003|Washout Period 3|Adverse Event|0|||
156397007|NCT05380947|564543579|FG000|Washout Period 3|Not attend visit|0|||
156397008|NCT05380947|564543580|FG001|Washout Period 3|Not attend visit|1|||
156397009|NCT05380947|564543581|FG002|Washout Period 3|Not attend visit|0|||
156397010|NCT05380947|564543582|FG003|Washout Period 3|Not attend visit|1|||
156397011|NCT01563536|564543583|FG000|Overall Study|Withdrawal by Subject|0|||
156397012|NCT01563536|564543584|FG001|Overall Study|Withdrawal by Subject|2|||
156397013|NCT01563536|564543583|FG000|Overall Study|Lost to Follow-up|1|||
156397014|NCT01563536|564543584|FG001|Overall Study|Lost to Follow-up|0|||
156397015|NCT02170025|564543587|FG000|Overall Study|Adverse Event|2|||
156397016|NCT02170025|564543588|FG001|Overall Study|Adverse Event|0|||
156397017|NCT00572195|564543589|FG000|Overall Study|Withdrawal by Subject|50|||
156397018|NCT00572195|564543589|FG000|Overall Study|Death|9|||
156397019|NCT00572195|564543589|FG000|Overall Study|Adverse Event|4|||
156397020|NCT00572195|564543589|FG000|Overall Study|Lost to Follow-up|5|||
156397021|NCT01525602|564543590|FG000|Overall Study|Adverse Event|1|||
156397022|NCT01525602|564543591|FG001|Overall Study|Adverse Event|0|||
156397023|NCT01525602|564543592|FG002|Overall Study|Adverse Event|1|||
156397024|NCT01525602|564543593|FG003|Overall Study|Adverse Event|1|||
156397025|NCT01525602|564543594|FG004|Overall Study|Adverse Event|3|||
156397026|NCT01525602|564543595|FG005|Overall Study|Adverse Event|3|||
156397027|NCT01525602|564543596|FG006|Overall Study|Adverse Event|0|||
156397028|NCT01525602|564543597|FG007|Overall Study|Adverse Event|1|||
156397029|NCT01525602|564543590|FG000|Overall Study|Disease progression|6|||
156397030|NCT01525602|564543591|FG001|Overall Study|Disease progression|3|||
156397031|NCT01525602|564543592|FG002|Overall Study|Disease progression|2|||
156397032|NCT01525602|564543593|FG003|Overall Study|Disease progression|5|||
156397033|NCT01525602|564543594|FG004|Overall Study|Disease progression|22|||
156397034|NCT01525602|564543595|FG005|Overall Study|Disease progression|2|||
156397035|NCT01525602|564543596|FG006|Overall Study|Disease progression|3|||
156397036|NCT01525602|564543597|FG007|Overall Study|Disease progression|3|||
156397037|NCT01525602|564543590|FG000|Overall Study|Clinical progression|2|||
156397038|NCT01525602|564543591|FG001|Overall Study|Clinical progression|0|||
156397039|NCT01525602|564543592|FG002|Overall Study|Clinical progression|0|||
156397040|NCT01525602|564543593|FG003|Overall Study|Clinical progression|0|||
156397041|NCT01525602|564543594|FG004|Overall Study|Clinical progression|0|||
156397042|NCT01525602|564543595|FG005|Overall Study|Clinical progression|0|||
156397043|NCT01525602|564543596|FG006|Overall Study|Clinical progression|1|||
156397044|NCT01525602|564543597|FG007|Overall Study|Clinical progression|1|||
156397045|NCT01525602|564543590|FG000|Overall Study|Non-compliance|0|||
156397046|NCT01525602|564543591|FG001|Overall Study|Non-compliance|0|||
156397047|NCT01525602|564543592|FG002|Overall Study|Non-compliance|0|||
156397048|NCT01525602|564543593|FG003|Overall Study|Non-compliance|0|||
156397049|NCT01525602|564543594|FG004|Overall Study|Non-compliance|1|||
156397050|NCT01525602|564543595|FG005|Overall Study|Non-compliance|0|||
156397051|NCT01525602|564543596|FG006|Overall Study|Non-compliance|0|||
156397052|NCT01525602|564543597|FG007|Overall Study|Non-compliance|0|||
156397053|NCT01525602|564543590|FG000|Overall Study|Withdrawal by Subject|0|||
156397054|NCT01525602|564543591|FG001|Overall Study|Withdrawal by Subject|0|||
156397055|NCT01525602|564543592|FG002|Overall Study|Withdrawal by Subject|0|||
156397056|NCT01525602|564543593|FG003|Overall Study|Withdrawal by Subject|0|||
156397057|NCT01525602|564543594|FG004|Overall Study|Withdrawal by Subject|3|||
156397058|NCT01525602|564543595|FG005|Overall Study|Withdrawal by Subject|1|||
156397059|NCT01525602|564543596|FG006|Overall Study|Withdrawal by Subject|0|||
156397060|NCT01525602|564543597|FG007|Overall Study|Withdrawal by Subject|1|||
156397061|NCT01525602|564543590|FG000|Overall Study|Physician Decision|0|||
156397062|NCT01525602|564543591|FG001|Overall Study|Physician Decision|0|||
156397063|NCT01525602|564543592|FG002|Overall Study|Physician Decision|0|||
156397064|NCT01525602|564543593|FG003|Overall Study|Physician Decision|0|||
156397065|NCT01525602|564543594|FG004|Overall Study|Physician Decision|3|||
156397066|NCT01525602|564543595|FG005|Overall Study|Physician Decision|0|||
156397067|NCT01525602|564543596|FG006|Overall Study|Physician Decision|1|||
156397068|NCT01525602|564543597|FG007|Overall Study|Physician Decision|0|||
156397069|NCT01525602|564543590|FG000|Overall Study|Death|0|||
156397070|NCT01525602|564543591|FG001|Overall Study|Death|0|||
156397071|NCT01525602|564543592|FG002|Overall Study|Death|0|||
156397072|NCT01525602|564543593|FG003|Overall Study|Death|0|||
156397073|NCT01525602|564543594|FG004|Overall Study|Death|1|||
156397074|NCT01525602|564543595|FG005|Overall Study|Death|1|||
156397075|NCT01525602|564543596|FG006|Overall Study|Death|0|||
156397076|NCT01525602|564543597|FG007|Overall Study|Death|0|||
156397077|NCT01525602|564543590|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
156397078|NCT01525602|564543591|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
156397079|NCT01525602|564543592|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
156397080|NCT01525602|564543593|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
156397081|NCT01525602|564543594|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
156397082|NCT01525602|564543595|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
156397083|NCT01525602|564543596|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
156397084|NCT01525602|564543597|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
156397085|NCT03703466|564543598|FG000|Overall Study|Death|2|||
156397086|NCT03703466|564543599|FG001|Overall Study|Death|1|||
156397087|NCT03703466|564543600|FG002|Overall Study|Death|0|||
156397088|NCT03703466|564543598|FG000|Overall Study|Withdrawal by Subject|0|||
156397089|NCT03703466|564543599|FG001|Overall Study|Withdrawal by Subject|3|||
156397090|NCT03703466|564543600|FG002|Overall Study|Withdrawal by Subject|0|||
156397091|NCT03703466|564543598|FG000|Overall Study|Completed < 3 Cycles|2|||
156397092|NCT03703466|564543599|FG001|Overall Study|Completed < 3 Cycles|2|||
156397093|NCT03703466|564543600|FG002|Overall Study|Completed < 3 Cycles|2|||
156397094|NCT02240108|564545501|FG000|Overall Study|Other than specified|8|||
156397095|NCT02240108|564545502|FG001|Overall Study|Other than specified|6|||
156397096|NCT02240108|564545501|FG000|Overall Study|Adverse Event|1|||
156397097|NCT02240108|564545502|FG001|Overall Study|Adverse Event|9|||
156397098|NCT02240108|564545501|FG000|Overall Study|Pregnancy|1|||
156397099|NCT02240108|564545502|FG001|Overall Study|Pregnancy|0|||
156397100|NCT02240108|564545501|FG000|Overall Study|Withdrawal by Subject|4|||
156397101|NCT02240108|564545502|FG001|Overall Study|Withdrawal by Subject|9|||
156397102|NCT02240108|564545501|FG000|Overall Study|StudyTerminated by Sponsor|0|||
156397103|NCT02240108|564545502|FG001|Overall Study|StudyTerminated by Sponsor|1|||
156397104|NCT05178121|564545509|FG000|Overall Study|Other|4|||
156397105|NCT05178121|564545509|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
156397106|NCT01953003|564545510|FG000|Overall Study|Not treated|0|||
156397107|NCT01953003|564545511|FG001|Overall Study|Not treated|1|||
156397108|NCT01953003|564545510|FG000|Overall Study|Progressive disease|35|||
156397109|NCT01953003|564545511|FG001|Overall Study|Progressive disease|45|||
156397110|NCT01953003|564545510|FG000|Overall Study|Related Adverse events|7|||
156397111|NCT01953003|564545511|FG001|Overall Study|Related Adverse events|2|||
156397112|NCT01953003|564545510|FG000|Overall Study|Non-related adverse events|0|||
156397113|NCT01953003|564545511|FG001|Overall Study|Non-related adverse events|2|||
156397114|NCT01953003|564545510|FG000|Overall Study|Protocol Violation|0|||
156397115|NCT01953003|564545511|FG001|Overall Study|Protocol Violation|1|||
156397116|NCT01953003|564545510|FG000|Overall Study|Withdrawal by Subject|14|||
156397117|NCT01953003|564545511|FG001|Overall Study|Withdrawal by Subject|4|||
156397118|NCT00553501|564545514|FG000|Overall Study|Adverse Event|2|||
156397119|NCT00553501|564545514|FG000|Overall Study|Death|1|||
156397120|NCT00553501|564545514|FG000|Overall Study|Progression|1|||
156397121|NCT01464021|564545518|FG000|Overall Study|Withdrawal by Subject|13|||
156397122|NCT01464021|564545518|FG000|Overall Study|Lost to Follow-up|1|||
156397123|NCT01464021|564545518|FG000|Overall Study|Lack of Efficacy|1|||
156397124|NCT01464021|564545518|FG000|Overall Study|various|11|||
156397125|NCT03391765|564545520|FG000|Overall Study|Adverse Event|2|||
156397126|NCT03391765|564545521|FG001|Overall Study|Adverse Event|0|||
156397127|NCT03391765|564545522|FG002|Overall Study|Adverse Event|0|||
156397128|NCT03391765|564545523|FG003|Overall Study|Adverse Event|2|||
156397129|NCT03391765|564545520|FG000|Overall Study|Withdrew consent|5|||
156397130|NCT03391765|564545521|FG001|Overall Study|Withdrew consent|7|||
156397131|NCT03391765|564545522|FG002|Overall Study|Withdrew consent|2|||
156397132|NCT03391765|564545523|FG003|Overall Study|Withdrew consent|5|||
156397133|NCT03391765|564545520|FG000|Overall Study|Other, not specified|44|||
156397134|NCT03391765|564545521|FG001|Overall Study|Other, not specified|38|||
156397135|NCT03391765|564545522|FG002|Overall Study|Other, not specified|21|||
156397136|NCT03391765|564545523|FG003|Overall Study|Other, not specified|16|||
156397137|NCT00944658|564545524|FG000|Treatment 12 Weeks|Adverse Event|0|||
156397138|NCT00944658|564545525|FG001|Treatment 12 Weeks|Adverse Event|2|||
156397139|NCT02563002|564545528|FG000|Overall Study|Death|72|||
156549594|NCT03445000|565103683|FG000|Overall Study|Physician Decision|1|||
156549595|NCT01982292|565103684|FG000|Overall Study|Adverse Event|2|||
156397140|NCT02563002|564545529|FG001|Overall Study|Death|87|||
156397141|NCT02563002|564545528|FG000|Overall Study|Lost to Follow-up|5|||
156397142|NCT02563002|564545529|FG001|Overall Study|Lost to Follow-up|0|||
156397143|NCT02563002|564545528|FG000|Overall Study|Physician Decision|0|||
156397144|NCT02563002|564545529|FG001|Overall Study|Physician Decision|2|||
156397145|NCT02563002|564545528|FG000|Overall Study|Withdrawal by Subject|2|||
156397146|NCT02563002|564545529|FG001|Overall Study|Withdrawal by Subject|10|||
156397147|NCT02563002|564545528|FG000|Overall Study|Sponsor decision|74|||
156397148|NCT02563002|564545529|FG001|Overall Study|Sponsor decision|55|||
156397149|NCT03518125|564545536|FG000|Overall Study|Lost to Follow-up|0|||
156397150|NCT03518125|564545537|FG001|Overall Study|Lost to Follow-up|2|||
156397151|NCT03518125|564545538|FG002|Overall Study|Lost to Follow-up|0|||
156397152|NCT03518125|564545539|FG003|Overall Study|Lost to Follow-up|0|||
156397153|NCT03518125|564545540|FG004|Overall Study|Lost to Follow-up|3|||
156397154|NCT03518125|564545541|FG005|Overall Study|Lost to Follow-up|5|||
156397155|NCT03518125|564545536|FG000|Overall Study|Physician Decision|0|||
156397156|NCT03518125|564545537|FG001|Overall Study|Physician Decision|1|||
156397157|NCT03518125|564545538|FG002|Overall Study|Physician Decision|0|||
156397158|NCT03518125|564545539|FG003|Overall Study|Physician Decision|0|||
156397159|NCT03518125|564545540|FG004|Overall Study|Physician Decision|0|||
156397160|NCT03518125|564545541|FG005|Overall Study|Physician Decision|0|||
156397161|NCT03518125|564545536|FG000|Overall Study|Withdrawal by Subject|1|||
156397162|NCT03518125|564545537|FG001|Overall Study|Withdrawal by Subject|1|||
156397163|NCT03518125|564545538|FG002|Overall Study|Withdrawal by Subject|0|||
156397164|NCT03518125|564545539|FG003|Overall Study|Withdrawal by Subject|1|||
156397165|NCT03518125|564545540|FG004|Overall Study|Withdrawal by Subject|1|||
156397166|NCT03518125|564545541|FG005|Overall Study|Withdrawal by Subject|3|||
156397167|NCT03518125|564545536|FG000|Overall Study|Missed Day 394 Visit|1|||
156397168|NCT03518125|564545537|FG001|Overall Study|Missed Day 394 Visit|0|||
156397169|NCT03518125|564545538|FG002|Overall Study|Missed Day 394 Visit|0|||
156397170|NCT03518125|564545539|FG003|Overall Study|Missed Day 394 Visit|0|||
156397171|NCT03518125|564545540|FG004|Overall Study|Missed Day 394 Visit|0|||
156397172|NCT03518125|564545541|FG005|Overall Study|Missed Day 394 Visit|0|||
156397173|NCT04452877|564545542|FG000|Overall Study|Adverse Event|5|||
156397174|NCT04452877|564545542|FG000|Overall Study|Lost to Follow-up|1|||
156397175|NCT04452877|564545542|FG000|Overall Study|Physician Decision|4|||
156397176|NCT04452877|564545542|FG000|Overall Study|Progressive Disease|18|||
156397177|NCT04452877|564545542|FG000|Overall Study|Withdrawal by Subject|3|||
156397178|NCT05453110|564545547|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
156397179|NCT05453110|564545548|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
156397180|NCT05453110|564545549|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
156397181|NCT05906368|564545550|FG000|Overall Study|Withdrawal by Subject|1|||
156397182|NCT05906368|564545551|FG001|Overall Study|Withdrawal by Subject|1|||
156397183|NCT05906368|564545550|FG000|Overall Study|Ineligibility criteria identified|2|||
156397184|NCT05906368|564545551|FG001|Overall Study|Ineligibility criteria identified|0|||
156397185|NCT00595504|564545554|FG000|Overall Study|Withdrawal by Subject|1|||
156397186|NCT00595504|564545555|FG001|Overall Study|Withdrawal by Subject|3|||
156397187|NCT00595504|564545554|FG000|Overall Study|Physician Decision|1|||
156397188|NCT00595504|564545555|FG001|Overall Study|Physician Decision|0|||
156397189|NCT01477853|564545556|FG000|Phase A|Adverse Event|1|||
156397190|NCT01477853|564545557|FG001|Phase A|Adverse Event|2|||
156397191|NCT01477853|564545558|FG002|Phase A|Adverse Event|2|||
156397192|NCT01477853|564545556|FG000|Phase A|Lost to Follow-up|4|||
156397193|NCT01477853|564545557|FG001|Phase A|Lost to Follow-up|3|||
156397194|NCT01477853|564545558|FG002|Phase A|Lost to Follow-up|2|||
156397195|NCT01477853|564545556|FG000|Phase A|Physician Decision|1|||
156397196|NCT01477853|564545557|FG001|Phase A|Physician Decision|0|||
156397197|NCT01477853|564545558|FG002|Phase A|Physician Decision|1|||
156397198|NCT01477853|564545556|FG000|Phase A|Study terminated by sponsor|37|||
156397199|NCT01477853|564545557|FG001|Phase A|Study terminated by sponsor|40|||
156397200|NCT01477853|564545558|FG002|Phase A|Study terminated by sponsor|39|||
156397201|NCT01477853|564545556|FG000|Phase B|Lost to Follow-up|0|||
156397202|NCT01477853|564545557|FG001|Phase B|Lost to Follow-up|1|||
156397203|NCT01477853|564545558|FG002|Phase B|Lost to Follow-up|0|||
156397204|NCT01477853|564545556|FG000|Phase B|Study terminated by sponsor|12|||
156397205|NCT01477853|564545557|FG001|Phase B|Study terminated by sponsor|10|||
156397206|NCT01477853|564545558|FG002|Phase B|Study terminated by sponsor|11|||
156397207|NCT01804816|564545559|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
156397208|NCT01804816|564545559|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
156397209|NCT01235546|564545562|FG000|Overall Study|Staff error, medication not administered|1|||
156397210|NCT01235546|564545563|FG001|Overall Study|Staff error, medication not administered|0|||
156397211|NCT01235546|564545562|FG000|Overall Study|Protocol Violation|1|||
156397212|NCT01235546|564545563|FG001|Overall Study|Protocol Violation|1|||
156397213|NCT01256411|564545564|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
156397214|NCT01256411|564545565|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
156397215|NCT01256411|564545566|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
156397216|NCT01256411|564545567|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
156397217|NCT01256411|564545568|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
156397218|NCT01256411|564545569|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
156397219|NCT01256411|564545564|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
156397220|NCT01256411|564545565|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
156397221|NCT01256411|564545566|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
156549596|NCT01982292|565103685|FG001|Overall Study|Adverse Event|0|||
156549597|NCT01982292|565103684|FG000|Overall Study|Death|1|||
156397222|NCT01256411|564545567|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
156397223|NCT01256411|564545568|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
156397224|NCT01256411|564545569|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
156397225|NCT01256411|564545564|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
156397226|NCT01256411|564545565|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
156397227|NCT01256411|564545566|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
156549598|NCT01982292|565103685|FG001|Overall Study|Death|0|||
156549599|NCT01982292|565103684|FG000|Overall Study|Lost to Follow-up|2|||
156397228|NCT01256411|564545567|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
156549600|NCT01982292|565103685|FG001|Overall Study|Lost to Follow-up|0|||
156397229|NCT01256411|564545568|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
156397230|NCT01256411|564545569|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
156397231|NCT01256411|564545564|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
156397232|NCT01256411|564545565|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
156397233|NCT01256411|564545566|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
156397234|NCT01256411|564545567|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
156397235|NCT01256411|564545568|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
156397236|NCT01256411|564545569|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
156397237|NCT01256411|564545564|FG000|Extension by Maximum Treatment|Adverse Event|4|||
156397238|NCT01256411|564545565|FG001|Extension by Maximum Treatment|Adverse Event|2|||
156397239|NCT01256411|564545566|FG002|Extension by Maximum Treatment|Adverse Event|1|||
156397240|NCT01256411|564545567|FG003|Extension by Maximum Treatment|Adverse Event|0|||
156397241|NCT01256411|564545568|FG004|Extension by Maximum Treatment|Adverse Event|0|||
156397242|NCT01256411|564545569|FG005|Extension by Maximum Treatment|Adverse Event|0|||
156397243|NCT01256411|564545564|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
156397244|NCT01256411|564545565|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
156397245|NCT01256411|564545566|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
156397246|NCT01256411|564545567|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
156397247|NCT01256411|564545568|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
156397248|NCT01256411|564545569|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
156397249|NCT01256411|564545564|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156397250|NCT01256411|564545565|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156397251|NCT01256411|564545566|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156397252|NCT01256411|564545567|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156397253|NCT01256411|564545568|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156397254|NCT01256411|564545569|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
156397255|NCT01256411|564545564|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156397256|NCT01256411|564545565|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156397257|NCT01256411|564545566|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156397258|NCT01256411|564545567|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156397259|NCT01256411|564545568|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
156397260|NCT01256411|564545569|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156397261|NCT01256411|564545564|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
156397262|NCT01256411|564545565|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
156397263|NCT01256411|564545566|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
156397264|NCT01256411|564545567|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
156397265|NCT01256411|564545568|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
156397266|NCT01256411|564545569|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
156397267|NCT01256411|564545564|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
156397268|NCT01256411|564545565|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
156397269|NCT01256411|564545566|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
156397270|NCT01256411|564545567|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
156397271|NCT01256411|564545568|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
156397272|NCT01256411|564545569|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
156397273|NCT01445652|564545571|FG000|Overall Study|Not comfortable in lenses|5|||
156397274|NCT01445652|564545572|FG001|Overall Study|Not comfortable in lenses|0|||
156397275|NCT01445652|564545571|FG000|Overall Study|Failed to attend scheduled visit|2|||
156397276|NCT01445652|564545572|FG001|Overall Study|Failed to attend scheduled visit|3|||
156397277|NCT01445652|564545571|FG000|Overall Study|Failed teach session|2|||
156549601|NCT01982292|565103684|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
156397278|NCT01445652|564545572|FG001|Overall Study|Failed teach session|0|||
156397279|NCT01445652|564545571|FG000|Overall Study|Adverse Event|1|||
156397280|NCT01445652|564545572|FG001|Overall Study|Adverse Event|0|||
156397281|NCT00929162|564545573|FG000|Overall Study|Adverse Event|8|||
156397282|NCT00929162|564545574|FG001|Overall Study|Adverse Event|5|||
156397283|NCT00929162|564545573|FG000|Overall Study|Withdrawal by Subject|3|||
156397284|NCT00929162|564545574|FG001|Overall Study|Withdrawal by Subject|1|||
156397285|NCT00929162|564545573|FG000|Overall Study|Protocol Violation|32|||
156397286|NCT00929162|564545574|FG001|Overall Study|Protocol Violation|30|||
156397287|NCT00929162|564545573|FG000|Overall Study|Other termination reason|5|||
156397288|NCT00929162|564545574|FG001|Overall Study|Other termination reason|6|||
156397289|NCT00658567|564545576|FG000|Overall Study|Adverse Event|5|||
156397290|NCT00658567|564545577|FG001|Overall Study|Adverse Event|2|||
156397291|NCT00658567|564545578|FG002|Overall Study|Adverse Event|3|||
156397292|NCT00658567|564545576|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
156397293|NCT00658567|564545577|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
156397294|NCT00658567|564545578|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
156397295|NCT00658567|564545576|FG000|Overall Study|Physician Decision|0|||
156397296|NCT00658567|564545577|FG001|Overall Study|Physician Decision|1|||
156397297|NCT00658567|564545578|FG002|Overall Study|Physician Decision|0|||
156397298|NCT00658567|564545576|FG000|Overall Study|At Discretion of Sponsor|1|||
156397299|NCT00658567|564545577|FG001|Overall Study|At Discretion of Sponsor|1|||
156397300|NCT00658567|564545578|FG002|Overall Study|At Discretion of Sponsor|1|||
156397301|NCT01755702|564545579|FG000|Wash Out Period I|Other Reason|3|||
156397302|NCT01755702|564545579|FG000|Washout Period II|Other Reason|5|||
156397303|NCT00691938|564545580|FG000|Overall Study|QTc prolongation|1|||
156397304|NCT00691938|564545581|FG001|Overall Study|QTc prolongation|0|||
156397305|NCT00691938|564545582|FG002|Overall Study|QTc prolongation|0|||
156397306|NCT00691938|564545583|FG003|Overall Study|QTc prolongation|0|||
156397307|NCT00691938|564545584|FG004|Overall Study|QTc prolongation|0|||
156397308|NCT00691938|564545585|FG005|Overall Study|QTc prolongation|0|||
156397309|NCT00691938|564545586|FG006|Overall Study|QTc prolongation|0|||
156397310|NCT04860518|564545588|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
156397311|NCT04860518|564545589|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
156397312|NCT00594854|564545593|FG000|Overall Study|Study terminated|7|||
156397313|NCT00594854|564545594|FG001|Overall Study|Study terminated|10|||
156397314|NCT03172702|564545597|FG000|Overall Study|Adverse Event|9|||
156397315|NCT03172702|564545597|FG000|Overall Study|Death|2|||
156397316|NCT03172702|564545597|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
156397317|NCT03172702|564545597|FG000|Overall Study|Withdrawal by Subject|5|||
156397318|NCT03172702|564545597|FG000|Overall Study|Other|2|||
156397319|NCT03292146|564545598|FG000|Baseline to 12 months|Relocation|1|||
156397320|NCT03292146|564545599|FG001|Baseline to 12 months|Relocation|0|||
156397321|NCT03292146|564545598|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
156397322|NCT03292146|564545599|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
156397323|NCT03292146|564545598|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
156397324|NCT03292146|564545599|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
156397325|NCT03292146|564545598|FG000|12 months to 24 months|Planning pregnancy|2|||
156397326|NCT03292146|564545599|FG001|12 months to 24 months|Planning pregnancy|2|||
156397327|NCT03292146|564545598|FG000|12 months to 24 months|Personal reasons|1|||
156397328|NCT03292146|564545599|FG001|12 months to 24 months|Personal reasons|0|||
156397329|NCT03292146|564545598|FG000|12 months to 24 months|Lost to Follow-up|0|||
156397330|NCT03292146|564545599|FG001|12 months to 24 months|Lost to Follow-up|1|||
156397331|NCT02954354|564545600|FG000|Overall Study|Adverse Event|2|||
156397332|NCT02954354|564545601|FG001|Overall Study|Adverse Event|2|||
156397333|NCT02954354|564545602|FG002|Overall Study|Adverse Event|4|||
156397334|NCT02954354|564545600|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
156397335|NCT02954354|564545601|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
156397336|NCT02954354|564545602|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
156397337|NCT02954354|564545600|FG000|Overall Study|Lack of Efficacy|0|||
156397338|NCT02954354|564545601|FG001|Overall Study|Lack of Efficacy|2|||
156397339|NCT02954354|564545602|FG002|Overall Study|Lack of Efficacy|0|||
156397340|NCT02954354|564545600|FG000|Overall Study|Withdrawal by Subject|17|||
156397341|NCT02954354|564545601|FG001|Overall Study|Withdrawal by Subject|9|||
156397342|NCT02954354|564545602|FG002|Overall Study|Withdrawal by Subject|11|||
156397343|NCT02954354|564545600|FG000|Overall Study|Lost to Follow-up|12|||
156397344|NCT02954354|564545601|FG001|Overall Study|Lost to Follow-up|5|||
156397345|NCT02954354|564545602|FG002|Overall Study|Lost to Follow-up|0|||
156397346|NCT02954354|564545600|FG000|Overall Study|Miscellaneous|2|||
156397347|NCT02954354|564545601|FG001|Overall Study|Miscellaneous|2|||
156397348|NCT02954354|564545602|FG002|Overall Study|Miscellaneous|1|||
156397349|NCT06134180|564545605|FG000|Overall Study|Lost to Follow-up|4|||
156397350|NCT03039023|564545606|FG000|Overall Study|Withdrawal by Subject|1|||
156397351|NCT03039023|564545607|FG001|Overall Study|Withdrawal by Subject|0|||
156549602|NCT01982292|565103685|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
156549603|NCT01982292|565103684|FG000|Overall Study|Protocol Deviation|1|||
156549604|NCT01982292|565103685|FG001|Overall Study|Protocol Deviation|0|||
156549605|NCT01982292|565103684|FG000|Overall Study|Patient/Guardian Decision|3|||
156549606|NCT01982292|565103685|FG001|Overall Study|Patient/Guardian Decision|1|||
156549607|NCT01982292|565103684|FG000|Overall Study|Technical Problems|2|||
156397352|NCT03039023|564545608|FG002|Overall Study|Withdrawal by Subject|1|||
156397353|NCT03039023|564545609|FG003|Overall Study|Withdrawal by Subject|1|||
156397354|NCT03039023|564545610|FG004|Overall Study|Withdrawal by Subject|0|||
156397355|NCT03039023|564545606|FG000|Overall Study|Physician Decision|0|||
156397356|NCT03039023|564545607|FG001|Overall Study|Physician Decision|0|||
156397357|NCT03039023|564545608|FG002|Overall Study|Physician Decision|0|||
156397358|NCT03039023|564545609|FG003|Overall Study|Physician Decision|1|||
156549608|NCT01982292|565103685|FG001|Overall Study|Technical Problems|0|||
156397359|NCT03039023|564545610|FG004|Overall Study|Physician Decision|0|||
156397360|NCT03701399|564545615|FG000|Overall Study|Adverse Event|3|||
156397361|NCT03701399|564545616|FG001|Overall Study|Adverse Event|5|||
156397362|NCT03701399|564545615|FG000|Overall Study|Withdrawal by Subject|6|||
156397363|NCT03701399|564545616|FG001|Overall Study|Withdrawal by Subject|3|||
156397364|NCT03701399|564545615|FG000|Overall Study|Investigators decision|1|||
156397365|NCT03701399|564545616|FG001|Overall Study|Investigators decision|2|||
156397366|NCT03701399|564545615|FG000|Overall Study|Lost to Follow-up|1|||
156397367|NCT03701399|564545616|FG001|Overall Study|Lost to Follow-up|2|||
156397368|NCT03701399|564545615|FG000|Overall Study|Death|1|||
156397369|NCT03701399|564545616|FG001|Overall Study|Death|1|||
156397370|NCT03701399|564545615|FG000|Overall Study|Randomized but not treated|1|||
156397371|NCT03701399|564545616|FG001|Overall Study|Randomized but not treated|0|||
156397372|NCT00448448|564545617|FG000|Overall Study|Withdrawal by Subject|13|||
156397373|NCT00448448|564545618|FG001|Overall Study|Withdrawal by Subject|2|||
156397374|NCT00448448|564545617|FG000|Overall Study|On protocol when study ended|83|||
156397375|NCT00448448|564545618|FG001|Overall Study|On protocol when study ended|36|||
156397376|NCT00448448|564545617|FG000|Overall Study|Lost to Follow-up|2|||
156397377|NCT00448448|564545618|FG001|Overall Study|Lost to Follow-up|1|||
156397378|NCT00448448|564545617|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
156397379|NCT00448448|564545618|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
156397380|NCT00448448|564545617|FG000|Overall Study|Signed consent lost|0|||
156397381|NCT00448448|564545618|FG001|Overall Study|Signed consent lost|1|||
156397382|NCT02340026|564545619|FG000|Treatment Phase|Withdrawal by Subject|2|||
156397383|NCT02340026|564545620|FG001|Treatment Phase|Withdrawal by Subject|2|||
156397384|NCT02340026|564545619|FG000|Follow-up Phase|Lost to Follow-up|1|||
156397385|NCT02340026|564545620|FG001|Follow-up Phase|Lost to Follow-up|0|||
156397386|NCT03945292|564545621|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
156397387|NCT03945292|564545622|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156397388|NCT03945292|564545623|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
156397389|NCT03945292|564545624|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156397390|NCT03945292|564545625|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156397391|NCT03945292|564545626|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156397392|NCT03945292|564545627|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156397393|NCT03945292|564545628|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156397394|NCT03945292|564545621|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156397395|NCT03945292|564545622|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156397396|NCT03945292|564545623|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
156397397|NCT03945292|564545624|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156397398|NCT03945292|564545625|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156397399|NCT03945292|564545626|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156397400|NCT03945292|564545627|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156397401|NCT03945292|564545628|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156397402|NCT03945292|564545621|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156397403|NCT03945292|564545622|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156397404|NCT03945292|564545623|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156397405|NCT03945292|564545624|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156397406|NCT03945292|564545625|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156397407|NCT03945292|564545626|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156397408|NCT03945292|564545627|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156397409|NCT03945292|564545628|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
156397410|NCT02684006|564545629|FG000|Overall Study|Other|18|||
156397411|NCT02684006|564545630|FG001|Overall Study|Other|6|||
156397412|NCT02684006|564545629|FG000|Overall Study|Protocol Violation|2|||
156397413|NCT02684006|564545630|FG001|Overall Study|Protocol Violation|1|||
156397414|NCT02684006|564545629|FG000|Overall Study|Non-compliance with study drug|1|||
156397415|NCT02684006|564545630|FG001|Overall Study|Non-compliance with study drug|1|||
156397416|NCT02684006|564545629|FG000|Overall Study|No longer met eligibility criteria|6|||
156397417|NCT02684006|564545630|FG001|Overall Study|No longer met eligibility criteria|2|||
156397418|NCT02684006|564545629|FG000|Overall Study|Lost to Follow-up|0|||
156397419|NCT02684006|564545630|FG001|Overall Study|Lost to Follow-up|1|||
156397420|NCT02684006|564545629|FG000|Overall Study|Death|25|||
156397421|NCT02684006|564545630|FG001|Overall Study|Death|22|||
156397422|NCT02684006|564545629|FG000|Overall Study|Global deterioration of health status|18|||
156397423|NCT02684006|564545630|FG001|Overall Study|Global deterioration of health status|20|||
156397424|NCT02684006|564545629|FG000|Overall Study|Physician Decision|15|||
156397425|NCT02684006|564545630|FG001|Overall Study|Physician Decision|8|||
156397426|NCT02684006|564545629|FG000|Overall Study|Adverse Event|86|||
156397427|NCT02684006|564545630|FG001|Overall Study|Adverse Event|65|||
156397428|NCT02684006|564545629|FG000|Overall Study|Withdrawal by Subject|29|||
156397429|NCT02684006|564545630|FG001|Overall Study|Withdrawal by Subject|43|||
156397430|NCT02684006|564545629|FG000|Overall Study|Progressive disease|236|||
156397431|NCT02684006|564545630|FG001|Overall Study|Progressive disease|266|||
156397432|NCT02684006|564545629|FG000|Overall Study|Participation terminated by sponsor|6|||
156397433|NCT02684006|564545630|FG001|Overall Study|Participation terminated by sponsor|9|||
156397434|NCT00946296|564545631|FG000|Overall Study|Physician Decision|3|||
156397435|NCT00946296|564545632|FG001|Overall Study|Physician Decision|0|||
156397436|NCT01368965|564545633|FG000|Overall Study|Lost to Follow-up|12|||
156397437|NCT04559568|564545650|FG000|Overall Study|Physician Decision|0|||
156397438|NCT04559568|564545651|FG001|Overall Study|Physician Decision|0|||
156397439|NCT04559568|564545652|FG002|Overall Study|Physician Decision|0|||
156397440|NCT04559568|564545653|FG003|Overall Study|Physician Decision|0|||
156397441|NCT04559568|564545654|FG004|Overall Study|Physician Decision|0|||
156397442|NCT04559568|564545655|FG005|Overall Study|Physician Decision|0|||
156397443|NCT04559568|564545656|FG006|Overall Study|Physician Decision|0|||
156397444|NCT04559568|564545657|FG007|Overall Study|Physician Decision|0|||
156397445|NCT04559568|564545658|FG008|Overall Study|Physician Decision|0|||
156397446|NCT04559568|564545659|FG009|Overall Study|Physician Decision|1|||
156397447|NCT04559568|564545660|FG010|Overall Study|Physician Decision|0|||
156397448|NCT04559568|564545650|FG000|Overall Study|Withdrawal by Subject|0|||
156397449|NCT04559568|564545651|FG001|Overall Study|Withdrawal by Subject|0|||
156397450|NCT04559568|564545652|FG002|Overall Study|Withdrawal by Subject|0|||
156397451|NCT04559568|564545653|FG003|Overall Study|Withdrawal by Subject|0|||
156397452|NCT04559568|564545654|FG004|Overall Study|Withdrawal by Subject|0|||
156397453|NCT04559568|564545655|FG005|Overall Study|Withdrawal by Subject|0|||
156397454|NCT04559568|564545656|FG006|Overall Study|Withdrawal by Subject|0|||
156397455|NCT04559568|564545657|FG007|Overall Study|Withdrawal by Subject|0|||
156397456|NCT04559568|564545658|FG008|Overall Study|Withdrawal by Subject|0|||
156397457|NCT04559568|564545659|FG009|Overall Study|Withdrawal by Subject|0|||
156397458|NCT04559568|564545660|FG010|Overall Study|Withdrawal by Subject|1|||
156397459|NCT03721965|564545661|FG000|Overall Study|Death|1|||
156397460|NCT03721965|564545661|FG000|Overall Study|Study Terminated by Sponsor|1|||
156397461|NCT05103384|564545662|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
156397462|NCT02612311|564545663|FG000|Overall Study|Adverse Event|16|||
156397463|NCT02612311|564545664|FG001|Overall Study|Adverse Event|12|||
156397464|NCT02612311|564545665|FG002|Overall Study|Adverse Event|7|||
156397465|NCT02612311|564545666|FG003|Overall Study|Adverse Event|13|||
156397466|NCT02612311|564545663|FG000|Overall Study|Death|29|||
156397467|NCT02612311|564545664|FG001|Overall Study|Death|10|||
156397468|NCT02612311|564545665|FG002|Overall Study|Death|11|||
156397469|NCT02612311|564545666|FG003|Overall Study|Death|11|||
156397470|NCT02612311|564545663|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
156397471|NCT02612311|564545664|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
156397472|NCT02612311|564545665|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
156397473|NCT02612311|564545666|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
156397474|NCT02612311|564545663|FG000|Overall Study|Investigator's Decision|11|||
156397475|NCT02612311|564545664|FG001|Overall Study|Investigator's Decision|15|||
156397476|NCT02612311|564545665|FG002|Overall Study|Investigator's Decision|6|||
156397477|NCT02612311|564545666|FG003|Overall Study|Investigator's Decision|6|||
156397478|NCT02612311|564545663|FG000|Overall Study|Lack of Efficacy|0|||
156397479|NCT02612311|564545664|FG001|Overall Study|Lack of Efficacy|0|||
156397480|NCT02612311|564545665|FG002|Overall Study|Lack of Efficacy|1|||
156397481|NCT02612311|564545666|FG003|Overall Study|Lack of Efficacy|1|||
156397482|NCT02612311|564545663|FG000|Overall Study|Lost to Follow-up|2|||
156397483|NCT02612311|564545664|FG001|Overall Study|Lost to Follow-up|2|||
156397484|NCT02612311|564545665|FG002|Overall Study|Lost to Follow-up|1|||
156397485|NCT02612311|564545666|FG003|Overall Study|Lost to Follow-up|2|||
156397486|NCT02612311|564545663|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
156397487|NCT02612311|564545664|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
156397488|NCT02612311|564545665|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
156397489|NCT02612311|564545666|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
156397490|NCT02612311|564545663|FG000|Overall Study|Site Terminated by Sponsor|29|||
156397491|NCT02612311|564545664|FG001|Overall Study|Site Terminated by Sponsor|12|||
156397492|NCT02612311|564545665|FG002|Overall Study|Site Terminated by Sponsor|13|||
156397493|NCT02612311|564545666|FG003|Overall Study|Site Terminated by Sponsor|5|||
156397494|NCT02612311|564545663|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
156397495|NCT02612311|564545664|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
156397496|NCT02612311|564545665|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
156397497|NCT02612311|564545666|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
156397498|NCT02612311|564545663|FG000|Overall Study|Reason Not Specified|3|||
156397499|NCT02612311|564545664|FG001|Overall Study|Reason Not Specified|7|||
156397500|NCT02612311|564545665|FG002|Overall Study|Reason Not Specified|4|||
156397501|NCT02612311|564545666|FG003|Overall Study|Reason Not Specified|5|||
156397502|NCT02612311|564545663|FG000|Overall Study|Unknown/Missing|10|||
156397503|NCT02612311|564545664|FG001|Overall Study|Unknown/Missing|13|||
156397504|NCT02612311|564545665|FG002|Overall Study|Unknown/Missing|4|||
156397505|NCT02612311|564545666|FG003|Overall Study|Unknown/Missing|0|||
156397506|NCT02612311|564545663|FG000|Overall Study|Non-Compliance with Study|1|||
156397507|NCT02612311|564545664|FG001|Overall Study|Non-Compliance with Study|0|||
156397508|NCT02612311|564545665|FG002|Overall Study|Non-Compliance with Study|0|||
156397509|NCT02612311|564545666|FG003|Overall Study|Non-Compliance with Study|0|||
156397510|NCT04085328|564545670|FG000|Overall Study|Witihdrew Consent|16|||
156397511|NCT04085328|564545671|FG001|Overall Study|Witihdrew Consent|16|||
156397512|NCT04085328|564545670|FG000|Overall Study|Adverse Event|8|||
156397513|NCT04085328|564545671|FG001|Overall Study|Adverse Event|7|||
156397514|NCT04085328|564545670|FG000|Overall Study|Lost to Follow-up|7|||
156397515|NCT04085328|564545671|FG001|Overall Study|Lost to Follow-up|2|||
156397516|NCT04085328|564545670|FG000|Overall Study|Physician Decision|0|||
156397517|NCT04085328|564545671|FG001|Overall Study|Physician Decision|1|||
156397518|NCT04085328|564545670|FG000|Overall Study|Pregnancy|0|||
156397519|NCT04085328|564545671|FG001|Overall Study|Pregnancy|1|||
156397520|NCT04085328|564545670|FG000|Overall Study|Reasons Related to COVID-19|5|||
156397521|NCT04085328|564545671|FG001|Overall Study|Reasons Related to COVID-19|8|||
156397522|NCT04085328|564545670|FG000|Overall Study|Did not meet inclusion criteria|1|||
156397523|NCT04085328|564545671|FG001|Overall Study|Did not meet inclusion criteria|1|||
156397524|NCT04085328|564545670|FG000|Overall Study|Early termination|1|||
156397525|NCT04085328|564545671|FG001|Overall Study|Early termination|0|||
156397526|NCT00514735|564545672|FG000|Overall Study|Withdrawal by Subject|13|||
156397527|NCT00514735|564545673|FG001|Overall Study|Withdrawal by Subject|5|||
156397528|NCT00514735|564545672|FG000|Overall Study|Death|1|||
156397529|NCT00514735|564545673|FG001|Overall Study|Death|0|||
156397530|NCT00514735|564545672|FG000|Overall Study|Lost to Follow-up|0|||
156397531|NCT00514735|564545673|FG001|Overall Study|Lost to Follow-up|1|||
156397532|NCT04751942|564545675|FG000|Overall Study|Lost to Follow-up|9|||
156397533|NCT04751942|564545676|FG001|Overall Study|Lost to Follow-up|6|||
156397534|NCT01422408|564545677|FG000|Overall Study|Adverse Event|1|||
156397535|NCT01422408|564545677|FG000|Overall Study|Withdrawal by Subject|3|||
156397536|NCT00724152|564545684|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
156397537|NCT00724152|564545685|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
156397538|NCT00724152|564545686|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
156397539|NCT00724152|564545684|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
156397540|NCT00724152|564545685|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
156397541|NCT00724152|564545686|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
156397542|NCT04274894|564545690|FG000|Overall Study|Adverse Event|7|||
156397543|NCT04274894|564545690|FG000|Overall Study|Withdrew consent|5|||
156397544|NCT04274894|564545690|FG000|Overall Study|Lost to Follow-up|9|||
156397545|NCT04274894|564545690|FG000|Overall Study|COVID-19 infection|1|||
156397546|NCT04274894|564545690|FG000|Overall Study|Other, not specified|20|||
156397547|NCT04510675|564545695|FG000|Overall Study|Withdrawal by Subject|5|||
156397548|NCT01499082|564545700|FG000|Overall Study|Randomized but not Treated|0|||
156397549|NCT01499082|564545701|FG001|Overall Study|Randomized but not Treated|1|||
156397550|NCT01499082|564545700|FG000|Overall Study|Adverse Event|12|||
156397551|NCT01499082|564545701|FG001|Overall Study|Adverse Event|16|||
156397552|NCT01499082|564545700|FG000|Overall Study|Lack of Efficacy|1|||
156397553|NCT01499082|564545701|FG001|Overall Study|Lack of Efficacy|1|||
156397554|NCT01499082|564545700|FG000|Overall Study|Protocol Violation|6|||
156397555|NCT01499082|564545701|FG001|Overall Study|Protocol Violation|8|||
156397556|NCT01499082|564545700|FG000|Overall Study|Diverse Reasons|18|||
156397557|NCT01499082|564545701|FG001|Overall Study|Diverse Reasons|14|||
156397558|NCT01499082|564545700|FG000|Overall Study|Site Closure for Noncompliance|5|||
156397559|NCT01499082|564545701|FG001|Overall Study|Site Closure for Noncompliance|2|||
156397560|NCT01499082|564545700|FG000|Overall Study|Hypoglycemia|2|||
156397561|NCT01499082|564545701|FG001|Overall Study|Hypoglycemia|3|||
156397562|NCT01499082|564545700|FG000|Overall Study|Lost to Follow-up|1|||
156397563|NCT01499082|564545701|FG001|Overall Study|Lost to Follow-up|3|||
156397564|NCT00636610|564545704|FG000|Overall Study|Adverse Event|4|||
156397565|NCT00636610|564545705|FG001|Overall Study|Adverse Event|4|||
156397566|NCT00636610|564545704|FG000|Overall Study|Death|6|||
156397567|NCT00636610|564545705|FG001|Overall Study|Death|3|||
156397568|NCT00636610|564545704|FG000|Overall Study|Physician decision to withdraw patient|15|||
156397569|NCT00636610|564545705|FG001|Overall Study|Physician decision to withdraw patient|9|||
156397570|NCT00636610|564545704|FG000|Overall Study|Subject decision to withdraw|15|||
156397571|NCT00636610|564545705|FG001|Overall Study|Subject decision to withdraw|11|||
156397572|NCT00636610|564545704|FG000|Overall Study|Disease progression - radiographic|41|||
156397573|NCT00636610|564545705|FG001|Overall Study|Disease progression - radiographic|51|||
156397574|NCT00636610|564545704|FG000|Overall Study|Disease progression - clinical|8|||
156397575|NCT00636610|564545705|FG001|Overall Study|Disease progression - clinical|3|||
156397576|NCT00636610|564545704|FG000|Overall Study|Reason for discontinuation not available|3|||
156397577|NCT00636610|564545705|FG001|Overall Study|Reason for discontinuation not available|2|||
156397578|NCT05899686|564545706|FG000|Overall Study|Protocol Violation|1|||
156397579|NCT03076970|564547659|FG000|Washout Period 2|Adverse Event|0|||
156397580|NCT03076970|564547660|FG001|Washout Period 2|Adverse Event|0|||
156397581|NCT03076970|564547661|FG002|Washout Period 2|Adverse Event|0|||
156397582|NCT03076970|564547662|FG003|Washout Period 2|Adverse Event|0|||
156397583|NCT03076970|564547663|FG004|Washout Period 2|Adverse Event|1|||
156397584|NCT03076970|564547664|FG005|Washout Period 2|Adverse Event|0|||
156397585|NCT03076970|564547659|FG000|Period 3|Withdrawal by Subject|0|||
156397586|NCT03076970|564547660|FG001|Period 3|Withdrawal by Subject|0|||
156397587|NCT03076970|564547661|FG002|Period 3|Withdrawal by Subject|0|||
156397588|NCT03076970|564547662|FG003|Period 3|Withdrawal by Subject|0|||
156397589|NCT03076970|564547663|FG004|Period 3|Withdrawal by Subject|0|||
156397590|NCT03076970|564547664|FG005|Period 3|Withdrawal by Subject|1|||
156397591|NCT03076970|564547659|FG000|Period 3|Failure to meet I/E criteria|0|||
156397592|NCT03076970|564547660|FG001|Period 3|Failure to meet I/E criteria|0|||
156397593|NCT03076970|564547661|FG002|Period 3|Failure to meet I/E criteria|0|||
156397594|NCT03076970|564547662|FG003|Period 3|Failure to meet I/E criteria|0|||
156397595|NCT03076970|564547663|FG004|Period 3|Failure to meet I/E criteria|1|||
156397596|NCT03076970|564547664|FG005|Period 3|Failure to meet I/E criteria|0|||
156397597|NCT03315143|564547687|FG000|Overall Study|Death|240|||
156397598|NCT03315143|564547688|FG001|Overall Study|Death|246|||
156397599|NCT03315143|564547687|FG000|Overall Study|Withdrawal by Subject|57|||
156397600|NCT03315143|564547688|FG001|Overall Study|Withdrawal by Subject|68|||
156397601|NCT03315143|564547687|FG000|Overall Study|Site Terminated by Sponsor|256|||
156397602|NCT03315143|564547688|FG001|Overall Study|Site Terminated by Sponsor|282|||
156397603|NCT03315143|564547687|FG000|Overall Study|Study Terminated by Sponsor|4723|||
156397604|NCT03315143|564547688|FG001|Overall Study|Study Terminated by Sponsor|4664|||
156397605|NCT03315143|564547687|FG000|Overall Study|Reason not Specified|16|||
156397606|NCT03315143|564547688|FG001|Overall Study|Reason not Specified|32|||
156397607|NCT01242748|564547693|FG000|Overall Study|Adverse Event|10|||
156397608|NCT01242748|564547694|FG001|Overall Study|Adverse Event|5|||
156397609|NCT01242748|564547693|FG000|Overall Study|Lost to Follow-up|6|||
156397610|NCT01242748|564547694|FG001|Overall Study|Lost to Follow-up|2|||
156397611|NCT01242748|564547693|FG000|Overall Study|Physician Decision|3|||
156397612|NCT01242748|564547694|FG001|Overall Study|Physician Decision|2|||
156397613|NCT01242748|564547693|FG000|Overall Study|Protocol Violation|1|||
156397614|NCT01242748|564547694|FG001|Overall Study|Protocol Violation|0|||
156397615|NCT01242748|564547693|FG000|Overall Study|Withdrawal by Subject|10|||
156397616|NCT01242748|564547694|FG001|Overall Study|Withdrawal by Subject|2|||
156397617|NCT01242748|564547693|FG000|Overall Study|Miscellaneous reasons|8|||
156397618|NCT01242748|564547694|FG001|Overall Study|Miscellaneous reasons|3|||
156397619|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
156397620|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
156397621|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
156397622|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
156397623|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
156397624|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
156397625|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
156397626|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
156397627|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
156397628|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
156397629|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
156397630|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
156397631|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
156397632|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
156397633|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
156397634|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
156397635|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
156397636|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
156397637|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
156397638|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
156397639|NCT00549757|564547704|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
156397640|NCT00549757|564547705|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
156397641|NCT00549757|564547704|FG000|Extension Period (in Average 9 Months)|Death|143|||
156397642|NCT00549757|564547705|FG001|Extension Period (in Average 9 Months)|Death|136|||
156397643|NCT00549757|564547704|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
156397644|NCT00549757|564547705|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
156549609|NCT00264004|565103687|FG000|Overall Study|Adverse Event|2|||
156549610|NCT00264004|565103688|FG001|Overall Study|Adverse Event|3|||
156397645|NCT00549757|564547704|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
156397646|NCT00549757|564547705|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
156397647|NCT00549757|564547704|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
156397648|NCT00549757|564547705|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
156397649|NCT00105235|564547706|FG000|Overall Study|Death|4|||
156397650|NCT00105235|564547706|FG000|Overall Study|Physician Decision|1|||
156397651|NCT00105235|564547706|FG000|Overall Study|Withdrawal by Subject|2|||
156397652|NCT02052310|564547707|FG000|Overall Study|Death|64|||
156397653|NCT02052310|564547708|FG001|Overall Study|Death|54|||
156397654|NCT02052310|564547707|FG000|Overall Study|Withdrawal by Subject|37|||
156397655|NCT02052310|564547708|FG001|Overall Study|Withdrawal by Subject|49|||
156397656|NCT02052310|564547707|FG000|Overall Study|Other than specified|32|||
156397657|NCT02052310|564547708|FG001|Overall Study|Other than specified|29|||
156397658|NCT02052310|564547707|FG000|Overall Study|Adverse Event|29|||
156397659|NCT02052310|564547708|FG001|Overall Study|Adverse Event|22|||
156397660|NCT02052310|564547707|FG000|Overall Study|Kidney Transplant|23|||
156397661|NCT02052310|564547708|FG001|Overall Study|Kidney Transplant|29|||
156397662|NCT02052310|564547707|FG000|Overall Study|Physician Decision|14|||
156397663|NCT02052310|564547708|FG001|Overall Study|Physician Decision|7|||
156397664|NCT02052310|564547707|FG000|Overall Study|Lack of Efficacy|6|||
156397665|NCT02052310|564547708|FG001|Overall Study|Lack of Efficacy|1|||
156397666|NCT02052310|564547707|FG000|Overall Study|Site Terminated by Sponsor|5|||
156397667|NCT02052310|564547708|FG001|Overall Study|Site Terminated by Sponsor|13|||
156397668|NCT02052310|564547707|FG000|Overall Study|Lost to Follow-up|4|||
156397669|NCT02052310|564547708|FG001|Overall Study|Lost to Follow-up|2|||
156397670|NCT02052310|564547707|FG000|Overall Study|Protocol Violation|1|||
156397671|NCT02052310|564547708|FG001|Overall Study|Protocol Violation|6|||
156397672|NCT01964326|564547709|FG000|Overall Study|Adverse Event|48|||
156397673|NCT01964326|564547709|FG000|Overall Study|Death|2|||
156397674|NCT01964326|564547709|FG000|Overall Study|Protocol Violation|4|||
156397675|NCT01964326|564547709|FG000|Overall Study|Lost to Follow-up|88|||
156397676|NCT01964326|564547709|FG000|Overall Study|Withdrawal by Subject|87|||
156397677|NCT01964326|564547709|FG000|Overall Study|Pregnancy|1|||
156397678|NCT01964326|564547709|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
156397679|NCT01964326|564547709|FG000|Overall Study|Physician Decision|55|||
156397680|NCT01964326|564547709|FG000|Overall Study|Investigator Discretion|1|||
156397681|NCT01964326|564547709|FG000|Overall Study|Other|9|||
156397682|NCT01964326|564547709|FG000|Overall Study|Did not meet eligibility criteria|1|||
156397683|NCT02093663|564547718|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
156397684|NCT02093663|564547719|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
156397685|NCT02093663|564547720|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
156397686|NCT02093663|564547721|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
156397687|NCT02093663|564547722|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
156397688|NCT02093663|564547718|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
156397689|NCT02093663|564547719|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156397690|NCT02093663|564547720|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156397691|NCT02093663|564547721|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156397692|NCT02093663|564547722|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156397693|NCT02093663|564547718|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
156397694|NCT02093663|564547719|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
156397695|NCT02093663|564547720|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
156397696|NCT02093663|564547721|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
156397697|NCT02093663|564547722|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
156397698|NCT02093663|564547718|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
156397699|NCT02093663|564547719|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
156397700|NCT02093663|564547720|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
156397701|NCT02093663|564547721|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
156397702|NCT02093663|564547722|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
156397703|NCT02093663|564547718|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156397704|NCT02093663|564547719|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156397705|NCT02093663|564547720|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
156397706|NCT02093663|564547721|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156397707|NCT02093663|564547722|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156397708|NCT02093663|564547718|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
156397709|NCT02093663|564547719|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
156397710|NCT02093663|564547720|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
156397711|NCT02093663|564547721|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
156397712|NCT02093663|564547722|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
156397713|NCT02093663|564547718|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
156397714|NCT02093663|564547719|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
156397715|NCT02093663|564547720|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
156397716|NCT02093663|564547721|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
156397717|NCT02093663|564547722|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
156397718|NCT02093663|564547718|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
156397719|NCT02093663|564547719|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
156397720|NCT02093663|564547720|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
156397721|NCT02093663|564547721|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
156397722|NCT02093663|564547722|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
156509015|NCT03635099|564955558|FG007|Period 2|Withdrawal by Subject|0|||
156509016|NCT04844879|564955559|FG000|Overall Study|Death|1|||
156397723|NCT02093663|564547718|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
156397724|NCT02093663|564547719|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
156509017|NCT04844879|564955559|FG000|Overall Study|Withdrawal by Subject|1|||
156509018|NCT04844879|564955559|FG000|Overall Study|Adverse Event|1|||
156397725|NCT02093663|564547720|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
156397726|NCT02093663|564547721|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
156397727|NCT02093663|564547722|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
156397728|NCT03086330|564547729|FG000|Overall Study|Withdrawal by Subject|3|||
156397729|NCT03086330|564547730|FG001|Overall Study|Withdrawal by Subject|2|||
156397730|NCT03086330|564547729|FG000|Overall Study|Lost to Follow-up|1|||
156397731|NCT03086330|564547730|FG001|Overall Study|Lost to Follow-up|2|||
156397732|NCT00645164|564547731|FG000|Overall Study|Lost to Follow-up|2|||
156397733|NCT00645164|564547731|FG000|Overall Study|Withdrawal by Subject|4|||
156397734|NCT00645164|564547731|FG000|Overall Study|Protocol Violation|1|||
156397735|NCT03338829|564547734|FG000|Overall Study|Lost to Follow-up|4|||
156397736|NCT03338829|564547735|FG001|Overall Study|Lost to Follow-up|2|||
156397737|NCT03338829|564547736|FG002|Overall Study|Lost to Follow-up|4|||
156397738|NCT03338829|564547734|FG000|Overall Study|Pregnancy loss|1|||
156397739|NCT03338829|564547735|FG001|Overall Study|Pregnancy loss|1|||
156397740|NCT03338829|564547736|FG002|Overall Study|Pregnancy loss|0|||
156397741|NCT03338829|564547734|FG000|Overall Study|Protocol Violation|0|||
156397742|NCT03338829|564547735|FG001|Overall Study|Protocol Violation|1|||
156397743|NCT03338829|564547736|FG002|Overall Study|Protocol Violation|0|||
156397744|NCT03434678|564547739|FG000|Overall Study|Withdrawal by Subject|13|||
156397745|NCT03434678|564547740|FG001|Overall Study|Withdrawal by Subject|13|||
156397746|NCT03434678|564547739|FG000|Overall Study|Found to be ineligible post randomization|2|||
156397747|NCT03434678|564547740|FG001|Overall Study|Found to be ineligible post randomization|1|||
156397748|NCT06060457|564547741|FG000|Overall Study|Adverse Event|1|||
156397749|NCT06060457|564547742|FG001|Overall Study|Adverse Event|1|||
156397750|NCT06060457|564547741|FG000|Overall Study|Death|2|||
156397751|NCT06060457|564547742|FG001|Overall Study|Death|2|||
156397752|NCT06060457|564547741|FG000|Overall Study|Lost to Follow-up|17|||
156397753|NCT06060457|564547742|FG001|Overall Study|Lost to Follow-up|19|||
156397754|NCT06060457|564547741|FG000|Overall Study|Physician Decision|0|||
156397755|NCT06060457|564547742|FG001|Overall Study|Physician Decision|1|||
156397756|NCT06060457|564547741|FG000|Overall Study|Protocol Violation|1|||
156397757|NCT06060457|564547742|FG001|Overall Study|Protocol Violation|1|||
156397758|NCT06060457|564547741|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
156397759|NCT06060457|564547742|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
156397760|NCT06060457|564547741|FG000|Overall Study|Withdrawal by Subject|12|||
156397761|NCT06060457|564547742|FG001|Overall Study|Withdrawal by Subject|15|||
156397762|NCT06060457|564547741|FG000|Overall Study|Other Than Specified|2|||
156397763|NCT06060457|564547742|FG001|Overall Study|Other Than Specified|1|||
156397764|NCT02061202|564547743|FG000|Overall Study|Lost to Follow-up|1|||
156397765|NCT02061202|564547744|FG001|Overall Study|Lost to Follow-up|1|||
156397766|NCT05608499|564547749|FG000|Overall Study|Lack of Efficacy|1|||
156397767|NCT05608499|564547750|FG001|Overall Study|Lack of Efficacy|0|||
156397768|NCT05608499|564547749|FG000|Overall Study|Lost to Follow-up|0|||
156397769|NCT05608499|564547750|FG001|Overall Study|Lost to Follow-up|1|||
156397770|NCT02660827|564547753|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
156397771|NCT02660827|564547753|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
156397772|NCT02660827|564547753|FG000|From Study to End of Continued Access|Adverse Event|3|||
156397773|NCT02660827|564547753|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
156397774|NCT02660827|564547753|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
156397775|NCT02660827|564547753|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
156397776|NCT02660827|564547753|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
156397777|NCT02660827|564547753|FG000|Period 2: Continued Access Period|Adverse Event|3|||
156397778|NCT04672941|564547754|FG000|Overall Study|Investigator decision|1|||
156397779|NCT04672941|564547754|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
156397780|NCT04672941|564547754|FG000|Overall Study|COVID-19 related but no adverse event|1|||
156397781|NCT04672941|564547754|FG000|Overall Study|Adverse Event|2|||
156397782|NCT04672941|564547754|FG000|Overall Study|Lost to Follow-up|2|||
156397783|NCT00045305|564547755|FG000|Overall Study|Lack of Efficacy|6|||
156397784|NCT00045305|564547755|FG000|Overall Study|Adverse Event|3|||
156397785|NCT00045305|564547755|FG000|Overall Study|Death|3|||
156397786|NCT00045305|564547755|FG000|Overall Study|site error|2|||
156397787|NCT02279043|564547756|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
156397788|NCT02279043|564547757|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
156397789|NCT02279043|564547758|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
156397790|NCT02279043|564547756|FG000|Overall Study|Lost to Follow-up|46|||
156397791|NCT02279043|564547757|FG001|Overall Study|Lost to Follow-up|88|||
156397792|NCT02279043|564547758|FG002|Overall Study|Lost to Follow-up|0|||
156397793|NCT03848403|564547759|FG000|Period 2 (Day 8)|Adverse Event|1|||
156397794|NCT03848403|564547760|FG001|Period 2 (Day 8)|Adverse Event|2|||
156397795|NCT03848403|564547761|FG002|Period 2 (Day 8)|Adverse Event|2|||
156397796|NCT03848403|564547759|FG000|Period 2 (Day 8)|Physician Decision|0|||
156397797|NCT03848403|564547760|FG001|Period 2 (Day 8)|Physician Decision|1|||
156397798|NCT03848403|564547761|FG002|Period 2 (Day 8)|Physician Decision|0|||
156397799|NCT03848403|564547759|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
156397800|NCT03848403|564547760|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
156397801|NCT03848403|564547761|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
156397802|NCT00168038|564547762|FG000|Overall Study|Adverse Event|1|||
156397803|NCT00168038|564547762|FG000|Overall Study|Therapy failure|1|||
156397804|NCT02657031|564547766|FG000|Overall Study|Adverse Event|1|||
156397805|NCT02657031|564547767|FG001|Overall Study|Adverse Event|2|||
156397806|NCT04198805|564547768|FG000|Overall Study|Death|0|||
156397807|NCT04198805|564547769|FG001|Overall Study|Death|0|||
156397808|NCT04198805|564547770|FG002|Overall Study|Death|0|||
156397809|NCT04198805|564547771|FG003|Overall Study|Death|1|||
156397810|NCT04198805|564547768|FG000|Overall Study|Early Termination|8|||
156397811|NCT04198805|564547769|FG001|Overall Study|Early Termination|4|||
156397812|NCT04198805|564547770|FG002|Overall Study|Early Termination|6|||
156397813|NCT04198805|564547771|FG003|Overall Study|Early Termination|9|||
156397814|NCT03599349|564547776|FG000|Overall Study|Lost to Follow-up|1|||
156397815|NCT00810264|564547781|FG000|Overall Study|Lost to Follow-up|191|||
156397816|NCT00810264|564547781|FG000|Overall Study|Withdrawal by subject or physician|721|||
156397817|NCT00810264|564547781|FG000|Overall Study|Death|641|||
156397818|NCT01860703|564547792|FG000|Overall Study|Adverse Event|1|||
156397819|NCT01860703|564547793|FG001|Overall Study|Adverse Event|4|||
156397820|NCT01860703|564547794|FG002|Overall Study|Adverse Event|0|||
156397821|NCT01860703|564547795|FG003|Overall Study|Adverse Event|2|||
156397822|NCT01860703|564547792|FG000|Overall Study|Withdrawal by Subject|0|||
156397823|NCT01860703|564547793|FG001|Overall Study|Withdrawal by Subject|1|||
156397824|NCT01860703|564547794|FG002|Overall Study|Withdrawal by Subject|0|||
156397825|NCT01860703|564547795|FG003|Overall Study|Withdrawal by Subject|0|||
156397826|NCT01860703|564547792|FG000|Overall Study|Personal reason|1|||
156397827|NCT01860703|564547793|FG001|Overall Study|Personal reason|0|||
156397828|NCT01860703|564547794|FG002|Overall Study|Personal reason|1|||
156397829|NCT01860703|564547795|FG003|Overall Study|Personal reason|0|||
156397830|NCT06213701|564547797|FG000|Overall Study|Withdrawal by Subject|2|||
156397831|NCT06213701|564547798|FG001|Overall Study|Withdrawal by Subject|1|||
156397832|NCT06213701|564547799|FG002|Overall Study|Withdrawal by Subject|0|||
156397833|NCT00538590|564547800|FG000|Overall Study|Death|1|||
156397834|NCT00538590|564547801|FG001|Overall Study|Death|0|||
156397835|NCT01256567|564547802|FG000|Overall Study|Withdrawal by Subject|1|||
156397836|NCT00567190|564547808|FG000|Overall Study|Death|235|||
156397837|NCT00567190|564547809|FG001|Overall Study|Death|280|||
156397838|NCT00567190|564547808|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
156397839|NCT00567190|564547809|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
156397840|NCT03184792|564547813|FG000|Overall Study|Pandemic|2|||
156397841|NCT03184792|564547814|FG001|Overall Study|Pandemic|2|||
156397842|NCT02495025|564547817|FG000|Overall Study|Lost to Follow-up|21|||
156397843|NCT02495025|564547818|FG001|Overall Study|Lost to Follow-up|14|||
156397844|NCT02495025|564547817|FG000|Overall Study|Withdrawal by Subject|5|||
156397845|NCT02495025|564547818|FG001|Overall Study|Withdrawal by Subject|0|||
156397846|NCT02412137|564547829|FG000|Overall Study|Withdrawal by Subject|2|||
156397847|NCT02412137|564547830|FG001|Overall Study|Withdrawal by Subject|0|||
156397848|NCT02412137|564547829|FG000|Overall Study|Lost to Follow-up|21|||
156397849|NCT02412137|564547830|FG001|Overall Study|Lost to Follow-up|14|||
156397850|NCT02412137|564547829|FG000|Overall Study|Physician Decision|28|||
156397851|NCT02412137|564547830|FG001|Overall Study|Physician Decision|9|||
156397852|NCT03355326|564547839|FG000|Overall Study|Protocol Violation|3|||
156397853|NCT03355326|564547840|FG001|Overall Study|Protocol Violation|3|||
156397854|NCT05809596|564547841|FG000|Overall Study|Death|16|||
156397855|NCT05809596|564547841|FG000|Overall Study|Withdrawal by Subject|4|||
156397856|NCT05809596|564547841|FG000|Overall Study|Physician Decision|1|||
156397857|NCT05809596|564547841|FG000|Overall Study|Missed Visit|2|||
156397858|NCT05809596|564547841|FG000|Overall Study|Other|3|||
156397859|NCT03770494|564547842|FG000|Overall Study|Lost to Follow-up|0|||
156397860|NCT03770494|564547843|FG001|Overall Study|Lost to Follow-up|0|||
156397861|NCT03770494|564547844|FG002|Overall Study|Lost to Follow-up|1|||
156549611|NCT00264004|565103689|FG002|Overall Study|Adverse Event|6|||
156397862|NCT03770494|564547845|FG003|Overall Study|Lost to Follow-up|1|||
156397863|NCT03770494|564547846|FG004|Overall Study|Lost to Follow-up|1|||
156397864|NCT03770494|564547847|FG005|Overall Study|Lost to Follow-up|0|||
156397865|NCT03770494|564547848|FG006|Overall Study|Lost to Follow-up|0|||
156397866|NCT03770494|564547849|FG007|Overall Study|Lost to Follow-up|0|||
156397867|NCT03770494|564547850|FG008|Overall Study|Lost to Follow-up|0|||
156549612|NCT00264004|565103690|FG003|Overall Study|Adverse Event|4|||
156397868|NCT03770494|564547851|FG009|Overall Study|Lost to Follow-up|0|||
156397869|NCT03770494|564547852|FG010|Overall Study|Lost to Follow-up|0|||
156397870|NCT03770494|564547853|FG011|Overall Study|Lost to Follow-up|0|||
156397871|NCT03770494|564547854|FG012|Overall Study|Lost to Follow-up|0|||
156397872|NCT03770494|564547855|FG013|Overall Study|Lost to Follow-up|0|||
156397873|NCT03770494|564547842|FG000|Overall Study|Study terminated by sponsor|1|||
156397874|NCT03770494|564547843|FG001|Overall Study|Study terminated by sponsor|2|||
156397875|NCT03770494|564547844|FG002|Overall Study|Study terminated by sponsor|1|||
156397876|NCT03770494|564547845|FG003|Overall Study|Study terminated by sponsor|1|||
156397877|NCT03770494|564547846|FG004|Overall Study|Study terminated by sponsor|1|||
156397878|NCT03770494|564547847|FG005|Overall Study|Study terminated by sponsor|2|||
156397879|NCT03770494|564547848|FG006|Overall Study|Study terminated by sponsor|1|||
156397880|NCT03770494|564547849|FG007|Overall Study|Study terminated by sponsor|2|||
156397881|NCT03770494|564547850|FG008|Overall Study|Study terminated by sponsor|1|||
156397882|NCT03770494|564547851|FG009|Overall Study|Study terminated by sponsor|2|||
156397883|NCT03770494|564547852|FG010|Overall Study|Study terminated by sponsor|1|||
156397884|NCT03770494|564547853|FG011|Overall Study|Study terminated by sponsor|2|||
156397885|NCT03770494|564547854|FG012|Overall Study|Study terminated by sponsor|0|||
156397886|NCT03770494|564547855|FG013|Overall Study|Study terminated by sponsor|0|||
156397887|NCT03770494|564547842|FG000|Overall Study|Withdrawal by Subject|1|||
156397888|NCT03770494|564547843|FG001|Overall Study|Withdrawal by Subject|1|||
156397889|NCT03770494|564547844|FG002|Overall Study|Withdrawal by Subject|0|||
156397890|NCT03770494|564547845|FG003|Overall Study|Withdrawal by Subject|0|||
156397891|NCT03770494|564547846|FG004|Overall Study|Withdrawal by Subject|2|||
156397892|NCT03770494|564547847|FG005|Overall Study|Withdrawal by Subject|2|||
156397893|NCT03770494|564547848|FG006|Overall Study|Withdrawal by Subject|2|||
156397894|NCT03770494|564547849|FG007|Overall Study|Withdrawal by Subject|0|||
156397895|NCT03770494|564547850|FG008|Overall Study|Withdrawal by Subject|2|||
156397896|NCT03770494|564547851|FG009|Overall Study|Withdrawal by Subject|3|||
156397897|NCT03770494|564547852|FG010|Overall Study|Withdrawal by Subject|1|||
156397898|NCT03770494|564547853|FG011|Overall Study|Withdrawal by Subject|0|||
156397899|NCT03770494|564547854|FG012|Overall Study|Withdrawal by Subject|0|||
156397900|NCT03770494|564547855|FG013|Overall Study|Withdrawal by Subject|0|||
156397901|NCT01984697|564549561|FG000|Overall Study|Adverse Event|0|||
156397902|NCT01984697|564549562|FG001|Overall Study|Adverse Event|0|||
156397903|NCT01984697|564549563|FG002|Overall Study|Adverse Event|2|||
156397904|NCT01984697|564549564|FG003|Overall Study|Adverse Event|0|||
156397905|NCT01984697|564549565|FG004|Overall Study|Adverse Event|0|||
156397906|NCT01984697|564549561|FG000|Overall Study|Lost to Follow-up|14|||
156397907|NCT01984697|564549562|FG001|Overall Study|Lost to Follow-up|5|||
156397908|NCT01984697|564549563|FG002|Overall Study|Lost to Follow-up|10|||
156397909|NCT01984697|564549564|FG003|Overall Study|Lost to Follow-up|6|||
156397910|NCT01984697|564549565|FG004|Overall Study|Lost to Follow-up|21|||
156397911|NCT01984697|564549561|FG000|Overall Study|Physician Decision|3|||
156397912|NCT01984697|564549562|FG001|Overall Study|Physician Decision|0|||
156397913|NCT01984697|564549563|FG002|Overall Study|Physician Decision|0|||
156397914|NCT01984697|564549564|FG003|Overall Study|Physician Decision|1|||
156397915|NCT01984697|564549565|FG004|Overall Study|Physician Decision|0|||
156397916|NCT01984697|564549561|FG000|Overall Study|Protocol Violation|8|||
156397917|NCT01984697|564549562|FG001|Overall Study|Protocol Violation|5|||
156397918|NCT01984697|564549563|FG002|Overall Study|Protocol Violation|3|||
156397919|NCT01984697|564549564|FG003|Overall Study|Protocol Violation|2|||
156397920|NCT01984697|564549565|FG004|Overall Study|Protocol Violation|0|||
156397921|NCT01984697|564549561|FG000|Overall Study|Withdrawal by Subject|15|||
156397922|NCT01984697|564549562|FG001|Overall Study|Withdrawal by Subject|21|||
156397923|NCT01984697|564549563|FG002|Overall Study|Withdrawal by Subject|13|||
156397924|NCT01984697|564549564|FG003|Overall Study|Withdrawal by Subject|11|||
156397925|NCT01984697|564549565|FG004|Overall Study|Withdrawal by Subject|13|||
156397926|NCT01984697|564549561|FG000|Overall Study|Missed last follow-up visit|1|||
156397927|NCT01984697|564549562|FG001|Overall Study|Missed last follow-up visit|0|||
156397928|NCT01984697|564549563|FG002|Overall Study|Missed last follow-up visit|0|||
156397929|NCT01984697|564549564|FG003|Overall Study|Missed last follow-up visit|0|||
156397930|NCT01984697|564549565|FG004|Overall Study|Missed last follow-up visit|0|||
156397931|NCT01984697|564549561|FG000|Overall Study|Death|0|||
156397932|NCT01984697|564549562|FG001|Overall Study|Death|0|||
156397933|NCT01984697|564549563|FG002|Overall Study|Death|0|||
156397934|NCT01984697|564549564|FG003|Overall Study|Death|1|||
156397935|NCT01984697|564549565|FG004|Overall Study|Death|0|||
156397936|NCT01984697|564549561|FG000|Overall Study|Pregnancy|2|||
156397937|NCT01984697|564549562|FG001|Overall Study|Pregnancy|0|||
156397938|NCT01984697|564549563|FG002|Overall Study|Pregnancy|1|||
156397939|NCT01984697|564549564|FG003|Overall Study|Pregnancy|0|||
156397940|NCT01984697|564549565|FG004|Overall Study|Pregnancy|1|||
156397941|NCT01345630|564549566|FG000|Overall Study|Adverse Event|22|||
156397942|NCT01345630|564549567|FG001|Overall Study|Adverse Event|23|||
156397943|NCT01345630|564549566|FG000|Overall Study|Lost to Follow-up|17|||
156397944|NCT01345630|564549567|FG001|Overall Study|Lost to Follow-up|16|||
156397945|NCT01345630|564549566|FG000|Overall Study|Protocol Violation|4|||
156397946|NCT01345630|564549567|FG001|Overall Study|Protocol Violation|1|||
156397947|NCT01345630|564549566|FG000|Overall Study|Medication error without associated AE|0|||
156397948|NCT01345630|564549567|FG001|Overall Study|Medication error without associated AE|1|||
156397949|NCT01345630|564549566|FG000|Overall Study|Study terminated by sponsor|254|||
156397950|NCT01345630|564549567|FG001|Overall Study|Study terminated by sponsor|285|||
156397951|NCT01345630|564549566|FG000|Overall Study|Other reasons|6|||
156397952|NCT01345630|564549567|FG001|Overall Study|Other reasons|8|||
156397953|NCT01345630|564549566|FG000|Overall Study|Withdrawn due to pregnancy|1|||
156549613|NCT00264004|565103687|FG000|Overall Study|Withdrawal by Subject|0|||
156397954|NCT01345630|564549567|FG001|Overall Study|Withdrawn due to pregnancy|2|||
156397955|NCT01345630|564549566|FG000|Overall Study|No longer willing to participate|9|||
156397956|NCT01345630|564549567|FG001|Overall Study|No longer willing to participate|12|||
156397957|NCT01345630|564549566|FG000|Overall Study|Insufficient clinical response|48|||
156397958|NCT01345630|564549567|FG001|Overall Study|Insufficient clinical response|11|||
156397959|NCT01364922|564549570|FG000|Open-label (OL) Period|Adverse Event|7|||
156397960|NCT01364922|564549571|FG001|Open-label (OL) Period|Adverse Event|0|||
156397961|NCT01364922|564549572|FG002|Open-label (OL) Period|Adverse Event|0|||
156397962|NCT01364922|564549570|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
156397963|NCT01364922|564549571|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
156397964|NCT01364922|564549572|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
156397965|NCT01364922|564549570|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
156397966|NCT01364922|564549571|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
156397967|NCT01364922|564549572|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
156397968|NCT01364922|564549570|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
156397969|NCT01364922|564549571|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
156397970|NCT01364922|564549572|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
156397971|NCT01364922|564549570|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
156397972|NCT01364922|564549571|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
156397973|NCT01364922|564549572|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
156397974|NCT01364922|564549570|FG000|Open-label (OL) Period|Other, Unspecified|1|||
156397975|NCT01364922|564549571|FG001|Open-label (OL) Period|Other, Unspecified|0|||
156397976|NCT01364922|564549572|FG002|Open-label (OL) Period|Other, Unspecified|0|||
156397977|NCT01364922|564549570|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
156397978|NCT01364922|564549571|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
156397979|NCT01364922|564549572|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
156397980|NCT01364922|564549570|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
156397981|NCT01364922|564549571|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
156397982|NCT01364922|564549572|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
156397983|NCT01364922|564549570|FG000|Double-Blind (DB) Period|Adverse Event|0|||
156397984|NCT01364922|564549571|FG001|Double-Blind (DB) Period|Adverse Event|0|||
156397985|NCT01364922|564549572|FG002|Double-Blind (DB) Period|Adverse Event|1|||
156397986|NCT01364922|564549570|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
156397987|NCT01364922|564549571|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
156397988|NCT01364922|564549572|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
156397989|NCT00949715|564549573|FG000|Overall Study|Physician Decision|1|||
156397990|NCT00949715|564549574|FG001|Overall Study|Physician Decision|0|||
156397991|NCT00949715|564549573|FG000|Overall Study|Lost to Follow-up|1|||
156397992|NCT00949715|564549574|FG001|Overall Study|Lost to Follow-up|0|||
156397993|NCT00949715|564549573|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
156397994|NCT00949715|564549574|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
156397995|NCT01289418|564549576|FG000|Day 8 Survey|email address invalid|283|||
156397996|NCT01289418|564549576|FG000|Day 8 Survey|participants did not complete the survey|1935|||
156397997|NCT01289418|564549576|FG000|Day 29 Survey|email address invalid|283|||
156397998|NCT01289418|564549576|FG000|Day 29 Survey|participants did not complete the survey|2185|||
156397999|NCT01352585|564549577|FG000|Overall Study|Adverse Event|2|||
156398000|NCT01352585|564549578|FG001|Overall Study|Adverse Event|1|||
156398001|NCT01352585|564549577|FG000|Overall Study|Lost to Follow-up|1|||
156398002|NCT01352585|564549578|FG001|Overall Study|Lost to Follow-up|0|||
156398003|NCT01352585|564549577|FG000|Overall Study|Other|5|||
156398004|NCT01352585|564549578|FG001|Overall Study|Other|2|||
156398005|NCT00838682|564549579|FG000|Overall Study|Lost to Follow-up|21|||
156398006|NCT00838682|564549580|FG001|Overall Study|Lost to Follow-up|14|||
156398007|NCT00838682|564549579|FG000|Overall Study|detection of exclusion criteria|4|||
156398008|NCT00838682|564549580|FG001|Overall Study|detection of exclusion criteria|3|||
156398009|NCT00838682|564549579|FG000|Overall Study|Protocol Violation|0|||
156398010|NCT00838682|564549580|FG001|Overall Study|Protocol Violation|1|||
156398011|NCT00838682|564549579|FG000|Overall Study|Withdrawal by Subject|0|||
156398012|NCT00838682|564549580|FG001|Overall Study|Withdrawal by Subject|1|||
156398013|NCT03928028|564549581|FG000|Overall Study|Physician Decision|9|||
156398014|NCT03928028|564549582|FG001|Overall Study|Physician Decision|6|||
156398015|NCT03928028|564549583|FG002|Overall Study|Physician Decision|3|||
156398016|NCT03928028|564549581|FG000|Overall Study|Withdrawal by Subject|12|||
156398017|NCT03928028|564549582|FG001|Overall Study|Withdrawal by Subject|3|||
156398018|NCT03928028|564549583|FG002|Overall Study|Withdrawal by Subject|3|||
156398019|NCT04525547|564549589|FG000|Overall Study|Not treated with Ofev|2|||
156398020|NCT04525547|564549589|FG000|Overall Study|Off-label use|2|||
156398021|NCT04525547|564549589|FG000|Overall Study|Lost to Follow-up|1|||
156398022|NCT00800202|564549590|FG000|Overall Study|Adverse Event|7|||
156398023|NCT00800202|564549591|FG001|Overall Study|Adverse Event|6|||
156398024|NCT00800202|564549590|FG000|Overall Study|Death|1|||
156398025|NCT00800202|564549591|FG001|Overall Study|Death|0|||
156398026|NCT00800202|564549590|FG000|Overall Study|Other|5|||
156398027|NCT00800202|564549591|FG001|Overall Study|Other|0|||
156398028|NCT00800202|564549590|FG000|Overall Study|Disease Progression|54|||
156398029|NCT00800202|564549591|FG001|Overall Study|Disease Progression|18|||
156398030|NCT00180479|564549592|FG000|Overall Study|Death|4|||
156398031|NCT00180479|564549593|FG001|Overall Study|Death|2|||
156398032|NCT00180479|564549592|FG000|Overall Study|Lost to Follow-up|9|||
156398033|NCT00180479|564549593|FG001|Overall Study|Lost to Follow-up|7|||
156398034|NCT00180479|564549592|FG000|Overall Study|Withdrawal by Subject|3|||
156398035|NCT00180479|564549593|FG001|Overall Study|Withdrawal by Subject|3|||
156398036|NCT00180479|564549592|FG000|Overall Study|Informed consent not signed|0|||
156398037|NCT00180479|564549593|FG001|Overall Study|Informed consent not signed|1|||
156398038|NCT02459262|564549594|FG000|Overall Study|Withdrawal by Subject|0|||
156398039|NCT02459262|564549595|FG001|Overall Study|Withdrawal by Subject|0|||
156398040|NCT02459262|564549596|FG002|Overall Study|Withdrawal by Subject|0|||
156398041|NCT02459262|564549597|FG003|Overall Study|Withdrawal by Subject|0|||
156398042|NCT02459262|564549598|FG004|Overall Study|Withdrawal by Subject|0|||
156398043|NCT02459262|564549599|FG005|Overall Study|Withdrawal by Subject|0|||
156398044|NCT02459262|564549600|FG006|Overall Study|Withdrawal by Subject|0|||
156398045|NCT02459262|564549601|FG007|Overall Study|Withdrawal by Subject|0|||
156398046|NCT02459262|564549602|FG008|Overall Study|Withdrawal by Subject|0|||
156398047|NCT02459262|564549603|FG009|Overall Study|Withdrawal by Subject|1|||
156398048|NCT02459262|564549604|FG010|Overall Study|Withdrawal by Subject|0|||
156398049|NCT05168579|564549605|FG000|Overall Study|Lack of Consent|1|||
156398050|NCT05168579|564549606|FG001|Overall Study|Lack of Consent|0|||
156398051|NCT05168579|564549605|FG000|Overall Study|Conflicts with time|2|||
156398052|NCT05168579|564549606|FG001|Overall Study|Conflicts with time|0|||
156549614|NCT00264004|565103688|FG001|Overall Study|Withdrawal by Subject|1|||
156549615|NCT00264004|565103689|FG002|Overall Study|Withdrawal by Subject|2|||
156549616|NCT00264004|565103690|FG003|Overall Study|Withdrawal by Subject|2|||
156549617|NCT00264004|565103687|FG000|Overall Study|Other|2|||
156398053|NCT05168579|564549605|FG000|Overall Study|Time slots were full|3|||
156398054|NCT05168579|564549606|FG001|Overall Study|Time slots were full|0|||
156398055|NCT05168579|564549605|FG000|Overall Study|Lost to Follow-up|0|||
156398056|NCT05168579|564549606|FG001|Overall Study|Lost to Follow-up|15|||
156398057|NCT00840801|564549607|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
156398058|NCT00840801|564549608|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
156398059|NCT00840801|564549609|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
156398060|NCT00840801|564549607|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
156398061|NCT00840801|564549608|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
156398062|NCT00840801|564549609|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
156398063|NCT00840801|564549607|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
156398064|NCT00840801|564549608|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
156398065|NCT00840801|564549609|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
156398066|NCT00840801|564549607|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
156398067|NCT00840801|564549608|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
156398068|NCT00840801|564549609|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
156398069|NCT00508404|564549610|FG000|Overall Study|Ongoing at Data Cut-off|12|||
156398070|NCT00508404|564549610|FG000|Overall Study|Adverse Event|2|||
156398071|NCT00508404|564549610|FG000|Overall Study|Death|16|||
156398072|NCT00508404|564549610|FG000|Overall Study|Physician Decision|2|||
156398073|NCT00508404|564549610|FG000|Overall Study|Withdrawal by Subject|3|||
156398074|NCT00508404|564549610|FG000|Overall Study|Protocol-specified Criteria|2|||
156398075|NCT00508404|564549610|FG000|Overall Study|Lost to Follow-up|2|||
156398076|NCT00508404|564549610|FG000|Overall Study|Other - Not Specified|3|||
156398077|NCT01505387|564549611|FG000|Overall Study|Protocol Violation|1|||
156398078|NCT01505387|564549612|FG001|Overall Study|Protocol Violation|0|||
156398079|NCT01505387|564549611|FG000|Overall Study|Withdrawal by Subject|1|||
156398080|NCT01505387|564549612|FG001|Overall Study|Withdrawal by Subject|1|||
156398081|NCT01424930|564549613|FG000|Overall Study|Adverse Event|0|||
156398082|NCT01424930|564549614|FG001|Overall Study|Adverse Event|1|||
156398083|NCT01424930|564549613|FG000|Overall Study|Death|1|||
156398084|NCT01424930|564549614|FG001|Overall Study|Death|0|||
156398085|NCT01424930|564549613|FG000|Overall Study|Progressive Disease|3|||
156398086|NCT01424930|564549614|FG001|Overall Study|Progressive Disease|6|||
156398087|NCT01424930|564549613|FG000|Overall Study|Screen Failure|0|||
156398088|NCT01424930|564549614|FG001|Overall Study|Screen Failure|1|||
156398089|NCT01424930|564549613|FG000|Overall Study|Reason not specified|0|||
156398090|NCT01424930|564549614|FG001|Overall Study|Reason not specified|6|||
156398091|NCT01197508|564549617|FG000|Overall Study|Withdrawal by Subject|8|||
156398092|NCT01197508|564549618|FG001|Overall Study|Withdrawal by Subject|7|||
156398093|NCT01197508|564549619|FG002|Overall Study|Withdrawal by Subject|15|||
156398094|NCT01197508|564549620|FG003|Overall Study|Withdrawal by Subject|4|||
156398095|NCT01197508|564549617|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
156549618|NCT00264004|565103688|FG001|Overall Study|Other|2|||
156549619|NCT00264004|565103689|FG002|Overall Study|Other|0|||
156549620|NCT00264004|565103690|FG003|Overall Study|Other|3|||
156398096|NCT01197508|564549618|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
156398097|NCT01197508|564549619|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
156398098|NCT01197508|564549620|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
156398099|NCT01197508|564549617|FG000|Overall Study|Adverse Event|10|||
156398100|NCT01197508|564549618|FG001|Overall Study|Adverse Event|13|||
156398101|NCT01197508|564549619|FG002|Overall Study|Adverse Event|23|||
156398102|NCT01197508|564549620|FG003|Overall Study|Adverse Event|3|||
156398103|NCT01197508|564549617|FG000|Overall Study|Severe non-compliance to protocol|0|||
156398104|NCT01197508|564549618|FG001|Overall Study|Severe non-compliance to protocol|3|||
156398105|NCT01197508|564549619|FG002|Overall Study|Severe non-compliance to protocol|1|||
156398106|NCT01197508|564549620|FG003|Overall Study|Severe non-compliance to protocol|3|||
156398107|NCT01197508|564549617|FG000|Overall Study|Condition under investigation worsened|1|||
156398108|NCT01197508|564549618|FG001|Overall Study|Condition under investigation worsened|1|||
156398109|NCT01197508|564549619|FG002|Overall Study|Condition under investigation worsened|1|||
156398110|NCT01197508|564549620|FG003|Overall Study|Condition under investigation worsened|1|||
156398111|NCT01197508|564549617|FG000|Overall Study|Lack of Efficacy|1|||
156398112|NCT01197508|564549618|FG001|Overall Study|Lack of Efficacy|2|||
156398113|NCT01197508|564549619|FG002|Overall Study|Lack of Efficacy|2|||
156398114|NCT01197508|564549620|FG003|Overall Study|Lack of Efficacy|1|||
156398115|NCT01197508|564549617|FG000|Overall Study|Study-specific withdrawal criteria|0|||
156398116|NCT01197508|564549618|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156398117|NCT01197508|564549619|FG002|Overall Study|Study-specific withdrawal criteria|1|||
156398118|NCT01197508|564549620|FG003|Overall Study|Study-specific withdrawal criteria|2|||
156398119|NCT01197508|564549617|FG000|Overall Study|Lost to Follow-up|1|||
156398120|NCT01197508|564549618|FG001|Overall Study|Lost to Follow-up|1|||
156398121|NCT01197508|564549619|FG002|Overall Study|Lost to Follow-up|2|||
156398122|NCT01197508|564549620|FG003|Overall Study|Lost to Follow-up|0|||
156398123|NCT01197508|564549617|FG000|Overall Study|Other|2|||
156398124|NCT01197508|564549618|FG001|Overall Study|Other|3|||
156398125|NCT01197508|564549619|FG002|Overall Study|Other|2|||
156398126|NCT01197508|564549620|FG003|Overall Study|Other|2|||
156398127|NCT03286751|564549621|FG000|Washout Period 1|Withdrawal by Subject|0|||
156398128|NCT03286751|564549622|FG001|Washout Period 1|Withdrawal by Subject|0|||
156398129|NCT03286751|564549623|FG002|Washout Period 1|Withdrawal by Subject|0|||
156398130|NCT03286751|564549624|FG003|Washout Period 1|Withdrawal by Subject|0|||
156398131|NCT03286751|564549625|FG004|Washout Period 1|Withdrawal by Subject|1|||
156398132|NCT03286751|564549626|FG005|Washout Period 1|Withdrawal by Subject|0|||
156398133|NCT03286751|564549621|FG000|Washout Period 2|Personal Reasons|0|||
156398134|NCT03286751|564549622|FG001|Washout Period 2|Personal Reasons|1|||
156398135|NCT03286751|564549623|FG002|Washout Period 2|Personal Reasons|0|||
156398136|NCT03286751|564549624|FG003|Washout Period 2|Personal Reasons|0|||
156398137|NCT03286751|564549625|FG004|Washout Period 2|Personal Reasons|0|||
156398138|NCT03286751|564549626|FG005|Washout Period 2|Personal Reasons|0|||
156398139|NCT03286751|564549621|FG000|Washout Period 5|Adverse Event|0|||
156398140|NCT03286751|564549622|FG001|Washout Period 5|Adverse Event|0|||
156398141|NCT03286751|564549623|FG002|Washout Period 5|Adverse Event|0|||
156398142|NCT03286751|564549624|FG003|Washout Period 5|Adverse Event|0|||
156398143|NCT03286751|564549625|FG004|Washout Period 5|Adverse Event|1|||
156398144|NCT03286751|564549626|FG005|Washout Period 5|Adverse Event|0|||
156398145|NCT01078155|564549627|FG000|Overall Study|Adverse Event|7|||
156398146|NCT01078155|564549627|FG000|Overall Study|Lack of Efficacy|16|||
156398147|NCT01078155|564549627|FG000|Overall Study|Participant's Decision|6|||
156398148|NCT01078155|564549627|FG000|Overall Study|Lost to Follow-up|15|||
156398149|NCT01119768|564549628|FG000|Treatment Period|Lack of Efficacy|18|||
156398150|NCT01119768|564549629|FG001|Treatment Period|Lack of Efficacy|25|||
156398151|NCT01301391|564549630|FG000|Overall Study|Death|13|||
156398152|NCT01301391|564549630|FG000|Overall Study|Lost to Follow-up|3|||
156398153|NCT01301391|564549630|FG000|Overall Study|Physician Decision|2|||
156398154|NCT01301391|564549630|FG000|Overall Study|Sponsor's decision|8|||
156398155|NCT01059643|564549631|FG000|Overall Study|Adverse Event|3|||
156398156|NCT01059643|564549631|FG000|Overall Study|Withdrawal by Subject|2|||
156398157|NCT01059643|564549631|FG000|Overall Study|Physician Decision|1|||
156398158|NCT01621880|564549632|FG000|Overall Study|Adverse Event|5|||
156398159|NCT01621880|564549633|FG001|Overall Study|Adverse Event|1|||
156398160|NCT01621880|564549632|FG000|Overall Study|Withdrawal by Subject|5|||
156398161|NCT01621880|564549633|FG001|Overall Study|Withdrawal by Subject|4|||
156398162|NCT01949870|564549634|FG000|Overall Study|Lack of Efficacy|2|||
156398163|NCT01949870|564549634|FG000|Overall Study|Adverse Event|1|||
156398164|NCT01949870|564549634|FG000|Overall Study|Study termination|1|||
156398165|NCT01949870|564549634|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
156398166|NCT04044456|564549640|FG000|Overall Study|Lost to Follow-up|4|||
156398167|NCT04044456|564549641|FG001|Overall Study|Lost to Follow-up|1|||
156398168|NCT04044456|564549640|FG000|Overall Study|Withdrawal by Subject|1|||
156398169|NCT04044456|564549641|FG001|Overall Study|Withdrawal by Subject|0|||
156398170|NCT00330174|564549642|FG000|Overall Study|Withdrawal by Subject|7|||
156398171|NCT00330174|564549643|FG001|Overall Study|Withdrawal by Subject|7|||
156398172|NCT00330174|564549642|FG000|Overall Study|Lost to Follow-up|4|||
156398173|NCT00330174|564549643|FG001|Overall Study|Lost to Follow-up|1|||
156398174|NCT00330174|564549642|FG000|Overall Study|Clinical deterioration|1|||
156398175|NCT00330174|564549643|FG001|Overall Study|Clinical deterioration|2|||
156398176|NCT00330174|564549642|FG000|Overall Study|Excessive missed visits|3|||
156398177|NCT00330174|564549643|FG001|Overall Study|Excessive missed visits|8|||
156398178|NCT00330174|564549642|FG000|Overall Study|Miscellaneous reasons|7|||
156398179|NCT00330174|564549643|FG001|Overall Study|Miscellaneous reasons|1|||
156398180|NCT02316769|564549646|FG000|Overall Study|Physician Decision|1|||
156398181|NCT02316769|564549647|FG001|Overall Study|Physician Decision|0|||
156398182|NCT02316769|564549646|FG000|Overall Study|Withdrawal by Subject|1|||
156398183|NCT02316769|564549647|FG001|Overall Study|Withdrawal by Subject|0|||
156398184|NCT01281644|564549650|FG000|Overall Study|Lost to Follow-up|3|||
156398185|NCT01281644|564549650|FG000|Overall Study|Withdrawal by Subject|2|||
156398186|NCT04393441|564549652|FG000|Overall Study|Adverse Event|0|||
156398187|NCT04393441|564549653|FG001|Overall Study|Adverse Event|3|||
156398188|NCT04393441|564549652|FG000|Overall Study|Withdrawal by Subject|5|||
156398189|NCT04393441|564549653|FG001|Overall Study|Withdrawal by Subject|7|||
156398190|NCT04393441|564549652|FG000|Overall Study|Lost to Follow-up|0|||
156398191|NCT04393441|564549653|FG001|Overall Study|Lost to Follow-up|2|||
156398192|NCT04393441|564549652|FG000|Overall Study|Protocol Deviation|2|||
156398193|NCT04393441|564549653|FG001|Overall Study|Protocol Deviation|1|||
156398194|NCT04393441|564549652|FG000|Overall Study|Reason not Specified|1|||
156398195|NCT04393441|564549653|FG001|Overall Study|Reason not Specified|1|||
156398196|NCT02782169|564549654|FG000|Overall Study|Lost to Follow-up|1|||
156398197|NCT02782169|564549655|FG001|Overall Study|Lost to Follow-up|2|||
156398198|NCT00771810|564549656|FG000|Overall Study|Adverse Event|3|||
156398199|NCT00771810|564549657|FG001|Overall Study|Adverse Event|0|||
156398200|NCT00771810|564549658|FG002|Overall Study|Adverse Event|2|||
156398201|NCT00771810|564549656|FG000|Overall Study|Lost to Follow-up|0|||
156398202|NCT00771810|564549657|FG001|Overall Study|Lost to Follow-up|0|||
156398203|NCT00771810|564549658|FG002|Overall Study|Lost to Follow-up|1|||
156398204|NCT00771810|564549656|FG000|Overall Study|Physician Decision|1|||
156398205|NCT00771810|564549657|FG001|Overall Study|Physician Decision|2|||
156398206|NCT00771810|564549658|FG002|Overall Study|Physician Decision|2|||
156398207|NCT00771810|564549656|FG000|Overall Study|Protocol Violation|0|||
156398208|NCT00771810|564549657|FG001|Overall Study|Protocol Violation|1|||
156398209|NCT00771810|564549658|FG002|Overall Study|Protocol Violation|1|||
156398210|NCT00771810|564549656|FG000|Overall Study|Withdrawal by Subject|1|||
156398211|NCT00771810|564549657|FG001|Overall Study|Withdrawal by Subject|2|||
156398212|NCT00771810|564549658|FG002|Overall Study|Withdrawal by Subject|0|||
156398213|NCT00771810|564549656|FG000|Overall Study|Other|0|||
156398214|NCT00771810|564549657|FG001|Overall Study|Other|0|||
156398215|NCT00771810|564549658|FG002|Overall Study|Other|1|||
156398216|NCT02953938|564549663|FG000|Overall Study|Adverse Event|0|||
156398217|NCT02953938|564549664|FG001|Overall Study|Adverse Event|1|||
156398218|NCT02953938|564549663|FG000|Overall Study|Withdrawal by Subject|1|||
156398219|NCT02953938|564549664|FG001|Overall Study|Withdrawal by Subject|1|||
156398220|NCT02638948|564549669|FG000|Overall Study|Withdrawal by Subject|4|||
156398221|NCT02638948|564549670|FG001|Overall Study|Withdrawal by Subject|5|||
156398222|NCT02638948|564549671|FG002|Overall Study|Withdrawal by Subject|3|||
156398223|NCT02638948|564549672|FG003|Overall Study|Withdrawal by Subject|1|||
156398224|NCT02638948|564549669|FG000|Overall Study|Administrative Reason by Sponsor|0|||
156398225|NCT02638948|564549670|FG001|Overall Study|Administrative Reason by Sponsor|1|||
156398226|NCT02638948|564549671|FG002|Overall Study|Administrative Reason by Sponsor|0|||
156398227|NCT02638948|564549672|FG003|Overall Study|Administrative Reason by Sponsor|4|||
156398228|NCT02638948|564549669|FG000|Overall Study|Adverse Event|0|||
156398229|NCT02638948|564549670|FG001|Overall Study|Adverse Event|0|||
156398230|NCT02638948|564549671|FG002|Overall Study|Adverse Event|1|||
156398231|NCT02638948|564549672|FG003|Overall Study|Adverse Event|1|||
156398232|NCT02638948|564549669|FG000|Overall Study|Lack of Efficacy|1|||
156398233|NCT02638948|564549670|FG001|Overall Study|Lack of Efficacy|1|||
156398234|NCT02638948|564549671|FG002|Overall Study|Lack of Efficacy|0|||
156398235|NCT02638948|564549672|FG003|Overall Study|Lack of Efficacy|0|||
156398236|NCT02638948|564549669|FG000|Overall Study|Lost to Follow-up|0|||
156398237|NCT02638948|564549670|FG001|Overall Study|Lost to Follow-up|0|||
156398238|NCT02638948|564549671|FG002|Overall Study|Lost to Follow-up|1|||
156398239|NCT02638948|564549672|FG003|Overall Study|Lost to Follow-up|1|||
156398240|NCT02638948|564549669|FG000|Overall Study|Poor/Non-Compliance|0|||
156398241|NCT02638948|564549670|FG001|Overall Study|Poor/Non-Compliance|2|||
156398242|NCT02638948|564549671|FG002|Overall Study|Poor/Non-Compliance|1|||
156398243|NCT02638948|564549672|FG003|Overall Study|Poor/Non-Compliance|0|||
156398244|NCT02638948|564549669|FG000|Overall Study|Participant no longer met study criteria|0|||
156509019|NCT05576662|564955560|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
156398245|NCT02638948|564549670|FG001|Overall Study|Participant no longer met study criteria|1|||
156398246|NCT02638948|564549671|FG002|Overall Study|Participant no longer met study criteria|0|||
156398247|NCT02638948|564549672|FG003|Overall Study|Participant no longer met study criteria|0|||
156398248|NCT02638948|564549669|FG000|Overall Study|Other than specified above|4|||
156398249|NCT02638948|564549670|FG001|Overall Study|Other than specified above|1|||
156398250|NCT02638948|564549671|FG002|Overall Study|Other than specified above|1|||
156398251|NCT02638948|564549672|FG003|Overall Study|Other than specified above|1|||
156398252|NCT05007392|564549673|FG000|Overall Study|Randomized but not treated|1|||
156398253|NCT05007392|564549674|FG001|Overall Study|Randomized but not treated|2|||
156398254|NCT05007392|564549673|FG000|Overall Study|Other|5|||
156398255|NCT05007392|564549674|FG001|Overall Study|Other|4|||
156398256|NCT05007392|564549673|FG000|Overall Study|Lost to Follow-up|1|||
156398257|NCT05007392|564549674|FG001|Overall Study|Lost to Follow-up|2|||
156398258|NCT05007392|564549673|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
156398259|NCT05007392|564549674|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
156398260|NCT05007392|564549673|FG000|Overall Study|Use of prohibited concomitant drug|1|||
156398261|NCT05007392|564549674|FG001|Overall Study|Use of prohibited concomitant drug|1|||
156398262|NCT05007392|564549673|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
156398263|NCT05007392|564549674|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
156398264|NCT05007392|564549673|FG000|Overall Study|Adverse Event|10|||
156398265|NCT05007392|564549674|FG001|Overall Study|Adverse Event|6|||
156398266|NCT05007392|564549673|FG000|Overall Study|Participant choice|5|||
156398267|NCT05007392|564549674|FG001|Overall Study|Participant choice|10|||
156398268|NCT05007392|564549673|FG000|Overall Study|Withdrawal of consent|5|||
156398269|NCT05007392|564549674|FG001|Overall Study|Withdrawal of consent|4|||
156398270|NCT01218126|564549677|FG000|Overall Study|Adverse Event|8|||
156398271|NCT01218126|564549678|FG001|Overall Study|Adverse Event|10|||
156398272|NCT01218126|564549679|FG002|Overall Study|Adverse Event|12|||
156398273|NCT01218126|564549680|FG003|Overall Study|Adverse Event|16|||
156398274|NCT01218126|564549677|FG000|Overall Study|Lack of Efficacy|7|||
156398275|NCT01218126|564549678|FG001|Overall Study|Lack of Efficacy|2|||
156398276|NCT01218126|564549679|FG002|Overall Study|Lack of Efficacy|2|||
156398277|NCT01218126|564549680|FG003|Overall Study|Lack of Efficacy|6|||
156398278|NCT01218126|564549677|FG000|Overall Study|Protocol Violation|5|||
156398279|NCT01218126|564549678|FG001|Overall Study|Protocol Violation|2|||
156398280|NCT01218126|564549679|FG002|Overall Study|Protocol Violation|2|||
156398281|NCT01218126|564549680|FG003|Overall Study|Protocol Violation|3|||
156398282|NCT01218126|564549677|FG000|Overall Study|Protocol-defined stopping criteria|1|||
156398283|NCT01218126|564549678|FG001|Overall Study|Protocol-defined stopping criteria|1|||
156398284|NCT01218126|564549679|FG002|Overall Study|Protocol-defined stopping criteria|0|||
156398285|NCT01218126|564549680|FG003|Overall Study|Protocol-defined stopping criteria|0|||
156398286|NCT01218126|564549677|FG000|Overall Study|Lost to Follow-up|0|||
156398287|NCT01218126|564549678|FG001|Overall Study|Lost to Follow-up|0|||
156398288|NCT01218126|564549679|FG002|Overall Study|Lost to Follow-up|0|||
156398289|NCT01218126|564549680|FG003|Overall Study|Lost to Follow-up|2|||
156398290|NCT01218126|564549677|FG000|Overall Study|Physician Decision|1|||
156398291|NCT01218126|564549678|FG001|Overall Study|Physician Decision|2|||
156398292|NCT01218126|564549679|FG002|Overall Study|Physician Decision|4|||
156398293|NCT01218126|564549680|FG003|Overall Study|Physician Decision|2|||
156398294|NCT01218126|564549677|FG000|Overall Study|Withdrawal by Subject|2|||
156398295|NCT01218126|564549678|FG001|Overall Study|Withdrawal by Subject|5|||
156398296|NCT01218126|564549679|FG002|Overall Study|Withdrawal by Subject|4|||
156398297|NCT01218126|564549680|FG003|Overall Study|Withdrawal by Subject|6|||
156398298|NCT00313820|564549684|FG000|Assigned to Treatment|Other|1|||
156398299|NCT00313820|564549685|FG001|Assigned to Treatment|Other|0|||
156398300|NCT00313820|564549684|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
156398301|NCT00313820|564549685|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
156398302|NCT00313820|564549684|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
156398303|NCT00313820|564549685|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
156398304|NCT00313820|564549684|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
156398305|NCT00313820|564549685|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
156398306|NCT00313820|564549684|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
156398307|NCT00313820|564549685|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
156398308|NCT00313820|564549684|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
156398309|NCT00313820|564549685|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
156398310|NCT02453685|564549689|FG000|Overall Study|Adverse Event|0|||
156398311|NCT02453685|564549690|FG001|Overall Study|Adverse Event|1|||
156398312|NCT02453685|564549689|FG000|Overall Study|Protocol Violation|7|||
156398313|NCT02453685|564549690|FG001|Overall Study|Protocol Violation|4|||
156398314|NCT02453685|564549689|FG000|Overall Study|Lost to Follow-up|0|||
156398315|NCT02453685|564549690|FG001|Overall Study|Lost to Follow-up|1|||
156398316|NCT02453685|564549689|FG000|Overall Study|Withdrawal by Subject|8|||
156398317|NCT02453685|564549690|FG001|Overall Study|Withdrawal by Subject|4|||
156398318|NCT02453685|564549689|FG000|Overall Study|Unclassified|4|||
156398319|NCT02453685|564549690|FG001|Overall Study|Unclassified|2|||
156398320|NCT02134587|564549691|FG000|Overall Study|Did not completed all meetings|30|||
156398321|NCT00265889|564549692|FG000|Overall Study|Physician Decision|1|||
156398322|NCT00265889|564549692|FG000|Overall Study|Protocol Violation|1|||
156398323|NCT00265889|564549692|FG000|Overall Study|Insurance denied the request|3|||
156398324|NCT00453986|564549693|FG000|Overall Study|Lost to Follow-up|6|||
156398325|NCT00453986|564549694|FG001|Overall Study|Lost to Follow-up|5|||
156398326|NCT00453986|564549695|FG002|Overall Study|Lost to Follow-up|6|||
156398327|NCT00453986|564549696|FG003|Overall Study|Lost to Follow-up|2|||
156398328|NCT00453986|564549697|FG004|Overall Study|Lost to Follow-up|0|||
156398329|NCT02778100|564549701|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
156398330|NCT02778100|564549702|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
156398331|NCT01515748|564549712|FG000|Overall Study|Withdrawal by Subject|32|||
156398332|NCT01515748|564549713|FG001|Overall Study|Withdrawal by Subject|41|||
156398333|NCT01515748|564549712|FG000|Overall Study|Lost to Follow-up|2|||
156398334|NCT01515748|564549713|FG001|Overall Study|Lost to Follow-up|4|||
156398335|NCT01515748|564549712|FG000|Overall Study|Other than specified above|5|||
156398336|NCT01515748|564549713|FG001|Overall Study|Other than specified above|10|||
156398337|NCT03221387|564549714|FG000|Overall Study|Lost to Follow-up|1|||
156398338|NCT03221387|564549714|FG000|Overall Study|Lung transplant|1|||
156398339|NCT00522626|564549715|FG000|Overall Study|Lost to Follow-up|7|||
156398340|NCT00803452|564549716|FG000|Overall Study|Adverse Event|0|||
156398341|NCT00803452|564549717|FG001|Overall Study|Adverse Event|2|||
156398342|NCT00803452|564549716|FG000|Overall Study|Lost to Follow-up|0|||
156398343|NCT00803452|564549717|FG001|Overall Study|Lost to Follow-up|3|||
156398344|NCT02365519|564549719|FG000|Randomized and Treated|Adverse Event|0|||
156398345|NCT02365519|564549720|FG001|Randomized and Treated|Adverse Event|1|||
156398346|NCT02365519|564549721|FG002|Randomized and Treated|Adverse Event|0|||
156398347|NCT02365519|564549719|FG000|Randomized and Treated|Withdrawal by Subject|0|||
156398348|NCT02365519|564549720|FG001|Randomized and Treated|Withdrawal by Subject|1|||
156398349|NCT02365519|564549721|FG002|Randomized and Treated|Withdrawal by Subject|1|||
156398350|NCT01971723|564549722|FG000|Overall Study|Withdrawal by Subject|1|||
156398351|NCT01971723|564549723|FG001|Overall Study|Withdrawal by Subject|1|||
156398352|NCT01971723|564549722|FG000|Overall Study|Protocol Violation|1|||
156398353|NCT01971723|564549723|FG001|Overall Study|Protocol Violation|2|||
156398354|NCT03017079|564549724|FG000|Overall Study|Physician Decision|1|||
156398355|NCT03017079|564549725|FG001|Overall Study|Physician Decision|1|||
156398356|NCT03017079|564549724|FG000|Overall Study|Death|3|||
156398357|NCT03017079|564549725|FG001|Overall Study|Death|2|||
156398358|NCT03017079|564549724|FG000|Overall Study|Lack of Efficacy|2|||
156398359|NCT03017079|564549725|FG001|Overall Study|Lack of Efficacy|2|||
156398360|NCT03017079|564549724|FG000|Overall Study|Protocol Violation|0|||
156398361|NCT03017079|564549725|FG001|Overall Study|Protocol Violation|1|||
156398362|NCT00608582|564549740|FG000|Overall Study|Lost to Follow-up|2|||
156398363|NCT00608582|564549741|FG001|Overall Study|Lost to Follow-up|0|||
156398364|NCT00608582|564549740|FG000|Overall Study|No Best Response in Phase 1 located|1|||
156398365|NCT00608582|564549741|FG001|Overall Study|No Best Response in Phase 1 located|1|||
156398366|NCT00608582|564549740|FG000|Overall Study|Illicit Drug Use|1|||
156398367|NCT00608582|564549741|FG001|Overall Study|Illicit Drug Use|0|||
156398368|NCT00608582|564549740|FG000|Overall Study|Early stage Design Change|0|||
156398369|NCT00608582|564549741|FG001|Overall Study|Early stage Design Change|3|||
156398370|NCT01582789|564551106|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
156398371|NCT01582789|564551107|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
156398372|NCT00861614|564551108|FG000|Overall Study|Disease Progression|182|||
156398373|NCT00861614|564551109|FG001|Overall Study|Disease Progression|263|||
156398374|NCT00861614|564551108|FG000|Overall Study|Study Drug Toxicity|79|||
156398375|NCT00861614|564551109|FG001|Overall Study|Study Drug Toxicity|6|||
156398376|NCT00861614|564551108|FG000|Overall Study|Death|32|||
156398377|NCT00861614|564551109|FG001|Overall Study|Death|19|||
156398378|NCT00861614|564551108|FG000|Overall Study|Adverse Event|27|||
156398379|NCT00861614|564551109|FG001|Overall Study|Adverse Event|23|||
156398380|NCT00861614|564551108|FG000|Overall Study|Withdrawal by Subject|34|||
156398381|NCT00861614|564551109|FG001|Overall Study|Withdrawal by Subject|35|||
156398382|NCT00861614|564551108|FG000|Overall Study|Other|17|||
156398383|NCT00861614|564551109|FG001|Overall Study|Other|22|||
156398384|NCT01255592|564551110|FG000|Overall Study|Adverse Event|5|||
156398385|NCT01255592|564551111|FG001|Overall Study|Adverse Event|0|||
156398386|NCT01255592|564551110|FG000|Overall Study|Withdrawal by Subject|1|||
156398387|NCT01255592|564551111|FG001|Overall Study|Withdrawal by Subject|0|||
156398388|NCT01255592|564551110|FG000|Overall Study|Other|0|||
156398389|NCT01255592|564551111|FG001|Overall Study|Other|1|||
156398390|NCT02259517|564551112|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
156398391|NCT02259517|564551113|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
156398392|NCT02259517|564551114|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
156398393|NCT02259517|564551112|FG000|Overall Study|Withdrawal by Subject|0|||
156398394|NCT02259517|564551113|FG001|Overall Study|Withdrawal by Subject|0|||
156398395|NCT02259517|564551114|FG002|Overall Study|Withdrawal by Subject|3|||
156398396|NCT02364180|564551122|FG000|Overall Study|Screen Fail|1|||
156398397|NCT02323646|564551123|FG000|Treatment Course 1|Adverse Event|1|||
156398398|NCT02323646|564551124|FG001|Treatment Course 1|Adverse Event|0|||
156398399|NCT02323646|564551125|FG002|Treatment Course 1|Adverse Event|1|||
156398400|NCT02323646|564551123|FG000|Treatment Course 1|Heavy Bleeding|1|||
156398401|NCT02323646|564551124|FG001|Treatment Course 1|Heavy Bleeding|1|||
156398402|NCT02323646|564551125|FG002|Treatment Course 1|Heavy Bleeding|0|||
156398403|NCT02323646|564551123|FG000|Treatment Course 1|Lost to Follow-up|1|||
156398404|NCT02323646|564551124|FG001|Treatment Course 1|Lost to Follow-up|0|||
156398405|NCT02323646|564551125|FG002|Treatment Course 1|Lost to Follow-up|2|||
156398406|NCT02323646|564551123|FG000|Treatment Course 1|Withdrawal by Subject|0|||
156398407|NCT02323646|564551124|FG001|Treatment Course 1|Withdrawal by Subject|2|||
156398408|NCT02323646|564551125|FG002|Treatment Course 1|Withdrawal by Subject|0|||
156398409|NCT02323646|564551123|FG000|Treatment Course 2|Adverse Event|1|||
156398410|NCT02323646|564551124|FG001|Treatment Course 2|Adverse Event|0|||
156398411|NCT02323646|564551125|FG002|Treatment Course 2|Adverse Event|1|||
156398412|NCT02323646|564551123|FG000|Treatment Course 2|Lost to Follow-up|0|||
156398413|NCT02323646|564551124|FG001|Treatment Course 2|Lost to Follow-up|0|||
156398414|NCT02323646|564551125|FG002|Treatment Course 2|Lost to Follow-up|1|||
156398415|NCT02323646|564551123|FG000|Treatment Course 2|Non-compliance|0|||
156398416|NCT02323646|564551124|FG001|Treatment Course 2|Non-compliance|1|||
156398417|NCT02323646|564551125|FG002|Treatment Course 2|Non-compliance|1|||
156398418|NCT01783418|564551126|FG000|Overall Study|Withdrawal by Subject|1|||
156398419|NCT01783418|564551127|FG001|Overall Study|Withdrawal by Subject|0|||
156398420|NCT00521144|564551128|FG000|Overall Study|Not Treated|0|||
156398421|NCT00521144|564551129|FG001|Overall Study|Not Treated|0|||
156398422|NCT00521144|564551130|FG002|Overall Study|Not Treated|0|||
156398423|NCT00521144|564551131|FG003|Overall Study|Not Treated|1|||
156398424|NCT00521144|564551132|FG004|Overall Study|Not Treated|0|||
156398425|NCT00521144|564551128|FG000|Overall Study|Adverse Event|0|||
156398426|NCT00521144|564551129|FG001|Overall Study|Adverse Event|1|||
156398427|NCT00521144|564551130|FG002|Overall Study|Adverse Event|0|||
156398428|NCT00521144|564551131|FG003|Overall Study|Adverse Event|0|||
156398429|NCT00521144|564551132|FG004|Overall Study|Adverse Event|1|||
156398430|NCT00521144|564551128|FG000|Overall Study|Progressive Disease|4|||
156398431|NCT00521144|564551129|FG001|Overall Study|Progressive Disease|2|||
156398432|NCT00521144|564551130|FG002|Overall Study|Progressive Disease|2|||
156398433|NCT00521144|564551131|FG003|Overall Study|Progressive Disease|0|||
156398434|NCT00521144|564551132|FG004|Overall Study|Progressive Disease|6|||
156398435|NCT00089141|564551133|FG000|Overall Study|Termination of trial|18|||
156398436|NCT00089141|564551134|FG001|Overall Study|Termination of trial|24|||
156398437|NCT00508261|564551137|FG000|Overall Study|Other|0|||
156398438|NCT00508261|564551138|FG001|Overall Study|Other|1|||
156398439|NCT00508261|564551139|FG002|Overall Study|Other|1|||
156398440|NCT00508261|564551140|FG003|Overall Study|Other|0|||
156398441|NCT00508261|564551137|FG000|Overall Study|Serious Adverse Event|0|||
156398442|NCT00508261|564551138|FG001|Overall Study|Serious Adverse Event|1|||
156398443|NCT00508261|564551139|FG002|Overall Study|Serious Adverse Event|0|||
156398444|NCT00508261|564551140|FG003|Overall Study|Serious Adverse Event|0|||
156398445|NCT00508261|564551137|FG000|Overall Study|Withdrawal by Subject|3|||
156398446|NCT00508261|564551138|FG001|Overall Study|Withdrawal by Subject|4|||
156398447|NCT00508261|564551139|FG002|Overall Study|Withdrawal by Subject|4|||
156398448|NCT00508261|564551140|FG003|Overall Study|Withdrawal by Subject|0|||
156398449|NCT00508261|564551137|FG000|Overall Study|Migrated/ moved from study area|0|||
156398450|NCT00508261|564551138|FG001|Overall Study|Migrated/ moved from study area|1|||
156398451|NCT00508261|564551139|FG002|Overall Study|Migrated/ moved from study area|0|||
156398452|NCT00508261|564551140|FG003|Overall Study|Migrated/ moved from study area|0|||
156398453|NCT00508261|564551137|FG000|Overall Study|Lost to Follow-up|0|||
156398454|NCT00508261|564551138|FG001|Overall Study|Lost to Follow-up|1|||
156398455|NCT00508261|564551139|FG002|Overall Study|Lost to Follow-up|1|||
156398456|NCT00508261|564551140|FG003|Overall Study|Lost to Follow-up|1|||
156398457|NCT02901626|564551141|FG000|Overall Study|Lost to Follow-up|1|||
156398458|NCT02901626|564551142|FG001|Overall Study|Lost to Follow-up|1|||
156398459|NCT04082884|564551143|FG000|Overall Study|Withdrawal by Subject|1|||
156398460|NCT00659490|564551146|FG000|Overall Study|Lost to Follow-up|2|||
156398461|NCT00659490|564551147|FG001|Overall Study|Lost to Follow-up|0|||
156398462|NCT00659490|564551148|FG002|Overall Study|Lost to Follow-up|1|||
156398463|NCT05674890|564551149|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
156398464|NCT05674890|564551150|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
156398465|NCT05674890|564551149|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
156398466|NCT05674890|564551150|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
156398467|NCT05674890|564551149|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
156398468|NCT05674890|564551150|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
156398469|NCT00827541|564551151|FG000|Overall Study|Exitus|1|||
156398470|NCT00827541|564551152|FG001|Overall Study|Exitus|8|||
156398471|NCT00827541|564551151|FG000|Overall Study|Other|1|||
156398472|NCT00827541|564551152|FG001|Overall Study|Other|3|||
156398473|NCT00827541|564551151|FG000|Overall Study|Pathogen not susceptible|1|||
156398474|NCT00827541|564551152|FG001|Overall Study|Pathogen not susceptible|0|||
156398475|NCT00827541|564551151|FG000|Overall Study|Lack of effectiveness|1|||
156398476|NCT00827541|564551152|FG001|Overall Study|Lack of effectiveness|0|||
156398477|NCT01649232|564551153|FG000|Overall Study|Physician Decision|2|||
156398478|NCT01649232|564551154|FG001|Overall Study|Physician Decision|0|||
156398479|NCT01750879|564551155|FG000|Overall Study|Adverse Event|8|||
156398480|NCT01750879|564551156|FG001|Overall Study|Adverse Event|0|||
156398481|NCT01750879|564551155|FG000|Overall Study|Lack of Efficacy|1|||
156398482|NCT01750879|564551156|FG001|Overall Study|Lack of Efficacy|0|||
156398483|NCT01750879|564551155|FG000|Overall Study|Withdrawal by Subject|1|||
156398484|NCT01750879|564551156|FG001|Overall Study|Withdrawal by Subject|0|||
156398485|NCT01750879|564551155|FG000|Overall Study|Did not complete per protocol|0|||
156398486|NCT01750879|564551156|FG001|Overall Study|Did not complete per protocol|3|||
156398487|NCT02421666|564551157|FG000|6-month Follow-up|Lost to Follow-up|8|||
156398488|NCT02421666|564551158|FG001|6-month Follow-up|Lost to Follow-up|7|||
156398489|NCT02421666|564551157|FG000|6-month Follow-up|Withdrawal by Subject|5|||
156398490|NCT02421666|564551158|FG001|6-month Follow-up|Withdrawal by Subject|6|||
156398491|NCT02421666|564551157|FG000|12-month Follow-up|Lost to Follow-up|5|||
156398492|NCT02421666|564551158|FG001|12-month Follow-up|Lost to Follow-up|5|||
156398493|NCT02421666|564551157|FG000|12-month Follow-up|Withdrawal by Subject|6|||
156398494|NCT02421666|564551158|FG001|12-month Follow-up|Withdrawal by Subject|11|||
156398495|NCT02347657|564551159|FG000|Overall Study|Physician Decision|0|||
156398496|NCT02347657|564551160|FG001|Overall Study|Physician Decision|1|||
156398497|NCT02347657|564551159|FG000|Overall Study|Adverse Event|8|||
156398498|NCT02347657|564551160|FG001|Overall Study|Adverse Event|4|||
156398499|NCT02347657|564551159|FG000|Overall Study|Withdrawal by Subject|6|||
156398500|NCT02347657|564551160|FG001|Overall Study|Withdrawal by Subject|7|||
156398501|NCT02347657|564551159|FG000|Overall Study|Randomized but not treated|1|||
156398502|NCT02347657|564551160|FG001|Overall Study|Randomized but not treated|0|||
156398503|NCT02347657|564551159|FG000|Overall Study|Other|3|||
156398504|NCT02347657|564551160|FG001|Overall Study|Other|3|||
156398505|NCT04681729|564551176|FG000|Overall Study|Lack of Efficacy|2|||
156398506|NCT04681729|564551177|FG001|Overall Study|Lack of Efficacy|2|||
156398507|NCT04681729|564551176|FG000|Overall Study|Withdrawal by Subject|8|||
156398508|NCT04681729|564551177|FG001|Overall Study|Withdrawal by Subject|9|||
156398509|NCT02436811|564551178|FG000|Overall Study|Lost to Follow-up|2|||
156398510|NCT02436811|564551179|FG001|Overall Study|Lost to Follow-up|9|||
156398511|NCT02436811|564551180|FG002|Overall Study|Lost to Follow-up|7|||
156398512|NCT04209725|564551183|FG000|Overall Study|Adverse Event|1|||
156398513|NCT03494166|564551184|FG000|Overall Study|Death|0|||
156398514|NCT03494166|564551185|FG001|Overall Study|Death|0|||
156398515|NCT03494166|564551186|FG002|Overall Study|Death|0|||
156398516|NCT03494166|564551187|FG003|Overall Study|Death|1|||
156398517|NCT03494166|564551188|FG004|Overall Study|Death|3|||
156398518|NCT03494166|564551189|FG005|Overall Study|Death|0|||
156398519|NCT03494166|564551184|FG000|Overall Study|Lost to Follow-up|2|||
156398520|NCT03494166|564551185|FG001|Overall Study|Lost to Follow-up|2|||
156398521|NCT03494166|564551186|FG002|Overall Study|Lost to Follow-up|2|||
156398522|NCT03494166|564551187|FG003|Overall Study|Lost to Follow-up|2|||
156398523|NCT03494166|564551188|FG004|Overall Study|Lost to Follow-up|14|||
156398524|NCT03494166|564551189|FG005|Overall Study|Lost to Follow-up|0|||
156398525|NCT03494166|564551184|FG000|Overall Study|Withdrawal by Subject|10|||
156398526|NCT03494166|564551185|FG001|Overall Study|Withdrawal by Subject|7|||
156398527|NCT03494166|564551186|FG002|Overall Study|Withdrawal by Subject|0|||
156398528|NCT03494166|564551187|FG003|Overall Study|Withdrawal by Subject|5|||
156398529|NCT03494166|564551188|FG004|Overall Study|Withdrawal by Subject|3|||
156398530|NCT03494166|564551189|FG005|Overall Study|Withdrawal by Subject|17|||
156398531|NCT03494166|564551184|FG000|Overall Study|Screen failure|1|||
156398532|NCT03494166|564551185|FG001|Overall Study|Screen failure|0|||
156398533|NCT03494166|564551186|FG002|Overall Study|Screen failure|0|||
156398534|NCT03494166|564551187|FG003|Overall Study|Screen failure|0|||
156398535|NCT03494166|564551188|FG004|Overall Study|Screen failure|1|||
156398536|NCT03494166|564551189|FG005|Overall Study|Screen failure|0|||
156398537|NCT02277990|564551190|FG000|Overall Study|Death|170|||
156398538|NCT02277990|564551191|FG001|Overall Study|Death|188|||
156398539|NCT02277990|564551190|FG000|Overall Study|Withdrawal by Subject|64|||
156398540|NCT02277990|564551191|FG001|Overall Study|Withdrawal by Subject|53|||
156398541|NCT02277990|564551190|FG000|Overall Study|Physician Decision|40|||
156398542|NCT02277990|564551191|FG001|Overall Study|Physician Decision|34|||
156398543|NCT02277990|564551190|FG000|Overall Study|Lost to Follow-up|66|||
156398544|NCT02277990|564551191|FG001|Overall Study|Lost to Follow-up|69|||
156398545|NCT02277990|564551190|FG000|Overall Study|Had other reason|26|||
156509020|NCT05576662|564955561|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
156398546|NCT02277990|564551191|FG001|Overall Study|Had other reason|32|||
156398547|NCT04179032|564551194|FG000|Part B (Up to Week 52)|Adverse Event|1|||
156398548|NCT04179032|564551194|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
156398549|NCT04179032|564551194|FG000|Access Extension Phase|Ongoing|11|||
156398550|NCT04003610|564551195|FG000|Overall Study|Lost to Follow-up|0|||
156398551|NCT04003610|564551196|FG001|Overall Study|Lost to Follow-up|1|||
156398552|NCT04003610|564551197|FG002|Overall Study|Lost to Follow-up|0|||
156398553|NCT04003610|564551195|FG000|Overall Study|Death|0|||
156398554|NCT04003610|564551196|FG001|Overall Study|Death|0|||
156398555|NCT04003610|564551197|FG002|Overall Study|Death|3|||
156398556|NCT04003610|564551195|FG000|Overall Study|Study Terminated by Sponsor|0|||
156398557|NCT04003610|564551196|FG001|Overall Study|Study Terminated by Sponsor|0|||
156398558|NCT04003610|564551197|FG002|Overall Study|Study Terminated by Sponsor|3|||
156398559|NCT03188055|564551204|FG000|Overall Study|Unavailable for training|0|||
156398560|NCT03188055|564551205|FG001|Overall Study|Unavailable for training|0|||
156398561|NCT03188055|564551206|FG002|Overall Study|Unavailable for training|19|||
156398562|NCT03188055|564551207|FG003|Overall Study|Unavailable for training|0|||
156398563|NCT03188055|564551208|FG004|Overall Study|Unavailable for training|0|||
156398564|NCT03188055|564551209|FG005|Overall Study|Unavailable for training|0|||
156398565|NCT03188055|564551204|FG000|Overall Study|Lost to Follow-up|0|||
156398566|NCT03188055|564551205|FG001|Overall Study|Lost to Follow-up|18|||
156398567|NCT03188055|564551206|FG002|Overall Study|Lost to Follow-up|0|||
156398568|NCT03188055|564551207|FG003|Overall Study|Lost to Follow-up|11|||
156398569|NCT03188055|564551208|FG004|Overall Study|Lost to Follow-up|0|||
156398570|NCT03188055|564551209|FG005|Overall Study|Lost to Follow-up|0|||
156398571|NCT03188055|564551204|FG000|Overall Study|Withdrawal by Subject|0|||
156398572|NCT03188055|564551205|FG001|Overall Study|Withdrawal by Subject|1|||
156398573|NCT03188055|564551206|FG002|Overall Study|Withdrawal by Subject|0|||
156398574|NCT03188055|564551207|FG003|Overall Study|Withdrawal by Subject|1|||
156398575|NCT03188055|564551208|FG004|Overall Study|Withdrawal by Subject|0|||
156398576|NCT03188055|564551209|FG005|Overall Study|Withdrawal by Subject|0|||
156398577|NCT03657277|564551210|FG000|Overall Study|Physician Decision|2|||
156398578|NCT03657277|564551210|FG000|Overall Study|Lost to Follow-up|1|||
156398579|NCT03657277|564551210|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
156398580|NCT01024608|564551213|FG000|Overall Study|Adverse Event|1|||
156398581|NCT01024608|564551214|FG001|Overall Study|Adverse Event|0|||
156398582|NCT01024608|564551213|FG000|Overall Study|Withdrawal by Subject|1|||
156398583|NCT01024608|564551214|FG001|Overall Study|Withdrawal by Subject|0|||
156398584|NCT01024608|564551213|FG000|Overall Study|Lost to Follow-up|0|||
156398585|NCT01024608|564551214|FG001|Overall Study|Lost to Follow-up|1|||
156398586|NCT01024608|564551213|FG000|Overall Study|Protocol Violation|0|||
156398587|NCT01024608|564551214|FG001|Overall Study|Protocol Violation|3|||
156398588|NCT01024608|564551213|FG000|Overall Study|Never received study treatment|2|||
156398589|NCT01024608|564551214|FG001|Overall Study|Never received study treatment|0|||
156398590|NCT04349280|564551215|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
156398591|NCT04349280|564551216|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
156398592|NCT04349280|564551215|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
156398593|NCT04349280|564551216|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
156398594|NCT04349280|564551215|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
156398595|NCT04349280|564551216|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
156398596|NCT00657618|564551219|FG000|Overall Study|Adverse Event|32|||
156398597|NCT00657618|564551219|FG000|Overall Study|Withdrawal by Subject|8|||
156398598|NCT00657618|564551219|FG000|Overall Study|negative for leishmaniasis|2|||
156398599|NCT00657618|564551219|FG000|Overall Study|didn't start due to schedule conflicts|1|||
156398600|NCT04120233|564551220|FG000|Overall Study|Adverse Event|0|||
156398601|NCT04120233|564551221|FG001|Overall Study|Adverse Event|0|||
156398602|NCT04120233|564551222|FG002|Overall Study|Adverse Event|0|||
156398603|NCT04120233|564551223|FG003|Overall Study|Adverse Event|0|||
156398604|NCT04120233|564551224|FG004|Overall Study|Adverse Event|1|||
156398605|NCT04120233|564551225|FG005|Overall Study|Adverse Event|0|||
156398606|NCT04922554|564551229|FG000|Overall Study|Adverse Event|4|||
156398607|NCT04922554|564551230|FG001|Overall Study|Adverse Event|0|||
156398608|NCT04922554|564551229|FG000|Overall Study|Withdrawal by Subject|1|||
156398609|NCT04922554|564551230|FG001|Overall Study|Withdrawal by Subject|0|||
156398610|NCT02276066|564552692|FG000|Overall Study|Lost to Follow-up|21|||
156398611|NCT02276066|564552693|FG001|Overall Study|Lost to Follow-up|11|||
156398612|NCT05050578|564552694|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
156398613|NCT05050578|564552695|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
156398614|NCT05050578|564552694|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
156398615|NCT05050578|564552695|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
156398616|NCT05050578|564552694|FG000|Period 2, 30 Days|Protocol Violation|0|||
156398617|NCT05050578|564552695|FG001|Period 2, 30 Days|Protocol Violation|1|||
156398618|NCT02243280|564552696|FG000|Treated|Adverse Event|1|||
156398619|NCT02243280|564552697|FG001|Treated|Adverse Event|0|||
156398620|NCT02243280|564552698|FG002|Treated|Adverse Event|0|||
156398621|NCT02243280|564552699|FG003|Treated|Adverse Event|0|||
156398622|NCT02243280|564552700|FG004|Treated|Adverse Event|0|||
156398623|NCT02243280|564552701|FG005|Treated|Adverse Event|0|||
156398624|NCT02243280|564552702|FG006|Treated|Adverse Event|0|||
156398625|NCT02243280|564552703|FG007|Treated|Adverse Event|0|||
156398626|NCT02243280|564552704|FG008|Treated|Adverse Event|0|||
156398627|NCT02243280|564552705|FG009|Treated|Adverse Event|0|||
156398628|NCT02243280|564552706|FG010|Treated|Adverse Event|1|||
156398629|NCT02243280|564552696|FG000|Treated|Lost to Follow-up|0|||
156398630|NCT02243280|564552697|FG001|Treated|Lost to Follow-up|0|||
156398631|NCT02243280|564552698|FG002|Treated|Lost to Follow-up|0|||
156398632|NCT02243280|564552699|FG003|Treated|Lost to Follow-up|0|||
156398633|NCT02243280|564552700|FG004|Treated|Lost to Follow-up|0|||
156398634|NCT02243280|564552701|FG005|Treated|Lost to Follow-up|0|||
156398635|NCT02243280|564552702|FG006|Treated|Lost to Follow-up|0|||
156398636|NCT02243280|564552703|FG007|Treated|Lost to Follow-up|0|||
156398637|NCT02243280|564552704|FG008|Treated|Lost to Follow-up|1|||
156398638|NCT02243280|564552705|FG009|Treated|Lost to Follow-up|0|||
156398639|NCT02243280|564552706|FG010|Treated|Lost to Follow-up|2|||
156398640|NCT03386032|564552708|FG000|Overall Study|Lack of Efficacy|6|||
156398641|NCT03386032|564552709|FG001|Overall Study|Lack of Efficacy|2|||
156398642|NCT03386032|564552710|FG002|Overall Study|Lack of Efficacy|0|||
156398643|NCT03386032|564552708|FG000|Overall Study|Adverse Event|2|||
156398644|NCT03386032|564552709|FG001|Overall Study|Adverse Event|2|||
156398645|NCT03386032|564552710|FG002|Overall Study|Adverse Event|0|||
156398646|NCT03386032|564552708|FG000|Overall Study|Withdrawal by Subject|1|||
156398647|NCT03386032|564552709|FG001|Overall Study|Withdrawal by Subject|0|||
156398648|NCT03386032|564552710|FG002|Overall Study|Withdrawal by Subject|0|||
156398649|NCT03386032|564552708|FG000|Overall Study|Lost to Follow-up|9|||
156398650|NCT03386032|564552709|FG001|Overall Study|Lost to Follow-up|3|||
156398651|NCT03386032|564552710|FG002|Overall Study|Lost to Follow-up|0|||
156398652|NCT01807156|564552711|FG000|Overall Study|Physician Decision|1|||
156398653|NCT02710292|564552716|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
156398654|NCT02710292|564552717|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
156398655|NCT02710292|564552716|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
156398656|NCT02710292|564552717|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
156398657|NCT03122119|564552718|FG000|Overall Study|Did not meet eligibility critria|1|||
156398658|NCT01493687|564552719|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
156398659|NCT01493687|564552720|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
156398660|NCT01493687|564552719|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
156398661|NCT01493687|564552720|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
156398662|NCT01493687|564552719|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
156398663|NCT01493687|564552720|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
156398664|NCT01493687|564552719|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
156398665|NCT01493687|564552720|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
156398666|NCT01493687|564552719|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
156398667|NCT01493687|564552720|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
156398668|NCT01493687|564552719|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
156398669|NCT01493687|564552720|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
156398670|NCT01493687|564552719|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
156398671|NCT01493687|564552720|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
156398672|NCT01493687|564552719|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
156398673|NCT01493687|564552720|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
156398674|NCT01493687|564552719|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
156398675|NCT01493687|564552720|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
156398676|NCT01493687|564552719|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
156398677|NCT01493687|564552720|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
156398678|NCT01493687|564552719|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
156398679|NCT01493687|564552720|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
156398680|NCT01493687|564552719|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
156398681|NCT01493687|564552720|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
156398682|NCT01493687|564552719|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
156398683|NCT01493687|564552720|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
156398684|NCT01493687|564552719|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
156398685|NCT01493687|564552720|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
156398686|NCT01493687|564552719|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
156398687|NCT01493687|564552720|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
156398688|NCT00335452|564552722|FG000|Overall Study|Death|156|||
156398689|NCT00335452|564552723|FG001|Overall Study|Death|144|||
156398690|NCT00335452|564552724|FG002|Overall Study|Death|158|||
156398691|NCT00335452|564552725|FG003|Overall Study|Death|129|||
156398692|NCT00335452|564552722|FG000|Overall Study|Lost to Follow-up|2|||
156398693|NCT00335452|564552723|FG001|Overall Study|Lost to Follow-up|3|||
156398694|NCT00335452|564552724|FG002|Overall Study|Lost to Follow-up|1|||
156398695|NCT00335452|564552725|FG003|Overall Study|Lost to Follow-up|2|||
156398696|NCT02736825|564552726|FG000|Overall Study|Lost to Follow-up|10|||
156398697|NCT02736825|564552727|FG001|Overall Study|Lost to Follow-up|11|||
156398698|NCT02736825|564552726|FG000|Overall Study|Early Termination|0|||
156398699|NCT02736825|564552727|FG001|Overall Study|Early Termination|1|||
156398700|NCT00790452|564552728|FG000|Overall Study|Drug supply issue|1|||
156398701|NCT00790452|564552729|FG001|Overall Study|Drug supply issue|0|||
156398702|NCT00387894|564552730|FG000|Overall Study|Withdrawal by Subject|1|||
156398703|NCT00677352|564552740|FG000|Treatment Phase|Adverse Event|14|||
156398704|NCT00677352|564552741|FG001|Treatment Phase|Adverse Event|22|||
156398705|NCT00677352|564552740|FG000|Treatment Phase|Lack of Efficacy|2|||
156398706|NCT00677352|564552741|FG001|Treatment Phase|Lack of Efficacy|3|||
156398707|NCT00677352|564552740|FG000|Treatment Phase|Lost to Follow-up|0|||
156398708|NCT00677352|564552741|FG001|Treatment Phase|Lost to Follow-up|1|||
156398709|NCT00677352|564552740|FG000|Treatment Phase|Withdrawal by Subject|7|||
156509021|NCT05576662|564955560|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
156398710|NCT00677352|564552741|FG001|Treatment Phase|Withdrawal by Subject|7|||
156398711|NCT00677352|564552740|FG000|Treatment Phase|Physician Decision|1|||
156398712|NCT00677352|564552741|FG001|Treatment Phase|Physician Decision|0|||
156398713|NCT00677352|564552740|FG000|Treatment Phase|Pregnancy|0|||
156398714|NCT00677352|564552741|FG001|Treatment Phase|Pregnancy|1|||
156398715|NCT00677352|564552740|FG000|Treatment Phase|Protocol Violation|1|||
156398716|NCT00677352|564552741|FG001|Treatment Phase|Protocol Violation|1|||
156398717|NCT00677352|564552740|FG000|Treatment Phase|Transference or work related matter|0|||
156398718|NCT00677352|564552741|FG001|Treatment Phase|Transference or work related matter|5|||
156398719|NCT00677352|564552740|FG000|Treatment Phase|Not treated|0|||
156398720|NCT00677352|564552741|FG001|Treatment Phase|Not treated|2|||
156398721|NCT00677352|564552740|FG000|Tapering Phase|Adverse Event|1|||
156398722|NCT00677352|564552741|FG001|Tapering Phase|Adverse Event|5|||
156398723|NCT00677352|564552740|FG000|Tapering Phase|Withdrawal by Subject|5|||
156398724|NCT00677352|564552741|FG001|Tapering Phase|Withdrawal by Subject|3|||
156398725|NCT00677352|564552740|FG000|Tapering Phase|Pregnancy|0|||
156398726|NCT00677352|564552741|FG001|Tapering Phase|Pregnancy|1|||
156398727|NCT00677352|564552740|FG000|Tapering Phase|Job transfer|0|||
156398728|NCT00677352|564552741|FG001|Tapering Phase|Job transfer|1|||
156398729|NCT02182973|564552744|FG000|Overall Study|Withdrawal by Subject|3|||
156398730|NCT02182973|564552745|FG001|Overall Study|Withdrawal by Subject|0|||
156398731|NCT01814748|564552747|FG000|Overall Study|Lost to Follow-up|1|||
156398732|NCT01814748|564552748|FG001|Overall Study|Lost to Follow-up|2|||
156398733|NCT01814748|564552747|FG000|Overall Study|Study site terminated by sponsor|1|||
156398734|NCT01814748|564552748|FG001|Overall Study|Study site terminated by sponsor|1|||
156398735|NCT01814748|564552747|FG000|Overall Study|Withdrawal by Subject|6|||
156398736|NCT01814748|564552748|FG001|Overall Study|Withdrawal by Subject|4|||
156398737|NCT01972529|564552749|FG000|Overall Study|Adverse Event|0|||
156398738|NCT01972529|564552750|FG001|Overall Study|Adverse Event|1|||
156398739|NCT01972529|564552751|FG002|Overall Study|Adverse Event|0|||
156398740|NCT01972529|564552752|FG003|Overall Study|Adverse Event|0|||
156398741|NCT01972529|564552749|FG000|Overall Study|Lost to Follow-up|1|||
156398742|NCT01972529|564552750|FG001|Overall Study|Lost to Follow-up|0|||
156398743|NCT01972529|564552751|FG002|Overall Study|Lost to Follow-up|0|||
156398744|NCT01972529|564552752|FG003|Overall Study|Lost to Follow-up|0|||
156398745|NCT01972529|564552749|FG000|Overall Study|Participant Choice|0|||
156398746|NCT01972529|564552750|FG001|Overall Study|Participant Choice|1|||
156398747|NCT01972529|564552751|FG002|Overall Study|Participant Choice|0|||
156398748|NCT01972529|564552752|FG003|Overall Study|Participant Choice|0|||
156398749|NCT01972529|564552749|FG000|Overall Study|Withdrawl of Consent|1|||
156398750|NCT01972529|564552750|FG001|Overall Study|Withdrawl of Consent|2|||
156398751|NCT01972529|564552751|FG002|Overall Study|Withdrawl of Consent|0|||
156398752|NCT01972529|564552752|FG003|Overall Study|Withdrawl of Consent|1|||
156398753|NCT01972529|564552749|FG000|Overall Study|Other|0|||
156398754|NCT01972529|564552750|FG001|Overall Study|Other|0|||
156398755|NCT01972529|564552751|FG002|Overall Study|Other|0|||
156398756|NCT01972529|564552752|FG003|Overall Study|Other|2|||
156398757|NCT01972529|564552749|FG000|Overall Study|Not treated|0|||
156398758|NCT01972529|564552750|FG001|Overall Study|Not treated|1|||
156398759|NCT01972529|564552751|FG002|Overall Study|Not treated|2|||
156398760|NCT01972529|564552752|FG003|Overall Study|Not treated|1|||
156398761|NCT01376323|564552753|FG000|Overall Study|Adverse Event|1|||
156398762|NCT01376323|564552754|FG001|Overall Study|Adverse Event|0|||
156398763|NCT01376323|564552755|FG002|Overall Study|Adverse Event|0|||
156398764|NCT01376323|564552756|FG003|Overall Study|Adverse Event|2|||
156398765|NCT01376323|564552757|FG004|Overall Study|Adverse Event|0|||
156398766|NCT01376323|564552753|FG000|Overall Study|Lost to Follow-up|0|||
156398767|NCT01376323|564552754|FG001|Overall Study|Lost to Follow-up|0|||
156398768|NCT01376323|564552755|FG002|Overall Study|Lost to Follow-up|0|||
156398769|NCT01376323|564552756|FG003|Overall Study|Lost to Follow-up|2|||
156398770|NCT01376323|564552757|FG004|Overall Study|Lost to Follow-up|0|||
156398771|NCT01376323|564552753|FG000|Overall Study|Physician Decision|1|||
156398772|NCT01376323|564552754|FG001|Overall Study|Physician Decision|0|||
156398773|NCT01376323|564552755|FG002|Overall Study|Physician Decision|2|||
156398774|NCT01376323|564552756|FG003|Overall Study|Physician Decision|1|||
156398775|NCT01376323|564552757|FG004|Overall Study|Physician Decision|1|||
156398776|NCT01376323|564552753|FG000|Overall Study|Withdrawal by Subject|0|||
156398777|NCT01376323|564552754|FG001|Overall Study|Withdrawal by Subject|1|||
156398778|NCT01376323|564552755|FG002|Overall Study|Withdrawal by Subject|1|||
156398779|NCT01376323|564552756|FG003|Overall Study|Withdrawal by Subject|0|||
156398780|NCT01376323|564552757|FG004|Overall Study|Withdrawal by Subject|0|||
156398781|NCT03595332|564552758|FG000|Overall Study|Lost to Follow-up|16|||
156398782|NCT03595332|564552759|FG001|Overall Study|Lost to Follow-up|22|||
156398783|NCT03595332|564552758|FG000|Overall Study|Unable to retrieve ID from school|0|||
156398784|NCT03595332|564552759|FG001|Overall Study|Unable to retrieve ID from school|2|||
156398785|NCT02227875|564552760|FG000|Overall Study|Protocol Violation|10|||
156398786|NCT02227875|564552761|FG001|Overall Study|Protocol Violation|7|||
156398787|NCT02227875|564552760|FG000|Overall Study|Other|1|||
156398788|NCT02227875|564552761|FG001|Overall Study|Other|3|||
156398789|NCT02227875|564552760|FG000|Overall Study|Physician Decision|1|||
156398790|NCT02227875|564552761|FG001|Overall Study|Physician Decision|0|||
156398791|NCT02227875|564552760|FG000|Overall Study|Adverse Event|3|||
156398792|NCT02227875|564552761|FG001|Overall Study|Adverse Event|0|||
156398793|NCT02227875|564552760|FG000|Overall Study|Withdrawal by Subject|12|||
156398794|NCT02227875|564552761|FG001|Overall Study|Withdrawal by Subject|13|||
156398795|NCT02227875|564552760|FG000|Overall Study|Lost to Follow-up|10|||
156398796|NCT02227875|564552761|FG001|Overall Study|Lost to Follow-up|10|||
156398797|NCT01201811|564552762|FG000|Overall Study|Adverse Event|6|||
156398798|NCT01201811|564552762|FG000|Overall Study|Disease progression|3|||
156398799|NCT01201811|564552762|FG000|Overall Study|Withdrawal by Subject|3|||
156398800|NCT01201811|564552762|FG000|Overall Study|Death|4|||
156398801|NCT01201811|564552762|FG000|Overall Study|Treatment Failure|2|||
156398802|NCT01201811|564552762|FG000|Overall Study|Physician Decision|1|||
156398803|NCT02856113|564552763|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156398804|NCT02856113|564552764|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
156398805|NCT02856113|564552763|FG000|Overall Study|Significant Protocol Deviation|1|||
156398806|NCT02856113|564552764|FG001|Overall Study|Significant Protocol Deviation|0|||
156398807|NCT02856113|564552763|FG000|Overall Study|Lost to Follow-up|3|||
156398808|NCT02856113|564552764|FG001|Overall Study|Lost to Follow-up|5|||
156398809|NCT02856113|564552763|FG000|Overall Study|Voluntary Withdrawal|3|||
156398810|NCT02856113|564552764|FG001|Overall Study|Voluntary Withdrawal|5|||
156398811|NCT02856113|564552763|FG000|Overall Study|Pregnancy|0|||
156398812|NCT02856113|564552764|FG001|Overall Study|Pregnancy|1|||
156398813|NCT02856113|564552763|FG000|Overall Study|Principal Investigator Discretion|2|||
156398814|NCT02856113|564552764|FG001|Overall Study|Principal Investigator Discretion|1|||
156398815|NCT02856113|564552763|FG000|Overall Study|Randomized but not Treated|1|||
156398816|NCT02856113|564552764|FG001|Overall Study|Randomized but not Treated|0|||
156398817|NCT02856113|564552763|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
156398818|NCT02856113|564552764|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
156398819|NCT02831257|564552768|FG000|Overall Study|Lack of Efficacy|3|||
156398820|NCT02831257|564552768|FG000|Overall Study|Adverse Event|2|||
156398821|NCT02831257|564552768|FG000|Overall Study|Physician Decision|1|||
156398822|NCT02831257|564552768|FG000|Overall Study|Withdrawal by Subject|6|||
156398823|NCT02618967|564552778|FG000|Overall Study|Lost to Follow-up|0|||
156398824|NCT02618967|564552779|FG001|Overall Study|Lost to Follow-up|0|||
156398825|NCT02618967|564552780|FG002|Overall Study|Lost to Follow-up|1|||
156398826|NCT02618967|564552781|FG003|Overall Study|Lost to Follow-up|0|||
156398827|NCT02618967|564552782|FG004|Overall Study|Lost to Follow-up|2|||
156398828|NCT02618967|564552783|FG005|Overall Study|Lost to Follow-up|0|||
156398829|NCT02618967|564552784|FG006|Overall Study|Lost to Follow-up|0|||
156398830|NCT02618967|564552785|FG007|Overall Study|Lost to Follow-up|0|||
156398831|NCT02618967|564552778|FG000|Overall Study|Withdrawal by Subject|1|||
156398832|NCT02618967|564552779|FG001|Overall Study|Withdrawal by Subject|0|||
156398833|NCT02618967|564552780|FG002|Overall Study|Withdrawal by Subject|0|||
156398834|NCT02618967|564552781|FG003|Overall Study|Withdrawal by Subject|0|||
156398835|NCT02618967|564552782|FG004|Overall Study|Withdrawal by Subject|0|||
156398836|NCT02618967|564552783|FG005|Overall Study|Withdrawal by Subject|0|||
156398837|NCT02618967|564552784|FG006|Overall Study|Withdrawal by Subject|0|||
156398838|NCT02618967|564552785|FG007|Overall Study|Withdrawal by Subject|0|||
156398839|NCT01533493|564552786|FG000|Overall Study|Adverse Event|2|||
156398840|NCT01533493|564552787|FG001|Overall Study|Adverse Event|1|||
156398841|NCT01533493|564552786|FG000|Overall Study|Withdrawal by Subject|1|||
156398842|NCT01533493|564552787|FG001|Overall Study|Withdrawal by Subject|2|||
156398843|NCT01533493|564552786|FG000|Overall Study|Lost to Follow-up|2|||
156398844|NCT01533493|564552787|FG001|Overall Study|Lost to Follow-up|0|||
156398845|NCT05614089|564552793|FG000|Overall Study|Pregnancy|5|||
156398846|NCT05614089|564552794|FG001|Overall Study|Pregnancy|2|||
156398847|NCT05614089|564552793|FG000|Overall Study|Lost to Follow-up|5|||
156398848|NCT05614089|564552794|FG001|Overall Study|Lost to Follow-up|1|||
156398849|NCT05614089|564552793|FG000|Overall Study|Death|0|||
156398850|NCT05614089|564552794|FG001|Overall Study|Death|1|||
156398851|NCT05614089|564552793|FG000|Overall Study|Adverse Event|1|||
156398852|NCT05614089|564552794|FG001|Overall Study|Adverse Event|0|||
156509022|NCT05576662|564955561|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
156398853|NCT02521285|564552795|FG000|Overall Study|Lost to Follow-up|1|||
156398854|NCT02521285|564552796|FG001|Overall Study|Lost to Follow-up|1|||
156398855|NCT02521285|564552795|FG000|Overall Study|Withdrawal by Subject|1|||
156398856|NCT02521285|564552796|FG001|Overall Study|Withdrawal by Subject|1|||
156398857|NCT02521285|564552795|FG000|Overall Study|Adverse Event|0|||
156398858|NCT02521285|564552796|FG001|Overall Study|Adverse Event|1|||
156398859|NCT05701995|564552798|FG000|Pre-Treatment|Randomization Error|1|||
156398860|NCT05701995|564552799|FG001|Pre-Treatment|Randomization Error|1|||
156509023|NCT05576662|564955560|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
156398861|NCT05701995|564552798|FG000|Treatment|Withdrawal by Subject|8|||
156398862|NCT05701995|564552799|FG001|Treatment|Withdrawal by Subject|4|||
156398863|NCT05701995|564552798|FG000|Treatment|Lost to Follow-up|2|||
156398864|NCT05701995|564552799|FG001|Treatment|Lost to Follow-up|3|||
156398865|NCT05701995|564552798|FG000|Treatment|Adverse Event|3|||
156398866|NCT05701995|564552799|FG001|Treatment|Adverse Event|1|||
156398867|NCT05701995|564552798|FG000|Treatment|Other Reason|1|||
156398868|NCT05701995|564552799|FG001|Treatment|Other Reason|1|||
156398869|NCT05701995|564552798|FG000|Treatment|Death|1|||
156398870|NCT05701995|564552799|FG001|Treatment|Death|0|||
156398871|NCT05701995|564552798|FG000|Treatment|Physician Decision|0|||
156398872|NCT05701995|564552799|FG001|Treatment|Physician Decision|1|||
156398873|NCT00715429|564552800|FG000|Overall Study|Did not complete the study diary|0|||
156398874|NCT00715429|564552801|FG001|Overall Study|Did not complete the study diary|1|||
156398875|NCT04899245|564552806|FG000|Overall Study|Withdrawal by Subject|3|||
156398876|NCT04899245|564552807|FG001|Overall Study|Withdrawal by Subject|5|||
156398877|NCT04899245|564552808|FG002|Overall Study|Withdrawal by Subject|2|||
156398878|NCT04899245|564552806|FG000|Overall Study|No longer eligible - Left staff position|0|||
156398879|NCT04899245|564552807|FG001|Overall Study|No longer eligible - Left staff position|0|||
156398880|NCT04899245|564552808|FG002|Overall Study|No longer eligible - Left staff position|1|||
156398881|NCT04899245|564552806|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
156398882|NCT04899245|564552807|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
156398883|NCT04899245|564552808|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
156398884|NCT04899245|564552806|FG000|Overall Study|No longer eligible - Moved away from area|2|||
156398885|NCT04899245|564552807|FG001|Overall Study|No longer eligible - Moved away from area|2|||
156398886|NCT04899245|564552808|FG002|Overall Study|No longer eligible - Moved away from area|0|||
156398887|NCT00386022|564552821|FG000|Plus Estrogen|Lost to Follow-up|2|||
156398888|NCT00386022|564552822|FG001|Plus Estrogen|Lost to Follow-up|0|||
156398889|NCT00386022|564552821|FG000|Plus Estrogen|Adverse Event|0|||
156398890|NCT00386022|564552822|FG001|Plus Estrogen|Adverse Event|1|||
156398891|NCT03078816|564552823|FG000|Overall Study|Withdrawal by Subject|1|||
156398892|NCT02114151|564552824|FG000|Overall Study|Death|1|||
156398893|NCT02114151|564552824|FG000|Overall Study|Lost to Follow-up|1|||
156398894|NCT02114151|564552824|FG000|Overall Study|Withdrawal by Subject|5|||
156398895|NCT03933826|564552825|FG000|Overall Study|Withdrawal by Subject|8|||
156398896|NCT03933826|564552826|FG001|Overall Study|Withdrawal by Subject|1|||
156398897|NCT03933826|564552825|FG000|Overall Study|Death|19|||
156398898|NCT03933826|564552826|FG001|Overall Study|Death|11|||
156398899|NCT03933826|564552825|FG000|Overall Study|Lost to Follow-up|41|||
156398900|NCT03933826|564552826|FG001|Overall Study|Lost to Follow-up|13|||
156398901|NCT04992546|564552827|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
156398902|NCT04992546|564552827|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
156398903|NCT04992546|564552827|FG000|Open-Label Treatment Period|Adverse Event|3|||
156398904|NCT04992546|564552827|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
156398905|NCT03419364|564552828|FG000|Overall Study|Delivery due to maternal condition|2|||
156398906|NCT03419364|564552829|FG001|Overall Study|Delivery due to maternal condition|0|||
156398907|NCT03419364|564552830|FG002|Overall Study|Delivery due to maternal condition|0|||
156398908|NCT01659151|564552831|FG000|Overall Study|Inadequate TIL growth|1|||
156398909|NCT05774197|564552832|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
156398910|NCT06223373|564552835|FG000|Overall Study|Lost to Follow-up|1|||
156398911|NCT06223373|564552836|FG001|Overall Study|Lost to Follow-up|2|||
156398912|NCT04981678|564552838|FG000|Overall Study|Lost to Follow-up|0|||
156398913|NCT04981678|564552839|FG001|Overall Study|Lost to Follow-up|1|||
156398914|NCT03421808|564552840|FG000|Overall Study|COVID related problems|2|||
156398915|NCT03421808|564552841|FG001|Overall Study|COVID related problems|0|||
156398916|NCT03421808|564552840|FG000|Overall Study|Withdrawal by Subject|1|||
156398917|NCT03421808|564552841|FG001|Overall Study|Withdrawal by Subject|0|||
156398918|NCT03421808|564552840|FG000|Overall Study|Protocol Violation|0|||
156398919|NCT03421808|564552841|FG001|Overall Study|Protocol Violation|1|||
156398920|NCT03764774|564552844|FG000|Overall Study|Withdrawal by Subject|0|||
156398921|NCT03764774|564552845|FG001|Overall Study|Withdrawal by Subject|0|||
156398922|NCT03764774|564552846|FG002|Overall Study|Withdrawal by Subject|0|||
156398923|NCT03764774|564552847|FG003|Overall Study|Withdrawal by Subject|0|||
156398924|NCT03764774|564552848|FG004|Overall Study|Withdrawal by Subject|0|||
156398925|NCT03764774|564552849|FG005|Overall Study|Withdrawal by Subject|0|||
156398926|NCT03764774|564552850|FG006|Overall Study|Withdrawal by Subject|0|||
156398927|NCT03764774|564552851|FG007|Overall Study|Withdrawal by Subject|0|||
156398928|NCT03764774|564552852|FG008|Overall Study|Withdrawal by Subject|0|||
156398929|NCT03764774|564552853|FG009|Overall Study|Withdrawal by Subject|0|||
156398930|NCT03764774|564552854|FG010|Overall Study|Withdrawal by Subject|1|||
156398931|NCT03764774|564552855|FG011|Overall Study|Withdrawal by Subject|0|||
156398932|NCT03764774|564552856|FG012|Overall Study|Withdrawal by Subject|0|||
156398933|NCT03764774|564552857|FG013|Overall Study|Withdrawal by Subject|0|||
156398934|NCT03764774|564552844|FG000|Overall Study|Adverse Event|0|||
156398935|NCT03764774|564552845|FG001|Overall Study|Adverse Event|0|||
156398936|NCT03764774|564552846|FG002|Overall Study|Adverse Event|0|||
156398937|NCT03764774|564552847|FG003|Overall Study|Adverse Event|0|||
156509024|NCT05576662|564955561|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
156398938|NCT03764774|564552848|FG004|Overall Study|Adverse Event|0|||
156398939|NCT03764774|564552849|FG005|Overall Study|Adverse Event|0|||
156398940|NCT03764774|564552850|FG006|Overall Study|Adverse Event|0|||
156398941|NCT03764774|564552851|FG007|Overall Study|Adverse Event|0|||
156398942|NCT03764774|564552852|FG008|Overall Study|Adverse Event|0|||
156398943|NCT03764774|564552853|FG009|Overall Study|Adverse Event|0|||
156398944|NCT03764774|564552854|FG010|Overall Study|Adverse Event|0|||
156398945|NCT03764774|564552855|FG011|Overall Study|Adverse Event|0|||
156398946|NCT03764774|564552856|FG012|Overall Study|Adverse Event|2|||
156398947|NCT03764774|564552857|FG013|Overall Study|Adverse Event|0|||
156398948|NCT03764774|564552844|FG000|Overall Study|Lost to Follow-up|0|||
156398949|NCT03764774|564552845|FG001|Overall Study|Lost to Follow-up|0|||
156398950|NCT03764774|564552846|FG002|Overall Study|Lost to Follow-up|0|||
156398951|NCT03764774|564552847|FG003|Overall Study|Lost to Follow-up|0|||
156398952|NCT03764774|564552848|FG004|Overall Study|Lost to Follow-up|0|||
156398953|NCT03764774|564552849|FG005|Overall Study|Lost to Follow-up|0|||
156398954|NCT03764774|564552850|FG006|Overall Study|Lost to Follow-up|0|||
156398955|NCT03764774|564552851|FG007|Overall Study|Lost to Follow-up|0|||
156398956|NCT03764774|564552852|FG008|Overall Study|Lost to Follow-up|0|||
156398957|NCT03764774|564552853|FG009|Overall Study|Lost to Follow-up|0|||
156398958|NCT03764774|564552854|FG010|Overall Study|Lost to Follow-up|0|||
156398959|NCT03764774|564552855|FG011|Overall Study|Lost to Follow-up|0|||
156398960|NCT03764774|564552856|FG012|Overall Study|Lost to Follow-up|0|||
156398961|NCT03764774|564552857|FG013|Overall Study|Lost to Follow-up|1|||
156398962|NCT03764774|564552844|FG000|Overall Study|Physician Decision|0|||
156398963|NCT03764774|564552845|FG001|Overall Study|Physician Decision|0|||
156398964|NCT03764774|564552846|FG002|Overall Study|Physician Decision|0|||
156398965|NCT03764774|564552847|FG003|Overall Study|Physician Decision|0|||
156398966|NCT03764774|564552848|FG004|Overall Study|Physician Decision|0|||
156398967|NCT03764774|564552849|FG005|Overall Study|Physician Decision|0|||
156398968|NCT03764774|564552850|FG006|Overall Study|Physician Decision|0|||
156398969|NCT03764774|564552851|FG007|Overall Study|Physician Decision|0|||
156398970|NCT03764774|564552852|FG008|Overall Study|Physician Decision|0|||
156398971|NCT03764774|564552853|FG009|Overall Study|Physician Decision|4|||
156398972|NCT03764774|564552854|FG010|Overall Study|Physician Decision|1|||
156398973|NCT03764774|564552855|FG011|Overall Study|Physician Decision|4|||
156398974|NCT03764774|564552856|FG012|Overall Study|Physician Decision|9|||
156398975|NCT03764774|564552857|FG013|Overall Study|Physician Decision|0|||
156398976|NCT03764774|564552844|FG000|Overall Study|Study Termination|0|||
156398977|NCT03764774|564552845|FG001|Overall Study|Study Termination|0|||
156398978|NCT03764774|564552846|FG002|Overall Study|Study Termination|0|||
156398979|NCT03764774|564552847|FG003|Overall Study|Study Termination|0|||
156398980|NCT03764774|564552848|FG004|Overall Study|Study Termination|0|||
156398981|NCT03764774|564552849|FG005|Overall Study|Study Termination|0|||
156398982|NCT03764774|564552850|FG006|Overall Study|Study Termination|0|||
156398983|NCT03764774|564552851|FG007|Overall Study|Study Termination|0|||
156398984|NCT03764774|564552852|FG008|Overall Study|Study Termination|0|||
156398985|NCT03764774|564552853|FG009|Overall Study|Study Termination|1|||
156398986|NCT03764774|564552854|FG010|Overall Study|Study Termination|0|||
156398987|NCT03764774|564552855|FG011|Overall Study|Study Termination|0|||
156398988|NCT03764774|564552856|FG012|Overall Study|Study Termination|0|||
156398989|NCT03764774|564552857|FG013|Overall Study|Study Termination|2|||
156398990|NCT01370525|564554365|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
156398991|NCT01370525|564554366|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
156398992|NCT01370525|564554365|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156398993|NCT01370525|564554366|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156398994|NCT01370525|564554365|FG000|Overall Study|Adverse Event|0|||
156398995|NCT01370525|564554366|FG001|Overall Study|Adverse Event|1|||
156398996|NCT01370525|564554365|FG000|Overall Study|Protocol Violation|2|||
156398997|NCT01370525|564554366|FG001|Overall Study|Protocol Violation|1|||
156398998|NCT01370525|564554365|FG000|Overall Study|Lost to follow up|2|||
156398999|NCT01370525|564554366|FG001|Overall Study|Lost to follow up|6|||
156399000|NCT04791761|564554367|FG000|Overall Study|Lost to Follow-up|8|||
156399001|NCT04791761|564554368|FG001|Overall Study|Lost to Follow-up|6|||
156399002|NCT04791761|564554369|FG002|Overall Study|Lost to Follow-up|10|||
156399003|NCT04791761|564554367|FG000|Overall Study|Withdrawal by Subject|0|||
156399004|NCT04791761|564554368|FG001|Overall Study|Withdrawal by Subject|1|||
156399005|NCT04791761|564554369|FG002|Overall Study|Withdrawal by Subject|1|||
156399006|NCT04791761|564554367|FG000|Overall Study|Protocol Violation|0|||
156509025|NCT05576662|564955560|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
156399007|NCT04791761|564554368|FG001|Overall Study|Protocol Violation|1|||
156399008|NCT04791761|564554369|FG002|Overall Study|Protocol Violation|1|||
156399009|NCT02940574|564554372|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
156399010|NCT02940574|564554373|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
156399011|NCT02940574|564554372|FG000|1-year Follow-up|Lost to Follow-up|3|||
156399012|NCT02940574|564554373|FG001|1-year Follow-up|Lost to Follow-up|4|||
156399013|NCT00520975|564554374|FG000|Overall Study|Disease progression|31|||
156399014|NCT00520975|564554375|FG001|Overall Study|Disease progression|23|||
156399015|NCT00520975|564554374|FG000|Overall Study|Adverse Event|7|||
156399016|NCT00520975|564554375|FG001|Overall Study|Adverse Event|10|||
156399017|NCT00520975|564554374|FG000|Overall Study|Death|0|||
156399018|NCT00520975|564554375|FG001|Overall Study|Death|2|||
156399019|NCT00520975|564554374|FG000|Overall Study|Withdrawal by Subject|3|||
156399020|NCT00520975|564554375|FG001|Overall Study|Withdrawal by Subject|5|||
156399021|NCT00520975|564554374|FG000|Overall Study|Other therapy|2|||
156399022|NCT00520975|564554375|FG001|Overall Study|Other therapy|4|||
156399023|NCT00520975|564554374|FG000|Overall Study|Other reasons|4|||
156399024|NCT00520975|564554375|FG001|Overall Study|Other reasons|2|||
156399025|NCT00520975|564554374|FG000|Overall Study|Not start protocol therapy|1|||
156399026|NCT00520975|564554375|FG001|Overall Study|Not start protocol therapy|2|||
156399027|NCT04810221|564554376|FG000|Overall Study|Physician Decision|3|||
156399028|NCT03642938|564554377|FG000|Overall Study|Withdrawal by Subject|0|||
156399029|NCT03642938|564554378|FG001|Overall Study|Withdrawal by Subject|0|||
156399030|NCT03642938|564554379|FG002|Overall Study|Withdrawal by Subject|0|||
156399031|NCT03642938|564554380|FG003|Overall Study|Withdrawal by Subject|1|||
156399032|NCT00642902|564554381|FG000|Overall Study|Adverse Event|0|||
156399033|NCT00642902|564554382|FG001|Overall Study|Adverse Event|1|||
156399034|NCT00642902|564554383|FG002|Overall Study|Adverse Event|3|||
156399035|NCT00642902|564554384|FG003|Overall Study|Adverse Event|1|||
156399036|NCT00642902|564554381|FG000|Overall Study|Lost to Follow-up|1|||
156399037|NCT00642902|564554382|FG001|Overall Study|Lost to Follow-up|1|||
156399038|NCT00642902|564554383|FG002|Overall Study|Lost to Follow-up|0|||
156399039|NCT00642902|564554384|FG003|Overall Study|Lost to Follow-up|0|||
156399040|NCT00642902|564554381|FG000|Overall Study|Lack of Efficacy|0|||
156399041|NCT00642902|564554382|FG001|Overall Study|Lack of Efficacy|3|||
156399042|NCT00642902|564554383|FG002|Overall Study|Lack of Efficacy|3|||
156399043|NCT00642902|564554384|FG003|Overall Study|Lack of Efficacy|0|||
156399044|NCT00642902|564554381|FG000|Overall Study|Death|1|||
156399045|NCT00642902|564554382|FG001|Overall Study|Death|0|||
156399046|NCT00642902|564554383|FG002|Overall Study|Death|0|||
156399047|NCT00642902|564554384|FG003|Overall Study|Death|0|||
156399048|NCT00642902|564554381|FG000|Overall Study|Premature termination of clinical trial|37|||
156399049|NCT00642902|564554382|FG001|Overall Study|Premature termination of clinical trial|32|||
156399050|NCT00642902|564554383|FG002|Overall Study|Premature termination of clinical trial|35|||
156399051|NCT00642902|564554384|FG003|Overall Study|Premature termination of clinical trial|35|||
156399052|NCT00642902|564554381|FG000|Overall Study|Randomized, but not treated|0|||
156399053|NCT00642902|564554382|FG001|Overall Study|Randomized, but not treated|0|||
156399054|NCT00642902|564554383|FG002|Overall Study|Randomized, but not treated|1|||
156399055|NCT00642902|564554384|FG003|Overall Study|Randomized, but not treated|0|||
156399056|NCT00642902|564554381|FG000|Overall Study|Other|1|||
156399057|NCT00642902|564554382|FG001|Overall Study|Other|5|||
156399058|NCT00642902|564554383|FG002|Overall Study|Other|1|||
156399059|NCT00642902|564554384|FG003|Overall Study|Other|4|||
156399060|NCT03953898|564554385|FG000|Overall Study|Lack of Efficacy|8|||
156399061|NCT03953898|564554385|FG000|Overall Study|Death|3|||
156399062|NCT03953898|564554385|FG000|Overall Study|Withdrawal by Subject|2|||
156399063|NCT03953898|564554385|FG000|Overall Study|Adverse Event|1|||
156399064|NCT00246337|564554386|FG000|Overall Study|Lost to Follow-up|3|||
156399065|NCT00246337|564554387|FG001|Overall Study|Lost to Follow-up|0|||
156399066|NCT00246337|564554388|FG002|Overall Study|Lost to Follow-up|0|||
156399067|NCT00246337|564554389|FG003|Overall Study|Lost to Follow-up|0|||
156399068|NCT00246337|564554390|FG004|Overall Study|Lost to Follow-up|2|||
156399069|NCT00246337|564554391|FG005|Overall Study|Lost to Follow-up|2|||
156399070|NCT00246337|564554392|FG006|Overall Study|Lost to Follow-up|1|||
156399071|NCT00246337|564554393|FG007|Overall Study|Lost to Follow-up|2|||
156399072|NCT00246337|564554394|FG008|Overall Study|Lost to Follow-up|0|||
156399073|NCT00246337|564554386|FG000|Overall Study|Protocol Violation|1|||
156399074|NCT00246337|564554387|FG001|Overall Study|Protocol Violation|0|||
156399075|NCT00246337|564554388|FG002|Overall Study|Protocol Violation|0|||
156399076|NCT00246337|564554389|FG003|Overall Study|Protocol Violation|0|||
156399077|NCT00246337|564554390|FG004|Overall Study|Protocol Violation|1|||
156399078|NCT00246337|564554391|FG005|Overall Study|Protocol Violation|0|||
156399079|NCT00246337|564554392|FG006|Overall Study|Protocol Violation|1|||
156399080|NCT00246337|564554393|FG007|Overall Study|Protocol Violation|1|||
156399081|NCT00246337|564554394|FG008|Overall Study|Protocol Violation|0|||
156399082|NCT00246337|564554386|FG000|Overall Study|Withdrawal by Subject|2|||
156399083|NCT00246337|564554387|FG001|Overall Study|Withdrawal by Subject|0|||
156399084|NCT00246337|564554388|FG002|Overall Study|Withdrawal by Subject|0|||
156399085|NCT00246337|564554389|FG003|Overall Study|Withdrawal by Subject|0|||
156399086|NCT00246337|564554390|FG004|Overall Study|Withdrawal by Subject|0|||
156509026|NCT05576662|564955561|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
156509027|NCT05217641|564955566|FG000|Overall Study|Lost to Follow-up|1|||
156399087|NCT00246337|564554391|FG005|Overall Study|Withdrawal by Subject|0|||
156509028|NCT05217641|564955567|FG001|Overall Study|Lost to Follow-up|1|||
156509029|NCT05217641|564955568|FG002|Overall Study|Lost to Follow-up|0|||
156399088|NCT00246337|564554392|FG006|Overall Study|Withdrawal by Subject|1|||
156399089|NCT00246337|564554393|FG007|Overall Study|Withdrawal by Subject|1|||
156399090|NCT00246337|564554394|FG008|Overall Study|Withdrawal by Subject|0|||
156399091|NCT00246337|564554386|FG000|Overall Study|Lack of Qualifying Event|8|||
156399092|NCT00246337|564554387|FG001|Overall Study|Lack of Qualifying Event|2|||
156399093|NCT00246337|564554388|FG002|Overall Study|Lack of Qualifying Event|1|||
156399094|NCT00246337|564554389|FG003|Overall Study|Lack of Qualifying Event|1|||
156399095|NCT00246337|564554390|FG004|Overall Study|Lack of Qualifying Event|1|||
156399096|NCT00246337|564554391|FG005|Overall Study|Lack of Qualifying Event|3|||
156399097|NCT00246337|564554392|FG006|Overall Study|Lack of Qualifying Event|3|||
156399098|NCT00246337|564554393|FG007|Overall Study|Lack of Qualifying Event|2|||
156399099|NCT00246337|564554394|FG008|Overall Study|Lack of Qualifying Event|5|||
156399100|NCT00246337|564554386|FG000|Overall Study|Site Terminated|10|||
156399101|NCT00246337|564554387|FG001|Overall Study|Site Terminated|0|||
156399102|NCT00246337|564554388|FG002|Overall Study|Site Terminated|0|||
156399103|NCT00246337|564554389|FG003|Overall Study|Site Terminated|0|||
156399104|NCT00246337|564554390|FG004|Overall Study|Site Terminated|0|||
156399105|NCT00246337|564554391|FG005|Overall Study|Site Terminated|7|||
156399106|NCT00246337|564554392|FG006|Overall Study|Site Terminated|1|||
156399107|NCT00246337|564554393|FG007|Overall Study|Site Terminated|6|||
156399108|NCT00246337|564554394|FG008|Overall Study|Site Terminated|2|||
156399109|NCT00246337|564554386|FG000|Overall Study|Abnormal baseline lab values|7|||
156399110|NCT00246337|564554387|FG001|Overall Study|Abnormal baseline lab values|0|||
156399111|NCT00246337|564554388|FG002|Overall Study|Abnormal baseline lab values|2|||
156399112|NCT00246337|564554389|FG003|Overall Study|Abnormal baseline lab values|0|||
156399113|NCT00246337|564554390|FG004|Overall Study|Abnormal baseline lab values|0|||
156399114|NCT00246337|564554391|FG005|Overall Study|Abnormal baseline lab values|2|||
156399115|NCT00246337|564554392|FG006|Overall Study|Abnormal baseline lab values|2|||
156399116|NCT00246337|564554393|FG007|Overall Study|Abnormal baseline lab values|0|||
156399117|NCT00246337|564554394|FG008|Overall Study|Abnormal baseline lab values|4|||
156399118|NCT00246337|564554386|FG000|Overall Study|Overwhelmed|0|||
156399119|NCT00246337|564554387|FG001|Overall Study|Overwhelmed|0|||
156399120|NCT00246337|564554388|FG002|Overall Study|Overwhelmed|0|||
156399121|NCT00246337|564554389|FG003|Overall Study|Overwhelmed|0|||
156399122|NCT00246337|564554390|FG004|Overall Study|Overwhelmed|0|||
156399123|NCT00246337|564554391|FG005|Overall Study|Overwhelmed|1|||
156399124|NCT00246337|564554392|FG006|Overall Study|Overwhelmed|0|||
156399125|NCT00246337|564554393|FG007|Overall Study|Overwhelmed|0|||
156399126|NCT00246337|564554394|FG008|Overall Study|Overwhelmed|0|||
156399127|NCT00246337|564554386|FG000|Overall Study|Protocol Violator|1|||
156399128|NCT00246337|564554387|FG001|Overall Study|Protocol Violator|0|||
156399129|NCT00246337|564554388|FG002|Overall Study|Protocol Violator|0|||
156399130|NCT00246337|564554389|FG003|Overall Study|Protocol Violator|0|||
156399131|NCT00246337|564554390|FG004|Overall Study|Protocol Violator|0|||
156399132|NCT00246337|564554391|FG005|Overall Study|Protocol Violator|0|||
156399133|NCT00246337|564554392|FG006|Overall Study|Protocol Violator|0|||
156399134|NCT00246337|564554393|FG007|Overall Study|Protocol Violator|0|||
156399135|NCT00246337|564554394|FG008|Overall Study|Protocol Violator|0|||
156399136|NCT00246337|564554386|FG000|Overall Study|Reported as completing trial in error|0|||
156399137|NCT00246337|564554387|FG001|Overall Study|Reported as completing trial in error|0|||
156399138|NCT00246337|564554388|FG002|Overall Study|Reported as completing trial in error|0|||
156399139|NCT00246337|564554389|FG003|Overall Study|Reported as completing trial in error|0|||
156399140|NCT00246337|564554390|FG004|Overall Study|Reported as completing trial in error|0|||
156399141|NCT00246337|564554391|FG005|Overall Study|Reported as completing trial in error|0|||
156399142|NCT00246337|564554392|FG006|Overall Study|Reported as completing trial in error|0|||
156399143|NCT00246337|564554393|FG007|Overall Study|Reported as completing trial in error|1|||
156399144|NCT00246337|564554394|FG008|Overall Study|Reported as completing trial in error|0|||
156399145|NCT01226511|564554397|FG000|Acute Treatment Period|Adverse Event|7|||
156399146|NCT01226511|564554398|FG001|Acute Treatment Period|Adverse Event|6|||
156399147|NCT01226511|564554397|FG000|Acute Treatment Period|Lack of Efficacy|2|||
156399148|NCT01226511|564554398|FG001|Acute Treatment Period|Lack of Efficacy|1|||
156399149|NCT01226511|564554397|FG000|Acute Treatment Period|Lost to Follow-up|3|||
156399150|NCT01226511|564554398|FG001|Acute Treatment Period|Lost to Follow-up|6|||
156399151|NCT01226511|564554397|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
156399152|NCT01226511|564554398|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
156399153|NCT01226511|564554397|FG000|Acute Treatment Period|Protocol Violation|5|||
156399154|NCT01226511|564554398|FG001|Acute Treatment Period|Protocol Violation|5|||
156399155|NCT01226511|564554397|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
156399156|NCT01226511|564554398|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
156399157|NCT01226511|564554397|FG000|Extension Treatment Period|Adverse Event|8|||
156399158|NCT01226511|564554398|FG001|Extension Treatment Period|Adverse Event|8|||
156399159|NCT01226511|564554397|FG000|Extension Treatment Period|Lack of Efficacy|3|||
156399160|NCT01226511|564554398|FG001|Extension Treatment Period|Lack of Efficacy|2|||
156399161|NCT01226511|564554397|FG000|Extension Treatment Period|Lost to Follow-up|4|||
156399162|NCT01226511|564554398|FG001|Extension Treatment Period|Lost to Follow-up|3|||
156399163|NCT01226511|564554397|FG000|Extension Treatment Period|Protocol Violation|2|||
156399164|NCT01226511|564554398|FG001|Extension Treatment Period|Protocol Violation|2|||
156399165|NCT01226511|564554397|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
156399166|NCT01226511|564554398|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
156399167|NCT01226511|564554397|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
156399168|NCT01226511|564554398|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
156399169|NCT01226511|564554397|FG000|Extension Treatment Period|Sponsor Decision|1|||
156399170|NCT01226511|564554398|FG001|Extension Treatment Period|Sponsor Decision|1|||
156399171|NCT01226511|564554397|FG000|Taper Period|Adverse Event|1|||
156399172|NCT01226511|564554398|FG001|Taper Period|Adverse Event|0|||
156399173|NCT01226511|564554397|FG000|Taper Period|Lost to Follow-up|2|||
156399174|NCT01226511|564554398|FG001|Taper Period|Lost to Follow-up|2|||
156399175|NCT01226511|564554397|FG000|Taper Period|Protocol Violation|1|||
156399176|NCT01226511|564554398|FG001|Taper Period|Protocol Violation|0|||
156399177|NCT01226511|564554397|FG000|Taper Period|Parent/Caregiver Decision|1|||
156399178|NCT01226511|564554398|FG001|Taper Period|Parent/Caregiver Decision|1|||
156399179|NCT05267600|564554403|FG000|Overall Study|Adverse Event|1|||
156399180|NCT05267600|564554404|FG001|Overall Study|Adverse Event|4|||
156399181|NCT05267600|564554403|FG000|Overall Study|Death|1|||
156399182|NCT05267600|564554404|FG001|Overall Study|Death|2|||
156399183|NCT05267600|564554403|FG000|Overall Study|Lack of Efficacy|1|||
156399184|NCT05267600|564554404|FG001|Overall Study|Lack of Efficacy|2|||
156399185|NCT05267600|564554403|FG000|Overall Study|Lost to Follow-up|3|||
156399186|NCT05267600|564554404|FG001|Overall Study|Lost to Follow-up|0|||
156399187|NCT05267600|564554403|FG000|Overall Study|Physician Decision|4|||
156399188|NCT05267600|564554404|FG001|Overall Study|Physician Decision|0|||
156399189|NCT05267600|564554403|FG000|Overall Study|Treatment Unblinded|0|||
156399190|NCT05267600|564554404|FG001|Overall Study|Treatment Unblinded|1|||
156399191|NCT05267600|564554403|FG000|Overall Study|Withdrawal by Subject|5|||
156399192|NCT05267600|564554404|FG001|Overall Study|Withdrawal by Subject|4|||
156399193|NCT00643123|564554409|FG000|Overall Study|Lost to Follow-up|4|||
156399194|NCT00643123|564554410|FG001|Overall Study|Lost to Follow-up|0|||
156399195|NCT00643123|564554409|FG000|Overall Study|Withdrawal by Subject|1|||
156399196|NCT00643123|564554410|FG001|Overall Study|Withdrawal by Subject|1|||
156399197|NCT05292534|564554411|FG000|Overall Study|Protocol Violation|3|||
156399198|NCT05292534|564554412|FG001|Overall Study|Protocol Violation|4|||
156399199|NCT05292534|564554411|FG000|Overall Study|Withdrawal by Subject|0|||
156399200|NCT05292534|564554412|FG001|Overall Study|Withdrawal by Subject|1|||
156399201|NCT01538472|564554414|FG000|Overall Study|Disease Progression|3|||
156399202|NCT01538472|564554414|FG000|Overall Study|Death|1|||
156399203|NCT02309112|564554415|FG000|Overall Study|Withdrawal by Subject|1|||
156399204|NCT02309112|564554416|FG001|Overall Study|Withdrawal by Subject|0|||
156399205|NCT02309112|564554417|FG002|Overall Study|Withdrawal by Subject|1|||
156399206|NCT02309112|564554415|FG000|Overall Study|Lost to Follow-up|0|||
156399207|NCT02309112|564554416|FG001|Overall Study|Lost to Follow-up|1|||
156399208|NCT02309112|564554417|FG002|Overall Study|Lost to Follow-up|0|||
156399209|NCT02133872|564554418|FG000|Overall Study|Withdrawal by Subject|5|||
156399210|NCT02133872|564554419|FG001|Overall Study|Withdrawal by Subject|3|||
156399211|NCT02133872|564554420|FG002|Overall Study|Withdrawal by Subject|0|||
156399212|NCT02923739|564554421|FG000|Overall Study|Withdrawal by Subject|2|||
156399213|NCT02923739|564554422|FG001|Overall Study|Withdrawal by Subject|0|||
156399214|NCT02923739|564554423|FG002|Overall Study|Withdrawal by Subject|0|||
156399215|NCT02923739|564554424|FG003|Overall Study|Withdrawal by Subject|0|||
156399216|NCT02923739|564554421|FG000|Overall Study|Failed Screening|3|||
156399217|NCT02923739|564554422|FG001|Overall Study|Failed Screening|0|||
156399218|NCT02923739|564554423|FG002|Overall Study|Failed Screening|0|||
156399219|NCT02923739|564554424|FG003|Overall Study|Failed Screening|0|||
156399220|NCT00948974|564554429|FG000|Overall Study|Lost to Follow-up|23|||
156399221|NCT00948974|564554430|FG001|Overall Study|Lost to Follow-up|20|||
156399222|NCT00238433|564554431|FG000|Overall Study|Screen failure|1|||
156399223|NCT00238433|564554431|FG000|Overall Study|Lost to Follow-up|1|||
156399224|NCT00238433|564554431|FG000|Overall Study|Death|1|||
156399225|NCT01889186|564554432|FG000|Overall Study|Adverse event- not related to progression|18|||
156399226|NCT01889186|564554433|FG001|Overall Study|Adverse event- not related to progression|5|||
156399227|NCT01889186|564554432|FG000|Overall Study|Adverse event- related to progression|7|||
156399228|NCT01889186|564554433|FG001|Overall Study|Adverse event- related to progression|2|||
156399229|NCT01889186|564554432|FG000|Overall Study|COVID-19 logistical restrictions|1|||
156399230|NCT01889186|564554433|FG001|Overall Study|COVID-19 logistical restrictions|0|||
156399231|NCT01889186|564554432|FG000|Overall Study|Investigator request|1|||
156399232|NCT01889186|564554433|FG001|Overall Study|Investigator request|1|||
156399233|NCT01889186|564554432|FG000|Overall Study|Progressive disease- Richter's|12|||
156399234|NCT01889186|564554433|FG001|Overall Study|Progressive disease- Richter's|7|||
156399235|NCT01889186|564554432|FG000|Overall Study|Progressive disease per protocol|46|||
156399236|NCT01889186|564554433|FG001|Overall Study|Progressive disease per protocol|17|||
156399237|NCT01889186|564554432|FG000|Overall Study|Stem cell transplant|2|||
156509030|NCT05217641|564955569|FG003|Overall Study|Lost to Follow-up|1|||
156399238|NCT01889186|564554433|FG001|Overall Study|Stem cell transplant|1|||
156399239|NCT01889186|564554432|FG000|Overall Study|Withdrew consent|2|||
156399240|NCT01889186|564554433|FG001|Overall Study|Withdrew consent|3|||
156399241|NCT01889186|564554432|FG000|Overall Study|Other, not specified|18|||
156399242|NCT01889186|564554433|FG001|Overall Study|Other, not specified|15|||
156399243|NCT00409682|564554435|FG000|Open-label Induction Period|Adverse Event|1|||
156399244|NCT00409682|564554436|FG001|Open-label Induction Period|Adverse Event|0|||
156399245|NCT00409682|564554437|FG002|Open-label Induction Period|Adverse Event|0|||
156399246|NCT00409682|564554435|FG000|Open-label Induction Period|Lack of Efficacy|1|||
156399247|NCT00409682|564554436|FG001|Open-label Induction Period|Lack of Efficacy|0|||
156399248|NCT00409682|564554437|FG002|Open-label Induction Period|Lack of Efficacy|0|||
156399249|NCT00409682|564554435|FG000|Open-label Induction Period|Protocol Violation|1|||
156399250|NCT00409682|564554436|FG001|Open-label Induction Period|Protocol Violation|0|||
156399251|NCT00409682|564554437|FG002|Open-label Induction Period|Protocol Violation|0|||
156399252|NCT00409682|564554435|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
156399253|NCT00409682|564554436|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
156399254|NCT00409682|564554437|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
156399255|NCT00409682|564554435|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
156399256|NCT00409682|564554436|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
156399257|NCT00409682|564554437|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
156399258|NCT00409682|564554435|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
156399259|NCT00409682|564554436|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
156399260|NCT00409682|564554437|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
156399261|NCT00409682|564554435|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
156399262|NCT00409682|564554436|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
156399263|NCT00409682|564554437|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
156399264|NCT00409682|564554435|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
156399265|NCT00409682|564554436|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
156399266|NCT00409682|564554437|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
156399267|NCT00409682|564554435|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
156399268|NCT00409682|564554436|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
156399269|NCT00409682|564554437|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
156399270|NCT00409682|564554435|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
156399271|NCT00409682|564554436|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
156399272|NCT00409682|564554437|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
156399273|NCT01896869|564554438|FG000|Overall Study|Withdrawal by Subject|0|||
156399274|NCT01896869|564554439|FG001|Overall Study|Withdrawal by Subject|6|||
156399275|NCT01896869|564554438|FG000|Overall Study|Lost to Follow-up|1|||
156399276|NCT01896869|564554439|FG001|Overall Study|Lost to Follow-up|0|||
156399277|NCT04710927|564554447|FG000|Overall Study|Lost to Follow-up|7|||
156399278|NCT04710927|564554448|FG001|Overall Study|Lost to Follow-up|6|||
156399279|NCT04710927|564554449|FG002|Overall Study|Lost to Follow-up|5|||
156399280|NCT00118716|564554450|FG000|Overall Study|Adverse Event|2|||
156399281|NCT00118716|564554451|FG001|Overall Study|Adverse Event|7|||
156399282|NCT00118716|564554450|FG000|Overall Study|Protocol Violation|5|||
156399283|NCT00118716|564554451|FG001|Overall Study|Protocol Violation|4|||
156399284|NCT00118716|564554450|FG000|Overall Study|Withdrawal by Subject|0|||
156399285|NCT00118716|564554451|FG001|Overall Study|Withdrawal by Subject|1|||
156399286|NCT00118716|564554450|FG000|Overall Study|Exacerbation|2|||
156399287|NCT00118716|564554451|FG001|Overall Study|Exacerbation|2|||
156399288|NCT00118716|564554450|FG000|Overall Study|Discontinued by sponsor|1|||
156399289|NCT00118716|564554451|FG001|Overall Study|Discontinued by sponsor|1|||
156399290|NCT00118716|564554450|FG000|Overall Study|Non-compliance|1|||
156399291|NCT00118716|564554451|FG001|Overall Study|Non-compliance|3|||
156399292|NCT00118716|564554450|FG000|Overall Study|misrandomized|1|||
156399293|NCT00118716|564554451|FG001|Overall Study|misrandomized|1|||
156399294|NCT00118716|564554450|FG000|Overall Study|Expired drug use|1|||
156399295|NCT00118716|564554451|FG001|Overall Study|Expired drug use|2|||
156399296|NCT00118716|564554450|FG000|Overall Study|Investigator discretion|0|||
156399297|NCT00118716|564554451|FG001|Overall Study|Investigator discretion|1|||
156399298|NCT00855062|564554453|FG000|Step1|Early Study Closure|5|||
156399299|NCT00855062|564554454|FG001|Step1|Early Study Closure|7|||
156399300|NCT00855062|564554453|FG000|Step1|Adverse Event|1|||
156399301|NCT00855062|564554454|FG001|Step1|Adverse Event|1|||
156399302|NCT00855062|564554453|FG000|Step1|Protocol Violation|1|||
156399303|NCT00855062|564554454|FG001|Step1|Protocol Violation|0|||
156399304|NCT00855062|564554453|FG000|Step1|Pregnancy|1|||
156399305|NCT00855062|564554454|FG001|Step1|Pregnancy|0|||
156399306|NCT00855062|564554453|FG000|Step1|Withdrawal by Subject|2|||
156399307|NCT00855062|564554454|FG001|Step1|Withdrawal by Subject|3|||
156399308|NCT00855062|564554453|FG000|Step2|Early Study Closure|6|||
156399309|NCT00855062|564554454|FG001|Step2|Early Study Closure|2|||
156399310|NCT00855062|564554453|FG000|Step2|Adverse Event|0|||
156509031|NCT05217641|564955570|FG004|Overall Study|Lost to Follow-up|1|||
156509032|NCT05217641|564955571|FG005|Overall Study|Lost to Follow-up|0|||
156509033|NCT05217641|564955566|FG000|Overall Study|Withdrawal by Subject|0|||
156509034|NCT05217641|564955567|FG001|Overall Study|Withdrawal by Subject|0|||
156509035|NCT05217641|564955568|FG002|Overall Study|Withdrawal by Subject|0|||
156509036|NCT05217641|564955569|FG003|Overall Study|Withdrawal by Subject|3|||
156509037|NCT05217641|564955570|FG004|Overall Study|Withdrawal by Subject|1|||
156399311|NCT00855062|564554454|FG001|Step2|Adverse Event|3|||
156399312|NCT00855062|564554453|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
156399313|NCT00855062|564554454|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
156399314|NCT00454571|564554460|FG000|Overall Study|Adverse Event|2|||
156399315|NCT00454571|564554461|FG001|Overall Study|Adverse Event|0|||
156399316|NCT00454571|564554460|FG000|Overall Study|Physician Decision|0|||
156399317|NCT00454571|564554461|FG001|Overall Study|Physician Decision|1|||
156399318|NCT00454571|564554460|FG000|Overall Study|Protocol Violation|1|||
156399319|NCT00454571|564554461|FG001|Overall Study|Protocol Violation|0|||
156399320|NCT00454571|564554460|FG000|Overall Study|Withdrawal by Subject|10|||
156399321|NCT00454571|564554461|FG001|Overall Study|Withdrawal by Subject|5|||
156399322|NCT01960725|564554462|FG000|Overall Study|Lost to Follow-up|4|||
156399323|NCT01960725|564554463|FG001|Overall Study|Lost to Follow-up|3|||
156399324|NCT01960725|564554462|FG000|Overall Study|Withdrawal by Subject|1|||
156399325|NCT01960725|564554463|FG001|Overall Study|Withdrawal by Subject|0|||
156399326|NCT01960725|564554462|FG000|Overall Study|unable to obtain blood sample|1|||
156399327|NCT01960725|564554463|FG001|Overall Study|unable to obtain blood sample|2|||
156399328|NCT01058304|564554466|FG000|Overall Study|Withdrawal by Subject|8|||
156399329|NCT01058304|564554467|FG001|Overall Study|Withdrawal by Subject|5|||
156399330|NCT01058304|564554466|FG000|Overall Study|Lost to Follow-up|13|||
156399331|NCT01058304|564554467|FG001|Overall Study|Lost to Follow-up|16|||
156399332|NCT01058304|564554466|FG000|Overall Study|Developed exclusion criterion|6|||
156399333|NCT01058304|564554467|FG001|Overall Study|Developed exclusion criterion|12|||
156399334|NCT02496767|564554469|FG000|Open-label Lead-in Phase|Adverse Event|176|||
156399335|NCT02496767|564554470|FG001|Open-label Lead-in Phase|Adverse Event|0|||
156399336|NCT02496767|564554471|FG002|Open-label Lead-in Phase|Adverse Event|0|||
156399337|NCT02496767|564554472|FG003|Open-label Lead-in Phase|Adverse Event|0|||
156399338|NCT02496767|564554473|FG004|Open-label Lead-in Phase|Adverse Event|0|||
156399339|NCT02496767|564554474|FG005|Open-label Lead-in Phase|Adverse Event|0|||
156399340|NCT02496767|564554475|FG006|Open-label Lead-in Phase|Adverse Event|0|||
156399341|NCT02496767|564554476|FG007|Open-label Lead-in Phase|Adverse Event|0|||
156399342|NCT02496767|564554469|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
156399343|NCT02496767|564554470|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
156399344|NCT02496767|564554471|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
156399345|NCT02496767|564554472|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
156399346|NCT02496767|564554473|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
156399347|NCT02496767|564554474|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
156399348|NCT02496767|564554475|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
156399349|NCT02496767|564554476|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
156399350|NCT02496767|564554469|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
156399351|NCT02496767|564554470|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
156399352|NCT02496767|564554471|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
156399353|NCT02496767|564554472|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
156399354|NCT02496767|564554473|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
156399355|NCT02496767|564554474|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
156399356|NCT02496767|564554475|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
156399357|NCT02496767|564554476|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
156399358|NCT02496767|564554469|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
156399359|NCT02496767|564554470|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
156399360|NCT02496767|564554471|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
156399361|NCT02496767|564554472|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
156399362|NCT02496767|564554473|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
156399363|NCT02496767|564554474|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
156399364|NCT02496767|564554475|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
156399365|NCT02496767|564554476|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
156399366|NCT02496767|564554469|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
156399367|NCT02496767|564554470|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
156399368|NCT02496767|564554471|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
156399369|NCT02496767|564554472|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
156399370|NCT02496767|564554473|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
156399371|NCT02496767|564554474|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
156399372|NCT02496767|564554475|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
156399373|NCT02496767|564554476|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
156399374|NCT02496767|564554469|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
156399375|NCT02496767|564554470|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
156399376|NCT02496767|564554471|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
156399377|NCT02496767|564554472|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
156399378|NCT02496767|564554473|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
156399379|NCT02496767|564554474|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
156399380|NCT02496767|564554475|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
156399381|NCT02496767|564554476|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
156399382|NCT02496767|564554469|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
156399383|NCT02496767|564554470|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
156399384|NCT02496767|564554471|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
156399385|NCT02496767|564554472|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
156399386|NCT02496767|564554473|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
156399387|NCT02496767|564554474|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
156399388|NCT02496767|564554475|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
156399389|NCT02496767|564554476|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
156399390|NCT02496767|564554469|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156399391|NCT02496767|564554470|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
156399392|NCT02496767|564554471|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
156399393|NCT02496767|564554472|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
156399394|NCT02496767|564554473|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
156399395|NCT02496767|564554474|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156399396|NCT02496767|564554475|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156399397|NCT02496767|564554476|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156399398|NCT02496767|564554469|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156399399|NCT02496767|564554470|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
156399400|NCT02496767|564554471|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
156399401|NCT02496767|564554472|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156399402|NCT02496767|564554473|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156399403|NCT02496767|564554474|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156399404|NCT02496767|564554475|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156399405|NCT02496767|564554476|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156399406|NCT02496767|564554469|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156399407|NCT02496767|564554470|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
156399408|NCT02496767|564554471|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156399409|NCT02496767|564554472|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
156399410|NCT02496767|564554473|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
156399411|NCT02496767|564554474|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156399412|NCT02496767|564554475|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156399413|NCT02496767|564554476|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156399414|NCT02496767|564554469|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156399415|NCT02496767|564554470|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
156399416|NCT02496767|564554471|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156399417|NCT02496767|564554472|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156399418|NCT02496767|564554473|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156399419|NCT02496767|564554474|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156399420|NCT02496767|564554475|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156399421|NCT02496767|564554476|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156399422|NCT02496767|564554469|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
156399423|NCT02496767|564554470|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
156399424|NCT02496767|564554471|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
156399425|NCT02496767|564554472|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
156399426|NCT02496767|564554473|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
156399427|NCT02496767|564554474|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
156399428|NCT02496767|564554475|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
156399429|NCT02496767|564554476|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
156399430|NCT02496767|564554469|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
156399431|NCT02496767|564554470|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
156399432|NCT02496767|564554471|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
156399433|NCT02496767|564554472|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
156399434|NCT02496767|564554473|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
156399435|NCT02496767|564554474|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
156399436|NCT02496767|564554475|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
156399437|NCT02496767|564554476|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
156399438|NCT02496767|564554469|FG000|Double-blind, Withdrawal Phase|Death|0|||
156399439|NCT02496767|564554470|FG001|Double-blind, Withdrawal Phase|Death|0|||
156399440|NCT02496767|564554471|FG002|Double-blind, Withdrawal Phase|Death|0|||
156399441|NCT02496767|564554472|FG003|Double-blind, Withdrawal Phase|Death|0|||
156399442|NCT02496767|564554473|FG004|Double-blind, Withdrawal Phase|Death|0|||
156399443|NCT02496767|564554474|FG005|Double-blind, Withdrawal Phase|Death|0|||
156399444|NCT02496767|564554475|FG006|Double-blind, Withdrawal Phase|Death|1|||
156399445|NCT02496767|564554476|FG007|Double-blind, Withdrawal Phase|Death|2|||
156549621|NCT00264004|565103687|FG000|Overall Study|Development study specific disc. crit.|1|||
156549622|NCT00264004|565103688|FG001|Overall Study|Development study specific disc. crit.|0|||
156549623|NCT00264004|565103689|FG002|Overall Study|Development study specific disc. crit.|1|||
156399446|NCT02496767|564554469|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156399447|NCT02496767|564554470|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156399448|NCT02496767|564554471|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156399449|NCT02496767|564554472|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156399450|NCT02496767|564554473|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156399451|NCT02496767|564554474|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
156399452|NCT02496767|564554475|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
156399453|NCT02496767|564554476|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
156399454|NCT04035200|564554477|FG000|Overall Study|Lost to Follow-up|0|||
156399455|NCT04035200|564554478|FG001|Overall Study|Lost to Follow-up|1|||
156399456|NCT04035200|564554479|FG002|Overall Study|Lost to Follow-up|0|||
156399457|NCT04035200|564554477|FG000|Overall Study|Withdrawal by Subject|1|||
156399458|NCT04035200|564554478|FG001|Overall Study|Withdrawal by Subject|4|||
156399459|NCT04035200|564554479|FG002|Overall Study|Withdrawal by Subject|4|||
156399460|NCT04035200|564554477|FG000|Overall Study|COVID-19|1|||
156399461|NCT04035200|564554478|FG001|Overall Study|COVID-19|0|||
156399462|NCT04035200|564554479|FG002|Overall Study|COVID-19|0|||
156399463|NCT04035200|564554477|FG000|Overall Study|Early Termination|0|||
156399464|NCT04035200|564554478|FG001|Overall Study|Early Termination|1|||
156399465|NCT04035200|564554479|FG002|Overall Study|Early Termination|0|||
156399466|NCT04035200|564554477|FG000|Overall Study|Non-compliance|0|||
156399467|NCT04035200|564554478|FG001|Overall Study|Non-compliance|1|||
156399468|NCT04035200|564554479|FG002|Overall Study|Non-compliance|0|||
156399469|NCT03138733|564554482|FG000|Overall Study|Death|17|||
156399470|NCT03138733|564554483|FG001|Overall Study|Death|18|||
156399471|NCT03138733|564554482|FG000|Overall Study|Withdrawal by Subject|11|||
156399472|NCT03138733|564554483|FG001|Overall Study|Withdrawal by Subject|6|||
156399473|NCT03138733|564554482|FG000|Overall Study|Lost to Follow-up|3|||
156399474|NCT03138733|564554483|FG001|Overall Study|Lost to Follow-up|2|||
156399475|NCT03138733|564554482|FG000|Overall Study|Adverse Event|1|||
156399476|NCT03138733|564554483|FG001|Overall Study|Adverse Event|0|||
156399477|NCT03138733|564554482|FG000|Overall Study|Protocol Violation|1|||
156399478|NCT03138733|564554483|FG001|Overall Study|Protocol Violation|3|||
156399479|NCT03138733|564554482|FG000|Overall Study|Administrative or logistical reason|1|||
156399480|NCT03138733|564554483|FG001|Overall Study|Administrative or logistical reason|0|||
156399481|NCT03138733|564554482|FG000|Overall Study|The patient was transferred to another hospital|1|||
156399482|NCT03138733|564554483|FG001|Overall Study|The patient was transferred to another hospital|0|||
156399483|NCT01089374|564554484|FG000|Overall Study|Lost to Follow-up|3|||
156399484|NCT01089374|564554485|FG001|Overall Study|Lost to Follow-up|0|||
156399485|NCT01089374|564554484|FG000|Overall Study|Withdrawal by Subject|1|||
156399486|NCT01089374|564554485|FG001|Overall Study|Withdrawal by Subject|0|||
156399487|NCT01089374|564554484|FG000|Overall Study|Study closed early - low accrual|6|||
156399488|NCT01089374|564554485|FG001|Overall Study|Study closed early - low accrual|0|||
156399489|NCT03641313|564554497|FG000|Overall Study|Death|1|||
156399490|NCT03641313|564554497|FG000|Overall Study|Withdrawal by Subject|2|||
156399491|NCT03641313|564554497|FG000|Overall Study|Declining health|1|||
156399492|NCT03641313|564554497|FG000|Overall Study|Adverse Event|1|||
156399493|NCT03033225|564554498|FG000|Overall Study|Withdrawal by Subject|5|||
156399494|NCT05163522|564554499|FG000|Overall Study|Withdrawal by Subject|0|||
156399495|NCT05163522|564554500|FG001|Overall Study|Withdrawal by Subject|0|||
156399496|NCT05163522|564554501|FG002|Overall Study|Withdrawal by Subject|1|||
156399497|NCT05163522|564554502|FG003|Overall Study|Withdrawal by Subject|0|||
156399498|NCT05163522|564554503|FG004|Overall Study|Withdrawal by Subject|0|||
156399499|NCT05163522|564554504|FG005|Overall Study|Withdrawal by Subject|0|||
156399500|NCT05163522|564554505|FG006|Overall Study|Withdrawal by Subject|0|||
156399501|NCT05163522|564554506|FG007|Overall Study|Withdrawal by Subject|0|||
156399502|NCT05163522|564554507|FG008|Overall Study|Withdrawal by Subject|0|||
156399503|NCT05163522|564554508|FG009|Overall Study|Withdrawal by Subject|0|||
156399504|NCT05163522|564554509|FG010|Overall Study|Withdrawal by Subject|0|||
156399505|NCT03937219|564554512|FG000|Overall Study|Death|223|||
156399506|NCT03937219|564554513|FG001|Overall Study|Death|211|||
156399507|NCT03937219|564554512|FG000|Overall Study|Withdrawal by Subject|17|||
156399508|NCT03937219|564554513|FG001|Overall Study|Withdrawal by Subject|25|||
156399509|NCT03937219|564554512|FG000|Overall Study|Lost to Follow-up|3|||
156399510|NCT03937219|564554513|FG001|Overall Study|Lost to Follow-up|4|||
156399511|NCT00500903|564554514|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
156399512|NCT00500903|564554515|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
156399513|NCT00500903|564554516|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
156399514|NCT00500903|564554514|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
156399515|NCT00500903|564554515|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
156399516|NCT00500903|564554516|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
156399517|NCT00500903|564554514|FG000|Overall Study|Progressive Disease|41|||
156399518|NCT00500903|564554515|FG001|Overall Study|Progressive Disease|2|||
156399519|NCT00500903|564554516|FG002|Overall Study|Progressive Disease|15|||
156399520|NCT00500903|564554514|FG000|Overall Study|Patient Declined Further Treatment|0|||
156399521|NCT00500903|564554515|FG001|Overall Study|Patient Declined Further Treatment|0|||
156399522|NCT00500903|564554516|FG002|Overall Study|Patient Declined Further Treatment|3|||
156399523|NCT00500903|564554514|FG000|Overall Study|Symptomatic Deterioration|2|||
156399524|NCT00500903|564554515|FG001|Overall Study|Symptomatic Deterioration|0|||
156399525|NCT00500903|564554516|FG002|Overall Study|Symptomatic Deterioration|0|||
156399526|NCT00500903|564554514|FG000|Overall Study|Reason Not Specified|10|||
156399527|NCT00500903|564554515|FG001|Overall Study|Reason Not Specified|0|||
156399528|NCT00500903|564554516|FG002|Overall Study|Reason Not Specified|2|||
156399529|NCT01648348|564554517|FG000|Overall Study|Cancel|1|||
156399530|NCT01648348|564554518|FG001|Overall Study|Cancel|0|||
156399531|NCT01648348|564554519|FG002|Overall Study|Cancel|0|||
156399532|NCT01648348|564554520|FG003|Overall Study|Cancel|0|||
156399533|NCT01648348|564554521|FG004|Overall Study|Cancel|3|||
156399534|NCT01648348|564554522|FG005|Overall Study|Cancel|6|||
156399535|NCT01648348|564554517|FG000|Overall Study|Replaced for MTD analysis|1|||
156399536|NCT01648348|564554518|FG001|Overall Study|Replaced for MTD analysis|0|||
156399537|NCT01648348|564554519|FG002|Overall Study|Replaced for MTD analysis|1|||
156399538|NCT01648348|564554520|FG003|Overall Study|Replaced for MTD analysis|0|||
156399539|NCT01648348|564554521|FG004|Overall Study|Replaced for MTD analysis|0|||
156399540|NCT01648348|564554522|FG005|Overall Study|Replaced for MTD analysis|0|||
156399541|NCT00696410|564554523|FG000|Overall Study|Lost to Follow-up|2|||
156399542|NCT00696410|564554524|FG001|Overall Study|Lost to Follow-up|0|||
156399543|NCT00696410|564554523|FG000|Overall Study|Withdrawal by Subject|8|||
156399544|NCT00696410|564554524|FG001|Overall Study|Withdrawal by Subject|0|||
156399545|NCT00696410|564554523|FG000|Overall Study|Physician Decision|3|||
156399546|NCT00696410|564554524|FG001|Overall Study|Physician Decision|0|||
156399547|NCT00847405|564556045|FG000|First Intervention|Adverse Event|0|||
156399548|NCT00847405|564556046|FG001|First Intervention|Adverse Event|1|||
156399549|NCT00847405|564556045|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156399550|NCT00847405|564556046|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156399551|NCT01728792|564556047|FG000|Overall Study|Withdrawal of Consent|1|||
156399552|NCT01728792|564556048|FG001|Overall Study|Withdrawal of Consent|1|||
156399553|NCT01728792|564556049|FG002|Overall Study|Withdrawal of Consent|0|||
156399554|NCT01728792|564556050|FG003|Overall Study|Withdrawal of Consent|1|||
156399555|NCT01728792|564556051|FG004|Overall Study|Withdrawal of Consent|0|||
156399556|NCT01728792|564556047|FG000|Overall Study|Lost to Follow-up|2|||
156399557|NCT01728792|564556048|FG001|Overall Study|Lost to Follow-up|1|||
156399558|NCT01728792|564556049|FG002|Overall Study|Lost to Follow-up|4|||
156399559|NCT01728792|564556050|FG003|Overall Study|Lost to Follow-up|2|||
156399560|NCT01728792|564556051|FG004|Overall Study|Lost to Follow-up|0|||
156399561|NCT03559218|564556052|FG000|Overall Study|Withdrawal by Subject|1|||
156399562|NCT03559218|564556053|FG001|Overall Study|Withdrawal by Subject|0|||
156399563|NCT04277455|564556054|FG000|Overall Study|Lost to Follow-up|1|||
156399564|NCT04737109|564556062|FG000|Study Treatment|Disease Progression|5|||
156399565|NCT04737109|564556063|FG001|Study Treatment|Disease Progression|0|||
156399566|NCT04737109|564556064|FG002|Study Treatment|Disease Progression|0|||
156399567|NCT04737109|564556065|FG003|Study Treatment|Disease Progression|0|||
156399568|NCT04737109|564556062|FG000|Study Treatment|Death on study|1|||
156399569|NCT04737109|564556063|FG001|Study Treatment|Death on study|0|||
156399570|NCT04737109|564556064|FG002|Study Treatment|Death on study|0|||
156399571|NCT04737109|564556065|FG003|Study Treatment|Death on study|0|||
156399572|NCT03092375|564556066|FG000|Overall Study|Lack of Efficacy|0|||
156399573|NCT03092375|564556067|FG001|Overall Study|Lack of Efficacy|1|||
156399574|NCT03092375|564556068|FG002|Overall Study|Lack of Efficacy|1|||
156399575|NCT03092375|564556069|FG003|Overall Study|Lack of Efficacy|0|||
156399576|NCT01679301|564556070|FG000|Screening Period|screen failure|3|||
156399577|NCT01679301|564556071|FG001|Screening Period|screen failure|0|||
156399578|NCT01679301|564556072|FG002|Screening Period|screen failure|0|||
156399579|NCT02790073|564556075|FG000|Overall Study|Death|1|||
156399580|NCT02790073|564556075|FG000|Overall Study|Withdrawal from HD|1|||
156399581|NCT02790073|564556075|FG000|Overall Study|Withdrawal by Subject|1|||
156549624|NCT00264004|565103690|FG003|Overall Study|Development study specific disc. crit.|0|||
156549625|NCT00264004|565103687|FG000|Overall Study|Cond. under inv. worsened|9|||
156549626|NCT00264004|565103688|FG001|Overall Study|Cond. under inv. worsened|5|||
156549627|NCT00264004|565103689|FG002|Overall Study|Cond. under inv. worsened|3|||
156549628|NCT00264004|565103690|FG003|Overall Study|Cond. under inv. worsened|4|||
156399582|NCT03328143|564556076|FG000|Overall Study|Declined|3|||
156399583|NCT03328143|564556076|FG000|Overall Study|Required increased sedation|4|||
156399584|NCT03328143|564556076|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
156399585|NCT03328143|564556076|FG000|Overall Study|Surgery cancelled|1|||
156399586|NCT02305381|564556077|FG000|Overall Study|Unclassified|5|||
156399587|NCT02305381|564556078|FG001|Overall Study|Unclassified|5|||
156399588|NCT02305381|564556079|FG002|Overall Study|Unclassified|7|||
156399589|NCT02882282|564556080|FG000|Overall Study|Adverse Event|1|||
156399590|NCT02882282|564556081|FG001|Overall Study|Adverse Event|0|||
156399591|NCT00514683|564556083|FG000|Overall Study|Not treated|2|||
156399592|NCT00514683|564556084|FG001|Overall Study|Not treated|1|||
156399593|NCT00514683|564556085|FG002|Overall Study|Not treated|0|||
156399594|NCT00514683|564556086|FG003|Overall Study|Not treated|0|||
156399595|NCT00514683|564556087|FG004|Overall Study|Not treated|1|||
156399596|NCT00514683|564556083|FG000|Overall Study|Adverse Event|21|||
156399597|NCT00514683|564556084|FG001|Overall Study|Adverse Event|20|||
156399598|NCT00514683|564556085|FG002|Overall Study|Adverse Event|15|||
156399599|NCT00514683|564556086|FG003|Overall Study|Adverse Event|13|||
156399600|NCT00514683|564556087|FG004|Overall Study|Adverse Event|27|||
156399601|NCT00514683|564556083|FG000|Overall Study|Protocol Violation|1|||
156399602|NCT00514683|564556084|FG001|Overall Study|Protocol Violation|1|||
156399603|NCT00514683|564556085|FG002|Overall Study|Protocol Violation|0|||
156399604|NCT00514683|564556086|FG003|Overall Study|Protocol Violation|1|||
156399605|NCT00514683|564556087|FG004|Overall Study|Protocol Violation|0|||
156399606|NCT00514683|564556083|FG000|Overall Study|Withdrawal by Subject|2|||
156399607|NCT00514683|564556084|FG001|Overall Study|Withdrawal by Subject|2|||
156399608|NCT00514683|564556085|FG002|Overall Study|Withdrawal by Subject|1|||
156399609|NCT00514683|564556086|FG003|Overall Study|Withdrawal by Subject|0|||
156399610|NCT00514683|564556087|FG004|Overall Study|Withdrawal by Subject|4|||
156399611|NCT00514683|564556083|FG000|Overall Study|Reason other than listed above|0|||
156399612|NCT00514683|564556084|FG001|Overall Study|Reason other than listed above|1|||
156399613|NCT00514683|564556085|FG002|Overall Study|Reason other than listed above|2|||
156399614|NCT00514683|564556086|FG003|Overall Study|Reason other than listed above|0|||
156399615|NCT00514683|564556087|FG004|Overall Study|Reason other than listed above|1|||
156399616|NCT02487498|564556088|FG000|Period: Period 1|Adverse Event|2|||
156399617|NCT02487498|564556089|FG001|Period: Period 1|Adverse Event|4|||
156399618|NCT02487498|564556088|FG000|Period: Period 1|Subject/guardian decision|2|||
156399619|NCT02487498|564556089|FG001|Period: Period 1|Subject/guardian decision|4|||
156399620|NCT02487498|564556088|FG000|Period: Period 1|Lost to Follow-up|0|||
156399621|NCT02487498|564556089|FG001|Period: Period 1|Lost to Follow-up|2|||
156399622|NCT02487498|564556088|FG000|Period: Period 1|Lack of Efficacy|1|||
156399623|NCT02487498|564556089|FG001|Period: Period 1|Lack of Efficacy|0|||
156399624|NCT02487498|564556088|FG000|Period: Period 1|Physician Decision|0|||
156399625|NCT02487498|564556089|FG001|Period: Period 1|Physician Decision|1|||
156399626|NCT02487498|564556088|FG000|Period: Period 1|Protocol deviation|1|||
156399627|NCT02487498|564556089|FG001|Period: Period 1|Protocol deviation|0|||
156399628|NCT02487498|564556088|FG000|Period: Washout|Subject/guardian decision|0|||
156399629|NCT02487498|564556089|FG001|Period: Washout|Subject/guardian decision|5|||
156399630|NCT02487498|564556088|FG000|Period: Washout|Lack of Efficacy|1|||
156399631|NCT02487498|564556089|FG001|Period: Washout|Lack of Efficacy|1|||
156399632|NCT02487498|564556088|FG000|Period: Washout|Physician Decision|1|||
156399633|NCT02487498|564556089|FG001|Period: Washout|Physician Decision|0|||
156399634|NCT02487498|564556088|FG000|Period: Washout|Non-compliance with study treatment|0|||
156399635|NCT02487498|564556089|FG001|Period: Washout|Non-compliance with study treatment|1|||
156399636|NCT02487498|564556088|FG000|Period: Period 2|Adverse Event|2|||
156399637|NCT02487498|564556089|FG001|Period: Period 2|Adverse Event|2|||
156399638|NCT02487498|564556088|FG000|Period: Period 2|Subject/guardian decision|2|||
156399639|NCT02487498|564556089|FG001|Period: Period 2|Subject/guardian decision|1|||
156399640|NCT02487498|564556088|FG000|Period: Period 2|Lost to Follow-up|1|||
156399641|NCT02487498|564556089|FG001|Period: Period 2|Lost to Follow-up|1|||
156399642|NCT02487498|564556088|FG000|Period: Period 2|Death|0|||
156399643|NCT02487498|564556089|FG001|Period: Period 2|Death|1|||
156399644|NCT02487498|564556088|FG000|Period: Period 2|Physician Decision|1|||
156399645|NCT02487498|564556089|FG001|Period: Period 2|Physician Decision|0|||
156399646|NCT00676130|564556096|FG000|Overall Study|Lost to Follow-up|0|||
156399647|NCT00676130|564556097|FG001|Overall Study|Lost to Follow-up|1|||
156399648|NCT00676130|564556096|FG000|Overall Study|Found ineligible|3|||
156399649|NCT00676130|564556097|FG001|Overall Study|Found ineligible|2|||
156399650|NCT00676130|564556096|FG000|Overall Study|Withdrawal by Subject|0|||
156399651|NCT00676130|564556097|FG001|Overall Study|Withdrawal by Subject|1|||
156399652|NCT01564368|564556098|FG000|Overall Study|Ineligible|18|||
156399653|NCT01564368|564556098|FG000|Overall Study|Not Randomized in Parent study|116|||
156399654|NCT01564368|564556098|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
156399655|NCT01564368|564556098|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
156399656|NCT01802437|564556099|FG000|Overall Study|Lost to Follow-up|1|||
156399657|NCT01802437|564556100|FG001|Overall Study|Lost to Follow-up|0|||
156399658|NCT01802437|564556099|FG000|Overall Study|Withdrawal by Subject|3|||
156399659|NCT01802437|564556100|FG001|Overall Study|Withdrawal by Subject|4|||
156399660|NCT04857034|564556101|FG000|Placebo-Controlled Period|Request to discontinue|2|||
156399661|NCT04857034|564556102|FG001|Placebo-Controlled Period|Request to discontinue|2|||
156399662|NCT04857034|564556103|FG002|Placebo-Controlled Period|Request to discontinue|0|||
156399663|NCT04857034|564556104|FG003|Placebo-Controlled Period|Request to discontinue|0|||
156399664|NCT04857034|564556105|FG004|Placebo-Controlled Period|Request to discontinue|0|||
156399665|NCT04857034|564556101|FG000|Placebo-Controlled Period|withdrew consent|1|||
156399666|NCT04857034|564556102|FG001|Placebo-Controlled Period|withdrew consent|1|||
156399667|NCT04857034|564556103|FG002|Placebo-Controlled Period|withdrew consent|2|||
156399668|NCT04857034|564556104|FG003|Placebo-Controlled Period|withdrew consent|0|||
156399669|NCT04857034|564556105|FG004|Placebo-Controlled Period|withdrew consent|0|||
156399670|NCT04857034|564556101|FG000|Placebo-Controlled Period|Pregnancy|1|||
156399671|NCT04857034|564556102|FG001|Placebo-Controlled Period|Pregnancy|1|||
156399672|NCT04857034|564556103|FG002|Placebo-Controlled Period|Pregnancy|0|||
156399673|NCT04857034|564556104|FG003|Placebo-Controlled Period|Pregnancy|0|||
156399674|NCT04857034|564556105|FG004|Placebo-Controlled Period|Pregnancy|0|||
156399675|NCT04857034|564556101|FG000|Placebo-Controlled Period|Ongoing study period|0|||
156399676|NCT04857034|564556102|FG001|Placebo-Controlled Period|Ongoing study period|1|||
156399677|NCT04857034|564556103|FG002|Placebo-Controlled Period|Ongoing study period|0|||
156399678|NCT04857034|564556104|FG003|Placebo-Controlled Period|Ongoing study period|0|||
156399679|NCT04857034|564556105|FG004|Placebo-Controlled Period|Ongoing study period|0|||
156399680|NCT04857034|564556101|FG000|Active Treatment Period|Lack of Efficacy|1|||
156399681|NCT04857034|564556102|FG001|Active Treatment Period|Lack of Efficacy|0|||
156399682|NCT04857034|564556103|FG002|Active Treatment Period|Lack of Efficacy|0|||
156399683|NCT04857034|564556104|FG003|Active Treatment Period|Lack of Efficacy|0|||
156399684|NCT04857034|564556105|FG004|Active Treatment Period|Lack of Efficacy|0|||
156399685|NCT04857034|564556101|FG000|Active Treatment Period|request to discontinue|0|||
156399686|NCT04857034|564556102|FG001|Active Treatment Period|request to discontinue|1|||
156399687|NCT04857034|564556103|FG002|Active Treatment Period|request to discontinue|0|||
156399688|NCT04857034|564556104|FG003|Active Treatment Period|request to discontinue|1|||
156399689|NCT04857034|564556105|FG004|Active Treatment Period|request to discontinue|0|||
156399690|NCT04857034|564556101|FG000|Active Treatment Period|administrative reason by sponsor|1|||
156399691|NCT04857034|564556102|FG001|Active Treatment Period|administrative reason by sponsor|5|||
156399692|NCT04857034|564556103|FG002|Active Treatment Period|administrative reason by sponsor|0|||
156399693|NCT04857034|564556104|FG003|Active Treatment Period|administrative reason by sponsor|2|||
156399694|NCT04857034|564556105|FG004|Active Treatment Period|administrative reason by sponsor|2|||
156399695|NCT04857034|564556101|FG000|Active Treatment Period|other reasons|1|||
156399696|NCT04857034|564556102|FG001|Active Treatment Period|other reasons|1|||
156399697|NCT04857034|564556103|FG002|Active Treatment Period|other reasons|0|||
156399698|NCT04857034|564556104|FG003|Active Treatment Period|other reasons|0|||
156399699|NCT04857034|564556105|FG004|Active Treatment Period|other reasons|1|||
156399700|NCT04857034|564556101|FG000|Active Treatment Period|Ongoing Study Period|2|||
156399701|NCT04857034|564556102|FG001|Active Treatment Period|Ongoing Study Period|4|||
156399702|NCT04857034|564556103|FG002|Active Treatment Period|Ongoing Study Period|0|||
156399703|NCT04857034|564556104|FG003|Active Treatment Period|Ongoing Study Period|1|||
156399704|NCT04857034|564556105|FG004|Active Treatment Period|Ongoing Study Period|0|||
156399705|NCT01682213|564556108|FG000|Overall Study|Withdrawal by Subject|2|||
156399706|NCT01181726|564556109|FG000|First Intervention|Adverse Event|1|||
156399707|NCT01181726|564556110|FG001|First Intervention|Adverse Event|0|||
156399708|NCT04998604|564556111|FG000|Overall Study|Adverse Event|3|||
156399709|NCT04998604|564556112|FG001|Overall Study|Adverse Event|2|||
156399710|NCT04998604|564556111|FG000|Overall Study|Withdrawal by Subject|2|||
156399711|NCT04998604|564556112|FG001|Overall Study|Withdrawal by Subject|4|||
156399712|NCT04998604|564556111|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
156399713|NCT04998604|564556112|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
156399714|NCT00429663|564556113|FG000|Overall Study|Lost to Follow-up|24|||
156399715|NCT00429663|564556114|FG001|Overall Study|Lost to Follow-up|31|||
156399716|NCT00429663|564556113|FG000|Overall Study|Physician Decision|6|||
156399717|NCT00429663|564556114|FG001|Overall Study|Physician Decision|3|||
156399718|NCT00429663|564556113|FG000|Overall Study|Withdrawal by Subject|2|||
156399719|NCT00429663|564556114|FG001|Overall Study|Withdrawal by Subject|5|||
156399720|NCT00429663|564556113|FG000|Overall Study|Death|4|||
156399721|NCT00429663|564556114|FG001|Overall Study|Death|0|||
156399722|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
156399723|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
156399724|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
156399725|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
156399726|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
156399727|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
156399728|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
156399729|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
156399730|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
156399731|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
156399732|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
156399733|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
156399734|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
156399735|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
156399736|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
156399737|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
156399738|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
156399739|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156399740|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156399741|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156399742|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Death|2|||
156399743|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Death|2|||
156399744|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Death|0|||
156399745|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Death|0|||
156399746|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Death|0|||
156399747|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
156399748|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
156399749|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
156399750|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
156399751|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
156399752|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
156399753|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
156399754|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
156399755|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
156399756|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
156399757|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
156399758|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
156399759|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
156399760|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
156399761|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
156399762|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
156399763|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
156399764|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
156399765|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
156399766|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
156399767|NCT03420781|564556115|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
156399768|NCT03420781|564556116|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
156399769|NCT03420781|564556117|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
156399770|NCT03420781|564556118|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
156399771|NCT03420781|564556119|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
156399772|NCT03420781|564556115|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
156399773|NCT03420781|564556116|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
156399774|NCT03420781|564556117|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
156399775|NCT03420781|564556118|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
156399776|NCT03420781|564556119|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
156399777|NCT03420781|564556115|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
156399778|NCT03420781|564556116|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
156399779|NCT03420781|564556117|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
156399780|NCT03420781|564556118|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
156399781|NCT03420781|564556119|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
156399782|NCT03420781|564556115|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
156399783|NCT03420781|564556116|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
156399784|NCT03420781|564556117|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
156399785|NCT03420781|564556118|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
156399786|NCT03420781|564556119|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
156399787|NCT02696564|564556120|FG000|Overall Study|Death|1|||
156399788|NCT02696564|564556121|FG001|Overall Study|Death|2|||
156399789|NCT02696564|564556120|FG000|Overall Study|Withdrawal by Subject|3|||
156399790|NCT02696564|564556121|FG001|Overall Study|Withdrawal by Subject|2|||
156399791|NCT02696564|564556120|FG000|Overall Study|Lost to Follow-up|3|||
156399792|NCT02696564|564556121|FG001|Overall Study|Lost to Follow-up|3|||
156399793|NCT02696564|564556120|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
156399794|NCT02696564|564556121|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
156399795|NCT02696564|564556120|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
156399796|NCT02696564|564556121|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
156399797|NCT02696564|564556120|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
156399798|NCT02696564|564556121|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
156399799|NCT02696564|564556120|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
156399800|NCT02696564|564556121|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
156399801|NCT02696564|564556120|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
156399802|NCT02696564|564556121|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
156399803|NCT04067401|564556122|FG000|Overall Study|Withdrawal by Subject|7|||
156399804|NCT04067401|564556123|FG001|Overall Study|Withdrawal by Subject|0|||
156399805|NCT04067401|564556122|FG000|Overall Study|no data provided|1|||
156399806|NCT04067401|564556123|FG001|Overall Study|no data provided|0|||
156399807|NCT03633929|564556124|FG000|Overall Study|Lost to Follow-up|1|||
156399808|NCT03633929|564556124|FG000|Overall Study|Did not login to software. Did not participate|3|||
156399809|NCT00106184|564556125|FG000|Overall Study|Withdrawal by Subject|3|||
156399810|NCT00106184|564556126|FG001|Overall Study|Withdrawal by Subject|2|||
156399811|NCT01722162|564556127|FG000|Overall Study|Withdrawal by Subject|1|||
156399812|NCT01722162|564556128|FG001|Overall Study|Withdrawal by Subject|1|||
156399813|NCT01722162|564556127|FG000|Overall Study|Found ineligible|1|||
156399814|NCT01722162|564556128|FG001|Overall Study|Found ineligible|0|||
156399815|NCT01722162|564556127|FG000|Overall Study|Unrelated to study adverse event|2|||
156399816|NCT01722162|564556128|FG001|Overall Study|Unrelated to study adverse event|2|||
156399817|NCT01722162|564556127|FG000|Overall Study|Adverse Event|1|||
156399818|NCT01722162|564556128|FG001|Overall Study|Adverse Event|1|||
156399819|NCT01722162|564556127|FG000|Overall Study|Insurance denial post enrollment|0|||
156399820|NCT01722162|564556128|FG001|Overall Study|Insurance denial post enrollment|1|||
156399821|NCT01722162|564556127|FG000|Overall Study|Noncompliance|0|||
156399822|NCT01722162|564556128|FG001|Overall Study|Noncompliance|1|||
156399823|NCT02857426|564556130|FG000|Overall Study|Disease progression|34|||
156399824|NCT02857426|564556131|FG001|Overall Study|Disease progression|13|||
156399825|NCT02857426|564556130|FG000|Overall Study|Study drug toxicity|4|||
156399826|NCT02857426|564556131|FG001|Overall Study|Study drug toxicity|1|||
156399827|NCT02857426|564556130|FG000|Overall Study|Death|1|||
156399828|NCT02857426|564556131|FG001|Overall Study|Death|0|||
156399829|NCT02857426|564556130|FG000|Overall Study|Adverse event unrelated to study drug|6|||
156399830|NCT02857426|564556131|FG001|Overall Study|Adverse event unrelated to study drug|2|||
156399831|NCT02857426|564556130|FG000|Overall Study|Participant withdrew consent|1|||
156399832|NCT02857426|564556131|FG001|Overall Study|Participant withdrew consent|1|||
156399833|NCT02857426|564556130|FG000|Overall Study|Maximum clinical benefit|1|||
156399834|NCT02857426|564556131|FG001|Overall Study|Maximum clinical benefit|0|||
156399835|NCT02857426|564556130|FG000|Overall Study|Completed treatment|0|||
156399836|NCT02857426|564556131|FG001|Overall Study|Completed treatment|2|||
156399837|NCT02110901|564556132|FG000|Overall Study|Death|6|||
156399838|NCT02110901|564556133|FG001|Overall Study|Death|3|||
156399839|NCT02110901|564556132|FG000|Overall Study|Lost to Follow-up|12|||
156399840|NCT02110901|564556133|FG001|Overall Study|Lost to Follow-up|8|||
156399841|NCT02110901|564556132|FG000|Overall Study|Withdrawal by Subject|7|||
156399842|NCT02110901|564556133|FG001|Overall Study|Withdrawal by Subject|3|||
156399843|NCT02110901|564556132|FG000|Overall Study|received a kidney transplant|5|||
156399844|NCT02110901|564556133|FG001|Overall Study|received a kidney transplant|0|||
156399845|NCT00855595|564556135|FG000|Overall Study|Withdrawal by Subject|1|||
156399846|NCT00855595|564556136|FG001|Overall Study|Withdrawal by Subject|2|||
156399847|NCT00855595|564556135|FG000|Overall Study|Lost to Follow-up|3|||
156399848|NCT00855595|564556136|FG001|Overall Study|Lost to Follow-up|3|||
156399849|NCT00855595|564556135|FG000|Overall Study|Adverse Event|1|||
156399850|NCT00855595|564556136|FG001|Overall Study|Adverse Event|1|||
156399851|NCT00855595|564556135|FG000|Overall Study|patient moved out of state|1|||
156399852|NCT00855595|564556136|FG001|Overall Study|patient moved out of state|0|||
156399853|NCT00855595|564556135|FG000|Overall Study|patient left country|0|||
156399854|NCT00855595|564556136|FG001|Overall Study|patient left country|1|||
156399855|NCT00701038|564556142|FG000|Overall Study|study amended pilot group of patients|4|||
156399856|NCT00701038|564556143|FG001|Overall Study|study amended pilot group of patients|4|||
156399857|NCT03988166|564556147|FG000|Overall Study|Lost to Follow-up|2|||
156399858|NCT03988166|564556147|FG000|Overall Study|Death|1|||
156399859|NCT02703922|564556149|FG000|Overall Study|Death|5|||
156399860|NCT02703922|564556150|FG001|Overall Study|Death|8|||
156399861|NCT02703922|564556149|FG000|Overall Study|Lost to Follow-up|10|||
156399862|NCT02703922|564556150|FG001|Overall Study|Lost to Follow-up|10|||
156399863|NCT05805657|564556157|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
156399864|NCT05805657|564556158|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
156399865|NCT04058353|564556159|FG000|Overall Study|Adverse Event|2|||
156399866|NCT04058353|564556160|FG001|Overall Study|Adverse Event|1|||
156399867|NCT04058353|564556159|FG000|Overall Study|Physician Decision|1|||
156399868|NCT04058353|564556160|FG001|Overall Study|Physician Decision|0|||
156399869|NCT04058353|564556159|FG000|Overall Study|Other|1|||
156399870|NCT04058353|564556160|FG001|Overall Study|Other|0|||
156399871|NCT00316173|564556164|FG000|Run-in Phase|Adverse Event|1|||
156399872|NCT00316173|564556165|FG001|Run-in Phase|Adverse Event|0|||
156399873|NCT00316173|564556164|FG000|Run-in Phase|Protocol Violation|1|||
156399874|NCT00316173|564556165|FG001|Run-in Phase|Protocol Violation|0|||
156399875|NCT00316173|564556164|FG000|Run-in Phase|Study Follow-up Stopped|5|||
156399876|NCT00316173|564556165|FG001|Run-in Phase|Study Follow-up Stopped|0|||
156399877|NCT00316173|564556164|FG000|Treatment Phase|Adverse Event|0|||
156399878|NCT00316173|564556165|FG001|Treatment Phase|Adverse Event|1|||
156399879|NCT00316173|564556164|FG000|Treatment Phase|Lack of Efficacy|0|||
156399880|NCT00316173|564556165|FG001|Treatment Phase|Lack of Efficacy|3|||
156399881|NCT00316173|564556164|FG000|Treatment Phase|Lost to Follow-up|0|||
156399882|NCT00316173|564556165|FG001|Treatment Phase|Lost to Follow-up|3|||
156399883|NCT00316173|564556164|FG000|Treatment Phase|Withdrawal by Subject|0|||
156399884|NCT00316173|564556165|FG001|Treatment Phase|Withdrawal by Subject|1|||
156399885|NCT00316173|564556164|FG000|Treatment Phase|Study Follow-up Stopped|0|||
156399886|NCT00316173|564556165|FG001|Treatment Phase|Study Follow-up Stopped|34|||
156399887|NCT02390531|564556166|FG000|Overall Study|Death|0|||
156399888|NCT02390531|564556167|FG001|Overall Study|Death|2|||
156399889|NCT02390531|564556168|FG002|Overall Study|Death|0|||
156399890|NCT02390531|564556169|FG003|Overall Study|Death|1|||
156399891|NCT02390531|564556170|FG004|Overall Study|Death|0|||
156399892|NCT02390531|564556171|FG005|Overall Study|Death|0|||
156399893|NCT02390531|564556172|FG006|Overall Study|Death|0|||
156399894|NCT02390531|564556173|FG007|Overall Study|Death|1|||
156399895|NCT02390531|564556166|FG000|Overall Study|Protocol Violation|0|||
156399896|NCT02390531|564556167|FG001|Overall Study|Protocol Violation|0|||
156399897|NCT02390531|564556168|FG002|Overall Study|Protocol Violation|0|||
156399898|NCT02390531|564556169|FG003|Overall Study|Protocol Violation|0|||
156399899|NCT02390531|564556170|FG004|Overall Study|Protocol Violation|1|||
156399900|NCT02390531|564556171|FG005|Overall Study|Protocol Violation|0|||
156399901|NCT02390531|564556172|FG006|Overall Study|Protocol Violation|2|||
156399902|NCT02390531|564556173|FG007|Overall Study|Protocol Violation|0|||
156399903|NCT01951638|564556177|FG000|Treatment Period|Protocol Violation|0|||
156399904|NCT01951638|564556178|FG001|Treatment Period|Protocol Violation|0|||
156399905|NCT01951638|564556179|FG002|Treatment Period|Protocol Violation|0|||
156399906|NCT01951638|564556180|FG003|Treatment Period|Protocol Violation|2|||
156399907|NCT01951638|564556181|FG004|Treatment Period|Protocol Violation|0|||
156399908|NCT01951638|564556177|FG000|Treatment Period|Protocol-driven decision point|1|||
156399909|NCT01951638|564556178|FG001|Treatment Period|Protocol-driven decision point|3|||
156399910|NCT01951638|564556179|FG002|Treatment Period|Protocol-driven decision point|0|||
156399911|NCT01951638|564556180|FG003|Treatment Period|Protocol-driven decision point|0|||
156399912|NCT01951638|564556181|FG004|Treatment Period|Protocol-driven decision point|0|||
156399913|NCT01951638|564556177|FG000|Treatment Period|Logistical difficulties|0|||
156399914|NCT01951638|564556178|FG001|Treatment Period|Logistical difficulties|1|||
156399915|NCT01951638|564556179|FG002|Treatment Period|Logistical difficulties|1|||
156399916|NCT01951638|564556180|FG003|Treatment Period|Logistical difficulties|0|||
156399917|NCT01951638|564556181|FG004|Treatment Period|Logistical difficulties|0|||
156399918|NCT01951638|564556177|FG000|Treatment Period|Withdrawal by Subject|9|||
156399919|NCT01951638|564556178|FG001|Treatment Period|Withdrawal by Subject|6|||
156399920|NCT01951638|564556179|FG002|Treatment Period|Withdrawal by Subject|4|||
156399921|NCT01951638|564556180|FG003|Treatment Period|Withdrawal by Subject|5|||
156399922|NCT01951638|564556181|FG004|Treatment Period|Withdrawal by Subject|4|||
156399923|NCT01951638|564556177|FG000|Treatment Period|Death|0|||
156399924|NCT01951638|564556178|FG001|Treatment Period|Death|0|||
156399925|NCT01951638|564556179|FG002|Treatment Period|Death|0|||
156399926|NCT01951638|564556180|FG003|Treatment Period|Death|3|||
156399927|NCT01951638|564556181|FG004|Treatment Period|Death|1|||
156399928|NCT01951638|564556177|FG000|Treatment Period|Adverse Event|3|||
156399929|NCT01951638|564556178|FG001|Treatment Period|Adverse Event|4|||
156399930|NCT01951638|564556179|FG002|Treatment Period|Adverse Event|8|||
156399931|NCT01951638|564556180|FG003|Treatment Period|Adverse Event|6|||
156399932|NCT01951638|564556181|FG004|Treatment Period|Adverse Event|5|||
156399933|NCT01951638|564556177|FG000|Follow-up Period|Protocol Violation|0|||
156399934|NCT01951638|564556178|FG001|Follow-up Period|Protocol Violation|0|||
156399935|NCT01951638|564556179|FG002|Follow-up Period|Protocol Violation|0|||
156399936|NCT01951638|564556180|FG003|Follow-up Period|Protocol Violation|1|||
156399937|NCT01951638|564556181|FG004|Follow-up Period|Protocol Violation|0|||
156399938|NCT01951638|564556177|FG000|Follow-up Period|Logistical difficulties|0|||
156399939|NCT01951638|564556178|FG001|Follow-up Period|Logistical difficulties|2|||
156399940|NCT01951638|564556179|FG002|Follow-up Period|Logistical difficulties|0|||
156399941|NCT01951638|564556180|FG003|Follow-up Period|Logistical difficulties|0|||
156509038|NCT05217641|564955571|FG005|Overall Study|Withdrawal by Subject|0|||
156509039|NCT05217641|564955566|FG000|Overall Study|Other: participant did not specify reason|0|||
156509040|NCT05217641|564955567|FG001|Overall Study|Other: participant did not specify reason|0|||
156509041|NCT05217641|564955568|FG002|Overall Study|Other: participant did not specify reason|0|||
156509042|NCT05217641|564955569|FG003|Overall Study|Other: participant did not specify reason|0|||
156509043|NCT05217641|564955570|FG004|Overall Study|Other: participant did not specify reason|1|||
156509044|NCT05217641|564955571|FG005|Overall Study|Other: participant did not specify reason|0|||
156509045|NCT05217641|564955566|FG000|Overall Study|Extended Follow up|1|||
156509046|NCT05217641|564955567|FG001|Overall Study|Extended Follow up|1|||
156509047|NCT05217641|564955568|FG002|Overall Study|Extended Follow up|0|||
156509048|NCT05217641|564955569|FG003|Overall Study|Extended Follow up|0|||
156509049|NCT05217641|564955570|FG004|Overall Study|Extended Follow up|1|||
156509050|NCT05217641|564955571|FG005|Overall Study|Extended Follow up|0|||
156509051|NCT05292586|564955572|FG000|Overall Study|Withdrawal by Subject|3|||
156509052|NCT05292586|564955573|FG001|Overall Study|Withdrawal by Subject|10|||
156509053|NCT05292586|564955572|FG000|Overall Study|Randomization error|3|||
156509054|NCT05292586|564955573|FG001|Overall Study|Randomization error|7|||
156509055|NCT05292586|564955572|FG000|Overall Study|Adverse Event|3|||
156509056|NCT05292586|564955573|FG001|Overall Study|Adverse Event|0|||
156509057|NCT05292586|564955572|FG000|Overall Study|Lost to Follow-up|0|||
156509058|NCT05292586|564955573|FG001|Overall Study|Lost to Follow-up|1|||
156509059|NCT05292586|564955572|FG000|Overall Study|Patient refused treatment|1|||
156509060|NCT05292586|564955573|FG001|Overall Study|Patient refused treatment|0|||
156509061|NCT05292586|564955572|FG000|Overall Study|Patient could not travel to the study site|1|||
156509062|NCT05292586|564955573|FG001|Overall Study|Patient could not travel to the study site|0|||
156509063|NCT05292586|564955572|FG000|Overall Study|Technical issues with the masterscope|0|||
156509064|NCT05292586|564955573|FG001|Overall Study|Technical issues with the masterscope|3|||
156509065|NCT05292586|564955572|FG000|Overall Study|Patient moved to a different state|0|||
156509066|NCT05292586|564955573|FG001|Overall Study|Patient moved to a different state|1|||
156509067|NCT01040169|564955587|FG000|Overall Study|Lost to Follow-up|3|||
156509068|NCT01040169|564955588|FG001|Overall Study|Lost to Follow-up|8|||
156509069|NCT00350727|564955589|FG000|Phase I: Dose Escalation|Adverse Event|4|||
156509070|NCT00350727|564955590|FG001|Phase I: Dose Escalation|Adverse Event|0|||
156509071|NCT00350727|564955591|FG002|Phase I: Dose Escalation|Adverse Event|0|||
156509072|NCT00350727|564955589|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
156509073|NCT00350727|564955590|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
156509074|NCT00350727|564955591|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
156509075|NCT00350727|564955589|FG000|Phase I: Dose Escalation|Death|1|||
156509076|NCT00350727|564955590|FG001|Phase I: Dose Escalation|Death|0|||
156509077|NCT00350727|564955591|FG002|Phase I: Dose Escalation|Death|0|||
156509078|NCT00350727|564955589|FG000|Phase I: Dose Escalation|Physician Decision|1|||
156509079|NCT00350727|564955590|FG001|Phase I: Dose Escalation|Physician Decision|0|||
156509080|NCT00350727|564955591|FG002|Phase I: Dose Escalation|Physician Decision|0|||
156509081|NCT00350727|564955589|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
156509082|NCT00350727|564955590|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
156509083|NCT00350727|564955591|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
156509084|NCT00350727|564955589|FG000|Phase II|Disease Progression|0|||
156509085|NCT00350727|564955590|FG001|Phase II|Disease Progression|15|||
156509086|NCT00350727|564955591|FG002|Phase II|Disease Progression|16|||
156509087|NCT00350727|564955589|FG000|Phase II|Clinical Deterioration|0|||
156509088|NCT00350727|564955590|FG001|Phase II|Clinical Deterioration|1|||
156509089|NCT00350727|564955591|FG002|Phase II|Clinical Deterioration|0|||
156509090|NCT00350727|564955589|FG000|Phase II|Withdrawal by Subject|0|||
156509091|NCT00350727|564955590|FG001|Phase II|Withdrawal by Subject|2|||
156509092|NCT00350727|564955591|FG002|Phase II|Withdrawal by Subject|1|||
156509093|NCT00350727|564955589|FG000|Phase II|Adverse Event|0|||
156509094|NCT00350727|564955590|FG001|Phase II|Adverse Event|1|||
156509095|NCT00350727|564955591|FG002|Phase II|Adverse Event|1|||
156509096|NCT00350727|564955589|FG000|Phase II|Death|0|||
156509097|NCT00350727|564955590|FG001|Phase II|Death|0|||
156509098|NCT00350727|564955591|FG002|Phase II|Death|2|||
156509099|NCT00350727|564955589|FG000|Phase II|Sponsor Terminated Study|0|||
156509100|NCT00350727|564955590|FG001|Phase II|Sponsor Terminated Study|0|||
156509101|NCT00350727|564955591|FG002|Phase II|Sponsor Terminated Study|1|||
156509102|NCT00350727|564955589|FG000|Phase II|Enrolled in Rollover Study|0|||
156509103|NCT00350727|564955590|FG001|Phase II|Enrolled in Rollover Study|0|||
156509104|NCT00350727|564955591|FG002|Phase II|Enrolled in Rollover Study|1|||
156509105|NCT03633799|564955599|FG000|Overall Study|Adverse Event|349|||
156509106|NCT03633799|564955599|FG000|Overall Study|Withdrawal by Subject|288|||
156509107|NCT03633799|564955599|FG000|Overall Study|Lost to Follow-up|97|||
156509108|NCT03633799|564955599|FG000|Overall Study|Physician Decision|9|||
156509109|NCT03633799|564955599|FG000|Overall Study|Protocol Violation|4|||
156509110|NCT03633799|564955599|FG000|Overall Study|Pregnancy|20|||
156509111|NCT03633799|564955599|FG000|Overall Study|other|39|||
156509112|NCT03633799|564955599|FG000|Overall Study|ongoing within third year of study|106|||
156509113|NCT03633799|564955599|FG000|Overall Study|unsuccessful study drug placement|19|||
156509114|NCT02477618|564955600|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
156509115|NCT02477618|564955601|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
156509116|NCT02477618|564955600|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
156509117|NCT02477618|564955601|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
156509118|NCT02477618|564955600|FG000|Overall Study|Adverse Event|1|||
156509119|NCT02477618|564955601|FG001|Overall Study|Adverse Event|1|||
156509120|NCT02477618|564955600|FG000|Overall Study|Transferred Away from Study Site|1|||
156509121|NCT02477618|564955601|FG001|Overall Study|Transferred Away from Study Site|0|||
156509122|NCT02477618|564955600|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
156509123|NCT02477618|564955601|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
156509124|NCT02446821|564955602|FG000|Overall Study|Adverse Event|28|||
156509125|NCT02446821|564955602|FG000|Overall Study|Withdrawal by Subject|6|||
156509126|NCT02446821|564955602|FG000|Overall Study|Lost to Follow-up|22|||
156509127|NCT02446821|564955602|FG000|Overall Study|other|9|||
156509128|NCT02446821|564955602|FG000|Overall Study|insertion failure|3|||
156509129|NCT03007420|564955603|FG000|Overall Study|Withdrawal by Subject|0|||
156509130|NCT03007420|564955604|FG001|Overall Study|Withdrawal by Subject|2|||
156509131|NCT03007420|564955603|FG000|Overall Study|Physician Decision|0|||
156509132|NCT03007420|564955604|FG001|Overall Study|Physician Decision|1|||
156509133|NCT02284009|564955608|FG000|Overall Study|Adverse Event|3|||
156509134|NCT02284009|564955609|FG001|Overall Study|Adverse Event|0|||
156509135|NCT02284009|564955608|FG000|Overall Study|Lost to Follow-up|1|||
156509136|NCT02284009|564955609|FG001|Overall Study|Lost to Follow-up|3|||
156509137|NCT02284009|564955608|FG000|Overall Study|Physician Decision|0|||
156549629|NCT00264004|565103687|FG000|Overall Study|Not treated|3|||
156549630|NCT00264004|565103688|FG001|Overall Study|Not treated|0|||
156549631|NCT00264004|565103689|FG002|Overall Study|Not treated|2|||
156399942|NCT01951638|564556181|FG004|Follow-up Period|Logistical difficulties|1|||
156399943|NCT01951638|564556177|FG000|Follow-up Period|Withdrawal by Subject|1|||
156399944|NCT01951638|564556178|FG001|Follow-up Period|Withdrawal by Subject|5|||
156399945|NCT01951638|564556179|FG002|Follow-up Period|Withdrawal by Subject|2|||
156399946|NCT01951638|564556180|FG003|Follow-up Period|Withdrawal by Subject|1|||
156399947|NCT01951638|564556181|FG004|Follow-up Period|Withdrawal by Subject|2|||
156399948|NCT01951638|564556177|FG000|Follow-up Period|Lost to Follow-up|0|||
156399949|NCT01951638|564556178|FG001|Follow-up Period|Lost to Follow-up|1|||
156399950|NCT01951638|564556179|FG002|Follow-up Period|Lost to Follow-up|0|||
156399951|NCT01951638|564556180|FG003|Follow-up Period|Lost to Follow-up|1|||
156399952|NCT01951638|564556181|FG004|Follow-up Period|Lost to Follow-up|0|||
156399953|NCT01951638|564556177|FG000|Follow-up Period|Death|1|||
156399954|NCT01951638|564556178|FG001|Follow-up Period|Death|0|||
156399955|NCT01951638|564556179|FG002|Follow-up Period|Death|1|||
156399956|NCT01951638|564556180|FG003|Follow-up Period|Death|4|||
156399957|NCT01951638|564556181|FG004|Follow-up Period|Death|1|||
156399958|NCT01951638|564556177|FG000|Follow-up Period|Adverse Event|0|||
156399959|NCT01951638|564556178|FG001|Follow-up Period|Adverse Event|1|||
156399960|NCT01951638|564556179|FG002|Follow-up Period|Adverse Event|2|||
156399961|NCT01951638|564556180|FG003|Follow-up Period|Adverse Event|1|||
156399962|NCT01951638|564556181|FG004|Follow-up Period|Adverse Event|1|||
156399963|NCT03764072|564556182|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156399964|NCT03764072|564556183|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156399965|NCT03764072|564556184|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
156399966|NCT03764072|564556185|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156399967|NCT03764072|564556186|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156399968|NCT03764072|564556187|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156399969|NCT03764072|564556182|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
156399970|NCT03764072|564556183|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
156399971|NCT03764072|564556184|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
156399972|NCT03764072|564556185|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
156399973|NCT03764072|564556186|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
156399974|NCT03764072|564556187|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
156399975|NCT03764072|564556182|FG000|Overall Study|Lost to Follow-up|0|||
156399976|NCT03764072|564556183|FG001|Overall Study|Lost to Follow-up|0|||
156399977|NCT03764072|564556184|FG002|Overall Study|Lost to Follow-up|0|||
156399978|NCT03764072|564556185|FG003|Overall Study|Lost to Follow-up|0|||
156399979|NCT03764072|564556186|FG004|Overall Study|Lost to Follow-up|1|||
156399980|NCT03764072|564556187|FG005|Overall Study|Lost to Follow-up|0|||
156399981|NCT00552084|564556188|FG000|Overall Study|Adverse Event|2|||
156399982|NCT00552084|564556189|FG001|Overall Study|Adverse Event|3|||
156399983|NCT00552084|564556188|FG000|Overall Study|Withdrawal by Subject|4|||
156399984|NCT00552084|564556189|FG001|Overall Study|Withdrawal by Subject|5|||
156399985|NCT00552084|564556188|FG000|Overall Study|Protocol Violation|1|||
156399986|NCT00552084|564556189|FG001|Overall Study|Protocol Violation|0|||
156399987|NCT00552084|564556188|FG000|Overall Study|change in anti-arrythmic drug|1|||
156399988|NCT00552084|564556189|FG001|Overall Study|change in anti-arrythmic drug|1|||
156399989|NCT01338025|564556190|FG000|Overall Study|Unexpected closure of study|10|||
156399990|NCT01338025|564556191|FG001|Overall Study|Unexpected closure of study|9|||
156399991|NCT01338025|564556190|FG000|Overall Study|Withdrawal by Subject|0|||
156399992|NCT01338025|564556191|FG001|Overall Study|Withdrawal by Subject|2|||
156399993|NCT01338025|564556190|FG000|Overall Study|Found ineligible after starting|1|||
156399994|NCT01338025|564556191|FG001|Overall Study|Found ineligible after starting|0|||
156399995|NCT02286089|564556194|FG000|Overall Study|Ongoing in Study|1|||
156399996|NCT02286089|564556195|FG001|Overall Study|Ongoing in Study|1|||
156399997|NCT02286089|564556196|FG002|Overall Study|Ongoing in Study|4|||
156399998|NCT02286089|564556197|FG003|Overall Study|Ongoing in Study|10|||
156399999|NCT02286089|564556194|FG000|Overall Study|Withdrawal by Subject|0|||
156400000|NCT02286089|564556195|FG001|Overall Study|Withdrawal by Subject|0|||
156400001|NCT02286089|564556196|FG002|Overall Study|Withdrawal by Subject|2|||
156400002|NCT02286089|564556197|FG003|Overall Study|Withdrawal by Subject|2|||
156400003|NCT05073133|564556199|FG000|Overall Study|Death|2|||
156400004|NCT05002218|564556203|FG000|Overall Study|Lost to Follow-up|5|||
156400005|NCT05002218|564556204|FG001|Overall Study|Lost to Follow-up|6|||
156400006|NCT03779906|564556205|FG000|Overall Study|Lost to Follow-up|7|||
156400007|NCT03779906|564556205|FG000|Overall Study|COVID pandemic|1|||
156400008|NCT03308825|564558271|FG000|Overall Study|Lost to Follow-up|2|||
156400009|NCT03308825|564558272|FG001|Overall Study|Lost to Follow-up|2|||
156400010|NCT03308825|564558273|FG002|Overall Study|Lost to Follow-up|1|||
156400011|NCT03308825|564558274|FG003|Overall Study|Lost to Follow-up|0|||
156400012|NCT03308825|564558271|FG000|Overall Study|Protocol Violation|0|||
156400013|NCT03308825|564558272|FG001|Overall Study|Protocol Violation|2|||
156400014|NCT03308825|564558273|FG002|Overall Study|Protocol Violation|0|||
156400015|NCT03308825|564558274|FG003|Overall Study|Protocol Violation|0|||
156400016|NCT01679236|564558276|FG000|Overall Study|Lost to Follow-up|15|||
156400017|NCT01679236|564558277|FG001|Overall Study|Lost to Follow-up|15|||
156400018|NCT01529008|564558283|FG000|Bone Marrow Harvesting|Physician Decision|1|||
156400019|NCT01529008|564558284|FG001|Bone Marrow Harvesting|Physician Decision|1|||
156400020|NCT01529008|564558283|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
156400021|NCT01529008|564558284|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
156400022|NCT01529008|564558283|FG000|Treatment|Adverse Event|6|||
156509138|NCT02284009|564955609|FG001|Overall Study|Physician Decision|2|||
156509139|NCT02284009|564955608|FG000|Overall Study|Withdrawal by Subject|2|||
156509140|NCT02284009|564955609|FG001|Overall Study|Withdrawal by Subject|5|||
156509141|NCT03841526|564955610|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
156509142|NCT03841526|564955611|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
156509143|NCT03841526|564955612|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
156509144|NCT03841526|564955613|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
156509145|NCT03841526|564955614|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
156509146|NCT03841526|564955615|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
156509147|NCT03841526|564955610|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
156509148|NCT03841526|564955611|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
156509149|NCT03841526|564955612|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
156509150|NCT03841526|564955613|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
156509151|NCT03841526|564955614|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
156509152|NCT03841526|564955615|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
156509153|NCT03841526|564955610|FG000|Outpatient Phase Treatment|Physician Decision|0|||
156509154|NCT03841526|564955611|FG001|Outpatient Phase Treatment|Physician Decision|1|||
156509155|NCT03841526|564955612|FG002|Outpatient Phase Treatment|Physician Decision|0|||
156509156|NCT03841526|564955613|FG003|Outpatient Phase Treatment|Physician Decision|0|||
156509157|NCT03841526|564955614|FG004|Outpatient Phase Treatment|Physician Decision|0|||
156509158|NCT03841526|564955615|FG005|Outpatient Phase Treatment|Physician Decision|0|||
156509159|NCT03841526|564955610|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
156509160|NCT03841526|564955611|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
156509161|NCT03841526|564955612|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
156509162|NCT03841526|564955613|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
156509163|NCT03841526|564955614|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
156509164|NCT03841526|564955615|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
156509165|NCT01435772|564955617|FG000|Overall Study|Adverse Event|1|||
156509166|NCT01435772|564955618|FG001|Overall Study|Adverse Event|0|||
156509167|NCT01435772|564955619|FG002|Overall Study|Adverse Event|2|||
156509168|NCT01435772|564955617|FG000|Overall Study|Withdrawal by Subject|0|||
156509169|NCT01435772|564955618|FG001|Overall Study|Withdrawal by Subject|1|||
156509170|NCT01435772|564955619|FG002|Overall Study|Withdrawal by Subject|3|||
156509171|NCT01435772|564955617|FG000|Overall Study|Other - study termination|2|||
156509172|NCT01435772|564955618|FG001|Overall Study|Other - study termination|2|||
156509173|NCT01435772|564955619|FG002|Overall Study|Other - study termination|10|||
156509174|NCT03238963|564955620|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
156509175|NCT03238963|564955621|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
156509176|NCT03238963|564955620|FG000|Overall Study|Withdrawal by Subject|1|||
156509177|NCT03238963|564955621|FG001|Overall Study|Withdrawal by Subject|1|||
156509178|NCT03238963|564955620|FG000|Overall Study|Lost to Follow-up|1|||
156509179|NCT03238963|564955621|FG001|Overall Study|Lost to Follow-up|0|||
156509180|NCT03238963|564955620|FG000|Overall Study|Protocol Violation|1|||
156509181|NCT03238963|564955621|FG001|Overall Study|Protocol Violation|1|||
156509182|NCT03238963|564955620|FG000|Overall Study|Adverse Event|1|||
156509183|NCT03238963|564955621|FG001|Overall Study|Adverse Event|0|||
156509184|NCT07149155|564955625|FG000|Overall Study|Lost to Follow-up|10|||
156509185|NCT01123070|564957486|FG000|Part B Double Blind Period|Protocol Violation|0|||
156509186|NCT01123070|564957487|FG001|Part B Double Blind Period|Protocol Violation|0|||
156509187|NCT01123070|564957488|FG002|Part B Double Blind Period|Protocol Violation|0|||
156509188|NCT01123070|564957489|FG003|Part B Double Blind Period|Protocol Violation|1|||
156509189|NCT01123070|564957486|FG000|Part B Double Blind Period|Adverse Event|0|||
156509190|NCT01123070|564957487|FG001|Part B Double Blind Period|Adverse Event|0|||
156549632|NCT00264004|565103690|FG003|Overall Study|Not treated|2|||
156549633|NCT00820898|565103697|FG000|Overall Study|Inelgible - wrong primary site|1|||
156400023|NCT01529008|564558284|FG001|Treatment|Adverse Event|0|||
156400024|NCT01529008|564558283|FG000|Treatment|Other|3|||
156400025|NCT01529008|564558284|FG001|Treatment|Other|1|||
156509191|NCT01123070|564957488|FG002|Part B Double Blind Period|Adverse Event|2|||
156509192|NCT01123070|564957489|FG003|Part B Double Blind Period|Adverse Event|0|||
156509193|NCT01123070|564957486|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
156509194|NCT01123070|564957487|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
156509195|NCT01123070|564957488|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
156509196|NCT01123070|564957489|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
156509197|NCT04942366|564957490|FG000|Overall Study|Withdrawal by Subject|5|||
156400026|NCT01529008|564558283|FG000|Efficacy Analysis|Protocol Violation|2|||
156400027|NCT01529008|564558284|FG001|Efficacy Analysis|Protocol Violation|0|||
156400028|NCT01529008|564558283|FG000|Efficacy Analysis|Physician Decision|0|||
156400029|NCT01529008|564558284|FG001|Efficacy Analysis|Physician Decision|1|||
156400030|NCT01529008|564558283|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
156400031|NCT01529008|564558284|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
156400032|NCT04425902|564558285|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
156400033|NCT01191840|564558286|FG000|Overall Study|withdrew consent|2|||
156400034|NCT01191840|564558287|FG001|Overall Study|withdrew consent|1|||
156400035|NCT01191840|564558286|FG000|Overall Study|Subject discontinued treatment|1|||
156400036|NCT01191840|564558287|FG001|Overall Study|Subject discontinued treatment|2|||
156400037|NCT01191840|564558286|FG000|Overall Study|Lost to Follow-up|4|||
156400038|NCT01191840|564558287|FG001|Overall Study|Lost to Follow-up|6|||
156400039|NCT01191840|564558286|FG000|Overall Study|Non Staph Infection|4|||
156400040|NCT01191840|564558287|FG001|Overall Study|Non Staph Infection|3|||
156400041|NCT01191840|564558286|FG000|Overall Study|ineligible at enrollment|1|||
156549634|NCT02921971|565103698|FG000|Overall Study|Adverse Event|1|||
156549635|NCT02921971|565103699|FG001|Overall Study|Adverse Event|2|||
156549636|NCT02921971|565103698|FG000|Overall Study|Lack of Efficacy|3|||
156549637|NCT02921971|565103699|FG001|Overall Study|Lack of Efficacy|1|||
156549638|NCT02921971|565103698|FG000|Overall Study|Other than specified above|2|||
156549639|NCT02921971|565103699|FG001|Overall Study|Other than specified above|1|||
156549640|NCT00452699|565103700|FG000|Overall Study|Adverse Event|10|||
156549641|NCT00452699|565103701|FG001|Overall Study|Adverse Event|3|||
156549642|NCT00452699|565103700|FG000|Overall Study|Lack of Efficacy|6|||
156549643|NCT00452699|565103701|FG001|Overall Study|Lack of Efficacy|4|||
156549644|NCT00452699|565103700|FG000|Overall Study|Lost to Follow-up|6|||
156549645|NCT00452699|565103701|FG001|Overall Study|Lost to Follow-up|9|||
156549646|NCT00452699|565103700|FG000|Overall Study|Protocol Violation|21|||
156549647|NCT00452699|565103701|FG001|Overall Study|Protocol Violation|25|||
156549648|NCT00452699|565103700|FG000|Overall Study|Withdrawal by Subject|26|||
156549649|NCT00452699|565103701|FG001|Overall Study|Withdrawal by Subject|25|||
156549650|NCT00452699|565103700|FG000|Overall Study|Other|12|||
156549651|NCT00452699|565103701|FG001|Overall Study|Other|7|||
156549652|NCT02105454|565103702|FG000|Overall Study|Withdrawal by Subject|1|||
156549653|NCT00326898|565103703|FG000|Overall Study|Disease progression|52|||
156549654|NCT00326898|565103704|FG001|Overall Study|Disease progression|54|||
156549655|NCT00326898|565103705|FG002|Overall Study|Disease progression|102|||
156549656|NCT00326898|565103703|FG000|Overall Study|Adverse Event|124|||
156549657|NCT00326898|565103704|FG001|Overall Study|Adverse Event|128|||
156549658|NCT00326898|565103705|FG002|Overall Study|Adverse Event|33|||
156549659|NCT00326898|565103703|FG000|Overall Study|Death|2|||
156549660|NCT00326898|565103704|FG001|Overall Study|Death|0|||
156549661|NCT00326898|565103705|FG002|Overall Study|Death|0|||
156549662|NCT00326898|565103703|FG000|Overall Study|Withdrawal by Subject|134|||
156549663|NCT00326898|565103704|FG001|Overall Study|Withdrawal by Subject|128|||
156549664|NCT00326898|565103705|FG002|Overall Study|Withdrawal by Subject|32|||
156549665|NCT00326898|565103703|FG000|Overall Study|Alternative therapy|1|||
156549666|NCT00326898|565103704|FG001|Overall Study|Alternative therapy|0|||
156549667|NCT00326898|565103705|FG002|Overall Study|Alternative therapy|0|||
156549668|NCT00326898|565103703|FG000|Overall Study|Other complicating disease|5|||
156549669|NCT00326898|565103704|FG001|Overall Study|Other complicating disease|5|||
156549670|NCT00326898|565103705|FG002|Overall Study|Other complicating disease|4|||
156549671|NCT00326898|565103703|FG000|Overall Study|Other/Missing/Unknown|33|||
156549672|NCT00326898|565103704|FG001|Overall Study|Other/Missing/Unknown|28|||
156549673|NCT00326898|565103705|FG002|Overall Study|Other/Missing/Unknown|32|||
156549674|NCT03847987|565103706|FG000|Overall Study|Lost to Follow-up|1|||
156400042|NCT01191840|564558287|FG001|Overall Study|ineligible at enrollment|0|||
156400043|NCT01191840|564558286|FG000|Overall Study|IRB approval lapse|0|||
156400044|NCT01191840|564558287|FG001|Overall Study|IRB approval lapse|2|||
156549675|NCT03847987|565103707|FG001|Overall Study|Lost to Follow-up|0|||
156549676|NCT03847987|565103706|FG000|Overall Study|Adverse Event|2|||
156549677|NCT03847987|565103707|FG001|Overall Study|Adverse Event|0|||
156549678|NCT02721355|565103708|FG000|Overall Study|Lost to Follow-up|6|||
156549679|NCT02721355|565103709|FG001|Overall Study|Lost to Follow-up|1|||
156549680|NCT00527605|565103714|FG000|Overall Study|Adverse Event|3|||
156549681|NCT00527605|565103715|FG001|Overall Study|Adverse Event|0|||
156549682|NCT00527605|565103714|FG000|Overall Study|Withdrawal by Subject|3|||
156400045|NCT01191840|564558286|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
156549683|NCT00527605|565103715|FG001|Overall Study|Withdrawal by Subject|7|||
156549684|NCT00527605|565103714|FG000|Overall Study|Lost to Follow-up|6|||
156549685|NCT00527605|565103715|FG001|Overall Study|Lost to Follow-up|2|||
156549686|NCT00527605|565103714|FG000|Overall Study|Protocol Violation|1|||
156549687|NCT00527605|565103715|FG001|Overall Study|Protocol Violation|2|||
156549688|NCT01592760|565103721|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
156549689|NCT01592760|565103722|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
156549690|NCT01592760|565103723|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
156400046|NCT01191840|564558287|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
156549691|NCT04312009|565103724|FG000|Overall Study|Withdrawal by Subject|2|||
156549692|NCT04312009|565103725|FG001|Overall Study|Withdrawal by Subject|1|||
156549693|NCT00687362|565103730|FG000|Overall Study|Protocol Violation|2|||
156549694|NCT00687362|565103730|FG000|Overall Study|Withdrawal by Subject|1|||
156549695|NCT05882318|565103735|FG000|Overall Study|Withdrawal by Subject|1|||
156549696|NCT05882318|565103736|FG001|Overall Study|Withdrawal by Subject|0|||
156549697|NCT05882318|565103735|FG000|Overall Study|Protocol Violation|0|||
156549698|NCT05882318|565103736|FG001|Overall Study|Protocol Violation|1|||
156549699|NCT03509350|565103737|FG000|Overall Study|Withdrawal by Subject|0|||
156549700|NCT03509350|565103738|FG001|Overall Study|Withdrawal by Subject|2|||
156549701|NCT01425203|565103739|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
156549702|NCT01425203|565103740|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
156549703|NCT01425203|565103741|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
156549704|NCT01425203|565103739|FG000|Treatment Phase|Failure at futility timepoint|8|||
156549705|NCT01425203|565103740|FG001|Treatment Phase|Failure at futility timepoint|27|||
156549706|NCT01425203|565103741|FG002|Treatment Phase|Failure at futility timepoint|0|||
156549707|NCT01425203|565103739|FG000|Treatment Phase|Other virologic failure criteria|5|||
156549708|NCT01425203|565103740|FG001|Treatment Phase|Other virologic failure criteria|3|||
156549709|NCT01425203|565103741|FG002|Treatment Phase|Other virologic failure criteria|0|||
156549710|NCT01425203|565103739|FG000|Treatment Phase|Unidentified reasons|11|||
156549711|NCT01425203|565103740|FG001|Treatment Phase|Unidentified reasons|5|||
156549712|NCT01425203|565103741|FG002|Treatment Phase|Unidentified reasons|0|||
156549713|NCT01425203|565103739|FG000|Treatment Phase|Did not receive treatment|0|||
156549714|NCT01425203|565103740|FG001|Treatment Phase|Did not receive treatment|1|||
156549715|NCT01425203|565103741|FG002|Treatment Phase|Did not receive treatment|0|||
156549716|NCT01425203|565103739|FG000|Crossover Phase|Failure at futility timepoint|0|||
156549717|NCT01425203|565103740|FG001|Crossover Phase|Failure at futility timepoint|0|||
156549718|NCT01425203|565103741|FG002|Crossover Phase|Failure at futility timepoint|3|||
156549719|NCT01425203|565103739|FG000|Crossover Phase|Other virologic failure criteria|0|||
156549720|NCT01425203|565103740|FG001|Crossover Phase|Other virologic failure criteria|0|||
156549721|NCT01425203|565103741|FG002|Crossover Phase|Other virologic failure criteria|3|||
156549722|NCT00290433|565103744|FG000|Overall Study|Disease Progression|13|||
156549723|NCT00290433|565103744|FG000|Overall Study|Adverse Event|14|||
156549724|NCT00290433|565103744|FG000|Overall Study|Withdrawal by Subject|1|||
156549725|NCT00290433|565103744|FG000|Overall Study|Non-Compliance|1|||
156549726|NCT00290433|565103744|FG000|Overall Study|Congestive Heart Failure|1|||
156549727|NCT00290433|565103744|FG000|Overall Study|Transplant in CR|5|||
156549728|NCT00290433|565103744|FG000|Overall Study|Unrelated Infection/Death|1|||
156549729|NCT01665807|565103747|FG000|Overall Study|Withdrawal by Subject|2|||
156549730|NCT01665807|565103748|FG001|Overall Study|Withdrawal by Subject|0|||
156549731|NCT01665807|565103749|FG002|Overall Study|Withdrawal by Subject|1|||
156549732|NCT00109707|565103750|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
156549733|NCT00109707|565103751|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
156549734|NCT00109707|565103752|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
156549735|NCT00109707|565103750|FG000|Overall Study|Abnormal laboratory values|1|||
156549736|NCT00109707|565103751|FG001|Overall Study|Abnormal laboratory values|0|||
156549737|NCT00109707|565103752|FG002|Overall Study|Abnormal laboratory values|0|||
156549738|NCT00109707|565103750|FG000|Overall Study|Administrative problems|2|||
156549739|NCT00109707|565103751|FG001|Overall Study|Administrative problems|0|||
156549740|NCT00109707|565103752|FG002|Overall Study|Administrative problems|1|||
156549741|NCT00109707|565103750|FG000|Overall Study|Adverse Event|10|||
156549742|NCT00109707|565103751|FG001|Overall Study|Adverse Event|2|||
156549743|NCT00109707|565103752|FG002|Overall Study|Adverse Event|3|||
156549744|NCT00109707|565103750|FG000|Overall Study|Death|4|||
156549745|NCT00109707|565103751|FG001|Overall Study|Death|0|||
156549746|NCT00109707|565103752|FG002|Overall Study|Death|0|||
156549747|NCT00109707|565103750|FG000|Overall Study|Disease progression|12|||
156549748|NCT00109707|565103751|FG001|Overall Study|Disease progression|4|||
156549749|NCT00109707|565103752|FG002|Overall Study|Disease progression|3|||
156549750|NCT00109707|565103750|FG000|Overall Study|Lost to Follow-up|3|||
156549751|NCT00109707|565103751|FG001|Overall Study|Lost to Follow-up|0|||
156549752|NCT00109707|565103752|FG002|Overall Study|Lost to Follow-up|0|||
156549753|NCT00109707|565103750|FG000|Overall Study|Protocol Violation|1|||
156549754|NCT00109707|565103751|FG001|Overall Study|Protocol Violation|0|||
156549755|NCT00109707|565103752|FG002|Overall Study|Protocol Violation|0|||
156549756|NCT00109707|565103750|FG000|Overall Study|Patient withdrew consent|6|||
156549757|NCT00109707|565103751|FG001|Overall Study|Patient withdrew consent|1|||
156400047|NCT01191840|564558286|FG000|Overall Study|Withdrawal by Subject|2|||
156549758|NCT00109707|565103752|FG002|Overall Study|Patient withdrew consent|0|||
156549759|NCT02443883|565103755|FG000|Overall Study|Adverse Event|0|||
156549760|NCT02443883|565103756|FG001|Overall Study|Adverse Event|1|||
156549761|NCT02443883|565103757|FG002|Overall Study|Adverse Event|0|||
156549762|NCT02443883|565103758|FG003|Overall Study|Adverse Event|0|||
156549763|NCT02443883|565103755|FG000|Overall Study|Lost to Follow-up|3|||
156549764|NCT02443883|565103756|FG001|Overall Study|Lost to Follow-up|2|||
156549765|NCT02443883|565103757|FG002|Overall Study|Lost to Follow-up|1|||
156400048|NCT01191840|564558287|FG001|Overall Study|Withdrawal by Subject|0|||
156400049|NCT04669600|564558288|FG000|Overall Study|Withdrawal by Subject|1|||
156400050|NCT04669600|564558288|FG000|Overall Study|Other|6|||
156400051|NCT00331344|564558295|FG000|Phase I|Adverse Event|0|||
156400052|NCT00331344|564558296|FG001|Phase I|Adverse Event|0|||
156400053|NCT00331344|564558297|FG002|Phase I|Adverse Event|0|||
156400054|NCT00331344|564558298|FG003|Phase I|Adverse Event|1|||
156400055|NCT00331344|564558299|FG004|Phase I|Adverse Event|2|||
156400056|NCT00331344|564558300|FG005|Phase I|Adverse Event|2|||
156400057|NCT00331344|564558301|FG006|Phase I|Adverse Event|0|||
156400058|NCT00331344|564558302|FG007|Phase I|Adverse Event|1|||
156400059|NCT00331344|564558303|FG008|Phase I|Adverse Event|0|||
156400060|NCT00331344|564558295|FG000|Phase II|Death|0|||
156400061|NCT00331344|564558296|FG001|Phase II|Death|0|||
156400062|NCT00331344|564558297|FG002|Phase II|Death|0|||
156400063|NCT00331344|564558298|FG003|Phase II|Death|0|||
156400064|NCT00331344|564558299|FG004|Phase II|Death|0|||
156400065|NCT00331344|564558300|FG005|Phase II|Death|0|||
156400066|NCT00331344|564558301|FG006|Phase II|Death|0|||
156400067|NCT00331344|564558302|FG007|Phase II|Death|0|||
156400068|NCT00331344|564558303|FG008|Phase II|Death|4|||
156400069|NCT02228967|564558304|FG000|Overall Study|Lost to Follow-up|146|||
156400070|NCT02228967|564558305|FG001|Overall Study|Lost to Follow-up|142|||
156400071|NCT02228967|564558304|FG000|Overall Study|Withdrawal by Subject|13|||
156400072|NCT02228967|564558305|FG001|Overall Study|Withdrawal by Subject|18|||
156400073|NCT04207840|564558306|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
156400074|NCT04207840|564558307|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
156400075|NCT04207840|564558308|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
156400076|NCT04207840|564558306|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
156400077|NCT04207840|564558307|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
156400078|NCT04207840|564558308|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
156400079|NCT03243422|564558311|FG000|Overall Study|Death|20|||
156400080|NCT03243422|564558312|FG001|Overall Study|Death|21|||
156400081|NCT03243422|564558311|FG000|Overall Study|Lost to Follow-up|9|||
156400082|NCT03243422|564558312|FG001|Overall Study|Lost to Follow-up|21|||
156400083|NCT03243422|564558311|FG000|Overall Study|Withdrawal by Subject|22|||
156400084|NCT03243422|564558312|FG001|Overall Study|Withdrawal by Subject|8|||
156400085|NCT03261271|564558316|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
156400086|NCT03261271|564558317|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
156400087|NCT02173054|564558318|FG000|Overall Study|lack of compliance|1|||
156400088|NCT02173054|564558319|FG001|Overall Study|lack of compliance|0|||
156400089|NCT02173054|564558320|FG002|Overall Study|lack of compliance|0|||
156400090|NCT02173054|564558318|FG000|Overall Study|Withdrawal by Subject|0|||
156400091|NCT02173054|564558319|FG001|Overall Study|Withdrawal by Subject|0|||
156400092|NCT02173054|564558320|FG002|Overall Study|Withdrawal by Subject|1|||
156400093|NCT01330316|564558321|FG000|Overall Study|Adverse Event|2|||
156400094|NCT01330316|564558322|FG001|Overall Study|Adverse Event|2|||
156400095|NCT01330316|564558321|FG000|Overall Study|Lack of Efficacy|0|||
156400096|NCT01330316|564558322|FG001|Overall Study|Lack of Efficacy|10|||
156400097|NCT01330316|564558321|FG000|Overall Study|Lost to Follow-up|0|||
156400098|NCT01330316|564558322|FG001|Overall Study|Lost to Follow-up|1|||
156400099|NCT01330316|564558321|FG000|Overall Study|Withdrawal by Subject|0|||
156400100|NCT01330316|564558322|FG001|Overall Study|Withdrawal by Subject|1|||
156400101|NCT01330316|564558321|FG000|Overall Study|other than above|0|||
156400102|NCT01330316|564558322|FG001|Overall Study|other than above|1|||
156400103|NCT01337986|564558325|FG000|Overall Study|Adverse Event|2|||
156400104|NCT01337986|564558326|FG001|Overall Study|Adverse Event|2|||
156400105|NCT01337986|564558325|FG000|Overall Study|Lost to Follow-up|1|||
156400106|NCT01337986|564558326|FG001|Overall Study|Lost to Follow-up|0|||
156400107|NCT01337986|564558325|FG000|Overall Study|Protocol Violation|0|||
156400108|NCT01337986|564558326|FG001|Overall Study|Protocol Violation|3|||
156400109|NCT01520402|564558328|FG000|Overall Study|Withdrawal by Subject|2|||
156400110|NCT01520402|564558328|FG000|Overall Study|Physician Decision|3|||
156400111|NCT02287584|564558329|FG000|the Double-blind Phase|Adverse Event|17|||
156400112|NCT02287584|564558330|FG001|the Double-blind Phase|Adverse Event|17|||
156509198|NCT04942366|564957491|FG001|Overall Study|Withdrawal by Subject|5|||
156509199|NCT00747227|564957498|FG000|Overall Study|Death|3|||
156509200|NCT00747227|564957499|FG001|Overall Study|Death|1|||
156509201|NCT00747227|564957498|FG000|Overall Study|Withdrawal by Subject|1|||
156509202|NCT00747227|564957499|FG001|Overall Study|Withdrawal by Subject|0|||
156509203|NCT00747227|564957498|FG000|Overall Study|Lost to Follow-up|1|||
156509204|NCT00747227|564957499|FG001|Overall Study|Lost to Follow-up|2|||
156509205|NCT00747227|564957498|FG000|Overall Study|Illness|1|||
156509206|NCT00747227|564957499|FG001|Overall Study|Illness|1|||
156509207|NCT03284229|564957500|FG000|Overall Study|Lost to Follow-up|3|||
156509208|NCT00918879|564957502|FG000|Overall Study|Withdrawal by Subject|4|||
156509209|NCT00918879|564957503|FG001|Overall Study|Withdrawal by Subject|4|||
156509210|NCT00918879|564957502|FG000|Overall Study|Lost to Follow-up|1|||
156509211|NCT00918879|564957503|FG001|Overall Study|Lost to Follow-up|1|||
156509212|NCT00918879|564957502|FG000|Overall Study|Severe non-compliance to protocol|1|||
156549766|NCT02443883|565103758|FG003|Overall Study|Lost to Follow-up|0|||
156549767|NCT02443883|565103755|FG000|Overall Study|Physician Decision|1|||
156549768|NCT02443883|565103756|FG001|Overall Study|Physician Decision|1|||
156549769|NCT02443883|565103757|FG002|Overall Study|Physician Decision|0|||
156549770|NCT02443883|565103758|FG003|Overall Study|Physician Decision|3|||
156549771|NCT02443883|565103755|FG000|Overall Study|Withdrawal by Subject|1|||
156549772|NCT02443883|565103756|FG001|Overall Study|Withdrawal by Subject|0|||
156549773|NCT02443883|565103757|FG002|Overall Study|Withdrawal by Subject|0|||
156549774|NCT02443883|565103758|FG003|Overall Study|Withdrawal by Subject|2|||
156549775|NCT02443883|565103755|FG000|Overall Study|Randomized, but never treated|1|||
156549776|NCT02443883|565103756|FG001|Overall Study|Randomized, but never treated|0|||
156549777|NCT02443883|565103757|FG002|Overall Study|Randomized, but never treated|0|||
156549778|NCT02443883|565103758|FG003|Overall Study|Randomized, but never treated|0|||
156549779|NCT02199080|565103759|FG000|Overall Study|Protocol Violation|12|||
156549780|NCT01618214|565103762|FG000|Overall Study|Adverse Event|3|||
156549781|NCT01618214|565103763|FG001|Overall Study|Adverse Event|1|||
156549782|NCT01618214|565103762|FG000|Overall Study|Lack of Efficacy|1|||
156549783|NCT01618214|565103763|FG001|Overall Study|Lack of Efficacy|1|||
156549784|NCT01618214|565103762|FG000|Overall Study|Protocol Violation|1|||
156549785|NCT01618214|565103763|FG001|Overall Study|Protocol Violation|4|||
156549786|NCT01618214|565103762|FG000|Overall Study|Withdrawal Criteria|1|||
156549787|NCT01618214|565103763|FG001|Overall Study|Withdrawal Criteria|2|||
156549788|NCT01618214|565103762|FG000|Overall Study|Unclassified|4|||
156549789|NCT01618214|565103763|FG001|Overall Study|Unclassified|5|||
156549790|NCT02937818|565103766|FG000|Overall Study|Participants decision|2|||
156549791|NCT02937818|565103767|FG001|Overall Study|Participants decision|1|||
156549792|NCT02937818|565103768|FG002|Overall Study|Participants decision|1|||
156549793|NCT02937818|565103769|FG003|Overall Study|Participants decision|1|||
156549794|NCT02937818|565103766|FG000|Overall Study|Adverse Event|2|||
156549795|NCT02937818|565103767|FG001|Overall Study|Adverse Event|4|||
156549796|NCT02937818|565103768|FG002|Overall Study|Adverse Event|1|||
156549797|NCT02937818|565103769|FG003|Overall Study|Adverse Event|1|||
156549798|NCT02937818|565103766|FG000|Overall Study|Disease progression|17|||
156549799|NCT02937818|565103767|FG001|Overall Study|Disease progression|15|||
156549800|NCT02937818|565103768|FG002|Overall Study|Disease progression|7|||
156549801|NCT02937818|565103769|FG003|Overall Study|Disease progression|19|||
156549802|NCT02937818|565103766|FG000|Overall Study|Condition under investigation worsened|0|||
156549803|NCT02937818|565103767|FG001|Overall Study|Condition under investigation worsened|0|||
156549804|NCT02937818|565103768|FG002|Overall Study|Condition under investigation worsened|1|||
156549805|NCT02937818|565103769|FG003|Overall Study|Condition under investigation worsened|0|||
156549806|NCT01508702|565103773|FG000|Overall Study|Adverse Event|7|||
156549807|NCT01508702|565103774|FG001|Overall Study|Adverse Event|3|||
156549808|NCT01508702|565103773|FG000|Overall Study|Gout flare|2|||
156549809|NCT01508702|565103774|FG001|Overall Study|Gout flare|0|||
156549810|NCT01508702|565103773|FG000|Overall Study|Protocol Violation|2|||
156549811|NCT01508702|565103774|FG001|Overall Study|Protocol Violation|1|||
156549812|NCT01508702|565103773|FG000|Overall Study|Lost to Follow-up|1|||
156549813|NCT01508702|565103774|FG001|Overall Study|Lost to Follow-up|2|||
156549814|NCT01508702|565103773|FG000|Overall Study|Withdrawal by Subject|11|||
156549815|NCT01508702|565103774|FG001|Overall Study|Withdrawal by Subject|7|||
156549816|NCT03861559|565103775|FG000|Overall Study|Adverse Event|0|||
156549817|NCT03861559|565103776|FG001|Overall Study|Adverse Event|2|||
156400113|NCT02287584|564558331|FG002|the Double-blind Phase|Adverse Event|12|||
156400114|NCT02287584|564558332|FG003|the Double-blind Phase|Adverse Event|0|||
156400115|NCT02287584|564558333|FG004|the Double-blind Phase|Adverse Event|0|||
156549818|NCT03861559|565103775|FG000|Overall Study|Treatment failure|0|||
156549819|NCT03861559|565103776|FG001|Overall Study|Treatment failure|2|||
156549820|NCT03861559|565103775|FG000|Overall Study|Noncompliance|1|||
156549821|NCT03861559|565103776|FG001|Overall Study|Noncompliance|1|||
156549822|NCT03861559|565103775|FG000|Overall Study|Did not meet eligibility requirements|1|||
156549823|NCT03861559|565103776|FG001|Overall Study|Did not meet eligibility requirements|0|||
156549824|NCT00879697|565103779|FG000|Overall Study|Physician Decision|2|||
156549825|NCT00879697|565103780|FG001|Overall Study|Physician Decision|2|||
156549826|NCT02500121|565103781|FG000|Overall Study|Lost to Follow-up|0|||
156549827|NCT02500121|565103782|FG001|Overall Study|Lost to Follow-up|1|||
156400116|NCT02287584|564558334|FG005|the Double-blind Phase|Adverse Event|0|||
156400117|NCT02287584|564558329|FG000|the Double-blind Phase|Lack of Efficacy|18|||
156400118|NCT02287584|564558330|FG001|the Double-blind Phase|Lack of Efficacy|8|||
156549828|NCT02500121|565103781|FG000|Overall Study|Withdrawal by Subject|1|||
156549829|NCT02500121|565103782|FG001|Overall Study|Withdrawal by Subject|1|||
156549830|NCT02500121|565103781|FG000|Overall Study|Death|26|||
156549831|NCT02500121|565103782|FG001|Overall Study|Death|24|||
156549832|NCT02124564|565103787|FG000|Treatment Period|Adverse Event|2|||
156549833|NCT02124564|565103787|FG000|Treatment Period|Lack of Efficacy|3|||
156549834|NCT02124564|565103787|FG000|Treatment Period|Withdrawal by Subject|2|||
156549835|NCT04489888|565103788|FG000|Overall Study|Death|75|||
156549836|NCT04489888|565103788|FG000|Overall Study|Sponsor Decision|26|||
156549837|NCT03829657|565103796|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
156549838|NCT03829657|565103797|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
156549839|NCT03829657|565103798|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
156549840|NCT03829657|565103799|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
156549841|NCT03829657|565103800|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
156549842|NCT03829657|565103796|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
156549843|NCT03829657|565103797|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156549844|NCT03829657|565103798|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156549845|NCT03829657|565103799|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156549846|NCT03829657|565103800|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156549847|NCT03829657|565103796|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
156549848|NCT03829657|565103797|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
156549849|NCT03829657|565103798|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
156549850|NCT03829657|565103799|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
156549851|NCT03829657|565103800|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
156549852|NCT03829657|565103796|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
156549853|NCT03829657|565103797|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
156549854|NCT03829657|565103798|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
156549855|NCT03829657|565103799|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156549856|NCT03829657|565103800|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156549857|NCT03829657|565103796|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
156549858|NCT03829657|565103797|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
156549859|NCT03829657|565103798|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
156549860|NCT03829657|565103799|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
156549861|NCT03829657|565103800|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
156549862|NCT03829657|565103796|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
156549863|NCT03829657|565103797|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
156549864|NCT03829657|565103798|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
156549865|NCT03829657|565103799|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
156549866|NCT03829657|565103800|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
156549867|NCT03829657|565103796|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
156549868|NCT03829657|565103797|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
156549869|NCT03829657|565103798|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
156549870|NCT03829657|565103799|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
156549871|NCT03829657|565103800|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
156549872|NCT03829657|565103796|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
156549873|NCT03829657|565103797|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
156549874|NCT03829657|565103798|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
156549875|NCT03829657|565103799|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
156549876|NCT03829657|565103800|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
156549877|NCT03829657|565103796|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
156549878|NCT03829657|565103797|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
156549879|NCT03829657|565103798|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
156549880|NCT03829657|565103799|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
156549881|NCT03829657|565103800|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
156549882|NCT03829657|565103796|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
156549883|NCT03829657|565103797|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
156549884|NCT03829657|565103798|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
156549885|NCT03829657|565103799|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
156549886|NCT03829657|565103800|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
156549887|NCT04418076|565103801|FG000|Overall Study|Death|1|||
156549888|NCT04418076|565103802|FG001|Overall Study|Death|0|||
156549889|NCT04418076|565103803|FG002|Overall Study|Death|0|||
156549890|NCT04418076|565103804|FG003|Overall Study|Death|0|||
156549891|NCT04418076|565103801|FG000|Overall Study|Lost to Follow-up|2|||
156549892|NCT04418076|565103802|FG001|Overall Study|Lost to Follow-up|5|||
156549893|NCT04418076|565103803|FG002|Overall Study|Lost to Follow-up|1|||
156549894|NCT04418076|565103804|FG003|Overall Study|Lost to Follow-up|2|||
156549895|NCT04418076|565103801|FG000|Overall Study|Withdrawal by Subject|1|||
156549896|NCT04418076|565103802|FG001|Overall Study|Withdrawal by Subject|0|||
156549897|NCT04418076|565103803|FG002|Overall Study|Withdrawal by Subject|1|||
156549898|NCT04418076|565103804|FG003|Overall Study|Withdrawal by Subject|1|||
156549899|NCT04418076|565103801|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
156549900|NCT04418076|565103802|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
156549901|NCT04418076|565103803|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
156549902|NCT04418076|565103804|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
156549903|NCT03368170|565106768|FG000|Overall Study|Adverse Event|2|||
156549904|NCT03368170|565106769|FG001|Overall Study|Adverse Event|1|||
156549905|NCT03047980|565106770|FG000|Overall Study|Adverse Event|1|||
156549906|NCT02164981|565106771|FG000|Started|Withdrawal by Subject|2|||
156549907|NCT02164981|565106772|FG001|Started|Withdrawal by Subject|1|||
156549908|NCT02164981|565106773|FG002|Started|Withdrawal by Subject|0|||
156549909|NCT02164981|565106771|FG000|Started|Protocol Violation|2|||
156549910|NCT02164981|565106772|FG001|Started|Protocol Violation|0|||
156549911|NCT02164981|565106773|FG002|Started|Protocol Violation|0|||
156549912|NCT02164981|565106771|FG000|Started|Adverse Event|1|||
156549913|NCT02164981|565106772|FG001|Started|Adverse Event|2|||
156549914|NCT02164981|565106773|FG002|Started|Adverse Event|0|||
156549915|NCT02164981|565106771|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
156549916|NCT02164981|565106772|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
156549917|NCT02164981|565106773|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
156549918|NCT02164981|565106771|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
156549919|NCT02164981|565106772|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
156549920|NCT02164981|565106773|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
156549921|NCT02164981|565106771|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
156549922|NCT02164981|565106772|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
156549923|NCT02164981|565106773|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
156549924|NCT00328627|565106779|FG000|Overall Study|Hyperglycemic Rescue|41|||
156549925|NCT00328627|565106780|FG001|Overall Study|Hyperglycemic Rescue|18|||
156549926|NCT00328627|565106781|FG002|Overall Study|Hyperglycemic Rescue|16|||
156549927|NCT00328627|565106782|FG003|Overall Study|Hyperglycemic Rescue|13|||
156549928|NCT00328627|565106783|FG004|Overall Study|Hyperglycemic Rescue|6|||
156549929|NCT00328627|565106784|FG005|Overall Study|Hyperglycemic Rescue|5|||
156549930|NCT00328627|565106785|FG006|Overall Study|Hyperglycemic Rescue|19|||
156549931|NCT00328627|565106786|FG007|Overall Study|Hyperglycemic Rescue|6|||
156549932|NCT00328627|565106787|FG008|Overall Study|Hyperglycemic Rescue|6|||
156549933|NCT00328627|565106788|FG009|Overall Study|Hyperglycemic Rescue|11|||
156549934|NCT00328627|565106789|FG010|Overall Study|Hyperglycemic Rescue|3|||
156549935|NCT00328627|565106790|FG011|Overall Study|Hyperglycemic Rescue|2|||
156549936|NCT00328627|565106779|FG000|Overall Study|Adverse Event|3|||
156549937|NCT00328627|565106780|FG001|Overall Study|Adverse Event|1|||
156549938|NCT00328627|565106781|FG002|Overall Study|Adverse Event|2|||
156549939|NCT00328627|565106782|FG003|Overall Study|Adverse Event|3|||
156549940|NCT00328627|565106783|FG004|Overall Study|Adverse Event|1|||
156549941|NCT00328627|565106784|FG005|Overall Study|Adverse Event|2|||
156549942|NCT00328627|565106785|FG006|Overall Study|Adverse Event|1|||
156549943|NCT00328627|565106786|FG007|Overall Study|Adverse Event|2|||
156549944|NCT00328627|565106787|FG008|Overall Study|Adverse Event|0|||
156549945|NCT00328627|565106788|FG009|Overall Study|Adverse Event|7|||
156549946|NCT00328627|565106789|FG010|Overall Study|Adverse Event|5|||
156549947|NCT00328627|565106790|FG011|Overall Study|Adverse Event|4|||
156549948|NCT00328627|565106779|FG000|Overall Study|Protocol Violation|2|||
156549949|NCT00328627|565106780|FG001|Overall Study|Protocol Violation|2|||
156549950|NCT00328627|565106781|FG002|Overall Study|Protocol Violation|2|||
156549951|NCT00328627|565106782|FG003|Overall Study|Protocol Violation|8|||
156549952|NCT00328627|565106783|FG004|Overall Study|Protocol Violation|5|||
156549953|NCT00328627|565106784|FG005|Overall Study|Protocol Violation|5|||
156549954|NCT00328627|565106785|FG006|Overall Study|Protocol Violation|6|||
156549955|NCT00328627|565106786|FG007|Overall Study|Protocol Violation|2|||
156549956|NCT00328627|565106787|FG008|Overall Study|Protocol Violation|1|||
156549957|NCT00328627|565106788|FG009|Overall Study|Protocol Violation|4|||
156400119|NCT02287584|564558331|FG002|the Double-blind Phase|Lack of Efficacy|8|||
156400120|NCT02287584|564558332|FG003|the Double-blind Phase|Lack of Efficacy|0|||
156549958|NCT00328627|565106789|FG010|Overall Study|Protocol Violation|6|||
156549959|NCT00328627|565106790|FG011|Overall Study|Protocol Violation|2|||
156549960|NCT00328627|565106779|FG000|Overall Study|Lost to Follow-up|4|||
156549961|NCT00328627|565106780|FG001|Overall Study|Lost to Follow-up|2|||
156549962|NCT00328627|565106781|FG002|Overall Study|Lost to Follow-up|2|||
156549963|NCT00328627|565106782|FG003|Overall Study|Lost to Follow-up|4|||
156549964|NCT00328627|565106783|FG004|Overall Study|Lost to Follow-up|0|||
156549965|NCT00328627|565106784|FG005|Overall Study|Lost to Follow-up|2|||
156549966|NCT00328627|565106785|FG006|Overall Study|Lost to Follow-up|3|||
156549967|NCT00328627|565106786|FG007|Overall Study|Lost to Follow-up|0|||
156549968|NCT00328627|565106787|FG008|Overall Study|Lost to Follow-up|3|||
156549969|NCT00328627|565106788|FG009|Overall Study|Lost to Follow-up|2|||
156549970|NCT00328627|565106789|FG010|Overall Study|Lost to Follow-up|0|||
156400121|NCT02287584|564558333|FG004|the Double-blind Phase|Lack of Efficacy|0|||
156400122|NCT02287584|564558334|FG005|the Double-blind Phase|Lack of Efficacy|0|||
156549971|NCT00328627|565106790|FG011|Overall Study|Lost to Follow-up|1|||
156549972|NCT00328627|565106779|FG000|Overall Study|Withdrawal by Subject|5|||
156549973|NCT00328627|565106780|FG001|Overall Study|Withdrawal by Subject|4|||
156549974|NCT00328627|565106781|FG002|Overall Study|Withdrawal by Subject|5|||
156549975|NCT00328627|565106782|FG003|Overall Study|Withdrawal by Subject|6|||
156509213|NCT00918879|564957503|FG001|Overall Study|Severe non-compliance to protocol|1|||
156509214|NCT04707664|564957504|FG000|Overall Study|Adverse Event|2|||
156509215|NCT04707664|564957505|FG001|Overall Study|Adverse Event|0|||
156509216|NCT04707664|564957504|FG000|Overall Study|Death|1|||
156509217|NCT04707664|564957505|FG001|Overall Study|Death|2|||
156509218|NCT04707664|564957504|FG000|Overall Study|Withdrawal by Subject|13|||
156509219|NCT04707664|564957505|FG001|Overall Study|Withdrawal by Subject|21|||
156509220|NCT04707664|564957504|FG000|Overall Study|Lost to Follow-up|11|||
156509221|NCT04707664|564957505|FG001|Overall Study|Lost to Follow-up|13|||
156509222|NCT04707664|564957504|FG000|Overall Study|Not treated|2|||
156509223|NCT04707664|564957505|FG001|Overall Study|Not treated|0|||
156509224|NCT00357110|564957506|FG000|Overall Study|Early study termination|5|||
156509225|NCT00357110|564957507|FG001|Overall Study|Early study termination|5|||
156509226|NCT01977677|564957525|FG000|Overall Study|Unrelated Adverse Event|0|||
156509227|NCT01977677|564957526|FG001|Overall Study|Unrelated Adverse Event|0|||
156509228|NCT01977677|564957527|FG002|Overall Study|Unrelated Adverse Event|1|||
156509229|NCT01498887|564957528|FG000|Overall Study|Administrative problems|1|||
156509230|NCT01498887|564957529|FG001|Overall Study|Administrative problems|0|||
156509231|NCT01498887|564957528|FG000|Overall Study|Lost to Follow-up|1|||
156509232|NCT01498887|564957529|FG001|Overall Study|Lost to Follow-up|1|||
156509233|NCT01498887|564957528|FG000|Overall Study|Withdrawal by Subject|1|||
156509234|NCT01498887|564957529|FG001|Overall Study|Withdrawal by Subject|0|||
156509235|NCT01498887|564957528|FG000|Overall Study|Protocol Violation|1|||
156509236|NCT01498887|564957529|FG001|Overall Study|Protocol Violation|3|||
156509237|NCT01498887|564957528|FG000|Overall Study|Lack of Efficacy|5|||
156509238|NCT01498887|564957529|FG001|Overall Study|Lack of Efficacy|3|||
156509239|NCT01498887|564957528|FG000|Overall Study|Abnormal result from test procedure|1|||
156509240|NCT01498887|564957529|FG001|Overall Study|Abnormal result from test procedure|1|||
156509241|NCT01498887|564957528|FG000|Overall Study|Abnormal laboratory value|2|||
156509242|NCT01498887|564957529|FG001|Overall Study|Abnormal laboratory value|2|||
156509243|NCT01498887|564957528|FG000|Overall Study|Adverse Event|4|||
156509244|NCT01498887|564957529|FG001|Overall Study|Adverse Event|1|||
156509245|NCT04335591|564957532|FG000|Overall Study|Adverse Event|5|||
156509246|NCT04335591|564957533|FG001|Overall Study|Adverse Event|2|||
156509247|NCT04335591|564957534|FG002|Overall Study|Adverse Event|3|||
156509248|NCT04335591|564957535|FG003|Overall Study|Adverse Event|2|||
156509249|NCT04335591|564957532|FG000|Overall Study|Protocol Violation|1|||
156509250|NCT04335591|564957533|FG001|Overall Study|Protocol Violation|0|||
156509251|NCT04335591|564957534|FG002|Overall Study|Protocol Violation|0|||
156509252|NCT04335591|564957535|FG003|Overall Study|Protocol Violation|0|||
156509253|NCT04335591|564957532|FG000|Overall Study|Withdrawal by Subject|8|||
156509254|NCT04335591|564957533|FG001|Overall Study|Withdrawal by Subject|4|||
156509255|NCT04335591|564957534|FG002|Overall Study|Withdrawal by Subject|4|||
156509256|NCT04335591|564957535|FG003|Overall Study|Withdrawal by Subject|5|||
156509257|NCT04335591|564957532|FG000|Overall Study|Subject planning pregnancy|0|||
156509258|NCT04335591|564957533|FG001|Overall Study|Subject planning pregnancy|1|||
156509259|NCT04335591|564957534|FG002|Overall Study|Subject planning pregnancy|0|||
156509260|NCT04335591|564957535|FG003|Overall Study|Subject planning pregnancy|0|||
156509261|NCT04335591|564957532|FG000|Overall Study|Ukrainian Russian war conflict|4|||
156509262|NCT04335591|564957533|FG001|Overall Study|Ukrainian Russian war conflict|5|||
156509263|NCT04335591|564957534|FG002|Overall Study|Ukrainian Russian war conflict|2|||
156509264|NCT04335591|564957535|FG003|Overall Study|Ukrainian Russian war conflict|0|||
156509265|NCT01706705|564957539|FG000|Overall Study|Death|1|||
156509266|NCT01706705|564957539|FG000|Overall Study|Lack of Efficacy|13|||
156509267|NCT01706705|564957539|FG000|Overall Study|Non-clinical|6|||
156509268|NCT02476175|564957543|FG000|Overall Study|Adverse Event|2|||
156509269|NCT04421950|564957546|FG000|Overall Study|Dropped or lost to follow up|4|||
156400123|NCT02287584|564558329|FG000|the Double-blind Phase|Lost to Follow-up|0|||
156400124|NCT02287584|564558330|FG001|the Double-blind Phase|Lost to Follow-up|1|||
156400125|NCT02287584|564558331|FG002|the Double-blind Phase|Lost to Follow-up|1|||
156400126|NCT02287584|564558332|FG003|the Double-blind Phase|Lost to Follow-up|0|||
156400127|NCT02287584|564558333|FG004|the Double-blind Phase|Lost to Follow-up|0|||
156400128|NCT02287584|564558334|FG005|the Double-blind Phase|Lost to Follow-up|0|||
156400129|NCT02287584|564558329|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
156400130|NCT02287584|564558330|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
156400131|NCT02287584|564558331|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
156509270|NCT04421950|564957547|FG001|Overall Study|Dropped or lost to follow up|2|||
156509271|NCT01252355|564957548|FG000|Overall Study|Adverse Event|9|||
156509272|NCT01252355|564957549|FG001|Overall Study|Adverse Event|17|||
156509273|NCT01252355|564957550|FG002|Overall Study|Adverse Event|22|||
156509274|NCT01252355|564957548|FG000|Overall Study|Lack of Efficacy|6|||
156509275|NCT01252355|564957549|FG001|Overall Study|Lack of Efficacy|4|||
156509276|NCT01252355|564957550|FG002|Overall Study|Lack of Efficacy|2|||
156509277|NCT01252355|564957548|FG000|Overall Study|Lost to Follow-up|0|||
156509278|NCT01252355|564957549|FG001|Overall Study|Lost to Follow-up|0|||
156509279|NCT01252355|564957550|FG002|Overall Study|Lost to Follow-up|1|||
156549976|NCT00328627|565106783|FG004|Overall Study|Withdrawal by Subject|2|||
156549977|NCT00328627|565106784|FG005|Overall Study|Withdrawal by Subject|5|||
156549978|NCT00328627|565106785|FG006|Overall Study|Withdrawal by Subject|4|||
156549979|NCT00328627|565106786|FG007|Overall Study|Withdrawal by Subject|4|||
156549980|NCT00328627|565106787|FG008|Overall Study|Withdrawal by Subject|4|||
156549981|NCT00328627|565106788|FG009|Overall Study|Withdrawal by Subject|5|||
156549982|NCT00328627|565106789|FG010|Overall Study|Withdrawal by Subject|2|||
156549983|NCT00328627|565106790|FG011|Overall Study|Withdrawal by Subject|7|||
156549984|NCT00328627|565106779|FG000|Overall Study|Pregnancy|0|||
156549985|NCT00328627|565106780|FG001|Overall Study|Pregnancy|1|||
156549986|NCT00328627|565106781|FG002|Overall Study|Pregnancy|0|||
156549987|NCT00328627|565106782|FG003|Overall Study|Pregnancy|0|||
156549988|NCT00328627|565106783|FG004|Overall Study|Pregnancy|0|||
156549989|NCT00328627|565106784|FG005|Overall Study|Pregnancy|0|||
156549990|NCT00328627|565106785|FG006|Overall Study|Pregnancy|0|||
156549991|NCT00328627|565106786|FG007|Overall Study|Pregnancy|0|||
156549992|NCT00328627|565106787|FG008|Overall Study|Pregnancy|0|||
156549993|NCT00328627|565106788|FG009|Overall Study|Pregnancy|0|||
156549994|NCT00328627|565106789|FG010|Overall Study|Pregnancy|0|||
156549995|NCT00328627|565106790|FG011|Overall Study|Pregnancy|0|||
156549996|NCT00328627|565106779|FG000|Overall Study|Physician Decision|4|||
156549997|NCT00328627|565106780|FG001|Overall Study|Physician Decision|3|||
156549998|NCT00328627|565106781|FG002|Overall Study|Physician Decision|1|||
156549999|NCT00328627|565106782|FG003|Overall Study|Physician Decision|2|||
156550000|NCT00328627|565106783|FG004|Overall Study|Physician Decision|1|||
156550001|NCT00328627|565106784|FG005|Overall Study|Physician Decision|1|||
156550002|NCT00328627|565106785|FG006|Overall Study|Physician Decision|1|||
156550003|NCT00328627|565106786|FG007|Overall Study|Physician Decision|0|||
156550004|NCT00328627|565106787|FG008|Overall Study|Physician Decision|3|||
156550005|NCT00328627|565106788|FG009|Overall Study|Physician Decision|2|||
156550006|NCT00328627|565106789|FG010|Overall Study|Physician Decision|1|||
156550007|NCT00328627|565106790|FG011|Overall Study|Physician Decision|0|||
156550008|NCT00328627|565106779|FG000|Overall Study|Other|0|||
156550009|NCT00328627|565106780|FG001|Overall Study|Other|0|||
156550010|NCT00328627|565106781|FG002|Overall Study|Other|0|||
156550011|NCT00328627|565106782|FG003|Overall Study|Other|1|||
156550012|NCT00328627|565106783|FG004|Overall Study|Other|0|||
156550013|NCT00328627|565106784|FG005|Overall Study|Other|0|||
156550014|NCT00328627|565106785|FG006|Overall Study|Other|1|||
156550015|NCT00328627|565106786|FG007|Overall Study|Other|0|||
156550016|NCT00328627|565106787|FG008|Overall Study|Other|0|||
156550017|NCT00328627|565106788|FG009|Overall Study|Other|1|||
156550018|NCT00328627|565106789|FG010|Overall Study|Other|1|||
156550019|NCT00328627|565106790|FG011|Overall Study|Other|0|||
156550020|NCT02049944|565106791|FG000|Overall Study|Protocol Violation|2|||
156550021|NCT01765673|565106792|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
156550022|NCT02600507|565106793|FG000|Overall Study|Adverse Event|3|||
156550023|NCT02600507|565106794|FG001|Overall Study|Adverse Event|15|||
156550024|NCT02600507|565106795|FG002|Overall Study|Adverse Event|5|||
156400132|NCT02287584|564558332|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
156550025|NCT02600507|565106793|FG000|Overall Study|Lack of Efficacy|3|||
156550026|NCT02600507|565106794|FG001|Overall Study|Lack of Efficacy|8|||
156550027|NCT02600507|565106795|FG002|Overall Study|Lack of Efficacy|5|||
156550028|NCT02600507|565106793|FG000|Overall Study|Lost to Follow-up|3|||
156550029|NCT02600507|565106794|FG001|Overall Study|Lost to Follow-up|5|||
156550030|NCT02600507|565106795|FG002|Overall Study|Lost to Follow-up|2|||
156550031|NCT02600507|565106793|FG000|Overall Study|Protocol Violation|12|||
156550032|NCT02600507|565106794|FG001|Overall Study|Protocol Violation|4|||
156550033|NCT02600507|565106795|FG002|Overall Study|Protocol Violation|4|||
156550034|NCT02600507|565106793|FG000|Overall Study|Physician Decision|1|||
156550035|NCT02600507|565106794|FG001|Overall Study|Physician Decision|0|||
156550036|NCT02600507|565106795|FG002|Overall Study|Physician Decision|1|||
156550037|NCT02600507|565106793|FG000|Overall Study|Withdrawal by Subject|7|||
156550038|NCT02600507|565106794|FG001|Overall Study|Withdrawal by Subject|11|||
156550039|NCT02600507|565106795|FG002|Overall Study|Withdrawal by Subject|7|||
156550040|NCT02600507|565106793|FG000|Overall Study|Other|0|||
156550041|NCT02600507|565106794|FG001|Overall Study|Other|1|||
156550042|NCT02600507|565106795|FG002|Overall Study|Other|1|||
156550043|NCT05048719|565106798|FG000|Overall Study|Withdrawal by Subject|2|||
156550044|NCT05048719|565106799|FG001|Overall Study|Withdrawal by Subject|1|||
156550045|NCT05048719|565106800|FG002|Overall Study|Withdrawal by Subject|3|||
156550046|NCT05048719|565106801|FG003|Overall Study|Withdrawal by Subject|1|||
156550047|NCT05048719|565106802|FG004|Overall Study|Withdrawal by Subject|0|||
156550048|NCT05048719|565106803|FG005|Overall Study|Withdrawal by Subject|2|||
156550049|NCT05048719|565106804|FG006|Overall Study|Withdrawal by Subject|1|||
156550050|NCT05048719|565106805|FG007|Overall Study|Withdrawal by Subject|1|||
156550051|NCT05048719|565106806|FG008|Overall Study|Withdrawal by Subject|0|||
156550052|NCT05048719|565106798|FG000|Overall Study|Death|1|||
156550053|NCT05048719|565106799|FG001|Overall Study|Death|0|||
156550054|NCT05048719|565106800|FG002|Overall Study|Death|0|||
156550055|NCT05048719|565106801|FG003|Overall Study|Death|0|||
156550056|NCT05048719|565106802|FG004|Overall Study|Death|0|||
156550057|NCT05048719|565106803|FG005|Overall Study|Death|0|||
156400133|NCT02287584|564558333|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
156400134|NCT02287584|564558334|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
156400135|NCT02287584|564558329|FG000|the Double-blind Phase|Pregnancy|0|||
156400136|NCT02287584|564558330|FG001|the Double-blind Phase|Pregnancy|1|||
156400137|NCT02287584|564558331|FG002|the Double-blind Phase|Pregnancy|0|||
156400138|NCT02287584|564558332|FG003|the Double-blind Phase|Pregnancy|0|||
156400139|NCT02287584|564558333|FG004|the Double-blind Phase|Pregnancy|0|||
156400140|NCT02287584|564558334|FG005|the Double-blind Phase|Pregnancy|0|||
156400141|NCT02287584|564558329|FG000|the Double-blind Phase|Protocol Violation|0|||
156400142|NCT02287584|564558330|FG001|the Double-blind Phase|Protocol Violation|3|||
156400143|NCT02287584|564558331|FG002|the Double-blind Phase|Protocol Violation|0|||
156400144|NCT02287584|564558332|FG003|the Double-blind Phase|Protocol Violation|0|||
156400145|NCT02287584|564558333|FG004|the Double-blind Phase|Protocol Violation|0|||
156400146|NCT02287584|564558334|FG005|the Double-blind Phase|Protocol Violation|0|||
156400147|NCT02287584|564558329|FG000|the Double-blind Phase|other reasons|0|||
156400148|NCT02287584|564558330|FG001|the Double-blind Phase|other reasons|0|||
156400149|NCT02287584|564558331|FG002|the Double-blind Phase|other reasons|1|||
156400150|NCT02287584|564558332|FG003|the Double-blind Phase|other reasons|0|||
156400151|NCT02287584|564558333|FG004|the Double-blind Phase|other reasons|0|||
156400152|NCT02287584|564558334|FG005|the Double-blind Phase|other reasons|0|||
156400153|NCT02287584|564558329|FG000|the Open-label Phase|Did not receive drug|0|||
156400154|NCT02287584|564558330|FG001|the Open-label Phase|Did not receive drug|0|||
156400155|NCT02287584|564558331|FG002|the Open-label Phase|Did not receive drug|0|||
156400156|NCT02287584|564558332|FG003|the Open-label Phase|Did not receive drug|7|||
156400157|NCT02287584|564558333|FG004|the Open-label Phase|Did not receive drug|6|||
156400158|NCT02287584|564558334|FG005|the Open-label Phase|Did not receive drug|4|||
156400159|NCT02287584|564558329|FG000|the Open-label Phase|Adverse Event|0|||
156400160|NCT02287584|564558330|FG001|the Open-label Phase|Adverse Event|0|||
156400161|NCT02287584|564558331|FG002|the Open-label Phase|Adverse Event|0|||
156400162|NCT02287584|564558332|FG003|the Open-label Phase|Adverse Event|15|||
156400163|NCT02287584|564558333|FG004|the Open-label Phase|Adverse Event|12|||
156400164|NCT02287584|564558334|FG005|the Open-label Phase|Adverse Event|16|||
156400165|NCT02287584|564558329|FG000|the Open-label Phase|Lack of Efficacy|0|||
156400166|NCT02287584|564558330|FG001|the Open-label Phase|Lack of Efficacy|0|||
156400167|NCT02287584|564558331|FG002|the Open-label Phase|Lack of Efficacy|0|||
156400168|NCT02287584|564558332|FG003|the Open-label Phase|Lack of Efficacy|8|||
156400169|NCT02287584|564558333|FG004|the Open-label Phase|Lack of Efficacy|3|||
156400170|NCT02287584|564558334|FG005|the Open-label Phase|Lack of Efficacy|7|||
156400171|NCT02287584|564558329|FG000|the Open-label Phase|Lost to Follow-up|0|||
156400172|NCT02287584|564558330|FG001|the Open-label Phase|Lost to Follow-up|0|||
156400173|NCT02287584|564558331|FG002|the Open-label Phase|Lost to Follow-up|0|||
156400174|NCT02287584|564558332|FG003|the Open-label Phase|Lost to Follow-up|4|||
156400175|NCT02287584|564558333|FG004|the Open-label Phase|Lost to Follow-up|1|||
156400176|NCT02287584|564558334|FG005|the Open-label Phase|Lost to Follow-up|2|||
156400177|NCT02287584|564558329|FG000|the Open-label Phase|Withdrawal by Subject|0|||
156400178|NCT02287584|564558330|FG001|the Open-label Phase|Withdrawal by Subject|0|||
156400179|NCT02287584|564558331|FG002|the Open-label Phase|Withdrawal by Subject|0|||
156400180|NCT02287584|564558332|FG003|the Open-label Phase|Withdrawal by Subject|18|||
156400181|NCT02287584|564558333|FG004|the Open-label Phase|Withdrawal by Subject|29|||
156400182|NCT02287584|564558334|FG005|the Open-label Phase|Withdrawal by Subject|21|||
156400183|NCT02287584|564558329|FG000|the Open-label Phase|non-compliance|0|||
156400184|NCT02287584|564558330|FG001|the Open-label Phase|non-compliance|0|||
156400185|NCT02287584|564558331|FG002|the Open-label Phase|non-compliance|0|||
156400186|NCT02287584|564558332|FG003|the Open-label Phase|non-compliance|2|||
156400187|NCT02287584|564558333|FG004|the Open-label Phase|non-compliance|5|||
156400188|NCT02287584|564558334|FG005|the Open-label Phase|non-compliance|1|||
156400189|NCT02287584|564558329|FG000|the Open-label Phase|other reasons|0|||
156400190|NCT02287584|564558330|FG001|the Open-label Phase|other reasons|0|||
156400191|NCT02287584|564558331|FG002|the Open-label Phase|other reasons|0|||
156400192|NCT02287584|564558332|FG003|the Open-label Phase|other reasons|3|||
156400193|NCT02287584|564558333|FG004|the Open-label Phase|other reasons|6|||
156400194|NCT02287584|564558334|FG005|the Open-label Phase|other reasons|6|||
156400195|NCT03430063|564558338|FG000|Overall Study|Adverse Event|0|||
156400196|NCT03430063|564558339|FG001|Overall Study|Adverse Event|1|||
156400197|NCT03430063|564558340|FG002|Overall Study|Adverse Event|0|||
156400198|NCT03430063|564558338|FG000|Overall Study|Death|3|||
156400199|NCT03430063|564558339|FG001|Overall Study|Death|2|||
156400200|NCT03430063|564558340|FG002|Overall Study|Death|3|||
156400201|NCT03430063|564558338|FG000|Overall Study|Lost to Follow-up|0|||
156400202|NCT03430063|564558339|FG001|Overall Study|Lost to Follow-up|1|||
156400203|NCT03430063|564558340|FG002|Overall Study|Lost to Follow-up|0|||
156400204|NCT03430063|564558338|FG000|Overall Study|Withdrawal by Subject|0|||
156400205|NCT03430063|564558339|FG001|Overall Study|Withdrawal by Subject|0|||
156400206|NCT03430063|564558340|FG002|Overall Study|Withdrawal by Subject|1|||
156400207|NCT03430063|564558338|FG000|Overall Study|Withdrawal of consent|3|||
156400208|NCT03430063|564558339|FG001|Overall Study|Withdrawal of consent|1|||
156550058|NCT05048719|565106804|FG006|Overall Study|Death|0|||
156550059|NCT05048719|565106805|FG007|Overall Study|Death|0|||
156550060|NCT05048719|565106806|FG008|Overall Study|Death|0|||
156550061|NCT05048719|565106798|FG000|Overall Study|Adverse Event|0|||
156550062|NCT05048719|565106799|FG001|Overall Study|Adverse Event|1|||
156550063|NCT05048719|565106800|FG002|Overall Study|Adverse Event|2|||
156550064|NCT05048719|565106801|FG003|Overall Study|Adverse Event|0|||
156550065|NCT05048719|565106802|FG004|Overall Study|Adverse Event|1|||
156550066|NCT05048719|565106803|FG005|Overall Study|Adverse Event|0|||
156550067|NCT05048719|565106804|FG006|Overall Study|Adverse Event|0|||
156550068|NCT05048719|565106805|FG007|Overall Study|Adverse Event|0|||
156550069|NCT05048719|565106806|FG008|Overall Study|Adverse Event|0|||
156550070|NCT05048719|565106798|FG000|Overall Study|Lost to Follow-up|0|||
156550071|NCT05048719|565106799|FG001|Overall Study|Lost to Follow-up|0|||
156550072|NCT05048719|565106800|FG002|Overall Study|Lost to Follow-up|1|||
156550073|NCT05048719|565106801|FG003|Overall Study|Lost to Follow-up|3|||
156550074|NCT05048719|565106802|FG004|Overall Study|Lost to Follow-up|1|||
156550075|NCT05048719|565106803|FG005|Overall Study|Lost to Follow-up|1|||
156550076|NCT05048719|565106804|FG006|Overall Study|Lost to Follow-up|1|||
156550077|NCT05048719|565106805|FG007|Overall Study|Lost to Follow-up|1|||
156550078|NCT05048719|565106806|FG008|Overall Study|Lost to Follow-up|0|||
156550079|NCT05048719|565106798|FG000|Overall Study|Physician Decision|0|||
156550080|NCT05048719|565106799|FG001|Overall Study|Physician Decision|0|||
156550081|NCT05048719|565106800|FG002|Overall Study|Physician Decision|0|||
156550082|NCT05048719|565106801|FG003|Overall Study|Physician Decision|0|||
156550083|NCT05048719|565106802|FG004|Overall Study|Physician Decision|0|||
156550084|NCT05048719|565106803|FG005|Overall Study|Physician Decision|0|||
156550085|NCT05048719|565106804|FG006|Overall Study|Physician Decision|0|||
156550086|NCT05048719|565106805|FG007|Overall Study|Physician Decision|1|||
156550087|NCT05048719|565106806|FG008|Overall Study|Physician Decision|1|||
156550088|NCT05048719|565106798|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
156550089|NCT05048719|565106799|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
156550090|NCT05048719|565106800|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
156550091|NCT05048719|565106801|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
156550092|NCT05048719|565106802|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
156550093|NCT05048719|565106803|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
156550094|NCT05048719|565106804|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
156550095|NCT05048719|565106805|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
156550096|NCT05048719|565106806|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
156550097|NCT05048719|565106798|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156550098|NCT05048719|565106799|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
156550099|NCT05048719|565106800|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156550100|NCT05048719|565106801|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156550101|NCT05048719|565106802|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156550102|NCT05048719|565106803|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156550103|NCT05048719|565106804|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156550104|NCT05048719|565106805|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156550105|NCT05048719|565106806|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156550106|NCT05048719|565106798|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
156550107|NCT05048719|565106799|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
156550108|NCT05048719|565106800|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
156550109|NCT05048719|565106801|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
156550110|NCT05048719|565106802|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
156550111|NCT05048719|565106803|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
156550112|NCT05048719|565106804|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
156550113|NCT05048719|565106805|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
156550114|NCT05048719|565106806|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
156550115|NCT05048719|565106798|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
156550116|NCT05048719|565106799|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
156550117|NCT05048719|565106800|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
156550118|NCT05048719|565106801|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
156550119|NCT05048719|565106802|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
156550120|NCT05048719|565106803|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
156550121|NCT05048719|565106804|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
156550122|NCT05048719|565106805|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
156550123|NCT05048719|565106806|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
156400209|NCT03430063|564558340|FG002|Overall Study|Withdrawal of consent|2|||
156400210|NCT03430063|564558338|FG000|Overall Study|Progressive disease|1|||
156550124|NCT05048719|565106798|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
156550125|NCT05048719|565106799|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
156550126|NCT05048719|565106800|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
156550127|NCT05048719|565106801|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
156550128|NCT05048719|565106802|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
156550129|NCT05048719|565106803|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
156550130|NCT05048719|565106804|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
156550131|NCT05048719|565106805|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
156550132|NCT05048719|565106806|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
156550133|NCT00605085|565106807|FG000|Overall Study|Withdrawal by Subject|8|||
156550134|NCT00605085|565106808|FG001|Overall Study|Withdrawal by Subject|5|||
156550135|NCT00605085|565106807|FG000|Overall Study|Adverse Event|9|||
156550136|NCT00605085|565106808|FG001|Overall Study|Adverse Event|5|||
156550137|NCT00605085|565106807|FG000|Overall Study|Pregnancy|2|||
156550138|NCT00605085|565106808|FG001|Overall Study|Pregnancy|0|||
156400211|NCT03430063|564558339|FG001|Overall Study|Progressive disease|2|||
156400212|NCT03430063|564558340|FG002|Overall Study|Progressive disease|1|||
156400213|NCT03430063|564558338|FG000|Overall Study|Other un-specified|1|||
156400214|NCT03430063|564558339|FG001|Overall Study|Other un-specified|1|||
156400215|NCT03430063|564558340|FG002|Overall Study|Other un-specified|0|||
156400216|NCT03430063|564558338|FG000|Overall Study|Randomized, but never treated|0|||
156400217|NCT03430063|564558339|FG001|Overall Study|Randomized, but never treated|0|||
156400218|NCT03430063|564558340|FG002|Overall Study|Randomized, but never treated|1|||
156400219|NCT03124199|564558341|FG000|Overall Study|Lost to Follow-up|4|||
156400220|NCT03086018|564558342|FG000|Final Testing for End of Trial|Adverse Event|1|||
156400221|NCT03086018|564558342|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
156400222|NCT01892345|564558343|FG000|Overall Study|Adverse Event|0|||
156400223|NCT01892345|564558344|FG001|Overall Study|Adverse Event|2|||
156400224|NCT01892345|564558343|FG000|Overall Study|Death|1|||
156400225|NCT01892345|564558344|FG001|Overall Study|Death|0|||
156400226|NCT01892345|564558343|FG000|Overall Study|Lost to Follow-up|3|||
156400227|NCT01892345|564558344|FG001|Overall Study|Lost to Follow-up|0|||
156400228|NCT01892345|564558343|FG000|Overall Study|Withdrawal by Subject|12|||
156400229|NCT01892345|564558344|FG001|Overall Study|Withdrawal by Subject|1|||
156400230|NCT00621543|564558346|FG000|Overall Study|Lost to Follow-up|23|||
156400231|NCT02192970|564558347|FG000|Overall Study|Lost to Follow-up|6|||
156400232|NCT02192970|564558348|FG001|Overall Study|Lost to Follow-up|0|||
156400233|NCT00792103|564558349|FG000|Overall Study|Enrolled, not treated|15|||
156400234|NCT00792103|564558349|FG000|Overall Study|Lost to Follow-up|17|||
156400235|NCT00792103|564558349|FG000|Overall Study|Adverse Event|25|||
156400236|NCT00792103|564558349|FG000|Overall Study|Withdrawal by Subject|52|||
156400237|NCT00792103|564558349|FG000|Overall Study|Protocol Violation|10|||
156400238|NCT00792103|564558349|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
156400239|NCT03745222|564558350|FG000|Overall Study|Withdrawal by Subject|0|||
156400240|NCT03745222|564558351|FG001|Overall Study|Withdrawal by Subject|1|||
156400241|NCT03745222|564558352|FG002|Overall Study|Withdrawal by Subject|0|||
156400242|NCT02657317|564558353|FG000|Overall Study|Withdrawal by Subject|2|||
156400243|NCT02657317|564558354|FG001|Overall Study|Withdrawal by Subject|0|||
156400244|NCT02657317|564558353|FG000|Overall Study|Lost to Follow-up|3|||
156400245|NCT02657317|564558354|FG001|Overall Study|Lost to Follow-up|3|||
156400246|NCT02634788|564558355|FG000|Overall Study|Adverse Event|0|||
156400247|NCT02634788|564558356|FG001|Overall Study|Adverse Event|8|||
156400248|NCT02634788|564558357|FG002|Overall Study|Adverse Event|3|||
156400249|NCT02634788|564558358|FG003|Overall Study|Adverse Event|1|||
156400250|NCT02634788|564558355|FG000|Overall Study|Lack of Efficacy|4|||
156400251|NCT02634788|564558356|FG001|Overall Study|Lack of Efficacy|0|||
156400252|NCT02634788|564558357|FG002|Overall Study|Lack of Efficacy|1|||
156400253|NCT02634788|564558358|FG003|Overall Study|Lack of Efficacy|4|||
156400254|NCT02634788|564558355|FG000|Overall Study|Lost to Follow-up|0|||
156400255|NCT02634788|564558356|FG001|Overall Study|Lost to Follow-up|1|||
156400256|NCT02634788|564558357|FG002|Overall Study|Lost to Follow-up|0|||
156400257|NCT02634788|564558358|FG003|Overall Study|Lost to Follow-up|0|||
156400258|NCT02634788|564558355|FG000|Overall Study|Withdrawal by Subject|0|||
156400259|NCT02634788|564558356|FG001|Overall Study|Withdrawal by Subject|1|||
156400260|NCT02634788|564558357|FG002|Overall Study|Withdrawal by Subject|1|||
156400261|NCT02634788|564558358|FG003|Overall Study|Withdrawal by Subject|0|||
156400262|NCT00758459|564558359|FG000|Overall Study|Adverse Event|3|||
156550139|NCT00605085|565106807|FG000|Overall Study|Protocol Violation|3|||
156550140|NCT00605085|565106808|FG001|Overall Study|Protocol Violation|2|||
156400263|NCT00758459|564558360|FG001|Overall Study|Adverse Event|2|||
156400264|NCT00758459|564558359|FG000|Overall Study|Protocol Violation|0|||
156400265|NCT00758459|564558360|FG001|Overall Study|Protocol Violation|1|||
156550141|NCT00605085|565106807|FG000|Overall Study|Lost to Follow-up|10|||
156550142|NCT00605085|565106808|FG001|Overall Study|Lost to Follow-up|5|||
156550143|NCT00605085|565106807|FG000|Overall Study|administrative reasons|18|||
156550144|NCT00605085|565106808|FG001|Overall Study|administrative reasons|8|||
156550145|NCT02229552|565106811|FG000|Baseline|Withdrawal by Subject|6|||
156550146|NCT02229552|565106811|FG000|1-year Follow up|Withdrawal by Subject|7|||
156550147|NCT02229552|565106811|FG000|1-year Follow up|Lost to Follow-up|18|||
156550148|NCT02229552|565106811|FG000|2-Year Follow up|Withdrawal by Subject|9|||
156550149|NCT02229552|565106811|FG000|2-Year Follow up|Lost to Follow-up|17|||
156550150|NCT00879229|565106812|FG000|Overall Study|Study terminated by Sponsor|13|||
156550151|NCT00879229|565106813|FG001|Overall Study|Study terminated by Sponsor|12|||
156550152|NCT00879229|565106812|FG000|Overall Study|Death|4|||
156550153|NCT00879229|565106813|FG001|Overall Study|Death|2|||
156550154|NCT00879229|565106812|FG000|Overall Study|Adverse Event|2|||
156550155|NCT00879229|565106813|FG001|Overall Study|Adverse Event|0|||
156550156|NCT00879229|565106812|FG000|Overall Study|Withdrawal by Subject|1|||
156550157|NCT00879229|565106813|FG001|Overall Study|Withdrawal by Subject|0|||
156550158|NCT00879229|565106812|FG000|Overall Study|Clinical status did not improve|1|||
156550159|NCT00879229|565106813|FG001|Overall Study|Clinical status did not improve|0|||
156550160|NCT00879229|565106812|FG000|Overall Study|Other|1|||
156550161|NCT00879229|565106813|FG001|Overall Study|Other|0|||
156550162|NCT01652287|565106823|FG000|Overall Study|Withdrawal by Subject|2|||
156550163|NCT01652287|565106824|FG001|Overall Study|Withdrawal by Subject|0|||
156550164|NCT02605642|565106825|FG000|Overall Study|Other|11|||
156550165|NCT02605642|565106826|FG001|Overall Study|Other|1|||
156550166|NCT02605642|565106825|FG000|Overall Study|Participant non-compliance|2|||
156550167|NCT02605642|565106826|FG001|Overall Study|Participant non-compliance|4|||
156550168|NCT02605642|565106825|FG000|Overall Study|Physician Decision|10|||
156550169|NCT02605642|565106826|FG001|Overall Study|Physician Decision|0|||
156550170|NCT02605642|565106825|FG000|Overall Study|Lost to Follow-up|12|||
156550171|NCT02605642|565106826|FG001|Overall Study|Lost to Follow-up|1|||
156550172|NCT02605642|565106825|FG000|Overall Study|Adverse Event|14|||
156550173|NCT02605642|565106826|FG001|Overall Study|Adverse Event|2|||
156550174|NCT02605642|565106825|FG000|Overall Study|Withdrawal by Subject|23|||
156550175|NCT02605642|565106826|FG001|Overall Study|Withdrawal by Subject|2|||
156550176|NCT02605642|565106825|FG000|Overall Study|Lack of response|24|||
156550177|NCT02605642|565106826|FG001|Overall Study|Lack of response|11|||
156550178|NCT02354703|565106827|FG000|Overall Study|Withdrawal by Subject|1|||
156550179|NCT02354703|565106828|FG001|Overall Study|Withdrawal by Subject|1|||
156550180|NCT02354703|565106829|FG002|Overall Study|Withdrawal by Subject|1|||
156550181|NCT02354703|565106830|FG003|Overall Study|Withdrawal by Subject|1|||
156550182|NCT02354703|565106827|FG000|Overall Study|Lost to Follow-up|2|||
156550183|NCT02354703|565106828|FG001|Overall Study|Lost to Follow-up|7|||
156550184|NCT02354703|565106829|FG002|Overall Study|Lost to Follow-up|9|||
156550185|NCT02354703|565106830|FG003|Overall Study|Lost to Follow-up|2|||
156550186|NCT02354703|565106827|FG000|Overall Study|Adverse Event|0|||
156550187|NCT02354703|565106828|FG001|Overall Study|Adverse Event|0|||
156550188|NCT02354703|565106829|FG002|Overall Study|Adverse Event|1|||
156550189|NCT02354703|565106830|FG003|Overall Study|Adverse Event|0|||
156550190|NCT03704194|565106834|FG000|Overall Study|Withdrawal by Subject|0|||
156550191|NCT03704194|565106835|FG001|Overall Study|Withdrawal by Subject|1|||
156400266|NCT00758459|564558359|FG000|Overall Study|Withdrawal by Subject|0|||
156400267|NCT00758459|564558360|FG001|Overall Study|Withdrawal by Subject|1|||
156550192|NCT00179309|565106836|FG000|Treatment|Toxicity|2|||
156550193|NCT00179309|565106837|FG001|Treatment|Toxicity|3|||
156550194|NCT00179309|565106836|FG000|Treatment|Withdrawal by Subject|1|||
156550195|NCT00179309|565106837|FG001|Treatment|Withdrawal by Subject|2|||
156550196|NCT00179309|565106836|FG000|Treatment|Allergy|1|||
156550197|NCT00179309|565106837|FG001|Treatment|Allergy|0|||
156550198|NCT05131204|565106838|FG000|Overall Study|Sponsor request|2|||
156550199|NCT05131204|565106839|FG001|Overall Study|Sponsor request|1|||
156550200|NCT00488982|565106840|FG000|Course 1|Physician Decision|0|||
156550201|NCT00488982|565106841|FG001|Course 1|Physician Decision|2|||
156550202|NCT00488982|565106842|FG002|Course 1|Physician Decision|4|||
156550203|NCT00488982|565106840|FG000|Course 1|Withdrawal by Subject|0|||
156550204|NCT00488982|565106841|FG001|Course 1|Withdrawal by Subject|8|||
156550205|NCT00488982|565106842|FG002|Course 1|Withdrawal by Subject|2|||
156550206|NCT00488982|565106840|FG000|Course 1|nonprotocol therapy|0|||
156550207|NCT00488982|565106841|FG001|Course 1|nonprotocol therapy|2|||
156550208|NCT00488982|565106842|FG002|Course 1|nonprotocol therapy|2|||
156550209|NCT00488982|565106840|FG000|Course 1|Adverse Event|0|||
156550210|NCT00488982|565106841|FG001|Course 1|Adverse Event|0|||
156550211|NCT00488982|565106842|FG002|Course 1|Adverse Event|6|||
156550212|NCT01368835|565106843|FG000|Overall Study|Inclusion criteria/photography quality|22|||
156550213|NCT01368835|565106843|FG000|Overall Study|Lost to Follow-up|11|||
156550214|NCT01885000|565106844|FG000|Overall Study|Adverse Event|1|||
156550215|NCT01885000|565106845|FG001|Overall Study|Adverse Event|0|||
156550216|NCT01885000|565106844|FG000|Overall Study|Withdrawal by Subject|1|||
156550217|NCT01885000|565106845|FG001|Overall Study|Withdrawal by Subject|1|||
156550218|NCT01885000|565106844|FG000|Overall Study|Protocol Violation|0|||
156550219|NCT01885000|565106845|FG001|Overall Study|Protocol Violation|1|||
156550220|NCT01777152|565106847|FG000|Overall Study|Withdrawal by Subject|22|||
156550221|NCT01777152|565106848|FG001|Overall Study|Withdrawal by Subject|16|||
156550222|NCT01777152|565106847|FG000|Overall Study|Lost to Follow-up|3|||
156550223|NCT01777152|565106848|FG001|Overall Study|Lost to Follow-up|5|||
156550224|NCT01777152|565106847|FG000|Overall Study|Death|68|||
156550225|NCT01777152|565106848|FG001|Overall Study|Death|89|||
156550226|NCT01777152|565106847|FG000|Overall Study|Not eligible, no study drug received|1|||
156550227|NCT01777152|565106848|FG001|Overall Study|Not eligible, no study drug received|0|||
156550228|NCT01777152|565106847|FG000|Overall Study|Change of diagnosis|1|||
156550229|NCT01777152|565106848|FG001|Overall Study|Change of diagnosis|0|||
156550230|NCT01289015|565106853|FG000|Overall Study|Protocol Violation|12|||
156550231|NCT01289015|565106854|FG001|Overall Study|Protocol Violation|9|||
156550232|NCT01289015|565106853|FG000|Overall Study|Adverse Event|3|||
156550233|NCT01289015|565106854|FG001|Overall Study|Adverse Event|0|||
156550234|NCT01289015|565106853|FG000|Overall Study|Lost to Follow-up|33|||
156550235|NCT01289015|565106854|FG001|Overall Study|Lost to Follow-up|17|||
156550236|NCT01289015|565106853|FG000|Overall Study|Withdrawal by Subject|17|||
156550237|NCT01289015|565106854|FG001|Overall Study|Withdrawal by Subject|8|||
156550238|NCT01289015|565106853|FG000|Overall Study|Disease progression|1|||
156550239|NCT01289015|565106854|FG001|Overall Study|Disease progression|0|||
156550240|NCT01289015|565106853|FG000|Overall Study|Negative baseline culture and others|33|||
156550241|NCT01289015|565106854|FG001|Overall Study|Negative baseline culture and others|20|||
156550242|NCT02275338|565106863|FG000|Overall Study|Adverse Event|15|||
156550243|NCT02275338|565106863|FG000|Overall Study|Lack of Efficacy|3|||
156550244|NCT02275338|565106863|FG000|Overall Study|Withdrawal by Subject|4|||
156550245|NCT02275338|565106863|FG000|Overall Study|Disease progression (death)|1|||
156550246|NCT02275338|565106863|FG000|Overall Study|Ineligible to start Phase 2|4|||
156550247|NCT02275338|565106863|FG000|Overall Study|Reason not specified|5|||
156550248|NCT02275338|565106863|FG000|Overall Study|Does not meet entry criteria|1|||
156550249|NCT01888640|565106868|FG000|Overall Study|Lost to Follow-up|1|||
156400268|NCT01780935|564558371|FG000|Overall Study|Admin problems due to early termination|321|||
156400269|NCT01780935|564558372|FG001|Overall Study|Admin problems due to early termination|309|||
156400270|NCT01780935|564558371|FG000|Overall Study|Adverse Event|2|||
156400271|NCT01780935|564558372|FG001|Overall Study|Adverse Event|4|||
156400272|NCT01780935|564558371|FG000|Overall Study|Death|1|||
156400273|NCT01780935|564558372|FG001|Overall Study|Death|6|||
156400274|NCT01780935|564558371|FG000|Overall Study|Lost to Follow-up|2|||
156400275|NCT01780935|564558372|FG001|Overall Study|Lost to Follow-up|6|||
156400276|NCT01780935|564558371|FG000|Overall Study|Physician Decision|1|||
156400277|NCT01780935|564558372|FG001|Overall Study|Physician Decision|1|||
156400278|NCT01780935|564558371|FG000|Overall Study|Protocol deviation|0|||
156400279|NCT01780935|564558372|FG001|Overall Study|Protocol deviation|1|||
156400280|NCT01780935|564558371|FG000|Overall Study|Patient withdrew consent|8|||
156400281|NCT01780935|564558372|FG001|Overall Study|Patient withdrew consent|9|||
156400282|NCT01844284|564558373|FG000|Overall Study|Lost to Follow-up|12|||
156400283|NCT01844284|564558374|FG001|Overall Study|Lost to Follow-up|7|||
156400284|NCT00611858|564558375|FG000|Overall Study|Adverse Event|2|||
156400285|NCT00611858|564558375|FG000|Overall Study|Withdrawal by Subject|2|||
156400286|NCT01820559|564558376|FG000|Overall Study|Adverse Event|4|||
156400287|NCT01820559|564558377|FG001|Overall Study|Adverse Event|6|||
156400288|NCT01820559|564558378|FG002|Overall Study|Adverse Event|13|||
156400289|NCT01820559|564558376|FG000|Overall Study|Withdrawal by Subject|1|||
156400290|NCT01820559|564558377|FG001|Overall Study|Withdrawal by Subject|2|||
156400291|NCT01820559|564558378|FG002|Overall Study|Withdrawal by Subject|5|||
156400292|NCT01820559|564558376|FG000|Overall Study|Protocol Violation|2|||
156400293|NCT01820559|564558377|FG001|Overall Study|Protocol Violation|1|||
156400294|NCT01820559|564558378|FG002|Overall Study|Protocol Violation|3|||
156400295|NCT01820559|564558376|FG000|Overall Study|Subject's non-compliance|1|||
156400296|NCT01820559|564558377|FG001|Overall Study|Subject's non-compliance|0|||
156400297|NCT01820559|564558378|FG002|Overall Study|Subject's non-compliance|2|||
156400298|NCT01820559|564558376|FG000|Overall Study|Lost to Follow-up|3|||
156550250|NCT01888640|565106869|FG001|Overall Study|Lost to Follow-up|2|||
156550251|NCT01888640|565106870|FG002|Overall Study|Lost to Follow-up|0|||
156550252|NCT01888640|565106868|FG000|Overall Study|Withdrawal by Subject|15|||
156550253|NCT01888640|565106869|FG001|Overall Study|Withdrawal by Subject|11|||
156550254|NCT01888640|565106870|FG002|Overall Study|Withdrawal by Subject|4|||
156550255|NCT01888640|565106868|FG000|Overall Study|Minimum dose not met|10|||
156550256|NCT01888640|565106869|FG001|Overall Study|Minimum dose not met|16|||
156550257|NCT01888640|565106870|FG002|Overall Study|Minimum dose not met|0|||
156550258|NCT01888640|565106868|FG000|Overall Study|Given wrong unit (placebo)|1|||
156550259|NCT01888640|565106869|FG001|Overall Study|Given wrong unit (placebo)|0|||
156550260|NCT01888640|565106870|FG002|Overall Study|Given wrong unit (placebo)|0|||
156550261|NCT01888640|565106868|FG000|Overall Study|Excluded for prior TENS|0|||
156400299|NCT01820559|564558377|FG001|Overall Study|Lost to Follow-up|2|||
156400300|NCT01820559|564558378|FG002|Overall Study|Lost to Follow-up|2|||
156400301|NCT01820559|564558376|FG000|Overall Study|At sponsor request|0|||
156400302|NCT01820559|564558377|FG001|Overall Study|At sponsor request|0|||
156400303|NCT01820559|564558378|FG002|Overall Study|At sponsor request|1|||
156400304|NCT01820559|564558376|FG000|Overall Study|Lack of Efficacy|3|||
156400305|NCT01820559|564558377|FG001|Overall Study|Lack of Efficacy|2|||
156400306|NCT01820559|564558378|FG002|Overall Study|Lack of Efficacy|3|||
156400307|NCT02755597|564558379|FG000|Overall Study|Withdrew consent|27|||
156400308|NCT02755597|564558380|FG001|Overall Study|Withdrew consent|11|||
156400309|NCT02755597|564558379|FG000|Overall Study|Lost to Follow-up|1|||
156400310|NCT02755597|564558380|FG001|Overall Study|Lost to Follow-up|0|||
156400311|NCT02755597|564558379|FG000|Overall Study|Death|78|||
156400312|NCT02755597|564558380|FG001|Overall Study|Death|36|||
156400313|NCT02755597|564558379|FG000|Overall Study|Study terminated by Sponsor|67|||
156400314|NCT02755597|564558380|FG001|Overall Study|Study terminated by Sponsor|47|||
156400315|NCT02755597|564558379|FG000|Overall Study|Other, not specified|20|||
156400316|NCT02755597|564558380|FG001|Overall Study|Other, not specified|3|||
156400317|NCT02755597|564558379|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
156400318|NCT02755597|564558380|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
156400319|NCT00166296|564558381|FG000|Overall Study|Withdrawal by Subject|1|||
156400320|NCT00166296|564558382|FG001|Overall Study|Withdrawal by Subject|3|||
156400321|NCT00166296|564558381|FG000|Overall Study|Adverse Event|2|||
156400322|NCT00166296|564558382|FG001|Overall Study|Adverse Event|4|||
156400323|NCT00166296|564558381|FG000|Overall Study|Lost to Follow-up|4|||
156400324|NCT00166296|564558382|FG001|Overall Study|Lost to Follow-up|2|||
156400325|NCT03351738|564558383|FG000|Overall Study|Withdrawal by Subject|0|||
156400326|NCT03351738|564558384|FG001|Overall Study|Withdrawal by Subject|1|||
156400327|NCT03351738|564558385|FG002|Overall Study|Withdrawal by Subject|0|||
156400328|NCT03351738|564558386|FG003|Overall Study|Withdrawal by Subject|1|||
156400329|NCT03351738|564558387|FG004|Overall Study|Withdrawal by Subject|0|||
156400330|NCT03351738|564558388|FG005|Overall Study|Withdrawal by Subject|0|||
156400331|NCT02597036|564558391|FG000|Overall Study|Progressive Disease|0|||
156400332|NCT02597036|564558392|FG001|Overall Study|Progressive Disease|0|||
156400333|NCT02597036|564558393|FG002|Overall Study|Progressive Disease|0|||
156400334|NCT02597036|564558394|FG003|Overall Study|Progressive Disease|0|||
156400335|NCT02597036|564558395|FG004|Overall Study|Progressive Disease|1|||
156400336|NCT02597036|564558396|FG005|Overall Study|Progressive Disease|1|||
156400337|NCT02597036|564558397|FG006|Overall Study|Progressive Disease|1|||
156400338|NCT02597036|564558398|FG007|Overall Study|Progressive Disease|0|||
156400339|NCT02597036|564558399|FG008|Overall Study|Progressive Disease|0|||
156400340|NCT02597036|564558400|FG009|Overall Study|Progressive Disease|0|||
156400341|NCT02597036|564558401|FG010|Overall Study|Progressive Disease|0|||
156400342|NCT02597036|564558402|FG011|Overall Study|Progressive Disease|0|||
156509280|NCT01252355|564957548|FG000|Overall Study|Poor Compliance to Protocol|1|||
156509281|NCT01252355|564957549|FG001|Overall Study|Poor Compliance to Protocol|1|||
156509282|NCT01252355|564957550|FG002|Overall Study|Poor Compliance to Protocol|1|||
156509283|NCT01252355|564957548|FG000|Overall Study|Progressive Disease|2|||
156509284|NCT01252355|564957549|FG001|Overall Study|Progressive Disease|0|||
156509285|NCT01252355|564957550|FG002|Overall Study|Progressive Disease|0|||
156509286|NCT01252355|564957548|FG000|Overall Study|Sponsor Early Termination of Study|149|||
156509287|NCT01252355|564957549|FG001|Overall Study|Sponsor Early Termination of Study|149|||
156509288|NCT01252355|564957550|FG002|Overall Study|Sponsor Early Termination of Study|146|||
156509289|NCT01252355|564957548|FG000|Overall Study|Randomized but not Treated|2|||
156509290|NCT01252355|564957549|FG001|Overall Study|Randomized but not Treated|0|||
156509291|NCT01252355|564957550|FG002|Overall Study|Randomized but not Treated|0|||
156509292|NCT01252355|564957548|FG000|Overall Study|Other Than Above|8|||
156509293|NCT01252355|564957549|FG001|Overall Study|Other Than Above|7|||
156509294|NCT01252355|564957550|FG002|Overall Study|Other Than Above|7|||
156509295|NCT04546425|564957553|FG000|Overall Study|Protocol Violation|1|||
156509296|NCT04546425|564957554|FG001|Overall Study|Protocol Violation|1|||
156509297|NCT04546425|564957555|FG002|Overall Study|Protocol Violation|0|||
156509298|NCT04546425|564957556|FG003|Overall Study|Protocol Violation|0|||
156400343|NCT02597036|564558391|FG000|Overall Study|Adverse Event|0|||
156400344|NCT02597036|564558392|FG001|Overall Study|Adverse Event|0|||
156400345|NCT02597036|564558393|FG002|Overall Study|Adverse Event|0|||
156400346|NCT02597036|564558394|FG003|Overall Study|Adverse Event|0|||
156400347|NCT02597036|564558395|FG004|Overall Study|Adverse Event|0|||
156400348|NCT02597036|564558396|FG005|Overall Study|Adverse Event|0|||
156400349|NCT02597036|564558397|FG006|Overall Study|Adverse Event|0|||
156400350|NCT02597036|564558398|FG007|Overall Study|Adverse Event|1|||
156400351|NCT02597036|564558399|FG008|Overall Study|Adverse Event|0|||
156400352|NCT02597036|564558400|FG009|Overall Study|Adverse Event|0|||
156400353|NCT02597036|564558401|FG010|Overall Study|Adverse Event|0|||
156509299|NCT04546425|564957553|FG000|Overall Study|Adverse Event|3|||
156509300|NCT04546425|564957554|FG001|Overall Study|Adverse Event|0|||
156400354|NCT02597036|564558402|FG011|Overall Study|Adverse Event|1|||
156400355|NCT02597036|564558391|FG000|Overall Study|Death|0|||
156400356|NCT02597036|564558392|FG001|Overall Study|Death|0|||
156400357|NCT02597036|564558393|FG002|Overall Study|Death|0|||
156400358|NCT02597036|564558394|FG003|Overall Study|Death|0|||
156509301|NCT04546425|564957555|FG002|Overall Study|Adverse Event|0|||
156509302|NCT04546425|564957556|FG003|Overall Study|Adverse Event|0|||
156400359|NCT02597036|564558395|FG004|Overall Study|Death|0|||
156400360|NCT02597036|564558396|FG005|Overall Study|Death|0|||
156400361|NCT02597036|564558397|FG006|Overall Study|Death|0|||
156400362|NCT02597036|564558398|FG007|Overall Study|Death|0|||
156400363|NCT02597036|564558399|FG008|Overall Study|Death|0|||
156400364|NCT02597036|564558400|FG009|Overall Study|Death|1|||
156400365|NCT02597036|564558401|FG010|Overall Study|Death|1|||
156400366|NCT02597036|564558402|FG011|Overall Study|Death|0|||
156400367|NCT02597036|564558391|FG000|Overall Study|Lost to Follow-up|0|||
156509303|NCT04546425|564957553|FG000|Overall Study|Lost to Follow-up|5|||
156509304|NCT04546425|564957554|FG001|Overall Study|Lost to Follow-up|4|||
156509305|NCT04546425|564957555|FG002|Overall Study|Lost to Follow-up|0|||
156509306|NCT04546425|564957556|FG003|Overall Study|Lost to Follow-up|0|||
156509307|NCT04546425|564957553|FG000|Overall Study|No Longer met eligibility criteria|3|||
156509308|NCT04546425|564957554|FG001|Overall Study|No Longer met eligibility criteria|3|||
156509309|NCT04546425|564957555|FG002|Overall Study|No Longer met eligibility criteria|1|||
156509310|NCT04546425|564957556|FG003|Overall Study|No Longer met eligibility criteria|1|||
156509311|NCT04546425|564957553|FG000|Overall Study|Withdrawal by parent/guardian|6|||
156509312|NCT04546425|564957554|FG001|Overall Study|Withdrawal by parent/guardian|5|||
156509313|NCT04546425|564957555|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156509314|NCT04546425|564957556|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156509315|NCT03435692|564957559|FG000|Overall Study|Lack of Efficacy|2|||
156509316|NCT03435692|564957560|FG001|Overall Study|Lack of Efficacy|2|||
156509317|NCT03435692|564957561|FG002|Overall Study|Lack of Efficacy|0|||
156509318|NCT02964325|564957562|FG000|Overall Study|Lost to Follow-up|3|||
156509319|NCT02964325|564957563|FG001|Overall Study|Lost to Follow-up|3|||
156509320|NCT02964325|564957562|FG000|Overall Study|Physician Decision|5|||
156509321|NCT02964325|564957563|FG001|Overall Study|Physician Decision|4|||
156509322|NCT02964325|564957562|FG000|Overall Study|Death|1|||
156509323|NCT02964325|564957563|FG001|Overall Study|Death|3|||
156509324|NCT02964325|564957562|FG000|Overall Study|Withdrawal by Subject|2|||
156509325|NCT02964325|564957563|FG001|Overall Study|Withdrawal by Subject|1|||
156509326|NCT02964325|564957562|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
156509327|NCT02964325|564957563|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
156509328|NCT02510040|564957564|FG000|Overall Study|Deemed no longer eligible|18|||
156509329|NCT02510040|564957565|FG001|Overall Study|Deemed no longer eligible|3|||
156509330|NCT02510040|564957566|FG002|Overall Study|Deemed no longer eligible|1|||
156509331|NCT02195479|564957568|FG000|Overall Study|Lost to Follow-up|18|||
156509332|NCT02195479|564957569|FG001|Overall Study|Lost to Follow-up|15|||
156509333|NCT02195479|564957568|FG000|Overall Study|Death|217|||
156509334|NCT02195479|564957569|FG001|Overall Study|Death|171|||
156509335|NCT02195479|564957568|FG000|Overall Study|Physician Decision|1|||
156509336|NCT02195479|564957569|FG001|Overall Study|Physician Decision|0|||
156509337|NCT02195479|564957568|FG000|Overall Study|Withdrawal by Subject|30|||
156509338|NCT02195479|564957569|FG001|Overall Study|Withdrawal by Subject|30|||
156509339|NCT02195479|564957568|FG000|Overall Study|Other|3|||
156509340|NCT02195479|564957569|FG001|Overall Study|Other|4|||
156509341|NCT02195479|564957568|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
156509342|NCT02195479|564957569|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
156509343|NCT01263509|564957570|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
156509344|NCT01263509|564957571|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
156509345|NCT01263509|564957572|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
156509346|NCT01263509|564957573|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
156509347|NCT01263509|564957570|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
156509348|NCT01263509|564957571|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
156509349|NCT01263509|564957572|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
156509350|NCT01263509|564957573|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
156509351|NCT01263509|564957570|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156509352|NCT01263509|564957571|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156509353|NCT01263509|564957572|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156509354|NCT01263509|564957573|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156509355|NCT01263509|564957570|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
156509356|NCT01263509|564957571|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
156509357|NCT01263509|564957572|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156509358|NCT01263509|564957573|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
156509359|NCT01263509|564957570|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
156509360|NCT01263509|564957571|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
156509361|NCT01263509|564957572|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
156550262|NCT01888640|565106869|FG001|Overall Study|Excluded for prior TENS|1|||
156400368|NCT02597036|564558392|FG001|Overall Study|Lost to Follow-up|0|||
156400369|NCT02597036|564558393|FG002|Overall Study|Lost to Follow-up|0|||
156400370|NCT02597036|564558394|FG003|Overall Study|Lost to Follow-up|0|||
156400371|NCT02597036|564558395|FG004|Overall Study|Lost to Follow-up|0|||
156400372|NCT02597036|564558396|FG005|Overall Study|Lost to Follow-up|0|||
156400373|NCT02597036|564558397|FG006|Overall Study|Lost to Follow-up|0|||
156400374|NCT02597036|564558398|FG007|Overall Study|Lost to Follow-up|0|||
156400375|NCT02597036|564558399|FG008|Overall Study|Lost to Follow-up|0|||
156400376|NCT02597036|564558400|FG009|Overall Study|Lost to Follow-up|0|||
156400377|NCT02597036|564558401|FG010|Overall Study|Lost to Follow-up|1|||
156400378|NCT02597036|564558402|FG011|Overall Study|Lost to Follow-up|0|||
156400379|NCT02597036|564558391|FG000|Overall Study|Withdrawal by Subject|0|||
156400380|NCT02597036|564558392|FG001|Overall Study|Withdrawal by Subject|0|||
156400381|NCT02597036|564558393|FG002|Overall Study|Withdrawal by Subject|0|||
156400382|NCT02597036|564558394|FG003|Overall Study|Withdrawal by Subject|0|||
156400383|NCT02597036|564558395|FG004|Overall Study|Withdrawal by Subject|0|||
156400384|NCT02597036|564558396|FG005|Overall Study|Withdrawal by Subject|0|||
156400385|NCT02597036|564558397|FG006|Overall Study|Withdrawal by Subject|0|||
156400386|NCT02597036|564558398|FG007|Overall Study|Withdrawal by Subject|0|||
156400387|NCT02597036|564558399|FG008|Overall Study|Withdrawal by Subject|0|||
156400388|NCT02597036|564558400|FG009|Overall Study|Withdrawal by Subject|0|||
156400389|NCT02597036|564558401|FG010|Overall Study|Withdrawal by Subject|0|||
156400390|NCT02597036|564558402|FG011|Overall Study|Withdrawal by Subject|1|||
156400391|NCT06351371|564558403|FG000|Overall Study|Mutation Status Not Confirmed|9|||
156400392|NCT06351371|564558403|FG000|Overall Study|Ineligible|1|||
156400393|NCT06351371|564558403|FG000|Overall Study|Adverse Event|4|||
156400394|NCT06351371|564558403|FG000|Overall Study|Death|1|||
156400395|NCT06351371|564558403|FG000|Overall Study|Disease progression|14|||
156400396|NCT06351371|564558403|FG000|Overall Study|Withdrawal by Subject|3|||
156400397|NCT06351371|564558403|FG000|Overall Study|Physician Decision|3|||
156400398|NCT03759834|564558404|FG000|Overall Study|Withdrawal by Subject|1|||
156400399|NCT02515279|564558405|FG000|Overall Study|Adverse Event|7|||
156400400|NCT02515279|564558405|FG000|Overall Study|Lack of Efficacy|31|||
156400401|NCT02515279|564558405|FG000|Overall Study|Lost to Follow-up|9|||
156400402|NCT02515279|564558405|FG000|Overall Study|Withdrawal by Subject|18|||
156400403|NCT02515279|564558405|FG000|Overall Study|End-of-treatment visit not attended|17|||
156400404|NCT02515279|564558405|FG000|Overall Study|Other|22|||
156400405|NCT01800968|564558406|FG000|Overall Study|Death|23|||
156400406|NCT01800968|564558407|FG001|Overall Study|Death|16|||
156400407|NCT01800968|564558406|FG000|Overall Study|Lost to Follow-up|5|||
156400408|NCT01800968|564558407|FG001|Overall Study|Lost to Follow-up|7|||
156400409|NCT01800968|564558406|FG000|Overall Study|Withdrawal by Subject|7|||
156400410|NCT01800968|564558407|FG001|Overall Study|Withdrawal by Subject|9|||
156400411|NCT01800968|564558406|FG000|Overall Study|Physician Decision|1|||
156400412|NCT01800968|564558407|FG001|Overall Study|Physician Decision|0|||
156400413|NCT04987762|564558409|FG000|Overall Study|Study was Terminated by Sponsor|103|||
156400414|NCT03185481|564558410|FG000|Overall Study|Adverse Event|1|||
156400415|NCT03185481|564558410|FG000|Overall Study|Study Terminated by Sponsor|4|||
156400416|NCT03371940|564558413|FG000|Overall Study|Withdrawal by Subject|8|||
156400417|NCT03371940|564558414|FG001|Overall Study|Withdrawal by Subject|1|||
156400418|NCT03371940|564558415|FG002|Overall Study|Withdrawal by Subject|3|||
156400419|NCT03371940|564558416|FG003|Overall Study|Withdrawal by Subject|4|||
156400420|NCT05099926|564558419|FG000|Overall Study|Lost to Follow-up|1|||
156400421|NCT00031486|564558427|FG000|Overall Study|Adverse Event|1|||
156400422|NCT00031486|564558428|FG001|Overall Study|Adverse Event|0|||
156400423|NCT00031486|564558427|FG000|Overall Study|Lost to Follow-up|0|||
156400424|NCT00031486|564558428|FG001|Overall Study|Lost to Follow-up|1|||
156400425|NCT00031486|564558427|FG000|Overall Study|Withdrawal by Subject|3|||
156400426|NCT00031486|564558428|FG001|Overall Study|Withdrawal by Subject|2|||
156400427|NCT00031486|564558427|FG000|Overall Study|Death|0|||
156400428|NCT00031486|564558428|FG001|Overall Study|Death|3|||
156400429|NCT00031486|564558427|FG000|Overall Study|Non-compliant|0|||
156400430|NCT00031486|564558428|FG001|Overall Study|Non-compliant|4|||
156400431|NCT00031486|564558427|FG000|Overall Study|Did not meet eligibility requirement|2|||
156400432|NCT00031486|564558428|FG001|Overall Study|Did not meet eligibility requirement|1|||
156400433|NCT00031486|564558427|FG000|Overall Study|Other|1|||
156400434|NCT00031486|564558428|FG001|Overall Study|Other|1|||
156400435|NCT03685591|564558429|FG000|Overall Study|Global Deterioration of Health Status|0|||
156400436|NCT03685591|564558430|FG001|Overall Study|Global Deterioration of Health Status|0|||
156400437|NCT03685591|564558431|FG002|Overall Study|Global Deterioration of Health Status|0|||
156400438|NCT03685591|564558432|FG003|Overall Study|Global Deterioration of Health Status|1|||
156400439|NCT03685591|564558433|FG004|Overall Study|Global Deterioration of Health Status|2|||
156400440|NCT03685591|564558434|FG005|Overall Study|Global Deterioration of Health Status|4|||
156400441|NCT03685591|564558435|FG006|Overall Study|Global Deterioration of Health Status|1|||
156400442|NCT03685591|564558436|FG007|Overall Study|Global Deterioration of Health Status|1|||
156400443|NCT03685591|564558437|FG008|Overall Study|Global Deterioration of Health Status|0|||
156400444|NCT03685591|564558429|FG000|Overall Study|Progressive Disease|1|||
156400445|NCT03685591|564558430|FG001|Overall Study|Progressive Disease|1|||
156400446|NCT03685591|564558431|FG002|Overall Study|Progressive Disease|0|||
156400447|NCT03685591|564558432|FG003|Overall Study|Progressive Disease|3|||
156400448|NCT03685591|564558433|FG004|Overall Study|Progressive Disease|5|||
156550263|NCT01888640|565106870|FG002|Overall Study|Excluded for prior TENS|0|||
156550264|NCT01888640|565106868|FG000|Overall Study|Researcher Termination of Participant|0|||
156550265|NCT01888640|565106869|FG001|Overall Study|Researcher Termination of Participant|1|||
156550266|NCT01888640|565106870|FG002|Overall Study|Researcher Termination of Participant|1|||
156550267|NCT01277549|565106871|FG000|Overall Study|Failed to meet eligibility criteria|13|||
156550268|NCT01277549|565106872|FG001|Overall Study|Failed to meet eligibility criteria|9|||
156550269|NCT01277549|565106871|FG000|Overall Study|Withdrawal by Subject|1|||
156550270|NCT01277549|565106872|FG001|Overall Study|Withdrawal by Subject|3|||
156550271|NCT01277549|565106871|FG000|Overall Study|Protocol Violation|10|||
156550272|NCT01277549|565106872|FG001|Overall Study|Protocol Violation|1|||
156550273|NCT01277549|565106871|FG000|Overall Study|Physician Decision|2|||
156550274|NCT01277549|565106872|FG001|Overall Study|Physician Decision|1|||
156550275|NCT01692301|565106873|FG000|Overall Study|Adverse Event|15|||
156550276|NCT01692301|565106874|FG001|Overall Study|Adverse Event|12|||
156550277|NCT01692301|565106873|FG000|Overall Study|Death|1|||
156550278|NCT01692301|565106874|FG001|Overall Study|Death|2|||
156550279|NCT01692301|565106873|FG000|Overall Study|Lack of Efficacy|0|||
156550280|NCT01692301|565106874|FG001|Overall Study|Lack of Efficacy|5|||
156550281|NCT01692301|565106873|FG000|Overall Study|Non-compliance with study treatment|1|||
156550282|NCT01692301|565106874|FG001|Overall Study|Non-compliance with study treatment|2|||
156550283|NCT01692301|565106873|FG000|Overall Study|Protocol deviation|9|||
156550284|NCT01692301|565106874|FG001|Overall Study|Protocol deviation|2|||
156550285|NCT01692301|565106873|FG000|Overall Study|Patient/guardian decision|16|||
156550286|NCT01692301|565106874|FG001|Overall Study|Patient/guardian decision|15|||
156550287|NCT01692301|565106873|FG000|Overall Study|Technical problems|0|||
156550288|NCT01692301|565106874|FG001|Overall Study|Technical problems|1|||
156550289|NCT01692301|565106873|FG000|Overall Study|Physician Decision|2|||
156550290|NCT01692301|565106874|FG001|Overall Study|Physician Decision|2|||
156550291|NCT01692301|565106873|FG000|Overall Study|Lost to Follow-up|1|||
156550292|NCT01692301|565106874|FG001|Overall Study|Lost to Follow-up|1|||
156550293|NCT02228590|565106875|FG000|Overall Study|Withdrawal by Subject|1|||
156550294|NCT02109484|565106876|FG000|Overall Study|Lost to Follow-up|0|||
156550295|NCT02109484|565106877|FG001|Overall Study|Lost to Follow-up|0|||
156550296|NCT02109484|565106878|FG002|Overall Study|Lost to Follow-up|0|||
156550297|NCT02109484|565106879|FG003|Overall Study|Lost to Follow-up|1|||
156550298|NCT02109484|565106880|FG004|Overall Study|Lost to Follow-up|1|||
156550299|NCT02109484|565106881|FG005|Overall Study|Lost to Follow-up|0|||
156550300|NCT02109484|565106882|FG006|Overall Study|Lost to Follow-up|1|||
156550301|NCT02109484|565106883|FG007|Overall Study|Lost to Follow-up|0|||
156550302|NCT02109484|565106876|FG000|Overall Study|Withdrawal by Subject|0|||
156550303|NCT02109484|565106877|FG001|Overall Study|Withdrawal by Subject|0|||
156550304|NCT02109484|565106878|FG002|Overall Study|Withdrawal by Subject|0|||
156550305|NCT02109484|565106879|FG003|Overall Study|Withdrawal by Subject|0|||
156550306|NCT02109484|565106880|FG004|Overall Study|Withdrawal by Subject|1|||
156550307|NCT02109484|565106881|FG005|Overall Study|Withdrawal by Subject|1|||
156550308|NCT02109484|565106882|FG006|Overall Study|Withdrawal by Subject|1|||
156550309|NCT02109484|565106883|FG007|Overall Study|Withdrawal by Subject|0|||
156550310|NCT02109484|565106876|FG000|Overall Study|Physician Decision|0|||
156550311|NCT02109484|565106877|FG001|Overall Study|Physician Decision|0|||
156550312|NCT02109484|565106878|FG002|Overall Study|Physician Decision|0|||
156550313|NCT02109484|565106879|FG003|Overall Study|Physician Decision|0|||
156550314|NCT02109484|565106880|FG004|Overall Study|Physician Decision|2|||
156550315|NCT02109484|565106881|FG005|Overall Study|Physician Decision|0|||
156550316|NCT02109484|565106882|FG006|Overall Study|Physician Decision|0|||
156550317|NCT02109484|565106883|FG007|Overall Study|Physician Decision|0|||
156550318|NCT02109484|565106876|FG000|Overall Study|Death|0|||
156550319|NCT02109484|565106877|FG001|Overall Study|Death|0|||
156550320|NCT02109484|565106878|FG002|Overall Study|Death|0|||
156550321|NCT02109484|565106879|FG003|Overall Study|Death|0|||
156550322|NCT02109484|565106880|FG004|Overall Study|Death|0|||
156550323|NCT02109484|565106881|FG005|Overall Study|Death|0|||
156550324|NCT02109484|565106882|FG006|Overall Study|Death|0|||
156550325|NCT02109484|565106883|FG007|Overall Study|Death|2|||
156550326|NCT02109484|565106876|FG000|Overall Study|Moved away from study area|0|||
156550327|NCT02109484|565106877|FG001|Overall Study|Moved away from study area|0|||
156550328|NCT02109484|565106878|FG002|Overall Study|Moved away from study area|0|||
156550329|NCT02109484|565106879|FG003|Overall Study|Moved away from study area|0|||
156550330|NCT02109484|565106880|FG004|Overall Study|Moved away from study area|0|||
156550331|NCT02109484|565106881|FG005|Overall Study|Moved away from study area|0|||
156550332|NCT02109484|565106882|FG006|Overall Study|Moved away from study area|1|||
156550333|NCT02109484|565106883|FG007|Overall Study|Moved away from study area|1|||
156550334|NCT02111993|565106884|FG000|Overall Study|Physician Decision|5|||
156550335|NCT02111993|565106885|FG001|Overall Study|Physician Decision|4|||
156550336|NCT00419380|565106886|FG000|Overall Study|Lack of Efficacy|1|||
156550337|NCT00419380|565106887|FG001|Overall Study|Lack of Efficacy|7|||
156550338|NCT00419380|565106886|FG000|Overall Study|Physician Decision|0|||
156550339|NCT00419380|565106887|FG001|Overall Study|Physician Decision|1|||
156550340|NCT00419380|565106886|FG000|Overall Study|Lost to Follow-up|0|||
156550341|NCT00419380|565106887|FG001|Overall Study|Lost to Follow-up|1|||
156550342|NCT00419380|565106886|FG000|Overall Study|Withdrawal by Subject|0|||
156550343|NCT00419380|565106887|FG001|Overall Study|Withdrawal by Subject|1|||
156550344|NCT00796315|565106888|FG000|Overall Study|Protocol Violation|0|||
156550345|NCT00796315|565106889|FG001|Overall Study|Protocol Violation|1|||
156550346|NCT00796315|565106890|FG002|Overall Study|Protocol Violation|0|||
156550347|NCT01400451|565106903|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
156550348|NCT01400451|565106904|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
156550349|NCT01400451|565106905|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
156550350|NCT01400451|565106903|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
156550351|NCT01400451|565106904|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
156550352|NCT01400451|565106905|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
156550353|NCT01400451|565106903|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
156550354|NCT01400451|565106904|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
156550355|NCT01400451|565106905|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
156550356|NCT01400451|565106903|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
156550357|NCT01400451|565106904|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
156550358|NCT01400451|565106905|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
156550359|NCT01400451|565106903|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
156550360|NCT01400451|565106904|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
156550361|NCT01400451|565106905|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
156550362|NCT00574275|565106906|FG000|Overall Study|Randomized but not treated|2|||
156550363|NCT00574275|565106907|FG001|Overall Study|Randomized but not treated|3|||
156550364|NCT00574275|565106906|FG000|Overall Study|Adverse Event|32|||
156550365|NCT00574275|565106907|FG001|Overall Study|Adverse Event|76|||
156400449|NCT03685591|564558434|FG005|Overall Study|Progressive Disease|4|||
156400450|NCT03685591|564558435|FG006|Overall Study|Progressive Disease|3|||
156400451|NCT03685591|564558436|FG007|Overall Study|Progressive Disease|2|||
156550366|NCT00574275|565106906|FG000|Overall Study|Disease progression|160|||
156550367|NCT00574275|565106907|FG001|Overall Study|Disease progression|146|||
156550368|NCT00574275|565106906|FG000|Overall Study|Lost to Follow-up|2|||
156550369|NCT00574275|565106907|FG001|Overall Study|Lost to Follow-up|1|||
156550370|NCT00574275|565106906|FG000|Overall Study|Study stopped based on DMC decision|62|||
156550371|NCT00574275|565106907|FG001|Overall Study|Study stopped based on DMC decision|23|||
156550372|NCT00574275|565106906|FG000|Overall Study|Withdrawal by Subject|15|||
156550373|NCT00574275|565106907|FG001|Overall Study|Withdrawal by Subject|17|||
156550374|NCT00574275|565106906|FG000|Overall Study|Error calculating tumor measurement|1|||
156550375|NCT00574275|565106907|FG001|Overall Study|Error calculating tumor measurement|0|||
156550376|NCT00574275|565106906|FG000|Overall Study|Physician Decision|1|||
156550377|NCT00574275|565106907|FG001|Overall Study|Physician Decision|1|||
156550378|NCT00574275|565106906|FG000|Overall Study|Protocol Violation|0|||
156550379|NCT00574275|565106907|FG001|Overall Study|Protocol Violation|1|||
156550380|NCT00574275|565106906|FG000|Overall Study|Patient and Investigator decision|0|||
156550381|NCT00574275|565106907|FG001|Overall Study|Patient and Investigator decision|1|||
156550382|NCT00574275|565106906|FG000|Overall Study|Insurance change|0|||
156550383|NCT00574275|565106907|FG001|Overall Study|Insurance change|1|||
156550384|NCT00574275|565106906|FG000|Overall Study|Operation for curative intent|0|||
156550385|NCT00574275|565106907|FG001|Overall Study|Operation for curative intent|1|||
156550386|NCT00889265|565106915|FG000|Overall Study|Adverse Event|1|||
156550387|NCT00889265|565106915|FG000|Overall Study|Lost to Follow-up|5|||
156550388|NCT00889265|565106915|FG000|Overall Study|Protocol Violation|1|||
156550389|NCT03028870|565106918|FG000|Overall Study|Adverse Event|7|||
156550390|NCT03028870|565106919|FG001|Overall Study|Adverse Event|4|||
156550391|NCT03028870|565106920|FG002|Overall Study|Adverse Event|3|||
156550392|NCT03028870|565106921|FG003|Overall Study|Adverse Event|3|||
156550393|NCT03028870|565106918|FG000|Overall Study|Withdrawal by Subject|1|||
156550394|NCT03028870|565106919|FG001|Overall Study|Withdrawal by Subject|1|||
156400452|NCT03685591|564558437|FG008|Overall Study|Progressive Disease|1|||
156550395|NCT03028870|565106920|FG002|Overall Study|Withdrawal by Subject|1|||
156550396|NCT03028870|565106921|FG003|Overall Study|Withdrawal by Subject|2|||
156550397|NCT03028870|565106918|FG000|Overall Study|Lost to Follow-up|1|||
156550398|NCT03028870|565106919|FG001|Overall Study|Lost to Follow-up|0|||
156400453|NCT03685591|564558429|FG000|Overall Study|Other|0|||
156400454|NCT03685591|564558430|FG001|Overall Study|Other|0|||
156550399|NCT03028870|565106920|FG002|Overall Study|Lost to Follow-up|0|||
156550400|NCT03028870|565106921|FG003|Overall Study|Lost to Follow-up|0|||
156550401|NCT03028870|565106918|FG000|Overall Study|Lack of Efficacy|3|||
156550402|NCT03028870|565106919|FG001|Overall Study|Lack of Efficacy|0|||
156550403|NCT03028870|565106920|FG002|Overall Study|Lack of Efficacy|0|||
156550404|NCT03028870|565106921|FG003|Overall Study|Lack of Efficacy|0|||
156550405|NCT03028870|565106918|FG000|Overall Study|Administrative|5|||
156550406|NCT03028870|565106919|FG001|Overall Study|Administrative|5|||
156550407|NCT03028870|565106920|FG002|Overall Study|Administrative|12|||
156550408|NCT03028870|565106921|FG003|Overall Study|Administrative|4|||
156550409|NCT00317109|565106922|FG000|Overall Study|Withdrawal by Subject|2|||
156550410|NCT00317109|565106923|FG001|Overall Study|Withdrawal by Subject|0|||
156400455|NCT03685591|564558431|FG002|Overall Study|Other|1|||
156400456|NCT03685591|564558432|FG003|Overall Study|Other|0|||
156400457|NCT03685591|564558433|FG004|Overall Study|Other|2|||
156400458|NCT03685591|564558434|FG005|Overall Study|Other|3|||
156400459|NCT03685591|564558435|FG006|Overall Study|Other|0|||
156400460|NCT03685591|564558436|FG007|Overall Study|Other|0|||
156400461|NCT03685591|564558437|FG008|Overall Study|Other|0|||
156400462|NCT03685591|564558429|FG000|Overall Study|Withdrawal by Subject|0|||
156400463|NCT03685591|564558430|FG001|Overall Study|Withdrawal by Subject|0|||
156400464|NCT03685591|564558431|FG002|Overall Study|Withdrawal by Subject|0|||
156400465|NCT03685591|564558432|FG003|Overall Study|Withdrawal by Subject|0|||
156400466|NCT03685591|564558433|FG004|Overall Study|Withdrawal by Subject|3|||
156400467|NCT03685591|564558434|FG005|Overall Study|Withdrawal by Subject|2|||
156400468|NCT03685591|564558435|FG006|Overall Study|Withdrawal by Subject|0|||
156400469|NCT03685591|564558436|FG007|Overall Study|Withdrawal by Subject|0|||
156400470|NCT03685591|564558437|FG008|Overall Study|Withdrawal by Subject|1|||
156400471|NCT03685591|564558429|FG000|Overall Study|Adverse Event|0|||
156400472|NCT03685591|564558430|FG001|Overall Study|Adverse Event|0|||
156400473|NCT03685591|564558431|FG002|Overall Study|Adverse Event|0|||
156400474|NCT03685591|564558432|FG003|Overall Study|Adverse Event|1|||
156400475|NCT03685591|564558433|FG004|Overall Study|Adverse Event|1|||
156400476|NCT03685591|564558434|FG005|Overall Study|Adverse Event|4|||
156400477|NCT03685591|564558435|FG006|Overall Study|Adverse Event|0|||
156400478|NCT03685591|564558436|FG007|Overall Study|Adverse Event|1|||
156400479|NCT03685591|564558437|FG008|Overall Study|Adverse Event|1|||
156400480|NCT01685138|564558440|FG000|Overall Study|Lost to Follow-up|1|||
156400481|NCT01685138|564558440|FG000|Overall Study|Protocol Violation|1|||
156400482|NCT01685138|564558440|FG000|Overall Study|No longer requires treatment|1|||
156400483|NCT01685138|564558440|FG000|Overall Study|Subject/guardian decision|2|||
156400484|NCT01685138|564558440|FG000|Overall Study|Physician Decision|6|||
156400485|NCT01685138|564558440|FG000|Overall Study|Death|10|||
156400486|NCT01685138|564558440|FG000|Overall Study|Adverse Event|18|||
156400487|NCT01685138|564558440|FG000|Overall Study|Progressive disease|53|||
156400488|NCT00689026|564558443|FG000|Overall Study|Withdrawal by Subject|13|||
156400489|NCT00689026|564558444|FG001|Overall Study|Withdrawal by Subject|6|||
156400490|NCT02220894|564558445|FG000|Overall Study|Adverse Event|127|||
156400491|NCT02220894|564558446|FG001|Overall Study|Adverse Event|74|||
156400492|NCT02220894|564558445|FG000|Overall Study|Death|418|||
156400493|NCT02220894|564558446|FG001|Overall Study|Death|508|||
156400494|NCT02220894|564558445|FG000|Overall Study|Lost to Follow-up|0|||
156400495|NCT02220894|564558446|FG001|Overall Study|Lost to Follow-up|4|||
156400496|NCT02220894|564558445|FG000|Overall Study|Site Terminated by Sponsor|2|||
156400497|NCT02220894|564558446|FG001|Overall Study|Site Terminated by Sponsor|0|||
156400498|NCT02220894|564558445|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
156400499|NCT02220894|564558446|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
156400500|NCT02220894|564558445|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156400501|NCT02220894|564558446|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156400502|NCT02220894|564558445|FG000|Overall Study|Withdrawal by Subject|10|||
156400503|NCT02220894|564558446|FG001|Overall Study|Withdrawal by Subject|9|||
156400504|NCT03217747|564558447|FG000|Overall Study|Adverse Event|0|||
156400505|NCT03217747|564558448|FG001|Overall Study|Adverse Event|1|||
156400506|NCT03217747|564558449|FG002|Overall Study|Adverse Event|0|||
156400507|NCT03217747|564558450|FG003|Overall Study|Adverse Event|0|||
156400508|NCT03217747|564558451|FG004|Overall Study|Adverse Event|0|||
156400509|NCT03217747|564558452|FG005|Overall Study|Adverse Event|0|||
156400510|NCT03217747|564558453|FG006|Overall Study|Adverse Event|0|||
156400511|NCT03217747|564558454|FG007|Overall Study|Adverse Event|0|||
156400512|NCT03217747|564558455|FG008|Overall Study|Adverse Event|0|||
156400513|NCT03217747|564558456|FG009|Overall Study|Adverse Event|0|||
156400514|NCT03217747|564558457|FG010|Overall Study|Adverse Event|0|||
156400515|NCT03217747|564558458|FG011|Overall Study|Adverse Event|0|||
156400516|NCT03217747|564558459|FG012|Overall Study|Adverse Event|1|||
156400517|NCT03217747|564558460|FG013|Overall Study|Adverse Event|1|||
156400518|NCT03217747|564558447|FG000|Overall Study|Death|0|||
156400519|NCT03217747|564558448|FG001|Overall Study|Death|0|||
156400520|NCT03217747|564558449|FG002|Overall Study|Death|0|||
156400521|NCT03217747|564558450|FG003|Overall Study|Death|0|||
156400522|NCT03217747|564558451|FG004|Overall Study|Death|0|||
156400523|NCT03217747|564558452|FG005|Overall Study|Death|0|||
156400524|NCT03217747|564558453|FG006|Overall Study|Death|0|||
156400525|NCT03217747|564558454|FG007|Overall Study|Death|0|||
156400526|NCT03217747|564558455|FG008|Overall Study|Death|1|||
156400527|NCT03217747|564558456|FG009|Overall Study|Death|0|||
156400528|NCT03217747|564558457|FG010|Overall Study|Death|0|||
156400529|NCT03217747|564558458|FG011|Overall Study|Death|0|||
156400530|NCT03217747|564558459|FG012|Overall Study|Death|0|||
156400531|NCT03217747|564558460|FG013|Overall Study|Death|0|||
156400532|NCT03217747|564558447|FG000|Overall Study|Lack of Efficacy|12|||
156400533|NCT03217747|564558448|FG001|Overall Study|Lack of Efficacy|6|||
156400534|NCT03217747|564558449|FG002|Overall Study|Lack of Efficacy|15|||
156400535|NCT03217747|564558450|FG003|Overall Study|Lack of Efficacy|11|||
156400536|NCT03217747|564558451|FG004|Overall Study|Lack of Efficacy|3|||
156550411|NCT00317109|565106922|FG000|Overall Study|Migated/moved from study area|1|||
156550412|NCT00317109|565106923|FG001|Overall Study|Migated/moved from study area|0|||
156550413|NCT04472429|565106924|FG000|Randomized Period|Ongoing|90|||
156550414|NCT04472429|565106925|FG001|Randomized Period|Ongoing|40|||
156550415|NCT04472429|565106926|FG002|Randomized Period|Ongoing|0|||
156550416|NCT04472429|565106924|FG000|Randomized Period|Death|52|||
156550417|NCT04472429|565106925|FG001|Randomized Period|Death|37|||
156550418|NCT04472429|565106926|FG002|Randomized Period|Death|0|||
156550419|NCT04472429|565106924|FG000|Randomized Period|Lost to Follow-up|4|||
156550420|NCT04472429|565106925|FG001|Randomized Period|Lost to Follow-up|0|||
156550421|NCT04472429|565106926|FG002|Randomized Period|Lost to Follow-up|0|||
156550422|NCT04472429|565106924|FG000|Randomized Period|Physician Decision|1|||
156550423|NCT04472429|565106925|FG001|Randomized Period|Physician Decision|2|||
156550424|NCT04472429|565106926|FG002|Randomized Period|Physician Decision|0|||
156550425|NCT04472429|565106924|FG000|Randomized Period|Withdrawal by Subject|6|||
156550426|NCT04472429|565106925|FG001|Randomized Period|Withdrawal by Subject|5|||
156550427|NCT04472429|565106926|FG002|Randomized Period|Withdrawal by Subject|0|||
156550428|NCT04472429|565106924|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
156550429|NCT04472429|565106925|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
156550430|NCT04472429|565106926|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
156550431|NCT04472429|565106924|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
156550432|NCT04472429|565106925|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
156400537|NCT03217747|564558452|FG005|Overall Study|Lack of Efficacy|14|||
156400538|NCT03217747|564558453|FG006|Overall Study|Lack of Efficacy|10|||
156400539|NCT03217747|564558454|FG007|Overall Study|Lack of Efficacy|4|||
156400540|NCT03217747|564558455|FG008|Overall Study|Lack of Efficacy|2|||
156400541|NCT03217747|564558456|FG009|Overall Study|Lack of Efficacy|7|||
156400542|NCT03217747|564558457|FG010|Overall Study|Lack of Efficacy|3|||
156400543|NCT03217747|564558458|FG011|Overall Study|Lack of Efficacy|1|||
156400544|NCT03217747|564558459|FG012|Overall Study|Lack of Efficacy|3|||
156400545|NCT03217747|564558460|FG013|Overall Study|Lack of Efficacy|1|||
156400546|NCT03217747|564558447|FG000|Overall Study|Withdrawal by Subject|2|||
156400547|NCT03217747|564558448|FG001|Overall Study|Withdrawal by Subject|1|||
156400548|NCT03217747|564558449|FG002|Overall Study|Withdrawal by Subject|1|||
156400549|NCT03217747|564558450|FG003|Overall Study|Withdrawal by Subject|1|||
156400550|NCT03217747|564558451|FG004|Overall Study|Withdrawal by Subject|1|||
156400551|NCT03217747|564558452|FG005|Overall Study|Withdrawal by Subject|2|||
156400552|NCT03217747|564558453|FG006|Overall Study|Withdrawal by Subject|1|||
156400553|NCT03217747|564558454|FG007|Overall Study|Withdrawal by Subject|0|||
156400554|NCT03217747|564558455|FG008|Overall Study|Withdrawal by Subject|0|||
156400555|NCT03217747|564558456|FG009|Overall Study|Withdrawal by Subject|0|||
156400556|NCT03217747|564558457|FG010|Overall Study|Withdrawal by Subject|0|||
156400557|NCT03217747|564558458|FG011|Overall Study|Withdrawal by Subject|1|||
156400558|NCT03217747|564558459|FG012|Overall Study|Withdrawal by Subject|0|||
156400559|NCT03217747|564558460|FG013|Overall Study|Withdrawal by Subject|1|||
156400560|NCT03217747|564558447|FG000|Overall Study|Toxicity and progression|1|||
156400561|NCT03217747|564558448|FG001|Overall Study|Toxicity and progression|0|||
156400562|NCT03217747|564558449|FG002|Overall Study|Toxicity and progression|0|||
156400563|NCT03217747|564558450|FG003|Overall Study|Toxicity and progression|0|||
156509362|NCT01263509|564957573|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
156509363|NCT00967005|564957574|FG000|Overall Study|Lost to Follow-up|7|||
156509364|NCT00967005|564957575|FG001|Overall Study|Lost to Follow-up|10|||
156509365|NCT02593123|564957576|FG000|Overall Study|Physician Decision|2|||
156509366|NCT02593123|564957577|FG001|Overall Study|Physician Decision|1|||
156509367|NCT02593123|564957576|FG000|Overall Study|Relapse|1|||
156509368|NCT02593123|564957577|FG001|Overall Study|Relapse|1|||
156509369|NCT05071053|564957578|FG000|Overall Study|Progressive disease|30|||
156509370|NCT05071053|564957578|FG000|Overall Study|Adverse Event|5|||
156509371|NCT04868539|564957589|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
156509372|NCT04868539|564957590|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
156509373|NCT01401153|564957591|FG000|First Test Day|Learning disabilities; illness|1|||
156509374|NCT01401153|564957592|FG001|First Test Day|Learning disabilities; illness|10|||
156509375|NCT01401153|564957591|FG000|Second Test Day|illness|0|||
156509376|NCT01401153|564957592|FG001|Second Test Day|illness|5|||
156509377|NCT01677767|564957595|FG000|Overall Study|Adverse Event|1|||
156509378|NCT01677767|564957595|FG000|Overall Study|Death|4|||
156509379|NCT01677767|564957595|FG000|Overall Study|Protocol Violation|4|||
156509380|NCT01677767|564957595|FG000|Overall Study|Withdrawal by Subject|10|||
156509381|NCT01677767|564957595|FG000|Overall Study|Non-compliance by the participants|3|||
156509382|NCT00842244|564957596|FG000|Overall Study|Death|3|||
156509383|NCT00842244|564957596|FG000|Overall Study|Withdrawal by Subject|1|||
156509384|NCT00842244|564957596|FG000|Overall Study|Other|17|||
156509385|NCT00588692|564957599|FG000|Overall Study|Withdrawal by Subject|4|||
156509386|NCT00588692|564957600|FG001|Overall Study|Withdrawal by Subject|2|||
156509387|NCT00588692|564957599|FG000|Overall Study|Hip Surgery|0|||
156509388|NCT00588692|564957600|FG001|Overall Study|Hip Surgery|1|||
156400564|NCT03217747|564558451|FG004|Overall Study|Toxicity and progression|0|||
156400565|NCT03217747|564558452|FG005|Overall Study|Toxicity and progression|0|||
156400566|NCT03217747|564558453|FG006|Overall Study|Toxicity and progression|0|||
156550433|NCT04472429|565106926|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
156550434|NCT04472429|565106924|FG000|Open-label Monotherapy Period|Ongoing|0|||
156550435|NCT04472429|565106925|FG001|Open-label Monotherapy Period|Ongoing|0|||
156550436|NCT04472429|565106926|FG002|Open-label Monotherapy Period|Ongoing|32|||
156550437|NCT04472429|565106924|FG000|Open-label Monotherapy Period|Death|0|||
156550438|NCT04472429|565106925|FG001|Open-label Monotherapy Period|Death|0|||
156550439|NCT04472429|565106926|FG002|Open-label Monotherapy Period|Death|35|||
156550440|NCT04472429|565106924|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
156550441|NCT04472429|565106925|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
156550442|NCT04472429|565106926|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
156550443|NCT01180660|565106927|FG000|Overall Study|Changed to open surgery|1|||
156550444|NCT01180660|565106928|FG001|Overall Study|Changed to open surgery|0|||
156550445|NCT03461757|565106929|FG000|Overall Study|Adverse Event|1|||
156550446|NCT03461757|565106930|FG001|Overall Study|Adverse Event|0|||
156550447|NCT03461757|565106929|FG000|Overall Study|Lost to Follow-up|13|||
156550448|NCT03461757|565106930|FG001|Overall Study|Lost to Follow-up|7|||
156550449|NCT03461757|565106929|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
156550450|NCT03461757|565106930|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
156550451|NCT03461757|565106929|FG000|Overall Study|Non-compliance with study treatment|0|||
156550452|NCT03461757|565106930|FG001|Overall Study|Non-compliance with study treatment|1|||
156550453|NCT03461757|565106929|FG000|Overall Study|Pregnancy|2|||
156550454|NCT03461757|565106930|FG001|Overall Study|Pregnancy|0|||
156550455|NCT03461757|565106929|FG000|Overall Study|Protocol Violation|1|||
156550456|NCT03461757|565106930|FG001|Overall Study|Protocol Violation|1|||
156400567|NCT03217747|564558454|FG007|Overall Study|Toxicity and progression|0|||
156400568|NCT03217747|564558455|FG008|Overall Study|Toxicity and progression|0|||
156400569|NCT03217747|564558456|FG009|Overall Study|Toxicity and progression|0|||
156400570|NCT03217747|564558457|FG010|Overall Study|Toxicity and progression|0|||
156400571|NCT03217747|564558458|FG011|Overall Study|Toxicity and progression|0|||
156509389|NCT00588692|564957599|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
156509390|NCT00588692|564957600|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
156509391|NCT00588692|564957599|FG000|Overall Study|Cancer|1|||
156509392|NCT00588692|564957600|FG001|Overall Study|Cancer|0|||
156509393|NCT00588692|564957599|FG000|Overall Study|Death|1|||
156509394|NCT00588692|564957600|FG001|Overall Study|Death|0|||
156509395|NCT03538938|564957602|FG000|Overall Study|Death|0|||
156509396|NCT03538938|564957603|FG001|Overall Study|Death|0|||
156509397|NCT03538938|564957604|FG002|Overall Study|Death|2|||
156509398|NCT03538938|564957605|FG003|Overall Study|Death|0|||
156509399|NCT03538938|564957606|FG004|Overall Study|Death|0|||
156509400|NCT03538938|564957607|FG005|Overall Study|Death|1|||
156509401|NCT03538938|564957608|FG006|Overall Study|Death|0|||
156509402|NCT03538938|564957609|FG007|Overall Study|Death|1|||
156509403|NCT03538938|564957610|FG008|Overall Study|Death|1|||
156509404|NCT03538938|564957611|FG009|Overall Study|Death|1|||
156509405|NCT03538938|564957612|FG010|Overall Study|Death|0|||
156509406|NCT03538938|564957613|FG011|Overall Study|Death|0|||
156509407|NCT03538938|564957614|FG012|Overall Study|Death|1|||
156509408|NCT03538938|564957615|FG013|Overall Study|Death|1|||
156509409|NCT03538938|564957616|FG014|Overall Study|Death|0|||
156509410|NCT03538938|564957617|FG015|Overall Study|Death|1|||
156509411|NCT03538938|564957602|FG000|Overall Study|Withdrawal by Subject|4|||
156509412|NCT03538938|564957603|FG001|Overall Study|Withdrawal by Subject|6|||
156509413|NCT03538938|564957604|FG002|Overall Study|Withdrawal by Subject|5|||
156509414|NCT03538938|564957605|FG003|Overall Study|Withdrawal by Subject|3|||
156509415|NCT03538938|564957606|FG004|Overall Study|Withdrawal by Subject|0|||
156509416|NCT03538938|564957607|FG005|Overall Study|Withdrawal by Subject|0|||
156509417|NCT03538938|564957608|FG006|Overall Study|Withdrawal by Subject|3|||
156509418|NCT03538938|564957609|FG007|Overall Study|Withdrawal by Subject|1|||
156509419|NCT03538938|564957610|FG008|Overall Study|Withdrawal by Subject|5|||
156509420|NCT03538938|564957611|FG009|Overall Study|Withdrawal by Subject|1|||
156509421|NCT03538938|564957612|FG010|Overall Study|Withdrawal by Subject|2|||
156509422|NCT03538938|564957613|FG011|Overall Study|Withdrawal by Subject|1|||
156509423|NCT03538938|564957614|FG012|Overall Study|Withdrawal by Subject|3|||
156550457|NCT03461757|565106929|FG000|Overall Study|Withdrawal by Subject|7|||
156550458|NCT03461757|565106930|FG001|Overall Study|Withdrawal by Subject|7|||
156550459|NCT03461757|565106929|FG000|Overall Study|Other Reasons|1|||
156550460|NCT03461757|565106930|FG001|Overall Study|Other Reasons|4|||
156550461|NCT02425826|565106931|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
156550462|NCT02425826|565106932|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
156550463|NCT02425826|565106933|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
156509424|NCT03538938|564957615|FG013|Overall Study|Withdrawal by Subject|0|||
156509425|NCT03538938|564957616|FG014|Overall Study|Withdrawal by Subject|2|||
156509426|NCT03538938|564957617|FG015|Overall Study|Withdrawal by Subject|4|||
156550464|NCT02425826|565106931|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
156400572|NCT03217747|564558459|FG012|Overall Study|Toxicity and progression|0|||
156400573|NCT03217747|564558460|FG013|Overall Study|Toxicity and progression|0|||
156400574|NCT03217747|564558447|FG000|Overall Study|Removal of sole target lesion|1|||
156400575|NCT03217747|564558448|FG001|Overall Study|Removal of sole target lesion|0|||
156400576|NCT03217747|564558449|FG002|Overall Study|Removal of sole target lesion|0|||
156400577|NCT03217747|564558450|FG003|Overall Study|Removal of sole target lesion|0|||
156400578|NCT03217747|564558451|FG004|Overall Study|Removal of sole target lesion|0|||
156400579|NCT03217747|564558452|FG005|Overall Study|Removal of sole target lesion|0|||
156400580|NCT03217747|564558453|FG006|Overall Study|Removal of sole target lesion|0|||
156400581|NCT03217747|564558454|FG007|Overall Study|Removal of sole target lesion|0|||
156400582|NCT03217747|564558455|FG008|Overall Study|Removal of sole target lesion|0|||
156400583|NCT03217747|564558456|FG009|Overall Study|Removal of sole target lesion|0|||
156400584|NCT03217747|564558457|FG010|Overall Study|Removal of sole target lesion|0|||
156400585|NCT03217747|564558458|FG011|Overall Study|Removal of sole target lesion|0|||
156400586|NCT03217747|564558459|FG012|Overall Study|Removal of sole target lesion|0|||
156400587|NCT03217747|564558460|FG013|Overall Study|Removal of sole target lesion|0|||
156400588|NCT03217747|564558447|FG000|Overall Study|Stroke|0|||
156400589|NCT03217747|564558448|FG001|Overall Study|Stroke|0|||
156400590|NCT03217747|564558449|FG002|Overall Study|Stroke|0|||
156400591|NCT03217747|564558450|FG003|Overall Study|Stroke|0|||
156400592|NCT03217747|564558451|FG004|Overall Study|Stroke|0|||
156400593|NCT03217747|564558452|FG005|Overall Study|Stroke|1|||
156400594|NCT03217747|564558453|FG006|Overall Study|Stroke|0|||
156400595|NCT03217747|564558454|FG007|Overall Study|Stroke|0|||
156400596|NCT03217747|564558455|FG008|Overall Study|Stroke|0|||
156400597|NCT03217747|564558456|FG009|Overall Study|Stroke|0|||
156400598|NCT03217747|564558457|FG010|Overall Study|Stroke|0|||
156400599|NCT03217747|564558458|FG011|Overall Study|Stroke|1|||
156400600|NCT03217747|564558459|FG012|Overall Study|Stroke|0|||
156400601|NCT03217747|564558460|FG013|Overall Study|Stroke|0|||
156400602|NCT03996291|564558461|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
156400603|NCT03996291|564558462|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
156400604|NCT03996291|564558463|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
156400605|NCT03996291|564558464|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
156400606|NCT03996291|564558465|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
156400607|NCT03996291|564558466|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
156400608|NCT03996291|564558467|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
156400609|NCT03996291|564558468|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
156400610|NCT03996291|564558461|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156400611|NCT03996291|564558462|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156400612|NCT03996291|564558463|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156400613|NCT03996291|564558464|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156509427|NCT03538938|564957602|FG000|Overall Study|Incarcerated|0|||
156509428|NCT03538938|564957603|FG001|Overall Study|Incarcerated|0|||
156509429|NCT03538938|564957604|FG002|Overall Study|Incarcerated|0|||
156509430|NCT03538938|564957605|FG003|Overall Study|Incarcerated|0|||
156509431|NCT03538938|564957606|FG004|Overall Study|Incarcerated|0|||
156509432|NCT03538938|564957607|FG005|Overall Study|Incarcerated|0|||
156509433|NCT03538938|564957608|FG006|Overall Study|Incarcerated|0|||
156509434|NCT03538938|564957609|FG007|Overall Study|Incarcerated|0|||
156509435|NCT03538938|564957610|FG008|Overall Study|Incarcerated|0|||
156509436|NCT03538938|564957611|FG009|Overall Study|Incarcerated|0|||
156509437|NCT03538938|564957612|FG010|Overall Study|Incarcerated|0|||
156509438|NCT03538938|564957613|FG011|Overall Study|Incarcerated|1|||
156509439|NCT03538938|564957614|FG012|Overall Study|Incarcerated|0|||
156509440|NCT03538938|564957615|FG013|Overall Study|Incarcerated|0|||
156509441|NCT03538938|564957616|FG014|Overall Study|Incarcerated|0|||
156509442|NCT03538938|564957617|FG015|Overall Study|Incarcerated|0|||
156509443|NCT00755105|564957618|FG000|Overall Study|Withdrawal by Subject|9|||
156509444|NCT00755105|564957619|FG001|Overall Study|Withdrawal by Subject|11|||
156509445|NCT00755105|564957620|FG002|Overall Study|Withdrawal by Subject|4|||
156509446|NCT02202785|564957621|FG000|Overall Study|Study Terminated by Sponsor|1|||
156509447|NCT02202785|564957622|FG001|Overall Study|Study Terminated by Sponsor|6|||
156509448|NCT02202785|564957623|FG002|Overall Study|Study Terminated by Sponsor|4|||
156509449|NCT02202785|564957621|FG000|Overall Study|Withdrawal by Subject|0|||
156509450|NCT02202785|564957622|FG001|Overall Study|Withdrawal by Subject|1|||
156509451|NCT02202785|564957623|FG002|Overall Study|Withdrawal by Subject|0|||
156509452|NCT02202785|564957621|FG000|Overall Study|Lost to Follow-up|0|||
156400614|NCT03996291|564558465|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156400615|NCT03996291|564558466|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
156509453|NCT02202785|564957622|FG001|Overall Study|Lost to Follow-up|1|||
156509454|NCT02202785|564957623|FG002|Overall Study|Lost to Follow-up|0|||
156509455|NCT02202785|564957621|FG000|Overall Study|Reason not Specified|10|||
156509456|NCT02202785|564957622|FG001|Overall Study|Reason not Specified|7|||
156509457|NCT02202785|564957623|FG002|Overall Study|Reason not Specified|13|||
156509458|NCT01137578|564957624|FG000|Overall Study|Participant requested to Discontinue|3|||
156550465|NCT02425826|565106932|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
156550466|NCT02425826|565106933|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
156550467|NCT02425826|565106931|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
156550468|NCT02425826|565106932|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
156550469|NCT02425826|565106933|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
156550470|NCT02425826|565106931|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
156550471|NCT02425826|565106932|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
156550472|NCT02425826|565106933|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
156550473|NCT02425826|565106931|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
156550474|NCT02425826|565106932|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
156550475|NCT02425826|565106933|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
156550476|NCT02425826|565106931|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
156550477|NCT02425826|565106932|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
156550478|NCT02425826|565106933|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
156550479|NCT02425826|565106931|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
156550480|NCT02425826|565106932|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
156550481|NCT02425826|565106933|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
156550482|NCT02425826|565106931|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
156550483|NCT02425826|565106932|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
156550484|NCT02425826|565106933|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
156550485|NCT02425826|565106931|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
156550486|NCT02425826|565106932|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
156550487|NCT02425826|565106933|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
156550488|NCT02425826|565106931|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
156550489|NCT02425826|565106932|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
156550490|NCT02425826|565106933|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
156550491|NCT04942925|565106936|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
156550492|NCT04942925|565106937|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
156550493|NCT04942925|565106936|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
156550494|NCT04942925|565106937|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
156550495|NCT01344876|565106938|FG000|Overall Study|Adverse Event|0|||
156550496|NCT01344876|565106939|FG001|Overall Study|Adverse Event|0|||
156550497|NCT01344876|565106940|FG002|Overall Study|Adverse Event|0|||
156550498|NCT01344876|565106941|FG003|Overall Study|Adverse Event|0|||
156550499|NCT01344876|565106942|FG004|Overall Study|Adverse Event|1|||
156550500|NCT01344876|565106938|FG000|Overall Study|Withdrawal by Subject|0|||
156550501|NCT01344876|565106939|FG001|Overall Study|Withdrawal by Subject|0|||
156550502|NCT01344876|565106940|FG002|Overall Study|Withdrawal by Subject|1|||
156550503|NCT01344876|565106941|FG003|Overall Study|Withdrawal by Subject|0|||
156550504|NCT01344876|565106942|FG004|Overall Study|Withdrawal by Subject|0|||
156550505|NCT01344876|565106938|FG000|Overall Study|Definite progression of primary disease|1|||
156550506|NCT01344876|565106939|FG001|Overall Study|Definite progression of primary disease|0|||
156550507|NCT01344876|565106940|FG002|Overall Study|Definite progression of primary disease|0|||
156550508|NCT01344876|565106941|FG003|Overall Study|Definite progression of primary disease|3|||
156550509|NCT01344876|565106942|FG004|Overall Study|Definite progression of primary disease|0|||
156550510|NCT05107765|565106943|FG000|Overall Study|Lost to Follow-up|4|||
156550511|NCT05107765|565106944|FG001|Overall Study|Lost to Follow-up|1|||
156550512|NCT05107765|565106943|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
156550513|NCT05107765|565106944|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
156550514|NCT05107765|565106943|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
156550515|NCT05107765|565106944|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
156550516|NCT00562588|565106945|FG000|Overall Study|Adverse Event|40|||
156550517|NCT00562588|565106946|FG001|Overall Study|Adverse Event|58|||
156550518|NCT00562588|565106945|FG000|Overall Study|Protocol Violation|30|||
156550519|NCT00562588|565106946|FG001|Overall Study|Protocol Violation|26|||
156550520|NCT00562588|565106945|FG000|Overall Study|Lost to Follow-up|12|||
156550521|NCT00562588|565106946|FG001|Overall Study|Lost to Follow-up|4|||
156550522|NCT00562588|565106945|FG000|Overall Study|Withdrawal by Subject|10|||
156550523|NCT00562588|565106946|FG001|Overall Study|Withdrawal by Subject|9|||
156550524|NCT00562588|565106945|FG000|Overall Study|Other|0|||
156550525|NCT00562588|565106946|FG001|Overall Study|Other|2|||
156550526|NCT01761266|565108913|FG000|Overall Study|Death|415|||
156550527|NCT01761266|565108914|FG001|Overall Study|Death|402|||
156550528|NCT01761266|565108913|FG000|Overall Study|Lost to Follow-up|8|||
156550529|NCT01761266|565108914|FG001|Overall Study|Lost to Follow-up|12|||
156550530|NCT01761266|565108913|FG000|Overall Study|Withdrawal by Subject|14|||
156550531|NCT01761266|565108914|FG001|Overall Study|Withdrawal by Subject|10|||
156550532|NCT01761266|565108913|FG000|Overall Study|Sponsor Decision|41|||
156550533|NCT01761266|565108914|FG001|Overall Study|Sponsor Decision|52|||
156550534|NCT01662440|565108915|FG000|Overall Study|Adverse Event|1|||
156550535|NCT01662440|565108916|FG001|Overall Study|Adverse Event|0|||
156400616|NCT03996291|564558467|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
156400617|NCT03996291|564558468|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156400618|NCT03996291|564558461|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156509459|NCT01137578|564957625|FG001|Overall Study|Participant requested to Discontinue|0|||
156509460|NCT01137578|564957626|FG002|Overall Study|Participant requested to Discontinue|0|||
156509461|NCT01137578|564957624|FG000|Overall Study|Withdrawal by Subject|1|||
156509462|NCT01137578|564957625|FG001|Overall Study|Withdrawal by Subject|0|||
156509463|NCT01137578|564957626|FG002|Overall Study|Withdrawal by Subject|0|||
156509464|NCT01137578|564957624|FG000|Overall Study|Other|12|||
156509465|NCT01137578|564957625|FG001|Overall Study|Other|2|||
156509466|NCT01137578|564957626|FG002|Overall Study|Other|6|||
156509467|NCT04954326|564957627|FG000|Overall Study|Protocol Violation|0|||
156509468|NCT04954326|564957628|FG001|Overall Study|Protocol Violation|1|||
156509469|NCT04954326|564957627|FG000|Overall Study|Death|0|||
156509470|NCT04954326|564957628|FG001|Overall Study|Death|2|||
156509471|NCT04954326|564957627|FG000|Overall Study|Physician Decision|0|||
156509472|NCT04954326|564957628|FG001|Overall Study|Physician Decision|1|||
156509473|NCT01289210|564957629|FG000|Overall Study|Adverse Event|1|||
156509474|NCT06285240|564957630|FG000|Overall Study|Withdrawal by Subject|2|||
156509475|NCT06285240|564957631|FG001|Overall Study|Withdrawal by Subject|0|||
156509476|NCT06285240|564957632|FG002|Overall Study|Withdrawal by Subject|0|||
156509477|NCT06285240|564957633|FG003|Overall Study|Withdrawal by Subject|0|||
156509478|NCT06285240|564957630|FG000|Overall Study|Serious Adverse Event|0|||
156509479|NCT06285240|564957631|FG001|Overall Study|Serious Adverse Event|0|||
156509480|NCT06285240|564957632|FG002|Overall Study|Serious Adverse Event|1|||
156509481|NCT06285240|564957633|FG003|Overall Study|Serious Adverse Event|0|||
156509482|NCT05140915|564957636|FG000|Overall Study|Lost to Follow-up|2|||
156509483|NCT05140915|564957637|FG001|Overall Study|Lost to Follow-up|1|||
156509484|NCT04520659|564957638|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
156509485|NCT04520659|564957639|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
156509486|NCT04520659|564957640|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
156509487|NCT04520659|564957641|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
156400619|NCT03996291|564558462|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156400620|NCT03996291|564558463|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156400621|NCT03996291|564558464|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156400622|NCT03996291|564558465|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
156400623|NCT03996291|564558466|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156400624|NCT03996291|564558467|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
156400625|NCT03996291|564558468|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156400626|NCT03996291|564558461|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
156400627|NCT03996291|564558462|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
156400628|NCT03996291|564558463|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
156400629|NCT03996291|564558464|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
156400630|NCT03996291|564558465|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
156400631|NCT03996291|564558466|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
156400632|NCT03996291|564558467|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
156400633|NCT03996291|564558468|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
156400634|NCT03996291|564558461|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156400635|NCT03996291|564558462|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156400636|NCT03996291|564558463|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156400637|NCT03996291|564558464|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156400638|NCT03996291|564558465|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
156400639|NCT03996291|564558466|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156400640|NCT03996291|564558467|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156400641|NCT03996291|564558468|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156400642|NCT00766675|564559609|FG000|Overall Study|Adverse Event|16|||
156400643|NCT00766675|564559609|FG000|Overall Study|Lost to Follow-up|2|||
156400644|NCT00766675|564559609|FG000|Overall Study|Withdrawal by Subject|11|||
156400645|NCT00766675|564559609|FG000|Overall Study|Protocol Violation|8|||
156400646|NCT00766675|564559609|FG000|Overall Study|Participant took prohibited medication|1|||
156400647|NCT00766675|564559609|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
156400648|NCT00766675|564559609|FG000|Overall Study|Insufficient therapy|1|||
156400649|NCT02044848|564559611|FG000|Overall Study|Administrative Problems|2|||
156400650|NCT02044848|564559612|FG001|Overall Study|Administrative Problems|3|||
156400651|NCT00045708|564559613|FG000|Phase 1|early progressive disease|0|||
156400652|NCT00045708|564559614|FG001|Phase 1|early progressive disease|1|||
156509488|NCT04485611|564957646|FG000|Prehabilitation|Physician Decision|1|||
156509489|NCT04879849|564957647|FG000|Overall Study|Lost to Follow-up|0|||
156509490|NCT04879849|564957648|FG001|Overall Study|Lost to Follow-up|0|||
156509491|NCT04879849|564957649|FG002|Overall Study|Lost to Follow-up|0|||
156509492|NCT04879849|564957650|FG003|Overall Study|Lost to Follow-up|1|||
156509493|NCT04879849|564957651|FG004|Overall Study|Lost to Follow-up|0|||
156400653|NCT00045708|564559615|FG002|Phase 1|early progressive disease|0|||
156400654|NCT00685945|564559616|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
156400655|NCT03183388|564559617|FG000|Overall Study|Lost to Follow-up|3|||
156400656|NCT03183388|564559618|FG001|Overall Study|Lost to Follow-up|5|||
156400657|NCT03183388|564559617|FG000|Overall Study|Physician Decision|1|||
156400658|NCT03183388|564559618|FG001|Overall Study|Physician Decision|4|||
156400659|NCT03183388|564559617|FG000|Overall Study|Withdrawal by Subject|4|||
156400660|NCT03183388|564559618|FG001|Overall Study|Withdrawal by Subject|1|||
156400661|NCT03183388|564559617|FG000|Overall Study|Moved|1|||
156400662|NCT03183388|564559618|FG001|Overall Study|Moved|0|||
156400663|NCT03183388|564559617|FG000|Overall Study|Met Exclusion Criteria|2|||
156400664|NCT03183388|564559618|FG001|Overall Study|Met Exclusion Criteria|2|||
156400665|NCT03183388|564559617|FG000|Overall Study|COVID Pandemic Related|2|||
156400666|NCT03183388|564559618|FG001|Overall Study|COVID Pandemic Related|4|||
156400667|NCT00284141|564559623|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
156400668|NCT00284141|564559623|FG000|Overall Study|Adverse Event|19|||
156400669|NCT00284141|564559623|FG000|Overall Study|Participant's request|9|||
156400670|NCT00284141|564559623|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
156400671|NCT00284141|564559623|FG000|Overall Study|Clinical deterioration / death|2|||
156400672|NCT00284141|564559623|FG000|Overall Study|General decline|1|||
156400673|NCT00284141|564559623|FG000|Overall Study|Pneumonia|1|||
156400674|NCT00284141|564559623|FG000|Overall Study|Did not take study medication|2|||
156400675|NCT00284141|564559623|FG000|Overall Study|Ongoing treatment|2|||
156400676|NCT00803101|564559629|FG000|Overall Study|Death / Serious Adverse Event|4|||
156400677|NCT00803101|564559630|FG001|Overall Study|Death / Serious Adverse Event|6|||
156400678|NCT00803101|564559629|FG000|Overall Study|Withdrawal by Subject|6|||
156400679|NCT00803101|564559630|FG001|Overall Study|Withdrawal by Subject|4|||
156400680|NCT00803101|564559629|FG000|Overall Study|Lost to Follow-up|2|||
156400681|NCT00803101|564559630|FG001|Overall Study|Lost to Follow-up|2|||
156400682|NCT00803101|564559629|FG000|Overall Study|Protocol Violation|1|||
156400683|NCT00803101|564559630|FG001|Overall Study|Protocol Violation|7|||
156400684|NCT00803101|564559629|FG000|Overall Study|Surgery finished outside protocol window|1|||
156400685|NCT00803101|564559630|FG001|Overall Study|Surgery finished outside protocol window|1|||
156400686|NCT00803101|564559629|FG000|Overall Study|Patient died outside SAE report period|1|||
156400687|NCT00803101|564559630|FG001|Overall Study|Patient died outside SAE report period|0|||
156400688|NCT00803101|564559629|FG000|Overall Study|Patient did not attend scheduled visit|2|||
156400689|NCT00803101|564559630|FG001|Overall Study|Patient did not attend scheduled visit|1|||
156400690|NCT00803101|564559629|FG000|Overall Study|Patient did not have surgery|1|||
156400691|NCT00803101|564559630|FG001|Overall Study|Patient did not have surgery|1|||
156400692|NCT01782742|564559631|FG000|Double-blind Treatment Phase|Adverse Event|1|||
156400693|NCT01782742|564559632|FG001|Double-blind Treatment Phase|Adverse Event|0|||
156400694|NCT04170686|564559633|FG000|Screening|Physician Decision|12|||
156400695|NCT04170686|564559634|FG001|Screening|Physician Decision|13|||
156400696|NCT04170686|564559633|FG000|Randomization and Treatment|Lost to Follow-up|26|||
156400697|NCT04170686|564559634|FG001|Randomization and Treatment|Lost to Follow-up|15|||
156400698|NCT04538144|564559640|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
156400699|NCT04538144|564559641|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
156400700|NCT04538144|564559642|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
156400701|NCT04538144|564559643|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
156400702|NCT01264380|564559644|FG000|Period C|Disease Progression|0|||
156400703|NCT01264380|564559645|FG001|Period C|Disease Progression|0|||
156400704|NCT01264380|564559646|FG002|Period C|Disease Progression|4|||
156400705|NCT01264380|564559644|FG000|Period C|Death|0|||
156400706|NCT01264380|564559645|FG001|Period C|Death|0|||
156400707|NCT01264380|564559646|FG002|Period C|Death|2|||
156400708|NCT01264380|564559644|FG000|Period C|Follow-up for survival status|0|||
156400709|NCT01264380|564559645|FG001|Period C|Follow-up for survival status|0|||
156400710|NCT01264380|564559646|FG002|Period C|Follow-up for survival status|6|||
156400711|NCT01264380|564559644|FG000|Period C|Withdrawal by Subject|0|||
156400712|NCT01264380|564559645|FG001|Period C|Withdrawal by Subject|0|||
156400713|NCT01264380|564559646|FG002|Period C|Withdrawal by Subject|1|||
156400714|NCT01264380|564559644|FG000|Period C|Adverse Event|0|||
156400715|NCT01264380|564559645|FG001|Period C|Adverse Event|0|||
156400716|NCT01264380|564559646|FG002|Period C|Adverse Event|1|||
156400717|NCT03474107|564559648|FG000|Overall Study|Adverse Event|42|||
156400718|NCT03474107|564559649|FG001|Overall Study|Adverse Event|46|||
156400719|NCT03474107|564559648|FG000|Overall Study|Death|2|||
156400720|NCT03474107|564559649|FG001|Overall Study|Death|2|||
156400721|NCT03474107|564559648|FG000|Overall Study|Lost to Follow-up|0|||
156400722|NCT03474107|564559649|FG001|Overall Study|Lost to Follow-up|1|||
156400723|NCT03474107|564559648|FG000|Overall Study|Progressive Disease|177|||
156400724|NCT03474107|564559649|FG001|Overall Study|Progressive Disease|180|||
156400725|NCT03474107|564559648|FG000|Overall Study|Protocol Violation|1|||
156400726|NCT03474107|564559649|FG001|Overall Study|Protocol Violation|1|||
156400727|NCT03474107|564559648|FG000|Overall Study|Withdrawal by Subject|15|||
156400728|NCT03474107|564559649|FG001|Overall Study|Withdrawal by Subject|27|||
156400729|NCT03474107|564559648|FG000|Overall Study|Physician Decision|7|||
156550536|NCT01662440|565108917|FG002|Overall Study|Adverse Event|0|||
156550537|NCT01662440|565108918|FG003|Overall Study|Adverse Event|1|||
156550538|NCT01662440|565108915|FG000|Overall Study|Death|0|||
156550539|NCT01662440|565108916|FG001|Overall Study|Death|1|||
156550540|NCT01662440|565108917|FG002|Overall Study|Death|0|||
156550541|NCT01662440|565108918|FG003|Overall Study|Death|0|||
156550542|NCT01662440|565108915|FG000|Overall Study|Lost to Follow-up|2|||
156550543|NCT01662440|565108916|FG001|Overall Study|Lost to Follow-up|2|||
156550544|NCT01662440|565108917|FG002|Overall Study|Lost to Follow-up|4|||
156550545|NCT01662440|565108918|FG003|Overall Study|Lost to Follow-up|1|||
156550546|NCT01662440|565108915|FG000|Overall Study|Subject moved to another country.|0|||
156550547|NCT01662440|565108916|FG001|Overall Study|Subject moved to another country.|1|||
156550548|NCT01662440|565108917|FG002|Overall Study|Subject moved to another country.|0|||
156550549|NCT01662440|565108918|FG003|Overall Study|Subject moved to another country.|0|||
156550550|NCT01662440|565108915|FG000|Overall Study|Protocol Violation|1|||
156550551|NCT01662440|565108916|FG001|Overall Study|Protocol Violation|0|||
156550552|NCT01662440|565108917|FG002|Overall Study|Protocol Violation|0|||
156550553|NCT01662440|565108918|FG003|Overall Study|Protocol Violation|0|||
156550554|NCT01662440|565108915|FG000|Overall Study|Withdrawal by Subject|5|||
156550555|NCT01662440|565108916|FG001|Overall Study|Withdrawal by Subject|2|||
156550556|NCT01662440|565108917|FG002|Overall Study|Withdrawal by Subject|2|||
156550557|NCT01662440|565108918|FG003|Overall Study|Withdrawal by Subject|2|||
156550558|NCT00112905|565108919|FG000|Overall Study|Adverse Event|4|||
156550559|NCT00112905|565108919|FG000|Overall Study|Death|1|||
156550560|NCT00112905|565108919|FG000|Overall Study|Ineligibility|5|||
156550561|NCT00112905|565108919|FG000|Overall Study|Alternative treatment|1|||
156550562|NCT00112905|565108919|FG000|Overall Study|performance status was deteiorating|1|||
156550563|NCT04541004|565108922|FG000|Overall Study|Adverse Event|2|||
156550564|NCT03257267|565108923|FG000|Overall Study|Adverse Event|17|||
156550565|NCT03257267|565108924|FG001|Overall Study|Adverse Event|7|||
156550566|NCT03257267|565108923|FG000|Overall Study|Death|96|||
156550567|NCT03257267|565108924|FG001|Overall Study|Death|98|||
156550568|NCT03257267|565108923|FG000|Overall Study|Lost to Follow-up|2|||
156550569|NCT03257267|565108924|FG001|Overall Study|Lost to Follow-up|2|||
156550570|NCT03257267|565108923|FG000|Overall Study|Non-compliance with Study Drug|0|||
156550571|NCT03257267|565108924|FG001|Overall Study|Non-compliance with Study Drug|2|||
156550572|NCT03257267|565108923|FG000|Overall Study|Participant Decision|35|||
156550573|NCT03257267|565108924|FG001|Overall Study|Participant Decision|43|||
156550574|NCT03257267|565108923|FG000|Overall Study|Sponsor Decision|1|||
156550575|NCT03257267|565108924|FG001|Overall Study|Sponsor Decision|0|||
156550576|NCT03257267|565108923|FG000|Overall Study|Physician Decision|1|||
156550577|NCT03257267|565108924|FG001|Overall Study|Physician Decision|3|||
156550578|NCT03257267|565108923|FG000|Overall Study|Disease Progression|109|||
156550579|NCT03257267|565108924|FG001|Overall Study|Disease Progression|121|||
156550580|NCT03257267|565108923|FG000|Overall Study|Withdrawal by Subject|8|||
156550581|NCT03257267|565108924|FG001|Overall Study|Withdrawal by Subject|26|||
156550582|NCT03257267|565108923|FG000|Overall Study|Other|0|||
156550583|NCT03257267|565108924|FG001|Overall Study|Other|2|||
156550584|NCT04872101|565108925|FG000|Overall Study|Withdrawal by Subject|10|||
156550585|NCT04872101|565108926|FG001|Overall Study|Withdrawal by Subject|16|||
156550586|NCT04872101|565108925|FG000|Overall Study|Lack of Efficacy|6|||
156550587|NCT04872101|565108926|FG001|Overall Study|Lack of Efficacy|14|||
156550588|NCT04872101|565108925|FG000|Overall Study|Adverse Event|1|||
156550589|NCT04872101|565108926|FG001|Overall Study|Adverse Event|6|||
156550590|NCT04872101|565108925|FG000|Overall Study|Lost to Follow-up|2|||
156550591|NCT04872101|565108926|FG001|Overall Study|Lost to Follow-up|1|||
156550592|NCT04872101|565108925|FG000|Overall Study|Pregnancy|2|||
156550593|NCT04872101|565108926|FG001|Overall Study|Pregnancy|0|||
156550594|NCT04872101|565108925|FG000|Overall Study|Prohibited Medication|1|||
156550595|NCT04872101|565108926|FG001|Overall Study|Prohibited Medication|0|||
156550596|NCT04872101|565108925|FG000|Overall Study|Not dosed|1|||
156550597|NCT04872101|565108926|FG001|Overall Study|Not dosed|0|||
156550598|NCT02475681|565108927|FG000|Overall Study|Death|16|||
156550599|NCT02475681|565108928|FG001|Overall Study|Death|6|||
156550600|NCT02475681|565108929|FG002|Overall Study|Death|9|||
156550601|NCT02475681|565108927|FG000|Overall Study|Physician Decision|0|||
156550602|NCT02475681|565108928|FG001|Overall Study|Physician Decision|3|||
156550603|NCT02475681|565108929|FG002|Overall Study|Physician Decision|1|||
156550604|NCT02475681|565108927|FG000|Overall Study|Withdrawal by Subject|12|||
156550605|NCT02475681|565108928|FG001|Overall Study|Withdrawal by Subject|6|||
156400730|NCT03474107|564559649|FG001|Overall Study|Physician Decision|22|||
156550606|NCT02475681|565108929|FG002|Overall Study|Withdrawal by Subject|9|||
156550607|NCT02475681|565108927|FG000|Overall Study|Lost to Follow-up|2|||
156550608|NCT02475681|565108928|FG001|Overall Study|Lost to Follow-up|1|||
156550609|NCT02475681|565108929|FG002|Overall Study|Lost to Follow-up|3|||
156550610|NCT02475681|565108927|FG000|Overall Study|Ongoing in Study|0|||
156550611|NCT02475681|565108928|FG001|Overall Study|Ongoing in Study|163|||
156550612|NCT02475681|565108929|FG002|Overall Study|Ongoing in Study|157|||
156550613|NCT02475681|565108927|FG000|Overall Study|Reasons other than above listed|2|||
156550614|NCT02475681|565108928|FG001|Overall Study|Reasons other than above listed|0|||
156400731|NCT03474107|564559648|FG000|Overall Study|Miscellaneous|1|||
156400732|NCT03474107|564559649|FG001|Overall Study|Miscellaneous|6|||
156400733|NCT00659984|564559655|FG000|Overall Study|Adverse Event|1|||
156400734|NCT01287611|564559657|FG000|Overall Study|Lost to Follow-up|29|||
156400735|NCT01287611|564559658|FG001|Overall Study|Lost to Follow-up|16|||
156400736|NCT01287611|564559657|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
156509494|NCT04879849|564957652|FG005|Overall Study|Lost to Follow-up|0|||
156509495|NCT04879849|564957653|FG006|Overall Study|Lost to Follow-up|0|||
156509496|NCT04879849|564957654|FG007|Overall Study|Lost to Follow-up|0|||
156509497|NCT04879849|564957647|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
156509498|NCT04879849|564957648|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
156509499|NCT04879849|564957649|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
156509500|NCT04879849|564957650|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
156509501|NCT04879849|564957651|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
156509502|NCT04879849|564957652|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
156509503|NCT04879849|564957653|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
156509504|NCT04879849|564957654|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
156509505|NCT04879849|564957647|FG000|Overall Study|Withdrawal by Subject|0|||
156509506|NCT04879849|564957648|FG001|Overall Study|Withdrawal by Subject|0|||
156509507|NCT04879849|564957649|FG002|Overall Study|Withdrawal by Subject|0|||
156509508|NCT04879849|564957650|FG003|Overall Study|Withdrawal by Subject|0|||
156509509|NCT04879849|564957651|FG004|Overall Study|Withdrawal by Subject|2|||
156509510|NCT04879849|564957652|FG005|Overall Study|Withdrawal by Subject|0|||
156509511|NCT04879849|564957653|FG006|Overall Study|Withdrawal by Subject|1|||
156509512|NCT04879849|564957654|FG007|Overall Study|Withdrawal by Subject|0|||
156509513|NCT04879849|564957647|FG000|Overall Study|Progressive Disease|0|||
156509514|NCT04879849|564957648|FG001|Overall Study|Progressive Disease|0|||
156509515|NCT04879849|564957649|FG002|Overall Study|Progressive Disease|1|||
156509516|NCT04879849|564957650|FG003|Overall Study|Progressive Disease|0|||
156509517|NCT04879849|564957651|FG004|Overall Study|Progressive Disease|0|||
156509518|NCT04879849|564957652|FG005|Overall Study|Progressive Disease|0|||
156509519|NCT04879849|564957653|FG006|Overall Study|Progressive Disease|0|||
156509520|NCT04879849|564957654|FG007|Overall Study|Progressive Disease|0|||
156509521|NCT04879849|564957647|FG000|Overall Study|Death|0|||
156509522|NCT04879849|564957648|FG001|Overall Study|Death|0|||
156509523|NCT04879849|564957649|FG002|Overall Study|Death|1|||
156509524|NCT04879849|564957650|FG003|Overall Study|Death|1|||
156509525|NCT04879849|564957651|FG004|Overall Study|Death|1|||
156509526|NCT04879849|564957652|FG005|Overall Study|Death|2|||
156509527|NCT04879849|564957653|FG006|Overall Study|Death|1|||
156509528|NCT04879849|564957654|FG007|Overall Study|Death|2|||
156509529|NCT04879849|564957647|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
156509530|NCT04879849|564957648|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
156509531|NCT04879849|564957649|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
156509532|NCT04879849|564957650|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
156509533|NCT04879849|564957651|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
156509534|NCT04879849|564957652|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
156509535|NCT04879849|564957653|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
156509536|NCT04879849|564957654|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
156509537|NCT04879849|564957647|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
156509538|NCT04879849|564957648|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
156509539|NCT04879849|564957649|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
156509540|NCT04879849|564957650|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
156509541|NCT04879849|564957651|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
156509542|NCT04879849|564957652|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
156509543|NCT04879849|564957653|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
156509544|NCT04879849|564957654|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
156509545|NCT04879849|564957647|FG000|Overall Study|Reason Not Specified|1|||
156509546|NCT04879849|564957648|FG001|Overall Study|Reason Not Specified|0|||
156400737|NCT01287611|564559658|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
156509547|NCT04879849|564957649|FG002|Overall Study|Reason Not Specified|0|||
156509548|NCT04879849|564957650|FG003|Overall Study|Reason Not Specified|0|||
156509549|NCT04879849|564957651|FG004|Overall Study|Reason Not Specified|0|||
156509550|NCT04879849|564957652|FG005|Overall Study|Reason Not Specified|0|||
156400738|NCT01281202|564559661|FG000|Overall Study|Adverse Event|2|||
156400739|NCT01281202|564559662|FG001|Overall Study|Adverse Event|0|||
156509551|NCT04879849|564957653|FG006|Overall Study|Reason Not Specified|0|||
156509552|NCT04879849|564957654|FG007|Overall Study|Reason Not Specified|0|||
156509553|NCT03361865|564957655|FG000|Overall Study|Death|17|||
156400740|NCT01281202|564559661|FG000|Overall Study|Withdrawal by Subject|2|||
156400741|NCT01281202|564559662|FG001|Overall Study|Withdrawal by Subject|2|||
156400742|NCT01281202|564559661|FG000|Overall Study|Protocol Violation|11|||
156400743|NCT01281202|564559662|FG001|Overall Study|Protocol Violation|10|||
156400744|NCT01281202|564559661|FG000|Overall Study|Administrative|2|||
156400745|NCT01281202|564559662|FG001|Overall Study|Administrative|8|||
156509554|NCT03361865|564957656|FG001|Overall Study|Death|18|||
156509555|NCT03361865|564957655|FG000|Overall Study|Physician Decision|1|||
156509556|NCT03361865|564957656|FG001|Overall Study|Physician Decision|9|||
156509557|NCT03361865|564957655|FG000|Overall Study|Withdrawal by Subject|1|||
156509558|NCT03361865|564957656|FG001|Overall Study|Withdrawal by Subject|0|||
156509559|NCT02819024|564957658|FG000|Overall Study|Withdrawal by Subject|1|||
156509560|NCT03551691|564957662|FG000|Overall Study|Withdrawal by Subject|3|||
156509561|NCT03551691|564957663|FG001|Overall Study|Withdrawal by Subject|3|||
156509562|NCT02367040|564957664|FG000|Overall Study|Lost to Follow-up|1|||
156509563|NCT02367040|564957665|FG001|Overall Study|Lost to Follow-up|1|||
156509564|NCT02367040|564957664|FG000|Overall Study|Lack of Efficacy|1|||
156509565|NCT02367040|564957665|FG001|Overall Study|Lack of Efficacy|0|||
156509566|NCT02367040|564957664|FG000|Overall Study|Additional primary malignancy|1|||
156509567|NCT02367040|564957665|FG001|Overall Study|Additional primary malignancy|1|||
156509568|NCT02367040|564957664|FG000|Overall Study|AE not associated with clinical disease progression|117|||
156509569|NCT02367040|564957665|FG001|Overall Study|AE not associated with clinical disease progression|12|||
156509570|NCT02367040|564957664|FG000|Overall Study|AE associated with clinical disease progression|1|||
156509571|NCT02367040|564957665|FG001|Overall Study|AE associated with clinical disease progression|4|||
156509572|NCT02367040|564957664|FG000|Overall Study|Physician Decision|2|||
156509573|NCT02367040|564957665|FG001|Overall Study|Physician Decision|8|||
156509574|NCT02367040|564957664|FG000|Overall Study|Non-compliance to study drug|1|||
156509575|NCT02367040|564957665|FG001|Overall Study|Non-compliance to study drug|0|||
156509576|NCT02367040|564957664|FG000|Overall Study|Failure to meet continuation criteria|1|||
156509577|NCT02367040|564957665|FG001|Overall Study|Failure to meet continuation criteria|0|||
156509578|NCT02367040|564957664|FG000|Overall Study|Switching to other therapy|2|||
156509579|NCT02367040|564957665|FG001|Overall Study|Switching to other therapy|0|||
156509580|NCT02367040|564957664|FG000|Overall Study|Withdrawal by Subject|51|||
156509581|NCT02367040|564957665|FG001|Overall Study|Withdrawal by Subject|16|||
156509582|NCT02367040|564957664|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
156509583|NCT02367040|564957665|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
156509584|NCT02367040|564957664|FG000|Overall Study|Patient decision|40|||
156509585|NCT02367040|564957665|FG001|Overall Study|Patient decision|14|||
156509586|NCT02367040|564957664|FG000|Overall Study|Required procedure failed|1|||
156509587|NCT02367040|564957665|FG001|Overall Study|Required procedure failed|0|||
156509588|NCT02367040|564957664|FG000|Overall Study|Randomized by mistake with study treatment|1|||
156509589|NCT02367040|564957665|FG001|Overall Study|Randomized by mistake with study treatment|0|||
156509590|NCT02367040|564957664|FG000|Overall Study|Protocol Violation|1|||
156509591|NCT02367040|564957665|FG001|Overall Study|Protocol Violation|0|||
156509592|NCT02367040|564957664|FG000|Overall Study|Progressive disease - radiological progression|54|||
156509593|NCT02367040|564957665|FG001|Overall Study|Progressive disease - radiological progression|80|||
156509594|NCT02367040|564957664|FG000|Overall Study|Progressive disease - clinical progression|6|||
156509595|NCT02367040|564957665|FG001|Overall Study|Progressive disease - clinical progression|6|||
156509596|NCT02367040|564957664|FG000|Overall Study|Drug not administered|3|||
156509597|NCT02367040|564957665|FG001|Overall Study|Drug not administered|2|||
156509598|NCT02367040|564957664|FG000|Overall Study|Progressive disease|0|||
156509599|NCT02367040|564957665|FG001|Overall Study|Progressive disease|1|||
156550615|NCT02475681|565108929|FG002|Overall Study|Reasons other than above listed|0|||
156400746|NCT01281202|564559661|FG000|Overall Study|Lost to Follow-up|11|||
156400747|NCT01281202|564559662|FG001|Overall Study|Lost to Follow-up|13|||
156400748|NCT01281202|564559661|FG000|Overall Study|Incarceration|0|||
156400749|NCT01281202|564559662|FG001|Overall Study|Incarceration|3|||
156400750|NCT04581200|564559663|FG000|Overall Study|Lost to Follow-up|6|||
156400751|NCT04581200|564559664|FG001|Overall Study|Lost to Follow-up|5|||
156400752|NCT04711603|564559665|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
156400753|NCT04711603|564559666|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
156400754|NCT04711603|564559667|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
156400755|NCT04711603|564559668|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
156400756|NCT04711603|564559665|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
156400757|NCT04711603|564559666|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
156400758|NCT04711603|564559667|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
156400759|NCT04711603|564559668|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
156400760|NCT04711603|564559665|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
156400761|NCT04711603|564559666|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
156509600|NCT02367040|564957664|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
156509601|NCT02367040|564957665|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
156509602|NCT02367040|564957664|FG000|Overall Study|Death|2|||
156509603|NCT02367040|564957665|FG001|Overall Study|Death|0|||
156400762|NCT04711603|564559667|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
156400763|NCT04711603|564559668|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
156400764|NCT04711603|564559665|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
156400765|NCT04711603|564559666|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
156400766|NCT04711603|564559667|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
156400767|NCT04711603|564559668|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
156400768|NCT04711603|564559665|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
156400769|NCT04711603|564559666|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
156400770|NCT04711603|564559667|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
156400771|NCT04711603|564559668|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
156400772|NCT04711603|564559665|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
156400773|NCT04711603|564559666|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
156400774|NCT04711603|564559667|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
156400775|NCT04711603|564559668|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
156400776|NCT04711603|564559665|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
156400777|NCT04711603|564559666|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
156400778|NCT04711603|564559667|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
156400779|NCT04711603|564559668|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
156400780|NCT04711603|564559665|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
156400781|NCT04711603|564559666|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
156400782|NCT04711603|564559667|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
156400783|NCT04711603|564559668|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
156400784|NCT04711603|564559665|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
156400785|NCT04711603|564559666|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
156550616|NCT02597855|565108933|FG000|Overall Study|Lost to Follow-up|2|||
156550617|NCT02597855|565108934|FG001|Overall Study|Lost to Follow-up|1|||
156550618|NCT04681170|565108942|FG000|Stratified Enrolment & run-in|Death|1|||
156550619|NCT04681170|565108943|FG001|Stratified Enrolment & run-in|Death|0|||
156550620|NCT04681170|565108942|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
156550621|NCT04681170|565108943|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
156550622|NCT04681170|565108942|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
156550623|NCT04681170|565108943|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
156550624|NCT04681170|565108942|FG000|Open Label Efficacy Phase|Adverse Event|0|||
156550625|NCT04681170|565108943|FG001|Open Label Efficacy Phase|Adverse Event|2|||
156550626|NCT04681170|565108942|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
156550627|NCT04681170|565108943|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
156550628|NCT04681170|565108942|FG000|Open Label Safety Phase|AEs and none compliance|0|||
156550629|NCT04681170|565108943|FG001|Open Label Safety Phase|AEs and none compliance|1|||
156550630|NCT01407926|565108948|FG000|Overall Study|Lost to Follow-up|55|||
156550631|NCT02468648|565108949|FG000|Overall Study|Death|1|||
156550632|NCT02118792|565108950|FG000|Overall Study|Withdrawal by Subject|6|||
156550633|NCT02118792|565108951|FG001|Overall Study|Withdrawal by Subject|3|||
156550634|NCT02118792|565108950|FG000|Overall Study|Lost to Follow-up|4|||
156550635|NCT02118792|565108951|FG001|Overall Study|Lost to Follow-up|4|||
156550636|NCT02118792|565108950|FG000|Overall Study|Adverse Event|5|||
156550637|NCT02118792|565108951|FG001|Overall Study|Adverse Event|4|||
156550638|NCT02118792|565108950|FG000|Overall Study|Withdrawal by parent/guardian|14|||
156550639|NCT02118792|565108951|FG001|Overall Study|Withdrawal by parent/guardian|20|||
156550640|NCT02118792|565108950|FG000|Overall Study|Other|1|||
156550641|NCT02118792|565108951|FG001|Overall Study|Other|6|||
156550642|NCT02118792|565108950|FG000|Overall Study|Randomised but not treated|1|||
156550643|NCT02118792|565108951|FG001|Overall Study|Randomised but not treated|0|||
156550644|NCT01678144|565108952|FG000|Stage 1: MAR Classic|Adverse Event|1|||
156550645|NCT02363686|565108957|FG000|Overall Study|Withdrawal by Subject|22|||
156550646|NCT02363686|565108957|FG000|Overall Study|incomplete FEES examinations|13|||
156550647|NCT02469090|565108961|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
156550648|NCT02469090|565108962|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
156550649|NCT02469090|565108963|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
156550650|NCT02469090|565108961|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
156550651|NCT02469090|565108962|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
156550652|NCT02469090|565108963|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
156550653|NCT02469090|565108961|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
156550654|NCT02469090|565108962|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
156550655|NCT02469090|565108963|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
156550656|NCT02469090|565108961|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
156550657|NCT02469090|565108962|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
156550658|NCT02469090|565108963|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
156550659|NCT02469090|565108961|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
156550660|NCT02469090|565108962|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
156550661|NCT02469090|565108963|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
156550662|NCT02469090|565108961|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
156550663|NCT02469090|565108962|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
156550664|NCT02469090|565108963|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
156550665|NCT02469090|565108961|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
156550666|NCT02469090|565108962|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
156550667|NCT02469090|565108963|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
156550668|NCT02469090|565108961|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
156550669|NCT02469090|565108962|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
156550670|NCT02469090|565108963|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
156550671|NCT03806127|565108965|FG000|Overall Study|Withdrawal by Subject|4|||
156550672|NCT03806127|565108966|FG001|Overall Study|Withdrawal by Subject|5|||
156550673|NCT03806127|565108965|FG000|Overall Study|Protocol Violation|3|||
156550674|NCT03806127|565108966|FG001|Overall Study|Protocol Violation|1|||
156550675|NCT03806127|565108965|FG000|Overall Study|Adverse Event|3|||
156550676|NCT03806127|565108966|FG001|Overall Study|Adverse Event|0|||
156550677|NCT03806127|565108965|FG000|Overall Study|Unable to Complete Procedures|0|||
156550678|NCT03806127|565108966|FG001|Overall Study|Unable to Complete Procedures|1|||
156550679|NCT03806127|565108965|FG000|Overall Study|Pregnancy|0|||
156550680|NCT03806127|565108966|FG001|Overall Study|Pregnancy|1|||
156550681|NCT03806127|565108965|FG000|Overall Study|Lost to Follow-up|5|||
156550682|NCT03806127|565108966|FG001|Overall Study|Lost to Follow-up|1|||
156550683|NCT03806127|565108965|FG000|Overall Study|Physician Decision|1|||
156550684|NCT03806127|565108966|FG001|Overall Study|Physician Decision|1|||
156550685|NCT03806127|565108965|FG000|Overall Study|Could Not Come Due to Covid|1|||
156550686|NCT03806127|565108966|FG001|Overall Study|Could Not Come Due to Covid|0|||
156550687|NCT03806127|565108965|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
156550688|NCT03806127|565108966|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
156550689|NCT03806127|565108965|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
156550690|NCT03806127|565108966|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
156550691|NCT03806127|565108965|FG000|Overall Study|Covid 19 Restrictions|2|||
156550692|NCT03806127|565108966|FG001|Overall Study|Covid 19 Restrictions|0|||
156550693|NCT03806127|565108965|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
156550694|NCT03806127|565108966|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
156550695|NCT03806127|565108965|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
156550696|NCT03806127|565108966|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
156550697|NCT03446885|565108970|FG000|Overall Study|Lost to Follow-up|1|||
156400786|NCT04711603|564559667|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
156400787|NCT04711603|564559668|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
156400788|NCT04711603|564559665|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
156400789|NCT04711603|564559666|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
156509604|NCT02367040|564957664|FG000|Overall Study|Study terminated by sponsor|19|||
156509605|NCT02367040|564957665|FG001|Overall Study|Study terminated by sponsor|2|||
156509606|NCT03345576|564957666|FG000|Overall Study|Withdrawal by Subject|2|||
156509607|NCT03345576|564957667|FG001|Overall Study|Withdrawal by Subject|2|||
156509608|NCT03345576|564957666|FG000|Overall Study|Adverse Event|1|||
156509609|NCT03345576|564957667|FG001|Overall Study|Adverse Event|0|||
156509610|NCT01876082|564960068|FG000|Overall Study|Withdrawal by Subject|0|||
156509611|NCT01876082|564960069|FG001|Overall Study|Withdrawal by Subject|2|||
156509612|NCT01876082|564960068|FG000|Overall Study|Protocol Violation|1|||
156509613|NCT01876082|564960069|FG001|Overall Study|Protocol Violation|0|||
156509614|NCT01876082|564960068|FG000|Overall Study|Adverse Event|1|||
156509615|NCT01876082|564960069|FG001|Overall Study|Adverse Event|1|||
156509616|NCT01876082|564960068|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
156509617|NCT01876082|564960069|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
156509618|NCT03829501|564960078|FG000|Overall Study|Withdrawal of Consent|2|||
156509619|NCT03829501|564960079|FG001|Overall Study|Withdrawal of Consent|0|||
156509620|NCT03829501|564960080|FG002|Overall Study|Withdrawal of Consent|3|||
156509621|NCT03829501|564960081|FG003|Overall Study|Withdrawal of Consent|0|||
156509622|NCT03829501|564960082|FG004|Overall Study|Withdrawal of Consent|1|||
156509623|NCT03829501|564960083|FG005|Overall Study|Withdrawal of Consent|1|||
156509624|NCT03829501|564960084|FG006|Overall Study|Withdrawal of Consent|0|||
156509625|NCT03829501|564960085|FG007|Overall Study|Withdrawal of Consent|10|||
156509626|NCT03829501|564960086|FG008|Overall Study|Withdrawal of Consent|10|||
156509627|NCT03829501|564960087|FG009|Overall Study|Withdrawal of Consent|3|||
156509628|NCT03829501|564960088|FG010|Overall Study|Withdrawal of Consent|4|||
156509629|NCT03829501|564960089|FG011|Overall Study|Withdrawal of Consent|4|||
156509630|NCT03829501|564960090|FG012|Overall Study|Withdrawal of Consent|4|||
156509631|NCT03829501|564960091|FG013|Overall Study|Withdrawal of Consent|0|||
156509632|NCT03829501|564960092|FG014|Overall Study|Withdrawal of Consent|3|||
156550698|NCT03446885|565108971|FG001|Overall Study|Lost to Follow-up|0|||
156550699|NCT03446885|565108970|FG000|Overall Study|Did not complete entire visit|1|||
156550700|NCT03446885|565108971|FG001|Overall Study|Did not complete entire visit|0|||
156550701|NCT03823391|565108972|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
156550702|NCT03823391|565108973|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
156550703|NCT03823391|565108972|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
156550704|NCT03823391|565108973|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
156550705|NCT05030311|565108983|FG000|Overall Study|Technical problems|0|||
156550706|NCT05030311|565108984|FG001|Overall Study|Technical problems|1|||
156550707|NCT05030311|565108983|FG000|Overall Study|Withdrawal by Subject|31|||
156550708|NCT05030311|565108984|FG001|Overall Study|Withdrawal by Subject|17|||
156550709|NCT05030311|565108983|FG000|Overall Study|Adverse Event|13|||
156550710|NCT05030311|565108984|FG001|Overall Study|Adverse Event|5|||
156550711|NCT05030311|565108983|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156550712|NCT05030311|565108984|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156550713|NCT05030311|565108983|FG000|Overall Study|Physician Decision|5|||
156550714|NCT05030311|565108984|FG001|Overall Study|Physician Decision|2|||
156550715|NCT05030311|565108983|FG000|Overall Study|Lost to Follow-up|5|||
156550716|NCT05030311|565108984|FG001|Overall Study|Lost to Follow-up|1|||
156550717|NCT05030311|565108983|FG000|Overall Study|Protocol Violation|4|||
156550718|NCT05030311|565108984|FG001|Overall Study|Protocol Violation|4|||
156550719|NCT03042468|565108985|FG000|Overall Study|Death|0|||
156550720|NCT03042468|565108986|FG001|Overall Study|Death|1|||
156550721|NCT03042468|565108987|FG002|Overall Study|Death|1|||
156550722|NCT03042468|565108988|FG003|Overall Study|Death|0|||
156550723|NCT03042468|565108989|FG004|Overall Study|Death|0|||
156550724|NCT03042468|565108990|FG005|Overall Study|Death|0|||
156550725|NCT03042468|565108985|FG000|Overall Study|Withdrawal by Subject|0|||
156550726|NCT03042468|565108986|FG001|Overall Study|Withdrawal by Subject|0|||
156550727|NCT03042468|565108987|FG002|Overall Study|Withdrawal by Subject|0|||
156550728|NCT03042468|565108988|FG003|Overall Study|Withdrawal by Subject|0|||
156550729|NCT03042468|565108989|FG004|Overall Study|Withdrawal by Subject|0|||
156550730|NCT03042468|565108990|FG005|Overall Study|Withdrawal by Subject|1|||
156550731|NCT03042468|565108985|FG000|Overall Study|Lost to Follow-up|0|||
156550732|NCT03042468|565108986|FG001|Overall Study|Lost to Follow-up|0|||
156550733|NCT03042468|565108987|FG002|Overall Study|Lost to Follow-up|0|||
156550734|NCT03042468|565108988|FG003|Overall Study|Lost to Follow-up|0|||
156550735|NCT03042468|565108989|FG004|Overall Study|Lost to Follow-up|1|||
156550736|NCT03042468|565108990|FG005|Overall Study|Lost to Follow-up|1|||
156550737|NCT03557359|565108991|FG000|Dose 1: 240 mg|Adverse Event|1|||
156550738|NCT03557359|565108992|FG001|Dose 1: 240 mg|Adverse Event|0|||
156550739|NCT05980299|565108997|FG000|Overall Study|Death|28|||
156550740|NCT05980299|565108998|FG001|Overall Study|Death|0|||
156550741|NCT05980299|565108997|FG000|Overall Study|Discharged from Nursing Home|9|||
156550742|NCT05980299|565108998|FG001|Overall Study|Discharged from Nursing Home|0|||
156550743|NCT05980299|565108997|FG000|Overall Study|Lost to Follow-up|0|||
156550744|NCT05980299|565108998|FG001|Overall Study|Lost to Follow-up|10|||
156550745|NCT02264990|565108999|FG000|Overall Study|Death|255|||
156550746|NCT02264990|565109000|FG001|Overall Study|Death|250|||
156550747|NCT02264990|565108999|FG000|Overall Study|Withdrawal by Subject|4|||
156550748|NCT02264990|565109000|FG001|Overall Study|Withdrawal by Subject|5|||
156550749|NCT02264990|565108999|FG000|Overall Study|Lost to Follow-up|1|||
156550750|NCT02264990|565109000|FG001|Overall Study|Lost to Follow-up|3|||
156550751|NCT02264990|565108999|FG000|Overall Study|Other|0|||
156550752|NCT02264990|565109000|FG001|Overall Study|Other|1|||
156550753|NCT03031301|565109002|FG000|Overall Study|Protocol Violation|4|||
156550754|NCT03031301|565109003|FG001|Overall Study|Protocol Violation|8|||
156550755|NCT03031301|565109002|FG000|Overall Study|Withdrawal by Subject|7|||
156550756|NCT03031301|565109003|FG001|Overall Study|Withdrawal by Subject|4|||
156550757|NCT03031301|565109002|FG000|Overall Study|Lost to Follow-up|4|||
156550758|NCT03031301|565109003|FG001|Overall Study|Lost to Follow-up|12|||
156550759|NCT03031301|565109002|FG000|Overall Study|Noncompliance|1|||
156550760|NCT03031301|565109003|FG001|Overall Study|Noncompliance|3|||
156550761|NCT03031301|565109002|FG000|Overall Study|Technical issue|1|||
156550762|NCT03031301|565109003|FG001|Overall Study|Technical issue|1|||
156550763|NCT03031301|565109002|FG000|Overall Study|Adverse Event|1|||
156550764|NCT03031301|565109003|FG001|Overall Study|Adverse Event|0|||
156550765|NCT01294800|565109004|FG000|Overall Study|Adverse Event|7|||
156550766|NCT01294800|565109005|FG001|Overall Study|Adverse Event|6|||
156550767|NCT01294800|565109006|FG002|Overall Study|Adverse Event|12|||
156550768|NCT01294800|565109007|FG003|Overall Study|Adverse Event|5|||
156550769|NCT01294800|565109004|FG000|Overall Study|Subject Withdrew Consent|2|||
156550770|NCT01294800|565109005|FG001|Overall Study|Subject Withdrew Consent|2|||
156550771|NCT01294800|565109006|FG002|Overall Study|Subject Withdrew Consent|2|||
156550772|NCT01294800|565109007|FG003|Overall Study|Subject Withdrew Consent|11|||
156550773|NCT01294800|565109004|FG000|Overall Study|Lost to Follow-up|0|||
156550774|NCT01294800|565109005|FG001|Overall Study|Lost to Follow-up|0|||
156550775|NCT01294800|565109006|FG002|Overall Study|Lost to Follow-up|1|||
156550776|NCT01294800|565109007|FG003|Overall Study|Lost to Follow-up|0|||
156550777|NCT01294800|565109004|FG000|Overall Study|Non-compliance With Protocol|0|||
156550778|NCT01294800|565109005|FG001|Overall Study|Non-compliance With Protocol|1|||
156550779|NCT01294800|565109006|FG002|Overall Study|Non-compliance With Protocol|1|||
156550780|NCT01294800|565109007|FG003|Overall Study|Non-compliance With Protocol|0|||
156550781|NCT01294800|565109004|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
156550782|NCT01294800|565109005|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
156550783|NCT01294800|565109006|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
156550784|NCT01294800|565109007|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
156550785|NCT01662895|565109009|FG000|Overall Study|Lost to Follow-up|0|||
156550786|NCT01662895|565109010|FG001|Overall Study|Lost to Follow-up|1|||
156550787|NCT05048342|565109011|FG000|Overall Study|Adverse Event|1|||
156550788|NCT05048342|565109011|FG000|Overall Study|Subject decision|2|||
156550789|NCT01100944|565109012|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
156550790|NCT01100944|565109013|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
156550791|NCT01100944|565109014|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
156550792|NCT01100944|565109012|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
156550793|NCT01100944|565109013|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
156550794|NCT01100944|565109014|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
156550795|NCT01100944|565109012|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
156550796|NCT01100944|565109013|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
156550797|NCT01100944|565109014|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
156550798|NCT01100944|565109012|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
156550799|NCT01100944|565109013|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
156550800|NCT01100944|565109014|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
156550801|NCT04607733|565109015|FG000|Overall Study|Lost to Follow-up|1|||
156550802|NCT04607733|565109016|FG001|Overall Study|Lost to Follow-up|0|||
156550803|NCT04607733|565109017|FG002|Overall Study|Lost to Follow-up|0|||
156550804|NCT04607733|565109018|FG003|Overall Study|Lost to Follow-up|1|||
156550805|NCT04607733|565109019|FG004|Overall Study|Lost to Follow-up|1|||
156550806|NCT04607733|565109020|FG005|Overall Study|Lost to Follow-up|0|||
156550807|NCT04607733|565109015|FG000|Overall Study|Withdrawal by Subject|0|||
156550808|NCT04607733|565109016|FG001|Overall Study|Withdrawal by Subject|0|||
156550809|NCT04607733|565109017|FG002|Overall Study|Withdrawal by Subject|0|||
156550810|NCT04607733|565109018|FG003|Overall Study|Withdrawal by Subject|0|||
156550811|NCT04607733|565109019|FG004|Overall Study|Withdrawal by Subject|1|||
156550812|NCT04607733|565109020|FG005|Overall Study|Withdrawal by Subject|0|||
156550813|NCT02296242|565109046|FG000|Overall Study|Death|1|||
156550814|NCT02296242|565109047|FG001|Overall Study|Death|1|||
156550815|NCT02296242|565109048|FG002|Overall Study|Death|1|||
156550816|NCT02296242|565109049|FG003|Overall Study|Death|1|||
156550817|NCT02296242|565109050|FG004|Overall Study|Death|1|||
156550818|NCT02296242|565109046|FG000|Overall Study|Withdrawal by Subject|0|||
156550819|NCT02296242|565109047|FG001|Overall Study|Withdrawal by Subject|0|||
156550820|NCT02296242|565109048|FG002|Overall Study|Withdrawal by Subject|1|||
156550821|NCT02296242|565109049|FG003|Overall Study|Withdrawal by Subject|1|||
156550822|NCT02296242|565109050|FG004|Overall Study|Withdrawal by Subject|3|||
156550823|NCT02296242|565109046|FG000|Overall Study|Disease Progression|1|||
156550824|NCT02296242|565109047|FG001|Overall Study|Disease Progression|3|||
156550825|NCT02296242|565109048|FG002|Overall Study|Disease Progression|2|||
156550826|NCT02296242|565109049|FG003|Overall Study|Disease Progression|8|||
156550827|NCT02296242|565109050|FG004|Overall Study|Disease Progression|11|||
156550828|NCT02296242|565109046|FG000|Overall Study|Unacceptable Toxicity|0|||
156550829|NCT02296242|565109047|FG001|Overall Study|Unacceptable Toxicity|0|||
156550830|NCT02296242|565109048|FG002|Overall Study|Unacceptable Toxicity|0|||
156550831|NCT02296242|565109049|FG003|Overall Study|Unacceptable Toxicity|0|||
156550832|NCT02296242|565109050|FG004|Overall Study|Unacceptable Toxicity|1|||
156550833|NCT02296242|565109046|FG000|Overall Study|Patient Condition Changed|0|||
156550834|NCT02296242|565109047|FG001|Overall Study|Patient Condition Changed|0|||
156550835|NCT02296242|565109048|FG002|Overall Study|Patient Condition Changed|2|||
156550836|NCT02296242|565109049|FG003|Overall Study|Patient Condition Changed|0|||
156550837|NCT02296242|565109050|FG004|Overall Study|Patient Condition Changed|1|||
156550838|NCT02296242|565109046|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
156550839|NCT02296242|565109047|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
156550840|NCT02296242|565109048|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
156550841|NCT02296242|565109049|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
156550842|NCT02296242|565109050|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
156550843|NCT02296242|565109046|FG000|Overall Study|Lost to Follow-up|1|||
156550844|NCT02296242|565109047|FG001|Overall Study|Lost to Follow-up|0|||
156550845|NCT02296242|565109048|FG002|Overall Study|Lost to Follow-up|0|||
156550846|NCT02296242|565109049|FG003|Overall Study|Lost to Follow-up|0|||
156550847|NCT02296242|565109050|FG004|Overall Study|Lost to Follow-up|0|||
156550848|NCT02296242|565109046|FG000|Overall Study|Need for Hydroxyurea|2|||
156550849|NCT02296242|565109047|FG001|Overall Study|Need for Hydroxyurea|0|||
156550850|NCT02296242|565109048|FG002|Overall Study|Need for Hydroxyurea|0|||
156550851|NCT02296242|565109049|FG003|Overall Study|Need for Hydroxyurea|0|||
156550852|NCT02296242|565109050|FG004|Overall Study|Need for Hydroxyurea|0|||
156550853|NCT02296242|565109046|FG000|Overall Study|Screened for Other Protocol|0|||
156550854|NCT02296242|565109047|FG001|Overall Study|Screened for Other Protocol|1|||
156550855|NCT02296242|565109048|FG002|Overall Study|Screened for Other Protocol|0|||
156550856|NCT02296242|565109049|FG003|Overall Study|Screened for Other Protocol|0|||
156550857|NCT02296242|565109050|FG004|Overall Study|Screened for Other Protocol|0|||
156550858|NCT02296242|565109046|FG000|Overall Study|Physician Decision|0|||
156550859|NCT02296242|565109047|FG001|Overall Study|Physician Decision|1|||
156550860|NCT02296242|565109048|FG002|Overall Study|Physician Decision|0|||
156550861|NCT02296242|565109049|FG003|Overall Study|Physician Decision|1|||
156550862|NCT02296242|565109050|FG004|Overall Study|Physician Decision|0|||
156550863|NCT02296242|565109046|FG000|Overall Study|Alternative Treatment|0|||
156550864|NCT02296242|565109047|FG001|Overall Study|Alternative Treatment|0|||
156550865|NCT02296242|565109048|FG002|Overall Study|Alternative Treatment|0|||
156550866|NCT02296242|565109049|FG003|Overall Study|Alternative Treatment|1|||
156550867|NCT02296242|565109050|FG004|Overall Study|Alternative Treatment|0|||
156550868|NCT02296242|565109046|FG000|Overall Study|Adverse Event|0|||
156550869|NCT02296242|565109047|FG001|Overall Study|Adverse Event|0|||
156550870|NCT02296242|565109048|FG002|Overall Study|Adverse Event|0|||
156550871|NCT02296242|565109049|FG003|Overall Study|Adverse Event|1|||
156550872|NCT02296242|565109050|FG004|Overall Study|Adverse Event|0|||
156550873|NCT02296242|565109046|FG000|Overall Study|Lack of Efficacy|0|||
156550874|NCT02296242|565109047|FG001|Overall Study|Lack of Efficacy|0|||
156550875|NCT02296242|565109048|FG002|Overall Study|Lack of Efficacy|0|||
156550876|NCT02296242|565109049|FG003|Overall Study|Lack of Efficacy|0|||
156550877|NCT02296242|565109050|FG004|Overall Study|Lack of Efficacy|3|||
156550878|NCT01639833|565109051|FG000|Overall Study|Death|4|||
156550879|NCT01639833|565109052|FG001|Overall Study|Death|2|||
156550880|NCT01639833|565109051|FG000|Overall Study|Withdrawal by Subject|2|||
156550881|NCT01639833|565109052|FG001|Overall Study|Withdrawal by Subject|2|||
156550882|NCT03504397|565109054|FG000|Overall Study|Progressive Disease|151|||
156550883|NCT03504397|565109055|FG001|Overall Study|Progressive Disease|199|||
156550884|NCT03504397|565109054|FG000|Overall Study|Withdrawal by Subject|29|||
156550885|NCT03504397|565109055|FG001|Overall Study|Withdrawal by Subject|17|||
156550886|NCT03504397|565109054|FG000|Overall Study|Lost to Follow-up|1|||
156550887|NCT03504397|565109055|FG001|Overall Study|Lost to Follow-up|0|||
156550888|NCT03504397|565109054|FG000|Overall Study|Death|14|||
156550889|NCT03504397|565109055|FG001|Overall Study|Death|16|||
156550890|NCT03504397|565109054|FG000|Overall Study|Adverse Event|40|||
156550891|NCT03504397|565109055|FG001|Overall Study|Adverse Event|14|||
156550892|NCT03504397|565109054|FG000|Overall Study|miscellaneous|17|||
156550893|NCT03504397|565109055|FG001|Overall Study|miscellaneous|15|||
156550894|NCT03504397|565109054|FG000|Overall Study|Protocol deviation|1|||
156550895|NCT03504397|565109055|FG001|Overall Study|Protocol deviation|0|||
156550896|NCT03504397|565109054|FG000|Overall Study|Participants who did not take the study drug|4|||
156550897|NCT03504397|565109055|FG001|Overall Study|Participants who did not take the study drug|4|||
156550898|NCT00070941|565109056|FG000|Overall Study|Adverse Event|10|||
156550899|NCT00070941|565109057|FG001|Overall Study|Adverse Event|8|||
156550900|NCT00070941|565109058|FG002|Overall Study|Adverse Event|4|||
156550901|NCT00623428|565109062|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
156550902|NCT00623428|565109063|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
156550903|NCT00623428|565109062|FG000|Treatment Period|Death|0|||
156550904|NCT00623428|565109063|FG001|Treatment Period|Death|1|||
156550905|NCT00623428|565109062|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
156550906|NCT00623428|565109063|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
156550907|NCT00623428|565109062|FG000|Treatment Period|Insufficient therapeutic response|0|||
156550908|NCT00623428|565109063|FG001|Treatment Period|Insufficient therapeutic response|2|||
156550909|NCT00623428|565109062|FG000|Treatment Period|Other|0|||
156550910|NCT00623428|565109063|FG001|Treatment Period|Other|1|||
156550911|NCT00623428|565109062|FG000|Treatment Period|Withdrawal by Subject|0|||
156550912|NCT00623428|565109063|FG001|Treatment Period|Withdrawal by Subject|1|||
156550913|NCT00623428|565109062|FG000|Follow-up Period|Relapse post-treatment|11|||
156550914|NCT00623428|565109063|FG001|Follow-up Period|Relapse post-treatment|3|||
156550915|NCT00623428|565109062|FG000|Follow-up Period|Failure to return|10|||
156550916|NCT00623428|565109063|FG001|Follow-up Period|Failure to return|2|||
156550917|NCT00623428|565109062|FG000|Follow-up Period|Patient withdrew consent|5|||
156550918|NCT00623428|565109063|FG001|Follow-up Period|Patient withdrew consent|4|||
156550919|NCT00623428|565109062|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
156550920|NCT00623428|565109063|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
156550921|NCT00623428|565109062|FG000|Follow-up Period|Did not cooperate|0|||
156550922|NCT00623428|565109063|FG001|Follow-up Period|Did not cooperate|3|||
156550923|NCT00623428|565109062|FG000|Follow-up Period|Reason not specified|1|||
156550924|NCT00623428|565109063|FG001|Follow-up Period|Reason not specified|1|||
156550925|NCT00623428|565109062|FG000|Follow-up Period|Death|0|||
156550926|NCT00623428|565109063|FG001|Follow-up Period|Death|1|||
156550927|NCT01142726|565109064|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
156509633|NCT03829501|564960093|FG015|Overall Study|Withdrawal of Consent|0|||
156509634|NCT03829501|564960094|FG016|Overall Study|Withdrawal of Consent|1|||
156509635|NCT03829501|564960095|FG017|Overall Study|Withdrawal of Consent|1|||
156509636|NCT03829501|564960096|FG018|Overall Study|Withdrawal of Consent|0|||
156509637|NCT03829501|564960097|FG019|Overall Study|Withdrawal of Consent|0|||
156509638|NCT03829501|564960098|FG020|Overall Study|Withdrawal of Consent|3|||
156509639|NCT03829501|564960099|FG021|Overall Study|Withdrawal of Consent|0|||
156509640|NCT03829501|564960100|FG022|Overall Study|Withdrawal of Consent|1|||
156509641|NCT03829501|564960078|FG000|Overall Study|PD|0|||
156509642|NCT03829501|564960079|FG001|Overall Study|PD|0|||
156509643|NCT03829501|564960080|FG002|Overall Study|PD|0|||
156509644|NCT03829501|564960081|FG003|Overall Study|PD|2|||
156509645|NCT03829501|564960082|FG004|Overall Study|PD|0|||
156509646|NCT03829501|564960083|FG005|Overall Study|PD|0|||
156509647|NCT03829501|564960084|FG006|Overall Study|PD|0|||
156509648|NCT03829501|564960085|FG007|Overall Study|PD|0|||
156509649|NCT03829501|564960086|FG008|Overall Study|PD|0|||
156509650|NCT03829501|564960087|FG009|Overall Study|PD|0|||
156509651|NCT03829501|564960088|FG010|Overall Study|PD|0|||
156509652|NCT03829501|564960089|FG011|Overall Study|PD|0|||
156509653|NCT03829501|564960090|FG012|Overall Study|PD|0|||
156509654|NCT03829501|564960091|FG013|Overall Study|PD|0|||
156509655|NCT03829501|564960092|FG014|Overall Study|PD|0|||
156509656|NCT03829501|564960093|FG015|Overall Study|PD|1|||
156509657|NCT03829501|564960094|FG016|Overall Study|PD|0|||
156509658|NCT03829501|564960095|FG017|Overall Study|PD|0|||
156509659|NCT03829501|564960096|FG018|Overall Study|PD|0|||
156509660|NCT03829501|564960097|FG019|Overall Study|PD|0|||
156509661|NCT03829501|564960098|FG020|Overall Study|PD|1|||
156509662|NCT03829501|564960099|FG021|Overall Study|PD|0|||
156509663|NCT03829501|564960100|FG022|Overall Study|PD|0|||
156509664|NCT03829501|564960078|FG000|Overall Study|Study Terminated by Sponsor|0|||
156509665|NCT03829501|564960079|FG001|Overall Study|Study Terminated by Sponsor|0|||
156509666|NCT03829501|564960080|FG002|Overall Study|Study Terminated by Sponsor|0|||
156509667|NCT03829501|564960081|FG003|Overall Study|Study Terminated by Sponsor|0|||
156509668|NCT03829501|564960082|FG004|Overall Study|Study Terminated by Sponsor|0|||
156509669|NCT03829501|564960083|FG005|Overall Study|Study Terminated by Sponsor|0|||
156509670|NCT03829501|564960084|FG006|Overall Study|Study Terminated by Sponsor|0|||
156509671|NCT03829501|564960085|FG007|Overall Study|Study Terminated by Sponsor|3|||
156509672|NCT03829501|564960086|FG008|Overall Study|Study Terminated by Sponsor|1|||
156509673|NCT03829501|564960087|FG009|Overall Study|Study Terminated by Sponsor|0|||
156509674|NCT03829501|564960088|FG010|Overall Study|Study Terminated by Sponsor|0|||
156509675|NCT03829501|564960089|FG011|Overall Study|Study Terminated by Sponsor|0|||
156509676|NCT03829501|564960090|FG012|Overall Study|Study Terminated by Sponsor|0|||
156509677|NCT03829501|564960091|FG013|Overall Study|Study Terminated by Sponsor|0|||
156509678|NCT03829501|564960092|FG014|Overall Study|Study Terminated by Sponsor|3|||
156509679|NCT03829501|564960093|FG015|Overall Study|Study Terminated by Sponsor|2|||
156509680|NCT03829501|564960094|FG016|Overall Study|Study Terminated by Sponsor|2|||
156509681|NCT03829501|564960095|FG017|Overall Study|Study Terminated by Sponsor|0|||
156509682|NCT03829501|564960096|FG018|Overall Study|Study Terminated by Sponsor|0|||
156509683|NCT03829501|564960097|FG019|Overall Study|Study Terminated by Sponsor|0|||
156509684|NCT03829501|564960098|FG020|Overall Study|Study Terminated by Sponsor|1|||
156509685|NCT03829501|564960099|FG021|Overall Study|Study Terminated by Sponsor|0|||
156509686|NCT03829501|564960100|FG022|Overall Study|Study Terminated by Sponsor|3|||
156509687|NCT03829501|564960078|FG000|Overall Study|Lost to Follow Up|0|||
156509688|NCT03829501|564960079|FG001|Overall Study|Lost to Follow Up|0|||
156509689|NCT03829501|564960080|FG002|Overall Study|Lost to Follow Up|0|||
156509690|NCT03829501|564960081|FG003|Overall Study|Lost to Follow Up|0|||
156509691|NCT03829501|564960082|FG004|Overall Study|Lost to Follow Up|1|||
156509692|NCT03829501|564960083|FG005|Overall Study|Lost to Follow Up|0|||
156509693|NCT03829501|564960084|FG006|Overall Study|Lost to Follow Up|0|||
156509694|NCT03829501|564960085|FG007|Overall Study|Lost to Follow Up|2|||
156509695|NCT03829501|564960086|FG008|Overall Study|Lost to Follow Up|2|||
156509696|NCT03829501|564960087|FG009|Overall Study|Lost to Follow Up|0|||
156509697|NCT03829501|564960088|FG010|Overall Study|Lost to Follow Up|2|||
156509698|NCT03829501|564960089|FG011|Overall Study|Lost to Follow Up|1|||
156509699|NCT03829501|564960090|FG012|Overall Study|Lost to Follow Up|0|||
156509700|NCT03829501|564960091|FG013|Overall Study|Lost to Follow Up|1|||
156509701|NCT03829501|564960092|FG014|Overall Study|Lost to Follow Up|1|||
156509702|NCT03829501|564960093|FG015|Overall Study|Lost to Follow Up|0|||
156509703|NCT03829501|564960094|FG016|Overall Study|Lost to Follow Up|0|||
156509704|NCT03829501|564960095|FG017|Overall Study|Lost to Follow Up|0|||
156509705|NCT03829501|564960096|FG018|Overall Study|Lost to Follow Up|0|||
156509706|NCT03829501|564960097|FG019|Overall Study|Lost to Follow Up|0|||
156509707|NCT03829501|564960098|FG020|Overall Study|Lost to Follow Up|0|||
156509708|NCT03829501|564960099|FG021|Overall Study|Lost to Follow Up|0|||
156509709|NCT03829501|564960100|FG022|Overall Study|Lost to Follow Up|1|||
156509710|NCT03829501|564960078|FG000|Overall Study|Death|2|||
156509711|NCT03829501|564960079|FG001|Overall Study|Death|4|||
156509712|NCT03829501|564960080|FG002|Overall Study|Death|5|||
156509713|NCT03829501|564960081|FG003|Overall Study|Death|6|||
156509714|NCT03829501|564960082|FG004|Overall Study|Death|5|||
156509715|NCT03829501|564960083|FG005|Overall Study|Death|4|||
156509716|NCT03829501|564960084|FG006|Overall Study|Death|5|||
156509717|NCT03829501|564960085|FG007|Overall Study|Death|24|||
156509718|NCT03829501|564960086|FG008|Overall Study|Death|22|||
156509719|NCT03829501|564960087|FG009|Overall Study|Death|6|||
156509720|NCT03829501|564960088|FG010|Overall Study|Death|3|||
156509721|NCT03829501|564960089|FG011|Overall Study|Death|10|||
156509722|NCT03829501|564960090|FG012|Overall Study|Death|10|||
156509723|NCT03829501|564960091|FG013|Overall Study|Death|5|||
156509724|NCT03829501|564960092|FG014|Overall Study|Death|7|||
156509725|NCT03829501|564960093|FG015|Overall Study|Death|2|||
156509726|NCT03829501|564960094|FG016|Overall Study|Death|2|||
156509727|NCT03829501|564960095|FG017|Overall Study|Death|1|||
156509728|NCT03829501|564960096|FG018|Overall Study|Death|1|||
156509729|NCT03829501|564960097|FG019|Overall Study|Death|1|||
156509730|NCT03829501|564960098|FG020|Overall Study|Death|1|||
156509731|NCT03829501|564960099|FG021|Overall Study|Death|2|||
156509732|NCT03829501|564960100|FG022|Overall Study|Death|3|||
156509733|NCT03829501|564960078|FG000|Overall Study|Miscellaneous|0|||
156509734|NCT03829501|564960079|FG001|Overall Study|Miscellaneous|0|||
156509735|NCT03829501|564960080|FG002|Overall Study|Miscellaneous|1|||
156509736|NCT03829501|564960081|FG003|Overall Study|Miscellaneous|0|||
156509737|NCT03829501|564960082|FG004|Overall Study|Miscellaneous|0|||
156509738|NCT03829501|564960083|FG005|Overall Study|Miscellaneous|0|||
156509739|NCT03829501|564960084|FG006|Overall Study|Miscellaneous|0|||
156509740|NCT03829501|564960085|FG007|Overall Study|Miscellaneous|1|||
156509741|NCT03829501|564960086|FG008|Overall Study|Miscellaneous|0|||
156509742|NCT03829501|564960087|FG009|Overall Study|Miscellaneous|0|||
156509743|NCT03829501|564960088|FG010|Overall Study|Miscellaneous|0|||
156509744|NCT03829501|564960089|FG011|Overall Study|Miscellaneous|0|||
156509745|NCT03829501|564960090|FG012|Overall Study|Miscellaneous|0|||
156509746|NCT03829501|564960091|FG013|Overall Study|Miscellaneous|0|||
156509747|NCT03829501|564960092|FG014|Overall Study|Miscellaneous|0|||
156509748|NCT03829501|564960093|FG015|Overall Study|Miscellaneous|0|||
156509749|NCT03829501|564960094|FG016|Overall Study|Miscellaneous|0|||
156509750|NCT03829501|564960095|FG017|Overall Study|Miscellaneous|0|||
156509751|NCT03829501|564960096|FG018|Overall Study|Miscellaneous|0|||
156509752|NCT03829501|564960097|FG019|Overall Study|Miscellaneous|0|||
156509753|NCT03829501|564960098|FG020|Overall Study|Miscellaneous|0|||
156509754|NCT03829501|564960099|FG021|Overall Study|Miscellaneous|0|||
156509755|NCT03829501|564960100|FG022|Overall Study|Miscellaneous|1|||
156509756|NCT02964013|564960101|FG000|Overall Study|Death|58|||
156509757|NCT02964013|564960102|FG001|Overall Study|Death|239|||
156509758|NCT02964013|564960103|FG002|Overall Study|Death|38|||
156509759|NCT02964013|564960104|FG003|Overall Study|Death|10|||
156509760|NCT02964013|564960105|FG004|Overall Study|Death|33|||
156509761|NCT02964013|564960101|FG000|Overall Study|Lost to Follow-up|1|||
156509762|NCT02964013|564960102|FG001|Overall Study|Lost to Follow-up|4|||
156509763|NCT02964013|564960103|FG002|Overall Study|Lost to Follow-up|2|||
156509764|NCT02964013|564960104|FG003|Overall Study|Lost to Follow-up|0|||
156509765|NCT02964013|564960105|FG004|Overall Study|Lost to Follow-up|0|||
156509766|NCT02964013|564960101|FG000|Overall Study|Physician Decision|0|||
156509767|NCT02964013|564960102|FG001|Overall Study|Physician Decision|1|||
156509768|NCT02964013|564960103|FG002|Overall Study|Physician Decision|0|||
156509769|NCT02964013|564960104|FG003|Overall Study|Physician Decision|0|||
156509770|NCT02964013|564960105|FG004|Overall Study|Physician Decision|0|||
156509771|NCT02964013|564960101|FG000|Overall Study|Sponsor Decision|3|||
156509772|NCT02964013|564960102|FG001|Overall Study|Sponsor Decision|22|||
156509773|NCT02964013|564960103|FG002|Overall Study|Sponsor Decision|11|||
156509774|NCT02964013|564960104|FG003|Overall Study|Sponsor Decision|0|||
156509775|NCT02964013|564960105|FG004|Overall Study|Sponsor Decision|7|||
156509776|NCT02964013|564960101|FG000|Overall Study|Withdrawal by Subject|6|||
156509777|NCT02964013|564960102|FG001|Overall Study|Withdrawal by Subject|27|||
156509778|NCT02964013|564960103|FG002|Overall Study|Withdrawal by Subject|9|||
156509779|NCT02964013|564960104|FG003|Overall Study|Withdrawal by Subject|0|||
156509780|NCT02964013|564960105|FG004|Overall Study|Withdrawal by Subject|0|||
156509781|NCT02964013|564960101|FG000|Overall Study|Not Treated|0|||
156509782|NCT02964013|564960102|FG001|Overall Study|Not Treated|2|||
156509783|NCT02964013|564960103|FG002|Overall Study|Not Treated|0|||
156550928|NCT01142726|565109065|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
156509784|NCT02964013|564960104|FG003|Overall Study|Not Treated|1|||
156509785|NCT02964013|564960105|FG004|Overall Study|Not Treated|0|||
156509786|NCT03339245|564960112|FG000|Overall Study|Adverse Event|1|||
156509787|NCT03339245|564960113|FG001|Overall Study|Adverse Event|1|||
156509788|NCT03339245|564960112|FG000|Overall Study|Withdrawal by Subject|1|||
156509789|NCT03339245|564960113|FG001|Overall Study|Withdrawal by Subject|0|||
156509790|NCT00515671|564960114|FG000|Overall Study|Lost to Follow-up|13|||
156509791|NCT00515671|564960115|FG001|Overall Study|Lost to Follow-up|10|||
156509792|NCT00515671|564960114|FG000|Overall Study|Withdrawal by Subject|3|||
156509793|NCT00515671|564960115|FG001|Overall Study|Withdrawal by Subject|5|||
156509794|NCT00515671|564960114|FG000|Overall Study|incarcerated|1|||
156509795|NCT00515671|564960115|FG001|Overall Study|incarcerated|2|||
156509796|NCT00288639|564960118|FG000|Overall Study|Adverse Event|5|||
156550929|NCT01142726|565109066|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
156550930|NCT01142726|565109064|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
156550931|NCT01142726|565109065|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
156550932|NCT01142726|565109066|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
156550933|NCT01142726|565109064|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
156550934|NCT01142726|565109065|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
156550935|NCT01142726|565109066|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
156550936|NCT01142726|565109064|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
156550937|NCT01142726|565109065|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
156550938|NCT01142726|565109066|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
156550939|NCT01142726|565109064|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
156550940|NCT01142726|565109065|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
156550941|NCT01142726|565109066|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
156550942|NCT01142726|565109064|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
156550943|NCT01142726|565109065|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
156550944|NCT01142726|565109066|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
156550945|NCT01142726|565109064|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
156550946|NCT01142726|565109065|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
156550947|NCT01142726|565109066|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
156550948|NCT01142726|565109064|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
156550949|NCT01142726|565109065|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
156550950|NCT01142726|565109066|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
156550951|NCT01142726|565109064|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
156550952|NCT01142726|565109065|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
156550953|NCT01142726|565109066|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
156550954|NCT01142726|565109064|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
156550955|NCT01142726|565109065|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
156550956|NCT01142726|565109066|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
156550957|NCT01142726|565109064|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
156550958|NCT01142726|565109065|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
156550959|NCT01142726|565109066|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
156550960|NCT01142726|565109064|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
156550961|NCT01142726|565109065|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
156550962|NCT01142726|565109066|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
156550963|NCT01142726|565109064|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
156550964|NCT01142726|565109065|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
156550965|NCT01142726|565109066|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
156550966|NCT01142726|565109064|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
156550967|NCT01142726|565109065|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
156550968|NCT01142726|565109066|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
156550969|NCT01142726|565109064|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
156550970|NCT01142726|565109065|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
156550971|NCT01142726|565109066|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
156550972|NCT01142726|565109064|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
156550973|NCT01142726|565109065|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
156550974|NCT01142726|565109066|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
156550975|NCT01568593|565109067|FG000|Overall Study|Lack of Efficacy|4|||
156550976|NCT01568593|565109068|FG001|Overall Study|Lack of Efficacy|1|||
156550977|NCT01568593|565109067|FG000|Overall Study|Adverse Event|3|||
156550978|NCT01568593|565109068|FG001|Overall Study|Adverse Event|2|||
156550979|NCT01097863|565109069|FG000|Overall Study|Discomfort|1|||
156550980|NCT01097863|565109070|FG001|Overall Study|Discomfort|0|||
156550981|NCT01097863|565109071|FG002|Overall Study|Discomfort|1|||
156550982|NCT01097863|565109069|FG000|Overall Study|Did not return for final visit|0|||
156550983|NCT01097863|565109070|FG001|Overall Study|Did not return for final visit|0|||
156550984|NCT01097863|565109071|FG002|Overall Study|Did not return for final visit|1|||
156550985|NCT02788747|565109072|FG000|Overall Study|Adverse Event|1|||
156550986|NCT02788747|565109073|FG001|Overall Study|Adverse Event|0|||
156550987|NCT02788747|565109074|FG002|Overall Study|Adverse Event|0|||
156550988|NCT01079182|565109075|FG000|Overall Study|Lost to Follow-up|1634|||
156550989|NCT01079182|565109075|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
156400790|NCT04711603|564559667|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
156400791|NCT04711603|564559668|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
156400792|NCT04711603|564559665|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
156550990|NCT01079182|565109075|FG000|Overall Study|Lack of Efficacy|514|||
156400793|NCT04711603|564559666|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
156550991|NCT01079182|565109075|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
156550992|NCT01079182|565109075|FG000|Overall Study|Reasons not Evaluated|271|||
156550993|NCT01026831|565109076|FG000|Overall Study|Adverse Event|4|||
156550994|NCT01026831|565109077|FG001|Overall Study|Adverse Event|3|||
156550995|NCT01026831|565109076|FG000|Overall Study|Lost to Follow-up|2|||
156550996|NCT01026831|565109077|FG001|Overall Study|Lost to Follow-up|0|||
156550997|NCT01026831|565109076|FG000|Overall Study|Physician Decision|1|||
156550998|NCT01026831|565109077|FG001|Overall Study|Physician Decision|1|||
156550999|NCT01026831|565109076|FG000|Overall Study|Protocol Violation|0|||
156551000|NCT01026831|565109077|FG001|Overall Study|Protocol Violation|2|||
156551001|NCT01026831|565109076|FG000|Overall Study|Withdrawal by Subject|7|||
156551002|NCT01026831|565109077|FG001|Overall Study|Withdrawal by Subject|5|||
156551003|NCT04417894|565109078|FG000|Overall Study|Lost to Follow-up|3|||
156551004|NCT04417894|565109079|FG001|Overall Study|Lost to Follow-up|0|||
156551005|NCT04417894|565109078|FG000|Overall Study|Withdrawal by Subject|7|||
156551006|NCT04417894|565109079|FG001|Overall Study|Withdrawal by Subject|6|||
156551007|NCT04417894|565109078|FG000|Overall Study|Lack of Efficacy|3|||
156551008|NCT04417894|565109079|FG001|Overall Study|Lack of Efficacy|1|||
156551009|NCT00371865|565109088|FG000|Overall Study|Lack of Efficacy|0|||
156551010|NCT00371865|565109089|FG001|Overall Study|Lack of Efficacy|2|||
156551011|NCT00371865|565109088|FG000|Overall Study|Protocol Violation|3|||
156551012|NCT00371865|565109089|FG001|Overall Study|Protocol Violation|2|||
156551013|NCT00371865|565109088|FG000|Overall Study|Withdrawal by Subject|12|||
156551014|NCT00371865|565109089|FG001|Overall Study|Withdrawal by Subject|10|||
156551015|NCT02043548|565109092|FG000|Overall Study|Lack of Efficacy|1|||
156551016|NCT02043548|565109093|FG001|Overall Study|Lack of Efficacy|0|||
156551017|NCT02043548|565109092|FG000|Overall Study|Adverse Event|0|||
156551018|NCT02043548|565109093|FG001|Overall Study|Adverse Event|1|||
156551019|NCT01425008|565109094|FG000|Dose Escalation Phase|Progressive Disease|2|||
156551020|NCT01425008|565109095|FG001|Dose Escalation Phase|Progressive Disease|3|||
156551021|NCT01425008|565109096|FG002|Dose Escalation Phase|Progressive Disease|2|||
156551022|NCT01425008|565109097|FG003|Dose Escalation Phase|Progressive Disease|3|||
156551023|NCT01425008|565109098|FG004|Dose Escalation Phase|Progressive Disease|5|||
156551024|NCT01425008|565109099|FG005|Dose Escalation Phase|Progressive Disease|4|||
156551025|NCT01425008|565109100|FG006|Dose Escalation Phase|Progressive Disease|0|||
156551026|NCT01425008|565109101|FG007|Dose Escalation Phase|Progressive Disease|2|||
156551027|NCT01425008|565109102|FG008|Dose Escalation Phase|Progressive Disease|6|||
156551028|NCT01425008|565109103|FG009|Dose Escalation Phase|Progressive Disease|2|||
156551029|NCT01425008|565109104|FG010|Dose Escalation Phase|Progressive Disease|0|||
156551030|NCT01425008|565109105|FG011|Dose Escalation Phase|Progressive Disease|0|||
156551031|NCT01425008|565109106|FG012|Dose Escalation Phase|Progressive Disease|0|||
156551032|NCT01425008|565109107|FG013|Dose Escalation Phase|Progressive Disease|0|||
156551033|NCT01425008|565109108|FG014|Dose Escalation Phase|Progressive Disease|0|||
156551034|NCT01425008|565109109|FG015|Dose Escalation Phase|Progressive Disease|0|||
156551035|NCT01425008|565109110|FG016|Dose Escalation Phase|Progressive Disease|0|||
156551036|NCT01425008|565109111|FG017|Dose Escalation Phase|Progressive Disease|0|||
156551037|NCT01425008|565109112|FG018|Dose Escalation Phase|Progressive Disease|0|||
156551038|NCT01425008|565109094|FG000|Dose Escalation Phase|Adverse Event|2|||
156551039|NCT01425008|565109095|FG001|Dose Escalation Phase|Adverse Event|0|||
156551040|NCT01425008|565109096|FG002|Dose Escalation Phase|Adverse Event|0|||
156551041|NCT01425008|565109097|FG003|Dose Escalation Phase|Adverse Event|0|||
156551042|NCT01425008|565109098|FG004|Dose Escalation Phase|Adverse Event|0|||
156551043|NCT01425008|565109099|FG005|Dose Escalation Phase|Adverse Event|2|||
156551044|NCT01425008|565109100|FG006|Dose Escalation Phase|Adverse Event|0|||
156551045|NCT01425008|565109101|FG007|Dose Escalation Phase|Adverse Event|0|||
156551046|NCT01425008|565109102|FG008|Dose Escalation Phase|Adverse Event|2|||
156551047|NCT01425008|565109103|FG009|Dose Escalation Phase|Adverse Event|0|||
156551048|NCT01425008|565109104|FG010|Dose Escalation Phase|Adverse Event|0|||
156551049|NCT01425008|565109105|FG011|Dose Escalation Phase|Adverse Event|0|||
156551050|NCT01425008|565109106|FG012|Dose Escalation Phase|Adverse Event|0|||
156551051|NCT01425008|565109107|FG013|Dose Escalation Phase|Adverse Event|0|||
156551052|NCT01425008|565109108|FG014|Dose Escalation Phase|Adverse Event|0|||
156551053|NCT01425008|565109109|FG015|Dose Escalation Phase|Adverse Event|0|||
156551054|NCT01425008|565109110|FG016|Dose Escalation Phase|Adverse Event|0|||
156551055|NCT01425008|565109111|FG017|Dose Escalation Phase|Adverse Event|0|||
156551056|NCT01425008|565109112|FG018|Dose Escalation Phase|Adverse Event|0|||
156551057|NCT01425008|565109094|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551058|NCT01425008|565109095|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551059|NCT01425008|565109096|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551060|NCT01425008|565109097|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551061|NCT01425008|565109098|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
156551062|NCT01425008|565109099|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551063|NCT01425008|565109100|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
156551064|NCT01425008|565109101|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
156551065|NCT01425008|565109102|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
156400794|NCT04711603|564559667|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
156400795|NCT04711603|564559668|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
156400796|NCT04711603|564559665|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
156400797|NCT04711603|564559666|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
156400798|NCT04711603|564559667|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
156400799|NCT04711603|564559668|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
156400800|NCT05479604|564559669|FG000|Overall Study|Lost to Follow-up|1|||
156400801|NCT05479604|564559670|FG001|Overall Study|Lost to Follow-up|5|||
156400802|NCT01591382|564559671|FG000|Overall Study|Discharged Prior to Study Completion|2|||
156400803|NCT01591382|564559672|FG001|Overall Study|Discharged Prior to Study Completion|1|||
156400804|NCT01591382|564559671|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
156509797|NCT00288639|564960118|FG000|Overall Study|Lack of Efficacy|4|||
156509798|NCT00288639|564960118|FG000|Overall Study|Withdrawal by Subject|2|||
156509799|NCT00288639|564960118|FG000|Overall Study|Other|1|||
156509800|NCT02815579|564960119|FG000|Overall Study|Non-payment of loan down-payment|16|||
156509801|NCT02815579|564960120|FG001|Overall Study|Non-payment of loan down-payment|0|||
156509802|NCT02815579|564960119|FG000|Overall Study|Withdrawal by Subject|7|||
156509803|NCT02815579|564960120|FG001|Overall Study|Withdrawal by Subject|1|||
156509804|NCT02815579|564960119|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
156509805|NCT02815579|564960120|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
156509806|NCT02815579|564960119|FG000|Overall Study|Lost to Follow-up|7|||
156509807|NCT02815579|564960120|FG001|Overall Study|Lost to Follow-up|4|||
156509808|NCT02815579|564960119|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
156509809|NCT02815579|564960120|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
156509810|NCT02815579|564960119|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
156509811|NCT02815579|564960120|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
156509812|NCT02815579|564960119|FG000|Overall Study|Death|5|||
156509813|NCT02815579|564960120|FG001|Overall Study|Death|4|||
156509814|NCT02815579|564960119|FG000|Overall Study|Imprisoned|0|||
156509815|NCT02815579|564960120|FG001|Overall Study|Imprisoned|2|||
156509816|NCT02815579|564960119|FG000|Overall Study|Did not meet enrollment criteria|0|||
156509817|NCT02815579|564960120|FG001|Overall Study|Did not meet enrollment criteria|1|||
156509818|NCT00264303|564960121|FG000|Overall Study|Adverse Event|4|||
156509819|NCT00264303|564960122|FG001|Overall Study|Adverse Event|3|||
156509820|NCT00264303|564960121|FG000|Overall Study|Lack of Efficacy|10|||
156509821|NCT00264303|564960122|FG001|Overall Study|Lack of Efficacy|13|||
156509822|NCT00264303|564960121|FG000|Overall Study|Lost to Follow-up|3|||
156509823|NCT00264303|564960122|FG001|Overall Study|Lost to Follow-up|3|||
156509824|NCT00264303|564960121|FG000|Overall Study|Withdrawal by Subject|2|||
156509825|NCT00264303|564960122|FG001|Overall Study|Withdrawal by Subject|3|||
156509826|NCT00264303|564960121|FG000|Overall Study|Various reasons listed in study report|6|||
156509827|NCT00264303|564960122|FG001|Overall Study|Various reasons listed in study report|7|||
156509828|NCT02311673|564960123|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
156509829|NCT02311673|564960124|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
156509830|NCT02311673|564960125|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
156509831|NCT02311673|564960126|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
156509832|NCT04325282|564960132|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
156509833|NCT04325282|564960133|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
156509834|NCT04325282|564960132|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
156509835|NCT04325282|564960133|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
156509836|NCT04020185|564960134|FG000|Overall Study|Death|0|||
156509837|NCT04020185|564960135|FG001|Overall Study|Death|0|||
156509838|NCT04020185|564960136|FG002|Overall Study|Death|1|||
156509839|NCT04020185|564960137|FG003|Overall Study|Death|2|||
156509840|NCT04020185|564960138|FG004|Overall Study|Death|1|||
156509841|NCT04020185|564960139|FG005|Overall Study|Death|0|||
156509842|NCT04020185|564960140|FG006|Overall Study|Death|1|||
156509843|NCT04020185|564960141|FG007|Overall Study|Death|0|||
156509844|NCT04020185|564960134|FG000|Overall Study|Consent withdrawn|1|||
156509845|NCT04020185|564960135|FG001|Overall Study|Consent withdrawn|0|||
156509846|NCT04020185|564960136|FG002|Overall Study|Consent withdrawn|0|||
156509847|NCT04020185|564960137|FG003|Overall Study|Consent withdrawn|0|||
156509848|NCT04020185|564960138|FG004|Overall Study|Consent withdrawn|2|||
156509849|NCT04020185|564960139|FG005|Overall Study|Consent withdrawn|0|||
156509850|NCT04020185|564960140|FG006|Overall Study|Consent withdrawn|1|||
156509851|NCT04020185|564960141|FG007|Overall Study|Consent withdrawn|1|||
156509852|NCT04020185|564960134|FG000|Overall Study|Patient in hospice|0|||
156509853|NCT04020185|564960135|FG001|Overall Study|Patient in hospice|1|||
156509854|NCT04020185|564960136|FG002|Overall Study|Patient in hospice|0|||
156509855|NCT04020185|564960137|FG003|Overall Study|Patient in hospice|0|||
156509856|NCT04020185|564960138|FG004|Overall Study|Patient in hospice|0|||
156509857|NCT04020185|564960139|FG005|Overall Study|Patient in hospice|0|||
156509858|NCT04020185|564960140|FG006|Overall Study|Patient in hospice|0|||
156509859|NCT04020185|564960141|FG007|Overall Study|Patient in hospice|0|||
156509860|NCT04020185|564960134|FG000|Overall Study|Continuing on expanded access|0|||
156509861|NCT04020185|564960135|FG001|Overall Study|Continuing on expanded access|0|||
156509862|NCT04020185|564960136|FG002|Overall Study|Continuing on expanded access|0|||
156509863|NCT04020185|564960137|FG003|Overall Study|Continuing on expanded access|0|||
156509864|NCT04020185|564960138|FG004|Overall Study|Continuing on expanded access|0|||
156509865|NCT04020185|564960139|FG005|Overall Study|Continuing on expanded access|0|||
156509866|NCT04020185|564960140|FG006|Overall Study|Continuing on expanded access|1|||
156509867|NCT04020185|564960141|FG007|Overall Study|Continuing on expanded access|1|||
156509868|NCT00527787|564960143|FG000|Overall Study|Adverse Event|14|||
156509869|NCT00527787|564960144|FG001|Overall Study|Adverse Event|24|||
156509870|NCT00527787|564960143|FG000|Overall Study|Withdrawal by Subject|13|||
156509871|NCT00527787|564960144|FG001|Overall Study|Withdrawal by Subject|25|||
156509872|NCT00527787|564960143|FG000|Overall Study|Lost to Follow-up|5|||
156509873|NCT00527787|564960144|FG001|Overall Study|Lost to Follow-up|2|||
156509874|NCT00527787|564960143|FG000|Overall Study|Duodenal Ulcer|1|||
156509875|NCT00527787|564960144|FG001|Overall Study|Duodenal Ulcer|10|||
156509876|NCT00527787|564960143|FG000|Overall Study|misc|5|||
156509877|NCT00527787|564960144|FG001|Overall Study|misc|2|||
156509878|NCT04833127|564960145|FG000|Overall Study|Lost to Follow-up|1|||
156509879|NCT04833127|564960146|FG001|Overall Study|Lost to Follow-up|1|||
156509880|NCT01499303|564960151|FG000|Overall Study|Ongoing|2|||
156509881|NCT01499303|564960152|FG001|Overall Study|Ongoing|1|||
156509882|NCT01499303|564960151|FG000|Overall Study|Withdrawal by Subject|0|||
156509883|NCT01499303|564960152|FG001|Overall Study|Withdrawal by Subject|1|||
156509884|NCT01499303|564960151|FG000|Overall Study|Adverse Event|1|||
156509885|NCT01499303|564960152|FG001|Overall Study|Adverse Event|4|||
156509886|NCT01499303|564960151|FG000|Overall Study|Other|0|||
156509887|NCT01499303|564960152|FG001|Overall Study|Other|1|||
156509888|NCT00461981|564960153|FG000|Overall Study|Lost to Follow-up|9|||
156509889|NCT00461981|564960154|FG001|Overall Study|Lost to Follow-up|6|||
156509890|NCT00461981|564960153|FG000|Overall Study|Withdrawal by Subject|2|||
156509891|NCT00461981|564960154|FG001|Overall Study|Withdrawal by Subject|3|||
156509892|NCT02242097|564960155|FG000|Ibrutinib Treatment|Adverse Event|16|||
156509893|NCT02242097|564960155|FG000|Ibrutinib Treatment|Physician Decision|1|||
156509894|NCT02242097|564960155|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
156509895|NCT02242097|564960155|FG000|Ibrutinib Treatment|Death|1|||
156509896|NCT02242097|564960155|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
156509897|NCT02242097|564960155|FG000|Post Therapy Follow Up|Death|3|||
156509898|NCT02242097|564960155|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
156509899|NCT03031496|564960157|FG000|Period 1|Adverse Event|2|||
156509900|NCT03031496|564960158|FG001|Period 1|Adverse Event|0|||
156509901|NCT03031496|564960157|FG000|Period 1|Withdrawal by Subject|0|||
156509902|NCT03031496|564960158|FG001|Period 1|Withdrawal by Subject|2|||
156509903|NCT03868787|564960160|FG000|Overall Study|Withdrawal by Subject|2|||
156509904|NCT03868787|564960161|FG001|Overall Study|Withdrawal by Subject|1|||
156509905|NCT01399697|564960162|FG000|Overall Study|Adverse Event|13|||
156509906|NCT01399697|564960163|FG001|Overall Study|Adverse Event|3|||
156509907|NCT01399697|564960164|FG002|Overall Study|Adverse Event|1|||
156509908|NCT01399697|564960162|FG000|Overall Study|Lost to Follow-up|2|||
156509909|NCT01399697|564960163|FG001|Overall Study|Lost to Follow-up|0|||
156509910|NCT01399697|564960164|FG002|Overall Study|Lost to Follow-up|0|||
156509911|NCT01399697|564960162|FG000|Overall Study|Withdrawal by Subject|8|||
156509912|NCT01399697|564960163|FG001|Overall Study|Withdrawal by Subject|0|||
156509913|NCT01399697|564960164|FG002|Overall Study|Withdrawal by Subject|0|||
156509914|NCT01399697|564960162|FG000|Overall Study|Investigator Decisión|1|||
156509915|NCT01399697|564960163|FG001|Overall Study|Investigator Decisión|0|||
156509916|NCT01399697|564960164|FG002|Overall Study|Investigator Decisión|2|||
156509917|NCT01399697|564960162|FG000|Overall Study|Lack of Efficacy|9|||
156509918|NCT01399697|564960163|FG001|Overall Study|Lack of Efficacy|0|||
156509919|NCT01399697|564960164|FG002|Overall Study|Lack of Efficacy|1|||
156509920|NCT01399697|564960162|FG000|Overall Study|Protocol Violation|2|||
156509921|NCT01399697|564960163|FG001|Overall Study|Protocol Violation|0|||
156509922|NCT01399697|564960164|FG002|Overall Study|Protocol Violation|0|||
156509923|NCT01399697|564960162|FG000|Overall Study|Non-Compliant|1|||
156509924|NCT01399697|564960163|FG001|Overall Study|Non-Compliant|0|||
156509925|NCT01399697|564960164|FG002|Overall Study|Non-Compliant|0|||
156509926|NCT01399697|564960162|FG000|Overall Study|Inclusion Error|2|||
156509927|NCT01399697|564960163|FG001|Overall Study|Inclusion Error|0|||
156509928|NCT01399697|564960164|FG002|Overall Study|Inclusion Error|0|||
156509929|NCT01399697|564960162|FG000|Overall Study|Positive result for hepatitis B|1|||
156509930|NCT01399697|564960163|FG001|Overall Study|Positive result for hepatitis B|0|||
156509931|NCT01399697|564960164|FG002|Overall Study|Positive result for hepatitis B|0|||
156509932|NCT01399697|564960162|FG000|Overall Study|Clinical RA remission|1|||
156509933|NCT01399697|564960163|FG001|Overall Study|Clinical RA remission|0|||
156509934|NCT01399697|564960164|FG002|Overall Study|Clinical RA remission|0|||
156509935|NCT01399697|564960162|FG000|Overall Study|Sponsor Decision|1|||
156551066|NCT01425008|565109103|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551067|NCT01425008|565109104|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551068|NCT01425008|565109105|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551069|NCT01425008|565109106|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551070|NCT01425008|565109107|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551071|NCT01425008|565109108|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551072|NCT01425008|565109109|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551073|NCT01425008|565109110|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551074|NCT01425008|565109111|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551075|NCT01425008|565109112|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156551076|NCT01425008|565109094|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
156551077|NCT01425008|565109095|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
156551078|NCT01425008|565109096|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
156551079|NCT01425008|565109097|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156551080|NCT01425008|565109098|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
156551081|NCT01425008|565109099|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
156551082|NCT01425008|565109100|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
156551083|NCT01425008|565109101|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
156551084|NCT01425008|565109102|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
156551085|NCT01425008|565109103|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
156551086|NCT01425008|565109104|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
156551087|NCT01425008|565109105|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
156551088|NCT01425008|565109106|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
156551089|NCT01425008|565109107|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
156551090|NCT01425008|565109108|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
156551091|NCT01425008|565109109|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
156551092|NCT01425008|565109110|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
156551093|NCT01425008|565109111|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
156551094|NCT01425008|565109112|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
156551095|NCT01425008|565109094|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551096|NCT01425008|565109095|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551097|NCT01425008|565109096|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
156551098|NCT01425008|565109097|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551099|NCT01425008|565109098|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551100|NCT01425008|565109099|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551101|NCT01425008|565109100|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551102|NCT01425008|565109101|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551103|NCT01425008|565109102|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
156551104|NCT01425008|565109103|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
156551105|NCT01425008|565109104|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551106|NCT01425008|565109105|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551107|NCT01425008|565109106|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551108|NCT01425008|565109107|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551109|NCT01425008|565109108|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551110|NCT01425008|565109109|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551111|NCT01425008|565109110|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551112|NCT01425008|565109111|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551113|NCT01425008|565109112|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
156551114|NCT01425008|565109094|FG000|Dose Escalation Phase|Other|0|||
156551115|NCT01425008|565109095|FG001|Dose Escalation Phase|Other|0|||
156551116|NCT01425008|565109096|FG002|Dose Escalation Phase|Other|0|||
156551117|NCT01425008|565109097|FG003|Dose Escalation Phase|Other|0|||
156551118|NCT01425008|565109098|FG004|Dose Escalation Phase|Other|0|||
156551119|NCT01425008|565109099|FG005|Dose Escalation Phase|Other|0|||
156551120|NCT01425008|565109100|FG006|Dose Escalation Phase|Other|0|||
156551121|NCT01425008|565109101|FG007|Dose Escalation Phase|Other|0|||
156551122|NCT01425008|565109102|FG008|Dose Escalation Phase|Other|1|||
156551123|NCT01425008|565109103|FG009|Dose Escalation Phase|Other|0|||
156551124|NCT01425008|565109104|FG010|Dose Escalation Phase|Other|0|||
156400805|NCT01591382|564559672|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
156551125|NCT01425008|565109105|FG011|Dose Escalation Phase|Other|0|||
156551126|NCT01425008|565109106|FG012|Dose Escalation Phase|Other|0|||
156551127|NCT01425008|565109107|FG013|Dose Escalation Phase|Other|0|||
156551128|NCT01425008|565109108|FG014|Dose Escalation Phase|Other|0|||
156551129|NCT01425008|565109109|FG015|Dose Escalation Phase|Other|0|||
156551130|NCT01425008|565109110|FG016|Dose Escalation Phase|Other|0|||
156551131|NCT01425008|565109111|FG017|Dose Escalation Phase|Other|0|||
156551132|NCT01425008|565109112|FG018|Dose Escalation Phase|Other|0|||
156551133|NCT01425008|565109094|FG000|Dose Expansion Phase|Progressive Disease|0|||
156551134|NCT01425008|565109095|FG001|Dose Expansion Phase|Progressive Disease|0|||
156551135|NCT01425008|565109096|FG002|Dose Expansion Phase|Progressive Disease|0|||
156551136|NCT01425008|565109097|FG003|Dose Expansion Phase|Progressive Disease|0|||
156551137|NCT01425008|565109098|FG004|Dose Expansion Phase|Progressive Disease|0|||
156551138|NCT01425008|565109099|FG005|Dose Expansion Phase|Progressive Disease|0|||
156551139|NCT01425008|565109100|FG006|Dose Expansion Phase|Progressive Disease|0|||
156551140|NCT01425008|565109101|FG007|Dose Expansion Phase|Progressive Disease|0|||
156551141|NCT01425008|565109102|FG008|Dose Expansion Phase|Progressive Disease|0|||
156551142|NCT01425008|565109103|FG009|Dose Expansion Phase|Progressive Disease|0|||
156551143|NCT01425008|565109104|FG010|Dose Expansion Phase|Progressive Disease|10|||
156551144|NCT01425008|565109105|FG011|Dose Expansion Phase|Progressive Disease|4|||
156551145|NCT01425008|565109106|FG012|Dose Expansion Phase|Progressive Disease|12|||
156551146|NCT01425008|565109107|FG013|Dose Expansion Phase|Progressive Disease|1|||
156551147|NCT01425008|565109108|FG014|Dose Expansion Phase|Progressive Disease|5|||
156551148|NCT01425008|565109109|FG015|Dose Expansion Phase|Progressive Disease|8|||
156551149|NCT01425008|565109110|FG016|Dose Expansion Phase|Progressive Disease|9|||
156551150|NCT01425008|565109111|FG017|Dose Expansion Phase|Progressive Disease|2|||
156551151|NCT01425008|565109112|FG018|Dose Expansion Phase|Progressive Disease|10|||
156551152|NCT01425008|565109094|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
156551153|NCT01425008|565109095|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
156551154|NCT01425008|565109096|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
156551155|NCT01425008|565109097|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
156551156|NCT01425008|565109098|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
156400806|NCT04252742|564559674|FG000|Overall Study|Decision by sponsor|0|||
156400807|NCT04252742|564559675|FG001|Overall Study|Decision by sponsor|2|||
156400808|NCT04252742|564559674|FG000|Overall Study|Withdrawal by Subject|15|||
156400809|NCT04252742|564559675|FG001|Overall Study|Withdrawal by Subject|9|||
156400810|NCT04252742|564559674|FG000|Overall Study|Lost to Follow-up|0|||
156400811|NCT04252742|564559675|FG001|Overall Study|Lost to Follow-up|1|||
156400812|NCT04359784|564559677|FG000|Overall Study|Death|2|||
156509936|NCT01399697|564960163|FG001|Overall Study|Sponsor Decision|0|||
156509937|NCT01399697|564960164|FG002|Overall Study|Sponsor Decision|0|||
156509938|NCT04313608|564960165|FG000|Overall Study|Death|12|||
156509939|NCT04313608|564960166|FG001|Overall Study|Death|3|||
156509940|NCT01712061|564960167|FG000|Overall Study|Adverse Event|4|||
156509941|NCT01712061|564960168|FG001|Overall Study|Adverse Event|9|||
156509942|NCT01712061|564960169|FG002|Overall Study|Adverse Event|5|||
156509943|NCT01712061|564960167|FG000|Overall Study|Death|0|||
156509944|NCT01712061|564960168|FG001|Overall Study|Death|0|||
156509945|NCT01712061|564960169|FG002|Overall Study|Death|1|||
156509946|NCT01712061|564960167|FG000|Overall Study|Lost to Follow-up|1|||
156509947|NCT01712061|564960168|FG001|Overall Study|Lost to Follow-up|0|||
156509948|NCT01712061|564960169|FG002|Overall Study|Lost to Follow-up|1|||
156509949|NCT01712061|564960167|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
156509950|NCT01712061|564960168|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
156509951|NCT01712061|564960169|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
156509952|NCT01712061|564960167|FG000|Overall Study|Medication Error Without Associated AE|0|||
156509953|NCT01712061|564960168|FG001|Overall Study|Medication Error Without Associated AE|1|||
156509954|NCT01712061|564960169|FG002|Overall Study|Medication Error Without Associated AE|0|||
156509955|NCT01712061|564960167|FG000|Overall Study|Withdrawal by Subject|1|||
156509956|NCT01712061|564960168|FG001|Overall Study|Withdrawal by Subject|7|||
156509957|NCT01712061|564960169|FG002|Overall Study|Withdrawal by Subject|1|||
156509958|NCT01712061|564960167|FG000|Overall Study|Other|0|||
156509959|NCT01712061|564960168|FG001|Overall Study|Other|3|||
156509960|NCT01712061|564960169|FG002|Overall Study|Other|0|||
156509961|NCT01068665|564960174|FG000|Overall Study|Adverse Event|5|||
156509962|NCT01068665|564960175|FG001|Overall Study|Adverse Event|4|||
156509963|NCT01068665|564960174|FG000|Overall Study|Lack of Efficacy|0|||
156509964|NCT01068665|564960175|FG001|Overall Study|Lack of Efficacy|2|||
156509965|NCT01068665|564960174|FG000|Overall Study|Protocol Violation|5|||
156509966|NCT01068665|564960175|FG001|Overall Study|Protocol Violation|2|||
156509967|NCT01068665|564960174|FG000|Overall Study|Withdrawal Criteria|3|||
156509968|NCT01068665|564960175|FG001|Overall Study|Withdrawal Criteria|9|||
156509969|NCT01068665|564960174|FG000|Overall Study|Other|17|||
156509970|NCT01068665|564960175|FG001|Overall Study|Other|12|||
156509971|NCT02807272|564960176|FG000|Overall Study|Death|9|||
156509972|NCT02807272|564960177|FG001|Overall Study|Death|5|||
156509973|NCT02807272|564960178|FG002|Overall Study|Death|2|||
156400813|NCT00504426|564559681|FG000|Overall Study|Adverse Event|0|||
156400814|NCT00504426|564559682|FG001|Overall Study|Adverse Event|0|||
156400815|NCT00504426|564559683|FG002|Overall Study|Adverse Event|2|||
156400816|NCT00504426|564559684|FG003|Overall Study|Adverse Event|0|||
156400817|NCT00504426|564559681|FG000|Overall Study|Protocol Violation|1|||
156509974|NCT02807272|564960179|FG003|Overall Study|Death|0|||
156509975|NCT02807272|564960180|FG004|Overall Study|Death|1|||
156509976|NCT02807272|564960176|FG000|Overall Study|Lost to Follow-up|1|||
156509977|NCT02807272|564960177|FG001|Overall Study|Lost to Follow-up|0|||
156509978|NCT02807272|564960178|FG002|Overall Study|Lost to Follow-up|0|||
156509979|NCT02807272|564960179|FG003|Overall Study|Lost to Follow-up|0|||
156551157|NCT01425008|565109099|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
156551158|NCT01425008|565109100|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
156509980|NCT02807272|564960180|FG004|Overall Study|Lost to Follow-up|0|||
156509981|NCT02807272|564960176|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
156509982|NCT02807272|564960177|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
156509983|NCT02807272|564960178|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
156509984|NCT02807272|564960179|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
156509985|NCT02807272|564960180|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
156509986|NCT02807272|564960176|FG000|Overall Study|Protocol-defined Disease Progression|0|||
156509987|NCT02807272|564960177|FG001|Overall Study|Protocol-defined Disease Progression|1|||
156509988|NCT02807272|564960178|FG002|Overall Study|Protocol-defined Disease Progression|0|||
156509989|NCT02807272|564960179|FG003|Overall Study|Protocol-defined Disease Progression|0|||
156509990|NCT02807272|564960180|FG004|Overall Study|Protocol-defined Disease Progression|1|||
156509991|NCT02807272|564960176|FG000|Overall Study|Study Terminated by Sponsor|1|||
156509992|NCT02807272|564960177|FG001|Overall Study|Study Terminated by Sponsor|0|||
156509993|NCT02807272|564960178|FG002|Overall Study|Study Terminated by Sponsor|0|||
156509994|NCT02807272|564960179|FG003|Overall Study|Study Terminated by Sponsor|1|||
156509995|NCT02807272|564960180|FG004|Overall Study|Study Terminated by Sponsor|0|||
156509996|NCT02807272|564960176|FG000|Overall Study|Other|1|||
156509997|NCT02807272|564960177|FG001|Overall Study|Other|0|||
156509998|NCT02807272|564960178|FG002|Overall Study|Other|0|||
156509999|NCT02807272|564960179|FG003|Overall Study|Other|0|||
156510000|NCT02807272|564960180|FG004|Overall Study|Other|1|||
156510001|NCT01162863|564960182|FG000|Overall Study|Lack of Efficacy|1|||
156510002|NCT01162863|564960183|FG001|Overall Study|Lack of Efficacy|0|||
156510003|NCT01162863|564960184|FG002|Overall Study|Lack of Efficacy|0|||
156510004|NCT01162863|564960182|FG000|Overall Study|Adverse Event|0|||
156510005|NCT01162863|564960183|FG001|Overall Study|Adverse Event|1|||
156510006|NCT01162863|564960184|FG002|Overall Study|Adverse Event|0|||
156510007|NCT02992691|564960185|FG000|Overall Study|Adverse Event|2|||
156510008|NCT02992691|564960185|FG000|Overall Study|Withdrawal by Subject|1|||
156510009|NCT00392925|564960186|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
156510010|NCT00392925|564960187|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
156510011|NCT00392925|564960188|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
156510012|NCT00392925|564960189|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
156510013|NCT00392925|564960186|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
156510014|NCT00392925|564960187|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
156510015|NCT00392925|564960188|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
156510016|NCT00392925|564960189|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
156510017|NCT00392925|564960186|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
156510018|NCT00392925|564960187|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
156510019|NCT00392925|564960188|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
156510020|NCT00392925|564960189|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
156510021|NCT00392925|564960186|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
156510022|NCT00392925|564960187|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
156510023|NCT00392925|564960188|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
156510024|NCT00392925|564960189|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
156510025|NCT00392925|564960186|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
156510026|NCT00392925|564960187|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
156510027|NCT00392925|564960188|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
156510028|NCT00392925|564960189|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
156510029|NCT00392925|564960186|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
156510030|NCT00392925|564960187|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
156510031|NCT00392925|564960188|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
156510032|NCT00392925|564960189|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
156510033|NCT00392925|564960186|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
156510034|NCT00392925|564960187|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
156510035|NCT00392925|564960188|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
156510036|NCT00392925|564960189|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
156510037|NCT00392925|564960186|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
156510038|NCT00392925|564960187|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
156510039|NCT00392925|564960188|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
156510040|NCT00392925|564960189|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
156510041|NCT00392925|564960186|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
156510042|NCT00392925|564960187|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
156510043|NCT00392925|564960188|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
156510044|NCT00392925|564960189|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
156510045|NCT03945825|564960197|FG000|Overall Study|Enrolled but treatment not administered|0|||
156510046|NCT03945825|564960198|FG001|Overall Study|Enrolled but treatment not administered|0|||
156510047|NCT03945825|564960199|FG002|Overall Study|Enrolled but treatment not administered|0|||
156510048|NCT03945825|564960200|FG003|Overall Study|Enrolled but treatment not administered|0|||
156510049|NCT03945825|564960201|FG004|Overall Study|Enrolled but treatment not administered|1|||
156510050|NCT03945825|564960202|FG005|Overall Study|Enrolled but treatment not administered|0|||
156510051|NCT03945825|564960197|FG000|Overall Study|Lost to Follow-up|1|||
156510052|NCT03945825|564960198|FG001|Overall Study|Lost to Follow-up|5|||
156510053|NCT03945825|564960199|FG002|Overall Study|Lost to Follow-up|0|||
156510054|NCT03945825|564960200|FG003|Overall Study|Lost to Follow-up|1|||
156510055|NCT03945825|564960201|FG004|Overall Study|Lost to Follow-up|2|||
156510056|NCT03945825|564960202|FG005|Overall Study|Lost to Follow-up|2|||
156510057|NCT03945825|564960197|FG000|Overall Study|Withdrawal by Subject|1|||
156510058|NCT03945825|564960198|FG001|Overall Study|Withdrawal by Subject|0|||
156510059|NCT03945825|564960199|FG002|Overall Study|Withdrawal by Subject|1|||
156510060|NCT03945825|564960200|FG003|Overall Study|Withdrawal by Subject|1|||
156510061|NCT03945825|564960201|FG004|Overall Study|Withdrawal by Subject|0|||
156510062|NCT03945825|564960202|FG005|Overall Study|Withdrawal by Subject|1|||
156510063|NCT00203268|564960203|FG000|Early Treatment|only treated one headache|2|||
156510064|NCT00203268|564960203|FG000|Early Treatment|Lost to Follow-up|1|||
156510065|NCT00203268|564960203|FG000|Early Treatment|Withdrawal by Subject|1|||
156510066|NCT00737698|564960207|FG000|Overall Study|Withdrawal by Subject|6|||
156510067|NCT00737698|564960208|FG001|Overall Study|Withdrawal by Subject|5|||
156510068|NCT00737698|564960209|FG002|Overall Study|Withdrawal by Subject|3|||
156510069|NCT00737698|564960207|FG000|Overall Study|Death|0|||
156510070|NCT00737698|564960208|FG001|Overall Study|Death|0|||
156510071|NCT00737698|564960209|FG002|Overall Study|Death|1|||
156510072|NCT01067846|564960210|FG000|Overall Study|Lost to Follow-up|17|||
156510073|NCT01067846|564960211|FG001|Overall Study|Lost to Follow-up|19|||
156510074|NCT01067846|564960210|FG000|Overall Study|Withdrawal by Subject|1|||
156510075|NCT01067846|564960211|FG001|Overall Study|Withdrawal by Subject|0|||
156510076|NCT01067846|564960210|FG000|Overall Study|participation in other tx study|1|||
156510077|NCT01067846|564960211|FG001|Overall Study|participation in other tx study|0|||
156510078|NCT02817906|564960212|FG000|Overall Study|Adverse Event|3|||
156510079|NCT02817906|564960213|FG001|Overall Study|Adverse Event|0|||
156510080|NCT02817906|564960212|FG000|Overall Study|Lack of Efficacy|1|||
156510081|NCT02817906|564960213|FG001|Overall Study|Lack of Efficacy|0|||
156510082|NCT02817906|564960212|FG000|Overall Study|Protocol Violation|1|||
156510083|NCT02817906|564960213|FG001|Overall Study|Protocol Violation|1|||
156510084|NCT02817906|564960212|FG000|Overall Study|Study Terminated by Sponsor|2|||
156510085|NCT02817906|564960213|FG001|Overall Study|Study Terminated by Sponsor|2|||
156510086|NCT02817906|564960212|FG000|Overall Study|Withdrawal by Subject|7|||
156510087|NCT02817906|564960213|FG001|Overall Study|Withdrawal by Subject|0|||
156510088|NCT02817906|564960212|FG000|Overall Study|Other|2|||
156510089|NCT02817906|564960213|FG001|Overall Study|Other|2|||
156510090|NCT03686423|564960220|FG000|Overall Study|Withdrawal by Subject|9|||
156510091|NCT03686423|564960220|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
156510092|NCT02833077|564960221|FG000|Overall Study|Adverse Event|1|||
156510093|NCT02833077|564960222|FG001|Overall Study|Adverse Event|2|||
156510094|NCT02833077|564960221|FG000|Overall Study|Lost to Follow-up|10|||
156510095|NCT02833077|564960222|FG001|Overall Study|Lost to Follow-up|1|||
156510096|NCT02833077|564960221|FG000|Overall Study|Personal Reasons|6|||
156510097|NCT02833077|564960222|FG001|Overall Study|Personal Reasons|4|||
156510098|NCT02833077|564960221|FG000|Overall Study|Protocol Deviation|0|||
156510099|NCT02833077|564960222|FG001|Overall Study|Protocol Deviation|1|||
156510100|NCT04958200|564960223|FG000|Overall Study|Withdrawal by Subject|0|||
156510101|NCT04958200|564960224|FG001|Overall Study|Withdrawal by Subject|2|||
156510102|NCT04958200|564960223|FG000|Overall Study|Lost to Follow-up|3|||
156510103|NCT04958200|564960224|FG001|Overall Study|Lost to Follow-up|2|||
156510104|NCT03852719|564960227|FG000|Overall Study|Withdrawal of consent|8|||
156510105|NCT03852719|564960228|FG001|Overall Study|Withdrawal of consent|8|||
156510106|NCT03852719|564960229|FG002|Overall Study|Withdrawal of consent|9|||
156510107|NCT03852719|564960227|FG000|Overall Study|Physician Decision|5|||
156510108|NCT03852719|564960228|FG001|Overall Study|Physician Decision|4|||
156510109|NCT03852719|564960229|FG002|Overall Study|Physician Decision|1|||
156510110|NCT03852719|564960227|FG000|Overall Study|Pregnancy|2|||
156551159|NCT01425008|565109101|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
156510111|NCT03852719|564960228|FG001|Overall Study|Pregnancy|1|||
156510112|NCT03852719|564960229|FG002|Overall Study|Pregnancy|0|||
156510113|NCT03852719|564960227|FG000|Overall Study|Death|1|||
156510114|NCT03852719|564960228|FG001|Overall Study|Death|0|||
156510115|NCT03852719|564960229|FG002|Overall Study|Death|0|||
156510116|NCT03852719|564960227|FG000|Overall Study|Reason not Specified|3|||
156510117|NCT03852719|564960228|FG001|Overall Study|Reason not Specified|3|||
156510118|NCT03852719|564960229|FG002|Overall Study|Reason not Specified|5|||
156510119|NCT03852719|564960227|FG000|Overall Study|Adverse Event|2|||
156510120|NCT03852719|564960228|FG001|Overall Study|Adverse Event|1|||
156510121|NCT03852719|564960229|FG002|Overall Study|Adverse Event|4|||
156510122|NCT03852719|564960227|FG000|Overall Study|Progressive disease|1|||
156510123|NCT03852719|564960228|FG001|Overall Study|Progressive disease|4|||
156510124|NCT03852719|564960229|FG002|Overall Study|Progressive disease|1|||
156551160|NCT01425008|565109102|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
156551161|NCT01425008|565109103|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
156551162|NCT01425008|565109104|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
156551163|NCT01425008|565109105|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
156551164|NCT01425008|565109106|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
156551165|NCT01425008|565109107|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
156551166|NCT01425008|565109108|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
156510125|NCT03852719|564960227|FG000|Overall Study|Lost to Follow-up|1|||
156510126|NCT03852719|564960228|FG001|Overall Study|Lost to Follow-up|0|||
156510127|NCT03852719|564960229|FG002|Overall Study|Lost to Follow-up|0|||
156510128|NCT01647542|564960231|FG000|Overall Study|Major Protocol Deviation|1|||
156510129|NCT01647542|564960232|FG001|Overall Study|Major Protocol Deviation|0|||
156510130|NCT01647542|564960233|FG002|Overall Study|Major Protocol Deviation|0|||
156510131|NCT01647542|564960231|FG000|Overall Study|Adverse Event|4|||
156510132|NCT01647542|564960232|FG001|Overall Study|Adverse Event|5|||
156510133|NCT01647542|564960233|FG002|Overall Study|Adverse Event|4|||
156510134|NCT01647542|564960231|FG000|Overall Study|Lost to Follow-up|0|||
156510135|NCT01647542|564960232|FG001|Overall Study|Lost to Follow-up|2|||
156510136|NCT01647542|564960233|FG002|Overall Study|Lost to Follow-up|2|||
156510137|NCT01647542|564960231|FG000|Overall Study|Withdrawal by Subject|6|||
156510138|NCT01647542|564960232|FG001|Overall Study|Withdrawal by Subject|4|||
156510139|NCT01647542|564960233|FG002|Overall Study|Withdrawal by Subject|0|||
156510140|NCT01647542|564960231|FG000|Overall Study|Study Termination|64|||
156510141|NCT01647542|564960232|FG001|Overall Study|Study Termination|61|||
156510142|NCT01647542|564960233|FG002|Overall Study|Study Termination|65|||
156510143|NCT01647542|564960231|FG000|Overall Study|Lack of Efficacy|1|||
156510144|NCT01647542|564960232|FG001|Overall Study|Lack of Efficacy|1|||
156510145|NCT01647542|564960233|FG002|Overall Study|Lack of Efficacy|0|||
156510146|NCT01647542|564960231|FG000|Overall Study|Death|0|||
156510147|NCT01647542|564960232|FG001|Overall Study|Death|0|||
156510148|NCT01647542|564960233|FG002|Overall Study|Death|1|||
156510149|NCT02397447|564960234|FG000|Overall Study|Lost to Follow-up|2|||
156510150|NCT02397447|564960235|FG001|Overall Study|Lost to Follow-up|2|||
156510151|NCT02994069|564960238|FG000|Overall Study|Death|7|||
156510152|NCT02994069|564960239|FG001|Overall Study|Death|13|||
156510153|NCT02994069|564960238|FG000|Overall Study|Adverse Event|1|||
156510154|NCT02994069|564960239|FG001|Overall Study|Adverse Event|0|||
156510155|NCT02994069|564960238|FG000|Overall Study|Other|2|||
156510156|NCT02994069|564960239|FG001|Overall Study|Other|0|||
156510157|NCT02994069|564960238|FG000|Overall Study|still on follow up/treatment|5|||
156510158|NCT02994069|564960239|FG001|Overall Study|still on follow up/treatment|6|||
156510159|NCT06926673|564960242|FG000|Overall Study|Lost to Follow-up|0|||
156510160|NCT06926673|564960243|FG001|Overall Study|Lost to Follow-up|0|||
156510161|NCT06926673|564960244|FG002|Overall Study|Lost to Follow-up|0|||
156510162|NCT06926673|564960245|FG003|Overall Study|Lost to Follow-up|1|||
156510163|NCT06926673|564960246|FG004|Overall Study|Lost to Follow-up|0|||
156510164|NCT06926673|564960247|FG005|Overall Study|Lost to Follow-up|0|||
156510165|NCT06926673|564960248|FG006|Overall Study|Lost to Follow-up|0|||
156510166|NCT06926673|564960242|FG000|Overall Study|Physician Decision|0|||
156510167|NCT06926673|564960243|FG001|Overall Study|Physician Decision|0|||
156551167|NCT01425008|565109109|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
156551168|NCT01425008|565109110|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
156551169|NCT01425008|565109111|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
156551170|NCT01425008|565109112|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
156510168|NCT06926673|564960244|FG002|Overall Study|Physician Decision|0|||
156510169|NCT06926673|564960245|FG003|Overall Study|Physician Decision|0|||
156510170|NCT06926673|564960246|FG004|Overall Study|Physician Decision|0|||
156510171|NCT06926673|564960247|FG005|Overall Study|Physician Decision|0|||
156510172|NCT06926673|564960248|FG006|Overall Study|Physician Decision|1|||
156510173|NCT06926673|564960242|FG000|Overall Study|Withdrawal by Subject|0|||
156510174|NCT06926673|564960243|FG001|Overall Study|Withdrawal by Subject|3|||
156510175|NCT06926673|564960244|FG002|Overall Study|Withdrawal by Subject|2|||
156510176|NCT06926673|564960245|FG003|Overall Study|Withdrawal by Subject|1|||
156510177|NCT06926673|564960246|FG004|Overall Study|Withdrawal by Subject|0|||
156510178|NCT06926673|564960247|FG005|Overall Study|Withdrawal by Subject|2|||
156510179|NCT06926673|564960248|FG006|Overall Study|Withdrawal by Subject|0|||
156510180|NCT01253135|564961546|FG000|Original Protocol|Protocol Amendment|15|||
156510181|NCT01253135|564961546|FG000|Amended Protocol|Non-compliance|1|||
156510182|NCT00833261|564961551|FG000|Overall Study|Withdrawal by Subject|4|||
156510183|NCT01255631|564961552|FG000|Overall Study|poor enrollment, no data analyzed|9|||
156510184|NCT01255631|564961553|FG001|Overall Study|poor enrollment, no data analyzed|6|||
156510185|NCT04165031|564961556|FG000|Overall Study|Adverse Event|1|||
156510186|NCT04165031|564961557|FG001|Overall Study|Adverse Event|1|||
156510187|NCT04165031|564961558|FG002|Overall Study|Adverse Event|0|||
156510188|NCT04165031|564961559|FG003|Overall Study|Adverse Event|0|||
156510189|NCT04165031|564961560|FG004|Overall Study|Adverse Event|0|||
156510190|NCT04165031|564961561|FG005|Overall Study|Adverse Event|0|||
156551171|NCT01425008|565109094|FG000|Dose Expansion Phase|Other|0|||
156551172|NCT01425008|565109095|FG001|Dose Expansion Phase|Other|0|||
156551173|NCT01425008|565109096|FG002|Dose Expansion Phase|Other|0|||
156551174|NCT01425008|565109097|FG003|Dose Expansion Phase|Other|0|||
156551175|NCT01425008|565109098|FG004|Dose Expansion Phase|Other|0|||
156551176|NCT01425008|565109099|FG005|Dose Expansion Phase|Other|0|||
156551177|NCT01425008|565109100|FG006|Dose Expansion Phase|Other|0|||
156551178|NCT01425008|565109101|FG007|Dose Expansion Phase|Other|0|||
156551179|NCT01425008|565109102|FG008|Dose Expansion Phase|Other|0|||
156551180|NCT01425008|565109103|FG009|Dose Expansion Phase|Other|0|||
156551181|NCT01425008|565109104|FG010|Dose Expansion Phase|Other|0|||
156551182|NCT01425008|565109105|FG011|Dose Expansion Phase|Other|0|||
156551183|NCT01425008|565109106|FG012|Dose Expansion Phase|Other|1|||
156551184|NCT01425008|565109107|FG013|Dose Expansion Phase|Other|0|||
156551185|NCT01425008|565109108|FG014|Dose Expansion Phase|Other|0|||
156551186|NCT01425008|565109109|FG015|Dose Expansion Phase|Other|0|||
156551187|NCT01425008|565109110|FG016|Dose Expansion Phase|Other|2|||
156551188|NCT01425008|565109111|FG017|Dose Expansion Phase|Other|0|||
156551189|NCT01425008|565109112|FG018|Dose Expansion Phase|Other|4|||
156551190|NCT01425008|565109094|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551191|NCT01425008|565109095|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551192|NCT01425008|565109096|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551193|NCT01425008|565109097|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551194|NCT01425008|565109098|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551195|NCT01425008|565109099|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551196|NCT01425008|565109100|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551197|NCT01425008|565109101|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551198|NCT01425008|565109102|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551199|NCT01425008|565109103|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551200|NCT01425008|565109104|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
156510191|NCT04165031|564961556|FG000|Overall Study|Withdrawal by Subject|0|||
156510192|NCT04165031|564961557|FG001|Overall Study|Withdrawal by Subject|0|||
156510193|NCT04165031|564961558|FG002|Overall Study|Withdrawal by Subject|1|||
156510194|NCT04165031|564961559|FG003|Overall Study|Withdrawal by Subject|0|||
156510195|NCT04165031|564961560|FG004|Overall Study|Withdrawal by Subject|0|||
156510196|NCT04165031|564961561|FG005|Overall Study|Withdrawal by Subject|0|||
156510197|NCT00818168|564961562|FG000|Overall Study|Lack of Efficacy|18|||
156510198|NCT00818168|564961562|FG000|Overall Study|Pregnancy|2|||
156510199|NCT00818168|564961562|FG000|Overall Study|Withdrawal by Subject|16|||
156510200|NCT00818168|564961562|FG000|Overall Study|Lost to Follow-up|7|||
156510201|NCT00818168|564961562|FG000|Overall Study|Adverse Event|19|||
156510202|NCT00818168|564961562|FG000|Overall Study|Reason for Non-completion Not reported|6|||
156510203|NCT00818168|564961562|FG000|Overall Study|Participant Moved|2|||
156510204|NCT00667225|564961565|FG000|Overall Study|Subject had no more lesions to treat.|1|||
156510205|NCT00667225|564961566|FG001|Overall Study|Subject had no more lesions to treat.|0|||
156510206|NCT00667225|564961565|FG000|Overall Study|Lost to Follow-up|0|||
156510207|NCT00667225|564961566|FG001|Overall Study|Lost to Follow-up|1|||
156510208|NCT02993406|564961567|FG000|Overall Study|Withdrawal by Subject|170|||
156510209|NCT02993406|564961568|FG001|Overall Study|Withdrawal by Subject|196|||
156510210|NCT02993406|564961567|FG000|Overall Study|Physician Decision|3|||
156510211|NCT02993406|564961568|FG001|Overall Study|Physician Decision|5|||
156510212|NCT02993406|564961567|FG000|Overall Study|Lost to Follow-up|12|||
156510213|NCT02993406|564961568|FG001|Overall Study|Lost to Follow-up|13|||
156510214|NCT02993406|564961567|FG000|Overall Study|Unclassifiable Response|105|||
156510215|NCT02993406|564961568|FG001|Overall Study|Unclassifiable Response|139|||
156510216|NCT02993406|564961567|FG000|Overall Study|Administrative decision|1|||
156510217|NCT02993406|564961568|FG001|Overall Study|Administrative decision|0|||
156510218|NCT02993406|564961567|FG000|Overall Study|Sponsor decision|4|||
156510219|NCT02993406|564961568|FG001|Overall Study|Sponsor decision|5|||
156510220|NCT03563157|564961569|FG000|Overall Study|Progressive Disease|2|||
156510221|NCT02248818|564961570|FG000|Screening|Protocol Violation|0|||
156510222|NCT02248818|564961571|FG001|Screening|Protocol Violation|0|||
156510223|NCT02248818|564961572|FG002|Screening|Protocol Violation|0|||
156510224|NCT02248818|564961573|FG003|Screening|Protocol Violation|0|||
156510225|NCT02248818|564961574|FG004|Screening|Protocol Violation|0|||
156510226|NCT02248818|564961575|FG005|Screening|Protocol Violation|0|||
156510227|NCT02248818|564961576|FG006|Screening|Protocol Violation|0|||
156510228|NCT02248818|564961577|FG007|Screening|Protocol Violation|0|||
156510229|NCT02248818|564961578|FG008|Screening|Protocol Violation|7|||
156510230|NCT02248818|564961570|FG000|Screening|Study fully enrolled|0|||
156510231|NCT02248818|564961571|FG001|Screening|Study fully enrolled|0|||
156510232|NCT02248818|564961572|FG002|Screening|Study fully enrolled|0|||
156510233|NCT02248818|564961573|FG003|Screening|Study fully enrolled|0|||
156510234|NCT02248818|564961574|FG004|Screening|Study fully enrolled|0|||
156510235|NCT02248818|564961575|FG005|Screening|Study fully enrolled|0|||
156551201|NCT01425008|565109105|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
156551202|NCT01425008|565109106|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551203|NCT01425008|565109107|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
156400818|NCT00504426|564559682|FG001|Overall Study|Protocol Violation|1|||
156400819|NCT00504426|564559683|FG002|Overall Study|Protocol Violation|2|||
156400820|NCT00504426|564559684|FG003|Overall Study|Protocol Violation|0|||
156400821|NCT00504426|564559681|FG000|Overall Study|Withdrawal by Subject|2|||
156400822|NCT00504426|564559682|FG001|Overall Study|Withdrawal by Subject|0|||
156400823|NCT00504426|564559683|FG002|Overall Study|Withdrawal by Subject|0|||
156400824|NCT00504426|564559684|FG003|Overall Study|Withdrawal by Subject|0|||
156400825|NCT03248375|564559689|FG000|Overall Study|Lost to Follow-up|5|||
156400826|NCT04098250|564559690|FG000|Overall Study|Withdrawal by Subject|1|||
156400827|NCT04098250|564559691|FG001|Overall Study|Withdrawal by Subject|0|||
156400828|NCT04098250|564559690|FG000|Overall Study|Lost to Follow-up|0|||
156400829|NCT04098250|564559691|FG001|Overall Study|Lost to Follow-up|1|||
156400830|NCT00394355|564559696|FG000|Overall Study|Adverse Event|10|||
156400831|NCT00394355|564559697|FG001|Overall Study|Adverse Event|6|||
156400832|NCT00394355|564559698|FG002|Overall Study|Adverse Event|7|||
156510236|NCT02248818|564961576|FG006|Screening|Study fully enrolled|0|||
156510237|NCT02248818|564961577|FG007|Screening|Study fully enrolled|0|||
156510238|NCT02248818|564961578|FG008|Screening|Study fully enrolled|14|||
156510239|NCT02248818|564961570|FG000|Screening|Physician Decision|0|||
156510240|NCT02248818|564961571|FG001|Screening|Physician Decision|0|||
156510241|NCT02248818|564961572|FG002|Screening|Physician Decision|0|||
156510242|NCT02248818|564961573|FG003|Screening|Physician Decision|0|||
156510243|NCT02248818|564961574|FG004|Screening|Physician Decision|0|||
156510244|NCT02248818|564961575|FG005|Screening|Physician Decision|0|||
156510245|NCT02248818|564961576|FG006|Screening|Physician Decision|0|||
156510246|NCT02248818|564961577|FG007|Screening|Physician Decision|0|||
156510247|NCT02248818|564961578|FG008|Screening|Physician Decision|73|||
156510248|NCT02248818|564961570|FG000|Screening|Withdrawal by Subject|0|||
156510249|NCT02248818|564961571|FG001|Screening|Withdrawal by Subject|0|||
156510250|NCT02248818|564961572|FG002|Screening|Withdrawal by Subject|0|||
156510251|NCT02248818|564961573|FG003|Screening|Withdrawal by Subject|0|||
156510252|NCT02248818|564961574|FG004|Screening|Withdrawal by Subject|0|||
156510253|NCT02248818|564961575|FG005|Screening|Withdrawal by Subject|0|||
156510254|NCT02248818|564961576|FG006|Screening|Withdrawal by Subject|0|||
156510255|NCT02248818|564961577|FG007|Screening|Withdrawal by Subject|0|||
156510256|NCT02248818|564961578|FG008|Screening|Withdrawal by Subject|6|||
156510257|NCT02248818|564961570|FG000|Screening|Lost to Follow-up|0|||
156510258|NCT02248818|564961571|FG001|Screening|Lost to Follow-up|0|||
156510259|NCT02248818|564961572|FG002|Screening|Lost to Follow-up|0|||
156510260|NCT02248818|564961573|FG003|Screening|Lost to Follow-up|0|||
156510261|NCT02248818|564961574|FG004|Screening|Lost to Follow-up|0|||
156510262|NCT02248818|564961575|FG005|Screening|Lost to Follow-up|0|||
156510263|NCT02248818|564961576|FG006|Screening|Lost to Follow-up|0|||
156510264|NCT02248818|564961577|FG007|Screening|Lost to Follow-up|0|||
156510265|NCT02248818|564961578|FG008|Screening|Lost to Follow-up|7|||
156510266|NCT02248818|564961570|FG000|Randomised Study|Administrative - randomization error|0|||
156510267|NCT02248818|564961571|FG001|Randomised Study|Administrative - randomization error|0|||
156510268|NCT02248818|564961572|FG002|Randomised Study|Administrative - randomization error|0|||
156510269|NCT02248818|564961573|FG003|Randomised Study|Administrative - randomization error|0|||
156510270|NCT02248818|564961574|FG004|Randomised Study|Administrative - randomization error|0|||
156510271|NCT02248818|564961575|FG005|Randomised Study|Administrative - randomization error|8|||
156510272|NCT02248818|564961576|FG006|Randomised Study|Administrative - randomization error|0|||
156510273|NCT02248818|564961577|FG007|Randomised Study|Administrative - randomization error|0|||
156510274|NCT02248818|564961578|FG008|Randomised Study|Administrative - randomization error|0|||
156510275|NCT02942277|564961579|FG000|Year 1|Withdrawal by Subject|0|||
156510276|NCT02942277|564961580|FG001|Year 1|Withdrawal by Subject|0|||
156510277|NCT02942277|564961581|FG002|Year 1|Withdrawal by Subject|0|||
156510278|NCT02942277|564961582|FG003|Year 1|Withdrawal by Subject|0|||
156510279|NCT02942277|564961583|FG004|Year 1|Withdrawal by Subject|1|||
156510280|NCT02942277|564961584|FG005|Year 1|Withdrawal by Subject|3|||
156510281|NCT02942277|564961585|FG006|Year 1|Withdrawal by Subject|0|||
156510282|NCT02942277|564961586|FG007|Year 1|Withdrawal by Subject|1|||
156551204|NCT01425008|565109108|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551205|NCT01425008|565109109|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
156551206|NCT01425008|565109110|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
156400833|NCT00394355|564559699|FG003|Overall Study|Adverse Event|8|||
156400834|NCT00394355|564559696|FG000|Overall Study|Did not meet protocol eligibility|1|||
156400835|NCT00394355|564559697|FG001|Overall Study|Did not meet protocol eligibility|5|||
156400836|NCT00394355|564559698|FG002|Overall Study|Did not meet protocol eligibility|4|||
156400837|NCT00394355|564559699|FG003|Overall Study|Did not meet protocol eligibility|2|||
156400838|NCT00394355|564559696|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
156400839|NCT00394355|564559697|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
156400840|NCT00394355|564559698|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
156510283|NCT02942277|564961587|FG008|Year 1|Withdrawal by Subject|0|||
156510284|NCT02942277|564961588|FG009|Year 1|Withdrawal by Subject|0|||
156510285|NCT02942277|564961589|FG010|Year 1|Withdrawal by Subject|3|||
156510286|NCT02942277|564961579|FG000|Year 1|Travel|0|||
156551207|NCT01425008|565109111|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
156551208|NCT01425008|565109112|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
156551209|NCT01425008|565109094|FG000|Dose Expansion Phase|Adverse Event|0|||
156551210|NCT01425008|565109095|FG001|Dose Expansion Phase|Adverse Event|0|||
156551211|NCT01425008|565109096|FG002|Dose Expansion Phase|Adverse Event|0|||
156551212|NCT01425008|565109097|FG003|Dose Expansion Phase|Adverse Event|0|||
156551213|NCT01425008|565109098|FG004|Dose Expansion Phase|Adverse Event|0|||
156551214|NCT01425008|565109099|FG005|Dose Expansion Phase|Adverse Event|0|||
156551215|NCT01425008|565109100|FG006|Dose Expansion Phase|Adverse Event|0|||
156551216|NCT01425008|565109101|FG007|Dose Expansion Phase|Adverse Event|0|||
156551217|NCT01425008|565109102|FG008|Dose Expansion Phase|Adverse Event|0|||
156551218|NCT01425008|565109103|FG009|Dose Expansion Phase|Adverse Event|0|||
156551219|NCT01425008|565109104|FG010|Dose Expansion Phase|Adverse Event|2|||
156551220|NCT01425008|565109105|FG011|Dose Expansion Phase|Adverse Event|3|||
156551221|NCT01425008|565109106|FG012|Dose Expansion Phase|Adverse Event|3|||
156551222|NCT01425008|565109107|FG013|Dose Expansion Phase|Adverse Event|0|||
156551223|NCT01425008|565109108|FG014|Dose Expansion Phase|Adverse Event|1|||
156551224|NCT01425008|565109109|FG015|Dose Expansion Phase|Adverse Event|1|||
156551225|NCT01425008|565109110|FG016|Dose Expansion Phase|Adverse Event|5|||
156551226|NCT01425008|565109111|FG017|Dose Expansion Phase|Adverse Event|0|||
156551227|NCT01425008|565109112|FG018|Dose Expansion Phase|Adverse Event|3|||
156551228|NCT01425008|565109094|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
156551229|NCT01425008|565109095|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
156551230|NCT01425008|565109096|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
156551231|NCT01425008|565109097|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
156551232|NCT01425008|565109098|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
156551233|NCT01425008|565109099|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
156551234|NCT01425008|565109100|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
156551235|NCT01425008|565109101|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
156551236|NCT01425008|565109102|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
156551237|NCT01425008|565109103|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
156551238|NCT01425008|565109104|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
156551239|NCT01425008|565109105|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
156551240|NCT01425008|565109106|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
156551241|NCT01425008|565109107|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
156551242|NCT01425008|565109108|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
156551243|NCT01425008|565109109|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
156551244|NCT01425008|565109110|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
156551245|NCT01425008|565109111|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
156551246|NCT01425008|565109112|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
156551247|NCT01425008|565109094|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551248|NCT01425008|565109095|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551249|NCT01425008|565109096|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551250|NCT01425008|565109097|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551251|NCT01425008|565109098|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551252|NCT01425008|565109099|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156400841|NCT00394355|564559699|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
156400842|NCT00394355|564559696|FG000|Overall Study|Subject withdrawal - related to drug|1|||
156400843|NCT00394355|564559697|FG001|Overall Study|Subject withdrawal - related to drug|0|||
156400844|NCT00394355|564559698|FG002|Overall Study|Subject withdrawal - related to drug|0|||
156400845|NCT00394355|564559699|FG003|Overall Study|Subject withdrawal - related to drug|0|||
156400846|NCT00394355|564559696|FG000|Overall Study|Lost to Follow-up|7|||
156400847|NCT00394355|564559697|FG001|Overall Study|Lost to Follow-up|5|||
156400848|NCT00394355|564559698|FG002|Overall Study|Lost to Follow-up|4|||
156400849|NCT00394355|564559699|FG003|Overall Study|Lost to Follow-up|3|||
156400850|NCT00394355|564559696|FG000|Overall Study|Noncompliance with protocol|4|||
156400851|NCT00394355|564559697|FG001|Overall Study|Noncompliance with protocol|3|||
156400852|NCT00394355|564559698|FG002|Overall Study|Noncompliance with protocol|10|||
156400853|NCT00394355|564559699|FG003|Overall Study|Noncompliance with protocol|8|||
156400854|NCT00394355|564559696|FG000|Overall Study|Administrative|0|||
156400855|NCT00394355|564559697|FG001|Overall Study|Administrative|1|||
156400856|NCT00394355|564559698|FG002|Overall Study|Administrative|1|||
156400857|NCT00394355|564559699|FG003|Overall Study|Administrative|1|||
156400858|NCT00394355|564559696|FG000|Overall Study|Lack of Efficacy|0|||
156400859|NCT00394355|564559697|FG001|Overall Study|Lack of Efficacy|0|||
156400860|NCT00394355|564559698|FG002|Overall Study|Lack of Efficacy|2|||
156400861|NCT00394355|564559699|FG003|Overall Study|Lack of Efficacy|3|||
156400862|NCT02612064|564559703|FG000|Overall Study|Withdrawal by Subject|1|||
156551253|NCT01425008|565109100|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551254|NCT01425008|565109101|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551255|NCT01425008|565109102|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551256|NCT01425008|565109103|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551257|NCT01425008|565109104|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551258|NCT01425008|565109105|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551259|NCT01425008|565109106|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551260|NCT01425008|565109107|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551261|NCT01425008|565109108|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551262|NCT01425008|565109109|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551263|NCT01425008|565109110|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551264|NCT01425008|565109111|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156551265|NCT01425008|565109112|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
156551266|NCT02600494|565109113|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
156551267|NCT02600494|565109114|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
156551268|NCT02600494|565109115|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
156551269|NCT02600494|565109113|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
156551270|NCT02600494|565109114|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
156551271|NCT02600494|565109115|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
156551272|NCT02600494|565109113|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
156551273|NCT02600494|565109114|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
156551274|NCT02600494|565109115|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
156551275|NCT02600494|565109113|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
156551276|NCT02600494|565109114|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
156551277|NCT02600494|565109115|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
156551278|NCT02600494|565109113|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
156551279|NCT02600494|565109114|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
156551280|NCT02600494|565109115|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
156551281|NCT02600494|565109113|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
156551282|NCT02600494|565109114|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
156551283|NCT02600494|565109115|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
156551284|NCT02600494|565109113|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
156551285|NCT02600494|565109114|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
156551286|NCT02600494|565109115|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
156551287|NCT02600494|565109113|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
156551288|NCT02600494|565109114|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
156551289|NCT02600494|565109115|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
156551290|NCT02600494|565109113|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
156551291|NCT02600494|565109114|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
156551292|NCT02600494|565109115|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
156551293|NCT02600494|565109113|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
156551294|NCT02600494|565109114|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
156551295|NCT02600494|565109115|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
156551296|NCT02600494|565109113|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
156551297|NCT02600494|565109114|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
156551298|NCT02600494|565109115|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
156551299|NCT02600494|565109113|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
156551300|NCT02600494|565109114|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
156551301|NCT02600494|565109115|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
156551302|NCT02600494|565109113|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
156551303|NCT02600494|565109114|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
156551304|NCT02600494|565109115|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
156551305|NCT03124563|565109116|FG000|Overall Study|Lost to Follow-up|1|||
156551306|NCT03124563|565109117|FG001|Overall Study|Lost to Follow-up|1|||
156551307|NCT03124563|565109116|FG000|Overall Study|Withdrawal by Subject|1|||
156551308|NCT03124563|565109117|FG001|Overall Study|Withdrawal by Subject|1|||
156565223|NCT02660580|565157660|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
156565224|NCT02660580|565157656|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
156565225|NCT02660580|565157657|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
156565226|NCT02660580|565157658|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
156565227|NCT02660580|565157659|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
156565228|NCT02660580|565157660|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
156565229|NCT02660580|565157656|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
156565230|NCT02660580|565157657|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
156400863|NCT02612064|564559704|FG001|Overall Study|Withdrawal by Subject|1|||
156400864|NCT02612064|564559703|FG000|Overall Study|Other|0|||
156400865|NCT02612064|564559704|FG001|Overall Study|Other|2|||
156400866|NCT02618616|564559705|FG000|Overall Study|Lack of Efficacy|4|||
156565231|NCT02660580|565157658|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
156400867|NCT02618616|564559706|FG001|Overall Study|Lack of Efficacy|0|||
156400868|NCT02618616|564559705|FG000|Overall Study|Pregnancy|0|||
156400869|NCT02618616|564559706|FG001|Overall Study|Pregnancy|1|||
156551309|NCT03409744|565110318|FG000|Overall Study|Death|2|||
156551310|NCT03409744|565110318|FG000|Overall Study|Physician Decision|5|||
156551311|NCT03409744|565110318|FG000|Overall Study|Pregnancy|1|||
156551312|NCT03409744|565110318|FG000|Overall Study|Lost to Follow-up|1|||
156551313|NCT03409744|565110318|FG000|Overall Study|Protocol Violation|1|||
156551314|NCT05804877|565110319|FG000|Overall Study|Lost to Follow-up|1|||
156551315|NCT05804877|565110320|FG001|Overall Study|Lost to Follow-up|3|||
156551316|NCT05804877|565110319|FG000|Overall Study|Withdrawal by Subject|1|||
156551317|NCT05804877|565110320|FG001|Overall Study|Withdrawal by Subject|0|||
156551318|NCT05804877|565110319|FG000|Overall Study|Withdrawal by Subject|1|||
156551319|NCT05804877|565110320|FG001|Overall Study|Withdrawal by Subject|0|||
156551320|NCT01745146|565110322|FG000|Overall Study|Withdrawal by Subject|1|||
156551321|NCT01745146|565110323|FG001|Overall Study|Withdrawal by Subject|3|||
156551322|NCT01745146|565110322|FG000|Overall Study|Lost to Follow-up|2|||
156551323|NCT01745146|565110323|FG001|Overall Study|Lost to Follow-up|0|||
156551324|NCT01262365|565110324|FG000|Overall Study|Lack of Efficacy|35|||
156551325|NCT01262365|565110325|FG001|Overall Study|Lack of Efficacy|30|||
156551326|NCT01262365|565110326|FG002|Overall Study|Lack of Efficacy|47|||
156551327|NCT01262365|565110324|FG000|Overall Study|Protocol Violation|3|||
156551328|NCT01262365|565110325|FG001|Overall Study|Protocol Violation|1|||
156551329|NCT01262365|565110326|FG002|Overall Study|Protocol Violation|1|||
156551330|NCT01262365|565110324|FG000|Overall Study|Lost to Follow-up|3|||
156551331|NCT01262365|565110325|FG001|Overall Study|Lost to Follow-up|7|||
156551332|NCT01262365|565110326|FG002|Overall Study|Lost to Follow-up|6|||
156551333|NCT01262365|565110324|FG000|Overall Study|Withdrawal by Subject|17|||
156551334|NCT01262365|565110325|FG001|Overall Study|Withdrawal by Subject|22|||
156551335|NCT01262365|565110326|FG002|Overall Study|Withdrawal by Subject|22|||
156551336|NCT01262365|565110324|FG000|Overall Study|Death|1|||
156551337|NCT01262365|565110325|FG001|Overall Study|Death|2|||
156510287|NCT02942277|564961580|FG001|Year 1|Travel|1|||
156510288|NCT02942277|564961581|FG002|Year 1|Travel|0|||
156510289|NCT02942277|564961582|FG003|Year 1|Travel|0|||
156510290|NCT02942277|564961583|FG004|Year 1|Travel|4|||
156510291|NCT02942277|564961584|FG005|Year 1|Travel|5|||
156510292|NCT02942277|564961585|FG006|Year 1|Travel|0|||
156510293|NCT02942277|564961586|FG007|Year 1|Travel|0|||
156510294|NCT02942277|564961587|FG008|Year 1|Travel|0|||
156510295|NCT02942277|564961588|FG009|Year 1|Travel|0|||
156510296|NCT02942277|564961589|FG010|Year 1|Travel|8|||
156510297|NCT02942277|564961579|FG000|Year 1|Joined Army|0|||
156510298|NCT02942277|564961580|FG001|Year 1|Joined Army|1|||
156510299|NCT02942277|564961581|FG002|Year 1|Joined Army|0|||
156510300|NCT02942277|564961582|FG003|Year 1|Joined Army|0|||
156510301|NCT02942277|564961583|FG004|Year 1|Joined Army|0|||
156510302|NCT02942277|564961584|FG005|Year 1|Joined Army|0|||
156510303|NCT02942277|564961585|FG006|Year 1|Joined Army|0|||
156510304|NCT02942277|564961586|FG007|Year 1|Joined Army|0|||
156510305|NCT02942277|564961587|FG008|Year 1|Joined Army|0|||
156510306|NCT02942277|564961588|FG009|Year 1|Joined Army|0|||
156510307|NCT02942277|564961589|FG010|Year 1|Joined Army|0|||
156510308|NCT02942277|564961579|FG000|Year 1|Subject met withdrawal criteria|0|||
156510309|NCT02942277|564961580|FG001|Year 1|Subject met withdrawal criteria|0|||
156510310|NCT02942277|564961581|FG002|Year 1|Subject met withdrawal criteria|0|||
156510311|NCT02942277|564961582|FG003|Year 1|Subject met withdrawal criteria|1|||
156510312|NCT02942277|564961583|FG004|Year 1|Subject met withdrawal criteria|0|||
156510313|NCT02942277|564961584|FG005|Year 1|Subject met withdrawal criteria|0|||
156510314|NCT02942277|564961585|FG006|Year 1|Subject met withdrawal criteria|0|||
156510315|NCT02942277|564961586|FG007|Year 1|Subject met withdrawal criteria|0|||
156510316|NCT02942277|564961587|FG008|Year 1|Subject met withdrawal criteria|0|||
156510317|NCT02942277|564961588|FG009|Year 1|Subject met withdrawal criteria|0|||
156510318|NCT02942277|564961589|FG010|Year 1|Subject met withdrawal criteria|0|||
156510319|NCT02942277|564961579|FG000|Year 1|Lost to Follow-up|0|||
156510320|NCT02942277|564961580|FG001|Year 1|Lost to Follow-up|0|||
156551338|NCT01262365|565110326|FG002|Overall Study|Death|1|||
156551339|NCT01262365|565110324|FG000|Overall Study|Adverse Event|26|||
156551340|NCT01262365|565110325|FG001|Overall Study|Adverse Event|16|||
156551341|NCT01262365|565110326|FG002|Overall Study|Adverse Event|11|||
156510321|NCT02942277|564961581|FG002|Year 1|Lost to Follow-up|0|||
156510322|NCT02942277|564961582|FG003|Year 1|Lost to Follow-up|0|||
156510323|NCT02942277|564961583|FG004|Year 1|Lost to Follow-up|1|||
156510324|NCT02942277|564961584|FG005|Year 1|Lost to Follow-up|0|||
156510325|NCT02942277|564961585|FG006|Year 1|Lost to Follow-up|0|||
156510326|NCT02942277|564961586|FG007|Year 1|Lost to Follow-up|0|||
156510327|NCT02942277|564961587|FG008|Year 1|Lost to Follow-up|0|||
156551342|NCT01262365|565110324|FG000|Overall Study|sponsor decision|1|||
156551343|NCT01262365|565110325|FG001|Overall Study|sponsor decision|1|||
156551344|NCT01262365|565110326|FG002|Overall Study|sponsor decision|0|||
156551345|NCT01262365|565110324|FG000|Overall Study|Randomization error|1|||
156510328|NCT02942277|564961588|FG009|Year 1|Lost to Follow-up|0|||
156510329|NCT02942277|564961589|FG010|Year 1|Lost to Follow-up|2|||
156510330|NCT02942277|564961579|FG000|Year 1|Protocol Violation|0|||
156510331|NCT02942277|564961580|FG001|Year 1|Protocol Violation|0|||
156551346|NCT01262365|565110325|FG001|Overall Study|Randomization error|0|||
156551347|NCT01262365|565110326|FG002|Overall Study|Randomization error|2|||
156510332|NCT02942277|564961581|FG002|Year 1|Protocol Violation|0|||
156510333|NCT02942277|564961582|FG003|Year 1|Protocol Violation|0|||
156510334|NCT02942277|564961583|FG004|Year 1|Protocol Violation|1|||
156510335|NCT02942277|564961584|FG005|Year 1|Protocol Violation|1|||
156510336|NCT02942277|564961585|FG006|Year 1|Protocol Violation|0|||
156510337|NCT02942277|564961586|FG007|Year 1|Protocol Violation|0|||
156510338|NCT02942277|564961587|FG008|Year 1|Protocol Violation|0|||
156510339|NCT02942277|564961588|FG009|Year 1|Protocol Violation|0|||
156510340|NCT02942277|564961589|FG010|Year 1|Protocol Violation|2|||
156510341|NCT02942277|564961579|FG000|Year 1|Pregnancy|0|||
156510342|NCT02942277|564961580|FG001|Year 1|Pregnancy|0|||
156510343|NCT02942277|564961581|FG002|Year 1|Pregnancy|0|||
156510344|NCT02942277|564961582|FG003|Year 1|Pregnancy|0|||
156510345|NCT02942277|564961583|FG004|Year 1|Pregnancy|0|||
156510346|NCT02942277|564961584|FG005|Year 1|Pregnancy|1|||
156510347|NCT02942277|564961585|FG006|Year 1|Pregnancy|0|||
156510348|NCT02942277|564961586|FG007|Year 1|Pregnancy|0|||
156510349|NCT02942277|564961587|FG008|Year 1|Pregnancy|0|||
156510350|NCT02942277|564961588|FG009|Year 1|Pregnancy|0|||
156510351|NCT02942277|564961589|FG010|Year 1|Pregnancy|0|||
156510352|NCT02942277|564961579|FG000|Year 2|Lost to Follow-up|0|||
156510353|NCT02942277|564961580|FG001|Year 2|Lost to Follow-up|0|||
156510354|NCT02942277|564961581|FG002|Year 2|Lost to Follow-up|0|||
156510355|NCT02942277|564961582|FG003|Year 2|Lost to Follow-up|0|||
156510356|NCT02942277|564961583|FG004|Year 2|Lost to Follow-up|2|||
156510357|NCT02942277|564961584|FG005|Year 2|Lost to Follow-up|1|||
156510358|NCT02942277|564961585|FG006|Year 2|Lost to Follow-up|0|||
156510359|NCT02942277|564961586|FG007|Year 2|Lost to Follow-up|0|||
156510360|NCT02942277|564961587|FG008|Year 2|Lost to Follow-up|0|||
156510361|NCT02942277|564961588|FG009|Year 2|Lost to Follow-up|0|||
156510362|NCT02942277|564961589|FG010|Year 2|Lost to Follow-up|0|||
156510363|NCT02942277|564961579|FG000|Year 2|Did not rescreen|0|||
156510364|NCT02942277|564961580|FG001|Year 2|Did not rescreen|0|||
156510365|NCT02942277|564961581|FG002|Year 2|Did not rescreen|1|||
156510366|NCT02942277|564961582|FG003|Year 2|Did not rescreen|1|||
156510367|NCT02942277|564961583|FG004|Year 2|Did not rescreen|9|||
156510368|NCT02942277|564961584|FG005|Year 2|Did not rescreen|6|||
156510369|NCT02942277|564961585|FG006|Year 2|Did not rescreen|0|||
156510370|NCT02942277|564961586|FG007|Year 2|Did not rescreen|1|||
156510371|NCT02942277|564961587|FG008|Year 2|Did not rescreen|0|||
156510372|NCT02942277|564961588|FG009|Year 2|Did not rescreen|0|||
156510373|NCT02942277|564961589|FG010|Year 2|Did not rescreen|21|||
156510374|NCT02942277|564961579|FG000|Year 2|Met withdrawal criteria|0|||
156510375|NCT02942277|564961580|FG001|Year 2|Met withdrawal criteria|0|||
156510376|NCT02942277|564961581|FG002|Year 2|Met withdrawal criteria|0|||
156510377|NCT02942277|564961582|FG003|Year 2|Met withdrawal criteria|0|||
156510378|NCT02942277|564961583|FG004|Year 2|Met withdrawal criteria|1|||
156510379|NCT02942277|564961584|FG005|Year 2|Met withdrawal criteria|2|||
156510380|NCT02942277|564961585|FG006|Year 2|Met withdrawal criteria|0|||
156510381|NCT02942277|564961586|FG007|Year 2|Met withdrawal criteria|0|||
156510382|NCT02942277|564961587|FG008|Year 2|Met withdrawal criteria|0|||
156510383|NCT02942277|564961588|FG009|Year 2|Met withdrawal criteria|0|||
156510384|NCT02942277|564961589|FG010|Year 2|Met withdrawal criteria|1|||
156510385|NCT02942277|564961579|FG000|Year 2|Travel|0|||
156510386|NCT02942277|564961580|FG001|Year 2|Travel|1|||
156510387|NCT02942277|564961581|FG002|Year 2|Travel|0|||
156510388|NCT02942277|564961582|FG003|Year 2|Travel|0|||
156510389|NCT02942277|564961583|FG004|Year 2|Travel|0|||
156510390|NCT02942277|564961584|FG005|Year 2|Travel|1|||
156510391|NCT02942277|564961585|FG006|Year 2|Travel|0|||
156510392|NCT02942277|564961586|FG007|Year 2|Travel|0|||
156510393|NCT02942277|564961587|FG008|Year 2|Travel|0|||
156510394|NCT02942277|564961588|FG009|Year 2|Travel|1|||
156510395|NCT02942277|564961589|FG010|Year 2|Travel|3|||
156510396|NCT02942277|564961579|FG000|Year 2|Non-compliant|0|||
156510397|NCT02942277|564961580|FG001|Year 2|Non-compliant|0|||
156551348|NCT01262365|565110324|FG000|Overall Study|Non-compliance|1|||
156510398|NCT02942277|564961581|FG002|Year 2|Non-compliant|0|||
156510399|NCT02942277|564961582|FG003|Year 2|Non-compliant|0|||
156551349|NCT01262365|565110325|FG001|Overall Study|Non-compliance|0|||
156551350|NCT01262365|565110326|FG002|Overall Study|Non-compliance|2|||
156510400|NCT02942277|564961583|FG004|Year 2|Non-compliant|1|||
156510401|NCT02942277|564961584|FG005|Year 2|Non-compliant|1|||
156510402|NCT02942277|564961585|FG006|Year 2|Non-compliant|0|||
156551351|NCT01262365|565110324|FG000|Overall Study|Suspected pregnancy|1|||
156510403|NCT02942277|564961586|FG007|Year 2|Non-compliant|0|||
156510404|NCT02942277|564961587|FG008|Year 2|Non-compliant|0|||
156510405|NCT02942277|564961588|FG009|Year 2|Non-compliant|0|||
156510406|NCT02942277|564961589|FG010|Year 2|Non-compliant|0|||
156510407|NCT02942277|564961579|FG000|Year 2|Withdrawal by Subject|0|||
156510408|NCT02942277|564961580|FG001|Year 2|Withdrawal by Subject|0|||
156510409|NCT02942277|564961581|FG002|Year 2|Withdrawal by Subject|0|||
156510410|NCT02942277|564961582|FG003|Year 2|Withdrawal by Subject|0|||
156510411|NCT02942277|564961583|FG004|Year 2|Withdrawal by Subject|0|||
156510412|NCT02942277|564961584|FG005|Year 2|Withdrawal by Subject|0|||
156510413|NCT02942277|564961585|FG006|Year 2|Withdrawal by Subject|1|||
156510414|NCT02942277|564961586|FG007|Year 2|Withdrawal by Subject|0|||
156510415|NCT02942277|564961587|FG008|Year 2|Withdrawal by Subject|0|||
156510416|NCT02942277|564961588|FG009|Year 2|Withdrawal by Subject|0|||
156510417|NCT02942277|564961589|FG010|Year 2|Withdrawal by Subject|0|||
156510418|NCT02187159|564961590|FG000|Overall Study|Protocol Violation|4|||
156510419|NCT02187159|564961591|FG001|Overall Study|Protocol Violation|6|||
156510420|NCT02187159|564961592|FG002|Overall Study|Protocol Violation|3|||
156510421|NCT02187159|564961593|FG003|Overall Study|Protocol Violation|4|||
156510422|NCT02187159|564961590|FG000|Overall Study|Lack of Efficacy|10|||
156510423|NCT02187159|564961591|FG001|Overall Study|Lack of Efficacy|5|||
156510424|NCT02187159|564961592|FG002|Overall Study|Lack of Efficacy|4|||
156510425|NCT02187159|564961593|FG003|Overall Study|Lack of Efficacy|7|||
156510426|NCT02187159|564961590|FG000|Overall Study|Adverse Event|28|||
156510427|NCT02187159|564961591|FG001|Overall Study|Adverse Event|33|||
156510428|NCT02187159|564961592|FG002|Overall Study|Adverse Event|42|||
156510429|NCT02187159|564961593|FG003|Overall Study|Adverse Event|50|||
156510430|NCT02187159|564961590|FG000|Overall Study|Withdrawal by Subject|24|||
156510431|NCT02187159|564961591|FG001|Overall Study|Withdrawal by Subject|28|||
156510432|NCT02187159|564961592|FG002|Overall Study|Withdrawal by Subject|25|||
156510433|NCT02187159|564961593|FG003|Overall Study|Withdrawal by Subject|26|||
156510434|NCT02187159|564961590|FG000|Overall Study|Other|3|||
156510435|NCT02187159|564961591|FG001|Overall Study|Other|7|||
156510436|NCT02187159|564961592|FG002|Overall Study|Other|3|||
156510437|NCT02187159|564961593|FG003|Overall Study|Other|9|||
156510438|NCT01283152|564961596|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
156510439|NCT01283152|564961597|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
156510440|NCT01283152|564961596|FG000|Overall Study|Refused HESA|1|||
156510441|NCT01283152|564961597|FG001|Overall Study|Refused HESA|0|||
156510442|NCT03330405|564961600|FG000|Overall Study|Other|1|||
156510443|NCT03330405|564961601|FG001|Overall Study|Other|3|||
156510444|NCT03330405|564961602|FG002|Overall Study|Other|1|||
156510445|NCT03330405|564961603|FG003|Overall Study|Other|0|||
156510446|NCT03330405|564961604|FG004|Overall Study|Other|2|||
156510447|NCT03330405|564961605|FG005|Overall Study|Other|0|||
156510448|NCT03330405|564961606|FG006|Overall Study|Other|1|||
156510449|NCT03330405|564961607|FG007|Overall Study|Other|0|||
156510450|NCT03330405|564961608|FG008|Overall Study|Other|0|||
156510451|NCT03330405|564961609|FG009|Overall Study|Other|0|||
156510452|NCT03330405|564961610|FG010|Overall Study|Other|0|||
156510453|NCT03330405|564961600|FG000|Overall Study|Progressive disease|8|||
156510454|NCT03330405|564961601|FG001|Overall Study|Progressive disease|27|||
156510455|NCT03330405|564961602|FG002|Overall Study|Progressive disease|4|||
156510456|NCT03330405|564961603|FG003|Overall Study|Progressive disease|18|||
156510457|NCT03330405|564961604|FG004|Overall Study|Progressive disease|16|||
156510458|NCT03330405|564961605|FG005|Overall Study|Progressive disease|14|||
156510459|NCT03330405|564961606|FG006|Overall Study|Progressive disease|7|||
156510460|NCT03330405|564961607|FG007|Overall Study|Progressive disease|29|||
156510461|NCT03330405|564961608|FG008|Overall Study|Progressive disease|9|||
156510462|NCT03330405|564961609|FG009|Overall Study|Progressive disease|11|||
156510463|NCT03330405|564961610|FG010|Overall Study|Progressive disease|5|||
156510464|NCT03330405|564961600|FG000|Overall Study|Withdrawal by Subject|1|||
156510465|NCT03330405|564961601|FG001|Overall Study|Withdrawal by Subject|4|||
156510466|NCT03330405|564961602|FG002|Overall Study|Withdrawal by Subject|0|||
156510467|NCT03330405|564961603|FG003|Overall Study|Withdrawal by Subject|1|||
156510468|NCT03330405|564961604|FG004|Overall Study|Withdrawal by Subject|1|||
156510469|NCT03330405|564961605|FG005|Overall Study|Withdrawal by Subject|1|||
156510470|NCT03330405|564961606|FG006|Overall Study|Withdrawal by Subject|0|||
156510471|NCT03330405|564961607|FG007|Overall Study|Withdrawal by Subject|2|||
156510472|NCT03330405|564961608|FG008|Overall Study|Withdrawal by Subject|2|||
156510473|NCT03330405|564961609|FG009|Overall Study|Withdrawal by Subject|1|||
156510474|NCT03330405|564961610|FG010|Overall Study|Withdrawal by Subject|1|||
156510475|NCT03330405|564961600|FG000|Overall Study|Global deterioration of health status|2|||
156510476|NCT03330405|564961601|FG001|Overall Study|Global deterioration of health status|3|||
156510477|NCT03330405|564961602|FG002|Overall Study|Global deterioration of health status|0|||
156510478|NCT03330405|564961603|FG003|Overall Study|Global deterioration of health status|2|||
156551352|NCT01262365|565110325|FG001|Overall Study|Suspected pregnancy|0|||
156510479|NCT03330405|564961604|FG004|Overall Study|Global deterioration of health status|3|||
156510480|NCT03330405|564961605|FG005|Overall Study|Global deterioration of health status|3|||
156510481|NCT03330405|564961606|FG006|Overall Study|Global deterioration of health status|0|||
156510482|NCT03330405|564961607|FG007|Overall Study|Global deterioration of health status|2|||
156510483|NCT03330405|564961608|FG008|Overall Study|Global deterioration of health status|8|||
156551353|NCT01262365|565110326|FG002|Overall Study|Suspected pregnancy|0|||
156551354|NCT01262365|565110324|FG000|Overall Study|Patient pregnant|1|||
156510484|NCT03330405|564961609|FG009|Overall Study|Global deterioration of health status|4|||
156510485|NCT03330405|564961610|FG010|Overall Study|Global deterioration of health status|1|||
156510486|NCT03330405|564961600|FG000|Overall Study|Adverse Event|0|||
156510487|NCT03330405|564961601|FG001|Overall Study|Adverse Event|1|||
156510488|NCT03330405|564961602|FG002|Overall Study|Adverse Event|0|||
156510489|NCT03330405|564961603|FG003|Overall Study|Adverse Event|1|||
156510490|NCT03330405|564961604|FG004|Overall Study|Adverse Event|1|||
156551355|NCT01262365|565110325|FG001|Overall Study|Patient pregnant|0|||
156551356|NCT01262365|565110326|FG002|Overall Study|Patient pregnant|1|||
156551357|NCT01262365|565110324|FG000|Overall Study|Toxicity related to study drug|0|||
156551358|NCT01262365|565110325|FG001|Overall Study|Toxicity related to study drug|1|||
156551359|NCT01262365|565110326|FG002|Overall Study|Toxicity related to study drug|0|||
156551360|NCT01262365|565110324|FG000|Overall Study|Cannot tolerate the protocol|0|||
156551361|NCT01262365|565110325|FG001|Overall Study|Cannot tolerate the protocol|1|||
156551362|NCT01262365|565110326|FG002|Overall Study|Cannot tolerate the protocol|0|||
156551363|NCT01262365|565110324|FG000|Overall Study|Patient unavailable|0|||
156551364|NCT01262365|565110325|FG001|Overall Study|Patient unavailable|0|||
156551365|NCT01262365|565110326|FG002|Overall Study|Patient unavailable|1|||
156551366|NCT00494091|565110327|FG000|Overall Study|Death|5|||
156551367|NCT00494091|565110328|FG001|Overall Study|Death|54|||
156551368|NCT00494091|565110327|FG000|Overall Study|Lost to Follow-up|0|||
156551369|NCT00494091|565110328|FG001|Overall Study|Lost to Follow-up|4|||
156551370|NCT00494091|565110327|FG000|Overall Study|Other|1|||
156551371|NCT00494091|565110328|FG001|Overall Study|Other|11|||
156551372|NCT00494091|565110327|FG000|Overall Study|Withdrawal by Subject|0|||
156551373|NCT00494091|565110328|FG001|Overall Study|Withdrawal by Subject|7|||
156551374|NCT00130832|565110332|FG000|Overall Study|Adverse Event|1|||
156551375|NCT00130832|565110333|FG001|Overall Study|Adverse Event|1|||
156551376|NCT00130832|565110332|FG000|Overall Study|Lost to Follow-up|1|||
156551377|NCT00130832|565110333|FG001|Overall Study|Lost to Follow-up|2|||
156551378|NCT00130832|565110332|FG000|Overall Study|Protocol Violation|6|||
156551379|NCT00130832|565110333|FG001|Overall Study|Protocol Violation|8|||
156551380|NCT00130832|565110332|FG000|Overall Study|Withdrawal by Subject|6|||
156551381|NCT00130832|565110333|FG001|Overall Study|Withdrawal by Subject|1|||
156551382|NCT00130832|565110332|FG000|Overall Study|Moved|2|||
156551383|NCT00130832|565110333|FG001|Overall Study|Moved|2|||
156551384|NCT00130832|565110332|FG000|Overall Study|Other|0|||
156400870|NCT02618616|564559705|FG000|Overall Study|Adverse Event|8|||
156510491|NCT03330405|564961605|FG005|Overall Study|Adverse Event|1|||
156510492|NCT03330405|564961606|FG006|Overall Study|Adverse Event|3|||
156510493|NCT03330405|564961607|FG007|Overall Study|Adverse Event|4|||
156510494|NCT03330405|564961608|FG008|Overall Study|Adverse Event|2|||
156510495|NCT03330405|564961609|FG009|Overall Study|Adverse Event|2|||
156510496|NCT03330405|564961610|FG010|Overall Study|Adverse Event|2|||
156510497|NCT03330405|564961600|FG000|Overall Study|Death|0|||
156510498|NCT03330405|564961601|FG001|Overall Study|Death|4|||
156510499|NCT03330405|564961602|FG002|Overall Study|Death|0|||
156510500|NCT03330405|564961603|FG003|Overall Study|Death|0|||
156510501|NCT03330405|564961604|FG004|Overall Study|Death|0|||
156510502|NCT03330405|564961605|FG005|Overall Study|Death|1|||
156510503|NCT03330405|564961606|FG006|Overall Study|Death|0|||
156510504|NCT03330405|564961607|FG007|Overall Study|Death|2|||
156510505|NCT03330405|564961608|FG008|Overall Study|Death|0|||
156510506|NCT03330405|564961609|FG009|Overall Study|Death|0|||
156510507|NCT03330405|564961610|FG010|Overall Study|Death|0|||
156510508|NCT03330405|564961600|FG000|Overall Study|Physician Decision|0|||
156510509|NCT03330405|564961601|FG001|Overall Study|Physician Decision|0|||
156510510|NCT03330405|564961602|FG002|Overall Study|Physician Decision|0|||
156510511|NCT03330405|564961603|FG003|Overall Study|Physician Decision|0|||
156510512|NCT03330405|564961604|FG004|Overall Study|Physician Decision|0|||
156510513|NCT03330405|564961605|FG005|Overall Study|Physician Decision|0|||
156510514|NCT03330405|564961606|FG006|Overall Study|Physician Decision|0|||
156510515|NCT03330405|564961607|FG007|Overall Study|Physician Decision|1|||
156510516|NCT03330405|564961608|FG008|Overall Study|Physician Decision|0|||
156400871|NCT02618616|564559706|FG001|Overall Study|Adverse Event|0|||
156400872|NCT02618616|564559705|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
156400873|NCT02618616|564559706|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
156400874|NCT02618616|564559705|FG000|Overall Study|Consent withdrawn by subject|8|||
156400875|NCT02618616|564559706|FG001|Overall Study|Consent withdrawn by subject|5|||
156400876|NCT02618616|564559705|FG000|Overall Study|Lost to Follow-up|0|||
156400877|NCT02618616|564559706|FG001|Overall Study|Lost to Follow-up|1|||
156510517|NCT03330405|564961609|FG009|Overall Study|Physician Decision|0|||
156551385|NCT00130832|565110333|FG001|Overall Study|Other|3|||
156551386|NCT00984204|565110341|FG000|Overall Study|Death|1|||
156551387|NCT00984204|565110341|FG000|Overall Study|Lost to Follow-up|4|||
156551388|NCT00984204|565110341|FG000|Overall Study|Lack of Efficacy|10|||
156551389|NCT00699348|565110343|FG000|Overall Study|Death|6|||
156551390|NCT00699348|565110343|FG000|Overall Study|Adverse Event|15|||
156510518|NCT03330405|564961610|FG010|Overall Study|Physician Decision|0|||
156510519|NCT01736189|564961613|FG000|Overall Study|Violation of registration criteria|41|||
156510520|NCT01736189|564961613|FG000|Overall Study|Protocol Violation|4|||
156510521|NCT01736189|564961613|FG000|Overall Study|Criteria and protocol violations|1|||
156510522|NCT00608868|564961616|FG000|Overall Study|Withdrawal by Subject|7|||
156510523|NCT00608868|564961616|FG000|Overall Study|Protocol Violation|3|||
156510524|NCT00608868|564961616|FG000|Overall Study|Lost to Follow-up|2|||
156551391|NCT00699348|565110343|FG000|Overall Study|Withdrawal by Subject|11|||
156551392|NCT00699348|565110343|FG000|Overall Study|Protocol Violation|10|||
156400878|NCT02686034|564559709|FG000|Run-In Period 1|Eligibility|12|||
156400879|NCT02686034|564559710|FG001|Run-In Period 1|Eligibility|10|||
156400880|NCT02686034|564559709|FG000|Run-In Period 1|Withdrawal by Subject|4|||
156400881|NCT02686034|564559710|FG001|Run-In Period 1|Withdrawal by Subject|3|||
156510525|NCT00608868|564961616|FG000|Overall Study|Adverse Event|1|||
156510526|NCT00608868|564961616|FG000|Overall Study|Physician Decision|2|||
156510527|NCT00702962|564961619|FG000|Overall Study|Progressive disease|0|||
156510528|NCT00702962|564961620|FG001|Overall Study|Progressive disease|1|||
156510529|NCT00702962|564961619|FG000|Overall Study|Hospitalized for other health disorder|1|||
156510530|NCT00702962|564961620|FG001|Overall Study|Hospitalized for other health disorder|0|||
156510531|NCT01923467|564961626|FG000|Overall Study|Lost to Follow-up|62|||
156510532|NCT01923467|564961626|FG000|Overall Study|Subject non-interest|479|||
156510533|NCT01876901|564961627|FG000|Overall Study|Protocol Violation|10|||
156510534|NCT01876901|564961628|FG001|Overall Study|Protocol Violation|2|||
156510535|NCT01876901|564961627|FG000|Overall Study|No or other surgical intervention|7|||
156510536|NCT01876901|564961628|FG001|Overall Study|No or other surgical intervention|5|||
156510537|NCT01145898|564961629|FG000|3-year Treatment|medication change by treating physician|3|||
156510538|NCT01145898|564961630|FG001|3-year Treatment|medication change by treating physician|16|||
156510539|NCT00879775|564961631|FG000|Overall Study|Lost to Follow-up|2|||
156510540|NCT00879775|564961632|FG001|Overall Study|Lost to Follow-up|1|||
156400882|NCT02686034|564559709|FG000|Run-In Period 1|Lost to Follow-up|4|||
156400883|NCT02686034|564559710|FG001|Run-In Period 1|Lost to Follow-up|4|||
156400884|NCT02686034|564559709|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
156400885|NCT02686034|564559710|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
156400886|NCT02686034|564559709|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
156400887|NCT02686034|564559710|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
156400888|NCT02686034|564559709|FG000|Randomized Controlled Period 2|Adverse Event|0|||
156400889|NCT02686034|564559710|FG001|Randomized Controlled Period 2|Adverse Event|2|||
156400890|NCT02686034|564559709|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
156400891|NCT02686034|564559710|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
156400892|NCT02686034|564559709|FG000|Open Label Period 3|Lost to Follow-up|0|||
156400893|NCT02686034|564559710|FG001|Open Label Period 3|Lost to Follow-up|1|||
156400894|NCT00459342|564559711|FG000|Overall Study|Not eligible|1|||
156400895|NCT00542880|564559712|FG000|Period 1|Eligibility criteria not fulfilled|2|||
156400896|NCT00542880|564559713|FG001|Period 1|Eligibility criteria not fulfilled|6|||
156400897|NCT00542880|564559712|FG000|Period 1|Adverse Event|2|||
156400898|NCT00542880|564559713|FG001|Period 1|Adverse Event|2|||
156400899|NCT00542880|564559712|FG000|Period 1|Development of study-specific criteria|1|||
156400900|NCT00542880|564559713|FG001|Period 1|Development of study-specific criteria|2|||
156400901|NCT00542880|564559712|FG000|Period 1|Withdrawal by Subject|1|||
156400902|NCT00542880|564559713|FG001|Period 1|Withdrawal by Subject|1|||
156400903|NCT00542880|564559712|FG000|Period 1|Protocol Violation|0|||
156400904|NCT00542880|564559713|FG001|Period 1|Protocol Violation|1|||
156400905|NCT00542880|564559712|FG000|Period 2|Adverse Event|5|||
156400906|NCT00542880|564559713|FG001|Period 2|Adverse Event|7|||
156400907|NCT00542880|564559712|FG000|Period 2|Eligibility not fulfilled|0|||
156400908|NCT00542880|564559713|FG001|Period 2|Eligibility not fulfilled|1|||
156400909|NCT00542880|564559712|FG000|Period 2|Discontinuation criteria|2|||
156510541|NCT02440425|564961633|FG000|Overall Study|Death likely due to disease progression|1|||
156510542|NCT02440425|564961633|FG000|Overall Study|Withdrawal by Subject|2|||
156510543|NCT02440425|564961633|FG000|Overall Study|Adverse Event|1|||
156510544|NCT02440425|564961633|FG000|Overall Study|Adverse Event/Ineligible|1|||
156510545|NCT03552523|564961639|FG000|Overall Study|Withdrawal by Subject|1|||
156510546|NCT03552523|564961640|FG001|Overall Study|Withdrawal by Subject|1|||
156510547|NCT04145700|564961641|FG000|Overall Study|Withdrawal by Subject|8|||
156510548|NCT04145700|564961642|FG001|Overall Study|Withdrawal by Subject|3|||
156510549|NCT00780559|564961643|FG000|Overall Study|Lost to Follow-up|2|||
156510550|NCT00780559|564961644|FG001|Overall Study|Lost to Follow-up|7|||
156510551|NCT00780559|564961643|FG000|Overall Study|Death|1|||
156510552|NCT00780559|564961644|FG001|Overall Study|Death|0|||
156510553|NCT01840410|564961646|FG000|Overall Study|Physician Decision|1|||
156510554|NCT01840410|564961647|FG001|Overall Study|Physician Decision|2|||
156510555|NCT01840410|564961646|FG000|Overall Study|Pregnancy|1|||
156510556|NCT01840410|564961647|FG001|Overall Study|Pregnancy|0|||
156510557|NCT01840410|564961646|FG000|Overall Study|Protocol deviation|1|||
156510558|NCT01840410|564961647|FG001|Overall Study|Protocol deviation|0|||
156510559|NCT01840410|564961646|FG000|Overall Study|Lost to Follow-up|1|||
156510560|NCT01840410|564961647|FG001|Overall Study|Lost to Follow-up|0|||
156510561|NCT01840410|564961646|FG000|Overall Study|Withdrawal by Subject|2|||
156510562|NCT01840410|564961647|FG001|Overall Study|Withdrawal by Subject|1|||
156400910|NCT00542880|564559713|FG001|Period 2|Discontinuation criteria|0|||
156400911|NCT00542880|564559712|FG000|Period 2|Severe non-compliance|0|||
156510563|NCT01840410|564961646|FG000|Overall Study|Adverse Event|1|||
156510564|NCT01840410|564961647|FG001|Overall Study|Adverse Event|1|||
156510565|NCT00839956|564961648|FG000|Overall Study|Adverse Event|2|||
156510566|NCT00839956|564961648|FG000|Overall Study|Lack of Efficacy|6|||
156510567|NCT00839956|564961648|FG000|Overall Study|Physician Decision|1|||
156551393|NCT00699348|565110343|FG000|Overall Study|Lack of Efficacy|8|||
156551394|NCT00699348|565110343|FG000|Overall Study|Failure to return|1|||
156551395|NCT00699348|565110343|FG000|Overall Study|Blood transfusion|24|||
156551396|NCT00699348|565110343|FG000|Overall Study|Renal transplantation|10|||
156551397|NCT00699348|565110343|FG000|Overall Study|Other|5|||
156551398|NCT00122135|565110344|FG000|Overall Study|Withdrawal by Subject|3|||
156551399|NCT00122135|565110345|FG001|Overall Study|Withdrawal by Subject|0|||
156551400|NCT04478708|565110348|FG000|Overall Study|Lost to Follow-up|0|||
156551401|NCT04478708|565110349|FG001|Overall Study|Lost to Follow-up|0|||
156551402|NCT04478708|565110350|FG002|Overall Study|Lost to Follow-up|0|||
156551403|NCT04478708|565110351|FG003|Overall Study|Lost to Follow-up|0|||
156551404|NCT04478708|565110352|FG004|Overall Study|Lost to Follow-up|0|||
156551405|NCT04478708|565110353|FG005|Overall Study|Lost to Follow-up|0|||
156551406|NCT04478708|565110354|FG006|Overall Study|Lost to Follow-up|0|||
156551407|NCT04478708|565110355|FG007|Overall Study|Lost to Follow-up|0|||
156551408|NCT04478708|565110356|FG008|Overall Study|Lost to Follow-up|1|||
156551409|NCT04478708|565110357|FG009|Overall Study|Lost to Follow-up|1|||
156551410|NCT04478708|565110358|FG010|Overall Study|Lost to Follow-up|1|||
156551411|NCT04478708|565110359|FG011|Overall Study|Lost to Follow-up|2|||
156551412|NCT04478708|565110360|FG012|Overall Study|Lost to Follow-up|1|||
156551413|NCT04478708|565110361|FG013|Overall Study|Lost to Follow-up|0|||
156551414|NCT04478708|565110362|FG014|Overall Study|Lost to Follow-up|0|||
156551415|NCT04478708|565110363|FG015|Overall Study|Lost to Follow-up|0|||
156551416|NCT04478708|565110364|FG016|Overall Study|Lost to Follow-up|0|||
156551417|NCT04478708|565110348|FG000|Overall Study|Withdrawal of consent from study|0|||
156551418|NCT04478708|565110349|FG001|Overall Study|Withdrawal of consent from study|1|||
156551419|NCT04478708|565110350|FG002|Overall Study|Withdrawal of consent from study|2|||
156551420|NCT04478708|565110351|FG003|Overall Study|Withdrawal of consent from study|0|||
156551421|NCT04478708|565110352|FG004|Overall Study|Withdrawal of consent from study|1|||
156551422|NCT04478708|565110353|FG005|Overall Study|Withdrawal of consent from study|1|||
156551423|NCT04478708|565110354|FG006|Overall Study|Withdrawal of consent from study|1|||
156551424|NCT04478708|565110355|FG007|Overall Study|Withdrawal of consent from study|0|||
156551425|NCT04478708|565110356|FG008|Overall Study|Withdrawal of consent from study|0|||
156551426|NCT04478708|565110357|FG009|Overall Study|Withdrawal of consent from study|0|||
156551427|NCT04478708|565110358|FG010|Overall Study|Withdrawal of consent from study|4|||
156551428|NCT04478708|565110359|FG011|Overall Study|Withdrawal of consent from study|3|||
156551429|NCT04478708|565110360|FG012|Overall Study|Withdrawal of consent from study|0|||
156551430|NCT04478708|565110361|FG013|Overall Study|Withdrawal of consent from study|0|||
156551431|NCT04478708|565110362|FG014|Overall Study|Withdrawal of consent from study|1|||
156551432|NCT04478708|565110363|FG015|Overall Study|Withdrawal of consent from study|0|||
156551433|NCT04478708|565110364|FG016|Overall Study|Withdrawal of consent from study|4|||
156551434|NCT01869114|565110367|FG000|Overall Study|Death|19|||
156551435|NCT01869114|565110368|FG001|Overall Study|Death|18|||
156551436|NCT01869114|565110369|FG002|Overall Study|Death|8|||
156551437|NCT01869114|565110367|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
156551438|NCT01869114|565110368|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
156551439|NCT01869114|565110369|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
156551440|NCT01869114|565110367|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
156551441|NCT01869114|565110368|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
156551442|NCT01869114|565110369|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
156551443|NCT01869114|565110367|FG000|Overall Study|Withdrawal by Subject|0|||
156551444|NCT01869114|565110368|FG001|Overall Study|Withdrawal by Subject|3|||
156551445|NCT01869114|565110369|FG002|Overall Study|Withdrawal by Subject|0|||
156551446|NCT01869114|565110367|FG000|Overall Study|Disease Progression|0|||
156551447|NCT01869114|565110368|FG001|Overall Study|Disease Progression|1|||
156551448|NCT01869114|565110369|FG002|Overall Study|Disease Progression|0|||
156551449|NCT00559507|565110373|FG000|Overall Study|Not treated, patient ineligible|3|||
156551450|NCT04232696|565110375|FG000|Overall Study|Implant attempted but not completed|5|||
156551451|NCT04232696|565110376|FG001|Overall Study|Implant attempted but not completed|2|||
156551452|NCT04232696|565110375|FG000|Overall Study|Not satisfied with therapy outcome|0|||
156551453|NCT04232696|565110376|FG001|Overall Study|Not satisfied with therapy outcome|8|||
156551454|NCT04232696|565110375|FG000|Overall Study|Adverse Event|0|||
156551455|NCT04232696|565110376|FG001|Overall Study|Adverse Event|3|||
156551456|NCT04232696|565110375|FG000|Overall Study|Withdrawal by Subject|0|||
156551457|NCT04232696|565110376|FG001|Overall Study|Withdrawal by Subject|3|||
156551458|NCT04232696|565110375|FG000|Overall Study|Missed Visit|0|||
156551459|NCT04232696|565110376|FG001|Overall Study|Missed Visit|2|||
156551460|NCT04232696|565110375|FG000|Overall Study|Other reason|0|||
156551461|NCT04232696|565110376|FG001|Overall Study|Other reason|1|||
156551462|NCT03118297|565110377|FG000|Overall Study|Lost to Follow-up|0|||
156551463|NCT03118297|565110378|FG001|Overall Study|Lost to Follow-up|2|||
156551464|NCT01441063|565110380|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
156551465|NCT01441063|565110380|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
156551466|NCT00493038|565110381|FG000|Treatment|Adverse Event|8|||
156551467|NCT00493038|565110382|FG001|Treatment|Adverse Event|4|||
156510568|NCT00839956|564961648|FG000|Overall Study|Withdrawal by Subject|3|||
156510569|NCT00594880|564961649|FG000|Overall Study|Withdrawal by Subject|1|||
156510570|NCT00594880|564961650|FG001|Overall Study|Withdrawal by Subject|1|||
156510571|NCT00594880|564961649|FG000|Overall Study|Lost to Follow-up|1|||
156510572|NCT00594880|564961650|FG001|Overall Study|Lost to Follow-up|0|||
156510573|NCT02206061|564961651|FG000|Overall Study|Withdrawal by Subject|4|||
156510574|NCT02206061|564961652|FG001|Overall Study|Withdrawal by Subject|7|||
156510575|NCT02206061|564961653|FG002|Overall Study|Withdrawal by Subject|1|||
156510576|NCT02206061|564961651|FG000|Overall Study|Lost to Follow-up|14|||
156510577|NCT02206061|564961652|FG001|Overall Study|Lost to Follow-up|7|||
156510578|NCT02206061|564961653|FG002|Overall Study|Lost to Follow-up|20|||
156510579|NCT00694109|564961654|FG000|Overall Study|Physician Decision|3|||
156510580|NCT00694109|564961654|FG000|Overall Study|Adverse Event|74|||
156510581|NCT00694109|564961654|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
156510582|NCT00694109|564961654|FG000|Overall Study|Lack of Efficacy|2|||
156510583|NCT00694109|564961654|FG000|Overall Study|Withdrawal by Subject|13|||
156510584|NCT00694109|564961654|FG000|Overall Study|Pregnancy|1|||
156510585|NCT00694109|564961654|FG000|Overall Study|Enrolled but not treated|1|||
156510586|NCT00694109|564961654|FG000|Overall Study|Other|2|||
156510587|NCT00694109|564961654|FG000|Overall Study|Consented but no additional treatment|3|||
156510588|NCT00846807|564961655|FG000|Overall Study|Adverse Event|270|||
156510589|NCT00846807|564961655|FG000|Overall Study|Lost to Follow-up|94|||
156510590|NCT00846807|564961655|FG000|Overall Study|Withdrawal by Subject|56|||
156510591|NCT00846807|564961655|FG000|Overall Study|Non compliant with European label|7|||
156510592|NCT00846807|564961655|FG000|Overall Study|Switch to other anticoagulants|89|||
156510593|NCT00846807|564961655|FG000|Overall Study|No prescription after hospital discharge|56|||
156510594|NCT00846807|564961655|FG000|Overall Study|Other|60|||
156510595|NCT00245960|564961656|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
156510596|NCT00245960|564961657|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
156510597|NCT00245960|564961656|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
156510598|NCT00245960|564961657|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
156510599|NCT00245960|564961656|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
156510600|NCT00245960|564961657|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
156510601|NCT00245960|564961656|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
156510602|NCT00245960|564961657|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
156510603|NCT00245960|564961656|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
156510604|NCT00245960|564961657|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
156510605|NCT00245960|564961656|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
156510606|NCT00245960|564961657|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
156510607|NCT00245960|564961656|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
156510608|NCT00245960|564961657|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
156510609|NCT00245960|564961656|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
156510610|NCT00245960|564961657|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
156510611|NCT00245960|564961656|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
156510612|NCT00245960|564961657|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
156510613|NCT00245960|564961656|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
156510614|NCT00245960|564961657|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
156510615|NCT00245960|564961656|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
156510616|NCT00245960|564961657|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
156510617|NCT00245960|564961656|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
156510618|NCT00245960|564961657|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
156510619|NCT00316017|564961662|FG000|Overall Study|Protocol Violation|11|||
156510620|NCT00316017|564961663|FG001|Overall Study|Protocol Violation|13|||
156510621|NCT00316017|564961664|FG002|Overall Study|Protocol Violation|19|||
156510622|NCT04157400|564961665|FG000|Overall Study|Withdrawal by Subject|1|||
156510623|NCT04157400|564961665|FG000|Overall Study|Lost to Follow-up|3|||
156510624|NCT04201262|564961667|FG000|Primary Treatment Period|Adverse Event|1|||
156510625|NCT04201262|564961668|FG001|Primary Treatment Period|Adverse Event|2|||
156510626|NCT04201262|564961667|FG000|Primary Treatment Period|Physician Decision|1|||
156510627|NCT04201262|564961668|FG001|Primary Treatment Period|Physician Decision|1|||
156510628|NCT04201262|564961667|FG000|Long-term Extension Period|Death|1|||
156510629|NCT04201262|564961668|FG001|Long-term Extension Period|Death|0|||
156510630|NCT03682185|564961672|FG000|Overall Study|Lost to Follow-up|4|||
156510631|NCT03682185|564961673|FG001|Overall Study|Lost to Follow-up|7|||
156510632|NCT03682185|564961674|FG002|Overall Study|Lost to Follow-up|4|||
156510633|NCT03682185|564961675|FG003|Overall Study|Lost to Follow-up|7|||
156510634|NCT03682185|564961676|FG004|Overall Study|Lost to Follow-up|1|||
156510635|NCT03682185|564961672|FG000|Overall Study|Withdrawal by Subject|7|||
156510636|NCT03682185|564961673|FG001|Overall Study|Withdrawal by Subject|3|||
156510637|NCT03682185|564961674|FG002|Overall Study|Withdrawal by Subject|7|||
156510638|NCT03682185|564961675|FG003|Overall Study|Withdrawal by Subject|3|||
156510639|NCT03682185|564961676|FG004|Overall Study|Withdrawal by Subject|0|||
156510640|NCT05718466|564962478|FG000|Overall Study|Withdrawal by Subject|1|||
156551468|NCT00493038|565110381|FG000|Treatment|Lost to Follow-up|5|||
156551469|NCT00493038|565110382|FG001|Treatment|Lost to Follow-up|3|||
156551470|NCT00493038|565110381|FG000|Treatment|Withdrawal by Subject|11|||
156551471|NCT00493038|565110382|FG001|Treatment|Withdrawal by Subject|12|||
156551472|NCT00493038|565110381|FG000|Treatment|Other|0|||
156551473|NCT00493038|565110382|FG001|Treatment|Other|1|||
156551474|NCT00493038|565110381|FG000|Follow-up|Lost to Follow-up|1|||
156551475|NCT00493038|565110382|FG001|Follow-up|Lost to Follow-up|0|||
156551476|NCT03345472|565110387|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
156551477|NCT03345472|565110387|FG000|Implant to 3 Months|Physician Decision|1|||
156551478|NCT03345472|565110387|FG000|Implant to 3 Months|Adverse Event|1|||
156551479|NCT03345472|565110387|FG000|3 Months to 12 Months|Physician Decision|3|||
156551480|NCT03345472|565110387|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
156551481|NCT03345472|565110387|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
156551482|NCT03345472|565110387|FG000|3 Months to 12 Months|Adverse Event|1|||
156551483|NCT03345472|565110387|FG000|3 Months to 12 Months|Death|1|||
156551484|NCT01926782|565110388|FG000|Overall Study|Participant moved|2|||
156551485|NCT01926782|565110389|FG001|Overall Study|Participant moved|0|||
156551486|NCT01926782|565110390|FG002|Overall Study|Participant moved|1|||
156551487|NCT01926782|565110391|FG003|Overall Study|Participant moved|1|||
156551488|NCT01926782|565110392|FG004|Overall Study|Participant moved|0|||
156551489|NCT01926782|565110393|FG005|Overall Study|Participant moved|3|||
156551490|NCT01926782|565110388|FG000|Overall Study|Physician Decision|0|||
156551491|NCT01926782|565110389|FG001|Overall Study|Physician Decision|2|||
156551492|NCT01926782|565110390|FG002|Overall Study|Physician Decision|1|||
156551493|NCT01926782|565110391|FG003|Overall Study|Physician Decision|1|||
156551494|NCT01926782|565110392|FG004|Overall Study|Physician Decision|0|||
156551495|NCT01926782|565110393|FG005|Overall Study|Physician Decision|0|||
156551496|NCT01926782|565110388|FG000|Overall Study|Other than specified|2|||
156551497|NCT01926782|565110389|FG001|Overall Study|Other than specified|3|||
156551498|NCT01926782|565110390|FG002|Overall Study|Other than specified|5|||
156551499|NCT01926782|565110391|FG003|Overall Study|Other than specified|12|||
156551500|NCT01926782|565110392|FG004|Overall Study|Other than specified|4|||
156551501|NCT01926782|565110393|FG005|Overall Study|Other than specified|11|||
156551502|NCT01926782|565110388|FG000|Overall Study|Adverse Event|13|||
156551503|NCT01926782|565110389|FG001|Overall Study|Adverse Event|4|||
156551504|NCT01926782|565110390|FG002|Overall Study|Adverse Event|17|||
156551505|NCT01926782|565110391|FG003|Overall Study|Adverse Event|4|||
156551506|NCT01926782|565110392|FG004|Overall Study|Adverse Event|3|||
156551507|NCT01926782|565110393|FG005|Overall Study|Adverse Event|14|||
156551508|NCT01926782|565110388|FG000|Overall Study|Poor compliance to protocol|5|||
156551509|NCT01926782|565110389|FG001|Overall Study|Poor compliance to protocol|3|||
156551510|NCT01926782|565110390|FG002|Overall Study|Poor compliance to protocol|8|||
156551511|NCT01926782|565110391|FG003|Overall Study|Poor compliance to protocol|0|||
156551512|NCT01926782|565110392|FG004|Overall Study|Poor compliance to protocol|1|||
156551513|NCT01926782|565110393|FG005|Overall Study|Poor compliance to protocol|6|||
156551514|NCT01926782|565110388|FG000|Overall Study|Randomized and not treated|0|||
156551515|NCT01926782|565110389|FG001|Overall Study|Randomized and not treated|0|||
156551516|NCT01926782|565110390|FG002|Overall Study|Randomized and not treated|0|||
156551517|NCT01926782|565110391|FG003|Overall Study|Randomized and not treated|1|||
156551518|NCT01926782|565110392|FG004|Overall Study|Randomized and not treated|0|||
156551519|NCT01926782|565110393|FG005|Overall Study|Randomized and not treated|0|||
156551520|NCT01926782|565110388|FG000|Overall Study|Withdrawal by Subject|6|||
156551521|NCT01926782|565110389|FG001|Overall Study|Withdrawal by Subject|1|||
156551522|NCT01926782|565110390|FG002|Overall Study|Withdrawal by Subject|8|||
156551523|NCT01926782|565110391|FG003|Overall Study|Withdrawal by Subject|1|||
156551524|NCT01926782|565110392|FG004|Overall Study|Withdrawal by Subject|0|||
156551525|NCT01926782|565110393|FG005|Overall Study|Withdrawal by Subject|5|||
156551526|NCT01926782|565110388|FG000|Overall Study|Related to study drug administration|0|||
156551527|NCT01926782|565110389|FG001|Overall Study|Related to study drug administration|0|||
156551528|NCT01926782|565110390|FG002|Overall Study|Related to study drug administration|0|||
156551529|NCT01926782|565110391|FG003|Overall Study|Related to study drug administration|0|||
156551530|NCT01926782|565110392|FG004|Overall Study|Related to study drug administration|0|||
156551531|NCT01926782|565110393|FG005|Overall Study|Related to study drug administration|2|||
156551532|NCT00075504|565110400|FG000|Overall Study|Withdrawal by Subject|9|||
156551533|NCT00075504|565110401|FG001|Overall Study|Withdrawal by Subject|7|||
156551534|NCT01290692|565110402|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
156551535|NCT03099707|565110410|FG000|Overall Study|Withdrawal by Subject|0|||
156551536|NCT03099707|565110411|FG001|Overall Study|Withdrawal by Subject|3|||
156551537|NCT03099707|565110410|FG000|Overall Study|Lost to Follow-up|0|||
156551538|NCT03099707|565110411|FG001|Overall Study|Lost to Follow-up|1|||
156551539|NCT03167073|565110412|FG000|Overall Study|Stillbirth|1|||
156551540|NCT03167073|565110413|FG001|Overall Study|Stillbirth|0|||
156551541|NCT00689871|565110421|FG000|Overall Study|Lost to Follow-up|123|||
156551542|NCT00689871|565110422|FG001|Overall Study|Lost to Follow-up|13|||
156551543|NCT00689871|565110423|FG002|Overall Study|Lost to Follow-up|37|||
156551544|NCT00689871|565110424|FG003|Overall Study|Lost to Follow-up|1|||
156551545|NCT00689871|565110421|FG000|Overall Study|Explanted of All Study Devices|36|||
156551546|NCT00689871|565110422|FG001|Overall Study|Explanted of All Study Devices|25|||
156551547|NCT00689871|565110423|FG002|Overall Study|Explanted of All Study Devices|29|||
156551548|NCT00689871|565110424|FG003|Overall Study|Explanted of All Study Devices|3|||
156551549|NCT00689871|565110421|FG000|Overall Study|Withdrawal by Subject|13|||
156551550|NCT00689871|565110422|FG001|Overall Study|Withdrawal by Subject|3|||
156551551|NCT00689871|565110423|FG002|Overall Study|Withdrawal by Subject|4|||
156551552|NCT00689871|565110424|FG003|Overall Study|Withdrawal by Subject|1|||
156551553|NCT00689871|565110421|FG000|Overall Study|Death|1|||
156551554|NCT00689871|565110422|FG001|Overall Study|Death|10|||
156551555|NCT00689871|565110423|FG002|Overall Study|Death|2|||
156551556|NCT00689871|565110424|FG003|Overall Study|Death|2|||
156551557|NCT00689871|565110421|FG000|Overall Study|Physician Decision|2|||
156551558|NCT00689871|565110422|FG001|Overall Study|Physician Decision|1|||
156551559|NCT00689871|565110423|FG002|Overall Study|Physician Decision|1|||
156551560|NCT00689871|565110424|FG003|Overall Study|Physician Decision|0|||
156551561|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
156551562|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
156551563|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
156551564|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
156551565|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
156551566|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
156551567|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
156551568|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
156551569|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
156551570|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
156551571|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
156551572|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
156551573|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
156400912|NCT00542880|564559713|FG001|Period 2|Severe non-compliance|1|||
156551574|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
156551575|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
156551576|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
156551577|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
156400913|NCT00542880|564559712|FG000|Period 2|Other|0|||
156400914|NCT00542880|564559713|FG001|Period 2|Other|1|||
156400915|NCT00542880|564559712|FG000|Period 3|Adverse Event|0|||
156400916|NCT00542880|564559713|FG001|Period 3|Adverse Event|2|||
156400917|NCT02027402|564559714|FG000|Overall Study|Withdrawal by Subject|4|||
156400918|NCT02027402|564559715|FG001|Overall Study|Withdrawal by Subject|1|||
156400919|NCT03904043|564559720|FG000|Overall Study|Adverse Event|1|||
156400920|NCT03904043|564559721|FG001|Overall Study|Adverse Event|1|||
156400921|NCT03904043|564559720|FG000|Overall Study|Withdrawal by Subject|1|||
156400922|NCT03904043|564559721|FG001|Overall Study|Withdrawal by Subject|0|||
156400923|NCT03904043|564559720|FG000|Overall Study|Non-compliance|1|||
156400924|NCT03904043|564559721|FG001|Overall Study|Non-compliance|0|||
156400925|NCT03904043|564559720|FG000|Overall Study|Did not start treatment|1|||
156400926|NCT03904043|564559721|FG001|Overall Study|Did not start treatment|0|||
156400927|NCT01995539|564561088|FG000|Overall Study|Screening Failure|1|||
156400928|NCT01995539|564561088|FG000|Overall Study|Withdrawal by Investigator|15|||
156400929|NCT01995539|564561088|FG000|Overall Study|Withdrawal by Subject|11|||
156400930|NCT01995539|564561088|FG000|Overall Study|Lost to Follow-up|5|||
156400931|NCT01995539|564561088|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
156400932|NCT04382924|564561089|FG000|Overall Study|Death|2|||
156400933|NCT04382924|564561090|FG001|Overall Study|Death|5|||
156400934|NCT04382924|564561091|FG002|Overall Study|Death|4|||
156400935|NCT04382924|564561089|FG000|Overall Study|Protocol Violation|0|||
156400936|NCT04382924|564561090|FG001|Overall Study|Protocol Violation|1|||
156400937|NCT04382924|564561091|FG002|Overall Study|Protocol Violation|1|||
156400938|NCT04382924|564561089|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
156400939|NCT04382924|564561090|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
156400940|NCT04382924|564561091|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
156400941|NCT04382924|564561089|FG000|Overall Study|Withdrawal by Subject|6|||
156400942|NCT04382924|564561090|FG001|Overall Study|Withdrawal by Subject|3|||
156400943|NCT04382924|564561091|FG002|Overall Study|Withdrawal by Subject|6|||
156400944|NCT00261495|564561096|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
156400945|NCT00261495|564561097|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
156400946|NCT00261495|564561096|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
156400947|NCT00261495|564561097|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
156400948|NCT00261495|564561096|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
156400949|NCT00261495|564561097|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
156400950|NCT00261495|564561096|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
156400951|NCT00261495|564561097|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
156551578|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
156551579|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
156551580|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
156551581|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
156551582|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
156551583|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
156551584|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
156551585|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
156551586|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
156551587|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
156551588|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
156551589|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
156551590|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
156551591|NCT00784654|565110425|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
156551592|NCT00784654|565110426|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
156551593|NCT00784654|565110427|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
156551594|NCT00784654|565110425|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
156551595|NCT00784654|565110426|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
156551596|NCT00784654|565110427|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
156551597|NCT00784654|565110425|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
156551598|NCT00784654|565110426|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
156551599|NCT00784654|565110427|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
156551600|NCT00784654|565110425|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156551601|NCT00784654|565110426|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
156551602|NCT00784654|565110427|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
156551603|NCT00784654|565110425|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
156551604|NCT00784654|565110426|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
156551605|NCT00784654|565110427|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
156551606|NCT00784654|565110425|FG000|Randomized Withdrawal Period|Adverse Event|0|||
156551607|NCT00784654|565110426|FG001|Randomized Withdrawal Period|Adverse Event|1|||
156551608|NCT00784654|565110427|FG002|Randomized Withdrawal Period|Adverse Event|1|||
156551609|NCT00784654|565110425|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
156551610|NCT00784654|565110426|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
156551611|NCT00784654|565110427|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
156551612|NCT00784654|565110425|FG000|Randomized Withdrawal Period|Family reasons|0|||
156551613|NCT00784654|565110426|FG001|Randomized Withdrawal Period|Family reasons|0|||
156551614|NCT00784654|565110427|FG002|Randomized Withdrawal Period|Family reasons|1|||
156551615|NCT00562354|565110428|FG000|Overall Study|Physician Decision|0|||
156510641|NCT05718466|564962479|FG001|Overall Study|Withdrawal by Subject|2|||
156510642|NCT05718466|564962478|FG000|Overall Study|Death|0|||
156510643|NCT05718466|564962479|FG001|Overall Study|Death|1|||
156510644|NCT02389452|564962485|FG000|Overall Study|Lost to Follow-up|13|||
156510645|NCT02389452|564962485|FG000|Overall Study|Adverse Event|1|||
156510646|NCT02389452|564962485|FG000|Overall Study|Withdrawal by Subject|5|||
156510647|NCT02389452|564962485|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
156510648|NCT01014208|564962491|FG000|Overall Study|Lost to Follow-up|2|||
156510649|NCT01014208|564962492|FG001|Overall Study|Lost to Follow-up|5|||
156510650|NCT01014208|564962491|FG000|Overall Study|Participant Withdrew Consent|12|||
156510651|NCT01014208|564962492|FG001|Overall Study|Participant Withdrew Consent|12|||
156510652|NCT01014208|564962491|FG000|Overall Study|Did Not Receive Study Drug|2|||
156510653|NCT01014208|564962492|FG001|Overall Study|Did Not Receive Study Drug|0|||
156510654|NCT01014208|564962491|FG000|Overall Study|Study Closed/terminated|78|||
156510655|NCT01014208|564962492|FG001|Overall Study|Study Closed/terminated|83|||
156510656|NCT00414908|564962493|FG000|Overall Study|Protocol Violation|1|||
156510657|NCT00414908|564962494|FG001|Overall Study|Protocol Violation|1|||
156510658|NCT01076153|564962495|FG000|Overall Study|Symptoms improved/resolved|10|||
156510659|NCT01076153|564962495|FG000|Overall Study|Adverse Event|1|||
156510660|NCT00567567|564962504|FG000|Overall Study|Adverse Event|0|||
156510661|NCT00567567|564962505|FG001|Overall Study|Adverse Event|2|||
156510662|NCT00567567|564962506|FG002|Overall Study|Adverse Event|5|||
156551616|NCT00562354|565110429|FG001|Overall Study|Physician Decision|1|||
156551617|NCT00562354|565110428|FG000|Overall Study|Lost to Follow-up|0|||
156510663|NCT00567567|564962504|FG000|Overall Study|Death|8|||
156510664|NCT00567567|564962505|FG001|Overall Study|Death|1|||
156510665|NCT00567567|564962506|FG002|Overall Study|Death|5|||
156510666|NCT00567567|564962504|FG000|Overall Study|Lack of Efficacy|16|||
156510667|NCT00567567|564962505|FG001|Overall Study|Lack of Efficacy|17|||
156510668|NCT00567567|564962506|FG002|Overall Study|Lack of Efficacy|48|||
156510669|NCT00567567|564962504|FG000|Overall Study|Lost to Follow-up|0|||
156510670|NCT00567567|564962505|FG001|Overall Study|Lost to Follow-up|0|||
156400952|NCT00261495|564561096|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
156400953|NCT00261495|564561097|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
156400954|NCT00261495|564561096|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
156400955|NCT00261495|564561097|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
156400956|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
156510671|NCT00567567|564962506|FG002|Overall Study|Lost to Follow-up|1|||
156510672|NCT00567567|564962504|FG000|Overall Study|Physician Decision|16|||
156510673|NCT00567567|564962505|FG001|Overall Study|Physician Decision|18|||
156510674|NCT00567567|564962506|FG002|Overall Study|Physician Decision|84|||
156510675|NCT00567567|564962504|FG000|Overall Study|Withdrawal by Subject|0|||
156510676|NCT00567567|564962505|FG001|Overall Study|Withdrawal by Subject|0|||
156510677|NCT00567567|564962506|FG002|Overall Study|Withdrawal by Subject|2|||
156510678|NCT00567567|564962504|FG000|Overall Study|Ineligible|4|||
156510679|NCT00567567|564962505|FG001|Overall Study|Ineligible|0|||
156510680|NCT00567567|564962506|FG002|Overall Study|Ineligible|9|||
156510681|NCT00567567|564962504|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
156510682|NCT00567567|564962505|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
156510683|NCT00567567|564962506|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
156510684|NCT00567567|564962504|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
156510685|NCT00567567|564962505|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
156510686|NCT00567567|564962506|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
156510687|NCT00567567|564962504|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
156510688|NCT00567567|564962505|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
156510689|NCT00567567|564962506|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
156510690|NCT03433677|564962507|FG000|Period 1|Protocol Violation|1|||
156510691|NCT03433677|564962508|FG001|Period 1|Protocol Violation|0|||
156510692|NCT03433677|564962507|FG000|Period 2|Withdrawal by Subject|1|||
156510693|NCT03433677|564962508|FG001|Period 2|Withdrawal by Subject|1|||
156510694|NCT04608773|564962517|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
156510695|NCT04608773|564962518|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
156510696|NCT04608773|564962517|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
156510697|NCT04608773|564962518|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
156510698|NCT04608773|564962517|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
156510699|NCT04608773|564962518|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
156510700|NCT04608773|564962517|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
156510701|NCT04608773|564962518|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
156510702|NCT04608773|564962517|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
156510703|NCT04608773|564962518|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
156510704|NCT01077518|564962521|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
156510705|NCT01077518|564962522|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
156510706|NCT01077518|564962523|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
156510707|NCT01077518|564962521|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
156510708|NCT01077518|564962522|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
156510709|NCT01077518|564962523|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
156510710|NCT01077518|564962521|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
156510711|NCT01077518|564962522|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
156510712|NCT01077518|564962523|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
156510713|NCT01077518|564962521|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
156510714|NCT01077518|564962522|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
156510715|NCT01077518|564962523|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
156510716|NCT01077518|564962521|FG000|Optional Ofa Phase|Physician Decision|0|||
156510717|NCT01077518|564962522|FG001|Optional Ofa Phase|Physician Decision|0|||
156510718|NCT01077518|564962523|FG002|Optional Ofa Phase|Physician Decision|1|||
156510719|NCT01077518|564962521|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
156510720|NCT01077518|564962522|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
156510721|NCT01077518|564962523|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
156510722|NCT01077518|564962521|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
156510723|NCT01077518|564962522|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
156510724|NCT01077518|564962523|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
156510725|NCT00972322|564962524|FG000|Overall Study|Adverse Event|2|||
156510726|NCT00972322|564962525|FG001|Overall Study|Adverse Event|1|||
156510727|NCT00972322|564962524|FG000|Overall Study|Positive drug screen|0|||
156510728|NCT00972322|564962525|FG001|Overall Study|Positive drug screen|1|||
156510729|NCT00972322|564962524|FG000|Overall Study|Lost to Follow-up|0|||
156510730|NCT00972322|564962525|FG001|Overall Study|Lost to Follow-up|1|||
156510731|NCT00972322|564962524|FG000|Overall Study|Consistently high glucose values|1|||
156510732|NCT00972322|564962525|FG001|Overall Study|Consistently high glucose values|0|||
156510733|NCT00623805|564962528|FG000|Overall Study|Adverse Event|9|||
156510734|NCT00623805|564962529|FG001|Overall Study|Adverse Event|6|||
156510735|NCT00623805|564962528|FG000|Overall Study|Death|2|||
156551618|NCT00562354|565110429|FG001|Overall Study|Lost to Follow-up|1|||
156551619|NCT00844753|565110430|FG000|Overall Study|Lack of Efficacy|1|||
156551620|NCT00844753|565110431|FG001|Overall Study|Lack of Efficacy|0|||
156551621|NCT00844753|565110432|FG002|Overall Study|Lack of Efficacy|2|||
156551622|NCT00844753|565110433|FG003|Overall Study|Lack of Efficacy|2|||
156551623|NCT00844753|565110430|FG000|Overall Study|Adverse Event|3|||
156551624|NCT00844753|565110431|FG001|Overall Study|Adverse Event|2|||
156551625|NCT00844753|565110432|FG002|Overall Study|Adverse Event|5|||
156551626|NCT00844753|565110433|FG003|Overall Study|Adverse Event|5|||
156551627|NCT00844753|565110430|FG000|Overall Study|Lost to Follow-up|1|||
156551628|NCT00844753|565110431|FG001|Overall Study|Lost to Follow-up|1|||
156551629|NCT00844753|565110432|FG002|Overall Study|Lost to Follow-up|0|||
156551630|NCT00844753|565110433|FG003|Overall Study|Lost to Follow-up|1|||
156551631|NCT00844753|565110430|FG000|Overall Study|could not swallow medication|2|||
156551632|NCT00844753|565110431|FG001|Overall Study|could not swallow medication|0|||
156551633|NCT00844753|565110432|FG002|Overall Study|could not swallow medication|0|||
156551634|NCT00844753|565110433|FG003|Overall Study|could not swallow medication|0|||
156551635|NCT00844753|565110430|FG000|Overall Study|Withdrawal by Subject|1|||
156551636|NCT00844753|565110431|FG001|Overall Study|Withdrawal by Subject|0|||
156551637|NCT00844753|565110432|FG002|Overall Study|Withdrawal by Subject|0|||
156551638|NCT00844753|565110433|FG003|Overall Study|Withdrawal by Subject|3|||
156551639|NCT05073458|565110442|FG000|24-week Double-blind Period|Adverse Event|1|||
156551640|NCT05073458|565110443|FG001|24-week Double-blind Period|Adverse Event|0|||
156551641|NCT05073458|565110442|FG000|24-week Double-blind Period|Physician Decision|1|||
156551642|NCT05073458|565110443|FG001|24-week Double-blind Period|Physician Decision|0|||
156551643|NCT05073458|565110442|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
156551644|NCT05073458|565110443|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
156551645|NCT05073458|565110442|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
156551646|NCT05073458|565110443|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
156551647|NCT05073458|565110442|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
156551648|NCT05073458|565110443|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
156551649|NCT05073458|565110442|FG000|24-week Open-label Period|Adverse Event|1|||
156551650|NCT05073458|565110443|FG001|24-week Open-label Period|Adverse Event|2|||
156551651|NCT01627899|565110446|FG000|Overall Study|Study terminated early by sponsor.|5|||
156551652|NCT01430455|565110452|FG000|Overall Study|Withdrawal by Subject|1|||
156551653|NCT01430455|565110452|FG000|Overall Study|Switched to follow-up phase|1|||
156551654|NCT00264238|565110455|FG000|Overall Study|Protocol Violation|1|||
156551655|NCT04818593|565110456|FG000|Overall Study|Low Oocyte Yield|8|||
156551656|NCT04818593|565110457|FG001|Overall Study|Low Oocyte Yield|8|||
156551657|NCT04818593|565110456|FG000|Overall Study|Not ICSI Insemination|7|||
156551658|NCT04818593|565110457|FG001|Overall Study|Not ICSI Insemination|7|||
156551659|NCT04818593|565110456|FG000|Overall Study|Poor Sperm Quality|2|||
156551660|NCT04818593|565110457|FG001|Overall Study|Poor Sperm Quality|2|||
156551661|NCT04818593|565110456|FG000|Overall Study|Withdrawal by Subject|2|||
156551662|NCT04818593|565110457|FG001|Overall Study|Withdrawal by Subject|2|||
156551663|NCT04818593|565110456|FG000|Overall Study|Conversion to IUI due to low response|1|||
156551664|NCT04818593|565110457|FG001|Overall Study|Conversion to IUI due to low response|1|||
156551665|NCT03809611|565110458|FG000|Overall Study|Withdrawal by Subject|1|||
156551666|NCT03809611|565110459|FG001|Overall Study|Withdrawal by Subject|1|||
156551667|NCT05061719|565110462|FG000|Overall Study|Adverse Event|60|||
156551668|NCT05061719|565110462|FG000|Overall Study|Death|1|||
156551669|NCT05061719|565110462|FG000|Overall Study|Lack of Efficacy|7|||
156551670|NCT05061719|565110462|FG000|Overall Study|Lost to Follow-up|5|||
156551671|NCT05061719|565110462|FG000|Overall Study|Pregnancy|1|||
156551672|NCT05061719|565110462|FG000|Overall Study|Protocol Violation|8|||
156551673|NCT05061719|565110462|FG000|Overall Study|Withdrawal by Subject|41|||
156551674|NCT05061719|565110462|FG000|Overall Study|Site Closure|2|||
156551675|NCT04179175|565111961|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
156551676|NCT04179175|565111962|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
156551677|NCT04179175|565111963|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
156551678|NCT04179175|565111964|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
156551679|NCT04179175|565111965|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
156551680|NCT04179175|565111966|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
156551681|NCT04179175|565111961|FG000|Overall Study|Adverse Event|5|||
156551682|NCT04179175|565111962|FG001|Overall Study|Adverse Event|3|||
156551683|NCT04179175|565111963|FG002|Overall Study|Adverse Event|3|||
156551684|NCT04179175|565111964|FG003|Overall Study|Adverse Event|4|||
156551685|NCT04179175|565111965|FG004|Overall Study|Adverse Event|6|||
156551686|NCT04179175|565111966|FG005|Overall Study|Adverse Event|6|||
156551687|NCT04179175|565111961|FG000|Overall Study|Lack of Efficacy|5|||
156551688|NCT04179175|565111962|FG001|Overall Study|Lack of Efficacy|1|||
156551689|NCT04179175|565111963|FG002|Overall Study|Lack of Efficacy|3|||
156551690|NCT04179175|565111964|FG003|Overall Study|Lack of Efficacy|2|||
156551691|NCT04179175|565111965|FG004|Overall Study|Lack of Efficacy|18|||
156551692|NCT04179175|565111966|FG005|Overall Study|Lack of Efficacy|7|||
156551693|NCT04179175|565111961|FG000|Overall Study|Lost to Follow-up|5|||
156551694|NCT04179175|565111962|FG001|Overall Study|Lost to Follow-up|3|||
156551695|NCT04179175|565111963|FG002|Overall Study|Lost to Follow-up|2|||
156551696|NCT04179175|565111964|FG003|Overall Study|Lost to Follow-up|2|||
156551697|NCT04179175|565111965|FG004|Overall Study|Lost to Follow-up|4|||
156551698|NCT04179175|565111966|FG005|Overall Study|Lost to Follow-up|5|||
156551699|NCT04179175|565111961|FG000|Overall Study|Physician Decision|2|||
156551700|NCT04179175|565111962|FG001|Overall Study|Physician Decision|0|||
156510736|NCT00623805|564962529|FG001|Overall Study|Death|0|||
156510737|NCT00623805|564962528|FG000|Overall Study|Lack of Efficacy|3|||
156510738|NCT00623805|564962529|FG001|Overall Study|Lack of Efficacy|7|||
156510739|NCT00623805|564962528|FG000|Overall Study|Lost to Follow-up|2|||
156510740|NCT00623805|564962529|FG001|Overall Study|Lost to Follow-up|2|||
156510741|NCT00623805|564962528|FG000|Overall Study|Protocol Violation|1|||
156510742|NCT00623805|564962529|FG001|Overall Study|Protocol Violation|1|||
156510743|NCT00623805|564962528|FG000|Overall Study|Reason not Specified|3|||
156510744|NCT00623805|564962529|FG001|Overall Study|Reason not Specified|6|||
156510745|NCT01803282|564962538|FG000|Overall Study|Progressive Disease|4|||
156510746|NCT01803282|564962539|FG001|Overall Study|Progressive Disease|3|||
156510747|NCT01803282|564962540|FG002|Overall Study|Progressive Disease|6|||
156510748|NCT01803282|564962541|FG003|Overall Study|Progressive Disease|22|||
156510749|NCT01803282|564962542|FG004|Overall Study|Progressive Disease|5|||
156510750|NCT01803282|564962543|FG005|Overall Study|Progressive Disease|8|||
156510751|NCT01803282|564962544|FG006|Overall Study|Progressive Disease|23|||
156510752|NCT01803282|564962545|FG007|Overall Study|Progressive Disease|24|||
156510753|NCT01803282|564962546|FG008|Overall Study|Progressive Disease|3|||
156510754|NCT01803282|564962547|FG009|Overall Study|Progressive Disease|29|||
156510755|NCT01803282|564962548|FG010|Overall Study|Progressive Disease|6|||
156510756|NCT01803282|564962549|FG011|Overall Study|Progressive Disease|11|||
156510757|NCT01803282|564962538|FG000|Overall Study|Death|0|||
156510758|NCT01803282|564962539|FG001|Overall Study|Death|0|||
156510759|NCT01803282|564962540|FG002|Overall Study|Death|0|||
156510760|NCT01803282|564962541|FG003|Overall Study|Death|0|||
156510761|NCT01803282|564962542|FG004|Overall Study|Death|2|||
156510762|NCT01803282|564962543|FG005|Overall Study|Death|1|||
156510763|NCT01803282|564962544|FG006|Overall Study|Death|1|||
156510764|NCT01803282|564962545|FG007|Overall Study|Death|5|||
156510765|NCT01803282|564962546|FG008|Overall Study|Death|1|||
156551701|NCT04179175|565111963|FG002|Overall Study|Physician Decision|2|||
156551702|NCT04179175|565111964|FG003|Overall Study|Physician Decision|3|||
156551703|NCT04179175|565111965|FG004|Overall Study|Physician Decision|1|||
156551704|NCT04179175|565111966|FG005|Overall Study|Physician Decision|1|||
156551705|NCT04179175|565111961|FG000|Overall Study|Pregnancy|3|||
156551706|NCT04179175|565111962|FG001|Overall Study|Pregnancy|0|||
156551707|NCT04179175|565111963|FG002|Overall Study|Pregnancy|3|||
156551708|NCT04179175|565111964|FG003|Overall Study|Pregnancy|0|||
156551709|NCT04179175|565111965|FG004|Overall Study|Pregnancy|1|||
156551710|NCT04179175|565111966|FG005|Overall Study|Pregnancy|2|||
156551711|NCT04179175|565111961|FG000|Overall Study|Withdrawal by Subject|22|||
156551712|NCT04179175|565111962|FG001|Overall Study|Withdrawal by Subject|10|||
156551713|NCT04179175|565111963|FG002|Overall Study|Withdrawal by Subject|12|||
156551714|NCT04179175|565111964|FG003|Overall Study|Withdrawal by Subject|8|||
156551715|NCT04179175|565111965|FG004|Overall Study|Withdrawal by Subject|23|||
156551716|NCT04179175|565111966|FG005|Overall Study|Withdrawal by Subject|31|||
156551717|NCT04179175|565111961|FG000|Overall Study|Technical problems|0|||
156551718|NCT04179175|565111962|FG001|Overall Study|Technical problems|0|||
156551719|NCT04179175|565111963|FG002|Overall Study|Technical problems|1|||
156551720|NCT04179175|565111964|FG003|Overall Study|Technical problems|1|||
156551721|NCT04179175|565111965|FG004|Overall Study|Technical problems|0|||
156551722|NCT04179175|565111966|FG005|Overall Study|Technical problems|0|||
156551723|NCT02754726|565111971|FG000|Overall Study|Progressive Disease by RECIST|13|||
156551724|NCT02754726|565111971|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
156551725|NCT02754726|565111971|FG000|Overall Study|Clinical Disease Progression|5|||
156551726|NCT02754726|565111971|FG000|Overall Study|Adverse Event|3|||
156551727|NCT02754726|565111971|FG000|Overall Study|Withdrawal by Subject|1|||
156551728|NCT02754726|565111971|FG000|Overall Study|Tolerability|1|||
156551729|NCT02792842|565111973|FG000|Overall Study|Adverse Event|4|||
156551730|NCT02792842|565111974|FG001|Overall Study|Adverse Event|2|||
156551731|NCT02792842|565111975|FG002|Overall Study|Adverse Event|3|||
156551732|NCT02792842|565111973|FG000|Overall Study|Withdrawal by Subject|0|||
156551733|NCT02792842|565111974|FG001|Overall Study|Withdrawal by Subject|1|||
156551734|NCT02792842|565111975|FG002|Overall Study|Withdrawal by Subject|2|||
156551735|NCT02792842|565111973|FG000|Overall Study|Lost to Follow-up|0|||
156551736|NCT02792842|565111974|FG001|Overall Study|Lost to Follow-up|0|||
156510766|NCT01803282|564962547|FG009|Overall Study|Death|1|||
156510767|NCT01803282|564962548|FG010|Overall Study|Death|0|||
156551737|NCT02792842|565111975|FG002|Overall Study|Lost to Follow-up|1|||
156510768|NCT01803282|564962549|FG011|Overall Study|Death|0|||
156510769|NCT01803282|564962538|FG000|Overall Study|Withdrew Consent|0|||
156510770|NCT01803282|564962539|FG001|Overall Study|Withdrew Consent|0|||
156510771|NCT01803282|564962540|FG002|Overall Study|Withdrew Consent|0|||
156510772|NCT01803282|564962541|FG003|Overall Study|Withdrew Consent|6|||
156510773|NCT01803282|564962542|FG004|Overall Study|Withdrew Consent|1|||
156510774|NCT01803282|564962543|FG005|Overall Study|Withdrew Consent|0|||
156510775|NCT01803282|564962544|FG006|Overall Study|Withdrew Consent|8|||
156510776|NCT01803282|564962545|FG007|Overall Study|Withdrew Consent|3|||
156510777|NCT01803282|564962546|FG008|Overall Study|Withdrew Consent|1|||
156510778|NCT01803282|564962547|FG009|Overall Study|Withdrew Consent|5|||
156510779|NCT01803282|564962548|FG010|Overall Study|Withdrew Consent|0|||
156510780|NCT01803282|564962549|FG011|Overall Study|Withdrew Consent|1|||
156510781|NCT01803282|564962538|FG000|Overall Study|Investigator's Discretion|0|||
156510782|NCT01803282|564962539|FG001|Overall Study|Investigator's Discretion|0|||
156510783|NCT01803282|564962540|FG002|Overall Study|Investigator's Discretion|0|||
156510784|NCT01803282|564962541|FG003|Overall Study|Investigator's Discretion|7|||
156510785|NCT01803282|564962542|FG004|Overall Study|Investigator's Discretion|2|||
156510786|NCT01803282|564962543|FG005|Overall Study|Investigator's Discretion|1|||
156510787|NCT01803282|564962544|FG006|Overall Study|Investigator's Discretion|7|||
156510788|NCT01803282|564962545|FG007|Overall Study|Investigator's Discretion|10|||
156510789|NCT01803282|564962546|FG008|Overall Study|Investigator's Discretion|6|||
156510790|NCT01803282|564962547|FG009|Overall Study|Investigator's Discretion|7|||
156510791|NCT01803282|564962548|FG010|Overall Study|Investigator's Discretion|1|||
156510792|NCT01803282|564962549|FG011|Overall Study|Investigator's Discretion|0|||
156510793|NCT01803282|564962538|FG000|Overall Study|Adverse Event|0|||
156510794|NCT01803282|564962539|FG001|Overall Study|Adverse Event|0|||
156510795|NCT01803282|564962540|FG002|Overall Study|Adverse Event|0|||
156510796|NCT01803282|564962541|FG003|Overall Study|Adverse Event|0|||
156510797|NCT01803282|564962542|FG004|Overall Study|Adverse Event|0|||
156510798|NCT01803282|564962543|FG005|Overall Study|Adverse Event|0|||
156510799|NCT01803282|564962544|FG006|Overall Study|Adverse Event|1|||
156510800|NCT01803282|564962545|FG007|Overall Study|Adverse Event|2|||
156510801|NCT01803282|564962546|FG008|Overall Study|Adverse Event|0|||
156510802|NCT01803282|564962547|FG009|Overall Study|Adverse Event|1|||
156510803|NCT01803282|564962548|FG010|Overall Study|Adverse Event|0|||
156510804|NCT01803282|564962549|FG011|Overall Study|Adverse Event|3|||
156510805|NCT01803282|564962538|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156510806|NCT01803282|564962539|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156510807|NCT01803282|564962540|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156510808|NCT01803282|564962541|FG003|Overall Study|Non-Compliance with Study Drug|1|||
156510809|NCT01803282|564962542|FG004|Overall Study|Non-Compliance with Study Drug|0|||
156510810|NCT01803282|564962543|FG005|Overall Study|Non-Compliance with Study Drug|0|||
156510811|NCT01803282|564962544|FG006|Overall Study|Non-Compliance with Study Drug|0|||
156510812|NCT01803282|564962545|FG007|Overall Study|Non-Compliance with Study Drug|0|||
156510813|NCT01803282|564962546|FG008|Overall Study|Non-Compliance with Study Drug|0|||
156510814|NCT01803282|564962547|FG009|Overall Study|Non-Compliance with Study Drug|0|||
156510815|NCT01803282|564962548|FG010|Overall Study|Non-Compliance with Study Drug|0|||
156510816|NCT01803282|564962549|FG011|Overall Study|Non-Compliance with Study Drug|0|||
156510817|NCT01803282|564962538|FG000|Overall Study|Unknown Reason|0|||
156510818|NCT01803282|564962539|FG001|Overall Study|Unknown Reason|0|||
156510819|NCT01803282|564962540|FG002|Overall Study|Unknown Reason|0|||
156510820|NCT01803282|564962541|FG003|Overall Study|Unknown Reason|0|||
156510821|NCT01803282|564962542|FG004|Overall Study|Unknown Reason|0|||
156510822|NCT01803282|564962543|FG005|Overall Study|Unknown Reason|0|||
156510823|NCT01803282|564962544|FG006|Overall Study|Unknown Reason|0|||
156510824|NCT01803282|564962545|FG007|Overall Study|Unknown Reason|1|||
156510825|NCT01803282|564962546|FG008|Overall Study|Unknown Reason|0|||
156510826|NCT01803282|564962547|FG009|Overall Study|Unknown Reason|0|||
156510827|NCT01803282|564962548|FG010|Overall Study|Unknown Reason|0|||
156510828|NCT01803282|564962549|FG011|Overall Study|Unknown Reason|0|||
156510829|NCT01803282|564962538|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
156510830|NCT01803282|564962539|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
156510831|NCT01803282|564962540|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
156510832|NCT01803282|564962541|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
156510833|NCT01803282|564962542|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
156510834|NCT01803282|564962543|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
156510835|NCT01803282|564962544|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
156510836|NCT01803282|564962545|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
156510837|NCT01803282|564962546|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
156510838|NCT01803282|564962547|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
156510839|NCT01803282|564962548|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
156510840|NCT01803282|564962549|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
156510841|NCT01803282|564962538|FG000|Overall Study|Enrolled but Never Treated|0|||
156510842|NCT01803282|564962539|FG001|Overall Study|Enrolled but Never Treated|0|||
156510843|NCT01803282|564962540|FG002|Overall Study|Enrolled but Never Treated|0|||
156510844|NCT01803282|564962541|FG003|Overall Study|Enrolled but Never Treated|0|||
156510845|NCT01803282|564962542|FG004|Overall Study|Enrolled but Never Treated|1|||
156510846|NCT01803282|564962543|FG005|Overall Study|Enrolled but Never Treated|0|||
156551738|NCT02792842|565111973|FG000|Overall Study|Schedule delay|0|||
156551739|NCT02792842|565111974|FG001|Overall Study|Schedule delay|1|||
156551740|NCT02792842|565111975|FG002|Overall Study|Schedule delay|1|||
156551741|NCT01046825|565111982|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
156551742|NCT01046825|565111983|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
156551743|NCT01046825|565111984|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
156551744|NCT01046825|565111985|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
156551745|NCT01046825|565111986|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
156551746|NCT01046825|565111982|FG000|Overall Study|Physician Decision|0|||
156551747|NCT01046825|565111983|FG001|Overall Study|Physician Decision|1|||
156551748|NCT01046825|565111984|FG002|Overall Study|Physician Decision|2|||
156551749|NCT01046825|565111985|FG003|Overall Study|Physician Decision|0|||
156551750|NCT01046825|565111986|FG004|Overall Study|Physician Decision|0|||
156551751|NCT01046825|565111982|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
156551752|NCT01046825|565111983|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
156551753|NCT01046825|565111984|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
156551754|NCT01046825|565111985|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
156551755|NCT01046825|565111986|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
156551756|NCT01046825|565111982|FG000|Overall Study|Found to be ineligible|0|||
156551757|NCT01046825|565111983|FG001|Overall Study|Found to be ineligible|1|||
156551758|NCT01046825|565111984|FG002|Overall Study|Found to be ineligible|0|||
156551759|NCT01046825|565111985|FG003|Overall Study|Found to be ineligible|0|||
156551760|NCT01046825|565111986|FG004|Overall Study|Found to be ineligible|0|||
156551761|NCT01046825|565111982|FG000|Overall Study|Death|0|||
156551762|NCT01046825|565111983|FG001|Overall Study|Death|0|||
156551763|NCT01046825|565111984|FG002|Overall Study|Death|0|||
156551764|NCT01046825|565111985|FG003|Overall Study|Death|1|||
156551765|NCT01046825|565111986|FG004|Overall Study|Death|0|||
156551766|NCT01046825|565111982|FG000|Overall Study|Did not submit biology samples|0|||
156551767|NCT01046825|565111983|FG001|Overall Study|Did not submit biology samples|0|||
156551768|NCT01046825|565111984|FG002|Overall Study|Did not submit biology samples|0|||
156551769|NCT01046825|565111985|FG003|Overall Study|Did not submit biology samples|0|||
156551770|NCT01046825|565111986|FG004|Overall Study|Did not submit biology samples|13|||
156551771|NCT05587296|565111988|FG000|Overall Study|Adverse Event|15|||
156551772|NCT05587296|565111989|FG001|Overall Study|Adverse Event|7|||
156551773|NCT05587296|565111988|FG000|Overall Study|Lack of Efficacy|2|||
156551774|NCT05587296|565111989|FG001|Overall Study|Lack of Efficacy|0|||
156551775|NCT05587296|565111988|FG000|Overall Study|Lost to Follow-up|1|||
156551776|NCT05587296|565111989|FG001|Overall Study|Lost to Follow-up|0|||
156551777|NCT05587296|565111988|FG000|Overall Study|Withdrawal by Subject|14|||
156551778|NCT05587296|565111989|FG001|Overall Study|Withdrawal by Subject|4|||
156551779|NCT05587296|565111988|FG000|Overall Study|miscellaneous|3|||
156551780|NCT05587296|565111989|FG001|Overall Study|miscellaneous|6|||
156551781|NCT05587296|565111988|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
156551782|NCT05587296|565111989|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
156551783|NCT02872311|565111992|FG000|Overall Study|Death|2|||
156551784|NCT02872311|565111993|FG001|Overall Study|Death|0|||
156551785|NCT02872311|565111994|FG002|Overall Study|Death|0|||
156551786|NCT02872311|565111995|FG003|Overall Study|Death|0|||
156551787|NCT02872311|565111996|FG004|Overall Study|Death|0|||
156551788|NCT02872311|565111992|FG000|Overall Study|Lost to Follow-up|2|||
156551789|NCT02872311|565111993|FG001|Overall Study|Lost to Follow-up|0|||
156551790|NCT02872311|565111994|FG002|Overall Study|Lost to Follow-up|0|||
156551791|NCT02872311|565111995|FG003|Overall Study|Lost to Follow-up|0|||
156551792|NCT02872311|565111996|FG004|Overall Study|Lost to Follow-up|0|||
156551793|NCT02872311|565111992|FG000|Overall Study|Protocol Violation|0|||
156551794|NCT02872311|565111993|FG001|Overall Study|Protocol Violation|2|||
156551795|NCT02872311|565111994|FG002|Overall Study|Protocol Violation|1|||
156551796|NCT02872311|565111995|FG003|Overall Study|Protocol Violation|0|||
156551797|NCT02872311|565111996|FG004|Overall Study|Protocol Violation|0|||
156551798|NCT05617911|565111997|FG000|Overall Study|Withdrawal by Subject|1|||
156551799|NCT05617911|565111998|FG001|Overall Study|Withdrawal by Subject|0|||
156551800|NCT03975647|565111999|FG000|Overall Study|Death|71|||
156551801|NCT03975647|565112000|FG001|Overall Study|Death|63|||
156551802|NCT03975647|565111999|FG000|Overall Study|Lost to Follow-up|2|||
156551803|NCT03975647|565112000|FG001|Overall Study|Lost to Follow-up|2|||
156551804|NCT03975647|565111999|FG000|Overall Study|Subject withdrawal of consent|7|||
156551805|NCT03975647|565112000|FG001|Overall Study|Subject withdrawal of consent|11|||
156551806|NCT04868903|565112001|FG000|Overall Study|Adverse Event|0|||
156551807|NCT04868903|565112002|FG001|Overall Study|Adverse Event|0|||
156551808|NCT04868903|565112003|FG002|Overall Study|Adverse Event|0|||
156551809|NCT04868903|565112004|FG003|Overall Study|Adverse Event|1|||
156551810|NCT04868903|565112001|FG000|Overall Study|Withdrawal by Subject|29|||
156551811|NCT04868903|565112002|FG001|Overall Study|Withdrawal by Subject|44|||
156551812|NCT04868903|565112003|FG002|Overall Study|Withdrawal by Subject|17|||
156551813|NCT04868903|565112004|FG003|Overall Study|Withdrawal by Subject|12|||
156510847|NCT01803282|564962544|FG006|Overall Study|Enrolled but Never Treated|1|||
156510848|NCT01803282|564962545|FG007|Overall Study|Enrolled but Never Treated|1|||
156510849|NCT01803282|564962546|FG008|Overall Study|Enrolled but Never Treated|0|||
156510850|NCT01803282|564962547|FG009|Overall Study|Enrolled but Never Treated|1|||
156510851|NCT01803282|564962548|FG010|Overall Study|Enrolled but Never Treated|0|||
156510852|NCT01803282|564962549|FG011|Overall Study|Enrolled but Never Treated|0|||
156510853|NCT02671500|564962551|FG000|Overall Study|Lack of Efficacy|12|||
156510854|NCT02671500|564962551|FG000|Overall Study|Lost to Follow-up|2|||
156510855|NCT05235269|564962553|FG000|Overall Study|Adverse Event|1|||
156510856|NCT05235269|564962553|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
156510857|NCT05235269|564962553|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
156510858|NCT03810235|564962556|FG000|Overall Study|Withdrawal by Subject|2|||
156510859|NCT03810235|564962557|FG001|Overall Study|Withdrawal by Subject|0|||
156510860|NCT03548220|564962558|FG000|Overall Study|Lost to Follow-up|1|||
156510861|NCT03548220|564962559|FG001|Overall Study|Lost to Follow-up|0|||
156510862|NCT03548220|564962560|FG002|Overall Study|Lost to Follow-up|0|||
156510863|NCT03548220|564962561|FG003|Overall Study|Lost to Follow-up|0|||
156510864|NCT01127893|564964092|FG000|Overall Study|Study Termination by the Sponsor|1|||
156510865|NCT02787044|564964093|FG000|Overall Study|Lost to Follow-up|15|||
156510866|NCT02787044|564964094|FG001|Overall Study|Lost to Follow-up|19|||
156510867|NCT03482466|564964096|FG000|Overall Study|Protocol Violation|2|||
156510868|NCT04552899|564964097|FG000|Overall Study|Adverse Event|4|||
156510869|NCT04552899|564964098|FG001|Overall Study|Adverse Event|3|||
156510870|NCT04552899|564964097|FG000|Overall Study|Death|4|||
156510871|NCT04552899|564964098|FG001|Overall Study|Death|4|||
156510872|NCT04552899|564964097|FG000|Overall Study|Lost to Follow-up|8|||
156510873|NCT04552899|564964098|FG001|Overall Study|Lost to Follow-up|13|||
156510874|NCT04552899|564964097|FG000|Overall Study|Lung Transplant|4|||
156510875|NCT04552899|564964098|FG001|Overall Study|Lung Transplant|3|||
156510876|NCT04552899|564964097|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
156510877|NCT04552899|564964098|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
156510878|NCT04552899|564964097|FG000|Overall Study|Physician Decision|3|||
156510879|NCT04552899|564964098|FG001|Overall Study|Physician Decision|4|||
156510880|NCT04552899|564964097|FG000|Overall Study|Study Terminated By Sponsor|237|||
156510881|NCT04552899|564964098|FG001|Overall Study|Study Terminated By Sponsor|239|||
156510882|NCT04552899|564964097|FG000|Overall Study|Withdrawal by Subject|15|||
156510883|NCT04552899|564964098|FG001|Overall Study|Withdrawal by Subject|17|||
156510884|NCT02383940|564964101|FG000|Overall Study|Adverse Event|1|||
156510885|NCT02383940|564964102|FG001|Overall Study|Adverse Event|0|||
156510886|NCT02383940|564964101|FG000|Overall Study|Lost to Follow-up|2|||
156510887|NCT02383940|564964102|FG001|Overall Study|Lost to Follow-up|2|||
156510888|NCT02383940|564964101|FG000|Overall Study|Physician Decision|2|||
156510889|NCT02383940|564964102|FG001|Overall Study|Physician Decision|0|||
156510890|NCT02383940|564964101|FG000|Overall Study|Withdrawal by Subject|1|||
156510891|NCT02383940|564964102|FG001|Overall Study|Withdrawal by Subject|1|||
156510892|NCT02383940|564964101|FG000|Overall Study|Randomized but not treated|2|||
156510893|NCT02383940|564964102|FG001|Overall Study|Randomized but not treated|0|||
156510894|NCT02383940|564964101|FG000|Overall Study|Other than specified above|1|||
156510895|NCT02383940|564964102|FG001|Overall Study|Other than specified above|0|||
156510896|NCT00565773|564964103|FG000|Overall Study|Withdrawal by Subject|1|||
156510897|NCT00565773|564964103|FG000|Overall Study|Physician Decision|1|||
156510898|NCT03853551|564964104|FG000|Overall Study|Death|2|||
156510899|NCT03853551|564964104|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
156510900|NCT01075958|564964105|FG000|Overall Study|Blood sample could not be obtained|44|||
156510901|NCT01240915|564964108|FG000|Overall Study|Adverse Event|0|||
156510902|NCT01240915|564964109|FG001|Overall Study|Adverse Event|0|||
156510903|NCT01240915|564964110|FG002|Overall Study|Adverse Event|0|||
156510904|NCT01240915|564964111|FG003|Overall Study|Adverse Event|1|||
156510905|NCT01240915|564964112|FG004|Overall Study|Adverse Event|0|||
156510906|NCT01240915|564964113|FG005|Overall Study|Adverse Event|2|||
156510907|NCT01240915|564964114|FG006|Overall Study|Adverse Event|0|||
156510908|NCT01240915|564964115|FG007|Overall Study|Adverse Event|0|||
156510909|NCT01240915|564964116|FG008|Overall Study|Adverse Event|1|||
156510910|NCT01240915|564964108|FG000|Overall Study|Lost to Follow-up|0|||
156510911|NCT01240915|564964109|FG001|Overall Study|Lost to Follow-up|0|||
156510912|NCT01240915|564964110|FG002|Overall Study|Lost to Follow-up|0|||
156510913|NCT01240915|564964111|FG003|Overall Study|Lost to Follow-up|0|||
156510914|NCT01240915|564964112|FG004|Overall Study|Lost to Follow-up|1|||
156510915|NCT01240915|564964113|FG005|Overall Study|Lost to Follow-up|1|||
156510916|NCT01240915|564964114|FG006|Overall Study|Lost to Follow-up|0|||
156510917|NCT01240915|564964115|FG007|Overall Study|Lost to Follow-up|1|||
156510918|NCT01240915|564964116|FG008|Overall Study|Lost to Follow-up|1|||
156510919|NCT01240915|564964108|FG000|Overall Study|Withdrawal by Subject|2|||
156510920|NCT01240915|564964109|FG001|Overall Study|Withdrawal by Subject|1|||
156510921|NCT01240915|564964110|FG002|Overall Study|Withdrawal by Subject|0|||
156510922|NCT01240915|564964111|FG003|Overall Study|Withdrawal by Subject|2|||
156510923|NCT01240915|564964112|FG004|Overall Study|Withdrawal by Subject|0|||
156400957|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
156400958|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
156400959|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
156400960|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
156400961|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
156400962|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
156400963|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
156510924|NCT01240915|564964113|FG005|Overall Study|Withdrawal by Subject|4|||
156510925|NCT01240915|564964114|FG006|Overall Study|Withdrawal by Subject|2|||
156510926|NCT01240915|564964115|FG007|Overall Study|Withdrawal by Subject|3|||
156510927|NCT01240915|564964116|FG008|Overall Study|Withdrawal by Subject|3|||
156510928|NCT01240915|564964108|FG000|Overall Study|Other|0|||
156510929|NCT01240915|564964109|FG001|Overall Study|Other|0|||
156510930|NCT01240915|564964110|FG002|Overall Study|Other|0|||
156510931|NCT01240915|564964111|FG003|Overall Study|Other|0|||
156510932|NCT01240915|564964112|FG004|Overall Study|Other|2|||
156510933|NCT01240915|564964113|FG005|Overall Study|Other|0|||
156510934|NCT01240915|564964114|FG006|Overall Study|Other|0|||
156510935|NCT01240915|564964115|FG007|Overall Study|Other|0|||
156510936|NCT01240915|564964116|FG008|Overall Study|Other|0|||
156510937|NCT01240915|564964108|FG000|Overall Study|Insufficient Clinical Response|0|||
156510938|NCT01240915|564964109|FG001|Overall Study|Insufficient Clinical Response|0|||
156510939|NCT01240915|564964110|FG002|Overall Study|Insufficient Clinical Response|0|||
156510940|NCT01240915|564964111|FG003|Overall Study|Insufficient Clinical Response|0|||
156510941|NCT01240915|564964112|FG004|Overall Study|Insufficient Clinical Response|1|||
156510942|NCT01240915|564964113|FG005|Overall Study|Insufficient Clinical Response|3|||
156510943|NCT01240915|564964114|FG006|Overall Study|Insufficient Clinical Response|6|||
156510944|NCT01240915|564964115|FG007|Overall Study|Insufficient Clinical Response|0|||
156510945|NCT01240915|564964116|FG008|Overall Study|Insufficient Clinical Response|3|||
156510946|NCT02574845|564964120|FG000|Overall Study|Consent withdrawn further participation|0|||
156510947|NCT02574845|564964121|FG001|Overall Study|Consent withdrawn further participation|0|||
156510948|NCT02574845|564964122|FG002|Overall Study|Consent withdrawn further participation|0|||
156510949|NCT02574845|564964123|FG003|Overall Study|Consent withdrawn further participation|0|||
156510950|NCT02574845|564964124|FG004|Overall Study|Consent withdrawn further participation|1|||
156510951|NCT02574845|564964125|FG005|Overall Study|Consent withdrawn further participation|0|||
156510952|NCT02574845|564964120|FG000|Overall Study|Adverse Event|0|||
156510953|NCT02574845|564964121|FG001|Overall Study|Adverse Event|1|||
156510954|NCT02574845|564964122|FG002|Overall Study|Adverse Event|0|||
156510955|NCT02574845|564964123|FG003|Overall Study|Adverse Event|0|||
156510956|NCT02574845|564964124|FG004|Overall Study|Adverse Event|0|||
156510957|NCT02574845|564964125|FG005|Overall Study|Adverse Event|1|||
156510958|NCT01867333|564964128|FG000|Overall Study|Withdrawal by Subject|1|||
156510959|NCT01867333|564964129|FG001|Overall Study|Withdrawal by Subject|0|||
156510960|NCT01867333|564964128|FG000|Overall Study|Adverse Event|1|||
156510961|NCT01867333|564964129|FG001|Overall Study|Adverse Event|0|||
156510962|NCT01867333|564964128|FG000|Overall Study|Participant choice|1|||
156510963|NCT01867333|564964129|FG001|Overall Study|Participant choice|2|||
156510964|NCT01867333|564964128|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
156510965|NCT01867333|564964129|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
156510966|NCT01867333|564964128|FG000|Overall Study|Death|0|||
156510967|NCT01867333|564964129|FG001|Overall Study|Death|1|||
156510968|NCT01867333|564964128|FG000|Overall Study|Physician Decision|3|||
156510969|NCT01867333|564964129|FG001|Overall Study|Physician Decision|2|||
156510970|NCT01867333|564964128|FG000|Overall Study|Switched to alternative treatment|1|||
156510971|NCT01867333|564964129|FG001|Overall Study|Switched to alternative treatment|0|||
156510972|NCT03101462|564964130|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
156510973|NCT03101462|564964131|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
156510974|NCT01696045|564964135|FG000|Overall Study|Study drug toxicity|1|||
156510975|NCT01696045|564964136|FG001|Overall Study|Study drug toxicity|5|||
156510976|NCT01696045|564964135|FG000|Overall Study|Disease progression|2|||
156510977|NCT01696045|564964136|FG001|Overall Study|Disease progression|2|||
156510978|NCT01559129|564964137|FG000|Treatment Phase|Adverse Event|0|||
156510979|NCT01559129|564964138|FG001|Treatment Phase|Adverse Event|2|||
156510980|NCT01559129|564964137|FG000|Treatment Phase|Progressive Disease|1|||
156510981|NCT01559129|564964138|FG001|Treatment Phase|Progressive Disease|1|||
156510982|NCT01559129|564964137|FG000|Treatment Phase|Lack of Efficacy|0|||
156510983|NCT01559129|564964138|FG001|Treatment Phase|Lack of Efficacy|1|||
156510984|NCT01559129|564964137|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
156510985|NCT01559129|564964138|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
156510986|NCT01559129|564964137|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
156510987|NCT01559129|564964138|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
156510988|NCT01559129|564964137|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
156510989|NCT01559129|564964138|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
156510990|NCT01559129|564964137|FG000|Open-label Extension Period|Adverse Event|1|||
156510991|NCT01559129|564964138|FG001|Open-label Extension Period|Adverse Event|0|||
156400964|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
156400965|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
156400966|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
156400967|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
156400968|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
156400969|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
156400970|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
156400971|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
156400972|NCT00261495|564561096|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
156400973|NCT00261495|564561097|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
156400974|NCT00261495|564561096|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
156400975|NCT00261495|564561097|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
156400976|NCT00261495|564561096|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
156400977|NCT00261495|564561097|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
156400978|NCT00261495|564561096|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
156400979|NCT00261495|564561097|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
156400980|NCT00261495|564561096|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
156400981|NCT00261495|564561097|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
156400982|NCT00261495|564561096|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
156400983|NCT00261495|564561097|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
156400984|NCT00261495|564561096|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
156400985|NCT00261495|564561097|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156400986|NCT01932697|564561098|FG000|Overall Study|Received a different amount of tx|1|||
156400987|NCT01932697|564561099|FG001|Overall Study|Received a different amount of tx|0|||
156400988|NCT01932697|564561098|FG000|Overall Study|Ineligible|1|||
156400989|NCT01932697|564561099|FG001|Overall Study|Ineligible|0|||
156400990|NCT00215540|564561109|FG000|Overall Study|Withdrew from study medication|1|||
156400991|NCT00215540|564561110|FG001|Overall Study|Withdrew from study medication|0|||
156400992|NCT00215540|564561111|FG002|Overall Study|Withdrew from study medication|0|||
156400993|NCT03010462|564561112|FG000|Overall Study|Withdrawal by Subject|3|||
156400994|NCT03010462|564561113|FG001|Overall Study|Withdrawal by Subject|1|||
156400995|NCT02487810|564561114|FG000|Overall Study|Withdrawal by Subject|1|||
156400996|NCT02487810|564561115|FG001|Overall Study|Withdrawal by Subject|0|||
156400997|NCT00763958|564561116|FG000|Overall Study|did not meet final criteria|4|||
156400998|NCT00763958|564561117|FG001|Overall Study|did not meet final criteria|4|||
156400999|NCT00763958|564561116|FG000|Overall Study|Lost to Follow-up|10|||
156401000|NCT00763958|564561117|FG001|Overall Study|Lost to Follow-up|2|||
156401001|NCT00763958|564561116|FG000|Overall Study|Believed they were receiving placebo|0|||
156401002|NCT00763958|564561117|FG001|Overall Study|Believed they were receiving placebo|5|||
156401003|NCT04074590|564561118|FG000|Overall Study|Adverse Event|1|||
156401004|NCT04074590|564561119|FG001|Overall Study|Adverse Event|0|||
156401005|NCT04074590|564561118|FG000|Overall Study|Physician Decision|1|||
156401006|NCT04074590|564561119|FG001|Overall Study|Physician Decision|0|||
156401007|NCT04074590|564561118|FG000|Overall Study|Withdrawal by Subject|2|||
156401008|NCT04074590|564561119|FG001|Overall Study|Withdrawal by Subject|0|||
156401009|NCT03299686|564561120|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
156401010|NCT03299686|564561121|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
156401011|NCT03299686|564561120|FG000|Treatment Epoch|Physician Decision|1|||
156401012|NCT03299686|564561121|FG001|Treatment Epoch|Physician Decision|0|||
156401013|NCT03299686|564561120|FG000|Treatment Epoch|Adverse Event|8|||
156401014|NCT03299686|564561121|FG001|Treatment Epoch|Adverse Event|4|||
156401015|NCT03299686|564561120|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
156401016|NCT03299686|564561121|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
156401017|NCT02709005|564561122|FG000|Overall Study|Lost to Follow-up|1|||
156401018|NCT02709005|564561123|FG001|Overall Study|Lost to Follow-up|1|||
156401019|NCT02709005|564561122|FG000|Overall Study|Withdrawal by Subject|3|||
156401020|NCT02709005|564561123|FG001|Overall Study|Withdrawal by Subject|0|||
156401021|NCT02535364|564561129|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
156401022|NCT02535364|564561129|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
156401023|NCT02535364|564561129|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
156401024|NCT02535364|564561129|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
156510992|NCT01559129|564964137|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
156510993|NCT01559129|564964138|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
156510994|NCT03525392|564964139|FG000|Overall Study|Adverse Event|1|||
156510995|NCT03525392|564964140|FG001|Overall Study|Adverse Event|0|||
156510996|NCT03525392|564964141|FG002|Overall Study|Adverse Event|2|||
156510997|NCT03525392|564964142|FG003|Overall Study|Adverse Event|0|||
156510998|NCT03525392|564964143|FG004|Overall Study|Adverse Event|0|||
156510999|NCT03525392|564964139|FG000|Overall Study|Progressive disease|0|||
156511000|NCT03525392|564964140|FG001|Overall Study|Progressive disease|1|||
156511001|NCT03525392|564964141|FG002|Overall Study|Progressive disease|1|||
156511002|NCT03525392|564964142|FG003|Overall Study|Progressive disease|3|||
156551814|NCT04868903|565112001|FG000|Overall Study|Hyperparathyroidism|3|||
156551815|NCT04868903|565112002|FG001|Overall Study|Hyperparathyroidism|5|||
156551816|NCT04868903|565112003|FG002|Overall Study|Hyperparathyroidism|2|||
156551817|NCT04868903|565112004|FG003|Overall Study|Hyperparathyroidism|3|||
156551818|NCT03735667|565112005|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
156551819|NCT03735667|565112006|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
156551820|NCT03735667|565112007|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
156551821|NCT03735667|565112005|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
156551822|NCT03735667|565112006|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
156551823|NCT03735667|565112007|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
156551824|NCT03735667|565112005|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
156551825|NCT03735667|565112006|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
156551826|NCT03735667|565112007|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
156551827|NCT03735667|565112005|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
156551828|NCT03735667|565112006|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
156551829|NCT03735667|565112007|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
156551830|NCT03735667|565112005|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
156551831|NCT03735667|565112006|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
156551832|NCT03735667|565112007|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
156551833|NCT03735667|565112005|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
156551834|NCT03735667|565112006|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
156551835|NCT03735667|565112007|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
156551836|NCT03735667|565112005|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
156551837|NCT03735667|565112006|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
156551838|NCT03735667|565112007|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
156551839|NCT03735667|565112005|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
156551840|NCT03735667|565112006|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
156551841|NCT03735667|565112007|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
156551842|NCT03735667|565112005|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
156551843|NCT03735667|565112006|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
156551844|NCT03735667|565112007|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
156551845|NCT03735667|565112005|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
156551846|NCT03735667|565112006|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
156551847|NCT03735667|565112007|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
156551848|NCT03735667|565112005|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
156551849|NCT03735667|565112006|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
156551850|NCT03735667|565112007|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
156551851|NCT03735667|565112005|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
156551852|NCT03735667|565112006|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
156551853|NCT03735667|565112007|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
156551854|NCT03092726|565112010|FG000|Overall Study|Adverse Event|3|||
156551855|NCT03092726|565112011|FG001|Overall Study|Adverse Event|10|||
156551856|NCT03092726|565112010|FG000|Overall Study|Lack of Efficacy|0|||
156551857|NCT03092726|565112011|FG001|Overall Study|Lack of Efficacy|1|||
156551858|NCT03092726|565112010|FG000|Overall Study|Lost to Follow-up|1|||
156551859|NCT03092726|565112011|FG001|Overall Study|Lost to Follow-up|0|||
156551860|NCT03092726|565112010|FG000|Overall Study|Withdrawal by Subject|5|||
156551861|NCT03092726|565112011|FG001|Overall Study|Withdrawal by Subject|3|||
156551862|NCT04418765|565112014|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
156551863|NCT04418765|565112015|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
156551864|NCT04418765|565112016|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
156551865|NCT04418765|565112014|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
156551866|NCT04418765|565112015|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
156551867|NCT04418765|565112016|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
156551868|NCT04418765|565112014|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
156551869|NCT04418765|565112015|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
156551870|NCT04418765|565112016|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
156551871|NCT04418765|565112014|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
156551872|NCT04418765|565112015|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
156551873|NCT04418765|565112016|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
156551874|NCT04418765|565112014|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
156551875|NCT04418765|565112015|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
156551876|NCT04418765|565112016|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
156551877|NCT04418765|565112014|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
156551878|NCT04418765|565112015|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
156551879|NCT04418765|565112016|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
156551880|NCT04418765|565112014|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
156551881|NCT04418765|565112015|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
156551882|NCT04418765|565112016|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
156551883|NCT04418765|565112014|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
156551884|NCT04418765|565112015|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
156551885|NCT04418765|565112016|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
156551886|NCT04418765|565112014|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
156551887|NCT04418765|565112015|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
156551888|NCT04418765|565112016|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
156551889|NCT04418765|565112014|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
156551890|NCT04418765|565112015|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
156551891|NCT04418765|565112016|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
156551892|NCT04418765|565112014|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
156551893|NCT04418765|565112015|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
156551894|NCT04418765|565112016|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
156551895|NCT04418765|565112014|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
156551896|NCT04418765|565112015|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
156551897|NCT04418765|565112016|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
156551898|NCT04418765|565112014|FG000|Extension Period (48 Weeks)|Other than specified|0|||
156551899|NCT04418765|565112015|FG001|Extension Period (48 Weeks)|Other than specified|5|||
156551900|NCT04418765|565112016|FG002|Extension Period (48 Weeks)|Other than specified|2|||
156551901|NCT02217566|565112017|FG000|Overall Study|Lost to Follow-up|2|||
156551902|NCT02217566|565112017|FG000|Overall Study|Death|3|||
156551903|NCT02217566|565112017|FG000|Overall Study|Early study termination|6|||
156551904|NCT02064387|565112018|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551905|NCT02064387|565112019|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551906|NCT02064387|565112020|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551907|NCT02064387|565112021|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551908|NCT02064387|565112022|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551909|NCT02064387|565112023|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551910|NCT02064387|565112024|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551911|NCT02064387|565112025|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
156551912|NCT02064387|565112026|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551913|NCT02064387|565112027|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
156551914|NCT02064387|565112028|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551915|NCT02064387|565112029|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
156551916|NCT02064387|565112018|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551917|NCT02064387|565112019|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551918|NCT02064387|565112020|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156511003|NCT03525392|564964143|FG004|Overall Study|Progressive disease|1|||
156511004|NCT00831129|564964146|FG000|Overall Study|Adverse Event|0|||
156511005|NCT00831129|564964147|FG001|Overall Study|Adverse Event|1|||
156511006|NCT00831129|564964146|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
156511007|NCT00831129|564964147|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
156511008|NCT01669577|564964148|FG000|Overall Study|Death|22|||
156511009|NCT01669577|564964148|FG000|Overall Study|Lost to Follow-up|78|||
156511010|NCT01669577|564964148|FG000|Overall Study|Physician Decision|34|||
156511011|NCT04462289|564964151|FG000|Overall Study|Lost to Follow-up|4|||
156511012|NCT04462289|564964152|FG001|Overall Study|Lost to Follow-up|5|||
156511013|NCT04462289|564964151|FG000|Overall Study|Death|0|||
156511014|NCT04462289|564964152|FG001|Overall Study|Death|3|||
156511015|NCT04462289|564964151|FG000|Overall Study|Withdrawal by Subject|1|||
156511016|NCT04462289|564964152|FG001|Overall Study|Withdrawal by Subject|3|||
156511017|NCT00818779|564964153|FG000|Overall Study|Protocol Violation|1|||
156511018|NCT00818779|564964154|FG001|Overall Study|Protocol Violation|0|||
156511019|NCT00818779|564964153|FG000|Overall Study|Lost to Follow-up|1|||
156511020|NCT00818779|564964154|FG001|Overall Study|Lost to Follow-up|0|||
156511021|NCT00818779|564964153|FG000|Overall Study|Adverse Event|4|||
156511022|NCT00818779|564964154|FG001|Overall Study|Adverse Event|1|||
156511023|NCT01518153|564964155|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
156511024|NCT01518153|564964156|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
156511025|NCT01518153|564964157|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
156511026|NCT01518153|564964155|FG000|Stem Cell Transplant|Death|2|||
156511027|NCT01518153|564964156|FG001|Stem Cell Transplant|Death|0|||
156511028|NCT01518153|564964157|FG002|Stem Cell Transplant|Death|0|||
156511029|NCT01518153|564964155|FG000|Stem Cell Transplant|Secondary graft failure|1|||
156511030|NCT01518153|564964156|FG001|Stem Cell Transplant|Secondary graft failure|0|||
156511031|NCT01518153|564964157|FG002|Stem Cell Transplant|Secondary graft failure|0|||
156511032|NCT01518153|564964155|FG000|Stem Cell Transplant|Adverse Event|1|||
156511033|NCT01518153|564964156|FG001|Stem Cell Transplant|Adverse Event|0|||
156511034|NCT01518153|564964157|FG002|Stem Cell Transplant|Adverse Event|0|||
156511035|NCT01518153|564964155|FG000|Donor Lymphocyte Infusion|Death|0|||
156511036|NCT01518153|564964156|FG001|Donor Lymphocyte Infusion|Death|2|||
156511037|NCT01518153|564964157|FG002|Donor Lymphocyte Infusion|Death|1|||
156511038|NCT00132873|564964158|FG000|Overall Study|Adverse Event|3|||
156511039|NCT00132873|564964158|FG000|Overall Study|Lost to Follow-up|1|||
156511040|NCT00132873|564964158|FG000|Overall Study|Lack of Efficacy|1|||
156511041|NCT00132873|564964158|FG000|Overall Study|Withdrawal by Subject|3|||
156511042|NCT00132873|564964158|FG000|Overall Study|Planned Pregnancy|1|||
156511043|NCT04276415|564964159|FG000|Overall Study|Adverse Event|0|||
156511044|NCT04276415|564964160|FG001|Overall Study|Adverse Event|0|||
156511045|NCT04276415|564964161|FG002|Overall Study|Adverse Event|0|||
156511046|NCT04276415|564964162|FG003|Overall Study|Adverse Event|3|||
156511047|NCT04276415|564964163|FG004|Overall Study|Adverse Event|0|||
156511048|NCT04276415|564964164|FG005|Overall Study|Adverse Event|0|||
156511049|NCT04276415|564964159|FG000|Overall Study|Clinical progression|1|||
156511050|NCT04276415|564964160|FG001|Overall Study|Clinical progression|1|||
156511051|NCT04276415|564964161|FG002|Overall Study|Clinical progression|0|||
156511052|NCT04276415|564964162|FG003|Overall Study|Clinical progression|0|||
156511053|NCT04276415|564964163|FG004|Overall Study|Clinical progression|1|||
156511054|NCT04276415|564964164|FG005|Overall Study|Clinical progression|0|||
156511055|NCT04276415|564964159|FG000|Overall Study|Other|0|||
156511056|NCT04276415|564964160|FG001|Overall Study|Other|0|||
156511057|NCT04276415|564964161|FG002|Overall Study|Other|0|||
156511058|NCT04276415|564964162|FG003|Overall Study|Other|1|||
156511059|NCT04276415|564964163|FG004|Overall Study|Other|0|||
156511060|NCT04276415|564964164|FG005|Overall Study|Other|0|||
156511061|NCT04276415|564964159|FG000|Overall Study|Physician Decision|0|||
156511062|NCT04276415|564964160|FG001|Overall Study|Physician Decision|0|||
156511063|NCT04276415|564964161|FG002|Overall Study|Physician Decision|1|||
156511064|NCT04276415|564964162|FG003|Overall Study|Physician Decision|3|||
156511065|NCT04276415|564964163|FG004|Overall Study|Physician Decision|2|||
156511066|NCT04276415|564964164|FG005|Overall Study|Physician Decision|0|||
156511067|NCT04276415|564964159|FG000|Overall Study|Progressive disease|3|||
156511068|NCT04276415|564964160|FG001|Overall Study|Progressive disease|3|||
156511069|NCT04276415|564964161|FG002|Overall Study|Progressive disease|4|||
156511070|NCT04276415|564964162|FG003|Overall Study|Progressive disease|5|||
156511071|NCT04276415|564964163|FG004|Overall Study|Progressive disease|1|||
156511072|NCT04276415|564964164|FG005|Overall Study|Progressive disease|2|||
156511073|NCT04276415|564964159|FG000|Overall Study|Withdrawal by patient|0|||
156511074|NCT04276415|564964160|FG001|Overall Study|Withdrawal by patient|0|||
156511075|NCT04276415|564964161|FG002|Overall Study|Withdrawal by patient|0|||
156511076|NCT04276415|564964162|FG003|Overall Study|Withdrawal by patient|1|||
156511077|NCT04276415|564964163|FG004|Overall Study|Withdrawal by patient|2|||
156511078|NCT04276415|564964164|FG005|Overall Study|Withdrawal by patient|0|||
156511079|NCT03309813|564964165|FG000|Main Randomized Study|Withdrawal by Subject|1|||
156511080|NCT03309813|564964166|FG001|Main Randomized Study|Withdrawal by Subject|0|||
156511081|NCT04978493|564964167|FG000|Overall Study|No reason available|0|||
156511082|NCT04978493|564964168|FG001|Overall Study|No reason available|1|||
156511083|NCT04978493|564964167|FG000|Overall Study|Adverse Event|1|||
156511084|NCT04978493|564964168|FG001|Overall Study|Adverse Event|0|||
156511085|NCT01896726|564964169|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
156511086|NCT01896726|564964169|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
156511087|NCT00208325|564964170|FG000|Overall Study|Death|18|||
156511088|NCT00208325|564964171|FG001|Overall Study|Death|19|||
156511089|NCT00208325|564964172|FG002|Overall Study|Death|7|||
156511090|NCT00208325|564964173|FG003|Overall Study|Death|5|||
156511091|NCT00208325|564964170|FG000|Overall Study|Withdrawal by Subject|0|||
156511092|NCT00208325|564964171|FG001|Overall Study|Withdrawal by Subject|1|||
156511093|NCT00208325|564964172|FG002|Overall Study|Withdrawal by Subject|0|||
156511094|NCT00208325|564964173|FG003|Overall Study|Withdrawal by Subject|0|||
156511095|NCT00208325|564964170|FG000|Overall Study|Revision|4|||
156511096|NCT00208325|564964171|FG001|Overall Study|Revision|1|||
156511097|NCT00208325|564964172|FG002|Overall Study|Revision|0|||
156511098|NCT00208325|564964173|FG003|Overall Study|Revision|4|||
156511099|NCT00208325|564964170|FG000|Overall Study|Lost to Follow-up|1|||
156511100|NCT00208325|564964171|FG001|Overall Study|Lost to Follow-up|0|||
156511101|NCT00208325|564964172|FG002|Overall Study|Lost to Follow-up|2|||
156511102|NCT00208325|564964173|FG003|Overall Study|Lost to Follow-up|0|||
156511103|NCT00208325|564964170|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
156511104|NCT00208325|564964171|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
156511105|NCT00208325|564964172|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
156511106|NCT00208325|564964173|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
156511107|NCT00208325|564964170|FG000|Overall Study|Does not wish to Continue in Study|5|||
156511108|NCT00208325|564964171|FG001|Overall Study|Does not wish to Continue in Study|8|||
156511109|NCT00208325|564964172|FG002|Overall Study|Does not wish to Continue in Study|3|||
156511110|NCT00208325|564964173|FG003|Overall Study|Does not wish to Continue in Study|2|||
156511111|NCT00208325|564964170|FG000|Overall Study|Other|2|||
156511112|NCT00208325|564964171|FG001|Overall Study|Other|1|||
156511113|NCT00208325|564964172|FG002|Overall Study|Other|1|||
156511114|NCT00208325|564964173|FG003|Overall Study|Other|0|||
156511115|NCT00208325|564964170|FG000|Overall Study|Mis-Randomized|17|||
156551919|NCT02064387|565112021|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551920|NCT02064387|565112022|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551921|NCT02064387|565112023|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551922|NCT02064387|565112024|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551923|NCT02064387|565112025|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
156551924|NCT02064387|565112026|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551925|NCT02064387|565112027|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551926|NCT02064387|565112028|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551927|NCT02064387|565112029|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156551928|NCT02064387|565112018|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551929|NCT02064387|565112019|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551930|NCT02064387|565112020|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551931|NCT02064387|565112021|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551932|NCT02064387|565112022|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551933|NCT02064387|565112023|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551934|NCT02064387|565112024|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551935|NCT02064387|565112025|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551936|NCT02064387|565112026|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
156551937|NCT02064387|565112027|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551938|NCT02064387|565112028|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551939|NCT02064387|565112029|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
156551940|NCT02064387|565112018|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
156551941|NCT02064387|565112019|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
156551942|NCT02064387|565112020|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
156551943|NCT02064387|565112021|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
156551944|NCT02064387|565112022|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
156551945|NCT02064387|565112023|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
156551946|NCT02064387|565112024|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
156551947|NCT02064387|565112025|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
156551948|NCT02064387|565112026|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
156551949|NCT02064387|565112027|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
156551950|NCT02064387|565112028|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
156551951|NCT02064387|565112029|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
156551952|NCT02064387|565112018|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551953|NCT02064387|565112019|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551954|NCT02064387|565112020|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551955|NCT02064387|565112021|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551956|NCT02064387|565112022|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551957|NCT02064387|565112023|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551958|NCT02064387|565112024|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551959|NCT02064387|565112025|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551960|NCT02064387|565112026|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551961|NCT02064387|565112027|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551962|NCT02064387|565112028|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
156551963|NCT02064387|565112029|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
156551964|NCT02436876|565112033|FG000|Overall Study|Lost to Follow-up|0|||
156551965|NCT02436876|565112034|FG001|Overall Study|Lost to Follow-up|1|||
156551966|NCT02436876|565112035|FG002|Overall Study|Lost to Follow-up|1|||
156551967|NCT02436876|565112036|FG003|Overall Study|Lost to Follow-up|1|||
156511116|NCT00208325|564964171|FG001|Overall Study|Mis-Randomized|20|||
156511117|NCT00208325|564964172|FG002|Overall Study|Mis-Randomized|0|||
156511118|NCT00208325|564964173|FG003|Overall Study|Mis-Randomized|0|||
156511119|NCT01327846|564964174|FG000|Core Phase|Subject decision (vital status: missing)|1|||
156511120|NCT01327846|564964175|FG001|Core Phase|Subject decision (vital status: missing)|2|||
156511121|NCT01327846|564964176|FG002|Core Phase|Subject decision (vital status: missing)|2|||
156511122|NCT01327846|564964177|FG003|Core Phase|Subject decision (vital status: missing)|1|||
156511123|NCT01327846|564964174|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
156511124|NCT01327846|564964175|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
156511125|NCT01327846|564964176|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
156511126|NCT01327846|564964177|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
156511127|NCT01327846|564964174|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
156511128|NCT01327846|564964175|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
156511129|NCT01327846|564964176|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
156511130|NCT01327846|564964177|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
156511131|NCT01327846|564964174|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
156511132|NCT01327846|564964175|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
156401025|NCT02535364|564561129|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
156401026|NCT02535364|564561129|FG000|Part B Screening|Death|2|||
156401027|NCT02535364|564561129|FG000|Part B Screening|Physician Decision|1|||
156401028|NCT02535364|564561129|FG000|Part B Screening|Withdrawal by Subject|1|||
156401029|NCT02535364|564561129|FG000|Part B Screening|Adverse Event|1|||
156401030|NCT02535364|564561129|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
156401031|NCT02535364|564561129|FG000|Study Treatment|Death|1|||
156401032|NCT02535364|564561129|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
156401033|NCT02535364|564561129|FG000|12-Month Follow-up Period|Disease progression|22|||
156401034|NCT02535364|564561129|FG000|12-Month Follow-up Period|Death|5|||
156511133|NCT01327846|564964176|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
156511134|NCT01327846|564964177|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
156511135|NCT01327846|564964174|FG000|Core Phase|Lost to Follow-up|3|||
156511136|NCT01327846|564964175|FG001|Core Phase|Lost to Follow-up|3|||
156511137|NCT01327846|564964176|FG002|Core Phase|Lost to Follow-up|4|||
156511138|NCT01327846|564964177|FG003|Core Phase|Lost to Follow-up|5|||
156511139|NCT01327846|564964174|FG000|Extension Phase|Study terminated by sponsor|1073|||
156511140|NCT01327846|564964175|FG001|Extension Phase|Study terminated by sponsor|1124|||
156511141|NCT01327846|564964176|FG002|Extension Phase|Study terminated by sponsor|1067|||
156511142|NCT01327846|564964177|FG003|Extension Phase|Study terminated by sponsor|1660|||
156511143|NCT01327846|564964174|FG000|Extension Phase|Withdrawal by Subject|20|||
156511144|NCT01327846|564964175|FG001|Extension Phase|Withdrawal by Subject|13|||
156511145|NCT01327846|564964176|FG002|Extension Phase|Withdrawal by Subject|19|||
156511146|NCT01327846|564964177|FG003|Extension Phase|Withdrawal by Subject|37|||
156511147|NCT01327846|564964174|FG000|Extension Phase|Lost to Follow-up|4|||
156511148|NCT01327846|564964175|FG001|Extension Phase|Lost to Follow-up|3|||
156511149|NCT01327846|564964176|FG002|Extension Phase|Lost to Follow-up|4|||
156511150|NCT01327846|564964177|FG003|Extension Phase|Lost to Follow-up|7|||
156511151|NCT01327846|564964174|FG000|Extension Phase|Technical Problems|2|||
156511152|NCT01327846|564964175|FG001|Extension Phase|Technical Problems|4|||
156511153|NCT01327846|564964176|FG002|Extension Phase|Technical Problems|2|||
156511154|NCT01327846|564964177|FG003|Extension Phase|Technical Problems|2|||
156511155|NCT04662931|564964178|FG000|Overall Study|Withdrawal by Subject|17|||
156511156|NCT04662931|564964178|FG000|Overall Study|Death|3|||
156511157|NCT04662931|564964178|FG000|Overall Study|Lost to Follow-up|3|||
156511158|NCT04662931|564964178|FG000|Overall Study|Guardian Decision|1|||
156511159|NCT04343976|564964182|FG000|Overall Study|Withdrawal by Subject|0|||
156511160|NCT04343976|564964183|FG001|Overall Study|Withdrawal by Subject|1|||
156511161|NCT02807883|564964184|FG000|Overall Study|Withdrawal by Subject|2|||
156511162|NCT02406677|564964185|FG000|Overall Study|Death|16|||
156511163|NCT02406677|564964186|FG001|Overall Study|Death|8|||
156511164|NCT02406677|564964185|FG000|Overall Study|Discharged without P2Y12|1|||
156511165|NCT02406677|564964186|FG001|Overall Study|Discharged without P2Y12|3|||
156511166|NCT02406677|564964185|FG000|Overall Study|Discharged on prasugrel|283|||
156511167|NCT02406677|564964186|FG001|Overall Study|Discharged on prasugrel|587|||
156511168|NCT02406677|564964185|FG000|Overall Study|Withdrawal by Subject|1|||
156511169|NCT02406677|564964186|FG001|Overall Study|Withdrawal by Subject|0|||
156511170|NCT04531098|564964189|FG000|Stage I|Adverse Event|0|||
156511171|NCT04531098|564964190|FG001|Stage I|Adverse Event|0|||
156511172|NCT04531098|564964191|FG002|Stage I|Adverse Event|3|||
156511173|NCT04531098|564964189|FG000|Stage I|Protocol Violation|0|||
156511174|NCT04531098|564964190|FG001|Stage I|Protocol Violation|0|||
156511175|NCT04531098|564964191|FG002|Stage I|Protocol Violation|5|||
156511176|NCT04531098|564964189|FG000|Stage I|Withdrawal by Subject|0|||
156511177|NCT04531098|564964190|FG001|Stage I|Withdrawal by Subject|5|||
156511178|NCT04531098|564964191|FG002|Stage I|Withdrawal by Subject|10|||
156511179|NCT04531098|564964189|FG000|Stage II|Adverse Event|1|||
156511180|NCT04531098|564964190|FG001|Stage II|Adverse Event|2|||
156511181|NCT04531098|564964191|FG002|Stage II|Adverse Event|0|||
156511182|NCT04531098|564964189|FG000|Stage II|Protocol Violation|1|||
156511183|NCT04531098|564964190|FG001|Stage II|Protocol Violation|2|||
156511184|NCT04531098|564964191|FG002|Stage II|Protocol Violation|0|||
156511185|NCT04531098|564964189|FG000|Stage II|Withdrawal by Subject|3|||
156511186|NCT04531098|564964190|FG001|Stage II|Withdrawal by Subject|1|||
156511187|NCT04531098|564964191|FG002|Stage II|Withdrawal by Subject|0|||
156511188|NCT04531098|564964189|FG000|Stage II|Moved from study area|8|||
156511189|NCT04531098|564964190|FG001|Stage II|Moved from study area|5|||
156511190|NCT04531098|564964191|FG002|Stage II|Moved from study area|0|||
156511191|NCT02145468|564964192|FG000|Overall Study|Withdrawal by Subject|5|||
156511192|NCT02145468|564964193|FG001|Overall Study|Withdrawal by Subject|8|||
156511193|NCT04777864|564964194|FG000|Overall Study|Lost to Follow-up|8|||
156401035|NCT02535364|564561129|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
156511194|NCT04777864|564964195|FG001|Overall Study|Lost to Follow-up|19|||
156511195|NCT03086655|564964198|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
156511196|NCT03086655|564964199|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
156511197|NCT03086655|564964198|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
156511198|NCT03086655|564964199|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
156551968|NCT02436876|565112033|FG000|Overall Study|Withdrawal by Subject|1|||
156551969|NCT02436876|565112034|FG001|Overall Study|Withdrawal by Subject|0|||
156551970|NCT02436876|565112035|FG002|Overall Study|Withdrawal by Subject|0|||
156551971|NCT02436876|565112036|FG003|Overall Study|Withdrawal by Subject|1|||
156551972|NCT02436876|565112033|FG000|Overall Study|Physician Decision|0|||
156551973|NCT02436876|565112034|FG001|Overall Study|Physician Decision|2|||
156551974|NCT02436876|565112035|FG002|Overall Study|Physician Decision|1|||
156551975|NCT02436876|565112036|FG003|Overall Study|Physician Decision|0|||
156551976|NCT02436876|565112033|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
156551977|NCT02436876|565112034|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
156401036|NCT02535364|564561129|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
156401037|NCT02535364|564561129|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
156401038|NCT02889133|564561135|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
156401039|NCT02889133|564561136|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
156401040|NCT02889133|564561135|FG000|Completed Primary Outcome|Manufacturing error|3|||
156401041|NCT02889133|564561136|FG001|Completed Primary Outcome|Manufacturing error|8|||
156401042|NCT02889133|564561135|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
156401043|NCT02889133|564561136|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
156401044|NCT02889133|564561135|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
156401045|NCT02889133|564561136|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
156401046|NCT02889133|564561135|FG000|Completed Primary Outcome|Protocol Violation|1|||
156401047|NCT02889133|564561136|FG001|Completed Primary Outcome|Protocol Violation|0|||
156401048|NCT02889133|564561135|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
156401049|NCT02889133|564561136|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
156401050|NCT02889133|564561135|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
156401051|NCT02889133|564561136|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
156401052|NCT02889133|564561135|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
156401053|NCT02889133|564561136|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
156401054|NCT02889133|564561135|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
156401055|NCT02889133|564561136|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
156401056|NCT02889133|564561135|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
156401057|NCT02889133|564561136|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
156401058|NCT03131960|564561137|FG000|Overall Study|Adverse Event|0|||
156401059|NCT03131960|564561138|FG001|Overall Study|Adverse Event|1|||
156401060|NCT01375205|564561139|FG000|Overall Study|Lost to Follow-up|15|||
156401061|NCT01375205|564561140|FG001|Overall Study|Lost to Follow-up|12|||
156401062|NCT01375205|564561139|FG000|Overall Study|Withdrawal by Subject|6|||
156401063|NCT01375205|564561140|FG001|Overall Study|Withdrawal by Subject|1|||
156401064|NCT01148862|564561141|FG000|Second Intervention|Withdrawal by Subject|0|||
156401065|NCT01148862|564561142|FG001|Second Intervention|Withdrawal by Subject|2|||
156401066|NCT04270747|564561143|FG000|Through Week 16|Adverse Event|1|||
156401067|NCT04270747|564561144|FG001|Through Week 16|Adverse Event|2|||
156401068|NCT04270747|564561145|FG002|Through Week 16|Adverse Event|0|||
156401069|NCT04270747|564561143|FG000|Through Week 16|Death|0|||
156401070|NCT04270747|564561144|FG001|Through Week 16|Death|2|||
156401071|NCT04270747|564561145|FG002|Through Week 16|Death|0|||
156401072|NCT04270747|564561143|FG000|Through Week 16|Consent Withdrawn|3|||
156401073|NCT04270747|564561144|FG001|Through Week 16|Consent Withdrawn|3|||
156401074|NCT04270747|564561145|FG002|Through Week 16|Consent Withdrawn|0|||
156401075|NCT04270747|564561143|FG000|Through Week 16|Physician Decision|1|||
156401076|NCT04270747|564561144|FG001|Through Week 16|Physician Decision|1|||
156401077|NCT04270747|564561145|FG002|Through Week 16|Physician Decision|0|||
156401078|NCT04270747|564561143|FG000|Through Week 16|Lost to Follow-up|2|||
156401079|NCT04270747|564561144|FG001|Through Week 16|Lost to Follow-up|0|||
156401080|NCT04270747|564561145|FG002|Through Week 16|Lost to Follow-up|0|||
156401081|NCT04270747|564561143|FG000|Through Week 16|Protocol Violation|1|||
156401082|NCT04270747|564561144|FG001|Through Week 16|Protocol Violation|2|||
156551978|NCT02436876|565112035|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
156551979|NCT02436876|565112036|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
156551980|NCT00999908|565112037|FG000|Treatment Period 1|Subject withdrew consent|2|||
156551981|NCT00999908|565112038|FG001|Treatment Period 1|Subject withdrew consent|0|||
156551982|NCT00999908|565112039|FG002|Treatment Period 1|Subject withdrew consent|0|||
156401083|NCT04270747|564561145|FG002|Through Week 16|Protocol Violation|0|||
156401084|NCT04270747|564561143|FG000|Through Week 16|Protocol Specified Criteria|6|||
156401085|NCT04270747|564561144|FG001|Through Week 16|Protocol Specified Criteria|7|||
156551983|NCT00999908|565112037|FG000|Treatment Period 2|Protocol Violation|1|||
156401086|NCT04270747|564561145|FG002|Through Week 16|Protocol Specified Criteria|0|||
156551984|NCT00999908|565112038|FG001|Treatment Period 2|Protocol Violation|0|||
156551985|NCT00999908|565112039|FG002|Treatment Period 2|Protocol Violation|0|||
156551986|NCT02780648|565112040|FG000|Overall Study|Disease Progression|1|||
156551987|NCT02780648|565112041|FG001|Overall Study|Disease Progression|0|||
156551988|NCT00293579|565112042|FG000|Overall Study|Withdrawal by Subject|1|||
156401087|NCT04270747|564561143|FG000|Through Week 16|Miscellaneous|1|||
156551989|NCT01276236|565112043|FG000|Overall Study|Lack of Efficacy|2|||
156551990|NCT01276236|565112043|FG000|Overall Study|Withdrawal by Subject|4|||
156551991|NCT03215771|565112044|FG000|Overall Study|Withdrawal by Subject|2|||
156551992|NCT03215771|565112044|FG000|Overall Study|Physician Decision|1|||
156551993|NCT03127384|565112045|FG000|Overall Study|Lost to Follow-up|4|||
156551994|NCT03127384|565112045|FG000|Overall Study|Subject request|2|||
156551995|NCT02703311|565112046|FG000|Overall Study|Death|5|||
156551996|NCT02703311|565112046|FG000|Overall Study|Withdrawal by Subject|3|||
156551997|NCT00343889|565112054|FG000|Overall Study|Lost to Follow-up|2|||
156551998|NCT00343889|565112055|FG001|Overall Study|Lost to Follow-up|0|||
156551999|NCT00343889|565112054|FG000|Overall Study|Withdrawal by Subject|0|||
156552000|NCT00343889|565112055|FG001|Overall Study|Withdrawal by Subject|1|||
156552001|NCT00343889|565112054|FG000|Overall Study|Protocol Violation|1|||
156552002|NCT00343889|565112055|FG001|Overall Study|Protocol Violation|0|||
156552003|NCT01294579|565112060|FG000|Overall Study|Disease progression|12|||
156552004|NCT01294579|565112060|FG000|Overall Study|Adverse Event|11|||
156552005|NCT01294579|565112060|FG000|Overall Study|Study closed/terminated|3|||
156552006|NCT01294579|565112060|FG000|Overall Study|Lost to Follow-up|1|||
156552007|NCT01294579|565112060|FG000|Overall Study|Physician Decision|3|||
156552008|NCT01294579|565112060|FG000|Overall Study|Withdrawal by Subject|5|||
156552009|NCT00137111|565112061|FG000|Total Therapy|Death|35|||
156552010|NCT00137111|565112062|FG001|Total Therapy|Death|0|||
156552011|NCT00137111|565112063|FG002|Total Therapy|Death|0|||
156552012|NCT00137111|565112064|FG003|Total Therapy|Death|0|||
156552013|NCT00137111|565112061|FG000|Total Therapy|Non Compliance|5|||
156552014|NCT00137111|565112062|FG001|Total Therapy|Non Compliance|0|||
156552015|NCT00137111|565112063|FG002|Total Therapy|Non Compliance|0|||
156552016|NCT00137111|565112064|FG003|Total Therapy|Non Compliance|0|||
156552017|NCT00262873|565112065|FG000|Overall Study|Adverse Event|3|||
156552018|NCT00262873|565112065|FG000|Overall Study|Withdrawal by Subject|5|||
156552019|NCT03440814|565112066|FG000|Overall Study|Adverse Event|2|||
156552020|NCT03440814|565112067|FG001|Overall Study|Adverse Event|1|||
156552021|NCT03440814|565112066|FG000|Overall Study|Lost to Follow-up|2|||
156552022|NCT03440814|565112067|FG001|Overall Study|Lost to Follow-up|0|||
156552023|NCT03440814|565112066|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
156552024|NCT03440814|565112067|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
156552025|NCT00903175|565112068|FG000|Period 1 - First Line|Adverse Event|36|||
156552026|NCT00903175|565112069|FG001|Period 1 - First Line|Adverse Event|50|||
156552027|NCT00903175|565112068|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
156552028|NCT00903175|565112069|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
156552029|NCT00903175|565112068|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
156552030|NCT00903175|565112069|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
156552031|NCT00903175|565112068|FG000|Period 1 - First Line|Protocol Violation|3|||
156552032|NCT00903175|565112069|FG001|Period 1 - First Line|Protocol Violation|3|||
156552033|NCT00903175|565112068|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
156552034|NCT00903175|565112069|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
156552035|NCT00903175|565112068|FG000|Period 1 - First Line|Administrative problems|12|||
156552036|NCT00903175|565112069|FG001|Period 1 - First Line|Administrative problems|13|||
156552037|NCT00903175|565112068|FG000|Period 1 - First Line|Death|17|||
156552038|NCT00903175|565112069|FG001|Period 1 - First Line|Death|10|||
156552039|NCT00903175|565112068|FG000|Period 2 - Second Line|Missing|1|||
156401088|NCT04270747|564561144|FG001|Through Week 16|Miscellaneous|1|||
156401089|NCT04270747|564561145|FG002|Through Week 16|Miscellaneous|0|||
156401090|NCT04270747|564561143|FG000|Post Week 16|Adverse Event|7|||
156401091|NCT04270747|564561144|FG001|Post Week 16|Adverse Event|5|||
156401092|NCT04270747|564561145|FG002|Post Week 16|Adverse Event|1|||
156401093|NCT04270747|564561143|FG000|Post Week 16|Death|2|||
156401094|NCT04270747|564561144|FG001|Post Week 16|Death|0|||
156401095|NCT04270747|564561145|FG002|Post Week 16|Death|2|||
156401096|NCT04270747|564561143|FG000|Post Week 16|Consent Withdrawn|4|||
156401097|NCT04270747|564561144|FG001|Post Week 16|Consent Withdrawn|3|||
156552040|NCT00903175|565112069|FG001|Period 2 - Second Line|Missing|0|||
156552041|NCT00903175|565112068|FG000|Period 2 - Second Line|Adverse Event|16|||
156552042|NCT00903175|565112069|FG001|Period 2 - Second Line|Adverse Event|20|||
156401098|NCT04270747|564561145|FG002|Post Week 16|Consent Withdrawn|6|||
156401099|NCT04270747|564561143|FG000|Post Week 16|Physician Decision|3|||
156552043|NCT00903175|565112068|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
156552044|NCT00903175|565112069|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
156552045|NCT00903175|565112068|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
156552046|NCT00903175|565112069|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
156552047|NCT00903175|565112068|FG000|Period 2 - Second Line|Administrative problems|19|||
156552048|NCT00903175|565112069|FG001|Period 2 - Second Line|Administrative problems|9|||
156552049|NCT00903175|565112068|FG000|Period 2 - Second Line|Death|5|||
156552050|NCT00903175|565112069|FG001|Period 2 - Second Line|Death|2|||
156401100|NCT04270747|564561144|FG001|Post Week 16|Physician Decision|1|||
156401101|NCT04270747|564561145|FG002|Post Week 16|Physician Decision|1|||
156401102|NCT04270747|564561143|FG000|Post Week 16|Lost to Follow-up|2|||
156552051|NCT03074474|565112070|FG000|Overall Study|Lost to Follow-up|10|||
156401103|NCT04270747|564561144|FG001|Post Week 16|Lost to Follow-up|1|||
156401104|NCT04270747|564561145|FG002|Post Week 16|Lost to Follow-up|0|||
156401105|NCT04270747|564561143|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
156511199|NCT03086655|564964198|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
156511200|NCT03086655|564964199|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
156511201|NCT03086655|564964198|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
156511202|NCT03086655|564964199|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
156511203|NCT03086655|564964198|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
156511204|NCT03086655|564964199|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
156511205|NCT03086655|564964198|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
156552052|NCT03074474|565112070|FG000|Overall Study|Withdrawal by Subject|10|||
156552053|NCT03074474|565112070|FG000|Overall Study|Death|4|||
156552054|NCT03074474|565112070|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
156401106|NCT04270747|564561144|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
156401107|NCT04270747|564561145|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
156401108|NCT04270747|564561143|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
156401109|NCT04270747|564561144|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
156401110|NCT04270747|564561145|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
156401111|NCT04270747|564561143|FG000|Post Week 16|Miscellaneous|1|||
156401112|NCT04270747|564561144|FG001|Post Week 16|Miscellaneous|0|||
156401113|NCT04270747|564561145|FG002|Post Week 16|Miscellaneous|1|||
156401114|NCT02063828|564561152|FG000|Overall Study|Withdrawal by Subject|4|||
156401115|NCT02063828|564561153|FG001|Overall Study|Withdrawal by Subject|6|||
156401116|NCT02063828|564561154|FG002|Overall Study|Withdrawal by Subject|3|||
156401117|NCT02063828|564561152|FG000|Overall Study|Death|0|||
156401118|NCT02063828|564561153|FG001|Overall Study|Death|0|||
156401119|NCT02063828|564561154|FG002|Overall Study|Death|1|||
156401120|NCT02753595|564561155|FG000|Overall Study|Sponsor termination|2|||
156401121|NCT02753595|564561156|FG001|Overall Study|Sponsor termination|2|||
156401122|NCT01064297|564561160|FG000|Overall Study|Lost to Follow-up|791|||
156401123|NCT01064297|564561161|FG001|Overall Study|Lost to Follow-up|48|||
156401124|NCT01064297|564561162|FG002|Overall Study|Lost to Follow-up|133|||
156401125|NCT02068495|564561165|FG000|Overall Study|Case Report Forms Uncollected|60|||
156401126|NCT02068495|564561165|FG000|Overall Study|Protocol Deviation|49|||
156401127|NCT01666808|564561173|FG000|Overall Study|Lost to Follow-up|9|||
156401128|NCT01666808|564561174|FG001|Overall Study|Lost to Follow-up|15|||
156401129|NCT01666808|564561173|FG000|Overall Study|Withdrawal by Subject|3|||
156401130|NCT01666808|564561174|FG001|Overall Study|Withdrawal by Subject|1|||
156401131|NCT01666808|564561173|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
156401132|NCT01666808|564561174|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
156401133|NCT00633464|564561177|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
156401134|NCT00633464|564561178|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
156401135|NCT00633464|564561177|FG000|Overall Study|Never Treated (Randomized in error)|0|||
156401136|NCT00633464|564561178|FG001|Overall Study|Never Treated (Randomized in error)|1|||
156401137|NCT00717860|564561179|FG000|Overall Study|Clinical adverse experience|5|||
156401138|NCT00717860|564561180|FG001|Overall Study|Clinical adverse experience|9|||
156401139|NCT00717860|564561179|FG000|Overall Study|Laboratory adverse experience|2|||
156401140|NCT00717860|564561180|FG001|Overall Study|Laboratory adverse experience|2|||
156401141|NCT00717860|564561179|FG000|Overall Study|Lack of Efficacy|7|||
156401142|NCT00717860|564561180|FG001|Overall Study|Lack of Efficacy|13|||
156401143|NCT00717860|564561179|FG000|Overall Study|Discontinued for other reason|6|||
156401144|NCT00717860|564561180|FG001|Overall Study|Discontinued for other reason|1|||
156401145|NCT00717860|564561179|FG000|Overall Study|Withdrew consent|7|||
156401146|NCT00717860|564561180|FG001|Overall Study|Withdrew consent|3|||
156401147|NCT00698646|564561184|FG000|Overall Study|Adverse Event|8|||
156401148|NCT00698646|564561185|FG001|Overall Study|Adverse Event|7|||
156401149|NCT00698646|564561186|FG002|Overall Study|Adverse Event|8|||
156401150|NCT00698646|564561184|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
156401151|NCT00698646|564561185|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
156401152|NCT00698646|564561186|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
156401153|NCT00698646|564561184|FG000|Overall Study|Protocol Deviation|6|||
156401154|NCT00698646|564561185|FG001|Overall Study|Protocol Deviation|2|||
156401155|NCT00698646|564561186|FG002|Overall Study|Protocol Deviation|3|||
156401156|NCT00698646|564561184|FG000|Overall Study|Withdrawal by Subject|10|||
156401157|NCT00698646|564561185|FG001|Overall Study|Withdrawal by Subject|11|||
156401158|NCT00698646|564561186|FG002|Overall Study|Withdrawal by Subject|8|||
156401159|NCT00698646|564561184|FG000|Overall Study|Lost to Follow-up|0|||
156401160|NCT00698646|564561185|FG001|Overall Study|Lost to Follow-up|0|||
156401161|NCT00698646|564561186|FG002|Overall Study|Lost to Follow-up|2|||
156401162|NCT00698646|564561184|FG000|Overall Study|Administrative problems|1|||
156401163|NCT00698646|564561185|FG001|Overall Study|Administrative problems|0|||
156401164|NCT00698646|564561186|FG002|Overall Study|Administrative problems|1|||
156401165|NCT00511875|564561192|FG000|Overall Study|Lost to Follow-up|4|||
156401166|NCT00511875|564561193|FG001|Overall Study|Lost to Follow-up|0|||
156401167|NCT00511875|564561192|FG000|Overall Study|Missing variables|1|||
156401168|NCT00511875|564561193|FG001|Overall Study|Missing variables|0|||
156401169|NCT00696384|564561195|FG000|Open Label Phase|Adverse Event|27|||
156401170|NCT00696384|564561196|FG001|Open Label Phase|Adverse Event|0|||
156401171|NCT00696384|564561197|FG002|Open Label Phase|Adverse Event|0|||
156401172|NCT00696384|564561195|FG000|Open Label Phase|Protocol Violation|18|||
156401173|NCT00696384|564561196|FG001|Open Label Phase|Protocol Violation|0|||
156511206|NCT03086655|564964199|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
156511207|NCT03086655|564964198|FG000|12 Month Follow-up = Final Assessment|Death|0|||
156511208|NCT03086655|564964199|FG001|12 Month Follow-up = Final Assessment|Death|1|||
156511209|NCT00798434|564964200|FG000|Double-Blind|Adverse Event|22|||
156511210|NCT00798434|564964201|FG001|Double-Blind|Adverse Event|46|||
156511211|NCT00798434|564964200|FG000|Double-Blind|Death|0|||
156511212|NCT00798434|564964201|FG001|Double-Blind|Death|1|||
156511213|NCT00798434|564964200|FG000|Double-Blind|Lost to Follow-up|1|||
156511214|NCT00798434|564964201|FG001|Double-Blind|Lost to Follow-up|0|||
156511215|NCT00798434|564964200|FG000|Double-Blind|Lack of Efficacy|8|||
156511216|NCT00798434|564964201|FG001|Double-Blind|Lack of Efficacy|12|||
156511217|NCT00798434|564964200|FG000|Double-Blind|Withdrawal by Subject|17|||
156511218|NCT00798434|564964201|FG001|Double-Blind|Withdrawal by Subject|14|||
156511219|NCT00798434|564964200|FG000|Double-Blind|Protocol Violation|1|||
156511220|NCT00798434|564964201|FG001|Double-Blind|Protocol Violation|4|||
156511221|NCT00798434|564964200|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
156511222|NCT00798434|564964201|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
156511223|NCT00798434|564964200|FG000|Double-Blind|Other|1|||
156511224|NCT00798434|564964201|FG001|Double-Blind|Other|0|||
156511225|NCT00798434|564964200|FG000|Double-Blind|Not Treated|3|||
156511226|NCT00798434|564964201|FG001|Double-Blind|Not Treated|6|||
156511227|NCT00798434|564964200|FG000|Open-Label|Adverse Event|33|||
156511228|NCT00798434|564964201|FG001|Open-Label|Adverse Event|11|||
156511229|NCT00798434|564964200|FG000|Open-Label|Lack of Efficacy|5|||
156511230|NCT00798434|564964201|FG001|Open-Label|Lack of Efficacy|11|||
156511231|NCT00798434|564964200|FG000|Open-Label|Withdrawal by Subject|2|||
156552055|NCT05103332|565112079|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552056|NCT05103332|565112080|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
156552057|NCT05103332|565112081|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
156552058|NCT05103332|565112082|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552059|NCT05103332|565112083|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156401174|NCT00696384|564561197|FG002|Open Label Phase|Protocol Violation|0|||
156401175|NCT00696384|564561195|FG000|Open Label Phase|Lost to Follow-up|24|||
156401176|NCT00696384|564561196|FG001|Open Label Phase|Lost to Follow-up|0|||
156401177|NCT00696384|564561197|FG002|Open Label Phase|Lost to Follow-up|0|||
156401178|NCT00696384|564561195|FG000|Open Label Phase|Withdrawal by Subject|37|||
156401179|NCT00696384|564561196|FG001|Open Label Phase|Withdrawal by Subject|0|||
156401180|NCT00696384|564561197|FG002|Open Label Phase|Withdrawal by Subject|0|||
156401181|NCT00696384|564561195|FG000|Open Label Phase|Other|6|||
156401182|NCT00696384|564561196|FG001|Open Label Phase|Other|0|||
156401183|NCT00696384|564561197|FG002|Open Label Phase|Other|0|||
156401184|NCT00696384|564561195|FG000|Open Label Phase|Lack of Efficacy|3|||
156401185|NCT00696384|564561196|FG001|Open Label Phase|Lack of Efficacy|0|||
156401186|NCT00696384|564561197|FG002|Open Label Phase|Lack of Efficacy|0|||
156401187|NCT00696384|564561195|FG000|Open Label Phase|Physician Decision|4|||
156401188|NCT00696384|564561196|FG001|Open Label Phase|Physician Decision|0|||
156401189|NCT00696384|564561197|FG002|Open Label Phase|Physician Decision|0|||
156401190|NCT00696384|564561195|FG000|Double Blind Phase|Adverse Event|0|||
156401191|NCT00696384|564561196|FG001|Double Blind Phase|Adverse Event|2|||
156401192|NCT00696384|564561197|FG002|Double Blind Phase|Adverse Event|2|||
156401193|NCT00696384|564561195|FG000|Double Blind Phase|Lost to Follow-up|0|||
156401194|NCT00696384|564561196|FG001|Double Blind Phase|Lost to Follow-up|2|||
156401195|NCT00696384|564561197|FG002|Double Blind Phase|Lost to Follow-up|1|||
156401196|NCT00696384|564561195|FG000|Double Blind Phase|Withdrawal by Subject|0|||
156401197|NCT00696384|564561196|FG001|Double Blind Phase|Withdrawal by Subject|4|||
156401198|NCT00696384|564561197|FG002|Double Blind Phase|Withdrawal by Subject|3|||
156401199|NCT00696384|564561195|FG000|Double Blind Phase|Lack of Efficacy|0|||
156401200|NCT00696384|564561196|FG001|Double Blind Phase|Lack of Efficacy|1|||
156401201|NCT00696384|564561197|FG002|Double Blind Phase|Lack of Efficacy|0|||
156401202|NCT00696384|564561195|FG000|Double Blind Phase|Physician Decision|0|||
156401203|NCT00696384|564561196|FG001|Double Blind Phase|Physician Decision|2|||
156401204|NCT00696384|564561197|FG002|Double Blind Phase|Physician Decision|0|||
156401205|NCT01678131|564561198|FG000|Overall Study|Adverse Event|0|||
156401206|NCT01678131|564561199|FG001|Overall Study|Adverse Event|1|||
156401207|NCT01678131|564561200|FG002|Overall Study|Adverse Event|0|||
156401208|NCT01678131|564561198|FG000|Overall Study|Withdrawal by Subject|0|||
156401209|NCT01678131|564561199|FG001|Overall Study|Withdrawal by Subject|0|||
156401210|NCT01678131|564561200|FG002|Overall Study|Withdrawal by Subject|2|||
156401211|NCT00558064|564561202|FG000|Overall Study|Adverse Event|3|||
156552060|NCT05103332|565112084|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
156552061|NCT05103332|565112085|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552062|NCT05103332|565112086|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552063|NCT05103332|565112087|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552064|NCT05103332|565112088|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552065|NCT05103332|565112089|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552066|NCT05103332|565112090|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552067|NCT05103332|565112091|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552068|NCT05103332|565112092|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552069|NCT05103332|565112093|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552070|NCT05103332|565112094|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552071|NCT05103332|565112095|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552072|NCT05103332|565112096|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552073|NCT05103332|565112079|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552074|NCT05103332|565112080|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
156552075|NCT05103332|565112081|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552076|NCT05103332|565112082|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
156552077|NCT05103332|565112083|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552078|NCT05103332|565112084|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552079|NCT05103332|565112085|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552080|NCT05103332|565112086|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552081|NCT05103332|565112087|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552082|NCT05103332|565112088|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552083|NCT05103332|565112089|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552084|NCT05103332|565112090|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552085|NCT05103332|565112091|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552086|NCT05103332|565112092|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552087|NCT05103332|565112093|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552088|NCT05103332|565112094|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552089|NCT05103332|565112095|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552090|NCT05103332|565112096|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
156552091|NCT05103332|565112079|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
156552092|NCT05103332|565112080|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
156552093|NCT05103332|565112081|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
156552094|NCT05103332|565112082|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
156552095|NCT05103332|565112083|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
156552096|NCT05103332|565112084|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
156552097|NCT05103332|565112085|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552098|NCT05103332|565112086|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552099|NCT05103332|565112087|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552100|NCT05103332|565112088|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552101|NCT05103332|565112089|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552102|NCT05103332|565112090|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552103|NCT05103332|565112091|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552104|NCT05103332|565112092|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552105|NCT05103332|565112093|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552106|NCT05103332|565112094|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552107|NCT05103332|565112095|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552108|NCT05103332|565112096|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552109|NCT05103332|565112079|FG000|DB Period (6 Months=168 Days)|Other|0|||
156552110|NCT05103332|565112080|FG001|DB Period (6 Months=168 Days)|Other|0|||
156552111|NCT05103332|565112081|FG002|DB Period (6 Months=168 Days)|Other|0|||
156552112|NCT05103332|565112082|FG003|DB Period (6 Months=168 Days)|Other|1|||
156552113|NCT05103332|565112083|FG004|DB Period (6 Months=168 Days)|Other|0|||
156552114|NCT05103332|565112084|FG005|DB Period (6 Months=168 Days)|Other|0|||
156552115|NCT05103332|565112085|FG006|DB Period (6 Months=168 Days)|Other|0|||
156552116|NCT05103332|565112086|FG007|DB Period (6 Months=168 Days)|Other|0|||
156552117|NCT05103332|565112087|FG008|DB Period (6 Months=168 Days)|Other|0|||
156552118|NCT05103332|565112088|FG009|DB Period (6 Months=168 Days)|Other|0|||
156552119|NCT05103332|565112089|FG010|DB Period (6 Months=168 Days)|Other|0|||
156552120|NCT05103332|565112090|FG011|DB Period (6 Months=168 Days)|Other|0|||
156552121|NCT05103332|565112091|FG012|DB Period (6 Months=168 Days)|Other|0|||
156552122|NCT05103332|565112092|FG013|DB Period (6 Months=168 Days)|Other|0|||
156552123|NCT05103332|565112093|FG014|DB Period (6 Months=168 Days)|Other|0|||
156552124|NCT05103332|565112094|FG015|DB Period (6 Months=168 Days)|Other|0|||
156552125|NCT05103332|565112095|FG016|DB Period (6 Months=168 Days)|Other|0|||
156401212|NCT00558064|564561203|FG001|Overall Study|Adverse Event|2|||
156401213|NCT00558064|564561202|FG000|Overall Study|Lack of Efficacy|0|||
156401214|NCT00558064|564561203|FG001|Overall Study|Lack of Efficacy|1|||
156401215|NCT00558064|564561202|FG000|Overall Study|Protocol Violation|1|||
156401216|NCT00558064|564561203|FG001|Overall Study|Protocol Violation|0|||
156401217|NCT00558064|564561202|FG000|Overall Study|Lost to Follow-up|0|||
156511232|NCT00798434|564964201|FG001|Open-Label|Withdrawal by Subject|7|||
156511233|NCT00798434|564964200|FG000|Open-Label|Protocol Violation|1|||
156511234|NCT00798434|564964201|FG001|Open-Label|Protocol Violation|0|||
156511235|NCT00798434|564964200|FG000|Open-Label|Other|1|||
156511236|NCT00798434|564964201|FG001|Open-Label|Other|2|||
156511237|NCT00798434|564964200|FG000|Open-Label|Not Treated|0|||
156511238|NCT00798434|564964201|FG001|Open-Label|Not Treated|1|||
156511239|NCT01217437|564964205|FG000|Overall Study|Adverse Event|0|||
156511240|NCT01217437|564964206|FG001|Overall Study|Adverse Event|8|||
156511241|NCT01217437|564964205|FG000|Overall Study|Death|5|||
156511242|NCT01217437|564964206|FG001|Overall Study|Death|0|||
156511243|NCT01217437|564964205|FG000|Overall Study|Lack of Efficacy|29|||
156511244|NCT01217437|564964206|FG001|Overall Study|Lack of Efficacy|25|||
156511245|NCT01217437|564964205|FG000|Overall Study|Physician Decision|8|||
156511246|NCT01217437|564964206|FG001|Overall Study|Physician Decision|5|||
156511247|NCT01217437|564964205|FG000|Overall Study|Withdrawal by Subject|0|||
156511248|NCT01217437|564964206|FG001|Overall Study|Withdrawal by Subject|2|||
156511249|NCT01217437|564964205|FG000|Overall Study|Ineligible|1|||
156511250|NCT01217437|564964206|FG001|Overall Study|Ineligible|1|||
156511251|NCT04908631|564964209|FG000|Overall Study|Lost to Follow-up|1|||
156511252|NCT04908631|564964209|FG000|Overall Study|Physician Decision|1|||
156511253|NCT04908631|564964209|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
156511254|NCT06655558|564964213|FG000|Overall Study|Protocol Violation|1|||
156511255|NCT04303780|564964214|FG000|Overall Study|Death|104|||
156511256|NCT04303780|564964215|FG001|Overall Study|Death|85|||
156511257|NCT04303780|564964214|FG000|Overall Study|Lost to Follow-up|5|||
156511258|NCT04303780|564964215|FG001|Overall Study|Lost to Follow-up|2|||
156511259|NCT04303780|564964214|FG000|Overall Study|Withdrawal by Subject|12|||
156511260|NCT04303780|564964215|FG001|Overall Study|Withdrawal by Subject|39|||
156511261|NCT04303780|564964214|FG000|Overall Study|Ongoing in study|50|||
156511262|NCT04303780|564964215|FG001|Overall Study|Ongoing in study|45|||
156511263|NCT04893460|564964216|FG000|Overall Study|Lost to Follow-up|18|||
156511264|NCT00387426|564965689|FG000|Overall Study|Lack of Response|7|||
156511265|NCT00387426|564965689|FG000|Overall Study|Toxicities|4|||
156511266|NCT00387426|564965689|FG000|Overall Study|Disease Progression|3|||
156511267|NCT00890695|564965692|FG000|Overall Study|Protocol Violation|1|||
156511268|NCT00890695|564965693|FG001|Overall Study|Protocol Violation|0|||
156511269|NCT02314780|564965696|FG000|Overall Study|organizational reasons|0|||
156511270|NCT02314780|564965697|FG001|Overall Study|organizational reasons|2|||
156511271|NCT02314780|564965698|FG002|Overall Study|organizational reasons|0|||
156511272|NCT02314780|564965696|FG000|Overall Study|Adverse Event|0|||
156511273|NCT02314780|564965697|FG001|Overall Study|Adverse Event|1|||
156511274|NCT02314780|564965698|FG002|Overall Study|Adverse Event|0|||
156511275|NCT00379288|564965701|FG000|Overall Study|Adverse Event|5|||
156511276|NCT00379288|564965702|FG001|Overall Study|Adverse Event|6|||
156511277|NCT00379288|564965703|FG002|Overall Study|Adverse Event|2|||
156511278|NCT00379288|564965704|FG003|Overall Study|Adverse Event|0|||
156511279|NCT00379288|564965701|FG000|Overall Study|Treatment Failure|0|||
156511280|NCT00379288|564965702|FG001|Overall Study|Treatment Failure|1|||
156511281|NCT00379288|564965703|FG002|Overall Study|Treatment Failure|0|||
156511282|NCT00379288|564965704|FG003|Overall Study|Treatment Failure|1|||
156511283|NCT00379288|564965701|FG000|Overall Study|Lost to Follow-up|3|||
156511284|NCT00379288|564965702|FG001|Overall Study|Lost to Follow-up|3|||
156511285|NCT00379288|564965703|FG002|Overall Study|Lost to Follow-up|2|||
156511286|NCT00379288|564965704|FG003|Overall Study|Lost to Follow-up|0|||
156511287|NCT00379288|564965701|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
156401218|NCT00558064|564561203|FG001|Overall Study|Lost to Follow-up|1|||
156401219|NCT00558064|564561202|FG000|Overall Study|Withdrawal by Subject|0|||
156401220|NCT00558064|564561203|FG001|Overall Study|Withdrawal by Subject|1|||
156511288|NCT00379288|564965702|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
156511289|NCT00379288|564965703|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
156511290|NCT00379288|564965704|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
156511291|NCT00379288|564965701|FG000|Overall Study|Subject withdrew-related to study drug|1|||
156511292|NCT00379288|564965702|FG001|Overall Study|Subject withdrew-related to study drug|0|||
156511293|NCT00379288|564965703|FG002|Overall Study|Subject withdrew-related to study drug|0|||
156511294|NCT00379288|564965704|FG003|Overall Study|Subject withdrew-related to study drug|1|||
156511295|NCT00379288|564965701|FG000|Overall Study|Noncompliance with protocol|8|||
156511296|NCT00379288|564965702|FG001|Overall Study|Noncompliance with protocol|6|||
156511297|NCT00379288|564965703|FG002|Overall Study|Noncompliance with protocol|2|||
156511298|NCT00379288|564965704|FG003|Overall Study|Noncompliance with protocol|1|||
156511299|NCT00379288|564965701|FG000|Overall Study|Did not meet protocol eligibility|0|||
156511300|NCT00379288|564965702|FG001|Overall Study|Did not meet protocol eligibility|1|||
156511301|NCT00379288|564965703|FG002|Overall Study|Did not meet protocol eligibility|0|||
156511302|NCT00379288|564965704|FG003|Overall Study|Did not meet protocol eligibility|2|||
156511303|NCT00379288|564965701|FG000|Overall Study|Administrative|2|||
156511304|NCT00379288|564965702|FG001|Overall Study|Administrative|2|||
156511305|NCT00379288|564965703|FG002|Overall Study|Administrative|0|||
156511306|NCT00379288|564965704|FG003|Overall Study|Administrative|1|||
156511307|NCT04396366|564965707|FG000|Overall Study|Adverse Event|1|||
156511308|NCT04396366|564965708|FG001|Overall Study|Adverse Event|0|||
156511309|NCT03986944|564965709|FG000|Overall Study|Adverse Event|1|||
156511310|NCT03986944|564965710|FG001|Overall Study|Adverse Event|2|||
156511311|NCT03986944|564965711|FG002|Overall Study|Adverse Event|3|||
156511312|NCT03986944|564965709|FG000|Overall Study|Protocol Violation|0|||
156511313|NCT03986944|564965710|FG001|Overall Study|Protocol Violation|1|||
156511314|NCT03986944|564965711|FG002|Overall Study|Protocol Violation|1|||
156511315|NCT03986944|564965709|FG000|Overall Study|Withdrawal by Subject|3|||
156511316|NCT03986944|564965710|FG001|Overall Study|Withdrawal by Subject|5|||
156511317|NCT03986944|564965711|FG002|Overall Study|Withdrawal by Subject|5|||
156511318|NCT03986944|564965709|FG000|Overall Study|Study termination|10|||
156511319|NCT03986944|564965710|FG001|Overall Study|Study termination|10|||
156511320|NCT03986944|564965711|FG002|Overall Study|Study termination|10|||
156511321|NCT03986944|564965709|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
156511322|NCT03986944|564965710|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
156511323|NCT03986944|564965711|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
156511324|NCT03986944|564965709|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
156511325|NCT03986944|564965710|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
156511326|NCT03986944|564965711|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
156511327|NCT03002220|564965712|FG000|Overall Study|Lack of Efficacy|2|||
156511328|NCT03002220|564965712|FG000|Overall Study|Withdrawal by Subject|3|||
156511329|NCT03002220|564965712|FG000|Overall Study|Adverse Event|2|||
156511330|NCT03002220|564965712|FG000|Overall Study|Disease progression|13|||
156511331|NCT03002220|564965712|FG000|Overall Study|Physician Decision|1|||
156511332|NCT01015560|564965713|FG000|Overall Study|Adverse Event|1|||
156511333|NCT01015560|564965713|FG000|Overall Study|Not protocol specified|1|||
156511334|NCT01015560|564965713|FG000|Overall Study|Withdrawal by Subject|1|||
156511335|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
156511336|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
156511337|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
156511338|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
156511339|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
156511340|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
156511341|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
156511342|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
156511343|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
156511344|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
156511345|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
156511346|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
156511347|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Death|1|||
156511348|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Death|2|||
156511349|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Death|2|||
156511350|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Death|0|||
156511351|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Death|0|||
156511352|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Death|0|||
156511353|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
156511354|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
156511355|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
156511356|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
156511357|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
156511358|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
156511359|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
156511360|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
156511361|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
156511362|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
156511363|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
156511364|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
156511365|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
156511366|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
156511367|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
156511368|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
156401221|NCT00558064|564561202|FG000|Overall Study|No visit within allowance period|1|||
156401222|NCT00558064|564561203|FG001|Overall Study|No visit within allowance period|0|||
156401223|NCT00982930|564561204|FG000|Overall Study|Adverse Event|1|||
156401224|NCT00982930|564561204|FG000|Overall Study|Withdrawal by Subject|1|||
156401225|NCT00982930|564561204|FG000|Overall Study|Administrative Problems|2|||
156401226|NCT00941798|564561205|FG000|Overall Study|Withdrawal by Subject|72|||
156401227|NCT00941798|564561206|FG001|Overall Study|Withdrawal by Subject|74|||
156401228|NCT00941798|564561205|FG000|Overall Study|Adverse Event|43|||
156401229|NCT00941798|564561206|FG001|Overall Study|Adverse Event|23|||
156401230|NCT00941798|564561205|FG000|Overall Study|Lost to Follow-up|29|||
156401231|NCT00941798|564561206|FG001|Overall Study|Lost to Follow-up|23|||
156401232|NCT00941798|564561205|FG000|Overall Study|Protocol Violation|17|||
156401233|NCT00941798|564561206|FG001|Overall Study|Protocol Violation|20|||
156401234|NCT00941798|564561205|FG000|Overall Study|Administrative problems|13|||
156401235|NCT00941798|564561206|FG001|Overall Study|Administrative problems|23|||
156401236|NCT00941798|564561205|FG000|Overall Study|Lack of Efficacy|10|||
156401237|NCT00941798|564561206|FG001|Overall Study|Lack of Efficacy|17|||
156401238|NCT00941798|564561205|FG000|Overall Study|Patient's inability to use device|6|||
156401239|NCT00941798|564561206|FG001|Overall Study|Patient's inability to use device|1|||
156401240|NCT00941798|564561205|FG000|Overall Study|Abnormal test procedure results|3|||
156401241|NCT00941798|564561206|FG001|Overall Study|Abnormal test procedure results|1|||
156401242|NCT00941798|564561205|FG000|Overall Study|Abnormal laboratory values|1|||
156401243|NCT00941798|564561206|FG001|Overall Study|Abnormal laboratory values|2|||
156401244|NCT00941798|564561205|FG000|Overall Study|Death|0|||
156401245|NCT00941798|564561206|FG001|Overall Study|Death|1|||
156401246|NCT04179721|564561209|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
156401247|NCT04179721|564561210|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
156401248|NCT04179721|564561209|FG000|Overall Study|Lost to Follow-up|0|||
156401249|NCT04179721|564561210|FG001|Overall Study|Lost to Follow-up|1|||
156401250|NCT04225988|564561211|FG000|Overall Study|Withdrawal by Subject|2|||
156401251|NCT04225988|564561212|FG001|Overall Study|Withdrawal by Subject|0|||
156401252|NCT05597722|564561213|FG000|Overall Study|Study was terminated|6|||
156401253|NCT05597722|564561214|FG001|Overall Study|Study was terminated|1|||
156401254|NCT00404495|564561215|FG000|Overall Study|Death|37|||
156401255|NCT00404495|564561216|FG001|Overall Study|Death|11|||
156401256|NCT00404495|564561215|FG000|Overall Study|Lost to Follow-up|5|||
156401257|NCT00404495|564561216|FG001|Overall Study|Lost to Follow-up|0|||
156401258|NCT00404495|564561215|FG000|Overall Study|Other|1|||
156401259|NCT00404495|564561216|FG001|Overall Study|Other|0|||
156401260|NCT00404495|564561215|FG000|Overall Study|Withdrawal by Subject|1|||
156401261|NCT00404495|564561216|FG001|Overall Study|Withdrawal by Subject|0|||
156401262|NCT04108000|564561217|FG000|Overall Study|Death of patient|1|||
156401263|NCT04108000|564561218|FG001|Overall Study|Death of patient|0|||
156401264|NCT04108000|564561219|FG002|Overall Study|Death of patient|1|||
156401265|NCT04108000|564561220|FG003|Overall Study|Death of patient|0|||
156401266|NCT04108000|564561217|FG000|Overall Study|Withdrawal by Subject|2|||
156401267|NCT04108000|564561218|FG001|Overall Study|Withdrawal by Subject|2|||
156401268|NCT04108000|564561219|FG002|Overall Study|Withdrawal by Subject|0|||
156401269|NCT04108000|564561220|FG003|Overall Study|Withdrawal by Subject|0|||
156401270|NCT04108000|564561217|FG000|Overall Study|Death of surrogate partner|0|||
156401271|NCT04108000|564561218|FG001|Overall Study|Death of surrogate partner|1|||
156401272|NCT04108000|564561219|FG002|Overall Study|Death of surrogate partner|0|||
156401273|NCT04108000|564561220|FG003|Overall Study|Death of surrogate partner|1|||
156401274|NCT05559866|564561225|FG000|Overall Study|Withdrawal by Subject|1|||
156401275|NCT05559866|564561226|FG001|Overall Study|Withdrawal by Subject|0|||
156401276|NCT03750006|564561227|FG000|Overall Study|Withdrawal by Subject|8|||
156401277|NCT03750006|564561227|FG000|Overall Study|COVID PANDEMIC|11|||
156401278|NCT01493960|564563445|FG000|Overall Study|Adverse Event|0|||
156401279|NCT01493960|564563446|FG001|Overall Study|Adverse Event|1|||
156401280|NCT01493960|564563445|FG000|Overall Study|Lack of Efficacy|15|||
156401281|NCT01493960|564563446|FG001|Overall Study|Lack of Efficacy|9|||
156401282|NCT01493960|564563445|FG000|Overall Study|Protocol Violation|3|||
156401283|NCT01493960|564563446|FG001|Overall Study|Protocol Violation|0|||
156401284|NCT01493960|564563445|FG000|Overall Study|Withdrawal by Subject|10|||
156401285|NCT01493960|564563446|FG001|Overall Study|Withdrawal by Subject|4|||
156401286|NCT01493960|564563445|FG000|Overall Study|Non-specified|4|||
156401287|NCT01493960|564563446|FG001|Overall Study|Non-specified|4|||
156401288|NCT03935217|564563447|FG000|Overall Study|Adverse Event|1|||
156401289|NCT03935217|564563448|FG001|Overall Study|Adverse Event|0|||
156401290|NCT03935217|564563447|FG000|Overall Study|Lost to Follow-up|0|||
156401291|NCT03935217|564563448|FG001|Overall Study|Lost to Follow-up|1|||
156401292|NCT03935217|564563447|FG000|Overall Study|Withdrawal by Subject|0|||
156401293|NCT03935217|564563448|FG001|Overall Study|Withdrawal by Subject|2|||
156401294|NCT03237858|564563449|FG000|Overall Study|Death|19|||
156401295|NCT03237858|564563449|FG000|Overall Study|Withdrawal by Subject|37|||
156401296|NCT01160484|564563451|FG000|Overall Study|Lack of Efficacy|9|||
156401297|NCT01160484|564563451|FG000|Overall Study|Adverse Event|6|||
156401298|NCT01160484|564563451|FG000|Overall Study|Withdrawal by Subject|2|||
156401299|NCT01160484|564563451|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
156401300|NCT02026232|564563454|FG000|Overall Study|incomplete visit/missing data|3|||
156401301|NCT02026232|564563455|FG001|Overall Study|incomplete visit/missing data|2|||
156401302|NCT00332332|564563456|FG000|Overall Study|Adverse Event|13|||
156401303|NCT00332332|564563456|FG000|Overall Study|Death|1|||
156401304|NCT00332332|564563456|FG000|Overall Study|Withdrawal by Subject|8|||
156401305|NCT00332332|564563456|FG000|Overall Study|Physician Decision|1|||
156401306|NCT00332332|564563456|FG000|Overall Study|Lost to Follow-up|3|||
156401307|NCT00332332|564563456|FG000|Overall Study|Protocol deviation|4|||
156401308|NCT00332332|564563456|FG000|Overall Study|Noncompliance|2|||
156401309|NCT00332332|564563456|FG000|Overall Study|Disease progression|2|||
156401310|NCT00332332|564563456|FG000|Overall Study|Other|18|||
156401311|NCT00332332|564563456|FG000|Overall Study|Did not receive study treatment|16|||
156401312|NCT01108458|564563457|FG000|Overall Study|Withdrawal by Subject|1|||
156401313|NCT00755222|564563466|FG000|Overall Study|Withdrawal by Subject|4|||
156401314|NCT00755222|564563467|FG001|Overall Study|Withdrawal by Subject|2|||
156401315|NCT00755222|564563466|FG000|Overall Study|Adverse Event|2|||
156401316|NCT00755222|564563467|FG001|Overall Study|Adverse Event|0|||
156401317|NCT00755222|564563466|FG000|Overall Study|Protocol Violation|2|||
156401318|NCT00755222|564563467|FG001|Overall Study|Protocol Violation|0|||
156401319|NCT01147822|564563474|FG000|Overall Study|Lost to Follow-up|14|||
156401320|NCT01147822|564563475|FG001|Overall Study|Lost to Follow-up|6|||
156401321|NCT01147822|564563474|FG000|Overall Study|Withdrawal by Subject|10|||
156401322|NCT01147822|564563475|FG001|Overall Study|Withdrawal by Subject|16|||
156401323|NCT01147822|564563474|FG000|Overall Study|Physician Decision|9|||
156401324|NCT01147822|564563475|FG001|Overall Study|Physician Decision|8|||
156401325|NCT01147822|564563474|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
156401326|NCT01147822|564563475|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
156401327|NCT01147822|564563474|FG000|Overall Study|Protocol Violation|1|||
156401328|NCT01147822|564563475|FG001|Overall Study|Protocol Violation|1|||
156401329|NCT01492686|564563483|FG000|Double-blind Phase|Adverse Event|0|||
156401330|NCT01492686|564563484|FG001|Double-blind Phase|Adverse Event|2|||
156511369|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
156511370|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
156511371|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
156511372|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
156511373|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
156511374|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
156511375|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
156511376|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
156511377|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
156511378|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
156511379|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
156511380|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
156511381|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
156511382|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
156511383|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
156511384|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
156511385|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
156511386|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
156511387|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
156511388|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
156511389|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
156511390|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
156511391|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
156511392|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
156552126|NCT05103332|565112096|FG017|DB Period (6 Months=168 Days)|Other|0|||
156552127|NCT05103332|565112079|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552128|NCT05103332|565112080|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156401331|NCT01492686|564563483|FG000|Double-blind Phase|Physician Decision|0|||
156401332|NCT01492686|564563484|FG001|Double-blind Phase|Physician Decision|1|||
156401333|NCT01492686|564563483|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156401334|NCT01492686|564563484|FG001|Double-blind Phase|Withdrawal by Subject|2|||
156401335|NCT01492686|564563483|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
156401336|NCT01492686|564563484|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
156552129|NCT05103332|565112081|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552130|NCT05103332|565112082|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552131|NCT05103332|565112083|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552132|NCT05103332|565112084|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552133|NCT05103332|565112085|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552134|NCT05103332|565112086|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552135|NCT05103332|565112087|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552136|NCT05103332|565112088|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552137|NCT05103332|565112089|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
156552138|NCT05103332|565112090|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552139|NCT05103332|565112091|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552140|NCT05103332|565112092|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552141|NCT05103332|565112093|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552142|NCT05103332|565112094|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552143|NCT05103332|565112095|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552144|NCT05103332|565112096|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156552145|NCT05103332|565112079|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552146|NCT05103332|565112080|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552147|NCT05103332|565112081|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552148|NCT05103332|565112082|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552149|NCT05103332|565112083|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552150|NCT05103332|565112084|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552151|NCT05103332|565112085|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552152|NCT05103332|565112086|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552153|NCT05103332|565112087|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
156552154|NCT05103332|565112088|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552155|NCT05103332|565112089|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552156|NCT05103332|565112090|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552157|NCT05103332|565112091|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552158|NCT05103332|565112092|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552159|NCT05103332|565112093|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552160|NCT05103332|565112094|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552161|NCT05103332|565112095|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552162|NCT05103332|565112096|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156552163|NCT05103332|565112079|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552164|NCT05103332|565112080|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552165|NCT05103332|565112081|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552166|NCT05103332|565112082|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552167|NCT05103332|565112083|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552168|NCT05103332|565112084|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552169|NCT05103332|565112085|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552170|NCT05103332|565112086|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552171|NCT05103332|565112087|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552172|NCT05103332|565112088|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552173|NCT05103332|565112089|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552174|NCT05103332|565112090|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
156552175|NCT05103332|565112091|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552176|NCT05103332|565112092|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552177|NCT05103332|565112093|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552178|NCT05103332|565112094|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552179|NCT05103332|565112095|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552180|NCT05103332|565112096|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
156552181|NCT05103332|565112079|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552182|NCT05103332|565112080|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552183|NCT05103332|565112081|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552184|NCT05103332|565112082|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552185|NCT05103332|565112083|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552186|NCT05103332|565112084|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552187|NCT05103332|565112085|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
156552188|NCT05103332|565112086|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
156552189|NCT05103332|565112087|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552190|NCT05103332|565112088|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
156552191|NCT05103332|565112089|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
156552192|NCT05103332|565112090|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
156552193|NCT05103332|565112091|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552194|NCT05103332|565112092|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552195|NCT05103332|565112093|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156552196|NCT05103332|565112094|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156401337|NCT01492686|564563483|FG000|Open-label Phase|Adverse Event|1|||
156401338|NCT01492686|564563484|FG001|Open-label Phase|Adverse Event|2|||
156401339|NCT01492686|564563483|FG000|Open-label Phase|Physician Decision|1|||
156401340|NCT01492686|564563484|FG001|Open-label Phase|Physician Decision|0|||
156401341|NCT01492686|564563483|FG000|Open-label Phase|Withdrawal by Subject|6|||
156401342|NCT01492686|564563484|FG001|Open-label Phase|Withdrawal by Subject|7|||
156401343|NCT01492686|564563483|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
156401344|NCT01492686|564563484|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
156401345|NCT02313909|564563485|FG000|Overall Study|Consent withdrawn by participant|33|||
156401346|NCT02313909|564563486|FG001|Overall Study|Consent withdrawn by participant|33|||
156401347|NCT02313909|564563485|FG000|Overall Study|Lost to Follow-up|24|||
156511393|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
156511394|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
156511395|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Site closure|0|||
156511396|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Site closure|0|||
156511397|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Site closure|1|||
156511398|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Site closure|0|||
156511399|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Site closure|0|||
156511400|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Site closure|0|||
156511401|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
156511402|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
156511403|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
156511404|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
156511405|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
156511406|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
156511407|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
156511408|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
156511409|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
156511410|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
156511411|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
156511412|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
156511413|NCT03439254|564965716|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
156511414|NCT03439254|564965717|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
156511415|NCT03439254|564965718|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
156511416|NCT03439254|564965719|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
156511417|NCT03439254|564965720|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
156511418|NCT03439254|564965721|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
156511419|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
156511420|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
156511421|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
156511422|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
156511423|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
156511424|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
156511425|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
156511426|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
156511427|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
156511428|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
156511429|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
156511430|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
156511431|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
156511432|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
156511433|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
156511434|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
156511435|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
156511436|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
156511437|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
156511438|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
156511439|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
156511440|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
156511441|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
156511442|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
156511443|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
156511444|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
156401348|NCT02313909|564563486|FG001|Overall Study|Lost to Follow-up|17|||
156401349|NCT02798211|564563487|FG000|Period 1|Adverse Event|1|||
156511445|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
156511446|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
156511447|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
156511448|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
156511449|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
156511450|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
156511451|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
156511452|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
156511453|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
156511454|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
156511455|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
156511456|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
156511457|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
156511458|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
156511459|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
156511460|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
156511461|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
156511462|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
156511463|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
156511464|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
156511465|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
156511466|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
156511467|NCT03439254|564965716|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
156511468|NCT03439254|564965717|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
156511469|NCT03439254|564965718|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
156511470|NCT03439254|564965719|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
156511471|NCT03439254|564965720|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
156511472|NCT03439254|564965721|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
156511473|NCT01531673|564965722|FG000|Overall Study|Non-Compliance|0|||
156511474|NCT01531673|564965723|FG001|Overall Study|Non-Compliance|0|||
156511475|NCT01531673|564965724|FG002|Overall Study|Non-Compliance|0|||
156511476|NCT01531673|564965725|FG003|Overall Study|Non-Compliance|0|||
156511477|NCT01531673|564965726|FG004|Overall Study|Non-Compliance|0|||
156511478|NCT01531673|564965727|FG005|Overall Study|Non-Compliance|1|||
156511479|NCT01531673|564965728|FG006|Overall Study|Non-Compliance|0|||
156511480|NCT01531673|564965729|FG007|Overall Study|Non-Compliance|0|||
156511481|NCT01531673|564965730|FG008|Overall Study|Non-Compliance|0|||
156511482|NCT01531673|564965731|FG009|Overall Study|Non-Compliance|0|||
156511483|NCT01531673|564965732|FG010|Overall Study|Non-Compliance|0|||
156511484|NCT01531673|564965733|FG011|Overall Study|Non-Compliance|0|||
156511485|NCT01531673|564965734|FG012|Overall Study|Non-Compliance|0|||
156511486|NCT01531673|564965722|FG000|Overall Study|Adverse Event|0|||
156511487|NCT01531673|564965723|FG001|Overall Study|Adverse Event|1|||
156511488|NCT01531673|564965724|FG002|Overall Study|Adverse Event|0|||
156511489|NCT01531673|564965725|FG003|Overall Study|Adverse Event|0|||
156511490|NCT01531673|564965726|FG004|Overall Study|Adverse Event|0|||
156511491|NCT01531673|564965727|FG005|Overall Study|Adverse Event|0|||
156511492|NCT01531673|564965728|FG006|Overall Study|Adverse Event|0|||
156511493|NCT01531673|564965729|FG007|Overall Study|Adverse Event|0|||
156511494|NCT01531673|564965730|FG008|Overall Study|Adverse Event|0|||
156511495|NCT01531673|564965731|FG009|Overall Study|Adverse Event|0|||
156511496|NCT01531673|564965732|FG010|Overall Study|Adverse Event|0|||
156511497|NCT01531673|564965733|FG011|Overall Study|Adverse Event|0|||
156511498|NCT01531673|564965734|FG012|Overall Study|Adverse Event|0|||
156511499|NCT01531673|564965722|FG000|Overall Study|Lost to Follow-up|0|||
156511500|NCT01531673|564965723|FG001|Overall Study|Lost to Follow-up|0|||
156511501|NCT01531673|564965724|FG002|Overall Study|Lost to Follow-up|0|||
156511502|NCT01531673|564965725|FG003|Overall Study|Lost to Follow-up|0|||
156511503|NCT01531673|564965726|FG004|Overall Study|Lost to Follow-up|1|||
156511504|NCT01531673|564965727|FG005|Overall Study|Lost to Follow-up|0|||
156511505|NCT01531673|564965728|FG006|Overall Study|Lost to Follow-up|0|||
156511506|NCT01531673|564965729|FG007|Overall Study|Lost to Follow-up|0|||
156552197|NCT05103332|565112095|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156511507|NCT01531673|564965730|FG008|Overall Study|Lost to Follow-up|0|||
156511508|NCT01531673|564965731|FG009|Overall Study|Lost to Follow-up|0|||
156511509|NCT01531673|564965732|FG010|Overall Study|Lost to Follow-up|0|||
156511510|NCT01531673|564965733|FG011|Overall Study|Lost to Follow-up|0|||
156511511|NCT01531673|564965734|FG012|Overall Study|Lost to Follow-up|0|||
156511512|NCT01531673|564965722|FG000|Overall Study|Other|0|||
156511513|NCT01531673|564965723|FG001|Overall Study|Other|0|||
156511514|NCT01531673|564965724|FG002|Overall Study|Other|0|||
156511515|NCT01531673|564965725|FG003|Overall Study|Other|1|||
156511516|NCT01531673|564965726|FG004|Overall Study|Other|0|||
156511517|NCT01531673|564965727|FG005|Overall Study|Other|0|||
156401350|NCT02798211|564563488|FG001|Period 1|Adverse Event|1|||
156401351|NCT02798211|564563489|FG002|Period 1|Adverse Event|0|||
156401352|NCT02798211|564563490|FG003|Period 1|Adverse Event|0|||
156401353|NCT02798211|564563491|FG004|Period 1|Adverse Event|0|||
156401354|NCT02798211|564563492|FG005|Period 1|Adverse Event|0|||
156401355|NCT02798211|564563487|FG000|Period 1|Lost to Follow-up|2|||
156401356|NCT02798211|564563488|FG001|Period 1|Lost to Follow-up|1|||
156401357|NCT02798211|564563489|FG002|Period 1|Lost to Follow-up|0|||
156401358|NCT02798211|564563490|FG003|Period 1|Lost to Follow-up|0|||
156401359|NCT02798211|564563491|FG004|Period 1|Lost to Follow-up|0|||
156401360|NCT02798211|564563492|FG005|Period 1|Lost to Follow-up|0|||
156401361|NCT02798211|564563487|FG000|Period 1|Protocol Violation|0|||
156401362|NCT02798211|564563488|FG001|Period 1|Protocol Violation|0|||
156401363|NCT02798211|564563489|FG002|Period 1|Protocol Violation|2|||
156401364|NCT02798211|564563490|FG003|Period 1|Protocol Violation|0|||
156401365|NCT02798211|564563491|FG004|Period 1|Protocol Violation|0|||
156401366|NCT02798211|564563492|FG005|Period 1|Protocol Violation|0|||
156401367|NCT02798211|564563487|FG000|Period 1|Withdrawal by Subject|1|||
156401368|NCT02798211|564563488|FG001|Period 1|Withdrawal by Subject|1|||
156401369|NCT02798211|564563489|FG002|Period 1|Withdrawal by Subject|0|||
156401370|NCT02798211|564563490|FG003|Period 1|Withdrawal by Subject|0|||
156401371|NCT02798211|564563491|FG004|Period 1|Withdrawal by Subject|0|||
156401372|NCT02798211|564563492|FG005|Period 1|Withdrawal by Subject|0|||
156401373|NCT02798211|564563487|FG000|Period 1|Death|0|||
156401374|NCT02798211|564563488|FG001|Period 1|Death|0|||
156401375|NCT02798211|564563489|FG002|Period 1|Death|1|||
156401376|NCT02798211|564563490|FG003|Period 1|Death|0|||
156401377|NCT02798211|564563491|FG004|Period 1|Death|0|||
156401378|NCT02798211|564563492|FG005|Period 1|Death|0|||
156401379|NCT02798211|564563487|FG000|Period 1|Withdrawal of Informed Consent|2|||
156511518|NCT01531673|564965728|FG006|Overall Study|Other|0|||
156511519|NCT01531673|564965729|FG007|Overall Study|Other|0|||
156511520|NCT01531673|564965730|FG008|Overall Study|Other|0|||
156511521|NCT01531673|564965731|FG009|Overall Study|Other|1|||
156552198|NCT05103332|565112096|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156511522|NCT01531673|564965732|FG010|Overall Study|Other|0|||
156511523|NCT01531673|564965733|FG011|Overall Study|Other|0|||
156511524|NCT01531673|564965734|FG012|Overall Study|Other|0|||
156511525|NCT00837694|564965735|FG000|Overall Study|Lost to Follow-up|2|||
156511526|NCT00837694|564965736|FG001|Overall Study|Lost to Follow-up|0|||
156511527|NCT00837694|564965737|FG002|Overall Study|Lost to Follow-up|2|||
156511528|NCT00837694|564965738|FG003|Overall Study|Lost to Follow-up|1|||
156511529|NCT00837694|564965739|FG004|Overall Study|Lost to Follow-up|1|||
156511530|NCT00837694|564965740|FG005|Overall Study|Lost to Follow-up|1|||
156511531|NCT04476251|564965743|FG000|Overall Study|Not treated|1|||
156511532|NCT01008553|564965744|FG000|Period 1 (Titration Period)|Physician Decision|2|||
156511533|NCT01008553|564965745|FG001|Period 1 (Titration Period)|Physician Decision|0|||
156511534|NCT01008553|564965746|FG002|Period 1 (Titration Period)|Physician Decision|0|||
156511535|NCT01008553|564965744|FG000|Period 1 (Titration Period)|Adverse Event|33|||
156511536|NCT01008553|564965745|FG001|Period 1 (Titration Period)|Adverse Event|0|||
156511537|NCT01008553|564965746|FG002|Period 1 (Titration Period)|Adverse Event|0|||
156511538|NCT01008553|564965744|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
156511539|NCT01008553|564965745|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
156511540|NCT01008553|564965746|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
156511541|NCT01008553|564965744|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
156511542|NCT01008553|564965745|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
156511543|NCT01008553|564965746|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
156511544|NCT01008553|564965744|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
156552199|NCT05103332|565112079|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552200|NCT05103332|565112080|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552201|NCT05103332|565112081|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552202|NCT05103332|565112082|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552203|NCT05103332|565112083|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552204|NCT05103332|565112084|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156401380|NCT02798211|564563488|FG001|Period 1|Withdrawal of Informed Consent|7|||
156401381|NCT02798211|564563489|FG002|Period 1|Withdrawal of Informed Consent|3|||
156401382|NCT02798211|564563490|FG003|Period 1|Withdrawal of Informed Consent|0|||
156511545|NCT01008553|564965745|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
156511546|NCT01008553|564965746|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
156511547|NCT01008553|564965744|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
156401383|NCT02798211|564563491|FG004|Period 1|Withdrawal of Informed Consent|0|||
156401384|NCT02798211|564563492|FG005|Period 1|Withdrawal of Informed Consent|0|||
156511548|NCT01008553|564965745|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
156552205|NCT05103332|565112085|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156401385|NCT02798211|564563487|FG000|Period 2|Withdrawal by Subject|2|||
156401386|NCT02798211|564563488|FG001|Period 2|Withdrawal by Subject|0|||
156401387|NCT02798211|564563489|FG002|Period 2|Withdrawal by Subject|0|||
156401388|NCT02798211|564563490|FG003|Period 2|Withdrawal by Subject|0|||
156552206|NCT05103332|565112086|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552207|NCT05103332|565112087|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552208|NCT05103332|565112088|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552209|NCT05103332|565112089|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552210|NCT05103332|565112090|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156552211|NCT05103332|565112091|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
156552212|NCT05103332|565112092|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
156552213|NCT05103332|565112093|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
156552214|NCT05103332|565112094|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
156552215|NCT05103332|565112095|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
156552216|NCT05103332|565112096|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
156552217|NCT05103332|565112079|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552218|NCT05103332|565112080|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552219|NCT05103332|565112081|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552220|NCT05103332|565112082|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552221|NCT05103332|565112083|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552222|NCT05103332|565112084|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552223|NCT05103332|565112085|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552224|NCT05103332|565112086|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552225|NCT05103332|565112087|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552226|NCT05103332|565112088|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552227|NCT05103332|565112089|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552228|NCT05103332|565112090|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552229|NCT05103332|565112091|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552230|NCT05103332|565112092|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552231|NCT05103332|565112093|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552232|NCT05103332|565112094|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552233|NCT05103332|565112095|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
156552234|NCT05103332|565112096|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
156552235|NCT05103332|565112079|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552236|NCT05103332|565112080|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552237|NCT05103332|565112081|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552238|NCT05103332|565112082|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552239|NCT05103332|565112083|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552240|NCT05103332|565112084|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552241|NCT05103332|565112085|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552242|NCT05103332|565112086|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552243|NCT05103332|565112087|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552244|NCT05103332|565112088|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552245|NCT05103332|565112089|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552246|NCT05103332|565112090|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156552247|NCT05103332|565112091|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
156552248|NCT05103332|565112092|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
156552249|NCT05103332|565112093|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
156552250|NCT05103332|565112094|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
156552251|NCT05103332|565112095|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
156552252|NCT05103332|565112096|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
156552253|NCT05103332|565112079|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552254|NCT05103332|565112080|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552255|NCT05103332|565112081|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552256|NCT05103332|565112082|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552257|NCT05103332|565112083|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552258|NCT05103332|565112084|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552259|NCT05103332|565112085|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552260|NCT05103332|565112086|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552261|NCT05103332|565112087|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552262|NCT05103332|565112088|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552263|NCT05103332|565112089|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552264|NCT05103332|565112090|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552265|NCT05103332|565112091|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552266|NCT05103332|565112092|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552267|NCT05103332|565112093|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
156401389|NCT02798211|564563491|FG004|Period 2|Withdrawal by Subject|2|||
156552268|NCT05103332|565112094|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
156552269|NCT05103332|565112095|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156552270|NCT05103332|565112096|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
156552271|NCT05103332|565112079|FG000|SFU Period (6 Months=168 Days)|Death|0|||
156552272|NCT05103332|565112080|FG001|SFU Period (6 Months=168 Days)|Death|0|||
156401390|NCT02798211|564563492|FG005|Period 2|Withdrawal by Subject|2|||
156401391|NCT02798211|564563487|FG000|Period 2|Adverse Event|5|||
156401392|NCT02798211|564563488|FG001|Period 2|Adverse Event|0|||
156401393|NCT02798211|564563489|FG002|Period 2|Adverse Event|0|||
156401394|NCT02798211|564563490|FG003|Period 2|Adverse Event|0|||
156401395|NCT02798211|564563491|FG004|Period 2|Adverse Event|1|||
156401396|NCT02798211|564563492|FG005|Period 2|Adverse Event|0|||
156401397|NCT02798211|564563487|FG000|Period 2|Lack of Efficacy|1|||
156401398|NCT02798211|564563488|FG001|Period 2|Lack of Efficacy|0|||
156401399|NCT02798211|564563489|FG002|Period 2|Lack of Efficacy|0|||
156401400|NCT02798211|564563490|FG003|Period 2|Lack of Efficacy|1|||
156401401|NCT02798211|564563491|FG004|Period 2|Lack of Efficacy|0|||
156401402|NCT02798211|564563492|FG005|Period 2|Lack of Efficacy|1|||
156401403|NCT02798211|564563487|FG000|Period 2|Lost to Follow-up|3|||
156401404|NCT02798211|564563488|FG001|Period 2|Lost to Follow-up|0|||
156401405|NCT02798211|564563489|FG002|Period 2|Lost to Follow-up|0|||
156401406|NCT02798211|564563490|FG003|Period 2|Lost to Follow-up|0|||
156401407|NCT02798211|564563491|FG004|Period 2|Lost to Follow-up|2|||
156401408|NCT02798211|564563492|FG005|Period 2|Lost to Follow-up|0|||
156401409|NCT02798211|564563487|FG000|Period 2|Physician Decision|1|||
156401410|NCT02798211|564563488|FG001|Period 2|Physician Decision|0|||
156401411|NCT02798211|564563489|FG002|Period 2|Physician Decision|0|||
156401412|NCT02798211|564563490|FG003|Period 2|Physician Decision|1|||
156401413|NCT02798211|564563491|FG004|Period 2|Physician Decision|1|||
156401414|NCT02798211|564563492|FG005|Period 2|Physician Decision|0|||
156401415|NCT02798211|564563487|FG000|Period 2|Pregnancy|0|||
156401416|NCT02798211|564563488|FG001|Period 2|Pregnancy|0|||
156401417|NCT02798211|564563489|FG002|Period 2|Pregnancy|0|||
156401418|NCT02798211|564563490|FG003|Period 2|Pregnancy|2|||
156401419|NCT02798211|564563491|FG004|Period 2|Pregnancy|0|||
156401420|NCT02798211|564563492|FG005|Period 2|Pregnancy|0|||
156401421|NCT02798211|564563487|FG000|Period 2|Technical problems|1|||
156401422|NCT02798211|564563488|FG001|Period 2|Technical problems|0|||
156401423|NCT02798211|564563489|FG002|Period 2|Technical problems|0|||
156401424|NCT02798211|564563490|FG003|Period 2|Technical problems|1|||
156401425|NCT02798211|564563491|FG004|Period 2|Technical problems|0|||
156401426|NCT02798211|564563492|FG005|Period 2|Technical problems|0|||
156401427|NCT02798211|564563487|FG000|Period 2|Withdrawal of Informed Consent|1|||
156401428|NCT02798211|564563488|FG001|Period 2|Withdrawal of Informed Consent|0|||
156401429|NCT02798211|564563489|FG002|Period 2|Withdrawal of Informed Consent|0|||
156401430|NCT02798211|564563490|FG003|Period 2|Withdrawal of Informed Consent|2|||
156401431|NCT02798211|564563491|FG004|Period 2|Withdrawal of Informed Consent|2|||
156401432|NCT02798211|564563492|FG005|Period 2|Withdrawal of Informed Consent|3|||
156401433|NCT01782872|564563493|FG000|Overall Study|Protocol Violation|0|||
156401434|NCT01782872|564563494|FG001|Overall Study|Protocol Violation|0|||
156401435|NCT01782872|564563495|FG002|Overall Study|Protocol Violation|0|||
156401436|NCT01782872|564563496|FG003|Overall Study|Protocol Violation|1|||
156401437|NCT01782872|564563493|FG000|Overall Study|Withdrawal by Subject|0|||
156401438|NCT01782872|564563494|FG001|Overall Study|Withdrawal by Subject|1|||
156401439|NCT01782872|564563495|FG002|Overall Study|Withdrawal by Subject|0|||
156401440|NCT01782872|564563496|FG003|Overall Study|Withdrawal by Subject|0|||
156401441|NCT03505476|564563497|FG000|Overall Study|Physician Decision|18|||
156401442|NCT03505476|564563497|FG000|Overall Study|Device Malfunctioned|101|||
156401443|NCT03505476|564563497|FG000|Overall Study|Data Corrupt|6|||
156401444|NCT03505476|564563497|FG000|Overall Study|Device application insufficiant|3|||
156401445|NCT02748694|564563498|FG000|Overall Study|Voluntary Withdrawal|0|||
156401446|NCT02748694|564563499|FG001|Overall Study|Voluntary Withdrawal|0|||
156401447|NCT02748694|564563500|FG002|Overall Study|Voluntary Withdrawal|0|||
156552273|NCT05103332|565112081|FG002|SFU Period (6 Months=168 Days)|Death|0|||
156401448|NCT02748694|564563501|FG003|Overall Study|Voluntary Withdrawal|0|||
156401449|NCT02748694|564563502|FG004|Overall Study|Voluntary Withdrawal|0|||
156401450|NCT02748694|564563503|FG005|Overall Study|Voluntary Withdrawal|0|||
156401451|NCT02748694|564563504|FG006|Overall Study|Voluntary Withdrawal|0|||
156401452|NCT02748694|564563505|FG007|Overall Study|Voluntary Withdrawal|0|||
156401453|NCT02748694|564563506|FG008|Overall Study|Voluntary Withdrawal|0|||
156401454|NCT02748694|564563507|FG009|Overall Study|Voluntary Withdrawal|0|||
156401455|NCT02748694|564563508|FG010|Overall Study|Voluntary Withdrawal|0|||
156401456|NCT02748694|564563509|FG011|Overall Study|Voluntary Withdrawal|0|||
156401457|NCT02748694|564563510|FG012|Overall Study|Voluntary Withdrawal|0|||
156401458|NCT02748694|564563511|FG013|Overall Study|Voluntary Withdrawal|0|||
156401459|NCT02748694|564563512|FG014|Overall Study|Voluntary Withdrawal|2|||
156401460|NCT04026165|564563515|FG000|Run-in Placebo Period|Enrollment Error|13|||
156401461|NCT04026165|564563516|FG001|Run-in Placebo Period|Enrollment Error|0|||
156401462|NCT04026165|564563517|FG002|Run-in Placebo Period|Enrollment Error|0|||
156401463|NCT04026165|564563518|FG003|Run-in Placebo Period|Enrollment Error|0|||
156401464|NCT04026165|564563515|FG000|Run-in Placebo Period|Run-in Failure|4|||
156401465|NCT04026165|564563516|FG001|Run-in Placebo Period|Run-in Failure|0|||
156401466|NCT04026165|564563517|FG002|Run-in Placebo Period|Run-in Failure|0|||
156401467|NCT04026165|564563518|FG003|Run-in Placebo Period|Run-in Failure|0|||
156401468|NCT04026165|564563515|FG000|Run-in Placebo Period|Protocol Violation|2|||
156401469|NCT04026165|564563516|FG001|Run-in Placebo Period|Protocol Violation|0|||
156401470|NCT04026165|564563517|FG002|Run-in Placebo Period|Protocol Violation|0|||
156401471|NCT04026165|564563518|FG003|Run-in Placebo Period|Protocol Violation|0|||
156401472|NCT04026165|564563515|FG000|Run-in Placebo Period|Withdrew Consent|2|||
156401473|NCT04026165|564563516|FG001|Run-in Placebo Period|Withdrew Consent|0|||
156401474|NCT04026165|564563517|FG002|Run-in Placebo Period|Withdrew Consent|0|||
156401475|NCT04026165|564563518|FG003|Run-in Placebo Period|Withdrew Consent|0|||
156401476|NCT04026165|564563515|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
156401477|NCT04026165|564563516|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
156401478|NCT04026165|564563517|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
156401479|NCT04026165|564563518|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
156511549|NCT01008553|564965746|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
156511550|NCT01008553|564965744|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
156511551|NCT01008553|564965745|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
156511552|NCT01008553|564965746|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
156511553|NCT01008553|564965744|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
156511554|NCT01008553|564965745|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
156511555|NCT01008553|564965746|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
156511556|NCT01008553|564965744|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
156511557|NCT01008553|564965745|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
156511558|NCT01008553|564965746|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
156511559|NCT01008553|564965744|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
156511560|NCT01008553|564965745|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
156511561|NCT01008553|564965746|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
156511562|NCT01008553|564965744|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
156511563|NCT01008553|564965745|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
156511564|NCT01008553|564965746|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
156511565|NCT01008553|564965744|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
156511566|NCT01008553|564965745|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
156511567|NCT01008553|564965746|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
156511568|NCT01008553|564965744|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
156511569|NCT01008553|564965745|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
156511570|NCT01008553|564965746|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
156511571|NCT01008553|564965744|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
156511572|NCT01008553|564965745|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
156511573|NCT01008553|564965746|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
156511574|NCT01008410|564965754|FG000|Overall Study|Adverse Event|13|||
156511575|NCT01008410|564965755|FG001|Overall Study|Adverse Event|7|||
156511576|NCT01008410|564965754|FG000|Overall Study|Withdrawal by Subject|6|||
156511577|NCT01008410|564965755|FG001|Overall Study|Withdrawal by Subject|2|||
156511578|NCT01008410|564965754|FG000|Overall Study|Lost to Follow-up|1|||
156511579|NCT01008410|564965755|FG001|Overall Study|Lost to Follow-up|0|||
156511580|NCT01008410|564965754|FG000|Overall Study|Noncompliance|1|||
156511581|NCT01008410|564965755|FG001|Overall Study|Noncompliance|0|||
156511582|NCT01008410|564965754|FG000|Overall Study|Low Cortisol|2|||
156511583|NCT01008410|564965755|FG001|Overall Study|Low Cortisol|0|||
156511584|NCT01008410|564965754|FG000|Overall Study|Lack of Efficacy|2|||
156511585|NCT01008410|564965755|FG001|Overall Study|Lack of Efficacy|6|||
156511586|NCT01008410|564965754|FG000|Overall Study|Met Exclusion Criterion|0|||
156511587|NCT01008410|564965755|FG001|Overall Study|Met Exclusion Criterion|1|||
156511588|NCT00297427|564965756|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
156511589|NCT00297427|564965757|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
156511590|NCT00297427|564965756|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
156511591|NCT00297427|564965757|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
156511592|NCT00297427|564965756|FG000|Phase 1: Initial Intervention|Death|0|||
156511593|NCT00297427|564965757|FG001|Phase 1: Initial Intervention|Death|1|||
156511594|NCT00297427|564965756|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
156511595|NCT00297427|564965757|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
156511596|NCT00297427|564965756|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
156401480|NCT04026165|564563515|FG000|Run-in SEL Period|Run-in Failure|0|||
156401481|NCT04026165|564563516|FG001|Run-in SEL Period|Run-in Failure|26|||
156401482|NCT04026165|564563517|FG002|Run-in SEL Period|Run-in Failure|0|||
156552274|NCT05103332|565112082|FG003|SFU Period (6 Months=168 Days)|Death|0|||
156552275|NCT05103332|565112083|FG004|SFU Period (6 Months=168 Days)|Death|0|||
156552276|NCT05103332|565112084|FG005|SFU Period (6 Months=168 Days)|Death|0|||
156552277|NCT05103332|565112085|FG006|SFU Period (6 Months=168 Days)|Death|0|||
156552278|NCT05103332|565112086|FG007|SFU Period (6 Months=168 Days)|Death|0|||
156552279|NCT05103332|565112087|FG008|SFU Period (6 Months=168 Days)|Death|0|||
156552280|NCT05103332|565112088|FG009|SFU Period (6 Months=168 Days)|Death|0|||
156552281|NCT05103332|565112089|FG010|SFU Period (6 Months=168 Days)|Death|0|||
156552282|NCT05103332|565112090|FG011|SFU Period (6 Months=168 Days)|Death|0|||
156552283|NCT05103332|565112091|FG012|SFU Period (6 Months=168 Days)|Death|0|||
156552284|NCT05103332|565112092|FG013|SFU Period (6 Months=168 Days)|Death|0|||
156552285|NCT05103332|565112093|FG014|SFU Period (6 Months=168 Days)|Death|1|||
156552286|NCT05103332|565112094|FG015|SFU Period (6 Months=168 Days)|Death|0|||
156552287|NCT05103332|565112095|FG016|SFU Period (6 Months=168 Days)|Death|0|||
156552288|NCT05103332|565112096|FG017|SFU Period (6 Months=168 Days)|Death|1|||
156552289|NCT03215030|565113575|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
156552290|NCT03215030|565113576|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
156552291|NCT03215030|565113577|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552292|NCT03215030|565113578|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
156552293|NCT03215030|565113579|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552294|NCT03215030|565113580|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552295|NCT03215030|565113581|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552296|NCT03215030|565113582|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552297|NCT03215030|565113583|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552298|NCT03215030|565113584|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552299|NCT03215030|565113585|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552300|NCT03215030|565113586|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
156552301|NCT03215030|565113575|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
156552302|NCT03215030|565113576|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552303|NCT03215030|565113577|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552304|NCT03215030|565113578|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
156552305|NCT03215030|565113579|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552306|NCT03215030|565113580|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552307|NCT03215030|565113581|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552308|NCT03215030|565113582|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552309|NCT03215030|565113583|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552310|NCT03215030|565113584|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552311|NCT03215030|565113585|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552312|NCT03215030|565113586|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156552313|NCT03215030|565113575|FG000|Part 1: Dose Escalation|Death|15|||
156552314|NCT03215030|565113576|FG001|Part 1: Dose Escalation|Death|6|||
156552315|NCT03215030|565113577|FG002|Part 1: Dose Escalation|Death|6|||
156552316|NCT03215030|565113578|FG003|Part 1: Dose Escalation|Death|8|||
156552317|NCT03215030|565113579|FG004|Part 1: Dose Escalation|Death|0|||
156552318|NCT03215030|565113580|FG005|Part 1: Dose Escalation|Death|0|||
156552319|NCT03215030|565113581|FG006|Part 1: Dose Escalation|Death|0|||
156552320|NCT03215030|565113582|FG007|Part 1: Dose Escalation|Death|0|||
156552321|NCT03215030|565113583|FG008|Part 1: Dose Escalation|Death|0|||
156552322|NCT03215030|565113584|FG009|Part 1: Dose Escalation|Death|0|||
156552323|NCT03215030|565113585|FG010|Part 1: Dose Escalation|Death|0|||
156552324|NCT03215030|565113586|FG011|Part 1: Dose Escalation|Death|0|||
156552325|NCT03215030|565113575|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
156552326|NCT03215030|565113576|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
156552327|NCT03215030|565113577|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
156552328|NCT03215030|565113578|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
156401483|NCT04026165|564563518|FG003|Run-in SEL Period|Run-in Failure|0|||
156401484|NCT04026165|564563515|FG000|Run-in SEL Period|Withdrew Consent|0|||
156401485|NCT04026165|564563516|FG001|Run-in SEL Period|Withdrew Consent|10|||
156552329|NCT03215030|565113579|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
156552330|NCT03215030|565113580|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
156552331|NCT03215030|565113581|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
156552332|NCT03215030|565113582|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
156552333|NCT03215030|565113583|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
156401486|NCT04026165|564563517|FG002|Run-in SEL Period|Withdrew Consent|0|||
156401487|NCT04026165|564563518|FG003|Run-in SEL Period|Withdrew Consent|0|||
156552334|NCT03215030|565113584|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
156552335|NCT03215030|565113585|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
156552336|NCT03215030|565113586|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
156552337|NCT03215030|565113575|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552338|NCT03215030|565113576|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552339|NCT03215030|565113577|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552340|NCT03215030|565113578|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156401488|NCT04026165|564563515|FG000|Run-in SEL Period|Enrollment Error|0|||
156552341|NCT03215030|565113579|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552342|NCT03215030|565113580|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552343|NCT03215030|565113581|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552344|NCT03215030|565113582|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
156552345|NCT03215030|565113583|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552346|NCT03215030|565113584|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552347|NCT03215030|565113585|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552348|NCT03215030|565113586|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
156552349|NCT03215030|565113575|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156552350|NCT03215030|565113576|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156552351|NCT03215030|565113577|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156552352|NCT03215030|565113578|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156552353|NCT03215030|565113579|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
156552354|NCT03215030|565113580|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
156552355|NCT03215030|565113581|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
156552356|NCT03215030|565113582|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
156552357|NCT03215030|565113583|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156552358|NCT03215030|565113584|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156552359|NCT03215030|565113585|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156552360|NCT03215030|565113586|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156552361|NCT03215030|565113575|FG000|Part 2: Dose Expansion|Death|0|||
156552362|NCT03215030|565113576|FG001|Part 2: Dose Expansion|Death|0|||
156552363|NCT03215030|565113577|FG002|Part 2: Dose Expansion|Death|0|||
156552364|NCT03215030|565113578|FG003|Part 2: Dose Expansion|Death|0|||
156552365|NCT03215030|565113579|FG004|Part 2: Dose Expansion|Death|3|||
156552366|NCT03215030|565113580|FG005|Part 2: Dose Expansion|Death|1|||
156552367|NCT03215030|565113581|FG006|Part 2: Dose Expansion|Death|5|||
156552368|NCT03215030|565113582|FG007|Part 2: Dose Expansion|Death|4|||
156552369|NCT03215030|565113583|FG008|Part 2: Dose Expansion|Death|0|||
156552370|NCT03215030|565113584|FG009|Part 2: Dose Expansion|Death|0|||
156552371|NCT03215030|565113585|FG010|Part 2: Dose Expansion|Death|0|||
156552372|NCT03215030|565113586|FG011|Part 2: Dose Expansion|Death|0|||
156552373|NCT03215030|565113575|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
156552374|NCT03215030|565113576|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
156552375|NCT03215030|565113577|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
156552376|NCT03215030|565113578|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
156552377|NCT03215030|565113579|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
156552378|NCT03215030|565113580|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
156552379|NCT03215030|565113581|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
156552380|NCT03215030|565113582|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
156552381|NCT03215030|565113583|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
156552382|NCT03215030|565113584|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
156552383|NCT03215030|565113585|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
156552384|NCT03215030|565113586|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
156552385|NCT03215030|565113575|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
156552386|NCT03215030|565113576|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
156552387|NCT03215030|565113577|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
156552388|NCT03215030|565113578|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
156552389|NCT03215030|565113579|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
156552390|NCT03215030|565113580|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
156552391|NCT03215030|565113581|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
156552392|NCT03215030|565113582|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
156552393|NCT03215030|565113583|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
156552394|NCT03215030|565113584|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
156401489|NCT04026165|564563516|FG001|Run-in SEL Period|Enrollment Error|4|||
156401490|NCT04026165|564563517|FG002|Run-in SEL Period|Enrollment Error|0|||
156401491|NCT04026165|564563518|FG003|Run-in SEL Period|Enrollment Error|0|||
156552395|NCT03215030|565113585|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
156552396|NCT03215030|565113586|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
156552397|NCT03215030|565113575|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552398|NCT03215030|565113576|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552399|NCT03215030|565113577|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552400|NCT03215030|565113578|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552401|NCT03215030|565113579|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552402|NCT03215030|565113580|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552403|NCT03215030|565113581|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552404|NCT03215030|565113582|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552405|NCT03215030|565113583|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
156552406|NCT03215030|565113584|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
156552407|NCT03215030|565113585|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552408|NCT03215030|565113586|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
156552409|NCT03215030|565113575|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552410|NCT03215030|565113576|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552411|NCT03215030|565113577|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552412|NCT03215030|565113578|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552413|NCT03215030|565113579|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552414|NCT03215030|565113580|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552415|NCT03215030|565113581|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552416|NCT03215030|565113582|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552417|NCT03215030|565113583|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
156552418|NCT03215030|565113584|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
156552419|NCT03215030|565113585|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552420|NCT03215030|565113586|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
156552421|NCT03215030|565113575|FG000|Part 3: Dose Extension|Death|0|||
156552422|NCT03215030|565113576|FG001|Part 3: Dose Extension|Death|0|||
156552423|NCT03215030|565113577|FG002|Part 3: Dose Extension|Death|0|||
156552424|NCT03215030|565113578|FG003|Part 3: Dose Extension|Death|0|||
156552425|NCT03215030|565113579|FG004|Part 3: Dose Extension|Death|0|||
156552426|NCT03215030|565113580|FG005|Part 3: Dose Extension|Death|0|||
156552427|NCT03215030|565113581|FG006|Part 3: Dose Extension|Death|0|||
156552428|NCT03215030|565113582|FG007|Part 3: Dose Extension|Death|0|||
156552429|NCT03215030|565113583|FG008|Part 3: Dose Extension|Death|19|||
156552430|NCT03215030|565113584|FG009|Part 3: Dose Extension|Death|20|||
156552431|NCT03215030|565113585|FG010|Part 3: Dose Extension|Death|0|||
156552432|NCT03215030|565113586|FG011|Part 3: Dose Extension|Death|0|||
156552433|NCT03215030|565113575|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
156552434|NCT03215030|565113576|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
156552435|NCT03215030|565113577|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
156552436|NCT03215030|565113578|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
156552437|NCT03215030|565113579|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
156552438|NCT03215030|565113580|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
156552439|NCT03215030|565113581|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
156552440|NCT03215030|565113582|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
156552441|NCT03215030|565113583|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
156552442|NCT03215030|565113584|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
156552443|NCT03215030|565113585|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
156552444|NCT03215030|565113586|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
156552445|NCT03215030|565113575|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552446|NCT03215030|565113576|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552447|NCT03215030|565113577|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552448|NCT03215030|565113578|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552449|NCT03215030|565113579|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552450|NCT03215030|565113580|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552451|NCT03215030|565113581|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552452|NCT03215030|565113582|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552453|NCT03215030|565113583|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552454|NCT03215030|565113584|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156552455|NCT03215030|565113585|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
156552456|NCT03215030|565113586|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
156552457|NCT05416138|565113587|FG000|Overall Study|Withdrawal by Subject|2|||
156552458|NCT05416138|565113588|FG001|Overall Study|Withdrawal by Subject|1|||
156552459|NCT04705051|565113589|FG000|Overall Study|Enrolled but not treated|1|||
156552460|NCT04705051|565113589|FG000|Overall Study|Study terminated by sponsor|23|||
156552461|NCT00482014|565113590|FG000|Overall Study|Withdrawal by Subject|1|||
156552462|NCT00482014|565113591|FG001|Overall Study|Withdrawal by Subject|2|||
156401492|NCT04026165|564563515|FG000|Run-in SEL Period|Protocol Violation|0|||
156401493|NCT04026165|564563516|FG001|Run-in SEL Period|Protocol Violation|3|||
156401494|NCT04026165|564563517|FG002|Run-in SEL Period|Protocol Violation|0|||
156401495|NCT04026165|564563518|FG003|Run-in SEL Period|Protocol Violation|0|||
156552463|NCT00482014|565113592|FG002|Overall Study|Withdrawal by Subject|3|||
156552464|NCT00482014|565113593|FG003|Overall Study|Withdrawal by Subject|4|||
156552465|NCT00482014|565113590|FG000|Overall Study|Adverse Event|3|||
156552466|NCT00482014|565113591|FG001|Overall Study|Adverse Event|0|||
156552467|NCT00482014|565113592|FG002|Overall Study|Adverse Event|2|||
156552468|NCT00482014|565113593|FG003|Overall Study|Adverse Event|8|||
156552469|NCT00482014|565113590|FG000|Overall Study|Death|1|||
156401496|NCT04026165|564563515|FG000|Run-in SEL Period|Investigator's Discretion|0|||
156401497|NCT04026165|564563516|FG001|Run-in SEL Period|Investigator's Discretion|2|||
156552470|NCT00482014|565113591|FG001|Overall Study|Death|2|||
156552471|NCT00482014|565113592|FG002|Overall Study|Death|1|||
156552472|NCT00482014|565113593|FG003|Overall Study|Death|4|||
156552473|NCT00482014|565113590|FG000|Overall Study|Lack of Efficacy|1|||
156552474|NCT00482014|565113591|FG001|Overall Study|Lack of Efficacy|0|||
156552475|NCT00482014|565113592|FG002|Overall Study|Lack of Efficacy|4|||
156552476|NCT00482014|565113593|FG003|Overall Study|Lack of Efficacy|6|||
156552477|NCT00482014|565113590|FG000|Overall Study|Sponsor Decision|1|||
156552478|NCT00482014|565113591|FG001|Overall Study|Sponsor Decision|2|||
156552479|NCT00482014|565113592|FG002|Overall Study|Sponsor Decision|1|||
156552480|NCT00482014|565113593|FG003|Overall Study|Sponsor Decision|1|||
156552481|NCT03686397|565113594|FG000|Overall Study|Lack of Efficacy|3|||
156552482|NCT03686397|565113595|FG001|Overall Study|Lack of Efficacy|5|||
156552483|NCT03686397|565113594|FG000|Overall Study|Adverse Event|0|||
156552484|NCT03686397|565113595|FG001|Overall Study|Adverse Event|1|||
156401498|NCT04026165|564563517|FG002|Run-in SEL Period|Investigator's Discretion|0|||
156401499|NCT04026165|564563518|FG003|Run-in SEL Period|Investigator's Discretion|0|||
156401500|NCT04026165|564563515|FG000|Run-in SEL Period|Death|0|||
156401501|NCT04026165|564563516|FG001|Run-in SEL Period|Death|1|||
156552485|NCT03686397|565113594|FG000|Overall Study|Protocol Violation|0|||
156552486|NCT03686397|565113595|FG001|Overall Study|Protocol Violation|1|||
156401502|NCT04026165|564563517|FG002|Run-in SEL Period|Death|0|||
156401503|NCT04026165|564563518|FG003|Run-in SEL Period|Death|0|||
156401504|NCT04026165|564563515|FG000|Randomized Period|Withdrew Consent|0|||
156401505|NCT04026165|564563516|FG001|Randomized Period|Withdrew Consent|0|||
156401506|NCT04026165|564563517|FG002|Randomized Period|Withdrew Consent|5|||
156401507|NCT04026165|564563518|FG003|Randomized Period|Withdrew Consent|8|||
156401508|NCT04026165|564563515|FG000|Randomized Period|Death|0|||
156401509|NCT04026165|564563516|FG001|Randomized Period|Death|0|||
156401510|NCT04026165|564563517|FG002|Randomized Period|Death|5|||
156401511|NCT04026165|564563518|FG003|Randomized Period|Death|7|||
156401512|NCT04026165|564563515|FG000|Randomized Period|Investigator's Discretion|0|||
156401513|NCT04026165|564563516|FG001|Randomized Period|Investigator's Discretion|0|||
156401514|NCT04026165|564563517|FG002|Randomized Period|Investigator's Discretion|2|||
156401515|NCT04026165|564563518|FG003|Randomized Period|Investigator's Discretion|2|||
156401516|NCT04026165|564563515|FG000|Randomized Period|Lost to Follow-up|0|||
156401517|NCT04026165|564563516|FG001|Randomized Period|Lost to Follow-up|0|||
156401518|NCT04026165|564563517|FG002|Randomized Period|Lost to Follow-up|2|||
156401519|NCT04026165|564563518|FG003|Randomized Period|Lost to Follow-up|2|||
156401520|NCT01059630|564563521|FG000|Overall Study|Death|100|||
156401521|NCT01059630|564563522|FG001|Overall Study|Death|84|||
156401522|NCT01059630|564563521|FG000|Overall Study|Lost to Follow-up|4|||
156401523|NCT01059630|564563522|FG001|Overall Study|Lost to Follow-up|1|||
156401524|NCT01059630|564563521|FG000|Overall Study|Physician Decision|2|||
156401525|NCT01059630|564563522|FG001|Overall Study|Physician Decision|4|||
156401526|NCT01059630|564563521|FG000|Overall Study|Withdrawal by Subject|21|||
156401527|NCT01059630|564563522|FG001|Overall Study|Withdrawal by Subject|14|||
156401528|NCT03170375|564563523|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
156401529|NCT03170375|564563524|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
156401530|NCT03170375|564563525|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
156401531|NCT03170375|564563523|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
156401532|NCT03170375|564563524|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
156401533|NCT03170375|564563525|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
156401534|NCT00441701|564563526|FG000|Overall Study|Adverse Event|3|||
156401535|NCT00441701|564563527|FG001|Overall Study|Adverse Event|2|||
156401536|NCT00441701|564563528|FG002|Overall Study|Adverse Event|1|||
156401537|NCT00441701|564563529|FG003|Overall Study|Adverse Event|0|||
156401538|NCT00441701|564563530|FG004|Overall Study|Adverse Event|2|||
156401539|NCT00441701|564563531|FG005|Overall Study|Adverse Event|2|||
156401540|NCT00441701|564563532|FG006|Overall Study|Adverse Event|0|||
156401541|NCT00441701|564563533|FG007|Overall Study|Adverse Event|0|||
156401542|NCT00441701|564563534|FG008|Overall Study|Adverse Event|0|||
156401543|NCT00441701|564563535|FG009|Overall Study|Adverse Event|0|||
156401544|NCT00441701|564563526|FG000|Overall Study|Lack of Efficacy|2|||
156401545|NCT00441701|564563527|FG001|Overall Study|Lack of Efficacy|0|||
156401546|NCT00441701|564563528|FG002|Overall Study|Lack of Efficacy|2|||
156401547|NCT00441701|564563529|FG003|Overall Study|Lack of Efficacy|2|||
156401548|NCT00441701|564563530|FG004|Overall Study|Lack of Efficacy|0|||
156401549|NCT00441701|564563531|FG005|Overall Study|Lack of Efficacy|1|||
156401550|NCT00441701|564563532|FG006|Overall Study|Lack of Efficacy|0|||
156401551|NCT00441701|564563533|FG007|Overall Study|Lack of Efficacy|0|||
156401552|NCT00441701|564563534|FG008|Overall Study|Lack of Efficacy|0|||
156401553|NCT00441701|564563535|FG009|Overall Study|Lack of Efficacy|0|||
156401554|NCT00441701|564563526|FG000|Overall Study|Withdrawal by Subject|0|||
156401555|NCT00441701|564563527|FG001|Overall Study|Withdrawal by Subject|2|||
156401556|NCT00441701|564563528|FG002|Overall Study|Withdrawal by Subject|1|||
156401557|NCT00441701|564563529|FG003|Overall Study|Withdrawal by Subject|1|||
156401558|NCT00441701|564563530|FG004|Overall Study|Withdrawal by Subject|0|||
156401559|NCT00441701|564563531|FG005|Overall Study|Withdrawal by Subject|0|||
156401560|NCT00441701|564563532|FG006|Overall Study|Withdrawal by Subject|0|||
156401561|NCT00441701|564563533|FG007|Overall Study|Withdrawal by Subject|0|||
156401562|NCT00441701|564563534|FG008|Overall Study|Withdrawal by Subject|0|||
156401563|NCT00441701|564563535|FG009|Overall Study|Withdrawal by Subject|0|||
156401564|NCT00077064|564563536|FG000|Overall Study|Adverse Event|0|||
156552487|NCT03686397|565113594|FG000|Overall Study|Withdrawal by Subject|0|||
156552488|NCT03686397|565113595|FG001|Overall Study|Withdrawal by Subject|1|||
156552489|NCT03686397|565113594|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
156552490|NCT03686397|565113595|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
156552491|NCT01284114|565113598|FG000|Overall Study|viral infection|1|||
156552492|NCT01284114|565113598|FG000|Overall Study|From the results of ALLTITUDE study|1|||
156552493|NCT01284114|565113598|FG000|Overall Study|Symptomatic hypotension|1|||
156552494|NCT01284114|565113598|FG000|Overall Study|dizziness|1|||
156552495|NCT00598975|565113599|FG000|Overall Study|Adverse Event|1|||
156552496|NCT00598975|565113600|FG001|Overall Study|Adverse Event|1|||
156552497|NCT00598975|565113599|FG000|Overall Study|Brain metastases|1|||
156552498|NCT00598975|565113600|FG001|Overall Study|Brain metastases|0|||
156552499|NCT00598975|565113599|FG000|Overall Study|Withdrawal by Subject|1|||
156552500|NCT00598975|565113600|FG001|Overall Study|Withdrawal by Subject|1|||
156552501|NCT00598975|565113599|FG000|Overall Study|Withdrawal of consent|0|||
156552502|NCT00598975|565113600|FG001|Overall Study|Withdrawal of consent|1|||
156552503|NCT00598975|565113599|FG000|Overall Study|Disease progression|8|||
156552504|NCT00598975|565113600|FG001|Overall Study|Disease progression|3|||
156552505|NCT00598975|565113599|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
156552506|NCT00598975|565113600|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
156552507|NCT03733392|565113613|FG000|Overall Study|Withdrawal by Subject|11|||
156552508|NCT03733392|565113614|FG001|Overall Study|Withdrawal by Subject|1|||
156552509|NCT03733392|565113613|FG000|Overall Study|Death|1|||
156552510|NCT03733392|565113614|FG001|Overall Study|Death|0|||
156552511|NCT03733392|565113613|FG000|Overall Study|Lost to Follow-up|5|||
156552512|NCT03733392|565113614|FG001|Overall Study|Lost to Follow-up|0|||
156552513|NCT03733392|565113613|FG000|Overall Study|Protocol Violation|0|||
156552514|NCT03733392|565113614|FG001|Overall Study|Protocol Violation|1|||
156552515|NCT03733392|565113613|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
156552516|NCT03733392|565113614|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
156552517|NCT03733392|565113613|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
156552518|NCT03733392|565113614|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
156552519|NCT03733392|565113613|FG000|Overall Study|Patient Non-Compliance|2|||
156552520|NCT03733392|565113614|FG001|Overall Study|Patient Non-Compliance|1|||
156552521|NCT03733392|565113613|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
156552522|NCT03733392|565113614|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
156552523|NCT03733392|565113613|FG000|Overall Study|Withdrawal prior to procedure|5|||
156552524|NCT03733392|565113614|FG001|Overall Study|Withdrawal prior to procedure|2|||
156552525|NCT02740478|565113615|FG000|Overall Study|Withdrawal by Subject|1|||
156552526|NCT02770326|565113617|FG000|Overall Study|Death|3|||
156552527|NCT02770326|565113617|FG000|Overall Study|Lost to Follow-up|1|||
156552528|NCT02814565|565113621|FG000|Overall Study|Lack of Efficacy|0|||
156552529|NCT02814565|565113622|FG001|Overall Study|Lack of Efficacy|1|||
156552530|NCT02814565|565113621|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
156552531|NCT02814565|565113622|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
156552532|NCT03124784|565113623|FG000|Overall Study|Adverse Event|1|||
156552533|NCT03124784|565113623|FG000|Overall Study|Computer/Equip Malfunction|1|||
156552534|NCT05702515|565113624|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
156552535|NCT05289830|565113625|FG000|Overall Study|Lost to Follow-up|1|||
156552536|NCT05289830|565113626|FG001|Overall Study|Lost to Follow-up|1|||
156552537|NCT05289830|565113625|FG000|Overall Study|Physician Decision|0|||
156552538|NCT05289830|565113626|FG001|Overall Study|Physician Decision|1|||
156552539|NCT04735653|565113627|FG000|Overall Study|Lost to Follow-up|17|||
156552540|NCT04735653|565113628|FG001|Overall Study|Lost to Follow-up|7|||
156552541|NCT04735653|565113627|FG000|Overall Study|Withdrawal by Subject|8|||
156552542|NCT04735653|565113628|FG001|Overall Study|Withdrawal by Subject|2|||
156552543|NCT04735653|565113627|FG000|Overall Study|Death|0|||
156552544|NCT04735653|565113628|FG001|Overall Study|Death|2|||
156552545|NCT04735653|565113627|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
156552546|NCT04735653|565113628|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
156552547|NCT01121393|565113638|FG000|Overall Study|Progressive disease|201|||
156401565|NCT00077064|564563537|FG001|Overall Study|Adverse Event|4|||
156401566|NCT00077064|564563536|FG000|Overall Study|Patient refusal|0|||
156401567|NCT00077064|564563537|FG001|Overall Study|Patient refusal|2|||
156401568|NCT02007434|564563543|FG000|Overall Study|Lost to Follow-up|0|||
156401569|NCT02007434|564563544|FG001|Overall Study|Lost to Follow-up|1|||
156401570|NCT02007434|564563545|FG002|Overall Study|Lost to Follow-up|0|||
156552548|NCT01121393|565113639|FG001|Overall Study|Progressive disease|20|||
156552549|NCT01121393|565113638|FG000|Overall Study|Other Adverse events|24|||
156552550|NCT01121393|565113639|FG001|Overall Study|Other Adverse events|45|||
156552551|NCT01121393|565113638|FG000|Overall Study|Non-compliant with protocol|0|||
156552552|NCT01121393|565113639|FG001|Overall Study|Non-compliant with protocol|3|||
156552553|NCT01121393|565113638|FG000|Overall Study|Lost to Follow-up|1|||
156552554|NCT01121393|565113639|FG001|Overall Study|Lost to Follow-up|0|||
156401571|NCT02007434|564563546|FG003|Overall Study|Lost to Follow-up|0|||
156552555|NCT01121393|565113638|FG000|Overall Study|Refused cont. medication|7|||
156552556|NCT01121393|565113639|FG001|Overall Study|Refused cont. medication|7|||
156552557|NCT01121393|565113638|FG000|Overall Study|Not treated|3|||
156552558|NCT01121393|565113639|FG001|Overall Study|Not treated|9|||
156552559|NCT01121393|565113638|FG000|Overall Study|Other than listed|6|||
156552560|NCT01121393|565113639|FG001|Overall Study|Other than listed|0|||
156552561|NCT00577993|565113641|FG000|Overall Study|Adverse Event|1|||
156552562|NCT00577993|565113642|FG001|Overall Study|Adverse Event|0|||
156552563|NCT00577993|565113643|FG002|Overall Study|Adverse Event|0|||
156552564|NCT00577993|565113641|FG000|Overall Study|Death|0|||
156552565|NCT00577993|565113642|FG001|Overall Study|Death|1|||
156552566|NCT00577993|565113643|FG002|Overall Study|Death|1|||
156552567|NCT00577993|565113641|FG000|Overall Study|Lack of Efficacy|0|||
156552568|NCT00577993|565113642|FG001|Overall Study|Lack of Efficacy|1|||
156552569|NCT00577993|565113643|FG002|Overall Study|Lack of Efficacy|0|||
156552570|NCT00577993|565113641|FG000|Overall Study|Protocol Violation|2|||
156552571|NCT00577993|565113642|FG001|Overall Study|Protocol Violation|3|||
156552572|NCT00577993|565113643|FG002|Overall Study|Protocol Violation|0|||
156552573|NCT00577993|565113641|FG000|Overall Study|Withdrawal by Subject|1|||
156552574|NCT00577993|565113642|FG001|Overall Study|Withdrawal by Subject|0|||
156552575|NCT00577993|565113643|FG002|Overall Study|Withdrawal by Subject|2|||
156552576|NCT00577993|565113641|FG000|Overall Study|Conversion|2|||
156552577|NCT00577993|565113642|FG001|Overall Study|Conversion|5|||
156511597|NCT00297427|564965757|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
156511598|NCT00297427|564965756|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
156511599|NCT00297427|564965757|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
156511600|NCT00297427|564965756|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
156511601|NCT00297427|564965757|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
156511602|NCT00297427|564965756|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
156511603|NCT00297427|564965757|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
156511604|NCT01262677|564965758|FG000|Overall Study|Does not meet entrance criteria|0|||
156511605|NCT01262677|564965759|FG001|Overall Study|Does not meet entrance criteria|2|||
156511606|NCT01262677|564965760|FG002|Overall Study|Does not meet entrance criteria|0|||
156511607|NCT01262677|564965758|FG000|Overall Study|Insufficient clinical response|0|||
156511608|NCT01262677|564965759|FG001|Overall Study|Insufficient clinical response|0|||
156511609|NCT01262677|564965760|FG002|Overall Study|Insufficient clinical response|1|||
156511610|NCT01262677|564965758|FG000|Overall Study|Lost to Follow-up|1|||
156511611|NCT01262677|564965759|FG001|Overall Study|Lost to Follow-up|0|||
156511612|NCT01262677|564965760|FG002|Overall Study|Lost to Follow-up|2|||
156511613|NCT01262677|564965758|FG000|Overall Study|No longer willing to participate|3|||
156511614|NCT01262677|564965759|FG001|Overall Study|No longer willing to participate|3|||
156511615|NCT01262677|564965760|FG002|Overall Study|No longer willing to participate|2|||
156511616|NCT01262677|564965758|FG000|Overall Study|Reason not provided|2|||
156511617|NCT01262677|564965759|FG001|Overall Study|Reason not provided|1|||
156511618|NCT01262677|564965760|FG002|Overall Study|Reason not provided|3|||
156511619|NCT01262677|564965758|FG000|Overall Study|Protocol Violation|0|||
156511620|NCT01262677|564965759|FG001|Overall Study|Protocol Violation|1|||
156511621|NCT01262677|564965760|FG002|Overall Study|Protocol Violation|1|||
156511622|NCT01262677|564965758|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
156511623|NCT01262677|564965759|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
156511624|NCT01262677|564965760|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
156511625|NCT01638429|564965766|FG000|Overall Study|Withdrawal by Subject|1|||
156511626|NCT03889704|564965767|FG000|Overall Study|Study terminated due to pandemic|1|||
156511627|NCT02591953|564965770|FG000|Overall Study|Lost to Follow-up|6|||
156511628|NCT02591953|564965771|FG001|Overall Study|Lost to Follow-up|6|||
156511629|NCT02060370|564965772|FG000|Overall Study|Physician Decision|1|||
156511630|NCT01896557|564965773|FG000|Clopidogrel Alone|Adverse Event|1|||
156511631|NCT01896557|564965774|FG001|Clopidogrel Alone|Adverse Event|0|||
156511632|NCT01896557|564965773|FG000|Clopidogrel + GI Protector|low adherence|1|||
156511633|NCT01896557|564965774|FG001|Clopidogrel + GI Protector|low adherence|1|||
156511634|NCT01896557|564965773|FG000|Clopidogrel + GI Protector|Reading error|1|||
156511635|NCT01896557|564965774|FG001|Clopidogrel + GI Protector|Reading error|3|||
156511636|NCT00731133|564965775|FG000|Overall Study|Withdrawal by Subject|10|||
156511637|NCT01517295|564965780|FG000|Overall Study|Physician Decision|1|||
156511638|NCT01517295|564965781|FG001|Overall Study|Physician Decision|0|||
156511639|NCT01598662|564965783|FG000|Overall Study|Lost to Follow-up|10|||
156511640|NCT01598662|564965784|FG001|Overall Study|Lost to Follow-up|17|||
156511641|NCT01598662|564965783|FG000|Overall Study|Physician Decision|1|||
156511642|NCT01598662|564965784|FG001|Overall Study|Physician Decision|2|||
156511643|NCT01598662|564965783|FG000|Overall Study|IUD expelled before month 6|0|||
156552578|NCT00577993|565113643|FG002|Overall Study|Conversion|0|||
156552579|NCT00577993|565113641|FG000|Overall Study|Uninsured|1|||
156552580|NCT00577993|565113642|FG001|Overall Study|Uninsured|0|||
156552581|NCT00577993|565113643|FG002|Overall Study|Uninsured|0|||
156552582|NCT03033745|565113650|FG000|Overall Study|Protocol Violation|0|||
156552583|NCT03033745|565113651|FG001|Overall Study|Protocol Violation|0|||
156552584|NCT03033745|565113652|FG002|Overall Study|Protocol Violation|1|||
156552585|NCT03033745|565113650|FG000|Overall Study|Adverse Event|1|||
156401572|NCT02007434|564563547|FG004|Overall Study|Lost to Follow-up|0|||
156401573|NCT02007434|564563548|FG005|Overall Study|Lost to Follow-up|0|||
156401574|NCT02007434|564563549|FG006|Overall Study|Lost to Follow-up|0|||
156401575|NCT02007434|564563550|FG007|Overall Study|Lost to Follow-up|0|||
156401576|NCT02007434|564563543|FG000|Overall Study|Non-compliance|1|||
156401577|NCT02007434|564563544|FG001|Overall Study|Non-compliance|0|||
156401578|NCT02007434|564563545|FG002|Overall Study|Non-compliance|1|||
156401579|NCT02007434|564563546|FG003|Overall Study|Non-compliance|0|||
156401580|NCT02007434|564563547|FG004|Overall Study|Non-compliance|0|||
156401581|NCT02007434|564563548|FG005|Overall Study|Non-compliance|0|||
156401582|NCT02007434|564563549|FG006|Overall Study|Non-compliance|0|||
156401583|NCT02007434|564563550|FG007|Overall Study|Non-compliance|0|||
156401584|NCT02255357|564563551|FG000|Overall Study|Physician Decision|10|||
156401585|NCT02255357|564563552|FG001|Overall Study|Physician Decision|24|||
156401586|NCT00509236|564563557|FG000|Overall Study|Adverse Event|7|||
156401587|NCT00509236|564563558|FG001|Overall Study|Adverse Event|9|||
156401588|NCT00509236|564563557|FG000|Overall Study|Withdrawal by Subject|5|||
156401589|NCT00509236|564563558|FG001|Overall Study|Withdrawal by Subject|10|||
156401590|NCT00509236|564563557|FG000|Overall Study|Protocol Violation|3|||
156401591|NCT00509236|564563558|FG001|Overall Study|Protocol Violation|0|||
156401592|NCT00509236|564563557|FG000|Overall Study|Excluded Medication|1|||
156401593|NCT00509236|564563558|FG001|Overall Study|Excluded Medication|1|||
156401594|NCT00509236|564563557|FG000|Overall Study|Scheduled Kidney Transplant|1|||
156401595|NCT00509236|564563558|FG001|Overall Study|Scheduled Kidney Transplant|0|||
156401596|NCT00927355|564563561|FG000|Overall Study|Adverse Event|1|||
156401597|NCT00927355|564563562|FG001|Overall Study|Adverse Event|1|||
156401598|NCT01572389|564563574|FG000|Overall Study|Death|1|||
156401599|NCT01572389|564563575|FG001|Overall Study|Death|3|||
156401600|NCT01572389|564563574|FG000|Overall Study|Withdrawal by Subject|14|||
156401601|NCT01572389|564563575|FG001|Overall Study|Withdrawal by Subject|2|||
156401602|NCT01572389|564563574|FG000|Overall Study|Lost to Follow-up|25|||
156401603|NCT01572389|564563575|FG001|Overall Study|Lost to Follow-up|14|||
156511644|NCT01598662|564965784|FG001|Overall Study|IUD expelled before month 6|2|||
156511645|NCT02530970|564965785|FG000|Overall Study|Adverse Event|8|||
156511646|NCT02530970|564965785|FG000|Overall Study|Lost to Follow-up|88|||
156511647|NCT02530970|564965785|FG000|Overall Study|Physician Decision|5|||
156511648|NCT02530970|564965785|FG000|Overall Study|Withdrawal by Subject|14|||
156511649|NCT02530970|564965785|FG000|Overall Study|Death|6|||
156511650|NCT02530970|564965785|FG000|Overall Study|Hospitalization|1|||
156511651|NCT02530970|564965785|FG000|Overall Study|Insurance|2|||
156511652|NCT02530970|564965785|FG000|Overall Study|Explant|2|||
156511653|NCT02530970|564965785|FG000|Overall Study|Change in Provider|5|||
156511654|NCT02530970|564965785|FG000|Overall Study|Relocation|3|||
156511655|NCT02770612|564965786|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
156511656|NCT02636725|564965787|FG000|Overall Study|Adverse Event|1|||
156511657|NCT00886795|564965789|FG000|Overall Study|Lack of Efficacy|1|||
156511658|NCT01283516|564965790|FG000|Overall Study|Adverse Event|0|||
156511659|NCT01283516|564965791|FG001|Overall Study|Adverse Event|0|||
156511660|NCT01283516|564965792|FG002|Overall Study|Adverse Event|0|||
156511661|NCT01283516|564965793|FG003|Overall Study|Adverse Event|0|||
156511662|NCT01283516|564965794|FG004|Overall Study|Adverse Event|0|||
156511663|NCT01283516|564965795|FG005|Overall Study|Adverse Event|0|||
156511664|NCT01283516|564965796|FG006|Overall Study|Adverse Event|2|||
156511665|NCT01283516|564965797|FG007|Overall Study|Adverse Event|0|||
156511666|NCT01283516|564965798|FG008|Overall Study|Adverse Event|28|||
156511667|NCT01283516|564965790|FG000|Overall Study|Death|0|||
156511668|NCT01283516|564965791|FG001|Overall Study|Death|0|||
156511669|NCT01283516|564965792|FG002|Overall Study|Death|0|||
156511670|NCT01283516|564965793|FG003|Overall Study|Death|0|||
156511671|NCT01283516|564965794|FG004|Overall Study|Death|0|||
156511672|NCT01283516|564965795|FG005|Overall Study|Death|1|||
156511673|NCT01283516|564965796|FG006|Overall Study|Death|0|||
156511674|NCT01283516|564965797|FG007|Overall Study|Death|1|||
156511675|NCT01283516|564965798|FG008|Overall Study|Death|12|||
156401604|NCT01572389|564563574|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
156401605|NCT01572389|564563575|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
156401606|NCT00499863|564563576|FG000|Overall Study|Lack of Efficacy|21|||
156401607|NCT00499863|564563577|FG001|Overall Study|Lack of Efficacy|27|||
156511676|NCT01283516|564965790|FG000|Overall Study|Disease Progression|2|||
156511677|NCT01283516|564965791|FG001|Overall Study|Disease Progression|2|||
156401608|NCT00499863|564563576|FG000|Overall Study|Protocol Violation|12|||
156401609|NCT00499863|564563577|FG001|Overall Study|Protocol Violation|7|||
156401610|NCT00499863|564563576|FG000|Overall Study|Withdrawal by Subject|6|||
156401611|NCT00499863|564563577|FG001|Overall Study|Withdrawal by Subject|4|||
156401612|NCT00499863|564563576|FG000|Overall Study|Adverse Event|8|||
156401613|NCT00499863|564563577|FG001|Overall Study|Adverse Event|2|||
156401614|NCT00499863|564563576|FG000|Overall Study|Sponsor decision|2|||
156511678|NCT01283516|564965792|FG002|Overall Study|Disease Progression|3|||
156511679|NCT01283516|564965793|FG003|Overall Study|Disease Progression|3|||
156511680|NCT01283516|564965794|FG004|Overall Study|Disease Progression|13|||
156511681|NCT01283516|564965795|FG005|Overall Study|Disease Progression|8|||
156401615|NCT00499863|564563577|FG001|Overall Study|Sponsor decision|2|||
156401616|NCT00499863|564563576|FG000|Overall Study|Lost to Follow-up|1|||
156401617|NCT00499863|564563577|FG001|Overall Study|Lost to Follow-up|1|||
156401618|NCT00571701|564563578|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
156401619|NCT00571701|564563579|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
156401620|NCT00571701|564563578|FG000|First Intervention 12 Months|Death|1|||
156401621|NCT00571701|564563579|FG001|First Intervention 12 Months|Death|0|||
156401622|NCT00571701|564563578|FG000|Second Intervention 12 Months|Adverse Event|0|||
156401623|NCT00571701|564563579|FG001|Second Intervention 12 Months|Adverse Event|1|||
156401624|NCT00571701|564563578|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
156401625|NCT00571701|564563579|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
156401626|NCT00691132|564563581|FG000|Overall Study|Adverse Event|2|||
156401627|NCT00691132|564563582|FG001|Overall Study|Adverse Event|3|||
156401628|NCT00691132|564563581|FG000|Overall Study|Withdrawal by Subject|10|||
156401629|NCT00691132|564563582|FG001|Overall Study|Withdrawal by Subject|10|||
156401630|NCT01959347|564563584|FG000|Overall Study|Protocol Violation|9|||
156552586|NCT03033745|565113651|FG001|Overall Study|Adverse Event|0|||
156552587|NCT03033745|565113652|FG002|Overall Study|Adverse Event|1|||
156552588|NCT03033745|565113650|FG000|Overall Study|Withdrawal by Subject|0|||
156552589|NCT03033745|565113651|FG001|Overall Study|Withdrawal by Subject|1|||
156552590|NCT03033745|565113652|FG002|Overall Study|Withdrawal by Subject|0|||
156552591|NCT00608985|565113653|FG000|Overall Study|Adverse Event|2|||
156552592|NCT00608985|565113654|FG001|Overall Study|Adverse Event|7|||
156552593|NCT00608985|565113655|FG002|Overall Study|Adverse Event|4|||
156401631|NCT01959347|564563585|FG001|Overall Study|Protocol Violation|7|||
156401632|NCT03541044|564563586|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
156401633|NCT03541044|564563587|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
156401634|NCT03541044|564563586|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
156401635|NCT03541044|564563587|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
156401636|NCT01060553|564563588|FG000|Overall Study|Lost to Follow-up|3|||
156401637|NCT01060553|564563589|FG001|Overall Study|Lost to Follow-up|5|||
156401638|NCT01060553|564563588|FG000|Overall Study|Withdrawal by Subject|5|||
156511682|NCT01283516|564965796|FG006|Overall Study|Disease Progression|6|||
156511683|NCT01283516|564965797|FG007|Overall Study|Disease Progression|3|||
156511684|NCT01283516|564965798|FG008|Overall Study|Disease Progression|139|||
156511685|NCT01283516|564965790|FG000|Overall Study|Withdrawal by Subject|0|||
156511686|NCT01283516|564965791|FG001|Overall Study|Withdrawal by Subject|0|||
156511687|NCT01283516|564965792|FG002|Overall Study|Withdrawal by Subject|0|||
156511688|NCT01283516|564965793|FG003|Overall Study|Withdrawal by Subject|0|||
156511689|NCT01283516|564965794|FG004|Overall Study|Withdrawal by Subject|1|||
156511690|NCT01283516|564965795|FG005|Overall Study|Withdrawal by Subject|0|||
156511691|NCT01283516|564965796|FG006|Overall Study|Withdrawal by Subject|1|||
156511692|NCT01283516|564965797|FG007|Overall Study|Withdrawal by Subject|0|||
156511693|NCT01283516|564965798|FG008|Overall Study|Withdrawal by Subject|36|||
156511694|NCT01283516|564965790|FG000|Overall Study|Administrative problems|0|||
156511695|NCT01283516|564965791|FG001|Overall Study|Administrative problems|0|||
156511696|NCT01283516|564965792|FG002|Overall Study|Administrative problems|0|||
156511697|NCT01283516|564965793|FG003|Overall Study|Administrative problems|0|||
156511698|NCT01283516|564965794|FG004|Overall Study|Administrative problems|0|||
156511699|NCT01283516|564965795|FG005|Overall Study|Administrative problems|1|||
156511700|NCT01283516|564965796|FG006|Overall Study|Administrative problems|1|||
156511701|NCT01283516|564965797|FG007|Overall Study|Administrative problems|1|||
156511702|NCT01283516|564965798|FG008|Overall Study|Administrative problems|39|||
156511703|NCT01283516|564965790|FG000|Overall Study|Lost to Follow-up|0|||
156511704|NCT01283516|564965791|FG001|Overall Study|Lost to Follow-up|0|||
156511705|NCT01283516|564965792|FG002|Overall Study|Lost to Follow-up|0|||
156511706|NCT01283516|564965793|FG003|Overall Study|Lost to Follow-up|0|||
156511707|NCT01283516|564965794|FG004|Overall Study|Lost to Follow-up|0|||
156511708|NCT01283516|564965795|FG005|Overall Study|Lost to Follow-up|0|||
156511709|NCT01283516|564965796|FG006|Overall Study|Lost to Follow-up|0|||
156511710|NCT01283516|564965797|FG007|Overall Study|Lost to Follow-up|0|||
156511711|NCT01283516|564965798|FG008|Overall Study|Lost to Follow-up|1|||
156511712|NCT00444275|564965804|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
156511713|NCT00444275|564965805|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
156511714|NCT00444275|564965806|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
156511715|NCT00444275|564965807|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
156511716|NCT00444275|564965808|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
156511717|NCT00444275|564965804|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
156401639|NCT01060553|564563589|FG001|Overall Study|Withdrawal by Subject|5|||
156401640|NCT01060553|564563588|FG000|Overall Study|Lack of Efficacy|1|||
156511718|NCT00444275|564965805|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
156511719|NCT00444275|564965806|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
156552594|NCT00608985|565113656|FG003|Overall Study|Adverse Event|6|||
156552595|NCT00608985|565113653|FG000|Overall Study|Administrative/Other|7|||
156552596|NCT00608985|565113654|FG001|Overall Study|Administrative/Other|4|||
156401641|NCT01060553|564563589|FG001|Overall Study|Lack of Efficacy|0|||
156401642|NCT01462162|564563592|FG000|Overall Study|Adverse Event|5|||
156401643|NCT01462162|564563592|FG000|Overall Study|Lack of Efficacy|4|||
156401644|NCT01462162|564563592|FG000|Overall Study|Abnormal laboratory parameters|1|||
156401645|NCT01462162|564563592|FG000|Overall Study|Other|2|||
156401646|NCT03485911|564563593|FG000|Part 1|Perceived lack of efficacy|1|||
156401647|NCT03485911|564563594|FG001|Part 1|Perceived lack of efficacy|1|||
156401648|NCT03485911|564563595|FG002|Part 1|Perceived lack of efficacy|2|||
156401649|NCT03485911|564563596|FG003|Part 1|Perceived lack of efficacy|0|||
156401650|NCT03485911|564563593|FG000|Part 1|Subject withdrew consent|0|||
156401651|NCT03485911|564563594|FG001|Part 1|Subject withdrew consent|1|||
156401652|NCT03485911|564563595|FG002|Part 1|Subject withdrew consent|0|||
156401653|NCT03485911|564563596|FG003|Part 1|Subject withdrew consent|1|||
156401654|NCT03485911|564563593|FG000|Part 1|Lab abnormalities/AEs|3|||
156401655|NCT03485911|564563594|FG001|Part 1|Lab abnormalities/AEs|1|||
156401656|NCT03485911|564563595|FG002|Part 1|Lab abnormalities/AEs|1|||
156401657|NCT03485911|564563596|FG003|Part 1|Lab abnormalities/AEs|0|||
156401658|NCT03485911|564563593|FG000|Part 1|Withdrew Consent prior to dosing|0|||
156401659|NCT03485911|564563594|FG001|Part 1|Withdrew Consent prior to dosing|0|||
156401660|NCT03485911|564563595|FG002|Part 1|Withdrew Consent prior to dosing|0|||
156401661|NCT03485911|564563596|FG003|Part 1|Withdrew Consent prior to dosing|1|||
156401662|NCT03485911|564563593|FG000|Part 1|Other NOS|0|||
156401663|NCT03485911|564563594|FG001|Part 1|Other NOS|0|||
156401664|NCT03485911|564563595|FG002|Part 1|Other NOS|0|||
156401665|NCT03485911|564563596|FG003|Part 1|Other NOS|1|||
156401666|NCT03485911|564563593|FG000|Part 2|Perceived lack of efficacy|5|||
156401667|NCT03485911|564563594|FG001|Part 2|Perceived lack of efficacy|3|||
156401668|NCT03485911|564563595|FG002|Part 2|Perceived lack of efficacy|0|||
156401669|NCT03485911|564563596|FG003|Part 2|Perceived lack of efficacy|2|||
156401670|NCT03485911|564563593|FG000|Part 2|Subject withdrew consent|1|||
156401671|NCT03485911|564563594|FG001|Part 2|Subject withdrew consent|0|||
156401672|NCT03485911|564563595|FG002|Part 2|Subject withdrew consent|2|||
156401673|NCT03485911|564563596|FG003|Part 2|Subject withdrew consent|1|||
156401674|NCT03485911|564563593|FG000|Part 2|Lab abnormalities/AEs|1|||
156401675|NCT03485911|564563594|FG001|Part 2|Lab abnormalities/AEs|2|||
156401676|NCT03485911|564563595|FG002|Part 2|Lab abnormalities/AEs|0|||
156401677|NCT03485911|564563596|FG003|Part 2|Lab abnormalities/AEs|0|||
156401678|NCT03485911|564563593|FG000|Part 2|Other NOS|0|||
156401679|NCT03485911|564563594|FG001|Part 2|Other NOS|1|||
156401680|NCT03485911|564563595|FG002|Part 2|Other NOS|0|||
156401681|NCT03485911|564563596|FG003|Part 2|Other NOS|0|||
156401682|NCT03485911|564563593|FG000|Part 2|Intercurrent illness/new medical condition|1|||
156401683|NCT03485911|564563594|FG001|Part 2|Intercurrent illness/new medical condition|0|||
156401684|NCT03485911|564563595|FG002|Part 2|Intercurrent illness/new medical condition|0|||
156401685|NCT03485911|564563596|FG003|Part 2|Intercurrent illness/new medical condition|0|||
156401686|NCT03485911|564563593|FG000|Part 2|Investigator judgement|1|||
156401687|NCT03485911|564563594|FG001|Part 2|Investigator judgement|0|||
156401688|NCT03485911|564563595|FG002|Part 2|Investigator judgement|0|||
156401689|NCT03485911|564563596|FG003|Part 2|Investigator judgement|0|||
156401690|NCT03485911|564563593|FG000|Part 3|Perceived lack of efficacy|2|||
156401691|NCT03485911|564563594|FG001|Part 3|Perceived lack of efficacy|2|||
156552597|NCT00608985|565113655|FG002|Overall Study|Administrative/Other|1|||
156552598|NCT00608985|565113656|FG003|Overall Study|Administrative/Other|2|||
156552599|NCT00608985|565113653|FG000|Overall Study|Withdrawal of Consent|5|||
156552600|NCT00608985|565113654|FG001|Overall Study|Withdrawal of Consent|1|||
156552601|NCT00608985|565113655|FG002|Overall Study|Withdrawal of Consent|1|||
156552602|NCT00608985|565113656|FG003|Overall Study|Withdrawal of Consent|1|||
156552603|NCT00608985|565113653|FG000|Overall Study|Lost to Follow-up|2|||
156552604|NCT00608985|565113654|FG001|Overall Study|Lost to Follow-up|1|||
156552605|NCT00608985|565113655|FG002|Overall Study|Lost to Follow-up|0|||
156552606|NCT00608985|565113656|FG003|Overall Study|Lost to Follow-up|0|||
156552607|NCT00661271|565113657|FG000|Overall Study|Lost to Follow-up|28|||
156552608|NCT00661271|565113658|FG001|Overall Study|Lost to Follow-up|25|||
156401692|NCT03485911|564563595|FG002|Part 3|Perceived lack of efficacy|2|||
156401693|NCT03485911|564563596|FG003|Part 3|Perceived lack of efficacy|0|||
156401694|NCT03485911|564563593|FG000|Part 3|Subject withdrew consent|1|||
156401695|NCT03485911|564563594|FG001|Part 3|Subject withdrew consent|4|||
156401696|NCT03485911|564563595|FG002|Part 3|Subject withdrew consent|0|||
156401697|NCT03485911|564563596|FG003|Part 3|Subject withdrew consent|1|||
156401698|NCT03485911|564563593|FG000|Part 3|Lab abnormalities/AEs|1|||
156401699|NCT03485911|564563594|FG001|Part 3|Lab abnormalities/AEs|1|||
156401700|NCT03485911|564563595|FG002|Part 3|Lab abnormalities/AEs|0|||
156401701|NCT03485911|564563596|FG003|Part 3|Lab abnormalities/AEs|2|||
156401702|NCT03485911|564563593|FG000|Part 3|Other NOS|1|||
156401703|NCT03485911|564563594|FG001|Part 3|Other NOS|1|||
156401704|NCT03485911|564563595|FG002|Part 3|Other NOS|0|||
156401705|NCT03485911|564563596|FG003|Part 3|Other NOS|0|||
156401706|NCT03485911|564563593|FG000|Part 3|Intercurrent illness/new medical condition|0|||
156552609|NCT00088374|565113659|FG000|Overall Study|patient did not receive any 17AAG|1|||
156552610|NCT00088374|565113659|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
156552611|NCT03205995|565113669|FG000|Overall Study|Adverse Event|1|||
156401707|NCT03485911|564563594|FG001|Part 3|Intercurrent illness/new medical condition|1|||
156401708|NCT03485911|564563595|FG002|Part 3|Intercurrent illness/new medical condition|1|||
156401709|NCT03485911|564563596|FG003|Part 3|Intercurrent illness/new medical condition|0|||
156401710|NCT03485911|564563593|FG000|Part 3|Sponsor discontinuation|1|||
156401711|NCT03485911|564563594|FG001|Part 3|Sponsor discontinuation|0|||
156401712|NCT03485911|564563595|FG002|Part 3|Sponsor discontinuation|0|||
156401713|NCT03485911|564563596|FG003|Part 3|Sponsor discontinuation|0|||
156401714|NCT03485911|564563593|FG000|Part 3|Berotralstat provided by alternative means|13|||
156401715|NCT03485911|564563594|FG001|Part 3|Berotralstat provided by alternative means|13|||
156401716|NCT03485911|564563595|FG002|Part 3|Berotralstat provided by alternative means|7|||
156401717|NCT03485911|564563596|FG003|Part 3|Berotralstat provided by alternative means|7|||
156401718|NCT01215357|564563597|FG000|Overall Study|Withdrawal by Subject|3|||
156401719|NCT01215357|564563597|FG000|Overall Study|Protocol Violation|9|||
156511720|NCT00444275|564965807|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
156511721|NCT00444275|564965808|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
156511722|NCT00444275|564965804|FG000|Maintenance Treatment Phase|Adverse Event|0|||
156511723|NCT00444275|564965805|FG001|Maintenance Treatment Phase|Adverse Event|0|||
156511724|NCT00444275|564965806|FG002|Maintenance Treatment Phase|Adverse Event|3|||
156511725|NCT00444275|564965807|FG003|Maintenance Treatment Phase|Adverse Event|2|||
156511726|NCT00444275|564965808|FG004|Maintenance Treatment Phase|Adverse Event|13|||
156511727|NCT00444275|564965804|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
156511728|NCT00444275|564965805|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
156511729|NCT00444275|564965806|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
156511730|NCT00444275|564965807|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
156511731|NCT00444275|564965808|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
156511732|NCT00444275|564965804|FG000|Maintenance Treatment Phase|Patient's wish|0|||
156511733|NCT00444275|564965805|FG001|Maintenance Treatment Phase|Patient's wish|0|||
156511734|NCT00444275|564965806|FG002|Maintenance Treatment Phase|Patient's wish|19|||
156511735|NCT00444275|564965807|FG003|Maintenance Treatment Phase|Patient's wish|9|||
156511736|NCT00444275|564965808|FG004|Maintenance Treatment Phase|Patient's wish|20|||
156511737|NCT00444275|564965804|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
156511738|NCT00444275|564965805|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
156511739|NCT00444275|564965806|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
156511740|NCT00444275|564965807|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
156511741|NCT00444275|564965808|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
156511742|NCT00444275|564965804|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
156511743|NCT00444275|564965805|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
156511744|NCT00444275|564965806|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
156511745|NCT00444275|564965807|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
156511746|NCT00444275|564965808|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
156511747|NCT00743431|564965812|FG000|Overall Study|Toxicity|6|||
156511748|NCT00743431|564965812|FG000|Overall Study|Tumor progression|56|||
156511749|NCT00743431|564965812|FG000|Overall Study|Withdrawal by Subject|13|||
156511750|NCT00743431|564965812|FG000|Overall Study|Death|9|||
156511751|NCT00743431|564965812|FG000|Overall Study|Reason for discontinuation not specified|29|||
156511752|NCT00743431|564965812|FG000|Overall Study|No documentation available|13|||
156511753|NCT03291288|564965813|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
156511754|NCT03291288|564965814|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
156511755|NCT03291288|564965813|FG000|Drug-drug Interaction Phase|Disease progression|1|||
156511756|NCT03291288|564965814|FG001|Drug-drug Interaction Phase|Disease progression|0|||
156511757|NCT03291288|564965813|FG000|Drug-drug Interaction Phase|Other|3|||
156511758|NCT03291288|564965814|FG001|Drug-drug Interaction Phase|Other|0|||
156511759|NCT03291288|564965813|FG000|Pexidartinib Only|Ongoing|0|||
156511760|NCT03291288|564965814|FG001|Pexidartinib Only|Ongoing|2|||
156511761|NCT01128114|564965815|FG000|Overall Study|Treatment Withdrawn|6|||
156511762|NCT01128114|564965815|FG000|Overall Study|Screening Failed|2|||
156511763|NCT01254747|564965816|FG000|Overall Study|Unacceptable subjective vision|0|||
156511764|NCT01254747|564965817|FG001|Overall Study|Unacceptable subjective vision|0|||
156511765|NCT01254747|564965818|FG002|Overall Study|Unacceptable subjective vision|0|||
156511766|NCT01254747|564965819|FG003|Overall Study|Unacceptable subjective vision|2|||
156511767|NCT01254747|564965816|FG000|Overall Study|Difficult removal handling|0|||
156511768|NCT01254747|564965817|FG001|Overall Study|Difficult removal handling|0|||
156511769|NCT01254747|564965818|FG002|Overall Study|Difficult removal handling|1|||
156511770|NCT01254747|564965819|FG003|Overall Study|Difficult removal handling|0|||
156511771|NCT01254747|564965816|FG000|Overall Study|Symptoms and problems|0|||
156511772|NCT01254747|564965817|FG001|Overall Study|Symptoms and problems|2|||
156401720|NCT03333928|564563598|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
156401721|NCT03333928|564563599|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
156401722|NCT03333928|564563600|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
156401723|NCT03333928|564563598|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
156511773|NCT01254747|564965818|FG002|Overall Study|Symptoms and problems|1|||
156511774|NCT01254747|564965819|FG003|Overall Study|Symptoms and problems|0|||
156511775|NCT01254747|564965816|FG000|Overall Study|Lost to Follow-up|0|||
156511776|NCT01254747|564965817|FG001|Overall Study|Lost to Follow-up|0|||
156511777|NCT01254747|564965818|FG002|Overall Study|Lost to Follow-up|1|||
156511778|NCT01254747|564965819|FG003|Overall Study|Lost to Follow-up|0|||
156511779|NCT01254747|564965816|FG000|Overall Study|Biomicroscopy|0|||
156511780|NCT01254747|564965817|FG001|Overall Study|Biomicroscopy|0|||
156511781|NCT01254747|564965818|FG002|Overall Study|Biomicroscopy|1|||
156511782|NCT01254747|564965819|FG003|Overall Study|Biomicroscopy|0|||
156511783|NCT01254747|564965816|FG000|Overall Study|Discomfort|0|||
156511784|NCT01254747|564965817|FG001|Overall Study|Discomfort|4|||
156511785|NCT01254747|564965818|FG002|Overall Study|Discomfort|0|||
156511786|NCT01254747|564965819|FG003|Overall Study|Discomfort|0|||
156511787|NCT04187326|564965820|FG000|Overall Study|Lost to Follow-up|2|||
156511788|NCT04187326|564965821|FG001|Overall Study|Lost to Follow-up|1|||
156511789|NCT04187326|564965820|FG000|Overall Study|Computer error- task was only partially completed.|0|||
156511790|NCT04187326|564965821|FG001|Overall Study|Computer error- task was only partially completed.|1|||
156511791|NCT02387970|564965824|FG000|Overall Study|Did not complete 1-year follow up|1|||
156511792|NCT02387970|564965825|FG001|Overall Study|Did not complete 1-year follow up|2|||
156511793|NCT00586612|564965826|FG000|Primary Phase|Protocol Violation|1|||
156511794|NCT00586612|564965827|FG001|Primary Phase|Protocol Violation|0|||
156511795|NCT00586612|564965826|FG000|Primary Phase|Lost to Follow-up|0|||
156511796|NCT00586612|564965827|FG001|Primary Phase|Lost to Follow-up|1|||
156511797|NCT00586612|564965826|FG000|Primary Phase|Withdrawal by Subject|0|||
156511798|NCT00586612|564965827|FG001|Primary Phase|Withdrawal by Subject|2|||
156511799|NCT00586612|564965826|FG000|Booster Phase|Lost to Follow-up|3|||
156511800|NCT00586612|564965827|FG001|Booster Phase|Lost to Follow-up|1|||
156511801|NCT05543707|564965832|FG000|Overall Study|Study drug non-compliance/|5|||
156511802|NCT05543707|564965833|FG001|Overall Study|Study drug non-compliance/|0|||
156511803|NCT05543707|564965832|FG000|Overall Study|Withdrawal by Subject|1|||
156511804|NCT05543707|564965833|FG001|Overall Study|Withdrawal by Subject|1|||
156511805|NCT05543707|564965832|FG000|Overall Study|Adverse Event|1|||
156511806|NCT05543707|564965833|FG001|Overall Study|Adverse Event|0|||
156511807|NCT05543707|564965832|FG000|Overall Study|concurrent illness|0|||
156511808|NCT05543707|564965833|FG001|Overall Study|concurrent illness|1|||
156511809|NCT05543707|564965832|FG000|Overall Study|Pregnancy|1|||
156511810|NCT05543707|564965833|FG001|Overall Study|Pregnancy|1|||
156511811|NCT04998812|564965838|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
156511812|NCT04998812|564965839|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
156511813|NCT04998812|564965838|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
156511814|NCT04998812|564965839|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
156511815|NCT04998812|564965838|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
156511816|NCT04998812|564965839|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
156511817|NCT04998812|564965838|FG000|Vaccination Period|Ongoing in study|23|||
156511818|NCT04998812|564965839|FG001|Vaccination Period|Ongoing in study|23|||
156511819|NCT03524092|564965843|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
156511820|NCT03524092|564965844|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
156511821|NCT03524092|564965845|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
156511822|NCT03524092|564965846|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
156511823|NCT03524092|564965847|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
156511824|NCT03524092|564965848|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
156511825|NCT03524092|564965843|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
156511826|NCT03524092|564965844|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
156511827|NCT03524092|564965845|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
156511828|NCT03524092|564965846|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
156511829|NCT03524092|564965847|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
156511830|NCT03524092|564965848|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
156511831|NCT03524092|564965843|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
156511832|NCT03524092|564965844|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
156511833|NCT03524092|564965845|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
156511834|NCT03524092|564965846|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
156511835|NCT03524092|564965847|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
156511836|NCT03524092|564965848|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
156511837|NCT03524092|564965843|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
156511838|NCT03524092|564965844|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
156511839|NCT03524092|564965845|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
156511840|NCT03524092|564965846|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
156511841|NCT03524092|564965847|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
156511842|NCT03524092|564965848|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
156511843|NCT03524092|564965843|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
156511844|NCT03524092|564965844|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
156511845|NCT03524092|564965845|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
156511846|NCT03524092|564965846|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
156552612|NCT03205995|565113669|FG000|Overall Study|Death|1|||
156552613|NCT03205995|565113669|FG000|Overall Study|Physician Decision|2|||
156552614|NCT03205995|565113669|FG000|Overall Study|Protocol Violation|2|||
156552615|NCT05913232|565113671|FG000|Overall Study|Adverse Event|0|||
156552616|NCT05913232|565113672|FG001|Overall Study|Adverse Event|2|||
156552617|NCT05913232|565113673|FG002|Overall Study|Adverse Event|1|||
156552618|NCT05913232|565113674|FG003|Overall Study|Adverse Event|1|||
156552619|NCT04428476|565113682|FG000|Overall Study|Withdrawal by Subject|1|||
156552620|NCT04428476|565113682|FG000|Overall Study|Still on treatment|12|||
156552621|NCT01358864|565113694|FG000|Overall Study|Adverse Event|0|||
156552622|NCT01358864|565113695|FG001|Overall Study|Adverse Event|6|||
156552623|NCT01358864|565113696|FG002|Overall Study|Adverse Event|9|||
156552624|NCT01358864|565113697|FG003|Overall Study|Adverse Event|0|||
156552625|NCT01358864|565113698|FG004|Overall Study|Adverse Event|4|||
156552626|NCT01358864|565113699|FG005|Overall Study|Adverse Event|8|||
156552627|NCT01358864|565113700|FG006|Overall Study|Adverse Event|12|||
156552628|NCT01358864|565113701|FG007|Overall Study|Adverse Event|7|||
156552629|NCT01358864|565113694|FG000|Overall Study|Lack of Efficacy|26|||
156552630|NCT01358864|565113695|FG001|Overall Study|Lack of Efficacy|3|||
156552631|NCT01358864|565113696|FG002|Overall Study|Lack of Efficacy|4|||
156552632|NCT01358864|565113697|FG003|Overall Study|Lack of Efficacy|19|||
156552633|NCT01358864|565113698|FG004|Overall Study|Lack of Efficacy|7|||
156552634|NCT01358864|565113699|FG005|Overall Study|Lack of Efficacy|4|||
156552635|NCT01358864|565113700|FG006|Overall Study|Lack of Efficacy|49|||
156552636|NCT01358864|565113701|FG007|Overall Study|Lack of Efficacy|44|||
156552637|NCT01358864|565113694|FG000|Overall Study|Lost to Follow-up|0|||
156552638|NCT01358864|565113695|FG001|Overall Study|Lost to Follow-up|0|||
156552639|NCT01358864|565113696|FG002|Overall Study|Lost to Follow-up|1|||
156552640|NCT01358864|565113697|FG003|Overall Study|Lost to Follow-up|0|||
156552641|NCT01358864|565113698|FG004|Overall Study|Lost to Follow-up|0|||
156552642|NCT01358864|565113699|FG005|Overall Study|Lost to Follow-up|0|||
156552643|NCT01358864|565113700|FG006|Overall Study|Lost to Follow-up|0|||
156552644|NCT01358864|565113701|FG007|Overall Study|Lost to Follow-up|1|||
156552645|NCT01358864|565113694|FG000|Overall Study|Withdrawal by Subject|3|||
156552646|NCT01358864|565113695|FG001|Overall Study|Withdrawal by Subject|4|||
156552647|NCT01358864|565113696|FG002|Overall Study|Withdrawal by Subject|2|||
156552648|NCT01358864|565113697|FG003|Overall Study|Withdrawal by Subject|0|||
156552649|NCT01358864|565113698|FG004|Overall Study|Withdrawal by Subject|0|||
156552650|NCT01358864|565113699|FG005|Overall Study|Withdrawal by Subject|1|||
156552651|NCT01358864|565113700|FG006|Overall Study|Withdrawal by Subject|1|||
156552652|NCT01358864|565113701|FG007|Overall Study|Withdrawal by Subject|3|||
156552653|NCT01358864|565113694|FG000|Overall Study|Other reason not defined above|2|||
156552654|NCT01358864|565113695|FG001|Overall Study|Other reason not defined above|0|||
156552655|NCT01358864|565113696|FG002|Overall Study|Other reason not defined above|0|||
156552656|NCT01358864|565113697|FG003|Overall Study|Other reason not defined above|0|||
156552657|NCT01358864|565113698|FG004|Overall Study|Other reason not defined above|0|||
156552658|NCT01358864|565113699|FG005|Overall Study|Other reason not defined above|0|||
156552659|NCT01358864|565113700|FG006|Overall Study|Other reason not defined above|2|||
156552660|NCT01358864|565113701|FG007|Overall Study|Other reason not defined above|0|||
156552661|NCT01358864|565113694|FG000|Overall Study|Not treated|0|||
156552662|NCT01358864|565113695|FG001|Overall Study|Not treated|0|||
156552663|NCT01358864|565113696|FG002|Overall Study|Not treated|0|||
156552664|NCT01358864|565113697|FG003|Overall Study|Not treated|0|||
156552665|NCT01358864|565113698|FG004|Overall Study|Not treated|0|||
156552666|NCT01358864|565113699|FG005|Overall Study|Not treated|0|||
156552667|NCT01358864|565113700|FG006|Overall Study|Not treated|1|||
156552668|NCT01358864|565113701|FG007|Overall Study|Not treated|0|||
156552669|NCT04042103|565113706|FG000|Overall Study|Lost to Follow-up|1|||
156552670|NCT04042103|565113706|FG000|Overall Study|Withdrawal by Subject|1|||
156552671|NCT04209855|565113707|FG000|Overall Study|Death|161|||
156552672|NCT04209855|565113708|FG001|Overall Study|Death|177|||
156552673|NCT04209855|565113707|FG000|Overall Study|PI Discretion|1|||
156552674|NCT04209855|565113708|FG001|Overall Study|PI Discretion|1|||
156552675|NCT04209855|565113707|FG000|Overall Study|Lost to Follow-up|5|||
156552676|NCT04209855|565113708|FG001|Overall Study|Lost to Follow-up|2|||
156552677|NCT04209855|565113707|FG000|Overall Study|Withdrew consent|10|||
156552678|NCT04209855|565113708|FG001|Overall Study|Withdrew consent|24|||
156552679|NCT04209855|565113707|FG000|Overall Study|Sponsor decision|44|||
156552680|NCT04209855|565113708|FG001|Overall Study|Sponsor decision|18|||
156552681|NCT04209855|565113707|FG000|Overall Study|Other than specified|6|||
156552682|NCT04209855|565113708|FG001|Overall Study|Other than specified|4|||
156552683|NCT00271817|565113709|FG000|Part 1|Adverse Event|68|||
156552684|NCT00271817|565113710|FG001|Part 1|Adverse Event|25|||
156552685|NCT00271817|565113711|FG002|Part 1|Adverse Event|156|||
156552686|NCT00271817|565113709|FG000|Part 1|Lost to Follow-up|6|||
156552687|NCT00271817|565113710|FG001|Part 1|Lost to Follow-up|8|||
156552688|NCT00271817|565113711|FG002|Part 1|Lost to Follow-up|24|||
156552689|NCT00271817|565113709|FG000|Part 1|Protocol Violation|5|||
156552690|NCT00271817|565113710|FG001|Part 1|Protocol Violation|4|||
156552691|NCT00271817|565113711|FG002|Part 1|Protocol Violation|7|||
156552692|NCT00271817|565113709|FG000|Part 1|Patient Moved|3|||
156401724|NCT03333928|564563599|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
156401725|NCT03333928|564563600|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
156401726|NCT03333928|564563598|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
156401727|NCT03333928|564563599|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
156401728|NCT03333928|564563600|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
156401729|NCT03333928|564563598|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
156401730|NCT03333928|564563599|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
156401731|NCT03333928|564563600|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
156401732|NCT03333928|564563598|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
156401733|NCT03333928|564563599|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
156401734|NCT03333928|564563600|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
156401735|NCT03333928|564563598|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
156401736|NCT03333928|564563599|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
156401737|NCT03333928|564563600|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
156401738|NCT03333928|564563598|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
156401739|NCT03333928|564563599|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
156401740|NCT03333928|564563600|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
156401741|NCT03333928|564563598|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
156401742|NCT03333928|564563599|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
156401743|NCT03333928|564563600|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
156401744|NCT01859793|564563605|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
156401745|NCT01859793|564563606|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
156401746|NCT01859793|564563605|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
156401747|NCT01859793|564563606|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
156401748|NCT01859793|564563605|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156401749|NCT01859793|564563606|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
156401750|NCT01859793|564563605|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
156401751|NCT01859793|564563606|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
156401752|NCT04543188|564563607|FG000|Phase 1a|Adverse Event|0|||
156401753|NCT04543188|564563608|FG001|Phase 1a|Adverse Event|0|||
156401754|NCT04543188|564563609|FG002|Phase 1a|Adverse Event|0|||
156401755|NCT04543188|564563610|FG003|Phase 1a|Adverse Event|1|||
156401756|NCT04543188|564563611|FG004|Phase 1a|Adverse Event|0|||
156401757|NCT04543188|564563612|FG005|Phase 1a|Adverse Event|0|||
156401758|NCT04543188|564563613|FG006|Phase 1a|Adverse Event|1|||
156401759|NCT04543188|564563614|FG007|Phase 1a|Adverse Event|0|||
156401760|NCT04543188|564563615|FG008|Phase 1a|Adverse Event|0|||
156401761|NCT04543188|564563616|FG009|Phase 1a|Adverse Event|0|||
156401762|NCT04543188|564563617|FG010|Phase 1a|Adverse Event|0|||
156401763|NCT04543188|564563618|FG011|Phase 1a|Adverse Event|0|||
156401764|NCT04543188|564563619|FG012|Phase 1a|Adverse Event|0|||
156401765|NCT04543188|564563620|FG013|Phase 1a|Adverse Event|0|||
156401766|NCT04543188|564563621|FG014|Phase 1a|Adverse Event|0|||
156401767|NCT04543188|564563607|FG000|Phase 1a|Other (Death)|0|||
156401768|NCT04543188|564563608|FG001|Phase 1a|Other (Death)|1|||
156401769|NCT04543188|564563609|FG002|Phase 1a|Other (Death)|0|||
156401770|NCT04543188|564563610|FG003|Phase 1a|Other (Death)|0|||
156401771|NCT04543188|564563611|FG004|Phase 1a|Other (Death)|1|||
156401772|NCT04543188|564563612|FG005|Phase 1a|Other (Death)|0|||
156401773|NCT04543188|564563613|FG006|Phase 1a|Other (Death)|0|||
156401774|NCT04543188|564563614|FG007|Phase 1a|Other (Death)|0|||
156401775|NCT04543188|564563615|FG008|Phase 1a|Other (Death)|0|||
156401776|NCT04543188|564563616|FG009|Phase 1a|Other (Death)|1|||
156401777|NCT04543188|564563617|FG010|Phase 1a|Other (Death)|0|||
156401778|NCT04543188|564563618|FG011|Phase 1a|Other (Death)|0|||
156401779|NCT04543188|564563619|FG012|Phase 1a|Other (Death)|0|||
156401780|NCT04543188|564563620|FG013|Phase 1a|Other (Death)|0|||
156401781|NCT04543188|564563621|FG014|Phase 1a|Other (Death)|0|||
156401782|NCT04543188|564563607|FG000|Phase 1a|Lost to Follow-up|0|||
156401783|NCT04543188|564563608|FG001|Phase 1a|Lost to Follow-up|0|||
156401784|NCT04543188|564563609|FG002|Phase 1a|Lost to Follow-up|0|||
156401785|NCT04543188|564563610|FG003|Phase 1a|Lost to Follow-up|0|||
156401786|NCT04543188|564563611|FG004|Phase 1a|Lost to Follow-up|0|||
156511847|NCT03524092|564965847|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
156401787|NCT04543188|564563612|FG005|Phase 1a|Lost to Follow-up|0|||
156401788|NCT04543188|564563613|FG006|Phase 1a|Lost to Follow-up|0|||
156401789|NCT04543188|564563614|FG007|Phase 1a|Lost to Follow-up|0|||
156401790|NCT04543188|564563615|FG008|Phase 1a|Lost to Follow-up|0|||
156401791|NCT04543188|564563616|FG009|Phase 1a|Lost to Follow-up|0|||
156401792|NCT04543188|564563617|FG010|Phase 1a|Lost to Follow-up|1|||
156401793|NCT04543188|564563618|FG011|Phase 1a|Lost to Follow-up|0|||
156401794|NCT04543188|564563619|FG012|Phase 1a|Lost to Follow-up|0|||
156401795|NCT04543188|564563620|FG013|Phase 1a|Lost to Follow-up|0|||
156401796|NCT04543188|564563621|FG014|Phase 1a|Lost to Follow-up|0|||
156401797|NCT04543188|564563607|FG000|Phase 1a|Progressive Disease|2|||
156511848|NCT03524092|564965848|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
156511849|NCT03524092|564965843|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
156511850|NCT03524092|564965844|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
156511851|NCT03524092|564965845|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
156511852|NCT03524092|564965846|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
156511853|NCT03524092|564965847|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
156511854|NCT03524092|564965848|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
156511855|NCT03524092|564965843|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
156511856|NCT03524092|564965844|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
156511857|NCT03524092|564965845|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
156511858|NCT03524092|564965846|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
156511859|NCT03524092|564965847|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
156511860|NCT03524092|564965848|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
156511861|NCT03524092|564965843|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
156511862|NCT03524092|564965844|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
156511863|NCT03524092|564965845|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
156511864|NCT03524092|564965846|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
156511865|NCT03524092|564965847|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
156511866|NCT03524092|564965848|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
156511867|NCT03524092|564965843|FG000|Loss of Response Rescue Period|Adverse Event|0|||
156511868|NCT03524092|564965844|FG001|Loss of Response Rescue Period|Adverse Event|0|||
156511869|NCT03524092|564965845|FG002|Loss of Response Rescue Period|Adverse Event|0|||
156511870|NCT03524092|564965846|FG003|Loss of Response Rescue Period|Adverse Event|2|||
156511871|NCT03524092|564965847|FG004|Loss of Response Rescue Period|Adverse Event|0|||
156511872|NCT03524092|564965848|FG005|Loss of Response Rescue Period|Adverse Event|0|||
156511873|NCT03524092|564965843|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
156511874|NCT03524092|564965844|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
156511875|NCT03524092|564965845|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
156511876|NCT03524092|564965846|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
156511877|NCT03524092|564965847|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
156511878|NCT03524092|564965848|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
156511879|NCT03524092|564965843|FG000|Loss of Response Rescue Period|Pregnancy|0|||
156511880|NCT03524092|564965844|FG001|Loss of Response Rescue Period|Pregnancy|0|||
156511881|NCT03524092|564965845|FG002|Loss of Response Rescue Period|Pregnancy|0|||
156511882|NCT03524092|564965846|FG003|Loss of Response Rescue Period|Pregnancy|1|||
156511883|NCT03524092|564965847|FG004|Loss of Response Rescue Period|Pregnancy|0|||
156511884|NCT03524092|564965848|FG005|Loss of Response Rescue Period|Pregnancy|0|||
156511885|NCT03524092|564965843|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
156511886|NCT03524092|564965844|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
156511887|NCT03524092|564965845|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
156511888|NCT03524092|564965846|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
156511889|NCT03524092|564965847|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
156511890|NCT03524092|564965848|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
156511891|NCT03524092|564965843|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
156511892|NCT03524092|564965844|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
156511893|NCT03524092|564965845|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
156511894|NCT03524092|564965846|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
156511895|NCT03524092|564965847|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
156511896|NCT03524092|564965848|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
156511897|NCT03524092|564965843|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
156511898|NCT03524092|564965844|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
156511899|NCT03524092|564965845|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
156511900|NCT03524092|564965846|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
156511901|NCT03524092|564965847|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
156511902|NCT03524092|564965848|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
156511903|NCT03524092|564965843|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
156511904|NCT03524092|564965844|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
156511905|NCT03524092|564965845|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
156511906|NCT03524092|564965846|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
156511907|NCT03524092|564965847|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
156511908|NCT03524092|564965848|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
156511909|NCT03524092|564965843|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
156511910|NCT03524092|564965844|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
156511911|NCT03524092|564965845|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
156511912|NCT03524092|564965846|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
156511913|NCT03524092|564965847|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
156401798|NCT04543188|564563608|FG001|Phase 1a|Progressive Disease|2|||
156401799|NCT04543188|564563609|FG002|Phase 1a|Progressive Disease|3|||
156401800|NCT04543188|564563610|FG003|Phase 1a|Progressive Disease|1|||
156401801|NCT04543188|564563611|FG004|Phase 1a|Progressive Disease|4|||
156401802|NCT04543188|564563612|FG005|Phase 1a|Progressive Disease|2|||
156401803|NCT04543188|564563613|FG006|Phase 1a|Progressive Disease|3|||
156401804|NCT04543188|564563614|FG007|Phase 1a|Progressive Disease|4|||
156401805|NCT04543188|564563615|FG008|Phase 1a|Progressive Disease|1|||
156401806|NCT04543188|564563616|FG009|Phase 1a|Progressive Disease|0|||
156401807|NCT04543188|564563617|FG010|Phase 1a|Progressive Disease|4|||
156401808|NCT04543188|564563618|FG011|Phase 1a|Progressive Disease|0|||
156401809|NCT04543188|564563619|FG012|Phase 1a|Progressive Disease|0|||
156401810|NCT04543188|564563620|FG013|Phase 1a|Progressive Disease|0|||
156401811|NCT04543188|564563621|FG014|Phase 1a|Progressive Disease|0|||
156401812|NCT04543188|564563607|FG000|Phase 1a|Study terminated by sponsor|0|||
156401813|NCT04543188|564563608|FG001|Phase 1a|Study terminated by sponsor|0|||
156401814|NCT04543188|564563609|FG002|Phase 1a|Study terminated by sponsor|0|||
156401815|NCT04543188|564563610|FG003|Phase 1a|Study terminated by sponsor|0|||
156401816|NCT04543188|564563611|FG004|Phase 1a|Study terminated by sponsor|1|||
156401817|NCT04543188|564563612|FG005|Phase 1a|Study terminated by sponsor|0|||
156401818|NCT04543188|564563613|FG006|Phase 1a|Study terminated by sponsor|0|||
156401819|NCT04543188|564563614|FG007|Phase 1a|Study terminated by sponsor|0|||
156401820|NCT04543188|564563615|FG008|Phase 1a|Study terminated by sponsor|0|||
156552693|NCT00271817|565113710|FG001|Part 1|Patient Moved|1|||
156552694|NCT00271817|565113711|FG002|Part 1|Patient Moved|5|||
156552695|NCT00271817|565113709|FG000|Part 1|Withdrawal by Subject|23|||
156552696|NCT00271817|565113710|FG001|Part 1|Withdrawal by Subject|17|||
156552697|NCT00271817|565113711|FG002|Part 1|Withdrawal by Subject|45|||
156552698|NCT00271817|565113709|FG000|Part 1|LDL < 50 mg/dL|1|||
156552699|NCT00271817|565113710|FG001|Part 1|LDL < 50 mg/dL|4|||
156552700|NCT00271817|565113711|FG002|Part 1|LDL < 50 mg/dL|48|||
156552701|NCT00271817|565113709|FG000|Part 2|Adverse Event|0|||
156552702|NCT00271817|565113710|FG001|Part 2|Adverse Event|17|||
156552703|NCT00271817|565113711|FG002|Part 2|Adverse Event|33|||
156552704|NCT00271817|565113709|FG000|Part 2|Lack of Efficacy|0|||
156552705|NCT00271817|565113710|FG001|Part 2|Lack of Efficacy|1|||
156552706|NCT00271817|565113711|FG002|Part 2|Lack of Efficacy|6|||
156552707|NCT00271817|565113709|FG000|Part 2|Lost to Follow-up|0|||
156552708|NCT00271817|565113710|FG001|Part 2|Lost to Follow-up|6|||
156552709|NCT00271817|565113711|FG002|Part 2|Lost to Follow-up|18|||
156552710|NCT00271817|565113709|FG000|Part 2|Protocol Violation|0|||
156552711|NCT00271817|565113710|FG001|Part 2|Protocol Violation|3|||
156552712|NCT00271817|565113711|FG002|Part 2|Protocol Violation|5|||
156552713|NCT00271817|565113709|FG000|Part 2|Patient Moved|0|||
156552714|NCT00271817|565113710|FG001|Part 2|Patient Moved|0|||
156552715|NCT00271817|565113711|FG002|Part 2|Patient Moved|5|||
156552716|NCT00271817|565113709|FG000|Part 2|Withdrawal by Subject|0|||
156552717|NCT00271817|565113710|FG001|Part 2|Withdrawal by Subject|2|||
156552718|NCT00271817|565113711|FG002|Part 2|Withdrawal by Subject|13|||
156552719|NCT00271817|565113709|FG000|Part 2|LDL < 50 mg/dL|0|||
156552720|NCT00271817|565113710|FG001|Part 2|LDL < 50 mg/dL|3|||
156552721|NCT00271817|565113711|FG002|Part 2|LDL < 50 mg/dL|4|||
156552722|NCT01471782|565113713|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
156552723|NCT01471782|565113714|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
156552724|NCT01471782|565113715|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
156552725|NCT01471782|565113716|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
156552726|NCT01471782|565113717|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
156552727|NCT01471782|565113718|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
156552728|NCT01471782|565113713|FG000|Overall Study|Lack of Efficacy|1|||
156552729|NCT01471782|565113714|FG001|Overall Study|Lack of Efficacy|2|||
156552730|NCT01471782|565113715|FG002|Overall Study|Lack of Efficacy|1|||
156552731|NCT01471782|565113716|FG003|Overall Study|Lack of Efficacy|1|||
156552732|NCT01471782|565113717|FG004|Overall Study|Lack of Efficacy|5|||
156552733|NCT01471782|565113718|FG005|Overall Study|Lack of Efficacy|18|||
156552734|NCT01471782|565113713|FG000|Overall Study|Adverse Event|1|||
156401821|NCT04543188|564563616|FG009|Phase 1a|Study terminated by sponsor|0|||
156552735|NCT01471782|565113714|FG001|Overall Study|Adverse Event|1|||
156552736|NCT01471782|565113715|FG002|Overall Study|Adverse Event|2|||
156401822|NCT04543188|564563617|FG010|Phase 1a|Study terminated by sponsor|1|||
156552737|NCT01471782|565113716|FG003|Overall Study|Adverse Event|2|||
156552738|NCT01471782|565113717|FG004|Overall Study|Adverse Event|3|||
156552739|NCT01471782|565113718|FG005|Overall Study|Adverse Event|1|||
156552740|NCT01471782|565113713|FG000|Overall Study|Other|0|||
156401823|NCT04543188|564563618|FG011|Phase 1a|Study terminated by sponsor|0|||
156401824|NCT04543188|564563619|FG012|Phase 1a|Study terminated by sponsor|0|||
156401825|NCT04543188|564563620|FG013|Phase 1a|Study terminated by sponsor|0|||
156401826|NCT04543188|564563621|FG014|Phase 1a|Study terminated by sponsor|0|||
156401827|NCT04543188|564563607|FG000|Phase 1a|Withdrawal by Subject|0|||
156552741|NCT01471782|565113714|FG001|Overall Study|Other|0|||
156552742|NCT01471782|565113715|FG002|Overall Study|Other|1|||
156552743|NCT01471782|565113716|FG003|Overall Study|Other|1|||
156401828|NCT04543188|564563608|FG001|Phase 1a|Withdrawal by Subject|0|||
156401829|NCT04543188|564563609|FG002|Phase 1a|Withdrawal by Subject|0|||
156401830|NCT04543188|564563610|FG003|Phase 1a|Withdrawal by Subject|0|||
156401831|NCT04543188|564563611|FG004|Phase 1a|Withdrawal by Subject|3|||
156401832|NCT04543188|564563612|FG005|Phase 1a|Withdrawal by Subject|0|||
156401833|NCT04543188|564563613|FG006|Phase 1a|Withdrawal by Subject|0|||
156401834|NCT04543188|564563614|FG007|Phase 1a|Withdrawal by Subject|0|||
156401835|NCT04543188|564563615|FG008|Phase 1a|Withdrawal by Subject|1|||
156511914|NCT03524092|564965848|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
156511915|NCT03524092|564965843|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
156511916|NCT03524092|564965844|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
156511917|NCT03524092|564965845|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
156511918|NCT03524092|564965846|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
156511919|NCT03524092|564965847|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
156511920|NCT03524092|564965848|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
156511921|NCT03524092|564965843|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
156511922|NCT03524092|564965844|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
156511923|NCT03524092|564965845|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
156511924|NCT03524092|564965846|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
156511925|NCT03524092|564965847|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
156511926|NCT03524092|564965848|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
156511927|NCT03524092|564965843|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
156511928|NCT03524092|564965844|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
156511929|NCT03524092|564965845|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
156511930|NCT03524092|564965846|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
156511931|NCT03524092|564965847|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
156511932|NCT03524092|564965848|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
156511933|NCT03524092|564965843|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
156511934|NCT03524092|564965844|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
156511935|NCT03524092|564965845|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
156511936|NCT03524092|564965846|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
156511937|NCT03524092|564965847|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
156511938|NCT03524092|564965848|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
156511939|NCT03524092|564965843|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
156511940|NCT03524092|564965844|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
156511941|NCT03524092|564965845|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
156511942|NCT03524092|564965846|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
156511943|NCT03524092|564965847|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
156511944|NCT03524092|564965848|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
156511945|NCT03524092|564965843|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
156511946|NCT03524092|564965844|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
156511947|NCT03524092|564965845|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
156511948|NCT03524092|564965846|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
156511949|NCT03524092|564965847|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
156511950|NCT03524092|564965848|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
156511951|NCT03524092|564965843|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
156401836|NCT04543188|564563616|FG009|Phase 1a|Withdrawal by Subject|1|||
156401837|NCT04543188|564563617|FG010|Phase 1a|Withdrawal by Subject|2|||
156401838|NCT04543188|564563618|FG011|Phase 1a|Withdrawal by Subject|0|||
156401839|NCT04543188|564563619|FG012|Phase 1a|Withdrawal by Subject|0|||
156401840|NCT04543188|564563620|FG013|Phase 1a|Withdrawal by Subject|0|||
156401841|NCT04543188|564563621|FG014|Phase 1a|Withdrawal by Subject|0|||
156401842|NCT04543188|564563607|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
156401843|NCT04543188|564563608|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
156401844|NCT04543188|564563609|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
156401845|NCT04543188|564563610|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
156401846|NCT04543188|564563611|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
156401847|NCT04543188|564563612|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
156401848|NCT04543188|564563613|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
156401849|NCT04543188|564563614|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
156401850|NCT04543188|564563615|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
156401851|NCT04543188|564563616|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
156401852|NCT04543188|564563617|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
156401853|NCT04543188|564563618|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
156401854|NCT04543188|564563619|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
156401855|NCT04543188|564563620|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
156401856|NCT04543188|564563621|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
156401857|NCT04543188|564563607|FG000|Phase 1a|Other|0|||
156401858|NCT04543188|564563608|FG001|Phase 1a|Other|0|||
156401859|NCT04543188|564563609|FG002|Phase 1a|Other|0|||
156401860|NCT04543188|564563610|FG003|Phase 1a|Other|0|||
156401861|NCT04543188|564563611|FG004|Phase 1a|Other|0|||
156401862|NCT04543188|564563612|FG005|Phase 1a|Other|0|||
156401863|NCT04543188|564563613|FG006|Phase 1a|Other|0|||
156401864|NCT04543188|564563614|FG007|Phase 1a|Other|0|||
156401865|NCT04543188|564563615|FG008|Phase 1a|Other|0|||
156401866|NCT04543188|564563616|FG009|Phase 1a|Other|1|||
156401867|NCT04543188|564563617|FG010|Phase 1a|Other|0|||
156401868|NCT04543188|564563618|FG011|Phase 1a|Other|0|||
156401869|NCT04543188|564563619|FG012|Phase 1a|Other|0|||
156401870|NCT04543188|564563620|FG013|Phase 1a|Other|0|||
156401871|NCT04543188|564563621|FG014|Phase 1a|Other|0|||
156401872|NCT04543188|564563607|FG000|Phase 1b|Adverse Event|0|||
156401873|NCT04543188|564563608|FG001|Phase 1b|Adverse Event|0|||
156401874|NCT04543188|564563609|FG002|Phase 1b|Adverse Event|0|||
156401875|NCT04543188|564563610|FG003|Phase 1b|Adverse Event|0|||
156401876|NCT04543188|564563611|FG004|Phase 1b|Adverse Event|0|||
156401877|NCT04543188|564563612|FG005|Phase 1b|Adverse Event|0|||
156401878|NCT04543188|564563613|FG006|Phase 1b|Adverse Event|0|||
156401879|NCT04543188|564563614|FG007|Phase 1b|Adverse Event|0|||
156401880|NCT04543188|564563615|FG008|Phase 1b|Adverse Event|0|||
156401881|NCT04543188|564563616|FG009|Phase 1b|Adverse Event|0|||
156401882|NCT04543188|564563617|FG010|Phase 1b|Adverse Event|0|||
156401883|NCT04543188|564563618|FG011|Phase 1b|Adverse Event|0|||
156401884|NCT04543188|564563619|FG012|Phase 1b|Adverse Event|0|||
156401885|NCT04543188|564563620|FG013|Phase 1b|Adverse Event|0|||
156401886|NCT04543188|564563621|FG014|Phase 1b|Adverse Event|2|||
156401887|NCT04543188|564563607|FG000|Phase 1b|Other (Death)|0|||
156401888|NCT04543188|564563608|FG001|Phase 1b|Other (Death)|0|||
156401889|NCT04543188|564563609|FG002|Phase 1b|Other (Death)|0|||
156401890|NCT04543188|564563610|FG003|Phase 1b|Other (Death)|0|||
156401891|NCT04543188|564563611|FG004|Phase 1b|Other (Death)|0|||
156401892|NCT04543188|564563612|FG005|Phase 1b|Other (Death)|0|||
156401893|NCT04543188|564563613|FG006|Phase 1b|Other (Death)|0|||
156401894|NCT04543188|564563614|FG007|Phase 1b|Other (Death)|0|||
156401895|NCT04543188|564563615|FG008|Phase 1b|Other (Death)|0|||
156401896|NCT04543188|564563616|FG009|Phase 1b|Other (Death)|0|||
156511952|NCT03524092|564965844|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
156511953|NCT03524092|564965845|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
156511954|NCT03524092|564965846|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
156511955|NCT03524092|564965847|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
156511956|NCT03524092|564965848|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
156511957|NCT03826030|564965849|FG000|Overall Study|Withdrawal by Subject|2|||
156511958|NCT03826030|564965850|FG001|Overall Study|Withdrawal by Subject|0|||
156511959|NCT03826030|564965851|FG002|Overall Study|Withdrawal by Subject|1|||
156511960|NCT03826030|564965849|FG000|Overall Study|Lost to Follow-up|1|||
156511961|NCT03826030|564965850|FG001|Overall Study|Lost to Follow-up|1|||
156511962|NCT03826030|564965851|FG002|Overall Study|Lost to Follow-up|1|||
156511963|NCT03826030|564965849|FG000|Overall Study|Too busy to return for visits|1|||
156511964|NCT03826030|564965850|FG001|Overall Study|Too busy to return for visits|0|||
156511965|NCT03826030|564965851|FG002|Overall Study|Too busy to return for visits|0|||
156511966|NCT06748729|564965855|FG000|Overall Study|Withdrawal by Subject|1|||
156511967|NCT03578887|564965856|FG000|Overall Study|Withdrawal by Subject|7|||
156511968|NCT03578887|564965857|FG001|Overall Study|Withdrawal by Subject|2|||
156511969|NCT03578887|564965858|FG002|Overall Study|Withdrawal by Subject|1|||
156511970|NCT03578887|564965856|FG000|Overall Study|Lost to Follow-up|13|||
156511971|NCT03578887|564965857|FG001|Overall Study|Lost to Follow-up|1|||
156511972|NCT03578887|564965858|FG002|Overall Study|Lost to Follow-up|4|||
156511973|NCT03578887|564965856|FG000|Overall Study|Physician Decision|0|||
156511974|NCT03578887|564965857|FG001|Overall Study|Physician Decision|1|||
156511975|NCT03578887|564965858|FG002|Overall Study|Physician Decision|1|||
156511976|NCT04500769|564968138|FG000|Overall Study|Withdrawal by Subject|5|||
156511977|NCT01967147|564968139|FG000|Overall Study|Adverse Event|5|||
156511978|NCT01967147|564968140|FG001|Overall Study|Adverse Event|2|||
156511979|NCT01967147|564968139|FG000|Overall Study|Lack of Efficacy|1|||
156511980|NCT01967147|564968140|FG001|Overall Study|Lack of Efficacy|4|||
156511981|NCT01967147|564968139|FG000|Overall Study|Lost to Follow-up|1|||
156511982|NCT01967147|564968140|FG001|Overall Study|Lost to Follow-up|2|||
156511983|NCT01967147|564968139|FG000|Overall Study|Withdrawal by Subject|2|||
156511984|NCT01967147|564968140|FG001|Overall Study|Withdrawal by Subject|4|||
156511985|NCT01967147|564968139|FG000|Overall Study|Non-compliance with Study Drug|0|||
156511986|NCT01967147|564968140|FG001|Overall Study|Non-compliance with Study Drug|3|||
156511987|NCT01967147|564968139|FG000|Overall Study|Other|4|||
156511988|NCT01967147|564968140|FG001|Overall Study|Other|5|||
156511989|NCT03843554|564968141|FG000|Overall Study|Physician Decision|0|||
156511990|NCT03843554|564968142|FG001|Overall Study|Physician Decision|2|||
156511991|NCT02218606|564968144|FG000|Overall Study|Adverse Event|1|||
156401897|NCT04543188|564563617|FG010|Phase 1b|Other (Death)|0|||
156401898|NCT04543188|564563618|FG011|Phase 1b|Other (Death)|0|||
156401899|NCT04543188|564563619|FG012|Phase 1b|Other (Death)|1|||
156401900|NCT04543188|564563620|FG013|Phase 1b|Other (Death)|0|||
156401901|NCT04543188|564563621|FG014|Phase 1b|Other (Death)|1|||
156401902|NCT04543188|564563607|FG000|Phase 1b|Progressive Disease|0|||
156401903|NCT04543188|564563608|FG001|Phase 1b|Progressive Disease|0|||
156401904|NCT04543188|564563609|FG002|Phase 1b|Progressive Disease|0|||
156401905|NCT04543188|564563610|FG003|Phase 1b|Progressive Disease|0|||
156401906|NCT04543188|564563611|FG004|Phase 1b|Progressive Disease|0|||
156401907|NCT04543188|564563612|FG005|Phase 1b|Progressive Disease|0|||
156401908|NCT04543188|564563613|FG006|Phase 1b|Progressive Disease|0|||
156401909|NCT04543188|564563614|FG007|Phase 1b|Progressive Disease|0|||
156401910|NCT04543188|564563615|FG008|Phase 1b|Progressive Disease|0|||
156401911|NCT04543188|564563616|FG009|Phase 1b|Progressive Disease|0|||
156401912|NCT04543188|564563617|FG010|Phase 1b|Progressive Disease|0|||
156401913|NCT04543188|564563618|FG011|Phase 1b|Progressive Disease|0|||
156401914|NCT04543188|564563619|FG012|Phase 1b|Progressive Disease|2|||
156401915|NCT04543188|564563620|FG013|Phase 1b|Progressive Disease|1|||
156401916|NCT04543188|564563621|FG014|Phase 1b|Progressive Disease|5|||
156401917|NCT04543188|564563607|FG000|Phase 1b|Study Terminated By Sponsor|0|||
156401918|NCT04543188|564563608|FG001|Phase 1b|Study Terminated By Sponsor|0|||
156401919|NCT04543188|564563609|FG002|Phase 1b|Study Terminated By Sponsor|0|||
156401920|NCT04543188|564563610|FG003|Phase 1b|Study Terminated By Sponsor|0|||
156401921|NCT04543188|564563611|FG004|Phase 1b|Study Terminated By Sponsor|0|||
156401922|NCT04543188|564563612|FG005|Phase 1b|Study Terminated By Sponsor|0|||
156401923|NCT04543188|564563613|FG006|Phase 1b|Study Terminated By Sponsor|0|||
156401924|NCT04543188|564563614|FG007|Phase 1b|Study Terminated By Sponsor|0|||
156401925|NCT04543188|564563615|FG008|Phase 1b|Study Terminated By Sponsor|0|||
156401926|NCT04543188|564563616|FG009|Phase 1b|Study Terminated By Sponsor|0|||
156401927|NCT04543188|564563617|FG010|Phase 1b|Study Terminated By Sponsor|0|||
156401928|NCT04543188|564563618|FG011|Phase 1b|Study Terminated By Sponsor|1|||
156401929|NCT04543188|564563619|FG012|Phase 1b|Study Terminated By Sponsor|1|||
156401930|NCT04543188|564563620|FG013|Phase 1b|Study Terminated By Sponsor|0|||
156401931|NCT04543188|564563621|FG014|Phase 1b|Study Terminated By Sponsor|1|||
156401932|NCT04543188|564563607|FG000|Phase 1b|Withdrawal by Subject|0|||
156401933|NCT04543188|564563608|FG001|Phase 1b|Withdrawal by Subject|0|||
156401934|NCT04543188|564563609|FG002|Phase 1b|Withdrawal by Subject|0|||
156401935|NCT04543188|564563610|FG003|Phase 1b|Withdrawal by Subject|0|||
156401936|NCT04543188|564563611|FG004|Phase 1b|Withdrawal by Subject|0|||
156401937|NCT04543188|564563612|FG005|Phase 1b|Withdrawal by Subject|0|||
156401938|NCT04543188|564563613|FG006|Phase 1b|Withdrawal by Subject|0|||
156401939|NCT04543188|564563614|FG007|Phase 1b|Withdrawal by Subject|0|||
156401940|NCT04543188|564563615|FG008|Phase 1b|Withdrawal by Subject|0|||
156401941|NCT04543188|564563616|FG009|Phase 1b|Withdrawal by Subject|0|||
156401942|NCT04543188|564563617|FG010|Phase 1b|Withdrawal by Subject|0|||
156401943|NCT04543188|564563618|FG011|Phase 1b|Withdrawal by Subject|0|||
156401944|NCT04543188|564563619|FG012|Phase 1b|Withdrawal by Subject|0|||
156401945|NCT04543188|564563620|FG013|Phase 1b|Withdrawal by Subject|0|||
156401946|NCT04543188|564563621|FG014|Phase 1b|Withdrawal by Subject|2|||
156401947|NCT03815019|564563622|FG000|Overall Study|Withdrawal by Subject|6|||
156401948|NCT03815019|564563623|FG001|Overall Study|Withdrawal by Subject|8|||
156401949|NCT05960097|564563626|FG000|Overall Study|Lost to Follow-up|3|||
156511992|NCT02218606|564968145|FG001|Overall Study|Adverse Event|1|||
156511993|NCT02218606|564968144|FG000|Overall Study|Death|15|||
156511994|NCT02218606|564968145|FG001|Overall Study|Death|28|||
156511995|NCT02218606|564968144|FG000|Overall Study|Physician Decision|0|||
156511996|NCT02218606|564968145|FG001|Overall Study|Physician Decision|1|||
156511997|NCT02218606|564968144|FG000|Overall Study|Withdrawal by Subject|4|||
156511998|NCT02218606|564968145|FG001|Overall Study|Withdrawal by Subject|0|||
156511999|NCT02218606|564968144|FG000|Overall Study|Noncompliance|1|||
156512000|NCT02218606|564968145|FG001|Overall Study|Noncompliance|0|||
156401950|NCT05960097|564563627|FG001|Overall Study|Lost to Follow-up|1|||
156401951|NCT05960097|564563628|FG002|Overall Study|Lost to Follow-up|1|||
156401952|NCT05960097|564563629|FG003|Overall Study|Lost to Follow-up|2|||
156401953|NCT05960097|564563630|FG004|Overall Study|Lost to Follow-up|1|||
156512001|NCT02218606|564968144|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
156512002|NCT02218606|564968145|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
156512003|NCT02218606|564968144|FG000|Overall Study|Other|2|||
156401954|NCT05960097|564563631|FG005|Overall Study|Lost to Follow-up|1|||
156401955|NCT05960097|564563632|FG006|Overall Study|Lost to Follow-up|2|||
156401956|NCT05960097|564563633|FG007|Overall Study|Lost to Follow-up|3|||
156401957|NCT05960097|564563626|FG000|Overall Study|Physician Decision|0|||
156401958|NCT05960097|564563627|FG001|Overall Study|Physician Decision|0|||
156401959|NCT05960097|564563628|FG002|Overall Study|Physician Decision|0|||
156401960|NCT05960097|564563629|FG003|Overall Study|Physician Decision|0|||
156401961|NCT05960097|564563630|FG004|Overall Study|Physician Decision|0|||
156401962|NCT05960097|564563631|FG005|Overall Study|Physician Decision|0|||
156401963|NCT05960097|564563632|FG006|Overall Study|Physician Decision|1|||
156401964|NCT05960097|564563633|FG007|Overall Study|Physician Decision|0|||
156401965|NCT05960097|564563626|FG000|Overall Study|Withdrawal by Subject|1|||
156401966|NCT05960097|564563627|FG001|Overall Study|Withdrawal by Subject|0|||
156401967|NCT05960097|564563628|FG002|Overall Study|Withdrawal by Subject|0|||
156401968|NCT05960097|564563629|FG003|Overall Study|Withdrawal by Subject|1|||
156401969|NCT05960097|564563630|FG004|Overall Study|Withdrawal by Subject|1|||
156401970|NCT05960097|564563631|FG005|Overall Study|Withdrawal by Subject|0|||
156401971|NCT05960097|564563632|FG006|Overall Study|Withdrawal by Subject|0|||
156401972|NCT05960097|564563633|FG007|Overall Study|Withdrawal by Subject|0|||
156401973|NCT05960097|564563626|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156401974|NCT05960097|564563627|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156401975|NCT05960097|564563628|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
156401976|NCT05960097|564563629|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156401977|NCT05960097|564563630|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156401978|NCT05960097|564563631|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156401979|NCT05960097|564563632|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156401980|NCT05960097|564563633|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156401981|NCT01784068|564563634|FG000|NTCS Phase|Adverse Event|5|||
156401982|NCT01784068|564563635|FG001|NTCS Phase|Adverse Event|0|||
156401983|NCT01784068|564563634|FG000|NTCS Phase|Physician Decision|2|||
156401984|NCT01784068|564563635|FG001|NTCS Phase|Physician Decision|0|||
156401985|NCT01784068|564563634|FG000|NTCS Phase|Patient/guardian decision|3|||
156401986|NCT01784068|564563635|FG001|NTCS Phase|Patient/guardian decision|0|||
156401987|NCT01784068|564563634|FG000|NTCS Phase|Death|2|||
156401988|NCT01784068|564563635|FG001|NTCS Phase|Death|0|||
156401989|NCT01784068|564563634|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
156401990|NCT01784068|564563635|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
156401991|NCT01784068|564563634|FG000|TFR Phase|Physician Decision|0|||
156401992|NCT01784068|564563635|FG001|TFR Phase|Physician Decision|1|||
156401993|NCT01784068|564563634|FG000|TFR Phase|Patient/guardian decision|0|||
156401994|NCT01784068|564563635|FG001|TFR Phase|Patient/guardian decision|3|||
156401995|NCT01784068|564563634|FG000|TFR Phase|Death|0|||
156401996|NCT01784068|564563635|FG001|TFR Phase|Death|1|||
156401997|NCT01784068|564563634|FG000|TFR Phase|Lack of Efficacy|0|||
156401998|NCT01784068|564563635|FG001|TFR Phase|Lack of Efficacy|88|||
156401999|NCT05619003|564563640|FG000|Overall Study|Adverse Event|1|||
156402000|NCT03538951|564563641|FG000|Overall Study|Withdrawal by Subject|1|||
156402001|NCT03538951|564563642|FG001|Overall Study|Withdrawal by Subject|2|||
156512004|NCT02218606|564968145|FG001|Overall Study|Other|1|||
156512005|NCT02218606|564968144|FG000|Overall Study|Never started treatment|0|||
156512006|NCT02218606|564968145|FG001|Overall Study|Never started treatment|1|||
156512007|NCT03203473|564968146|FG000|Induction Phase|Never started primary treatment|2|||
156512008|NCT03203473|564968147|FG001|Induction Phase|Never started primary treatment|0|||
156512009|NCT03203473|564968148|FG002|Induction Phase|Never started primary treatment|0|||
156512010|NCT03203473|564968146|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
156512011|NCT03203473|564968147|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
156512012|NCT03203473|564968148|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
156512013|NCT03203473|564968146|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
156512014|NCT03203473|564968147|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
156512015|NCT03203473|564968148|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
156512016|NCT03203473|564968146|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
156512017|NCT03203473|564968147|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
156512018|NCT03203473|564968148|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
156512019|NCT03203473|564968146|FG000|Arm Allocation Phase|started salvage therapy|0|||
156512020|NCT03203473|564968147|FG001|Arm Allocation Phase|started salvage therapy|5|||
156512021|NCT03203473|564968148|FG002|Arm Allocation Phase|started salvage therapy|0|||
156512022|NCT03203473|564968146|FG000|Arm Allocation Phase|Disease progression|0|||
156512023|NCT03203473|564968147|FG001|Arm Allocation Phase|Disease progression|0|||
156512024|NCT03203473|564968148|FG002|Arm Allocation Phase|Disease progression|37|||
156512025|NCT03203473|564968146|FG000|Arm Allocation Phase|Adverse Event|0|||
156512026|NCT03203473|564968147|FG001|Arm Allocation Phase|Adverse Event|0|||
156552744|NCT01471782|565113717|FG004|Overall Study|Other|6|||
156402002|NCT07018999|564563648|FG000|Overall Study|Protocol Violation|0|||
156402003|NCT07018999|564563649|FG001|Overall Study|Protocol Violation|1|||
156402004|NCT07018999|564563648|FG000|Overall Study|Incomplete data entry|4|||
156402005|NCT07018999|564563649|FG001|Overall Study|Incomplete data entry|7|||
156402006|NCT03444376|564563650|FG000|Part A|Disease relapse or Progression|1|||
156552745|NCT01471782|565113718|FG005|Overall Study|Other|5|||
156552746|NCT01471782|565113713|FG000|Overall Study|Change of Chemotherapy|1|||
156552747|NCT01471782|565113714|FG001|Overall Study|Change of Chemotherapy|1|||
156402007|NCT03444376|564563650|FG000|Part A|Withdrawal by Subject|2|||
156402008|NCT03444376|564563650|FG000|Part A|Adverse Event|1|||
156402009|NCT03444376|564563650|FG000|Part B|Disease relapse or Progression|18|||
156402010|NCT03444376|564563650|FG000|Part B|Withdrawal by Subject|2|||
156402011|NCT03444376|564563650|FG000|Part B|Adverse Event|2|||
156402012|NCT03444376|564563650|FG000|Part B|Physician Decision|1|||
156552748|NCT01471782|565113715|FG002|Overall Study|Change of Chemotherapy|0|||
156552749|NCT01471782|565113716|FG003|Overall Study|Change of Chemotherapy|0|||
156552750|NCT01471782|565113717|FG004|Overall Study|Change of Chemotherapy|1|||
156552751|NCT01471782|565113718|FG005|Overall Study|Change of Chemotherapy|4|||
156552752|NCT01471782|565113713|FG000|Overall Study|Disease Relapse|0|||
156552753|NCT01471782|565113714|FG001|Overall Study|Disease Relapse|0|||
156552754|NCT01471782|565113715|FG002|Overall Study|Disease Relapse|0|||
156552755|NCT01471782|565113716|FG003|Overall Study|Disease Relapse|1|||
156552756|NCT01471782|565113717|FG004|Overall Study|Disease Relapse|2|||
156552757|NCT01471782|565113718|FG005|Overall Study|Disease Relapse|1|||
156552758|NCT01471782|565113713|FG000|Overall Study|Physician Decision|0|||
156552759|NCT01471782|565113714|FG001|Overall Study|Physician Decision|0|||
156552760|NCT01471782|565113715|FG002|Overall Study|Physician Decision|0|||
156552761|NCT01471782|565113716|FG003|Overall Study|Physician Decision|0|||
156552762|NCT01471782|565113717|FG004|Overall Study|Physician Decision|3|||
156552763|NCT01471782|565113718|FG005|Overall Study|Physician Decision|8|||
156552764|NCT01471782|565113713|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156552765|NCT01471782|565113714|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156552766|NCT01471782|565113715|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156552767|NCT01471782|565113716|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156552768|NCT01471782|565113717|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
156552769|NCT01471782|565113718|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156552770|NCT01471782|565113713|FG000|Overall Study|Death|0|||
156552771|NCT01471782|565113714|FG001|Overall Study|Death|0|||
156552772|NCT01471782|565113715|FG002|Overall Study|Death|0|||
156552773|NCT01471782|565113716|FG003|Overall Study|Death|0|||
156552774|NCT01471782|565113717|FG004|Overall Study|Death|0|||
156552775|NCT01471782|565113718|FG005|Overall Study|Death|1|||
156552776|NCT00936208|565113719|FG000|Overall Study|Protocol Violation|37|||
156552777|NCT00936208|565113720|FG001|Overall Study|Protocol Violation|22|||
156552778|NCT04428424|565113721|FG000|Overall Study|Does not meet entrance criteria|132|||
156552779|NCT04428424|565113721|FG000|Overall Study|Lost to Follow-up|115|||
156552780|NCT01564862|565113722|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
156552781|NCT01564862|565113723|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
156552782|NCT01564862|565113724|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
156552783|NCT01564862|565113722|FG000|Overall Study|Major Protocol Deviation|3|||
156402013|NCT03444376|564563650|FG000|Part C|Disease relapse or Progression|43|||
156402014|NCT03444376|564563650|FG000|Part C|Withdrawal by Subject|5|||
156402015|NCT03444376|564563650|FG000|Part C|Adverse Event|2|||
156402016|NCT03444376|564563650|FG000|Part C|Physician Decision|2|||
156402017|NCT03444376|564563650|FG000|Part C|Death|1|||
156402018|NCT01382602|564564699|FG000|Overall Study|Protocol Violation|0|||
156402019|NCT01382602|564564700|FG001|Overall Study|Protocol Violation|3|||
156552784|NCT01564862|565113723|FG001|Overall Study|Major Protocol Deviation|3|||
156552785|NCT01564862|565113724|FG002|Overall Study|Major Protocol Deviation|4|||
156552786|NCT01564862|565113722|FG000|Overall Study|Lost to Follow-up|10|||
156552787|NCT01564862|565113723|FG001|Overall Study|Lost to Follow-up|8|||
156552788|NCT01564862|565113724|FG002|Overall Study|Lost to Follow-up|6|||
156552789|NCT01564862|565113722|FG000|Overall Study|Voluntary Withdrawal|9|||
156552790|NCT01564862|565113723|FG001|Overall Study|Voluntary Withdrawal|6|||
156552791|NCT01564862|565113724|FG002|Overall Study|Voluntary Withdrawal|8|||
156552792|NCT01564862|565113722|FG000|Overall Study|Lack of Efficacy|1|||
156402020|NCT01382602|564564699|FG000|Overall Study|Withdrawal by Subject|0|||
156402021|NCT01382602|564564700|FG001|Overall Study|Withdrawal by Subject|1|||
156402022|NCT01392300|564564704|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
156402023|NCT01392300|564564705|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
156402024|NCT01392300|564564706|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
156402025|NCT01392300|564564704|FG000|Main Period (MP)|Withdrawal by Subject|5|||
156402026|NCT01392300|564564705|FG001|Main Period (MP)|Withdrawal by Subject|1|||
156402027|NCT01392300|564564706|FG002|Main Period (MP)|Withdrawal by Subject|0|||
156402028|NCT01392300|564564704|FG000|Main Period (MP)|Lost to Follow-up|3|||
156402029|NCT01392300|564564705|FG001|Main Period (MP)|Lost to Follow-up|3|||
156402030|NCT01392300|564564706|FG002|Main Period (MP)|Lost to Follow-up|0|||
156402031|NCT01392300|564564704|FG000|Main Period (MP)|Non-compliance|1|||
156402032|NCT01392300|564564705|FG001|Main Period (MP)|Non-compliance|0|||
156402033|NCT01392300|564564706|FG002|Main Period (MP)|Non-compliance|0|||
156402034|NCT01392300|564564704|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
156402035|NCT01392300|564564705|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
156402036|NCT01392300|564564706|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
156402037|NCT01392300|564564704|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
156402038|NCT01392300|564564705|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
156402039|NCT01392300|564564706|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
156402040|NCT01392300|564564704|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
156402041|NCT01392300|564564705|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
156402042|NCT01392300|564564706|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
156402043|NCT01392300|564564704|FG000|Open Label Extension (OLEX) Period|Death|0|||
156402044|NCT01392300|564564705|FG001|Open Label Extension (OLEX) Period|Death|0|||
156402045|NCT01392300|564564706|FG002|Open Label Extension (OLEX) Period|Death|4|||
156402046|NCT01392300|564564704|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
156402047|NCT01392300|564564705|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
156402048|NCT01392300|564564706|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
156402049|NCT01392300|564564704|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
156402050|NCT01392300|564564705|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
156402051|NCT01392300|564564706|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
156402052|NCT01392300|564564704|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
156402053|NCT01392300|564564705|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
156402054|NCT01392300|564564706|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
156402055|NCT05056870|564564707|FG000|Period 1|Site COVID-19 Related|3|||
156552793|NCT01564862|565113723|FG001|Overall Study|Lack of Efficacy|5|||
156552794|NCT01564862|565113724|FG002|Overall Study|Lack of Efficacy|6|||
156552795|NCT01564862|565113722|FG000|Overall Study|Other reason(s)|1|||
156552796|NCT01564862|565113723|FG001|Overall Study|Other reason(s)|0|||
156552797|NCT01564862|565113724|FG002|Overall Study|Other reason(s)|0|||
156402056|NCT05056870|564564708|FG001|Period 1|Site COVID-19 Related|3|||
156402057|NCT05056870|564564707|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156402058|NCT05056870|564564708|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
156402059|NCT05056870|564564707|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
156402060|NCT05056870|564564708|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156402061|NCT05056870|564564707|FG000|Period 2|COVID-19 Related|1|||
156402062|NCT05056870|564564708|FG001|Period 2|COVID-19 Related|0|||
156402063|NCT05056870|564564707|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
156402064|NCT05056870|564564708|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
156402065|NCT01114204|564564714|FG000|Overall Study|Adverse Event|3|||
156402066|NCT01114204|564564715|FG001|Overall Study|Adverse Event|2|||
156552798|NCT02193074|565113727|FG000|Overall Study|Withdrawal by Subject|1|||
156552799|NCT02193074|565113728|FG001|Overall Study|Withdrawal by Subject|2|||
156552800|NCT02193074|565113727|FG000|Overall Study|Adverse Event|16|||
156552801|NCT02193074|565113728|FG001|Overall Study|Adverse Event|13|||
156402067|NCT01114204|564564714|FG000|Overall Study|Lost to Follow-up|1|||
156402068|NCT01114204|564564715|FG001|Overall Study|Lost to Follow-up|0|||
156402069|NCT01114204|564564714|FG000|Overall Study|Withdrawal by Subject|10|||
156402070|NCT01114204|564564715|FG001|Overall Study|Withdrawal by Subject|6|||
156402071|NCT01114204|564564714|FG000|Overall Study|Death|1|||
156512027|NCT03203473|564968148|FG002|Arm Allocation Phase|Adverse Event|11|||
156512028|NCT03203473|564968146|FG000|Arm Allocation Phase|Physician Decision|0|||
156512029|NCT03203473|564968147|FG001|Arm Allocation Phase|Physician Decision|0|||
156512030|NCT03203473|564968148|FG002|Arm Allocation Phase|Physician Decision|3|||
156512031|NCT03203473|564968146|FG000|Arm Allocation Phase|Death|0|||
156512032|NCT03203473|564968147|FG001|Arm Allocation Phase|Death|0|||
156512033|NCT03203473|564968148|FG002|Arm Allocation Phase|Death|1|||
156512034|NCT03203473|564968146|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
156512035|NCT03203473|564968147|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
156512036|NCT03203473|564968148|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
156512037|NCT03203473|564968146|FG000|Arm Allocation Phase|Intercurrent illness|0|||
156512038|NCT03203473|564968147|FG001|Arm Allocation Phase|Intercurrent illness|0|||
156512039|NCT03203473|564968148|FG002|Arm Allocation Phase|Intercurrent illness|1|||
156512040|NCT03203473|564968146|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
156512041|NCT03203473|564968147|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
156512042|NCT03203473|564968148|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
156512043|NCT01901432|564968151|FG000|Overall Study|Adverse Event|0|||
156512044|NCT01901432|564968152|FG001|Overall Study|Adverse Event|1|||
156512045|NCT01901432|564968153|FG002|Overall Study|Adverse Event|1|||
156512046|NCT01901432|564968154|FG003|Overall Study|Adverse Event|0|||
156512047|NCT01901432|564968155|FG004|Overall Study|Adverse Event|1|||
156512048|NCT01901432|564968151|FG000|Overall Study|Withdrawal by Subject|0|||
156512049|NCT01901432|564968152|FG001|Overall Study|Withdrawal by Subject|0|||
156512050|NCT01901432|564968153|FG002|Overall Study|Withdrawal by Subject|1|||
156512051|NCT01901432|564968154|FG003|Overall Study|Withdrawal by Subject|0|||
156512052|NCT01901432|564968155|FG004|Overall Study|Withdrawal by Subject|5|||
156512053|NCT01901432|564968151|FG000|Overall Study|Physician Decision|0|||
156512054|NCT01901432|564968152|FG001|Overall Study|Physician Decision|0|||
156512055|NCT01901432|564968153|FG002|Overall Study|Physician Decision|0|||
156512056|NCT01901432|564968154|FG003|Overall Study|Physician Decision|0|||
156512057|NCT01901432|564968155|FG004|Overall Study|Physician Decision|2|||
156512058|NCT01901432|564968151|FG000|Overall Study|Patient decision to stop study drug|0|||
156512059|NCT01901432|564968152|FG001|Overall Study|Patient decision to stop study drug|0|||
156552802|NCT05593016|565116320|FG000|Overall Study|Death|1|||
156552803|NCT05593016|565116321|FG001|Overall Study|Death|1|||
156402072|NCT01114204|564564715|FG001|Overall Study|Death|0|||
156402073|NCT01114204|564564714|FG000|Overall Study|Other-Personal reasons|2|||
156402074|NCT01114204|564564715|FG001|Overall Study|Other-Personal reasons|0|||
156402075|NCT01114204|564564714|FG000|Overall Study|Other-Medical monitor request|1|||
156402076|NCT01114204|564564715|FG001|Overall Study|Other-Medical monitor request|0|||
156402077|NCT01114204|564564714|FG000|Overall Study|Other-Participant request|2|||
156402078|NCT01114204|564564715|FG001|Overall Study|Other-Participant request|0|||
156402079|NCT01114204|564564714|FG000|Overall Study|Other-Protocol Violation|1|||
156402080|NCT01114204|564564715|FG001|Overall Study|Other-Protocol Violation|0|||
156402081|NCT02207725|564564716|FG000|Overall Study|Did Not Receive Treatment|0|||
156402082|NCT02207725|564564717|FG001|Overall Study|Did Not Receive Treatment|1|||
156402083|NCT02207725|564564718|FG002|Overall Study|Did Not Receive Treatment|1|||
156402084|NCT02207725|564564719|FG003|Overall Study|Did Not Receive Treatment|1|||
156402085|NCT02799472|564564722|FG000|Overall Study|Withdrawal by Subject|2|||
156402086|NCT02799472|564564723|FG001|Overall Study|Withdrawal by Subject|4|||
156402087|NCT02799472|564564722|FG000|Overall Study|Lack of Efficacy|2|||
156402088|NCT02799472|564564723|FG001|Overall Study|Lack of Efficacy|0|||
156402089|NCT02799472|564564722|FG000|Overall Study|Lost to Follow-up|0|||
156402090|NCT02799472|564564723|FG001|Overall Study|Lost to Follow-up|1|||
156402091|NCT00674570|564564724|FG000|Overall Study|Withdrawal by Subject|0|||
156402092|NCT00674570|564564725|FG001|Overall Study|Withdrawal by Subject|2|||
156402093|NCT00674570|564564726|FG002|Overall Study|Withdrawal by Subject|0|||
156402094|NCT02801669|564564727|FG000|Overall Study|Death|66|||
156402095|NCT02801669|564564728|FG001|Overall Study|Death|69|||
156402096|NCT02801669|564564727|FG000|Overall Study|Withdrawal by Subject|81|||
156402097|NCT02801669|564564728|FG001|Overall Study|Withdrawal by Subject|77|||
156402098|NCT02801669|564564727|FG000|Overall Study|Other|4|||
156402099|NCT02801669|564564728|FG001|Overall Study|Other|6|||
156402100|NCT01966003|564564729|FG000|Overall Study|Death|43|||
156402101|NCT01966003|564564730|FG001|Overall Study|Death|36|||
156402102|NCT01966003|564564729|FG000|Overall Study|Protocol Violation|6|||
156402103|NCT01966003|564564730|FG001|Overall Study|Protocol Violation|4|||
156402104|NCT01966003|564564729|FG000|Overall Study|Lost to Follow-up|4|||
156402105|NCT01966003|564564730|FG001|Overall Study|Lost to Follow-up|3|||
156402106|NCT01966003|564564729|FG000|Overall Study|Physician Decision|12|||
156402107|NCT01966003|564564730|FG001|Overall Study|Physician Decision|13|||
156402108|NCT01966003|564564729|FG000|Overall Study|Withdrawal by Subject|29|||
156402109|NCT01966003|564564730|FG001|Overall Study|Withdrawal by Subject|19|||
156402110|NCT01966003|564564729|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
156402111|NCT01966003|564564730|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
156402112|NCT01966003|564564729|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
156402113|NCT01966003|564564730|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
156402114|NCT01966003|564564729|FG000|Overall Study|Other|1|||
156402115|NCT01966003|564564730|FG001|Overall Study|Other|1|||
156402116|NCT02569437|564564732|FG000|Overall Study|Lost to Follow-up|12|||
156402117|NCT02569437|564564733|FG001|Overall Study|Lost to Follow-up|14|||
156402118|NCT00985985|564564734|FG000|Overall Study|Adverse Event|4|||
156402119|NCT00985985|564564735|FG001|Overall Study|Adverse Event|2|||
156512060|NCT01901432|564968153|FG002|Overall Study|Patient decision to stop study drug|0|||
156512061|NCT01901432|564968154|FG003|Overall Study|Patient decision to stop study drug|0|||
156512062|NCT01901432|564968155|FG004|Overall Study|Patient decision to stop study drug|1|||
156512063|NCT00128102|564968158|FG000|Overall Study|Site Discontinued|3|||
156512064|NCT00128102|564968159|FG001|Overall Study|Site Discontinued|6|||
156512065|NCT00128102|564968158|FG000|Overall Study|Other|0|||
156512066|NCT00128102|564968159|FG001|Overall Study|Other|1|||
156512067|NCT00128102|564968158|FG000|Overall Study|Progressive Disease|255|||
156512068|NCT00128102|564968159|FG001|Overall Study|Progressive Disease|285|||
156512069|NCT00128102|564968158|FG000|Overall Study|Adverse Event|34|||
156512070|NCT00128102|564968159|FG001|Overall Study|Adverse Event|11|||
156512071|NCT00128102|564968158|FG000|Overall Study|Death|12|||
156512072|NCT00128102|564968159|FG001|Overall Study|Death|13|||
156512073|NCT00128102|564968158|FG000|Overall Study|Physician Decision|3|||
156552804|NCT05593016|565116322|FG002|Overall Study|Death|1|||
156402120|NCT00985985|564564736|FG002|Overall Study|Adverse Event|2|||
156402121|NCT00985985|564564737|FG003|Overall Study|Adverse Event|2|||
156402122|NCT00985985|564564734|FG000|Overall Study|Lost to Follow-up|4|||
156402123|NCT00985985|564564735|FG001|Overall Study|Lost to Follow-up|11|||
156402124|NCT00985985|564564736|FG002|Overall Study|Lost to Follow-up|2|||
156402125|NCT00985985|564564737|FG003|Overall Study|Lost to Follow-up|3|||
156402126|NCT00985985|564564734|FG000|Overall Study|Protocol Violation|1|||
156402127|NCT00985985|564564735|FG001|Overall Study|Protocol Violation|2|||
156402128|NCT00985985|564564736|FG002|Overall Study|Protocol Violation|0|||
156402129|NCT00985985|564564737|FG003|Overall Study|Protocol Violation|1|||
156402130|NCT00985985|564564734|FG000|Overall Study|Lack of Efficacy|5|||
156402131|NCT00985985|564564735|FG001|Overall Study|Lack of Efficacy|6|||
156402132|NCT00985985|564564736|FG002|Overall Study|Lack of Efficacy|1|||
156512074|NCT00128102|564968159|FG001|Overall Study|Physician Decision|3|||
156512075|NCT00128102|564968158|FG000|Overall Study|Withdrawal by Subject|19|||
156512076|NCT00128102|564968159|FG001|Overall Study|Withdrawal by Subject|11|||
156402133|NCT00985985|564564737|FG003|Overall Study|Lack of Efficacy|3|||
156402134|NCT00985985|564564734|FG000|Overall Study|Withdrawal by Subject|4|||
156402135|NCT00985985|564564735|FG001|Overall Study|Withdrawal by Subject|2|||
156402136|NCT00985985|564564736|FG002|Overall Study|Withdrawal by Subject|2|||
156402137|NCT00985985|564564737|FG003|Overall Study|Withdrawal by Subject|2|||
156402138|NCT00985985|564564734|FG000|Overall Study|Other Reason|6|||
156402139|NCT00985985|564564735|FG001|Overall Study|Other Reason|1|||
156402140|NCT00985985|564564736|FG002|Overall Study|Other Reason|4|||
156402141|NCT00985985|564564737|FG003|Overall Study|Other Reason|2|||
156402142|NCT04766086|564564739|FG000|Overall Study|Lost to Follow-up|3|||
156402143|NCT04766086|564564740|FG001|Overall Study|Lost to Follow-up|5|||
156402144|NCT04766086|564564741|FG002|Overall Study|Lost to Follow-up|3|||
156402145|NCT04766086|564564739|FG000|Overall Study|Withdrawal by Subject|1|||
156402146|NCT04766086|564564740|FG001|Overall Study|Withdrawal by Subject|1|||
156402147|NCT04766086|564564741|FG002|Overall Study|Withdrawal by Subject|2|||
156402148|NCT04766086|564564739|FG000|Overall Study|Other|0|||
156402149|NCT04766086|564564740|FG001|Overall Study|Other|0|||
156402150|NCT04766086|564564741|FG002|Overall Study|Other|1|||
156402151|NCT01282801|564564744|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
156402152|NCT01282801|564564745|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
156402153|NCT00312702|564564746|FG000|Immunization Phase|Lost to Follow-up|0|||
156402154|NCT00312702|564564747|FG001|Immunization Phase|Lost to Follow-up|1|||
156402155|NCT00312702|564564748|FG002|Immunization Phase|Lost to Follow-up|0|||
156402156|NCT03592277|564564754|FG000|Overall Study|Withdrawal by Subject|6|||
156402157|NCT03592277|564564755|FG001|Overall Study|Withdrawal by Subject|8|||
156402158|NCT01781390|564564756|FG000|Overall Study|Withdrawal of Consent|0|||
156402159|NCT01781390|564564757|FG001|Overall Study|Withdrawal of Consent|3|||
156402160|NCT01781390|564564758|FG002|Overall Study|Withdrawal of Consent|1|||
156402161|NCT01781390|564564756|FG000|Overall Study|Lost to Follow-up|1|||
156402162|NCT01781390|564564757|FG001|Overall Study|Lost to Follow-up|1|||
156402163|NCT01781390|564564758|FG002|Overall Study|Lost to Follow-up|1|||
156402164|NCT01781390|564564756|FG000|Overall Study|Adverse Event|1|||
156402165|NCT01781390|564564757|FG001|Overall Study|Adverse Event|2|||
156402166|NCT01781390|564564758|FG002|Overall Study|Adverse Event|1|||
156402167|NCT01781390|564564756|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
156402168|NCT01781390|564564757|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
156402169|NCT01781390|564564758|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
156402170|NCT04707196|564564759|FG000|Overall Study|Withdrawal by Subject|9|||
156402171|NCT04707196|564564760|FG001|Overall Study|Withdrawal by Subject|6|||
156402172|NCT04707196|564564759|FG000|Overall Study|Lost to Follow-up|1|||
156402173|NCT04707196|564564760|FG001|Overall Study|Lost to Follow-up|0|||
156402174|NCT04707196|564564759|FG000|Overall Study|Protocol Violation|4|||
156402175|NCT04707196|564564760|FG001|Overall Study|Protocol Violation|1|||
156402176|NCT04707196|564564759|FG000|Overall Study|Adverse Event|2|||
156402177|NCT04707196|564564760|FG001|Overall Study|Adverse Event|2|||
156402178|NCT04707196|564564759|FG000|Overall Study|Death|3|||
156402179|NCT04707196|564564760|FG001|Overall Study|Death|1|||
156402180|NCT04707196|564564759|FG000|Overall Study|Non-compliance with study drug|1|||
156402181|NCT04707196|564564760|FG001|Overall Study|Non-compliance with study drug|0|||
156402182|NCT04707196|564564759|FG000|Overall Study|Progressive disease|9|||
156402183|NCT04707196|564564760|FG001|Overall Study|Progressive disease|10|||
156402184|NCT01862796|564564762|FG000|Overall Study|Prohibited medications|0|||
156402185|NCT01862796|564564763|FG001|Overall Study|Prohibited medications|0|||
156402186|NCT01862796|564564764|FG002|Overall Study|Prohibited medications|1|||
156402187|NCT04404478|564564765|FG000|Overall Study|Withdrawal by Subject|1|||
156402188|NCT04404478|564564766|FG001|Overall Study|Withdrawal by Subject|3|||
156402189|NCT01674621|564564767|FG000|Overall Study|Adverse Event|3|||
156402190|NCT01674621|564564768|FG001|Overall Study|Adverse Event|2|||
156402191|NCT01674621|564564769|FG002|Overall Study|Adverse Event|5|||
156402192|NCT01674621|564564770|FG003|Overall Study|Adverse Event|5|||
156402193|NCT01674621|564564771|FG004|Overall Study|Adverse Event|1|||
156402194|NCT01674621|564564767|FG000|Overall Study|Inability to Complete Study Procedures|0|||
156402195|NCT01674621|564564768|FG001|Overall Study|Inability to Complete Study Procedures|0|||
156402196|NCT01674621|564564769|FG002|Overall Study|Inability to Complete Study Procedures|0|||
156552805|NCT05593016|565116323|FG003|Overall Study|Death|0|||
156402197|NCT01674621|564564770|FG003|Overall Study|Inability to Complete Study Procedures|0|||
156402198|NCT01674621|564564771|FG004|Overall Study|Inability to Complete Study Procedures|2|||
156402199|NCT01674621|564564767|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
156402200|NCT01674621|564564768|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
156402201|NCT01674621|564564769|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
156402202|NCT01674621|564564770|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
156402203|NCT01674621|564564771|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
156402204|NCT01674621|564564767|FG000|Overall Study|Withdrawal by Subject|2|||
156402205|NCT01674621|564564768|FG001|Overall Study|Withdrawal by Subject|5|||
156402206|NCT01674621|564564769|FG002|Overall Study|Withdrawal by Subject|2|||
156552806|NCT05593016|565116324|FG004|Overall Study|Death|0|||
156402207|NCT01674621|564564770|FG003|Overall Study|Withdrawal by Subject|0|||
156402208|NCT01674621|564564771|FG004|Overall Study|Withdrawal by Subject|1|||
156402209|NCT01674621|564564767|FG000|Overall Study|Other than specified|0|||
156402210|NCT01674621|564564768|FG001|Overall Study|Other than specified|1|||
156402211|NCT01674621|564564769|FG002|Overall Study|Other than specified|0|||
156402212|NCT01674621|564564770|FG003|Overall Study|Other than specified|0|||
156402213|NCT01674621|564564771|FG004|Overall Study|Other than specified|2|||
156402214|NCT05398796|564564774|FG000|Overall Study|Participant moved from the area|0|||
156402215|NCT05398796|564564775|FG001|Overall Study|Participant moved from the area|1|||
156402216|NCT05398796|564564776|FG002|Overall Study|Participant moved from the area|0|||
156402217|NCT05398796|564564777|FG003|Overall Study|Participant moved from the area|0|||
156402218|NCT00728962|564564778|FG000|Implant Placement Surgery|Adverse Event|8|||
156402219|NCT00728962|564564778|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
156402220|NCT00728962|564564778|FG000|Implant Placement Surgery|Protocol Violation|1|||
156402221|NCT00728962|564564778|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
156402222|NCT00728962|564564778|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
156402223|NCT05918978|564564789|FG000|Overall Study|Study Terminated by Sponsor|17|||
156402224|NCT05918978|564564790|FG001|Overall Study|Study Terminated by Sponsor|11|||
156402225|NCT05918978|564564789|FG000|Overall Study|Withdrawal by Subject|1|||
156402226|NCT05918978|564564790|FG001|Overall Study|Withdrawal by Subject|1|||
156402227|NCT05918978|564564789|FG000|Overall Study|Adverse Event|1|||
156402228|NCT05918978|564564790|FG001|Overall Study|Adverse Event|0|||
156402229|NCT05918978|564564789|FG000|Overall Study|Other|0|||
156402230|NCT05918978|564564790|FG001|Overall Study|Other|1|||
156402231|NCT00622180|564564791|FG000|Overall Study|Lost to Follow-up|1|||
156402232|NCT00622180|564564792|FG001|Overall Study|Lost to Follow-up|2|||
156402233|NCT00856167|564564798|FG000|Period 1|Withdrawal by Subject|1|||
156402234|NCT00856167|564564799|FG001|Period 1|Withdrawal by Subject|4|||
156402235|NCT00856167|564564800|FG002|Period 1|Withdrawal by Subject|0|||
156402236|NCT00856167|564564801|FG003|Period 1|Withdrawal by Subject|0|||
156402237|NCT00856167|564564798|FG000|Period 1|Lost to Follow-up|2|||
156402238|NCT00856167|564564799|FG001|Period 1|Lost to Follow-up|1|||
156402239|NCT00856167|564564800|FG002|Period 1|Lost to Follow-up|0|||
156402240|NCT00856167|564564801|FG003|Period 1|Lost to Follow-up|0|||
156402241|NCT00856167|564564798|FG000|Period 2|Lost to Follow-up|0|||
156402242|NCT00856167|564564799|FG001|Period 2|Lost to Follow-up|0|||
156402243|NCT00856167|564564800|FG002|Period 2|Lost to Follow-up|3|||
156402244|NCT00856167|564564801|FG003|Period 2|Lost to Follow-up|1|||
156402245|NCT00856167|564564798|FG000|Period 2|Withdrawal by Subject|0|||
156402246|NCT00856167|564564799|FG001|Period 2|Withdrawal by Subject|0|||
156402247|NCT00856167|564564800|FG002|Period 2|Withdrawal by Subject|2|||
156402248|NCT00856167|564564801|FG003|Period 2|Withdrawal by Subject|4|||
156402249|NCT06027619|564564802|FG000|Overall Study|Adverse Event|0|||
156402250|NCT06027619|564564803|FG001|Overall Study|Adverse Event|0|||
156402251|NCT06027619|564564804|FG002|Overall Study|Adverse Event|1|||
156402252|NCT03075501|564566671|FG000|Overall Study|Scheduling difficulties|15|||
156402253|NCT03075501|564566672|FG001|Overall Study|Scheduling difficulties|9|||
156402254|NCT03610737|564566679|FG000|Overall Study|Withdrawal by Subject|1|||
156402255|NCT03610737|564566680|FG001|Overall Study|Withdrawal by Subject|5|||
156402256|NCT03610737|564566679|FG000|Overall Study|Death|1|||
156402257|NCT03610737|564566680|FG001|Overall Study|Death|0|||
156402258|NCT03610737|564566679|FG000|Overall Study|Not treated|5|||
156402259|NCT03610737|564566680|FG001|Overall Study|Not treated|2|||
156402260|NCT03610737|564566679|FG000|Overall Study|Missed Visit|1|||
156402261|NCT03610737|564566680|FG001|Overall Study|Missed Visit|2|||
156402262|NCT00615264|564566687|FG000|Overall Study|Withdrawal by Subject|17|||
156402263|NCT00615264|564566688|FG001|Overall Study|Withdrawal by Subject|19|||
156402264|NCT00615264|564566687|FG000|Overall Study|Lost to Follow-up|6|||
156402265|NCT00615264|564566688|FG001|Overall Study|Lost to Follow-up|13|||
156402266|NCT00615264|564566687|FG000|Overall Study|Adverse Event|8|||
156512077|NCT00128102|564968158|FG000|Overall Study|Protocol Violation|2|||
156512078|NCT00128102|564968159|FG001|Overall Study|Protocol Violation|2|||
156402267|NCT00615264|564566688|FG001|Overall Study|Adverse Event|5|||
156402268|NCT00615264|564566687|FG000|Overall Study|Death|1|||
156402269|NCT00615264|564566688|FG001|Overall Study|Death|1|||
156402270|NCT00615264|564566687|FG000|Overall Study|Protocol Violation|11|||
156402271|NCT00615264|564566688|FG001|Overall Study|Protocol Violation|7|||
156402272|NCT00615264|564566687|FG000|Overall Study|Not defined|7|||
156402273|NCT00615264|564566688|FG001|Overall Study|Not defined|4|||
156402274|NCT00615264|564566687|FG000|Overall Study|Dermal Hypersensitivity|0|||
156402275|NCT00615264|564566688|FG001|Overall Study|Dermal Hypersensitivity|3|||
156402276|NCT00871403|564566694|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
156402277|NCT00871403|564566695|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
156402278|NCT00871403|564566696|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
156402279|NCT00871403|564566694|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
156512079|NCT00568178|564968160|FG000|Double Blind Base Study|Adverse Event|0|||
156512080|NCT00568178|564968161|FG001|Double Blind Base Study|Adverse Event|2|||
156512081|NCT00568178|564968162|FG002|Double Blind Base Study|Adverse Event|1|||
156402280|NCT00871403|564566695|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
156402281|NCT00871403|564566696|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
156402282|NCT00871403|564566694|FG000|Combination Treatment Phase|Adverse Event|0|||
156402283|NCT00871403|564566695|FG001|Combination Treatment Phase|Adverse Event|17|||
156402284|NCT00871403|564566696|FG002|Combination Treatment Phase|Adverse Event|2|||
156402285|NCT00871403|564566694|FG000|Combination Treatment Phase|Disease Progression|0|||
156402286|NCT00871403|564566695|FG001|Combination Treatment Phase|Disease Progression|8|||
156402287|NCT00871403|564566696|FG002|Combination Treatment Phase|Disease Progression|5|||
156402288|NCT00871403|564566694|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
156402289|NCT00871403|564566695|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
156402290|NCT00871403|564566696|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
156402291|NCT00871403|564566694|FG000|Combination Treatment Phase|Physician Decision|0|||
156402292|NCT00871403|564566695|FG001|Combination Treatment Phase|Physician Decision|1|||
156402293|NCT00871403|564566696|FG002|Combination Treatment Phase|Physician Decision|3|||
156402294|NCT00871403|564566694|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
156402295|NCT00871403|564566695|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
156402296|NCT00871403|564566696|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
156402297|NCT00871403|564566694|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
156402298|NCT00871403|564566695|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
156402299|NCT00871403|564566696|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
156402300|NCT00708435|564566697|FG000|Overall Study|Death / Serious Adverse Event|10|||
156402301|NCT00708435|564566698|FG001|Overall Study|Death / Serious Adverse Event|5|||
156402302|NCT00708435|564566697|FG000|Overall Study|Lost to Follow-up|9|||
156402303|NCT00708435|564566698|FG001|Overall Study|Lost to Follow-up|4|||
156402304|NCT00708435|564566697|FG000|Overall Study|Withdrawal by Subject|3|||
156402305|NCT00708435|564566698|FG001|Overall Study|Withdrawal by Subject|7|||
156402306|NCT00708435|564566697|FG000|Overall Study|Adverse Event|1|||
156402307|NCT00708435|564566698|FG001|Overall Study|Adverse Event|0|||
156402308|NCT00708435|564566697|FG000|Overall Study|Protocol Violation|0|||
156402309|NCT00708435|564566698|FG001|Overall Study|Protocol Violation|1|||
156402310|NCT00708435|564566697|FG000|Overall Study|Intervention by primary care physician|1|||
156402311|NCT00708435|564566698|FG001|Overall Study|Intervention by primary care physician|0|||
156402312|NCT00708435|564566697|FG000|Overall Study|Refused hospitalization|1|||
156402313|NCT00708435|564566698|FG001|Overall Study|Refused hospitalization|0|||
156402314|NCT02343003|564566699|FG000|Overall Study|Withdrawal by Subject|9|||
156402315|NCT02343003|564566700|FG001|Overall Study|Withdrawal by Subject|4|||
156402316|NCT02343003|564566699|FG000|Overall Study|Lost to Follow-up|5|||
156402317|NCT02343003|564566700|FG001|Overall Study|Lost to Follow-up|1|||
156402318|NCT02343003|564566699|FG000|Overall Study|Protocol Violation|1|||
156402319|NCT02343003|564566700|FG001|Overall Study|Protocol Violation|0|||
156402320|NCT02343003|564566699|FG000|Overall Study|Death|0|||
156402321|NCT02343003|564566700|FG001|Overall Study|Death|1|||
156402322|NCT02343003|564566699|FG000|Overall Study|exclusion criteria met|1|||
156402323|NCT02343003|564566700|FG001|Overall Study|exclusion criteria met|1|||
156402324|NCT02343003|564566699|FG000|Overall Study|terminated by sponsor|2|||
156402325|NCT02343003|564566700|FG001|Overall Study|terminated by sponsor|0|||
156402326|NCT01153269|564566701|FG000|Overall Study|Withdrawal by Subject|1|||
156402327|NCT01153269|564566701|FG000|Overall Study|Antiretroviral therapy break|1|||
156402328|NCT02635724|564566712|FG000|Overall Study|Withdrawal by Subject|0|||
156402329|NCT02635724|564566713|FG001|Overall Study|Withdrawal by Subject|1|||
156402330|NCT02635724|564566714|FG002|Overall Study|Withdrawal by Subject|0|||
156402331|NCT02424591|564566719|FG000|Overall Study|Protocol Violation|2|||
156402332|NCT02424591|564566720|FG001|Overall Study|Protocol Violation|3|||
156402333|NCT00770432|564566721|FG000|Overall Study|Other|4|||
156402334|NCT00770432|564566722|FG001|Overall Study|Other|6|||
156402335|NCT00770432|564566721|FG000|Overall Study|Non-compliance|0|||
156402336|NCT00770432|564566722|FG001|Overall Study|Non-compliance|1|||
156402337|NCT01453348|564566723|FG000|Overall Study|Death|0|||
156402338|NCT01453348|564566724|FG001|Overall Study|Death|0|||
156402339|NCT01453348|564566725|FG002|Overall Study|Death|1|||
156402340|NCT01453348|564566723|FG000|Overall Study|Withdrawal by Subject|0|||
156402341|NCT01453348|564566724|FG001|Overall Study|Withdrawal by Subject|1|||
156402342|NCT01453348|564566725|FG002|Overall Study|Withdrawal by Subject|0|||
156402343|NCT01453348|564566723|FG000|Overall Study|Protocol Violation|1|||
156402344|NCT01453348|564566724|FG001|Overall Study|Protocol Violation|0|||
156402345|NCT01453348|564566725|FG002|Overall Study|Protocol Violation|0|||
156552807|NCT05593016|565116320|FG000|Overall Study|Lost to Follow-up|1|||
156402346|NCT01498822|564566726|FG000|Overall Study|Protocol Violation|8|||
156402347|NCT01498822|564566727|FG001|Overall Study|Protocol Violation|4|||
156402348|NCT01498822|564566726|FG000|Overall Study|Other Reason|5|||
156402349|NCT01498822|564566727|FG001|Overall Study|Other Reason|2|||
156402350|NCT01498822|564566726|FG000|Overall Study|Lack of Efficacy|7|||
156402351|NCT01498822|564566727|FG001|Overall Study|Lack of Efficacy|2|||
156402352|NCT01498822|564566726|FG000|Overall Study|AE, non-serious non-fatal|8|||
156402353|NCT01498822|564566727|FG001|Overall Study|AE, non-serious non-fatal|17|||
156402354|NCT01498822|564566726|FG000|Overall Study|SAE, non-fatal|2|||
156402355|NCT01498822|564566727|FG001|Overall Study|SAE, non-fatal|2|||
156402356|NCT01498822|564566726|FG000|Overall Study|Adverse Event, serious fatal|1|||
156402357|NCT01498822|564566727|FG001|Overall Study|Adverse Event, serious fatal|1|||
156402358|NCT01498822|564566726|FG000|Overall Study|Withdrawal by Subject|15|||
156402359|NCT01498822|564566727|FG001|Overall Study|Withdrawal by Subject|25|||
156402360|NCT01498822|564566726|FG000|Overall Study|Lost to Follow-up|8|||
156402361|NCT01498822|564566727|FG001|Overall Study|Lost to Follow-up|3|||
156402362|NCT03056534|564566739|FG000|Overall Study|Participant withdrew consent|8|||
156402363|NCT03056534|564566739|FG000|Overall Study|Participant not able to return|6|||
156402364|NCT03056534|564566739|FG000|Overall Study|Lost to Follow-up|37|||
156402365|NCT03056534|564566739|FG000|Overall Study|Investigator judgment|1|||
156402366|NCT03056534|564566739|FG000|Overall Study|Death|4|||
156402367|NCT03056534|564566739|FG000|Overall Study|Adverse Event|1|||
156402368|NCT03056534|564566739|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
156402369|NCT04146896|564566744|FG000|Overall Study|Adverse Event|5|||
156402370|NCT04146896|564566745|FG001|Overall Study|Adverse Event|8|||
156402371|NCT04146896|564566744|FG000|Overall Study|Lack of Efficacy|3|||
156402372|NCT04146896|564566745|FG001|Overall Study|Lack of Efficacy|2|||
156402373|NCT04146896|564566744|FG000|Overall Study|Lost to Follow-up|0|||
156402374|NCT04146896|564566745|FG001|Overall Study|Lost to Follow-up|1|||
156402375|NCT04146896|564566744|FG000|Overall Study|Non-compliance|5|||
156402376|NCT04146896|564566745|FG001|Overall Study|Non-compliance|4|||
156402377|NCT04146896|564566744|FG000|Overall Study|Withdrawal by Subject|3|||
156402378|NCT04146896|564566745|FG001|Overall Study|Withdrawal by Subject|5|||
156402379|NCT04146896|564566744|FG000|Overall Study|Randomized in error|1|||
156402380|NCT04146896|564566745|FG001|Overall Study|Randomized in error|2|||
156402381|NCT01597505|564566746|FG000|Overall Study|Physician Decision|5|||
156402382|NCT01597505|564566747|FG001|Overall Study|Physician Decision|0|||
156402383|NCT01597505|564566746|FG000|Overall Study|Adverse Event|19|||
156402384|NCT01597505|564566747|FG001|Overall Study|Adverse Event|7|||
156402385|NCT01597505|564566746|FG000|Overall Study|Lost to Follow-up|4|||
156402386|NCT01597505|564566747|FG001|Overall Study|Lost to Follow-up|2|||
156402387|NCT01597505|564566746|FG000|Overall Study|Withdrawal by Subject|10|||
156402388|NCT01597505|564566747|FG001|Overall Study|Withdrawal by Subject|18|||
156402389|NCT01597505|564566746|FG000|Overall Study|Other|5|||
156402390|NCT01597505|564566747|FG001|Overall Study|Other|6|||
156402391|NCT01597505|564566746|FG000|Overall Study|Missing|1|||
156402392|NCT01597505|564566747|FG001|Overall Study|Missing|0|||
156402393|NCT02675465|564566748|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
156402394|NCT02675465|564566749|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
156402395|NCT02675465|564566750|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
156402396|NCT02675465|564566751|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
156402397|NCT02675465|564566752|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
156402398|NCT02675465|564566753|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
156402399|NCT02675465|564566748|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156402400|NCT02675465|564566749|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156402401|NCT02675465|564566750|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
156402402|NCT02675465|564566751|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156402403|NCT02675465|564566752|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156402404|NCT02675465|564566753|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156402405|NCT02675465|564566748|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
156402406|NCT02675465|564566749|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
156402407|NCT02675465|564566750|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
156402408|NCT02675465|564566751|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
156402409|NCT02675465|564566752|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
156402410|NCT02675465|564566753|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
156402411|NCT02675465|564566748|FG000|Stage 4: Long Term Extension|Death|0|||
156402412|NCT02675465|564566749|FG001|Stage 4: Long Term Extension|Death|0|||
156402413|NCT02675465|564566750|FG002|Stage 4: Long Term Extension|Death|0|||
156402414|NCT02675465|564566751|FG003|Stage 4: Long Term Extension|Death|1|||
156402415|NCT02675465|564566752|FG004|Stage 4: Long Term Extension|Death|0|||
156402416|NCT02675465|564566753|FG005|Stage 4: Long Term Extension|Death|0|||
156402417|NCT05031078|564566754|FG000|Overall Study|Withdrawal by Subject|0|||
156402418|NCT05031078|564566755|FG001|Overall Study|Withdrawal by Subject|1|||
156512082|NCT00568178|564968163|FG003|Double Blind Base Study|Adverse Event|2|||
156512083|NCT00568178|564968164|FG004|Double Blind Base Study|Adverse Event|0|||
156402419|NCT05031078|564566756|FG002|Overall Study|Withdrawal by Subject|0|||
156402420|NCT05004688|564566757|FG000|Overall Study|Protocol Violation|7|||
156402421|NCT05004688|564566757|FG000|Overall Study|Physician Decision|2|||
156402422|NCT05004688|564566757|FG000|Overall Study|Withdrawal by Subject|2|||
156402423|NCT04954586|564566758|FG000|Overall Study|Withdrawal by Subject|5|||
156402424|NCT00532155|564566759|FG000|Overall Study|Adverse Event|66|||
156402425|NCT00532155|564566760|FG001|Overall Study|Adverse Event|123|||
156402426|NCT00532155|564566759|FG000|Overall Study|Lack of Efficacy|332|||
156402427|NCT00532155|564566760|FG001|Overall Study|Lack of Efficacy|255|||
156512084|NCT00568178|564968165|FG005|Double Blind Base Study|Adverse Event|0|||
156402428|NCT00532155|564566759|FG000|Overall Study|Protocol Violation|1|||
156402429|NCT00532155|564566760|FG001|Overall Study|Protocol Violation|3|||
156402430|NCT00532155|564566759|FG000|Overall Study|Lost to Follow-up|2|||
156402431|NCT00532155|564566760|FG001|Overall Study|Lost to Follow-up|0|||
156402432|NCT00532155|564566759|FG000|Overall Study|Physician Decision|16|||
156402433|NCT00532155|564566760|FG001|Overall Study|Physician Decision|15|||
156402434|NCT00532155|564566759|FG000|Overall Study|Withdrawal by Subject|23|||
156402435|NCT00532155|564566760|FG001|Overall Study|Withdrawal by Subject|44|||
156402436|NCT00532155|564566759|FG000|Overall Study|Consent withdrawn|5|||
156402437|NCT00532155|564566760|FG001|Overall Study|Consent withdrawn|7|||
156402438|NCT00532155|564566759|FG000|Overall Study|Moved|1|||
156402439|NCT00532155|564566760|FG001|Overall Study|Moved|0|||
156402440|NCT00532155|564566759|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
156402441|NCT00532155|564566760|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
156402442|NCT00532155|564566759|FG000|Overall Study|Occurence of a second cancer|0|||
156402443|NCT00532155|564566760|FG001|Overall Study|Occurence of a second cancer|1|||
156402444|NCT00532155|564566759|FG000|Overall Study|Occurence of a secondary cancer|0|||
156402445|NCT00532155|564566760|FG001|Overall Study|Occurence of a secondary cancer|1|||
156402446|NCT00532155|564566759|FG000|Overall Study|Promotor ended study|1|||
156402447|NCT00532155|564566760|FG001|Overall Study|Promotor ended study|0|||
156402448|NCT00532155|564566759|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
156402449|NCT00532155|564566760|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
156402450|NCT00532155|564566759|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
156402451|NCT00532155|564566760|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
156402452|NCT00532155|564566759|FG000|Overall Study|Study stopped|1|||
156402453|NCT00532155|564566760|FG001|Overall Study|Study stopped|0|||
156402454|NCT00532155|564566759|FG000|Overall Study|Study terminated by sponsor|1|||
156402455|NCT00532155|564566760|FG001|Overall Study|Study terminated by sponsor|0|||
156402456|NCT00532155|564566759|FG000|Overall Study|Study termination stop further treatment|4|||
156402457|NCT00532155|564566760|FG001|Overall Study|Study termination stop further treatment|0|||
156402458|NCT00532155|564566759|FG000|Overall Study|Did not receive study medication|2|||
156402459|NCT00532155|564566760|FG001|Overall Study|Did not receive study medication|6|||
156402460|NCT03483038|564566761|FG000|Overall Study|Subjects still in follow-up|18|||
156402461|NCT02134925|564566762|FG000|Overall Study|Withdrawal by Subject|1|||
156402462|NCT02134925|564566763|FG001|Overall Study|Withdrawal by Subject|0|||
156402463|NCT02134925|564566762|FG000|Overall Study|Cancel|1|||
156402464|NCT02134925|564566763|FG001|Overall Study|Cancel|6|||
156402465|NCT04027348|564566764|FG000|Overall Study|Adverse Event|2|||
156402466|NCT02158884|564566765|FG000|Baseline Assessment|Missed performance assessment|3|||
156402467|NCT02158884|564566765|FG000|Baseline Assessment|Missed SMFA|1|||
156402468|NCT02158884|564566765|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
156402469|NCT02158884|564566765|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
156402470|NCT02158884|564566765|FG000|6 Month Assessment|Missed SMFA|20|||
156402471|NCT02158884|564566765|FG000|12 Month Assessment|Missed SMFA|17|||
156402472|NCT02487472|564566766|FG000|Overall Study|Did not complete telephonic interviews|9|||
156402473|NCT02487472|564566766|FG000|Overall Study|Other|2|||
156402474|NCT01313286|564566767|FG000|Period 1|Withdrawal by Subject|2|||
156402475|NCT01313286|564566768|FG001|Period 1|Withdrawal by Subject|0|||
156402476|NCT04843930|564566769|FG000|Randomization|Withdrawal by Subject|6|||
156402477|NCT04843930|564566770|FG001|Randomization|Withdrawal by Subject|6|||
156402478|NCT04843930|564566771|FG002|Randomization|Withdrawal by Subject|0|||
156402479|NCT04843930|564566772|FG003|Randomization|Withdrawal by Subject|0|||
156402480|NCT04843930|564566769|FG000|Week 6 Assessment|Adverse Event|3|||
156402481|NCT04843930|564566770|FG001|Week 6 Assessment|Adverse Event|0|||
156402482|NCT04843930|564566771|FG002|Week 6 Assessment|Adverse Event|0|||
156402483|NCT04843930|564566772|FG003|Week 6 Assessment|Adverse Event|0|||
156402484|NCT04843930|564566769|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
156402485|NCT04843930|564566770|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
156402486|NCT04843930|564566771|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
156402487|NCT04843930|564566772|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
156402488|NCT04843930|564566769|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
156402489|NCT04843930|564566770|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
156402490|NCT04843930|564566771|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
156402491|NCT04843930|564566772|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
156402492|NCT05158296|564566773|FG000|Overall Study|Sponsor Decision|2|||
156402493|NCT05158296|564566774|FG001|Overall Study|Sponsor Decision|3|||
156402494|NCT05158296|564566775|FG002|Overall Study|Sponsor Decision|2|||
156512085|NCT00568178|564968160|FG000|Double Blind Base Study|Lost to Follow-up|1|||
156512086|NCT00568178|564968161|FG001|Double Blind Base Study|Lost to Follow-up|0|||
156512087|NCT00568178|564968162|FG002|Double Blind Base Study|Lost to Follow-up|0|||
156402495|NCT02552238|564566776|FG000|Overall Study|Withdrawal by Subject|2|||
156402496|NCT02552238|564566776|FG000|Overall Study|Adverse Event|2|||
156402497|NCT01576718|564566780|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
156512088|NCT00568178|564968163|FG003|Double Blind Base Study|Lost to Follow-up|1|||
156512089|NCT00568178|564968164|FG004|Double Blind Base Study|Lost to Follow-up|0|||
156402498|NCT01576718|564566781|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156402499|NCT01576718|564566782|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156402500|NCT01576718|564566783|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156402501|NCT01576718|564566784|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156402502|NCT01576718|564566785|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156402503|NCT01576718|564566786|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156402504|NCT01576718|564566780|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
156402505|NCT01576718|564566781|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156402506|NCT01576718|564566782|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156402507|NCT01576718|564566783|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156402508|NCT01576718|564566784|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156402509|NCT01576718|564566785|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156402510|NCT01576718|564566786|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156402511|NCT01576718|564566780|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
156402512|NCT01576718|564566781|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156402513|NCT01576718|564566782|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156402514|NCT01576718|564566783|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156402515|NCT01576718|564566784|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156402516|NCT01576718|564566785|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156402517|NCT01576718|564566786|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156402518|NCT01576718|564566780|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
156402519|NCT01576718|564566781|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156402520|NCT01576718|564566782|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156402521|NCT01576718|564566783|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156402522|NCT01576718|564566784|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156402523|NCT01576718|564566785|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156402524|NCT01576718|564566786|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156402525|NCT01576718|564566780|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
156402526|NCT01576718|564566781|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156402527|NCT01576718|564566782|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156402528|NCT01576718|564566783|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156402529|NCT01576718|564566784|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156402530|NCT01576718|564566785|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156402531|NCT01576718|564566786|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156402532|NCT01576718|564566780|FG000|Treatment Period|Adverse Event|0|||
156402533|NCT01576718|564566781|FG001|Treatment Period|Adverse Event|1|||
156402534|NCT01576718|564566782|FG002|Treatment Period|Adverse Event|1|||
156402535|NCT01576718|564566783|FG003|Treatment Period|Adverse Event|1|||
156402536|NCT01576718|564566784|FG004|Treatment Period|Adverse Event|1|||
156402537|NCT01576718|564566785|FG005|Treatment Period|Adverse Event|1|||
156402538|NCT01576718|564566786|FG006|Treatment Period|Adverse Event|0|||
156402539|NCT01576718|564566780|FG000|Treatment Period|Withdrawal by Subject|0|||
156402540|NCT01576718|564566781|FG001|Treatment Period|Withdrawal by Subject|1|||
156402541|NCT01576718|564566782|FG002|Treatment Period|Withdrawal by Subject|1|||
156402542|NCT01576718|564566783|FG003|Treatment Period|Withdrawal by Subject|0|||
156402543|NCT01576718|564566784|FG004|Treatment Period|Withdrawal by Subject|2|||
156402544|NCT01576718|564566785|FG005|Treatment Period|Withdrawal by Subject|4|||
156402545|NCT01576718|564566786|FG006|Treatment Period|Withdrawal by Subject|2|||
156402546|NCT01576718|564566780|FG000|Treatment Period|Physician Decision|0|||
156402547|NCT01576718|564566781|FG001|Treatment Period|Physician Decision|1|||
156512090|NCT00568178|564968165|FG005|Double Blind Base Study|Lost to Follow-up|0|||
156512091|NCT00568178|564968160|FG000|Double Blind Base Study|Physician Decision|1|||
156512092|NCT00568178|564968161|FG001|Double Blind Base Study|Physician Decision|1|||
156512093|NCT00568178|564968162|FG002|Double Blind Base Study|Physician Decision|0|||
156512094|NCT00568178|564968163|FG003|Double Blind Base Study|Physician Decision|1|||
156512095|NCT00568178|564968164|FG004|Double Blind Base Study|Physician Decision|0|||
156552808|NCT05593016|565116321|FG001|Overall Study|Lost to Follow-up|1|||
156402548|NCT01576718|564566782|FG002|Treatment Period|Physician Decision|1|||
156402549|NCT01576718|564566783|FG003|Treatment Period|Physician Decision|1|||
156402550|NCT01576718|564566784|FG004|Treatment Period|Physician Decision|1|||
156402551|NCT01576718|564566785|FG005|Treatment Period|Physician Decision|0|||
156402552|NCT01576718|564566786|FG006|Treatment Period|Physician Decision|0|||
156402553|NCT01576718|564566780|FG000|Treatment Period|Protocol Violation|0|||
156402554|NCT01576718|564566781|FG001|Treatment Period|Protocol Violation|5|||
156402555|NCT01576718|564566782|FG002|Treatment Period|Protocol Violation|4|||
156402556|NCT01576718|564566783|FG003|Treatment Period|Protocol Violation|10|||
156512096|NCT00568178|564968165|FG005|Double Blind Base Study|Physician Decision|0|||
156512097|NCT00568178|564968160|FG000|Double Blind Base Study|Protocol Violation|3|||
156402557|NCT01576718|564566784|FG004|Treatment Period|Protocol Violation|6|||
156402558|NCT01576718|564566785|FG005|Treatment Period|Protocol Violation|8|||
156402559|NCT01576718|564566786|FG006|Treatment Period|Protocol Violation|12|||
156402560|NCT01576718|564566780|FG000|Treatment Period|Sponsor request|0|||
156402561|NCT01576718|564566781|FG001|Treatment Period|Sponsor request|1|||
156402562|NCT01576718|564566782|FG002|Treatment Period|Sponsor request|0|||
156402563|NCT01576718|564566783|FG003|Treatment Period|Sponsor request|0|||
156402564|NCT01576718|564566784|FG004|Treatment Period|Sponsor request|0|||
156402565|NCT01576718|564566785|FG005|Treatment Period|Sponsor request|1|||
156402566|NCT01576718|564566786|FG006|Treatment Period|Sponsor request|0|||
156402567|NCT01576718|564566780|FG000|Treatment Period|Met stopping criteria|0|||
156402568|NCT01576718|564566781|FG001|Treatment Period|Met stopping criteria|16|||
156402569|NCT01576718|564566782|FG002|Treatment Period|Met stopping criteria|13|||
156402570|NCT01576718|564566783|FG003|Treatment Period|Met stopping criteria|19|||
156402571|NCT01576718|564566784|FG004|Treatment Period|Met stopping criteria|16|||
156402572|NCT01576718|564566785|FG005|Treatment Period|Met stopping criteria|33|||
156402573|NCT01576718|564566786|FG006|Treatment Period|Met stopping criteria|15|||
156402574|NCT01576718|564566780|FG000|Treatment Period|Lost to Follow-up|0|||
156402575|NCT01576718|564566781|FG001|Treatment Period|Lost to Follow-up|0|||
156402576|NCT01576718|564566782|FG002|Treatment Period|Lost to Follow-up|0|||
156402577|NCT01576718|564566783|FG003|Treatment Period|Lost to Follow-up|0|||
156402578|NCT01576718|564566784|FG004|Treatment Period|Lost to Follow-up|1|||
156402579|NCT01576718|564566785|FG005|Treatment Period|Lost to Follow-up|0|||
156402580|NCT01576718|564566786|FG006|Treatment Period|Lost to Follow-up|0|||
156402581|NCT01576718|564566780|FG000|Treatment Period|Noncompliance to study medication|0|||
156402582|NCT01576718|564566781|FG001|Treatment Period|Noncompliance to study medication|0|||
156402583|NCT01576718|564566782|FG002|Treatment Period|Noncompliance to study medication|0|||
156402584|NCT01576718|564566783|FG003|Treatment Period|Noncompliance to study medication|0|||
156402585|NCT01576718|564566784|FG004|Treatment Period|Noncompliance to study medication|0|||
156402586|NCT01576718|564566785|FG005|Treatment Period|Noncompliance to study medication|1|||
156402587|NCT01576718|564566786|FG006|Treatment Period|Noncompliance to study medication|1|||
156402588|NCT01669798|564566787|FG000|Overall Study|Physician Decision|5|||
156402589|NCT06387472|564566791|FG000|Overall Study|Withdrawal by Subject|1|||
156402590|NCT06387472|564566791|FG000|Overall Study|Lost to Follow-up|2|||
156402591|NCT06387472|564566791|FG000|Overall Study|Physician Decision|1|||
156402592|NCT04182880|564566792|FG000|Overall Study|Pregnancy|1|||
156402593|NCT04182880|564566793|FG001|Overall Study|Pregnancy|0|||
156402594|NCT02036645|564566794|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402595|NCT02036645|564566795|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402596|NCT02036645|564566796|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402597|NCT02036645|564566797|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402598|NCT02036645|564566798|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402599|NCT02036645|564566799|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402600|NCT02036645|564566800|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
156402601|NCT02036645|564566801|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402602|NCT02036645|564566802|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402603|NCT02036645|564566803|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402604|NCT02036645|564566804|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402605|NCT02036645|564566805|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156402606|NCT02036645|564566794|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402607|NCT02036645|564566795|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402608|NCT02036645|564566796|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402609|NCT02036645|564566797|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
156402610|NCT02036645|564566798|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402611|NCT02036645|564566799|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402612|NCT02036645|564566800|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402613|NCT02036645|564566801|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402614|NCT02036645|564566802|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402615|NCT02036645|564566803|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402616|NCT02036645|564566804|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156402617|NCT02036645|564566805|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156512098|NCT00568178|564968161|FG001|Double Blind Base Study|Protocol Violation|2|||
156512099|NCT00568178|564968162|FG002|Double Blind Base Study|Protocol Violation|0|||
156512100|NCT00568178|564968163|FG003|Double Blind Base Study|Protocol Violation|0|||
156402618|NCT02332590|564566812|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
156402619|NCT02332590|564566813|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
156402620|NCT02332590|564566812|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
156402621|NCT02332590|564566813|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
156402622|NCT02332590|564566812|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
156402623|NCT02332590|564566813|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
156402624|NCT02332590|564566812|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
156402625|NCT02332590|564566813|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
156402626|NCT02332590|564566812|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
156402627|NCT02332590|564566813|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
156402628|NCT02332590|564566812|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
156402629|NCT02332590|564566813|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
156402630|NCT02332590|564566812|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
156402631|NCT02332590|564566813|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
156402632|NCT02332590|564566812|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
156402633|NCT02332590|564566813|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
156402634|NCT02332590|564566812|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
156402635|NCT02332590|564566813|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
156402636|NCT00279201|564566814|FG000|Initiation|Death|1|||
156402637|NCT00279201|564566815|FG001|Initiation|Death|5|||
156402638|NCT00279201|564566816|FG002|Initiation|Death|0|||
156402639|NCT00279201|564566817|FG003|Initiation|Death|0|||
156402640|NCT00279201|564566818|FG004|Initiation|Death|0|||
156402641|NCT00279201|564566819|FG005|Initiation|Death|0|||
156402642|NCT00279201|564566814|FG000|Initiation|Adverse Event|6|||
156402643|NCT00279201|564566815|FG001|Initiation|Adverse Event|15|||
156402644|NCT00279201|564566816|FG002|Initiation|Adverse Event|0|||
156402645|NCT00279201|564566817|FG003|Initiation|Adverse Event|0|||
156402646|NCT00279201|564566818|FG004|Initiation|Adverse Event|0|||
156402647|NCT00279201|564566819|FG005|Initiation|Adverse Event|0|||
156402648|NCT00279201|564566814|FG000|Initiation|Lost to Follow-up|42|||
156402649|NCT00279201|564566815|FG001|Initiation|Lost to Follow-up|41|||
156402650|NCT00279201|564566816|FG002|Initiation|Lost to Follow-up|0|||
156402651|NCT00279201|564566817|FG003|Initiation|Lost to Follow-up|0|||
156402652|NCT00279201|564566818|FG004|Initiation|Lost to Follow-up|0|||
156402653|NCT00279201|564566819|FG005|Initiation|Lost to Follow-up|0|||
156402654|NCT00279201|564566814|FG000|Initiation|Entry Criteria Exclusion|7|||
156402655|NCT00279201|564566815|FG001|Initiation|Entry Criteria Exclusion|9|||
156402656|NCT00279201|564566816|FG002|Initiation|Entry Criteria Exclusion|0|||
156402657|NCT00279201|564566817|FG003|Initiation|Entry Criteria Exclusion|0|||
156402658|NCT00279201|564566818|FG004|Initiation|Entry Criteria Exclusion|0|||
156402659|NCT00279201|564566819|FG005|Initiation|Entry Criteria Exclusion|0|||
156402660|NCT00279201|564566814|FG000|Initiation|Protocol Violation|9|||
156402661|NCT00279201|564566815|FG001|Initiation|Protocol Violation|10|||
156402662|NCT00279201|564566816|FG002|Initiation|Protocol Violation|0|||
156402663|NCT00279201|564566817|FG003|Initiation|Protocol Violation|0|||
156402664|NCT00279201|564566818|FG004|Initiation|Protocol Violation|0|||
156402665|NCT00279201|564566819|FG005|Initiation|Protocol Violation|0|||
156402666|NCT00279201|564566814|FG000|Initiation|Withdrawal by Subject|35|||
156402667|NCT00279201|564566815|FG001|Initiation|Withdrawal by Subject|41|||
156402668|NCT00279201|564566816|FG002|Initiation|Withdrawal by Subject|0|||
156402669|NCT00279201|564566817|FG003|Initiation|Withdrawal by Subject|0|||
156402670|NCT00279201|564566818|FG004|Initiation|Withdrawal by Subject|0|||
156402671|NCT00279201|564566819|FG005|Initiation|Withdrawal by Subject|0|||
156402672|NCT00279201|564566814|FG000|Initiation|Physician Decision|15|||
156402673|NCT00279201|564566815|FG001|Initiation|Physician Decision|18|||
156402674|NCT00279201|564566816|FG002|Initiation|Physician Decision|0|||
156402675|NCT00279201|564566817|FG003|Initiation|Physician Decision|0|||
156402676|NCT00279201|564566818|FG004|Initiation|Physician Decision|0|||
156402677|NCT00279201|564566819|FG005|Initiation|Physician Decision|0|||
156402678|NCT00279201|564566814|FG000|Initiation|Sponsor Decision|13|||
156512101|NCT00568178|564968164|FG004|Double Blind Base Study|Protocol Violation|0|||
156512102|NCT00568178|564968165|FG005|Double Blind Base Study|Protocol Violation|0|||
156512103|NCT00568178|564968160|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
156512104|NCT00568178|564968161|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
156512105|NCT00568178|564968162|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
156512106|NCT00568178|564968163|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
156512107|NCT00568178|564968164|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
156512108|NCT00568178|564968165|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
156512109|NCT00568178|564968160|FG000|Double Blind Base Study|Progressive Disease|0|||
156512110|NCT00568178|564968161|FG001|Double Blind Base Study|Progressive Disease|0|||
156512111|NCT00568178|564968162|FG002|Double Blind Base Study|Progressive Disease|0|||
156402679|NCT00279201|564566815|FG001|Initiation|Sponsor Decision|5|||
156402680|NCT00279201|564566816|FG002|Initiation|Sponsor Decision|0|||
156402681|NCT00279201|564566817|FG003|Initiation|Sponsor Decision|0|||
156402682|NCT00279201|564566818|FG004|Initiation|Sponsor Decision|0|||
156402683|NCT00279201|564566819|FG005|Initiation|Sponsor Decision|0|||
156402684|NCT00279201|564566814|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156402685|NCT00279201|564566815|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
156402686|NCT00279201|564566816|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156512112|NCT00568178|564968163|FG003|Double Blind Base Study|Progressive Disease|1|||
156512113|NCT00568178|564968164|FG004|Double Blind Base Study|Progressive Disease|0|||
156512114|NCT00568178|564968165|FG005|Double Blind Base Study|Progressive Disease|0|||
156402687|NCT00279201|564566817|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156402688|NCT00279201|564566818|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156402689|NCT00279201|564566819|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156402690|NCT00279201|564566814|FG000|Maintenance|Lack of Efficacy|32|||
156402691|NCT00279201|564566815|FG001|Maintenance|Lack of Efficacy|30|||
156402692|NCT00279201|564566816|FG002|Maintenance|Lack of Efficacy|0|||
156402693|NCT00279201|564566817|FG003|Maintenance|Lack of Efficacy|0|||
156402694|NCT00279201|564566818|FG004|Maintenance|Lack of Efficacy|0|||
156402695|NCT00279201|564566819|FG005|Maintenance|Lack of Efficacy|0|||
156402696|NCT00279201|564566814|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
156402697|NCT00279201|564566815|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
156402698|NCT00279201|564566816|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
156402699|NCT00279201|564566817|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
156402700|NCT00279201|564566818|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
156402701|NCT00279201|564566819|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
156402702|NCT00279201|564566814|FG000|Maintenance|Adverse Event|4|||
156402703|NCT00279201|564566815|FG001|Maintenance|Adverse Event|4|||
156402704|NCT00279201|564566816|FG002|Maintenance|Adverse Event|0|||
156402705|NCT00279201|564566817|FG003|Maintenance|Adverse Event|0|||
156402706|NCT00279201|564566818|FG004|Maintenance|Adverse Event|0|||
156402707|NCT00279201|564566819|FG005|Maintenance|Adverse Event|0|||
156402708|NCT00279201|564566814|FG000|Maintenance|Death|4|||
156402709|NCT00279201|564566815|FG001|Maintenance|Death|4|||
156402710|NCT00279201|564566816|FG002|Maintenance|Death|0|||
156402711|NCT00279201|564566817|FG003|Maintenance|Death|0|||
156402712|NCT00279201|564566818|FG004|Maintenance|Death|0|||
156402713|NCT00279201|564566819|FG005|Maintenance|Death|0|||
156402714|NCT00279201|564566814|FG000|Maintenance|Lost to Follow-up|17|||
156402715|NCT00279201|564566815|FG001|Maintenance|Lost to Follow-up|13|||
156402716|NCT00279201|564566816|FG002|Maintenance|Lost to Follow-up|0|||
156402717|NCT00279201|564566817|FG003|Maintenance|Lost to Follow-up|0|||
156402718|NCT00279201|564566818|FG004|Maintenance|Lost to Follow-up|0|||
156402719|NCT00279201|564566819|FG005|Maintenance|Lost to Follow-up|0|||
156402720|NCT00279201|564566814|FG000|Maintenance|Entry Criteria Exclusion|1|||
156402721|NCT00279201|564566815|FG001|Maintenance|Entry Criteria Exclusion|4|||
156402722|NCT00279201|564566816|FG002|Maintenance|Entry Criteria Exclusion|0|||
156402723|NCT00279201|564566817|FG003|Maintenance|Entry Criteria Exclusion|0|||
156402724|NCT00279201|564566818|FG004|Maintenance|Entry Criteria Exclusion|0|||
156402725|NCT00279201|564566819|FG005|Maintenance|Entry Criteria Exclusion|0|||
156402726|NCT00279201|564566814|FG000|Maintenance|Protocol Violation|16|||
156402727|NCT00279201|564566815|FG001|Maintenance|Protocol Violation|24|||
156402728|NCT00279201|564566816|FG002|Maintenance|Protocol Violation|0|||
156402729|NCT00279201|564566817|FG003|Maintenance|Protocol Violation|0|||
156402730|NCT00279201|564566818|FG004|Maintenance|Protocol Violation|0|||
156402731|NCT00279201|564566819|FG005|Maintenance|Protocol Violation|0|||
156402732|NCT00279201|564566814|FG000|Maintenance|Withdrawal by Subject|18|||
156402733|NCT00279201|564566815|FG001|Maintenance|Withdrawal by Subject|18|||
156402734|NCT00279201|564566816|FG002|Maintenance|Withdrawal by Subject|0|||
156402735|NCT00279201|564566817|FG003|Maintenance|Withdrawal by Subject|0|||
156402736|NCT00279201|564566818|FG004|Maintenance|Withdrawal by Subject|0|||
156402737|NCT00279201|564566819|FG005|Maintenance|Withdrawal by Subject|0|||
156402738|NCT00279201|564566814|FG000|Maintenance|Physician Decision|9|||
156402739|NCT00279201|564566815|FG001|Maintenance|Physician Decision|9|||
156402740|NCT00279201|564566816|FG002|Maintenance|Physician Decision|0|||
156402741|NCT00279201|564566817|FG003|Maintenance|Physician Decision|0|||
156402742|NCT00279201|564566818|FG004|Maintenance|Physician Decision|0|||
156402743|NCT00279201|564566819|FG005|Maintenance|Physician Decision|0|||
156402744|NCT00279201|564566814|FG000|Maintenance|Sponsor Decision|4|||
156402745|NCT00279201|564566815|FG001|Maintenance|Sponsor Decision|0|||
156402746|NCT00279201|564566816|FG002|Maintenance|Sponsor Decision|0|||
156402747|NCT00279201|564566817|FG003|Maintenance|Sponsor Decision|0|||
156402748|NCT00279201|564566818|FG004|Maintenance|Sponsor Decision|0|||
156402749|NCT00279201|564566819|FG005|Maintenance|Sponsor Decision|0|||
156402750|NCT00279201|564566814|FG000|Maintenance|HbA1c>7.5%|123|||
156402751|NCT00279201|564566815|FG001|Maintenance|HbA1c>7.5%|126|||
156402752|NCT00279201|564566816|FG002|Maintenance|HbA1c>7.5%|0|||
156402753|NCT00279201|564566817|FG003|Maintenance|HbA1c>7.5%|0|||
156402754|NCT00279201|564566818|FG004|Maintenance|HbA1c>7.5%|0|||
156402755|NCT00279201|564566819|FG005|Maintenance|HbA1c>7.5%|0|||
156402756|NCT00279201|564566814|FG000|Intensification Addendum|Withdrawal by Subject|0|||
156402757|NCT00279201|564566815|FG001|Intensification Addendum|Withdrawal by Subject|0|||
156402758|NCT00279201|564566816|FG002|Intensification Addendum|Withdrawal by Subject|12|||
156402759|NCT00279201|564566817|FG003|Intensification Addendum|Withdrawal by Subject|14|||
156402760|NCT00279201|564566818|FG004|Intensification Addendum|Withdrawal by Subject|9|||
156402761|NCT00279201|564566819|FG005|Intensification Addendum|Withdrawal by Subject|18|||
156402762|NCT00279201|564566814|FG000|Intensification Addendum|Lost to Follow-up|0|||
156402763|NCT00279201|564566815|FG001|Intensification Addendum|Lost to Follow-up|0|||
156402764|NCT00279201|564566816|FG002|Intensification Addendum|Lost to Follow-up|4|||
156402765|NCT00279201|564566817|FG003|Intensification Addendum|Lost to Follow-up|6|||
156402766|NCT00279201|564566818|FG004|Intensification Addendum|Lost to Follow-up|7|||
156402767|NCT00279201|564566819|FG005|Intensification Addendum|Lost to Follow-up|7|||
156402768|NCT00279201|564566814|FG000|Intensification Addendum|Protocol Violation|0|||
156402769|NCT00279201|564566815|FG001|Intensification Addendum|Protocol Violation|0|||
156402770|NCT00279201|564566816|FG002|Intensification Addendum|Protocol Violation|2|||
156402771|NCT00279201|564566817|FG003|Intensification Addendum|Protocol Violation|2|||
156402772|NCT00279201|564566818|FG004|Intensification Addendum|Protocol Violation|6|||
156402773|NCT00279201|564566819|FG005|Intensification Addendum|Protocol Violation|6|||
156402774|NCT00279201|564566814|FG000|Intensification Addendum|Adverse Event|0|||
156402775|NCT00279201|564566815|FG001|Intensification Addendum|Adverse Event|0|||
156402776|NCT00279201|564566816|FG002|Intensification Addendum|Adverse Event|0|||
156402777|NCT00279201|564566817|FG003|Intensification Addendum|Adverse Event|4|||
156402778|NCT00279201|564566818|FG004|Intensification Addendum|Adverse Event|1|||
156402779|NCT00279201|564566819|FG005|Intensification Addendum|Adverse Event|3|||
156402780|NCT00279201|564566814|FG000|Intensification Addendum|Physician Decision|0|||
156402781|NCT00279201|564566815|FG001|Intensification Addendum|Physician Decision|0|||
156402782|NCT00279201|564566816|FG002|Intensification Addendum|Physician Decision|4|||
156402783|NCT00279201|564566817|FG003|Intensification Addendum|Physician Decision|1|||
156402784|NCT00279201|564566818|FG004|Intensification Addendum|Physician Decision|3|||
156402785|NCT00279201|564566819|FG005|Intensification Addendum|Physician Decision|2|||
156402786|NCT00279201|564566814|FG000|Intensification Addendum|Sponsor Decision|0|||
156402787|NCT00279201|564566815|FG001|Intensification Addendum|Sponsor Decision|0|||
156402788|NCT00279201|564566816|FG002|Intensification Addendum|Sponsor Decision|0|||
156402789|NCT00279201|564566817|FG003|Intensification Addendum|Sponsor Decision|0|||
156402790|NCT00279201|564566818|FG004|Intensification Addendum|Sponsor Decision|1|||
156402791|NCT00279201|564566819|FG005|Intensification Addendum|Sponsor Decision|1|||
156402792|NCT00279201|564566814|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
156402793|NCT00279201|564566815|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
156402794|NCT00279201|564566816|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
156402795|NCT00279201|564566817|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
156402796|NCT00279201|564566818|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
156402797|NCT00279201|564566819|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
156402798|NCT00279201|564566814|FG000|Intensification Addendum|Lack of Efficacy|0|||
156402799|NCT00279201|564566815|FG001|Intensification Addendum|Lack of Efficacy|0|||
156402800|NCT00279201|564566816|FG002|Intensification Addendum|Lack of Efficacy|0|||
156402801|NCT00279201|564566817|FG003|Intensification Addendum|Lack of Efficacy|1|||
156402802|NCT00279201|564566818|FG004|Intensification Addendum|Lack of Efficacy|1|||
156402803|NCT00279201|564566819|FG005|Intensification Addendum|Lack of Efficacy|0|||
156402804|NCT00279201|564566814|FG000|Intensification Addendum|Death|0|||
156402805|NCT00279201|564566815|FG001|Intensification Addendum|Death|0|||
156402806|NCT00279201|564566816|FG002|Intensification Addendum|Death|0|||
156402807|NCT00279201|564566817|FG003|Intensification Addendum|Death|0|||
156402808|NCT00279201|564566818|FG004|Intensification Addendum|Death|1|||
156402809|NCT00279201|564566819|FG005|Intensification Addendum|Death|0|||
156402810|NCT01806584|564566826|FG000|Overall Study|Adverse Event|2|||
156402811|NCT01806584|564566827|FG001|Overall Study|Adverse Event|1|||
156402812|NCT01806584|564566826|FG000|Overall Study|Death|1|||
156402813|NCT01806584|564566827|FG001|Overall Study|Death|0|||
156402814|NCT01806584|564566826|FG000|Overall Study|Lost to Follow-up|0|||
156402815|NCT01806584|564566827|FG001|Overall Study|Lost to Follow-up|2|||
156402816|NCT01806584|564566826|FG000|Overall Study|Study terminated by sponsor|9|||
156402817|NCT01806584|564566827|FG001|Overall Study|Study terminated by sponsor|14|||
156402818|NCT01806584|564566826|FG000|Overall Study|Withdrawal by Subject|1|||
156402819|NCT01806584|564566827|FG001|Overall Study|Withdrawal by Subject|1|||
156402820|NCT01806584|564566826|FG000|Overall Study|Other unspecified|1|||
156402821|NCT01806584|564566827|FG001|Overall Study|Other unspecified|0|||
156402822|NCT03995784|564566832|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
156402823|NCT01489189|564566833|FG000|Overall Study|Withdrawal by Subject|20|||
156402824|NCT01489189|564566834|FG001|Overall Study|Withdrawal by Subject|23|||
156512115|NCT00568178|564968160|FG000|Open Label Extension|Adverse Event|0|||
156512116|NCT00568178|564968161|FG001|Open Label Extension|Adverse Event|0|||
156512117|NCT00568178|564968162|FG002|Open Label Extension|Adverse Event|0|||
156512118|NCT00568178|564968163|FG003|Open Label Extension|Adverse Event|0|||
156512119|NCT00568178|564968164|FG004|Open Label Extension|Adverse Event|11|||
156512120|NCT00568178|564968165|FG005|Open Label Extension|Adverse Event|8|||
156512121|NCT00568178|564968160|FG000|Open Label Extension|Protocol Violation|0|||
156512122|NCT00568178|564968161|FG001|Open Label Extension|Protocol Violation|0|||
156402825|NCT01489189|564566833|FG000|Overall Study|Death|10|||
156402826|NCT01489189|564566834|FG001|Overall Study|Death|8|||
156402827|NCT01489189|564566833|FG000|Overall Study|Missed Visit|1|||
156402828|NCT01489189|564566834|FG001|Overall Study|Missed Visit|4|||
156402829|NCT00112580|564566835|FG000|Overall Study|Adverse Event|1|||
156402830|NCT00112580|564566836|FG001|Overall Study|Adverse Event|2|||
156402831|NCT00112580|564566835|FG000|Overall Study|Disease progression|5|||
156402832|NCT00112580|564566836|FG001|Overall Study|Disease progression|16|||
156402833|NCT00112580|564566835|FG000|Overall Study|Participant withdrew consent|2|||
156402834|NCT00112580|564566836|FG001|Overall Study|Participant withdrew consent|1|||
156402835|NCT02272725|564566840|FG000|Overall Study|equipment malfunction|2|||
156402836|NCT02272725|564566841|FG001|Overall Study|equipment malfunction|0|||
156402837|NCT04739761|564566848|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
156402838|NCT04739761|564566849|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
156402839|NCT04739761|564566848|FG000|Overall Study|By complete response from the participant|1|||
156402840|NCT04739761|564566849|FG001|Overall Study|By complete response from the participant|0|||
156402841|NCT04739761|564566848|FG000|Overall Study|Lost to Follow-up|3|||
156552809|NCT05593016|565116322|FG002|Overall Study|Lost to Follow-up|1|||
156552810|NCT05593016|565116323|FG003|Overall Study|Lost to Follow-up|2|||
156552811|NCT05593016|565116324|FG004|Overall Study|Lost to Follow-up|0|||
156552812|NCT04161131|565116325|FG000|Overall Study|Ineligible|2|||
156552813|NCT04161131|565116325|FG000|Overall Study|Lost to Follow-up|4|||
156552814|NCT04316585|565116326|FG000|Overall Study|Adverse Event|2|||
156552815|NCT04316585|565116327|FG001|Overall Study|Adverse Event|1|||
156552816|NCT04316585|565116326|FG000|Overall Study|Lost to Follow-up|1|||
156552817|NCT04316585|565116327|FG001|Overall Study|Lost to Follow-up|0|||
156552818|NCT04316585|565116326|FG000|Overall Study|Withdrawal by Subject|2|||
156552819|NCT04316585|565116327|FG001|Overall Study|Withdrawal by Subject|3|||
156552820|NCT04316585|565116326|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
156552821|NCT04316585|565116327|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
156402842|NCT04739761|564566849|FG001|Overall Study|Lost to Follow-up|3|||
156402843|NCT04739761|564566848|FG000|Overall Study|Death|13|||
156402844|NCT04739761|564566849|FG001|Overall Study|Death|13|||
156402845|NCT04739761|564566848|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
156402846|NCT04739761|564566849|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
156402847|NCT04739761|564566848|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
156402848|NCT04739761|564566849|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
156402849|NCT04739761|564566848|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
156402850|NCT04739761|564566849|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
156402851|NCT04739761|564566848|FG000|Overall Study|Adverse Event|0|||
156402852|NCT04739761|564566849|FG001|Overall Study|Adverse Event|3|||
156402853|NCT04739761|564566848|FG000|Overall Study|Participant decision|1|||
156402854|NCT04739761|564566849|FG001|Overall Study|Participant decision|0|||
156402855|NCT04739761|564566848|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
156402856|NCT04739761|564566849|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
156402857|NCT04739761|564566848|FG000|Overall Study|Participant immediately started next line of treatment|1|||
156402858|NCT04739761|564566849|FG001|Overall Study|Participant immediately started next line of treatment|0|||
156402859|NCT04739761|564566848|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
156402860|NCT04739761|564566849|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
156402861|NCT04739761|564566848|FG000|Overall Study|Lack of clinical benefit|1|||
156402862|NCT04739761|564566849|FG001|Overall Study|Lack of clinical benefit|0|||
156402863|NCT04739761|564566848|FG000|Overall Study|Disease progression|5|||
156402864|NCT04739761|564566849|FG001|Overall Study|Disease progression|5|||
156402865|NCT04739761|564566848|FG000|Overall Study|Withdrawal by Subject|14|||
156402866|NCT04739761|564566849|FG001|Overall Study|Withdrawal by Subject|13|||
156512123|NCT00568178|564968162|FG002|Open Label Extension|Protocol Violation|0|||
156512124|NCT00568178|564968163|FG003|Open Label Extension|Protocol Violation|0|||
156512125|NCT00568178|564968164|FG004|Open Label Extension|Protocol Violation|1|||
156512126|NCT00568178|564968165|FG005|Open Label Extension|Protocol Violation|0|||
156512127|NCT00568178|564968160|FG000|Open Label Extension|Lost to Follow-up|0|||
156512128|NCT00568178|564968161|FG001|Open Label Extension|Lost to Follow-up|0|||
156512129|NCT00568178|564968162|FG002|Open Label Extension|Lost to Follow-up|0|||
156512130|NCT00568178|564968163|FG003|Open Label Extension|Lost to Follow-up|0|||
156512131|NCT00568178|564968164|FG004|Open Label Extension|Lost to Follow-up|6|||
156512132|NCT00568178|564968165|FG005|Open Label Extension|Lost to Follow-up|11|||
156512133|NCT00568178|564968160|FG000|Open Label Extension|Physician Decision|0|||
156512134|NCT00568178|564968161|FG001|Open Label Extension|Physician Decision|0|||
156512135|NCT00568178|564968162|FG002|Open Label Extension|Physician Decision|0|||
156512136|NCT00568178|564968163|FG003|Open Label Extension|Physician Decision|0|||
156512137|NCT00568178|564968164|FG004|Open Label Extension|Physician Decision|9|||
156512138|NCT00568178|564968165|FG005|Open Label Extension|Physician Decision|8|||
156512139|NCT00568178|564968160|FG000|Open Label Extension|Pregnancy|0|||
156512140|NCT00568178|564968161|FG001|Open Label Extension|Pregnancy|0|||
156512141|NCT00568178|564968162|FG002|Open Label Extension|Pregnancy|0|||
156552822|NCT04316585|565116326|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
156552823|NCT04316585|565116327|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
156402867|NCT04739761|564566848|FG000|Overall Study|Protocol Violation|1|||
156512142|NCT00568178|564968163|FG003|Open Label Extension|Pregnancy|0|||
156512143|NCT00568178|564968164|FG004|Open Label Extension|Pregnancy|0|||
156552824|NCT00618748|565116328|FG000|Overall Study|Adverse Event|4|||
156552825|NCT00618748|565116329|FG001|Overall Study|Adverse Event|3|||
156402868|NCT04739761|564566849|FG001|Overall Study|Protocol Violation|0|||
156402869|NCT04739761|564566848|FG000|Overall Study|Physician Decision|2|||
156402870|NCT04739761|564566849|FG001|Overall Study|Physician Decision|0|||
156402871|NCT03881696|564566850|FG000|Overall Study|Adverse Event|2|||
156402872|NCT03881696|564566851|FG001|Overall Study|Adverse Event|0|||
156402873|NCT03881696|564566850|FG000|Overall Study|Withdrawal by Subject|2|||
156402874|NCT03881696|564566851|FG001|Overall Study|Withdrawal by Subject|0|||
156402875|NCT03881696|564566850|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
156402876|NCT03881696|564566851|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
156402877|NCT03881696|564566850|FG000|Overall Study|Failure to meet continuation criteria|1|||
156402878|NCT03881696|564566851|FG001|Overall Study|Failure to meet continuation criteria|0|||
156402879|NCT01061333|564566853|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
156402880|NCT01061333|564566854|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
156402881|NCT01816763|564568468|FG000|Overall Study|The main reason for an incomplete survey|4|||
156402882|NCT01816763|564568469|FG001|Overall Study|The main reason for an incomplete survey|15|||
156402883|NCT01816763|564568470|FG002|Overall Study|The main reason for an incomplete survey|11|||
156402884|NCT01186328|564568475|FG000|Overall Study|Death|1|||
156402885|NCT01186328|564568476|FG001|Overall Study|Death|0|||
156402886|NCT01186328|564568477|FG002|Overall Study|Death|0|||
156402887|NCT02670538|564568478|FG000|Overall Study|Withdrawal of Consent|8|||
156402888|NCT02670538|564568479|FG001|Overall Study|Withdrawal of Consent|6|||
156402889|NCT02670538|564568480|FG002|Overall Study|Withdrawal of Consent|5|||
156402890|NCT02670538|564568478|FG000|Overall Study|Lost to Follow-up|8|||
156402891|NCT02670538|564568479|FG001|Overall Study|Lost to Follow-up|12|||
156402892|NCT02670538|564568480|FG002|Overall Study|Lost to Follow-up|7|||
156402893|NCT02670538|564568478|FG000|Overall Study|Adverse Event|5|||
156402894|NCT02670538|564568479|FG001|Overall Study|Adverse Event|5|||
156402895|NCT02670538|564568480|FG002|Overall Study|Adverse Event|11|||
156402896|NCT02670538|564568478|FG000|Overall Study|Lack of Efficacy|7|||
156402897|NCT02670538|564568479|FG001|Overall Study|Lack of Efficacy|1|||
156402898|NCT02670538|564568480|FG002|Overall Study|Lack of Efficacy|2|||
156402899|NCT02670538|564568478|FG000|Overall Study|Protocol Violation|3|||
156402900|NCT02670538|564568479|FG001|Overall Study|Protocol Violation|4|||
156402901|NCT02670538|564568480|FG002|Overall Study|Protocol Violation|1|||
156402902|NCT02670538|564568478|FG000|Overall Study|Noncompliance with Study Drug|1|||
156402903|NCT02670538|564568479|FG001|Overall Study|Noncompliance with Study Drug|3|||
156402904|NCT02670538|564568480|FG002|Overall Study|Noncompliance with Study Drug|2|||
156402905|NCT02670538|564568478|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156402906|NCT02670538|564568479|FG001|Overall Study|Other Miscellaneous Reasons|1|||
156402907|NCT02670538|564568480|FG002|Overall Study|Other Miscellaneous Reasons|2|||
156402908|NCT01373931|564568481|FG000|Lead-in Period|Adverse Event|2|||
156402909|NCT01373931|564568482|FG001|Lead-in Period|Adverse Event|0|||
156402910|NCT01373931|564568481|FG000|Period 1|Adverse Event|2|||
156402911|NCT01373931|564568482|FG001|Period 1|Adverse Event|0|||
156402912|NCT01373931|564568481|FG000|Period 1|Withdrawal by Subject|0|||
156402913|NCT01373931|564568482|FG001|Period 1|Withdrawal by Subject|2|||
156402914|NCT00742079|564568483|FG000|Overall Study|Lost to Follow-up|0|||
156402915|NCT00742079|564568484|FG001|Overall Study|Lost to Follow-up|1|||
156402916|NCT02243202|564568486|FG000|Overall Study|Adverse Event|5|||
156402917|NCT02243202|564568487|FG001|Overall Study|Adverse Event|6|||
156402918|NCT02243202|564568488|FG002|Overall Study|Adverse Event|10|||
156402919|NCT02243202|564568489|FG003|Overall Study|Adverse Event|4|||
156402920|NCT02243202|564568486|FG000|Overall Study|Lost to Follow-up|9|||
156402921|NCT02243202|564568487|FG001|Overall Study|Lost to Follow-up|9|||
156402922|NCT02243202|564568488|FG002|Overall Study|Lost to Follow-up|14|||
156402923|NCT02243202|564568489|FG003|Overall Study|Lost to Follow-up|11|||
156402924|NCT02243202|564568486|FG000|Overall Study|Protocol Violation|3|||
156402925|NCT02243202|564568487|FG001|Overall Study|Protocol Violation|1|||
156402926|NCT02243202|564568488|FG002|Overall Study|Protocol Violation|2|||
156402927|NCT02243202|564568489|FG003|Overall Study|Protocol Violation|1|||
156402928|NCT02243202|564568486|FG000|Overall Study|Withdrawal by Subject|7|||
156402929|NCT02243202|564568487|FG001|Overall Study|Withdrawal by Subject|6|||
156512144|NCT00568178|564968165|FG005|Open Label Extension|Pregnancy|1|||
156512145|NCT00568178|564968160|FG000|Open Label Extension|Progressive Disease|0|||
156512146|NCT00568178|564968161|FG001|Open Label Extension|Progressive Disease|0|||
156512147|NCT00568178|564968162|FG002|Open Label Extension|Progressive Disease|0|||
156512148|NCT00568178|564968163|FG003|Open Label Extension|Progressive Disease|0|||
156512149|NCT00568178|564968164|FG004|Open Label Extension|Progressive Disease|3|||
156402930|NCT02243202|564568488|FG002|Overall Study|Withdrawal by Subject|4|||
156402931|NCT02243202|564568489|FG003|Overall Study|Withdrawal by Subject|4|||
156512150|NCT00568178|564968165|FG005|Open Label Extension|Progressive Disease|1|||
156402932|NCT02243202|564568486|FG000|Overall Study|Other|1|||
156402933|NCT02243202|564568487|FG001|Overall Study|Other|3|||
156402934|NCT02243202|564568488|FG002|Overall Study|Other|1|||
156402935|NCT02243202|564568489|FG003|Overall Study|Other|2|||
156402936|NCT02243202|564568486|FG000|Overall Study|Randomized but not received treatment|0|||
156402937|NCT02243202|564568487|FG001|Overall Study|Randomized but not received treatment|0|||
156402938|NCT02243202|564568488|FG002|Overall Study|Randomized but not received treatment|0|||
156402939|NCT02243202|564568489|FG003|Overall Study|Randomized but not received treatment|1|||
156402940|NCT00991341|564568493|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
156402941|NCT00991341|564568494|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
156402942|NCT00991341|564568493|FG000|Overall Study|Death|3|||
156402943|NCT00991341|564568494|FG001|Overall Study|Death|0|||
156402944|NCT00991341|564568493|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
156402945|NCT00991341|564568494|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
156402946|NCT00991341|564568493|FG000|Overall Study|Physician Decision|1|||
156402947|NCT00991341|564568494|FG001|Overall Study|Physician Decision|2|||
156402948|NCT00991341|564568493|FG000|Overall Study|Withdrawal by Subject|3|||
156402949|NCT00991341|564568494|FG001|Overall Study|Withdrawal by Subject|4|||
156402950|NCT03145766|564568506|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
156402951|NCT03145766|564568507|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
156402952|NCT03145766|564568508|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
156402953|NCT03145766|564568509|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
156402954|NCT03145766|564568510|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
156402955|NCT03145766|564568506|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
156402956|NCT03145766|564568507|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
156402957|NCT03145766|564568508|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
156402958|NCT03145766|564568509|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
156402959|NCT03145766|564568510|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
156402960|NCT03145766|564568506|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
156402961|NCT03145766|564568507|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
156402962|NCT03145766|564568508|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
156402963|NCT03145766|564568509|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
156402964|NCT03145766|564568510|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
156402965|NCT03145766|564568506|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
156402966|NCT03145766|564568507|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
156402967|NCT03145766|564568508|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
156402968|NCT03145766|564568509|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
156402969|NCT03145766|564568510|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
156402970|NCT03145766|564568506|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
156402971|NCT03145766|564568507|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
156402972|NCT03145766|564568508|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
156402973|NCT03145766|564568509|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
156402974|NCT03145766|564568510|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
156402975|NCT03145766|564568506|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
156402976|NCT03145766|564568507|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
156402977|NCT03145766|564568508|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
156402978|NCT03145766|564568509|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
156402979|NCT03145766|564568510|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
156402980|NCT03145766|564568506|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
156402981|NCT03145766|564568507|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
156402982|NCT03145766|564568508|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
156402983|NCT03145766|564568509|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
156402984|NCT03145766|564568510|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
156402985|NCT04461795|564568511|FG000|Overall Study|Lost to Follow-up|2|||
156402986|NCT04461795|564568511|FG000|Overall Study|Withdrawal by Subject|2|||
156402987|NCT04461795|564568511|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
156402988|NCT00185640|564568512|FG000|Overall Study|Not Eligible|4|||
156402989|NCT00185640|564568512|FG000|Overall Study|Withdrawal by Subject|3|||
156402990|NCT00185640|564568512|FG000|Overall Study|Death|138|||
156402991|NCT00058422|564568513|FG000|Overall Study|Not treated|2|||
156402992|NCT02396537|564568516|FG000|Overall Study|Protocol Violation|0|||
156402993|NCT02396537|564568517|FG001|Overall Study|Protocol Violation|1|||
156402994|NCT01691521|564568518|FG000|Overall Study|Adverse Event|4|||
156402995|NCT01691521|564568519|FG001|Overall Study|Adverse Event|0|||
156402996|NCT01691521|564568520|FG002|Overall Study|Adverse Event|1|||
156402997|NCT01691521|564568518|FG000|Overall Study|Lack of Efficacy|1|||
156402998|NCT01691521|564568519|FG001|Overall Study|Lack of Efficacy|1|||
156402999|NCT01691521|564568520|FG002|Overall Study|Lack of Efficacy|2|||
156403000|NCT01691521|564568518|FG000|Overall Study|Protocol Violation|0|||
156403001|NCT01691521|564568519|FG001|Overall Study|Protocol Violation|3|||
156403002|NCT01691521|564568520|FG002|Overall Study|Protocol Violation|0|||
156403003|NCT01691521|564568518|FG000|Overall Study|Lost to Follow-up|0|||
156403004|NCT01691521|564568519|FG001|Overall Study|Lost to Follow-up|2|||
156403005|NCT01691521|564568520|FG002|Overall Study|Lost to Follow-up|2|||
156403006|NCT01691521|564568518|FG000|Overall Study|Physician Decision|2|||
156403007|NCT01691521|564568519|FG001|Overall Study|Physician Decision|1|||
156403008|NCT01691521|564568520|FG002|Overall Study|Physician Decision|0|||
156403009|NCT01691521|564568518|FG000|Overall Study|Withdrawal by Subject|5|||
156403010|NCT01691521|564568519|FG001|Overall Study|Withdrawal by Subject|9|||
156403011|NCT01691521|564568520|FG002|Overall Study|Withdrawal by Subject|4|||
156403012|NCT03954743|564568521|FG000|Overall Study|Adverse Event|1|||
156403013|NCT03954743|564568522|FG001|Overall Study|Adverse Event|0|||
156403014|NCT03954743|564568521|FG000|Overall Study|Lost to Follow-up|6|||
156403015|NCT03954743|564568522|FG001|Overall Study|Lost to Follow-up|4|||
156403016|NCT03954743|564568521|FG000|Overall Study|Protocol Violation|1|||
156403017|NCT03954743|564568522|FG001|Overall Study|Protocol Violation|0|||
156403018|NCT03954743|564568521|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
156403019|NCT03954743|564568522|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
156403020|NCT03954743|564568521|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
156403021|NCT03954743|564568522|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156403022|NCT02281760|564568525|FG000|Overall Study|Withdrawal by Subject|1|||
156403023|NCT00860067|564568526|FG000|Overall Study|Lost to Follow-up|46|||
156403024|NCT00860067|564568527|FG001|Overall Study|Lost to Follow-up|9|||
156403025|NCT00860067|564568528|FG002|Overall Study|Lost to Follow-up|9|||
156403026|NCT00860067|564568526|FG000|Overall Study|Withdrawal by Subject|4|||
156403027|NCT00860067|564568527|FG001|Overall Study|Withdrawal by Subject|0|||
156403028|NCT00860067|564568528|FG002|Overall Study|Withdrawal by Subject|0|||
156403029|NCT00860067|564568526|FG000|Overall Study|Pregnancy|1|||
156403030|NCT00860067|564568527|FG001|Overall Study|Pregnancy|0|||
156403031|NCT00860067|564568528|FG002|Overall Study|Pregnancy|0|||
156403032|NCT00100932|564568529|FG000|Overall Study|Adverse Event|11|||
156403033|NCT00100932|564568530|FG001|Overall Study|Adverse Event|2|||
156403034|NCT00100932|564568529|FG000|Overall Study|Withdrawal by Subject|6|||
156403035|NCT00100932|564568530|FG001|Overall Study|Withdrawal by Subject|0|||
156403036|NCT00100932|564568529|FG000|Overall Study|Progressive Disease|44|||
156403037|NCT00100932|564568530|FG001|Overall Study|Progressive Disease|18|||
156403038|NCT00100932|564568529|FG000|Overall Study|Physician Decision|7|||
156403039|NCT00100932|564568530|FG001|Overall Study|Physician Decision|5|||
156403040|NCT00100932|564568529|FG000|Overall Study|Other|5|||
156403041|NCT00100932|564568530|FG001|Overall Study|Other|2|||
156403042|NCT02387996|564568531|FG000|Overall Study|Disease Progression|167|||
156403043|NCT02387996|564568531|FG000|Overall Study|Study Drug Toxicity|31|||
156403044|NCT02387996|564568531|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
156403045|NCT02387996|564568531|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
156403046|NCT02387996|564568531|FG000|Overall Study|Subject Withdrew Consent|5|||
156403047|NCT02387996|564568531|FG000|Overall Study|Lost to Follow-up|1|||
156403048|NCT02387996|564568531|FG000|Overall Study|Poor/Non-Compliance|1|||
156403049|NCT02387996|564568531|FG000|Overall Study|Other Reasons|5|||
156403050|NCT02387996|564568531|FG000|Overall Study|Death|1|||
156403051|NCT01446796|564568532|FG000|Overall Study|Withdrawal by Subject|1|||
156403052|NCT01446796|564568533|FG001|Overall Study|Withdrawal by Subject|0|||
156403053|NCT00988221|564568536|FG000|Part I|Adverse Event|0|||
156403054|NCT00988221|564568537|FG001|Part I|Adverse Event|1|||
156403055|NCT00988221|564568538|FG002|Part I|Adverse Event|2|||
156403056|NCT00988221|564568539|FG003|Part I|Adverse Event|0|||
156403057|NCT00988221|564568536|FG000|Part I|Insufficient Therapeutic Response|4|||
156403058|NCT00988221|564568537|FG001|Part I|Insufficient Therapeutic Response|6|||
156403059|NCT00988221|564568538|FG002|Part I|Insufficient Therapeutic Response|5|||
156403060|NCT00988221|564568539|FG003|Part I|Insufficient Therapeutic Response|0|||
156403061|NCT00988221|564568536|FG000|Part I|Refused Treatment|0|||
156403062|NCT00988221|564568537|FG001|Part I|Refused Treatment|2|||
156403063|NCT00988221|564568538|FG002|Part I|Refused Treatment|1|||
156403064|NCT00988221|564568539|FG003|Part I|Refused Treatment|0|||
156403065|NCT00988221|564568536|FG000|Part I|Lost to Follow-up|0|||
156403066|NCT00988221|564568537|FG001|Part I|Lost to Follow-up|1|||
156403067|NCT00988221|564568538|FG002|Part I|Lost to Follow-up|0|||
156403068|NCT00988221|564568539|FG003|Part I|Lost to Follow-up|0|||
156403069|NCT00988221|564568536|FG000|Part II|Adverse Event|1|||
156403070|NCT00988221|564568537|FG001|Part II|Adverse Event|0|||
156403071|NCT00988221|564568538|FG002|Part II|Adverse Event|0|||
156403072|NCT00988221|564568539|FG003|Part II|Adverse Event|1|||
156403073|NCT00988221|564568536|FG000|Part II|Withdrawal by Subject|0|||
156403074|NCT00988221|564568537|FG001|Part II|Withdrawal by Subject|0|||
156403075|NCT00988221|564568538|FG002|Part II|Withdrawal by Subject|2|||
156403076|NCT00988221|564568539|FG003|Part II|Withdrawal by Subject|2|||
156403077|NCT00988221|564568536|FG000|Part II|Reason not Specified|0|||
156403078|NCT00988221|564568537|FG001|Part II|Reason not Specified|0|||
156403079|NCT00988221|564568538|FG002|Part II|Reason not Specified|1|||
156403080|NCT00988221|564568539|FG003|Part II|Reason not Specified|0|||
156403081|NCT00988221|564568536|FG000|Part III|Adverse Event|1|||
156403082|NCT00988221|564568537|FG001|Part III|Adverse Event|0|||
156403083|NCT00988221|564568538|FG002|Part III|Adverse Event|1|||
156403084|NCT00988221|564568539|FG003|Part III|Adverse Event|0|||
156403085|NCT00988221|564568536|FG000|Part III|Insufficient Therapeutic Response|0|||
156403086|NCT00988221|564568537|FG001|Part III|Insufficient Therapeutic Response|1|||
156403087|NCT00988221|564568538|FG002|Part III|Insufficient Therapeutic Response|1|||
156403088|NCT00988221|564568539|FG003|Part III|Insufficient Therapeutic Response|0|||
156403089|NCT00988221|564568536|FG000|Part III|Refused Treatment|0|||
156403090|NCT00988221|564568537|FG001|Part III|Refused Treatment|0|||
156403091|NCT00988221|564568538|FG002|Part III|Refused Treatment|1|||
156403092|NCT00988221|564568539|FG003|Part III|Refused Treatment|0|||
156403093|NCT02756832|564568542|FG000|Overall Study|Lost for Observation after Baseline|6|||
156403094|NCT02756832|564568542|FG000|Overall Study|Lost for Observation|13|||
156403095|NCT02756832|564568542|FG000|Overall Study|Patient's Unwillingness|12|||
156403096|NCT02756832|564568542|FG000|Overall Study|Insufficient Efficacy|2|||
156403097|NCT02756832|564568542|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
156403098|NCT02756832|564568542|FG000|Overall Study|Reason not Specified|9|||
156403099|NCT02756832|564568542|FG000|Overall Study|Protocol Deviation|10|||
156403100|NCT00954733|564568543|FG000|Overall Study|blood gas machine did not work|1|||
156403101|NCT03579290|564568544|FG000|Overall Study|Lost to Follow-up|9|||
156403102|NCT00622713|564568549|FG000|Overall Study|Adverse Event|35|||
156403103|NCT00622713|564568549|FG000|Overall Study|Administrative problems|4|||
156403104|NCT00622713|564568549|FG000|Overall Study|Withdrawal by Subject|11|||
156403105|NCT00622713|564568549|FG000|Overall Study|Lost to Follow-up|5|||
156403106|NCT00622713|564568549|FG000|Overall Study|Death|2|||
156403107|NCT00622713|564568549|FG000|Overall Study|Subject no longer required study drug|1|||
156403108|NCT00622713|564568549|FG000|Overall Study|Did not meet eligibility criteria|1|||
156403109|NCT03728972|564568567|FG000|Overall Study|Death|1|||
156403110|NCT03728972|564568568|FG001|Overall Study|Death|0|||
156403111|NCT03728972|564568567|FG000|Overall Study|Lack of Efficacy|1|||
156403112|NCT03728972|564568568|FG001|Overall Study|Lack of Efficacy|0|||
156403113|NCT03728972|564568567|FG000|Overall Study|Physician Decision|3|||
156403114|NCT03728972|564568568|FG001|Overall Study|Physician Decision|0|||
156403115|NCT03728972|564568567|FG000|Overall Study|Disease progression|4|||
156403116|NCT03728972|564568568|FG001|Overall Study|Disease progression|3|||
156403117|NCT00895622|564568576|FG000|Overall Study|Protocol Violation|5|||
156403118|NCT00895622|564568577|FG001|Overall Study|Protocol Violation|4|||
156403119|NCT00895622|564568578|FG002|Overall Study|Protocol Violation|4|||
156403120|NCT03635489|564568582|FG000|Overall Study|Death|19|||
156403121|NCT03635489|564568583|FG001|Overall Study|Death|13|||
156403122|NCT03635489|564568582|FG000|Overall Study|Lost to Follow-up|1|||
156403123|NCT03635489|564568583|FG001|Overall Study|Lost to Follow-up|2|||
156403124|NCT03635489|564568582|FG000|Overall Study|Withdrawal by Subject|1|||
156403125|NCT03635489|564568583|FG001|Overall Study|Withdrawal by Subject|2|||
156403126|NCT03635489|564568582|FG000|Overall Study|Study Ended by Sponsor|28|||
156403127|NCT03635489|564568583|FG001|Overall Study|Study Ended by Sponsor|34|||
156403128|NCT00654901|564568584|FG000|Overall Study|Lost to Follow-up|1|||
156403129|NCT00654901|564568585|FG001|Overall Study|Lost to Follow-up|0|||
156403130|NCT00654901|564568586|FG002|Overall Study|Lost to Follow-up|1|||
156403131|NCT00654901|564568587|FG003|Overall Study|Lost to Follow-up|0|||
156403132|NCT00654901|564568584|FG000|Overall Study|Withdrawal by Subject|3|||
156403133|NCT00654901|564568585|FG001|Overall Study|Withdrawal by Subject|0|||
156403134|NCT00654901|564568586|FG002|Overall Study|Withdrawal by Subject|1|||
156403135|NCT00654901|564568587|FG003|Overall Study|Withdrawal by Subject|0|||
156403136|NCT02010632|564568589|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
156403137|NCT02010632|564568590|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
156403138|NCT00652938|564568594|FG000|Overall Study|Adverse Event|1|||
156403139|NCT00652938|564568595|FG001|Overall Study|Adverse Event|0|||
156403140|NCT00652938|564568596|FG002|Overall Study|Adverse Event|2|||
156403141|NCT00652938|564568594|FG000|Overall Study|Withdrawal by Subject|0|||
156403142|NCT00652938|564568595|FG001|Overall Study|Withdrawal by Subject|6|||
156403143|NCT00652938|564568596|FG002|Overall Study|Withdrawal by Subject|1|||
156403144|NCT00652938|564568594|FG000|Overall Study|Lost to Follow-up|0|||
156403145|NCT00652938|564568595|FG001|Overall Study|Lost to Follow-up|0|||
156403146|NCT00652938|564568596|FG002|Overall Study|Lost to Follow-up|2|||
156403147|NCT00652938|564568594|FG000|Overall Study|fear of blood sampling|0|||
156403148|NCT00652938|564568595|FG001|Overall Study|fear of blood sampling|1|||
156403149|NCT00652938|564568596|FG002|Overall Study|fear of blood sampling|0|||
156403150|NCT01547299|564568600|FG000|Overall Study|Withdrawal by Subject|2|||
156403151|NCT01547299|564568601|FG001|Overall Study|Withdrawal by Subject|2|||
156403152|NCT00782496|564568602|FG000|Overall Study|Lost to Follow-up|14|||
156403153|NCT00782496|564568603|FG001|Overall Study|Lost to Follow-up|15|||
156403154|NCT00117156|564568605|FG000|Overall Study|Adverse Event|9|||
156403155|NCT00117156|564568605|FG000|Overall Study|Physician Decision|1|||
156403156|NCT00117156|564568605|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
156403157|NCT01987817|564568607|FG000|Overall Study|Adverse Event|4|||
156403158|NCT01987817|564568608|FG001|Overall Study|Adverse Event|0|||
156403159|NCT01987817|564568607|FG000|Overall Study|Withdrawal by Subject|1|||
156403160|NCT01987817|564568608|FG001|Overall Study|Withdrawal by Subject|1|||
156403161|NCT01987817|564568607|FG000|Overall Study|Physician Decision|1|||
156403162|NCT01987817|564568608|FG001|Overall Study|Physician Decision|0|||
156403163|NCT01874145|564568611|FG000|Core Period|Non-compliance|1|||
156403164|NCT01874145|564568612|FG001|Core Period|Non-compliance|0|||
156403165|NCT01874145|564568611|FG000|Core Period|Protocol Violation|1|||
156403166|NCT01874145|564568612|FG001|Core Period|Protocol Violation|1|||
156403167|NCT01874145|564568611|FG000|Core Period|Physician Decision|1|||
156403168|NCT01874145|564568612|FG001|Core Period|Physician Decision|1|||
156403169|NCT01874145|564568611|FG000|Core Period|Adverse Event|0|||
156403170|NCT01874145|564568612|FG001|Core Period|Adverse Event|1|||
156403171|NCT01874145|564568611|FG000|Core Period|Withdrawal by Subject|0|||
156403172|NCT01874145|564568612|FG001|Core Period|Withdrawal by Subject|4|||
156403173|NCT01874145|564568611|FG000|Extension Period|Adverse Event|3|||
156403174|NCT01874145|564568612|FG001|Extension Period|Adverse Event|2|||
156403175|NCT01874145|564568611|FG000|Extension Period|Withdrawal by Subject|2|||
156403176|NCT01874145|564568612|FG001|Extension Period|Withdrawal by Subject|1|||
156403177|NCT01874145|564568611|FG000|Extension Period|Lost to Follow-up|1|||
156403178|NCT01874145|564568612|FG001|Extension Period|Lost to Follow-up|1|||
156403179|NCT04631705|564568613|FG000|Overall Study|Withdrawal by Subject|0|||
156403180|NCT04631705|564568614|FG001|Overall Study|Withdrawal by Subject|0|||
156403181|NCT04631705|564568615|FG002|Overall Study|Withdrawal by Subject|0|||
156403182|NCT04631705|564568616|FG003|Overall Study|Withdrawal by Subject|0|||
156403183|NCT04631705|564568617|FG004|Overall Study|Withdrawal by Subject|0|||
156403184|NCT04631705|564568618|FG005|Overall Study|Withdrawal by Subject|0|||
156403185|NCT04631705|564568619|FG006|Overall Study|Withdrawal by Subject|1|||
156403186|NCT04631705|564568620|FG007|Overall Study|Withdrawal by Subject|0|||
156403187|NCT04631705|564568621|FG008|Overall Study|Withdrawal by Subject|0|||
156403188|NCT02070484|564568627|FG000|Overall Study|Withdrawal by Subject|1|||
156403189|NCT02070484|564568628|FG001|Overall Study|Withdrawal by Subject|0|||
156403190|NCT01521884|564568629|FG000|Overall Study|Non Responders|10|||
156403191|NCT01521884|564568629|FG000|Overall Study|Adverse Event|5|||
156403192|NCT01521884|564568629|FG000|Overall Study|Pregnancy|1|||
156403193|NCT01521884|564568629|FG000|Overall Study|Withdrawal by Subject|1|||
156403194|NCT01521884|564568629|FG000|Overall Study|Physician Decision|2|||
156403195|NCT01521884|564568629|FG000|Overall Study|Protocol Violation|3|||
156403196|NCT01521884|564568629|FG000|Overall Study|Participant non-eligible|1|||
156403197|NCT01521884|564568629|FG000|Overall Study|Lost to Follow-up|4|||
156403198|NCT02821819|564568630|FG000|Overall Study|Protocol Violation|1|||
156403199|NCT04241094|564568631|FG000|Overall Study|Dropped out of treatment|4|||
156403200|NCT04241094|564568631|FG000|Overall Study|Ineligible after clinical assessment|2|||
156403201|NCT04241094|564568631|FG000|Overall Study|Lost to Follow-up|2|||
156403202|NCT02202434|564570122|FG000|Overall Study|Death|70|||
156403203|NCT02202434|564570123|FG001|Overall Study|Death|39|||
156403204|NCT02202434|564570124|FG002|Overall Study|Death|13|||
156403205|NCT02202434|564570125|FG003|Overall Study|Death|27|||
156403206|NCT02202434|564570122|FG000|Overall Study|Lost to Follow-up|1|||
156403207|NCT02202434|564570123|FG001|Overall Study|Lost to Follow-up|1|||
156403208|NCT02202434|564570124|FG002|Overall Study|Lost to Follow-up|1|||
156403209|NCT02202434|564570125|FG003|Overall Study|Lost to Follow-up|0|||
156403210|NCT02202434|564570122|FG000|Overall Study|Physician Decision|2|||
156403211|NCT02202434|564570123|FG001|Overall Study|Physician Decision|3|||
156403212|NCT02202434|564570124|FG002|Overall Study|Physician Decision|0|||
156403213|NCT02202434|564570125|FG003|Overall Study|Physician Decision|0|||
156403214|NCT02202434|564570122|FG000|Overall Study|Withdrawal by Subject|13|||
156403215|NCT02202434|564570123|FG001|Overall Study|Withdrawal by Subject|14|||
156403216|NCT02202434|564570124|FG002|Overall Study|Withdrawal by Subject|1|||
156403217|NCT02202434|564570125|FG003|Overall Study|Withdrawal by Subject|4|||
156403218|NCT02202434|564570122|FG000|Overall Study|Completed Study|1|||
156403219|NCT02202434|564570123|FG001|Overall Study|Completed Study|0|||
156403220|NCT02202434|564570124|FG002|Overall Study|Completed Study|0|||
156403221|NCT02202434|564570125|FG003|Overall Study|Completed Study|0|||
156403222|NCT02202434|564570122|FG000|Overall Study|Visit Missed|21|||
156403223|NCT02202434|564570123|FG001|Overall Study|Visit Missed|12|||
156403224|NCT02202434|564570124|FG002|Overall Study|Visit Missed|0|||
156403225|NCT02202434|564570125|FG003|Overall Study|Visit Missed|5|||
156403226|NCT02202434|564570122|FG000|Overall Study|Other|1|||
156403227|NCT02202434|564570123|FG001|Overall Study|Other|0|||
156403228|NCT02202434|564570124|FG002|Overall Study|Other|0|||
156403229|NCT02202434|564570125|FG003|Overall Study|Other|1|||
156403230|NCT01862991|564570126|FG000|Overall Study|Lost to Follow-up|2|||
156403231|NCT01862991|564570127|FG001|Overall Study|Lost to Follow-up|1|||
156403232|NCT01862991|564570128|FG002|Overall Study|Lost to Follow-up|1|||
156403233|NCT01862991|564570126|FG000|Overall Study|Protocol Violation|1|||
156403234|NCT01862991|564570127|FG001|Overall Study|Protocol Violation|0|||
156403235|NCT01862991|564570128|FG002|Overall Study|Protocol Violation|0|||
156403236|NCT04858802|564570129|FG000|Overall Study|Lost to Follow-up|1|||
156403237|NCT04858802|564570130|FG001|Overall Study|Lost to Follow-up|1|||
156403238|NCT04858802|564570129|FG000|Overall Study|Withdrawal by Subject|1|||
156403239|NCT04858802|564570130|FG001|Overall Study|Withdrawal by Subject|1|||
156403240|NCT00857805|564570134|FG000|Overall Study|Withdrawal by Subject|1|||
156403241|NCT00857805|564570135|FG001|Overall Study|Withdrawal by Subject|1|||
156403242|NCT01289041|564570136|FG000|Overall Study|Adverse Event|24|||
156403243|NCT01289041|564570136|FG000|Overall Study|Physician Decision|1|||
156552826|NCT00618748|565116330|FG002|Overall Study|Adverse Event|8|||
156403244|NCT01289041|564570136|FG000|Overall Study|Progressive Disease|41|||
156403245|NCT01289041|564570136|FG000|Overall Study|Withdrawal by Subject|3|||
156403246|NCT01289041|564570136|FG000|Overall Study|Death|1|||
156403247|NCT02714868|564570138|FG000|Overall Study|Withdrawal by Subject|3|||
156403248|NCT02714868|564570139|FG001|Overall Study|Withdrawal by Subject|0|||
156403249|NCT02714868|564570138|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
156403250|NCT02714868|564570139|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
156403251|NCT02714868|564570138|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
156403252|NCT02714868|564570139|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
156403253|NCT00710606|564570145|FG000|Overall Study|Adverse Event|0|||
156403254|NCT00710606|564570146|FG001|Overall Study|Adverse Event|2|||
156403255|NCT05648357|564570149|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
156403256|NCT00674323|564570150|FG000|Overall Study|Adverse Event|0|||
156403257|NCT00674323|564570151|FG001|Overall Study|Adverse Event|1|||
156403258|NCT00674323|564570152|FG002|Overall Study|Adverse Event|0|||
156403259|NCT00674323|564570150|FG000|Overall Study|Protocol Violation|1|||
156403260|NCT00674323|564570151|FG001|Overall Study|Protocol Violation|0|||
156403261|NCT00674323|564570152|FG002|Overall Study|Protocol Violation|0|||
156403262|NCT02013388|564570153|FG000|Overall Study|work emergency|1|||
156403263|NCT02013388|564570154|FG001|Overall Study|work emergency|0|||
156403264|NCT02013388|564570155|FG002|Overall Study|work emergency|0|||
156403265|NCT02013388|564570156|FG003|Overall Study|work emergency|0|||
156403266|NCT02013388|564570157|FG004|Overall Study|work emergency|1|||
156403267|NCT02013388|564570158|FG005|Overall Study|work emergency|0|||
156403268|NCT02013388|564570159|FG006|Overall Study|work emergency|0|||
156403269|NCT02013388|564570160|FG007|Overall Study|work emergency|0|||
156403270|NCT02110732|564570164|FG000|Overall Study|Physician Decision|5|||
156403271|NCT02110732|564570165|FG001|Overall Study|Physician Decision|2|||
156403272|NCT02110732|564570164|FG000|Overall Study|Lost to Follow-up|1|||
156403273|NCT02110732|564570165|FG001|Overall Study|Lost to Follow-up|1|||
156403274|NCT00633932|564570166|FG000|Overall Study|Adverse Event|1|||
156403275|NCT00633932|564570167|FG001|Overall Study|Adverse Event|3|||
156403276|NCT00633932|564570168|FG002|Overall Study|Adverse Event|4|||
156403277|NCT00633932|564570166|FG000|Overall Study|Withdrawal by Subject|3|||
156403278|NCT00633932|564570167|FG001|Overall Study|Withdrawal by Subject|9|||
156403279|NCT00633932|564570168|FG002|Overall Study|Withdrawal by Subject|1|||
156403280|NCT00633932|564570166|FG000|Overall Study|Lost to Follow-up|1|||
156403281|NCT00633932|564570167|FG001|Overall Study|Lost to Follow-up|0|||
156403282|NCT00633932|564570168|FG002|Overall Study|Lost to Follow-up|2|||
156403283|NCT00633932|564570166|FG000|Overall Study|Protocol Violation|5|||
156403284|NCT00633932|564570167|FG001|Overall Study|Protocol Violation|2|||
156403285|NCT00633932|564570168|FG002|Overall Study|Protocol Violation|3|||
156403286|NCT00633932|564570166|FG000|Overall Study|Physician Decision|0|||
156403287|NCT00633932|564570167|FG001|Overall Study|Physician Decision|0|||
156403288|NCT00633932|564570168|FG002|Overall Study|Physician Decision|1|||
156403289|NCT00633932|564570166|FG000|Overall Study|Doctor's judgement|1|||
156403290|NCT00633932|564570167|FG001|Overall Study|Doctor's judgement|0|||
156403291|NCT00633932|564570168|FG002|Overall Study|Doctor's judgement|0|||
156403292|NCT00633932|564570166|FG000|Overall Study|Moved Away|1|||
156552827|NCT00618748|565116328|FG000|Overall Study|Physician Decision|3|||
156552828|NCT00618748|565116329|FG001|Overall Study|Physician Decision|1|||
156552829|NCT00618748|565116330|FG002|Overall Study|Physician Decision|1|||
156552830|NCT00618748|565116328|FG000|Overall Study|Withdrawal by Subject|4|||
156552831|NCT00618748|565116329|FG001|Overall Study|Withdrawal by Subject|1|||
156552832|NCT00618748|565116330|FG002|Overall Study|Withdrawal by Subject|5|||
156552833|NCT03269344|565116331|FG000|Overall Study|Protocol Violation|4|||
156552834|NCT03269344|565116332|FG001|Overall Study|Protocol Violation|3|||
156552835|NCT02162732|565116335|FG000|Overall Study|Biopsy not performed.|18|||
156552836|NCT01784965|565116336|FG000|Overall Study|Withdrawal by Subject|6|||
156552837|NCT01784965|565116337|FG001|Overall Study|Withdrawal by Subject|3|||
156403293|NCT00633932|564570167|FG001|Overall Study|Moved Away|0|||
156403294|NCT00633932|564570168|FG002|Overall Study|Moved Away|0|||
156552838|NCT01784965|565116336|FG000|Overall Study|Adverse Event|0|||
156552839|NCT01784965|565116337|FG001|Overall Study|Adverse Event|8|||
156552840|NCT03757988|565116340|FG000|Overall Study|Withdrawal by Subject|1|||
156552841|NCT02847624|565116341|FG000|Overall Study|Lost to Follow-up|28|||
156552842|NCT02847624|565116341|FG000|Overall Study|Protocol Violation|98|||
156552843|NCT02847624|565116341|FG000|Overall Study|Case report failures|4|||
156552844|NCT04372927|565116344|FG000|Overall Study|Death|1|||
156403295|NCT04836858|564570169|FG000|Overall Study|Adverse Event|0|||
156403296|NCT04836858|564570170|FG001|Overall Study|Adverse Event|0|||
156552845|NCT01999582|565116345|FG000|Overall Study|Withdrawal by Subject|0|||
156403297|NCT04836858|564570171|FG002|Overall Study|Adverse Event|0|||
156403298|NCT04836858|564570172|FG003|Overall Study|Adverse Event|1|||
156403299|NCT04836858|564570169|FG000|Overall Study|Lost to Follow-up|1|||
156403300|NCT04836858|564570170|FG001|Overall Study|Lost to Follow-up|0|||
156403301|NCT04836858|564570171|FG002|Overall Study|Lost to Follow-up|0|||
156552846|NCT01999582|565116346|FG001|Overall Study|Withdrawal by Subject|0|||
156403302|NCT04836858|564570172|FG003|Overall Study|Lost to Follow-up|0|||
156403303|NCT04836858|564570169|FG000|Overall Study|Subject/Guardian decision|3|||
156403304|NCT04836858|564570170|FG001|Overall Study|Subject/Guardian decision|0|||
156403305|NCT04836858|564570171|FG002|Overall Study|Subject/Guardian decision|0|||
156403306|NCT04836858|564570172|FG003|Overall Study|Subject/Guardian decision|1|||
156403307|NCT04836858|564570169|FG000|Overall Study|Randomized but not treated|4|||
156403308|NCT04836858|564570170|FG001|Overall Study|Randomized but not treated|0|||
156403309|NCT04836858|564570171|FG002|Overall Study|Randomized but not treated|0|||
156403310|NCT04836858|564570172|FG003|Overall Study|Randomized but not treated|0|||
156403311|NCT01982435|564570174|FG000|Overall Study|Adverse Event|1|||
156403312|NCT01982435|564570175|FG001|Overall Study|Adverse Event|0|||
156403313|NCT00597714|564570179|FG000|Overall Study|Death|56|||
156403314|NCT00597714|564570180|FG001|Overall Study|Death|46|||
156403315|NCT00597714|564570181|FG002|Overall Study|Death|0|||
156403316|NCT00597714|564570179|FG000|Overall Study|Recipient death|0|||
156403317|NCT00597714|564570180|FG001|Overall Study|Recipient death|0|||
156403318|NCT00597714|564570181|FG002|Overall Study|Recipient death|10|||
156403319|NCT00539643|564570188|FG000|Overall Study|Adverse Event|1|||
156403320|NCT00539643|564570189|FG001|Overall Study|Adverse Event|0|||
156403321|NCT00539643|564570188|FG000|Overall Study|Death|2|||
156403322|NCT00539643|564570189|FG001|Overall Study|Death|1|||
156403323|NCT00539643|564570188|FG000|Overall Study|Physician Decision|3|||
156403324|NCT00539643|564570189|FG001|Overall Study|Physician Decision|1|||
156403325|NCT00539643|564570188|FG000|Overall Study|Withdrawal by Subject|0|||
156403326|NCT00539643|564570189|FG001|Overall Study|Withdrawal by Subject|1|||
156403327|NCT02228395|564570190|FG000|First Intervention Period|No longer willing to participate|1|||
156403328|NCT02228395|564570191|FG001|First Intervention Period|No longer willing to participate|0|||
156403329|NCT02228395|564570192|FG002|First Intervention Period|No longer willing to participate|0|||
156403330|NCT02228395|564570190|FG000|First Intervention Period|Unable to comply with study dates|0|||
156403331|NCT02228395|564570191|FG001|First Intervention Period|Unable to comply with study dates|1|||
156403332|NCT02228395|564570192|FG002|First Intervention Period|Unable to comply with study dates|1|||
156403333|NCT01480596|564570195|FG000|Overall Study|Adverse Event|3|||
156403334|NCT01480596|564570196|FG001|Overall Study|Adverse Event|0|||
156403335|NCT01480596|564570195|FG000|Overall Study|MG exacerbation or change in medication|2|||
156403336|NCT01480596|564570196|FG001|Overall Study|MG exacerbation or change in medication|2|||
156403337|NCT02917265|564570203|FG000|Overall Study|Physician Decision|1|||
156403338|NCT02917265|564570204|FG001|Overall Study|Physician Decision|0|||
156403339|NCT02917265|564570203|FG000|Overall Study|Withdrawal by Subject|1|||
156403340|NCT02917265|564570204|FG001|Overall Study|Withdrawal by Subject|0|||
156403341|NCT02712398|564570212|FG000|Overall Study|Withdrawal by Subject|6|||
156403342|NCT02712398|564570212|FG000|Overall Study|Lost to Follow-up|6|||
156403343|NCT02712398|564570212|FG000|Overall Study|Sponsor Decision|1|||
156403344|NCT02712398|564570212|FG000|Overall Study|Physician Decision|1|||
156403345|NCT02712398|564570212|FG000|Overall Study|Death|2|||
156403346|NCT02712398|564570212|FG000|Overall Study|Re-operation|21|||
156403347|NCT01725386|564570214|FG000|Overall Study|Death|84|||
156403348|NCT01725386|564570215|FG001|Overall Study|Death|40|||
156403349|NCT01725386|564570214|FG000|Overall Study|Lost to Follow-up|81|||
156403350|NCT01725386|564570215|FG001|Overall Study|Lost to Follow-up|6|||
156403351|NCT01725386|564570214|FG000|Overall Study|Withdrawal by Subject|10|||
156403352|NCT01725386|564570215|FG001|Overall Study|Withdrawal by Subject|0|||
156403353|NCT00879996|564570219|FG000|Overall Study|Lost to Follow-up|7|||
156403354|NCT00879996|564570220|FG001|Overall Study|Lost to Follow-up|6|||
156403355|NCT00879996|564570219|FG000|Overall Study|non-compliance|6|||
156403356|NCT00879996|564570220|FG001|Overall Study|non-compliance|4|||
156403357|NCT00879996|564570219|FG000|Overall Study|Physician Decision|1|||
156403358|NCT00879996|564570220|FG001|Overall Study|Physician Decision|2|||
156403359|NCT00879996|564570219|FG000|Overall Study|psychiatric problem|0|||
156403360|NCT00879996|564570220|FG001|Overall Study|psychiatric problem|1|||
156403361|NCT00879996|564570219|FG000|Overall Study|put on parole|1|||
156403362|NCT00879996|564570220|FG001|Overall Study|put on parole|0|||
156403363|NCT01216163|564570225|FG000|Overall Study|Withdrawal by Subject|1|||
156403364|NCT01216163|564570226|FG001|Overall Study|Withdrawal by Subject|1|||
156403365|NCT01216163|564570227|FG002|Overall Study|Withdrawal by Subject|0|||
156403366|NCT02914314|564570228|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
156403367|NCT02914314|564570229|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
156403368|NCT02914314|564570230|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
156403369|NCT02914314|564570231|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
156403370|NCT02914314|564570228|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
156403371|NCT02914314|564570229|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
156403372|NCT02914314|564570230|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
156403373|NCT02914314|564570231|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
156403374|NCT02914314|564570228|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
156403375|NCT02914314|564570229|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
156403376|NCT02914314|564570230|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
156403377|NCT02914314|564570231|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
156552847|NCT01999582|565116347|FG002|Overall Study|Withdrawal by Subject|0|||
156552848|NCT01999582|565116348|FG003|Overall Study|Withdrawal by Subject|1|||
156552849|NCT01999582|565116349|FG004|Overall Study|Withdrawal by Subject|0|||
156552850|NCT01999582|565116350|FG005|Overall Study|Withdrawal by Subject|0|||
156552851|NCT01999582|565116345|FG000|Overall Study|Adverse Event|0|||
156552852|NCT01999582|565116346|FG001|Overall Study|Adverse Event|0|||
156552853|NCT01999582|565116347|FG002|Overall Study|Adverse Event|3|||
156552854|NCT01999582|565116348|FG003|Overall Study|Adverse Event|0|||
156552855|NCT01999582|565116349|FG004|Overall Study|Adverse Event|1|||
156552856|NCT01999582|565116350|FG005|Overall Study|Adverse Event|0|||
156403378|NCT02914314|564570228|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
156403379|NCT02914314|564570229|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
156403380|NCT02914314|564570230|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
156403381|NCT02914314|564570231|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
156403382|NCT02914314|564570228|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
156403383|NCT02914314|564570229|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
156403384|NCT02914314|564570230|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
156403385|NCT02914314|564570231|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
156552857|NCT01999582|565116345|FG000|Overall Study|Other Reasons|1|||
156552858|NCT01999582|565116346|FG001|Overall Study|Other Reasons|0|||
156552859|NCT01999582|565116347|FG002|Overall Study|Other Reasons|3|||
156552860|NCT01999582|565116348|FG003|Overall Study|Other Reasons|1|||
156552861|NCT01999582|565116349|FG004|Overall Study|Other Reasons|1|||
156552862|NCT01999582|565116350|FG005|Overall Study|Other Reasons|2|||
156552863|NCT01999582|565116345|FG000|Overall Study|Protocol Violation|1|||
156552864|NCT01999582|565116346|FG001|Overall Study|Protocol Violation|0|||
156552865|NCT01999582|565116347|FG002|Overall Study|Protocol Violation|0|||
156552866|NCT01999582|565116348|FG003|Overall Study|Protocol Violation|0|||
156552867|NCT01999582|565116349|FG004|Overall Study|Protocol Violation|0|||
156552868|NCT01999582|565116350|FG005|Overall Study|Protocol Violation|1|||
156552869|NCT01999582|565116345|FG000|Overall Study|Lack of Efficacy|1|||
156552870|NCT01999582|565116346|FG001|Overall Study|Lack of Efficacy|3|||
156552871|NCT01999582|565116347|FG002|Overall Study|Lack of Efficacy|0|||
156552872|NCT01999582|565116348|FG003|Overall Study|Lack of Efficacy|1|||
156552873|NCT01999582|565116349|FG004|Overall Study|Lack of Efficacy|0|||
156552874|NCT01999582|565116350|FG005|Overall Study|Lack of Efficacy|0|||
156552875|NCT03728309|565116355|FG000|Overall Study|Randomized but not Treated|0|||
156552876|NCT03728309|565116356|FG001|Overall Study|Randomized but not Treated|1|||
156552877|NCT03728309|565116355|FG000|Overall Study|Adverse Event|0|||
156552878|NCT03728309|565116356|FG001|Overall Study|Adverse Event|1|||
156552879|NCT03728309|565116355|FG000|Overall Study|Withdrawal by Subject|2|||
156552880|NCT03728309|565116356|FG001|Overall Study|Withdrawal by Subject|8|||
156403386|NCT02002182|564570233|FG000|Overall Study|Withdraw from study|3|||
156403387|NCT02002182|564570234|FG001|Overall Study|Withdraw from study|1|||
156403388|NCT02002182|564570233|FG000|Overall Study|Health Reasons|1|||
156403389|NCT02002182|564570234|FG001|Overall Study|Health Reasons|0|||
156403390|NCT02002182|564570233|FG000|Overall Study|Death|1|||
156403391|NCT02002182|564570234|FG001|Overall Study|Death|0|||
156403392|NCT04772053|564570235|FG000|Overall Study|Physician Decision|2|||
156552881|NCT03728309|565116355|FG000|Overall Study|Lost to Follow-up|9|||
156552882|NCT03728309|565116356|FG001|Overall Study|Lost to Follow-up|10|||
156552883|NCT03728309|565116355|FG000|Overall Study|Protocol Deviation|0|||
156552884|NCT03728309|565116356|FG001|Overall Study|Protocol Deviation|1|||
156403393|NCT04772053|564570235|FG000|Overall Study|Withdrawal by Subject|3|||
156403394|NCT04772053|564570235|FG000|Overall Study|Study Terminated by Sponsor|1|||
156403395|NCT03107377|564570236|FG000|Overall Study|Adverse Event|3|||
156403396|NCT03107377|564570237|FG001|Overall Study|Adverse Event|3|||
156403397|NCT03107377|564570236|FG000|Overall Study|Protocol Violation|9|||
156403398|NCT03107377|564570237|FG001|Overall Study|Protocol Violation|12|||
156403399|NCT03107377|564570236|FG000|Overall Study|Physician Decision|3|||
156403400|NCT03107377|564570237|FG001|Overall Study|Physician Decision|6|||
156403401|NCT03107377|564570236|FG000|Overall Study|Pregnancy|7|||
156403402|NCT03107377|564570237|FG001|Overall Study|Pregnancy|7|||
156403403|NCT03107377|564570236|FG000|Overall Study|Withdrawal by Subject|16|||
156403404|NCT03107377|564570237|FG001|Overall Study|Withdrawal by Subject|22|||
156552885|NCT03728309|565116355|FG000|Overall Study|Due to COVID|1|||
156552886|NCT03728309|565116356|FG001|Overall Study|Due to COVID|3|||
156552887|NCT00953758|565116357|FG000|Overall Study|Death|2|||
156552888|NCT00953758|565116358|FG001|Overall Study|Death|0|||
156403405|NCT03107377|564570236|FG000|Overall Study|Lost to Follow-up|37|||
156403406|NCT03107377|564570237|FG001|Overall Study|Lost to Follow-up|34|||
156403407|NCT03107377|564570236|FG000|Overall Study|Other reason not specified|16|||
156403408|NCT03107377|564570237|FG001|Overall Study|Other reason not specified|15|||
156403409|NCT03787680|564570239|FG000|Overall Study|Physician Decision|2|||
156403410|NCT03787680|564570240|FG001|Overall Study|Physician Decision|3|||
156403411|NCT03787680|564570239|FG000|Overall Study|Adverse Event|7|||
156552889|NCT00953758|565116359|FG002|Overall Study|Death|1|||
156552890|NCT00953758|565116360|FG003|Overall Study|Death|1|||
156552891|NCT00953758|565116361|FG004|Overall Study|Death|1|||
156403412|NCT03787680|564570240|FG001|Overall Study|Adverse Event|3|||
156403413|NCT03787680|564570239|FG000|Overall Study|Withdrawal by Subject|2|||
156403414|NCT03787680|564570240|FG001|Overall Study|Withdrawal by Subject|1|||
156403415|NCT05454410|564570243|FG000|Overall Study|Withdrawal by Subject|0|||
156403416|NCT05454410|564570244|FG001|Overall Study|Withdrawal by Subject|0|||
156552892|NCT00953758|565116362|FG005|Overall Study|Death|1|||
156552893|NCT00953758|565116363|FG006|Overall Study|Death|1|||
156552894|NCT00953758|565116364|FG007|Overall Study|Death|3|||
156552895|NCT00953758|565116365|FG008|Overall Study|Death|1|||
156552896|NCT00953758|565116366|FG009|Overall Study|Death|0|||
156552897|NCT00953758|565116357|FG000|Overall Study|Participant refused further follow-up|0|||
156552898|NCT00953758|565116358|FG001|Overall Study|Participant refused further follow-up|0|||
156552899|NCT00953758|565116359|FG002|Overall Study|Participant refused further follow-up|1|||
156552900|NCT00953758|565116360|FG003|Overall Study|Participant refused further follow-up|0|||
156552901|NCT00953758|565116361|FG004|Overall Study|Participant refused further follow-up|3|||
156552902|NCT00953758|565116362|FG005|Overall Study|Participant refused further follow-up|0|||
156552903|NCT00953758|565116363|FG006|Overall Study|Participant refused further follow-up|0|||
156552904|NCT00953758|565116364|FG007|Overall Study|Participant refused further follow-up|0|||
156552905|NCT00953758|565116365|FG008|Overall Study|Participant refused further follow-up|1|||
156552906|NCT00953758|565116366|FG009|Overall Study|Participant refused further follow-up|0|||
156552907|NCT00953758|565116357|FG000|Overall Study|Lost to Follow-up|0|||
156552908|NCT00953758|565116358|FG001|Overall Study|Lost to Follow-up|0|||
156403417|NCT05454410|564570245|FG002|Overall Study|Withdrawal by Subject|1|||
156403418|NCT05454410|564570246|FG003|Overall Study|Withdrawal by Subject|1|||
156512151|NCT00568178|564968160|FG000|Open Label Extension|Termination of Trial|0|||
156512152|NCT00568178|564968161|FG001|Open Label Extension|Termination of Trial|0|||
156512153|NCT00568178|564968162|FG002|Open Label Extension|Termination of Trial|0|||
156512154|NCT00568178|564968163|FG003|Open Label Extension|Termination of Trial|0|||
156512155|NCT00568178|564968164|FG004|Open Label Extension|Termination of Trial|45|||
156512156|NCT00568178|564968165|FG005|Open Label Extension|Termination of Trial|47|||
156512157|NCT00568178|564968160|FG000|Open Label Extension|Withdrawal by Subject|0|||
156512158|NCT00568178|564968161|FG001|Open Label Extension|Withdrawal by Subject|0|||
156512159|NCT00568178|564968162|FG002|Open Label Extension|Withdrawal by Subject|0|||
156512160|NCT00568178|564968163|FG003|Open Label Extension|Withdrawal by Subject|0|||
156512161|NCT00568178|564968164|FG004|Open Label Extension|Withdrawal by Subject|4|||
156512162|NCT00568178|564968165|FG005|Open Label Extension|Withdrawal by Subject|4|||
156512163|NCT01332630|564968166|FG000|Overall Study|Withdrawal by Subject|3|||
156512164|NCT00581555|564968178|FG000|Overall Study|Adverse Event|4|||
156512165|NCT00581555|564968179|FG001|Overall Study|Adverse Event|3|||
156512166|NCT00581555|564968178|FG000|Overall Study|Physician Decision|3|||
156512167|NCT00581555|564968179|FG001|Overall Study|Physician Decision|2|||
156512168|NCT00581555|564968178|FG000|Overall Study|Withdrawal by Subject|18|||
156512169|NCT00581555|564968179|FG001|Overall Study|Withdrawal by Subject|9|||
156512170|NCT00581555|564968178|FG000|Overall Study|Lost to Follow-up|2|||
156512171|NCT00581555|564968179|FG001|Overall Study|Lost to Follow-up|2|||
156512172|NCT00581555|564968178|FG000|Overall Study|Other reasons|16|||
156512173|NCT00581555|564968179|FG001|Overall Study|Other reasons|4|||
156512174|NCT00201643|564968182|FG000|Overall Study|Withdrawal by Subject|5|||
156512175|NCT00201643|564968183|FG001|Overall Study|Withdrawal by Subject|4|||
156512176|NCT03446781|564968184|FG000|Overall Study|Lost to Follow-up|11|||
156512177|NCT03446781|564968185|FG001|Overall Study|Lost to Follow-up|5|||
156512178|NCT03446781|564968184|FG000|Overall Study|Withdrawal by Subject|9|||
156512179|NCT03446781|564968185|FG001|Overall Study|Withdrawal by Subject|7|||
156512180|NCT03446781|564968184|FG000|Overall Study|Adverse Event|8|||
156512181|NCT03446781|564968185|FG001|Overall Study|Adverse Event|2|||
156512182|NCT03446781|564968184|FG000|Overall Study|Protocol Violation|0|||
156512183|NCT03446781|564968185|FG001|Overall Study|Protocol Violation|3|||
156512184|NCT02672852|564968193|FG000|Part A1|Disease Worsening|1|||
156512185|NCT02672852|564968194|FG001|Part A1|Disease Worsening|0|||
156512186|NCT02672852|564968195|FG002|Part A1|Disease Worsening|0|||
156512187|NCT02672852|564968196|FG003|Part A1|Disease Worsening|0|||
156512188|NCT02672852|564968197|FG004|Part A1|Disease Worsening|0|||
156512189|NCT02672852|564968198|FG005|Part A1|Disease Worsening|0|||
156552909|NCT00953758|565116359|FG002|Overall Study|Lost to Follow-up|0|||
156552910|NCT00953758|565116360|FG003|Overall Study|Lost to Follow-up|1|||
156552911|NCT00953758|565116361|FG004|Overall Study|Lost to Follow-up|0|||
156552912|NCT00953758|565116362|FG005|Overall Study|Lost to Follow-up|0|||
156403419|NCT01368900|564570251|FG000|Overall Study|Lost to Follow-up|7|||
156512190|NCT02672852|564968199|FG006|Part A1|Disease Worsening|0|||
156512191|NCT02672852|564968193|FG000|Part A1|Adverse Event|0|||
156512192|NCT02672852|564968194|FG001|Part A1|Adverse Event|1|||
156512193|NCT02672852|564968195|FG002|Part A1|Adverse Event|0|||
156512194|NCT02672852|564968196|FG003|Part A1|Adverse Event|0|||
156512195|NCT02672852|564968197|FG004|Part A1|Adverse Event|0|||
156403420|NCT02404389|564570258|FG000|Overall Study|Adverse Event|1|||
156512196|NCT02672852|564968198|FG005|Part A1|Adverse Event|0|||
156512197|NCT02672852|564968199|FG006|Part A1|Adverse Event|0|||
156512198|NCT02672852|564968193|FG000|Part A1|Lost to Follow-up|1|||
156552913|NCT00953758|565116363|FG006|Overall Study|Lost to Follow-up|0|||
156552914|NCT00953758|565116364|FG007|Overall Study|Lost to Follow-up|1|||
156403421|NCT02404389|564570259|FG001|Overall Study|Adverse Event|0|||
156403422|NCT02404389|564570260|FG002|Overall Study|Adverse Event|1|||
156403423|NCT02404389|564570261|FG003|Overall Study|Adverse Event|0|||
156403424|NCT02404389|564570262|FG004|Overall Study|Adverse Event|2|||
156403425|NCT02404389|564570258|FG000|Overall Study|Subject/guardian decision|1|||
156403426|NCT02404389|564570259|FG001|Overall Study|Subject/guardian decision|0|||
156403427|NCT02404389|564570260|FG002|Overall Study|Subject/guardian decision|0|||
156552915|NCT00953758|565116365|FG008|Overall Study|Lost to Follow-up|0|||
156552916|NCT00953758|565116366|FG009|Overall Study|Lost to Follow-up|1|||
156552917|NCT00953758|565116357|FG000|Overall Study|Physician Decision|0|||
156552918|NCT00953758|565116358|FG001|Overall Study|Physician Decision|0|||
156552919|NCT00953758|565116359|FG002|Overall Study|Physician Decision|0|||
156552920|NCT00953758|565116360|FG003|Overall Study|Physician Decision|0|||
156552921|NCT00953758|565116361|FG004|Overall Study|Physician Decision|1|||
156552922|NCT00953758|565116362|FG005|Overall Study|Physician Decision|0|||
156552923|NCT00953758|565116363|FG006|Overall Study|Physician Decision|0|||
156552924|NCT00953758|565116364|FG007|Overall Study|Physician Decision|0|||
156552925|NCT00953758|565116365|FG008|Overall Study|Physician Decision|0|||
156552926|NCT00953758|565116366|FG009|Overall Study|Physician Decision|0|||
156552927|NCT00953758|565116357|FG000|Overall Study|Disease progression|0|||
156403428|NCT02404389|564570261|FG003|Overall Study|Subject/guardian decision|1|||
156403429|NCT02404389|564570262|FG004|Overall Study|Subject/guardian decision|1|||
156403430|NCT01412801|564570263|FG000|Overall Study|Death|0|||
156403431|NCT01412801|564570264|FG001|Overall Study|Death|1|||
156403432|NCT01412801|564570265|FG002|Overall Study|Death|0|||
156403433|NCT01412801|564570266|FG003|Overall Study|Death|4|||
156403434|NCT01412801|564570267|FG004|Overall Study|Death|2|||
156552928|NCT00953758|565116358|FG001|Overall Study|Disease progression|0|||
156552929|NCT00953758|565116359|FG002|Overall Study|Disease progression|0|||
156552930|NCT00953758|565116360|FG003|Overall Study|Disease progression|0|||
156552931|NCT00953758|565116361|FG004|Overall Study|Disease progression|1|||
156552932|NCT00953758|565116362|FG005|Overall Study|Disease progression|0|||
156552933|NCT00953758|565116363|FG006|Overall Study|Disease progression|0|||
156552934|NCT00953758|565116364|FG007|Overall Study|Disease progression|0|||
156552935|NCT00953758|565116365|FG008|Overall Study|Disease progression|0|||
156552936|NCT00953758|565116366|FG009|Overall Study|Disease progression|0|||
156552937|NCT00953758|565116357|FG000|Overall Study|Participant went for transplant|0|||
156552938|NCT00953758|565116358|FG001|Overall Study|Participant went for transplant|0|||
156552939|NCT00953758|565116359|FG002|Overall Study|Participant went for transplant|0|||
156552940|NCT00953758|565116360|FG003|Overall Study|Participant went for transplant|0|||
156552941|NCT00953758|565116361|FG004|Overall Study|Participant went for transplant|0|||
156552942|NCT00953758|565116362|FG005|Overall Study|Participant went for transplant|0|||
156552943|NCT00953758|565116363|FG006|Overall Study|Participant went for transplant|0|||
156552944|NCT00953758|565116364|FG007|Overall Study|Participant went for transplant|0|||
156552945|NCT00953758|565116365|FG008|Overall Study|Participant went for transplant|1|||
156552946|NCT00953758|565116366|FG009|Overall Study|Participant went for transplant|0|||
156552947|NCT00927095|565116369|FG000|Overall Study|Adverse Event|3|||
156552948|NCT00927095|565116370|FG001|Overall Study|Adverse Event|1|||
156552949|NCT00927095|565116371|FG002|Overall Study|Adverse Event|0|||
156552950|NCT00927095|565116369|FG000|Overall Study|Withdrawal by Subject|2|||
156552951|NCT00927095|565116370|FG001|Overall Study|Withdrawal by Subject|1|||
156552952|NCT00927095|565116371|FG002|Overall Study|Withdrawal by Subject|1|||
156552953|NCT00927095|565116369|FG000|Overall Study|Physician Decision|1|||
156552954|NCT00927095|565116370|FG001|Overall Study|Physician Decision|2|||
156552955|NCT00927095|565116371|FG002|Overall Study|Physician Decision|1|||
156552956|NCT00044512|565116378|FG000|Follow Up|Lost to Follow-up|2|||
156552958|NCT05130463|565116390|FG000|Overall Study|Unspecified reasons|2|||
156552959|NCT05130463|565116390|FG000|Overall Study|off-label indication dose|435|||
156552960|NCT03652662|565116394|FG000|Overall Study|Withdrawal by Subject|2|||
156552961|NCT03652662|565116395|FG001|Overall Study|Withdrawal by Subject|1|||
156552962|NCT03652662|565116394|FG000|Overall Study|Lost to Follow-up|1|||
156552963|NCT03652662|565116395|FG001|Overall Study|Lost to Follow-up|0|||
156552964|NCT00487539|565116396|FG000|Overall Study|Adverse Event|3|||
156552965|NCT00487539|565116397|FG001|Overall Study|Adverse Event|2|||
156552966|NCT00487539|565116398|FG002|Overall Study|Adverse Event|1|||
156552967|NCT00487539|565116399|FG003|Overall Study|Adverse Event|1|||
156403435|NCT01412801|564570268|FG005|Overall Study|Death|2|||
156403436|NCT01412801|564570263|FG000|Overall Study|Lost to Follow-up|1|||
156403437|NCT01412801|564570264|FG001|Overall Study|Lost to Follow-up|2|||
156403438|NCT01412801|564570265|FG002|Overall Study|Lost to Follow-up|4|||
156552968|NCT00487539|565116396|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156552969|NCT00487539|565116397|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156552970|NCT00487539|565116398|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156403439|NCT01412801|564570266|FG003|Overall Study|Lost to Follow-up|0|||
156403440|NCT01412801|564570267|FG004|Overall Study|Lost to Follow-up|1|||
156403441|NCT01412801|564570268|FG005|Overall Study|Lost to Follow-up|1|||
156403442|NCT01412801|564570263|FG000|Overall Study|Withdrawal by Subject|3|||
156403443|NCT01412801|564570264|FG001|Overall Study|Withdrawal by Subject|2|||
156403444|NCT01412801|564570265|FG002|Overall Study|Withdrawal by Subject|1|||
156403445|NCT01412801|564570266|FG003|Overall Study|Withdrawal by Subject|0|||
156403446|NCT01412801|564570267|FG004|Overall Study|Withdrawal by Subject|0|||
156403447|NCT01412801|564570268|FG005|Overall Study|Withdrawal by Subject|0|||
156403448|NCT01412801|564570263|FG000|Overall Study|Relocated to another area|0|||
156403449|NCT01412801|564570264|FG001|Overall Study|Relocated to another area|0|||
156403450|NCT01412801|564570265|FG002|Overall Study|Relocated to another area|2|||
156403451|NCT01412801|564570266|FG003|Overall Study|Relocated to another area|0|||
156403452|NCT01412801|564570267|FG004|Overall Study|Relocated to another area|0|||
156403453|NCT01412801|564570268|FG005|Overall Study|Relocated to another area|0|||
156403454|NCT01483937|564570274|FG000|Overall Study|Withdrawal by Subject|4|||
156403455|NCT01483937|564570275|FG001|Overall Study|Withdrawal by Subject|3|||
156403456|NCT01919970|564570276|FG000|Overall Study|Withdrawal by Subject|3|||
156403457|NCT01919970|564570277|FG001|Overall Study|Withdrawal by Subject|0|||
156403458|NCT02764775|564573310|FG000|Overall Study|Death|1|||
156403459|NCT02764775|564573310|FG000|Overall Study|Lost to Follow-up|2|||
156403460|NCT02764775|564573310|FG000|Overall Study|Withdrawal by Subject|3|||
156403461|NCT00429494|564573311|FG000|Overall Study|Withdrawal by Subject|9|||
156403462|NCT00429494|564573311|FG000|Overall Study|Death|6|||
156403463|NCT00976703|564573314|FG000|Overall Study|Physician Decision|1|||
156403464|NCT00976703|564573315|FG001|Overall Study|Physician Decision|1|||
156403465|NCT00976703|564573314|FG000|Overall Study|ineligible for study|2|||
156403466|NCT00976703|564573315|FG001|Overall Study|ineligible for study|2|||
156403467|NCT00975221|564573318|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
156403468|NCT00975221|564573319|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
156403469|NCT00975221|564573318|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
156403470|NCT00975221|564573319|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
156403471|NCT00975221|564573318|FG000|Titration Phase (Weeks 1-12)|Other|0|||
156403472|NCT00975221|564573319|FG001|Titration Phase (Weeks 1-12)|Other|1|||
156403473|NCT00975221|564573318|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
156403474|NCT00975221|564573319|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
156403475|NCT00975221|564573318|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
156403476|NCT00975221|564573319|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
156403477|NCT00975221|564573318|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
156403478|NCT00975221|564573319|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
156403479|NCT02243631|564573322|FG000|Overall Study|no synovial fluid on second aspirate|0|||
156403480|NCT02243631|564573323|FG001|Overall Study|no synovial fluid on second aspirate|1|||
156403481|NCT01992549|564573328|FG000|Overall Study|Lost to Follow-up|2|||
156403482|NCT01992549|564573328|FG000|Overall Study|Serious Adverse Event|1|||
156403483|NCT01992549|564573328|FG000|Overall Study|Product Switch to Extend Half Life|1|||
156403484|NCT05044325|564573332|FG000|Part A:Treatment Period 1|Adverse Event|0|||
156403485|NCT05044325|564573333|FG001|Part A:Treatment Period 1|Adverse Event|0|||
156403486|NCT05044325|564573334|FG002|Part A:Treatment Period 1|Adverse Event|0|||
156403487|NCT05044325|564573335|FG003|Part A:Treatment Period 1|Adverse Event|0|||
156403488|NCT05044325|564573336|FG004|Part A:Treatment Period 1|Adverse Event|0|||
156403489|NCT05044325|564573337|FG005|Part A:Treatment Period 1|Adverse Event|1|||
156403490|NCT05044325|564573338|FG006|Part A:Treatment Period 1|Adverse Event|0|||
156403491|NCT05044325|564573339|FG007|Part A:Treatment Period 1|Adverse Event|1|||
156512199|NCT02672852|564968194|FG001|Part A1|Lost to Follow-up|2|||
156512200|NCT02672852|564968195|FG002|Part A1|Lost to Follow-up|0|||
156512201|NCT02672852|564968196|FG003|Part A1|Lost to Follow-up|0|||
156512202|NCT02672852|564968197|FG004|Part A1|Lost to Follow-up|0|||
156512203|NCT02672852|564968198|FG005|Part A1|Lost to Follow-up|0|||
156512204|NCT02672852|564968199|FG006|Part A1|Lost to Follow-up|0|||
156512205|NCT02672852|564968193|FG000|Part A1|Withdrawal by Subject|1|||
156512206|NCT02672852|564968194|FG001|Part A1|Withdrawal by Subject|1|||
156512207|NCT02672852|564968195|FG002|Part A1|Withdrawal by Subject|0|||
156512208|NCT02672852|564968196|FG003|Part A1|Withdrawal by Subject|0|||
156512209|NCT02672852|564968197|FG004|Part A1|Withdrawal by Subject|0|||
156512210|NCT02672852|564968198|FG005|Part A1|Withdrawal by Subject|0|||
156512211|NCT02672852|564968199|FG006|Part A1|Withdrawal by Subject|0|||
156512212|NCT02672852|564968193|FG000|Part A2|Disease worsening|0|||
156403492|NCT05044325|564573340|FG008|Part A:Treatment Period 1|Adverse Event|0|||
156512213|NCT02672852|564968194|FG001|Part A2|Disease worsening|0|||
156512214|NCT02672852|564968195|FG002|Part A2|Disease worsening|1|||
156403493|NCT05044325|564573341|FG009|Part A:Treatment Period 1|Adverse Event|0|||
156403494|NCT05044325|564573332|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156512215|NCT02672852|564968196|FG003|Part A2|Disease worsening|0|||
156512216|NCT02672852|564968197|FG004|Part A2|Disease worsening|0|||
156512217|NCT02672852|564968198|FG005|Part A2|Disease worsening|0|||
156512218|NCT02672852|564968199|FG006|Part A2|Disease worsening|0|||
156512219|NCT02672852|564968193|FG000|Part A2|Adverse Event|0|||
156512220|NCT02672852|564968194|FG001|Part A2|Adverse Event|0|||
156512221|NCT02672852|564968195|FG002|Part A2|Adverse Event|3|||
156403495|NCT05044325|564573333|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156403496|NCT05044325|564573334|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156403497|NCT05044325|564573335|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
156403498|NCT05044325|564573336|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
156403499|NCT05044325|564573337|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
156403500|NCT05044325|564573338|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156403501|NCT05044325|564573339|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156403502|NCT05044325|564573340|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156403503|NCT05044325|564573341|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156403504|NCT05044325|564573332|FG000|Part A:Treatment Period 1|Physician Decision|0|||
156403505|NCT05044325|564573333|FG001|Part A:Treatment Period 1|Physician Decision|0|||
156403506|NCT05044325|564573334|FG002|Part A:Treatment Period 1|Physician Decision|0|||
156403507|NCT05044325|564573335|FG003|Part A:Treatment Period 1|Physician Decision|0|||
156403508|NCT05044325|564573336|FG004|Part A:Treatment Period 1|Physician Decision|0|||
156403509|NCT05044325|564573337|FG005|Part A:Treatment Period 1|Physician Decision|0|||
156403510|NCT05044325|564573338|FG006|Part A:Treatment Period 1|Physician Decision|1|||
156403511|NCT05044325|564573339|FG007|Part A:Treatment Period 1|Physician Decision|0|||
156403512|NCT05044325|564573340|FG008|Part A:Treatment Period 1|Physician Decision|0|||
156403513|NCT05044325|564573341|FG009|Part A:Treatment Period 1|Physician Decision|0|||
156403514|NCT05044325|564573332|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403515|NCT05044325|564573333|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403516|NCT05044325|564573334|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
156403517|NCT05044325|564573335|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403518|NCT05044325|564573336|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403519|NCT05044325|564573337|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403520|NCT05044325|564573338|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403521|NCT05044325|564573339|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403522|NCT05044325|564573340|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403523|NCT05044325|564573341|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156403524|NCT05044325|564573332|FG000|Part A:Treatment Period 2|Adverse Event|0|||
156403525|NCT05044325|564573333|FG001|Part A:Treatment Period 2|Adverse Event|1|||
156403526|NCT05044325|564573334|FG002|Part A:Treatment Period 2|Adverse Event|0|||
156403527|NCT05044325|564573335|FG003|Part A:Treatment Period 2|Adverse Event|0|||
156403528|NCT05044325|564573336|FG004|Part A:Treatment Period 2|Adverse Event|1|||
156403529|NCT05044325|564573337|FG005|Part A:Treatment Period 2|Adverse Event|1|||
156403530|NCT05044325|564573338|FG006|Part A:Treatment Period 2|Adverse Event|0|||
156403531|NCT05044325|564573339|FG007|Part A:Treatment Period 2|Adverse Event|0|||
156403532|NCT05044325|564573340|FG008|Part A:Treatment Period 2|Adverse Event|0|||
156403533|NCT05044325|564573341|FG009|Part A:Treatment Period 2|Adverse Event|0|||
156403534|NCT05044325|564573332|FG000|Part A:Treatment Period 2|Physician Decision|0|||
156403535|NCT05044325|564573333|FG001|Part A:Treatment Period 2|Physician Decision|0|||
156403536|NCT05044325|564573334|FG002|Part A:Treatment Period 2|Physician Decision|0|||
156403537|NCT05044325|564573335|FG003|Part A:Treatment Period 2|Physician Decision|0|||
156403538|NCT05044325|564573336|FG004|Part A:Treatment Period 2|Physician Decision|0|||
156403539|NCT05044325|564573337|FG005|Part A:Treatment Period 2|Physician Decision|1|||
156403540|NCT05044325|564573338|FG006|Part A:Treatment Period 2|Physician Decision|0|||
156403541|NCT05044325|564573339|FG007|Part A:Treatment Period 2|Physician Decision|0|||
156403542|NCT05044325|564573340|FG008|Part A:Treatment Period 2|Physician Decision|0|||
156403543|NCT05044325|564573341|FG009|Part A:Treatment Period 2|Physician Decision|0|||
156403544|NCT05044325|564573332|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156403545|NCT05044325|564573333|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156403546|NCT05044325|564573334|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156403547|NCT05044325|564573335|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
156403548|NCT05044325|564573336|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
156403549|NCT05044325|564573337|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156403550|NCT05044325|564573338|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156403551|NCT05044325|564573339|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156403552|NCT05044325|564573340|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156403553|NCT05044325|564573341|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156403554|NCT01250119|564573344|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
156403555|NCT01250119|564573345|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
156403556|NCT01250119|564573344|FG000|Diagnostic Phase|Participants Not Tested|44|||
156403557|NCT01250119|564573345|FG001|Diagnostic Phase|Participants Not Tested|0|||
156403558|NCT01250119|564573344|FG000|Treatment Phase|Progressive Disease|0|||
156403559|NCT01250119|564573345|FG001|Treatment Phase|Progressive Disease|32|||
156403560|NCT01250119|564573344|FG000|Treatment Phase|Death|0|||
156403561|NCT01250119|564573345|FG001|Treatment Phase|Death|2|||
156403562|NCT01250119|564573344|FG000|Treatment Phase|Withdrawal by Subject|0|||
156403563|NCT01250119|564573345|FG001|Treatment Phase|Withdrawal by Subject|1|||
156403564|NCT01250119|564573344|FG000|Treatment Phase|Adverse Event|0|||
156403565|NCT01250119|564573345|FG001|Treatment Phase|Adverse Event|2|||
156403566|NCT01250119|564573344|FG000|Treatment Phase|Unknown reason|0|||
156403567|NCT01250119|564573345|FG001|Treatment Phase|Unknown reason|4|||
156403568|NCT01559454|564573348|FG000|Overall Study|Lost to Follow-up|3|||
156403569|NCT01559454|564573349|FG001|Overall Study|Lost to Follow-up|2|||
156403570|NCT01559454|564573348|FG000|Overall Study|Withdrawal by Subject|0|||
156403571|NCT01559454|564573349|FG001|Overall Study|Withdrawal by Subject|1|||
156403572|NCT01559454|564573348|FG000|Overall Study|Physician Decision|0|||
156403573|NCT01559454|564573349|FG001|Overall Study|Physician Decision|1|||
156403574|NCT01559454|564573348|FG000|Overall Study|Protocol Violation|0|||
156403575|NCT01559454|564573349|FG001|Overall Study|Protocol Violation|1|||
156403576|NCT01559454|564573348|FG000|Overall Study|Lack of Efficacy|0|||
156403577|NCT01559454|564573349|FG001|Overall Study|Lack of Efficacy|1|||
156403578|NCT00462670|564573354|FG000|Overall Study|Adverse Event|3|||
156403579|NCT00462670|564573355|FG001|Overall Study|Adverse Event|5|||
156403580|NCT00462670|564573354|FG000|Overall Study|Lack of Efficacy|1|||
156403581|NCT00462670|564573355|FG001|Overall Study|Lack of Efficacy|0|||
156403582|NCT00462670|564573354|FG000|Overall Study|Protocol Violation|1|||
156403583|NCT00462670|564573355|FG001|Overall Study|Protocol Violation|0|||
156403584|NCT00462670|564573354|FG000|Overall Study|Resolution of signs and symptoms|0|||
156403585|NCT00462670|564573355|FG001|Overall Study|Resolution of signs and symptoms|2|||
156403586|NCT00482274|564573358|FG000|Overall Study|Adverse Event|1|||
156403587|NCT04887948|564573362|FG000|Overall Study|Death|1|||
156403588|NCT04887948|564573363|FG001|Overall Study|Death|0|||
156403589|NCT04887948|564573364|FG002|Overall Study|Death|0|||
156403590|NCT04887948|564573362|FG000|Overall Study|Lost to Follow-up|1|||
156403591|NCT04887948|564573363|FG001|Overall Study|Lost to Follow-up|0|||
156403592|NCT04887948|564573364|FG002|Overall Study|Lost to Follow-up|3|||
156403593|NCT04887948|564573362|FG000|Overall Study|Physician Decision|0|||
156403594|NCT04887948|564573363|FG001|Overall Study|Physician Decision|4|||
156403595|NCT04887948|564573364|FG002|Overall Study|Physician Decision|1|||
156403596|NCT04887948|564573362|FG000|Overall Study|Protocol Violation|1|||
156403597|NCT04887948|564573363|FG001|Overall Study|Protocol Violation|1|||
156403598|NCT04887948|564573364|FG002|Overall Study|Protocol Violation|0|||
156403599|NCT04887948|564573362|FG000|Overall Study|Withdrawal by Subject|0|||
156403600|NCT04887948|564573363|FG001|Overall Study|Withdrawal by Subject|6|||
156403601|NCT04887948|564573364|FG002|Overall Study|Withdrawal by Subject|1|||
156403602|NCT04887948|564573362|FG000|Overall Study|No longer met eligibility criteria|1|||
156403603|NCT04887948|564573363|FG001|Overall Study|No longer met eligibility criteria|2|||
156403604|NCT04887948|564573364|FG002|Overall Study|No longer met eligibility criteria|1|||
156403605|NCT04887948|564573362|FG000|Overall Study|Other|2|||
156403606|NCT04887948|564573363|FG001|Overall Study|Other|1|||
156403607|NCT04887948|564573364|FG002|Overall Study|Other|1|||
156403608|NCT02948959|564573365|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
156403609|NCT02948959|564573366|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
156403610|NCT02948959|564573365|FG000|52 Weeks Treatment Period|Adverse Event|2|||
156403611|NCT02948959|564573366|FG001|52 Weeks Treatment Period|Adverse Event|5|||
156403612|NCT02948959|564573365|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
156403613|NCT02948959|564573366|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
156403614|NCT02948959|564573365|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
156403615|NCT02948959|564573366|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
156512222|NCT02672852|564968196|FG003|Part A2|Adverse Event|0|||
156512223|NCT02672852|564968197|FG004|Part A2|Adverse Event|0|||
156512224|NCT02672852|564968198|FG005|Part A2|Adverse Event|0|||
156512225|NCT02672852|564968199|FG006|Part A2|Adverse Event|0|||
156512226|NCT02672852|564968193|FG000|Part A2|Lost to Follow-up|0|||
156403616|NCT02948959|564573365|FG000|52 Weeks Treatment Period|Randomized by error|0|||
156403617|NCT02948959|564573366|FG001|52 Weeks Treatment Period|Randomized by error|5|||
156512227|NCT02672852|564968194|FG001|Part A2|Lost to Follow-up|0|||
156512228|NCT02672852|564968195|FG002|Part A2|Lost to Follow-up|2|||
156512229|NCT02672852|564968196|FG003|Part A2|Lost to Follow-up|0|||
156403618|NCT02948959|564573365|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
156403619|NCT02948959|564573366|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
156403620|NCT02948959|564573365|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
156403621|NCT02948959|564573366|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
156512230|NCT02672852|564968197|FG004|Part A2|Lost to Follow-up|0|||
156512231|NCT02672852|564968198|FG005|Part A2|Lost to Follow-up|0|||
156403622|NCT02948959|564573365|FG000|52 Weeks Treatment Period|Change of residence location|0|||
156403623|NCT02948959|564573366|FG001|52 Weeks Treatment Period|Change of residence location|1|||
156403624|NCT02948959|564573365|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
156403625|NCT02948959|564573366|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
156403626|NCT02948959|564573365|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
156403627|NCT02948959|564573366|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
156403628|NCT02948959|564573365|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
156512232|NCT02672852|564968199|FG006|Part A2|Lost to Follow-up|0|||
156512233|NCT02672852|564968193|FG000|Part A2|Withdrawal by Subject|0|||
156403629|NCT02948959|564573366|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
156403630|NCT02948959|564573365|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
156403631|NCT02948959|564573366|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
156403632|NCT02948959|564573365|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
156403633|NCT02948959|564573366|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
156403634|NCT02948959|564573365|FG000|12 Weeks Follow-up Period|Study site closure|1|||
156403635|NCT02948959|564573366|FG001|12 Weeks Follow-up Period|Study site closure|0|||
156403636|NCT00787319|564573367|FG000|Overall Study|Lost to Follow-up|2|||
156403637|NCT00787319|564573367|FG000|Overall Study|Withdrawal by Subject|15|||
156403638|NCT00787319|564573367|FG000|Overall Study|Adverse Event|3|||
156403639|NCT00787319|564573367|FG000|Overall Study|Objective progression or relapse|30|||
156403640|NCT00787319|564573367|FG000|Overall Study|Lack of Efficacy|1|||
156403641|NCT00787319|564573367|FG000|Overall Study|Budget exhausted/exceeded|1|||
156403642|NCT00787319|564573367|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
156403643|NCT00787319|564573367|FG000|Overall Study|No health insurance reimbursement|2|||
156403644|NCT00787319|564573367|FG000|Overall Study|Stabilized disease findings|3|||
156403645|NCT00787319|564573367|FG000|Overall Study|Inactive disease|5|||
156403646|NCT02312856|564573368|FG000|Overall Study|Death|1|||
156403647|NCT02312856|564573368|FG000|Overall Study|Lost to Follow-up|3|||
156403648|NCT01932294|564573369|FG000|Overall Study|Death|43|||
156403649|NCT01932294|564573369|FG000|Overall Study|Lost to Follow-up|8|||
156403650|NCT01932294|564573369|FG000|Overall Study|VAD Implantation|20|||
156403651|NCT01932294|564573369|FG000|Overall Study|Heart Transplantation|16|||
156403652|NCT01932294|564573369|FG000|Overall Study|Transferred to other hospitals|12|||
156403653|NCT04415151|564573370|FG000|Overall Study|Death|1|||
156403654|NCT04415151|564573371|FG001|Overall Study|Death|1|||
156403655|NCT04415151|564573370|FG000|Overall Study|Withdrawal by Subject|1|||
156403656|NCT04415151|564573371|FG001|Overall Study|Withdrawal by Subject|0|||
156403657|NCT00409786|564573375|FG000|Overall Study|Withdrawal by Subject|3|||
156403658|NCT00638235|564573378|FG000|Overall Study|Lost to Follow-up|31|||
156403659|NCT00638235|564573379|FG001|Overall Study|Lost to Follow-up|3|||
156403660|NCT00638235|564573380|FG002|Overall Study|Lost to Follow-up|18|||
156403661|NCT00638235|564573381|FG003|Overall Study|Lost to Follow-up|10|||
156403662|NCT00638235|564573382|FG004|Overall Study|Lost to Follow-up|13|||
156403663|NCT00638235|564573383|FG005|Overall Study|Lost to Follow-up|26|||
156403664|NCT00638235|564573384|FG006|Overall Study|Lost to Follow-up|0|||
156403665|NCT00638235|564573385|FG007|Overall Study|Lost to Follow-up|1|||
156403666|NCT00638235|564573386|FG008|Overall Study|Lost to Follow-up|18|||
156403667|NCT03075904|564573389|FG000|Overall Study|Physician Decision|3|||
156403668|NCT03075904|564573389|FG000|Overall Study|Need for Medication not Permitted|1|||
156403669|NCT01588990|564573390|FG000|Phase A|Withdrawal by Subject|5|||
156403670|NCT01588990|564573390|FG000|Phase A|Physician Decision|11|||
156403671|NCT01588990|564573390|FG000|Phase A|Other|14|||
156403672|NCT01588990|564573390|FG000|Phase A|Lost to Follow-up|1|||
156403673|NCT01588990|564573390|FG000|Phase A|Death|5|||
156403674|NCT01588990|564573390|FG000|Phase A|Adverse Event|28|||
156403675|NCT01588990|564573390|FG000|Phase A|Still on therapy at end of study|6|||
156403676|NCT01588990|564573390|FG000|Phase B|Adverse Event|2|||
156403677|NCT01588990|564573390|FG000|Phase B|Still on therapy at end of study|5|||
156403678|NCT01588990|564573390|FG000|Phase B|Withdrawal by Subject|3|||
156403679|NCT01588990|564573390|FG000|Phase B|Physician Decision|4|||
156403680|NCT01588990|564573390|FG000|Phase B|Other|2|||
156403681|NCT01641926|564573393|FG000|Overall Study|Adverse Event|5|||
156403682|NCT01641926|564573394|FG001|Overall Study|Adverse Event|2|||
156403683|NCT01641926|564573395|FG002|Overall Study|Adverse Event|3|||
156403684|NCT01641926|564573396|FG003|Overall Study|Adverse Event|1|||
156403685|NCT01641926|564573393|FG000|Overall Study|Lost to Follow-up|2|||
156403686|NCT01641926|564573394|FG001|Overall Study|Lost to Follow-up|2|||
156403687|NCT01641926|564573395|FG002|Overall Study|Lost to Follow-up|1|||
156403688|NCT01641926|564573396|FG003|Overall Study|Lost to Follow-up|0|||
156403689|NCT01641926|564573393|FG000|Overall Study|Physician Decision|6|||
156403690|NCT01641926|564573394|FG001|Overall Study|Physician Decision|5|||
156403691|NCT01641926|564573395|FG002|Overall Study|Physician Decision|0|||
156403692|NCT01641926|564573396|FG003|Overall Study|Physician Decision|1|||
156403693|NCT01641926|564573393|FG000|Overall Study|Protocol Violation|1|||
156403694|NCT01641926|564573394|FG001|Overall Study|Protocol Violation|0|||
156403695|NCT01641926|564573395|FG002|Overall Study|Protocol Violation|0|||
156512234|NCT02672852|564968194|FG001|Part A2|Withdrawal by Subject|0|||
156512235|NCT02672852|564968195|FG002|Part A2|Withdrawal by Subject|1|||
156403696|NCT01641926|564573396|FG003|Overall Study|Protocol Violation|1|||
156403697|NCT01641926|564573393|FG000|Overall Study|Withdrawal by Subject|13|||
156403698|NCT01641926|564573394|FG001|Overall Study|Withdrawal by Subject|5|||
156403699|NCT01641926|564573395|FG002|Overall Study|Withdrawal by Subject|6|||
156403700|NCT01641926|564573396|FG003|Overall Study|Withdrawal by Subject|1|||
156403701|NCT01641926|564573393|FG000|Overall Study|Not Treated|1|||
156403702|NCT01641926|564573394|FG001|Overall Study|Not Treated|1|||
156403703|NCT01641926|564573395|FG002|Overall Study|Not Treated|1|||
156403704|NCT01641926|564573396|FG003|Overall Study|Not Treated|0|||
156403705|NCT01287520|564573397|FG000|Overall Study|Adverse Event|2|||
156403706|NCT01287520|564573398|FG001|Overall Study|Adverse Event|2|||
156403707|NCT01287520|564573399|FG002|Overall Study|Adverse Event|2|||
156403708|NCT01287520|564573400|FG003|Overall Study|Adverse Event|1|||
156403709|NCT01287520|564573401|FG004|Overall Study|Adverse Event|1|||
156403710|NCT01287520|564573402|FG005|Overall Study|Adverse Event|2|||
156403711|NCT01287520|564573403|FG006|Overall Study|Adverse Event|0|||
156403712|NCT01287520|564573404|FG007|Overall Study|Adverse Event|2|||
156403713|NCT01287520|564573405|FG008|Overall Study|Adverse Event|0|||
156403714|NCT01287520|564573397|FG000|Overall Study|Physician Decision|1|||
156403715|NCT01287520|564573398|FG001|Overall Study|Physician Decision|1|||
156403716|NCT01287520|564573399|FG002|Overall Study|Physician Decision|2|||
156403717|NCT01287520|564573400|FG003|Overall Study|Physician Decision|0|||
156403718|NCT01287520|564573401|FG004|Overall Study|Physician Decision|1|||
156403719|NCT01287520|564573402|FG005|Overall Study|Physician Decision|1|||
156403720|NCT01287520|564573403|FG006|Overall Study|Physician Decision|0|||
156403721|NCT01287520|564573404|FG007|Overall Study|Physician Decision|1|||
156403722|NCT01287520|564573405|FG008|Overall Study|Physician Decision|0|||
156403723|NCT01287520|564573397|FG000|Overall Study|Progressive disease|0|||
156403724|NCT01287520|564573398|FG001|Overall Study|Progressive disease|4|||
156403725|NCT01287520|564573399|FG002|Overall Study|Progressive disease|1|||
156403726|NCT01287520|564573400|FG003|Overall Study|Progressive disease|6|||
156403727|NCT01287520|564573401|FG004|Overall Study|Progressive disease|1|||
156403728|NCT01287520|564573402|FG005|Overall Study|Progressive disease|0|||
156403729|NCT01287520|564573403|FG006|Overall Study|Progressive disease|2|||
156403730|NCT01287520|564573404|FG007|Overall Study|Progressive disease|2|||
156403731|NCT01287520|564573405|FG008|Overall Study|Progressive disease|4|||
156403732|NCT01287520|564573397|FG000|Overall Study|Withdrawal by Subject|0|||
156403733|NCT01287520|564573398|FG001|Overall Study|Withdrawal by Subject|0|||
156403734|NCT01287520|564573399|FG002|Overall Study|Withdrawal by Subject|0|||
156403735|NCT01287520|564573400|FG003|Overall Study|Withdrawal by Subject|0|||
156403736|NCT01287520|564573401|FG004|Overall Study|Withdrawal by Subject|0|||
156403737|NCT01287520|564573402|FG005|Overall Study|Withdrawal by Subject|1|||
156403738|NCT01287520|564573403|FG006|Overall Study|Withdrawal by Subject|0|||
156403739|NCT01287520|564573404|FG007|Overall Study|Withdrawal by Subject|0|||
156403740|NCT01287520|564573405|FG008|Overall Study|Withdrawal by Subject|1|||
156403741|NCT03587142|564573406|FG000|Overall Study|Lost to Follow-up|5|||
156403742|NCT03587142|564573407|FG001|Overall Study|Lost to Follow-up|3|||
156403743|NCT03587142|564573406|FG000|Overall Study|Did not complete the f4 visit|3|||
156403744|NCT03587142|564573407|FG001|Overall Study|Did not complete the f4 visit|7|||
156403745|NCT01800201|564573408|FG000|Overall Study|Withdrawal by Subject|2|||
156403746|NCT01800201|564573409|FG001|Overall Study|Withdrawal by Subject|0|||
156403747|NCT01800201|564573408|FG000|Overall Study|patient privacy concerns|1|||
156403748|NCT01800201|564573409|FG001|Overall Study|patient privacy concerns|1|||
156403749|NCT01800201|564573408|FG000|Overall Study|did not want to use device|0|||
156403750|NCT01800201|564573409|FG001|Overall Study|did not want to use device|1|||
156403751|NCT01800201|564573408|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
156403752|NCT01800201|564573409|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
156403753|NCT02387216|564573413|FG000|Overall Study|Progressive disease|2|||
156403754|NCT02387216|564573414|FG001|Overall Study|Progressive disease|0|||
156403755|NCT02387216|564573413|FG000|Overall Study|Withdrawal by Subject|3|||
156403756|NCT02387216|564573414|FG001|Overall Study|Withdrawal by Subject|5|||
156403757|NCT02387216|564573413|FG000|Overall Study|Physician Decision|2|||
156403758|NCT02387216|564573414|FG001|Overall Study|Physician Decision|0|||
156403759|NCT02387216|564573413|FG000|Overall Study|Sponsor Decision|28|||
156403760|NCT02387216|564573414|FG001|Overall Study|Sponsor Decision|12|||
156403761|NCT02387216|564573413|FG000|Overall Study|Death|60|||
156403762|NCT02387216|564573414|FG001|Overall Study|Death|23|||
156403763|NCT02387216|564573413|FG000|Overall Study|Other|5|||
156403764|NCT02387216|564573414|FG001|Overall Study|Other|4|||
156403765|NCT02387216|564573413|FG000|Overall Study|Lost to Follow-up|0|||
156403766|NCT02387216|564573414|FG001|Overall Study|Lost to Follow-up|3|||
156403767|NCT00909480|564573415|FG000|Overall Study|Adverse Event|5|||
156403768|NCT00909480|564573416|FG001|Overall Study|Adverse Event|3|||
156403769|NCT00909480|564573415|FG000|Overall Study|Protocol Violation|6|||
156403770|NCT00909480|564573416|FG001|Overall Study|Protocol Violation|8|||
156403771|NCT00909480|564573415|FG000|Overall Study|Withdrawal criteria|9|||
156403772|NCT00909480|564573416|FG001|Overall Study|Withdrawal criteria|11|||
156403773|NCT00909480|564573415|FG000|Overall Study|Unclassified|18|||
156403774|NCT00909480|564573416|FG001|Overall Study|Unclassified|19|||
156552971|NCT00487539|565116399|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
156403775|NCT03528174|564573419|FG000|Overall Study|Adverse Event|1|||
156552972|NCT00487539|565116396|FG000|Overall Study|Other|3|||
156403776|NCT03528174|564573419|FG000|Overall Study|sensors dislodged|1|||
156403777|NCT00979602|564573428|FG000|Overall Study|Serious Adverse Event|5|||
156403778|NCT00979602|564573429|FG001|Overall Study|Serious Adverse Event|3|||
156403779|NCT00979602|564573428|FG000|Overall Study|Protocol Violation|3|||
156403780|NCT00979602|564573429|FG001|Overall Study|Protocol Violation|0|||
156403781|NCT00979602|564573428|FG000|Overall Study|Withdrawal by Subject|31|||
156403782|NCT00979602|564573429|FG001|Overall Study|Withdrawal by Subject|25|||
156403783|NCT00979602|564573428|FG000|Overall Study|Lost to Follow-up|100|||
156403784|NCT00979602|564573429|FG001|Overall Study|Lost to Follow-up|96|||
156403785|NCT00979602|564573428|FG000|Overall Study|Migrated/moved from study area|3|||
156403786|NCT00979602|564573429|FG001|Overall Study|Migrated/moved from study area|6|||
156403787|NCT00979602|564573428|FG000|Overall Study|Others|3|||
156403788|NCT00979602|564573429|FG001|Overall Study|Others|3|||
156403789|NCT02904902|564573430|FG000|Overall Study|Withdrawal by Subject|1|||
156403790|NCT01719237|564573431|FG000|Overall Study|Physician Decision|0|||
156403791|NCT01719237|564573432|FG001|Overall Study|Physician Decision|1|||
156403792|NCT00453102|564573436|FG000|Overall Study|Withdrawal by Subject|2|||
156403793|NCT05400746|564573441|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
156403794|NCT05400746|564573442|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
156403795|NCT05400746|564573443|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
156403796|NCT05375955|564573444|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
156403797|NCT05375955|564573445|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
156403798|NCT05375955|564573446|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
156403799|NCT05375955|564573447|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
156403800|NCT05375955|564573448|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
156403801|NCT05375955|564573449|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
156403802|NCT05375955|564573450|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
156403803|NCT05375955|564573444|FG000|Treatment (12 Weeks)|Physician Decision|4|||
156403804|NCT05375955|564573445|FG001|Treatment (12 Weeks)|Physician Decision|1|||
156403805|NCT05375955|564573446|FG002|Treatment (12 Weeks)|Physician Decision|3|||
156403806|NCT05375955|564573447|FG003|Treatment (12 Weeks)|Physician Decision|0|||
156403807|NCT05375955|564573448|FG004|Treatment (12 Weeks)|Physician Decision|0|||
156403808|NCT05375955|564573449|FG005|Treatment (12 Weeks)|Physician Decision|1|||
156403809|NCT05375955|564573450|FG006|Treatment (12 Weeks)|Physician Decision|0|||
156403810|NCT05375955|564573444|FG000|Treatment (12 Weeks)|Other|0|||
156403811|NCT05375955|564573445|FG001|Treatment (12 Weeks)|Other|1|||
156403812|NCT05375955|564573446|FG002|Treatment (12 Weeks)|Other|0|||
156403813|NCT05375955|564573447|FG003|Treatment (12 Weeks)|Other|0|||
156403814|NCT05375955|564573448|FG004|Treatment (12 Weeks)|Other|0|||
156403815|NCT05375955|564573449|FG005|Treatment (12 Weeks)|Other|0|||
156403816|NCT05375955|564573450|FG006|Treatment (12 Weeks)|Other|0|||
156403817|NCT05375955|564573444|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156403818|NCT05375955|564573445|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156403819|NCT05375955|564573446|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156403820|NCT05375955|564573447|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156403821|NCT05375955|564573448|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156403822|NCT05375955|564573449|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156403823|NCT05375955|564573450|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
156403824|NCT05375955|564573444|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
156403825|NCT05375955|564573445|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
156403826|NCT05375955|564573446|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
156403827|NCT05375955|564573447|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
156403828|NCT05375955|564573448|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
156403829|NCT05375955|564573449|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
156403830|NCT05375955|564573450|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
156403831|NCT05375955|564573444|FG000|Treatment (12 Weeks)|Pregnancy|0|||
156403832|NCT05375955|564573445|FG001|Treatment (12 Weeks)|Pregnancy|0|||
156403833|NCT05375955|564573446|FG002|Treatment (12 Weeks)|Pregnancy|1|||
156403834|NCT05375955|564573447|FG003|Treatment (12 Weeks)|Pregnancy|0|||
156403835|NCT05375955|564573448|FG004|Treatment (12 Weeks)|Pregnancy|0|||
156403836|NCT05375955|564573449|FG005|Treatment (12 Weeks)|Pregnancy|0|||
156403837|NCT05375955|564573450|FG006|Treatment (12 Weeks)|Pregnancy|0|||
156403838|NCT05375955|564573444|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156403839|NCT05375955|564573445|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156403840|NCT05375955|564573446|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
156403841|NCT05375955|564573447|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156403842|NCT05375955|564573448|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156403843|NCT05375955|564573449|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156403844|NCT05375955|564573450|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156403845|NCT05375955|564573444|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
156403846|NCT05375955|564573445|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
156403847|NCT05375955|564573446|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
156403848|NCT05375955|564573447|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
156403849|NCT05375955|564573448|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
156403850|NCT05375955|564573449|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
156403851|NCT05375955|564573450|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
156403852|NCT05375955|564573444|FG000|Follow-up (up to 5 Weeks)|Other|0|||
156403853|NCT05375955|564573445|FG001|Follow-up (up to 5 Weeks)|Other|1|||
156403854|NCT05375955|564573446|FG002|Follow-up (up to 5 Weeks)|Other|0|||
156403855|NCT05375955|564573447|FG003|Follow-up (up to 5 Weeks)|Other|0|||
156403856|NCT05375955|564573448|FG004|Follow-up (up to 5 Weeks)|Other|0|||
156403857|NCT05375955|564573449|FG005|Follow-up (up to 5 Weeks)|Other|0|||
156403858|NCT05375955|564573450|FG006|Follow-up (up to 5 Weeks)|Other|0|||
156403859|NCT05375955|564573444|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
156403860|NCT05375955|564573445|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156403861|NCT05375955|564573446|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
156403862|NCT05375955|564573447|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156403863|NCT05375955|564573448|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156403864|NCT05375955|564573449|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156403865|NCT05375955|564573450|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156403866|NCT05375955|564573444|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
156403867|NCT05375955|564573445|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
156403868|NCT05375955|564573446|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
156403869|NCT05375955|564573447|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
156403870|NCT05375955|564573448|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
156403871|NCT05375955|564573449|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
156403872|NCT05375955|564573450|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
156403873|NCT03724396|564573460|FG000|Overall Study|Lost to Follow-up|1|||
156403874|NCT03724396|564573461|FG001|Overall Study|Lost to Follow-up|1|||
156403875|NCT03724396|564573460|FG000|Overall Study|Withdrawal by Subject|1|||
156403876|NCT03724396|564573461|FG001|Overall Study|Withdrawal by Subject|0|||
156403877|NCT03879408|564573462|FG000|Overall Study|Lost to Follow-up|0|||
156403878|NCT03879408|564573463|FG001|Overall Study|Lost to Follow-up|3|||
156403879|NCT03879408|564573464|FG002|Overall Study|Lost to Follow-up|2|||
156403880|NCT03879408|564573465|FG003|Overall Study|Lost to Follow-up|1|||
156403881|NCT03879408|564573466|FG004|Overall Study|Lost to Follow-up|0|||
156403882|NCT03879408|564573462|FG000|Overall Study|Withdrawal by Subject|2|||
156403883|NCT03879408|564573463|FG001|Overall Study|Withdrawal by Subject|1|||
156403884|NCT03879408|564573464|FG002|Overall Study|Withdrawal by Subject|1|||
156403885|NCT03879408|564573465|FG003|Overall Study|Withdrawal by Subject|0|||
156403886|NCT03879408|564573466|FG004|Overall Study|Withdrawal by Subject|1|||
156403887|NCT01320943|564573467|FG000|Overall Study|Lost to Follow-up|1|||
156403888|NCT01320943|564573468|FG001|Overall Study|Lost to Follow-up|0|||
156403889|NCT01320943|564573467|FG000|Overall Study|Physician Decision|0|||
156403890|NCT01320943|564573468|FG001|Overall Study|Physician Decision|1|||
156403891|NCT01320943|564573467|FG000|Overall Study|Randomized but not Treated|0|||
156403892|NCT01320943|564573468|FG001|Overall Study|Randomized but not Treated|1|||
156403893|NCT01490125|564573469|FG000|Period I|Adverse Event|4|||
156403894|NCT01490125|564573470|FG001|Period I|Adverse Event|1|||
156403895|NCT01490125|564573471|FG002|Period I|Adverse Event|1|||
156403896|NCT01490125|564573472|FG003|Period I|Adverse Event|3|||
156403897|NCT01490125|564573473|FG004|Period I|Adverse Event|2|||
156403898|NCT01490125|564573474|FG005|Period I|Adverse Event|4|||
156403899|NCT01490125|564573469|FG000|Period I|Protocol Violation|1|||
156403900|NCT01490125|564573470|FG001|Period I|Protocol Violation|1|||
156403901|NCT01490125|564573471|FG002|Period I|Protocol Violation|1|||
156403902|NCT01490125|564573472|FG003|Period I|Protocol Violation|1|||
156403903|NCT01490125|564573473|FG004|Period I|Protocol Violation|0|||
156403904|NCT01490125|564573474|FG005|Period I|Protocol Violation|0|||
156403905|NCT01490125|564573469|FG000|Period I|Withdrawal by Subject|1|||
156403906|NCT01490125|564573470|FG001|Period I|Withdrawal by Subject|3|||
156403907|NCT01490125|564573471|FG002|Period I|Withdrawal by Subject|2|||
156403908|NCT01490125|564573472|FG003|Period I|Withdrawal by Subject|1|||
156403909|NCT01490125|564573473|FG004|Period I|Withdrawal by Subject|2|||
156403910|NCT01490125|564573474|FG005|Period I|Withdrawal by Subject|1|||
156403911|NCT01490125|564573469|FG000|Period II|Adverse Event|2|||
156403912|NCT01490125|564573470|FG001|Period II|Adverse Event|3|||
156403913|NCT01490125|564573471|FG002|Period II|Adverse Event|2|||
156403914|NCT01490125|564573472|FG003|Period II|Adverse Event|2|||
156403915|NCT01490125|564573473|FG004|Period II|Adverse Event|4|||
156403916|NCT01490125|564573474|FG005|Period II|Adverse Event|2|||
156403917|NCT01490125|564573469|FG000|Period II|Protocol Violation|0|||
156403918|NCT01490125|564573470|FG001|Period II|Protocol Violation|0|||
156403919|NCT01490125|564573471|FG002|Period II|Protocol Violation|1|||
156552973|NCT00487539|565116397|FG001|Overall Study|Other|1|||
156403920|NCT01490125|564573472|FG003|Period II|Protocol Violation|1|||
156403921|NCT01490125|564573473|FG004|Period II|Protocol Violation|0|||
156403922|NCT01490125|564573474|FG005|Period II|Protocol Violation|0|||
156403923|NCT01490125|564573469|FG000|Period II|Lost to Follow-up|0|||
156403924|NCT01490125|564573470|FG001|Period II|Lost to Follow-up|1|||
156403925|NCT01490125|564573471|FG002|Period II|Lost to Follow-up|0|||
156403926|NCT01490125|564573472|FG003|Period II|Lost to Follow-up|0|||
156403927|NCT01490125|564573473|FG004|Period II|Lost to Follow-up|0|||
156403928|NCT01490125|564573474|FG005|Period II|Lost to Follow-up|0|||
156403929|NCT01490125|564573469|FG000|Period II|Withdrawal by Subject|1|||
156403930|NCT01490125|564573470|FG001|Period II|Withdrawal by Subject|0|||
156403931|NCT01490125|564573471|FG002|Period II|Withdrawal by Subject|0|||
156403932|NCT01490125|564573472|FG003|Period II|Withdrawal by Subject|0|||
156403933|NCT01490125|564573473|FG004|Period II|Withdrawal by Subject|0|||
156403934|NCT01490125|564573474|FG005|Period II|Withdrawal by Subject|0|||
156403935|NCT01490125|564573469|FG000|Period III|Adverse Event|3|||
156403936|NCT01490125|564573470|FG001|Period III|Adverse Event|1|||
156403937|NCT01490125|564573471|FG002|Period III|Adverse Event|0|||
156403938|NCT01490125|564573472|FG003|Period III|Adverse Event|1|||
156403939|NCT01490125|564573473|FG004|Period III|Adverse Event|0|||
156403940|NCT01490125|564573474|FG005|Period III|Adverse Event|0|||
156403941|NCT01490125|564573469|FG000|Period III|Death|0|||
156403942|NCT01490125|564573470|FG001|Period III|Death|0|||
156403943|NCT01490125|564573471|FG002|Period III|Death|0|||
156403944|NCT01490125|564573472|FG003|Period III|Death|1|||
156403945|NCT01490125|564573473|FG004|Period III|Death|0|||
156403946|NCT01490125|564573474|FG005|Period III|Death|0|||
156403947|NCT01490125|564573469|FG000|Period III|Lack of Efficacy|0|||
156403948|NCT01490125|564573470|FG001|Period III|Lack of Efficacy|0|||
156403949|NCT01490125|564573471|FG002|Period III|Lack of Efficacy|0|||
156403950|NCT01490125|564573472|FG003|Period III|Lack of Efficacy|0|||
156403951|NCT01490125|564573473|FG004|Period III|Lack of Efficacy|1|||
156403952|NCT01490125|564573474|FG005|Period III|Lack of Efficacy|0|||
156403953|NCT05458024|564573476|FG000|Overall Study|Withdrawal by Subject|1|||
156403954|NCT05458024|564573477|FG001|Overall Study|Withdrawal by Subject|1|||
156403955|NCT05807919|564573478|FG000|Overall Study|Received antibiotics - excluded|0|||
156512236|NCT02672852|564968196|FG003|Part A2|Withdrawal by Subject|0|||
156512237|NCT02672852|564968197|FG004|Part A2|Withdrawal by Subject|0|||
156512238|NCT02672852|564968198|FG005|Part A2|Withdrawal by Subject|0|||
156512239|NCT02672852|564968199|FG006|Part A2|Withdrawal by Subject|0|||
156512240|NCT02672852|564968193|FG000|Part A2|Other|0|||
156512241|NCT02672852|564968194|FG001|Part A2|Other|0|||
156512242|NCT02672852|564968195|FG002|Part A2|Other|3|||
156512243|NCT02672852|564968196|FG003|Part A2|Other|0|||
156512244|NCT02672852|564968197|FG004|Part A2|Other|0|||
156512245|NCT02672852|564968198|FG005|Part A2|Other|0|||
156512246|NCT02672852|564968199|FG006|Part A2|Other|0|||
156512247|NCT02672852|564968193|FG000|Part A2|Not entered in Part B|0|||
156512248|NCT02672852|564968194|FG001|Part A2|Not entered in Part B|0|||
156512249|NCT02672852|564968195|FG002|Part A2|Not entered in Part B|0|||
156512250|NCT02672852|564968196|FG003|Part A2|Not entered in Part B|4|||
156512251|NCT02672852|564968197|FG004|Part A2|Not entered in Part B|0|||
156512252|NCT02672852|564968198|FG005|Part A2|Not entered in Part B|0|||
156512253|NCT02672852|564968199|FG006|Part A2|Not entered in Part B|0|||
156512254|NCT02672852|564968193|FG000|Part B|Disease worsening|0|||
156512255|NCT02672852|564968194|FG001|Part B|Disease worsening|0|||
156512256|NCT02672852|564968195|FG002|Part B|Disease worsening|0|||
156512257|NCT02672852|564968196|FG003|Part B|Disease worsening|0|||
156512258|NCT02672852|564968197|FG004|Part B|Disease worsening|1|||
156512259|NCT02672852|564968198|FG005|Part B|Disease worsening|0|||
156512260|NCT02672852|564968199|FG006|Part B|Disease worsening|1|||
156512261|NCT02672852|564968193|FG000|Part B|Worsening pre-existing condition|0|||
156512262|NCT02672852|564968194|FG001|Part B|Worsening pre-existing condition|0|||
156512263|NCT02672852|564968195|FG002|Part B|Worsening pre-existing condition|0|||
156512264|NCT02672852|564968196|FG003|Part B|Worsening pre-existing condition|0|||
156512265|NCT02672852|564968197|FG004|Part B|Worsening pre-existing condition|0|||
156512266|NCT02672852|564968198|FG005|Part B|Worsening pre-existing condition|1|||
156512267|NCT02672852|564968199|FG006|Part B|Worsening pre-existing condition|0|||
156512268|NCT02672852|564968193|FG000|Part B|Other adverse event|0|||
156512269|NCT02672852|564968194|FG001|Part B|Other adverse event|0|||
156512270|NCT02672852|564968195|FG002|Part B|Other adverse event|0|||
156512271|NCT02672852|564968196|FG003|Part B|Other adverse event|0|||
156512272|NCT02672852|564968197|FG004|Part B|Other adverse event|3|||
156512273|NCT02672852|564968198|FG005|Part B|Other adverse event|5|||
156512274|NCT02672852|564968199|FG006|Part B|Other adverse event|1|||
156512275|NCT02672852|564968193|FG000|Part B|Lost to Follow-up|0|||
156512276|NCT02672852|564968194|FG001|Part B|Lost to Follow-up|0|||
156512277|NCT02672852|564968195|FG002|Part B|Lost to Follow-up|0|||
156512278|NCT02672852|564968196|FG003|Part B|Lost to Follow-up|0|||
156512279|NCT02672852|564968197|FG004|Part B|Lost to Follow-up|3|||
156512280|NCT02672852|564968198|FG005|Part B|Lost to Follow-up|4|||
156512281|NCT02672852|564968199|FG006|Part B|Lost to Follow-up|1|||
156512282|NCT02672852|564968193|FG000|Part B|Withdrawal by Subject|0|||
156512283|NCT02672852|564968194|FG001|Part B|Withdrawal by Subject|0|||
156512284|NCT02672852|564968195|FG002|Part B|Withdrawal by Subject|0|||
156512285|NCT02672852|564968196|FG003|Part B|Withdrawal by Subject|0|||
156512286|NCT02672852|564968197|FG004|Part B|Withdrawal by Subject|5|||
156403956|NCT05807919|564573479|FG001|Overall Study|Received antibiotics - excluded|1|||
156403957|NCT05807919|564573478|FG000|Overall Study|Withdrawal by Subject|0|||
156403958|NCT05807919|564573479|FG001|Overall Study|Withdrawal by Subject|3|||
156403959|NCT05807919|564573478|FG000|Overall Study|Adverse Event|1|||
156403960|NCT05807919|564573479|FG001|Overall Study|Adverse Event|1|||
156403961|NCT03489057|564573483|FG000|Overall Study|Lost to Follow-up|16|||
156512287|NCT02672852|564968198|FG005|Part B|Withdrawal by Subject|0|||
156512288|NCT02672852|564968199|FG006|Part B|Withdrawal by Subject|7|||
156512289|NCT02672852|564968193|FG000|Part B|Other|0|||
156512290|NCT02672852|564968194|FG001|Part B|Other|0|||
156512291|NCT02672852|564968195|FG002|Part B|Other|0|||
156512292|NCT02672852|564968196|FG003|Part B|Other|0|||
156552974|NCT00487539|565116398|FG002|Overall Study|Other|2|||
156552975|NCT00487539|565116399|FG003|Overall Study|Other|2|||
156552976|NCT02751502|565116400|FG000|Overall Study|Lack of funding|4|||
156552977|NCT00852995|565116401|FG000|Overall Study|Adverse Event|1|||
156552978|NCT00852995|565116402|FG001|Overall Study|Adverse Event|0|||
156552979|NCT00852995|565116403|FG002|Overall Study|Adverse Event|4|||
156552980|NCT00852995|565116404|FG003|Overall Study|Adverse Event|0|||
156552981|NCT00852995|565116405|FG004|Overall Study|Adverse Event|0|||
156552982|NCT00852995|565116401|FG000|Overall Study|Lost to Follow-up|0|||
156552983|NCT00852995|565116402|FG001|Overall Study|Lost to Follow-up|1|||
156552984|NCT00852995|565116403|FG002|Overall Study|Lost to Follow-up|1|||
156552985|NCT00852995|565116404|FG003|Overall Study|Lost to Follow-up|0|||
156552986|NCT00852995|565116405|FG004|Overall Study|Lost to Follow-up|0|||
156552987|NCT00852995|565116401|FG000|Overall Study|Withdrawal by Subject|4|||
156552988|NCT00852995|565116402|FG001|Overall Study|Withdrawal by Subject|0|||
156552989|NCT00852995|565116403|FG002|Overall Study|Withdrawal by Subject|0|||
156552990|NCT00852995|565116404|FG003|Overall Study|Withdrawal by Subject|1|||
156552991|NCT00852995|565116405|FG004|Overall Study|Withdrawal by Subject|2|||
156552992|NCT00852995|565116401|FG000|Overall Study|Non-Compliance|0|||
156552993|NCT00852995|565116402|FG001|Overall Study|Non-Compliance|0|||
156552994|NCT00852995|565116403|FG002|Overall Study|Non-Compliance|0|||
156552995|NCT00852995|565116404|FG003|Overall Study|Non-Compliance|2|||
156552996|NCT00852995|565116405|FG004|Overall Study|Non-Compliance|0|||
156552997|NCT00852995|565116401|FG000|Overall Study|Progressive Disease|1|||
156552998|NCT00852995|565116402|FG001|Overall Study|Progressive Disease|0|||
156552999|NCT00852995|565116403|FG002|Overall Study|Progressive Disease|0|||
156553000|NCT00852995|565116404|FG003|Overall Study|Progressive Disease|2|||
156553001|NCT00852995|565116405|FG004|Overall Study|Progressive Disease|1|||
156553002|NCT00852995|565116401|FG000|Overall Study|Physician Decision|1|||
156553003|NCT00852995|565116402|FG001|Overall Study|Physician Decision|0|||
156553004|NCT00852995|565116403|FG002|Overall Study|Physician Decision|0|||
156553005|NCT00852995|565116404|FG003|Overall Study|Physician Decision|0|||
156553006|NCT00852995|565116405|FG004|Overall Study|Physician Decision|0|||
156553007|NCT00852995|565116401|FG000|Overall Study|Protocol Violation|0|||
156553008|NCT00852995|565116402|FG001|Overall Study|Protocol Violation|0|||
156553009|NCT00852995|565116403|FG002|Overall Study|Protocol Violation|0|||
156553010|NCT00852995|565116404|FG003|Overall Study|Protocol Violation|0|||
156553011|NCT00852995|565116405|FG004|Overall Study|Protocol Violation|1|||
156553012|NCT00852995|565116401|FG000|Overall Study|Moved Out of Area|1|||
156553013|NCT00852995|565116402|FG001|Overall Study|Moved Out of Area|0|||
156553014|NCT00852995|565116403|FG002|Overall Study|Moved Out of Area|0|||
156553015|NCT00852995|565116404|FG003|Overall Study|Moved Out of Area|0|||
156553016|NCT00852995|565116405|FG004|Overall Study|Moved Out of Area|0|||
156553017|NCT02678390|565116406|FG000|AE (1 Day)|Withdrawal by Subject|0|||
156553018|NCT02678390|565116407|FG001|AE (1 Day)|Withdrawal by Subject|1|||
156553019|NCT03499028|565116408|FG000|Overall Study|Lost to Follow-up|12|||
156553020|NCT03499028|565116409|FG001|Overall Study|Lost to Follow-up|9|||
156553021|NCT03499028|565116408|FG000|Overall Study|Withdrawal by Subject|5|||
156553022|NCT03499028|565116409|FG001|Overall Study|Withdrawal by Subject|8|||
156553023|NCT03499028|565116408|FG000|Overall Study|Unplanned SNF discharge|5|||
156553024|NCT03499028|565116409|FG001|Overall Study|Unplanned SNF discharge|8|||
156553025|NCT01110200|565116410|FG000|Overall Study|Adverse Event|28|||
156553026|NCT01110200|565116411|FG001|Overall Study|Adverse Event|28|||
156553027|NCT01110200|565116410|FG000|Overall Study|Withdrawal by Subject|25|||
156553028|NCT01110200|565116411|FG001|Overall Study|Withdrawal by Subject|32|||
156553029|NCT01110200|565116410|FG000|Overall Study|Lack of Efficacy|16|||
156553030|NCT01110200|565116411|FG001|Overall Study|Lack of Efficacy|25|||
156553031|NCT01110200|565116410|FG000|Overall Study|Protocol Violation|14|||
156553032|NCT01110200|565116411|FG001|Overall Study|Protocol Violation|12|||
156553033|NCT01110200|565116410|FG000|Overall Study|Physician Decision|13|||
156553034|NCT01110200|565116411|FG001|Overall Study|Physician Decision|17|||
156553035|NCT01110200|565116410|FG000|Overall Study|Lost to Follow-up|10|||
156553036|NCT01110200|565116411|FG001|Overall Study|Lost to Follow-up|7|||
156553037|NCT01437397|565116412|FG000|Overall Study|Lost to Follow-up|9|||
156553038|NCT01437397|565116413|FG001|Overall Study|Lost to Follow-up|4|||
156553039|NCT01437397|565116414|FG002|Overall Study|Lost to Follow-up|2|||
156553040|NCT01437397|565116415|FG003|Overall Study|Lost to Follow-up|4|||
156553041|NCT01437397|565116416|FG004|Overall Study|Lost to Follow-up|5|||
156553042|NCT01437397|565116412|FG000|Overall Study|Withdrawal by Subject|11|||
156553043|NCT01437397|565116413|FG001|Overall Study|Withdrawal by Subject|12|||
156553044|NCT01437397|565116414|FG002|Overall Study|Withdrawal by Subject|24|||
156553045|NCT01437397|565116415|FG003|Overall Study|Withdrawal by Subject|11|||
156553046|NCT01437397|565116416|FG004|Overall Study|Withdrawal by Subject|22|||
156553047|NCT01437397|565116412|FG000|Overall Study|Protocol Violation|10|||
156553048|NCT01437397|565116413|FG001|Overall Study|Protocol Violation|12|||
156553049|NCT01437397|565116414|FG002|Overall Study|Protocol Violation|13|||
156553050|NCT01437397|565116415|FG003|Overall Study|Protocol Violation|21|||
156553051|NCT01437397|565116416|FG004|Overall Study|Protocol Violation|19|||
156553052|NCT01437397|565116412|FG000|Overall Study|Lack of Efficacy|5|||
156553053|NCT01437397|565116413|FG001|Overall Study|Lack of Efficacy|4|||
156553054|NCT01437397|565116414|FG002|Overall Study|Lack of Efficacy|8|||
156553055|NCT01437397|565116415|FG003|Overall Study|Lack of Efficacy|10|||
156553056|NCT01437397|565116416|FG004|Overall Study|Lack of Efficacy|20|||
156553057|NCT01437397|565116412|FG000|Overall Study|Adverse Event|21|||
156553058|NCT01437397|565116413|FG001|Overall Study|Adverse Event|22|||
156553059|NCT01437397|565116414|FG002|Overall Study|Adverse Event|16|||
156553060|NCT01437397|565116415|FG003|Overall Study|Adverse Event|14|||
156553061|NCT01437397|565116416|FG004|Overall Study|Adverse Event|21|||
156553062|NCT01437397|565116412|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
156553063|NCT01437397|565116413|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
156553064|NCT01437397|565116414|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
156553065|NCT01437397|565116415|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
156553066|NCT01437397|565116416|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
156553067|NCT00866307|565116418|FG000|Induction|Adverse Event|5|||
156553068|NCT00866307|565116419|FG001|Induction|Adverse Event|0|||
156553069|NCT00866307|565116420|FG002|Induction|Adverse Event|0|||
156553070|NCT00866307|565116418|FG000|Induction|Death|2|||
156553071|NCT00866307|565116419|FG001|Induction|Death|0|||
156553072|NCT00866307|565116420|FG002|Induction|Death|0|||
156553073|NCT00866307|565116418|FG000|Induction|Physician Decision|5|||
156553074|NCT00866307|565116419|FG001|Induction|Physician Decision|0|||
156553075|NCT00866307|565116420|FG002|Induction|Physician Decision|0|||
156553076|NCT00866307|565116418|FG000|Induction|Progressive Disease|1|||
156553077|NCT00866307|565116419|FG001|Induction|Progressive Disease|0|||
156553078|NCT00866307|565116420|FG002|Induction|Progressive Disease|0|||
156553079|NCT00866307|565116418|FG000|Induction|Identification of Patients with Day 29 M|3|||
156553080|NCT00866307|565116419|FG001|Induction|Identification of Patients with Day 29 M|0|||
156553081|NCT00866307|565116420|FG002|Induction|Identification of Patients with Day 29 M|0|||
156553082|NCT00866307|565116418|FG000|Induction|Inadequate cytognetic samples th|1|||
156553083|NCT00866307|565116419|FG001|Induction|Inadequate cytognetic samples th|0|||
156553084|NCT00866307|565116420|FG002|Induction|Inadequate cytognetic samples th|0|||
156553085|NCT00866307|565116418|FG000|Induction|Improper post-induction consent|2|||
156553086|NCT00866307|565116419|FG001|Induction|Improper post-induction consent|0|||
156553087|NCT00866307|565116420|FG002|Induction|Improper post-induction consent|0|||
156553088|NCT00866307|565116418|FG000|Induction|Study was closed at the time|1|||
156553089|NCT00866307|565116419|FG001|Induction|Study was closed at the time|0|||
156553090|NCT00866307|565116420|FG002|Induction|Study was closed at the time|0|||
156553091|NCT00866307|565116418|FG000|Consolidation/Maintenance|Adverse Event|0|||
156553092|NCT00866307|565116419|FG001|Consolidation/Maintenance|Adverse Event|0|||
156553093|NCT00866307|565116420|FG002|Consolidation/Maintenance|Adverse Event|8|||
156553094|NCT00866307|565116418|FG000|Consolidation/Maintenance|Death|0|||
156553095|NCT00866307|565116419|FG001|Consolidation/Maintenance|Death|0|||
156553096|NCT00866307|565116420|FG002|Consolidation/Maintenance|Death|1|||
156553097|NCT00866307|565116418|FG000|Consolidation/Maintenance|Physician Decision|0|||
156553098|NCT00866307|565116419|FG001|Consolidation/Maintenance|Physician Decision|3|||
156553099|NCT00866307|565116420|FG002|Consolidation/Maintenance|Physician Decision|2|||
156553100|NCT00866307|565116418|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
156553101|NCT00866307|565116419|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
156553102|NCT00866307|565116420|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
156553103|NCT00866307|565116418|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
156553104|NCT00866307|565116419|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
156553105|NCT00866307|565116420|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
156553106|NCT00866307|565116418|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
156553107|NCT00866307|565116419|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
156553108|NCT00866307|565116420|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
156553109|NCT00866307|565116418|FG000|Consolidation/Maintenance|Therapy error|0|||
156553110|NCT00866307|565116419|FG001|Consolidation/Maintenance|Therapy error|1|||
156553111|NCT00866307|565116420|FG002|Consolidation/Maintenance|Therapy error|0|||
156553112|NCT00866307|565116418|FG000|Consolidation/Maintenance|Non-compliance|0|||
156553113|NCT00866307|565116419|FG001|Consolidation/Maintenance|Non-compliance|0|||
156553114|NCT00866307|565116420|FG002|Consolidation/Maintenance|Non-compliance|1|||
156553115|NCT00866307|565116418|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
156553116|NCT00866307|565116419|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
156553117|NCT00866307|565116420|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
156553118|NCT02573155|565116421|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
156553119|NCT02573155|565116422|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
156553120|NCT02573155|565116421|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
156553121|NCT02573155|565116422|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
156553122|NCT02573155|565116421|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
156553123|NCT02573155|565116422|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
156553124|NCT02573155|565116421|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
156553125|NCT02573155|565116422|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
156403962|NCT03489057|564573484|FG001|Overall Study|Lost to Follow-up|16|||
156403963|NCT03489057|564573485|FG002|Overall Study|Lost to Follow-up|14|||
156403964|NCT03489057|564573486|FG003|Overall Study|Lost to Follow-up|14|||
156403965|NCT03489057|564573483|FG000|Overall Study|Withdrawal by Subject|12|||
156403966|NCT03489057|564573484|FG001|Overall Study|Withdrawal by Subject|12|||
156403967|NCT03489057|564573485|FG002|Overall Study|Withdrawal by Subject|8|||
156403968|NCT03489057|564573486|FG003|Overall Study|Withdrawal by Subject|8|||
156403969|NCT03489057|564573483|FG000|Overall Study|Protocol Violation|7|||
156403970|NCT03489057|564573484|FG001|Overall Study|Protocol Violation|7|||
156403971|NCT03489057|564573485|FG002|Overall Study|Protocol Violation|2|||
156403972|NCT03489057|564573486|FG003|Overall Study|Protocol Violation|2|||
156403973|NCT02034708|564573487|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
156403974|NCT02034708|564573488|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
156403975|NCT02034708|564573487|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
156403976|NCT02034708|564573488|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
156403977|NCT02034708|564573487|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
156403978|NCT02034708|564573488|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
156403979|NCT02034708|564573487|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
156403980|NCT02034708|564573488|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
156403981|NCT00733980|564573489|FG000|Overall Study|Adverse Event|5|||
156403982|NCT00733980|564573490|FG001|Overall Study|Adverse Event|2|||
156403983|NCT00733980|564573489|FG000|Overall Study|Lack of Efficacy|0|||
156403984|NCT00733980|564573490|FG001|Overall Study|Lack of Efficacy|1|||
156403985|NCT00733980|564573489|FG000|Overall Study|Protocol Violation|2|||
156403986|NCT00733980|564573490|FG001|Overall Study|Protocol Violation|1|||
156403987|NCT00733980|564573489|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
156403988|NCT00733980|564573490|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
156403989|NCT00733980|564573489|FG000|Overall Study|Lost to Follow-up|6|||
156403990|NCT00733980|564573490|FG001|Overall Study|Lost to Follow-up|11|||
156403991|NCT00733980|564573489|FG000|Overall Study|Physician Decision|2|||
156403992|NCT00733980|564573490|FG001|Overall Study|Physician Decision|3|||
156403993|NCT00733980|564573489|FG000|Overall Study|Withdrawal by Subject|6|||
156403994|NCT00733980|564573490|FG001|Overall Study|Withdrawal by Subject|2|||
156403995|NCT01931735|564573491|FG000|Randomized Phase|Lost to Follow-up|2|||
156403996|NCT01931735|564573492|FG001|Randomized Phase|Lost to Follow-up|2|||
156403997|NCT01931735|564573493|FG002|Randomized Phase|Lost to Follow-up|5|||
156403998|NCT01931735|564573494|FG003|Randomized Phase|Lost to Follow-up|0|||
156403999|NCT01931735|564573491|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
156404000|NCT01931735|564573492|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
156404001|NCT01931735|564573493|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
156404002|NCT01931735|564573494|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
156404003|NCT01931735|564573491|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
156404004|NCT01931735|564573492|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
156404005|NCT01931735|564573493|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
156404006|NCT01931735|564573494|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
156404007|NCT02719990|564573495|FG000|Overall Study|Physician Decision|2|||
156404008|NCT02719990|564573495|FG000|Overall Study|Withdrawal by Subject|2|||
156404009|NCT02719990|564573495|FG000|Overall Study|Study Terminated By Sponsor|32|||
156404010|NCT03324880|564573496|FG000|Overall Study|Adverse Event|0|||
156404011|NCT03324880|564573497|FG001|Overall Study|Adverse Event|2|||
156404012|NCT03324880|564573496|FG000|Overall Study|Withdrawal by Subject|2|||
156404013|NCT03324880|564573497|FG001|Overall Study|Withdrawal by Subject|2|||
156404014|NCT03324880|564573496|FG000|Overall Study|Lost to Follow-up|0|||
156404015|NCT03324880|564573497|FG001|Overall Study|Lost to Follow-up|1|||
156404016|NCT03324880|564573496|FG000|Overall Study|Product Recall|0|||
156404017|NCT03324880|564573497|FG001|Overall Study|Product Recall|1|||
156404018|NCT00717314|564573498|FG000|Overall Study|Adverse Event|3|||
156404019|NCT00717314|564573499|FG001|Overall Study|Adverse Event|2|||
156404020|NCT00717314|564573498|FG000|Overall Study|Protocol Violation|1|||
156404021|NCT00717314|564573499|FG001|Overall Study|Protocol Violation|0|||
156404022|NCT00717314|564573498|FG000|Overall Study|Lost to Follow-up|1|||
156404023|NCT00717314|564573499|FG001|Overall Study|Lost to Follow-up|5|||
156404024|NCT00717314|564573498|FG000|Overall Study|Withdrawal by Subject|1|||
156404025|NCT00717314|564573499|FG001|Overall Study|Withdrawal by Subject|3|||
156404026|NCT05076149|564573500|FG000|Overall Study|Adverse Event|3|||
156404027|NCT05076149|564573501|FG001|Overall Study|Adverse Event|9|||
156404028|NCT05076149|564573500|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156404029|NCT05076149|564573501|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
156404030|NCT05076149|564573500|FG000|Overall Study|Lost to Follow-up|0|||
156404031|NCT05076149|564573501|FG001|Overall Study|Lost to Follow-up|1|||
156404032|NCT05076149|564573500|FG000|Overall Study|Commercial drug is available for participant|0|||
156404033|NCT05076149|564573501|FG001|Overall Study|Commercial drug is available for participant|1|||
156404034|NCT05076149|564573500|FG000|Overall Study|Other non compliance|1|||
156404035|NCT05076149|564573501|FG001|Overall Study|Other non compliance|1|||
156404036|NCT05076149|564573500|FG000|Overall Study|Physician Decision|0|||
156404037|NCT05076149|564573501|FG001|Overall Study|Physician Decision|1|||
156404038|NCT05076149|564573500|FG000|Overall Study|Other|5|||
156512293|NCT02672852|564968197|FG004|Part B|Other|4|||
156404039|NCT05076149|564573501|FG001|Overall Study|Other|4|||
156404040|NCT05096208|564573502|FG000|Overall Study|Lost to Follow-up|3|||
156404041|NCT05096208|564573503|FG001|Overall Study|Lost to Follow-up|5|||
156404042|NCT05096208|564573504|FG002|Overall Study|Lost to Follow-up|5|||
156404043|NCT05096208|564573505|FG003|Overall Study|Lost to Follow-up|2|||
156404044|NCT05096208|564573502|FG000|Overall Study|Withdrawal by Subject|0|||
156404045|NCT05096208|564573503|FG001|Overall Study|Withdrawal by Subject|1|||
156404046|NCT05096208|564573504|FG002|Overall Study|Withdrawal by Subject|2|||
156404047|NCT05096208|564573505|FG003|Overall Study|Withdrawal by Subject|3|||
156404048|NCT05096208|564573502|FG000|Overall Study|No longer met eligibility criteria|1|||
156404049|NCT05096208|564573503|FG001|Overall Study|No longer met eligibility criteria|0|||
156404050|NCT05096208|564573504|FG002|Overall Study|No longer met eligibility criteria|0|||
156404051|NCT05096208|564573505|FG003|Overall Study|No longer met eligibility criteria|0|||
156404052|NCT05096208|564573502|FG000|Overall Study|Other|0|||
156404053|NCT05096208|564573503|FG001|Overall Study|Other|0|||
156404054|NCT05096208|564573504|FG002|Overall Study|Other|1|||
156404055|NCT05096208|564573505|FG003|Overall Study|Other|0|||
156404056|NCT02087501|564573506|FG000|Overall Study|Death|7|||
156404057|NCT02087501|564573506|FG000|Overall Study|Open repair of aneurysm|1|||
156404058|NCT02087501|564573506|FG000|Overall Study|Lost to Follow-up|2|||
156404059|NCT00094328|564573507|FG000|Overall Study|Lost to Follow-up|1|||
156404060|NCT02213328|564573508|FG000|Overall Study|Withdrawal by Subject|10|||
156404061|NCT02213328|564573508|FG000|Overall Study|Physician Decision|2|||
156404062|NCT02213328|564573508|FG000|Overall Study|Lost to Follow-up|16|||
156404063|NCT00990340|564573509|FG000|First 14-day Treatment|Not Compliant|2|||
156404064|NCT00990340|564573510|FG001|First 14-day Treatment|Not Compliant|1|||
156404065|NCT00990340|564573509|FG000|First 14-day Treatment|Lost to Follow-up|2|||
156404066|NCT00990340|564573510|FG001|First 14-day Treatment|Lost to Follow-up|1|||
156404067|NCT00990340|564573509|FG000|First 14-day Treatment|Protocol Violation|2|||
156404068|NCT00990340|564573510|FG001|First 14-day Treatment|Protocol Violation|2|||
156404069|NCT04615182|564573511|FG000|Overall Study|Re-transplanted|2|||
156404070|NCT04615182|564573511|FG000|Overall Study|Protocol Violation|6|||
156404071|NCT04615182|564573511|FG000|Overall Study|Death|6|||
156404072|NCT04615182|564573511|FG000|Overall Study|Death and protocol violation|1|||
156404073|NCT01126060|564573512|FG000|Overall Study|Protocol Violation|0|||
156404074|NCT01126060|564573513|FG001|Overall Study|Protocol Violation|2|||
156404075|NCT00402337|564573514|FG000|Overall Study|Adverse Event|0|||
156404076|NCT00402337|564573515|FG001|Overall Study|Adverse Event|2|||
156404077|NCT00402337|564573516|FG002|Overall Study|Adverse Event|2|||
156404078|NCT00402337|564573517|FG003|Overall Study|Adverse Event|3|||
156404079|NCT00402337|564573518|FG004|Overall Study|Adverse Event|2|||
156404080|NCT00402337|564573514|FG000|Overall Study|Noncompliance|0|||
156404081|NCT00402337|564573515|FG001|Overall Study|Noncompliance|0|||
156404082|NCT00402337|564573516|FG002|Overall Study|Noncompliance|0|||
156404083|NCT00402337|564573517|FG003|Overall Study|Noncompliance|0|||
156404084|NCT00402337|564573518|FG004|Overall Study|Noncompliance|2|||
156404085|NCT00402337|564573514|FG000|Overall Study|Withdrawal by Subject|5|||
156404086|NCT00402337|564573515|FG001|Overall Study|Withdrawal by Subject|3|||
156404087|NCT00402337|564573516|FG002|Overall Study|Withdrawal by Subject|1|||
156404088|NCT00402337|564573517|FG003|Overall Study|Withdrawal by Subject|6|||
156404089|NCT00402337|564573518|FG004|Overall Study|Withdrawal by Subject|4|||
156404090|NCT00402337|564573514|FG000|Overall Study|Lost to Follow-up|0|||
156404091|NCT00402337|564573515|FG001|Overall Study|Lost to Follow-up|0|||
156404092|NCT00402337|564573516|FG002|Overall Study|Lost to Follow-up|1|||
156404093|NCT00402337|564573517|FG003|Overall Study|Lost to Follow-up|2|||
156404094|NCT00402337|564573518|FG004|Overall Study|Lost to Follow-up|0|||
156404095|NCT00402337|564573514|FG000|Overall Study|Physician Decision|0|||
156404096|NCT00402337|564573515|FG001|Overall Study|Physician Decision|0|||
156404097|NCT00402337|564573516|FG002|Overall Study|Physician Decision|0|||
156404098|NCT00402337|564573517|FG003|Overall Study|Physician Decision|1|||
156404099|NCT00402337|564573518|FG004|Overall Study|Physician Decision|0|||
156404100|NCT00402337|564573514|FG000|Overall Study|Other Reason|0|||
156404101|NCT00402337|564573515|FG001|Overall Study|Other Reason|1|||
156404102|NCT00402337|564573516|FG002|Overall Study|Other Reason|0|||
156404103|NCT00402337|564573517|FG003|Overall Study|Other Reason|0|||
156404104|NCT00402337|564573518|FG004|Overall Study|Other Reason|0|||
156404105|NCT03565068|564573519|FG000|Overall Study|Protocol Violation|0|||
156404106|NCT03565068|564573520|FG001|Overall Study|Protocol Violation|0|||
156404107|NCT03565068|564573521|FG002|Overall Study|Protocol Violation|0|||
156512294|NCT02672852|564968198|FG005|Part B|Other|1|||
156404108|NCT03565068|564573522|FG003|Overall Study|Protocol Violation|0|||
156404109|NCT03565068|564573523|FG004|Overall Study|Protocol Violation|1|||
156404110|NCT03565068|564573524|FG005|Overall Study|Protocol Violation|0|||
156404111|NCT03565068|564573525|FG006|Overall Study|Protocol Violation|0|||
156404112|NCT03565068|564573526|FG007|Overall Study|Protocol Violation|1|||
156404113|NCT03565068|564573527|FG008|Overall Study|Protocol Violation|0|||
156404114|NCT03565068|564573519|FG000|Overall Study|Sponsor decision|0|||
156553126|NCT02573155|565116421|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
156404115|NCT03565068|564573520|FG001|Overall Study|Sponsor decision|0|||
156404116|NCT03565068|564573521|FG002|Overall Study|Sponsor decision|0|||
156404117|NCT03565068|564573522|FG003|Overall Study|Sponsor decision|0|||
156553127|NCT02573155|565116422|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
156553128|NCT02573155|565116421|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
156553129|NCT02573155|565116422|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
156553130|NCT02573155|565116421|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
156553131|NCT02573155|565116422|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
156553132|NCT02573155|565116421|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
156553133|NCT02573155|565116422|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
156553134|NCT02508194|565116426|FG000|Overall Study|Death|5|||
156553135|NCT02508194|565116427|FG001|Overall Study|Death|3|||
156553136|NCT02508194|565116426|FG000|Overall Study|Lost to Follow-up|25|||
156553137|NCT02508194|565116427|FG001|Overall Study|Lost to Follow-up|18|||
156553138|NCT02508194|565116426|FG000|Overall Study|Withdrawal by Subject|20|||
156553139|NCT02508194|565116427|FG001|Overall Study|Withdrawal by Subject|18|||
156553140|NCT02508194|565116426|FG000|Overall Study|Error in Randomization|1|||
156553141|NCT02508194|565116427|FG001|Overall Study|Error in Randomization|3|||
156553142|NCT02508194|565116426|FG000|Overall Study|Principal Investigator Decision|1|||
156553143|NCT02508194|565116427|FG001|Overall Study|Principal Investigator Decision|2|||
156553144|NCT00511355|565116428|FG000|Overall Study|Adverse Event|4|||
156553145|NCT00511355|565116429|FG001|Overall Study|Adverse Event|4|||
156553146|NCT00511355|565116428|FG000|Overall Study|Pregnancy Wish|1|||
156553147|NCT00511355|565116429|FG001|Overall Study|Pregnancy Wish|0|||
156553148|NCT00511355|565116428|FG000|Overall Study|Lost to Follow-up|2|||
156553149|NCT00511355|565116429|FG001|Overall Study|Lost to Follow-up|1|||
156553150|NCT00511355|565116428|FG000|Overall Study|Other Reason|0|||
156553151|NCT00511355|565116429|FG001|Overall Study|Other Reason|1|||
156553152|NCT00511355|565116428|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
156553153|NCT00511355|565116429|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
156553154|NCT00511355|565116428|FG000|Overall Study|Withdrawal of informed consent|0|||
156553155|NCT00511355|565116429|FG001|Overall Study|Withdrawal of informed consent|1|||
156553156|NCT00511355|565116428|FG000|Overall Study|Other reason pre-treatment|0|||
156553157|NCT00511355|565116429|FG001|Overall Study|Other reason pre-treatment|1|||
156553158|NCT00454805|565116431|FG000|Overall Study|Withdrawal by Subject|9|||
156553159|NCT00454805|565116432|FG001|Overall Study|Withdrawal by Subject|2|||
156553160|NCT00454805|565116431|FG000|Overall Study|Death|0|||
156553161|NCT00454805|565116432|FG001|Overall Study|Death|2|||
156553162|NCT00454805|565116431|FG000|Overall Study|Disease progression|16|||
156553163|NCT00454805|565116432|FG001|Overall Study|Disease progression|19|||
156553164|NCT00454805|565116431|FG000|Overall Study|In order to begin radiotherapy|1|||
156553165|NCT00454805|565116432|FG001|Overall Study|In order to begin radiotherapy|0|||
156553166|NCT00217087|565116433|FG000|Overall Study|decided to have esophagectomy|1|||
156553167|NCT00217087|565116434|FG001|Overall Study|decided to have esophagectomy|2|||
156553168|NCT00217087|565116433|FG000|Overall Study|completed less than 12 months return|10|||
156553169|NCT00217087|565116434|FG001|Overall Study|completed less than 12 months return|18|||
156553170|NCT04947800|565116441|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
156553171|NCT04947800|565116442|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
156553172|NCT04947800|565116443|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
156553173|NCT03892746|565116444|FG000|Overall Study|Withdrawal by Subject|2|||
156553174|NCT03892746|565116445|FG001|Overall Study|Withdrawal by Subject|1|||
156553175|NCT03892746|565116444|FG000|Overall Study|Lost to Follow-up|2|||
156404118|NCT03565068|564573523|FG004|Overall Study|Sponsor decision|1|||
156404119|NCT03565068|564573524|FG005|Overall Study|Sponsor decision|1|||
156404120|NCT03565068|564573525|FG006|Overall Study|Sponsor decision|0|||
156404121|NCT03565068|564573526|FG007|Overall Study|Sponsor decision|0|||
156404122|NCT03565068|564573527|FG008|Overall Study|Sponsor decision|0|||
156404123|NCT03565068|564573519|FG000|Overall Study|Withdrawal by Subject|0|||
156404124|NCT03565068|564573520|FG001|Overall Study|Withdrawal by Subject|0|||
156404125|NCT03565068|564573521|FG002|Overall Study|Withdrawal by Subject|1|||
156404126|NCT03565068|564573522|FG003|Overall Study|Withdrawal by Subject|0|||
156553176|NCT03892746|565116445|FG001|Overall Study|Lost to Follow-up|0|||
156553177|NCT02158091|565116446|FG000|Overall Study|DLT|2|||
156553178|NCT02158091|565116447|FG001|Overall Study|DLT|1|||
156553179|NCT02158091|565116448|FG002|Overall Study|DLT|0|||
156553180|NCT03977467|565116449|FG000|Overall Study|Disease Progression|1|||
156404127|NCT03565068|564573523|FG004|Overall Study|Withdrawal by Subject|2|||
156404128|NCT03565068|564573524|FG005|Overall Study|Withdrawal by Subject|0|||
156404129|NCT03565068|564573525|FG006|Overall Study|Withdrawal by Subject|1|||
156553181|NCT03977467|565116450|FG001|Overall Study|Disease Progression|1|||
156404130|NCT03565068|564573526|FG007|Overall Study|Withdrawal by Subject|5|||
156553182|NCT03977467|565116451|FG002|Overall Study|Disease Progression|30|||
156553183|NCT03977467|565116452|FG003|Overall Study|Disease Progression|0|||
156553184|NCT03977467|565116449|FG000|Overall Study|Adverse Event|0|||
156553185|NCT03977467|565116450|FG001|Overall Study|Adverse Event|1|||
156553186|NCT03977467|565116451|FG002|Overall Study|Adverse Event|0|||
156553187|NCT03977467|565116452|FG003|Overall Study|Adverse Event|0|||
156553188|NCT03977467|565116449|FG000|Overall Study|Death|0|||
156553189|NCT03977467|565116450|FG001|Overall Study|Death|0|||
156553190|NCT03977467|565116451|FG002|Overall Study|Death|3|||
156553191|NCT03977467|565116452|FG003|Overall Study|Death|0|||
156553192|NCT03977467|565116449|FG000|Overall Study|Lack of Efficacy|0|||
156553193|NCT03977467|565116450|FG001|Overall Study|Lack of Efficacy|0|||
156553194|NCT03977467|565116451|FG002|Overall Study|Lack of Efficacy|1|||
156553195|NCT03977467|565116452|FG003|Overall Study|Lack of Efficacy|0|||
156553196|NCT03977467|565116449|FG000|Overall Study|Withdrawal by Subject|2|||
156553197|NCT03977467|565116450|FG001|Overall Study|Withdrawal by Subject|1|||
156553198|NCT03977467|565116451|FG002|Overall Study|Withdrawal by Subject|4|||
156553199|NCT03977467|565116452|FG003|Overall Study|Withdrawal by Subject|0|||
156553200|NCT03977467|565116449|FG000|Overall Study|Study Terminated|1|||
156553201|NCT03977467|565116450|FG001|Overall Study|Study Terminated|0|||
156553202|NCT03977467|565116451|FG002|Overall Study|Study Terminated|0|||
156553203|NCT03977467|565116452|FG003|Overall Study|Study Terminated|1|||
156553204|NCT01318109|565116453|FG000|Overall Study|Adverse Event|0|||
156553205|NCT01318109|565116454|FG001|Overall Study|Adverse Event|2|||
156553206|NCT01318109|565116455|FG002|Overall Study|Adverse Event|0|||
156553207|NCT01318109|565116453|FG000|Overall Study|Withdrawal by Subject|1|||
156553208|NCT01318109|565116454|FG001|Overall Study|Withdrawal by Subject|0|||
156553209|NCT01318109|565116455|FG002|Overall Study|Withdrawal by Subject|0|||
156553210|NCT01318109|565116453|FG000|Overall Study|Schedule Conflict|0|||
156553211|NCT01318109|565116454|FG001|Overall Study|Schedule Conflict|1|||
156553212|NCT01318109|565116455|FG002|Overall Study|Schedule Conflict|0|||
156553213|NCT01328951|565116456|FG000|Overall Study|Disease Progression|17|||
156553214|NCT01328951|565116457|FG001|Overall Study|Disease Progression|14|||
156553215|NCT01328951|565116456|FG000|Overall Study|Adverse Event|2|||
156553216|NCT01328951|565116457|FG001|Overall Study|Adverse Event|0|||
156553217|NCT01328951|565116456|FG000|Overall Study|Death|243|||
156553218|NCT01328951|565116457|FG001|Overall Study|Death|258|||
156553219|NCT01328951|565116456|FG000|Overall Study|Lost to Follow-up|6|||
156553220|NCT01328951|565116457|FG001|Overall Study|Lost to Follow-up|7|||
156404131|NCT03565068|564573527|FG008|Overall Study|Withdrawal by Subject|1|||
156553221|NCT01328951|565116456|FG000|Overall Study|Withdrawal by Subject|6|||
156553222|NCT01328951|565116457|FG001|Overall Study|Withdrawal by Subject|6|||
156553223|NCT01328951|565116456|FG000|Overall Study|Study Closed by the Sponsor|36|||
156553224|NCT01328951|565116457|FG001|Overall Study|Study Closed by the Sponsor|31|||
156553225|NCT01328951|565116456|FG000|Overall Study|Other|11|||
156553226|NCT01328951|565116457|FG001|Overall Study|Other|6|||
156553227|NCT02289950|565116459|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
156553228|NCT02289950|565116460|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
156553229|NCT02289950|565116459|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
156553230|NCT02289950|565116460|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
156553231|NCT02289950|565116459|FG000|Overall Study|Lost to Follow-up|1|||
156553232|NCT02289950|565116460|FG001|Overall Study|Lost to Follow-up|0|||
156404132|NCT03565068|564573519|FG000|Overall Study|Physician Decision|0|||
156404133|NCT03565068|564573520|FG001|Overall Study|Physician Decision|0|||
156404134|NCT03565068|564573521|FG002|Overall Study|Physician Decision|0|||
156404135|NCT03565068|564573522|FG003|Overall Study|Physician Decision|0|||
156404136|NCT03565068|564573523|FG004|Overall Study|Physician Decision|0|||
156404137|NCT03565068|564573524|FG005|Overall Study|Physician Decision|0|||
156404138|NCT03565068|564573525|FG006|Overall Study|Physician Decision|0|||
156404139|NCT03565068|564573526|FG007|Overall Study|Physician Decision|1|||
156404140|NCT03565068|564573527|FG008|Overall Study|Physician Decision|0|||
156404141|NCT03565068|564573519|FG000|Overall Study|Lost to Follow-up|0|||
156404142|NCT03565068|564573520|FG001|Overall Study|Lost to Follow-up|0|||
156404143|NCT03565068|564573521|FG002|Overall Study|Lost to Follow-up|0|||
156404144|NCT03565068|564573522|FG003|Overall Study|Lost to Follow-up|0|||
156404145|NCT03565068|564573523|FG004|Overall Study|Lost to Follow-up|0|||
156404146|NCT03565068|564573524|FG005|Overall Study|Lost to Follow-up|0|||
156404147|NCT03565068|564573525|FG006|Overall Study|Lost to Follow-up|0|||
156404148|NCT03565068|564573526|FG007|Overall Study|Lost to Follow-up|1|||
156404149|NCT03565068|564573527|FG008|Overall Study|Lost to Follow-up|0|||
156404150|NCT00311155|564575437|FG000|Overall Study|Adverse Event|21|||
156553233|NCT02289950|565116459|FG000|Overall Study|Physician Decision|9|||
156553234|NCT02289950|565116460|FG001|Overall Study|Physician Decision|3|||
156553235|NCT02289950|565116459|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
156553236|NCT02289950|565116460|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
156553237|NCT02289950|565116459|FG000|Overall Study|Withdrawal by Subject|1|||
156553238|NCT02289950|565116460|FG001|Overall Study|Withdrawal by Subject|3|||
156553239|NCT02289950|565116459|FG000|Overall Study|Test article held for greater than 28 days|0|||
156553240|NCT02289950|565116460|FG001|Overall Study|Test article held for greater than 28 days|1|||
156553241|NCT02289950|565116459|FG000|Overall Study|Adverse Event|11|||
156553242|NCT02289950|565116460|FG001|Overall Study|Adverse Event|3|||
156553243|NCT02289950|565116459|FG000|Overall Study|Death|1|||
156553244|NCT02289950|565116460|FG001|Overall Study|Death|1|||
156553245|NCT02289950|565116459|FG000|Overall Study|Other|5|||
156553246|NCT02289950|565116460|FG001|Overall Study|Other|2|||
156553247|NCT02289950|565116459|FG000|Overall Study|Not Treated|2|||
156553248|NCT02289950|565116460|FG001|Overall Study|Not Treated|1|||
156553249|NCT04518462|565116461|FG000|Overall Study|Withdrawal by Subject|0|||
156553250|NCT04518462|565116462|FG001|Overall Study|Withdrawal by Subject|0|||
156553251|NCT04518462|565116463|FG002|Overall Study|Withdrawal by Subject|1|||
156553252|NCT04518462|565116461|FG000|Overall Study|Physician Decision|1|||
156553253|NCT04518462|565116462|FG001|Overall Study|Physician Decision|1|||
156553254|NCT04518462|565116463|FG002|Overall Study|Physician Decision|0|||
156553255|NCT01003210|565116464|FG000|Overall Study|Lost to Follow-up|1|||
156553256|NCT01003210|565116465|FG001|Overall Study|Lost to Follow-up|3|||
156553257|NCT00861744|565116468|FG000|Overall Study|Adverse Event|0|||
156553258|NCT00861744|565116469|FG001|Overall Study|Adverse Event|0|||
156553259|NCT00861744|565116470|FG002|Overall Study|Adverse Event|0|||
156553260|NCT00861744|565116471|FG003|Overall Study|Adverse Event|1|||
156404151|NCT00311155|564575437|FG000|Overall Study|Withdrawal by Subject|17|||
156404152|NCT00311155|564575437|FG000|Overall Study|Did not meet entry criteria|55|||
156404153|NCT01590771|564575443|FG000|Overall Study|Other Protocol Specified Criteria|5|||
156404154|NCT01590771|564575444|FG001|Overall Study|Other Protocol Specified Criteria|14|||
156404155|NCT01590771|564575443|FG000|Overall Study|Withdrawal by Subject|8|||
156404156|NCT01590771|564575444|FG001|Overall Study|Withdrawal by Subject|15|||
156404157|NCT01590771|564575443|FG000|Overall Study|Protocol Violation|1|||
156404158|NCT01590771|564575444|FG001|Overall Study|Protocol Violation|2|||
156404159|NCT01590771|564575443|FG000|Overall Study|Lost to Follow-up|1|||
156404160|NCT01590771|564575444|FG001|Overall Study|Lost to Follow-up|1|||
156404161|NCT01590771|564575443|FG000|Overall Study|Lack of Efficacy|1|||
156404162|NCT01590771|564575444|FG001|Overall Study|Lack of Efficacy|0|||
156553261|NCT00861744|565116468|FG000|Overall Study|Lost to Follow-up|7|||
156404163|NCT01590771|564575443|FG000|Overall Study|Adverse Event|3|||
156404164|NCT01590771|564575444|FG001|Overall Study|Adverse Event|7|||
156404165|NCT01785628|564575448|FG000|Overall Study|Lost to Follow-up|2|||
156404166|NCT01785628|564575449|FG001|Overall Study|Lost to Follow-up|3|||
156404167|NCT00767104|564575452|FG000|Overall Study|Lost to Follow-up|1|||
156404168|NCT00767104|564575453|FG001|Overall Study|Lost to Follow-up|2|||
156404169|NCT00840996|564575454|FG000|Overall Study|Withdrawal by Subject|1|||
156404170|NCT00840996|564575455|FG001|Overall Study|Withdrawal by Subject|0|||
156404171|NCT04022889|564575456|FG000|Stage 1: Period 1|Adverse Event|1|||
156404172|NCT04022889|564575457|FG001|Stage 1: Period 1|Adverse Event|0|||
156404173|NCT04022889|564575458|FG002|Stage 1: Period 1|Adverse Event|0|||
156404174|NCT04022889|564575456|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
156404175|NCT04022889|564575457|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
156404176|NCT04022889|564575458|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
156404177|NCT04022889|564575456|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
156404178|NCT04022889|564575457|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
156404179|NCT04022889|564575458|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
156404180|NCT04022889|564575456|FG000|Stage 2|Screen Failure|0|||
156404181|NCT04022889|564575457|FG001|Stage 2|Screen Failure|0|||
156404182|NCT04022889|564575458|FG002|Stage 2|Screen Failure|3|||
156404183|NCT04022889|564575456|FG000|Stage 2|Ineligible for apheresis donation|0|||
156404184|NCT04022889|564575457|FG001|Stage 2|Ineligible for apheresis donation|0|||
156404185|NCT04022889|564575458|FG002|Stage 2|Ineligible for apheresis donation|2|||
156404186|NCT04022889|564575456|FG000|Stage 2|Adverse Event|0|||
156404187|NCT04022889|564575457|FG001|Stage 2|Adverse Event|0|||
156404188|NCT04022889|564575458|FG002|Stage 2|Adverse Event|2|||
156404189|NCT04022889|564575456|FG000|Stage 2|Protocol Violation|0|||
156404190|NCT04022889|564575457|FG001|Stage 2|Protocol Violation|0|||
156404191|NCT04022889|564575458|FG002|Stage 2|Protocol Violation|1|||
156404192|NCT04022889|564575456|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
156404193|NCT04022889|564575457|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
156404194|NCT04022889|564575458|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
156404195|NCT01900054|564575462|FG000|Overall Study|Physician Decision|1|||
156404196|NCT01900054|564575462|FG000|Overall Study|Withdrawal by Subject|1|||
156404197|NCT03285295|564575467|FG000|Alinity s HBsAg|Protocol Violation|11|||
156404198|NCT03285295|564575468|FG001|Alinity s HBsAg|Protocol Violation|0|||
156404199|NCT03285295|564575469|FG002|Alinity s HBsAg|Protocol Violation|0|||
156404200|NCT03285295|564575470|FG003|Alinity s HBsAg|Protocol Violation|0|||
156404201|NCT03285295|564575471|FG004|Alinity s HBsAg|Protocol Violation|0|||
156404202|NCT03285295|564575467|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
156404203|NCT03285295|564575468|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
156404204|NCT03285295|564575469|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
156404205|NCT03285295|564575470|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
156553262|NCT00861744|565116469|FG001|Overall Study|Lost to Follow-up|19|||
156553263|NCT00861744|565116470|FG002|Overall Study|Lost to Follow-up|17|||
156404206|NCT03285295|564575471|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
156404207|NCT03285295|564575467|FG000|Alinity s HBsAg|No Results Generated|74|||
156404208|NCT03285295|564575468|FG001|Alinity s HBsAg|No Results Generated|6|||
156404209|NCT03285295|564575469|FG002|Alinity s HBsAg|No Results Generated|0|||
156404210|NCT03285295|564575470|FG003|Alinity s HBsAg|No Results Generated|0|||
156404211|NCT03285295|564575471|FG004|Alinity s HBsAg|No Results Generated|0|||
156404212|NCT03285295|564575467|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
156404213|NCT03285295|564575468|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
156512295|NCT02672852|564968199|FG006|Part B|Other|2|||
156512296|NCT02182947|564968200|FG000|Overall Study|Withdrawal by Subject|7|||
156512297|NCT02182947|564968200|FG000|Overall Study|Lost to Follow-up|3|||
156512298|NCT02182947|564968200|FG000|Overall Study|Failed screening activities|8|||
156512299|NCT03248882|564968201|FG000|Overall Study|Adverse Event|3|||
156512300|NCT03248882|564968202|FG001|Overall Study|Adverse Event|3|||
156512301|NCT03248882|564968203|FG002|Overall Study|Adverse Event|2|||
156512302|NCT03248882|564968204|FG003|Overall Study|Adverse Event|6|||
156512303|NCT03248882|564968205|FG004|Overall Study|Adverse Event|9|||
156512304|NCT03248882|564968201|FG000|Overall Study|Lost to Follow-up|0|||
156512305|NCT03248882|564968202|FG001|Overall Study|Lost to Follow-up|0|||
156512306|NCT03248882|564968203|FG002|Overall Study|Lost to Follow-up|0|||
156512307|NCT03248882|564968204|FG003|Overall Study|Lost to Follow-up|0|||
156512308|NCT03248882|564968205|FG004|Overall Study|Lost to Follow-up|1|||
156512309|NCT03248882|564968201|FG000|Overall Study|Protocol Violation|2|||
156512310|NCT03248882|564968202|FG001|Overall Study|Protocol Violation|0|||
156512311|NCT03248882|564968203|FG002|Overall Study|Protocol Violation|2|||
156512312|NCT03248882|564968204|FG003|Overall Study|Protocol Violation|0|||
156512313|NCT03248882|564968205|FG004|Overall Study|Protocol Violation|1|||
156512314|NCT03248882|564968201|FG000|Overall Study|Withdrawal by Subject|2|||
156512315|NCT03248882|564968202|FG001|Overall Study|Withdrawal by Subject|2|||
156512316|NCT03248882|564968203|FG002|Overall Study|Withdrawal by Subject|3|||
156512317|NCT03248882|564968204|FG003|Overall Study|Withdrawal by Subject|4|||
156512318|NCT03248882|564968205|FG004|Overall Study|Withdrawal by Subject|2|||
156512319|NCT04308590|564968206|FG000|Overall Study|Adverse Event|12|||
156512320|NCT04308590|564968207|FG001|Overall Study|Adverse Event|2|||
156512321|NCT04308590|564968206|FG000|Overall Study|Withdrawal by Subject|10|||
156512322|NCT04308590|564968207|FG001|Overall Study|Withdrawal by Subject|4|||
156512323|NCT04308590|564968206|FG000|Overall Study|Death|1|||
156512324|NCT04308590|564968207|FG001|Overall Study|Death|0|||
156512325|NCT04308590|564968206|FG000|Overall Study|Lost to Follow-up|1|||
156512326|NCT04308590|564968207|FG001|Overall Study|Lost to Follow-up|1|||
156512327|NCT04308590|564968206|FG000|Overall Study|Physician Decision|1|||
156512328|NCT04308590|564968207|FG001|Overall Study|Physician Decision|0|||
156512329|NCT04308590|564968206|FG000|Overall Study|Subject does not want to continue with Pi|0|||
156512330|NCT04308590|564968207|FG001|Overall Study|Subject does not want to continue with Pi|1|||
156512331|NCT01156376|564968209|FG000|Overall Study|Adverse Event|1|||
156512332|NCT01156376|564968210|FG001|Overall Study|Adverse Event|0|||
156512333|NCT01156376|564968211|FG002|Overall Study|Adverse Event|1|||
156512334|NCT01156376|564968209|FG000|Overall Study|Withdrawal by Subject|0|||
156512335|NCT01156376|564968210|FG001|Overall Study|Withdrawal by Subject|0|||
156512336|NCT01156376|564968211|FG002|Overall Study|Withdrawal by Subject|3|||
156512337|NCT01493427|564968212|FG000|Overall Study|Adverse Event|10|||
156512338|NCT01493427|564968212|FG000|Overall Study|Personal Reasons|4|||
156512339|NCT01493427|564968212|FG000|Overall Study|Lost to Follow-up|2|||
156512340|NCT01493427|564968212|FG000|Overall Study|Inability to Follow Instructions|2|||
156512341|NCT01493427|564968212|FG000|Overall Study|Other|2|||
156512342|NCT02075073|564968213|FG000|Overall Study|Withdrawal by Subject|0|||
156512343|NCT02075073|564968214|FG001|Overall Study|Withdrawal by Subject|1|||
156512344|NCT02075073|564968215|FG002|Overall Study|Withdrawal by Subject|0|||
156512345|NCT02683785|564968231|FG000|Overall Study|Withdrawal by Subject|1|||
156512346|NCT02683785|564968232|FG001|Overall Study|Withdrawal by Subject|1|||
156512347|NCT02683785|564968231|FG000|Overall Study|Lost to Follow-up|0|||
156512348|NCT02683785|564968232|FG001|Overall Study|Lost to Follow-up|1|||
156553264|NCT00861744|565116471|FG003|Overall Study|Lost to Follow-up|12|||
156512349|NCT02683785|564968231|FG000|Overall Study|Adverse Event|0|||
156512350|NCT02683785|564968232|FG001|Overall Study|Adverse Event|2|||
156512351|NCT01305408|564968233|FG000|Overall Study|Adverse Event|10|||
156512352|NCT01305408|564968234|FG001|Overall Study|Adverse Event|7|||
156512353|NCT01305408|564968233|FG000|Overall Study|Lack of Efficacy|3|||
156553265|NCT00861744|565116468|FG000|Overall Study|Withdrawal by Subject|10|||
156512354|NCT01305408|564968234|FG001|Overall Study|Lack of Efficacy|4|||
156512355|NCT01305408|564968233|FG000|Overall Study|Withdrawal by Subject|9|||
156512356|NCT01305408|564968234|FG001|Overall Study|Withdrawal by Subject|9|||
156512357|NCT01305408|564968233|FG000|Overall Study|Protocol Violation|4|||
156512358|NCT01305408|564968234|FG001|Overall Study|Protocol Violation|6|||
156512359|NCT01305408|564968233|FG000|Overall Study|Lost to Follow-up|5|||
156512360|NCT01305408|564968234|FG001|Overall Study|Lost to Follow-up|3|||
156512361|NCT01305408|564968233|FG000|Overall Study|Noncompliance with study medication|0|||
156553266|NCT00861744|565116469|FG001|Overall Study|Withdrawal by Subject|6|||
156553267|NCT00861744|565116470|FG002|Overall Study|Withdrawal by Subject|6|||
156553268|NCT00861744|565116471|FG003|Overall Study|Withdrawal by Subject|19|||
156553269|NCT00861744|565116468|FG000|Overall Study|Protocol Violation|0|||
156404214|NCT03285295|564575469|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
156404215|NCT03285295|564575470|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
156404216|NCT03285295|564575471|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
156404217|NCT03285295|564575467|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
156404218|NCT03285295|564575468|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
156404219|NCT03285295|564575469|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
156404220|NCT03285295|564575470|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
156404221|NCT03285295|564575471|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
156404222|NCT03285295|564575467|FG000|Alinity s HTLV I/II|No Results Generated|70|||
156404223|NCT03285295|564575468|FG001|Alinity s HTLV I/II|No Results Generated|0|||
156553270|NCT00861744|565116469|FG001|Overall Study|Protocol Violation|1|||
156553271|NCT00861744|565116470|FG002|Overall Study|Protocol Violation|0|||
156553272|NCT00861744|565116471|FG003|Overall Study|Protocol Violation|0|||
156553273|NCT00861744|565116468|FG000|Overall Study|Migration from study area|0|||
156553274|NCT00861744|565116469|FG001|Overall Study|Migration from study area|3|||
156553275|NCT00861744|565116470|FG002|Overall Study|Migration from study area|1|||
156553276|NCT00861744|565116471|FG003|Overall Study|Migration from study area|0|||
156553277|NCT00861744|565116468|FG000|Overall Study|Blood draws|0|||
156553278|NCT00861744|565116469|FG001|Overall Study|Blood draws|0|||
156553279|NCT00861744|565116470|FG002|Overall Study|Blood draws|0|||
156553280|NCT00861744|565116471|FG003|Overall Study|Blood draws|1|||
156553281|NCT03359759|565116472|FG000|Overall Study|Death|3|||
156553282|NCT03359759|565116472|FG000|Overall Study|Lost to Follow-up|2|||
156553283|NCT01411085|565116473|FG000|Overall Study|Physician Decision|1|||
156553284|NCT01411085|565116473|FG000|Overall Study|Protocol Violation|1|||
156553285|NCT01411085|565116473|FG000|Overall Study|Adverse Event|1|||
156553286|NCT05568888|565116474|FG000|Overall Study|Physician Decision|1|||
156553287|NCT05568888|565116475|FG001|Overall Study|Physician Decision|0|||
156553288|NCT05568888|565116474|FG000|Overall Study|Protocol Deviation|2|||
156553289|NCT05568888|565116475|FG001|Overall Study|Protocol Deviation|1|||
156553290|NCT05568888|565116474|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
156553291|NCT05568888|565116475|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
156553292|NCT05568888|565116474|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
156553293|NCT05568888|565116475|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
156553294|NCT05568888|565116474|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
156553295|NCT05568888|565116475|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
156553296|NCT05036083|565116483|FG000|Overall Study|Physician Decision|1|||
156553297|NCT05036083|565116483|FG000|Overall Study|Withdrawal by Subject|1|||
156553298|NCT05036083|565116483|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
156553299|NCT05036083|565116483|FG000|Overall Study|IV not sustainable|1|||
156553300|NCT04745689|565116484|FG000|Overall Study|Death|9|||
156553301|NCT04745689|565116485|FG001|Overall Study|Death|6|||
156553302|NCT04745689|565116484|FG000|Overall Study|Lost to Follow-up|1|||
156553303|NCT04745689|565116485|FG001|Overall Study|Lost to Follow-up|0|||
156553304|NCT04745689|565116484|FG000|Overall Study|Withdrawal by Subject|2|||
156553305|NCT04745689|565116485|FG001|Overall Study|Withdrawal by Subject|0|||
156553306|NCT04745689|565116484|FG000|Overall Study|Study terminated by sponsor|10|||
156553307|NCT04745689|565116485|FG001|Overall Study|Study terminated by sponsor|3|||
156553308|NCT02028455|565116488|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
156553309|NCT02028455|565116489|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
156553310|NCT02028455|565116490|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
156553311|NCT02028455|565116491|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
156553312|NCT02028455|565116492|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
156553313|NCT02028455|565116493|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
156553314|NCT02028455|565116494|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
156553315|NCT02028455|565116495|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
156553316|NCT02028455|565116488|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
156553317|NCT02028455|565116489|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
156553318|NCT02028455|565116490|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
156553319|NCT02028455|565116491|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
156404224|NCT03285295|564575469|FG002|Alinity s HTLV I/II|No Results Generated|0|||
156553320|NCT02028455|565116492|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
156553321|NCT02028455|565116493|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
156553322|NCT02028455|565116494|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
156553323|NCT02028455|565116495|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
156553324|NCT02028455|565116488|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
156404225|NCT03285295|564575470|FG003|Alinity s HTLV I/II|No Results Generated|0|||
156553325|NCT02028455|565116489|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
156404226|NCT03285295|564575471|FG004|Alinity s HTLV I/II|No Results Generated|0|||
156404227|NCT03285295|564575467|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
156404228|NCT03285295|564575468|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
156404229|NCT03285295|564575469|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
156404230|NCT03285295|564575470|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
156404231|NCT03285295|564575471|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
156404232|NCT03285295|564575467|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
156404233|NCT03285295|564575468|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
156404234|NCT03285295|564575469|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
156404235|NCT03285295|564575470|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
156404236|NCT03285295|564575471|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
156404237|NCT03285295|564575467|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
156404238|NCT03285295|564575468|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
156404239|NCT03285295|564575469|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
156404240|NCT03285295|564575470|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
156404241|NCT03285295|564575471|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
156404242|NCT03285295|564575467|FG000|Alinity s Anti-HCV|No Results Generated|71|||
156404243|NCT03285295|564575468|FG001|Alinity s Anti-HCV|No Results Generated|0|||
156404244|NCT03285295|564575469|FG002|Alinity s Anti-HCV|No Results Generated|0|||
156404245|NCT03285295|564575470|FG003|Alinity s Anti-HCV|No Results Generated|0|||
156404246|NCT03285295|564575471|FG004|Alinity s Anti-HCV|No Results Generated|0|||
156404247|NCT03285295|564575467|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
156404248|NCT03285295|564575468|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
156404249|NCT03285295|564575469|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
156512362|NCT01305408|564968234|FG001|Overall Study|Noncompliance with study medication|1|||
156512363|NCT01305408|564968233|FG000|Overall Study|Noncompliance with study procedures|0|||
156512364|NCT01305408|564968234|FG001|Overall Study|Noncompliance with study procedures|1|||
156512365|NCT01305408|564968233|FG000|Overall Study|Other|1|||
156512366|NCT01305408|564968234|FG001|Overall Study|Other|0|||
156512367|NCT02233803|564968238|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
156512368|NCT02233803|564968239|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
156512369|NCT02233803|564968238|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
156512370|NCT02233803|564968239|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
156512371|NCT02233803|564968238|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
156512372|NCT02233803|564968239|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
156512373|NCT02233803|564968238|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
156512374|NCT02233803|564968239|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
156512375|NCT02233803|564968238|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
156512376|NCT02233803|564968239|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
156512377|NCT02233803|564968238|FG000|Washout Period (4-Wks)|Physician Decision|1|||
156512378|NCT02233803|564968239|FG001|Washout Period (4-Wks)|Physician Decision|0|||
156512379|NCT02233803|564968238|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
156512380|NCT02233803|564968239|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
156512381|NCT02233803|564968238|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
156512382|NCT02233803|564968239|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
156512383|NCT02233803|564968238|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
156512384|NCT02233803|564968239|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
156512385|NCT03846453|564968240|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
156512386|NCT03846453|564968241|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
156512387|NCT03846453|564968242|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
156512388|NCT03846453|564968240|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
156512389|NCT03846453|564968241|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
156512390|NCT03846453|564968242|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
156512391|NCT03846453|564968240|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
156512392|NCT03846453|564968241|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
156512393|NCT03846453|564968242|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
156512394|NCT03846453|564968240|FG000|Placebo Run-in (14 Days)|Other|2|||
156512395|NCT03846453|564968241|FG001|Placebo Run-in (14 Days)|Other|0|||
156512396|NCT03846453|564968242|FG002|Placebo Run-in (14 Days)|Other|0|||
156512397|NCT03846453|564968240|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
156512398|NCT03846453|564968241|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
156512399|NCT03846453|564968242|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
156512400|NCT03846453|564968240|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
156512401|NCT03846453|564968241|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
156512402|NCT03846453|564968242|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
156512403|NCT03846453|564968240|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
156512404|NCT03846453|564968241|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
156512405|NCT03846453|564968242|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
156512406|NCT03846453|564968240|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
156512407|NCT03846453|564968241|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
156404250|NCT03285295|564575470|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
156404251|NCT03285295|564575471|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
156404252|NCT03285295|564575467|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
156404253|NCT03285295|564575468|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
156404254|NCT03285295|564575469|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
156512408|NCT03846453|564968242|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
156404255|NCT03285295|564575470|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
156404256|NCT03285295|564575471|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
156404257|NCT03285295|564575467|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
156404258|NCT03285295|564575468|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
156404259|NCT03285295|564575469|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
156404260|NCT03285295|564575470|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
156404261|NCT03285295|564575471|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
156404262|NCT03285295|564575467|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
156404263|NCT03285295|564575468|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
156404264|NCT03285295|564575469|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
156404265|NCT03285295|564575470|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
156404266|NCT03285295|564575471|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
156404267|NCT03285295|564575467|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
156404268|NCT03285295|564575468|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
156404269|NCT03285295|564575469|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
156404270|NCT03285295|564575470|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
156404271|NCT03285295|564575471|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
156404272|NCT03285295|564575467|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
156404273|NCT03285295|564575468|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
156404274|NCT03285295|564575469|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
156404275|NCT03285295|564575470|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
156404276|NCT03285295|564575471|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
156404277|NCT03285295|564575467|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
156404278|NCT03285295|564575468|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
156404279|NCT03285295|564575469|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
156404280|NCT03285295|564575470|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
156404281|NCT03285295|564575471|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
156404282|NCT03285295|564575467|FG000|Alinity s Anti-HBc|No Results Generated|70|||
156404283|NCT03285295|564575468|FG001|Alinity s Anti-HBc|No Results Generated|0|||
156404284|NCT03285295|564575469|FG002|Alinity s Anti-HBc|No Results Generated|0|||
156404285|NCT03285295|564575470|FG003|Alinity s Anti-HBc|No Results Generated|0|||
156404286|NCT03285295|564575471|FG004|Alinity s Anti-HBc|No Results Generated|0|||
156404287|NCT03285295|564575467|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
156404288|NCT03285295|564575468|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
156404289|NCT03285295|564575469|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
156404290|NCT03285295|564575470|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
156404291|NCT03285295|564575471|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
156404292|NCT03285295|564575467|FG000|Alinity s Chagas|Protocol Violation|76|||
156404293|NCT03285295|564575468|FG001|Alinity s Chagas|Protocol Violation|0|||
156404294|NCT03285295|564575469|FG002|Alinity s Chagas|Protocol Violation|0|||
156404295|NCT03285295|564575470|FG003|Alinity s Chagas|Protocol Violation|0|||
156404296|NCT03285295|564575471|FG004|Alinity s Chagas|Protocol Violation|0|||
156404297|NCT03285295|564575467|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
156404298|NCT03285295|564575468|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
156404299|NCT03285295|564575469|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
156404300|NCT03285295|564575470|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
156404301|NCT03285295|564575471|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
156404302|NCT03285295|564575467|FG000|Alinity s Chagas|No Results Generated|105|||
156404303|NCT03285295|564575468|FG001|Alinity s Chagas|No Results Generated|0|||
156404304|NCT03285295|564575469|FG002|Alinity s Chagas|No Results Generated|0|||
156404305|NCT03285295|564575470|FG003|Alinity s Chagas|No Results Generated|0|||
156404306|NCT03285295|564575471|FG004|Alinity s Chagas|No Results Generated|0|||
156404307|NCT03285295|564575467|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
156404308|NCT03285295|564575468|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
156404309|NCT03285295|564575469|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
156404310|NCT03285295|564575470|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
156404311|NCT03285295|564575471|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
156404312|NCT03015116|564575472|FG000|Overall Study|Lost to Follow-up|3|||
156404313|NCT03015116|564575473|FG001|Overall Study|Lost to Follow-up|0|||
156404314|NCT03015116|564575474|FG002|Overall Study|Lost to Follow-up|2|||
156404315|NCT03015116|564575472|FG000|Overall Study|Withdrawal by Subject|3|||
156404316|NCT03015116|564575473|FG001|Overall Study|Withdrawal by Subject|1|||
156404317|NCT03015116|564575474|FG002|Overall Study|Withdrawal by Subject|0|||
156404318|NCT03015116|564575472|FG000|Overall Study|Subject has New Medical Status|1|||
156404319|NCT03015116|564575473|FG001|Overall Study|Subject has New Medical Status|0|||
156553326|NCT02028455|565116490|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
156553327|NCT02028455|565116491|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
156553328|NCT02028455|565116492|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
156553329|NCT02028455|565116493|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
156553330|NCT02028455|565116494|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
156553331|NCT02028455|565116495|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
156553332|NCT02028455|565116488|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
156553333|NCT02028455|565116489|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
156553334|NCT02028455|565116490|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
156553335|NCT02028455|565116491|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
156553336|NCT02028455|565116492|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
156553337|NCT02028455|565116493|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
156553338|NCT02028455|565116494|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
156553339|NCT02028455|565116495|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
156553340|NCT07099521|565116496|FG000|Overall Study|Incompeleted stimulus program|1|||
156553341|NCT07099521|565116497|FG001|Overall Study|Incompeleted stimulus program|0|||
156553342|NCT07099521|565116496|FG000|Overall Study|Non-social anxiety symtpoms|0|||
156553343|NCT07099521|565116497|FG001|Overall Study|Non-social anxiety symtpoms|1|||
156553344|NCT07099521|565116496|FG000|Overall Study|Extreme values|2|||
156553345|NCT07099521|565116497|FG001|Overall Study|Extreme values|4|||
156553346|NCT02396589|565116498|FG000|Intervention|Lost to Follow-up|1|||
156553347|NCT02396589|565116499|FG001|Intervention|Lost to Follow-up|0|||
156553348|NCT02396589|565116498|FG000|6 Month Follow-up|change in health status|0|||
156553349|NCT02396589|565116499|FG001|6 Month Follow-up|change in health status|1|||
156553350|NCT02396589|565116498|FG000|9 Month Follow-up|Death|0|||
156553351|NCT02396589|565116499|FG001|9 Month Follow-up|Death|1|||
156553352|NCT02396589|565116498|FG000|12 Month Follow up|Lost to Follow-up|0|||
156553353|NCT02396589|565116499|FG001|12 Month Follow up|Lost to Follow-up|2|||
156553354|NCT04381650|565116500|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553355|NCT04381650|565116501|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553356|NCT04381650|565116502|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553357|NCT04381650|565116503|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
156553358|NCT04381650|565116504|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553359|NCT04381650|565116505|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553360|NCT04381650|565116506|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553361|NCT04381650|565116507|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553362|NCT04381650|565116508|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553363|NCT04381650|565116509|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553364|NCT04381650|565116510|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
156553365|NCT04381650|565116500|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156553366|NCT04381650|565116501|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156553367|NCT04381650|565116502|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156553368|NCT04381650|565116503|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
156404320|NCT03015116|564575474|FG002|Overall Study|Subject has New Medical Status|0|||
156404321|NCT03015116|564575472|FG000|Overall Study|Physician Decision|0|||
156404322|NCT03015116|564575473|FG001|Overall Study|Physician Decision|1|||
156404323|NCT03015116|564575474|FG002|Overall Study|Physician Decision|0|||
156404324|NCT02200939|564575478|FG000|Overall Study|Participant withdrew consent|0|||
156404325|NCT02200939|564575479|FG001|Overall Study|Participant withdrew consent|1|||
156404326|NCT02200939|564575478|FG000|Overall Study|Lost to Follow-up|2|||
156404327|NCT02200939|564575479|FG001|Overall Study|Lost to Follow-up|9|||
156404328|NCT02200939|564575478|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
156404329|NCT02200939|564575479|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
156404330|NCT04567693|564575480|FG000|Overall Study|Death|0|||
156404331|NCT04567693|564575481|FG001|Overall Study|Death|0|||
156404332|NCT04567693|564575482|FG002|Overall Study|Death|2|||
156404333|NCT04567693|564575480|FG000|Overall Study|Lost to Follow-up|1|||
156404334|NCT04567693|564575481|FG001|Overall Study|Lost to Follow-up|0|||
156404335|NCT04567693|564575482|FG002|Overall Study|Lost to Follow-up|2|||
156404336|NCT04567693|564575480|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
156404337|NCT04567693|564575481|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
156404338|NCT04567693|564575482|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
156553369|NCT04381650|565116504|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156404339|NCT02762981|564575483|FG000|Overall Study|Adverse Event|2|||
156553370|NCT04381650|565116505|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156553371|NCT04381650|565116506|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156553372|NCT04381650|565116507|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156404340|NCT02762981|564575484|FG001|Overall Study|Adverse Event|3|||
156404341|NCT02762981|564575485|FG002|Overall Study|Adverse Event|1|||
156404342|NCT02762981|564575486|FG003|Overall Study|Adverse Event|1|||
156512409|NCT03846453|564968240|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
156512410|NCT03846453|564968241|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
156512411|NCT03846453|564968242|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
156512412|NCT02628028|564968245|FG000|Dosing Period|Withdrawal by Subject|0|||
156512413|NCT02628028|564968246|FG001|Dosing Period|Withdrawal by Subject|0|||
156512414|NCT02628028|564968247|FG002|Dosing Period|Withdrawal by Subject|1|||
156512415|NCT02628028|564968248|FG003|Dosing Period|Withdrawal by Subject|0|||
156512416|NCT02628028|564968249|FG004|Dosing Period|Withdrawal by Subject|2|||
156512417|NCT02628028|564968250|FG005|Dosing Period|Withdrawal by Subject|4|||
156512418|NCT02628028|564968251|FG006|Dosing Period|Withdrawal by Subject|1|||
156512419|NCT02628028|564968252|FG007|Dosing Period|Withdrawal by Subject|1|||
156512420|NCT02628028|564968245|FG000|Dosing Period|Adverse Event|0|||
156512421|NCT02628028|564968246|FG001|Dosing Period|Adverse Event|0|||
156512422|NCT02628028|564968247|FG002|Dosing Period|Adverse Event|0|||
156512423|NCT02628028|564968248|FG003|Dosing Period|Adverse Event|0|||
156512424|NCT02628028|564968249|FG004|Dosing Period|Adverse Event|2|||
156512425|NCT02628028|564968250|FG005|Dosing Period|Adverse Event|1|||
156512426|NCT02628028|564968251|FG006|Dosing Period|Adverse Event|3|||
156512427|NCT02628028|564968252|FG007|Dosing Period|Adverse Event|2|||
156512428|NCT02628028|564968245|FG000|Dosing Period|Death|0|||
156512429|NCT02628028|564968246|FG001|Dosing Period|Death|0|||
156512430|NCT02628028|564968247|FG002|Dosing Period|Death|0|||
156512431|NCT02628028|564968248|FG003|Dosing Period|Death|0|||
156512432|NCT02628028|564968249|FG004|Dosing Period|Death|0|||
156512433|NCT02628028|564968250|FG005|Dosing Period|Death|0|||
156512434|NCT02628028|564968251|FG006|Dosing Period|Death|0|||
156512435|NCT02628028|564968252|FG007|Dosing Period|Death|1|||
156512436|NCT02628028|564968245|FG000|Dosing Period|Lack of Efficacy|0|||
156404343|NCT02762981|564575487|FG004|Overall Study|Adverse Event|3|||
156404344|NCT02762981|564575483|FG000|Overall Study|Physician Decision|0|||
156404345|NCT02762981|564575484|FG001|Overall Study|Physician Decision|1|||
156404346|NCT02762981|564575485|FG002|Overall Study|Physician Decision|0|||
156404347|NCT02762981|564575486|FG003|Overall Study|Physician Decision|0|||
156404348|NCT02762981|564575487|FG004|Overall Study|Physician Decision|1|||
156404349|NCT02762981|564575483|FG000|Overall Study|Disease progression|11|||
156404350|NCT02762981|564575484|FG001|Overall Study|Disease progression|23|||
156404351|NCT02762981|564575485|FG002|Overall Study|Disease progression|4|||
156404352|NCT02762981|564575486|FG003|Overall Study|Disease progression|10|||
156404353|NCT02762981|564575487|FG004|Overall Study|Disease progression|1|||
156404354|NCT02762981|564575483|FG000|Overall Study|Enrolled not treated|1|||
156404355|NCT02762981|564575484|FG001|Overall Study|Enrolled not treated|5|||
156404356|NCT02762981|564575485|FG002|Overall Study|Enrolled not treated|0|||
156404357|NCT02762981|564575486|FG003|Overall Study|Enrolled not treated|2|||
156404358|NCT02762981|564575487|FG004|Overall Study|Enrolled not treated|0|||
156404359|NCT02762981|564575483|FG000|Overall Study|Other|2|||
156404360|NCT02762981|564575484|FG001|Overall Study|Other|3|||
156404361|NCT02762981|564575485|FG002|Overall Study|Other|1|||
156404362|NCT02762981|564575486|FG003|Overall Study|Other|0|||
156404363|NCT02762981|564575487|FG004|Overall Study|Other|0|||
156404364|NCT02762981|564575483|FG000|Overall Study|Missing|1|||
156404365|NCT02762981|564575484|FG001|Overall Study|Missing|0|||
156404366|NCT02762981|564575485|FG002|Overall Study|Missing|0|||
156404367|NCT02762981|564575486|FG003|Overall Study|Missing|0|||
156404368|NCT02762981|564575487|FG004|Overall Study|Missing|0|||
156404369|NCT02762981|564575483|FG000|Overall Study|Withdrawal by Subject|0|||
156404370|NCT02762981|564575484|FG001|Overall Study|Withdrawal by Subject|5|||
156404371|NCT02762981|564575485|FG002|Overall Study|Withdrawal by Subject|1|||
156404372|NCT02762981|564575486|FG003|Overall Study|Withdrawal by Subject|3|||
156404373|NCT02762981|564575487|FG004|Overall Study|Withdrawal by Subject|0|||
156404374|NCT00957931|564575488|FG000|Overall Study|Death|4|||
156404375|NCT04867785|564575489|FG000|Overall Study|Adverse Event|1|||
156404376|NCT04867785|564575490|FG001|Overall Study|Adverse Event|0|||
156404377|NCT04867785|564575491|FG002|Overall Study|Adverse Event|1|||
156404378|NCT04867785|564575492|FG003|Overall Study|Adverse Event|0|||
156404379|NCT04867785|564575493|FG004|Overall Study|Adverse Event|0|||
156404380|NCT04867785|564575494|FG005|Overall Study|Adverse Event|0|||
156404381|NCT04867785|564575495|FG006|Overall Study|Adverse Event|0|||
156404382|NCT04867785|564575496|FG007|Overall Study|Adverse Event|2|||
156404383|NCT04867785|564575489|FG000|Overall Study|Lost to Follow-up|4|||
156404384|NCT04867785|564575490|FG001|Overall Study|Lost to Follow-up|4|||
156404385|NCT04867785|564575491|FG002|Overall Study|Lost to Follow-up|3|||
156404386|NCT04867785|564575492|FG003|Overall Study|Lost to Follow-up|2|||
156404387|NCT04867785|564575493|FG004|Overall Study|Lost to Follow-up|0|||
156404388|NCT04867785|564575494|FG005|Overall Study|Lost to Follow-up|1|||
156404389|NCT04867785|564575495|FG006|Overall Study|Lost to Follow-up|0|||
156404390|NCT04867785|564575496|FG007|Overall Study|Lost to Follow-up|1|||
156404391|NCT04867785|564575489|FG000|Overall Study|Withdrawal by Subject|6|||
156512437|NCT02628028|564968246|FG001|Dosing Period|Lack of Efficacy|0|||
156512438|NCT02628028|564968247|FG002|Dosing Period|Lack of Efficacy|0|||
156404392|NCT04867785|564575490|FG001|Overall Study|Withdrawal by Subject|2|||
156404393|NCT04867785|564575491|FG002|Overall Study|Withdrawal by Subject|2|||
156404394|NCT04867785|564575492|FG003|Overall Study|Withdrawal by Subject|1|||
156404395|NCT04867785|564575493|FG004|Overall Study|Withdrawal by Subject|2|||
156404396|NCT04867785|564575494|FG005|Overall Study|Withdrawal by Subject|0|||
156404397|NCT04867785|564575495|FG006|Overall Study|Withdrawal by Subject|2|||
156404398|NCT04867785|564575496|FG007|Overall Study|Withdrawal by Subject|5|||
156404399|NCT04867785|564575489|FG000|Overall Study|Physician Decision|0|||
156404400|NCT04867785|564575490|FG001|Overall Study|Physician Decision|0|||
156404401|NCT04867785|564575491|FG002|Overall Study|Physician Decision|0|||
156404402|NCT04867785|564575492|FG003|Overall Study|Physician Decision|0|||
156404403|NCT04867785|564575493|FG004|Overall Study|Physician Decision|0|||
156404404|NCT04867785|564575494|FG005|Overall Study|Physician Decision|0|||
156404405|NCT04867785|564575495|FG006|Overall Study|Physician Decision|0|||
156404406|NCT04867785|564575496|FG007|Overall Study|Physician Decision|1|||
156404407|NCT04867785|564575489|FG000|Overall Study|Inadvertent Enrollment|0|||
156404408|NCT04867785|564575490|FG001|Overall Study|Inadvertent Enrollment|0|||
156404409|NCT04867785|564575491|FG002|Overall Study|Inadvertent Enrollment|0|||
156404410|NCT04867785|564575492|FG003|Overall Study|Inadvertent Enrollment|1|||
156404411|NCT04867785|564575493|FG004|Overall Study|Inadvertent Enrollment|1|||
156404412|NCT04867785|564575494|FG005|Overall Study|Inadvertent Enrollment|0|||
156404413|NCT04867785|564575495|FG006|Overall Study|Inadvertent Enrollment|0|||
156512439|NCT02628028|564968248|FG003|Dosing Period|Lack of Efficacy|0|||
156512440|NCT02628028|564968249|FG004|Dosing Period|Lack of Efficacy|3|||
156512441|NCT02628028|564968250|FG005|Dosing Period|Lack of Efficacy|0|||
156512442|NCT02628028|564968251|FG006|Dosing Period|Lack of Efficacy|1|||
156512443|NCT02628028|564968252|FG007|Dosing Period|Lack of Efficacy|0|||
156512444|NCT02628028|564968245|FG000|Dosing Period|Study Terminated by Sponsor|0|||
156512445|NCT02628028|564968246|FG001|Dosing Period|Study Terminated by Sponsor|0|||
156512446|NCT02628028|564968247|FG002|Dosing Period|Study Terminated by Sponsor|0|||
156512447|NCT02628028|564968248|FG003|Dosing Period|Study Terminated by Sponsor|0|||
156512448|NCT02628028|564968249|FG004|Dosing Period|Study Terminated by Sponsor|7|||
156512449|NCT02628028|564968250|FG005|Dosing Period|Study Terminated by Sponsor|6|||
156512450|NCT02628028|564968251|FG006|Dosing Period|Study Terminated by Sponsor|7|||
156512451|NCT02628028|564968252|FG007|Dosing Period|Study Terminated by Sponsor|7|||
156512452|NCT02628028|564968245|FG000|Dosing Period|Physician Decision|0|||
156512453|NCT02628028|564968246|FG001|Dosing Period|Physician Decision|0|||
156512454|NCT02628028|564968247|FG002|Dosing Period|Physician Decision|0|||
156512455|NCT02628028|564968248|FG003|Dosing Period|Physician Decision|0|||
156512456|NCT02628028|564968249|FG004|Dosing Period|Physician Decision|0|||
156512457|NCT02628028|564968250|FG005|Dosing Period|Physician Decision|1|||
156512458|NCT02628028|564968251|FG006|Dosing Period|Physician Decision|0|||
156512459|NCT02628028|564968252|FG007|Dosing Period|Physician Decision|0|||
156512460|NCT02628028|564968245|FG000|Dosing Period|Site Terminated by Sponsor|0|||
156512461|NCT02628028|564968246|FG001|Dosing Period|Site Terminated by Sponsor|0|||
156512462|NCT02628028|564968247|FG002|Dosing Period|Site Terminated by Sponsor|0|||
156512463|NCT02628028|564968248|FG003|Dosing Period|Site Terminated by Sponsor|0|||
156512464|NCT02628028|564968249|FG004|Dosing Period|Site Terminated by Sponsor|0|||
156512465|NCT02628028|564968250|FG005|Dosing Period|Site Terminated by Sponsor|1|||
156512466|NCT02628028|564968251|FG006|Dosing Period|Site Terminated by Sponsor|1|||
156512467|NCT02628028|564968252|FG007|Dosing Period|Site Terminated by Sponsor|0|||
156512468|NCT02628028|564968245|FG000|Dosing Period|Lost to Follow-up|0|||
156512469|NCT02628028|564968246|FG001|Dosing Period|Lost to Follow-up|0|||
156512470|NCT02628028|564968247|FG002|Dosing Period|Lost to Follow-up|0|||
156512471|NCT02628028|564968248|FG003|Dosing Period|Lost to Follow-up|0|||
156512472|NCT02628028|564968249|FG004|Dosing Period|Lost to Follow-up|0|||
156512473|NCT02628028|564968250|FG005|Dosing Period|Lost to Follow-up|0|||
156512474|NCT02628028|564968251|FG006|Dosing Period|Lost to Follow-up|1|||
156512475|NCT02628028|564968252|FG007|Dosing Period|Lost to Follow-up|0|||
156512476|NCT02628028|564968245|FG000|Dosing Period|Other|0|||
156512477|NCT02628028|564968246|FG001|Dosing Period|Other|0|||
156512478|NCT02628028|564968247|FG002|Dosing Period|Other|0|||
156512479|NCT02628028|564968248|FG003|Dosing Period|Other|0|||
156512480|NCT02628028|564968249|FG004|Dosing Period|Other|2|||
156404414|NCT04867785|564575496|FG007|Overall Study|Inadvertent Enrollment|1|||
156404415|NCT04867785|564575489|FG000|Overall Study|Eligibility Criteria Not Met|0|||
156404416|NCT04867785|564575490|FG001|Overall Study|Eligibility Criteria Not Met|0|||
156404417|NCT04867785|564575491|FG002|Overall Study|Eligibility Criteria Not Met|0|||
156512481|NCT02628028|564968250|FG005|Dosing Period|Other|1|||
156512482|NCT02628028|564968251|FG006|Dosing Period|Other|2|||
156512483|NCT02628028|564968252|FG007|Dosing Period|Other|4|||
156512484|NCT02628028|564968245|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
156512485|NCT02628028|564968246|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
156512486|NCT02628028|564968247|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
156512487|NCT02628028|564968248|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
156512488|NCT02628028|564968249|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
156512489|NCT02628028|564968250|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
156512490|NCT02628028|564968251|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
156404418|NCT04867785|564575492|FG003|Overall Study|Eligibility Criteria Not Met|0|||
156404419|NCT04867785|564575493|FG004|Overall Study|Eligibility Criteria Not Met|0|||
156404420|NCT04867785|564575494|FG005|Overall Study|Eligibility Criteria Not Met|0|||
156404421|NCT04867785|564575495|FG006|Overall Study|Eligibility Criteria Not Met|0|||
156404422|NCT04867785|564575496|FG007|Overall Study|Eligibility Criteria Not Met|1|||
156404423|NCT00605319|564575507|FG000|Overall Study|Adverse Event|6|||
156404424|NCT02991482|564575509|FG000|Overall Study|Disease progression|56|||
156404425|NCT02991482|564575510|FG001|Overall Study|Disease progression|47|||
156404426|NCT02991482|564575509|FG000|Overall Study|Death|4|||
156404427|NCT02991482|564575510|FG001|Overall Study|Death|4|||
156404428|NCT02991482|564575509|FG000|Overall Study|Adverse Event|1|||
156404429|NCT02991482|564575510|FG001|Overall Study|Adverse Event|6|||
156404430|NCT02991482|564575509|FG000|Overall Study|Patient decision|1|||
156404431|NCT02991482|564575510|FG001|Overall Study|Patient decision|1|||
156404432|NCT02991482|564575509|FG000|Overall Study|Physician Decision|0|||
156404433|NCT02991482|564575510|FG001|Overall Study|Physician Decision|6|||
156404434|NCT02991482|564575509|FG000|Overall Study|Clinical deterioration|1|||
156404435|NCT02991482|564575510|FG001|Overall Study|Clinical deterioration|0|||
156404436|NCT02991482|564575509|FG000|Overall Study|Patient feeling too unwell|1|||
156404437|NCT02991482|564575510|FG001|Overall Study|Patient feeling too unwell|0|||
156404438|NCT02991482|564575509|FG000|Overall Study|Worsening of performance status|0|||
156404439|NCT02991482|564575510|FG001|Overall Study|Worsening of performance status|1|||
156404440|NCT02991482|564575509|FG000|Overall Study|Death prior to study drug initiation|1|||
156404441|NCT02991482|564575510|FG001|Overall Study|Death prior to study drug initiation|0|||
156404442|NCT02991482|564575509|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
156404443|NCT02991482|564575510|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
156404444|NCT02887989|564575511|FG000|Overall Study|Withdrawal by Subject|8|||
156404445|NCT02887989|564575512|FG001|Overall Study|Withdrawal by Subject|11|||
156404446|NCT02887989|564575511|FG000|Overall Study|Death|1|||
156404447|NCT02887989|564575512|FG001|Overall Study|Death|0|||
156553373|NCT04381650|565116508|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156553374|NCT04381650|565116509|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156553375|NCT04381650|565116510|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156553376|NCT04381650|565116500|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
156553377|NCT04381650|565116501|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
156553378|NCT04381650|565116502|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
156553379|NCT04381650|565116503|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
156553380|NCT04381650|565116504|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
156553381|NCT04381650|565116505|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
156553382|NCT04381650|565116506|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
156553383|NCT04381650|565116507|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
156553384|NCT04381650|565116508|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
156553385|NCT04381650|565116509|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
156553386|NCT04381650|565116510|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
156553387|NCT04381650|565116500|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553388|NCT04381650|565116501|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553389|NCT04381650|565116502|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
156553390|NCT04381650|565116503|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
156553391|NCT04381650|565116504|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553392|NCT04381650|565116505|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553393|NCT04381650|565116506|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553394|NCT04381650|565116507|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553395|NCT04381650|565116508|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553396|NCT04381650|565116509|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553397|NCT04381650|565116510|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
156553398|NCT04381650|565116500|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
156553399|NCT04381650|565116501|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
156553400|NCT04381650|565116502|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
156553401|NCT04381650|565116503|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
156553402|NCT04381650|565116504|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
156553403|NCT04381650|565116505|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
156553404|NCT04381650|565116506|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
156553405|NCT04381650|565116507|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
156553406|NCT04381650|565116508|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
156404448|NCT02045433|564575519|FG000|Overall Study|Withdrawal by Subject|1|||
156404449|NCT03673462|564575520|FG000|Overall Study|Adverse Event|11|||
156404450|NCT03673462|564575521|FG001|Overall Study|Adverse Event|1|||
156404451|NCT03673462|564575520|FG000|Overall Study|Protocol Violation|25|||
156404452|NCT03673462|564575521|FG001|Overall Study|Protocol Violation|11|||
156404453|NCT03673462|564575520|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
156404454|NCT03673462|564575521|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
156404455|NCT03673462|564575520|FG000|Overall Study|Lost to Follow-up|102|||
156404456|NCT03673462|564575521|FG001|Overall Study|Lost to Follow-up|19|||
156553407|NCT04381650|565116509|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
156553408|NCT04381650|565116510|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
156553409|NCT04381650|565116500|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156553410|NCT04381650|565116501|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156553411|NCT04381650|565116502|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156553412|NCT04381650|565116503|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156553413|NCT04381650|565116504|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
156553414|NCT04381650|565116505|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
156553415|NCT04381650|565116506|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156553416|NCT04381650|565116507|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156553417|NCT04381650|565116508|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156553418|NCT04381650|565116509|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
156553419|NCT04381650|565116510|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156553420|NCT04381650|565116500|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156553421|NCT04381650|565116501|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156553422|NCT04381650|565116502|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156553423|NCT04381650|565116503|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156553424|NCT04381650|565116504|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156553425|NCT04381650|565116505|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156553426|NCT04381650|565116506|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156553427|NCT04381650|565116507|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
156553428|NCT04381650|565116508|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
156553429|NCT04381650|565116509|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
156553430|NCT04381650|565116510|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156553431|NCT04381650|565116500|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
156553432|NCT04381650|565116501|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
156553433|NCT04381650|565116502|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
156553434|NCT04381650|565116503|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
156553435|NCT04381650|565116504|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
156553436|NCT04381650|565116505|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
156553437|NCT04381650|565116506|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
156553438|NCT04381650|565116507|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
156553439|NCT04381650|565116508|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
156553440|NCT04381650|565116509|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
156553441|NCT04381650|565116510|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
156553442|NCT04381650|565116500|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
156553443|NCT04381650|565116501|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
156553444|NCT04381650|565116502|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
156553445|NCT04381650|565116503|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
156553446|NCT04381650|565116504|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
156553447|NCT04381650|565116505|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
156553448|NCT04381650|565116506|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
156553449|NCT04381650|565116507|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
156553450|NCT04381650|565116508|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
156553451|NCT04381650|565116509|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
156553452|NCT04381650|565116510|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
156553453|NCT04381650|565116500|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553454|NCT04381650|565116501|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553455|NCT04381650|565116502|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553456|NCT04381650|565116503|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553457|NCT04381650|565116504|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553458|NCT04381650|565116505|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553459|NCT04381650|565116506|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553460|NCT04381650|565116507|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
156553461|NCT04381650|565116508|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553462|NCT04381650|565116509|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553463|NCT04381650|565116510|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156553464|NCT02479802|565117494|FG000|Overall Study|Lost to Follow-up|1|||
156553465|NCT02479802|565117494|FG000|Overall Study|Adverse Event|1|||
156553466|NCT02268058|565117499|FG000|Overall Study|Protocol Violation|1|||
156553467|NCT02268058|565117500|FG001|Overall Study|Protocol Violation|0|||
156553468|NCT02268058|565117501|FG002|Overall Study|Protocol Violation|0|||
156553469|NCT02268058|565117502|FG003|Overall Study|Protocol Violation|0|||
156553470|NCT04142983|565117504|FG000|Overall Study|Lost to Follow-up|73|||
156553471|NCT04142983|565117504|FG000|Overall Study|Withdrawal by Subject|10|||
156553472|NCT04142983|565117504|FG000|Overall Study|Physician Decision|1|||
156553473|NCT04142983|565117504|FG000|Overall Study|Adverse Event|1|||
156553474|NCT04142983|565117504|FG000|Overall Study|No longer eligible|4|||
156553475|NCT04142983|565117504|FG000|Overall Study|Screen Failure|10|||
156553476|NCT03403205|565117505|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
156553477|NCT03403205|565117506|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
156553478|NCT03403205|565117507|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
156553479|NCT03403205|565117508|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
156553480|NCT03403205|565117509|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
156553481|NCT03403205|565117510|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
156553482|NCT03403205|565117505|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
156553483|NCT03403205|565117506|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156553484|NCT03403205|565117507|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
156553485|NCT03403205|565117508|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156553486|NCT03403205|565117509|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156553487|NCT03403205|565117510|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156553488|NCT03403205|565117505|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
156553489|NCT03403205|565117506|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
156553490|NCT03403205|565117507|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
156553491|NCT03403205|565117508|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
156553492|NCT03403205|565117509|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
156553493|NCT03403205|565117510|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
156553494|NCT03403205|565117505|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
156553495|NCT03403205|565117506|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
156553496|NCT03403205|565117507|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
156553497|NCT03403205|565117508|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
156553498|NCT03403205|565117509|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
156553499|NCT03403205|565117510|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
156553500|NCT03403205|565117505|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
156553501|NCT03403205|565117506|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
156553502|NCT03403205|565117507|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
156553503|NCT03403205|565117508|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
156553504|NCT03403205|565117509|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
156404457|NCT02768662|564575522|FG000|Overall Study|Adverse Event|1|||
156404458|NCT02768662|564575522|FG000|Overall Study|Lost to Follow-up|4|||
156404459|NCT02768662|564575522|FG000|Overall Study|Withdrawal by Subject|3|||
156404460|NCT02768662|564575522|FG000|Overall Study|Study terminated by Sponsor|78|||
156404461|NCT01346514|564575523|FG000|Overall Study|Lost to Follow-up|19|||
156404462|NCT01346514|564575524|FG001|Overall Study|Lost to Follow-up|30|||
156404463|NCT01346514|564575523|FG000|Overall Study|Withdrawal by Subject|7|||
156404464|NCT01346514|564575524|FG001|Overall Study|Withdrawal by Subject|3|||
156404465|NCT01346514|564575523|FG000|Overall Study|Death|3|||
156404466|NCT01346514|564575524|FG001|Overall Study|Death|4|||
156553505|NCT03403205|565117510|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
156553506|NCT03403205|565117505|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
156553507|NCT03403205|565117506|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
156553508|NCT03403205|565117507|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
156553509|NCT03403205|565117508|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
156553510|NCT03403205|565117509|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
156553511|NCT03403205|565117510|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
156553512|NCT03403205|565117505|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
156553513|NCT03403205|565117506|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
156553514|NCT03403205|565117507|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
156404467|NCT02118337|564575527|FG000|Overall Study|Other|1|||
156404468|NCT02118337|564575528|FG001|Overall Study|Other|0|||
156404469|NCT02118337|564575529|FG002|Overall Study|Other|0|||
156404470|NCT02118337|564575530|FG003|Overall Study|Other|0|||
156404471|NCT02118337|564575531|FG004|Overall Study|Other|2|||
156404472|NCT02118337|564575532|FG005|Overall Study|Other|3|||
156404473|NCT02118337|564575533|FG006|Overall Study|Other|1|||
156404474|NCT02118337|564575534|FG007|Overall Study|Other|28|||
156404475|NCT02118337|564575535|FG008|Overall Study|Other|15|||
156404476|NCT02118337|564575527|FG000|Overall Study|Lost to Follow-up|0|||
156404477|NCT02118337|564575528|FG001|Overall Study|Lost to Follow-up|0|||
156404478|NCT02118337|564575529|FG002|Overall Study|Lost to Follow-up|0|||
156404479|NCT02118337|564575530|FG003|Overall Study|Lost to Follow-up|0|||
156404480|NCT02118337|564575531|FG004|Overall Study|Lost to Follow-up|0|||
156404481|NCT02118337|564575532|FG005|Overall Study|Lost to Follow-up|0|||
156404482|NCT02118337|564575533|FG006|Overall Study|Lost to Follow-up|0|||
156553515|NCT03403205|565117508|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
156404483|NCT02118337|564575534|FG007|Overall Study|Lost to Follow-up|1|||
156404484|NCT02118337|564575535|FG008|Overall Study|Lost to Follow-up|0|||
156404485|NCT02118337|564575527|FG000|Overall Study|Withdrawal by Subject|1|||
156404486|NCT02118337|564575528|FG001|Overall Study|Withdrawal by Subject|3|||
156404487|NCT02118337|564575529|FG002|Overall Study|Withdrawal by Subject|2|||
156404488|NCT02118337|564575530|FG003|Overall Study|Withdrawal by Subject|1|||
156404489|NCT02118337|564575531|FG004|Overall Study|Withdrawal by Subject|2|||
156404490|NCT02118337|564575532|FG005|Overall Study|Withdrawal by Subject|2|||
156404491|NCT02118337|564575533|FG006|Overall Study|Withdrawal by Subject|1|||
156404492|NCT02118337|564575534|FG007|Overall Study|Withdrawal by Subject|4|||
156404493|NCT02118337|564575535|FG008|Overall Study|Withdrawal by Subject|2|||
156404494|NCT02118337|564575527|FG000|Overall Study|Death|2|||
156404495|NCT02118337|564575528|FG001|Overall Study|Death|2|||
156404496|NCT02118337|564575529|FG002|Overall Study|Death|1|||
156404497|NCT02118337|564575530|FG003|Overall Study|Death|2|||
156404498|NCT02118337|564575531|FG004|Overall Study|Death|5|||
156404499|NCT02118337|564575532|FG005|Overall Study|Death|1|||
156404500|NCT02118337|564575533|FG006|Overall Study|Death|2|||
156404501|NCT02118337|564575534|FG007|Overall Study|Death|9|||
156404502|NCT02118337|564575535|FG008|Overall Study|Death|4|||
156404503|NCT04522180|564575538|FG000|Overall Study|Investigator judgement|3|||
156404504|NCT04522180|564575539|FG001|Overall Study|Investigator judgement|4|||
156404505|NCT04522180|564575538|FG000|Overall Study|Voluntary withdrawal|1|||
156404506|NCT04522180|564575539|FG001|Overall Study|Voluntary withdrawal|0|||
156404507|NCT04522180|564575538|FG000|Overall Study|Pregnancy|0|||
156404508|NCT04522180|564575539|FG001|Overall Study|Pregnancy|1|||
156404509|NCT04522180|564575538|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
156404510|NCT04522180|564575539|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
156404511|NCT04522180|564575538|FG000|Overall Study|Reason not specified|8|||
156404512|NCT04522180|564575539|FG001|Overall Study|Reason not specified|5|||
156404513|NCT00747123|564575540|FG000|Overall Study|Investigator's request|0|||
156404514|NCT00747123|564575541|FG001|Overall Study|Investigator's request|0|||
156404515|NCT00747123|564575542|FG002|Overall Study|Investigator's request|1|||
156404516|NCT00747123|564575543|FG003|Overall Study|Investigator's request|0|||
156404517|NCT00747123|564575540|FG000|Overall Study|Withdrew consent|0|||
156404518|NCT00747123|564575541|FG001|Overall Study|Withdrew consent|1|||
156553516|NCT03403205|565117509|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
156553517|NCT03403205|565117510|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
156553518|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
156553519|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
156553520|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
156553521|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
156404519|NCT00747123|564575542|FG002|Overall Study|Withdrew consent|0|||
156404520|NCT00747123|564575543|FG003|Overall Study|Withdrew consent|0|||
156404521|NCT00747123|564575540|FG000|Overall Study|Adverse Event|0|||
156404522|NCT00747123|564575541|FG001|Overall Study|Adverse Event|1|||
156404523|NCT00747123|564575542|FG002|Overall Study|Adverse Event|0|||
156404524|NCT00747123|564575543|FG003|Overall Study|Adverse Event|1|||
156404525|NCT02277743|564575550|FG000|Overall Study|Protocol Violation|1|||
156404526|NCT02277743|564575551|FG001|Overall Study|Protocol Violation|1|||
156404527|NCT02277743|564575552|FG002|Overall Study|Protocol Violation|1|||
156404528|NCT02277743|564575550|FG000|Overall Study|Adverse Event|10|||
156404529|NCT02277743|564575551|FG001|Overall Study|Adverse Event|6|||
156404530|NCT02277743|564575552|FG002|Overall Study|Adverse Event|6|||
156404531|NCT02277743|564575550|FG000|Overall Study|Lack of Efficacy|11|||
156404532|NCT02277743|564575551|FG001|Overall Study|Lack of Efficacy|4|||
156404533|NCT02277743|564575552|FG002|Overall Study|Lack of Efficacy|3|||
156404534|NCT02277743|564575550|FG000|Overall Study|Other than specified above|18|||
156404535|NCT02277743|564575551|FG001|Overall Study|Other than specified above|5|||
156404536|NCT02277743|564575552|FG002|Overall Study|Other than specified above|16|||
156404537|NCT01224158|564575553|FG000|Overall Study|Withdrawal by Subject|1|||
156404538|NCT01224158|564575554|FG001|Overall Study|Withdrawal by Subject|0|||
156404539|NCT02055157|564575557|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
156404540|NCT02055157|564575558|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
156404541|NCT02055157|564575559|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
156404542|NCT02055157|564575560|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
156404543|NCT02055157|564575557|FG000|Initial 6 Months|Adverse Event|0|||
156404544|NCT02055157|564575558|FG001|Initial 6 Months|Adverse Event|0|||
156404545|NCT02055157|564575559|FG002|Initial 6 Months|Adverse Event|0|||
156404546|NCT02055157|564575560|FG003|Initial 6 Months|Adverse Event|1|||
156404547|NCT02055157|564575557|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
156404548|NCT02055157|564575558|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
156553522|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
156404549|NCT02055157|564575559|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
156404550|NCT02055157|564575560|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
156404551|NCT02055157|564575557|FG000|18-month Extension|Investigator decision|0|||
156404552|NCT02055157|564575558|FG001|18-month Extension|Investigator decision|1|||
156404553|NCT02055157|564575559|FG002|18-month Extension|Investigator decision|0|||
156553523|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
156404554|NCT02055157|564575560|FG003|18-month Extension|Investigator decision|0|||
156404555|NCT02055157|564575557|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
156404556|NCT02055157|564575558|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
156404557|NCT02055157|564575559|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
156404558|NCT02055157|564575560|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
156404559|NCT03976466|564575561|FG000|Overall Study|Lost to Follow-up|1|||
156404560|NCT03976466|564575562|FG001|Overall Study|Lost to Follow-up|3|||
156404561|NCT00943306|564575565|FG000|Overall Study|Physician Decision|1|||
156404562|NCT00943306|564575565|FG000|Overall Study|Death|1|||
156404563|NCT00943306|564575565|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
156404564|NCT00733499|564575566|FG000|Pre-operative|Protocol Violation|0|||
156404565|NCT00733499|564575567|FG001|Pre-operative|Protocol Violation|1|||
156404566|NCT00733499|564575566|FG000|3 Months Follow-up|Death|1|||
156404567|NCT00733499|564575567|FG001|3 Months Follow-up|Death|2|||
156404568|NCT00733499|564575566|FG000|6 Months Follow-up|Death|0|||
156404569|NCT00733499|564575567|FG001|6 Months Follow-up|Death|2|||
156404570|NCT00733499|564575566|FG000|6 Months Follow-up|Adverse Event|0|||
156404571|NCT00733499|564575567|FG001|6 Months Follow-up|Adverse Event|1|||
156404572|NCT00733499|564575566|FG000|12 Months Follow-up|Death|2|||
156404573|NCT00733499|564575567|FG001|12 Months Follow-up|Death|1|||
156404574|NCT00733499|564575566|FG000|24 Months Follow-up|Death|0|||
156404575|NCT00733499|564575567|FG001|24 Months Follow-up|Death|1|||
156404576|NCT00733499|564575566|FG000|5 Year Followup|Adverse Event|2|||
156404577|NCT00733499|564575567|FG001|5 Year Followup|Adverse Event|2|||
156512491|NCT02628028|564968252|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
156512492|NCT02628028|564968245|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
156512493|NCT02628028|564968246|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
156512494|NCT02628028|564968247|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
156512495|NCT02628028|564968248|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
156512496|NCT02628028|564968249|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
156512497|NCT02628028|564968250|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
156512498|NCT02628028|564968251|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
156512499|NCT02628028|564968252|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
156512500|NCT02628028|564968245|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
156512501|NCT02628028|564968246|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
156512502|NCT02628028|564968247|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
156512503|NCT02628028|564968248|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
156512504|NCT02628028|564968249|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
156512505|NCT02628028|564968250|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
156512506|NCT02628028|564968251|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
156512507|NCT02628028|564968252|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
156512508|NCT02628028|564968245|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
156512509|NCT02628028|564968246|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
156512510|NCT02628028|564968247|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
156512511|NCT02628028|564968248|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
156512512|NCT02628028|564968249|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
156512513|NCT02628028|564968250|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
156512514|NCT02628028|564968251|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
156512515|NCT02628028|564968252|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
156512516|NCT02628028|564968245|FG000|Long-term Extension (LTE) Period|Other|0|||
156512517|NCT02628028|564968246|FG001|Long-term Extension (LTE) Period|Other|0|||
156512518|NCT02628028|564968247|FG002|Long-term Extension (LTE) Period|Other|0|||
156512519|NCT02628028|564968248|FG003|Long-term Extension (LTE) Period|Other|0|||
156512520|NCT02628028|564968249|FG004|Long-term Extension (LTE) Period|Other|0|||
156512521|NCT02628028|564968250|FG005|Long-term Extension (LTE) Period|Other|3|||
156512522|NCT02628028|564968251|FG006|Long-term Extension (LTE) Period|Other|4|||
156512523|NCT02628028|564968252|FG007|Long-term Extension (LTE) Period|Other|3|||
156512524|NCT02738853|564968255|FG000|Enrollment|Inclusion/Exclusion not met|21|||
156512525|NCT02738853|564968255|FG000|Enrollment|Withdrawal by Subject|3|||
156512526|NCT02738853|564968255|FG000|Enrollment|Subject treated with commercially available device|6|||
156512527|NCT02738853|564968255|FG000|Enrollment|Study Enrollment Closed|3|||
156512528|NCT02738853|564968255|FG000|Procedure|Death|1|||
156512529|NCT02738853|564968255|FG000|1 Month|Death|2|||
156512530|NCT02738853|564968255|FG000|6 Month|Death|4|||
156512531|NCT02738853|564968255|FG000|6 Month|Withdrawal by Subject|2|||
156512532|NCT02738853|564968255|FG000|1 Year|Death|6|||
156512533|NCT02738853|564968255|FG000|1 Year|Withdrawal by Subject|1|||
156512534|NCT02738853|564968255|FG000|2 Year|Death|2|||
156512535|NCT02738853|564968255|FG000|2 Year|Lost to Follow-up|1|||
156512536|NCT02738853|564968255|FG000|3 Year|Death|2|||
156512537|NCT02738853|564968255|FG000|3 Year|Withdrawal by Subject|1|||
156512538|NCT02738853|564968255|FG000|4 Year|Death|9|||
156512539|NCT02738853|564968255|FG000|5 Year|Lost to Follow-up|4|||
156512540|NCT00653523|564968263|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
156512541|NCT00653523|564968263|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
156404578|NCT00733499|564575566|FG000|5 Year Followup|Non device related AE|0|||
156512542|NCT00653523|564968263|FG000|Overall Study|Adverse Event|7|||
156404579|NCT00733499|564575567|FG001|5 Year Followup|Non device related AE|1|||
156404580|NCT00733499|564575566|FG000|5 Year Followup|Revision of Study Implant|0|||
156553524|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
156553525|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
156553526|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
156553527|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
156404581|NCT00733499|564575567|FG001|5 Year Followup|Revision of Study Implant|1|||
156404582|NCT00733499|564575566|FG000|5 Year Followup|Lost to Follow-up|2|||
156404583|NCT00733499|564575567|FG001|5 Year Followup|Lost to Follow-up|0|||
156404584|NCT00733499|564575566|FG000|5 Year Followup|Death|13|||
156404585|NCT00733499|564575567|FG001|5 Year Followup|Death|19|||
156404586|NCT00733499|564575566|FG000|5 Year Followup|missing, unable to locate|0|||
156404587|NCT00733499|564575567|FG001|5 Year Followup|missing, unable to locate|1|||
156404588|NCT00733499|564575566|FG000|5 Year Followup|Withdrawal by Subject|4|||
156404589|NCT00733499|564575567|FG001|5 Year Followup|Withdrawal by Subject|1|||
156404590|NCT00733499|564575566|FG000|10 Year Followup|Death|9|||
156553528|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
156553529|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
156553530|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Death|1|||
156553531|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Death|0|||
156553532|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Death|0|||
156553533|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Death|0|||
156553534|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Death|0|||
156553535|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Death|0|||
156553536|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
156553537|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
156553538|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
156553539|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
156553540|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
156553541|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
156553542|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
156553543|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
156553544|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
156553545|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
156553546|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
156553547|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
156553548|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
156553549|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
156553550|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
156553551|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
156553552|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
156553553|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
156553554|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
156553555|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
156553556|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
156553557|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
156553558|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
156553559|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
156553560|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
156553561|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
156553562|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
156553563|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
156553564|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
156553565|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
156553566|NCT03403205|565117505|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
156553567|NCT03403205|565117506|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
156553568|NCT03403205|565117507|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
156553569|NCT03403205|565117508|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
156553570|NCT03403205|565117509|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
156553571|NCT03403205|565117510|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
156553572|NCT00706030|565117511|FG000|Overall Study|Disease Progression|4|||
156553573|NCT00706030|565117512|FG001|Overall Study|Disease Progression|6|||
156553574|NCT00706030|565117513|FG002|Overall Study|Disease Progression|46|||
156553575|NCT00706030|565117514|FG003|Overall Study|Disease Progression|12|||
156404591|NCT00733499|564575567|FG001|10 Year Followup|Death|7|||
156404592|NCT00733499|564575566|FG000|10 Year Followup|Adverse Event|3|||
156404593|NCT00733499|564575567|FG001|10 Year Followup|Adverse Event|3|||
156404594|NCT00733499|564575566|FG000|10 Year Followup|Lost to Follow-up|3|||
156404595|NCT00733499|564575567|FG001|10 Year Followup|Lost to Follow-up|2|||
156404596|NCT00733499|564575566|FG000|10 Year Followup|Withdrawal by Subject|5|||
156404597|NCT00733499|564575567|FG001|10 Year Followup|Withdrawal by Subject|5|||
156404598|NCT00733499|564575566|FG000|10 Year Followup|missing, unable to locate|0|||
156553576|NCT00706030|565117511|FG000|Overall Study|Adverse Event|1|||
156553577|NCT00706030|565117512|FG001|Overall Study|Adverse Event|0|||
156553578|NCT00706030|565117513|FG002|Overall Study|Adverse Event|4|||
156553579|NCT00706030|565117514|FG003|Overall Study|Adverse Event|2|||
156553580|NCT00706030|565117511|FG000|Overall Study|Withdrawal by Subject|1|||
156553581|NCT00706030|565117512|FG001|Overall Study|Withdrawal by Subject|0|||
156553582|NCT00706030|565117513|FG002|Overall Study|Withdrawal by Subject|2|||
156553583|NCT00706030|565117514|FG003|Overall Study|Withdrawal by Subject|0|||
156553584|NCT00706030|565117511|FG000|Overall Study|Physician Decision|0|||
156553585|NCT00706030|565117512|FG001|Overall Study|Physician Decision|0|||
156553586|NCT00706030|565117513|FG002|Overall Study|Physician Decision|2|||
156553587|NCT00706030|565117514|FG003|Overall Study|Physician Decision|0|||
156553588|NCT00706030|565117511|FG000|Overall Study|Not recorded|0|||
156553589|NCT00706030|565117512|FG001|Overall Study|Not recorded|0|||
156553590|NCT00706030|565117513|FG002|Overall Study|Not recorded|2|||
156553591|NCT00706030|565117514|FG003|Overall Study|Not recorded|0|||
156553592|NCT00706030|565117511|FG000|Overall Study|Protocol Violation|0|||
156553593|NCT00706030|565117512|FG001|Overall Study|Protocol Violation|0|||
156553594|NCT00706030|565117513|FG002|Overall Study|Protocol Violation|1|||
156553595|NCT00706030|565117514|FG003|Overall Study|Protocol Violation|1|||
156553596|NCT00706030|565117511|FG000|Overall Study|Failed to return|0|||
156553597|NCT00706030|565117512|FG001|Overall Study|Failed to return|0|||
156553598|NCT00706030|565117513|FG002|Overall Study|Failed to return|1|||
156553599|NCT00706030|565117514|FG003|Overall Study|Failed to return|0|||
156553600|NCT00706030|565117511|FG000|Overall Study|Symptomatic Deterioration|0|||
156553601|NCT00706030|565117512|FG001|Overall Study|Symptomatic Deterioration|0|||
156553602|NCT00706030|565117513|FG002|Overall Study|Symptomatic Deterioration|1|||
156553603|NCT00706030|565117514|FG003|Overall Study|Symptomatic Deterioration|0|||
156553604|NCT00706030|565117511|FG000|Overall Study|No treatment received|0|||
156553605|NCT00706030|565117512|FG001|Overall Study|No treatment received|0|||
156553606|NCT00706030|565117513|FG002|Overall Study|No treatment received|0|||
156553607|NCT00706030|565117514|FG003|Overall Study|No treatment received|1|||
156553608|NCT00706030|565117511|FG000|Overall Study|Death|0|||
156553609|NCT00706030|565117512|FG001|Overall Study|Death|0|||
156553610|NCT00706030|565117513|FG002|Overall Study|Death|1|||
156553611|NCT00706030|565117514|FG003|Overall Study|Death|0|||
156553612|NCT05779072|565117515|FG000|Overall Study|Lost to Follow-up|0|||
156553613|NCT05779072|565117516|FG001|Overall Study|Lost to Follow-up|1|||
156553614|NCT05779072|565117515|FG000|Overall Study|Withdrawal by Subject|1|||
156553615|NCT05779072|565117516|FG001|Overall Study|Withdrawal by Subject|5|||
156553616|NCT03870555|565117517|FG000|Period 3 (2 Days)|Adverse Event|1|||
156553617|NCT03870555|565117518|FG001|Period 3 (2 Days)|Adverse Event|0|||
156553618|NCT03870555|565117519|FG002|Period 3 (2 Days)|Adverse Event|0|||
156553619|NCT03847610|565117520|FG000|Overall Study|Withdrawal by Subject|1|||
156553620|NCT02004873|565117521|FG000|Overall Study|Implant unsuccessful|6|||
156553621|NCT02004873|565117521|FG000|Overall Study|Awaiting 6-month visit|390|||
156553622|NCT02004873|565117521|FG000|Overall Study|Missed 6-month visit|4|||
156553623|NCT02004873|565117521|FG000|Overall Study|Death|23|||
156553624|NCT02004873|565117521|FG000|Overall Study|Withdrawal by Subject|1|||
156553625|NCT01445769|565117523|FG000|Overall Study|Consent Withdrawn|2|||
156553626|NCT01445769|565117523|FG000|Overall Study|Disease Progression|1|||
156553627|NCT01445769|565117523|FG000|Overall Study|Lost to Follow-up|5|||
156553628|NCT02799069|565117526|FG000|Overall Study|Adverse Event|0|||
156553629|NCT02799069|565117527|FG001|Overall Study|Adverse Event|2|||
156553630|NCT02799069|565117528|FG002|Overall Study|Adverse Event|2|||
156553631|NCT02799069|565117526|FG000|Overall Study|Lack of Efficacy|2|||
156553632|NCT02799069|565117527|FG001|Overall Study|Lack of Efficacy|0|||
156553633|NCT02799069|565117528|FG002|Overall Study|Lack of Efficacy|0|||
156553634|NCT02799069|565117526|FG000|Overall Study|Lost to Follow-up|1|||
156553635|NCT02799069|565117527|FG001|Overall Study|Lost to Follow-up|1|||
156553636|NCT02799069|565117528|FG002|Overall Study|Lost to Follow-up|0|||
156553637|NCT02799069|565117526|FG000|Overall Study|Withdrawal by Subject|4|||
156553638|NCT02799069|565117527|FG001|Overall Study|Withdrawal by Subject|4|||
156553639|NCT02799069|565117528|FG002|Overall Study|Withdrawal by Subject|3|||
156553640|NCT02799069|565117526|FG000|Overall Study|Protocol Violation|1|||
156553641|NCT02799069|565117527|FG001|Overall Study|Protocol Violation|0|||
156553642|NCT02799069|565117528|FG002|Overall Study|Protocol Violation|2|||
156553643|NCT02695628|565117529|FG000|Overall Study|Withdrawal by Subject|1|||
156553644|NCT02925156|565117530|FG000|Overall Study|Lost to Follow-up|27|||
156553645|NCT02925156|565117531|FG001|Overall Study|Lost to Follow-up|53|||
156553646|NCT02925156|565117532|FG002|Overall Study|Lost to Follow-up|51|||
156553647|NCT02925156|565117533|FG003|Overall Study|Lost to Follow-up|59|||
156553648|NCT02925156|565117534|FG004|Overall Study|Lost to Follow-up|89|||
156553649|NCT02925156|565117535|FG005|Overall Study|Lost to Follow-up|107|||
156553650|NCT02925156|565117536|FG006|Overall Study|Lost to Follow-up|34|||
156553651|NCT02925156|565117537|FG007|Overall Study|Lost to Follow-up|36|||
156553652|NCT02925156|565117538|FG008|Overall Study|Lost to Follow-up|73|||
156553653|NCT02925156|565117539|FG009|Overall Study|Lost to Follow-up|34|||
156553654|NCT01681433|565117542|FG000|Overall Study|Lack of Efficacy|23|||
156553655|NCT01681433|565117543|FG001|Overall Study|Lack of Efficacy|23|||
156553656|NCT01681433|565117542|FG000|Overall Study|Withdrawal by Subject|5|||
156553657|NCT01681433|565117543|FG001|Overall Study|Withdrawal by Subject|5|||
156553658|NCT01681433|565117542|FG000|Overall Study|Protocol Violation|2|||
156553659|NCT01681433|565117543|FG001|Overall Study|Protocol Violation|0|||
156553660|NCT01681433|565117542|FG000|Overall Study|Adverse Event|2|||
156553661|NCT01681433|565117543|FG001|Overall Study|Adverse Event|4|||
156553662|NCT01681433|565117542|FG000|Overall Study|Lost to Follow-up|0|||
156553663|NCT01681433|565117543|FG001|Overall Study|Lost to Follow-up|1|||
156553664|NCT00730639|565117544|FG000|Overall Study|Adverse Event|3|||
156553665|NCT00730639|565117545|FG001|Overall Study|Adverse Event|0|||
156553666|NCT00730639|565117546|FG002|Overall Study|Adverse Event|9|||
156553667|NCT00730639|565117547|FG003|Overall Study|Adverse Event|8|||
156553668|NCT00730639|565117548|FG004|Overall Study|Adverse Event|23|||
156553669|NCT00730639|565117544|FG000|Overall Study|Complete Response|0|||
156553670|NCT00730639|565117545|FG001|Overall Study|Complete Response|0|||
156553671|NCT00730639|565117546|FG002|Overall Study|Complete Response|2|||
156553672|NCT00730639|565117547|FG003|Overall Study|Complete Response|2|||
156553673|NCT00730639|565117548|FG004|Overall Study|Complete Response|1|||
156553674|NCT00730639|565117544|FG000|Overall Study|Completed Maximum Cycles|0|||
156553675|NCT00730639|565117545|FG001|Overall Study|Completed Maximum Cycles|0|||
156553676|NCT00730639|565117546|FG002|Overall Study|Completed Maximum Cycles|11|||
156553677|NCT00730639|565117547|FG003|Overall Study|Completed Maximum Cycles|3|||
156553678|NCT00730639|565117548|FG004|Overall Study|Completed Maximum Cycles|6|||
156553679|NCT00730639|565117544|FG000|Overall Study|Death|0|||
156553680|NCT00730639|565117545|FG001|Overall Study|Death|0|||
156553681|NCT00730639|565117546|FG002|Overall Study|Death|0|||
156553682|NCT00730639|565117547|FG003|Overall Study|Death|0|||
156553683|NCT00730639|565117548|FG004|Overall Study|Death|2|||
156553684|NCT00730639|565117544|FG000|Overall Study|Disease Progression|12|||
156553685|NCT00730639|565117545|FG001|Overall Study|Disease Progression|13|||
156553686|NCT00730639|565117546|FG002|Overall Study|Disease Progression|48|||
156553687|NCT00730639|565117547|FG003|Overall Study|Disease Progression|32|||
156553688|NCT00730639|565117548|FG004|Overall Study|Disease Progression|88|||
156553689|NCT00730639|565117544|FG000|Overall Study|non-specified|0|||
156553690|NCT00730639|565117545|FG001|Overall Study|non-specified|0|||
156553691|NCT00730639|565117546|FG002|Overall Study|non-specified|4|||
156553692|NCT00730639|565117547|FG003|Overall Study|non-specified|2|||
156553693|NCT00730639|565117548|FG004|Overall Study|non-specified|3|||
156553694|NCT00730639|565117544|FG000|Overall Study|Protocol Violation|0|||
156553695|NCT00730639|565117545|FG001|Overall Study|Protocol Violation|0|||
156553696|NCT00730639|565117546|FG002|Overall Study|Protocol Violation|1|||
156553697|NCT00730639|565117547|FG003|Overall Study|Protocol Violation|0|||
156553698|NCT00730639|565117548|FG004|Overall Study|Protocol Violation|0|||
156553699|NCT00730639|565117544|FG000|Overall Study|Withdrawal by Subject|0|||
156553700|NCT00730639|565117545|FG001|Overall Study|Withdrawal by Subject|0|||
156553701|NCT00730639|565117546|FG002|Overall Study|Withdrawal by Subject|6|||
156553702|NCT00730639|565117547|FG003|Overall Study|Withdrawal by Subject|3|||
156553703|NCT00730639|565117548|FG004|Overall Study|Withdrawal by Subject|4|||
156553704|NCT00730639|565117544|FG000|Overall Study|Treatment on-going|2|||
156553705|NCT00730639|565117545|FG001|Overall Study|Treatment on-going|5|||
156553706|NCT00730639|565117546|FG002|Overall Study|Treatment on-going|5|||
156553707|NCT00730639|565117547|FG003|Overall Study|Treatment on-going|4|||
156553708|NCT00730639|565117548|FG004|Overall Study|Treatment on-going|4|||
156553709|NCT00903929|565117549|FG000|Overall Study|Withdrawal by Subject|0|||
156553710|NCT00903929|565117550|FG001|Overall Study|Withdrawal by Subject|0|||
156553711|NCT00903929|565117551|FG002|Overall Study|Withdrawal by Subject|1|||
156553712|NCT00903929|565117552|FG003|Overall Study|Withdrawal by Subject|2|||
156553713|NCT00903929|565117549|FG000|Overall Study|Adverse Event|0|||
156553714|NCT00903929|565117550|FG001|Overall Study|Adverse Event|0|||
156553715|NCT00903929|565117551|FG002|Overall Study|Adverse Event|0|||
156553716|NCT00903929|565117552|FG003|Overall Study|Adverse Event|1|||
156553717|NCT02665286|565117553|FG000|Overall Study|Lost to Follow-up|3|||
156553718|NCT02665286|565117554|FG001|Overall Study|Lost to Follow-up|2|||
156404599|NCT00733499|564575567|FG001|10 Year Followup|missing, unable to locate|2|||
156553719|NCT02665286|565117555|FG002|Overall Study|Lost to Follow-up|1|||
156553720|NCT01844895|565117557|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
156404600|NCT02739347|564575568|FG000|Overall Study|Adverse Event|3|||
156553721|NCT01844895|565117557|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
156553722|NCT01844895|565117557|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
156553723|NCT01844895|565117557|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
156553724|NCT01844895|565117557|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
156404601|NCT02739347|564575569|FG001|Overall Study|Adverse Event|0|||
156553725|NCT01844895|565117557|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
156553726|NCT01844895|565117557|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
156553727|NCT00626093|565117559|FG000|Overall Study|Lost to Follow-up|5|||
156553728|NCT00626093|565117559|FG000|Overall Study|Death|1|||
156553729|NCT00626093|565117559|FG000|Overall Study|Physician Decision|4|||
156553730|NCT00626093|565117559|FG000|Overall Study|Withdrawal by Subject|6|||
156553731|NCT00626093|565117559|FG000|Overall Study|Protocol Violation|1|||
156404602|NCT02739347|564575568|FG000|Overall Study|Protocol Violation|0|||
156404603|NCT02739347|564575569|FG001|Overall Study|Protocol Violation|1|||
156404604|NCT02739347|564575568|FG000|Overall Study|Lost to Follow-up|0|||
156404605|NCT02739347|564575569|FG001|Overall Study|Lost to Follow-up|2|||
156404606|NCT01235403|564575571|FG000|Overall Study|Adverse Event|14|||
156404607|NCT01235403|564575571|FG000|Overall Study|Lost to Follow-up|2|||
156404608|NCT01235403|564575571|FG000|Overall Study|Withdrawal by Subject|4|||
156404609|NCT01235403|564575571|FG000|Overall Study|Lack of Efficacy|2|||
156404610|NCT01235403|564575571|FG000|Overall Study|Other reasons for premature termination|4|||
156404611|NCT03682705|564575572|FG000|Overall Study|Adverse Event|1|||
156404612|NCT03682705|564575573|FG001|Overall Study|Adverse Event|1|||
156404613|NCT03682705|564575574|FG002|Overall Study|Adverse Event|1|||
156404614|NCT03682705|564575575|FG003|Overall Study|Adverse Event|0|||
156404615|NCT03682705|564575576|FG004|Overall Study|Adverse Event|1|||
156404616|NCT03682705|564575577|FG005|Overall Study|Adverse Event|1|||
156404617|NCT03682705|564575572|FG000|Overall Study|Withdrawal by Subject|1|||
156404618|NCT03682705|564575573|FG001|Overall Study|Withdrawal by Subject|3|||
156404619|NCT03682705|564575574|FG002|Overall Study|Withdrawal by Subject|2|||
156404620|NCT03682705|564575575|FG003|Overall Study|Withdrawal by Subject|4|||
156404621|NCT03682705|564575576|FG004|Overall Study|Withdrawal by Subject|0|||
156404622|NCT03682705|564575577|FG005|Overall Study|Withdrawal by Subject|1|||
156404623|NCT03682705|564575572|FG000|Overall Study|Other, not specified|0|||
156404624|NCT03682705|564575573|FG001|Overall Study|Other, not specified|0|||
156404625|NCT03682705|564575574|FG002|Overall Study|Other, not specified|0|||
156404626|NCT03682705|564575575|FG003|Overall Study|Other, not specified|1|||
156404627|NCT03682705|564575576|FG004|Overall Study|Other, not specified|2|||
156404628|NCT03682705|564575577|FG005|Overall Study|Other, not specified|0|||
156404629|NCT03682705|564575572|FG000|Overall Study|Lost to Follow-up|0|||
156404630|NCT03682705|564575573|FG001|Overall Study|Lost to Follow-up|0|||
156404631|NCT03682705|564575574|FG002|Overall Study|Lost to Follow-up|0|||
156404632|NCT03682705|564575575|FG003|Overall Study|Lost to Follow-up|0|||
156404633|NCT03682705|564575576|FG004|Overall Study|Lost to Follow-up|3|||
156404634|NCT03682705|564575577|FG005|Overall Study|Lost to Follow-up|0|||
156404635|NCT00265330|564575578|FG000|Overall Study|Adverse Event|41|||
156404636|NCT00265330|564575578|FG000|Overall Study|Lost to Follow-up|8|||
156404637|NCT00265330|564575578|FG000|Overall Study|Withdrawal by Subject|34|||
156404638|NCT00265330|564575578|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
156404639|NCT00265330|564575578|FG000|Overall Study|Lack of Efficacy|4|||
156404640|NCT00265330|564575578|FG000|Overall Study|Family Scheduling Conflicts|1|||
156404641|NCT00265330|564575578|FG000|Overall Study|Began Taking Formulary Geodon|1|||
156404642|NCT00265330|564575578|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
156404643|NCT00265330|564575578|FG000|Overall Study|Site Closed by Sponsor|1|||
156404644|NCT00265330|564575578|FG000|Overall Study|Principal Investigators Request|1|||
156404645|NCT00265330|564575578|FG000|Overall Study|Withdrew Consent|1|||
156404646|NCT00265330|564575578|FG000|Overall Study|Protocol Violation|1|||
156404647|NCT04043962|564575579|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
156404648|NCT04043962|564575579|FG000|Post-Treatment|Withdrawal by Subject|5|||
156404649|NCT04043962|564575579|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
156404650|NCT02658630|564575580|FG000|Overall Study|Withdrawal by Subject|4|||
156404651|NCT02613221|564575581|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
156404652|NCT02613221|564575581|FG000|Overall Study|Adverse Event|2|||
156404653|NCT02613221|564575581|FG000|Overall Study|Voluntary Discontinuation|1|||
156404654|NCT02613221|564575581|FG000|Overall Study|Delayed Treatment|1|||
156404655|NCT02613221|564575581|FG000|Overall Study|Enrolled but Not Treated|1|||
156404656|NCT01654601|564575589|FG000|1st Administration|Withdrawal by Subject|2|||
156404657|NCT01654601|564575590|FG001|1st Administration|Withdrawal by Subject|0|||
156404658|NCT01654601|564575589|FG000|1st Administration|Protocol Violation|0|||
156404659|NCT01654601|564575590|FG001|1st Administration|Protocol Violation|2|||
156404660|NCT01654601|564575589|FG000|2nd Administration|Adverse Event|1|||
156512543|NCT00653523|564968263|FG000|Overall Study|Withdrawal by Subject|6|||
156512544|NCT00653523|564968263|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
156512545|NCT00653523|564968263|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
156512546|NCT00186888|564968266|FG000|Overall Study|Toxicity|0|||
156512547|NCT00186888|564968267|FG001|Overall Study|Toxicity|1|||
156512548|NCT00186888|564968268|FG002|Overall Study|Toxicity|0|||
156512549|NCT00186888|564968266|FG000|Overall Study|Relapse or progression of disease|4|||
156512550|NCT00186888|564968267|FG001|Overall Study|Relapse or progression of disease|2|||
156512551|NCT00186888|564968268|FG002|Overall Study|Relapse or progression of disease|0|||
156512552|NCT05511038|564968269|FG000|Overall|Withdrawal by Subject|5|||
156512553|NCT05511038|564968270|FG001|Overall|Withdrawal by Subject|3|||
156512554|NCT05511038|564968269|FG000|Overall|Screen Failure|20|||
156512555|NCT05511038|564968270|FG001|Overall|Screen Failure|1|||
156404661|NCT01654601|564575590|FG001|2nd Administration|Adverse Event|0|||
156404662|NCT01654601|564575589|FG000|2nd Administration|Protocol Violation|0|||
156404663|NCT01654601|564575590|FG001|2nd Administration|Protocol Violation|1|||
156404664|NCT02636270|564575591|FG000|Overall Study|Adverse Event|1|||
156404665|NCT02636270|564575592|FG001|Overall Study|Adverse Event|0|||
156404666|NCT02636270|564575593|FG002|Overall Study|Adverse Event|0|||
156404667|NCT02636270|564575591|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
156404668|NCT02636270|564575592|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
156404669|NCT02636270|564575593|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
156404670|NCT01833143|564575594|FG000|Overall Study|Not Treated|1|||
156404671|NCT01786330|564575597|FG000|Overall Study|Withdrawal by Subject|0|||
156404672|NCT01786330|564575598|FG001|Overall Study|Withdrawal by Subject|1|||
156404673|NCT01786330|564575597|FG000|Overall Study|Lost to Follow-up|0|||
156404674|NCT01786330|564575598|FG001|Overall Study|Lost to Follow-up|1|||
156404675|NCT01786330|564575597|FG000|Overall Study|Excluded intraoperatively|0|||
156404676|NCT01786330|564575598|FG001|Overall Study|Excluded intraoperatively|1|||
156404677|NCT01786330|564575597|FG000|Overall Study|Protocol Violation|1|||
156404678|NCT01786330|564575598|FG001|Overall Study|Protocol Violation|0|||
156404679|NCT00553202|564577131|FG000|Overall Study|Death|16|||
156404680|NCT00553202|564577131|FG000|Overall Study|Lost to Follow-up|1|||
156404681|NCT00553202|564577131|FG000|Overall Study|Physician Decision|28|||
156404682|NCT00553202|564577131|FG000|Overall Study|Withdrawal by Subject|1|||
156404683|NCT00553202|564577131|FG000|Overall Study|No donor identified|16|||
156404684|NCT00553202|564577131|FG000|Overall Study|Fails to meet organ function|6|||
156404685|NCT00369681|564577132|FG000|Overall Study|Death|1|||
156404686|NCT02966002|564577139|FG000|Overall Study|Withdrawal by Subject|2|||
156404687|NCT02966002|564577139|FG000|Overall Study|Adverse Event|1|||
156404688|NCT02966002|564577139|FG000|Overall Study|Lost to Follow-up|1|||
156404689|NCT02291432|564577140|FG000|Overall Study|Withdrawal by Subject|2|||
156404690|NCT02145078|564577143|FG000|Overall Study|Death|1|||
156404691|NCT02145078|564577143|FG000|Overall Study|Reason not given|3|||
156404692|NCT01350141|564577144|FG000|Overall Study|Lost to Follow-up|1|||
156404693|NCT01350141|564577145|FG001|Overall Study|Lost to Follow-up|0|||
156404694|NCT01350141|564577146|FG002|Overall Study|Lost to Follow-up|1|||
156404695|NCT01350141|564577144|FG000|Overall Study|Withdrawal by Subject|1|||
156404696|NCT01350141|564577145|FG001|Overall Study|Withdrawal by Subject|0|||
156404697|NCT01350141|564577146|FG002|Overall Study|Withdrawal by Subject|0|||
156404698|NCT01350141|564577144|FG000|Overall Study|Randomized but not treated|1|||
156404699|NCT01350141|564577145|FG001|Overall Study|Randomized but not treated|0|||
156404700|NCT01350141|564577146|FG002|Overall Study|Randomized but not treated|0|||
156404701|NCT02367716|564577147|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
156404702|NCT01473381|564577148|FG000|Overall Study|Adverse Event|8|||
156404703|NCT01473381|564577149|FG001|Overall Study|Adverse Event|20|||
156404704|NCT01473381|564577150|FG002|Overall Study|Adverse Event|25|||
156404705|NCT01473381|564577151|FG003|Overall Study|Adverse Event|17|||
156404706|NCT01473381|564577148|FG000|Overall Study|Insufficient Therapeutic Response|10|||
156404707|NCT01473381|564577149|FG001|Overall Study|Insufficient Therapeutic Response|1|||
156404708|NCT01473381|564577150|FG002|Overall Study|Insufficient Therapeutic Response|2|||
156404709|NCT01473381|564577151|FG003|Overall Study|Insufficient Therapeutic Response|3|||
156404710|NCT01473381|564577148|FG000|Overall Study|Protocol Violation|17|||
156404711|NCT01473381|564577149|FG001|Overall Study|Protocol Violation|23|||
156404712|NCT01473381|564577150|FG002|Overall Study|Protocol Violation|19|||
156404713|NCT01473381|564577151|FG003|Overall Study|Protocol Violation|17|||
156404714|NCT01473381|564577148|FG000|Overall Study|Withdrawal of Consent|20|||
156404715|NCT01473381|564577149|FG001|Overall Study|Withdrawal of Consent|21|||
156512556|NCT05511038|564968269|FG000|Overall|Physician Decision|3|||
156512557|NCT05511038|564968270|FG001|Overall|Physician Decision|0|||
156512558|NCT05511038|564968269|FG000|Overall|Lost to Follow-up|3|||
156512559|NCT05511038|564968270|FG001|Overall|Lost to Follow-up|0|||
156512560|NCT05511038|564968269|FG000|Overall|Death|1|||
156512561|NCT05511038|564968270|FG001|Overall|Death|0|||
156512562|NCT05511038|564968269|FG000|Screening|Withdrawal by Subject|1|||
156512563|NCT05511038|564968270|FG001|Screening|Withdrawal by Subject|0|||
156512564|NCT05511038|564968269|FG000|Screening|Lost to Follow Up (1 participant)|1|||
156512565|NCT05511038|564968270|FG001|Screening|Lost to Follow Up (1 participant)|0|||
156512566|NCT05511038|564968269|FG000|Screening|Screen Failure|3|||
156512567|NCT05511038|564968270|FG001|Screening|Screen Failure|0|||
156512568|NCT05511038|564968269|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
156512569|NCT05511038|564968270|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
156512570|NCT05511038|564968269|FG000|Treatment|Withdrawal by Subject|5|||
156512571|NCT05511038|564968270|FG001|Treatment|Withdrawal by Subject|3|||
156512572|NCT05511038|564968269|FG000|Treatment|Physician Decision|4|||
156404716|NCT01473381|564577150|FG002|Overall Study|Withdrawal of Consent|20|||
156404717|NCT01473381|564577151|FG003|Overall Study|Withdrawal of Consent|26|||
156404718|NCT01473381|564577148|FG000|Overall Study|Lost to Follow-up|25|||
156404719|NCT01473381|564577149|FG001|Overall Study|Lost to Follow-up|28|||
156404720|NCT01473381|564577150|FG002|Overall Study|Lost to Follow-up|35|||
156512573|NCT05511038|564968270|FG001|Treatment|Physician Decision|0|||
156404721|NCT01473381|564577151|FG003|Overall Study|Lost to Follow-up|23|||
156404722|NCT01473381|564577148|FG000|Overall Study|Other Reasons|0|||
156404723|NCT01473381|564577149|FG001|Overall Study|Other Reasons|0|||
156404724|NCT01473381|564577150|FG002|Overall Study|Other Reasons|1|||
156404725|NCT01473381|564577151|FG003|Overall Study|Other Reasons|3|||
156404726|NCT02508532|564577157|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156404727|NCT02508532|564577158|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156404728|NCT02508532|564577159|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156404729|NCT02508532|564577160|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156404730|NCT02508532|564577161|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156404731|NCT02508532|564577162|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156404732|NCT02508532|564577163|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
156404733|NCT02508532|564577164|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156404734|NCT02508532|564577165|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156404735|NCT02508532|564577157|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
156404736|NCT02508532|564577158|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
156404737|NCT02508532|564577159|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
156404738|NCT02508532|564577160|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
156404739|NCT02508532|564577161|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
156404740|NCT02508532|564577162|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
156404741|NCT02508532|564577163|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
156404742|NCT02508532|564577164|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
156404743|NCT02508532|564577165|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
156404744|NCT02508532|564577157|FG000|Part 2 - Treatment|Disease Progression|0|||
156404745|NCT02508532|564577158|FG001|Part 2 - Treatment|Disease Progression|0|||
156404746|NCT02508532|564577159|FG002|Part 2 - Treatment|Disease Progression|0|||
156404747|NCT02508532|564577160|FG003|Part 2 - Treatment|Disease Progression|0|||
156404748|NCT02508532|564577161|FG004|Part 2 - Treatment|Disease Progression|0|||
156404749|NCT02508532|564577162|FG005|Part 2 - Treatment|Disease Progression|0|||
156404750|NCT02508532|564577163|FG006|Part 2 - Treatment|Disease Progression|0|||
156404751|NCT02508532|564577164|FG007|Part 2 - Treatment|Disease Progression|0|||
156404752|NCT02508532|564577165|FG008|Part 2 - Treatment|Disease Progression|118|||
156404753|NCT02508532|564577157|FG000|Part 2 - Treatment|Adverse Event|0|||
156404754|NCT02508532|564577158|FG001|Part 2 - Treatment|Adverse Event|0|||
156404755|NCT02508532|564577159|FG002|Part 2 - Treatment|Adverse Event|0|||
156404756|NCT02508532|564577160|FG003|Part 2 - Treatment|Adverse Event|0|||
156512574|NCT05511038|564968269|FG000|Treatment|Lost to Follow-up|2|||
156512575|NCT05511038|564968270|FG001|Treatment|Lost to Follow-up|0|||
156512576|NCT05511038|564968269|FG000|Treatment|Death|1|||
156512577|NCT05511038|564968270|FG001|Treatment|Death|0|||
156512578|NCT05511038|564968269|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
156512579|NCT05511038|564968270|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
156512580|NCT05511038|564968269|FG000|Treatment|Refuse by subject|1|||
156512581|NCT05511038|564968270|FG001|Treatment|Refuse by subject|0|||
156512582|NCT05511038|564968269|FG000|Treatment|Subject did not go to the site for visit|1|||
156512583|NCT05511038|564968270|FG001|Treatment|Subject did not go to the site for visit|0|||
156512584|NCT02108964|564968271|FG000|Overall Study|Progressive disease|15|||
156512585|NCT02108964|564968272|FG001|Overall Study|Progressive disease|31|||
156512586|NCT02108964|564968273|FG002|Overall Study|Progressive disease|54|||
156512587|NCT02108964|564968274|FG003|Overall Study|Progressive disease|7|||
156512588|NCT02108964|564968275|FG004|Overall Study|Progressive disease|20|||
156512589|NCT02108964|564968276|FG005|Overall Study|Progressive disease|4|||
156512590|NCT02108964|564968277|FG006|Overall Study|Progressive disease|6|||
156512591|NCT02108964|564968278|FG007|Overall Study|Progressive disease|33|||
156512592|NCT02108964|564968271|FG000|Overall Study|Physician Decision|1|||
156512593|NCT02108964|564968272|FG001|Overall Study|Physician Decision|5|||
156512594|NCT02108964|564968273|FG002|Overall Study|Physician Decision|7|||
156512595|NCT02108964|564968274|FG003|Overall Study|Physician Decision|1|||
156512596|NCT02108964|564968275|FG004|Overall Study|Physician Decision|2|||
156512597|NCT02108964|564968276|FG005|Overall Study|Physician Decision|1|||
156512598|NCT02108964|564968277|FG006|Overall Study|Physician Decision|1|||
156512599|NCT02108964|564968278|FG007|Overall Study|Physician Decision|3|||
156404757|NCT02508532|564577161|FG004|Part 2 - Treatment|Adverse Event|0|||
156404758|NCT02508532|564577162|FG005|Part 2 - Treatment|Adverse Event|0|||
156404759|NCT02508532|564577163|FG006|Part 2 - Treatment|Adverse Event|0|||
156512600|NCT02108964|564968271|FG000|Overall Study|Adverse Event|0|||
156404760|NCT02508532|564577164|FG007|Part 2 - Treatment|Adverse Event|0|||
156404761|NCT02508532|564577165|FG008|Part 2 - Treatment|Adverse Event|49|||
156404762|NCT02508532|564577157|FG000|Part 2 - Treatment|Physician Decision|0|||
156404763|NCT02508532|564577158|FG001|Part 2 - Treatment|Physician Decision|0|||
156404764|NCT02508532|564577159|FG002|Part 2 - Treatment|Physician Decision|0|||
156512601|NCT02108964|564968272|FG001|Overall Study|Adverse Event|0|||
156512602|NCT02108964|564968273|FG002|Overall Study|Adverse Event|4|||
156512603|NCT02108964|564968274|FG003|Overall Study|Adverse Event|0|||
156512604|NCT02108964|564968275|FG004|Overall Study|Adverse Event|1|||
156512605|NCT02108964|564968276|FG005|Overall Study|Adverse Event|0|||
156404765|NCT02508532|564577160|FG003|Part 2 - Treatment|Physician Decision|0|||
156404766|NCT02508532|564577161|FG004|Part 2 - Treatment|Physician Decision|0|||
156404767|NCT02508532|564577162|FG005|Part 2 - Treatment|Physician Decision|0|||
156404768|NCT02508532|564577163|FG006|Part 2 - Treatment|Physician Decision|0|||
156404769|NCT02508532|564577164|FG007|Part 2 - Treatment|Physician Decision|0|||
156404770|NCT02508532|564577165|FG008|Part 2 - Treatment|Physician Decision|12|||
156404771|NCT02508532|564577157|FG000|Part 2 - Treatment|Administrative|0|||
156404772|NCT02508532|564577158|FG001|Part 2 - Treatment|Administrative|0|||
156404773|NCT02508532|564577159|FG002|Part 2 - Treatment|Administrative|0|||
156404774|NCT02508532|564577160|FG003|Part 2 - Treatment|Administrative|0|||
156404775|NCT02508532|564577161|FG004|Part 2 - Treatment|Administrative|0|||
156404776|NCT02508532|564577162|FG005|Part 2 - Treatment|Administrative|0|||
156404777|NCT02508532|564577163|FG006|Part 2 - Treatment|Administrative|0|||
156404778|NCT02508532|564577164|FG007|Part 2 - Treatment|Administrative|0|||
156404779|NCT02508532|564577165|FG008|Part 2 - Treatment|Administrative|3|||
156404780|NCT02508532|564577157|FG000|Part 2 - Treatment|Sponsor Decision|0|||
156404781|NCT02508532|564577158|FG001|Part 2 - Treatment|Sponsor Decision|0|||
156404782|NCT02508532|564577159|FG002|Part 2 - Treatment|Sponsor Decision|0|||
156404783|NCT02508532|564577160|FG003|Part 2 - Treatment|Sponsor Decision|0|||
156404784|NCT02508532|564577161|FG004|Part 2 - Treatment|Sponsor Decision|0|||
156404785|NCT02508532|564577162|FG005|Part 2 - Treatment|Sponsor Decision|0|||
156404786|NCT02508532|564577163|FG006|Part 2 - Treatment|Sponsor Decision|0|||
156404787|NCT02508532|564577164|FG007|Part 2 - Treatment|Sponsor Decision|0|||
156404788|NCT02508532|564577165|FG008|Part 2 - Treatment|Sponsor Decision|28|||
156404789|NCT02508532|564577157|FG000|Part 2 - Treatment|Death|0|||
156404790|NCT02508532|564577158|FG001|Part 2 - Treatment|Death|0|||
156404791|NCT02508532|564577159|FG002|Part 2 - Treatment|Death|0|||
156404792|NCT02508532|564577160|FG003|Part 2 - Treatment|Death|0|||
156404793|NCT02508532|564577161|FG004|Part 2 - Treatment|Death|0|||
156404794|NCT02508532|564577162|FG005|Part 2 - Treatment|Death|0|||
156404795|NCT02508532|564577163|FG006|Part 2 - Treatment|Death|0|||
156404796|NCT02508532|564577164|FG007|Part 2 - Treatment|Death|0|||
156404797|NCT02508532|564577165|FG008|Part 2 - Treatment|Death|1|||
156404798|NCT02508532|564577157|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
156404799|NCT02508532|564577158|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
156404800|NCT02508532|564577159|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
156404801|NCT02508532|564577160|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
156404802|NCT02508532|564577161|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
156404803|NCT02508532|564577162|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
156404804|NCT02508532|564577163|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
156404805|NCT02508532|564577164|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
156404806|NCT02508532|564577165|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
156404807|NCT02508532|564577157|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
156404808|NCT02508532|564577158|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
156404809|NCT02508532|564577159|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
156404810|NCT02508532|564577160|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
156404811|NCT02508532|564577161|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
156404812|NCT02508532|564577162|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
156404813|NCT02508532|564577163|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
156404814|NCT02508532|564577164|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
156404815|NCT02508532|564577165|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
156404816|NCT02508532|564577157|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
156404817|NCT02508532|564577158|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
156404818|NCT02508532|564577159|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
156404819|NCT02508532|564577160|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
156404820|NCT02508532|564577161|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
156404821|NCT02508532|564577162|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
156404822|NCT02508532|564577163|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
156404823|NCT02508532|564577164|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
156404824|NCT02508532|564577165|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
156404825|NCT02508532|564577157|FG000|Part 1 and Part 2 End of Study|Death|0|||
156404826|NCT02508532|564577158|FG001|Part 1 and Part 2 End of Study|Death|4|||
156404827|NCT02508532|564577159|FG002|Part 1 and Part 2 End of Study|Death|2|||
156404828|NCT02508532|564577160|FG003|Part 1 and Part 2 End of Study|Death|4|||
156404829|NCT02508532|564577161|FG004|Part 1 and Part 2 End of Study|Death|3|||
156404830|NCT02508532|564577162|FG005|Part 1 and Part 2 End of Study|Death|0|||
156404831|NCT02508532|564577163|FG006|Part 1 and Part 2 End of Study|Death|0|||
156404832|NCT02508532|564577164|FG007|Part 1 and Part 2 End of Study|Death|1|||
156404833|NCT02508532|564577165|FG008|Part 1 and Part 2 End of Study|Death|111|||
156404834|NCT02508532|564577157|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
156404835|NCT02508532|564577158|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
156404836|NCT02508532|564577159|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
156404837|NCT02508532|564577160|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156404838|NCT02508532|564577161|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156512606|NCT02108964|564968277|FG006|Overall Study|Adverse Event|3|||
156404839|NCT02508532|564577162|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156404840|NCT02508532|564577163|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156404841|NCT02508532|564577164|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156404842|NCT02508532|564577165|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
156404843|NCT02508532|564577157|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156404844|NCT02508532|564577158|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156404845|NCT02508532|564577159|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156404846|NCT02508532|564577160|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156404847|NCT02508532|564577161|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156404848|NCT02508532|564577162|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156404849|NCT02508532|564577163|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156404850|NCT02508532|564577164|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156404851|NCT02508532|564577165|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
156404852|NCT02508532|564577157|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
156404853|NCT02508532|564577158|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
156404854|NCT02508532|564577159|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
156404855|NCT02508532|564577160|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
156404856|NCT02508532|564577161|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
156404857|NCT02508532|564577162|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
156404858|NCT02508532|564577163|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
156404859|NCT02508532|564577164|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
156404860|NCT02508532|564577165|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
156404861|NCT02508532|564577157|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156404862|NCT02508532|564577158|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156404863|NCT02508532|564577159|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156404864|NCT02508532|564577160|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156404865|NCT02508532|564577161|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156404866|NCT02508532|564577162|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156404867|NCT02508532|564577163|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156404868|NCT02508532|564577164|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156404869|NCT02508532|564577165|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
156404870|NCT02508532|564577157|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
156404871|NCT02508532|564577158|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
156404872|NCT02508532|564577159|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
156404873|NCT02508532|564577160|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
156404874|NCT02508532|564577161|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
156404875|NCT02508532|564577162|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
156404876|NCT02508532|564577163|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
156404877|NCT02508532|564577164|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
156404878|NCT02508532|564577165|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
156404879|NCT04503096|564577168|FG000|Overall Study|Withdrawal by Subject|3|||
156404880|NCT01576367|564577169|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156404881|NCT01576367|564577169|FG000|Overall Study|Moved to commercial use after 6 months|1|||
156404882|NCT04399356|564577173|FG000|Overall Study|Lost to Follow-up|1|||
156404883|NCT04399356|564577174|FG001|Overall Study|Lost to Follow-up|1|||
156404884|NCT04399356|564577173|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
156404885|NCT04399356|564577174|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
156404886|NCT04399356|564577173|FG000|Overall Study|Withdrawal by Subject|1|||
156404887|NCT04399356|564577174|FG001|Overall Study|Withdrawal by Subject|0|||
156404888|NCT04359771|564577175|FG000|Overall Study|Lack of Efficacy|2|||
156404889|NCT04359771|564577176|FG001|Overall Study|Lack of Efficacy|2|||
156404890|NCT02091739|564577177|FG000|MP: 16 Weeks|Adverse Event|1|||
156404891|NCT02091739|564577178|FG001|MP: 16 Weeks|Adverse Event|1|||
156404892|NCT02091739|564577179|FG002|MP: 16 Weeks|Adverse Event|1|||
156404893|NCT02091739|564577180|FG003|MP: 16 Weeks|Adverse Event|0|||
156404894|NCT02091739|564577181|FG004|MP: 16 Weeks|Adverse Event|0|||
156404895|NCT02091739|564577177|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
156404896|NCT02091739|564577178|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
156404897|NCT02091739|564577179|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
156404898|NCT02091739|564577180|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
156404899|NCT02091739|564577181|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
156512607|NCT02108964|564968278|FG007|Overall Study|Adverse Event|2|||
156512608|NCT02108964|564968271|FG000|Overall Study|Death|1|||
156512609|NCT02108964|564968272|FG001|Overall Study|Death|1|||
156512610|NCT02108964|564968273|FG002|Overall Study|Death|4|||
156512611|NCT02108964|564968274|FG003|Overall Study|Death|0|||
156512612|NCT02108964|564968275|FG004|Overall Study|Death|3|||
156512613|NCT02108964|564968276|FG005|Overall Study|Death|0|||
156512614|NCT02108964|564968277|FG006|Overall Study|Death|0|||
156512615|NCT02108964|564968278|FG007|Overall Study|Death|2|||
156512616|NCT02108964|564968271|FG000|Overall Study|Subject/Guardian decision|0|||
156512617|NCT02108964|564968272|FG001|Overall Study|Subject/Guardian decision|1|||
156553732|NCT00626093|565117559|FG000|Overall Study|One of the required devices not implante|6|||
156553733|NCT01632566|565117560|FG000|Overall Study|Withdrawal by Subject|0|||
156553734|NCT01632566|565117561|FG001|Overall Study|Withdrawal by Subject|1|||
156553735|NCT01632566|565117562|FG002|Overall Study|Withdrawal by Subject|0|||
156553736|NCT01632566|565117563|FG003|Overall Study|Withdrawal by Subject|0|||
156553737|NCT01632566|565117564|FG004|Overall Study|Withdrawal by Subject|0|||
156553738|NCT01632566|565117560|FG000|Overall Study|Sponsor Decision|0|||
156553739|NCT01632566|565117561|FG001|Overall Study|Sponsor Decision|2|||
156553740|NCT01632566|565117562|FG002|Overall Study|Sponsor Decision|9|||
156553741|NCT01632566|565117563|FG003|Overall Study|Sponsor Decision|2|||
156553742|NCT01632566|565117564|FG004|Overall Study|Sponsor Decision|2|||
156553743|NCT03208231|565117565|FG000|Overall Study|Death|1|||
156553744|NCT03208231|565117566|FG001|Overall Study|Death|2|||
156553745|NCT03208231|565117565|FG000|Overall Study|Moved and unable to get to clinic|1|||
156553746|NCT03208231|565117566|FG001|Overall Study|Moved and unable to get to clinic|0|||
156553747|NCT03208231|565117565|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
156553748|NCT03208231|565117566|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
156553749|NCT04982250|565117572|FG000|Overall Study|Lost to Follow-up|0|||
156553750|NCT04982250|565117573|FG001|Overall Study|Lost to Follow-up|26|||
156553751|NCT04982250|565117574|FG002|Overall Study|Lost to Follow-up|0|||
156553752|NCT04982250|565117575|FG003|Overall Study|Lost to Follow-up|0|||
156553753|NCT04982250|565117576|FG004|Overall Study|Lost to Follow-up|72|||
156553754|NCT04982250|565117577|FG005|Overall Study|Lost to Follow-up|69|||
156553755|NCT04982250|565117572|FG000|Overall Study|Not Eligible to Enroll|0|||
156553756|NCT04982250|565117573|FG001|Overall Study|Not Eligible to Enroll|0|||
156553757|NCT04982250|565117574|FG002|Overall Study|Not Eligible to Enroll|0|||
156553758|NCT04982250|565117575|FG003|Overall Study|Not Eligible to Enroll|0|||
156553759|NCT04982250|565117576|FG004|Overall Study|Not Eligible to Enroll|10|||
156553760|NCT04982250|565117577|FG005|Overall Study|Not Eligible to Enroll|7|||
156553761|NCT04153188|565117585|FG000|Overall Study|Lost to Follow-up|1|||
156553762|NCT04153188|565117586|FG001|Overall Study|Lost to Follow-up|1|||
156553763|NCT04153188|565117585|FG000|Overall Study|Withdrawal by Subject|2|||
156553764|NCT04153188|565117586|FG001|Overall Study|Withdrawal by Subject|0|||
156553765|NCT04153188|565117585|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
156553766|NCT04153188|565117586|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
156553767|NCT01489527|565117587|FG000|Overall Study|Pregnancy|9|||
156553768|NCT01489527|565117588|FG001|Overall Study|Pregnancy|14|||
156553769|NCT01489527|565117587|FG000|Overall Study|Participant moved|6|||
156553770|NCT01489527|565117588|FG001|Overall Study|Participant moved|7|||
156553771|NCT01489527|565117587|FG000|Overall Study|Withdrawal by Subject|0|||
156553772|NCT01489527|565117588|FG001|Overall Study|Withdrawal by Subject|4|||
156553773|NCT01489527|565117587|FG000|Overall Study|Lost to Follow-up|5|||
156553774|NCT01489527|565117588|FG001|Overall Study|Lost to Follow-up|1|||
156553775|NCT01489527|565117587|FG000|Overall Study|Procedures|1|||
156553776|NCT01489527|565117588|FG001|Overall Study|Procedures|0|||
156553777|NCT01489527|565117587|FG000|Overall Study|Not compliant|1|||
156553778|NCT01489527|565117588|FG001|Overall Study|Not compliant|0|||
156553779|NCT02926950|565117589|FG000|Overall Study|Adverse Event|4|||
156553780|NCT02926950|565117590|FG001|Overall Study|Adverse Event|6|||
156553781|NCT02926950|565117589|FG000|Overall Study|At the participant's own request|21|||
156553782|NCT02926950|565117590|FG001|Overall Study|At the participant's own request|25|||
156553783|NCT02926950|565117589|FG000|Overall Study|Reason not Specified|17|||
156553784|NCT02926950|565117590|FG001|Overall Study|Reason not Specified|9|||
156553785|NCT02926950|565117589|FG000|Overall Study|Lost to Follow-up|7|||
156553786|NCT02926950|565117590|FG001|Overall Study|Lost to Follow-up|8|||
156553787|NCT04622046|565117591|FG000|Intervention Period|Adverse Event|1|||
156553788|NCT04622046|565117591|FG000|Intervention Period|Withdrawal by Subject|2|||
156553789|NCT04622046|565117591|FG000|Extension Period|Ongoing in the Extension Period|21|||
156553790|NCT02553460|565117592|FG000|Overall Study|Death|3|||
156553791|NCT02553460|565117592|FG000|Overall Study|Withdrawal by Subject|1|||
156553792|NCT02553460|565117592|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
156404900|NCT02091739|564577177|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
156404901|NCT02091739|564577178|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
156553793|NCT02553460|565117592|FG000|Overall Study|Relapse or Transplant|14|||
156553794|NCT02553460|565117592|FG000|Overall Study|No response to treatment|2|||
156553795|NCT02553460|565117592|FG000|Overall Study|CAR T cells|2|||
156553796|NCT03505021|565117593|FG000|Overall Study|Protocol Violation|1|||
156553797|NCT03505021|565117594|FG001|Overall Study|Protocol Violation|0|||
156553798|NCT03505021|565117593|FG000|Overall Study|Death|9|||
156553799|NCT03505021|565117594|FG001|Overall Study|Death|8|||
156553800|NCT03505021|565117593|FG000|Overall Study|Consent withdrawn by subject|6|||
156404902|NCT02091739|564577179|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
156553801|NCT03505021|565117594|FG001|Overall Study|Consent withdrawn by subject|1|||
156404903|NCT02091739|564577180|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
156553802|NCT03505021|565117593|FG000|Overall Study|Lost to Follow-up|5|||
156553803|NCT03505021|565117594|FG001|Overall Study|Lost to Follow-up|3|||
156553804|NCT03505021|565117593|FG000|Overall Study|Adverse Event|26|||
156553805|NCT03505021|565117594|FG001|Overall Study|Adverse Event|9|||
156553806|NCT03505021|565117593|FG000|Overall Study|Disease progression|33|||
156553807|NCT03505021|565117594|FG001|Overall Study|Disease progression|17|||
156553808|NCT03505021|565117593|FG000|Overall Study|Other|11|||
156553809|NCT03505021|565117594|FG001|Overall Study|Other|5|||
156553810|NCT03505021|565117593|FG000|Overall Study|Personal reason|21|||
156553811|NCT03505021|565117594|FG001|Overall Study|Personal reason|12|||
156553812|NCT01844986|565117595|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
156553813|NCT01844986|565117596|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
156553814|NCT01844986|565117595|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
156553815|NCT01844986|565117596|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
156553816|NCT01844986|565117595|FG000|Overall Study (Global Cohort)|Death|55|||
156553817|NCT01844986|565117596|FG001|Overall Study (Global Cohort)|Death|26|||
156553818|NCT01844986|565117595|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
156553819|NCT01844986|565117596|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
156553820|NCT01844986|565117595|FG000|Overall Study (China Cohort)|Death|10|||
156553821|NCT01844986|565117596|FG001|Overall Study (China Cohort)|Death|6|||
156553822|NCT02392429|565119724|FG000|Screening|Screen failure|15|||
156553823|NCT02392429|565119724|FG000|Enrolled Participants|Ineligible due to disease|3|||
156553824|NCT02392429|565119724|FG000|Enrolled Participants|Withdrawal by Subject|4|||
156553825|NCT02392429|565119724|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
156553826|NCT02392429|565119724|FG000|Evaluable|Death|5|||
156553827|NCT02392429|565119724|FG000|Evaluable|Withdrawal by Subject|1|||
156553828|NCT02392429|565119724|FG000|Evaluable|Adverse Event|1|||
156553829|NCT02392429|565119724|FG000|Evaluable|remission bone marrow biopsy|3|||
156553830|NCT01178138|565119725|FG000|Overall Study|Lost to Follow-up|8|||
156553831|NCT01178138|565119725|FG000|Overall Study|Withdrawal by Subject|7|||
156553832|NCT01178138|565119725|FG000|Overall Study|Physician Decision|8|||
156553833|NCT00403260|565119726|FG000|Overall Study|Adverse Event|5|||
156553834|NCT00403260|565119727|FG001|Overall Study|Adverse Event|4|||
156553835|NCT00403260|565119726|FG000|Overall Study|Withdrawal by Subject|5|||
156553836|NCT00403260|565119727|FG001|Overall Study|Withdrawal by Subject|6|||
156553837|NCT00403260|565119726|FG000|Overall Study|Lost to Follow-up|49|||
156553838|NCT00403260|565119727|FG001|Overall Study|Lost to Follow-up|25|||
156553839|NCT00403260|565119726|FG000|Overall Study|Re-appearance of P. falciparum|34|||
156553840|NCT00403260|565119727|FG001|Overall Study|Re-appearance of P. falciparum|25|||
156553841|NCT00403260|565119726|FG000|Overall Study|P. vivax infection|26|||
156553842|NCT00403260|565119727|FG001|Overall Study|P. vivax infection|4|||
156553843|NCT00403260|565119726|FG000|Overall Study|Mixed infection with P. vivax|2|||
156553844|NCT00403260|565119727|FG001|Overall Study|Mixed infection with P. vivax|0|||
156553845|NCT00403260|565119726|FG000|Overall Study|Mixed infection with P. falciparum|1|||
156553846|NCT00403260|565119727|FG001|Overall Study|Mixed infection with P. falciparum|0|||
156553847|NCT00403260|565119726|FG000|Overall Study|P. vivax infection at screening|1|||
156553848|NCT00403260|565119727|FG001|Overall Study|P. vivax infection at screening|0|||
156553849|NCT00403260|565119726|FG000|Overall Study|P. ovale infection|1|||
156553850|NCT00403260|565119727|FG001|Overall Study|P. ovale infection|0|||
156553851|NCT00403260|565119726|FG000|Overall Study|Gametocyte re-appearance|1|||
156553852|NCT00403260|565119727|FG001|Overall Study|Gametocyte re-appearance|1|||
156553853|NCT00403260|565119726|FG000|Overall Study|Withdrawn from study accidentally|0|||
156553854|NCT00403260|565119727|FG001|Overall Study|Withdrawn from study accidentally|1|||
156553855|NCT01241708|565119728|FG000|Overall Study|Withdrawal by Subject|6|||
156553856|NCT01241708|565119728|FG000|Overall Study|Screen Failure|6|||
156553857|NCT01241708|565119728|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
156553858|NCT01241708|565119728|FG000|Overall Study|Lost to Follow-up|5|||
156553859|NCT04137887|565119729|FG000|Overall Study|Death|102|||
156553860|NCT04137887|565119730|FG001|Overall Study|Death|92|||
156553861|NCT04137887|565119729|FG000|Overall Study|Withdrawal by Subject|2|||
156553862|NCT04137887|565119730|FG001|Overall Study|Withdrawal by Subject|3|||
156553863|NCT04137887|565119729|FG000|Overall Study|Randomized but not treated|0|||
156553864|NCT04137887|565119730|FG001|Overall Study|Randomized but not treated|1|||
156553865|NCT01790503|565119733|FG000|Overall Study|Adverse Event|1|||
156553866|NCT01790503|565119734|FG001|Overall Study|Adverse Event|0|||
156553867|NCT01790503|565119735|FG002|Overall Study|Adverse Event|0|||
156553868|NCT01790503|565119736|FG003|Overall Study|Adverse Event|0|||
156553869|NCT01790503|565119737|FG004|Overall Study|Adverse Event|0|||
156553870|NCT01790503|565119738|FG005|Overall Study|Adverse Event|2|||
156553871|NCT01790503|565119739|FG006|Overall Study|Adverse Event|0|||
156553872|NCT01790503|565119740|FG007|Overall Study|Adverse Event|0|||
156553873|NCT01790503|565119741|FG008|Overall Study|Adverse Event|2|||
156553874|NCT01790503|565119742|FG009|Overall Study|Adverse Event|4|||
156553875|NCT01790503|565119743|FG010|Overall Study|Adverse Event|7|||
156553876|NCT01790503|565119733|FG000|Overall Study|Withdrawal by Subject|0|||
156553877|NCT01790503|565119734|FG001|Overall Study|Withdrawal by Subject|0|||
156553878|NCT01790503|565119735|FG002|Overall Study|Withdrawal by Subject|1|||
156553879|NCT01790503|565119736|FG003|Overall Study|Withdrawal by Subject|1|||
156553880|NCT01790503|565119737|FG004|Overall Study|Withdrawal by Subject|1|||
156404904|NCT02091739|564577181|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
156404905|NCT02091739|564577177|FG000|EP: 48 Weeks|Other|0|||
156404906|NCT02091739|564577178|FG001|EP: 48 Weeks|Other|0|||
156404907|NCT02091739|564577179|FG002|EP: 48 Weeks|Other|0|||
156404908|NCT02091739|564577180|FG003|EP: 48 Weeks|Other|1|||
156404909|NCT02091739|564577181|FG004|EP: 48 Weeks|Other|0|||
156404910|NCT02091739|564577177|FG000|EP: 48 Weeks|Death|0|||
156404911|NCT02091739|564577178|FG001|EP: 48 Weeks|Death|0|||
156404912|NCT02091739|564577179|FG002|EP: 48 Weeks|Death|0|||
156404913|NCT02091739|564577180|FG003|EP: 48 Weeks|Death|3|||
156404914|NCT02091739|564577181|FG004|EP: 48 Weeks|Death|2|||
156404915|NCT02091739|564577177|FG000|EP: 48 Weeks|Adverse Event|0|||
156404916|NCT02091739|564577178|FG001|EP: 48 Weeks|Adverse Event|0|||
156404917|NCT02091739|564577179|FG002|EP: 48 Weeks|Adverse Event|0|||
156404918|NCT02091739|564577180|FG003|EP: 48 Weeks|Adverse Event|2|||
156404919|NCT02091739|564577181|FG004|EP: 48 Weeks|Adverse Event|6|||
156404920|NCT02091739|564577177|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
156404921|NCT02091739|564577178|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
156404922|NCT02091739|564577179|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
156404923|NCT02091739|564577180|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
156404924|NCT02091739|564577181|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
156404925|NCT04041440|564577183|FG000|Overall Study|Withdrawal by Subject|0|||
156404926|NCT04041440|564577184|FG001|Overall Study|Withdrawal by Subject|1|||
156404927|NCT04041440|564577183|FG000|Overall Study|Lost to Follow-up|0|||
156404928|NCT04041440|564577184|FG001|Overall Study|Lost to Follow-up|1|||
156404929|NCT02306265|564577185|FG000|Overall Study|Withdrawal by Subject|1|||
156404930|NCT03002038|564577193|FG000|Overall Study|Adverse Event|3|||
156404931|NCT03002038|564577194|FG001|Overall Study|Adverse Event|1|||
156404932|NCT03002038|564577193|FG000|Overall Study|Withdrawal by Subject|8|||
156512618|NCT02108964|564968273|FG002|Overall Study|Subject/Guardian decision|4|||
156512619|NCT02108964|564968274|FG003|Overall Study|Subject/Guardian decision|0|||
156512620|NCT02108964|564968275|FG004|Overall Study|Subject/Guardian decision|2|||
156512621|NCT02108964|564968276|FG005|Overall Study|Subject/Guardian decision|0|||
156512622|NCT02108964|564968277|FG006|Overall Study|Subject/Guardian decision|1|||
156512623|NCT02108964|564968278|FG007|Overall Study|Subject/Guardian decision|2|||
156512624|NCT02108964|564968271|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
156512625|NCT02108964|564968272|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
156512626|NCT02108964|564968273|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
156512627|NCT02108964|564968274|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
156512628|NCT02108964|564968275|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
156512629|NCT02108964|564968276|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
156512630|NCT02108964|564968277|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
156512631|NCT02108964|564968278|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
156512632|NCT03006848|564968279|FG000|Overall Study|Adverse Event|1|||
156512633|NCT03006848|564968279|FG000|Overall Study|Physician Decision|1|||
156512634|NCT03006848|564968279|FG000|Overall Study|Lack of Efficacy|16|||
156512635|NCT05543187|564968280|FG000|Overall Study|Ongoing|3|||
156512636|NCT05543187|564968281|FG001|Overall Study|Ongoing|2|||
156512637|NCT00384397|564968282|FG000|Overall Study|Adverse Event|0|||
156512638|NCT00384397|564968283|FG001|Overall Study|Adverse Event|1|||
156512639|NCT00384397|564968284|FG002|Overall Study|Adverse Event|2|||
156512640|NCT00384397|564968282|FG000|Overall Study|Protocol Violation|7|||
156512641|NCT00384397|564968283|FG001|Overall Study|Protocol Violation|15|||
156512642|NCT00384397|564968284|FG002|Overall Study|Protocol Violation|13|||
156512643|NCT00384397|564968282|FG000|Overall Study|Lost to Follow-up|11|||
156512644|NCT00384397|564968283|FG001|Overall Study|Lost to Follow-up|13|||
156512645|NCT00384397|564968284|FG002|Overall Study|Lost to Follow-up|3|||
156512646|NCT00384397|564968282|FG000|Overall Study|Withdrawal by Subject|14|||
156512647|NCT00384397|564968283|FG001|Overall Study|Withdrawal by Subject|17|||
156512648|NCT00384397|564968284|FG002|Overall Study|Withdrawal by Subject|15|||
156512649|NCT02336451|564968285|FG000|Overall Study|Adverse Event|1|||
156512650|NCT02336451|564968286|FG001|Overall Study|Adverse Event|2|||
156512651|NCT02336451|564968287|FG002|Overall Study|Adverse Event|0|||
156512652|NCT02336451|564968288|FG003|Overall Study|Adverse Event|6|||
156512653|NCT02336451|564968289|FG004|Overall Study|Adverse Event|4|||
156512654|NCT02336451|564968285|FG000|Overall Study|Death|6|||
156512655|NCT02336451|564968286|FG001|Overall Study|Death|2|||
156512656|NCT02336451|564968287|FG002|Overall Study|Death|3|||
156512657|NCT02336451|564968288|FG003|Overall Study|Death|6|||
156512658|NCT02336451|564968289|FG004|Overall Study|Death|6|||
156512659|NCT02336451|564968285|FG000|Overall Study|Physician Decision|9|||
156512660|NCT02336451|564968286|FG001|Overall Study|Physician Decision|6|||
156512661|NCT02336451|564968287|FG002|Overall Study|Physician Decision|7|||
156512662|NCT02336451|564968288|FG003|Overall Study|Physician Decision|16|||
156512663|NCT02336451|564968289|FG004|Overall Study|Physician Decision|3|||
156512664|NCT02336451|564968285|FG000|Overall Study|Progressive disease|23|||
156512665|NCT02336451|564968286|FG001|Overall Study|Progressive disease|26|||
156512666|NCT02336451|564968287|FG002|Overall Study|Progressive disease|2|||
156512667|NCT02336451|564968288|FG003|Overall Study|Progressive disease|14|||
156512668|NCT02336451|564968289|FG004|Overall Study|Progressive disease|4|||
156512669|NCT02336451|564968285|FG000|Overall Study|Protocol Violation|1|||
156512670|NCT02336451|564968286|FG001|Overall Study|Protocol Violation|0|||
156512671|NCT02336451|564968287|FG002|Overall Study|Protocol Violation|0|||
156512672|NCT02336451|564968288|FG003|Overall Study|Protocol Violation|0|||
156512673|NCT02336451|564968289|FG004|Overall Study|Protocol Violation|0|||
156512674|NCT02336451|564968285|FG000|Overall Study|Patient/guardian decision|2|||
156512675|NCT02336451|564968286|FG001|Overall Study|Patient/guardian decision|4|||
156512676|NCT02336451|564968287|FG002|Overall Study|Patient/guardian decision|0|||
156512677|NCT02336451|564968288|FG003|Overall Study|Patient/guardian decision|2|||
156512678|NCT02336451|564968289|FG004|Overall Study|Patient/guardian decision|1|||
156512679|NCT03520712|564968290|FG000|Overall Study|Early termination of the study by Sponsor|2|||
156512680|NCT04531982|564968293|FG000|Overall Study|Withdrawal by Subject|10|||
156512681|NCT04531982|564968294|FG001|Overall Study|Withdrawal by Subject|11|||
156512682|NCT04531982|564968293|FG000|Overall Study|Adverse Event|6|||
156512683|NCT04531982|564968294|FG001|Overall Study|Adverse Event|14|||
156512684|NCT04531982|564968293|FG000|Overall Study|Protocol Violation|6|||
156512685|NCT04531982|564968294|FG001|Overall Study|Protocol Violation|9|||
156512686|NCT04531982|564968293|FG000|Overall Study|Non-compliance with study drug|3|||
156512687|NCT04531982|564968294|FG001|Overall Study|Non-compliance with study drug|2|||
156512688|NCT04531982|564968293|FG000|Overall Study|Use of prohibited medication|2|||
156512689|NCT04531982|564968294|FG001|Overall Study|Use of prohibited medication|0|||
156512690|NCT04531982|564968293|FG000|Overall Study|Lost to Follow-up|0|||
156512691|NCT04531982|564968294|FG001|Overall Study|Lost to Follow-up|1|||
156512692|NCT04531982|564968293|FG000|Overall Study|Geopolitical conflict|2|||
156512693|NCT04531982|564968294|FG001|Overall Study|Geopolitical conflict|0|||
156512694|NCT04531982|564968293|FG000|Overall Study|Lack of Efficacy|3|||
156512695|NCT04531982|564968294|FG001|Overall Study|Lack of Efficacy|1|||
156512696|NCT04047862|564968302|FG000|Overall Study|Death|0|||
156512697|NCT04047862|564968303|FG001|Overall Study|Death|0|||
156512698|NCT04047862|564968304|FG002|Overall Study|Death|4|||
156512699|NCT04047862|564968305|FG003|Overall Study|Death|7|||
156512700|NCT04047862|564968306|FG004|Overall Study|Death|2|||
156512701|NCT04047862|564968307|FG005|Overall Study|Death|4|||
156512702|NCT04047862|564968308|FG006|Overall Study|Death|3|||
156512703|NCT04047862|564968309|FG007|Overall Study|Death|24|||
156512704|NCT04047862|564968310|FG008|Overall Study|Death|24|||
156512705|NCT04047862|564968311|FG009|Overall Study|Death|22|||
156512706|NCT04047862|564968312|FG010|Overall Study|Death|35|||
156512707|NCT04047862|564968313|FG011|Overall Study|Death|18|||
156512708|NCT04047862|564968314|FG012|Overall Study|Death|14|||
156512709|NCT04047862|564968315|FG013|Overall Study|Death|6|||
156512710|NCT04047862|564968316|FG014|Overall Study|Death|19|||
156512711|NCT04047862|564968317|FG015|Overall Study|Death|42|||
156512712|NCT04047862|564968318|FG016|Overall Study|Death|9|||
156512713|NCT04047862|564968319|FG017|Overall Study|Death|8|||
156512714|NCT04047862|564968320|FG018|Overall Study|Death|10|||
156512715|NCT04047862|564968302|FG000|Overall Study|Withdrawal by Subject|0|||
156512716|NCT04047862|564968303|FG001|Overall Study|Withdrawal by Subject|0|||
156512717|NCT04047862|564968304|FG002|Overall Study|Withdrawal by Subject|0|||
156512718|NCT04047862|564968305|FG003|Overall Study|Withdrawal by Subject|5|||
156512719|NCT04047862|564968306|FG004|Overall Study|Withdrawal by Subject|2|||
156512720|NCT04047862|564968307|FG005|Overall Study|Withdrawal by Subject|0|||
156512721|NCT04047862|564968308|FG006|Overall Study|Withdrawal by Subject|1|||
156512722|NCT04047862|564968309|FG007|Overall Study|Withdrawal by Subject|0|||
156512723|NCT04047862|564968310|FG008|Overall Study|Withdrawal by Subject|4|||
156512724|NCT04047862|564968311|FG009|Overall Study|Withdrawal by Subject|4|||
156512725|NCT04047862|564968312|FG010|Overall Study|Withdrawal by Subject|4|||
156512726|NCT04047862|564968313|FG011|Overall Study|Withdrawal by Subject|2|||
156512727|NCT04047862|564968314|FG012|Overall Study|Withdrawal by Subject|3|||
156512728|NCT04047862|564968315|FG013|Overall Study|Withdrawal by Subject|0|||
156512729|NCT04047862|564968316|FG014|Overall Study|Withdrawal by Subject|9|||
156512730|NCT04047862|564968317|FG015|Overall Study|Withdrawal by Subject|5|||
156512731|NCT04047862|564968318|FG016|Overall Study|Withdrawal by Subject|1|||
156512732|NCT04047862|564968319|FG017|Overall Study|Withdrawal by Subject|3|||
156512733|NCT04047862|564968320|FG018|Overall Study|Withdrawal by Subject|1|||
156512734|NCT04047862|564968302|FG000|Overall Study|Lost to Follow-up|0|||
156512735|NCT04047862|564968303|FG001|Overall Study|Lost to Follow-up|0|||
156512736|NCT04047862|564968304|FG002|Overall Study|Lost to Follow-up|1|||
156512737|NCT04047862|564968305|FG003|Overall Study|Lost to Follow-up|0|||
156512738|NCT04047862|564968306|FG004|Overall Study|Lost to Follow-up|0|||
156512739|NCT04047862|564968307|FG005|Overall Study|Lost to Follow-up|0|||
156512740|NCT04047862|564968308|FG006|Overall Study|Lost to Follow-up|0|||
156512741|NCT04047862|564968309|FG007|Overall Study|Lost to Follow-up|1|||
156512742|NCT04047862|564968310|FG008|Overall Study|Lost to Follow-up|0|||
156512743|NCT04047862|564968311|FG009|Overall Study|Lost to Follow-up|1|||
156512744|NCT04047862|564968312|FG010|Overall Study|Lost to Follow-up|0|||
156512745|NCT04047862|564968313|FG011|Overall Study|Lost to Follow-up|3|||
156512746|NCT04047862|564968314|FG012|Overall Study|Lost to Follow-up|0|||
156512747|NCT04047862|564968315|FG013|Overall Study|Lost to Follow-up|0|||
156512748|NCT04047862|564968316|FG014|Overall Study|Lost to Follow-up|2|||
156512749|NCT04047862|564968317|FG015|Overall Study|Lost to Follow-up|2|||
156512750|NCT04047862|564968318|FG016|Overall Study|Lost to Follow-up|1|||
156512751|NCT04047862|564968319|FG017|Overall Study|Lost to Follow-up|0|||
156512752|NCT04047862|564968320|FG018|Overall Study|Lost to Follow-up|0|||
156512753|NCT04047862|564968302|FG000|Overall Study|Physician Decision|0|||
156512754|NCT04047862|564968303|FG001|Overall Study|Physician Decision|0|||
156512755|NCT04047862|564968304|FG002|Overall Study|Physician Decision|0|||
156512756|NCT04047862|564968305|FG003|Overall Study|Physician Decision|1|||
156512757|NCT04047862|564968306|FG004|Overall Study|Physician Decision|0|||
156512758|NCT04047862|564968307|FG005|Overall Study|Physician Decision|0|||
156512759|NCT04047862|564968308|FG006|Overall Study|Physician Decision|0|||
156512760|NCT04047862|564968309|FG007|Overall Study|Physician Decision|0|||
156512761|NCT04047862|564968310|FG008|Overall Study|Physician Decision|0|||
156512762|NCT04047862|564968311|FG009|Overall Study|Physician Decision|0|||
156512763|NCT04047862|564968312|FG010|Overall Study|Physician Decision|0|||
156512764|NCT04047862|564968313|FG011|Overall Study|Physician Decision|0|||
156553881|NCT01790503|565119738|FG005|Overall Study|Withdrawal by Subject|2|||
156553882|NCT01790503|565119739|FG006|Overall Study|Withdrawal by Subject|1|||
156553883|NCT01790503|565119740|FG007|Overall Study|Withdrawal by Subject|0|||
156553884|NCT01790503|565119741|FG008|Overall Study|Withdrawal by Subject|0|||
156553885|NCT01790503|565119742|FG009|Overall Study|Withdrawal by Subject|0|||
156553886|NCT01790503|565119743|FG010|Overall Study|Withdrawal by Subject|1|||
156553887|NCT01790503|565119733|FG000|Overall Study|Disease progression|2|||
156553888|NCT01790503|565119734|FG001|Overall Study|Disease progression|1|||
156553889|NCT01790503|565119735|FG002|Overall Study|Disease progression|0|||
156553890|NCT01790503|565119736|FG003|Overall Study|Disease progression|1|||
156553891|NCT01790503|565119737|FG004|Overall Study|Disease progression|2|||
156553892|NCT01790503|565119738|FG005|Overall Study|Disease progression|1|||
156553893|NCT01790503|565119739|FG006|Overall Study|Disease progression|0|||
156553894|NCT01790503|565119740|FG007|Overall Study|Disease progression|1|||
156553895|NCT01790503|565119741|FG008|Overall Study|Disease progression|0|||
156512765|NCT04047862|564968314|FG012|Overall Study|Physician Decision|0|||
156512766|NCT04047862|564968315|FG013|Overall Study|Physician Decision|0|||
156512767|NCT04047862|564968316|FG014|Overall Study|Physician Decision|1|||
156512768|NCT04047862|564968317|FG015|Overall Study|Physician Decision|0|||
156512769|NCT04047862|564968318|FG016|Overall Study|Physician Decision|1|||
156512770|NCT04047862|564968319|FG017|Overall Study|Physician Decision|0|||
156512771|NCT04047862|564968320|FG018|Overall Study|Physician Decision|0|||
156512772|NCT04047862|564968302|FG000|Overall Study|Completed all Assessments|1|||
156512773|NCT04047862|564968303|FG001|Overall Study|Completed all Assessments|3|||
156512774|NCT04047862|564968304|FG002|Overall Study|Completed all Assessments|1|||
156512775|NCT04047862|564968305|FG003|Overall Study|Completed all Assessments|3|||
156512776|NCT04047862|564968306|FG004|Overall Study|Completed all Assessments|2|||
156512777|NCT04047862|564968307|FG005|Overall Study|Completed all Assessments|5|||
156512778|NCT04047862|564968308|FG006|Overall Study|Completed all Assessments|7|||
156512779|NCT04047862|564968309|FG007|Overall Study|Completed all Assessments|0|||
156512780|NCT04047862|564968310|FG008|Overall Study|Completed all Assessments|0|||
156512781|NCT04047862|564968311|FG009|Overall Study|Completed all Assessments|0|||
156512782|NCT04047862|564968312|FG010|Overall Study|Completed all Assessments|0|||
156512783|NCT04047862|564968313|FG011|Overall Study|Completed all Assessments|0|||
156512784|NCT04047862|564968314|FG012|Overall Study|Completed all Assessments|0|||
156512785|NCT04047862|564968315|FG013|Overall Study|Completed all Assessments|0|||
156512786|NCT04047862|564968316|FG014|Overall Study|Completed all Assessments|0|||
156512787|NCT04047862|564968317|FG015|Overall Study|Completed all Assessments|0|||
156512788|NCT04047862|564968318|FG016|Overall Study|Completed all Assessments|0|||
156512789|NCT04047862|564968319|FG017|Overall Study|Completed all Assessments|0|||
156512790|NCT04047862|564968320|FG018|Overall Study|Completed all Assessments|0|||
156512791|NCT04047862|564968302|FG000|Overall Study|Sponsor Decision|0|||
156512792|NCT04047862|564968303|FG001|Overall Study|Sponsor Decision|0|||
156512793|NCT04047862|564968304|FG002|Overall Study|Sponsor Decision|0|||
156512794|NCT04047862|564968305|FG003|Overall Study|Sponsor Decision|0|||
156512795|NCT04047862|564968306|FG004|Overall Study|Sponsor Decision|0|||
156512796|NCT04047862|564968307|FG005|Overall Study|Sponsor Decision|0|||
156512797|NCT04047862|564968308|FG006|Overall Study|Sponsor Decision|0|||
156512798|NCT04047862|564968309|FG007|Overall Study|Sponsor Decision|13|||
156512799|NCT04047862|564968310|FG008|Overall Study|Sponsor Decision|10|||
156553896|NCT01790503|565119742|FG009|Overall Study|Disease progression|17|||
156553897|NCT01790503|565119743|FG010|Overall Study|Disease progression|7|||
156553898|NCT01790503|565119733|FG000|Overall Study|Protocol Violation|0|||
156512800|NCT04047862|564968311|FG009|Overall Study|Sponsor Decision|18|||
156553899|NCT01790503|565119734|FG001|Overall Study|Protocol Violation|0|||
156553900|NCT01790503|565119735|FG002|Overall Study|Protocol Violation|0|||
156553901|NCT01790503|565119736|FG003|Overall Study|Protocol Violation|0|||
156553902|NCT01790503|565119737|FG004|Overall Study|Protocol Violation|0|||
156404933|NCT03002038|564577194|FG001|Overall Study|Withdrawal by Subject|4|||
156404934|NCT03002038|564577193|FG000|Overall Study|Immigration to another region|0|||
156404935|NCT03002038|564577194|FG001|Overall Study|Immigration to another region|2|||
156404936|NCT04251065|564577195|FG000|Overall Study|Death|2|||
156404937|NCT04251065|564577195|FG000|Overall Study|Lack of Efficacy|3|||
156404938|NCT04251065|564577195|FG000|Overall Study|Death|1|||
156404939|NCT00130793|564577209|FG000|Overall Study|Lost to Follow-up|1|||
156404940|NCT00130793|564577210|FG001|Overall Study|Lost to Follow-up|4|||
156404941|NCT00130793|564577209|FG000|Overall Study|Withdrew consent|2|||
156404942|NCT00130793|564577210|FG001|Overall Study|Withdrew consent|0|||
156404943|NCT00211237|564577211|FG000|Baseline|Withdrew|1|||
156404944|NCT00211237|564577212|FG001|Baseline|Withdrew|3|||
156404945|NCT00211237|564577213|FG002|Baseline|Withdrew|0|||
156404946|NCT00211237|564577211|FG000|Baseline|Refused random assignment|1|||
156404947|NCT00211237|564577212|FG001|Baseline|Refused random assignment|0|||
156404948|NCT00211237|564577213|FG002|Baseline|Refused random assignment|0|||
156404949|NCT00211237|564577211|FG000|1 Month|Death|2|||
156404950|NCT00211237|564577212|FG001|1 Month|Death|1|||
156404951|NCT00211237|564577213|FG002|1 Month|Death|0|||
156404952|NCT00211237|564577211|FG000|1 Month|Lost to Follow-up|0|||
156404953|NCT00211237|564577212|FG001|1 Month|Lost to Follow-up|2|||
156404954|NCT00211237|564577213|FG002|1 Month|Lost to Follow-up|0|||
156404955|NCT00211237|564577211|FG000|1 Month|Withdrew|0|||
156404956|NCT00211237|564577212|FG001|1 Month|Withdrew|4|||
156404957|NCT00211237|564577213|FG002|1 Month|Withdrew|0|||
156404958|NCT00211237|564577211|FG000|1 Month|Additional surgery needed|1|||
156404959|NCT00211237|564577212|FG001|1 Month|Additional surgery needed|0|||
156404960|NCT00211237|564577213|FG002|1 Month|Additional surgery needed|0|||
156404961|NCT00211237|564577211|FG000|1 Month|Non-medical problem|0|||
156404962|NCT00211237|564577212|FG001|1 Month|Non-medical problem|2|||
156404963|NCT00211237|564577213|FG002|1 Month|Non-medical problem|0|||
156404964|NCT00211237|564577211|FG000|3 Months|Death|7|||
156404965|NCT00211237|564577212|FG001|3 Months|Death|3|||
156404966|NCT00211237|564577213|FG002|3 Months|Death|0|||
156404967|NCT00211237|564577211|FG000|3 Months|Could not comply with protocol|1|||
156404968|NCT00211237|564577212|FG001|3 Months|Could not comply with protocol|0|||
156404969|NCT00211237|564577213|FG002|3 Months|Could not comply with protocol|0|||
156404970|NCT00211237|564577211|FG000|3 Months|Withdrew|0|||
156404971|NCT00211237|564577212|FG001|3 Months|Withdrew|1|||
156404972|NCT00211237|564577213|FG002|3 Months|Withdrew|0|||
156404973|NCT00211237|564577211|FG000|3 Months|Non-medical problem|0|||
156404974|NCT00211237|564577212|FG001|3 Months|Non-medical problem|0|||
156404975|NCT00211237|564577213|FG002|3 Months|Non-medical problem|1|||
156404976|NCT00211237|564577211|FG000|6 Months|Death|6|||
156404977|NCT00211237|564577212|FG001|6 Months|Death|0|||
156404978|NCT00211237|564577213|FG002|6 Months|Death|3|||
156404979|NCT00211237|564577211|FG000|6 Months|Lost to Follow-up|2|||
156404980|NCT00211237|564577212|FG001|6 Months|Lost to Follow-up|0|||
156404981|NCT00211237|564577213|FG002|6 Months|Lost to Follow-up|0|||
156404982|NCT00211237|564577211|FG000|6 Months|Could not comply with protocol|0|||
156404983|NCT00211237|564577212|FG001|6 Months|Could not comply with protocol|2|||
156404984|NCT00211237|564577213|FG002|6 Months|Could not comply with protocol|0|||
156404985|NCT00211237|564577211|FG000|12 Months|Death|8|||
156404986|NCT00211237|564577212|FG001|12 Months|Death|2|||
156404987|NCT00211237|564577213|FG002|12 Months|Death|3|||
156404988|NCT00211237|564577211|FG000|12 Months|Lost to Follow-up|1|||
156404989|NCT00211237|564577212|FG001|12 Months|Lost to Follow-up|0|||
156404990|NCT00211237|564577213|FG002|12 Months|Lost to Follow-up|1|||
156404991|NCT00211237|564577211|FG000|12 Months|Withdrew|0|||
156404992|NCT00211237|564577212|FG001|12 Months|Withdrew|0|||
156404993|NCT00211237|564577213|FG002|12 Months|Withdrew|1|||
156404994|NCT00211237|564577211|FG000|12 Months|unrelated medical problem|0|||
156404995|NCT00211237|564577212|FG001|12 Months|unrelated medical problem|0|||
156404996|NCT00211237|564577213|FG002|12 Months|unrelated medical problem|1|||
156404997|NCT01003639|564577216|FG000|Overall Study|Lost to Follow-up|6|||
156404998|NCT01003639|564577217|FG001|Overall Study|Lost to Follow-up|9|||
156404999|NCT01003639|564577216|FG000|Overall Study|Withdrawal by Subject|9|||
156405000|NCT01003639|564577217|FG001|Overall Study|Withdrawal by Subject|5|||
156405001|NCT01003639|564577216|FG000|Overall Study|Lack of Efficacy|1|||
156405002|NCT01003639|564577217|FG001|Overall Study|Lack of Efficacy|6|||
156405003|NCT01003639|564577216|FG000|Overall Study|Adverse Event|0|||
156405004|NCT01003639|564577217|FG001|Overall Study|Adverse Event|1|||
156405005|NCT01003639|564577216|FG000|Overall Study|Protocol Violation|0|||
156405006|NCT01003639|564577217|FG001|Overall Study|Protocol Violation|1|||
156405007|NCT01003639|564577216|FG000|Overall Study|Physician Decision|1|||
156405008|NCT01003639|564577217|FG001|Overall Study|Physician Decision|0|||
156405009|NCT04296890|564577218|FG000|Overall Study|Withdrawal by Subject|1|||
156405010|NCT04296890|564577218|FG000|Overall Study|Death|62|||
156405011|NCT04296890|564577218|FG000|Overall Study|Lost to Follow-up|3|||
156405012|NCT04296890|564577218|FG000|Overall Study|Other than specified|2|||
156405013|NCT02237508|564577220|FG000|Overall Study|Withdrawal by Subject|0|||
156405014|NCT02237508|564577221|FG001|Overall Study|Withdrawal by Subject|2|||
156405015|NCT02237508|564577222|FG002|Overall Study|Withdrawal by Subject|0|||
156512801|NCT04047862|564968312|FG010|Overall Study|Sponsor Decision|3|||
156512802|NCT04047862|564968313|FG011|Overall Study|Sponsor Decision|3|||
156512803|NCT04047862|564968314|FG012|Overall Study|Sponsor Decision|4|||
156512804|NCT04047862|564968315|FG013|Overall Study|Sponsor Decision|0|||
156512805|NCT04047862|564968316|FG014|Overall Study|Sponsor Decision|7|||
156512806|NCT04047862|564968317|FG015|Overall Study|Sponsor Decision|8|||
156512807|NCT04047862|564968318|FG016|Overall Study|Sponsor Decision|9|||
156512808|NCT04047862|564968319|FG017|Overall Study|Sponsor Decision|7|||
156512809|NCT04047862|564968320|FG018|Overall Study|Sponsor Decision|8|||
156512810|NCT04047862|564968302|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512811|NCT04047862|564968303|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512812|NCT04047862|564968304|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512813|NCT04047862|564968305|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512814|NCT04047862|564968306|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512815|NCT04047862|564968307|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512816|NCT04047862|564968308|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512817|NCT04047862|564968309|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
156512818|NCT04047862|564968310|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
156512819|NCT04047862|564968311|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512820|NCT04047862|564968312|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
156512821|NCT04047862|564968313|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512822|NCT04047862|564968314|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156512823|NCT04047862|564968315|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
156553903|NCT01790503|565119738|FG005|Overall Study|Protocol Violation|0|||
156553904|NCT01790503|565119739|FG006|Overall Study|Protocol Violation|0|||
156553905|NCT01790503|565119740|FG007|Overall Study|Protocol Violation|0|||
156553906|NCT01790503|565119741|FG008|Overall Study|Protocol Violation|0|||
156553907|NCT01790503|565119742|FG009|Overall Study|Protocol Violation|1|||
156553908|NCT01790503|565119743|FG010|Overall Study|Protocol Violation|0|||
156553909|NCT01790503|565119733|FG000|Overall Study|Physician Decision|0|||
156553910|NCT01790503|565119734|FG001|Overall Study|Physician Decision|0|||
156553911|NCT01790503|565119735|FG002|Overall Study|Physician Decision|0|||
156553912|NCT01790503|565119736|FG003|Overall Study|Physician Decision|0|||
156553913|NCT01790503|565119737|FG004|Overall Study|Physician Decision|0|||
156553914|NCT01790503|565119738|FG005|Overall Study|Physician Decision|0|||
156553915|NCT01790503|565119739|FG006|Overall Study|Physician Decision|0|||
156553916|NCT01790503|565119740|FG007|Overall Study|Physician Decision|0|||
156553917|NCT01790503|565119741|FG008|Overall Study|Physician Decision|0|||
156553918|NCT01790503|565119742|FG009|Overall Study|Physician Decision|1|||
156553919|NCT01790503|565119743|FG010|Overall Study|Physician Decision|1|||
156553920|NCT01790503|565119733|FG000|Overall Study|Death|0|||
156553921|NCT01790503|565119734|FG001|Overall Study|Death|0|||
156553922|NCT01790503|565119735|FG002|Overall Study|Death|0|||
156553923|NCT01790503|565119736|FG003|Overall Study|Death|0|||
156553924|NCT01790503|565119737|FG004|Overall Study|Death|0|||
156553925|NCT01790503|565119738|FG005|Overall Study|Death|0|||
156553926|NCT01790503|565119739|FG006|Overall Study|Death|0|||
156553927|NCT01790503|565119740|FG007|Overall Study|Death|0|||
156553928|NCT01790503|565119741|FG008|Overall Study|Death|0|||
156553929|NCT01790503|565119742|FG009|Overall Study|Death|1|||
156553930|NCT01790503|565119743|FG010|Overall Study|Death|0|||
156553931|NCT01790503|565119733|FG000|Overall Study|Non Compliance|0|||
156553932|NCT01790503|565119734|FG001|Overall Study|Non Compliance|0|||
156553933|NCT01790503|565119735|FG002|Overall Study|Non Compliance|0|||
156553934|NCT01790503|565119736|FG003|Overall Study|Non Compliance|0|||
156553935|NCT01790503|565119737|FG004|Overall Study|Non Compliance|1|||
156553936|NCT01790503|565119738|FG005|Overall Study|Non Compliance|0|||
156553937|NCT01790503|565119739|FG006|Overall Study|Non Compliance|0|||
156553938|NCT01790503|565119740|FG007|Overall Study|Non Compliance|0|||
156512824|NCT04047862|564968316|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
156512825|NCT04047862|564968317|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
156512826|NCT04047862|564968318|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
156512827|NCT04047862|564968319|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
156512828|NCT04047862|564968320|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
156512829|NCT04047862|564968302|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156553939|NCT01790503|565119741|FG008|Overall Study|Non Compliance|0|||
156553940|NCT01790503|565119742|FG009|Overall Study|Non Compliance|0|||
156553941|NCT01790503|565119743|FG010|Overall Study|Non Compliance|0|||
156553942|NCT01790503|565119733|FG000|Overall Study|Other|0|||
156553943|NCT01790503|565119734|FG001|Overall Study|Other|0|||
156553944|NCT01790503|565119735|FG002|Overall Study|Other|0|||
156553945|NCT01790503|565119736|FG003|Overall Study|Other|0|||
156553946|NCT01790503|565119737|FG004|Overall Study|Other|1|||
156553947|NCT01790503|565119738|FG005|Overall Study|Other|0|||
156553948|NCT01790503|565119739|FG006|Overall Study|Other|0|||
156553949|NCT01790503|565119740|FG007|Overall Study|Other|0|||
156553950|NCT01790503|565119741|FG008|Overall Study|Other|1|||
156553951|NCT01790503|565119742|FG009|Overall Study|Other|2|||
156553952|NCT01790503|565119743|FG010|Overall Study|Other|0|||
156553953|NCT04183335|565119744|FG000|Overall Study|Adverse Event|1|||
156553954|NCT04183335|565119745|FG001|Overall Study|Adverse Event|0|||
156553955|NCT04183335|565119744|FG000|Overall Study|Withdrawal by Subject|12|||
156553956|NCT04183335|565119745|FG001|Overall Study|Withdrawal by Subject|3|||
156553957|NCT00049673|565119746|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
156553958|NCT00049673|565119747|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
156553959|NCT02322710|565119751|FG000|Overall Study|No efficacy assessment post-baseline|0|||
156553960|NCT02322710|565119752|FG001|Overall Study|No efficacy assessment post-baseline|1|||
156553961|NCT02322710|565119751|FG000|Overall Study|Protocol Violation|20|||
156553962|NCT02322710|565119752|FG001|Overall Study|Protocol Violation|25|||
156553963|NCT05064059|565119753|FG000|Overall Study|Death|199|||
156553964|NCT05064059|565119754|FG001|Overall Study|Death|196|||
156553965|NCT05064059|565119753|FG000|Overall Study|Physician Decision|4|||
156553966|NCT05064059|565119754|FG001|Overall Study|Physician Decision|2|||
156553967|NCT05064059|565119753|FG000|Overall Study|Sponsor Decision|14|||
156553968|NCT05064059|565119754|FG001|Overall Study|Sponsor Decision|11|||
156553969|NCT05064059|565119753|FG000|Overall Study|Withdrawal by Subject|4|||
156553970|NCT05064059|565119754|FG001|Overall Study|Withdrawal by Subject|11|||
156553971|NCT02615990|565119755|FG000|Overall Study|study terminated|1|||
156553972|NCT02615990|565119756|FG001|Overall Study|study terminated|1|||
156553973|NCT01934140|565119763|FG000|Persistence Phase (Year 6-10)|Other|24|||
156553974|NCT01934140|565119764|FG001|Persistence Phase (Year 6-10)|Other|6|||
156553975|NCT01934140|565119763|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
156553976|NCT01934140|565119764|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
156553977|NCT01934140|565119763|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
156553978|NCT01934140|565119764|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
156553979|NCT01934140|565119763|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
156553980|NCT01934140|565119764|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
156553981|NCT01934140|565119763|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
156553982|NCT01934140|565119764|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
156553983|NCT01934140|565119763|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
156553984|NCT01934140|565119764|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
156553985|NCT01934140|565119763|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
156553986|NCT01934140|565119764|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
156553987|NCT01934140|565119763|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
156553988|NCT01934140|565119764|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
156553989|NCT00808444|565119770|FG000|Overall Study|Withdrawal by Subject|1|||
156553990|NCT00808444|565119771|FG001|Overall Study|Withdrawal by Subject|0|||
156553991|NCT00808444|565119770|FG000|Overall Study|Lost to Follow-up|0|||
156553992|NCT00808444|565119771|FG001|Overall Study|Lost to Follow-up|1|||
156553993|NCT01461044|565119772|FG000|Overall Study|Death|58|||
156553994|NCT01461044|565119773|FG001|Overall Study|Death|35|||
156553995|NCT01461044|565119772|FG000|Overall Study|Lost to Follow-up|12|||
156553996|NCT01461044|565119773|FG001|Overall Study|Lost to Follow-up|5|||
156553997|NCT04401267|565119774|FG000|Overall Study|Death|0|||
156553998|NCT04401267|565119775|FG001|Overall Study|Death|1|||
156553999|NCT04401267|565119774|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
156554000|NCT04401267|565119775|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
156554001|NCT04401267|565119774|FG000|Overall Study|Found to be Ineligible|1|||
156554002|NCT04401267|565119775|FG001|Overall Study|Found to be Ineligible|0|||
156554003|NCT00200850|565119776|FG000|Overall Study|relocation|1|||
156554004|NCT00200850|565119777|FG001|Overall Study|relocation|0|||
156554005|NCT00200850|565119778|FG002|Overall Study|relocation|1|||
156554006|NCT00200850|565119776|FG000|Overall Study|too busy|1|||
156554007|NCT00200850|565119777|FG001|Overall Study|too busy|0|||
156554008|NCT00200850|565119778|FG002|Overall Study|too busy|0|||
156554009|NCT00200850|565119776|FG000|Overall Study|Pregnancy|0|||
156554010|NCT00200850|565119777|FG001|Overall Study|Pregnancy|0|||
156554011|NCT00200850|565119778|FG002|Overall Study|Pregnancy|1|||
156554012|NCT00200850|565119776|FG000|Overall Study|Poor adherence|0|||
156554013|NCT00200850|565119777|FG001|Overall Study|Poor adherence|0|||
156554014|NCT00200850|565119778|FG002|Overall Study|Poor adherence|1|||
156554015|NCT00200850|565119776|FG000|Overall Study|optic neuritis|0|||
156554016|NCT00200850|565119777|FG001|Overall Study|optic neuritis|0|||
156554017|NCT00200850|565119778|FG002|Overall Study|optic neuritis|1|||
156554018|NCT00200850|565119776|FG000|Overall Study|Adverse Event|1|||
156554019|NCT00200850|565119777|FG001|Overall Study|Adverse Event|1|||
156554020|NCT00200850|565119778|FG002|Overall Study|Adverse Event|2|||
156554021|NCT01449708|565119784|FG000|Overall Study|Protocol Violation|0|||
156554022|NCT01449708|565119785|FG001|Overall Study|Protocol Violation|1|||
156554023|NCT01449708|565119784|FG000|Overall Study|surgical complication|1|||
156554024|NCT01449708|565119785|FG001|Overall Study|surgical complication|2|||
156554025|NCT01449708|565119784|FG000|Overall Study|respiratory failure|1|||
156554026|NCT01449708|565119785|FG001|Overall Study|respiratory failure|0|||
156554027|NCT02889796|565119786|FG000|Overall Study|Withdrew Consent|18|||
156554028|NCT02889796|565119787|FG001|Overall Study|Withdrew Consent|29|||
156554029|NCT02889796|565119788|FG002|Overall Study|Withdrew Consent|20|||
156554030|NCT02889796|565119789|FG003|Overall Study|Withdrew Consent|1|||
156554031|NCT02889796|565119790|FG004|Overall Study|Withdrew Consent|2|||
156554032|NCT02889796|565119791|FG005|Overall Study|Withdrew Consent|35|||
156405016|NCT02237508|564577223|FG003|Overall Study|Withdrawal by Subject|1|||
156405017|NCT02237508|564577224|FG004|Overall Study|Withdrawal by Subject|0|||
156405018|NCT02237508|564577225|FG005|Overall Study|Withdrawal by Subject|1|||
156405019|NCT02237508|564577226|FG006|Overall Study|Withdrawal by Subject|1|||
156405020|NCT02237508|564577227|FG007|Overall Study|Withdrawal by Subject|0|||
156405021|NCT02237508|564577228|FG008|Overall Study|Withdrawal by Subject|1|||
156405022|NCT02237508|564577229|FG009|Overall Study|Withdrawal by Subject|0|||
156405023|NCT02237508|564577220|FG000|Overall Study|Physician Decision|0|||
156554033|NCT02889796|565119786|FG000|Overall Study|Investigator's Discretion|10|||
156554034|NCT02889796|565119787|FG001|Overall Study|Investigator's Discretion|9|||
156554035|NCT02889796|565119788|FG002|Overall Study|Investigator's Discretion|10|||
156554036|NCT02889796|565119789|FG003|Overall Study|Investigator's Discretion|3|||
156554037|NCT02889796|565119790|FG004|Overall Study|Investigator's Discretion|0|||
156554038|NCT02889796|565119791|FG005|Overall Study|Investigator's Discretion|15|||
156554039|NCT02889796|565119786|FG000|Overall Study|Adverse Event|17|||
156554040|NCT02889796|565119787|FG001|Overall Study|Adverse Event|8|||
156554041|NCT02889796|565119788|FG002|Overall Study|Adverse Event|8|||
156554042|NCT02889796|565119789|FG003|Overall Study|Adverse Event|4|||
156554043|NCT02889796|565119790|FG004|Overall Study|Adverse Event|1|||
156554044|NCT02889796|565119791|FG005|Overall Study|Adverse Event|7|||
156554045|NCT02889796|565119786|FG000|Overall Study|Lost to Follow-up|5|||
156554046|NCT02889796|565119787|FG001|Overall Study|Lost to Follow-up|7|||
156554047|NCT02889796|565119788|FG002|Overall Study|Lost to Follow-up|2|||
156554048|NCT02889796|565119789|FG003|Overall Study|Lost to Follow-up|0|||
156554049|NCT02889796|565119790|FG004|Overall Study|Lost to Follow-up|2|||
156554050|NCT02889796|565119791|FG005|Overall Study|Lost to Follow-up|6|||
156554051|NCT02889796|565119786|FG000|Overall Study|Protocol Violation|0|||
156554052|NCT02889796|565119787|FG001|Overall Study|Protocol Violation|1|||
156554053|NCT02889796|565119788|FG002|Overall Study|Protocol Violation|3|||
156554054|NCT02889796|565119789|FG003|Overall Study|Protocol Violation|0|||
156554055|NCT02889796|565119790|FG004|Overall Study|Protocol Violation|0|||
156554056|NCT02889796|565119791|FG005|Overall Study|Protocol Violation|4|||
156554057|NCT02889796|565119786|FG000|Overall Study|Non-compliance With Study Drug|0|||
156554058|NCT02889796|565119787|FG001|Overall Study|Non-compliance With Study Drug|2|||
156554059|NCT02889796|565119788|FG002|Overall Study|Non-compliance With Study Drug|0|||
156554060|NCT02889796|565119789|FG003|Overall Study|Non-compliance With Study Drug|0|||
156554061|NCT02889796|565119790|FG004|Overall Study|Non-compliance With Study Drug|1|||
156554062|NCT02889796|565119791|FG005|Overall Study|Non-compliance With Study Drug|2|||
156554063|NCT02889796|565119786|FG000|Overall Study|Death|1|||
156554064|NCT02889796|565119787|FG001|Overall Study|Death|1|||
156554065|NCT02889796|565119788|FG002|Overall Study|Death|0|||
156554066|NCT02889796|565119789|FG003|Overall Study|Death|1|||
156554067|NCT02889796|565119790|FG004|Overall Study|Death|0|||
156554068|NCT02889796|565119791|FG005|Overall Study|Death|1|||
156554069|NCT02889796|565119786|FG000|Overall Study|Pregnancy|0|||
156554070|NCT02889796|565119787|FG001|Overall Study|Pregnancy|1|||
156554071|NCT02889796|565119788|FG002|Overall Study|Pregnancy|1|||
156554072|NCT02889796|565119789|FG003|Overall Study|Pregnancy|0|||
156554073|NCT02889796|565119790|FG004|Overall Study|Pregnancy|0|||
156554074|NCT02889796|565119791|FG005|Overall Study|Pregnancy|0|||
156554075|NCT02889796|565119786|FG000|Overall Study|Randomized but not Dosed|2|||
156554076|NCT02889796|565119787|FG001|Overall Study|Randomized but not Dosed|0|||
156554077|NCT02889796|565119788|FG002|Overall Study|Randomized but not Dosed|0|||
156554078|NCT02889796|565119789|FG003|Overall Study|Randomized but not Dosed|0|||
156554079|NCT02889796|565119790|FG004|Overall Study|Randomized but not Dosed|0|||
156554080|NCT02889796|565119791|FG005|Overall Study|Randomized but not Dosed|2|||
156554081|NCT04294459|565119792|FG000|Overall Study|Adverse Event|0|||
156554082|NCT04294459|565119793|FG001|Overall Study|Adverse Event|1|||
156554083|NCT02787863|565119794|FG000|Overall Study|Death|1|||
156554084|NCT02787863|565119795|FG001|Overall Study|Death|0|||
156405024|NCT02237508|564577221|FG001|Overall Study|Physician Decision|1|||
156405025|NCT02237508|564577222|FG002|Overall Study|Physician Decision|0|||
156405026|NCT02237508|564577223|FG003|Overall Study|Physician Decision|0|||
156405027|NCT02237508|564577224|FG004|Overall Study|Physician Decision|0|||
156405028|NCT02237508|564577225|FG005|Overall Study|Physician Decision|0|||
156554085|NCT02787863|565119796|FG002|Overall Study|Death|1|||
156554086|NCT02787863|565119797|FG003|Overall Study|Death|0|||
156554087|NCT02787863|565119798|FG004|Overall Study|Death|0|||
156554088|NCT02787863|565119799|FG005|Overall Study|Death|0|||
156554089|NCT02787863|565119800|FG006|Overall Study|Death|0|||
156554090|NCT02787863|565119801|FG007|Overall Study|Death|0|||
156554091|NCT02787863|565119794|FG000|Overall Study|Withdrawal by Subject|0|||
156554092|NCT02787863|565119795|FG001|Overall Study|Withdrawal by Subject|1|||
156554093|NCT02787863|565119796|FG002|Overall Study|Withdrawal by Subject|1|||
156405029|NCT02237508|564577226|FG006|Overall Study|Physician Decision|0|||
156405030|NCT02237508|564577227|FG007|Overall Study|Physician Decision|0|||
156405031|NCT02237508|564577228|FG008|Overall Study|Physician Decision|0|||
156405032|NCT02237508|564577229|FG009|Overall Study|Physician Decision|0|||
156405033|NCT02237508|564577220|FG000|Overall Study|Protocol Violation|0|||
156405034|NCT02237508|564577221|FG001|Overall Study|Protocol Violation|0|||
156405035|NCT02237508|564577222|FG002|Overall Study|Protocol Violation|1|||
156405036|NCT02237508|564577223|FG003|Overall Study|Protocol Violation|0|||
156405037|NCT02237508|564577224|FG004|Overall Study|Protocol Violation|0|||
156405038|NCT02237508|564577225|FG005|Overall Study|Protocol Violation|0|||
156405039|NCT02237508|564577226|FG006|Overall Study|Protocol Violation|0|||
156405040|NCT02237508|564577227|FG007|Overall Study|Protocol Violation|0|||
156405041|NCT02237508|564577228|FG008|Overall Study|Protocol Violation|0|||
156405042|NCT02237508|564577229|FG009|Overall Study|Protocol Violation|0|||
156405043|NCT01650519|564577230|FG000|Overall Study|Withdrawal by Subject|1|||
156405044|NCT01650519|564577231|FG001|Overall Study|Withdrawal by Subject|0|||
156405045|NCT01552954|564577234|FG000|Overall Study|Adverse Event|1|||
156405046|NCT01552954|564577235|FG001|Overall Study|Adverse Event|2|||
156405047|NCT01552954|564577234|FG000|Overall Study|Lost to Follow-up|1|||
156405048|NCT01552954|564577235|FG001|Overall Study|Lost to Follow-up|1|||
156405049|NCT01552954|564577234|FG000|Overall Study|Withdrawal by Subject|1|||
156405050|NCT01552954|564577235|FG001|Overall Study|Withdrawal by Subject|1|||
156405051|NCT01552954|564577234|FG000|Overall Study|Protocol Violation|1|||
156405052|NCT01552954|564577235|FG001|Overall Study|Protocol Violation|2|||
156405053|NCT01552954|564577234|FG000|Overall Study|diagnosed DM|1|||
156405054|NCT01552954|564577235|FG001|Overall Study|diagnosed DM|0|||
156405055|NCT00779779|564577236|FG000|Overall Study|Adverse Event|1|||
156405056|NCT00779779|564577236|FG000|Overall Study|Protocol Violation|14|||
156405057|NCT00779779|564577236|FG000|Overall Study|Withdrawal by Subject|4|||
156405058|NCT00779779|564577236|FG000|Overall Study|Lost to Follow-up|5|||
156405059|NCT01395823|564577237|FG000|Overall Study|Death|4|||
156405060|NCT01395823|564577238|FG001|Overall Study|Death|4|||
156405061|NCT01395823|564577237|FG000|Overall Study|Physician Decision|3|||
156405062|NCT01395823|564577238|FG001|Overall Study|Physician Decision|1|||
156405063|NCT01395823|564577237|FG000|Overall Study|Lost to Follow-up|1|||
156405064|NCT01395823|564577238|FG001|Overall Study|Lost to Follow-up|0|||
156405065|NCT01395823|564577237|FG000|Overall Study|Transplant|1|||
156405066|NCT01395823|564577238|FG001|Overall Study|Transplant|0|||
156405067|NCT01395823|564577237|FG000|Overall Study|GI symptoms|1|||
156405068|NCT01395823|564577238|FG001|Overall Study|GI symptoms|0|||
156405069|NCT01395823|564577237|FG000|Overall Study|Withdrawal by Subject|5|||
156405070|NCT01395823|564577238|FG001|Overall Study|Withdrawal by Subject|4|||
156405071|NCT01778556|564577239|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
156512830|NCT04047862|564968303|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512831|NCT04047862|564968304|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512832|NCT04047862|564968305|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512833|NCT04047862|564968306|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512834|NCT04047862|564968307|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512835|NCT04047862|564968308|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512836|NCT04047862|564968309|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512837|NCT04047862|564968310|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512838|NCT04047862|564968311|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512839|NCT04047862|564968312|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512840|NCT04047862|564968313|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512841|NCT04047862|564968314|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512842|NCT04047862|564968315|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512843|NCT04047862|564968316|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512844|NCT04047862|564968317|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
156512845|NCT04047862|564968318|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512846|NCT04047862|564968319|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
156512847|NCT04047862|564968320|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
156512848|NCT04047862|564968302|FG000|Overall Study|Other|0|||
156512849|NCT04047862|564968303|FG001|Overall Study|Other|0|||
156512850|NCT04047862|564968304|FG002|Overall Study|Other|0|||
156512851|NCT04047862|564968305|FG003|Overall Study|Other|0|||
156512852|NCT04047862|564968306|FG004|Overall Study|Other|0|||
156405072|NCT01778556|564577240|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
156405073|NCT01778556|564577239|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156405074|NCT01778556|564577240|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
156405075|NCT01778556|564577239|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
156405076|NCT01778556|564577240|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
156405077|NCT01778556|564577239|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
156405078|NCT01778556|564577240|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
156405079|NCT03300570|564577242|FG000|Overall Study|Adverse Event|0|||
156405080|NCT03300570|564577243|FG001|Overall Study|Adverse Event|1|||
156405081|NCT03300570|564577242|FG000|Overall Study|Withdrawal by Subject|1|||
156405082|NCT03300570|564577243|FG001|Overall Study|Withdrawal by Subject|0|||
156405083|NCT03300570|564577242|FG000|Overall Study|Inadequate bowel prep|1|||
156405084|NCT03300570|564577243|FG001|Overall Study|Inadequate bowel prep|0|||
156405085|NCT00116272|564577244|FG000|Overall Study|Lost to Follow-up|11|||
156405086|NCT00116272|564577245|FG001|Overall Study|Lost to Follow-up|6|||
156405087|NCT00576732|564577246|FG000|DOUBLE BLIND|Adverse Event|0|||
156405088|NCT00576732|564577247|FG001|DOUBLE BLIND|Adverse Event|0|||
156405089|NCT00576732|564577248|FG002|DOUBLE BLIND|Adverse Event|1|||
156405090|NCT00576732|564577249|FG003|DOUBLE BLIND|Adverse Event|0|||
156405091|NCT00576732|564577250|FG004|DOUBLE BLIND|Adverse Event|0|||
156405092|NCT00576732|564577251|FG005|DOUBLE BLIND|Adverse Event|0|||
156405093|NCT00576732|564577246|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
156405094|NCT00576732|564577247|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
156405095|NCT00576732|564577248|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
156405096|NCT00576732|564577249|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
156405097|NCT00576732|564577250|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
156405098|NCT00576732|564577251|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
156405099|NCT00576732|564577246|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
156405100|NCT00576732|564577247|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
156405101|NCT00576732|564577248|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
156405102|NCT00576732|564577249|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
156405103|NCT00576732|564577250|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
156405104|NCT00576732|564577251|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
156405105|NCT00576732|564577246|FG000|DOUBLE BLIND|OTHER|0|||
156405106|NCT00576732|564577247|FG001|DOUBLE BLIND|OTHER|2|||
156405107|NCT00576732|564577248|FG002|DOUBLE BLIND|OTHER|1|||
156405108|NCT00576732|564577249|FG003|DOUBLE BLIND|OTHER|0|||
156405109|NCT00576732|564577250|FG004|DOUBLE BLIND|OTHER|0|||
156554094|NCT02787863|565119797|FG003|Overall Study|Withdrawal by Subject|0|||
156554095|NCT02787863|565119798|FG004|Overall Study|Withdrawal by Subject|0|||
156554096|NCT02787863|565119799|FG005|Overall Study|Withdrawal by Subject|0|||
156554097|NCT02787863|565119800|FG006|Overall Study|Withdrawal by Subject|0|||
156554098|NCT02787863|565119801|FG007|Overall Study|Withdrawal by Subject|0|||
156554099|NCT01414257|565119802|FG000|Overall Study|No Visit After First Day of Treatment|12|||
156554100|NCT01414257|565119802|FG000|Overall Study|Protocol Violation|10|||
156554101|NCT02421887|565119803|FG000|Overall Study|Lost to Follow-up|5|||
156554102|NCT02421887|565119804|FG001|Overall Study|Lost to Follow-up|0|||
156554103|NCT02421887|565119803|FG000|Overall Study|Withdrawal by Subject|8|||
156554104|NCT02421887|565119804|FG001|Overall Study|Withdrawal by Subject|5|||
156554105|NCT02421887|565119803|FG000|Overall Study|Physician Decision|2|||
156554106|NCT02421887|565119804|FG001|Overall Study|Physician Decision|4|||
156554107|NCT02421887|565119803|FG000|Overall Study|Adverse Event|2|||
156554108|NCT02421887|565119804|FG001|Overall Study|Adverse Event|0|||
156554109|NCT01882907|565119805|FG000|Overall Study|Adverse Event|3|||
156554110|NCT01882907|565119806|FG001|Overall Study|Adverse Event|1|||
156554111|NCT01882907|565119805|FG000|Overall Study|Lack of Efficacy|0|||
156554112|NCT01882907|565119806|FG001|Overall Study|Lack of Efficacy|3|||
156554113|NCT01882907|565119805|FG000|Overall Study|Lost to Follow-up|1|||
156554114|NCT01882907|565119806|FG001|Overall Study|Lost to Follow-up|4|||
156554115|NCT01882907|565119805|FG000|Overall Study|Protocol Violation|10|||
156554116|NCT01882907|565119806|FG001|Overall Study|Protocol Violation|14|||
156554117|NCT01882907|565119805|FG000|Overall Study|Withdrawal by Subject|0|||
156554118|NCT01882907|565119806|FG001|Overall Study|Withdrawal by Subject|6|||
156554119|NCT01978093|565119807|FG000|Overall Study|Death|1|||
156554120|NCT01978093|565119808|FG001|Overall Study|Death|0|||
156554121|NCT01978093|565119807|FG000|Overall Study|Adverse Event|0|||
156554122|NCT01978093|565119808|FG001|Overall Study|Adverse Event|5|||
156554123|NCT01978093|565119807|FG000|Overall Study|Protocol Violation|8|||
156554124|NCT01978093|565119808|FG001|Overall Study|Protocol Violation|2|||
156554125|NCT01978093|565119807|FG000|Overall Study|Withdrawal by Subject|29|||
156554126|NCT01978093|565119808|FG001|Overall Study|Withdrawal by Subject|25|||
156554127|NCT01978093|565119807|FG000|Overall Study|Lost to Follow-up|11|||
156554128|NCT01978093|565119808|FG001|Overall Study|Lost to Follow-up|15|||
156405110|NCT00576732|564577251|FG005|DOUBLE BLIND|OTHER|0|||
156405111|NCT00576732|564577246|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
156405112|NCT00576732|564577247|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
156405113|NCT00576732|564577248|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
156405114|NCT00576732|564577249|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
156405115|NCT00576732|564577250|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
156405116|NCT00576732|564577251|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
156554129|NCT01978093|565119807|FG000|Overall Study|Migrated/moved from study area|11|||
156554130|NCT01978093|565119808|FG001|Overall Study|Migrated/moved from study area|13|||
156554131|NCT01978093|565119807|FG000|Overall Study|Loss of kaiser coverage|4|||
156554132|NCT01978093|565119808|FG001|Overall Study|Loss of kaiser coverage|10|||
156554133|NCT01978093|565119807|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
156554134|NCT01978093|565119808|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
156554135|NCT01978093|565119807|FG000|Overall Study|Mother lost custody of child|0|||
156405117|NCT00576732|564577246|FG000|DOUBLE BLIND|Protocol Violation|1|||
156405118|NCT00576732|564577247|FG001|DOUBLE BLIND|Protocol Violation|0|||
156405119|NCT00576732|564577248|FG002|DOUBLE BLIND|Protocol Violation|0|||
156405120|NCT00576732|564577249|FG003|DOUBLE BLIND|Protocol Violation|0|||
156405121|NCT00576732|564577250|FG004|DOUBLE BLIND|Protocol Violation|0|||
156405122|NCT00576732|564577251|FG005|DOUBLE BLIND|Protocol Violation|0|||
156405123|NCT00576732|564577246|FG000|OPEN LABEL|Adverse Event|0|||
156405124|NCT00576732|564577247|FG001|OPEN LABEL|Adverse Event|0|||
156405125|NCT00576732|564577248|FG002|OPEN LABEL|Adverse Event|0|||
156405126|NCT00576732|564577249|FG003|OPEN LABEL|Adverse Event|4|||
156405127|NCT00576732|564577250|FG004|OPEN LABEL|Adverse Event|0|||
156405128|NCT00576732|564577251|FG005|OPEN LABEL|Adverse Event|1|||
156405129|NCT00576732|564577246|FG000|OPEN LABEL|Lost to Follow-up|0|||
156405130|NCT00576732|564577247|FG001|OPEN LABEL|Lost to Follow-up|0|||
156405131|NCT00576732|564577248|FG002|OPEN LABEL|Lost to Follow-up|0|||
156405132|NCT00576732|564577249|FG003|OPEN LABEL|Lost to Follow-up|2|||
156405133|NCT00576732|564577250|FG004|OPEN LABEL|Lost to Follow-up|1|||
156405134|NCT00576732|564577251|FG005|OPEN LABEL|Lost to Follow-up|1|||
156405135|NCT00576732|564577246|FG000|OPEN LABEL|Withdrawal by Subject|0|||
156405136|NCT00576732|564577247|FG001|OPEN LABEL|Withdrawal by Subject|0|||
156405137|NCT00576732|564577248|FG002|OPEN LABEL|Withdrawal by Subject|0|||
156405138|NCT00576732|564577249|FG003|OPEN LABEL|Withdrawal by Subject|1|||
156405139|NCT00576732|564577250|FG004|OPEN LABEL|Withdrawal by Subject|0|||
156405140|NCT00576732|564577251|FG005|OPEN LABEL|Withdrawal by Subject|1|||
156405141|NCT00576732|564577246|FG000|OPEN LABEL|OTHER|0|||
156405142|NCT00576732|564577247|FG001|OPEN LABEL|OTHER|0|||
156405143|NCT00576732|564577248|FG002|OPEN LABEL|OTHER|0|||
156405144|NCT00576732|564577249|FG003|OPEN LABEL|OTHER|0|||
156405145|NCT00576732|564577250|FG004|OPEN LABEL|OTHER|0|||
156405146|NCT00576732|564577251|FG005|OPEN LABEL|OTHER|2|||
156405147|NCT00576732|564577246|FG000|OPEN LABEL|Lack of Efficacy|0|||
156405148|NCT00576732|564577247|FG001|OPEN LABEL|Lack of Efficacy|0|||
156405149|NCT00576732|564577248|FG002|OPEN LABEL|Lack of Efficacy|0|||
156405150|NCT00576732|564577249|FG003|OPEN LABEL|Lack of Efficacy|2|||
156405151|NCT00576732|564577250|FG004|OPEN LABEL|Lack of Efficacy|2|||
156405152|NCT00576732|564577251|FG005|OPEN LABEL|Lack of Efficacy|3|||
156405153|NCT00576732|564577246|FG000|OPEN LABEL|Protocol Violation|0|||
156405154|NCT00576732|564577247|FG001|OPEN LABEL|Protocol Violation|0|||
156405155|NCT00576732|564577248|FG002|OPEN LABEL|Protocol Violation|0|||
156405156|NCT00576732|564577249|FG003|OPEN LABEL|Protocol Violation|2|||
156405157|NCT00576732|564577250|FG004|OPEN LABEL|Protocol Violation|1|||
156405158|NCT00576732|564577251|FG005|OPEN LABEL|Protocol Violation|0|||
156405159|NCT03188120|564577252|FG000|Overall Study|Adverse Event|4|||
156405160|NCT03188120|564577252|FG000|Overall Study|Insufficient Effectiveness|8|||
156405161|NCT03188120|564577252|FG000|Overall Study|Improved|12|||
156405162|NCT03188120|564577252|FG000|Overall Study|Lost to Follow-up|7|||
156405163|NCT03188120|564577252|FG000|Overall Study|Other than specified|3|||
156405164|NCT03188120|564577252|FG000|Overall Study|No visit after the first visit|13|||
156405165|NCT02296190|564577253|FG000|Overall Study|Lost to Follow-up|0|||
156405166|NCT02296190|564577254|FG001|Overall Study|Lost to Follow-up|0|||
156405167|NCT02296190|564577255|FG002|Overall Study|Lost to Follow-up|0|||
156405168|NCT02296190|564577256|FG003|Overall Study|Lost to Follow-up|0|||
156405169|NCT02296190|564577257|FG004|Overall Study|Lost to Follow-up|1|||
156405170|NCT02296190|564577258|FG005|Overall Study|Lost to Follow-up|0|||
156405171|NCT02296190|564577253|FG000|Overall Study|Failure to induce PSVT|6|||
156405172|NCT02296190|564577254|FG001|Overall Study|Failure to induce PSVT|10|||
156405173|NCT02296190|564577255|FG002|Overall Study|Failure to induce PSVT|5|||
156405174|NCT02296190|564577256|FG003|Overall Study|Failure to induce PSVT|13|||
156405175|NCT02296190|564577257|FG004|Overall Study|Failure to induce PSVT|8|||
156405176|NCT02296190|564577258|FG005|Overall Study|Failure to induce PSVT|0|||
156405177|NCT02296190|564577253|FG000|Overall Study|Physician Decision|1|||
156405178|NCT02296190|564577254|FG001|Overall Study|Physician Decision|1|||
156405179|NCT02296190|564577255|FG002|Overall Study|Physician Decision|0|||
156405180|NCT02296190|564577256|FG003|Overall Study|Physician Decision|1|||
156405181|NCT02296190|564577257|FG004|Overall Study|Physician Decision|2|||
156405182|NCT02296190|564577258|FG005|Overall Study|Physician Decision|0|||
156405183|NCT02296190|564577253|FG000|Overall Study|Withdrawal by Subject|0|||
156405184|NCT02296190|564577254|FG001|Overall Study|Withdrawal by Subject|1|||
156405185|NCT02296190|564577255|FG002|Overall Study|Withdrawal by Subject|0|||
156405186|NCT02296190|564577256|FG003|Overall Study|Withdrawal by Subject|0|||
156405187|NCT02296190|564577257|FG004|Overall Study|Withdrawal by Subject|0|||
156405188|NCT02296190|564577258|FG005|Overall Study|Withdrawal by Subject|0|||
156405189|NCT02296190|564577253|FG000|Overall Study|PSVT < 5 minutes|5|||
156405190|NCT02296190|564577254|FG001|Overall Study|PSVT < 5 minutes|6|||
156405191|NCT02296190|564577255|FG002|Overall Study|PSVT < 5 minutes|6|||
156405192|NCT02296190|564577256|FG003|Overall Study|PSVT < 5 minutes|6|||
156405193|NCT02296190|564577257|FG004|Overall Study|PSVT < 5 minutes|5|||
156405194|NCT02296190|564577258|FG005|Overall Study|PSVT < 5 minutes|0|||
156405195|NCT02296190|564577253|FG000|Overall Study|Patient was given Propofol|0|||
156405196|NCT02296190|564577254|FG001|Overall Study|Patient was given Propofol|1|||
156405197|NCT02296190|564577255|FG002|Overall Study|Patient was given Propofol|0|||
156405198|NCT02296190|564577256|FG003|Overall Study|Patient was given Propofol|1|||
156405199|NCT02296190|564577257|FG004|Overall Study|Patient was given Propofol|0|||
156405200|NCT02296190|564577258|FG005|Overall Study|Patient was given Propofol|0|||
156405201|NCT02296190|564577253|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
156405202|NCT02296190|564577254|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
156405203|NCT02296190|564577255|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
156405204|NCT02296190|564577256|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
156405205|NCT02296190|564577257|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
156405206|NCT02296190|564577258|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
156405207|NCT02296190|564577253|FG000|Overall Study|Blood pressure <100 after sedation|0|||
156405208|NCT02296190|564577254|FG001|Overall Study|Blood pressure <100 after sedation|0|||
156405209|NCT02296190|564577255|FG002|Overall Study|Blood pressure <100 after sedation|0|||
156405210|NCT02296190|564577256|FG003|Overall Study|Blood pressure <100 after sedation|1|||
156405211|NCT02296190|564577257|FG004|Overall Study|Blood pressure <100 after sedation|0|||
156405212|NCT02296190|564577258|FG005|Overall Study|Blood pressure <100 after sedation|0|||
156405213|NCT02296190|564577253|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
156405214|NCT02296190|564577254|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
156405215|NCT02296190|564577255|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
156405216|NCT02296190|564577256|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
156405217|NCT02296190|564577257|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
156405218|NCT02296190|564577258|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
156405219|NCT02296190|564577253|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
156405220|NCT02296190|564577254|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
156405221|NCT02296190|564577255|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
156405222|NCT02296190|564577256|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
156405223|NCT02296190|564577257|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
156405224|NCT02296190|564577258|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
156405225|NCT02296190|564577253|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156405226|NCT02296190|564577254|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
156405227|NCT02296190|564577255|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156405228|NCT02296190|564577256|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156405229|NCT02296190|564577257|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156405230|NCT02296190|564577258|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156405231|NCT02296190|564577253|FG000|Overall Study|Lab result not available in time|1|||
156405232|NCT02296190|564577254|FG001|Overall Study|Lab result not available in time|0|||
156405233|NCT02296190|564577255|FG002|Overall Study|Lab result not available in time|0|||
156405234|NCT02296190|564577256|FG003|Overall Study|Lab result not available in time|0|||
156405235|NCT02296190|564577257|FG004|Overall Study|Lab result not available in time|0|||
156405236|NCT02296190|564577258|FG005|Overall Study|Lab result not available in time|0|||
156554136|NCT01978093|565119808|FG001|Overall Study|Mother lost custody of child|1|||
156554137|NCT01978093|565119807|FG000|Overall Study|Child was in care of grandmother|0|||
156554138|NCT01978093|565119808|FG001|Overall Study|Child was in care of grandmother|1|||
156554139|NCT01978093|565119807|FG000|Overall Study|N/A for vaccine administration|0|||
156554140|NCT01978093|565119808|FG001|Overall Study|N/A for vaccine administration|1|||
156554141|NCT01396005|565119809|FG000|Overall Study|Withdrawal by Subject|0|||
156554142|NCT01396005|565119810|FG001|Overall Study|Withdrawal by Subject|1|||
156554143|NCT01396005|565119809|FG000|Overall Study|Non-compliance with protocol|0|||
156554144|NCT01396005|565119810|FG001|Overall Study|Non-compliance with protocol|1|||
156554145|NCT01467492|565119813|FG000|Overall Study|Withdrawal by Subject|6|||
156554146|NCT01467492|565119814|FG001|Overall Study|Withdrawal by Subject|4|||
156554147|NCT01467492|565119813|FG000|Overall Study|Study Terminated by Sponsor|6|||
156554148|NCT01467492|565119814|FG001|Overall Study|Study Terminated by Sponsor|4|||
156554149|NCT01467492|565119813|FG000|Overall Study|Adverse Event|4|||
156554150|NCT01467492|565119814|FG001|Overall Study|Adverse Event|3|||
156554151|NCT01467492|565119813|FG000|Overall Study|Lost to Follow-up|3|||
156554152|NCT01467492|565119814|FG001|Overall Study|Lost to Follow-up|2|||
156554153|NCT01467492|565119813|FG000|Overall Study|Undefined|2|||
156554154|NCT01467492|565119814|FG001|Overall Study|Undefined|0|||
156554155|NCT01467492|565119813|FG000|Overall Study|Enrolled But Not Treated|1|||
156554156|NCT01467492|565119814|FG001|Overall Study|Enrolled But Not Treated|0|||
156554157|NCT02450487|565119815|FG000|Overall Study|Lost to Follow-up|3|||
156554158|NCT04269395|565119816|FG000|Overall Study|Lost to Follow-up|1|||
156554159|NCT04269395|565119817|FG001|Overall Study|Lost to Follow-up|0|||
156554160|NCT04269395|565119816|FG000|Overall Study|Study terminated by Sponsor|13|||
156554161|NCT04269395|565119817|FG001|Overall Study|Study terminated by Sponsor|10|||
156554162|NCT01491178|565119818|FG000|Overall Study|Adverse Event|1016|||
156554163|NCT01491178|565119818|FG000|Overall Study|Improvement of NVAF|210|||
156554164|NCT01491178|565119818|FG000|Overall Study|To conduct invasive treatment|59|||
156554165|NCT01491178|565119818|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
156554166|NCT01491178|565119818|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
156554167|NCT01491178|565119818|FG000|Overall Study|To take a contraindication|20|||
156554168|NCT01491178|565119818|FG000|Overall Study|Other than specified above|657|||
156405237|NCT02978443|564577259|FG000|Overall Study|Withdrawal by Subject|1|||
156405238|NCT02978443|564577259|FG000|Overall Study|Adverse Event|3|||
156405239|NCT02978443|564577259|FG000|Overall Study|Disease Progression on study|6|||
156405240|NCT02978443|564577259|FG000|Overall Study|Death|1|||
156405241|NCT02978443|564577259|FG000|Overall Study|Physician Decision|1|||
156405242|NCT02978443|564577259|FG000|Overall Study|Switch to alternative therapy|1|||
156405243|NCT02978443|564577259|FG000|Overall Study|Refused further treatment|1|||
156405244|NCT02178566|564577267|FG000|Overall Study|patient did not complete due to noncompliance|0|||
156405245|NCT02178566|564577268|FG001|Overall Study|patient did not complete due to noncompliance|1|||
156405246|NCT00682643|564577269|FG000|Overall Study|Adverse Event|12|||
156405247|NCT00682643|564577270|FG001|Overall Study|Adverse Event|23|||
156405248|NCT00682643|564577269|FG000|Overall Study|Lack of Efficacy|2|||
156405249|NCT00682643|564577270|FG001|Overall Study|Lack of Efficacy|0|||
156405250|NCT00682643|564577269|FG000|Overall Study|Protocol Violation|38|||
156405251|NCT00682643|564577270|FG001|Overall Study|Protocol Violation|76|||
156405252|NCT00682643|564577269|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
156405253|NCT00682643|564577270|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
156405254|NCT00682643|564577269|FG000|Overall Study|Lost to Follow-up|1|||
156405255|NCT00682643|564577270|FG001|Overall Study|Lost to Follow-up|6|||
156405256|NCT00682643|564577269|FG000|Overall Study|Physician Decision|2|||
156405257|NCT00682643|564577270|FG001|Overall Study|Physician Decision|6|||
156405258|NCT00682643|564577269|FG000|Overall Study|Withdrawal by Subject|19|||
156405259|NCT00682643|564577270|FG001|Overall Study|Withdrawal by Subject|53|||
156405260|NCT00682643|564577269|FG000|Overall Study|Did Not Receive Study Drug|1|||
156405261|NCT00682643|564577270|FG001|Overall Study|Did Not Receive Study Drug|1|||
156405262|NCT01875185|564577271|FG000|Overall Study|study was terminated|52|||
156405263|NCT01875185|564577272|FG001|Overall Study|study was terminated|48|||
156405264|NCT00110890|564577278|FG000|Overall Study|Adverse Event|30|||
156405265|NCT00110890|564577279|FG001|Overall Study|Adverse Event|7|||
156405266|NCT00110890|564577278|FG000|Overall Study|Death|16|||
156405267|NCT00110890|564577279|FG001|Overall Study|Death|9|||
156405268|NCT00110890|564577278|FG000|Overall Study|Lost to Follow-up|3|||
156405269|NCT00110890|564577279|FG001|Overall Study|Lost to Follow-up|1|||
156405270|NCT00110890|564577278|FG000|Overall Study|Physician Decision|4|||
156405271|NCT00110890|564577279|FG001|Overall Study|Physician Decision|5|||
156405272|NCT00110890|564577278|FG000|Overall Study|Withdrawal by Subject|17|||
156405273|NCT00110890|564577279|FG001|Overall Study|Withdrawal by Subject|5|||
156405274|NCT00110890|564577278|FG000|Overall Study|Protocol Deviation|1|||
156405275|NCT00110890|564577279|FG001|Overall Study|Protocol Deviation|0|||
156405276|NCT00110890|564577278|FG000|Overall Study|Noncompliance|10|||
156405277|NCT00110890|564577279|FG001|Overall Study|Noncompliance|0|||
156405278|NCT00110890|564577278|FG000|Overall Study|Kidney Transplant|16|||
156405279|NCT00110890|564577279|FG001|Overall Study|Kidney Transplant|12|||
156554169|NCT05689047|565119821|FG000|Overall Study|Lost to Follow-up|0|||
156554170|NCT05689047|565119822|FG001|Overall Study|Lost to Follow-up|1|||
156554171|NCT05689047|565119821|FG000|Overall Study|Protocol Deviation|1|||
156554172|NCT05689047|565119822|FG001|Overall Study|Protocol Deviation|0|||
156554173|NCT01604512|565119823|FG000|Overall Study|Withdrawal by Subject|3|||
156554174|NCT01604512|565119823|FG000|Overall Study|Not treated|4|||
156554175|NCT03132636|565119824|FG000|Overall Study|Adverse Event|1|||
156554176|NCT03132636|565119825|FG001|Overall Study|Adverse Event|2|||
156554177|NCT03132636|565119824|FG000|Overall Study|Death|4|||
156554178|NCT03132636|565119825|FG001|Overall Study|Death|7|||
156554179|NCT03132636|565119824|FG000|Overall Study|Lost to Follow-up|3|||
156554180|NCT03132636|565119825|FG001|Overall Study|Lost to Follow-up|2|||
156554181|NCT03132636|565119824|FG000|Overall Study|Non compliance with protocol by participant|1|||
156554182|NCT03132636|565119825|FG001|Overall Study|Non compliance with protocol by participant|1|||
156554183|NCT03132636|565119824|FG000|Overall Study|Subject decision|1|||
156554184|NCT03132636|565119825|FG001|Overall Study|Subject decision|9|||
156554185|NCT03132636|565119824|FG000|Overall Study|Sponsor decision|0|||
156554186|NCT03132636|565119825|FG001|Overall Study|Sponsor decision|1|||
156554187|NCT03132636|565119824|FG000|Overall Study|Physician Decision|1|||
156554188|NCT03132636|565119825|FG001|Overall Study|Physician Decision|0|||
156405280|NCT00110890|564577278|FG000|Overall Study|Invest. Product Commercially Available|217|||
156405281|NCT00110890|564577279|FG001|Overall Study|Invest. Product Commercially Available|110|||
156405282|NCT00110890|564577278|FG000|Overall Study|Other|34|||
156405283|NCT00110890|564577279|FG001|Overall Study|Other|23|||
156405284|NCT00110890|564577278|FG000|Overall Study|Ineligibility determined|3|||
156405285|NCT00110890|564577279|FG001|Overall Study|Ineligibility determined|0|||
156405286|NCT00110890|564577278|FG000|Overall Study|Requirement for alternative therapy|0|||
156554189|NCT03132636|565119824|FG000|Overall Study|Progressive disease|33|||
156405287|NCT00110890|564577279|FG001|Overall Study|Requirement for alternative therapy|1|||
156405288|NCT00110890|564577278|FG000|Overall Study|Disease progression|0|||
156405289|NCT00110890|564577279|FG001|Overall Study|Disease progression|1|||
156554190|NCT03132636|565119825|FG001|Overall Study|Progressive disease|36|||
156554191|NCT03132636|565119824|FG000|Overall Study|Withdrawal of consent|2|||
156554192|NCT03132636|565119825|FG001|Overall Study|Withdrawal of consent|5|||
156554193|NCT03132636|565119824|FG000|Overall Study|Did not re-consent|1|||
156405290|NCT00110890|564577278|FG000|Overall Study|Parathyroidectomy|0|||
156405291|NCT00110890|564577279|FG001|Overall Study|Parathyroidectomy|1|||
156405292|NCT00110890|564577278|FG000|Overall Study|Did not enter follow-up phase|10|||
156405293|NCT00110890|564577279|FG001|Overall Study|Did not enter follow-up phase|4|||
156405294|NCT01686581|564577280|FG000|Overall Study|Side-effects or Health Problems|15|||
156405295|NCT01686581|564577280|FG000|Overall Study|Lack of Efficacy|90|||
156405296|NCT01686581|564577280|FG000|Overall Study|Participant Concerned about Risks|6|||
156405297|NCT01686581|564577280|FG000|Overall Study|Thinks Injections Too Painful|8|||
156405298|NCT01686581|564577280|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
156405299|NCT01686581|564577280|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
156405300|NCT01686581|564577280|FG000|Overall Study|Thinks it is Inconvenient|17|||
156405301|NCT01686581|564577280|FG000|Overall Study|Other Miscellaneous Reasons|36|||
156405302|NCT01686581|564577280|FG000|Overall Study|Reason Missing|1|||
156405303|NCT01975220|564577281|FG000|Test Period 1|Not treated|0|||
156405304|NCT01975220|564577282|FG001|Test Period 1|Not treated|1|||
156405305|NCT01975220|564577283|FG002|Test Period 1|Not treated|0|||
156405306|NCT01975220|564577284|FG003|Test Period 1|Not treated|0|||
156405307|NCT01975220|564577285|FG004|Test Period 1|Not treated|0|||
156405308|NCT01975220|564577286|FG005|Test Period 1|Not treated|0|||
156405309|NCT00263328|564577287|FG000|Overall Study|Death|0|||
156405310|NCT00263328|564577288|FG001|Overall Study|Death|0|||
156405311|NCT00263328|564577289|FG002|Overall Study|Death|1|||
156405312|NCT00263328|564577287|FG000|Overall Study|Lost to Follow-up|1|||
156405313|NCT00263328|564577288|FG001|Overall Study|Lost to Follow-up|1|||
156405314|NCT00263328|564577289|FG002|Overall Study|Lost to Follow-up|0|||
156405315|NCT00263328|564577287|FG000|Overall Study|Withdrawal by Subject|3|||
156405316|NCT00263328|564577288|FG001|Overall Study|Withdrawal by Subject|0|||
156405317|NCT00263328|564577289|FG002|Overall Study|Withdrawal by Subject|1|||
156405318|NCT00263328|564577287|FG000|Overall Study|Other|3|||
156405319|NCT00263328|564577288|FG001|Overall Study|Other|0|||
156405320|NCT00263328|564577289|FG002|Overall Study|Other|1|||
156405321|NCT00263328|564577287|FG000|Overall Study|Adverse Event|1|||
156405322|NCT00263328|564577288|FG001|Overall Study|Adverse Event|1|||
156405323|NCT00263328|564577289|FG002|Overall Study|Adverse Event|4|||
156405324|NCT03287414|564577290|FG000|Treatment Epoch|Adverse Event|0|||
156405325|NCT03287414|564577291|FG001|Treatment Epoch|Adverse Event|1|||
156405326|NCT03287414|564577290|FG000|Treatment Epoch|Study terminated by sponsor|2|||
156405327|NCT03287414|564577291|FG001|Treatment Epoch|Study terminated by sponsor|2|||
156405328|NCT03287414|564577290|FG000|Treatment Epoch|Subject/Guardian decision|4|||
156405329|NCT03287414|564577291|FG001|Treatment Epoch|Subject/Guardian decision|0|||
156405330|NCT03287414|564577290|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
156405331|NCT03287414|564577291|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
156405332|NCT03287414|564577290|FG000|Treatment Epoch|Withdrawal by Subject|1|||
156405333|NCT03287414|564577291|FG001|Treatment Epoch|Withdrawal by Subject|0|||
156405334|NCT03287414|564577290|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
156405335|NCT03287414|564577291|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
156405336|NCT03287414|564577290|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
156405337|NCT03287414|564577291|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
156405338|NCT01301274|564577296|FG000|Overall Study|Physician Decision|2|||
156405339|NCT01301274|564577297|FG001|Overall Study|Physician Decision|1|||
156405340|NCT02917941|564577298|FG000|Treatment Period|Adverse Event|11|||
156405341|NCT02917941|564577298|FG000|Treatment Period|Progressive Disease|11|||
156405342|NCT02917941|564577298|FG000|Treatment Period|Reason not Specified|2|||
156405343|NCT02917941|564577298|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
156405344|NCT02917941|564577298|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
156405345|NCT01893827|564577299|FG000|Overall Study|Lost to Follow-up|19|||
156405346|NCT01893827|564577300|FG001|Overall Study|Lost to Follow-up|26|||
156405347|NCT00399763|564577301|FG000|Overall Study|Lost to Follow-up|2|||
156405348|NCT00399763|564577302|FG001|Overall Study|Lost to Follow-up|3|||
156512853|NCT04047862|564968307|FG005|Overall Study|Other|0|||
156512854|NCT04047862|564968308|FG006|Overall Study|Other|0|||
156512855|NCT04047862|564968309|FG007|Overall Study|Other|0|||
156512856|NCT04047862|564968310|FG008|Overall Study|Other|0|||
156512857|NCT04047862|564968311|FG009|Overall Study|Other|0|||
156512858|NCT04047862|564968312|FG010|Overall Study|Other|0|||
156405349|NCT00909428|564577303|FG000|Overall Study|Lost to Follow-up|13|||
156405350|NCT00909428|564577304|FG001|Overall Study|Lost to Follow-up|10|||
156405351|NCT00909428|564577305|FG002|Overall Study|Lost to Follow-up|9|||
156405352|NCT03021668|564577306|FG000|Overall Study|Physician Decision|0|||
156405353|NCT03021668|564577307|FG001|Overall Study|Physician Decision|1|||
156405354|NCT03722264|564579248|FG000|Overall Study|Physician Decision|3|||
156405355|NCT01486758|564579249|FG000|Overall Study|Lost to Follow-up|0|||
156405356|NCT01486758|564579250|FG001|Overall Study|Lost to Follow-up|1|||
156405357|NCT01062763|564579251|FG000|Overall Study|Adverse Event|3|||
156405358|NCT01062763|564579252|FG001|Overall Study|Adverse Event|4|||
156405359|NCT02494921|564579253|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
156405360|NCT02494921|564579254|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
156405361|NCT02494921|564579255|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
156405362|NCT02494921|564579256|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
156405363|NCT02494921|564579257|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
156405364|NCT02494921|564579253|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
156405365|NCT02494921|564579254|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
156405366|NCT02494921|564579255|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
156405367|NCT02494921|564579256|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
156405368|NCT02494921|564579257|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
156405369|NCT02494921|564579253|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
156405370|NCT02494921|564579254|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
156405371|NCT02494921|564579255|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
156405372|NCT02494921|564579256|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
156405373|NCT02494921|564579257|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
156405374|NCT02392611|564579258|FG000|Overall Study|Adverse Event|0|||
156405375|NCT02392611|564579259|FG001|Overall Study|Adverse Event|0|||
156405376|NCT02392611|564579260|FG002|Overall Study|Adverse Event|0|||
156405377|NCT02392611|564579261|FG003|Overall Study|Adverse Event|1|||
156405378|NCT02392611|564579262|FG004|Overall Study|Adverse Event|0|||
156405379|NCT02392611|564579263|FG005|Overall Study|Adverse Event|0|||
156405380|NCT02392611|564579264|FG006|Overall Study|Adverse Event|0|||
156405381|NCT02392611|564579265|FG007|Overall Study|Adverse Event|0|||
156405382|NCT02392611|564579266|FG008|Overall Study|Adverse Event|0|||
156405383|NCT02392611|564579258|FG000|Overall Study|Progressive disease|0|||
156405384|NCT02392611|564579259|FG001|Overall Study|Progressive disease|0|||
156405385|NCT02392611|564579260|FG002|Overall Study|Progressive disease|0|||
156405386|NCT02392611|564579261|FG003|Overall Study|Progressive disease|2|||
156405387|NCT02392611|564579262|FG004|Overall Study|Progressive disease|1|||
156405388|NCT02392611|564579263|FG005|Overall Study|Progressive disease|0|||
156405389|NCT02392611|564579264|FG006|Overall Study|Progressive disease|0|||
156405390|NCT02392611|564579265|FG007|Overall Study|Progressive disease|0|||
156405391|NCT02392611|564579266|FG008|Overall Study|Progressive disease|0|||
156405392|NCT02392611|564579258|FG000|Overall Study|Death|1|||
156405393|NCT02392611|564579259|FG001|Overall Study|Death|0|||
156405394|NCT02392611|564579260|FG002|Overall Study|Death|0|||
156405395|NCT02392611|564579261|FG003|Overall Study|Death|0|||
156405396|NCT02392611|564579262|FG004|Overall Study|Death|0|||
156405397|NCT02392611|564579263|FG005|Overall Study|Death|1|||
156405398|NCT02392611|564579264|FG006|Overall Study|Death|0|||
156405399|NCT02392611|564579265|FG007|Overall Study|Death|0|||
156405400|NCT02392611|564579266|FG008|Overall Study|Death|0|||
156405401|NCT02392611|564579258|FG000|Overall Study|Withdrawal by Subject|0|||
156405402|NCT02392611|564579259|FG001|Overall Study|Withdrawal by Subject|0|||
156405403|NCT02392611|564579260|FG002|Overall Study|Withdrawal by Subject|0|||
156405404|NCT02392611|564579261|FG003|Overall Study|Withdrawal by Subject|1|||
156405405|NCT02392611|564579262|FG004|Overall Study|Withdrawal by Subject|0|||
156405406|NCT02392611|564579263|FG005|Overall Study|Withdrawal by Subject|0|||
156405407|NCT02392611|564579264|FG006|Overall Study|Withdrawal by Subject|0|||
156405408|NCT02392611|564579265|FG007|Overall Study|Withdrawal by Subject|0|||
156405409|NCT02392611|564579266|FG008|Overall Study|Withdrawal by Subject|0|||
156405410|NCT02392611|564579258|FG000|Overall Study|Lost to Follow-up|0|||
156405411|NCT02392611|564579259|FG001|Overall Study|Lost to Follow-up|0|||
156405412|NCT02392611|564579260|FG002|Overall Study|Lost to Follow-up|0|||
156405413|NCT02392611|564579261|FG003|Overall Study|Lost to Follow-up|0|||
156405414|NCT02392611|564579262|FG004|Overall Study|Lost to Follow-up|0|||
156405415|NCT02392611|564579263|FG005|Overall Study|Lost to Follow-up|0|||
156405416|NCT02392611|564579264|FG006|Overall Study|Lost to Follow-up|1|||
156405417|NCT02392611|564579265|FG007|Overall Study|Lost to Follow-up|0|||
156405418|NCT02392611|564579266|FG008|Overall Study|Lost to Follow-up|0|||
156405419|NCT02392611|564579258|FG000|Overall Study|Enrolled, not treated|0|||
156405420|NCT02392611|564579259|FG001|Overall Study|Enrolled, not treated|0|||
156405421|NCT02392611|564579260|FG002|Overall Study|Enrolled, not treated|0|||
156405422|NCT02392611|564579261|FG003|Overall Study|Enrolled, not treated|2|||
156405423|NCT02392611|564579262|FG004|Overall Study|Enrolled, not treated|0|||
156405424|NCT02392611|564579263|FG005|Overall Study|Enrolled, not treated|0|||
156405425|NCT02392611|564579264|FG006|Overall Study|Enrolled, not treated|0|||
156405426|NCT02392611|564579265|FG007|Overall Study|Enrolled, not treated|0|||
156405427|NCT02392611|564579266|FG008|Overall Study|Enrolled, not treated|0|||
156405428|NCT03239873|564579270|FG000|Overall Study|Lost to Follow-up|15|||
156405429|NCT03239873|564579271|FG001|Overall Study|Lost to Follow-up|16|||
156405430|NCT03239873|564579270|FG000|Overall Study|Physician Decision|1|||
156405431|NCT03239873|564579271|FG001|Overall Study|Physician Decision|0|||
156405432|NCT03239873|564579270|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
156405433|NCT03239873|564579271|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
156405434|NCT03239873|564579270|FG000|Overall Study|Withdrawal by Subject|2|||
156405435|NCT03239873|564579271|FG001|Overall Study|Withdrawal by Subject|0|||
156405436|NCT03239873|564579270|FG000|Overall Study|Contraindication to study medication|1|||
156405437|NCT03239873|564579271|FG001|Overall Study|Contraindication to study medication|0|||
156405438|NCT03239873|564579270|FG000|Overall Study|Protocol Violation|1|||
156405439|NCT03239873|564579271|FG001|Overall Study|Protocol Violation|0|||
156405440|NCT00768430|564579274|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
156405441|NCT00768430|564579275|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
156405442|NCT03585296|564579280|FG000|Overall Study|Adverse Event|1|||
156405443|NCT03585296|564579280|FG000|Overall Study|Lost to Follow-up|2|||
156405444|NCT03585296|564579280|FG000|Overall Study|Withdrawal by Subject|2|||
156405445|NCT00041756|564579281|FG000|Overall Study|Adverse Event|4|||
156405446|NCT00041756|564579282|FG001|Overall Study|Adverse Event|10|||
156405447|NCT00041756|564579283|FG002|Overall Study|Adverse Event|6|||
156405448|NCT00041756|564579284|FG003|Overall Study|Adverse Event|11|||
156405449|NCT00041756|564579285|FG004|Overall Study|Adverse Event|34|||
156405450|NCT00041756|564579281|FG000|Overall Study|Protocol Violation|1|||
156405451|NCT00041756|564579282|FG001|Overall Study|Protocol Violation|1|||
156405452|NCT00041756|564579283|FG002|Overall Study|Protocol Violation|2|||
156405453|NCT00041756|564579284|FG003|Overall Study|Protocol Violation|2|||
156405454|NCT00041756|564579285|FG004|Overall Study|Protocol Violation|1|||
156405455|NCT00041756|564579281|FG000|Overall Study|Withdrawal by Subject|3|||
156405456|NCT00041756|564579282|FG001|Overall Study|Withdrawal by Subject|3|||
156405457|NCT00041756|564579283|FG002|Overall Study|Withdrawal by Subject|4|||
156405458|NCT00041756|564579284|FG003|Overall Study|Withdrawal by Subject|2|||
156405459|NCT00041756|564579285|FG004|Overall Study|Withdrawal by Subject|3|||
156405460|NCT00041756|564579281|FG000|Overall Study|Lost to Follow-up|0|||
156405461|NCT00041756|564579282|FG001|Overall Study|Lost to Follow-up|1|||
156405462|NCT00041756|564579283|FG002|Overall Study|Lost to Follow-up|0|||
156405463|NCT00041756|564579284|FG003|Overall Study|Lost to Follow-up|1|||
156405464|NCT00041756|564579285|FG004|Overall Study|Lost to Follow-up|0|||
156405465|NCT00041756|564579281|FG000|Overall Study|Unable to meet protocol criteria|0|||
156405466|NCT00041756|564579282|FG001|Overall Study|Unable to meet protocol criteria|0|||
156405467|NCT00041756|564579283|FG002|Overall Study|Unable to meet protocol criteria|1|||
156405468|NCT00041756|564579284|FG003|Overall Study|Unable to meet protocol criteria|0|||
156405469|NCT00041756|564579285|FG004|Overall Study|Unable to meet protocol criteria|1|||
156405470|NCT00041756|564579281|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
156405471|NCT00041756|564579282|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
156405472|NCT00041756|564579283|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
156405473|NCT00041756|564579284|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
156405474|NCT00041756|564579285|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
156405475|NCT00519896|564579286|FG000|Overall Study|Protocol Violation|1|||
156405476|NCT00519896|564579286|FG000|Overall Study|Adverse Event|1|||
156405477|NCT00810082|564579287|FG000|Overall Study|Lost to Follow-up|0|||
156405478|NCT00810082|564579288|FG001|Overall Study|Lost to Follow-up|4|||
156405479|NCT03327402|564579289|FG000|Overall Study|Withdrawal by Subject|1|||
156405480|NCT03327402|564579289|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
156405481|NCT01454830|564579292|FG000|Overall Study|Withdrawal by Subject|4|||
156405482|NCT01454830|564579293|FG001|Overall Study|Withdrawal by Subject|4|||
156405483|NCT01454830|564579292|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
156405484|NCT01454830|564579293|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
156405485|NCT01454830|564579292|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
156405486|NCT01454830|564579293|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
156405487|NCT01454830|564579292|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
156405488|NCT01454830|564579293|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
156512859|NCT04047862|564968313|FG011|Overall Study|Other|0|||
156405489|NCT01454830|564579292|FG000|Overall Study|Withdrawal - no polysomnography|3|||
156512860|NCT04047862|564968314|FG012|Overall Study|Other|0|||
156512861|NCT04047862|564968315|FG013|Overall Study|Other|0|||
156512862|NCT04047862|564968316|FG014|Overall Study|Other|2|||
156512863|NCT04047862|564968317|FG015|Overall Study|Other|1|||
156512864|NCT04047862|564968318|FG016|Overall Study|Other|1|||
156512865|NCT04047862|564968319|FG017|Overall Study|Other|1|||
156512866|NCT04047862|564968320|FG018|Overall Study|Other|0|||
156512867|NCT01099215|564970597|FG000|Overall Study|Withdrawal by Subject|1|||
156512868|NCT01099215|564970598|FG001|Overall Study|Withdrawal by Subject|0|||
156512869|NCT01099215|564970597|FG000|Overall Study|Adverse Event|0|||
156512870|NCT01099215|564970598|FG001|Overall Study|Adverse Event|1|||
156512871|NCT01732822|564970599|FG000|Overall Study|Withdrawal by Subject|123|||
156512872|NCT01732822|564970600|FG001|Overall Study|Withdrawal by Subject|113|||
156405490|NCT01454830|564579293|FG001|Overall Study|Withdrawal - no polysomnography|2|||
156405491|NCT00584805|564579294|FG000|Overall Study|No longer at risk of exposure|39|||
156405492|NCT00584805|564579294|FG000|Overall Study|Relocation|36|||
156405493|NCT00584805|564579294|FG000|Overall Study|Withdrawal by Subject|18|||
156405494|NCT00584805|564579294|FG000|Overall Study|Non-compliance|1|||
156405495|NCT00584805|564579294|FG000|Overall Study|Lost to follow up|3|||
156512873|NCT01077271|564970604|FG000|Overall Study|Parental desire|8|||
156405496|NCT00584805|564579294|FG000|Overall Study|Screen failures|2|||
156405497|NCT01077362|564579295|FG000|Overall Study|Lack of Efficacy|13|||
156405498|NCT01077362|564579296|FG001|Overall Study|Lack of Efficacy|8|||
156405499|NCT01077362|564579297|FG002|Overall Study|Lack of Efficacy|10|||
156512874|NCT01077271|564970604|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
156512875|NCT01077271|564970604|FG000|Overall Study|Noncompliance|2|||
156554194|NCT03132636|565119825|FG001|Overall Study|Did not re-consent|0|||
156554195|NCT03132636|565119824|FG000|Overall Study|Lost insurance coverage|1|||
156554196|NCT03132636|565119825|FG001|Overall Study|Lost insurance coverage|0|||
156554197|NCT03132636|565119824|FG000|Overall Study|Related to radiological outcomes|0|||
156554198|NCT03132636|565119825|FG001|Overall Study|Related to radiological outcomes|1|||
156554199|NCT03132636|565119824|FG000|Overall Study|Unable to come to site for continued visits|0|||
156554200|NCT03132636|565119825|FG001|Overall Study|Unable to come to site for continued visits|1|||
156554201|NCT02926209|565119826|FG000|Study Cohort|Poor Bowel Preparation|1|||
156554202|NCT02926209|565119827|FG001|Study Cohort|Poor Bowel Preparation|0|||
156554203|NCT01789970|565119828|FG000|Open-label Titration Period|Adverse Event|68|||
156554204|NCT01789970|565119829|FG001|Open-label Titration Period|Adverse Event|0|||
156554205|NCT01789970|565119830|FG002|Open-label Titration Period|Adverse Event|0|||
156554206|NCT01789970|565119828|FG000|Open-label Titration Period|Lack of Efficacy|31|||
156554207|NCT01789970|565119829|FG001|Open-label Titration Period|Lack of Efficacy|0|||
156554208|NCT01789970|565119830|FG002|Open-label Titration Period|Lack of Efficacy|0|||
156554209|NCT01789970|565119828|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
156554210|NCT01789970|565119829|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
156554211|NCT01789970|565119830|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
156554212|NCT01789970|565119828|FG000|Open-label Titration Period|Protocol Violation|18|||
156554213|NCT01789970|565119829|FG001|Open-label Titration Period|Protocol Violation|0|||
156554214|NCT01789970|565119830|FG002|Open-label Titration Period|Protocol Violation|0|||
156554215|NCT01789970|565119828|FG000|Open-label Titration Period|Lost to Follow-up|5|||
156554216|NCT01789970|565119829|FG001|Open-label Titration Period|Lost to Follow-up|0|||
156554217|NCT01789970|565119830|FG002|Open-label Titration Period|Lost to Follow-up|0|||
156554218|NCT01789970|565119828|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
156554219|NCT01789970|565119829|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
156554220|NCT01789970|565119830|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
156554221|NCT01789970|565119828|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
156554222|NCT01789970|565119829|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
156554223|NCT01789970|565119830|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
156554224|NCT01789970|565119828|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
156554225|NCT01789970|565119829|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
156554226|NCT01789970|565119830|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
156554227|NCT01789970|565119828|FG000|Open-label Titration Period|Pregnancy|2|||
156554228|NCT01789970|565119829|FG001|Open-label Titration Period|Pregnancy|0|||
156554229|NCT01789970|565119830|FG002|Open-label Titration Period|Pregnancy|0|||
156554230|NCT01789970|565119828|FG000|Open-label Titration Period|Other|76|||
156405500|NCT01077362|564579295|FG000|Overall Study|Lost to Follow-up|1|||
156405501|NCT01077362|564579296|FG001|Overall Study|Lost to Follow-up|0|||
156405502|NCT01077362|564579297|FG002|Overall Study|Lost to Follow-up|3|||
156405503|NCT01077362|564579295|FG000|Overall Study|Adverse Event|12|||
156405504|NCT01077362|564579296|FG001|Overall Study|Adverse Event|7|||
156405505|NCT01077362|564579297|FG002|Overall Study|Adverse Event|4|||
156405506|NCT01077362|564579295|FG000|Overall Study|Withdrawal by Subject|5|||
156405507|NCT01077362|564579296|FG001|Overall Study|Withdrawal by Subject|3|||
156405508|NCT01077362|564579297|FG002|Overall Study|Withdrawal by Subject|5|||
156405509|NCT01077362|564579295|FG000|Overall Study|Other|0|||
156405510|NCT01077362|564579296|FG001|Overall Study|Other|1|||
156405511|NCT01077362|564579297|FG002|Overall Study|Other|2|||
156405512|NCT00301080|564579298|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
156405513|NCT00301080|564579299|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
156405514|NCT00301080|564579300|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
156405515|NCT00301080|564579301|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
156554231|NCT01789970|565119829|FG001|Open-label Titration Period|Other|0|||
156554232|NCT01789970|565119830|FG002|Open-label Titration Period|Other|0|||
156554233|NCT01789970|565119828|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
156405516|NCT00301080|564579302|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
156554234|NCT01789970|565119829|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
156554235|NCT01789970|565119830|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
156554236|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
156554237|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
156405517|NCT01111838|564579303|FG000|Overall Study|Patient Ineligible|2|||
156554238|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
156554239|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
156554240|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
156405518|NCT01111838|564579303|FG000|Overall Study|Not Treated|3|||
156405519|NCT01111838|564579303|FG000|Overall Study|Clinical deterioration|1|||
156405520|NCT01111838|564579303|FG000|Overall Study|Other Complicating Disease|1|||
156405521|NCT01616771|564579309|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
156405522|NCT00744328|564579310|FG000|Overall Study|Lost to Follow-up|2|||
156405523|NCT00744328|564579311|FG001|Overall Study|Lost to Follow-up|5|||
156512876|NCT01077271|564970604|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
156512877|NCT01077271|564970604|FG000|Overall Study|Changed doctors|2|||
156512878|NCT01077271|564970604|FG000|Overall Study|Parents thought too many injections|2|||
156512879|NCT01077271|564970604|FG000|Overall Study|End of RSV season nearly reached|1|||
156512880|NCT01077271|564970604|FG000|Overall Study|Mother unconvinced of the necessity|1|||
156512881|NCT00215137|564970605|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
156512882|NCT00215137|564970606|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
156512883|NCT00215137|564970607|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
156512884|NCT00215137|564970605|FG000|Randomization Period|Lost to Follow-up|0|||
156512885|NCT00215137|564970606|FG001|Randomization Period|Lost to Follow-up|1|||
156512886|NCT00215137|564970607|FG002|Randomization Period|Lost to Follow-up|0|||
156512887|NCT00215137|564970605|FG000|Randomization Period|Withdrawal by Subject|0|||
156512888|NCT00215137|564970606|FG001|Randomization Period|Withdrawal by Subject|1|||
156512889|NCT00215137|564970607|FG002|Randomization Period|Withdrawal by Subject|0|||
156512890|NCT03333876|564970608|FG000|Screening Period|Screen Failure|4|||
156512891|NCT03333876|564970608|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
156512892|NCT03333876|564970608|FG000|Mandibular Advancement|Adverse Event|2|||
156512893|NCT03333876|564970608|FG000|Mandibular Advancement|Product Damage|2|||
156512894|NCT00095498|564970610|FG000|Overall Study|Physician Decision|9|||
156512895|NCT00095498|564970611|FG001|Overall Study|Physician Decision|10|||
156512896|NCT00095498|564970612|FG002|Overall Study|Physician Decision|8|||
156512897|NCT00095498|564970610|FG000|Overall Study|Adverse Event|1|||
156512898|NCT00095498|564970611|FG001|Overall Study|Adverse Event|0|||
156512899|NCT00095498|564970612|FG002|Overall Study|Adverse Event|1|||
156512900|NCT00095498|564970610|FG000|Overall Study|Withdrawal by Subject|15|||
156512901|NCT00095498|564970611|FG001|Overall Study|Withdrawal by Subject|16|||
156512902|NCT00095498|564970612|FG002|Overall Study|Withdrawal by Subject|15|||
156512903|NCT00095498|564970610|FG000|Overall Study|Disease progression|0|||
156512904|NCT00095498|564970611|FG001|Overall Study|Disease progression|1|||
156512905|NCT00095498|564970612|FG002|Overall Study|Disease progression|1|||
156512906|NCT00095498|564970610|FG000|Overall Study|Ineligibility determined|3|||
156512907|NCT00095498|564970611|FG001|Overall Study|Ineligibility determined|0|||
156512908|NCT00095498|564970612|FG002|Overall Study|Ineligibility determined|2|||
156512909|NCT00095498|564970610|FG000|Overall Study|Lost to Follow-up|1|||
156512910|NCT00095498|564970611|FG001|Overall Study|Lost to Follow-up|1|||
156512911|NCT00095498|564970612|FG002|Overall Study|Lost to Follow-up|2|||
156512912|NCT00095498|564970610|FG000|Overall Study|Noncompliance|1|||
156512913|NCT00095498|564970611|FG001|Overall Study|Noncompliance|0|||
156512914|NCT00095498|564970612|FG002|Overall Study|Noncompliance|1|||
156512915|NCT00095498|564970610|FG000|Overall Study|Other|6|||
156512916|NCT00095498|564970611|FG001|Overall Study|Other|7|||
156512917|NCT00095498|564970612|FG002|Overall Study|Other|6|||
156512918|NCT00095498|564970610|FG000|Overall Study|Protocol Violation|0|||
156512919|NCT00095498|564970611|FG001|Overall Study|Protocol Violation|0|||
156512920|NCT00095498|564970612|FG002|Overall Study|Protocol Violation|1|||
156512921|NCT00095498|564970610|FG000|Overall Study|Requirement for alternative therapy|1|||
156512922|NCT00095498|564970611|FG001|Overall Study|Requirement for alternative therapy|0|||
156512923|NCT00095498|564970612|FG002|Overall Study|Requirement for alternative therapy|2|||
156512924|NCT05020327|564970614|FG000|Overall Study|Physician Decision|3|||
156512925|NCT05020327|564970615|FG001|Overall Study|Physician Decision|0|||
156512926|NCT05020327|564970616|FG002|Overall Study|Physician Decision|0|||
156512927|NCT05020327|564970614|FG000|Overall Study|Withdrawal by Subject|1|||
156512928|NCT05020327|564970615|FG001|Overall Study|Withdrawal by Subject|1|||
156512929|NCT05020327|564970616|FG002|Overall Study|Withdrawal by Subject|0|||
156512930|NCT05020327|564970614|FG000|Overall Study|personal/cultural, ineligible|12|||
156512931|NCT05020327|564970615|FG001|Overall Study|personal/cultural, ineligible|0|||
156512932|NCT05020327|564970616|FG002|Overall Study|personal/cultural, ineligible|0|||
156512933|NCT00166712|564970617|FG000|Overall Study|Death|0|||
156512934|NCT00166712|564970618|FG001|Overall Study|Death|1|||
156512935|NCT00166712|564970617|FG000|Overall Study|Adverse Event|1|||
156512936|NCT00166712|564970618|FG001|Overall Study|Adverse Event|0|||
156512937|NCT00166712|564970617|FG000|Overall Study|Withdrawal by Subject|1|||
156512938|NCT00166712|564970618|FG001|Overall Study|Withdrawal by Subject|2|||
156512939|NCT00166712|564970617|FG000|Overall Study|Physician Decision|0|||
156512940|NCT00166712|564970618|FG001|Overall Study|Physician Decision|2|||
156512941|NCT04684394|564970619|FG000|Overall Study|Death|1|||
156512942|NCT04684394|564970620|FG001|Overall Study|Death|2|||
156512943|NCT04684394|564970619|FG000|Overall Study|Lost to Follow-up|1|||
156512944|NCT04684394|564970620|FG001|Overall Study|Lost to Follow-up|0|||
156512945|NCT04684394|564970619|FG000|Overall Study|Withdrawal by Subject|2|||
156512946|NCT04684394|564970620|FG001|Overall Study|Withdrawal by Subject|0|||
156512947|NCT04684394|564970619|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
156512948|NCT04684394|564970620|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
156512949|NCT00591370|564970623|FG000|Overall Study|Not Treated|2|||
156512950|NCT00640133|564970624|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
156512951|NCT00640133|564970625|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
156512952|NCT00640133|564970624|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
156554241|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
156554242|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156554243|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
156554244|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
156554245|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156554246|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
156554247|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
156554248|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
156554249|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
156554250|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
156554251|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
156554252|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
156554253|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
156554254|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156554255|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156554256|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
156554257|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
156554258|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
156554259|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
156554260|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
156554261|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
156554262|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
156554263|NCT01789970|565119828|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
156554264|NCT01789970|565119829|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
156554265|NCT01789970|565119830|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
156554266|NCT01847885|565119834|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
156554267|NCT01847885|565119835|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
156554268|NCT01847885|565119836|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
156554269|NCT01847885|565119834|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
156405524|NCT00744328|564579312|FG002|Overall Study|Lost to Follow-up|3|||
156405525|NCT00744328|564579310|FG000|Overall Study|Withdrawal by Subject|5|||
156554270|NCT01847885|565119835|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
156554271|NCT01847885|565119836|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
156554272|NCT01847885|565119834|FG000|Initial Enrollment (Consented)|Screen failure|39|||
156554273|NCT01847885|565119835|FG001|Initial Enrollment (Consented)|Screen failure|0|||
156554274|NCT01847885|565119836|FG002|Initial Enrollment (Consented)|Screen failure|0|||
156554275|NCT01847885|565119834|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
156554276|NCT01847885|565119835|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
156554277|NCT01847885|565119836|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
156554278|NCT01847885|565119834|FG000|Randomization|Protocol Violation|0|||
156554279|NCT01847885|565119835|FG001|Randomization|Protocol Violation|1|||
156405526|NCT00744328|564579311|FG001|Overall Study|Withdrawal by Subject|3|||
156405527|NCT00744328|564579312|FG002|Overall Study|Withdrawal by Subject|4|||
156405528|NCT00744328|564579310|FG000|Overall Study|Found ineligible after randomization|0|||
156405529|NCT00744328|564579311|FG001|Overall Study|Found ineligible after randomization|0|||
156405530|NCT00744328|564579312|FG002|Overall Study|Found ineligible after randomization|1|||
156405531|NCT02247804|564579314|FG000|Treatment Period 1|Adverse Event|9|||
156405532|NCT02247804|564579315|FG001|Treatment Period 1|Adverse Event|2|||
156405533|NCT02247804|564579316|FG002|Treatment Period 1|Adverse Event|0|||
156405534|NCT02247804|564579314|FG000|Treatment Period 1|Lack of Efficacy|0|||
156405535|NCT02247804|564579315|FG001|Treatment Period 1|Lack of Efficacy|0|||
156405536|NCT02247804|564579316|FG002|Treatment Period 1|Lack of Efficacy|2|||
156405537|NCT02247804|564579314|FG000|Treatment Period 1|Lost to Follow-up|1|||
156405538|NCT02247804|564579315|FG001|Treatment Period 1|Lost to Follow-up|0|||
156405539|NCT02247804|564579316|FG002|Treatment Period 1|Lost to Follow-up|2|||
156405540|NCT02247804|564579314|FG000|Treatment Period 1|Personal Reasons|7|||
156405541|NCT02247804|564579315|FG001|Treatment Period 1|Personal Reasons|1|||
156405542|NCT02247804|564579316|FG002|Treatment Period 1|Personal Reasons|2|||
156405543|NCT02247804|564579314|FG000|Treatment Period 1|Protocol Deviation|0|||
156405544|NCT02247804|564579315|FG001|Treatment Period 1|Protocol Deviation|0|||
156554280|NCT01847885|565119836|FG002|Randomization|Protocol Violation|0|||
156554281|NCT01847885|565119834|FG000|Randomization|Withdrawal by Subject|0|||
156405545|NCT02247804|564579316|FG002|Treatment Period 1|Protocol Deviation|1|||
156405546|NCT02247804|564579314|FG000|Treatment Period 1|Randomized but not Treated|5|||
156405547|NCT02247804|564579315|FG001|Treatment Period 1|Randomized but not Treated|1|||
156405548|NCT02247804|564579316|FG002|Treatment Period 1|Randomized but not Treated|1|||
156405549|NCT02247804|564579314|FG000|Treatment Period 2|Adverse Event|6|||
156405550|NCT02247804|564579315|FG001|Treatment Period 2|Adverse Event|3|||
156405551|NCT02247804|564579316|FG002|Treatment Period 2|Adverse Event|3|||
156405552|NCT02247804|564579314|FG000|Treatment Period 2|Lack of Efficacy|0|||
156405553|NCT02247804|564579315|FG001|Treatment Period 2|Lack of Efficacy|0|||
156405554|NCT02247804|564579316|FG002|Treatment Period 2|Lack of Efficacy|1|||
156405555|NCT02247804|564579314|FG000|Treatment Period 2|Lost to Follow-up|0|||
156405556|NCT02247804|564579315|FG001|Treatment Period 2|Lost to Follow-up|1|||
156405557|NCT02247804|564579316|FG002|Treatment Period 2|Lost to Follow-up|1|||
156405558|NCT02247804|564579314|FG000|Treatment Period 2|Personal Reasons|2|||
156405559|NCT02247804|564579315|FG001|Treatment Period 2|Personal Reasons|1|||
156405560|NCT02247804|564579316|FG002|Treatment Period 2|Personal Reasons|1|||
156405561|NCT02247804|564579314|FG000|Treatment Period 2|Reason not Specified|0|||
156405562|NCT02247804|564579315|FG001|Treatment Period 2|Reason not Specified|0|||
156405563|NCT02247804|564579316|FG002|Treatment Period 2|Reason not Specified|2|||
156405564|NCT02247804|564579314|FG000|Treatment Period 3|Adverse Event|4|||
156405565|NCT02247804|564579315|FG001|Treatment Period 3|Adverse Event|3|||
156405566|NCT02247804|564579316|FG002|Treatment Period 3|Adverse Event|3|||
156405567|NCT02247804|564579314|FG000|Treatment Period 3|Lack of Efficacy|0|||
156405568|NCT02247804|564579315|FG001|Treatment Period 3|Lack of Efficacy|1|||
156405569|NCT02247804|564579316|FG002|Treatment Period 3|Lack of Efficacy|0|||
156405570|NCT02247804|564579314|FG000|Treatment Period 3|Lost to Follow-up|1|||
156405571|NCT02247804|564579315|FG001|Treatment Period 3|Lost to Follow-up|2|||
156405572|NCT02247804|564579316|FG002|Treatment Period 3|Lost to Follow-up|2|||
156405573|NCT02247804|564579314|FG000|Treatment Period 3|Personal Reasons|4|||
156405574|NCT02247804|564579315|FG001|Treatment Period 3|Personal Reasons|3|||
156405575|NCT02247804|564579316|FG002|Treatment Period 3|Personal Reasons|2|||
156405576|NCT02247804|564579314|FG000|Treatment Period 3|Reason not Specified|2|||
156405577|NCT02247804|564579315|FG001|Treatment Period 3|Reason not Specified|1|||
156405578|NCT02247804|564579316|FG002|Treatment Period 3|Reason not Specified|3|||
156405579|NCT01054573|564579317|FG000|Overall Study|Adverse Event|1|||
156405580|NCT01054573|564579318|FG001|Overall Study|Adverse Event|0|||
156405581|NCT01054573|564579319|FG002|Overall Study|Adverse Event|1|||
156405582|NCT01054573|564579320|FG003|Overall Study|Adverse Event|1|||
156405583|NCT01054573|564579317|FG000|Overall Study|Lost to Follow-up|0|||
156405584|NCT01054573|564579318|FG001|Overall Study|Lost to Follow-up|2|||
156405585|NCT01054573|564579319|FG002|Overall Study|Lost to Follow-up|0|||
156405586|NCT01054573|564579320|FG003|Overall Study|Lost to Follow-up|0|||
156405587|NCT01054573|564579317|FG000|Overall Study|Withdrawal by Subject|0|||
156405588|NCT01054573|564579318|FG001|Overall Study|Withdrawal by Subject|2|||
156405589|NCT01054573|564579319|FG002|Overall Study|Withdrawal by Subject|2|||
156405590|NCT01054573|564579320|FG003|Overall Study|Withdrawal by Subject|1|||
156405591|NCT00152009|564579321|FG000|Overall Study|Adverse Event|9|||
156405592|NCT00152009|564579322|FG001|Overall Study|Adverse Event|13|||
156405593|NCT00152009|564579323|FG002|Overall Study|Adverse Event|20|||
156405594|NCT00152009|564579324|FG003|Overall Study|Adverse Event|1|||
156405595|NCT00152009|564579321|FG000|Overall Study|Protocol Violation|3|||
156405596|NCT00152009|564579322|FG001|Overall Study|Protocol Violation|0|||
156405597|NCT00152009|564579323|FG002|Overall Study|Protocol Violation|0|||
156405598|NCT00152009|564579324|FG003|Overall Study|Protocol Violation|1|||
156405599|NCT00152009|564579321|FG000|Overall Study|Withdrawal by Subject|2|||
156405600|NCT00152009|564579322|FG001|Overall Study|Withdrawal by Subject|3|||
156405601|NCT00152009|564579323|FG002|Overall Study|Withdrawal by Subject|4|||
156405602|NCT00152009|564579324|FG003|Overall Study|Withdrawal by Subject|9|||
156405603|NCT00152009|564579321|FG000|Overall Study|Lost to Follow-up|2|||
156405604|NCT00152009|564579322|FG001|Overall Study|Lost to Follow-up|4|||
156405605|NCT00152009|564579323|FG002|Overall Study|Lost to Follow-up|3|||
156405606|NCT00152009|564579324|FG003|Overall Study|Lost to Follow-up|3|||
156405607|NCT00152009|564579321|FG000|Overall Study|Lack of Efficacy|8|||
156405608|NCT00152009|564579322|FG001|Overall Study|Lack of Efficacy|6|||
156405609|NCT00152009|564579323|FG002|Overall Study|Lack of Efficacy|7|||
156405610|NCT00152009|564579324|FG003|Overall Study|Lack of Efficacy|15|||
156405611|NCT00152009|564579321|FG000|Overall Study|ECG abnormalities|2|||
156405612|NCT00152009|564579322|FG001|Overall Study|ECG abnormalities|2|||
156405613|NCT00152009|564579323|FG002|Overall Study|ECG abnormalities|2|||
156405614|NCT00152009|564579324|FG003|Overall Study|ECG abnormalities|1|||
156405615|NCT00152009|564579321|FG000|Overall Study|Sponsor's decision|3|||
156405616|NCT00152009|564579322|FG001|Overall Study|Sponsor's decision|3|||
156405617|NCT00152009|564579323|FG002|Overall Study|Sponsor's decision|1|||
156405618|NCT00152009|564579324|FG003|Overall Study|Sponsor's decision|3|||
156405619|NCT00393523|564579325|FG000|Overall Study|Lost to Follow-up|0|||
156405620|NCT00393523|564579326|FG001|Overall Study|Lost to Follow-up|0|||
156405621|NCT00393523|564579327|FG002|Overall Study|Lost to Follow-up|0|||
156405622|NCT00393523|564579328|FG003|Overall Study|Lost to Follow-up|2|||
156405623|NCT00393523|564579329|FG004|Overall Study|Lost to Follow-up|1|||
156405624|NCT00393523|564579325|FG000|Overall Study|Protocol Violation|6|||
156405625|NCT00393523|564579326|FG001|Overall Study|Protocol Violation|2|||
156405626|NCT00393523|564579327|FG002|Overall Study|Protocol Violation|0|||
156405627|NCT00393523|564579328|FG003|Overall Study|Protocol Violation|1|||
156405628|NCT00393523|564579329|FG004|Overall Study|Protocol Violation|0|||
156405629|NCT00393523|564579325|FG000|Overall Study|Withdrawal by Subject|6|||
156405630|NCT00393523|564579326|FG001|Overall Study|Withdrawal by Subject|7|||
156405631|NCT00393523|564579327|FG002|Overall Study|Withdrawal by Subject|2|||
156405632|NCT00393523|564579328|FG003|Overall Study|Withdrawal by Subject|3|||
156405633|NCT00393523|564579329|FG004|Overall Study|Withdrawal by Subject|0|||
156405634|NCT00393523|564579325|FG000|Overall Study|Difficulties in specimen collection|0|||
156405635|NCT00393523|564579326|FG001|Overall Study|Difficulties in specimen collection|0|||
156405636|NCT00393523|564579327|FG002|Overall Study|Difficulties in specimen collection|1|||
156405637|NCT00393523|564579328|FG003|Overall Study|Difficulties in specimen collection|0|||
156405638|NCT00393523|564579329|FG004|Overall Study|Difficulties in specimen collection|0|||
156405639|NCT00393523|564579325|FG000|Overall Study|Vaccine supply issue|0|||
156405640|NCT00393523|564579326|FG001|Overall Study|Vaccine supply issue|0|||
156405641|NCT00393523|564579327|FG002|Overall Study|Vaccine supply issue|1|||
156405642|NCT00393523|564579328|FG003|Overall Study|Vaccine supply issue|0|||
156405643|NCT00393523|564579329|FG004|Overall Study|Vaccine supply issue|0|||
156405644|NCT02954458|564579333|FG000|Overall Study|Adverse Event|0|||
156405645|NCT02954458|564579334|FG001|Overall Study|Adverse Event|0|||
156405646|NCT02954458|564579335|FG002|Overall Study|Adverse Event|0|||
156405647|NCT02954458|564579336|FG003|Overall Study|Adverse Event|1|||
156405648|NCT02954458|564579333|FG000|Overall Study|Withdrawal by Subject|0|||
156405649|NCT02954458|564579334|FG001|Overall Study|Withdrawal by Subject|0|||
156405650|NCT02954458|564579335|FG002|Overall Study|Withdrawal by Subject|0|||
156405651|NCT02954458|564579336|FG003|Overall Study|Withdrawal by Subject|1|||
156405652|NCT02954458|564579333|FG000|Overall Study|Physician Decision|0|||
156405653|NCT02954458|564579334|FG001|Overall Study|Physician Decision|0|||
156405654|NCT02954458|564579335|FG002|Overall Study|Physician Decision|1|||
156405655|NCT02954458|564579336|FG003|Overall Study|Physician Decision|1|||
156405656|NCT02954458|564579333|FG000|Overall Study|Lost to Follow-up|1|||
156405657|NCT02954458|564579334|FG001|Overall Study|Lost to Follow-up|0|||
156405658|NCT02954458|564579335|FG002|Overall Study|Lost to Follow-up|0|||
156405659|NCT02954458|564579336|FG003|Overall Study|Lost to Follow-up|1|||
156405660|NCT02954458|564579333|FG000|Overall Study|Death|0|||
156405661|NCT02954458|564579334|FG001|Overall Study|Death|0|||
156405662|NCT02954458|564579335|FG002|Overall Study|Death|0|||
156405663|NCT02954458|564579336|FG003|Overall Study|Death|1|||
156405664|NCT02954458|564579333|FG000|Overall Study|Other|0|||
156405665|NCT02954458|564579334|FG001|Overall Study|Other|0|||
156405666|NCT02954458|564579335|FG002|Overall Study|Other|0|||
156405667|NCT02954458|564579336|FG003|Overall Study|Other|7|||
156405668|NCT04000594|564579337|FG000|Overall Study|Withdrawal by Subject|1|||
156405669|NCT04000594|564579338|FG001|Overall Study|Withdrawal by Subject|0|||
156405670|NCT04000594|564579339|FG002|Overall Study|Withdrawal by Subject|0|||
156405671|NCT00085202|564579341|FG000|Overall Study|Still on therapy|2|||
156405672|NCT00085202|564579342|FG001|Overall Study|Still on therapy|0|||
156405673|NCT00085202|564579341|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
156405674|NCT00085202|564579342|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
156405675|NCT00085202|564579341|FG000|Overall Study|Excessive toxicity|6|||
156405676|NCT00085202|564579342|FG001|Overall Study|Excessive toxicity|5|||
156405677|NCT00085202|564579341|FG000|Overall Study|Non-specified|3|||
156405678|NCT00085202|564579342|FG001|Overall Study|Non-specified|5|||
156405679|NCT00085202|564579341|FG000|Overall Study|Withdrawal by Subject|2|||
156405680|NCT00085202|564579342|FG001|Overall Study|Withdrawal by Subject|1|||
156405681|NCT00085202|564579341|FG000|Overall Study|Physician Decision|4|||
156405682|NCT00085202|564579342|FG001|Overall Study|Physician Decision|1|||
156405683|NCT00085202|564579341|FG000|Overall Study|Progressive disease|1|||
156405684|NCT00085202|564579342|FG001|Overall Study|Progressive disease|11|||
156405685|NCT03238300|564579343|FG000|Baseline (Before Intervention)|Physician Decision|0|||
156405686|NCT03238300|564579344|FG001|Baseline (Before Intervention)|Physician Decision|1|||
156405687|NCT03238300|564579343|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
156405688|NCT03238300|564579344|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
156405689|NCT03238300|564579343|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
156405690|NCT03238300|564579344|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
156405691|NCT03238300|564579343|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
156405692|NCT03238300|564579344|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
156405693|NCT02839343|564579347|FG000|Overall Study|Withdrawal by Subject|3|||
156405694|NCT02839343|564579348|FG001|Overall Study|Withdrawal by Subject|1|||
156405695|NCT02839343|564579347|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
156405696|NCT02839343|564579348|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
156405697|NCT02839343|564579347|FG000|Overall Study|Adverse Event|1|||
156405698|NCT02839343|564579348|FG001|Overall Study|Adverse Event|0|||
156405699|NCT01852058|564579351|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
156405700|NCT01852058|564579352|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405701|NCT01852058|564579353|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405702|NCT01852058|564579354|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405703|NCT01852058|564579355|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405704|NCT01852058|564579356|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405705|NCT01852058|564579357|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405706|NCT01852058|564579358|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405707|NCT01852058|564579359|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405708|NCT01852058|564579360|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405709|NCT01852058|564579361|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405710|NCT01852058|564579362|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156405711|NCT01852058|564579351|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405712|NCT01852058|564579352|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405713|NCT01852058|564579353|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405714|NCT01852058|564579354|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405715|NCT01852058|564579355|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
156405716|NCT01852058|564579356|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405717|NCT01852058|564579357|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405718|NCT01852058|564579358|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405719|NCT01852058|564579359|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405720|NCT01852058|564579360|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405721|NCT01852058|564579361|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405722|NCT01852058|564579362|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156405723|NCT01852058|564579351|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405724|NCT01852058|564579352|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405725|NCT01852058|564579353|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405726|NCT01852058|564579354|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405727|NCT01852058|564579355|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
156405728|NCT01852058|564579356|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
156405729|NCT01852058|564579357|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405730|NCT01852058|564579358|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405731|NCT01852058|564579359|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405732|NCT01852058|564579360|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405733|NCT01852058|564579361|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405734|NCT01852058|564579362|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156405735|NCT01852058|564579351|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405736|NCT01852058|564579352|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405737|NCT01852058|564579353|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405738|NCT01852058|564579354|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405739|NCT01852058|564579355|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
156405740|NCT01852058|564579356|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405741|NCT01852058|564579357|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405742|NCT01852058|564579358|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405743|NCT01852058|564579359|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405744|NCT01852058|564579360|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405745|NCT01852058|564579361|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405746|NCT01852058|564579362|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156405747|NCT01852058|564579351|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405748|NCT01852058|564579352|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405749|NCT01852058|564579353|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405750|NCT01852058|564579354|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405751|NCT01852058|564579355|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
156405752|NCT01852058|564579356|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
156405753|NCT01852058|564579357|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405754|NCT01852058|564579358|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405755|NCT01852058|564579359|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405756|NCT01852058|564579360|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405757|NCT01852058|564579361|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405758|NCT01852058|564579362|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156405759|NCT01852058|564579351|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405760|NCT01852058|564579352|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405761|NCT01852058|564579353|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405762|NCT01852058|564579354|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
156405763|NCT01852058|564579355|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156512953|NCT00640133|564970625|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
156512954|NCT00640133|564970624|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
156405764|NCT01852058|564579356|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405765|NCT01852058|564579357|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405766|NCT01852058|564579358|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405767|NCT01852058|564579359|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405768|NCT01852058|564579360|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405769|NCT01852058|564579361|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405770|NCT01852058|564579362|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156405771|NCT01852058|564579351|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405772|NCT01852058|564579352|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405773|NCT01852058|564579353|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405774|NCT01852058|564579354|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405775|NCT01852058|564579355|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
156405776|NCT01852058|564579356|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
156405777|NCT01852058|564579357|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405778|NCT01852058|564579358|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405779|NCT01852058|564579359|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405780|NCT01852058|564579360|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405781|NCT01852058|564579361|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156405782|NCT01852058|564579362|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156554282|NCT01847885|565119835|FG001|Randomization|Withdrawal by Subject|0|||
156554283|NCT01847885|565119836|FG002|Randomization|Withdrawal by Subject|2|||
156554284|NCT01847885|565119834|FG000|Randomization|Screen Failure|0|||
156405783|NCT01852058|564579351|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405784|NCT01852058|564579352|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405785|NCT01852058|564579353|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405786|NCT01852058|564579354|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405787|NCT01852058|564579355|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405788|NCT01852058|564579356|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405789|NCT01852058|564579357|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405790|NCT01852058|564579358|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
156405791|NCT01852058|564579359|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405792|NCT01852058|564579360|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405793|NCT01852058|564579361|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405794|NCT01852058|564579362|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156405795|NCT01852058|564579351|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405796|NCT01852058|564579352|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405797|NCT01852058|564579353|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405798|NCT01852058|564579354|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405799|NCT01852058|564579355|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405800|NCT01852058|564579356|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405801|NCT01852058|564579357|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405802|NCT01852058|564579358|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405803|NCT01852058|564579359|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
156405804|NCT01852058|564579360|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405805|NCT01852058|564579361|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405806|NCT01852058|564579362|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156405807|NCT01279343|564579364|FG000|Overall Study|Did not receive treatment|2|||
156405808|NCT01279343|564579365|FG001|Overall Study|Did not receive treatment|6|||
156405809|NCT03389477|564579368|FG000|Step 1|Withdrawal by Subject|1|||
156405810|NCT03389477|564579369|FG001|Step 1|Withdrawal by Subject|0|||
156405811|NCT03389477|564579368|FG000|Step 2|Withdrawal by Subject|1|||
156405812|NCT03389477|564579369|FG001|Step 2|Withdrawal by Subject|2|||
156405813|NCT03389477|564579368|FG000|Step 2|Disease progression|1|||
156405814|NCT03389477|564579369|FG001|Step 2|Disease progression|0|||
156405815|NCT03389477|564579368|FG000|Step 2|Death|0|||
156405816|NCT03389477|564579369|FG001|Step 2|Death|1|||
156405817|NCT03389477|564579368|FG000|Step 2|Poor performance status and nutrition|0|||
156405818|NCT03389477|564579369|FG001|Step 2|Poor performance status and nutrition|1|||
156405819|NCT03389477|564579368|FG000|Step 3|Withdrawal after 3 cycles|0|||
156405820|NCT03389477|564579369|FG001|Step 3|Withdrawal after 3 cycles|1|||
156405821|NCT03389477|564579368|FG000|Step 3|Still receiving active treatment|4|||
156405822|NCT03389477|564579369|FG001|Step 3|Still receiving active treatment|0|||
156405823|NCT03389477|564579368|FG000|Step 3|Progressive disease after 2 cycles|1|||
156405824|NCT03389477|564579369|FG001|Step 3|Progressive disease after 2 cycles|0|||
156405825|NCT04512066|564579372|FG000|Double-blind Treatment Period|Adverse Event|6|||
156405826|NCT04512066|564579373|FG001|Double-blind Treatment Period|Adverse Event|4|||
156405827|NCT04512066|564579374|FG002|Double-blind Treatment Period|Adverse Event|5|||
156405828|NCT04512066|564579375|FG003|Double-blind Treatment Period|Adverse Event|1|||
156405829|NCT04512066|564579376|FG004|Double-blind Treatment Period|Adverse Event|0|||
156405830|NCT04512066|564579377|FG005|Double-blind Treatment Period|Adverse Event|0|||
156405831|NCT04512066|564579372|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
156405832|NCT04512066|564579373|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
156405833|NCT04512066|564579374|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
156405834|NCT04512066|564579375|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
156405835|NCT04512066|564579376|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
156405836|NCT04512066|564579377|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
156405837|NCT04512066|564579372|FG000|Double-blind Treatment Period|Physician Decision|1|||
156405838|NCT04512066|564579373|FG001|Double-blind Treatment Period|Physician Decision|0|||
156405839|NCT04512066|564579374|FG002|Double-blind Treatment Period|Physician Decision|1|||
156405840|NCT04512066|564579375|FG003|Double-blind Treatment Period|Physician Decision|0|||
156405841|NCT04512066|564579376|FG004|Double-blind Treatment Period|Physician Decision|0|||
156405842|NCT04512066|564579377|FG005|Double-blind Treatment Period|Physician Decision|0|||
156405843|NCT04512066|564579372|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
156405844|NCT04512066|564579373|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
156405845|NCT04512066|564579374|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
156405846|NCT04512066|564579375|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
156405847|NCT04512066|564579376|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
156405848|NCT04512066|564579377|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
156405849|NCT04512066|564579372|FG000|Extension Period|Adverse Event|0|||
156405850|NCT04512066|564579373|FG001|Extension Period|Adverse Event|1|||
156405851|NCT04512066|564579374|FG002|Extension Period|Adverse Event|4|||
156405852|NCT04512066|564579375|FG003|Extension Period|Adverse Event|3|||
156405853|NCT04512066|564579376|FG004|Extension Period|Adverse Event|1|||
156405854|NCT04512066|564579377|FG005|Extension Period|Adverse Event|3|||
156405855|NCT04512066|564579372|FG000|Extension Period|Death|0|||
156405856|NCT04512066|564579373|FG001|Extension Period|Death|0|||
156405857|NCT04512066|564579374|FG002|Extension Period|Death|0|||
156405858|NCT04512066|564579375|FG003|Extension Period|Death|0|||
156405859|NCT04512066|564579376|FG004|Extension Period|Death|0|||
156405860|NCT04512066|564579377|FG005|Extension Period|Death|1|||
156405861|NCT04512066|564579372|FG000|Extension Period|Lack of Efficacy|0|||
156405862|NCT04512066|564579373|FG001|Extension Period|Lack of Efficacy|4|||
156405863|NCT04512066|564579374|FG002|Extension Period|Lack of Efficacy|4|||
156405864|NCT04512066|564579375|FG003|Extension Period|Lack of Efficacy|1|||
156405865|NCT04512066|564579376|FG004|Extension Period|Lack of Efficacy|3|||
156405866|NCT04512066|564579377|FG005|Extension Period|Lack of Efficacy|3|||
156405867|NCT04512066|564579372|FG000|Extension Period|Lost to Follow-up|0|||
156405868|NCT04512066|564579373|FG001|Extension Period|Lost to Follow-up|1|||
156405869|NCT04512066|564579374|FG002|Extension Period|Lost to Follow-up|5|||
156405870|NCT04512066|564579375|FG003|Extension Period|Lost to Follow-up|2|||
156405871|NCT04512066|564579376|FG004|Extension Period|Lost to Follow-up|3|||
156405872|NCT04512066|564579377|FG005|Extension Period|Lost to Follow-up|2|||
156405873|NCT04512066|564579372|FG000|Extension Period|Non-compliance with study drug|0|||
156405874|NCT04512066|564579373|FG001|Extension Period|Non-compliance with study drug|1|||
156405875|NCT04512066|564579374|FG002|Extension Period|Non-compliance with study drug|0|||
156405876|NCT04512066|564579375|FG003|Extension Period|Non-compliance with study drug|0|||
156405877|NCT04512066|564579376|FG004|Extension Period|Non-compliance with study drug|0|||
156405878|NCT04512066|564579377|FG005|Extension Period|Non-compliance with study drug|1|||
156405879|NCT04512066|564579372|FG000|Extension Period|Other|0|||
156405880|NCT04512066|564579373|FG001|Extension Period|Other|2|||
156405881|NCT04512066|564579374|FG002|Extension Period|Other|0|||
156405882|NCT04512066|564579375|FG003|Extension Period|Other|0|||
156405883|NCT04512066|564579376|FG004|Extension Period|Other|0|||
156405884|NCT04512066|564579377|FG005|Extension Period|Other|0|||
156405885|NCT04512066|564579372|FG000|Extension Period|Physician Decision|0|||
156405886|NCT04512066|564579373|FG001|Extension Period|Physician Decision|2|||
156405887|NCT04512066|564579374|FG002|Extension Period|Physician Decision|0|||
156405888|NCT04512066|564579375|FG003|Extension Period|Physician Decision|1|||
156405889|NCT04512066|564579376|FG004|Extension Period|Physician Decision|1|||
156405890|NCT04512066|564579377|FG005|Extension Period|Physician Decision|0|||
156405891|NCT04512066|564579372|FG000|Extension Period|Withdrawal by Subject|0|||
156405892|NCT04512066|564579373|FG001|Extension Period|Withdrawal by Subject|3|||
156405893|NCT04512066|564579374|FG002|Extension Period|Withdrawal by Subject|7|||
156405894|NCT04512066|564579375|FG003|Extension Period|Withdrawal by Subject|11|||
156405895|NCT04512066|564579376|FG004|Extension Period|Withdrawal by Subject|8|||
156554285|NCT01847885|565119835|FG001|Randomization|Screen Failure|3|||
156405896|NCT04512066|564579377|FG005|Extension Period|Withdrawal by Subject|4|||
156405897|NCT03403426|564579378|FG000|Overall Study|Death|1|||
156405898|NCT03403426|564579378|FG000|Overall Study|Lost to Follow-up|2|||
156405899|NCT01657266|564579381|FG000|Overall Study|Lost to Follow-up|2|||
156405900|NCT01657266|564579382|FG001|Overall Study|Lost to Follow-up|2|||
156405901|NCT01657266|564579381|FG000|Overall Study|Adverse Event|2|||
156405902|NCT01657266|564579382|FG001|Overall Study|Adverse Event|3|||
156405903|NCT03520400|564579383|FG000|Overall Study|Physician Decision|15|||
156405904|NCT03520400|564579384|FG001|Overall Study|Physician Decision|7|||
156405905|NCT00445679|564579385|FG000|Overall Study|Adverse Event|22|||
156405906|NCT00445679|564579386|FG001|Overall Study|Adverse Event|12|||
156405907|NCT00445679|564579387|FG002|Overall Study|Adverse Event|30|||
156405908|NCT00445679|564579388|FG003|Overall Study|Adverse Event|19|||
156405909|NCT00445679|564579385|FG000|Overall Study|Failed to return|1|||
156405910|NCT00445679|564579386|FG001|Overall Study|Failed to return|3|||
156405911|NCT00445679|564579387|FG002|Overall Study|Failed to return|2|||
156405912|NCT00445679|564579388|FG003|Overall Study|Failed to return|2|||
156405913|NCT00445679|564579385|FG000|Overall Study|Physician Decision|0|||
156405914|NCT00445679|564579386|FG001|Overall Study|Physician Decision|0|||
156405915|NCT00445679|564579387|FG002|Overall Study|Physician Decision|1|||
156405916|NCT00445679|564579388|FG003|Overall Study|Physician Decision|0|||
156405917|NCT00445679|564579385|FG000|Overall Study|Lost to Follow-up|10|||
156405918|NCT00445679|564579386|FG001|Overall Study|Lost to Follow-up|6|||
156405919|NCT00445679|564579387|FG002|Overall Study|Lost to Follow-up|6|||
156405920|NCT00445679|564579388|FG003|Overall Study|Lost to Follow-up|5|||
156405921|NCT00445679|564579385|FG000|Overall Study|Compliance|3|||
156405922|NCT00445679|564579386|FG001|Overall Study|Compliance|2|||
156405923|NCT00445679|564579387|FG002|Overall Study|Compliance|1|||
156405924|NCT00445679|564579388|FG003|Overall Study|Compliance|2|||
156405925|NCT00445679|564579385|FG000|Overall Study|Withdrawal of Informed Consent|0|||
156405926|NCT00445679|564579386|FG001|Overall Study|Withdrawal of Informed Consent|0|||
156405927|NCT00445679|564579387|FG002|Overall Study|Withdrawal of Informed Consent|1|||
156405928|NCT00445679|564579388|FG003|Overall Study|Withdrawal of Informed Consent|0|||
156405929|NCT00445679|564579385|FG000|Overall Study|Protocol Violation|2|||
156405930|NCT00445679|564579386|FG001|Overall Study|Protocol Violation|3|||
156405931|NCT00445679|564579387|FG002|Overall Study|Protocol Violation|3|||
156405932|NCT00445679|564579388|FG003|Overall Study|Protocol Violation|1|||
156405933|NCT00445679|564579385|FG000|Overall Study|Withdrawal by Subject|8|||
156405934|NCT00445679|564579386|FG001|Overall Study|Withdrawal by Subject|14|||
156405935|NCT00445679|564579387|FG002|Overall Study|Withdrawal by Subject|20|||
156405936|NCT00445679|564579388|FG003|Overall Study|Withdrawal by Subject|18|||
156405937|NCT00445679|564579385|FG000|Overall Study|Lack of Efficacy|2|||
156405938|NCT00445679|564579386|FG001|Overall Study|Lack of Efficacy|6|||
156405939|NCT00445679|564579387|FG002|Overall Study|Lack of Efficacy|2|||
156405940|NCT00445679|564579388|FG003|Overall Study|Lack of Efficacy|0|||
156405941|NCT01353222|564579393|FG000|Overall Study|Death|30|||
156405942|NCT01353222|564579394|FG001|Overall Study|Death|30|||
156405943|NCT01353222|564579393|FG000|Overall Study|Withdrawal by Subject|8|||
156405944|NCT01353222|564579394|FG001|Overall Study|Withdrawal by Subject|5|||
156405945|NCT01353222|564579393|FG000|Overall Study|Study Terminated|31|||
156405946|NCT01353222|564579394|FG001|Overall Study|Study Terminated|37|||
156405947|NCT01353222|564579393|FG000|Overall Study|Site closed research department|1|||
156405948|NCT01353222|564579394|FG001|Overall Study|Site closed research department|0|||
156405949|NCT01119898|564579395|FG000|Overall Study|Adverse Event|4|||
156405950|NCT01119898|564579396|FG001|Overall Study|Adverse Event|5|||
156405951|NCT01119898|564579395|FG000|Overall Study|Withdrawal by Subject|1|||
156405952|NCT01119898|564579396|FG001|Overall Study|Withdrawal by Subject|4|||
156405953|NCT01119898|564579395|FG000|Overall Study|Lack of Efficacy|0|||
156405954|NCT01119898|564579396|FG001|Overall Study|Lack of Efficacy|2|||
156405955|NCT01119898|564579395|FG000|Overall Study|Protocol Violation|1|||
156405956|NCT01119898|564579396|FG001|Overall Study|Protocol Violation|1|||
156405957|NCT01119898|564579395|FG000|Overall Study|Medical procedure|1|||
156405958|NCT01119898|564579396|FG001|Overall Study|Medical procedure|0|||
156405959|NCT01119898|564579395|FG000|Overall Study|Randomized in error did not participate|1|||
156405960|NCT01119898|564579396|FG001|Overall Study|Randomized in error did not participate|0|||
156405961|NCT02217280|564579399|FG000|Overall Study|Withdrawal by Subject|2|||
156405962|NCT02217280|564579399|FG000|Overall Study|Post-consent sceen fail|2|||
156405963|NCT00116844|564579400|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
156405964|NCT00116844|564579401|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
156405965|NCT00116844|564579400|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
156512955|NCT00640133|564970625|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
156512956|NCT01183260|564970626|FG000|Overall Study|Intraop screen failure|2|||
156512957|NCT01183260|564970627|FG001|Overall Study|Intraop screen failure|0|||
156512958|NCT01183260|564970626|FG000|Overall Study|Withdrawal by Subject|1|||
156512959|NCT01183260|564970627|FG001|Overall Study|Withdrawal by Subject|1|||
156512960|NCT01183260|564970626|FG000|Overall Study|Revised within 30 days|0|||
156512961|NCT01183260|564970627|FG001|Overall Study|Revised within 30 days|1|||
156512962|NCT01183260|564970626|FG000|Overall Study|Death|1|||
156512963|NCT01183260|564970627|FG001|Overall Study|Death|0|||
156512964|NCT01202903|564970630|FG000|Overall Study|Administrative Probelms|1|||
156512965|NCT01202903|564970631|FG001|Overall Study|Administrative Probelms|4|||
156512966|NCT01202903|564970630|FG000|Overall Study|Protocol Violation|0|||
156512967|NCT01202903|564970631|FG001|Overall Study|Protocol Violation|1|||
156512968|NCT01202903|564970630|FG000|Overall Study|Death|1|||
156405966|NCT00116844|564579401|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
156405967|NCT00116844|564579400|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
156405968|NCT00116844|564579401|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
156405969|NCT00116844|564579400|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
156405970|NCT00116844|564579401|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
156405971|NCT00116844|564579400|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
156405972|NCT00116844|564579401|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
156405973|NCT00116844|564579400|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
156405974|NCT00116844|564579401|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
156405975|NCT00116844|564579400|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
156405976|NCT00116844|564579401|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
156405977|NCT00116844|564579400|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
156405978|NCT00116844|564579401|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
156405979|NCT00116844|564579400|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
156405980|NCT00116844|564579401|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
156405981|NCT01933880|564579402|FG000|Overall Study|Withdrawal by Subject|5|||
156405982|NCT01933880|564579403|FG001|Overall Study|Withdrawal by Subject|0|||
156405983|NCT01933880|564579402|FG000|Overall Study|Lack of Efficacy|1|||
156405984|NCT01933880|564579403|FG001|Overall Study|Lack of Efficacy|0|||
156405985|NCT01933880|564579402|FG000|Overall Study|Concomitant medication Interference|0|||
156405986|NCT01933880|564579403|FG001|Overall Study|Concomitant medication Interference|1|||
156405987|NCT01933880|564579402|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
156405988|NCT01933880|564579403|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
156405989|NCT01933880|564579402|FG000|Overall Study|Other|4|||
156405990|NCT01933880|564579403|FG001|Overall Study|Other|0|||
156405991|NCT01933880|564579402|FG000|Overall Study|Protocol Violation|1|||
156405992|NCT01933880|564579403|FG001|Overall Study|Protocol Violation|0|||
156405993|NCT01125722|564579406|FG000|Overall Study|Withdrawal by Subject|2|||
156405994|NCT01125722|564579407|FG001|Overall Study|Withdrawal by Subject|1|||
156405995|NCT01125722|564579406|FG000|Overall Study|Lost to Follow-up|1|||
156405996|NCT01125722|564579407|FG001|Overall Study|Lost to Follow-up|0|||
156405997|NCT03474549|564579408|FG000|Overall Study|Death|31|||
156405998|NCT03474549|564579408|FG000|Overall Study|Lost to Follow-up|4|||
156405999|NCT03474549|564579408|FG000|Overall Study|Withdrawal by Subject|2|||
156406000|NCT03573908|564579412|FG000|Treatment Period|Adverse Event|4|||
156406001|NCT03573908|564579413|FG001|Treatment Period|Adverse Event|9|||
156406002|NCT03573908|564579414|FG002|Treatment Period|Adverse Event|0|||
156406003|NCT03573908|564579415|FG003|Treatment Period|Adverse Event|0|||
156406004|NCT03573908|564579416|FG004|Treatment Period|Adverse Event|0|||
156406005|NCT03573908|564579412|FG000|Treatment Period|Protocol Violation|1|||
156406006|NCT03573908|564579413|FG001|Treatment Period|Protocol Violation|0|||
156406007|NCT03573908|564579414|FG002|Treatment Period|Protocol Violation|0|||
156406008|NCT03573908|564579415|FG003|Treatment Period|Protocol Violation|0|||
156406009|NCT03573908|564579416|FG004|Treatment Period|Protocol Violation|0|||
156554286|NCT01847885|565119836|FG002|Randomization|Screen Failure|0|||
156554287|NCT02574637|565119837|FG000|Double-blind Period|Adverse Event|1|||
156554288|NCT02574637|565119838|FG001|Double-blind Period|Adverse Event|0|||
156554289|NCT02574637|565119839|FG002|Double-blind Period|Adverse Event|0|||
156554290|NCT02574637|565119840|FG003|Double-blind Period|Adverse Event|0|||
156554291|NCT02574637|565119841|FG004|Double-blind Period|Adverse Event|0|||
156406010|NCT03573908|564579412|FG000|Treatment Period|Withdrawal by Subject|7|||
156406011|NCT03573908|564579413|FG001|Treatment Period|Withdrawal by Subject|5|||
156406012|NCT03573908|564579414|FG002|Treatment Period|Withdrawal by Subject|0|||
156406013|NCT03573908|564579415|FG003|Treatment Period|Withdrawal by Subject|0|||
156406014|NCT03573908|564579416|FG004|Treatment Period|Withdrawal by Subject|0|||
156406015|NCT03573908|564579412|FG000|Treatment Period|Lost to Follow-up|7|||
156406016|NCT03573908|564579413|FG001|Treatment Period|Lost to Follow-up|6|||
156406017|NCT03573908|564579414|FG002|Treatment Period|Lost to Follow-up|0|||
156406018|NCT03573908|564579415|FG003|Treatment Period|Lost to Follow-up|0|||
156406019|NCT03573908|564579416|FG004|Treatment Period|Lost to Follow-up|0|||
156406020|NCT03573908|564579412|FG000|Treatment Period|Pregnancy|1|||
156554292|NCT02574637|565119842|FG005|Double-blind Period|Adverse Event|0|||
156554293|NCT02574637|565119843|FG006|Double-blind Period|Adverse Event|0|||
156554294|NCT02574637|565119844|FG007|Double-blind Period|Adverse Event|0|||
156406021|NCT03573908|564579413|FG001|Treatment Period|Pregnancy|0|||
156406022|NCT03573908|564579414|FG002|Treatment Period|Pregnancy|0|||
156406023|NCT03573908|564579415|FG003|Treatment Period|Pregnancy|0|||
156406024|NCT03573908|564579416|FG004|Treatment Period|Pregnancy|0|||
156406025|NCT03573908|564579412|FG000|Treatment Period|Other, Not Specified|4|||
156406026|NCT03573908|564579413|FG001|Treatment Period|Other, Not Specified|6|||
156406027|NCT03573908|564579414|FG002|Treatment Period|Other, Not Specified|0|||
156406028|NCT03573908|564579415|FG003|Treatment Period|Other, Not Specified|0|||
156554295|NCT02574637|565119845|FG008|Double-blind Period|Adverse Event|0|||
156554296|NCT02574637|565119846|FG009|Double-blind Period|Adverse Event|0|||
156554297|NCT02574637|565119837|FG000|Double-blind Period|Lack of Efficacy|0|||
156406029|NCT03573908|564579416|FG004|Treatment Period|Other, Not Specified|0|||
156406030|NCT03573908|564579412|FG000|Randomized Withdrawal Period|Adverse Event|0|||
156406031|NCT03573908|564579413|FG001|Randomized Withdrawal Period|Adverse Event|0|||
156406032|NCT03573908|564579414|FG002|Randomized Withdrawal Period|Adverse Event|3|||
156406033|NCT03573908|564579415|FG003|Randomized Withdrawal Period|Adverse Event|0|||
156406034|NCT03573908|564579416|FG004|Randomized Withdrawal Period|Adverse Event|0|||
156406035|NCT03573908|564579412|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156406036|NCT03573908|564579413|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156406037|NCT03573908|564579414|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156406038|NCT03573908|564579415|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156406039|NCT03573908|564579416|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
156406040|NCT03573908|564579412|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
156406041|NCT03573908|564579413|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
156406042|NCT03573908|564579414|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
156406043|NCT03573908|564579415|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
156406044|NCT03573908|564579416|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
156406045|NCT03573908|564579412|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
156406046|NCT03573908|564579413|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
156406047|NCT03573908|564579414|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
156406048|NCT03573908|564579415|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
156406049|NCT03573908|564579416|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
156406050|NCT04006925|564579417|FG000|Overall Study|Side effects|2|||
156406051|NCT04006925|564579418|FG001|Overall Study|Side effects|0|||
156406052|NCT00738101|564579425|FG000|Overall Study|Physician Decision|5|||
156406053|NCT00738101|564579425|FG000|Overall Study|Death|1|||
156406054|NCT00738101|564579425|FG000|Overall Study|Repeat enrollment|1|||
156406055|NCT00926003|564579426|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
156406056|NCT00926003|564579427|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
156406057|NCT00926003|564579428|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
156406058|NCT00926003|564579426|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
156406059|NCT00926003|564579427|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
156406060|NCT00926003|564579428|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
156406061|NCT00709059|564579430|FG000|Overall Study|Lost to Follow-up|34|||
156406062|NCT00709059|564579430|FG000|Overall Study|Withdrawal by Subject|19|||
156406063|NCT00709059|564579430|FG000|Overall Study|Physician Decision|7|||
156406064|NCT00709059|564579430|FG000|Overall Study|Disease complication|3|||
156406065|NCT00709059|564579430|FG000|Overall Study|Side effects|20|||
156406066|NCT00709059|564579430|FG000|Overall Study|Serious side effects|11|||
156406067|NCT01396317|564579431|FG000|Overall Study|Adverse Event|1|||
156406068|NCT01396317|564579432|FG001|Overall Study|Adverse Event|0|||
156406069|NCT02172625|564579435|FG000|Overall Study|Adverse Event|0|||
156406070|NCT02172625|564579436|FG001|Overall Study|Adverse Event|1|||
156406071|NCT02172625|564579435|FG000|Overall Study|Pregnancy|0|||
156406072|NCT02172625|564579436|FG001|Overall Study|Pregnancy|1|||
156406073|NCT02172625|564579435|FG000|Overall Study|car accident|0|||
156406074|NCT02172625|564579436|FG001|Overall Study|car accident|1|||
156406075|NCT00524030|564579437|FG000|Overall Study|Lack of Efficacy|10|||
156406076|NCT00524030|564579438|FG001|Overall Study|Lack of Efficacy|24|||
156406077|NCT00524030|564579437|FG000|Overall Study|Lost to Follow-up|0|||
156406078|NCT00524030|564579438|FG001|Overall Study|Lost to Follow-up|2|||
156406079|NCT00524030|564579437|FG000|Overall Study|Withdrawal by Subject|3|||
156406080|NCT00524030|564579438|FG001|Overall Study|Withdrawal by Subject|8|||
156406081|NCT00524030|564579437|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
156406082|NCT00524030|564579438|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
156406083|NCT00524030|564579437|FG000|Overall Study|Protocol Violation|0|||
156406084|NCT00524030|564579438|FG001|Overall Study|Protocol Violation|1|||
156406085|NCT00524030|564579437|FG000|Overall Study|Pregnancy|1|||
156406086|NCT00524030|564579438|FG001|Overall Study|Pregnancy|0|||
156406087|NCT00524030|564579437|FG000|Overall Study|Adverse Event|3|||
156406088|NCT00524030|564579438|FG001|Overall Study|Adverse Event|21|||
156406089|NCT00524030|564579437|FG000|Overall Study|Death|0|||
156406090|NCT00524030|564579438|FG001|Overall Study|Death|1|||
156406091|NCT03315130|564579439|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
156406092|NCT03315130|564579440|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
156406093|NCT03315130|564579441|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
156554298|NCT02574637|565119838|FG001|Double-blind Period|Lack of Efficacy|0|||
156554299|NCT02574637|565119839|FG002|Double-blind Period|Lack of Efficacy|2|||
156406094|NCT03315130|564579442|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
156406095|NCT03315130|564579439|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
156406096|NCT03315130|564579440|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
156406097|NCT03315130|564579441|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
156406098|NCT03315130|564579442|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
156406099|NCT03315130|564579439|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
156406100|NCT03315130|564579440|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
156406101|NCT03315130|564579441|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
156406102|NCT03315130|564579442|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
156406103|NCT03315130|564579439|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
156406104|NCT03315130|564579440|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
156406105|NCT03315130|564579441|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
156406106|NCT03315130|564579442|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
156406107|NCT03315130|564579439|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
156406108|NCT03315130|564579440|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
156406109|NCT03315130|564579441|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
156406110|NCT03315130|564579442|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
156406111|NCT03315130|564579439|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
156406112|NCT03315130|564579440|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
156406113|NCT03315130|564579441|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
156406114|NCT03315130|564579442|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
156406115|NCT02944656|564579443|FG000|Overall Study|No longer eligible|3|||
156406116|NCT02944656|564579444|FG001|Overall Study|No longer eligible|0|||
156406117|NCT02944656|564579443|FG000|Overall Study|Lost to Follow-up|7|||
156554300|NCT02574637|565119840|FG003|Double-blind Period|Lack of Efficacy|0|||
156554301|NCT02574637|565119841|FG004|Double-blind Period|Lack of Efficacy|0|||
156554302|NCT02574637|565119842|FG005|Double-blind Period|Lack of Efficacy|0|||
156554303|NCT02574637|565119843|FG006|Double-blind Period|Lack of Efficacy|0|||
156554304|NCT02574637|565119844|FG007|Double-blind Period|Lack of Efficacy|0|||
156554305|NCT02574637|565119845|FG008|Double-blind Period|Lack of Efficacy|0|||
156406118|NCT02944656|564579444|FG001|Overall Study|Lost to Follow-up|10|||
156406119|NCT03535337|564579445|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
156406120|NCT03535337|564579446|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
156406121|NCT03535337|564579447|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
156406122|NCT03535337|564579448|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
156406123|NCT03535337|564579449|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
156406124|NCT03535337|564579450|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
156406125|NCT03535337|564579451|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
156406126|NCT03535337|564579452|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
156406127|NCT03535337|564579453|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
156406128|NCT03535337|564579454|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
156406129|NCT00386308|564580975|FG000|Overall Study|Adverse Event|3|||
156406130|NCT00386308|564580976|FG001|Overall Study|Adverse Event|3|||
156406131|NCT00386308|564580975|FG000|Overall Study|Protocol Violation|2|||
156406132|NCT00386308|564580976|FG001|Overall Study|Protocol Violation|5|||
156406133|NCT00386308|564580975|FG000|Overall Study|Lack of Efficacy|0|||
156406134|NCT00386308|564580976|FG001|Overall Study|Lack of Efficacy|2|||
156406135|NCT00386308|564580975|FG000|Overall Study|Lost to Follow-up|10|||
156406136|NCT00386308|564580976|FG001|Overall Study|Lost to Follow-up|6|||
156554306|NCT02574637|565119846|FG009|Double-blind Period|Lack of Efficacy|0|||
156554307|NCT02574637|565119837|FG000|Double-blind Period|Protocol Deviation|1|||
156554308|NCT02574637|565119838|FG001|Double-blind Period|Protocol Deviation|0|||
156554309|NCT02574637|565119839|FG002|Double-blind Period|Protocol Deviation|0|||
156554310|NCT02574637|565119840|FG003|Double-blind Period|Protocol Deviation|0|||
156554311|NCT02574637|565119841|FG004|Double-blind Period|Protocol Deviation|0|||
156554312|NCT02574637|565119842|FG005|Double-blind Period|Protocol Deviation|0|||
156554313|NCT02574637|565119843|FG006|Double-blind Period|Protocol Deviation|0|||
156554314|NCT02574637|565119844|FG007|Double-blind Period|Protocol Deviation|0|||
156554315|NCT02574637|565119845|FG008|Double-blind Period|Protocol Deviation|0|||
156554316|NCT02574637|565119846|FG009|Double-blind Period|Protocol Deviation|0|||
156554317|NCT02574637|565119837|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
156554318|NCT02574637|565119838|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
156554319|NCT02574637|565119839|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
156406137|NCT00386308|564580975|FG000|Overall Study|Withdrawal by Subject|6|||
156406138|NCT00386308|564580976|FG001|Overall Study|Withdrawal by Subject|2|||
156406139|NCT00386308|564580975|FG000|Overall Study|Other Event|8|||
156406140|NCT00386308|564580976|FG001|Overall Study|Other Event|1|||
156406141|NCT03518658|564580977|FG000|Overall Study|Other|51|||
156406142|NCT03518658|564580978|FG001|Overall Study|Other|0|||
156554320|NCT02574637|565119840|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
156554321|NCT02574637|565119841|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
156554322|NCT02574637|565119842|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
156406143|NCT00649389|564580979|FG000|Overall Study|Adverse Event|22|||
156406144|NCT00649389|564580980|FG001|Overall Study|Adverse Event|46|||
156406145|NCT00649389|564580981|FG002|Overall Study|Adverse Event|38|||
156406146|NCT00649389|564580982|FG003|Overall Study|Adverse Event|48|||
156554323|NCT02574637|565119843|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
156554324|NCT02574637|565119844|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
156406147|NCT00649389|564580979|FG000|Overall Study|Lost to Follow-up|15|||
156406148|NCT00649389|564580980|FG001|Overall Study|Lost to Follow-up|17|||
156406149|NCT00649389|564580981|FG002|Overall Study|Lost to Follow-up|21|||
156406150|NCT00649389|564580982|FG003|Overall Study|Lost to Follow-up|26|||
156406151|NCT00649389|564580979|FG000|Overall Study|Protocol Violation|11|||
156406152|NCT00649389|564580980|FG001|Overall Study|Protocol Violation|13|||
156406153|NCT00649389|564580981|FG002|Overall Study|Protocol Violation|9|||
156406154|NCT00649389|564580982|FG003|Overall Study|Protocol Violation|8|||
156406155|NCT00649389|564580979|FG000|Overall Study|Withdrawal by Subject|20|||
156406156|NCT00649389|564580980|FG001|Overall Study|Withdrawal by Subject|21|||
156406157|NCT00649389|564580981|FG002|Overall Study|Withdrawal by Subject|19|||
156406158|NCT00649389|564580982|FG003|Overall Study|Withdrawal by Subject|23|||
156406159|NCT00649389|564580979|FG000|Overall Study|Other|3|||
156406160|NCT00649389|564580980|FG001|Overall Study|Other|9|||
156406161|NCT00649389|564580981|FG002|Overall Study|Other|1|||
156406162|NCT00649389|564580982|FG003|Overall Study|Other|6|||
156406163|NCT02746575|564580985|FG000|Overall Study|Surgery cancelled or time chaned|13|||
156406164|NCT02746575|564580985|FG000|Overall Study|Received epidural|10|||
156406165|NCT02746575|564580985|FG000|Overall Study|Withdrawal by Subject|3|||
156406166|NCT02746575|564580985|FG000|Overall Study|Bradycardia/hypotension|9|||
156406167|NCT02746575|564580985|FG000|Overall Study|Study paused|8|||
156406168|NCT02746575|564580985|FG000|Overall Study|put on beta-blocker|3|||
156406169|NCT02746575|564580985|FG000|Overall Study|type of surgery|1|||
156406170|NCT02746575|564580985|FG000|Overall Study|typ of surgery|1|||
156406171|NCT02746575|564580985|FG000|Overall Study|PI unavailable|1|||
156406172|NCT02746575|564580985|FG000|Overall Study|Unknown history of CVA|1|||
156406173|NCT00976482|564580986|FG000|Overall Study|Death|208|||
156406174|NCT00976482|564580986|FG000|Overall Study|Withdrawal by Subject|45|||
156406175|NCT00976482|564580986|FG000|Overall Study|Center terminated|1|||
156406176|NCT00976482|564580986|FG000|Overall Study|Protocol Violation|5|||
156406177|NCT02959671|564580987|FG000|Overall Study|Adverse Event|2|||
156406178|NCT02959671|564580987|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
156406179|NCT04105972|564580996|FG000|Overall Study|Adverse Event|2|||
156406180|NCT04105972|564580997|FG001|Overall Study|Adverse Event|1|||
156406181|NCT02254408|564581000|FG000|Overall Study|Randomized But Not Treated|1|||
156406182|NCT02254408|564581001|FG001|Overall Study|Randomized But Not Treated|3|||
156406183|NCT02254408|564581000|FG000|Overall Study|Adverse Event|1|||
156406184|NCT02254408|564581001|FG001|Overall Study|Adverse Event|0|||
156406185|NCT02254408|564581000|FG000|Overall Study|Death|2|||
156406186|NCT02254408|564581001|FG001|Overall Study|Death|3|||
156406187|NCT02254408|564581000|FG000|Overall Study|Investigator's Discretion|0|||
156406188|NCT02254408|564581001|FG001|Overall Study|Investigator's Discretion|1|||
156406189|NCT02254408|564581000|FG000|Overall Study|Withdrawal by Subject|3|||
156406190|NCT02254408|564581001|FG001|Overall Study|Withdrawal by Subject|3|||
156406191|NCT02254408|564581000|FG000|Overall Study|Lost to Follow-up|1|||
156406192|NCT02254408|564581001|FG001|Overall Study|Lost to Follow-up|0|||
156406193|NCT01478113|564581005|FG000|Overall Study|Withdrawal by Subject|0|||
156406194|NCT01478113|564581006|FG001|Overall Study|Withdrawal by Subject|1|||
156406195|NCT01478113|564581005|FG000|Overall Study|Physician Decision|1|||
156406196|NCT01478113|564581006|FG001|Overall Study|Physician Decision|0|||
156406197|NCT03980184|564581013|FG000|Overall Study|Dropped out before treatment|2|||
156406198|NCT03980184|564581014|FG001|Overall Study|Dropped out before treatment|2|||
156406199|NCT03980184|564581013|FG000|Overall Study|Lost to Follow-up|11|||
156406200|NCT03980184|564581014|FG001|Overall Study|Lost to Follow-up|13|||
156406201|NCT02002884|564581015|FG000|Main Period (MP)|Other|0|||
156406202|NCT02002884|564581016|FG001|Main Period (MP)|Other|3|||
156406203|NCT02002884|564581017|FG002|Main Period (MP)|Other|3|||
156512969|NCT01202903|564970631|FG001|Overall Study|Death|0|||
156512970|NCT01202903|564970630|FG000|Overall Study|Lost to Follow-up|1|||
156512971|NCT01202903|564970631|FG001|Overall Study|Lost to Follow-up|1|||
156512972|NCT01202903|564970630|FG000|Overall Study|Lack of Efficacy|1|||
156512973|NCT01202903|564970631|FG001|Overall Study|Lack of Efficacy|3|||
156512974|NCT01202903|564970630|FG000|Overall Study|Adverse Event|3|||
156512975|NCT01202903|564970631|FG001|Overall Study|Adverse Event|3|||
156512976|NCT01202903|564970630|FG000|Overall Study|Withdrawal by Subject|4|||
156512977|NCT01202903|564970631|FG001|Overall Study|Withdrawal by Subject|4|||
156512978|NCT01302080|564970632|FG000|Overall Study|Withdrew Consent|92|||
156406204|NCT02002884|564581018|FG003|Main Period (MP)|Other|0|||
156512979|NCT01302080|564970633|FG001|Overall Study|Withdrew Consent|39|||
156512980|NCT01302080|564970632|FG000|Overall Study|Patient/Family Moved|28|||
156406205|NCT02002884|564581015|FG000|Main Period (MP)|Adverse Event|0|||
156406206|NCT02002884|564581016|FG001|Main Period (MP)|Adverse Event|1|||
156406207|NCT02002884|564581017|FG002|Main Period (MP)|Adverse Event|1|||
156406208|NCT02002884|564581018|FG003|Main Period (MP)|Adverse Event|0|||
156406209|NCT02002884|564581015|FG000|Main Period (MP)|Withdrawal by Subject|6|||
156406210|NCT02002884|564581016|FG001|Main Period (MP)|Withdrawal by Subject|2|||
156406211|NCT02002884|564581017|FG002|Main Period (MP)|Withdrawal by Subject|2|||
156406212|NCT02002884|564581018|FG003|Main Period (MP)|Withdrawal by Subject|0|||
156406213|NCT02002884|564581015|FG000|Main Period (MP)|Lost to Follow-up|0|||
156406214|NCT02002884|564581016|FG001|Main Period (MP)|Lost to Follow-up|0|||
156406215|NCT02002884|564581017|FG002|Main Period (MP)|Lost to Follow-up|2|||
156406216|NCT02002884|564581018|FG003|Main Period (MP)|Lost to Follow-up|0|||
156406217|NCT02002884|564581015|FG000|Open-Label Extension Period (OLEX)|Other|0|||
156406218|NCT02002884|564581016|FG001|Open-Label Extension Period (OLEX)|Other|0|||
156406219|NCT02002884|564581017|FG002|Open-Label Extension Period (OLEX)|Other|0|||
156406220|NCT02002884|564581018|FG003|Open-Label Extension Period (OLEX)|Other|24|||
156406221|NCT02002884|564581015|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
156406222|NCT02002884|564581016|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
156406223|NCT02002884|564581017|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
156406224|NCT02002884|564581018|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
156406225|NCT02002884|564581015|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
156406226|NCT02002884|564581016|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
156406227|NCT02002884|564581017|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
156406228|NCT02002884|564581018|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
156406229|NCT02002884|564581015|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
156406230|NCT02002884|564581016|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
156406231|NCT02002884|564581017|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
156406232|NCT02002884|564581018|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
156406233|NCT02002884|564581015|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
156406234|NCT02002884|564581016|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
156406235|NCT02002884|564581017|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
156406236|NCT02002884|564581018|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
156406237|NCT00067990|564581020|FG000|Overall Study|Death|5|||
156406238|NCT00067990|564581021|FG001|Overall Study|Death|7|||
156406239|NCT00067990|564581020|FG000|Overall Study|ESRD, Non IF/TA|1|||
156406240|NCT00067990|564581021|FG001|Overall Study|ESRD, Non IF/TA|3|||
156406241|NCT00067990|564581020|FG000|Overall Study|Withdrawal by Subject|4|||
156406242|NCT00067990|564581021|FG001|Overall Study|Withdrawal by Subject|12|||
156406243|NCT02341456|564581030|FG000|Overall Study|Disease progression|2|||
156406244|NCT02341456|564581031|FG001|Overall Study|Disease progression|3|||
156406245|NCT02341456|564581032|FG002|Overall Study|Disease progression|1|||
156406246|NCT02341456|564581030|FG000|Overall Study|Death|1|||
156406247|NCT02341456|564581031|FG001|Overall Study|Death|1|||
156406248|NCT02341456|564581032|FG002|Overall Study|Death|1|||
156406249|NCT02341456|564581030|FG000|Overall Study|Withdrawal by Subject|0|||
156406250|NCT02341456|564581031|FG001|Overall Study|Withdrawal by Subject|1|||
156406251|NCT02341456|564581032|FG002|Overall Study|Withdrawal by Subject|1|||
156406252|NCT02341456|564581030|FG000|Overall Study|Moved to local access programme.|0|||
156406253|NCT02341456|564581031|FG001|Overall Study|Moved to local access programme.|1|||
156406254|NCT02341456|564581032|FG002|Overall Study|Moved to local access programme.|1|||
156406255|NCT02341456|564581030|FG000|Overall Study|Physician Decision|1|||
156406256|NCT02341456|564581031|FG001|Overall Study|Physician Decision|0|||
156406257|NCT02341456|564581032|FG002|Overall Study|Physician Decision|0|||
156406258|NCT02567825|564581036|FG000|Overall Study|No follow-up post-randomization|5|||
156406259|NCT02567825|564581037|FG001|Overall Study|No follow-up post-randomization|1|||
156406260|NCT02567825|564581036|FG000|Overall Study|Follow-up less than 23 months|16|||
156406261|NCT02567825|564581037|FG001|Overall Study|Follow-up less than 23 months|20|||
156406262|NCT03097861|564581040|FG000|Overall Study|Adverse Event|3|||
156406263|NCT03097861|564581041|FG001|Overall Study|Adverse Event|8|||
156406264|NCT03097861|564581042|FG002|Overall Study|Adverse Event|4|||
156406265|NCT03097861|564581040|FG000|Overall Study|Investigator Decision|0|||
156406266|NCT03097861|564581041|FG001|Overall Study|Investigator Decision|1|||
156406267|NCT03097861|564581042|FG002|Overall Study|Investigator Decision|0|||
156406268|NCT03097861|564581040|FG000|Overall Study|Lost to Follow-up|0|||
156406269|NCT03097861|564581041|FG001|Overall Study|Lost to Follow-up|7|||
156406270|NCT03097861|564581042|FG002|Overall Study|Lost to Follow-up|1|||
156406271|NCT03097861|564581040|FG000|Overall Study|Withdrawal by Subject|1|||
156406272|NCT03097861|564581041|FG001|Overall Study|Withdrawal by Subject|5|||
156406273|NCT03097861|564581042|FG002|Overall Study|Withdrawal by Subject|3|||
156406274|NCT03097861|564581040|FG000|Overall Study|Reason not provided|3|||
156406275|NCT03097861|564581041|FG001|Overall Study|Reason not provided|1|||
156406276|NCT03097861|564581042|FG002|Overall Study|Reason not provided|1|||
156406277|NCT05061537|564581043|FG000|Treatment Phase|Progressive disease|0|||
156406278|NCT05061537|564581044|FG001|Treatment Phase|Progressive disease|1|||
156406279|NCT05061537|564581045|FG002|Treatment Phase|Progressive disease|2|||
156406280|NCT05061537|564581046|FG003|Treatment Phase|Progressive disease|0|||
156406281|NCT05061537|564581047|FG004|Treatment Phase|Progressive disease|0|||
156406282|NCT05061537|564581043|FG000|Treatment Phase|Adverse Event|0|||
156406283|NCT05061537|564581044|FG001|Treatment Phase|Adverse Event|0|||
156406284|NCT05061537|564581045|FG002|Treatment Phase|Adverse Event|2|||
156406285|NCT05061537|564581046|FG003|Treatment Phase|Adverse Event|0|||
156406286|NCT05061537|564581047|FG004|Treatment Phase|Adverse Event|0|||
156406287|NCT05061537|564581043|FG000|Treatment Phase|Global deterioration of health status|0|||
156406288|NCT05061537|564581044|FG001|Treatment Phase|Global deterioration of health status|1|||
156406289|NCT05061537|564581045|FG002|Treatment Phase|Global deterioration of health status|0|||
156406290|NCT05061537|564581046|FG003|Treatment Phase|Global deterioration of health status|0|||
156406291|NCT05061537|564581047|FG004|Treatment Phase|Global deterioration of health status|0|||
156406292|NCT05061537|564581043|FG000|Follow up|Other|2|||
156406293|NCT05061537|564581044|FG001|Follow up|Other|0|||
156406294|NCT05061537|564581045|FG002|Follow up|Other|2|||
156406295|NCT05061537|564581046|FG003|Follow up|Other|0|||
156406296|NCT05061537|564581047|FG004|Follow up|Other|0|||
156406297|NCT05061537|564581043|FG000|Follow up|Study terminated by sponsor|0|||
156406298|NCT05061537|564581044|FG001|Follow up|Study terminated by sponsor|0|||
156406299|NCT05061537|564581045|FG002|Follow up|Study terminated by sponsor|2|||
156406300|NCT05061537|564581046|FG003|Follow up|Study terminated by sponsor|0|||
156406301|NCT05061537|564581047|FG004|Follow up|Study terminated by sponsor|0|||
156406302|NCT05061537|564581043|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
156406303|NCT05061537|564581044|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
156406304|NCT05061537|564581045|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
156406305|NCT05061537|564581046|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
156406306|NCT05061537|564581047|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
156406307|NCT05061537|564581043|FG000|Long-term Follow-up|Death|0|||
156406308|NCT05061537|564581044|FG001|Long-term Follow-up|Death|1|||
156406309|NCT05061537|564581045|FG002|Long-term Follow-up|Death|0|||
156406310|NCT05061537|564581046|FG003|Long-term Follow-up|Death|0|||
156406311|NCT05061537|564581047|FG004|Long-term Follow-up|Death|0|||
156406312|NCT03502616|564581051|FG000|Up to Week 16|Withdrawal by Subject|1|||
156406313|NCT03502616|564581052|FG001|Up to Week 16|Withdrawal by Subject|2|||
156406314|NCT03502616|564581051|FG000|Up to Week 16|Lost to Follow-up|0|||
156406315|NCT03502616|564581052|FG001|Up to Week 16|Lost to Follow-up|1|||
156406316|NCT03502616|564581051|FG000|Up to Week 16|Randomized, but not treated|1|||
156406317|NCT03502616|564581052|FG001|Up to Week 16|Randomized, but not treated|0|||
156406318|NCT03502616|564581051|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
156406319|NCT03502616|564581052|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
156406320|NCT03502616|564581051|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
156406321|NCT03502616|564581052|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
156406322|NCT01785563|564581053|FG000|Overall Study|Physician Decision|10|||
156406323|NCT01785563|564581053|FG000|Overall Study|Withdrawal by Subject|1|||
156406324|NCT01785563|564581053|FG000|Overall Study|Protocol Violation|2|||
156406325|NCT01872910|564581055|FG000|Overall Study|Lost to Follow-up|2|||
156406326|NCT01872910|564581056|FG001|Overall Study|Lost to Follow-up|0|||
156406327|NCT01872910|564581057|FG002|Overall Study|Lost to Follow-up|2|||
156406328|NCT01872910|564581058|FG003|Overall Study|Lost to Follow-up|0|||
156406329|NCT01872910|564581059|FG004|Overall Study|Lost to Follow-up|0|||
156406330|NCT01872910|564581060|FG005|Overall Study|Lost to Follow-up|0|||
156406331|NCT01540565|564581066|FG000|Overall Study|Ineligible|2|||
156406332|NCT01834222|564581067|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
156406333|NCT03812536|564581068|FG000|Overall Study|Protocol Violation|2|||
156406334|NCT03812536|564581069|FG001|Overall Study|Protocol Violation|0|||
156406335|NCT03812536|564581068|FG000|Overall Study|Withdrawal by Subject|1|||
156406336|NCT03812536|564581069|FG001|Overall Study|Withdrawal by Subject|1|||
156406337|NCT01306201|564581070|FG000|Overall Study|Arrhythmia|4|||
156406338|NCT01306201|564581070|FG000|Overall Study|Files could not be processed|3|||
156406339|NCT01306201|564581070|FG000|Overall Study|Files unreadable|3|||
156406340|NCT01735396|564581071|FG000|Overall Study|not evaluable|1|||
156554325|NCT02574637|565119845|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
156554326|NCT02574637|565119846|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
156554327|NCT02574637|565119837|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
156554328|NCT02574637|565119838|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
156554329|NCT02574637|565119839|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
156554330|NCT02574637|565119840|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
156554331|NCT02574637|565119841|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
156554332|NCT02574637|565119842|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
156554333|NCT02574637|565119843|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
156554334|NCT02574637|565119844|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
156554335|NCT02574637|565119845|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
156554336|NCT02574637|565119846|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
156554337|NCT02574637|565119837|FG000|Double-blind Period|Reason Not Specified|0|||
156554338|NCT02574637|565119838|FG001|Double-blind Period|Reason Not Specified|0|||
156554339|NCT02574637|565119839|FG002|Double-blind Period|Reason Not Specified|0|||
156406341|NCT00423852|564581076|FG000|Overall Study|Removed pior to the high-dose portion|3|||
156406342|NCT00980005|564581077|FG000|Overall Study|Withdrawal by Subject|6|||
156406343|NCT00980005|564581078|FG001|Overall Study|Withdrawal by Subject|17|||
156554340|NCT02574637|565119840|FG003|Double-blind Period|Reason Not Specified|1|||
156406344|NCT00980005|564581077|FG000|Overall Study|Lost to Follow-up|37|||
156406345|NCT00980005|564581078|FG001|Overall Study|Lost to Follow-up|43|||
156406346|NCT00980005|564581077|FG000|Overall Study|Other|4|||
156406347|NCT00980005|564581078|FG001|Overall Study|Other|3|||
156406348|NCT00572624|564581079|FG000|Overall Study|Lost to Follow-up|10|||
156406349|NCT00572624|564581080|FG001|Overall Study|Lost to Follow-up|4|||
156406350|NCT00572624|564581079|FG000|Overall Study|Wanted to do a different diet program|1|||
156406351|NCT00572624|564581080|FG001|Overall Study|Wanted to do a different diet program|0|||
156406352|NCT00572624|564581079|FG000|Overall Study|Medication change|1|||
156406353|NCT00572624|564581080|FG001|Overall Study|Medication change|0|||
156406354|NCT00572624|564581079|FG000|Overall Study|Started a new job-- no time for study|1|||
156406355|NCT00572624|564581080|FG001|Overall Study|Started a new job-- no time for study|0|||
156406356|NCT00572624|564581079|FG000|Overall Study|Admitted to being a smoker|1|||
156406357|NCT00572624|564581080|FG001|Overall Study|Admitted to being a smoker|0|||
156406358|NCT00572624|564581079|FG000|Overall Study|Refused to do the stress test|1|||
156406359|NCT00572624|564581080|FG001|Overall Study|Refused to do the stress test|0|||
156406360|NCT00572624|564581079|FG000|Overall Study|Problem with vascular access|1|||
156406361|NCT00572624|564581080|FG001|Overall Study|Problem with vascular access|0|||
156406362|NCT00572624|564581079|FG000|Overall Study|Health issues unrelated to the study|1|||
156406363|NCT00572624|564581080|FG001|Overall Study|Health issues unrelated to the study|0|||
156406364|NCT04145037|564581083|FG000|Overall Study|Study terminated|2|||
156406365|NCT04145037|564581084|FG001|Overall Study|Study terminated|0|||
156406366|NCT04145037|564581083|FG000|Overall Study|Withdrawal by Subject|1|||
156406367|NCT04145037|564581084|FG001|Overall Study|Withdrawal by Subject|0|||
156406368|NCT04145037|564581083|FG000|Overall Study|Lost to Follow-up|1|||
156406369|NCT04145037|564581084|FG001|Overall Study|Lost to Follow-up|0|||
156406370|NCT00525265|564581089|FG000|Overall Study|Protocol Violation|1|||
156406371|NCT00525265|564581090|FG001|Overall Study|Protocol Violation|0|||
156406372|NCT00098254|564581093|FG000|Overall Study|Adverse Event|2|||
156406373|NCT00098254|564581093|FG000|Overall Study|Death|1|||
156406374|NCT00744263|564581094|FG000|Overall Study|Death|3006|||
156406375|NCT00744263|564581095|FG001|Overall Study|Death|3005|||
156406376|NCT00744263|564581094|FG000|Overall Study|Lost to Follow-up|2038|||
156406377|NCT00744263|564581095|FG001|Overall Study|Lost to Follow-up|2135|||
156406378|NCT00744263|564581094|FG000|Overall Study|Withdrawal by Subject|166|||
156406379|NCT00744263|564581095|FG001|Overall Study|Withdrawal by Subject|150|||
156406380|NCT00744263|564581094|FG000|Overall Study|Physician Decision|20|||
156406381|NCT00744263|564581095|FG001|Overall Study|Physician Decision|23|||
156406382|NCT00744263|564581094|FG000|Overall Study|Protocol Violation|3|||
156406383|NCT00744263|564581095|FG001|Overall Study|Protocol Violation|5|||
156406384|NCT00744263|564581094|FG000|Overall Study|Adverse Event|1|||
156406385|NCT00744263|564581095|FG001|Overall Study|Adverse Event|0|||
156406386|NCT00744263|564581094|FG000|Overall Study|Other|2|||
156406387|NCT00744263|564581095|FG001|Overall Study|Other|2|||
156406388|NCT03500640|564581096|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
156406389|NCT03500640|564581097|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
156406390|NCT03500640|564581098|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
156406391|NCT03500640|564581096|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
156406392|NCT03500640|564581097|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
156406393|NCT03500640|564581098|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
156554341|NCT02574637|565119841|FG004|Double-blind Period|Reason Not Specified|0|||
156554342|NCT02574637|565119842|FG005|Double-blind Period|Reason Not Specified|0|||
156554343|NCT02574637|565119843|FG006|Double-blind Period|Reason Not Specified|0|||
156554344|NCT02574637|565119844|FG007|Double-blind Period|Reason Not Specified|0|||
156554345|NCT02574637|565119845|FG008|Double-blind Period|Reason Not Specified|0|||
156554346|NCT02574637|565119846|FG009|Double-blind Period|Reason Not Specified|0|||
156554347|NCT02574637|565119837|FG000|Open-label (OL) Period|Adverse Event|0|||
156554348|NCT02574637|565119838|FG001|Open-label (OL) Period|Adverse Event|0|||
156554349|NCT02574637|565119839|FG002|Open-label (OL) Period|Adverse Event|0|||
156554350|NCT02574637|565119840|FG003|Open-label (OL) Period|Adverse Event|0|||
156554351|NCT02574637|565119841|FG004|Open-label (OL) Period|Adverse Event|0|||
156554352|NCT02574637|565119842|FG005|Open-label (OL) Period|Adverse Event|0|||
156554353|NCT02574637|565119843|FG006|Open-label (OL) Period|Adverse Event|0|||
156554354|NCT02574637|565119844|FG007|Open-label (OL) Period|Adverse Event|0|||
156554355|NCT02574637|565119845|FG008|Open-label (OL) Period|Adverse Event|1|||
156554356|NCT02574637|565119846|FG009|Open-label (OL) Period|Adverse Event|0|||
156554357|NCT02574637|565119837|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
156554358|NCT02574637|565119838|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
156554359|NCT02574637|565119839|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
156554360|NCT02574637|565119840|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
156554361|NCT02574637|565119841|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
156554362|NCT02574637|565119842|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
156554363|NCT02574637|565119843|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
156406394|NCT03500640|564581096|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
156406395|NCT03500640|564581097|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
156406396|NCT03500640|564581098|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
156406397|NCT03500640|564581096|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
156406398|NCT03500640|564581097|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
156554364|NCT02574637|565119844|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
156554365|NCT02574637|565119845|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
156554366|NCT02574637|565119846|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
156406399|NCT03500640|564581098|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
156406400|NCT03500640|564581096|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
156406401|NCT03500640|564581097|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
156406402|NCT03500640|564581098|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
156406403|NCT03500640|564581096|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
156406404|NCT03500640|564581097|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
156406405|NCT03500640|564581098|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
156406406|NCT03500640|564581096|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
156406407|NCT03500640|564581097|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
156406408|NCT03500640|564581098|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
156406409|NCT03500640|564581096|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
156406410|NCT03500640|564581097|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
156406411|NCT03500640|564581098|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
156406412|NCT03500640|564581096|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
156406413|NCT03500640|564581097|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
156406414|NCT03500640|564581098|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
156406415|NCT03500640|564581096|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
156406416|NCT03500640|564581097|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
156406417|NCT03500640|564581098|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
156406418|NCT01905046|564581099|FG000|Months 13-24|Withdrawal by Subject|10|||
156406419|NCT01905046|564581100|FG001|Months 13-24|Withdrawal by Subject|10|||
156406420|NCT01905046|564581099|FG000|Months 13-24|Adverse Event|3|||
156406421|NCT01905046|564581100|FG001|Months 13-24|Adverse Event|2|||
156406422|NCT01905046|564581099|FG000|Months 13-24|Protocol Violation|3|||
156406423|NCT01905046|564581100|FG001|Months 13-24|Protocol Violation|3|||
156406424|NCT01905046|564581099|FG000|Months 13-24|Physician Decision|1|||
156406425|NCT01905046|564581100|FG001|Months 13-24|Physician Decision|0|||
156406426|NCT00612534|564581104|FG000|Overall Study|Adverse Event|0|||
156406427|NCT00612534|564581105|FG001|Overall Study|Adverse Event|4|||
156406428|NCT00612534|564581106|FG002|Overall Study|Adverse Event|2|||
156406429|NCT00612534|564581107|FG003|Overall Study|Adverse Event|1|||
156406430|NCT00612534|564581104|FG000|Overall Study|Lack of Efficacy|13|||
156406431|NCT00612534|564581105|FG001|Overall Study|Lack of Efficacy|12|||
156406432|NCT00612534|564581106|FG002|Overall Study|Lack of Efficacy|5|||
156406433|NCT00612534|564581107|FG003|Overall Study|Lack of Efficacy|16|||
156406434|NCT00612534|564581104|FG000|Overall Study|Other Reason|0|||
156406435|NCT00612534|564581105|FG001|Overall Study|Other Reason|1|||
156406436|NCT00612534|564581106|FG002|Overall Study|Other Reason|0|||
156406437|NCT00612534|564581107|FG003|Overall Study|Other Reason|0|||
156406438|NCT05778526|564581109|FG000|Overall Study|Lost to Follow-up|0|||
156406439|NCT05778526|564581110|FG001|Overall Study|Lost to Follow-up|1|||
156406440|NCT05778526|564581111|FG002|Overall Study|Lost to Follow-up|3|||
156406441|NCT05778526|564581109|FG000|Overall Study|Protocol Violation|0|||
156406442|NCT05778526|564581110|FG001|Overall Study|Protocol Violation|0|||
156406443|NCT05778526|564581111|FG002|Overall Study|Protocol Violation|8|||
156406444|NCT01436201|564581114|FG000|Overall Study|Adverse Event|2|||
156406445|NCT01436201|564581114|FG000|Overall Study|Withdrawal by Subject|1|||
156406446|NCT01436201|564581114|FG000|Overall Study|Protocol Violation|1|||
156406447|NCT00661661|564581118|FG000|Overall Study|Adverse Event|99|||
156406448|NCT00661661|564581119|FG001|Overall Study|Adverse Event|24|||
156406449|NCT00661661|564581118|FG000|Overall Study|Lack of Efficacy|3|||
156406450|NCT00661661|564581119|FG001|Overall Study|Lack of Efficacy|2|||
156406451|NCT00661661|564581118|FG000|Overall Study|Lost to Follow-up|0|||
156406452|NCT00661661|564581119|FG001|Overall Study|Lost to Follow-up|1|||
156406453|NCT00661661|564581118|FG000|Overall Study|Withdrawal by Subject|15|||
156406454|NCT00661661|564581119|FG001|Overall Study|Withdrawal by Subject|5|||
156406455|NCT00661661|564581118|FG000|Overall Study|Other|22|||
156406456|NCT00661661|564581119|FG001|Overall Study|Other|7|||
156406457|NCT00661661|564581118|FG000|Overall Study|Not assigned treatment|1|||
156554367|NCT02574637|565119837|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
156554368|NCT02574637|565119838|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
156554369|NCT02574637|565119839|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
156554370|NCT02574637|565119840|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
156554371|NCT02574637|565119841|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
156406458|NCT00661661|564581119|FG001|Overall Study|Not assigned treatment|0|||
156406459|NCT01861522|564581123|FG000|Overall Study|Adverse Event|1|||
156406460|NCT01861522|564581124|FG001|Overall Study|Adverse Event|0|||
156406461|NCT01861522|564581123|FG000|Overall Study|Withdrawal by Subject|2|||
156406462|NCT01861522|564581124|FG001|Overall Study|Withdrawal by Subject|0|||
156406463|NCT00917267|564582797|FG000|Overall Study|Adverse Event|15|||
156554372|NCT02574637|565119842|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
156406464|NCT00917267|564582798|FG001|Overall Study|Adverse Event|36|||
156406465|NCT00917267|564582797|FG000|Overall Study|Physician Decision|2|||
156406466|NCT00917267|564582798|FG001|Overall Study|Physician Decision|4|||
156406467|NCT00917267|564582797|FG000|Overall Study|Protocol Violation|9|||
156406468|NCT00917267|564582798|FG001|Overall Study|Protocol Violation|18|||
156406469|NCT00917267|564582797|FG000|Overall Study|Withdrawal by Subject|5|||
156406470|NCT00917267|564582798|FG001|Overall Study|Withdrawal by Subject|12|||
156406471|NCT00917267|564582797|FG000|Overall Study|Lost to follow up|0|||
156406472|NCT00917267|564582798|FG001|Overall Study|Lost to follow up|2|||
156406473|NCT00917267|564582797|FG000|Overall Study|Entry Criteria Not Met|1|||
156406474|NCT00917267|564582798|FG001|Overall Study|Entry Criteria Not Met|0|||
156406475|NCT00917267|564582797|FG000|Overall Study|Sponsor Decision|5|||
156406476|NCT00917267|564582798|FG001|Overall Study|Sponsor Decision|5|||
156406477|NCT00917267|564582797|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
156406478|NCT00917267|564582798|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
156406479|NCT00432835|564582803|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
156406480|NCT00432835|564582804|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
156406481|NCT00802659|564582805|FG000|Overall Study|Physician Decision|0|||
156406482|NCT00802659|564582806|FG001|Overall Study|Physician Decision|1|||
156406483|NCT00802659|564582807|FG002|Overall Study|Physician Decision|0|||
156406484|NCT00802659|564582808|FG003|Overall Study|Physician Decision|0|||
156406485|NCT00289770|564582809|FG000|Year 15|Withdrawal by Subject|1|||
156406486|NCT00423293|564582810|FG000|Overall Study|Ineligible / No protocol treatment|11|||
156406487|NCT03810313|564582816|FG000|Overall Study|Study terminated by sponsor|164|||
156406488|NCT03810313|564582817|FG001|Overall Study|Study terminated by sponsor|159|||
156406489|NCT03810313|564582816|FG000|Overall Study|Subject decision|10|||
156406490|NCT03810313|564582817|FG001|Overall Study|Subject decision|11|||
156406491|NCT03810313|564582816|FG000|Overall Study|Lost to Follow-up|3|||
156406492|NCT03810313|564582817|FG001|Overall Study|Lost to Follow-up|3|||
156406493|NCT03810313|564582816|FG000|Overall Study|Adverse Event|2|||
156406494|NCT03810313|564582817|FG001|Overall Study|Adverse Event|1|||
156406495|NCT03810313|564582816|FG000|Overall Study|Death|2|||
156406496|NCT03810313|564582817|FG001|Overall Study|Death|1|||
156406497|NCT03810313|564582816|FG000|Overall Study|Physician Decision|0|||
156406498|NCT03810313|564582817|FG001|Overall Study|Physician Decision|1|||
156406499|NCT00154310|564582818|FG000|Overall Study|Adverse Event|19|||
156406500|NCT00154310|564582819|FG001|Overall Study|Adverse Event|9|||
156406501|NCT00154310|564582818|FG000|Overall Study|Lack of Efficacy|5|||
156406502|NCT00154310|564582819|FG001|Overall Study|Lack of Efficacy|4|||
156406503|NCT00154310|564582818|FG000|Overall Study|Protocol Violation|4|||
156406504|NCT00154310|564582819|FG001|Overall Study|Protocol Violation|2|||
156406505|NCT00154310|564582818|FG000|Overall Study|Withdrawal by Subject|9|||
156406506|NCT00154310|564582819|FG001|Overall Study|Withdrawal by Subject|3|||
156406507|NCT00154310|564582818|FG000|Overall Study|Lost to Follow-up|0|||
156406508|NCT00154310|564582819|FG001|Overall Study|Lost to Follow-up|8|||
156406509|NCT00154310|564582818|FG000|Overall Study|Administrative problems|0|||
156406510|NCT00154310|564582819|FG001|Overall Study|Administrative problems|1|||
156406511|NCT00154310|564582818|FG000|Overall Study|Death|0|||
156406512|NCT00154310|564582819|FG001|Overall Study|Death|1|||
156406513|NCT03469349|564582820|FG000|Overall Study|Withdrawal by Subject|1|||
156406514|NCT03469349|564582821|FG001|Overall Study|Withdrawal by Subject|3|||
156406515|NCT03469349|564582820|FG000|Overall Study|Progressive Disease|0|||
156406516|NCT03469349|564582821|FG001|Overall Study|Progressive Disease|1|||
156554373|NCT02574637|565119843|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
156554374|NCT02574637|565119844|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
156554375|NCT02574637|565119845|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
156554376|NCT02574637|565119846|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
156554377|NCT02706730|565119850|FG000|Overall Study|Adverse Event|3|||
156554378|NCT02706730|565119850|FG000|Overall Study|Lack of Efficacy|5|||
156554379|NCT02706730|565119850|FG000|Overall Study|Withdrawal by Subject|11|||
156554380|NCT02706730|565119850|FG000|Overall Study|Study Terminated by Sponsor|11|||
156406517|NCT03469349|564582820|FG000|Overall Study|Lost to Follow-up|2|||
156406518|NCT03469349|564582821|FG001|Overall Study|Lost to Follow-up|2|||
156406519|NCT03469349|564582820|FG000|Overall Study|Adverse Event|2|||
156406520|NCT03469349|564582821|FG001|Overall Study|Adverse Event|4|||
156406521|NCT02086162|564582823|FG000|Overall Study|Withdrawal by Subject|4|||
156406522|NCT02086162|564582824|FG001|Overall Study|Withdrawal by Subject|4|||
156406523|NCT02086162|564582823|FG000|Overall Study|moved|1|||
156406524|NCT02086162|564582824|FG001|Overall Study|moved|1|||
156406525|NCT02086162|564582823|FG000|Overall Study|Lost to Follow-up|4|||
156406526|NCT02086162|564582824|FG001|Overall Study|Lost to Follow-up|2|||
156406527|NCT02086162|564582823|FG000|Overall Study|Death|1|||
156406528|NCT02086162|564582824|FG001|Overall Study|Death|0|||
156406529|NCT03447730|564582825|FG000|Overall Study|Adverse Event|0|||
156406530|NCT03447730|564582826|FG001|Overall Study|Adverse Event|2|||
156406531|NCT03447730|564582827|FG002|Overall Study|Adverse Event|0|||
156406532|NCT01827254|564582831|FG000|Overall Study|Death|10|||
156406533|NCT01827254|564582831|FG000|Overall Study|Case report form not completed|4|||
156406534|NCT01827254|564582831|FG000|Overall Study|Invalidated centre|3|||
156406535|NCT01827254|564582831|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
156406536|NCT01827254|564582831|FG000|Overall Study|Did not complete re-challenge|1|||
156406537|NCT01827254|564582831|FG000|Overall Study|Disease progression|36|||
156406538|NCT01827254|564582831|FG000|Overall Study|Intolerance to treatment|4|||
156406539|NCT01350505|564582832|FG000|Overall Study|Lost to Follow-up|4|||
156406540|NCT04702568|564582836|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
156406541|NCT04702568|564582837|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
156406542|NCT04702568|564582836|FG000|Overall Study|Pregnancy|1|||
156406543|NCT04702568|564582837|FG001|Overall Study|Pregnancy|0|||
156406544|NCT04702568|564582836|FG000|Overall Study|Bone marrow transplant|1|||
156406545|NCT04702568|564582837|FG001|Overall Study|Bone marrow transplant|0|||
156406546|NCT04702568|564582836|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
156406547|NCT04702568|564582837|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
156406548|NCT04702568|564582836|FG000|Overall Study|Withdrawal by Subject|0|||
156406549|NCT04702568|564582837|FG001|Overall Study|Withdrawal by Subject|2|||
156406550|NCT01225822|564582840|FG000|Overall Study|Adverse Event|13|||
156406551|NCT01225822|564582841|FG001|Overall Study|Adverse Event|31|||
156406552|NCT01225822|564582842|FG002|Overall Study|Adverse Event|18|||
156406553|NCT01225822|564582843|FG003|Overall Study|Adverse Event|23|||
156406554|NCT01225822|564582844|FG004|Overall Study|Adverse Event|14|||
156406555|NCT01225822|564582840|FG000|Overall Study|Protocol Violation|6|||
156406556|NCT01225822|564582841|FG001|Overall Study|Protocol Violation|8|||
156406557|NCT01225822|564582842|FG002|Overall Study|Protocol Violation|6|||
156406558|NCT01225822|564582843|FG003|Overall Study|Protocol Violation|7|||
156406559|NCT01225822|564582844|FG004|Overall Study|Protocol Violation|4|||
156406560|NCT01225822|564582840|FG000|Overall Study|Lost to Follow-up|0|||
156406561|NCT01225822|564582841|FG001|Overall Study|Lost to Follow-up|0|||
156406562|NCT01225822|564582842|FG002|Overall Study|Lost to Follow-up|0|||
156406563|NCT01225822|564582843|FG003|Overall Study|Lost to Follow-up|1|||
156406564|NCT01225822|564582844|FG004|Overall Study|Lost to Follow-up|0|||
156406565|NCT01225822|564582840|FG000|Overall Study|Withdrawal by Subject|6|||
156406566|NCT01225822|564582841|FG001|Overall Study|Withdrawal by Subject|7|||
156406567|NCT01225822|564582842|FG002|Overall Study|Withdrawal by Subject|7|||
156406568|NCT01225822|564582843|FG003|Overall Study|Withdrawal by Subject|11|||
156406569|NCT01225822|564582844|FG004|Overall Study|Withdrawal by Subject|6|||
156406570|NCT01225822|564582840|FG000|Overall Study|Other|13|||
156406571|NCT01225822|564582841|FG001|Overall Study|Other|10|||
156406572|NCT01225822|564582842|FG002|Overall Study|Other|7|||
156406573|NCT01225822|564582843|FG003|Overall Study|Other|10|||
156406574|NCT01225822|564582844|FG004|Overall Study|Other|7|||
156406575|NCT04078035|564582845|FG000|Session 2|Lost to Follow-up|3|||
156406576|NCT04078035|564582846|FG001|Session 2|Lost to Follow-up|1|||
156406577|NCT04078035|564582845|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
156406578|NCT04078035|564582846|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
156406579|NCT02667886|564582853|FG000|Dose Escalation (Part A)|Adverse Event|1|||
156406580|NCT02667886|564582854|FG001|Dose Escalation (Part A)|Adverse Event|3|||
156406581|NCT02667886|564582855|FG002|Dose Escalation (Part A)|Adverse Event|1|||
156406582|NCT02667886|564582856|FG003|Dose Escalation (Part A)|Adverse Event|0|||
156406583|NCT02667886|564582857|FG004|Dose Escalation (Part A)|Adverse Event|0|||
156406584|NCT02667886|564582853|FG000|Dose Escalation (Part A)|Disease Progression|1|||
156406585|NCT02667886|564582854|FG001|Dose Escalation (Part A)|Disease Progression|4|||
156406586|NCT02667886|564582855|FG002|Dose Escalation (Part A)|Disease Progression|3|||
156406587|NCT02667886|564582856|FG003|Dose Escalation (Part A)|Disease Progression|0|||
156406588|NCT02667886|564582857|FG004|Dose Escalation (Part A)|Disease Progression|0|||
156406589|NCT02667886|564582853|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
156406590|NCT02667886|564582854|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
156406591|NCT02667886|564582855|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
156406592|NCT02667886|564582856|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
156554381|NCT02706730|565119850|FG000|Overall Study|Subject chose not to receive injection|3|||
156554382|NCT02499029|565119851|FG000|Overall Study|Lost to Follow-up|2|||
156554383|NCT02499029|565119852|FG001|Overall Study|Lost to Follow-up|2|||
156554384|NCT02499029|565119851|FG000|Overall Study|Physician Decision|2|||
156554385|NCT02499029|565119852|FG001|Overall Study|Physician Decision|1|||
156554386|NCT02499029|565119851|FG000|Overall Study|Death|1|||
156554387|NCT02499029|565119852|FG001|Overall Study|Death|0|||
156554388|NCT04823949|565119853|FG000|Overall Study|Withdrawal by Subject|0|||
156406593|NCT02667886|564582857|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
156406594|NCT02667886|564582853|FG000|Dose Expansion (Part B)|Adverse Event|0|||
156406595|NCT02667886|564582854|FG001|Dose Expansion (Part B)|Adverse Event|0|||
156406596|NCT02667886|564582855|FG002|Dose Expansion (Part B)|Adverse Event|0|||
156554389|NCT04823949|565119854|FG001|Overall Study|Withdrawal by Subject|4|||
156554390|NCT04823949|565119853|FG000|Overall Study|Physician Decision|0|||
156554391|NCT04823949|565119854|FG001|Overall Study|Physician Decision|1|||
156406597|NCT02667886|564582856|FG003|Dose Expansion (Part B)|Adverse Event|9|||
156406598|NCT02667886|564582857|FG004|Dose Expansion (Part B)|Adverse Event|0|||
156406599|NCT02667886|564582853|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
156406600|NCT02667886|564582854|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
156406601|NCT02667886|564582855|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
156554392|NCT00756938|565119855|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
156406602|NCT02667886|564582856|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
156406603|NCT02667886|564582857|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
156406604|NCT02667886|564582853|FG000|Dose Expansion (Part B)|Disease Progression|0|||
156406605|NCT02667886|564582854|FG001|Dose Expansion (Part B)|Disease Progression|0|||
156406606|NCT02667886|564582855|FG002|Dose Expansion (Part B)|Disease Progression|0|||
156406607|NCT02667886|564582856|FG003|Dose Expansion (Part B)|Disease Progression|38|||
156406608|NCT02667886|564582857|FG004|Dose Expansion (Part B)|Disease Progression|0|||
156406609|NCT02667886|564582853|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
156406610|NCT02667886|564582854|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
156406611|NCT02667886|564582855|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
156406612|NCT02667886|564582856|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
156406613|NCT02667886|564582857|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
156406614|NCT02667886|564582853|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
156406615|NCT02667886|564582854|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
156406616|NCT02667886|564582855|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
156406617|NCT02667886|564582856|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
156406618|NCT02667886|564582857|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
156406619|NCT02667886|564582853|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
156406620|NCT02667886|564582854|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
156406621|NCT02667886|564582855|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
156406622|NCT02667886|564582856|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
156406623|NCT02667886|564582857|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
156406624|NCT04186403|564582858|FG000|Overall Study|Adverse Event|1|||
156406625|NCT04186403|564582859|FG001|Overall Study|Adverse Event|8|||
156406626|NCT04186403|564582858|FG000|Overall Study|Lost to Follow-up|7|||
156406627|NCT04186403|564582859|FG001|Overall Study|Lost to Follow-up|3|||
156406628|NCT04186403|564582858|FG000|Overall Study|Physician Decision|1|||
156406629|NCT04186403|564582859|FG001|Overall Study|Physician Decision|0|||
156406630|NCT04186403|564582858|FG000|Overall Study|Withdrawal by Subject|7|||
156406631|NCT04186403|564582859|FG001|Overall Study|Withdrawal by Subject|8|||
156406632|NCT04186403|564582858|FG000|Overall Study|Other: Not Related to Covid-19|3|||
156406633|NCT04186403|564582859|FG001|Overall Study|Other: Not Related to Covid-19|0|||
156406634|NCT03929562|564582860|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
156406635|NCT03929562|564582861|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
156406636|NCT03929562|564582860|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
156406637|NCT03929562|564582861|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
156406638|NCT03929562|564582860|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
156406639|NCT03929562|564582861|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
156406640|NCT01407354|564582862|FG000|First Intervention|Withdrawal by Subject|0|||
156406641|NCT01407354|564582863|FG001|First Intervention|Withdrawal by Subject|2|||
156406642|NCT01407354|564582862|FG000|First Intervention|Adverse Event|1|||
156406643|NCT01407354|564582863|FG001|First Intervention|Adverse Event|0|||
156406644|NCT01407354|564582862|FG000|First Intervention|Physician Decision|1|||
156406645|NCT01407354|564582863|FG001|First Intervention|Physician Decision|0|||
156406646|NCT02778399|564582864|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
156406647|NCT02778399|564582865|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
156406648|NCT02778399|564582866|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
156406649|NCT02778399|564582867|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
156406650|NCT02778399|564582868|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
156406651|NCT02778399|564582869|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
156406652|NCT02778399|564582864|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
156406653|NCT02778399|564582865|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
156406654|NCT02778399|564582866|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
156406655|NCT02778399|564582867|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
156406656|NCT02778399|564582868|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
156406657|NCT02778399|564582869|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
156406658|NCT02778399|564582864|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
156406659|NCT02778399|564582865|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
156406660|NCT02778399|564582866|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
156406661|NCT02778399|564582867|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
156406662|NCT02778399|564582868|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
156406663|NCT02778399|564582869|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
156406664|NCT02778399|564582864|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
156406665|NCT02778399|564582865|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
156406666|NCT02778399|564582866|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
156406667|NCT02778399|564582867|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
156406668|NCT02778399|564582868|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
156406669|NCT02778399|564582869|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
156406670|NCT02778399|564582864|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
156406671|NCT02778399|564582865|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
156406672|NCT02778399|564582866|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
156406673|NCT02778399|564582867|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
156406674|NCT02778399|564582868|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
156406675|NCT02778399|564582869|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
156406676|NCT02778399|564582864|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
156406677|NCT02778399|564582865|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
156406678|NCT02778399|564582866|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
156406679|NCT02778399|564582867|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
156406680|NCT02778399|564582868|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
156406681|NCT02778399|564582869|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
156406682|NCT02778399|564582864|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
156406683|NCT02778399|564582865|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
156406684|NCT02778399|564582866|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
156406685|NCT02778399|564582867|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
156406686|NCT02778399|564582868|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
156406687|NCT02778399|564582869|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
156406688|NCT02778399|564582864|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156406689|NCT02778399|564582865|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
156406690|NCT02778399|564582866|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156406691|NCT02778399|564582867|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156406692|NCT02778399|564582868|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156406693|NCT02778399|564582869|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156406694|NCT02778399|564582864|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
156406695|NCT02778399|564582865|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
156406696|NCT02778399|564582866|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
156406697|NCT02778399|564582867|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
156406698|NCT02778399|564582868|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
156406699|NCT02778399|564582869|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
156406700|NCT02778399|564582864|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
156406701|NCT02778399|564582865|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
156406702|NCT02778399|564582866|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
156406703|NCT02778399|564582867|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
156406704|NCT02778399|564582868|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
156406705|NCT02778399|564582869|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
156406706|NCT02778399|564582864|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
156406707|NCT02778399|564582865|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
156406708|NCT02778399|564582866|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
156406709|NCT02778399|564582867|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
156406710|NCT02778399|564582868|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
156406711|NCT02778399|564582869|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
156406712|NCT00405639|564582871|FG000|Overall Study|Withdrawal by Subject|1|||
156406713|NCT00405639|564582872|FG001|Overall Study|Withdrawal by Subject|0|||
156406714|NCT00405639|564582871|FG000|Overall Study|Adverse Event|1|||
156406715|NCT00405639|564582872|FG001|Overall Study|Adverse Event|0|||
156406716|NCT00405639|564582871|FG000|Overall Study|Seizure prior to receiving BNP|1|||
156406717|NCT00405639|564582872|FG001|Overall Study|Seizure prior to receiving BNP|0|||
156406718|NCT02130284|564582876|FG000|Overall Study|Withdrawal by Subject|3|||
156406719|NCT02130284|564582876|FG000|Overall Study|Subject Withdrew Consent|1|||
156406720|NCT02130284|564582876|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
156406721|NCT02130284|564582876|FG000|Overall Study|Subject was screened as backup for study|3|||
156406722|NCT02130284|564582876|FG000|Overall Study|Screen Failure|1|||
156406723|NCT01435655|564582881|FG000|Overall Study|Death|2|||
156406724|NCT01435655|564582881|FG000|Overall Study|Other|1|||
156406725|NCT04534114|564582882|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
156406726|NCT04534114|564582883|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
156406727|NCT04534114|564582884|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
156406728|NCT04534114|564582885|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
156406729|NCT04534114|564582882|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
156406730|NCT04534114|564582883|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
156406731|NCT04534114|564582884|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
156406732|NCT04534114|564582885|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
156406733|NCT04534114|564582882|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
156406734|NCT04534114|564582883|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
156406735|NCT04534114|564582884|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
156406736|NCT04534114|564582885|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
156406737|NCT04534114|564582882|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
156512981|NCT01302080|564970633|FG001|Overall Study|Patient/Family Moved|3|||
156512982|NCT01302080|564970632|FG000|Overall Study|Lost to Follow-up|192|||
156406738|NCT04534114|564582883|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
156406739|NCT04534114|564582884|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
156406740|NCT04534114|564582885|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
156406741|NCT04534114|564582882|FG000|Main Treatment Period|Physician Decision|0|||
156406742|NCT04534114|564582883|FG001|Main Treatment Period|Physician Decision|0|||
156406743|NCT04534114|564582884|FG002|Main Treatment Period|Physician Decision|0|||
156406744|NCT04534114|564582885|FG003|Main Treatment Period|Physician Decision|1|||
156406745|NCT04534114|564582882|FG000|Main Treatment Period|Death|1|||
156406746|NCT04534114|564582883|FG001|Main Treatment Period|Death|0|||
156406747|NCT04534114|564582884|FG002|Main Treatment Period|Death|0|||
156406748|NCT04534114|564582885|FG003|Main Treatment Period|Death|1|||
156406749|NCT04534114|564582882|FG000|Main Treatment Period|Other reason|1|||
156406750|NCT04534114|564582883|FG001|Main Treatment Period|Other reason|1|||
156406751|NCT04534114|564582884|FG002|Main Treatment Period|Other reason|0|||
156406752|NCT04534114|564582885|FG003|Main Treatment Period|Other reason|0|||
156406753|NCT04534114|564582882|FG000|Main Treatment Period|Participant decision|1|||
156406754|NCT04534114|564582883|FG001|Main Treatment Period|Participant decision|3|||
156406755|NCT04534114|564582884|FG002|Main Treatment Period|Participant decision|3|||
156406756|NCT04534114|564582885|FG003|Main Treatment Period|Participant decision|1|||
156406757|NCT04534114|564582882|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
156406758|NCT04534114|564582883|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
156406759|NCT04534114|564582884|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
156406760|NCT04534114|564582885|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
156406761|NCT04534114|564582882|FG000|Main Treatment Period|Adverse Event|4|||
156406762|NCT04534114|564582883|FG001|Main Treatment Period|Adverse Event|2|||
156406763|NCT04534114|564582884|FG002|Main Treatment Period|Adverse Event|1|||
156406764|NCT04534114|564582885|FG003|Main Treatment Period|Adverse Event|2|||
156406765|NCT04534114|564582882|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
156406766|NCT04534114|564582883|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
156406767|NCT04534114|564582884|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
156406768|NCT04534114|564582885|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
156406769|NCT04534114|564582882|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
156406770|NCT04534114|564582883|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
156406771|NCT04534114|564582884|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
156406772|NCT04534114|564582885|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
156406773|NCT04534114|564582882|FG000|Extension Treatment Period|Other reason|0|||
156406774|NCT04534114|564582883|FG001|Extension Treatment Period|Other reason|1|||
156406775|NCT04534114|564582884|FG002|Extension Treatment Period|Other reason|0|||
156406776|NCT04534114|564582885|FG003|Extension Treatment Period|Other reason|0|||
156406777|NCT04534114|564582882|FG000|Extension Treatment Period|Death|0|||
156406778|NCT04534114|564582883|FG001|Extension Treatment Period|Death|0|||
156406779|NCT04534114|564582884|FG002|Extension Treatment Period|Death|1|||
156406780|NCT04534114|564582885|FG003|Extension Treatment Period|Death|2|||
156406781|NCT04534114|564582882|FG000|Extension Treatment Period|Adverse Event|0|||
156406782|NCT04534114|564582883|FG001|Extension Treatment Period|Adverse Event|1|||
156406783|NCT04534114|564582884|FG002|Extension Treatment Period|Adverse Event|0|||
156406784|NCT04534114|564582885|FG003|Extension Treatment Period|Adverse Event|1|||
156512983|NCT01302080|564970633|FG001|Overall Study|Lost to Follow-up|93|||
156512984|NCT01302080|564970632|FG000|Overall Study|Death|1|||
156512985|NCT01302080|564970633|FG001|Overall Study|Death|0|||
156512986|NCT01302080|564970632|FG000|Overall Study|Other|52|||
156512987|NCT01302080|564970633|FG001|Overall Study|Other|8|||
156512988|NCT01302080|564970632|FG000|Overall Study|Reason Missing For Discontinuation|1|||
156512989|NCT01302080|564970633|FG001|Overall Study|Reason Missing For Discontinuation|0|||
156512990|NCT00503139|564970636|FG000|Overall Study|Case Report Forms were not collected|4|||
156512991|NCT00503139|564970636|FG000|Overall Study|Protocol Violation|4|||
156512992|NCT00833833|564970640|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
156512993|NCT00833833|564970641|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
156512994|NCT00833833|564970642|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
156512995|NCT00833833|564970643|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
156512996|NCT00833833|564970644|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
156512997|NCT00833833|564970645|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
156512998|NCT00833833|564970640|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
156512999|NCT00833833|564970641|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
156513000|NCT00833833|564970642|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
156513001|NCT00833833|564970643|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
156513002|NCT00833833|564970644|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
156513003|NCT00833833|564970645|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
156513004|NCT00833833|564970640|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
156513005|NCT00833833|564970641|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
156406785|NCT04534114|564582882|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
156406786|NCT04534114|564582883|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
156406787|NCT04534114|564582884|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
156406788|NCT04534114|564582885|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
156406789|NCT02223754|564582886|FG000|Period 1|Adverse Event|1|||
156406790|NCT02223754|564582887|FG001|Period 1|Adverse Event|0|||
156406791|NCT02223754|564582886|FG000|Period 1|Lost to Follow-up|0|||
156406792|NCT02223754|564582887|FG001|Period 1|Lost to Follow-up|1|||
156406793|NCT02223754|564582886|FG000|Period 1|Protocol Violation|2|||
156406794|NCT02223754|564582887|FG001|Period 1|Protocol Violation|4|||
156406795|NCT02223754|564582886|FG000|Period 1|Withdrawal by Subject|0|||
156406796|NCT02223754|564582887|FG001|Period 1|Withdrawal by Subject|4|||
156406797|NCT02223754|564582886|FG000|Period 1|Test Article No Longer Available|1|||
156406798|NCT02223754|564582887|FG001|Period 1|Test Article No Longer Available|5|||
156406799|NCT02223754|564582886|FG000|Period 1|Unsatisfactory Visual Response|0|||
156406800|NCT02223754|564582887|FG001|Period 1|Unsatisfactory Visual Response|1|||
156406801|NCT02223754|564582886|FG000|Period 2|Adverse Event|0|||
156406802|NCT02223754|564582887|FG001|Period 2|Adverse Event|1|||
156406803|NCT02223754|564582886|FG000|Period 2|Protocol Violation|1|||
156406804|NCT02223754|564582887|FG001|Period 2|Protocol Violation|0|||
156406805|NCT02223754|564582886|FG000|Period 2|Lens Discomfort|1|||
156406806|NCT02223754|564582887|FG001|Period 2|Lens Discomfort|1|||
156406807|NCT02223754|564582886|FG000|Period 2|Lost to Follow-up|1|||
156406808|NCT02223754|564582887|FG001|Period 2|Lost to Follow-up|0|||
156406809|NCT02223754|564582886|FG000|Period 2|Test Article No Longer Available|0|||
156406810|NCT02223754|564582887|FG001|Period 2|Test Article No Longer Available|1|||
156406811|NCT01008475|564582889|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
156406812|NCT01008475|564582890|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
156406813|NCT01008475|564582891|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
156406814|NCT01008475|564582892|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
156406815|NCT01008475|564582893|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
156406816|NCT01008475|564582894|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
156406817|NCT01008475|564582895|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
156406818|NCT02668016|564582896|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
156406819|NCT02668016|564582896|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
156513006|NCT00833833|564970642|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
156513007|NCT00833833|564970643|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
156513008|NCT00833833|564970644|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
156513009|NCT00833833|564970645|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
156513010|NCT00833833|564970640|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
156513011|NCT00833833|564970641|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
156513012|NCT00833833|564970642|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
156513013|NCT00833833|564970643|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
156513014|NCT00833833|564970644|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
156513015|NCT00833833|564970645|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
156513016|NCT00833833|564970640|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
156513017|NCT00833833|564970641|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
156513018|NCT00833833|564970642|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
156513019|NCT00833833|564970643|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
156513020|NCT00833833|564970644|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
156513021|NCT00833833|564970645|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
156513022|NCT00833833|564970640|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
156513023|NCT00833833|564970641|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
156513024|NCT00833833|564970642|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
156513025|NCT00833833|564970643|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
156513026|NCT00833833|564970644|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
156513027|NCT00833833|564970645|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
156513028|NCT00833833|564970640|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
156513029|NCT00833833|564970641|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
156513030|NCT00833833|564970642|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
156513031|NCT00833833|564970643|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
156513032|NCT00833833|564970644|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
156513033|NCT00833833|564970645|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
156513034|NCT00833833|564970640|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
156513035|NCT00833833|564970641|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
156513036|NCT00833833|564970642|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
156513037|NCT00833833|564970643|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
156513038|NCT00833833|564970644|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
156513039|NCT00833833|564970645|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
156406820|NCT02668016|564582896|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
156406821|NCT02668016|564582896|FG000|Month 4|Withdrawal due to severe symptoms|1|||
156406822|NCT02668016|564582896|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
156406823|NCT02668016|564582896|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
156406824|NCT02668016|564582896|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
156406825|NCT02668016|564582896|FG000|Month 6|Withdrawal due to severe symptoms|2|||
156406826|NCT02668016|564582896|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
156406827|NCT02668016|564582896|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
156406828|NCT02668016|564582896|FG000|Month 8|Withdrawal due to severe symptoms|1|||
156406829|NCT02668016|564582896|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
156406830|NCT02668016|564582896|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
156406831|NCT02668016|564582896|FG000|Month 10|Withdrawal due to severe symptoms|1|||
156406832|NCT02668016|564582896|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
156406833|NCT01807650|564582903|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
156406834|NCT01807650|564582903|FG000|Overall Study|Adverse Event|5|||
156406835|NCT01807650|564582903|FG000|Overall Study|Other|2|||
156406836|NCT01122381|564582904|FG000|Overall Study|study terminated early|0|||
156406837|NCT01122381|564582905|FG001|Overall Study|study terminated early|1|||
156406838|NCT00736489|564582906|FG000|Period 1|Lost to Follow-up|1|||
156406839|NCT00736489|564582907|FG001|Period 1|Lost to Follow-up|0|||
156406840|NCT00736489|564582908|FG002|Period 1|Lost to Follow-up|0|||
156406841|NCT00736489|564582909|FG003|Period 1|Lost to Follow-up|0|||
156406842|NCT00736489|564582910|FG004|Period 1|Lost to Follow-up|0|||
156406843|NCT00736489|564582911|FG005|Period 1|Lost to Follow-up|0|||
156406844|NCT00736489|564582906|FG000|Period 1|Withdrawal by Subject|0|||
156406845|NCT00736489|564582907|FG001|Period 1|Withdrawal by Subject|0|||
156406846|NCT00736489|564582908|FG002|Period 1|Withdrawal by Subject|0|||
156406847|NCT00736489|564582909|FG003|Period 1|Withdrawal by Subject|0|||
156406848|NCT00736489|564582910|FG004|Period 1|Withdrawal by Subject|0|||
156513040|NCT00833833|564970640|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
156513041|NCT00833833|564970641|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
156554393|NCT00756938|565119856|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
156554394|NCT00756938|565119857|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
156554395|NCT00756938|565119858|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
156554396|NCT00756938|565119855|FG000|12-week Base Study|Protocol Violation|0|||
156554397|NCT00756938|565119856|FG001|12-week Base Study|Protocol Violation|0|||
156554398|NCT00756938|565119857|FG002|12-week Base Study|Protocol Violation|1|||
156554399|NCT00756938|565119858|FG003|12-week Base Study|Protocol Violation|0|||
156554400|NCT00756938|565119855|FG000|12-week Base Study|Lost to Follow-up|1|||
156554401|NCT00756938|565119856|FG001|12-week Base Study|Lost to Follow-up|0|||
156554402|NCT00756938|565119857|FG002|12-week Base Study|Lost to Follow-up|0|||
156554403|NCT00756938|565119858|FG003|12-week Base Study|Lost to Follow-up|0|||
156554404|NCT00756938|565119855|FG000|Optional Extension|Lack of Efficacy|0|||
156554405|NCT00756938|565119856|FG001|Optional Extension|Lack of Efficacy|0|||
156554406|NCT00756938|565119857|FG002|Optional Extension|Lack of Efficacy|0|||
156554407|NCT00756938|565119858|FG003|Optional Extension|Lack of Efficacy|1|||
156554408|NCT00756938|565119855|FG000|Optional Extension|End of Study|0|||
156554409|NCT00756938|565119856|FG001|Optional Extension|End of Study|0|||
156554410|NCT00756938|565119857|FG002|Optional Extension|End of Study|0|||
156554411|NCT00756938|565119858|FG003|Optional Extension|End of Study|11|||
156554412|NCT00756938|565119855|FG000|Optional Extension|Protocol-specific criteria met|0|||
156513042|NCT00833833|564970642|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
156513043|NCT00833833|564970643|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
156513044|NCT00833833|564970644|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
156513045|NCT00833833|564970645|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
156513046|NCT00833833|564970640|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
156513047|NCT00833833|564970641|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
156513048|NCT00833833|564970642|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
156513049|NCT00833833|564970643|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
156513050|NCT00833833|564970644|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
156513051|NCT00833833|564970645|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
156513052|NCT00833833|564970640|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
156554413|NCT00756938|565119856|FG001|Optional Extension|Protocol-specific criteria met|0|||
156554414|NCT00756938|565119857|FG002|Optional Extension|Protocol-specific criteria met|0|||
156554415|NCT00756938|565119858|FG003|Optional Extension|Protocol-specific criteria met|9|||
156406849|NCT00736489|564582911|FG005|Period 1|Withdrawal by Subject|1|||
156406850|NCT02395133|564582912|FG000|Overall Study|Adverse Event|4|||
156406851|NCT02395133|564582913|FG001|Overall Study|Adverse Event|1|||
156406852|NCT02395133|564582914|FG002|Overall Study|Adverse Event|3|||
156513053|NCT00833833|564970641|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
156554416|NCT00756938|565119855|FG000|Optional Extension|Physician Decision|0|||
156406853|NCT02395133|564582915|FG003|Overall Study|Adverse Event|0|||
156406854|NCT02395133|564582912|FG000|Overall Study|Lack of Efficacy|1|||
156406855|NCT02395133|564582913|FG001|Overall Study|Lack of Efficacy|0|||
156406856|NCT02395133|564582914|FG002|Overall Study|Lack of Efficacy|1|||
156406857|NCT02395133|564582915|FG003|Overall Study|Lack of Efficacy|1|||
156406858|NCT02395133|564582912|FG000|Overall Study|Protocol Violation|1|||
156406859|NCT02395133|564582913|FG001|Overall Study|Protocol Violation|1|||
156406860|NCT02395133|564582914|FG002|Overall Study|Protocol Violation|0|||
156406861|NCT02395133|564582915|FG003|Overall Study|Protocol Violation|3|||
156406862|NCT02395133|564582912|FG000|Overall Study|Lost to Follow-up|0|||
156406863|NCT02395133|564582913|FG001|Overall Study|Lost to Follow-up|1|||
156406864|NCT02395133|564582914|FG002|Overall Study|Lost to Follow-up|1|||
156406865|NCT02395133|564582915|FG003|Overall Study|Lost to Follow-up|0|||
156406866|NCT02395133|564582912|FG000|Overall Study|Pregnancy|0|||
156406867|NCT02395133|564582913|FG001|Overall Study|Pregnancy|0|||
156406868|NCT02395133|564582914|FG002|Overall Study|Pregnancy|3|||
156406869|NCT02395133|564582915|FG003|Overall Study|Pregnancy|0|||
156406870|NCT02395133|564582912|FG000|Overall Study|Consent withdrawn with no reason given|1|||
156406871|NCT02395133|564582913|FG001|Overall Study|Consent withdrawn with no reason given|3|||
156406872|NCT02395133|564582914|FG002|Overall Study|Consent withdrawn with no reason given|0|||
156406873|NCT02395133|564582915|FG003|Overall Study|Consent withdrawn with no reason given|2|||
156406874|NCT02395133|564582912|FG000|Overall Study|Consent withdrawn with personal reason|0|||
156406875|NCT02395133|564582913|FG001|Overall Study|Consent withdrawn with personal reason|1|||
156406876|NCT02395133|564582914|FG002|Overall Study|Consent withdrawn with personal reason|0|||
156406877|NCT02395133|564582915|FG003|Overall Study|Consent withdrawn with personal reason|3|||
156406878|NCT02395133|564582912|FG000|Overall Study|Sponsor decision|2|||
156406879|NCT02395133|564582913|FG001|Overall Study|Sponsor decision|0|||
156406880|NCT02395133|564582914|FG002|Overall Study|Sponsor decision|0|||
156406881|NCT02395133|564582915|FG003|Overall Study|Sponsor decision|1|||
156406882|NCT02395133|564582912|FG000|Overall Study|Other than specified above|5|||
156406883|NCT02395133|564582913|FG001|Overall Study|Other than specified above|2|||
156406884|NCT02395133|564582914|FG002|Overall Study|Other than specified above|2|||
156406885|NCT02395133|564582915|FG003|Overall Study|Other than specified above|4|||
156406886|NCT00510458|564582916|FG000|Overall Study|5 year not evaluable/missed|21|||
156406887|NCT00510458|564582916|FG000|Overall Study|Death|1|||
156406888|NCT00510458|564582916|FG000|Overall Study|Terminated|14|||
156406889|NCT00510458|564582916|FG000|Overall Study|Lost to Follow-up|6|||
156406890|NCT00510458|564582916|FG000|Overall Study|Withdrawal by Subject|3|||
156406891|NCT00510458|564582916|FG000|Overall Study|Revision|2|||
156406892|NCT02569710|564582917|FG000|Overall Study|Adverse Event|1|||
156406893|NCT02569710|564582918|FG001|Overall Study|Adverse Event|0|||
156406894|NCT02569710|564582919|FG002|Overall Study|Adverse Event|0|||
156406895|NCT02569710|564582920|FG003|Overall Study|Adverse Event|0|||
156406896|NCT02569710|564582921|FG004|Overall Study|Adverse Event|0|||
156406897|NCT02569710|564582922|FG005|Overall Study|Adverse Event|0|||
156406898|NCT02569710|564582923|FG006|Overall Study|Adverse Event|0|||
156406899|NCT02569710|564582924|FG007|Overall Study|Adverse Event|0|||
156406900|NCT02569710|564582925|FG008|Overall Study|Adverse Event|0|||
156406901|NCT02569710|564582926|FG009|Overall Study|Adverse Event|0|||
156406902|NCT02569710|564582917|FG000|Overall Study|Lost to Follow-up|0|||
156406903|NCT02569710|564582918|FG001|Overall Study|Lost to Follow-up|0|||
156406904|NCT02569710|564582919|FG002|Overall Study|Lost to Follow-up|0|||
156406905|NCT02569710|564582920|FG003|Overall Study|Lost to Follow-up|0|||
156406906|NCT02569710|564582921|FG004|Overall Study|Lost to Follow-up|0|||
156406907|NCT02569710|564582922|FG005|Overall Study|Lost to Follow-up|0|||
156406908|NCT02569710|564582923|FG006|Overall Study|Lost to Follow-up|1|||
156406909|NCT02569710|564582924|FG007|Overall Study|Lost to Follow-up|0|||
156406910|NCT02569710|564582925|FG008|Overall Study|Lost to Follow-up|1|||
156406911|NCT02569710|564582926|FG009|Overall Study|Lost to Follow-up|0|||
156406912|NCT02569710|564582917|FG000|Overall Study|Virologic failure|0|||
156406913|NCT02569710|564582918|FG001|Overall Study|Virologic failure|0|||
156406914|NCT02569710|564582919|FG002|Overall Study|Virologic failure|0|||
156406915|NCT02569710|564582920|FG003|Overall Study|Virologic failure|0|||
156406916|NCT02569710|564582921|FG004|Overall Study|Virologic failure|1|||
156406917|NCT02569710|564582922|FG005|Overall Study|Virologic failure|0|||
156406918|NCT02569710|564582923|FG006|Overall Study|Virologic failure|1|||
156554417|NCT00756938|565119856|FG001|Optional Extension|Physician Decision|0|||
156406919|NCT02569710|564582924|FG007|Overall Study|Virologic failure|0|||
156406920|NCT02569710|564582925|FG008|Overall Study|Virologic failure|0|||
156406921|NCT02569710|564582926|FG009|Overall Study|Virologic failure|0|||
156406922|NCT02569710|564582917|FG000|Overall Study|Withdrawal by Subject|0|||
156406923|NCT02569710|564582918|FG001|Overall Study|Withdrawal by Subject|0|||
156406924|NCT02569710|564582919|FG002|Overall Study|Withdrawal by Subject|0|||
156554418|NCT00756938|565119857|FG002|Optional Extension|Physician Decision|0|||
156406925|NCT02569710|564582920|FG003|Overall Study|Withdrawal by Subject|0|||
156406926|NCT02569710|564582921|FG004|Overall Study|Withdrawal by Subject|0|||
156406927|NCT02569710|564582922|FG005|Overall Study|Withdrawal by Subject|1|||
156406928|NCT02569710|564582923|FG006|Overall Study|Withdrawal by Subject|0|||
156406929|NCT02569710|564582924|FG007|Overall Study|Withdrawal by Subject|0|||
156406930|NCT02569710|564582925|FG008|Overall Study|Withdrawal by Subject|0|||
156406931|NCT02569710|564582926|FG009|Overall Study|Withdrawal by Subject|0|||
156406932|NCT02946918|564582927|FG000|Overall Study|Patient unblinded himself|1|||
156406933|NCT02946918|564582928|FG001|Overall Study|Patient unblinded himself|0|||
156406934|NCT02946918|564582927|FG000|Overall Study|Physician Decision|0|||
156406935|NCT02946918|564582928|FG001|Overall Study|Physician Decision|2|||
156406936|NCT02946918|564582927|FG000|Overall Study|Ran out of study medication|0|||
156406937|NCT02946918|564582928|FG001|Overall Study|Ran out of study medication|1|||
156406938|NCT00069784|564582929|FG000|Overall Study|Adverse Event|105|||
156406939|NCT00069784|564582930|FG001|Overall Study|Adverse Event|0|||
156406940|NCT00069784|564582929|FG000|Overall Study|Withdrawal by Subject|1090|||
156406941|NCT00069784|564582930|FG001|Overall Study|Withdrawal by Subject|0|||
156406942|NCT00069784|564582929|FG000|Overall Study|Other|17|||
156406943|NCT00069784|564582930|FG001|Overall Study|Other|0|||
156406944|NCT02669095|564582934|FG000|Overall Study|Adverse Event|1|||
156406945|NCT02669095|564582935|FG001|Overall Study|Adverse Event|0|||
156406946|NCT02669095|564582934|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
156406947|NCT02669095|564582935|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
156406948|NCT02669095|564582934|FG000|Overall Study|Torn Lens|0|||
156406949|NCT02669095|564582935|FG001|Overall Study|Torn Lens|1|||
156406950|NCT02669095|564582934|FG000|Overall Study|Visit 5 assessments not completed|0|||
156406951|NCT02669095|564582935|FG001|Overall Study|Visit 5 assessments not completed|1|||
156406952|NCT04398537|564582936|FG000|Overall Study|Physician Decision|10|||
156406953|NCT04398537|564582937|FG001|Overall Study|Physician Decision|15|||
156406954|NCT03017235|564584630|FG000|Overall Study|Withdrawal by Subject|4|||
156406955|NCT03017235|564584631|FG001|Overall Study|Withdrawal by Subject|3|||
156554419|NCT00756938|565119858|FG003|Optional Extension|Physician Decision|3|||
156554420|NCT00756938|565119855|FG000|Optional Extension|Lost to Follow-up|0|||
156554421|NCT00756938|565119856|FG001|Optional Extension|Lost to Follow-up|0|||
156554422|NCT00756938|565119857|FG002|Optional Extension|Lost to Follow-up|0|||
156554423|NCT00756938|565119858|FG003|Optional Extension|Lost to Follow-up|1|||
156554424|NCT00756938|565119855|FG000|Optional Extension|Protocol Violation|0|||
156554425|NCT00756938|565119856|FG001|Optional Extension|Protocol Violation|0|||
156554426|NCT00756938|565119857|FG002|Optional Extension|Protocol Violation|0|||
156554427|NCT00756938|565119858|FG003|Optional Extension|Protocol Violation|1|||
156554428|NCT00756938|565119855|FG000|Optional Extension|Withdrawal by Subject|0|||
156554429|NCT00756938|565119856|FG001|Optional Extension|Withdrawal by Subject|0|||
156554430|NCT00756938|565119857|FG002|Optional Extension|Withdrawal by Subject|0|||
156554431|NCT00756938|565119858|FG003|Optional Extension|Withdrawal by Subject|10|||
156554432|NCT00756938|565119855|FG000|Optional Extension|Adverse Event|0|||
156554433|NCT00756938|565119856|FG001|Optional Extension|Adverse Event|0|||
156554434|NCT00756938|565119857|FG002|Optional Extension|Adverse Event|0|||
156554435|NCT00756938|565119858|FG003|Optional Extension|Adverse Event|1|||
156554436|NCT00094055|565119859|FG000|Overall Study|Adverse Event|11|||
156554437|NCT00094055|565119859|FG000|Overall Study|Death|4|||
156554438|NCT00094055|565119859|FG000|Overall Study|Lack of Efficacy|17|||
156554439|NCT00094055|565119859|FG000|Overall Study|Lost to Follow-up|2|||
156554440|NCT00094055|565119859|FG000|Overall Study|progressive disease|2|||
156554441|NCT00094055|565119859|FG000|Overall Study|clinical progression|1|||
156554442|NCT00094055|565119859|FG000|Overall Study|roll-over to another study|14|||
156554443|NCT00094055|565119859|FG000|Overall Study|Withdrawal by Subject|9|||
156554444|NCT00441545|565119860|FG000|First Intervention|Adverse Event|6|||
156554445|NCT00441545|565119861|FG001|First Intervention|Adverse Event|5|||
156554446|NCT00441545|565119860|FG000|First Intervention|Protocol Violation|2|||
156554447|NCT00441545|565119861|FG001|First Intervention|Protocol Violation|2|||
156554448|NCT00441545|565119860|FG000|First Intervention|Withdrawal by Subject|3|||
156554449|NCT00441545|565119861|FG001|First Intervention|Withdrawal by Subject|3|||
156554450|NCT00441545|565119860|FG000|First Intervention|Kidney transplant|1|||
156554451|NCT00441545|565119861|FG001|First Intervention|Kidney transplant|1|||
156554452|NCT00441545|565119860|FG000|First Intervention|Lack of Efficacy|2|||
156554453|NCT00441545|565119861|FG001|First Intervention|Lack of Efficacy|0|||
156554454|NCT00441545|565119860|FG000|First Intervention|Subject exceeded safety criteria|0|||
156554455|NCT00441545|565119861|FG001|First Intervention|Subject exceeded safety criteria|1|||
156554456|NCT00441545|565119860|FG000|First Intervention|Subject met an exclusionary criteria|1|||
156406956|NCT03017235|564584630|FG000|Overall Study|Lost to Follow-up|2|||
156406957|NCT03017235|564584631|FG001|Overall Study|Lost to Follow-up|7|||
156554457|NCT00441545|565119861|FG001|First Intervention|Subject met an exclusionary criteria|0|||
156554458|NCT00441545|565119860|FG000|First Intervention|Extended hospitalization|1|||
156554459|NCT00441545|565119861|FG001|First Intervention|Extended hospitalization|0|||
156554460|NCT00441545|565119860|FG000|First Intervention|Site error|1|||
156554461|NCT00441545|565119861|FG001|First Intervention|Site error|0|||
156406958|NCT03017235|564584630|FG000|Overall Study|Adverse Event|0|||
156406959|NCT03017235|564584631|FG001|Overall Study|Adverse Event|1|||
156406960|NCT03017235|564584630|FG000|Overall Study|Protocol Violation|2|||
156406961|NCT03017235|564584631|FG001|Overall Study|Protocol Violation|1|||
156554462|NCT00441545|565119860|FG000|First Intervention|Sponsor's request|1|||
156554463|NCT00441545|565119861|FG001|First Intervention|Sponsor's request|0|||
156554464|NCT00441545|565119860|FG000|Second Intervention|Adverse Event|5|||
156554465|NCT00441545|565119861|FG001|Second Intervention|Adverse Event|2|||
156554466|NCT00441545|565119860|FG000|Second Intervention|Protocol Violation|4|||
156554467|NCT00441545|565119861|FG001|Second Intervention|Protocol Violation|1|||
156554468|NCT00441545|565119860|FG000|Second Intervention|Withdrawal by Subject|1|||
156554469|NCT00441545|565119861|FG001|Second Intervention|Withdrawal by Subject|1|||
156554470|NCT00441545|565119860|FG000|Second Intervention|Kidney Transplant|1|||
156554471|NCT00441545|565119861|FG001|Second Intervention|Kidney Transplant|1|||
156554472|NCT00441545|565119860|FG000|Second Intervention|Lack of Efficacy|0|||
156554473|NCT00441545|565119861|FG001|Second Intervention|Lack of Efficacy|1|||
156554474|NCT00441545|565119860|FG000|Second Intervention|Subject exceeded safety criteria|1|||
156554475|NCT00441545|565119861|FG001|Second Intervention|Subject exceeded safety criteria|0|||
156554476|NCT00441545|565119860|FG000|Second Intervention|Subject moved|0|||
156554477|NCT00441545|565119861|FG001|Second Intervention|Subject moved|1|||
156554478|NCT00411554|565119864|FG000|Overall Study|Adverse Event|2|||
156554479|NCT00411554|565119865|FG001|Overall Study|Adverse Event|4|||
156554480|NCT00411554|565119864|FG000|Overall Study|Lack of Efficacy|2|||
156554481|NCT00411554|565119865|FG001|Overall Study|Lack of Efficacy|5|||
156554482|NCT00411554|565119864|FG000|Overall Study|Withdrawal by Subject|3|||
156554483|NCT00411554|565119865|FG001|Overall Study|Withdrawal by Subject|0|||
156554484|NCT00411554|565119864|FG000|Overall Study|Patient Moved|1|||
156554485|NCT00411554|565119865|FG001|Overall Study|Patient Moved|0|||
156554486|NCT01707693|565119870|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
156554487|NCT01707693|565119871|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
156554488|NCT01707693|565119870|FG000|Overall Study Allocation|Protocol Violation|4|||
156554489|NCT01707693|565119871|FG001|Overall Study Allocation|Protocol Violation|3|||
156554490|NCT01707693|565119870|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
156554491|NCT01707693|565119871|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
156554492|NCT01707693|565119870|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
156554493|NCT01707693|565119871|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
156554494|NCT02556255|565119873|FG000|Overall Study|Lost to Follow-up|4|||
156554495|NCT03115151|565119874|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
156554496|NCT03115151|565119875|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
156554497|NCT03115151|565119874|FG000|Overall Study|Epidural catheter removal|1|||
156554498|NCT03115151|565119875|FG001|Overall Study|Epidural catheter removal|0|||
156554499|NCT03115151|565119874|FG000|Overall Study|Withdrawal by Subject|0|||
156554500|NCT03115151|565119875|FG001|Overall Study|Withdrawal by Subject|1|||
156554501|NCT03115151|565119874|FG000|Overall Study|Intervention not received according to the protocol.|1|||
156554502|NCT03115151|565119875|FG001|Overall Study|Intervention not received according to the protocol.|1|||
156554503|NCT03115151|565119874|FG000|Overall Study|Physician Decision|1|||
156554504|NCT03115151|565119875|FG001|Overall Study|Physician Decision|0|||
156554505|NCT03115151|565119874|FG000|Overall Study|Randomization not applied|1|||
156554506|NCT03115151|565119875|FG001|Overall Study|Randomization not applied|1|||
156554507|NCT00143455|565119880|FG000|Cohort 1|Adverse Event|8|||
156554508|NCT00143455|565119881|FG001|Cohort 1|Adverse Event|4|||
156554509|NCT00143455|565119882|FG002|Cohort 1|Adverse Event|0|||
156554510|NCT00143455|565119883|FG003|Cohort 1|Adverse Event|0|||
156554511|NCT00143455|565119880|FG000|Cohort 1|Death|5|||
156554512|NCT00143455|565119881|FG001|Cohort 1|Death|2|||
156554513|NCT00143455|565119882|FG002|Cohort 1|Death|0|||
156554514|NCT00143455|565119883|FG003|Cohort 1|Death|0|||
156554515|NCT00143455|565119880|FG000|Cohort 1|Progressive Disease|0|||
156406962|NCT03017235|564584630|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
156406963|NCT03017235|564584631|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
156406964|NCT00453310|564584636|FG000|Overall Study|Progression of Disease|10|||
156406965|NCT01806740|564584637|FG000|Overall Study|Withdrawal by Subject|4|||
156406966|NCT01806740|564584637|FG000|Overall Study|Physician Decision|1|||
156406967|NCT01806740|564584637|FG000|Overall Study|Patient's refusal of treatment|1|||
156406968|NCT04666922|564584638|FG000|Overall Study|Withdrawal by Subject|1|||
156554516|NCT00143455|565119881|FG001|Cohort 1|Progressive Disease|6|||
156554517|NCT00143455|565119882|FG002|Cohort 1|Progressive Disease|0|||
156554518|NCT00143455|565119883|FG003|Cohort 1|Progressive Disease|0|||
156554519|NCT00143455|565119880|FG000|Cohort 1|Withdrawal by Subject|1|||
156554520|NCT00143455|565119881|FG001|Cohort 1|Withdrawal by Subject|4|||
156554521|NCT00143455|565119882|FG002|Cohort 1|Withdrawal by Subject|0|||
156554522|NCT00143455|565119883|FG003|Cohort 1|Withdrawal by Subject|0|||
156554523|NCT00143455|565119880|FG000|Cohort 1|Randomized But Not Treated|0|||
156554524|NCT00143455|565119881|FG001|Cohort 1|Randomized But Not Treated|1|||
156554525|NCT00143455|565119882|FG002|Cohort 1|Randomized But Not Treated|0|||
156554526|NCT00143455|565119883|FG003|Cohort 1|Randomized But Not Treated|0|||
156554527|NCT00143455|565119880|FG000|Cohort 2|Adverse Event|0|||
156554528|NCT00143455|565119881|FG001|Cohort 2|Adverse Event|0|||
156554529|NCT00143455|565119882|FG002|Cohort 2|Adverse Event|42|||
156406969|NCT04666922|564584639|FG001|Overall Study|Withdrawal by Subject|0|||
156554530|NCT00143455|565119883|FG003|Cohort 2|Adverse Event|30|||
156554531|NCT00143455|565119880|FG000|Cohort 2|No Longer Required Study Treatment|0|||
156554532|NCT00143455|565119881|FG001|Cohort 2|No Longer Required Study Treatment|0|||
156554533|NCT00143455|565119882|FG002|Cohort 2|No Longer Required Study Treatment|1|||
156554534|NCT00143455|565119883|FG003|Cohort 2|No Longer Required Study Treatment|0|||
156554535|NCT00143455|565119880|FG000|Cohort 2|Protocol Violation|0|||
156554536|NCT00143455|565119881|FG001|Cohort 2|Protocol Violation|0|||
156554537|NCT00143455|565119882|FG002|Cohort 2|Protocol Violation|1|||
156554538|NCT00143455|565119883|FG003|Cohort 2|Protocol Violation|1|||
156554539|NCT00143455|565119880|FG000|Cohort 2|Lost to Follow-up|0|||
156554540|NCT00143455|565119881|FG001|Cohort 2|Lost to Follow-up|0|||
156554541|NCT00143455|565119882|FG002|Cohort 2|Lost to Follow-up|1|||
156554542|NCT00143455|565119883|FG003|Cohort 2|Lost to Follow-up|4|||
156554543|NCT00143455|565119880|FG000|Cohort 2|Death|0|||
156554544|NCT00143455|565119881|FG001|Cohort 2|Death|0|||
156554545|NCT00143455|565119882|FG002|Cohort 2|Death|20|||
156554546|NCT00143455|565119883|FG003|Cohort 2|Death|12|||
156554547|NCT00143455|565119880|FG000|Cohort 2|Progressive Disease|0|||
156554548|NCT00143455|565119881|FG001|Cohort 2|Progressive Disease|0|||
156554549|NCT00143455|565119882|FG002|Cohort 2|Progressive Disease|20|||
156554550|NCT00143455|565119883|FG003|Cohort 2|Progressive Disease|27|||
156554551|NCT00143455|565119880|FG000|Cohort 2|Withdrawal by Subject|0|||
156554552|NCT00143455|565119881|FG001|Cohort 2|Withdrawal by Subject|0|||
156554553|NCT00143455|565119882|FG002|Cohort 2|Withdrawal by Subject|13|||
156554554|NCT00143455|565119883|FG003|Cohort 2|Withdrawal by Subject|12|||
156554555|NCT00143455|565119880|FG000|Cohort 2|Other|0|||
156554556|NCT00143455|565119881|FG001|Cohort 2|Other|0|||
156554557|NCT00143455|565119882|FG002|Cohort 2|Other|7|||
156554558|NCT00143455|565119883|FG003|Cohort 2|Other|6|||
156554559|NCT00143455|565119880|FG000|Cohort 2|Randomized But Not Treated|0|||
156554560|NCT00143455|565119881|FG001|Cohort 2|Randomized But Not Treated|0|||
156554561|NCT00143455|565119882|FG002|Cohort 2|Randomized But Not Treated|1|||
156554562|NCT00143455|565119883|FG003|Cohort 2|Randomized But Not Treated|1|||
156554563|NCT01325428|565119884|FG000|Part A|Progressive disease according to RECIST|9|||
156554564|NCT01325428|565119884|FG000|Part A|Clinical signs, symptoms of progression|2|||
156554565|NCT01325428|565119884|FG000|Part A|Other adverse event|1|||
156554566|NCT01325428|565119884|FG000|Part A|Refused continue taking trial medication|2|||
156554567|NCT01325428|565119884|FG000|Part A|Other reason not defined above|2|||
156554568|NCT01325428|565119884|FG000|Part B|Refused continue taking trial medication|2|||
156554569|NCT01325428|565119884|FG000|Part B|Other reason not defined above|1|||
156554570|NCT02682901|565119885|FG000|Overall Study|Adverse Event|10|||
156554571|NCT02682901|565119886|FG001|Overall Study|Adverse Event|3|||
156554572|NCT02682901|565119885|FG000|Overall Study|Lack of Efficacy|0|||
156554573|NCT02682901|565119886|FG001|Overall Study|Lack of Efficacy|1|||
156554574|NCT03713944|565119887|FG000|Study Treatment|Patient non-compliance|1|||
156554575|NCT03713944|565119887|FG000|Study Treatment|Alternative Cancer Therapy|3|||
156554576|NCT03713944|565119887|FG000|Study Treatment|Disease Progression|18|||
156554577|NCT03713944|565119887|FG000|Study Treatment|AE/Side Effects/Complications|2|||
156554578|NCT03713944|565119887|FG000|Study Treatment|Death|2|||
156554579|NCT03713944|565119887|FG000|Study Treatment|Withdrawal by Subject|1|||
156554580|NCT03713944|565119887|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
156554581|NCT03713944|565119887|FG000|Study Treatment|Symptomatic Deterioration|2|||
156554582|NCT03713944|565119887|FG000|Follow up|Withdrawal by Subject|2|||
156554583|NCT03713944|565119887|FG000|Follow up|Death|11|||
156554584|NCT03713944|565119887|FG000|Follow up|Study Terminated|3|||
156554585|NCT01422239|565119890|FG000|Overall Study|Lost to Follow-up|4|||
156554586|NCT01422239|565119891|FG001|Overall Study|Lost to Follow-up|3|||
156554587|NCT00720109|565119906|FG000|Induction Period|Did not meet eligibility criteria|3|||
156554588|NCT00720109|565119907|FG001|Induction Period|Did not meet eligibility criteria|0|||
156554589|NCT00720109|565119908|FG002|Induction Period|Did not meet eligibility criteria|0|||
156554590|NCT00720109|565119906|FG000|Induction Period|Bone Marrow Transplant|2|||
156554591|NCT00720109|565119907|FG001|Induction Period|Bone Marrow Transplant|0|||
156554592|NCT00720109|565119908|FG002|Induction Period|Bone Marrow Transplant|0|||
156554593|NCT00720109|565119906|FG000|Induction Period|Physician Decision|1|||
156554594|NCT00720109|565119907|FG001|Induction Period|Physician Decision|0|||
156554595|NCT00720109|565119908|FG002|Induction Period|Physician Decision|0|||
156554596|NCT00720109|565119906|FG000|Risk Stratification Period|Adverse Event|0|||
156554597|NCT00720109|565119907|FG001|Risk Stratification Period|Adverse Event|1|||
156554598|NCT00720109|565119908|FG002|Risk Stratification Period|Adverse Event|0|||
156554599|NCT00720109|565119906|FG000|Risk Stratification Period|Physician Decision|0|||
156554600|NCT00720109|565119907|FG001|Risk Stratification Period|Physician Decision|2|||
156554601|NCT00720109|565119908|FG002|Risk Stratification Period|Physician Decision|1|||
156554602|NCT00720109|565119906|FG000|Risk Stratification Period|Bone marrow transplant|0|||
156554603|NCT00720109|565119907|FG001|Risk Stratification Period|Bone marrow transplant|9|||
156554604|NCT00720109|565119908|FG002|Risk Stratification Period|Bone marrow transplant|7|||
156554605|NCT00720109|565119906|FG000|Risk Stratification Period|Disease progression or relapse|0|||
156554606|NCT00720109|565119907|FG001|Risk Stratification Period|Disease progression or relapse|2|||
156554607|NCT00720109|565119908|FG002|Risk Stratification Period|Disease progression or relapse|0|||
156554608|NCT00720109|565119906|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
156554609|NCT00720109|565119907|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
156554610|NCT00720109|565119908|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
156554611|NCT03595553|565119909|FG000|Overall Study|Withdrawal by Subject|20|||
156554612|NCT03595553|565119910|FG001|Overall Study|Withdrawal by Subject|8|||
156554613|NCT03595553|565119909|FG000|Overall Study|Physician Decision|3|||
156554614|NCT03595553|565119910|FG001|Overall Study|Physician Decision|2|||
156554615|NCT03595553|565119909|FG000|Overall Study|Adverse Event|2|||
156554616|NCT03595553|565119910|FG001|Overall Study|Adverse Event|5|||
156554617|NCT03595553|565119909|FG000|Overall Study|Death|24|||
156554618|NCT03595553|565119910|FG001|Overall Study|Death|22|||
156554619|NCT03595553|565119909|FG000|Overall Study|Lost to Follow-up|6|||
156554620|NCT03595553|565119910|FG001|Overall Study|Lost to Follow-up|7|||
156554621|NCT03595553|565119909|FG000|Overall Study|Other as indicated in CSR|3|||
156554622|NCT03595553|565119910|FG001|Overall Study|Other as indicated in CSR|3|||
156554623|NCT03595553|565119909|FG000|Overall Study|Sponsor Decision|0|||
156554624|NCT03595553|565119910|FG001|Overall Study|Sponsor Decision|1|||
156554625|NCT04899232|565119916|FG000|Screening Period|Physician Decision|1|||
156554626|NCT04899232|565119917|FG001|Screening Period|Physician Decision|0|||
156554627|NCT04899232|565119918|FG002|Screening Period|Physician Decision|0|||
156554628|NCT04899232|565119916|FG000|Screening Period|Withdrawal by Subject|1|||
156554629|NCT04899232|565119917|FG001|Screening Period|Withdrawal by Subject|0|||
156554630|NCT04899232|565119918|FG002|Screening Period|Withdrawal by Subject|0|||
156554631|NCT04899232|565119916|FG000|Screening Period|Participant discharged before receiving intervention|3|||
156554632|NCT04899232|565119917|FG001|Screening Period|Participant discharged before receiving intervention|0|||
156554633|NCT04899232|565119918|FG002|Screening Period|Participant discharged before receiving intervention|0|||
156554634|NCT00700271|565119919|FG000|Overall Study|Adverse Event|4|||
156554635|NCT00700271|565119920|FG001|Overall Study|Adverse Event|6|||
156554636|NCT00700271|565119919|FG000|Overall Study|Protocol Violation|1|||
156554637|NCT00700271|565119920|FG001|Overall Study|Protocol Violation|0|||
156554638|NCT00700271|565119919|FG000|Overall Study|Administrative Reasons|1|||
156554639|NCT00700271|565119920|FG001|Overall Study|Administrative Reasons|0|||
156554640|NCT00700271|565119919|FG000|Overall Study|Withdrawal by Subject|6|||
156554641|NCT00700271|565119920|FG001|Overall Study|Withdrawal by Subject|4|||
156554642|NCT00700271|565119919|FG000|Overall Study|Lost to Follow-up|2|||
156554643|NCT00700271|565119920|FG001|Overall Study|Lost to Follow-up|2|||
156554644|NCT02406781|565119921|FG000|Overall Study|Protocol Violation|2|||
156554645|NCT02406781|565119922|FG001|Overall Study|Protocol Violation|2|||
156554646|NCT02406781|565119923|FG002|Overall Study|Protocol Violation|2|||
156554647|NCT02406781|565119924|FG003|Overall Study|Protocol Violation|2|||
156554648|NCT02406781|565119925|FG004|Overall Study|Protocol Violation|1|||
156554649|NCT02406781|565119926|FG005|Overall Study|Protocol Violation|5|||
156554650|NCT02406781|565119927|FG006|Overall Study|Protocol Violation|3|||
156554651|NCT02634580|565122268|FG000|Double-blind Treatment Period|Subject Request|1|||
156554652|NCT02634580|565122269|FG001|Double-blind Treatment Period|Subject Request|0|||
156554653|NCT02634580|565122270|FG002|Double-blind Treatment Period|Subject Request|1|||
156554654|NCT02634580|565122271|FG003|Double-blind Treatment Period|Subject Request|1|||
156554655|NCT02634580|565122268|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
156554656|NCT02634580|565122269|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
156554657|NCT02634580|565122270|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
156554658|NCT02634580|565122271|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
156554659|NCT00424827|565122272|FG000|Overall Study|Adverse Event|1|||
156554660|NCT02397473|565122275|FG000|Treatment Phase|Adverse Event|1|||
156554661|NCT02397473|565122276|FG001|Treatment Phase|Adverse Event|2|||
156554662|NCT02397473|565122275|FG000|Treatment Phase|Lack of Efficacy|8|||
156554663|NCT02397473|565122276|FG001|Treatment Phase|Lack of Efficacy|1|||
156554664|NCT02397473|565122275|FG000|Treatment Phase|Lost to Follow-up|1|||
156554665|NCT02397473|565122276|FG001|Treatment Phase|Lost to Follow-up|0|||
156554666|NCT02397473|565122275|FG000|Treatment Phase|Withdrawal by Subject|2|||
156406970|NCT04666922|564584640|FG002|Overall Study|Withdrawal by Subject|0|||
156406971|NCT04666922|564584641|FG003|Overall Study|Withdrawal by Subject|0|||
156406972|NCT04666922|564584642|FG004|Overall Study|Withdrawal by Subject|0|||
156406973|NCT04666922|564584643|FG005|Overall Study|Withdrawal by Subject|0|||
156406974|NCT04666922|564584644|FG006|Overall Study|Withdrawal by Subject|0|||
156554667|NCT02397473|565122276|FG001|Treatment Phase|Withdrawal by Subject|1|||
156554668|NCT02397473|565122275|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
156554669|NCT02397473|565122276|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
156554670|NCT02397473|565122275|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
156554671|NCT02397473|565122276|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
156554672|NCT02397473|565122275|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
156554673|NCT02397473|565122276|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
156554674|NCT02397473|565122275|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
156554675|NCT02397473|565122276|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
156554676|NCT02397473|565122275|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
156406975|NCT01382940|564584647|FG000|Overall Study|Adverse Event|19|||
156406976|NCT01382940|564584647|FG000|Overall Study|Lost to Follow-up|4|||
156406977|NCT01382940|564584647|FG000|Overall Study|Physician Decision|7|||
156406978|NCT01382940|564584647|FG000|Overall Study|Withdrawal by Subject|23|||
156406979|NCT01382940|564584647|FG000|Overall Study|Protocol Violation|20|||
156406980|NCT00244374|564584650|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
156406981|NCT00244374|564584651|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
156406982|NCT00244374|564584652|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
156513054|NCT00833833|564970642|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
156513055|NCT00833833|564970643|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
156513056|NCT00833833|564970644|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
156513057|NCT00833833|564970645|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
156513058|NCT00833833|564970640|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
156513059|NCT00833833|564970641|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
156513060|NCT00833833|564970642|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
156513061|NCT00833833|564970643|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
156513062|NCT00833833|564970644|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
156513063|NCT00833833|564970645|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
156513064|NCT00833833|564970640|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
156513065|NCT00833833|564970641|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
156513066|NCT00833833|564970642|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
156513067|NCT00833833|564970643|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
156513068|NCT00833833|564970644|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
156513069|NCT00833833|564970645|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
156513070|NCT02040259|564970646|FG000|Overall Study|Death|280|||
156513071|NCT02040259|564970646|FG000|Overall Study|Lost to Follow-up|76|||
156513072|NCT02040259|564970646|FG000|Overall Study|Assessment not completed|3|||
156513073|NCT02040259|564970646|FG000|Overall Study|Withdrawal by Subject|4|||
156513074|NCT00316602|564970647|FG000|Overall Study|Withdrawal by Subject|3|||
156513075|NCT00316602|564970648|FG001|Overall Study|Withdrawal by Subject|2|||
156513076|NCT00316602|564970647|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
156513077|NCT00316602|564970648|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
156513078|NCT00316602|564970647|FG000|Overall Study|Adverse Event|1|||
156513079|NCT00316602|564970648|FG001|Overall Study|Adverse Event|0|||
156513080|NCT00316602|564970647|FG000|Overall Study|Other|3|||
156513081|NCT00316602|564970648|FG001|Overall Study|Other|6|||
156513082|NCT01142232|564970649|FG000|Overall Study|Adverse Event|1|||
156513083|NCT01142232|564970650|FG001|Overall Study|Adverse Event|2|||
156513084|NCT01142232|564970651|FG002|Overall Study|Adverse Event|1|||
156513085|NCT01142232|564970652|FG003|Overall Study|Adverse Event|0|||
156513086|NCT01142232|564970653|FG004|Overall Study|Adverse Event|4|||
156513087|NCT01142232|564970649|FG000|Overall Study|Death|0|||
156513088|NCT01142232|564970650|FG001|Overall Study|Death|0|||
156513089|NCT01142232|564970651|FG002|Overall Study|Death|0|||
156513090|NCT01142232|564970652|FG003|Overall Study|Death|0|||
156513091|NCT01142232|564970653|FG004|Overall Study|Death|1|||
156513092|NCT01142232|564970649|FG000|Overall Study|Disease Progression|2|||
156513093|NCT01142232|564970650|FG001|Overall Study|Disease Progression|0|||
156513094|NCT01142232|564970651|FG002|Overall Study|Disease Progression|1|||
156513095|NCT01142232|564970652|FG003|Overall Study|Disease Progression|2|||
156513096|NCT01142232|564970653|FG004|Overall Study|Disease Progression|12|||
156513097|NCT01142232|564970649|FG000|Overall Study|Withdrawal by Subject|0|||
156513098|NCT01142232|564970650|FG001|Overall Study|Withdrawal by Subject|0|||
156513099|NCT01142232|564970651|FG002|Overall Study|Withdrawal by Subject|0|||
156513100|NCT01142232|564970652|FG003|Overall Study|Withdrawal by Subject|1|||
156513101|NCT01142232|564970653|FG004|Overall Study|Withdrawal by Subject|3|||
156513102|NCT01142232|564970649|FG000|Overall Study|Physician Decision|0|||
156513103|NCT01142232|564970650|FG001|Overall Study|Physician Decision|1|||
156513104|NCT01142232|564970651|FG002|Overall Study|Physician Decision|0|||
156513105|NCT01142232|564970652|FG003|Overall Study|Physician Decision|2|||
156513106|NCT01142232|564970653|FG004|Overall Study|Physician Decision|10|||
156513107|NCT01142232|564970649|FG000|Overall Study|Alternative Therapy|0|||
156513108|NCT01142232|564970650|FG001|Overall Study|Alternative Therapy|1|||
156513109|NCT01142232|564970651|FG002|Overall Study|Alternative Therapy|1|||
156513110|NCT01142232|564970652|FG003|Overall Study|Alternative Therapy|0|||
156513111|NCT01142232|564970653|FG004|Overall Study|Alternative Therapy|1|||
156513112|NCT01142232|564970649|FG000|Overall Study|Off Trt for other complicating disease|0|||
156513113|NCT01142232|564970650|FG001|Overall Study|Off Trt for other complicating disease|0|||
156513114|NCT01142232|564970651|FG002|Overall Study|Off Trt for other complicating disease|0|||
156513115|NCT01142232|564970652|FG003|Overall Study|Off Trt for other complicating disease|0|||
156513116|NCT01142232|564970653|FG004|Overall Study|Off Trt for other complicating disease|1|||
156513117|NCT01142232|564970649|FG000|Overall Study|Noncompliance|0|||
156513118|NCT01142232|564970650|FG001|Overall Study|Noncompliance|0|||
156513119|NCT01142232|564970651|FG002|Overall Study|Noncompliance|0|||
156554677|NCT02397473|565122276|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
156554678|NCT01415752|565122279|FG000|Induction (Step 1)|Ineligible|4|||
156554679|NCT01415752|565122280|FG001|Induction (Step 1)|Ineligible|3|||
156554680|NCT01415752|565122281|FG002|Induction (Step 1)|Ineligible|4|||
156554681|NCT01415752|565122282|FG003|Induction (Step 1)|Ineligible|4|||
156554682|NCT01415752|565122279|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
156554683|NCT01415752|565122280|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
156554684|NCT01415752|565122281|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
156554685|NCT01415752|565122282|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
156554686|NCT01415752|565122279|FG000|Maintenance (Step 2)|Adverse Event|3|||
156554687|NCT01415752|565122280|FG001|Maintenance (Step 2)|Adverse Event|4|||
156554688|NCT01415752|565122281|FG002|Maintenance (Step 2)|Adverse Event|9|||
156554689|NCT01415752|565122282|FG003|Maintenance (Step 2)|Adverse Event|6|||
156554690|NCT01415752|565122279|FG000|Maintenance (Step 2)|Death|1|||
156554691|NCT01415752|565122280|FG001|Maintenance (Step 2)|Death|1|||
156554692|NCT01415752|565122281|FG002|Maintenance (Step 2)|Death|2|||
156554693|NCT01415752|565122282|FG003|Maintenance (Step 2)|Death|0|||
156554694|NCT01415752|565122279|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
156554695|NCT01415752|565122280|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
156554696|NCT01415752|565122281|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
156554697|NCT01415752|565122282|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
156554698|NCT01415752|565122279|FG000|Maintenance (Step 2)|Alternative therapy|0|||
156554699|NCT01415752|565122280|FG001|Maintenance (Step 2)|Alternative therapy|1|||
156554700|NCT01415752|565122281|FG002|Maintenance (Step 2)|Alternative therapy|0|||
156554701|NCT01415752|565122282|FG003|Maintenance (Step 2)|Alternative therapy|0|||
156554702|NCT01415752|565122279|FG000|Maintenance (Step 2)|Other reasons|3|||
156554703|NCT01415752|565122280|FG001|Maintenance (Step 2)|Other reasons|6|||
156554704|NCT01415752|565122281|FG002|Maintenance (Step 2)|Other reasons|4|||
156554705|NCT01415752|565122282|FG003|Maintenance (Step 2)|Other reasons|6|||
156554706|NCT01415752|565122279|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
156554707|NCT01415752|565122280|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
156554708|NCT01415752|565122281|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
156554709|NCT01415752|565122282|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
156554710|NCT01415752|565122279|FG000|Maintenance (Step 2)|ineligible|1|||
156554711|NCT01415752|565122280|FG001|Maintenance (Step 2)|ineligible|1|||
156554712|NCT01415752|565122281|FG002|Maintenance (Step 2)|ineligible|1|||
156554713|NCT01415752|565122282|FG003|Maintenance (Step 2)|ineligible|0|||
156554714|NCT01415752|565122279|FG000|Maintenance (Step 2)|Missing|4|||
156554715|NCT01415752|565122280|FG001|Maintenance (Step 2)|Missing|1|||
156554716|NCT01415752|565122281|FG002|Maintenance (Step 2)|Missing|4|||
156554717|NCT01415752|565122282|FG003|Maintenance (Step 2)|Missing|3|||
156554718|NCT03083886|565122283|FG000|Overall Study|Withdrawal by Subject|51|||
156554719|NCT03083886|565122284|FG001|Overall Study|Withdrawal by Subject|73|||
156554720|NCT03083886|565122285|FG002|Overall Study|Withdrawal by Subject|104|||
156554721|NCT03083886|565122283|FG000|Overall Study|Missing Baseline data|43|||
156554722|NCT03083886|565122284|FG001|Overall Study|Missing Baseline data|42|||
156554723|NCT03083886|565122285|FG002|Overall Study|Missing Baseline data|31|||
156554724|NCT03083886|565122283|FG000|Overall Study|Investigator terminated|1|||
156554725|NCT03083886|565122284|FG001|Overall Study|Investigator terminated|6|||
156554726|NCT03083886|565122285|FG002|Overall Study|Investigator terminated|3|||
156554727|NCT03286842|565122286|FG000|Overall Study|Patients rolled over to another study|80|||
156554728|NCT01391507|565122287|FG000|Overall Study|Death|0|||
156554729|NCT01391507|565122288|FG001|Overall Study|Death|0|||
156554730|NCT01391507|565122289|FG002|Overall Study|Death|0|||
156554731|NCT01391507|565122290|FG003|Overall Study|Death|1|||
156554732|NCT01391507|565122287|FG000|Overall Study|Adverse Event|1|||
156554733|NCT01391507|565122288|FG001|Overall Study|Adverse Event|1|||
156554734|NCT01391507|565122289|FG002|Overall Study|Adverse Event|2|||
156554735|NCT01391507|565122290|FG003|Overall Study|Adverse Event|2|||
156554736|NCT01391507|565122287|FG000|Overall Study|Withdrawal by Subject|1|||
156554737|NCT01391507|565122288|FG001|Overall Study|Withdrawal by Subject|2|||
156554738|NCT01391507|565122289|FG002|Overall Study|Withdrawal by Subject|1|||
156554739|NCT01391507|565122290|FG003|Overall Study|Withdrawal by Subject|1|||
156554740|NCT01391507|565122287|FG000|Overall Study|Lack of Efficacy|0|||
156554741|NCT01391507|565122288|FG001|Overall Study|Lack of Efficacy|0|||
156554742|NCT01391507|565122289|FG002|Overall Study|Lack of Efficacy|0|||
156554743|NCT01391507|565122290|FG003|Overall Study|Lack of Efficacy|1|||
156554744|NCT01391507|565122287|FG000|Overall Study|Protocol Violation|2|||
156554745|NCT01391507|565122288|FG001|Overall Study|Protocol Violation|1|||
156554746|NCT01391507|565122289|FG002|Overall Study|Protocol Violation|1|||
156554747|NCT01391507|565122290|FG003|Overall Study|Protocol Violation|2|||
156554748|NCT01453855|565122291|FG000|Overall Study|Adverse Event|3|||
156554749|NCT01453855|565122292|FG001|Overall Study|Adverse Event|4|||
156554750|NCT01453855|565122291|FG000|Overall Study|Lost to Follow-up|2|||
156554751|NCT01453855|565122292|FG001|Overall Study|Lost to Follow-up|1|||
156554752|NCT01453855|565122291|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
156554753|NCT01453855|565122292|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
156554754|NCT01453855|565122291|FG000|Overall Study|Noncompliance|1|||
156554755|NCT01453855|565122292|FG001|Overall Study|Noncompliance|0|||
156554756|NCT01453855|565122291|FG000|Overall Study|Inadequate Control of IOP|1|||
156554757|NCT01453855|565122292|FG001|Overall Study|Inadequate Control of IOP|5|||
156554758|NCT01453855|565122291|FG000|Overall Study|Other|0|||
156554759|NCT01453855|565122292|FG001|Overall Study|Other|1|||
156554760|NCT04161495|565122295|FG000|Overall Study|Withdrawal by Subject|3|||
156554761|NCT04161495|565122296|FG001|Overall Study|Withdrawal by Subject|0|||
156554762|NCT04161495|565122295|FG000|Overall Study|Protocol Violation|1|||
156554763|NCT04161495|565122296|FG001|Overall Study|Protocol Violation|0|||
156554764|NCT04161495|565122295|FG000|Overall Study|Prohibited concomitant medication|3|||
156554765|NCT04161495|565122296|FG001|Overall Study|Prohibited concomitant medication|0|||
156554766|NCT04161495|565122295|FG000|Overall Study|Adverse Event|1|||
156554767|NCT04161495|565122296|FG001|Overall Study|Adverse Event|0|||
156554768|NCT04161495|565122295|FG000|Overall Study|Other - Unspecified|1|||
156554769|NCT04161495|565122296|FG001|Overall Study|Other - Unspecified|0|||
156554770|NCT04161495|565122295|FG000|Overall Study|Death|0|||
156554771|NCT04161495|565122296|FG001|Overall Study|Death|1|||
156554772|NCT01285908|565122299|FG000|Baseline Measurement|unable to insert catheter|1|||
156554773|NCT01285908|565122300|FG001|Baseline Measurement|unable to insert catheter|0|||
156554774|NCT01285908|565122301|FG002|Baseline Measurement|unable to insert catheter|0|||
156554775|NCT01285908|565122299|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
156554776|NCT01285908|565122300|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
156554777|NCT01285908|565122301|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
156554778|NCT01285908|565122299|FG000|Baseline Measurement|unable to tolerate procedure|1|||
156554779|NCT01285908|565122300|FG001|Baseline Measurement|unable to tolerate procedure|0|||
156554780|NCT01285908|565122301|FG002|Baseline Measurement|unable to tolerate procedure|0|||
156554781|NCT01562548|565122302|FG000|Overall Study|Lost to Follow-up|0|||
156554782|NCT01562548|565122303|FG001|Overall Study|Lost to Follow-up|0|||
156554783|NCT01562548|565122304|FG002|Overall Study|Lost to Follow-up|1|||
156554784|NCT01562548|565122305|FG003|Overall Study|Lost to Follow-up|0|||
156554785|NCT00252057|565122306|FG000|Overall Study|Withdrawal by Subject|2|||
156554786|NCT00252057|565122307|FG001|Overall Study|Withdrawal by Subject|5|||
156554787|NCT00252057|565122306|FG000|Overall Study|Death|1|||
156554788|NCT00252057|565122307|FG001|Overall Study|Death|2|||
156554789|NCT00252057|565122306|FG000|Overall Study|Participant previously enrolled|0|||
156554790|NCT00252057|565122307|FG001|Overall Study|Participant previously enrolled|1|||
156554791|NCT03529773|565122308|FG000|Overall Study|Adverse Event|0|||
156554792|NCT03529773|565122309|FG001|Overall Study|Adverse Event|0|||
156554793|NCT03529773|565122310|FG002|Overall Study|Adverse Event|0|||
156554794|NCT03529773|565122311|FG003|Overall Study|Adverse Event|0|||
156554795|NCT03529773|565122312|FG004|Overall Study|Adverse Event|0|||
156554796|NCT03529773|565122313|FG005|Overall Study|Adverse Event|0|||
156554797|NCT03529773|565122314|FG006|Overall Study|Adverse Event|0|||
156554798|NCT03529773|565122315|FG007|Overall Study|Adverse Event|0|||
156554799|NCT03529773|565122316|FG008|Overall Study|Adverse Event|0|||
156554800|NCT03529773|565122317|FG009|Overall Study|Adverse Event|0|||
156554801|NCT03529773|565122318|FG010|Overall Study|Adverse Event|0|||
156554802|NCT03529773|565122319|FG011|Overall Study|Adverse Event|0|||
156406983|NCT00244374|564584653|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
156406984|NCT00244374|564584654|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
156406985|NCT00244374|564584650|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
156406986|NCT00244374|564584651|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
156406987|NCT00244374|564584652|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
156406988|NCT00244374|564584653|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
156406989|NCT00244374|564584654|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
156554803|NCT03529773|565122320|FG012|Overall Study|Adverse Event|0|||
156554804|NCT03529773|565122321|FG013|Overall Study|Adverse Event|0|||
156554805|NCT03529773|565122322|FG014|Overall Study|Adverse Event|0|||
156554806|NCT03529773|565122323|FG015|Overall Study|Adverse Event|0|||
156554807|NCT03529773|565122324|FG016|Overall Study|Adverse Event|0|||
156554808|NCT03529773|565122325|FG017|Overall Study|Adverse Event|0|||
156554809|NCT03529773|565122326|FG018|Overall Study|Adverse Event|0|||
156554810|NCT03529773|565122327|FG019|Overall Study|Adverse Event|0|||
156554811|NCT03529773|565122328|FG020|Overall Study|Adverse Event|0|||
156554812|NCT03529773|565122329|FG021|Overall Study|Adverse Event|0|||
156554813|NCT03529773|565122330|FG022|Overall Study|Adverse Event|0|||
156554814|NCT03529773|565122331|FG023|Overall Study|Adverse Event|0|||
156554815|NCT03529773|565122332|FG024|Overall Study|Adverse Event|0|||
156554816|NCT03529773|565122333|FG025|Overall Study|Adverse Event|0|||
156554817|NCT03529773|565122334|FG026|Overall Study|Adverse Event|0|||
156554818|NCT03529773|565122335|FG027|Overall Study|Adverse Event|0|||
156554819|NCT03529773|565122336|FG028|Overall Study|Adverse Event|0|||
156554820|NCT03529773|565122337|FG029|Overall Study|Adverse Event|0|||
156554821|NCT03529773|565122338|FG030|Overall Study|Adverse Event|1|||
156554822|NCT03529773|565122339|FG031|Overall Study|Adverse Event|0|||
156406990|NCT00244374|564584650|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
156406991|NCT00244374|564584651|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
156406992|NCT00244374|564584652|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
156406993|NCT00244374|564584653|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
156406994|NCT00244374|564584654|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
156406995|NCT00244374|564584650|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
156406996|NCT00244374|564584651|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
156406997|NCT00244374|564584652|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
156406998|NCT00244374|564584653|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
156406999|NCT00244374|564584654|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
156407000|NCT00244374|564584650|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
156407001|NCT00244374|564584651|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
156407002|NCT00244374|564584652|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
156407003|NCT00244374|564584653|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
156407004|NCT00244374|564584654|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
156407005|NCT00244374|564584650|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
156407006|NCT00244374|564584651|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
156407007|NCT00244374|564584652|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
156407008|NCT00244374|564584653|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
156407009|NCT00244374|564584654|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
156407010|NCT00244374|564584650|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
156407011|NCT00244374|564584651|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
156407012|NCT00244374|564584652|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
156407013|NCT00244374|564584653|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
156407014|NCT00244374|564584654|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
156407015|NCT00244374|564584650|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
156407016|NCT00244374|564584651|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
156407017|NCT00244374|564584652|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
156407018|NCT00244374|564584653|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
156407019|NCT00244374|564584654|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
156407020|NCT00244374|564584650|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
156407021|NCT00244374|564584651|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
156407022|NCT00244374|564584652|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
156407023|NCT00244374|564584653|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
156407024|NCT00244374|564584654|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
156407025|NCT02105636|564584656|FG000|Pre-Treatment|Disease Progression|1|||
156407026|NCT02105636|564584657|FG001|Pre-Treatment|Disease Progression|0|||
156407027|NCT02105636|564584656|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
156407028|NCT02105636|564584657|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
156407029|NCT02105636|564584656|FG000|Pre-Treatment|Participant withdrew consent|0|||
156407030|NCT02105636|564584657|FG001|Pre-Treatment|Participant withdrew consent|6|||
156407031|NCT02105636|564584656|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
156407032|NCT02105636|564584657|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
156407033|NCT02105636|564584656|FG000|Treatment|Study Drug Toxicity|14|||
156407034|NCT02105636|564584657|FG001|Treatment|Study Drug Toxicity|10|||
156407035|NCT02105636|564584656|FG000|Treatment|Adverse event unrelated to study drug|19|||
156407036|NCT02105636|564584657|FG001|Treatment|Adverse event unrelated to study drug|3|||
156407037|NCT02105636|564584656|FG000|Treatment|Participant request to discontinue study treatment|8|||
156407038|NCT02105636|564584657|FG001|Treatment|Participant request to discontinue study treatment|6|||
156407039|NCT02105636|564584656|FG000|Treatment|Participant withdrew consent|5|||
156407040|NCT02105636|564584657|FG001|Treatment|Participant withdrew consent|1|||
156407041|NCT02105636|564584656|FG000|Treatment|Lost to Follow-up|1|||
156407042|NCT02105636|564584657|FG001|Treatment|Lost to Follow-up|0|||
156407043|NCT02105636|564584656|FG000|Treatment|Maximum Clinical Benefit|1|||
156407044|NCT02105636|564584657|FG001|Treatment|Maximum Clinical Benefit|3|||
156407045|NCT02105636|564584656|FG000|Treatment|Poor/Non-compliance|0|||
156407046|NCT02105636|564584657|FG001|Treatment|Poor/Non-compliance|1|||
156407047|NCT02105636|564584656|FG000|Treatment|Participant no longer meets study criteria|1|||
156513120|NCT01142232|564970652|FG003|Overall Study|Noncompliance|0|||
156513121|NCT01142232|564970653|FG004|Overall Study|Noncompliance|2|||
156513122|NCT00626990|564970654|FG000|Overall Study|Lack of Efficacy|6|||
156513123|NCT00626990|564970655|FG001|Overall Study|Lack of Efficacy|7|||
156407048|NCT02105636|564584657|FG001|Treatment|Participant no longer meets study criteria|0|||
156407049|NCT02105636|564584656|FG000|Treatment|Other reasons|1|||
156407050|NCT02105636|564584657|FG001|Treatment|Other reasons|0|||
156407051|NCT02105636|564584656|FG000|Treatment|Disease Progression|185|||
156407052|NCT02105636|564584657|FG001|Treatment|Disease Progression|87|||
156407053|NCT00720902|564584658|FG000|Overall Study|Withdrawal by Subject|1|||
156407054|NCT00720902|564584659|FG001|Overall Study|Withdrawal by Subject|0|||
156407055|NCT00720902|564584658|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
156513124|NCT00626990|564970656|FG002|Overall Study|Lack of Efficacy|49|||
156513125|NCT00626990|564970657|FG003|Overall Study|Lack of Efficacy|40|||
156513126|NCT00626990|564970654|FG000|Overall Study|Adverse Event|1|||
156513127|NCT00626990|564970655|FG001|Overall Study|Adverse Event|7|||
156513128|NCT00626990|564970656|FG002|Overall Study|Adverse Event|14|||
156513129|NCT00626990|564970657|FG003|Overall Study|Adverse Event|28|||
156513130|NCT00626990|564970654|FG000|Overall Study|Death|0|||
156513131|NCT00626990|564970655|FG001|Overall Study|Death|1|||
156513132|NCT00626990|564970656|FG002|Overall Study|Death|0|||
156513133|NCT00626990|564970657|FG003|Overall Study|Death|0|||
156513134|NCT00626990|564970654|FG000|Overall Study|Withdrawal by Subject|3|||
156513135|NCT00626990|564970655|FG001|Overall Study|Withdrawal by Subject|1|||
156513136|NCT00626990|564970656|FG002|Overall Study|Withdrawal by Subject|5|||
156513137|NCT00626990|564970657|FG003|Overall Study|Withdrawal by Subject|11|||
156513138|NCT00626990|564970654|FG000|Overall Study|Protocol Violation|0|||
156513139|NCT00626990|564970655|FG001|Overall Study|Protocol Violation|1|||
156513140|NCT00626990|564970656|FG002|Overall Study|Protocol Violation|1|||
156513141|NCT00626990|564970657|FG003|Overall Study|Protocol Violation|0|||
156513142|NCT00626990|564970654|FG000|Overall Study|Various different reasons/missing|4|||
156513143|NCT00626990|564970655|FG001|Overall Study|Various different reasons/missing|8|||
156513144|NCT00626990|564970656|FG002|Overall Study|Various different reasons/missing|8|||
156513145|NCT00626990|564970657|FG003|Overall Study|Various different reasons/missing|16|||
156513146|NCT04138576|564970658|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
156513147|NCT01994837|564970659|FG000|Overall Study|Progressive disease per protocol|23|||
156513148|NCT01994837|564970659|FG000|Overall Study|Adv event related to progressive disease|3|||
156513149|NCT01994837|564970659|FG000|Overall Study|Fatal progressive disease|2|||
156513150|NCT01994837|564970659|FG000|Overall Study|Adverse event not related to progression|1|||
156513151|NCT01994837|564970659|FG000|Overall Study|Chose palliative care|1|||
156513152|NCT01994837|564970659|FG000|Overall Study|Proceeded to transplant|1|||
156513153|NCT01994837|564970659|FG000|Overall Study|Removed from study due to no response|1|||
156513154|NCT00574873|564970660|FG000|Overall Study|Withdrawal by Subject|18|||
156513155|NCT00574873|564970661|FG001|Overall Study|Withdrawal by Subject|19|||
156513156|NCT00574873|564970660|FG000|Overall Study|Investigator request|18|||
156513157|NCT00574873|564970661|FG001|Overall Study|Investigator request|8|||
156513158|NCT00574873|564970660|FG000|Overall Study|Death|15|||
156513159|NCT00574873|564970661|FG001|Overall Study|Death|14|||
156513160|NCT00574873|564970660|FG000|Overall Study|Lost to Follow-up|14|||
156513161|NCT00574873|564970661|FG001|Overall Study|Lost to Follow-up|5|||
156513162|NCT00574873|564970660|FG000|Overall Study|Other|40|||
156513163|NCT00574873|564970661|FG001|Overall Study|Other|4|||
156513164|NCT00574873|564970660|FG000|Overall Study|Discontinuation of study by sponsor|5|||
156513165|NCT00574873|564970661|FG001|Overall Study|Discontinuation of study by sponsor|199|||
156513166|NCT00574873|564970660|FG000|Overall Study|Blank, site closed per local regulations|2|||
156513167|NCT00574873|564970661|FG001|Overall Study|Blank, site closed per local regulations|2|||
156513168|NCT00574873|564970660|FG000|Overall Study|Extension Study|126|||
156513169|NCT00574873|564970661|FG001|Overall Study|Extension Study|0|||
156513170|NCT05816330|564970662|FG000|Overall Study|Withdrawal by Subject|4|||
156513171|NCT05816330|564970663|FG001|Overall Study|Withdrawal by Subject|1|||
156513172|NCT02898077|564970664|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
156513173|NCT02898077|564970665|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
156513174|NCT02898077|564970664|FG000|Overall Study|Lost to Follow-up|4|||
156513175|NCT02898077|564970665|FG001|Overall Study|Lost to Follow-up|3|||
156513176|NCT02898077|564970664|FG000|Overall Study|Physician Decision|0|||
156513177|NCT02898077|564970665|FG001|Overall Study|Physician Decision|2|||
156513178|NCT02898077|564970664|FG000|Overall Study|Sponsor Decision|32|||
156513179|NCT02898077|564970665|FG001|Overall Study|Sponsor Decision|13|||
156513180|NCT02898077|564970664|FG000|Overall Study|Withdrawal by Subject|6|||
156513181|NCT02898077|564970665|FG001|Overall Study|Withdrawal by Subject|3|||
156513182|NCT02898077|564970664|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
156513183|NCT02898077|564970665|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
156513184|NCT02898077|564970664|FG000|Overall Study|Ended extension period|3|||
156513185|NCT02898077|564970665|FG001|Overall Study|Ended extension period|0|||
156513186|NCT02040584|564970666|FG000|Overall Study|Adverse Event|13|||
156513187|NCT02040584|564970667|FG001|Overall Study|Adverse Event|6|||
156513188|NCT02040584|564970666|FG000|Overall Study|Protocol Violation|9|||
156554823|NCT03529773|565122340|FG032|Overall Study|Adverse Event|0|||
156554824|NCT03529773|565122341|FG033|Overall Study|Adverse Event|0|||
156554825|NCT03529773|565122342|FG034|Overall Study|Adverse Event|0|||
156554826|NCT03529773|565122343|FG035|Overall Study|Adverse Event|1|||
156554827|NCT03529773|565122344|FG036|Overall Study|Adverse Event|0|||
156554828|NCT03529773|565122345|FG037|Overall Study|Adverse Event|0|||
156554829|NCT03529773|565122346|FG038|Overall Study|Adverse Event|1|||
156554830|NCT03529773|565122347|FG039|Overall Study|Adverse Event|1|||
156554831|NCT03529773|565122308|FG000|Overall Study|Death|0|||
156554832|NCT03529773|565122309|FG001|Overall Study|Death|0|||
156554833|NCT03529773|565122310|FG002|Overall Study|Death|0|||
156554834|NCT03529773|565122311|FG003|Overall Study|Death|0|||
156554835|NCT03529773|565122312|FG004|Overall Study|Death|0|||
156554836|NCT03529773|565122313|FG005|Overall Study|Death|0|||
156554837|NCT03529773|565122314|FG006|Overall Study|Death|0|||
156554838|NCT03529773|565122315|FG007|Overall Study|Death|0|||
156554839|NCT03529773|565122316|FG008|Overall Study|Death|0|||
156554840|NCT03529773|565122317|FG009|Overall Study|Death|0|||
156554841|NCT03529773|565122318|FG010|Overall Study|Death|0|||
156554842|NCT03529773|565122319|FG011|Overall Study|Death|0|||
156554843|NCT03529773|565122320|FG012|Overall Study|Death|1|||
156554844|NCT03529773|565122321|FG013|Overall Study|Death|0|||
156554845|NCT03529773|565122322|FG014|Overall Study|Death|0|||
156554846|NCT03529773|565122323|FG015|Overall Study|Death|0|||
156554847|NCT03529773|565122324|FG016|Overall Study|Death|0|||
156554848|NCT03529773|565122325|FG017|Overall Study|Death|0|||
156554849|NCT03529773|565122326|FG018|Overall Study|Death|0|||
156554850|NCT03529773|565122327|FG019|Overall Study|Death|1|||
156554851|NCT03529773|565122328|FG020|Overall Study|Death|0|||
156554852|NCT03529773|565122329|FG021|Overall Study|Death|0|||
156554853|NCT03529773|565122330|FG022|Overall Study|Death|1|||
156554854|NCT03529773|565122331|FG023|Overall Study|Death|0|||
156554855|NCT03529773|565122332|FG024|Overall Study|Death|0|||
156554856|NCT03529773|565122333|FG025|Overall Study|Death|0|||
156407056|NCT00720902|564584659|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
156407057|NCT03462706|564584661|FG000|Overall Study|Polyp was pedunculated|1|||
156407058|NCT03462706|564584662|FG001|Overall Study|Polyp was pedunculated|0|||
156407059|NCT03462706|564584663|FG002|Overall Study|Polyp was pedunculated|1|||
156407060|NCT03462706|564584664|FG003|Overall Study|Polyp was pedunculated|0|||
156407061|NCT03462706|564584661|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
156407062|NCT03462706|564584662|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
156407063|NCT03462706|564584663|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
156407064|NCT03462706|564584664|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
156554857|NCT03529773|565122334|FG026|Overall Study|Death|0|||
156554858|NCT03529773|565122335|FG027|Overall Study|Death|0|||
156554859|NCT03529773|565122336|FG028|Overall Study|Death|0|||
156554860|NCT03529773|565122337|FG029|Overall Study|Death|0|||
156554861|NCT03529773|565122338|FG030|Overall Study|Death|0|||
156554862|NCT03529773|565122339|FG031|Overall Study|Death|0|||
156554863|NCT03529773|565122340|FG032|Overall Study|Death|0|||
156554864|NCT03529773|565122341|FG033|Overall Study|Death|1|||
156554865|NCT03529773|565122342|FG034|Overall Study|Death|1|||
156554866|NCT03529773|565122343|FG035|Overall Study|Death|0|||
156554867|NCT03529773|565122344|FG036|Overall Study|Death|1|||
156554868|NCT03529773|565122345|FG037|Overall Study|Death|0|||
156407065|NCT02176421|564584669|FG000|Overall Study|Lost to Follow-up|4|||
156407066|NCT02176421|564584669|FG000|Overall Study|Adverse Event|1|||
156407067|NCT02912468|564584674|FG000|Overall Study|Adverse Event|3|||
156554869|NCT03529773|565122346|FG038|Overall Study|Death|0|||
156407068|NCT02912468|564584675|FG001|Overall Study|Adverse Event|2|||
156407069|NCT02912468|564584674|FG000|Overall Study|Withdrawal by Subject|6|||
156407070|NCT02912468|564584675|FG001|Overall Study|Withdrawal by Subject|2|||
156554870|NCT03529773|565122347|FG039|Overall Study|Death|0|||
156554871|NCT03529773|565122308|FG000|Overall Study|Lost to Follow-up|0|||
156554872|NCT03529773|565122309|FG001|Overall Study|Lost to Follow-up|0|||
156554873|NCT03529773|565122310|FG002|Overall Study|Lost to Follow-up|1|||
156554874|NCT03529773|565122311|FG003|Overall Study|Lost to Follow-up|0|||
156554875|NCT03529773|565122312|FG004|Overall Study|Lost to Follow-up|1|||
156554876|NCT03529773|565122313|FG005|Overall Study|Lost to Follow-up|1|||
156554877|NCT03529773|565122314|FG006|Overall Study|Lost to Follow-up|0|||
156407071|NCT02912468|564584674|FG000|Overall Study|Randomized and not treated|0|||
156407072|NCT02912468|564584675|FG001|Overall Study|Randomized and not treated|1|||
156407073|NCT01107743|564584679|FG000|Overall Study|Protocol Violation|46|||
156407074|NCT00308737|564584680|FG000|Overall Study|Adverse Event|104|||
156407075|NCT00308737|564584681|FG001|Overall Study|Adverse Event|9|||
156554878|NCT03529773|565122315|FG007|Overall Study|Lost to Follow-up|0|||
156554879|NCT03529773|565122316|FG008|Overall Study|Lost to Follow-up|0|||
156554880|NCT03529773|565122317|FG009|Overall Study|Lost to Follow-up|0|||
156554881|NCT03529773|565122318|FG010|Overall Study|Lost to Follow-up|0|||
156554882|NCT03529773|565122319|FG011|Overall Study|Lost to Follow-up|0|||
156554883|NCT03529773|565122320|FG012|Overall Study|Lost to Follow-up|0|||
156554884|NCT03529773|565122321|FG013|Overall Study|Lost to Follow-up|1|||
156407076|NCT00308737|564584682|FG002|Overall Study|Adverse Event|0|||
156407077|NCT00308737|564584680|FG000|Overall Study|Death|4|||
156407078|NCT00308737|564584681|FG001|Overall Study|Death|3|||
156407079|NCT00308737|564584682|FG002|Overall Study|Death|0|||
156407080|NCT00308737|564584680|FG000|Overall Study|Lost to Follow-up|56|||
156407081|NCT00308737|564584681|FG001|Overall Study|Lost to Follow-up|80|||
156407082|NCT00308737|564584682|FG002|Overall Study|Lost to Follow-up|5|||
156554885|NCT03529773|565122322|FG014|Overall Study|Lost to Follow-up|4|||
156554886|NCT03529773|565122323|FG015|Overall Study|Lost to Follow-up|1|||
156554887|NCT03529773|565122324|FG016|Overall Study|Lost to Follow-up|1|||
156554888|NCT03529773|565122325|FG017|Overall Study|Lost to Follow-up|0|||
156554889|NCT03529773|565122326|FG018|Overall Study|Lost to Follow-up|1|||
156554890|NCT03529773|565122327|FG019|Overall Study|Lost to Follow-up|1|||
156554891|NCT03529773|565122328|FG020|Overall Study|Lost to Follow-up|2|||
156554892|NCT03529773|565122329|FG021|Overall Study|Lost to Follow-up|4|||
156554893|NCT03529773|565122330|FG022|Overall Study|Lost to Follow-up|3|||
156554894|NCT03529773|565122331|FG023|Overall Study|Lost to Follow-up|4|||
156554895|NCT03529773|565122332|FG024|Overall Study|Lost to Follow-up|3|||
156554896|NCT03529773|565122333|FG025|Overall Study|Lost to Follow-up|5|||
156554897|NCT03529773|565122334|FG026|Overall Study|Lost to Follow-up|5|||
156554898|NCT03529773|565122335|FG027|Overall Study|Lost to Follow-up|0|||
156554899|NCT03529773|565122336|FG028|Overall Study|Lost to Follow-up|0|||
156554900|NCT03529773|565122337|FG029|Overall Study|Lost to Follow-up|0|||
156554901|NCT03529773|565122338|FG030|Overall Study|Lost to Follow-up|1|||
156554902|NCT03529773|565122339|FG031|Overall Study|Lost to Follow-up|0|||
156554903|NCT03529773|565122340|FG032|Overall Study|Lost to Follow-up|0|||
156554904|NCT03529773|565122341|FG033|Overall Study|Lost to Follow-up|1|||
156554905|NCT03529773|565122342|FG034|Overall Study|Lost to Follow-up|1|||
156554906|NCT03529773|565122343|FG035|Overall Study|Lost to Follow-up|0|||
156554907|NCT03529773|565122344|FG036|Overall Study|Lost to Follow-up|0|||
156554908|NCT03529773|565122345|FG037|Overall Study|Lost to Follow-up|3|||
156554909|NCT03529773|565122346|FG038|Overall Study|Lost to Follow-up|1|||
156554910|NCT03529773|565122347|FG039|Overall Study|Lost to Follow-up|1|||
156554911|NCT03529773|565122308|FG000|Overall Study|No longer meets eligibility criteria|0|||
156554912|NCT03529773|565122309|FG001|Overall Study|No longer meets eligibility criteria|0|||
156554913|NCT03529773|565122310|FG002|Overall Study|No longer meets eligibility criteria|0|||
156554914|NCT03529773|565122311|FG003|Overall Study|No longer meets eligibility criteria|0|||
156554915|NCT03529773|565122312|FG004|Overall Study|No longer meets eligibility criteria|0|||
156554916|NCT03529773|565122313|FG005|Overall Study|No longer meets eligibility criteria|0|||
156554917|NCT03529773|565122314|FG006|Overall Study|No longer meets eligibility criteria|0|||
156554918|NCT03529773|565122315|FG007|Overall Study|No longer meets eligibility criteria|0|||
156554919|NCT03529773|565122316|FG008|Overall Study|No longer meets eligibility criteria|0|||
156554920|NCT03529773|565122317|FG009|Overall Study|No longer meets eligibility criteria|0|||
156554921|NCT03529773|565122318|FG010|Overall Study|No longer meets eligibility criteria|0|||
156554922|NCT03529773|565122319|FG011|Overall Study|No longer meets eligibility criteria|0|||
156554923|NCT03529773|565122320|FG012|Overall Study|No longer meets eligibility criteria|0|||
156554924|NCT03529773|565122321|FG013|Overall Study|No longer meets eligibility criteria|0|||
156554925|NCT03529773|565122322|FG014|Overall Study|No longer meets eligibility criteria|0|||
156554926|NCT03529773|565122323|FG015|Overall Study|No longer meets eligibility criteria|0|||
156554927|NCT03529773|565122324|FG016|Overall Study|No longer meets eligibility criteria|0|||
156554928|NCT03529773|565122325|FG017|Overall Study|No longer meets eligibility criteria|0|||
156554929|NCT03529773|565122326|FG018|Overall Study|No longer meets eligibility criteria|0|||
156554930|NCT03529773|565122327|FG019|Overall Study|No longer meets eligibility criteria|0|||
156407083|NCT00308737|564584680|FG000|Overall Study|Physician Decision|15|||
156407084|NCT00308737|564584681|FG001|Overall Study|Physician Decision|2|||
156407085|NCT00308737|564584682|FG002|Overall Study|Physician Decision|1|||
156407086|NCT00308737|564584680|FG000|Overall Study|Protocol Violation|34|||
156407087|NCT00308737|564584681|FG001|Overall Study|Protocol Violation|9|||
156554931|NCT03529773|565122328|FG020|Overall Study|No longer meets eligibility criteria|0|||
156554932|NCT03529773|565122329|FG021|Overall Study|No longer meets eligibility criteria|0|||
156554933|NCT03529773|565122330|FG022|Overall Study|No longer meets eligibility criteria|1|||
156554934|NCT03529773|565122331|FG023|Overall Study|No longer meets eligibility criteria|0|||
156554935|NCT03529773|565122332|FG024|Overall Study|No longer meets eligibility criteria|0|||
156554936|NCT03529773|565122333|FG025|Overall Study|No longer meets eligibility criteria|0|||
156554937|NCT03529773|565122334|FG026|Overall Study|No longer meets eligibility criteria|0|||
156554938|NCT03529773|565122335|FG027|Overall Study|No longer meets eligibility criteria|0|||
156554939|NCT03529773|565122336|FG028|Overall Study|No longer meets eligibility criteria|0|||
156554940|NCT03529773|565122337|FG029|Overall Study|No longer meets eligibility criteria|0|||
156554941|NCT03529773|565122338|FG030|Overall Study|No longer meets eligibility criteria|0|||
156554942|NCT03529773|565122339|FG031|Overall Study|No longer meets eligibility criteria|0|||
156554943|NCT03529773|565122340|FG032|Overall Study|No longer meets eligibility criteria|0|||
156407088|NCT00308737|564584682|FG002|Overall Study|Protocol Violation|5|||
156407089|NCT00308737|564584680|FG000|Overall Study|Withdrawal by Subject|218|||
156407090|NCT00308737|564584681|FG001|Overall Study|Withdrawal by Subject|166|||
156554944|NCT03529773|565122341|FG033|Overall Study|No longer meets eligibility criteria|0|||
156554945|NCT03529773|565122342|FG034|Overall Study|No longer meets eligibility criteria|0|||
156554946|NCT03529773|565122343|FG035|Overall Study|No longer meets eligibility criteria|0|||
156554947|NCT03529773|565122344|FG036|Overall Study|No longer meets eligibility criteria|0|||
156554948|NCT03529773|565122345|FG037|Overall Study|No longer meets eligibility criteria|0|||
156554949|NCT03529773|565122346|FG038|Overall Study|No longer meets eligibility criteria|1|||
156554950|NCT03529773|565122347|FG039|Overall Study|No longer meets eligibility criteria|0|||
156554951|NCT03529773|565122308|FG000|Overall Study|Other|0|||
156554952|NCT03529773|565122309|FG001|Overall Study|Other|0|||
156554953|NCT03529773|565122310|FG002|Overall Study|Other|0|||
156554954|NCT03529773|565122311|FG003|Overall Study|Other|0|||
156554955|NCT03529773|565122312|FG004|Overall Study|Other|0|||
156554956|NCT03529773|565122313|FG005|Overall Study|Other|0|||
156554957|NCT03529773|565122314|FG006|Overall Study|Other|0|||
156554958|NCT03529773|565122315|FG007|Overall Study|Other|0|||
156554959|NCT03529773|565122316|FG008|Overall Study|Other|0|||
156554960|NCT03529773|565122317|FG009|Overall Study|Other|0|||
156554961|NCT03529773|565122318|FG010|Overall Study|Other|0|||
156407091|NCT00308737|564584682|FG002|Overall Study|Withdrawal by Subject|18|||
156407092|NCT00308737|564584680|FG000|Overall Study|Various|32|||
156407093|NCT00308737|564584681|FG001|Overall Study|Various|20|||
156407094|NCT00308737|564584682|FG002|Overall Study|Various|8|||
156407095|NCT01290822|564584683|FG000|Overall Study|Withdrawal by Subject|1|||
156407096|NCT01290822|564584683|FG000|Overall Study|Physician Decision|10|||
156407097|NCT01515189|564584684|FG000|Induction|Disease Progression|109|||
156407098|NCT01515189|564584685|FG001|Induction|Disease Progression|155|||
156407099|NCT01515189|564584684|FG000|Induction|Study drug toxicity|86|||
156407100|NCT01515189|564584685|FG001|Induction|Study drug toxicity|36|||
156407101|NCT01515189|564584684|FG000|Induction|Death|24|||
156407102|NCT01515189|564584685|FG001|Induction|Death|17|||
156407103|NCT01515189|564584684|FG000|Induction|Adverse Event|14|||
156407104|NCT01515189|564584685|FG001|Induction|Adverse Event|9|||
156407105|NCT01515189|564584684|FG000|Induction|Withdrawal by Subject|3|||
156407106|NCT01515189|564584685|FG001|Induction|Withdrawal by Subject|9|||
156407107|NCT01515189|564584684|FG000|Induction|No longer meets study criteria|0|||
156407108|NCT01515189|564584685|FG001|Induction|No longer meets study criteria|2|||
156407109|NCT01515189|564584684|FG000|Induction|Lost to Follow-up|1|||
156407110|NCT01515189|564584685|FG001|Induction|Lost to Follow-up|0|||
156407111|NCT01515189|564584684|FG000|Induction|Other|0|||
156407112|NCT01515189|564584685|FG001|Induction|Other|4|||
156407113|NCT01515189|564584684|FG000|First Re-Induction Phase|Disease progression|6|||
156407114|NCT01515189|564584685|FG001|First Re-Induction Phase|Disease progression|14|||
156407115|NCT01515189|564584684|FG000|First Re-Induction Phase|Study drug toxicity|5|||
156407116|NCT01515189|564584685|FG001|First Re-Induction Phase|Study drug toxicity|0|||
156407117|NCT01515189|564584684|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
156407118|NCT01515189|564584685|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
156407119|NCT01515189|564584684|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
156407120|NCT01515189|564584685|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
156407121|NCT01515189|564584684|FG000|First Re-Induction Phase|Other|1|||
156407122|NCT01515189|564584685|FG001|First Re-Induction Phase|Other|0|||
156407123|NCT02100722|564584686|FG000|Overall Study|Withdrawal pre-procedure|4|||
156407124|NCT02100722|564584687|FG001|Overall Study|Withdrawal pre-procedure|9|||
156407125|NCT02100722|564584686|FG000|Overall Study|Withdrawal post-procedure|0|||
156407126|NCT02100722|564584687|FG001|Overall Study|Withdrawal post-procedure|3|||
156407127|NCT02100722|564584686|FG000|Overall Study|Lost to Follow-up|2|||
156407128|NCT02100722|564584687|FG001|Overall Study|Lost to Follow-up|2|||
156407129|NCT02100722|564584686|FG000|Overall Study|Continuing on study|751|||
156407130|NCT02100722|564584687|FG001|Overall Study|Continuing on study|729|||
156407131|NCT02541383|564584688|FG000|Overall Study|Death|50|||
156407132|NCT02541383|564584689|FG001|Overall Study|Death|37|||
156407133|NCT02541383|564584690|FG002|Overall Study|Death|48|||
156407134|NCT02541383|564584691|FG003|Overall Study|Death|41|||
156407135|NCT02541383|564584692|FG004|Overall Study|Death|21|||
156407136|NCT02541383|564584693|FG005|Overall Study|Death|25|||
156407137|NCT02541383|564584688|FG000|Overall Study|Lost to Follow-up|5|||
156407138|NCT02541383|564584689|FG001|Overall Study|Lost to Follow-up|3|||
156407139|NCT02541383|564584690|FG002|Overall Study|Lost to Follow-up|1|||
156407140|NCT02541383|564584691|FG003|Overall Study|Lost to Follow-up|1|||
156407141|NCT02541383|564584692|FG004|Overall Study|Lost to Follow-up|3|||
156407142|NCT02541383|564584693|FG005|Overall Study|Lost to Follow-up|0|||
156407143|NCT02541383|564584688|FG000|Overall Study|Consent withdrawn|5|||
156407144|NCT02541383|564584689|FG001|Overall Study|Consent withdrawn|6|||
156407145|NCT02541383|564584690|FG002|Overall Study|Consent withdrawn|1|||
156407146|NCT02541383|564584691|FG003|Overall Study|Consent withdrawn|1|||
156407147|NCT02541383|564584692|FG004|Overall Study|Consent withdrawn|0|||
156554962|NCT03529773|565122319|FG011|Overall Study|Other|0|||
156407148|NCT02541383|564584693|FG005|Overall Study|Consent withdrawn|0|||
156407149|NCT02541383|564584688|FG000|Overall Study|Sponsor's decision|1|||
156407150|NCT02541383|564584689|FG001|Overall Study|Sponsor's decision|1|||
156554963|NCT03529773|565122320|FG012|Overall Study|Other|1|||
156554964|NCT03529773|565122321|FG013|Overall Study|Other|0|||
156554965|NCT03529773|565122322|FG014|Overall Study|Other|2|||
156554966|NCT03529773|565122323|FG015|Overall Study|Other|0|||
156554967|NCT03529773|565122324|FG016|Overall Study|Other|0|||
156554968|NCT03529773|565122325|FG017|Overall Study|Other|3|||
156554969|NCT03529773|565122326|FG018|Overall Study|Other|0|||
156554970|NCT03529773|565122327|FG019|Overall Study|Other|0|||
156554971|NCT03529773|565122328|FG020|Overall Study|Other|1|||
156554972|NCT03529773|565122329|FG021|Overall Study|Other|0|||
156554973|NCT03529773|565122330|FG022|Overall Study|Other|1|||
156554974|NCT03529773|565122331|FG023|Overall Study|Other|0|||
156554975|NCT03529773|565122332|FG024|Overall Study|Other|3|||
156554976|NCT03529773|565122333|FG025|Overall Study|Other|2|||
156554977|NCT03529773|565122334|FG026|Overall Study|Other|2|||
156554978|NCT03529773|565122335|FG027|Overall Study|Other|0|||
156554979|NCT03529773|565122336|FG028|Overall Study|Other|0|||
156554980|NCT03529773|565122337|FG029|Overall Study|Other|0|||
156554981|NCT03529773|565122338|FG030|Overall Study|Other|0|||
156554982|NCT03529773|565122339|FG031|Overall Study|Other|0|||
156554983|NCT03529773|565122340|FG032|Overall Study|Other|0|||
156554984|NCT03529773|565122341|FG033|Overall Study|Other|0|||
156554985|NCT03529773|565122342|FG034|Overall Study|Other|1|||
156554986|NCT03529773|565122343|FG035|Overall Study|Other|1|||
156554987|NCT03529773|565122344|FG036|Overall Study|Other|0|||
156554988|NCT03529773|565122345|FG037|Overall Study|Other|0|||
156554989|NCT03529773|565122346|FG038|Overall Study|Other|0|||
156554990|NCT03529773|565122347|FG039|Overall Study|Other|0|||
156554991|NCT03529773|565122308|FG000|Overall Study|Physician Decision|0|||
156554992|NCT03529773|565122309|FG001|Overall Study|Physician Decision|0|||
156554993|NCT03529773|565122310|FG002|Overall Study|Physician Decision|0|||
156554994|NCT03529773|565122311|FG003|Overall Study|Physician Decision|0|||
156554995|NCT03529773|565122312|FG004|Overall Study|Physician Decision|0|||
156554996|NCT03529773|565122313|FG005|Overall Study|Physician Decision|0|||
156554997|NCT03529773|565122314|FG006|Overall Study|Physician Decision|0|||
156554998|NCT03529773|565122315|FG007|Overall Study|Physician Decision|0|||
156554999|NCT03529773|565122316|FG008|Overall Study|Physician Decision|0|||
156555000|NCT03529773|565122317|FG009|Overall Study|Physician Decision|0|||
156555001|NCT03529773|565122318|FG010|Overall Study|Physician Decision|0|||
156555002|NCT03529773|565122319|FG011|Overall Study|Physician Decision|0|||
156555003|NCT03529773|565122320|FG012|Overall Study|Physician Decision|0|||
156555004|NCT03529773|565122321|FG013|Overall Study|Physician Decision|0|||
156555005|NCT03529773|565122322|FG014|Overall Study|Physician Decision|0|||
156555006|NCT03529773|565122323|FG015|Overall Study|Physician Decision|0|||
156555007|NCT03529773|565122324|FG016|Overall Study|Physician Decision|0|||
156555008|NCT03529773|565122325|FG017|Overall Study|Physician Decision|0|||
156555009|NCT03529773|565122326|FG018|Overall Study|Physician Decision|0|||
156555010|NCT03529773|565122327|FG019|Overall Study|Physician Decision|1|||
156555011|NCT03529773|565122328|FG020|Overall Study|Physician Decision|1|||
156555012|NCT03529773|565122329|FG021|Overall Study|Physician Decision|0|||
156555013|NCT03529773|565122330|FG022|Overall Study|Physician Decision|0|||
156555014|NCT03529773|565122331|FG023|Overall Study|Physician Decision|0|||
156555015|NCT03529773|565122332|FG024|Overall Study|Physician Decision|0|||
156555016|NCT03529773|565122333|FG025|Overall Study|Physician Decision|0|||
156555017|NCT03529773|565122334|FG026|Overall Study|Physician Decision|0|||
156555018|NCT03529773|565122335|FG027|Overall Study|Physician Decision|0|||
156555019|NCT03529773|565122336|FG028|Overall Study|Physician Decision|0|||
156555020|NCT03529773|565122337|FG029|Overall Study|Physician Decision|0|||
156555021|NCT03529773|565122338|FG030|Overall Study|Physician Decision|0|||
156555022|NCT03529773|565122339|FG031|Overall Study|Physician Decision|0|||
156555023|NCT03529773|565122340|FG032|Overall Study|Physician Decision|0|||
156555024|NCT03529773|565122341|FG033|Overall Study|Physician Decision|0|||
156555025|NCT03529773|565122342|FG034|Overall Study|Physician Decision|0|||
156555026|NCT03529773|565122343|FG035|Overall Study|Physician Decision|0|||
156555027|NCT03529773|565122344|FG036|Overall Study|Physician Decision|0|||
156555028|NCT03529773|565122345|FG037|Overall Study|Physician Decision|0|||
156555029|NCT03529773|565122346|FG038|Overall Study|Physician Decision|0|||
156555030|NCT03529773|565122347|FG039|Overall Study|Physician Decision|0|||
156555031|NCT03529773|565122308|FG000|Overall Study|Protocol Violation|0|||
156555032|NCT03529773|565122309|FG001|Overall Study|Protocol Violation|0|||
156555033|NCT03529773|565122310|FG002|Overall Study|Protocol Violation|0|||
156555034|NCT03529773|565122311|FG003|Overall Study|Protocol Violation|0|||
156555035|NCT03529773|565122312|FG004|Overall Study|Protocol Violation|0|||
156555036|NCT03529773|565122313|FG005|Overall Study|Protocol Violation|0|||
156555037|NCT03529773|565122314|FG006|Overall Study|Protocol Violation|0|||
156555038|NCT03529773|565122315|FG007|Overall Study|Protocol Violation|0|||
156555039|NCT03529773|565122316|FG008|Overall Study|Protocol Violation|0|||
156555040|NCT03529773|565122317|FG009|Overall Study|Protocol Violation|0|||
156555041|NCT03529773|565122318|FG010|Overall Study|Protocol Violation|0|||
156555042|NCT03529773|565122319|FG011|Overall Study|Protocol Violation|0|||
156555043|NCT03529773|565122320|FG012|Overall Study|Protocol Violation|0|||
156555044|NCT03529773|565122321|FG013|Overall Study|Protocol Violation|0|||
156555045|NCT03529773|565122322|FG014|Overall Study|Protocol Violation|0|||
156555046|NCT03529773|565122323|FG015|Overall Study|Protocol Violation|0|||
156555047|NCT03529773|565122324|FG016|Overall Study|Protocol Violation|0|||
156555048|NCT03529773|565122325|FG017|Overall Study|Protocol Violation|0|||
156555049|NCT03529773|565122326|FG018|Overall Study|Protocol Violation|0|||
156555050|NCT03529773|565122327|FG019|Overall Study|Protocol Violation|0|||
156555051|NCT03529773|565122328|FG020|Overall Study|Protocol Violation|0|||
156555052|NCT03529773|565122329|FG021|Overall Study|Protocol Violation|0|||
156555053|NCT03529773|565122330|FG022|Overall Study|Protocol Violation|0|||
156555054|NCT03529773|565122331|FG023|Overall Study|Protocol Violation|0|||
156555055|NCT03529773|565122332|FG024|Overall Study|Protocol Violation|0|||
156555056|NCT03529773|565122333|FG025|Overall Study|Protocol Violation|0|||
156555057|NCT03529773|565122334|FG026|Overall Study|Protocol Violation|0|||
156555058|NCT03529773|565122335|FG027|Overall Study|Protocol Violation|0|||
156555059|NCT03529773|565122336|FG028|Overall Study|Protocol Violation|0|||
156555060|NCT03529773|565122337|FG029|Overall Study|Protocol Violation|0|||
156555061|NCT03529773|565122338|FG030|Overall Study|Protocol Violation|1|||
156555062|NCT03529773|565122339|FG031|Overall Study|Protocol Violation|0|||
156555063|NCT03529773|565122340|FG032|Overall Study|Protocol Violation|0|||
156555064|NCT03529773|565122341|FG033|Overall Study|Protocol Violation|0|||
156555065|NCT03529773|565122342|FG034|Overall Study|Protocol Violation|0|||
156555066|NCT03529773|565122343|FG035|Overall Study|Protocol Violation|0|||
156555067|NCT03529773|565122344|FG036|Overall Study|Protocol Violation|0|||
156407151|NCT02541383|564584690|FG002|Overall Study|Sponsor's decision|0|||
156407152|NCT02541383|564584691|FG003|Overall Study|Sponsor's decision|0|||
156407153|NCT02541383|564584692|FG004|Overall Study|Sponsor's decision|0|||
156407154|NCT02541383|564584693|FG005|Overall Study|Sponsor's decision|0|||
156407155|NCT05644353|564584694|FG000|Overall Study|Physician Decision|1|||
156407156|NCT05644353|564584695|FG001|Overall Study|Physician Decision|0|||
156407157|NCT05644353|564584696|FG002|Overall Study|Physician Decision|0|||
156407158|NCT05644353|564584697|FG003|Overall Study|Physician Decision|0|||
156407159|NCT05644353|564584698|FG004|Overall Study|Physician Decision|0|||
156407160|NCT05644353|564584699|FG005|Overall Study|Physician Decision|0|||
156407161|NCT05644353|564584694|FG000|Overall Study|Protocol Violation|1|||
156407162|NCT05644353|564584695|FG001|Overall Study|Protocol Violation|0|||
156407163|NCT05644353|564584696|FG002|Overall Study|Protocol Violation|0|||
156407164|NCT05644353|564584697|FG003|Overall Study|Protocol Violation|0|||
156407165|NCT05644353|564584698|FG004|Overall Study|Protocol Violation|0|||
156407166|NCT05644353|564584699|FG005|Overall Study|Protocol Violation|0|||
156407167|NCT05644353|564584694|FG000|Overall Study|Withdrawal by Subject|0|||
156407168|NCT05644353|564584695|FG001|Overall Study|Withdrawal by Subject|2|||
156555068|NCT03529773|565122345|FG037|Overall Study|Protocol Violation|0|||
156555069|NCT03529773|565122346|FG038|Overall Study|Protocol Violation|0|||
156555070|NCT03529773|565122347|FG039|Overall Study|Protocol Violation|0|||
156555071|NCT03529773|565122308|FG000|Overall Study|Withdrawal by Subject|0|||
156555072|NCT03529773|565122309|FG001|Overall Study|Withdrawal by Subject|0|||
156555073|NCT03529773|565122310|FG002|Overall Study|Withdrawal by Subject|0|||
156555074|NCT03529773|565122311|FG003|Overall Study|Withdrawal by Subject|0|||
156555075|NCT03529773|565122312|FG004|Overall Study|Withdrawal by Subject|0|||
156555076|NCT03529773|565122313|FG005|Overall Study|Withdrawal by Subject|0|||
156555077|NCT03529773|565122314|FG006|Overall Study|Withdrawal by Subject|0|||
156555078|NCT03529773|565122315|FG007|Overall Study|Withdrawal by Subject|1|||
156555079|NCT03529773|565122316|FG008|Overall Study|Withdrawal by Subject|0|||
156555080|NCT03529773|565122317|FG009|Overall Study|Withdrawal by Subject|1|||
156555081|NCT03529773|565122318|FG010|Overall Study|Withdrawal by Subject|1|||
156555082|NCT03529773|565122319|FG011|Overall Study|Withdrawal by Subject|0|||
156555083|NCT03529773|565122320|FG012|Overall Study|Withdrawal by Subject|0|||
156555084|NCT03529773|565122321|FG013|Overall Study|Withdrawal by Subject|0|||
156555085|NCT03529773|565122322|FG014|Overall Study|Withdrawal by Subject|0|||
156555086|NCT03529773|565122323|FG015|Overall Study|Withdrawal by Subject|3|||
156555087|NCT03529773|565122324|FG016|Overall Study|Withdrawal by Subject|0|||
156555088|NCT03529773|565122325|FG017|Overall Study|Withdrawal by Subject|2|||
156555089|NCT03529773|565122326|FG018|Overall Study|Withdrawal by Subject|3|||
156555090|NCT03529773|565122327|FG019|Overall Study|Withdrawal by Subject|1|||
156555091|NCT03529773|565122328|FG020|Overall Study|Withdrawal by Subject|3|||
156555092|NCT03529773|565122329|FG021|Overall Study|Withdrawal by Subject|1|||
156555093|NCT03529773|565122330|FG022|Overall Study|Withdrawal by Subject|1|||
156555094|NCT03529773|565122331|FG023|Overall Study|Withdrawal by Subject|2|||
156555095|NCT03529773|565122332|FG024|Overall Study|Withdrawal by Subject|2|||
156407169|NCT05644353|564584696|FG002|Overall Study|Withdrawal by Subject|0|||
156407170|NCT05644353|564584697|FG003|Overall Study|Withdrawal by Subject|0|||
156555096|NCT03529773|565122333|FG025|Overall Study|Withdrawal by Subject|4|||
156555097|NCT03529773|565122334|FG026|Overall Study|Withdrawal by Subject|2|||
156555098|NCT03529773|565122335|FG027|Overall Study|Withdrawal by Subject|1|||
156555099|NCT03529773|565122336|FG028|Overall Study|Withdrawal by Subject|1|||
156555100|NCT03529773|565122337|FG029|Overall Study|Withdrawal by Subject|0|||
156555101|NCT03529773|565122338|FG030|Overall Study|Withdrawal by Subject|0|||
156407171|NCT05644353|564584698|FG004|Overall Study|Withdrawal by Subject|1|||
156407172|NCT05644353|564584699|FG005|Overall Study|Withdrawal by Subject|0|||
156555102|NCT03529773|565122339|FG031|Overall Study|Withdrawal by Subject|0|||
156555103|NCT03529773|565122340|FG032|Overall Study|Withdrawal by Subject|0|||
156555104|NCT03529773|565122341|FG033|Overall Study|Withdrawal by Subject|0|||
156555105|NCT03529773|565122342|FG034|Overall Study|Withdrawal by Subject|1|||
156555106|NCT03529773|565122343|FG035|Overall Study|Withdrawal by Subject|2|||
156555107|NCT03529773|565122344|FG036|Overall Study|Withdrawal by Subject|0|||
156555108|NCT03529773|565122345|FG037|Overall Study|Withdrawal by Subject|2|||
156555109|NCT03529773|565122346|FG038|Overall Study|Withdrawal by Subject|1|||
156555110|NCT03529773|565122347|FG039|Overall Study|Withdrawal by Subject|1|||
156555111|NCT03529773|565122308|FG000|Overall Study|Screen Failure|0|||
156555112|NCT03529773|565122309|FG001|Overall Study|Screen Failure|0|||
156555113|NCT03529773|565122310|FG002|Overall Study|Screen Failure|0|||
156555114|NCT03529773|565122311|FG003|Overall Study|Screen Failure|0|||
156555115|NCT03529773|565122312|FG004|Overall Study|Screen Failure|0|||
156555116|NCT03529773|565122313|FG005|Overall Study|Screen Failure|0|||
156555117|NCT03529773|565122314|FG006|Overall Study|Screen Failure|0|||
156555118|NCT03529773|565122315|FG007|Overall Study|Screen Failure|0|||
156555119|NCT03529773|565122316|FG008|Overall Study|Screen Failure|0|||
156555120|NCT03529773|565122317|FG009|Overall Study|Screen Failure|0|||
156555121|NCT03529773|565122318|FG010|Overall Study|Screen Failure|0|||
156555122|NCT03529773|565122319|FG011|Overall Study|Screen Failure|0|||
156555123|NCT03529773|565122320|FG012|Overall Study|Screen Failure|0|||
156555124|NCT03529773|565122321|FG013|Overall Study|Screen Failure|0|||
156555125|NCT03529773|565122322|FG014|Overall Study|Screen Failure|0|||
156555126|NCT03529773|565122323|FG015|Overall Study|Screen Failure|0|||
156555127|NCT03529773|565122324|FG016|Overall Study|Screen Failure|0|||
156555128|NCT03529773|565122325|FG017|Overall Study|Screen Failure|0|||
156555129|NCT03529773|565122326|FG018|Overall Study|Screen Failure|0|||
156555130|NCT03529773|565122327|FG019|Overall Study|Screen Failure|0|||
156555131|NCT03529773|565122328|FG020|Overall Study|Screen Failure|0|||
156555132|NCT03529773|565122329|FG021|Overall Study|Screen Failure|0|||
156555133|NCT03529773|565122330|FG022|Overall Study|Screen Failure|0|||
156555134|NCT03529773|565122331|FG023|Overall Study|Screen Failure|0|||
156555135|NCT03529773|565122332|FG024|Overall Study|Screen Failure|0|||
156555136|NCT03529773|565122333|FG025|Overall Study|Screen Failure|0|||
156555137|NCT03529773|565122334|FG026|Overall Study|Screen Failure|0|||
156555138|NCT03529773|565122335|FG027|Overall Study|Screen Failure|0|||
156555139|NCT03529773|565122336|FG028|Overall Study|Screen Failure|0|||
156555140|NCT03529773|565122337|FG029|Overall Study|Screen Failure|0|||
156555141|NCT03529773|565122338|FG030|Overall Study|Screen Failure|0|||
156555142|NCT03529773|565122339|FG031|Overall Study|Screen Failure|0|||
156555143|NCT03529773|565122340|FG032|Overall Study|Screen Failure|0|||
156555144|NCT03529773|565122341|FG033|Overall Study|Screen Failure|0|||
156555145|NCT03529773|565122342|FG034|Overall Study|Screen Failure|0|||
156555146|NCT03529773|565122343|FG035|Overall Study|Screen Failure|0|||
156555147|NCT03529773|565122344|FG036|Overall Study|Screen Failure|1|||
156555148|NCT03529773|565122345|FG037|Overall Study|Screen Failure|1|||
156555149|NCT03529773|565122346|FG038|Overall Study|Screen Failure|0|||
156555150|NCT03529773|565122347|FG039|Overall Study|Screen Failure|1|||
156555151|NCT03529773|565122308|FG000|Overall Study|Randomized but not vaccinated|0|||
156555152|NCT03529773|565122309|FG001|Overall Study|Randomized but not vaccinated|0|||
156555153|NCT03529773|565122310|FG002|Overall Study|Randomized but not vaccinated|0|||
156555154|NCT03529773|565122311|FG003|Overall Study|Randomized but not vaccinated|0|||
156555155|NCT03529773|565122312|FG004|Overall Study|Randomized but not vaccinated|0|||
156555156|NCT03529773|565122313|FG005|Overall Study|Randomized but not vaccinated|0|||
156555157|NCT03529773|565122314|FG006|Overall Study|Randomized but not vaccinated|0|||
156555158|NCT03529773|565122315|FG007|Overall Study|Randomized but not vaccinated|0|||
156407173|NCT05644353|564584694|FG000|Overall Study|Lost to Follow-up|0|||
156407174|NCT05644353|564584695|FG001|Overall Study|Lost to Follow-up|0|||
156407175|NCT05644353|564584696|FG002|Overall Study|Lost to Follow-up|1|||
156407176|NCT05644353|564584697|FG003|Overall Study|Lost to Follow-up|0|||
156407177|NCT05644353|564584698|FG004|Overall Study|Lost to Follow-up|0|||
156555159|NCT03529773|565122316|FG008|Overall Study|Randomized but not vaccinated|0|||
156555160|NCT03529773|565122317|FG009|Overall Study|Randomized but not vaccinated|0|||
156555161|NCT03529773|565122318|FG010|Overall Study|Randomized but not vaccinated|0|||
156555162|NCT03529773|565122319|FG011|Overall Study|Randomized but not vaccinated|0|||
156555163|NCT03529773|565122320|FG012|Overall Study|Randomized but not vaccinated|0|||
156555164|NCT03529773|565122321|FG013|Overall Study|Randomized but not vaccinated|0|||
156555165|NCT03529773|565122322|FG014|Overall Study|Randomized but not vaccinated|0|||
156407178|NCT05644353|564584699|FG005|Overall Study|Lost to Follow-up|0|||
156555166|NCT03529773|565122323|FG015|Overall Study|Randomized but not vaccinated|0|||
156555167|NCT03529773|565122324|FG016|Overall Study|Randomized but not vaccinated|0|||
156555168|NCT03529773|565122325|FG017|Overall Study|Randomized but not vaccinated|1|||
156555169|NCT03529773|565122326|FG018|Overall Study|Randomized but not vaccinated|0|||
156555170|NCT03529773|565122327|FG019|Overall Study|Randomized but not vaccinated|0|||
156555171|NCT03529773|565122328|FG020|Overall Study|Randomized but not vaccinated|0|||
156555172|NCT03529773|565122329|FG021|Overall Study|Randomized but not vaccinated|0|||
156555173|NCT03529773|565122330|FG022|Overall Study|Randomized but not vaccinated|0|||
156555174|NCT03529773|565122331|FG023|Overall Study|Randomized but not vaccinated|0|||
156555175|NCT03529773|565122332|FG024|Overall Study|Randomized but not vaccinated|0|||
156555176|NCT03529773|565122333|FG025|Overall Study|Randomized but not vaccinated|0|||
156555177|NCT03529773|565122334|FG026|Overall Study|Randomized but not vaccinated|0|||
156555178|NCT03529773|565122335|FG027|Overall Study|Randomized but not vaccinated|1|||
156555179|NCT03529773|565122336|FG028|Overall Study|Randomized but not vaccinated|0|||
156555180|NCT03529773|565122337|FG029|Overall Study|Randomized but not vaccinated|0|||
156555181|NCT03529773|565122338|FG030|Overall Study|Randomized but not vaccinated|0|||
156555182|NCT03529773|565122339|FG031|Overall Study|Randomized but not vaccinated|0|||
156555183|NCT03529773|565122340|FG032|Overall Study|Randomized but not vaccinated|0|||
156555184|NCT03529773|565122341|FG033|Overall Study|Randomized but not vaccinated|0|||
156555185|NCT03529773|565122342|FG034|Overall Study|Randomized but not vaccinated|0|||
156555186|NCT03529773|565122343|FG035|Overall Study|Randomized but not vaccinated|0|||
156555187|NCT03529773|565122344|FG036|Overall Study|Randomized but not vaccinated|0|||
156555188|NCT03529773|565122345|FG037|Overall Study|Randomized but not vaccinated|0|||
156555189|NCT03529773|565122346|FG038|Overall Study|Randomized but not vaccinated|0|||
156555190|NCT03529773|565122347|FG039|Overall Study|Randomized but not vaccinated|0|||
156555191|NCT01496066|565122349|FG000|Overall Study|Lost to Follow-up|8|||
156555192|NCT01496066|565122350|FG001|Overall Study|Lost to Follow-up|5|||
156555193|NCT01496066|565122349|FG000|Overall Study|Explant|3|||
156555194|NCT01496066|565122350|FG001|Overall Study|Explant|0|||
156555195|NCT01496066|565122349|FG000|Overall Study|Death|1|||
156555196|NCT01496066|565122350|FG001|Overall Study|Death|4|||
156555197|NCT01340209|565122351|FG000|Overall Study|Adverse Event|1|||
156555198|NCT01340209|565122352|FG001|Overall Study|Adverse Event|1|||
156555199|NCT01340209|565122353|FG002|Overall Study|Adverse Event|2|||
156555200|NCT01340209|565122351|FG000|Overall Study|Protocol Violation|1|||
156555201|NCT01340209|565122352|FG001|Overall Study|Protocol Violation|2|||
156555202|NCT01340209|565122353|FG002|Overall Study|Protocol Violation|1|||
156555203|NCT01340209|565122351|FG000|Overall Study|Withdrawal by Subject|0|||
156555204|NCT01340209|565122352|FG001|Overall Study|Withdrawal by Subject|0|||
156555205|NCT01340209|565122353|FG002|Overall Study|Withdrawal by Subject|1|||
156555206|NCT01340209|565122351|FG000|Overall Study|Other reason not defined above|3|||
156555207|NCT01340209|565122352|FG001|Overall Study|Other reason not defined above|5|||
156555208|NCT01340209|565122353|FG002|Overall Study|Other reason not defined above|4|||
156555209|NCT00253630|565122354|FG000|Overall Study|ineligible|2|||
156555210|NCT00209339|565122355|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
156555211|NCT00209339|565122355|FG000|At 12 Months Follow-up|Death|1|||
156555212|NCT00209339|565122355|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
156555213|NCT00209339|565122355|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
156555214|NCT00209339|565122355|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
156555215|NCT00209339|565122355|FG000|At 24 Months Follow-up|Death|1|||
156555216|NCT00209339|565122355|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
156555217|NCT00209339|565122355|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
156555218|NCT00209339|565122355|FG000|At 4 Years Follow-up|Death|1|||
156555219|NCT00209339|565122355|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
156555220|NCT00209339|565122355|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
156555221|NCT00209339|565122355|FG000|At 5 Years Follow-up|Death|1|||
156555222|NCT00429858|565122356|FG000|Overall Study|Withdrawal by Subject|1|||
156555223|NCT00429858|565122356|FG000|Overall Study|Study Termination|1|||
156555224|NCT01587079|565122357|FG000|Overall Study|Protocol-specified criteria|9|||
156555225|NCT01587079|565122357|FG000|Overall Study|Protocol Violation|5|||
156555226|NCT01587079|565122357|FG000|Overall Study|Lost to Follow-up|2|||
156555227|NCT01587079|565122357|FG000|Overall Study|Physician Decision|2|||
156407179|NCT04986982|564584700|FG000|Overall Study|Withdrawal by Subject|3|||
156407180|NCT04986982|564584701|FG001|Overall Study|Withdrawal by Subject|1|||
156555228|NCT01587079|565122357|FG000|Overall Study|Withdrawal by Subject|7|||
156555229|NCT01587079|565122357|FG000|Overall Study|Adverse Event|14|||
156555230|NCT01239160|565122358|FG000|Overall Study|Lost to Follow-up|3|||
156555231|NCT01239160|565122359|FG001|Overall Study|Lost to Follow-up|5|||
156555232|NCT01239160|565122360|FG002|Overall Study|Lost to Follow-up|0|||
156555233|NCT01239160|565122358|FG000|Overall Study|Withdrawal by Subject|17|||
156555234|NCT01239160|565122359|FG001|Overall Study|Withdrawal by Subject|6|||
156555235|NCT01239160|565122360|FG002|Overall Study|Withdrawal by Subject|2|||
156555236|NCT01239160|565122358|FG000|Overall Study|Physician Decision|5|||
156555237|NCT01239160|565122359|FG001|Overall Study|Physician Decision|7|||
156555238|NCT01239160|565122360|FG002|Overall Study|Physician Decision|2|||
156555239|NCT01239160|565122358|FG000|Overall Study|Early Termination Due to Study Closure|0|||
156555240|NCT01239160|565122359|FG001|Overall Study|Early Termination Due to Study Closure|1|||
156555241|NCT01239160|565122360|FG002|Overall Study|Early Termination Due to Study Closure|6|||
156555242|NCT01764633|565122361|FG000|Overall Study|Withdrawal by Subject|105|||
156555243|NCT01764633|565122362|FG001|Overall Study|Withdrawal by Subject|88|||
156555244|NCT01764633|565122361|FG000|Overall Study|Lost to Follow-up|13|||
156407181|NCT04986982|564584700|FG000|Overall Study|Lack of Efficacy|0|||
156555245|NCT01764633|565122362|FG001|Overall Study|Lost to Follow-up|5|||
156555246|NCT04781816|565122368|FG000|Overall Study|Adverse Event|0|||
156555247|NCT04781816|565122369|FG001|Overall Study|Adverse Event|1|||
156555248|NCT04781816|565122368|FG000|Overall Study|Withdrawal by Subject|1|||
156555249|NCT04781816|565122369|FG001|Overall Study|Withdrawal by Subject|1|||
156555250|NCT04781816|565122368|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
156555251|NCT04781816|565122369|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
156555252|NCT02062658|565122370|FG000|Overall Study|Withdrawal by Subject|1|||
156555253|NCT02062658|565122370|FG000|Overall Study|Lack of Efficacy|1|||
156555254|NCT00643994|565122371|FG000|Overall Study|Death|24|||
156555255|NCT00643994|565122371|FG000|Overall Study|Lost to Follow-up|72|||
156555256|NCT04016311|565122382|FG000|Overall Study|Withdrawal by Subject|1|||
156555257|NCT04016311|565122383|FG001|Overall Study|Withdrawal by Subject|0|||
156555258|NCT04029519|565122384|FG000|Overall Study|Protocol Violation|1|||
156555259|NCT04029519|565122384|FG000|Overall Study|Withdrawal by Subject|3|||
156555260|NCT04029519|565122384|FG000|Overall Study|Lost to Follow-up|1|||
156555261|NCT02347176|565122391|FG000|Overall Study|Lost to Follow-up|2|||
156555262|NCT02347176|565122392|FG001|Overall Study|Lost to Follow-up|3|||
156555263|NCT02347176|565122393|FG002|Overall Study|Lost to Follow-up|1|||
156555264|NCT02347176|565122394|FG003|Overall Study|Lost to Follow-up|1|||
156555265|NCT02347176|565122391|FG000|Overall Study|Withdrawal by Subject|9|||
156555266|NCT02347176|565122392|FG001|Overall Study|Withdrawal by Subject|5|||
156555267|NCT02347176|565122393|FG002|Overall Study|Withdrawal by Subject|5|||
156555268|NCT02347176|565122394|FG003|Overall Study|Withdrawal by Subject|3|||
156555269|NCT02347176|565122391|FG000|Overall Study|Other|1|||
156555270|NCT02347176|565122392|FG001|Overall Study|Other|2|||
156555271|NCT02347176|565122393|FG002|Overall Study|Other|2|||
156555272|NCT02347176|565122394|FG003|Overall Study|Other|0|||
156555273|NCT01081795|565122395|FG000|Overall Study|Adverse Event|18|||
156555274|NCT01081795|565122396|FG001|Overall Study|Adverse Event|23|||
156555275|NCT01081795|565122397|FG002|Overall Study|Adverse Event|6|||
156555276|NCT01081795|565122395|FG000|Overall Study|Lack of Efficacy|7|||
156555277|NCT01081795|565122396|FG001|Overall Study|Lack of Efficacy|5|||
156555278|NCT01081795|565122397|FG002|Overall Study|Lack of Efficacy|19|||
156555279|NCT01081795|565122395|FG000|Overall Study|Subject's schedule|1|||
156555280|NCT01081795|565122396|FG001|Overall Study|Subject's schedule|1|||
156555281|NCT01081795|565122397|FG002|Overall Study|Subject's schedule|2|||
156555282|NCT01081795|565122395|FG000|Overall Study|Revocation of informed consent|2|||
156555283|NCT01081795|565122396|FG001|Overall Study|Revocation of informed consent|0|||
156555284|NCT01081795|565122397|FG002|Overall Study|Revocation of informed consent|0|||
156555285|NCT01081795|565122395|FG000|Overall Study|Ineligible for participation|1|||
156555286|NCT01081795|565122396|FG001|Overall Study|Ineligible for participation|0|||
156555287|NCT01081795|565122397|FG002|Overall Study|Ineligible for participation|0|||
156555288|NCT01081795|565122395|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
156555289|NCT01081795|565122396|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
156555290|NCT01081795|565122397|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
156555291|NCT01081795|565122395|FG000|Overall Study|Using drug with restricted days of use|2|||
156555292|NCT01081795|565122396|FG001|Overall Study|Using drug with restricted days of use|3|||
156555293|NCT01081795|565122397|FG002|Overall Study|Using drug with restricted days of use|2|||
156555294|NCT01081795|565122395|FG000|Overall Study|Other|1|||
156555295|NCT01081795|565122396|FG001|Overall Study|Other|2|||
156555296|NCT01081795|565122397|FG002|Overall Study|Other|0|||
156555297|NCT02462473|565122398|FG000|Overall Study|Death|1|||
156555298|NCT02462473|565122398|FG000|Overall Study|Other|3|||
156555299|NCT01536860|565122399|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
156555300|NCT01536860|565122400|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
156555301|NCT01536860|565122401|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
156555302|NCT01164722|565122402|FG000|Overall Study|Adverse Event|0|||
156555303|NCT01164722|565122403|FG001|Overall Study|Adverse Event|1|||
156555304|NCT01164722|565122402|FG000|Overall Study|Withdrawal by Subject|3|||
156555305|NCT01164722|565122403|FG001|Overall Study|Withdrawal by Subject|4|||
156555306|NCT01164722|565122402|FG000|Overall Study|Lost to Follow-up|3|||
156555307|NCT01164722|565122403|FG001|Overall Study|Lost to Follow-up|6|||
156555308|NCT01164722|565122402|FG000|Overall Study|met protocol criteria for non-treatment|11|||
156555309|NCT01164722|565122403|FG001|Overall Study|met protocol criteria for non-treatment|1|||
156555310|NCT01164722|565122402|FG000|Overall Study|enrolled on other study, concomitant med|1|||
156555311|NCT01164722|565122403|FG001|Overall Study|enrolled on other study, concomitant med|3|||
156407182|NCT04986982|564584701|FG001|Overall Study|Lack of Efficacy|2|||
156555312|NCT03889639|565122405|FG000|Overall Study|Withdrawal by Subject|0|||
156555313|NCT03889639|565122406|FG001|Overall Study|Withdrawal by Subject|0|||
156555314|NCT03889639|565122407|FG002|Overall Study|Withdrawal by Subject|0|||
156555315|NCT03889639|565122408|FG003|Overall Study|Withdrawal by Subject|0|||
156407183|NCT04986982|564584700|FG000|Overall Study|Ineligibility|3|||
156555316|NCT03889639|565122409|FG004|Overall Study|Withdrawal by Subject|0|||
156555317|NCT03889639|565122410|FG005|Overall Study|Withdrawal by Subject|0|||
156555318|NCT03889639|565122411|FG006|Overall Study|Withdrawal by Subject|0|||
156555319|NCT03889639|565122412|FG007|Overall Study|Withdrawal by Subject|1|||
156555320|NCT01703858|565122413|FG000|Overall Study|Withdrawal by Subject|0|||
156555321|NCT01703858|565122414|FG001|Overall Study|Withdrawal by Subject|1|||
156555322|NCT01703858|565122415|FG002|Overall Study|Withdrawal by Subject|0|||
156555323|NCT00993031|565122416|FG000|Overall Study|Death|0|||
156555324|NCT00993031|565122417|FG001|Overall Study|Death|1|||
156555325|NCT00993031|565122416|FG000|Overall Study|Physician Decision|0|||
156555326|NCT00993031|565122417|FG001|Overall Study|Physician Decision|2|||
156555327|NCT00993031|565122416|FG000|Overall Study|Withdrawal by Subject|3|||
156555328|NCT00993031|565122417|FG001|Overall Study|Withdrawal by Subject|3|||
156555329|NCT00993031|565122416|FG000|Overall Study|Lost to Follow-up|19|||
156555330|NCT00993031|565122417|FG001|Overall Study|Lost to Follow-up|13|||
156555331|NCT01834729|565122420|FG000|Overall Study|Did not return bowel diaries|0|||
156555332|NCT01834729|565122421|FG001|Overall Study|Did not return bowel diaries|0|||
156555333|NCT01834729|565122422|FG002|Overall Study|Did not return bowel diaries|3|||
156555334|NCT01834729|565122423|FG003|Overall Study|Did not return bowel diaries|0|||
156555335|NCT01834729|565122420|FG000|Overall Study|Withdrawal by Subject|1|||
156555336|NCT01834729|565122421|FG001|Overall Study|Withdrawal by Subject|1|||
156555337|NCT01834729|565122422|FG002|Overall Study|Withdrawal by Subject|0|||
156555338|NCT01834729|565122423|FG003|Overall Study|Withdrawal by Subject|0|||
156555339|NCT01834729|565122420|FG000|Overall Study|Adverse Event|0|||
156555340|NCT01834729|565122421|FG001|Overall Study|Adverse Event|0|||
156555341|NCT01834729|565122422|FG002|Overall Study|Adverse Event|0|||
156555342|NCT01834729|565122423|FG003|Overall Study|Adverse Event|2|||
156555343|NCT01543087|565122424|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
156555344|NCT01543087|565122425|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
156555345|NCT01543087|565122426|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
156555346|NCT01543087|565122427|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
156555347|NCT01543087|565122428|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
156555348|NCT01543087|565122429|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
156555349|NCT01543087|565122424|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
156555350|NCT01543087|565122425|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
156555351|NCT01543087|565122426|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
156555352|NCT01543087|565122427|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
156555353|NCT01543087|565122428|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
156555354|NCT01543087|565122429|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
156555355|NCT01543087|565122424|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
156555356|NCT01543087|565122425|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
156555357|NCT01543087|565122426|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
156555358|NCT01543087|565122427|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
156555359|NCT01543087|565122428|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
156555360|NCT01543087|565122429|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
156555361|NCT01543087|565122424|FG000|Stage 1 (48 Months)|Other than specified|5|||
156555362|NCT01543087|565122425|FG001|Stage 1 (48 Months)|Other than specified|0|||
156555363|NCT01543087|565122426|FG002|Stage 1 (48 Months)|Other than specified|9|||
156555364|NCT01543087|565122427|FG003|Stage 1 (48 Months)|Other than specified|0|||
156555365|NCT01543087|565122428|FG004|Stage 1 (48 Months)|Other than specified|0|||
156555366|NCT01543087|565122429|FG005|Stage 1 (48 Months)|Other than specified|0|||
156555367|NCT01543087|565122424|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
156555368|NCT01543087|565122425|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
156555369|NCT01543087|565122426|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
156555370|NCT01543087|565122427|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
156555371|NCT01543087|565122428|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
156555372|NCT01543087|565122429|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
156555373|NCT01543087|565122424|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
156555374|NCT01543087|565122425|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
156555375|NCT01543087|565122426|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
156555376|NCT01543087|565122427|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
156555377|NCT01543087|565122428|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
156555378|NCT01543087|565122429|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
156555379|NCT01543087|565122424|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
156555380|NCT01543087|565122425|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
156555381|NCT01543087|565122426|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
156555382|NCT01543087|565122427|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
156555383|NCT01543087|565122428|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
156555384|NCT01543087|565122429|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
156555385|NCT03403192|565122430|FG000|Overall Study|Lost to Follow-up|1|||
156555386|NCT03403192|565122431|FG001|Overall Study|Lost to Follow-up|2|||
156555387|NCT03403192|565122432|FG002|Overall Study|Lost to Follow-up|0|||
156555388|NCT03403192|565122433|FG003|Overall Study|Lost to Follow-up|0|||
156555389|NCT03403192|565122430|FG000|Overall Study|Unable to respond|0|||
156555390|NCT03403192|565122431|FG001|Overall Study|Unable to respond|1|||
156555391|NCT03403192|565122432|FG002|Overall Study|Unable to respond|0|||
156555392|NCT03403192|565122433|FG003|Overall Study|Unable to respond|0|||
156555393|NCT03403192|565122430|FG000|Overall Study|Incomplete|3|||
156555394|NCT03403192|565122431|FG001|Overall Study|Incomplete|1|||
156555395|NCT03403192|565122432|FG002|Overall Study|Incomplete|3|||
156555396|NCT03403192|565122433|FG003|Overall Study|Incomplete|6|||
156555397|NCT04673786|565122437|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
156555398|NCT04673786|565122438|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
156555399|NCT04673786|565122439|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
156555400|NCT04673786|565122437|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
156555401|NCT04673786|565122438|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
156555402|NCT04673786|565122439|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
156555403|NCT04673786|565122437|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
156555404|NCT04673786|565122438|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
156555405|NCT04673786|565122439|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
156555406|NCT04673786|565122437|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
156555407|NCT04673786|565122438|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
156555408|NCT04673786|565122439|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
156555409|NCT04673786|565122437|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
156555410|NCT04673786|565122438|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
156555411|NCT04673786|565122439|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
156555412|NCT04673786|565122437|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
156555413|NCT04673786|565122438|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
156555414|NCT04673786|565122439|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
156555415|NCT01298492|565122440|FG000|Overall Study|Death|2|||
156555416|NCT01298492|565122440|FG000|Overall Study|Insufficient Clinical Response|22|||
156555417|NCT01298492|565122440|FG000|Overall Study|Lost to Follow-up|12|||
156555418|NCT01298492|565122440|FG000|Overall Study|Withdrawal by Subject|47|||
156555419|NCT01298492|565122440|FG000|Overall Study|Other (Unspecified)|7|||
156555420|NCT01298492|565122440|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
156555421|NCT01298492|565122440|FG000|Overall Study|Protocol Violation|2|||
156555422|NCT01298492|565122440|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
156555423|NCT01298492|565122440|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
156555424|NCT02902120|565122442|FG000|Overall Study|Lack of Efficacy|1|||
156555425|NCT03298022|565122443|FG000|Overall Study|Lack of Efficacy|4|||
156555426|NCT03298022|565122443|FG000|Overall Study|Withdrawal by Subject|7|||
156555427|NCT03298022|565122443|FG000|Overall Study|Adverse Event|1|||
156555428|NCT03298022|565122443|FG000|Overall Study|disease relapse|1|||
156555429|NCT03694925|565122444|FG000|Overall Study|Inadequate laboratory testing|0|||
156555430|NCT03694925|565122445|FG001|Overall Study|Inadequate laboratory testing|3|||
156555431|NCT03694925|565122446|FG002|Overall Study|Inadequate laboratory testing|0|||
156555432|NCT03467958|565122447|FG000|Overall Study|Adverse Event|20|||
156555433|NCT03467958|565122448|FG001|Overall Study|Adverse Event|32|||
156555434|NCT03467958|565122449|FG002|Overall Study|Adverse Event|5|||
156555435|NCT03467958|565122450|FG003|Overall Study|Adverse Event|3|||
156555436|NCT03467958|565122451|FG004|Overall Study|Adverse Event|3|||
156555437|NCT03467958|565122452|FG005|Overall Study|Adverse Event|3|||
156555438|NCT03467958|565122453|FG006|Overall Study|Adverse Event|6|||
156555439|NCT03467958|565122454|FG007|Overall Study|Adverse Event|5|||
156555440|NCT03467958|565122455|FG008|Overall Study|Adverse Event|0|||
156555441|NCT03467958|565122447|FG000|Overall Study|Lack of Efficacy|59|||
156555442|NCT03467958|565122448|FG001|Overall Study|Lack of Efficacy|120|||
156555443|NCT03467958|565122449|FG002|Overall Study|Lack of Efficacy|6|||
156555444|NCT03467958|565122450|FG003|Overall Study|Lack of Efficacy|9|||
156555445|NCT03467958|565122451|FG004|Overall Study|Lack of Efficacy|8|||
156555446|NCT03467958|565122452|FG005|Overall Study|Lack of Efficacy|9|||
156555447|NCT03467958|565122453|FG006|Overall Study|Lack of Efficacy|11|||
156555448|NCT03467958|565122454|FG007|Overall Study|Lack of Efficacy|9|||
156555449|NCT03467958|565122455|FG008|Overall Study|Lack of Efficacy|3|||
156555450|NCT03467958|565122447|FG000|Overall Study|Lost to Follow-up|1|||
156555451|NCT03467958|565122448|FG001|Overall Study|Lost to Follow-up|2|||
156555452|NCT03467958|565122449|FG002|Overall Study|Lost to Follow-up|1|||
156555453|NCT03467958|565122450|FG003|Overall Study|Lost to Follow-up|0|||
156555454|NCT03467958|565122451|FG004|Overall Study|Lost to Follow-up|4|||
156407184|NCT04986982|564584701|FG001|Overall Study|Ineligibility|0|||
156407185|NCT04986982|564584700|FG000|Overall Study|Adverse Event|4|||
156407186|NCT04986982|564584701|FG001|Overall Study|Adverse Event|4|||
156555455|NCT03467958|565122452|FG005|Overall Study|Lost to Follow-up|0|||
156407187|NCT04986982|564584700|FG000|Overall Study|Lost to Follow-up|0|||
156555456|NCT03467958|565122453|FG006|Overall Study|Lost to Follow-up|0|||
156555457|NCT03467958|565122454|FG007|Overall Study|Lost to Follow-up|0|||
156555458|NCT03467958|565122455|FG008|Overall Study|Lost to Follow-up|0|||
156555459|NCT03467958|565122447|FG000|Overall Study|Other reasons|8|||
156555460|NCT03467958|565122448|FG001|Overall Study|Other reasons|14|||
156555461|NCT03467958|565122449|FG002|Overall Study|Other reasons|2|||
156555462|NCT03467958|565122450|FG003|Overall Study|Other reasons|1|||
156555463|NCT03467958|565122451|FG004|Overall Study|Other reasons|4|||
156555464|NCT03467958|565122452|FG005|Overall Study|Other reasons|0|||
156555465|NCT03467958|565122453|FG006|Overall Study|Other reasons|1|||
156555466|NCT03467958|565122454|FG007|Overall Study|Other reasons|0|||
156555467|NCT03467958|565122455|FG008|Overall Study|Other reasons|1|||
156555468|NCT03467958|565122447|FG000|Overall Study|Pregnancy|1|||
156555469|NCT03467958|565122448|FG001|Overall Study|Pregnancy|0|||
156555470|NCT03467958|565122449|FG002|Overall Study|Pregnancy|0|||
156555471|NCT03467958|565122450|FG003|Overall Study|Pregnancy|0|||
156555472|NCT03467958|565122451|FG004|Overall Study|Pregnancy|0|||
156555473|NCT03467958|565122452|FG005|Overall Study|Pregnancy|1|||
156555474|NCT03467958|565122453|FG006|Overall Study|Pregnancy|0|||
156555475|NCT03467958|565122454|FG007|Overall Study|Pregnancy|0|||
156555476|NCT03467958|565122455|FG008|Overall Study|Pregnancy|0|||
156555477|NCT03467958|565122447|FG000|Overall Study|Study terminated by sponsor|65|||
156555478|NCT03467958|565122448|FG001|Overall Study|Study terminated by sponsor|117|||
156555479|NCT03467958|565122449|FG002|Overall Study|Study terminated by sponsor|45|||
156555480|NCT03467958|565122450|FG003|Overall Study|Study terminated by sponsor|64|||
156555481|NCT03467958|565122451|FG004|Overall Study|Study terminated by sponsor|66|||
156555482|NCT03467958|565122452|FG005|Overall Study|Study terminated by sponsor|17|||
156555483|NCT03467958|565122453|FG006|Overall Study|Study terminated by sponsor|11|||
156555484|NCT03467958|565122454|FG007|Overall Study|Study terminated by sponsor|5|||
156555485|NCT03467958|565122455|FG008|Overall Study|Study terminated by sponsor|5|||
156555486|NCT03467958|565122447|FG000|Overall Study|Withdrawal by Subject|25|||
156555487|NCT03467958|565122448|FG001|Overall Study|Withdrawal by Subject|44|||
156555488|NCT03467958|565122449|FG002|Overall Study|Withdrawal by Subject|7|||
156555489|NCT03467958|565122450|FG003|Overall Study|Withdrawal by Subject|8|||
156555490|NCT03467958|565122451|FG004|Overall Study|Withdrawal by Subject|6|||
156555491|NCT03467958|565122452|FG005|Overall Study|Withdrawal by Subject|8|||
156555492|NCT03467958|565122453|FG006|Overall Study|Withdrawal by Subject|4|||
156555493|NCT03467958|565122454|FG007|Overall Study|Withdrawal by Subject|1|||
156555494|NCT03467958|565122455|FG008|Overall Study|Withdrawal by Subject|4|||
156555495|NCT01687712|565122456|FG000|Cycle 1|Not Biochemically Pregnant|386|||
156555496|NCT01687712|565122457|FG001|Cycle 1|Not Biochemically Pregnant|348|||
156555497|NCT01687712|565122456|FG000|Cycle 1|Early Pregnancy Loss|43|||
156555498|NCT01687712|565122457|FG001|Cycle 1|Early Pregnancy Loss|60|||
156555499|NCT01687712|565122456|FG000|Cycle 1|Ectopic Pregnancy|5|||
156555500|NCT01687712|565122457|FG001|Cycle 1|Ectopic Pregnancy|5|||
156555501|NCT01687712|565122456|FG000|Cycle 1|Heterotropic Pregnancy|1|||
156555502|NCT01687712|565122457|FG001|Cycle 1|Heterotropic Pregnancy|0|||
156555503|NCT01687712|565122456|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
156555504|NCT01687712|565122457|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
156555505|NCT01687712|565122456|FG000|Cycle 1|Abortion|3|||
156555506|NCT01687712|565122457|FG001|Cycle 1|Abortion|0|||
156555507|NCT01687712|565122456|FG000|Cycle 1|Intrauterine Fetal Death|0|||
156555508|NCT01687712|565122457|FG001|Cycle 1|Intrauterine Fetal Death|1|||
156555509|NCT01687712|565122456|FG000|Cycle 1|Lost to Follow-up|1|||
156555510|NCT01687712|565122457|FG001|Cycle 1|Lost to Follow-up|1|||
156555511|NCT01687712|565122456|FG000|Cycle 2|Not Biochemically Pregnant|74|||
156555512|NCT01687712|565122457|FG001|Cycle 2|Not Biochemically Pregnant|77|||
156555513|NCT01687712|565122456|FG000|Cycle 2|Early Pregnancy Loss|18|||
156555514|NCT01687712|565122457|FG001|Cycle 2|Early Pregnancy Loss|16|||
156555515|NCT01687712|565122456|FG000|Cycle 2|Ectopic Pregnancy|0|||
156555516|NCT01687712|565122457|FG001|Cycle 2|Ectopic Pregnancy|1|||
156555517|NCT01687712|565122456|FG000|Cycle 2|Still Birth|1|||
156555518|NCT01687712|565122457|FG001|Cycle 2|Still Birth|0|||
156555519|NCT01687712|565122456|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
156555520|NCT01687712|565122457|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
156555521|NCT01687712|565122456|FG000|Cycle 3|Not Biochemically Pregnant|21|||
156555522|NCT01687712|565122457|FG001|Cycle 3|Not Biochemically Pregnant|22|||
156555523|NCT01687712|565122456|FG000|Cycle 3|Early Pregnancy Loss|1|||
156555524|NCT01687712|565122457|FG001|Cycle 3|Early Pregnancy Loss|2|||
156555525|NCT01687712|565122456|FG000|Cycle 3|Ectopic Pregnancy|1|||
156555526|NCT01687712|565122457|FG001|Cycle 3|Ectopic Pregnancy|0|||
156407188|NCT04986982|564584701|FG001|Overall Study|Lost to Follow-up|1|||
156407189|NCT04986982|564584700|FG000|Overall Study|Sponsor's discretion|1|||
156407190|NCT04986982|564584701|FG001|Overall Study|Sponsor's discretion|0|||
156555527|NCT01687712|565122456|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
156555528|NCT01687712|565122457|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
156555529|NCT00516737|565122462|FG000|Overall Study|Lost to Follow-up|2|||
156555530|NCT00516737|565122463|FG001|Overall Study|Lost to Follow-up|0|||
156555531|NCT00516737|565122462|FG000|Overall Study|Physician Decision|0|||
156555532|NCT00516737|565122463|FG001|Overall Study|Physician Decision|1|||
156555533|NCT00516737|565122462|FG000|Overall Study|Withdrawal by Subject|0|||
156555534|NCT00516737|565122463|FG001|Overall Study|Withdrawal by Subject|1|||
156555535|NCT00516737|565122462|FG000|Overall Study|Lack of Qualifying Event|9|||
156555536|NCT00516737|565122463|FG001|Overall Study|Lack of Qualifying Event|6|||
156407191|NCT05796518|564584702|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
156555537|NCT00848354|565122464|FG000|Phase 1|Adverse Event|5|||
156555538|NCT00848354|565122465|FG001|Phase 1|Adverse Event|4|||
156555539|NCT00848354|565122464|FG000|Phase 1|Discontinuation of study by sponsor|2|||
156555540|NCT00848354|565122465|FG001|Phase 1|Discontinuation of study by sponsor|1|||
156555541|NCT00848354|565122464|FG000|Phase 1|Failed to return|0|||
156555542|NCT00848354|565122465|FG001|Phase 1|Failed to return|1|||
156555543|NCT00848354|565122464|FG000|Phase 1|Lost to Follow-up|1|||
156555544|NCT00848354|565122465|FG001|Phase 1|Lost to Follow-up|1|||
156555545|NCT00848354|565122464|FG000|Phase 1|Unspecified Reason|1|||
156555546|NCT00848354|565122465|FG001|Phase 1|Unspecified Reason|1|||
156555547|NCT00848354|565122464|FG000|Phase 1|Protocol Violation|1|||
156555548|NCT00848354|565122465|FG001|Phase 1|Protocol Violation|1|||
156555549|NCT00848354|565122464|FG000|Phase 1|Withdrawal by Subject|2|||
156555550|NCT00848354|565122465|FG001|Phase 1|Withdrawal by Subject|4|||
156555551|NCT00848354|565122464|FG000|Phase 1|Lack of Efficacy|0|||
156555552|NCT00848354|565122465|FG001|Phase 1|Lack of Efficacy|1|||
156555553|NCT00848354|565122464|FG000|Phase 2 Year 1|Adverse Event|7|||
156555554|NCT00848354|565122465|FG001|Phase 2 Year 1|Adverse Event|2|||
156555555|NCT00848354|565122464|FG000|Phase 2 Year 1|Death|1|||
156555556|NCT00848354|565122465|FG001|Phase 2 Year 1|Death|0|||
156555557|NCT00848354|565122464|FG000|Phase 2 Year 1|Failed to Return|1|||
156555558|NCT00848354|565122465|FG001|Phase 2 Year 1|Failed to Return|1|||
156555559|NCT00848354|565122464|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
156555560|NCT00848354|565122465|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
156555561|NCT00848354|565122464|FG000|Phase 2 Year 1|Unspecified Reason|3|||
156555562|NCT00848354|565122465|FG001|Phase 2 Year 1|Unspecified Reason|0|||
156555563|NCT00848354|565122464|FG000|Phase 2 Year 1|Protocol Violation|4|||
156555564|NCT00848354|565122465|FG001|Phase 2 Year 1|Protocol Violation|1|||
156555565|NCT00848354|565122464|FG000|Phase 2 Year 1|Subject Request|1|||
156555566|NCT00848354|565122465|FG001|Phase 2 Year 1|Subject Request|2|||
156555567|NCT00848354|565122464|FG000|Phase 2 Year 2|Adverse Event|12|||
156555568|NCT00848354|565122465|FG001|Phase 2 Year 2|Adverse Event|2|||
156555569|NCT00848354|565122464|FG000|Phase 2 Year 2|Death|2|||
156555570|NCT00848354|565122465|FG001|Phase 2 Year 2|Death|0|||
156555571|NCT00848354|565122464|FG000|Phase 2 Year 2|Failed to return|3|||
156555572|NCT00848354|565122465|FG001|Phase 2 Year 2|Failed to return|0|||
156555573|NCT00848354|565122464|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
156555574|NCT00848354|565122465|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
156555575|NCT00848354|565122464|FG000|Phase 2 Year 2|Unspecified Reason|1|||
156555576|NCT00848354|565122465|FG001|Phase 2 Year 2|Unspecified Reason|0|||
156555577|NCT00848354|565122464|FG000|Phase 2 Year 2|Protocol Violation|1|||
156555578|NCT00848354|565122465|FG001|Phase 2 Year 2|Protocol Violation|1|||
156555579|NCT00848354|565122464|FG000|Phase 2 Year 2|Subject Request|1|||
156555580|NCT00848354|565122465|FG001|Phase 2 Year 2|Subject Request|1|||
156555581|NCT00848354|565122464|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
156555582|NCT00848354|565122465|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
156555583|NCT00512798|565122466|FG000|Overall Study|Death|0|||
156555584|NCT00512798|565122467|FG001|Overall Study|Death|3|||
156555585|NCT00512798|565122466|FG000|Overall Study|Adverse Event|2|||
156555586|NCT00512798|565122467|FG001|Overall Study|Adverse Event|4|||
156555587|NCT00512798|565122466|FG000|Overall Study|Progression of disease|14|||
156555588|NCT00512798|565122467|FG001|Overall Study|Progression of disease|20|||
156555589|NCT00512798|565122466|FG000|Overall Study|Withdrawal by Subject|3|||
156555590|NCT00512798|565122467|FG001|Overall Study|Withdrawal by Subject|0|||
156555591|NCT00915343|565122468|FG000|Part B - Open Label Period|Treatment switch|0|||
156555592|NCT00915343|565122469|FG001|Part B - Open Label Period|Treatment switch|0|||
156555593|NCT00915343|565122470|FG002|Part B - Open Label Period|Treatment switch|1|||
156555594|NCT00915343|565122468|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
156555595|NCT00915343|565122469|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
156555596|NCT00915343|565122470|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
156555597|NCT00911989|565122471|FG000|Overall Study|Adverse Event|1|||
156555598|NCT03064841|565122472|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
156555599|NCT03064841|565122472|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
156555600|NCT03064841|565122472|FG000|Overall Study|Screen failure|2|||
156555601|NCT03434977|565122473|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
156555602|NCT03434977|565122474|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
156555603|NCT01250379|565122476|FG000|Overall Study|Death|141|||
156555604|NCT01250379|565122477|FG001|Overall Study|Death|148|||
156555605|NCT01250379|565122476|FG000|Overall Study|Withdrawal by Subject|32|||
156555606|NCT01250379|565122477|FG001|Overall Study|Withdrawal by Subject|20|||
156555607|NCT01250379|565122476|FG000|Overall Study|Physician Decision|11|||
156555608|NCT01250379|565122477|FG001|Overall Study|Physician Decision|3|||
156555609|NCT01250379|565122476|FG000|Overall Study|Protocol Violation|2|||
156555610|NCT01250379|565122477|FG001|Overall Study|Protocol Violation|8|||
156555611|NCT01250379|565122476|FG000|Overall Study|Lost to Follow-up|9|||
156555612|NCT01250379|565122477|FG001|Overall Study|Lost to Follow-up|6|||
156555613|NCT01250379|565122476|FG000|Overall Study|Adverse Event|5|||
156555614|NCT01250379|565122477|FG001|Overall Study|Adverse Event|4|||
156555615|NCT01250379|565122476|FG000|Overall Study|Other|0|||
156555616|NCT01250379|565122477|FG001|Overall Study|Other|4|||
156555617|NCT01250379|565122476|FG000|Overall Study|Participant noncompliance|2|||
156555618|NCT01250379|565122477|FG001|Overall Study|Participant noncompliance|0|||
156407192|NCT01535274|564584703|FG000|Overall Study|Determined to be ineligible|0|||
156407193|NCT01535274|564584704|FG001|Overall Study|Determined to be ineligible|1|||
156407194|NCT01535274|564584703|FG000|Overall Study|Misallocated to propofol intervention|0|||
156407195|NCT01535274|564584704|FG001|Overall Study|Misallocated to propofol intervention|1|||
156555619|NCT01314716|565122478|FG000|Double-Blind Phase|Randomized but not treated|1|||
156555620|NCT01314716|565122479|FG001|Double-Blind Phase|Randomized but not treated|1|||
156555621|NCT01314716|565122478|FG000|Double-Blind Phase|Adverse Event|10|||
156555622|NCT01314716|565122479|FG001|Double-Blind Phase|Adverse Event|4|||
156555623|NCT01314716|565122478|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
156555624|NCT01314716|565122479|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
156555625|NCT01314716|565122478|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156555626|NCT01314716|565122479|FG001|Double-Blind Phase|Lost to Follow-up|1|||
156555627|NCT01314716|565122478|FG000|Double-Blind Phase|Sponsor request|1|||
156555628|NCT01314716|565122479|FG001|Double-Blind Phase|Sponsor request|2|||
156555629|NCT01314716|565122478|FG000|Double-Blind Phase|Physician Decision|0|||
156555630|NCT01314716|565122479|FG001|Double-Blind Phase|Physician Decision|1|||
156555631|NCT01314716|565122478|FG000|Open-Label Phase|Adverse Event|4|||
156555632|NCT01314716|565122479|FG001|Open-Label Phase|Adverse Event|6|||
156555633|NCT01314716|565122478|FG000|Open-Label Phase|Withdrawal by Subject|1|||
156555634|NCT01314716|565122479|FG001|Open-Label Phase|Withdrawal by Subject|2|||
156555635|NCT01314716|565122478|FG000|Open-Label Phase|Physician Decision|5|||
156555636|NCT01314716|565122479|FG001|Open-Label Phase|Physician Decision|4|||
156555637|NCT01928381|565122483|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
156555638|NCT01928381|565122484|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
156555639|NCT01928381|565122485|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
156555640|NCT01928381|565122486|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
156555641|NCT01928381|565122487|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
156555642|NCT01928381|565122488|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
156555643|NCT01928381|565122489|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
156555644|NCT01928381|565122483|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
156555645|NCT01928381|565122484|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
156555646|NCT01928381|565122485|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
156555647|NCT01928381|565122486|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
156555648|NCT01928381|565122487|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
156555649|NCT01928381|565122488|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
156555650|NCT01928381|565122489|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
156555651|NCT01928381|565122483|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
156555652|NCT01928381|565122484|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
156555653|NCT01928381|565122485|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
156555654|NCT01928381|565122486|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
156555655|NCT01928381|565122487|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
156555656|NCT01928381|565122488|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
156555657|NCT01928381|565122489|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
156555658|NCT01928381|565122483|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
156555659|NCT01928381|565122484|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
156555660|NCT01928381|565122485|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
156555661|NCT01928381|565122486|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
156555662|NCT01928381|565122487|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
156555663|NCT01928381|565122488|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
156555664|NCT01928381|565122489|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
156555665|NCT01928381|565122483|FG000|Part 1 - Pain Training|Protocol Violation|1|||
156555666|NCT01928381|565122484|FG001|Part 1 - Pain Training|Protocol Violation|0|||
156555667|NCT01928381|565122485|FG002|Part 1 - Pain Training|Protocol Violation|0|||
156555668|NCT01928381|565122486|FG003|Part 1 - Pain Training|Protocol Violation|0|||
156555669|NCT01928381|565122487|FG004|Part 1 - Pain Training|Protocol Violation|0|||
156555670|NCT01928381|565122488|FG005|Part 1 - Pain Training|Protocol Violation|0|||
156555671|NCT01928381|565122489|FG006|Part 1 - Pain Training|Protocol Violation|0|||
156555672|NCT01928381|565122483|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
156555673|NCT01928381|565122484|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
156555674|NCT01928381|565122485|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
156555675|NCT01928381|565122486|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
156555676|NCT01928381|565122487|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
156555677|NCT01928381|565122488|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
156555678|NCT01928381|565122489|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
156555679|NCT01928381|565122483|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
156555680|NCT01928381|565122484|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156555681|NCT01928381|565122485|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156555682|NCT01928381|565122486|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156555683|NCT01928381|565122487|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156555684|NCT01928381|565122488|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156555685|NCT01928381|565122489|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156555686|NCT01928381|565122483|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
156555687|NCT01928381|565122484|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156555688|NCT01928381|565122485|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156555689|NCT01928381|565122486|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156555690|NCT01928381|565122487|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156555691|NCT01928381|565122488|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156555692|NCT01928381|565122489|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156555693|NCT01928381|565122483|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
156555694|NCT01928381|565122484|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
156555695|NCT01928381|565122485|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
156555696|NCT01928381|565122486|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
156555697|NCT01928381|565122487|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
156555698|NCT01928381|565122488|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
156555699|NCT01928381|565122489|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
156555700|NCT01928381|565122483|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
156555701|NCT01928381|565122484|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
156555702|NCT01928381|565122485|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
156555703|NCT01928381|565122486|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
156555704|NCT01928381|565122487|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
156555705|NCT01928381|565122488|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
156555706|NCT01928381|565122489|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
156555707|NCT01928381|565122483|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
156555708|NCT01928381|565122484|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
156555709|NCT01928381|565122485|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
156555710|NCT01928381|565122486|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
156555711|NCT01928381|565122487|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
156555712|NCT01928381|565122488|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
156555713|NCT01928381|565122489|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
156555714|NCT01928381|565122483|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
156555715|NCT01928381|565122484|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
156555716|NCT01928381|565122485|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
156555717|NCT01928381|565122486|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
156555718|NCT01928381|565122487|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
156555719|NCT01928381|565122488|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
156555720|NCT01928381|565122489|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
156555721|NCT01928381|565122483|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
156555722|NCT01928381|565122484|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
156555723|NCT01928381|565122485|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
156555724|NCT01928381|565122486|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
156555725|NCT01928381|565122487|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
156555726|NCT01928381|565122488|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
156555727|NCT01928381|565122489|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
156555728|NCT01928381|565122483|FG000|Washout First Intervention|Protocol Violation|0|||
156555729|NCT01928381|565122484|FG001|Washout First Intervention|Protocol Violation|0|||
156555730|NCT01928381|565122485|FG002|Washout First Intervention|Protocol Violation|0|||
156555731|NCT01928381|565122486|FG003|Washout First Intervention|Protocol Violation|0|||
156555732|NCT01928381|565122487|FG004|Washout First Intervention|Protocol Violation|1|||
156555733|NCT01928381|565122488|FG005|Washout First Intervention|Protocol Violation|0|||
156555734|NCT01928381|565122489|FG006|Washout First Intervention|Protocol Violation|0|||
156555735|NCT01928381|565122483|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
156555736|NCT01928381|565122484|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
156555737|NCT01928381|565122485|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
156555738|NCT01928381|565122486|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
156555739|NCT01928381|565122487|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
156555740|NCT01928381|565122488|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
156555741|NCT01928381|565122489|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
156555742|NCT01928381|565122483|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
156555743|NCT01928381|565122484|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
156555744|NCT01928381|565122485|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
156555745|NCT01928381|565122486|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
156555746|NCT01928381|565122487|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
156555747|NCT01928381|565122488|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
156555748|NCT01928381|565122489|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
156407196|NCT02690077|564584705|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
156555749|NCT03087955|565124207|FG000|Overall Study|Death|4|||
156555750|NCT03087955|565124208|FG001|Overall Study|Death|0|||
156555751|NCT03087955|565124207|FG000|Overall Study|Lack of Efficacy|2|||
156555752|NCT03087955|565124208|FG001|Overall Study|Lack of Efficacy|0|||
156555753|NCT03087955|565124207|FG000|Overall Study|Lost to Follow-up|1|||
156555754|NCT03087955|565124208|FG001|Overall Study|Lost to Follow-up|0|||
156555755|NCT03266016|565124215|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
156555756|NCT03266016|565124216|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
156555757|NCT03266016|565124217|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
156555758|NCT03266016|565124218|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
156555759|NCT03266016|565124215|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
156555760|NCT03266016|565124216|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
156555761|NCT03266016|565124217|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
156555762|NCT03266016|565124218|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
156555763|NCT05280756|565124219|FG000|Overall Study|Lost to Follow-up|1|||
156555764|NCT05280756|565124220|FG001|Overall Study|Lost to Follow-up|1|||
156555765|NCT00768898|565124221|FG000|Overall Study|Unrelated injury|1|||
156555766|NCT00768898|565124221|FG000|Overall Study|Headache|1|||
156555767|NCT00542997|565124226|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
156555768|NCT00542997|565124226|FG000|Wash in / Wash Out Period|Adverse Event|3|||
156555769|NCT00542997|565124226|FG000|Efficacy Period|Adverse Event|3|||
156555770|NCT03160560|565124229|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
156555771|NCT03160560|565124230|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156555772|NCT03160560|565124231|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156555773|NCT03160560|565124232|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
156555774|NCT03160560|565124229|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
156555775|NCT03160560|565124230|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
156555776|NCT03160560|565124231|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
156555777|NCT03160560|565124232|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
156555778|NCT01777763|565124243|FG000|Overall Study|Adverse Event|2|||
156555779|NCT01777763|565124244|FG001|Overall Study|Adverse Event|32|||
156555780|NCT01777763|565124243|FG000|Overall Study|Protocol Violation|1|||
156555781|NCT01777763|565124244|FG001|Overall Study|Protocol Violation|7|||
156555782|NCT01777763|565124243|FG000|Overall Study|Withdrawal by Subject|0|||
156555783|NCT01777763|565124244|FG001|Overall Study|Withdrawal by Subject|2|||
156555784|NCT01777763|565124243|FG000|Overall Study|Treatment Failure|1|||
156555785|NCT01777763|565124244|FG001|Overall Study|Treatment Failure|6|||
156555786|NCT02968810|565124248|FG000|Overall Study|Lost to Follow-up|1|||
156555787|NCT02968810|565124249|FG001|Overall Study|Lost to Follow-up|0|||
156555788|NCT02968810|565124248|FG000|Overall Study|Physician Decision|1|||
156555789|NCT02968810|565124249|FG001|Overall Study|Physician Decision|0|||
156555790|NCT02968810|565124248|FG000|Overall Study|Withdrawal by Subject|1|||
156555791|NCT02968810|565124249|FG001|Overall Study|Withdrawal by Subject|3|||
156555792|NCT02968810|565124248|FG000|Overall Study|Disease Progression|0|||
156555793|NCT02968810|565124249|FG001|Overall Study|Disease Progression|1|||
156555794|NCT01535729|565124251|FG000|Overall Study|Withdrawal by Subject|2|||
156555795|NCT01535729|565124251|FG000|Overall Study|Disease progression|230|||
156555796|NCT01535729|565124251|FG000|Overall Study|Discontinued treatment|25|||
156555797|NCT01535729|565124251|FG000|Overall Study|Lost to Follow-up|8|||
156555798|NCT01535729|565124251|FG000|Overall Study|Death|52|||
156555799|NCT01535729|565124251|FG000|Overall Study|Other|19|||
156555800|NCT01535729|565124251|FG000|Overall Study|Did not sign informed consent|1|||
156555801|NCT01535729|565124251|FG000|Overall Study|No previous chemotherapy|33|||
156555802|NCT01535729|565124251|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
156555803|NCT01535729|565124251|FG000|Overall Study|Protocol Violation|11|||
156555804|NCT01535729|565124251|FG000|Overall Study|Screening failure|1|||
156555805|NCT01535729|565124251|FG000|Overall Study|Not treated|9|||
156555806|NCT01535729|565124251|FG000|Overall Study|No participant record available|5|||
156555807|NCT02787850|565124252|FG000|Overall Study|Withdrawal by Subject|0|||
156555808|NCT02787850|565124253|FG001|Overall Study|Withdrawal by Subject|1|||
156555809|NCT03718143|565124254|FG000|Overall Study|Death|1|||
156555810|NCT03718143|565124255|FG001|Overall Study|Death|0|||
156555811|NCT03718143|565124256|FG002|Overall Study|Death|0|||
156555812|NCT03718143|565124254|FG000|Overall Study|Progression of Disease|1|||
156555813|NCT03718143|565124255|FG001|Overall Study|Progression of Disease|0|||
156555814|NCT03718143|565124256|FG002|Overall Study|Progression of Disease|0|||
156555815|NCT03718143|565124254|FG000|Overall Study|Withdrawal of Informed Consent|1|||
156555816|NCT03718143|565124255|FG001|Overall Study|Withdrawal of Informed Consent|2|||
156555817|NCT03718143|565124256|FG002|Overall Study|Withdrawal of Informed Consent|1|||
156555818|NCT03905863|565124257|FG000|Overall Study|Adverse Event|2|||
156555819|NCT03905863|565124258|FG001|Overall Study|Adverse Event|4|||
156555820|NCT03905863|565124257|FG000|Overall Study|Withdrawal by Subject|2|||
156555821|NCT03905863|565124258|FG001|Overall Study|Withdrawal by Subject|2|||
156555822|NCT03905863|565124257|FG000|Overall Study|Physician Decision|0|||
156555823|NCT03905863|565124258|FG001|Overall Study|Physician Decision|3|||
156555824|NCT03905863|565124257|FG000|Overall Study|Lost to Follow-up|1|||
156555825|NCT03905863|565124258|FG001|Overall Study|Lost to Follow-up|0|||
156555826|NCT03905863|565124257|FG000|Overall Study|Protocol Violation|0|||
156555827|NCT03905863|565124258|FG001|Overall Study|Protocol Violation|2|||
156555828|NCT03905863|565124257|FG000|Overall Study|Death|0|||
156555829|NCT03905863|565124258|FG001|Overall Study|Death|1|||
156555830|NCT02944448|565124262|FG000|Overall Study|Adverse Event|37|||
156555831|NCT02944448|565124263|FG001|Overall Study|Adverse Event|6|||
156555832|NCT02944448|565124262|FG000|Overall Study|Lack of Efficacy|8|||
156555833|NCT02944448|565124263|FG001|Overall Study|Lack of Efficacy|5|||
156555834|NCT02944448|565124262|FG000|Overall Study|Lost to Follow-up|3|||
156555835|NCT02944448|565124263|FG001|Overall Study|Lost to Follow-up|1|||
156555836|NCT02944448|565124262|FG000|Overall Study|Protocol Violation|25|||
156555837|NCT02944448|565124263|FG001|Overall Study|Protocol Violation|7|||
156555838|NCT02944448|565124262|FG000|Overall Study|Withdrawal by Subject|14|||
156555839|NCT02944448|565124263|FG001|Overall Study|Withdrawal by Subject|4|||
156555840|NCT02944448|565124262|FG000|Overall Study|Sponsor did not supply drug in time|0|||
156555841|NCT02944448|565124263|FG001|Overall Study|Sponsor did not supply drug in time|1|||
156555842|NCT02944448|565124262|FG000|Overall Study|Noncompliant with dosing|1|||
156555843|NCT02944448|565124263|FG001|Overall Study|Noncompliant with dosing|0|||
156555844|NCT02944448|565124262|FG000|Overall Study|Abnormal laboratory values|1|||
156555845|NCT02944448|565124263|FG001|Overall Study|Abnormal laboratory values|0|||
156555846|NCT00716976|565124266|FG000|Overall Study|Adverse Event|2|||
156555847|NCT00716976|565124267|FG001|Overall Study|Adverse Event|0|||
156555848|NCT00716976|565124266|FG000|Overall Study|Death|1|||
156555849|NCT00716976|565124267|FG001|Overall Study|Death|0|||
156555850|NCT00716976|565124266|FG000|Overall Study|Physician Decision|2|||
156555851|NCT00716976|565124267|FG001|Overall Study|Physician Decision|2|||
156555852|NCT00716976|565124266|FG000|Overall Study|Withdrawal by Subject|5|||
156555853|NCT00716976|565124267|FG001|Overall Study|Withdrawal by Subject|1|||
156555854|NCT00716976|565124266|FG000|Overall Study|Premature discontinuation cisplatin|5|||
156555855|NCT00716976|565124267|FG001|Overall Study|Premature discontinuation cisplatin|4|||
156555856|NCT00716976|565124266|FG000|Overall Study|Radiation during protocol|1|||
156555857|NCT00716976|565124267|FG001|Overall Study|Radiation during protocol|0|||
156555858|NCT00716976|565124266|FG000|Overall Study|Ineligibles|4|||
156555859|NCT00716976|565124267|FG001|Overall Study|Ineligibles|2|||
156555860|NCT00805740|565124268|FG000|Overall Study|Death|7|||
156555861|NCT00805740|565124269|FG001|Overall Study|Death|4|||
156555862|NCT00805740|565124268|FG000|Overall Study|Withdrawal by Subject|1|||
156555863|NCT00805740|565124269|FG001|Overall Study|Withdrawal by Subject|0|||
156555864|NCT00805740|565124268|FG000|Overall Study|Lost to Follow-up|1|||
156555865|NCT00805740|565124269|FG001|Overall Study|Lost to Follow-up|0|||
156555866|NCT00805740|565124268|FG000|Overall Study|Randomized, but not treated|2|||
156555867|NCT00805740|565124269|FG001|Overall Study|Randomized, but not treated|0|||
156555868|NCT05227690|565124281|FG000|Overall Study|Adverse Event|5|||
156555869|NCT05227690|565124282|FG001|Overall Study|Adverse Event|6|||
156555870|NCT05227690|565124283|FG002|Overall Study|Adverse Event|10|||
156555871|NCT05227690|565124281|FG000|Overall Study|Lack of Efficacy|2|||
156555872|NCT05227690|565124282|FG001|Overall Study|Lack of Efficacy|4|||
156555873|NCT05227690|565124283|FG002|Overall Study|Lack of Efficacy|1|||
156555874|NCT05227690|565124281|FG000|Overall Study|Physician Decision|6|||
156555875|NCT05227690|565124282|FG001|Overall Study|Physician Decision|0|||
156555876|NCT05227690|565124283|FG002|Overall Study|Physician Decision|4|||
156555877|NCT05227690|565124281|FG000|Overall Study|Withdrawal of consent|28|||
156555878|NCT05227690|565124282|FG001|Overall Study|Withdrawal of consent|27|||
156555879|NCT05227690|565124283|FG002|Overall Study|Withdrawal of consent|21|||
156555880|NCT05227690|565124281|FG000|Overall Study|Other, not specified|2|||
156555881|NCT05227690|565124282|FG001|Overall Study|Other, not specified|2|||
156555882|NCT05227690|565124283|FG002|Overall Study|Other, not specified|1|||
156555883|NCT04033367|565124284|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
156555884|NCT04033367|565124285|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
156555885|NCT04033367|565124284|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
156555886|NCT04033367|565124285|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
156555887|NCT04033367|565124284|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
156555888|NCT04033367|565124285|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
156407197|NCT02690077|564584706|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
156407198|NCT02690077|564584705|FG000|Overall Study|Withdrawal by Subject|0|||
156555889|NCT04033367|565124284|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
156555890|NCT04033367|565124285|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
156555891|NCT01191697|565124286|FG000|Overall Study|Death|1|||
156555892|NCT01191697|565124286|FG000|Overall Study|Physician Decision|2|||
156555893|NCT01191697|565124286|FG000|Overall Study|Pursue chemoradiation|2|||
156555894|NCT01191697|565124286|FG000|Overall Study|Break from chemotherapy|2|||
156555895|NCT01191697|565124286|FG000|Overall Study|Withdrawal by Subject|1|||
156555896|NCT01191697|565124286|FG000|Overall Study|Surveillance|1|||
156407199|NCT02690077|564584706|FG001|Overall Study|Withdrawal by Subject|5|||
156555897|NCT01191697|565124286|FG000|Overall Study|Adverse Event|2|||
156555898|NCT01191697|565124286|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
156555899|NCT01191697|565124286|FG000|Overall Study|Not completed but analyzed|25|||
156555900|NCT01534676|565124287|FG000|Overall Study|Study closed due to poor enrollment|2|||
156555901|NCT01534676|565124288|FG001|Overall Study|Study closed due to poor enrollment|1|||
156555902|NCT00491179|565124289|FG000|Overall Study|Adverse Event|5|||
156555903|NCT00491179|565124290|FG001|Overall Study|Adverse Event|1|||
156555904|NCT00491179|565124289|FG000|Overall Study|Withdrawal by Subject|2|||
156555905|NCT00491179|565124290|FG001|Overall Study|Withdrawal by Subject|1|||
156555906|NCT02009878|565124292|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
156555907|NCT02009878|565124293|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
156555908|NCT02009878|565124294|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
156555909|NCT01790048|565124296|FG000|Overall Study|Incorrect Age|9|||
156555910|NCT01790048|565124297|FG001|Overall Study|Incorrect Age|14|||
156555911|NCT01790048|565124296|FG000|Overall Study|data entry error|0|||
156555912|NCT01790048|565124297|FG001|Overall Study|data entry error|1|||
156555913|NCT01790048|565124296|FG000|Overall Study|Other|0|||
156555914|NCT01790048|565124297|FG001|Overall Study|Other|2|||
156555915|NCT01790048|565124296|FG000|Overall Study|SAM at Enrollment|2|||
156555916|NCT01790048|565124297|FG001|Overall Study|SAM at Enrollment|0|||
156555917|NCT01790048|565124296|FG000|Overall Study|Measurement error|1|||
156555918|NCT01790048|565124297|FG001|Overall Study|Measurement error|0|||
156555919|NCT03178487|565124298|FG000|Period 1|Adverse Event|1|||
156555920|NCT03178487|565124299|FG001|Period 1|Adverse Event|2|||
156555921|NCT03178487|565124298|FG000|Period 1|Withdrawal by Subject|2|||
156555922|NCT03178487|565124299|FG001|Period 1|Withdrawal by Subject|1|||
156555923|NCT03178487|565124298|FG000|Period 1|Lost to Follow-up|1|||
156555924|NCT03178487|565124299|FG001|Period 1|Lost to Follow-up|0|||
156555925|NCT03178487|565124298|FG000|Period 1|Other|0|||
156555926|NCT03178487|565124299|FG001|Period 1|Other|1|||
156555927|NCT03178487|565124298|FG000|Period 2|Adverse Event|4|||
156555928|NCT03178487|565124299|FG001|Period 2|Adverse Event|4|||
156555929|NCT03178487|565124298|FG000|Period 2|Withdrawal by Subject|6|||
156555930|NCT03178487|565124299|FG001|Period 2|Withdrawal by Subject|6|||
156555931|NCT03178487|565124298|FG000|Period 2|Lost to Follow-up|2|||
156555932|NCT03178487|565124299|FG001|Period 2|Lost to Follow-up|2|||
156555933|NCT03178487|565124298|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
156555934|NCT03178487|565124299|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
156555935|NCT03178487|565124298|FG000|Period 2|Other|8|||
156555936|NCT03178487|565124299|FG001|Period 2|Other|7|||
156555937|NCT03655756|565124302|FG000|Overall Study|Death|1|||
156555938|NCT03237065|565124305|FG000|Overall Study|Adverse Event|0|||
156555939|NCT03237065|565124306|FG001|Overall Study|Adverse Event|2|||
156555940|NCT03237065|565124305|FG000|Overall Study|Protocol Violation|0|||
156555941|NCT03237065|565124306|FG001|Overall Study|Protocol Violation|1|||
156555942|NCT03237065|565124305|FG000|Overall Study|Withdrawal by Subject|3|||
156555943|NCT03237065|565124306|FG001|Overall Study|Withdrawal by Subject|0|||
156555944|NCT03237065|565124305|FG000|Overall Study|Lost to Follow-up|1|||
156555945|NCT03237065|565124306|FG001|Overall Study|Lost to Follow-up|0|||
156555946|NCT03237065|565124305|FG000|Overall Study|Unable to obtain venous access|0|||
156555947|NCT03237065|565124306|FG001|Overall Study|Unable to obtain venous access|1|||
156555948|NCT02475655|565124308|FG000|Overall Study|Lost to Follow-up|0|||
156555949|NCT02475655|565124309|FG001|Overall Study|Lost to Follow-up|1|||
156555950|NCT00257010|565124314|FG000|Overall Study|Lack of Efficacy|11|||
156555951|NCT00257010|565124314|FG000|Overall Study|Lost to Follow-up|53|||
156555952|NCT00257010|565124314|FG000|Overall Study|Withdrawal by Subject|34|||
156555953|NCT00257010|565124314|FG000|Overall Study|Adverse Event|10|||
156555954|NCT00257010|565124314|FG000|Overall Study|various|11|||
156555955|NCT00257010|565124314|FG000|Overall Study|no headache reported|9|||
156555956|NCT00662792|565124315|FG000|Period 1|Personal Reasons|0|||
156555957|NCT00662792|565124316|FG001|Period 1|Personal Reasons|0|||
156555958|NCT00662792|565124317|FG002|Period 1|Personal Reasons|1|||
156555959|NCT00662792|565124318|FG003|Period 1|Personal Reasons|0|||
156555960|NCT00662792|565124315|FG000|Period 1|Refused continuing medication|0|||
156555961|NCT00662792|565124316|FG001|Period 1|Refused continuing medication|1|||
156555962|NCT00662792|565124317|FG002|Period 1|Refused continuing medication|1|||
156407200|NCT02690077|564584705|FG000|Overall Study|Excluded by IRB|0|||
156407201|NCT02690077|564584706|FG001|Overall Study|Excluded by IRB|2|||
156407202|NCT01845974|564584707|FG000|Overall Study|screen failure|1|||
156407203|NCT01845974|564584708|FG001|Overall Study|screen failure|0|||
156555963|NCT00662792|565124318|FG003|Period 1|Refused continuing medication|0|||
156555964|NCT00662792|565124315|FG000|Period 1|Lost to Follow-up|1|||
156555965|NCT00662792|565124316|FG001|Period 1|Lost to Follow-up|0|||
156555966|NCT00662792|565124317|FG002|Period 1|Lost to Follow-up|0|||
156555967|NCT00662792|565124318|FG003|Period 1|Lost to Follow-up|0|||
156555968|NCT00662792|565124315|FG000|Period 1|Other adverse event (AE)|0|||
156555969|NCT00662792|565124316|FG001|Period 1|Other adverse event (AE)|2|||
156555970|NCT00662792|565124317|FG002|Period 1|Other adverse event (AE)|0|||
156555971|NCT00662792|565124318|FG003|Period 1|Other adverse event (AE)|0|||
156555972|NCT00662792|565124315|FG000|Period 1|Worsening of disease under study (AE)|1|||
156555973|NCT00662792|565124316|FG001|Period 1|Worsening of disease under study (AE)|3|||
156555974|NCT00662792|565124317|FG002|Period 1|Worsening of disease under study (AE)|2|||
156555975|NCT00662792|565124318|FG003|Period 1|Worsening of disease under study (AE)|0|||
156555976|NCT00662792|565124315|FG000|Period 1|Not treated|0|||
156555977|NCT00662792|565124316|FG001|Period 1|Not treated|1|||
156555978|NCT00662792|565124317|FG002|Period 1|Not treated|0|||
156555979|NCT00662792|565124318|FG003|Period 1|Not treated|0|||
156555980|NCT00662792|565124315|FG000|Period 2|Worsening of disease under study|1|||
156555981|NCT00662792|565124316|FG001|Period 2|Worsening of disease under study|0|||
156555982|NCT00662792|565124317|FG002|Period 2|Worsening of disease under study|0|||
156555983|NCT00662792|565124318|FG003|Period 2|Worsening of disease under study|3|||
156555984|NCT00662792|565124315|FG000|Period 3|Refused continuing medication|1|||
156555985|NCT00662792|565124316|FG001|Period 3|Refused continuing medication|0|||
156555986|NCT00662792|565124317|FG002|Period 3|Refused continuing medication|1|||
156555987|NCT00662792|565124318|FG003|Period 3|Refused continuing medication|0|||
156555988|NCT00662792|565124315|FG000|Period 3|Other adverse event (AE)|0|||
156555989|NCT00662792|565124316|FG001|Period 3|Other adverse event (AE)|0|||
156555990|NCT00662792|565124317|FG002|Period 3|Other adverse event (AE)|1|||
156555991|NCT00662792|565124318|FG003|Period 3|Other adverse event (AE)|1|||
156555992|NCT00662792|565124315|FG000|Period 4|Refused continuing medication|0|||
156555993|NCT00662792|565124316|FG001|Period 4|Refused continuing medication|1|||
156555994|NCT00662792|565124317|FG002|Period 4|Refused continuing medication|0|||
156555995|NCT00662792|565124318|FG003|Period 4|Refused continuing medication|0|||
156555996|NCT00662792|565124315|FG000|Period 4|Other adverse event (AE)|1|||
156555997|NCT00662792|565124316|FG001|Period 4|Other adverse event (AE)|0|||
156555998|NCT00662792|565124317|FG002|Period 4|Other adverse event (AE)|0|||
156555999|NCT00662792|565124318|FG003|Period 4|Other adverse event (AE)|0|||
156556000|NCT00662792|565124315|FG000|Period 4|Worsening of disease under study (AE)|0|||
156556001|NCT00662792|565124316|FG001|Period 4|Worsening of disease under study (AE)|0|||
156556002|NCT00662792|565124317|FG002|Period 4|Worsening of disease under study (AE)|0|||
156556003|NCT00662792|565124318|FG003|Period 4|Worsening of disease under study (AE)|1|||
156556004|NCT00939692|565124325|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
156556005|NCT00939692|565124326|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
156556006|NCT00939692|565124325|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
156556007|NCT00939692|565124326|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
156556008|NCT04317274|565124327|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
156556009|NCT04317274|565124328|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
156556010|NCT04317274|565124329|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
156556011|NCT04317274|565124330|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
156556012|NCT00699907|565124331|FG000|Overall Study|Withdrawal by Subject|2|||
156556013|NCT00699907|565124332|FG001|Overall Study|Withdrawal by Subject|1|||
156556014|NCT00699907|565124333|FG002|Overall Study|Withdrawal by Subject|0|||
156556015|NCT00699907|565124331|FG000|Overall Study|No usable sample|0|||
156556016|NCT00699907|565124332|FG001|Overall Study|No usable sample|9|||
156556017|NCT00699907|565124333|FG002|Overall Study|No usable sample|8|||
156556018|NCT02161211|565124334|FG000|Overall Study|Lost to Follow-up|21|||
156556019|NCT02161211|565124335|FG001|Overall Study|Lost to Follow-up|27|||
156556020|NCT02161211|565124336|FG002|Overall Study|Lost to Follow-up|21|||
156556021|NCT02161211|565124334|FG000|Overall Study|Dropped|12|||
156556022|NCT02161211|565124335|FG001|Overall Study|Dropped|5|||
156556023|NCT02161211|565124336|FG002|Overall Study|Dropped|9|||
156556024|NCT00430508|565124338|FG000|Overall Study|Adverse Event|2|||
156556025|NCT00430508|565124339|FG001|Overall Study|Adverse Event|3|||
156556026|NCT00430508|565124340|FG002|Overall Study|Adverse Event|5|||
156556027|NCT00430508|565124341|FG003|Overall Study|Adverse Event|3|||
156556028|NCT00430508|565124338|FG000|Overall Study|Withdrawal by Subject|0|||
156556029|NCT00430508|565124339|FG001|Overall Study|Withdrawal by Subject|1|||
156556030|NCT00430508|565124340|FG002|Overall Study|Withdrawal by Subject|1|||
156556031|NCT00430508|565124341|FG003|Overall Study|Withdrawal by Subject|1|||
156556032|NCT00430508|565124338|FG000|Overall Study|responder at visit 4|0|||
156556033|NCT00430508|565124339|FG001|Overall Study|responder at visit 4|0|||
156556034|NCT00430508|565124340|FG002|Overall Study|responder at visit 4|2|||
156556035|NCT00430508|565124341|FG003|Overall Study|responder at visit 4|0|||
156407204|NCT00594217|564584709|FG000|Overall Study|Withdrawal by Subject|1|||
156407205|NCT00594217|564584710|FG001|Overall Study|Withdrawal by Subject|3|||
156556036|NCT00430508|565124338|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
156556037|NCT00430508|565124339|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
156556038|NCT00430508|565124340|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
156556039|NCT00430508|565124341|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
156556040|NCT00430508|565124338|FG000|Overall Study|Other|1|||
156556041|NCT00430508|565124339|FG001|Overall Study|Other|1|||
156556042|NCT00430508|565124340|FG002|Overall Study|Other|3|||
156556043|NCT00430508|565124341|FG003|Overall Study|Other|0|||
156556044|NCT02971670|565124343|FG000|Overall Study|Withdrawal by Subject|4|||
156407206|NCT05672680|564584711|FG000|Overall Study|Patient Did Not Complete the Form|5|||
156407207|NCT05672680|564584712|FG001|Overall Study|Patient Did Not Complete the Form|4|||
156556045|NCT02971670|565124344|FG001|Overall Study|Withdrawal by Subject|1|||
156556046|NCT02971670|565124345|FG002|Overall Study|Withdrawal by Subject|1|||
156556047|NCT02971670|565124346|FG003|Overall Study|Withdrawal by Subject|2|||
156556048|NCT02340663|565124347|FG000|Overall Study|Lost to Follow-up|1|||
156556049|NCT02340663|565124348|FG001|Overall Study|Lost to Follow-up|0|||
156556050|NCT02340663|565124347|FG000|Overall Study|Protocol Violation|1|||
156556051|NCT02340663|565124348|FG001|Overall Study|Protocol Violation|0|||
156556052|NCT02340663|565124347|FG000|Overall Study|Withdrawal by Subject|3|||
156556053|NCT02340663|565124348|FG001|Overall Study|Withdrawal by Subject|1|||
156556054|NCT01353703|565124349|FG000|Overall Study|Migrated/moved from study area|1|||
156556055|NCT01353703|565124350|FG001|Overall Study|Migrated/moved from study area|0|||
156556056|NCT03033875|565124358|FG000|Overall Study|Withdrawal by Subject|5|||
156556057|NCT03033875|565124359|FG001|Overall Study|Withdrawal by Subject|9|||
156556058|NCT03033875|565124360|FG002|Overall Study|Withdrawal by Subject|4|||
156556059|NCT03033875|565124358|FG000|Overall Study|Other|14|||
156556060|NCT03033875|565124359|FG001|Overall Study|Other|15|||
156556061|NCT03033875|565124360|FG002|Overall Study|Other|8|||
156556062|NCT01145066|565124365|FG000|Overall Study|To resume NSAIDs|2|||
156556063|NCT01145066|565124366|FG001|Overall Study|To resume NSAIDs|2|||
156556064|NCT01145066|565124367|FG002|Overall Study|To resume NSAIDs|1|||
156556065|NCT01145066|565124365|FG000|Overall Study|Non-related surgery|0|||
156556066|NCT01145066|565124366|FG001|Overall Study|Non-related surgery|0|||
156556067|NCT01145066|565124367|FG002|Overall Study|Non-related surgery|1|||
156556068|NCT01145066|565124365|FG000|Overall Study|Withdrawal by Subject|0|||
156556069|NCT01145066|565124366|FG001|Overall Study|Withdrawal by Subject|0|||
156556070|NCT01145066|565124367|FG002|Overall Study|Withdrawal by Subject|2|||
156556071|NCT01145066|565124365|FG000|Overall Study|To start new med|1|||
156556072|NCT01145066|565124366|FG001|Overall Study|To start new med|0|||
156556073|NCT01145066|565124367|FG002|Overall Study|To start new med|0|||
156556074|NCT01145066|565124365|FG000|Overall Study|problems swallowing capsule|1|||
156556075|NCT01145066|565124366|FG001|Overall Study|problems swallowing capsule|0|||
156556076|NCT01145066|565124367|FG002|Overall Study|problems swallowing capsule|0|||
156556077|NCT01145066|565124365|FG000|Overall Study|Abdominal discomfort|0|||
156556078|NCT01145066|565124366|FG001|Overall Study|Abdominal discomfort|1|||
156556079|NCT01145066|565124367|FG002|Overall Study|Abdominal discomfort|0|||
156556080|NCT01145066|565124365|FG000|Overall Study|Low platelet count|0|||
156556081|NCT01145066|565124366|FG001|Overall Study|Low platelet count|1|||
156556082|NCT01145066|565124367|FG002|Overall Study|Low platelet count|0|||
156556083|NCT03920670|565124368|FG000|Overall Study|Protocol Violation|2|||
156556084|NCT03920670|565124369|FG001|Overall Study|Protocol Violation|2|||
156556085|NCT03920670|565124368|FG000|Overall Study|Adverse Event|1|||
156556086|NCT03920670|565124369|FG001|Overall Study|Adverse Event|0|||
156556087|NCT04484285|565126349|FG000|Overall Study|Unable to operate stimulator|3|||
156556088|NCT04484285|565126350|FG001|Overall Study|Unable to operate stimulator|0|||
156556089|NCT01227902|565126352|FG000|Overall Study|Adverse Event|12|||
156556090|NCT01227902|565126353|FG001|Overall Study|Adverse Event|8|||
156556091|NCT01227902|565126354|FG002|Overall Study|Adverse Event|11|||
156556092|NCT01227902|565126355|FG003|Overall Study|Adverse Event|4|||
156556093|NCT01227902|565126352|FG000|Overall Study|Lack of Efficacy|1|||
156556094|NCT01227902|565126353|FG001|Overall Study|Lack of Efficacy|2|||
156556095|NCT01227902|565126354|FG002|Overall Study|Lack of Efficacy|2|||
156556096|NCT01227902|565126355|FG003|Overall Study|Lack of Efficacy|1|||
156556097|NCT01227902|565126352|FG000|Overall Study|Protocol Violation|1|||
156556098|NCT01227902|565126353|FG001|Overall Study|Protocol Violation|0|||
156556099|NCT01227902|565126354|FG002|Overall Study|Protocol Violation|0|||
156556100|NCT01227902|565126355|FG003|Overall Study|Protocol Violation|0|||
156556101|NCT01227902|565126352|FG000|Overall Study|Lost to Follow-up|0|||
156556102|NCT01227902|565126353|FG001|Overall Study|Lost to Follow-up|0|||
156556103|NCT01227902|565126354|FG002|Overall Study|Lost to Follow-up|1|||
156407208|NCT05672680|564584711|FG000|Overall Study|Procedure Aborted|1|||
156556104|NCT01227902|565126355|FG003|Overall Study|Lost to Follow-up|2|||
156556105|NCT01227902|565126352|FG000|Overall Study|Physician Decision|0|||
156556106|NCT01227902|565126353|FG001|Overall Study|Physician Decision|1|||
156556107|NCT01227902|565126354|FG002|Overall Study|Physician Decision|1|||
156556108|NCT01227902|565126355|FG003|Overall Study|Physician Decision|0|||
156556109|NCT01227902|565126352|FG000|Overall Study|Withdrawal by Subject|4|||
156556110|NCT01227902|565126353|FG001|Overall Study|Withdrawal by Subject|2|||
156556111|NCT01227902|565126354|FG002|Overall Study|Withdrawal by Subject|4|||
156556112|NCT01227902|565126355|FG003|Overall Study|Withdrawal by Subject|3|||
156556113|NCT02527707|565126357|FG000|Overall Study|Adverse Event|1|||
156556114|NCT02527707|565126357|FG000|Overall Study|Adverse Event|1|||
156556115|NCT02090855|565126358|FG000|Overall Study|no evaluable Standard of Truth results|2|||
156556116|NCT01354028|565126359|FG000|Overall Study|Physician Decision|0|||
156556117|NCT01354028|565126360|FG001|Overall Study|Physician Decision|2|||
156556118|NCT01354028|565126359|FG000|Overall Study|Discharged before study start|2|||
156556119|NCT01354028|565126360|FG001|Overall Study|Discharged before study start|2|||
156556120|NCT01354028|565126359|FG000|Overall Study|No quiet alert state|0|||
156556121|NCT01354028|565126360|FG001|Overall Study|No quiet alert state|1|||
156556122|NCT00935883|565126363|FG000|Treatment Period|Physician Decision|1|||
156556123|NCT00935883|565126364|FG001|Treatment Period|Physician Decision|0|||
156556124|NCT00935883|565126363|FG000|Treatment Period|Withdrawal by Subject|0|||
156556125|NCT00935883|565126364|FG001|Treatment Period|Withdrawal by Subject|2|||
156556126|NCT01641939|565126365|FG000|Overall Study|Death|90|||
156556127|NCT01641939|565126366|FG001|Overall Study|Death|187|||
156556128|NCT01641939|565126367|FG002|Overall Study|Death|61|||
156556129|NCT01641939|565126365|FG000|Overall Study|Lost to Follow-up|3|||
156556130|NCT01641939|565126366|FG001|Overall Study|Lost to Follow-up|2|||
156556131|NCT01641939|565126367|FG002|Overall Study|Lost to Follow-up|1|||
156556132|NCT01641939|565126365|FG000|Overall Study|Withdrawal by Subject|14|||
156556133|NCT01641939|565126366|FG001|Overall Study|Withdrawal by Subject|11|||
156556134|NCT01641939|565126367|FG002|Overall Study|Withdrawal by Subject|5|||
156556135|NCT01641939|565126365|FG000|Overall Study|Study Terminated by Sponsor|10|||
156556136|NCT01641939|565126366|FG001|Overall Study|Study Terminated by Sponsor|28|||
156556137|NCT01641939|565126367|FG002|Overall Study|Study Terminated by Sponsor|3|||
156556138|NCT01072344|565126372|FG000|Overall Study|Relasped-reached end point|7|||
156556139|NCT01072344|565126373|FG001|Overall Study|Relasped-reached end point|12|||
156556140|NCT01072344|565126372|FG000|Overall Study|Protocol Violation|1|||
156556141|NCT01072344|565126373|FG001|Overall Study|Protocol Violation|2|||
156556142|NCT01072344|565126372|FG000|Overall Study|Lost to Follow-up|3|||
156556143|NCT01072344|565126373|FG001|Overall Study|Lost to Follow-up|4|||
156556144|NCT00804687|565126374|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
156556145|NCT00804687|565126375|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
156556146|NCT00804687|565126376|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
156556147|NCT00804687|565126377|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
156556148|NCT00804687|565126378|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
156556149|NCT00804687|565126379|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
156556150|NCT00804687|565126374|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
156556151|NCT00804687|565126375|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
156556152|NCT00804687|565126376|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
156556153|NCT00804687|565126377|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
156556154|NCT00804687|565126378|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
156556155|NCT00804687|565126379|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
156556156|NCT00804687|565126374|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
156556157|NCT00804687|565126375|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
156556158|NCT00804687|565126376|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
156556159|NCT00804687|565126377|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
156556160|NCT00804687|565126378|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
156556161|NCT00804687|565126379|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
156556162|NCT00804687|565126374|FG000|Period 5: Treatment Period|Positive drug test|1|||
156556163|NCT00804687|565126375|FG001|Period 5: Treatment Period|Positive drug test|0|||
156556164|NCT00804687|565126376|FG002|Period 5: Treatment Period|Positive drug test|0|||
156556165|NCT00804687|565126377|FG003|Period 5: Treatment Period|Positive drug test|0|||
156556166|NCT00804687|565126378|FG004|Period 5: Treatment Period|Positive drug test|0|||
156556167|NCT00804687|565126379|FG005|Period 5: Treatment Period|Positive drug test|0|||
156556168|NCT00975156|565126383|FG000|Overall Study|Protocol Violation|0|||
156556169|NCT00975156|565126384|FG001|Overall Study|Protocol Violation|1|||
156556170|NCT05499559|565126385|FG000|Overall Study|Lost to Follow-up|467|||
156556171|NCT02971202|565126392|FG000|Overall Study|Pregnancy|1|||
156556172|NCT02971202|565126393|FG001|Overall Study|Pregnancy|0|||
156556173|NCT02971202|565126394|FG002|Overall Study|Pregnancy|0|||
156556174|NCT02971202|565126392|FG000|Overall Study|screen fail after consent|1|||
156556175|NCT02971202|565126393|FG001|Overall Study|screen fail after consent|0|||
156407209|NCT05672680|564584712|FG001|Overall Study|Procedure Aborted|0|||
156407210|NCT01036022|564584724|FG000|Overall Study|Adverse Event|1|||
156407211|NCT01036022|564584725|FG001|Overall Study|Adverse Event|3|||
156407212|NCT01036022|564584726|FG002|Overall Study|Adverse Event|2|||
156407213|NCT01036022|564584727|FG003|Overall Study|Adverse Event|1|||
156407214|NCT01036022|564584728|FG004|Overall Study|Adverse Event|0|||
156407215|NCT01036022|564584729|FG005|Overall Study|Adverse Event|2|||
156407216|NCT01036022|564584724|FG000|Overall Study|Lack of Efficacy|1|||
156407217|NCT01036022|564584725|FG001|Overall Study|Lack of Efficacy|1|||
156407218|NCT01036022|564584726|FG002|Overall Study|Lack of Efficacy|1|||
156407219|NCT01036022|564584727|FG003|Overall Study|Lack of Efficacy|0|||
156407220|NCT01036022|564584728|FG004|Overall Study|Lack of Efficacy|1|||
156407221|NCT01036022|564584729|FG005|Overall Study|Lack of Efficacy|1|||
156407222|NCT01036022|564584724|FG000|Overall Study|Physician Decision|0|||
156407223|NCT01036022|564584725|FG001|Overall Study|Physician Decision|0|||
156407224|NCT01036022|564584726|FG002|Overall Study|Physician Decision|1|||
156407225|NCT01036022|564584727|FG003|Overall Study|Physician Decision|0|||
156407226|NCT01036022|564584728|FG004|Overall Study|Physician Decision|0|||
156407227|NCT01036022|564584729|FG005|Overall Study|Physician Decision|0|||
156556176|NCT02971202|565126394|FG002|Overall Study|screen fail after consent|1|||
156407228|NCT01036022|564584724|FG000|Overall Study|Withdrawal by Subject|0|||
156407229|NCT01036022|564584725|FG001|Overall Study|Withdrawal by Subject|0|||
156556177|NCT02723201|565126395|FG000|Second Intervention Period|Protocol Violation|1|||
156556178|NCT02723201|565126396|FG001|Second Intervention Period|Protocol Violation|0|||
156556179|NCT02723201|565126397|FG002|Second Intervention Period|Protocol Violation|0|||
156556180|NCT02723201|565126395|FG000|Second Intervention Period|Adverse Event|1|||
156556181|NCT02723201|565126396|FG001|Second Intervention Period|Adverse Event|0|||
156556182|NCT02723201|565126397|FG002|Second Intervention Period|Adverse Event|0|||
156556183|NCT03472560|565126398|FG000|Overall Study|Subject transfer to continuation protocol|0|||
156556184|NCT03472560|565126399|FG001|Overall Study|Subject transfer to continuation protocol|1|||
156556185|NCT03472560|565126398|FG000|Overall Study|Withdrawal by Subject|4|||
156556186|NCT03472560|565126399|FG001|Overall Study|Withdrawal by Subject|0|||
156556187|NCT03472560|565126398|FG000|Overall Study|Progressive disease|24|||
156556188|NCT03472560|565126399|FG001|Overall Study|Progressive disease|8|||
156556189|NCT03472560|565126398|FG000|Overall Study|Physician Decision|1|||
156556190|NCT03472560|565126399|FG001|Overall Study|Physician Decision|0|||
156556191|NCT03472560|565126398|FG000|Overall Study|Death|7|||
156556192|NCT03472560|565126399|FG001|Overall Study|Death|4|||
156556193|NCT03472560|565126398|FG000|Overall Study|Adverse Event|5|||
156556194|NCT03472560|565126399|FG001|Overall Study|Adverse Event|3|||
156556195|NCT03472560|565126398|FG000|Overall Study|Global deterioration of health status|0|||
156556196|NCT03472560|565126399|FG001|Overall Study|Global deterioration of health status|4|||
156556197|NCT01946178|565126400|FG000|Overall Study|Pregnancy|1|||
156556198|NCT01946178|565126400|FG000|Overall Study|Lost to Follow-up|1|||
156556199|NCT02908880|565126407|FG000|Overall Study|Lost to Follow-up|4|||
156556200|NCT02908880|565126407|FG000|Overall Study|Explantation of the device|1|||
156556201|NCT02908880|565126407|FG000|Overall Study|Withdrawal by Subject|17|||
156556202|NCT02908880|565126407|FG000|Overall Study|Death|5|||
156556203|NCT00584233|565126412|FG000|Overall Study|Withdrawal by Subject|5|||
156556204|NCT00584233|565126412|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
156556205|NCT01537211|565126416|FG000|Overall Study|Lost to Follow-up|0|||
156556206|NCT01537211|565126417|FG001|Overall Study|Lost to Follow-up|1|||
156556207|NCT02474082|565126420|FG000|Overall Study|Adverse Event|2|||
156556208|NCT02474082|565126421|FG001|Overall Study|Adverse Event|32|||
156556209|NCT02474082|565126420|FG000|Overall Study|Withdrawal of informed consent|1|||
156556210|NCT02474082|565126421|FG001|Overall Study|Withdrawal of informed consent|11|||
156556211|NCT02474082|565126420|FG000|Overall Study|Lost to Follow-up|2|||
156556212|NCT02474082|565126421|FG001|Overall Study|Lost to Follow-up|2|||
156556213|NCT02474082|565126420|FG000|Overall Study|Dose tapering not achieved|0|||
156556214|NCT02474082|565126421|FG001|Overall Study|Dose tapering not achieved|4|||
156556215|NCT02474082|565126420|FG000|Overall Study|Participant/guardian decision|1|||
156556216|NCT02474082|565126421|FG001|Overall Study|Participant/guardian decision|2|||
156556217|NCT02474082|565126420|FG000|Overall Study|Non-compliance with study treatment|0|||
156556218|NCT02474082|565126421|FG001|Overall Study|Non-compliance with study treatment|2|||
156556219|NCT02474082|565126420|FG000|Overall Study|Protocol deviation|0|||
156556220|NCT02474082|565126421|FG001|Overall Study|Protocol deviation|1|||
156556221|NCT01463098|565126422|FG000|Part A (11 Days)|Participant Choice|2|||
156556222|NCT01463098|565126423|FG001|Part A (11 Days)|Participant Choice|0|||
156556223|NCT01463098|565126424|FG002|Part A (11 Days)|Participant Choice|0|||
156556224|NCT01463098|565126425|FG003|Part A (11 Days)|Participant Choice|0|||
156556225|NCT01463098|565126426|FG004|Part A (11 Days)|Participant Choice|0|||
156556226|NCT01463098|565126427|FG005|Part A (11 Days)|Participant Choice|0|||
156556227|NCT01463098|565126428|FG006|Part A (11 Days)|Participant Choice|0|||
156556228|NCT01463098|565126429|FG007|Part A (11 Days)|Participant Choice|0|||
156556229|NCT01463098|565126430|FG008|Part A (11 Days)|Participant Choice|1|||
156556230|NCT01463098|565126431|FG009|Part A (11 Days)|Participant Choice|0|||
156556231|NCT01463098|565126432|FG010|Part A (11 Days)|Participant Choice|0|||
156556232|NCT01463098|565126433|FG011|Part A (11 Days)|Participant Choice|0|||
156556233|NCT01463098|565126434|FG012|Part A (11 Days)|Participant Choice|0|||
156556234|NCT01463098|565126435|FG013|Part A (11 Days)|Participant Choice|0|||
156556235|NCT01463098|565126422|FG000|Part A (11 Days)|Lost to Follow-up|0|||
156407230|NCT01036022|564584726|FG002|Overall Study|Withdrawal by Subject|0|||
156407231|NCT01036022|564584727|FG003|Overall Study|Withdrawal by Subject|1|||
156407232|NCT01036022|564584728|FG004|Overall Study|Withdrawal by Subject|2|||
156407233|NCT01036022|564584729|FG005|Overall Study|Withdrawal by Subject|0|||
156407234|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
156407235|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
156407236|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
156407237|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
156407238|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
156407239|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
156556236|NCT01463098|565126423|FG001|Part A (11 Days)|Lost to Follow-up|0|||
156556237|NCT01463098|565126424|FG002|Part A (11 Days)|Lost to Follow-up|0|||
156556238|NCT01463098|565126425|FG003|Part A (11 Days)|Lost to Follow-up|0|||
156556239|NCT01463098|565126426|FG004|Part A (11 Days)|Lost to Follow-up|1|||
156556240|NCT01463098|565126427|FG005|Part A (11 Days)|Lost to Follow-up|0|||
156407240|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
156407241|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
156407242|NCT01336621|564584733|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
156407243|NCT01336621|564584733|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
156407244|NCT01336621|564584733|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
156407245|NCT01336621|564584733|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
156407246|NCT01336621|564584733|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
156407247|NCT01336621|564584733|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
156407248|NCT02487095|564584734|FG000|Dose Expansion|Unable to scan/restage participant|0|||
156407249|NCT02487095|564584735|FG001|Dose Expansion|Unable to scan/restage participant|0|||
156407250|NCT02487095|564584736|FG002|Dose Expansion|Unable to scan/restage participant|0|||
156407251|NCT02487095|564584737|FG003|Dose Expansion|Unable to scan/restage participant|0|||
156407252|NCT02487095|564584738|FG004|Dose Expansion|Unable to scan/restage participant|1|||
156407253|NCT03108157|564584745|FG000|Overall Study|Protocol Violation|15|||
156407254|NCT03108157|564584746|FG001|Overall Study|Protocol Violation|4|||
156407255|NCT01555164|564584761|FG000|Overall Study|Adverse Event|5|||
156407256|NCT01555164|564584762|FG001|Overall Study|Adverse Event|7|||
156407257|NCT01555164|564584761|FG000|Overall Study|Hyperglycemia|0|||
156407258|NCT01555164|564584762|FG001|Overall Study|Hyperglycemia|1|||
156407259|NCT01555164|564584761|FG000|Overall Study|Investigator's Discretion|2|||
156407260|NCT01555164|564584762|FG001|Overall Study|Investigator's Discretion|2|||
156407261|NCT01555164|564584761|FG000|Overall Study|Lost to Follow-up|4|||
156407262|NCT01555164|564584762|FG001|Overall Study|Lost to Follow-up|3|||
156407263|NCT01555164|564584761|FG000|Overall Study|Protocol Violation|9|||
156407264|NCT01555164|564584762|FG001|Overall Study|Protocol Violation|5|||
156407265|NCT01555164|564584761|FG000|Overall Study|Subject Non-compliance|14|||
156407266|NCT01555164|564584762|FG001|Overall Study|Subject Non-compliance|6|||
156407267|NCT01555164|564584761|FG000|Overall Study|Subject Withdrew Consent|6|||
156407268|NCT01555164|564584762|FG001|Overall Study|Subject Withdrew Consent|11|||
156407269|NCT03203694|564584763|FG000|Overall Study|Withdrawal by Subject|2|||
156407270|NCT03203694|564584764|FG001|Overall Study|Withdrawal by Subject|0|||
156407271|NCT03203694|564584765|FG002|Overall Study|Withdrawal by Subject|0|||
156407272|NCT03203694|564584766|FG003|Overall Study|Withdrawal by Subject|0|||
156407273|NCT03203694|564584767|FG004|Overall Study|Withdrawal by Subject|0|||
156407274|NCT03203694|564584768|FG005|Overall Study|Withdrawal by Subject|0|||
156407275|NCT01709305|564584769|FG000|Phase 1|Clinical Adverse Event|80|||
156407276|NCT01709305|564584770|FG001|Phase 1|Clinical Adverse Event|0|||
156407277|NCT01709305|564584771|FG002|Phase 1|Clinical Adverse Event|0|||
156407278|NCT01709305|564584772|FG003|Phase 1|Clinical Adverse Event|0|||
156407279|NCT01709305|564584773|FG004|Phase 1|Clinical Adverse Event|0|||
156407280|NCT01709305|564584769|FG000|Phase 1|Death|2|||
156407281|NCT01709305|564584770|FG001|Phase 1|Death|0|||
156407282|NCT01709305|564584771|FG002|Phase 1|Death|0|||
156407283|NCT01709305|564584772|FG003|Phase 1|Death|0|||
156407284|NCT01709305|564584773|FG004|Phase 1|Death|0|||
156407285|NCT01709305|564584769|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
156407286|NCT01709305|564584770|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
156407287|NCT01709305|564584771|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
156407288|NCT01709305|564584772|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
156407289|NCT01709305|564584773|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
156407290|NCT01709305|564584769|FG000|Phase 1|Laboratory Adverse Event|16|||
156407291|NCT01709305|564584770|FG001|Phase 1|Laboratory Adverse Event|0|||
156407292|NCT01709305|564584771|FG002|Phase 1|Laboratory Adverse Event|0|||
156407293|NCT01709305|564584772|FG003|Phase 1|Laboratory Adverse Event|0|||
156407294|NCT01709305|564584773|FG004|Phase 1|Laboratory Adverse Event|0|||
156407295|NCT01709305|564584769|FG000|Phase 1|Lost to Follow-up|147|||
156407296|NCT01709305|564584770|FG001|Phase 1|Lost to Follow-up|0|||
156407297|NCT01709305|564584771|FG002|Phase 1|Lost to Follow-up|0|||
156407298|NCT01709305|564584772|FG003|Phase 1|Lost to Follow-up|0|||
156407299|NCT01709305|564584773|FG004|Phase 1|Lost to Follow-up|0|||
156407300|NCT01709305|564584769|FG000|Phase 1|Travel, moving, etc.|30|||
156556241|NCT01463098|565126428|FG006|Part A (11 Days)|Lost to Follow-up|0|||
156556242|NCT01463098|565126429|FG007|Part A (11 Days)|Lost to Follow-up|0|||
156556243|NCT01463098|565126430|FG008|Part A (11 Days)|Lost to Follow-up|0|||
156556244|NCT01463098|565126431|FG009|Part A (11 Days)|Lost to Follow-up|0|||
156556245|NCT01463098|565126432|FG010|Part A (11 Days)|Lost to Follow-up|0|||
156556246|NCT01463098|565126433|FG011|Part A (11 Days)|Lost to Follow-up|0|||
156556247|NCT01463098|565126434|FG012|Part A (11 Days)|Lost to Follow-up|0|||
156407301|NCT01709305|564584770|FG001|Phase 1|Travel, moving, etc.|0|||
156407302|NCT01709305|564584771|FG002|Phase 1|Travel, moving, etc.|0|||
156407303|NCT01709305|564584772|FG003|Phase 1|Travel, moving, etc.|0|||
156407304|NCT01709305|564584773|FG004|Phase 1|Travel, moving, etc.|0|||
156407305|NCT01709305|564584769|FG000|Phase 1|Physician Decision|13|||
156407306|NCT01709305|564584770|FG001|Phase 1|Physician Decision|0|||
156407307|NCT01709305|564584771|FG002|Phase 1|Physician Decision|0|||
156407308|NCT01709305|564584772|FG003|Phase 1|Physician Decision|0|||
156407309|NCT01709305|564584773|FG004|Phase 1|Physician Decision|0|||
156556248|NCT01463098|565126435|FG013|Part A (11 Days)|Lost to Follow-up|0|||
156556249|NCT01463098|565126422|FG000|Part B (11 Days)|Participant Choice|0|||
156556250|NCT01463098|565126423|FG001|Part B (11 Days)|Participant Choice|0|||
156556251|NCT01463098|565126424|FG002|Part B (11 Days)|Participant Choice|0|||
156556252|NCT01463098|565126425|FG003|Part B (11 Days)|Participant Choice|0|||
156556253|NCT01463098|565126426|FG004|Part B (11 Days)|Participant Choice|0|||
156556254|NCT01463098|565126427|FG005|Part B (11 Days)|Participant Choice|0|||
156556255|NCT01463098|565126428|FG006|Part B (11 Days)|Participant Choice|0|||
156556256|NCT01463098|565126429|FG007|Part B (11 Days)|Participant Choice|0|||
156556257|NCT01463098|565126430|FG008|Part B (11 Days)|Participant Choice|0|||
156556258|NCT01463098|565126431|FG009|Part B (11 Days)|Participant Choice|0|||
156556259|NCT01463098|565126432|FG010|Part B (11 Days)|Participant Choice|0|||
156556260|NCT01463098|565126433|FG011|Part B (11 Days)|Participant Choice|1|||
156556261|NCT01463098|565126434|FG012|Part B (11 Days)|Participant Choice|0|||
156556262|NCT01463098|565126435|FG013|Part B (11 Days)|Participant Choice|0|||
156556263|NCT00523991|565126445|FG000|Overall Study|Adverse Event|6|||
156556264|NCT00523991|565126446|FG001|Overall Study|Adverse Event|5|||
156556265|NCT00523991|565126445|FG000|Overall Study|Protocol Violation|1|||
156556266|NCT00523991|565126446|FG001|Overall Study|Protocol Violation|4|||
156556267|NCT00523991|565126445|FG000|Overall Study|Lost to Follow-up|4|||
156556268|NCT00523991|565126446|FG001|Overall Study|Lost to Follow-up|1|||
156556269|NCT00523991|565126445|FG000|Overall Study|Withdrawal by Subject|7|||
156556270|NCT00523991|565126446|FG001|Overall Study|Withdrawal by Subject|17|||
156556271|NCT00523991|565126445|FG000|Overall Study|Other reason (not specified)|3|||
156556272|NCT00523991|565126446|FG001|Overall Study|Other reason (not specified)|0|||
156556273|NCT00288080|565126453|FG000|Overall Study|Withdrawal by Subject|1|||
156556274|NCT00288080|565126454|FG001|Overall Study|Withdrawal by Subject|3|||
156556275|NCT00288080|565126453|FG000|Overall Study|Protocol Violation|25|||
156556276|NCT00288080|565126454|FG001|Overall Study|Protocol Violation|20|||
156556277|NCT00379795|565126455|FG000|Overall Study|Death|31|||
156556278|NCT00379795|565126456|FG001|Overall Study|Death|8|||
156556279|NCT00379795|565126457|FG002|Overall Study|Death|6|||
156556280|NCT00379795|565126458|FG003|Overall Study|Death|4|||
156556281|NCT00379795|565126459|FG004|Overall Study|Death|7|||
156556282|NCT00379795|565126455|FG000|Overall Study|Adverse Event|17|||
156556283|NCT00379795|565126456|FG001|Overall Study|Adverse Event|3|||
156556284|NCT00379795|565126457|FG002|Overall Study|Adverse Event|3|||
156556285|NCT00379795|565126458|FG003|Overall Study|Adverse Event|1|||
156556286|NCT00379795|565126459|FG004|Overall Study|Adverse Event|4|||
156556287|NCT00379795|565126455|FG000|Overall Study|Lost to Follow-up|8|||
156556288|NCT00379795|565126456|FG001|Overall Study|Lost to Follow-up|1|||
156556289|NCT00379795|565126457|FG002|Overall Study|Lost to Follow-up|2|||
156556290|NCT00379795|565126458|FG003|Overall Study|Lost to Follow-up|1|||
156556291|NCT00379795|565126459|FG004|Overall Study|Lost to Follow-up|4|||
156556292|NCT00379795|565126455|FG000|Overall Study|Physician Decision|25|||
156556293|NCT00379795|565126456|FG001|Overall Study|Physician Decision|0|||
156556294|NCT00379795|565126457|FG002|Overall Study|Physician Decision|2|||
156556295|NCT00379795|565126458|FG003|Overall Study|Physician Decision|2|||
156556296|NCT00379795|565126459|FG004|Overall Study|Physician Decision|2|||
156556297|NCT00379795|565126455|FG000|Overall Study|Withdrawal by Subject|94|||
156556298|NCT00379795|565126456|FG001|Overall Study|Withdrawal by Subject|11|||
156556299|NCT00379795|565126457|FG002|Overall Study|Withdrawal by Subject|19|||
156556300|NCT00379795|565126458|FG003|Overall Study|Withdrawal by Subject|7|||
156556301|NCT00379795|565126459|FG004|Overall Study|Withdrawal by Subject|14|||
156556302|NCT00379795|565126455|FG000|Overall Study|Subject non-compliance|7|||
156556303|NCT00379795|565126456|FG001|Overall Study|Subject non-compliance|2|||
156556304|NCT00379795|565126457|FG002|Overall Study|Subject non-compliance|0|||
156556305|NCT00379795|565126458|FG003|Overall Study|Subject non-compliance|0|||
156556306|NCT00379795|565126459|FG004|Overall Study|Subject non-compliance|1|||
156556307|NCT00379795|565126455|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
156556308|NCT00379795|565126456|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
156556309|NCT00379795|565126457|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
156556310|NCT00379795|565126458|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
156556311|NCT00379795|565126459|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
156556312|NCT00379795|565126455|FG000|Overall Study|Subjects condition mandated intervention|34|||
156407310|NCT01709305|564584769|FG000|Phase 1|Protocol Violation|118|||
156556313|NCT00379795|565126456|FG001|Overall Study|Subjects condition mandated intervention|9|||
156556314|NCT00379795|565126457|FG002|Overall Study|Subjects condition mandated intervention|7|||
156556315|NCT00379795|565126458|FG003|Overall Study|Subjects condition mandated intervention|5|||
156556316|NCT00379795|565126459|FG004|Overall Study|Subjects condition mandated intervention|7|||
156556317|NCT00379795|565126455|FG000|Overall Study|Sponsor's decision|257|||
156556318|NCT00379795|565126456|FG001|Overall Study|Sponsor's decision|17|||
156556319|NCT00379795|565126457|FG002|Overall Study|Sponsor's decision|54|||
156556320|NCT00379795|565126458|FG003|Overall Study|Sponsor's decision|47|||
156556321|NCT00379795|565126459|FG004|Overall Study|Sponsor's decision|10|||
156556322|NCT03175549|565126460|FG000|Overall Study|Lost to Follow-up|2|||
156556323|NCT03175549|565126461|FG001|Overall Study|Lost to Follow-up|2|||
156556324|NCT03175549|565126460|FG000|Overall Study|Medication non-compliance|2|||
156513189|NCT02040584|564970667|FG001|Overall Study|Protocol Violation|11|||
156513190|NCT02040584|564970666|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156513191|NCT02040584|564970667|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156513192|NCT02040584|564970666|FG000|Overall Study|Death|6|||
156513193|NCT02040584|564970667|FG001|Overall Study|Death|3|||
156513194|NCT02040584|564970666|FG000|Overall Study|Transplant rejection/retransplant|0|||
156513195|NCT02040584|564970667|FG001|Overall Study|Transplant rejection/retransplant|1|||
156513196|NCT02040584|564970666|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
156513197|NCT02040584|564970667|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
156513198|NCT00996476|564970668|FG000|Overall Study|Withdrawal by Subject|1|||
156513199|NCT00996476|564970669|FG001|Overall Study|Withdrawal by Subject|2|||
156513200|NCT00996476|564970670|FG002|Overall Study|Withdrawal by Subject|1|||
156513201|NCT00996476|564970671|FG003|Overall Study|Withdrawal by Subject|0|||
156513202|NCT00996476|564970672|FG004|Overall Study|Withdrawal by Subject|1|||
156513203|NCT00996476|564970668|FG000|Overall Study|Adverse Event|0|||
156513204|NCT00996476|564970669|FG001|Overall Study|Adverse Event|1|||
156513205|NCT00996476|564970670|FG002|Overall Study|Adverse Event|0|||
156513206|NCT00996476|564970671|FG003|Overall Study|Adverse Event|0|||
156513207|NCT00996476|564970672|FG004|Overall Study|Adverse Event|1|||
156513208|NCT01802567|564970673|FG000|Overall Study|Withdrawal by Subject|2|||
156513209|NCT01802567|564970673|FG000|Overall Study|Physician Decision|1|||
156513210|NCT01802567|564970673|FG000|Overall Study|Lack of Efficacy|7|||
156513211|NCT01802567|564970673|FG000|Overall Study|Consented but did not start therapy|7|||
156513212|NCT01802567|564970673|FG000|Overall Study|Protocol Violation|1|||
156513213|NCT01940939|564970674|FG000|Overall Study|Withdrawal by Subject|2|||
156513214|NCT01940939|564970675|FG001|Overall Study|Withdrawal by Subject|8|||
156513215|NCT01470001|564970676|FG000|Overall Study|Lost to Follow-up|1|||
156513216|NCT01470001|564970677|FG001|Overall Study|Lost to Follow-up|1|||
156513217|NCT01470001|564970676|FG000|Overall Study|Physician Decision|2|||
156513218|NCT01470001|564970677|FG001|Overall Study|Physician Decision|0|||
156513219|NCT01470001|564970676|FG000|Overall Study|Withdrawal by Subject|2|||
156513220|NCT01470001|564970677|FG001|Overall Study|Withdrawal by Subject|1|||
156513221|NCT01895101|564970678|FG000|Overall Study|OPCAB procedure|1|||
156513222|NCT01895101|564970679|FG001|Overall Study|OPCAB procedure|1|||
156513223|NCT01895101|564970680|FG002|Overall Study|OPCAB procedure|3|||
156513224|NCT01895101|564970678|FG000|Overall Study|Withdrawal by Subject|0|||
156513225|NCT01895101|564970679|FG001|Overall Study|Withdrawal by Subject|1|||
156513226|NCT01895101|564970680|FG002|Overall Study|Withdrawal by Subject|2|||
156513227|NCT01895101|564970678|FG000|Overall Study|another study, enrolled in other study|0|||
156513228|NCT01895101|564970679|FG001|Overall Study|another study, enrolled in other study|1|||
156513229|NCT01895101|564970680|FG002|Overall Study|another study, enrolled in other study|0|||
156513230|NCT01895101|564970678|FG000|Overall Study|Death|0|||
156513231|NCT01895101|564970679|FG001|Overall Study|Death|1|||
156513232|NCT01895101|564970680|FG002|Overall Study|Death|0|||
156513233|NCT01895101|564970678|FG000|Overall Study|coagulation disorder|0|||
156513234|NCT01895101|564970679|FG001|Overall Study|coagulation disorder|1|||
156513235|NCT01895101|564970680|FG002|Overall Study|coagulation disorder|0|||
156513236|NCT03268603|564970681|FG000|Overall Study|Withdrawal by Subject|6|||
156513237|NCT03268603|564970681|FG000|Overall Study|Physician Decision|1|||
156513238|NCT03268603|564970681|FG000|Overall Study|Withdrawn due to disease progression|2|||
156513239|NCT04939701|564970685|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
156513240|NCT04939701|564970686|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
156513241|NCT04939701|564970687|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
156513242|NCT04939701|564970685|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
156513243|NCT04939701|564970686|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
156513244|NCT04939701|564970687|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
156513245|NCT04939701|564970685|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
156513246|NCT04939701|564970686|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
156513247|NCT04939701|564970687|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
156513248|NCT04939701|564970685|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
156513249|NCT04939701|564970686|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
156513250|NCT04939701|564970687|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
156513251|NCT04939701|564970685|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
156513252|NCT04939701|564970686|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
156513253|NCT04939701|564970687|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
156513254|NCT04939701|564970685|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
156513255|NCT04939701|564970686|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
156513256|NCT04939701|564970687|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
156513257|NCT04939701|564970685|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
156513258|NCT04939701|564970686|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
156513259|NCT04939701|564970687|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
156513260|NCT01353859|564970688|FG000|Overall Study|Adverse Event|3|||
156513261|NCT01353859|564970688|FG000|Overall Study|Lack of Efficacy|1|||
156513262|NCT01725126|564970689|FG000|Overall Study|Protocol Violation|0|||
156556325|NCT03175549|565126461|FG001|Overall Study|Medication non-compliance|2|||
156556326|NCT00763321|565126462|FG000|Open-label Period|Adverse Event|24|||
156556327|NCT00763321|565126463|FG001|Open-label Period|Adverse Event|0|||
156556328|NCT00763321|565126464|FG002|Open-label Period|Adverse Event|0|||
156556329|NCT00763321|565126462|FG000|Open-label Period|Lost to Follow-up|14|||
156556330|NCT00763321|565126463|FG001|Open-label Period|Lost to Follow-up|0|||
156556331|NCT00763321|565126464|FG002|Open-label Period|Lost to Follow-up|0|||
156556332|NCT00763321|565126462|FG000|Open-label Period|Withdrawal by Subject|7|||
156556333|NCT00763321|565126463|FG001|Open-label Period|Withdrawal by Subject|0|||
156556334|NCT00763321|565126464|FG002|Open-label Period|Withdrawal by Subject|0|||
156556335|NCT00763321|565126462|FG000|Open-label Period|Subject noncompliant|7|||
156556336|NCT00763321|565126463|FG001|Open-label Period|Subject noncompliant|0|||
156556337|NCT00763321|565126464|FG002|Open-label Period|Subject noncompliant|0|||
156556338|NCT00763321|565126462|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
156556339|NCT00763321|565126463|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
156556340|NCT00763321|565126464|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
156556341|NCT00763321|565126462|FG000|Open-label Period|Lack of Efficacy|2|||
156556342|NCT00763321|565126463|FG001|Open-label Period|Lack of Efficacy|0|||
156556343|NCT00763321|565126464|FG002|Open-label Period|Lack of Efficacy|0|||
156556344|NCT00763321|565126462|FG000|Open-label Period|Other|4|||
156556345|NCT00763321|565126463|FG001|Open-label Period|Other|0|||
156556346|NCT00763321|565126464|FG002|Open-label Period|Other|0|||
156556347|NCT00763321|565126462|FG000|Double-blind Period|Lack of Efficacy|0|||
156556348|NCT00763321|565126463|FG001|Double-blind Period|Lack of Efficacy|9|||
156556349|NCT00763321|565126464|FG002|Double-blind Period|Lack of Efficacy|17|||
156556350|NCT00763321|565126462|FG000|Double-blind Period|Adverse Event|0|||
156556351|NCT00763321|565126463|FG001|Double-blind Period|Adverse Event|4|||
156556352|NCT00763321|565126464|FG002|Double-blind Period|Adverse Event|4|||
156556353|NCT00763321|565126462|FG000|Double-blind Period|Lost to Follow-up|0|||
156556354|NCT00763321|565126463|FG001|Double-blind Period|Lost to Follow-up|4|||
156556355|NCT00763321|565126464|FG002|Double-blind Period|Lost to Follow-up|2|||
156556356|NCT00763321|565126462|FG000|Double-blind Period|Withdrawal by Subject|0|||
156556357|NCT00763321|565126463|FG001|Double-blind Period|Withdrawal by Subject|2|||
156556358|NCT00763321|565126464|FG002|Double-blind Period|Withdrawal by Subject|3|||
156556359|NCT00763321|565126462|FG000|Double-blind Period|Other|0|||
156556360|NCT00763321|565126463|FG001|Double-blind Period|Other|2|||
156556361|NCT00763321|565126464|FG002|Double-blind Period|Other|3|||
156556362|NCT02486757|565126465|FG000|Overall Study|Lost to Follow-up|1|||
156556363|NCT02793232|565126466|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156556364|NCT02793232|565126467|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156556365|NCT02793232|565126468|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156556366|NCT02793232|565126469|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156556367|NCT02793232|565126470|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
156556368|NCT02793232|565126471|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156556369|NCT02793232|565126472|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
156556370|NCT02793232|565126473|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156556371|NCT02793232|565126474|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156556372|NCT02387580|565126475|FG000|Overall Study|Withdrawal by Subject|0|||
156556373|NCT02387580|565126476|FG001|Overall Study|Withdrawal by Subject|0|||
156556374|NCT02387580|565126477|FG002|Overall Study|Withdrawal by Subject|0|||
156556375|NCT02387580|565126478|FG003|Overall Study|Withdrawal by Subject|1|||
156556376|NCT02387580|565126479|FG004|Overall Study|Withdrawal by Subject|0|||
156556377|NCT02387580|565126480|FG005|Overall Study|Withdrawal by Subject|0|||
156556378|NCT04849780|565126481|FG000|Period 1|Covid-19 Related|1|||
156556379|NCT04849780|565126482|FG001|Period 1|Covid-19 Related|0|||
156556380|NCT04849780|565126481|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
156556381|NCT04849780|565126482|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
156556382|NCT04849780|565126481|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
156556383|NCT04849780|565126482|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
156556384|NCT00725075|565126483|FG000|Overall Study|Use of Excluded Medication|0|||
156556385|NCT00725075|565126484|FG001|Overall Study|Use of Excluded Medication|1|||
156556386|NCT00725075|565126485|FG002|Overall Study|Use of Excluded Medication|0|||
156556387|NCT00725075|565126483|FG000|Overall Study|Protocol Violation|0|||
156556388|NCT00725075|565126484|FG001|Overall Study|Protocol Violation|0|||
156556389|NCT00725075|565126485|FG002|Overall Study|Protocol Violation|1|||
156556390|NCT00725075|565126483|FG000|Overall Study|Lost to Follow-up|1|||
156556391|NCT00725075|565126484|FG001|Overall Study|Lost to Follow-up|0|||
156556392|NCT00725075|565126485|FG002|Overall Study|Lost to Follow-up|0|||
156556393|NCT00725075|565126483|FG000|Overall Study|Withdrawal by Subject|4|||
156556394|NCT00725075|565126484|FG001|Overall Study|Withdrawal by Subject|5|||
156556395|NCT00725075|565126485|FG002|Overall Study|Withdrawal by Subject|4|||
156556396|NCT00725075|565126483|FG000|Overall Study|Adverse Event|2|||
156407311|NCT01709305|564584770|FG001|Phase 1|Protocol Violation|0|||
156556397|NCT00725075|565126484|FG001|Overall Study|Adverse Event|1|||
156556398|NCT00725075|565126485|FG002|Overall Study|Adverse Event|1|||
156556399|NCT00725075|565126483|FG000|Overall Study|Worsening of Disease|2|||
156556400|NCT00725075|565126484|FG001|Overall Study|Worsening of Disease|1|||
156556401|NCT00725075|565126485|FG002|Overall Study|Worsening of Disease|2|||
156556402|NCT00725075|565126483|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
156556403|NCT00725075|565126484|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
156556404|NCT00725075|565126485|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
156556405|NCT00725075|565126483|FG000|Overall Study|Other|1|||
156556406|NCT00725075|565126484|FG001|Overall Study|Other|0|||
156556407|NCT00725075|565126485|FG002|Overall Study|Other|0|||
156556408|NCT02286947|565126488|FG000|Overall Study|Withdrawal by Subject|2|||
156556409|NCT00573794|565126489|FG000|Overall Study|Adverse Event|81|||
156556410|NCT00573794|565126489|FG000|Overall Study|Withdrew Consent|90|||
156556411|NCT00573794|565126489|FG000|Overall Study|Lost to Follow-up|13|||
156556412|NCT00573794|565126489|FG000|Overall Study|Protocol Violation|6|||
156556413|NCT00573794|565126489|FG000|Overall Study|Lack of Efficacy|94|||
156556414|NCT00573794|565126489|FG000|Overall Study|Other|46|||
156556415|NCT04820309|565126490|FG000|Overall Study|Adverse Event|96|||
156556416|NCT04820309|565126490|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
156556417|NCT04820309|565126490|FG000|Overall Study|Consent Withdrawn|93|||
156556418|NCT04820309|565126490|FG000|Overall Study|failure to adhere to protocol|32|||
156556419|NCT04820309|565126490|FG000|Overall Study|alcohol or drug use|6|||
156556420|NCT04820309|565126490|FG000|Overall Study|Lost to Follow-up|46|||
156556421|NCT04820309|565126490|FG000|Overall Study|Death|2|||
156556422|NCT04820309|565126490|FG000|Overall Study|Pregnancy|1|||
156407312|NCT01709305|564584771|FG002|Phase 1|Protocol Violation|0|||
156407313|NCT01709305|564584772|FG003|Phase 1|Protocol Violation|0|||
156407314|NCT01709305|564584773|FG004|Phase 1|Protocol Violation|0|||
156407315|NCT01709305|564584769|FG000|Phase 1|Withdrawal by Subject|218|||
156407316|NCT01709305|564584770|FG001|Phase 1|Withdrawal by Subject|0|||
156407317|NCT01709305|564584771|FG002|Phase 1|Withdrawal by Subject|0|||
156407318|NCT01709305|564584772|FG003|Phase 1|Withdrawal by Subject|0|||
156556423|NCT04820309|565126490|FG000|Overall Study|Other reasons|12|||
156556424|NCT04202679|565126493|FG000|Overall Study|Adverse Event|2|||
156556425|NCT04202679|565126494|FG001|Overall Study|Adverse Event|0|||
156556426|NCT04202679|565126493|FG000|Overall Study|Poor compliance to protocol|1|||
156556427|NCT04202679|565126494|FG001|Overall Study|Poor compliance to protocol|0|||
156556428|NCT04202679|565126493|FG000|Overall Study|Withdrawal by Subject|23|||
156556429|NCT04202679|565126494|FG001|Overall Study|Withdrawal by Subject|6|||
156556430|NCT05902364|565126495|FG000|Overall Study|Adverse Event|1|||
156556431|NCT05902364|565126496|FG001|Overall Study|Adverse Event|0|||
156556432|NCT02270242|565126497|FG000|Overall Study|Withdrawal by Subject|18|||
156556433|NCT02270242|565126498|FG001|Overall Study|Withdrawal by Subject|25|||
156556434|NCT02270242|565126497|FG000|Overall Study|Lost to Follow-up|41|||
156556435|NCT02270242|565126498|FG001|Overall Study|Lost to Follow-up|27|||
156556436|NCT02270242|565126497|FG000|Overall Study|Physician Decision|0|||
156556437|NCT02270242|565126498|FG001|Overall Study|Physician Decision|1|||
156556438|NCT03864653|565126499|FG000|Overall Study|Withdrawal by Subject|1|||
156556439|NCT01984268|565126500|FG000|Overall Study|Study Terminated|15|||
156556440|NCT06272370|565128355|FG000|Overall Study|Lost to Follow-up|0|||
156556441|NCT06272370|565128356|FG001|Overall Study|Lost to Follow-up|3|||
156556442|NCT06272370|565128357|FG002|Overall Study|Lost to Follow-up|1|||
156556443|NCT06272370|565128358|FG003|Overall Study|Lost to Follow-up|1|||
156556444|NCT02363478|565128363|FG000|Overall Study|Lost to Follow-up|4|||
156556445|NCT02363478|565128363|FG000|Overall Study|Adverse Event|4|||
156556446|NCT00930059|565128364|FG000|Overall Study|Death|1|||
156556447|NCT00930059|565128365|FG001|Overall Study|Death|0|||
156556448|NCT00930059|565128364|FG000|Overall Study|Did not meet entrance criteria|1|||
156556449|NCT00930059|565128365|FG001|Overall Study|Did not meet entrance criteria|1|||
156556450|NCT00930059|565128364|FG000|Overall Study|Withdrawal by Subject|3|||
156556451|NCT00930059|565128365|FG001|Overall Study|Withdrawal by Subject|4|||
156556452|NCT00930059|565128364|FG000|Overall Study|Other|1|||
156556453|NCT00930059|565128365|FG001|Overall Study|Other|0|||
156556454|NCT00930059|565128364|FG000|Overall Study|1 site terminated by sponsor|1|||
156556455|NCT00930059|565128365|FG001|Overall Study|1 site terminated by sponsor|1|||
156556456|NCT00930059|565128364|FG000|Overall Study|Adverse Event|1|||
156556457|NCT00930059|565128365|FG001|Overall Study|Adverse Event|6|||
156556458|NCT01299766|565128367|FG000|Overall Study|Death|5|||
156556459|NCT01299766|565128368|FG001|Overall Study|Death|4|||
156556460|NCT01299766|565128367|FG000|Overall Study|Withdrawal by Subject|29|||
156556461|NCT01299766|565128368|FG001|Overall Study|Withdrawal by Subject|19|||
156556462|NCT04002310|565128369|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
156556463|NCT04002310|565128370|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
156407319|NCT01709305|564584773|FG004|Phase 1|Withdrawal by Subject|0|||
156556464|NCT04002310|565128371|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
156556465|NCT04002310|565128372|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
156556466|NCT04002310|565128373|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
156556467|NCT00352534|565128374|FG000|Initial Staging|Ineligible|8|||
156556468|NCT00352534|565128375|FG001|Initial Staging|Ineligible|9|||
156556469|NCT00352534|565128376|FG002|Initial Staging|Ineligible|0|||
156556470|NCT00352534|565128377|FG003|Initial Staging|Ineligible|0|||
156556471|NCT00352534|565128378|FG004|Initial Staging|Ineligible|0|||
156556472|NCT00352534|565128379|FG005|Initial Staging|Ineligible|0|||
156556473|NCT00352534|565128380|FG006|Initial Staging|Ineligible|0|||
156556474|NCT00352534|565128374|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
156556475|NCT00352534|565128375|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
156556476|NCT00352534|565128376|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
156556477|NCT00352534|565128377|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
156556478|NCT00352534|565128378|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
156556479|NCT00352534|565128379|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
156556480|NCT00352534|565128380|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
156556481|NCT00352534|565128374|FG000|Final Risk Group Assignment|Physician Decision|0|||
156556482|NCT00352534|565128375|FG001|Final Risk Group Assignment|Physician Decision|0|||
156556483|NCT00352534|565128376|FG002|Final Risk Group Assignment|Physician Decision|0|||
156556484|NCT00352534|565128377|FG003|Final Risk Group Assignment|Physician Decision|0|||
156556485|NCT00352534|565128378|FG004|Final Risk Group Assignment|Physician Decision|0|||
156556486|NCT00352534|565128379|FG005|Final Risk Group Assignment|Physician Decision|8|||
156556487|NCT00352534|565128380|FG006|Final Risk Group Assignment|Physician Decision|0|||
156556488|NCT00352534|565128374|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
156556489|NCT00352534|565128375|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
156556490|NCT00352534|565128376|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
156556491|NCT00352534|565128377|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
156556492|NCT00352534|565128378|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
156556493|NCT00352534|565128379|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
156556494|NCT00352534|565128380|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
156556495|NCT00352534|565128374|FG000|Final Risk Group Assignment|Ineligible|0|||
156556496|NCT00352534|565128375|FG001|Final Risk Group Assignment|Ineligible|0|||
156556497|NCT00352534|565128376|FG002|Final Risk Group Assignment|Ineligible|3|||
156556498|NCT00352534|565128377|FG003|Final Risk Group Assignment|Ineligible|1|||
156556499|NCT00352534|565128378|FG004|Final Risk Group Assignment|Ineligible|0|||
156556500|NCT00352534|565128379|FG005|Final Risk Group Assignment|Ineligible|13|||
156556501|NCT00352534|565128380|FG006|Final Risk Group Assignment|Ineligible|0|||
156556502|NCT00352534|565128374|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
156556503|NCT00352534|565128375|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
156556504|NCT00352534|565128376|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
156556505|NCT00352534|565128377|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
156556506|NCT00352534|565128378|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
156556507|NCT00352534|565128379|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
156556508|NCT00352534|565128380|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
156556509|NCT00352534|565128374|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
156556510|NCT00352534|565128375|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
156556511|NCT00352534|565128376|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
156556512|NCT00352534|565128377|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
156556513|NCT00352534|565128378|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
156556514|NCT00352534|565128379|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
156556515|NCT00352534|565128380|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
156556516|NCT00352534|565128374|FG000|Final Risk Group Assignment|Death|0|||
156556517|NCT00352534|565128375|FG001|Final Risk Group Assignment|Death|0|||
156556518|NCT00352534|565128376|FG002|Final Risk Group Assignment|Death|0|||
156556519|NCT00352534|565128377|FG003|Final Risk Group Assignment|Death|0|||
156556520|NCT00352534|565128378|FG004|Final Risk Group Assignment|Death|0|||
156556521|NCT00352534|565128379|FG005|Final Risk Group Assignment|Death|2|||
156556522|NCT00352534|565128380|FG006|Final Risk Group Assignment|Death|0|||
156556523|NCT03064763|565128383|FG000|Overall Study|Lost to Follow-up|1|||
156556524|NCT03064763|565128383|FG000|Overall Study|Death|8|||
156556525|NCT00544869|565128387|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
156556526|NCT00544869|565128388|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
156556527|NCT00544869|565128389|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
156556528|NCT00544869|565128387|FG000|Overall Study|Adverse Event|6|||
156556529|NCT00544869|565128388|FG001|Overall Study|Adverse Event|1|||
156407320|NCT01709305|564584769|FG000|Phase 2|Clinical Adverse Event|0|||
156407321|NCT01709305|564584770|FG001|Phase 2|Clinical Adverse Event|10|||
156556530|NCT00544869|565128389|FG002|Overall Study|Adverse Event|0|||
156556531|NCT00544869|565128387|FG000|Overall Study|Lack of Efficacy|1|||
156556532|NCT00544869|565128388|FG001|Overall Study|Lack of Efficacy|1|||
156556533|NCT00544869|565128389|FG002|Overall Study|Lack of Efficacy|0|||
156556534|NCT00544869|565128387|FG000|Overall Study|Physician Decision|2|||
156556535|NCT00544869|565128388|FG001|Overall Study|Physician Decision|0|||
156556536|NCT00544869|565128389|FG002|Overall Study|Physician Decision|0|||
156556537|NCT00619502|565128390|FG000|Overall Study|Lost to Follow-up|8|||
156556538|NCT00619502|565128391|FG001|Overall Study|Lost to Follow-up|10|||
156556539|NCT03968419|565128392|FG000|Treatment Period|Adverse Event|0|||
156556540|NCT03968419|565128393|FG001|Treatment Period|Adverse Event|0|||
156556541|NCT03968419|565128394|FG002|Treatment Period|Adverse Event|1|||
156556542|NCT03968419|565128392|FG000|Safety Follow-up Period|Death|3|||
156556543|NCT03968419|565128393|FG001|Safety Follow-up Period|Death|2|||
156556544|NCT03968419|565128394|FG002|Safety Follow-up Period|Death|1|||
156556545|NCT03968419|565128392|FG000|Safety Follow-up Period|Subject Decision|2|||
156556546|NCT03968419|565128393|FG001|Safety Follow-up Period|Subject Decision|1|||
156556547|NCT03968419|565128394|FG002|Safety Follow-up Period|Subject Decision|0|||
156556548|NCT02894840|565128397|FG000|Overall Study|Lost to Follow-up|1|||
156556549|NCT02894840|565128398|FG001|Overall Study|Lost to Follow-up|0|||
156556550|NCT02894840|565128399|FG002|Overall Study|Lost to Follow-up|3|||
156556551|NCT02894840|565128400|FG003|Overall Study|Lost to Follow-up|0|||
156556552|NCT05425563|565128403|FG000|Overall Study|Withdrawal by Subject|17|||
156556553|NCT01001702|565128404|FG000|Overall Study|Lost to Follow-up|7|||
156556554|NCT01001702|565128404|FG000|Overall Study|Adverse Event|7|||
156556555|NCT01001702|565128404|FG000|Overall Study|Sponsor Discontinued Study|4|||
156556556|NCT01001702|565128404|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
156556557|NCT01001702|565128404|FG000|Overall Study|Investigator withdrew Subject|10|||
156556558|NCT01001702|565128404|FG000|Overall Study|Withdrawal by Subject|19|||
156556559|NCT01001702|565128404|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
156556560|NCT02494596|565128407|FG000|Overall Study|Insufficient Therapeutic Response|3|||
156556561|NCT02494596|565128408|FG001|Overall Study|Insufficient Therapeutic Response|3|||
156556562|NCT02494596|565128409|FG002|Overall Study|Insufficient Therapeutic Response|1|||
156556563|NCT02494596|565128407|FG000|Overall Study|Adverse Event|0|||
156556564|NCT02494596|565128408|FG001|Overall Study|Adverse Event|1|||
156556565|NCT02494596|565128409|FG002|Overall Study|Adverse Event|0|||
156556566|NCT02494596|565128407|FG000|Overall Study|Refused Treatment|0|||
156556567|NCT02494596|565128408|FG001|Overall Study|Refused Treatment|1|||
156556568|NCT02494596|565128409|FG002|Overall Study|Refused Treatment|0|||
156556569|NCT02222714|565128410|FG000|Overall Study|Death|0|||
156556570|NCT02222714|565128411|FG001|Overall Study|Death|2|||
156556571|NCT02222714|565128412|FG002|Overall Study|Death|3|||
156556572|NCT02222714|565128413|FG003|Overall Study|Death|4|||
156556573|NCT02222714|565128414|FG004|Overall Study|Death|6|||
156556574|NCT02222714|565128410|FG000|Overall Study|Withdrawal by Subject|0|||
156407322|NCT01709305|564584771|FG002|Phase 2|Clinical Adverse Event|10|||
156407323|NCT01709305|564584772|FG003|Phase 2|Clinical Adverse Event|6|||
156556575|NCT02222714|565128411|FG001|Overall Study|Withdrawal by Subject|0|||
156556576|NCT02222714|565128412|FG002|Overall Study|Withdrawal by Subject|1|||
156556577|NCT02222714|565128413|FG003|Overall Study|Withdrawal by Subject|0|||
156556578|NCT02222714|565128414|FG004|Overall Study|Withdrawal by Subject|1|||
156556579|NCT00159432|565128415|FG000|Overall Study|Adverse Event|1|||
156556580|NCT00159432|565128415|FG000|Overall Study|Death|1|||
156556581|NCT00159432|565128415|FG000|Overall Study|Lack of Efficacy|8|||
156556582|NCT04537208|565128420|FG000|Overall Study|Adverse Event|0|||
156556583|NCT04537208|565128421|FG001|Overall Study|Adverse Event|0|||
156556584|NCT04537208|565128422|FG002|Overall Study|Adverse Event|0|||
156556585|NCT04537208|565128423|FG003|Overall Study|Adverse Event|0|||
156556586|NCT04537208|565128424|FG004|Overall Study|Adverse Event|0|||
156556587|NCT04537208|565128425|FG005|Overall Study|Adverse Event|0|||
156556588|NCT04537208|565128426|FG006|Overall Study|Adverse Event|0|||
156556589|NCT04537208|565128427|FG007|Overall Study|Adverse Event|0|||
156556590|NCT04537208|565128428|FG008|Overall Study|Adverse Event|1|||
156556591|NCT04537208|565128429|FG009|Overall Study|Adverse Event|0|||
156556592|NCT04537208|565128430|FG010|Overall Study|Adverse Event|0|||
156556593|NCT04537208|565128420|FG000|Overall Study|Protocol deviation|0|||
156556594|NCT04537208|565128421|FG001|Overall Study|Protocol deviation|0|||
156556595|NCT04537208|565128422|FG002|Overall Study|Protocol deviation|2|||
156556596|NCT04537208|565128423|FG003|Overall Study|Protocol deviation|0|||
156556597|NCT04537208|565128424|FG004|Overall Study|Protocol deviation|0|||
156556598|NCT04537208|565128425|FG005|Overall Study|Protocol deviation|2|||
156556599|NCT04537208|565128426|FG006|Overall Study|Protocol deviation|4|||
156556600|NCT04537208|565128427|FG007|Overall Study|Protocol deviation|0|||
156407324|NCT01709305|564584773|FG004|Phase 2|Clinical Adverse Event|11|||
156556601|NCT04537208|565128428|FG008|Overall Study|Protocol deviation|1|||
156556602|NCT04537208|565128429|FG009|Overall Study|Protocol deviation|0|||
156556603|NCT04537208|565128430|FG010|Overall Study|Protocol deviation|2|||
156556604|NCT04537208|565128420|FG000|Overall Study|Withdrawal by Subject|4|||
156556605|NCT04537208|565128421|FG001|Overall Study|Withdrawal by Subject|2|||
156556606|NCT04537208|565128422|FG002|Overall Study|Withdrawal by Subject|1|||
156556607|NCT04537208|565128423|FG003|Overall Study|Withdrawal by Subject|3|||
156556608|NCT04537208|565128424|FG004|Overall Study|Withdrawal by Subject|5|||
156556609|NCT04537208|565128425|FG005|Overall Study|Withdrawal by Subject|1|||
156556610|NCT04537208|565128426|FG006|Overall Study|Withdrawal by Subject|6|||
156556611|NCT04537208|565128427|FG007|Overall Study|Withdrawal by Subject|1|||
156556612|NCT04537208|565128428|FG008|Overall Study|Withdrawal by Subject|7|||
156556613|NCT04537208|565128429|FG009|Overall Study|Withdrawal by Subject|2|||
156556614|NCT04537208|565128430|FG010|Overall Study|Withdrawal by Subject|4|||
156556615|NCT04537208|565128420|FG000|Overall Study|Lost to Follow-up|4|||
156556616|NCT04537208|565128421|FG001|Overall Study|Lost to Follow-up|1|||
156556617|NCT04537208|565128422|FG002|Overall Study|Lost to Follow-up|3|||
156556618|NCT04537208|565128423|FG003|Overall Study|Lost to Follow-up|4|||
156556619|NCT04537208|565128424|FG004|Overall Study|Lost to Follow-up|3|||
156556620|NCT04537208|565128425|FG005|Overall Study|Lost to Follow-up|2|||
156556621|NCT04537208|565128426|FG006|Overall Study|Lost to Follow-up|3|||
156556622|NCT04537208|565128427|FG007|Overall Study|Lost to Follow-up|2|||
156556623|NCT04537208|565128428|FG008|Overall Study|Lost to Follow-up|7|||
156556624|NCT04537208|565128429|FG009|Overall Study|Lost to Follow-up|2|||
156556625|NCT04537208|565128430|FG010|Overall Study|Lost to Follow-up|2|||
156556626|NCT00704964|565128432|FG000|Overall Study|Not completed on time|328|||
156556627|NCT02161562|565128434|FG000|Overall Study|Withdrawal by Subject|5|||
156556628|NCT02161562|565128435|FG001|Overall Study|Withdrawal by Subject|8|||
156556629|NCT02161562|565128434|FG000|Overall Study|Protocol Violation|9|||
156556630|NCT02161562|565128435|FG001|Overall Study|Protocol Violation|4|||
156556631|NCT02161562|565128434|FG000|Overall Study|Pregnancy|1|||
156556632|NCT02161562|565128435|FG001|Overall Study|Pregnancy|2|||
156556633|NCT02161562|565128434|FG000|Overall Study|Lost to Follow-up|3|||
156556634|NCT02161562|565128435|FG001|Overall Study|Lost to Follow-up|1|||
156556635|NCT02161562|565128434|FG000|Overall Study|Lack of Efficacy|4|||
156556636|NCT02161562|565128435|FG001|Overall Study|Lack of Efficacy|1|||
156556637|NCT02161562|565128434|FG000|Overall Study|Adverse Event|1|||
156556638|NCT02161562|565128435|FG001|Overall Study|Adverse Event|1|||
156556639|NCT02161562|565128434|FG000|Overall Study|Participant moved back to home country|1|||
156556640|NCT02161562|565128435|FG001|Overall Study|Participant moved back to home country|0|||
156556641|NCT02161562|565128434|FG000|Overall Study|Withdrew due to being out of the country|1|||
156556642|NCT02161562|565128435|FG001|Overall Study|Withdrew due to being out of the country|0|||
156556643|NCT02161562|565128434|FG000|Overall Study|Participant moved out of province|1|||
156556644|NCT02161562|565128435|FG001|Overall Study|Participant moved out of province|0|||
156556645|NCT00197054|565128451|FG000|Overall Study|Withdrawal by Subject|9|||
156407325|NCT01709305|564584769|FG000|Phase 2|Death|0|||
156407326|NCT01709305|564584770|FG001|Phase 2|Death|0|||
156407327|NCT01709305|564584771|FG002|Phase 2|Death|1|||
156556646|NCT00197054|565128452|FG001|Overall Study|Withdrawal by Subject|3|||
156556647|NCT00197054|565128453|FG002|Overall Study|Withdrawal by Subject|3|||
156556648|NCT00197054|565128451|FG000|Overall Study|Moved from area|7|||
156556649|NCT00197054|565128452|FG001|Overall Study|Moved from area|14|||
156556650|NCT00197054|565128453|FG002|Overall Study|Moved from area|9|||
156556651|NCT00197054|565128451|FG000|Overall Study|Lost to Follow-up|1|||
156556652|NCT00197054|565128452|FG001|Overall Study|Lost to Follow-up|4|||
156556653|NCT00197054|565128453|FG002|Overall Study|Lost to Follow-up|0|||
156556654|NCT00323557|565128454|FG000|Overall Study|Physician Decision|1|||
156556655|NCT00323557|565128455|FG001|Overall Study|Physician Decision|0|||
156556656|NCT00684515|565128456|FG000|Overall Study|Adverse Event|3|||
156556657|NCT00684515|565128457|FG001|Overall Study|Adverse Event|3|||
156556658|NCT00684515|565128458|FG002|Overall Study|Adverse Event|1|||
156556659|NCT00684515|565128456|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
156556660|NCT00684515|565128457|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
156556661|NCT00684515|565128458|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
156556662|NCT02450578|565128459|FG000|Overall Study|ECG abnormality so not treated|1|||
156556663|NCT02450578|565128460|FG001|Overall Study|ECG abnormality so not treated|0|||
156556664|NCT02450578|565128461|FG002|Overall Study|ECG abnormality so not treated|0|||
156556665|NCT02450578|565128462|FG003|Overall Study|ECG abnormality so not treated|0|||
156556666|NCT00094757|565128464|FG000|Overall Study|Adverse Event|11|||
156407328|NCT01709305|564584772|FG003|Phase 2|Death|0|||
156407329|NCT01709305|564584773|FG004|Phase 2|Death|0|||
156407330|NCT01709305|564584769|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
156556667|NCT00094757|565128465|FG001|Overall Study|Adverse Event|9|||
156556668|NCT00094757|565128466|FG002|Overall Study|Adverse Event|6|||
156556669|NCT00094757|565128464|FG000|Overall Study|Lack of Efficacy|11|||
156556670|NCT00094757|565128465|FG001|Overall Study|Lack of Efficacy|15|||
156556671|NCT00094757|565128466|FG002|Overall Study|Lack of Efficacy|8|||
156556672|NCT00094757|565128464|FG000|Overall Study|Lost to Follow-up|3|||
156407331|NCT01709305|564584770|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
156556673|NCT00094757|565128465|FG001|Overall Study|Lost to Follow-up|5|||
156556674|NCT00094757|565128466|FG002|Overall Study|Lost to Follow-up|6|||
156556675|NCT00094757|565128464|FG000|Overall Study|Patient Moved|2|||
156556676|NCT00094757|565128465|FG001|Overall Study|Patient Moved|1|||
156556677|NCT00094757|565128466|FG002|Overall Study|Patient Moved|1|||
156556678|NCT00094757|565128464|FG000|Overall Study|Protocol Violation|8|||
156556679|NCT00094757|565128465|FG001|Overall Study|Protocol Violation|5|||
156556680|NCT00094757|565128466|FG002|Overall Study|Protocol Violation|3|||
156556681|NCT00094757|565128464|FG000|Overall Study|Withdrawal by Subject|14|||
156556682|NCT00094757|565128465|FG001|Overall Study|Withdrawal by Subject|21|||
156556683|NCT00094757|565128466|FG002|Overall Study|Withdrawal by Subject|5|||
156407332|NCT01709305|564584771|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
156556684|NCT00094757|565128464|FG000|Overall Study|Other|3|||
156556685|NCT00094757|565128465|FG001|Overall Study|Other|3|||
156556686|NCT00094757|565128466|FG002|Overall Study|Other|1|||
156556687|NCT00094757|565128464|FG000|Overall Study|Protocol specified discontinuation|1|||
156556688|NCT00094757|565128465|FG001|Overall Study|Protocol specified discontinuation|3|||
156556689|NCT00094757|565128466|FG002|Overall Study|Protocol specified discontinuation|0|||
156556690|NCT03021642|565128470|FG000|Washout Period (21 Days)|Adverse Event|1|||
156556691|NCT03021642|565128471|FG001|Washout Period (21 Days)|Adverse Event|1|||
156556692|NCT01192347|565128472|FG000|Overall Study|Death|3|||
156556693|NCT01192347|565128472|FG000|Overall Study|Lost to Follow-up|3|||
156556694|NCT01192347|565128472|FG000|Overall Study|Withdrawal by Subject|1|||
156556695|NCT01192347|565128472|FG000|Overall Study|Adverse Event|1|||
156556696|NCT01192347|565128472|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
156556697|NCT01192347|565128472|FG000|Overall Study|Patient seen in different hospital|1|||
156556698|NCT01192347|565128472|FG000|Overall Study|Patient not visiting hospital regularly|1|||
156556699|NCT01192347|565128472|FG000|Overall Study|Patient did not show up for visits|1|||
156556700|NCT02623335|565128473|FG000|Overall Study|Death|8|||
156556701|NCT02623335|565128474|FG001|Overall Study|Death|7|||
156556702|NCT02623335|565128473|FG000|Overall Study|Lost to Follow-up|15|||
156556703|NCT02623335|565128474|FG001|Overall Study|Lost to Follow-up|23|||
156556704|NCT02623335|565128473|FG000|Overall Study|Withdrawal by Subject|2|||
156556705|NCT02623335|565128474|FG001|Overall Study|Withdrawal by Subject|5|||
156556706|NCT02623335|565128473|FG000|Overall Study|Protocol Violation|2|||
156556707|NCT02623335|565128474|FG001|Overall Study|Protocol Violation|1|||
156556708|NCT00090545|565128475|FG000|Overall Study|Disease progression on study|21|||
156556709|NCT00090545|565128476|FG001|Overall Study|Disease progression on study|17|||
156556710|NCT00090545|565128475|FG000|Overall Study|Refused further treatment|1|||
156556711|NCT00090545|565128476|FG001|Overall Study|Refused further treatment|4|||
156556712|NCT00090545|565128475|FG000|Overall Study|Death|0|||
156556713|NCT00090545|565128476|FG001|Overall Study|Death|1|||
156556714|NCT00090545|565128475|FG000|Overall Study|Adverse Event|0|||
156556715|NCT00090545|565128476|FG001|Overall Study|Adverse Event|2|||
156556716|NCT03433781|565128478|FG000|Overall Study|Progression of Disease|1|||
156556717|NCT03433781|565128479|FG001|Overall Study|Progression of Disease|0|||
156556718|NCT03433781|565128480|FG002|Overall Study|Progression of Disease|0|||
156556719|NCT03433781|565128478|FG000|Overall Study|Physician Decision|0|||
156556720|NCT03433781|565128479|FG001|Overall Study|Physician Decision|1|||
156556721|NCT03433781|565128480|FG002|Overall Study|Physician Decision|0|||
156556722|NCT00408694|565128481|FG000|Overall Study|Ineligible|1|||
156556723|NCT00408694|565128481|FG000|Overall Study|No protocol treatment|1|||
156556724|NCT00087646|565128484|FG000|Overall Study|Adverse Event|37|||
156556725|NCT00087646|565128485|FG001|Overall Study|Adverse Event|6|||
156556726|NCT00087646|565128486|FG002|Overall Study|Adverse Event|18|||
156556727|NCT00087646|565128487|FG003|Overall Study|Adverse Event|20|||
156556728|NCT00087646|565128484|FG000|Overall Study|Death|0|||
156556729|NCT00087646|565128485|FG001|Overall Study|Death|1|||
156556730|NCT00087646|565128486|FG002|Overall Study|Death|0|||
156556731|NCT00087646|565128487|FG003|Overall Study|Death|0|||
156556732|NCT00087646|565128484|FG000|Overall Study|Withdrawal by Subject|6|||
156556733|NCT00087646|565128485|FG001|Overall Study|Withdrawal by Subject|1|||
156556734|NCT00087646|565128486|FG002|Overall Study|Withdrawal by Subject|2|||
156556735|NCT00087646|565128487|FG003|Overall Study|Withdrawal by Subject|2|||
156556736|NCT00087646|565128484|FG000|Overall Study|Insufficient therapeutic response|64|||
156556737|NCT00087646|565128485|FG001|Overall Study|Insufficient therapeutic response|24|||
156556738|NCT00087646|565128486|FG002|Overall Study|Insufficient therapeutic response|38|||
156556739|NCT00087646|565128487|FG003|Overall Study|Insufficient therapeutic response|51|||
156556740|NCT00087646|565128484|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
156556741|NCT00087646|565128485|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
156556742|NCT00087646|565128486|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
156556743|NCT00087646|565128487|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
156556744|NCT00087646|565128484|FG000|Overall Study|Failure to Return|5|||
156556745|NCT00087646|565128485|FG001|Overall Study|Failure to Return|2|||
156556746|NCT00087646|565128486|FG002|Overall Study|Failure to Return|2|||
156407333|NCT01709305|564584772|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
156407334|NCT01709305|564584773|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
156407335|NCT01709305|564584769|FG000|Phase 2|Laboratory Adverse Event|0|||
156407336|NCT01709305|564584770|FG001|Phase 2|Laboratory Adverse Event|1|||
156407337|NCT01709305|564584771|FG002|Phase 2|Laboratory Adverse Event|0|||
156407338|NCT01709305|564584772|FG003|Phase 2|Laboratory Adverse Event|1|||
156407339|NCT01709305|564584773|FG004|Phase 2|Laboratory Adverse Event|1|||
156407340|NCT01709305|564584769|FG000|Phase 2|Lost to Follow-up|0|||
156556747|NCT00087646|565128487|FG003|Overall Study|Failure to Return|3|||
156556748|NCT00087646|565128484|FG000|Overall Study|Administrative/Other|6|||
156556749|NCT00087646|565128485|FG001|Overall Study|Administrative/Other|1|||
156556750|NCT00087646|565128486|FG002|Overall Study|Administrative/Other|1|||
156556751|NCT00087646|565128487|FG003|Overall Study|Administrative/Other|2|||
156556752|NCT00087646|565128484|FG000|Overall Study|Other Protocol Violation|3|||
156556753|NCT00087646|565128485|FG001|Overall Study|Other Protocol Violation|1|||
156407341|NCT01709305|564584770|FG001|Phase 2|Lost to Follow-up|10|||
156556754|NCT00087646|565128486|FG002|Overall Study|Other Protocol Violation|0|||
156556755|NCT00087646|565128487|FG003|Overall Study|Other Protocol Violation|0|||
156556756|NCT00087646|565128484|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
156556757|NCT00087646|565128485|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
156556758|NCT00087646|565128486|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
156556759|NCT00087646|565128487|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
156556760|NCT03979274|565128490|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156556761|NCT03979274|565128491|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156556762|NCT01060059|565128494|FG000|Overall Study|Adverse Event|1|||
156556763|NCT01060059|565128495|FG001|Overall Study|Adverse Event|1|||
156556764|NCT01060059|565128494|FG000|Overall Study|Death|2|||
156556765|NCT01060059|565128495|FG001|Overall Study|Death|3|||
156556766|NCT01060059|565128494|FG000|Overall Study|Lost to Follow-up|18|||
156556767|NCT01060059|565128495|FG001|Overall Study|Lost to Follow-up|34|||
156556768|NCT01060059|565128494|FG000|Overall Study|entry criteria not met|4|||
156556769|NCT01060059|565128495|FG001|Overall Study|entry criteria not met|3|||
156556770|NCT01060059|565128494|FG000|Overall Study|Withdrawal by Subject|35|||
156556771|NCT01060059|565128495|FG001|Overall Study|Withdrawal by Subject|23|||
156556772|NCT01060059|565128494|FG000|Overall Study|lack of glycemic control|2|||
156556773|NCT01060059|565128495|FG001|Overall Study|lack of glycemic control|1|||
156556774|NCT01060059|565128494|FG000|Overall Study|lack of compliance|5|||
156556775|NCT01060059|565128495|FG001|Overall Study|lack of compliance|2|||
156556776|NCT02302963|565128496|FG000|Overall Study|Withdrawal by Subject|2|||
156556777|NCT02302963|565128497|FG001|Overall Study|Withdrawal by Subject|1|||
156556778|NCT02302963|565128496|FG000|Overall Study|Steroid injection|0|||
156556779|NCT02302963|565128497|FG001|Overall Study|Steroid injection|1|||
156556780|NCT02302963|565128496|FG000|Overall Study|Physician Decision|1|||
156556781|NCT02302963|565128497|FG001|Overall Study|Physician Decision|0|||
156556782|NCT01614093|565128498|FG000|Overall Study|Withdrawal by Subject|1|||
156556783|NCT02317562|565128499|FG000|Overall Study|Physician Decision|1|||
156556784|NCT02317562|565128499|FG000|Overall Study|early termination of the study|8|||
156556785|NCT02317562|565128499|FG000|Overall Study|Lack of Efficacy|4|||
156556786|NCT02317562|565128499|FG000|Overall Study|Withdrawal by Subject|1|||
156556787|NCT03551743|565128500|FG000|Overall Study|Adverse Event|1|||
156556788|NCT03551743|565128501|FG001|Overall Study|Adverse Event|0|||
156556789|NCT03551743|565128502|FG002|Overall Study|Adverse Event|0|||
156556790|NCT03551743|565128503|FG003|Overall Study|Adverse Event|0|||
156556791|NCT03551743|565128500|FG000|Overall Study|Withdrawal by Subject|1|||
156556792|NCT03551743|565128501|FG001|Overall Study|Withdrawal by Subject|0|||
156556793|NCT03551743|565128502|FG002|Overall Study|Withdrawal by Subject|0|||
156556794|NCT03551743|565128503|FG003|Overall Study|Withdrawal by Subject|0|||
156407342|NCT01709305|564584771|FG002|Phase 2|Lost to Follow-up|6|||
156407343|NCT01709305|564584772|FG003|Phase 2|Lost to Follow-up|9|||
156407344|NCT01709305|564584773|FG004|Phase 2|Lost to Follow-up|5|||
156407345|NCT01709305|564584769|FG000|Phase 2|Travel, moving, etc.|0|||
156407346|NCT01709305|564584770|FG001|Phase 2|Travel, moving, etc.|2|||
156407347|NCT01709305|564584771|FG002|Phase 2|Travel, moving, etc.|3|||
156407348|NCT01709305|564584772|FG003|Phase 2|Travel, moving, etc.|3|||
156407349|NCT01709305|564584773|FG004|Phase 2|Travel, moving, etc.|5|||
156407350|NCT01709305|564584769|FG000|Phase 2|Physician Decision|0|||
156407351|NCT01709305|564584770|FG001|Phase 2|Physician Decision|2|||
156407352|NCT01709305|564584771|FG002|Phase 2|Physician Decision|0|||
156407353|NCT01709305|564584772|FG003|Phase 2|Physician Decision|1|||
156556795|NCT00603915|565128504|FG000|Overall Study|Physician Decision|1|||
156556796|NCT03891901|565128505|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
156556797|NCT03891901|565128506|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156556798|NCT03891901|565128507|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156556799|NCT03891901|565128508|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156556800|NCT03891901|565128509|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156556801|NCT03891901|565128510|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156556802|NCT03891901|565128511|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156556803|NCT03891901|565128512|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156556804|NCT03891901|565128513|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156556805|NCT03891901|565128505|FG000|Overall Study|Adverse Event|2|||
156556806|NCT03891901|565128506|FG001|Overall Study|Adverse Event|2|||
156556807|NCT03891901|565128507|FG002|Overall Study|Adverse Event|0|||
156556808|NCT03891901|565128508|FG003|Overall Study|Adverse Event|0|||
156556809|NCT03891901|565128509|FG004|Overall Study|Adverse Event|0|||
156556810|NCT03891901|565128510|FG005|Overall Study|Adverse Event|0|||
156556811|NCT03891901|565128511|FG006|Overall Study|Adverse Event|0|||
156556812|NCT03891901|565128512|FG007|Overall Study|Adverse Event|0|||
156407354|NCT01709305|564584773|FG004|Phase 2|Physician Decision|2|||
156407355|NCT01709305|564584769|FG000|Phase 2|Protocol Violation|0|||
156407356|NCT01709305|564584770|FG001|Phase 2|Protocol Violation|19|||
156407357|NCT01709305|564584771|FG002|Phase 2|Protocol Violation|19|||
156407358|NCT01709305|564584772|FG003|Phase 2|Protocol Violation|13|||
156556813|NCT03891901|565128513|FG008|Overall Study|Adverse Event|0|||
156556814|NCT03891901|565128505|FG000|Overall Study|Poor venous access|1|||
156556815|NCT03891901|565128506|FG001|Overall Study|Poor venous access|0|||
156556816|NCT03891901|565128507|FG002|Overall Study|Poor venous access|0|||
156556817|NCT03891901|565128508|FG003|Overall Study|Poor venous access|0|||
156556818|NCT03891901|565128509|FG004|Overall Study|Poor venous access|0|||
156556819|NCT03891901|565128510|FG005|Overall Study|Poor venous access|0|||
156556820|NCT03891901|565128511|FG006|Overall Study|Poor venous access|0|||
156556821|NCT03891901|565128512|FG007|Overall Study|Poor venous access|0|||
156556822|NCT03891901|565128513|FG008|Overall Study|Poor venous access|0|||
156556823|NCT03891901|565128505|FG000|Overall Study|Withdrawal by Subject|0|||
156556824|NCT03891901|565128506|FG001|Overall Study|Withdrawal by Subject|2|||
156556825|NCT03891901|565128507|FG002|Overall Study|Withdrawal by Subject|0|||
156556826|NCT03891901|565128508|FG003|Overall Study|Withdrawal by Subject|0|||
156556827|NCT03891901|565128509|FG004|Overall Study|Withdrawal by Subject|0|||
156556828|NCT03891901|565128510|FG005|Overall Study|Withdrawal by Subject|0|||
156556829|NCT03891901|565128511|FG006|Overall Study|Withdrawal by Subject|0|||
156556830|NCT03891901|565128512|FG007|Overall Study|Withdrawal by Subject|0|||
156556831|NCT03891901|565128513|FG008|Overall Study|Withdrawal by Subject|0|||
156556832|NCT01724528|565128517|FG000|Overall Study|Death|3|||
156556833|NCT01724528|565128518|FG001|Overall Study|Death|0|||
156556834|NCT01724528|565128517|FG000|Overall Study|Withdrawal by Subject|0|||
156556835|NCT01724528|565128518|FG001|Overall Study|Withdrawal by Subject|2|||
156556836|NCT01724528|565128517|FG000|Overall Study|Protocol Violation|0|||
156556837|NCT01724528|565128518|FG001|Overall Study|Protocol Violation|1|||
156556838|NCT01724528|565128517|FG000|Overall Study|Patient refused to attend last visit|1|||
156556839|NCT01724528|565128518|FG001|Overall Study|Patient refused to attend last visit|0|||
156556840|NCT05574062|565128519|FG000|Pre Run-In|Screening failure|3|||
156556841|NCT05574062|565128520|FG001|Pre Run-In|Screening failure|0|||
156556842|NCT05574062|565128521|FG002|Pre Run-In|Screening failure|0|||
156556843|NCT05574062|565128522|FG003|Pre Run-In|Screening failure|0|||
156556844|NCT05574062|565128523|FG004|Pre Run-In|Screening failure|0|||
156556845|NCT05574062|565128519|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
156556846|NCT05574062|565128520|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
156556847|NCT05574062|565128521|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
156556848|NCT05574062|565128522|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
156556849|NCT05574062|565128523|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
156556850|NCT05574062|565128519|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
156556851|NCT05574062|565128520|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
156556852|NCT05574062|565128521|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
156556853|NCT05574062|565128522|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
156556854|NCT05574062|565128523|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
156556855|NCT05574062|565128519|FG000|Continuation Phase Period 1|Physician Decision|1|||
156556856|NCT05574062|565128520|FG001|Continuation Phase Period 1|Physician Decision|0|||
156556857|NCT05574062|565128521|FG002|Continuation Phase Period 1|Physician Decision|0|||
156556858|NCT05574062|565128522|FG003|Continuation Phase Period 1|Physician Decision|0|||
156556859|NCT05574062|565128523|FG004|Continuation Phase Period 1|Physician Decision|0|||
156556860|NCT05574062|565128519|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
156556861|NCT05574062|565128520|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
156556862|NCT05574062|565128521|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
156556863|NCT05574062|565128522|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
156556864|NCT05574062|565128523|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
156556865|NCT05574062|565128519|FG000|Continuation Phase Period 1|Adverse Event|1|||
156556866|NCT05574062|565128520|FG001|Continuation Phase Period 1|Adverse Event|0|||
156556867|NCT05574062|565128521|FG002|Continuation Phase Period 1|Adverse Event|0|||
156556868|NCT05574062|565128522|FG003|Continuation Phase Period 1|Adverse Event|0|||
156556869|NCT05574062|565128523|FG004|Continuation Phase Period 1|Adverse Event|0|||
156556870|NCT05574062|565128519|FG000|Continuation Phase Period 1|Death|1|||
156556871|NCT05574062|565128520|FG001|Continuation Phase Period 1|Death|0|||
156556872|NCT05574062|565128521|FG002|Continuation Phase Period 1|Death|0|||
156556873|NCT05574062|565128522|FG003|Continuation Phase Period 1|Death|0|||
156556874|NCT05574062|565128523|FG004|Continuation Phase Period 1|Death|0|||
156556875|NCT05574062|565128519|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
156556876|NCT05574062|565128520|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
156556877|NCT05574062|565128521|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
156556878|NCT05574062|565128522|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
156556879|NCT05574062|565128523|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
156556880|NCT02482129|565128526|FG000|Overall Study|Adverse Event-prior to treatment|0|||
156556881|NCT02482129|565128527|FG001|Overall Study|Adverse Event-prior to treatment|1|||
156556882|NCT02482129|565128526|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
156556883|NCT02482129|565128527|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
156556884|NCT02482129|565128526|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
156556885|NCT02482129|565128527|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
156556886|NCT02482129|565128526|FG000|Overall Study|Criteria not met-prior to treatment|1|||
156556887|NCT02482129|565128527|FG001|Overall Study|Criteria not met-prior to treatment|0|||
156556888|NCT02482129|565128526|FG000|Overall Study|Adverse Event|1|||
156556889|NCT02482129|565128527|FG001|Overall Study|Adverse Event|0|||
156556890|NCT02482129|565128526|FG000|Overall Study|Withdrawal by Subject|2|||
156556891|NCT02482129|565128527|FG001|Overall Study|Withdrawal by Subject|0|||
156556892|NCT02482129|565128526|FG000|Overall Study|Criteria not met|1|||
156556893|NCT02482129|565128527|FG001|Overall Study|Criteria not met|0|||
156556894|NCT01877083|565128528|FG000|Treatment Phase|Disease Progression|10|||
156556895|NCT01877083|565128528|FG000|Treatment Phase|Clinical Progression|1|||
156556896|NCT01877083|565128528|FG000|Treatment Phase|Adverse Event|6|||
156556897|NCT01877083|565128528|FG000|Treatment Phase|Withdrawal by Subject|2|||
156556898|NCT01877083|565128528|FG000|Treatment Phase|Lost to Follow-up|1|||
156556899|NCT01877083|565128528|FG000|Extension Phase|Disease Progression|3|||
156556900|NCT01877083|565128528|FG000|Extension Phase|Adverse Event|2|||
156556901|NCT00429585|565128531|FG000|Overall Study|Death|1|||
156556902|NCT00429585|565128532|FG001|Overall Study|Death|0|||
156556903|NCT00429585|565128531|FG000|Overall Study|Lost to Follow-up|27|||
156556904|NCT00429585|565128532|FG001|Overall Study|Lost to Follow-up|20|||
156556905|NCT00429585|565128531|FG000|Overall Study|Physician Decision|2|||
156556906|NCT00429585|565128532|FG001|Overall Study|Physician Decision|0|||
156556907|NCT01582308|565128533|FG000|Period 1|Withdrawal by Subject|0|||
156556908|NCT01582308|565128534|FG001|Period 1|Withdrawal by Subject|0|||
156556909|NCT01582308|565128535|FG002|Period 1|Withdrawal by Subject|0|||
156556910|NCT01582308|565128536|FG003|Period 1|Withdrawal by Subject|0|||
156556911|NCT01582308|565128537|FG004|Period 1|Withdrawal by Subject|0|||
156556912|NCT01582308|565128538|FG005|Period 1|Withdrawal by Subject|0|||
156556913|NCT01582308|565128539|FG006|Period 1|Withdrawal by Subject|1|||
156556914|NCT01582308|565128540|FG007|Period 1|Withdrawal by Subject|0|||
156556915|NCT01582308|565128541|FG008|Period 1|Withdrawal by Subject|0|||
156556916|NCT01582308|565128542|FG009|Period 1|Withdrawal by Subject|0|||
156556917|NCT01582308|565128533|FG000|10-day Washout Following Period 1|Physician Decision|0|||
156556918|NCT01582308|565128534|FG001|10-day Washout Following Period 1|Physician Decision|0|||
156556919|NCT01582308|565128535|FG002|10-day Washout Following Period 1|Physician Decision|0|||
156556920|NCT01582308|565128536|FG003|10-day Washout Following Period 1|Physician Decision|0|||
156556921|NCT01582308|565128537|FG004|10-day Washout Following Period 1|Physician Decision|1|||
156556922|NCT01582308|565128538|FG005|10-day Washout Following Period 1|Physician Decision|0|||
156556923|NCT01582308|565128539|FG006|10-day Washout Following Period 1|Physician Decision|0|||
156556924|NCT01582308|565128540|FG007|10-day Washout Following Period 1|Physician Decision|0|||
156556925|NCT01582308|565128541|FG008|10-day Washout Following Period 1|Physician Decision|0|||
156556926|NCT01582308|565128542|FG009|10-day Washout Following Period 1|Physician Decision|0|||
156556927|NCT01582308|565128533|FG000|Period 4|Physician Decision|1|||
156556928|NCT01582308|565128534|FG001|Period 4|Physician Decision|0|||
156556929|NCT01582308|565128535|FG002|Period 4|Physician Decision|0|||
156556930|NCT01582308|565128536|FG003|Period 4|Physician Decision|0|||
156556931|NCT01582308|565128537|FG004|Period 4|Physician Decision|0|||
156556932|NCT01582308|565128538|FG005|Period 4|Physician Decision|1|||
156556933|NCT01582308|565128539|FG006|Period 4|Physician Decision|0|||
156556934|NCT01582308|565128540|FG007|Period 4|Physician Decision|0|||
156556935|NCT01582308|565128541|FG008|Period 4|Physician Decision|0|||
156556936|NCT01582308|565128542|FG009|Period 4|Physician Decision|1|||
156556937|NCT00684957|565128546|FG000|Overall Study|Withdrawal by Subject|1|||
156556938|NCT00684957|565128547|FG001|Overall Study|Withdrawal by Subject|1|||
156556939|NCT00684957|565128546|FG000|Overall Study|Lost to Follow-up|1|||
156556940|NCT00684957|565128547|FG001|Overall Study|Lost to Follow-up|0|||
156556941|NCT04341948|565128548|FG000|Overall Study|Adverse Event|0|||
156556942|NCT04341948|565128549|FG001|Overall Study|Adverse Event|1|||
156556943|NCT04341948|565128548|FG000|Overall Study|Lost to Follow-up|6|||
156556944|NCT04341948|565128549|FG001|Overall Study|Lost to Follow-up|1|||
156556945|NCT04341948|565128548|FG000|Overall Study|Physician Decision|1|||
156556946|NCT04341948|565128549|FG001|Overall Study|Physician Decision|2|||
156556947|NCT04341948|565128548|FG000|Overall Study|Withdrawal by Participant|6|||
156556948|NCT04341948|565128549|FG001|Overall Study|Withdrawal by Participant|3|||
156556949|NCT04341948|565128548|FG000|Overall Study|Lack of compliance by Participant|1|||
156556950|NCT04341948|565128549|FG001|Overall Study|Lack of compliance by Participant|0|||
156556951|NCT03406897|565128550|FG000|Overall Study|Lost to Follow-up|1|||
156556952|NCT03406897|565128551|FG001|Overall Study|Lost to Follow-up|2|||
156407359|NCT01709305|564584773|FG004|Phase 2|Protocol Violation|9|||
156556953|NCT03406897|565128550|FG000|Overall Study|Withdrawal by Subject|4|||
156556954|NCT03406897|565128551|FG001|Overall Study|Withdrawal by Subject|4|||
156556955|NCT03406897|565128550|FG000|Overall Study|Physician Decision|0|||
156556956|NCT03406897|565128551|FG001|Overall Study|Physician Decision|1|||
156556957|NCT02624492|565130101|FG000|Overall Study|Adverse Event|2|||
156556958|NCT02624492|565130102|FG001|Overall Study|Adverse Event|2|||
156556959|NCT02624492|565130103|FG002|Overall Study|Adverse Event|2|||
156556960|NCT02624492|565130101|FG000|Overall Study|Progressive disease|0|||
156556961|NCT02624492|565130102|FG001|Overall Study|Progressive disease|2|||
156556962|NCT02624492|565130103|FG002|Overall Study|Progressive disease|3|||
156407360|NCT01709305|564584769|FG000|Phase 2|Withdrawal by Subject|0|||
156556963|NCT00343512|565130109|FG000|Overall Study|Withdrawal by Subject|2|||
156556964|NCT04428411|565130112|FG000|Overall Study|Lost to Follow-up|114|||
156556965|NCT00634569|565130113|FG000|Overall Study|Withdrawal by Subject|0|||
156556966|NCT00634569|565130114|FG001|Overall Study|Withdrawal by Subject|4|||
156556967|NCT00634569|565130113|FG000|Overall Study|Physician Decision|0|||
156556968|NCT00634569|565130114|FG001|Overall Study|Physician Decision|1|||
156556969|NCT01163786|565130115|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
156556970|NCT01163786|565130115|FG000|Treatment With Bortezomib|Adverse Event|2|||
156556971|NCT01163786|565130115|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
156556972|NCT02918019|565130116|FG000|Overall Study|Death|0|||
156556973|NCT02918019|565130117|FG001|Overall Study|Death|0|||
156556974|NCT02918019|565130118|FG002|Overall Study|Death|1|||
156556975|NCT02918019|565130119|FG003|Overall Study|Death|0|||
156556976|NCT02918019|565130116|FG000|Overall Study|Lost to Follow-up|1|||
156556977|NCT02918019|565130117|FG001|Overall Study|Lost to Follow-up|1|||
156556978|NCT02918019|565130118|FG002|Overall Study|Lost to Follow-up|0|||
156556979|NCT02918019|565130119|FG003|Overall Study|Lost to Follow-up|1|||
156556980|NCT02918019|565130116|FG000|Overall Study|Principal investigator request|0|||
156556981|NCT02918019|565130117|FG001|Overall Study|Principal investigator request|0|||
156556982|NCT02918019|565130118|FG002|Overall Study|Principal investigator request|0|||
156556983|NCT02918019|565130119|FG003|Overall Study|Principal investigator request|1|||
156407361|NCT01709305|564584770|FG001|Phase 2|Withdrawal by Subject|8|||
156407362|NCT01709305|564584771|FG002|Phase 2|Withdrawal by Subject|6|||
156407363|NCT01709305|564584772|FG003|Phase 2|Withdrawal by Subject|15|||
156407364|NCT01709305|564584773|FG004|Phase 2|Withdrawal by Subject|12|||
156407365|NCT03443713|564584776|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
156407366|NCT03443713|564584777|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
156407367|NCT03443713|564584778|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
156513263|NCT01725126|564970690|FG001|Overall Study|Protocol Violation|1|||
156513264|NCT01725126|564970691|FG002|Overall Study|Protocol Violation|0|||
156513265|NCT01725126|564970692|FG003|Overall Study|Protocol Violation|0|||
156513266|NCT01725126|564970693|FG004|Overall Study|Protocol Violation|0|||
156513267|NCT01725126|564970694|FG005|Overall Study|Protocol Violation|0|||
156513268|NCT01725126|564970689|FG000|Overall Study|Withdrawal by Subject|0|||
156513269|NCT01725126|564970690|FG001|Overall Study|Withdrawal by Subject|0|||
156513270|NCT01725126|564970691|FG002|Overall Study|Withdrawal by Subject|0|||
156513271|NCT01725126|564970692|FG003|Overall Study|Withdrawal by Subject|1|||
156513272|NCT01725126|564970693|FG004|Overall Study|Withdrawal by Subject|0|||
156513273|NCT01725126|564970694|FG005|Overall Study|Withdrawal by Subject|0|||
156513274|NCT03733314|564970695|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
156513275|NCT03733314|564970696|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
156513276|NCT03733314|564970695|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
156513277|NCT03733314|564970696|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
156513278|NCT03733314|564970695|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
156513279|NCT03733314|564970696|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
156513280|NCT03733314|564970695|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
156513281|NCT03733314|564970696|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
156513282|NCT03733314|564970695|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
156513283|NCT03733314|564970696|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
156513284|NCT03733314|564970695|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
156513285|NCT03733314|564970696|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
156513286|NCT03214640|564970697|FG000|Overall Study|Protocol Violation|1|||
156513287|NCT03214640|564970698|FG001|Overall Study|Protocol Violation|2|||
156513288|NCT03214640|564970699|FG002|Overall Study|Protocol Violation|1|||
156513289|NCT03214640|564970700|FG003|Overall Study|Protocol Violation|4|||
156513290|NCT00468143|564970706|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
156513291|NCT00468143|564970707|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
156513292|NCT00468143|564970706|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
156513293|NCT00468143|564970707|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
156513294|NCT01204710|564970712|FG000|Randomization Treatment|Lost to Follow-up|1|||
156513295|NCT01204710|564970713|FG001|Randomization Treatment|Lost to Follow-up|0|||
156513296|NCT01204710|564970712|FG000|Randomization Treatment|Withdrawal by Subject|6|||
156513297|NCT01204710|564970713|FG001|Randomization Treatment|Withdrawal by Subject|5|||
156513298|NCT01204710|564970712|FG000|Randomization Treatment|Physician Decision|3|||
156513299|NCT01204710|564970713|FG001|Randomization Treatment|Physician Decision|2|||
156513300|NCT01204710|564970712|FG000|Randomization Treatment|Entry criteria not met|0|||
156513301|NCT01204710|564970713|FG001|Randomization Treatment|Entry criteria not met|1|||
156513302|NCT01204710|564970712|FG000|Randomization Treatment|Adverse Event|4|||
156513303|NCT01204710|564970713|FG001|Randomization Treatment|Adverse Event|2|||
156513304|NCT01204710|564970712|FG000|Randomization Treatment|Sponsor Decision|0|||
156513305|NCT01204710|564970713|FG001|Randomization Treatment|Sponsor Decision|1|||
156556984|NCT02918019|565130116|FG000|Overall Study|Physician Decision|1|||
156556985|NCT02918019|565130117|FG001|Overall Study|Physician Decision|3|||
156556986|NCT02918019|565130118|FG002|Overall Study|Physician Decision|2|||
156556987|NCT02918019|565130119|FG003|Overall Study|Physician Decision|0|||
156556988|NCT02918019|565130116|FG000|Overall Study|Protocol deviation|1|||
156556989|NCT02918019|565130117|FG001|Overall Study|Protocol deviation|1|||
156556990|NCT02918019|565130118|FG002|Overall Study|Protocol deviation|0|||
156556991|NCT02918019|565130119|FG003|Overall Study|Protocol deviation|2|||
156556992|NCT02918019|565130116|FG000|Overall Study|Withdrawal by Subject|3|||
156556993|NCT02918019|565130117|FG001|Overall Study|Withdrawal by Subject|4|||
156556994|NCT02918019|565130118|FG002|Overall Study|Withdrawal by Subject|6|||
156556995|NCT02918019|565130119|FG003|Overall Study|Withdrawal by Subject|4|||
156556996|NCT02918019|565130116|FG000|Overall Study|Adverse Event|0|||
156556997|NCT02918019|565130117|FG001|Overall Study|Adverse Event|1|||
156556998|NCT02918019|565130118|FG002|Overall Study|Adverse Event|0|||
156556999|NCT02918019|565130119|FG003|Overall Study|Adverse Event|1|||
156557000|NCT01212185|565130120|FG000|Overall Study|Protocol Violation|2|||
156557001|NCT01212185|565130121|FG001|Overall Study|Protocol Violation|1|||
156557002|NCT03555266|565130122|FG000|Overall Study|Protocol Violation|6|||
156557003|NCT03555266|565130123|FG001|Overall Study|Protocol Violation|4|||
156557004|NCT03370770|565130124|FG000|Overall Study|Patient was followed in another hospital center|1|||
156557005|NCT03370770|565130124|FG000|Overall Study|Progressive Disease|98|||
156557006|NCT03370770|565130124|FG000|Overall Study|Adverse Event|2|||
156557007|NCT03370770|565130124|FG000|Overall Study|Death|5|||
156557008|NCT01699087|565130128|FG000|Overall Study|Lost to Follow-up|7|||
156557009|NCT01699087|565130128|FG000|Overall Study|Screen failure (prior to treatment)|15|||
156557010|NCT01699087|565130128|FG000|Overall Study|Unable to make future visits|2|||
156557011|NCT02167945|565130129|FG000|Overall Study|Adverse Event|16|||
156557012|NCT02167945|565130129|FG000|Overall Study|Withdrew Consent|42|||
156557013|NCT02167945|565130129|FG000|Overall Study|Lost to Follow-up|122|||
156557014|NCT02167945|565130129|FG000|Overall Study|COVID-19 logistical restrictions|6|||
156557015|NCT02167945|565130129|FG000|Overall Study|Other, not specified|63|||
156557016|NCT00132730|565130130|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
156557017|NCT00132730|565130131|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
156557018|NCT00132730|565130132|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
156557019|NCT00132730|565130133|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
156557020|NCT00132730|565130134|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
156557021|NCT00132730|565130135|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
156557022|NCT00132730|565130130|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
156557023|NCT00132730|565130131|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
156557024|NCT00132730|565130132|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
156557025|NCT00132730|565130133|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
156557026|NCT00132730|565130134|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
156557027|NCT00132730|565130135|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
156557028|NCT00132730|565130130|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
156557029|NCT00132730|565130131|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
156557030|NCT00132730|565130132|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
156557031|NCT00132730|565130133|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
156557032|NCT00132730|565130134|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
156557033|NCT00132730|565130135|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
156557034|NCT00132730|565130130|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
156557035|NCT00132730|565130131|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
156557036|NCT00132730|565130132|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
156557037|NCT00132730|565130133|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
156557038|NCT00132730|565130134|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
156557039|NCT00132730|565130135|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
156557040|NCT00132730|565130130|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
156557041|NCT00132730|565130131|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
156557042|NCT00132730|565130132|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
156557043|NCT00132730|565130133|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
156557044|NCT00132730|565130134|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
156557045|NCT00132730|565130135|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
156557046|NCT00132730|565130130|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
156557047|NCT00132730|565130131|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
156557048|NCT00132730|565130132|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
156557049|NCT00132730|565130133|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
156557050|NCT00132730|565130134|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
156557051|NCT00132730|565130135|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
156557052|NCT00132730|565130130|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
156557053|NCT00132730|565130131|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
156557054|NCT00132730|565130132|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
156557055|NCT00132730|565130133|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
156557056|NCT00132730|565130134|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
156557057|NCT00132730|565130135|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
156557058|NCT00132730|565130130|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
156557059|NCT00132730|565130131|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
156557060|NCT00132730|565130132|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
156557061|NCT00132730|565130133|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
156557062|NCT00132730|565130134|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
156557063|NCT00132730|565130135|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
156557064|NCT00132730|565130130|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
156557065|NCT00132730|565130131|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
156557066|NCT00132730|565130132|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
156557067|NCT00132730|565130133|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
156557068|NCT00132730|565130134|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
156557069|NCT00132730|565130135|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
156557070|NCT00132730|565130130|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
156557071|NCT00132730|565130131|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
156557072|NCT00132730|565130132|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
156557073|NCT00132730|565130133|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
156557074|NCT00132730|565130134|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
156557075|NCT00132730|565130135|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
156557076|NCT00132730|565130130|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
156557077|NCT00132730|565130131|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
156557078|NCT00132730|565130132|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
156557079|NCT00132730|565130133|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
156557080|NCT00132730|565130134|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
156557081|NCT00132730|565130135|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
156557082|NCT00132730|565130130|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
156557083|NCT00132730|565130131|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
156557084|NCT00132730|565130132|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
156557085|NCT00132730|565130133|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
156557086|NCT00132730|565130134|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
156557087|NCT00132730|565130135|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
156557088|NCT00395967|565130136|FG000|Treatment Period|Failed Mobilization|1|||
156557089|NCT00395967|565130136|FG000|Follow-up Period|Death|1|||
156557090|NCT00395967|565130136|FG000|Follow-up Period|Lost to Follow-up|1|||
156557091|NCT01262976|565130137|FG000|Up to Month 2|Serious Adverse Event|0|||
156557092|NCT01262976|565130138|FG001|Up to Month 2|Serious Adverse Event|0|||
156557093|NCT01262976|565130139|FG002|Up to Month 2|Serious Adverse Event|1|||
156557094|NCT01262976|565130140|FG003|Up to Month 2|Serious Adverse Event|0|||
156557095|NCT01262976|565130141|FG004|Up to Month 2|Serious Adverse Event|0|||
156557096|NCT01262976|565130142|FG005|Up to Month 2|Serious Adverse Event|0|||
156557097|NCT01262976|565130137|FG000|Up to Month 2|Withdrawal by Subject|1|||
156557098|NCT01262976|565130138|FG001|Up to Month 2|Withdrawal by Subject|0|||
156557099|NCT01262976|565130139|FG002|Up to Month 2|Withdrawal by Subject|0|||
156557100|NCT01262976|565130140|FG003|Up to Month 2|Withdrawal by Subject|0|||
156557101|NCT01262976|565130141|FG004|Up to Month 2|Withdrawal by Subject|0|||
156557102|NCT01262976|565130142|FG005|Up to Month 2|Withdrawal by Subject|0|||
156557103|NCT01262976|565130137|FG000|Up to Month 2|Migrated/moved from study area|0|||
156557104|NCT01262976|565130138|FG001|Up to Month 2|Migrated/moved from study area|1|||
156557105|NCT01262976|565130139|FG002|Up to Month 2|Migrated/moved from study area|0|||
156557106|NCT01262976|565130140|FG003|Up to Month 2|Migrated/moved from study area|0|||
156557107|NCT01262976|565130141|FG004|Up to Month 2|Migrated/moved from study area|1|||
156557108|NCT01262976|565130142|FG005|Up to Month 2|Migrated/moved from study area|1|||
156407368|NCT01672853|564584783|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
156407369|NCT01672853|564584784|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
156407370|NCT01672853|564584785|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
156407371|NCT01672853|564584783|FG000|Overall Study|Pregnancy|0|||
156407372|NCT01672853|564584784|FG001|Overall Study|Pregnancy|1|||
156407373|NCT01672853|564584785|FG002|Overall Study|Pregnancy|0|||
156557109|NCT01262976|565130137|FG000|Up to Month 2|Lost to Follow-up|1|||
156557110|NCT01262976|565130138|FG001|Up to Month 2|Lost to Follow-up|0|||
156557111|NCT01262976|565130139|FG002|Up to Month 2|Lost to Follow-up|0|||
156557112|NCT01262976|565130140|FG003|Up to Month 2|Lost to Follow-up|1|||
156557113|NCT01262976|565130141|FG004|Up to Month 2|Lost to Follow-up|1|||
156557114|NCT01262976|565130142|FG005|Up to Month 2|Lost to Follow-up|1|||
156557115|NCT01262976|565130137|FG000|Up to Month 2|Other|1|||
156557116|NCT01262976|565130138|FG001|Up to Month 2|Other|0|||
156557117|NCT01262976|565130139|FG002|Up to Month 2|Other|0|||
156557118|NCT01262976|565130140|FG003|Up to Month 2|Other|1|||
156557119|NCT01262976|565130141|FG004|Up to Month 2|Other|0|||
156557120|NCT01262976|565130142|FG005|Up to Month 2|Other|2|||
156557121|NCT01262976|565130137|FG000|Up to Month 7|Serious Adverse Event|0|||
156557122|NCT01262976|565130138|FG001|Up to Month 7|Serious Adverse Event|0|||
156557123|NCT01262976|565130139|FG002|Up to Month 7|Serious Adverse Event|2|||
156557124|NCT01262976|565130140|FG003|Up to Month 7|Serious Adverse Event|0|||
156557125|NCT01262976|565130141|FG004|Up to Month 7|Serious Adverse Event|0|||
156557126|NCT01262976|565130142|FG005|Up to Month 7|Serious Adverse Event|0|||
156557127|NCT01262976|565130137|FG000|Up to Month 7|Withdrawal by Subject|1|||
156557128|NCT01262976|565130138|FG001|Up to Month 7|Withdrawal by Subject|0|||
156557129|NCT01262976|565130139|FG002|Up to Month 7|Withdrawal by Subject|0|||
156557130|NCT01262976|565130140|FG003|Up to Month 7|Withdrawal by Subject|0|||
156557131|NCT01262976|565130141|FG004|Up to Month 7|Withdrawal by Subject|0|||
156557132|NCT01262976|565130142|FG005|Up to Month 7|Withdrawal by Subject|0|||
156557133|NCT01262976|565130137|FG000|Up to Month 7|Migrated/moved from study area|0|||
156557134|NCT01262976|565130138|FG001|Up to Month 7|Migrated/moved from study area|0|||
156557135|NCT01262976|565130139|FG002|Up to Month 7|Migrated/moved from study area|1|||
156557136|NCT01262976|565130140|FG003|Up to Month 7|Migrated/moved from study area|3|||
156557137|NCT01262976|565130141|FG004|Up to Month 7|Migrated/moved from study area|1|||
156557138|NCT01262976|565130142|FG005|Up to Month 7|Migrated/moved from study area|1|||
156557139|NCT01262976|565130137|FG000|Up to Month 7|Lost to Follow-up|1|||
156557140|NCT01262976|565130138|FG001|Up to Month 7|Lost to Follow-up|0|||
156557141|NCT01262976|565130139|FG002|Up to Month 7|Lost to Follow-up|1|||
156557142|NCT01262976|565130140|FG003|Up to Month 7|Lost to Follow-up|3|||
156557143|NCT01262976|565130141|FG004|Up to Month 7|Lost to Follow-up|1|||
156557144|NCT01262976|565130142|FG005|Up to Month 7|Lost to Follow-up|3|||
156557145|NCT01262976|565130137|FG000|Up to Month 7|Other|3|||
156557146|NCT01262976|565130138|FG001|Up to Month 7|Other|0|||
156557147|NCT01262976|565130139|FG002|Up to Month 7|Other|2|||
156557148|NCT01262976|565130140|FG003|Up to Month 7|Other|0|||
156557149|NCT01262976|565130141|FG004|Up to Month 7|Other|0|||
156557150|NCT01262976|565130142|FG005|Up to Month 7|Other|0|||
156557151|NCT01262976|565130137|FG000|Up to Year 1|Serious Adverse Event|0|||
156557152|NCT01262976|565130138|FG001|Up to Year 1|Serious Adverse Event|0|||
156557153|NCT01262976|565130139|FG002|Up to Year 1|Serious Adverse Event|2|||
156557154|NCT01262976|565130140|FG003|Up to Year 1|Serious Adverse Event|0|||
156557155|NCT01262976|565130141|FG004|Up to Year 1|Serious Adverse Event|0|||
156557156|NCT01262976|565130142|FG005|Up to Year 1|Serious Adverse Event|0|||
156557157|NCT01262976|565130137|FG000|Up to Year 1|Withdrawal by Subject|1|||
156557158|NCT01262976|565130138|FG001|Up to Year 1|Withdrawal by Subject|0|||
156557159|NCT01262976|565130139|FG002|Up to Year 1|Withdrawal by Subject|0|||
156557160|NCT01262976|565130140|FG003|Up to Year 1|Withdrawal by Subject|0|||
156557161|NCT01262976|565130141|FG004|Up to Year 1|Withdrawal by Subject|0|||
156557162|NCT01262976|565130142|FG005|Up to Year 1|Withdrawal by Subject|0|||
156557163|NCT01262976|565130137|FG000|Up to Year 1|Migrated/moved from study area|1|||
156557164|NCT01262976|565130138|FG001|Up to Year 1|Migrated/moved from study area|0|||
156557165|NCT01262976|565130139|FG002|Up to Year 1|Migrated/moved from study area|0|||
156557166|NCT01262976|565130140|FG003|Up to Year 1|Migrated/moved from study area|3|||
156557167|NCT01262976|565130141|FG004|Up to Year 1|Migrated/moved from study area|3|||
156557168|NCT01262976|565130142|FG005|Up to Year 1|Migrated/moved from study area|2|||
156557169|NCT01262976|565130137|FG000|Up to Year 1|Lost to Follow-up|4|||
156557170|NCT01262976|565130138|FG001|Up to Year 1|Lost to Follow-up|0|||
156557171|NCT01262976|565130139|FG002|Up to Year 1|Lost to Follow-up|0|||
156557172|NCT01262976|565130140|FG003|Up to Year 1|Lost to Follow-up|1|||
156557173|NCT01262976|565130141|FG004|Up to Year 1|Lost to Follow-up|6|||
156407374|NCT01672853|564584783|FG000|Overall Study|Investigator's Discretion|1|||
156407375|NCT01672853|564584784|FG001|Overall Study|Investigator's Discretion|0|||
156557174|NCT01262976|565130142|FG005|Up to Year 1|Lost to Follow-up|5|||
156557175|NCT01262976|565130137|FG000|Up to Year 1|Other|3|||
156557176|NCT01262976|565130138|FG001|Up to Year 1|Other|1|||
156557177|NCT01262976|565130139|FG002|Up to Year 1|Other|0|||
156557178|NCT01262976|565130140|FG003|Up to Year 1|Other|0|||
156407376|NCT01672853|564584785|FG002|Overall Study|Investigator's Discretion|0|||
156557179|NCT01262976|565130141|FG004|Up to Year 1|Other|2|||
156557180|NCT01262976|565130142|FG005|Up to Year 1|Other|1|||
156557181|NCT01262976|565130137|FG000|Up to Year 1|Subjects with unknown completion status|0|||
156557182|NCT01262976|565130138|FG001|Up to Year 1|Subjects with unknown completion status|0|||
156557183|NCT01262976|565130139|FG002|Up to Year 1|Subjects with unknown completion status|1|||
156557184|NCT01262976|565130140|FG003|Up to Year 1|Subjects with unknown completion status|0|||
156557185|NCT01262976|565130141|FG004|Up to Year 1|Subjects with unknown completion status|0|||
156557186|NCT01262976|565130142|FG005|Up to Year 1|Subjects with unknown completion status|1|||
156557187|NCT01262976|565130137|FG000|Up to Year 2|Serious Adverse Event|0|||
156557188|NCT01262976|565130138|FG001|Up to Year 2|Serious Adverse Event|0|||
156557189|NCT01262976|565130139|FG002|Up to Year 2|Serious Adverse Event|2|||
156557190|NCT01262976|565130140|FG003|Up to Year 2|Serious Adverse Event|0|||
156557191|NCT01262976|565130141|FG004|Up to Year 2|Serious Adverse Event|0|||
156557192|NCT01262976|565130142|FG005|Up to Year 2|Serious Adverse Event|0|||
156557193|NCT01262976|565130137|FG000|Up to Year 2|Withdrawal by Subject|1|||
156557194|NCT01262976|565130138|FG001|Up to Year 2|Withdrawal by Subject|0|||
156557195|NCT01262976|565130139|FG002|Up to Year 2|Withdrawal by Subject|0|||
156557196|NCT01262976|565130140|FG003|Up to Year 2|Withdrawal by Subject|0|||
156557197|NCT01262976|565130141|FG004|Up to Year 2|Withdrawal by Subject|0|||
156557198|NCT01262976|565130142|FG005|Up to Year 2|Withdrawal by Subject|0|||
156557199|NCT01262976|565130137|FG000|Up to Year 2|Migrated/moved from study area|0|||
156557200|NCT01262976|565130138|FG001|Up to Year 2|Migrated/moved from study area|0|||
156557201|NCT01262976|565130139|FG002|Up to Year 2|Migrated/moved from study area|0|||
156557202|NCT01262976|565130140|FG003|Up to Year 2|Migrated/moved from study area|2|||
156557203|NCT01262976|565130141|FG004|Up to Year 2|Migrated/moved from study area|1|||
156557204|NCT01262976|565130142|FG005|Up to Year 2|Migrated/moved from study area|2|||
156557205|NCT01262976|565130137|FG000|Up to Year 2|Lost to Follow-up|1|||
156557206|NCT01262976|565130138|FG001|Up to Year 2|Lost to Follow-up|1|||
156557207|NCT01262976|565130139|FG002|Up to Year 2|Lost to Follow-up|2|||
156557208|NCT01262976|565130140|FG003|Up to Year 2|Lost to Follow-up|2|||
156557209|NCT01262976|565130141|FG004|Up to Year 2|Lost to Follow-up|3|||
156557210|NCT01262976|565130142|FG005|Up to Year 2|Lost to Follow-up|3|||
156557211|NCT01262976|565130137|FG000|Up to Year 2|Subjects with unknown completion status|0|||
156557212|NCT01262976|565130138|FG001|Up to Year 2|Subjects with unknown completion status|0|||
156557213|NCT01262976|565130139|FG002|Up to Year 2|Subjects with unknown completion status|1|||
156557214|NCT01262976|565130140|FG003|Up to Year 2|Subjects with unknown completion status|0|||
156557215|NCT01262976|565130141|FG004|Up to Year 2|Subjects with unknown completion status|0|||
156557216|NCT01262976|565130142|FG005|Up to Year 2|Subjects with unknown completion status|0|||
156557217|NCT01262976|565130137|FG000|Up to Year 2|Other|3|||
156557218|NCT01262976|565130138|FG001|Up to Year 2|Other|0|||
156557219|NCT01262976|565130139|FG002|Up to Year 2|Other|0|||
156557220|NCT01262976|565130140|FG003|Up to Year 2|Other|0|||
156557221|NCT01262976|565130141|FG004|Up to Year 2|Other|0|||
156557222|NCT01262976|565130142|FG005|Up to Year 2|Other|0|||
156557223|NCT01262976|565130137|FG000|Up to Year 3|Serious Adverse Event|0|||
156557224|NCT01262976|565130138|FG001|Up to Year 3|Serious Adverse Event|0|||
156557225|NCT01262976|565130139|FG002|Up to Year 3|Serious Adverse Event|2|||
156557226|NCT01262976|565130140|FG003|Up to Year 3|Serious Adverse Event|0|||
156557227|NCT01262976|565130141|FG004|Up to Year 3|Serious Adverse Event|0|||
156557228|NCT01262976|565130142|FG005|Up to Year 3|Serious Adverse Event|0|||
156557229|NCT01262976|565130137|FG000|Up to Year 3|Withdrawal by Subject|1|||
156557230|NCT01262976|565130138|FG001|Up to Year 3|Withdrawal by Subject|0|||
156557231|NCT01262976|565130139|FG002|Up to Year 3|Withdrawal by Subject|0|||
156557232|NCT01262976|565130140|FG003|Up to Year 3|Withdrawal by Subject|0|||
156557233|NCT01262976|565130141|FG004|Up to Year 3|Withdrawal by Subject|0|||
156557234|NCT01262976|565130142|FG005|Up to Year 3|Withdrawal by Subject|0|||
156557235|NCT01262976|565130137|FG000|Up to Year 3|Migrated/moved from study area|0|||
156557236|NCT01262976|565130138|FG001|Up to Year 3|Migrated/moved from study area|0|||
156557237|NCT01262976|565130139|FG002|Up to Year 3|Migrated/moved from study area|0|||
156557238|NCT01262976|565130140|FG003|Up to Year 3|Migrated/moved from study area|2|||
156557239|NCT01262976|565130141|FG004|Up to Year 3|Migrated/moved from study area|1|||
156557240|NCT01262976|565130142|FG005|Up to Year 3|Migrated/moved from study area|1|||
156557241|NCT01262976|565130137|FG000|Up to Year 3|Lost to Follow-up|2|||
156557242|NCT01262976|565130138|FG001|Up to Year 3|Lost to Follow-up|2|||
156557243|NCT01262976|565130139|FG002|Up to Year 3|Lost to Follow-up|4|||
156557244|NCT01262976|565130140|FG003|Up to Year 3|Lost to Follow-up|3|||
156557245|NCT01262976|565130141|FG004|Up to Year 3|Lost to Follow-up|1|||
156557246|NCT01262976|565130142|FG005|Up to Year 3|Lost to Follow-up|3|||
156557247|NCT01262976|565130137|FG000|Up to Year 3|Subjects with unknown completion status|0|||
156557248|NCT01262976|565130138|FG001|Up to Year 3|Subjects with unknown completion status|0|||
156557249|NCT01262976|565130139|FG002|Up to Year 3|Subjects with unknown completion status|1|||
156557250|NCT01262976|565130140|FG003|Up to Year 3|Subjects with unknown completion status|0|||
156557251|NCT01262976|565130141|FG004|Up to Year 3|Subjects with unknown completion status|0|||
156557252|NCT01262976|565130142|FG005|Up to Year 3|Subjects with unknown completion status|0|||
156557253|NCT01262976|565130137|FG000|Up to Year 3|Other|3|||
156557254|NCT01262976|565130138|FG001|Up to Year 3|Other|0|||
156557255|NCT01262976|565130139|FG002|Up to Year 3|Other|0|||
156557256|NCT01262976|565130140|FG003|Up to Year 3|Other|0|||
156557257|NCT01262976|565130141|FG004|Up to Year 3|Other|0|||
156557258|NCT01262976|565130142|FG005|Up to Year 3|Other|0|||
156557259|NCT01528787|565130143|FG000|Overall Study|Withdrawal by Subject|0|||
156557260|NCT01528787|565130144|FG001|Overall Study|Withdrawal by Subject|0|||
156557261|NCT01528787|565130145|FG002|Overall Study|Withdrawal by Subject|0|||
156557262|NCT01528787|565130146|FG003|Overall Study|Withdrawal by Subject|1|||
156557263|NCT01528787|565130143|FG000|Overall Study|Family Emergency|0|||
156557264|NCT01528787|565130144|FG001|Overall Study|Family Emergency|0|||
156557265|NCT01528787|565130145|FG002|Overall Study|Family Emergency|1|||
156557266|NCT01528787|565130146|FG003|Overall Study|Family Emergency|0|||
156557267|NCT00797823|565130149|FG000|First Period (Initial Randomization)|Physician Decision|1|||
156557268|NCT00797823|565130150|FG001|First Period (Initial Randomization)|Physician Decision|0|||
156557269|NCT00797823|565130151|FG002|First Period (Initial Randomization)|Physician Decision|0|||
156557270|NCT02400255|565130152|FG000|Overall Study|Relapse|4|||
156557271|NCT02400255|565130153|FG001|Overall Study|Relapse|1|||
156557272|NCT02400255|565130154|FG002|Overall Study|Relapse|1|||
156557273|NCT02400255|565130155|FG003|Overall Study|Relapse|2|||
156557274|NCT02400255|565130152|FG000|Overall Study|Adverse Event|6|||
156557275|NCT02400255|565130153|FG001|Overall Study|Adverse Event|3|||
156557276|NCT02400255|565130154|FG002|Overall Study|Adverse Event|0|||
156557277|NCT02400255|565130155|FG003|Overall Study|Adverse Event|0|||
156557278|NCT02400255|565130152|FG000|Overall Study|Physician Decision|6|||
156557279|NCT02400255|565130153|FG001|Overall Study|Physician Decision|0|||
156557280|NCT02400255|565130154|FG002|Overall Study|Physician Decision|0|||
156557281|NCT02400255|565130155|FG003|Overall Study|Physician Decision|0|||
156557282|NCT02400255|565130152|FG000|Overall Study|Loss of insurance|1|||
156557283|NCT02400255|565130153|FG001|Overall Study|Loss of insurance|0|||
156557284|NCT02400255|565130154|FG002|Overall Study|Loss of insurance|0|||
156557285|NCT02400255|565130155|FG003|Overall Study|Loss of insurance|0|||
156557286|NCT02568046|565130156|FG000|Overall Study|Adverse Event|0|||
156557287|NCT02568046|565130157|FG001|Overall Study|Adverse Event|1|||
156557288|NCT02568046|565130156|FG000|Overall Study|Death|2|||
156557289|NCT02568046|565130157|FG001|Overall Study|Death|0|||
156557290|NCT02568046|565130156|FG000|Overall Study|Progressive Disease|1|||
156557291|NCT02568046|565130157|FG001|Overall Study|Progressive Disease|0|||
156557292|NCT02568046|565130156|FG000|Overall Study|Withdrawal by Subject|2|||
156557293|NCT02568046|565130157|FG001|Overall Study|Withdrawal by Subject|1|||
156557294|NCT02568046|565130156|FG000|Overall Study|Other Events|0|||
156557295|NCT02568046|565130157|FG001|Overall Study|Other Events|1|||
156557296|NCT02809833|565130158|FG000|Overall Study|Death|3|||
156557297|NCT02809833|565130158|FG000|Overall Study|Intolerance|54|||
156557298|NCT02809833|565130158|FG000|Overall Study|Lack of Efficacy|89|||
156557299|NCT02809833|565130158|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
156557300|NCT02809833|565130158|FG000|Overall Study|Noncompliance|1|||
156557301|NCT02809833|565130158|FG000|Overall Study|Withdrawal by Subject|34|||
156557302|NCT02809833|565130158|FG000|Overall Study|Lost to Follow-up|35|||
156557303|NCT02809833|565130158|FG000|Overall Study|Adverse Event (AE)|24|||
156557304|NCT02809833|565130158|FG000|Overall Study|Other|5|||
156557305|NCT02809833|565130158|FG000|Overall Study|Missing Information|52|||
156557306|NCT00193063|565130160|FG000|Overall Study|Lack of Efficacy|3|||
156557307|NCT00193063|565130160|FG000|Overall Study|Adverse Event|1|||
156557308|NCT03261531|565130161|FG000|Overall Study|Withdrawal by Subject|4|||
156557309|NCT01700192|565130162|FG000|Overall Study|Adverse Event|73|||
156557310|NCT01700192|565130163|FG001|Overall Study|Adverse Event|18|||
156557311|NCT01700192|565130162|FG000|Overall Study|Lack of Efficacy|1|||
156557312|NCT01700192|565130163|FG001|Overall Study|Lack of Efficacy|0|||
156557313|NCT01700192|565130162|FG000|Overall Study|Lost to Follow-up|42|||
156557314|NCT01700192|565130163|FG001|Overall Study|Lost to Follow-up|29|||
156557315|NCT01700192|565130162|FG000|Overall Study|Noncompliance with study drug|0|||
156557316|NCT01700192|565130163|FG001|Overall Study|Noncompliance with study drug|5|||
156557317|NCT01700192|565130162|FG000|Overall Study|Physician Decision|2|||
156557318|NCT01700192|565130163|FG001|Overall Study|Physician Decision|3|||
156557319|NCT01700192|565130162|FG000|Overall Study|Pregnancy|1|||
156557320|NCT01700192|565130163|FG001|Overall Study|Pregnancy|4|||
156557321|NCT01700192|565130162|FG000|Overall Study|Progressive disease|1|||
156557322|NCT01700192|565130163|FG001|Overall Study|Progressive disease|0|||
156557323|NCT01700192|565130162|FG000|Overall Study|Protocol Violation|3|||
156557324|NCT01700192|565130163|FG001|Overall Study|Protocol Violation|4|||
156557325|NCT01700192|565130162|FG000|Overall Study|Technical problems|0|||
156557326|NCT01700192|565130163|FG001|Overall Study|Technical problems|1|||
156557327|NCT01700192|565130162|FG000|Overall Study|Withdrawal by Subject|56|||
156557328|NCT01700192|565130163|FG001|Overall Study|Withdrawal by Subject|64|||
156557329|NCT01700192|565130162|FG000|Overall Study|Never received study drug|1|||
156557330|NCT01700192|565130163|FG001|Overall Study|Never received study drug|0|||
156557331|NCT00744874|565130165|FG000|Overall Study|Lost to Follow-up|1|||
156557332|NCT00744874|565130165|FG000|Overall Study|Withdrawal by Subject|1|||
156407377|NCT01672853|564584783|FG000|Overall Study|Withdrew Consent|5|||
156557333|NCT00744874|565130165|FG000|Overall Study|Study Device not available at procedure|1|||
156557334|NCT00744874|565130165|FG000|Overall Study|Unable to accomodate schedule|1|||
156557335|NCT01818726|565130183|FG000|Overall Study|Administrative reasons|5|||
156557336|NCT01818726|565130184|FG001|Overall Study|Administrative reasons|1|||
156557337|NCT01818726|565130183|FG000|Overall Study|Withdrawal by Subject|0|||
156557338|NCT01818726|565130184|FG001|Overall Study|Withdrawal by Subject|1|||
156557339|NCT01818726|565130183|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
156407378|NCT01672853|564584784|FG001|Overall Study|Withdrew Consent|5|||
156557340|NCT01818726|565130184|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
156557341|NCT00357500|565130187|FG000|Overall Study|Adverse Event|3|||
156557342|NCT00357500|565130187|FG000|Overall Study|Withdrawal by Subject|5|||
156557343|NCT00357500|565130187|FG000|Overall Study|Progressive Disease|65|||
156557344|NCT00357500|565130187|FG000|Overall Study|Not Started Protocol Therapy|4|||
156557345|NCT02301403|565130191|FG000|Overall Study|Withdrawal by Subject|28|||
156557346|NCT02301403|565130192|FG001|Overall Study|Withdrawal by Subject|41|||
156557347|NCT01816243|565130195|FG000|Overall Study|Adverse Event|6|||
156557348|NCT01816243|565130195|FG000|Overall Study|Lost to Follow-up|1|||
156557349|NCT01816243|565130195|FG000|Overall Study|Lack of Efficacy|1|||
156557350|NCT01816243|565130195|FG000|Overall Study|Not eligible for the study|1|||
156557351|NCT01816243|565130195|FG000|Overall Study|Amputation|3|||
156557352|NCT01920711|565130196|FG000|Overall Study|Death|347|||
156557353|NCT01920711|565130197|FG001|Overall Study|Death|356|||
156557354|NCT01920711|565130196|FG000|Overall Study|Lost to Follow-up|13|||
156557355|NCT01920711|565130197|FG001|Overall Study|Lost to Follow-up|14|||
156557356|NCT01920711|565130196|FG000|Overall Study|Withdrawal by Subject|4|||
156557357|NCT01920711|565130197|FG001|Overall Study|Withdrawal by Subject|3|||
156557358|NCT04556617|565130208|FG000|Overall Study|progressive disease|0|||
156557359|NCT04556617|565130209|FG001|Overall Study|progressive disease|2|||
156557360|NCT04556617|565130210|FG002|Overall Study|progressive disease|2|||
156557361|NCT04556617|565130211|FG003|Overall Study|progressive disease|1|||
156557362|NCT04556617|565130212|FG004|Overall Study|progressive disease|1|||
156557363|NCT04556617|565130208|FG000|Overall Study|Physician Decision|0|||
156557364|NCT04556617|565130209|FG001|Overall Study|Physician Decision|0|||
156557365|NCT04556617|565130210|FG002|Overall Study|Physician Decision|2|||
156557366|NCT04556617|565130211|FG003|Overall Study|Physician Decision|0|||
156557367|NCT04556617|565130212|FG004|Overall Study|Physician Decision|0|||
156557368|NCT04556617|565130208|FG000|Overall Study|Adverse Event|0|||
156557369|NCT04556617|565130209|FG001|Overall Study|Adverse Event|0|||
156557370|NCT04556617|565130210|FG002|Overall Study|Adverse Event|2|||
156557371|NCT04556617|565130211|FG003|Overall Study|Adverse Event|3|||
156557372|NCT04556617|565130212|FG004|Overall Study|Adverse Event|0|||
156557373|NCT04556617|565130208|FG000|Overall Study|Withdrawal by Subject|0|||
156557374|NCT04556617|565130209|FG001|Overall Study|Withdrawal by Subject|2|||
156557375|NCT04556617|565130210|FG002|Overall Study|Withdrawal by Subject|1|||
156557376|NCT04556617|565130211|FG003|Overall Study|Withdrawal by Subject|1|||
156557377|NCT04556617|565130212|FG004|Overall Study|Withdrawal by Subject|0|||
156557378|NCT04556617|565130208|FG000|Overall Study|PSA increase|0|||
156557379|NCT04556617|565130209|FG001|Overall Study|PSA increase|1|||
156557380|NCT04556617|565130210|FG002|Overall Study|PSA increase|0|||
156557381|NCT04556617|565130211|FG003|Overall Study|PSA increase|0|||
156557382|NCT04556617|565130212|FG004|Overall Study|PSA increase|0|||
156557383|NCT04556617|565130208|FG000|Overall Study|Sponsor study termination|1|||
156557384|NCT04556617|565130209|FG001|Overall Study|Sponsor study termination|0|||
156557385|NCT04556617|565130210|FG002|Overall Study|Sponsor study termination|0|||
156557386|NCT04556617|565130211|FG003|Overall Study|Sponsor study termination|0|||
156557387|NCT04556617|565130212|FG004|Overall Study|Sponsor study termination|0|||
156557388|NCT04949841|565130213|FG000|Overall Study|Adverse Event|7|||
156557389|NCT04949841|565130213|FG000|Overall Study|Death|1|||
156557390|NCT04949841|565130213|FG000|Overall Study|Withdrawal by Subject|52|||
156557391|NCT04949841|565130213|FG000|Overall Study|Pregnancy|4|||
156557392|NCT04949841|565130213|FG000|Overall Study|Lost to Follow-up|9|||
156557393|NCT04949841|565130213|FG000|Overall Study|Lack of Efficacy|55|||
156557394|NCT04949841|565130213|FG000|Overall Study|Various reasons|9|||
156557395|NCT00546052|565130228|FG000|Overall Study|Adverse Event|47|||
156557396|NCT00546052|565130228|FG000|Overall Study|Lost to Follow-up|144|||
156557397|NCT00546052|565130228|FG000|Overall Study|Protocol Violation|9|||
156407379|NCT01672853|564584785|FG002|Overall Study|Withdrew Consent|5|||
156407380|NCT01672853|564584783|FG000|Overall Study|Adverse Event|4|||
156407381|NCT01672853|564584784|FG001|Overall Study|Adverse Event|6|||
156407382|NCT01672853|564584785|FG002|Overall Study|Adverse Event|8|||
156407383|NCT01672853|564584783|FG000|Overall Study|Lost to Follow-up|0|||
156407384|NCT01672853|564584784|FG001|Overall Study|Lost to Follow-up|1|||
156407385|NCT01672853|564584785|FG002|Overall Study|Lost to Follow-up|0|||
156407386|NCT01672853|564584783|FG000|Overall Study|Randomized but Never Treated|0|||
156407387|NCT01672853|564584784|FG001|Overall Study|Randomized but Never Treated|0|||
156557398|NCT00546052|565130228|FG000|Overall Study|Withdrawal by Subject|20|||
156557399|NCT00546052|565130228|FG000|Overall Study|Non Compliance|7|||
156557400|NCT03048422|565130229|FG000|Overall Study|Death|1|||
156557401|NCT03048422|565130230|FG001|Overall Study|Death|0|||
156557402|NCT03048422|565130231|FG002|Overall Study|Death|0|||
156557403|NCT03048422|565130229|FG000|Overall Study|Lost to Follow-up|5|||
156557404|NCT03048422|565130230|FG001|Overall Study|Lost to Follow-up|0|||
156407388|NCT01672853|564584785|FG002|Overall Study|Randomized but Never Treated|1|||
156407389|NCT02969525|564584786|FG000|Double-Blind Period|Adverse Event|0|||
156557405|NCT03048422|565130231|FG002|Overall Study|Lost to Follow-up|1|||
156557406|NCT03048422|565130229|FG000|Overall Study|Withdrawal by Subject|5|||
156557407|NCT03048422|565130230|FG001|Overall Study|Withdrawal by Subject|7|||
156557408|NCT03048422|565130231|FG002|Overall Study|Withdrawal by Subject|4|||
156557409|NCT03048422|565130229|FG000|Overall Study|Moved|3|||
156557410|NCT03048422|565130230|FG001|Overall Study|Moved|2|||
156557411|NCT03048422|565130231|FG002|Overall Study|Moved|2|||
156557412|NCT03048422|565130229|FG000|Overall Study|Noncompliant with Study Requirements|2|||
156557413|NCT03048422|565130230|FG001|Overall Study|Noncompliant with Study Requirements|1|||
156557414|NCT03048422|565130231|FG002|Overall Study|Noncompliant with Study Requirements|2|||
156557415|NCT03048422|565130229|FG000|Overall Study|Not Able to Get to Clinic|1|||
156557416|NCT03048422|565130230|FG001|Overall Study|Not Able to Get to Clinic|0|||
156557417|NCT03048422|565130231|FG002|Overall Study|Not Able to Get to Clinic|0|||
156557418|NCT01031446|565130232|FG000|Overall Study|Disease Progression|38|||
156557419|NCT01031446|565130232|FG000|Overall Study|Adverse Event|9|||
156557420|NCT01031446|565130232|FG000|Overall Study|Physician Decision|4|||
156557421|NCT01031446|565130232|FG000|Overall Study|Withdrawal by Subject|3|||
156557422|NCT01031446|565130232|FG000|Overall Study|Still on treatment|1|||
156557423|NCT00500682|565130233|FG000|Overall Study|Adverse Event|37|||
156557424|NCT00500682|565130234|FG001|Overall Study|Adverse Event|29|||
156557425|NCT00500682|565130233|FG000|Overall Study|Death|25|||
156557426|NCT00500682|565130234|FG001|Overall Study|Death|16|||
156557427|NCT00500682|565130233|FG000|Overall Study|Lost to Follow-up|11|||
156557428|NCT00500682|565130234|FG001|Overall Study|Lost to Follow-up|11|||
156557429|NCT00500682|565130233|FG000|Overall Study|Physician Decision|6|||
156557430|NCT00500682|565130234|FG001|Overall Study|Physician Decision|10|||
156557431|NCT00500682|565130233|FG000|Overall Study|Pregnancy|2|||
156557432|NCT00500682|565130234|FG001|Overall Study|Pregnancy|0|||
156557433|NCT00500682|565130233|FG000|Overall Study|Protocol Violation|1|||
156557434|NCT00500682|565130234|FG001|Overall Study|Protocol Violation|3|||
156557435|NCT00500682|565130233|FG000|Overall Study|Withdrawal by Subject|80|||
156557436|NCT00500682|565130234|FG001|Overall Study|Withdrawal by Subject|74|||
156557437|NCT00500682|565130233|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
156557438|NCT00500682|565130234|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
156557439|NCT02531646|565130237|FG000|Overall Study|equip. image processing issue|5|||
156557440|NCT02531646|565130238|FG001|Overall Study|equip. image processing issue|1|||
156557441|NCT02531646|565130239|FG002|Overall Study|equip. image processing issue|0|||
156557442|NCT00772668|565130240|FG000|Overall Study|Physician Decision|3|||
156557443|NCT01182428|565130241|FG000|Overall Study|Physician Decision|1|||
156557444|NCT01182428|565130242|FG001|Overall Study|Physician Decision|0|||
156557445|NCT01182428|565130241|FG000|Overall Study|Lost to Follow-up|9|||
156557446|NCT01182428|565130242|FG001|Overall Study|Lost to Follow-up|1|||
156557447|NCT01182428|565130241|FG000|Overall Study|Withdrawal by Subject|1|||
156557448|NCT01182428|565130242|FG001|Overall Study|Withdrawal by Subject|0|||
156557449|NCT03631706|565130244|FG000|Overall Study|Randomized, not treated|1|||
156557450|NCT03631706|565130245|FG001|Overall Study|Randomized, not treated|0|||
156557451|NCT00865020|565130251|FG000|Overall Study|Withdrawal by Subject|22|||
156557452|NCT00865020|565130252|FG001|Overall Study|Withdrawal by Subject|16|||
156557453|NCT00865020|565130251|FG000|Overall Study|Adverse Event|9|||
156557454|NCT00865020|565130252|FG001|Overall Study|Adverse Event|14|||
156557455|NCT00865020|565130251|FG000|Overall Study|Abnormal test procedure result(s)|6|||
156557456|NCT00865020|565130252|FG001|Overall Study|Abnormal test procedure result(s)|8|||
156557457|NCT00865020|565130251|FG000|Overall Study|Lost to Follow-up|6|||
156557458|NCT00865020|565130252|FG001|Overall Study|Lost to Follow-up|4|||
156557459|NCT00865020|565130251|FG000|Overall Study|Protocol deviation|4|||
156557460|NCT00865020|565130252|FG001|Overall Study|Protocol deviation|1|||
156557461|NCT00865020|565130251|FG000|Overall Study|Administrative problems|0|||
156557462|NCT00865020|565130252|FG001|Overall Study|Administrative problems|2|||
156557463|NCT00865020|565130251|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156557464|NCT00865020|565130252|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156557465|NCT00865020|565130251|FG000|Overall Study|Death|0|||
156557466|NCT00865020|565130252|FG001|Overall Study|Death|1|||
156557467|NCT00865020|565130251|FG000|Overall Study|Randomized but discontinued|2|||
156557468|NCT00865020|565130252|FG001|Overall Study|Randomized but discontinued|4|||
156557469|NCT05900115|565131687|FG000|Overall Study|Lost to Follow-up|129|||
156557470|NCT05900115|565131688|FG001|Overall Study|Lost to Follow-up|98|||
156557471|NCT01916980|565131689|FG000|Overall Study|Adverse Event|4|||
156557472|NCT01916980|565131690|FG001|Overall Study|Adverse Event|2|||
156557473|NCT01916980|565131689|FG000|Overall Study|Lack of Efficacy|2|||
156557474|NCT01916980|565131690|FG001|Overall Study|Lack of Efficacy|2|||
156557475|NCT01916980|565131689|FG000|Overall Study|Withdrawal by Subject|1|||
156557476|NCT01916980|565131690|FG001|Overall Study|Withdrawal by Subject|0|||
156557477|NCT02324270|565131691|FG000|Overall Study|Withdrawal by Subject|0|||
156557478|NCT02324270|565131692|FG001|Overall Study|Withdrawal by Subject|1|||
156557479|NCT02324270|565131693|FG002|Overall Study|Withdrawal by Subject|0|||
156557480|NCT02324270|565131691|FG000|Overall Study|Lost to Follow-up|4|||
156557481|NCT02324270|565131692|FG001|Overall Study|Lost to Follow-up|3|||
156557482|NCT02324270|565131693|FG002|Overall Study|Lost to Follow-up|4|||
156557483|NCT02324270|565131691|FG000|Overall Study|Protocol Violation|0|||
156557484|NCT02324270|565131692|FG001|Overall Study|Protocol Violation|1|||
156557485|NCT02324270|565131693|FG002|Overall Study|Protocol Violation|1|||
156557486|NCT02324270|565131691|FG000|Overall Study|Non Compliance with Study Drug|1|||
156557487|NCT02324270|565131692|FG001|Overall Study|Non Compliance with Study Drug|2|||
156557488|NCT02324270|565131693|FG002|Overall Study|Non Compliance with Study Drug|0|||
156557489|NCT00546364|565131694|FG000|Overall Study|Disease progression|5|||
156557490|NCT00546364|565131695|FG001|Overall Study|Disease progression|11|||
156557491|NCT00546364|565131696|FG002|Overall Study|Disease progression|8|||
156557492|NCT00546364|565131694|FG000|Overall Study|Completed and off treatment|1|||
156557493|NCT00546364|565131695|FG001|Overall Study|Completed and off treatment|0|||
156407390|NCT02969525|564584787|FG001|Double-Blind Period|Adverse Event|0|||
156407391|NCT02969525|564584788|FG002|Double-Blind Period|Adverse Event|1|||
156407392|NCT02969525|564584789|FG003|Double-Blind Period|Adverse Event|1|||
156557494|NCT00546364|565131696|FG002|Overall Study|Completed and off treatment|2|||
156557495|NCT00546364|565131694|FG000|Overall Study|Administrative reason by sponsor|1|||
156557496|NCT00546364|565131695|FG001|Overall Study|Administrative reason by sponsor|0|||
156557497|NCT00546364|565131696|FG002|Overall Study|Administrative reason by sponsor|0|||
156557498|NCT00546364|565131694|FG000|Overall Study|Poor compliance/noncompliance|0|||
156557499|NCT00546364|565131695|FG001|Overall Study|Poor compliance/noncompliance|0|||
156557500|NCT00546364|565131696|FG002|Overall Study|Poor compliance/noncompliance|1|||
156557501|NCT00546364|565131694|FG000|Overall Study|No longer meets study criteria|1|||
156557502|NCT00546364|565131695|FG001|Overall Study|No longer meets study criteria|1|||
156557503|NCT00546364|565131696|FG002|Overall Study|No longer meets study criteria|0|||
156557504|NCT00546364|565131694|FG000|Overall Study|Withdrawal by Subject|5|||
156557505|NCT00546364|565131695|FG001|Overall Study|Withdrawal by Subject|6|||
156557506|NCT00546364|565131696|FG002|Overall Study|Withdrawal by Subject|3|||
156557507|NCT00546364|565131694|FG000|Overall Study|Prior taxotere|1|||
156557508|NCT00546364|565131695|FG001|Overall Study|Prior taxotere|0|||
156557509|NCT00546364|565131696|FG002|Overall Study|Prior taxotere|0|||
156557510|NCT00546364|565131694|FG000|Overall Study|Mixed response|1|||
156557511|NCT00546364|565131695|FG001|Overall Study|Mixed response|0|||
156557512|NCT00546364|565131696|FG002|Overall Study|Mixed response|0|||
156557513|NCT00546364|565131694|FG000|Overall Study|Palliative treatment|1|||
156557514|NCT00546364|565131695|FG001|Overall Study|Palliative treatment|0|||
156557515|NCT00546364|565131696|FG002|Overall Study|Palliative treatment|1|||
156557516|NCT00546364|565131694|FG000|Overall Study|Target lesions resected|1|||
156557517|NCT00546364|565131695|FG001|Overall Study|Target lesions resected|0|||
156557518|NCT00546364|565131696|FG002|Overall Study|Target lesions resected|0|||
156557519|NCT00546364|565131694|FG000|Overall Study|Physician Decision|0|||
156557520|NCT00546364|565131695|FG001|Overall Study|Physician Decision|0|||
156557521|NCT00546364|565131696|FG002|Overall Study|Physician Decision|1|||
156557522|NCT00546364|565131694|FG000|Overall Study|Sponsor decision|0|||
156557523|NCT00546364|565131695|FG001|Overall Study|Sponsor decision|0|||
156557524|NCT00546364|565131696|FG002|Overall Study|Sponsor decision|1|||
156557525|NCT00388947|565131698|FG000|Overall Study|Protocol Violation|47|||
156557526|NCT03038308|565131699|FG000|Overall Study|Surgical resection|1|||
156557527|NCT03038308|565131699|FG000|Overall Study|Withdrawal by Subject|2|||
156557528|NCT03038308|565131699|FG000|Overall Study|Lost to Follow-up|1|||
156557529|NCT04187092|565131700|FG000|Overall Study|Lost to Follow-up|1|||
156557530|NCT04187092|565131701|FG001|Overall Study|Lost to Follow-up|1|||
156557531|NCT04187092|565131700|FG000|Overall Study|Withdrawal by Subject|1|||
156557532|NCT04187092|565131701|FG001|Overall Study|Withdrawal by Subject|1|||
156557533|NCT04187092|565131700|FG000|Overall Study|Adverse Event|0|||
156557534|NCT04187092|565131701|FG001|Overall Study|Adverse Event|1|||
156557535|NCT00771472|565131703|FG000|Overall Study|Physician Decision|2|||
156557536|NCT00771472|565131704|FG001|Overall Study|Physician Decision|3|||
156557537|NCT00771472|565131703|FG000|Overall Study|Progressive Disease|3|||
156557538|NCT00771472|565131704|FG001|Overall Study|Progressive Disease|1|||
156557539|NCT00771472|565131703|FG000|Overall Study|Protocol Violation|1|||
156557540|NCT00771472|565131704|FG001|Overall Study|Protocol Violation|0|||
156557541|NCT02002975|565131705|FG000|Overall Study|Case Report Forms Uncollected|135|||
156557542|NCT02002975|565131705|FG000|Overall Study|Protocol Deviation|437|||
156557543|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
156557544|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
156557545|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
156557546|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
156557547|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
156557548|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
156407393|NCT02969525|564584790|FG004|Double-Blind Period|Adverse Event|0|||
156557549|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
156557550|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
156557551|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
156557552|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
156557553|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
156557554|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
156557555|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
156407394|NCT02969525|564584791|FG005|Double-Blind Period|Adverse Event|0|||
156557556|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
156557557|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
156557558|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
156557559|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
156557560|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
156557561|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
156557562|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
156557563|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
156557564|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
156557565|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
156557566|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
156557567|NCT04660643|565131706|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
156557568|NCT04660643|565131707|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
156557569|NCT04660643|565131708|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
156557570|NCT04660643|565131706|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
156557571|NCT04660643|565131707|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
156557572|NCT04660643|565131708|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
156557573|NCT04660643|565131706|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
156557574|NCT04660643|565131707|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
156557575|NCT04660643|565131708|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
156557576|NCT04660643|565131706|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
156557577|NCT04660643|565131707|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
156557578|NCT04660643|565131708|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
156557579|NCT04660643|565131706|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
156557580|NCT04660643|565131707|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
156557581|NCT04660643|565131708|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
156557582|NCT04660643|565131706|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
156557583|NCT04660643|565131707|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
156557584|NCT04660643|565131708|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
156557585|NCT04660643|565131706|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
156557586|NCT04660643|565131707|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
156557587|NCT04660643|565131708|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
156557588|NCT04660643|565131706|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
156557589|NCT04660643|565131707|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
156557590|NCT04660643|565131708|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
156557591|NCT03988907|565131709|FG000|Overall Study|Unable to complete visit|0|||
156557592|NCT03988907|565131710|FG001|Overall Study|Unable to complete visit|1|||
156557593|NCT03609619|565131714|FG000|Overall Study|Adverse Event|1|||
156557594|NCT03609619|565131715|FG001|Overall Study|Adverse Event|0|||
156557595|NCT03609619|565131714|FG000|Overall Study|Lack of Efficacy|1|||
156557596|NCT03609619|565131715|FG001|Overall Study|Lack of Efficacy|2|||
156557597|NCT03609619|565131714|FG000|Overall Study|Protocol Violation|5|||
156557598|NCT03609619|565131715|FG001|Overall Study|Protocol Violation|0|||
156557599|NCT03609619|565131714|FG000|Overall Study|Withdrawal by Subject|2|||
156557600|NCT03609619|565131715|FG001|Overall Study|Withdrawal by Subject|3|||
156557601|NCT03609619|565131714|FG000|Overall Study|Lost to Follow-up|1|||
156557602|NCT03609619|565131715|FG001|Overall Study|Lost to Follow-up|1|||
156557603|NCT05162066|565131716|FG000|Overall Study|Adverse Event|1|||
156557604|NCT05162066|565131717|FG001|Overall Study|Adverse Event|0|||
156557605|NCT05162066|565131718|FG002|Overall Study|Adverse Event|0|||
156557606|NCT05162066|565131716|FG000|Overall Study|Perceived lack of efficacy|1|||
156557607|NCT05162066|565131717|FG001|Overall Study|Perceived lack of efficacy|0|||
156557608|NCT05162066|565131718|FG002|Overall Study|Perceived lack of efficacy|0|||
156557609|NCT00568555|565131719|FG000|Overall Study|Withdrawal by Subject|1|||
156557610|NCT00568555|565131720|FG001|Overall Study|Withdrawal by Subject|1|||
156557611|NCT01231555|565131721|FG000|Overall Study|Study terminated|8|||
156557612|NCT01231555|565131722|FG001|Overall Study|Study terminated|5|||
156407395|NCT02969525|564584792|FG006|Double-Blind Period|Adverse Event|0|||
156407396|NCT02969525|564584793|FG007|Double-Blind Period|Adverse Event|0|||
156407397|NCT02969525|564584794|FG008|Double-Blind Period|Adverse Event|0|||
156557613|NCT01231555|565131723|FG002|Overall Study|Study terminated|8|||
156557614|NCT01231555|565131721|FG000|Overall Study|Withdrawal by Subject|0|||
156557615|NCT01231555|565131722|FG001|Overall Study|Withdrawal by Subject|2|||
156557616|NCT01231555|565131723|FG002|Overall Study|Withdrawal by Subject|0|||
156557617|NCT01220414|565131724|FG000|Overall Study|Withdrawal by Subject|1|||
156557618|NCT01220414|565131725|FG001|Overall Study|Withdrawal by Subject|0|||
156557619|NCT01220414|565131726|FG002|Overall Study|Withdrawal by Subject|0|||
156557620|NCT01220414|565131727|FG003|Overall Study|Withdrawal by Subject|1|||
156407398|NCT02969525|564584795|FG009|Double-Blind Period|Adverse Event|0|||
156557621|NCT00669617|565131730|FG000|Period 1|Withdrawal by Subject|0|||
156557622|NCT00669617|565131731|FG001|Period 1|Withdrawal by Subject|0|||
156557623|NCT00669617|565131732|FG002|Period 1|Withdrawal by Subject|1|||
156557624|NCT00669617|565131733|FG003|Period 1|Withdrawal by Subject|0|||
156557625|NCT00669617|565131734|FG004|Period 1|Withdrawal by Subject|0|||
156557626|NCT00669617|565131730|FG000|Period 1|Protocol Deviation|0|||
156557627|NCT00669617|565131731|FG001|Period 1|Protocol Deviation|0|||
156557628|NCT00669617|565131732|FG002|Period 1|Protocol Deviation|0|||
156557629|NCT00669617|565131733|FG003|Period 1|Protocol Deviation|0|||
156557630|NCT00669617|565131734|FG004|Period 1|Protocol Deviation|1|||
156557631|NCT00669617|565131730|FG000|Period 3|Lost to Follow-up|1|||
156557632|NCT00669617|565131731|FG001|Period 3|Lost to Follow-up|0|||
156557633|NCT00669617|565131732|FG002|Period 3|Lost to Follow-up|0|||
156557634|NCT00669617|565131733|FG003|Period 3|Lost to Follow-up|0|||
156557635|NCT00669617|565131734|FG004|Period 3|Lost to Follow-up|0|||
156557636|NCT00623831|565131735|FG000|Overall Study|Withdrawal by Subject|1|||
156557637|NCT00623831|565131736|FG001|Overall Study|Withdrawal by Subject|0|||
156407399|NCT02969525|564584796|FG010|Double-Blind Period|Adverse Event|0|||
156407400|NCT02969525|564584797|FG011|Double-Blind Period|Adverse Event|0|||
156407401|NCT02969525|564584786|FG000|Double-Blind Period|LOW EGFR|0|||
156407402|NCT02969525|564584787|FG001|Double-Blind Period|LOW EGFR|0|||
156407403|NCT02969525|564584788|FG002|Double-Blind Period|LOW EGFR|0|||
156407404|NCT02969525|564584789|FG003|Double-Blind Period|LOW EGFR|1|||
156407405|NCT02969525|564584790|FG004|Double-Blind Period|LOW EGFR|0|||
156407406|NCT02969525|564584791|FG005|Double-Blind Period|LOW EGFR|0|||
156407407|NCT02969525|564584792|FG006|Double-Blind Period|LOW EGFR|0|||
156407408|NCT02969525|564584793|FG007|Double-Blind Period|LOW EGFR|0|||
156407409|NCT02969525|564584794|FG008|Double-Blind Period|LOW EGFR|0|||
156407410|NCT02969525|564584795|FG009|Double-Blind Period|LOW EGFR|0|||
156407411|NCT02969525|564584796|FG010|Double-Blind Period|LOW EGFR|0|||
156407412|NCT02969525|564584797|FG011|Double-Blind Period|LOW EGFR|0|||
156407413|NCT02969525|564584786|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
156407414|NCT02969525|564584787|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407415|NCT02969525|564584788|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407416|NCT02969525|564584789|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
156407417|NCT02969525|564584790|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407418|NCT02969525|564584791|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407419|NCT02969525|564584792|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407420|NCT02969525|564584793|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407421|NCT02969525|564584794|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407422|NCT02969525|564584795|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407423|NCT02969525|564584796|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407424|NCT02969525|564584797|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156407425|NCT02969525|564584786|FG000|Dose-Blind Period|Adverse Event|0|||
156407426|NCT02969525|564584787|FG001|Dose-Blind Period|Adverse Event|0|||
156407427|NCT02969525|564584788|FG002|Dose-Blind Period|Adverse Event|0|||
156407428|NCT02969525|564584789|FG003|Dose-Blind Period|Adverse Event|0|||
156407429|NCT02969525|564584790|FG004|Dose-Blind Period|Adverse Event|0|||
156407430|NCT02969525|564584791|FG005|Dose-Blind Period|Adverse Event|0|||
156407431|NCT02969525|564584792|FG006|Dose-Blind Period|Adverse Event|0|||
156407432|NCT02969525|564584793|FG007|Dose-Blind Period|Adverse Event|0|||
156407433|NCT02969525|564584794|FG008|Dose-Blind Period|Adverse Event|0|||
156407434|NCT02969525|564584795|FG009|Dose-Blind Period|Adverse Event|1|||
156407435|NCT02969525|564584796|FG010|Dose-Blind Period|Adverse Event|1|||
156557638|NCT00623831|565131735|FG000|Overall Study|Progressive Disease|0|||
156557639|NCT00623831|565131736|FG001|Overall Study|Progressive Disease|1|||
156557640|NCT01276821|565131737|FG000|Overall Study|Protocol Violation|0|||
156407436|NCT02969525|564584797|FG011|Dose-Blind Period|Adverse Event|1|||
156557641|NCT01276821|565131738|FG001|Overall Study|Protocol Violation|1|||
156557642|NCT01748071|565131739|FG000|Overall Study|Adverse Event|2|||
156557643|NCT01748071|565131740|FG001|Overall Study|Adverse Event|2|||
156557644|NCT01748071|565131741|FG002|Overall Study|Adverse Event|0|||
156557645|NCT03068325|565131742|FG000|Overall Study|Lost to Follow-up|5|||
156407437|NCT02969525|564584786|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
156407438|NCT02969525|564584787|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
156407439|NCT02969525|564584788|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
156407440|NCT02969525|564584789|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
156557646|NCT00066690|565131745|FG000|Overall Study|Adverse Event|145|||
156557647|NCT00066690|565131746|FG001|Overall Study|Adverse Event|58|||
156557648|NCT00066690|565131747|FG002|Overall Study|Adverse Event|126|||
156557649|NCT00066690|565131745|FG000|Overall Study|Death|3|||
156407441|NCT02969525|564584790|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
156557650|NCT00066690|565131746|FG001|Overall Study|Death|0|||
156557651|NCT00066690|565131747|FG002|Overall Study|Death|2|||
156557652|NCT00066690|565131745|FG000|Overall Study|Lack of Efficacy|114|||
156557653|NCT00066690|565131746|FG001|Overall Study|Lack of Efficacy|110|||
156557654|NCT00066690|565131747|FG002|Overall Study|Lack of Efficacy|76|||
156407442|NCT02969525|564584791|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
156407443|NCT02969525|564584792|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
156557655|NCT00066690|565131745|FG000|Overall Study|Lost to Follow-up|40|||
156557656|NCT00066690|565131746|FG001|Overall Study|Lost to Follow-up|21|||
156557657|NCT00066690|565131747|FG002|Overall Study|Lost to Follow-up|29|||
156557658|NCT00066690|565131745|FG000|Overall Study|Withdrawal by Subject|50|||
156557659|NCT00066690|565131746|FG001|Overall Study|Withdrawal by Subject|55|||
156557660|NCT00066690|565131747|FG002|Overall Study|Withdrawal by Subject|49|||
156557661|NCT00066690|565131745|FG000|Overall Study|Treatment Ongoing|246|||
156557662|NCT00066690|565131746|FG001|Overall Study|Treatment Ongoing|278|||
156557663|NCT00066690|565131747|FG002|Overall Study|Treatment Ongoing|282|||
156557664|NCT00223496|565131748|FG000|Overall Study|screen failure|9|||
156557665|NCT00223496|565131748|FG000|Overall Study|Lost to Follow-up|4|||
156557666|NCT00223496|565131748|FG000|Overall Study|Lack of Efficacy|6|||
156557667|NCT00223496|565131748|FG000|Overall Study|Withdrawal by Subject|1|||
156557668|NCT00223496|565131748|FG000|Overall Study|Physician Decision|2|||
156557669|NCT02939131|565131751|FG000|Overall Study|Unable to get to clinic|6|||
156557670|NCT02939131|565131752|FG001|Overall Study|Unable to get to clinic|4|||
156557671|NCT02939131|565131751|FG000|Overall Study|Lost to Follow-up|2|||
156557672|NCT02939131|565131752|FG001|Overall Study|Lost to Follow-up|4|||
156557673|NCT02939131|565131751|FG000|Overall Study|severe debilitation|1|||
156557674|NCT02939131|565131752|FG001|Overall Study|severe debilitation|0|||
156557675|NCT02939131|565131751|FG000|Overall Study|Other|0|||
156557676|NCT02939131|565131752|FG001|Overall Study|Other|1|||
156557677|NCT02939131|565131751|FG000|Overall Study|not willing to adhere to protocol|2|||
156557678|NCT02939131|565131752|FG001|Overall Study|not willing to adhere to protocol|0|||
156557679|NCT03569202|565131756|FG000|Part 3|Physician Decision|1|||
156557680|NCT03569202|565131757|FG001|Part 3|Physician Decision|0|||
156557681|NCT03569202|565131756|FG000|Part 3|Other|1|||
156557682|NCT03569202|565131757|FG001|Part 3|Other|1|||
156557683|NCT00420511|565131758|FG000|Overall Study|Adverse Event|1|||
156557684|NCT00420511|565131759|FG001|Overall Study|Adverse Event|1|||
156557685|NCT00420511|565131758|FG000|Overall Study|Lost to Follow-up|1|||
156557686|NCT00420511|565131759|FG001|Overall Study|Lost to Follow-up|0|||
156557687|NCT02415712|565131760|FG000|Overall Study|Protocol Violation|16|||
156557688|NCT01127165|565131762|FG000|Overall Study|Adverse Event|2|||
156557689|NCT01127165|565131763|FG001|Overall Study|Adverse Event|2|||
156557690|NCT01127165|565131762|FG000|Overall Study|Lack of Efficacy|10|||
156557691|NCT01127165|565131763|FG001|Overall Study|Lack of Efficacy|8|||
156557692|NCT01127165|565131762|FG000|Overall Study|Lost to Follow-up|3|||
156557693|NCT01127165|565131763|FG001|Overall Study|Lost to Follow-up|5|||
156557694|NCT01127165|565131762|FG000|Overall Study|Withdrawal by Subject|1|||
156557695|NCT01127165|565131763|FG001|Overall Study|Withdrawal by Subject|3|||
156557696|NCT01127165|565131762|FG000|Overall Study|Protocol Violation|0|||
156557697|NCT01127165|565131763|FG001|Overall Study|Protocol Violation|1|||
156557698|NCT02435849|565131764|FG000|Overall Study|Death|23|||
156557699|NCT02435849|565131765|FG001|Overall Study|Death|0|||
156557700|NCT02435849|565131764|FG000|Overall Study|Lack of Efficacy|10|||
156557701|NCT02435849|565131765|FG001|Overall Study|Lack of Efficacy|0|||
156557702|NCT02435849|565131764|FG000|Overall Study|New therapy for study indication|8|||
156557703|NCT02435849|565131765|FG001|Overall Study|New therapy for study indication|0|||
156557704|NCT02435849|565131764|FG000|Overall Study|Subject/guardian decision|5|||
156557705|NCT02435849|565131765|FG001|Overall Study|Subject/guardian decision|1|||
156557706|NCT02435849|565131764|FG000|Overall Study|Lost to Follow-up|1|||
156557707|NCT02435849|565131765|FG001|Overall Study|Lost to Follow-up|0|||
156557708|NCT02435849|565131764|FG000|Overall Study|Physician Decision|1|||
156557709|NCT02435849|565131765|FG001|Overall Study|Physician Decision|0|||
156557710|NCT01017952|565131766|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
156557711|NCT01017952|565131767|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
156557712|NCT01017952|565131768|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
156557713|NCT01017952|565131769|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
156557714|NCT01017952|565131770|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
156557715|NCT01017952|565131766|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
156557716|NCT01017952|565131767|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
156557717|NCT01017952|565131768|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
156557718|NCT01017952|565131769|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
156557719|NCT01017952|565131770|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
156557720|NCT01017952|565131766|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
156557721|NCT01017952|565131767|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
156557722|NCT01017952|565131768|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
156557723|NCT01017952|565131769|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
156557724|NCT01017952|565131770|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
156557725|NCT01017952|565131766|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
156557726|NCT01017952|565131767|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
156557727|NCT01017952|565131768|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
156557728|NCT01017952|565131769|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
156557729|NCT01017952|565131770|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
156557730|NCT01017952|565131766|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
156557731|NCT01017952|565131767|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
156557732|NCT01017952|565131768|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
156557733|NCT01017952|565131769|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
156557734|NCT01017952|565131770|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
156557735|NCT01017952|565131766|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
156557736|NCT01017952|565131767|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
156557737|NCT01017952|565131768|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
156557738|NCT01017952|565131769|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
156557739|NCT01017952|565131770|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
156557740|NCT01017952|565131766|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
156557741|NCT01017952|565131767|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
156557742|NCT01017952|565131768|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
156557743|NCT01017952|565131769|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
156557744|NCT01017952|565131770|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
156557745|NCT01017952|565131766|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156557746|NCT01017952|565131767|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
156557747|NCT01017952|565131768|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
156557748|NCT01017952|565131769|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
156557749|NCT01017952|565131770|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
156557750|NCT01017952|565131766|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
156557751|NCT01017952|565131767|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
156557752|NCT01017952|565131768|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
156557753|NCT01017952|565131769|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
156557754|NCT01017952|565131770|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
156557755|NCT01017952|565131766|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
156557756|NCT01017952|565131767|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
156557757|NCT01017952|565131768|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
156557758|NCT01017952|565131769|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
156557759|NCT01017952|565131770|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
156557760|NCT01017952|565131766|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
156557761|NCT01017952|565131767|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
156557762|NCT01017952|565131768|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
156557763|NCT01017952|565131769|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
156557764|NCT01017952|565131770|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
156557765|NCT01017952|565131766|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
156557766|NCT01017952|565131767|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
156557767|NCT01017952|565131768|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
156557768|NCT01017952|565131769|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
156557769|NCT01017952|565131770|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
156557770|NCT01017952|565131766|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156557771|NCT01017952|565131767|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
156407444|NCT02969525|564584793|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
156407445|NCT02969525|564584794|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
156407446|NCT02969525|564584795|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
156407447|NCT02969525|564584796|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
156407448|NCT02969525|564584797|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
156407449|NCT02969525|564584786|FG000|Dose-Blind Period|Non-cooperating patient|0|||
156407450|NCT02969525|564584787|FG001|Dose-Blind Period|Non-cooperating patient|0|||
156407451|NCT02969525|564584788|FG002|Dose-Blind Period|Non-cooperating patient|0|||
156407452|NCT02969525|564584789|FG003|Dose-Blind Period|Non-cooperating patient|0|||
156407453|NCT02969525|564584790|FG004|Dose-Blind Period|Non-cooperating patient|0|||
156407454|NCT02969525|564584791|FG005|Dose-Blind Period|Non-cooperating patient|0|||
156407455|NCT02969525|564584792|FG006|Dose-Blind Period|Non-cooperating patient|0|||
156407456|NCT02969525|564584793|FG007|Dose-Blind Period|Non-cooperating patient|0|||
156557772|NCT01017952|565131768|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
156557773|NCT01017952|565131769|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
156557774|NCT01017952|565131770|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
156557775|NCT01017952|565131766|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
156557776|NCT01017952|565131767|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
156557777|NCT01017952|565131768|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
156557778|NCT01017952|565131769|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
156557779|NCT01017952|565131770|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
156407457|NCT02969525|564584794|FG008|Dose-Blind Period|Non-cooperating patient|0|||
156557780|NCT01064167|565131771|FG000|Overall Study|Protocol Violation|14|||
156557781|NCT01064167|565131772|FG001|Overall Study|Protocol Violation|15|||
156557782|NCT03984305|565131775|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
156557783|NCT03984305|565131776|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
156557784|NCT03984305|565131775|FG000|Overall Study|Withdrawal by Subject|3|||
156557785|NCT03984305|565131776|FG001|Overall Study|Withdrawal by Subject|3|||
156557786|NCT03984305|565131775|FG000|Overall Study|Lost to Follow-up|1|||
156557787|NCT03984305|565131776|FG001|Overall Study|Lost to Follow-up|0|||
156557788|NCT00352105|565131777|FG000|Overall Study|Death|5|||
156557789|NCT00352105|565131777|FG000|Overall Study|Withdrawal by Subject|5|||
156557790|NCT00352105|565131777|FG000|Overall Study|Lack of Efficacy|9|||
156557791|NCT00352105|565131777|FG000|Overall Study|Adverse Event|19|||
156557792|NCT00352105|565131777|FG000|Overall Study|Protocol Violation|2|||
156557793|NCT02979431|565131778|FG000|Overall Study|Parent/guardian withdrew consent|2|||
156557794|NCT02979431|565131779|FG001|Overall Study|Parent/guardian withdrew consent|1|||
156557795|NCT02979431|565131780|FG002|Overall Study|Parent/guardian withdrew consent|1|||
156557796|NCT02979431|565131781|FG003|Overall Study|Parent/guardian withdrew consent|1|||
156557797|NCT02979431|565131778|FG000|Overall Study|Randomized but received no study drug|1|||
156557798|NCT02979431|565131779|FG001|Overall Study|Randomized but received no study drug|1|||
156557799|NCT02979431|565131780|FG002|Overall Study|Randomized but received no study drug|0|||
156557800|NCT02979431|565131781|FG003|Overall Study|Randomized but received no study drug|0|||
156557801|NCT02979431|565131778|FG000|Overall Study|Adverse Event|0|||
156557802|NCT02979431|565131779|FG001|Overall Study|Adverse Event|0|||
156407458|NCT02969525|564584795|FG009|Dose-Blind Period|Non-cooperating patient|0|||
156407459|NCT02969525|564584796|FG010|Dose-Blind Period|Non-cooperating patient|0|||
156407460|NCT02969525|564584797|FG011|Dose-Blind Period|Non-cooperating patient|1|||
156407461|NCT02969525|564584786|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156407462|NCT02969525|564584787|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156407463|NCT02969525|564584788|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156407464|NCT02969525|564584789|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156557803|NCT02979431|565131780|FG002|Overall Study|Adverse Event|1|||
156557804|NCT02979431|565131781|FG003|Overall Study|Adverse Event|0|||
156557805|NCT02979431|565131778|FG000|Overall Study|Subject left country after Day14|1|||
156557806|NCT02979431|565131779|FG001|Overall Study|Subject left country after Day14|0|||
156557807|NCT02979431|565131780|FG002|Overall Study|Subject left country after Day14|0|||
156557808|NCT02979431|565131781|FG003|Overall Study|Subject left country after Day14|0|||
156557809|NCT01656434|565131782|FG000|Overall Study|Adverse Event|199|||
156557810|NCT01656434|565131783|FG001|Overall Study|Adverse Event|63|||
156557811|NCT01656434|565131782|FG000|Overall Study|Enrollment terminated at trial site|2|||
156557812|NCT01656434|565131783|FG001|Overall Study|Enrollment terminated at trial site|0|||
156557813|NCT01656434|565131782|FG000|Overall Study|Lost to Follow-up|309|||
156557814|NCT01656434|565131783|FG001|Overall Study|Lost to Follow-up|76|||
156557815|NCT01656434|565131782|FG000|Overall Study|Site discontinued study participation|24|||
156557816|NCT01656434|565131783|FG001|Overall Study|Site discontinued study participation|9|||
156557817|NCT01656434|565131782|FG000|Overall Study|Screen failure|2|||
156557818|NCT01656434|565131783|FG001|Overall Study|Screen failure|0|||
156557819|NCT01656434|565131782|FG000|Overall Study|Protocol Violation|7|||
156557820|NCT01656434|565131783|FG001|Overall Study|Protocol Violation|0|||
156557821|NCT01656434|565131782|FG000|Overall Study|Pregnancy wish|18|||
156557822|NCT01656434|565131783|FG001|Overall Study|Pregnancy wish|6|||
156557823|NCT01656434|565131782|FG000|Overall Study|Pregnancy|45|||
156557824|NCT01656434|565131783|FG001|Overall Study|Pregnancy|10|||
156557825|NCT01656434|565131782|FG000|Overall Study|Physician Decision|7|||
156557826|NCT01656434|565131783|FG001|Overall Study|Physician Decision|2|||
156557827|NCT01656434|565131782|FG000|Overall Study|Non-compliance with study drug|48|||
156557828|NCT01656434|565131783|FG001|Overall Study|Non-compliance with study drug|9|||
156557829|NCT01656434|565131782|FG000|Overall Study|Study terminated by sponsor|1501|||
156557830|NCT01656434|565131783|FG001|Overall Study|Study terminated by sponsor|348|||
156557831|NCT01656434|565131782|FG000|Overall Study|Participant discontinued; drug related|13|||
156557832|NCT01656434|565131783|FG001|Overall Study|Participant discontinued; drug related|4|||
156557833|NCT01656434|565131782|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
156557834|NCT01656434|565131783|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
156557835|NCT01656434|565131782|FG000|Overall Study|Non-compliance with protocol|39|||
156557836|NCT01656434|565131783|FG001|Overall Study|Non-compliance with protocol|15|||
156557837|NCT01656434|565131782|FG000|Overall Study|Participant moved|40|||
156557838|NCT01656434|565131783|FG001|Overall Study|Participant moved|12|||
156557839|NCT01656434|565131782|FG000|Overall Study|Participant withdrew consent|28|||
156557840|NCT01656434|565131783|FG001|Overall Study|Participant withdrew consent|9|||
156557841|NCT01656434|565131782|FG000|Overall Study|Withdrawal by Subject|64|||
156557842|NCT01656434|565131783|FG001|Overall Study|Withdrawal by Subject|7|||
156557843|NCT01580397|565131784|FG000|Overall Study|Lack of Efficacy|14|||
156557844|NCT02883244|565131785|FG000|Overall Study|Lost to Follow-up|0|||
156557845|NCT02883244|565131786|FG001|Overall Study|Lost to Follow-up|1|||
156557846|NCT02435914|565131787|FG000|Overall Study|Ocular Adverse Event|1|||
156557847|NCT02435914|565131788|FG001|Overall Study|Ocular Adverse Event|0|||
156557848|NCT02435914|565131789|FG002|Overall Study|Ocular Adverse Event|0|||
156557849|NCT02435914|565131790|FG003|Overall Study|Ocular Adverse Event|0|||
156557850|NCT02435914|565131787|FG000|Overall Study|Withdrawal by Subject|0|||
156557851|NCT02435914|565131788|FG001|Overall Study|Withdrawal by Subject|1|||
156557852|NCT02435914|565131789|FG002|Overall Study|Withdrawal by Subject|0|||
156557853|NCT02435914|565131790|FG003|Overall Study|Withdrawal by Subject|0|||
156557854|NCT02435914|565131787|FG000|Overall Study|Other Miscellaneous Reason|0|||
156557855|NCT02435914|565131788|FG001|Overall Study|Other Miscellaneous Reason|0|||
156557856|NCT02435914|565131789|FG002|Overall Study|Other Miscellaneous Reason|1|||
156557857|NCT02435914|565131790|FG003|Overall Study|Other Miscellaneous Reason|0|||
156557858|NCT01727258|565131791|FG000|Overall Study|Adverse Event|0|||
156557859|NCT01727258|565131792|FG001|Overall Study|Adverse Event|2|||
156557860|NCT01727258|565131793|FG002|Overall Study|Adverse Event|0|||
156557861|NCT01727258|565131791|FG000|Overall Study|Noncompliance with Study Drug|0|||
156557862|NCT01727258|565131792|FG001|Overall Study|Noncompliance with Study Drug|0|||
156557863|NCT01727258|565131793|FG002|Overall Study|Noncompliance with Study Drug|1|||
156557864|NCT01727258|565131791|FG000|Overall Study|Withdrawal by Subject|1|||
156557865|NCT01727258|565131792|FG001|Overall Study|Withdrawal by Subject|1|||
156557866|NCT01727258|565131793|FG002|Overall Study|Withdrawal by Subject|0|||
156557867|NCT01727258|565131791|FG000|Overall Study|Lost to Follow-up|1|||
156557868|NCT01727258|565131792|FG001|Overall Study|Lost to Follow-up|0|||
156557869|NCT01727258|565131793|FG002|Overall Study|Lost to Follow-up|0|||
156557870|NCT01405053|565131794|FG000|Overall Study|Adverse Event|3|||
156557871|NCT01405053|565131795|FG001|Overall Study|Adverse Event|0|||
156557872|NCT01405053|565131794|FG000|Overall Study|Lost to Follow-up|0|||
156557873|NCT01405053|565131795|FG001|Overall Study|Lost to Follow-up|1|||
156557874|NCT01405053|565131794|FG000|Overall Study|Participant choice|2|||
156557875|NCT01405053|565131795|FG001|Overall Study|Participant choice|1|||
156557876|NCT01405053|565131794|FG000|Overall Study|Inadequate therapeutic effect|2|||
156557877|NCT01405053|565131795|FG001|Overall Study|Inadequate therapeutic effect|1|||
156557878|NCT01405053|565131794|FG000|Overall Study|Withdrawal by Subject|3|||
156557879|NCT01405053|565131795|FG001|Overall Study|Withdrawal by Subject|4|||
156557880|NCT01405053|565131794|FG000|Overall Study|Other|0|||
156557881|NCT01405053|565131795|FG001|Overall Study|Other|1|||
156557882|NCT00993928|565131799|FG000|Overall Study|Withdrawal by Subject|4|||
156557883|NCT00993928|565131800|FG001|Overall Study|Withdrawal by Subject|7|||
156557884|NCT00993928|565131799|FG000|Overall Study|ineligible|1|||
156557885|NCT00993928|565131800|FG001|Overall Study|ineligible|0|||
156557886|NCT04871711|565131801|FG000|Overall Study|Withdrawal by Subject|11|||
156557887|NCT04871711|565131802|FG001|Overall Study|Withdrawal by Subject|5|||
156557888|NCT04871711|565131801|FG000|Overall Study|Lack of Efficacy|5|||
156557889|NCT04871711|565131802|FG001|Overall Study|Lack of Efficacy|7|||
156557890|NCT04871711|565131801|FG000|Overall Study|Adverse Event|2|||
156557891|NCT04871711|565131802|FG001|Overall Study|Adverse Event|6|||
156557892|NCT04871711|565131801|FG000|Overall Study|Various reasons|2|||
156557893|NCT04871711|565131802|FG001|Overall Study|Various reasons|1|||
156557894|NCT04871711|565131801|FG000|Overall Study|Lost to Follow-up|0|||
156557895|NCT04871711|565131802|FG001|Overall Study|Lost to Follow-up|2|||
156557896|NCT02319044|565131803|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
156557897|NCT02319044|565131804|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
156557898|NCT02319044|565131805|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
156557899|NCT02319044|565131803|FG000|Overall Study|Withdrawal by Subject|3|||
156557900|NCT02319044|565131804|FG001|Overall Study|Withdrawal by Subject|3|||
156557901|NCT02319044|565131805|FG002|Overall Study|Withdrawal by Subject|6|||
156557902|NCT02319044|565131803|FG000|Overall Study|Condition under investigation worsened|100|||
156557903|NCT02319044|565131804|FG001|Overall Study|Condition under investigation worsened|50|||
156557904|NCT02319044|565131805|FG002|Overall Study|Condition under investigation worsened|46|||
156557905|NCT02319044|565131803|FG000|Overall Study|Adverse Event|17|||
156557906|NCT02319044|565131804|FG001|Overall Study|Adverse Event|2|||
156557907|NCT02319044|565131805|FG002|Overall Study|Adverse Event|8|||
156557908|NCT02319044|565131803|FG000|Overall Study|Study specific discontinuation criteria|2|||
156557909|NCT02319044|565131804|FG001|Overall Study|Study specific discontinuation criteria|2|||
156557910|NCT02319044|565131805|FG002|Overall Study|Study specific discontinuation criteria|1|||
156557911|NCT02319044|565131803|FG000|Overall Study|Not treated|0|||
156557912|NCT02319044|565131804|FG001|Overall Study|Not treated|2|||
156557913|NCT02319044|565131805|FG002|Overall Study|Not treated|2|||
156557914|NCT02026063|565131808|FG000|Overall Study|Physician Decision|0|||
156557915|NCT02026063|565131809|FG001|Overall Study|Physician Decision|10|||
156557916|NCT02026063|565131808|FG000|Overall Study|Noncompliance with Study Drug|1|||
156557917|NCT02026063|565131809|FG001|Overall Study|Noncompliance with Study Drug|1|||
156557918|NCT02026063|565131808|FG000|Overall Study|Withdrawal of Consent|1|||
156557919|NCT02026063|565131809|FG001|Overall Study|Withdrawal of Consent|6|||
156557920|NCT02026063|565131808|FG000|Overall Study|Adverse Event|5|||
156557921|NCT02026063|565131809|FG001|Overall Study|Adverse Event|20|||
156557922|NCT02026063|565131808|FG000|Overall Study|Lack of Efficacy|0|||
156557923|NCT02026063|565131809|FG001|Overall Study|Lack of Efficacy|4|||
156557924|NCT02026063|565131808|FG000|Overall Study|Lost to Follow-up|0|||
156557925|NCT02026063|565131809|FG001|Overall Study|Lost to Follow-up|1|||
156557926|NCT02026063|565131808|FG000|Overall Study|Reason not Specified|2|||
156557927|NCT02026063|565131809|FG001|Overall Study|Reason not Specified|7|||
156557928|NCT02154087|565131811|FG000|Overall Study|Study Termination|1|||
156557929|NCT05702736|565131814|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
156557930|NCT05702736|565131815|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
156557931|NCT05702736|565131814|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
156557932|NCT05702736|565131815|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
156557933|NCT04811716|565131818|FG000|Overall Study|Withdrawal by Subject|2|||
156557934|NCT04811716|565131819|FG001|Overall Study|Withdrawal by Subject|0|||
156557935|NCT05888103|565133080|FG000|Overall Study|Participant decision|3|||
156557936|NCT05888103|565133081|FG001|Overall Study|Participant decision|3|||
156557937|NCT02554929|565133082|FG000|Overall Study|Lost to Follow-up|4|||
156557938|NCT02554929|565133083|FG001|Overall Study|Lost to Follow-up|4|||
156557939|NCT02554929|565133082|FG000|Overall Study|Withdrawal by Subject|2|||
156557940|NCT02554929|565133083|FG001|Overall Study|Withdrawal by Subject|8|||
156557941|NCT03521791|565133084|FG000|Overall Study|Protocol Violation|7|||
156557942|NCT03521791|565133085|FG001|Overall Study|Protocol Violation|17|||
156557943|NCT00680836|565133086|FG000|Overall Study|Withdrawal by Subject|3|||
156557944|NCT00680836|565133087|FG001|Overall Study|Withdrawal by Subject|0|||
156557945|NCT00680836|565133086|FG000|Overall Study|Lost to Follow-up|3|||
156557946|NCT00680836|565133087|FG001|Overall Study|Lost to Follow-up|1|||
156557947|NCT00680836|565133086|FG000|Overall Study|Physician Decision|2|||
156557948|NCT00680836|565133087|FG001|Overall Study|Physician Decision|1|||
156557949|NCT03786432|565133088|FG000|Overall Study|Screen Failure after consent|1|||
156557950|NCT03786432|565133088|FG000|Overall Study|Lost to Follow-up|4|||
156557951|NCT03786432|565133088|FG000|Overall Study|did not complete 12 month CT scan|1|||
156557952|NCT00880750|565133092|FG000|First Intervention|Adverse Event|1|||
156557953|NCT00880750|565133093|FG001|First Intervention|Adverse Event|0|||
156557954|NCT00880750|565133092|FG000|First Intervention|Unable to collect urine|4|||
156557955|NCT00880750|565133093|FG001|First Intervention|Unable to collect urine|0|||
156557956|NCT00880750|565133092|FG000|First Intervention|Non-compliance with meals|0|||
156557957|NCT00880750|565133093|FG001|First Intervention|Non-compliance with meals|1|||
156557958|NCT00880750|565133092|FG000|First Intervention|Withdrawal by Subject|2|||
156557959|NCT00880750|565133093|FG001|First Intervention|Withdrawal by Subject|0|||
156557960|NCT00880750|565133092|FG000|First Intervention|Lost to Follow-up|2|||
156557961|NCT00880750|565133093|FG001|First Intervention|Lost to Follow-up|0|||
156557962|NCT00880750|565133092|FG000|Second Intervention|Withdrawal by Subject|2|||
156557963|NCT00880750|565133093|FG001|Second Intervention|Withdrawal by Subject|2|||
156557964|NCT00880750|565133092|FG000|Second Intervention|Protocol Violation|1|||
156557965|NCT00880750|565133093|FG001|Second Intervention|Protocol Violation|0|||
156557966|NCT00880750|565133092|FG000|Second Intervention|Unable to collect urine|1|||
156557967|NCT00880750|565133093|FG001|Second Intervention|Unable to collect urine|0|||
156557968|NCT01246206|565133094|FG000|Overall Study|Patient did not receive study regiments.|1|||
156557969|NCT00688909|565133100|FG000|Overall Study|Adverse Event|28|||
156557970|NCT00688909|565133100|FG000|Overall Study|Patient withdrew consent|2|||
156557971|NCT00688909|565133100|FG000|Overall Study|Administrative problems|1|||
156557972|NCT00688909|565133100|FG000|Overall Study|Protocol Violation|2|||
156557973|NCT01668654|565133101|FG000|Overall Study|Study Closed/Terminated|3|||
156557974|NCT01668654|565133101|FG000|Overall Study|Withdrawal by Subject|1|||
156557975|NCT03634800|565133102|FG000|Overall Study|Adverse Event|1|||
156557976|NCT03634800|565133102|FG000|Overall Study|Disease Progression|4|||
156557977|NCT03634800|565133102|FG000|Overall Study|Withdrawal by Subject|1|||
156557978|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
156557979|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
156557980|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
156557981|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
156557982|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
156557983|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
156557984|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
156557985|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
156557986|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
156407465|NCT02969525|564584790|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156407466|NCT02969525|564584791|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156407467|NCT02969525|564584792|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156557987|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
156557988|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
156557989|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
156557990|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
156557991|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
156557992|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
156557993|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
156557994|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
156557995|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
156557996|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
156557997|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
156557998|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
156557999|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
156558000|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
156558001|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
156558002|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Death|2|||
156558003|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Death|1|||
156558004|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Death|2|||
156558005|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Graft loss|0|||
156558006|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Graft loss|2|||
156558007|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Graft loss|0|||
156558008|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
156558009|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
156558010|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
156558011|NCT01114529|565133103|FG000|Completed Study Medication at Month 24|Missing|2|||
156558012|NCT01114529|565133104|FG001|Completed Study Medication at Month 24|Missing|0|||
156558013|NCT01114529|565133105|FG002|Completed Study Medication at Month 24|Missing|0|||
156558014|NCT01114529|565133103|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
156558015|NCT01114529|565133104|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
156558016|NCT01114529|565133105|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
156558017|NCT01114529|565133103|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
156558018|NCT01114529|565133104|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
156558019|NCT01114529|565133105|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
156558020|NCT01114529|565133103|FG000|Completed Study Phase at Month 24|Death|8|||
156558021|NCT01114529|565133104|FG001|Completed Study Phase at Month 24|Death|5|||
156558022|NCT01114529|565133105|FG002|Completed Study Phase at Month 24|Death|4|||
156558023|NCT01114529|565133103|FG000|Completed Study Phase at Month 24|Other|2|||
156558024|NCT01114529|565133104|FG001|Completed Study Phase at Month 24|Other|0|||
156558025|NCT01114529|565133105|FG002|Completed Study Phase at Month 24|Other|0|||
156558026|NCT01114529|565133103|FG000|Completed Study Phase at Month 24|Missing|2|||
156558027|NCT01114529|565133104|FG001|Completed Study Phase at Month 24|Missing|0|||
156558028|NCT01114529|565133105|FG002|Completed Study Phase at Month 24|Missing|0|||
156558029|NCT01235962|565133110|FG000|Overall Study|Withdrawal by Subject|20|||
156558030|NCT01235962|565133111|FG001|Overall Study|Withdrawal by Subject|19|||
156558031|NCT01235962|565133112|FG002|Overall Study|Withdrawal by Subject|62|||
156558032|NCT01235962|565133113|FG003|Overall Study|Withdrawal by Subject|49|||
156558033|NCT01235962|565133110|FG000|Overall Study|Lost to Follow-up|21|||
156558034|NCT01235962|565133111|FG001|Overall Study|Lost to Follow-up|16|||
156558035|NCT01235962|565133112|FG002|Overall Study|Lost to Follow-up|47|||
156558036|NCT01235962|565133113|FG003|Overall Study|Lost to Follow-up|32|||
156558037|NCT01235962|565133110|FG000|Overall Study|Physician Decision|5|||
156558038|NCT01235962|565133111|FG001|Overall Study|Physician Decision|0|||
156558039|NCT01235962|565133112|FG002|Overall Study|Physician Decision|9|||
156558040|NCT01235962|565133113|FG003|Overall Study|Physician Decision|5|||
156558041|NCT00130286|565133114|FG000|Overall Study|Withdrawal by Subject|0|||
156558042|NCT00130286|565133115|FG001|Overall Study|Withdrawal by Subject|1|||
156558043|NCT00130286|565133116|FG002|Overall Study|Withdrawal by Subject|2|||
156558044|NCT00130286|565133117|FG003|Overall Study|Withdrawal by Subject|2|||
156558045|NCT00130286|565133114|FG000|Overall Study|Adverse Event|0|||
156558046|NCT00130286|565133115|FG001|Overall Study|Adverse Event|0|||
156558047|NCT00130286|565133116|FG002|Overall Study|Adverse Event|2|||
156558048|NCT00130286|565133117|FG003|Overall Study|Adverse Event|0|||
156558049|NCT00130286|565133114|FG000|Overall Study|Missing lab specimens|0|||
156558050|NCT00130286|565133115|FG001|Overall Study|Missing lab specimens|2|||
156558051|NCT00130286|565133116|FG002|Overall Study|Missing lab specimens|0|||
156558052|NCT00130286|565133117|FG003|Overall Study|Missing lab specimens|0|||
156407468|NCT02969525|564584793|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156407469|NCT02969525|564584794|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156558053|NCT01890421|565133118|FG000|Overall Study|Adverse Event|1|||
156558054|NCT01890421|565133118|FG000|Overall Study|Other reason|10|||
156558055|NCT00268242|565133119|FG000|Overall Study|Death|1|||
156558056|NCT03969888|565133120|FG000|Overall Study|Never Received Study Drug|0|||
156407470|NCT02969525|564584795|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156407471|NCT02969525|564584796|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
156558057|NCT03969888|565133121|FG001|Overall Study|Never Received Study Drug|0|||
156558058|NCT03969888|565133122|FG002|Overall Study|Never Received Study Drug|1|||
156558059|NCT03969888|565133123|FG003|Overall Study|Never Received Study Drug|0|||
156558060|NCT03969888|565133124|FG004|Overall Study|Never Received Study Drug|0|||
156558061|NCT03969888|565133125|FG005|Overall Study|Never Received Study Drug|0|||
156558062|NCT03969888|565133126|FG006|Overall Study|Never Received Study Drug|1|||
156558063|NCT03969888|565133127|FG007|Overall Study|Never Received Study Drug|0|||
156558064|NCT03969888|565133120|FG000|Overall Study|Reason Not Specified|0|||
156558065|NCT03969888|565133121|FG001|Overall Study|Reason Not Specified|0|||
156558066|NCT03969888|565133122|FG002|Overall Study|Reason Not Specified|0|||
156558067|NCT03969888|565133123|FG003|Overall Study|Reason Not Specified|0|||
156558068|NCT03969888|565133124|FG004|Overall Study|Reason Not Specified|0|||
156558069|NCT03969888|565133125|FG005|Overall Study|Reason Not Specified|0|||
156407472|NCT02969525|564584797|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156407473|NCT03445065|564584798|FG000|Overall Study|Withdrawal by Subject|3|||
156407474|NCT03445065|564584799|FG001|Overall Study|Withdrawal by Subject|6|||
156407475|NCT03445065|564584800|FG002|Overall Study|Withdrawal by Subject|2|||
156407476|NCT03445065|564584801|FG003|Overall Study|Withdrawal by Subject|2|||
156407477|NCT03445065|564584798|FG000|Overall Study|Other|4|||
156407478|NCT03445065|564584799|FG001|Overall Study|Other|3|||
156407479|NCT03445065|564584800|FG002|Overall Study|Other|3|||
156407480|NCT03445065|564584801|FG003|Overall Study|Other|1|||
156407481|NCT05879198|564584802|FG000|Overall Study|Lost to Follow-up|1|||
156407482|NCT01598298|564584803|FG000|Overall Study|Not eligible|5|||
156407483|NCT01598298|564584804|FG001|Overall Study|Not eligible|5|||
156407484|NCT01598298|564584803|FG000|Overall Study|Adverse Event|21|||
156407485|NCT01598298|564584804|FG001|Overall Study|Adverse Event|19|||
156407486|NCT01598298|564584803|FG000|Overall Study|Progression/relapse|0|||
156407487|NCT01598298|564584804|FG001|Overall Study|Progression/relapse|2|||
156407488|NCT01598298|564584803|FG000|Overall Study|Withdrawal by Subject|10|||
156407489|NCT01598298|564584804|FG001|Overall Study|Withdrawal by Subject|15|||
156407490|NCT01598298|564584803|FG000|Overall Study|Other reason (not protocol specified)|4|||
156407491|NCT01598298|564584804|FG001|Overall Study|Other reason (not protocol specified)|0|||
156407492|NCT02073097|564584805|FG000|Overall Study|Adverse Event|0|||
156407493|NCT02073097|564584806|FG001|Overall Study|Adverse Event|0|||
156407494|NCT02073097|564584807|FG002|Overall Study|Adverse Event|0|||
156407495|NCT02073097|564584808|FG003|Overall Study|Adverse Event|0|||
156407496|NCT02073097|564584809|FG004|Overall Study|Adverse Event|0|||
156407497|NCT02073097|564584810|FG005|Overall Study|Adverse Event|0|||
156407498|NCT02073097|564584811|FG006|Overall Study|Adverse Event|0|||
156407499|NCT02073097|564584812|FG007|Overall Study|Adverse Event|2|||
156407500|NCT02073097|564584805|FG000|Overall Study|Withdrawal by Subject|0|||
156407501|NCT02073097|564584806|FG001|Overall Study|Withdrawal by Subject|0|||
156407502|NCT02073097|564584807|FG002|Overall Study|Withdrawal by Subject|0|||
156407503|NCT02073097|564584808|FG003|Overall Study|Withdrawal by Subject|0|||
156407504|NCT02073097|564584809|FG004|Overall Study|Withdrawal by Subject|0|||
156407505|NCT02073097|564584810|FG005|Overall Study|Withdrawal by Subject|0|||
156407506|NCT02073097|564584811|FG006|Overall Study|Withdrawal by Subject|0|||
156407507|NCT02073097|564584812|FG007|Overall Study|Withdrawal by Subject|2|||
156407508|NCT02073097|564584805|FG000|Overall Study|Death|0|||
156407509|NCT02073097|564584806|FG001|Overall Study|Death|0|||
156558070|NCT03969888|565133126|FG006|Overall Study|Reason Not Specified|0|||
156558071|NCT03969888|565133127|FG007|Overall Study|Reason Not Specified|1|||
156558072|NCT00464178|565133132|FG000|Overall Study|Protocol Violation|1|||
156558073|NCT00464178|565133132|FG000|Overall Study|Withdrawal by Subject|1|||
156407510|NCT02073097|564584807|FG002|Overall Study|Death|0|||
156407511|NCT02073097|564584808|FG003|Overall Study|Death|0|||
156407512|NCT02073097|564584809|FG004|Overall Study|Death|0|||
156407513|NCT02073097|564584810|FG005|Overall Study|Death|0|||
156407514|NCT02073097|564584811|FG006|Overall Study|Death|0|||
156407515|NCT02073097|564584812|FG007|Overall Study|Death|1|||
156407516|NCT02073097|564584805|FG000|Overall Study|Physician Decision|0|||
156407517|NCT02073097|564584806|FG001|Overall Study|Physician Decision|0|||
156407518|NCT02073097|564584807|FG002|Overall Study|Physician Decision|0|||
156407519|NCT02073097|564584808|FG003|Overall Study|Physician Decision|0|||
156407520|NCT02073097|564584809|FG004|Overall Study|Physician Decision|0|||
156407521|NCT02073097|564584810|FG005|Overall Study|Physician Decision|0|||
156558074|NCT01972074|565133141|FG000|Overall Study|Adverse Event|4|||
156407522|NCT02073097|564584811|FG006|Overall Study|Physician Decision|0|||
156407523|NCT02073097|564584812|FG007|Overall Study|Physician Decision|1|||
156407524|NCT01693692|564584813|FG000|Overall Study|Withdrawal by Subject|12|||
156407525|NCT01693692|564584814|FG001|Overall Study|Withdrawal by Subject|10|||
156407526|NCT01693692|564584815|FG002|Overall Study|Withdrawal by Subject|11|||
156407527|NCT01693692|564584813|FG000|Overall Study|Adverse Event|7|||
156407528|NCT01693692|564584814|FG001|Overall Study|Adverse Event|14|||
156407529|NCT01693692|564584815|FG002|Overall Study|Adverse Event|9|||
156407530|NCT01693692|564584813|FG000|Overall Study|Physician Decision|0|||
156407531|NCT01693692|564584814|FG001|Overall Study|Physician Decision|0|||
156558075|NCT01972074|565133142|FG001|Overall Study|Adverse Event|1|||
156558076|NCT01972074|565133143|FG002|Overall Study|Adverse Event|0|||
156558077|NCT01972074|565133141|FG000|Overall Study|Lack of Efficacy|1|||
156558078|NCT01972074|565133142|FG001|Overall Study|Lack of Efficacy|1|||
156558079|NCT01972074|565133143|FG002|Overall Study|Lack of Efficacy|0|||
156558080|NCT01972074|565133141|FG000|Overall Study|Lost to Follow-up|0|||
156558081|NCT01972074|565133142|FG001|Overall Study|Lost to Follow-up|1|||
156558082|NCT01972074|565133143|FG002|Overall Study|Lost to Follow-up|1|||
156558083|NCT01972074|565133141|FG000|Overall Study|Withdrawal by Subject|1|||
156558084|NCT01972074|565133142|FG001|Overall Study|Withdrawal by Subject|1|||
156558085|NCT01972074|565133143|FG002|Overall Study|Withdrawal by Subject|1|||
156558086|NCT01972074|565133141|FG000|Overall Study|Scanner Unavailable|0|||
156558087|NCT01972074|565133142|FG001|Overall Study|Scanner Unavailable|0|||
156558088|NCT01972074|565133143|FG002|Overall Study|Scanner Unavailable|1|||
156558089|NCT03687502|565133154|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
156558090|NCT03687502|565133154|FG000|Overall Study|Lumason not available|1|||
156558091|NCT00486278|565133156|FG000|Overall Study|Adverse Event|5|||
156558092|NCT00486278|565133156|FG000|Overall Study|Withdrawal by Subject|2|||
156558093|NCT00486278|565133156|FG000|Overall Study|Physician Decision|2|||
156558094|NCT02183519|565133162|FG000|Overall Study|computer error|3|||
156558095|NCT02183519|565133163|FG001|Overall Study|computer error|0|||
156558096|NCT02183519|565133162|FG000|Overall Study|Did not respond to cough inducter|0|||
156558097|NCT02183519|565133163|FG001|Overall Study|Did not respond to cough inducter|3|||
156558098|NCT01777581|565133165|FG000|Overall Study|Lost to Follow-up|1|||
156558099|NCT01777581|565133166|FG001|Overall Study|Lost to Follow-up|1|||
156558100|NCT01777581|565133165|FG000|Overall Study|Adverse Event|2|||
156558101|NCT01777581|565133166|FG001|Overall Study|Adverse Event|0|||
156558102|NCT01777581|565133165|FG000|Overall Study|Lack of Efficacy|0|||
156558103|NCT01777581|565133166|FG001|Overall Study|Lack of Efficacy|1|||
156558104|NCT05168267|565133167|FG000|Overall Study|Withdrawal by Subject|2|||
156558105|NCT05168267|565133168|FG001|Overall Study|Withdrawal by Subject|1|||
156558106|NCT05168267|565133167|FG000|Overall Study|Withdrawn by Therapist|1|||
156558107|NCT05168267|565133168|FG001|Overall Study|Withdrawn by Therapist|1|||
156558108|NCT05168267|565133167|FG000|Overall Study|Left Facility|1|||
156558109|NCT05168267|565133168|FG001|Overall Study|Left Facility|0|||
156558110|NCT02887521|565133169|FG000|Overall Study|Withdrawal by Subject|0|||
156558111|NCT02887521|565133170|FG001|Overall Study|Withdrawal by Subject|3|||
156558112|NCT00695565|565133171|FG000|Overall Study|Lost to Follow-up|4|||
156558113|NCT00695565|565133172|FG001|Overall Study|Lost to Follow-up|4|||
156558114|NCT00695565|565133171|FG000|Overall Study|Adverse Event|3|||
156558115|NCT00695565|565133172|FG001|Overall Study|Adverse Event|1|||
156558116|NCT00695565|565133171|FG000|Overall Study|Protocol Violation|3|||
156558117|NCT00695565|565133172|FG001|Overall Study|Protocol Violation|1|||
156558118|NCT00695565|565133171|FG000|Overall Study|Withdrawal by Subject|1|||
156558119|NCT00695565|565133172|FG001|Overall Study|Withdrawal by Subject|1|||
156558120|NCT00695565|565133171|FG000|Overall Study|Lack of Efficacy|1|||
156558121|NCT00695565|565133172|FG001|Overall Study|Lack of Efficacy|1|||
156407532|NCT01693692|564584815|FG002|Overall Study|Physician Decision|1|||
156407533|NCT01693692|564584813|FG000|Overall Study|Protocol Violation|5|||
156407534|NCT01693692|564584814|FG001|Overall Study|Protocol Violation|4|||
156407535|NCT01693692|564584815|FG002|Overall Study|Protocol Violation|6|||
156407536|NCT01693692|564584813|FG000|Overall Study|Lost to Follow-up|2|||
156407537|NCT01693692|564584814|FG001|Overall Study|Lost to Follow-up|2|||
156407538|NCT01693692|564584815|FG002|Overall Study|Lost to Follow-up|3|||
156407539|NCT01693692|564584813|FG000|Overall Study|Other|4|||
156407540|NCT01693692|564584814|FG001|Overall Study|Other|4|||
156407541|NCT01693692|564584815|FG002|Overall Study|Other|6|||
156513306|NCT01204710|564970712|FG000|Randomization Treatment|Worsening of General condition|0|||
156513307|NCT01204710|564970713|FG001|Randomization Treatment|Worsening of General condition|1|||
156513308|NCT01204710|564970712|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
156513309|NCT01204710|564970713|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
156513310|NCT01204710|564970712|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
156513311|NCT01204710|564970713|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
156513312|NCT01204710|564970712|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
156513313|NCT01204710|564970713|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
156513314|NCT01204710|564970712|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
156513315|NCT01204710|564970713|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
156513316|NCT04531904|564970716|FG000|Overall Study|Lost to Follow-up|1|||
156558122|NCT00695565|565133171|FG000|Overall Study|Subject did not follow instructions|1|||
156558123|NCT00695565|565133172|FG001|Overall Study|Subject did not follow instructions|1|||
156558124|NCT02937350|565133173|FG000|Overall Study|Withdrawal by Subject|0|||
156558125|NCT02937350|565133174|FG001|Overall Study|Withdrawal by Subject|1|||
156558126|NCT02937350|565133175|FG002|Overall Study|Withdrawal by Subject|0|||
156558127|NCT01462266|565133176|FG000|Overall Study|Adverse Event|7|||
156558128|NCT01462266|565133177|FG001|Overall Study|Adverse Event|6|||
156558129|NCT01462266|565133176|FG000|Overall Study|Death|2|||
156558130|NCT01462266|565133177|FG001|Overall Study|Death|1|||
156558131|NCT01462266|565133176|FG000|Overall Study|Lack of Efficacy|0|||
156558132|NCT01462266|565133177|FG001|Overall Study|Lack of Efficacy|2|||
156558133|NCT01462266|565133176|FG000|Overall Study|Lost to Follow-up|4|||
156558134|NCT01462266|565133177|FG001|Overall Study|Lost to Follow-up|3|||
156558135|NCT01462266|565133176|FG000|Overall Study|Non-compliance with study drug|3|||
156558136|NCT01462266|565133177|FG001|Overall Study|Non-compliance with study drug|0|||
156558137|NCT01462266|565133176|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
156558138|NCT01462266|565133177|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
156558139|NCT01462266|565133176|FG000|Overall Study|Physician Decision|2|||
156558140|NCT01462266|565133177|FG001|Overall Study|Physician Decision|5|||
156558141|NCT01462266|565133176|FG000|Overall Study|Protocol Violation|1|||
156558142|NCT01462266|565133177|FG001|Overall Study|Protocol Violation|3|||
156558143|NCT01462266|565133176|FG000|Overall Study|Withdrawal by Subject|7|||
156558144|NCT01462266|565133177|FG001|Overall Study|Withdrawal by Subject|2|||
156558145|NCT01462266|565133176|FG000|Overall Study|Screen failure|1|||
156558146|NCT01462266|565133177|FG001|Overall Study|Screen failure|1|||
156558147|NCT01106846|565133178|FG000|Overall Study|Change in surgical procedure|0|||
156558148|NCT01106846|565133179|FG001|Overall Study|Change in surgical procedure|1|||
156558149|NCT03110900|565133181|FG000|Overall Study|Sponsor withdrew|1|||
156558150|NCT03110900|565133182|FG001|Overall Study|Sponsor withdrew|1|||
156558151|NCT02321436|565133183|FG000|Overall Study|Withdrawal by Subject|1|||
156558152|NCT02321436|565133184|FG001|Overall Study|Withdrawal by Subject|0|||
156558153|NCT02321436|565133183|FG000|Overall Study|Lost to Follow-up|0|||
156558154|NCT02321436|565133184|FG001|Overall Study|Lost to Follow-up|1|||
156558155|NCT00644787|565133185|FG000|Period 1: Titration Phase|Adverse Event|11|||
156558156|NCT00644787|565133186|FG001|Period 1: Titration Phase|Adverse Event|0|||
156558157|NCT00644787|565133187|FG002|Period 1: Titration Phase|Adverse Event|0|||
156558158|NCT00644787|565133185|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
156558159|NCT00644787|565133186|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
156558160|NCT00644787|565133187|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
156558161|NCT00644787|565133185|FG000|Period 1: Titration Phase|Physician Decision|1|||
156558162|NCT00644787|565133186|FG001|Period 1: Titration Phase|Physician Decision|0|||
156558163|NCT00644787|565133187|FG002|Period 1: Titration Phase|Physician Decision|0|||
156558164|NCT00644787|565133185|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
156558165|NCT00644787|565133186|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
156558166|NCT00644787|565133187|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
156558167|NCT00644787|565133185|FG000|Period 1: Titration Phase|Worsening of complications|1|||
156558168|NCT00644787|565133186|FG001|Period 1: Titration Phase|Worsening of complications|0|||
156558169|NCT00644787|565133187|FG002|Period 1: Titration Phase|Worsening of complications|0|||
156558170|NCT00644787|565133185|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
156558171|NCT00644787|565133186|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
156558172|NCT00644787|565133187|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
156558173|NCT00644787|565133185|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
156558174|NCT00644787|565133186|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
156558175|NCT00644787|565133187|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
156558176|NCT00644787|565133185|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
156558177|NCT00644787|565133186|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
156558178|NCT00644787|565133187|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
156558179|NCT00644787|565133185|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
156558180|NCT00644787|565133186|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
156558181|NCT00644787|565133187|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
156558182|NCT00644787|565133185|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
156558183|NCT00644787|565133186|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
156558184|NCT00644787|565133187|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
156558185|NCT00644787|565133185|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
156558186|NCT00644787|565133186|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
156558187|NCT00644787|565133187|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
156558188|NCT00644787|565133185|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
156558189|NCT00644787|565133186|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
156558190|NCT00644787|565133187|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
156558191|NCT03355300|565133188|FG000|Overall Study|Physician Decision|0|||
156558192|NCT03355300|565133189|FG001|Overall Study|Physician Decision|1|||
156558193|NCT03355300|565133188|FG000|Overall Study|Lack of Efficacy|2|||
156558194|NCT03355300|565133189|FG001|Overall Study|Lack of Efficacy|1|||
156558195|NCT03355300|565133188|FG000|Overall Study|Other reason|1|||
156558196|NCT03355300|565133189|FG001|Overall Study|Other reason|0|||
156558197|NCT03344003|565133205|FG000|Overall Study|Switched to alternative treatment|1|||
156558198|NCT03344003|565133206|FG001|Overall Study|Switched to alternative treatment|0|||
156558199|NCT03344003|565133205|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
156558200|NCT03344003|565133206|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
156558201|NCT02949128|565135064|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
156558202|NCT02949128|565135064|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
156558203|NCT02949128|565135064|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
156558204|NCT02949128|565135064|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
156558205|NCT02949128|565135064|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
156558206|NCT02949128|565135064|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
156558207|NCT02949128|565135064|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
156558208|NCT02949128|565135064|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
156558209|NCT02949128|565135064|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
156558210|NCT02949128|565135064|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
156558211|NCT01602341|565135065|FG000|Overall Study|Adverse Event|0|||
156558212|NCT01602341|565135066|FG001|Overall Study|Adverse Event|1|||
156558213|NCT02152345|565135067|FG000|Overall Study|Case Cancellations|2|||
156558214|NCT02152345|565135068|FG001|Overall Study|Case Cancellations|4|||
156558215|NCT02152345|565135067|FG000|Overall Study|Withdrawal by Subject|2|||
156558216|NCT02152345|565135068|FG001|Overall Study|Withdrawal by Subject|1|||
156558217|NCT01475734|565135072|FG000|Overall Study|Withdrawal by Subject|1|||
156558218|NCT01475734|565135073|FG001|Overall Study|Withdrawal by Subject|0|||
156558219|NCT01475734|565135072|FG000|Overall Study|Protocol Violation|1|||
156558220|NCT01475734|565135073|FG001|Overall Study|Protocol Violation|0|||
156558221|NCT01475734|565135072|FG000|Overall Study|Physician Decision|0|||
156558222|NCT01475734|565135073|FG001|Overall Study|Physician Decision|1|||
156558223|NCT00667576|565135076|FG000|Overall Study|Withdrawal by Subject|1|||
156558224|NCT00667576|565135077|FG001|Overall Study|Withdrawal by Subject|0|||
156558225|NCT00667576|565135078|FG002|Overall Study|Withdrawal by Subject|1|||
156558226|NCT00667576|565135079|FG003|Overall Study|Withdrawal by Subject|1|||
156558227|NCT00667576|565135080|FG004|Overall Study|Withdrawal by Subject|1|||
156558228|NCT00667576|565135076|FG000|Overall Study|Adverse Event|1|||
156558229|NCT00667576|565135077|FG001|Overall Study|Adverse Event|1|||
156558230|NCT00667576|565135078|FG002|Overall Study|Adverse Event|0|||
156558231|NCT00667576|565135079|FG003|Overall Study|Adverse Event|0|||
156558232|NCT00667576|565135080|FG004|Overall Study|Adverse Event|0|||
156558233|NCT00667576|565135076|FG000|Overall Study|Lost to Follow-up|0|||
156558234|NCT00667576|565135077|FG001|Overall Study|Lost to Follow-up|0|||
156558235|NCT00667576|565135078|FG002|Overall Study|Lost to Follow-up|1|||
156558236|NCT00667576|565135079|FG003|Overall Study|Lost to Follow-up|0|||
156558237|NCT00667576|565135080|FG004|Overall Study|Lost to Follow-up|0|||
156558238|NCT00667576|565135076|FG000|Overall Study|Protocol Violation|0|||
156558239|NCT00667576|565135077|FG001|Overall Study|Protocol Violation|0|||
156558240|NCT00667576|565135078|FG002|Overall Study|Protocol Violation|0|||
156558241|NCT00667576|565135079|FG003|Overall Study|Protocol Violation|1|||
156558242|NCT00667576|565135080|FG004|Overall Study|Protocol Violation|0|||
156558243|NCT00667576|565135076|FG000|Overall Study|Physician Decision|0|||
156558244|NCT00667576|565135077|FG001|Overall Study|Physician Decision|0|||
156558245|NCT00667576|565135078|FG002|Overall Study|Physician Decision|0|||
156558246|NCT00667576|565135079|FG003|Overall Study|Physician Decision|1|||
156558247|NCT00667576|565135080|FG004|Overall Study|Physician Decision|0|||
156558248|NCT00667576|565135076|FG000|Overall Study|Missed Visit|0|||
156558249|NCT00667576|565135077|FG001|Overall Study|Missed Visit|0|||
156558250|NCT00667576|565135078|FG002|Overall Study|Missed Visit|0|||
156558251|NCT00667576|565135079|FG003|Overall Study|Missed Visit|1|||
156558252|NCT00667576|565135080|FG004|Overall Study|Missed Visit|0|||
156558253|NCT00483327|565135084|FG000|Overall Study|Adverse Event|1|||
156558254|NCT00483327|565135084|FG000|Overall Study|Withdrawal by Subject|3|||
156558255|NCT00483327|565135084|FG000|Overall Study|Lost to Follow-up|4|||
156558256|NCT00483327|565135084|FG000|Overall Study|Patient Non Compliance|2|||
156558257|NCT01390389|565135085|FG000|Overall Study|Withdrawal by Subject|2|||
156558258|NCT01390389|565135086|FG001|Overall Study|Withdrawal by Subject|0|||
156558259|NCT01390389|565135085|FG000|Overall Study|Screen Fail|2|||
156558260|NCT01390389|565135086|FG001|Overall Study|Screen Fail|1|||
156558261|NCT03593915|565135087|FG000|Overall Study|Adverse Event|0|||
156558262|NCT03593915|565135088|FG001|Overall Study|Adverse Event|0|||
156558263|NCT03593915|565135089|FG002|Overall Study|Adverse Event|0|||
156558264|NCT03593915|565135090|FG003|Overall Study|Adverse Event|1|||
156558265|NCT03593915|565135091|FG004|Overall Study|Adverse Event|0|||
156558266|NCT03593915|565135092|FG005|Overall Study|Adverse Event|0|||
156558267|NCT03593915|565135087|FG000|Overall Study|Physician Decision|0|||
156558268|NCT03593915|565135088|FG001|Overall Study|Physician Decision|0|||
156558269|NCT03593915|565135089|FG002|Overall Study|Physician Decision|0|||
156558270|NCT03593915|565135090|FG003|Overall Study|Physician Decision|0|||
156558271|NCT03593915|565135091|FG004|Overall Study|Physician Decision|0|||
156558272|NCT03593915|565135092|FG005|Overall Study|Physician Decision|1|||
156558273|NCT01583179|565135093|FG000|Overall Study|Screen failure|1|||
156558274|NCT01583179|565135094|FG001|Overall Study|Screen failure|2|||
156558275|NCT02810964|565135095|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
156558276|NCT02810964|565135096|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
156558277|NCT02810964|565135095|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
156558278|NCT02810964|565135096|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
156513317|NCT04531904|564970716|FG000|Overall Study|Death|14|||
156513318|NCT01743989|564970717|FG000|Treatment Phase|Unstable MR4.0|0|||
156513319|NCT01743989|564970718|FG001|Treatment Phase|Unstable MR4.0|6|||
156513320|NCT01743989|564970719|FG002|Treatment Phase|Unstable MR4.0|263|||
156513321|NCT01743989|564970717|FG000|Treatment Phase|Adverse Event|0|||
156513322|NCT01743989|564970718|FG001|Treatment Phase|Adverse Event|4|||
156513323|NCT01743989|564970719|FG002|Treatment Phase|Adverse Event|67|||
156513324|NCT01743989|564970717|FG000|Treatment Phase|Withdrawal by Subject|1|||
156513325|NCT01743989|564970718|FG001|Treatment Phase|Withdrawal by Subject|3|||
156513326|NCT01743989|564970719|FG002|Treatment Phase|Withdrawal by Subject|28|||
156513327|NCT01743989|564970717|FG000|Treatment Phase|Death|0|||
156513328|NCT01743989|564970718|FG001|Treatment Phase|Death|1|||
156513329|NCT01743989|564970719|FG002|Treatment Phase|Death|3|||
156513330|NCT01743989|564970717|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
156513331|NCT01743989|564970718|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
156513332|NCT01743989|564970719|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
156513333|NCT01743989|564970717|FG000|Treatment Phase|Protocol deviation|0|||
156513334|NCT01743989|564970718|FG001|Treatment Phase|Protocol deviation|0|||
156513335|NCT01743989|564970719|FG002|Treatment Phase|Protocol deviation|3|||
156513336|NCT01743989|564970717|FG000|Treatment Phase|Pregnancy|0|||
156513337|NCT01743989|564970718|FG001|Treatment Phase|Pregnancy|0|||
156513338|NCT01743989|564970719|FG002|Treatment Phase|Pregnancy|2|||
156513339|NCT01743989|564970717|FG000|Treatment Phase|Lost to Follow-up|0|||
156513340|NCT01743989|564970718|FG001|Treatment Phase|Lost to Follow-up|0|||
156513341|NCT01743989|564970719|FG002|Treatment Phase|Lost to Follow-up|2|||
156513342|NCT01743989|564970717|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
156513343|NCT01743989|564970718|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
156513344|NCT01743989|564970719|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
156513345|NCT01743989|564970717|FG000|Treatment Phase|Administrative problems|0|||
156513346|NCT01743989|564970718|FG001|Treatment Phase|Administrative problems|0|||
156513347|NCT01743989|564970719|FG002|Treatment Phase|Administrative problems|1|||
156513348|NCT01743989|564970717|FG000|Treatment Phase|New cancer (CML) therapy|0|||
156513349|NCT01743989|564970718|FG001|Treatment Phase|New cancer (CML) therapy|1|||
156513350|NCT01743989|564970719|FG002|Treatment Phase|New cancer (CML) therapy|0|||
156513351|NCT01743989|564970717|FG000|Treatment Phase|Physician Decision|0|||
156513352|NCT01743989|564970718|FG001|Treatment Phase|Physician Decision|0|||
156513353|NCT01743989|564970719|FG002|Treatment Phase|Physician Decision|3|||
156513354|NCT01743989|564970717|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
156513355|NCT01743989|564970718|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
156513356|NCT01743989|564970719|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
156513357|NCT01743989|564970717|FG000|Treatment Phase|Not randomized by mistake|0|||
156513358|NCT01743989|564970718|FG001|Treatment Phase|Not randomized by mistake|0|||
156513359|NCT01743989|564970719|FG002|Treatment Phase|Not randomized by mistake|1|||
156513360|NCT01743989|564970717|FG000|Treatment Phase|Included by mistake|0|||
156513361|NCT01743989|564970718|FG001|Treatment Phase|Included by mistake|0|||
156513362|NCT01743989|564970719|FG002|Treatment Phase|Included by mistake|1|||
156513363|NCT01743989|564970717|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
156513364|NCT01743989|564970718|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
156513365|NCT01743989|564970719|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
156513366|NCT01743989|564970717|FG000|TFR Phase|Adverse Event|0|||
156513367|NCT01743989|564970718|FG001|TFR Phase|Adverse Event|1|||
156513368|NCT01743989|564970719|FG002|TFR Phase|Adverse Event|0|||
156513369|NCT01743989|564970717|FG000|TFR Phase|Lost to Follow-up|0|||
156513370|NCT01743989|564970718|FG001|TFR Phase|Lost to Follow-up|2|||
156513371|NCT01743989|564970719|FG002|TFR Phase|Lost to Follow-up|0|||
156513372|NCT01743989|564970717|FG000|TFR Phase|Physician Decision|0|||
156513373|NCT01743989|564970718|FG001|TFR Phase|Physician Decision|1|||
156513374|NCT01743989|564970719|FG002|TFR Phase|Physician Decision|0|||
156513375|NCT01743989|564970717|FG000|TFR Phase|Logistical problems|0|||
156513376|NCT01743989|564970718|FG001|TFR Phase|Logistical problems|2|||
156513377|NCT01743989|564970719|FG002|TFR Phase|Logistical problems|0|||
156513378|NCT01743989|564970717|FG000|TFR Phase|Protocol deviation|0|||
156513379|NCT01743989|564970718|FG001|TFR Phase|Protocol deviation|1|||
156513380|NCT01743989|564970719|FG002|TFR Phase|Protocol deviation|0|||
156513381|NCT01743989|564970717|FG000|TFR Phase|Withdrawal by Subject|0|||
156513382|NCT01743989|564970718|FG001|TFR Phase|Withdrawal by Subject|2|||
156513383|NCT01743989|564970719|FG002|TFR Phase|Withdrawal by Subject|0|||
156513384|NCT01743989|564970717|FG000|Re-treatment Phase|Adverse Event|8|||
156513385|NCT01743989|564970718|FG001|Re-treatment Phase|Adverse Event|4|||
156513386|NCT01743989|564970719|FG002|Re-treatment Phase|Adverse Event|0|||
156513387|NCT01743989|564970717|FG000|Re-treatment Phase|Death|1|||
156513388|NCT01743989|564970718|FG001|Re-treatment Phase|Death|1|||
156513389|NCT01743989|564970719|FG002|Re-treatment Phase|Death|0|||
156513390|NCT01743989|564970717|FG000|Re-treatment Phase|Administrative problems|1|||
156513391|NCT01743989|564970718|FG001|Re-treatment Phase|Administrative problems|1|||
156513392|NCT01743989|564970719|FG002|Re-treatment Phase|Administrative problems|0|||
156513393|NCT01743989|564970717|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
156513394|NCT01743989|564970718|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
156513395|NCT01743989|564970719|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
156513396|NCT01743989|564970717|FG000|Re-treatment Phase|Unstable MR|1|||
156513397|NCT01743989|564970718|FG001|Re-treatment Phase|Unstable MR|0|||
156513398|NCT01743989|564970719|FG002|Re-treatment Phase|Unstable MR|0|||
156513399|NCT01743989|564970717|FG000|Re-treatment Phase|Physician Decision|0|||
156513400|NCT01743989|564970718|FG001|Re-treatment Phase|Physician Decision|1|||
156513401|NCT01743989|564970719|FG002|Re-treatment Phase|Physician Decision|0|||
156513402|NCT01743989|564970717|FG000|Re-treatment Phase|Lost to Follow-up|0|||
156513403|NCT01743989|564970718|FG001|Re-treatment Phase|Lost to Follow-up|1|||
156513404|NCT01743989|564970719|FG002|Re-treatment Phase|Lost to Follow-up|0|||
156513405|NCT04655027|564970720|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
156513406|NCT04655027|564970721|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
156513407|NCT03519997|564970722|FG000|Overall Study|Adverse Event|4|||
156513408|NCT03519997|564970722|FG000|Overall Study|Withdrawal by Subject|2|||
156513409|NCT03519997|564970722|FG000|Overall Study|Protocol Violation|1|||
156513410|NCT03361605|564970723|FG000|Overall Study|Analyzable data not available|3|||
156513411|NCT02906007|564970725|FG000|Overall Study|Physician Decision|0|||
156513412|NCT02906007|564970726|FG001|Overall Study|Physician Decision|0|||
156513413|NCT02906007|564970727|FG002|Overall Study|Physician Decision|1|||
156513414|NCT02906007|564970725|FG000|Overall Study|Died|1|||
156513415|NCT02906007|564970726|FG001|Overall Study|Died|0|||
156513416|NCT02906007|564970727|FG002|Overall Study|Died|0|||
156513417|NCT04372121|564970737|FG000|Overall Study|Lost to Follow-up|0|||
156513418|NCT04372121|564970738|FG001|Overall Study|Lost to Follow-up|0|||
156513419|NCT04372121|564970739|FG002|Overall Study|Lost to Follow-up|0|||
156513420|NCT04372121|564970740|FG003|Overall Study|Lost to Follow-up|1|||
156513421|NCT04372121|564970737|FG000|Overall Study|Protocol Violation|0|||
156513422|NCT04372121|564970738|FG001|Overall Study|Protocol Violation|0|||
156513423|NCT04372121|564970739|FG002|Overall Study|Protocol Violation|1|||
156513424|NCT04372121|564970740|FG003|Overall Study|Protocol Violation|0|||
156513425|NCT04372121|564970737|FG000|Overall Study|Withdrawal by Subject|3|||
156513426|NCT04372121|564970738|FG001|Overall Study|Withdrawal by Subject|1|||
156513427|NCT04372121|564970739|FG002|Overall Study|Withdrawal by Subject|0|||
156513428|NCT04372121|564970740|FG003|Overall Study|Withdrawal by Subject|0|||
156513429|NCT04372121|564970737|FG000|Overall Study|Study termination|6|||
156513430|NCT04372121|564970738|FG001|Overall Study|Study termination|5|||
156513431|NCT04372121|564970739|FG002|Overall Study|Study termination|1|||
156513432|NCT04372121|564970740|FG003|Overall Study|Study termination|1|||
156513433|NCT04372121|564970737|FG000|Overall Study|Hysterectomy planned|1|||
156513434|NCT04372121|564970738|FG001|Overall Study|Hysterectomy planned|0|||
156513435|NCT04372121|564970739|FG002|Overall Study|Hysterectomy planned|0|||
156513436|NCT04372121|564970740|FG003|Overall Study|Hysterectomy planned|0|||
156513437|NCT02344290|564970741|FG000|Overall Study|Withdrawal by Subject|315|||
156513438|NCT02344290|564970742|FG001|Overall Study|Withdrawal by Subject|324|||
156513439|NCT02344290|564970741|FG000|Overall Study|Lost to Follow-up|258|||
156513440|NCT02344290|564970742|FG001|Overall Study|Lost to Follow-up|249|||
156513441|NCT02344290|564970741|FG000|Overall Study|Unable to get to clinic|69|||
156513442|NCT02344290|564970742|FG001|Overall Study|Unable to get to clinic|60|||
156513443|NCT02344290|564970741|FG000|Overall Study|Physician Decision|25|||
156513444|NCT02344290|564970742|FG001|Overall Study|Physician Decision|25|||
156513445|NCT02344290|564970741|FG000|Overall Study|Site Closure|15|||
156513446|NCT02344290|564970742|FG001|Overall Study|Site Closure|19|||
156513447|NCT02344290|564970741|FG000|Overall Study|Other|5|||
156513448|NCT02344290|564970742|FG001|Overall Study|Other|3|||
156513449|NCT00095056|564972209|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
156513450|NCT00095056|564972210|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
156513451|NCT00095056|564972209|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
156513452|NCT00095056|564972210|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
156513453|NCT00095056|564972209|FG000|Phase A (Weeks 0-12)|Death|1|||
156513454|NCT00095056|564972210|FG001|Phase A (Weeks 0-12)|Death|0|||
156513455|NCT00095056|564972209|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
156513456|NCT00095056|564972210|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
156513457|NCT00095056|564972209|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
156513458|NCT00095056|564972210|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
156513459|NCT00095056|564972209|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
156513460|NCT00095056|564972210|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
156513461|NCT00095056|564972209|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
156513462|NCT00095056|564972210|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
156513463|NCT00095056|564972209|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
156513464|NCT00095056|564972210|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
156513465|NCT00095056|564972209|FG000|Phase B (Weeks 12-54)|Death|3|||
156558279|NCT02810964|565135095|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
156558280|NCT02810964|565135096|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
156558281|NCT02810964|565135095|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
156558282|NCT02810964|565135096|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
156558283|NCT03523351|565135097|FG000|Overall Study|Death|13|||
156558284|NCT03523351|565135098|FG001|Overall Study|Death|11|||
156558285|NCT03523351|565135097|FG000|Overall Study|Lost to Follow-up|2|||
156558286|NCT03523351|565135098|FG001|Overall Study|Lost to Follow-up|3|||
156558287|NCT03523351|565135097|FG000|Overall Study|Withdrawal by Subject|4|||
156558288|NCT03523351|565135098|FG001|Overall Study|Withdrawal by Subject|0|||
156558289|NCT03523351|565135097|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
156558290|NCT03523351|565135098|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
156558291|NCT01430442|565135100|FG000|Overall Study|Subject Withdrew Consent|3|||
156558292|NCT01430442|565135101|FG001|Overall Study|Subject Withdrew Consent|0|||
156558293|NCT01430442|565135102|FG002|Overall Study|Subject Withdrew Consent|1|||
156558294|NCT01430442|565135103|FG003|Overall Study|Subject Withdrew Consent|0|||
156558295|NCT01430442|565135104|FG004|Overall Study|Subject Withdrew Consent|2|||
156558296|NCT01430442|565135105|FG005|Overall Study|Subject Withdrew Consent|1|||
156558297|NCT01430442|565135106|FG006|Overall Study|Subject Withdrew Consent|5|||
156558298|NCT01430442|565135107|FG007|Overall Study|Subject Withdrew Consent|2|||
156558299|NCT01430442|565135100|FG000|Overall Study|Lost to Follow-up|2|||
156558300|NCT01430442|565135101|FG001|Overall Study|Lost to Follow-up|0|||
156558301|NCT01430442|565135102|FG002|Overall Study|Lost to Follow-up|1|||
156558302|NCT01430442|565135103|FG003|Overall Study|Lost to Follow-up|2|||
156558303|NCT01430442|565135104|FG004|Overall Study|Lost to Follow-up|2|||
156558304|NCT01430442|565135105|FG005|Overall Study|Lost to Follow-up|1|||
156558305|NCT01430442|565135106|FG006|Overall Study|Lost to Follow-up|5|||
156558306|NCT01430442|565135107|FG007|Overall Study|Lost to Follow-up|1|||
156558307|NCT01430442|565135100|FG000|Overall Study|Pregnancy|1|||
156558308|NCT01430442|565135101|FG001|Overall Study|Pregnancy|0|||
156558309|NCT01430442|565135102|FG002|Overall Study|Pregnancy|0|||
156558310|NCT01430442|565135103|FG003|Overall Study|Pregnancy|0|||
156558311|NCT01430442|565135104|FG004|Overall Study|Pregnancy|0|||
156558312|NCT01430442|565135105|FG005|Overall Study|Pregnancy|1|||
156558313|NCT01430442|565135106|FG006|Overall Study|Pregnancy|0|||
156558314|NCT01430442|565135107|FG007|Overall Study|Pregnancy|0|||
156558315|NCT01430442|565135100|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
156558316|NCT01430442|565135101|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
156558317|NCT01430442|565135102|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
156558318|NCT01430442|565135103|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
156558319|NCT01430442|565135104|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
156558320|NCT01430442|565135105|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
156558321|NCT01430442|565135106|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
156558322|NCT01430442|565135107|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
156558323|NCT00700180|565135114|FG000|Overall Study|Death|99|||
156558324|NCT00700180|565135115|FG001|Overall Study|Death|114|||
156558325|NCT00700180|565135114|FG000|Overall Study|Alive on treatment|5|||
156558326|NCT00700180|565135115|FG001|Overall Study|Alive on treatment|3|||
156558327|NCT00700180|565135114|FG000|Overall Study|Alive in follow-up|46|||
156558328|NCT00700180|565135115|FG001|Overall Study|Alive in follow-up|27|||
156558329|NCT00700180|565135114|FG000|Overall Study|Lost to Follow-up|4|||
156558330|NCT00700180|565135115|FG001|Overall Study|Lost to Follow-up|5|||
156558331|NCT01613326|565135116|FG000|Overall Study|Adverse Event|7|||
156558332|NCT01613326|565135117|FG001|Overall Study|Adverse Event|5|||
156558333|NCT01613326|565135116|FG000|Overall Study|Withdrawal by Subject|3|||
156558334|NCT01613326|565135117|FG001|Overall Study|Withdrawal by Subject|4|||
156558335|NCT01613326|565135116|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156558336|NCT01613326|565135117|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156558337|NCT01613326|565135116|FG000|Overall Study|inability to use device|1|||
156558338|NCT01613326|565135117|FG001|Overall Study|inability to use device|0|||
156558339|NCT01613326|565135116|FG000|Overall Study|Lack of Efficacy|0|||
156558340|NCT01613326|565135117|FG001|Overall Study|Lack of Efficacy|1|||
156558341|NCT01613326|565135116|FG000|Overall Study|Lost to Follow-up|0|||
156558342|NCT01613326|565135117|FG001|Overall Study|Lost to Follow-up|1|||
156558343|NCT01613326|565135116|FG000|Overall Study|Administrative|0|||
156558344|NCT01613326|565135117|FG001|Overall Study|Administrative|2|||
156558345|NCT01613326|565135116|FG000|Overall Study|Protocol Violation|0|||
156558346|NCT01613326|565135117|FG001|Overall Study|Protocol Violation|1|||
156558347|NCT03588741|565135120|FG000|Overall Study|Withdrawal by Subject|1|||
156558348|NCT00605267|565135121|FG000|Overall Study|Adverse Event|0|||
156558349|NCT00605267|565135122|FG001|Overall Study|Adverse Event|1|||
156558350|NCT00605267|565135121|FG000|Overall Study|Lack of Efficacy|1|||
156558351|NCT00605267|565135122|FG001|Overall Study|Lack of Efficacy|5|||
156558352|NCT00605267|565135121|FG000|Overall Study|Withdrawal by Subject|2|||
156558353|NCT00605267|565135122|FG001|Overall Study|Withdrawal by Subject|3|||
156558354|NCT00793793|565135123|FG000|Overall Study|Adverse Event|0|||
156558355|NCT00793793|565135124|FG001|Overall Study|Adverse Event|0|||
156558356|NCT00793793|565135125|FG002|Overall Study|Adverse Event|1|||
156558357|NCT00793793|565135126|FG003|Overall Study|Adverse Event|1|||
156558358|NCT00793793|565135127|FG004|Overall Study|Adverse Event|0|||
156558359|NCT00793793|565135128|FG005|Overall Study|Adverse Event|1|||
156558360|NCT00793793|565135129|FG006|Overall Study|Adverse Event|2|||
156558361|NCT00793793|565135130|FG007|Overall Study|Adverse Event|0|||
156558362|NCT00793793|565135131|FG008|Overall Study|Adverse Event|0|||
156558363|NCT00793793|565135132|FG009|Overall Study|Adverse Event|0|||
156558364|NCT00793793|565135133|FG010|Overall Study|Adverse Event|0|||
156558365|NCT00793793|565135134|FG011|Overall Study|Adverse Event|2|||
156558366|NCT00793793|565135123|FG000|Overall Study|Protocol Violation|0|||
156558367|NCT00793793|565135124|FG001|Overall Study|Protocol Violation|0|||
156558368|NCT00793793|565135125|FG002|Overall Study|Protocol Violation|0|||
156558369|NCT00793793|565135126|FG003|Overall Study|Protocol Violation|1|||
156558370|NCT00793793|565135127|FG004|Overall Study|Protocol Violation|0|||
156558371|NCT00793793|565135128|FG005|Overall Study|Protocol Violation|0|||
156558372|NCT00793793|565135129|FG006|Overall Study|Protocol Violation|0|||
156558373|NCT00793793|565135130|FG007|Overall Study|Protocol Violation|0|||
156558374|NCT00793793|565135131|FG008|Overall Study|Protocol Violation|0|||
156558375|NCT00793793|565135132|FG009|Overall Study|Protocol Violation|0|||
156558376|NCT00793793|565135133|FG010|Overall Study|Protocol Violation|0|||
156558377|NCT00793793|565135134|FG011|Overall Study|Protocol Violation|0|||
156558378|NCT00793793|565135123|FG000|Overall Study|Lost to Follow-up|0|||
156558379|NCT00793793|565135124|FG001|Overall Study|Lost to Follow-up|0|||
156558380|NCT00793793|565135125|FG002|Overall Study|Lost to Follow-up|1|||
156558381|NCT00793793|565135126|FG003|Overall Study|Lost to Follow-up|0|||
156558382|NCT00793793|565135127|FG004|Overall Study|Lost to Follow-up|0|||
156558383|NCT00793793|565135128|FG005|Overall Study|Lost to Follow-up|0|||
156558384|NCT00793793|565135129|FG006|Overall Study|Lost to Follow-up|0|||
156558385|NCT00793793|565135130|FG007|Overall Study|Lost to Follow-up|0|||
156558386|NCT00793793|565135131|FG008|Overall Study|Lost to Follow-up|1|||
156558387|NCT00793793|565135132|FG009|Overall Study|Lost to Follow-up|3|||
156558388|NCT00793793|565135133|FG010|Overall Study|Lost to Follow-up|1|||
156558389|NCT00793793|565135134|FG011|Overall Study|Lost to Follow-up|0|||
156558390|NCT00793793|565135123|FG000|Overall Study|Withdrawal by Subject|0|||
156558391|NCT00793793|565135124|FG001|Overall Study|Withdrawal by Subject|0|||
156558392|NCT00793793|565135125|FG002|Overall Study|Withdrawal by Subject|0|||
156558393|NCT00793793|565135126|FG003|Overall Study|Withdrawal by Subject|0|||
156558394|NCT00793793|565135127|FG004|Overall Study|Withdrawal by Subject|1|||
156558395|NCT00793793|565135128|FG005|Overall Study|Withdrawal by Subject|0|||
156558396|NCT00793793|565135129|FG006|Overall Study|Withdrawal by Subject|0|||
156558397|NCT00793793|565135130|FG007|Overall Study|Withdrawal by Subject|0|||
156558398|NCT00793793|565135131|FG008|Overall Study|Withdrawal by Subject|1|||
156558399|NCT00793793|565135132|FG009|Overall Study|Withdrawal by Subject|0|||
156558400|NCT00793793|565135133|FG010|Overall Study|Withdrawal by Subject|0|||
156558401|NCT00793793|565135134|FG011|Overall Study|Withdrawal by Subject|0|||
156558402|NCT00793793|565135123|FG000|Overall Study|reason not specified|0|||
156558403|NCT00793793|565135124|FG001|Overall Study|reason not specified|1|||
156558404|NCT00793793|565135125|FG002|Overall Study|reason not specified|0|||
156558405|NCT00793793|565135126|FG003|Overall Study|reason not specified|1|||
156558406|NCT00793793|565135127|FG004|Overall Study|reason not specified|1|||
156558407|NCT00793793|565135128|FG005|Overall Study|reason not specified|1|||
156558408|NCT00793793|565135129|FG006|Overall Study|reason not specified|2|||
156558409|NCT00793793|565135130|FG007|Overall Study|reason not specified|0|||
156558410|NCT00793793|565135131|FG008|Overall Study|reason not specified|7|||
156558411|NCT00793793|565135132|FG009|Overall Study|reason not specified|6|||
156558412|NCT00793793|565135133|FG010|Overall Study|reason not specified|2|||
156558413|NCT00793793|565135134|FG011|Overall Study|reason not specified|4|||
156558414|NCT01445535|565135135|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
156558415|NCT01445535|565135136|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
156558416|NCT01445535|565135137|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
156558417|NCT01445535|565135138|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
156558418|NCT01445535|565135135|FG000|Overall Study|Disease progression|1|||
156558419|NCT01445535|565135136|FG001|Overall Study|Disease progression|0|||
156558420|NCT01445535|565135137|FG002|Overall Study|Disease progression|1|||
156558421|NCT01445535|565135138|FG003|Overall Study|Disease progression|0|||
156558422|NCT01445535|565135135|FG000|Overall Study|PI discretion|0|||
156558423|NCT01445535|565135136|FG001|Overall Study|PI discretion|0|||
156558424|NCT01445535|565135137|FG002|Overall Study|PI discretion|0|||
156558425|NCT01445535|565135138|FG003|Overall Study|PI discretion|1|||
156558426|NCT04557384|565135143|FG000|Overall Study|Study Terminated by Sponsor|1|||
156558427|NCT04557384|565135143|FG000|Overall Study|Death|1|||
156558428|NCT00454779|565135144|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
156558429|NCT00454779|565135145|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
156558430|NCT00454779|565135144|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
156558431|NCT00454779|565135145|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
156558432|NCT00454779|565135144|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
156513466|NCT00095056|564972210|FG001|Phase B (Weeks 12-54)|Death|1|||
156513467|NCT00095056|564972209|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
156513468|NCT00095056|564972210|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
156513469|NCT00095056|564972209|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
156513470|NCT00095056|564972210|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
156513471|NCT00306670|564972214|FG000|Overall Study|patients recruited; Genentech, the st|0|||
156513472|NCT00306670|564972215|FG001|Overall Study|patients recruited; Genentech, the st|2|||
156513473|NCT00091169|564972216|FG000|Overall Study|Disease progression|3|||
156513474|NCT00091169|564972217|FG001|Overall Study|Disease progression|1|||
156513475|NCT00091169|564972216|FG000|Overall Study|Adverse Event|11|||
156513476|NCT00091169|564972217|FG001|Overall Study|Adverse Event|17|||
156513477|NCT00091169|564972216|FG000|Overall Study|Death|4|||
156513478|NCT00091169|564972217|FG001|Overall Study|Death|1|||
156513479|NCT00091169|564972216|FG000|Overall Study|Withdrawal by Subject|10|||
156513480|NCT00091169|564972217|FG001|Overall Study|Withdrawal by Subject|13|||
156513481|NCT00091169|564972216|FG000|Overall Study|Other|3|||
156513482|NCT00091169|564972217|FG001|Overall Study|Other|4|||
156513483|NCT00091169|564972216|FG000|Overall Study|Not start protocol therapy|26|||
156513484|NCT00091169|564972217|FG001|Overall Study|Not start protocol therapy|17|||
156513485|NCT02735577|564972218|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
156513486|NCT02735577|564972218|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
156513487|NCT04410523|564972223|FG000|Overall Study|Study terminated by sponsor|1|||
156513488|NCT04410523|564972224|FG001|Overall Study|Study terminated by sponsor|3|||
156513489|NCT04410523|564972225|FG002|Overall Study|Study terminated by sponsor|2|||
156513490|NCT04410523|564972226|FG003|Overall Study|Study terminated by sponsor|6|||
156513491|NCT04410523|564972227|FG004|Overall Study|Study terminated by sponsor|3|||
156513492|NCT04410523|564972228|FG005|Overall Study|Study terminated by sponsor|4|||
156513493|NCT04410523|564972223|FG000|Overall Study|Adverse Event|1|||
156513494|NCT04410523|564972224|FG001|Overall Study|Adverse Event|0|||
156513495|NCT04410523|564972225|FG002|Overall Study|Adverse Event|0|||
156513496|NCT04410523|564972226|FG003|Overall Study|Adverse Event|0|||
156513497|NCT04410523|564972227|FG004|Overall Study|Adverse Event|0|||
156513498|NCT04410523|564972228|FG005|Overall Study|Adverse Event|2|||
156513499|NCT04410523|564972223|FG000|Overall Study|Lost to Follow-up|0|||
156513500|NCT04410523|564972224|FG001|Overall Study|Lost to Follow-up|1|||
156513501|NCT04410523|564972225|FG002|Overall Study|Lost to Follow-up|0|||
156513502|NCT04410523|564972226|FG003|Overall Study|Lost to Follow-up|0|||
156513503|NCT04410523|564972227|FG004|Overall Study|Lost to Follow-up|0|||
156513504|NCT04410523|564972228|FG005|Overall Study|Lost to Follow-up|0|||
156513505|NCT04410523|564972223|FG000|Overall Study|Physician Decision|0|||
156513506|NCT04410523|564972224|FG001|Overall Study|Physician Decision|1|||
156513507|NCT04410523|564972225|FG002|Overall Study|Physician Decision|0|||
156513508|NCT04410523|564972226|FG003|Overall Study|Physician Decision|0|||
156513509|NCT04410523|564972227|FG004|Overall Study|Physician Decision|0|||
156513510|NCT04410523|564972228|FG005|Overall Study|Physician Decision|0|||
156513511|NCT04410523|564972223|FG000|Overall Study|Pregnancy|0|||
156513512|NCT04410523|564972224|FG001|Overall Study|Pregnancy|0|||
156513513|NCT04410523|564972225|FG002|Overall Study|Pregnancy|0|||
156513514|NCT04410523|564972226|FG003|Overall Study|Pregnancy|0|||
156513515|NCT04410523|564972227|FG004|Overall Study|Pregnancy|0|||
156513516|NCT04410523|564972228|FG005|Overall Study|Pregnancy|1|||
156513517|NCT04410523|564972223|FG000|Overall Study|Protocol deviation|0|||
156513518|NCT04410523|564972224|FG001|Overall Study|Protocol deviation|0|||
156513519|NCT04410523|564972225|FG002|Overall Study|Protocol deviation|0|||
156513520|NCT04410523|564972226|FG003|Overall Study|Protocol deviation|0|||
156513521|NCT04410523|564972227|FG004|Overall Study|Protocol deviation|0|||
156513522|NCT04410523|564972228|FG005|Overall Study|Protocol deviation|2|||
156513523|NCT04410523|564972223|FG000|Overall Study|Subject decision|2|||
156513524|NCT04410523|564972224|FG001|Overall Study|Subject decision|0|||
156513525|NCT04410523|564972225|FG002|Overall Study|Subject decision|0|||
156513526|NCT04410523|564972226|FG003|Overall Study|Subject decision|1|||
156513527|NCT04410523|564972227|FG004|Overall Study|Subject decision|0|||
156513528|NCT04410523|564972228|FG005|Overall Study|Subject decision|1|||
156513529|NCT00490490|564972231|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
156513530|NCT00490490|564972231|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
156513531|NCT03207451|564972232|FG000|Overall Study|scheduling conflict|1|||
156513532|NCT03207451|564972233|FG001|Overall Study|scheduling conflict|0|||
156513533|NCT03207451|564972234|FG002|Overall Study|scheduling conflict|2|||
156513534|NCT03207451|564972235|FG003|Overall Study|scheduling conflict|2|||
156513535|NCT03207451|564972232|FG000|Overall Study|Adverse Event|0|||
156513536|NCT03207451|564972233|FG001|Overall Study|Adverse Event|0|||
156513537|NCT03207451|564972234|FG002|Overall Study|Adverse Event|0|||
156513538|NCT03207451|564972235|FG003|Overall Study|Adverse Event|1|||
156513539|NCT03896152|564972236|FG000|Overall Study|Patient/guardian decision|1|||
156513540|NCT03896152|564972237|FG001|Overall Study|Patient/guardian decision|1|||
156513541|NCT03896152|564972236|FG000|Overall Study|Adverse Event|0|||
156513542|NCT03896152|564972237|FG001|Overall Study|Adverse Event|1|||
156513543|NCT03896152|564972236|FG000|Overall Study|Physician Decision|1|||
156513544|NCT03896152|564972237|FG001|Overall Study|Physician Decision|0|||
156513545|NCT03896152|564972236|FG000|Overall Study|Technical problems|1|||
156513546|NCT03896152|564972237|FG001|Overall Study|Technical problems|0|||
156513547|NCT00436852|564972238|FG000|Overall Study|Death|23|||
156513548|NCT00436852|564972239|FG001|Overall Study|Death|34|||
156513549|NCT00436852|564972238|FG000|Overall Study|Lack of Efficacy|9|||
156513550|NCT00436852|564972239|FG001|Overall Study|Lack of Efficacy|7|||
156513551|NCT00436852|564972238|FG000|Overall Study|Withdrawal by Subject|2|||
156513552|NCT00436852|564972239|FG001|Overall Study|Withdrawal by Subject|4|||
156513553|NCT00436852|564972238|FG000|Overall Study|Ineligible|1|||
156513554|NCT00436852|564972239|FG001|Overall Study|Ineligible|0|||
156513555|NCT00370682|564972240|FG000|Overall Study|Moved from area|0|||
156513556|NCT00370682|564972241|FG001|Overall Study|Moved from area|2|||
156513557|NCT00370682|564972242|FG002|Overall Study|Moved from area|0|||
156513558|NCT00370682|564972240|FG000|Overall Study|Lost to Follow-up|0|||
156513559|NCT00370682|564972241|FG001|Overall Study|Lost to Follow-up|1|||
156513560|NCT00370682|564972242|FG002|Overall Study|Lost to Follow-up|1|||
156513561|NCT03167359|564972243|FG000|Overall Study|Physician Decision|1|||
156513562|NCT03167359|564972243|FG000|Overall Study|Lost to Follow-up|1|||
156513563|NCT03339583|564972244|FG000|First Intervention (14 Days)|Adverse Event|1|||
156513564|NCT03339583|564972245|FG001|First Intervention (14 Days)|Adverse Event|0|||
156513565|NCT03339583|564972244|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
156513566|NCT03339583|564972245|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
156513567|NCT03339583|564972244|FG000|Second Intervention (14 Days)|Adverse Event|0|||
156513568|NCT03339583|564972245|FG001|Second Intervention (14 Days)|Adverse Event|1|||
156513569|NCT03339583|564972244|FG000|Follow-up (14 Days)|Physician Decision|6|||
156513570|NCT03339583|564972245|FG001|Follow-up (14 Days)|Physician Decision|3|||
156513571|NCT00943852|564972246|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513572|NCT00943852|564972247|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513573|NCT00943852|564972248|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513574|NCT00943852|564972249|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
156513575|NCT00943852|564972250|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513576|NCT00943852|564972251|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513577|NCT00943852|564972252|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513578|NCT00943852|564972253|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513579|NCT00943852|564972254|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513580|NCT00943852|564972255|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
156513581|NCT00943852|564972246|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513582|NCT00943852|564972247|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513583|NCT00943852|564972248|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513584|NCT00943852|564972249|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513585|NCT00943852|564972250|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513586|NCT00943852|564972251|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
156513587|NCT00943852|564972252|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513588|NCT00943852|564972253|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513589|NCT00943852|564972254|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513590|NCT00943852|564972255|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
156513591|NCT00943852|564972246|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513592|NCT00943852|564972247|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513593|NCT00943852|564972248|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513594|NCT00943852|564972249|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513595|NCT00943852|564972250|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513596|NCT00943852|564972251|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513597|NCT00943852|564972252|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
156513598|NCT00943852|564972253|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513599|NCT00943852|564972254|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513600|NCT00943852|564972255|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
156513601|NCT00943852|564972246|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156513602|NCT00943852|564972247|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156513603|NCT00943852|564972248|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156558433|NCT00454779|565135145|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
156558434|NCT00454779|565135144|FG000|First-line Treatment Phase|Protocol Violation|0|||
156558435|NCT00454779|565135145|FG001|First-line Treatment Phase|Protocol Violation|1|||
156558436|NCT00454779|565135144|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
156558437|NCT00454779|565135145|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
156558438|NCT00454779|565135144|FG000|First-line Treatment Phase|Ongoing|1|||
156558439|NCT00454779|565135145|FG001|First-line Treatment Phase|Ongoing|0|||
156558440|NCT00454779|565135144|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
156558441|NCT00454779|565135145|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
156513604|NCT00943852|564972249|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156513605|NCT00943852|564972250|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156513606|NCT00943852|564972251|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156513607|NCT00943852|564972252|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156513608|NCT00943852|564972253|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
156513609|NCT00943852|564972254|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156513610|NCT00943852|564972255|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
156513611|NCT00943852|564972246|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
156513612|NCT00943852|564972247|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
156513613|NCT00943852|564972248|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
156513614|NCT00943852|564972249|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
156513615|NCT00943852|564972250|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
156513616|NCT00943852|564972251|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
156513617|NCT00943852|564972252|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
156558442|NCT00454779|565135144|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
156558443|NCT00454779|565135145|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
156558444|NCT00454779|565135144|FG000|Second-line Treatment Phase|Ongoing|0|||
156558445|NCT00454779|565135145|FG001|Second-line Treatment Phase|Ongoing|1|||
156558446|NCT01337973|565135147|FG000|Overall Study|Lost to Follow-up|2|||
156558447|NCT01337973|565135148|FG001|Overall Study|Lost to Follow-up|4|||
156558448|NCT01337973|565135149|FG002|Overall Study|Lost to Follow-up|3|||
156558449|NCT01337973|565135147|FG000|Overall Study|Death|1|||
156558450|NCT01337973|565135148|FG001|Overall Study|Death|2|||
156558451|NCT01337973|565135149|FG002|Overall Study|Death|1|||
156558452|NCT01337973|565135147|FG000|Overall Study|Withdrawal by Subject|10|||
156558453|NCT01337973|565135148|FG001|Overall Study|Withdrawal by Subject|8|||
156558454|NCT01337973|565135149|FG002|Overall Study|Withdrawal by Subject|4|||
156558455|NCT01337973|565135147|FG000|Overall Study|missing data on primary outcome|3|||
156558456|NCT01337973|565135148|FG001|Overall Study|missing data on primary outcome|1|||
156558457|NCT01337973|565135149|FG002|Overall Study|missing data on primary outcome|3|||
156558458|NCT02522767|565135152|FG000|Double-blind|Withdrawal by Subject|8|||
156558459|NCT02522767|565135153|FG001|Double-blind|Withdrawal by Subject|11|||
156558460|NCT02522767|565135152|FG000|Double-blind|Lost to Follow-up|1|||
156558461|NCT02522767|565135153|FG001|Double-blind|Lost to Follow-up|0|||
156558462|NCT02522767|565135152|FG000|Double-blind|Adverse Event|1|||
156558463|NCT02522767|565135153|FG001|Double-blind|Adverse Event|10|||
156558464|NCT02522767|565135152|FG000|Double-blind|Protocol Violation|0|||
156558465|NCT02522767|565135153|FG001|Double-blind|Protocol Violation|1|||
156558466|NCT02522767|565135152|FG000|Double-blind|Lack of Efficacy|0|||
156558467|NCT02522767|565135153|FG001|Double-blind|Lack of Efficacy|2|||
156558468|NCT02522767|565135152|FG000|Double-blind|Protocol Deviation|1|||
156558469|NCT02522767|565135153|FG001|Double-blind|Protocol Deviation|0|||
156558470|NCT02522767|565135152|FG000|Open-label|Withdrawal by Subject|2|||
156558471|NCT02522767|565135153|FG001|Open-label|Withdrawal by Subject|3|||
156558472|NCT02522767|565135152|FG000|Open-label|Lost to Follow-up|0|||
156558473|NCT02522767|565135153|FG001|Open-label|Lost to Follow-up|1|||
156558474|NCT02522767|565135152|FG000|Open-label|Adverse Event|2|||
156558475|NCT02522767|565135153|FG001|Open-label|Adverse Event|1|||
156558476|NCT02522767|565135152|FG000|Open-label|Lack of Efficacy|1|||
156558477|NCT02522767|565135153|FG001|Open-label|Lack of Efficacy|1|||
156558478|NCT02522767|565135152|FG000|Open-label|Protocol Violation|0|||
156558479|NCT02522767|565135153|FG001|Open-label|Protocol Violation|1|||
156558480|NCT00254566|565135155|FG000|Overall Study|Death|1|||
156558481|NCT00254566|565135156|FG001|Overall Study|Death|0|||
156558482|NCT00254566|565135155|FG000|Overall Study|Adverse Event|5|||
156558483|NCT00254566|565135156|FG001|Overall Study|Adverse Event|4|||
156558484|NCT00254566|565135155|FG000|Overall Study|Lack of Efficacy|12|||
156558485|NCT00254566|565135156|FG001|Overall Study|Lack of Efficacy|9|||
156558486|NCT00254566|565135155|FG000|Overall Study|Other|1|||
156558487|NCT00254566|565135156|FG001|Overall Study|Other|5|||
156558488|NCT00254566|565135155|FG000|Overall Study|Withdrawal by Subject|5|||
156558489|NCT00254566|565135156|FG001|Overall Study|Withdrawal by Subject|6|||
156558490|NCT00254566|565135155|FG000|Overall Study|Lost to Follow-up|7|||
156558491|NCT00254566|565135156|FG001|Overall Study|Lost to Follow-up|2|||
156558492|NCT00548548|565135157|FG000|Overall Study|Death|345|||
156558493|NCT00548548|565135158|FG001|Overall Study|Death|348|||
156558494|NCT00548548|565135157|FG000|Overall Study|Lost to Follow-up|17|||
156558495|NCT00548548|565135158|FG001|Overall Study|Lost to Follow-up|18|||
156558496|NCT01705691|565135161|FG000|Overall Study|Death|1|||
156558497|NCT01705691|565135162|FG001|Overall Study|Death|2|||
156558498|NCT01705691|565135161|FG000|Overall Study|Withdrawal by Subject|1|||
156558499|NCT01705691|565135162|FG001|Overall Study|Withdrawal by Subject|2|||
156558500|NCT01705691|565135161|FG000|Overall Study|Lost to Follow-up|1|||
156558501|NCT01705691|565135162|FG001|Overall Study|Lost to Follow-up|1|||
156558502|NCT01705691|565135161|FG000|Overall Study|Other|0|||
156558503|NCT01705691|565135162|FG001|Overall Study|Other|1|||
156558504|NCT02658448|565135163|FG000|Overall Study|Lost to Follow-up|1|||
156558505|NCT03106779|565135164|FG000|Overall Study|Lack of Efficacy|33|||
156558506|NCT03106779|565135165|FG001|Overall Study|Lack of Efficacy|24|||
156558507|NCT03106779|565135164|FG000|Overall Study|Adverse Event|8|||
156558508|NCT03106779|565135165|FG001|Overall Study|Adverse Event|16|||
156558509|NCT03106779|565135164|FG000|Overall Study|Physician Decision|10|||
156558510|NCT03106779|565135165|FG001|Overall Study|Physician Decision|6|||
156558511|NCT03106779|565135164|FG000|Overall Study|Patient/guardian decision|4|||
156558512|NCT03106779|565135165|FG001|Overall Study|Patient/guardian decision|3|||
156558513|NCT03106779|565135164|FG000|Overall Study|Progressive disease|1|||
156558514|NCT03106779|565135165|FG001|Overall Study|Progressive disease|3|||
156558515|NCT03106779|565135164|FG000|Overall Study|Lost to Follow-up|1|||
156558516|NCT03106779|565135165|FG001|Overall Study|Lost to Follow-up|2|||
156558517|NCT03106779|565135164|FG000|Overall Study|Death|1|||
156558518|NCT03106779|565135165|FG001|Overall Study|Death|0|||
156558519|NCT03106779|565135164|FG000|Overall Study|Protocol Violation|1|||
156558520|NCT03106779|565135165|FG001|Overall Study|Protocol Violation|0|||
156558521|NCT03106779|565135164|FG000|Overall Study|Not treated|1|||
156558522|NCT03106779|565135165|FG001|Overall Study|Not treated|0|||
156558523|NCT04233229|565135166|FG000|Overall Study|Withdrawal by Subject|0|||
156558524|NCT04233229|565135167|FG001|Overall Study|Withdrawal by Subject|1|||
156558525|NCT04233229|565135166|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
156558526|NCT04233229|565135167|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
156558527|NCT04233229|565135166|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
156558528|NCT04233229|565135167|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
156558529|NCT04093531|565135168|FG000|Overall Study|failed screening|4|||
156558530|NCT00841763|565135169|FG000|Overall Study|Withdrawal by Subject|60|||
156558531|NCT00841763|565135170|FG001|Overall Study|Withdrawal by Subject|17|||
156558532|NCT00841763|565135171|FG002|Overall Study|Withdrawal by Subject|4|||
156558533|NCT00841763|565135172|FG003|Overall Study|Withdrawal by Subject|1|||
156558534|NCT00841763|565135169|FG000|Overall Study|Adverse Event|9|||
156558535|NCT00841763|565135170|FG001|Overall Study|Adverse Event|10|||
156558536|NCT00841763|565135171|FG002|Overall Study|Adverse Event|3|||
156513618|NCT00943852|564972253|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
156513619|NCT00943852|564972254|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
156513620|NCT00943852|564972255|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
156513621|NCT02141620|564972256|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
156513622|NCT02141620|564972257|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
156513623|NCT00772330|564972258|FG000|Overall Study|Lost to Follow-up|3|||
156513624|NCT00734591|564972259|FG000|Screening for Prospective Period|Site did not participate|1604|||
156513625|NCT00734591|564972260|FG001|Screening for Prospective Period|Site did not participate|1488|||
156513626|NCT00734591|564972259|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
156513627|NCT00734591|564972260|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
156513628|NCT00734591|564972259|FG000|Prospective Period|Withdrawal by Subject|11|||
156513629|NCT00734591|564972260|FG001|Prospective Period|Withdrawal by Subject|9|||
156513630|NCT00734591|564972259|FG000|Prospective Period|Lost to Follow-up|37|||
156513631|NCT00734591|564972260|FG001|Prospective Period|Lost to Follow-up|33|||
156513632|NCT00734591|564972259|FG000|Prospective Period|Study Terminated|1|||
156513633|NCT00734591|564972260|FG001|Prospective Period|Study Terminated|0|||
156513634|NCT00734591|564972259|FG000|Prospective Period|Other|2|||
156513635|NCT00734591|564972260|FG001|Prospective Period|Other|2|||
156513636|NCT01656200|564972263|FG000|Overall Study|Withdrawal by Subject|1|||
156513637|NCT02236988|564972264|FG000|Overall Study|Lost to Follow-up|0|||
156558537|NCT00841763|565135172|FG003|Overall Study|Adverse Event|2|||
156558538|NCT00841763|565135169|FG000|Overall Study|Lost to Follow-up|63|||
156558539|NCT00841763|565135170|FG001|Overall Study|Lost to Follow-up|25|||
156513638|NCT02236988|564972265|FG001|Overall Study|Lost to Follow-up|0|||
156513639|NCT02236988|564972266|FG002|Overall Study|Lost to Follow-up|0|||
156558540|NCT00841763|565135171|FG002|Overall Study|Lost to Follow-up|0|||
156558541|NCT00841763|565135172|FG003|Overall Study|Lost to Follow-up|0|||
156513640|NCT02236988|564972267|FG003|Overall Study|Lost to Follow-up|1|||
156558542|NCT00841763|565135169|FG000|Overall Study|Protocol Violation|20|||
156558543|NCT00841763|565135170|FG001|Overall Study|Protocol Violation|3|||
156558544|NCT00841763|565135171|FG002|Overall Study|Protocol Violation|1|||
156558545|NCT00841763|565135172|FG003|Overall Study|Protocol Violation|0|||
156558546|NCT00841763|565135169|FG000|Overall Study|Administrative Reasons|3|||
156558547|NCT00841763|565135170|FG001|Overall Study|Administrative Reasons|1|||
156558548|NCT00841763|565135171|FG002|Overall Study|Administrative Reasons|0|||
156558549|NCT00841763|565135172|FG003|Overall Study|Administrative Reasons|0|||
156558550|NCT00841763|565135169|FG000|Overall Study|Unable to Classify|7|||
156558551|NCT00841763|565135170|FG001|Overall Study|Unable to Classify|1|||
156558552|NCT00841763|565135171|FG002|Overall Study|Unable to Classify|0|||
156558553|NCT00841763|565135172|FG003|Overall Study|Unable to Classify|0|||
156558554|NCT00191451|565135173|FG000|Overall Study|Withdrawal by Subject|2|||
156558555|NCT00191451|565135174|FG001|Overall Study|Withdrawal by Subject|3|||
156558556|NCT00191451|565135175|FG002|Overall Study|Withdrawal by Subject|5|||
156558557|NCT00191451|565135173|FG000|Overall Study|Physician Decision|2|||
156558558|NCT00191451|565135174|FG001|Overall Study|Physician Decision|9|||
156558559|NCT00191451|565135175|FG002|Overall Study|Physician Decision|6|||
156558560|NCT00191451|565135173|FG000|Overall Study|Sponsor Decision|1|||
156558561|NCT00191451|565135174|FG001|Overall Study|Sponsor Decision|0|||
156558562|NCT00191451|565135175|FG002|Overall Study|Sponsor Decision|0|||
156558563|NCT00191451|565135173|FG000|Overall Study|Ineligible|0|||
156558564|NCT00191451|565135174|FG001|Overall Study|Ineligible|1|||
156558565|NCT00191451|565135175|FG002|Overall Study|Ineligible|0|||
156558566|NCT00191451|565135173|FG000|Overall Study|Reason Not Specified|2|||
156558567|NCT00191451|565135174|FG001|Overall Study|Reason Not Specified|1|||
156558568|NCT00191451|565135175|FG002|Overall Study|Reason Not Specified|3|||
156558569|NCT00272987|565135180|FG000|Overall Study|Adverse Event|1|||
156558570|NCT00272987|565135181|FG001|Overall Study|Adverse Event|0|||
156558571|NCT00272987|565135182|FG002|Overall Study|Adverse Event|0|||
156558572|NCT00272987|565135180|FG000|Overall Study|Lost to Follow-up|3|||
156558573|NCT00272987|565135181|FG001|Overall Study|Lost to Follow-up|1|||
156558574|NCT00272987|565135182|FG002|Overall Study|Lost to Follow-up|1|||
156558575|NCT00272987|565135180|FG000|Overall Study|Withdrawal by Subject|1|||
156558576|NCT00272987|565135181|FG001|Overall Study|Withdrawal by Subject|0|||
156558577|NCT00272987|565135182|FG002|Overall Study|Withdrawal by Subject|3|||
156558578|NCT00272987|565135180|FG000|Overall Study|Sponsor Terminated study|0|||
156558579|NCT00272987|565135181|FG001|Overall Study|Sponsor Terminated study|1|||
156558580|NCT00272987|565135182|FG002|Overall Study|Sponsor Terminated study|1|||
156558581|NCT00272987|565135180|FG000|Overall Study|Disease progression|1|||
156558582|NCT00272987|565135181|FG001|Overall Study|Disease progression|1|||
156558583|NCT00272987|565135182|FG002|Overall Study|Disease progression|2|||
156558584|NCT00272987|565135180|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
156558585|NCT00272987|565135181|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
156558586|NCT00272987|565135182|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
156558587|NCT00272987|565135180|FG000|Overall Study|Death|1|||
156558588|NCT00272987|565135181|FG001|Overall Study|Death|0|||
156558589|NCT00272987|565135182|FG002|Overall Study|Death|0|||
156558590|NCT02614079|565135183|FG000|Overall Study|Withdrawal by Subject|1|||
156558591|NCT00236080|565135184|FG000|Overall Study|Adverse Event|0|||
156558592|NCT00236080|565135185|FG001|Overall Study|Adverse Event|0|||
156558593|NCT00236080|565135186|FG002|Overall Study|Adverse Event|3|||
156558594|NCT00236080|565135187|FG003|Overall Study|Adverse Event|1|||
156558595|NCT00236080|565135188|FG004|Overall Study|Adverse Event|0|||
156558596|NCT00236080|565135184|FG000|Overall Study|Lost to Follow-up|0|||
156513641|NCT02236988|564972264|FG000|Overall Study|Unable to Comply with Study Visits|0|||
156513642|NCT02236988|564972265|FG001|Overall Study|Unable to Comply with Study Visits|0|||
156513643|NCT02236988|564972266|FG002|Overall Study|Unable to Comply with Study Visits|0|||
156513644|NCT02236988|564972267|FG003|Overall Study|Unable to Comply with Study Visits|2|||
156513645|NCT05775991|564972270|FG000|Overall Study|Withdrawal by Subject|0|||
156513646|NCT05775991|564972271|FG001|Overall Study|Withdrawal by Subject|0|||
156513647|NCT05775991|564972272|FG002|Overall Study|Withdrawal by Subject|2|||
156513648|NCT03921723|564972275|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
156513649|NCT03921723|564972275|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
156513650|NCT01461811|564972276|FG000|Overall Study|Adverse Event|2|||
156513651|NCT01461811|564972277|FG001|Overall Study|Adverse Event|1|||
156513652|NCT01461811|564972276|FG000|Overall Study|Subject decision unrelated to an AE|1|||
156558597|NCT00236080|565135185|FG001|Overall Study|Lost to Follow-up|1|||
156558598|NCT00236080|565135186|FG002|Overall Study|Lost to Follow-up|0|||
156558599|NCT00236080|565135187|FG003|Overall Study|Lost to Follow-up|0|||
156558600|NCT00236080|565135188|FG004|Overall Study|Lost to Follow-up|0|||
156558601|NCT00236080|565135184|FG000|Overall Study|Physician Decision|1|||
156558602|NCT00236080|565135185|FG001|Overall Study|Physician Decision|0|||
156558603|NCT00236080|565135186|FG002|Overall Study|Physician Decision|1|||
156513653|NCT01461811|564972277|FG001|Overall Study|Subject decision unrelated to an AE|1|||
156558604|NCT00236080|565135187|FG003|Overall Study|Physician Decision|1|||
156558605|NCT00236080|565135188|FG004|Overall Study|Physician Decision|1|||
156558606|NCT00236080|565135184|FG000|Overall Study|Withdrawal by Subject|1|||
156558607|NCT00236080|565135185|FG001|Overall Study|Withdrawal by Subject|0|||
156558608|NCT00236080|565135186|FG002|Overall Study|Withdrawal by Subject|0|||
156558609|NCT00236080|565135187|FG003|Overall Study|Withdrawal by Subject|0|||
156513654|NCT01461811|564972276|FG000|Overall Study|Noncompliance|1|||
156513655|NCT01461811|564972277|FG001|Overall Study|Noncompliance|1|||
156513656|NCT03015129|564972278|FG000|Overall Study|Death|2|||
156513657|NCT03015129|564972279|FG001|Overall Study|Death|2|||
156513658|NCT03015129|564972278|FG000|Overall Study|Lost to Follow-up|0|||
156513659|NCT03015129|564972279|FG001|Overall Study|Lost to Follow-up|1|||
156513660|NCT03015129|564972278|FG000|Overall Study|Progression of disease|38|||
156513661|NCT03015129|564972279|FG001|Overall Study|Progression of disease|33|||
156513662|NCT03015129|564972278|FG000|Overall Study|Adverse Event|0|||
156558610|NCT00236080|565135188|FG004|Overall Study|Withdrawal by Subject|0|||
156558611|NCT00236080|565135184|FG000|Overall Study|Miscellaneous|0|||
156558612|NCT00236080|565135185|FG001|Overall Study|Miscellaneous|0|||
156558613|NCT00236080|565135186|FG002|Overall Study|Miscellaneous|1|||
156558614|NCT00236080|565135187|FG003|Overall Study|Miscellaneous|0|||
156558615|NCT00236080|565135188|FG004|Overall Study|Miscellaneous|0|||
156558616|NCT01214044|565135189|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
156558617|NCT01214044|565135189|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
156558618|NCT01214044|565135189|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
156558619|NCT01214044|565135189|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
156558620|NCT01214044|565135189|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
156558621|NCT01214044|565135189|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
156558622|NCT04698525|565135190|FG000|Overall Study|Lost to Follow-up|1|||
156558623|NCT04698525|565135191|FG001|Overall Study|Lost to Follow-up|2|||
156558624|NCT04698525|565135190|FG000|Overall Study|Three suffered of Covid-19|2|||
156558625|NCT04698525|565135191|FG001|Overall Study|Three suffered of Covid-19|1|||
156558626|NCT03604445|565135193|FG000|Overall Study|Death|0|||
156558627|NCT03604445|565135194|FG001|Overall Study|Death|0|||
156558628|NCT03604445|565135195|FG002|Overall Study|Death|0|||
156558629|NCT03604445|565135196|FG003|Overall Study|Death|0|||
156558630|NCT03604445|565135197|FG004|Overall Study|Death|0|||
156558631|NCT03604445|565135198|FG005|Overall Study|Death|0|||
156558632|NCT03604445|565135199|FG006|Overall Study|Death|0|||
156558633|NCT03604445|565135200|FG007|Overall Study|Death|0|||
156558634|NCT03604445|565135201|FG008|Overall Study|Death|1|||
156558635|NCT03604445|565135193|FG000|Overall Study|Withdrawal by Subject|0|||
156558636|NCT03604445|565135194|FG001|Overall Study|Withdrawal by Subject|0|||
156558637|NCT03604445|565135195|FG002|Overall Study|Withdrawal by Subject|0|||
156558638|NCT03604445|565135196|FG003|Overall Study|Withdrawal by Subject|0|||
156558639|NCT03604445|565135197|FG004|Overall Study|Withdrawal by Subject|0|||
156558640|NCT03604445|565135198|FG005|Overall Study|Withdrawal by Subject|0|||
156558641|NCT03604445|565135199|FG006|Overall Study|Withdrawal by Subject|1|||
156558642|NCT03604445|565135200|FG007|Overall Study|Withdrawal by Subject|0|||
156558643|NCT03604445|565135201|FG008|Overall Study|Withdrawal by Subject|0|||
156558644|NCT03604445|565135193|FG000|Overall Study|Missing visit|0|||
156558645|NCT03604445|565135194|FG001|Overall Study|Missing visit|0|||
156558646|NCT03604445|565135195|FG002|Overall Study|Missing visit|0|||
156558647|NCT03604445|565135196|FG003|Overall Study|Missing visit|0|||
156558648|NCT03604445|565135197|FG004|Overall Study|Missing visit|0|||
156558649|NCT03604445|565135198|FG005|Overall Study|Missing visit|1|||
156558650|NCT03604445|565135199|FG006|Overall Study|Missing visit|0|||
156558651|NCT03604445|565135200|FG007|Overall Study|Missing visit|1|||
156558652|NCT03604445|565135201|FG008|Overall Study|Missing visit|0|||
156558653|NCT03604445|565135193|FG000|Overall Study|Adverse Event|0|||
156558654|NCT03604445|565135194|FG001|Overall Study|Adverse Event|0|||
156558655|NCT03604445|565135195|FG002|Overall Study|Adverse Event|0|||
156558656|NCT03604445|565135196|FG003|Overall Study|Adverse Event|1|||
156558657|NCT03604445|565135197|FG004|Overall Study|Adverse Event|0|||
156558658|NCT03604445|565135198|FG005|Overall Study|Adverse Event|0|||
156558659|NCT03604445|565135199|FG006|Overall Study|Adverse Event|0|||
156558660|NCT03604445|565135200|FG007|Overall Study|Adverse Event|0|||
156558661|NCT03604445|565135201|FG008|Overall Study|Adverse Event|1|||
156558662|NCT02817087|565135202|FG000|Overall Study|Withdrawal by Subject|2|||
156558663|NCT02817087|565135203|FG001|Overall Study|Withdrawal by Subject|0|||
156558664|NCT00611247|565135206|FG000|Overall Study|Death|1|||
156558665|NCT00611247|565135207|FG001|Overall Study|Death|5|||
156558666|NCT00611247|565135206|FG000|Overall Study|Lack of Efficacy|1|||
156558667|NCT00611247|565135207|FG001|Overall Study|Lack of Efficacy|16|||
156558668|NCT02551159|565135210|FG000|Overall Study|Death|352|||
156558669|NCT02551159|565135211|FG001|Overall Study|Death|174|||
156558670|NCT02551159|565135212|FG002|Overall Study|Death|161|||
156558671|NCT02551159|565135210|FG000|Overall Study|Withdrawal by Subject|8|||
156558672|NCT02551159|565135211|FG001|Overall Study|Withdrawal by Subject|5|||
156558673|NCT02551159|565135212|FG002|Overall Study|Withdrawal by Subject|16|||
156558674|NCT02551159|565135210|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
156558675|NCT02551159|565135211|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
156513663|NCT03015129|564972279|FG001|Overall Study|Adverse Event|4|||
156558676|NCT02551159|565135212|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
156558677|NCT00243659|565135213|FG000|Overall Study|Withdrawal by Subject|1|||
156513664|NCT01072630|564972281|FG000|Overall Study|Adverse Event|11|||
156513665|NCT01072630|564972282|FG001|Overall Study|Adverse Event|19|||
156513666|NCT01072630|564972283|FG002|Overall Study|Adverse Event|2|||
156513667|NCT01072630|564972281|FG000|Overall Study|Lack of Efficacy|10|||
156513668|NCT01072630|564972282|FG001|Overall Study|Lack of Efficacy|10|||
156513669|NCT01072630|564972283|FG002|Overall Study|Lack of Efficacy|1|||
156513670|NCT01072630|564972281|FG000|Overall Study|Withdrawal by Subject|8|||
156513671|NCT01072630|564972282|FG001|Overall Study|Withdrawal by Subject|7|||
156513672|NCT01072630|564972283|FG002|Overall Study|Withdrawal by Subject|2|||
156513673|NCT01072630|564972281|FG000|Overall Study|Protocol Violation|10|||
156513674|NCT01072630|564972282|FG001|Overall Study|Protocol Violation|8|||
156513675|NCT01072630|564972283|FG002|Overall Study|Protocol Violation|4|||
156513676|NCT01072630|564972281|FG000|Overall Study|Lost to Follow-up|11|||
156513677|NCT01072630|564972282|FG001|Overall Study|Lost to Follow-up|11|||
156513678|NCT01072630|564972283|FG002|Overall Study|Lost to Follow-up|1|||
156513679|NCT01072630|564972281|FG000|Overall Study|Noncompliance with study medication|1|||
156513680|NCT01072630|564972282|FG001|Overall Study|Noncompliance with study medication|1|||
156513681|NCT01072630|564972283|FG002|Overall Study|Noncompliance with study medication|1|||
156513682|NCT01072630|564972281|FG000|Overall Study|Noncompliance with study procedures|1|||
156513683|NCT01072630|564972282|FG001|Overall Study|Noncompliance with study procedures|2|||
156513684|NCT01072630|564972283|FG002|Overall Study|Noncompliance with study procedures|1|||
156513685|NCT01072630|564972281|FG000|Overall Study|Other|3|||
156513686|NCT01072630|564972282|FG001|Overall Study|Other|2|||
156513687|NCT01072630|564972283|FG002|Overall Study|Other|1|||
156513688|NCT03046121|564972284|FG000|Overall Study|Death|32|||
156513689|NCT03046121|564972285|FG001|Overall Study|Death|60|||
156513690|NCT03046121|564972284|FG000|Overall Study|Withdrawal by Subject|14|||
156513691|NCT03046121|564972285|FG001|Overall Study|Withdrawal by Subject|12|||
156513692|NCT04155047|564972286|FG000|Overall Study|Adverse Event|1|||
156513693|NCT04155047|564972287|FG001|Overall Study|Adverse Event|0|||
156513694|NCT04155047|564972286|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
156513695|NCT04155047|564972287|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
156513696|NCT04514510|564972288|FG000|Overall Study|Lost to Follow-up|0|||
156513697|NCT04514510|564972289|FG001|Overall Study|Lost to Follow-up|1|||
156513698|NCT04514510|564972288|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
156513699|NCT04514510|564972289|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
156513700|NCT02781090|564972290|FG000|3-Month Follow-Up|Missed Visit|20|||
156513701|NCT02781090|564972291|FG001|3-Month Follow-Up|Missed Visit|20|||
156513702|NCT02781090|564972290|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
156513703|NCT02781090|564972291|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
156513704|NCT02781090|564972290|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
156513705|NCT02781090|564972291|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
156513706|NCT02781090|564972290|FG000|3-Month Follow-Up|Death|1|||
156513707|NCT02781090|564972291|FG001|3-Month Follow-Up|Death|0|||
156513708|NCT02781090|564972290|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
156513709|NCT02781090|564972291|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
156513710|NCT02781090|564972290|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
156513711|NCT02781090|564972291|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
156513712|NCT02781090|564972290|FG000|6-Month Follow-Up|Death|0|||
156513713|NCT02781090|564972291|FG001|6-Month Follow-Up|Death|1|||
156513714|NCT00643617|564972292|FG000|Overall Study|Death|6|||
156513715|NCT00643617|564972293|FG001|Overall Study|Death|9|||
156513716|NCT00643617|564972292|FG000|Overall Study|Lost to Follow-up|42|||
156513717|NCT00643617|564972293|FG001|Overall Study|Lost to Follow-up|51|||
156513718|NCT01208103|564972294|FG000|Overall Study|Adverse Event|1|||
156513719|NCT01208103|564972294|FG000|Overall Study|Withdrawal by Subject|1|||
156513720|NCT00416195|564972297|FG000|Overall Study|Adverse Event|1|||
156513721|NCT00416195|564972298|FG001|Overall Study|Adverse Event|2|||
156513722|NCT00416195|564972297|FG000|Overall Study|Protocol Violation|1|||
156513723|NCT00416195|564972298|FG001|Overall Study|Protocol Violation|1|||
156513724|NCT00416195|564972297|FG000|Overall Study|Other|0|||
156513725|NCT00416195|564972298|FG001|Overall Study|Other|1|||
156513726|NCT01606670|564972305|FG000|Overall Study|Adverse Event|6|||
156513727|NCT01606670|564972305|FG000|Overall Study|Lack of Efficacy|2|||
156513728|NCT01606670|564972305|FG000|Overall Study|Lost to Follow-up|3|||
156513729|NCT01606670|564972305|FG000|Overall Study|Withdrawal by Subject|3|||
156513730|NCT01606670|564972305|FG000|Overall Study|Other Reason|2|||
156513731|NCT03653208|564972308|FG000|Overall Study|Withdrawal by Subject|0|||
156513732|NCT03653208|564972309|FG001|Overall Study|Withdrawal by Subject|0|||
156513733|NCT03653208|564972310|FG002|Overall Study|Withdrawal by Subject|0|||
156513734|NCT03653208|564972311|FG003|Overall Study|Withdrawal by Subject|0|||
156513735|NCT03653208|564972312|FG004|Overall Study|Withdrawal by Subject|1|||
156513736|NCT03653208|564972313|FG005|Overall Study|Withdrawal by Subject|0|||
156513737|NCT03653208|564972314|FG006|Overall Study|Withdrawal by Subject|0|||
156513738|NCT03653208|564972315|FG007|Overall Study|Withdrawal by Subject|1|||
156558678|NCT00243659|565135214|FG001|Overall Study|Withdrawal by Subject|1|||
156558679|NCT00243659|565135213|FG000|Overall Study|Protocol Violation|1|||
156558680|NCT00243659|565135214|FG001|Overall Study|Protocol Violation|2|||
156558681|NCT06098729|565135215|FG000|Overall Study|Withdrawal by Subject|1|||
156558682|NCT01665144|565135216|FG000|Core Part|Withdrawal by Subject|96|||
156558683|NCT01665144|565135217|FG001|Core Part|Withdrawal by Subject|77|||
156558684|NCT01665144|565135218|FG002|Core Part|Withdrawal by Subject|0|||
156558685|NCT01665144|565135216|FG000|Core Part|Adverse Event|45|||
156558686|NCT01665144|565135217|FG001|Core Part|Adverse Event|18|||
156558687|NCT01665144|565135218|FG002|Core Part|Adverse Event|0|||
156558688|NCT01665144|565135216|FG000|Core Part|Lack of Efficacy|16|||
156558689|NCT01665144|565135217|FG001|Core Part|Lack of Efficacy|11|||
156558690|NCT01665144|565135218|FG002|Core Part|Lack of Efficacy|0|||
156558691|NCT01665144|565135216|FG000|Core Part|Lost to Follow-up|9|||
156558692|NCT01665144|565135217|FG001|Core Part|Lost to Follow-up|8|||
156558693|NCT01665144|565135218|FG002|Core Part|Lost to Follow-up|0|||
156558694|NCT01665144|565135216|FG000|Core Part|Physician Decision|13|||
156558695|NCT01665144|565135217|FG001|Core Part|Physician Decision|1|||
156558696|NCT01665144|565135218|FG002|Core Part|Physician Decision|0|||
156558697|NCT01665144|565135216|FG000|Core Part|Progressive disease|8|||
156558698|NCT01665144|565135217|FG001|Core Part|Progressive disease|4|||
156558699|NCT01665144|565135218|FG002|Core Part|Progressive disease|0|||
156558700|NCT01665144|565135216|FG000|Core Part|Non-compliance with study treatment|5|||
156558701|NCT01665144|565135217|FG001|Core Part|Non-compliance with study treatment|0|||
156558702|NCT01665144|565135218|FG002|Core Part|Non-compliance with study treatment|0|||
156558703|NCT01665144|565135216|FG000|Core Part|Death|3|||
156558704|NCT01665144|565135217|FG001|Core Part|Death|1|||
156558705|NCT01665144|565135218|FG002|Core Part|Death|0|||
156558706|NCT01665144|565135216|FG000|Core Part|Protocol deviation|3|||
156558707|NCT01665144|565135217|FG001|Core Part|Protocol deviation|1|||
156558708|NCT01665144|565135218|FG002|Core Part|Protocol deviation|0|||
156558709|NCT01665144|565135216|FG000|Core Part|New therapy for study indication|2|||
156558710|NCT01665144|565135217|FG001|Core Part|New therapy for study indication|1|||
156558711|NCT01665144|565135218|FG002|Core Part|New therapy for study indication|0|||
156558712|NCT01665144|565135216|FG000|Core Part|Technical problems|2|||
156558713|NCT01665144|565135217|FG001|Core Part|Technical problems|0|||
156558714|NCT01665144|565135218|FG002|Core Part|Technical problems|0|||
156558715|NCT01665144|565135216|FG000|Extension Part|Patient/guardian decision|180|||
156558716|NCT01665144|565135217|FG001|Extension Part|Patient/guardian decision|0|||
156558717|NCT01665144|565135218|FG002|Extension Part|Patient/guardian decision|98|||
156558718|NCT01665144|565135216|FG000|Extension Part|Adverse Event|104|||
156558719|NCT01665144|565135217|FG001|Extension Part|Adverse Event|0|||
156558720|NCT01665144|565135218|FG002|Extension Part|Adverse Event|59|||
156558721|NCT01665144|565135216|FG000|Extension Part|Study closed early|42|||
156558722|NCT01665144|565135217|FG001|Extension Part|Study closed early|0|||
156558723|NCT01665144|565135218|FG002|Extension Part|Study closed early|19|||
156558724|NCT01665144|565135216|FG000|Extension Part|Progressive disease|36|||
156558725|NCT01665144|565135217|FG001|Extension Part|Progressive disease|0|||
156558726|NCT01665144|565135218|FG002|Extension Part|Progressive disease|14|||
156558727|NCT01665144|565135216|FG000|Extension Part|Lack of Efficacy|37|||
156558728|NCT01665144|565135217|FG001|Extension Part|Lack of Efficacy|0|||
156558729|NCT01665144|565135218|FG002|Extension Part|Lack of Efficacy|12|||
156558730|NCT01665144|565135216|FG000|Extension Part|Physician Decision|29|||
156558731|NCT01665144|565135217|FG001|Extension Part|Physician Decision|0|||
156558732|NCT01665144|565135218|FG002|Extension Part|Physician Decision|13|||
156558733|NCT01665144|565135216|FG000|Extension Part|Technical problems|20|||
156558734|NCT01665144|565135217|FG001|Extension Part|Technical problems|0|||
156558735|NCT01665144|565135218|FG002|Extension Part|Technical problems|8|||
156558736|NCT01665144|565135216|FG000|Extension Part|Death|20|||
156558737|NCT01665144|565135217|FG001|Extension Part|Death|0|||
156558738|NCT01665144|565135218|FG002|Extension Part|Death|4|||
156558739|NCT01665144|565135216|FG000|Extension Part|Missing|12|||
156558740|NCT01665144|565135217|FG001|Extension Part|Missing|0|||
156558741|NCT01665144|565135218|FG002|Extension Part|Missing|6|||
156558742|NCT01665144|565135216|FG000|Extension Part|Lost to Follow-up|9|||
156558743|NCT01665144|565135217|FG001|Extension Part|Lost to Follow-up|0|||
156558744|NCT01665144|565135218|FG002|Extension Part|Lost to Follow-up|5|||
156558745|NCT01665144|565135216|FG000|Extension Part|New therapy for study indication|3|||
156558746|NCT01665144|565135217|FG001|Extension Part|New therapy for study indication|0|||
156558747|NCT01665144|565135218|FG002|Extension Part|New therapy for study indication|2|||
156558748|NCT01665144|565135216|FG000|Extension Part|Protocol deviation|3|||
156558749|NCT01665144|565135217|FG001|Extension Part|Protocol deviation|0|||
156558750|NCT01665144|565135218|FG002|Extension Part|Protocol deviation|0|||
156558751|NCT01913483|565135219|FG000|Overall Study|Withdrawal by Subject|1|||
156558752|NCT01913483|565135220|FG001|Overall Study|Withdrawal by Subject|2|||
156558753|NCT01913483|565135219|FG000|Overall Study|Lost to Follow-up|6|||
156558754|NCT01913483|565135220|FG001|Overall Study|Lost to Follow-up|3|||
156558755|NCT01913483|565135219|FG000|Overall Study|Death|14|||
156558756|NCT01913483|565135220|FG001|Overall Study|Death|17|||
156558757|NCT04506294|565135221|FG000|Overall Study|Lost to Follow-up|70|||
156558758|NCT04506294|565135222|FG001|Overall Study|Lost to Follow-up|20|||
156558759|NCT04506294|565135221|FG000|Overall Study|Withdrawal by Subject|16|||
156558760|NCT04506294|565135222|FG001|Overall Study|Withdrawal by Subject|2|||
156558761|NCT01469000|565135223|FG000|Overall Study|Withdrawal by Subject|16|||
156558762|NCT01469000|565135224|FG001|Overall Study|Withdrawal by Subject|3|||
156558763|NCT01469000|565135223|FG000|Overall Study|Sponsor Decision|4|||
156558764|NCT01469000|565135224|FG001|Overall Study|Sponsor Decision|1|||
156558765|NCT00769119|565135226|FG000|Overall Study|Voluntary discontinuation|0|||
156558766|NCT00769119|565135227|FG001|Overall Study|Voluntary discontinuation|2|||
156558767|NCT00769119|565135226|FG000|Overall Study|Adverse Event|1|||
156513739|NCT03653208|564972316|FG008|Overall Study|Withdrawal by Subject|1|||
156513740|NCT00368927|564972317|FG000|Overall Study|Lost to Follow-up|2|||
156513741|NCT00368927|564972318|FG001|Overall Study|Lost to Follow-up|0|||
156513742|NCT00368927|564972317|FG000|Overall Study|Adverse Event|1|||
156513743|NCT00368927|564972318|FG001|Overall Study|Adverse Event|1|||
156513744|NCT00368927|564972317|FG000|Overall Study|Withdrawal by Subject|1|||
156513745|NCT00368927|564972318|FG001|Overall Study|Withdrawal by Subject|2|||
156558768|NCT00769119|565135227|FG001|Overall Study|Adverse Event|1|||
156558769|NCT00769119|565135226|FG000|Overall Study|Disallowed medication|1|||
156558770|NCT00769119|565135227|FG001|Overall Study|Disallowed medication|0|||
156558771|NCT04698629|565135232|FG000|Overall Study|Adverse Event|1|||
156558772|NCT02320487|565135235|FG000|Overall Study|Reason not Specified|1|||
156558773|NCT02320487|565135235|FG000|Overall Study|Physician Decision|5|||
156558774|NCT02320487|565135235|FG000|Overall Study|Withdrawal by Subject|1|||
156558775|NCT02320487|565135235|FG000|Overall Study|Death|3|||
156558776|NCT02320487|565135235|FG000|Overall Study|Adverse Event|11|||
156558777|NCT06228586|565135236|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
156558778|NCT06228586|565135237|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
156558779|NCT00618722|565137497|FG000|Overall Study|Refusal of Treatment|0|||
156558780|NCT00618722|565137498|FG001|Overall Study|Refusal of Treatment|0|||
156558781|NCT00618722|565137499|FG002|Overall Study|Refusal of Treatment|1|||
156558782|NCT00618722|565137500|FG003|Overall Study|Refusal of Treatment|0|||
156558783|NCT00618722|565137497|FG000|Overall Study|Patient Request|1|||
156558784|NCT00618722|565137498|FG001|Overall Study|Patient Request|1|||
156513746|NCT00368927|564972317|FG000|Overall Study|Physician Decision|1|||
156558785|NCT00618722|565137499|FG002|Overall Study|Patient Request|1|||
156558786|NCT00618722|565137500|FG003|Overall Study|Patient Request|1|||
156558787|NCT00618722|565137497|FG000|Overall Study|Inability to Complete Study Procedure|0|||
156558788|NCT00618722|565137498|FG001|Overall Study|Inability to Complete Study Procedure|1|||
156558789|NCT00618722|565137499|FG002|Overall Study|Inability to Complete Study Procedure|0|||
156558790|NCT00618722|565137500|FG003|Overall Study|Inability to Complete Study Procedure|0|||
156558791|NCT00618722|565137497|FG000|Overall Study|Lost to Follow-up|2|||
156558792|NCT00618722|565137498|FG001|Overall Study|Lost to Follow-up|0|||
156558793|NCT00618722|565137499|FG002|Overall Study|Lost to Follow-up|0|||
156558794|NCT00618722|565137500|FG003|Overall Study|Lost to Follow-up|2|||
156558795|NCT00618722|565137497|FG000|Overall Study|Miscellaneous Reasons|0|||
156558796|NCT00618722|565137498|FG001|Overall Study|Miscellaneous Reasons|0|||
156558797|NCT00618722|565137499|FG002|Overall Study|Miscellaneous Reasons|1|||
156558798|NCT00618722|565137500|FG003|Overall Study|Miscellaneous Reasons|1|||
156558799|NCT05512949|565137502|FG000|Overall Study|Lost to Follow-up|4|||
156558800|NCT05512949|565137503|FG001|Overall Study|Lost to Follow-up|6|||
156558801|NCT05512949|565137504|FG002|Overall Study|Lost to Follow-up|2|||
156558802|NCT05512949|565137502|FG000|Overall Study|Protocol Violation|0|||
156558803|NCT05512949|565137503|FG001|Overall Study|Protocol Violation|0|||
156558804|NCT05512949|565137504|FG002|Overall Study|Protocol Violation|1|||
156558805|NCT05512949|565137502|FG000|Overall Study|Withdrawal by Subject|1|||
156558806|NCT05512949|565137503|FG001|Overall Study|Withdrawal by Subject|1|||
156558807|NCT05512949|565137504|FG002|Overall Study|Withdrawal by Subject|2|||
156558808|NCT05512949|565137502|FG000|Overall Study|Completion status unknown|1|||
156558809|NCT05512949|565137503|FG001|Overall Study|Completion status unknown|3|||
156558810|NCT05512949|565137504|FG002|Overall Study|Completion status unknown|0|||
156558811|NCT00772629|565137505|FG000|Overall Study|Subject was not vaccinated|1|||
156558812|NCT00772629|565137506|FG001|Overall Study|Subject was not vaccinated|0|||
156558813|NCT01171820|565137509|FG000|Overall Study|Death|3|||
156558814|NCT01171820|565137510|FG001|Overall Study|Death|3|||
156558815|NCT01171820|565137509|FG000|Overall Study|Lost to Follow-up|0|||
156558816|NCT01171820|565137510|FG001|Overall Study|Lost to Follow-up|1|||
156558817|NCT01171820|565137509|FG000|Overall Study|Withdrawal by Subject|2|||
156558818|NCT01171820|565137510|FG001|Overall Study|Withdrawal by Subject|0|||
156558819|NCT01171820|565137509|FG000|Overall Study|Physician Decision|0|||
156513747|NCT00368927|564972318|FG001|Overall Study|Physician Decision|0|||
156558820|NCT01171820|565137510|FG001|Overall Study|Physician Decision|1|||
156558821|NCT01171820|565137509|FG000|Overall Study|1-Year Missed Visit|1|||
156558822|NCT01171820|565137510|FG001|Overall Study|1-Year Missed Visit|1|||
156558823|NCT01871090|565137511|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
156558824|NCT01871090|565137512|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
156513748|NCT01877239|564972319|FG000|Overall Study|Adverse Event|4|||
156558825|NCT01871090|565137511|FG000|Overall Study|Interrogation not completed correctly|1|||
156558826|NCT01871090|565137512|FG001|Overall Study|Interrogation not completed correctly|0|||
156558827|NCT01871090|565137511|FG000|Overall Study|Subject Non-Compliance|0|||
156558828|NCT01871090|565137512|FG001|Overall Study|Subject Non-Compliance|1|||
156558829|NCT02911688|565137516|FG000|Washout|Lost to Follow-up|1|||
156558830|NCT02911688|565137517|FG001|Washout|Lost to Follow-up|1|||
156558831|NCT02911688|565137516|FG000|Washout|Withdrawal by Subject|0|||
156558832|NCT02911688|565137517|FG001|Washout|Withdrawal by Subject|1|||
156558833|NCT01307033|565137520|FG000|8-week Double-blind Period|Adverse Event|2|||
156558834|NCT01307033|565137521|FG001|8-week Double-blind Period|Adverse Event|0|||
156558835|NCT01307033|565137522|FG002|8-week Double-blind Period|Adverse Event|0|||
156558836|NCT01307033|565137523|FG003|8-week Double-blind Period|Adverse Event|0|||
156558837|NCT01307033|565137520|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
156558838|NCT01307033|565137521|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
156558839|NCT01307033|565137522|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
156558840|NCT01307033|565137523|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
156558841|NCT01307033|565137520|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
156558842|NCT01307033|565137521|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
156558843|NCT01307033|565137522|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
156558844|NCT01307033|565137523|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
156558845|NCT01307033|565137520|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
156558846|NCT01307033|565137521|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
156558847|NCT01307033|565137522|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
156558848|NCT01307033|565137523|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
156558849|NCT01307033|565137520|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
156558850|NCT01307033|565137521|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
156558851|NCT01307033|565137522|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
156558852|NCT01307033|565137523|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
156558853|NCT01307033|565137520|FG000|44-week Open-label Extension|Adverse Event|0|||
156558854|NCT01307033|565137521|FG001|44-week Open-label Extension|Adverse Event|0|||
156558855|NCT01307033|565137522|FG002|44-week Open-label Extension|Adverse Event|2|||
156558856|NCT01307033|565137523|FG003|44-week Open-label Extension|Adverse Event|1|||
156558857|NCT01307033|565137520|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
156558858|NCT01307033|565137521|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
156558859|NCT01307033|565137522|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
156558860|NCT01307033|565137523|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
156558861|NCT01307033|565137520|FG000|44-week Open-label Extension|Physician Decision|0|||
156558862|NCT01307033|565137521|FG001|44-week Open-label Extension|Physician Decision|0|||
156558863|NCT01307033|565137522|FG002|44-week Open-label Extension|Physician Decision|1|||
156558864|NCT01307033|565137523|FG003|44-week Open-label Extension|Physician Decision|0|||
156558865|NCT01307033|565137520|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
156558866|NCT01307033|565137521|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
156558867|NCT01307033|565137522|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
156558868|NCT01307033|565137523|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
156558869|NCT01307033|565137520|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
156558870|NCT01307033|565137521|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
156558871|NCT01307033|565137522|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
156558872|NCT01307033|565137523|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
156558873|NCT01307033|565137520|FG000|44-week Open-label Extension|Death|0|||
156558874|NCT01307033|565137521|FG001|44-week Open-label Extension|Death|0|||
156558875|NCT01307033|565137522|FG002|44-week Open-label Extension|Death|0|||
156558876|NCT01307033|565137523|FG003|44-week Open-label Extension|Death|1|||
156558877|NCT01773421|565137528|FG000|Treatment Phase|Other|0|||
156558878|NCT01773421|565137529|FG001|Treatment Phase|Other|0|||
156558879|NCT01773421|565137530|FG002|Treatment Phase|Other|2|||
156558880|NCT01773421|565137531|FG003|Treatment Phase|Other|0|||
156558881|NCT01773421|565137532|FG004|Treatment Phase|Other|0|||
156558882|NCT01773421|565137533|FG005|Treatment Phase|Other|0|||
156558883|NCT01773421|565137534|FG006|Treatment Phase|Other|0|||
156558884|NCT01773421|565137528|FG000|Treatment Phase|Adverse Event|0|||
156558885|NCT01773421|565137529|FG001|Treatment Phase|Adverse Event|0|||
156558886|NCT01773421|565137530|FG002|Treatment Phase|Adverse Event|3|||
156558887|NCT01773421|565137531|FG003|Treatment Phase|Adverse Event|1|||
156558888|NCT01773421|565137532|FG004|Treatment Phase|Adverse Event|0|||
156558889|NCT01773421|565137533|FG005|Treatment Phase|Adverse Event|0|||
156558890|NCT01773421|565137534|FG006|Treatment Phase|Adverse Event|0|||
156558891|NCT01773421|565137528|FG000|Treatment Phase|Withdrawal by Subject|0|||
156558892|NCT01773421|565137529|FG001|Treatment Phase|Withdrawal by Subject|0|||
156558893|NCT01773421|565137530|FG002|Treatment Phase|Withdrawal by Subject|1|||
156558894|NCT01773421|565137531|FG003|Treatment Phase|Withdrawal by Subject|1|||
156558895|NCT01773421|565137532|FG004|Treatment Phase|Withdrawal by Subject|0|||
156513749|NCT01877239|564972319|FG000|Overall Study|Disease Remission|1|||
156513750|NCT01877239|564972319|FG000|Overall Study|Withdrawal by Subject|4|||
156513751|NCT01877239|564972319|FG000|Overall Study|Other|2|||
156513752|NCT01877239|564972319|FG000|Overall Study|Lack of Efficacy|4|||
156513753|NCT01877239|564972319|FG000|Overall Study|Data not available|35|||
156513754|NCT01989169|564972323|FG000|Period 2|Adverse Event|0|||
156513755|NCT01989169|564972324|FG001|Period 2|Adverse Event|1|||
156513756|NCT01114880|564972325|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
156513757|NCT01114880|564972326|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
156513758|NCT01114880|564972325|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
156513759|NCT01114880|564972326|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
156513760|NCT01114880|564972325|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
156513761|NCT01114880|564972326|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
156513762|NCT01114880|564972325|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
156513763|NCT01114880|564972326|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
156513764|NCT01114880|564972325|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
156513765|NCT01114880|564972326|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
156513766|NCT01114880|564972325|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
156513767|NCT01114880|564972326|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
156513768|NCT00283244|564972328|FG000|Overall Study|Adverse Event|0|||
156513769|NCT00283244|564972329|FG001|Overall Study|Adverse Event|8|||
156513770|NCT00283244|564972330|FG002|Overall Study|Adverse Event|11|||
156513771|NCT00283244|564972328|FG000|Overall Study|Death|4|||
156513772|NCT00283244|564972329|FG001|Overall Study|Death|3|||
156513773|NCT00283244|564972330|FG002|Overall Study|Death|2|||
156513774|NCT00283244|564972328|FG000|Overall Study|Lack of Efficacy|8|||
156513775|NCT00283244|564972329|FG001|Overall Study|Lack of Efficacy|32|||
156513776|NCT00283244|564972330|FG002|Overall Study|Lack of Efficacy|26|||
156513777|NCT00283244|564972328|FG000|Overall Study|Withdrawal by Subject|1|||
156513778|NCT00283244|564972329|FG001|Overall Study|Withdrawal by Subject|2|||
156513779|NCT00283244|564972330|FG002|Overall Study|Withdrawal by Subject|2|||
156513780|NCT00283244|564972328|FG000|Overall Study|Physician Decision|0|||
156513781|NCT00283244|564972329|FG001|Overall Study|Physician Decision|0|||
156513782|NCT00283244|564972330|FG002|Overall Study|Physician Decision|1|||
156513783|NCT00283244|564972328|FG000|Overall Study|Medical illness (other complicating dz)|4|||
156513784|NCT00283244|564972329|FG001|Overall Study|Medical illness (other complicating dz)|3|||
156513785|NCT00283244|564972330|FG002|Overall Study|Medical illness (other complicating dz)|6|||
156513786|NCT00283244|564972328|FG000|Overall Study|Clinical deterioration|1|||
156513787|NCT00283244|564972329|FG001|Overall Study|Clinical deterioration|3|||
156513788|NCT00283244|564972330|FG002|Overall Study|Clinical deterioration|3|||
156513789|NCT01585155|564972331|FG000|Overall Study|Adverse Event|1|||
156513790|NCT01585155|564972331|FG000|Overall Study|Lack of Efficacy|2|||
156513791|NCT01585155|564972331|FG000|Overall Study|Worsening ulcerative colitis|2|||
156513792|NCT02235311|564972332|FG000|Overall Study|Lost to Follow-up|0|||
156513793|NCT02235311|564972333|FG001|Overall Study|Lost to Follow-up|1|||
156513794|NCT02235311|564972332|FG000|Overall Study|Protocol Violation|0|||
156513795|NCT02235311|564972333|FG001|Overall Study|Protocol Violation|1|||
156513796|NCT00658788|564972334|FG000|Overall Study|Adverse Event|11|||
156513797|NCT00658788|564972334|FG000|Overall Study|Withdrawal by Subject|13|||
156513798|NCT00658788|564972334|FG000|Overall Study|Lost to Follow-up|18|||
156513799|NCT00658788|564972334|FG000|Overall Study|Treatment Discontinuation|32|||
156513800|NCT03898167|564972335|FG000|Overall Study|Terminated phone call early|7|||
156513801|NCT03898167|564972336|FG001|Overall Study|Terminated phone call early|0|||
156513802|NCT03898167|564972337|FG002|Overall Study|Terminated phone call early|0|||
156513803|NCT03898167|564972335|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
156513804|NCT03898167|564972336|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
156513805|NCT03898167|564972337|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
156513806|NCT03900416|564973848|FG000|Six Week Follow-up|Lost to Follow-up|1|||
156513807|NCT03900416|564973849|FG001|Six Week Follow-up|Lost to Follow-up|0|||
156513808|NCT03900416|564973848|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
156513809|NCT03900416|564973849|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
156513810|NCT03900416|564973848|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
156513811|NCT03900416|564973849|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
156513812|NCT03900416|564973848|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
156513813|NCT03900416|564973849|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
156513814|NCT03900416|564973848|FG000|Twelve Week Follow-up|Adverse Event|1|||
156513815|NCT03900416|564973849|FG001|Twelve Week Follow-up|Adverse Event|1|||
156513816|NCT03900416|564973848|FG000|Six Month Follow-up|Lost to Follow-up|4|||
156513817|NCT03900416|564973849|FG001|Six Month Follow-up|Lost to Follow-up|3|||
156513818|NCT03900416|564973848|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
156513819|NCT03900416|564973849|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
156513820|NCT00730275|564973850|FG000|Overall Study|Withdrawal by Subject|0|||
156558896|NCT01773421|565137533|FG005|Treatment Phase|Withdrawal by Subject|0|||
156513821|NCT00730275|564973851|FG001|Overall Study|Withdrawal by Subject|0|||
156513822|NCT00730275|564973852|FG002|Overall Study|Withdrawal by Subject|0|||
156513823|NCT00730275|564973853|FG003|Overall Study|Withdrawal by Subject|1|||
156513824|NCT00356408|564973854|FG000|Overall Study|Adverse Event|9|||
156513825|NCT00356408|564973854|FG000|Overall Study|Lack of Efficacy|36|||
156513826|NCT00356408|564973854|FG000|Overall Study|Lost to Follow-up|2|||
156513827|NCT00356408|564973854|FG000|Overall Study|Withdrawal by Subject|6|||
156513828|NCT00356408|564973854|FG000|Overall Study|Other: Principal investigator discretion|3|||
156513829|NCT00356408|564973854|FG000|Overall Study|Other: Sponsor request|1|||
156513830|NCT00356408|564973854|FG000|Overall Study|Other: Azathioprine stopped|1|||
156513831|NCT00356408|564973854|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
156513832|NCT00356408|564973854|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
156513833|NCT05487586|564973855|FG000|Overall Study|Death|22|||
156513834|NCT05487586|564973855|FG000|Overall Study|Physician Decision|1|||
156513835|NCT05487586|564973855|FG000|Overall Study|Transfer to another hospital|4|||
156513836|NCT05487586|564973855|FG000|Overall Study|Other|1|||
156513837|NCT00939822|564973860|FG000|Overall Study|Lost to Follow-up|1|||
156513838|NCT00939822|564973861|FG001|Overall Study|Lost to Follow-up|0|||
156513839|NCT00939822|564973860|FG000|Overall Study|withdrew from study due to busy schedule|1|||
156513840|NCT00939822|564973861|FG001|Overall Study|withdrew from study due to busy schedule|1|||
156513841|NCT00939822|564973860|FG000|Overall Study|Mental health issues|0|||
156513842|NCT00939822|564973861|FG001|Overall Study|Mental health issues|2|||
156513843|NCT05032872|564973862|FG000|Overall Study|Adverse Event|1|||
156513844|NCT05032872|564973863|FG001|Overall Study|Adverse Event|0|||
156513845|NCT05032872|564973862|FG000|Overall Study|Lost to Follow-up|2|||
156513846|NCT05032872|564973863|FG001|Overall Study|Lost to Follow-up|4|||
156513847|NCT05032872|564973862|FG000|Overall Study|Withdrawal by Subject|4|||
156513848|NCT05032872|564973863|FG001|Overall Study|Withdrawal by Subject|3|||
156513849|NCT00338962|564973864|FG000|Overall Study|Lost to Follow-up|3|||
156513850|NCT00338962|564973865|FG001|Overall Study|Lost to Follow-up|3|||
156513851|NCT00338962|564973866|FG002|Overall Study|Lost to Follow-up|2|||
156513852|NCT00338962|564973867|FG003|Overall Study|Lost to Follow-up|3|||
156513853|NCT00338962|564973864|FG000|Overall Study|Withdrawal by Subject|1|||
156513854|NCT00338962|564973865|FG001|Overall Study|Withdrawal by Subject|0|||
156513855|NCT00338962|564973866|FG002|Overall Study|Withdrawal by Subject|0|||
156513856|NCT00338962|564973867|FG003|Overall Study|Withdrawal by Subject|0|||
156513857|NCT00338962|564973864|FG000|Overall Study|No Transportation|2|||
156513858|NCT00338962|564973865|FG001|Overall Study|No Transportation|0|||
156513859|NCT00338962|564973866|FG002|Overall Study|No Transportation|0|||
156513860|NCT00338962|564973867|FG003|Overall Study|No Transportation|0|||
156513861|NCT00338962|564973864|FG000|Overall Study|Time Constraint|2|||
156513862|NCT00338962|564973865|FG001|Overall Study|Time Constraint|0|||
156513863|NCT00338962|564973866|FG002|Overall Study|Time Constraint|0|||
156513864|NCT00338962|564973867|FG003|Overall Study|Time Constraint|0|||
156513865|NCT00338962|564973864|FG000|Overall Study|Moved|0|||
156513866|NCT00338962|564973865|FG001|Overall Study|Moved|1|||
156513867|NCT00338962|564973866|FG002|Overall Study|Moved|0|||
156513868|NCT00338962|564973867|FG003|Overall Study|Moved|0|||
156513869|NCT00338962|564973864|FG000|Overall Study|Adverse Event|0|||
156513870|NCT00338962|564973865|FG001|Overall Study|Adverse Event|0|||
156513871|NCT00338962|564973866|FG002|Overall Study|Adverse Event|2|||
156513872|NCT00338962|564973867|FG003|Overall Study|Adverse Event|0|||
156513873|NCT00338962|564973864|FG000|Overall Study|Poor Compliance|0|||
156513874|NCT00338962|564973865|FG001|Overall Study|Poor Compliance|0|||
156513875|NCT00338962|564973866|FG002|Overall Study|Poor Compliance|2|||
156513876|NCT00338962|564973867|FG003|Overall Study|Poor Compliance|0|||
156513877|NCT00910039|564973868|FG000|Overall Study|Physician Decision|1|||
156513878|NCT00406692|564973879|FG000|Overall Study|Withdrawal by Subject|4|||
156513879|NCT00406692|564973879|FG000|Overall Study|Physician Decision|1|||
156513880|NCT00406692|564973879|FG000|Overall Study|Adverse Event|1|||
156513881|NCT00406692|564973879|FG000|Overall Study|Lack of Efficacy|1|||
156513882|NCT00821587|564973880|FG000|Overall Study|Physician Decision|0|||
156513883|NCT00821587|564973881|FG001|Overall Study|Physician Decision|1|||
156513884|NCT04488770|564973882|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513885|NCT04488770|564973883|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513886|NCT04488770|564973884|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513887|NCT04488770|564973885|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
156513888|NCT04488770|564973886|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513889|NCT04488770|564973887|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513890|NCT04488770|564973888|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513891|NCT04488770|564973889|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513892|NCT04488770|564973890|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513893|NCT04488770|564973891|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156558897|NCT01773421|565137534|FG006|Treatment Phase|Withdrawal by Subject|0|||
156558898|NCT01773421|565137528|FG000|Extension Phase|Other|0|||
156558899|NCT01773421|565137529|FG001|Extension Phase|Other|0|||
156558900|NCT01773421|565137530|FG002|Extension Phase|Other|0|||
156558901|NCT01773421|565137531|FG003|Extension Phase|Other|0|||
156558902|NCT01773421|565137532|FG004|Extension Phase|Other|1|||
156558903|NCT01773421|565137533|FG005|Extension Phase|Other|2|||
156558904|NCT01773421|565137534|FG006|Extension Phase|Other|0|||
156558905|NCT01773421|565137528|FG000|Extension Phase|Adverse Event|0|||
156558906|NCT01773421|565137529|FG001|Extension Phase|Adverse Event|0|||
156558907|NCT01773421|565137530|FG002|Extension Phase|Adverse Event|0|||
156558908|NCT01773421|565137531|FG003|Extension Phase|Adverse Event|0|||
156558909|NCT01773421|565137532|FG004|Extension Phase|Adverse Event|2|||
156558910|NCT01773421|565137533|FG005|Extension Phase|Adverse Event|0|||
156558911|NCT01773421|565137534|FG006|Extension Phase|Adverse Event|0|||
156558912|NCT02327260|565137535|FG000|Overall Study|Lost to Follow-up|2|||
156558913|NCT02327260|565137536|FG001|Overall Study|Lost to Follow-up|3|||
156558914|NCT02327260|565137537|FG002|Overall Study|Lost to Follow-up|2|||
156558915|NCT02327260|565137535|FG000|Overall Study|invalid phone number|1|||
156558916|NCT02327260|565137536|FG001|Overall Study|invalid phone number|1|||
156558917|NCT02327260|565137537|FG002|Overall Study|invalid phone number|0|||
156558918|NCT02327260|565137535|FG000|Overall Study|non-adherence to protocol|2|||
156558919|NCT02327260|565137536|FG001|Overall Study|non-adherence to protocol|0|||
156558920|NCT02327260|565137537|FG002|Overall Study|non-adherence to protocol|0|||
156558921|NCT02327260|565137535|FG000|Overall Study|cognitive concerns|1|||
156558922|NCT02327260|565137536|FG001|Overall Study|cognitive concerns|0|||
156558923|NCT02327260|565137537|FG002|Overall Study|cognitive concerns|0|||
156558924|NCT03502330|565137538|FG000|Overall Study|Adverse Event|2|||
156558925|NCT03502330|565137539|FG001|Overall Study|Adverse Event|1|||
156558926|NCT03502330|565137540|FG002|Overall Study|Adverse Event|0|||
156558927|NCT03502330|565137541|FG003|Overall Study|Adverse Event|0|||
156558928|NCT03502330|565137542|FG004|Overall Study|Adverse Event|1|||
156558929|NCT03502330|565137543|FG005|Overall Study|Adverse Event|0|||
156558930|NCT03502330|565137544|FG006|Overall Study|Adverse Event|1|||
156558931|NCT03502330|565137545|FG007|Overall Study|Adverse Event|1|||
156558932|NCT03502330|565137546|FG008|Overall Study|Adverse Event|0|||
156558933|NCT03502330|565137538|FG000|Overall Study|Lack of Efficacy|1|||
156558934|NCT03502330|565137539|FG001|Overall Study|Lack of Efficacy|5|||
156558935|NCT03502330|565137540|FG002|Overall Study|Lack of Efficacy|3|||
156558936|NCT03502330|565137541|FG003|Overall Study|Lack of Efficacy|5|||
156558937|NCT03502330|565137542|FG004|Overall Study|Lack of Efficacy|1|||
156558938|NCT03502330|565137543|FG005|Overall Study|Lack of Efficacy|5|||
156558939|NCT03502330|565137544|FG006|Overall Study|Lack of Efficacy|5|||
156558940|NCT03502330|565137545|FG007|Overall Study|Lack of Efficacy|6|||
156558941|NCT03502330|565137546|FG008|Overall Study|Lack of Efficacy|0|||
156558942|NCT03502330|565137538|FG000|Overall Study|Physician Decision|0|||
156558943|NCT03502330|565137539|FG001|Overall Study|Physician Decision|0|||
156558944|NCT03502330|565137540|FG002|Overall Study|Physician Decision|0|||
156558945|NCT03502330|565137541|FG003|Overall Study|Physician Decision|0|||
156558946|NCT03502330|565137542|FG004|Overall Study|Physician Decision|1|||
156558947|NCT03502330|565137543|FG005|Overall Study|Physician Decision|0|||
156558948|NCT03502330|565137544|FG006|Overall Study|Physician Decision|0|||
156558949|NCT03502330|565137545|FG007|Overall Study|Physician Decision|0|||
156558950|NCT03502330|565137546|FG008|Overall Study|Physician Decision|0|||
156558951|NCT03502330|565137538|FG000|Overall Study|Withdrawal by Subject|0|||
156558952|NCT03502330|565137539|FG001|Overall Study|Withdrawal by Subject|0|||
156558953|NCT03502330|565137540|FG002|Overall Study|Withdrawal by Subject|0|||
156558954|NCT03502330|565137541|FG003|Overall Study|Withdrawal by Subject|0|||
156558955|NCT03502330|565137542|FG004|Overall Study|Withdrawal by Subject|0|||
156558956|NCT03502330|565137543|FG005|Overall Study|Withdrawal by Subject|1|||
156558957|NCT03502330|565137544|FG006|Overall Study|Withdrawal by Subject|0|||
156558958|NCT03502330|565137545|FG007|Overall Study|Withdrawal by Subject|1|||
156558959|NCT03502330|565137546|FG008|Overall Study|Withdrawal by Subject|0|||
156558960|NCT03502330|565137538|FG000|Overall Study|Death|0|||
156558961|NCT03502330|565137539|FG001|Overall Study|Death|0|||
156558962|NCT03502330|565137540|FG002|Overall Study|Death|0|||
156558963|NCT03502330|565137541|FG003|Overall Study|Death|0|||
156558964|NCT03502330|565137542|FG004|Overall Study|Death|0|||
156558965|NCT03502330|565137543|FG005|Overall Study|Death|0|||
156558966|NCT03502330|565137544|FG006|Overall Study|Death|2|||
156558967|NCT03502330|565137545|FG007|Overall Study|Death|0|||
156558968|NCT03502330|565137546|FG008|Overall Study|Death|0|||
156558969|NCT02804763|565137549|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
156558970|NCT02804763|565137550|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
156558971|NCT02804763|565137551|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
156558972|NCT02804763|565137552|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
156558973|NCT02804763|565137549|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
156558974|NCT02804763|565137550|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
156558975|NCT02804763|565137551|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
156558976|NCT02804763|565137552|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
156558977|NCT02804763|565137549|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
156558978|NCT02804763|565137550|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
156558979|NCT02804763|565137551|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
156558980|NCT02804763|565137552|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
156558981|NCT02804763|565137549|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
156558982|NCT02804763|565137550|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
156558983|NCT02804763|565137551|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
156558984|NCT02804763|565137552|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
156558985|NCT02804763|565137549|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
156558986|NCT02804763|565137550|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
156558987|NCT02804763|565137551|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
156558988|NCT02804763|565137552|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
156558989|NCT02804763|565137549|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
156558990|NCT02804763|565137550|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
156558991|NCT02804763|565137551|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
156558992|NCT02804763|565137552|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
156558993|NCT01400932|565137557|FG000|Overall Study|Adverse Event|10|||
156558994|NCT01400932|565137558|FG001|Overall Study|Adverse Event|5|||
156558995|NCT01400932|565137557|FG000|Overall Study|Lack of Efficacy|0|||
156558996|NCT01400932|565137558|FG001|Overall Study|Lack of Efficacy|3|||
156558997|NCT01400932|565137557|FG000|Overall Study|Withdrawal by Subject|2|||
156558998|NCT01400932|565137558|FG001|Overall Study|Withdrawal by Subject|6|||
156558999|NCT01400932|565137557|FG000|Overall Study|Lost to Follow-up|1|||
156559000|NCT01400932|565137558|FG001|Overall Study|Lost to Follow-up|0|||
156559001|NCT01400932|565137557|FG000|Overall Study|Protocol Deviation|0|||
156513894|NCT04488770|564973892|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513895|NCT04488770|564973893|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513896|NCT04488770|564973894|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
156513897|NCT04488770|564973882|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
156513898|NCT04488770|564973883|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513899|NCT04488770|564973884|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513900|NCT04488770|564973885|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513901|NCT04488770|564973886|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513902|NCT04488770|564973887|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513903|NCT04488770|564973888|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513904|NCT04488770|564973889|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513905|NCT04488770|564973890|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513906|NCT04488770|564973891|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513907|NCT04488770|564973892|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156513908|NCT04488770|564973893|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156559002|NCT01400932|565137558|FG001|Overall Study|Protocol Deviation|1|||
156559003|NCT01400932|565137557|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156559004|NCT01400932|565137558|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
156559005|NCT00860158|565137559|FG000|Overall Study|Study Terminated|1|||
156559006|NCT02472847|565137560|FG000|Overall Study|Withdrawal by Subject|1|||
156559007|NCT02472847|565137561|FG001|Overall Study|Withdrawal by Subject|5|||
156559008|NCT04656990|565137562|FG000|Baseline|pandemic|20|||
156559009|NCT04656990|565137563|FG001|Baseline|pandemic|24|||
156559010|NCT04656990|565137562|FG000|Follow Up Period|Lost to Follow-up|61|||
156559011|NCT04656990|565137563|FG001|Follow Up Period|Lost to Follow-up|73|||
156559012|NCT03244059|565137564|FG000|Specific Aim 1|Physician Decision|1|||
156559013|NCT03244059|565137565|FG001|Specific Aim 1|Physician Decision|0|||
156559014|NCT03244059|565137564|FG000|Specific Aim 2|Physician Decision|1|||
156559015|NCT03244059|565137565|FG001|Specific Aim 2|Physician Decision|0|||
156559016|NCT05499520|565137566|FG000|Overall Study|Lost to Follow-up|0|||
156559017|NCT05499520|565137567|FG001|Overall Study|Lost to Follow-up|0|||
156559018|NCT05499520|565137568|FG002|Overall Study|Lost to Follow-up|38|||
156559019|NCT05499520|565137569|FG003|Overall Study|Lost to Follow-up|41|||
156559020|NCT05499520|565137570|FG004|Overall Study|Lost to Follow-up|46|||
156559021|NCT05499520|565137571|FG005|Overall Study|Lost to Follow-up|0|||
156559022|NCT05499520|565137572|FG006|Overall Study|Lost to Follow-up|31|||
156559023|NCT05499520|565137573|FG007|Overall Study|Lost to Follow-up|45|||
156559024|NCT05499520|565137574|FG008|Overall Study|Lost to Follow-up|42|||
156513909|NCT04488770|564973894|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
156559025|NCT05499520|565137575|FG009|Overall Study|Lost to Follow-up|0|||
156559026|NCT05499520|565137576|FG010|Overall Study|Lost to Follow-up|0|||
156559027|NCT05499520|565137577|FG011|Overall Study|Lost to Follow-up|37|||
156559028|NCT05499520|565137578|FG012|Overall Study|Lost to Follow-up|53|||
156559029|NCT05499520|565137579|FG013|Overall Study|Lost to Follow-up|49|||
156559030|NCT05499520|565137580|FG014|Overall Study|Lost to Follow-up|0|||
156513910|NCT04488770|564973882|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513911|NCT04488770|564973883|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513912|NCT04488770|564973884|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513913|NCT04488770|564973885|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513914|NCT04488770|564973886|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513915|NCT04488770|564973887|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
156513916|NCT04488770|564973888|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
156513917|NCT04488770|564973889|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513918|NCT04488770|564973890|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513919|NCT04488770|564973891|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513920|NCT04488770|564973892|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513921|NCT04488770|564973893|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513922|NCT04488770|564973894|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156513923|NCT04488770|564973882|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513924|NCT04488770|564973883|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513925|NCT04488770|564973884|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513926|NCT04488770|564973885|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513927|NCT04488770|564973886|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
156513928|NCT04488770|564973887|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513929|NCT04488770|564973888|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513930|NCT04488770|564973889|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513931|NCT04488770|564973890|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513932|NCT04488770|564973891|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513933|NCT04488770|564973892|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513934|NCT04488770|564973893|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513935|NCT04488770|564973894|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
156513936|NCT03547739|564973895|FG000|Overall Study|Death|0|||
156513937|NCT03547739|564973896|FG001|Overall Study|Death|1|||
156513938|NCT03547739|564973897|FG002|Overall Study|Death|5|||
156513939|NCT03547739|564973895|FG000|Overall Study|Adverse Event|24|||
156513940|NCT03547739|564973896|FG001|Overall Study|Adverse Event|11|||
156513941|NCT03547739|564973897|FG002|Overall Study|Adverse Event|13|||
156513942|NCT03547739|564973895|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
156513943|NCT03547739|564973896|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
156513944|NCT03547739|564973897|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
156513945|NCT03547739|564973895|FG000|Overall Study|Lost to Follow-up|80|||
156513946|NCT03547739|564973896|FG001|Overall Study|Lost to Follow-up|84|||
156513947|NCT03547739|564973897|FG002|Overall Study|Lost to Follow-up|116|||
156513948|NCT01744392|564973902|FG000|Overall Study|Physician Decision|1|||
156513949|NCT00635661|564973905|FG000|Overall Study|Withdrawal by Subject|4|||
156513950|NCT01696955|564973909|FG000|Main Study|Protocol Violation|1|||
156513951|NCT01696955|564973910|FG001|Main Study|Protocol Violation|0|||
156513952|NCT01696955|564973909|FG000|Main Study|Withdrawal by Subject|1|||
156513953|NCT01696955|564973910|FG001|Main Study|Withdrawal by Subject|1|||
156513954|NCT03192475|564973917|FG000|Overall Study|Death|0|||
156513955|NCT03192475|564973918|FG001|Overall Study|Death|1|||
156513956|NCT03192475|564973917|FG000|Overall Study|Lost to Follow-up|13|||
156513957|NCT03192475|564973918|FG001|Overall Study|Lost to Follow-up|8|||
156513958|NCT01641159|564973919|FG000|Overall Study|Lost to Follow-up|2|||
156513959|NCT01641159|564973920|FG001|Overall Study|Lost to Follow-up|1|||
156513960|NCT01641159|564973919|FG000|Overall Study|Withdrawal by Subject|0|||
156513961|NCT01641159|564973920|FG001|Overall Study|Withdrawal by Subject|1|||
156513962|NCT00798590|564973921|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
156513963|NCT00798590|564973922|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
156513964|NCT03980808|564973923|FG000|Overall Study|Lost to Follow-up|2|||
156513965|NCT03980808|564973924|FG001|Overall Study|Lost to Follow-up|2|||
156513966|NCT00436605|564973927|FG000|Overall Study|Protocol Violation|3|||
156513967|NCT02755818|564973928|FG000|Overall Study|Withdrawal by Subject|0|||
156513968|NCT02755818|564973929|FG001|Overall Study|Withdrawal by Subject|0|||
156513969|NCT02755818|564973930|FG002|Overall Study|Withdrawal by Subject|0|||
156513970|NCT02755818|564973931|FG003|Overall Study|Withdrawal by Subject|2|||
156513971|NCT02755818|564973928|FG000|Overall Study|withdrawal by PI|0|||
156513972|NCT02755818|564973929|FG001|Overall Study|withdrawal by PI|0|||
156513973|NCT02755818|564973930|FG002|Overall Study|withdrawal by PI|1|||
156513974|NCT02755818|564973931|FG003|Overall Study|withdrawal by PI|1|||
156513975|NCT03014011|564973932|FG000|First Intervention|Withdrawal by Subject|1|||
156513976|NCT03014011|564973933|FG001|First Intervention|Withdrawal by Subject|0|||
156559031|NCT05499520|565137581|FG015|Overall Study|Lost to Follow-up|36|||
156559032|NCT05499520|565137582|FG016|Overall Study|Lost to Follow-up|58|||
156559033|NCT05499520|565137583|FG017|Overall Study|Lost to Follow-up|53|||
156559034|NCT00840827|565137585|FG000|Overall Study|Adverse Event|1|||
156559035|NCT00840827|565137585|FG000|Overall Study|Lack of Efficacy|4|||
156559036|NCT00840827|565137585|FG000|Overall Study|Physician Decision|1|||
156559037|NCT05195528|565137586|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
156559038|NCT05195528|565137587|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
156559039|NCT05195528|565137588|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
156559040|NCT05195528|565137589|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
156559041|NCT05195528|565137590|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
156559042|NCT05195528|565137586|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
156559043|NCT05195528|565137587|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
156559044|NCT05195528|565137588|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
156559045|NCT05195528|565137589|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
156559046|NCT05195528|565137590|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
156559047|NCT05195528|565137586|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
156559048|NCT05195528|565137587|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
156559049|NCT05195528|565137588|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
156559050|NCT05195528|565137589|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
156559051|NCT05195528|565137590|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
156559052|NCT05195528|565137586|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
156559053|NCT05195528|565137587|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
156559054|NCT05195528|565137588|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
156559055|NCT05195528|565137589|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
156559056|NCT05195528|565137590|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
156559057|NCT05195528|565137586|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
156559058|NCT05195528|565137587|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
156559059|NCT05195528|565137588|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
156559060|NCT05195528|565137589|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
156559061|NCT05195528|565137590|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
156559062|NCT05195528|565137586|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
156559063|NCT05195528|565137587|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
156559064|NCT05195528|565137588|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
156559065|NCT05195528|565137589|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
156559066|NCT05195528|565137590|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
156559067|NCT05195528|565137586|FG000|Placebo-controlled Treatment Period|Other|0|||
156559068|NCT05195528|565137587|FG001|Placebo-controlled Treatment Period|Other|0|||
156559069|NCT05195528|565137588|FG002|Placebo-controlled Treatment Period|Other|1|||
156559070|NCT05195528|565137589|FG003|Placebo-controlled Treatment Period|Other|0|||
156559071|NCT05195528|565137590|FG004|Placebo-controlled Treatment Period|Other|0|||
156559072|NCT05195528|565137586|FG000|Extension Period|PTE or AE or SAE|0|||
156559073|NCT05195528|565137587|FG001|Extension Period|PTE or AE or SAE|4|||
156559074|NCT05195528|565137588|FG002|Extension Period|PTE or AE or SAE|5|||
156559075|NCT05195528|565137589|FG003|Extension Period|PTE or AE or SAE|4|||
156559076|NCT05195528|565137590|FG004|Extension Period|PTE or AE or SAE|4|||
156559077|NCT05195528|565137586|FG000|Extension Period|Protocol Violation|0|||
156559078|NCT05195528|565137587|FG001|Extension Period|Protocol Violation|2|||
156559079|NCT05195528|565137588|FG002|Extension Period|Protocol Violation|1|||
156559080|NCT05195528|565137589|FG003|Extension Period|Protocol Violation|0|||
156559081|NCT05195528|565137590|FG004|Extension Period|Protocol Violation|1|||
156559082|NCT05195528|565137586|FG000|Extension Period|Lost to Follow-up|0|||
156559083|NCT05195528|565137587|FG001|Extension Period|Lost to Follow-up|6|||
156559084|NCT05195528|565137588|FG002|Extension Period|Lost to Follow-up|13|||
156559085|NCT05195528|565137589|FG003|Extension Period|Lost to Follow-up|3|||
156559086|NCT05195528|565137590|FG004|Extension Period|Lost to Follow-up|7|||
156559087|NCT05195528|565137586|FG000|Extension Period|Withdrawal by Subject|0|||
156559088|NCT05195528|565137587|FG001|Extension Period|Withdrawal by Subject|12|||
156559089|NCT05195528|565137588|FG002|Extension Period|Withdrawal by Subject|9|||
156559090|NCT05195528|565137589|FG003|Extension Period|Withdrawal by Subject|6|||
156559091|NCT05195528|565137590|FG004|Extension Period|Withdrawal by Subject|5|||
156559092|NCT05195528|565137586|FG000|Extension Period|Lack of Efficacy|0|||
156559093|NCT05195528|565137587|FG001|Extension Period|Lack of Efficacy|3|||
156559094|NCT05195528|565137588|FG002|Extension Period|Lack of Efficacy|0|||
156559095|NCT05195528|565137589|FG003|Extension Period|Lack of Efficacy|0|||
156559096|NCT05195528|565137590|FG004|Extension Period|Lack of Efficacy|2|||
156559097|NCT05195528|565137586|FG000|Extension Period|Not Treated|0|||
156559098|NCT05195528|565137587|FG001|Extension Period|Not Treated|0|||
156559099|NCT05195528|565137588|FG002|Extension Period|Not Treated|2|||
156559100|NCT05195528|565137589|FG003|Extension Period|Not Treated|3|||
156559101|NCT05195528|565137590|FG004|Extension Period|Not Treated|0|||
156559102|NCT05195528|565137586|FG000|Extension Period|Other|0|||
156559103|NCT05195528|565137587|FG001|Extension Period|Other|1|||
156559104|NCT05195528|565137588|FG002|Extension Period|Other|1|||
156559105|NCT05195528|565137589|FG003|Extension Period|Other|0|||
156559106|NCT05195528|565137590|FG004|Extension Period|Other|0|||
156559107|NCT01552902|565137591|FG000|Overall Study|Adverse Event|1|||
156559108|NCT01552902|565137592|FG001|Overall Study|Adverse Event|15|||
156559109|NCT01552902|565137593|FG002|Overall Study|Adverse Event|14|||
156559110|NCT01552902|565137591|FG000|Overall Study|Protocol Violation|3|||
156559111|NCT01552902|565137592|FG001|Overall Study|Protocol Violation|3|||
156559112|NCT01552902|565137593|FG002|Overall Study|Protocol Violation|3|||
156559113|NCT01552902|565137591|FG000|Overall Study|Lack of Efficacy|4|||
156559114|NCT01552902|565137592|FG001|Overall Study|Lack of Efficacy|3|||
156559115|NCT01552902|565137593|FG002|Overall Study|Lack of Efficacy|1|||
156559116|NCT01552902|565137591|FG000|Overall Study|Withdrawal by Subject|1|||
156559117|NCT01552902|565137592|FG001|Overall Study|Withdrawal by Subject|9|||
156559118|NCT01552902|565137593|FG002|Overall Study|Withdrawal by Subject|6|||
156559119|NCT01552902|565137591|FG000|Overall Study|Lost to Follow-up|1|||
156559120|NCT01552902|565137592|FG001|Overall Study|Lost to Follow-up|3|||
156559121|NCT01552902|565137593|FG002|Overall Study|Lost to Follow-up|6|||
156559122|NCT01552902|565137591|FG000|Overall Study|Other|3|||
156559123|NCT01552902|565137592|FG001|Overall Study|Other|4|||
156559124|NCT01552902|565137593|FG002|Overall Study|Other|3|||
156559125|NCT00883493|565137594|FG000|Overall Study|Adverse Event|11|||
156559126|NCT00883493|565137595|FG001|Overall Study|Adverse Event|12|||
156559127|NCT00883493|565137594|FG000|Overall Study|Lack of Efficacy|4|||
156559128|NCT00883493|565137595|FG001|Overall Study|Lack of Efficacy|3|||
156559129|NCT00883493|565137594|FG000|Overall Study|Lost to Follow-up|7|||
156559130|NCT00883493|565137595|FG001|Overall Study|Lost to Follow-up|6|||
156559131|NCT00883493|565137594|FG000|Overall Study|Withdrawal by Subject|11|||
156559132|NCT00883493|565137595|FG001|Overall Study|Withdrawal by Subject|20|||
156559133|NCT00883493|565137594|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
156559134|NCT00883493|565137595|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
156559135|NCT00883493|565137594|FG000|Overall Study|Study specific disc. criteria|2|||
156559136|NCT00883493|565137595|FG001|Overall Study|Study specific disc. criteria|0|||
156559137|NCT00883493|565137594|FG000|Overall Study|Other|5|||
156559138|NCT00883493|565137595|FG001|Overall Study|Other|3|||
156559139|NCT00168831|565137597|FG000|Overall Study|Adverse Event|36|||
156559140|NCT00168831|565137598|FG001|Overall Study|Adverse Event|47|||
156559141|NCT00168831|565137599|FG002|Overall Study|Adverse Event|74|||
156559142|NCT00168831|565137597|FG000|Overall Study|Lost to Follow-up|5|||
156559143|NCT00168831|565137598|FG001|Overall Study|Lost to Follow-up|6|||
156559144|NCT00168831|565137599|FG002|Overall Study|Lost to Follow-up|4|||
156559145|NCT00168831|565137597|FG000|Overall Study|Withdrawal by Subject|7|||
156559146|NCT00168831|565137598|FG001|Overall Study|Withdrawal by Subject|14|||
156559147|NCT00168831|565137599|FG002|Overall Study|Withdrawal by Subject|19|||
156559148|NCT00168831|565137597|FG000|Overall Study|Protocol Violation|6|||
156559149|NCT00168831|565137598|FG001|Overall Study|Protocol Violation|11|||
156559150|NCT00168831|565137599|FG002|Overall Study|Protocol Violation|11|||
156559151|NCT00168831|565137597|FG000|Overall Study|Other|6|||
156559152|NCT00168831|565137598|FG001|Overall Study|Other|3|||
156559153|NCT00168831|565137599|FG002|Overall Study|Other|6|||
156559154|NCT01505894|565137600|FG000|Overall Study|Adverse Event|1|||
156559155|NCT01505894|565137601|FG001|Overall Study|Adverse Event|0|||
156559156|NCT01505894|565137602|FG002|Overall Study|Adverse Event|0|||
156559157|NCT01505894|565137603|FG003|Overall Study|Adverse Event|0|||
156559158|NCT01505894|565137604|FG004|Overall Study|Adverse Event|0|||
156559159|NCT01505894|565137605|FG005|Overall Study|Adverse Event|0|||
156559160|NCT01505894|565137606|FG006|Overall Study|Adverse Event|0|||
156559161|NCT01505894|565137607|FG007|Overall Study|Adverse Event|0|||
156559162|NCT01505894|565137608|FG008|Overall Study|Adverse Event|0|||
156559163|NCT01505894|565137600|FG000|Overall Study|Other than specified|0|||
156559164|NCT01505894|565137601|FG001|Overall Study|Other than specified|0|||
156559165|NCT01505894|565137602|FG002|Overall Study|Other than specified|0|||
156559166|NCT01505894|565137603|FG003|Overall Study|Other than specified|0|||
156559167|NCT01505894|565137604|FG004|Overall Study|Other than specified|1|||
156559168|NCT01505894|565137605|FG005|Overall Study|Other than specified|0|||
156559169|NCT01505894|565137606|FG006|Overall Study|Other than specified|0|||
156559170|NCT01505894|565137607|FG007|Overall Study|Other than specified|0|||
156559171|NCT01505894|565137608|FG008|Overall Study|Other than specified|0|||
156559172|NCT01622569|565137609|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
156559173|NCT01622569|565137610|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
156559174|NCT01622569|565137611|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
156559175|NCT01622569|565137612|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
156559176|NCT01622569|565137609|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
156559177|NCT01622569|565137610|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
156559178|NCT01622569|565137611|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
156559179|NCT01622569|565137612|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
156559180|NCT01622569|565137609|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
156559181|NCT01622569|565137610|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
156559182|NCT01622569|565137611|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
156559183|NCT01622569|565137612|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
156559184|NCT01622569|565137609|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
156559185|NCT01622569|565137610|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
156559186|NCT01622569|565137611|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
156559187|NCT01622569|565137612|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
156559188|NCT01622569|565137609|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
156559189|NCT01622569|565137610|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
156559190|NCT01622569|565137611|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
156559191|NCT01622569|565137612|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
156559192|NCT01622569|565137609|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
156559193|NCT01622569|565137610|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
156559194|NCT01622569|565137611|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
156559195|NCT01622569|565137612|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
156559196|NCT01622569|565137609|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
156559197|NCT01622569|565137610|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
156559198|NCT01622569|565137611|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
156559199|NCT01622569|565137612|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
156559200|NCT01622569|565137609|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
156559201|NCT01622569|565137610|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
156559202|NCT01622569|565137611|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
156559203|NCT01622569|565137612|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
156559204|NCT04173741|565137613|FG000|Overall Study|IVC measurement cannot be done|1|||
156559205|NCT04173741|565137614|FG001|Overall Study|IVC measurement cannot be done|1|||
156559206|NCT00059202|565137615|FG000|Overall Study|Withdrawal by Subject|5|||
156559207|NCT00059202|565137616|FG001|Overall Study|Withdrawal by Subject|9|||
156559208|NCT00059202|565137615|FG000|Overall Study|Protocol Violation|1|||
156559209|NCT00059202|565137616|FG001|Overall Study|Protocol Violation|3|||
156559210|NCT00059202|565137615|FG000|Overall Study|drug toxicity|0|||
156559211|NCT00059202|565137616|FG001|Overall Study|drug toxicity|3|||
156559212|NCT01940484|565137619|FG000|Overall Study|Withdrawal by Subject|3|||
156559213|NCT01940484|565137619|FG000|Overall Study|Underwent transplantation|4|||
156559214|NCT01940484|565137619|FG000|Overall Study|Death|2|||
156559215|NCT01940484|565137619|FG000|Overall Study|Adverse Event|1|||
156559216|NCT02288247|565137620|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
156559217|NCT02288247|565137621|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
156559218|NCT02288247|565137620|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
156559219|NCT02288247|565137621|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
156559220|NCT02288247|565137620|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
156559221|NCT02288247|565137621|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
156559222|NCT02288247|565137620|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
156559223|NCT02288247|565137621|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
156559224|NCT02288247|565137620|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
156559225|NCT02288247|565137621|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
156559226|NCT02288247|565137620|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
156559227|NCT02288247|565137621|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
156559228|NCT02288247|565137620|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
156559229|NCT02288247|565137621|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
156559230|NCT02288247|565137620|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
156559231|NCT02288247|565137621|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
156559232|NCT02288247|565137620|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
156559233|NCT02288247|565137621|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
156559234|NCT02288247|565137620|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
156559235|NCT02288247|565137621|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
156559236|NCT02288247|565137620|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
156559237|NCT02288247|565137621|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
156559238|NCT02288247|565137620|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
156559239|NCT02288247|565137621|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
156559240|NCT02288247|565137620|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
156559241|NCT02288247|565137621|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
156559242|NCT02288247|565137620|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
156559243|NCT02288247|565137621|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
156559244|NCT02288247|565137620|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
156559245|NCT02288247|565137621|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
156559246|NCT02288247|565137620|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
156559247|NCT02288247|565137621|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
156559248|NCT04652804|565137622|FG000|Overall Study|Ineligible post randomization|1|||
156559249|NCT04652804|565137623|FG001|Overall Study|Ineligible post randomization|0|||
156559250|NCT04652804|565137624|FG002|Overall Study|Ineligible post randomization|1|||
156559251|NCT04652804|565137625|FG003|Overall Study|Ineligible post randomization|0|||
156559252|NCT04652804|565137626|FG004|Overall Study|Ineligible post randomization|1|||
156559253|NCT04652804|565137627|FG005|Overall Study|Ineligible post randomization|1|||
156559254|NCT04652804|565137622|FG000|Overall Study|Missing SVR lab results|2|||
156559255|NCT04652804|565137623|FG001|Overall Study|Missing SVR lab results|0|||
156559256|NCT04652804|565137624|FG002|Overall Study|Missing SVR lab results|0|||
156559257|NCT04652804|565137625|FG003|Overall Study|Missing SVR lab results|0|||
156559258|NCT04652804|565137626|FG004|Overall Study|Missing SVR lab results|0|||
156559259|NCT04652804|565137627|FG005|Overall Study|Missing SVR lab results|0|||
156559260|NCT00584194|565137628|FG000|Overall Study|Other|135|||
156559261|NCT00648167|565137629|FG000|Overall Study|Adverse Event|6|||
156559262|NCT00648167|565137629|FG000|Overall Study|unable to swallow tablets|1|||
156559263|NCT00927368|565137630|FG000|Overall Study|enrollment in another study|1|||
156559264|NCT00927368|565137631|FG001|Overall Study|enrollment in another study|1|||
156559265|NCT00927368|565137632|FG002|Overall Study|enrollment in another study|2|||
156559266|NCT00927368|565137630|FG000|Overall Study|Lost to Follow-up|4|||
156559267|NCT00927368|565137631|FG001|Overall Study|Lost to Follow-up|0|||
156559268|NCT00927368|565137632|FG002|Overall Study|Lost to Follow-up|0|||
156559269|NCT00927368|565137630|FG000|Overall Study|equipment failure|1|||
156559270|NCT00927368|565137631|FG001|Overall Study|equipment failure|0|||
156559271|NCT00927368|565137632|FG002|Overall Study|equipment failure|0|||
156559272|NCT00927368|565137630|FG000|Overall Study|ineligible post randomization|0|||
156559273|NCT00927368|565137631|FG001|Overall Study|ineligible post randomization|3|||
156559274|NCT00927368|565137632|FG002|Overall Study|ineligible post randomization|1|||
156559275|NCT00927368|565137630|FG000|Overall Study|cancellation of surgery|0|||
156559276|NCT00927368|565137631|FG001|Overall Study|cancellation of surgery|1|||
156559277|NCT00927368|565137632|FG002|Overall Study|cancellation of surgery|2|||
156559278|NCT01482910|565137639|FG000|Overall Study|Adverse Event|6|||
156559279|NCT01482910|565137640|FG001|Overall Study|Adverse Event|5|||
156559280|NCT01482910|565137639|FG000|Overall Study|Lost to Follow-up|0|||
156559281|NCT01482910|565137640|FG001|Overall Study|Lost to Follow-up|1|||
156559282|NCT01482910|565137639|FG000|Overall Study|Protocol Violation|1|||
156559283|NCT01482910|565137640|FG001|Overall Study|Protocol Violation|1|||
156559284|NCT01482910|565137639|FG000|Overall Study|Withdrawal by Subject|7|||
156559285|NCT01482910|565137640|FG001|Overall Study|Withdrawal by Subject|2|||
156559286|NCT01482910|565137639|FG000|Overall Study|Death|1|||
156559287|NCT01482910|565137640|FG001|Overall Study|Death|0|||
156559288|NCT00331409|565137642|FG000|Overall Study|Lack of Efficacy|4|||
156559289|NCT03222349|565137645|FG000|Overall Study|Treatment B not done|5|||
156559290|NCT03222349|565137646|FG001|Overall Study|Treatment B not done|0|||
156559291|NCT03222349|565137645|FG000|Overall Study|Lost to Follow-up|1|||
156559292|NCT03222349|565137646|FG001|Overall Study|Lost to Follow-up|2|||
156559293|NCT03222349|565137645|FG000|Overall Study|Withdrawal by Subject|1|||
156559294|NCT03222349|565137646|FG001|Overall Study|Withdrawal by Subject|0|||
156559295|NCT03222349|565137645|FG000|Overall Study|Treatment A not done|0|||
156559296|NCT03222349|565137646|FG001|Overall Study|Treatment A not done|5|||
156559297|NCT03222349|565137645|FG000|Overall Study|Study terminated by sponsor|1|||
156559298|NCT03222349|565137646|FG001|Overall Study|Study terminated by sponsor|0|||
156559299|NCT03739528|565137649|FG000|Overall Study|Not treated|8|||
156559300|NCT03739528|565137650|FG001|Overall Study|Not treated|12|||
156559301|NCT03739528|565137649|FG000|Overall Study|Treatment and study discontinued|6|||
156559302|NCT03739528|565137650|FG001|Overall Study|Treatment and study discontinued|2|||
156559303|NCT03739528|565137649|FG000|Overall Study|Treatment discontinued + study completed|1|||
156559304|NCT03739528|565137650|FG001|Overall Study|Treatment discontinued + study completed|3|||
156559305|NCT01109940|565137653|FG000|Overall Study|Administrative problems|2|||
156559306|NCT01109940|565137654|FG001|Overall Study|Administrative problems|0|||
156559307|NCT01109940|565137655|FG002|Overall Study|Administrative problems|0|||
156559308|NCT01109940|565137656|FG003|Overall Study|Administrative problems|0|||
156559309|NCT01109940|565137653|FG000|Overall Study|Serious Adverse Event|2|||
156559310|NCT01109940|565137654|FG001|Overall Study|Serious Adverse Event|1|||
156559311|NCT01109940|565137655|FG002|Overall Study|Serious Adverse Event|0|||
156559312|NCT01109940|565137656|FG003|Overall Study|Serious Adverse Event|0|||
156559313|NCT01109940|565137653|FG000|Overall Study|Lost to Follow-up|1|||
156559314|NCT01109940|565137654|FG001|Overall Study|Lost to Follow-up|0|||
156559315|NCT01109940|565137655|FG002|Overall Study|Lost to Follow-up|0|||
156559316|NCT01109940|565137656|FG003|Overall Study|Lost to Follow-up|0|||
156559317|NCT01109940|565137653|FG000|Overall Study|Patient withdrew consent|1|||
156559318|NCT01109940|565137654|FG001|Overall Study|Patient withdrew consent|1|||
156559319|NCT01109940|565137655|FG002|Overall Study|Patient withdrew consent|0|||
156559320|NCT01109940|565137656|FG003|Overall Study|Patient withdrew consent|0|||
156559321|NCT01109940|565137653|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156559322|NCT01109940|565137654|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156559323|NCT01109940|565137655|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
156559324|NCT01109940|565137656|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156559325|NCT02769624|565137657|FG000|Overall Study|Lost to Follow-up|0|||
156559326|NCT02769624|565137658|FG001|Overall Study|Lost to Follow-up|1|||
156559327|NCT05099640|565137659|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
156559328|NCT05099640|565137660|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
156559329|NCT05099640|565137661|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
156559330|NCT05099640|565137659|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
156559331|NCT05099640|565137660|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
156559332|NCT05099640|565137661|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
156559333|NCT05099640|565137659|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
156559334|NCT05099640|565137660|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
156559335|NCT05099640|565137661|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
156559336|NCT05099640|565137659|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
156559337|NCT05099640|565137660|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
156559338|NCT05099640|565137661|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
156559339|NCT05099640|565137659|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
156559340|NCT05099640|565137660|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
156559341|NCT05099640|565137661|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
156559342|NCT05099640|565137659|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
156559343|NCT05099640|565137660|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
156559344|NCT05099640|565137661|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
156559345|NCT00179959|565137662|FG000|Overall Study|Lost to Follow-up|3|||
156559346|NCT00179959|565137663|FG001|Overall Study|Lost to Follow-up|1|||
156559347|NCT00179959|565137662|FG000|Overall Study|Withdrawal by Subject|3|||
156559348|NCT00179959|565137663|FG001|Overall Study|Withdrawal by Subject|2|||
156559349|NCT01552681|565137664|FG000|Overall Study|Withdrawal by Subject|4|||
156559350|NCT01552681|565137665|FG001|Overall Study|Withdrawal by Subject|0|||
156559351|NCT01552681|565137664|FG000|Overall Study|Physician Decision|1|||
156559352|NCT01552681|565137665|FG001|Overall Study|Physician Decision|0|||
156559353|NCT01552681|565137664|FG000|Overall Study|Subject moved away|0|||
156559354|NCT01552681|565137665|FG001|Overall Study|Subject moved away|1|||
156559355|NCT03075163|565137666|FG000|Overall Study|not eligible for treatment limb|138|||
156559356|NCT03075163|565137667|FG001|Overall Study|not eligible for treatment limb|138|||
156559357|NCT01961544|565137668|FG000|Overall Study|Protocol Violation|1|||
156559358|NCT01961544|565137668|FG000|Overall Study|Withdrawal by Subject|7|||
156559359|NCT01961544|565137668|FG000|Overall Study|Adverse Event|1|||
156559360|NCT01961544|565137668|FG000|Overall Study|Physician Decision|2|||
156559361|NCT01961544|565137668|FG000|Overall Study|Poor Tolerance|1|||
156559362|NCT01961544|565137668|FG000|Overall Study|Aggravation of Steral Pain|1|||
156559363|NCT03665285|565137671|FG000|Overall Study|Started New Anticancer Treatment|1|||
156559364|NCT03665285|565137672|FG001|Overall Study|Started New Anticancer Treatment|1|||
156559365|NCT03665285|565137673|FG002|Overall Study|Started New Anticancer Treatment|2|||
156559366|NCT03665285|565137674|FG003|Overall Study|Started New Anticancer Treatment|4|||
156559367|NCT03665285|565137675|FG004|Overall Study|Started New Anticancer Treatment|1|||
156559368|NCT03665285|565137676|FG005|Overall Study|Started New Anticancer Treatment|1|||
156559369|NCT03665285|565137677|FG006|Overall Study|Started New Anticancer Treatment|2|||
156559370|NCT03665285|565137678|FG007|Overall Study|Started New Anticancer Treatment|15|||
156559371|NCT03665285|565137679|FG008|Overall Study|Started New Anticancer Treatment|1|||
156559372|NCT03665285|565137671|FG000|Overall Study|Disease Progression|0|||
156559373|NCT03665285|565137672|FG001|Overall Study|Disease Progression|0|||
156559374|NCT03665285|565137673|FG002|Overall Study|Disease Progression|3|||
156559375|NCT03665285|565137674|FG003|Overall Study|Disease Progression|1|||
156559376|NCT03665285|565137675|FG004|Overall Study|Disease Progression|0|||
156559377|NCT03665285|565137676|FG005|Overall Study|Disease Progression|0|||
156559378|NCT03665285|565137677|FG006|Overall Study|Disease Progression|0|||
156559379|NCT03665285|565137678|FG007|Overall Study|Disease Progression|7|||
156559380|NCT03665285|565137679|FG008|Overall Study|Disease Progression|1|||
156559381|NCT03665285|565137671|FG000|Overall Study|Hospice|0|||
156559382|NCT03665285|565137672|FG001|Overall Study|Hospice|0|||
156559383|NCT03665285|565137673|FG002|Overall Study|Hospice|0|||
156559384|NCT03665285|565137674|FG003|Overall Study|Hospice|0|||
156559385|NCT03665285|565137675|FG004|Overall Study|Hospice|0|||
156559386|NCT03665285|565137676|FG005|Overall Study|Hospice|0|||
156559387|NCT03665285|565137677|FG006|Overall Study|Hospice|0|||
156559388|NCT03665285|565137678|FG007|Overall Study|Hospice|2|||
156559389|NCT03665285|565137679|FG008|Overall Study|Hospice|0|||
156559390|NCT03665285|565137671|FG000|Overall Study|Withdrawal by Subject|0|||
156559391|NCT03665285|565137672|FG001|Overall Study|Withdrawal by Subject|0|||
156559392|NCT03665285|565137673|FG002|Overall Study|Withdrawal by Subject|0|||
156559393|NCT03665285|565137674|FG003|Overall Study|Withdrawal by Subject|0|||
156559394|NCT03665285|565137675|FG004|Overall Study|Withdrawal by Subject|1|||
156559395|NCT03665285|565137676|FG005|Overall Study|Withdrawal by Subject|0|||
156559396|NCT03665285|565137677|FG006|Overall Study|Withdrawal by Subject|0|||
156559397|NCT03665285|565137678|FG007|Overall Study|Withdrawal by Subject|2|||
156559398|NCT03665285|565137679|FG008|Overall Study|Withdrawal by Subject|0|||
156559399|NCT03665285|565137671|FG000|Overall Study|Physician Decision|0|||
156559400|NCT03665285|565137672|FG001|Overall Study|Physician Decision|0|||
156513977|NCT03014011|564973932|FG000|Washout|Withdrawal by Subject|1|||
156513978|NCT03014011|564973933|FG001|Washout|Withdrawal by Subject|0|||
156513979|NCT00573859|564973938|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
156513980|NCT00573859|564973938|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
156513981|NCT01152814|564973939|FG000|Overall Study|Lost to Follow-up|2|||
156513982|NCT01280357|564973940|FG000|Overall Study|Excluded no internal monitoring|14|||
156513983|NCT01280357|564973940|FG000|Overall Study|IInsufficient data/No data supplied|12|||
156513984|NCT03284203|564973941|FG000|Overall Study|Lost to Follow-up|3|||
156513985|NCT00992225|564973942|FG000|Overall Study|Entry Criteria Not Met|8|||
156513986|NCT00992225|564973942|FG000|Overall Study|Adverse Event|2|||
156513987|NCT03466073|564973943|FG000|Overall Study|Death|1|||
156513988|NCT03466073|564973944|FG001|Overall Study|Death|0|||
156513989|NCT03466073|564973945|FG002|Overall Study|Death|0|||
156513990|NCT03466073|564973946|FG003|Overall Study|Death|0|||
156513991|NCT03466073|564973947|FG004|Overall Study|Death|0|||
156513992|NCT03466073|564973948|FG005|Overall Study|Death|1|||
156513993|NCT00744757|564973949|FG000|Overall Study|Objective disease progression|7|||
156513994|NCT00744757|564973949|FG000|Overall Study|Physician Decision|5|||
156513995|NCT00744757|564973949|FG000|Overall Study|Withdrawal by Subject|1|||
156513996|NCT00744757|564973949|FG000|Overall Study|Death|6|||
156513997|NCT00744757|564973949|FG000|Overall Study|Adverse Event|2|||
156513998|NCT00532493|564973950|FG000|Overall Study|Death|1|||
156513999|NCT00532493|564973951|FG001|Overall Study|Death|1|||
156514000|NCT00532493|564973950|FG000|Overall Study|Lost to Follow-up|10|||
156514001|NCT00532493|564973951|FG001|Overall Study|Lost to Follow-up|7|||
156514002|NCT00532493|564973950|FG000|Overall Study|Withdrawal by Subject|7|||
156514003|NCT00532493|564973951|FG001|Overall Study|Withdrawal by Subject|9|||
156514004|NCT00532493|564973950|FG000|Overall Study|Physician Decision|1|||
156514005|NCT00532493|564973951|FG001|Overall Study|Physician Decision|6|||
156514006|NCT00532493|564973950|FG000|Overall Study|Adverse Event|6|||
156514007|NCT00532493|564973951|FG001|Overall Study|Adverse Event|5|||
156514008|NCT00532493|564973950|FG000|Overall Study|Protocol Deviation|1|||
156514009|NCT00532493|564973951|FG001|Overall Study|Protocol Deviation|0|||
156514010|NCT00532493|564973950|FG000|Overall Study|Subject Moved Away|3|||
156514011|NCT00532493|564973951|FG001|Overall Study|Subject Moved Away|1|||
156514012|NCT00532493|564973950|FG000|Overall Study|Contraindicative Medication|1|||
156514013|NCT00532493|564973951|FG001|Overall Study|Contraindicative Medication|0|||
156514014|NCT02045875|564973955|FG000|Overall Study|Lost to Follow-up|3|||
156514015|NCT02045875|564973956|FG001|Overall Study|Lost to Follow-up|0|||
156514016|NCT02045875|564973955|FG000|Overall Study|Withdrawal by Subject|4|||
156514017|NCT02045875|564973956|FG001|Overall Study|Withdrawal by Subject|3|||
156514018|NCT05384938|564973960|FG000|Overall Study|Withdrawal by Subject|8|||
156514019|NCT05384938|564973960|FG000|Overall Study|Lost to Follow-up|6|||
156514020|NCT05384938|564973960|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
156514021|NCT06665919|564973961|FG000|Overall Study|Withdrawal by Subject|4|||
156514022|NCT06665919|564973962|FG001|Overall Study|Withdrawal by Subject|4|||
156514023|NCT06665919|564973963|FG002|Overall Study|Withdrawal by Subject|4|||
156514024|NCT06665919|564973961|FG000|Overall Study|Non-compliance to Treatment|4|||
156514025|NCT06665919|564973962|FG001|Overall Study|Non-compliance to Treatment|1|||
156514026|NCT06665919|564973963|FG002|Overall Study|Non-compliance to Treatment|6|||
156514027|NCT06665919|564973961|FG000|Overall Study|Lost to Follow-up|3|||
156514028|NCT06665919|564973962|FG001|Overall Study|Lost to Follow-up|0|||
156514029|NCT06665919|564973963|FG002|Overall Study|Lost to Follow-up|2|||
156514030|NCT06665919|564973961|FG000|Overall Study|Physician Decision|4|||
156514031|NCT06665919|564973962|FG001|Overall Study|Physician Decision|0|||
156514032|NCT06665919|564973963|FG002|Overall Study|Physician Decision|1|||
156514033|NCT00775463|564976022|FG000|Overall Study|Withdrawal by Subject|0|||
156514034|NCT00775463|564976023|FG001|Overall Study|Withdrawal by Subject|1|||
156514035|NCT00775463|564976022|FG000|Overall Study|Adverse Event|7|||
156514036|NCT00775463|564976023|FG001|Overall Study|Adverse Event|9|||
156514037|NCT00775463|564976022|FG000|Overall Study|Protocol Violation|2|||
156514038|NCT00775463|564976023|FG001|Overall Study|Protocol Violation|2|||
156514039|NCT00775463|564976022|FG000|Overall Study|Lost to Follow-up|1|||
156514040|NCT00775463|564976023|FG001|Overall Study|Lost to Follow-up|0|||
156514041|NCT00775463|564976022|FG000|Overall Study|Lack of Efficacy|1|||
156514042|NCT00775463|564976023|FG001|Overall Study|Lack of Efficacy|1|||
156514043|NCT02980731|564976024|FG000|Overall Study|Death|63|||
156514044|NCT02980731|564976024|FG000|Overall Study|Withdrawal by Subject|6|||
156514045|NCT02980731|564976024|FG000|Overall Study|Lost to Follow-up|5|||
156514046|NCT02980731|564976024|FG000|Overall Study|Study terminated by Sponsor|4|||
156863409|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
156514047|NCT02980731|564976024|FG000|Overall Study|Completed survival follow-up period|65|||
156514048|NCT02980731|564976024|FG000|Overall Study|COVID-19 infection|1|||
156514049|NCT02980731|564976024|FG000|Overall Study|Other, not specified|66|||
156514050|NCT01789567|564976026|FG000|Overall Study|Death|6|||
156514051|NCT02731690|564976029|FG000|Overall Study|Adverse Event|1|||
156514052|NCT02731690|564976029|FG000|Overall Study|Withdrawal by Subject|3|||
156514053|NCT02731690|564976029|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
156514054|NCT00872989|564976030|FG000|Overall Study|Adverse Event|7|||
156514055|NCT00872989|564976031|FG001|Overall Study|Adverse Event|15|||
156514056|NCT00872989|564976030|FG000|Overall Study|Withdrawal by Subject|8|||
156514057|NCT00872989|564976031|FG001|Overall Study|Withdrawal by Subject|5|||
156514058|NCT00872989|564976030|FG000|Overall Study|Progression/relapse|47|||
156514059|NCT00872989|564976031|FG001|Overall Study|Progression/relapse|35|||
156514060|NCT00872989|564976030|FG000|Overall Study|Not protocol specified|3|||
156514061|NCT00872989|564976031|FG001|Overall Study|Not protocol specified|8|||
156514062|NCT00307684|564976037|FG000|Open Label Phase|Lack of Efficacy|0|||
156514063|NCT00307684|564976038|FG001|Open Label Phase|Lack of Efficacy|0|||
156514064|NCT00307684|564976039|FG002|Open Label Phase|Lack of Efficacy|3|||
156514065|NCT00307684|564976037|FG000|Open Label Phase|Adverse Event|0|||
156514066|NCT00307684|564976038|FG001|Open Label Phase|Adverse Event|0|||
156514067|NCT00307684|564976039|FG002|Open Label Phase|Adverse Event|16|||
156514068|NCT00307684|564976037|FG000|Open Label Phase|Withdrawal by Subject|0|||
156514069|NCT00307684|564976038|FG001|Open Label Phase|Withdrawal by Subject|0|||
156514070|NCT00307684|564976039|FG002|Open Label Phase|Withdrawal by Subject|15|||
156514071|NCT00307684|564976037|FG000|Open Label Phase|Lost to Follow-up|0|||
156514072|NCT00307684|564976038|FG001|Open Label Phase|Lost to Follow-up|0|||
156514073|NCT00307684|564976039|FG002|Open Label Phase|Lost to Follow-up|11|||
156514074|NCT00307684|564976037|FG000|Open Label Phase|non compliance|0|||
156514075|NCT00307684|564976038|FG001|Open Label Phase|non compliance|0|||
156514076|NCT00307684|564976039|FG002|Open Label Phase|non compliance|5|||
156514077|NCT00307684|564976037|FG000|Open Label Phase|other|0|||
156514078|NCT00307684|564976038|FG001|Open Label Phase|other|0|||
156514079|NCT00307684|564976039|FG002|Open Label Phase|other|6|||
156514080|NCT00307684|564976037|FG000|Double Blind Phase|Lack of Efficacy|2|||
156514081|NCT00307684|564976038|FG001|Double Blind Phase|Lack of Efficacy|5|||
156514082|NCT00307684|564976039|FG002|Double Blind Phase|Lack of Efficacy|0|||
156514083|NCT00224887|564976040|FG000|Overall Study|Pregnancy|6|||
156514084|NCT00224887|564976041|FG001|Overall Study|Pregnancy|6|||
156514085|NCT00299494|564976049|FG000|Overall Study|Withdrawal by Subject|0|||
156514086|NCT00299494|564976050|FG001|Overall Study|Withdrawal by Subject|0|||
156514087|NCT00299494|564976051|FG002|Overall Study|Withdrawal by Subject|0|||
156514088|NCT00299494|564976052|FG003|Overall Study|Withdrawal by Subject|3|||
156514089|NCT00299494|564976053|FG004|Overall Study|Withdrawal by Subject|1|||
156514090|NCT00299494|564976054|FG005|Overall Study|Withdrawal by Subject|4|||
156514091|NCT00299494|564976049|FG000|Overall Study|Physician Decision|0|||
156514092|NCT00299494|564976050|FG001|Overall Study|Physician Decision|0|||
156514093|NCT00299494|564976051|FG002|Overall Study|Physician Decision|0|||
156514094|NCT00299494|564976052|FG003|Overall Study|Physician Decision|0|||
156514095|NCT00299494|564976053|FG004|Overall Study|Physician Decision|1|||
156514096|NCT00299494|564976054|FG005|Overall Study|Physician Decision|0|||
156514097|NCT00299494|564976049|FG000|Overall Study|Death|3|||
156514098|NCT00299494|564976050|FG001|Overall Study|Death|1|||
156514099|NCT00299494|564976051|FG002|Overall Study|Death|4|||
156514100|NCT00299494|564976052|FG003|Overall Study|Death|6|||
156514101|NCT00299494|564976053|FG004|Overall Study|Death|18|||
156514102|NCT00299494|564976054|FG005|Overall Study|Death|19|||
156514103|NCT00299494|564976049|FG000|Overall Study|Lost to Follow-up|0|||
156514104|NCT00299494|564976050|FG001|Overall Study|Lost to Follow-up|0|||
156514105|NCT00299494|564976051|FG002|Overall Study|Lost to Follow-up|0|||
156514106|NCT00299494|564976052|FG003|Overall Study|Lost to Follow-up|0|||
156514107|NCT00299494|564976053|FG004|Overall Study|Lost to Follow-up|3|||
156514108|NCT00299494|564976054|FG005|Overall Study|Lost to Follow-up|1|||
156514109|NCT00299494|564976049|FG000|Overall Study|Other - Unspecified|0|||
156514110|NCT00299494|564976050|FG001|Overall Study|Other - Unspecified|0|||
156514111|NCT00299494|564976051|FG002|Overall Study|Other - Unspecified|0|||
156514112|NCT00299494|564976052|FG003|Overall Study|Other - Unspecified|0|||
156514113|NCT00299494|564976053|FG004|Overall Study|Other - Unspecified|3|||
156514114|NCT00299494|564976054|FG005|Overall Study|Other - Unspecified|1|||
156514115|NCT00299494|564976049|FG000|Overall Study|Other - site closure|0|||
156514116|NCT00299494|564976050|FG001|Overall Study|Other - site closure|0|||
156514117|NCT00299494|564976051|FG002|Overall Study|Other - site closure|0|||
156514118|NCT00299494|564976052|FG003|Overall Study|Other - site closure|1|||
156514119|NCT00299494|564976053|FG004|Overall Study|Other - site closure|1|||
156514120|NCT00299494|564976054|FG005|Overall Study|Other - site closure|1|||
156514121|NCT01417104|564976058|FG000|Overall Study|Withdrawal by Subject|5|||
156559401|NCT03665285|565137673|FG002|Overall Study|Physician Decision|0|||
156559402|NCT03665285|565137674|FG003|Overall Study|Physician Decision|0|||
156559403|NCT03665285|565137675|FG004|Overall Study|Physician Decision|0|||
156559404|NCT03665285|565137676|FG005|Overall Study|Physician Decision|0|||
156559405|NCT03665285|565137677|FG006|Overall Study|Physician Decision|0|||
156559406|NCT03665285|565137678|FG007|Overall Study|Physician Decision|2|||
156559407|NCT03665285|565137679|FG008|Overall Study|Physician Decision|0|||
156559408|NCT03543410|565137680|FG000|Overall Study|Adverse Event|10|||
156559409|NCT03543410|565137681|FG001|Overall Study|Adverse Event|8|||
156559410|NCT03543410|565137682|FG002|Overall Study|Adverse Event|2|||
156559411|NCT03543410|565137680|FG000|Overall Study|Lack of Efficacy|0|||
156559412|NCT03543410|565137681|FG001|Overall Study|Lack of Efficacy|1|||
156559413|NCT03543410|565137682|FG002|Overall Study|Lack of Efficacy|0|||
156559414|NCT03543410|565137680|FG000|Overall Study|Lost to Follow-up|0|||
156559415|NCT03543410|565137681|FG001|Overall Study|Lost to Follow-up|1|||
156514122|NCT01417104|564976059|FG001|Overall Study|Withdrawal by Subject|1|||
156514123|NCT01417104|564976058|FG000|Overall Study|Failure to make contact|0|||
156514124|NCT01417104|564976059|FG001|Overall Study|Failure to make contact|1|||
156514125|NCT01417104|564976058|FG000|Overall Study|Adverse Event|1|||
156514126|NCT01417104|564976059|FG001|Overall Study|Adverse Event|0|||
156514127|NCT00403767|564976067|FG000|Overall Study|Adverse Event|993|||
156514128|NCT00403767|564976068|FG001|Overall Study|Adverse Event|919|||
156514129|NCT00403767|564976067|FG000|Overall Study|Non-compliant with study medication|134|||
156514130|NCT00403767|564976068|FG001|Overall Study|Non-compliant with study medication|164|||
156514131|NCT00403767|564976067|FG000|Overall Study|Consent withdrawn|671|||
156514132|NCT00403767|564976068|FG001|Overall Study|Consent withdrawn|673|||
156514133|NCT00403767|564976067|FG000|Overall Study|Investigator dec./not protocol-related|191|||
156559416|NCT03543410|565137682|FG002|Overall Study|Lost to Follow-up|0|||
156559417|NCT03543410|565137680|FG000|Overall Study|Withdrawal by Subject|5|||
156559418|NCT03543410|565137681|FG001|Overall Study|Withdrawal by Subject|2|||
156559419|NCT03543410|565137682|FG002|Overall Study|Withdrawal by Subject|8|||
156559420|NCT03543410|565137680|FG000|Overall Study|Protocol Violation|0|||
156559421|NCT03543410|565137681|FG001|Overall Study|Protocol Violation|1|||
156559422|NCT03543410|565137682|FG002|Overall Study|Protocol Violation|0|||
156559423|NCT03543410|565137680|FG000|Overall Study|Due to COVID-19|4|||
156559424|NCT03543410|565137681|FG001|Overall Study|Due to COVID-19|0|||
156559425|NCT03543410|565137682|FG002|Overall Study|Due to COVID-19|2|||
156559426|NCT03543410|565137680|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
156559427|NCT03543410|565137681|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
156559428|NCT03543410|565137682|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
156559429|NCT03543410|565137680|FG000|Overall Study|Not Due to COVID-19|2|||
156559430|NCT03543410|565137681|FG001|Overall Study|Not Due to COVID-19|0|||
156559431|NCT03543410|565137682|FG002|Overall Study|Not Due to COVID-19|1|||
156559432|NCT02211261|565137683|FG000|Overall Study|Withdrawal by Subject|0|||
156559433|NCT02211261|565137684|FG001|Overall Study|Withdrawal by Subject|0|||
156559434|NCT02211261|565137685|FG002|Overall Study|Withdrawal by Subject|1|||
156559435|NCT02211261|565137686|FG003|Overall Study|Withdrawal by Subject|0|||
156559436|NCT02211261|565137687|FG004|Overall Study|Withdrawal by Subject|2|||
156559437|NCT02211261|565137688|FG005|Overall Study|Withdrawal by Subject|0|||
156559438|NCT02211261|565137689|FG006|Overall Study|Withdrawal by Subject|0|||
156559439|NCT02211261|565137690|FG007|Overall Study|Withdrawal by Subject|0|||
156559440|NCT02211261|565137691|FG008|Overall Study|Withdrawal by Subject|0|||
156559441|NCT02211261|565137692|FG009|Overall Study|Withdrawal by Subject|0|||
156559442|NCT02211261|565137693|FG010|Overall Study|Withdrawal by Subject|0|||
156559443|NCT02211261|565137683|FG000|Overall Study|Other|0|||
156559444|NCT02211261|565137684|FG001|Overall Study|Other|0|||
156514134|NCT00403767|564976068|FG001|Overall Study|Investigator dec./not protocol-related|178|||
156514135|NCT00403767|564976067|FG000|Overall Study|Lost to Follow-up|6|||
156514136|NCT00403767|564976068|FG001|Overall Study|Lost to Follow-up|8|||
156559445|NCT02211261|565137685|FG002|Overall Study|Other|0|||
156514137|NCT00403767|564976067|FG000|Overall Study|Protocol Violation|142|||
156514138|NCT00403767|564976068|FG001|Overall Study|Protocol Violation|124|||
156514139|NCT00403767|564976067|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
156514140|NCT00403767|564976068|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
156514141|NCT00403767|564976067|FG000|Overall Study|Study terminated by sponsor|82|||
156559446|NCT02211261|565137686|FG003|Overall Study|Other|0|||
156559447|NCT02211261|565137687|FG004|Overall Study|Other|0|||
156559448|NCT02211261|565137688|FG005|Overall Study|Other|1|||
156559449|NCT02211261|565137689|FG006|Overall Study|Other|0|||
156559450|NCT02211261|565137690|FG007|Overall Study|Other|0|||
156559451|NCT02211261|565137691|FG008|Overall Study|Other|0|||
156559452|NCT02211261|565137692|FG009|Overall Study|Other|2|||
156559453|NCT02211261|565137693|FG010|Overall Study|Other|0|||
156559454|NCT02211261|565137683|FG000|Overall Study|Lost to Follow-up|0|||
156559455|NCT02211261|565137684|FG001|Overall Study|Lost to Follow-up|0|||
156559456|NCT02211261|565137685|FG002|Overall Study|Lost to Follow-up|0|||
156559457|NCT02211261|565137686|FG003|Overall Study|Lost to Follow-up|0|||
156559458|NCT02211261|565137687|FG004|Overall Study|Lost to Follow-up|0|||
156559459|NCT02211261|565137688|FG005|Overall Study|Lost to Follow-up|0|||
156514142|NCT00403767|564976068|FG001|Overall Study|Study terminated by sponsor|69|||
156514143|NCT00403767|564976067|FG000|Overall Study|Missing/incomplete data|1|||
156514144|NCT00403767|564976068|FG001|Overall Study|Missing/incomplete data|1|||
156514145|NCT05330676|564976072|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
156514146|NCT05330676|564976073|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
156514147|NCT02416453|564976074|FG000|Overall Study|Adverse Event|0|||
156514148|NCT02416453|564976075|FG001|Overall Study|Adverse Event|0|||
156514149|NCT02416453|564976076|FG002|Overall Study|Adverse Event|0|||
156514150|NCT02416453|564976077|FG003|Overall Study|Adverse Event|2|||
156514151|NCT02416453|564976078|FG004|Overall Study|Adverse Event|0|||
156514152|NCT02416453|564976079|FG005|Overall Study|Adverse Event|1|||
156514153|NCT02416453|564976080|FG006|Overall Study|Adverse Event|0|||
156514154|NCT02416453|564976081|FG007|Overall Study|Adverse Event|0|||
156514155|NCT02416453|564976082|FG008|Overall Study|Adverse Event|0|||
156514156|NCT02416453|564976083|FG009|Overall Study|Adverse Event|0|||
156514157|NCT02416453|564976084|FG010|Overall Study|Adverse Event|0|||
156514158|NCT02416453|564976074|FG000|Overall Study|Lost to Follow-up|1|||
156514159|NCT02416453|564976075|FG001|Overall Study|Lost to Follow-up|3|||
156514160|NCT02416453|564976076|FG002|Overall Study|Lost to Follow-up|0|||
156514161|NCT02416453|564976077|FG003|Overall Study|Lost to Follow-up|8|||
156514162|NCT02416453|564976078|FG004|Overall Study|Lost to Follow-up|0|||
156514163|NCT02416453|564976079|FG005|Overall Study|Lost to Follow-up|5|||
156514164|NCT02416453|564976080|FG006|Overall Study|Lost to Follow-up|1|||
156514165|NCT02416453|564976081|FG007|Overall Study|Lost to Follow-up|3|||
156514166|NCT02416453|564976082|FG008|Overall Study|Lost to Follow-up|1|||
156514167|NCT02416453|564976083|FG009|Overall Study|Lost to Follow-up|0|||
156514168|NCT02416453|564976084|FG010|Overall Study|Lost to Follow-up|0|||
156514169|NCT02416453|564976074|FG000|Overall Study|Physician Decision|0|||
156514170|NCT02416453|564976075|FG001|Overall Study|Physician Decision|0|||
156514171|NCT02416453|564976076|FG002|Overall Study|Physician Decision|0|||
156514172|NCT02416453|564976077|FG003|Overall Study|Physician Decision|0|||
156514173|NCT02416453|564976078|FG004|Overall Study|Physician Decision|0|||
156514174|NCT02416453|564976079|FG005|Overall Study|Physician Decision|1|||
156514175|NCT02416453|564976080|FG006|Overall Study|Physician Decision|1|||
156514176|NCT02416453|564976081|FG007|Overall Study|Physician Decision|1|||
156514177|NCT02416453|564976082|FG008|Overall Study|Physician Decision|0|||
156514178|NCT02416453|564976083|FG009|Overall Study|Physician Decision|0|||
156514179|NCT02416453|564976084|FG010|Overall Study|Physician Decision|0|||
156514180|NCT02416453|564976074|FG000|Overall Study|Withdrawal by Subject|2|||
156514181|NCT02416453|564976075|FG001|Overall Study|Withdrawal by Subject|0|||
156514182|NCT02416453|564976076|FG002|Overall Study|Withdrawal by Subject|0|||
156514183|NCT02416453|564976077|FG003|Overall Study|Withdrawal by Subject|5|||
156514184|NCT02416453|564976078|FG004|Overall Study|Withdrawal by Subject|1|||
156514185|NCT02416453|564976079|FG005|Overall Study|Withdrawal by Subject|8|||
156514186|NCT02416453|564976080|FG006|Overall Study|Withdrawal by Subject|0|||
156514187|NCT02416453|564976081|FG007|Overall Study|Withdrawal by Subject|8|||
156514188|NCT02416453|564976082|FG008|Overall Study|Withdrawal by Subject|4|||
156514189|NCT02416453|564976083|FG009|Overall Study|Withdrawal by Subject|0|||
156514190|NCT02416453|564976084|FG010|Overall Study|Withdrawal by Subject|0|||
156514191|NCT02416453|564976074|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514192|NCT02416453|564976075|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514193|NCT02416453|564976076|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
156514194|NCT02416453|564976077|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514195|NCT02416453|564976078|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514196|NCT02416453|564976079|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514197|NCT02416453|564976080|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514198|NCT02416453|564976081|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514199|NCT02416453|564976082|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514200|NCT02416453|564976083|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514201|NCT02416453|564976084|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
156514202|NCT02416453|564976074|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514203|NCT02416453|564976075|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514204|NCT02416453|564976076|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514205|NCT02416453|564976077|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514206|NCT02416453|564976078|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514207|NCT02416453|564976079|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
156514208|NCT02416453|564976080|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514209|NCT02416453|564976081|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514210|NCT02416453|564976082|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514211|NCT02416453|564976083|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514212|NCT02416453|564976084|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
156514213|NCT03223662|564976089|FG000|Overall Study|Physician Decision|1|||
156514214|NCT03223662|564976089|FG000|Overall Study|Study closure|1|||
156514215|NCT02229851|564976090|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
156514216|NCT02229851|564976091|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
156514217|NCT02229851|564976092|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
156514218|NCT02229851|564976093|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
156514219|NCT02229851|564976094|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
156514220|NCT02229851|564976095|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
156514221|NCT02229851|564976096|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
156514222|NCT02229851|564976090|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
156514223|NCT02229851|564976091|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
156514224|NCT02229851|564976092|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
156514225|NCT02229851|564976093|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
156514226|NCT02229851|564976094|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
156514227|NCT02229851|564976095|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
156514228|NCT02229851|564976096|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
156514229|NCT02229851|564976090|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
156514230|NCT02229851|564976091|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
156514231|NCT02229851|564976092|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
156514232|NCT02229851|564976093|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
156514233|NCT02229851|564976094|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
156514234|NCT02229851|564976095|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
156514235|NCT02229851|564976096|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
156514236|NCT02229851|564976090|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
156514237|NCT02229851|564976091|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
156514238|NCT02229851|564976092|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
156514239|NCT02229851|564976093|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
156514240|NCT02229851|564976094|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
156514241|NCT02229851|564976095|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
156514242|NCT02229851|564976096|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
156514243|NCT02229851|564976090|FG000|Main Phase (Double-blind Phase)|Death|1|||
156514244|NCT02229851|564976091|FG001|Main Phase (Double-blind Phase)|Death|1|||
156514245|NCT02229851|564976092|FG002|Main Phase (Double-blind Phase)|Death|0|||
156514246|NCT02229851|564976093|FG003|Main Phase (Double-blind Phase)|Death|0|||
156514247|NCT02229851|564976094|FG004|Main Phase (Double-blind Phase)|Death|0|||
156514248|NCT02229851|564976095|FG005|Main Phase (Double-blind Phase)|Death|0|||
156514249|NCT02229851|564976096|FG006|Main Phase (Double-blind Phase)|Death|0|||
156514250|NCT02229851|564976090|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
156514251|NCT02229851|564976091|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
156514252|NCT02229851|564976092|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
156514253|NCT02229851|564976093|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
156514254|NCT02229851|564976094|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
156514255|NCT02229851|564976095|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
156514256|NCT02229851|564976096|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
156514257|NCT02229851|564976090|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
156514258|NCT02229851|564976091|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
156514259|NCT02229851|564976092|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
156514260|NCT02229851|564976093|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
156514261|NCT02229851|564976094|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
156514262|NCT02229851|564976095|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
156514263|NCT02229851|564976096|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
156514264|NCT02229851|564976090|FG000|Extension Phase (Open-label Phase)|Death|0|||
156514265|NCT02229851|564976091|FG001|Extension Phase (Open-label Phase)|Death|0|||
156514266|NCT02229851|564976092|FG002|Extension Phase (Open-label Phase)|Death|0|||
156514267|NCT02229851|564976093|FG003|Extension Phase (Open-label Phase)|Death|1|||
156514268|NCT02229851|564976094|FG004|Extension Phase (Open-label Phase)|Death|0|||
156514269|NCT02229851|564976095|FG005|Extension Phase (Open-label Phase)|Death|1|||
156514270|NCT02229851|564976096|FG006|Extension Phase (Open-label Phase)|Death|1|||
156514271|NCT01769326|564976097|FG000|Overall Study|Lost to Follow-up|1|||
156514272|NCT01769326|564976098|FG001|Overall Study|Lost to Follow-up|2|||
156514273|NCT01769326|564976099|FG002|Overall Study|Lost to Follow-up|0|||
156514274|NCT01769326|564976100|FG003|Overall Study|Lost to Follow-up|0|||
156514275|NCT01769326|564976097|FG000|Overall Study|unrelated injry|1|||
156514276|NCT01769326|564976098|FG001|Overall Study|unrelated injry|1|||
156514277|NCT01769326|564976099|FG002|Overall Study|unrelated injry|0|||
156514278|NCT01769326|564976100|FG003|Overall Study|unrelated injry|0|||
156514279|NCT01769326|564976097|FG000|Overall Study|got a job|0|||
156514280|NCT01769326|564976098|FG001|Overall Study|got a job|1|||
156514281|NCT01769326|564976099|FG002|Overall Study|got a job|0|||
156514282|NCT01769326|564976100|FG003|Overall Study|got a job|0|||
156514283|NCT01769326|564976097|FG000|Overall Study|Got sick and could not complete study|0|||
156514284|NCT01769326|564976098|FG001|Overall Study|Got sick and could not complete study|0|||
156514285|NCT01769326|564976099|FG002|Overall Study|Got sick and could not complete study|1|||
156514286|NCT01769326|564976100|FG003|Overall Study|Got sick and could not complete study|0|||
156514287|NCT01036438|564976101|FG000|Overall Study|Adverse Event|7|||
156514288|NCT01036438|564976102|FG001|Overall Study|Adverse Event|8|||
156514289|NCT01036438|564976101|FG000|Overall Study|Death|0|||
156514290|NCT01036438|564976102|FG001|Overall Study|Death|1|||
156514291|NCT01036438|564976101|FG000|Overall Study|No effect of study treatment|3|||
156514292|NCT01036438|564976102|FG001|Overall Study|No effect of study treatment|1|||
156514293|NCT03459443|564976103|FG000|Overall Study|Lack of Efficacy|3|||
156514294|NCT03459443|564976103|FG000|Overall Study|Adverse Event|1|||
156514295|NCT03459443|564976103|FG000|Overall Study|Sponsor's decision to close the study|18|||
156514296|NCT01276379|564976104|FG000|Overall Study|Screening failure|40|||
156514297|NCT02729831|564976106|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
156514298|NCT02729831|564976107|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
156514299|NCT02729831|564976108|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
156514300|NCT02729831|564976109|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
156514301|NCT02729831|564976106|FG000|1 Week Post-visit|Lost to Follow-up|43|||
156514302|NCT02729831|564976107|FG001|1 Week Post-visit|Lost to Follow-up|40|||
156514303|NCT02729831|564976108|FG002|1 Week Post-visit|Lost to Follow-up|38|||
156514304|NCT02729831|564976109|FG003|1 Week Post-visit|Lost to Follow-up|36|||
156514305|NCT02729831|564976106|FG000|6 Month Follow-up|Lost to Follow-up|54|||
156514306|NCT02729831|564976107|FG001|6 Month Follow-up|Lost to Follow-up|51|||
156514307|NCT02729831|564976108|FG002|6 Month Follow-up|Lost to Follow-up|48|||
156514308|NCT02729831|564976109|FG003|6 Month Follow-up|Lost to Follow-up|42|||
156514309|NCT02729831|564976106|FG000|6 Month Follow-up|Death|1|||
156514310|NCT02729831|564976107|FG001|6 Month Follow-up|Death|3|||
156514311|NCT02729831|564976108|FG002|6 Month Follow-up|Death|0|||
156514312|NCT02729831|564976109|FG003|6 Month Follow-up|Death|1|||
156514313|NCT00864253|564976110|FG000|Overall Study|Adverse Event|56|||
156514314|NCT00864253|564976111|FG001|Overall Study|Adverse Event|11|||
156514315|NCT00864253|564976110|FG000|Overall Study|Unrelated Adverse Event|3|||
156514316|NCT00864253|564976111|FG001|Overall Study|Unrelated Adverse Event|1|||
156514317|NCT00864253|564976110|FG000|Overall Study|Physician Decision|11|||
156514318|NCT00864253|564976111|FG001|Overall Study|Physician Decision|15|||
156514319|NCT00864253|564976110|FG000|Overall Study|Protocol Violation|0|||
156514320|NCT00864253|564976111|FG001|Overall Study|Protocol Violation|2|||
156514321|NCT00864253|564976110|FG000|Overall Study|Lost to Follow-up|1|||
156514322|NCT00864253|564976111|FG001|Overall Study|Lost to Follow-up|1|||
156514323|NCT00864253|564976110|FG000|Overall Study|Withdrawal by Subject|18|||
156514324|NCT00864253|564976111|FG001|Overall Study|Withdrawal by Subject|18|||
156514325|NCT00864253|564976110|FG000|Overall Study|Death|1|||
156514326|NCT00864253|564976111|FG001|Overall Study|Death|0|||
156514327|NCT00864253|564976110|FG000|Overall Study|Ongoing|2|||
156514328|NCT00864253|564976111|FG001|Overall Study|Ongoing|3|||
156514329|NCT00864253|564976110|FG000|Overall Study|Untreated|7|||
156514330|NCT00864253|564976111|FG001|Overall Study|Untreated|7|||
156514331|NCT01111240|564976112|FG000|Overall Study|Adverse Event|190|||
156514332|NCT01111240|564976112|FG000|Overall Study|Lack of Efficacy|545|||
156514333|NCT01111240|564976112|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
156514334|NCT01111240|564976112|FG000|Overall Study|Other|312|||
156514335|NCT01747551|564976113|FG000|Overall Study|Progressive Disease|24|||
156514336|NCT01747551|564976114|FG001|Overall Study|Progressive Disease|17|||
156514337|NCT01747551|564976113|FG000|Overall Study|Death|3|||
156514338|NCT01747551|564976114|FG001|Overall Study|Death|1|||
156514339|NCT01747551|564976113|FG000|Overall Study|Adverse Event|7|||
156514340|NCT01747551|564976114|FG001|Overall Study|Adverse Event|1|||
156514341|NCT01747551|564976113|FG000|Overall Study|Prolonged Treatment Delay|2|||
156514342|NCT01747551|564976114|FG001|Overall Study|Prolonged Treatment Delay|0|||
156514343|NCT01747551|564976113|FG000|Overall Study|Withdrawal by Subject|3|||
156514344|NCT01747551|564976114|FG001|Overall Study|Withdrawal by Subject|1|||
156514345|NCT01747551|564976113|FG000|Overall Study|Physician Decision|2|||
156514346|NCT01747551|564976114|FG001|Overall Study|Physician Decision|1|||
156514347|NCT01747551|564976113|FG000|Overall Study|Other|2|||
156514348|NCT01747551|564976114|FG001|Overall Study|Other|0|||
156514349|NCT01607476|564976115|FG000|Overall Study|Withdrawal by Subject|1|||
156514350|NCT01607476|564976116|FG001|Overall Study|Withdrawal by Subject|0|||
156514351|NCT01607476|564976117|FG002|Overall Study|Withdrawal by Subject|1|||
156514352|NCT01607476|564976115|FG000|Overall Study|Lost to Follow-up|0|||
156514353|NCT01607476|564976116|FG001|Overall Study|Lost to Follow-up|0|||
156514354|NCT01607476|564976117|FG002|Overall Study|Lost to Follow-up|2|||
156514355|NCT04445987|564976118|FG000|Overall Study|Adverse Event|0|||
156514356|NCT04445987|564976119|FG001|Overall Study|Adverse Event|0|||
156514357|NCT04445987|564976120|FG002|Overall Study|Adverse Event|1|||
156514358|NCT04445987|564976121|FG003|Overall Study|Adverse Event|0|||
156514359|NCT04445987|564976122|FG004|Overall Study|Adverse Event|4|||
156514360|NCT04445987|564976123|FG005|Overall Study|Adverse Event|0|||
156559460|NCT02211261|565137689|FG006|Overall Study|Lost to Follow-up|0|||
156559461|NCT02211261|565137690|FG007|Overall Study|Lost to Follow-up|1|||
156559462|NCT02211261|565137691|FG008|Overall Study|Lost to Follow-up|0|||
156559463|NCT02211261|565137692|FG009|Overall Study|Lost to Follow-up|0|||
156559464|NCT02211261|565137693|FG010|Overall Study|Lost to Follow-up|0|||
156559465|NCT00480857|565137696|FG000|Overall Study|Lack of Efficacy|2|||
156559466|NCT02175680|565137703|FG000|Overall Study|non-compliance|1|||
156559467|NCT02175680|565137703|FG000|Overall Study|other non-medical reason|1|||
156559468|NCT01116544|565137707|FG000|Overall Study|Protocol Violation|1|||
156559469|NCT01116544|565137708|FG001|Overall Study|Protocol Violation|0|||
156559470|NCT01116544|565137707|FG000|Overall Study|Withdrawal by Subject|1|||
156559471|NCT01116544|565137708|FG001|Overall Study|Withdrawal by Subject|1|||
156559472|NCT02419508|565137709|FG000|Overall Study|Adverse Event|9|||
156559473|NCT02419508|565137710|FG001|Overall Study|Adverse Event|3|||
156559474|NCT02419508|565137709|FG000|Overall Study|Withdrawal by Subject|1|||
156559475|NCT02419508|565137710|FG001|Overall Study|Withdrawal by Subject|0|||
156559476|NCT02419508|565137709|FG000|Overall Study|Other - Reason not specified|0|||
156559477|NCT02419508|565137710|FG001|Overall Study|Other - Reason not specified|1|||
156559478|NCT01738971|565137719|FG000|Overall Study|Lost to Follow-up|19|||
156559479|NCT01738971|565137720|FG001|Overall Study|Lost to Follow-up|30|||
156559480|NCT01738971|565137721|FG002|Overall Study|Lost to Follow-up|17|||
156559481|NCT00670007|565140031|FG000|Overall Study|Drug abuse|1|||
156559482|NCT00670007|565140031|FG000|Overall Study|Lung transplant|1|||
156559483|NCT00670007|565140031|FG000|Overall Study|Travel/Vacation|1|||
156559484|NCT00670007|565140031|FG000|Overall Study|Adverse event, serious fatal|1|||
156559485|NCT00670007|565140031|FG000|Overall Study|Adverse Event|1|||
156559486|NCT00670007|565140031|FG000|Overall Study|Withdrawal by Subject|4|||
156559487|NCT00925600|565140032|FG000|Overall Study|Withdrawal by Subject|16|||
156559488|NCT00925600|565140033|FG001|Overall Study|Withdrawal by Subject|14|||
156559489|NCT00925600|565140032|FG000|Overall Study|Death|4|||
156559490|NCT00925600|565140033|FG001|Overall Study|Death|3|||
156559491|NCT00925600|565140032|FG000|Overall Study|Lost to Follow-up|2|||
156559492|NCT00925600|565140033|FG001|Overall Study|Lost to Follow-up|2|||
156559493|NCT00925600|565140032|FG000|Overall Study|Disease Progression|1|||
156559494|NCT00925600|565140033|FG001|Overall Study|Disease Progression|3|||
156559495|NCT00925600|565140032|FG000|Overall Study|Administrative Decision|1|||
156559496|NCT00925600|565140033|FG001|Overall Study|Administrative Decision|1|||
156559497|NCT00925600|565140032|FG000|Overall Study|Noncompliance|2|||
156559498|NCT00925600|565140033|FG001|Overall Study|Noncompliance|0|||
156559499|NCT00925600|565140032|FG000|Overall Study|Ineligibility Determined|2|||
156559500|NCT00925600|565140033|FG001|Overall Study|Ineligibility Determined|0|||
156559501|NCT00925600|565140032|FG000|Overall Study|Protocol Deviation|0|||
156559502|NCT00925600|565140033|FG001|Overall Study|Protocol Deviation|1|||
156559503|NCT00925600|565140032|FG000|Overall Study|Requirement for Alternative Therapy|0|||
156559504|NCT00925600|565140033|FG001|Overall Study|Requirement for Alternative Therapy|1|||
156559505|NCT00925600|565140032|FG000|Overall Study|Other|3|||
156559506|NCT00925600|565140033|FG001|Overall Study|Other|1|||
156559507|NCT00925600|565140032|FG000|Overall Study|Adverse Event|1|||
156559508|NCT00925600|565140033|FG001|Overall Study|Adverse Event|2|||
156559509|NCT00127127|565140038|FG000|Overall Study|Adverse Event|0|||
156559510|NCT00127127|565140039|FG001|Overall Study|Adverse Event|2|||
156559511|NCT00127127|565140040|FG002|Overall Study|Adverse Event|0|||
156559512|NCT00127127|565140041|FG003|Overall Study|Adverse Event|1|||
156559513|NCT00127127|565140038|FG000|Overall Study|Lack of Efficacy|1|||
156559514|NCT00127127|565140039|FG001|Overall Study|Lack of Efficacy|3|||
156559515|NCT00127127|565140040|FG002|Overall Study|Lack of Efficacy|0|||
156559516|NCT00127127|565140041|FG003|Overall Study|Lack of Efficacy|2|||
156559517|NCT00200057|565140042|FG000|Overall Study|Lack of Efficacy|3|||
156559518|NCT00200057|565140042|FG000|Overall Study|Exited due to terminal illness of PI|2|||
156559519|NCT00200057|565140042|FG000|Overall Study|Withdrawal by Subject|1|||
156559520|NCT00200057|565140042|FG000|Overall Study|Change in medical condition|1|||
156559521|NCT00200057|565140042|FG000|Overall Study|Infection|1|||
156559522|NCT00200057|565140042|FG000|Overall Study|Death|1|||
156559523|NCT01059448|565140043|FG000|Overall Study|Adverse Event|1|||
156559524|NCT01059448|565140044|FG001|Overall Study|Adverse Event|3|||
156559525|NCT01059448|565140045|FG002|Overall Study|Adverse Event|0|||
156559526|NCT01059448|565140046|FG003|Overall Study|Adverse Event|1|||
156559527|NCT01059448|565140043|FG000|Overall Study|Withdrawal by Subject|2|||
156559528|NCT01059448|565140044|FG001|Overall Study|Withdrawal by Subject|0|||
156559529|NCT01059448|565140045|FG002|Overall Study|Withdrawal by Subject|2|||
156559530|NCT01059448|565140046|FG003|Overall Study|Withdrawal by Subject|4|||
156559531|NCT01059448|565140043|FG000|Overall Study|Disease Progression|2|||
156559532|NCT01059448|565140044|FG001|Overall Study|Disease Progression|1|||
156559533|NCT01059448|565140045|FG002|Overall Study|Disease Progression|4|||
156559534|NCT01059448|565140046|FG003|Overall Study|Disease Progression|2|||
156559535|NCT01059448|565140043|FG000|Overall Study|Administrative Decision|43|||
156559536|NCT01059448|565140044|FG001|Overall Study|Administrative Decision|49|||
156559537|NCT01059448|565140045|FG002|Overall Study|Administrative Decision|45|||
156559538|NCT01059448|565140046|FG003|Overall Study|Administrative Decision|46|||
156559539|NCT01059448|565140043|FG000|Overall Study|Lost to Follow-up|0|||
156559540|NCT01059448|565140044|FG001|Overall Study|Lost to Follow-up|0|||
156559541|NCT01059448|565140045|FG002|Overall Study|Lost to Follow-up|2|||
156559542|NCT01059448|565140046|FG003|Overall Study|Lost to Follow-up|0|||
156559543|NCT01059448|565140043|FG000|Overall Study|Death|0|||
156559544|NCT01059448|565140044|FG001|Overall Study|Death|1|||
156559545|NCT01059448|565140045|FG002|Overall Study|Death|0|||
156559546|NCT01059448|565140046|FG003|Overall Study|Death|0|||
156559547|NCT01059448|565140043|FG000|Overall Study|Other|1|||
156559548|NCT01059448|565140044|FG001|Overall Study|Other|1|||
156559549|NCT01059448|565140045|FG002|Overall Study|Other|0|||
156559550|NCT01059448|565140046|FG003|Overall Study|Other|1|||
156559551|NCT00778830|565140047|FG000|Overall Study|Ongoing at data cut-off|0|||
156559552|NCT00778830|565140048|FG001|Overall Study|Ongoing at data cut-off|1|||
156559553|NCT01891643|565140049|FG000|Overall Study|Adverse event unrelated to study drug|2|||
156559554|NCT01891643|565140050|FG001|Overall Study|Adverse event unrelated to study drug|5|||
156559555|NCT01891643|565140049|FG000|Overall Study|Disease Progression|4|||
156559556|NCT01891643|565140050|FG001|Overall Study|Disease Progression|3|||
156559557|NCT01891643|565140049|FG000|Overall Study|Study Drug Toxicity|3|||
156559558|NCT01891643|565140050|FG001|Overall Study|Study Drug Toxicity|0|||
156559559|NCT01891643|565140049|FG000|Overall Study|Maximum Clinical Benefit|0|||
156559560|NCT01891643|565140050|FG001|Overall Study|Maximum Clinical Benefit|1|||
156559561|NCT01891643|565140049|FG000|Overall Study|Poor/Non-compliance|0|||
156559562|NCT01891643|565140050|FG001|Overall Study|Poor/Non-compliance|1|||
156559563|NCT01891643|565140049|FG000|Overall Study|Participant request to discontinue|1|||
156559564|NCT01891643|565140050|FG001|Overall Study|Participant request to discontinue|0|||
156559565|NCT04047797|565140053|FG000|Overall Study|Progressive Disease|1|||
156559566|NCT00132041|565140058|FG000|Baseline|Ineligible|6|||
156559567|NCT00132041|565140058|FG000|3 Months Post Ablation|Transplant|1|||
156559568|NCT00132041|565140058|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
156559569|NCT00132041|565140058|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
156559570|NCT00132041|565140058|FG000|6 Months Post Ablation|Death|2|||
156559571|NCT00132041|565140058|FG000|6 Months Post Ablation|Transplant|6|||
156559572|NCT00132041|565140058|FG000|9 Months Post Ablation|Death|1|||
156559573|NCT00132041|565140058|FG000|9 Months Post Ablation|Transplant|1|||
156559574|NCT00132041|565140058|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
156514361|NCT04445987|564976118|FG000|Overall Study|Lost to Follow-up|4|||
156514362|NCT04445987|564976119|FG001|Overall Study|Lost to Follow-up|3|||
156514363|NCT04445987|564976120|FG002|Overall Study|Lost to Follow-up|1|||
156514364|NCT04445987|564976121|FG003|Overall Study|Lost to Follow-up|1|||
156514365|NCT04445987|564976122|FG004|Overall Study|Lost to Follow-up|29|||
156514366|NCT04445987|564976123|FG005|Overall Study|Lost to Follow-up|0|||
156514367|NCT04445987|564976118|FG000|Overall Study|Physician Decision|0|||
156514368|NCT04445987|564976119|FG001|Overall Study|Physician Decision|0|||
156514369|NCT04445987|564976120|FG002|Overall Study|Physician Decision|0|||
156514370|NCT04445987|564976121|FG003|Overall Study|Physician Decision|0|||
156514371|NCT04445987|564976122|FG004|Overall Study|Physician Decision|1|||
156514372|NCT04445987|564976123|FG005|Overall Study|Physician Decision|0|||
156514373|NCT04445987|564976118|FG000|Overall Study|Protocol Violation|1|||
156514374|NCT04445987|564976119|FG001|Overall Study|Protocol Violation|0|||
156514375|NCT04445987|564976120|FG002|Overall Study|Protocol Violation|0|||
156514376|NCT04445987|564976121|FG003|Overall Study|Protocol Violation|0|||
156514377|NCT04445987|564976122|FG004|Overall Study|Protocol Violation|2|||
156514378|NCT04445987|564976123|FG005|Overall Study|Protocol Violation|0|||
156514379|NCT04445987|564976118|FG000|Overall Study|Withdrawal by Subject|4|||
156514380|NCT04445987|564976119|FG001|Overall Study|Withdrawal by Subject|0|||
156514381|NCT04445987|564976120|FG002|Overall Study|Withdrawal by Subject|1|||
156514382|NCT04445987|564976121|FG003|Overall Study|Withdrawal by Subject|0|||
156514383|NCT04445987|564976122|FG004|Overall Study|Withdrawal by Subject|18|||
156514384|NCT04445987|564976123|FG005|Overall Study|Withdrawal by Subject|1|||
156514385|NCT04445987|564976118|FG000|Overall Study|Other reason|0|||
156514386|NCT04445987|564976119|FG001|Overall Study|Other reason|0|||
156514387|NCT04445987|564976120|FG002|Overall Study|Other reason|1|||
156514388|NCT04445987|564976121|FG003|Overall Study|Other reason|0|||
156514389|NCT04445987|564976122|FG004|Overall Study|Other reason|2|||
156514390|NCT04445987|564976123|FG005|Overall Study|Other reason|0|||
156514391|NCT01609062|564976129|FG000|Extension Phase|Terminated by Sponsor|14|||
156514392|NCT01609062|564976130|FG001|Extension Phase|Terminated by Sponsor|9|||
156514393|NCT01609062|564976129|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
156514394|NCT01609062|564976130|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
156514395|NCT01609062|564976129|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
156514396|NCT01609062|564976130|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
156514397|NCT00680992|564976131|FG000|Overall Study|Complete Resection (as per protocol)|25|||
156514398|NCT00680992|564976132|FG001|Overall Study|Complete Resection (as per protocol)|121|||
156514399|NCT00680992|564976133|FG002|Overall Study|Complete Resection (as per protocol)|0|||
156514400|NCT00680992|564976131|FG000|Overall Study|Administrative Decision|83|||
156559575|NCT00132041|565140058|FG000|12 Months Post Ablation|Death|1|||
156559576|NCT00132041|565140058|FG000|12 Months Post Ablation|Transplant|1|||
156559577|NCT00132041|565140058|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
156559578|NCT00132041|565140058|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
156559579|NCT00132041|565140058|FG000|15 Months Post Ablation|Death|1|||
156559580|NCT00132041|565140058|FG000|15 Months Post Ablation|Transplant|5|||
156559581|NCT00132041|565140058|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
156559582|NCT00132041|565140058|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
156559583|NCT00132041|565140058|FG000|18 Months Post Ablation|Transplant|1|||
156559584|NCT00132041|565140058|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
156559585|NCT00132041|565140058|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
156559586|NCT03969875|565140059|FG000|Overall Study|did not receive allocated intervention|3|||
156559587|NCT03969875|565140060|FG001|Overall Study|did not receive allocated intervention|3|||
156559588|NCT03969875|565140061|FG002|Overall Study|did not receive allocated intervention|4|||
156559589|NCT03969875|565140059|FG000|Overall Study|Protocol Violation|4|||
156559590|NCT03969875|565140060|FG001|Overall Study|Protocol Violation|2|||
156559591|NCT03969875|565140061|FG002|Overall Study|Protocol Violation|2|||
156559592|NCT00167245|565140062|FG000|Overall Study|Lost to Follow-up|20|||
156559593|NCT00167245|565140063|FG001|Overall Study|Lost to Follow-up|31|||
156559594|NCT00167245|565140062|FG000|Overall Study|Withdrawal by Subject|5|||
156559595|NCT00167245|565140063|FG001|Overall Study|Withdrawal by Subject|8|||
156559596|NCT00167245|565140062|FG000|Overall Study|Incarcerated|3|||
156559597|NCT00167245|565140063|FG001|Overall Study|Incarcerated|2|||
156559598|NCT00167245|565140062|FG000|Overall Study|Drowsy|1|||
156559599|NCT00167245|565140063|FG001|Overall Study|Drowsy|0|||
156559600|NCT00947531|565140064|FG000|Overall Study|Withdrawal by Subject|10|||
156559601|NCT00947531|565140065|FG001|Overall Study|Withdrawal by Subject|7|||
156559602|NCT00947531|565140064|FG000|Overall Study|Administrative Reason|0|||
156559603|NCT00947531|565140065|FG001|Overall Study|Administrative Reason|1|||
156559604|NCT00947531|565140064|FG000|Overall Study|Adverse Event|2|||
156559605|NCT00947531|565140065|FG001|Overall Study|Adverse Event|2|||
156559606|NCT00947531|565140064|FG000|Overall Study|Lack of Efficacy|1|||
156559607|NCT00947531|565140065|FG001|Overall Study|Lack of Efficacy|0|||
156559608|NCT00947531|565140064|FG000|Overall Study|Other|1|||
156559609|NCT00947531|565140065|FG001|Overall Study|Other|1|||
156559610|NCT02487108|565140070|FG000|Overall Study|Adverse Event|1|||
156559611|NCT02487108|565140071|FG001|Overall Study|Adverse Event|6|||
156559612|NCT02487108|565140072|FG002|Overall Study|Adverse Event|12|||
156559613|NCT02487108|565140073|FG003|Overall Study|Adverse Event|6|||
156559614|NCT02487108|565140070|FG000|Overall Study|Withdrawal by Subject|8|||
156559615|NCT02487108|565140071|FG001|Overall Study|Withdrawal by Subject|5|||
156559616|NCT02487108|565140072|FG002|Overall Study|Withdrawal by Subject|5|||
156559617|NCT02487108|565140073|FG003|Overall Study|Withdrawal by Subject|0|||
156559618|NCT02487108|565140070|FG000|Overall Study|Non-compliance to study medication|3|||
156559619|NCT02487108|565140071|FG001|Overall Study|Non-compliance to study medication|2|||
156559620|NCT02487108|565140072|FG002|Overall Study|Non-compliance to study medication|5|||
156559621|NCT02487108|565140073|FG003|Overall Study|Non-compliance to study medication|4|||
156559622|NCT02487108|565140070|FG000|Overall Study|Protocol Violation|1|||
156559623|NCT02487108|565140071|FG001|Overall Study|Protocol Violation|1|||
156559624|NCT02487108|565140072|FG002|Overall Study|Protocol Violation|2|||
156559625|NCT02487108|565140073|FG003|Overall Study|Protocol Violation|0|||
156514401|NCT00680992|564976132|FG001|Overall Study|Administrative Decision|42|||
156514402|NCT00680992|564976133|FG002|Overall Study|Administrative Decision|5|||
156514403|NCT00680992|564976131|FG000|Overall Study|End of Trial|32|||
156514404|NCT00680992|564976132|FG001|Overall Study|End of Trial|12|||
156514405|NCT00680992|564976133|FG002|Overall Study|End of Trial|3|||
156514406|NCT00680992|564976131|FG000|Overall Study|Withdrawal by Subject|33|||
156514407|NCT00680992|564976132|FG001|Overall Study|Withdrawal by Subject|11|||
156514408|NCT00680992|564976133|FG002|Overall Study|Withdrawal by Subject|1|||
156514409|NCT00680992|564976131|FG000|Overall Study|Adverse Event|21|||
156514410|NCT00680992|564976132|FG001|Overall Study|Adverse Event|19|||
156514411|NCT00680992|564976133|FG002|Overall Study|Adverse Event|1|||
156514412|NCT00680992|564976131|FG000|Overall Study|Other|19|||
156514413|NCT00680992|564976132|FG001|Overall Study|Other|14|||
156559626|NCT02487108|565140070|FG000|Overall Study|Non-compliance to study procedures|0|||
156559627|NCT02487108|565140071|FG001|Overall Study|Non-compliance to study procedures|0|||
156559628|NCT02487108|565140072|FG002|Overall Study|Non-compliance to study procedures|0|||
156559629|NCT02487108|565140073|FG003|Overall Study|Non-compliance to study procedures|1|||
156559630|NCT02487108|565140070|FG000|Overall Study|Other than specified|3|||
156559631|NCT02487108|565140071|FG001|Overall Study|Other than specified|2|||
156559632|NCT02487108|565140072|FG002|Overall Study|Other than specified|2|||
156559633|NCT02487108|565140073|FG003|Overall Study|Other than specified|0|||
156559634|NCT02720757|565140074|FG000|Overall Study|Other reason|5|||
156559635|NCT02720757|565140074|FG000|Overall Study|Loss of contact|4|||
156559636|NCT02720757|565140074|FG000|Overall Study|Informed consent withdrawal|1|||
156559637|NCT02720757|565140074|FG000|Overall Study|Patients wish to withdraw|2|||
156559638|NCT02720757|565140074|FG000|Overall Study|Missing|3|||
156559639|NCT02720757|565140074|FG000|Overall Study|General exclusion|3|||
156559640|NCT04088409|565140075|FG000|Part A|Withdrawal by Subject|2|||
156559641|NCT04088409|565140076|FG001|Part A|Withdrawal by Subject|1|||
156559642|NCT04088409|565140075|FG000|Part A|Did Not Meet Randomization Criteria|2|||
156559643|NCT04088409|565140076|FG001|Part A|Did Not Meet Randomization Criteria|0|||
156559644|NCT04088409|565140075|FG000|Part A|Lack of Efficacy|9|||
156559645|NCT04088409|565140076|FG001|Part A|Lack of Efficacy|0|||
156559646|NCT04088409|565140075|FG000|Part A|Lost to Follow-up|1|||
156559647|NCT04088409|565140076|FG001|Part A|Lost to Follow-up|0|||
156559648|NCT04088409|565140075|FG000|Part A|Adverse Event|1|||
156559649|NCT04088409|565140076|FG001|Part A|Adverse Event|0|||
156559650|NCT04088409|565140075|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
156559651|NCT04088409|565140076|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
156559652|NCT04088409|565140075|FG000|Part B|Ongoing Treatment|10|||
156559653|NCT04088409|565140076|FG001|Part B|Ongoing Treatment|0|||
156559654|NCT01058096|565140082|FG000|Double-blind Treatment Phase|Adverse Event|11|||
156559655|NCT01058096|565140083|FG001|Double-blind Treatment Phase|Adverse Event|15|||
156559656|NCT01058096|565140082|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
156559657|NCT01058096|565140083|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
156559658|NCT01058096|565140082|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
156559659|NCT01058096|565140083|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
156559660|NCT01058096|565140082|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
156559661|NCT01058096|565140083|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
156559662|NCT01058096|565140082|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156559663|NCT01058096|565140083|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
156559664|NCT01058096|565140082|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
156559665|NCT01058096|565140083|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
156559666|NCT05655377|565140084|FG000|Overall Study|Withdrawal by Subject|2|||
156559667|NCT03118947|565140085|FG000|Overall Study|Adverse Event|7|||
156559668|NCT03118947|565140085|FG000|Overall Study|Death|3|||
156559669|NCT03118947|565140085|FG000|Overall Study|Lack of Efficacy|4|||
156559670|NCT03118947|565140085|FG000|Overall Study|Non-compliance with study drug|1|||
156559671|NCT03118947|565140085|FG000|Overall Study|Protocol Violation|2|||
156559672|NCT03118947|565140085|FG000|Overall Study|Withdrawal by Subject|3|||
156559673|NCT03118947|565140085|FG000|Overall Study|Withdrawal by caregiver|3|||
156559674|NCT03118947|565140085|FG000|Overall Study|Change in patient's living situation|4|||
156559675|NCT03118947|565140085|FG000|Overall Study|Lost to Follow-up|2|||
156559676|NCT03653390|565140086|FG000|Overall Study|Lost to Follow-up|12|||
156559677|NCT03653390|565140087|FG001|Overall Study|Lost to Follow-up|8|||
156559678|NCT03653390|565140088|FG002|Overall Study|Lost to Follow-up|7|||
156559679|NCT03653390|565140086|FG000|Overall Study|Withdrawal by Subject|6|||
156559680|NCT03653390|565140087|FG001|Overall Study|Withdrawal by Subject|1|||
156559681|NCT03653390|565140088|FG002|Overall Study|Withdrawal by Subject|1|||
156559682|NCT03653390|565140086|FG000|Overall Study|Death|1|||
156559683|NCT03653390|565140087|FG001|Overall Study|Death|0|||
156559684|NCT03653390|565140088|FG002|Overall Study|Death|0|||
156559685|NCT03653390|565140086|FG000|Overall Study|Paper Survey Lost|1|||
156559686|NCT03653390|565140087|FG001|Overall Study|Paper Survey Lost|0|||
156559687|NCT03653390|565140088|FG002|Overall Study|Paper Survey Lost|0|||
156559688|NCT04451330|565140089|FG000|Overall Study|Adverse Event|1|||
156559689|NCT04451330|565140090|FG001|Overall Study|Adverse Event|2|||
156559690|NCT04451330|565140089|FG000|Overall Study|Lost to Follow-up|5|||
156559691|NCT04451330|565140090|FG001|Overall Study|Lost to Follow-up|0|||
156559692|NCT04451330|565140089|FG000|Overall Study|Withdrawal by Subject|3|||
156559693|NCT04451330|565140090|FG001|Overall Study|Withdrawal by Subject|1|||
156559694|NCT04451330|565140089|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156559695|NCT04451330|565140090|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156559696|NCT04451330|565140089|FG000|Overall Study|Other than specified|0|||
156559697|NCT04451330|565140090|FG001|Overall Study|Other than specified|1|||
156559698|NCT01987908|565140103|FG000|Placebo Lead-in Period|Adverse Event|2|||
156559699|NCT01987908|565140104|FG001|Placebo Lead-in Period|Adverse Event|0|||
156559700|NCT01987908|565140105|FG002|Placebo Lead-in Period|Adverse Event|0|||
156559701|NCT01987908|565140103|FG000|Placebo Lead-in Period|Physician Decision|2|||
156559702|NCT01987908|565140104|FG001|Placebo Lead-in Period|Physician Decision|0|||
156559703|NCT01987908|565140105|FG002|Placebo Lead-in Period|Physician Decision|0|||
156559704|NCT01987908|565140103|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
156559705|NCT01987908|565140104|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
156559706|NCT01987908|565140105|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
156559707|NCT01987908|565140103|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
156559708|NCT01987908|565140104|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
156559709|NCT01987908|565140105|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
156559710|NCT01987908|565140103|FG000|Treatment Period|Adverse Event|0|||
156559711|NCT01987908|565140104|FG001|Treatment Period|Adverse Event|1|||
156559712|NCT01987908|565140105|FG002|Treatment Period|Adverse Event|1|||
156559713|NCT01987908|565140103|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
156514414|NCT00680992|564976133|FG002|Overall Study|Other|1|||
156514415|NCT00680992|564976131|FG000|Overall Study|Disease Progression|21|||
156514416|NCT00680992|564976132|FG001|Overall Study|Disease Progression|9|||
156514417|NCT00680992|564976133|FG002|Overall Study|Disease Progression|0|||
156514418|NCT00680992|564976131|FG000|Overall Study|Lost to Follow-up|12|||
156514419|NCT00680992|564976132|FG001|Overall Study|Lost to Follow-up|14|||
156514420|NCT00680992|564976133|FG002|Overall Study|Lost to Follow-up|0|||
156514421|NCT00680992|564976131|FG000|Overall Study|Noncompliance|4|||
156514422|NCT00680992|564976132|FG001|Overall Study|Noncompliance|6|||
156514423|NCT00680992|564976133|FG002|Overall Study|Noncompliance|0|||
156514424|NCT00680992|564976131|FG000|Overall Study|Requirement for Alternative Therapy|8|||
156514425|NCT00680992|564976132|FG001|Overall Study|Requirement for Alternative Therapy|2|||
156514426|NCT00680992|564976133|FG002|Overall Study|Requirement for Alternative Therapy|0|||
156514427|NCT00680992|564976131|FG000|Overall Study|Pregnancy|5|||
156514428|NCT00680992|564976132|FG001|Overall Study|Pregnancy|0|||
156514429|NCT00680992|564976133|FG002|Overall Study|Pregnancy|1|||
156514430|NCT00680992|564976131|FG000|Overall Study|Death|5|||
156514431|NCT00680992|564976132|FG001|Overall Study|Death|1|||
156514432|NCT00680992|564976133|FG002|Overall Study|Death|0|||
156514433|NCT00680992|564976131|FG000|Overall Study|Ineligibility Determined|0|||
156514434|NCT00680992|564976132|FG001|Overall Study|Ineligibility Determined|1|||
156514435|NCT00680992|564976133|FG002|Overall Study|Ineligibility Determined|0|||
156514436|NCT03772587|564976134|FG000|Overall Study|COVID-19|0|||
156514437|NCT03772587|564976135|FG001|Overall Study|COVID-19|0|||
156514438|NCT03772587|564976136|FG002|Overall Study|COVID-19|1|||
156514439|NCT03772587|564976137|FG003|Overall Study|COVID-19|1|||
156514440|NCT03772587|564976138|FG004|Overall Study|COVID-19|0|||
156514441|NCT03772587|564976134|FG000|Overall Study|Withdrawal by Subject|1|||
156514442|NCT03772587|564976135|FG001|Overall Study|Withdrawal by Subject|0|||
156514443|NCT03772587|564976136|FG002|Overall Study|Withdrawal by Subject|0|||
156514444|NCT03772587|564976137|FG003|Overall Study|Withdrawal by Subject|0|||
156514445|NCT03772587|564976138|FG004|Overall Study|Withdrawal by Subject|0|||
156514446|NCT02425904|564976143|FG000|Overall Study|Lost to Follow-up|1|||
156514447|NCT02425904|564976144|FG001|Overall Study|Lost to Follow-up|0|||
156514448|NCT02425904|564976143|FG000|Overall Study|Withdrawal by Subject|2|||
156514449|NCT02425904|564976144|FG001|Overall Study|Withdrawal by Subject|0|||
156514450|NCT02425904|564976143|FG000|Overall Study|Death|0|||
156514451|NCT02425904|564976144|FG001|Overall Study|Death|3|||
156514452|NCT05260021|564976145|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
156514453|NCT05260021|564976146|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
156514454|NCT05260021|564976147|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
156514455|NCT05260021|564976145|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
156514456|NCT05260021|564976146|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
156514457|NCT05260021|564976147|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
156514458|NCT05260021|564976145|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
156514459|NCT05260021|564976146|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
156514460|NCT05260021|564976147|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
156514461|NCT05260021|564976145|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
156514462|NCT05260021|564976146|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
156514463|NCT05260021|564976147|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
156514464|NCT05260021|564976145|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
156514465|NCT05260021|564976146|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
156514466|NCT05260021|564976147|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
156514467|NCT03842358|564976148|FG000|Overall Study|Poor DOT probe contact with breast|2|||
156514468|NCT03842358|564976148|FG000|Overall Study|DOT system problem|1|||
156514469|NCT03842358|564976148|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
156514470|NCT03842358|564976148|FG000|Overall Study|No biopsy after physician review|4|||
156514471|NCT03842358|564976148|FG000|Overall Study|Patient withdrew|2|||
156514472|NCT02626455|564976149|FG000|Overall Study|Other|1|||
156514473|NCT02626455|564976150|FG001|Overall Study|Other|1|||
156514474|NCT02626455|564976151|FG002|Overall Study|Other|0|||
156514475|NCT02626455|564976152|FG003|Overall Study|Other|0|||
156514476|NCT02626455|564976153|FG004|Overall Study|Other|0|||
156514477|NCT02626455|564976154|FG005|Overall Study|Other|17|||
156514478|NCT02626455|564976155|FG006|Overall Study|Other|23|||
156514479|NCT02626455|564976149|FG000|Overall Study|Withdrawal by Subject|1|||
156514480|NCT02626455|564976150|FG001|Overall Study|Withdrawal by Subject|0|||
156514481|NCT02626455|564976151|FG002|Overall Study|Withdrawal by Subject|0|||
156514482|NCT02626455|564976152|FG003|Overall Study|Withdrawal by Subject|0|||
156514483|NCT02626455|564976153|FG004|Overall Study|Withdrawal by Subject|0|||
156514484|NCT02626455|564976154|FG005|Overall Study|Withdrawal by Subject|10|||
156514485|NCT02626455|564976155|FG006|Overall Study|Withdrawal by Subject|6|||
156514486|NCT02626455|564976149|FG000|Overall Study|Physician Decision|0|||
156514487|NCT02626455|564976150|FG001|Overall Study|Physician Decision|2|||
156514488|NCT02626455|564976151|FG002|Overall Study|Physician Decision|2|||
156514489|NCT02626455|564976152|FG003|Overall Study|Physician Decision|2|||
156514490|NCT02626455|564976153|FG004|Overall Study|Physician Decision|1|||
156514491|NCT02626455|564976154|FG005|Overall Study|Physician Decision|10|||
156514492|NCT02626455|564976155|FG006|Overall Study|Physician Decision|3|||
156514493|NCT02626455|564976149|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
156514494|NCT02626455|564976150|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
156514495|NCT02626455|564976151|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
156514496|NCT02626455|564976152|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
156514497|NCT02626455|564976153|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
156514498|NCT02626455|564976154|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
156514499|NCT02626455|564976155|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
156514500|NCT02626455|564976149|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
156514501|NCT02626455|564976150|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
156514502|NCT02626455|564976151|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
156514503|NCT02626455|564976152|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
156514504|NCT02626455|564976153|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
156514505|NCT02626455|564976154|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
156514506|NCT02626455|564976155|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
156514507|NCT02626455|564976149|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
156514508|NCT02626455|564976150|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
156514509|NCT02626455|564976151|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
156514510|NCT02626455|564976152|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
156514511|NCT02626455|564976153|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
156514512|NCT02626455|564976154|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
156514513|NCT02626455|564976155|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
156514514|NCT02626455|564976149|FG000|Overall Study|Patient decision|0|||
156514515|NCT02626455|564976150|FG001|Overall Study|Patient decision|1|||
156514516|NCT02626455|564976151|FG002|Overall Study|Patient decision|0|||
156514517|NCT02626455|564976152|FG003|Overall Study|Patient decision|0|||
156514518|NCT02626455|564976153|FG004|Overall Study|Patient decision|1|||
156514519|NCT02626455|564976154|FG005|Overall Study|Patient decision|36|||
156514520|NCT02626455|564976155|FG006|Overall Study|Patient decision|22|||
156514521|NCT02626455|564976149|FG000|Overall Study|Protocol Violation|0|||
156514522|NCT02626455|564976150|FG001|Overall Study|Protocol Violation|0|||
156514523|NCT02626455|564976151|FG002|Overall Study|Protocol Violation|0|||
156514524|NCT02626455|564976152|FG003|Overall Study|Protocol Violation|0|||
156514525|NCT02626455|564976153|FG004|Overall Study|Protocol Violation|0|||
156514526|NCT02626455|564976154|FG005|Overall Study|Protocol Violation|0|||
156514527|NCT02626455|564976155|FG006|Overall Study|Protocol Violation|1|||
156514528|NCT02626455|564976149|FG000|Overall Study|Progressive disease - radiological progression|0|||
156514529|NCT02626455|564976150|FG001|Overall Study|Progressive disease - radiological progression|0|||
156514530|NCT02626455|564976151|FG002|Overall Study|Progressive disease - radiological progression|0|||
156514531|NCT02626455|564976152|FG003|Overall Study|Progressive disease - radiological progression|0|||
156514532|NCT02626455|564976153|FG004|Overall Study|Progressive disease - radiological progression|0|||
156514533|NCT02626455|564976154|FG005|Overall Study|Progressive disease - radiological progression|11|||
156514534|NCT02626455|564976155|FG006|Overall Study|Progressive disease - radiological progression|22|||
156514535|NCT02626455|564976149|FG000|Overall Study|Progressive disease - clinical progression|0|||
156514536|NCT02626455|564976150|FG001|Overall Study|Progressive disease - clinical progression|0|||
156514537|NCT02626455|564976151|FG002|Overall Study|Progressive disease - clinical progression|0|||
156514538|NCT02626455|564976152|FG003|Overall Study|Progressive disease - clinical progression|0|||
156514539|NCT02626455|564976153|FG004|Overall Study|Progressive disease - clinical progression|0|||
156514540|NCT02626455|564976154|FG005|Overall Study|Progressive disease - clinical progression|1|||
156514541|NCT02626455|564976155|FG006|Overall Study|Progressive disease - clinical progression|2|||
156514542|NCT02626455|564976149|FG000|Overall Study|Lost to Follow-up|0|||
156514543|NCT02626455|564976150|FG001|Overall Study|Lost to Follow-up|0|||
156514544|NCT02626455|564976151|FG002|Overall Study|Lost to Follow-up|0|||
156514545|NCT02626455|564976152|FG003|Overall Study|Lost to Follow-up|0|||
156514546|NCT02626455|564976153|FG004|Overall Study|Lost to Follow-up|0|||
156514547|NCT02626455|564976154|FG005|Overall Study|Lost to Follow-up|1|||
156514548|NCT02626455|564976155|FG006|Overall Study|Lost to Follow-up|0|||
156514549|NCT02626455|564976149|FG000|Overall Study|AE not associated with clinical disease progression|1|||
156514550|NCT02626455|564976150|FG001|Overall Study|AE not associated with clinical disease progression|1|||
156514551|NCT02626455|564976151|FG002|Overall Study|AE not associated with clinical disease progression|0|||
156514552|NCT02626455|564976152|FG003|Overall Study|AE not associated with clinical disease progression|2|||
156514553|NCT02626455|564976153|FG004|Overall Study|AE not associated with clinical disease progression|1|||
156514554|NCT02626455|564976154|FG005|Overall Study|AE not associated with clinical disease progression|65|||
156514555|NCT02626455|564976155|FG006|Overall Study|AE not associated with clinical disease progression|21|||
156514556|NCT02626455|564976149|FG000|Overall Study|AE associated with clinical disease progression|0|||
156514557|NCT02626455|564976150|FG001|Overall Study|AE associated with clinical disease progression|0|||
156863410|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
156514558|NCT02626455|564976151|FG002|Overall Study|AE associated with clinical disease progression|0|||
156514559|NCT02626455|564976152|FG003|Overall Study|AE associated with clinical disease progression|0|||
156514560|NCT02626455|564976153|FG004|Overall Study|AE associated with clinical disease progression|0|||
156514561|NCT02626455|564976154|FG005|Overall Study|AE associated with clinical disease progression|1|||
156514562|NCT02626455|564976155|FG006|Overall Study|AE associated with clinical disease progression|2|||
156514563|NCT02626455|564976149|FG000|Overall Study|Study intervention never administered|0|||
156514564|NCT02626455|564976150|FG001|Overall Study|Study intervention never administered|0|||
156514565|NCT02626455|564976151|FG002|Overall Study|Study intervention never administered|0|||
156514566|NCT02626455|564976152|FG003|Overall Study|Study intervention never administered|0|||
156514567|NCT02626455|564976153|FG004|Overall Study|Study intervention never administered|0|||
156514568|NCT02626455|564976154|FG005|Overall Study|Study intervention never administered|1|||
156514569|NCT02626455|564976155|FG006|Overall Study|Study intervention never administered|3|||
156514570|NCT05148962|564976156|FG000|Overall Study|Withdrawal by Subject|1|||
156514571|NCT05148962|564976157|FG001|Overall Study|Withdrawal by Subject|1|||
156514572|NCT05148962|564976158|FG002|Overall Study|Withdrawal by Subject|0|||
156514573|NCT05148962|564976159|FG003|Overall Study|Withdrawal by Subject|1|||
156514574|NCT05148962|564976160|FG004|Overall Study|Withdrawal by Subject|0|||
156514575|NCT05148962|564976156|FG000|Overall Study|Participant was early terminated per protocol|0|||
156514576|NCT05148962|564976157|FG001|Overall Study|Participant was early terminated per protocol|0|||
156514577|NCT05148962|564976158|FG002|Overall Study|Participant was early terminated per protocol|3|||
156514578|NCT05148962|564976159|FG003|Overall Study|Participant was early terminated per protocol|5|||
156514579|NCT05148962|564976160|FG004|Overall Study|Participant was early terminated per protocol|2|||
156514580|NCT05148962|564976156|FG000|Overall Study|Miscellaneous|0|||
156514581|NCT05148962|564976157|FG001|Overall Study|Miscellaneous|0|||
156514582|NCT05148962|564976158|FG002|Overall Study|Miscellaneous|0|||
156514583|NCT05148962|564976159|FG003|Overall Study|Miscellaneous|1|||
156514584|NCT05148962|564976160|FG004|Overall Study|Miscellaneous|0|||
156514585|NCT01144377|564976161|FG000|52 Week Treatment Period|Adverse Event|0|||
156514586|NCT01144377|564976162|FG001|52 Week Treatment Period|Adverse Event|0|||
156514587|NCT01144377|564976163|FG002|52 Week Treatment Period|Adverse Event|3|||
156514588|NCT01144377|564976164|FG003|52 Week Treatment Period|Adverse Event|2|||
156514589|NCT01144377|564976165|FG004|52 Week Treatment Period|Adverse Event|1|||
156514590|NCT01144377|564976161|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
156514591|NCT01144377|564976162|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
156514592|NCT01144377|564976163|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
156514593|NCT01144377|564976164|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
156514594|NCT01144377|564976165|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
156514595|NCT01144377|564976161|FG000|52 Week Treatment Period|Protocol Violation|0|||
156514596|NCT01144377|564976162|FG001|52 Week Treatment Period|Protocol Violation|0|||
156514597|NCT01144377|564976163|FG002|52 Week Treatment Period|Protocol Violation|0|||
156514598|NCT01144377|564976164|FG003|52 Week Treatment Period|Protocol Violation|0|||
156514599|NCT01144377|564976165|FG004|52 Week Treatment Period|Protocol Violation|1|||
156514600|NCT01144377|564976161|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
156514601|NCT01144377|564976162|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
156514602|NCT01144377|564976163|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
156514603|NCT01144377|564976164|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
156514604|NCT01144377|564976165|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
156514605|NCT01144377|564976161|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
156514606|NCT01144377|564976162|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
156514607|NCT01144377|564976163|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
156514608|NCT01144377|564976164|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
156514609|NCT01144377|564976165|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
156514610|NCT01144377|564976161|FG000|52 Week Treatment Period|Sponsor Decision|0|||
156514611|NCT01144377|564976162|FG001|52 Week Treatment Period|Sponsor Decision|0|||
156514612|NCT01144377|564976163|FG002|52 Week Treatment Period|Sponsor Decision|0|||
156514613|NCT01144377|564976164|FG003|52 Week Treatment Period|Sponsor Decision|0|||
156514614|NCT01144377|564976165|FG004|52 Week Treatment Period|Sponsor Decision|1|||
156514615|NCT01144377|564976161|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
156514616|NCT01144377|564976162|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
156514617|NCT01144377|564976163|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
156514618|NCT01144377|564976164|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
156514619|NCT01144377|564976165|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
156514620|NCT01144377|564976161|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
156514621|NCT01144377|564976162|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
156514622|NCT01144377|564976163|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
156514623|NCT01144377|564976164|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
156514624|NCT01144377|564976165|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
156514625|NCT01144377|564976161|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
156514626|NCT01144377|564976162|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
156514627|NCT01144377|564976163|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
156514628|NCT01144377|564976164|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
156514629|NCT01144377|564976165|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
156514630|NCT01525238|564976166|FG000|Overall Study|Withdrawal by Subject|1|||
156514631|NCT01525238|564976167|FG001|Overall Study|Withdrawal by Subject|0|||
156514632|NCT01525238|564976168|FG002|Overall Study|Withdrawal by Subject|0|||
156514633|NCT00607724|564976169|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
156514634|NCT00607724|564976170|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
156514635|NCT00607724|564976171|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
156514636|NCT00607724|564976172|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
156514637|NCT00607724|564976173|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
156514638|NCT00607724|564976174|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
156514639|NCT00607724|564976175|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
156514640|NCT00607724|564976169|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
156514641|NCT00607724|564976170|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
156514642|NCT00607724|564976171|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
156514643|NCT00607724|564976172|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
156514644|NCT00607724|564976173|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
156514645|NCT00607724|564976174|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
156514646|NCT00607724|564976175|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
156514647|NCT00607724|564976169|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
156514648|NCT00607724|564976170|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
156514649|NCT00607724|564976171|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
156514650|NCT00607724|564976172|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
156514651|NCT00607724|564976173|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
156514652|NCT00607724|564976174|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
156514653|NCT00607724|564976175|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
156514654|NCT00607724|564976169|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
156514655|NCT00607724|564976170|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
156514656|NCT00607724|564976171|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
156514657|NCT00607724|564976172|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
156514658|NCT00607724|564976173|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
156514659|NCT00607724|564976174|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
156514660|NCT00607724|564976175|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
156514661|NCT00607724|564976169|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
156514662|NCT00607724|564976170|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
156514663|NCT00607724|564976171|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
156514664|NCT00607724|564976172|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
156514665|NCT00607724|564976173|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
156514666|NCT00607724|564976174|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
156514667|NCT00607724|564976175|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
156514668|NCT01214642|564976176|FG000|Overall Study|Progressive Disease|3|||
156514669|NCT01214642|564976177|FG001|Overall Study|Progressive Disease|2|||
156514670|NCT01214642|564976178|FG002|Overall Study|Progressive Disease|3|||
156514671|NCT01214642|564976179|FG003|Overall Study|Progressive Disease|5|||
156514672|NCT01214642|564976180|FG004|Overall Study|Progressive Disease|5|||
156514673|NCT01214642|564976181|FG005|Overall Study|Progressive Disease|3|||
156514674|NCT01214642|564976182|FG006|Overall Study|Progressive Disease|5|||
156514675|NCT01214642|564976183|FG007|Overall Study|Progressive Disease|3|||
156514676|NCT01214642|564976184|FG008|Overall Study|Progressive Disease|10|||
156514677|NCT01214642|564976185|FG009|Overall Study|Progressive Disease|2|||
156514678|NCT01214642|564976186|FG010|Overall Study|Progressive Disease|1|||
156514679|NCT01214642|564976187|FG011|Overall Study|Progressive Disease|4|||
156514680|NCT01214642|564976176|FG000|Overall Study|Adverse Event|0|||
156514681|NCT01214642|564976177|FG001|Overall Study|Adverse Event|1|||
156514682|NCT01214642|564976178|FG002|Overall Study|Adverse Event|0|||
156514683|NCT01214642|564976179|FG003|Overall Study|Adverse Event|0|||
156514684|NCT01214642|564976180|FG004|Overall Study|Adverse Event|0|||
156514685|NCT01214642|564976181|FG005|Overall Study|Adverse Event|0|||
156514686|NCT01214642|564976182|FG006|Overall Study|Adverse Event|1|||
156514687|NCT01214642|564976183|FG007|Overall Study|Adverse Event|0|||
156514688|NCT01214642|564976184|FG008|Overall Study|Adverse Event|0|||
156514689|NCT01214642|564976185|FG009|Overall Study|Adverse Event|1|||
156514690|NCT01214642|564976186|FG010|Overall Study|Adverse Event|1|||
156514691|NCT01214642|564976187|FG011|Overall Study|Adverse Event|0|||
156514692|NCT01214642|564976176|FG000|Overall Study|Death|0|||
156514693|NCT01214642|564976177|FG001|Overall Study|Death|0|||
156514694|NCT01214642|564976178|FG002|Overall Study|Death|1|||
156514695|NCT01214642|564976179|FG003|Overall Study|Death|0|||
156514696|NCT01214642|564976180|FG004|Overall Study|Death|0|||
156514697|NCT01214642|564976181|FG005|Overall Study|Death|0|||
156514698|NCT01214642|564976182|FG006|Overall Study|Death|0|||
156514699|NCT01214642|564976183|FG007|Overall Study|Death|0|||
156514700|NCT01214642|564976184|FG008|Overall Study|Death|0|||
156514701|NCT01214642|564976185|FG009|Overall Study|Death|0|||
156514702|NCT01214642|564976186|FG010|Overall Study|Death|1|||
156514703|NCT01214642|564976187|FG011|Overall Study|Death|0|||
156514704|NCT01214642|564976176|FG000|Overall Study|Withdrawal by Subject|0|||
156514705|NCT01214642|564976177|FG001|Overall Study|Withdrawal by Subject|0|||
156514706|NCT01214642|564976178|FG002|Overall Study|Withdrawal by Subject|1|||
156514707|NCT01214642|564976179|FG003|Overall Study|Withdrawal by Subject|0|||
156514708|NCT01214642|564976180|FG004|Overall Study|Withdrawal by Subject|0|||
156514709|NCT01214642|564976181|FG005|Overall Study|Withdrawal by Subject|0|||
156514710|NCT01214642|564976182|FG006|Overall Study|Withdrawal by Subject|0|||
156514711|NCT01214642|564976183|FG007|Overall Study|Withdrawal by Subject|0|||
156514712|NCT01214642|564976184|FG008|Overall Study|Withdrawal by Subject|3|||
156514713|NCT01214642|564976185|FG009|Overall Study|Withdrawal by Subject|1|||
156514714|NCT01214642|564976186|FG010|Overall Study|Withdrawal by Subject|1|||
156514715|NCT01214642|564976187|FG011|Overall Study|Withdrawal by Subject|0|||
156514716|NCT01214642|564976176|FG000|Overall Study|Physician Decision|0|||
156514717|NCT01214642|564976177|FG001|Overall Study|Physician Decision|0|||
156514718|NCT01214642|564976178|FG002|Overall Study|Physician Decision|1|||
156514719|NCT01214642|564976179|FG003|Overall Study|Physician Decision|1|||
156514720|NCT01214642|564976180|FG004|Overall Study|Physician Decision|1|||
156514721|NCT01214642|564976181|FG005|Overall Study|Physician Decision|0|||
156514722|NCT01214642|564976182|FG006|Overall Study|Physician Decision|0|||
156514723|NCT01214642|564976183|FG007|Overall Study|Physician Decision|0|||
156514724|NCT01214642|564976184|FG008|Overall Study|Physician Decision|0|||
156514725|NCT01214642|564976185|FG009|Overall Study|Physician Decision|0|||
156514726|NCT01214642|564976186|FG010|Overall Study|Physician Decision|0|||
156514727|NCT01214642|564976187|FG011|Overall Study|Physician Decision|2|||
156514728|NCT00151281|564976188|FG000|Overall Study|Not evaluable|3|||
156514729|NCT04696653|564976189|FG000|Overall Study|left organization|18|||
156514730|NCT04696653|564976189|FG000|Overall Study|Lost to Follow-up|3|||
156514731|NCT04349631|564976193|FG000|Overall Study|Lost to Follow-up|3|||
156514732|NCT04349631|564976193|FG000|Overall Study|Withdrawal by Subject|7|||
156514733|NCT03037931|564977842|FG000|Overall Study|Death|354|||
156514734|NCT03037931|564977843|FG001|Overall Study|Death|367|||
156514735|NCT03037931|564977842|FG000|Overall Study|Lost to Follow-up|7|||
156514736|NCT03037931|564977843|FG001|Overall Study|Lost to Follow-up|4|||
156514737|NCT03037931|564977842|FG000|Overall Study|Withdrawal by Subject|48|||
156514738|NCT03037931|564977843|FG001|Overall Study|Withdrawal by Subject|41|||
156514739|NCT02075476|564977844|FG000|Overall Study|Death|2|||
156514740|NCT02075476|564977845|FG001|Overall Study|Death|2|||
156514741|NCT02075476|564977844|FG000|Overall Study|Lost to Follow-up|1|||
156514742|NCT02075476|564977845|FG001|Overall Study|Lost to Follow-up|3|||
156514743|NCT02914275|564977848|FG000|Overall Study|Lost to Follow-up|84|||
156514744|NCT02914275|564977849|FG001|Overall Study|Lost to Follow-up|29|||
156514745|NCT02914275|564977848|FG000|Overall Study|Withdrawal by Subject|26|||
156514746|NCT02914275|564977849|FG001|Overall Study|Withdrawal by Subject|10|||
156514747|NCT02914275|564977848|FG000|Overall Study|Protocol Violation|1|||
156514748|NCT02914275|564977849|FG001|Overall Study|Protocol Violation|1|||
156514749|NCT02914275|564977848|FG000|Overall Study|Physician Decision|3|||
156514750|NCT02914275|564977849|FG001|Overall Study|Physician Decision|1|||
156514751|NCT02914275|564977848|FG000|Overall Study|Other|4|||
156514752|NCT02914275|564977849|FG001|Overall Study|Other|1|||
156514753|NCT02914275|564977848|FG000|Overall Study|Excluded due to invalid informed consent|3|||
156514754|NCT02914275|564977849|FG001|Overall Study|Excluded due to invalid informed consent|0|||
156514755|NCT02407990|564977850|FG000|Overall Study|Death|2|||
156514756|NCT02407990|564977851|FG001|Overall Study|Death|22|||
156514757|NCT02407990|564977852|FG002|Overall Study|Death|23|||
156514758|NCT02407990|564977853|FG003|Overall Study|Death|7|||
156514759|NCT02407990|564977854|FG004|Overall Study|Death|17|||
156514760|NCT02407990|564977855|FG005|Overall Study|Death|16|||
156514761|NCT02407990|564977856|FG006|Overall Study|Death|10|||
156514762|NCT02407990|564977857|FG007|Overall Study|Death|248|||
156514763|NCT02407990|564977850|FG000|Overall Study|Lost to Follow-up|0|||
156514764|NCT02407990|564977851|FG001|Overall Study|Lost to Follow-up|1|||
156514765|NCT02407990|564977852|FG002|Overall Study|Lost to Follow-up|0|||
156514766|NCT02407990|564977853|FG003|Overall Study|Lost to Follow-up|0|||
156514767|NCT02407990|564977854|FG004|Overall Study|Lost to Follow-up|0|||
156514768|NCT02407990|564977855|FG005|Overall Study|Lost to Follow-up|0|||
156514769|NCT02407990|564977856|FG006|Overall Study|Lost to Follow-up|0|||
156514770|NCT02407990|564977857|FG007|Overall Study|Lost to Follow-up|17|||
156514771|NCT02407990|564977850|FG000|Overall Study|Progressive Disease|0|||
156514772|NCT02407990|564977851|FG001|Overall Study|Progressive Disease|0|||
156514773|NCT02407990|564977852|FG002|Overall Study|Progressive Disease|0|||
156514774|NCT02407990|564977853|FG003|Overall Study|Progressive Disease|0|||
156514775|NCT02407990|564977854|FG004|Overall Study|Progressive Disease|0|||
156514776|NCT02407990|564977855|FG005|Overall Study|Progressive Disease|0|||
156514777|NCT02407990|564977856|FG006|Overall Study|Progressive Disease|0|||
156514778|NCT02407990|564977857|FG007|Overall Study|Progressive Disease|1|||
156514779|NCT02407990|564977850|FG000|Overall Study|Withdrawal by Subject|0|||
156514780|NCT02407990|564977851|FG001|Overall Study|Withdrawal by Subject|0|||
156514781|NCT02407990|564977852|FG002|Overall Study|Withdrawal by Subject|0|||
156514782|NCT02407990|564977853|FG003|Overall Study|Withdrawal by Subject|0|||
156514783|NCT02407990|564977854|FG004|Overall Study|Withdrawal by Subject|1|||
156514784|NCT02407990|564977855|FG005|Overall Study|Withdrawal by Subject|0|||
156514785|NCT02407990|564977856|FG006|Overall Study|Withdrawal by Subject|0|||
156514786|NCT02407990|564977857|FG007|Overall Study|Withdrawal by Subject|30|||
156514787|NCT02407990|564977850|FG000|Overall Study|Study Terminated by Sponsor|1|||
156514788|NCT02407990|564977851|FG001|Overall Study|Study Terminated by Sponsor|3|||
156514789|NCT02407990|564977852|FG002|Overall Study|Study Terminated by Sponsor|3|||
156514790|NCT02407990|564977853|FG003|Overall Study|Study Terminated by Sponsor|0|||
156514791|NCT02407990|564977854|FG004|Overall Study|Study Terminated by Sponsor|3|||
156514792|NCT02407990|564977855|FG005|Overall Study|Study Terminated by Sponsor|4|||
156514793|NCT02407990|564977856|FG006|Overall Study|Study Terminated by Sponsor|3|||
156514794|NCT02407990|564977857|FG007|Overall Study|Study Terminated by Sponsor|37|||
156514795|NCT02407990|564977850|FG000|Overall Study|Logistics|0|||
156514796|NCT02407990|564977851|FG001|Overall Study|Logistics|0|||
156514797|NCT02407990|564977852|FG002|Overall Study|Logistics|0|||
156514798|NCT02407990|564977853|FG003|Overall Study|Logistics|0|||
156514799|NCT02407990|564977854|FG004|Overall Study|Logistics|0|||
156514800|NCT02407990|564977855|FG005|Overall Study|Logistics|0|||
156514801|NCT02407990|564977856|FG006|Overall Study|Logistics|0|||
156514802|NCT02407990|564977857|FG007|Overall Study|Logistics|1|||
156514803|NCT02407990|564977850|FG000|Overall Study|Rolled into long-term extension study|0|||
156514804|NCT02407990|564977851|FG001|Overall Study|Rolled into long-term extension study|0|||
156514805|NCT02407990|564977852|FG002|Overall Study|Rolled into long-term extension study|0|||
156514806|NCT02407990|564977853|FG003|Overall Study|Rolled into long-term extension study|0|||
156514807|NCT02407990|564977854|FG004|Overall Study|Rolled into long-term extension study|0|||
156514808|NCT02407990|564977855|FG005|Overall Study|Rolled into long-term extension study|0|||
156514809|NCT02407990|564977856|FG006|Overall Study|Rolled into long-term extension study|0|||
156514810|NCT02407990|564977857|FG007|Overall Study|Rolled into long-term extension study|1|||
156514811|NCT00923260|564977858|FG000|Overall Study|Lost to Follow-up|1|||
156514812|NCT00923260|564977859|FG001|Overall Study|Lost to Follow-up|1|||
156514813|NCT01238900|564977860|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
156514814|NCT01238900|564977860|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
156514815|NCT03241927|564977861|FG000|Overall Study|study terminated|1|||
156514816|NCT03241927|564977862|FG001|Overall Study|study terminated|0|||
156514817|NCT01198756|564977863|FG000|Overall Study|Adverse Event|0|||
156514818|NCT01198756|564977864|FG001|Overall Study|Adverse Event|0|||
156514819|NCT01198756|564977865|FG002|Overall Study|Adverse Event|0|||
156514820|NCT01198756|564977866|FG003|Overall Study|Adverse Event|1|||
156514821|NCT01198756|564977863|FG000|Overall Study|Protocol Violation|0|||
156514822|NCT01198756|564977864|FG001|Overall Study|Protocol Violation|0|||
156514823|NCT01198756|564977865|FG002|Overall Study|Protocol Violation|0|||
156514824|NCT01198756|564977866|FG003|Overall Study|Protocol Violation|2|||
156514825|NCT01198756|564977863|FG000|Overall Study|Withdrawal by Subject|9|||
156514826|NCT01198756|564977864|FG001|Overall Study|Withdrawal by Subject|4|||
156514827|NCT01198756|564977865|FG002|Overall Study|Withdrawal by Subject|7|||
156514828|NCT01198756|564977866|FG003|Overall Study|Withdrawal by Subject|5|||
156514829|NCT01198756|564977863|FG000|Overall Study|Lost to Follow-up|29|||
156514830|NCT01198756|564977864|FG001|Overall Study|Lost to Follow-up|36|||
156514831|NCT01198756|564977865|FG002|Overall Study|Lost to Follow-up|23|||
156514832|NCT01198756|564977866|FG003|Overall Study|Lost to Follow-up|18|||
156514833|NCT02915302|564977867|FG000|Overall Study|Adverse Event|3|||
156514834|NCT02915302|564977868|FG001|Overall Study|Adverse Event|0|||
156514835|NCT02915302|564977867|FG000|Overall Study|Protocol Violation|20|||
156514836|NCT02915302|564977868|FG001|Overall Study|Protocol Violation|27|||
156514837|NCT02915302|564977867|FG000|Overall Study|Lost to Follow-up|19|||
156514838|NCT02915302|564977868|FG001|Overall Study|Lost to Follow-up|22|||
156514839|NCT02915302|564977867|FG000|Overall Study|Withdrawal by Subject|22|||
156514840|NCT02915302|564977868|FG001|Overall Study|Withdrawal by Subject|29|||
156514841|NCT02915302|564977867|FG000|Overall Study|Other|1|||
156514842|NCT02915302|564977868|FG001|Overall Study|Other|0|||
156514843|NCT04343872|564977871|FG000|Overall Study|Lost to Follow-up|6|||
156514844|NCT04343872|564977872|FG001|Overall Study|Lost to Follow-up|3|||
156514845|NCT01850446|564977873|FG000|Overall Study|Lack of Efficacy|1|||
156514846|NCT01850446|564977874|FG001|Overall Study|Lack of Efficacy|0|||
156514847|NCT01850446|564977873|FG000|Overall Study|Withdrawal by Subject|4|||
156514848|NCT01850446|564977874|FG001|Overall Study|Withdrawal by Subject|0|||
156514849|NCT01850446|564977873|FG000|Overall Study|Protocol Violation|0|||
156514850|NCT01850446|564977874|FG001|Overall Study|Protocol Violation|2|||
156514851|NCT00591721|564977875|FG000|Overall Study|Withdrawal by Subject|10|||
156514852|NCT00591721|564977876|FG001|Overall Study|Withdrawal by Subject|10|||
156514853|NCT00591721|564977875|FG000|Overall Study|Lost to Follow-up|1|||
156559714|NCT01987908|565140104|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
156559715|NCT01987908|565140105|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
156559716|NCT01987908|565140103|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
156559717|NCT01987908|565140104|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
156559718|NCT01987908|565140105|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
156559719|NCT00189462|565140106|FG000|Overall Study|Lack of Efficacy|5|||
156559720|NCT00189462|565140107|FG001|Overall Study|Lack of Efficacy|1|||
156559721|NCT00189462|565140106|FG000|Overall Study|Lost to Follow-up|18|||
156559722|NCT00189462|565140107|FG001|Overall Study|Lost to Follow-up|20|||
156559723|NCT00849667|565140108|FG000|Overall Study|Withdrawal by Subject|16|||
156559724|NCT00849667|565140109|FG001|Overall Study|Withdrawal by Subject|33|||
156559725|NCT00849667|565140110|FG002|Overall Study|Withdrawal by Subject|35|||
156559726|NCT00849667|565140108|FG000|Overall Study|Lost to Follow-up|8|||
156559727|NCT00849667|565140109|FG001|Overall Study|Lost to Follow-up|8|||
156559728|NCT00849667|565140110|FG002|Overall Study|Lost to Follow-up|8|||
156559729|NCT00849667|565140108|FG000|Overall Study|Adverse Event|1|||
156559730|NCT00849667|565140109|FG001|Overall Study|Adverse Event|2|||
156559731|NCT00849667|565140110|FG002|Overall Study|Adverse Event|0|||
156559732|NCT00849667|565140108|FG000|Overall Study|Other|18|||
156559733|NCT00849667|565140109|FG001|Overall Study|Other|19|||
156559734|NCT00849667|565140110|FG002|Overall Study|Other|18|||
156559735|NCT00849667|565140108|FG000|Overall Study|Progressive disease|119|||
156559736|NCT00849667|565140109|FG001|Overall Study|Progressive disease|100|||
156559737|NCT00849667|565140110|FG002|Overall Study|Progressive disease|112|||
156559738|NCT00849667|565140108|FG000|Overall Study|Sponsor decision|208|||
156559739|NCT00849667|565140109|FG001|Overall Study|Sponsor decision|204|||
156559740|NCT00849667|565140110|FG002|Overall Study|Sponsor decision|190|||
156559741|NCT00849667|565140108|FG000|Overall Study|Investigator discretion|0|||
156559742|NCT00849667|565140109|FG001|Overall Study|Investigator discretion|0|||
156559743|NCT00849667|565140110|FG002|Overall Study|Investigator discretion|1|||
156559744|NCT01869348|565140111|FG000|Overall Study|Withdrawal by Subject|1|||
156559745|NCT01869348|565140112|FG001|Overall Study|Withdrawal by Subject|1|||
156559746|NCT02789657|565140113|FG000|Overall Study|Withdrawal by Subject|2|||
156559747|NCT02789657|565140114|FG001|Overall Study|Withdrawal by Subject|0|||
156559748|NCT02789657|565140115|FG002|Overall Study|Withdrawal by Subject|0|||
156559749|NCT02789657|565140116|FG003|Overall Study|Withdrawal by Subject|0|||
156559750|NCT00510276|565140125|FG000|Acute Double-Blind Phase|Adverse Event|21|||
156559751|NCT00510276|565140126|FG001|Acute Double-Blind Phase|Adverse Event|6|||
156559752|NCT00510276|565140125|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
156559753|NCT00510276|565140126|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
156559754|NCT00510276|565140125|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
156559755|NCT00510276|565140126|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
156559756|NCT00510276|565140125|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
156559757|NCT00510276|565140126|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
156559758|NCT00510276|565140125|FG000|Acute Double-Blind Phase|Physician Decision|0|||
156559759|NCT00510276|565140126|FG001|Acute Double-Blind Phase|Physician Decision|3|||
156559760|NCT00510276|565140125|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
156559761|NCT00510276|565140126|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
156559762|NCT00510276|565140125|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
156559763|NCT00510276|565140126|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
156559764|NCT00510276|565140125|FG000|Acute Double-Blind Phase|Subject Decision|26|||
156559765|NCT00510276|565140126|FG001|Acute Double-Blind Phase|Subject Decision|28|||
156559766|NCT00510276|565140125|FG000|Extension Open-Label Phase|Adverse Event|9|||
156559767|NCT00510276|565140126|FG001|Extension Open-Label Phase|Adverse Event|18|||
156559768|NCT00510276|565140125|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
156559769|NCT00510276|565140126|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
156559770|NCT00510276|565140125|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
156559771|NCT00510276|565140126|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
156559772|NCT00510276|565140125|FG000|Extension Open-Label Phase|Physician Decision|2|||
156559773|NCT00510276|565140126|FG001|Extension Open-Label Phase|Physician Decision|3|||
156559774|NCT00510276|565140125|FG000|Extension Open-Label Phase|Protocol Violation|0|||
156559775|NCT00510276|565140126|FG001|Extension Open-Label Phase|Protocol Violation|1|||
156559776|NCT00510276|565140125|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
156559777|NCT00510276|565140126|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
156559778|NCT00510276|565140125|FG000|Extension Open-Label Phase|Subject Decision|7|||
156559779|NCT00510276|565140126|FG001|Extension Open-Label Phase|Subject Decision|9|||
156559780|NCT01731678|565140129|FG000|Overall Study|Withdrawal by Subject|3|||
156559781|NCT01731678|565140129|FG000|Overall Study|Did not meet inclusion criteria|1|||
156559782|NCT01731678|565140129|FG000|Overall Study|RMT too high, making TMS difficult|3|||
156559783|NCT00354601|565140130|FG000|Overall Study|Protocol Violation|1|||
156559784|NCT00354601|565140130|FG000|Overall Study|progression|1|||
156559785|NCT00666926|565140131|FG000|Overall Study|Adverse Event|0|||
156559786|NCT00666926|565140132|FG001|Overall Study|Adverse Event|0|||
156559787|NCT00666926|565140133|FG002|Overall Study|Adverse Event|0|||
156559788|NCT00666926|565140134|FG003|Overall Study|Adverse Event|0|||
156559789|NCT00666926|565140135|FG004|Overall Study|Adverse Event|0|||
156559790|NCT00666926|565140136|FG005|Overall Study|Adverse Event|0|||
156559791|NCT00666926|565140137|FG006|Overall Study|Adverse Event|0|||
156559792|NCT00666926|565140138|FG007|Overall Study|Adverse Event|0|||
156559793|NCT00666926|565140139|FG008|Overall Study|Adverse Event|0|||
156559794|NCT00666926|565140140|FG009|Overall Study|Adverse Event|2|||
156559795|NCT00666926|565140141|FG010|Overall Study|Adverse Event|2|||
156559796|NCT00666926|565140142|FG011|Overall Study|Adverse Event|2|||
156559797|NCT00666926|565140143|FG012|Overall Study|Adverse Event|0|||
156559798|NCT00666926|565140144|FG013|Overall Study|Adverse Event|1|||
156559799|NCT00666926|565140145|FG014|Overall Study|Adverse Event|0|||
156559800|NCT00666926|565140146|FG015|Overall Study|Adverse Event|0|||
156559801|NCT00666926|565140131|FG000|Overall Study|Laboratory abnormality|0|||
156559802|NCT00666926|565140132|FG001|Overall Study|Laboratory abnormality|0|||
156559803|NCT00666926|565140133|FG002|Overall Study|Laboratory abnormality|0|||
156559804|NCT00666926|565140134|FG003|Overall Study|Laboratory abnormality|0|||
156559805|NCT00666926|565140135|FG004|Overall Study|Laboratory abnormality|0|||
156559806|NCT00666926|565140136|FG005|Overall Study|Laboratory abnormality|0|||
156559807|NCT00666926|565140137|FG006|Overall Study|Laboratory abnormality|0|||
156559808|NCT00666926|565140138|FG007|Overall Study|Laboratory abnormality|0|||
156559809|NCT00666926|565140139|FG008|Overall Study|Laboratory abnormality|0|||
156559810|NCT00666926|565140140|FG009|Overall Study|Laboratory abnormality|0|||
156559811|NCT00666926|565140141|FG010|Overall Study|Laboratory abnormality|1|||
156559812|NCT00666926|565140142|FG011|Overall Study|Laboratory abnormality|0|||
156559813|NCT00666926|565140143|FG012|Overall Study|Laboratory abnormality|0|||
156559814|NCT00666926|565140144|FG013|Overall Study|Laboratory abnormality|0|||
156559815|NCT00666926|565140145|FG014|Overall Study|Laboratory abnormality|0|||
156559816|NCT00666926|565140146|FG015|Overall Study|Laboratory abnormality|1|||
156559817|NCT00666926|565140131|FG000|Overall Study|Lack of Efficacy|0|||
156559818|NCT00666926|565140132|FG001|Overall Study|Lack of Efficacy|0|||
156559819|NCT00666926|565140133|FG002|Overall Study|Lack of Efficacy|0|||
156559820|NCT00666926|565140134|FG003|Overall Study|Lack of Efficacy|0|||
156559821|NCT00666926|565140135|FG004|Overall Study|Lack of Efficacy|0|||
156559822|NCT00666926|565140136|FG005|Overall Study|Lack of Efficacy|1|||
156559823|NCT00666926|565140137|FG006|Overall Study|Lack of Efficacy|0|||
156559824|NCT00666926|565140138|FG007|Overall Study|Lack of Efficacy|0|||
156559825|NCT00666926|565140139|FG008|Overall Study|Lack of Efficacy|0|||
156559826|NCT00666926|565140140|FG009|Overall Study|Lack of Efficacy|0|||
156559827|NCT00666926|565140141|FG010|Overall Study|Lack of Efficacy|0|||
156559828|NCT00666926|565140142|FG011|Overall Study|Lack of Efficacy|1|||
156559829|NCT00666926|565140143|FG012|Overall Study|Lack of Efficacy|0|||
156559830|NCT00666926|565140144|FG013|Overall Study|Lack of Efficacy|0|||
156559831|NCT00666926|565140145|FG014|Overall Study|Lack of Efficacy|0|||
156559832|NCT00666926|565140146|FG015|Overall Study|Lack of Efficacy|0|||
156559833|NCT00666926|565140131|FG000|Overall Study|Lost to Follow-up|0|||
156559834|NCT00666926|565140132|FG001|Overall Study|Lost to Follow-up|0|||
156559835|NCT00666926|565140133|FG002|Overall Study|Lost to Follow-up|0|||
156559836|NCT00666926|565140134|FG003|Overall Study|Lost to Follow-up|1|||
156559837|NCT00666926|565140135|FG004|Overall Study|Lost to Follow-up|0|||
156559838|NCT00666926|565140136|FG005|Overall Study|Lost to Follow-up|0|||
156559839|NCT00666926|565140137|FG006|Overall Study|Lost to Follow-up|0|||
156559840|NCT00666926|565140138|FG007|Overall Study|Lost to Follow-up|0|||
156559841|NCT00666926|565140139|FG008|Overall Study|Lost to Follow-up|0|||
156559842|NCT00666926|565140140|FG009|Overall Study|Lost to Follow-up|0|||
156559843|NCT00666926|565140141|FG010|Overall Study|Lost to Follow-up|0|||
156559844|NCT00666926|565140142|FG011|Overall Study|Lost to Follow-up|0|||
156559845|NCT00666926|565140143|FG012|Overall Study|Lost to Follow-up|0|||
156559846|NCT00666926|565140144|FG013|Overall Study|Lost to Follow-up|0|||
156559847|NCT00666926|565140145|FG014|Overall Study|Lost to Follow-up|0|||
156559848|NCT00666926|565140146|FG015|Overall Study|Lost to Follow-up|0|||
156559849|NCT00666926|565140131|FG000|Overall Study|Other|2|||
156559850|NCT00666926|565140132|FG001|Overall Study|Other|4|||
156559851|NCT00666926|565140133|FG002|Overall Study|Other|3|||
156559852|NCT00666926|565140134|FG003|Overall Study|Other|3|||
156559853|NCT00666926|565140135|FG004|Overall Study|Other|3|||
156559854|NCT00666926|565140136|FG005|Overall Study|Other|3|||
156559855|NCT00666926|565140137|FG006|Overall Study|Other|4|||
156559856|NCT00666926|565140138|FG007|Overall Study|Other|0|||
156559857|NCT00666926|565140139|FG008|Overall Study|Other|3|||
156559858|NCT00666926|565140140|FG009|Overall Study|Other|5|||
156559859|NCT00666926|565140141|FG010|Overall Study|Other|3|||
156559860|NCT00666926|565140142|FG011|Overall Study|Other|26|||
156559861|NCT00666926|565140143|FG012|Overall Study|Other|3|||
156559862|NCT00666926|565140144|FG013|Overall Study|Other|2|||
156559863|NCT00666926|565140145|FG014|Overall Study|Other|4|||
156559864|NCT00666926|565140146|FG015|Overall Study|Other|4|||
156559865|NCT00666926|565140131|FG000|Overall Study|Withdrawal by Subject|0|||
156559866|NCT00666926|565140132|FG001|Overall Study|Withdrawal by Subject|0|||
156559867|NCT00666926|565140133|FG002|Overall Study|Withdrawal by Subject|0|||
156559868|NCT00666926|565140134|FG003|Overall Study|Withdrawal by Subject|0|||
156559869|NCT00666926|565140135|FG004|Overall Study|Withdrawal by Subject|0|||
156559870|NCT00666926|565140136|FG005|Overall Study|Withdrawal by Subject|0|||
156559871|NCT00666926|565140137|FG006|Overall Study|Withdrawal by Subject|0|||
156559872|NCT00666926|565140138|FG007|Overall Study|Withdrawal by Subject|1|||
156559873|NCT00666926|565140139|FG008|Overall Study|Withdrawal by Subject|0|||
156559874|NCT00666926|565140140|FG009|Overall Study|Withdrawal by Subject|3|||
156559875|NCT00666926|565140141|FG010|Overall Study|Withdrawal by Subject|0|||
156559876|NCT00666926|565140142|FG011|Overall Study|Withdrawal by Subject|3|||
156559877|NCT00666926|565140143|FG012|Overall Study|Withdrawal by Subject|0|||
156559878|NCT00666926|565140144|FG013|Overall Study|Withdrawal by Subject|1|||
156559879|NCT00666926|565140145|FG014|Overall Study|Withdrawal by Subject|3|||
156559880|NCT00666926|565140146|FG015|Overall Study|Withdrawal by Subject|3|||
156559881|NCT00666926|565140131|FG000|Overall Study|Death|0|||
156559882|NCT00666926|565140132|FG001|Overall Study|Death|0|||
156559883|NCT00666926|565140133|FG002|Overall Study|Death|0|||
156559884|NCT00666926|565140134|FG003|Overall Study|Death|0|||
156559885|NCT00666926|565140135|FG004|Overall Study|Death|0|||
156559886|NCT00666926|565140136|FG005|Overall Study|Death|0|||
156559887|NCT00666926|565140137|FG006|Overall Study|Death|0|||
156559888|NCT00666926|565140138|FG007|Overall Study|Death|0|||
156559889|NCT00666926|565140139|FG008|Overall Study|Death|0|||
156559890|NCT00666926|565140140|FG009|Overall Study|Death|0|||
156559891|NCT00666926|565140141|FG010|Overall Study|Death|0|||
156559892|NCT00666926|565140142|FG011|Overall Study|Death|1|||
156559893|NCT00666926|565140143|FG012|Overall Study|Death|0|||
156559894|NCT00666926|565140144|FG013|Overall Study|Death|0|||
156559895|NCT00666926|565140145|FG014|Overall Study|Death|0|||
156559896|NCT00666926|565140146|FG015|Overall Study|Death|0|||
156559897|NCT01960855|565140147|FG000|Overall Study|Subject noncompliant|1|||
156559898|NCT01960855|565140148|FG001|Overall Study|Subject noncompliant|0|||
156559899|NCT01960855|565140149|FG002|Overall Study|Subject noncompliant|0|||
156559900|NCT01960855|565140150|FG003|Overall Study|Subject noncompliant|0|||
156559901|NCT01960855|565140151|FG004|Overall Study|Subject noncompliant|0|||
156559902|NCT01960855|565140147|FG000|Overall Study|Adverse Event|2|||
156559903|NCT01960855|565140148|FG001|Overall Study|Adverse Event|0|||
156559904|NCT01960855|565140149|FG002|Overall Study|Adverse Event|6|||
156559905|NCT01960855|565140150|FG003|Overall Study|Adverse Event|2|||
156559906|NCT01960855|565140151|FG004|Overall Study|Adverse Event|2|||
156559907|NCT01960855|565140147|FG000|Overall Study|Lack of Efficacy|1|||
156559908|NCT01960855|565140148|FG001|Overall Study|Lack of Efficacy|1|||
156559909|NCT01960855|565140149|FG002|Overall Study|Lack of Efficacy|0|||
156559910|NCT01960855|565140150|FG003|Overall Study|Lack of Efficacy|0|||
156559911|NCT01960855|565140151|FG004|Overall Study|Lack of Efficacy|0|||
156559912|NCT01960855|565140147|FG000|Overall Study|Other|2|||
156559913|NCT01960855|565140148|FG001|Overall Study|Other|1|||
156559914|NCT01960855|565140149|FG002|Overall Study|Other|1|||
156514854|NCT00591721|564977876|FG001|Overall Study|Lost to Follow-up|4|||
156514855|NCT00591721|564977875|FG000|Overall Study|Intervention not received|10|||
156514856|NCT00591721|564977876|FG001|Overall Study|Intervention not received|8|||
156514857|NCT02134977|564977877|FG000|Overall Study|Protocol Deviation|102|||
156514858|NCT03828747|564977878|FG000|Double-Blind Treatment Period|Adverse Event|6|||
156514859|NCT03828747|564977879|FG001|Double-Blind Treatment Period|Adverse Event|6|||
156514860|NCT03828747|564977878|FG000|Double-Blind Treatment Period|Death|1|||
156514861|NCT03828747|564977879|FG001|Double-Blind Treatment Period|Death|1|||
156514862|NCT03828747|564977878|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156514863|NCT03828747|564977879|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
156514864|NCT03828747|564977878|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
156514865|NCT03828747|564977879|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
156514866|NCT03828747|564977878|FG000|Double-Blind Treatment Period|Physician Decision|1|||
156514867|NCT03828747|564977879|FG001|Double-Blind Treatment Period|Physician Decision|4|||
156559915|NCT01960855|565140150|FG003|Overall Study|Other|1|||
156559916|NCT01960855|565140151|FG004|Overall Study|Other|0|||
156559917|NCT01960855|565140147|FG000|Overall Study|Consent withdrawn by subject|3|||
156559918|NCT01960855|565140148|FG001|Overall Study|Consent withdrawn by subject|1|||
156559919|NCT01960855|565140149|FG002|Overall Study|Consent withdrawn by subject|2|||
156559920|NCT01960855|565140150|FG003|Overall Study|Consent withdrawn by subject|1|||
156514868|NCT03828747|564977878|FG000|Double-Blind Treatment Period|Various reasons|5|||
156514869|NCT03828747|564977879|FG001|Double-Blind Treatment Period|Various reasons|3|||
156514870|NCT03828747|564977878|FG000|Open-Label Extension|Adverse Event|9|||
156514871|NCT03828747|564977879|FG001|Open-Label Extension|Adverse Event|7|||
156559921|NCT01960855|565140151|FG004|Overall Study|Consent withdrawn by subject|1|||
156559922|NCT01960855|565140147|FG000|Overall Study|Lost to Follow-up|2|||
156559923|NCT01960855|565140148|FG001|Overall Study|Lost to Follow-up|1|||
156559924|NCT01960855|565140149|FG002|Overall Study|Lost to Follow-up|0|||
156559925|NCT01960855|565140150|FG003|Overall Study|Lost to Follow-up|0|||
156559926|NCT01960855|565140151|FG004|Overall Study|Lost to Follow-up|2|||
156559927|NCT01318122|565140154|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156559928|NCT01318122|565140155|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156559929|NCT01318122|565140156|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
156514872|NCT03828747|564977878|FG000|Open-Label Extension|Death|0|||
156514873|NCT03828747|564977879|FG001|Open-Label Extension|Death|2|||
156514874|NCT03828747|564977878|FG000|Open-Label Extension|Lost to Follow-up|4|||
156514875|NCT03828747|564977879|FG001|Open-Label Extension|Lost to Follow-up|0|||
156514876|NCT03828747|564977878|FG000|Open-Label Extension|Withdrawal by Subject|31|||
156514877|NCT03828747|564977879|FG001|Open-Label Extension|Withdrawal by Subject|30|||
156514878|NCT03828747|564977878|FG000|Open-Label Extension|Various reasons|4|||
156514879|NCT03828747|564977879|FG001|Open-Label Extension|Various reasons|4|||
156514880|NCT03828747|564977878|FG000|Open-Label Extension|Physician Decision|6|||
156514881|NCT03828747|564977879|FG001|Open-Label Extension|Physician Decision|2|||
156514882|NCT03646656|564977880|FG000|Overall Study|Lost to Follow-up|1|||
156514883|NCT03646656|564977881|FG001|Overall Study|Lost to Follow-up|0|||
156514884|NCT03646656|564977880|FG000|Overall Study|Withdrawal by Subject|2|||
156559930|NCT01318122|565140157|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
156559931|NCT01318122|565140154|FG000|Enrolled - Long-Term Extension Study|Other|1|||
156559932|NCT01318122|565140155|FG001|Enrolled - Long-Term Extension Study|Other|0|||
156559933|NCT01318122|565140156|FG002|Enrolled - Long-Term Extension Study|Other|0|||
156559934|NCT01318122|565140157|FG003|Enrolled - Long-Term Extension Study|Other|0|||
156559935|NCT01318122|565140154|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
156559936|NCT01318122|565140155|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
156559937|NCT01318122|565140156|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
156559938|NCT01318122|565140157|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
156559939|NCT01318122|565140154|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
156559940|NCT01318122|565140155|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156559941|NCT01318122|565140156|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156559942|NCT01318122|565140157|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
156559943|NCT01318122|565140154|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156559944|NCT01318122|565140155|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
156559945|NCT01318122|565140156|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156559946|NCT01318122|565140157|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156559947|NCT01318122|565140154|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
156559948|NCT01318122|565140155|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
156559949|NCT01318122|565140156|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
156559950|NCT01318122|565140157|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
156559951|NCT01486199|565140158|FG000|Two Year Period Between Study Days|Physician Decision|1|||
156559952|NCT01486199|565140159|FG001|Two Year Period Between Study Days|Physician Decision|0|||
156559953|NCT00820755|565140160|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
156559954|NCT00820755|565140161|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
156559955|NCT00820755|565140162|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
156559956|NCT00820755|565140160|FG000|Period 1: Combination Therapy Phase|Death|28|||
156559957|NCT00820755|565140161|FG001|Period 1: Combination Therapy Phase|Death|0|||
156559958|NCT00820755|565140162|FG002|Period 1: Combination Therapy Phase|Death|0|||
156559959|NCT00820755|565140160|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
156559960|NCT00820755|565140161|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
156559961|NCT00820755|565140162|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
156559962|NCT00820755|565140160|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
156559963|NCT00820755|565140161|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
156559964|NCT00820755|565140162|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
156559965|NCT00820755|565140160|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
156559966|NCT00820755|565140161|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
156559967|NCT00820755|565140162|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
156559968|NCT00820755|565140160|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
156559969|NCT00820755|565140161|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
156559970|NCT00820755|565140162|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
156559971|NCT00820755|565140160|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
156559972|NCT00820755|565140161|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
156559973|NCT00820755|565140162|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
156559974|NCT00820755|565140160|FG000|Period 1: Combination Therapy Phase|Other|11|||
156559975|NCT00820755|565140161|FG001|Period 1: Combination Therapy Phase|Other|0|||
156559976|NCT00820755|565140162|FG002|Period 1: Combination Therapy Phase|Other|0|||
156559977|NCT00820755|565140160|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
156514885|NCT03646656|564977881|FG001|Overall Study|Withdrawal by Subject|0|||
156514886|NCT03507777|564977882|FG000|Overall Study|Lost to Follow-up|5|||
156514887|NCT03507777|564977883|FG001|Overall Study|Lost to Follow-up|7|||
156514888|NCT03507777|564977882|FG000|Overall Study|Withdrawal by Subject|6|||
156514889|NCT03507777|564977883|FG001|Overall Study|Withdrawal by Subject|11|||
156514890|NCT03507777|564977882|FG000|Overall Study|Death|30|||
156514891|NCT03507777|564977883|FG001|Overall Study|Death|44|||
156514892|NCT03507777|564977882|FG000|Overall Study|Other Reasons|3|||
156514893|NCT03507777|564977883|FG001|Overall Study|Other Reasons|8|||
156559978|NCT00820755|565140161|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
156559979|NCT00820755|565140162|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
156559980|NCT02154425|565140168|FG000|Screening Period|Adverse Event|1|||
156559981|NCT02251912|565140169|FG000|Overall Study|Withdrawal by Subject|2|||
156559982|NCT02251912|565140170|FG001|Overall Study|Withdrawal by Subject|3|||
156559983|NCT02251912|565140169|FG000|Overall Study|Adverse Event|0|||
156559984|NCT02251912|565140170|FG001|Overall Study|Adverse Event|2|||
156559985|NCT01133171|565140172|FG000|Overall Study|Withdrawal by Subject|1|||
156559986|NCT01133171|565140173|FG001|Overall Study|Withdrawal by Subject|2|||
156559987|NCT01133171|565140174|FG002|Overall Study|Withdrawal by Subject|0|||
156559988|NCT04062214|565140176|FG000|Week 12|Death|1|||
156559989|NCT04062214|565140177|FG001|Week 12|Death|1|||
156559990|NCT04062214|565140176|FG000|Week 12|Withdrawal by Subject|14|||
156559991|NCT04062214|565140177|FG001|Week 12|Withdrawal by Subject|13|||
156559992|NCT04062214|565140176|FG000|Week 12|Lost to Follow-up|55|||
156559993|NCT04062214|565140177|FG001|Week 12|Lost to Follow-up|68|||
156559994|NCT04062214|565140176|FG000|Week 12|Intermittent missing|31|||
156559995|NCT04062214|565140177|FG001|Week 12|Intermittent missing|29|||
156559996|NCT04062214|565140176|FG000|Week 36|Withdrawal by Subject|4|||
156559997|NCT04062214|565140177|FG001|Week 36|Withdrawal by Subject|5|||
156559998|NCT04062214|565140176|FG000|Week 36|Lost to Follow-up|50|||
156559999|NCT04062214|565140177|FG001|Week 36|Lost to Follow-up|46|||
156560000|NCT04062214|565140176|FG000|Week 36|Death|0|||
156560001|NCT04062214|565140177|FG001|Week 36|Death|1|||
156560002|NCT00091832|565140178|FG000|Overall Study|Physician Decision|1|||
156560003|NCT00091832|565140179|FG001|Overall Study|Physician Decision|0|||
156560004|NCT00091832|565140180|FG002|Overall Study|Physician Decision|0|||
156560005|NCT00091832|565140181|FG003|Overall Study|Physician Decision|0|||
156560006|NCT00091832|565140182|FG004|Overall Study|Physician Decision|0|||
156560007|NCT00091832|565140183|FG005|Overall Study|Physician Decision|0|||
156560008|NCT00091832|565140178|FG000|Overall Study|Adverse Event|0|||
156560009|NCT00091832|565140179|FG001|Overall Study|Adverse Event|0|||
156560010|NCT00091832|565140180|FG002|Overall Study|Adverse Event|0|||
156560011|NCT00091832|565140181|FG003|Overall Study|Adverse Event|1|||
156560012|NCT00091832|565140182|FG004|Overall Study|Adverse Event|3|||
156560013|NCT00091832|565140183|FG005|Overall Study|Adverse Event|0|||
156560014|NCT00091832|565140178|FG000|Overall Study|Withdrawal by Subject|4|||
156560015|NCT00091832|565140179|FG001|Overall Study|Withdrawal by Subject|5|||
156560016|NCT00091832|565140180|FG002|Overall Study|Withdrawal by Subject|0|||
156560017|NCT00091832|565140181|FG003|Overall Study|Withdrawal by Subject|1|||
156560018|NCT00091832|565140182|FG004|Overall Study|Withdrawal by Subject|3|||
156560019|NCT00091832|565140183|FG005|Overall Study|Withdrawal by Subject|1|||
156560020|NCT00091832|565140178|FG000|Overall Study|Death|6|||
156560021|NCT00091832|565140179|FG001|Overall Study|Death|4|||
156560022|NCT00091832|565140180|FG002|Overall Study|Death|5|||
156560023|NCT00091832|565140181|FG003|Overall Study|Death|8|||
156560024|NCT00091832|565140182|FG004|Overall Study|Death|5|||
156560025|NCT00091832|565140183|FG005|Overall Study|Death|6|||
156560026|NCT00091832|565140178|FG000|Overall Study|Disease Progression|2|||
156560027|NCT00091832|565140179|FG001|Overall Study|Disease Progression|0|||
156560028|NCT00091832|565140180|FG002|Overall Study|Disease Progression|0|||
156560029|NCT00091832|565140181|FG003|Overall Study|Disease Progression|1|||
156560030|NCT00091832|565140182|FG004|Overall Study|Disease Progression|1|||
156560031|NCT00091832|565140183|FG005|Overall Study|Disease Progression|2|||
156560032|NCT00091832|565140178|FG000|Overall Study|Ineligibility Determined|0|||
156560033|NCT00091832|565140179|FG001|Overall Study|Ineligibility Determined|0|||
156560034|NCT00091832|565140180|FG002|Overall Study|Ineligibility Determined|1|||
156560035|NCT00091832|565140181|FG003|Overall Study|Ineligibility Determined|0|||
156560036|NCT00091832|565140182|FG004|Overall Study|Ineligibility Determined|1|||
156560037|NCT00091832|565140183|FG005|Overall Study|Ineligibility Determined|0|||
156560038|NCT00091832|565140178|FG000|Overall Study|Lost to Follow-up|1|||
156560039|NCT00091832|565140179|FG001|Overall Study|Lost to Follow-up|0|||
156560040|NCT00091832|565140180|FG002|Overall Study|Lost to Follow-up|3|||
156560041|NCT00091832|565140181|FG003|Overall Study|Lost to Follow-up|3|||
156560042|NCT00091832|565140182|FG004|Overall Study|Lost to Follow-up|2|||
156560043|NCT00091832|565140183|FG005|Overall Study|Lost to Follow-up|1|||
156560044|NCT00091832|565140178|FG000|Overall Study|Noncompliance|0|||
156560045|NCT00091832|565140179|FG001|Overall Study|Noncompliance|1|||
156560046|NCT00091832|565140180|FG002|Overall Study|Noncompliance|0|||
156560047|NCT00091832|565140181|FG003|Overall Study|Noncompliance|0|||
156560048|NCT00091832|565140182|FG004|Overall Study|Noncompliance|0|||
156560049|NCT00091832|565140183|FG005|Overall Study|Noncompliance|0|||
156560050|NCT00091832|565140178|FG000|Overall Study|Other|0|||
156560051|NCT00091832|565140179|FG001|Overall Study|Other|1|||
156560052|NCT00091832|565140180|FG002|Overall Study|Other|2|||
156863431|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
156560053|NCT00091832|565140181|FG003|Overall Study|Other|0|||
156560054|NCT00091832|565140182|FG004|Overall Study|Other|0|||
156560055|NCT00091832|565140183|FG005|Overall Study|Other|0|||
156560056|NCT00091832|565140178|FG000|Overall Study|Protocol Violation|0|||
156560057|NCT00091832|565140179|FG001|Overall Study|Protocol Violation|0|||
156514894|NCT01879722|564977886|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156514895|NCT01879722|564977887|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
156514896|NCT01879722|564977888|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156514897|NCT01879722|564977889|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
156514898|NCT01879722|564977890|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
156514899|NCT01879722|564977891|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
156560058|NCT00091832|565140180|FG002|Overall Study|Protocol Violation|1|||
156560059|NCT00091832|565140181|FG003|Overall Study|Protocol Violation|0|||
156560060|NCT00091832|565140182|FG004|Overall Study|Protocol Violation|0|||
156560061|NCT00091832|565140183|FG005|Overall Study|Protocol Violation|1|||
156560062|NCT03434379|565140187|FG000|Global Period|Lost to Follow-up|3|||
156560063|NCT03434379|565140188|FG001|Global Period|Lost to Follow-up|6|||
156560064|NCT03434379|565140189|FG002|Global Period|Lost to Follow-up|0|||
156560065|NCT03434379|565140190|FG003|Global Period|Lost to Follow-up|0|||
156560066|NCT03434379|565140187|FG000|Global Period|Death|115|||
156560067|NCT03434379|565140188|FG001|Global Period|Death|228|||
156560068|NCT03434379|565140189|FG002|Global Period|Death|0|||
156560069|NCT03434379|565140190|FG003|Global Period|Death|0|||
156560070|NCT03434379|565140187|FG000|Global Period|Withdrawal by Subject|20|||
156560071|NCT03434379|565140188|FG001|Global Period|Withdrawal by Subject|21|||
156560072|NCT03434379|565140189|FG002|Global Period|Withdrawal by Subject|0|||
156560073|NCT03434379|565140190|FG003|Global Period|Withdrawal by Subject|0|||
156560074|NCT03434379|565140187|FG000|Global Period|Reason Unspecified|0|||
156560075|NCT03434379|565140188|FG001|Global Period|Reason Unspecified|1|||
156560076|NCT03434379|565140189|FG002|Global Period|Reason Unspecified|0|||
156560077|NCT03434379|565140190|FG003|Global Period|Reason Unspecified|0|||
156560078|NCT03434379|565140187|FG000|Global Period|Study Ended by Sponsor|26|||
156560079|NCT03434379|565140188|FG001|Global Period|Study Ended by Sponsor|80|||
156560080|NCT03434379|565140189|FG002|Global Period|Study Ended by Sponsor|0|||
156560081|NCT03434379|565140190|FG003|Global Period|Study Ended by Sponsor|0|||
156560082|NCT03434379|565140187|FG000|Global Period|Physician Decision|1|||
156560083|NCT03434379|565140188|FG001|Global Period|Physician Decision|0|||
156560084|NCT03434379|565140189|FG002|Global Period|Physician Decision|0|||
156560085|NCT03434379|565140190|FG003|Global Period|Physician Decision|0|||
156560086|NCT03434379|565140187|FG000|China Extension Period|Lost to Follow-up|0|||
156560087|NCT03434379|565140188|FG001|China Extension Period|Lost to Follow-up|0|||
156560088|NCT03434379|565140189|FG002|China Extension Period|Lost to Follow-up|2|||
156560089|NCT03434379|565140190|FG003|China Extension Period|Lost to Follow-up|3|||
156560090|NCT03434379|565140187|FG000|China Extension Period|Death|0|||
156560091|NCT03434379|565140188|FG001|China Extension Period|Death|0|||
156560092|NCT03434379|565140189|FG002|China Extension Period|Death|46|||
156560093|NCT03434379|565140190|FG003|China Extension Period|Death|88|||
156560094|NCT03434379|565140187|FG000|China Extension Period|Withdrawal by Subject|0|||
156560095|NCT03434379|565140188|FG001|China Extension Period|Withdrawal by Subject|0|||
156560096|NCT03434379|565140189|FG002|China Extension Period|Withdrawal by Subject|8|||
156560097|NCT03434379|565140190|FG003|China Extension Period|Withdrawal by Subject|6|||
156560098|NCT03434379|565140187|FG000|China Extension Period|Study Ended by Sponsor|0|||
156560099|NCT03434379|565140188|FG001|China Extension Period|Study Ended by Sponsor|0|||
156560100|NCT03434379|565140189|FG002|China Extension Period|Study Ended by Sponsor|5|||
156560101|NCT03434379|565140190|FG003|China Extension Period|Study Ended by Sponsor|36|||
156560102|NCT00686647|565140196|FG000|Overall Study|Lost to Follow-up|1|||
156560103|NCT00686647|565140196|FG000|Overall Study|Death|1|||
156560104|NCT00578643|565140197|FG000|Overall Study|Death|1|||
156560105|NCT00578643|565140197|FG000|Overall Study|Lost to Follow-up|1|||
156560106|NCT01725750|565140198|FG000|Overall Study|Adverse Event|1|||
156560107|NCT01725750|565140199|FG001|Overall Study|Adverse Event|0|||
156560108|NCT01725750|565140198|FG000|Overall Study|Lost to Follow-up|1|||
156560109|NCT01725750|565140199|FG001|Overall Study|Lost to Follow-up|1|||
156560110|NCT01725750|565140198|FG000|Overall Study|Withdrawal by Subject|0|||
156560111|NCT01725750|565140199|FG001|Overall Study|Withdrawal by Subject|9|||
156560112|NCT03828487|565140202|FG000|Overall Study|Physician Decision|1|||
156560113|NCT03179436|565140204|FG000|Overall Study|Withdrawal by Subject|1|||
156514900|NCT01879722|564977892|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
156514901|NCT01879722|564977893|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
156514902|NCT01879722|564977894|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
156560114|NCT03179436|565140205|FG001|Overall Study|Withdrawal by Subject|0|||
156560115|NCT03179436|565140206|FG002|Overall Study|Withdrawal by Subject|0|||
156560116|NCT03179436|565140207|FG003|Overall Study|Withdrawal by Subject|4|||
156560117|NCT03179436|565140208|FG004|Overall Study|Withdrawal by Subject|2|||
156560118|NCT03179436|565140209|FG005|Overall Study|Withdrawal by Subject|2|||
156560119|NCT03179436|565140210|FG006|Overall Study|Withdrawal by Subject|5|||
156560120|NCT03179436|565140211|FG007|Overall Study|Withdrawal by Subject|0|||
156560121|NCT03179436|565140212|FG008|Overall Study|Withdrawal by Subject|3|||
156514903|NCT01879722|564977895|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
156560122|NCT03179436|565140213|FG009|Overall Study|Withdrawal by Subject|0|||
156560123|NCT03179436|565140214|FG010|Overall Study|Withdrawal by Subject|0|||
156560124|NCT03179436|565140215|FG011|Overall Study|Withdrawal by Subject|0|||
156514904|NCT01879722|564977886|FG000|Overall Study|Voluntary Withdrawal|0|||
156514905|NCT01879722|564977887|FG001|Overall Study|Voluntary Withdrawal|0|||
156514906|NCT01879722|564977888|FG002|Overall Study|Voluntary Withdrawal|0|||
156514907|NCT01879722|564977889|FG003|Overall Study|Voluntary Withdrawal|0|||
156514908|NCT01879722|564977890|FG004|Overall Study|Voluntary Withdrawal|0|||
156514909|NCT01879722|564977891|FG005|Overall Study|Voluntary Withdrawal|0|||
156514910|NCT01879722|564977892|FG006|Overall Study|Voluntary Withdrawal|0|||
156514911|NCT01879722|564977893|FG007|Overall Study|Voluntary Withdrawal|0|||
156514912|NCT01879722|564977894|FG008|Overall Study|Voluntary Withdrawal|1|||
156514913|NCT01879722|564977895|FG009|Overall Study|Voluntary Withdrawal|0|||
156514914|NCT03651622|564977898|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
156514915|NCT03651622|564977899|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
156514916|NCT03651622|564977900|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
156514917|NCT03651622|564977898|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
156514918|NCT03651622|564977899|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
156514919|NCT03651622|564977900|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
156514920|NCT03651622|564977898|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
156514921|NCT03651622|564977899|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
156514922|NCT03651622|564977900|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
156514923|NCT03651622|564977898|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
156514924|NCT03651622|564977899|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
156514925|NCT03651622|564977900|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
156514926|NCT03651622|564977898|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
156514927|NCT03651622|564977899|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
156514928|NCT03651622|564977900|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
156514929|NCT01519089|564977901|FG000|Overall Study|Adverse Event|4|||
156514930|NCT01519089|564977902|FG001|Overall Study|Adverse Event|4|||
156514931|NCT01519089|564977901|FG000|Overall Study|Lack of Efficacy|0|||
156514932|NCT01519089|564977902|FG001|Overall Study|Lack of Efficacy|2|||
156514933|NCT01519089|564977901|FG000|Overall Study|Lost to Follow-up|1|||
156514934|NCT01519089|564977902|FG001|Overall Study|Lost to Follow-up|0|||
156514935|NCT01519089|564977901|FG000|Overall Study|Withdrawal by Subject|0|||
156514936|NCT01519089|564977902|FG001|Overall Study|Withdrawal by Subject|2|||
156514937|NCT01519089|564977901|FG000|Overall Study|Other|2|||
156514938|NCT01519089|564977902|FG001|Overall Study|Other|6|||
156514939|NCT01519089|564977901|FG000|Overall Study|Not received study drug|0|||
156514940|NCT01519089|564977902|FG001|Overall Study|Not received study drug|1|||
156514941|NCT00127205|564977903|FG000|Overall Study|Adverse Event|228|||
156514942|NCT00127205|564977904|FG001|Overall Study|Adverse Event|387|||
156514943|NCT00127205|564977905|FG002|Overall Study|Adverse Event|273|||
156514944|NCT00127205|564977903|FG000|Overall Study|Death|8|||
156514945|NCT00127205|564977904|FG001|Overall Study|Death|6|||
156514946|NCT00127205|564977905|FG002|Overall Study|Death|5|||
156514947|NCT00127205|564977903|FG000|Overall Study|Withdrawal by Subject|318|||
156514948|NCT00127205|564977904|FG001|Overall Study|Withdrawal by Subject|310|||
156514949|NCT00127205|564977905|FG002|Overall Study|Withdrawal by Subject|172|||
156514950|NCT00127205|564977903|FG000|Overall Study|Other-non protocol specified|142|||
156514951|NCT00127205|564977904|FG001|Overall Study|Other-non protocol specified|129|||
156514952|NCT00127205|564977905|FG002|Overall Study|Other-non protocol specified|77|||
156514953|NCT00127205|564977903|FG000|Overall Study|Data not reported|6|||
156514954|NCT00127205|564977904|FG001|Overall Study|Data not reported|10|||
156514955|NCT00127205|564977905|FG002|Overall Study|Data not reported|1|||
156514956|NCT00127205|564977903|FG000|Overall Study|Progression|127|||
156514957|NCT00127205|564977904|FG001|Overall Study|Progression|131|||
156514958|NCT00127205|564977905|FG002|Overall Study|Progression|84|||
156514959|NCT03527550|564977908|FG000|Overall Study|Lost to Follow-up|4|||
156514960|NCT03527550|564977909|FG001|Overall Study|Lost to Follow-up|2|||
156514961|NCT03527550|564977908|FG000|Overall Study|Withdrawal by Subject|4|||
156514962|NCT03527550|564977909|FG001|Overall Study|Withdrawal by Subject|1|||
156514963|NCT03527550|564977908|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
156514964|NCT03527550|564977909|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
156514965|NCT01659853|564977910|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
156514966|NCT01659853|564977911|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
156514967|NCT01659853|564977910|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
156514968|NCT01659853|564977911|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
156514969|NCT03053518|564977914|FG000|Overall Study|Withdrawal by Subject|3|||
156514970|NCT03053518|564977914|FG000|Overall Study|Lost to Follow-up|2|||
156514971|NCT03053518|564977914|FG000|Overall Study|Ineligible|5|||
156514972|NCT02683876|564977915|FG000|Overall Study|samples damaged during shipping|2|||
156514973|NCT02683876|564977916|FG001|Overall Study|samples damaged during shipping|0|||
156514974|NCT00859222|564977919|FG000|Overall Study|Adverse Event|2|||
156514975|NCT00859222|564977920|FG001|Overall Study|Adverse Event|3|||
156514976|NCT00859222|564977921|FG002|Overall Study|Adverse Event|6|||
156514977|NCT00859222|564977922|FG003|Overall Study|Adverse Event|24|||
156514978|NCT00859222|564977923|FG004|Overall Study|Adverse Event|15|||
156514979|NCT00859222|564977919|FG000|Overall Study|DLT|1|||
156514980|NCT00859222|564977920|FG001|Overall Study|DLT|0|||
156560125|NCT03179436|565140204|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156560126|NCT03179436|565140205|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156560127|NCT03179436|565140206|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156560128|NCT03179436|565140207|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156560129|NCT03179436|565140208|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156560130|NCT03179436|565140209|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156514981|NCT00859222|564977921|FG002|Overall Study|DLT|0|||
156514982|NCT00859222|564977922|FG003|Overall Study|DLT|0|||
156514983|NCT00859222|564977923|FG004|Overall Study|DLT|0|||
156514984|NCT00488475|564977924|FG000|Overall Study|Other|1754|||
156514985|NCT02797080|564977928|FG000|Overall Study|Lost to Follow-up|1|||
156514986|NCT02797080|564977928|FG000|Overall Study|Withdrawal by Subject|1|||
156514987|NCT04035499|564977931|FG000|Overall Study|Death|2|||
156514988|NCT04035499|564977931|FG000|Overall Study|Withdrawal by Subject|1|||
156514989|NCT00951015|564977932|FG000|Randomization Phase 96 Week|Adverse Event|1|||
156514990|NCT00951015|564977933|FG001|Randomization Phase 96 Week|Adverse Event|1|||
156514991|NCT00951015|564977934|FG002|Randomization Phase 96 Week|Adverse Event|2|||
156514992|NCT00951015|564977935|FG003|Randomization Phase 96 Week|Adverse Event|5|||
156514993|NCT00951015|564977936|FG004|Randomization Phase 96 Week|Adverse Event|0|||
156514994|NCT00951015|564977932|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
156514995|NCT00951015|564977933|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
156514996|NCT00951015|564977934|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
156514997|NCT00951015|564977935|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
156514998|NCT00951015|564977936|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
156514999|NCT00951015|564977932|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
156515000|NCT00951015|564977933|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
156515001|NCT00951015|564977934|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
156515002|NCT00951015|564977935|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
156515003|NCT00951015|564977936|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
156515004|NCT00951015|564977932|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
156515005|NCT00951015|564977933|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
156515006|NCT00951015|564977934|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
156515007|NCT00951015|564977935|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
156515008|NCT00951015|564977936|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
156515009|NCT00951015|564977932|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
156515010|NCT00951015|564977933|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
156515011|NCT00951015|564977934|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
156515012|NCT00951015|564977935|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
156515013|NCT00951015|564977936|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
156515014|NCT00951015|564977932|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
156515015|NCT00951015|564977933|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
156515016|NCT00951015|564977934|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
156515017|NCT00951015|564977935|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
156515018|NCT00951015|564977936|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
156515019|NCT00951015|564977932|FG000|Open-label Phase|Adverse Event|0|||
156515020|NCT00951015|564977933|FG001|Open-label Phase|Adverse Event|0|||
156515021|NCT00951015|564977934|FG002|Open-label Phase|Adverse Event|0|||
156515022|NCT00951015|564977935|FG003|Open-label Phase|Adverse Event|0|||
156515023|NCT00951015|564977936|FG004|Open-label Phase|Adverse Event|3|||
156515024|NCT00951015|564977932|FG000|Open-label Phase|Lack of Efficacy|0|||
156515025|NCT00951015|564977933|FG001|Open-label Phase|Lack of Efficacy|0|||
156515026|NCT00951015|564977934|FG002|Open-label Phase|Lack of Efficacy|0|||
156515027|NCT00951015|564977935|FG003|Open-label Phase|Lack of Efficacy|0|||
156515028|NCT00951015|564977936|FG004|Open-label Phase|Lack of Efficacy|1|||
156515029|NCT00951015|564977932|FG000|Open-label Phase|Protocol Violation|0|||
156515030|NCT00951015|564977933|FG001|Open-label Phase|Protocol Violation|0|||
156515031|NCT00951015|564977934|FG002|Open-label Phase|Protocol Violation|0|||
156515032|NCT00951015|564977935|FG003|Open-label Phase|Protocol Violation|0|||
156560131|NCT03179436|565140210|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
156560132|NCT03179436|565140211|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
156515033|NCT00951015|564977936|FG004|Open-label Phase|Protocol Violation|12|||
156515034|NCT00951015|564977932|FG000|Open-label Phase|Lost to Follow-up|0|||
156515035|NCT00951015|564977933|FG001|Open-label Phase|Lost to Follow-up|0|||
156515036|NCT00951015|564977934|FG002|Open-label Phase|Lost to Follow-up|0|||
156515037|NCT00951015|564977935|FG003|Open-label Phase|Lost to Follow-up|0|||
156515038|NCT00951015|564977936|FG004|Open-label Phase|Lost to Follow-up|12|||
156515039|NCT00951015|564977932|FG000|Open-label Phase|Withdrawal by Subject|0|||
156515040|NCT00951015|564977933|FG001|Open-label Phase|Withdrawal by Subject|0|||
156515041|NCT00951015|564977934|FG002|Open-label Phase|Withdrawal by Subject|0|||
156560133|NCT03179436|565140212|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
156560134|NCT03179436|565140213|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
156560135|NCT03179436|565140214|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
156560136|NCT03179436|565140215|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
156560137|NCT03179436|565140204|FG000|Overall Study|Sponsor Decision|0|||
156560138|NCT03179436|565140205|FG001|Overall Study|Sponsor Decision|0|||
156560139|NCT03179436|565140206|FG002|Overall Study|Sponsor Decision|1|||
156560140|NCT03179436|565140207|FG003|Overall Study|Sponsor Decision|3|||
156560141|NCT03179436|565140208|FG004|Overall Study|Sponsor Decision|9|||
156560142|NCT03179436|565140209|FG005|Overall Study|Sponsor Decision|7|||
156560143|NCT03179436|565140210|FG006|Overall Study|Sponsor Decision|2|||
156560144|NCT03179436|565140211|FG007|Overall Study|Sponsor Decision|4|||
156560145|NCT03179436|565140212|FG008|Overall Study|Sponsor Decision|23|||
156560146|NCT03179436|565140213|FG009|Overall Study|Sponsor Decision|6|||
156560147|NCT03179436|565140214|FG010|Overall Study|Sponsor Decision|7|||
156560148|NCT03179436|565140215|FG011|Overall Study|Sponsor Decision|5|||
156560149|NCT03179436|565140204|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560150|NCT03179436|565140205|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
156560151|NCT03179436|565140206|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560152|NCT03179436|565140207|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560153|NCT03179436|565140208|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560154|NCT03179436|565140209|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
156560155|NCT03179436|565140210|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560156|NCT03179436|565140211|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560157|NCT03179436|565140212|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560158|NCT03179436|565140213|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560159|NCT03179436|565140214|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560160|NCT03179436|565140215|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
156560161|NCT03179436|565140204|FG000|Overall Study|Lost to Follow-up|1|||
156560162|NCT03179436|565140205|FG001|Overall Study|Lost to Follow-up|0|||
156560163|NCT03179436|565140206|FG002|Overall Study|Lost to Follow-up|0|||
156560164|NCT03179436|565140207|FG003|Overall Study|Lost to Follow-up|1|||
156560165|NCT03179436|565140208|FG004|Overall Study|Lost to Follow-up|0|||
156560166|NCT03179436|565140209|FG005|Overall Study|Lost to Follow-up|1|||
156560167|NCT03179436|565140210|FG006|Overall Study|Lost to Follow-up|0|||
156560168|NCT03179436|565140211|FG007|Overall Study|Lost to Follow-up|0|||
156560169|NCT03179436|565140212|FG008|Overall Study|Lost to Follow-up|1|||
156560170|NCT03179436|565140213|FG009|Overall Study|Lost to Follow-up|1|||
156560171|NCT03179436|565140214|FG010|Overall Study|Lost to Follow-up|0|||
156560172|NCT03179436|565140215|FG011|Overall Study|Lost to Follow-up|0|||
156560173|NCT03179436|565140204|FG000|Overall Study|Death|12|||
156560174|NCT03179436|565140205|FG001|Overall Study|Death|17|||
156560175|NCT03179436|565140206|FG002|Overall Study|Death|7|||
156560176|NCT03179436|565140207|FG003|Overall Study|Death|32|||
156560177|NCT03179436|565140208|FG004|Overall Study|Death|29|||
156560178|NCT03179436|565140209|FG005|Overall Study|Death|30|||
156560179|NCT03179436|565140210|FG006|Overall Study|Death|33|||
156560180|NCT03179436|565140211|FG007|Overall Study|Death|9|||
156560181|NCT03179436|565140212|FG008|Overall Study|Death|84|||
156560182|NCT03179436|565140213|FG009|Overall Study|Death|33|||
156560183|NCT03179436|565140214|FG010|Overall Study|Death|22|||
156560184|NCT03179436|565140215|FG011|Overall Study|Death|15|||
156560185|NCT01634555|565140216|FG000|Overall Study|Adverse Event|3|||
156560186|NCT01634555|565140216|FG000|Overall Study|Physician Decision|1|||
156560187|NCT02591615|565141955|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
156560188|NCT02591615|565141956|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
156560189|NCT02591615|565141957|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
156560190|NCT02591615|565141958|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
156560191|NCT02591615|565141955|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
156560192|NCT02591615|565141956|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
156560193|NCT02591615|565141957|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
156560194|NCT02591615|565141958|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
156560195|NCT02591615|565141955|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
156560196|NCT02591615|565141956|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
156560197|NCT02591615|565141957|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
156560198|NCT02591615|565141958|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
156560199|NCT02591615|565141955|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
156560200|NCT02591615|565141956|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
156560201|NCT02591615|565141957|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
156560202|NCT02591615|565141958|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
156560203|NCT02591615|565141955|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
156560204|NCT02591615|565141956|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
156560205|NCT02591615|565141957|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
156515042|NCT00951015|564977935|FG003|Open-label Phase|Withdrawal by Subject|0|||
156515043|NCT00951015|564977936|FG004|Open-label Phase|Withdrawal by Subject|14|||
156515044|NCT00951015|564977932|FG000|Open-label Phase|Physician Decision|0|||
156515045|NCT00951015|564977933|FG001|Open-label Phase|Physician Decision|0|||
156515046|NCT00951015|564977934|FG002|Open-label Phase|Physician Decision|0|||
156515047|NCT00951015|564977935|FG003|Open-label Phase|Physician Decision|0|||
156515048|NCT00951015|564977936|FG004|Open-label Phase|Physician Decision|8|||
156515049|NCT03819634|564977938|FG000|Overall Study|Physician Decision|2|||
156515050|NCT01416389|564977939|FG000|Overall Study|Lost to Follow-up|1|||
156515051|NCT01416389|564977940|FG001|Overall Study|Lost to Follow-up|0|||
156515052|NCT01416389|564977939|FG000|Overall Study|Started New Therapy|2|||
156515053|NCT01416389|564977940|FG001|Overall Study|Started New Therapy|0|||
156515054|NCT01365481|564977941|FG000|Overall Study|Adverse Event|6|||
156515055|NCT01365481|564977942|FG001|Overall Study|Adverse Event|9|||
156515056|NCT01365481|564977943|FG002|Overall Study|Adverse Event|0|||
156515057|NCT01365481|564977944|FG003|Overall Study|Adverse Event|2|||
156515058|NCT01365481|564977941|FG000|Overall Study|Withdrawal by Subject|0|||
156515059|NCT01365481|564977942|FG001|Overall Study|Withdrawal by Subject|2|||
156515060|NCT01365481|564977943|FG002|Overall Study|Withdrawal by Subject|1|||
156515061|NCT01365481|564977944|FG003|Overall Study|Withdrawal by Subject|1|||
156515062|NCT01365481|564977941|FG000|Overall Study|Lost to Follow-up|1|||
156515063|NCT01365481|564977942|FG001|Overall Study|Lost to Follow-up|1|||
156515064|NCT01365481|564977943|FG002|Overall Study|Lost to Follow-up|2|||
156515065|NCT01365481|564977944|FG003|Overall Study|Lost to Follow-up|3|||
156515066|NCT01365481|564977941|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156515067|NCT01365481|564977942|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156515068|NCT01365481|564977943|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156515069|NCT01365481|564977944|FG003|Overall Study|Abnormal laboratory value(s)|0|||
156515070|NCT01365481|564977941|FG000|Overall Study|Administrative problems|0|||
156515071|NCT01365481|564977942|FG001|Overall Study|Administrative problems|1|||
156515072|NCT01365481|564977943|FG002|Overall Study|Administrative problems|0|||
156515073|NCT01365481|564977944|FG003|Overall Study|Administrative problems|0|||
156515074|NCT01365481|564977941|FG000|Overall Study|Protocol deviation|0|||
156515075|NCT01365481|564977942|FG001|Overall Study|Protocol deviation|1|||
156515076|NCT01365481|564977943|FG002|Overall Study|Protocol deviation|0|||
156515077|NCT01365481|564977944|FG003|Overall Study|Protocol deviation|1|||
156515078|NCT01365481|564977941|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156515079|NCT01365481|564977942|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156515080|NCT01365481|564977943|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
156515081|NCT01365481|564977944|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156515082|NCT00757627|564977945|FG000|Overall Study|Adverse Event|15|||
156515083|NCT00757627|564977945|FG000|Overall Study|Lack of Efficacy|10|||
156515084|NCT00757627|564977945|FG000|Overall Study|Lost to Follow-up|28|||
156515085|NCT00757627|564977945|FG000|Overall Study|Withdrawal by Subject|27|||
156515086|NCT00757627|564977945|FG000|Overall Study|Other|1|||
156515087|NCT00958841|564977948|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156515088|NCT00958841|564977948|FG000|Overall Study|Abnormal test procedure result(s)|3|||
156515089|NCT00958841|564977948|FG000|Overall Study|Administrative problems|1|||
156515090|NCT00958841|564977948|FG000|Overall Study|Adverse Event|8|||
156515091|NCT00958841|564977948|FG000|Overall Study|New cancer therapy|5|||
156515092|NCT00958841|564977948|FG000|Overall Study|Withdrawal by Subject|1|||
156515093|NCT00958841|564977948|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
156515094|NCT00958841|564977948|FG000|Overall Study|Completed M6/did not enter extension|27|||
156515095|NCT00958841|564977948|FG000|Overall Study|Discontinued prior to M*|28|||
156515096|NCT00858364|564977949|FG000|Overall Study|Administrative Decision|3|||
156515097|NCT00858364|564977950|FG001|Overall Study|Administrative Decision|2|||
156515098|NCT00858364|564977949|FG000|Overall Study|Adverse Event|5|||
156515099|NCT00858364|564977950|FG001|Overall Study|Adverse Event|2|||
156515100|NCT00858364|564977949|FG000|Overall Study|Withdrawal by Subject|44|||
156515101|NCT00858364|564977950|FG001|Overall Study|Withdrawal by Subject|118|||
156515102|NCT00858364|564977949|FG000|Overall Study|Ineligibility Determined|1|||
156515103|NCT00858364|564977950|FG001|Overall Study|Ineligibility Determined|10|||
156515104|NCT00858364|564977949|FG000|Overall Study|Lost to Follow-up|24|||
156515105|NCT00858364|564977950|FG001|Overall Study|Lost to Follow-up|54|||
156515106|NCT00858364|564977949|FG000|Overall Study|Noncompliance|3|||
156515107|NCT00858364|564977950|FG001|Overall Study|Noncompliance|4|||
156515108|NCT00858364|564977949|FG000|Overall Study|Protocol Deviation|0|||
156515109|NCT00858364|564977950|FG001|Overall Study|Protocol Deviation|2|||
156515110|NCT00858364|564977949|FG000|Overall Study|Other|9|||
156515111|NCT00858364|564977950|FG001|Overall Study|Other|17|||
156515112|NCT00858364|564977949|FG000|Overall Study|Missing|1|||
156515113|NCT00858364|564977950|FG001|Overall Study|Missing|1|||
156515114|NCT00858364|564977949|FG000|Overall Study|Still on-study|114|||
156515115|NCT00858364|564977950|FG001|Overall Study|Still on-study|247|||
156515116|NCT00688870|564977955|FG000|Infant Series|Parent or legal guardian request|4|||
156515117|NCT00688870|564977956|FG001|Infant Series|Parent or legal guardian request|0|||
156515118|NCT03682302|564977959|FG000|Overall Study|Lost to Follow-up|1|||
156515119|NCT03682302|564977960|FG001|Overall Study|Lost to Follow-up|2|||
156515120|NCT03682302|564977961|FG002|Overall Study|Lost to Follow-up|0|||
156515121|NCT03682302|564977962|FG003|Overall Study|Lost to Follow-up|1|||
156515122|NCT03682302|564977959|FG000|Overall Study|Study drug was not administered|0|||
156515123|NCT03682302|564977960|FG001|Overall Study|Study drug was not administered|0|||
156515124|NCT03682302|564977961|FG002|Overall Study|Study drug was not administered|1|||
156515125|NCT03682302|564977962|FG003|Overall Study|Study drug was not administered|1|||
156515126|NCT01489891|564977964|FG000|Overall Study|Endoscopy failure|1|||
156515127|NCT01489891|564977965|FG001|Overall Study|Endoscopy failure|0|||
156515128|NCT00948766|564977968|FG000|Core Study|Adverse Event|73|||
156515129|NCT00948766|564977969|FG001|Core Study|Adverse Event|51|||
156515130|NCT00948766|564977968|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
156515131|NCT00948766|564977969|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
156515132|NCT00948766|564977968|FG000|Core Study|Patient Withdrew Consent|27|||
156515133|NCT00948766|564977969|FG001|Core Study|Patient Withdrew Consent|46|||
156515134|NCT00948766|564977968|FG000|Core Study|Lost to Follow-up|3|||
156515135|NCT00948766|564977969|FG001|Core Study|Lost to Follow-up|2|||
156515136|NCT00948766|564977968|FG000|Core Study|Administrative Problems|2|||
156515137|NCT00948766|564977969|FG001|Core Study|Administrative Problems|2|||
156515138|NCT00948766|564977968|FG000|Core Study|Death|1|||
156515139|NCT00948766|564977969|FG001|Core Study|Death|1|||
156515140|NCT00948766|564977968|FG000|Core Study|Protocol Deviation|8|||
156515141|NCT00948766|564977969|FG001|Core Study|Protocol Deviation|10|||
156515142|NCT00948766|564977968|FG000|Extension Study|Adverse Event|43|||
156515143|NCT00948766|564977969|FG001|Extension Study|Adverse Event|0|||
156515144|NCT00948766|564977968|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
156515145|NCT00948766|564977969|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
156515146|NCT00948766|564977968|FG000|Extension Study|Study Drug No Longer Required|1|||
156515147|NCT00948766|564977969|FG001|Extension Study|Study Drug No Longer Required|0|||
156515148|NCT00948766|564977968|FG000|Extension Study|Patient Withdrew Consent|32|||
156515149|NCT00948766|564977969|FG001|Extension Study|Patient Withdrew Consent|0|||
156515150|NCT00948766|564977968|FG000|Extension Study|Lost to Follow-up|8|||
156515151|NCT00948766|564977969|FG001|Extension Study|Lost to Follow-up|0|||
156515152|NCT00948766|564977968|FG000|Extension Study|Administrative Problems|1|||
156515153|NCT00948766|564977969|FG001|Extension Study|Administrative Problems|0|||
156515154|NCT00948766|564977968|FG000|Extension Study|Death|4|||
156515155|NCT00948766|564977969|FG001|Extension Study|Death|0|||
156515156|NCT00888927|564977970|FG000|Overall Study|Adverse Event|0|||
156515157|NCT00888927|564977971|FG001|Overall Study|Adverse Event|0|||
156515158|NCT00888927|564977972|FG002|Overall Study|Adverse Event|0|||
156515159|NCT00888927|564977973|FG003|Overall Study|Adverse Event|1|||
156515160|NCT00888927|564977970|FG000|Overall Study|Withdrawal of consent|0|||
156515161|NCT00888927|564977971|FG001|Overall Study|Withdrawal of consent|0|||
156515162|NCT00888927|564977972|FG002|Overall Study|Withdrawal of consent|0|||
156515163|NCT00888927|564977973|FG003|Overall Study|Withdrawal of consent|1|||
156515164|NCT02153073|564977974|FG000|Overall Study|Case Report Forms Uncollected|230|||
156515165|NCT02153073|564977974|FG000|Overall Study|Protocol Deviation|68|||
156515166|NCT03189745|564977975|FG000|Overall Study|Conflict in work schedule of participant|1|||
156515167|NCT03189745|564977976|FG001|Overall Study|Conflict in work schedule of participant|1|||
156515168|NCT03702231|564977977|FG000|Overall Study|Withdrawal by Subject|1|||
156515169|NCT03702231|564977978|FG001|Overall Study|Withdrawal by Subject|0|||
156515170|NCT03702231|564977979|FG002|Overall Study|Withdrawal by Subject|0|||
156515171|NCT03702231|564977977|FG000|Overall Study|Protocol Violation|0|||
156515172|NCT03702231|564977978|FG001|Overall Study|Protocol Violation|0|||
156515173|NCT03702231|564977979|FG002|Overall Study|Protocol Violation|1|||
156515174|NCT03702231|564977977|FG000|Overall Study|Change in CLL Treatment|0|||
156515175|NCT03702231|564977978|FG001|Overall Study|Change in CLL Treatment|0|||
156515176|NCT03702231|564977979|FG002|Overall Study|Change in CLL Treatment|1|||
156515177|NCT03702231|564977977|FG000|Overall Study|COVID Pandemic|1|||
156515178|NCT03702231|564977978|FG001|Overall Study|COVID Pandemic|4|||
156515179|NCT03702231|564977979|FG002|Overall Study|COVID Pandemic|1|||
156515180|NCT03702231|564977977|FG000|Overall Study|Non-compliance|0|||
156515181|NCT03702231|564977978|FG001|Overall Study|Non-compliance|0|||
156515182|NCT03702231|564977979|FG002|Overall Study|Non-compliance|1|||
156515183|NCT01278173|564977980|FG000|Overall Study|Lack of Efficacy|13|||
156515184|NCT01278173|564977980|FG000|Overall Study|Adverse Event|8|||
156515185|NCT01278173|564977980|FG000|Overall Study|Administrative or other reason|4|||
156515186|NCT01278173|564977980|FG000|Overall Study|Protocol Violation|1|||
156515187|NCT01278173|564977980|FG000|Overall Study|Withdrawal by Subject|1|||
156515188|NCT01200290|564977983|FG000|Treatment Period|Adverse Event|1|||
156515189|NCT01200290|564977983|FG000|Post-Treatment Follow-Up Period|Death|2|||
156515190|NCT01241604|564977985|FG000|Screening Period|Screen Failure|3|||
156515191|NCT01241604|564977986|FG001|Screening Period|Screen Failure|0|||
156515192|NCT01241604|564977987|FG002|Screening Period|Screen Failure|0|||
156515193|NCT00037830|564979814|FG000|Overall Study|Adverse Event|2|||
156515194|NCT00037830|564979815|FG001|Overall Study|Adverse Event|0|||
156515195|NCT00037830|564979816|FG002|Overall Study|Adverse Event|0|||
156515196|NCT00037830|564979814|FG000|Overall Study|Withdrawal by Subject|4|||
156515197|NCT00037830|564979815|FG001|Overall Study|Withdrawal by Subject|5|||
156515198|NCT00037830|564979816|FG002|Overall Study|Withdrawal by Subject|1|||
156515199|NCT00037830|564979814|FG000|Overall Study|Protocol Violation|2|||
156515200|NCT00037830|564979815|FG001|Overall Study|Protocol Violation|2|||
156515201|NCT00037830|564979816|FG002|Overall Study|Protocol Violation|0|||
156515202|NCT00037830|564979814|FG000|Overall Study|Unrelated Medical Problem|2|||
156515203|NCT00037830|564979815|FG001|Overall Study|Unrelated Medical Problem|0|||
156515204|NCT00037830|564979816|FG002|Overall Study|Unrelated Medical Problem|0|||
156515205|NCT03377699|564979817|FG000|Overall Study|Withdrawal by Subject|2|||
156515206|NCT03377699|564979818|FG001|Overall Study|Withdrawal by Subject|9|||
156515207|NCT03377699|564979817|FG000|Overall Study|Lost to Follow-up|1|||
156515208|NCT03377699|564979818|FG001|Overall Study|Lost to Follow-up|1|||
156515209|NCT03377699|564979817|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
156515210|NCT03377699|564979818|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
156515211|NCT03377699|564979817|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
156515212|NCT03377699|564979818|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
156515213|NCT03377699|564979817|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
156515214|NCT03377699|564979818|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
156515215|NCT03377699|564979817|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
156515216|NCT03377699|564979818|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
156515217|NCT02580305|564979822|FG000|Overall Study|Adverse Event|15|||
156515218|NCT02580305|564979823|FG001|Overall Study|Adverse Event|19|||
156515219|NCT02580305|564979824|FG002|Overall Study|Adverse Event|10|||
156515220|NCT02580305|564979822|FG000|Overall Study|Lack of Efficacy|5|||
156515221|NCT02580305|564979823|FG001|Overall Study|Lack of Efficacy|0|||
156515222|NCT02580305|564979824|FG002|Overall Study|Lack of Efficacy|2|||
156515223|NCT02580305|564979822|FG000|Overall Study|Protocol Violation|4|||
156515224|NCT02580305|564979823|FG001|Overall Study|Protocol Violation|9|||
156515225|NCT02580305|564979824|FG002|Overall Study|Protocol Violation|6|||
156515226|NCT02580305|564979822|FG000|Overall Study|Lost to Follow-up|4|||
156515227|NCT02580305|564979823|FG001|Overall Study|Lost to Follow-up|4|||
156515228|NCT02580305|564979824|FG002|Overall Study|Lost to Follow-up|2|||
156515229|NCT02580305|564979822|FG000|Overall Study|Withdrawal by Subject|11|||
156515230|NCT02580305|564979823|FG001|Overall Study|Withdrawal by Subject|9|||
156515231|NCT02580305|564979824|FG002|Overall Study|Withdrawal by Subject|7|||
156515232|NCT02580305|564979822|FG000|Overall Study|Randomized in error and never treated|4|||
156515233|NCT02580305|564979823|FG001|Overall Study|Randomized in error and never treated|8|||
156515234|NCT02580305|564979824|FG002|Overall Study|Randomized in error and never treated|5|||
156515235|NCT03582943|564979825|FG000|Allocated to Groups|Withdrawal by Subject|1|||
156515236|NCT03582943|564979826|FG001|Allocated to Groups|Withdrawal by Subject|1|||
156515237|NCT03582943|564979825|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
156515238|NCT03582943|564979826|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
156515239|NCT03582943|564979825|FG000|Analyzed|Protocol Violation|4|||
156515240|NCT03582943|564979826|FG001|Analyzed|Protocol Violation|1|||
156515241|NCT00774930|564979829|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
156515242|NCT00774930|564979830|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
156515243|NCT00774930|564979829|FG000|DB Phase|Adverse Event|1|||
156515244|NCT00774930|564979830|FG001|DB Phase|Adverse Event|2|||
156515245|NCT00774930|564979829|FG000|DB Phase|Subject Decision|1|||
156515246|NCT00774930|564979830|FG001|DB Phase|Subject Decision|5|||
156515247|NCT00774930|564979829|FG000|DB Phase|Sponsor Decision|0|||
156515248|NCT00774930|564979830|FG001|DB Phase|Sponsor Decision|1|||
156515249|NCT00774930|564979829|FG000|DB Phase|Disease Progression|1|||
156515250|NCT00774930|564979830|FG001|DB Phase|Disease Progression|1|||
156515251|NCT00774930|564979829|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
156515252|NCT00774930|564979830|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
156515253|NCT00774930|564979829|FG000|IOL Phase|Adverse Event|1|||
156515254|NCT00774930|564979830|FG001|IOL Phase|Adverse Event|1|||
156515255|NCT00774930|564979829|FG000|IOL Phase|Subject Decision|4|||
156515256|NCT00774930|564979830|FG001|IOL Phase|Subject Decision|3|||
156515257|NCT00774930|564979829|FG000|IOL Phase|Physician Decision|3|||
156515258|NCT00774930|564979830|FG001|IOL Phase|Physician Decision|2|||
156515259|NCT00774930|564979829|FG000|IOL Phase|Sponsor Decision|1|||
156515260|NCT00774930|564979830|FG001|IOL Phase|Sponsor Decision|0|||
156515261|NCT00774930|564979829|FG000|IOL Phase|Disease Progression|2|||
156515262|NCT00774930|564979830|FG001|IOL Phase|Disease Progression|1|||
156515263|NCT00774930|564979829|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
156515264|NCT00774930|564979830|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
156515265|NCT00774930|564979829|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
156515266|NCT00774930|564979830|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
156515267|NCT00774930|564979829|FG000|IOL Phase|Other|1|||
156515268|NCT00774930|564979830|FG001|IOL Phase|Other|0|||
156515269|NCT00774930|564979829|FG000|IOL Phase|Brain radiation|0|||
156515270|NCT00774930|564979830|FG001|IOL Phase|Brain radiation|1|||
156515271|NCT00774930|564979829|FG000|LTOLE Phase|Adverse Event|7|||
156515272|NCT00774930|564979830|FG001|LTOLE Phase|Adverse Event|3|||
156515273|NCT00774930|564979829|FG000|LTOLE Phase|Subject decision|0|||
156515274|NCT00774930|564979830|FG001|LTOLE Phase|Subject decision|5|||
156515275|NCT00774930|564979829|FG000|LTOLE Phase|Physician Decision|4|||
156515276|NCT00774930|564979830|FG001|LTOLE Phase|Physician Decision|1|||
156515277|NCT00774930|564979829|FG000|LTOLE Phase|Sponsor decision|2|||
156515278|NCT00774930|564979830|FG001|LTOLE Phase|Sponsor decision|1|||
156515279|NCT00774930|564979829|FG000|LTOLE Phase|Disease Progression|2|||
156515280|NCT00774930|564979830|FG001|LTOLE Phase|Disease Progression|5|||
156515281|NCT00774930|564979829|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
156515282|NCT00774930|564979830|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
156515283|NCT00774930|564979829|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
156515284|NCT00774930|564979830|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
156515285|NCT01153321|564979835|FG000|Overall Study|Development of study withdrawal criteria|0|||
156515286|NCT01153321|564979836|FG001|Overall Study|Development of study withdrawal criteria|1|||
156515287|NCT01153321|564979835|FG000|Overall Study|Withdrawal by Subject|0|||
156515288|NCT01153321|564979836|FG001|Overall Study|Withdrawal by Subject|1|||
156515289|NCT01153321|564979835|FG000|Overall Study|Adverse Event|1|||
156515290|NCT01153321|564979836|FG001|Overall Study|Adverse Event|1|||
156515291|NCT01177800|564979838|FG000|Overall Study|Adverse Event|9|||
156515292|NCT01177800|564979839|FG001|Overall Study|Adverse Event|3|||
156515293|NCT01177800|564979838|FG000|Overall Study|Protocol Violation|0|||
156515294|NCT01177800|564979839|FG001|Overall Study|Protocol Violation|1|||
156515295|NCT01177800|564979838|FG000|Overall Study|Physician Decision|1|||
156515296|NCT01177800|564979839|FG001|Overall Study|Physician Decision|0|||
156515297|NCT01177800|564979838|FG000|Overall Study|Withdrawal of informed consent|0|||
156515298|NCT01177800|564979839|FG001|Overall Study|Withdrawal of informed consent|1|||
156515299|NCT04032613|564979843|FG000|Overall Study|Did not complete post-program assessment|5|||
156515300|NCT04032613|564979844|FG001|Overall Study|Did not complete post-program assessment|2|||
156515301|NCT02071290|564979845|FG000|Overall Study|Death|1|||
156515302|NCT02071290|564979846|FG001|Overall Study|Death|0|||
156515303|NCT02071290|564979845|FG000|Overall Study|Withdrawal by Subject|0|||
156515304|NCT02071290|564979846|FG001|Overall Study|Withdrawal by Subject|1|||
156515305|NCT02071290|564979845|FG000|Overall Study|Protocol Violation|3|||
156515306|NCT02071290|564979846|FG001|Overall Study|Protocol Violation|5|||
156515307|NCT02071290|564979845|FG000|Overall Study|Physician Decision|0|||
156515308|NCT02071290|564979846|FG001|Overall Study|Physician Decision|1|||
156515309|NCT00964886|564979853|FG000|Overall Study|Lost to Follow-up|2|||
156515310|NCT00964886|564979854|FG001|Overall Study|Lost to Follow-up|2|||
156515311|NCT00964886|564979855|FG002|Overall Study|Lost to Follow-up|6|||
156515312|NCT00964886|564979856|FG003|Overall Study|Lost to Follow-up|4|||
156515313|NCT00964886|564979853|FG000|Overall Study|Withdrawal by Subject|6|||
156515314|NCT00964886|564979854|FG001|Overall Study|Withdrawal by Subject|2|||
156515315|NCT00964886|564979855|FG002|Overall Study|Withdrawal by Subject|5|||
156515316|NCT00964886|564979856|FG003|Overall Study|Withdrawal by Subject|3|||
156515317|NCT00964886|564979853|FG000|Overall Study|Adverse Event|3|||
156515318|NCT00964886|564979854|FG001|Overall Study|Adverse Event|1|||
156515319|NCT00964886|564979855|FG002|Overall Study|Adverse Event|5|||
156515320|NCT00964886|564979856|FG003|Overall Study|Adverse Event|2|||
156515321|NCT00964886|564979853|FG000|Overall Study|Protocol Violation|0|||
156515322|NCT00964886|564979854|FG001|Overall Study|Protocol Violation|2|||
156515323|NCT00964886|564979855|FG002|Overall Study|Protocol Violation|0|||
156515324|NCT00964886|564979856|FG003|Overall Study|Protocol Violation|0|||
156515325|NCT05560243|564979857|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
156515326|NCT01232738|564979858|FG000|Overall Study|Death|3|||
156515327|NCT01232738|564979858|FG000|Overall Study|Physician Decision|2|||
156515328|NCT01232738|564979858|FG000|Overall Study|Lost to Follow-up|1|||
156515329|NCT01232738|564979858|FG000|Overall Study|Withdrawal by Subject|2|||
156515330|NCT01232738|564979858|FG000|Overall Study|Adverse Event|5|||
156515331|NCT03231800|564979863|FG000|Overall Study|Lost to Follow-up|0|||
156515332|NCT03231800|564979864|FG001|Overall Study|Lost to Follow-up|2|||
156515333|NCT03231800|564979863|FG000|Overall Study|Protocol Violation|1|||
156515334|NCT03231800|564979864|FG001|Overall Study|Protocol Violation|1|||
156515335|NCT03231800|564979863|FG000|Overall Study|reason not provided|2|||
156515336|NCT03231800|564979864|FG001|Overall Study|reason not provided|0|||
156515337|NCT00400725|564979875|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
156515338|NCT00400725|564979876|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
156515339|NCT00400725|564979877|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
156515340|NCT00400725|564979875|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
156515341|NCT00400725|564979876|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
156515342|NCT00400725|564979877|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
156515343|NCT00400725|564979875|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
156515344|NCT00400725|564979876|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
156515345|NCT00400725|564979877|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
156515346|NCT00400725|564979875|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
156515347|NCT00400725|564979876|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
156515348|NCT00400725|564979877|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
156515349|NCT00400725|564979875|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
156515350|NCT00400725|564979876|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
156515351|NCT00400725|564979877|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
156515352|NCT00400725|564979875|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
156515353|NCT00400725|564979876|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
156515354|NCT00400725|564979877|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
156515355|NCT00400725|564979875|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
156515356|NCT00400725|564979876|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
156515357|NCT00400725|564979877|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
156515358|NCT00400725|564979875|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
156515359|NCT00400725|564979876|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
156515360|NCT00400725|564979877|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
156515361|NCT00400725|564979875|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
156515362|NCT00400725|564979876|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
156515363|NCT00400725|564979877|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
156515364|NCT04075994|564979880|FG000|Overall Study|Withdrawal by Subject|8|||
156515365|NCT04075994|564979881|FG001|Overall Study|Withdrawal by Subject|9|||
156515366|NCT04075994|564979880|FG000|Overall Study|Adverse Event|2|||
156515367|NCT04075994|564979881|FG001|Overall Study|Adverse Event|2|||
156515368|NCT04075994|564979880|FG000|Overall Study|Investigator withdrew|3|||
156515369|NCT04075994|564979881|FG001|Overall Study|Investigator withdrew|1|||
156515370|NCT01941719|564979884|FG000|Overall Study|Lost to Follow-up|20|||
156515371|NCT01941719|564979885|FG001|Overall Study|Lost to Follow-up|19|||
156515372|NCT00252577|564979886|FG000|Overall Study|Lost to Follow-up|20|||
156515373|NCT01655693|564979889|FG000|Overall Study|Progression of Disease|92|||
156515374|NCT01655693|564979890|FG001|Overall Study|Progression of Disease|76|||
156515375|NCT01655693|564979891|FG002|Overall Study|Progression of Disease|58|||
156515376|NCT01655693|564979889|FG000|Overall Study|Death|8|||
156515377|NCT01655693|564979890|FG001|Overall Study|Death|9|||
156515378|NCT01655693|564979891|FG002|Overall Study|Death|12|||
156515379|NCT01655693|564979889|FG000|Overall Study|Serious Adverse Event|3|||
156515380|NCT01655693|564979890|FG001|Overall Study|Serious Adverse Event|15|||
156515381|NCT01655693|564979891|FG002|Overall Study|Serious Adverse Event|11|||
156515382|NCT01655693|564979889|FG000|Overall Study|Withdrawal by Subject|3|||
156515383|NCT01655693|564979890|FG001|Overall Study|Withdrawal by Subject|2|||
156515384|NCT01655693|564979891|FG002|Overall Study|Withdrawal by Subject|20|||
156515385|NCT01655693|564979889|FG000|Overall Study|Adverse Event|3|||
156515386|NCT01655693|564979890|FG001|Overall Study|Adverse Event|11|||
156515387|NCT01655693|564979891|FG002|Overall Study|Adverse Event|3|||
156515388|NCT01655693|564979889|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
156515389|NCT01655693|564979890|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
156515390|NCT01655693|564979891|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
156515391|NCT01655693|564979889|FG000|Overall Study|Non-Compliance|0|||
156515392|NCT01655693|564979890|FG001|Overall Study|Non-Compliance|0|||
156515393|NCT01655693|564979891|FG002|Overall Study|Non-Compliance|7|||
156515394|NCT01655693|564979889|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
156515395|NCT01655693|564979890|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
156515396|NCT01655693|564979891|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
156515397|NCT01655693|564979889|FG000|Overall Study|Protocol Violation|1|||
156515398|NCT01655693|564979890|FG001|Overall Study|Protocol Violation|0|||
156515399|NCT01655693|564979891|FG002|Overall Study|Protocol Violation|3|||
156515400|NCT01655693|564979889|FG000|Overall Study|Lost to Follow-up|1|||
156515401|NCT01655693|564979890|FG001|Overall Study|Lost to Follow-up|0|||
156515402|NCT01655693|564979891|FG002|Overall Study|Lost to Follow-up|1|||
156515403|NCT01655693|564979889|FG000|Overall Study|Screening Failure|1|||
156515404|NCT01655693|564979890|FG001|Overall Study|Screening Failure|0|||
156515405|NCT01655693|564979891|FG002|Overall Study|Screening Failure|0|||
156515406|NCT01655693|564979889|FG000|Overall Study|Other|8|||
156515407|NCT01655693|564979890|FG001|Overall Study|Other|6|||
156515408|NCT01655693|564979891|FG002|Overall Study|Other|15|||
156515409|NCT02535091|564979892|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
156515410|NCT02535091|564979893|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
156515411|NCT02535091|564979894|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
156515412|NCT02535091|564979892|FG000|Overall Study|Withdrawal by Subject|14|||
156515413|NCT02535091|564979893|FG001|Overall Study|Withdrawal by Subject|5|||
156515414|NCT02535091|564979894|FG002|Overall Study|Withdrawal by Subject|121|||
156515415|NCT02535091|564979892|FG000|Overall Study|Adverse Event|9|||
156515416|NCT02535091|564979893|FG001|Overall Study|Adverse Event|4|||
156515417|NCT02535091|564979894|FG002|Overall Study|Adverse Event|170|||
156515418|NCT02535091|564979892|FG000|Overall Study|Other|4|||
156515419|NCT02535091|564979893|FG001|Overall Study|Other|3|||
156515420|NCT02535091|564979894|FG002|Overall Study|Other|81|||
156515421|NCT02535091|564979892|FG000|Overall Study|Lost to Follow-up|0|||
156515422|NCT02535091|564979893|FG001|Overall Study|Lost to Follow-up|1|||
156515423|NCT02535091|564979894|FG002|Overall Study|Lost to Follow-up|19|||
156515424|NCT02535091|564979892|FG000|Overall Study|Protocol Violation|0|||
156515425|NCT02535091|564979893|FG001|Overall Study|Protocol Violation|1|||
156515426|NCT02535091|564979894|FG002|Overall Study|Protocol Violation|11|||
156515427|NCT02535091|564979892|FG000|Overall Study|Pregnancy|0|||
156515428|NCT02535091|564979893|FG001|Overall Study|Pregnancy|0|||
156515429|NCT02535091|564979894|FG002|Overall Study|Pregnancy|7|||
156515430|NCT01259089|564979904|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
156515431|NCT01259089|564979905|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
156515432|NCT01259089|564979906|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
156515433|NCT01259089|564979907|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
156515434|NCT01259089|564979908|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
156515435|NCT01259089|564979909|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
156515436|NCT01259089|564979904|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
156515437|NCT01259089|564979905|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
156515438|NCT01259089|564979906|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
156515439|NCT01259089|564979907|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
156515440|NCT01259089|564979908|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
156515441|NCT01259089|564979909|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
156515442|NCT01259089|564979904|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
156515443|NCT01259089|564979905|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
156515444|NCT01259089|564979906|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
156515445|NCT01259089|564979907|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
156515446|NCT01259089|564979908|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
156515447|NCT01259089|564979909|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
156515448|NCT01259089|564979904|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
156515449|NCT01259089|564979905|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
156515450|NCT01259089|564979906|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
156515451|NCT01259089|564979907|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
156515452|NCT01259089|564979908|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
156515453|NCT01259089|564979909|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
156515454|NCT01259089|564979904|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
156515455|NCT01259089|564979905|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
156515456|NCT01259089|564979906|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
156515457|NCT01259089|564979907|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
156515458|NCT01259089|564979908|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
156515459|NCT01259089|564979909|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
156515460|NCT01259089|564979904|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
156515461|NCT01259089|564979905|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
156515462|NCT01259089|564979906|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
156515463|NCT01259089|564979907|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
156515464|NCT01259089|564979908|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
156515465|NCT01259089|564979909|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
156515466|NCT01259089|564979904|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
156515467|NCT01259089|564979905|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
156515468|NCT01259089|564979906|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
156515469|NCT01259089|564979907|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
156515470|NCT01259089|564979908|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
156515471|NCT01259089|564979909|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
156515472|NCT01259089|564979904|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
156515473|NCT01259089|564979905|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
156515474|NCT01259089|564979906|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
156515475|NCT01259089|564979907|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
156515476|NCT01259089|564979908|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
156515477|NCT01259089|564979909|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
156515478|NCT01259089|564979904|FG000|Survival Follow up for Two Years|Death|3|||
156515479|NCT01259089|564979905|FG001|Survival Follow up for Two Years|Death|2|||
156515480|NCT01259089|564979906|FG002|Survival Follow up for Two Years|Death|2|||
156515481|NCT01259089|564979907|FG003|Survival Follow up for Two Years|Death|3|||
156515482|NCT01259089|564979908|FG004|Survival Follow up for Two Years|Death|6|||
156515483|NCT01259089|564979909|FG005|Survival Follow up for Two Years|Death|13|||
156515484|NCT01259089|564979904|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
156515485|NCT01259089|564979905|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
156515486|NCT01259089|564979906|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
156515487|NCT01259089|564979907|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
156515488|NCT01259089|564979908|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
156515489|NCT01259089|564979909|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
156515490|NCT01259089|564979904|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
156515491|NCT01259089|564979905|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
156515492|NCT01259089|564979906|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
156515493|NCT01259089|564979907|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
156515494|NCT01259089|564979908|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
156515495|NCT01259089|564979909|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
156515496|NCT02310100|564979910|FG000|Overall Study|Physician Decision|3|||
156515497|NCT02310100|564979910|FG000|Overall Study|Withdrawal by Subject|10|||
156515498|NCT02310100|564979910|FG000|Overall Study|Enrollment closure|1|||
156515499|NCT02310100|564979910|FG000|Overall Study|Unapproved ablation operator|1|||
156515500|NCT02310100|564979910|FG000|Overall Study|Visit compliance|1|||
156515501|NCT02310100|564979910|FG000|Overall Study|Lost to Follow-up|2|||
156515502|NCT01127763|564979914|FG000|Overall Study|Adverse Event|2|||
156515503|NCT01127763|564979914|FG000|Overall Study|Withdrawal by Subject|1|||
156515504|NCT01127763|564979914|FG000|Overall Study|Physician Decision|2|||
156515505|NCT00528931|564979915|FG000|Overall Study|Lost to Follow-up|1|||
156515506|NCT01151410|564979916|FG000|Overall Study|Withdrawal by Subject|3|||
156515507|NCT01151410|564979917|FG001|Overall Study|Withdrawal by Subject|5|||
156515508|NCT01151410|564979916|FG000|Overall Study|Lost to Follow-up|3|||
156515509|NCT01151410|564979917|FG001|Overall Study|Lost to Follow-up|4|||
156515510|NCT01151410|564979916|FG000|Overall Study|Adverse Event|1|||
156515511|NCT01151410|564979917|FG001|Overall Study|Adverse Event|2|||
156515512|NCT01151410|564979916|FG000|Overall Study|Protocol deviation|2|||
156515513|NCT01151410|564979917|FG001|Overall Study|Protocol deviation|1|||
156515514|NCT01151410|564979916|FG000|Overall Study|Administrative problems|1|||
156515515|NCT01151410|564979917|FG001|Overall Study|Administrative problems|1|||
156515516|NCT01151410|564979916|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156515517|NCT01151410|564979917|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156515518|NCT01151410|564979916|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156515519|NCT01151410|564979917|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156515520|NCT01253018|564979918|FG000|Overall Study|Lost to Follow-up|1|||
156515521|NCT01253018|564979919|FG001|Overall Study|Lost to Follow-up|1|||
156515522|NCT01253018|564979918|FG000|Overall Study|Robot Repair Issues|2|||
156515523|NCT01253018|564979919|FG001|Overall Study|Robot Repair Issues|0|||
156515524|NCT01253018|564979918|FG000|Overall Study|Withdrawal by Subject|1|||
156515525|NCT01253018|564979919|FG001|Overall Study|Withdrawal by Subject|1|||
156515526|NCT01820585|564979920|FG000|Overall Study|Adverse Event|9|||
156515527|NCT01820585|564979921|FG001|Overall Study|Adverse Event|13|||
156515528|NCT01820585|564979922|FG002|Overall Study|Adverse Event|23|||
156515529|NCT01820585|564979923|FG003|Overall Study|Adverse Event|34|||
156515530|NCT01820585|564979920|FG000|Overall Study|Lack of Efficacy|9|||
156515531|NCT01820585|564979921|FG001|Overall Study|Lack of Efficacy|7|||
156515532|NCT01820585|564979922|FG002|Overall Study|Lack of Efficacy|5|||
156515533|NCT01820585|564979923|FG003|Overall Study|Lack of Efficacy|1|||
156515534|NCT01820585|564979920|FG000|Overall Study|Withdrawal by Subject|3|||
156515535|NCT01820585|564979921|FG001|Overall Study|Withdrawal by Subject|7|||
156515536|NCT01820585|564979922|FG002|Overall Study|Withdrawal by Subject|3|||
156515537|NCT01820585|564979923|FG003|Overall Study|Withdrawal by Subject|8|||
156515538|NCT01820585|564979920|FG000|Overall Study|Lost to Follow-up|3|||
156515539|NCT01820585|564979921|FG001|Overall Study|Lost to Follow-up|3|||
156515540|NCT01820585|564979922|FG002|Overall Study|Lost to Follow-up|0|||
156515541|NCT01820585|564979923|FG003|Overall Study|Lost to Follow-up|3|||
156515542|NCT01820585|564979920|FG000|Overall Study|Protocol Violation|3|||
156515543|NCT01820585|564979921|FG001|Overall Study|Protocol Violation|1|||
156515544|NCT01820585|564979922|FG002|Overall Study|Protocol Violation|1|||
156515545|NCT01820585|564979923|FG003|Overall Study|Protocol Violation|1|||
156515546|NCT01820585|564979920|FG000|Overall Study|Subject non-compliance|0|||
156515547|NCT01820585|564979921|FG001|Overall Study|Subject non-compliance|0|||
156515548|NCT01820585|564979922|FG002|Overall Study|Subject non-compliance|1|||
156515549|NCT01820585|564979923|FG003|Overall Study|Subject non-compliance|2|||
156515550|NCT01820585|564979920|FG000|Overall Study|at sponsor request|0|||
156515551|NCT01820585|564979921|FG001|Overall Study|at sponsor request|0|||
156515552|NCT01820585|564979922|FG002|Overall Study|at sponsor request|1|||
156515553|NCT01820585|564979923|FG003|Overall Study|at sponsor request|0|||
156515554|NCT01820585|564979920|FG000|Overall Study|Pregnancy|0|||
156515555|NCT01820585|564979921|FG001|Overall Study|Pregnancy|1|||
156515556|NCT01820585|564979922|FG002|Overall Study|Pregnancy|0|||
156515557|NCT01820585|564979923|FG003|Overall Study|Pregnancy|0|||
156515558|NCT00548262|564979924|FG000|Overall Study|Death|21|||
156515559|NCT00548262|564979924|FG000|Overall Study|Adverse Event|2|||
156515560|NCT00548262|564979924|FG000|Overall Study|Lack of Efficacy|4|||
156515561|NCT00548262|564979924|FG000|Overall Study|Lost to Follow-up|1|||
156515562|NCT00548262|564979924|FG000|Overall Study|Other|3|||
156515563|NCT00548262|564979924|FG000|Overall Study|Withdrawal by Subject|1|||
156515564|NCT01712659|564979925|FG000|Dose Escalation|Physician Decision|0|||
156515565|NCT01712659|564979926|FG001|Dose Escalation|Physician Decision|1|||
156515566|NCT01712659|564979927|FG002|Dose Escalation|Physician Decision|0|||
156515567|NCT01712659|564979928|FG003|Dose Escalation|Physician Decision|0|||
156515568|NCT01712659|564979929|FG004|Dose Escalation|Physician Decision|0|||
156515569|NCT01712659|564979925|FG000|Dose Escalation|Unable to take study drug|0|||
156515570|NCT01712659|564979926|FG001|Dose Escalation|Unable to take study drug|1|||
156515571|NCT01712659|564979927|FG002|Dose Escalation|Unable to take study drug|0|||
156515572|NCT01712659|564979928|FG003|Dose Escalation|Unable to take study drug|0|||
156515573|NCT01712659|564979929|FG004|Dose Escalation|Unable to take study drug|0|||
156515574|NCT01712659|564979925|FG000|Dose Expansion|Early disease progression|1|||
156515575|NCT01712659|564979926|FG001|Dose Expansion|Early disease progression|0|||
156515576|NCT01712659|564979927|FG002|Dose Expansion|Early disease progression|0|||
156515577|NCT01712659|564979928|FG003|Dose Expansion|Early disease progression|0|||
156515578|NCT01712659|564979929|FG004|Dose Expansion|Early disease progression|0|||
156515579|NCT01712659|564979925|FG000|Dose Expansion|Physician Decision|1|||
156515580|NCT01712659|564979926|FG001|Dose Expansion|Physician Decision|0|||
156515581|NCT01712659|564979927|FG002|Dose Expansion|Physician Decision|0|||
156515582|NCT01712659|564979928|FG003|Dose Expansion|Physician Decision|0|||
156515583|NCT01712659|564979929|FG004|Dose Expansion|Physician Decision|0|||
156515584|NCT02091206|564979934|FG000|Treatment Period|Adverse Event|0|||
156515585|NCT02091206|564979935|FG001|Treatment Period|Adverse Event|1|||
156515586|NCT02091206|564979936|FG002|Treatment Period|Adverse Event|0|||
156515587|NCT02091206|564979937|FG003|Treatment Period|Adverse Event|0|||
156515588|NCT02091206|564979934|FG000|Treatment Period|Met withdrawal criteria|0|||
156515589|NCT02091206|564979935|FG001|Treatment Period|Met withdrawal criteria|0|||
156560206|NCT02591615|565141958|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
156560207|NCT02591615|565141955|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
156515590|NCT02091206|564979936|FG002|Treatment Period|Met withdrawal criteria|1|||
156515591|NCT02091206|564979937|FG003|Treatment Period|Met withdrawal criteria|0|||
156515592|NCT02091206|564979934|FG000|Taper Period|Participant refused study drug|1|||
156515593|NCT02091206|564979935|FG001|Taper Period|Participant refused study drug|0|||
156515594|NCT02091206|564979936|FG002|Taper Period|Participant refused study drug|0|||
156515595|NCT02091206|564979937|FG003|Taper Period|Participant refused study drug|1|||
156515596|NCT02091206|564979934|FG000|Taper Period|Lost to Follow-up|0|||
156515597|NCT02091206|564979935|FG001|Taper Period|Lost to Follow-up|0|||
156515598|NCT02091206|564979936|FG002|Taper Period|Lost to Follow-up|0|||
156515599|NCT02091206|564979937|FG003|Taper Period|Lost to Follow-up|1|||
156515600|NCT00293059|564979938|FG000|Overall Study|Adverse Event|12|||
156515601|NCT00293059|564979939|FG001|Overall Study|Adverse Event|4|||
156515602|NCT00293059|564979938|FG000|Overall Study|Lack of Efficacy|2|||
156515603|NCT00293059|564979939|FG001|Overall Study|Lack of Efficacy|0|||
156515604|NCT00293059|564979938|FG000|Overall Study|Lost to Follow-up|2|||
156515605|NCT00293059|564979939|FG001|Overall Study|Lost to Follow-up|3|||
156515606|NCT00293059|564979938|FG000|Overall Study|Pregnancy|1|||
156515607|NCT00293059|564979939|FG001|Overall Study|Pregnancy|1|||
156515608|NCT00293059|564979938|FG000|Overall Study|Protocol Violation|2|||
156515609|NCT00293059|564979939|FG001|Overall Study|Protocol Violation|0|||
156515610|NCT00293059|564979938|FG000|Overall Study|Withdrawal by Subject|11|||
156515611|NCT00293059|564979939|FG001|Overall Study|Withdrawal by Subject|5|||
156515612|NCT00293059|564979938|FG000|Overall Study|Participant moved out of state|1|||
156515613|NCT00293059|564979939|FG001|Overall Study|Participant moved out of state|0|||
156515614|NCT00293059|564979938|FG000|Overall Study|Participant stopped study drug|1|||
156515615|NCT00293059|564979939|FG001|Overall Study|Participant stopped study drug|0|||
156515616|NCT00293059|564979938|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
156515617|NCT00293059|564979939|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
156515618|NCT00293059|564979938|FG000|Overall Study|missing|3|||
156515619|NCT00293059|564979939|FG001|Overall Study|missing|5|||
156515620|NCT02297139|564979942|FG000|Overall Study|Disease progression|0|||
156515621|NCT02297139|564979943|FG001|Overall Study|Disease progression|1|||
156515622|NCT02297139|564979942|FG000|Overall Study|Study drug toxicity|0|||
156515623|NCT02297139|564979943|FG001|Overall Study|Study drug toxicity|4|||
156515624|NCT02297139|564979942|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156515625|NCT02297139|564979943|FG001|Overall Study|Participant request to discontinue study treatment|1|||
156515626|NCT02297139|564979942|FG000|Overall Study|Maximum clinical benefit|1|||
156515627|NCT02297139|564979943|FG001|Overall Study|Maximum clinical benefit|0|||
156515628|NCT02297139|564979942|FG000|Overall Study|Administrative reason by sponsor|0|||
156515629|NCT02297139|564979943|FG001|Overall Study|Administrative reason by sponsor|2|||
156515630|NCT02297139|564979942|FG000|Overall Study|Other reasons|0|||
156515631|NCT02297139|564979943|FG001|Overall Study|Other reasons|8|||
156515632|NCT05051462|564979949|FG000|Overall Study|Lost to Follow-up|1|||
156515633|NCT05051462|564979950|FG001|Overall Study|Lost to Follow-up|8|||
156515634|NCT05051462|564979949|FG000|Overall Study|Withdrawal by Subject|1|||
156515635|NCT05051462|564979950|FG001|Overall Study|Withdrawal by Subject|0|||
156515636|NCT05051462|564979949|FG000|Overall Study|Protocol Violation|0|||
156515637|NCT05051462|564979950|FG001|Overall Study|Protocol Violation|2|||
156515638|NCT05597787|564979951|FG000|Overall Study|Withdrawal by Subject|0|||
156515639|NCT05597787|564979952|FG001|Overall Study|Withdrawal by Subject|0|||
156515640|NCT05597787|564979953|FG002|Overall Study|Withdrawal by Subject|1|||
156515641|NCT01593787|564979954|FG000|Overall Study|Adverse Event|1|||
156560208|NCT02591615|565141956|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
156560209|NCT02591615|565141957|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
156560210|NCT02591615|565141958|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
156560211|NCT02591615|565141955|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
156560212|NCT02591615|565141956|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
156560213|NCT02591615|565141957|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
156560214|NCT02591615|565141958|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
156560215|NCT02591615|565141955|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
156560216|NCT02591615|565141956|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
156560217|NCT02591615|565141957|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
156560218|NCT02591615|565141958|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
156560219|NCT02591615|565141955|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
156560220|NCT02591615|565141956|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
156560221|NCT02591615|565141957|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
156560222|NCT02591615|565141958|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
156560223|NCT02591615|565141955|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
156560224|NCT02591615|565141956|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
156560225|NCT02591615|565141957|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
156560226|NCT02591615|565141958|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
156560227|NCT02591615|565141955|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
156560228|NCT02591615|565141956|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
156560229|NCT02591615|565141957|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
156560230|NCT02591615|565141958|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
156560231|NCT02591615|565141955|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
156560232|NCT02591615|565141956|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
156560233|NCT02591615|565141957|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
156560234|NCT02591615|565141958|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
156560235|NCT02591615|565141955|FG000|Maintenance MK-3475|Adverse Event|0|||
156560236|NCT02591615|565141956|FG001|Maintenance MK-3475|Adverse Event|3|||
156560237|NCT02591615|565141957|FG002|Maintenance MK-3475|Adverse Event|1|||
156560238|NCT02591615|565141958|FG003|Maintenance MK-3475|Adverse Event|2|||
156560239|NCT02591615|565141955|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
156560240|NCT02591615|565141956|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
156560241|NCT02591615|565141957|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
156560242|NCT02591615|565141958|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
156560243|NCT02591615|565141955|FG000|Maintenance MK-3475|Death|0|||
156560244|NCT02591615|565141956|FG001|Maintenance MK-3475|Death|1|||
156560245|NCT02591615|565141957|FG002|Maintenance MK-3475|Death|1|||
156560246|NCT02591615|565141958|FG003|Maintenance MK-3475|Death|0|||
156560247|NCT02591615|565141955|FG000|Maintenance MK-3475|Physician discretion|0|||
156560248|NCT02591615|565141956|FG001|Maintenance MK-3475|Physician discretion|0|||
156560249|NCT02591615|565141957|FG002|Maintenance MK-3475|Physician discretion|1|||
156560250|NCT02591615|565141958|FG003|Maintenance MK-3475|Physician discretion|0|||
156560251|NCT02591615|565141955|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
156560252|NCT02591615|565141956|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
156560253|NCT02591615|565141957|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
156560254|NCT02591615|565141958|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
156560255|NCT02591615|565141955|FG000|Maintenance MK-3475|In active treatment|2|||
156560256|NCT02591615|565141956|FG001|Maintenance MK-3475|In active treatment|0|||
156560257|NCT02591615|565141957|FG002|Maintenance MK-3475|In active treatment|0|||
156560258|NCT02591615|565141958|FG003|Maintenance MK-3475|In active treatment|1|||
156560259|NCT00809328|565141959|FG000|Overall Study|Lack of Efficacy|18|||
156560260|NCT00809328|565141959|FG000|Overall Study|Adverse Event|6|||
156560261|NCT00809328|565141959|FG000|Overall Study|Protocol Violation|3|||
156560262|NCT00809328|565141959|FG000|Overall Study|Withdrawal by Subject|2|||
156560263|NCT00282243|565141960|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
156560264|NCT00282243|565141960|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
156560265|NCT00282243|565141960|FG000|Extension Treatment Period|Adverse Event|15|||
156560266|NCT00282243|565141960|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
156560267|NCT00282243|565141960|FG000|Extension Treatment Period|Non-compliance|2|||
156560268|NCT00282243|565141960|FG000|Extension Treatment Period|Physician Decision|1|||
156560269|NCT00270894|565141961|FG000|Overall Study|Adverse Event|1|||
156560270|NCT00270894|565141961|FG000|Overall Study|Withdrawal by Subject|1|||
156560271|NCT01070329|565141962|FG000|Overall Study|Adverse Event|13|||
156560272|NCT01070329|565141963|FG001|Overall Study|Adverse Event|10|||
156560273|NCT01070329|565141962|FG000|Overall Study|Lost to Follow-up|22|||
156560274|NCT01070329|565141963|FG001|Overall Study|Lost to Follow-up|12|||
156560275|NCT01070329|565141962|FG000|Overall Study|Withdrawal by Subject|9|||
156560276|NCT01070329|565141963|FG001|Overall Study|Withdrawal by Subject|11|||
156560277|NCT01070329|565141962|FG000|Overall Study|Protocol Violation|3|||
156560278|NCT01070329|565141963|FG001|Overall Study|Protocol Violation|8|||
156560279|NCT01070329|565141962|FG000|Overall Study|Lack of Efficacy|2|||
156560280|NCT01070329|565141963|FG001|Overall Study|Lack of Efficacy|6|||
156515642|NCT01593787|564979955|FG001|Overall Study|Adverse Event|0|||
156515643|NCT01593787|564979956|FG002|Overall Study|Adverse Event|0|||
156515644|NCT01133418|564979959|FG000|Overall Study|Lost to Follow-up|5|||
156515645|NCT01133418|564979960|FG001|Overall Study|Lost to Follow-up|6|||
156515646|NCT04150068|564979966|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
156515647|NCT04150068|564979967|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
156515648|NCT04150068|564979968|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
156515649|NCT04150068|564979966|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
156515650|NCT04150068|564979967|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
156515651|NCT04150068|564979968|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
156515652|NCT05316701|564979969|FG000|Overall Study|Adverse Event|0|||
156515653|NCT05316701|564979970|FG001|Overall Study|Adverse Event|1|||
156515654|NCT05316701|564979969|FG000|Overall Study|Death|3|||
156515655|NCT05316701|564979970|FG001|Overall Study|Death|9|||
156515656|NCT05316701|564979969|FG000|Overall Study|Lost to Follow-up|1|||
156515657|NCT05316701|564979970|FG001|Overall Study|Lost to Follow-up|0|||
156515658|NCT05316701|564979969|FG000|Overall Study|Physician Decision|1|||
156515659|NCT05316701|564979970|FG001|Overall Study|Physician Decision|4|||
156515660|NCT05316701|564979969|FG000|Overall Study|Withdrawal by Subject|3|||
156515661|NCT05316701|564979970|FG001|Overall Study|Withdrawal by Subject|5|||
156515662|NCT05316701|564979969|FG000|Overall Study|Progression/Relapse|14|||
156515663|NCT05316701|564979970|FG001|Overall Study|Progression/Relapse|9|||
156515664|NCT05316701|564979969|FG000|Overall Study|Received Standard of Care|1|||
156515665|NCT05316701|564979970|FG001|Overall Study|Received Standard of Care|0|||
156515666|NCT05316701|564979969|FG000|Overall Study|Ongoing|70|||
156515667|NCT05316701|564979970|FG001|Overall Study|Ongoing|64|||
156515668|NCT01946529|564979971|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
156515669|NCT01946529|564979972|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
156515670|NCT01946529|564979973|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
156515671|NCT01946529|564979971|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
156515672|NCT01946529|564979972|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
156515673|NCT01946529|564979973|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
156515674|NCT04679935|564979974|FG000|Overall Study|Death|0|||
156515675|NCT04679935|564979975|FG001|Overall Study|Death|1|||
156515676|NCT04362189|564979976|FG000|Overall Study|Lost to Follow-up|0|||
156515677|NCT04362189|564979977|FG001|Overall Study|Lost to Follow-up|1|||
156515678|NCT04362189|564979976|FG000|Overall Study|Withdrawal by Subject|1|||
156515679|NCT04362189|564979977|FG001|Overall Study|Withdrawal by Subject|0|||
156515680|NCT04362189|564979976|FG000|Overall Study|FDA Clinical Hold|7|||
156515681|NCT04362189|564979977|FG001|Overall Study|FDA Clinical Hold|2|||
156515682|NCT04362189|564979976|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
156515683|NCT04362189|564979977|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
156515684|NCT04362189|564979976|FG000|Overall Study|Adverse Event|0|||
156515685|NCT04362189|564979977|FG001|Overall Study|Adverse Event|2|||
156515686|NCT04362189|564979976|FG000|Overall Study|Death|4|||
156515687|NCT04362189|564979977|FG001|Overall Study|Death|1|||
156515688|NCT02111681|564979978|FG000|Overall Study|Death|5|||
156515689|NCT02111681|564979978|FG000|Overall Study|Lack of Efficacy|2|||
156515690|NCT02111681|564979978|FG000|Overall Study|Progression of disease|4|||
156515691|NCT01327495|564981519|FG000|Overall Study|Adverse Event|2|||
156515692|NCT01327495|564981520|FG001|Overall Study|Adverse Event|1|||
156515693|NCT01327495|564981521|FG002|Overall Study|Adverse Event|1|||
156515694|NCT01327495|564981522|FG003|Overall Study|Adverse Event|0|||
156515695|NCT01327495|564981523|FG004|Overall Study|Adverse Event|0|||
156515696|NCT01327495|564981524|FG005|Overall Study|Adverse Event|2|||
156515697|NCT01327495|564981519|FG000|Overall Study|Withdrawal by Subject|0|||
156515698|NCT01327495|564981520|FG001|Overall Study|Withdrawal by Subject|1|||
156515699|NCT01327495|564981521|FG002|Overall Study|Withdrawal by Subject|1|||
156515700|NCT01327495|564981522|FG003|Overall Study|Withdrawal by Subject|0|||
156515701|NCT01327495|564981523|FG004|Overall Study|Withdrawal by Subject|1|||
156515702|NCT01327495|564981524|FG005|Overall Study|Withdrawal by Subject|0|||
156515703|NCT01327495|564981519|FG000|Overall Study|Physician Decision|0|||
156515704|NCT01327495|564981520|FG001|Overall Study|Physician Decision|0|||
156515705|NCT01327495|564981521|FG002|Overall Study|Physician Decision|0|||
156515706|NCT01327495|564981522|FG003|Overall Study|Physician Decision|0|||
156515707|NCT01327495|564981523|FG004|Overall Study|Physician Decision|2|||
156515708|NCT01327495|564981524|FG005|Overall Study|Physician Decision|0|||
156515709|NCT00424385|564981527|FG000|Cohort 0|Withdrawal by Subject|5|||
156515710|NCT00424385|564981527|FG000|Cohort 0|Physician Decision|1|||
156515711|NCT00424385|564981527|FG000|Cohort 1|Withdrawal by Subject|1|||
156515712|NCT05870228|564981531|FG000|Overall Study|Lost to Follow-up|2|||
156560281|NCT01070329|565141962|FG000|Overall Study|Physician Decision|2|||
156515713|NCT05870228|564981532|FG001|Overall Study|Lost to Follow-up|0|||
156515714|NCT05870228|564981531|FG000|Overall Study|Withdrawal by Subject|1|||
156515715|NCT05870228|564981532|FG001|Overall Study|Withdrawal by Subject|0|||
156560282|NCT01070329|565141963|FG001|Overall Study|Physician Decision|1|||
156515716|NCT03500159|564981534|FG000|Overall Study|Study Terminated|2|||
156560283|NCT01070329|565141962|FG000|Overall Study|Entry Criteria Not Met|1|||
156560284|NCT01070329|565141963|FG001|Overall Study|Entry Criteria Not Met|0|||
156560285|NCT01070329|565141962|FG000|Overall Study|Sponsor Decision|0|||
156560286|NCT01070329|565141963|FG001|Overall Study|Sponsor Decision|1|||
156560287|NCT02863848|565141964|FG000|Overall Study|Lost to Follow-up|1|||
156560288|NCT02863848|565141965|FG001|Overall Study|Lost to Follow-up|1|||
156560289|NCT02863848|565141964|FG000|Overall Study|Protocol Violation|1|||
156560290|NCT02863848|565141965|FG001|Overall Study|Protocol Violation|2|||
156560291|NCT00686127|565141966|FG000|Overall Study|Withdrawal by Subject|14|||
156560292|NCT00686127|565141967|FG001|Overall Study|Withdrawal by Subject|6|||
156560293|NCT03980938|565141974|FG000|Treatment Period 1|Study Terminated|1|||
156560294|NCT03980938|565141975|FG001|Treatment Period 1|Study Terminated|1|||
156560295|NCT03980938|565141974|FG000|Treatment Period 2|Study Terminated|2|||
156560296|NCT03980938|565141975|FG001|Treatment Period 2|Study Terminated|2|||
156560297|NCT00400400|565141980|FG000|Overall Study|Adverse Event|9|||
156560298|NCT00400400|565141981|FG001|Overall Study|Adverse Event|8|||
156560299|NCT00400400|565141980|FG000|Overall Study|Protocol Violation|2|||
156560300|NCT00400400|565141981|FG001|Overall Study|Protocol Violation|0|||
156560301|NCT00400400|565141980|FG000|Overall Study|Withdrawal by Subject|1|||
156560302|NCT00400400|565141981|FG001|Overall Study|Withdrawal by Subject|3|||
156560303|NCT00400400|565141980|FG000|Overall Study|Administrative Problem|1|||
156560304|NCT00400400|565141981|FG001|Overall Study|Administrative Problem|0|||
156560305|NCT00400400|565141980|FG000|Overall Study|Lost to Follow-up|0|||
156560306|NCT00400400|565141981|FG001|Overall Study|Lost to Follow-up|1|||
156560307|NCT00400400|565141980|FG000|Overall Study|Did not receive study drug|1|||
156560308|NCT00400400|565141981|FG001|Overall Study|Did not receive study drug|3|||
156560309|NCT01848145|565141982|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
156560310|NCT01848145|565141982|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
156560311|NCT01848145|565141982|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
156560312|NCT01848145|565141982|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
156560313|NCT01848145|565141982|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
156560314|NCT01848145|565141982|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
156560315|NCT01848145|565141982|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
156560316|NCT00364689|565141983|FG000|Overall Study|Lost to Follow-up|1|||
156560317|NCT00234039|565141985|FG000|Overall Study|Adverse Event|2|||
156560318|NCT00234039|565141985|FG000|Overall Study|Progression/relapse|34|||
156560319|NCT00234039|565141985|FG000|Overall Study|Other - Not Protocol Specified|3|||
156560320|NCT00234039|565141985|FG000|Overall Study|Ineligible|9|||
156560321|NCT00234039|565141985|FG000|Overall Study|No Protocol Treatment Received|2|||
156560322|NCT04426695|565141986|FG000|Overall Study|Death|2|||
156560323|NCT04426695|565141987|FG001|Overall Study|Death|0|||
156560324|NCT04426695|565141988|FG002|Overall Study|Death|1|||
156560325|NCT04426695|565141989|FG003|Overall Study|Death|27|||
156560326|NCT04426695|565141990|FG004|Overall Study|Death|25|||
156560327|NCT04426695|565141991|FG005|Overall Study|Death|21|||
156560328|NCT04426695|565141992|FG006|Overall Study|Death|42|||
156560329|NCT04426695|565141993|FG007|Overall Study|Death|23|||
156560330|NCT04426695|565141994|FG008|Overall Study|Death|37|||
156560331|NCT04426695|565141995|FG009|Overall Study|Death|14|||
156560332|NCT04426695|565141996|FG010|Overall Study|Death|8|||
156560333|NCT04426695|565141997|FG011|Overall Study|Death|7|||
156560334|NCT04426695|565141998|FG012|Overall Study|Death|13|||
156560335|NCT04426695|565141999|FG013|Overall Study|Death|25|||
156560336|NCT04426695|565142000|FG014|Overall Study|Death|19|||
156560337|NCT04426695|565142001|FG015|Overall Study|Death|7|||
156560338|NCT04426695|565142002|FG016|Overall Study|Death|8|||
156560339|NCT04426695|565142003|FG017|Overall Study|Death|4|||
156560340|NCT04426695|565141986|FG000|Overall Study|Lost to Follow-up|2|||
156515717|NCT03500159|564981535|FG001|Overall Study|Study Terminated|1|||
156515718|NCT00560066|564981538|FG000|Overall Study|Death|2|||
156515719|NCT00560066|564981539|FG001|Overall Study|Death|1|||
156515720|NCT00560066|564981538|FG000|Overall Study|Withdrawal by Subject|0|||
156515721|NCT00560066|564981539|FG001|Overall Study|Withdrawal by Subject|3|||
156515722|NCT00560066|564981538|FG000|Overall Study|Lost to Follow-up|4|||
156515723|NCT00560066|564981539|FG001|Overall Study|Lost to Follow-up|10|||
156560341|NCT04426695|565141987|FG001|Overall Study|Lost to Follow-up|4|||
156560342|NCT04426695|565141988|FG002|Overall Study|Lost to Follow-up|1|||
156560343|NCT04426695|565141989|FG003|Overall Study|Lost to Follow-up|19|||
156515724|NCT00560066|564981538|FG000|Overall Study|Protocol Violation|0|||
156560344|NCT04426695|565141990|FG004|Overall Study|Lost to Follow-up|10|||
156560345|NCT04426695|565141991|FG005|Overall Study|Lost to Follow-up|14|||
156560346|NCT04426695|565141992|FG006|Overall Study|Lost to Follow-up|5|||
156515725|NCT00560066|564981539|FG001|Overall Study|Protocol Violation|1|||
156515726|NCT00560066|564981538|FG000|Overall Study|Administrative reason|0|||
156560347|NCT04426695|565141993|FG007|Overall Study|Lost to Follow-up|14|||
156560348|NCT04426695|565141994|FG008|Overall Study|Lost to Follow-up|10|||
156560349|NCT04426695|565141995|FG009|Overall Study|Lost to Follow-up|11|||
156560350|NCT04426695|565141996|FG010|Overall Study|Lost to Follow-up|12|||
156560351|NCT04426695|565141997|FG011|Overall Study|Lost to Follow-up|6|||
156560352|NCT04426695|565141998|FG012|Overall Study|Lost to Follow-up|2|||
156560353|NCT04426695|565141999|FG013|Overall Study|Lost to Follow-up|2|||
156560354|NCT04426695|565142000|FG014|Overall Study|Lost to Follow-up|2|||
156560355|NCT04426695|565142001|FG015|Overall Study|Lost to Follow-up|0|||
156560356|NCT04426695|565142002|FG016|Overall Study|Lost to Follow-up|0|||
156515727|NCT00560066|564981539|FG001|Overall Study|Administrative reason|5|||
156515728|NCT00560066|564981538|FG000|Overall Study|Missing primary reason|0|||
156515729|NCT00560066|564981539|FG001|Overall Study|Missing primary reason|2|||
156515730|NCT01125514|564981541|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
156515731|NCT01125514|564981541|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
156515732|NCT01125514|564981541|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
156515733|NCT01125514|564981541|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
156515734|NCT01125514|564981541|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
156515735|NCT01125514|564981541|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
156515736|NCT00929110|564981544|FG000|Overall Study|Adverse Event|40|||
156515737|NCT00929110|564981545|FG001|Overall Study|Adverse Event|29|||
156515738|NCT00929110|564981546|FG002|Overall Study|Adverse Event|18|||
156515739|NCT00929110|564981544|FG000|Overall Study|Subject withdrew consent|40|||
156515740|NCT00929110|564981545|FG001|Overall Study|Subject withdrew consent|23|||
156515741|NCT00929110|564981546|FG002|Overall Study|Subject withdrew consent|26|||
156515742|NCT00929110|564981544|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
156515743|NCT00929110|564981545|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
156515744|NCT00929110|564981546|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
156560357|NCT04426695|565142003|FG017|Overall Study|Lost to Follow-up|0|||
156560358|NCT04426695|565141986|FG000|Overall Study|Participant Decision|1|||
156560359|NCT04426695|565141987|FG001|Overall Study|Participant Decision|2|||
156560360|NCT04426695|565141988|FG002|Overall Study|Participant Decision|2|||
156560361|NCT04426695|565141989|FG003|Overall Study|Participant Decision|12|||
156560362|NCT04426695|565141990|FG004|Overall Study|Participant Decision|18|||
156560363|NCT04426695|565141991|FG005|Overall Study|Participant Decision|22|||
156560364|NCT04426695|565141992|FG006|Overall Study|Participant Decision|13|||
156560365|NCT04426695|565141993|FG007|Overall Study|Participant Decision|13|||
156560366|NCT04426695|565141994|FG008|Overall Study|Participant Decision|10|||
156560367|NCT04426695|565141995|FG009|Overall Study|Participant Decision|15|||
156560368|NCT04426695|565141996|FG010|Overall Study|Participant Decision|16|||
156560369|NCT04426695|565141997|FG011|Overall Study|Participant Decision|17|||
156560370|NCT04426695|565141998|FG012|Overall Study|Participant Decision|2|||
156560371|NCT04426695|565141999|FG013|Overall Study|Participant Decision|1|||
156560372|NCT04426695|565142000|FG014|Overall Study|Participant Decision|2|||
156560373|NCT04426695|565142001|FG015|Overall Study|Participant Decision|0|||
156560374|NCT04426695|565142002|FG016|Overall Study|Participant Decision|0|||
156560375|NCT04426695|565142003|FG017|Overall Study|Participant Decision|0|||
156560376|NCT04426695|565141986|FG000|Overall Study|Adverse Event|0|||
156560377|NCT04426695|565141987|FG001|Overall Study|Adverse Event|0|||
156560378|NCT04426695|565141988|FG002|Overall Study|Adverse Event|0|||
156560379|NCT04426695|565141989|FG003|Overall Study|Adverse Event|0|||
156560380|NCT04426695|565141990|FG004|Overall Study|Adverse Event|0|||
156560381|NCT04426695|565141991|FG005|Overall Study|Adverse Event|0|||
156560382|NCT04426695|565141992|FG006|Overall Study|Adverse Event|0|||
156560383|NCT04426695|565141993|FG007|Overall Study|Adverse Event|1|||
156560384|NCT04426695|565141994|FG008|Overall Study|Adverse Event|0|||
156560385|NCT04426695|565141995|FG009|Overall Study|Adverse Event|0|||
156560386|NCT04426695|565141996|FG010|Overall Study|Adverse Event|1|||
156560387|NCT04426695|565141997|FG011|Overall Study|Adverse Event|1|||
156560388|NCT04426695|565141998|FG012|Overall Study|Adverse Event|0|||
156560389|NCT04426695|565141999|FG013|Overall Study|Adverse Event|0|||
156560390|NCT04426695|565142000|FG014|Overall Study|Adverse Event|0|||
156560391|NCT04426695|565142001|FG015|Overall Study|Adverse Event|0|||
156560392|NCT04426695|565142002|FG016|Overall Study|Adverse Event|0|||
156515745|NCT00929110|564981544|FG000|Overall Study|Lost to Follow-up|7|||
156515746|NCT00929110|564981545|FG001|Overall Study|Lost to Follow-up|7|||
156515747|NCT00929110|564981546|FG002|Overall Study|Lost to Follow-up|3|||
156515748|NCT00929110|564981544|FG000|Overall Study|Protocol deviation|5|||
156515749|NCT00929110|564981545|FG001|Overall Study|Protocol deviation|2|||
156560393|NCT04426695|565142003|FG017|Overall Study|Adverse Event|0|||
156560394|NCT04426695|565141986|FG000|Overall Study|Sponsor Request|0|||
156560395|NCT04426695|565141987|FG001|Overall Study|Sponsor Request|0|||
156560396|NCT04426695|565141988|FG002|Overall Study|Sponsor Request|0|||
156560397|NCT04426695|565141989|FG003|Overall Study|Sponsor Request|0|||
156560398|NCT04426695|565141990|FG004|Overall Study|Sponsor Request|0|||
156560399|NCT04426695|565141991|FG005|Overall Study|Sponsor Request|0|||
156560400|NCT04426695|565141992|FG006|Overall Study|Sponsor Request|1|||
156560401|NCT04426695|565141993|FG007|Overall Study|Sponsor Request|0|||
156560402|NCT04426695|565141994|FG008|Overall Study|Sponsor Request|0|||
156560403|NCT04426695|565141995|FG009|Overall Study|Sponsor Request|0|||
156560404|NCT04426695|565141996|FG010|Overall Study|Sponsor Request|0|||
156560405|NCT04426695|565141997|FG011|Overall Study|Sponsor Request|0|||
156560406|NCT04426695|565141998|FG012|Overall Study|Sponsor Request|0|||
156515750|NCT00929110|564981546|FG002|Overall Study|Protocol deviation|4|||
156515751|NCT00929110|564981544|FG000|Overall Study|Administrative problems|4|||
156515752|NCT00929110|564981545|FG001|Overall Study|Administrative problems|1|||
156515753|NCT00929110|564981546|FG002|Overall Study|Administrative problems|2|||
156515754|NCT00929110|564981544|FG000|Overall Study|Death|2|||
156515755|NCT00929110|564981545|FG001|Overall Study|Death|2|||
156515756|NCT00929110|564981546|FG002|Overall Study|Death|2|||
156515757|NCT00929110|564981544|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156515758|NCT00929110|564981545|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156515759|NCT00929110|564981546|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156515760|NCT00929110|564981544|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156515761|NCT00929110|564981545|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156515762|NCT00929110|564981546|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156515763|NCT00929110|564981544|FG000|Overall Study|Patient inability to use the device|0|||
156515764|NCT00929110|564981545|FG001|Overall Study|Patient inability to use the device|1|||
156515765|NCT00929110|564981546|FG002|Overall Study|Patient inability to use the device|0|||
156515766|NCT01163292|564981550|FG000|Overall Study|Lack of Efficacy|9|||
156515767|NCT01163292|564981551|FG001|Overall Study|Lack of Efficacy|0|||
156515768|NCT01163292|564981550|FG000|Overall Study|Adverse Event|6|||
156515769|NCT01163292|564981551|FG001|Overall Study|Adverse Event|0|||
156515770|NCT01163292|564981550|FG000|Overall Study|Initiation of biological therapy|0|||
156515771|NCT01163292|564981551|FG001|Overall Study|Initiation of biological therapy|15|||
156515772|NCT01163292|564981550|FG000|Overall Study|Sufficient response to adalimumab|8|||
156515773|NCT01163292|564981551|FG001|Overall Study|Sufficient response to adalimumab|0|||
156515774|NCT01163292|564981550|FG000|Overall Study|Refusal to receive adalimumab|7|||
156515775|NCT01163292|564981551|FG001|Overall Study|Refusal to receive adalimumab|0|||
156515776|NCT01163292|564981550|FG000|Overall Study|Economic reasons|6|||
156515777|NCT01163292|564981551|FG001|Overall Study|Economic reasons|0|||
156515778|NCT01163292|564981550|FG000|Overall Study|No further visits|5|||
156515779|NCT01163292|564981551|FG001|Overall Study|No further visits|7|||
156515780|NCT02643472|564981552|FG000|Overall Study|Death|2|||
156515781|NCT02643472|564981553|FG001|Overall Study|Death|5|||
156515782|NCT02643472|564981552|FG000|Overall Study|Withdrawal by Subject|3|||
156515783|NCT02643472|564981553|FG001|Overall Study|Withdrawal by Subject|2|||
156515784|NCT02643472|564981552|FG000|Overall Study|Protocol Violation|0|||
156515785|NCT02643472|564981553|FG001|Overall Study|Protocol Violation|1|||
156515786|NCT02643472|564981552|FG000|Overall Study|Lost to Follow-up|22|||
156515787|NCT02643472|564981553|FG001|Overall Study|Lost to Follow-up|26|||
156515788|NCT01258595|564981554|FG000|Overall Study|Lost to Follow-up|1|||
156515789|NCT01258595|564981555|FG001|Overall Study|Lost to Follow-up|0|||
156515790|NCT01258595|564981554|FG000|Overall Study|Withdrawal by Subject|0|||
156515791|NCT01258595|564981555|FG001|Overall Study|Withdrawal by Subject|1|||
156515792|NCT01215188|564981556|FG000|Overall Study|Lost to Follow-up|22|||
156515793|NCT01215188|564981557|FG001|Overall Study|Lost to Follow-up|22|||
156515794|NCT01215188|564981558|FG002|Overall Study|Lost to Follow-up|16|||
156515795|NCT01215188|564981556|FG000|Overall Study|Adverse Event|1|||
156515796|NCT01215188|564981557|FG001|Overall Study|Adverse Event|1|||
156515797|NCT01215188|564981558|FG002|Overall Study|Adverse Event|3|||
156515798|NCT01215188|564981556|FG000|Overall Study|Physician Decision|2|||
156515799|NCT01215188|564981557|FG001|Overall Study|Physician Decision|1|||
156515800|NCT01215188|564981558|FG002|Overall Study|Physician Decision|0|||
156515801|NCT01215188|564981556|FG000|Overall Study|Lack of Efficacy|0|||
156515802|NCT01215188|564981557|FG001|Overall Study|Lack of Efficacy|0|||
156515803|NCT01215188|564981558|FG002|Overall Study|Lack of Efficacy|1|||
156515804|NCT01215188|564981556|FG000|Overall Study|Protocol Violation|1|||
156515805|NCT01215188|564981557|FG001|Overall Study|Protocol Violation|1|||
156515806|NCT01215188|564981558|FG002|Overall Study|Protocol Violation|1|||
156515807|NCT01215188|564981556|FG000|Overall Study|Withdrawal by Subject|32|||
156515808|NCT01215188|564981557|FG001|Overall Study|Withdrawal by Subject|34|||
156515809|NCT01215188|564981558|FG002|Overall Study|Withdrawal by Subject|31|||
156515810|NCT01012414|564981559|FG000|Overall Study|Withdrawal by Subject|2|||
156515811|NCT01012414|564981559|FG000|Overall Study|Lost to Follow-up|1|||
156515812|NCT01012414|564981559|FG000|Overall Study|Trial was stopped before completed|7|||
156515813|NCT02601300|564981560|FG000|Induction Phase|Lack of Efficacy|2|||
156515814|NCT02601300|564981560|FG000|Induction Phase|Protocol Violation|1|||
156515815|NCT02601300|564981560|FG000|Extension Phase|Withdrawal by Subject|3|||
156515816|NCT02601300|564981560|FG000|Extension Phase|Adverse Event|4|||
156515817|NCT02601300|564981560|FG000|Extension Phase|Lack of Efficacy|10|||
156515818|NCT03122223|564981565|FG000|Overall Study|Withdrawal by Subject|2|||
156515819|NCT03122223|564981566|FG001|Overall Study|Withdrawal by Subject|2|||
156515820|NCT03122223|564981567|FG002|Overall Study|Withdrawal by Subject|1|||
156515821|NCT03122223|564981568|FG003|Overall Study|Withdrawal by Subject|0|||
156515822|NCT03122223|564981565|FG000|Overall Study|Lost to Follow-up|0|||
156515823|NCT03122223|564981566|FG001|Overall Study|Lost to Follow-up|2|||
156515824|NCT03122223|564981567|FG002|Overall Study|Lost to Follow-up|2|||
156515825|NCT03122223|564981568|FG003|Overall Study|Lost to Follow-up|0|||
156515826|NCT03122223|564981565|FG000|Overall Study|Participant unable to adhere|1|||
156560407|NCT04426695|565141999|FG013|Overall Study|Sponsor Request|0|||
156515827|NCT03122223|564981566|FG001|Overall Study|Participant unable to adhere|1|||
156515828|NCT03122223|564981567|FG002|Overall Study|Participant unable to adhere|1|||
156515829|NCT03122223|564981568|FG003|Overall Study|Participant unable to adhere|0|||
156515830|NCT00291642|564981572|FG000|Overall Study|Adverse Event|1|||
156515831|NCT00291642|564981573|FG001|Overall Study|Adverse Event|0|||
156515832|NCT00291642|564981574|FG002|Overall Study|Adverse Event|1|||
156515833|NCT00291642|564981575|FG003|Overall Study|Adverse Event|0|||
156515834|NCT00291642|564981576|FG004|Overall Study|Adverse Event|1|||
156515835|NCT00291642|564981572|FG000|Overall Study|Patient missed visit|0|||
156515836|NCT00291642|564981573|FG001|Overall Study|Patient missed visit|0|||
156515837|NCT00291642|564981574|FG002|Overall Study|Patient missed visit|1|||
156515838|NCT00291642|564981575|FG003|Overall Study|Patient missed visit|0|||
156515839|NCT00291642|564981576|FG004|Overall Study|Patient missed visit|0|||
156515840|NCT00291642|564981572|FG000|Overall Study|Intake of prohibited medication|1|||
156515841|NCT00291642|564981573|FG001|Overall Study|Intake of prohibited medication|0|||
156515842|NCT00291642|564981574|FG002|Overall Study|Intake of prohibited medication|0|||
156515843|NCT00291642|564981575|FG003|Overall Study|Intake of prohibited medication|0|||
156515844|NCT00291642|564981576|FG004|Overall Study|Intake of prohibited medication|0|||
156515845|NCT02285153|564981577|FG000|Overall Study|Adverse Event|1|||
156515846|NCT02285153|564981578|FG001|Overall Study|Adverse Event|0|||
156515847|NCT03592745|564981584|FG000|Overall Study|Adverse Event|0|||
156515848|NCT03592745|564981585|FG001|Overall Study|Adverse Event|2|||
156515849|NCT03592745|564981584|FG000|Overall Study|Lost to Follow-up|2|||
156515850|NCT03592745|564981585|FG001|Overall Study|Lost to Follow-up|0|||
156515851|NCT03592745|564981584|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
156515852|NCT03592745|564981585|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
156515853|NCT02270515|564981586|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
156515854|NCT02270515|564981586|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
156515855|NCT02270515|564981586|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
156515856|NCT02270515|564981586|FG000|Intervention Period 1: 0-6 Months|Death|7|||
156515857|NCT02270515|564981586|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
156515858|NCT02270515|564981586|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
156515859|NCT02270515|564981586|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
156515860|NCT02270515|564981586|FG000|Intervention Period 2: 6-12 Months|Death|5|||
156515861|NCT02270515|564981586|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
156515862|NCT02270515|564981586|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
156515863|NCT02270515|564981586|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
156515864|NCT02270515|564981586|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
156515865|NCT02270515|564981586|FG000|Intervention Period 3: 12-18 Months|Death|3|||
156515866|NCT02270515|564981586|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
156515867|NCT03590366|564981587|FG000|Overall Study|Adverse Event|0|||
156515868|NCT03590366|564981588|FG001|Overall Study|Adverse Event|3|||
156515869|NCT03590366|564981587|FG000|Overall Study|Lost to Follow-up|3|||
156515870|NCT03590366|564981588|FG001|Overall Study|Lost to Follow-up|3|||
156515871|NCT03590366|564981587|FG000|Overall Study|Withdrawal by Subject|0|||
156515872|NCT03590366|564981588|FG001|Overall Study|Withdrawal by Subject|2|||
156515873|NCT02546921|564981601|FG000|Overall Study|Adverse Event|0|||
156515874|NCT02546921|564981602|FG001|Overall Study|Adverse Event|5|||
156515875|NCT02546921|564981603|FG002|Overall Study|Adverse Event|2|||
156515876|NCT02546921|564981604|FG003|Overall Study|Adverse Event|0|||
156515877|NCT02546921|564981605|FG004|Overall Study|Adverse Event|0|||
156515878|NCT02546921|564981606|FG005|Overall Study|Adverse Event|0|||
156515879|NCT02546921|564981607|FG006|Overall Study|Adverse Event|0|||
156515880|NCT02546921|564981601|FG000|Overall Study|Evidence of Disease Progression|1|||
156515881|NCT02546921|564981602|FG001|Overall Study|Evidence of Disease Progression|0|||
156515882|NCT02546921|564981603|FG002|Overall Study|Evidence of Disease Progression|0|||
156515883|NCT02546921|564981604|FG003|Overall Study|Evidence of Disease Progression|0|||
156515884|NCT02546921|564981605|FG004|Overall Study|Evidence of Disease Progression|1|||
156515885|NCT02546921|564981606|FG005|Overall Study|Evidence of Disease Progression|0|||
156560408|NCT04426695|565142000|FG014|Overall Study|Sponsor Request|0|||
156560409|NCT04426695|565142001|FG015|Overall Study|Sponsor Request|0|||
156515886|NCT02546921|564981607|FG006|Overall Study|Evidence of Disease Progression|0|||
156515887|NCT02546921|564981601|FG000|Overall Study|Patient Choice|0|||
156515888|NCT02546921|564981602|FG001|Overall Study|Patient Choice|1|||
156515889|NCT02546921|564981603|FG002|Overall Study|Patient Choice|0|||
156515890|NCT02546921|564981604|FG003|Overall Study|Patient Choice|0|||
156515891|NCT02546921|564981605|FG004|Overall Study|Patient Choice|0|||
156515892|NCT02546921|564981606|FG005|Overall Study|Patient Choice|1|||
156515893|NCT02546921|564981607|FG006|Overall Study|Patient Choice|0|||
156515894|NCT01413503|564981608|FG000|Overall Study|Lost to Follow-up|1|||
156515895|NCT01373151|564981609|FG000|Period 1|Lack of Efficacy|3|||
156515896|NCT01373151|564981610|FG001|Period 1|Lack of Efficacy|0|||
156515897|NCT01373151|564981611|FG002|Period 1|Lack of Efficacy|0|||
156560410|NCT04426695|565142002|FG016|Overall Study|Sponsor Request|0|||
156515898|NCT01373151|564981612|FG003|Period 1|Lack of Efficacy|0|||
156515899|NCT01373151|564981613|FG004|Period 1|Lack of Efficacy|1|||
156515900|NCT01373151|564981614|FG005|Period 1|Lack of Efficacy|0|||
156515901|NCT01373151|564981615|FG006|Period 1|Lack of Efficacy|0|||
156515902|NCT01373151|564981609|FG000|Period 1|Adverse Event|0|||
156515903|NCT01373151|564981610|FG001|Period 1|Adverse Event|0|||
156515904|NCT01373151|564981611|FG002|Period 1|Adverse Event|1|||
156515905|NCT01373151|564981612|FG003|Period 1|Adverse Event|0|||
156515906|NCT01373151|564981613|FG004|Period 1|Adverse Event|4|||
156515907|NCT01373151|564981614|FG005|Period 1|Adverse Event|3|||
156515908|NCT01373151|564981615|FG006|Period 1|Adverse Event|0|||
156515909|NCT01373151|564981609|FG000|Period 1|Withdrawal by Subject|2|||
156515910|NCT01373151|564981610|FG001|Period 1|Withdrawal by Subject|0|||
156515911|NCT01373151|564981611|FG002|Period 1|Withdrawal by Subject|3|||
156515912|NCT01373151|564981612|FG003|Period 1|Withdrawal by Subject|1|||
156515913|NCT01373151|564981613|FG004|Period 1|Withdrawal by Subject|0|||
156515914|NCT01373151|564981614|FG005|Period 1|Withdrawal by Subject|1|||
156515915|NCT01373151|564981615|FG006|Period 1|Withdrawal by Subject|0|||
156515916|NCT01373151|564981609|FG000|Period 2|Lack of Efficacy|9|||
156515917|NCT01373151|564981610|FG001|Period 2|Lack of Efficacy|0|||
156515918|NCT01373151|564981611|FG002|Period 2|Lack of Efficacy|0|||
156515919|NCT01373151|564981612|FG003|Period 2|Lack of Efficacy|1|||
156515920|NCT01373151|564981613|FG004|Period 2|Lack of Efficacy|2|||
156515921|NCT01373151|564981614|FG005|Period 2|Lack of Efficacy|0|||
156515922|NCT01373151|564981615|FG006|Period 2|Lack of Efficacy|3|||
156515923|NCT01373151|564981609|FG000|Period 2|Adverse Event|0|||
156515924|NCT01373151|564981610|FG001|Period 2|Adverse Event|0|||
156515925|NCT01373151|564981611|FG002|Period 2|Adverse Event|3|||
156515926|NCT01373151|564981612|FG003|Period 2|Adverse Event|3|||
156515927|NCT01373151|564981613|FG004|Period 2|Adverse Event|0|||
156515928|NCT01373151|564981614|FG005|Period 2|Adverse Event|0|||
156515929|NCT01373151|564981615|FG006|Period 2|Adverse Event|1|||
156515930|NCT01373151|564981609|FG000|Period 2|subject request to discontinue|0|||
156515931|NCT01373151|564981610|FG001|Period 2|subject request to discontinue|1|||
156515932|NCT01373151|564981611|FG002|Period 2|subject request to discontinue|0|||
156515933|NCT01373151|564981612|FG003|Period 2|subject request to discontinue|0|||
156515934|NCT01373151|564981613|FG004|Period 2|subject request to discontinue|0|||
156515935|NCT01373151|564981614|FG005|Period 2|subject request to discontinue|0|||
156515936|NCT01373151|564981615|FG006|Period 2|subject request to discontinue|0|||
156515937|NCT01373151|564981609|FG000|Period 2|Withdrawal by Subject|0|||
156515938|NCT01373151|564981610|FG001|Period 2|Withdrawal by Subject|0|||
156515939|NCT01373151|564981611|FG002|Period 2|Withdrawal by Subject|0|||
156515940|NCT01373151|564981612|FG003|Period 2|Withdrawal by Subject|1|||
156515941|NCT01373151|564981613|FG004|Period 2|Withdrawal by Subject|0|||
156515942|NCT01373151|564981614|FG005|Period 2|Withdrawal by Subject|0|||
156515943|NCT01373151|564981615|FG006|Period 2|Withdrawal by Subject|0|||
156515944|NCT01373151|564981609|FG000|Period 2|Other|0|||
156515945|NCT01373151|564981610|FG001|Period 2|Other|0|||
156515946|NCT01373151|564981611|FG002|Period 2|Other|1|||
156515947|NCT01373151|564981612|FG003|Period 2|Other|0|||
156515948|NCT01373151|564981613|FG004|Period 2|Other|0|||
156515949|NCT01373151|564981614|FG005|Period 2|Other|0|||
156515950|NCT01373151|564981615|FG006|Period 2|Other|1|||
156515951|NCT03026075|564981619|FG000|Overall Study|Physician Decision|1|||
156515952|NCT03381339|564981620|FG000|Overall Study|Protocol Violation|4|||
156515953|NCT03381339|564981621|FG001|Overall Study|Protocol Violation|3|||
156515954|NCT03381339|564981620|FG000|Overall Study|Lost to Follow-up|0|||
156515955|NCT03381339|564981621|FG001|Overall Study|Lost to Follow-up|1|||
156515956|NCT02001064|564981623|FG000|Overall Study|Withdrawal by Subject|2|||
156515957|NCT02001064|564981624|FG001|Overall Study|Withdrawal by Subject|1|||
156515958|NCT01468181|564981625|FG000|Overall Study|Adverse Event|8|||
156515959|NCT01468181|564981626|FG001|Overall Study|Adverse Event|1|||
156515960|NCT01468181|564981627|FG002|Overall Study|Adverse Event|6|||
156515961|NCT01468181|564981628|FG003|Overall Study|Adverse Event|2|||
156515962|NCT01468181|564981629|FG004|Overall Study|Adverse Event|2|||
156515963|NCT01468181|564981625|FG000|Overall Study|Protocol Violation|2|||
156515964|NCT01468181|564981626|FG001|Overall Study|Protocol Violation|0|||
156515965|NCT01468181|564981627|FG002|Overall Study|Protocol Violation|1|||
156515966|NCT01468181|564981628|FG003|Overall Study|Protocol Violation|0|||
156515967|NCT01468181|564981629|FG004|Overall Study|Protocol Violation|1|||
156515968|NCT01468181|564981625|FG000|Overall Study|Physician Decision|0|||
156515969|NCT01468181|564981626|FG001|Overall Study|Physician Decision|0|||
156515970|NCT01468181|564981627|FG002|Overall Study|Physician Decision|0|||
156515971|NCT01468181|564981628|FG003|Overall Study|Physician Decision|1|||
156515972|NCT01468181|564981629|FG004|Overall Study|Physician Decision|1|||
156515973|NCT01468181|564981625|FG000|Overall Study|Lost to Follow-up|0|||
156515974|NCT01468181|564981626|FG001|Overall Study|Lost to Follow-up|0|||
156515975|NCT01468181|564981627|FG002|Overall Study|Lost to Follow-up|1|||
156515976|NCT01468181|564981628|FG003|Overall Study|Lost to Follow-up|0|||
156515977|NCT01468181|564981629|FG004|Overall Study|Lost to Follow-up|1|||
156515978|NCT01468181|564981625|FG000|Overall Study|Withdrawal by Subject|0|||
156515979|NCT01468181|564981626|FG001|Overall Study|Withdrawal by Subject|1|||
156515980|NCT01468181|564981627|FG002|Overall Study|Withdrawal by Subject|0|||
156515981|NCT01468181|564981628|FG003|Overall Study|Withdrawal by Subject|0|||
156515982|NCT01468181|564981629|FG004|Overall Study|Withdrawal by Subject|0|||
156515983|NCT01982448|564981633|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
156515984|NCT01982448|564981634|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
156515985|NCT01982448|564981633|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
156515986|NCT01982448|564981634|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
156515987|NCT01982448|564981633|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
156515988|NCT01982448|564981634|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
156515989|NCT01982448|564981633|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
156515990|NCT01982448|564981634|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
156515991|NCT00969709|564983077|FG000|Overall Study|Adverse Event|3|||
156515992|NCT00969709|564983078|FG001|Overall Study|Adverse Event|13|||
156515993|NCT00969709|564983079|FG002|Overall Study|Adverse Event|26|||
156515994|NCT00969709|564983080|FG003|Overall Study|Adverse Event|12|||
156515995|NCT00969709|564983077|FG000|Overall Study|Lack of Efficacy|7|||
156515996|NCT00969709|564983078|FG001|Overall Study|Lack of Efficacy|4|||
156515997|NCT00969709|564983079|FG002|Overall Study|Lack of Efficacy|1|||
156515998|NCT00969709|564983080|FG003|Overall Study|Lack of Efficacy|3|||
156515999|NCT00969709|564983077|FG000|Overall Study|Protocol Violation|9|||
156516000|NCT00969709|564983078|FG001|Overall Study|Protocol Violation|5|||
156516001|NCT00969709|564983079|FG002|Overall Study|Protocol Violation|9|||
156516002|NCT00969709|564983080|FG003|Overall Study|Protocol Violation|10|||
156516003|NCT00969709|564983077|FG000|Overall Study|Withdrawal by Subject|9|||
156516004|NCT00969709|564983078|FG001|Overall Study|Withdrawal by Subject|12|||
156516005|NCT00969709|564983079|FG002|Overall Study|Withdrawal by Subject|11|||
156516006|NCT00969709|564983080|FG003|Overall Study|Withdrawal by Subject|23|||
156516007|NCT00969709|564983077|FG000|Overall Study|Lost to Follow-up|10|||
156516008|NCT00969709|564983078|FG001|Overall Study|Lost to Follow-up|14|||
156516009|NCT00969709|564983079|FG002|Overall Study|Lost to Follow-up|8|||
156516010|NCT00969709|564983080|FG003|Overall Study|Lost to Follow-up|15|||
156516011|NCT00969709|564983077|FG000|Overall Study|Other reasons|0|||
156516012|NCT00969709|564983078|FG001|Overall Study|Other reasons|0|||
156516013|NCT00969709|564983079|FG002|Overall Study|Other reasons|3|||
156516014|NCT00969709|564983080|FG003|Overall Study|Other reasons|0|||
156516015|NCT03695237|564983081|FG000|Overall Study|Withdrawal by Subject|1|||
156516016|NCT03695237|564983082|FG001|Overall Study|Withdrawal by Subject|3|||
156516017|NCT03695237|564983081|FG000|Overall Study|Lost to Follow-up|1|||
156516018|NCT03695237|564983082|FG001|Overall Study|Lost to Follow-up|2|||
156516019|NCT03695237|564983081|FG000|Overall Study|Other, Not Specified|8|||
156516020|NCT03695237|564983082|FG001|Overall Study|Other, Not Specified|2|||
156516021|NCT02516332|564983083|FG000|Overall Study|Withdrawal by Subject|2|||
156516022|NCT02516332|564983084|FG001|Overall Study|Withdrawal by Subject|1|||
156516023|NCT02516332|564983085|FG002|Overall Study|Withdrawal by Subject|2|||
156516024|NCT00055601|564983086|FG000|Overall Study|Protocol Violation|1|||
156516025|NCT00055601|564983087|FG001|Overall Study|Protocol Violation|1|||
156516026|NCT00055601|564983086|FG000|Overall Study|No protocol treatment received|1|||
156516027|NCT00055601|564983087|FG001|Overall Study|No protocol treatment received|1|||
156516028|NCT02217332|564983094|FG000|Overall Study|Adverse Event|3|||
156516029|NCT02217332|564983094|FG000|Overall Study|Dose interruption >1 month|1|||
156516030|NCT02217332|564983094|FG000|Overall Study|Protocol Violation (eligibility)|1|||
156516031|NCT02217332|564983094|FG000|Overall Study|Withdrawal by Subject|1|||
156516032|NCT02217332|564983094|FG000|Overall Study|Lost to Follow-up|1|||
156516033|NCT03573583|564983097|FG000|Overall Study|Lost to Follow-up|1|||
156516034|NCT03573583|564983098|FG001|Overall Study|Lost to Follow-up|0|||
156516035|NCT03573583|564983097|FG000|Overall Study|Withdrawal by Subject|1|||
156516036|NCT03573583|564983098|FG001|Overall Study|Withdrawal by Subject|1|||
156516037|NCT03725085|564983106|FG000|Overall Study|Lost to Follow-up|2|||
156516038|NCT00705679|564983107|FG000|Overall Study|Adverse Event|1|||
156516039|NCT00705679|564983108|FG001|Overall Study|Adverse Event|1|||
156516040|NCT00705679|564983109|FG002|Overall Study|Adverse Event|0|||
156516041|NCT00705679|564983110|FG003|Overall Study|Adverse Event|0|||
156516042|NCT00705679|564983111|FG004|Overall Study|Adverse Event|0|||
156516043|NCT00705679|564983107|FG000|Overall Study|Death|0|||
156516044|NCT00705679|564983108|FG001|Overall Study|Death|0|||
156516045|NCT00705679|564983109|FG002|Overall Study|Death|3|||
156516046|NCT00705679|564983110|FG003|Overall Study|Death|2|||
156516047|NCT00705679|564983111|FG004|Overall Study|Death|1|||
156516048|NCT00705679|564983107|FG000|Overall Study|Lost to Follow-up|32|||
156516049|NCT00705679|564983108|FG001|Overall Study|Lost to Follow-up|60|||
156516050|NCT00705679|564983109|FG002|Overall Study|Lost to Follow-up|44|||
156516051|NCT00705679|564983110|FG003|Overall Study|Lost to Follow-up|30|||
156516052|NCT00705679|564983111|FG004|Overall Study|Lost to Follow-up|35|||
156516053|NCT00705679|564983107|FG000|Overall Study|Physician Decision|0|||
156516054|NCT00705679|564983108|FG001|Overall Study|Physician Decision|1|||
156516055|NCT00705679|564983109|FG002|Overall Study|Physician Decision|0|||
156516056|NCT00705679|564983110|FG003|Overall Study|Physician Decision|1|||
156516057|NCT00705679|564983111|FG004|Overall Study|Physician Decision|0|||
156560411|NCT04426695|565142003|FG017|Overall Study|Sponsor Request|0|||
156516058|NCT00705679|564983107|FG000|Overall Study|Withdrawal by Subject|32|||
156516059|NCT00705679|564983108|FG001|Overall Study|Withdrawal by Subject|77|||
156516060|NCT00705679|564983109|FG002|Overall Study|Withdrawal by Subject|68|||
156516061|NCT00705679|564983110|FG003|Overall Study|Withdrawal by Subject|47|||
156516062|NCT00705679|564983111|FG004|Overall Study|Withdrawal by Subject|33|||
156516063|NCT02704754|564983112|FG000|Overall Study|Lost to Follow-up|1|||
156516064|NCT02704754|564983113|FG001|Overall Study|Lost to Follow-up|1|||
156516065|NCT02704754|564983112|FG000|Overall Study|Lack of Efficacy|1|||
156516066|NCT02704754|564983113|FG001|Overall Study|Lack of Efficacy|0|||
156516067|NCT02704754|564983112|FG000|Overall Study|Withdrawal by Subject|1|||
156516068|NCT02704754|564983113|FG001|Overall Study|Withdrawal by Subject|0|||
156516069|NCT01227577|564983119|FG000|Overall Study|Protocol deviation|3|||
156516070|NCT01227577|564983119|FG000|Overall Study|Death|3|||
156516071|NCT01227577|564983119|FG000|Overall Study|Administrative problems|2|||
156516072|NCT01227577|564983119|FG000|Overall Study|Lost to Follow-up|1|||
156516073|NCT01227577|564983119|FG000|Overall Study|Withdrawal by Subject|4|||
156516074|NCT01227577|564983119|FG000|Overall Study|Lack of Efficacy|5|||
156516075|NCT01227577|564983119|FG000|Overall Study|Adverse Event|17|||
156516076|NCT03809429|564983120|FG000|Overall Study|Withdrawal by Subject|7|||
156516077|NCT03809429|564983121|FG001|Overall Study|Withdrawal by Subject|3|||
156516078|NCT03809429|564983120|FG000|Overall Study|Adverse Event|6|||
156516079|NCT03809429|564983121|FG001|Overall Study|Adverse Event|9|||
156516080|NCT03809429|564983120|FG000|Overall Study|COVID-19|3|||
156516081|NCT03809429|564983121|FG001|Overall Study|COVID-19|1|||
156516082|NCT03809429|564983120|FG000|Overall Study|Participant was discontinued by investigator|12|||
156516083|NCT03809429|564983121|FG001|Overall Study|Participant was discontinued by investigator|7|||
156516084|NCT00107120|564983125|FG000|Overall Study|Adverse Event|4|||
156516085|NCT00107120|564983126|FG001|Overall Study|Adverse Event|1|||
156516086|NCT00107120|564983125|FG000|Overall Study|Lack of Efficacy|5|||
156516087|NCT00107120|564983126|FG001|Overall Study|Lack of Efficacy|5|||
156516088|NCT00107120|564983125|FG000|Overall Study|Protocol Violation|3|||
156516089|NCT00107120|564983126|FG001|Overall Study|Protocol Violation|0|||
156516090|NCT00107120|564983125|FG000|Overall Study|Withdrawal by Subject|8|||
156516091|NCT00107120|564983126|FG001|Overall Study|Withdrawal by Subject|9|||
156516092|NCT00107120|564983125|FG000|Overall Study|Lost to Follow-up|8|||
156516093|NCT00107120|564983126|FG001|Overall Study|Lost to Follow-up|6|||
156516094|NCT00107120|564983125|FG000|Overall Study|Pregnancy|0|||
156516095|NCT00107120|564983126|FG001|Overall Study|Pregnancy|1|||
156516096|NCT00107120|564983125|FG000|Overall Study|moving away from site|1|||
156516097|NCT00107120|564983126|FG001|Overall Study|moving away from site|1|||
156516098|NCT00107120|564983125|FG000|Overall Study|death of parent|0|||
156516099|NCT00107120|564983126|FG001|Overall Study|death of parent|1|||
156516100|NCT01119105|564983129|FG000|Overall Study|Withdrawal by Subject|1|||
156516101|NCT01119105|564983130|FG001|Overall Study|Withdrawal by Subject|1|||
156516102|NCT01119105|564983131|FG002|Overall Study|Withdrawal by Subject|1|||
156516103|NCT01119105|564983129|FG000|Overall Study|Lost to Follow-up|0|||
156516104|NCT01119105|564983130|FG001|Overall Study|Lost to Follow-up|2|||
156516105|NCT01119105|564983131|FG002|Overall Study|Lost to Follow-up|5|||
156516106|NCT01119105|564983129|FG000|Overall Study|Adverse Event|1|||
156516107|NCT01119105|564983130|FG001|Overall Study|Adverse Event|0|||
156516108|NCT01119105|564983131|FG002|Overall Study|Adverse Event|1|||
156516109|NCT01119105|564983129|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
156516110|NCT01119105|564983130|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
156516111|NCT01119105|564983131|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
156516112|NCT01119105|564983129|FG000|Overall Study|Other|1|||
156516113|NCT01119105|564983130|FG001|Overall Study|Other|1|||
156516114|NCT01119105|564983131|FG002|Overall Study|Other|0|||
156516115|NCT01639495|564983132|FG000|Overall Study|Lost to Follow-up|6|||
156516116|NCT01639495|564983132|FG000|Overall Study|Consented but didn't have study catheter|4|||
156516117|NCT01639495|564983132|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
156516118|NCT01639495|564983132|FG000|Overall Study|No radiofrequency energy applied|2|||
156516119|NCT04214600|564983133|FG000|Overall Study|Lost to Follow-up|9|||
156516120|NCT04214600|564983134|FG001|Overall Study|Lost to Follow-up|14|||
156516121|NCT01635920|564983135|FG000|Overall Study|Adverse Event|1|||
156516122|NCT01635920|564983136|FG001|Overall Study|Adverse Event|0|||
156516123|NCT01635920|564983135|FG000|Overall Study|Lost to Follow-up|0|||
156516124|NCT01635920|564983136|FG001|Overall Study|Lost to Follow-up|1|||
156516125|NCT01635920|564983135|FG000|Overall Study|Subject decision|2|||
156516126|NCT01635920|564983136|FG001|Overall Study|Subject decision|0|||
156516127|NCT01658150|564983138|FG000|Overall Study|Withdrawal by Subject|1|||
156516128|NCT04187989|564983139|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
156516129|NCT04187989|564983140|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
156516130|NCT04187989|564983139|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
156516131|NCT04187989|564983140|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
156516132|NCT02245737|564983141|FG000|Overall Study|Adverse Event|23|||
156516133|NCT02245737|564983142|FG001|Overall Study|Adverse Event|26|||
156516134|NCT02245737|564983143|FG002|Overall Study|Adverse Event|33|||
156516135|NCT02245737|564983141|FG000|Overall Study|Condition Worsened|9|||
156516136|NCT02245737|564983142|FG001|Overall Study|Condition Worsened|10|||
156516137|NCT02245737|564983143|FG002|Overall Study|Condition Worsened|9|||
156516138|NCT02245737|564983141|FG000|Overall Study|Death|2|||
156516139|NCT02245737|564983142|FG001|Overall Study|Death|4|||
156516140|NCT02245737|564983143|FG002|Overall Study|Death|4|||
156516141|NCT02245737|564983141|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
156516142|NCT02245737|564983142|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
156516143|NCT02245737|564983143|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
156516144|NCT02245737|564983141|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
156516145|NCT02245737|564983142|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
156516146|NCT02245737|564983143|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
156516147|NCT02245737|564983141|FG000|Overall Study|Lost to Follow-up|2|||
156516148|NCT02245737|564983142|FG001|Overall Study|Lost to Follow-up|5|||
156516149|NCT02245737|564983143|FG002|Overall Study|Lost to Follow-up|4|||
156516150|NCT02245737|564983141|FG000|Overall Study|Other-determined by Investigator|9|||
156516151|NCT02245737|564983142|FG001|Overall Study|Other-determined by Investigator|10|||
156516152|NCT02245737|564983143|FG002|Overall Study|Other-determined by Investigator|10|||
156516153|NCT02245737|564983141|FG000|Overall Study|Physician Decision|6|||
156516154|NCT02245737|564983142|FG001|Overall Study|Physician Decision|3|||
156516155|NCT02245737|564983143|FG002|Overall Study|Physician Decision|6|||
156516156|NCT02245737|564983141|FG000|Overall Study|Protocol Violation|3|||
156516157|NCT02245737|564983142|FG001|Overall Study|Protocol Violation|2|||
156516158|NCT02245737|564983143|FG002|Overall Study|Protocol Violation|3|||
156516159|NCT02245737|564983141|FG000|Overall Study|Withdrawal by Subject|40|||
156516160|NCT02245737|564983142|FG001|Overall Study|Withdrawal by Subject|41|||
156516161|NCT02245737|564983143|FG002|Overall Study|Withdrawal by Subject|44|||
156516162|NCT02245737|564983141|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
156516163|NCT02245737|564983142|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
156516164|NCT02245737|564983143|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
156516165|NCT02245737|564983141|FG000|Overall Study|Sponsor Decision|445|||
156516166|NCT02245737|564983142|FG001|Overall Study|Sponsor Decision|430|||
156516167|NCT02245737|564983143|FG002|Overall Study|Sponsor Decision|432|||
156516168|NCT00836745|564983147|FG000|Overall Study|Death|2|||
156516169|NCT00836745|564983147|FG000|Overall Study|Lost to Follow-up|10|||
156516170|NCT00836745|564983147|FG000|Overall Study|Adverse Event|3|||
156516171|NCT00836745|564983147|FG000|Overall Study|Objective progression or relapse|4|||
156516172|NCT00836745|564983147|FG000|Overall Study|Other|2|||
156516173|NCT02366468|564983149|FG000|Overall Study|Adverse Event|2|||
156516174|NCT02366468|564983150|FG001|Overall Study|Adverse Event|0|||
156516175|NCT02366468|564983149|FG000|Overall Study|Withdrawal by Subject|1|||
156516176|NCT02366468|564983150|FG001|Overall Study|Withdrawal by Subject|5|||
156516177|NCT02366468|564983149|FG000|Overall Study|Lost to Follow-up|2|||
156516178|NCT02366468|564983150|FG001|Overall Study|Lost to Follow-up|0|||
156516179|NCT02366468|564983149|FG000|Overall Study|Death|1|||
156516180|NCT02366468|564983150|FG001|Overall Study|Death|2|||
156516181|NCT02366468|564983149|FG000|Overall Study|Other|0|||
156516182|NCT02366468|564983150|FG001|Overall Study|Other|2|||
156516183|NCT00446043|564983151|FG000|Overall Study|Adverse Event|9|||
156516184|NCT00446043|564983151|FG000|Overall Study|Withdrawal by Subject|70|||
156516185|NCT00446043|564983151|FG000|Overall Study|Protocol Violation|2|||
156516186|NCT00446043|564983151|FG000|Overall Study|Lost to Follow-up|42|||
156516187|NCT00446043|564983151|FG000|Overall Study|Pregnancy|2|||
156516188|NCT05540717|564983154|FG000|Overall Study|Lost to Follow-up|2|||
156516189|NCT05540717|564983155|FG001|Overall Study|Lost to Follow-up|5|||
156516190|NCT05540717|564983154|FG000|Overall Study|Withdrawal by Subject|6|||
156516191|NCT05540717|564983155|FG001|Overall Study|Withdrawal by Subject|6|||
156516192|NCT05540717|564983154|FG000|Overall Study|Sponsor request|1|||
156516193|NCT05540717|564983155|FG001|Overall Study|Sponsor request|0|||
156516194|NCT05540717|564983154|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
156516195|NCT05540717|564983155|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
156516196|NCT05540717|564983154|FG000|Overall Study|Other|0|||
156516197|NCT05540717|564983155|FG001|Overall Study|Other|1|||
156516198|NCT01631227|564983156|FG000|Overall Study|withdrawn consent|27|||
156516199|NCT01631227|564983157|FG001|Overall Study|withdrawn consent|21|||
156516200|NCT01631227|564983156|FG000|Overall Study|Adverse Event|1|||
156516201|NCT01631227|564983157|FG001|Overall Study|Adverse Event|0|||
156516202|NCT01631227|564983156|FG000|Overall Study|administrative|2|||
156516203|NCT01631227|564983157|FG001|Overall Study|administrative|1|||
156516204|NCT03292432|564983158|FG000|Overall Study|Lost to Follow-up|11|||
156516205|NCT03292432|564983159|FG001|Overall Study|Lost to Follow-up|8|||
156516206|NCT03292432|564983158|FG000|Overall Study|Death|2|||
156516207|NCT03292432|564983159|FG001|Overall Study|Death|1|||
156516208|NCT03292432|564983158|FG000|Overall Study|Withdrawal by Subject|1|||
156516209|NCT03292432|564983159|FG001|Overall Study|Withdrawal by Subject|2|||
156516210|NCT03292432|564983158|FG000|Overall Study|Site closed before any data collected|1|||
156516211|NCT03292432|564983159|FG001|Overall Study|Site closed before any data collected|0|||
156516212|NCT03020576|564983160|FG000|Overall Study|Withdrawal by Subject|1|||
156516213|NCT03020576|564983161|FG001|Overall Study|Withdrawal by Subject|2|||
156516214|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
156516215|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
156516216|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
156516217|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
156516218|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
156516219|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
156516220|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
156516221|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
156516222|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
156516223|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
156516224|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
156516225|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
156516226|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
156516227|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
156516228|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
156516229|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
156516230|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
156516231|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
156516232|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
156516233|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
156516234|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
156516235|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
156516236|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
156516237|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
156516238|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
156516239|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
156516240|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
156516241|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
156516242|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
156516243|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
156516244|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
156516245|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
156516246|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
156516247|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
156516248|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
156516249|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
156516250|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
156516251|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
156516252|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
156516253|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
156516254|NCT00700427|564983162|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
156516255|NCT00700427|564983163|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
156516256|NCT00700427|564983164|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
156516257|NCT00700427|564983165|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
156516258|NCT00700427|564983166|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
156516259|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
156516260|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
156516261|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
156516262|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
156516263|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
156516264|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
156516265|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
156516266|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
156516267|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
156516268|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
156516269|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
156516270|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
156516271|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
156516272|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
156516273|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
156516274|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
156560412|NCT04426695|565141986|FG000|Overall Study|Physician Decision|0|||
156516275|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
156516276|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
156516277|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
156516278|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
156516279|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
156516280|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
156516281|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
156516282|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
156516283|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
156516284|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
156516285|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
156516286|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
156516287|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
156516288|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
156516289|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
156516290|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
156516291|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
156516292|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
156516293|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
156516294|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
156516295|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
156516296|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
156516297|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
156516298|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
156516299|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
156516300|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
156516301|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
156516302|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
156516303|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
156516304|NCT00700427|564983162|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
156516305|NCT00700427|564983163|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
156516306|NCT00700427|564983164|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
156516307|NCT00700427|564983165|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
156516308|NCT00700427|564983166|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
156516309|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
156516310|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
156516311|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
156516312|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
156516313|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
156516314|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
156516315|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
156516316|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
156516317|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
156516318|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
156516319|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
156516320|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
156516321|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
156516322|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
156516323|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
156516324|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
156516325|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
156516326|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
156516327|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
156516328|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
156516329|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
156516330|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
156516331|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
156516332|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
156516333|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
156516334|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
156516335|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
156516336|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
156516337|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
156560413|NCT04426695|565141987|FG001|Overall Study|Physician Decision|0|||
156516338|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
156516339|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
156516340|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
156516341|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
156516342|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
156516343|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
156516344|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
156516345|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
156516346|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
156516347|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
156516348|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
156516349|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
156516350|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
156516351|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
156516352|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
156516353|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
156516354|NCT00700427|564983162|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
156560414|NCT04426695|565141988|FG002|Overall Study|Physician Decision|0|||
156560415|NCT04426695|565141989|FG003|Overall Study|Physician Decision|0|||
156560416|NCT04426695|565141990|FG004|Overall Study|Physician Decision|0|||
156560417|NCT04426695|565141991|FG005|Overall Study|Physician Decision|0|||
156560418|NCT04426695|565141992|FG006|Overall Study|Physician Decision|0|||
156560419|NCT04426695|565141993|FG007|Overall Study|Physician Decision|0|||
156560420|NCT04426695|565141994|FG008|Overall Study|Physician Decision|0|||
156516355|NCT00700427|564983163|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
156516356|NCT00700427|564983164|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
156516357|NCT00700427|564983165|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
156516358|NCT00700427|564983166|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
156516359|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
156516360|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
156516361|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
156516362|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
156516363|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
156516364|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
156516365|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
156516366|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
156516367|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
156516368|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
156516369|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
156516370|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
156516371|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
156516372|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
156516373|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
156516374|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
156516375|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
156516376|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
156516377|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
156516378|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
156516379|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
156516380|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
156516381|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
156516382|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
156516383|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
156516384|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
156516385|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
156516386|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
156516387|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
156516388|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
156516389|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
156516390|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
156516391|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
156516392|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
156516393|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
156516394|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
156560421|NCT04426695|565141995|FG009|Overall Study|Physician Decision|1|||
156560422|NCT04426695|565141996|FG010|Overall Study|Physician Decision|0|||
156560423|NCT04426695|565141997|FG011|Overall Study|Physician Decision|0|||
156560424|NCT04426695|565141998|FG012|Overall Study|Physician Decision|1|||
156516395|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
156516396|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
156516397|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
156516398|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
156516399|NCT00700427|564983162|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
156516400|NCT00700427|564983163|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
156516401|NCT00700427|564983164|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
156516402|NCT00700427|564983165|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
156516403|NCT00700427|564983166|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
156516404|NCT02057523|564983168|FG000|Overall Study|Withdrawal by Subject|1|||
156516405|NCT02057523|564983168|FG000|Overall Study|Lack of Efficacy|1|||
156516406|NCT00941070|564983170|FG000|Overall Study|Patient non-compliant|1|||
156516407|NCT03174431|564983171|FG000|Overall Study|Withdrawal by Subject|14|||
156516408|NCT03174431|564983172|FG001|Overall Study|Withdrawal by Subject|11|||
156516409|NCT03174431|564983171|FG000|Overall Study|alternative treatment|2|||
156516410|NCT03174431|564983172|FG001|Overall Study|alternative treatment|0|||
156516411|NCT03174431|564983171|FG000|Overall Study|Lost to Follow-up|1|||
156516412|NCT03174431|564983172|FG001|Overall Study|Lost to Follow-up|5|||
156516413|NCT04811131|564983180|FG000|Overall Study|Adverse Event|0|||
156516414|NCT04811131|564983181|FG001|Overall Study|Adverse Event|0|||
156516415|NCT04811131|564983182|FG002|Overall Study|Adverse Event|1|||
156516416|NCT04811131|564983183|FG003|Overall Study|Adverse Event|0|||
156516417|NCT04811131|564983180|FG000|Overall Study|Lack of Efficacy|0|||
156516418|NCT04811131|564983181|FG001|Overall Study|Lack of Efficacy|0|||
156516419|NCT04811131|564983182|FG002|Overall Study|Lack of Efficacy|0|||
156516420|NCT04811131|564983183|FG003|Overall Study|Lack of Efficacy|1|||
156516421|NCT04811131|564983180|FG000|Overall Study|Lost to Follow-up|0|||
156516422|NCT04811131|564983181|FG001|Overall Study|Lost to Follow-up|1|||
156516423|NCT04811131|564983182|FG002|Overall Study|Lost to Follow-up|0|||
156516424|NCT04811131|564983183|FG003|Overall Study|Lost to Follow-up|0|||
156516425|NCT04811131|564983180|FG000|Overall Study|Sponsor request|31|||
156516426|NCT04811131|564983181|FG001|Overall Study|Sponsor request|35|||
156516427|NCT04811131|564983182|FG002|Overall Study|Sponsor request|27|||
156516428|NCT04811131|564983183|FG003|Overall Study|Sponsor request|10|||
156516429|NCT04811131|564983180|FG000|Overall Study|Withdrawal by Subject|3|||
156516430|NCT04811131|564983181|FG001|Overall Study|Withdrawal by Subject|1|||
156516431|NCT04811131|564983182|FG002|Overall Study|Withdrawal by Subject|3|||
156516432|NCT04811131|564983183|FG003|Overall Study|Withdrawal by Subject|1|||
156516433|NCT00506441|564983184|FG000|Period 1; Open-label Period|Adverse Event|21|||
156516434|NCT00506441|564983185|FG001|Period 1; Open-label Period|Adverse Event|0|||
156516435|NCT00506441|564983184|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
156516436|NCT00506441|564983185|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
156516437|NCT00506441|564983184|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
156516438|NCT00506441|564983185|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
156516439|NCT00506441|564983184|FG000|Period 1; Open-label Period|Physician Decision|5|||
156516440|NCT00506441|564983185|FG001|Period 1; Open-label Period|Physician Decision|0|||
156516441|NCT00506441|564983184|FG000|Period 1; Open-label Period|Protocol Violation|9|||
156516442|NCT00506441|564983185|FG001|Period 1; Open-label Period|Protocol Violation|0|||
156516443|NCT00506441|564983184|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
156516444|NCT00506441|564983185|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
156560425|NCT04426695|565141999|FG013|Overall Study|Physician Decision|0|||
156560426|NCT04426695|565142000|FG014|Overall Study|Physician Decision|0|||
156560427|NCT04426695|565142001|FG015|Overall Study|Physician Decision|0|||
156560428|NCT04426695|565142002|FG016|Overall Study|Physician Decision|0|||
156560429|NCT04426695|565142003|FG017|Overall Study|Physician Decision|0|||
156560430|NCT04426695|565141986|FG000|Overall Study|Randomized but Never Treated|3|||
156560431|NCT04426695|565141987|FG001|Overall Study|Randomized but Never Treated|1|||
156560432|NCT04426695|565141988|FG002|Overall Study|Randomized but Never Treated|0|||
156516445|NCT00506441|564983184|FG000|Period 1; Open-label Period|Other Reasons|13|||
156516446|NCT00506441|564983185|FG001|Period 1; Open-label Period|Other Reasons|0|||
156516447|NCT00506441|564983184|FG000|Period 2; Double-blind Period|Adverse Event|0|||
156516448|NCT00506441|564983185|FG001|Period 2; Double-blind Period|Adverse Event|1|||
156560433|NCT04426695|565141989|FG003|Overall Study|Randomized but Never Treated|4|||
156560434|NCT04426695|565141990|FG004|Overall Study|Randomized but Never Treated|5|||
156516449|NCT00506441|564983184|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
156560435|NCT04426695|565141991|FG005|Overall Study|Randomized but Never Treated|5|||
156516450|NCT00506441|564983185|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
156516451|NCT00506441|564983184|FG000|Period 2; Double-blind Period|Physician Decision|1|||
156560436|NCT04426695|565141992|FG006|Overall Study|Randomized but Never Treated|4|||
156516452|NCT00506441|564983185|FG001|Period 2; Double-blind Period|Physician Decision|1|||
156516453|NCT00506441|564983184|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
156560437|NCT04426695|565141993|FG007|Overall Study|Randomized but Never Treated|6|||
156560438|NCT04426695|565141994|FG008|Overall Study|Randomized but Never Treated|6|||
156560439|NCT04426695|565141995|FG009|Overall Study|Randomized but Never Treated|3|||
156516454|NCT00506441|564983185|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
156516455|NCT00506441|564983184|FG000|Period 2; Double-blind Period|Other Reason|1|||
156516456|NCT00506441|564983185|FG001|Period 2; Double-blind Period|Other Reason|1|||
156516457|NCT00735475|564983186|FG000|Overall Study|Adverse Event|0|||
156516458|NCT00735475|564983187|FG001|Overall Study|Adverse Event|1|||
156516459|NCT00735475|564983186|FG000|Overall Study|Death|1|||
156516460|NCT00735475|564983187|FG001|Overall Study|Death|1|||
156516461|NCT00735475|564983186|FG000|Overall Study|Lost to Follow-up|3|||
156516462|NCT00735475|564983187|FG001|Overall Study|Lost to Follow-up|3|||
156516463|NCT00735475|564983186|FG000|Overall Study|Physician Decision|0|||
156516464|NCT00735475|564983187|FG001|Overall Study|Physician Decision|1|||
156516465|NCT00735475|564983186|FG000|Overall Study|Withdrawal by Subject|4|||
156516466|NCT00735475|564983187|FG001|Overall Study|Withdrawal by Subject|5|||
156516467|NCT02544451|564983190|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
156516468|NCT02544451|564983191|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
156516469|NCT02544451|564983192|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
156516470|NCT02544451|564983193|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
156516471|NCT02544451|564983190|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
156516472|NCT02544451|564983191|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
156516473|NCT02544451|564983192|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
156516474|NCT02544451|564983193|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
156516475|NCT02544451|564983190|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
156516476|NCT02544451|564983191|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
156516477|NCT02544451|564983192|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
156516478|NCT02544451|564983193|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
156516479|NCT02544451|564983190|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
156516480|NCT02544451|564983191|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
156516481|NCT02544451|564983192|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
156516482|NCT02544451|564983193|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
156516483|NCT02544451|564983190|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
156516484|NCT02544451|564983191|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
156516485|NCT02544451|564983192|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
156516486|NCT02544451|564983193|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
156516487|NCT02544451|564983190|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
156516488|NCT02544451|564983191|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
156516489|NCT02544451|564983192|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
156516490|NCT02544451|564983193|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
156516491|NCT00844532|564983194|FG000|Overall Study|Death|16|||
156516492|NCT00844532|564983194|FG000|Overall Study|Withdrawal by Subject|16|||
156516493|NCT00844532|564983194|FG000|Overall Study|Lost to Follow-up|7|||
156516494|NCT05086276|564983195|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
156516495|NCT05086276|564983196|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
156516496|NCT00738894|564983197|FG000|Overall Study|Lost to Follow-up|23|||
156516497|NCT00738894|564983198|FG001|Overall Study|Lost to Follow-up|13|||
156516498|NCT00738894|564983197|FG000|Overall Study|Withdrawal by Subject|10|||
156516499|NCT00738894|564983198|FG001|Overall Study|Withdrawal by Subject|15|||
156516500|NCT00738894|564983197|FG000|Overall Study|Physician Decision|4|||
156516501|NCT00738894|564983198|FG001|Overall Study|Physician Decision|5|||
156516502|NCT00738894|564983197|FG000|Overall Study|Death|2|||
156516503|NCT00738894|564983198|FG001|Overall Study|Death|0|||
156516504|NCT05017103|564983199|FG000|Overall Study|Death|2|||
156516505|NCT02656329|564983200|FG000|Overall Study|Lost to Follow-up|2|||
156560440|NCT04426695|565141996|FG010|Overall Study|Randomized but Never Treated|3|||
156560441|NCT04426695|565141997|FG011|Overall Study|Randomized but Never Treated|6|||
156560442|NCT04426695|565141998|FG012|Overall Study|Randomized but Never Treated|1|||
156560443|NCT04426695|565141999|FG013|Overall Study|Randomized but Never Treated|2|||
156560444|NCT04426695|565142000|FG014|Overall Study|Randomized but Never Treated|0|||
156560445|NCT04426695|565142001|FG015|Overall Study|Randomized but Never Treated|0|||
156560446|NCT04426695|565142002|FG016|Overall Study|Randomized but Never Treated|0|||
156560447|NCT04426695|565142003|FG017|Overall Study|Randomized but Never Treated|0|||
156560448|NCT02772757|565142011|FG000|Overall Study|Withdrawal by Subject|1|||
156560449|NCT02772757|565142012|FG001|Overall Study|Withdrawal by Subject|0|||
156516506|NCT02656329|564983201|FG001|Overall Study|Lost to Follow-up|3|||
156560450|NCT02772757|565142013|FG002|Overall Study|Withdrawal by Subject|1|||
156560451|NCT02772757|565142011|FG000|Overall Study|Protocol Violation|0|||
156560452|NCT02772757|565142012|FG001|Overall Study|Protocol Violation|0|||
156560453|NCT02772757|565142013|FG002|Overall Study|Protocol Violation|1|||
156560454|NCT02772757|565142011|FG000|Overall Study|Physician Decision|0|||
156516507|NCT02656329|564983200|FG000|Overall Study|Withdrawal by Subject|7|||
156516508|NCT02656329|564983201|FG001|Overall Study|Withdrawal by Subject|6|||
156560455|NCT02772757|565142012|FG001|Overall Study|Physician Decision|3|||
156560456|NCT02772757|565142013|FG002|Overall Study|Physician Decision|3|||
156560457|NCT01500057|565142016|FG000|Overall Study|Lost to Follow-up|6|||
156516509|NCT02656329|564983200|FG000|Overall Study|Study termination by Sponsor|150|||
156516510|NCT02656329|564983201|FG001|Overall Study|Study termination by Sponsor|142|||
156516511|NCT02656329|564983200|FG000|Overall Study|Other than specified above|5|||
156516512|NCT02656329|564983201|FG001|Overall Study|Other than specified above|6|||
156516513|NCT01081665|564983203|FG000|Overall Study|Death|41|||
156516514|NCT01081665|564983203|FG000|Overall Study|Lost to Follow-up|18|||
156516515|NCT01081665|564983203|FG000|Overall Study|Withdrawal by Subject|17|||
156516516|NCT01081665|564983203|FG000|Overall Study|Change of dialysis unit|10|||
156516517|NCT01081665|564983203|FG000|Overall Study|Regulation of iPTH|5|||
156516518|NCT01081665|564983203|FG000|Overall Study|Change in renal replacement therapy|2|||
156516519|NCT01081665|564983203|FG000|Overall Study|Adverse Event|1|||
156516520|NCT01081665|564983203|FG000|Overall Study|Lack of Efficacy|1|||
156516521|NCT00513305|564983204|FG000|Overall Study|Adverse Event|6|||
156516522|NCT00513305|564983205|FG001|Overall Study|Adverse Event|2|||
156516523|NCT00513305|564983204|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
156516524|NCT00513305|564983205|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
156516525|NCT00513305|564983204|FG000|Overall Study|Lack of Efficacy|8|||
156516526|NCT00513305|564983205|FG001|Overall Study|Lack of Efficacy|13|||
156516527|NCT00513305|564983204|FG000|Overall Study|Withdrawal by Subject|1|||
156516528|NCT00513305|564983205|FG001|Overall Study|Withdrawal by Subject|2|||
156516529|NCT00513305|564983204|FG000|Overall Study|Disease progression|8|||
156516530|NCT00513305|564983205|FG001|Overall Study|Disease progression|5|||
156516531|NCT00513305|564983204|FG000|Overall Study|Eligible for stem cell transplant|1|||
156516532|NCT00513305|564983205|FG001|Overall Study|Eligible for stem cell transplant|0|||
156516533|NCT00513305|564983204|FG000|Overall Study|Hematologic counts did not recover|1|||
156516534|NCT00513305|564983205|FG001|Overall Study|Hematologic counts did not recover|0|||
156516535|NCT00513305|564983204|FG000|Overall Study|Physician Decision|1|||
156516536|NCT00513305|564983205|FG001|Overall Study|Physician Decision|0|||
156516537|NCT00513305|564983204|FG000|Overall Study|Persistent hypocellularity|0|||
156516538|NCT00513305|564983205|FG001|Overall Study|Persistent hypocellularity|1|||
156516539|NCT00513305|564983204|FG000|Overall Study|Sponsor Decision|0|||
156516540|NCT00513305|564983205|FG001|Overall Study|Sponsor Decision|2|||
156516541|NCT02101385|564983213|FG000|Study Treatment|Disease Progression|9|||
156516542|NCT02101385|564983214|FG001|Study Treatment|Disease Progression|3|||
156516543|NCT02101385|564983213|FG000|Study Treatment|Alternative therapy|0|||
156516544|NCT02101385|564983214|FG001|Study Treatment|Alternative therapy|1|||
156516545|NCT02101385|564983213|FG000|Study Treatment|No treatment, per protocol criteria|0|||
156516546|NCT02101385|564983214|FG001|Study Treatment|No treatment, per protocol criteria|4|||
156516547|NCT02101385|564983213|FG000|Study Treatment|Patient Non compliance|0|||
156516548|NCT02101385|564983214|FG001|Study Treatment|Patient Non compliance|2|||
156516549|NCT02101385|564983213|FG000|Study Treatment|Withdrawal by Subject|5|||
156516550|NCT02101385|564983214|FG001|Study Treatment|Withdrawal by Subject|2|||
156516551|NCT02101385|564983213|FG000|Study Treatment|screen failure|1|||
156516552|NCT02101385|564983214|FG001|Study Treatment|screen failure|0|||
156516553|NCT02101385|564983213|FG000|Study Treatment|AE/Side Effects/Complications|8|||
156516554|NCT02101385|564983214|FG001|Study Treatment|AE/Side Effects/Complications|0|||
156516555|NCT02101385|564983213|FG000|Study Treatment|Lost to Follow-up|1|||
156516556|NCT02101385|564983214|FG001|Study Treatment|Lost to Follow-up|0|||
156516557|NCT02101385|564983213|FG000|Study Treatment|Disease Progression before treatment|1|||
156516558|NCT02101385|564983214|FG001|Study Treatment|Disease Progression before treatment|0|||
156516559|NCT02101385|564983213|FG000|Study Treatment|Death|1|||
156516560|NCT02101385|564983214|FG001|Study Treatment|Death|0|||
156516561|NCT02101385|564983213|FG000|Follow up|Lost to Follow-up|4|||
156516562|NCT02101385|564983214|FG001|Follow up|Lost to Follow-up|9|||
156516563|NCT02101385|564983213|FG000|Follow up|Refused to follow up|5|||
156516564|NCT02101385|564983214|FG001|Follow up|Refused to follow up|4|||
156516565|NCT02101385|564983213|FG000|Follow up|Death|21|||
156516566|NCT02101385|564983214|FG001|Follow up|Death|39|||
156516567|NCT02101385|564983213|FG000|Follow up|study completed|33|||
156516568|NCT02101385|564983214|FG001|Follow up|study completed|52|||
156516569|NCT02101385|564983213|FG000|Follow up|screen failure|2|||
156516570|NCT02101385|564983214|FG001|Follow up|screen failure|0|||
156516571|NCT02101385|564983213|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
156516572|NCT02101385|564983214|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
156516573|NCT02101385|564983213|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
156516574|NCT02101385|564983214|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
156516575|NCT02101385|564983213|FG000|Follow up|Withdrawal by Subject|2|||
156516576|NCT02101385|564983214|FG001|Follow up|Withdrawal by Subject|2|||
156516577|NCT02101385|564983213|FG000|Follow up|PI requested closure of site|0|||
156516578|NCT02101385|564983214|FG001|Follow up|PI requested closure of site|5|||
156516579|NCT03738423|564983217|FG000|Overall Study|Withdrawal by Subject|9|||
156516580|NCT03738423|564983218|FG001|Overall Study|Withdrawal by Subject|12|||
156516581|NCT03738423|564983219|FG002|Overall Study|Withdrawal by Subject|9|||
156516582|NCT03738423|564983220|FG003|Overall Study|Withdrawal by Subject|12|||
156516583|NCT03738423|564983221|FG004|Overall Study|Withdrawal by Subject|10|||
156516584|NCT03738423|564983217|FG000|Overall Study|Lack of Efficacy|3|||
156516585|NCT03738423|564983218|FG001|Overall Study|Lack of Efficacy|1|||
156516586|NCT03738423|564983219|FG002|Overall Study|Lack of Efficacy|1|||
156516587|NCT03738423|564983220|FG003|Overall Study|Lack of Efficacy|1|||
156516588|NCT03738423|564983221|FG004|Overall Study|Lack of Efficacy|2|||
156516589|NCT03738423|564983217|FG000|Overall Study|Lost to Follow-up|1|||
156516590|NCT03738423|564983218|FG001|Overall Study|Lost to Follow-up|0|||
156516591|NCT03738423|564983219|FG002|Overall Study|Lost to Follow-up|1|||
156516592|NCT03738423|564983220|FG003|Overall Study|Lost to Follow-up|1|||
156516593|NCT03738423|564983221|FG004|Overall Study|Lost to Follow-up|0|||
156516594|NCT03738423|564983217|FG000|Overall Study|Protocol Violation|1|||
156516595|NCT03738423|564983218|FG001|Overall Study|Protocol Violation|0|||
156516596|NCT03738423|564983219|FG002|Overall Study|Protocol Violation|0|||
156516597|NCT03738423|564983220|FG003|Overall Study|Protocol Violation|0|||
156516598|NCT03738423|564983221|FG004|Overall Study|Protocol Violation|1|||
156516599|NCT03738423|564983217|FG000|Overall Study|Physician Decision|0|||
156516600|NCT03738423|564983218|FG001|Overall Study|Physician Decision|0|||
156516601|NCT03738423|564983219|FG002|Overall Study|Physician Decision|1|||
156516602|NCT03738423|564983220|FG003|Overall Study|Physician Decision|0|||
156516603|NCT03738423|564983221|FG004|Overall Study|Physician Decision|1|||
156516604|NCT03738423|564983217|FG000|Overall Study|Death|0|||
156516605|NCT03738423|564983218|FG001|Overall Study|Death|0|||
156516606|NCT03738423|564983219|FG002|Overall Study|Death|0|||
156516607|NCT03738423|564983220|FG003|Overall Study|Death|0|||
156516608|NCT03738423|564983221|FG004|Overall Study|Death|1|||
156516609|NCT03738423|564983217|FG000|Overall Study|Randomized but never treated|0|||
156516610|NCT03738423|564983218|FG001|Overall Study|Randomized but never treated|0|||
156516611|NCT03738423|564983219|FG002|Overall Study|Randomized but never treated|1|||
156516612|NCT03738423|564983220|FG003|Overall Study|Randomized but never treated|1|||
156516613|NCT03738423|564983221|FG004|Overall Study|Randomized but never treated|0|||
156516614|NCT03981861|564983228|FG000|Overall Study|Withdrawal by Subject|3|||
156516615|NCT03973931|564983229|FG000|Overall Study|Lost to Follow-up|47|||
156516616|NCT03973931|564983230|FG001|Overall Study|Lost to Follow-up|63|||
156516617|NCT03973931|564983231|FG002|Overall Study|Lost to Follow-up|51|||
156516618|NCT03973931|564983232|FG003|Overall Study|Lost to Follow-up|54|||
156516619|NCT03973931|564983229|FG000|Overall Study|opted out|6|||
156516620|NCT03973931|564983230|FG001|Overall Study|opted out|5|||
156516621|NCT03973931|564983231|FG002|Overall Study|opted out|5|||
156516622|NCT03973931|564983232|FG003|Overall Study|opted out|1|||
156516623|NCT00978627|564984721|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
156516624|NCT00978627|564984722|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
156516625|NCT00978627|564984721|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
156516626|NCT00978627|564984722|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
156516627|NCT00978627|564984721|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
156516628|NCT00978627|564984722|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
156516629|NCT00978627|564984721|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
156516630|NCT00978627|564984722|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
156516631|NCT00978627|564984721|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
156516632|NCT00978627|564984722|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
156516633|NCT00978627|564984721|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
156516634|NCT00978627|564984722|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
156516635|NCT00978627|564984721|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
156516636|NCT00978627|564984722|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
156516637|NCT00978627|564984721|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
156516638|NCT00978627|564984722|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
156516639|NCT00978627|564984721|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
156560458|NCT01500057|565142017|FG001|Overall Study|Lost to Follow-up|4|||
156516640|NCT00978627|564984722|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
156516641|NCT02738203|564984723|FG000|Overall Study|Failed IUD Insertion|2|||
156516642|NCT02738203|564984724|FG001|Overall Study|Failed IUD Insertion|2|||
156516643|NCT02738203|564984723|FG000|Overall Study|Protocol Violation|0|||
156516644|NCT02738203|564984724|FG001|Overall Study|Protocol Violation|1|||
156516645|NCT05087979|564984725|FG000|Overall Study|Converted to general anesthesia|1|||
156516646|NCT05087979|564984726|FG001|Overall Study|Converted to general anesthesia|0|||
156516647|NCT01290315|564984727|FG000|Overall Study|Adverse Event|0|||
156516648|NCT01290315|564984728|FG001|Overall Study|Adverse Event|0|||
156516649|NCT01290315|564984729|FG002|Overall Study|Adverse Event|0|||
156516650|NCT01290315|564984730|FG003|Overall Study|Adverse Event|3|||
156516651|NCT01290315|564984727|FG000|Overall Study|Selection criteria/compliance|2|||
156516652|NCT01290315|564984728|FG001|Overall Study|Selection criteria/compliance|1|||
156516653|NCT01290315|564984729|FG002|Overall Study|Selection criteria/compliance|0|||
156516654|NCT01290315|564984730|FG003|Overall Study|Selection criteria/compliance|2|||
156516655|NCT01290315|564984727|FG000|Overall Study|Lost to Follow-up|0|||
156516656|NCT01290315|564984728|FG001|Overall Study|Lost to Follow-up|1|||
156516657|NCT01290315|564984729|FG002|Overall Study|Lost to Follow-up|0|||
156516658|NCT01290315|564984730|FG003|Overall Study|Lost to Follow-up|0|||
156516659|NCT01290315|564984727|FG000|Overall Study|Withdrawal by Subject|1|||
156516660|NCT01290315|564984728|FG001|Overall Study|Withdrawal by Subject|1|||
156516661|NCT01290315|564984729|FG002|Overall Study|Withdrawal by Subject|0|||
156516662|NCT01290315|564984730|FG003|Overall Study|Withdrawal by Subject|0|||
156516663|NCT00423943|564984733|FG000|Overall Study|Withdrawal by Subject|3|||
156516664|NCT00423943|564984734|FG001|Overall Study|Withdrawal by Subject|1|||
156516665|NCT03730480|564984735|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
156516666|NCT01248780|564984736|FG000|Overall Study|Lack of Efficacy|2|||
156516667|NCT01248780|564984737|FG001|Overall Study|Lack of Efficacy|0|||
156516668|NCT01248780|564984736|FG000|Overall Study|Lost to Follow-up|0|||
156516669|NCT01248780|564984737|FG001|Overall Study|Lost to Follow-up|1|||
156516670|NCT01248780|564984736|FG000|Overall Study|Death|0|||
156516671|NCT01248780|564984737|FG001|Overall Study|Death|1|||
156516672|NCT01248780|564984736|FG000|Overall Study|Adverse Event|2|||
156516673|NCT01248780|564984737|FG001|Overall Study|Adverse Event|7|||
156516674|NCT01248780|564984736|FG000|Overall Study|Protocol Violation|1|||
156516675|NCT01248780|564984737|FG001|Overall Study|Protocol Violation|1|||
156516676|NCT01248780|564984736|FG000|Overall Study|Withdrawal by Subject|4|||
156516677|NCT01248780|564984737|FG001|Overall Study|Withdrawal by Subject|4|||
156516678|NCT01248780|564984736|FG000|Overall Study|Not treated|0|||
156516679|NCT01248780|564984737|FG001|Overall Study|Not treated|1|||
156516680|NCT01144052|564984738|FG000|Overall Study|Withdrawal by Subject|1|||
156516681|NCT01144052|564984739|FG001|Overall Study|Withdrawal by Subject|1|||
156516682|NCT03836716|564984743|FG000|Overall Study|Adverse Event|3|||
156516683|NCT03836716|564984743|FG000|Overall Study|Death|22|||
156516684|NCT03836716|564984743|FG000|Overall Study|Withdrawal by Subject|8|||
156516685|NCT03836716|564984743|FG000|Overall Study|Study terminated by sponsor|87|||
156516686|NCT01983254|564984744|FG000|Overall Study|Death|6|||
156516687|NCT01983254|564984745|FG001|Overall Study|Death|6|||
156516688|NCT01983254|564984744|FG000|Overall Study|Lost to Follow-up|17|||
156516689|NCT01983254|564984745|FG001|Overall Study|Lost to Follow-up|16|||
156516690|NCT01983254|564984744|FG000|Overall Study|too ill|11|||
156516691|NCT01983254|564984745|FG001|Overall Study|too ill|8|||
156516692|NCT01699503|564984748|FG000|Overall Study|Death|31|||
156516693|NCT01699503|564984749|FG001|Overall Study|Death|40|||
156516694|NCT01699503|564984748|FG000|Overall Study|Withdrawal by Subject|65|||
156516695|NCT01699503|564984749|FG001|Overall Study|Withdrawal by Subject|57|||
156516696|NCT01699503|564984748|FG000|Overall Study|Lost to Follow-up|121|||
156516697|NCT01699503|564984749|FG001|Overall Study|Lost to Follow-up|117|||
156516698|NCT01699503|564984748|FG000|Overall Study|Excluded due to quality|783|||
156516699|NCT01699503|564984749|FG001|Overall Study|Excluded due to quality|791|||
156516700|NCT01639560|564984752|FG000|Overall Study|Withdrawal by Subject|9|||
156516701|NCT01639560|564984753|FG001|Overall Study|Withdrawal by Subject|14|||
156516702|NCT01639560|564984752|FG000|Overall Study|Lack of Efficacy|1|||
156516703|NCT01639560|564984753|FG001|Overall Study|Lack of Efficacy|2|||
156516704|NCT01639560|564984752|FG000|Overall Study|Lost to Follow-up|9|||
156516705|NCT01639560|564984753|FG001|Overall Study|Lost to Follow-up|11|||
156516706|NCT01639560|564984752|FG000|Overall Study|Adverse Event|0|||
156516707|NCT01639560|564984753|FG001|Overall Study|Adverse Event|2|||
156516708|NCT00766363|564984755|FG000|Overall Study|Withdrawal by Subject|1|||
156516709|NCT00766363|564984756|FG001|Overall Study|Withdrawal by Subject|0|||
156516710|NCT00766363|564984757|FG002|Overall Study|Withdrawal by Subject|0|||
156516711|NCT00766363|564984758|FG003|Overall Study|Withdrawal by Subject|0|||
156516712|NCT00766363|564984755|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
156516713|NCT00766363|564984756|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
156516714|NCT00766363|564984757|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
156516715|NCT00766363|564984758|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
156516716|NCT00911937|564984759|FG000|Overall Study|Death|1|||
156516717|NCT00911937|564984760|FG001|Overall Study|Death|0|||
156516718|NCT00911937|564984759|FG000|Overall Study|Lost to Follow-up|8|||
156516719|NCT00911937|564984760|FG001|Overall Study|Lost to Follow-up|5|||
156516720|NCT00911937|564984759|FG000|Overall Study|Withdrawal by Subject|10|||
156516721|NCT00911937|564984760|FG001|Overall Study|Withdrawal by Subject|7|||
156516722|NCT00911937|564984759|FG000|Overall Study|Withdrawn due to pregnancy|1|||
156516723|NCT00911937|564984760|FG001|Overall Study|Withdrawn due to pregnancy|0|||
156516724|NCT00911937|564984759|FG000|Overall Study|Adverse Event|11|||
156516725|NCT00911937|564984760|FG001|Overall Study|Adverse Event|25|||
156516726|NCT00911937|564984759|FG000|Overall Study|Lack of Efficacy|11|||
156516727|NCT00911937|564984760|FG001|Overall Study|Lack of Efficacy|6|||
156516728|NCT00911937|564984759|FG000|Overall Study|Did not meet inclusion criteria|9|||
156516729|NCT00911937|564984760|FG001|Overall Study|Did not meet inclusion criteria|11|||
156516730|NCT00911937|564984759|FG000|Overall Study|Protocol Violation|14|||
156516731|NCT00911937|564984760|FG001|Overall Study|Protocol Violation|23|||
156516732|NCT00911937|564984759|FG000|Overall Study|Randomized but not treated|13|||
156516733|NCT00911937|564984760|FG001|Overall Study|Randomized but not treated|13|||
156516734|NCT00911937|564984759|FG000|Overall Study|Other|9|||
156516735|NCT00911937|564984760|FG001|Overall Study|Other|5|||
156516736|NCT01498679|564984761|FG000|Overall Study|Adverse Event|1|||
156516737|NCT01498679|564984762|FG001|Overall Study|Adverse Event|4|||
156516738|NCT01498679|564984761|FG000|Overall Study|Lack of Efficacy|72|||
156516739|NCT01498679|564984762|FG001|Overall Study|Lack of Efficacy|12|||
156516740|NCT01498679|564984761|FG000|Overall Study|Protocol Violation|4|||
156516741|NCT01498679|564984762|FG001|Overall Study|Protocol Violation|0|||
156516742|NCT01498679|564984761|FG000|Overall Study|Physician Decision|0|||
156516743|NCT01498679|564984762|FG001|Overall Study|Physician Decision|2|||
156516744|NCT01498679|564984761|FG000|Overall Study|Withdrawal by Subject|12|||
156516745|NCT01498679|564984762|FG001|Overall Study|Withdrawal by Subject|4|||
156516746|NCT01871805|564984766|FG000|Phase I|Death|7|||
156516747|NCT01871805|564984767|FG001|Phase I|Death|4|||
156516748|NCT01871805|564984768|FG002|Phase I|Death|6|||
156516749|NCT01871805|564984769|FG003|Phase I|Death|2|||
156516750|NCT01871805|564984770|FG004|Phase I|Death|9|||
156516751|NCT01871805|564984771|FG005|Phase I|Death|0|||
156516752|NCT01871805|564984766|FG000|Phase I|Alive in Survival Follow-up|0|||
156516753|NCT01871805|564984767|FG001|Phase I|Alive in Survival Follow-up|2|||
156516754|NCT01871805|564984768|FG002|Phase I|Alive in Survival Follow-up|4|||
156516755|NCT01871805|564984769|FG003|Phase I|Alive in Survival Follow-up|5|||
156516756|NCT01871805|564984770|FG004|Phase I|Alive in Survival Follow-up|4|||
156516757|NCT01871805|564984771|FG005|Phase I|Alive in Survival Follow-up|0|||
156516758|NCT01871805|564984766|FG000|Phase I|Lost to Follow-up|0|||
156516759|NCT01871805|564984767|FG001|Phase I|Lost to Follow-up|1|||
156516760|NCT01871805|564984768|FG002|Phase I|Lost to Follow-up|3|||
156516761|NCT01871805|564984769|FG003|Phase I|Lost to Follow-up|0|||
156516762|NCT01871805|564984770|FG004|Phase I|Lost to Follow-up|0|||
156516763|NCT01871805|564984771|FG005|Phase I|Lost to Follow-up|0|||
156516764|NCT01871805|564984766|FG000|Phase II|Death|0|||
156516765|NCT01871805|564984767|FG001|Phase II|Death|0|||
156516766|NCT01871805|564984768|FG002|Phase II|Death|0|||
156516767|NCT01871805|564984769|FG003|Phase II|Death|0|||
156516768|NCT01871805|564984770|FG004|Phase II|Death|0|||
156516769|NCT01871805|564984771|FG005|Phase II|Death|45|||
156516770|NCT01871805|564984766|FG000|Phase II|Alive in Survival Follow-up|0|||
156516771|NCT01871805|564984767|FG001|Phase II|Alive in Survival Follow-up|0|||
156516772|NCT01871805|564984768|FG002|Phase II|Alive in Survival Follow-up|0|||
156516773|NCT01871805|564984769|FG003|Phase II|Alive in Survival Follow-up|0|||
156516774|NCT01871805|564984770|FG004|Phase II|Alive in Survival Follow-up|0|||
156516775|NCT01871805|564984771|FG005|Phase II|Alive in Survival Follow-up|29|||
156516776|NCT01871805|564984766|FG000|Phase II|Lost to Follow-up|0|||
156516777|NCT01871805|564984767|FG001|Phase II|Lost to Follow-up|0|||
156516778|NCT01871805|564984768|FG002|Phase II|Lost to Follow-up|0|||
156516779|NCT01871805|564984769|FG003|Phase II|Lost to Follow-up|0|||
156516780|NCT01871805|564984770|FG004|Phase II|Lost to Follow-up|0|||
156516781|NCT01871805|564984771|FG005|Phase II|Lost to Follow-up|13|||
156516782|NCT03484273|564984780|FG000|Overall Study|Equipment Malfunction|1|||
156516783|NCT03484273|564984780|FG000|Overall Study|Data excluded from analysis|1|||
156516784|NCT00468104|564984786|FG000|First Intervention|Protocol Violation|2|||
156516785|NCT00468104|564984787|FG001|First Intervention|Protocol Violation|1|||
156516786|NCT00468104|564984786|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
156516787|NCT00468104|564984787|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
156516788|NCT00468104|564984786|FG000|First Intervention|died within 3 weeks|1|||
156516789|NCT00468104|564984787|FG001|First Intervention|died within 3 weeks|0|||
156516790|NCT00468104|564984786|FG000|First Intervention|malposition/blocked chest tube tube|2|||
156516791|NCT00468104|564984787|FG001|First Intervention|malposition/blocked chest tube tube|0|||
156516792|NCT00468104|564984786|FG000|First Intervention|large lung mass with minimal effusion|1|||
156516793|NCT00468104|564984787|FG001|First Intervention|large lung mass with minimal effusion|0|||
156516794|NCT00468104|564984786|FG000|First Intervention|associated prolonged pneumothorax|1|||
156516795|NCT00468104|564984787|FG001|First Intervention|associated prolonged pneumothorax|0|||
156516796|NCT00468104|564984786|FG000|First Intervention|trapped lung|1|||
156516797|NCT00468104|564984787|FG001|First Intervention|trapped lung|0|||
156516798|NCT00468104|564984786|FG000|Second Intervention|Withdrawal by Subject|5|||
156516799|NCT00468104|564984787|FG001|Second Intervention|Withdrawal by Subject|2|||
156516800|NCT00468104|564984786|FG000|Second Intervention|discarded for malposition of chest tube|0|||
156516801|NCT00468104|564984787|FG001|Second Intervention|discarded for malposition of chest tube|2|||
156560459|NCT00441792|565142018|FG000|Overall Study|Lost to Follow-up|0|||
156516802|NCT01263665|564984788|FG000|Overall Study|Withdrew Consent|1|||
156516803|NCT01263665|564984788|FG000|Overall Study|Lost to Follow-up|3|||
156516804|NCT01263665|564984788|FG000|Overall Study|Death|2|||
156516805|NCT01263665|564984788|FG000|Overall Study|Amputation above the ankle|1|||
156516806|NCT01263665|564984788|FG000|Overall Study|Surgical Bypass|2|||
156516807|NCT02706899|564984793|FG000|Overall Study|Withdrawal by Subject|1|||
156516808|NCT02706899|564984794|FG001|Overall Study|Withdrawal by Subject|0|||
156516809|NCT02706899|564984793|FG000|Overall Study|Death|8|||
156516810|NCT02706899|564984794|FG001|Overall Study|Death|0|||
156516811|NCT02706899|564984793|FG000|Overall Study|Study Termination by Sponsor|4|||
156516812|NCT02706899|564984794|FG001|Overall Study|Study Termination by Sponsor|6|||
156516813|NCT00324675|564984795|FG000|Overall Study|Adverse Event|1|||
156516814|NCT00324675|564984796|FG001|Overall Study|Adverse Event|0|||
156516815|NCT00381615|564984797|FG000|Overall Study|Withdrawal by Subject|1|||
156516816|NCT00381615|564984798|FG001|Overall Study|Withdrawal by Subject|3|||
156516817|NCT00381615|564984799|FG002|Overall Study|Withdrawal by Subject|0|||
156516818|NCT00381615|564984800|FG003|Overall Study|Withdrawal by Subject|1|||
156516819|NCT00381615|564984797|FG000|Overall Study|Lost to Follow-up|3|||
156516820|NCT00381615|564984798|FG001|Overall Study|Lost to Follow-up|2|||
156516821|NCT00381615|564984799|FG002|Overall Study|Lost to Follow-up|0|||
156516822|NCT00381615|564984800|FG003|Overall Study|Lost to Follow-up|1|||
156516823|NCT00381615|564984797|FG000|Overall Study|Protocol Violation|0|||
156516824|NCT00381615|564984798|FG001|Overall Study|Protocol Violation|0|||
156516825|NCT00381615|564984799|FG002|Overall Study|Protocol Violation|1|||
156516826|NCT00381615|564984800|FG003|Overall Study|Protocol Violation|0|||
156516827|NCT03181789|564984808|FG000|Overall Study|Withdrawal by Subject|0|||
156516828|NCT03181789|564984809|FG001|Overall Study|Withdrawal by Subject|1|||
156516829|NCT03181789|564984810|FG002|Overall Study|Withdrawal by Subject|1|||
156516830|NCT03181789|564984811|FG003|Overall Study|Withdrawal by Subject|0|||
156516831|NCT03181789|564984808|FG000|Overall Study|Lost to Follow-up|7|||
156516832|NCT03181789|564984809|FG001|Overall Study|Lost to Follow-up|1|||
156516833|NCT03181789|564984810|FG002|Overall Study|Lost to Follow-up|0|||
156516834|NCT03181789|564984811|FG003|Overall Study|Lost to Follow-up|0|||
156516835|NCT03181789|564984808|FG000|Overall Study|Participant unable to adhere to visit|0|||
156516836|NCT03181789|564984809|FG001|Overall Study|Participant unable to adhere to visit|1|||
156516837|NCT03181789|564984810|FG002|Overall Study|Participant unable to adhere to visit|0|||
156516838|NCT03181789|564984811|FG003|Overall Study|Participant unable to adhere to visit|0|||
156516839|NCT01131182|564984812|FG000|Overall Study|Withdrawal by Subject|1|||
156516840|NCT01131182|564984813|FG001|Overall Study|Withdrawal by Subject|1|||
156516841|NCT01131182|564984812|FG000|Overall Study|Lost to Follow-up|14|||
156516842|NCT01131182|564984813|FG001|Overall Study|Lost to Follow-up|15|||
156516843|NCT01131182|564984812|FG000|Overall Study|Other Reason|1|||
156516844|NCT01131182|564984813|FG001|Overall Study|Other Reason|0|||
156516845|NCT03001076|564984814|FG000|Overall Study|Withdrawal by patient|2|||
156560460|NCT00441792|565142019|FG001|Overall Study|Lost to Follow-up|2|||
156560461|NCT00888355|565142024|FG000|Overall Study|Adverse Event|10|||
156560462|NCT00888355|565142025|FG001|Overall Study|Adverse Event|0|||
156560463|NCT00888355|565142026|FG002|Overall Study|Adverse Event|3|||
156560464|NCT00888355|565142027|FG003|Overall Study|Adverse Event|3|||
156560465|NCT00888355|565142024|FG000|Overall Study|Lack of Efficacy|9|||
156560466|NCT00888355|565142025|FG001|Overall Study|Lack of Efficacy|2|||
156560467|NCT00888355|565142026|FG002|Overall Study|Lack of Efficacy|5|||
156560468|NCT00888355|565142027|FG003|Overall Study|Lack of Efficacy|2|||
156560469|NCT00888355|565142024|FG000|Overall Study|Lost to Follow-up|0|||
156516846|NCT03001076|564984815|FG001|Overall Study|Withdrawal by patient|0|||
156516847|NCT03001076|564984814|FG000|Overall Study|Other|1|||
156516848|NCT03001076|564984815|FG001|Overall Study|Other|0|||
156516849|NCT03001076|564984814|FG000|Overall Study|Adverse Event|3|||
156516850|NCT03001076|564984815|FG001|Overall Study|Adverse Event|3|||
156516851|NCT03001076|564984814|FG000|Overall Study|Sponsor decision|1|||
156516852|NCT03001076|564984815|FG001|Overall Study|Sponsor decision|0|||
156516853|NCT03001076|564984814|FG000|Overall Study|Lost to Follow-up|0|||
156516854|NCT03001076|564984815|FG001|Overall Study|Lost to Follow-up|2|||
156516855|NCT04602221|564984816|FG000|Overall Study|Discontinuation of trial treatment|0|||
156516856|NCT04602221|564984817|FG001|Overall Study|Discontinuation of trial treatment|0|||
156516857|NCT04602221|564984818|FG002|Overall Study|Discontinuation of trial treatment|1|||
156516858|NCT04602221|564984819|FG003|Overall Study|Discontinuation of trial treatment|0|||
156516859|NCT04602221|564984820|FG004|Overall Study|Discontinuation of trial treatment|0|||
156516860|NCT04602221|564984821|FG005|Overall Study|Discontinuation of trial treatment|0|||
156516861|NCT04602221|564984822|FG006|Overall Study|Discontinuation of trial treatment|0|||
156516862|NCT04602221|564984823|FG007|Overall Study|Discontinuation of trial treatment|0|||
156560470|NCT00888355|565142025|FG001|Overall Study|Lost to Follow-up|2|||
156560471|NCT00888355|565142026|FG002|Overall Study|Lost to Follow-up|2|||
156560472|NCT00888355|565142027|FG003|Overall Study|Lost to Follow-up|0|||
156560473|NCT00888355|565142024|FG000|Overall Study|Protocol Violation|3|||
156560474|NCT00888355|565142025|FG001|Overall Study|Protocol Violation|2|||
156560475|NCT00888355|565142026|FG002|Overall Study|Protocol Violation|1|||
156560476|NCT00888355|565142027|FG003|Overall Study|Protocol Violation|2|||
156560477|NCT00888355|565142024|FG000|Overall Study|Withdrawal by Subject|0|||
156516863|NCT04602221|564984824|FG008|Overall Study|Discontinuation of trial treatment|0|||
156516864|NCT04602221|564984825|FG009|Overall Study|Discontinuation of trial treatment|0|||
156516865|NCT04602221|564984826|FG010|Overall Study|Discontinuation of trial treatment|0|||
156516866|NCT04602221|564984827|FG011|Overall Study|Discontinuation of trial treatment|0|||
156516867|NCT04602221|564984828|FG012|Overall Study|Discontinuation of trial treatment|0|||
156516868|NCT04602221|564984829|FG013|Overall Study|Discontinuation of trial treatment|0|||
156516869|NCT04602221|564984830|FG014|Overall Study|Discontinuation of trial treatment|0|||
156516870|NCT04602221|564984831|FG015|Overall Study|Discontinuation of trial treatment|0|||
156560478|NCT00888355|565142025|FG001|Overall Study|Withdrawal by Subject|3|||
156560479|NCT00888355|565142026|FG002|Overall Study|Withdrawal by Subject|1|||
156560480|NCT00888355|565142027|FG003|Overall Study|Withdrawal by Subject|3|||
156516871|NCT04602221|564984832|FG016|Overall Study|Discontinuation of trial treatment|0|||
156516872|NCT04602221|564984833|FG017|Overall Study|Discontinuation of trial treatment|0|||
156516873|NCT04602221|564984816|FG000|Overall Study|Other than listed|0|||
156516874|NCT04602221|564984817|FG001|Overall Study|Other than listed|0|||
156516875|NCT04602221|564984818|FG002|Overall Study|Other than listed|0|||
156516876|NCT04602221|564984819|FG003|Overall Study|Other than listed|0|||
156516877|NCT04602221|564984820|FG004|Overall Study|Other than listed|0|||
156516878|NCT04602221|564984821|FG005|Overall Study|Other than listed|0|||
156516879|NCT04602221|564984822|FG006|Overall Study|Other than listed|0|||
156516880|NCT04602221|564984823|FG007|Overall Study|Other than listed|0|||
156516881|NCT04602221|564984824|FG008|Overall Study|Other than listed|0|||
156516882|NCT04602221|564984825|FG009|Overall Study|Other than listed|0|||
156516883|NCT04602221|564984826|FG010|Overall Study|Other than listed|0|||
156516884|NCT04602221|564984827|FG011|Overall Study|Other than listed|0|||
156516885|NCT04602221|564984828|FG012|Overall Study|Other than listed|0|||
156516886|NCT04602221|564984829|FG013|Overall Study|Other than listed|0|||
156516887|NCT04602221|564984830|FG014|Overall Study|Other than listed|0|||
156516888|NCT04602221|564984831|FG015|Overall Study|Other than listed|1|||
156516889|NCT04602221|564984832|FG016|Overall Study|Other than listed|0|||
156516890|NCT04602221|564984833|FG017|Overall Study|Other than listed|1|||
156516891|NCT04602221|564984816|FG000|Overall Study|Withdrawal by Subject|0|||
156516892|NCT04602221|564984817|FG001|Overall Study|Withdrawal by Subject|0|||
156516893|NCT04602221|564984818|FG002|Overall Study|Withdrawal by Subject|0|||
156516894|NCT04602221|564984819|FG003|Overall Study|Withdrawal by Subject|0|||
156516895|NCT04602221|564984820|FG004|Overall Study|Withdrawal by Subject|0|||
156516896|NCT04602221|564984821|FG005|Overall Study|Withdrawal by Subject|0|||
156516897|NCT04602221|564984822|FG006|Overall Study|Withdrawal by Subject|0|||
156516898|NCT04602221|564984823|FG007|Overall Study|Withdrawal by Subject|0|||
156516899|NCT04602221|564984824|FG008|Overall Study|Withdrawal by Subject|0|||
156516900|NCT04602221|564984825|FG009|Overall Study|Withdrawal by Subject|0|||
156516901|NCT04602221|564984826|FG010|Overall Study|Withdrawal by Subject|0|||
156516902|NCT04602221|564984827|FG011|Overall Study|Withdrawal by Subject|0|||
156516903|NCT04602221|564984828|FG012|Overall Study|Withdrawal by Subject|1|||
156516904|NCT04602221|564984829|FG013|Overall Study|Withdrawal by Subject|0|||
156516905|NCT04602221|564984830|FG014|Overall Study|Withdrawal by Subject|0|||
156516906|NCT04602221|564984831|FG015|Overall Study|Withdrawal by Subject|0|||
156516907|NCT04602221|564984832|FG016|Overall Study|Withdrawal by Subject|0|||
156516908|NCT04602221|564984833|FG017|Overall Study|Withdrawal by Subject|0|||
156516909|NCT04602221|564984816|FG000|Overall Study|Lost to Follow-up|0|||
156516910|NCT04602221|564984817|FG001|Overall Study|Lost to Follow-up|0|||
156516911|NCT04602221|564984818|FG002|Overall Study|Lost to Follow-up|0|||
156516912|NCT04602221|564984819|FG003|Overall Study|Lost to Follow-up|0|||
156516913|NCT04602221|564984820|FG004|Overall Study|Lost to Follow-up|0|||
156516914|NCT04602221|564984821|FG005|Overall Study|Lost to Follow-up|1|||
156516915|NCT04602221|564984822|FG006|Overall Study|Lost to Follow-up|0|||
156516916|NCT04602221|564984823|FG007|Overall Study|Lost to Follow-up|0|||
156516917|NCT04602221|564984824|FG008|Overall Study|Lost to Follow-up|0|||
156516918|NCT04602221|564984825|FG009|Overall Study|Lost to Follow-up|0|||
156516919|NCT04602221|564984826|FG010|Overall Study|Lost to Follow-up|0|||
156516920|NCT04602221|564984827|FG011|Overall Study|Lost to Follow-up|0|||
156516921|NCT04602221|564984828|FG012|Overall Study|Lost to Follow-up|0|||
156516922|NCT04602221|564984829|FG013|Overall Study|Lost to Follow-up|0|||
156516923|NCT04602221|564984830|FG014|Overall Study|Lost to Follow-up|0|||
156516924|NCT04602221|564984831|FG015|Overall Study|Lost to Follow-up|0|||
156516925|NCT04602221|564984832|FG016|Overall Study|Lost to Follow-up|0|||
156516926|NCT04602221|564984833|FG017|Overall Study|Lost to Follow-up|0|||
156516927|NCT02576587|564984834|FG000|Baseline|Equipment failure|0|||
156516928|NCT02576587|564984835|FG001|Baseline|Equipment failure|1|||
156516929|NCT02576587|564984834|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
156560481|NCT03157531|565142034|FG000|Overall Study|Death|2|||
156560482|NCT03157531|565142034|FG000|Overall Study|Lost to Follow-up|4|||
156560483|NCT03603652|565142035|FG000|Overall Study|Death|2|||
156560484|NCT03213366|565142040|FG000|Overall Study|Lost to Follow-up|9|||
156560485|NCT03213366|565142041|FG001|Overall Study|Lost to Follow-up|4|||
156560486|NCT02532855|565142042|FG000|Overall Study|Lost to Follow-up|4|||
156560487|NCT02532855|565142043|FG001|Overall Study|Lost to Follow-up|3|||
156516930|NCT02576587|564984835|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
156516931|NCT02576587|564984834|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
156516932|NCT02576587|564984835|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
156516933|NCT02576587|564984834|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
156516934|NCT02576587|564984835|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
156516935|NCT01080716|564984836|FG000|Part 1|Physician Decision|1|||
156516936|NCT01080716|564984837|FG001|Part 1|Physician Decision|0|||
156516937|NCT01080716|564984838|FG002|Part 1|Physician Decision|0|||
156516938|NCT01080716|564984839|FG003|Part 1|Physician Decision|0|||
156516939|NCT01056718|564984840|FG000|Overall Study|Withdrawal by Subject|2|||
156560488|NCT02532855|565142042|FG000|Overall Study|Withdrawal by Subject|4|||
156560489|NCT02532855|565142043|FG001|Overall Study|Withdrawal by Subject|8|||
156516940|NCT01056718|564984840|FG000|Overall Study|Ischemia on baseline stress test|1|||
156516941|NCT00777088|564984841|FG000|Overall Study|PED Treatment not attempted|1|||
156516942|NCT01139580|564984842|FG000|Overall Study|Adverse Event|5|||
156516943|NCT01139580|564984843|FG001|Overall Study|Adverse Event|4|||
156516944|NCT01139580|564984842|FG000|Overall Study|Lost to Follow-up|9|||
156516945|NCT01139580|564984843|FG001|Overall Study|Lost to Follow-up|1|||
156516946|NCT01139580|564984842|FG000|Overall Study|Lack of Efficacy|0|||
156516947|NCT01139580|564984843|FG001|Overall Study|Lack of Efficacy|2|||
156516948|NCT01139580|564984842|FG000|Overall Study|Withdrawal by Subject|6|||
156516949|NCT01139580|564984843|FG001|Overall Study|Withdrawal by Subject|9|||
156516950|NCT01139580|564984842|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
156516951|NCT01139580|564984843|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
156516952|NCT01139580|564984842|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
156516953|NCT01139580|564984843|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
156516954|NCT01139580|564984842|FG000|Overall Study|Misrandomized|1|||
156516955|NCT01139580|564984843|FG001|Overall Study|Misrandomized|0|||
156516956|NCT01139580|564984842|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
156516957|NCT01139580|564984843|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
156516958|NCT01139580|564984842|FG000|Overall Study|Participant Randomization in Error|0|||
156516959|NCT01139580|564984843|FG001|Overall Study|Participant Randomization in Error|1|||
156516960|NCT00633880|564984844|FG000|Open Label Titration|Lack of Efficacy|1|||
156516961|NCT00633880|564984845|FG001|Open Label Titration|Lack of Efficacy|0|||
156516962|NCT00633880|564984846|FG002|Open Label Titration|Lack of Efficacy|0|||
156516963|NCT00633880|564984844|FG000|Open Label Titration|Adverse Event|13|||
156516964|NCT00633880|564984845|FG001|Open Label Titration|Adverse Event|0|||
156516965|NCT00633880|564984846|FG002|Open Label Titration|Adverse Event|0|||
156516966|NCT00633880|564984844|FG000|Open Label Titration|Treatment Failure|55|||
156516967|NCT00633880|564984845|FG001|Open Label Titration|Treatment Failure|0|||
156516968|NCT00633880|564984846|FG002|Open Label Titration|Treatment Failure|0|||
156516969|NCT00633880|564984844|FG000|Open Label Titration|Protocol Violation|6|||
156516970|NCT00633880|564984845|FG001|Open Label Titration|Protocol Violation|0|||
156516971|NCT00633880|564984846|FG002|Open Label Titration|Protocol Violation|0|||
156516972|NCT00633880|564984844|FG000|Open Label Titration|Physician Decision|1|||
156516973|NCT00633880|564984845|FG001|Open Label Titration|Physician Decision|0|||
156516974|NCT00633880|564984846|FG002|Open Label Titration|Physician Decision|0|||
156516975|NCT00633880|564984844|FG000|Open Label Titration|Withdrawal by Subject|4|||
156516976|NCT00633880|564984845|FG001|Open Label Titration|Withdrawal by Subject|0|||
156516977|NCT00633880|564984846|FG002|Open Label Titration|Withdrawal by Subject|0|||
156516978|NCT03117998|564984852|FG000|Overall Study|Adverse Event|1|||
156516979|NCT03117998|564984853|FG001|Overall Study|Adverse Event|0|||
156516980|NCT03117998|564984854|FG002|Overall Study|Adverse Event|0|||
156516981|NCT03117998|564984855|FG003|Overall Study|Adverse Event|0|||
156560490|NCT02058147|565142046|FG000|Overall Study|Randomized but not treated|0|||
156560491|NCT02058147|565142047|FG001|Overall Study|Randomized but not treated|0|||
156560492|NCT02058147|565142048|FG002|Overall Study|Randomized but not treated|1|||
156560493|NCT02058147|565142046|FG000|Overall Study|Adverse Event|12|||
156560494|NCT02058147|565142047|FG001|Overall Study|Adverse Event|9|||
156560495|NCT02058147|565142048|FG002|Overall Study|Adverse Event|21|||
156560496|NCT02058147|565142046|FG000|Overall Study|Lack of Efficacy|1|||
156560497|NCT02058147|565142047|FG001|Overall Study|Lack of Efficacy|0|||
156560498|NCT02058147|565142048|FG002|Overall Study|Lack of Efficacy|3|||
156560499|NCT02058147|565142046|FG000|Overall Study|Poor compliance to protocol|8|||
156560500|NCT02058147|565142047|FG001|Overall Study|Poor compliance to protocol|9|||
156560501|NCT02058147|565142048|FG002|Overall Study|Poor compliance to protocol|4|||
156560502|NCT02058147|565142046|FG000|Overall Study|Other than specified|8|||
156560503|NCT02058147|565142047|FG001|Overall Study|Other than specified|9|||
156560504|NCT02058147|565142048|FG002|Overall Study|Other than specified|0|||
156516982|NCT03117998|564984856|FG004|Overall Study|Adverse Event|0|||
156516983|NCT03117998|564984857|FG005|Overall Study|Adverse Event|0|||
156560505|NCT02471716|565142049|FG000|Overall Study|Withdrawal by Subject|0|||
156560506|NCT02471716|565142050|FG001|Overall Study|Withdrawal by Subject|1|||
156516984|NCT03117998|564984852|FG000|Overall Study|Withdrawal by Subject|0|||
156516985|NCT03117998|564984853|FG001|Overall Study|Withdrawal by Subject|0|||
156516986|NCT03117998|564984854|FG002|Overall Study|Withdrawal by Subject|2|||
156516987|NCT03117998|564984855|FG003|Overall Study|Withdrawal by Subject|3|||
156560507|NCT02471716|565142051|FG002|Overall Study|Withdrawal by Subject|0|||
156516988|NCT03117998|564984856|FG004|Overall Study|Withdrawal by Subject|3|||
156516989|NCT03117998|564984857|FG005|Overall Study|Withdrawal by Subject|0|||
156516990|NCT03117998|564984852|FG000|Overall Study|Physician Decision|0|||
156560508|NCT02471716|565142052|FG003|Overall Study|Withdrawal by Subject|2|||
156560509|NCT02471716|565142053|FG004|Overall Study|Withdrawal by Subject|5|||
156516991|NCT03117998|564984853|FG001|Overall Study|Physician Decision|1|||
156516992|NCT03117998|564984854|FG002|Overall Study|Physician Decision|1|||
156516993|NCT03117998|564984855|FG003|Overall Study|Physician Decision|0|||
156560510|NCT02471716|565142049|FG000|Overall Study|Study Terminiated by sponsor|0|||
156560511|NCT02471716|565142050|FG001|Overall Study|Study Terminiated by sponsor|0|||
156560512|NCT02471716|565142051|FG002|Overall Study|Study Terminiated by sponsor|0|||
156560513|NCT02471716|565142052|FG003|Overall Study|Study Terminiated by sponsor|1|||
156560514|NCT02471716|565142053|FG004|Overall Study|Study Terminiated by sponsor|0|||
156560515|NCT02471716|565142049|FG000|Overall Study|Lost to Follow-up|0|||
156560516|NCT02471716|565142050|FG001|Overall Study|Lost to Follow-up|0|||
156560517|NCT02471716|565142051|FG002|Overall Study|Lost to Follow-up|0|||
156560518|NCT02471716|565142052|FG003|Overall Study|Lost to Follow-up|3|||
156560519|NCT02471716|565142053|FG004|Overall Study|Lost to Follow-up|2|||
156560520|NCT02471716|565142049|FG000|Overall Study|Death|0|||
156560521|NCT02471716|565142050|FG001|Overall Study|Death|0|||
156560522|NCT02471716|565142051|FG002|Overall Study|Death|0|||
156560523|NCT02471716|565142052|FG003|Overall Study|Death|1|||
156560524|NCT02471716|565142053|FG004|Overall Study|Death|0|||
156560525|NCT02471716|565142049|FG000|Overall Study|Other|0|||
156560526|NCT02471716|565142050|FG001|Overall Study|Other|0|||
156560527|NCT02471716|565142051|FG002|Overall Study|Other|0|||
156560528|NCT02471716|565142052|FG003|Overall Study|Other|8|||
156560529|NCT02471716|565142053|FG004|Overall Study|Other|9|||
156560530|NCT00773279|565142068|FG000|Period 1|Adverse Event|2|||
156560531|NCT00773279|565142069|FG001|Period 1|Adverse Event|1|||
156560532|NCT00773279|565142068|FG000|Period 1|Lack of Efficacy|0|||
156560533|NCT00773279|565142069|FG001|Period 1|Lack of Efficacy|2|||
156560534|NCT00773279|565142068|FG000|Period 1|Unclassified|5|||
156560535|NCT00773279|565142069|FG001|Period 1|Unclassified|1|||
156560536|NCT00773279|565142068|FG000|Period 2|Adverse Event|0|||
156560537|NCT00773279|565142069|FG001|Period 2|Adverse Event|1|||
156560538|NCT00773279|565142068|FG000|Period 2|Lack of Efficacy|1|||
156560539|NCT00773279|565142069|FG001|Period 2|Lack of Efficacy|0|||
156516994|NCT03117998|564984856|FG004|Overall Study|Physician Decision|0|||
156516995|NCT03117998|564984857|FG005|Overall Study|Physician Decision|0|||
156516996|NCT03117998|564984852|FG000|Overall Study|Lost to Follow-up|0|||
156516997|NCT03117998|564984853|FG001|Overall Study|Lost to Follow-up|0|||
156516998|NCT03117998|564984854|FG002|Overall Study|Lost to Follow-up|0|||
156516999|NCT03117998|564984855|FG003|Overall Study|Lost to Follow-up|1|||
156517000|NCT03117998|564984856|FG004|Overall Study|Lost to Follow-up|4|||
156517001|NCT03117998|564984857|FG005|Overall Study|Lost to Follow-up|0|||
156517002|NCT03117998|564984852|FG000|Overall Study|Subject noncompliance|0|||
156517003|NCT03117998|564984853|FG001|Overall Study|Subject noncompliance|0|||
156517004|NCT03117998|564984854|FG002|Overall Study|Subject noncompliance|1|||
156517005|NCT03117998|564984855|FG003|Overall Study|Subject noncompliance|0|||
156517006|NCT03117998|564984856|FG004|Overall Study|Subject noncompliance|0|||
156517007|NCT03117998|564984857|FG005|Overall Study|Subject noncompliance|2|||
156517008|NCT03117998|564984852|FG000|Overall Study|Protocol Violation|0|||
156517009|NCT03117998|564984853|FG001|Overall Study|Protocol Violation|0|||
156517010|NCT03117998|564984854|FG002|Overall Study|Protocol Violation|0|||
156517011|NCT03117998|564984855|FG003|Overall Study|Protocol Violation|0|||
156517012|NCT03117998|564984856|FG004|Overall Study|Protocol Violation|0|||
156517013|NCT03117998|564984857|FG005|Overall Study|Protocol Violation|1|||
156517014|NCT00545753|564984862|FG000|Overall Study|Withdrawal by Subject|0|||
156517015|NCT00545753|564984863|FG001|Overall Study|Withdrawal by Subject|1|||
156517016|NCT00545753|564984864|FG002|Overall Study|Withdrawal by Subject|10|||
156517017|NCT00545753|564984862|FG000|Overall Study|Lost to Follow-up|13|||
156517018|NCT00545753|564984863|FG001|Overall Study|Lost to Follow-up|3|||
156517019|NCT00545753|564984864|FG002|Overall Study|Lost to Follow-up|12|||
156517020|NCT00545753|564984862|FG000|Overall Study|Protocol Violation|3|||
156517021|NCT00545753|564984863|FG001|Overall Study|Protocol Violation|1|||
156517022|NCT00545753|564984864|FG002|Overall Study|Protocol Violation|4|||
156517023|NCT01262027|564984865|FG000|Overall Study|Adverse Event|1|||
156517024|NCT01262027|564984865|FG000|Overall Study|Withdrawal by Subject|3|||
156517025|NCT01262027|564984865|FG000|Overall Study|Protocol Violation|1|||
156517026|NCT01011153|564984867|FG000|Overall Study|Less than 78 cases completed|8|||
156517027|NCT01011153|564984868|FG001|Overall Study|Less than 78 cases completed|11|||
156517028|NCT01011153|564984869|FG002|Overall Study|Less than 78 cases completed|9|||
156517029|NCT03014479|564984870|FG000|Overall Study|Adverse Event|0|||
156560540|NCT00773279|565142068|FG000|Period 2|Protocol Violation|0|||
156560541|NCT00773279|565142069|FG001|Period 2|Protocol Violation|3|||
156560542|NCT00773279|565142068|FG000|Period 2|Unclassified|2|||
156560543|NCT00773279|565142069|FG001|Period 2|Unclassified|2|||
156560544|NCT04178772|565142070|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
156560545|NCT04178772|565142070|FG000|Overall Study|study terminated early due to COVID-19|7|||
156560546|NCT00330187|565142071|FG000|Overall Study|Lost to Follow-up|12|||
156517030|NCT03014479|564984871|FG001|Overall Study|Adverse Event|1|||
156517031|NCT03014479|564984870|FG000|Overall Study|Voluntary Withdrawal|0|||
156517032|NCT03014479|564984871|FG001|Overall Study|Voluntary Withdrawal|2|||
156560547|NCT00330187|565142072|FG001|Overall Study|Lost to Follow-up|13|||
156560548|NCT00330187|565142073|FG002|Overall Study|Lost to Follow-up|14|||
156560549|NCT00330187|565142074|FG003|Overall Study|Lost to Follow-up|10|||
156560550|NCT00330187|565142071|FG000|Overall Study|Withdrawal by Subject|8|||
156560551|NCT00330187|565142072|FG001|Overall Study|Withdrawal by Subject|5|||
156560552|NCT00330187|565142073|FG002|Overall Study|Withdrawal by Subject|4|||
156517033|NCT03014479|564984870|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
156517034|NCT03014479|564984871|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
156517035|NCT01081132|564984877|FG000|Overall Study|Lack of Efficacy|25|||
156517036|NCT01081132|564984878|FG001|Overall Study|Lack of Efficacy|9|||
156517037|NCT01081132|564984877|FG000|Overall Study|Withdrawal by Subject|13|||
156517038|NCT01081132|564984878|FG001|Overall Study|Withdrawal by Subject|16|||
156517039|NCT01081132|564984877|FG000|Overall Study|Lost to Follow-up|4|||
156517040|NCT01081132|564984878|FG001|Overall Study|Lost to Follow-up|11|||
156517041|NCT01081132|564984877|FG000|Overall Study|Adverse Event|3|||
156517042|NCT01081132|564984878|FG001|Overall Study|Adverse Event|9|||
156517043|NCT01081132|564984877|FG000|Overall Study|Non Compliance|4|||
156517044|NCT01081132|564984878|FG001|Overall Study|Non Compliance|2|||
156517045|NCT01081132|564984877|FG000|Overall Study|Lack Of Compliance|0|||
156517046|NCT01081132|564984878|FG001|Overall Study|Lack Of Compliance|1|||
156517047|NCT01081132|564984877|FG000|Overall Study|Missed Visits|1|||
156517048|NCT01081132|564984878|FG001|Overall Study|Missed Visits|1|||
156517049|NCT01081132|564984877|FG000|Overall Study|Stopped Taking Meds|2|||
156517050|NCT01081132|564984878|FG001|Overall Study|Stopped Taking Meds|0|||
156517051|NCT01081132|564984877|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
156517052|NCT01081132|564984878|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
156517053|NCT01081132|564984877|FG000|Overall Study|Declined Taper Phase|0|||
156517054|NCT01081132|564984878|FG001|Overall Study|Declined Taper Phase|1|||
156517055|NCT01081132|564984877|FG000|Overall Study|Protocol Violation|3|||
156517056|NCT01081132|564984878|FG001|Overall Study|Protocol Violation|1|||
156517057|NCT02489968|564984884|FG000|Open-label Treatment Period|Adverse Event|14|||
156517058|NCT02489968|564984885|FG001|Open-label Treatment Period|Adverse Event|7|||
156517059|NCT02489968|564984886|FG002|Open-label Treatment Period|Adverse Event|0|||
156517060|NCT02489968|564984887|FG003|Open-label Treatment Period|Adverse Event|0|||
156517061|NCT02489968|564984888|FG004|Open-label Treatment Period|Adverse Event|0|||
156517062|NCT02489968|564984889|FG005|Open-label Treatment Period|Adverse Event|0|||
156517063|NCT02489968|564984884|FG000|Open-label Treatment Period|Protocol Violation|2|||
156517064|NCT02489968|564984885|FG001|Open-label Treatment Period|Protocol Violation|2|||
156517065|NCT02489968|564984886|FG002|Open-label Treatment Period|Protocol Violation|0|||
156517066|NCT02489968|564984887|FG003|Open-label Treatment Period|Protocol Violation|0|||
156517067|NCT02489968|564984888|FG004|Open-label Treatment Period|Protocol Violation|0|||
156517068|NCT02489968|564984889|FG005|Open-label Treatment Period|Protocol Violation|0|||
156517069|NCT02489968|564984884|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
156517070|NCT02489968|564984885|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
156517071|NCT02489968|564984886|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
156517072|NCT02489968|564984887|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
156517073|NCT02489968|564984888|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
156517074|NCT02489968|564984889|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
156517075|NCT02489968|564984884|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
156517076|NCT02489968|564984885|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
156517077|NCT02489968|564984886|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
156517078|NCT02489968|564984887|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
156517079|NCT02489968|564984888|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
156517080|NCT02489968|564984889|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
156517081|NCT02489968|564984884|FG000|Open-label Treatment Period|Other than specified above|204|||
156517082|NCT02489968|564984885|FG001|Open-label Treatment Period|Other than specified above|189|||
156517083|NCT02489968|564984886|FG002|Open-label Treatment Period|Other than specified above|0|||
156517084|NCT02489968|564984887|FG003|Open-label Treatment Period|Other than specified above|0|||
156517085|NCT02489968|564984888|FG004|Open-label Treatment Period|Other than specified above|0|||
156517086|NCT02489968|564984889|FG005|Open-label Treatment Period|Other than specified above|0|||
156517087|NCT02489968|564984884|FG000|Double-blind Treatment Period|Adverse Event|0|||
156517088|NCT02489968|564984885|FG001|Double-blind Treatment Period|Adverse Event|0|||
156517089|NCT02489968|564984886|FG002|Double-blind Treatment Period|Adverse Event|2|||
156560553|NCT00330187|565142074|FG003|Overall Study|Withdrawal by Subject|4|||
156517090|NCT02489968|564984887|FG003|Double-blind Treatment Period|Adverse Event|6|||
156517091|NCT02489968|564984888|FG004|Double-blind Treatment Period|Adverse Event|4|||
156517092|NCT02489968|564984889|FG005|Double-blind Treatment Period|Adverse Event|5|||
156517093|NCT02489968|564984884|FG000|Double-blind Treatment Period|Protocol Violation|0|||
156517094|NCT02489968|564984885|FG001|Double-blind Treatment Period|Protocol Violation|0|||
156517095|NCT02489968|564984886|FG002|Double-blind Treatment Period|Protocol Violation|0|||
156517096|NCT02489968|564984887|FG003|Double-blind Treatment Period|Protocol Violation|0|||
156517097|NCT02489968|564984888|FG004|Double-blind Treatment Period|Protocol Violation|1|||
156517098|NCT02489968|564984889|FG005|Double-blind Treatment Period|Protocol Violation|1|||
156560554|NCT01481896|565142077|FG000|Overall Study|Lost to Follow-up|12|||
156517099|NCT02489968|564984884|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
156517100|NCT02489968|564984885|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
156517101|NCT02489968|564984886|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156517102|NCT02489968|564984887|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
156517103|NCT02489968|564984888|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
156517104|NCT02489968|564984889|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
156517105|NCT02489968|564984884|FG000|Double-blind Treatment Period|Other than specified above|0|||
156517106|NCT02489968|564984885|FG001|Double-blind Treatment Period|Other than specified above|0|||
156517107|NCT02489968|564984886|FG002|Double-blind Treatment Period|Other than specified above|0|||
156517108|NCT02489968|564984887|FG003|Double-blind Treatment Period|Other than specified above|0|||
156517109|NCT02489968|564984888|FG004|Double-blind Treatment Period|Other than specified above|1|||
156517110|NCT02489968|564984889|FG005|Double-blind Treatment Period|Other than specified above|0|||
156517111|NCT00611975|564984890|FG000|Overall Study|Withdrawal by Subject|3|||
156517112|NCT00611975|564984891|FG001|Overall Study|Withdrawal by Subject|7|||
156517113|NCT00611975|564984890|FG000|Overall Study|Pregnancy|2|||
156517114|NCT00611975|564984891|FG001|Overall Study|Pregnancy|1|||
156517115|NCT05618912|564984892|FG000|Overall Study|Lost to Follow-up|14|||
156517116|NCT05618912|564984893|FG001|Overall Study|Lost to Follow-up|19|||
156517117|NCT01022112|564984894|FG000|Overall Study|Adverse Event|1|||
156517118|NCT01022112|564984895|FG001|Overall Study|Adverse Event|2|||
156517119|NCT01022112|564984896|FG002|Overall Study|Adverse Event|0|||
156517120|NCT01022112|564984897|FG003|Overall Study|Adverse Event|1|||
156517121|NCT01022112|564984898|FG004|Overall Study|Adverse Event|0|||
156517122|NCT01022112|564984894|FG000|Overall Study|Lack of Efficacy|1|||
156517123|NCT01022112|564984895|FG001|Overall Study|Lack of Efficacy|0|||
156517124|NCT01022112|564984896|FG002|Overall Study|Lack of Efficacy|0|||
156517125|NCT01022112|564984897|FG003|Overall Study|Lack of Efficacy|0|||
156517126|NCT01022112|564984898|FG004|Overall Study|Lack of Efficacy|1|||
156517127|NCT01022112|564984894|FG000|Overall Study|Physician Decision|0|||
156517128|NCT01022112|564984895|FG001|Overall Study|Physician Decision|0|||
156517129|NCT01022112|564984896|FG002|Overall Study|Physician Decision|1|||
156517130|NCT01022112|564984897|FG003|Overall Study|Physician Decision|0|||
156517131|NCT01022112|564984898|FG004|Overall Study|Physician Decision|1|||
156517132|NCT01022112|564984894|FG000|Overall Study|Withdrawal by Subject|0|||
156517133|NCT01022112|564984895|FG001|Overall Study|Withdrawal by Subject|1|||
156517134|NCT01022112|564984896|FG002|Overall Study|Withdrawal by Subject|2|||
156517135|NCT01022112|564984897|FG003|Overall Study|Withdrawal by Subject|2|||
156517136|NCT01022112|564984898|FG004|Overall Study|Withdrawal by Subject|1|||
156517137|NCT01022112|564984894|FG000|Overall Study|Fasting plasma glucose level increased|1|||
156517138|NCT01022112|564984895|FG001|Overall Study|Fasting plasma glucose level increased|0|||
156517139|NCT01022112|564984896|FG002|Overall Study|Fasting plasma glucose level increased|0|||
156517140|NCT01022112|564984897|FG003|Overall Study|Fasting plasma glucose level increased|0|||
156517141|NCT01022112|564984898|FG004|Overall Study|Fasting plasma glucose level increased|7|||
156517142|NCT03541174|564986223|FG000|Part 1 Double-Blind|Adverse Event|6|||
156517143|NCT03541174|564986224|FG001|Part 1 Double-Blind|Adverse Event|5|||
156517144|NCT03541174|564986225|FG002|Part 1 Double-Blind|Adverse Event|2|||
156517145|NCT03541174|564986226|FG003|Part 1 Double-Blind|Adverse Event|0|||
156517146|NCT03541174|564986227|FG004|Part 1 Double-Blind|Adverse Event|0|||
156517147|NCT03541174|564986228|FG005|Part 1 Double-Blind|Adverse Event|0|||
156517148|NCT03541174|564986223|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
156517149|NCT03541174|564986224|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
156517150|NCT03541174|564986225|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
156517151|NCT03541174|564986226|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
156517152|NCT03541174|564986227|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
156517153|NCT03541174|564986228|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
156517154|NCT03541174|564986223|FG000|Part 1 Double-Blind|Other reasons|3|||
156517155|NCT03541174|564986224|FG001|Part 1 Double-Blind|Other reasons|2|||
156517156|NCT03541174|564986225|FG002|Part 1 Double-Blind|Other reasons|3|||
156517157|NCT03541174|564986226|FG003|Part 1 Double-Blind|Other reasons|0|||
156517158|NCT03541174|564986227|FG004|Part 1 Double-Blind|Other reasons|0|||
156517159|NCT03541174|564986228|FG005|Part 1 Double-Blind|Other reasons|0|||
156517160|NCT03541174|564986223|FG000|Part 2 Single-Blind|Adverse Event|0|||
156517161|NCT03541174|564986224|FG001|Part 2 Single-Blind|Adverse Event|0|||
156517162|NCT03541174|564986225|FG002|Part 2 Single-Blind|Adverse Event|0|||
156517163|NCT03541174|564986226|FG003|Part 2 Single-Blind|Adverse Event|25|||
156517164|NCT03541174|564986227|FG004|Part 2 Single-Blind|Adverse Event|0|||
156517165|NCT03541174|564986228|FG005|Part 2 Single-Blind|Adverse Event|0|||
156517166|NCT03541174|564986223|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
156517167|NCT03541174|564986224|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
156517168|NCT03541174|564986225|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
156560555|NCT01573910|565142081|FG000|Overall Study|Adverse Event|4|||
156517169|NCT03541174|564986226|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
156517170|NCT03541174|564986227|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
156517171|NCT03541174|564986228|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
156517172|NCT03541174|564986223|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
156517173|NCT03541174|564986224|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
156517174|NCT03541174|564986225|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
156517175|NCT03541174|564986226|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
156517176|NCT03541174|564986227|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
156517177|NCT03541174|564986228|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
156517178|NCT03541174|564986223|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
156517179|NCT03541174|564986224|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
156517180|NCT03541174|564986225|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
156517181|NCT03541174|564986226|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
156517182|NCT03541174|564986227|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
156517183|NCT03541174|564986228|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
156517184|NCT03541174|564986223|FG000|Part 2 Single-Blind|Death|0|||
156517185|NCT03541174|564986224|FG001|Part 2 Single-Blind|Death|0|||
156517186|NCT03541174|564986225|FG002|Part 2 Single-Blind|Death|0|||
156517187|NCT03541174|564986226|FG003|Part 2 Single-Blind|Death|5|||
156517188|NCT03541174|564986227|FG004|Part 2 Single-Blind|Death|0|||
156517189|NCT03541174|564986228|FG005|Part 2 Single-Blind|Death|0|||
156517190|NCT03541174|564986223|FG000|Part 2 Single-Blind|Pregnancy|0|||
156517191|NCT03541174|564986224|FG001|Part 2 Single-Blind|Pregnancy|0|||
156517192|NCT03541174|564986225|FG002|Part 2 Single-Blind|Pregnancy|0|||
156517193|NCT03541174|564986226|FG003|Part 2 Single-Blind|Pregnancy|1|||
156517194|NCT03541174|564986227|FG004|Part 2 Single-Blind|Pregnancy|0|||
156517195|NCT03541174|564986228|FG005|Part 2 Single-Blind|Pregnancy|0|||
156517196|NCT03541174|564986223|FG000|Part 2 Single-Blind|Other reasons|0|||
156517197|NCT03541174|564986224|FG001|Part 2 Single-Blind|Other reasons|0|||
156517198|NCT03541174|564986225|FG002|Part 2 Single-Blind|Other reasons|0|||
156517199|NCT03541174|564986226|FG003|Part 2 Single-Blind|Other reasons|32|||
156517200|NCT03541174|564986227|FG004|Part 2 Single-Blind|Other reasons|0|||
156517201|NCT03541174|564986228|FG005|Part 2 Single-Blind|Other reasons|0|||
156517202|NCT03541174|564986223|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
156517203|NCT03541174|564986224|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
156517204|NCT03541174|564986225|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
156517205|NCT03541174|564986226|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
156517206|NCT03541174|564986227|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
156517207|NCT03541174|564986228|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
156517208|NCT03541174|564986223|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
156517209|NCT03541174|564986224|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
156517210|NCT03541174|564986225|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
156517211|NCT03541174|564986226|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
156517212|NCT03541174|564986227|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
156517213|NCT03541174|564986228|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
156517214|NCT03541174|564986223|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
156517215|NCT03541174|564986224|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
156517216|NCT03541174|564986225|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
156517217|NCT03541174|564986226|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
156517218|NCT03541174|564986227|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
156517219|NCT03541174|564986228|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
156517220|NCT03541174|564986223|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
156517221|NCT03541174|564986224|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
156517222|NCT03541174|564986225|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
156517223|NCT03541174|564986226|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
156517224|NCT03541174|564986227|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
156517225|NCT03541174|564986228|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
156517226|NCT03541174|564986223|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
156517227|NCT03541174|564986224|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
156517228|NCT03541174|564986225|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
156517229|NCT03541174|564986226|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
156517230|NCT03541174|564986227|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
156517231|NCT03541174|564986228|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
156517232|NCT00605215|564986229|FG000|Overall Study|Death|0|||
156517233|NCT00605215|564986230|FG001|Overall Study|Death|0|||
156517234|NCT00605215|564986231|FG002|Overall Study|Death|1|||
156517235|NCT00605215|564986229|FG000|Overall Study|Adverse Event|19|||
156517236|NCT00605215|564986230|FG001|Overall Study|Adverse Event|21|||
156517237|NCT00605215|564986231|FG002|Overall Study|Adverse Event|26|||
156517238|NCT00605215|564986229|FG000|Overall Study|Refusal to sign the re-consent form|8|||
156517239|NCT00605215|564986230|FG001|Overall Study|Refusal to sign the re-consent form|3|||
156517240|NCT00605215|564986231|FG002|Overall Study|Refusal to sign the re-consent form|3|||
156560556|NCT01573910|565142082|FG001|Overall Study|Adverse Event|4|||
156560557|NCT01573910|565142081|FG000|Overall Study|Lost to Follow-up|2|||
156560558|NCT01573910|565142082|FG001|Overall Study|Lost to Follow-up|1|||
156517241|NCT00605215|564986229|FG000|Overall Study|Withdrawal by Subject|39|||
156517242|NCT00605215|564986230|FG001|Overall Study|Withdrawal by Subject|37|||
156517243|NCT00605215|564986231|FG002|Overall Study|Withdrawal by Subject|27|||
156517244|NCT00605215|564986229|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
156517245|NCT00605215|564986230|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
156517246|NCT00605215|564986231|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
156517247|NCT00605215|564986229|FG000|Overall Study|Protocol Violation|3|||
156517248|NCT00605215|564986230|FG001|Overall Study|Protocol Violation|4|||
156517249|NCT00605215|564986231|FG002|Overall Study|Protocol Violation|1|||
156517250|NCT00605215|564986229|FG000|Overall Study|Pregnancy|8|||
156517251|NCT00605215|564986230|FG001|Overall Study|Pregnancy|5|||
156517252|NCT00605215|564986231|FG002|Overall Study|Pregnancy|4|||
156517253|NCT00605215|564986229|FG000|Overall Study|Lost to Follow-up|8|||
156517254|NCT00605215|564986230|FG001|Overall Study|Lost to Follow-up|5|||
156517255|NCT00605215|564986231|FG002|Overall Study|Lost to Follow-up|2|||
156517256|NCT00605215|564986229|FG000|Overall Study|Other than specified|0|||
156517257|NCT00605215|564986230|FG001|Overall Study|Other than specified|2|||
156517258|NCT00605215|564986231|FG002|Overall Study|Other than specified|1|||
156517259|NCT00275262|564986232|FG000|Overall Study|Adverse Event|2|||
156517260|NCT00275262|564986233|FG001|Overall Study|Adverse Event|0|||
156517261|NCT00275262|564986232|FG000|Overall Study|Disease progression|2|||
156517262|NCT00275262|564986233|FG001|Overall Study|Disease progression|5|||
156517263|NCT00275262|564986232|FG000|Overall Study|Lost to Follow-up|0|||
156517264|NCT00275262|564986233|FG001|Overall Study|Lost to Follow-up|2|||
156517265|NCT00275262|564986232|FG000|Overall Study|Protocol Violation|0|||
156517266|NCT00275262|564986233|FG001|Overall Study|Protocol Violation|2|||
156517267|NCT00275262|564986232|FG000|Overall Study|Death|1|||
156517268|NCT00275262|564986233|FG001|Overall Study|Death|0|||
156517269|NCT00275262|564986232|FG000|Overall Study|Started Chemotherapy|1|||
156517270|NCT00275262|564986233|FG001|Overall Study|Started Chemotherapy|0|||
156517271|NCT04058366|564986236|FG000|Overall Study|Adverse Event|14|||
156517272|NCT04058366|564986236|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
156517273|NCT04058366|564986236|FG000|Overall Study|Commercial drug is available for participants|6|||
156517274|NCT04058366|564986236|FG000|Overall Study|Death|1|||
156517275|NCT04058366|564986236|FG000|Overall Study|Other non-compliance|2|||
156517276|NCT04058366|564986236|FG000|Overall Study|Other|6|||
156517277|NCT02594163|564986237|FG000|Treatment Period|Progressive disease|2|||
156517278|NCT02594163|564986238|FG001|Treatment Period|Progressive disease|3|||
156517279|NCT02594163|564986237|FG000|Treatment Period|Adverse Event|1|||
156517280|NCT02594163|564986238|FG001|Treatment Period|Adverse Event|5|||
156517281|NCT02594163|564986237|FG000|Treatment Period|Physician Decision|1|||
156517282|NCT02594163|564986238|FG001|Treatment Period|Physician Decision|3|||
156517283|NCT02594163|564986237|FG000|Treatment Period|Study termination by sponsor|2|||
156517284|NCT02594163|564986238|FG001|Treatment Period|Study termination by sponsor|1|||
156517285|NCT02594163|564986237|FG000|Treatment Period|Other, Non-AE|1|||
156517286|NCT02594163|564986238|FG001|Treatment Period|Other, Non-AE|0|||
156517287|NCT02594163|564986237|FG000|Follow-up Period|Withdrawal by Subject|0|||
156517288|NCT02594163|564986238|FG001|Follow-up Period|Withdrawal by Subject|1|||
156517289|NCT02594163|564986237|FG000|Follow-up Period|Study Termination by Sponsor|6|||
156517290|NCT02594163|564986238|FG001|Follow-up Period|Study Termination by Sponsor|4|||
156517291|NCT02594163|564986237|FG000|Follow-up Period|Lost to Follow-up|1|||
156517292|NCT02594163|564986238|FG001|Follow-up Period|Lost to Follow-up|0|||
156517293|NCT02594163|564986237|FG000|Follow-up Period|Death|2|||
156517294|NCT02594163|564986238|FG001|Follow-up Period|Death|5|||
156517295|NCT02594163|564986237|FG000|Follow-up Period|Adverse Event|0|||
156517296|NCT02594163|564986238|FG001|Follow-up Period|Adverse Event|1|||
156517297|NCT02594163|564986237|FG000|Follow-up Period|Progressive Disease|2|||
156517298|NCT02594163|564986238|FG001|Follow-up Period|Progressive Disease|0|||
156517299|NCT02594163|564986237|FG000|Follow-up Period|Physician Decision|0|||
156517300|NCT02594163|564986238|FG001|Follow-up Period|Physician Decision|1|||
156517301|NCT01342341|564986239|FG000|Overall Study|Lost to Follow-up|4|||
156517302|NCT01342341|564986240|FG001|Overall Study|Lost to Follow-up|4|||
156517303|NCT01076192|564986241|FG000|Overall Study|Other|197|||
156517304|NCT01034176|564986242|FG000|Overall Study|Physician Decision|2|||
156517305|NCT01034176|564986243|FG001|Overall Study|Physician Decision|0|||
156517306|NCT01034176|564986242|FG000|Overall Study|Withdrawal by Subject|0|||
156517307|NCT01034176|564986243|FG001|Overall Study|Withdrawal by Subject|1|||
156517308|NCT01034176|564986242|FG000|Overall Study|Lost to Follow-up|0|||
156517309|NCT01034176|564986243|FG001|Overall Study|Lost to Follow-up|1|||
156517310|NCT02680002|564986246|FG000|Overall Study|Lost to Follow-up|5|||
156517311|NCT02680002|564986247|FG001|Overall Study|Lost to Follow-up|1|||
156517312|NCT02680002|564986248|FG002|Overall Study|Lost to Follow-up|4|||
156517313|NCT02680002|564986249|FG003|Overall Study|Lost to Follow-up|2|||
156517314|NCT02680002|564986250|FG004|Overall Study|Lost to Follow-up|0|||
156517315|NCT02680002|564986251|FG005|Overall Study|Lost to Follow-up|2|||
156517316|NCT02680002|564986246|FG000|Overall Study|Physician Decision|5|||
156517317|NCT02680002|564986247|FG001|Overall Study|Physician Decision|1|||
156517318|NCT02680002|564986248|FG002|Overall Study|Physician Decision|1|||
156517319|NCT02680002|564986249|FG003|Overall Study|Physician Decision|1|||
156517320|NCT02680002|564986250|FG004|Overall Study|Physician Decision|1|||
156517321|NCT02680002|564986251|FG005|Overall Study|Physician Decision|1|||
156517322|NCT02680002|564986246|FG000|Overall Study|Protocol Violation|1|||
156517323|NCT02680002|564986247|FG001|Overall Study|Protocol Violation|0|||
156517324|NCT02680002|564986248|FG002|Overall Study|Protocol Violation|1|||
156517325|NCT02680002|564986249|FG003|Overall Study|Protocol Violation|0|||
156517326|NCT02680002|564986250|FG004|Overall Study|Protocol Violation|1|||
156517327|NCT02680002|564986251|FG005|Overall Study|Protocol Violation|2|||
156517328|NCT02680002|564986246|FG000|Overall Study|Withdrawal by Subject|0|||
156517329|NCT02680002|564986247|FG001|Overall Study|Withdrawal by Subject|0|||
156517330|NCT02680002|564986248|FG002|Overall Study|Withdrawal by Subject|1|||
156517331|NCT02680002|564986249|FG003|Overall Study|Withdrawal by Subject|0|||
156517332|NCT02680002|564986250|FG004|Overall Study|Withdrawal by Subject|2|||
156517333|NCT02680002|564986251|FG005|Overall Study|Withdrawal by Subject|2|||
156517334|NCT02680002|564986246|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
156517335|NCT02680002|564986247|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
156517336|NCT02680002|564986248|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
156517337|NCT02680002|564986249|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
156517338|NCT02680002|564986250|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
156517339|NCT02680002|564986251|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
156517340|NCT02680002|564986246|FG000|Overall Study|Other|0|||
156517341|NCT02680002|564986247|FG001|Overall Study|Other|1|||
156517342|NCT02680002|564986248|FG002|Overall Study|Other|0|||
156517343|NCT02680002|564986249|FG003|Overall Study|Other|0|||
156517344|NCT02680002|564986250|FG004|Overall Study|Other|1|||
156517345|NCT02680002|564986251|FG005|Overall Study|Other|0|||
156517346|NCT02680002|564986246|FG000|Overall Study|Adverse Event|0|||
156517347|NCT02680002|564986247|FG001|Overall Study|Adverse Event|0|||
156517348|NCT02680002|564986248|FG002|Overall Study|Adverse Event|0|||
156517349|NCT02680002|564986249|FG003|Overall Study|Adverse Event|0|||
156517350|NCT02680002|564986250|FG004|Overall Study|Adverse Event|1|||
156517351|NCT02680002|564986251|FG005|Overall Study|Adverse Event|2|||
156517352|NCT03527173|564986252|FG000|Overall Study|Lost to Follow-up|4|||
156517353|NCT03527173|564986253|FG001|Overall Study|Lost to Follow-up|2|||
156517354|NCT03527173|564986252|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
156517355|NCT03527173|564986253|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
156517356|NCT03527173|564986252|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
156517357|NCT03527173|564986253|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
156517358|NCT03527173|564986252|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
156517359|NCT03527173|564986253|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156517360|NCT04097301|564986254|FG000|Overall Study|Death|1|||
156517361|NCT04097301|564986254|FG000|Overall Study|Withdrawal by Subject|1|||
156517362|NCT04097301|564986254|FG000|Overall Study|Screening Failure|5|||
156517363|NCT00901186|564986255|FG000|Overall Study|Lack of Efficacy|0|||
156517364|NCT00901186|564986256|FG001|Overall Study|Lack of Efficacy|1|||
156517365|NCT00901186|564986255|FG000|Overall Study|Abnormal laboratory values|0|||
156517366|NCT00901186|564986256|FG001|Overall Study|Abnormal laboratory values|1|||
156517367|NCT00901186|564986255|FG000|Overall Study|Lost to Follow-up|2|||
156517368|NCT00901186|564986256|FG001|Overall Study|Lost to Follow-up|0|||
156517369|NCT00901186|564986255|FG000|Overall Study|Adverse Event|2|||
156517370|NCT00901186|564986256|FG001|Overall Study|Adverse Event|4|||
156517371|NCT00901186|564986255|FG000|Overall Study|Administration problems|0|||
156517372|NCT00901186|564986256|FG001|Overall Study|Administration problems|1|||
156517373|NCT00901186|564986255|FG000|Overall Study|Protocol deviations|5|||
156517374|NCT00901186|564986256|FG001|Overall Study|Protocol deviations|4|||
156517375|NCT02383056|564986257|FG000|Overall Study|Adverse Event|1|||
156517376|NCT02383056|564986258|FG001|Overall Study|Adverse Event|0|||
156517377|NCT02383056|564986257|FG000|Overall Study|Lost to Follow-up|0|||
156517378|NCT02383056|564986258|FG001|Overall Study|Lost to Follow-up|2|||
156517379|NCT00896051|564986260|FG000|Overall Study|Adverse Event|2|||
156517380|NCT00896051|564986261|FG001|Overall Study|Adverse Event|1|||
156517381|NCT00896051|564986260|FG000|Overall Study|Lost to Follow-up|3|||
156517382|NCT00896051|564986261|FG001|Overall Study|Lost to Follow-up|2|||
156517383|NCT00896051|564986260|FG000|Overall Study|Withdrawal by Subject|3|||
156517384|NCT00896051|564986261|FG001|Overall Study|Withdrawal by Subject|2|||
156517385|NCT00896051|564986260|FG000|Overall Study|Subject noncompliant|1|||
156517386|NCT00896051|564986261|FG001|Overall Study|Subject noncompliant|3|||
156517387|NCT00896051|564986260|FG000|Overall Study|Other|1|||
156517388|NCT00896051|564986261|FG001|Overall Study|Other|1|||
156517389|NCT02935452|564986262|FG000|Overall Study|work and life commintment|3|||
156517390|NCT02935452|564986263|FG001|Overall Study|work and life commintment|1|||
156517391|NCT01813929|564986264|FG000|Overall Study|Withdrawal by Subject|0|||
156517392|NCT01813929|564986265|FG001|Overall Study|Withdrawal by Subject|1|||
156517393|NCT00007345|564986266|FG000|Overall Study|Refused further treatment|0|||
156517394|NCT00007345|564986267|FG001|Overall Study|Refused further treatment|7|||
156517395|NCT00007345|564986266|FG000|Overall Study|Switched to alternative treatment|0|||
156517396|NCT00007345|564986267|FG001|Overall Study|Switched to alternative treatment|3|||
156517397|NCT00007345|564986266|FG000|Overall Study|Intercurrent illness|1|||
156517398|NCT00007345|564986267|FG001|Overall Study|Intercurrent illness|0|||
156517399|NCT00007345|564986266|FG000|Overall Study|Death on study|1|||
156517400|NCT00007345|564986267|FG001|Overall Study|Death on study|1|||
156517401|NCT04433585|564986268|FG000|Overall Study|Withdrawal by Subject|15|||
156517402|NCT04433585|564986269|FG001|Overall Study|Withdrawal by Subject|3|||
156517403|NCT04433585|564986270|FG002|Overall Study|Withdrawal by Subject|15|||
156517404|NCT04433585|564986271|FG003|Overall Study|Withdrawal by Subject|6|||
156517405|NCT04433585|564986268|FG000|Overall Study|Adverse Event|10|||
156517406|NCT04433585|564986269|FG001|Overall Study|Adverse Event|4|||
156517407|NCT04433585|564986270|FG002|Overall Study|Adverse Event|1|||
156517408|NCT04433585|564986271|FG003|Overall Study|Adverse Event|0|||
156517409|NCT04433585|564986268|FG000|Overall Study|Due to the conflict in Ukraine|2|||
156517410|NCT04433585|564986269|FG001|Overall Study|Due to the conflict in Ukraine|1|||
156517411|NCT04433585|564986270|FG002|Overall Study|Due to the conflict in Ukraine|1|||
156517412|NCT04433585|564986271|FG003|Overall Study|Due to the conflict in Ukraine|2|||
156517413|NCT04433585|564986268|FG000|Overall Study|Physician Decision|1|||
156517414|NCT04433585|564986269|FG001|Overall Study|Physician Decision|2|||
156517415|NCT04433585|564986270|FG002|Overall Study|Physician Decision|0|||
156517416|NCT04433585|564986271|FG003|Overall Study|Physician Decision|0|||
156517417|NCT04433585|564986268|FG000|Overall Study|Lost to Follow-up|1|||
156517418|NCT04433585|564986269|FG001|Overall Study|Lost to Follow-up|1|||
156517419|NCT04433585|564986270|FG002|Overall Study|Lost to Follow-up|1|||
156517420|NCT04433585|564986271|FG003|Overall Study|Lost to Follow-up|0|||
156517421|NCT04433585|564986268|FG000|Overall Study|Lack of Efficacy|0|||
156517422|NCT04433585|564986269|FG001|Overall Study|Lack of Efficacy|1|||
156517423|NCT04433585|564986270|FG002|Overall Study|Lack of Efficacy|1|||
156517424|NCT04433585|564986271|FG003|Overall Study|Lack of Efficacy|1|||
156517425|NCT04433585|564986268|FG000|Overall Study|Death|0|||
156517426|NCT04433585|564986269|FG001|Overall Study|Death|1|||
156517427|NCT04433585|564986270|FG002|Overall Study|Death|0|||
156517428|NCT04433585|564986271|FG003|Overall Study|Death|0|||
156517429|NCT01239043|564986276|FG000|Overall Study|Protocol Violation|2|||
156517430|NCT01239043|564986277|FG001|Overall Study|Protocol Violation|1|||
156517431|NCT02929329|564986278|FG000|Overall Study|Withdrawal by Subject|24|||
156517432|NCT02929329|564986279|FG001|Overall Study|Withdrawal by Subject|21|||
156517433|NCT02929329|564986278|FG000|Overall Study|Lost to Follow-up|26|||
156517434|NCT02929329|564986279|FG001|Overall Study|Lost to Follow-up|20|||
156517435|NCT02929329|564986278|FG000|Overall Study|Death|1054|||
156517436|NCT02929329|564986279|FG001|Overall Study|Death|1051|||
156517437|NCT02121301|564986280|FG000|Overall Study|Protocol Violation|1|||
156517438|NCT02121301|564986281|FG001|Overall Study|Protocol Violation|4|||
156517439|NCT02121301|564986282|FG002|Overall Study|Protocol Violation|1|||
156517440|NCT00434213|564986290|FG000|Overall Study|Adverse Event|12|||
156517441|NCT00434213|564986290|FG000|Overall Study|Lack of Efficacy|9|||
156517442|NCT00434213|564986290|FG000|Overall Study|Lost to Follow-up|14|||
156517443|NCT00434213|564986290|FG000|Overall Study|Withdrawal by Subject|7|||
156517444|NCT00434213|564986290|FG000|Overall Study|Protocol Violation|3|||
156517445|NCT00434213|564986290|FG000|Overall Study|Unable to comply with study visit window|2|||
156517446|NCT00434213|564986290|FG000|Overall Study|Application site reaction|1|||
156517447|NCT00434213|564986290|FG000|Overall Study|Non-compliant to study schedule|1|||
156517448|NCT04988867|564986291|FG000|Overall Study|Study terminated by Sponsor|12|||
156517449|NCT04988867|564986291|FG000|Overall Study|Adverse Event|2|||
156517450|NCT04988867|564986291|FG000|Overall Study|Study drug noncompliance|1|||
156517451|NCT00700778|564986292|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
156517452|NCT04927247|564986294|FG000|Overall Study|Other|2|||
156517453|NCT04927247|564986295|FG001|Overall Study|Other|1|||
156517454|NCT04927247|564986294|FG000|Overall Study|Physician Decision|0|||
156517455|NCT04927247|564986295|FG001|Overall Study|Physician Decision|1|||
156517456|NCT04927247|564986294|FG000|Overall Study|Adverse Event|1|||
156517457|NCT04927247|564986295|FG001|Overall Study|Adverse Event|0|||
156517458|NCT00350103|564986296|FG000|Overall Study|Adverse Event|12|||
156517459|NCT00350103|564986297|FG001|Overall Study|Adverse Event|29|||
156517460|NCT00350103|564986298|FG002|Overall Study|Adverse Event|17|||
156517461|NCT00350103|564986296|FG000|Overall Study|Lack of Efficacy|5|||
156517462|NCT00350103|564986297|FG001|Overall Study|Lack of Efficacy|1|||
156517463|NCT00350103|564986298|FG002|Overall Study|Lack of Efficacy|3|||
156517464|NCT00350103|564986296|FG000|Overall Study|Withdrawal by Subject|6|||
156517465|NCT00350103|564986297|FG001|Overall Study|Withdrawal by Subject|6|||
156517466|NCT00350103|564986298|FG002|Overall Study|Withdrawal by Subject|8|||
156517467|NCT00350103|564986296|FG000|Overall Study|Protocol Violation|0|||
156517468|NCT00350103|564986297|FG001|Overall Study|Protocol Violation|0|||
156517469|NCT00350103|564986298|FG002|Overall Study|Protocol Violation|1|||
156517470|NCT00350103|564986296|FG000|Overall Study|Unsatisfactory Compliance|2|||
156517471|NCT00350103|564986297|FG001|Overall Study|Unsatisfactory Compliance|2|||
156517472|NCT00350103|564986298|FG002|Overall Study|Unsatisfactory Compliance|1|||
156517473|NCT00350103|564986296|FG000|Overall Study|Investigator´s decision|1|||
156517474|NCT00350103|564986297|FG001|Overall Study|Investigator´s decision|1|||
156517475|NCT00350103|564986298|FG002|Overall Study|Investigator´s decision|0|||
156517476|NCT00350103|564986296|FG000|Overall Study|Exclusion criteria met|0|||
156517477|NCT00350103|564986297|FG001|Overall Study|Exclusion criteria met|0|||
156517478|NCT00350103|564986298|FG002|Overall Study|Exclusion criteria met|1|||
156517479|NCT00350103|564986296|FG000|Overall Study|Patient relocated|0|||
156517480|NCT00350103|564986297|FG001|Overall Study|Patient relocated|0|||
156517481|NCT00350103|564986298|FG002|Overall Study|Patient relocated|1|||
156517482|NCT00350103|564986296|FG000|Overall Study|Need for prohibited medication|1|||
156517483|NCT00350103|564986297|FG001|Overall Study|Need for prohibited medication|0|||
156560559|NCT01573910|565142081|FG000|Overall Study|Withdrawal by Subject|0|||
156560560|NCT01573910|565142082|FG001|Overall Study|Withdrawal by Subject|1|||
156560561|NCT01573910|565142081|FG000|Overall Study|Protocol Violation|3|||
156560562|NCT01573910|565142082|FG001|Overall Study|Protocol Violation|0|||
156560563|NCT01573910|565142081|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
156560564|NCT01573910|565142082|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
156560565|NCT00364182|565142083|FG000|First Intervention|Secondary prophylaxis|1|||
156560566|NCT00364182|565142084|FG001|First Intervention|Secondary prophylaxis|0|||
156560567|NCT00364182|565142085|FG002|First Intervention|Secondary prophylaxis|0|||
156560568|NCT00364182|565142083|FG000|First Intervention|Withdrawal by Subject|2|||
156560569|NCT00364182|565142084|FG001|First Intervention|Withdrawal by Subject|0|||
156560570|NCT00364182|565142085|FG002|First Intervention|Withdrawal by Subject|0|||
156560571|NCT00364182|565142083|FG000|Second Intervention|non-compliance|0|||
156560572|NCT00364182|565142084|FG001|Second Intervention|non-compliance|1|||
156560573|NCT00364182|565142085|FG002|Second Intervention|non-compliance|1|||
156560574|NCT00364182|565142083|FG000|Second Intervention|Protocol Violation|0|||
156560575|NCT00364182|565142084|FG001|Second Intervention|Protocol Violation|1|||
156560576|NCT00364182|565142085|FG002|Second Intervention|Protocol Violation|0|||
156560577|NCT00364182|565142083|FG000|Second Intervention|Adverse Event|0|||
156560578|NCT00364182|565142084|FG001|Second Intervention|Adverse Event|0|||
156560579|NCT00364182|565142085|FG002|Second Intervention|Adverse Event|1|||
156560580|NCT00364182|565142083|FG000|Third Intervention|non-compliance|0|||
156560581|NCT00364182|565142084|FG001|Third Intervention|non-compliance|1|||
156560582|NCT00364182|565142085|FG002|Third Intervention|non-compliance|0|||
156560583|NCT00364182|565142083|FG000|Third Intervention|Lost to Follow-up|0|||
156560584|NCT00364182|565142084|FG001|Third Intervention|Lost to Follow-up|0|||
156560585|NCT00364182|565142085|FG002|Third Intervention|Lost to Follow-up|1|||
156560586|NCT01162421|565142089|FG000|Overall Study|Did not receive study drug|2|||
156560587|NCT01162421|565142090|FG001|Overall Study|Did not receive study drug|1|||
156560588|NCT01162421|565142089|FG000|Overall Study|Adverse Event|2|||
156560589|NCT01162421|565142090|FG001|Overall Study|Adverse Event|5|||
156560590|NCT01162421|565142089|FG000|Overall Study|Lost to Follow-up|0|||
156560591|NCT01162421|565142090|FG001|Overall Study|Lost to Follow-up|2|||
156560592|NCT01162421|565142089|FG000|Overall Study|Lack of Efficacy|2|||
156560593|NCT01162421|565142090|FG001|Overall Study|Lack of Efficacy|2|||
156560594|NCT01162421|565142089|FG000|Overall Study|Other|2|||
156560595|NCT01162421|565142090|FG001|Overall Study|Other|3|||
156560596|NCT02526550|565142094|FG000|Overall Study|Lost to Follow-up|1|||
156560597|NCT01557166|565142097|FG000|Overall Study|Adverse Event|20|||
156560598|NCT01557166|565142098|FG001|Overall Study|Adverse Event|6|||
156560599|NCT01557166|565142097|FG000|Overall Study|Lack of Efficacy|2|||
156560600|NCT01557166|565142098|FG001|Overall Study|Lack of Efficacy|1|||
156560601|NCT01557166|565142097|FG000|Overall Study|Protocol Violation|8|||
156560602|NCT01557166|565142098|FG001|Overall Study|Protocol Violation|5|||
156560603|NCT01557166|565142097|FG000|Overall Study|Withdrawn consent|12|||
156560604|NCT01557166|565142098|FG001|Overall Study|Withdrawn consent|20|||
156560605|NCT01557166|565142097|FG000|Overall Study|Target dose not tolerated|1|||
156560606|NCT01557166|565142098|FG001|Overall Study|Target dose not tolerated|0|||
156560607|NCT01557166|565142097|FG000|Overall Study|Psychiatric disorder|1|||
156560608|NCT01557166|565142098|FG001|Overall Study|Psychiatric disorder|0|||
156560609|NCT01557166|565142097|FG000|Overall Study|Unclassified|2|||
156560610|NCT01557166|565142098|FG001|Overall Study|Unclassified|5|||
156560611|NCT00946309|565142099|FG000|Overall Study|Protocol Violation|1|||
156560612|NCT00946309|565142100|FG001|Overall Study|Protocol Violation|0|||
156560613|NCT00946309|565142099|FG000|Overall Study|Lost to Follow-up|0|||
156560614|NCT00946309|565142100|FG001|Overall Study|Lost to Follow-up|1|||
156560615|NCT00946309|565142099|FG000|Overall Study|Procedure cancelled/discontinued|0|||
156560616|NCT00946309|565142100|FG001|Overall Study|Procedure cancelled/discontinued|3|||
156560617|NCT01465659|565142104|FG000|Completed 1 Cycle of Treatment|Death|0|||
156560618|NCT01465659|565142105|FG001|Completed 1 Cycle of Treatment|Death|1|||
156560619|NCT01465659|565142106|FG002|Completed 1 Cycle of Treatment|Death|0|||
156560620|NCT01465659|565142107|FG003|Completed 1 Cycle of Treatment|Death|0|||
156560621|NCT01465659|565142104|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
156560622|NCT01465659|565142105|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
156560623|NCT01465659|565142106|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
156560624|NCT01465659|565142107|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
156560625|NCT01465659|565142104|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
156560626|NCT01465659|565142105|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
156560627|NCT01465659|565142106|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
156560628|NCT01465659|565142107|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
156560629|NCT01465659|565142104|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
156560630|NCT01465659|565142105|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
156560631|NCT01465659|565142106|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
156560632|NCT01465659|565142107|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
156560633|NCT01465659|565142104|FG000|Completed Follow for 1 Year|Death|6|||
156560634|NCT01465659|565142105|FG001|Completed Follow for 1 Year|Death|3|||
156560635|NCT01465659|565142106|FG002|Completed Follow for 1 Year|Death|2|||
156560636|NCT01465659|565142107|FG003|Completed Follow for 1 Year|Death|4|||
156560637|NCT02445586|565142113|FG000|Overall Study|Death|14|||
156560638|NCT02445586|565142113|FG000|Overall Study|Withdrawal by Subject|13|||
156560639|NCT02445586|565142113|FG000|Overall Study|Disease Progression|10|||
156560640|NCT02445586|565142113|FG000|Overall Study|Protocol Violation|1|||
156560641|NCT02445586|565142113|FG000|Overall Study|Medical Condition|1|||
156560642|NCT00428597|565142114|FG000|Overall Study|Randomized but not treated|3|||
156560643|NCT00428597|565142115|FG001|Overall Study|Randomized but not treated|3|||
156560644|NCT00428597|565142114|FG000|Overall Study|Objective Progression or Relapse|19|||
156560645|NCT00428597|565142115|FG001|Overall Study|Objective Progression or Relapse|47|||
156560646|NCT00428597|565142114|FG000|Overall Study|Study Terminated by Sponsor|41|||
156560647|NCT00428597|565142115|FG001|Overall Study|Study Terminated by Sponsor|16|||
156560648|NCT00428597|565142114|FG000|Overall Study|Adverse Event|15|||
156560649|NCT00428597|565142115|FG001|Overall Study|Adverse Event|7|||
156560650|NCT00428597|565142114|FG000|Overall Study|Global Deterioration of Health Status|1|||
156560651|NCT00428597|565142115|FG001|Overall Study|Global Deterioration of Health Status|5|||
156560652|NCT00428597|565142114|FG000|Overall Study|Protocol Violation|2|||
156560653|NCT00428597|565142115|FG001|Overall Study|Protocol Violation|1|||
156560654|NCT00428597|565142114|FG000|Overall Study|Withdrawal by Subject|2|||
156560655|NCT00428597|565142115|FG001|Overall Study|Withdrawal by Subject|1|||
156560656|NCT00428597|565142114|FG000|Overall Study|Other|1|||
156560657|NCT00428597|565142115|FG001|Overall Study|Other|1|||
156560658|NCT00428597|565142114|FG000|Overall Study|Lost to Follow-up|0|||
156560659|NCT00428597|565142115|FG001|Overall Study|Lost to Follow-up|1|||
156560660|NCT00428597|565142114|FG000|Overall Study|Pregnancy|1|||
156560661|NCT00428597|565142115|FG001|Overall Study|Pregnancy|0|||
156560662|NCT00428597|565142114|FG000|Overall Study|Death|1|||
156560663|NCT00428597|565142115|FG001|Overall Study|Death|3|||
156560664|NCT02447848|565142116|FG000|Overall Study|Patient discharged|3|||
156560665|NCT02447848|565142116|FG000|Overall Study|Lack of Efficacy|4|||
156560666|NCT02447848|565142116|FG000|Overall Study|Withdrawal by Subject|4|||
156560667|NCT02307370|565142117|FG000|Overall Study|Death|5|||
156560668|NCT02307370|565142117|FG000|Overall Study|Lost to Follow-up|1|||
156560669|NCT02307370|565142117|FG000|Overall Study|Withdrawal by Subject|1|||
156560670|NCT02307370|565142117|FG000|Overall Study|Declined Addendum ICF|6|||
156560671|NCT02307370|565142117|FG000|Overall Study|No response during telephone contact|5|||
156560672|NCT02307370|565142117|FG000|Overall Study|Protocol Violation|1|||
156560673|NCT01506882|565142118|FG000|Overall Study|Lack of Efficacy|4|||
156560674|NCT01506882|565142119|FG001|Overall Study|Lack of Efficacy|3|||
156560675|NCT01506882|565142118|FG000|Overall Study|Lost to Follow-up|1|||
156560676|NCT01506882|565142119|FG001|Overall Study|Lost to Follow-up|0|||
156560677|NCT01506882|565142118|FG000|Overall Study|Withdrawal by Subject|9|||
156560678|NCT01506882|565142119|FG001|Overall Study|Withdrawal by Subject|3|||
156560679|NCT01506882|565142118|FG000|Overall Study|SAE, non-fatal|2|||
156560680|NCT01506882|565142119|FG001|Overall Study|SAE, non-fatal|0|||
156560681|NCT01506882|565142118|FG000|Overall Study|AE, non-serious non-fatal|3|||
156560682|NCT01506882|565142119|FG001|Overall Study|AE, non-serious non-fatal|1|||
156560683|NCT01506882|565142118|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
156560684|NCT01506882|565142119|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156560685|NCT01506882|565142118|FG000|Overall Study|Other Reason|2|||
156560686|NCT01506882|565142119|FG001|Overall Study|Other Reason|0|||
156560687|NCT04025632|565143807|FG000|Overall Study|Adverse Event|1|||
156560688|NCT04025632|565143808|FG001|Overall Study|Adverse Event|1|||
156560689|NCT04025632|565143807|FG000|Overall Study|Withdrawal by Subject|1|||
156560690|NCT04025632|565143808|FG001|Overall Study|Withdrawal by Subject|1|||
156560691|NCT04025632|565143807|FG000|Overall Study|Study Terminated by Sponsor|10|||
156560692|NCT04025632|565143808|FG001|Overall Study|Study Terminated by Sponsor|9|||
156560693|NCT04025632|565143807|FG000|Overall Study|Physician Decision|3|||
156560694|NCT04025632|565143808|FG001|Overall Study|Physician Decision|1|||
156560695|NCT01097629|565143816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
156560696|NCT01097629|565143817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
156560697|NCT01097629|565143818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
156560698|NCT01097629|565143819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156560699|NCT01097629|565143820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156560700|NCT01097629|565143821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156560701|NCT01097629|565143822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156560702|NCT01097629|565143823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156560703|NCT01097629|565143816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
156560704|NCT01097629|565143817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
156560705|NCT01097629|565143818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
156560706|NCT01097629|565143819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156560707|NCT01097629|565143820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156560708|NCT01097629|565143821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156560709|NCT01097629|565143822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156560710|NCT01097629|565143823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156560711|NCT01097629|565143816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
156560712|NCT01097629|565143817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
156560713|NCT01097629|565143818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
156560714|NCT01097629|565143819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156560715|NCT01097629|565143820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156560716|NCT01097629|565143821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156560717|NCT01097629|565143822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156560718|NCT01097629|565143823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156560719|NCT01097629|565143816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
156560720|NCT01097629|565143817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
156560721|NCT01097629|565143818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
156560722|NCT01097629|565143819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156560723|NCT01097629|565143820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156560724|NCT01097629|565143821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156560725|NCT01097629|565143822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156560726|NCT01097629|565143823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156560727|NCT01097629|565143816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
156560728|NCT01097629|565143817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
156560729|NCT01097629|565143818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
156560730|NCT01097629|565143819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156560731|NCT01097629|565143820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156560732|NCT01097629|565143821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156560733|NCT01097629|565143822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156560734|NCT01097629|565143823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156560735|NCT01097629|565143816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
156560736|NCT01097629|565143817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
156560737|NCT01097629|565143818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156560738|NCT01097629|565143819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156560739|NCT01097629|565143820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156560740|NCT01097629|565143821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156560741|NCT01097629|565143822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156517484|NCT00350103|564986298|FG002|Overall Study|Need for prohibited medication|0|||
156517485|NCT00350103|564986296|FG000|Overall Study|Personal reasons|0|||
156517486|NCT00350103|564986297|FG001|Overall Study|Personal reasons|0|||
156517487|NCT00350103|564986298|FG002|Overall Study|Personal reasons|1|||
156517488|NCT00350103|564986296|FG000|Overall Study|Patient stopped feeling pain|1|||
156517489|NCT00350103|564986297|FG001|Overall Study|Patient stopped feeling pain|0|||
156517490|NCT00350103|564986298|FG002|Overall Study|Patient stopped feeling pain|0|||
156517491|NCT00350103|564986296|FG000|Overall Study|PR greater than 250ms|0|||
156517492|NCT00350103|564986297|FG001|Overall Study|PR greater than 250ms|0|||
156517493|NCT00350103|564986298|FG002|Overall Study|PR greater than 250ms|1|||
156517494|NCT00350103|564986296|FG000|Overall Study|Wrong calculation of QT interval|0|||
156517495|NCT00350103|564986297|FG001|Overall Study|Wrong calculation of QT interval|0|||
156517496|NCT00350103|564986298|FG002|Overall Study|Wrong calculation of QT interval|1|||
156517497|NCT00350103|564986296|FG000|Overall Study|Sponsor mistake|1|||
156517498|NCT00350103|564986297|FG001|Overall Study|Sponsor mistake|0|||
156517499|NCT00350103|564986298|FG002|Overall Study|Sponsor mistake|0|||
156517500|NCT00350103|564986296|FG000|Overall Study|Randomization mistake|0|||
156517501|NCT00350103|564986297|FG001|Overall Study|Randomization mistake|1|||
156517502|NCT00350103|564986298|FG002|Overall Study|Randomization mistake|1|||
156517503|NCT00350103|564986296|FG000|Overall Study|Sponsor´s decision|0|||
156517504|NCT00350103|564986297|FG001|Overall Study|Sponsor´s decision|1|||
156517505|NCT00350103|564986298|FG002|Overall Study|Sponsor´s decision|0|||
156517506|NCT00350103|564986296|FG000|Overall Study|Lost, Reason unknown|1|||
156517507|NCT00350103|564986297|FG001|Overall Study|Lost, Reason unknown|1|||
156517508|NCT00350103|564986298|FG002|Overall Study|Lost, Reason unknown|0|||
156517509|NCT02842151|564986299|FG000|Overall Study|Adverse Event|1|||
156517510|NCT02842151|564986299|FG000|Overall Study|Subject moved too far away|1|||
156517511|NCT02559895|564986300|FG000|Overall Study|Adverse Event|3|||
156517512|NCT02559895|564986301|FG001|Overall Study|Adverse Event|3|||
156517513|NCT02559895|564986302|FG002|Overall Study|Adverse Event|2|||
156517514|NCT02559895|564986303|FG003|Overall Study|Adverse Event|1|||
156517515|NCT02559895|564986300|FG000|Overall Study|Lack of Efficacy|2|||
156517516|NCT02559895|564986301|FG001|Overall Study|Lack of Efficacy|3|||
156517517|NCT02559895|564986302|FG002|Overall Study|Lack of Efficacy|2|||
156517518|NCT02559895|564986303|FG003|Overall Study|Lack of Efficacy|8|||
156517519|NCT02559895|564986300|FG000|Overall Study|Lost to Follow-up|22|||
156517520|NCT02559895|564986301|FG001|Overall Study|Lost to Follow-up|16|||
156517521|NCT02559895|564986302|FG002|Overall Study|Lost to Follow-up|12|||
156560742|NCT01097629|565143823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156560743|NCT01097629|565143816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
156560744|NCT01097629|565143817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
156560745|NCT01097629|565143818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
156560746|NCT01097629|565143819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156560747|NCT01097629|565143820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156560748|NCT01097629|565143821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156560749|NCT01097629|565143822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156560750|NCT01097629|565143823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156560751|NCT01097629|565143816|FG000|DB RO Phase|Withdrawal by Subject|0|||
156560752|NCT01097629|565143817|FG001|DB RO Phase|Withdrawal by Subject|0|||
156560753|NCT01097629|565143818|FG002|DB RO Phase|Withdrawal by Subject|0|||
156560754|NCT01097629|565143819|FG003|DB RO Phase|Withdrawal by Subject|0|||
156560755|NCT01097629|565143820|FG004|DB RO Phase|Withdrawal by Subject|0|||
156560756|NCT01097629|565143821|FG005|DB RO Phase|Withdrawal by Subject|0|||
156560757|NCT01097629|565143822|FG006|DB RO Phase|Withdrawal by Subject|0|||
156560758|NCT01097629|565143823|FG007|DB RO Phase|Withdrawal by Subject|1|||
156560759|NCT01097629|565143816|FG000|DB RO Phase|Protocol Violation|0|||
156560760|NCT01097629|565143817|FG001|DB RO Phase|Protocol Violation|0|||
156560761|NCT01097629|565143818|FG002|DB RO Phase|Protocol Violation|0|||
156560762|NCT01097629|565143819|FG003|DB RO Phase|Protocol Violation|1|||
156560763|NCT01097629|565143820|FG004|DB RO Phase|Protocol Violation|0|||
156560764|NCT01097629|565143821|FG005|DB RO Phase|Protocol Violation|1|||
156560765|NCT01097629|565143822|FG006|DB RO Phase|Protocol Violation|1|||
156560766|NCT01097629|565143823|FG007|DB RO Phase|Protocol Violation|0|||
156560767|NCT01097629|565143816|FG000|DB RO Phase|Lost to Follow-up|0|||
156560768|NCT01097629|565143817|FG001|DB RO Phase|Lost to Follow-up|0|||
156560769|NCT01097629|565143818|FG002|DB RO Phase|Lost to Follow-up|0|||
156560770|NCT01097629|565143819|FG003|DB RO Phase|Lost to Follow-up|0|||
156560771|NCT01097629|565143820|FG004|DB RO Phase|Lost to Follow-up|0|||
156560772|NCT01097629|565143821|FG005|DB RO Phase|Lost to Follow-up|0|||
156560773|NCT01097629|565143822|FG006|DB RO Phase|Lost to Follow-up|2|||
156560774|NCT01097629|565143823|FG007|DB RO Phase|Lost to Follow-up|0|||
156560775|NCT00956943|565143824|FG000|Overall Study|Lost to Follow-up|9|||
156560776|NCT00956943|565143825|FG001|Overall Study|Lost to Follow-up|10|||
156560777|NCT02663895|565143826|FG000|Overall Study|Adverse Event|3|||
156560778|NCT02663895|565143826|FG000|Overall Study|Physician Decision|2|||
156560779|NCT02663895|565143826|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
156560780|NCT02663895|565143826|FG000|Overall Study|Withdrawal by Subject|1|||
156560781|NCT01793792|565143827|FG000|Overall Study|Death|5|||
156560782|NCT01793792|565143827|FG000|Overall Study|Lost to Follow-up|5|||
156560783|NCT01793792|565143827|FG000|Overall Study|Withdrawal by Subject|1|||
156560784|NCT01793792|565143827|FG000|Overall Study|Device Not Implanted|1|||
156560785|NCT00851903|565143832|FG000|Overall Study|Withdrawal by Subject|2|||
156560786|NCT06441877|565143833|FG000|Overall Study|Withdrawal by Subject|0|||
156560787|NCT06441877|565143834|FG001|Overall Study|Withdrawal by Subject|2|||
156560788|NCT06441877|565143835|FG002|Overall Study|Withdrawal by Subject|0|||
156560789|NCT06441877|565143836|FG003|Overall Study|Withdrawal by Subject|0|||
156560790|NCT03706365|565143837|FG000|Overall Study|Lost to Follow-up|7|||
156560791|NCT03706365|565143838|FG001|Overall Study|Lost to Follow-up|0|||
156560792|NCT03706365|565143837|FG000|Overall Study|Withdrawal by Subject|17|||
156560793|NCT03706365|565143838|FG001|Overall Study|Withdrawal by Subject|15|||
156560794|NCT03706365|565143837|FG000|Overall Study|On Study Treatment|51|||
156560795|NCT03706365|565143838|FG001|Overall Study|On Study Treatment|51|||
156560796|NCT03116113|565143839|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
156560797|NCT03116113|565143840|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
156560798|NCT03116113|565143841|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
156560799|NCT03116113|565143842|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
156560800|NCT03116113|565143843|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
156560801|NCT03116113|565143844|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
156560802|NCT03116113|565143845|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
156560803|NCT03116113|565143846|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
156560804|NCT03116113|565143847|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
156560805|NCT02159807|565143848|FG000|Overall Study|Adverse Event|0|||
156560806|NCT02159807|565143849|FG001|Overall Study|Adverse Event|0|||
156560807|NCT02159807|565143850|FG002|Overall Study|Adverse Event|1|||
156560808|NCT02159807|565143848|FG000|Overall Study|No CSF|1|||
156560809|NCT02159807|565143849|FG001|Overall Study|No CSF|1|||
156560810|NCT02159807|565143850|FG002|Overall Study|No CSF|1|||
156560811|NCT02159807|565143848|FG000|Overall Study|elevated blood pressure|0|||
156560812|NCT02159807|565143849|FG001|Overall Study|elevated blood pressure|0|||
156560813|NCT02159807|565143850|FG002|Overall Study|elevated blood pressure|1|||
156560814|NCT00950170|565143851|FG000|Overall Study|Parent/Legal Guardian Request|1|||
156560815|NCT00950170|565143851|FG000|Overall Study|Adverse Event|2|||
156560816|NCT00950170|565143851|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
156560817|NCT00600171|565143854|FG000|Overall Study|Adverse Event|0|||
156560818|NCT00600171|565143855|FG001|Overall Study|Adverse Event|1|||
156560819|NCT00600171|565143856|FG002|Overall Study|Adverse Event|0|||
156560820|NCT00600171|565143857|FG003|Overall Study|Adverse Event|0|||
156560821|NCT00600171|565143858|FG004|Overall Study|Adverse Event|1|||
156560822|NCT00600171|565143859|FG005|Overall Study|Adverse Event|0|||
156560823|NCT00600171|565143854|FG000|Overall Study|Lack of Efficacy|9|||
156560824|NCT00600171|565143855|FG001|Overall Study|Lack of Efficacy|12|||
156560825|NCT00600171|565143856|FG002|Overall Study|Lack of Efficacy|3|||
156560826|NCT00600171|565143857|FG003|Overall Study|Lack of Efficacy|5|||
156560827|NCT00600171|565143858|FG004|Overall Study|Lack of Efficacy|4|||
156560828|NCT00600171|565143859|FG005|Overall Study|Lack of Efficacy|0|||
156560829|NCT00600171|565143854|FG000|Overall Study|Protocol Violation|1|||
156560830|NCT00600171|565143855|FG001|Overall Study|Protocol Violation|2|||
156560831|NCT00600171|565143856|FG002|Overall Study|Protocol Violation|0|||
156560832|NCT00600171|565143857|FG003|Overall Study|Protocol Violation|1|||
156560833|NCT00600171|565143858|FG004|Overall Study|Protocol Violation|0|||
156560834|NCT00600171|565143859|FG005|Overall Study|Protocol Violation|0|||
156560835|NCT00600171|565143854|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
156560836|NCT00600171|565143855|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156560837|NCT00600171|565143856|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
156560838|NCT00600171|565143857|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
156560839|NCT00600171|565143858|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
156560840|NCT00600171|565143859|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
156560841|NCT00600171|565143854|FG000|Overall Study|Withdrawal by Subject|3|||
156560842|NCT00600171|565143855|FG001|Overall Study|Withdrawal by Subject|0|||
156560843|NCT00600171|565143856|FG002|Overall Study|Withdrawal by Subject|0|||
156560844|NCT00600171|565143857|FG003|Overall Study|Withdrawal by Subject|1|||
156560845|NCT00600171|565143858|FG004|Overall Study|Withdrawal by Subject|1|||
156560846|NCT00600171|565143859|FG005|Overall Study|Withdrawal by Subject|1|||
156560847|NCT00600171|565143854|FG000|Overall Study|Physician Decision|0|||
156560848|NCT00600171|565143855|FG001|Overall Study|Physician Decision|1|||
156560849|NCT00600171|565143856|FG002|Overall Study|Physician Decision|0|||
156560850|NCT00600171|565143857|FG003|Overall Study|Physician Decision|1|||
156560851|NCT00600171|565143858|FG004|Overall Study|Physician Decision|0|||
156560852|NCT00600171|565143859|FG005|Overall Study|Physician Decision|2|||
156560853|NCT00600171|565143854|FG000|Overall Study|Lost to Follow-up|0|||
156560854|NCT00600171|565143855|FG001|Overall Study|Lost to Follow-up|0|||
156560855|NCT00600171|565143856|FG002|Overall Study|Lost to Follow-up|0|||
156560856|NCT00600171|565143857|FG003|Overall Study|Lost to Follow-up|1|||
156560857|NCT00600171|565143858|FG004|Overall Study|Lost to Follow-up|0|||
156560858|NCT00600171|565143859|FG005|Overall Study|Lost to Follow-up|0|||
156560859|NCT02367521|565143860|FG000|Overall Study|severe headache after intervention|2|||
156560860|NCT02367521|565143861|FG001|Overall Study|severe headache after intervention|0|||
156560861|NCT02367521|565143860|FG000|Overall Study|unable to find transportation|2|||
156560862|NCT02367521|565143861|FG001|Overall Study|unable to find transportation|0|||
156560863|NCT00469612|565143862|FG000|Overall Study|Study terminated before data collected|2|||
156560864|NCT00469612|565143863|FG001|Overall Study|Study terminated before data collected|0|||
156560865|NCT00542191|565143864|FG000|Overall Study|Death|3|||
156560866|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560867|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
156560868|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560869|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560870|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560871|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
156560872|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
156560873|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
156560874|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
156560875|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
156560876|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
156560877|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
156560878|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
156560879|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
156560880|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
156560881|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
156560882|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
156560883|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
156560884|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
156560885|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
156560886|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560887|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560888|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560889|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
156560890|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560891|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
156560892|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
156560893|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
156560894|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
156560895|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
156560896|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
156560897|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
156560898|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
156560899|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
156560900|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
156560901|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
156560902|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
156560903|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
156560904|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
156560905|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
156560906|NCT00289913|565143865|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
156560907|NCT00289913|565143866|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
156560908|NCT00289913|565143867|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
156560909|NCT00289913|565143868|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
156560910|NCT00289913|565143869|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
156560911|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560912|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560913|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
156560914|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560915|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560916|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
156560917|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
156560918|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
156560919|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
156560920|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
156560921|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
156560922|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
156560923|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
156560924|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
156560925|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
156560926|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
156517522|NCT02559895|564986303|FG003|Overall Study|Lost to Follow-up|17|||
156517523|NCT02559895|564986300|FG000|Overall Study|Physician Decision|1|||
156517524|NCT02559895|564986301|FG001|Overall Study|Physician Decision|1|||
156517525|NCT02559895|564986302|FG002|Overall Study|Physician Decision|3|||
156517526|NCT02559895|564986303|FG003|Overall Study|Physician Decision|0|||
156517527|NCT02559895|564986300|FG000|Overall Study|Withdrawal by Subject|16|||
156517528|NCT02559895|564986301|FG001|Overall Study|Withdrawal by Subject|9|||
156517529|NCT02559895|564986302|FG002|Overall Study|Withdrawal by Subject|20|||
156517530|NCT02559895|564986303|FG003|Overall Study|Withdrawal by Subject|9|||
156517531|NCT02559895|564986300|FG000|Overall Study|Study Burden|10|||
156517532|NCT02559895|564986301|FG001|Overall Study|Study Burden|16|||
156517533|NCT02559895|564986302|FG002|Overall Study|Study Burden|12|||
156517534|NCT02559895|564986303|FG003|Overall Study|Study Burden|22|||
156517535|NCT02559895|564986300|FG000|Overall Study|Other|1|||
156517536|NCT02559895|564986301|FG001|Overall Study|Other|5|||
156517537|NCT02559895|564986302|FG002|Overall Study|Other|3|||
156517538|NCT02559895|564986303|FG003|Overall Study|Other|3|||
156517539|NCT00320528|564986304|FG000|Study Period II|Adverse Event|3|||
156517540|NCT00320528|564986305|FG001|Study Period II|Adverse Event|4|||
156517541|NCT00320528|564986306|FG002|Study Period II|Adverse Event|8|||
156517542|NCT00320528|564986304|FG000|Study Period II|Parent/Caregiver Decision|8|||
156517543|NCT00320528|564986305|FG001|Study Period II|Parent/Caregiver Decision|3|||
156517544|NCT00320528|564986306|FG002|Study Period II|Parent/Caregiver Decision|11|||
156517545|NCT00320528|564986304|FG000|Study Period II|Withdrawal by Subject|0|||
156517546|NCT00320528|564986305|FG001|Study Period II|Withdrawal by Subject|1|||
156517547|NCT00320528|564986306|FG002|Study Period II|Withdrawal by Subject|1|||
156517548|NCT00320528|564986304|FG000|Study Period II|Entry Criteria Exclusion|0|||
156560927|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
156560928|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
156560929|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
156560930|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
156560931|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
156560932|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560933|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
156560934|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560935|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560936|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
156560937|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
156560938|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
156560939|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
156560940|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
156560941|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
156560942|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
156560943|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
156560944|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
156560945|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
156560946|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
156560947|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
156560948|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
156560949|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
156560950|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
156560951|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
156560952|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
156560953|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
156560954|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
156560955|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
156560956|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
156560957|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
156560958|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
156560959|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
156517549|NCT00320528|564986305|FG001|Study Period II|Entry Criteria Exclusion|2|||
156517550|NCT00320528|564986306|FG002|Study Period II|Entry Criteria Exclusion|2|||
156517551|NCT00320528|564986304|FG000|Study Period III|Adverse Event|1|||
156517552|NCT00320528|564986305|FG001|Study Period III|Adverse Event|0|||
156517553|NCT00320528|564986306|FG002|Study Period III|Adverse Event|0|||
156517554|NCT00320528|564986304|FG000|Study Period III|Lost to Follow-up|1|||
156517555|NCT00320528|564986305|FG001|Study Period III|Lost to Follow-up|0|||
156517556|NCT00320528|564986306|FG002|Study Period III|Lost to Follow-up|0|||
156517557|NCT00320528|564986304|FG000|Study Period III|Withdrawal by Subject|1|||
156517558|NCT00320528|564986305|FG001|Study Period III|Withdrawal by Subject|1|||
156517559|NCT00320528|564986306|FG002|Study Period III|Withdrawal by Subject|2|||
156517560|NCT00320528|564986304|FG000|Study Period III|Lack of Efficacy|2|||
156517561|NCT00320528|564986305|FG001|Study Period III|Lack of Efficacy|0|||
156517562|NCT00320528|564986306|FG002|Study Period III|Lack of Efficacy|0|||
156517563|NCT00320528|564986304|FG000|Study Period III|Parent/Caregiver Decision|14|||
156517564|NCT00320528|564986305|FG001|Study Period III|Parent/Caregiver Decision|3|||
156517565|NCT00320528|564986306|FG002|Study Period III|Parent/Caregiver Decision|11|||
156517566|NCT00320528|564986304|FG000|Study Period III|Protocol Violation|0|||
156517567|NCT00320528|564986305|FG001|Study Period III|Protocol Violation|1|||
156517568|NCT00320528|564986306|FG002|Study Period III|Protocol Violation|0|||
156517569|NCT00320528|564986304|FG000|Study Period III|Physician Decision|0|||
156517570|NCT00320528|564986305|FG001|Study Period III|Physician Decision|1|||
156517571|NCT00320528|564986306|FG002|Study Period III|Physician Decision|2|||
156517572|NCT00320528|564986304|FG000|Study Period III|Sponsor Decision|0|||
156517573|NCT00320528|564986305|FG001|Study Period III|Sponsor Decision|0|||
156517574|NCT00320528|564986306|FG002|Study Period III|Sponsor Decision|1|||
156517575|NCT00320528|564986304|FG000|Study Period III|Atomoxetine Commercially Available|68|||
156517576|NCT00320528|564986305|FG001|Study Period III|Atomoxetine Commercially Available|25|||
156517577|NCT00320528|564986306|FG002|Study Period III|Atomoxetine Commercially Available|90|||
156517578|NCT04828837|564986307|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
156517579|NCT04828837|564986308|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
156517580|NCT04828837|564986307|FG000|Overall Study|Lost to Follow-up|2|||
156517581|NCT04828837|564986308|FG001|Overall Study|Lost to Follow-up|6|||
156517582|NCT04828837|564986307|FG000|Overall Study|Lack of Efficacy|1|||
156517583|NCT04828837|564986308|FG001|Overall Study|Lack of Efficacy|0|||
156517584|NCT04828837|564986307|FG000|Overall Study|Admitted due to pneumothorax.|1|||
156517585|NCT04828837|564986308|FG001|Overall Study|Admitted due to pneumothorax.|0|||
156517586|NCT04828837|564986307|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
156517587|NCT04828837|564986308|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
156517588|NCT01397422|564986309|FG000|Overall Study|Adverse Event|0|||
156517589|NCT01397422|564986310|FG001|Overall Study|Adverse Event|3|||
156517590|NCT01397422|564986311|FG002|Overall Study|Adverse Event|3|||
156517591|NCT01397422|564986312|FG003|Overall Study|Adverse Event|8|||
156517592|NCT01397422|564986309|FG000|Overall Study|Withdrawal by Subject|1|||
156517593|NCT01397422|564986310|FG001|Overall Study|Withdrawal by Subject|0|||
156517594|NCT01397422|564986311|FG002|Overall Study|Withdrawal by Subject|0|||
156517595|NCT01397422|564986312|FG003|Overall Study|Withdrawal by Subject|0|||
156517596|NCT01397422|564986309|FG000|Overall Study|Increased bradykinesia related to PD|1|||
156517597|NCT01397422|564986310|FG001|Overall Study|Increased bradykinesia related to PD|0|||
156517598|NCT01397422|564986311|FG002|Overall Study|Increased bradykinesia related to PD|0|||
156517599|NCT01397422|564986312|FG003|Overall Study|Increased bradykinesia related to PD|0|||
156517600|NCT00760474|564986313|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
156517601|NCT00760474|564986314|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
156517602|NCT00760474|564986313|FG000|Placebo Washout Period|Other|0|||
156517603|NCT00760474|564986314|FG001|Placebo Washout Period|Other|1|||
156517604|NCT00760474|564986313|FG000|Period 2 (P2)|Lost to Follow-up|1|||
156517605|NCT00760474|564986314|FG001|Period 2 (P2)|Lost to Follow-up|0|||
156517606|NCT00760474|564986313|FG000|Period 2 (P2)|Adverse Event|0|||
156517607|NCT00760474|564986314|FG001|Period 2 (P2)|Adverse Event|1|||
156517608|NCT04664400|564986315|FG000|Overall Study|Withdrawal by Subject|2|||
156517609|NCT01394978|564986321|FG000|Overall Study|Withdrawal by Subject|2|||
156517610|NCT01394978|564986322|FG001|Overall Study|Withdrawal by Subject|4|||
156517611|NCT01394978|564986321|FG000|Overall Study|Lost to Follow-up|13|||
156517612|NCT01394978|564986322|FG001|Overall Study|Lost to Follow-up|20|||
156517613|NCT01394978|564986321|FG000|Overall Study|Death|6|||
156517614|NCT01394978|564986322|FG001|Overall Study|Death|7|||
156517615|NCT01905150|564986330|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
156517616|NCT01905150|564986331|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
156517617|NCT01758900|564986336|FG000|Overall Study|difficulty for further intubation|7|||
156517618|NCT01758900|564986337|FG001|Overall Study|difficulty for further intubation|8|||
156517619|NCT03762200|564986339|FG000|Overall Study|Death|2|||
156517620|NCT04577001|564986340|FG000|Overall Study|Subject became ineligible|0|||
156517621|NCT04577001|564986341|FG001|Overall Study|Subject became ineligible|1|||
156517622|NCT01865747|564986344|FG000|Overall Study (ITT)|Adverse Event|32|||
156517623|NCT01865747|564986345|FG001|Overall Study (ITT)|Adverse Event|31|||
156517624|NCT01865747|564986344|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
156517625|NCT01865747|564986345|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
156517626|NCT01865747|564986344|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
156517627|NCT01865747|564986345|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
156517628|NCT01865747|564986344|FG000|Overall Study (ITT)|Protocol Violation|1|||
156517629|NCT01865747|564986345|FG001|Overall Study (ITT)|Protocol Violation|1|||
156517630|NCT01865747|564986344|FG000|Overall Study (ITT)|Physician Decision|5|||
156517631|NCT01865747|564986345|FG001|Overall Study (ITT)|Physician Decision|2|||
156517632|NCT01865747|564986344|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
156517633|NCT01865747|564986345|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
156517634|NCT01865747|564986344|FG000|Overall Study (ITT)|Sponsor Decision|0|||
156517635|NCT01865747|564986345|FG001|Overall Study (ITT)|Sponsor Decision|1|||
156517636|NCT01865747|564986344|FG000|Overall Study (ITT)|Progressive Disease|122|||
156517637|NCT01865747|564986345|FG001|Overall Study (ITT)|Progressive Disease|158|||
156517638|NCT01865747|564986344|FG000|Overall Study (ITT)|Reason Not Provided|0|||
156517639|NCT01865747|564986345|FG001|Overall Study (ITT)|Reason Not Provided|1|||
156517640|NCT01865747|564986344|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
156517641|NCT01865747|564986345|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
156517642|NCT01865747|564986344|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
156517643|NCT01865747|564986345|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
156517644|NCT01865747|564986344|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
156517645|NCT01865747|564986345|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
156517646|NCT01865747|564986344|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
156517647|NCT01865747|564986345|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
156517648|NCT01865747|564986344|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
156517649|NCT01865747|564986345|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
156517650|NCT01865747|564986344|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
156517651|NCT01865747|564986345|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
156517652|NCT01865747|564986344|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
156517653|NCT01865747|564986345|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
156517654|NCT01865747|564986344|FG000|Primary Intent to Treat (PITT)|Other|0|||
156517655|NCT01865747|564986345|FG001|Primary Intent to Treat (PITT)|Other|1|||
156517656|NCT04625413|564986348|FG000|Overall Study|Hospice|2|||
156517657|NCT04625413|564986348|FG000|Overall Study|Distress|1|||
156517658|NCT04625413|564986348|FG000|Overall Study|Not feeling well|1|||
156517659|NCT00432666|564988322|FG000|Main Period|Adverse Event|1|||
156517660|NCT00432666|564988323|FG001|Main Period|Adverse Event|1|||
156517661|NCT00432666|564988322|FG000|Main Period|Consent Withdrawn|1|||
156517662|NCT00432666|564988323|FG001|Main Period|Consent Withdrawn|0|||
156517663|NCT00432666|564988322|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
156517664|NCT00432666|564988323|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
156517665|NCT00432666|564988322|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
156517666|NCT00432666|564988323|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
156517667|NCT00432666|564988322|FG000|Open-Label Extension Period|Adverse Event|5|||
156517668|NCT00432666|564988323|FG001|Open-Label Extension Period|Adverse Event|0|||
156517669|NCT00432666|564988322|FG000|Open-Label Extension Period|Consent withdrawn|10|||
156517670|NCT00432666|564988323|FG001|Open-Label Extension Period|Consent withdrawn|0|||
156517671|NCT00432666|564988322|FG000|Open-Label Extension Period|Physician Decision|3|||
156517672|NCT00432666|564988323|FG001|Open-Label Extension Period|Physician Decision|0|||
156517673|NCT01506453|564988324|FG000|Overall Study|Withdrawal prior to treatment|0|||
156517674|NCT01506453|564988325|FG001|Overall Study|Withdrawal prior to treatment|2|||
156517675|NCT03694275|564988326|FG000|Overall Study|Adverse Event|0|||
156517676|NCT03694275|564988327|FG001|Overall Study|Adverse Event|1|||
156517677|NCT03694275|564988326|FG000|Overall Study|Reason not Specified|0|||
156517678|NCT03694275|564988327|FG001|Overall Study|Reason not Specified|1|||
156517679|NCT01022268|564988330|FG000|Overall Study|Withdrawal by Subject|1|||
156517680|NCT01022268|564988331|FG001|Overall Study|Withdrawal by Subject|0|||
156517681|NCT01022268|564988330|FG000|Overall Study|Withdrawal by Subject|1|||
156517682|NCT01022268|564988331|FG001|Overall Study|Withdrawal by Subject|0|||
156517683|NCT00734097|564988332|FG000|Screening|Protocol Violation|12|||
156517684|NCT00734097|564988332|FG000|Screening|Withdrawal by Subject|5|||
156517685|NCT00734097|564988332|FG000|Screening|Lost to Follow-up|2|||
156517686|NCT00734097|564988332|FG000|Screening|Unconfirmed pregnancy|1|||
156517687|NCT00734097|564988332|FG000|Open Label|Lost to Follow-up|7|||
156517688|NCT00734097|564988332|FG000|Open Label|Withdrawal by Subject|5|||
156517689|NCT00734097|564988332|FG000|Open Label|Protocol Violation|4|||
156517690|NCT02233543|564988335|FG000|Period 1|Withdrawal by Subject|1|||
156517691|NCT02233543|564988336|FG001|Period 1|Withdrawal by Subject|0|||
156517692|NCT02233543|564988335|FG000|Period 1|Participants required other treatment.|2|||
156517693|NCT02233543|564988336|FG001|Period 1|Participants required other treatment.|3|||
156517694|NCT02233543|564988335|FG000|Period 2|Adverse Event|1|||
156517695|NCT02233543|564988336|FG001|Period 2|Adverse Event|0|||
156517696|NCT02233543|564988335|FG000|Period 2|Participant required other treatment.|0|||
156517697|NCT02233543|564988336|FG001|Period 2|Participant required other treatment.|1|||
156517698|NCT02233543|564988335|FG000|Period 2|COPD exacerbation|1|||
156517699|NCT02233543|564988336|FG001|Period 2|COPD exacerbation|0|||
156517700|NCT01302067|564988337|FG000|Overall Study|Death|0|||
156517701|NCT01302067|564988338|FG001|Overall Study|Death|0|||
156517702|NCT01302067|564988339|FG002|Overall Study|Death|1|||
156517703|NCT01302067|564988337|FG000|Overall Study|Physician Decision|9|||
156517704|NCT01302067|564988338|FG001|Overall Study|Physician Decision|5|||
156517705|NCT01302067|564988339|FG002|Overall Study|Physician Decision|14|||
156517706|NCT01302067|564988337|FG000|Overall Study|Lack of Efficacy|8|||
156517707|NCT01302067|564988338|FG001|Overall Study|Lack of Efficacy|4|||
156517708|NCT01302067|564988339|FG002|Overall Study|Lack of Efficacy|2|||
156517709|NCT01302067|564988337|FG000|Overall Study|Lost to Follow-up|9|||
156517710|NCT01302067|564988338|FG001|Overall Study|Lost to Follow-up|4|||
156517711|NCT01302067|564988339|FG002|Overall Study|Lost to Follow-up|15|||
156517712|NCT01302067|564988337|FG000|Overall Study|Withdrawal by Subject|13|||
156517713|NCT01302067|564988338|FG001|Overall Study|Withdrawal by Subject|6|||
156517714|NCT01302067|564988339|FG002|Overall Study|Withdrawal by Subject|10|||
156517715|NCT01302067|564988337|FG000|Overall Study|Other|1|||
156517716|NCT01302067|564988338|FG001|Overall Study|Other|1|||
156517717|NCT01302067|564988339|FG002|Overall Study|Other|3|||
156517718|NCT01302067|564988337|FG000|Overall Study|Protocol Violation|11|||
156517719|NCT01302067|564988338|FG001|Overall Study|Protocol Violation|0|||
156517720|NCT01302067|564988339|FG002|Overall Study|Protocol Violation|8|||
156517721|NCT01302067|564988337|FG000|Overall Study|Adverse Event|27|||
156517722|NCT01302067|564988338|FG001|Overall Study|Adverse Event|14|||
156517723|NCT01302067|564988339|FG002|Overall Study|Adverse Event|45|||
156517724|NCT00603304|564988340|FG000|Overall Study|Lost to Follow-up|5|||
156517725|NCT00603304|564988341|FG001|Overall Study|Lost to Follow-up|7|||
156517726|NCT00603304|564988340|FG000|Overall Study|Withdrawal by Subject|8|||
156517727|NCT00603304|564988341|FG001|Overall Study|Withdrawal by Subject|5|||
156517728|NCT00603304|564988340|FG000|Overall Study|Protocol Violation|1|||
156517729|NCT00603304|564988341|FG001|Overall Study|Protocol Violation|0|||
156517730|NCT00603304|564988340|FG000|Overall Study|Adverse Event|4|||
156517731|NCT00603304|564988341|FG001|Overall Study|Adverse Event|2|||
156517732|NCT00603304|564988340|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
156517733|NCT00603304|564988341|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
156560960|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
156517734|NCT00603304|564988340|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
156517735|NCT00603304|564988341|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
156517736|NCT00603304|564988340|FG000|Overall Study|Exclusionary Medication|2|||
156517737|NCT00603304|564988341|FG001|Overall Study|Exclusionary Medication|3|||
156517738|NCT00603304|564988340|FG000|Overall Study|Non-Compliant|0|||
156517739|NCT00603304|564988341|FG001|Overall Study|Non-Compliant|1|||
156517740|NCT00603304|564988340|FG000|Overall Study|Moved Away|0|||
156517741|NCT00603304|564988341|FG001|Overall Study|Moved Away|2|||
156517742|NCT00603304|564988340|FG000|Overall Study|Other|2|||
156517743|NCT00603304|564988341|FG001|Overall Study|Other|0|||
156517744|NCT00603304|564988340|FG000|Overall Study|Patient Decision|2|||
156517745|NCT00603304|564988341|FG001|Overall Study|Patient Decision|0|||
156517746|NCT00266227|564988342|FG000|Initial Treatment|Adverse Event|0|||
156517747|NCT00266227|564988343|FG001|Initial Treatment|Adverse Event|0|||
156517748|NCT00266227|564988344|FG002|Initial Treatment|Adverse Event|13|||
156517749|NCT00266227|564988342|FG000|Initial Treatment|Lost to Follow-up|0|||
156517750|NCT00266227|564988343|FG001|Initial Treatment|Lost to Follow-up|0|||
156517751|NCT00266227|564988344|FG002|Initial Treatment|Lost to Follow-up|6|||
156517752|NCT00266227|564988342|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
156517753|NCT00266227|564988343|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
156517754|NCT00266227|564988344|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
156517755|NCT00266227|564988342|FG000|Initial Treatment|Physician decision to withdraw|0|||
156517756|NCT00266227|564988343|FG001|Initial Treatment|Physician decision to withdraw|0|||
156517757|NCT00266227|564988344|FG002|Initial Treatment|Physician decision to withdraw|12|||
156517758|NCT00266227|564988342|FG000|Initial Treatment|Pregnancy|0|||
156517759|NCT00266227|564988343|FG001|Initial Treatment|Pregnancy|0|||
156517760|NCT00266227|564988344|FG002|Initial Treatment|Pregnancy|1|||
156517761|NCT00266227|564988342|FG000|Retreatment: Up to Week 48|Death|1|||
156517762|NCT00266227|564988343|FG001|Retreatment: Up to Week 48|Death|0|||
156517763|NCT00266227|564988344|FG002|Retreatment: Up to Week 48|Death|0|||
156517764|NCT00266227|564988342|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
156517765|NCT00266227|564988343|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
156517766|NCT00266227|564988344|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
156517767|NCT00266227|564988342|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
156517768|NCT00266227|564988343|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
156517769|NCT00266227|564988344|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
156517770|NCT00266227|564988342|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
156517771|NCT00266227|564988343|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
156560961|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
156560962|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
156560963|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
156560964|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
156560965|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
156560966|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
156560967|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
156560968|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
156560969|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
156560970|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
156560971|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
156560972|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
156560973|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
156560974|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
156560975|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
156560976|NCT00289913|565143865|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
156560977|NCT00289913|565143866|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
156560978|NCT00289913|565143867|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
156560979|NCT00289913|565143868|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
156517772|NCT00266227|564988344|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
156517773|NCT00266227|564988342|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
156517774|NCT00266227|564988343|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
156517775|NCT00266227|564988344|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
156517776|NCT00266227|564988342|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
156517777|NCT00266227|564988343|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
156560980|NCT00289913|565143869|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
156560981|NCT00289913|565143865|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156517778|NCT00266227|564988344|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
156560982|NCT00289913|565143866|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
156517779|NCT00266227|564988342|FG000|Retreatment: Week 48 to Week 72|Death|1|||
156517780|NCT00266227|564988343|FG001|Retreatment: Week 48 to Week 72|Death|1|||
156517781|NCT00266227|564988344|FG002|Retreatment: Week 48 to Week 72|Death|0|||
156517782|NCT00266227|564988342|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
156517783|NCT00266227|564988343|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
156517784|NCT00266227|564988344|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
156517785|NCT00266227|564988342|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
156517786|NCT00266227|564988343|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
156517787|NCT00266227|564988344|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
156517788|NCT00266227|564988342|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
156517789|NCT00266227|564988343|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
156517790|NCT00266227|564988344|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
156517791|NCT00266227|564988342|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
156517792|NCT00266227|564988343|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
156517793|NCT00266227|564988344|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
156517794|NCT01775475|564988348|FG000|Overall Study|Death|3|||
156517795|NCT01775475|564988349|FG001|Overall Study|Death|3|||
156517796|NCT02074553|564988356|FG000|Intervention Period 1|Family Emergency|0|||
156517797|NCT02074553|564988357|FG001|Intervention Period 1|Family Emergency|0|||
156517798|NCT02074553|564988358|FG002|Intervention Period 1|Family Emergency|0|||
156517799|NCT02074553|564988359|FG003|Intervention Period 1|Family Emergency|1|||
156517800|NCT02074553|564988360|FG004|Intervention Period 1|Family Emergency|0|||
156517801|NCT02074553|564988361|FG005|Intervention Period 1|Family Emergency|0|||
156517802|NCT02074553|564988362|FG006|Intervention Period 1|Family Emergency|0|||
156517803|NCT02074553|564988363|FG007|Intervention Period 1|Family Emergency|0|||
156517804|NCT02074553|564988356|FG000|Washout Period 1|Adverse Event|1|||
156517805|NCT02074553|564988357|FG001|Washout Period 1|Adverse Event|0|||
156517806|NCT02074553|564988358|FG002|Washout Period 1|Adverse Event|0|||
156517807|NCT02074553|564988359|FG003|Washout Period 1|Adverse Event|0|||
156517808|NCT02074553|564988360|FG004|Washout Period 1|Adverse Event|0|||
156517809|NCT02074553|564988361|FG005|Washout Period 1|Adverse Event|0|||
156517810|NCT02074553|564988362|FG006|Washout Period 1|Adverse Event|0|||
156517811|NCT02074553|564988363|FG007|Washout Period 1|Adverse Event|0|||
156517812|NCT02074553|564988356|FG000|Washout Period 1|Physician Decision|0|||
156517813|NCT02074553|564988357|FG001|Washout Period 1|Physician Decision|0|||
156517814|NCT02074553|564988358|FG002|Washout Period 1|Physician Decision|0|||
156517815|NCT02074553|564988359|FG003|Washout Period 1|Physician Decision|1|||
156517816|NCT02074553|564988360|FG004|Washout Period 1|Physician Decision|0|||
156517817|NCT02074553|564988361|FG005|Washout Period 1|Physician Decision|0|||
156517818|NCT02074553|564988362|FG006|Washout Period 1|Physician Decision|0|||
156517819|NCT02074553|564988363|FG007|Washout Period 1|Physician Decision|0|||
156517820|NCT02074553|564988356|FG000|Washout Period 1|Other|0|||
156517821|NCT02074553|564988357|FG001|Washout Period 1|Other|0|||
156517822|NCT02074553|564988358|FG002|Washout Period 1|Other|0|||
156517823|NCT02074553|564988359|FG003|Washout Period 1|Other|0|||
156517824|NCT02074553|564988360|FG004|Washout Period 1|Other|0|||
156517825|NCT02074553|564988361|FG005|Washout Period 1|Other|1|||
156517826|NCT02074553|564988362|FG006|Washout Period 1|Other|0|||
156517827|NCT02074553|564988363|FG007|Washout Period 1|Other|0|||
156517828|NCT02074553|564988356|FG000|Washout Period 2|Adverse Event|0|||
156517829|NCT02074553|564988357|FG001|Washout Period 2|Adverse Event|0|||
156517830|NCT02074553|564988358|FG002|Washout Period 2|Adverse Event|0|||
156517831|NCT02074553|564988359|FG003|Washout Period 2|Adverse Event|0|||
156517832|NCT02074553|564988360|FG004|Washout Period 2|Adverse Event|0|||
156517833|NCT02074553|564988361|FG005|Washout Period 2|Adverse Event|0|||
156517834|NCT02074553|564988362|FG006|Washout Period 2|Adverse Event|1|||
156517835|NCT02074553|564988363|FG007|Washout Period 2|Adverse Event|0|||
156517836|NCT02074553|564988356|FG000|Washout Period 2|Physician Decision|0|||
156517837|NCT02074553|564988357|FG001|Washout Period 2|Physician Decision|0|||
156517838|NCT02074553|564988358|FG002|Washout Period 2|Physician Decision|0|||
156517839|NCT02074553|564988359|FG003|Washout Period 2|Physician Decision|0|||
156517840|NCT02074553|564988360|FG004|Washout Period 2|Physician Decision|0|||
156517841|NCT02074553|564988361|FG005|Washout Period 2|Physician Decision|1|||
156517842|NCT02074553|564988362|FG006|Washout Period 2|Physician Decision|0|||
156517843|NCT02074553|564988363|FG007|Washout Period 2|Physician Decision|0|||
156517844|NCT02074553|564988356|FG000|Washout Period 2|Lost to Follow-up|0|||
156517845|NCT02074553|564988357|FG001|Washout Period 2|Lost to Follow-up|0|||
156517846|NCT02074553|564988358|FG002|Washout Period 2|Lost to Follow-up|1|||
156517847|NCT02074553|564988359|FG003|Washout Period 2|Lost to Follow-up|0|||
156517848|NCT02074553|564988360|FG004|Washout Period 2|Lost to Follow-up|0|||
156517849|NCT02074553|564988361|FG005|Washout Period 2|Lost to Follow-up|0|||
156517850|NCT02074553|564988362|FG006|Washout Period 2|Lost to Follow-up|0|||
156517851|NCT02074553|564988363|FG007|Washout Period 2|Lost to Follow-up|0|||
156517852|NCT02074553|564988356|FG000|Washout Period 3|Physician Decision|0|||
156517853|NCT02074553|564988357|FG001|Washout Period 3|Physician Decision|0|||
156517854|NCT02074553|564988358|FG002|Washout Period 3|Physician Decision|0|||
156517855|NCT02074553|564988359|FG003|Washout Period 3|Physician Decision|0|||
156517856|NCT02074553|564988360|FG004|Washout Period 3|Physician Decision|0|||
156517857|NCT02074553|564988361|FG005|Washout Period 3|Physician Decision|0|||
156517858|NCT02074553|564988362|FG006|Washout Period 3|Physician Decision|0|||
156517859|NCT02074553|564988363|FG007|Washout Period 3|Physician Decision|1|||
156517860|NCT00194987|564988364|FG000|Overall Study|Withdrawal by Subject|0|||
156517861|NCT00194987|564988365|FG001|Overall Study|Withdrawal by Subject|3|||
156517862|NCT01664598|564988366|FG000|Overall Study|Sponsor Decision|1|||
156517863|NCT01664598|564988366|FG000|Overall Study|Withdrawal of Informed Consent|4|||
156517864|NCT01664598|564988366|FG000|Overall Study|Adverse Event|1|||
156517865|NCT02342743|564988367|FG000|Baseline Period|Withdrawal by Subject|3|||
156517866|NCT02342743|564988367|FG000|Baseline Period|Lost to Follow-up|2|||
156517867|NCT02342743|564988367|FG000|Baseline Period|Change in prophylactic medication|3|||
156517868|NCT02342743|564988367|FG000|Baseline Period|Screening failure regarding baseline|7|||
156517869|NCT02342743|564988367|FG000|Treatment Period|Withdrawal by Subject|2|||
156517870|NCT02342743|564988367|FG000|Treatment Period|Lost to Follow-up|8|||
156560983|NCT00289913|565143867|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560984|NCT00289913|565143868|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560985|NCT00289913|565143869|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156560986|NCT00289913|565143865|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
156560987|NCT00289913|565143866|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
156560988|NCT00289913|565143867|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
156560989|NCT00289913|565143868|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
156560990|NCT00289913|565143869|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
156560991|NCT00289913|565143865|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
156560992|NCT00289913|565143866|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
156560993|NCT00289913|565143867|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
156560994|NCT00289913|565143868|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
156560995|NCT00289913|565143869|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
156560996|NCT00289913|565143865|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560997|NCT00289913|565143866|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560998|NCT00289913|565143867|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156560999|NCT00289913|565143868|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
156561000|NCT00289913|565143869|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
156561001|NCT00289913|565143865|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
156561002|NCT00289913|565143866|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
156561003|NCT00289913|565143867|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
156561004|NCT00289913|565143868|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
156561005|NCT00289913|565143869|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
156561006|NCT00289913|565143865|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
156561007|NCT00289913|565143866|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
156561008|NCT00289913|565143867|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
156561009|NCT00289913|565143868|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
156561010|NCT00289913|565143869|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
156561011|NCT00289913|565143865|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
156561012|NCT00289913|565143866|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
156561013|NCT00289913|565143867|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
156561014|NCT00289913|565143868|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
156561015|NCT00289913|565143869|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
156561016|NCT00289913|565143865|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
156561017|NCT00289913|565143866|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
156561018|NCT00289913|565143867|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
156561019|NCT00289913|565143868|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
156561020|NCT00289913|565143869|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
156561021|NCT03822884|565143870|FG000|Overall Study|Withdrawal by Subject|0|||
156517871|NCT02342743|564988367|FG000|Treatment Period|Change in prophylactic medication|1|||
156517872|NCT00686725|564988368|FG000|Overall Study|Adverse Event|1|||
156517873|NCT00686725|564988369|FG001|Overall Study|Adverse Event|1|||
156517874|NCT00686725|564988368|FG000|Overall Study|Progressive Disease|17|||
156517875|NCT00686725|564988369|FG001|Overall Study|Progressive Disease|23|||
156561022|NCT03822884|565143871|FG001|Overall Study|Withdrawal by Subject|0|||
156561023|NCT03822884|565143872|FG002|Overall Study|Withdrawal by Subject|0|||
156561024|NCT03822884|565143873|FG003|Overall Study|Withdrawal by Subject|0|||
156561025|NCT03822884|565143874|FG004|Overall Study|Withdrawal by Subject|1|||
156561026|NCT03822884|565143875|FG005|Overall Study|Withdrawal by Subject|0|||
156561027|NCT02357420|565143882|FG000|Overall Study|Adverse Event|3|||
156517876|NCT00686725|564988368|FG000|Overall Study|Lost to Follow-up|7|||
156517877|NCT00686725|564988369|FG001|Overall Study|Lost to Follow-up|5|||
156517878|NCT00686725|564988368|FG000|Overall Study|Death|6|||
156517879|NCT00686725|564988369|FG001|Overall Study|Death|3|||
156517880|NCT00686725|564988368|FG000|Overall Study|Withdrawal by Subject|13|||
156517881|NCT00686725|564988369|FG001|Overall Study|Withdrawal by Subject|4|||
156517882|NCT00686725|564988368|FG000|Overall Study|Protocol Violation|1|||
156517883|NCT00686725|564988369|FG001|Overall Study|Protocol Violation|3|||
156517884|NCT00686725|564988368|FG000|Overall Study|Other|1|||
156517885|NCT00686725|564988369|FG001|Overall Study|Other|3|||
156517886|NCT03602066|564988370|FG000|Overall Study|Withdrawal by Subject|2|||
156517887|NCT03602066|564988371|FG001|Overall Study|Withdrawal by Subject|0|||
156517888|NCT03602066|564988370|FG000|Overall Study|Physician Decision|1|||
156517889|NCT03602066|564988371|FG001|Overall Study|Physician Decision|0|||
156517890|NCT00092495|564988372|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
156517891|NCT00092495|564988373|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
156517892|NCT00092495|564988374|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
156517893|NCT00092495|564988375|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
156517894|NCT00092495|564988376|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
156517895|NCT00092495|564988372|FG000|Base Study Vaccination Period|Extended|0|||
156517896|NCT00092495|564988373|FG001|Base Study Vaccination Period|Extended|0|||
156517897|NCT00092495|564988374|FG002|Base Study Vaccination Period|Extended|0|||
156517898|NCT00092495|564988375|FG003|Base Study Vaccination Period|Extended|1|||
156517899|NCT00092495|564988376|FG004|Base Study Vaccination Period|Extended|0|||
156517900|NCT00092495|564988372|FG000|Base Study Vaccination Period|*Clinical AE|1|||
156517901|NCT00092495|564988373|FG001|Base Study Vaccination Period|*Clinical AE|0|||
156517902|NCT00092495|564988374|FG002|Base Study Vaccination Period|*Clinical AE|1|||
156517903|NCT00092495|564988375|FG003|Base Study Vaccination Period|*Clinical AE|2|||
156517904|NCT00092495|564988376|FG004|Base Study Vaccination Period|*Clinical AE|0|||
156517905|NCT00092495|564988372|FG000|Base Study Vaccination Period|*Other reasons|1|||
156517906|NCT00092495|564988373|FG001|Base Study Vaccination Period|*Other reasons|0|||
156517907|NCT00092495|564988374|FG002|Base Study Vaccination Period|*Other reasons|0|||
156517908|NCT00092495|564988375|FG003|Base Study Vaccination Period|*Other reasons|1|||
156517909|NCT00092495|564988376|FG004|Base Study Vaccination Period|*Other reasons|0|||
156517910|NCT00092495|564988372|FG000|Base Study Vaccination Period|*Pregnancy|0|||
156517911|NCT00092495|564988373|FG001|Base Study Vaccination Period|*Pregnancy|2|||
156517912|NCT00092495|564988374|FG002|Base Study Vaccination Period|*Pregnancy|5|||
156517913|NCT00092495|564988375|FG003|Base Study Vaccination Period|*Pregnancy|7|||
156517914|NCT00092495|564988376|FG004|Base Study Vaccination Period|*Pregnancy|0|||
156517915|NCT00092495|564988372|FG000|Base Study Vaccination Period|Adverse Event|1|||
156517916|NCT00092495|564988373|FG001|Base Study Vaccination Period|Adverse Event|0|||
156517917|NCT00092495|564988374|FG002|Base Study Vaccination Period|Adverse Event|0|||
156517918|NCT00092495|564988375|FG003|Base Study Vaccination Period|Adverse Event|3|||
156517919|NCT00092495|564988376|FG004|Base Study Vaccination Period|Adverse Event|0|||
156517920|NCT00092495|564988372|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
156517921|NCT00092495|564988373|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
156517922|NCT00092495|564988374|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
156517923|NCT00092495|564988375|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
156517924|NCT00092495|564988376|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
156517925|NCT00092495|564988372|FG000|Base Study Vaccination Period|Moved|3|||
156517926|NCT00092495|564988373|FG001|Base Study Vaccination Period|Moved|1|||
156517927|NCT00092495|564988374|FG002|Base Study Vaccination Period|Moved|2|||
156517928|NCT00092495|564988375|FG003|Base Study Vaccination Period|Moved|2|||
156517929|NCT00092495|564988376|FG004|Base Study Vaccination Period|Moved|0|||
156517930|NCT00092495|564988372|FG000|Base Study Vaccination Period|Other|1|||
156517931|NCT00092495|564988373|FG001|Base Study Vaccination Period|Other|1|||
156517932|NCT00092495|564988374|FG002|Base Study Vaccination Period|Other|0|||
156517933|NCT00092495|564988375|FG003|Base Study Vaccination Period|Other|2|||
156517934|NCT00092495|564988376|FG004|Base Study Vaccination Period|Other|0|||
156517935|NCT00092495|564988372|FG000|Base Study Vaccination Period|Pregnancy|2|||
156517936|NCT00092495|564988373|FG001|Base Study Vaccination Period|Pregnancy|0|||
156517937|NCT00092495|564988374|FG002|Base Study Vaccination Period|Pregnancy|0|||
156517938|NCT00092495|564988375|FG003|Base Study Vaccination Period|Pregnancy|0|||
156517939|NCT00092495|564988376|FG004|Base Study Vaccination Period|Pregnancy|0|||
156517940|NCT00092495|564988372|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
156517941|NCT00092495|564988373|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
156517942|NCT00092495|564988374|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
156517943|NCT00092495|564988375|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
156517944|NCT00092495|564988376|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
156517945|NCT00092495|564988372|FG000|Base Study Vaccination Period|Protocol Violation|1|||
156517946|NCT00092495|564988373|FG001|Base Study Vaccination Period|Protocol Violation|0|||
156517947|NCT00092495|564988374|FG002|Base Study Vaccination Period|Protocol Violation|0|||
156517948|NCT00092495|564988375|FG003|Base Study Vaccination Period|Protocol Violation|0|||
156517949|NCT00092495|564988376|FG004|Base Study Vaccination Period|Protocol Violation|0|||
156517950|NCT00092495|564988372|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
156517951|NCT00092495|564988373|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
156517952|NCT00092495|564988374|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
156561028|NCT02357420|565143883|FG001|Overall Study|Adverse Event|3|||
156561029|NCT02357420|565143884|FG002|Overall Study|Adverse Event|8|||
156561030|NCT02357420|565143885|FG003|Overall Study|Adverse Event|9|||
156561031|NCT02357420|565143882|FG000|Overall Study|Investigator Decision|1|||
156561032|NCT02357420|565143883|FG001|Overall Study|Investigator Decision|0|||
156561033|NCT02357420|565143884|FG002|Overall Study|Investigator Decision|0|||
156561034|NCT02357420|565143885|FG003|Overall Study|Investigator Decision|0|||
156561035|NCT02357420|565143882|FG000|Overall Study|Prohibited Medication|1|||
156561036|NCT02357420|565143883|FG001|Overall Study|Prohibited Medication|1|||
156561037|NCT02357420|565143884|FG002|Overall Study|Prohibited Medication|0|||
156561038|NCT02357420|565143885|FG003|Overall Study|Prohibited Medication|0|||
156561039|NCT02357420|565143882|FG000|Overall Study|Protocol Non-compliance|0|||
156561040|NCT02357420|565143883|FG001|Overall Study|Protocol Non-compliance|0|||
156561041|NCT02357420|565143884|FG002|Overall Study|Protocol Non-compliance|0|||
156561042|NCT02357420|565143885|FG003|Overall Study|Protocol Non-compliance|1|||
156561043|NCT02357420|565143882|FG000|Overall Study|Withdrawn Consent|4|||
156561044|NCT02357420|565143883|FG001|Overall Study|Withdrawn Consent|8|||
156561045|NCT02357420|565143884|FG002|Overall Study|Withdrawn Consent|6|||
156561046|NCT02357420|565143885|FG003|Overall Study|Withdrawn Consent|6|||
156561047|NCT02357420|565143882|FG000|Overall Study|Lost to Follow-up|3|||
156561048|NCT02357420|565143883|FG001|Overall Study|Lost to Follow-up|0|||
156561049|NCT02357420|565143884|FG002|Overall Study|Lost to Follow-up|2|||
156561050|NCT02357420|565143885|FG003|Overall Study|Lost to Follow-up|3|||
156561051|NCT03617705|565143886|FG000|Overall Study|Withdrawal by Subject|2|||
156561052|NCT03617705|565143886|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
156561053|NCT03617705|565143886|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
156561054|NCT00214461|565143887|FG000|Overall Study|Adverse Event|0|||
156561055|NCT00214461|565143888|FG001|Overall Study|Adverse Event|0|||
156561056|NCT00214461|565143889|FG002|Overall Study|Adverse Event|1|||
156561057|NCT00214461|565143890|FG003|Overall Study|Adverse Event|1|||
156561058|NCT00214461|565143887|FG000|Overall Study|Withdrawal by Subject|0|||
156561059|NCT00214461|565143888|FG001|Overall Study|Withdrawal by Subject|0|||
156561060|NCT00214461|565143889|FG002|Overall Study|Withdrawal by Subject|1|||
156561061|NCT00214461|565143890|FG003|Overall Study|Withdrawal by Subject|0|||
156561062|NCT02411448|565143892|FG000|Overall Study|Withdrawal by Subject|1|||
156561063|NCT02411448|565143893|FG001|Overall Study|Withdrawal by Subject|14|||
156561064|NCT02411448|565143894|FG002|Overall Study|Withdrawal by Subject|9|||
156561065|NCT02411448|565143892|FG000|Overall Study|Other|0|||
156561066|NCT02411448|565143893|FG001|Overall Study|Other|2|||
156561067|NCT02411448|565143894|FG002|Overall Study|Other|0|||
156561068|NCT02411448|565143892|FG000|Overall Study|Did not receive study treatment|0|||
156561069|NCT02411448|565143893|FG001|Overall Study|Did not receive study treatment|3|||
156561070|NCT02411448|565143894|FG002|Overall Study|Did not receive study treatment|0|||
156561071|NCT02411448|565143892|FG000|Overall Study|Alive on study treatment|3|||
156561072|NCT02411448|565143893|FG001|Overall Study|Alive on study treatment|64|||
156561073|NCT02411448|565143894|FG002|Overall Study|Alive on study treatment|43|||
156561074|NCT02631538|565143897|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
156561075|NCT02631538|565143898|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
156561076|NCT02631538|565143899|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
156561077|NCT02631538|565143900|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
156561078|NCT02631538|565143897|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
156561079|NCT02631538|565143898|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
156561080|NCT02631538|565143899|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
156561081|NCT02631538|565143900|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
156561082|NCT02631538|565143897|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
156517953|NCT00092495|564988375|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
156517954|NCT00092495|564988376|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
156517955|NCT00092495|564988372|FG000|Base Study Follow-up Period|Extended|0|||
156517956|NCT00092495|564988373|FG001|Base Study Follow-up Period|Extended|0|||
156517957|NCT00092495|564988374|FG002|Base Study Follow-up Period|Extended|1|||
156517958|NCT00092495|564988375|FG003|Base Study Follow-up Period|Extended|2|||
156517959|NCT00092495|564988376|FG004|Base Study Follow-up Period|Extended|0|||
156517960|NCT00092495|564988372|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
156561083|NCT02631538|565143898|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
156561084|NCT02631538|565143899|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
156561085|NCT02631538|565143900|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
156561086|NCT02631538|565143897|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
156561087|NCT02631538|565143898|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
156561088|NCT02631538|565143899|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
156561089|NCT02631538|565143900|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
156561090|NCT02631538|565143897|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
156517961|NCT00092495|564988373|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
156517962|NCT00092495|564988374|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
156517963|NCT00092495|564988375|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
156517964|NCT00092495|564988376|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
156517965|NCT00092495|564988372|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
156517966|NCT00092495|564988373|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
156561091|NCT02631538|565143898|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
156561092|NCT02631538|565143899|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
156561093|NCT02631538|565143900|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
156561094|NCT02631538|565143897|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
156561095|NCT02631538|565143898|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
156561096|NCT02631538|565143899|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
156561097|NCT02631538|565143900|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
156561098|NCT01688050|565143901|FG000|Overall Study|Death|7|||
156561099|NCT01688050|565143901|FG000|Overall Study|Conversion to open repair|1|||
156561100|NCT01688050|565143901|FG000|Overall Study|Lost to Follow-up|13|||
156561101|NCT01688050|565143901|FG000|Overall Study|Withdrawal by Subject|10|||
156561102|NCT00440726|565143902|FG000|Phase 1|Dose-Limiting Toxicity|0|||
156561103|NCT00440726|565143903|FG001|Phase 1|Dose-Limiting Toxicity|1|||
156561104|NCT00440726|565143904|FG002|Phase 1|Dose-Limiting Toxicity|0|||
156561105|NCT00440726|565143902|FG000|Phase 1|Physician Decision|1|||
156561106|NCT00440726|565143903|FG001|Phase 1|Physician Decision|0|||
156561107|NCT00440726|565143904|FG002|Phase 1|Physician Decision|0|||
156561108|NCT00440726|565143902|FG000|Phase 2|Death|0|||
156561109|NCT00440726|565143903|FG001|Phase 2|Death|0|||
156561110|NCT00440726|565143904|FG002|Phase 2|Death|1|||
156561111|NCT00440726|565143902|FG000|Phase 2|Adverse Event|0|||
156561112|NCT00440726|565143903|FG001|Phase 2|Adverse Event|0|||
156561113|NCT00440726|565143904|FG002|Phase 2|Adverse Event|1|||
156561114|NCT01554579|565143905|FG000|Overall Study|Adverse Event|6|||
156561115|NCT01554579|565143906|FG001|Overall Study|Adverse Event|25|||
156517967|NCT00092495|564988374|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
156517968|NCT00092495|564988375|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
156517969|NCT00092495|564988376|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
156517970|NCT00938470|564988381|FG000|Overall Study|Disease Progression|3|||
156517971|NCT00938470|564988382|FG001|Overall Study|Disease Progression|0|||
156517972|NCT00938470|564988381|FG000|Overall Study|Alternate Treatment|1|||
156517973|NCT00938470|564988382|FG001|Overall Study|Alternate Treatment|0|||
156517974|NCT00938470|564988381|FG000|Overall Study|Death|3|||
156517975|NCT00938470|564988382|FG001|Overall Study|Death|2|||
156517976|NCT00938470|564988381|FG000|Overall Study|Other Reason|0|||
156517977|NCT00938470|564988382|FG001|Overall Study|Other Reason|1|||
156517978|NCT01097707|564988395|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
156517979|NCT01097707|564988396|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
156517980|NCT01097707|564988397|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
156517981|NCT01097707|564988398|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
156517982|NCT01097707|564988399|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
156517983|NCT01097707|564988395|FG000|Overall Study|Adverse Event|4|||
156517984|NCT01097707|564988396|FG001|Overall Study|Adverse Event|2|||
156517985|NCT01097707|564988397|FG002|Overall Study|Adverse Event|3|||
156517986|NCT01097707|564988398|FG003|Overall Study|Adverse Event|1|||
156517987|NCT01097707|564988399|FG004|Overall Study|Adverse Event|3|||
156517988|NCT01097707|564988395|FG000|Overall Study|Entry Criteria Not Met|2|||
156517989|NCT01097707|564988396|FG001|Overall Study|Entry Criteria Not Met|1|||
156517990|NCT01097707|564988397|FG002|Overall Study|Entry Criteria Not Met|1|||
156517991|NCT01097707|564988398|FG003|Overall Study|Entry Criteria Not Met|0|||
156517992|NCT01097707|564988399|FG004|Overall Study|Entry Criteria Not Met|1|||
156517993|NCT01097707|564988395|FG000|Overall Study|Lack of Efficacy|1|||
156517994|NCT01097707|564988396|FG001|Overall Study|Lack of Efficacy|0|||
156517995|NCT01097707|564988397|FG002|Overall Study|Lack of Efficacy|0|||
156517996|NCT01097707|564988398|FG003|Overall Study|Lack of Efficacy|1|||
156517997|NCT01097707|564988399|FG004|Overall Study|Lack of Efficacy|0|||
156517998|NCT01097707|564988395|FG000|Overall Study|Lost to Follow-up|1|||
156517999|NCT01097707|564988396|FG001|Overall Study|Lost to Follow-up|1|||
156518000|NCT01097707|564988397|FG002|Overall Study|Lost to Follow-up|2|||
156518001|NCT01097707|564988398|FG003|Overall Study|Lost to Follow-up|0|||
156561116|NCT01554579|565143905|FG000|Overall Study|Lack of Efficacy|2|||
156561117|NCT01554579|565143906|FG001|Overall Study|Lack of Efficacy|1|||
156561118|NCT01554579|565143905|FG000|Overall Study|Withdrawal by Subject|2|||
156561119|NCT01554579|565143906|FG001|Overall Study|Withdrawal by Subject|1|||
156561120|NCT01808612|565143907|FG000|Treatment Period|Adverse Event|8|||
156561121|NCT01808612|565143908|FG001|Treatment Period|Adverse Event|4|||
156518002|NCT01097707|564988399|FG004|Overall Study|Lost to Follow-up|3|||
156518003|NCT01097707|564988395|FG000|Overall Study|Protocol Violation|2|||
156518004|NCT01097707|564988396|FG001|Overall Study|Protocol Violation|2|||
156518005|NCT01097707|564988397|FG002|Overall Study|Protocol Violation|3|||
156518006|NCT01097707|564988398|FG003|Overall Study|Protocol Violation|2|||
156561122|NCT01808612|565143909|FG002|Treatment Period|Adverse Event|3|||
156561123|NCT01808612|565143907|FG000|Treatment Period|Lost to Follow-up|2|||
156561124|NCT01808612|565143908|FG001|Treatment Period|Lost to Follow-up|2|||
156561125|NCT01808612|565143909|FG002|Treatment Period|Lost to Follow-up|1|||
156561126|NCT01808612|565143907|FG000|Treatment Period|Protocol Violation|1|||
156561127|NCT01808612|565143908|FG001|Treatment Period|Protocol Violation|0|||
156561128|NCT01808612|565143909|FG002|Treatment Period|Protocol Violation|0|||
156561129|NCT01808612|565143907|FG000|Treatment Period|Withdrawal by Subject|1|||
156561130|NCT01808612|565143908|FG001|Treatment Period|Withdrawal by Subject|0|||
156561131|NCT01808612|565143909|FG002|Treatment Period|Withdrawal by Subject|4|||
156561132|NCT01808612|565143907|FG000|Treatment Period|Physician Decision|1|||
156561133|NCT01808612|565143908|FG001|Treatment Period|Physician Decision|0|||
156561134|NCT01808612|565143909|FG002|Treatment Period|Physician Decision|4|||
156561135|NCT01808612|565143907|FG000|Treatment Period|Sponsor Decision|1|||
156561136|NCT01808612|565143908|FG001|Treatment Period|Sponsor Decision|0|||
156561137|NCT01808612|565143909|FG002|Treatment Period|Sponsor Decision|0|||
156561138|NCT01808612|565143907|FG000|Treatment Period|Lack of Efficacy|1|||
156561139|NCT01808612|565143908|FG001|Treatment Period|Lack of Efficacy|1|||
156561140|NCT01808612|565143909|FG002|Treatment Period|Lack of Efficacy|2|||
156561141|NCT01808612|565143907|FG000|Discontinuation Period|Adverse Event|1|||
156561142|NCT01808612|565143908|FG001|Discontinuation Period|Adverse Event|0|||
156561143|NCT01808612|565143909|FG002|Discontinuation Period|Adverse Event|0|||
156561144|NCT01808612|565143907|FG000|Discontinuation Period|Physician Decision|1|||
156561145|NCT01808612|565143908|FG001|Discontinuation Period|Physician Decision|0|||
156561146|NCT01808612|565143909|FG002|Discontinuation Period|Physician Decision|0|||
156561147|NCT01808612|565143907|FG000|Discontinuation Period|Lost to Follow-up|0|||
156561148|NCT01808612|565143908|FG001|Discontinuation Period|Lost to Follow-up|1|||
156561149|NCT01808612|565143909|FG002|Discontinuation Period|Lost to Follow-up|0|||
156561150|NCT03683394|565143910|FG000|Overall Study|Withdrawal by Subject|4|||
156561151|NCT03683394|565143911|FG001|Overall Study|Withdrawal by Subject|8|||
156561152|NCT03683394|565143910|FG000|Overall Study|Lost to Follow-up|7|||
156561153|NCT03683394|565143911|FG001|Overall Study|Lost to Follow-up|0|||
156561154|NCT03683394|565143910|FG000|Overall Study|Death|3|||
156561155|NCT03683394|565143911|FG001|Overall Study|Death|1|||
156561156|NCT00110019|565143912|FG000|Overall Study|Lack of Efficacy|253|||
156561157|NCT00110019|565143913|FG001|Overall Study|Lack of Efficacy|285|||
156561158|NCT00110019|565143912|FG000|Overall Study|Adverse Event|61|||
156561159|NCT00110019|565143913|FG001|Overall Study|Adverse Event|40|||
156561160|NCT00110019|565143912|FG000|Overall Study|Death|13|||
156561161|NCT00110019|565143913|FG001|Overall Study|Death|15|||
156561162|NCT00110019|565143912|FG000|Overall Study|Withdrawal by Subject|21|||
156561163|NCT00110019|565143913|FG001|Overall Study|Withdrawal by Subject|9|||
156561164|NCT00110019|565143912|FG000|Overall Study|alternative therapy|5|||
156561165|NCT00110019|565143913|FG001|Overall Study|alternative therapy|1|||
156561166|NCT00110019|565143912|FG000|Overall Study|complicating disease|1|||
156561167|NCT00110019|565143913|FG001|Overall Study|complicating disease|1|||
156561168|NCT00110019|565143912|FG000|Overall Study|symptom deterioration|13|||
156561169|NCT00110019|565143913|FG001|Overall Study|symptom deterioration|16|||
156561170|NCT00110019|565143912|FG000|Overall Study|Not start protocol therapy|17|||
156561171|NCT00110019|565143913|FG001|Overall Study|Not start protocol therapy|16|||
156561172|NCT00110019|565143912|FG000|Overall Study|other reasons|22|||
156561173|NCT00110019|565143913|FG001|Overall Study|other reasons|30|||
156561174|NCT03072160|565143916|FG000|Overall Study|Adverse Event|3|||
156561175|NCT03072160|565143917|FG001|Overall Study|Adverse Event|1|||
156561176|NCT03072160|565143916|FG000|Overall Study|Refused further treatment|6|||
156561177|NCT03072160|565143917|FG001|Overall Study|Refused further treatment|1|||
156561178|NCT03072160|565143916|FG000|Overall Study|Physician Decision|1|||
156561179|NCT03072160|565143917|FG001|Overall Study|Physician Decision|0|||
156561180|NCT03072160|565143916|FG000|Overall Study|Disease progression on study|1|||
156561181|NCT03072160|565143917|FG001|Overall Study|Disease progression on study|1|||
156561182|NCT03072160|565143916|FG000|Overall Study|No contact|0|||
156561183|NCT03072160|565143917|FG001|Overall Study|No contact|1|||
156561184|NCT02239263|565143918|FG000|Overall Study|Protocol Violation|6|||
156561185|NCT01046695|565143919|FG000|Overall Study|Subject had a pacemaker|0|||
156561186|NCT01046695|565143920|FG001|Overall Study|Subject had a pacemaker|1|||
156561187|NCT01046695|565143919|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
156561188|NCT01046695|565143920|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
156561189|NCT04303000|565143921|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
156561190|NCT04303000|565143922|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
156561191|NCT04303000|565143923|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
156561192|NCT00553462|565143924|FG000|Overall Study|Adverse Event|4|||
156561193|NCT00553462|565143924|FG000|Overall Study|Progression|4|||
156561194|NCT00553462|565143924|FG000|Overall Study|Withdrawal by Subject|5|||
156561195|NCT00553462|565143924|FG000|Overall Study|Physician Decision|1|||
156561196|NCT01262625|565143927|FG000|Overall Study|Administrative Error|1|||
156561197|NCT01262625|565143928|FG001|Overall Study|Administrative Error|1|||
156561198|NCT01262625|565143927|FG000|Overall Study|Site Closed|1|||
156561199|NCT01262625|565143928|FG001|Overall Study|Site Closed|0|||
156561200|NCT01728779|565143930|FG000|Overall Study|Withdrawal by Subject|1|||
156561201|NCT01925209|565143931|FG000|Treatment Epoch|Physician Decision|1|||
156561202|NCT01925209|565143932|FG001|Treatment Epoch|Physician Decision|0|||
156561203|NCT01925209|565143933|FG002|Treatment Epoch|Physician Decision|0|||
156561204|NCT01925209|565143934|FG003|Treatment Epoch|Physician Decision|0|||
156561205|NCT01925209|565143931|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
156561206|NCT01925209|565143932|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
156561207|NCT01925209|565143933|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
156561208|NCT01925209|565143934|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
156561209|NCT01925209|565143931|FG000|Treatment Epoch|Death|1|||
156561210|NCT01925209|565143932|FG001|Treatment Epoch|Death|0|||
156561211|NCT01925209|565143933|FG002|Treatment Epoch|Death|0|||
156561212|NCT01925209|565143934|FG003|Treatment Epoch|Death|0|||
156561213|NCT01925209|565143931|FG000|Treatment Epoch|Protocol deviation|0|||
156561214|NCT01925209|565143932|FG001|Treatment Epoch|Protocol deviation|0|||
156561215|NCT01925209|565143933|FG002|Treatment Epoch|Protocol deviation|1|||
156561216|NCT01925209|565143934|FG003|Treatment Epoch|Protocol deviation|1|||
156561217|NCT01925209|565143931|FG000|Treatment Epoch|Withdrawal by Subject|4|||
156561218|NCT01925209|565143932|FG001|Treatment Epoch|Withdrawal by Subject|3|||
156561219|NCT01925209|565143933|FG002|Treatment Epoch|Withdrawal by Subject|3|||
156561220|NCT01925209|565143934|FG003|Treatment Epoch|Withdrawal by Subject|2|||
156561221|NCT01925209|565143931|FG000|Treatment Epoch|Adverse Event|3|||
156561222|NCT01925209|565143932|FG001|Treatment Epoch|Adverse Event|5|||
156561223|NCT01925209|565143933|FG002|Treatment Epoch|Adverse Event|3|||
156561224|NCT01925209|565143934|FG003|Treatment Epoch|Adverse Event|1|||
156561225|NCT01925209|565143931|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
156561226|NCT01925209|565143932|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
156561227|NCT01925209|565143933|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
156561228|NCT01925209|565143934|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
156561229|NCT01925209|565143931|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
156561230|NCT01925209|565143932|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
156561231|NCT01925209|565143933|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
156518007|NCT01097707|564988399|FG004|Overall Study|Protocol Violation|2|||
156518008|NCT01097707|564988395|FG000|Overall Study|Sponsor Decision|31|||
156518009|NCT01097707|564988396|FG001|Overall Study|Sponsor Decision|31|||
156518010|NCT01097707|564988397|FG002|Overall Study|Sponsor Decision|34|||
156518011|NCT01097707|564988398|FG003|Overall Study|Sponsor Decision|35|||
156518012|NCT01097707|564988399|FG004|Overall Study|Sponsor Decision|36|||
156518013|NCT01097707|564988395|FG000|Overall Study|Withdrawal by Subject|3|||
156518014|NCT01097707|564988396|FG001|Overall Study|Withdrawal by Subject|6|||
156518015|NCT01097707|564988397|FG002|Overall Study|Withdrawal by Subject|1|||
156518016|NCT01097707|564988398|FG003|Overall Study|Withdrawal by Subject|4|||
156518017|NCT01097707|564988399|FG004|Overall Study|Withdrawal by Subject|3|||
156518018|NCT01097707|564988395|FG000|Overall Study|Reason unknown|0|||
156518019|NCT01097707|564988396|FG001|Overall Study|Reason unknown|0|||
156518020|NCT01097707|564988397|FG002|Overall Study|Reason unknown|0|||
156518021|NCT01097707|564988398|FG003|Overall Study|Reason unknown|0|||
156518022|NCT01097707|564988399|FG004|Overall Study|Reason unknown|1|||
156518023|NCT03212989|564988400|FG000|Overall Study|Physician Decision|8|||
156518024|NCT01236534|564988403|FG000|Overall Study|Adverse Event|3|||
156518025|NCT01236534|564988404|FG001|Overall Study|Adverse Event|0|||
156518026|NCT01844687|564988407|FG000|Visit 1|Protocol Violation|3|||
156518027|NCT01844687|564988407|FG000|Visit 1|Lost to Follow-up|5|||
156518028|NCT01844687|564988407|FG000|Visit 2|Withdrawal by Subject|1|||
156518029|NCT01844687|564988407|FG000|Visit 2|Protocol Violation|1|||
156518030|NCT01844687|564988407|FG000|Visit 3|Lost to Follow-up|1|||
156518031|NCT01844687|564988407|FG000|Visit 3|Withdrawal by Subject|3|||
156518032|NCT01844687|564988407|FG000|Visit 3|child care problems|1|||
156518033|NCT01844687|564988407|FG000|Visit 4|Pregnancy|1|||
156518034|NCT01844687|564988407|FG000|Visit 4|Lost to Follow-up|1|||
156518035|NCT01844687|564988407|FG000|Visit 4|Withdrawal by Subject|2|||
156518036|NCT00158860|564988416|FG000|Overall Study|Adverse Event|3|||
156518037|NCT00158860|564988417|FG001|Overall Study|Adverse Event|6|||
156518038|NCT00158860|564988416|FG000|Overall Study|Lost to Follow-up|11|||
156518039|NCT00158860|564988417|FG001|Overall Study|Lost to Follow-up|17|||
156518040|NCT00158860|564988416|FG000|Overall Study|Protocol Violation|8|||
156518041|NCT00158860|564988417|FG001|Overall Study|Protocol Violation|23|||
156518042|NCT00158860|564988416|FG000|Overall Study|Withdrawal by Subject|7|||
156518043|NCT00158860|564988417|FG001|Overall Study|Withdrawal by Subject|17|||
156518044|NCT00158860|564988416|FG000|Overall Study|MOVING OUT OF STATE|1|||
156518045|NCT00158860|564988417|FG001|Overall Study|MOVING OUT OF STATE|0|||
156561232|NCT01925209|565143934|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
156518046|NCT00158860|564988416|FG000|Overall Study|Pregnancy|3|||
156518047|NCT00158860|564988417|FG001|Overall Study|Pregnancy|3|||
156518048|NCT00158860|564988416|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
156518049|NCT00158860|564988417|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
156518050|NCT00158860|564988416|FG000|Overall Study|SPONSOR REQUEST|0|||
156518051|NCT00158860|564988417|FG001|Overall Study|SPONSOR REQUEST|1|||
156518052|NCT00158860|564988416|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
156561233|NCT01925209|565143931|FG000|Follow-up|Adverse Event|1|||
156561234|NCT01925209|565143932|FG001|Follow-up|Adverse Event|4|||
156561235|NCT01925209|565143933|FG002|Follow-up|Adverse Event|0|||
156561236|NCT01925209|565143934|FG003|Follow-up|Adverse Event|1|||
156561237|NCT01925209|565143931|FG000|Follow-up|Physician Decision|0|||
156561238|NCT01925209|565143932|FG001|Follow-up|Physician Decision|0|||
156561239|NCT01925209|565143933|FG002|Follow-up|Physician Decision|1|||
156561240|NCT01925209|565143934|FG003|Follow-up|Physician Decision|0|||
156561241|NCT01925209|565143931|FG000|Follow-up|Non-compliance with study treatment|0|||
156561242|NCT01925209|565143932|FG001|Follow-up|Non-compliance with study treatment|0|||
156561243|NCT01925209|565143933|FG002|Follow-up|Non-compliance with study treatment|0|||
156561244|NCT01925209|565143934|FG003|Follow-up|Non-compliance with study treatment|1|||
156561245|NCT01925209|565143931|FG000|Follow-up|Withdrawal by Subject|0|||
156561246|NCT01925209|565143932|FG001|Follow-up|Withdrawal by Subject|2|||
156561247|NCT01925209|565143933|FG002|Follow-up|Withdrawal by Subject|0|||
156561248|NCT01925209|565143934|FG003|Follow-up|Withdrawal by Subject|2|||
156561249|NCT00448708|565143935|FG000|Overall Study|Death|21|||
156561250|NCT00448708|565143936|FG001|Overall Study|Death|17|||
156561251|NCT00448708|565143935|FG000|Overall Study|Withdrawal by Subject|8|||
156561252|NCT00448708|565143936|FG001|Overall Study|Withdrawal by Subject|4|||
156561253|NCT00448708|565143935|FG000|Overall Study|Lost to Follow-up|6|||
156561254|NCT00448708|565143936|FG001|Overall Study|Lost to Follow-up|8|||
156561255|NCT00448708|565143935|FG000|Overall Study|not listed|0|||
156561256|NCT00448708|565143936|FG001|Overall Study|not listed|2|||
156561257|NCT00110994|565143937|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
156561258|NCT00110994|565143938|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
156518053|NCT00158860|564988417|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
156561259|NCT00110994|565143937|FG000|Double-blind (DB) Treatment|Death|1|||
156561260|NCT00110994|565143938|FG001|Double-blind (DB) Treatment|Death|0|||
156561261|NCT00110994|565143937|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
156561262|NCT00110994|565143938|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
156561263|NCT00110994|565143937|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
156561264|NCT00110994|565143938|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
156561265|NCT00110994|565143937|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
156561266|NCT00110994|565143938|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
156561267|NCT00110994|565143937|FG000|Double-blind (DB) Treatment|other reasons|2|||
156561268|NCT00110994|565143938|FG001|Double-blind (DB) Treatment|other reasons|3|||
156561269|NCT00110994|565143937|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
156561270|NCT00110994|565143938|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
156561271|NCT00110994|565143937|FG000|Active Follow-up|Other reasons|0|||
156561272|NCT00110994|565143938|FG001|Active Follow-up|Other reasons|2|||
156561273|NCT00110994|565143937|FG000|Long Term Follow-up|Death|19|||
156561274|NCT00110994|565143938|FG001|Long Term Follow-up|Death|17|||
156561275|NCT04398732|565143939|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
156518054|NCT00158860|564988416|FG000|Overall Study|Closed per sponsor|0|||
156518055|NCT00158860|564988417|FG001|Overall Study|Closed per sponsor|1|||
156518056|NCT04638920|564988418|FG000|Overall Study|Withdrawal by Subject|5|||
156518057|NCT03775434|564988419|FG000|Overall Study|Adverse Event|2|||
156518058|NCT03775434|564988419|FG000|Overall Study|Withdrawal by Subject|1|||
156518059|NCT01435616|564988422|FG000|Overall Study|Adverse Event|39|||
156518060|NCT01435616|564988423|FG001|Overall Study|Adverse Event|21|||
156518061|NCT01435616|564988422|FG000|Overall Study|Death|7|||
156518062|NCT01435616|564988423|FG001|Overall Study|Death|2|||
156518063|NCT01435616|564988422|FG000|Overall Study|Lost to Follow-up|22|||
156518064|NCT01435616|564988423|FG001|Overall Study|Lost to Follow-up|13|||
156518065|NCT01435616|564988422|FG000|Overall Study|Protocol Violation|16|||
156518066|NCT01435616|564988423|FG001|Overall Study|Protocol Violation|13|||
156518067|NCT01435616|564988422|FG000|Overall Study|Withdrawal by Subject|66|||
156561276|NCT01299727|565143940|FG000|Overall Study|Withdrawal by Subject|1|||
156561277|NCT01299727|565143941|FG001|Overall Study|Withdrawal by Subject|0|||
156561278|NCT01299727|565143942|FG002|Overall Study|Withdrawal by Subject|0|||
156561279|NCT01299727|565143940|FG000|Overall Study|Adverse Event|0|||
156561280|NCT01299727|565143941|FG001|Overall Study|Adverse Event|0|||
156561281|NCT01299727|565143942|FG002|Overall Study|Adverse Event|1|||
156561282|NCT01299727|565143940|FG000|Overall Study|Completed the Treatment Period|3|||
156561283|NCT01299727|565143941|FG001|Overall Study|Completed the Treatment Period|4|||
156561284|NCT01299727|565143942|FG002|Overall Study|Completed the Treatment Period|3|||
156561285|NCT03882424|565143943|FG000|Overall Study|Lost to Follow-up|3|||
156561286|NCT03882424|565143944|FG001|Overall Study|Lost to Follow-up|0|||
156561287|NCT03882424|565143945|FG002|Overall Study|Lost to Follow-up|0|||
156561288|NCT03882424|565143943|FG000|Overall Study|schedule conflict|1|||
156561289|NCT03882424|565143944|FG001|Overall Study|schedule conflict|0|||
156561290|NCT03882424|565143945|FG002|Overall Study|schedule conflict|0|||
156518068|NCT01435616|564988423|FG001|Overall Study|Withdrawal by Subject|24|||
156518069|NCT01435616|564988422|FG000|Overall Study|Physician Decision|20|||
156518070|NCT01435616|564988423|FG001|Overall Study|Physician Decision|7|||
156518071|NCT01435616|564988422|FG000|Overall Study|Sponsor Decision|1|||
156518072|NCT01435616|564988423|FG001|Overall Study|Sponsor Decision|0|||
156518073|NCT02217475|564988424|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
156518074|NCT02217475|564988425|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
156518075|NCT02217475|564988426|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
156518076|NCT02217475|564988424|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
156518077|NCT02217475|564988425|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
156518078|NCT02217475|564988426|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
156518079|NCT02217475|564988424|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
156518080|NCT02217475|564988425|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
156518081|NCT02217475|564988426|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
156518082|NCT02217475|564988424|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
156518083|NCT02217475|564988425|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
156518084|NCT02217475|564988426|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
156518085|NCT02217475|564988424|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
156518086|NCT02217475|564988425|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
156518087|NCT02217475|564988426|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
156518088|NCT02217475|564988424|FG000|Discontinued After Period 1|Adverse Event|1|||
156518089|NCT02217475|564988425|FG001|Discontinued After Period 1|Adverse Event|2|||
156518090|NCT02217475|564988426|FG002|Discontinued After Period 1|Adverse Event|0|||
156518091|NCT02217475|564988424|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
156518092|NCT02217475|564988425|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
156518093|NCT02217475|564988426|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
156518094|NCT02217475|564988424|FG000|Discontinued After Period 1|Physician Decision|0|||
156518095|NCT02217475|564988425|FG001|Discontinued After Period 1|Physician Decision|0|||
156518096|NCT02217475|564988426|FG002|Discontinued After Period 1|Physician Decision|1|||
156518097|NCT02217475|564988424|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
156518098|NCT02217475|564988425|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
156518099|NCT02217475|564988426|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
156518100|NCT02217475|564988424|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
156518101|NCT02217475|564988425|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
156518102|NCT02217475|564988426|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
156518103|NCT02217475|564988424|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
156518104|NCT02217475|564988425|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
156518105|NCT02217475|564988426|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
156518106|NCT02217475|564988424|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
156518107|NCT02217475|564988425|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
156518108|NCT02217475|564988426|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
156518109|NCT02217475|564988424|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
156518110|NCT02217475|564988425|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
156518111|NCT02217475|564988426|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
156518112|NCT04738292|564988431|FG000|Overall Study|Death|1|||
156518113|NCT00371683|564988432|FG000|DB Treatment Period-Randomized Patients|Death|1|||
156518114|NCT00371683|564988433|FG001|DB Treatment Period-Randomized Patients|Death|1|||
156518115|NCT00371683|564988432|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
156518116|NCT00371683|564988433|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
156518117|NCT00371683|564988432|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
156518118|NCT00371683|564988433|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
156518119|NCT00371683|564988432|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
156518120|NCT00371683|564988433|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
156518121|NCT00371683|564988432|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
156518122|NCT00371683|564988433|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
156518123|NCT00371683|564988432|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
156518124|NCT00371683|564988433|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
156518125|NCT00371683|564988432|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
156518126|NCT00371683|564988433|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
156518127|NCT00371683|564988432|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
156518128|NCT00371683|564988433|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
156518129|NCT00371683|564988432|FG000|Follow-Up Period - Randomized Patients|Death|0|||
156518130|NCT00371683|564988433|FG001|Follow-Up Period - Randomized Patients|Death|2|||
156518131|NCT00371683|564988432|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
156518132|NCT00371683|564988433|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
156518133|NCT00371683|564988432|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
156518134|NCT00371683|564988433|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
156518135|NCT02971761|564988434|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
156518136|NCT02442336|564988435|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
156518137|NCT02442336|564988435|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
156518138|NCT02442336|564988435|FG000|Overall Study|Lost to Follow-up|11|||
156561291|NCT00531960|565143950|FG000|Overall Study|Adverse Event|5|||
156561292|NCT00531960|565143951|FG001|Overall Study|Adverse Event|4|||
156561293|NCT00531960|565143950|FG000|Overall Study|Death|3|||
156561294|NCT00531960|565143951|FG001|Overall Study|Death|2|||
156561295|NCT00531960|565143950|FG000|Overall Study|Lack of Efficacy|42|||
156561296|NCT00531960|565143951|FG001|Overall Study|Lack of Efficacy|41|||
156561297|NCT00531960|565143950|FG000|Overall Study|Violation of Selection Criteria|2|||
156561298|NCT00531960|565143951|FG001|Overall Study|Violation of Selection Criteria|0|||
156561299|NCT00531960|565143950|FG000|Overall Study|Refused Treatment|5|||
156561300|NCT00531960|565143951|FG001|Overall Study|Refused Treatment|6|||
156561301|NCT00531960|565143950|FG000|Overall Study|Other|4|||
156561302|NCT00531960|565143951|FG001|Overall Study|Other|10|||
156561303|NCT03336502|565143955|FG000|Overall Study|Physician Decision|0|||
156561304|NCT03336502|565143956|FG001|Overall Study|Physician Decision|1|||
156561305|NCT03336502|565143955|FG000|Overall Study|Prohibited Drugs|1|||
156561306|NCT03336502|565143956|FG001|Overall Study|Prohibited Drugs|1|||
156561307|NCT03336502|565143955|FG000|Overall Study|Death|1|||
156561308|NCT03336502|565143956|FG001|Overall Study|Death|2|||
156561309|NCT03336502|565143955|FG000|Overall Study|Adverse Event|2|||
156561310|NCT03336502|565143956|FG001|Overall Study|Adverse Event|5|||
156561311|NCT02921425|565143957|FG000|Overall Study|Protocol Violation|9|||
156561312|NCT01227967|565143958|FG000|Overall Study|Protocol Violation|3|||
156561313|NCT01227967|565143959|FG001|Overall Study|Protocol Violation|1|||
156561314|NCT01227967|565143958|FG000|Overall Study|Death|0|||
156561315|NCT01227967|565143959|FG001|Overall Study|Death|1|||
156561316|NCT01227967|565143958|FG000|Overall Study|Lost to Follow-up|8|||
156561317|NCT01227967|565143959|FG001|Overall Study|Lost to Follow-up|3|||
156561318|NCT01227967|565143958|FG000|Overall Study|Withdrawal by Subject|4|||
156561319|NCT01227967|565143959|FG001|Overall Study|Withdrawal by Subject|3|||
156561320|NCT01227967|565143958|FG000|Overall Study|Physician Decision|0|||
156561321|NCT01227967|565143959|FG001|Overall Study|Physician Decision|1|||
156561322|NCT01227967|565143958|FG000|Overall Study|Never Started Treatment|0|||
156561323|NCT01227967|565143959|FG001|Overall Study|Never Started Treatment|4|||
156561324|NCT01227967|565143958|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
156561325|NCT01227967|565143959|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
156561326|NCT01107444|565143963|FG000|Overall Study|Withdrawal by Subject|8|||
156561327|NCT01107444|565143964|FG001|Overall Study|Withdrawal by Subject|12|||
156561328|NCT01107444|565143963|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
156561329|NCT01107444|565143964|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
156561330|NCT03310970|565143968|FG000|Overall Study|Withdrawal by Subject|0|||
156561331|NCT03310970|565143969|FG001|Overall Study|Withdrawal by Subject|1|||
156561332|NCT01446419|565143970|FG000|Overall Study|Death|1|||
156561333|NCT01446419|565143971|FG001|Overall Study|Death|0|||
156561334|NCT01446419|565143970|FG000|Overall Study|Withdrawal by Subject|1|||
156561335|NCT01446419|565143971|FG001|Overall Study|Withdrawal by Subject|1|||
156561336|NCT01446419|565143970|FG000|Overall Study|Terminated per protocol|3|||
156561337|NCT01446419|565143971|FG001|Overall Study|Terminated per protocol|0|||
156561338|NCT02149810|565143972|FG000|Overall Study|Physician Decision|1|||
156561339|NCT02149810|565143973|FG001|Overall Study|Physician Decision|2|||
156561340|NCT02149810|565143972|FG000|Overall Study|Lost to Follow-up|2|||
156561341|NCT02149810|565143973|FG001|Overall Study|Lost to Follow-up|1|||
156561342|NCT02149810|565143972|FG000|Overall Study|Withdrawal by Subject|5|||
156561343|NCT02149810|565143973|FG001|Overall Study|Withdrawal by Subject|1|||
156561344|NCT05032950|565143975|FG000|Overall Study|Adverse Event|0|||
156561345|NCT05032950|565143976|FG001|Overall Study|Adverse Event|0|||
156561346|NCT05032950|565143977|FG002|Overall Study|Adverse Event|1|||
156561347|NCT05032950|565143978|FG003|Overall Study|Adverse Event|1|||
156561348|NCT05032950|565143979|FG004|Overall Study|Adverse Event|0|||
156561349|NCT05032950|565143980|FG005|Overall Study|Adverse Event|0|||
156561350|NCT01990261|565143981|FG000|Overall Study|Death Before Treatment Start|2|||
156561351|NCT01990261|565143981|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
156561352|NCT01990261|565143981|FG000|Overall Study|Death From other Causes|1|||
156561353|NCT01990261|565143981|FG000|Overall Study|Disease Progression (PD)|8|||
156561354|NCT01990261|565143981|FG000|Overall Study|PD Before Treatment Start|1|||
156561355|NCT01990261|565143981|FG000|Overall Study|Dossier not Approved|1|||
156561356|NCT01990261|565143981|FG000|Overall Study|Lost to Follow-up|2|||
156561357|NCT02474329|565143985|FG000|Overall Study|Withdraw or did not contribute data.|13|||
156561358|NCT01356589|565143986|FG000|Overall Study|Enrolled, but not treated|3|||
156561359|NCT01356589|565143986|FG000|Overall Study|Dose data not recorded|2|||
156561360|NCT00376961|565145437|FG000|Initial Registration|Adverse Event|1|||
156561361|NCT00376961|565145438|FG001|Initial Registration|Adverse Event|0|||
156561362|NCT00376961|565145437|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
156561363|NCT00376961|565145438|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
156561364|NCT00376961|565145437|FG000|Initial Registration|Progression/relapse|1|||
156561365|NCT00376961|565145438|FG001|Initial Registration|Progression/relapse|0|||
156561366|NCT00376961|565145437|FG000|Initial Registration|Ineligible|3|||
156561367|NCT00376961|565145438|FG001|Initial Registration|Ineligible|0|||
156561368|NCT00376961|565145437|FG000|Maintenance|Adverse Event|0|||
156561369|NCT00376961|565145438|FG001|Maintenance|Adverse Event|1|||
156561370|NCT00376961|565145437|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
156561371|NCT00376961|565145438|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
156561372|NCT00376961|565145437|FG000|Maintenance|Progression/relapse|0|||
156561373|NCT00376961|565145438|FG001|Maintenance|Progression/relapse|18|||
156561374|NCT00376961|565145437|FG000|Maintenance|Ineligible|0|||
156561375|NCT00376961|565145438|FG001|Maintenance|Ineligible|3|||
156561376|NCT04188197|565145445|FG000|Overall Study|Lost to Follow-up|4|||
156561377|NCT04188197|565145446|FG001|Overall Study|Lost to Follow-up|1|||
156561378|NCT04188197|565145445|FG000|Overall Study|Withdrawal by Subject|1|||
156561379|NCT04188197|565145446|FG001|Overall Study|Withdrawal by Subject|1|||
156561380|NCT04188197|565145445|FG000|Overall Study|Pregnancy|0|||
156561381|NCT04188197|565145446|FG001|Overall Study|Pregnancy|1|||
156561382|NCT02613208|565145447|FG000|Overall Study|Withdrawal by Subject|1|||
156561383|NCT02613208|565145447|FG000|Overall Study|Change of address|2|||
156561384|NCT02613208|565145447|FG000|Overall Study|Physician Decision|2|||
156561385|NCT02613208|565145447|FG000|Overall Study|Lost to Follow-up|5|||
156561386|NCT02613208|565145447|FG000|Overall Study|Death|37|||
156561387|NCT00008385|565145448|FG000|Overall Study|Off treatment reasons not reported|79|||
156561388|NCT00008385|565145449|FG001|Overall Study|Off treatment reasons not reported|70|||
156561389|NCT00008385|565145448|FG000|Overall Study|Progressive disease|52|||
156561390|NCT00008385|565145449|FG001|Overall Study|Progressive disease|117|||
156561391|NCT00008385|565145448|FG000|Overall Study|Adverse Event|8|||
156561392|NCT00008385|565145449|FG001|Overall Study|Adverse Event|20|||
156561393|NCT00008385|565145448|FG000|Overall Study|Death|12|||
156561394|NCT00008385|565145449|FG001|Overall Study|Death|18|||
156561395|NCT00008385|565145448|FG000|Overall Study|Withdrawal by Subject|67|||
156518139|NCT01237587|564988436|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
156518140|NCT01237587|564988437|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
156518141|NCT01237587|564988436|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
156518142|NCT01237587|564988437|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
156518143|NCT01237587|564988436|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
156518144|NCT01237587|564988437|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
156561396|NCT00008385|565145449|FG001|Overall Study|Withdrawal by Subject|157|||
156561397|NCT00008385|565145448|FG000|Overall Study|Start non-protocol therapy|3|||
156561398|NCT00008385|565145449|FG001|Overall Study|Start non-protocol therapy|1|||
156561399|NCT00008385|565145448|FG000|Overall Study|Other complicating disease|17|||
156561400|NCT00008385|565145449|FG001|Overall Study|Other complicating disease|30|||
156561401|NCT00008385|565145448|FG000|Overall Study|Maximum dose reached|0|||
156561402|NCT00008385|565145449|FG001|Overall Study|Maximum dose reached|2|||
156561403|NCT00008385|565145448|FG000|Overall Study|Other|105|||
156561404|NCT00008385|565145449|FG001|Overall Study|Other|212|||
156561405|NCT00008385|565145448|FG000|Overall Study|Not start protocol therapy|44|||
156561406|NCT00008385|565145449|FG001|Overall Study|Not start protocol therapy|175|||
156561407|NCT01719757|565145452|FG000|Overall Study|Adverse Event|38|||
156561408|NCT01719757|565145452|FG000|Overall Study|Withdrawal by Subject|15|||
156561409|NCT01719757|565145452|FG000|Overall Study|Lost to Follow-up|20|||
156561410|NCT01719757|565145452|FG000|Overall Study|Protocol Violation|1|||
156561411|NCT01719757|565145452|FG000|Overall Study|well controlled pain|27|||
156561412|NCT05742984|565145453|FG000|Overall Study|Adverse Event|0|||
156561413|NCT05742984|565145454|FG001|Overall Study|Adverse Event|0|||
156561414|NCT05742984|565145455|FG002|Overall Study|Adverse Event|1|||
156561415|NCT05742984|565145456|FG003|Overall Study|Adverse Event|0|||
156561416|NCT05742984|565145457|FG004|Overall Study|Adverse Event|1|||
156561417|NCT05742984|565145458|FG005|Overall Study|Adverse Event|1|||
156561418|NCT05742984|565145453|FG000|Overall Study|Withdrawal by Subject|0|||
156561419|NCT05742984|565145454|FG001|Overall Study|Withdrawal by Subject|1|||
156561420|NCT05742984|565145455|FG002|Overall Study|Withdrawal by Subject|0|||
156561421|NCT05742984|565145456|FG003|Overall Study|Withdrawal by Subject|0|||
156561422|NCT05742984|565145457|FG004|Overall Study|Withdrawal by Subject|0|||
156561423|NCT05742984|565145458|FG005|Overall Study|Withdrawal by Subject|2|||
156518145|NCT01237587|564988436|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
156518146|NCT01237587|564988437|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
156518147|NCT01237587|564988436|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
156518148|NCT01237587|564988437|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
156518149|NCT01237587|564988436|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
156561424|NCT02162862|565145459|FG000|Overall Study|Lost to Follow-up|0|||
156561425|NCT02162862|565145460|FG001|Overall Study|Lost to Follow-up|11|||
156561426|NCT02162862|565145461|FG002|Overall Study|Lost to Follow-up|0|||
156561427|NCT02162862|565145459|FG000|Overall Study|Subject did not feel the med was needed|0|||
156561428|NCT02162862|565145460|FG001|Overall Study|Subject did not feel the med was needed|0|||
156561429|NCT02162862|565145461|FG002|Overall Study|Subject did not feel the med was needed|4|||
156561430|NCT00434967|565145468|FG000|Overall Study|Adverse Event|2|||
156561431|NCT00434967|565145469|FG001|Overall Study|Adverse Event|4|||
156561432|NCT00434967|565145470|FG002|Overall Study|Adverse Event|3|||
156561433|NCT00434967|565145471|FG003|Overall Study|Adverse Event|3|||
156561434|NCT00434967|565145468|FG000|Overall Study|Lost to Follow-up|0|||
156518150|NCT01237587|564988437|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
156518151|NCT01237587|564988436|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
156518152|NCT01237587|564988437|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
156561435|NCT00434967|565145469|FG001|Overall Study|Lost to Follow-up|0|||
156561436|NCT00434967|565145470|FG002|Overall Study|Lost to Follow-up|1|||
156561437|NCT00434967|565145471|FG003|Overall Study|Lost to Follow-up|0|||
156561438|NCT00434967|565145468|FG000|Overall Study|Withdrawal by Subject|2|||
156561439|NCT00434967|565145469|FG001|Overall Study|Withdrawal by Subject|2|||
156561440|NCT00434967|565145470|FG002|Overall Study|Withdrawal by Subject|4|||
156561441|NCT00434967|565145471|FG003|Overall Study|Withdrawal by Subject|6|||
156561442|NCT00434967|565145468|FG000|Overall Study|Randomized in error|0|||
156561443|NCT00434967|565145469|FG001|Overall Study|Randomized in error|0|||
156561444|NCT00434967|565145470|FG002|Overall Study|Randomized in error|0|||
156561445|NCT00434967|565145471|FG003|Overall Study|Randomized in error|1|||
156561446|NCT00434967|565145468|FG000|Overall Study|Protocol Violation|0|||
156561447|NCT00434967|565145469|FG001|Overall Study|Protocol Violation|1|||
156561448|NCT00434967|565145470|FG002|Overall Study|Protocol Violation|0|||
156561449|NCT00434967|565145471|FG003|Overall Study|Protocol Violation|1|||
156561450|NCT00434967|565145468|FG000|Overall Study|Physician Decision|1|||
156561451|NCT00434967|565145469|FG001|Overall Study|Physician Decision|1|||
156561452|NCT00434967|565145470|FG002|Overall Study|Physician Decision|1|||
156561453|NCT00434967|565145471|FG003|Overall Study|Physician Decision|0|||
156561454|NCT00434967|565145468|FG000|Overall Study|Patient Disposition Challenges|2|||
156561455|NCT00434967|565145469|FG001|Overall Study|Patient Disposition Challenges|0|||
156561456|NCT00434967|565145470|FG002|Overall Study|Patient Disposition Challenges|0|||
156561457|NCT00434967|565145471|FG003|Overall Study|Patient Disposition Challenges|3|||
156561458|NCT00559273|565145475|FG000|Correction Period (20 Weeks)|Death|3|||
156561459|NCT00559273|565145476|FG001|Correction Period (20 Weeks)|Death|4|||
156561460|NCT00559273|565145475|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
156561461|NCT00559273|565145476|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
156561462|NCT00559273|565145475|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
156561463|NCT00559273|565145476|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
156561464|NCT00559273|565145475|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
156561465|NCT00559273|565145476|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
156561466|NCT00559273|565145475|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
156561467|NCT00559273|565145476|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
156518153|NCT01237587|564988436|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
156518154|NCT01237587|564988437|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
156518155|NCT01237587|564988436|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
156518156|NCT01237587|564988437|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
156518157|NCT01237587|564988436|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
156518158|NCT01237587|564988437|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
156518159|NCT01237587|564988436|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
156518160|NCT01237587|564988437|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
156518161|NCT01237587|564988436|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
156518162|NCT01237587|564988437|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
156518163|NCT01237587|564988436|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
156518164|NCT01237587|564988437|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
156518165|NCT01237587|564988436|FG000|Taper Phase|Adverse Event|0|||
156518166|NCT01237587|564988437|FG001|Taper Phase|Adverse Event|2|||
156518167|NCT01237587|564988436|FG000|Taper Phase|Protocol Violation|2|||
156518168|NCT01237587|564988437|FG001|Taper Phase|Protocol Violation|0|||
156518169|NCT01237587|564988436|FG000|Taper Phase|Lack of Efficacy|2|||
156518170|NCT01237587|564988437|FG001|Taper Phase|Lack of Efficacy|5|||
156518171|NCT01237587|564988436|FG000|Taper Phase|Parent/Guardian Decision|0|||
156518172|NCT01237587|564988437|FG001|Taper Phase|Parent/Guardian Decision|2|||
156518173|NCT01237587|564988436|FG000|Taper Phase|Sponsor Decision|1|||
156518174|NCT01237587|564988437|FG001|Taper Phase|Sponsor Decision|0|||
156518175|NCT01237587|564988436|FG000|Taper Phase|Withdrawal by Subject|0|||
156518176|NCT01237587|564988437|FG001|Taper Phase|Withdrawal by Subject|1|||
156518177|NCT01011387|564988438|FG000|Overall Study|Withdrawal by Subject|3|||
156561468|NCT00559273|565145475|FG000|Evaluation Period (8 Weeks)|Death|1|||
156561469|NCT00559273|565145476|FG001|Evaluation Period (8 Weeks)|Death|3|||
156561470|NCT00559273|565145475|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
156561471|NCT00559273|565145476|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
156561472|NCT00559273|565145475|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
156561473|NCT00559273|565145476|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
156561474|NCT00559273|565145475|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
156561475|NCT00559273|565145476|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
156561476|NCT01256177|565145477|FG000|Overall Study|Withdrawal by Subject|23|||
156561477|NCT01256177|565145478|FG001|Overall Study|Withdrawal by Subject|22|||
156561478|NCT01256177|565145477|FG000|Overall Study|Lost to Follow-up|2|||
156561479|NCT01256177|565145478|FG001|Overall Study|Lost to Follow-up|2|||
156561480|NCT01256177|565145477|FG000|Overall Study|Adverse Event|8|||
156561481|NCT01256177|565145478|FG001|Overall Study|Adverse Event|9|||
156561482|NCT01256177|565145477|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
156561483|NCT01256177|565145478|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
156561484|NCT01256177|565145477|FG000|Overall Study|Condition under Investigation Worsened|1|||
156561485|NCT01256177|565145478|FG001|Overall Study|Condition under Investigation Worsened|0|||
156561486|NCT01256177|565145477|FG000|Overall Study|Lack of Efficacy|11|||
156561487|NCT01256177|565145478|FG001|Overall Study|Lack of Efficacy|2|||
156561488|NCT01256177|565145477|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
156561489|NCT01256177|565145478|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
156561490|NCT01596257|565145483|FG000|Overall Study|Inadequate Collection|23|||
156561491|NCT01596257|565145484|FG001|Overall Study|Inadequate Collection|19|||
156561492|NCT01570244|565145488|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
156561493|NCT03486392|565145489|FG000|Overall Study|Lost to Follow-up|0|||
156561494|NCT03486392|565145490|FG001|Overall Study|Lost to Follow-up|0|||
156561495|NCT03486392|565145491|FG002|Overall Study|Lost to Follow-up|8|||
156561496|NCT03486392|565145492|FG003|Overall Study|Lost to Follow-up|5|||
156561497|NCT03486392|565145493|FG004|Overall Study|Lost to Follow-up|2|||
156561498|NCT03486392|565145489|FG000|Overall Study|Withdrawal by Subject|3|||
156561499|NCT03486392|565145490|FG001|Overall Study|Withdrawal by Subject|0|||
156561500|NCT03486392|565145491|FG002|Overall Study|Withdrawal by Subject|6|||
156561501|NCT03486392|565145492|FG003|Overall Study|Withdrawal by Subject|4|||
156561502|NCT03486392|565145493|FG004|Overall Study|Withdrawal by Subject|1|||
156561503|NCT03486392|565145489|FG000|Overall Study|Death|0|||
156561504|NCT03486392|565145490|FG001|Overall Study|Death|0|||
156561505|NCT03486392|565145491|FG002|Overall Study|Death|0|||
156561506|NCT03486392|565145492|FG003|Overall Study|Death|0|||
156561507|NCT03486392|565145493|FG004|Overall Study|Death|1|||
156561508|NCT01950819|565145494|FG000|Overall Study|Graft Loss|35|||
156561509|NCT01950819|565145495|FG001|Overall Study|Graft Loss|30|||
156561510|NCT01950819|565145494|FG000|Overall Study|Death|29|||
156561511|NCT01950819|565145495|FG001|Overall Study|Death|34|||
156561512|NCT01950819|565145494|FG000|Overall Study|Subject / Gardian decision|54|||
156561513|NCT01950819|565145495|FG001|Overall Study|Subject / Gardian decision|51|||
156561514|NCT01950819|565145494|FG000|Overall Study|technical problems|2|||
156561515|NCT01950819|565145495|FG001|Overall Study|technical problems|0|||
156518178|NCT01011387|564988438|FG000|Overall Study|Adverse Event|2|||
156518179|NCT01011387|564988438|FG000|Overall Study|Protocol Violation|1|||
156518180|NCT01285609|564988439|FG000|Randomized|Progressive Disease|41|||
156518181|NCT01285609|564988440|FG001|Randomized|Progressive Disease|61|||
156518182|NCT01285609|564988439|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
156518183|NCT01285609|564988440|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
156518184|NCT01285609|564988439|FG000|Randomized|Study Drug Toxicity|13|||
156518185|NCT01285609|564988440|FG001|Randomized|Study Drug Toxicity|14|||
156518186|NCT01285609|564988439|FG000|Randomized|Death|5|||
156518187|NCT01285609|564988440|FG001|Randomized|Death|7|||
156518188|NCT01285609|564988439|FG000|Randomized|Withdrawal by Subject|8|||
156518189|NCT01285609|564988440|FG001|Randomized|Withdrawal by Subject|11|||
156518190|NCT01285609|564988439|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
156518191|NCT01285609|564988440|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
156518192|NCT01285609|564988439|FG000|Randomized|Undisclosed Reasons|1|||
156518193|NCT01285609|564988440|FG001|Randomized|Undisclosed Reasons|0|||
156518194|NCT01285609|564988439|FG000|Randomized|Randomized but not Treated|4|||
156518195|NCT01285609|564988440|FG001|Randomized|Randomized but not Treated|4|||
156518196|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
156518197|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
156561516|NCT01950819|565145494|FG000|Overall Study|Pregnancy|0|||
156561517|NCT01950819|565145495|FG001|Overall Study|Pregnancy|2|||
156561518|NCT01950819|565145494|FG000|Overall Study|Lost to Follow-up|9|||
156561519|NCT01950819|565145495|FG001|Overall Study|Lost to Follow-up|17|||
156561520|NCT01879410|565145499|FG000|Overall Study|Adverse Event|9|||
156561521|NCT01879410|565145500|FG001|Overall Study|Adverse Event|14|||
156561522|NCT01879410|565145499|FG000|Overall Study|Lack of Efficacy|4|||
156561523|NCT01879410|565145500|FG001|Overall Study|Lack of Efficacy|6|||
156561524|NCT01879410|565145499|FG000|Overall Study|Protocol Violation|1|||
156561525|NCT01879410|565145500|FG001|Overall Study|Protocol Violation|7|||
156561526|NCT01879410|565145499|FG000|Overall Study|Lost to Follow-up|2|||
156561527|NCT01879410|565145500|FG001|Overall Study|Lost to Follow-up|1|||
156561528|NCT01879410|565145499|FG000|Overall Study|Withdrawal by Subject|7|||
156561529|NCT01879410|565145500|FG001|Overall Study|Withdrawal by Subject|8|||
156561530|NCT01879410|565145499|FG000|Overall Study|Randomised in Error|1|||
156561531|NCT01879410|565145500|FG001|Overall Study|Randomised in Error|2|||
156561532|NCT01360645|565145505|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
156561533|NCT01360645|565145506|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
156561534|NCT01360645|565145507|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
156561535|NCT01360645|565145508|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
156561536|NCT01360645|565145505|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
156561537|NCT01360645|565145506|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
156561538|NCT01360645|565145507|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
156561539|NCT01360645|565145508|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
156561540|NCT01360645|565145505|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
156561541|NCT01360645|565145506|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
156561542|NCT01360645|565145507|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
156561543|NCT01360645|565145508|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
156561544|NCT01360645|565145505|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
156561545|NCT01360645|565145506|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
156561546|NCT01360645|565145507|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
156561547|NCT01360645|565145508|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
156561548|NCT01360645|565145505|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
156561549|NCT01360645|565145506|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
156561550|NCT01360645|565145507|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
156561551|NCT01360645|565145508|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
156561552|NCT01360645|565145505|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
156561553|NCT01360645|565145506|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
156561554|NCT01360645|565145507|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
156561555|NCT01360645|565145508|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
156561556|NCT01360645|565145505|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
156561557|NCT01360645|565145506|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
156561558|NCT01360645|565145507|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
156561559|NCT01360645|565145508|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
156561560|NCT01360645|565145505|FG000|Phase B (6 Weeks)|Adverse Event|0|||
156561561|NCT01360645|565145506|FG001|Phase B (6 Weeks)|Adverse Event|6|||
156561562|NCT01360645|565145507|FG002|Phase B (6 Weeks)|Adverse Event|0|||
156561563|NCT01360645|565145508|FG003|Phase B (6 Weeks)|Adverse Event|0|||
156561564|NCT01360645|565145505|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
156561565|NCT01360645|565145506|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
156561566|NCT01360645|565145507|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
156561567|NCT01360645|565145508|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
156561568|NCT01360645|565145505|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
156561569|NCT01360645|565145506|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
156561570|NCT01360645|565145507|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
156561571|NCT01360645|565145508|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
156561572|NCT01360645|565145505|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
156561573|NCT01360645|565145506|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
156561574|NCT01360645|565145507|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
156561575|NCT01360645|565145508|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
156561576|NCT01360645|565145505|FG000|Phase A+|Lost to Follow-up|0|||
156561577|NCT01360645|565145506|FG001|Phase A+|Lost to Follow-up|0|||
156561578|NCT01360645|565145507|FG002|Phase A+|Lost to Follow-up|0|||
156561579|NCT01360645|565145508|FG003|Phase A+|Lost to Follow-up|7|||
156561580|NCT01360645|565145505|FG000|Phase A+|Adverse Event|0|||
156561581|NCT01360645|565145506|FG001|Phase A+|Adverse Event|0|||
156561582|NCT01360645|565145507|FG002|Phase A+|Adverse Event|0|||
156561583|NCT01360645|565145508|FG003|Phase A+|Adverse Event|2|||
156561584|NCT01360645|565145505|FG000|Phase A+|Met Withdrawal Criteria|0|||
156561585|NCT01360645|565145506|FG001|Phase A+|Met Withdrawal Criteria|0|||
156561586|NCT01360645|565145507|FG002|Phase A+|Met Withdrawal Criteria|0|||
156561587|NCT01360645|565145508|FG003|Phase A+|Met Withdrawal Criteria|4|||
156561588|NCT01360645|565145505|FG000|Phase A+|Physician Decision|0|||
156561589|NCT01360645|565145506|FG001|Phase A+|Physician Decision|0|||
156561590|NCT01360645|565145507|FG002|Phase A+|Physician Decision|0|||
156561591|NCT01360645|565145508|FG003|Phase A+|Physician Decision|2|||
156561592|NCT01360645|565145505|FG000|Phase A+|Withdrawal by Subject|0|||
156561593|NCT01360645|565145506|FG001|Phase A+|Withdrawal by Subject|0|||
156561594|NCT01360645|565145507|FG002|Phase A+|Withdrawal by Subject|0|||
156561595|NCT01360645|565145508|FG003|Phase A+|Withdrawal by Subject|5|||
156561596|NCT01360645|565145505|FG000|Phase A+|Protocol Deviation|0|||
156561597|NCT01360645|565145506|FG001|Phase A+|Protocol Deviation|0|||
156561598|NCT01360645|565145507|FG002|Phase A+|Protocol Deviation|0|||
156561599|NCT01360645|565145508|FG003|Phase A+|Protocol Deviation|4|||
156561600|NCT01014585|565145509|FG000|Overall Study|Adverse Event|0|||
156561601|NCT01014585|565145510|FG001|Overall Study|Adverse Event|2|||
156561602|NCT01014585|565145511|FG002|Overall Study|Adverse Event|0|||
156561603|NCT01014585|565145512|FG003|Overall Study|Adverse Event|3|||
156561604|NCT01014585|565145509|FG000|Overall Study|Withdrawal by Subject|2|||
156561605|NCT01014585|565145510|FG001|Overall Study|Withdrawal by Subject|0|||
156561606|NCT01014585|565145511|FG002|Overall Study|Withdrawal by Subject|1|||
156561607|NCT01014585|565145512|FG003|Overall Study|Withdrawal by Subject|3|||
156561608|NCT01014585|565145509|FG000|Overall Study|Lost to Follow-up|0|||
156561609|NCT01014585|565145510|FG001|Overall Study|Lost to Follow-up|0|||
156561610|NCT01014585|565145511|FG002|Overall Study|Lost to Follow-up|0|||
156518198|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
156518199|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
156518200|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
156518201|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
156518202|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
156518203|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
156518204|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Death|11|||
156518205|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Death|3|||
156518206|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
156518207|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
156518208|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Not Reported|0|||
156518209|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Not Reported|2|||
156518210|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
156518211|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
156518212|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
156518213|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
156518214|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
156518215|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
156518216|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
156518217|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
156518218|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
156518219|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
156518220|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
156518221|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
156518222|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
156518223|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
156518224|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
156518225|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
156518226|NCT01285609|564988439|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
156518227|NCT01285609|564988440|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
156518228|NCT01285609|564988439|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
156518229|NCT01285609|564988440|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
156518230|NCT01142115|564988441|FG000|First Intervention|Lack of Efficacy|1|||
156518231|NCT01142115|564988442|FG001|First Intervention|Lack of Efficacy|1|||
156518232|NCT01142115|564988441|FG000|First Intervention|Adverse Event|1|||
156518233|NCT01142115|564988442|FG001|First Intervention|Adverse Event|0|||
156518234|NCT00438672|564988444|FG000|Overall Study|Lost to Follow-up|7|||
156518235|NCT00438672|564988445|FG001|Overall Study|Lost to Follow-up|9|||
156518236|NCT04540887|564988451|FG000|Overall Study|Withdrawal by Subject|2|||
156518237|NCT02019667|564988452|FG000|First Intervention (6 Months)|Adverse Event|0|||
156518238|NCT02019667|564988453|FG001|First Intervention (6 Months)|Adverse Event|1|||
156518239|NCT02019667|564988452|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
156518240|NCT02019667|564988453|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
156518241|NCT02019667|564988452|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
156518242|NCT02019667|564988453|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
156518243|NCT05038163|564988457|FG000|Stage 1|Did not complete survey|374|||
156518244|NCT05038163|564988458|FG001|Stage 1|Did not complete survey|0|||
156518245|NCT05038163|564988459|FG002|Stage 1|Did not complete survey|0|||
156518246|NCT05038163|564988460|FG003|Stage 1|Did not complete survey|0|||
156518247|NCT05038163|564988461|FG004|Stage 1|Did not complete survey|0|||
156518248|NCT05038163|564988462|FG005|Stage 1|Did not complete survey|0|||
156518249|NCT05038163|564988457|FG000|Stage 2|Did not complete Stage 2 survey|0|||
156518250|NCT05038163|564988458|FG001|Stage 2|Did not complete Stage 2 survey|29|||
156518251|NCT05038163|564988459|FG002|Stage 2|Did not complete Stage 2 survey|30|||
156518252|NCT05038163|564988460|FG003|Stage 2|Did not complete Stage 2 survey|24|||
156518253|NCT05038163|564988461|FG004|Stage 2|Did not complete Stage 2 survey|21|||
156518254|NCT05038163|564988462|FG005|Stage 2|Did not complete Stage 2 survey|100|||
156518255|NCT03562975|564988463|FG000|Overall Study|Death|1|||
156518256|NCT03562975|564988463|FG000|Overall Study|Lost to Follow-up|1|||
156518257|NCT03562975|564988463|FG000|Overall Study|Withdrawal by Subject|1|||
156518258|NCT00552929|564988464|FG000|Overall Study|Lost to Follow-up|0|||
156518259|NCT00552929|564988465|FG001|Overall Study|Lost to Follow-up|0|||
156518260|NCT00552929|564988466|FG002|Overall Study|Lost to Follow-up|0|||
156518261|NCT00552929|564988467|FG003|Overall Study|Lost to Follow-up|0|||
156518262|NCT00552929|564988468|FG004|Overall Study|Lost to Follow-up|0|||
156518263|NCT00552929|564988469|FG005|Overall Study|Lost to Follow-up|0|||
156518264|NCT00552929|564988470|FG006|Overall Study|Lost to Follow-up|0|||
156518265|NCT00552929|564988471|FG007|Overall Study|Lost to Follow-up|0|||
156518266|NCT00552929|564988472|FG008|Overall Study|Lost to Follow-up|1|||
156518267|NCT00552929|564988473|FG009|Overall Study|Lost to Follow-up|0|||
156518268|NCT00552929|564988464|FG000|Overall Study|Not Eligible|0|||
156518269|NCT00552929|564988465|FG001|Overall Study|Not Eligible|0|||
156561611|NCT01014585|565145512|FG003|Overall Study|Lost to Follow-up|2|||
156561612|NCT01014585|565145509|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
156561613|NCT01014585|565145510|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
156561614|NCT01014585|565145511|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
156561615|NCT01014585|565145512|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
156561616|NCT01737931|565145519|FG000|Overall Study|Withdrawal by Subject|0|||
156561617|NCT01737931|565145520|FG001|Overall Study|Withdrawal by Subject|1|||
156561618|NCT01737931|565145521|FG002|Overall Study|Withdrawal by Subject|1|||
156561619|NCT01737931|565145519|FG000|Overall Study|Physician Decision|0|||
156561620|NCT01737931|565145520|FG001|Overall Study|Physician Decision|1|||
156561621|NCT01737931|565145521|FG002|Overall Study|Physician Decision|0|||
156561622|NCT04897867|565145522|FG000|Overall Study|Withdrawal of Consent|1|||
156561623|NCT04897867|565145522|FG000|Overall Study|Pregnancy|1|||
156561624|NCT04897867|565145522|FG000|Overall Study|Lost to Follow-up|7|||
156561625|NCT04897867|565145522|FG000|Overall Study|Reason not Specified|2|||
156561626|NCT00508391|565145523|FG000|First Treatment|Withdrawal by Subject|6|||
156561627|NCT00508391|565145524|FG001|First Treatment|Withdrawal by Subject|3|||
156561628|NCT00508391|565145523|FG000|Second Treatment|Withdrawal by Subject|2|||
156561629|NCT00508391|565145524|FG001|Second Treatment|Withdrawal by Subject|0|||
156561630|NCT00880256|565145528|FG000|Overall Study|Lost to Follow-up|28|||
156561631|NCT02041962|565145529|FG000|Overall Study|Lost Aetna Coverage|43|||
156561632|NCT02041962|565145530|FG001|Overall Study|Lost Aetna Coverage|40|||
156561633|NCT02041962|565145529|FG000|Overall Study|Death|1|||
156561634|NCT02041962|565145530|FG001|Overall Study|Death|1|||
156561635|NCT02041962|565145529|FG000|Overall Study|Lost to Follow-up|37|||
156561636|NCT02041962|565145530|FG001|Overall Study|Lost to Follow-up|32|||
156561637|NCT02041962|565145529|FG000|Overall Study|Withdrawal by Subject|0|||
156561638|NCT02041962|565145530|FG001|Overall Study|Withdrawal by Subject|11|||
156561639|NCT01686568|565145531|FG000|Main Study|Withdrawal by Subject|1|||
156561640|NCT01686568|565145532|FG001|Main Study|Withdrawal by Subject|3|||
156561641|NCT01686568|565145531|FG000|Main Study|Noncompliance with protocol|0|||
156561642|NCT01686568|565145532|FG001|Main Study|Noncompliance with protocol|1|||
156561643|NCT01686568|565145531|FG000|Main Study|Liver enzymes above range of exclusion|1|||
156561644|NCT01686568|565145532|FG001|Main Study|Liver enzymes above range of exclusion|0|||
156561645|NCT01686568|565145531|FG000|Sub-Study|Not consented for sub-study|2|||
156561646|NCT01686568|565145532|FG001|Sub-Study|Not consented for sub-study|2|||
156561647|NCT02601573|565145533|FG000|Overall Study|Lost to Follow-up|0|||
156561648|NCT02601573|565145534|FG001|Overall Study|Lost to Follow-up|3|||
156561649|NCT02601573|565145535|FG002|Overall Study|Lost to Follow-up|1|||
156561650|NCT02601573|565145536|FG003|Overall Study|Lost to Follow-up|0|||
156561651|NCT02601573|565145537|FG004|Overall Study|Lost to Follow-up|2|||
156561652|NCT02601573|565145533|FG000|Overall Study|Withdrawal by Subject|0|||
156561653|NCT02601573|565145534|FG001|Overall Study|Withdrawal by Subject|1|||
156561654|NCT02601573|565145535|FG002|Overall Study|Withdrawal by Subject|0|||
156561655|NCT02601573|565145536|FG003|Overall Study|Withdrawal by Subject|1|||
156561656|NCT02601573|565145537|FG004|Overall Study|Withdrawal by Subject|0|||
156561657|NCT01850615|565145538|FG000|Overall Study|Protocol Violation|4|||
156561658|NCT01850615|565145539|FG001|Overall Study|Protocol Violation|1|||
156561659|NCT01850615|565145538|FG000|Overall Study|Adverse Event|2|||
156561660|NCT01850615|565145539|FG001|Overall Study|Adverse Event|1|||
156561661|NCT01850615|565145538|FG000|Overall Study|Withdrawal by Subject|3|||
156561662|NCT01850615|565145539|FG001|Overall Study|Withdrawal by Subject|1|||
156561663|NCT01850615|565145538|FG000|Overall Study|Lost to Follow-up|0|||
156561664|NCT01850615|565145539|FG001|Overall Study|Lost to Follow-up|1|||
156561665|NCT01850615|565145538|FG000|Overall Study|Unclassified|0|||
156561666|NCT01850615|565145539|FG001|Overall Study|Unclassified|1|||
156518270|NCT00552929|564988466|FG002|Overall Study|Not Eligible|0|||
156518271|NCT00552929|564988467|FG003|Overall Study|Not Eligible|0|||
156518272|NCT00552929|564988468|FG004|Overall Study|Not Eligible|0|||
156518273|NCT00552929|564988469|FG005|Overall Study|Not Eligible|1|||
156518274|NCT00552929|564988470|FG006|Overall Study|Not Eligible|0|||
156518275|NCT00552929|564988471|FG007|Overall Study|Not Eligible|0|||
156518276|NCT00552929|564988472|FG008|Overall Study|Not Eligible|0|||
156518277|NCT00552929|564988473|FG009|Overall Study|Not Eligible|0|||
156518278|NCT01147536|564988474|FG000|Overall Study|Administrative study close|2|||
156518279|NCT01147536|564988474|FG000|Overall Study|Death|1|||
156518280|NCT00935818|564988475|FG000|Overall Study|Withdrawal by Subject|45|||
156518281|NCT00935818|564988476|FG001|Overall Study|Withdrawal by Subject|50|||
156561667|NCT00974220|565145540|FG000|Treatment Period 1|Adverse Event|2|||
156561668|NCT00974220|565145541|FG001|Treatment Period 1|Adverse Event|1|||
156561669|NCT00974220|565145540|FG000|Treatment Period 1|noncompliant subjects|0|||
156561670|NCT00974220|565145541|FG001|Treatment Period 1|noncompliant subjects|1|||
156561671|NCT00706628|565145542|FG000|Overall Study|Other Adverse Event|16|||
156561672|NCT00706628|565145543|FG001|Overall Study|Other Adverse Event|5|||
156561673|NCT00706628|565145544|FG002|Overall Study|Other Adverse Event|5|||
156518282|NCT00935818|564988475|FG000|Overall Study|Lost to Follow-up|40|||
156561674|NCT00706628|565145545|FG003|Overall Study|Other Adverse Event|2|||
156561675|NCT00706628|565145542|FG000|Overall Study|Non compliant with protocol|0|||
156518283|NCT00935818|564988476|FG001|Overall Study|Lost to Follow-up|42|||
156518284|NCT00935818|564988475|FG000|Overall Study|Adverse Event|6|||
156518285|NCT00935818|564988476|FG001|Overall Study|Adverse Event|7|||
156518286|NCT00935818|564988475|FG000|Overall Study|Physician Decision|0|||
156518287|NCT00935818|564988476|FG001|Overall Study|Physician Decision|1|||
156518288|NCT02592876|564988479|FG000|Overall Study|Withdrawal by Subject|3|||
156518289|NCT02592876|564988480|FG001|Overall Study|Withdrawal by Subject|3|||
156518290|NCT02592876|564988479|FG000|Overall Study|Study Termination by Sponsor|32|||
156518291|NCT02592876|564988480|FG001|Overall Study|Study Termination by Sponsor|27|||
156518292|NCT02592876|564988479|FG000|Overall Study|Lost to Follow-up|0|||
156518293|NCT02592876|564988480|FG001|Overall Study|Lost to Follow-up|1|||
156518294|NCT02592876|564988479|FG000|Overall Study|Death|6|||
156518295|NCT02592876|564988480|FG001|Overall Study|Death|9|||
156518296|NCT00867308|564988481|FG000|Overall Study|Death|1|||
156518297|NCT00867308|564988482|FG001|Overall Study|Death|0|||
156518298|NCT00867308|564988481|FG000|Overall Study|Adverse Event|1|||
156518299|NCT00867308|564988482|FG001|Overall Study|Adverse Event|4|||
156518300|NCT00867308|564988481|FG000|Overall Study|Lack of Efficacy|6|||
156518301|NCT00867308|564988482|FG001|Overall Study|Lack of Efficacy|12|||
156518302|NCT00867308|564988481|FG000|Overall Study|Withdrawal by Subject|1|||
156518303|NCT00867308|564988482|FG001|Overall Study|Withdrawal by Subject|2|||
156518304|NCT00604825|564988483|FG000|Overall Study|Adverse Event|2|||
156518305|NCT00604825|564988484|FG001|Overall Study|Adverse Event|6|||
156518306|NCT00604825|564988485|FG002|Overall Study|Adverse Event|7|||
156518307|NCT00604825|564988486|FG003|Overall Study|Adverse Event|4|||
156518308|NCT00604825|564988483|FG000|Overall Study|Lost to Follow-up|0|||
156518309|NCT00604825|564988484|FG001|Overall Study|Lost to Follow-up|3|||
156518310|NCT00604825|564988485|FG002|Overall Study|Lost to Follow-up|1|||
156518311|NCT00604825|564988486|FG003|Overall Study|Lost to Follow-up|0|||
156518312|NCT00604825|564988483|FG000|Overall Study|Protocol Violation|0|||
156518313|NCT00604825|564988484|FG001|Overall Study|Protocol Violation|1|||
156518314|NCT00604825|564988485|FG002|Overall Study|Protocol Violation|0|||
156518315|NCT00604825|564988486|FG003|Overall Study|Protocol Violation|0|||
156518316|NCT00604825|564988483|FG000|Overall Study|Withdrawal by Subject|4|||
156518317|NCT00604825|564988484|FG001|Overall Study|Withdrawal by Subject|3|||
156518318|NCT00604825|564988485|FG002|Overall Study|Withdrawal by Subject|5|||
156518319|NCT00604825|564988486|FG003|Overall Study|Withdrawal by Subject|5|||
156518320|NCT00604825|564988483|FG000|Overall Study|Lack of Efficacy|3|||
156518321|NCT00604825|564988484|FG001|Overall Study|Lack of Efficacy|2|||
156518322|NCT00604825|564988485|FG002|Overall Study|Lack of Efficacy|1|||
156518323|NCT00604825|564988486|FG003|Overall Study|Lack of Efficacy|0|||
156518324|NCT00604825|564988483|FG000|Overall Study|Did not meet eligibility criteria|0|||
156518325|NCT00604825|564988484|FG001|Overall Study|Did not meet eligibility criteria|0|||
156518326|NCT00604825|564988485|FG002|Overall Study|Did not meet eligibility criteria|2|||
156518327|NCT00604825|564988486|FG003|Overall Study|Did not meet eligibility criteria|0|||
156518328|NCT00604825|564988483|FG000|Overall Study|Physician Decision|0|||
156518329|NCT00604825|564988484|FG001|Overall Study|Physician Decision|0|||
156518330|NCT00604825|564988485|FG002|Overall Study|Physician Decision|0|||
156518331|NCT00604825|564988486|FG003|Overall Study|Physician Decision|1|||
156518332|NCT00604825|564988483|FG000|Overall Study|Exclusion criterion met|0|||
156518333|NCT00604825|564988484|FG001|Overall Study|Exclusion criterion met|0|||
156518334|NCT00604825|564988485|FG002|Overall Study|Exclusion criterion met|0|||
156518335|NCT00604825|564988486|FG003|Overall Study|Exclusion criterion met|1|||
156518336|NCT01305200|564988487|FG000|Overall Study|Physician Decision|4|||
156518337|NCT01305200|564988488|FG001|Overall Study|Physician Decision|6|||
156518338|NCT01305200|564988489|FG002|Overall Study|Physician Decision|1|||
156518339|NCT01305200|564988487|FG000|Overall Study|Withdrawal by Subject|24|||
156518340|NCT01305200|564988488|FG001|Overall Study|Withdrawal by Subject|21|||
156518341|NCT01305200|564988489|FG002|Overall Study|Withdrawal by Subject|1|||
156518342|NCT01305200|564988487|FG000|Overall Study|Ineligible|1|||
156518343|NCT01305200|564988488|FG001|Overall Study|Ineligible|2|||
156518344|NCT01305200|564988489|FG002|Overall Study|Ineligible|1|||
156518345|NCT01305200|564988487|FG000|Overall Study|Death|0|||
156518346|NCT01305200|564988488|FG001|Overall Study|Death|2|||
156518347|NCT01305200|564988489|FG002|Overall Study|Death|0|||
156518348|NCT00925353|564988490|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
156518349|NCT03647488|564990329|FG000|Overall Study|Progressive disease|10|||
156518350|NCT03647488|564990330|FG001|Overall Study|Progressive disease|0|||
156518351|NCT03647488|564990331|FG002|Overall Study|Progressive disease|0|||
156518352|NCT03647488|564990329|FG000|Overall Study|Adverse Event|5|||
156518353|NCT03647488|564990330|FG001|Overall Study|Adverse Event|0|||
156518354|NCT03647488|564990331|FG002|Overall Study|Adverse Event|0|||
156518355|NCT03647488|564990329|FG000|Overall Study|Clinical progression|2|||
156518356|NCT03647488|564990330|FG001|Overall Study|Clinical progression|0|||
156518357|NCT03647488|564990331|FG002|Overall Study|Clinical progression|0|||
156518358|NCT03647488|564990329|FG000|Overall Study|Participant refused to take investigational product|1|||
156518359|NCT03647488|564990330|FG001|Overall Study|Participant refused to take investigational product|0|||
156518360|NCT03647488|564990331|FG002|Overall Study|Participant refused to take investigational product|0|||
156518361|NCT00812331|564990332|FG000|Overall Study|Adverse Event|1|||
156518362|NCT00812331|564990333|FG001|Overall Study|Adverse Event|0|||
156518363|NCT00812331|564990334|FG002|Overall Study|Adverse Event|0|||
156518364|NCT00812331|564990335|FG003|Overall Study|Adverse Event|0|||
156518365|NCT00812331|564990336|FG004|Overall Study|Adverse Event|0|||
156518366|NCT02502799|564990337|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
156518367|NCT02502799|564990338|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
156518368|NCT02502799|564990339|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
156518369|NCT02502799|564990340|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
156518370|NCT02502799|564990337|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
156518371|NCT02502799|564990338|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
156518372|NCT02502799|564990339|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
156518373|NCT02502799|564990340|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
156518374|NCT02502799|564990337|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
156518375|NCT02502799|564990338|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
156518376|NCT02502799|564990339|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
156518377|NCT02502799|564990340|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
156518378|NCT02502799|564990337|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
156518379|NCT02502799|564990338|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
156518380|NCT02502799|564990339|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
156518381|NCT02502799|564990340|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
156518382|NCT02502799|564990337|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
156518383|NCT02502799|564990338|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
156518384|NCT02502799|564990339|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
156518385|NCT02502799|564990340|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
156518386|NCT00153062|564990341|FG000|Overall Study|Death|360|||
156518387|NCT00153062|564990342|FG001|Overall Study|Death|352|||
156518388|NCT00153062|564990343|FG002|Overall Study|Death|369|||
156518389|NCT00153062|564990344|FG003|Overall Study|Death|365|||
156518390|NCT00153062|564990341|FG000|Overall Study|Withdrawal by Subject|14|||
156518391|NCT00153062|564990342|FG001|Overall Study|Withdrawal by Subject|30|||
156518392|NCT00153062|564990343|FG002|Overall Study|Withdrawal by Subject|27|||
156518393|NCT00153062|564990344|FG003|Overall Study|Withdrawal by Subject|28|||
156518394|NCT00153062|564990341|FG000|Overall Study|Lost to Follow-up|12|||
156518395|NCT00153062|564990342|FG001|Overall Study|Lost to Follow-up|20|||
156518396|NCT00153062|564990343|FG002|Overall Study|Lost to Follow-up|15|||
156518397|NCT00153062|564990344|FG003|Overall Study|Lost to Follow-up|16|||
156518398|NCT00153062|564990341|FG000|Overall Study|Adverse Event|0|||
156518399|NCT00153062|564990342|FG001|Overall Study|Adverse Event|1|||
156518400|NCT00153062|564990343|FG002|Overall Study|Adverse Event|1|||
156518401|NCT00153062|564990344|FG003|Overall Study|Adverse Event|0|||
156518402|NCT00153062|564990341|FG000|Overall Study|Protocol Violation|0|||
156518403|NCT00153062|564990342|FG001|Overall Study|Protocol Violation|2|||
156518404|NCT00153062|564990343|FG002|Overall Study|Protocol Violation|1|||
156518405|NCT00153062|564990344|FG003|Overall Study|Protocol Violation|1|||
156518406|NCT00153062|564990341|FG000|Overall Study|No disposition data available|1|||
156518407|NCT00153062|564990342|FG001|Overall Study|No disposition data available|1|||
156518408|NCT00153062|564990343|FG002|Overall Study|No disposition data available|1|||
156518409|NCT00153062|564990344|FG003|Overall Study|No disposition data available|1|||
156518410|NCT00153062|564990341|FG000|Overall Study|Other|0|||
156518411|NCT00153062|564990342|FG001|Overall Study|Other|0|||
156518412|NCT00153062|564990343|FG002|Overall Study|Other|1|||
156518413|NCT00153062|564990344|FG003|Overall Study|Other|0|||
156518414|NCT01589237|564990357|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
156518415|NCT01589237|564990358|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
156518416|NCT01589237|564990359|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
156518417|NCT01589237|564990360|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
156518418|NCT01589237|564990357|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
156518419|NCT01589237|564990358|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
156518420|NCT01589237|564990359|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
156518421|NCT01589237|564990360|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
156518422|NCT01589237|564990357|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
156518423|NCT01589237|564990358|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
156518424|NCT01589237|564990359|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
156518425|NCT01589237|564990360|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
156518426|NCT01589237|564990357|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
156518427|NCT01589237|564990358|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
156518428|NCT01589237|564990359|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
156518429|NCT01589237|564990360|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
156518430|NCT00117845|564990361|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
156561676|NCT00706628|565145543|FG001|Overall Study|Non compliant with protocol|1|||
156561677|NCT00706628|565145544|FG002|Overall Study|Non compliant with protocol|0|||
156561678|NCT00706628|565145545|FG003|Overall Study|Non compliant with protocol|0|||
156561679|NCT00706628|565145542|FG000|Overall Study|Consent withdrawn|6|||
156561680|NCT00706628|565145543|FG001|Overall Study|Consent withdrawn|1|||
156561681|NCT00706628|565145544|FG002|Overall Study|Consent withdrawn|3|||
156561682|NCT00706628|565145545|FG003|Overall Study|Consent withdrawn|0|||
156561683|NCT00706628|565145542|FG000|Overall Study|Progressive disease|20|||
156561684|NCT00706628|565145543|FG001|Overall Study|Progressive disease|13|||
156561685|NCT00706628|565145544|FG002|Overall Study|Progressive disease|8|||
156561686|NCT00706628|565145545|FG003|Overall Study|Progressive disease|1|||
156561687|NCT00706628|565145542|FG000|Overall Study|Other than those stated above|4|||
156561688|NCT00706628|565145543|FG001|Overall Study|Other than those stated above|0|||
156561689|NCT00706628|565145544|FG002|Overall Study|Other than those stated above|0|||
156561690|NCT00706628|565145545|FG003|Overall Study|Other than those stated above|0|||
156561691|NCT00706628|565145542|FG000|Overall Study|Not treated|1|||
156561692|NCT00706628|565145543|FG001|Overall Study|Not treated|1|||
156561693|NCT00706628|565145544|FG002|Overall Study|Not treated|0|||
156561694|NCT00706628|565145545|FG003|Overall Study|Not treated|0|||
156561695|NCT03403400|565145546|FG000|Overall Study|Lost to Follow-up|1|||
156561696|NCT03403400|565145547|FG001|Overall Study|Lost to Follow-up|0|||
156561697|NCT03403400|565145548|FG002|Overall Study|Lost to Follow-up|1|||
156561698|NCT03403400|565145546|FG000|Overall Study|Hospitalization|1|||
156561699|NCT03403400|565145547|FG001|Overall Study|Hospitalization|0|||
156561700|NCT03403400|565145548|FG002|Overall Study|Hospitalization|0|||
156561701|NCT03403400|565145546|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
156561702|NCT03403400|565145547|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
156561703|NCT03403400|565145548|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
156561704|NCT01948830|565145549|FG000|Overall Study|Physician Decision|1|||
156561705|NCT01948830|565145550|FG001|Overall Study|Physician Decision|3|||
156561706|NCT01948830|565145549|FG000|Overall Study|Protocol deviation|1|||
156561707|NCT01948830|565145550|FG001|Overall Study|Protocol deviation|2|||
156561708|NCT01948830|565145549|FG000|Overall Study|Lost to Follow-up|5|||
156561709|NCT01948830|565145550|FG001|Overall Study|Lost to Follow-up|4|||
156561710|NCT01948830|565145549|FG000|Overall Study|Withdrawal by Subject|14|||
156561711|NCT01948830|565145550|FG001|Overall Study|Withdrawal by Subject|17|||
156561712|NCT01948830|565145549|FG000|Overall Study|Adverse Event|9|||
156561713|NCT01948830|565145550|FG001|Overall Study|Adverse Event|2|||
156561714|NCT01948830|565145549|FG000|Overall Study|Death|3|||
156561715|NCT01948830|565145550|FG001|Overall Study|Death|4|||
156561716|NCT01145560|565145551|FG000|Overall Study|Withdrawal by Subject|2|||
156561717|NCT01145560|565145552|FG001|Overall Study|Withdrawal by Subject|1|||
156561718|NCT01145560|565145553|FG002|Overall Study|Withdrawal by Subject|0|||
156561719|NCT01145560|565145551|FG000|Overall Study|Lost to Follow-up|1|||
156561720|NCT01145560|565145552|FG001|Overall Study|Lost to Follow-up|1|||
156561721|NCT01145560|565145553|FG002|Overall Study|Lost to Follow-up|1|||
156561722|NCT01145560|565145551|FG000|Overall Study|No study drug by 24h after organ failure|1|||
156561723|NCT01145560|565145552|FG001|Overall Study|No study drug by 24h after organ failure|0|||
156561724|NCT01145560|565145553|FG002|Overall Study|No study drug by 24h after organ failure|0|||
156561725|NCT01145560|565145551|FG000|Overall Study|Accidental unblinding of study treatment|0|||
156561726|NCT01145560|565145552|FG001|Overall Study|Accidental unblinding of study treatment|1|||
156561727|NCT01145560|565145553|FG002|Overall Study|Accidental unblinding of study treatment|0|||
156561728|NCT01145560|565145551|FG000|Overall Study|False insurance information|0|||
156561729|NCT01145560|565145552|FG001|Overall Study|False insurance information|1|||
156561730|NCT01145560|565145553|FG002|Overall Study|False insurance information|0|||
156561731|NCT01145560|565145551|FG000|Overall Study|Withdrawal of therapy|0|||
156561732|NCT01145560|565145552|FG001|Overall Study|Withdrawal of therapy|0|||
156561733|NCT01145560|565145553|FG002|Overall Study|Withdrawal of therapy|1|||
156561734|NCT02411747|565145555|FG000|Overall Study|Withdrawal by Subject|1|||
156561735|NCT02411747|565145556|FG001|Overall Study|Withdrawal by Subject|0|||
156561736|NCT02411747|565145555|FG000|Overall Study|Protocol Violation|2|||
156561737|NCT02411747|565145556|FG001|Overall Study|Protocol Violation|4|||
156561738|NCT00675597|565145557|FG000|Overall Study|Withdrawal by Subject|3|||
156561739|NCT00560755|565145559|FG000|Overall Study|Protocol Violation|15|||
156561740|NCT00560755|565145559|FG000|Overall Study|Withdrawal by Subject|26|||
156561741|NCT00560755|565145559|FG000|Overall Study|Lost to Follow-up|9|||
156561742|NCT00560755|565145559|FG000|Overall Study|Adverse Event|8|||
156561743|NCT00560755|565145559|FG000|Overall Study|Physician Decision|2|||
156561744|NCT01439945|565145564|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
156561745|NCT01439945|565145565|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
156561746|NCT01439945|565145566|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
156561747|NCT01439945|565145567|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
156561748|NCT01439945|565145564|FG000|Double-Blind Treatment Phase|Ineligible|1|||
156561749|NCT01439945|565145565|FG001|Double-Blind Treatment Phase|Ineligible|2|||
156561750|NCT01439945|565145566|FG002|Double-Blind Treatment Phase|Ineligible|0|||
156561751|NCT01439945|565145567|FG003|Double-Blind Treatment Phase|Ineligible|1|||
156561752|NCT04082663|565145580|FG000|Overall Study|Adverse Event|6|||
156518431|NCT03207009|564990362|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
156518432|NCT00759915|564990363|FG000|Overall Study|Withdrawal by Subject|1|||
156518433|NCT00759915|564990364|FG001|Overall Study|Withdrawal by Subject|0|||
156518434|NCT00759915|564990363|FG000|Overall Study|Adverse Event|0|||
156518435|NCT00759915|564990364|FG001|Overall Study|Adverse Event|1|||
156518436|NCT00932113|564990367|FG000|Overall Study|Lost to Follow-up|1|||
156518437|NCT00932113|564990368|FG001|Overall Study|Lost to Follow-up|0|||
156518438|NCT01403610|564990371|FG000|Overall Study|Withdrawal by Subject|2|||
156518439|NCT01403610|564990372|FG001|Overall Study|Withdrawal by Subject|0|||
156518440|NCT01403610|564990373|FG002|Overall Study|Withdrawal by Subject|0|||
156518441|NCT01403610|564990374|FG003|Overall Study|Withdrawal by Subject|0|||
156518442|NCT01403610|564990371|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
156518443|NCT01403610|564990372|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
156518444|NCT01403610|564990373|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
156518445|NCT01403610|564990374|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
156518446|NCT00512317|564990375|FG000|Overall Study|Insufficient clinical response|36|||
156518447|NCT00512317|564990375|FG000|Overall Study|Withdrawal by Subject|23|||
156518448|NCT00512317|564990375|FG000|Overall Study|Sponsor closure of study|21|||
156518449|NCT00512317|564990375|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
156518450|NCT00512317|564990375|FG000|Overall Study|Adverse Event|13|||
156518451|NCT00512317|564990375|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
156518452|NCT00512317|564990375|FG000|Overall Study|Lost to Follow-up|2|||
156518453|NCT00512317|564990375|FG000|Overall Study|Other|2|||
156518454|NCT01491672|564990376|FG000|Overall Study|Lost to Follow-up|0|||
156518455|NCT01491672|564990377|FG001|Overall Study|Lost to Follow-up|4|||
156518456|NCT01491672|564990378|FG002|Overall Study|Lost to Follow-up|1|||
156518457|NCT01491672|564990376|FG000|Overall Study|Withdrawal by Subject|6|||
156518458|NCT01491672|564990377|FG001|Overall Study|Withdrawal by Subject|7|||
156518459|NCT01491672|564990378|FG002|Overall Study|Withdrawal by Subject|0|||
156518460|NCT01491672|564990376|FG000|Overall Study|Adverse Event|8|||
156518461|NCT01491672|564990377|FG001|Overall Study|Adverse Event|10|||
156518462|NCT01491672|564990378|FG002|Overall Study|Adverse Event|4|||
156518463|NCT01491672|564990376|FG000|Overall Study|Disease progression|42|||
156518464|NCT01491672|564990377|FG001|Overall Study|Disease progression|34|||
156518465|NCT01491672|564990378|FG002|Overall Study|Disease progression|6|||
156518466|NCT01491672|564990376|FG000|Overall Study|Protocol deviation|0|||
156518467|NCT01491672|564990377|FG001|Overall Study|Protocol deviation|1|||
156518468|NCT01491672|564990378|FG002|Overall Study|Protocol deviation|0|||
156518469|NCT01491672|564990376|FG000|Overall Study|Death|0|||
156518470|NCT01491672|564990377|FG001|Overall Study|Death|4|||
156518471|NCT01491672|564990378|FG002|Overall Study|Death|0|||
156518472|NCT04875676|564990379|FG000|Overall Study|Lost to Follow-up|1|||
156518473|NCT04875676|564990380|FG001|Overall Study|Lost to Follow-up|0|||
156518474|NCT04875676|564990381|FG002|Overall Study|Lost to Follow-up|0|||
156518475|NCT03103763|564990384|FG000|Overall Study|Death|15|||
156518476|NCT03103763|564990385|FG001|Overall Study|Death|5|||
156518477|NCT03103763|564990386|FG002|Overall Study|Death|5|||
156518478|NCT03103763|564990384|FG000|Overall Study|Withdrawal by Subject|0|||
156518479|NCT03103763|564990385|FG001|Overall Study|Withdrawal by Subject|3|||
156518480|NCT03103763|564990386|FG002|Overall Study|Withdrawal by Subject|2|||
156518481|NCT03245151|564990387|FG000|Overall Study|Withdrawal by Subject|2|||
156518482|NCT03245151|564990388|FG001|Overall Study|Withdrawal by Subject|0|||
156518483|NCT03245151|564990389|FG002|Overall Study|Withdrawal by Subject|0|||
156518484|NCT03245151|564990390|FG003|Overall Study|Withdrawal by Subject|2|||
156518485|NCT03245151|564990391|FG004|Overall Study|Withdrawal by Subject|1|||
156518486|NCT03245151|564990387|FG000|Overall Study|Death|3|||
156518487|NCT03245151|564990388|FG001|Overall Study|Death|14|||
156518488|NCT03245151|564990389|FG002|Overall Study|Death|9|||
156518489|NCT03245151|564990390|FG003|Overall Study|Death|16|||
156518490|NCT03245151|564990391|FG004|Overall Study|Death|7|||
156518491|NCT03245151|564990387|FG000|Overall Study|Sponsor's decision|0|||
156518492|NCT03245151|564990388|FG001|Overall Study|Sponsor's decision|1|||
156518493|NCT03245151|564990389|FG002|Overall Study|Sponsor's decision|0|||
156518494|NCT03245151|564990390|FG003|Overall Study|Sponsor's decision|0|||
156518495|NCT03245151|564990391|FG004|Overall Study|Sponsor's decision|0|||
156518496|NCT01970345|564990392|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
156518497|NCT01970345|564990393|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
156518498|NCT01970345|564990392|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
156518499|NCT01970345|564990393|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
156518500|NCT01346475|564990394|FG000|First Intervention|Lost to Follow-up|4|||
156518501|NCT01346475|564990395|FG001|First Intervention|Lost to Follow-up|3|||
156518502|NCT01552603|564990396|FG000|Overall Study|Physician Decision|1|||
156518503|NCT00618618|564990397|FG000|Overall Study|Patient Request|0|||
156518504|NCT00618618|564990398|FG001|Overall Study|Patient Request|0|||
156518505|NCT00618618|564990399|FG002|Overall Study|Patient Request|2|||
156518506|NCT00618618|564990400|FG003|Overall Study|Patient Request|0|||
156518507|NCT00618618|564990397|FG000|Overall Study|Inability to Complete Study Procedures|0|||
156518508|NCT00618618|564990398|FG001|Overall Study|Inability to Complete Study Procedures|1|||
156518509|NCT00618618|564990399|FG002|Overall Study|Inability to Complete Study Procedures|0|||
156518510|NCT00618618|564990400|FG003|Overall Study|Inability to Complete Study Procedures|0|||
156518511|NCT00618618|564990397|FG000|Overall Study|Lost to Follow-up|3|||
156518512|NCT00618618|564990398|FG001|Overall Study|Lost to Follow-up|0|||
156518513|NCT00618618|564990399|FG002|Overall Study|Lost to Follow-up|0|||
156518514|NCT00618618|564990400|FG003|Overall Study|Lost to Follow-up|1|||
156518515|NCT00618618|564990397|FG000|Overall Study|Non-compliance|1|||
156518516|NCT00618618|564990398|FG001|Overall Study|Non-compliance|1|||
156518517|NCT00618618|564990399|FG002|Overall Study|Non-compliance|0|||
156518518|NCT00618618|564990400|FG003|Overall Study|Non-compliance|0|||
156518519|NCT00618618|564990397|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
156518520|NCT00618618|564990398|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
156518521|NCT00618618|564990399|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
156518522|NCT00618618|564990400|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
156518523|NCT00618618|564990397|FG000|Overall Study|Death|0|||
156518524|NCT00618618|564990398|FG001|Overall Study|Death|1|||
156518525|NCT00618618|564990399|FG002|Overall Study|Death|0|||
156518526|NCT00618618|564990400|FG003|Overall Study|Death|0|||
156518527|NCT00621777|564990404|FG000|Open Phase|Adverse Event|20|||
156518528|NCT00621777|564990405|FG001|Open Phase|Adverse Event|0|||
156518529|NCT00621777|564990404|FG000|Open Phase|Did not abstain during open phase|56|||
156518530|NCT00621777|564990405|FG001|Open Phase|Did not abstain during open phase|0|||
156518531|NCT00621777|564990404|FG000|Open Phase|Withdrawal by Subject|17|||
156518532|NCT00621777|564990405|FG001|Open Phase|Withdrawal by Subject|0|||
156518533|NCT00621777|564990404|FG000|Open Phase|administrative|13|||
156518534|NCT00621777|564990405|FG001|Open Phase|administrative|0|||
156518535|NCT00621777|564990404|FG000|Open Phase|Lost to Follow-up|10|||
156518536|NCT00621777|564990405|FG001|Open Phase|Lost to Follow-up|0|||
156518537|NCT00621777|564990404|FG000|Randomized Phase|Adverse Event|3|||
156518538|NCT00621777|564990405|FG001|Randomized Phase|Adverse Event|3|||
156518539|NCT00621777|564990404|FG000|Randomized Phase|Lost to Follow-up|3|||
156518540|NCT00621777|564990405|FG001|Randomized Phase|Lost to Follow-up|3|||
156518541|NCT00621777|564990404|FG000|Randomized Phase|Withdrawal by Subject|1|||
156518542|NCT00621777|564990405|FG001|Randomized Phase|Withdrawal by Subject|9|||
156518543|NCT00621777|564990404|FG000|Randomized Phase|administrative|0|||
156518544|NCT00621777|564990405|FG001|Randomized Phase|administrative|3|||
156518545|NCT00621777|564990404|FG000|Randomized Phase|Death|0|||
156518546|NCT00621777|564990405|FG001|Randomized Phase|Death|1|||
156518547|NCT04797650|564990408|FG000|Overall Study|Reason Not Specified|5|||
156518548|NCT04797650|564990409|FG001|Overall Study|Reason Not Specified|12|||
156518549|NCT04797650|564990410|FG002|Overall Study|Reason Not Specified|5|||
156518550|NCT04797650|564990408|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
156518551|NCT04797650|564990409|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
156518552|NCT04797650|564990410|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
156518553|NCT04797650|564990408|FG000|Overall Study|Lack of Efficacy|1|||
156518554|NCT04797650|564990409|FG001|Overall Study|Lack of Efficacy|0|||
156518555|NCT04797650|564990410|FG002|Overall Study|Lack of Efficacy|1|||
156518556|NCT04797650|564990408|FG000|Overall Study|Non-compliance with Study Drug|0|||
156518557|NCT04797650|564990409|FG001|Overall Study|Non-compliance with Study Drug|0|||
156518558|NCT04797650|564990410|FG002|Overall Study|Non-compliance with Study Drug|2|||
156518559|NCT04797650|564990408|FG000|Overall Study|Lost to Follow-up|4|||
156518560|NCT04797650|564990409|FG001|Overall Study|Lost to Follow-up|6|||
156518561|NCT04797650|564990410|FG002|Overall Study|Lost to Follow-up|1|||
156518562|NCT00700258|564990411|FG000|Overall Study|Premature discontinuation of documentation|136|||
156518563|NCT00700258|564990411|FG000|Overall Study|Type of study end not documented|1|||
156518564|NCT00700258|564990411|FG000|Overall Study|Lost to Follow-up|81|||
156518565|NCT00700258|564990411|FG000|Overall Study|Premature discontinuation of therapy|1013|||
156518566|NCT00473265|564990413|FG000|Overall Study|Unrelated adverse event|5|||
156518567|NCT00473265|564990413|FG000|Overall Study|Off treatment early|15|||
156518568|NCT00309959|564990417|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
156518569|NCT02663518|564990418|FG000|Part 1: Phase 1a Escalation|Death|0|||
156518570|NCT02663518|564990419|FG001|Part 1: Phase 1a Escalation|Death|0|||
156518571|NCT02663518|564990420|FG002|Part 1: Phase 1a Escalation|Death|1|||
156518572|NCT02663518|564990421|FG003|Part 1: Phase 1a Escalation|Death|0|||
156518573|NCT02663518|564990422|FG004|Part 1: Phase 1a Escalation|Death|0|||
156518574|NCT02663518|564990423|FG005|Part 1: Phase 1a Escalation|Death|0|||
156518575|NCT02663518|564990424|FG006|Part 1: Phase 1a Escalation|Death|0|||
156518576|NCT02663518|564990425|FG007|Part 1: Phase 1a Escalation|Death|0|||
156518577|NCT02663518|564990426|FG008|Part 1: Phase 1a Escalation|Death|0|||
156518578|NCT02663518|564990427|FG009|Part 1: Phase 1a Escalation|Death|0|||
156518579|NCT02663518|564990428|FG010|Part 1: Phase 1a Escalation|Death|0|||
156518580|NCT02663518|564990429|FG011|Part 1: Phase 1a Escalation|Death|0|||
156518581|NCT02663518|564990430|FG012|Part 1: Phase 1a Escalation|Death|0|||
156518582|NCT02663518|564990431|FG013|Part 1: Phase 1a Escalation|Death|0|||
156518583|NCT02663518|564990418|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518584|NCT02663518|564990419|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518585|NCT02663518|564990420|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
156518586|NCT02663518|564990421|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518587|NCT02663518|564990422|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518588|NCT02663518|564990423|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518589|NCT02663518|564990424|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518590|NCT02663518|564990425|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518591|NCT02663518|564990426|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518592|NCT02663518|564990427|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518593|NCT02663518|564990428|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518594|NCT02663518|564990429|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518595|NCT02663518|564990430|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518596|NCT02663518|564990431|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
156518597|NCT02663518|564990418|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
156518598|NCT02663518|564990419|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
156518599|NCT02663518|564990420|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
156518600|NCT02663518|564990421|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
156518601|NCT02663518|564990422|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518602|NCT02663518|564990423|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518603|NCT02663518|564990424|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518604|NCT02663518|564990425|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518605|NCT02663518|564990426|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518606|NCT02663518|564990427|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518607|NCT02663518|564990428|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518608|NCT02663518|564990429|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518609|NCT02663518|564990430|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518610|NCT02663518|564990431|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
156518611|NCT02663518|564990418|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
156518612|NCT02663518|564990419|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518613|NCT02663518|564990420|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
156518614|NCT02663518|564990421|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
156518615|NCT02663518|564990422|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518616|NCT02663518|564990423|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518617|NCT02663518|564990424|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518618|NCT02663518|564990425|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518619|NCT02663518|564990426|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518620|NCT02663518|564990427|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518621|NCT02663518|564990428|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518622|NCT02663518|564990429|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518623|NCT02663518|564990430|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518624|NCT02663518|564990431|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
156518625|NCT02663518|564990418|FG000|Part 1: Phase 1a Escalation|Other|0|||
156518626|NCT02663518|564990419|FG001|Part 1: Phase 1a Escalation|Other|0|||
156518627|NCT02663518|564990420|FG002|Part 1: Phase 1a Escalation|Other|2|||
156518628|NCT02663518|564990421|FG003|Part 1: Phase 1a Escalation|Other|0|||
156518629|NCT02663518|564990422|FG004|Part 1: Phase 1a Escalation|Other|0|||
156518630|NCT02663518|564990423|FG005|Part 1: Phase 1a Escalation|Other|0|||
156518631|NCT02663518|564990424|FG006|Part 1: Phase 1a Escalation|Other|0|||
156518632|NCT02663518|564990425|FG007|Part 1: Phase 1a Escalation|Other|0|||
156518633|NCT02663518|564990426|FG008|Part 1: Phase 1a Escalation|Other|0|||
156518634|NCT02663518|564990427|FG009|Part 1: Phase 1a Escalation|Other|0|||
156518635|NCT02663518|564990428|FG010|Part 1: Phase 1a Escalation|Other|0|||
156518636|NCT02663518|564990429|FG011|Part 1: Phase 1a Escalation|Other|0|||
156518637|NCT02663518|564990430|FG012|Part 1: Phase 1a Escalation|Other|0|||
156518638|NCT02663518|564990431|FG013|Part 1: Phase 1a Escalation|Other|0|||
156518639|NCT02663518|564990418|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518640|NCT02663518|564990419|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518641|NCT02663518|564990420|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518642|NCT02663518|564990421|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518643|NCT02663518|564990422|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
156518644|NCT02663518|564990423|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518645|NCT02663518|564990424|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
156518646|NCT02663518|564990425|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
156518647|NCT02663518|564990426|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518648|NCT02663518|564990427|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518649|NCT02663518|564990428|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518650|NCT02663518|564990429|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518651|NCT02663518|564990430|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518652|NCT02663518|564990431|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
156518653|NCT02663518|564990418|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518654|NCT02663518|564990419|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518655|NCT02663518|564990420|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518656|NCT02663518|564990421|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518657|NCT02663518|564990422|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
156518658|NCT02663518|564990423|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518659|NCT02663518|564990424|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
156518660|NCT02663518|564990425|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
156518661|NCT02663518|564990426|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518662|NCT02663518|564990427|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518663|NCT02663518|564990428|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518664|NCT02663518|564990429|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518665|NCT02663518|564990430|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518666|NCT02663518|564990431|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
156518667|NCT02663518|564990418|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518668|NCT02663518|564990419|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518669|NCT02663518|564990420|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518670|NCT02663518|564990421|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518671|NCT02663518|564990422|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
156518672|NCT02663518|564990423|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518673|NCT02663518|564990424|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518674|NCT02663518|564990425|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518675|NCT02663518|564990426|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518676|NCT02663518|564990427|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518677|NCT02663518|564990428|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518678|NCT02663518|564990429|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518679|NCT02663518|564990430|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518680|NCT02663518|564990431|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
156518681|NCT02663518|564990418|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518682|NCT02663518|564990419|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518683|NCT02663518|564990420|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518684|NCT02663518|564990421|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518685|NCT02663518|564990422|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
156518686|NCT02663518|564990423|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
156518687|NCT02663518|564990424|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
156518688|NCT02663518|564990425|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
156518689|NCT02663518|564990426|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518690|NCT02663518|564990427|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518691|NCT02663518|564990428|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518692|NCT02663518|564990429|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518693|NCT02663518|564990430|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518694|NCT02663518|564990431|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
156518695|NCT02663518|564990418|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518696|NCT02663518|564990419|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518697|NCT02663518|564990420|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518698|NCT02663518|564990421|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518699|NCT02663518|564990422|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
156518700|NCT02663518|564990423|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518701|NCT02663518|564990424|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
156518702|NCT02663518|564990425|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518703|NCT02663518|564990426|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518704|NCT02663518|564990427|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518705|NCT02663518|564990428|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518706|NCT02663518|564990429|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518707|NCT02663518|564990430|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518708|NCT02663518|564990431|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
156518709|NCT02663518|564990418|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518710|NCT02663518|564990419|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518711|NCT02663518|564990420|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518712|NCT02663518|564990421|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518713|NCT02663518|564990422|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518714|NCT02663518|564990423|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518715|NCT02663518|564990424|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
156518716|NCT02663518|564990425|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518717|NCT02663518|564990426|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518718|NCT02663518|564990427|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518719|NCT02663518|564990428|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518720|NCT02663518|564990429|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518721|NCT02663518|564990430|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156561753|NCT04082663|565145580|FG000|Overall Study|Lost to Follow-up|1|||
156518722|NCT02663518|564990431|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
156518723|NCT02663518|564990418|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
156518724|NCT02663518|564990419|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
156518725|NCT02663518|564990420|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
156518726|NCT02663518|564990421|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
156518727|NCT02663518|564990422|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
156518728|NCT02663518|564990423|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
156518729|NCT02663518|564990424|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
156518730|NCT02663518|564990425|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
156518731|NCT02663518|564990426|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
156518732|NCT02663518|564990427|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
156518733|NCT02663518|564990428|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
156518734|NCT02663518|564990429|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
156518735|NCT02663518|564990430|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
156518736|NCT02663518|564990431|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
156518737|NCT02663518|564990418|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518738|NCT02663518|564990419|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518739|NCT02663518|564990420|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518740|NCT02663518|564990421|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518741|NCT02663518|564990422|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518742|NCT02663518|564990423|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518743|NCT02663518|564990424|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518744|NCT02663518|564990425|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518745|NCT02663518|564990426|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518746|NCT02663518|564990427|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518747|NCT02663518|564990428|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518748|NCT02663518|564990429|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518749|NCT02663518|564990430|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
156518750|NCT02663518|564990431|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
156518751|NCT02663518|564990418|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518752|NCT02663518|564990419|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518753|NCT02663518|564990420|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518754|NCT02663518|564990421|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518755|NCT02663518|564990422|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518756|NCT02663518|564990423|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518757|NCT02663518|564990424|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518758|NCT02663518|564990425|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518759|NCT02663518|564990426|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518760|NCT02663518|564990427|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518761|NCT02663518|564990428|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518762|NCT02663518|564990429|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
156518763|NCT02663518|564990430|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518764|NCT02663518|564990431|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
156518765|NCT02663518|564990418|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518766|NCT02663518|564990419|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518767|NCT02663518|564990420|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518768|NCT02663518|564990421|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518769|NCT02663518|564990422|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518770|NCT02663518|564990423|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518771|NCT02663518|564990424|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518772|NCT02663518|564990425|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518773|NCT02663518|564990426|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518774|NCT02663518|564990427|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
156518775|NCT02663518|564990428|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
156518776|NCT02663518|564990429|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
156518777|NCT02663518|564990430|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
156518778|NCT02663518|564990431|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
156518779|NCT02663518|564990418|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
156518780|NCT02663518|564990419|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
156518781|NCT02663518|564990420|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
156518782|NCT02663518|564990421|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
156518783|NCT02663518|564990422|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
156518784|NCT02663518|564990423|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
156518785|NCT02663518|564990424|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
156518786|NCT02663518|564990425|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
156518787|NCT02663518|564990426|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
156518788|NCT02663518|564990427|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
156518789|NCT02663518|564990428|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
156561754|NCT02542072|565145581|FG000|First Intervention (1 Month)|Adverse Event|1|||
156561755|NCT02542072|565145582|FG001|First Intervention (1 Month)|Adverse Event|1|||
156561756|NCT02542072|565145581|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
156561757|NCT02542072|565145582|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
156561758|NCT02542072|565145581|FG000|First Intervention (1 Month)|Lens discomfort|1|||
156561759|NCT02542072|565145582|FG001|First Intervention (1 Month)|Lens discomfort|2|||
156561760|NCT02542072|565145581|FG000|First Intervention (1 Month)|Protocol Violation|1|||
156561761|NCT02542072|565145582|FG001|First Intervention (1 Month)|Protocol Violation|0|||
156561762|NCT02542072|565145581|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
156561763|NCT02542072|565145582|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
156561764|NCT02542072|565145581|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
156561765|NCT02542072|565145582|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
156561766|NCT02959814|565145583|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
156561767|NCT02959814|565145583|FG000|Overall Study|Excluded based on anatomical criteria|2|||
156561768|NCT02959814|565145583|FG000|Overall Study|Protocol Violation|7|||
156561769|NCT02959814|565145583|FG000|Overall Study|FFR not measured|2|||
156561770|NCT02959814|565145583|FG000|Overall Study|In-procedure QFR not computed|6|||
156561771|NCT02959814|565145583|FG000|Overall Study|Excluded by FFR core-lab|24|||
156561772|NCT04343651|565145587|FG000|Overall Study|Physician Decision|2|||
156561773|NCT04343651|565145588|FG001|Overall Study|Physician Decision|1|||
156561774|NCT04343651|565145587|FG000|Overall Study|Lost to Follow-up|2|||
156561775|NCT04343651|565145588|FG001|Overall Study|Lost to Follow-up|1|||
156561776|NCT04343651|565145587|FG000|Overall Study|Protocol Violation|4|||
156561777|NCT04343651|565145588|FG001|Overall Study|Protocol Violation|6|||
156561778|NCT04343651|565145587|FG000|Overall Study|Missing|3|||
156561779|NCT04343651|565145588|FG001|Overall Study|Missing|9|||
156561780|NCT04343651|565145587|FG000|Overall Study|Withdrawal by Subject|0|||
156561781|NCT04343651|565145588|FG001|Overall Study|Withdrawal by Subject|4|||
156561782|NCT04343651|565145587|FG000|Overall Study|Death|0|||
156561783|NCT04343651|565145588|FG001|Overall Study|Death|1|||
156561784|NCT04343651|565145587|FG000|Overall Study|Did not start treatment|1|||
156561785|NCT04343651|565145588|FG001|Overall Study|Did not start treatment|1|||
156561786|NCT04343651|565145587|FG000|Overall Study|Patient did not complete visits 3-6|0|||
156561787|NCT04343651|565145588|FG001|Overall Study|Patient did not complete visits 3-6|1|||
156561788|NCT03219164|565148093|FG000|Overall Study|Study Terminated by Sponsor|16|||
156561789|NCT03219164|565148094|FG001|Overall Study|Study Terminated by Sponsor|12|||
156561790|NCT03219164|565148093|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
156561791|NCT03219164|565148094|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
156561792|NCT03219164|565148093|FG000|Overall Study|Lost to Follow-up|1|||
156561793|NCT03219164|565148094|FG001|Overall Study|Lost to Follow-up|1|||
156561794|NCT03219164|565148093|FG000|Overall Study|Adverse Event|1|||
156561795|NCT03219164|565148094|FG001|Overall Study|Adverse Event|0|||
156561796|NCT03219164|565148093|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156561797|NCT03219164|565148094|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156561798|NCT03219164|565148093|FG000|Overall Study|Protocol Violation|0|||
156561799|NCT03219164|565148094|FG001|Overall Study|Protocol Violation|1|||
156561800|NCT03219164|565148093|FG000|Overall Study|Withdrew Assent|1|||
156561801|NCT03219164|565148094|FG001|Overall Study|Withdrew Assent|0|||
156561802|NCT04574999|565148098|FG000|Overall Study|Adverse Event|1|||
156561803|NCT04574999|565148099|FG001|Overall Study|Adverse Event|0|||
156561804|NCT04574999|565148098|FG000|Overall Study|Lack of Efficacy|2|||
156561805|NCT04574999|565148099|FG001|Overall Study|Lack of Efficacy|3|||
156518790|NCT02663518|564990429|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
156518791|NCT02663518|564990430|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
156518792|NCT02663518|564990431|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
156518793|NCT02663518|564990418|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518794|NCT02663518|564990419|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518795|NCT02663518|564990420|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518796|NCT02663518|564990421|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518797|NCT02663518|564990422|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156561806|NCT04574999|565148098|FG000|Overall Study|Protocol Violation|1|||
156561807|NCT04574999|565148099|FG001|Overall Study|Protocol Violation|0|||
156561808|NCT04574999|565148098|FG000|Overall Study|Withdrawal by Subject|2|||
156561809|NCT04574999|565148099|FG001|Overall Study|Withdrawal by Subject|2|||
156561810|NCT04574999|565148098|FG000|Overall Study|Lost to Follow-up|1|||
156561811|NCT04574999|565148099|FG001|Overall Study|Lost to Follow-up|0|||
156561812|NCT04574999|565148098|FG000|Overall Study|Personal problems|1|||
156561813|NCT04574999|565148099|FG001|Overall Study|Personal problems|0|||
156561814|NCT04574999|565148098|FG000|Overall Study|Previous planned surgery|1|||
156561815|NCT04574999|565148099|FG001|Overall Study|Previous planned surgery|0|||
156561816|NCT00206726|565148101|FG000|Overall Study|Delayed recovery of blood counts|1|||
156561817|NCT00206726|565148101|FG000|Overall Study|Progressive disease or relapsed disease|18|||
156561818|NCT00206726|565148101|FG000|Overall Study|Placed on new protocol|1|||
156561819|NCT00206726|565148101|FG000|Overall Study|Bone marrow transplant|1|||
156561820|NCT00206726|565148101|FG000|Overall Study|Adverse Event|17|||
156561821|NCT00206726|565148101|FG000|Overall Study|Death|4|||
156561822|NCT00206726|565148101|FG000|Overall Study|Protocol Violation|1|||
156561823|NCT00206726|565148101|FG000|Overall Study|Withdrawal by Subject|8|||
156561824|NCT05148884|565148102|FG000|Overall Study|Withdrawal by Subject|3|||
156561825|NCT05148884|565148103|FG001|Overall Study|Withdrawal by Subject|0|||
156561826|NCT05148884|565148102|FG000|Overall Study|Deep brain stimulation operation|0|||
156561827|NCT05148884|565148103|FG001|Overall Study|Deep brain stimulation operation|1|||
156561828|NCT01341457|565148106|FG000|Overall Study|Adverse Event|2|||
156561829|NCT01341457|565148107|FG001|Overall Study|Adverse Event|0|||
156561830|NCT00365989|565148108|FG000|Overall Study|Withdrawal by Subject|1|||
156561831|NCT00365989|565148108|FG000|Overall Study|Non-compliance|1|||
156561832|NCT00832819|565148111|FG000|Overall Study|Adverse Event|0|||
156561833|NCT00832819|565148112|FG001|Overall Study|Adverse Event|1|||
156561834|NCT00832819|565148113|FG002|Overall Study|Adverse Event|0|||
156561835|NCT00832819|565148111|FG000|Overall Study|Protocol Violation|0|||
156561836|NCT00832819|565148112|FG001|Overall Study|Protocol Violation|0|||
156561837|NCT00832819|565148113|FG002|Overall Study|Protocol Violation|1|||
156561838|NCT00317044|565148114|FG000|Overall Study|Protocol Violation|28|||
156561839|NCT00317044|565148115|FG001|Overall Study|Protocol Violation|22|||
156561840|NCT00317044|565148116|FG002|Overall Study|Protocol Violation|20|||
156561841|NCT00317044|565148114|FG000|Overall Study|Adverse Event|4|||
156561842|NCT00317044|565148115|FG001|Overall Study|Adverse Event|7|||
156561843|NCT00317044|565148116|FG002|Overall Study|Adverse Event|4|||
156561844|NCT00317044|565148114|FG000|Overall Study|Withdrawal by Subject|10|||
156561845|NCT00317044|565148115|FG001|Overall Study|Withdrawal by Subject|7|||
156561846|NCT00317044|565148116|FG002|Overall Study|Withdrawal by Subject|12|||
156561847|NCT00317044|565148114|FG000|Overall Study|Lost to Follow-up|0|||
156561848|NCT00317044|565148115|FG001|Overall Study|Lost to Follow-up|2|||
156561849|NCT00317044|565148116|FG002|Overall Study|Lost to Follow-up|3|||
156561850|NCT00317044|565148114|FG000|Overall Study|Multiple Reasons|6|||
156561851|NCT00317044|565148115|FG001|Overall Study|Multiple Reasons|2|||
156561852|NCT00317044|565148116|FG002|Overall Study|Multiple Reasons|6|||
156561853|NCT04317690|565148119|FG000|Overall Study|did not have complete information for primary outcome|0|||
156561854|NCT04317690|565148120|FG001|Overall Study|did not have complete information for primary outcome|4|||
156561855|NCT04317690|565148121|FG002|Overall Study|did not have complete information for primary outcome|0|||
156561856|NCT04317690|565148122|FG003|Overall Study|did not have complete information for primary outcome|2|||
156561857|NCT04317690|565148123|FG004|Overall Study|did not have complete information for primary outcome|0|||
156561858|NCT02318095|565148124|FG000|Overall Study|Adverse Event|1|||
156561859|NCT01717638|565148125|FG000|Overall Study|Lost to Follow-up|0|||
156561860|NCT01717638|565148126|FG001|Overall Study|Lost to Follow-up|0|||
156561861|NCT01717638|565148127|FG002|Overall Study|Lost to Follow-up|0|||
156561862|NCT01717638|565148128|FG003|Overall Study|Lost to Follow-up|0|||
156561863|NCT01717638|565148129|FG004|Overall Study|Lost to Follow-up|0|||
156561864|NCT01717638|565148130|FG005|Overall Study|Lost to Follow-up|1|||
156561865|NCT01717638|565148131|FG006|Overall Study|Lost to Follow-up|0|||
156561866|NCT01717638|565148132|FG007|Overall Study|Lost to Follow-up|0|||
156561867|NCT01717638|565148133|FG008|Overall Study|Lost to Follow-up|0|||
156561868|NCT01717638|565148134|FG009|Overall Study|Lost to Follow-up|0|||
156561869|NCT01717638|565148135|FG010|Overall Study|Lost to Follow-up|0|||
156561870|NCT01717638|565148136|FG011|Overall Study|Lost to Follow-up|0|||
156561871|NCT01717638|565148137|FG012|Overall Study|Lost to Follow-up|0|||
156561872|NCT01717638|565148125|FG000|Overall Study|Father in hospital|0|||
156561873|NCT01717638|565148126|FG001|Overall Study|Father in hospital|0|||
156561874|NCT01717638|565148127|FG002|Overall Study|Father in hospital|0|||
156561875|NCT01717638|565148128|FG003|Overall Study|Father in hospital|0|||
156561876|NCT01717638|565148129|FG004|Overall Study|Father in hospital|0|||
156561877|NCT01717638|565148130|FG005|Overall Study|Father in hospital|0|||
156561878|NCT01717638|565148131|FG006|Overall Study|Father in hospital|0|||
156561879|NCT01717638|565148132|FG007|Overall Study|Father in hospital|0|||
156561880|NCT01717638|565148133|FG008|Overall Study|Father in hospital|0|||
156561881|NCT01717638|565148134|FG009|Overall Study|Father in hospital|0|||
156561882|NCT01717638|565148135|FG010|Overall Study|Father in hospital|0|||
156561883|NCT01717638|565148136|FG011|Overall Study|Father in hospital|0|||
156561884|NCT01717638|565148137|FG012|Overall Study|Father in hospital|1|||
156561885|NCT01717638|565148125|FG000|Overall Study|Withdrawal by Subject|0|||
156561886|NCT01717638|565148126|FG001|Overall Study|Withdrawal by Subject|1|||
156561887|NCT01717638|565148127|FG002|Overall Study|Withdrawal by Subject|1|||
156561888|NCT01717638|565148128|FG003|Overall Study|Withdrawal by Subject|0|||
156561889|NCT01717638|565148129|FG004|Overall Study|Withdrawal by Subject|1|||
156561890|NCT01717638|565148130|FG005|Overall Study|Withdrawal by Subject|0|||
156561891|NCT01717638|565148131|FG006|Overall Study|Withdrawal by Subject|2|||
156561892|NCT01717638|565148132|FG007|Overall Study|Withdrawal by Subject|1|||
156561893|NCT01717638|565148133|FG008|Overall Study|Withdrawal by Subject|2|||
156561894|NCT01717638|565148134|FG009|Overall Study|Withdrawal by Subject|1|||
156561895|NCT01717638|565148135|FG010|Overall Study|Withdrawal by Subject|0|||
156561896|NCT01717638|565148136|FG011|Overall Study|Withdrawal by Subject|0|||
156561897|NCT01717638|565148137|FG012|Overall Study|Withdrawal by Subject|18|||
156561898|NCT02626338|565148138|FG000|Overall Study|Lack of Efficacy|3|||
156561899|NCT02626338|565148139|FG001|Overall Study|Lack of Efficacy|2|||
156561900|NCT02626338|565148140|FG002|Overall Study|Lack of Efficacy|0|||
156561901|NCT03312218|565148146|FG000|Overall Study|Never signed in to access the app|54|||
156561902|NCT03312218|565148147|FG001|Overall Study|Never signed in to access the app|58|||
156561903|NCT01901224|565148148|FG000|Overall Study|study was not funded and terminated|2|||
156561904|NCT01279057|565148149|FG000|Overall Study|Adverse Event|1|||
156561905|NCT01279057|565148150|FG001|Overall Study|Adverse Event|0|||
156561906|NCT01279057|565148151|FG002|Overall Study|Adverse Event|1|||
156561907|NCT01279057|565148149|FG000|Overall Study|Insufficient therapeutic response|0|||
156561908|NCT01279057|565148150|FG001|Overall Study|Insufficient therapeutic response|0|||
156561909|NCT01279057|565148151|FG002|Overall Study|Insufficient therapeutic response|1|||
156561910|NCT01279057|565148149|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
156561911|NCT01279057|565148150|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
156561912|NCT01279057|565148151|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
156561913|NCT01279057|565148149|FG000|Overall Study|Withdrew consent|2|||
156561914|NCT01279057|565148150|FG001|Overall Study|Withdrew consent|0|||
156561915|NCT01279057|565148151|FG002|Overall Study|Withdrew consent|1|||
156561916|NCT01279057|565148149|FG000|Overall Study|Pregnancy|0|||
156561917|NCT01279057|565148150|FG001|Overall Study|Pregnancy|1|||
156561918|NCT01279057|565148151|FG002|Overall Study|Pregnancy|0|||
156561919|NCT01279057|565148149|FG000|Overall Study|Other|3|||
156561920|NCT01279057|565148150|FG001|Overall Study|Other|3|||
156561921|NCT01279057|565148151|FG002|Overall Study|Other|0|||
156561922|NCT01427309|565148152|FG000|Overall Study|Lost to Follow-up|130|||
156561923|NCT01427309|565148153|FG001|Overall Study|Lost to Follow-up|145|||
156561924|NCT01427309|565148154|FG002|Overall Study|Lost to Follow-up|122|||
156561925|NCT01427309|565148155|FG003|Overall Study|Lost to Follow-up|135|||
156561926|NCT01427309|565148152|FG000|Overall Study|Protocol Violation|42|||
156561927|NCT01427309|565148153|FG001|Overall Study|Protocol Violation|69|||
156561928|NCT01427309|565148154|FG002|Overall Study|Protocol Violation|125|||
156561929|NCT01427309|565148155|FG003|Overall Study|Protocol Violation|124|||
156561930|NCT01427309|565148152|FG000|Overall Study|Adverse Event|0|||
156561931|NCT01427309|565148153|FG001|Overall Study|Adverse Event|0|||
156561932|NCT01427309|565148154|FG002|Overall Study|Adverse Event|3|||
156561933|NCT01427309|565148155|FG003|Overall Study|Adverse Event|1|||
156561934|NCT01427309|565148152|FG000|Overall Study|Serious adverse event|52|||
156561935|NCT01427309|565148153|FG001|Overall Study|Serious adverse event|45|||
156561936|NCT01427309|565148154|FG002|Overall Study|Serious adverse event|50|||
156561937|NCT01427309|565148155|FG003|Overall Study|Serious adverse event|61|||
156561938|NCT01427309|565148152|FG000|Overall Study|Withdrawal by Subject|148|||
156561939|NCT01427309|565148153|FG001|Overall Study|Withdrawal by Subject|148|||
156561940|NCT01427309|565148154|FG002|Overall Study|Withdrawal by Subject|61|||
156561941|NCT01427309|565148155|FG003|Overall Study|Withdrawal by Subject|55|||
156561942|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
156561943|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
156561944|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
156561945|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
156561946|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
156561947|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
156561948|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
156561949|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
156561950|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
156561951|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
156561952|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
156561953|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
156561954|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
156561955|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
156561956|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
156561957|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
156561958|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
156561959|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
156561960|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
156561961|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
156561962|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
156561963|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
156561964|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
156561965|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
156561966|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
156561967|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
156561968|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
156561969|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
156561970|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
156518798|NCT02663518|564990423|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518799|NCT02663518|564990424|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518800|NCT02663518|564990425|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518801|NCT02663518|564990426|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518802|NCT02663518|564990427|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518803|NCT02663518|564990428|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518804|NCT02663518|564990429|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518805|NCT02663518|564990430|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
156518806|NCT02663518|564990431|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
156518807|NCT00006011|564990433|FG000|Overall Study|Disease progression|13|||
156518808|NCT00006011|564990434|FG001|Overall Study|Disease progression|6|||
156518809|NCT00006011|564990435|FG002|Overall Study|Disease progression|26|||
156518810|NCT00006011|564990433|FG000|Overall Study|Refused further treatment|15|||
156518811|NCT00006011|564990434|FG001|Overall Study|Refused further treatment|13|||
156518812|NCT00006011|564990435|FG002|Overall Study|Refused further treatment|26|||
156518813|NCT00006011|564990433|FG000|Overall Study|Adverse Event|15|||
156518814|NCT00006011|564990434|FG001|Overall Study|Adverse Event|39|||
156518815|NCT00006011|564990435|FG002|Overall Study|Adverse Event|5|||
156518816|NCT00006011|564990433|FG000|Overall Study|Death|0|||
156518817|NCT00006011|564990434|FG001|Overall Study|Death|1|||
156518818|NCT00006011|564990435|FG002|Overall Study|Death|2|||
156518819|NCT00006011|564990433|FG000|Overall Study|Other|4|||
156518820|NCT00006011|564990434|FG001|Overall Study|Other|2|||
156518821|NCT00006011|564990435|FG002|Overall Study|Other|5|||
156518822|NCT00006011|564990433|FG000|Overall Study|Ineligible|18|||
156518823|NCT00006011|564990434|FG001|Overall Study|Ineligible|16|||
156518824|NCT00006011|564990435|FG002|Overall Study|Ineligible|9|||
156518825|NCT03047395|564990445|FG000|Overall Study|Adverse Event|142|||
156518826|NCT03047395|564990445|FG000|Overall Study|Withdrawal by Subject|155|||
156518827|NCT03047395|564990445|FG000|Overall Study|Lost to Follow-up|144|||
156518828|NCT03047395|564990445|FG000|Overall Study|COVID-19 Infection|2|||
156518829|NCT03047395|564990445|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
156518830|NCT03047395|564990445|FG000|Overall Study|Other, Not Specified|117|||
156518831|NCT01157676|564990451|FG000|Randomization|Death|1|||
156518832|NCT01157676|564990452|FG001|Randomization|Death|1|||
156518833|NCT01157676|564990451|FG000|Randomization|unresectable|2|||
156518834|NCT01157676|564990452|FG001|Randomization|unresectable|3|||
156518835|NCT01157676|564990451|FG000|Randomization|Withdrawal by Subject|17|||
156518836|NCT01157676|564990452|FG001|Randomization|Withdrawal by Subject|13|||
156518837|NCT01157676|564990451|FG000|Randomization|Physician Decision|1|||
156518838|NCT01157676|564990452|FG001|Randomization|Physician Decision|0|||
156518839|NCT01157676|564990451|FG000|Surgery|underwent open cystectomy|0|||
156518840|NCT01157676|564990452|FG001|Surgery|underwent open cystectomy|4|||
156518841|NCT01157676|564990451|FG000|Surgery|converted to open procedure|0|||
156518842|NCT01157676|564990452|FG001|Surgery|converted to open procedure|5|||
156518843|NCT01157676|564990451|FG000|Surgery|underwent robotic cystectomy|1|||
156518844|NCT01157676|564990452|FG001|Surgery|underwent robotic cystectomy|0|||
156518845|NCT00682890|564990453|FG000|Overall Study|Lost to Follow-up|1|||
156518846|NCT00682890|564990454|FG001|Overall Study|Lost to Follow-up|1|||
156518847|NCT00682890|564990453|FG000|Overall Study|subject moved away|0|||
156518848|NCT00682890|564990454|FG001|Overall Study|subject moved away|1|||
156518849|NCT00682890|564990453|FG000|Overall Study|heavy menstrual bleeding|1|||
156518850|NCT00682890|564990454|FG001|Overall Study|heavy menstrual bleeding|0|||
156518851|NCT00141219|564990457|FG000|Overall Study|Protocol violations|5|||
156518852|NCT00141219|564990458|FG001|Overall Study|Protocol violations|4|||
156518853|NCT00141219|564990457|FG000|Overall Study|Adverse Event|8|||
156518854|NCT00141219|564990458|FG001|Overall Study|Adverse Event|6|||
156518855|NCT00141219|564990457|FG000|Overall Study|Lack of Efficacy|5|||
156518856|NCT00141219|564990458|FG001|Overall Study|Lack of Efficacy|4|||
156518857|NCT00141219|564990457|FG000|Overall Study|Withdrawal by Subject|6|||
156518858|NCT00141219|564990458|FG001|Overall Study|Withdrawal by Subject|2|||
156518859|NCT01577745|564990460|FG000|Overall Study|Withdrawal by Subject|0|||
156518860|NCT01577745|564990461|FG001|Overall Study|Withdrawal by Subject|1|||
156518861|NCT01577745|564990462|FG002|Overall Study|Withdrawal by Subject|0|||
156518862|NCT01577745|564990463|FG003|Overall Study|Withdrawal by Subject|3|||
156518863|NCT01577745|564990464|FG004|Overall Study|Withdrawal by Subject|2|||
156518864|NCT01577745|564990465|FG005|Overall Study|Withdrawal by Subject|0|||
156518865|NCT01577745|564990460|FG000|Overall Study|Death|3|||
156518866|NCT01577745|564990461|FG001|Overall Study|Death|2|||
156518867|NCT01577745|564990462|FG002|Overall Study|Death|2|||
156518868|NCT01577745|564990463|FG003|Overall Study|Death|1|||
156518869|NCT01577745|564990464|FG004|Overall Study|Death|1|||
156518870|NCT01577745|564990465|FG005|Overall Study|Death|3|||
156518871|NCT01577745|564990460|FG000|Overall Study|Physician Decision|0|||
156518872|NCT01577745|564990461|FG001|Overall Study|Physician Decision|0|||
156518873|NCT01577745|564990462|FG002|Overall Study|Physician Decision|0|||
156518874|NCT01577745|564990463|FG003|Overall Study|Physician Decision|1|||
156518875|NCT01577745|564990464|FG004|Overall Study|Physician Decision|1|||
156561971|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
156561972|NCT00849017|565148158|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
156561973|NCT00849017|565148159|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
156561974|NCT00849017|565148160|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
156561975|NCT00849017|565148158|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
156561976|NCT00849017|565148159|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
156561977|NCT00849017|565148160|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
156561978|NCT00849017|565148158|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
156561979|NCT00849017|565148159|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
156561980|NCT00849017|565148160|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
156561981|NCT00849017|565148158|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
156561982|NCT00849017|565148159|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
156561983|NCT00849017|565148160|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
156561984|NCT00849017|565148158|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
156561985|NCT00849017|565148159|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
156561986|NCT00849017|565148160|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
156561987|NCT00849017|565148158|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
156561988|NCT00849017|565148159|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
156561989|NCT00849017|565148160|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
156561990|NCT00849017|565148158|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
156561991|NCT00849017|565148159|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
156561992|NCT00849017|565148160|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
156561993|NCT00849017|565148158|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
156561994|NCT00849017|565148159|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
156561995|NCT00849017|565148160|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
156561996|NCT00849017|565148158|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
156561997|NCT00849017|565148159|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
156561998|NCT00849017|565148160|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
156561999|NCT03502187|565148161|FG000|Overall Study|Withdrawal by Subject|4|||
156562000|NCT03502187|565148162|FG001|Overall Study|Withdrawal by Subject|3|||
156562001|NCT03502187|565148163|FG002|Overall Study|Withdrawal by Subject|3|||
156562002|NCT03502187|565148161|FG000|Overall Study|Lost to Follow-up|5|||
156562003|NCT03502187|565148162|FG001|Overall Study|Lost to Follow-up|4|||
156562004|NCT03502187|565148163|FG002|Overall Study|Lost to Follow-up|5|||
156518876|NCT01577745|564990465|FG005|Overall Study|Physician Decision|0|||
156518877|NCT01577745|564990460|FG000|Overall Study|Lost to Follow-up|0|||
156518878|NCT01577745|564990461|FG001|Overall Study|Lost to Follow-up|0|||
156518879|NCT01577745|564990462|FG002|Overall Study|Lost to Follow-up|0|||
156518880|NCT01577745|564990463|FG003|Overall Study|Lost to Follow-up|0|||
156518881|NCT01577745|564990464|FG004|Overall Study|Lost to Follow-up|0|||
156518882|NCT01577745|564990465|FG005|Overall Study|Lost to Follow-up|1|||
156518883|NCT01577745|564990460|FG000|Overall Study|Alternative Therapy|0|||
156518884|NCT01577745|564990461|FG001|Overall Study|Alternative Therapy|0|||
156518885|NCT01577745|564990462|FG002|Overall Study|Alternative Therapy|0|||
156518886|NCT01577745|564990463|FG003|Overall Study|Alternative Therapy|1|||
156518887|NCT01577745|564990464|FG004|Overall Study|Alternative Therapy|1|||
156518888|NCT01577745|564990465|FG005|Overall Study|Alternative Therapy|0|||
156518889|NCT02595073|564990466|FG000|Overall Study|Progressive Disease|0|||
156518890|NCT02595073|564990467|FG001|Overall Study|Progressive Disease|1|||
156518891|NCT02595073|564990466|FG000|Overall Study|Protocol Violation|2|||
156518892|NCT02595073|564990467|FG001|Overall Study|Protocol Violation|0|||
156518893|NCT04860297|564990468|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
156518894|NCT04860297|564990469|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
156518895|NCT04860297|564990470|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
156518896|NCT04860297|564990471|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
156518897|NCT04860297|564990472|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
156518898|NCT04860297|564990473|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
156518899|NCT04860297|564990474|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
156518900|NCT04860297|564990475|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
156518901|NCT04860297|564990468|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
156518902|NCT04860297|564990469|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
156518903|NCT04860297|564990470|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
156518904|NCT04860297|564990471|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
156518905|NCT04860297|564990472|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
156518906|NCT04860297|564990473|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
156518907|NCT04860297|564990474|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
156518908|NCT04860297|564990475|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
156518909|NCT04860297|564990468|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
156518910|NCT04860297|564990469|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
156518911|NCT04860297|564990470|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
156518912|NCT04860297|564990471|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
156518913|NCT04860297|564990472|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
156518914|NCT04860297|564990473|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
156562005|NCT02913313|565148164|FG000|Overall Study|DISEASE PROGRESSION|1|||
156562006|NCT02913313|565148165|FG001|Overall Study|DISEASE PROGRESSION|2|||
156562007|NCT02913313|565148166|FG002|Overall Study|DISEASE PROGRESSION|2|||
156562008|NCT02913313|565148167|FG003|Overall Study|DISEASE PROGRESSION|4|||
156562009|NCT02913313|565148168|FG004|Overall Study|DISEASE PROGRESSION|6|||
156562010|NCT02913313|565148169|FG005|Overall Study|DISEASE PROGRESSION|4|||
156562011|NCT02913313|565148170|FG006|Overall Study|DISEASE PROGRESSION|19|||
156562012|NCT02913313|565148171|FG007|Overall Study|DISEASE PROGRESSION|3|||
156562013|NCT02913313|565148172|FG008|Overall Study|DISEASE PROGRESSION|4|||
156562014|NCT02913313|565148173|FG009|Overall Study|DISEASE PROGRESSION|4|||
156562015|NCT02913313|565148174|FG010|Overall Study|DISEASE PROGRESSION|11|||
156562016|NCT02913313|565148175|FG011|Overall Study|DISEASE PROGRESSION|5|||
156562017|NCT02913313|565148176|FG012|Overall Study|DISEASE PROGRESSION|14|||
156562018|NCT02913313|565148177|FG013|Overall Study|DISEASE PROGRESSION|3|||
156562019|NCT02913313|565148164|FG000|Overall Study|Not Reported|0|||
156562020|NCT02913313|565148165|FG001|Overall Study|Not Reported|0|||
156562021|NCT02913313|565148166|FG002|Overall Study|Not Reported|0|||
156562022|NCT02913313|565148167|FG003|Overall Study|Not Reported|0|||
156562023|NCT02913313|565148168|FG004|Overall Study|Not Reported|1|||
156562024|NCT02913313|565148169|FG005|Overall Study|Not Reported|0|||
156562025|NCT02913313|565148170|FG006|Overall Study|Not Reported|0|||
156562026|NCT02913313|565148171|FG007|Overall Study|Not Reported|0|||
156562027|NCT02913313|565148172|FG008|Overall Study|Not Reported|0|||
156562028|NCT02913313|565148173|FG009|Overall Study|Not Reported|0|||
156562029|NCT02913313|565148174|FG010|Overall Study|Not Reported|4|||
156562030|NCT02913313|565148175|FG011|Overall Study|Not Reported|0|||
156562031|NCT02913313|565148176|FG012|Overall Study|Not Reported|0|||
156562032|NCT02913313|565148177|FG013|Overall Study|Not Reported|0|||
156562033|NCT02913313|565148164|FG000|Overall Study|Other reasons|0|||
156562034|NCT02913313|565148165|FG001|Overall Study|Other reasons|0|||
156562035|NCT02913313|565148166|FG002|Overall Study|Other reasons|0|||
156562036|NCT02913313|565148167|FG003|Overall Study|Other reasons|0|||
156562037|NCT02913313|565148168|FG004|Overall Study|Other reasons|1|||
156562038|NCT02913313|565148169|FG005|Overall Study|Other reasons|0|||
156562039|NCT02913313|565148170|FG006|Overall Study|Other reasons|0|||
156562040|NCT02913313|565148171|FG007|Overall Study|Other reasons|0|||
156562041|NCT02913313|565148172|FG008|Overall Study|Other reasons|0|||
156562042|NCT02913313|565148173|FG009|Overall Study|Other reasons|0|||
156562043|NCT02913313|565148174|FG010|Overall Study|Other reasons|1|||
156562044|NCT02913313|565148175|FG011|Overall Study|Other reasons|0|||
156562045|NCT02913313|565148176|FG012|Overall Study|Other reasons|0|||
156562046|NCT02913313|565148177|FG013|Overall Study|Other reasons|0|||
156562047|NCT02913313|565148164|FG000|Overall Study|Withdrawal by Subject|0|||
156562048|NCT02913313|565148165|FG001|Overall Study|Withdrawal by Subject|0|||
156562049|NCT02913313|565148166|FG002|Overall Study|Withdrawal by Subject|1|||
156562050|NCT02913313|565148167|FG003|Overall Study|Withdrawal by Subject|0|||
156562051|NCT02913313|565148168|FG004|Overall Study|Withdrawal by Subject|0|||
156562052|NCT02913313|565148169|FG005|Overall Study|Withdrawal by Subject|0|||
156562053|NCT02913313|565148170|FG006|Overall Study|Withdrawal by Subject|1|||
156562054|NCT02913313|565148171|FG007|Overall Study|Withdrawal by Subject|1|||
156562055|NCT02913313|565148172|FG008|Overall Study|Withdrawal by Subject|0|||
156562056|NCT02913313|565148173|FG009|Overall Study|Withdrawal by Subject|0|||
156562057|NCT02913313|565148174|FG010|Overall Study|Withdrawal by Subject|1|||
156562058|NCT02913313|565148175|FG011|Overall Study|Withdrawal by Subject|0|||
156562059|NCT02913313|565148176|FG012|Overall Study|Withdrawal by Subject|0|||
156562060|NCT02913313|565148177|FG013|Overall Study|Withdrawal by Subject|0|||
156562061|NCT02913313|565148164|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562062|NCT02913313|565148165|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562063|NCT02913313|565148166|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562064|NCT02913313|565148167|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562065|NCT02913313|565148168|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562066|NCT02913313|565148169|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562067|NCT02913313|565148170|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562068|NCT02913313|565148171|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562069|NCT02913313|565148172|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562070|NCT02913313|565148173|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562071|NCT02913313|565148174|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
156562072|NCT02913313|565148175|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
156562073|NCT02913313|565148176|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
156562074|NCT02913313|565148177|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
156562075|NCT02913313|565148164|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
156562076|NCT02913313|565148165|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
156562077|NCT02913313|565148166|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
156562078|NCT02913313|565148167|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
156562079|NCT02913313|565148168|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
156562080|NCT02913313|565148169|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
156562081|NCT02913313|565148170|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
156562082|NCT02913313|565148171|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
156562083|NCT02913313|565148172|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
156562084|NCT02913313|565148173|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
156562085|NCT02913313|565148174|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
156562086|NCT02913313|565148175|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
156562087|NCT02913313|565148176|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
156562088|NCT02913313|565148177|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
156562089|NCT02024971|565148180|FG000|Overall Study|Data Not Available|30|||
156562090|NCT02024971|565148180|FG000|Overall Study|Lost to Follow-up|6|||
156562091|NCT02908100|565148181|FG000|Overall Study|Adverse Event|7|||
156562092|NCT02908100|565148182|FG001|Overall Study|Adverse Event|6|||
156562093|NCT02908100|565148183|FG002|Overall Study|Adverse Event|9|||
156562094|NCT02908100|565148181|FG000|Overall Study|Death|2|||
156562095|NCT02908100|565148182|FG001|Overall Study|Death|0|||
156562096|NCT02908100|565148183|FG002|Overall Study|Death|0|||
156562097|NCT02908100|565148181|FG000|Overall Study|Lack of Efficacy|2|||
156562098|NCT02908100|565148182|FG001|Overall Study|Lack of Efficacy|3|||
156562099|NCT02908100|565148183|FG002|Overall Study|Lack of Efficacy|3|||
156562100|NCT02908100|565148181|FG000|Overall Study|Lost to Follow-up|0|||
156562101|NCT02908100|565148182|FG001|Overall Study|Lost to Follow-up|1|||
156562102|NCT02908100|565148183|FG002|Overall Study|Lost to Follow-up|2|||
156562103|NCT02908100|565148181|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156562104|NCT02908100|565148182|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156562105|NCT02908100|565148183|FG002|Overall Study|Non-Compliance With Study Drug|2|||
156562106|NCT02908100|565148181|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
156562107|NCT02908100|565148182|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
156562108|NCT02908100|565148183|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
156562109|NCT02908100|565148181|FG000|Overall Study|Physician Decision|0|||
156562110|NCT02908100|565148182|FG001|Overall Study|Physician Decision|1|||
156562111|NCT02908100|565148183|FG002|Overall Study|Physician Decision|0|||
156562112|NCT02908100|565148181|FG000|Overall Study|Pregnancy|1|||
156562113|NCT02908100|565148182|FG001|Overall Study|Pregnancy|2|||
156562114|NCT02908100|565148183|FG002|Overall Study|Pregnancy|0|||
156562115|NCT02908100|565148181|FG000|Overall Study|Withdrawal by Subject|8|||
156562116|NCT02908100|565148182|FG001|Overall Study|Withdrawal by Subject|7|||
156562117|NCT02908100|565148183|FG002|Overall Study|Withdrawal by Subject|5|||
156562118|NCT02908100|565148181|FG000|Overall Study|Randomised in Error|1|||
156562119|NCT02908100|565148182|FG001|Overall Study|Randomised in Error|0|||
156562120|NCT02908100|565148183|FG002|Overall Study|Randomised in Error|0|||
156562121|NCT05254418|565148184|FG000|Overall Study|Adverse Event|2|||
156562122|NCT06118385|565148186|FG000|Overall Study|Protocol Violation|0|||
156562123|NCT06118385|565148187|FG001|Overall Study|Protocol Violation|0|||
156562124|NCT06118385|565148188|FG002|Overall Study|Protocol Violation|0|||
156562125|NCT06118385|565148189|FG003|Overall Study|Protocol Violation|0|||
156562126|NCT06118385|565148190|FG004|Overall Study|Protocol Violation|0|||
156562127|NCT06118385|565148191|FG005|Overall Study|Protocol Violation|0|||
156562128|NCT06118385|565148192|FG006|Overall Study|Protocol Violation|0|||
156562129|NCT06118385|565148193|FG007|Overall Study|Protocol Violation|0|||
156562130|NCT06118385|565148194|FG008|Overall Study|Protocol Violation|1|||
156562131|NCT06118385|565148195|FG009|Overall Study|Protocol Violation|0|||
156562132|NCT06118385|565148196|FG010|Overall Study|Protocol Violation|0|||
156562133|NCT06118385|565148197|FG011|Overall Study|Protocol Violation|0|||
156562134|NCT06118385|565148186|FG000|Overall Study|Out-of-range blood tests|0|||
156562135|NCT06118385|565148187|FG001|Overall Study|Out-of-range blood tests|0|||
156562136|NCT06118385|565148188|FG002|Overall Study|Out-of-range blood tests|0|||
156562137|NCT06118385|565148189|FG003|Overall Study|Out-of-range blood tests|0|||
156562138|NCT06118385|565148190|FG004|Overall Study|Out-of-range blood tests|0|||
156562139|NCT06118385|565148191|FG005|Overall Study|Out-of-range blood tests|0|||
156562140|NCT06118385|565148192|FG006|Overall Study|Out-of-range blood tests|0|||
156562141|NCT06118385|565148193|FG007|Overall Study|Out-of-range blood tests|0|||
156562142|NCT06118385|565148194|FG008|Overall Study|Out-of-range blood tests|1|||
156562143|NCT06118385|565148195|FG009|Overall Study|Out-of-range blood tests|0|||
156562144|NCT06118385|565148196|FG010|Overall Study|Out-of-range blood tests|0|||
156562145|NCT06118385|565148197|FG011|Overall Study|Out-of-range blood tests|0|||
156562146|NCT04276207|565148198|FG000|Period 1|Withdrawal by Subject|0|||
156562147|NCT04276207|565148199|FG001|Period 1|Withdrawal by Subject|1|||
156562148|NCT02690194|565148200|FG000|Overall Study|Withdrawal by Subject|1|||
156562149|NCT02690194|565148201|FG001|Overall Study|Withdrawal by Subject|4|||
156562150|NCT02690194|565148202|FG002|Overall Study|Withdrawal by Subject|0|||
156562151|NCT03624946|565148203|FG000|Overall Study|Lost to Follow-up|0|||
156562152|NCT03624946|565148204|FG001|Overall Study|Lost to Follow-up|1|||
156562153|NCT00624520|565148205|FG000|Overall Study|Withdrawal by Subject|12|||
156562154|NCT00624520|565148206|FG001|Overall Study|Withdrawal by Subject|7|||
156562155|NCT00624520|565148205|FG000|Overall Study|Death|0|||
156562156|NCT00624520|565148206|FG001|Overall Study|Death|1|||
156562157|NCT00944034|565148208|FG000|Overall Study|Inappropriate enrollment|0|||
156562158|NCT00944034|565148209|FG001|Overall Study|Inappropriate enrollment|1|||
156562159|NCT00944034|565148210|FG002|Overall Study|Inappropriate enrollment|0|||
156562160|NCT00944034|565148211|FG003|Overall Study|Inappropriate enrollment|1|||
156562161|NCT00944034|565148212|FG004|Overall Study|Inappropriate enrollment|2|||
156562162|NCT00944034|565148213|FG005|Overall Study|Inappropriate enrollment|1|||
156562163|NCT00944034|565148214|FG006|Overall Study|Inappropriate enrollment|0|||
156518915|NCT04860297|564990474|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
156518916|NCT04860297|564990475|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
156518917|NCT04860297|564990468|FG000|Part B (Booster Dose)|Other Than Specified|0|||
156518918|NCT04860297|564990469|FG001|Part B (Booster Dose)|Other Than Specified|0|||
156518919|NCT04860297|564990470|FG002|Part B (Booster Dose)|Other Than Specified|0|||
156518920|NCT04860297|564990471|FG003|Part B (Booster Dose)|Other Than Specified|0|||
156518921|NCT04860297|564990472|FG004|Part B (Booster Dose)|Other Than Specified|0|||
156518922|NCT04860297|564990473|FG005|Part B (Booster Dose)|Other Than Specified|1|||
156518923|NCT04860297|564990474|FG006|Part B (Booster Dose)|Other Than Specified|1|||
156518924|NCT04860297|564990475|FG007|Part B (Booster Dose)|Other Than Specified|0|||
156518925|NCT04860297|564990468|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
156518926|NCT04860297|564990469|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
156518927|NCT04860297|564990470|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
156518928|NCT04860297|564990471|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
156518929|NCT04860297|564990472|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
156518930|NCT04860297|564990473|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
156518931|NCT04860297|564990474|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
156518932|NCT04860297|564990475|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
156562164|NCT00944034|565148215|FG007|Overall Study|Inappropriate enrollment|0|||
156562165|NCT00944034|565148216|FG008|Overall Study|Inappropriate enrollment|1|||
156562166|NCT00944034|565148217|FG009|Overall Study|Inappropriate enrollment|1|||
156562167|NCT00944034|565148218|FG010|Overall Study|Inappropriate enrollment|0|||
156562168|NCT00944034|565148219|FG011|Overall Study|Inappropriate enrollment|0|||
156518933|NCT04860297|564990468|FG000|Part B (Booster Dose)|Death|0|||
156518934|NCT04860297|564990469|FG001|Part B (Booster Dose)|Death|0|||
156518935|NCT04860297|564990470|FG002|Part B (Booster Dose)|Death|0|||
156518936|NCT04860297|564990471|FG003|Part B (Booster Dose)|Death|0|||
156518937|NCT04860297|564990472|FG004|Part B (Booster Dose)|Death|1|||
156518938|NCT04860297|564990473|FG005|Part B (Booster Dose)|Death|2|||
156518939|NCT04860297|564990474|FG006|Part B (Booster Dose)|Death|1|||
156518940|NCT04860297|564990475|FG007|Part B (Booster Dose)|Death|0|||
156518941|NCT04860297|564990468|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
156518942|NCT04860297|564990469|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
156518943|NCT04860297|564990470|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
156518944|NCT04860297|564990471|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
156518945|NCT04860297|564990472|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
156518946|NCT04860297|564990473|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
156518947|NCT04860297|564990474|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
156518948|NCT04860297|564990475|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
156518949|NCT00620282|564990484|FG000|Overall Study|Adverse Event|0|||
156518950|NCT00620282|564990485|FG001|Overall Study|Adverse Event|1|||
156518951|NCT00620282|564990486|FG002|Overall Study|Adverse Event|0|||
156518952|NCT00620282|564990484|FG000|Overall Study|Arterial line unable to be placed|0|||
156518953|NCT00620282|564990485|FG001|Overall Study|Arterial line unable to be placed|0|||
156518954|NCT00620282|564990486|FG002|Overall Study|Arterial line unable to be placed|1|||
156518955|NCT00620282|564990484|FG000|Overall Study|Withdrawal by Subject|0|||
156518956|NCT00620282|564990485|FG001|Overall Study|Withdrawal by Subject|1|||
156518957|NCT00620282|564990486|FG002|Overall Study|Withdrawal by Subject|0|||
156518958|NCT03208036|564990489|FG000|Baseline Assessment|Withdrawal by Subject|1|||
156518959|NCT03208036|564990490|FG001|Baseline Assessment|Withdrawal by Subject|1|||
156518960|NCT03208036|564990489|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
156518961|NCT03208036|564990490|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
156518962|NCT03208036|564990489|FG000|Intervention|Withdrawal by Subject|3|||
156518963|NCT03208036|564990490|FG001|Intervention|Withdrawal by Subject|2|||
156518964|NCT03208036|564990489|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
156518965|NCT03208036|564990490|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
156518966|NCT01879553|564990491|FG000|Overall Study|Withdrawal by Subject|1|||
156518967|NCT01879553|564990492|FG001|Overall Study|Withdrawal by Subject|0|||
156518968|NCT02217501|564990498|FG000|Overall Study|Death|3|||
156518969|NCT02217501|564990499|FG001|Overall Study|Death|4|||
156518970|NCT02432196|564990500|FG000|Overall Study|Exit - did not receive study device|1|||
156518971|NCT02432196|564990500|FG000|Overall Study|Death|2|||
156518972|NCT02432196|564990500|FG000|Overall Study|Reoperation|3|||
156518973|NCT01942785|564990505|FG000|Overall Study|Adverse Event|2|||
156518974|NCT01942785|564990505|FG000|Overall Study|Withdrawal by Subject|1|||
156518975|NCT01942785|564990505|FG000|Overall Study|Protocol Violation|1|||
156518976|NCT05453201|564990506|FG000|Overall Study|Withdrawal by Subject|1|||
156518977|NCT01934790|564990507|FG000|Treatment|Adverse Event|3|||
156562169|NCT00944034|565148208|FG000|Overall Study|Withdrawal by Subject|3|||
156562170|NCT00944034|565148209|FG001|Overall Study|Withdrawal by Subject|2|||
156562171|NCT00944034|565148210|FG002|Overall Study|Withdrawal by Subject|6|||
156518978|NCT01934790|564990507|FG000|Treatment|Clinical progression|6|||
156518979|NCT01934790|564990507|FG000|Treatment|Radiological progression|4|||
156518980|NCT01934790|564990507|FG000|Treatment|Withdrawal by Subject|2|||
156518981|NCT01934790|564990507|FG000|Treatment|Study drug never administered|1|||
156518982|NCT01934790|564990507|FG000|Active Follow up|Death|20|||
156518983|NCT01934790|564990507|FG000|Active Follow up|Physician Decision|2|||
156518984|NCT01934790|564990507|FG000|Active Follow up|Progressive disease|1|||
156518985|NCT01934790|564990507|FG000|Active Follow up|Other reason|1|||
156518986|NCT03465904|564990510|FG000|Overall Study|Withdrawal by Subject|9|||
156518987|NCT03465904|564990511|FG001|Overall Study|Withdrawal by Subject|5|||
156518988|NCT03465904|564990510|FG000|Overall Study|Lost to Follow-up|11|||
156518989|NCT03465904|564990511|FG001|Overall Study|Lost to Follow-up|9|||
156518990|NCT03465904|564990510|FG000|Overall Study|Protocol Violation|20|||
156518991|NCT03465904|564990511|FG001|Overall Study|Protocol Violation|15|||
156518992|NCT00616902|564992443|FG000|Overall Study|Termination of study|6|||
156518993|NCT00616902|564992444|FG001|Overall Study|Termination of study|6|||
156518994|NCT02924428|564992445|FG000|Overall Study|Adverse Event|1|||
156518995|NCT02924428|564992446|FG001|Overall Study|Adverse Event|0|||
156518996|NCT02924428|564992445|FG000|Overall Study|Physician Decision|1|||
156518997|NCT02924428|564992446|FG001|Overall Study|Physician Decision|0|||
156518998|NCT02924428|564992445|FG000|Overall Study|Lost to Follow-up|2|||
156518999|NCT02924428|564992446|FG001|Overall Study|Lost to Follow-up|4|||
156519000|NCT02924428|564992445|FG000|Overall Study|Pregnancy|0|||
156519001|NCT02924428|564992446|FG001|Overall Study|Pregnancy|1|||
156519002|NCT01877837|564992447|FG000|Overall Study|Lost to Follow-up|1|||
156519003|NCT01877837|564992447|FG000|Overall Study|Ineligible|4|||
156519004|NCT00645801|564992448|FG000|Overall Study|unclear if patient took all the medication.|1|||
156519005|NCT00645801|564992449|FG001|Overall Study|unclear if patient took all the medication.|0|||
156519006|NCT00645801|564992448|FG000|Overall Study|Lost to Follow-up|19|||
156519007|NCT00645801|564992449|FG001|Overall Study|Lost to Follow-up|15|||
156519008|NCT01773291|564992450|FG000|Overall Study|Protocol Violation|1|||
156519009|NCT01773291|564992451|FG001|Overall Study|Protocol Violation|0|||
156519010|NCT01773291|564992452|FG002|Overall Study|Protocol Violation|0|||
156519011|NCT01773291|564992450|FG000|Overall Study|Withdrawal by Subject|0|||
156519012|NCT01773291|564992451|FG001|Overall Study|Withdrawal by Subject|0|||
156519013|NCT01773291|564992452|FG002|Overall Study|Withdrawal by Subject|1|||
156519014|NCT02480153|564992453|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
156519015|NCT02480153|564992454|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
156519016|NCT02480153|564992455|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
156519017|NCT02480153|564992453|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
156519018|NCT02480153|564992454|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
156519019|NCT02480153|564992455|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
156519020|NCT02480153|564992453|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
156519021|NCT02480153|564992454|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
156519022|NCT02480153|564992455|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
156519023|NCT02480153|564992453|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
156519024|NCT02480153|564992454|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
156519025|NCT02480153|564992455|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
156519026|NCT02480153|564992453|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
156519027|NCT02480153|564992454|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
156519028|NCT02480153|564992455|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
156519029|NCT02480153|564992453|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
156519030|NCT02480153|564992454|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
156519031|NCT02480153|564992455|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
156519032|NCT02480153|564992453|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
156519033|NCT02480153|564992454|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
156519034|NCT02480153|564992455|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
156519035|NCT02480153|564992453|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
156519036|NCT02480153|564992454|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
156519037|NCT02480153|564992455|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
156519038|NCT02480153|564992453|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
156519039|NCT02480153|564992454|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
156519040|NCT02480153|564992455|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
156519041|NCT02480153|564992453|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
156519042|NCT02480153|564992454|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
156519043|NCT02480153|564992455|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
156519044|NCT02480153|564992453|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
156519045|NCT02480153|564992454|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
156519046|NCT02480153|564992455|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
156519047|NCT02480153|564992453|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
156562172|NCT00944034|565148211|FG003|Overall Study|Withdrawal by Subject|2|||
156562173|NCT00944034|565148212|FG004|Overall Study|Withdrawal by Subject|5|||
156562174|NCT00944034|565148213|FG005|Overall Study|Withdrawal by Subject|8|||
156562175|NCT00944034|565148214|FG006|Overall Study|Withdrawal by Subject|2|||
156562176|NCT00944034|565148215|FG007|Overall Study|Withdrawal by Subject|2|||
156562177|NCT00944034|565148216|FG008|Overall Study|Withdrawal by Subject|3|||
156562178|NCT00944034|565148217|FG009|Overall Study|Withdrawal by Subject|4|||
156562179|NCT00944034|565148218|FG010|Overall Study|Withdrawal by Subject|0|||
156562180|NCT00944034|565148219|FG011|Overall Study|Withdrawal by Subject|4|||
156562181|NCT00944034|565148208|FG000|Overall Study|Lost to Follow-up|0|||
156562182|NCT00944034|565148209|FG001|Overall Study|Lost to Follow-up|4|||
156562183|NCT00944034|565148210|FG002|Overall Study|Lost to Follow-up|2|||
156562184|NCT00944034|565148211|FG003|Overall Study|Lost to Follow-up|0|||
156562185|NCT00944034|565148212|FG004|Overall Study|Lost to Follow-up|5|||
156562186|NCT00944034|565148213|FG005|Overall Study|Lost to Follow-up|7|||
156562187|NCT00944034|565148214|FG006|Overall Study|Lost to Follow-up|0|||
156562188|NCT00944034|565148215|FG007|Overall Study|Lost to Follow-up|1|||
156562189|NCT00944034|565148216|FG008|Overall Study|Lost to Follow-up|5|||
156562190|NCT00944034|565148217|FG009|Overall Study|Lost to Follow-up|1|||
156562191|NCT00944034|565148218|FG010|Overall Study|Lost to Follow-up|1|||
156562192|NCT00944034|565148219|FG011|Overall Study|Lost to Follow-up|0|||
156562193|NCT00944034|565148208|FG000|Overall Study|Death|0|||
156562194|NCT00944034|565148209|FG001|Overall Study|Death|0|||
156562195|NCT00944034|565148210|FG002|Overall Study|Death|1|||
156562196|NCT00944034|565148211|FG003|Overall Study|Death|0|||
156562197|NCT00944034|565148212|FG004|Overall Study|Death|0|||
156562198|NCT00944034|565148213|FG005|Overall Study|Death|0|||
156562199|NCT00944034|565148214|FG006|Overall Study|Death|0|||
156562200|NCT00944034|565148215|FG007|Overall Study|Death|0|||
156562201|NCT00944034|565148216|FG008|Overall Study|Death|0|||
156562202|NCT00944034|565148217|FG009|Overall Study|Death|0|||
156562203|NCT00944034|565148218|FG010|Overall Study|Death|0|||
156562204|NCT00944034|565148219|FG011|Overall Study|Death|0|||
156562205|NCT00944034|565148208|FG000|Overall Study|Protocol Violation|2|||
156562206|NCT00944034|565148209|FG001|Overall Study|Protocol Violation|0|||
156562207|NCT00944034|565148210|FG002|Overall Study|Protocol Violation|0|||
156562208|NCT00944034|565148211|FG003|Overall Study|Protocol Violation|1|||
156562209|NCT00944034|565148212|FG004|Overall Study|Protocol Violation|2|||
156562210|NCT00944034|565148213|FG005|Overall Study|Protocol Violation|3|||
156562211|NCT00944034|565148214|FG006|Overall Study|Protocol Violation|0|||
156562212|NCT00944034|565148215|FG007|Overall Study|Protocol Violation|1|||
156562213|NCT00944034|565148216|FG008|Overall Study|Protocol Violation|1|||
156562214|NCT00944034|565148217|FG009|Overall Study|Protocol Violation|4|||
156562215|NCT00944034|565148218|FG010|Overall Study|Protocol Violation|0|||
156562216|NCT00944034|565148219|FG011|Overall Study|Protocol Violation|0|||
156562217|NCT00944034|565148208|FG000|Overall Study|Unable to classify|0|||
156562218|NCT00944034|565148209|FG001|Overall Study|Unable to classify|0|||
156562219|NCT00944034|565148210|FG002|Overall Study|Unable to classify|0|||
156562220|NCT00944034|565148211|FG003|Overall Study|Unable to classify|0|||
156562221|NCT00944034|565148212|FG004|Overall Study|Unable to classify|0|||
156562222|NCT00944034|565148213|FG005|Overall Study|Unable to classify|1|||
156562223|NCT00944034|565148214|FG006|Overall Study|Unable to classify|1|||
156562224|NCT00944034|565148215|FG007|Overall Study|Unable to classify|1|||
156562225|NCT00944034|565148216|FG008|Overall Study|Unable to classify|0|||
156562226|NCT00944034|565148217|FG009|Overall Study|Unable to classify|0|||
156562227|NCT00944034|565148218|FG010|Overall Study|Unable to classify|0|||
156562228|NCT00944034|565148219|FG011|Overall Study|Unable to classify|0|||
156562229|NCT00944034|565148208|FG000|Overall Study|Administrative reason|0|||
156562230|NCT00944034|565148209|FG001|Overall Study|Administrative reason|0|||
156562231|NCT00944034|565148210|FG002|Overall Study|Administrative reason|0|||
156562232|NCT00944034|565148211|FG003|Overall Study|Administrative reason|0|||
156562233|NCT00944034|565148212|FG004|Overall Study|Administrative reason|0|||
156562234|NCT00944034|565148213|FG005|Overall Study|Administrative reason|0|||
156562235|NCT00944034|565148214|FG006|Overall Study|Administrative reason|1|||
156562236|NCT00944034|565148215|FG007|Overall Study|Administrative reason|0|||
156562237|NCT00944034|565148216|FG008|Overall Study|Administrative reason|0|||
156562238|NCT00944034|565148217|FG009|Overall Study|Administrative reason|0|||
156562239|NCT00944034|565148218|FG010|Overall Study|Administrative reason|0|||
156562240|NCT00944034|565148219|FG011|Overall Study|Administrative reason|0|||
156562241|NCT02318784|565148220|FG000|Overall Study|Adverse Event|13|||
156562242|NCT02318784|565148220|FG000|Overall Study|Death|2|||
156562243|NCT02318784|565148220|FG000|Overall Study|Progressive Disease|37|||
156562244|NCT02318784|565148220|FG000|Overall Study|Withdrawal by Subject|10|||
156562245|NCT00331006|565148221|FG000|Screening Phase|Withdrawal by Subject|1|||
156562246|NCT00331006|565148221|FG000|Screening Phase|enrollment halted|1|||
156562247|NCT00331006|565148221|FG000|Screening Phase|Lost to Follow-up|1|||
156562248|NCT00331006|565148221|FG000|Screening Phase|Ineligible for treatment phase|4|||
156562249|NCT00331006|565148221|FG000|Treatment Phase|Withdrawal by Subject|1|||
156562250|NCT00331006|565148221|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
156562251|NCT00331006|565148221|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
156519048|NCT02480153|564992454|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
156519049|NCT02480153|564992455|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
156519050|NCT02480153|564992453|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
156519051|NCT02480153|564992454|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
156519052|NCT02480153|564992455|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
156519053|NCT02480153|564992453|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
156519054|NCT02480153|564992454|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
156519055|NCT02480153|564992455|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
156519056|NCT02480153|564992453|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
156519057|NCT02480153|564992454|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
156519058|NCT02480153|564992455|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
156519059|NCT02480153|564992453|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
156519060|NCT02480153|564992454|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
156519061|NCT02480153|564992455|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
156519062|NCT02480153|564992453|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
156519063|NCT02480153|564992454|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
156519064|NCT02480153|564992455|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
156519065|NCT02480153|564992453|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
156519066|NCT02480153|564992454|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
156519067|NCT02480153|564992455|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
156519068|NCT00203476|564992456|FG000|Overall Study|Lost to Follow-up|1|||
156519069|NCT00203476|564992457|FG001|Overall Study|Lost to Follow-up|0|||
156519070|NCT00203476|564992458|FG002|Overall Study|Lost to Follow-up|0|||
156519071|NCT00203476|564992456|FG000|Overall Study|Withdrawal by Subject|0|||
156519072|NCT00203476|564992457|FG001|Overall Study|Withdrawal by Subject|1|||
156519073|NCT00203476|564992458|FG002|Overall Study|Withdrawal by Subject|0|||
156519074|NCT01190514|564992459|FG000|First Intervention (Period 1)|Adverse Event|1|||
156519075|NCT01190514|564992460|FG001|First Intervention (Period 1)|Adverse Event|0|||
156519076|NCT01190514|564992461|FG002|First Intervention (Period 1)|Adverse Event|0|||
156519077|NCT01190514|564992462|FG003|First Intervention (Period 1)|Adverse Event|0|||
156519078|NCT01190514|564992459|FG000|Third Intervention (Period 3)|Adverse Event|1|||
156519079|NCT01190514|564992460|FG001|Third Intervention (Period 3)|Adverse Event|0|||
156519080|NCT01190514|564992461|FG002|Third Intervention (Period 3)|Adverse Event|0|||
156519081|NCT01190514|564992462|FG003|Third Intervention (Period 3)|Adverse Event|0|||
156519082|NCT03241225|564992466|FG000|Overall Study|Lost to Follow-up|2|||
156519083|NCT03241225|564992467|FG001|Overall Study|Lost to Follow-up|1|||
156519084|NCT03241225|564992466|FG000|Overall Study|Protocol Violation|4|||
156519085|NCT03241225|564992467|FG001|Overall Study|Protocol Violation|1|||
156519086|NCT03241225|564992466|FG000|Overall Study|Withdrawal by Subject|1|||
156519087|NCT03241225|564992467|FG001|Overall Study|Withdrawal by Subject|0|||
156519088|NCT00852540|564992468|FG000|Overall Study|Adverse Event|10|||
156519089|NCT00852540|564992469|FG001|Overall Study|Adverse Event|3|||
156519090|NCT00852540|564992468|FG000|Overall Study|Lack of Efficacy|15|||
156519091|NCT00852540|564992469|FG001|Overall Study|Lack of Efficacy|3|||
156519092|NCT00852540|564992468|FG000|Overall Study|Protocol Violation|1|||
156519093|NCT00852540|564992469|FG001|Overall Study|Protocol Violation|2|||
156519094|NCT00852540|564992468|FG000|Overall Study|Lost to Follow-up|2|||
156519095|NCT00852540|564992469|FG001|Overall Study|Lost to Follow-up|3|||
156519096|NCT00852540|564992468|FG000|Overall Study|Investigator Discretion|2|||
156519097|NCT00852540|564992469|FG001|Overall Study|Investigator Discretion|3|||
156519098|NCT00852540|564992468|FG000|Overall Study|Withdrawal by Subject|3|||
156519099|NCT00852540|564992469|FG001|Overall Study|Withdrawal by Subject|1|||
156519100|NCT00852540|564992468|FG000|Overall Study|Did Not Receive Study Drug|3|||
156519101|NCT00852540|564992469|FG001|Overall Study|Did Not Receive Study Drug|3|||
156519102|NCT03064035|564992473|FG000|Overall Study|Did not receive allocated intervention|4|||
156519103|NCT03064035|564992474|FG001|Overall Study|Did not receive allocated intervention|2|||
156519104|NCT03064035|564992473|FG000|Overall Study|Lost to Follow-up|1|||
156519105|NCT03064035|564992474|FG001|Overall Study|Lost to Follow-up|1|||
156519106|NCT02336178|564992475|FG000|Overall Study|Lost to Follow-up|1|||
156519107|NCT02336178|564992475|FG000|Overall Study|Protocol Violation|1|||
156519108|NCT02336178|564992475|FG000|Overall Study|Withdrawal by Subject|1|||
156519109|NCT02336178|564992475|FG000|Overall Study|Other|1|||
156519110|NCT03310268|564992476|FG000|Overall Study|(Not specified)|1|||
156519111|NCT03310268|564992477|FG001|Overall Study|(Not specified)|5|||
156519112|NCT03310268|564992478|FG002|Overall Study|(Not specified)|0|||
156519113|NCT01236365|564992479|FG000|Overall Study|Lost to Follow-up|0|||
156519114|NCT01236365|564992480|FG001|Overall Study|Lost to Follow-up|2|||
156519115|NCT01236365|564992479|FG000|Overall Study|Moved Out of State|1|||
156519116|NCT01236365|564992480|FG001|Overall Study|Moved Out of State|0|||
156519117|NCT01236365|564992479|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
156519118|NCT01236365|564992480|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
156519119|NCT00558259|564992481|FG000|Overall Study|Adverse Event|50|||
156519120|NCT00558259|564992482|FG001|Overall Study|Adverse Event|81|||
156519121|NCT00558259|564992481|FG000|Overall Study|Protocol Violation|9|||
156519122|NCT00558259|564992482|FG001|Overall Study|Protocol Violation|5|||
156519123|NCT00558259|564992481|FG000|Overall Study|Withdrawal by Subject|12|||
156519124|NCT00558259|564992482|FG001|Overall Study|Withdrawal by Subject|13|||
156519125|NCT01183234|564992485|FG000|First Intervention|Adverse Event|1|||
156519126|NCT01183234|564992486|FG001|First Intervention|Adverse Event|0|||
156519127|NCT00822172|564992491|FG000|Overall Study|Adverse Event|10|||
156519128|NCT00822172|564992492|FG001|Overall Study|Adverse Event|12|||
156519129|NCT00822172|564992491|FG000|Overall Study|Death|1|||
156519130|NCT00822172|564992492|FG001|Overall Study|Death|0|||
156519131|NCT00822172|564992491|FG000|Overall Study|Lost to Follow-up|3|||
156519132|NCT00822172|564992492|FG001|Overall Study|Lost to Follow-up|1|||
156519133|NCT00822172|564992491|FG000|Overall Study|Withdrawal by Subject|1|||
156519134|NCT00822172|564992492|FG001|Overall Study|Withdrawal by Subject|4|||
156519135|NCT00822172|564992491|FG000|Overall Study|site closed|0|||
156519136|NCT00822172|564992492|FG001|Overall Study|site closed|1|||
156519137|NCT00822172|564992491|FG000|Overall Study|Other|0|||
156519138|NCT00822172|564992492|FG001|Overall Study|Other|1|||
156519139|NCT04772898|564992493|FG000|Overall Study|Withdrawal by Subject|0|||
156519140|NCT04772898|564992494|FG001|Overall Study|Withdrawal by Subject|1|||
156519141|NCT00370331|564992495|FG000|Overall Study|Adverse Event|4|||
156519142|NCT00370331|564992496|FG001|Overall Study|Adverse Event|13|||
156519143|NCT00370331|564992495|FG000|Overall Study|Withdrawal by Subject|2|||
156519144|NCT00370331|564992496|FG001|Overall Study|Withdrawal by Subject|4|||
156519145|NCT00370331|564992495|FG000|Overall Study|Lost to Follow-up|0|||
156519146|NCT00370331|564992496|FG001|Overall Study|Lost to Follow-up|3|||
156519147|NCT00370331|564992495|FG000|Overall Study|Lack of Efficacy|0|||
156519148|NCT00370331|564992496|FG001|Overall Study|Lack of Efficacy|1|||
156519149|NCT00370331|564992495|FG000|Overall Study|Non-compliance|0|||
156519150|NCT00370331|564992496|FG001|Overall Study|Non-compliance|1|||
156519151|NCT00370331|564992495|FG000|Overall Study|Protocol Violation|1|||
156519152|NCT00370331|564992496|FG001|Overall Study|Protocol Violation|1|||
156519153|NCT02947087|564992497|FG000|Overall Study|Withdrawal by Subject|3|||
156519154|NCT02947087|564992498|FG001|Overall Study|Withdrawal by Subject|2|||
156519155|NCT00545051|564992501|FG000|Overall Study|Adverse Event|7|||
156519156|NCT00545051|564992502|FG001|Overall Study|Adverse Event|3|||
156519157|NCT00545051|564992501|FG000|Overall Study|Death|1|||
156519158|NCT00545051|564992502|FG001|Overall Study|Death|0|||
156519159|NCT00545051|564992501|FG000|Overall Study|Violation of inclusion/exclusion|0|||
156519160|NCT00545051|564992502|FG001|Overall Study|Violation of inclusion/exclusion|2|||
156519161|NCT00545051|564992501|FG000|Overall Study|Protocol Violation|1|||
156519162|NCT00545051|564992502|FG001|Overall Study|Protocol Violation|0|||
156519163|NCT00545051|564992501|FG000|Overall Study|Withdrawal by Subject|0|||
156519164|NCT00545051|564992502|FG001|Overall Study|Withdrawal by Subject|1|||
156519165|NCT00545051|564992501|FG000|Overall Study|Administrative reasons|0|||
156519166|NCT00545051|564992502|FG001|Overall Study|Administrative reasons|1|||
156519167|NCT01253304|564992503|FG000|Overall Study|Adverse Event|0|||
156519168|NCT01253304|564992504|FG001|Overall Study|Adverse Event|0|||
156519169|NCT01253304|564992505|FG002|Overall Study|Adverse Event|0|||
156519170|NCT01253304|564992506|FG003|Overall Study|Adverse Event|1|||
156519171|NCT01888900|564992510|FG000|Overall Study|failed treatment|0|||
156519172|NCT01888900|564992511|FG001|Overall Study|failed treatment|2|||
156519173|NCT01004848|564992512|FG000|Overall Study|Lost to Follow-up|55|||
156519174|NCT01004848|564992513|FG001|Overall Study|Lost to Follow-up|45|||
156519175|NCT01160289|564992514|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
156519176|NCT01160289|564992515|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
156519177|NCT01160289|564992516|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
156519178|NCT01160289|564992517|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
156519179|NCT01160289|564992518|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
156519180|NCT01160289|564992519|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
156519181|NCT01160289|564992514|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
156519182|NCT01160289|564992515|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
156519183|NCT01160289|564992516|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
156519184|NCT01160289|564992517|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
156519185|NCT01160289|564992518|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
156519186|NCT01160289|564992519|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
156519187|NCT01160289|564992514|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
156519188|NCT01160289|564992515|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
156519189|NCT01160289|564992516|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
156519190|NCT01160289|564992517|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
156519191|NCT01160289|564992518|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
156519192|NCT01160289|564992519|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
156519193|NCT01160289|564992514|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
156519194|NCT01160289|564992515|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
156519195|NCT01160289|564992516|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
156519196|NCT01160289|564992517|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
156562252|NCT00238264|565148224|FG000|Overall Study|Death|7|||
156519197|NCT01160289|564992518|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
156519198|NCT01160289|564992519|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
156519199|NCT01160289|564992514|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
156519200|NCT01160289|564992515|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
156519201|NCT01160289|564992516|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
156519202|NCT01160289|564992517|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
156519203|NCT01160289|564992518|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
156519204|NCT01160289|564992519|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
156519205|NCT01160289|564992514|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
156519206|NCT01160289|564992515|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
156519207|NCT01160289|564992516|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
156519208|NCT01160289|564992517|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
156519209|NCT01160289|564992518|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
156519210|NCT01160289|564992519|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
156519211|NCT01160289|564992514|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
156519212|NCT01160289|564992515|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
156519213|NCT01160289|564992516|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
156519214|NCT01160289|564992517|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
156519215|NCT01160289|564992518|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
156519216|NCT01160289|564992519|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
156519217|NCT01160289|564992514|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
156519218|NCT01160289|564992515|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
156519219|NCT01160289|564992516|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
156519220|NCT01160289|564992517|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
156519221|NCT01160289|564992518|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
156519222|NCT01160289|564992519|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
156519223|NCT01160289|564992514|FG000|Post-Randomization Period|Adverse Event|0|||
156519224|NCT01160289|564992515|FG001|Post-Randomization Period|Adverse Event|4|||
156519225|NCT01160289|564992516|FG002|Post-Randomization Period|Adverse Event|4|||
156519226|NCT01160289|564992517|FG003|Post-Randomization Period|Adverse Event|2|||
156519227|NCT01160289|564992518|FG004|Post-Randomization Period|Adverse Event|0|||
156519228|NCT01160289|564992519|FG005|Post-Randomization Period|Adverse Event|0|||
156519229|NCT01160289|564992514|FG000|Post-Randomization Period|Death|0|||
156519230|NCT01160289|564992515|FG001|Post-Randomization Period|Death|0|||
156519231|NCT01160289|564992516|FG002|Post-Randomization Period|Death|0|||
156519232|NCT01160289|564992517|FG003|Post-Randomization Period|Death|1|||
156519233|NCT01160289|564992518|FG004|Post-Randomization Period|Death|0|||
156519234|NCT01160289|564992519|FG005|Post-Randomization Period|Death|0|||
156519235|NCT01160289|564992514|FG000|Post-Randomization Period|Lack of Efficacy|0|||
156519236|NCT01160289|564992515|FG001|Post-Randomization Period|Lack of Efficacy|1|||
156519237|NCT01160289|564992516|FG002|Post-Randomization Period|Lack of Efficacy|0|||
156519238|NCT01160289|564992517|FG003|Post-Randomization Period|Lack of Efficacy|3|||
156519239|NCT01160289|564992518|FG004|Post-Randomization Period|Lack of Efficacy|0|||
156519240|NCT01160289|564992519|FG005|Post-Randomization Period|Lack of Efficacy|0|||
156519241|NCT01160289|564992514|FG000|Post-Randomization Period|Lost to Follow-up|0|||
156519242|NCT01160289|564992515|FG001|Post-Randomization Period|Lost to Follow-up|3|||
156519243|NCT01160289|564992516|FG002|Post-Randomization Period|Lost to Follow-up|2|||
156519244|NCT01160289|564992517|FG003|Post-Randomization Period|Lost to Follow-up|5|||
156519245|NCT01160289|564992518|FG004|Post-Randomization Period|Lost to Follow-up|3|||
156519246|NCT01160289|564992519|FG005|Post-Randomization Period|Lost to Follow-up|4|||
156519247|NCT01160289|564992514|FG000|Post-Randomization Period|Physician Decision|0|||
156519248|NCT01160289|564992515|FG001|Post-Randomization Period|Physician Decision|0|||
156519249|NCT01160289|564992516|FG002|Post-Randomization Period|Physician Decision|1|||
156519250|NCT01160289|564992517|FG003|Post-Randomization Period|Physician Decision|0|||
156519251|NCT01160289|564992518|FG004|Post-Randomization Period|Physician Decision|0|||
156519252|NCT01160289|564992519|FG005|Post-Randomization Period|Physician Decision|0|||
156519253|NCT01160289|564992514|FG000|Post-Randomization Period|Protocol Violation|0|||
156519254|NCT01160289|564992515|FG001|Post-Randomization Period|Protocol Violation|4|||
156519255|NCT01160289|564992516|FG002|Post-Randomization Period|Protocol Violation|2|||
156519256|NCT01160289|564992517|FG003|Post-Randomization Period|Protocol Violation|0|||
156519257|NCT01160289|564992518|FG004|Post-Randomization Period|Protocol Violation|1|||
156562253|NCT00238264|565148224|FG000|Overall Study|Lost to Follow-up|18|||
156519258|NCT01160289|564992519|FG005|Post-Randomization Period|Protocol Violation|3|||
156519259|NCT01160289|564992514|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
156519260|NCT01160289|564992515|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
156519261|NCT01160289|564992516|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
156519262|NCT01160289|564992517|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
156519263|NCT01160289|564992518|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
156562254|NCT00238264|565148224|FG000|Overall Study|Withdrawal by Subject|4|||
156562255|NCT00238264|565148224|FG000|Overall Study|Ineligible|7|||
156562256|NCT00713219|565148225|FG000|Overall Study|Death|1|||
156562257|NCT00713219|565148225|FG000|Overall Study|Protocol Violation|1|||
156562258|NCT01838044|565148226|FG000|Overall Study|Adverse Event|4|||
156562259|NCT01838044|565148227|FG001|Overall Study|Adverse Event|6|||
156562260|NCT01838044|565148226|FG000|Overall Study|Protocol Violation|3|||
156562261|NCT01838044|565148227|FG001|Overall Study|Protocol Violation|3|||
156562262|NCT01838044|565148226|FG000|Overall Study|Withdrawal by Subject|0|||
156562263|NCT01838044|565148227|FG001|Overall Study|Withdrawal by Subject|2|||
156562264|NCT01838044|565148226|FG000|Overall Study|Insufficient clinical response|1|||
156562265|NCT01838044|565148227|FG001|Overall Study|Insufficient clinical response|2|||
156562266|NCT01838044|565148226|FG000|Overall Study|Medication error without associated AE|0|||
156562267|NCT01838044|565148227|FG001|Overall Study|Medication error without associated AE|1|||
156562268|NCT01838044|565148226|FG000|Overall Study|Lost to Follow-up|0|||
156562269|NCT01838044|565148227|FG001|Overall Study|Lost to Follow-up|2|||
156562270|NCT01413958|565148228|FG000|Overall Study|Lost to Follow-up|0|||
156562271|NCT01413958|565148229|FG001|Overall Study|Lost to Follow-up|1|||
156562272|NCT02908516|565148230|FG000|Overall Study|Study Terminated|3|||
156562273|NCT02908516|565148231|FG001|Overall Study|Study Terminated|3|||
156562274|NCT01225562|565148234|FG000|Overall Study|Withdrawal by Subject|52|||
156562275|NCT01225562|565148235|FG001|Overall Study|Withdrawal by Subject|50|||
156562276|NCT01225562|565148236|FG002|Overall Study|Withdrawal by Subject|52|||
156562277|NCT01225562|565148234|FG000|Overall Study|Lost to Follow-up|3|||
156562278|NCT01225562|565148235|FG001|Overall Study|Lost to Follow-up|6|||
156562279|NCT01225562|565148236|FG002|Overall Study|Lost to Follow-up|1|||
156562280|NCT02928952|565148238|FG000|Overall Study|Lost to Follow-up|5|||
156562281|NCT02928952|565148239|FG001|Overall Study|Lost to Follow-up|5|||
156562282|NCT02928952|565148238|FG000|Overall Study|Withdrawal by Subject|5|||
156519264|NCT01160289|564992519|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
156519265|NCT01160289|564992514|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
156562283|NCT02928952|565148239|FG001|Overall Study|Withdrawal by Subject|1|||
156562284|NCT02928952|565148238|FG000|Overall Study|Physician Decision|0|||
156562285|NCT02928952|565148239|FG001|Overall Study|Physician Decision|1|||
156562286|NCT00712348|565148243|FG000|Overall Study|Withdrawal by Subject|1|||
156562287|NCT01273064|565148246|FG000|Overall Study|Adverse Event|5|||
156562288|NCT01273064|565148247|FG001|Overall Study|Adverse Event|1|||
156562289|NCT01273064|565148248|FG002|Overall Study|Adverse Event|3|||
156562290|NCT01273064|565148249|FG003|Overall Study|Adverse Event|2|||
156562291|NCT01273064|565148250|FG004|Overall Study|Adverse Event|1|||
156562292|NCT01273064|565148246|FG000|Overall Study|Withdrawal by Subject|4|||
156562293|NCT01273064|565148247|FG001|Overall Study|Withdrawal by Subject|2|||
156562294|NCT01273064|565148248|FG002|Overall Study|Withdrawal by Subject|2|||
156562295|NCT01273064|565148249|FG003|Overall Study|Withdrawal by Subject|2|||
156562296|NCT01273064|565148250|FG004|Overall Study|Withdrawal by Subject|0|||
156562297|NCT01273064|565148246|FG000|Overall Study|Study Termination|13|||
156562298|NCT01273064|565148247|FG001|Overall Study|Study Termination|27|||
156562299|NCT01273064|565148248|FG002|Overall Study|Study Termination|26|||
156562300|NCT01273064|565148249|FG003|Overall Study|Study Termination|16|||
156562301|NCT01273064|565148250|FG004|Overall Study|Study Termination|8|||
156562302|NCT01273064|565148246|FG000|Overall Study|Lost to Follow-up|1|||
156562303|NCT01273064|565148247|FG001|Overall Study|Lost to Follow-up|0|||
156562304|NCT01273064|565148248|FG002|Overall Study|Lost to Follow-up|0|||
156562305|NCT01273064|565148249|FG003|Overall Study|Lost to Follow-up|0|||
156562306|NCT01273064|565148250|FG004|Overall Study|Lost to Follow-up|0|||
156562307|NCT01273064|565148246|FG000|Overall Study|Physician Decision|0|||
156519266|NCT01160289|564992515|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
156519267|NCT01160289|564992516|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
156519268|NCT01160289|564992517|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
156562308|NCT01273064|565148247|FG001|Overall Study|Physician Decision|0|||
156562309|NCT01273064|565148248|FG002|Overall Study|Physician Decision|0|||
156562310|NCT01273064|565148249|FG003|Overall Study|Physician Decision|0|||
156519269|NCT01160289|564992518|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
156562311|NCT01273064|565148250|FG004|Overall Study|Physician Decision|1|||
156562312|NCT04666038|565148251|FG000|Overall Study|Progressive Disease|2|||
156562313|NCT04666038|565148252|FG001|Overall Study|Progressive Disease|0|||
156519270|NCT01160289|564992519|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
156519271|NCT01160289|564992514|FG000|Post-Randomization Period|Sponsor Decision|0|||
156519272|NCT01160289|564992515|FG001|Post-Randomization Period|Sponsor Decision|1|||
156519273|NCT01160289|564992516|FG002|Post-Randomization Period|Sponsor Decision|0|||
156519274|NCT01160289|564992517|FG003|Post-Randomization Period|Sponsor Decision|0|||
156519275|NCT01160289|564992518|FG004|Post-Randomization Period|Sponsor Decision|0|||
156519276|NCT01160289|564992519|FG005|Post-Randomization Period|Sponsor Decision|0|||
156519277|NCT01156792|564992524|FG000|Overall Study|Adverse Event|1|||
156562314|NCT04666038|565148251|FG000|Overall Study|Death|38|||
156562315|NCT04666038|565148252|FG001|Overall Study|Death|32|||
156562316|NCT04666038|565148251|FG000|Overall Study|Withdrawal by Subject|10|||
156519278|NCT01156792|564992524|FG000|Overall Study|Lack of Efficacy|36|||
156519279|NCT01156792|564992524|FG000|Overall Study|Protocol Violation|6|||
156519280|NCT01156792|564992524|FG000|Overall Study|Lost to Follow-up|3|||
156519281|NCT01156792|564992524|FG000|Overall Study|Physician Decision|3|||
156519282|NCT01156792|564992524|FG000|Overall Study|Withdrawal by Subject|9|||
156519283|NCT01156792|564992524|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
156519284|NCT00768079|564992525|FG000|Overall Study|Lost to Follow-up|2|||
156519285|NCT00768079|564992526|FG001|Overall Study|Lost to Follow-up|0|||
156519286|NCT00768079|564992527|FG002|Overall Study|Lost to Follow-up|4|||
156519287|NCT00768079|564992525|FG000|Overall Study|Participant incarcerated|0|||
156519288|NCT00768079|564992526|FG001|Overall Study|Participant incarcerated|1|||
156519289|NCT00768079|564992527|FG002|Overall Study|Participant incarcerated|0|||
156519290|NCT03271021|564992528|FG000|Overall Study|Adverse Event|3|||
156519291|NCT03271021|564992529|FG001|Overall Study|Adverse Event|2|||
156519292|NCT03271021|564992528|FG000|Overall Study|Withdrawal by Subject|36|||
156519293|NCT03271021|564992529|FG001|Overall Study|Withdrawal by Subject|53|||
156519294|NCT03271021|564992528|FG000|Overall Study|Lost to Follow-up|34|||
156519295|NCT03271021|564992529|FG001|Overall Study|Lost to Follow-up|39|||
156519296|NCT03271021|564992528|FG000|Overall Study|Protocol Violation|6|||
156519297|NCT03271021|564992529|FG001|Overall Study|Protocol Violation|4|||
156519298|NCT03271021|564992528|FG000|Overall Study|Abnormal Lab Results|1|||
156519299|NCT03271021|564992529|FG001|Overall Study|Abnormal Lab Results|0|||
156519300|NCT03271021|564992528|FG000|Overall Study|Miscellaneous|9|||
156519301|NCT03271021|564992529|FG001|Overall Study|Miscellaneous|8|||
156519302|NCT00564889|564992532|FG000|Overall Study|Death|7|||
156519303|NCT00564889|564992532|FG000|Overall Study|Adverse Event|12|||
156562317|NCT04666038|565148252|FG001|Overall Study|Withdrawal by Subject|19|||
156562318|NCT04666038|565148251|FG000|Overall Study|Lost to Follow-up|0|||
156562319|NCT04666038|565148252|FG001|Overall Study|Lost to Follow-up|2|||
156562320|NCT04666038|565148251|FG000|Overall Study|On Study Treatment|46|||
156562321|NCT04666038|565148252|FG001|Overall Study|On Study Treatment|5|||
156562322|NCT04666038|565148251|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
156562323|NCT04666038|565148252|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
156562324|NCT01375764|565148257|FG000|Overall Study|Lost to Follow-up|0|||
156562325|NCT01375764|565148258|FG001|Overall Study|Lost to Follow-up|1|||
156562326|NCT01375764|565148259|FG002|Overall Study|Lost to Follow-up|0|||
156562327|NCT01375764|565148260|FG003|Overall Study|Lost to Follow-up|0|||
156562328|NCT01375764|565148261|FG004|Overall Study|Lost to Follow-up|0|||
156519304|NCT00564889|564992532|FG000|Overall Study|Alternative treatment|3|||
156519305|NCT00564889|564992532|FG000|Overall Study|Disease progression|3|||
156519306|NCT00564889|564992532|FG000|Overall Study|Other, not specified|4|||
156519307|NCT00635427|564992533|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
156519308|NCT00635427|564992534|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
156519309|NCT00635427|564992535|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
156519310|NCT00635427|564992536|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
156519311|NCT00635427|564992537|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
156519312|NCT00635427|564992533|FG000|Overall Study|Death|0|||
156519313|NCT00635427|564992534|FG001|Overall Study|Death|0|||
156519314|NCT00635427|564992535|FG002|Overall Study|Death|0|||
156519315|NCT00635427|564992536|FG003|Overall Study|Death|1|||
156519316|NCT00635427|564992537|FG004|Overall Study|Death|0|||
156519317|NCT00635427|564992533|FG000|Overall Study|Termination Of Study By Sponsor|12|||
156519318|NCT00635427|564992534|FG001|Overall Study|Termination Of Study By Sponsor|6|||
156519319|NCT00635427|564992535|FG002|Overall Study|Termination Of Study By Sponsor|10|||
156519320|NCT00635427|564992536|FG003|Overall Study|Termination Of Study By Sponsor|6|||
156519321|NCT00635427|564992537|FG004|Overall Study|Termination Of Study By Sponsor|6|||
156519322|NCT00635427|564992533|FG000|Overall Study|Withdrawal Of Consent|0|||
156519323|NCT00635427|564992534|FG001|Overall Study|Withdrawal Of Consent|0|||
156519324|NCT00635427|564992535|FG002|Overall Study|Withdrawal Of Consent|0|||
156519325|NCT00635427|564992536|FG003|Overall Study|Withdrawal Of Consent|2|||
156519326|NCT00635427|564992537|FG004|Overall Study|Withdrawal Of Consent|2|||
156519327|NCT01506609|564992541|FG000|Overall Study|Adverse Event Related to Progression|0|||
156519328|NCT01506609|564992542|FG001|Overall Study|Adverse Event Related to Progression|0|||
156519329|NCT01506609|564992543|FG002|Overall Study|Adverse Event Related to Progression|0|||
156519330|NCT01506609|564992544|FG003|Overall Study|Adverse Event Related to Progression|3|||
156519331|NCT01506609|564992545|FG004|Overall Study|Adverse Event Related to Progression|7|||
156519332|NCT01506609|564992546|FG005|Overall Study|Adverse Event Related to Progression|3|||
156519333|NCT01506609|564992541|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
156519334|NCT01506609|564992542|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
156519335|NCT01506609|564992543|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
156519336|NCT01506609|564992544|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
156519337|NCT01506609|564992545|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
156562329|NCT01375764|565148257|FG000|Overall Study|Withdrawal by Subject|2|||
156519338|NCT01506609|564992546|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
156519339|NCT01506609|564992541|FG000|Overall Study|Withdrawal by Subject|0|||
156519340|NCT01506609|564992542|FG001|Overall Study|Withdrawal by Subject|0|||
156519341|NCT01506609|564992543|FG002|Overall Study|Withdrawal by Subject|0|||
156519342|NCT01506609|564992544|FG003|Overall Study|Withdrawal by Subject|9|||
156519343|NCT01506609|564992545|FG004|Overall Study|Withdrawal by Subject|7|||
156519344|NCT01506609|564992546|FG005|Overall Study|Withdrawal by Subject|7|||
156519345|NCT01506609|564992541|FG000|Overall Study|Lost to Follow-up|0|||
156519346|NCT01506609|564992542|FG001|Overall Study|Lost to Follow-up|0|||
156519347|NCT01506609|564992543|FG002|Overall Study|Lost to Follow-up|0|||
156519348|NCT01506609|564992544|FG003|Overall Study|Lost to Follow-up|1|||
156519349|NCT01506609|564992545|FG004|Overall Study|Lost to Follow-up|2|||
156519350|NCT01506609|564992546|FG005|Overall Study|Lost to Follow-up|0|||
156519351|NCT01506609|564992541|FG000|Overall Study|Sponsor Discontinued Study|0|||
156519352|NCT01506609|564992542|FG001|Overall Study|Sponsor Discontinued Study|0|||
156519353|NCT01506609|564992543|FG002|Overall Study|Sponsor Discontinued Study|0|||
156519354|NCT01506609|564992544|FG003|Overall Study|Sponsor Discontinued Study|2|||
156519355|NCT01506609|564992545|FG004|Overall Study|Sponsor Discontinued Study|2|||
156519356|NCT01506609|564992546|FG005|Overall Study|Sponsor Discontinued Study|0|||
156519357|NCT01506609|564992541|FG000|Overall Study|Progressive Disease per Protocol|1|||
156519358|NCT01506609|564992542|FG001|Overall Study|Progressive Disease per Protocol|0|||
156519359|NCT01506609|564992543|FG002|Overall Study|Progressive Disease per Protocol|0|||
156519360|NCT01506609|564992544|FG003|Overall Study|Progressive Disease per Protocol|64|||
156519361|NCT01506609|564992545|FG004|Overall Study|Progressive Disease per Protocol|57|||
156519362|NCT01506609|564992546|FG005|Overall Study|Progressive Disease per Protocol|74|||
156519363|NCT01506609|564992541|FG000|Overall Study|Other, Not Specified|0|||
156519364|NCT01506609|564992542|FG001|Overall Study|Other, Not Specified|0|||
156519365|NCT01506609|564992543|FG002|Overall Study|Other, Not Specified|0|||
156519366|NCT01506609|564992544|FG003|Overall Study|Other, Not Specified|10|||
156519367|NCT01506609|564992545|FG004|Overall Study|Other, Not Specified|7|||
156519368|NCT01506609|564992546|FG005|Overall Study|Other, Not Specified|3|||
156519369|NCT01506609|564992541|FG000|Overall Study|Missing / Unknown Reason|1|||
156519370|NCT01506609|564992542|FG001|Overall Study|Missing / Unknown Reason|0|||
156519371|NCT01506609|564992543|FG002|Overall Study|Missing / Unknown Reason|1|||
156519372|NCT01506609|564992544|FG003|Overall Study|Missing / Unknown Reason|4|||
156519373|NCT01506609|564992545|FG004|Overall Study|Missing / Unknown Reason|4|||
156519374|NCT01506609|564992546|FG005|Overall Study|Missing / Unknown Reason|2|||
156519375|NCT00577473|564992551|FG000|Overall Study|Protocol Violation|1|||
156519376|NCT00577473|564992552|FG001|Overall Study|Protocol Violation|4|||
156519377|NCT00577473|564992551|FG000|Overall Study|Adverse Event|8|||
156519378|NCT00577473|564992552|FG001|Overall Study|Adverse Event|5|||
156519379|NCT00577473|564992551|FG000|Overall Study|Withdrawal by Subject|2|||
156519380|NCT00577473|564992552|FG001|Overall Study|Withdrawal by Subject|6|||
156519381|NCT00577473|564992551|FG000|Overall Study|Physician Decision|2|||
156519382|NCT00577473|564992552|FG001|Overall Study|Physician Decision|2|||
156519383|NCT00577473|564992551|FG000|Overall Study|Lack of Efficacy|8|||
156519384|NCT00577473|564992552|FG001|Overall Study|Lack of Efficacy|7|||
156519385|NCT01990560|564992555|FG000|Overall Study|Withdrawal by Subject|1|||
156519386|NCT02884908|564992556|FG000|Overall Study|Lost to Follow-up|13|||
156519387|NCT02884908|564992557|FG001|Overall Study|Lost to Follow-up|18|||
156519388|NCT01324440|564992558|FG000|Overall Study|Subject moved|0|||
156519389|NCT01324440|564992559|FG001|Overall Study|Subject moved|1|||
156519390|NCT01801735|564992568|FG000|Overall Study|Adverse Event|79|||
156519391|NCT01801735|564992568|FG000|Overall Study|Lack of Efficacy|28|||
156519392|NCT01801735|564992568|FG000|Overall Study|Withdrawal by Subject|27|||
156519393|NCT01801735|564992568|FG000|Overall Study|Protocol Violation|25|||
156519394|NCT01801735|564992568|FG000|Overall Study|Lost to Follow-up|15|||
156519395|NCT01801735|564992568|FG000|Overall Study|Non-compliance with Trial Drug|13|||
156519396|NCT01801735|564992568|FG000|Overall Study|Physician Decision|3|||
156519397|NCT01801735|564992568|FG000|Overall Study|Death|1|||
156519398|NCT01801735|564992568|FG000|Overall Study|Other, including site closure|19|||
156519399|NCT01293487|564992570|FG000|Overall Study|Lost to Follow-up|0|||
156519400|NCT01293487|564992571|FG001|Overall Study|Lost to Follow-up|0|||
156519401|NCT01293487|564992572|FG002|Overall Study|Lost to Follow-up|0|||
156519402|NCT01293487|564992573|FG003|Overall Study|Lost to Follow-up|1|||
156519403|NCT01293487|564992574|FG004|Overall Study|Lost to Follow-up|0|||
156519404|NCT01293487|564992575|FG005|Overall Study|Lost to Follow-up|0|||
156519405|NCT01293487|564992576|FG006|Overall Study|Lost to Follow-up|0|||
156519406|NCT01293487|564992577|FG007|Overall Study|Lost to Follow-up|0|||
156519407|NCT01293487|564992570|FG000|Overall Study|Withdrawal by Subject|0|||
156519408|NCT01293487|564992571|FG001|Overall Study|Withdrawal by Subject|0|||
156519409|NCT01293487|564992572|FG002|Overall Study|Withdrawal by Subject|0|||
156519410|NCT01293487|564992573|FG003|Overall Study|Withdrawal by Subject|0|||
156519411|NCT01293487|564992574|FG004|Overall Study|Withdrawal by Subject|0|||
156519412|NCT01293487|564992575|FG005|Overall Study|Withdrawal by Subject|0|||
156519413|NCT01293487|564992576|FG006|Overall Study|Withdrawal by Subject|0|||
156519414|NCT01293487|564992577|FG007|Overall Study|Withdrawal by Subject|2|||
156519415|NCT02703259|564992579|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
156519416|NCT02703259|564992580|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
156519417|NCT02703259|564992579|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
156519418|NCT02703259|564992580|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
156519419|NCT02703259|564992579|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
156519420|NCT02703259|564992580|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
156519421|NCT00287690|564992581|FG000|Overall Study|Protocol Violation|20|||
156519422|NCT00287690|564992582|FG001|Overall Study|Protocol Violation|26|||
156519423|NCT01146782|564992583|FG000|Screening Cohort|Screen Failure|187|||
156519424|NCT01146782|564992583|FG000|Screening Cohort|Lost to Follow-up|4|||
156519425|NCT01146782|564992583|FG000|Screening Cohort|Physician Decision|1|||
156519426|NCT01146782|564992583|FG000|Screening Cohort|Withdrawal by Subject|29|||
156519427|NCT01146782|564992583|FG000|Safety Cohort|Screen Failure|61|||
156519428|NCT01146782|564992583|FG000|Safety Cohort|Withdrawal by Subject|4|||
156519429|NCT01146782|564992583|FG000|Safety Cohort|Control AHI <5|4|||
156519430|NCT01146782|564992583|FG000|Safety Cohort|TST <4 hrs|14|||
156519431|NCT01146782|564992583|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
156519432|NCT01146782|564992583|FG000|Primary Endpoint Cohort|Physician Decision|1|||
156519433|NCT00470366|564992584|FG000|Overall Study|Adverse Event|3|||
156519434|NCT00470366|564992584|FG000|Overall Study|Poor compliance|1|||
156519435|NCT02414932|564992585|FG000|Overall Study|Withdrawal by Subject|2|||
156519436|NCT02414932|564992586|FG001|Overall Study|Withdrawal by Subject|3|||
156519437|NCT02414932|564992585|FG000|Overall Study|Adverse Event|1|||
156519438|NCT02414932|564992586|FG001|Overall Study|Adverse Event|0|||
156519439|NCT01021215|564992587|FG000|Overall Study|Lost to Follow-up|3|||
156519440|NCT01021215|564992588|FG001|Overall Study|Lost to Follow-up|0|||
156519441|NCT01688830|564992589|FG000|Overall Study|Lost to Follow-up|0|||
156519442|NCT01688830|564992590|FG001|Overall Study|Lost to Follow-up|0|||
156519443|NCT01688830|564992591|FG002|Overall Study|Lost to Follow-up|0|||
156519444|NCT01688830|564992592|FG003|Overall Study|Lost to Follow-up|0|||
156519445|NCT01688830|564992593|FG004|Overall Study|Lost to Follow-up|0|||
156519446|NCT01688830|564992594|FG005|Overall Study|Lost to Follow-up|0|||
156519447|NCT01688830|564992595|FG006|Overall Study|Lost to Follow-up|0|||
156519448|NCT01688830|564992596|FG007|Overall Study|Lost to Follow-up|0|||
156519449|NCT01688830|564992597|FG008|Overall Study|Lost to Follow-up|0|||
156519450|NCT01688830|564992598|FG009|Overall Study|Lost to Follow-up|0|||
156519451|NCT01688830|564992599|FG010|Overall Study|Lost to Follow-up|1|||
156519452|NCT01688830|564992600|FG011|Overall Study|Lost to Follow-up|0|||
156519453|NCT01688830|564992601|FG012|Overall Study|Lost to Follow-up|0|||
156519454|NCT01688830|564992602|FG013|Overall Study|Lost to Follow-up|0|||
156519455|NCT01688830|564992603|FG014|Overall Study|Lost to Follow-up|0|||
156519456|NCT01688830|564992604|FG015|Overall Study|Lost to Follow-up|0|||
156519457|NCT01688830|564992605|FG016|Overall Study|Lost to Follow-up|0|||
156519458|NCT01688830|564992606|FG017|Overall Study|Lost to Follow-up|0|||
156519459|NCT01688830|564992607|FG018|Overall Study|Lost to Follow-up|0|||
156519460|NCT01688830|564992608|FG019|Overall Study|Lost to Follow-up|0|||
156519461|NCT01688830|564992609|FG020|Overall Study|Lost to Follow-up|0|||
156519462|NCT04822597|564992610|FG000|Overall Study|Withdrawal by Subject|0|||
156519463|NCT04822597|564992611|FG001|Overall Study|Withdrawal by Subject|1|||
156562330|NCT01375764|565148258|FG001|Overall Study|Withdrawal by Subject|0|||
156562331|NCT01375764|565148259|FG002|Overall Study|Withdrawal by Subject|0|||
156562332|NCT01375764|565148260|FG003|Overall Study|Withdrawal by Subject|0|||
156562333|NCT01375764|565148261|FG004|Overall Study|Withdrawal by Subject|1|||
156562334|NCT01375764|565148257|FG000|Overall Study|Other|0|||
156562335|NCT01375764|565148258|FG001|Overall Study|Other|0|||
156562336|NCT01375764|565148259|FG002|Overall Study|Other|0|||
156562337|NCT01375764|565148260|FG003|Overall Study|Other|1|||
156562338|NCT01375764|565148261|FG004|Overall Study|Other|0|||
156562339|NCT02867761|565148264|FG000|Overall Study|Participant withdrawn by investigator|0|||
156562340|NCT02867761|565148265|FG001|Overall Study|Participant withdrawn by investigator|1|||
156562341|NCT02867761|565148264|FG000|Overall Study|Lost to Follow-up|25|||
156562342|NCT02867761|565148265|FG001|Overall Study|Lost to Follow-up|18|||
156562343|NCT02867761|565148264|FG000|Overall Study|Unable to complete protocol|3|||
156562344|NCT02867761|565148265|FG001|Overall Study|Unable to complete protocol|7|||
156562345|NCT03595280|565148266|FG000|Overall Study|Lost to Follow-up|6|||
156562346|NCT03595280|565148267|FG001|Overall Study|Lost to Follow-up|9|||
156562347|NCT03595280|565148268|FG002|Overall Study|Lost to Follow-up|15|||
156519464|NCT04822597|564992612|FG002|Overall Study|Withdrawal by Subject|1|||
156519465|NCT04822597|564992613|FG003|Overall Study|Withdrawal by Subject|0|||
156519466|NCT04822597|564992610|FG000|Overall Study|Physician Decision|0|||
156519467|NCT04822597|564992611|FG001|Overall Study|Physician Decision|0|||
156562348|NCT02292212|565148269|FG000|ViE Phase|Withdrawal by Subject|1|||
156562349|NCT02292212|565148269|FG000|ViE Phase|Protocol Violation|2|||
156562350|NCT04957290|565148270|FG000|Overall Study|Progressive disease|3|||
156562351|NCT04957290|565148271|FG001|Overall Study|Progressive disease|3|||
156562352|NCT04957290|565148272|FG002|Overall Study|Progressive disease|2|||
156519468|NCT04822597|564992612|FG002|Overall Study|Physician Decision|1|||
156519469|NCT04822597|564992613|FG003|Overall Study|Physician Decision|1|||
156519470|NCT04822597|564992610|FG000|Overall Study|Subject withdrawn after enrollment|0|||
156519471|NCT04822597|564992611|FG001|Overall Study|Subject withdrawn after enrollment|1|||
156519472|NCT04822597|564992612|FG002|Overall Study|Subject withdrawn after enrollment|0|||
156519473|NCT04822597|564992613|FG003|Overall Study|Subject withdrawn after enrollment|1|||
156519474|NCT04822597|564992610|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
156519475|NCT04822597|564992611|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
156519476|NCT04822597|564992612|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
156519477|NCT04822597|564992613|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
156519478|NCT00591851|564992614|FG000|Overall Study|Withdrawal by Subject|3|||
156519479|NCT00591851|564992614|FG000|Overall Study|Adverse Event|2|||
156519480|NCT00591851|564992614|FG000|Overall Study|Progressive Disease|1|||
156519481|NCT02359877|564994245|FG000|Overall Study|Withdrawal by Subject|1|||
156519482|NCT02359877|564994246|FG001|Overall Study|Withdrawal by Subject|0|||
156519483|NCT02359877|564994247|FG002|Overall Study|Withdrawal by Subject|0|||
156519484|NCT02359877|564994248|FG003|Overall Study|Withdrawal by Subject|2|||
156519485|NCT02359877|564994245|FG000|Overall Study|Adverse Event|0|||
156519486|NCT02359877|564994246|FG001|Overall Study|Adverse Event|0|||
156519487|NCT02359877|564994247|FG002|Overall Study|Adverse Event|0|||
156519488|NCT02359877|564994248|FG003|Overall Study|Adverse Event|1|||
156519489|NCT00910689|564994262|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
156519490|NCT00910689|564994263|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
156519491|NCT00910689|564994264|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
156519492|NCT00910689|564994265|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
156519493|NCT00910689|564994262|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
156519494|NCT00910689|564994263|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
156519495|NCT00910689|564994264|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
156519496|NCT00910689|564994265|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
156519497|NCT00910689|564994262|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
156519498|NCT00910689|564994263|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
156519499|NCT00910689|564994264|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
156519500|NCT00910689|564994265|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
156519501|NCT00910689|564994262|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
156519502|NCT00910689|564994263|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
156519503|NCT00910689|564994264|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
156519504|NCT00910689|564994265|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
156519505|NCT00910689|564994262|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
156519506|NCT00910689|564994263|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
156519507|NCT00910689|564994264|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
156519508|NCT00910689|564994265|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
156519509|NCT00910689|564994262|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
156519510|NCT00910689|564994263|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
156519511|NCT00910689|564994264|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
156519512|NCT00910689|564994265|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
156519513|NCT00910689|564994262|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
156519514|NCT00910689|564994263|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
156519515|NCT00910689|564994264|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
156519516|NCT00910689|564994265|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
156519517|NCT00910689|564994262|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
156519518|NCT00910689|564994263|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
156519519|NCT00910689|564994264|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
156519520|NCT00910689|564994265|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
156519521|NCT00910689|564994262|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
156519522|NCT00910689|564994263|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
156519523|NCT00910689|564994264|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
156519524|NCT00910689|564994265|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
156519525|NCT00910689|564994262|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
156519526|NCT00910689|564994263|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
156519527|NCT00910689|564994264|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
156519528|NCT00910689|564994265|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
156519529|NCT00910689|564994262|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
156519530|NCT00910689|564994263|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
156519531|NCT00910689|564994264|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
156519532|NCT00910689|564994265|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
156519533|NCT00910689|564994262|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
156519534|NCT00910689|564994263|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
156519535|NCT00910689|564994264|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
156519536|NCT00910689|564994265|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
156562353|NCT04957290|565148273|FG003|Overall Study|Progressive disease|0|||
156519537|NCT00910689|564994262|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
156519538|NCT00910689|564994263|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
156519539|NCT00910689|564994264|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
156519540|NCT00910689|564994265|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
156519541|NCT00910689|564994262|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
156519542|NCT00910689|564994263|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
156519543|NCT00910689|564994264|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
156519544|NCT00910689|564994265|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
156519545|NCT00910689|564994262|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
156519546|NCT00910689|564994263|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
156519547|NCT00910689|564994264|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
156519548|NCT00910689|564994265|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
156519549|NCT00910689|564994262|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
156519550|NCT00910689|564994263|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
156519551|NCT00910689|564994264|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
156519552|NCT00910689|564994265|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
156519553|NCT00910689|564994262|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
156519554|NCT00910689|564994263|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
156519555|NCT00910689|564994264|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
156519556|NCT00910689|564994265|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
156519557|NCT00910689|564994262|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
156519558|NCT00910689|564994263|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
156519559|NCT00910689|564994264|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
156519560|NCT00910689|564994265|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
156519561|NCT00910689|564994262|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
156519562|NCT00910689|564994263|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
156519563|NCT00910689|564994264|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
156519564|NCT00910689|564994265|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
156519565|NCT00910689|564994262|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
156519566|NCT00910689|564994263|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
156519567|NCT00910689|564994264|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
156519568|NCT00910689|564994265|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
156519569|NCT00910689|564994262|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
156519570|NCT00910689|564994263|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
156519571|NCT00910689|564994264|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
156519572|NCT00910689|564994265|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
156519573|NCT01290029|564994266|FG000|Overall Study|Other|2|||
156519574|NCT00189488|564994267|FG000|Overall Study|Ineligibility determined|1|||
156519575|NCT00189488|564994268|FG001|Overall Study|Ineligibility determined|0|||
156519576|NCT00189488|564994267|FG000|Overall Study|Protocol deviation|2|||
156519577|NCT00189488|564994268|FG001|Overall Study|Protocol deviation|1|||
156519578|NCT00189488|564994267|FG000|Overall Study|Adverse Event|2|||
156519579|NCT00189488|564994268|FG001|Overall Study|Adverse Event|1|||
156519580|NCT00189488|564994267|FG000|Overall Study|Withdrawal by Subject|2|||
156519581|NCT00189488|564994268|FG001|Overall Study|Withdrawal by Subject|6|||
156519582|NCT00189488|564994267|FG000|Overall Study|Disease progression|2|||
156519583|NCT00189488|564994268|FG001|Overall Study|Disease progression|4|||
156519584|NCT00189488|564994267|FG000|Overall Study|Administrative Decision|0|||
156519585|NCT00189488|564994268|FG001|Overall Study|Administrative Decision|2|||
156519586|NCT00189488|564994267|FG000|Overall Study|Death|5|||
156519587|NCT00189488|564994268|FG001|Overall Study|Death|8|||
156519588|NCT00189488|564994267|FG000|Overall Study|Other|1|||
156519589|NCT00189488|564994268|FG001|Overall Study|Other|0|||
156519590|NCT02349425|564994271|FG000|Period 1|Adverse Event|1|||
156519591|NCT02349425|564994272|FG001|Period 1|Adverse Event|1|||
156519592|NCT02349425|564994273|FG002|Period 1|Adverse Event|0|||
156519593|NCT02349425|564994274|FG003|Period 1|Adverse Event|0|||
156519594|NCT02349425|564994271|FG000|Period 2|Adverse Event|0|||
156519595|NCT02349425|564994272|FG001|Period 2|Adverse Event|1|||
156519596|NCT02349425|564994273|FG002|Period 2|Adverse Event|1|||
156519597|NCT02349425|564994274|FG003|Period 2|Adverse Event|0|||
156519598|NCT01143038|564994275|FG000|Overall Study|Withdrawal by Subject|4|||
156519599|NCT01143038|564994275|FG000|Overall Study|Requirement for alternative therapy|5|||
156519600|NCT01143038|564994275|FG000|Overall Study|Adverse Event|3|||
156519601|NCT01143038|564994275|FG000|Overall Study|Lost to Follow-up|2|||
156519602|NCT01143038|564994275|FG000|Overall Study|Protocol Deviation|1|||
156519603|NCT01143038|564994275|FG000|Overall Study|Death|1|||
156519604|NCT03215810|564994278|FG000|Overall Study|Still responding to nivolumab|1|||
156519605|NCT03215810|564994278|FG000|Overall Study|Insufficient TIL growth|1|||
156519606|NCT03215810|564994278|FG000|Overall Study|Decline in performance status|1|||
156519607|NCT03215810|564994278|FG000|Overall Study|Withdrawal by Subject|1|||
156519608|NCT02313233|564994282|FG000|Overall Study|Withdrawal by Subject|1|||
156519609|NCT02313233|564994283|FG001|Overall Study|Withdrawal by Subject|2|||
156519610|NCT02313233|564994282|FG000|Overall Study|Administrative reason|1|||
156519611|NCT02313233|564994283|FG001|Overall Study|Administrative reason|1|||
156519612|NCT02095951|564994284|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
156519613|NCT02095951|564994285|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
156519614|NCT03618823|564994286|FG000|Overall Study|Lost to Follow-up|63|||
156562354|NCT04957290|565148274|FG004|Overall Study|Progressive disease|0|||
156562355|NCT04957290|565148275|FG005|Overall Study|Progressive disease|0|||
156562356|NCT04957290|565148270|FG000|Overall Study|Withdrawal by Subject|1|||
156562357|NCT04957290|565148271|FG001|Overall Study|Withdrawal by Subject|0|||
156562358|NCT04957290|565148272|FG002|Overall Study|Withdrawal by Subject|1|||
156562359|NCT04957290|565148273|FG003|Overall Study|Withdrawal by Subject|0|||
156562360|NCT04957290|565148274|FG004|Overall Study|Withdrawal by Subject|0|||
156562361|NCT04957290|565148275|FG005|Overall Study|Withdrawal by Subject|0|||
156562362|NCT04957290|565148270|FG000|Overall Study|Death|0|||
156562363|NCT04957290|565148271|FG001|Overall Study|Death|2|||
156562364|NCT04957290|565148272|FG002|Overall Study|Death|1|||
156562365|NCT04957290|565148273|FG003|Overall Study|Death|0|||
156562366|NCT04957290|565148274|FG004|Overall Study|Death|0|||
156562367|NCT04957290|565148275|FG005|Overall Study|Death|0|||
156562368|NCT04957290|565148270|FG000|Overall Study|non compliance with study drug|0|||
156562369|NCT04957290|565148271|FG001|Overall Study|non compliance with study drug|1|||
156562370|NCT04957290|565148272|FG002|Overall Study|non compliance with study drug|0|||
156562371|NCT04957290|565148273|FG003|Overall Study|non compliance with study drug|0|||
156562372|NCT04957290|565148274|FG004|Overall Study|non compliance with study drug|0|||
156562373|NCT04957290|565148275|FG005|Overall Study|non compliance with study drug|0|||
156562374|NCT04957290|565148270|FG000|Overall Study|none specified.|0|||
156562375|NCT04957290|565148271|FG001|Overall Study|none specified.|1|||
156562376|NCT04957290|565148272|FG002|Overall Study|none specified.|2|||
156562377|NCT04957290|565148273|FG003|Overall Study|none specified.|0|||
156562378|NCT04957290|565148274|FG004|Overall Study|none specified.|0|||
156562379|NCT04957290|565148275|FG005|Overall Study|none specified.|0|||
156562380|NCT04957290|565148270|FG000|Overall Study|unacceptable toxicity|0|||
156562381|NCT04957290|565148271|FG001|Overall Study|unacceptable toxicity|0|||
156562382|NCT04957290|565148272|FG002|Overall Study|unacceptable toxicity|1|||
156562383|NCT04957290|565148273|FG003|Overall Study|unacceptable toxicity|0|||
156562384|NCT04957290|565148274|FG004|Overall Study|unacceptable toxicity|0|||
156562385|NCT04957290|565148275|FG005|Overall Study|unacceptable toxicity|0|||
156562386|NCT04957290|565148270|FG000|Overall Study|Adverse Event|0|||
156562387|NCT04957290|565148271|FG001|Overall Study|Adverse Event|0|||
156562388|NCT04957290|565148272|FG002|Overall Study|Adverse Event|1|||
156562389|NCT04957290|565148273|FG003|Overall Study|Adverse Event|0|||
156562390|NCT04957290|565148274|FG004|Overall Study|Adverse Event|0|||
156562391|NCT04957290|565148275|FG005|Overall Study|Adverse Event|0|||
156562392|NCT04957290|565148270|FG000|Overall Study|study terminated by sponsor|0|||
156562393|NCT04957290|565148271|FG001|Overall Study|study terminated by sponsor|0|||
156562394|NCT04957290|565148272|FG002|Overall Study|study terminated by sponsor|2|||
156519615|NCT03618823|564994287|FG001|Overall Study|Lost to Follow-up|61|||
156519616|NCT05383508|564994288|FG000|Overall Study|Withdrawal by Subject|1|||
156519617|NCT05383508|564994289|FG001|Overall Study|Withdrawal by Subject|0|||
156519618|NCT05383508|564994290|FG002|Overall Study|Withdrawal by Subject|1|||
156519619|NCT05383508|564994291|FG003|Overall Study|Withdrawal by Subject|1|||
156519620|NCT05383508|564994292|FG004|Overall Study|Withdrawal by Subject|2|||
156519621|NCT05383508|564994293|FG005|Overall Study|Withdrawal by Subject|0|||
156519622|NCT01621568|564994295|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
156519623|NCT01621568|564994296|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
156519624|NCT01621568|564994295|FG000|Week 5-6 No Treatment|Death|1|||
156519625|NCT01621568|564994296|FG001|Week 5-6 No Treatment|Death|0|||
156519626|NCT01859988|564994297|FG000|Overall Study|Withdrawal by Subject|6|||
156519627|NCT01859988|564994298|FG001|Overall Study|Withdrawal by Subject|3|||
156519628|NCT01859988|564994299|FG002|Overall Study|Withdrawal by Subject|4|||
156519629|NCT01859988|564994300|FG003|Overall Study|Withdrawal by Subject|3|||
156519630|NCT01859988|564994301|FG004|Overall Study|Withdrawal by Subject|2|||
156519631|NCT01859988|564994302|FG005|Overall Study|Withdrawal by Subject|2|||
156519632|NCT01859988|564994297|FG000|Overall Study|Lack of Efficacy|1|||
156519633|NCT01859988|564994298|FG001|Overall Study|Lack of Efficacy|1|||
156519634|NCT01859988|564994299|FG002|Overall Study|Lack of Efficacy|5|||
156519635|NCT01859988|564994300|FG003|Overall Study|Lack of Efficacy|0|||
156562395|NCT04957290|565148273|FG003|Overall Study|study terminated by sponsor|0|||
156562396|NCT04957290|565148274|FG004|Overall Study|study terminated by sponsor|0|||
156562397|NCT04957290|565148275|FG005|Overall Study|study terminated by sponsor|0|||
156562398|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156519636|NCT01859988|564994301|FG004|Overall Study|Lack of Efficacy|7|||
156562399|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562400|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562401|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
156562402|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156519637|NCT01859988|564994302|FG005|Overall Study|Lack of Efficacy|9|||
156519638|NCT01859988|564994297|FG000|Overall Study|Physician Decision|1|||
156519639|NCT01859988|564994298|FG001|Overall Study|Physician Decision|3|||
156519640|NCT01859988|564994299|FG002|Overall Study|Physician Decision|1|||
156519641|NCT01859988|564994300|FG003|Overall Study|Physician Decision|3|||
156519642|NCT01859988|564994301|FG004|Overall Study|Physician Decision|4|||
156519643|NCT01859988|564994302|FG005|Overall Study|Physician Decision|1|||
156519644|NCT01859988|564994297|FG000|Overall Study|Adverse Event|2|||
156519645|NCT01859988|564994298|FG001|Overall Study|Adverse Event|1|||
156562403|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
156562404|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156519646|NCT01859988|564994299|FG002|Overall Study|Adverse Event|3|||
156519647|NCT01859988|564994300|FG003|Overall Study|Adverse Event|1|||
156519648|NCT01859988|564994301|FG004|Overall Study|Adverse Event|2|||
156519649|NCT01859988|564994302|FG005|Overall Study|Adverse Event|2|||
156519650|NCT01859988|564994297|FG000|Overall Study|Lost to Follow-up|1|||
156519651|NCT01859988|564994298|FG001|Overall Study|Lost to Follow-up|2|||
156519652|NCT01859988|564994299|FG002|Overall Study|Lost to Follow-up|3|||
156519653|NCT01859988|564994300|FG003|Overall Study|Lost to Follow-up|0|||
156519654|NCT01859988|564994301|FG004|Overall Study|Lost to Follow-up|3|||
156519655|NCT01859988|564994302|FG005|Overall Study|Lost to Follow-up|2|||
156519656|NCT01859988|564994297|FG000|Overall Study|Protocol Violation|0|||
156519657|NCT01859988|564994298|FG001|Overall Study|Protocol Violation|0|||
156519658|NCT01859988|564994299|FG002|Overall Study|Protocol Violation|1|||
156519659|NCT01859988|564994300|FG003|Overall Study|Protocol Violation|0|||
156519660|NCT01859988|564994301|FG004|Overall Study|Protocol Violation|0|||
156519661|NCT01859988|564994302|FG005|Overall Study|Protocol Violation|0|||
156519662|NCT01859988|564994297|FG000|Overall Study|Other than specified above|0|||
156519663|NCT01859988|564994298|FG001|Overall Study|Other than specified above|2|||
156519664|NCT01859988|564994299|FG002|Overall Study|Other than specified above|11|||
156519665|NCT01859988|564994300|FG003|Overall Study|Other than specified above|3|||
156519666|NCT01859988|564994301|FG004|Overall Study|Other than specified above|5|||
156519667|NCT01859988|564994302|FG005|Overall Study|Other than specified above|3|||
156519668|NCT02930226|564994303|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
156519669|NCT02930226|564994304|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
156519670|NCT02930226|564994305|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
156519671|NCT02930226|564994306|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
156519672|NCT02930226|564994307|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
156519673|NCT02930226|564994308|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
156519674|NCT02084056|564994309|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
156519675|NCT02084056|564994310|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
156519676|NCT02084056|564994311|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
156519677|NCT02084056|564994312|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
156519678|NCT02084056|564994309|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
156519679|NCT02084056|564994310|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156519680|NCT02084056|564994311|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156519681|NCT02084056|564994312|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156519682|NCT00938860|564994313|FG000|Overall Study|Adverse Event|2|||
156519683|NCT00938860|564994314|FG001|Overall Study|Adverse Event|1|||
156519684|NCT00938860|564994313|FG000|Overall Study|Abnormal laboratory values|2|||
156519685|NCT00938860|564994314|FG001|Overall Study|Abnormal laboratory values|2|||
156519686|NCT00938860|564994313|FG000|Overall Study|Withdrawal by Subject|11|||
156519687|NCT00938860|564994314|FG001|Overall Study|Withdrawal by Subject|8|||
156519688|NCT00938860|564994313|FG000|Overall Study|Lost to Follow-up|4|||
156519689|NCT00938860|564994314|FG001|Overall Study|Lost to Follow-up|4|||
156562405|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562406|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562407|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562408|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156519690|NCT00938860|564994313|FG000|Overall Study|Administration problems|2|||
156519691|NCT00938860|564994314|FG001|Overall Study|Administration problems|0|||
156519692|NCT00938860|564994313|FG000|Overall Study|Death|1|||
156519693|NCT00938860|564994314|FG001|Overall Study|Death|1|||
156519694|NCT00938860|564994313|FG000|Overall Study|Protocol Violation|3|||
156519695|NCT00938860|564994314|FG001|Overall Study|Protocol Violation|1|||
156519696|NCT01605019|564994315|FG000|Overall Study|pt did not meet transplant endpoint|3|||
156519697|NCT01605019|564994316|FG001|Overall Study|pt did not meet transplant endpoint|0|||
156562409|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562410|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156519698|NCT00468559|564994320|FG000|Open-label Treatment Phase|Adverse Event|5|||
156519699|NCT00468559|564994321|FG001|Open-label Treatment Phase|Adverse Event|0|||
156519700|NCT00468559|564994322|FG002|Open-label Treatment Phase|Adverse Event|0|||
156519701|NCT00468559|564994320|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
156562411|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562412|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156519702|NCT00468559|564994321|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
156562413|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562414|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562415|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562416|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562417|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562418|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562419|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562420|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
156562421|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
156562422|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
156562423|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
156562424|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
156562425|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
156562426|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
156562427|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
156562428|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562429|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562430|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562431|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562432|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562433|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562434|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562435|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562436|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562437|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562438|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562439|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562440|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562441|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562442|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562443|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
156562444|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
156562445|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
156562446|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
156562447|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
156562448|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
156562449|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
156562450|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
156562451|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
156562452|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156519703|NCT00468559|564994322|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
156519704|NCT00468559|564994320|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
156519705|NCT00468559|564994321|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
156519706|NCT00468559|564994322|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
156519707|NCT00468559|564994320|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
156519708|NCT00468559|564994321|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
156519709|NCT00468559|564994322|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
156519710|NCT00468559|564994320|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
156519711|NCT00468559|564994321|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
156519712|NCT00468559|564994322|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
156519713|NCT00862719|564994323|FG000|Overall Study|Disease Progression|5|||
156519714|NCT00862719|564994324|FG001|Overall Study|Disease Progression|0|||
156519715|NCT00862719|564994325|FG002|Overall Study|Disease Progression|1|||
156519716|NCT00862719|564994326|FG003|Overall Study|Disease Progression|0|||
156519717|NCT00862719|564994323|FG000|Overall Study|Death|5|||
156519718|NCT00862719|564994324|FG001|Overall Study|Death|6|||
156519719|NCT00862719|564994325|FG002|Overall Study|Death|1|||
156519720|NCT00862719|564994326|FG003|Overall Study|Death|1|||
156519721|NCT00862719|564994323|FG000|Overall Study|Engraftment failure|0|||
156519722|NCT00862719|564994324|FG001|Overall Study|Engraftment failure|0|||
156519723|NCT00862719|564994325|FG002|Overall Study|Engraftment failure|1|||
156519724|NCT00862719|564994326|FG003|Overall Study|Engraftment failure|0|||
156519725|NCT00862719|564994323|FG000|Overall Study|Veno-Occlusive Disease|0|||
156519726|NCT00862719|564994324|FG001|Overall Study|Veno-Occlusive Disease|0|||
156519727|NCT00862719|564994325|FG002|Overall Study|Veno-Occlusive Disease|1|||
156519728|NCT00862719|564994326|FG003|Overall Study|Veno-Occlusive Disease|0|||
156519729|NCT00324116|564994327|FG000|Overall Study|Adverse Event|5|||
156519730|NCT00324116|564994327|FG000|Overall Study|Lack of Efficacy|17|||
156519731|NCT00324116|564994327|FG000|Overall Study|Withdrawal by Subject|5|||
156519732|NCT00324116|564994327|FG000|Overall Study|Other|5|||
156519733|NCT01153958|564994328|FG000|Overall Study|Study Terminated|36|||
156519734|NCT01153958|564994329|FG001|Overall Study|Study Terminated|32|||
156519735|NCT02624791|564994331|FG000|Overall Study|Withdrawal by Subject|2|||
156519736|NCT02624791|564994332|FG001|Overall Study|Withdrawal by Subject|0|||
156519737|NCT02624791|564994333|FG002|Overall Study|Withdrawal by Subject|0|||
156519738|NCT02624791|564994334|FG003|Overall Study|Withdrawal by Subject|0|||
156519739|NCT02624791|564994335|FG004|Overall Study|Withdrawal by Subject|0|||
156519740|NCT02624791|564994336|FG005|Overall Study|Withdrawal by Subject|0|||
156519741|NCT00998790|564994339|FG000|Overall Study|Withdrawal by Subject|21|||
156519742|NCT01605916|564994341|FG000|Overall Study|Adverse Event|1|||
156519743|NCT01605916|564994342|FG001|Overall Study|Adverse Event|0|||
156519744|NCT01605916|564994343|FG002|Overall Study|Adverse Event|0|||
156519745|NCT01605916|564994344|FG003|Overall Study|Adverse Event|1|||
156519746|NCT01605916|564994345|FG004|Overall Study|Adverse Event|0|||
156519747|NCT01605916|564994341|FG000|Overall Study|Lack of Efficacy|2|||
156519748|NCT01605916|564994342|FG001|Overall Study|Lack of Efficacy|3|||
156519749|NCT01605916|564994343|FG002|Overall Study|Lack of Efficacy|3|||
156519750|NCT01605916|564994344|FG003|Overall Study|Lack of Efficacy|5|||
156519751|NCT01605916|564994345|FG004|Overall Study|Lack of Efficacy|4|||
156519752|NCT01605916|564994341|FG000|Overall Study|Withdrawal by Subject|1|||
156519753|NCT01605916|564994342|FG001|Overall Study|Withdrawal by Subject|1|||
156519754|NCT01605916|564994343|FG002|Overall Study|Withdrawal by Subject|0|||
156519755|NCT01605916|564994344|FG003|Overall Study|Withdrawal by Subject|0|||
156519756|NCT01605916|564994345|FG004|Overall Study|Withdrawal by Subject|2|||
156519757|NCT01103362|564994354|FG000|Overall Study|study terminated|596|||
156519758|NCT02047903|564994355|FG000|Overall Study|Adverse Event|14|||
156519759|NCT02047903|564994355|FG000|Overall Study|Serious adverse event|10|||
156519760|NCT02047903|564994355|FG000|Overall Study|Withdrawal by Subject|16|||
156519761|NCT02047903|564994355|FG000|Overall Study|Lost to Follow-up|4|||
156519762|NCT02047903|564994355|FG000|Overall Study|Reason not listed|6|||
156519763|NCT02047903|564994355|FG000|Overall Study|Not Treated|9|||
156519764|NCT01014533|564994356|FG000|Overall Study|Protocol Violation|3|||
156519765|NCT01014533|564994357|FG001|Overall Study|Protocol Violation|2|||
156519766|NCT01014533|564994356|FG000|Overall Study|Withdrawal by Subject|2|||
156519767|NCT01014533|564994357|FG001|Overall Study|Withdrawal by Subject|0|||
156519768|NCT01014533|564994356|FG000|Overall Study|unable to come to appointment|0|||
156519769|NCT01014533|564994357|FG001|Overall Study|unable to come to appointment|3|||
156519770|NCT00412061|564994359|FG000|Double Blind Phase|Disease Progression|101|||
156562453|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562454|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562455|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562456|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562457|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562458|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562459|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562460|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562461|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562462|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562463|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562464|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562465|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562466|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
156562467|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562468|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562469|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
156562470|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562471|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
156562472|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562473|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562474|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562475|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562476|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562477|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562478|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156519771|NCT00412061|564994360|FG001|Double Blind Phase|Disease Progression|154|||
156519772|NCT00412061|564994359|FG000|Double Blind Phase|Adverse Event|61|||
156519773|NCT00412061|564994360|FG001|Double Blind Phase|Adverse Event|16|||
156519774|NCT00412061|564994359|FG000|Double Blind Phase|Final Primary Analysis|26|||
156519775|NCT00412061|564994360|FG001|Double Blind Phase|Final Primary Analysis|14|||
156519776|NCT00412061|564994359|FG000|Double Blind Phase|Withdrawal by Subject|18|||
156519777|NCT00412061|564994360|FG001|Double Blind Phase|Withdrawal by Subject|20|||
156519778|NCT00412061|564994359|FG000|Double Blind Phase|Death|6|||
156519779|NCT00412061|564994360|FG001|Double Blind Phase|Death|3|||
156519780|NCT00412061|564994359|FG000|Double Blind Phase|Protocol Violation|3|||
156519781|NCT00412061|564994360|FG001|Double Blind Phase|Protocol Violation|4|||
156519782|NCT00412061|564994359|FG000|Double Blind Phase|New Cander Therapy|1|||
156519783|NCT00412061|564994360|FG001|Double Blind Phase|New Cander Therapy|1|||
156519784|NCT00412061|564994359|FG000|Double Blind Phase|Lost to Follow-up|0|||
156519785|NCT00412061|564994360|FG001|Double Blind Phase|Lost to Follow-up|1|||
156519786|NCT00412061|564994359|FG000|Open Label Phase|Disease Progression|0|||
156519787|NCT00412061|564994360|FG001|Open Label Phase|Disease Progression|86|||
156519788|NCT00412061|564994359|FG000|Open Label Phase|Adverse Event|0|||
156519789|NCT00412061|564994360|FG001|Open Label Phase|Adverse Event|46|||
156519790|NCT00412061|564994359|FG000|Open Label Phase|Withdrawal by Subject|0|||
156519791|NCT00412061|564994360|FG001|Open Label Phase|Withdrawal by Subject|15|||
156519792|NCT00412061|564994359|FG000|Open Label Phase|Administrative Problems|0|||
156519793|NCT00412061|564994360|FG001|Open Label Phase|Administrative Problems|13|||
156519794|NCT00412061|564994359|FG000|Open Label Phase|Death|0|||
156519795|NCT00412061|564994360|FG001|Open Label Phase|Death|7|||
156519796|NCT00412061|564994359|FG000|Open Label Phase|Lost to Follow-up|0|||
156519797|NCT00412061|564994360|FG001|Open Label Phase|Lost to Follow-up|2|||
156519798|NCT00412061|564994359|FG000|Open Label Phase|New Cancer Therapy|0|||
156519799|NCT00412061|564994360|FG001|Open Label Phase|New Cancer Therapy|1|||
156519800|NCT02689518|564994362|FG000|Overall Study|Withdrawal by Subject|3|||
156519801|NCT01942590|564994363|FG000|Overall Study|Withdrawal by Subject|0|||
156519802|NCT01942590|564994364|FG001|Overall Study|Withdrawal by Subject|1|||
156519803|NCT01942590|564994363|FG000|Overall Study|Adverse Event|1|||
156519804|NCT01942590|564994364|FG001|Overall Study|Adverse Event|0|||
156519805|NCT01226095|564994367|FG000|Overall Study|Poor compliance|1|||
156519806|NCT00911768|564994373|FG000|Overall Study|Protocol Violation|5|||
156519807|NCT00911768|564994374|FG001|Overall Study|Protocol Violation|4|||
156519808|NCT00911768|564994373|FG000|Overall Study|Withdrawal by Subject|1|||
156519809|NCT00911768|564994374|FG001|Overall Study|Withdrawal by Subject|0|||
156519810|NCT03406078|564994376|FG000|Overall Study|Death|1|||
156519811|NCT03406078|564994377|FG001|Overall Study|Death|0|||
156519812|NCT03406078|564994376|FG000|Overall Study|Lost to Follow-up|0|||
156519813|NCT03406078|564994377|FG001|Overall Study|Lost to Follow-up|1|||
156519814|NCT03406078|564994376|FG000|Overall Study|Withdrawal by Subject|5|||
156519815|NCT03406078|564994377|FG001|Overall Study|Withdrawal by Subject|2|||
156519816|NCT03616977|564994381|FG000|Period 1|Physician Decision|0|||
156519817|NCT03616977|564994382|FG001|Period 1|Physician Decision|1|||
156519818|NCT03616977|564994381|FG000|Period 3|Adverse Event|1|||
156519819|NCT03616977|564994382|FG001|Period 3|Adverse Event|1|||
156519820|NCT00515853|564994383|FG000|Overall Study|Lost to Follow-up|9|||
156519821|NCT00515853|564994384|FG001|Overall Study|Lost to Follow-up|13|||
156519822|NCT00515853|564994383|FG000|Overall Study|Withdrawal by Subject|6|||
156519823|NCT00515853|564994384|FG001|Overall Study|Withdrawal by Subject|4|||
156519824|NCT03965351|564994389|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
156519825|NCT03965351|564994390|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
156519826|NCT03965351|564994389|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
156519827|NCT03965351|564994390|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
156519828|NCT02859324|564994391|FG000|Overall Study|Death|4|||
156519829|NCT02859324|564994392|FG001|Overall Study|Death|6|||
156519830|NCT02859324|564994393|FG002|Overall Study|Death|5|||
156519831|NCT02859324|564994391|FG000|Overall Study|Other reasons|3|||
156519832|NCT02859324|564994392|FG001|Overall Study|Other reasons|3|||
156562479|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562480|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562481|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562482|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562483|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562484|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562485|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562486|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156519833|NCT02859324|564994393|FG002|Overall Study|Other reasons|0|||
156519834|NCT03798691|564994394|FG000|Overall Study|Lost to Follow-up|2|||
156519835|NCT03798691|564994395|FG001|Overall Study|Lost to Follow-up|2|||
156519836|NCT05593445|564994396|FG000|12-Week DBVC Period|Adverse Event|1|||
156519837|NCT05593445|564994397|FG001|12-Week DBVC Period|Adverse Event|0|||
156519838|NCT05593445|564994398|FG002|12-Week DBVC Period|Adverse Event|0|||
156519839|NCT05593445|564994399|FG003|12-Week DBVC Period|Adverse Event|0|||
156519840|NCT05593445|564994396|FG000|12-Week DBVC Period|Physician Decision|0|||
156519841|NCT05593445|564994397|FG001|12-Week DBVC Period|Physician Decision|1|||
156519842|NCT05593445|564994398|FG002|12-Week DBVC Period|Physician Decision|0|||
156519843|NCT05593445|564994399|FG003|12-Week DBVC Period|Physician Decision|0|||
156519844|NCT05593445|564994396|FG000|12-Week DBVC Period|Protocol Violation|0|||
156519845|NCT05593445|564994397|FG001|12-Week DBVC Period|Protocol Violation|1|||
156519846|NCT05593445|564994398|FG002|12-Week DBVC Period|Protocol Violation|0|||
156519847|NCT05593445|564994399|FG003|12-Week DBVC Period|Protocol Violation|0|||
156519848|NCT05593445|564994396|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
156519849|NCT05593445|564994397|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
156519850|NCT05593445|564994398|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
156519851|NCT05593445|564994399|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
156519852|NCT05593445|564994396|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
156519853|NCT05593445|564994397|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
156519854|NCT05593445|564994398|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
156519855|NCT05593445|564994399|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
156519856|NCT05593445|564994396|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
156519857|NCT05593445|564994397|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
156519858|NCT05593445|564994398|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
156519859|NCT05593445|564994399|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
156519860|NCT05593445|564994396|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
156519861|NCT05593445|564994397|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
156519862|NCT05593445|564994398|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
156519863|NCT05593445|564994399|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
156519864|NCT05593445|564994396|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156519865|NCT05593445|564994397|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156519866|NCT05593445|564994398|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
156519867|NCT05593445|564994399|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156519868|NCT05559476|564994400|FG000|Overall Study|Adverse Event|2|||
156519869|NCT05559476|564994401|FG001|Overall Study|Adverse Event|0|||
156519870|NCT05559476|564994400|FG000|Overall Study|Lost to Follow-up|13|||
156519871|NCT05559476|564994401|FG001|Overall Study|Lost to Follow-up|12|||
156519872|NCT05559476|564994400|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
156519873|NCT05559476|564994401|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
156519874|NCT05559476|564994400|FG000|Overall Study|Other|0|||
156519875|NCT05559476|564994401|FG001|Overall Study|Other|2|||
156519876|NCT05110690|564994402|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
156519877|NCT05110690|564994402|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
156519878|NCT05110690|564994402|FG000|Completion of Intervention|Lost to Follow-up|1|||
156519879|NCT05110690|564994402|FG000|Completion of Intervention|Death|1|||
156519880|NCT05110690|564994402|FG000|Completion of Intervention|Withdrawal by Subject|2|||
156519881|NCT02186223|564995993|FG000|Overall Study|Not eligible for device placement|6|||
156519882|NCT02186223|564995993|FG000|Overall Study|Unable to obtain femoral access|3|||
156519883|NCT02186223|564995993|FG000|Overall Study|Death|3|||
156519884|NCT02186223|564995993|FG000|Overall Study|Device in place less than 48 hours|9|||
156519885|NCT00252733|564995994|FG000|Overall Study|Withdrawal by Subject|73|||
156519886|NCT00252733|564995995|FG001|Overall Study|Withdrawal by Subject|67|||
156519887|NCT00252733|564995994|FG000|Overall Study|Death|7|||
156519888|NCT00252733|564995995|FG001|Overall Study|Death|5|||
156519889|NCT00252733|564995994|FG000|Overall Study|Lost to Follow-up|12|||
156519890|NCT00252733|564995995|FG001|Overall Study|Lost to Follow-up|6|||
156519891|NCT00252733|564995994|FG000|Overall Study|Multiple Reasons|14|||
156519892|NCT00252733|564995995|FG001|Overall Study|Multiple Reasons|14|||
156519893|NCT00618982|564995996|FG000|Overall Study|Adverse Event|23|||
156519894|NCT00618982|564995996|FG000|Overall Study|Withdrawal by Subject|1|||
156519895|NCT00618982|564995996|FG000|Overall Study|Protocol Violation|1|||
156519896|NCT00618982|564995996|FG000|Overall Study|ongoing, still treated with study med.|25|||
156519897|NCT00706433|564996000|FG000|Overall Study|Lost to Follow-up|3|||
156519898|NCT00706433|564996001|FG001|Overall Study|Lost to Follow-up|1|||
156519899|NCT00706433|564996002|FG002|Overall Study|Lost to Follow-up|6|||
156519900|NCT00706433|564996003|FG003|Overall Study|Lost to Follow-up|0|||
156519901|NCT00706433|564996000|FG000|Overall Study|Withdrawal by Subject|1|||
156519902|NCT00706433|564996001|FG001|Overall Study|Withdrawal by Subject|2|||
156519903|NCT00706433|564996002|FG002|Overall Study|Withdrawal by Subject|3|||
156519904|NCT00706433|564996003|FG003|Overall Study|Withdrawal by Subject|1|||
156519905|NCT00706433|564996000|FG000|Overall Study|Adverse Event|0|||
156519906|NCT00706433|564996001|FG001|Overall Study|Adverse Event|0|||
156519907|NCT00706433|564996002|FG002|Overall Study|Adverse Event|1|||
156519908|NCT00706433|564996003|FG003|Overall Study|Adverse Event|0|||
156519909|NCT00706433|564996000|FG000|Overall Study|Protocol Violation|1|||
156519910|NCT00706433|564996001|FG001|Overall Study|Protocol Violation|0|||
156519911|NCT00706433|564996002|FG002|Overall Study|Protocol Violation|0|||
156519912|NCT00706433|564996003|FG003|Overall Study|Protocol Violation|0|||
156519913|NCT00706433|564996000|FG000|Overall Study|new job|0|||
156519914|NCT00706433|564996001|FG001|Overall Study|new job|0|||
156519915|NCT00706433|564996002|FG002|Overall Study|new job|0|||
156519916|NCT00706433|564996003|FG003|Overall Study|new job|1|||
156519917|NCT04101318|564996005|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
156519918|NCT04101318|564996006|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
156519919|NCT04101318|564996005|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
156519920|NCT04101318|564996006|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
156519921|NCT04101318|564996005|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
156519922|NCT04101318|564996006|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
156519923|NCT00717067|564996007|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
156519924|NCT00717067|564996008|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
156519925|NCT00717067|564996009|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
156519926|NCT00717067|564996010|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
156519927|NCT00717067|564996011|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
156519928|NCT02090959|564996012|FG000|Overall Study|Withdrawal by Subject|10|||
156519929|NCT02090959|564996012|FG000|Overall Study|Adverse Event|1|||
156519930|NCT02090959|564996012|FG000|Overall Study|Investigator decision|2|||
156519931|NCT02090959|564996012|FG000|Overall Study|Study termination|6|||
156519932|NCT02090959|564996012|FG000|Overall Study|Enrolled but not treated|1|||
156519933|NCT02090959|564996012|FG000|Overall Study|Transfer for compassionate use medicine|4|||
156519934|NCT02090959|564996012|FG000|Overall Study|Move to medical need program|3|||
156519935|NCT02090959|564996012|FG000|Overall Study|Entered in to other study|34|||
156519936|NCT02090959|564996012|FG000|Overall Study|Switched to commercial supply|88|||
156519937|NCT02090959|564996012|FG000|Overall Study|Other than specified|2|||
156519938|NCT00522873|564996015|FG000|Overall Study|Adverse Event|41|||
156519939|NCT00522873|564996016|FG001|Overall Study|Adverse Event|26|||
156519940|NCT00522873|564996015|FG000|Overall Study|Withdrawal by Subject|20|||
156519941|NCT00522873|564996016|FG001|Overall Study|Withdrawal by Subject|9|||
156519942|NCT00522873|564996015|FG000|Overall Study|Protocol Violation|14|||
156519943|NCT00522873|564996016|FG001|Overall Study|Protocol Violation|4|||
156519944|NCT00522873|564996015|FG000|Overall Study|Lost to Follow-up|11|||
156519945|NCT00522873|564996016|FG001|Overall Study|Lost to Follow-up|3|||
156519946|NCT00522873|564996015|FG000|Overall Study|Personal Reasons|8|||
156519947|NCT00522873|564996016|FG001|Overall Study|Personal Reasons|1|||
156519948|NCT00522873|564996015|FG000|Overall Study|Medication Errors|1|||
156519949|NCT00522873|564996016|FG001|Overall Study|Medication Errors|1|||
156519950|NCT00522873|564996015|FG000|Overall Study|Never Received Medication|1|||
156519951|NCT00522873|564996016|FG001|Overall Study|Never Received Medication|0|||
156519952|NCT00657020|564996017|FG000|PERIOD 1|Adverse Event|0|||
156519953|NCT00657020|564996018|FG001|PERIOD 1|Adverse Event|1|||
156519954|NCT02029846|564996021|FG000|Overall Study|n=1 each arm|1|||
156519955|NCT02029846|564996022|FG001|Overall Study|n=1 each arm|1|||
156562487|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562488|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562489|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
156562490|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
156562491|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562492|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562493|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
156562494|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562495|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562496|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562497|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562498|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562499|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562500|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562501|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562502|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562503|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562504|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562505|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562506|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562507|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562508|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156519956|NCT02966301|564996023|FG000|Overall Study|Death|2|||
156519957|NCT02966301|564996023|FG000|Overall Study|Withdrawal by Subject|1|||
156519958|NCT02937454|564996028|FG000|Overall Study|Adverse Event|0|||
156519959|NCT02937454|564996029|FG001|Overall Study|Adverse Event|1|||
156562509|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562510|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562511|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156519960|NCT02937454|564996028|FG000|Overall Study|Death|98|||
156519961|NCT02937454|564996029|FG001|Overall Study|Death|95|||
156519962|NCT02937454|564996028|FG000|Overall Study|Lost to Follow-up|1|||
156519963|NCT02937454|564996029|FG001|Overall Study|Lost to Follow-up|1|||
156519964|NCT02937454|564996028|FG000|Overall Study|Physician Decision|0|||
156519965|NCT02937454|564996029|FG001|Overall Study|Physician Decision|1|||
156519966|NCT02937454|564996028|FG000|Overall Study|Protocol Violation|6|||
156519967|NCT02937454|564996029|FG001|Overall Study|Protocol Violation|10|||
156519968|NCT02937454|564996028|FG000|Overall Study|Withdrawal by Subject|27|||
156519969|NCT02937454|564996029|FG001|Overall Study|Withdrawal by Subject|15|||
156519970|NCT02937454|564996028|FG000|Overall Study|Other|8|||
156519971|NCT02937454|564996029|FG001|Overall Study|Other|5|||
156519972|NCT01375114|564996031|FG000|Overall Study|Lost to Follow-up|1|||
156519973|NCT01375114|564996032|FG001|Overall Study|Lost to Follow-up|0|||
156519974|NCT01375114|564996033|FG002|Overall Study|Lost to Follow-up|1|||
156519975|NCT01375114|564996031|FG000|Overall Study|Disease Progression|3|||
156519976|NCT01375114|564996032|FG001|Overall Study|Disease Progression|2|||
156519977|NCT01375114|564996033|FG002|Overall Study|Disease Progression|2|||
156519978|NCT01375114|564996031|FG000|Overall Study|Patient Changed Mind|0|||
156519979|NCT01375114|564996032|FG001|Overall Study|Patient Changed Mind|0|||
156519980|NCT01375114|564996033|FG002|Overall Study|Patient Changed Mind|2|||
156519981|NCT01375114|564996031|FG000|Overall Study|Pruritus|0|||
156519982|NCT01375114|564996032|FG001|Overall Study|Pruritus|0|||
156519983|NCT01375114|564996033|FG002|Overall Study|Pruritus|1|||
156519984|NCT01375114|564996031|FG000|Overall Study|Restlessness|0|||
156519985|NCT01375114|564996032|FG001|Overall Study|Restlessness|0|||
156519986|NCT01375114|564996033|FG002|Overall Study|Restlessness|1|||
156519987|NCT01375114|564996031|FG000|Overall Study|Diarrhea|0|||
156519988|NCT01375114|564996032|FG001|Overall Study|Diarrhea|0|||
156519989|NCT01375114|564996033|FG002|Overall Study|Diarrhea|1|||
156519990|NCT01375114|564996031|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
156519991|NCT01375114|564996032|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
156519992|NCT01375114|564996033|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
156519993|NCT01375114|564996031|FG000|Overall Study|Nausea|0|||
156519994|NCT01375114|564996032|FG001|Overall Study|Nausea|1|||
156519995|NCT01375114|564996033|FG002|Overall Study|Nausea|0|||
156519996|NCT01375114|564996031|FG000|Overall Study|Increased AST/ALT|0|||
156519997|NCT01375114|564996032|FG001|Overall Study|Increased AST/ALT|1|||
156519998|NCT01375114|564996033|FG002|Overall Study|Increased AST/ALT|0|||
156519999|NCT01375114|564996031|FG000|Overall Study|Vaginal Hemorrhage|0|||
156520000|NCT01375114|564996032|FG001|Overall Study|Vaginal Hemorrhage|1|||
156520001|NCT01375114|564996033|FG002|Overall Study|Vaginal Hemorrhage|0|||
156520002|NCT01375114|564996031|FG000|Overall Study|Family problem|0|||
156520003|NCT01375114|564996032|FG001|Overall Study|Family problem|1|||
156520004|NCT01375114|564996033|FG002|Overall Study|Family problem|0|||
156520005|NCT01375114|564996031|FG000|Overall Study|Protocol Violation|2|||
156520006|NCT01375114|564996032|FG001|Overall Study|Protocol Violation|0|||
156520007|NCT01375114|564996033|FG002|Overall Study|Protocol Violation|0|||
156520008|NCT01474434|564996038|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
156520009|NCT01474434|564996039|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
156520010|NCT01474434|564996040|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
156520011|NCT01474434|564996041|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
156520012|NCT01474434|564996038|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
156520013|NCT01474434|564996039|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
156520014|NCT01474434|564996040|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
156520015|NCT01474434|564996041|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
156520016|NCT01474434|564996038|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
156520017|NCT01474434|564996039|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
156520018|NCT01474434|564996040|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
156520019|NCT01474434|564996041|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
156520020|NCT00993668|564996042|FG000|Single-Blind Period|Adverse Event|1|||
156520021|NCT00993668|564996043|FG001|Single-Blind Period|Adverse Event|1|||
156520022|NCT00993668|564996042|FG000|Single-Blind Period|Lack of Efficacy|0|||
156520023|NCT00993668|564996043|FG001|Single-Blind Period|Lack of Efficacy|1|||
156520024|NCT00993668|564996042|FG000|Single-Blind Period|Lost to Follow-up|3|||
156520025|NCT00993668|564996043|FG001|Single-Blind Period|Lost to Follow-up|1|||
156520026|NCT00993668|564996042|FG000|Open-Label Period|Adverse Event|9|||
156520027|NCT00993668|564996043|FG001|Open-Label Period|Adverse Event|8|||
156520028|NCT00993668|564996042|FG000|Open-Label Period|Lack of Efficacy|4|||
156520029|NCT00993668|564996043|FG001|Open-Label Period|Lack of Efficacy|3|||
156520030|NCT00993668|564996042|FG000|Open-Label Period|Withdrawal by Subject|4|||
156520031|NCT00993668|564996043|FG001|Open-Label Period|Withdrawal by Subject|3|||
156520032|NCT00993668|564996042|FG000|Open-Label Period|Lost to Follow-up|6|||
156520033|NCT00993668|564996043|FG001|Open-Label Period|Lost to Follow-up|1|||
156520034|NCT02207569|564996045|FG000|1-Month|Death|6|||
156520035|NCT02207569|564996045|FG000|1-Month|Withdrawal by Subject|2|||
156520036|NCT02207569|564996045|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
156520037|NCT02207569|564996045|FG000|6-Month|Death|8|||
156520038|NCT02207569|564996045|FG000|6-Month|Withdrawal by Subject|2|||
156520039|NCT02207569|564996045|FG000|12-Month|Death|14|||
156520040|NCT02207569|564996045|FG000|12-Month|Withdrawal by Subject|2|||
156520041|NCT02207569|564996045|FG000|24-Month|Death|23|||
156520042|NCT02207569|564996045|FG000|24-Month|Withdrawal by Subject|3|||
156520043|NCT02207569|564996045|FG000|36-Month|Death|23|||
156520044|NCT02207569|564996045|FG000|36-Month|Withdrawal by Subject|4|||
156520045|NCT02207569|564996045|FG000|48-Month|Death|25|||
156520046|NCT02207569|564996045|FG000|48-Month|Withdrawal by Subject|2|||
156520047|NCT02207569|564996045|FG000|48-Month|Lost to Follow-up|4|||
156520048|NCT02207569|564996045|FG000|60-Month|Death|1|||
156520049|NCT02207569|564996045|FG000|60-Month|Lost to Follow-up|1|||
156520050|NCT02207569|564996045|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
156520051|NCT02207569|564996045|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
156520052|NCT03606668|564996046|FG000|Overall Study|Screen Failure|1|||
156520053|NCT03606668|564996046|FG000|Overall Study|Lost to Follow-up|1|||
156520054|NCT01014143|564996047|FG000|Second Intervention|Lost to Follow-up|2|||
156520055|NCT01014143|564996048|FG001|Second Intervention|Lost to Follow-up|0|||
156520056|NCT01014143|564996049|FG002|Second Intervention|Lost to Follow-up|0|||
156520057|NCT02585232|564996050|FG000|Overall Study|Lost to Follow-up|8|||
156520058|NCT02585232|564996051|FG001|Overall Study|Lost to Follow-up|8|||
156520059|NCT02585232|564996050|FG000|Overall Study|Withdrawal by Subject|4|||
156520060|NCT02585232|564996051|FG001|Overall Study|Withdrawal by Subject|8|||
156520061|NCT00297232|564996057|FG000|Overall Study|Lack of Efficacy|7|||
156520062|NCT00297232|564996057|FG000|Overall Study|Lost to Follow-up|10|||
156520063|NCT00297232|564996057|FG000|Overall Study|Adverse Event|63|||
156520064|NCT00297232|564996057|FG000|Overall Study|Voluntary Withdrawal|120|||
156520065|NCT00297232|564996057|FG000|Overall Study|Subject was Noncompliant|9|||
156520066|NCT00297232|564996057|FG000|Overall Study|Death|9|||
156520067|NCT00297232|564996057|FG000|Overall Study|Anti-natalizumab Positive|8|||
156520068|NCT00297232|564996057|FG000|Overall Study|Switched to Commercial Tysabri|22|||
156520069|NCT00297232|564996057|FG000|Overall Study|Disease Progression|8|||
156520070|NCT00297232|564996057|FG000|Overall Study|Fear of PML|10|||
156520071|NCT00297232|564996057|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
156520072|NCT00297232|564996057|FG000|Overall Study|Miscellaneous|5|||
156520073|NCT00297232|564996057|FG000|Overall Study|Sponsor Decision|34|||
156520074|NCT00297232|564996057|FG000|Overall Study|Subject Relocated|7|||
156520075|NCT00297232|564996057|FG000|Overall Study|Subject Withdrew Consent|37|||
156520076|NCT00297232|564996057|FG000|Overall Study|Persistently Positive Antibodies|11|||
156520077|NCT00297232|564996057|FG000|Overall Study|Investigator Withdrew From Program|19|||
156520078|NCT00297232|564996057|FG000|Overall Study|Did Not Enroll to Week 264|34|||
156520079|NCT00297232|564996057|FG000|Overall Study|Did Not Enroll to Week 480|17|||
156520080|NCT00297232|564996057|FG000|Overall Study|No data available after Week 264|161|||
156520081|NCT00297232|564996057|FG000|Overall Study|Other|1|||
156520082|NCT01878214|564996060|FG000|Overall Study|Withdrawal by Subject|18|||
156520083|NCT01878214|564996061|FG001|Overall Study|Withdrawal by Subject|7|||
156520084|NCT01878214|564996060|FG000|Overall Study|Death|0|||
156520085|NCT01878214|564996061|FG001|Overall Study|Death|1|||
156520086|NCT01878214|564996060|FG000|Overall Study|Lost to Follow-up|35|||
156520087|NCT01878214|564996061|FG001|Overall Study|Lost to Follow-up|36|||
156520088|NCT00495586|564996062|FG000|Overall Study|Withdrawal by Subject|4|||
156520089|NCT00495586|564996063|FG001|Overall Study|Withdrawal by Subject|4|||
156520090|NCT03038438|564996064|FG000|Overall Study|Death|3|||
156520091|NCT03038438|564996064|FG000|Overall Study|Lost to Follow-up|8|||
156520092|NCT03038438|564996064|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
156520093|NCT03038438|564996064|FG000|Overall Study|Withdrawal by Subject|5|||
156520094|NCT03038438|564996064|FG000|Overall Study|No 36-Month Follow-Up|18|||
156520095|NCT02038543|564996067|FG000|Overall Study|Screen Failure|0|||
156520096|NCT02038543|564996068|FG001|Overall Study|Screen Failure|0|||
156520097|NCT02038543|564996069|FG002|Overall Study|Screen Failure|0|||
156520098|NCT02038543|564996070|FG003|Overall Study|Screen Failure|1|||
156520099|NCT02038543|564996067|FG000|Overall Study|Withdrawal by Subject|0|||
156520100|NCT02038543|564996068|FG001|Overall Study|Withdrawal by Subject|0|||
156520101|NCT02038543|564996069|FG002|Overall Study|Withdrawal by Subject|0|||
156520102|NCT02038543|564996070|FG003|Overall Study|Withdrawal by Subject|1|||
156520103|NCT03406260|564996071|FG000|Period 1|Adverse Event|0|||
156520104|NCT03406260|564996072|FG001|Period 1|Adverse Event|0|||
156520105|NCT03406260|564996073|FG002|Period 1|Adverse Event|0|||
156520106|NCT03406260|564996074|FG003|Period 1|Adverse Event|0|||
156520107|NCT03406260|564996075|FG004|Period 1|Adverse Event|1|||
156520108|NCT03406260|564996076|FG005|Period 1|Adverse Event|0|||
156520109|NCT02647866|564996077|FG000|Overall Study|Adverse Event|0|||
156520110|NCT02647866|564996078|FG001|Overall Study|Adverse Event|0|||
156520111|NCT02647866|564996079|FG002|Overall Study|Adverse Event|2|||
156520112|NCT02647866|564996080|FG003|Overall Study|Adverse Event|2|||
156520113|NCT02647866|564996081|FG004|Overall Study|Adverse Event|1|||
156520114|NCT02647866|564996077|FG000|Overall Study|Disease Worsening|3|||
156520115|NCT02647866|564996078|FG001|Overall Study|Disease Worsening|1|||
156520116|NCT02647866|564996079|FG002|Overall Study|Disease Worsening|0|||
156520117|NCT02647866|564996080|FG003|Overall Study|Disease Worsening|0|||
156520118|NCT02647866|564996081|FG004|Overall Study|Disease Worsening|1|||
156520119|NCT02647866|564996077|FG000|Overall Study|Withdrawal by Subject|1|||
156520120|NCT02647866|564996078|FG001|Overall Study|Withdrawal by Subject|1|||
156562512|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156562513|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562514|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562515|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
156520121|NCT02647866|564996079|FG002|Overall Study|Withdrawal by Subject|2|||
156520122|NCT02647866|564996080|FG003|Overall Study|Withdrawal by Subject|4|||
156520123|NCT02647866|564996081|FG004|Overall Study|Withdrawal by Subject|4|||
156520124|NCT02647866|564996077|FG000|Overall Study|Physician Decision|0|||
156520125|NCT02647866|564996078|FG001|Overall Study|Physician Decision|1|||
156520126|NCT02647866|564996079|FG002|Overall Study|Physician Decision|1|||
156520127|NCT02647866|564996080|FG003|Overall Study|Physician Decision|0|||
156520128|NCT02647866|564996081|FG004|Overall Study|Physician Decision|2|||
156520129|NCT02647866|564996077|FG000|Overall Study|Death|0|||
156520130|NCT02647866|564996078|FG001|Overall Study|Death|1|||
156520131|NCT02647866|564996079|FG002|Overall Study|Death|0|||
156520132|NCT02647866|564996080|FG003|Overall Study|Death|0|||
156520133|NCT02647866|564996081|FG004|Overall Study|Death|0|||
156520134|NCT02647866|564996077|FG000|Overall Study|Subject moved to different country|1|||
156520135|NCT02647866|564996078|FG001|Overall Study|Subject moved to different country|0|||
156520136|NCT02647866|564996079|FG002|Overall Study|Subject moved to different country|0|||
156520137|NCT02647866|564996080|FG003|Overall Study|Subject moved to different country|0|||
156520138|NCT02647866|564996081|FG004|Overall Study|Subject moved to different country|0|||
156520139|NCT01029652|564996085|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
156520140|NCT01029652|564996086|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
156520141|NCT01029652|564996085|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
156520142|NCT01029652|564996086|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
156520143|NCT01029652|564996085|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
156520144|NCT01029652|564996086|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
156520145|NCT01029652|564996085|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
156520146|NCT01029652|564996086|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
156520147|NCT01029652|564996085|FG000|Core Study (0-12 Weeks)|Death|0|||
156520148|NCT01029652|564996086|FG001|Core Study (0-12 Weeks)|Death|1|||
156520149|NCT01029652|564996085|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
156520150|NCT01029652|564996086|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
156520151|NCT01029652|564996085|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
156520152|NCT01029652|564996086|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
156520153|NCT01029652|564996085|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
156520154|NCT01029652|564996086|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
156520155|NCT01029652|564996085|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
156520156|NCT01029652|564996086|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
156520157|NCT01029652|564996085|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
156520158|NCT01029652|564996086|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
156520159|NCT01029652|564996085|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
156520160|NCT01029652|564996086|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
156520161|NCT01029652|564996085|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
156520162|NCT01029652|564996086|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
156520163|NCT02399254|564996087|FG000|Overall Study|Physician Decision|2|||
156520164|NCT01642251|564996090|FG000|Overall Study|Progressive disease|0|||
156520165|NCT01642251|564996091|FG001|Overall Study|Progressive disease|0|||
156520166|NCT01642251|564996092|FG002|Overall Study|Progressive disease|3|||
156520167|NCT01642251|564996093|FG003|Overall Study|Progressive disease|3|||
156520168|NCT01642251|564996090|FG000|Overall Study|Adverse Event|0|||
156520169|NCT01642251|564996091|FG001|Overall Study|Adverse Event|0|||
156520170|NCT01642251|564996092|FG002|Overall Study|Adverse Event|5|||
156520171|NCT01642251|564996093|FG003|Overall Study|Adverse Event|4|||
156520172|NCT01642251|564996090|FG000|Overall Study|Death|0|||
156520173|NCT01642251|564996091|FG001|Overall Study|Death|0|||
156520174|NCT01642251|564996092|FG002|Overall Study|Death|1|||
156520175|NCT01642251|564996093|FG003|Overall Study|Death|3|||
156520176|NCT01642251|564996090|FG000|Overall Study|Withdrawal by Subject|0|||
156520177|NCT01642251|564996091|FG001|Overall Study|Withdrawal by Subject|0|||
156520178|NCT01642251|564996092|FG002|Overall Study|Withdrawal by Subject|1|||
156520179|NCT01642251|564996093|FG003|Overall Study|Withdrawal by Subject|3|||
156562516|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156520180|NCT01642251|564996090|FG000|Overall Study|Alternative therapy|0|||
156520181|NCT01642251|564996091|FG001|Overall Study|Alternative therapy|0|||
156520182|NCT01642251|564996092|FG002|Overall Study|Alternative therapy|0|||
156562517|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156520183|NCT01642251|564996093|FG003|Overall Study|Alternative therapy|2|||
156520184|NCT01642251|564996090|FG000|Overall Study|Other complicating disease|0|||
156520185|NCT01642251|564996091|FG001|Overall Study|Other complicating disease|0|||
156520186|NCT01642251|564996092|FG002|Overall Study|Other complicating disease|1|||
156520187|NCT01642251|564996093|FG003|Overall Study|Other complicating disease|0|||
156520188|NCT01642251|564996090|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
156562518|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562519|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562520|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562521|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562522|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562523|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562524|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562525|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562526|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562527|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562528|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562529|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562530|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562531|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562532|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562533|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562534|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562535|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
156562536|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562537|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562538|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
156562539|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562540|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562541|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562542|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562543|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562544|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562545|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562546|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562547|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562548|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562549|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562550|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562551|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562552|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562553|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562554|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562555|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562556|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562557|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562558|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
156562559|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562560|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562561|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562562|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
156562563|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562564|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562565|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562566|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562567|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562568|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562569|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562570|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562571|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562572|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562573|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562574|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562575|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562576|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562577|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562578|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562579|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562580|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562581|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156562582|NCT00896532|565148276|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562583|NCT00896532|565148277|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
156562584|NCT00896532|565148278|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562585|NCT00896532|565148279|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
156562586|NCT00896532|565148280|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
156562587|NCT00896532|565148281|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562588|NCT00896532|565148282|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562589|NCT00896532|565148283|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562590|NCT00896532|565148284|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562591|NCT00896532|565148285|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562592|NCT00896532|565148286|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156520189|NCT01642251|564996091|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
156520190|NCT01642251|564996092|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
156520191|NCT01642251|564996093|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
156520192|NCT00895154|564996094|FG000|Overall Study|Lost to Follow-up|1|||
156520193|NCT00895154|564996095|FG001|Overall Study|Lost to Follow-up|1|||
156520194|NCT00895154|564996094|FG000|Overall Study|Withdrawal by Subject|0|||
156520195|NCT00895154|564996095|FG001|Overall Study|Withdrawal by Subject|1|||
156520196|NCT01993927|564996096|FG000|Overall Study|Case Report Forms Uncollected|18|||
156520197|NCT01993927|564996096|FG000|Overall Study|Protocol Violation|11|||
156520198|NCT00540046|564996099|FG000|Overall Study|Lost to Follow-up|33|||
156520199|NCT00540046|564996100|FG001|Overall Study|Lost to Follow-up|23|||
156520200|NCT02533531|564996102|FG000|Overall Study|Device did not turn on|1|||
156520201|NCT03814187|564996103|FG000|Overall Study|Sponsor's Administrative Decision|0|||
156520202|NCT03814187|564996104|FG001|Overall Study|Sponsor's Administrative Decision|0|||
156520203|NCT03814187|564996105|FG002|Overall Study|Sponsor's Administrative Decision|272|||
156520204|NCT03814187|564996103|FG000|Overall Study|Death|80|||
156520205|NCT03814187|564996104|FG001|Overall Study|Death|81|||
156520206|NCT03814187|564996105|FG002|Overall Study|Death|4|||
156520207|NCT03814187|564996103|FG000|Overall Study|Withdrew Consent|77|||
156520208|NCT03814187|564996104|FG001|Overall Study|Withdrew Consent|78|||
156520209|NCT03814187|564996105|FG002|Overall Study|Withdrew Consent|2|||
156520210|NCT03814187|564996103|FG000|Overall Study|Lost to Follow-up|47|||
156520211|NCT03814187|564996104|FG001|Overall Study|Lost to Follow-up|52|||
156520212|NCT03814187|564996105|FG002|Overall Study|Lost to Follow-up|1|||
156520213|NCT03814187|564996103|FG000|Overall Study|Adverse Event|22|||
156520214|NCT03814187|564996104|FG001|Overall Study|Adverse Event|23|||
156520215|NCT03814187|564996105|FG002|Overall Study|Adverse Event|0|||
156520216|NCT03814187|564996103|FG000|Overall Study|Physician Decision|7|||
156520217|NCT03814187|564996104|FG001|Overall Study|Physician Decision|4|||
156520218|NCT03814187|564996105|FG002|Overall Study|Physician Decision|2|||
156520219|NCT03814187|564996103|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
156520220|NCT03814187|564996104|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
156520221|NCT03814187|564996105|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
156520222|NCT03814187|564996103|FG000|Overall Study|Other reasons|34|||
156520223|NCT03814187|564996104|FG001|Overall Study|Other reasons|40|||
156520224|NCT03814187|564996105|FG002|Overall Study|Other reasons|2|||
156520225|NCT00943111|564996106|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
156520226|NCT00943111|564996107|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
156520227|NCT00943111|564996108|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
156520228|NCT00943111|564996106|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
156520229|NCT00943111|564996107|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
156520230|NCT00943111|564996108|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
156520231|NCT00943111|564996106|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
156520232|NCT00943111|564996107|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
156520233|NCT00943111|564996108|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
156520234|NCT00943111|564996106|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
156520235|NCT00943111|564996107|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
156520236|NCT00943111|564996108|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
156520237|NCT00943111|564996106|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
156520238|NCT00943111|564996107|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
156520239|NCT00943111|564996108|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
156520240|NCT00943111|564996106|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
156520241|NCT00943111|564996107|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
156520242|NCT00943111|564996108|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
156520243|NCT00943111|564996106|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
156520244|NCT00943111|564996107|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
156520245|NCT00943111|564996108|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
156562593|NCT00896532|565148287|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562594|NCT00896532|565148288|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562595|NCT00896532|565148289|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562596|NCT00896532|565148290|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562597|NCT00896532|565148291|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562598|NCT00896532|565148292|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562599|NCT00896532|565148293|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562600|NCT00896532|565148294|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562601|NCT00896532|565148295|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562602|NCT00896532|565148296|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562603|NCT00896532|565148297|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562604|NCT00896532|565148298|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
156562605|NCT00896532|565148276|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562606|NCT00896532|565148277|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562607|NCT00896532|565148278|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562608|NCT00896532|565148279|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562609|NCT00896532|565148280|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562610|NCT00896532|565148281|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562611|NCT00896532|565148282|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562612|NCT00896532|565148283|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562613|NCT00896532|565148284|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
156562614|NCT00896532|565148285|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562615|NCT00896532|565148286|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562616|NCT00896532|565148287|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562617|NCT00896532|565148288|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562618|NCT00896532|565148289|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562619|NCT00896532|565148290|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562620|NCT00896532|565148291|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562621|NCT00896532|565148292|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562622|NCT00896532|565148293|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562623|NCT00896532|565148294|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562624|NCT00896532|565148295|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562625|NCT00896532|565148296|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562626|NCT00896532|565148297|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562627|NCT00896532|565148298|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
156562628|NCT00896532|565148276|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562629|NCT00896532|565148277|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562630|NCT00896532|565148278|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562631|NCT00896532|565148279|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562632|NCT00896532|565148280|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562633|NCT00896532|565148281|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562634|NCT00896532|565148282|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562635|NCT00896532|565148283|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562636|NCT00896532|565148284|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562637|NCT00896532|565148285|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562638|NCT00896532|565148286|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562639|NCT00896532|565148287|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562640|NCT00896532|565148288|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
156562641|NCT00896532|565148289|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562642|NCT00896532|565148290|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562643|NCT00896532|565148291|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562644|NCT00896532|565148292|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562645|NCT00896532|565148293|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562646|NCT00896532|565148294|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562647|NCT00896532|565148295|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562648|NCT00896532|565148296|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562649|NCT00896532|565148297|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562650|NCT00896532|565148298|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
156562651|NCT00896532|565148276|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562652|NCT00896532|565148277|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562653|NCT00896532|565148278|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562654|NCT00896532|565148279|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562655|NCT00896532|565148280|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562656|NCT00896532|565148281|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562657|NCT00896532|565148282|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562658|NCT00896532|565148283|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562659|NCT00896532|565148284|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562660|NCT00896532|565148285|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562661|NCT00896532|565148286|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
156562662|NCT00896532|565148287|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562663|NCT00896532|565148288|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
156562664|NCT00896532|565148289|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562665|NCT00896532|565148290|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562666|NCT00896532|565148291|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562667|NCT00896532|565148292|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562668|NCT00896532|565148293|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562669|NCT00896532|565148294|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562670|NCT00896532|565148295|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562671|NCT00896532|565148296|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562672|NCT00896532|565148297|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562673|NCT00896532|565148298|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156562674|NCT00896532|565148276|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156520246|NCT00943111|564996106|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
156520247|NCT00943111|564996107|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
156520248|NCT00943111|564996108|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
156520249|NCT02665338|564996110|FG000|Overall Study|Withdrawal by Subject|0|||
156520250|NCT02665338|564996111|FG001|Overall Study|Withdrawal by Subject|1|||
156520251|NCT00998335|564996112|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
156520252|NCT00998335|564996113|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
156520253|NCT02631577|564996124|FG000|Overall Study|Death|1|||
156520254|NCT02631577|564996125|FG001|Overall Study|Death|7|||
156520255|NCT02631577|564996124|FG000|Overall Study|Withdrawal by Subject|0|||
156520256|NCT02631577|564996125|FG001|Overall Study|Withdrawal by Subject|3|||
156520257|NCT00953407|564998640|FG000|Overall Study|Failed inclusion criteria|1|||
156520258|NCT00953407|564998641|FG001|Overall Study|Failed inclusion criteria|1|||
156520259|NCT00953407|564998642|FG002|Overall Study|Failed inclusion criteria|1|||
156520260|NCT00953407|564998643|FG003|Overall Study|Failed inclusion criteria|1|||
156520261|NCT00953407|564998644|FG004|Overall Study|Failed inclusion criteria|1|||
156520262|NCT00953407|564998640|FG000|Overall Study|Lost to Follow-up|0|||
156520263|NCT00953407|564998641|FG001|Overall Study|Lost to Follow-up|0|||
156520264|NCT00953407|564998642|FG002|Overall Study|Lost to Follow-up|0|||
156520265|NCT00953407|564998643|FG003|Overall Study|Lost to Follow-up|1|||
156520266|NCT00953407|564998644|FG004|Overall Study|Lost to Follow-up|0|||
156520267|NCT01111474|564998645|FG000|Overall Study|Lost to Follow-up|12|||
156520268|NCT04289051|564998646|FG000|Overall Study|Lost to Follow-up|0|||
156520269|NCT04289051|564998647|FG001|Overall Study|Lost to Follow-up|0|||
156520270|NCT04289051|564998648|FG002|Overall Study|Lost to Follow-up|2|||
156520271|NCT00523640|564998668|FG000|Overall Study|Death|1|||
156520272|NCT06377488|564998669|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
156520273|NCT06377488|564998669|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
156520274|NCT06377488|564998669|FG000|Overall Study|Protocol Violation|1|||
156520275|NCT06377488|564998669|FG000|Overall Study|Lost to Follow-up|1|||
156520276|NCT06377488|564998669|FG000|Overall Study|Incorrect Lens Dispensed|2|||
156520277|NCT02334423|564998672|FG000|Overall Study|Protocol Violation|10|||
156520278|NCT02334423|564998673|FG001|Overall Study|Protocol Violation|3|||
156520279|NCT00652327|564998674|FG000|Overall Study|Adverse Event|0|||
156520280|NCT00652327|564998675|FG001|Overall Study|Adverse Event|2|||
156520281|NCT00652327|564998674|FG000|Overall Study|Lost to Follow-up|0|||
156520282|NCT00652327|564998675|FG001|Overall Study|Lost to Follow-up|3|||
156520283|NCT01076647|564998676|FG000|Overall Study|Adverse Event|4|||
156520284|NCT01076647|564998677|FG001|Overall Study|Adverse Event|1|||
156520285|NCT01076647|564998676|FG000|Overall Study|Lack of Efficacy|0|||
156520286|NCT01076647|564998677|FG001|Overall Study|Lack of Efficacy|1|||
156520287|NCT01076647|564998676|FG000|Overall Study|Protocol Violation|7|||
156520288|NCT01076647|564998677|FG001|Overall Study|Protocol Violation|9|||
156520289|NCT01076647|564998676|FG000|Overall Study|Withdrawal criteria|2|||
156520290|NCT01076647|564998677|FG001|Overall Study|Withdrawal criteria|2|||
156520291|NCT01076647|564998676|FG000|Overall Study|Unclassified|12|||
156520292|NCT01076647|564998677|FG001|Overall Study|Unclassified|12|||
156520293|NCT02292927|564998685|FG000|Overall Study|Protocol Violation|13|||
156520294|NCT02292927|564998686|FG001|Overall Study|Protocol Violation|7|||
156520295|NCT01656733|564998690|FG000|Overall Study|No permission to collect birth outcomes|0|||
156520296|NCT01656733|564998691|FG001|Overall Study|No permission to collect birth outcomes|1|||
156520297|NCT01656733|564998690|FG000|Overall Study|Delivery at another hospital|0|||
156520298|NCT01656733|564998691|FG001|Overall Study|Delivery at another hospital|2|||
156520299|NCT01656733|564998690|FG000|Overall Study|Spontaneous abortion|0|||
156520300|NCT01656733|564998691|FG001|Overall Study|Spontaneous abortion|1|||
156520301|NCT02224690|564998692|FG000|Overall Study|Adverse Event|8|||
156520302|NCT02224690|564998693|FG001|Overall Study|Adverse Event|1|||
156520303|NCT02224690|564998692|FG000|Overall Study|Met Withdrawal Criteria|4|||
156520304|NCT02224690|564998693|FG001|Overall Study|Met Withdrawal Criteria|0|||
156520305|NCT02224690|564998692|FG000|Overall Study|Use of G-tube|1|||
156520306|NCT02224690|564998693|FG001|Overall Study|Use of G-tube|0|||
156562675|NCT00896532|565148277|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562676|NCT00896532|565148278|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562677|NCT00896532|565148279|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562678|NCT00896532|565148280|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562679|NCT00896532|565148281|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562680|NCT00896532|565148282|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562681|NCT00896532|565148283|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562682|NCT00896532|565148284|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562683|NCT00896532|565148285|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562684|NCT00896532|565148286|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562685|NCT00896532|565148287|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562686|NCT00896532|565148288|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
156562687|NCT00896532|565148289|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
156562688|NCT00896532|565148290|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562689|NCT00896532|565148291|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562690|NCT00896532|565148292|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562691|NCT00896532|565148293|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562692|NCT00896532|565148294|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562693|NCT00896532|565148295|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562694|NCT00896532|565148296|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562695|NCT00896532|565148297|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562696|NCT00896532|565148298|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
156562697|NCT00896532|565148276|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
156562698|NCT00896532|565148277|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
156562699|NCT00896532|565148278|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
156562700|NCT00896532|565148279|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
156562701|NCT00896532|565148280|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
156562702|NCT00896532|565148281|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
156562703|NCT00896532|565148282|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
156562704|NCT00896532|565148283|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
156520307|NCT02224690|564998692|FG000|Overall Study|Did not meet eligibility criteria|1|||
156520308|NCT02224690|564998693|FG001|Overall Study|Did not meet eligibility criteria|0|||
156520309|NCT01415531|564998694|FG000|Overall Study|Adverse Event|7|||
156520310|NCT01415531|564998695|FG001|Overall Study|Adverse Event|10|||
156520311|NCT01415531|564998694|FG000|Overall Study|Lack of Efficacy|3|||
156520312|NCT01415531|564998695|FG001|Overall Study|Lack of Efficacy|2|||
156520313|NCT01415531|564998694|FG000|Overall Study|Protocol Violation|0|||
156520314|NCT01415531|564998695|FG001|Overall Study|Protocol Violation|1|||
156520315|NCT01415531|564998694|FG000|Overall Study|Withdrawal by Subject|5|||
156520316|NCT01415531|564998695|FG001|Overall Study|Withdrawal by Subject|4|||
156520317|NCT01415531|564998694|FG000|Overall Study|Lost to Follow-up|6|||
156520318|NCT01415531|564998695|FG001|Overall Study|Lost to Follow-up|14|||
156520319|NCT01415531|564998694|FG000|Overall Study|Lack of Compliance|1|||
156520320|NCT01415531|564998695|FG001|Overall Study|Lack of Compliance|4|||
156520321|NCT01415531|564998694|FG000|Overall Study|Other Reasons|3|||
156520322|NCT01415531|564998695|FG001|Overall Study|Other Reasons|2|||
156520323|NCT05753670|564998696|FG000|Overall Study|Withdrawal by Subject|6|||
156520324|NCT05753670|564998697|FG001|Overall Study|Withdrawal by Subject|8|||
156520325|NCT05753670|564998696|FG000|Overall Study|Protocol Violation|3|||
156520326|NCT05753670|564998697|FG001|Overall Study|Protocol Violation|1|||
156520327|NCT00122460|564998698|FG000|Overall Study|investigational study phase ongoing|7|||
156520328|NCT00122460|564998699|FG001|Overall Study|investigational study phase ongoing|1|||
156520329|NCT02962960|564998700|FG000|Overall Study|Withdrawal by Subject|1|||
156520330|NCT02962960|564998701|FG001|Overall Study|Withdrawal by Subject|1|||
156520331|NCT02962960|564998702|FG002|Overall Study|Withdrawal by Subject|0|||
156520332|NCT02962960|564998700|FG000|Overall Study|Adverse Event|1|||
156520333|NCT02962960|564998701|FG001|Overall Study|Adverse Event|1|||
156520334|NCT02962960|564998702|FG002|Overall Study|Adverse Event|0|||
156520335|NCT02962960|564998700|FG000|Overall Study|Protocol Violation|1|||
156520336|NCT02962960|564998701|FG001|Overall Study|Protocol Violation|0|||
156520337|NCT02962960|564998702|FG002|Overall Study|Protocol Violation|0|||
156520338|NCT01236339|564998703|FG000|Overall Study|Termination of study by sponsor|11|||
156520339|NCT01236339|564998704|FG001|Overall Study|Termination of study by sponsor|13|||
156520340|NCT02325557|564998705|FG000|Overall Study|Progressive disease|1|||
156520341|NCT02325557|564998706|FG001|Overall Study|Progressive disease|0|||
156520342|NCT02325557|564998707|FG002|Overall Study|Progressive disease|0|||
156520343|NCT02325557|564998708|FG003|Overall Study|Progressive disease|0|||
156562705|NCT00896532|565148284|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
156562706|NCT00896532|565148285|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
156562707|NCT00896532|565148286|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
156562708|NCT00896532|565148287|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
156562709|NCT00896532|565148288|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
156562710|NCT00896532|565148289|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
156562711|NCT00896532|565148290|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
156562712|NCT00896532|565148291|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
156562713|NCT00896532|565148292|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
156562714|NCT00896532|565148293|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
156562715|NCT00896532|565148294|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
156562716|NCT00896532|565148295|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
156562717|NCT00896532|565148296|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
156562718|NCT00896532|565148297|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
156562719|NCT00896532|565148298|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
156562720|NCT00896532|565148276|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562721|NCT00896532|565148277|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562722|NCT00896532|565148278|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562723|NCT00896532|565148279|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562724|NCT00896532|565148280|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562725|NCT00896532|565148281|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562726|NCT00896532|565148282|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562727|NCT00896532|565148283|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562728|NCT00896532|565148284|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562729|NCT00896532|565148285|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562730|NCT00896532|565148286|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562731|NCT00896532|565148287|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562732|NCT00896532|565148288|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562733|NCT00896532|565148289|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562734|NCT00896532|565148290|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562735|NCT00896532|565148291|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
156562736|NCT00896532|565148292|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
156562737|NCT00896532|565148293|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562738|NCT00896532|565148294|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562739|NCT00896532|565148295|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562740|NCT00896532|565148296|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562741|NCT00896532|565148297|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562742|NCT00896532|565148298|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156562743|NCT00896532|565148276|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562744|NCT00896532|565148277|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562745|NCT00896532|565148278|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562746|NCT00896532|565148279|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562747|NCT00896532|565148280|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562748|NCT00896532|565148281|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562749|NCT00896532|565148282|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562750|NCT00896532|565148283|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562751|NCT00896532|565148284|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562752|NCT00896532|565148285|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562753|NCT00896532|565148286|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562754|NCT00896532|565148287|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562755|NCT00896532|565148288|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562756|NCT00896532|565148289|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562757|NCT00896532|565148290|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562758|NCT00896532|565148291|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
156562759|NCT00896532|565148292|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
156562760|NCT00896532|565148293|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
156562761|NCT00896532|565148294|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562762|NCT00896532|565148295|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562763|NCT00896532|565148296|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562764|NCT00896532|565148297|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562765|NCT00896532|565148298|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
156562766|NCT00896532|565148276|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562767|NCT00896532|565148277|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562768|NCT00896532|565148278|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562769|NCT00896532|565148279|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562770|NCT00896532|565148280|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562771|NCT00896532|565148281|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562772|NCT00896532|565148282|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562773|NCT00896532|565148283|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562774|NCT00896532|565148284|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562775|NCT00896532|565148285|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562776|NCT00896532|565148286|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562777|NCT00896532|565148287|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562778|NCT00896532|565148288|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562779|NCT00896532|565148289|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562780|NCT00896532|565148290|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562781|NCT00896532|565148291|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562782|NCT00896532|565148292|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
156562783|NCT00896532|565148293|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562784|NCT00896532|565148294|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562785|NCT00896532|565148295|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562786|NCT00896532|565148296|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562787|NCT00896532|565148297|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562788|NCT00896532|565148298|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156562789|NCT00896532|565148276|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
156562790|NCT00896532|565148277|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
156562791|NCT00896532|565148278|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
156562792|NCT00896532|565148279|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
156562793|NCT00896532|565148280|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
156562794|NCT00896532|565148281|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
156562795|NCT00896532|565148282|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
156562796|NCT00896532|565148283|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
156562797|NCT00896532|565148284|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
156562798|NCT00896532|565148285|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
156562799|NCT00896532|565148286|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
156562800|NCT00896532|565148287|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
156562801|NCT00896532|565148288|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
156562802|NCT00896532|565148289|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
156562803|NCT00896532|565148290|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
156562804|NCT00896532|565148291|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
156562805|NCT00896532|565148292|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
156562806|NCT00896532|565148293|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
156562807|NCT00896532|565148294|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
156562808|NCT00896532|565148295|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
156562809|NCT00896532|565148296|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
156562810|NCT00896532|565148297|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
156562811|NCT00896532|565148298|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
156562812|NCT00896532|565148276|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562813|NCT00896532|565148277|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562814|NCT00896532|565148278|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562815|NCT00896532|565148279|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562816|NCT00896532|565148280|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562817|NCT00896532|565148281|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562818|NCT00896532|565148282|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562819|NCT00896532|565148283|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562820|NCT00896532|565148284|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562821|NCT00896532|565148285|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562822|NCT00896532|565148286|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562823|NCT00896532|565148287|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562824|NCT00896532|565148288|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562825|NCT00896532|565148289|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562826|NCT00896532|565148290|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562827|NCT00896532|565148291|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562828|NCT00896532|565148292|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
156562829|NCT00896532|565148293|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562830|NCT00896532|565148294|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562831|NCT00896532|565148295|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562832|NCT00896532|565148296|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562833|NCT00896532|565148297|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562834|NCT00896532|565148298|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156562835|NCT00896532|565148276|FG000|Months 48-72: Follow-on Phase|Death|0|||
156562836|NCT00896532|565148277|FG001|Months 48-72: Follow-on Phase|Death|0|||
156562837|NCT00896532|565148278|FG002|Months 48-72: Follow-on Phase|Death|0|||
156562838|NCT00896532|565148279|FG003|Months 48-72: Follow-on Phase|Death|0|||
156562839|NCT00896532|565148280|FG004|Months 48-72: Follow-on Phase|Death|0|||
156562840|NCT00896532|565148281|FG005|Months 48-72: Follow-on Phase|Death|0|||
156562841|NCT00896532|565148282|FG006|Months 48-72: Follow-on Phase|Death|0|||
156562842|NCT00896532|565148283|FG007|Months 48-72: Follow-on Phase|Death|0|||
156562843|NCT00896532|565148284|FG008|Months 48-72: Follow-on Phase|Death|0|||
156562844|NCT00896532|565148285|FG009|Months 48-72: Follow-on Phase|Death|0|||
156562845|NCT00896532|565148286|FG010|Months 48-72: Follow-on Phase|Death|0|||
156562846|NCT00896532|565148287|FG011|Months 48-72: Follow-on Phase|Death|0|||
156562847|NCT00896532|565148288|FG012|Months 48-72: Follow-on Phase|Death|0|||
156562848|NCT00896532|565148289|FG013|Months 48-72: Follow-on Phase|Death|0|||
156562849|NCT00896532|565148290|FG014|Months 48-72: Follow-on Phase|Death|0|||
156562850|NCT00896532|565148291|FG015|Months 48-72: Follow-on Phase|Death|0|||
156562851|NCT00896532|565148292|FG016|Months 48-72: Follow-on Phase|Death|0|||
156562852|NCT00896532|565148293|FG017|Months 48-72: Follow-on Phase|Death|0|||
156562853|NCT00896532|565148294|FG018|Months 48-72: Follow-on Phase|Death|1|||
156562854|NCT00896532|565148295|FG019|Months 48-72: Follow-on Phase|Death|0|||
156562855|NCT00896532|565148296|FG020|Months 48-72: Follow-on Phase|Death|0|||
156562856|NCT00896532|565148297|FG021|Months 48-72: Follow-on Phase|Death|0|||
156562857|NCT00896532|565148298|FG022|Months 48-72: Follow-on Phase|Death|0|||
156562858|NCT00896532|565148276|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562859|NCT00896532|565148277|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562860|NCT00896532|565148278|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562861|NCT00896532|565148279|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562862|NCT00896532|565148280|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562863|NCT00896532|565148281|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562864|NCT00896532|565148282|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562865|NCT00896532|565148283|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562866|NCT00896532|565148284|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562867|NCT00896532|565148285|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562868|NCT00896532|565148286|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562869|NCT00896532|565148287|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562870|NCT00896532|565148288|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562871|NCT00896532|565148289|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562872|NCT00896532|565148290|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562873|NCT00896532|565148291|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562874|NCT00896532|565148292|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562875|NCT00896532|565148293|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562876|NCT00896532|565148294|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562877|NCT00896532|565148295|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562878|NCT00896532|565148296|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562879|NCT00896532|565148297|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
156562880|NCT00896532|565148298|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
156562881|NCT00896532|565148276|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562882|NCT00896532|565148277|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562883|NCT00896532|565148278|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562884|NCT00896532|565148279|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562885|NCT00896532|565148280|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562886|NCT00896532|565148281|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562887|NCT00896532|565148282|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562888|NCT00896532|565148283|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562889|NCT00896532|565148284|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562890|NCT00896532|565148285|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562891|NCT00896532|565148286|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562892|NCT00896532|565148287|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562893|NCT00896532|565148288|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562894|NCT00896532|565148289|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562895|NCT00896532|565148290|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562896|NCT00896532|565148291|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562897|NCT00896532|565148292|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562898|NCT00896532|565148293|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562899|NCT00896532|565148294|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562900|NCT00896532|565148295|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562901|NCT00896532|565148296|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562902|NCT00896532|565148297|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
156562903|NCT00896532|565148298|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
156562904|NCT01176916|565148299|FG000|Overall Study|Adverse Event|61|||
156562905|NCT01176916|565148299|FG000|Overall Study|Death|1|||
156562906|NCT01176916|565148299|FG000|Overall Study|Lost to Follow-up|15|||
156562907|NCT01176916|565148299|FG000|Overall Study|Objective progression or relapse|17|||
156562908|NCT01176916|565148299|FG000|Overall Study|Protocol Violation|24|||
156562909|NCT01176916|565148299|FG000|Overall Study|Withdrawal by Subject|37|||
156562910|NCT01176916|565148299|FG000|Overall Study|Other|6|||
156562911|NCT01176916|565148299|FG000|Overall Study|Withdrawal prior to Treatment|6|||
156562912|NCT03158220|565148302|FG000|Overall Study|Screen Failure|0|||
156562913|NCT03158220|565148303|FG001|Overall Study|Screen Failure|1|||
156562914|NCT03158220|565148302|FG000|Overall Study|Withdrawal by Subject|8|||
156562915|NCT03158220|565148303|FG001|Overall Study|Withdrawal by Subject|9|||
156562916|NCT03158220|565148302|FG000|Overall Study|Status unknown|0|||
156562917|NCT03158220|565148303|FG001|Overall Study|Status unknown|1|||
156562918|NCT03158220|565148302|FG000|Overall Study|Lost to Follow-up|8|||
156562919|NCT03158220|565148303|FG001|Overall Study|Lost to Follow-up|5|||
156562920|NCT03158220|565148302|FG000|Overall Study|Physician Decision|1|||
156562921|NCT03158220|565148303|FG001|Overall Study|Physician Decision|0|||
156562922|NCT01609842|565148306|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
156562923|NCT01609842|565148307|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
156562924|NCT03186989|565148308|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
156562925|NCT03186989|565148309|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
156562926|NCT03186989|565148310|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
156562927|NCT03186989|565148311|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
156562928|NCT03186989|565148312|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
156562929|NCT03186989|565148313|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
156562930|NCT03186989|565148314|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
156562931|NCT03186989|565148315|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
156562932|NCT03186989|565148316|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
156562933|NCT03186989|565148317|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
156562934|NCT03186989|565148318|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
156562935|NCT03186989|565148308|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562936|NCT03186989|565148309|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562937|NCT03186989|565148310|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562938|NCT03186989|565148311|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562939|NCT03186989|565148312|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562940|NCT03186989|565148313|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
156562941|NCT03186989|565148314|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562942|NCT03186989|565148315|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562943|NCT03186989|565148316|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562944|NCT03186989|565148317|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562945|NCT03186989|565148318|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
156562946|NCT03186989|565148308|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562947|NCT03186989|565148309|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562948|NCT03186989|565148310|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562949|NCT03186989|565148311|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562950|NCT03186989|565148312|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562951|NCT03186989|565148313|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562952|NCT03186989|565148314|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
156562953|NCT03186989|565148315|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562954|NCT03186989|565148316|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562955|NCT03186989|565148317|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562956|NCT03186989|565148318|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
156562957|NCT03186989|565148308|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
156562958|NCT03186989|565148309|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
156562959|NCT03186989|565148310|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
156562960|NCT03186989|565148311|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
156562961|NCT03186989|565148312|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
156562962|NCT03186989|565148313|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
156562963|NCT03186989|565148314|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
156562964|NCT03186989|565148315|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
156562965|NCT03186989|565148316|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
156562966|NCT03186989|565148317|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
156562967|NCT03186989|565148318|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
156520344|NCT02325557|564998705|FG000|Overall Study|Withdrawal by Subject|4|||
156520345|NCT02325557|564998706|FG001|Overall Study|Withdrawal by Subject|0|||
156520346|NCT02325557|564998707|FG002|Overall Study|Withdrawal by Subject|0|||
156520347|NCT02325557|564998708|FG003|Overall Study|Withdrawal by Subject|15|||
156520348|NCT02325557|564998705|FG000|Overall Study|Death|5|||
156520349|NCT02325557|564998706|FG001|Overall Study|Death|1|||
156520350|NCT02325557|564998707|FG002|Overall Study|Death|1|||
156520351|NCT02325557|564998708|FG003|Overall Study|Death|16|||
156520352|NCT02325557|564998705|FG000|Overall Study|Lost to Follow-up|0|||
156520353|NCT02325557|564998706|FG001|Overall Study|Lost to Follow-up|0|||
156520354|NCT02325557|564998707|FG002|Overall Study|Lost to Follow-up|1|||
156520355|NCT02325557|564998708|FG003|Overall Study|Lost to Follow-up|1|||
156520356|NCT02325557|564998705|FG000|Overall Study|Other|0|||
156520357|NCT02325557|564998706|FG001|Overall Study|Other|0|||
156520358|NCT02325557|564998707|FG002|Overall Study|Other|0|||
156520359|NCT02325557|564998708|FG003|Overall Study|Other|5|||
156520360|NCT00528645|564998710|FG000|Overall Study|Adverse Event|3|||
156520361|NCT01154010|564998711|FG000|Overall Study|Lost to Follow-up|0|||
156520362|NCT01154010|564998712|FG001|Overall Study|Lost to Follow-up|1|||
156520363|NCT00439231|564998713|FG000|Overall Study|Lack of Efficacy|28|||
156520364|NCT02413333|564998719|FG000|Period 1|Adverse Event|1|||
156520365|NCT02413333|564998720|FG001|Period 1|Adverse Event|0|||
156520366|NCT02413333|564998719|FG000|Period 1|Reason Not Specified|0|||
156520367|NCT02413333|564998720|FG001|Period 1|Reason Not Specified|1|||
156520368|NCT02413333|564998719|FG000|Period 2|Protocol Deviation|1|||
156520369|NCT02413333|564998720|FG001|Period 2|Protocol Deviation|0|||
156520370|NCT01465347|564998721|FG000|Overall Study|Withdrawal by Subject|1|||
156520371|NCT01465347|564998722|FG001|Overall Study|Withdrawal by Subject|1|||
156520372|NCT01465347|564998721|FG000|Overall Study|Physician Decision|0|||
156520373|NCT01465347|564998722|FG001|Overall Study|Physician Decision|1|||
156520374|NCT01465347|564998721|FG000|Overall Study|Admitted to hospice|0|||
156520375|NCT01465347|564998722|FG001|Overall Study|Admitted to hospice|1|||
156520376|NCT02996474|564998723|FG000|Overall Study|Physician Decision|5|||
156520377|NCT04493502|564998724|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
156520378|NCT04493502|564998725|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
156520379|NCT04493502|564998724|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
156520380|NCT04493502|564998725|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
156520381|NCT04493502|564998724|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
156520382|NCT04493502|564998725|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
156520383|NCT04493502|564998724|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
156520384|NCT04493502|564998725|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
156520385|NCT04493502|564998724|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
156520386|NCT04493502|564998725|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
156520387|NCT04493502|564998724|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
156520388|NCT04493502|564998725|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
156520389|NCT04493502|564998724|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
156520390|NCT04493502|564998725|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
156520391|NCT04493502|564998724|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
156520392|NCT04493502|564998725|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
156520393|NCT04493502|564998724|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
156520394|NCT04493502|564998725|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
156520395|NCT04493502|564998724|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
156520396|NCT04493502|564998725|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
156520397|NCT04493502|564998724|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
156520398|NCT04493502|564998725|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
156520399|NCT04493502|564998724|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
156520400|NCT04493502|564998725|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
156520401|NCT04493502|564998724|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
156520402|NCT04493502|564998725|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
156520403|NCT02891837|564998726|FG000|Overall Study|Lost to Follow-up|2|||
156520404|NCT02891837|564998727|FG001|Overall Study|Lost to Follow-up|0|||
156520405|NCT02891837|564998726|FG000|Overall Study|Withdrawal by Subject|1|||
156520406|NCT02891837|564998727|FG001|Overall Study|Withdrawal by Subject|0|||
156520407|NCT00709852|564998728|FG000|Period 1|Adverse Event|2|||
156520408|NCT00709852|564998729|FG001|Period 1|Adverse Event|0|||
156520409|NCT00709852|564998728|FG000|Period 1|Withdrawal by Subject|4|||
156520410|NCT00709852|564998729|FG001|Period 1|Withdrawal by Subject|2|||
156520411|NCT00709852|564998728|FG000|Period 1|Protocol Violation|1|||
156520412|NCT00709852|564998729|FG001|Period 1|Protocol Violation|0|||
156520413|NCT00709852|564998728|FG000|Period 1|Defective scanner|0|||
156520414|NCT00709852|564998729|FG001|Period 1|Defective scanner|1|||
156520415|NCT00709852|564998728|FG000|Period 1|Lost to Follow-up|1|||
156520416|NCT00709852|564998729|FG001|Period 1|Lost to Follow-up|0|||
156520417|NCT00709852|564998728|FG000|Period 2|Protocol Violation|4|||
156520418|NCT00709852|564998729|FG001|Period 2|Protocol Violation|1|||
156520419|NCT00709852|564998728|FG000|Period 2|Adverse Event|1|||
156520420|NCT00709852|564998729|FG001|Period 2|Adverse Event|1|||
156520421|NCT00709852|564998728|FG000|Period 2|Lost to Follow-up|1|||
156520422|NCT00709852|564998729|FG001|Period 2|Lost to Follow-up|0|||
156520423|NCT00709852|564998728|FG000|Period 2|No 72-hour follow-up|3|||
156520424|NCT00709852|564998729|FG001|Period 2|No 72-hour follow-up|0|||
156520425|NCT00185965|564998730|FG000|Overall Study|Adverse Event|0|||
156520426|NCT00185965|564998731|FG001|Overall Study|Adverse Event|1|||
156520427|NCT01048671|564998732|FG000|Overall Study|Protocol Violation|0|||
156520428|NCT01048671|564998733|FG001|Overall Study|Protocol Violation|1|||
156520429|NCT01048671|564998734|FG002|Overall Study|Protocol Violation|1|||
156520430|NCT00296400|564998735|FG000|Overall Study|Adverse Event|7|||
156520431|NCT00296400|564998736|FG001|Overall Study|Adverse Event|7|||
156520432|NCT00296400|564998737|FG002|Overall Study|Adverse Event|7|||
156520433|NCT00296400|564998735|FG000|Overall Study|Withdrawal by Subject|5|||
156520434|NCT00296400|564998736|FG001|Overall Study|Withdrawal by Subject|6|||
156520435|NCT00296400|564998737|FG002|Overall Study|Withdrawal by Subject|2|||
156520436|NCT00296400|564998735|FG000|Overall Study|Incorrect enrollment|2|||
156520437|NCT00296400|564998736|FG001|Overall Study|Incorrect enrollment|0|||
156520438|NCT00296400|564998737|FG002|Overall Study|Incorrect enrollment|0|||
156520439|NCT00296400|564998735|FG000|Overall Study|Protocol Violation|1|||
156520440|NCT00296400|564998736|FG001|Overall Study|Protocol Violation|1|||
156520441|NCT00296400|564998737|FG002|Overall Study|Protocol Violation|1|||
156520442|NCT00296400|564998735|FG000|Overall Study|Lost to Follow-up|1|||
156520443|NCT00296400|564998736|FG001|Overall Study|Lost to Follow-up|1|||
156520444|NCT00296400|564998737|FG002|Overall Study|Lost to Follow-up|2|||
156520445|NCT00296400|564998735|FG000|Overall Study|Study specific discontinuation criteria|0|||
156520446|NCT00296400|564998736|FG001|Overall Study|Study specific discontinuation criteria|0|||
156520447|NCT00296400|564998737|FG002|Overall Study|Study specific discontinuation criteria|1|||
156520448|NCT00296400|564998735|FG000|Overall Study|Visit 10 was performed earlier|0|||
156520449|NCT00296400|564998736|FG001|Overall Study|Visit 10 was performed earlier|1|||
156520450|NCT00296400|564998737|FG002|Overall Study|Visit 10 was performed earlier|0|||
156520451|NCT00296400|564998735|FG000|Overall Study|Pregnancy|1|||
156520452|NCT00296400|564998736|FG001|Overall Study|Pregnancy|2|||
156520453|NCT00296400|564998737|FG002|Overall Study|Pregnancy|0|||
156520454|NCT00513604|564998741|FG000|Overall Study|Not treated|2|||
156520455|NCT00513604|564998742|FG001|Overall Study|Not treated|0|||
156520456|NCT00513604|564998743|FG002|Overall Study|Not treated|1|||
156520457|NCT00513604|564998744|FG003|Overall Study|Not treated|0|||
156520458|NCT00513604|564998745|FG004|Overall Study|Not treated|0|||
156520459|NCT00513604|564998741|FG000|Overall Study|Death during treatment|0|||
156520460|NCT00513604|564998742|FG001|Overall Study|Death during treatment|3|||
156520461|NCT00513604|564998743|FG002|Overall Study|Death during treatment|2|||
156520462|NCT00513604|564998744|FG003|Overall Study|Death during treatment|0|||
156520463|NCT00513604|564998745|FG004|Overall Study|Death during treatment|0|||
156520464|NCT02433340|564998750|FG000|Overall Study|Adverse Event|0|||
156520465|NCT02433340|564998751|FG001|Overall Study|Adverse Event|0|||
156520466|NCT02433340|564998752|FG002|Overall Study|Adverse Event|1|||
156520467|NCT02433340|564998753|FG003|Overall Study|Adverse Event|0|||
156520468|NCT02433340|564998750|FG000|Overall Study|Withdrawal by Subject|1|||
156520469|NCT02433340|564998751|FG001|Overall Study|Withdrawal by Subject|0|||
156520470|NCT02433340|564998752|FG002|Overall Study|Withdrawal by Subject|1|||
156520471|NCT02433340|564998753|FG003|Overall Study|Withdrawal by Subject|2|||
156520472|NCT02433340|564998750|FG000|Overall Study|Lost to Follow-up|0|||
156520473|NCT02433340|564998751|FG001|Overall Study|Lost to Follow-up|1|||
156520474|NCT02433340|564998752|FG002|Overall Study|Lost to Follow-up|0|||
156520475|NCT02433340|564998753|FG003|Overall Study|Lost to Follow-up|0|||
156520476|NCT02433340|564998750|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
156520477|NCT02433340|564998751|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
156520478|NCT02433340|564998752|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
156520479|NCT02433340|564998753|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
156520480|NCT02433340|564998750|FG000|Overall Study|Other|0|||
156520481|NCT02433340|564998751|FG001|Overall Study|Other|1|||
156520482|NCT02433340|564998752|FG002|Overall Study|Other|0|||
156520483|NCT02433340|564998753|FG003|Overall Study|Other|0|||
156520484|NCT01178385|564998754|FG000|Overall Study|Withdrawal by Subject|2|||
156520485|NCT01178385|564998755|FG001|Overall Study|Withdrawal by Subject|0|||
156520486|NCT00985946|564998760|FG000|Overall Study|Lost to Follow-up|6|||
156520487|NCT00985946|564998760|FG000|Overall Study|Withdrawal by Subject|1|||
156520488|NCT02679508|564998762|FG000|Healing Phase|Protocol Violation|1|||
156520489|NCT02679508|564998763|FG001|Healing Phase|Protocol Violation|1|||
156520490|NCT02679508|564998762|FG000|Healing Phase|Lost to Follow-up|1|||
156520491|NCT02679508|564998763|FG001|Healing Phase|Lost to Follow-up|0|||
156520492|NCT02679508|564998762|FG000|Maintenance Phase|Adverse Event|12|||
156520493|NCT02679508|564998763|FG001|Maintenance Phase|Adverse Event|2|||
156520494|NCT02679508|564998762|FG000|Maintenance Phase|Lost to Follow-up|0|||
156520495|NCT02679508|564998763|FG001|Maintenance Phase|Lost to Follow-up|1|||
156520496|NCT02679508|564998762|FG000|Maintenance Phase|Withdrawal by Subject|15|||
156562968|NCT01583374|565148319|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
156562969|NCT01583374|565148320|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
156562970|NCT01583374|565148321|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
156562971|NCT01583374|565148322|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156562972|NCT01583374|565148323|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156562973|NCT01583374|565148324|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156562974|NCT01583374|565148325|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156562975|NCT01583374|565148326|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156562976|NCT01583374|565148327|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156562977|NCT01583374|565148319|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
156520497|NCT02679508|564998763|FG001|Maintenance Phase|Withdrawal by Subject|8|||
156520498|NCT02679508|564998762|FG000|Maintenance Phase|Other|5|||
156520499|NCT02679508|564998763|FG001|Maintenance Phase|Other|4|||
156520500|NCT03538301|564998764|FG000|Overall Study|Adverse Event|1|||
156520501|NCT03538301|564998765|FG001|Overall Study|Adverse Event|4|||
156520502|NCT03538301|564998766|FG002|Overall Study|Adverse Event|4|||
156520503|NCT03538301|564998764|FG000|Overall Study|Death|1|||
156520504|NCT03538301|564998765|FG001|Overall Study|Death|1|||
156520505|NCT03538301|564998766|FG002|Overall Study|Death|0|||
156520506|NCT03538301|564998764|FG000|Overall Study|Physician Decision|0|||
156520507|NCT03538301|564998765|FG001|Overall Study|Physician Decision|1|||
156520508|NCT03538301|564998766|FG002|Overall Study|Physician Decision|0|||
156520509|NCT03538301|564998764|FG000|Overall Study|Protocol Violation|0|||
156520510|NCT03538301|564998765|FG001|Overall Study|Protocol Violation|0|||
156520511|NCT03538301|564998766|FG002|Overall Study|Protocol Violation|1|||
156520512|NCT03538301|564998764|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
156520513|NCT03538301|564998765|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
156520514|NCT03538301|564998766|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
156520515|NCT05326815|564998768|FG000|Overall Study|Withdrawal by Subject|3|||
156520516|NCT05326815|564998768|FG000|Overall Study|Did not complete required labs|6|||
156520517|NCT05326815|564998768|FG000|Overall Study|Screen fail- abnormal labs|5|||
156520518|NCT00979134|564998769|FG000|Overall Study|Disease progression|18|||
156520519|NCT00979134|564998770|FG001|Overall Study|Disease progression|2|||
156520520|NCT00979134|564998771|FG002|Overall Study|Disease progression|5|||
156520521|NCT00979134|564998769|FG000|Overall Study|Adverse Event|0|||
156520522|NCT00979134|564998770|FG001|Overall Study|Adverse Event|0|||
156520523|NCT00979134|564998771|FG002|Overall Study|Adverse Event|2|||
156520524|NCT00979134|564998769|FG000|Overall Study|Withdrawal by Subject|1|||
156520525|NCT00979134|564998770|FG001|Overall Study|Withdrawal by Subject|1|||
156520526|NCT00979134|564998771|FG002|Overall Study|Withdrawal by Subject|2|||
156520527|NCT00979134|564998769|FG000|Overall Study|Lost to Follow-up|2|||
156520528|NCT00979134|564998770|FG001|Overall Study|Lost to Follow-up|2|||
156520529|NCT00979134|564998771|FG002|Overall Study|Lost to Follow-up|0|||
156520530|NCT00979134|564998769|FG000|Overall Study|Death|4|||
156520531|NCT00979134|564998770|FG001|Overall Study|Death|0|||
156520532|NCT00979134|564998771|FG002|Overall Study|Death|26|||
156520533|NCT00979134|564998769|FG000|Overall Study|Other|8|||
156520534|NCT00979134|564998770|FG001|Overall Study|Other|1|||
156520535|NCT00979134|564998771|FG002|Overall Study|Other|5|||
156520536|NCT05172050|564998772|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
156520537|NCT05172050|564998773|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
156520538|NCT05172050|564998774|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
156520539|NCT05172050|564998772|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
156520540|NCT05172050|564998773|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
156520541|NCT05172050|564998774|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
156520542|NCT05172050|564998772|FG000|Overall Study|Other|2|||
156520543|NCT05172050|564998773|FG001|Overall Study|Other|2|||
156520544|NCT05172050|564998774|FG002|Overall Study|Other|1|||
156520545|NCT05917470|564998775|FG000|Overall Study|Progressive Disease|1|||
156520546|NCT05917470|564998776|FG001|Overall Study|Progressive Disease|1|||
156520547|NCT05917470|564998777|FG002|Overall Study|Progressive Disease|2|||
156520548|NCT05917470|564998778|FG003|Overall Study|Progressive Disease|3|||
156520549|NCT05917470|564998779|FG004|Overall Study|Progressive Disease|1|||
156520550|NCT05917470|564998780|FG005|Overall Study|Progressive Disease|1|||
156520551|NCT05917470|564998781|FG006|Overall Study|Progressive Disease|0|||
156520552|NCT05917470|564998782|FG007|Overall Study|Progressive Disease|0|||
156520553|NCT05917470|564998775|FG000|Overall Study|Withdrawal by Subject|0|||
156520554|NCT05917470|564998776|FG001|Overall Study|Withdrawal by Subject|0|||
156520555|NCT05917470|564998777|FG002|Overall Study|Withdrawal by Subject|1|||
156520556|NCT05917470|564998778|FG003|Overall Study|Withdrawal by Subject|0|||
156520557|NCT05917470|564998779|FG004|Overall Study|Withdrawal by Subject|0|||
156562978|NCT01583374|565148320|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
156520558|NCT05917470|564998780|FG005|Overall Study|Withdrawal by Subject|0|||
156520559|NCT05917470|564998781|FG006|Overall Study|Withdrawal by Subject|0|||
156520560|NCT05917470|564998782|FG007|Overall Study|Withdrawal by Subject|0|||
156520561|NCT05917470|564998775|FG000|Overall Study|Sponsor Decision|0|||
156562979|NCT01583374|565148321|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
156562980|NCT01583374|565148322|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156562981|NCT01583374|565148323|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156562982|NCT01583374|565148324|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156562983|NCT01583374|565148325|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156562984|NCT01583374|565148326|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156562985|NCT01583374|565148327|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156562986|NCT01583374|565148319|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
156562987|NCT01583374|565148320|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
156562988|NCT01583374|565148321|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156562989|NCT01583374|565148322|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156562990|NCT01583374|565148323|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156562991|NCT01583374|565148324|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156562992|NCT01583374|565148325|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156562993|NCT01583374|565148326|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156562994|NCT01583374|565148327|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156562995|NCT01583374|565148319|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
156562996|NCT01583374|565148320|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
156562997|NCT01583374|565148321|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
156562998|NCT01583374|565148322|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156562999|NCT01583374|565148323|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156563000|NCT01583374|565148324|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156563001|NCT01583374|565148325|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156563002|NCT01583374|565148326|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156563003|NCT01583374|565148327|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156563004|NCT01583374|565148319|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
156563005|NCT01583374|565148320|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
156520562|NCT05917470|564998776|FG001|Overall Study|Sponsor Decision|0|||
156520563|NCT05917470|564998777|FG002|Overall Study|Sponsor Decision|1|||
156520564|NCT05917470|564998778|FG003|Overall Study|Sponsor Decision|0|||
156520565|NCT05917470|564998779|FG004|Overall Study|Sponsor Decision|2|||
156520566|NCT05917470|564998780|FG005|Overall Study|Sponsor Decision|1|||
156520567|NCT05917470|564998781|FG006|Overall Study|Sponsor Decision|3|||
156563006|NCT01583374|565148321|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
156563007|NCT01583374|565148322|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
156563008|NCT01583374|565148323|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
156563009|NCT01583374|565148324|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
156563010|NCT01583374|565148325|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
156563011|NCT01583374|565148326|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
156563012|NCT01583374|565148327|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
156563013|NCT01583374|565148319|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156563014|NCT01583374|565148320|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156563015|NCT01583374|565148321|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
156563016|NCT01583374|565148322|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156563017|NCT01583374|565148323|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156563018|NCT01583374|565148324|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156563019|NCT01583374|565148325|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156563020|NCT01583374|565148326|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156563021|NCT01583374|565148327|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156520568|NCT05917470|564998782|FG007|Overall Study|Sponsor Decision|3|||
156520569|NCT05917470|564998775|FG000|Overall Study|Adverse Event|0|||
156520570|NCT05917470|564998776|FG001|Overall Study|Adverse Event|0|||
156520571|NCT05917470|564998777|FG002|Overall Study|Adverse Event|0|||
156520572|NCT05917470|564998778|FG003|Overall Study|Adverse Event|0|||
156520573|NCT05917470|564998779|FG004|Overall Study|Adverse Event|0|||
156520574|NCT05917470|564998780|FG005|Overall Study|Adverse Event|1|||
156520575|NCT05917470|564998781|FG006|Overall Study|Adverse Event|0|||
156520576|NCT05917470|564998782|FG007|Overall Study|Adverse Event|0|||
156520577|NCT01586910|565001195|FG000|Overall Study|Death|4|||
156520578|NCT01586910|565001196|FG001|Overall Study|Death|4|||
156520579|NCT01586910|565001195|FG000|Overall Study|Withdrawal by Subject|6|||
156520580|NCT01586910|565001196|FG001|Overall Study|Withdrawal by Subject|43|||
156520581|NCT01586910|565001195|FG000|Overall Study|Physician withdrew Subject|5|||
156520582|NCT01586910|565001196|FG001|Overall Study|Physician withdrew Subject|24|||
156520583|NCT02502097|565001197|FG000|Period 1|Adverse Event|0|||
156520584|NCT02502097|565001198|FG001|Period 1|Adverse Event|0|||
156520585|NCT02502097|565001199|FG002|Period 1|Adverse Event|1|||
156520586|NCT02502097|565001200|FG003|Period 1|Adverse Event|0|||
156563022|NCT01583374|565148319|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
156563023|NCT01583374|565148320|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
156563024|NCT01583374|565148321|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
156563025|NCT01583374|565148322|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
156563026|NCT01583374|565148323|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
156563027|NCT01583374|565148324|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
156563028|NCT01583374|565148325|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
156563029|NCT01583374|565148326|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
156563030|NCT01583374|565148327|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
156563031|NCT01583374|565148319|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156563032|NCT01583374|565148320|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156563033|NCT01583374|565148321|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156563034|NCT01583374|565148322|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156563035|NCT01583374|565148323|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156563036|NCT01583374|565148324|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156563037|NCT01583374|565148325|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156563038|NCT01583374|565148326|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
156563039|NCT01583374|565148327|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156563040|NCT01583374|565148319|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
156563041|NCT01583374|565148320|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
156563042|NCT01583374|565148321|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
156563043|NCT01583374|565148322|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
156563044|NCT01583374|565148323|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
156563045|NCT01583374|565148324|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
156563046|NCT01583374|565148325|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
156563047|NCT01583374|565148326|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
156563048|NCT01583374|565148327|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
156563049|NCT01583374|565148319|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
156563050|NCT01583374|565148320|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
156563051|NCT01583374|565148321|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
156563052|NCT01583374|565148322|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
156563053|NCT01583374|565148323|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
156563054|NCT01583374|565148324|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
156563055|NCT01583374|565148325|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
156563056|NCT01583374|565148326|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
156563057|NCT01583374|565148327|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
156563058|NCT01583374|565148319|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
156563059|NCT01583374|565148320|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
156563060|NCT01583374|565148321|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
156563061|NCT01583374|565148322|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
156563062|NCT01583374|565148323|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
156563063|NCT01583374|565148324|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
156563064|NCT01583374|565148325|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
156563065|NCT01583374|565148326|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
156563066|NCT01583374|565148327|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
156563067|NCT01583374|565148319|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
156563068|NCT01583374|565148320|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
156563069|NCT01583374|565148321|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
156563070|NCT01583374|565148322|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
156563071|NCT01583374|565148323|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
156563072|NCT01583374|565148324|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
156563073|NCT01583374|565148325|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
156563074|NCT01583374|565148326|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
156563075|NCT01583374|565148327|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
156563076|NCT01583374|565148319|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
156563077|NCT01583374|565148320|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
156563078|NCT01583374|565148321|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
156563079|NCT01583374|565148322|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
156563080|NCT01583374|565148323|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
156563081|NCT01583374|565148324|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
156563082|NCT01583374|565148325|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
156563083|NCT01583374|565148326|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
156563084|NCT01583374|565148327|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
156563085|NCT01583374|565148319|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
156563086|NCT01583374|565148320|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
156563087|NCT01583374|565148321|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
156563088|NCT01583374|565148322|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
156563089|NCT01583374|565148323|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
156563090|NCT01583374|565148324|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
156563091|NCT01583374|565148325|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
156563092|NCT01583374|565148326|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
156563093|NCT01583374|565148327|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
156563094|NCT01583374|565148319|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
156563095|NCT01583374|565148320|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
156563096|NCT01583374|565148321|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
156563097|NCT01583374|565148322|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
156563098|NCT01583374|565148323|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
156563099|NCT01583374|565148324|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
156563100|NCT01583374|565148325|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
156563101|NCT01583374|565148326|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
156563102|NCT01583374|565148327|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
156563103|NCT01583374|565148319|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
156563104|NCT01583374|565148320|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
156563105|NCT01583374|565148321|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
156563106|NCT01583374|565148322|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
156563107|NCT01583374|565148323|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
156563108|NCT01583374|565148324|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
156563109|NCT01583374|565148325|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
156563110|NCT01583374|565148326|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
156563111|NCT01583374|565148327|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
156563112|NCT01583374|565148319|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
156563113|NCT01583374|565148320|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
156563114|NCT01583374|565148321|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
156563115|NCT01583374|565148322|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
156563116|NCT01583374|565148323|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
156563117|NCT01583374|565148324|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
156563118|NCT01583374|565148325|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
156563119|NCT01583374|565148326|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
156563120|NCT01583374|565148327|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
156563121|NCT01583374|565148319|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
156563122|NCT01583374|565148320|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
156563123|NCT01583374|565148321|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
156563124|NCT01583374|565148322|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
156563125|NCT01583374|565148323|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
156563126|NCT01583374|565148324|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
156563127|NCT01583374|565148325|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
156563128|NCT01583374|565148326|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
156563129|NCT01583374|565148327|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
156563130|NCT01583374|565148319|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
156563131|NCT01583374|565148320|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
156563132|NCT01583374|565148321|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
156563133|NCT01583374|565148322|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
156563134|NCT01583374|565148323|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
156563135|NCT01583374|565148324|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
156563136|NCT01583374|565148325|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
156563137|NCT01583374|565148326|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
156563138|NCT01583374|565148327|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
156563139|NCT01292057|565148328|FG000|Overall Study|Protocol Violation|1|||
156563140|NCT01292057|565148329|FG001|Overall Study|Protocol Violation|1|||
156563141|NCT01292057|565148328|FG000|Overall Study|Lost to Follow-up|1|||
156563142|NCT01292057|565148329|FG001|Overall Study|Lost to Follow-up|1|||
156563143|NCT00821678|565148332|FG000|Overall Study|Withdrawal by Subject|8|||
156563144|NCT00821678|565148333|FG001|Overall Study|Withdrawal by Subject|0|||
156563145|NCT00821678|565148332|FG000|Overall Study|Lost to Follow-up|13|||
156563146|NCT00821678|565148333|FG001|Overall Study|Lost to Follow-up|12|||
156563147|NCT00821678|565148332|FG000|Overall Study|Death|0|||
156563148|NCT00821678|565148333|FG001|Overall Study|Death|2|||
156563149|NCT01254669|565150115|FG000|Overall Study|Withdrawal by Subject|0|||
156563150|NCT01254669|565150116|FG001|Overall Study|Withdrawal by Subject|1|||
156563151|NCT01254669|565150115|FG000|Overall Study|time constraint|2|||
156563152|NCT01254669|565150116|FG001|Overall Study|time constraint|2|||
156563153|NCT01254669|565150115|FG000|Overall Study|called to clinic during intervention|1|||
156563154|NCT01254669|565150116|FG001|Overall Study|called to clinic during intervention|1|||
156520587|NCT02502097|565001197|FG000|Wash Out Period|Adverse Event|0|||
156520588|NCT02502097|565001198|FG001|Wash Out Period|Adverse Event|1|||
156520589|NCT02502097|565001199|FG002|Wash Out Period|Adverse Event|1|||
156520590|NCT02502097|565001200|FG003|Wash Out Period|Adverse Event|1|||
156520591|NCT02502097|565001197|FG000|Period 2|Adverse Event|0|||
156520592|NCT02502097|565001198|FG001|Period 2|Adverse Event|0|||
156520593|NCT02502097|565001199|FG002|Period 2|Adverse Event|1|||
156520594|NCT02502097|565001200|FG003|Period 2|Adverse Event|0|||
156520595|NCT00156819|565001203|FG000|Overall Study|Lost to Follow-up|1|||
156520596|NCT00156819|565001204|FG001|Overall Study|Lost to Follow-up|1|||
156520597|NCT00156819|565001205|FG002|Overall Study|Lost to Follow-up|3|||
156520598|NCT03718533|565001206|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
156520599|NCT03718533|565001206|FG000|Overall Study|Protocol deviation|1|||
156520600|NCT03718533|565001206|FG000|Overall Study|Disease progression|1|||
156520601|NCT03718533|565001206|FG000|Overall Study|Relapse|1|||
156520602|NCT03718533|565001206|FG000|Overall Study|Physician Decision|2|||
156520603|NCT03718533|565001206|FG000|Overall Study|Physician Decision and Adverse Event|1|||
156520604|NCT01248065|565001207|FG000|Overall Study|Lost to Follow-up|3|||
156520605|NCT01248065|565001208|FG001|Overall Study|Lost to Follow-up|5|||
156520606|NCT01248065|565001207|FG000|Overall Study|Withdrawal by Subject|14|||
156520607|NCT01248065|565001208|FG001|Overall Study|Withdrawal by Subject|11|||
156520608|NCT01248065|565001207|FG000|Overall Study|Adverse Event|3|||
156520609|NCT01248065|565001208|FG001|Overall Study|Adverse Event|0|||
156520610|NCT01248065|565001207|FG000|Overall Study|Third treatment failure event|3|||
156520611|NCT01248065|565001208|FG001|Overall Study|Third treatment failure event|1|||
156520612|NCT01248065|565001207|FG000|Overall Study|Other|3|||
156520613|NCT01248065|565001208|FG001|Overall Study|Other|5|||
156520614|NCT02781844|565001209|FG000|Treatment Period 1|Adverse Event|0|||
156520615|NCT02781844|565001210|FG001|Treatment Period 1|Adverse Event|0|||
156520616|NCT02781844|565001211|FG002|Treatment Period 1|Adverse Event|0|||
156520617|NCT02781844|565001212|FG003|Treatment Period 1|Adverse Event|0|||
156520618|NCT02781844|565001213|FG004|Treatment Period 1|Adverse Event|0|||
156520619|NCT02781844|565001214|FG005|Treatment Period 1|Adverse Event|1|||
156520620|NCT02781844|565001215|FG006|Treatment Period 1|Adverse Event|0|||
156520621|NCT02781844|565001216|FG007|Treatment Period 1|Adverse Event|0|||
156520622|NCT02518490|565001219|FG000|Overall Study|Withdrawal by Subject|1|||
156520623|NCT02518490|565001220|FG001|Overall Study|Withdrawal by Subject|1|||
156520624|NCT04256629|565001221|FG000|Overall Study|Adverse Event|0|||
156520625|NCT04256629|565001222|FG001|Overall Study|Adverse Event|0|||
156520626|NCT04256629|565001223|FG002|Overall Study|Adverse Event|0|||
156520627|NCT04256629|565001224|FG003|Overall Study|Adverse Event|0|||
156520628|NCT04256629|565001225|FG004|Overall Study|Adverse Event|0|||
156520629|NCT04256629|565001226|FG005|Overall Study|Adverse Event|1|||
156520630|NCT04256629|565001221|FG000|Overall Study|Protocol Violation|0|||
156520631|NCT04256629|565001222|FG001|Overall Study|Protocol Violation|1|||
156520632|NCT04256629|565001223|FG002|Overall Study|Protocol Violation|0|||
156520633|NCT04256629|565001224|FG003|Overall Study|Protocol Violation|0|||
156520634|NCT04256629|565001225|FG004|Overall Study|Protocol Violation|0|||
156520635|NCT04256629|565001226|FG005|Overall Study|Protocol Violation|0|||
156520636|NCT00321373|565001227|FG000|Overall Study|Adverse Event|0|||
156520637|NCT00321373|565001228|FG001|Overall Study|Adverse Event|0|||
156520638|NCT00321373|565001229|FG002|Overall Study|Adverse Event|1|||
156520639|NCT00321373|565001227|FG000|Overall Study|Lost to Follow-up|1|||
156520640|NCT00321373|565001228|FG001|Overall Study|Lost to Follow-up|0|||
156520641|NCT00321373|565001229|FG002|Overall Study|Lost to Follow-up|1|||
156520642|NCT00321373|565001227|FG000|Overall Study|Withdrawal by Subject|1|||
156520643|NCT00321373|565001228|FG001|Overall Study|Withdrawal by Subject|0|||
156520644|NCT00321373|565001229|FG002|Overall Study|Withdrawal by Subject|0|||
156520645|NCT00321373|565001227|FG000|Overall Study|Other|0|||
156520646|NCT00321373|565001228|FG001|Overall Study|Other|0|||
156520647|NCT00321373|565001229|FG002|Overall Study|Other|1|||
156520648|NCT01774487|565001230|FG000|Overall Study|Did not tolerate taste|4|||
156520649|NCT01774487|565001231|FG001|Overall Study|Did not tolerate taste|4|||
156520650|NCT01383499|565001232|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
156520651|NCT01383499|565001233|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
156520652|NCT01383499|565001234|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
156520653|NCT01383499|565001235|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
156520654|NCT00346632|565001236|FG000|Overall Study|Progressive Disease|2|||
156520655|NCT00346632|565001237|FG001|Overall Study|Progressive Disease|2|||
156520656|NCT00346632|565001238|FG002|Overall Study|Progressive Disease|4|||
156520657|NCT00346632|565001239|FG003|Overall Study|Progressive Disease|3|||
156520658|NCT00346632|565001240|FG004|Overall Study|Progressive Disease|3|||
156520659|NCT00346632|565001241|FG005|Overall Study|Progressive Disease|1|||
156520660|NCT00346632|565001242|FG006|Overall Study|Progressive Disease|2|||
156520661|NCT00346632|565001243|FG007|Overall Study|Progressive Disease|2|||
156520662|NCT00346632|565001244|FG008|Overall Study|Progressive Disease|2|||
156520663|NCT00346632|565001245|FG009|Overall Study|Progressive Disease|2|||
156520664|NCT00346632|565001236|FG000|Overall Study|Adverse Event|0|||
156520665|NCT00346632|565001237|FG001|Overall Study|Adverse Event|0|||
156520666|NCT00346632|565001238|FG002|Overall Study|Adverse Event|0|||
156520667|NCT00346632|565001239|FG003|Overall Study|Adverse Event|0|||
156520668|NCT00346632|565001240|FG004|Overall Study|Adverse Event|1|||
156520669|NCT00346632|565001241|FG005|Overall Study|Adverse Event|1|||
156520670|NCT00346632|565001242|FG006|Overall Study|Adverse Event|1|||
156520671|NCT00346632|565001243|FG007|Overall Study|Adverse Event|0|||
156520672|NCT00346632|565001244|FG008|Overall Study|Adverse Event|0|||
156520673|NCT00346632|565001245|FG009|Overall Study|Adverse Event|0|||
156520674|NCT00346632|565001236|FG000|Overall Study|Death|0|||
156520675|NCT00346632|565001237|FG001|Overall Study|Death|0|||
156520676|NCT00346632|565001238|FG002|Overall Study|Death|1|||
156520677|NCT00346632|565001239|FG003|Overall Study|Death|0|||
156520678|NCT00346632|565001240|FG004|Overall Study|Death|0|||
156520679|NCT00346632|565001241|FG005|Overall Study|Death|0|||
156520680|NCT00346632|565001242|FG006|Overall Study|Death|0|||
156520681|NCT00346632|565001243|FG007|Overall Study|Death|0|||
156520682|NCT00346632|565001244|FG008|Overall Study|Death|0|||
156520683|NCT00346632|565001245|FG009|Overall Study|Death|0|||
156520684|NCT00346632|565001236|FG000|Overall Study|Protocol Violation|0|||
156520685|NCT00346632|565001237|FG001|Overall Study|Protocol Violation|0|||
156520686|NCT00346632|565001238|FG002|Overall Study|Protocol Violation|0|||
156520687|NCT00346632|565001239|FG003|Overall Study|Protocol Violation|0|||
156520688|NCT00346632|565001240|FG004|Overall Study|Protocol Violation|0|||
156520689|NCT00346632|565001241|FG005|Overall Study|Protocol Violation|0|||
156520690|NCT00346632|565001242|FG006|Overall Study|Protocol Violation|1|||
156520691|NCT00346632|565001243|FG007|Overall Study|Protocol Violation|0|||
156520692|NCT00346632|565001244|FG008|Overall Study|Protocol Violation|0|||
156520693|NCT00346632|565001245|FG009|Overall Study|Protocol Violation|0|||
156520694|NCT00346632|565001236|FG000|Overall Study|Withdrawal by Subject|0|||
156520695|NCT00346632|565001237|FG001|Overall Study|Withdrawal by Subject|0|||
156520696|NCT00346632|565001238|FG002|Overall Study|Withdrawal by Subject|0|||
156520697|NCT00346632|565001239|FG003|Overall Study|Withdrawal by Subject|0|||
156520698|NCT00346632|565001240|FG004|Overall Study|Withdrawal by Subject|0|||
156520699|NCT00346632|565001241|FG005|Overall Study|Withdrawal by Subject|0|||
156520700|NCT00346632|565001242|FG006|Overall Study|Withdrawal by Subject|1|||
156520701|NCT00346632|565001243|FG007|Overall Study|Withdrawal by Subject|0|||
156520702|NCT00346632|565001244|FG008|Overall Study|Withdrawal by Subject|0|||
156520703|NCT00346632|565001245|FG009|Overall Study|Withdrawal by Subject|0|||
156520704|NCT00346632|565001236|FG000|Overall Study|Switched to alternative treatment|0|||
156520705|NCT00346632|565001237|FG001|Overall Study|Switched to alternative treatment|0|||
156520706|NCT00346632|565001238|FG002|Overall Study|Switched to alternative treatment|1|||
156520707|NCT00346632|565001239|FG003|Overall Study|Switched to alternative treatment|0|||
156520708|NCT00346632|565001240|FG004|Overall Study|Switched to alternative treatment|0|||
156520709|NCT00346632|565001241|FG005|Overall Study|Switched to alternative treatment|0|||
156520710|NCT00346632|565001242|FG006|Overall Study|Switched to alternative treatment|0|||
156520711|NCT00346632|565001243|FG007|Overall Study|Switched to alternative treatment|0|||
156520712|NCT00346632|565001244|FG008|Overall Study|Switched to alternative treatment|0|||
156520713|NCT00346632|565001245|FG009|Overall Study|Switched to alternative treatment|0|||
156520714|NCT00346632|565001236|FG000|Overall Study|Not Stated|1|||
156520715|NCT00346632|565001237|FG001|Overall Study|Not Stated|1|||
156520716|NCT00346632|565001238|FG002|Overall Study|Not Stated|0|||
156520717|NCT00346632|565001239|FG003|Overall Study|Not Stated|0|||
156520718|NCT00346632|565001240|FG004|Overall Study|Not Stated|0|||
156520719|NCT00346632|565001241|FG005|Overall Study|Not Stated|0|||
156520720|NCT00346632|565001242|FG006|Overall Study|Not Stated|0|||
156520721|NCT00346632|565001243|FG007|Overall Study|Not Stated|2|||
156520722|NCT00346632|565001244|FG008|Overall Study|Not Stated|2|||
156520723|NCT00346632|565001245|FG009|Overall Study|Not Stated|1|||
156520724|NCT00477334|565001246|FG000|Overall Study|Discontinued prior to taking study drug|106|||
156520725|NCT00477334|565001247|FG001|Overall Study|Discontinued prior to taking study drug|53|||
156520726|NCT00477334|565001246|FG000|Overall Study|Adverse Event|1|||
156520727|NCT00477334|565001247|FG001|Overall Study|Adverse Event|2|||
156520728|NCT00477334|565001246|FG000|Overall Study|Withdrawal by Subject|2|||
156520729|NCT00477334|565001247|FG001|Overall Study|Withdrawal by Subject|1|||
156520730|NCT00477334|565001246|FG000|Overall Study|Lost to Follow-up|15|||
156520731|NCT00477334|565001247|FG001|Overall Study|Lost to Follow-up|4|||
156520732|NCT00477334|565001246|FG000|Overall Study|Administrative Problems|39|||
156520733|NCT00477334|565001247|FG001|Overall Study|Administrative Problems|15|||
156520734|NCT00477334|565001246|FG000|Overall Study|Protocol Violation|7|||
156520735|NCT00477334|565001247|FG001|Overall Study|Protocol Violation|1|||
156520736|NCT02572882|565001248|FG000|Overall Study|Withdrawal by Subject|1|||
156520737|NCT02572882|565001248|FG000|Overall Study|Participant received kidney transplant|1|||
156520738|NCT01079663|565001254|FG000|Overall Study|Adverse Event|0|||
156520739|NCT01079663|565001255|FG001|Overall Study|Adverse Event|2|||
156520740|NCT01079663|565001254|FG000|Overall Study|Protocol Violation|0|||
156520741|NCT01079663|565001255|FG001|Overall Study|Protocol Violation|2|||
156520742|NCT03587974|565001256|FG000|Overall Study|caregiver demented, care recipient died|3|||
156520743|NCT03587974|565001257|FG001|Overall Study|caregiver demented, care recipient died|3|||
156520744|NCT03587974|565001256|FG000|Overall Study|Withdrawal by Subject|2|||
156520745|NCT03587974|565001257|FG001|Overall Study|Withdrawal by Subject|1|||
156520746|NCT02354508|565001258|FG000|Period 1: Core Phase|Adverse Event|1|||
156520747|NCT02354508|565001259|FG001|Period 1: Core Phase|Adverse Event|1|||
156520748|NCT02354508|565001260|FG002|Period 1: Core Phase|Adverse Event|2|||
156520749|NCT02354508|565001258|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
156520750|NCT02354508|565001259|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
156520751|NCT02354508|565001260|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
156520752|NCT02354508|565001258|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
156520753|NCT02354508|565001259|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
156520754|NCT02354508|565001260|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
156520755|NCT02354508|565001258|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
156520756|NCT02354508|565001259|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
156520757|NCT02354508|565001260|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
156520758|NCT02354508|565001258|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
156520759|NCT02354508|565001259|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
156520760|NCT02354508|565001260|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
156520761|NCT02354508|565001258|FG000|Period 2: Extension Phase|Physician Decision|5|||
156520762|NCT02354508|565001259|FG001|Period 2: Extension Phase|Physician Decision|0|||
156520763|NCT02354508|565001260|FG002|Period 2: Extension Phase|Physician Decision|1|||
156520764|NCT02354508|565001258|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
156520765|NCT02354508|565001259|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
156520766|NCT02354508|565001260|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
156520767|NCT02354508|565001258|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
156520768|NCT02354508|565001259|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
156520769|NCT02354508|565001260|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
156520770|NCT02354508|565001258|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
156520771|NCT02354508|565001259|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
156520772|NCT02354508|565001260|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
156520773|NCT04447846|565001264|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
156520774|NCT00461032|565001265|FG000|Overall Study|Adverse Event|5|||
156520775|NCT00461032|565001266|FG001|Overall Study|Adverse Event|6|||
156520776|NCT00461032|565001265|FG000|Overall Study|Lack of Efficacy|5|||
156520777|NCT00461032|565001266|FG001|Overall Study|Lack of Efficacy|1|||
156520778|NCT00461032|565001265|FG000|Overall Study|Lost to Follow-up|7|||
156520779|NCT00461032|565001266|FG001|Overall Study|Lost to Follow-up|12|||
156520780|NCT00461032|565001265|FG000|Overall Study|Protocol Violation|4|||
156520781|NCT00461032|565001266|FG001|Overall Study|Protocol Violation|4|||
156520782|NCT00461032|565001265|FG000|Overall Study|Withdrawal by Subject|7|||
156520783|NCT00461032|565001266|FG001|Overall Study|Withdrawal by Subject|15|||
156520784|NCT00461032|565001265|FG000|Overall Study|Patient Moved or Relocated|2|||
156520785|NCT00461032|565001266|FG001|Overall Study|Patient Moved or Relocated|1|||
156520786|NCT00461032|565001265|FG000|Overall Study|Other|7|||
156520787|NCT00461032|565001266|FG001|Overall Study|Other|5|||
156520788|NCT03486457|565001268|FG000|Up to Month 3|Adverse Event|2|||
156520789|NCT03486457|565001269|FG001|Up to Month 3|Adverse Event|5|||
156520790|NCT03486457|565001268|FG000|Up to Month 3|Lack of Efficacy|1|||
156520791|NCT03486457|565001269|FG001|Up to Month 3|Lack of Efficacy|0|||
156520792|NCT03486457|565001268|FG000|Up to Month 3|Withdrawal by Subject|1|||
156520793|NCT03486457|565001269|FG001|Up to Month 3|Withdrawal by Subject|0|||
156520794|NCT03486457|565001268|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
156520795|NCT03486457|565001269|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
156520796|NCT03486457|565001268|FG000|Up to Month 3|Other|1|||
156520797|NCT03486457|565001269|FG001|Up to Month 3|Other|0|||
156520798|NCT03486457|565001268|FG000|Month 3 to Month 6|Adverse Event|2|||
156520799|NCT03486457|565001269|FG001|Month 3 to Month 6|Adverse Event|0|||
156520800|NCT03486457|565001268|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
156520801|NCT03486457|565001269|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
156520802|NCT03486457|565001268|FG000|Month 3 to Month 6|Pregnancy|0|||
156520803|NCT03486457|565001269|FG001|Month 3 to Month 6|Pregnancy|1|||
156520804|NCT03486457|565001268|FG000|Month 3 to Month 6|Other|1|||
156520805|NCT03486457|565001269|FG001|Month 3 to Month 6|Other|0|||
156520806|NCT02257567|565001270|FG000|Overall Study|Adverse Event|0|||
156520807|NCT02257567|565001271|FG001|Overall Study|Adverse Event|0|||
156520808|NCT02257567|565001272|FG002|Overall Study|Adverse Event|0|||
156520809|NCT02257567|565001273|FG003|Overall Study|Adverse Event|1|||
156520810|NCT02257567|565001274|FG004|Overall Study|Adverse Event|1|||
156520811|NCT02257567|565001275|FG005|Overall Study|Adverse Event|0|||
156520812|NCT02257567|565001276|FG006|Overall Study|Adverse Event|0|||
156520813|NCT02257567|565001277|FG007|Overall Study|Adverse Event|0|||
156520814|NCT02257567|565001278|FG008|Overall Study|Adverse Event|1|||
156520815|NCT02257567|565001279|FG009|Overall Study|Adverse Event|0|||
156520816|NCT02257567|565001280|FG010|Overall Study|Adverse Event|0|||
156520817|NCT02257567|565001270|FG000|Overall Study|Death|2|||
156520818|NCT02257567|565001271|FG001|Overall Study|Death|2|||
156520819|NCT02257567|565001272|FG002|Overall Study|Death|2|||
156563155|NCT00103012|565150117|FG000|Overall Study|Withdrawal by Subject|2|||
156563156|NCT00103012|565150118|FG001|Overall Study|Withdrawal by Subject|1|||
156563157|NCT00103012|565150119|FG002|Overall Study|Withdrawal by Subject|2|||
156563158|NCT00103012|565150117|FG000|Overall Study|Pregnancy|1|||
156563159|NCT00103012|565150118|FG001|Overall Study|Pregnancy|0|||
156563160|NCT00103012|565150119|FG002|Overall Study|Pregnancy|0|||
156563161|NCT00103012|565150117|FG000|Overall Study|Adverse Event|0|||
156563162|NCT00103012|565150118|FG001|Overall Study|Adverse Event|0|||
156563163|NCT00103012|565150119|FG002|Overall Study|Adverse Event|1|||
156563164|NCT00103012|565150117|FG000|Overall Study|Subject non-compliant with medications|0|||
156563165|NCT00103012|565150118|FG001|Overall Study|Subject non-compliant with medications|0|||
156563166|NCT00103012|565150119|FG002|Overall Study|Subject non-compliant with medications|1|||
156563167|NCT05211336|565150122|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
156563168|NCT05211336|565150123|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
156563169|NCT05211336|565150122|FG000|Overall Study|Progressive disease|0|||
156563170|NCT05211336|565150123|FG001|Overall Study|Progressive disease|4|||
156563171|NCT05211336|565150122|FG000|Overall Study|Death due to myocardial infarction|0|||
156563172|NCT05211336|565150123|FG001|Overall Study|Death due to myocardial infarction|1|||
156563173|NCT05211336|565150122|FG000|Overall Study|Death due to unknown cause|0|||
156563174|NCT05211336|565150123|FG001|Overall Study|Death due to unknown cause|1|||
156563175|NCT05211336|565150122|FG000|Overall Study|Worsening kidney function and quality of response|0|||
156563176|NCT05211336|565150123|FG001|Overall Study|Worsening kidney function and quality of response|1|||
156563177|NCT00393718|565150131|FG000|Overall Study|Adverse Event|20|||
156563178|NCT00393718|565150132|FG001|Overall Study|Adverse Event|8|||
156563179|NCT00393718|565150131|FG000|Overall Study|Protocol Violation|1|||
156563180|NCT00393718|565150132|FG001|Overall Study|Protocol Violation|2|||
156563181|NCT00393718|565150131|FG000|Overall Study|Lack of Efficacy|10|||
156563182|NCT00393718|565150132|FG001|Overall Study|Lack of Efficacy|9|||
156563183|NCT00393718|565150131|FG000|Overall Study|Hypoglycaemia|3|||
156563184|NCT00393718|565150132|FG001|Overall Study|Hypoglycaemia|2|||
156563185|NCT00393718|565150131|FG000|Overall Study|Subject decision|5|||
156563186|NCT00393718|565150132|FG001|Overall Study|Subject decision|0|||
156563187|NCT00393718|565150131|FG000|Overall Study|Withdrawal of consent|2|||
156563188|NCT00393718|565150132|FG001|Overall Study|Withdrawal of consent|1|||
156563189|NCT00393718|565150131|FG000|Overall Study|Missed measurement|1|||
156563190|NCT00393718|565150132|FG001|Overall Study|Missed measurement|0|||
156563191|NCT00393718|565150131|FG000|Overall Study|Move|1|||
156563192|NCT00393718|565150132|FG001|Overall Study|Move|0|||
156563193|NCT01084551|565150134|FG000|Overall Study|Adverse Event|2|||
156563194|NCT01084551|565150135|FG001|Overall Study|Adverse Event|9|||
156563195|NCT01084551|565150136|FG002|Overall Study|Adverse Event|4|||
156563196|NCT01084551|565150134|FG000|Overall Study|Lack of Efficacy|2|||
156563197|NCT01084551|565150135|FG001|Overall Study|Lack of Efficacy|0|||
156563198|NCT01084551|565150136|FG002|Overall Study|Lack of Efficacy|1|||
156563199|NCT01084551|565150134|FG000|Overall Study|Withdrawal by Subject|2|||
156563200|NCT01084551|565150135|FG001|Overall Study|Withdrawal by Subject|1|||
156563201|NCT01084551|565150136|FG002|Overall Study|Withdrawal by Subject|0|||
156563202|NCT01084551|565150134|FG000|Overall Study|Protocol Violation|2|||
156563203|NCT01084551|565150135|FG001|Overall Study|Protocol Violation|4|||
156563204|NCT01084551|565150136|FG002|Overall Study|Protocol Violation|0|||
156563205|NCT01084551|565150134|FG000|Overall Study|Lost to Follow-up|0|||
156563206|NCT01084551|565150135|FG001|Overall Study|Lost to Follow-up|0|||
156563207|NCT01084551|565150136|FG002|Overall Study|Lost to Follow-up|3|||
156563208|NCT01084551|565150134|FG000|Overall Study|Physician Decision|1|||
156563209|NCT01084551|565150135|FG001|Overall Study|Physician Decision|0|||
156563210|NCT01084551|565150136|FG002|Overall Study|Physician Decision|0|||
156563211|NCT03902080|565150137|FG000|Overall Study|Adverse Event|17|||
156563212|NCT03902080|565150138|FG001|Overall Study|Adverse Event|15|||
156563213|NCT03902080|565150137|FG000|Overall Study|Withdrawal by Subject|28|||
156563214|NCT03902080|565150138|FG001|Overall Study|Withdrawal by Subject|35|||
156563215|NCT03902080|565150137|FG000|Overall Study|Lost to Follow-up|6|||
156563216|NCT03902080|565150138|FG001|Overall Study|Lost to Follow-up|7|||
156563217|NCT03902080|565150137|FG000|Overall Study|Other|3|||
156563218|NCT03902080|565150138|FG001|Overall Study|Other|5|||
156563219|NCT03902080|565150137|FG000|Overall Study|Non compliance|4|||
156563220|NCT03902080|565150138|FG001|Overall Study|Non compliance|3|||
156563221|NCT03902080|565150137|FG000|Overall Study|Physician Decision|5|||
156563222|NCT03902080|565150138|FG001|Overall Study|Physician Decision|1|||
156563223|NCT03902080|565150137|FG000|Overall Study|Protocol Violation|3|||
156563224|NCT03902080|565150138|FG001|Overall Study|Protocol Violation|3|||
156563225|NCT03902080|565150137|FG000|Overall Study|Lack of Efficacy|1|||
156563226|NCT03902080|565150138|FG001|Overall Study|Lack of Efficacy|3|||
156563227|NCT03902080|565150137|FG000|Overall Study|Withdrawn prior to dosing|0|||
156563228|NCT03902080|565150138|FG001|Overall Study|Withdrawn prior to dosing|1|||
156563229|NCT04684420|565150139|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156563230|NCT04684420|565150140|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156563231|NCT04684420|565150141|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
156563232|NCT04684420|565150142|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
156563233|NCT04684420|565150139|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
156563234|NCT04684420|565150140|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
156563235|NCT04684420|565150141|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
156563236|NCT04684420|565150142|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
156563237|NCT00463476|565150143|FG000|Overall Study|Withdrawal by Subject|1|||
156563238|NCT00463476|565150144|FG001|Overall Study|Withdrawal by Subject|2|||
156563239|NCT00463476|565150143|FG000|Overall Study|Lost to Follow-up|1|||
156563240|NCT00463476|565150144|FG001|Overall Study|Lost to Follow-up|1|||
156563241|NCT01703000|565150146|FG000|Overall Study|Death|1|||
156563242|NCT01061008|565150147|FG000|Overall Study|Badiocephalic fistula failed|3|||
156563243|NCT01061008|565150148|FG001|Overall Study|Badiocephalic fistula failed|2|||
156563244|NCT01061008|565150147|FG000|Overall Study|Death|1|||
156563245|NCT01061008|565150148|FG001|Overall Study|Death|0|||
156563246|NCT01061008|565150147|FG000|Overall Study|Withdrawal by Subject|1|||
156563247|NCT01061008|565150148|FG001|Overall Study|Withdrawal by Subject|3|||
156563248|NCT01061008|565150147|FG000|Overall Study|Unable to exercise following surgery|1|||
156563249|NCT01061008|565150148|FG001|Overall Study|Unable to exercise following surgery|0|||
156563250|NCT01061008|565150147|FG000|Overall Study|Adverse Event|0|||
156563251|NCT01061008|565150148|FG001|Overall Study|Adverse Event|1|||
156563252|NCT04067518|565150149|FG000|Overall Study|Adverse Event|1|||
156563253|NCT04067518|565150150|FG001|Overall Study|Adverse Event|3|||
156563254|NCT04067518|565150149|FG000|Overall Study|Screen failures|0|||
156563255|NCT04067518|565150150|FG001|Overall Study|Screen failures|1|||
156563256|NCT04067518|565150149|FG000|Overall Study|Enrolled but not treated|0|||
156563257|NCT04067518|565150150|FG001|Overall Study|Enrolled but not treated|1|||
156563258|NCT00675025|565150151|FG000|Overall Study|Study Terminated by Sponsor|38|||
156563259|NCT00675025|565150152|FG001|Overall Study|Study Terminated by Sponsor|42|||
156563260|NCT00675025|565150151|FG000|Overall Study|Adverse Event|6|||
156563261|NCT00675025|565150152|FG001|Overall Study|Adverse Event|11|||
156563262|NCT00675025|565150151|FG000|Overall Study|Lost to Follow-up|6|||
156563263|NCT00675025|565150152|FG001|Overall Study|Lost to Follow-up|4|||
156563264|NCT00675025|565150151|FG000|Overall Study|Withdrawal by Subject|4|||
156563265|NCT00675025|565150152|FG001|Overall Study|Withdrawal by Subject|6|||
156563266|NCT00556426|565150156|FG000|Overall Study|Withdrawal by Subject|3|||
156563267|NCT00556426|565150156|FG000|Overall Study|Death|6|||
156563268|NCT02347631|565150165|FG000|First Intervention (2 Months)|Adverse Event|1|||
156563269|NCT02347631|565150166|FG001|First Intervention (2 Months)|Adverse Event|1|||
156563270|NCT02347631|565150165|FG000|First Intervention (2 Months)|Pregnancy|1|||
156563271|NCT02347631|565150166|FG001|First Intervention (2 Months)|Pregnancy|0|||
156563272|NCT02347631|565150165|FG000|First Intervention (2 Months)|Moved out of area|0|||
156563273|NCT02347631|565150166|FG001|First Intervention (2 Months)|Moved out of area|2|||
156563274|NCT02347631|565150165|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
156563275|NCT02347631|565150166|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
156563276|NCT02347631|565150165|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
156563277|NCT02347631|565150166|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
156563278|NCT02347631|565150165|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
156563279|NCT02347631|565150166|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
156563280|NCT02347631|565150165|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
156563281|NCT02347631|565150166|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
156563282|NCT02347631|565150165|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
156563283|NCT02347631|565150166|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
156563284|NCT03804684|565150168|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
156563285|NCT03804684|565150169|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
156563286|NCT03183128|565150173|FG000|Overall Study|Adverse Event|1|||
156563287|NCT03183128|565150174|FG001|Overall Study|Adverse Event|2|||
156563288|NCT03183128|565150173|FG000|Overall Study|Withdrawal by Subject|1|||
156563289|NCT03183128|565150174|FG001|Overall Study|Withdrawal by Subject|8|||
156563290|NCT03183128|565150173|FG000|Overall Study|Protocol Violation|2|||
156563291|NCT03183128|565150174|FG001|Overall Study|Protocol Violation|0|||
156563292|NCT03183128|565150173|FG000|Overall Study|Lack of Efficacy|4|||
156563293|NCT03183128|565150174|FG001|Overall Study|Lack of Efficacy|27|||
156563294|NCT03183128|565150173|FG000|Overall Study|Lost to Follow-up|1|||
156563295|NCT03183128|565150174|FG001|Overall Study|Lost to Follow-up|0|||
156563296|NCT03183128|565150173|FG000|Overall Study|Death|2|||
156563297|NCT03183128|565150174|FG001|Overall Study|Death|0|||
156563298|NCT03183128|565150173|FG000|Overall Study|Physician Decision|1|||
156563299|NCT03183128|565150174|FG001|Overall Study|Physician Decision|0|||
156563300|NCT00802360|565150175|FG000|Overall Study|Stimulation failure|4|||
156563301|NCT00802360|565150176|FG001|Overall Study|Stimulation failure|0|||
156563302|NCT00802360|565150177|FG002|Overall Study|Stimulation failure|3|||
156563303|NCT00802360|565150178|FG003|Overall Study|Stimulation failure|3|||
156563304|NCT00802360|565150175|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
156563305|NCT00802360|565150176|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
156563306|NCT00802360|565150177|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
156563307|NCT00802360|565150178|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
156520820|NCT02257567|565001273|FG003|Overall Study|Death|4|||
156520821|NCT02257567|565001274|FG004|Overall Study|Death|15|||
156520822|NCT02257567|565001275|FG005|Overall Study|Death|11|||
156520823|NCT02257567|565001276|FG006|Overall Study|Death|26|||
156520824|NCT02257567|565001277|FG007|Overall Study|Death|30|||
156520825|NCT02257567|565001278|FG008|Overall Study|Death|2|||
156520826|NCT02257567|565001279|FG009|Overall Study|Death|18|||
156520827|NCT02257567|565001280|FG010|Overall Study|Death|65|||
156520828|NCT02257567|565001270|FG000|Overall Study|Lost to Follow-up|0|||
156520829|NCT02257567|565001271|FG001|Overall Study|Lost to Follow-up|0|||
156520830|NCT02257567|565001272|FG002|Overall Study|Lost to Follow-up|0|||
156520831|NCT02257567|565001273|FG003|Overall Study|Lost to Follow-up|0|||
156520832|NCT02257567|565001274|FG004|Overall Study|Lost to Follow-up|2|||
156520833|NCT02257567|565001275|FG005|Overall Study|Lost to Follow-up|2|||
156520834|NCT02257567|565001276|FG006|Overall Study|Lost to Follow-up|0|||
156520835|NCT02257567|565001277|FG007|Overall Study|Lost to Follow-up|0|||
156520836|NCT02257567|565001278|FG008|Overall Study|Lost to Follow-up|0|||
156520837|NCT02257567|565001279|FG009|Overall Study|Lost to Follow-up|1|||
156520838|NCT02257567|565001280|FG010|Overall Study|Lost to Follow-up|1|||
156520839|NCT02257567|565001270|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520840|NCT02257567|565001271|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520841|NCT02257567|565001272|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520842|NCT02257567|565001273|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520843|NCT02257567|565001274|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
156520844|NCT02257567|565001275|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520845|NCT02257567|565001276|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
156520846|NCT02257567|565001277|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520847|NCT02257567|565001278|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520848|NCT02257567|565001279|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520849|NCT02257567|565001280|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
156520850|NCT02257567|565001270|FG000|Overall Study|Physician Decision|0|||
156520851|NCT02257567|565001271|FG001|Overall Study|Physician Decision|0|||
156520852|NCT02257567|565001272|FG002|Overall Study|Physician Decision|0|||
156520853|NCT02257567|565001273|FG003|Overall Study|Physician Decision|0|||
156520854|NCT02257567|565001274|FG004|Overall Study|Physician Decision|0|||
156520855|NCT02257567|565001275|FG005|Overall Study|Physician Decision|0|||
156520856|NCT02257567|565001276|FG006|Overall Study|Physician Decision|0|||
156520857|NCT02257567|565001277|FG007|Overall Study|Physician Decision|2|||
156520858|NCT02257567|565001278|FG008|Overall Study|Physician Decision|0|||
156520859|NCT02257567|565001279|FG009|Overall Study|Physician Decision|1|||
156520860|NCT02257567|565001280|FG010|Overall Study|Physician Decision|0|||
156520861|NCT02257567|565001270|FG000|Overall Study|Withdrawal by Subject|0|||
156520862|NCT02257567|565001271|FG001|Overall Study|Withdrawal by Subject|0|||
156520863|NCT02257567|565001272|FG002|Overall Study|Withdrawal by Subject|2|||
156520864|NCT02257567|565001273|FG003|Overall Study|Withdrawal by Subject|0|||
156520865|NCT02257567|565001274|FG004|Overall Study|Withdrawal by Subject|0|||
156520866|NCT02257567|565001275|FG005|Overall Study|Withdrawal by Subject|6|||
156520867|NCT02257567|565001276|FG006|Overall Study|Withdrawal by Subject|6|||
156520868|NCT02257567|565001277|FG007|Overall Study|Withdrawal by Subject|6|||
156520869|NCT02257567|565001278|FG008|Overall Study|Withdrawal by Subject|1|||
156520870|NCT02257567|565001279|FG009|Overall Study|Withdrawal by Subject|1|||
156520871|NCT02257567|565001280|FG010|Overall Study|Withdrawal by Subject|10|||
156520872|NCT03536143|565001281|FG000|Overall Study|Early termination, Sponsor decision|1|||
156520873|NCT00946101|565001282|FG000|Overall Study|Lost to Follow-up|2|||
156520874|NCT00946101|565001283|FG001|Overall Study|Lost to Follow-up|1|||
156520875|NCT00946101|565001282|FG000|Overall Study|Withdrawal of consent|2|||
156520876|NCT00946101|565001283|FG001|Overall Study|Withdrawal of consent|0|||
156520877|NCT00946101|565001282|FG000|Overall Study|Physician Decision|0|||
156520878|NCT00946101|565001283|FG001|Overall Study|Physician Decision|1|||
156520879|NCT01174160|565001284|FG000|Overall Study|Adverse Event|1|||
156520880|NCT01174160|565001285|FG001|Overall Study|Adverse Event|0|||
156520881|NCT01174160|565001284|FG000|Overall Study|Lost to Follow-up|1|||
156520882|NCT01174160|565001285|FG001|Overall Study|Lost to Follow-up|0|||
156520883|NCT01174160|565001284|FG000|Overall Study|Physician Decision|1|||
156520884|NCT01174160|565001285|FG001|Overall Study|Physician Decision|0|||
156520885|NCT01174160|565001284|FG000|Overall Study|Protocol Violation|4|||
156520886|NCT01174160|565001285|FG001|Overall Study|Protocol Violation|6|||
156520887|NCT01174160|565001284|FG000|Overall Study|Withdrawal by Subject|1|||
156520888|NCT01174160|565001285|FG001|Overall Study|Withdrawal by Subject|0|||
156563308|NCT00802360|565150175|FG000|Overall Study|Cycle cancelled|0|||
156563309|NCT00802360|565150176|FG001|Overall Study|Cycle cancelled|1|||
156563310|NCT00802360|565150177|FG002|Overall Study|Cycle cancelled|1|||
156563311|NCT00802360|565150178|FG003|Overall Study|Cycle cancelled|1|||
156563312|NCT00802360|565150175|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
156563313|NCT00802360|565150176|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
156563314|NCT00802360|565150177|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
156563315|NCT00802360|565150178|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
156563316|NCT00802360|565150175|FG000|Overall Study|No positive serum pregnancy|17|||
156563317|NCT00802360|565150176|FG001|Overall Study|No positive serum pregnancy|20|||
156563318|NCT00802360|565150177|FG002|Overall Study|No positive serum pregnancy|14|||
156563319|NCT00802360|565150178|FG003|Overall Study|No positive serum pregnancy|10|||
156563320|NCT00802360|565150175|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
156563321|NCT00802360|565150176|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
156563322|NCT00802360|565150177|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
156563323|NCT00802360|565150178|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
156563324|NCT00802360|565150175|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
156563325|NCT00802360|565150176|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
156563326|NCT00802360|565150177|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
156563327|NCT00802360|565150178|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
156563328|NCT00802360|565150175|FG000|Overall Study|Other|2|||
156563329|NCT00802360|565150176|FG001|Overall Study|Other|3|||
156563330|NCT00802360|565150177|FG002|Overall Study|Other|6|||
156563331|NCT00802360|565150178|FG003|Overall Study|Other|3|||
156563332|NCT02978222|565150181|FG000|Overall Study|Withdrawal by Subject|2|||
156563333|NCT02978222|565150182|FG001|Overall Study|Withdrawal by Subject|2|||
156563334|NCT02978222|565150181|FG000|Overall Study|Physician Decision|2|||
156563335|NCT02978222|565150182|FG001|Overall Study|Physician Decision|0|||
156563336|NCT02978222|565150181|FG000|Overall Study|Adverse Event|0|||
156563337|NCT02978222|565150182|FG001|Overall Study|Adverse Event|1|||
156563338|NCT02978222|565150181|FG000|Overall Study|Death|1|||
156563339|NCT02978222|565150182|FG001|Overall Study|Death|0|||
156563340|NCT02978222|565150181|FG000|Overall Study|Disease Progression|32|||
156563341|NCT02978222|565150182|FG001|Overall Study|Disease Progression|32|||
156563342|NCT02978222|565150181|FG000|Overall Study|Early Study Termination|24|||
156563343|NCT02978222|565150182|FG001|Overall Study|Early Study Termination|21|||
156563344|NCT03258814|565150185|FG000|Overall Study|Early Termination|4|||
156563345|NCT03258814|565150186|FG001|Overall Study|Early Termination|3|||
156563346|NCT03258814|565150187|FG002|Overall Study|Early Termination|10|||
156520889|NCT01590017|565001286|FG000|Overall Study|Adverse Event|1|||
156520890|NCT01590017|565001286|FG000|Overall Study|Withdrawal by Subject|1|||
156520891|NCT01590017|565001286|FG000|Overall Study|Lack of Efficacy|1|||
156520892|NCT01590017|565001286|FG000|Overall Study|Physician Decision|1|||
156520893|NCT00093808|565001287|FG000|Overall Study|Cancel participation before receiving tx|1|||
156520894|NCT00093808|565001287|FG000|Overall Study|Protocol Violation|1|||
156520895|NCT00871780|565001288|FG000|Overall Study|Enrolled But Not Treated|6|||
156520896|NCT00871780|565001288|FG000|Overall Study|Withdrawal by Subject|9|||
156520897|NCT00871780|565001288|FG000|Overall Study|Adverse Event|6|||
156520898|NCT00871780|565001288|FG000|Overall Study|Voluntary Discontinuation|4|||
156520899|NCT00871780|565001288|FG000|Overall Study|Death|1|||
156520900|NCT00871780|565001288|FG000|Overall Study|Physician Decision|1|||
156520901|NCT02527343|565001289|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
156520902|NCT02527343|565001290|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
156520903|NCT02527343|565001291|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
156520904|NCT02527343|565001292|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
156520905|NCT02527343|565001293|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
156520906|NCT02527343|565001294|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
156520907|NCT02527343|565001289|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
156520908|NCT02527343|565001290|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
156520909|NCT02527343|565001291|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
156520910|NCT02527343|565001292|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
156520911|NCT02527343|565001293|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
156520912|NCT02527343|565001294|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
156520913|NCT02527343|565001289|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
156520914|NCT02527343|565001290|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
156520915|NCT02527343|565001291|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
156520916|NCT02527343|565001292|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
156520917|NCT02527343|565001293|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
156520918|NCT02527343|565001294|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
156563347|NCT01900002|565150188|FG000|Overall Study|Withdrawal by Subject|2|||
156563348|NCT01900002|565150188|FG000|Overall Study|ineligible for Y-90|4|||
156563349|NCT00348140|565150194|FG000|Overall Study|Adverse Event|46|||
156520919|NCT02527343|565001289|FG000|RT Period: Weeks 1 to 52|Other|4|||
156520920|NCT02527343|565001290|FG001|RT Period: Weeks 1 to 52|Other|3|||
156520921|NCT02527343|565001291|FG002|RT Period: Weeks 1 to 52|Other|0|||
156520922|NCT02527343|565001292|FG003|RT Period: Weeks 1 to 52|Other|0|||
156520923|NCT02527343|565001293|FG004|RT Period: Weeks 1 to 52|Other|0|||
156520924|NCT02527343|565001294|FG005|RT Period: Weeks 1 to 52|Other|0|||
156520925|NCT02527343|565001289|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
156520926|NCT02527343|565001290|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
156520927|NCT02527343|565001291|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
156520928|NCT02527343|565001292|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
156520929|NCT02527343|565001293|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
156520930|NCT02527343|565001294|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
156520931|NCT02527343|565001289|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
156520932|NCT02527343|565001290|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
156520933|NCT02527343|565001291|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
156520934|NCT02527343|565001292|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
156520935|NCT02527343|565001293|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
156520936|NCT02527343|565001294|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
156520937|NCT02527343|565001289|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
156520938|NCT02527343|565001290|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
156520939|NCT02527343|565001291|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
156520940|NCT02527343|565001292|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
156520941|NCT02527343|565001293|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
156520942|NCT02527343|565001294|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
156520943|NCT02527343|565001289|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
156520944|NCT02527343|565001290|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
156520945|NCT02527343|565001291|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
156520946|NCT02527343|565001292|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
156520947|NCT02527343|565001293|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
156520948|NCT02527343|565001294|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
156520949|NCT02527343|565001289|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
156520950|NCT02527343|565001290|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
156520951|NCT02527343|565001291|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
156520952|NCT02527343|565001292|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
156520953|NCT02527343|565001293|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
156520954|NCT02527343|565001294|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
156520955|NCT02527343|565001289|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
156520956|NCT02527343|565001290|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
156520957|NCT02527343|565001291|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
156520958|NCT02527343|565001292|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
156520959|NCT02527343|565001293|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
156520960|NCT02527343|565001294|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
156520961|NCT02527343|565001289|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
156520962|NCT02527343|565001290|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
156520963|NCT02527343|565001291|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
156520964|NCT02527343|565001292|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
156520965|NCT02527343|565001293|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
156520966|NCT02527343|565001294|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
156520967|NCT02527343|565001289|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
156520968|NCT02527343|565001290|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
156520969|NCT02527343|565001291|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
156520970|NCT02527343|565001292|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
156520971|NCT02527343|565001293|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
156520972|NCT02527343|565001294|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
156520973|NCT02527343|565001289|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
156520974|NCT02527343|565001290|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
156520975|NCT02527343|565001291|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
156520976|NCT02527343|565001292|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
156520977|NCT02527343|565001293|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
156520978|NCT02527343|565001294|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
156520979|NCT05767021|565001295|FG000|Overall Study|Adverse Event|2|||
156520980|NCT05767021|565001295|FG000|Overall Study|Protocol Deviation|1|||
156520981|NCT05767021|565001295|FG000|Overall Study|Withdrawal by Subject|1|||
156520982|NCT05767021|565001295|FG000|Overall Study|Physician Decision|1|||
156520983|NCT05767021|565001295|FG000|Overall Study|Lack of Efficacy|11|||
156520984|NCT05767021|565001295|FG000|Overall Study|Assigned Treatment by Mistake|1|||
156520985|NCT04055090|565001296|FG000|Overall Study|screen failure|1|||
156520986|NCT04055090|565001297|FG001|Overall Study|screen failure|0|||
156520987|NCT04055090|565001296|FG000|Overall Study|Withdrawal by Subject|1|||
156520988|NCT04055090|565001297|FG001|Overall Study|Withdrawal by Subject|0|||
156520989|NCT04745026|565001298|FG000|Overall Study|Physician Decision|1|||
156520990|NCT04745026|565001299|FG001|Overall Study|Physician Decision|0|||
156520991|NCT04745026|565001298|FG000|Overall Study|Adverse Event|2|||
156520992|NCT04745026|565001299|FG001|Overall Study|Adverse Event|2|||
156520993|NCT04745026|565001298|FG000|Overall Study|Protocol Violation|1|||
156520994|NCT04745026|565001299|FG001|Overall Study|Protocol Violation|3|||
156520995|NCT04745026|565001298|FG000|Overall Study|Lost to Follow-up|4|||
156520996|NCT04745026|565001299|FG001|Overall Study|Lost to Follow-up|3|||
156520997|NCT04745026|565001298|FG000|Overall Study|Withdrawal by Subject|5|||
156520998|NCT04745026|565001299|FG001|Overall Study|Withdrawal by Subject|5|||
156520999|NCT04426851|565001302|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
156521000|NCT04426851|565001303|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
156521001|NCT04426851|565001302|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
156521002|NCT04426851|565001303|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
156521003|NCT03625895|565001307|FG000|Overall Study|Protocol Violation|585|||
156521004|NCT01065844|565001308|FG000|Overall Study|Adverse Event|5|||
156521005|NCT02081417|565001309|FG000|Overall Study|Lost to Follow-up|26|||
156521006|NCT02081417|565001310|FG001|Overall Study|Lost to Follow-up|23|||
156521007|NCT02081417|565001309|FG000|Overall Study|Moved Away|1|||
156521008|NCT02081417|565001310|FG001|Overall Study|Moved Away|2|||
156521009|NCT02081417|565001309|FG000|Overall Study|Incarcerated|2|||
156521010|NCT02081417|565001310|FG001|Overall Study|Incarcerated|2|||
156521011|NCT02081417|565001309|FG000|Overall Study|Death|4|||
156521012|NCT02081417|565001310|FG001|Overall Study|Death|3|||
156521013|NCT02081417|565001309|FG000|Overall Study|Withdrawal by Subject|4|||
156521014|NCT02081417|565001310|FG001|Overall Study|Withdrawal by Subject|0|||
156521015|NCT02081417|565001309|FG000|Overall Study|Admitted to Residential Treatment|2|||
156521016|NCT02081417|565001310|FG001|Overall Study|Admitted to Residential Treatment|0|||
156521017|NCT02081417|565001309|FG000|Overall Study|Did not start treatment|17|||
156521018|NCT02081417|565001310|FG001|Overall Study|Did not start treatment|21|||
156521019|NCT00552240|565001313|FG000|Overall Study|Adverse Event|9|||
156521020|NCT00552240|565001314|FG001|Overall Study|Adverse Event|9|||
156521021|NCT00552240|565001313|FG000|Overall Study|Protocol Violation|1|||
156521022|NCT00552240|565001314|FG001|Overall Study|Protocol Violation|1|||
156521023|NCT00552240|565001313|FG000|Overall Study|Lost to Follow-up|5|||
156521024|NCT00552240|565001314|FG001|Overall Study|Lost to Follow-up|6|||
156521025|NCT00552240|565001313|FG000|Overall Study|Withdrawal by Subject|2|||
156521026|NCT00552240|565001314|FG001|Overall Study|Withdrawal by Subject|2|||
156521027|NCT00552240|565001313|FG000|Overall Study|Lack of Efficacy|6|||
156521028|NCT00552240|565001314|FG001|Overall Study|Lack of Efficacy|0|||
156521029|NCT00552240|565001313|FG000|Overall Study|Other|1|||
156521030|NCT00552240|565001314|FG001|Overall Study|Other|0|||
156521031|NCT02679573|565001315|FG000|Overall Study|Adverse Event|13|||
156521032|NCT02679573|565001316|FG001|Overall Study|Adverse Event|6|||
156521033|NCT02679573|565001315|FG000|Overall Study|Lack of Efficacy|12|||
156521034|NCT02679573|565001316|FG001|Overall Study|Lack of Efficacy|15|||
156521035|NCT02679573|565001315|FG000|Overall Study|Could not complete required study visits|6|||
156521036|NCT02679573|565001316|FG001|Overall Study|Could not complete required study visits|2|||
156521037|NCT02679573|565001315|FG000|Overall Study|Withdrawal by Subject|2|||
156521038|NCT02679573|565001316|FG001|Overall Study|Withdrawal by Subject|9|||
156521039|NCT02679573|565001315|FG000|Overall Study|Death|2|||
156521040|NCT02679573|565001316|FG001|Overall Study|Death|0|||
156521041|NCT02679573|565001315|FG000|Overall Study|Physician Decision|2|||
156521042|NCT02679573|565001316|FG001|Overall Study|Physician Decision|4|||
156521043|NCT02679573|565001315|FG000|Overall Study|Lost to Follow-up|0|||
156521044|NCT02679573|565001316|FG001|Overall Study|Lost to Follow-up|3|||
156521045|NCT02128542|565001317|FG000|Overall Study|Lost to Follow-up|3|||
156521046|NCT02128542|565001318|FG001|Overall Study|Lost to Follow-up|0|||
156521047|NCT02128542|565001317|FG000|Overall Study|Withdrew Consent|1|||
156521048|NCT02128542|565001318|FG001|Overall Study|Withdrew Consent|0|||
156521049|NCT02483585|565001319|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
156521050|NCT02483585|565001320|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
156521051|NCT02483585|565001319|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
156521052|NCT02483585|565001320|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
156521053|NCT02483585|565001319|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
156521054|NCT02483585|565001320|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
156521055|NCT02483585|565001319|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
156521056|NCT02483585|565001320|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
156521057|NCT02483585|565001319|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
156521058|NCT02483585|565001320|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
156521059|NCT02483585|565001319|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
156521060|NCT02483585|565001320|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
156521061|NCT02483585|565001319|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
156521062|NCT02483585|565001320|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
156521063|NCT02054741|565001324|FG000|Overall Study|Protocol Violation|13|||
156521064|NCT02054741|565001325|FG001|Overall Study|Protocol Violation|2|||
156521065|NCT02054741|565001324|FG000|Overall Study|Withdrawal by Subject|10|||
156521066|NCT02054741|565001325|FG001|Overall Study|Withdrawal by Subject|5|||
156521067|NCT02054741|565001324|FG000|Overall Study|Death|94|||
156563350|NCT00348140|565150195|FG001|Overall Study|Adverse Event|49|||
156563351|NCT00348140|565150196|FG002|Overall Study|Adverse Event|78|||
156563352|NCT00348140|565150194|FG000|Overall Study|Lost to Follow-up|4|||
156563353|NCT00348140|565150195|FG001|Overall Study|Lost to Follow-up|4|||
156563354|NCT00348140|565150196|FG002|Overall Study|Lost to Follow-up|4|||
156563355|NCT00348140|565150194|FG000|Overall Study|Protocol Violation|12|||
156563356|NCT00348140|565150195|FG001|Overall Study|Protocol Violation|13|||
156563357|NCT00348140|565150196|FG002|Overall Study|Protocol Violation|14|||
156563358|NCT00348140|565150194|FG000|Overall Study|Withdrawal by Subject|32|||
156563359|NCT00348140|565150195|FG001|Overall Study|Withdrawal by Subject|40|||
156563360|NCT00348140|565150196|FG002|Overall Study|Withdrawal by Subject|40|||
156563361|NCT00348140|565150194|FG000|Overall Study|Non-compliance|8|||
156563362|NCT00348140|565150195|FG001|Overall Study|Non-compliance|13|||
156563363|NCT00348140|565150196|FG002|Overall Study|Non-compliance|5|||
156563364|NCT00348140|565150194|FG000|Overall Study|Participant at risk due to study drug|2|||
156563365|NCT00348140|565150195|FG001|Overall Study|Participant at risk due to study drug|0|||
156563366|NCT00348140|565150196|FG002|Overall Study|Participant at risk due to study drug|0|||
156563367|NCT00348140|565150194|FG000|Overall Study|Conditional medication increased dose|1|||
156563368|NCT00348140|565150195|FG001|Overall Study|Conditional medication increased dose|0|||
156563369|NCT00348140|565150196|FG002|Overall Study|Conditional medication increased dose|0|||
156563370|NCT00348140|565150194|FG000|Overall Study|Caregiver related|4|||
156563371|NCT00348140|565150195|FG001|Overall Study|Caregiver related|7|||
156563372|NCT00348140|565150196|FG002|Overall Study|Caregiver related|3|||
156563373|NCT00348140|565150194|FG000|Overall Study|Participant hospitalised|3|||
156563374|NCT00348140|565150195|FG001|Overall Study|Participant hospitalised|0|||
156563375|NCT00348140|565150196|FG002|Overall Study|Participant hospitalised|0|||
156563376|NCT00348140|565150194|FG000|Overall Study|Efficacy related|1|||
156563377|NCT00348140|565150195|FG001|Overall Study|Efficacy related|1|||
156563378|NCT00348140|565150196|FG002|Overall Study|Efficacy related|0|||
156563379|NCT00348140|565150194|FG000|Overall Study|Administration related|3|||
156563380|NCT00348140|565150195|FG001|Overall Study|Administration related|1|||
156563381|NCT00348140|565150196|FG002|Overall Study|Administration related|1|||
156563382|NCT00348140|565150194|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
156563383|NCT00348140|565150195|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
156563384|NCT00348140|565150196|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
156563385|NCT00348140|565150194|FG000|Overall Study|Participant unwell|1|||
156563386|NCT00348140|565150195|FG001|Overall Study|Participant unwell|0|||
156563387|NCT00348140|565150196|FG002|Overall Study|Participant unwell|0|||
156563388|NCT00348140|565150194|FG000|Overall Study|Screen failure|1|||
156563389|NCT00348140|565150195|FG001|Overall Study|Screen failure|0|||
156563390|NCT00348140|565150196|FG002|Overall Study|Screen failure|0|||
156563391|NCT00348140|565150194|FG000|Overall Study|Investigator decided to discontinue|4|||
156563392|NCT00348140|565150195|FG001|Overall Study|Investigator decided to discontinue|1|||
156563393|NCT00348140|565150196|FG002|Overall Study|Investigator decided to discontinue|4|||
156563394|NCT00348140|565150194|FG000|Overall Study|Decided to discontinue on their own|1|||
156563395|NCT00348140|565150195|FG001|Overall Study|Decided to discontinue on their own|4|||
156563396|NCT00348140|565150196|FG002|Overall Study|Decided to discontinue on their own|1|||
156563397|NCT00348140|565150194|FG000|Overall Study|Use of prohibited drug|1|||
156563398|NCT00348140|565150195|FG001|Overall Study|Use of prohibited drug|0|||
156563399|NCT00348140|565150196|FG002|Overall Study|Use of prohibited drug|2|||
156563400|NCT00348140|565150194|FG000|Overall Study|Disease progression|1|||
156563401|NCT00348140|565150195|FG001|Overall Study|Disease progression|2|||
156563402|NCT00348140|565150196|FG002|Overall Study|Disease progression|5|||
156563403|NCT00348140|565150194|FG000|Overall Study|Increased risk of cardiac infarction|0|||
156563404|NCT00348140|565150195|FG001|Overall Study|Increased risk of cardiac infarction|1|||
156563405|NCT00348140|565150196|FG002|Overall Study|Increased risk of cardiac infarction|0|||
156563406|NCT00348140|565150194|FG000|Overall Study|Serious adverse event|0|||
156563407|NCT00348140|565150195|FG001|Overall Study|Serious adverse event|1|||
156563408|NCT00348140|565150196|FG002|Overall Study|Serious adverse event|0|||
156563409|NCT00348140|565150194|FG000|Overall Study|Abnormal ECG|0|||
156563410|NCT00348140|565150195|FG001|Overall Study|Abnormal ECG|1|||
156563411|NCT00348140|565150196|FG002|Overall Study|Abnormal ECG|3|||
156563412|NCT00348140|565150194|FG000|Overall Study|Participant died|0|||
156563413|NCT00348140|565150195|FG001|Overall Study|Participant died|1|||
156563414|NCT00348140|565150196|FG002|Overall Study|Participant died|0|||
156563415|NCT00348140|565150194|FG000|Overall Study|Exclusion criteria met|0|||
156563416|NCT00348140|565150195|FG001|Overall Study|Exclusion criteria met|0|||
156563417|NCT00348140|565150196|FG002|Overall Study|Exclusion criteria met|1|||
156563418|NCT00348140|565150194|FG000|Overall Study|Memory declined|0|||
156563419|NCT00348140|565150195|FG001|Overall Study|Memory declined|0|||
156563420|NCT00348140|565150196|FG002|Overall Study|Memory declined|1|||
156563421|NCT01662648|565150199|FG000|Overall Study|Death|1|||
156563422|NCT01662648|565150200|FG001|Overall Study|Death|3|||
156563423|NCT01662648|565150199|FG000|Overall Study|Adverse Event|40|||
156563424|NCT01662648|565150200|FG001|Overall Study|Adverse Event|37|||
156563425|NCT01662648|565150199|FG000|Overall Study|Lack of Efficacy|17|||
156563426|NCT01662648|565150200|FG001|Overall Study|Lack of Efficacy|16|||
156563427|NCT01662648|565150199|FG000|Overall Study|Participant ineligible to continue trial|1|||
156563428|NCT01662648|565150200|FG001|Overall Study|Participant ineligible to continue trial|1|||
156563429|NCT01662648|565150199|FG000|Overall Study|Lost to Follow-up|24|||
156563430|NCT01662648|565150200|FG001|Overall Study|Lost to Follow-up|36|||
156563431|NCT01662648|565150199|FG000|Overall Study|Withdrawal by Subject|36|||
156563432|NCT01662648|565150200|FG001|Overall Study|Withdrawal by Subject|53|||
156563433|NCT01662648|565150199|FG000|Overall Study|Participant non-compliant|16|||
156563434|NCT01662648|565150200|FG001|Overall Study|Participant non-compliant|20|||
156563435|NCT01662648|565150199|FG000|Overall Study|Other|8|||
156563436|NCT01662648|565150200|FG001|Overall Study|Other|11|||
156563437|NCT01662648|565150199|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
156563438|NCT01662648|565150200|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
156563439|NCT01662648|565150199|FG000|Overall Study|LOE and other reason unspecified|1|||
156563440|NCT01662648|565150200|FG001|Overall Study|LOE and other reason unspecified|0|||
156563441|NCT01662648|565150199|FG000|Overall Study|LOE and Participant non-compliant|0|||
156563442|NCT01662648|565150200|FG001|Overall Study|LOE and Participant non-compliant|1|||
156563443|NCT00868790|565150203|FG000|Period 1|Adverse Event|1|||
156563444|NCT00868790|565150204|FG001|Period 1|Adverse Event|0|||
156563445|NCT00868790|565150205|FG002|Period 1|Adverse Event|0|||
156563446|NCT00868790|565150206|FG003|Period 1|Adverse Event|0|||
156563447|NCT00868790|565150207|FG004|Period 1|Adverse Event|0|||
156563448|NCT00868790|565150208|FG005|Period 1|Adverse Event|0|||
156563449|NCT00868790|565150209|FG006|Period 1|Adverse Event|0|||
156563450|NCT00868790|565150210|FG007|Period 1|Adverse Event|3|||
156563451|NCT00868790|565150211|FG008|Period 1|Adverse Event|1|||
156563452|NCT00868790|565150212|FG009|Period 1|Adverse Event|0|||
156563453|NCT00868790|565150213|FG010|Period 1|Adverse Event|0|||
156563454|NCT00868790|565150214|FG011|Period 1|Adverse Event|0|||
156563455|NCT00868790|565150215|FG012|Period 1|Adverse Event|0|||
156563456|NCT00868790|565150216|FG013|Period 1|Adverse Event|1|||
156563457|NCT00868790|565150203|FG000|Period 1|Protocol Violation|1|||
156563458|NCT00868790|565150204|FG001|Period 1|Protocol Violation|0|||
156563459|NCT00868790|565150205|FG002|Period 1|Protocol Violation|0|||
156563460|NCT00868790|565150206|FG003|Period 1|Protocol Violation|0|||
156563461|NCT00868790|565150207|FG004|Period 1|Protocol Violation|0|||
156563462|NCT00868790|565150208|FG005|Period 1|Protocol Violation|0|||
156563463|NCT00868790|565150209|FG006|Period 1|Protocol Violation|0|||
156563464|NCT00868790|565150210|FG007|Period 1|Protocol Violation|0|||
156563465|NCT00868790|565150211|FG008|Period 1|Protocol Violation|0|||
156563466|NCT00868790|565150212|FG009|Period 1|Protocol Violation|0|||
156563467|NCT00868790|565150213|FG010|Period 1|Protocol Violation|0|||
156521068|NCT02054741|565001325|FG001|Overall Study|Death|90|||
156521069|NCT02054741|565001324|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
156521070|NCT02054741|565001325|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
156521071|NCT01502631|565001326|FG000|Overall Study|Adverse Event|5|||
156521072|NCT01502631|565001327|FG001|Overall Study|Adverse Event|8|||
156521073|NCT01502631|565001326|FG000|Overall Study|Lost to Follow-up|2|||
156521074|NCT01502631|565001327|FG001|Overall Study|Lost to Follow-up|2|||
156521075|NCT01502631|565001326|FG000|Overall Study|Participant withdrew consent|2|||
156521076|NCT01502631|565001327|FG001|Overall Study|Participant withdrew consent|4|||
156521077|NCT01502631|565001326|FG000|Overall Study|Participant non-compliant|1|||
156521078|NCT01502631|565001327|FG001|Overall Study|Participant non-compliant|0|||
156521079|NCT01502631|565001326|FG000|Overall Study|Investigator's decision|0|||
156521080|NCT01502631|565001327|FG001|Overall Study|Investigator's decision|1|||
156521081|NCT01502631|565001326|FG000|Overall Study|Other|10|||
156521082|NCT01502631|565001327|FG001|Overall Study|Other|5|||
156521083|NCT01488487|565001330|FG000|Overall Study|Adverse Event|6|||
156521084|NCT01488487|565001330|FG000|Overall Study|Death|1|||
156521085|NCT01488487|565001330|FG000|Overall Study|Withdrawal by Subject|2|||
156521086|NCT00395460|565001331|FG000|Overall Study|Withdrawal by Subject|1|||
156521087|NCT00395460|565001332|FG001|Overall Study|Withdrawal by Subject|0|||
156521088|NCT02319525|565001338|FG000|Overall Study|Withdrawal by Subject|2|||
156521089|NCT02319525|565001339|FG001|Overall Study|Withdrawal by Subject|1|||
156521090|NCT04223830|565001343|FG000|Overall Study|Lost to Follow-up|9|||
156521091|NCT04223830|565001343|FG000|Overall Study|Adverse Event|1|||
156563468|NCT00868790|565150214|FG011|Period 1|Protocol Violation|0|||
156563469|NCT00868790|565150215|FG012|Period 1|Protocol Violation|0|||
156563470|NCT00868790|565150216|FG013|Period 1|Protocol Violation|0|||
156563471|NCT00868790|565150203|FG000|Period 1|Withdrawal by Subject|0|||
156563472|NCT00868790|565150204|FG001|Period 1|Withdrawal by Subject|1|||
156563473|NCT00868790|565150205|FG002|Period 1|Withdrawal by Subject|0|||
156563474|NCT00868790|565150206|FG003|Period 1|Withdrawal by Subject|0|||
156563475|NCT00868790|565150207|FG004|Period 1|Withdrawal by Subject|0|||
156563476|NCT00868790|565150208|FG005|Period 1|Withdrawal by Subject|0|||
156563477|NCT00868790|565150209|FG006|Period 1|Withdrawal by Subject|0|||
156563478|NCT00868790|565150210|FG007|Period 1|Withdrawal by Subject|0|||
156563479|NCT00868790|565150211|FG008|Period 1|Withdrawal by Subject|0|||
156521092|NCT01806623|565001344|FG000|Overall Study|Withdrawal by Subject|1|||
156521093|NCT01806623|565001344|FG000|Overall Study|Adverse Event|1|||
156521094|NCT01806623|565001344|FG000|Overall Study|Did not meet the inclusion criteria|56|||
156521095|NCT01737827|565001345|FG000|Overall Study|Adverse Event|3|||
156521096|NCT01737827|565001346|FG001|Overall Study|Adverse Event|6|||
156521097|NCT01737827|565001347|FG002|Overall Study|Adverse Event|0|||
156521098|NCT01737827|565001345|FG000|Overall Study|Lost to Follow-up|0|||
156521099|NCT01737827|565001346|FG001|Overall Study|Lost to Follow-up|1|||
156521100|NCT01737827|565001347|FG002|Overall Study|Lost to Follow-up|0|||
156521101|NCT01737827|565001345|FG000|Overall Study|Physician Decision|0|||
156521102|NCT01737827|565001346|FG001|Overall Study|Physician Decision|2|||
156521103|NCT01737827|565001347|FG002|Overall Study|Physician Decision|0|||
156521104|NCT01737827|565001345|FG000|Overall Study|Progressive Disease|5|||
156521105|NCT01737827|565001346|FG001|Overall Study|Progressive Disease|16|||
156521106|NCT01737827|565001347|FG002|Overall Study|Progressive Disease|2|||
156521107|NCT01737827|565001345|FG000|Overall Study|Study Terminated by Sponsor|0|||
156521108|NCT01737827|565001346|FG001|Overall Study|Study Terminated by Sponsor|1|||
156521109|NCT01737827|565001347|FG002|Overall Study|Study Terminated by Sponsor|0|||
156521110|NCT01737827|565001345|FG000|Overall Study|Subject/Guardian Decision|0|||
156521111|NCT01737827|565001346|FG001|Overall Study|Subject/Guardian Decision|2|||
156521112|NCT01737827|565001347|FG002|Overall Study|Subject/Guardian Decision|0|||
156521113|NCT01451827|565001348|FG000|Overall Study|Adverse Event|2|||
156521114|NCT01451827|565001349|FG001|Overall Study|Adverse Event|0|||
156521115|NCT01451827|565001350|FG002|Overall Study|Adverse Event|1|||
156521116|NCT01451827|565001351|FG003|Overall Study|Adverse Event|1|||
156521117|NCT01451827|565001348|FG000|Overall Study|Protocol deviation|1|||
156521118|NCT01451827|565001349|FG001|Overall Study|Protocol deviation|0|||
156521119|NCT01451827|565001350|FG002|Overall Study|Protocol deviation|0|||
156521120|NCT01451827|565001351|FG003|Overall Study|Protocol deviation|0|||
156521121|NCT01451827|565001348|FG000|Overall Study|Lost to Follow-up|0|||
156521122|NCT01451827|565001349|FG001|Overall Study|Lost to Follow-up|3|||
156521123|NCT01451827|565001350|FG002|Overall Study|Lost to Follow-up|0|||
156521124|NCT01451827|565001351|FG003|Overall Study|Lost to Follow-up|2|||
156521125|NCT01451827|565001348|FG000|Overall Study|Participant met withdrawal criteria|0|||
156521126|NCT01451827|565001349|FG001|Overall Study|Participant met withdrawal criteria|2|||
156521127|NCT01451827|565001350|FG002|Overall Study|Participant met withdrawal criteria|0|||
156521128|NCT01451827|565001351|FG003|Overall Study|Participant met withdrawal criteria|0|||
156521129|NCT01451827|565001348|FG000|Overall Study|Withdrawal by Subject|0|||
156521130|NCT01451827|565001349|FG001|Overall Study|Withdrawal by Subject|0|||
156521131|NCT01451827|565001350|FG002|Overall Study|Withdrawal by Subject|1|||
156521132|NCT01451827|565001351|FG003|Overall Study|Withdrawal by Subject|1|||
156521133|NCT01964924|565001352|FG000|Trametinib Monotherapy|Progression|19|||
156521134|NCT01964924|565001353|FG001|Trametinib Monotherapy|Progression|0|||
156521135|NCT01528345|565001354|FG000|Overall Study|Adverse Event|10|||
156521136|NCT01528345|565001355|FG001|Overall Study|Adverse Event|1|||
156521137|NCT01528345|565001354|FG000|Overall Study|Death|1|||
156521138|NCT01528345|565001355|FG001|Overall Study|Death|1|||
156521139|NCT01528345|565001354|FG000|Overall Study|Non-compliance with study treatment|1|||
156521140|NCT01528345|565001355|FG001|Overall Study|Non-compliance with study treatment|0|||
156521141|NCT01528345|565001354|FG000|Overall Study|Progressive Disease|26|||
156521142|NCT01528345|565001355|FG001|Overall Study|Progressive Disease|40|||
156521143|NCT01528345|565001354|FG000|Overall Study|Study Terminated by Sponsor|4|||
156521144|NCT01528345|565001355|FG001|Overall Study|Study Terminated by Sponsor|8|||
156521145|NCT01528345|565001354|FG000|Overall Study|Subject/Guardian Decision|5|||
156521146|NCT01528345|565001355|FG001|Overall Study|Subject/Guardian Decision|0|||
156521147|NCT01034163|565001356|FG000|Overall Study|Treatment completed as per protocol|8|||
156521148|NCT01034163|565001357|FG001|Overall Study|Treatment completed as per protocol|7|||
156521149|NCT01034163|565001356|FG000|Overall Study|Withdrawal by Subject|8|||
156521150|NCT01034163|565001357|FG001|Overall Study|Withdrawal by Subject|2|||
156521151|NCT01034163|565001356|FG000|Overall Study|Protocol deviation|1|||
156521152|NCT01034163|565001357|FG001|Overall Study|Protocol deviation|0|||
156521153|NCT01034163|565001356|FG000|Overall Study|Disease progression|3|||
156521154|NCT01034163|565001357|FG001|Overall Study|Disease progression|4|||
156521155|NCT01034163|565001356|FG000|Overall Study|Adverse Event|6|||
156521156|NCT01034163|565001357|FG001|Overall Study|Adverse Event|0|||
156521157|NCT01034163|565001356|FG000|Overall Study|Administrative problems|0|||
156521158|NCT01034163|565001357|FG001|Overall Study|Administrative problems|1|||
156521159|NCT01034163|565001356|FG000|Overall Study|Abnormal laboratory value|1|||
156521160|NCT01034163|565001357|FG001|Overall Study|Abnormal laboratory value|0|||
156521161|NCT02424734|565001358|FG000|Overall Study|Treatment stopped to be discharged home|2|||
156521162|NCT02424734|565001359|FG001|Overall Study|Treatment stopped to be discharged home|2|||
156521163|NCT02424734|565001360|FG002|Overall Study|Treatment stopped to be discharged home|0|||
156521164|NCT01445301|565001361|FG000|Overall Study|Adverse Event|15|||
156521165|NCT01445301|565001362|FG001|Overall Study|Adverse Event|25|||
156521166|NCT01445301|565001363|FG002|Overall Study|Adverse Event|4|||
156521167|NCT01445301|565001361|FG000|Overall Study|Lack of Efficacy|0|||
156521168|NCT01445301|565001362|FG001|Overall Study|Lack of Efficacy|1|||
156521169|NCT01445301|565001363|FG002|Overall Study|Lack of Efficacy|0|||
156521170|NCT01445301|565001361|FG000|Overall Study|Protocol Violation|1|||
156521171|NCT01445301|565001362|FG001|Overall Study|Protocol Violation|0|||
156521172|NCT01445301|565001363|FG002|Overall Study|Protocol Violation|0|||
156521173|NCT01445301|565001361|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
156521174|NCT01445301|565001362|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
156521175|NCT01445301|565001363|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
156521176|NCT01445301|565001361|FG000|Overall Study|Physician Decision|0|||
156521177|NCT01445301|565001362|FG001|Overall Study|Physician Decision|2|||
156521178|NCT01445301|565001363|FG002|Overall Study|Physician Decision|0|||
156521179|NCT01445301|565001361|FG000|Overall Study|Withdrawal by Subject|5|||
156521180|NCT01445301|565001362|FG001|Overall Study|Withdrawal by Subject|6|||
156521181|NCT01445301|565001363|FG002|Overall Study|Withdrawal by Subject|4|||
156521182|NCT00752557|565001364|FG000|Overall Study|Withdrawal by Subject|4|||
156521183|NCT00752557|565001365|FG001|Overall Study|Withdrawal by Subject|3|||
156521184|NCT00752557|565001366|FG002|Overall Study|Withdrawal by Subject|3|||
156521185|NCT00752557|565001364|FG000|Overall Study|Unspecified resaons|0|||
156521186|NCT00752557|565001365|FG001|Overall Study|Unspecified resaons|2|||
156521187|NCT00752557|565001366|FG002|Overall Study|Unspecified resaons|2|||
156521188|NCT00752557|565001364|FG000|Overall Study|Lost to Follow-up|1|||
156521189|NCT00752557|565001365|FG001|Overall Study|Lost to Follow-up|0|||
156521190|NCT00752557|565001366|FG002|Overall Study|Lost to Follow-up|1|||
156521191|NCT02150343|565001371|FG000|Overall Study|Adverse Event|2|||
156521192|NCT02150343|565001372|FG001|Overall Study|Adverse Event|0|||
156521193|NCT02150343|565001373|FG002|Overall Study|Adverse Event|1|||
156521194|NCT02150343|565001374|FG003|Overall Study|Adverse Event|1|||
156521195|NCT02150343|565001371|FG000|Overall Study|Withdrawal by Subject|13|||
156521196|NCT02150343|565001372|FG001|Overall Study|Withdrawal by Subject|10|||
156521197|NCT02150343|565001373|FG002|Overall Study|Withdrawal by Subject|9|||
156521198|NCT02150343|565001374|FG003|Overall Study|Withdrawal by Subject|4|||
156521199|NCT02150343|565001371|FG000|Overall Study|Lost to Follow-up|4|||
156521200|NCT02150343|565001372|FG001|Overall Study|Lost to Follow-up|4|||
156521201|NCT02150343|565001373|FG002|Overall Study|Lost to Follow-up|2|||
156521202|NCT02150343|565001374|FG003|Overall Study|Lost to Follow-up|3|||
156521203|NCT02150343|565001371|FG000|Overall Study|Other|2|||
156521204|NCT02150343|565001372|FG001|Overall Study|Other|6|||
156521205|NCT02150343|565001373|FG002|Overall Study|Other|0|||
156521206|NCT02150343|565001374|FG003|Overall Study|Other|2|||
156521207|NCT00190749|565001375|FG000|Overall Study|Lost to Follow-up|8|||
156521208|NCT00190749|565001376|FG001|Overall Study|Lost to Follow-up|11|||
156521209|NCT00190749|565001375|FG000|Overall Study|Withdrawal by Subject|10|||
156521210|NCT00190749|565001376|FG001|Overall Study|Withdrawal by Subject|6|||
156521211|NCT00190749|565001375|FG000|Overall Study|Protocol Violation|5|||
156521212|NCT00190749|565001376|FG001|Overall Study|Protocol Violation|4|||
156521213|NCT00190749|565001375|FG000|Overall Study|Adverse Event|0|||
156521214|NCT00190749|565001376|FG001|Overall Study|Adverse Event|5|||
156521215|NCT00190749|565001375|FG000|Overall Study|Lack of Efficacy|2|||
156521216|NCT00190749|565001376|FG001|Overall Study|Lack of Efficacy|3|||
156521217|NCT00190749|565001375|FG000|Overall Study|Reason Not Specified|0|||
156521218|NCT00190749|565001376|FG001|Overall Study|Reason Not Specified|2|||
156521219|NCT00190749|565001375|FG000|Overall Study|Sponsor Decision|1|||
156521220|NCT00190749|565001376|FG001|Overall Study|Sponsor Decision|0|||
156521221|NCT02729753|565001377|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
156521222|NCT02729753|565001378|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
156521223|NCT01090427|565001379|FG000|After Controlled Period|Death|0|||
156521224|NCT01090427|565001380|FG001|After Controlled Period|Death|0|||
156521225|NCT01090427|565001381|FG002|After Controlled Period|Death|0|||
156521226|NCT01090427|565001382|FG003|After Controlled Period|Death|0|||
156521227|NCT01090427|565001383|FG004|After Controlled Period|Death|0|||
156521228|NCT01090427|565001384|FG005|After Controlled Period|Death|1|||
156521229|NCT01090427|565001385|FG006|After Controlled Period|Death|0|||
156521230|NCT01090427|565001379|FG000|After Controlled Period|Lack of Efficacy|0|||
156521231|NCT01090427|565001380|FG001|After Controlled Period|Lack of Efficacy|0|||
156521232|NCT01090427|565001381|FG002|After Controlled Period|Lack of Efficacy|0|||
156521233|NCT01090427|565001382|FG003|After Controlled Period|Lack of Efficacy|0|||
156521234|NCT01090427|565001383|FG004|After Controlled Period|Lack of Efficacy|0|||
156521235|NCT01090427|565001384|FG005|After Controlled Period|Lack of Efficacy|3|||
156521236|NCT01090427|565001385|FG006|After Controlled Period|Lack of Efficacy|2|||
156521237|NCT01090427|565001379|FG000|After Controlled Period|Adverse Event|0|||
156521238|NCT01090427|565001380|FG001|After Controlled Period|Adverse Event|0|||
156521239|NCT01090427|565001381|FG002|After Controlled Period|Adverse Event|0|||
156521240|NCT01090427|565001382|FG003|After Controlled Period|Adverse Event|2|||
156521241|NCT01090427|565001383|FG004|After Controlled Period|Adverse Event|0|||
156521242|NCT01090427|565001384|FG005|After Controlled Period|Adverse Event|1|||
156521243|NCT01090427|565001385|FG006|After Controlled Period|Adverse Event|0|||
156521244|NCT00928018|565001393|FG000|Overall Study|Withdrawal by Subject|1|||
156521245|NCT00928018|565001394|FG001|Overall Study|Withdrawal by Subject|0|||
156521246|NCT02008877|565001395|FG000|Overall Study|Inevaluable|0|||
156563480|NCT00868790|565150212|FG009|Period 1|Withdrawal by Subject|0|||
156563481|NCT00868790|565150213|FG010|Period 1|Withdrawal by Subject|0|||
156563482|NCT00868790|565150214|FG011|Period 1|Withdrawal by Subject|0|||
156563483|NCT00868790|565150215|FG012|Period 1|Withdrawal by Subject|0|||
156563484|NCT00868790|565150216|FG013|Period 1|Withdrawal by Subject|1|||
156563485|NCT00868790|565150203|FG000|Period 1|Abnormal Triglycerides|0|||
156563486|NCT00868790|565150204|FG001|Period 1|Abnormal Triglycerides|0|||
156563487|NCT00868790|565150205|FG002|Period 1|Abnormal Triglycerides|0|||
156563488|NCT00868790|565150206|FG003|Period 1|Abnormal Triglycerides|0|||
156563489|NCT00868790|565150207|FG004|Period 1|Abnormal Triglycerides|1|||
156563490|NCT00868790|565150208|FG005|Period 1|Abnormal Triglycerides|0|||
156563491|NCT00868790|565150209|FG006|Period 1|Abnormal Triglycerides|0|||
156563492|NCT00868790|565150210|FG007|Period 1|Abnormal Triglycerides|0|||
156563493|NCT00868790|565150211|FG008|Period 1|Abnormal Triglycerides|0|||
156563494|NCT00868790|565150212|FG009|Period 1|Abnormal Triglycerides|0|||
156563495|NCT00868790|565150213|FG010|Period 1|Abnormal Triglycerides|0|||
156563496|NCT00868790|565150214|FG011|Period 1|Abnormal Triglycerides|0|||
156563497|NCT00868790|565150215|FG012|Period 1|Abnormal Triglycerides|0|||
156563498|NCT00868790|565150216|FG013|Period 1|Abnormal Triglycerides|0|||
156563499|NCT00868790|565150203|FG000|Period 1|Lost to Follow-up|0|||
156563500|NCT00868790|565150204|FG001|Period 1|Lost to Follow-up|0|||
156563501|NCT00868790|565150205|FG002|Period 1|Lost to Follow-up|0|||
156563502|NCT00868790|565150206|FG003|Period 1|Lost to Follow-up|0|||
156563503|NCT00868790|565150207|FG004|Period 1|Lost to Follow-up|0|||
156563504|NCT00868790|565150208|FG005|Period 1|Lost to Follow-up|1|||
156563505|NCT00868790|565150209|FG006|Period 1|Lost to Follow-up|0|||
156563506|NCT00868790|565150210|FG007|Period 1|Lost to Follow-up|0|||
156563507|NCT00868790|565150211|FG008|Period 1|Lost to Follow-up|0|||
156563508|NCT00868790|565150212|FG009|Period 1|Lost to Follow-up|0|||
156563509|NCT00868790|565150213|FG010|Period 1|Lost to Follow-up|0|||
156563510|NCT00868790|565150214|FG011|Period 1|Lost to Follow-up|0|||
156521247|NCT02008877|565001396|FG001|Overall Study|Inevaluable|1|||
156521248|NCT02008877|565001397|FG002|Overall Study|Inevaluable|0|||
156521249|NCT04227704|565001400|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
156521250|NCT04227704|565001401|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
156521251|NCT04227704|565001402|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
156521252|NCT04227704|565001400|FG000|Overall Study|due to C/S being cancelled|1|||
156521253|NCT04227704|565001401|FG001|Overall Study|due to C/S being cancelled|0|||
156521254|NCT04227704|565001402|FG002|Overall Study|due to C/S being cancelled|0|||
156521255|NCT02317432|565001403|FG000|Overall Study|Death|4|||
156521256|NCT02317432|565001404|FG001|Overall Study|Death|1|||
156521257|NCT02317432|565001403|FG000|Overall Study|Lost to Follow-up|0|||
156521258|NCT02317432|565001404|FG001|Overall Study|Lost to Follow-up|5|||
156521259|NCT02317432|565001403|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
156521260|NCT02317432|565001404|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
156563511|NCT00868790|565150215|FG012|Period 1|Lost to Follow-up|0|||
156563512|NCT00868790|565150216|FG013|Period 1|Lost to Follow-up|0|||
156563513|NCT00868790|565150203|FG000|Period 2|Adverse Event|0|||
156563514|NCT00868790|565150204|FG001|Period 2|Adverse Event|0|||
156563515|NCT00868790|565150205|FG002|Period 2|Adverse Event|0|||
156563516|NCT00868790|565150206|FG003|Period 2|Adverse Event|0|||
156563517|NCT00868790|565150207|FG004|Period 2|Adverse Event|0|||
156563518|NCT00868790|565150208|FG005|Period 2|Adverse Event|0|||
156563519|NCT00868790|565150209|FG006|Period 2|Adverse Event|0|||
156563520|NCT00868790|565150210|FG007|Period 2|Adverse Event|0|||
156563521|NCT00868790|565150211|FG008|Period 2|Adverse Event|1|||
156563522|NCT00868790|565150212|FG009|Period 2|Adverse Event|0|||
156563523|NCT00868790|565150213|FG010|Period 2|Adverse Event|0|||
156563524|NCT00868790|565150214|FG011|Period 2|Adverse Event|0|||
156563525|NCT00868790|565150215|FG012|Period 2|Adverse Event|0|||
156563526|NCT00868790|565150216|FG013|Period 2|Adverse Event|0|||
156563527|NCT00868790|565150203|FG000|Period 2|Lost to Follow-up|0|||
156563528|NCT00868790|565150204|FG001|Period 2|Lost to Follow-up|1|||
156563529|NCT00868790|565150205|FG002|Period 2|Lost to Follow-up|0|||
156563530|NCT00868790|565150206|FG003|Period 2|Lost to Follow-up|0|||
156563531|NCT00868790|565150207|FG004|Period 2|Lost to Follow-up|0|||
156563532|NCT00868790|565150208|FG005|Period 2|Lost to Follow-up|1|||
156563533|NCT00868790|565150209|FG006|Period 2|Lost to Follow-up|0|||
156563534|NCT00868790|565150210|FG007|Period 2|Lost to Follow-up|0|||
156563535|NCT00868790|565150211|FG008|Period 2|Lost to Follow-up|0|||
156563536|NCT00868790|565150212|FG009|Period 2|Lost to Follow-up|0|||
156563537|NCT00868790|565150213|FG010|Period 2|Lost to Follow-up|0|||
156563538|NCT00868790|565150214|FG011|Period 2|Lost to Follow-up|0|||
156563539|NCT00868790|565150215|FG012|Period 2|Lost to Follow-up|0|||
156563540|NCT00868790|565150216|FG013|Period 2|Lost to Follow-up|0|||
156563541|NCT00868790|565150203|FG000|Period 2|Withdrawal by Subject|0|||
156563542|NCT00868790|565150204|FG001|Period 2|Withdrawal by Subject|0|||
156563543|NCT00868790|565150205|FG002|Period 2|Withdrawal by Subject|0|||
156563544|NCT00868790|565150206|FG003|Period 2|Withdrawal by Subject|0|||
156563545|NCT00868790|565150207|FG004|Period 2|Withdrawal by Subject|0|||
156563546|NCT00868790|565150208|FG005|Period 2|Withdrawal by Subject|0|||
156563547|NCT00868790|565150209|FG006|Period 2|Withdrawal by Subject|0|||
156563548|NCT00868790|565150210|FG007|Period 2|Withdrawal by Subject|0|||
156563549|NCT00868790|565150211|FG008|Period 2|Withdrawal by Subject|1|||
156563550|NCT00868790|565150212|FG009|Period 2|Withdrawal by Subject|0|||
156563551|NCT00868790|565150213|FG010|Period 2|Withdrawal by Subject|0|||
156563552|NCT00868790|565150214|FG011|Period 2|Withdrawal by Subject|0|||
156563553|NCT00868790|565150215|FG012|Period 2|Withdrawal by Subject|0|||
156563554|NCT00868790|565150216|FG013|Period 2|Withdrawal by Subject|1|||
156563555|NCT00868790|565150203|FG000|Period 3|Adverse Event|0|||
156563556|NCT00868790|565150204|FG001|Period 3|Adverse Event|0|||
156563557|NCT00868790|565150205|FG002|Period 3|Adverse Event|0|||
156563558|NCT00868790|565150206|FG003|Period 3|Adverse Event|0|||
156563559|NCT00868790|565150207|FG004|Period 3|Adverse Event|0|||
156563560|NCT00868790|565150208|FG005|Period 3|Adverse Event|0|||
156563561|NCT00868790|565150209|FG006|Period 3|Adverse Event|0|||
156563562|NCT00868790|565150210|FG007|Period 3|Adverse Event|0|||
156563563|NCT00868790|565150211|FG008|Period 3|Adverse Event|0|||
156563564|NCT00868790|565150212|FG009|Period 3|Adverse Event|1|||
156563565|NCT00868790|565150213|FG010|Period 3|Adverse Event|0|||
156563566|NCT00868790|565150214|FG011|Period 3|Adverse Event|0|||
156563567|NCT00868790|565150215|FG012|Period 3|Adverse Event|0|||
156563568|NCT00868790|565150216|FG013|Period 3|Adverse Event|0|||
156563569|NCT00868790|565150203|FG000|Period 3|Protocol Violation|0|||
156563570|NCT00868790|565150204|FG001|Period 3|Protocol Violation|0|||
156563571|NCT00868790|565150205|FG002|Period 3|Protocol Violation|0|||
156563572|NCT00868790|565150206|FG003|Period 3|Protocol Violation|0|||
156563573|NCT00868790|565150207|FG004|Period 3|Protocol Violation|0|||
156563574|NCT00868790|565150208|FG005|Period 3|Protocol Violation|0|||
156563575|NCT00868790|565150209|FG006|Period 3|Protocol Violation|0|||
156563576|NCT00868790|565150210|FG007|Period 3|Protocol Violation|0|||
156563577|NCT00868790|565150211|FG008|Period 3|Protocol Violation|0|||
156563578|NCT00868790|565150212|FG009|Period 3|Protocol Violation|0|||
156563579|NCT00868790|565150213|FG010|Period 3|Protocol Violation|1|||
156563580|NCT00868790|565150214|FG011|Period 3|Protocol Violation|0|||
156563581|NCT00868790|565150215|FG012|Period 3|Protocol Violation|0|||
156563582|NCT00868790|565150216|FG013|Period 3|Protocol Violation|0|||
156563583|NCT00868790|565150203|FG000|Period 3|Study Terminated by Sponsor|0|||
156563584|NCT00868790|565150204|FG001|Period 3|Study Terminated by Sponsor|0|||
156563585|NCT00868790|565150205|FG002|Period 3|Study Terminated by Sponsor|0|||
156563586|NCT00868790|565150206|FG003|Period 3|Study Terminated by Sponsor|1|||
156563587|NCT00868790|565150207|FG004|Period 3|Study Terminated by Sponsor|0|||
156563588|NCT00868790|565150208|FG005|Period 3|Study Terminated by Sponsor|0|||
156563589|NCT00868790|565150209|FG006|Period 3|Study Terminated by Sponsor|0|||
156563590|NCT00868790|565150210|FG007|Period 3|Study Terminated by Sponsor|0|||
156563591|NCT00868790|565150211|FG008|Period 3|Study Terminated by Sponsor|0|||
156563592|NCT00868790|565150212|FG009|Period 3|Study Terminated by Sponsor|0|||
156563593|NCT00868790|565150213|FG010|Period 3|Study Terminated by Sponsor|0|||
156563594|NCT00868790|565150214|FG011|Period 3|Study Terminated by Sponsor|0|||
156563595|NCT00868790|565150215|FG012|Period 3|Study Terminated by Sponsor|0|||
156563596|NCT00868790|565150216|FG013|Period 3|Study Terminated by Sponsor|0|||
156563597|NCT00868790|565150203|FG000|Period 4|Adverse Event|0|||
156563598|NCT00868790|565150204|FG001|Period 4|Adverse Event|0|||
156563599|NCT00868790|565150205|FG002|Period 4|Adverse Event|0|||
156563600|NCT00868790|565150206|FG003|Period 4|Adverse Event|0|||
156563601|NCT00868790|565150207|FG004|Period 4|Adverse Event|0|||
156563602|NCT00868790|565150208|FG005|Period 4|Adverse Event|0|||
156563603|NCT00868790|565150209|FG006|Period 4|Adverse Event|0|||
156563604|NCT00868790|565150210|FG007|Period 4|Adverse Event|1|||
156563605|NCT00868790|565150211|FG008|Period 4|Adverse Event|0|||
156563606|NCT00868790|565150212|FG009|Period 4|Adverse Event|0|||
156563607|NCT00868790|565150213|FG010|Period 4|Adverse Event|1|||
156563608|NCT00868790|565150214|FG011|Period 4|Adverse Event|0|||
156563609|NCT00868790|565150215|FG012|Period 4|Adverse Event|1|||
156563610|NCT00868790|565150216|FG013|Period 4|Adverse Event|0|||
156563611|NCT00868790|565150203|FG000|Period 4|Lost to Follow-up|0|||
156563612|NCT00868790|565150204|FG001|Period 4|Lost to Follow-up|0|||
156563613|NCT00868790|565150205|FG002|Period 4|Lost to Follow-up|0|||
156563614|NCT00868790|565150206|FG003|Period 4|Lost to Follow-up|0|||
156563615|NCT00868790|565150207|FG004|Period 4|Lost to Follow-up|0|||
156563616|NCT00868790|565150208|FG005|Period 4|Lost to Follow-up|0|||
156563617|NCT00868790|565150209|FG006|Period 4|Lost to Follow-up|0|||
156563618|NCT00868790|565150210|FG007|Period 4|Lost to Follow-up|1|||
156563619|NCT00868790|565150211|FG008|Period 4|Lost to Follow-up|0|||
156563620|NCT00868790|565150212|FG009|Period 4|Lost to Follow-up|0|||
156563621|NCT00868790|565150213|FG010|Period 4|Lost to Follow-up|0|||
156563622|NCT00868790|565150214|FG011|Period 4|Lost to Follow-up|0|||
156563623|NCT00868790|565150215|FG012|Period 4|Lost to Follow-up|0|||
156563624|NCT00868790|565150216|FG013|Period 4|Lost to Follow-up|0|||
156563625|NCT00868790|565150203|FG000|Period 4|Study Terminated by Sponsor|2|||
156563626|NCT00868790|565150204|FG001|Period 4|Study Terminated by Sponsor|0|||
156563627|NCT00868790|565150205|FG002|Period 4|Study Terminated by Sponsor|0|||
156563628|NCT00868790|565150206|FG003|Period 4|Study Terminated by Sponsor|0|||
156563629|NCT00868790|565150207|FG004|Period 4|Study Terminated by Sponsor|0|||
156563630|NCT00868790|565150208|FG005|Period 4|Study Terminated by Sponsor|0|||
156563631|NCT00868790|565150209|FG006|Period 4|Study Terminated by Sponsor|0|||
156563632|NCT00868790|565150210|FG007|Period 4|Study Terminated by Sponsor|1|||
156563633|NCT00868790|565150211|FG008|Period 4|Study Terminated by Sponsor|2|||
156563634|NCT00868790|565150212|FG009|Period 4|Study Terminated by Sponsor|0|||
156563635|NCT00868790|565150213|FG010|Period 4|Study Terminated by Sponsor|2|||
156563636|NCT00868790|565150214|FG011|Period 4|Study Terminated by Sponsor|1|||
156563637|NCT00868790|565150215|FG012|Period 4|Study Terminated by Sponsor|0|||
156563638|NCT00868790|565150216|FG013|Period 4|Study Terminated by Sponsor|1|||
156563639|NCT00868790|565150203|FG000|Period 4|Abnormal ALT/AST|0|||
156563640|NCT00868790|565150204|FG001|Period 4|Abnormal ALT/AST|0|||
156563641|NCT00868790|565150205|FG002|Period 4|Abnormal ALT/AST|1|||
156563642|NCT00868790|565150206|FG003|Period 4|Abnormal ALT/AST|0|||
156563643|NCT00868790|565150207|FG004|Period 4|Abnormal ALT/AST|0|||
156563644|NCT00868790|565150208|FG005|Period 4|Abnormal ALT/AST|0|||
156563645|NCT00868790|565150209|FG006|Period 4|Abnormal ALT/AST|0|||
156563646|NCT00868790|565150210|FG007|Period 4|Abnormal ALT/AST|0|||
156563647|NCT00868790|565150211|FG008|Period 4|Abnormal ALT/AST|0|||
156563648|NCT00868790|565150212|FG009|Period 4|Abnormal ALT/AST|0|||
156563649|NCT00868790|565150213|FG010|Period 4|Abnormal ALT/AST|0|||
156563650|NCT00868790|565150214|FG011|Period 4|Abnormal ALT/AST|0|||
156563651|NCT00868790|565150215|FG012|Period 4|Abnormal ALT/AST|0|||
156563652|NCT00868790|565150216|FG013|Period 4|Abnormal ALT/AST|0|||
156563653|NCT00868790|565150203|FG000|Post-study|Withdrawal by Subject|0|||
156563654|NCT00868790|565150204|FG001|Post-study|Withdrawal by Subject|0|||
156563655|NCT00868790|565150205|FG002|Post-study|Withdrawal by Subject|0|||
156563656|NCT00868790|565150206|FG003|Post-study|Withdrawal by Subject|0|||
156563657|NCT00868790|565150207|FG004|Post-study|Withdrawal by Subject|1|||
156563658|NCT00868790|565150208|FG005|Post-study|Withdrawal by Subject|0|||
156563659|NCT00868790|565150209|FG006|Post-study|Withdrawal by Subject|0|||
156563660|NCT00868790|565150210|FG007|Post-study|Withdrawal by Subject|0|||
156563661|NCT00868790|565150211|FG008|Post-study|Withdrawal by Subject|0|||
156563662|NCT00868790|565150212|FG009|Post-study|Withdrawal by Subject|0|||
156563663|NCT00868790|565150213|FG010|Post-study|Withdrawal by Subject|0|||
156563664|NCT00868790|565150214|FG011|Post-study|Withdrawal by Subject|0|||
156563665|NCT00868790|565150215|FG012|Post-study|Withdrawal by Subject|0|||
156563666|NCT00868790|565150216|FG013|Post-study|Withdrawal by Subject|0|||
156563667|NCT00868790|565150203|FG000|Post-study|Excluded Medication|0|||
156563668|NCT00868790|565150204|FG001|Post-study|Excluded Medication|0|||
156563669|NCT00868790|565150205|FG002|Post-study|Excluded Medication|0|||
156563670|NCT00868790|565150206|FG003|Post-study|Excluded Medication|0|||
156563671|NCT00868790|565150207|FG004|Post-study|Excluded Medication|0|||
156563672|NCT00868790|565150208|FG005|Post-study|Excluded Medication|0|||
156563673|NCT00868790|565150209|FG006|Post-study|Excluded Medication|0|||
156563674|NCT00868790|565150210|FG007|Post-study|Excluded Medication|2|||
156563675|NCT00868790|565150211|FG008|Post-study|Excluded Medication|0|||
156563676|NCT00868790|565150212|FG009|Post-study|Excluded Medication|1|||
156563677|NCT00868790|565150213|FG010|Post-study|Excluded Medication|0|||
156563678|NCT00868790|565150214|FG011|Post-study|Excluded Medication|0|||
156563679|NCT00868790|565150215|FG012|Post-study|Excluded Medication|0|||
156563680|NCT00868790|565150216|FG013|Post-study|Excluded Medication|0|||
156563681|NCT01264939|565150217|FG000|Overall Study|Adverse Event|1|||
156563682|NCT01264939|565150218|FG001|Overall Study|Adverse Event|3|||
156563683|NCT01264939|565150217|FG000|Overall Study|Lost to Follow-up|0|||
156563684|NCT01264939|565150218|FG001|Overall Study|Lost to Follow-up|3|||
156563685|NCT01264939|565150217|FG000|Overall Study|Physician Decision|1|||
156563686|NCT01264939|565150218|FG001|Overall Study|Physician Decision|1|||
156563687|NCT01264939|565150217|FG000|Overall Study|Patient/Guardian Decision|8|||
156563688|NCT01264939|565150218|FG001|Overall Study|Patient/Guardian Decision|10|||
156563689|NCT01264939|565150217|FG000|Overall Study|Disease Progression|8|||
156563690|NCT01264939|565150218|FG001|Overall Study|Disease Progression|11|||
156563691|NCT02266433|565150225|FG000|Overall Study|Lost to Follow-up|54|||
156563692|NCT02266433|565150226|FG001|Overall Study|Lost to Follow-up|46|||
156563693|NCT02266433|565150225|FG000|Overall Study|Withdrawal by Subject|5|||
156563694|NCT02266433|565150226|FG001|Overall Study|Withdrawal by Subject|7|||
156563695|NCT00737529|565150227|FG000|Overall Study|Disease Progression|95|||
156563696|NCT00737529|565150227|FG000|Overall Study|Adverse Event|24|||
156563697|NCT00737529|565150227|FG000|Overall Study|Withdrawal by Subject|5|||
156563698|NCT00737529|565150227|FG000|Overall Study|Death|4|||
156563699|NCT00737529|565150227|FG000|Overall Study|Protocol Violation|1|||
156563700|NCT00737529|565150227|FG000|Overall Study|Other|4|||
156563701|NCT01512264|565150228|FG000|Overall Study|Lost to Follow-up|0|||
156563702|NCT01512264|565150229|FG001|Overall Study|Lost to Follow-up|0|||
156563703|NCT01512264|565150230|FG002|Overall Study|Lost to Follow-up|0|||
156563704|NCT01512264|565150231|FG003|Overall Study|Lost to Follow-up|1|||
156563705|NCT01194440|565150232|FG000|Baseline (First Dose)|Reason not specified|4|||
156563706|NCT01194440|565150232|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
156563707|NCT01194440|565150232|FG000|Baseline (First Dose)|Change in therapy|1|||
156563708|NCT01194440|565150232|FG000|Baseline (First Dose)|Adverse Event|1|||
156563709|NCT01194440|565150232|FG000|6-months (2nd Dose)|Change in therapy|4|||
156563710|NCT01931059|565150233|FG000|Day 1|Pregnancy|0|||
156563711|NCT01931059|565150234|FG001|Day 1|Pregnancy|1|||
156563712|NCT01931059|565150233|FG000|Day3|Lost to Follow-up|1|||
156563713|NCT01931059|565150234|FG001|Day3|Lost to Follow-up|0|||
156563714|NCT02675075|565150244|FG000|Overall Study|Lost to Follow-up|3|||
156563715|NCT02675075|565150245|FG001|Overall Study|Lost to Follow-up|0|||
156563716|NCT00848120|565150246|FG000|Overall Study|Adverse Event|1|||
156563717|NCT01961115|565150254|FG000|Overall Study|Disease Progression|1|||
156563718|NCT01961115|565150255|FG001|Overall Study|Disease Progression|0|||
156563719|NCT01961115|565150256|FG002|Overall Study|Disease Progression|3|||
156563720|NCT01961115|565150254|FG000|Overall Study|Adverse Event|1|||
156563721|NCT01961115|565150255|FG001|Overall Study|Adverse Event|0|||
156563722|NCT01961115|565150256|FG002|Overall Study|Adverse Event|1|||
156563723|NCT00705263|565150262|FG000|Overall Study|Withdrawal by Subject|2|||
156563724|NCT05501119|565150263|FG000|Overall Study|Withdrawal by Subject|2|||
156563725|NCT05501119|565150263|FG000|Overall Study|Lost to Follow-up|5|||
156563726|NCT01752023|565150264|FG000|Overall Study|Physician Decision|2|||
156563727|NCT01752023|565150265|FG001|Overall Study|Physician Decision|1|||
156563728|NCT02899156|565150266|FG000|Overall Study|Death|1|||
156563729|NCT02899156|565150267|FG001|Overall Study|Death|0|||
156563730|NCT02899156|565150266|FG000|Overall Study|Physician Decision|0|||
156563731|NCT02899156|565150267|FG001|Overall Study|Physician Decision|1|||
156563732|NCT02440581|565150268|FG000|Overall Study|Death|0|||
156563733|NCT02440581|565150269|FG001|Overall Study|Death|0|||
156563734|NCT02440581|565150270|FG002|Overall Study|Death|7|||
156563735|NCT02440581|565150271|FG003|Overall Study|Death|5|||
156563736|NCT02440581|565150268|FG000|Overall Study|Transplanted|1|||
156563737|NCT02440581|565150269|FG001|Overall Study|Transplanted|0|||
156563738|NCT02440581|565150270|FG002|Overall Study|Transplanted|3|||
156563739|NCT02440581|565150271|FG003|Overall Study|Transplanted|2|||
156563740|NCT02440581|565150268|FG000|Overall Study|Withdrawal by Subject|4|||
156563741|NCT02440581|565150269|FG001|Overall Study|Withdrawal by Subject|11|||
156563742|NCT02440581|565150270|FG002|Overall Study|Withdrawal by Subject|3|||
156563743|NCT02440581|565150271|FG003|Overall Study|Withdrawal by Subject|7|||
156563744|NCT00654498|565150272|FG000|Overall Study|Not Treated|1|||
156563745|NCT00654498|565150273|FG001|Overall Study|Not Treated|0|||
156563746|NCT00654498|565150272|FG000|Overall Study|Adverse Event|6|||
156563747|NCT00654498|565150273|FG001|Overall Study|Adverse Event|1|||
156563748|NCT00654498|565150272|FG000|Overall Study|Protocol Violation|1|||
156563749|NCT00654498|565150273|FG001|Overall Study|Protocol Violation|1|||
156563750|NCT00654498|565150272|FG000|Overall Study|Lost to Follow-up|1|||
156563751|NCT00654498|565150273|FG001|Overall Study|Lost to Follow-up|5|||
156563752|NCT00654498|565150272|FG000|Overall Study|Withdrawal by Subject|1|||
156563753|NCT00654498|565150273|FG001|Overall Study|Withdrawal by Subject|0|||
156563754|NCT00654498|565150272|FG000|Overall Study|Other reason not defined above|4|||
156563755|NCT00654498|565150273|FG001|Overall Study|Other reason not defined above|5|||
156563756|NCT00787787|565150274|FG000|Overall Study|Lack of Efficacy|4|||
156563757|NCT00787787|565150274|FG000|Overall Study|Adverse Event|3|||
156563758|NCT01468987|565150275|FG000|Overall Study|Adverse Event|12|||
156563759|NCT01468987|565150276|FG001|Overall Study|Adverse Event|9|||
156563760|NCT01468987|565150275|FG000|Overall Study|Death|4|||
156563761|NCT01468987|565150276|FG001|Overall Study|Death|1|||
156563762|NCT01468987|565150275|FG000|Overall Study|Lost to Follow-up|10|||
156563763|NCT01468987|565150276|FG001|Overall Study|Lost to Follow-up|5|||
156563764|NCT01468987|565150275|FG000|Overall Study|Protocol Violation|8|||
156563765|NCT01468987|565150276|FG001|Overall Study|Protocol Violation|2|||
156563766|NCT01468987|565150275|FG000|Overall Study|Withdrawal by Subject|28|||
156563767|NCT01468987|565150276|FG001|Overall Study|Withdrawal by Subject|28|||
156563768|NCT01468987|565150275|FG000|Overall Study|Physician Decision|8|||
156563769|NCT01468987|565150276|FG001|Overall Study|Physician Decision|15|||
156563770|NCT01468987|565150275|FG000|Overall Study|Sponsor Decision|1|||
156563771|NCT01468987|565150276|FG001|Overall Study|Sponsor Decision|0|||
156563772|NCT01889602|565150280|FG000|First Intervention|Adverse Event|1|||
156563773|NCT01889602|565150281|FG001|First Intervention|Adverse Event|1|||
156563774|NCT01889602|565150282|FG002|First Intervention|Adverse Event|1|||
156563775|NCT01889602|565150280|FG000|First Intervention|Protocol Violation|0|||
156563776|NCT01889602|565150281|FG001|First Intervention|Protocol Violation|1|||
156563777|NCT01889602|565150282|FG002|First Intervention|Protocol Violation|1|||
156563778|NCT01889602|565150280|FG000|First Intervention|Study ending|0|||
156563779|NCT01889602|565150281|FG001|First Intervention|Study ending|1|||
156563780|NCT01889602|565150282|FG002|First Intervention|Study ending|0|||
156563781|NCT01889602|565150280|FG000|Second Intervention|Adverse Event|0|||
156563782|NCT01889602|565150281|FG001|Second Intervention|Adverse Event|0|||
156563783|NCT01889602|565150282|FG002|Second Intervention|Adverse Event|1|||
156563784|NCT01889602|565150280|FG000|Second Intervention|Study ending|1|||
156563785|NCT01889602|565150281|FG001|Second Intervention|Study ending|0|||
156563786|NCT01889602|565150282|FG002|Second Intervention|Study ending|0|||
156563787|NCT01889602|565150280|FG000|Second Intervention|Withdrawal by Subject|0|||
156563788|NCT01889602|565150281|FG001|Second Intervention|Withdrawal by Subject|0|||
156563789|NCT01889602|565150282|FG002|Second Intervention|Withdrawal by Subject|1|||
156563790|NCT01889602|565150280|FG000|Third Intervention|Protocol Violation|1|||
156563791|NCT01889602|565150281|FG001|Third Intervention|Protocol Violation|0|||
156563792|NCT01889602|565150282|FG002|Third Intervention|Protocol Violation|0|||
156563793|NCT01889602|565150280|FG000|Third Intervention|Withdrawal by Subject|2|||
156563794|NCT01889602|565150281|FG001|Third Intervention|Withdrawal by Subject|2|||
156563795|NCT01889602|565150282|FG002|Third Intervention|Withdrawal by Subject|0|||
156563796|NCT01245673|565150283|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
156563797|NCT01078805|565150287|FG000|Overall Study|Clinically significant abnormal lab|5|||
156563798|NCT01078805|565150287|FG000|Overall Study|Death|134|||
156563799|NCT01078805|565150287|FG000|Overall Study|Lost to Follow-up|676|||
156563800|NCT01078805|565150287|FG000|Overall Study|Physician Decision|169|||
156563801|NCT01078805|565150287|FG000|Overall Study|Serious adverse event|26|||
156563802|NCT01078805|565150287|FG000|Overall Study|Sponsor decision|46|||
156563803|NCT01078805|565150287|FG000|Overall Study|Withdrawal by Subject|739|||
156563804|NCT01078805|565150287|FG000|Overall Study|Other|173|||
156563805|NCT01078805|565150287|FG000|Overall Study|Didn't take study drug|82|||
156563806|NCT04722991|565150296|FG000|Overall Study|Adverse Event|12|||
156563807|NCT04722991|565150297|FG001|Overall Study|Adverse Event|4|||
156563808|NCT04722991|565150296|FG000|Overall Study|Death|2|||
156563809|NCT04722991|565150297|FG001|Overall Study|Death|0|||
156563810|NCT04722991|565150296|FG000|Overall Study|Lost to Follow-up|1|||
156563811|NCT04722991|565150297|FG001|Overall Study|Lost to Follow-up|1|||
156563812|NCT04722991|565150296|FG000|Overall Study|Withdrawal cirterion met|2|||
156563813|NCT04722991|565150297|FG001|Overall Study|Withdrawal cirterion met|2|||
156563814|NCT04722991|565150296|FG000|Overall Study|Other|1|||
156563815|NCT04722991|565150297|FG001|Overall Study|Other|0|||
156563816|NCT04722991|565150296|FG000|Overall Study|Non-compliance|0|||
156563817|NCT04722991|565150297|FG001|Overall Study|Non-compliance|1|||
156563818|NCT04722991|565150296|FG000|Overall Study|Withdrawal by Subject|0|||
156563819|NCT04722991|565150297|FG001|Overall Study|Withdrawal by Subject|1|||
156563820|NCT02246621|565150301|FG000|Overall Study|Withdrawal by Subject|28|||
156563821|NCT02246621|565150302|FG001|Overall Study|Withdrawal by Subject|16|||
156563822|NCT02246621|565150301|FG000|Overall Study|Lost to Follow-up|1|||
156563823|NCT02246621|565150302|FG001|Overall Study|Lost to Follow-up|0|||
156563824|NCT02246621|565150301|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
156563825|NCT02246621|565150302|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
156563826|NCT02078219|565150309|FG000|Overall Study|Other|2|||
156563827|NCT02078219|565150310|FG001|Overall Study|Other|2|||
156563828|NCT02078219|565150311|FG002|Overall Study|Other|3|||
156563829|NCT02078219|565150312|FG003|Overall Study|Other|0|||
156563830|NCT02078219|565150313|FG004|Overall Study|Other|1|||
156563831|NCT02078219|565150309|FG000|Overall Study|Withdrawal by Subject|0|||
156563832|NCT02078219|565150310|FG001|Overall Study|Withdrawal by Subject|1|||
156563833|NCT02078219|565150311|FG002|Overall Study|Withdrawal by Subject|0|||
156563834|NCT02078219|565150312|FG003|Overall Study|Withdrawal by Subject|1|||
156563835|NCT02078219|565150313|FG004|Overall Study|Withdrawal by Subject|1|||
156563836|NCT02078219|565150309|FG000|Overall Study|Protocol Violation|0|||
156563837|NCT02078219|565150310|FG001|Overall Study|Protocol Violation|0|||
156563838|NCT02078219|565150311|FG002|Overall Study|Protocol Violation|0|||
156563839|NCT02078219|565150312|FG003|Overall Study|Protocol Violation|1|||
156563840|NCT02078219|565150313|FG004|Overall Study|Protocol Violation|0|||
156563841|NCT02078219|565150309|FG000|Overall Study|Death|0|||
156563842|NCT02078219|565150310|FG001|Overall Study|Death|0|||
156563843|NCT02078219|565150311|FG002|Overall Study|Death|0|||
156563844|NCT02078219|565150312|FG003|Overall Study|Death|1|||
156563845|NCT02078219|565150313|FG004|Overall Study|Death|0|||
156563846|NCT02078219|565150309|FG000|Overall Study|Adverse Event|1|||
156563847|NCT02078219|565150310|FG001|Overall Study|Adverse Event|1|||
156563848|NCT02078219|565150311|FG002|Overall Study|Adverse Event|3|||
156563849|NCT02078219|565150312|FG003|Overall Study|Adverse Event|1|||
156563850|NCT02078219|565150313|FG004|Overall Study|Adverse Event|0|||
156563851|NCT01468311|565150315|FG000|Overall Study|mobilization failure|1|||
156563852|NCT01468311|565150315|FG000|Overall Study|Withdrawal by Subject|1|||
156563853|NCT03641560|565150316|FG000|Overall Study|Withdrawal by Subject|6|||
156563854|NCT03641560|565150316|FG000|Overall Study|Progressive disease|40|||
156563855|NCT03641560|565150316|FG000|Overall Study|Death|6|||
156563856|NCT04439279|565152033|FG000|Overall Study|Adverse Event|7|||
156563857|NCT04439279|565152033|FG000|Overall Study|Death|4|||
156563858|NCT04439279|565152033|FG000|Overall Study|Disease progression|17|||
156563859|NCT04439279|565152033|FG000|Overall Study|Complicating disease|3|||
156563860|NCT04439279|565152033|FG000|Overall Study|Withdrawal by Subject|2|||
156563861|NCT04439279|565152033|FG000|Overall Study|Ineligible|1|||
156563862|NCT04439279|565152033|FG000|Overall Study|Treatment still ongoing|1|||
156563863|NCT02689492|565152034|FG000|Overall Study|Lost to Follow-up|61|||
156563864|NCT02689492|565152034|FG000|Overall Study|Withdrawal by Subject|11|||
156563865|NCT02689492|565152034|FG000|Overall Study|Death|9|||
156563866|NCT02689492|565152034|FG000|Overall Study|Physician Decision|2|||
156563867|NCT02689492|565152034|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
156563868|NCT02689492|565152034|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
156563869|NCT02689492|565152034|FG000|Overall Study|Other than listed|1|||
156563870|NCT02732951|565152035|FG000|Overall Study|Other than listed|1|||
156563871|NCT02732951|565152036|FG001|Overall Study|Other than listed|0|||
156563872|NCT02732951|565152035|FG000|Overall Study|Lost to Follow-up|0|||
156563873|NCT02732951|565152036|FG001|Overall Study|Lost to Follow-up|1|||
156563874|NCT02732951|565152035|FG000|Overall Study|Adverse Event|4|||
156563875|NCT02732951|565152036|FG001|Overall Study|Adverse Event|4|||
156563876|NCT02732951|565152035|FG000|Overall Study|Protocol Violation|0|||
156563877|NCT02732951|565152036|FG001|Overall Study|Protocol Violation|1|||
156563878|NCT01750918|565152037|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
156563879|NCT01750918|565152038|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
156563880|NCT01750918|565152039|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
156563881|NCT01750918|565152040|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
156563882|NCT01750918|565152041|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
156563883|NCT01750918|565152042|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
156563884|NCT01750918|565152043|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
156563885|NCT01750918|565152044|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
156563886|NCT01750918|565152037|FG000|Overall Study|Lost to Follow-up|0|||
156563887|NCT01750918|565152038|FG001|Overall Study|Lost to Follow-up|0|||
156563888|NCT01750918|565152039|FG002|Overall Study|Lost to Follow-up|2|||
156563889|NCT01750918|565152040|FG003|Overall Study|Lost to Follow-up|2|||
156563890|NCT01750918|565152041|FG004|Overall Study|Lost to Follow-up|0|||
156563891|NCT01750918|565152042|FG005|Overall Study|Lost to Follow-up|0|||
156563892|NCT01750918|565152043|FG006|Overall Study|Lost to Follow-up|0|||
156563893|NCT01750918|565152044|FG007|Overall Study|Lost to Follow-up|1|||
156563894|NCT01750918|565152037|FG000|Overall Study|Withdrawal by Subject|0|||
156563895|NCT01750918|565152038|FG001|Overall Study|Withdrawal by Subject|0|||
156563896|NCT01750918|565152039|FG002|Overall Study|Withdrawal by Subject|1|||
156563897|NCT01750918|565152040|FG003|Overall Study|Withdrawal by Subject|2|||
156563898|NCT01750918|565152041|FG004|Overall Study|Withdrawal by Subject|1|||
156563899|NCT01750918|565152042|FG005|Overall Study|Withdrawal by Subject|1|||
156563900|NCT01750918|565152043|FG006|Overall Study|Withdrawal by Subject|2|||
156563901|NCT01750918|565152044|FG007|Overall Study|Withdrawal by Subject|2|||
156563902|NCT02031679|565152045|FG000|Overall Study|Protocol Violation|0|||
156563903|NCT02031679|565152046|FG001|Overall Study|Protocol Violation|1|||
156563904|NCT02031679|565152045|FG000|Overall Study|Lack of Efficacy|0|||
156563905|NCT02031679|565152046|FG001|Overall Study|Lack of Efficacy|1|||
156563906|NCT01974817|565152047|FG000|Overall Study|Death|4|||
156563907|NCT01974817|565152047|FG000|Overall Study|Lost to Follow-up|2|||
156563908|NCT01974817|565152047|FG000|Overall Study|Protocol Violation|2|||
156563909|NCT03658889|565152052|FG000|Overall Study|Protocol Violation|2|||
156563910|NCT03658889|565152053|FG001|Overall Study|Protocol Violation|0|||
156563911|NCT01524991|565152058|FG000|Overall Study|Adverse Event|12|||
156563912|NCT01524991|565152058|FG000|Overall Study|Death|1|||
156563913|NCT01524991|565152058|FG000|Overall Study|Disease ProgressionDu|17|||
156563914|NCT01524991|565152058|FG000|Overall Study|Other complicating disease|1|||
156563915|NCT01524991|565152058|FG000|Overall Study|Withdrawal by Subject|2|||
156563916|NCT01524991|565152058|FG000|Overall Study|Symptomatic Deterioration|1|||
156563917|NCT01805180|565152059|FG000|Lead-in Donor Phase|screen failure|1|||
156563918|NCT01805180|565152060|FG001|Lead-in Donor Phase|screen failure|0|||
156563919|NCT01805180|565152061|FG002|Lead-in Donor Phase|screen failure|0|||
156563920|NCT00928070|565152067|FG000|Overall Study|Lost to Follow-up|1|||
156563921|NCT00928070|565152068|FG001|Overall Study|Lost to Follow-up|2|||
156563922|NCT00928070|565152067|FG000|Overall Study|Withdrawal by Subject|10|||
156563923|NCT00928070|565152068|FG001|Overall Study|Withdrawal by Subject|3|||
156563924|NCT00928070|565152067|FG000|Overall Study|Adverse Event|14|||
156563925|NCT00928070|565152068|FG001|Overall Study|Adverse Event|26|||
156563926|NCT00928070|565152067|FG000|Overall Study|Lack of Efficacy|9|||
156563927|NCT00928070|565152068|FG001|Overall Study|Lack of Efficacy|5|||
156563928|NCT00928070|565152067|FG000|Overall Study|Did not meet entrance criteria|16|||
156563929|NCT00928070|565152068|FG001|Overall Study|Did not meet entrance criteria|9|||
156563930|NCT00928070|565152067|FG000|Overall Study|Protocol Violation|6|||
156563931|NCT00928070|565152068|FG001|Overall Study|Protocol Violation|5|||
156563932|NCT00928070|565152067|FG000|Overall Study|Randomized but not treated|2|||
156563933|NCT00928070|565152068|FG001|Overall Study|Randomized but not treated|2|||
156563934|NCT00928070|565152067|FG000|Overall Study|Other|5|||
156563935|NCT00928070|565152068|FG001|Overall Study|Other|5|||
156563936|NCT00862251|565152072|FG000|Overall Study|Adverse Event|8|||
156563937|NCT00862251|565152073|FG001|Overall Study|Adverse Event|3|||
156563938|NCT00862251|565152074|FG002|Overall Study|Adverse Event|1|||
156563939|NCT00862251|565152072|FG000|Overall Study|Lost to Follow-up|0|||
156563940|NCT00862251|565152073|FG001|Overall Study|Lost to Follow-up|0|||
156563941|NCT00862251|565152074|FG002|Overall Study|Lost to Follow-up|1|||
156563942|NCT00862251|565152072|FG000|Overall Study|Protocol Violation|2|||
156563943|NCT00862251|565152073|FG001|Overall Study|Protocol Violation|0|||
156563944|NCT00862251|565152074|FG002|Overall Study|Protocol Violation|1|||
156563945|NCT00862251|565152072|FG000|Overall Study|Withdrawal by Subject|9|||
156563946|NCT00862251|565152073|FG001|Overall Study|Withdrawal by Subject|2|||
156563947|NCT00862251|565152074|FG002|Overall Study|Withdrawal by Subject|6|||
156563948|NCT02796755|565152075|FG000|Overall Study|Adverse Event|2|||
156563949|NCT02796755|565152076|FG001|Overall Study|Adverse Event|0|||
156563950|NCT03049449|565152077|FG000|Overall Study|Did not receive treatment.|0|||
156563951|NCT03049449|565152078|FG001|Overall Study|Did not receive treatment.|0|||
156563952|NCT03049449|565152079|FG002|Overall Study|Did not receive treatment.|0|||
156563953|NCT03049449|565152080|FG003|Overall Study|Did not receive treatment.|0|||
156563954|NCT03049449|565152081|FG004|Overall Study|Did not receive treatment.|0|||
156563955|NCT03049449|565152082|FG005|Overall Study|Did not receive treatment.|0|||
156563956|NCT03049449|565152083|FG006|Overall Study|Did not receive treatment.|0|||
156563957|NCT03049449|565152084|FG007|Overall Study|Did not receive treatment.|0|||
156563958|NCT03049449|565152085|FG008|Overall Study|Did not receive treatment.|1|||
156563959|NCT03049449|565152086|FG009|Overall Study|Did not receive treatment.|0|||
156563960|NCT03049449|565152077|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
156563961|NCT03049449|565152078|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
156563962|NCT03049449|565152079|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
156563963|NCT03049449|565152080|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
156563964|NCT03049449|565152081|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
156563965|NCT03049449|565152082|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
156563966|NCT03049449|565152083|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
156563967|NCT03049449|565152084|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
156563968|NCT03049449|565152085|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
156563969|NCT03049449|565152086|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
156563970|NCT03049449|565152077|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
156563971|NCT03049449|565152078|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
156563972|NCT03049449|565152079|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
156563973|NCT03049449|565152080|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
156563974|NCT03049449|565152081|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
156563975|NCT03049449|565152082|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
156563976|NCT03049449|565152083|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
156563977|NCT03049449|565152084|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
156563978|NCT03049449|565152085|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
156563979|NCT03049449|565152086|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
156563980|NCT02304926|565152088|FG000|Overall Study|Lost to Follow-up|2|||
156563981|NCT02304926|565152089|FG001|Overall Study|Lost to Follow-up|1|||
156563982|NCT04007159|565152090|FG000|Induction Phase|(missed study visits)|16|||
156563983|NCT04007159|565152090|FG000|Induction Phase|Withdrawal by Subject|4|||
156563984|NCT04007159|565152090|FG000|Induction Phase|Adverse Event|2|||
156563985|NCT04007159|565152090|FG000|Challenge Phase|missed study visits|3|||
156563986|NCT04258579|565152091|FG000|Overall Study|Withdrawal by Subject|7|||
156563987|NCT04258579|565152091|FG000|Overall Study|Lost to Follow-up|3|||
156563988|NCT04258579|565152091|FG000|Overall Study|Protocol Violation|2|||
156563989|NCT04258579|565152091|FG000|Overall Study|Adverse Event|1|||
156563990|NCT02076165|565152094|FG000|Overall Study|Lost to Follow-up|7|||
156563991|NCT02076165|565152095|FG001|Overall Study|Lost to Follow-up|5|||
156563992|NCT02076165|565152094|FG000|Overall Study|Refused follow-up assessment|1|||
156563993|NCT02076165|565152095|FG001|Overall Study|Refused follow-up assessment|1|||
156563994|NCT02429856|565152096|FG000|Overall Study|Death|12|||
156563995|NCT02429856|565152097|FG001|Overall Study|Death|13|||
156563996|NCT02429856|565152096|FG000|Overall Study|Lost to Follow-up|6|||
156563997|NCT02429856|565152097|FG001|Overall Study|Lost to Follow-up|5|||
156563998|NCT02429856|565152096|FG000|Overall Study|Withdrawal by Subject|1|||
156563999|NCT02429856|565152097|FG001|Overall Study|Withdrawal by Subject|1|||
156564000|NCT01384292|565152104|FG000|Part B|Severe non-compliance to protocol|1|||
156564001|NCT01384292|565152105|FG001|Part B|Severe non-compliance to protocol|0|||
156564002|NCT01384292|565152106|FG002|Part B|Severe non-compliance to protocol|0|||
156564003|NCT01171612|565152107|FG000|Overall Study|Lost to Follow-up|51|||
156564004|NCT01285349|565152108|FG000|Overall Study|Lost to Follow-up|27|||
156564005|NCT01285349|565152109|FG001|Overall Study|Lost to Follow-up|20|||
156564006|NCT01285349|565152110|FG002|Overall Study|Lost to Follow-up|27|||
156564007|NCT02909153|565152111|FG000|Overall Study|Withdrawal by Subject|0|||
156564008|NCT02909153|565152112|FG001|Overall Study|Withdrawal by Subject|1|||
156564009|NCT02909153|565152113|FG002|Overall Study|Withdrawal by Subject|0|||
156564010|NCT02909153|565152114|FG003|Overall Study|Withdrawal by Subject|0|||
156564011|NCT02909153|565152115|FG004|Overall Study|Withdrawal by Subject|0|||
156564012|NCT00565617|565152116|FG000|Overall Study|Withdrawal by Subject|1|||
156564013|NCT03040024|565152117|FG000|Overall Study|Adverse Event|0|||
156564014|NCT03040024|565152118|FG001|Overall Study|Adverse Event|1|||
156564015|NCT03040024|565152119|FG002|Overall Study|Adverse Event|0|||
156564016|NCT03040024|565152117|FG000|Overall Study|Death|0|||
156564017|NCT03040024|565152118|FG001|Overall Study|Death|1|||
156564018|NCT03040024|565152119|FG002|Overall Study|Death|0|||
156564019|NCT03040024|565152117|FG000|Overall Study|Physician Decision|0|||
156564020|NCT03040024|565152118|FG001|Overall Study|Physician Decision|0|||
156564021|NCT03040024|565152119|FG002|Overall Study|Physician Decision|1|||
156564022|NCT02658812|565152122|FG000|Overall Study|Disease Progression|7|||
156564023|NCT02658812|565152122|FG000|Overall Study|Unrelated to study treatment|1|||
156564024|NCT02658812|565152122|FG000|Overall Study|Adverse Event|1|||
156564025|NCT00854828|565152125|FG000|Overall Study|Death|1|||
156564026|NCT00854828|565152126|FG001|Overall Study|Death|0|||
156564027|NCT00854828|565152127|FG002|Overall Study|Death|0|||
156564028|NCT00854828|565152128|FG003|Overall Study|Death|0|||
156564029|NCT00854828|565152125|FG000|Overall Study|Withdrawal by Subject|1|||
156564030|NCT00854828|565152126|FG001|Overall Study|Withdrawal by Subject|1|||
156564031|NCT00854828|565152127|FG002|Overall Study|Withdrawal by Subject|0|||
156564032|NCT00854828|565152128|FG003|Overall Study|Withdrawal by Subject|9|||
156564033|NCT00854828|565152125|FG000|Overall Study|Missed 24mo visit|1|||
156564034|NCT00854828|565152126|FG001|Overall Study|Missed 24mo visit|1|||
156564035|NCT00854828|565152127|FG002|Overall Study|Missed 24mo visit|8|||
156564036|NCT00854828|565152128|FG003|Overall Study|Missed 24mo visit|8|||
156564037|NCT01282229|565152129|FG000|Overall Study|Protocol Violation|2|||
156564038|NCT01671280|565152130|FG000|Overall Study|Withdrawal by Subject|2|||
156564039|NCT00996203|565152131|FG000|Overall Study|Adverse Event|3|||
156564040|NCT00996203|565152131|FG000|Overall Study|Lost to Follow-up|1|||
156564041|NCT00996203|565152131|FG000|Overall Study|Lack of Efficacy|1|||
156564042|NCT00996203|565152131|FG000|Overall Study|Protocol Violation|2|||
156564043|NCT01959165|565152132|FG000|Overall Study|Adverse Event|0|||
156564044|NCT01959165|565152133|FG001|Overall Study|Adverse Event|0|||
156564045|NCT01959165|565152134|FG002|Overall Study|Adverse Event|0|||
156564046|NCT01959165|565152135|FG003|Overall Study|Adverse Event|1|||
156564047|NCT01959165|565152132|FG000|Overall Study|Lack of Efficacy|1|||
156564048|NCT01959165|565152133|FG001|Overall Study|Lack of Efficacy|0|||
156564049|NCT01959165|565152134|FG002|Overall Study|Lack of Efficacy|0|||
156564050|NCT01959165|565152135|FG003|Overall Study|Lack of Efficacy|0|||
156564051|NCT01959165|565152132|FG000|Overall Study|overdose|0|||
156564052|NCT01959165|565152133|FG001|Overall Study|overdose|0|||
156564053|NCT01959165|565152134|FG002|Overall Study|overdose|0|||
156564054|NCT01959165|565152135|FG003|Overall Study|overdose|1|||
156564055|NCT01959165|565152132|FG000|Overall Study|Welfare recipient|0|||
156564056|NCT01959165|565152133|FG001|Overall Study|Welfare recipient|1|||
156564057|NCT01959165|565152134|FG002|Overall Study|Welfare recipient|0|||
156564058|NCT01959165|565152135|FG003|Overall Study|Welfare recipient|0|||
156564059|NCT03686969|565152136|FG000|Overall Study|Study terminated|1|||
156564060|NCT03686969|565152137|FG001|Overall Study|Study terminated|0|||
156564061|NCT01988090|565152142|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
156564062|NCT01988090|565152143|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
156564063|NCT01988090|565152142|FG000|Start Treament After Randomization|Protocol Violation|0|||
156564064|NCT01988090|565152143|FG001|Start Treament After Randomization|Protocol Violation|1|||
156564065|NCT01988090|565152142|FG000|Complete Study After Start|Withdrawal by Subject|2|||
156564066|NCT01988090|565152143|FG001|Complete Study After Start|Withdrawal by Subject|0|||
156564067|NCT01988090|565152142|FG000|Complete Study After Start|Protocol Violation|1|||
156564068|NCT01988090|565152143|FG001|Complete Study After Start|Protocol Violation|1|||
156564069|NCT03887130|565152146|FG000|Overall Study|Progressive disease|23|||
156564070|NCT03887130|565152147|FG001|Overall Study|Progressive disease|14|||
156564071|NCT03887130|565152148|FG002|Overall Study|Progressive disease|7|||
156564072|NCT03887130|565152146|FG000|Overall Study|Protocol Violation|3|||
156564073|NCT03887130|565152147|FG001|Overall Study|Protocol Violation|1|||
156564074|NCT03887130|565152148|FG002|Overall Study|Protocol Violation|2|||
156564075|NCT03887130|565152146|FG000|Overall Study|Drug related toxicity|7|||
156564076|NCT03887130|565152147|FG001|Overall Study|Drug related toxicity|7|||
156564077|NCT03887130|565152148|FG002|Overall Study|Drug related toxicity|13|||
156564078|NCT03887130|565152146|FG000|Overall Study|Non drug related toxicity|3|||
156564079|NCT03887130|565152147|FG001|Overall Study|Non drug related toxicity|0|||
156564080|NCT03887130|565152148|FG002|Overall Study|Non drug related toxicity|0|||
156564081|NCT03887130|565152146|FG000|Overall Study|Death|2|||
156564082|NCT03887130|565152147|FG001|Overall Study|Death|2|||
156564083|NCT03887130|565152148|FG002|Overall Study|Death|1|||
156564084|NCT03887130|565152146|FG000|Overall Study|Withdrawal by Subject|7|||
156564085|NCT03887130|565152147|FG001|Overall Study|Withdrawal by Subject|6|||
156564086|NCT03887130|565152148|FG002|Overall Study|Withdrawal by Subject|11|||
156564087|NCT03887130|565152146|FG000|Overall Study|other reason|6|||
156564088|NCT03887130|565152147|FG001|Overall Study|other reason|20|||
156564089|NCT03887130|565152148|FG002|Overall Study|other reason|17|||
156564090|NCT00927563|565152149|FG000|Overall Study|Lost to Follow-up|1|||
156564091|NCT00927563|565152149|FG000|Overall Study|Withdrawal by Subject|1|||
156564092|NCT02497001|565152152|FG000|Overall Study|Lost to Follow-up|10|||
156564093|NCT02497001|565152153|FG001|Overall Study|Lost to Follow-up|2|||
156564094|NCT02497001|565152154|FG002|Overall Study|Lost to Follow-up|0|||
156564095|NCT02497001|565152155|FG003|Overall Study|Lost to Follow-up|2|||
156564096|NCT02497001|565152152|FG000|Overall Study|Adverse Event|28|||
156564097|NCT02497001|565152153|FG001|Overall Study|Adverse Event|30|||
156564098|NCT02497001|565152154|FG002|Overall Study|Adverse Event|11|||
156564099|NCT02497001|565152155|FG003|Overall Study|Adverse Event|11|||
156564100|NCT02497001|565152152|FG000|Overall Study|Withdrawal by Subject|14|||
156564101|NCT02497001|565152153|FG001|Overall Study|Withdrawal by Subject|37|||
156564102|NCT02497001|565152154|FG002|Overall Study|Withdrawal by Subject|19|||
156564103|NCT02497001|565152155|FG003|Overall Study|Withdrawal by Subject|15|||
156564104|NCT02497001|565152152|FG000|Overall Study|Physician Decision|5|||
156564105|NCT02497001|565152153|FG001|Overall Study|Physician Decision|11|||
156564106|NCT02497001|565152154|FG002|Overall Study|Physician Decision|5|||
156564107|NCT02497001|565152155|FG003|Overall Study|Physician Decision|1|||
156564108|NCT02497001|565152152|FG000|Overall Study|subjects that were not treated|1|||
156564109|NCT02497001|565152153|FG001|Overall Study|subjects that were not treated|2|||
156564110|NCT02497001|565152154|FG002|Overall Study|subjects that were not treated|2|||
156564111|NCT02497001|565152155|FG003|Overall Study|subjects that were not treated|1|||
156564112|NCT02497001|565152152|FG000|Overall Study|Major Protocol Deviation|3|||
156564113|NCT02497001|565152153|FG001|Overall Study|Major Protocol Deviation|4|||
156564114|NCT02497001|565152154|FG002|Overall Study|Major Protocol Deviation|4|||
156564115|NCT02497001|565152155|FG003|Overall Study|Major Protocol Deviation|4|||
156564116|NCT02497001|565152152|FG000|Overall Study|Lack of Efficacy|10|||
156564117|NCT02497001|565152153|FG001|Overall Study|Lack of Efficacy|16|||
156564118|NCT02497001|565152154|FG002|Overall Study|Lack of Efficacy|6|||
156564119|NCT02497001|565152155|FG003|Overall Study|Lack of Efficacy|6|||
156564120|NCT02497001|565152152|FG000|Overall Study|Protocol Violation|3|||
156564121|NCT02497001|565152153|FG001|Overall Study|Protocol Violation|1|||
156564122|NCT02497001|565152154|FG002|Overall Study|Protocol Violation|3|||
156564123|NCT02497001|565152155|FG003|Overall Study|Protocol Violation|1|||
156564124|NCT03430986|565152162|FG000|24-week Control Period|Adverse Event|1|||
156564125|NCT03430986|565152163|FG001|24-week Control Period|Adverse Event|0|||
156564126|NCT03430986|565152162|FG000|24-week Control Period|Lost to Follow-up|2|||
156564127|NCT03430986|565152163|FG001|24-week Control Period|Lost to Follow-up|2|||
156564128|NCT03430986|565152162|FG000|24-week Control Period|Withdrawal by Participant|5|||
156564129|NCT03430986|565152163|FG001|24-week Control Period|Withdrawal by Participant|0|||
156564130|NCT03430986|565152162|FG000|24-week Control Period|Protocol Deviation|0|||
156564131|NCT03430986|565152163|FG001|24-week Control Period|Protocol Deviation|2|||
156564132|NCT03430986|565152162|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
156564133|NCT03430986|565152163|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
156564134|NCT03430986|565152162|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
156564135|NCT03430986|565152163|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
156564136|NCT01412957|565152164|FG000|Overall Study|Withdrawal by Subject|6|||
156564137|NCT01412957|565152165|FG001|Overall Study|Withdrawal by Subject|22|||
156564138|NCT01412957|565152164|FG000|Overall Study|Lost to Follow-up|7|||
156564139|NCT01412957|565152165|FG001|Overall Study|Lost to Follow-up|2|||
156564140|NCT01412957|565152164|FG000|Overall Study|Death|136|||
156564141|NCT01412957|565152165|FG001|Overall Study|Death|133|||
156564142|NCT00484315|565152166|FG000|12-Month Clinical Follow-up|Death|6|||
156564143|NCT00484315|565152167|FG001|12-Month Clinical Follow-up|Death|2|||
156564144|NCT00484315|565152166|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
156564145|NCT00484315|565152167|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
156564146|NCT00484315|565152166|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
156564147|NCT00484315|565152167|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
156564148|NCT00484315|565152166|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
156564149|NCT00484315|565152167|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
156564150|NCT00484315|565152166|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
156564151|NCT00484315|565152167|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
156564152|NCT00484315|565152166|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
156564153|NCT00484315|565152167|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
156564154|NCT00484315|565152166|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
156564155|NCT00484315|565152167|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
156564156|NCT00943683|565152168|FG000|Overall Study|Adverse Event|3|||
156564157|NCT00943683|565152169|FG001|Overall Study|Adverse Event|3|||
156564158|NCT00943683|565152168|FG000|Overall Study|Lost to Follow-up|1|||
156564159|NCT00943683|565152169|FG001|Overall Study|Lost to Follow-up|1|||
156564160|NCT00943683|565152168|FG000|Overall Study|Protocol Violation|1|||
156564161|NCT00943683|565152169|FG001|Overall Study|Protocol Violation|2|||
156564162|NCT00943683|565152168|FG000|Overall Study|Withdrawal by Subject|1|||
156564163|NCT00943683|565152169|FG001|Overall Study|Withdrawal by Subject|0|||
156564164|NCT00943683|565152168|FG000|Overall Study|Patient Moved|1|||
156564165|NCT00943683|565152169|FG001|Overall Study|Patient Moved|0|||
156564166|NCT01445678|565152177|FG000|Overall Study|Adverse Event|12|||
156564167|NCT01445678|565152178|FG001|Overall Study|Adverse Event|8|||
156564168|NCT01445678|565152177|FG000|Overall Study|Lack of Efficacy|0|||
156564169|NCT01445678|565152178|FG001|Overall Study|Lack of Efficacy|2|||
156564170|NCT01445678|565152177|FG000|Overall Study|Lost to Follow-up|8|||
156564171|NCT01445678|565152178|FG001|Overall Study|Lost to Follow-up|5|||
156564172|NCT01445678|565152177|FG000|Overall Study|Protocol Violation|1|||
156564173|NCT01445678|565152178|FG001|Overall Study|Protocol Violation|1|||
156564174|NCT01445678|565152177|FG000|Overall Study|Withdrawal by Subject|9|||
156564175|NCT01445678|565152178|FG001|Overall Study|Withdrawal by Subject|5|||
156564176|NCT01870739|565152179|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
156564177|NCT01870739|565152180|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
156564178|NCT01870739|565152179|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
156564179|NCT01870739|565152180|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
156564180|NCT01870739|565152179|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
156564181|NCT01870739|565152180|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
156564182|NCT01870739|565152179|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
156564183|NCT01870739|565152180|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
156564184|NCT01870739|565152179|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
156564185|NCT01870739|565152180|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
156564186|NCT01870739|565152179|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
156564187|NCT01870739|565152180|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
156564188|NCT01870739|565152179|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
156564189|NCT01870739|565152180|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
156564190|NCT01459614|565152181|FG000|Overall Study|Adverse Event|1|||
156564191|NCT01459614|565152182|FG001|Overall Study|Adverse Event|0|||
156564192|NCT00630331|565152185|FG000|Overall Study|Death|2|||
156564193|NCT00630331|565152186|FG001|Overall Study|Death|1|||
156564194|NCT00630331|565152187|FG002|Overall Study|Death|1|||
156564195|NCT00630331|565152185|FG000|Overall Study|Adverse Event|1|||
156564196|NCT00630331|565152186|FG001|Overall Study|Adverse Event|0|||
156564197|NCT00630331|565152187|FG002|Overall Study|Adverse Event|0|||
156564198|NCT00630331|565152185|FG000|Overall Study|Withdrawal by Subject|12|||
156564199|NCT00630331|565152186|FG001|Overall Study|Withdrawal by Subject|7|||
156564200|NCT00630331|565152187|FG002|Overall Study|Withdrawal by Subject|5|||
156564201|NCT00630331|565152185|FG000|Overall Study|Lost to Follow-up|175|||
156564202|NCT00630331|565152186|FG001|Overall Study|Lost to Follow-up|143|||
156564203|NCT00630331|565152187|FG002|Overall Study|Lost to Follow-up|170|||
156564204|NCT00630331|565152185|FG000|Overall Study|Inappropriate enrollment|3|||
156564205|NCT00630331|565152186|FG001|Overall Study|Inappropriate enrollment|6|||
156564206|NCT00630331|565152187|FG002|Overall Study|Inappropriate enrollment|3|||
156564207|NCT00630331|565152185|FG000|Overall Study|Unable to classify|9|||
156564208|NCT00630331|565152186|FG001|Overall Study|Unable to classify|4|||
156564209|NCT00630331|565152187|FG002|Overall Study|Unable to classify|3|||
156564210|NCT00630331|565152185|FG000|Overall Study|Protocol Violation|4|||
156564211|NCT00630331|565152186|FG001|Overall Study|Protocol Violation|5|||
156564212|NCT00630331|565152187|FG002|Overall Study|Protocol Violation|6|||
156564213|NCT01565980|565152189|FG000|Overall Study|Death|1|||
156564214|NCT01565980|565152190|FG001|Overall Study|Death|0|||
156564215|NCT01565980|565152189|FG000|Overall Study|Lost to Follow-up|1|||
156564216|NCT01565980|565152190|FG001|Overall Study|Lost to Follow-up|0|||
156564217|NCT01565980|565152189|FG000|Overall Study|health complications|1|||
156564218|NCT01565980|565152190|FG001|Overall Study|health complications|1|||
156564219|NCT01565980|565152189|FG000|Overall Study|stopped medical treatment|1|||
156564220|NCT01565980|565152190|FG001|Overall Study|stopped medical treatment|0|||
156564221|NCT01565980|565152189|FG000|Overall Study|Withdrawal by Subject|0|||
156564222|NCT01565980|565152190|FG001|Overall Study|Withdrawal by Subject|3|||
156564223|NCT02425098|565152199|FG000|Overall Study|Lost to Follow-up|7|||
156564224|NCT02425098|565152200|FG001|Overall Study|Lost to Follow-up|7|||
156564225|NCT02425098|565152199|FG000|Overall Study|Withdrawal by Subject|4|||
156564226|NCT02425098|565152200|FG001|Overall Study|Withdrawal by Subject|8|||
156564227|NCT02425098|565152199|FG000|Overall Study|Pregnancy|2|||
156564228|NCT02425098|565152200|FG001|Overall Study|Pregnancy|0|||
156564229|NCT02425098|565152199|FG000|Overall Study|Reason not Specified|0|||
156564230|NCT02425098|565152200|FG001|Overall Study|Reason not Specified|1|||
156564231|NCT01929135|565152201|FG000|Overall Study|Lost to Follow-up|1|||
156564232|NCT01929135|565152202|FG001|Overall Study|Lost to Follow-up|1|||
156564233|NCT01926626|565152203|FG000|Overall Study|Withdrawal by Subject|15|||
156564234|NCT01926626|565152203|FG000|Overall Study|Lost to Follow-up|7|||
156564235|NCT02338843|565153830|FG000|Overall Study|Adverse Event|2|||
156564236|NCT02338843|565153831|FG001|Overall Study|Adverse Event|1|||
156564237|NCT02338843|565153830|FG000|Overall Study|Death|40|||
156564238|NCT02338843|565153831|FG001|Overall Study|Death|53|||
156564239|NCT02338843|565153830|FG000|Overall Study|Physician Decision|1|||
156564240|NCT02338843|565153831|FG001|Overall Study|Physician Decision|0|||
156564241|NCT02338843|565153830|FG000|Overall Study|Withdrawal by Subject|0|||
156564242|NCT02338843|565153831|FG001|Overall Study|Withdrawal by Subject|2|||
156564243|NCT02338843|565153830|FG000|Overall Study|Subject Recovered|0|||
156564244|NCT02338843|565153831|FG001|Overall Study|Subject Recovered|2|||
156564245|NCT02338843|565153830|FG000|Overall Study|Discontinued prior to randomizat|1|||
156564246|NCT02338843|565153831|FG001|Overall Study|Discontinued prior to randomizat|0|||
156564247|NCT00110305|565153832|FG000|Overall Study|Adverse Event|46|||
156564248|NCT00110305|565153833|FG001|Overall Study|Adverse Event|13|||
156564249|NCT00110305|565153832|FG000|Overall Study|Sponsors Decision|1|||
156564250|NCT00110305|565153833|FG001|Overall Study|Sponsors Decision|0|||
156564251|NCT00110305|565153832|FG000|Overall Study|Subject Non-Compliant|9|||
156564252|NCT00110305|565153833|FG001|Overall Study|Subject Non-Compliant|2|||
156564253|NCT00110305|565153832|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
156564254|NCT00110305|565153833|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
156564255|NCT00110305|565153832|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
156564256|NCT00110305|565153833|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
156564257|NCT00110305|565153832|FG000|Overall Study|Protocol Violation|0|||
156564258|NCT00110305|565153833|FG001|Overall Study|Protocol Violation|1|||
156564259|NCT00110305|565153832|FG000|Overall Study|Withdrawal by Subject|7|||
156564260|NCT00110305|565153833|FG001|Overall Study|Withdrawal by Subject|7|||
156564261|NCT00110305|565153832|FG000|Overall Study|Lost to Follow-up|20|||
156564262|NCT00110305|565153833|FG001|Overall Study|Lost to Follow-up|3|||
156564263|NCT00110305|565153832|FG000|Overall Study|Other|8|||
156564264|NCT00110305|565153833|FG001|Overall Study|Other|2|||
156564265|NCT05047523|565153841|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
156564266|NCT05047523|565153842|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
156564267|NCT05047523|565153843|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
156564268|NCT05047523|565153844|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
156564269|NCT05047523|565153845|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
156564270|NCT05047523|565153846|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
156564271|NCT05047523|565153841|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
156564272|NCT05047523|565153842|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
156564273|NCT05047523|565153843|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
156564274|NCT05047523|565153844|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
156564275|NCT05047523|565153845|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
156564276|NCT05047523|565153846|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
156564277|NCT05047523|565153841|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
156564278|NCT05047523|565153842|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
156564279|NCT05047523|565153843|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
156564280|NCT05047523|565153844|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
156564281|NCT05047523|565153845|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
156564282|NCT05047523|565153846|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
156564283|NCT05047523|565153841|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
156564284|NCT05047523|565153842|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156564285|NCT05047523|565153843|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156564286|NCT05047523|565153844|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156564287|NCT05047523|565153845|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156564288|NCT05047523|565153846|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
156564289|NCT05047523|565153841|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
156564290|NCT05047523|565153842|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
156564291|NCT05047523|565153843|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
156564292|NCT05047523|565153844|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
156564293|NCT05047523|565153845|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
156564294|NCT05047523|565153846|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
156564295|NCT05047523|565153841|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
156564296|NCT05047523|565153842|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
156564297|NCT05047523|565153843|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
156564298|NCT05047523|565153844|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
156564299|NCT05047523|565153845|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
156564300|NCT05047523|565153846|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
156564301|NCT00224016|565153847|FG000|Titration Period|Withdrawal by Subject|0|||
156564302|NCT00224016|565153848|FG001|Titration Period|Withdrawal by Subject|1|||
156564303|NCT00224016|565153847|FG000|Titration Period|Lost to Follow-up|1|||
156564304|NCT00224016|565153848|FG001|Titration Period|Lost to Follow-up|0|||
156564305|NCT00224016|565153847|FG000|Maintenance Period|Withdrawal by Subject|2|||
156564306|NCT00224016|565153848|FG001|Maintenance Period|Withdrawal by Subject|0|||
156564307|NCT00224016|565153847|FG000|Maintenance Period|Lost to Follow-up|0|||
156564308|NCT00224016|565153848|FG001|Maintenance Period|Lost to Follow-up|1|||
156564309|NCT04854499|565153850|FG000|Overall Study|Study Terminated by Sponsor|5|||
156564310|NCT04854499|565153851|FG001|Overall Study|Study Terminated by Sponsor|27|||
156564311|NCT04854499|565153852|FG002|Overall Study|Study Terminated by Sponsor|28|||
156564312|NCT04854499|565153853|FG003|Overall Study|Study Terminated by Sponsor|19|||
156564313|NCT04854499|565153854|FG004|Overall Study|Study Terminated by Sponsor|1|||
156564314|NCT04854499|565153855|FG005|Overall Study|Study Terminated by Sponsor|10|||
156564315|NCT04854499|565153850|FG000|Overall Study|Death|1|||
156564316|NCT04854499|565153851|FG001|Overall Study|Death|23|||
156564317|NCT04854499|565153852|FG002|Overall Study|Death|21|||
156564318|NCT04854499|565153853|FG003|Overall Study|Death|7|||
156564319|NCT04854499|565153854|FG004|Overall Study|Death|6|||
156564320|NCT04854499|565153855|FG005|Overall Study|Death|24|||
156564321|NCT04854499|565153850|FG000|Overall Study|Investigator's Discretion|0|||
156564322|NCT04854499|565153851|FG001|Overall Study|Investigator's Discretion|1|||
156564323|NCT04854499|565153852|FG002|Overall Study|Investigator's Discretion|3|||
156564324|NCT04854499|565153853|FG003|Overall Study|Investigator's Discretion|4|||
156564325|NCT04854499|565153854|FG004|Overall Study|Investigator's Discretion|1|||
156564326|NCT04854499|565153855|FG005|Overall Study|Investigator's Discretion|5|||
156564327|NCT04854499|565153850|FG000|Overall Study|Withdrew Consent|0|||
156564328|NCT04854499|565153851|FG001|Overall Study|Withdrew Consent|1|||
156564329|NCT04854499|565153852|FG002|Overall Study|Withdrew Consent|2|||
156564330|NCT04854499|565153853|FG003|Overall Study|Withdrew Consent|2|||
156564331|NCT04854499|565153854|FG004|Overall Study|Withdrew Consent|0|||
156564332|NCT04854499|565153855|FG005|Overall Study|Withdrew Consent|1|||
156564333|NCT04854499|565153850|FG000|Overall Study|Lost to Follow-up|0|||
156564334|NCT04854499|565153851|FG001|Overall Study|Lost to Follow-up|0|||
156564335|NCT04854499|565153852|FG002|Overall Study|Lost to Follow-up|0|||
156564336|NCT04854499|565153853|FG003|Overall Study|Lost to Follow-up|0|||
156564337|NCT04854499|565153854|FG004|Overall Study|Lost to Follow-up|0|||
156564338|NCT04854499|565153855|FG005|Overall Study|Lost to Follow-up|1|||
156564339|NCT00582556|565153858|FG000|Overall Study|Withdrawal by Subject|0|||
156564340|NCT00582556|565153859|FG001|Overall Study|Withdrawal by Subject|1|||
156564341|NCT00582556|565153860|FG002|Overall Study|Withdrawal by Subject|1|||
156564342|NCT00582556|565153858|FG000|Overall Study|Physician Decision|0|||
156564343|NCT00582556|565153859|FG001|Overall Study|Physician Decision|0|||
156564344|NCT00582556|565153860|FG002|Overall Study|Physician Decision|1|||
156564345|NCT01993888|565153861|FG000|Overall Study|Death|1|||
156564346|NCT01993888|565153862|FG001|Overall Study|Death|1|||
156564347|NCT01993888|565153861|FG000|Overall Study|Lost to Follow-up|1|||
156564348|NCT01993888|565153862|FG001|Overall Study|Lost to Follow-up|1|||
156564349|NCT01993888|565153861|FG000|Overall Study|Withdrawal by Subject|0|||
156564350|NCT01993888|565153862|FG001|Overall Study|Withdrawal by Subject|1|||
156564351|NCT02300129|565153867|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
156564352|NCT02300129|565153868|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
156564353|NCT02300129|565153869|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
156564354|NCT02300129|565153870|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
156564355|NCT02300129|565153867|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
156564356|NCT02300129|565153868|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
156564357|NCT02300129|565153869|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
156564358|NCT02300129|565153870|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
156564359|NCT02300129|565153867|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
156564360|NCT02300129|565153868|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
156564361|NCT02300129|565153869|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
156564362|NCT02300129|565153870|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
156564363|NCT02747927|565153871|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
156564364|NCT02747927|565153872|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
156564365|NCT02747927|565153871|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
156564366|NCT02747927|565153872|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
156564367|NCT02747927|565153871|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
156564368|NCT02747927|565153872|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
156564369|NCT02747927|565153871|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
156564370|NCT02747927|565153872|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
156564371|NCT02747927|565153871|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
156564372|NCT02747927|565153872|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
156564373|NCT02747927|565153871|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
156564374|NCT02747927|565153872|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
156564375|NCT02747927|565153871|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
156564376|NCT02747927|565153872|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
156564377|NCT02747927|565153871|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
156564378|NCT02747927|565153872|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
156564379|NCT02747927|565153871|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
156564380|NCT02747927|565153872|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
156564381|NCT02747927|565153871|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
156564382|NCT02747927|565153872|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
156564383|NCT02747927|565153871|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
156564384|NCT02747927|565153872|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
156564385|NCT02747927|565153871|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
156564386|NCT02747927|565153872|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
156564387|NCT02747927|565153871|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
156564388|NCT02747927|565153872|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
156564389|NCT02747927|565153871|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
156564390|NCT02747927|565153872|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
156564391|NCT02747927|565153871|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
156564392|NCT02747927|565153872|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
156564393|NCT02747927|565153871|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
156564394|NCT02747927|565153872|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
156564395|NCT02747927|565153871|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
156564396|NCT02747927|565153872|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
156564397|NCT02747927|565153871|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
156564398|NCT02747927|565153872|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
156564399|NCT02747927|565153871|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
156564400|NCT02747927|565153872|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
156564401|NCT02747927|565153871|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
156564402|NCT02747927|565153872|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
156564403|NCT02747927|565153871|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
156564404|NCT02747927|565153872|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
156564405|NCT02747927|565153871|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
156564406|NCT02747927|565153872|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
156564407|NCT02747927|565153871|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
156564408|NCT02747927|565153872|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
156564409|NCT02747927|565153871|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
156564410|NCT02747927|565153872|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
156564411|NCT02747927|565153871|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
156564412|NCT02747927|565153872|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
156564413|NCT02747927|565153871|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
156564414|NCT02747927|565153872|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
156564415|NCT02747927|565153871|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
156564416|NCT02747927|565153872|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
156564417|NCT02747927|565153871|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
156564418|NCT02747927|565153872|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
156564419|NCT02747927|565153871|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
156564420|NCT02747927|565153872|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
156564421|NCT02747927|565153871|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
156564422|NCT02747927|565153872|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
156564423|NCT02747927|565153871|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
156564424|NCT02747927|565153872|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
156564425|NCT02747927|565153871|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
156564426|NCT02747927|565153872|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
156564427|NCT00522392|565153876|FG000|Overall Study|Disease progression|0|||
156564428|NCT00522392|565153877|FG001|Overall Study|Disease progression|3|||
156564429|NCT00522392|565153876|FG000|Overall Study|Adverse Event|7|||
156564430|NCT00522392|565153877|FG001|Overall Study|Adverse Event|7|||
156564431|NCT00522392|565153876|FG000|Overall Study|Withdrawal by Subject|1|||
156564432|NCT00522392|565153877|FG001|Overall Study|Withdrawal by Subject|1|||
156564433|NCT00522392|565153876|FG000|Overall Study|Physician Decision|0|||
156564434|NCT00522392|565153877|FG001|Overall Study|Physician Decision|1|||
156564435|NCT00522392|565153876|FG000|Overall Study|Non-compliance|0|||
156564436|NCT00522392|565153877|FG001|Overall Study|Non-compliance|1|||
156564437|NCT00430755|565153880|FG000|Overall Study|Withdrawal by Subject|53|||
156564438|NCT01154101|565153881|FG000|Overall Study|Adverse Event|0|||
156564439|NCT01154101|565153882|FG001|Overall Study|Adverse Event|2|||
156564440|NCT01154101|565153883|FG002|Overall Study|Adverse Event|1|||
156564441|NCT01154101|565153884|FG003|Overall Study|Adverse Event|1|||
156564442|NCT01154101|565153885|FG004|Overall Study|Adverse Event|0|||
156564443|NCT01154101|565153881|FG000|Overall Study|Lost to Follow-up|0|||
156564444|NCT01154101|565153882|FG001|Overall Study|Lost to Follow-up|1|||
156564445|NCT01154101|565153883|FG002|Overall Study|Lost to Follow-up|0|||
156564446|NCT01154101|565153884|FG003|Overall Study|Lost to Follow-up|1|||
156564447|NCT01154101|565153885|FG004|Overall Study|Lost to Follow-up|0|||
156564448|NCT01154101|565153881|FG000|Overall Study|Withdrawal by Subject|0|||
156564449|NCT01154101|565153882|FG001|Overall Study|Withdrawal by Subject|1|||
156564450|NCT01154101|565153883|FG002|Overall Study|Withdrawal by Subject|2|||
156564451|NCT01154101|565153884|FG003|Overall Study|Withdrawal by Subject|0|||
156564452|NCT01154101|565153885|FG004|Overall Study|Withdrawal by Subject|1|||
156564453|NCT05019131|565153886|FG000|Overall Study|Lost to Follow-up|0|||
156564454|NCT05019131|565153887|FG001|Overall Study|Lost to Follow-up|3|||
156564455|NCT03575104|565153888|FG000|Overall Study|Adverse Event|4|||
156564456|NCT03575104|565153889|FG001|Overall Study|Adverse Event|3|||
156564457|NCT03575104|565153890|FG002|Overall Study|Adverse Event|4|||
156564458|NCT03575104|565153888|FG000|Overall Study|Withdrawal by Subject|13|||
156564459|NCT03575104|565153889|FG001|Overall Study|Withdrawal by Subject|16|||
156564460|NCT03575104|565153890|FG002|Overall Study|Withdrawal by Subject|11|||
156564461|NCT03575104|565153888|FG000|Overall Study|Other reasons|6|||
156564462|NCT03575104|565153889|FG001|Overall Study|Other reasons|8|||
156564463|NCT03575104|565153890|FG002|Overall Study|Other reasons|6|||
156564464|NCT03575104|565153888|FG000|Overall Study|Lost to Follow-up|1|||
156564465|NCT03575104|565153889|FG001|Overall Study|Lost to Follow-up|2|||
156564466|NCT03575104|565153890|FG002|Overall Study|Lost to Follow-up|1|||
156564467|NCT00988247|565153891|FG000|Overall Study|Adverse Event|17|||
156564468|NCT00988247|565153892|FG001|Overall Study|Adverse Event|3|||
156564469|NCT00988247|565153891|FG000|Overall Study|Withdrawal by Subject|44|||
156564470|NCT00988247|565153892|FG001|Overall Study|Withdrawal by Subject|13|||
156564471|NCT00988247|565153891|FG000|Overall Study|Pregnancy|1|||
156564472|NCT00988247|565153892|FG001|Overall Study|Pregnancy|2|||
156564473|NCT00988247|565153891|FG000|Overall Study|Lost to Follow-up|11|||
156564474|NCT00988247|565153892|FG001|Overall Study|Lost to Follow-up|2|||
156564475|NCT00988247|565153891|FG000|Overall Study|Protocol Violation|4|||
156564476|NCT00988247|565153892|FG001|Overall Study|Protocol Violation|5|||
156564477|NCT00988247|565153891|FG000|Overall Study|Sponsor requested withdrawal|3|||
156564478|NCT00988247|565153892|FG001|Overall Study|Sponsor requested withdrawal|1|||
156564479|NCT00988247|565153891|FG000|Overall Study|Other|3|||
156564480|NCT00988247|565153892|FG001|Overall Study|Other|0|||
156564481|NCT01409928|565153893|FG000|Overall Study|Physician Decision|12|||
156564482|NCT02661594|565153894|FG000|Overall Study|Protocol Violation|1|||
156564483|NCT02661594|565153895|FG001|Overall Study|Protocol Violation|0|||
156564484|NCT02661594|565153896|FG002|Overall Study|Protocol Violation|1|||
156564485|NCT02661594|565153897|FG003|Overall Study|Protocol Violation|0|||
156564486|NCT00432237|565153898|FG000|Overall Study|Adverse Event|0|||
156564487|NCT00432237|565153899|FG001|Overall Study|Adverse Event|0|||
156564488|NCT00432237|565153900|FG002|Overall Study|Adverse Event|0|||
156564489|NCT00432237|565153901|FG003|Overall Study|Adverse Event|1|||
156564490|NCT00432237|565153898|FG000|Overall Study|Lack of Efficacy|0|||
156564491|NCT00432237|565153899|FG001|Overall Study|Lack of Efficacy|0|||
156564492|NCT00432237|565153900|FG002|Overall Study|Lack of Efficacy|0|||
156564493|NCT00432237|565153901|FG003|Overall Study|Lack of Efficacy|1|||
156564494|NCT00432237|565153898|FG000|Overall Study|Lost to Follow-up|10|||
156564495|NCT00432237|565153899|FG001|Overall Study|Lost to Follow-up|10|||
156564496|NCT00432237|565153900|FG002|Overall Study|Lost to Follow-up|18|||
156564497|NCT00432237|565153901|FG003|Overall Study|Lost to Follow-up|18|||
156564498|NCT00432237|565153898|FG000|Overall Study|Physician Decision|1|||
156564499|NCT00432237|565153899|FG001|Overall Study|Physician Decision|3|||
156564500|NCT00432237|565153900|FG002|Overall Study|Physician Decision|2|||
156564501|NCT00432237|565153901|FG003|Overall Study|Physician Decision|1|||
156564502|NCT00432237|565153898|FG000|Overall Study|Pregnancy|0|||
156564503|NCT00432237|565153899|FG001|Overall Study|Pregnancy|1|||
156564504|NCT00432237|565153900|FG002|Overall Study|Pregnancy|0|||
156564505|NCT00432237|565153901|FG003|Overall Study|Pregnancy|0|||
156564506|NCT00432237|565153898|FG000|Overall Study|Protocol Violation|13|||
156564507|NCT00432237|565153899|FG001|Overall Study|Protocol Violation|10|||
156564508|NCT00432237|565153900|FG002|Overall Study|Protocol Violation|11|||
156564509|NCT00432237|565153901|FG003|Overall Study|Protocol Violation|8|||
156564510|NCT00432237|565153898|FG000|Overall Study|Withdrawal by Subject|5|||
156564511|NCT00432237|565153899|FG001|Overall Study|Withdrawal by Subject|6|||
156564512|NCT00432237|565153900|FG002|Overall Study|Withdrawal by Subject|9|||
156564513|NCT00432237|565153901|FG003|Overall Study|Withdrawal by Subject|11|||
156564514|NCT00432237|565153898|FG000|Overall Study|Lack of Qualifying Event|38|||
156564515|NCT00432237|565153899|FG001|Overall Study|Lack of Qualifying Event|71|||
156564516|NCT00432237|565153900|FG002|Overall Study|Lack of Qualifying Event|69|||
156564517|NCT00432237|565153901|FG003|Overall Study|Lack of Qualifying Event|84|||
156564518|NCT01354132|565153902|FG000|Randomization|Physician Decision|1|||
156564519|NCT01354132|565153903|FG001|Randomization|Physician Decision|0|||
156564520|NCT01354132|565153902|FG000|Randomization|Withdrawal by Subject|0|||
156564521|NCT01354132|565153903|FG001|Randomization|Withdrawal by Subject|1|||
156564522|NCT01354132|565153902|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
156564523|NCT01354132|565153903|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
156564524|NCT01354132|565153902|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
156564525|NCT01354132|565153903|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
156564526|NCT01354132|565153902|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
156564527|NCT01354132|565153903|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
156564528|NCT02360098|565153904|FG000|Overall Study|Physician Decision|7|||
156564529|NCT01919307|565153910|FG000|Overall Study|Withdrawal by Subject|9|||
156564530|NCT05052723|565153912|FG000|Overall Study|Death|19|||
156564531|NCT02771522|565153913|FG000|Overall Study|Lost to Follow-up|3|||
156564532|NCT02771522|565153913|FG000|Overall Study|Withdrawal by Subject|2|||
156564533|NCT02771522|565153913|FG000|Overall Study|No white spot lesions|3|||
156564534|NCT02054702|565153918|FG000|Overall Study|Lost to Follow-up|3|||
156564535|NCT02054702|565153919|FG001|Overall Study|Lost to Follow-up|5|||
156564536|NCT02054702|565153918|FG000|Overall Study|Adverse Event|3|||
156564537|NCT02054702|565153919|FG001|Overall Study|Adverse Event|1|||
156564538|NCT02054702|565153918|FG000|Overall Study|Met Withdrawal Criteria|4|||
156564539|NCT02054702|565153919|FG001|Overall Study|Met Withdrawal Criteria|1|||
156564540|NCT02054702|565153918|FG000|Overall Study|Physician Decision|0|||
156564541|NCT02054702|565153919|FG001|Overall Study|Physician Decision|1|||
156564542|NCT02054702|565153918|FG000|Overall Study|Withdrawal by Subject|14|||
156564543|NCT02054702|565153919|FG001|Overall Study|Withdrawal by Subject|4|||
156564544|NCT01262898|565153920|FG000|Overall Study|Protocol Violation|1|||
156564545|NCT01262898|565153921|FG001|Overall Study|Protocol Violation|1|||
156564546|NCT01262898|565153922|FG002|Overall Study|Protocol Violation|0|||
156564547|NCT01262898|565153923|FG003|Overall Study|Protocol Violation|0|||
156564548|NCT01262898|565153920|FG000|Overall Study|Lost to Follow-up|1|||
156564549|NCT01262898|565153921|FG001|Overall Study|Lost to Follow-up|0|||
156564550|NCT01262898|565153922|FG002|Overall Study|Lost to Follow-up|0|||
156564551|NCT01262898|565153923|FG003|Overall Study|Lost to Follow-up|0|||
156564552|NCT01262898|565153920|FG000|Overall Study|Withdrawal by Subject|1|||
156564553|NCT01262898|565153921|FG001|Overall Study|Withdrawal by Subject|1|||
156564554|NCT01262898|565153922|FG002|Overall Study|Withdrawal by Subject|0|||
156564555|NCT01262898|565153923|FG003|Overall Study|Withdrawal by Subject|0|||
156564556|NCT02388295|565153929|FG000|Dose Escalation Week 1|Adverse Event|1|||
156564557|NCT02388295|565153930|FG001|Dose Escalation Week 1|Adverse Event|2|||
156564558|NCT02388295|565153931|FG002|Dose Escalation Week 1|Adverse Event|1|||
156564559|NCT02388295|565153929|FG000|Dose Escalation Week 1|Determined not eligible|1|||
156564560|NCT02388295|565153930|FG001|Dose Escalation Week 1|Determined not eligible|1|||
156564561|NCT02388295|565153931|FG002|Dose Escalation Week 1|Determined not eligible|1|||
156564562|NCT02388295|565153929|FG000|Dose Escalation Week 2|Protocol Violation|0|||
156564563|NCT02388295|565153930|FG001|Dose Escalation Week 2|Protocol Violation|1|||
156564564|NCT02388295|565153931|FG002|Dose Escalation Week 2|Protocol Violation|0|||
156564565|NCT02388295|565153929|FG000|Dose Escalation Week 2|Determined not eligible|1|||
156564566|NCT02388295|565153930|FG001|Dose Escalation Week 2|Determined not eligible|1|||
156564567|NCT02388295|565153931|FG002|Dose Escalation Week 2|Determined not eligible|1|||
156564568|NCT02388295|565153929|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
156564569|NCT02388295|565153930|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
156564570|NCT02388295|565153931|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
156564571|NCT01551693|565153932|FG000|Overall Study|Disease Progression|1|||
156564572|NCT01551693|565153933|FG001|Overall Study|Disease Progression|0|||
156564573|NCT01551693|565153932|FG000|Overall Study|Adverse Event|0|||
156564574|NCT01551693|565153933|FG001|Overall Study|Adverse Event|1|||
156564575|NCT01551693|565153932|FG000|Overall Study|Withdrawal by Subject|0|||
156564576|NCT01551693|565153933|FG001|Overall Study|Withdrawal by Subject|1|||
156564577|NCT04134494|565153937|FG000|Overall Study|Lost to Follow-up|2|||
156564578|NCT00781365|565153938|FG000|Overall Study|Withdrawal by Subject|13|||
156564579|NCT00781365|565153939|FG001|Overall Study|Withdrawal by Subject|8|||
156564580|NCT00781365|565153938|FG000|Overall Study|Did Not Attend Visit|20|||
156564581|NCT00781365|565153939|FG001|Overall Study|Did Not Attend Visit|28|||
156564582|NCT00781365|565153938|FG000|Overall Study|Language barrier|1|||
156564583|NCT00781365|565153939|FG001|Overall Study|Language barrier|0|||
156564584|NCT00723957|565153944|FG000|Overall Study|Adverse event unrelated to study drug|1|||
156564585|NCT00723957|565153945|FG001|Overall Study|Adverse event unrelated to study drug|4|||
156564586|NCT00723957|565153944|FG000|Overall Study|Death|3|||
156564587|NCT00723957|565153945|FG001|Overall Study|Death|4|||
156564588|NCT00723957|565153944|FG000|Overall Study|Disease progression|27|||
156564589|NCT00723957|565153945|FG001|Overall Study|Disease progression|25|||
156564590|NCT00723957|565153944|FG000|Overall Study|Maximum clinical benefit|4|||
156564591|NCT00723957|565153945|FG001|Overall Study|Maximum clinical benefit|5|||
156564592|NCT00723957|565153944|FG000|Overall Study|Investigator decision|1|||
156564593|NCT00723957|565153945|FG001|Overall Study|Investigator decision|1|||
156564594|NCT00723957|565153944|FG000|Overall Study|Study drug toxicity|4|||
156564595|NCT00723957|565153945|FG001|Overall Study|Study drug toxicity|6|||
156564596|NCT00723957|565153944|FG000|Overall Study|Withdrawal by Subject|7|||
156564597|NCT00723957|565153945|FG001|Overall Study|Withdrawal by Subject|5|||
156564598|NCT00723957|565153944|FG000|Overall Study|Reason not analyzed|1|||
156564599|NCT00723957|565153945|FG001|Overall Study|Reason not analyzed|0|||
156564600|NCT00723957|565153944|FG000|Overall Study|Never received treatment|3|||
156564601|NCT00723957|565153945|FG001|Overall Study|Never received treatment|3|||
156564602|NCT01360996|565153950|FG000|Overall Study|Withdrawal by Subject|4|||
156564603|NCT01360996|565153951|FG001|Overall Study|Withdrawal by Subject|3|||
156564604|NCT01360996|565153952|FG002|Overall Study|Withdrawal by Subject|2|||
156564605|NCT01360996|565153950|FG000|Overall Study|Noncompliant|2|||
156564606|NCT01360996|565153951|FG001|Overall Study|Noncompliant|0|||
156564607|NCT01360996|565153952|FG002|Overall Study|Noncompliant|0|||
156564608|NCT03377634|565153953|FG000|Study Period|Adverse Event|1|||
156564609|NCT03377634|565153954|FG001|Study Period|Adverse Event|0|||
156564610|NCT03377634|565153953|FG000|Study Period|Withdrawal by Subject|1|||
156564611|NCT03377634|565153954|FG001|Study Period|Withdrawal by Subject|0|||
156564612|NCT01454076|565153955|FG000|Overall Study|Other|2|||
156564613|NCT01454076|565153956|FG001|Overall Study|Other|0|||
156564614|NCT01454076|565153957|FG002|Overall Study|Other|0|||
156564615|NCT01454076|565153958|FG003|Overall Study|Other|1|||
156564616|NCT01454076|565153959|FG004|Overall Study|Other|2|||
156564617|NCT01454076|565153955|FG000|Overall Study|Withdrawal by Subject|3|||
156564618|NCT01454076|565153956|FG001|Overall Study|Withdrawal by Subject|4|||
156564619|NCT01454076|565153957|FG002|Overall Study|Withdrawal by Subject|2|||
156564620|NCT01454076|565153958|FG003|Overall Study|Withdrawal by Subject|1|||
156564621|NCT01454076|565153959|FG004|Overall Study|Withdrawal by Subject|2|||
156564622|NCT01454076|565153955|FG000|Overall Study|Adverse Event|8|||
156564623|NCT01454076|565153956|FG001|Overall Study|Adverse Event|2|||
156564624|NCT01454076|565153957|FG002|Overall Study|Adverse Event|7|||
156564625|NCT01454076|565153958|FG003|Overall Study|Adverse Event|0|||
156564626|NCT01454076|565153959|FG004|Overall Study|Adverse Event|2|||
156564627|NCT02965378|565153960|FG000|Overall Study|Progression|16|||
156564628|NCT02965378|565153961|FG001|Overall Study|Progression|4|||
156564629|NCT02965378|565153960|FG000|Overall Study|Adverse Event|5|||
156564630|NCT02965378|565153961|FG001|Overall Study|Adverse Event|2|||
156564631|NCT02965378|565153960|FG000|Overall Study|Death|2|||
156564632|NCT02965378|565153961|FG001|Overall Study|Death|0|||
156564633|NCT02965378|565153960|FG000|Overall Study|Refusal|2|||
156564634|NCT02965378|565153961|FG001|Overall Study|Refusal|1|||
156564635|NCT02965378|565153960|FG000|Overall Study|Not protocol specified|0|||
156564636|NCT02965378|565153961|FG001|Overall Study|Not protocol specified|2|||
156564637|NCT04964258|565153962|FG000|Overall Study|Lost to Follow-up|1|||
156564638|NCT04964258|565153963|FG001|Overall Study|Lost to Follow-up|0|||
156564639|NCT04964258|565153964|FG002|Overall Study|Lost to Follow-up|0|||
156564640|NCT04964258|565153965|FG003|Overall Study|Lost to Follow-up|0|||
156564641|NCT04964258|565153966|FG004|Overall Study|Lost to Follow-up|0|||
156564642|NCT04964258|565153967|FG005|Overall Study|Lost to Follow-up|1|||
156564643|NCT04964258|565153968|FG006|Overall Study|Lost to Follow-up|0|||
156564644|NCT04964258|565153969|FG007|Overall Study|Lost to Follow-up|0|||
156564645|NCT04964258|565153970|FG008|Overall Study|Lost to Follow-up|0|||
156564646|NCT04964258|565153971|FG009|Overall Study|Lost to Follow-up|0|||
156564647|NCT04964258|565153972|FG010|Overall Study|Lost to Follow-up|0|||
156564648|NCT04525703|565153975|FG000|Overall Study|Lost to Follow-up|6|||
156564649|NCT04525703|565153976|FG001|Overall Study|Lost to Follow-up|15|||
156564650|NCT04525703|565153977|FG002|Overall Study|Lost to Follow-up|8|||
156564651|NCT00961961|565153978|FG000|Phase I|Withdrawal by Subject|7|||
156564652|NCT00961961|565153979|FG001|Phase I|Withdrawal by Subject|0|||
156564653|NCT00961961|565153980|FG002|Phase I|Withdrawal by Subject|0|||
156564654|NCT00961961|565153981|FG003|Phase I|Withdrawal by Subject|0|||
156564655|NCT00961961|565153978|FG000|Phase I|Lost to Follow-up|10|||
156564656|NCT00961961|565153979|FG001|Phase I|Lost to Follow-up|0|||
156564657|NCT00961961|565153980|FG002|Phase I|Lost to Follow-up|0|||
156564658|NCT00961961|565153981|FG003|Phase I|Lost to Follow-up|0|||
156564659|NCT00961961|565153978|FG000|Phase I|Lack of Efficacy|94|||
156564660|NCT00961961|565153979|FG001|Phase I|Lack of Efficacy|0|||
156564661|NCT00961961|565153980|FG002|Phase I|Lack of Efficacy|0|||
156564662|NCT00961961|565153981|FG003|Phase I|Lack of Efficacy|0|||
156564663|NCT00961961|565153978|FG000|Phase I|Adverse Event|7|||
156564664|NCT00961961|565153979|FG001|Phase I|Adverse Event|0|||
156564665|NCT00961961|565153980|FG002|Phase I|Adverse Event|0|||
156564666|NCT00961961|565153981|FG003|Phase I|Adverse Event|0|||
156564667|NCT00961961|565153978|FG000|Phase I|Physician Decision|8|||
156564668|NCT00961961|565153979|FG001|Phase I|Physician Decision|0|||
156564669|NCT00961961|565153980|FG002|Phase I|Physician Decision|0|||
156564670|NCT00961961|565153981|FG003|Phase I|Physician Decision|0|||
156564671|NCT00961961|565153978|FG000|Phase II|Lost to Follow-up|0|||
156564672|NCT00961961|565153979|FG001|Phase II|Lost to Follow-up|0|||
156564673|NCT00961961|565153980|FG002|Phase II|Lost to Follow-up|10|||
156564674|NCT00961961|565153981|FG003|Phase II|Lost to Follow-up|7|||
156564675|NCT00961961|565153978|FG000|Phase II|Adverse Event|0|||
156564676|NCT00961961|565153979|FG001|Phase II|Adverse Event|0|||
156564677|NCT00961961|565153980|FG002|Phase II|Adverse Event|0|||
156564678|NCT00961961|565153981|FG003|Phase II|Adverse Event|1|||
156564679|NCT00961961|565153978|FG000|Phase II|Physician Decision|0|||
156564680|NCT00961961|565153979|FG001|Phase II|Physician Decision|0|||
156564681|NCT00961961|565153980|FG002|Phase II|Physician Decision|1|||
156564682|NCT00961961|565153981|FG003|Phase II|Physician Decision|0|||
156564683|NCT00961961|565153978|FG000|Phase II|Withdrawal by Subject|0|||
156564684|NCT00961961|565153979|FG001|Phase II|Withdrawal by Subject|0|||
156564685|NCT00961961|565153980|FG002|Phase II|Withdrawal by Subject|1|||
156564686|NCT00961961|565153981|FG003|Phase II|Withdrawal by Subject|0|||
156564687|NCT03136107|565153984|FG000|Overall Study|Other (Not specified)|1|||
156564688|NCT03283085|565153985|FG000|Overall Study|Adverse Event|18|||
156564689|NCT03283085|565153986|FG001|Overall Study|Adverse Event|3|||
156564690|NCT03283085|565153987|FG002|Overall Study|Adverse Event|13|||
156564691|NCT03283085|565153988|FG003|Overall Study|Adverse Event|0|||
156564692|NCT03283085|565153989|FG004|Overall Study|Adverse Event|0|||
156564693|NCT03283085|565153990|FG005|Overall Study|Adverse Event|5|||
156564694|NCT03283085|565153985|FG000|Overall Study|Death|0|||
156564695|NCT03283085|565153986|FG001|Overall Study|Death|0|||
156564696|NCT03283085|565153987|FG002|Overall Study|Death|3|||
156564697|NCT03283085|565153988|FG003|Overall Study|Death|1|||
156564698|NCT03283085|565153989|FG004|Overall Study|Death|0|||
156564699|NCT03283085|565153990|FG005|Overall Study|Death|0|||
156564700|NCT03283085|565153985|FG000|Overall Study|Withdrawal by Subject|42|||
156564701|NCT03283085|565153986|FG001|Overall Study|Withdrawal by Subject|21|||
156564702|NCT03283085|565153987|FG002|Overall Study|Withdrawal by Subject|66|||
156564703|NCT03283085|565153988|FG003|Overall Study|Withdrawal by Subject|3|||
156564704|NCT03283085|565153989|FG004|Overall Study|Withdrawal by Subject|3|||
156564705|NCT03283085|565153990|FG005|Overall Study|Withdrawal by Subject|5|||
156564706|NCT03283085|565153985|FG000|Overall Study|Physician Decision|14|||
156564707|NCT03283085|565153986|FG001|Overall Study|Physician Decision|8|||
156564708|NCT03283085|565153987|FG002|Overall Study|Physician Decision|19|||
156564709|NCT03283085|565153988|FG003|Overall Study|Physician Decision|0|||
156564710|NCT03283085|565153989|FG004|Overall Study|Physician Decision|0|||
156564711|NCT03283085|565153990|FG005|Overall Study|Physician Decision|2|||
156564712|NCT03283085|565153985|FG000|Overall Study|Site Terminated by Sponsor|1|||
156564713|NCT03283085|565153986|FG001|Overall Study|Site Terminated by Sponsor|0|||
156564714|NCT03283085|565153987|FG002|Overall Study|Site Terminated by Sponsor|3|||
156564715|NCT03283085|565153988|FG003|Overall Study|Site Terminated by Sponsor|0|||
156564716|NCT03283085|565153989|FG004|Overall Study|Site Terminated by Sponsor|0|||
156564717|NCT03283085|565153990|FG005|Overall Study|Site Terminated by Sponsor|0|||
156564718|NCT03283085|565153985|FG000|Overall Study|Lost to Follow-up|2|||
156564719|NCT03283085|565153986|FG001|Overall Study|Lost to Follow-up|0|||
156564720|NCT03283085|565153987|FG002|Overall Study|Lost to Follow-up|2|||
156564721|NCT03283085|565153988|FG003|Overall Study|Lost to Follow-up|0|||
156564722|NCT03283085|565153989|FG004|Overall Study|Lost to Follow-up|0|||
156564723|NCT03283085|565153990|FG005|Overall Study|Lost to Follow-up|1|||
156564724|NCT03283085|565153985|FG000|Overall Study|Pregnancy|0|||
156564725|NCT03283085|565153986|FG001|Overall Study|Pregnancy|0|||
156564726|NCT03283085|565153987|FG002|Overall Study|Pregnancy|1|||
156564727|NCT03283085|565153988|FG003|Overall Study|Pregnancy|0|||
156564728|NCT03283085|565153989|FG004|Overall Study|Pregnancy|0|||
156564729|NCT03283085|565153990|FG005|Overall Study|Pregnancy|0|||
156564730|NCT03283085|565153985|FG000|Overall Study|Lack of Efficacy|12|||
156564731|NCT03283085|565153986|FG001|Overall Study|Lack of Efficacy|6|||
156564732|NCT03283085|565153987|FG002|Overall Study|Lack of Efficacy|24|||
156564733|NCT03283085|565153988|FG003|Overall Study|Lack of Efficacy|1|||
156564734|NCT03283085|565153989|FG004|Overall Study|Lack of Efficacy|1|||
156564735|NCT03283085|565153990|FG005|Overall Study|Lack of Efficacy|0|||
156564736|NCT03283085|565153985|FG000|Overall Study|Reason not Specified|0|||
156564737|NCT03283085|565153986|FG001|Overall Study|Reason not Specified|4|||
156564738|NCT03283085|565153987|FG002|Overall Study|Reason not Specified|8|||
156564739|NCT03283085|565153988|FG003|Overall Study|Reason not Specified|0|||
156564740|NCT03283085|565153989|FG004|Overall Study|Reason not Specified|0|||
156564741|NCT03283085|565153990|FG005|Overall Study|Reason not Specified|1|||
156564742|NCT00891202|565153991|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
156564743|NCT00891202|565153992|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
156564744|NCT00891202|565153993|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
156564745|NCT00891202|565153994|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
156564746|NCT00891202|565153991|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
156564747|NCT00891202|565153992|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
156564748|NCT00891202|565153993|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
156564749|NCT00891202|565153994|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
156564750|NCT00891202|565153991|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
156564751|NCT00891202|565153992|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
156564752|NCT00891202|565153993|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
156564753|NCT00891202|565153994|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
156564754|NCT00891202|565153991|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
156564755|NCT00891202|565153992|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
156564756|NCT00891202|565153993|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
156564757|NCT00891202|565153994|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
156564758|NCT02292771|565153998|FG000|Overall Study|Withdrawal by Subject|2|||
156564759|NCT02292771|565153999|FG001|Overall Study|Withdrawal by Subject|1|||
156564760|NCT02292771|565153998|FG000|Overall Study|Lost to Follow-up|2|||
156564761|NCT02292771|565153999|FG001|Overall Study|Lost to Follow-up|1|||
156564762|NCT04280081|565154000|FG000|Overall Study|Adverse Event|4|||
156564763|NCT04280081|565154000|FG000|Overall Study|Death|2|||
156564764|NCT04280081|565154000|FG000|Overall Study|Progressive Disease|6|||
156564765|NCT04840667|565155677|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
156564766|NCT01609933|565155681|FG000|Overall Study|Adverse Event|1|||
156564767|NCT01609933|565155681|FG000|Overall Study|Withdrawal by Subject|3|||
156564768|NCT01252966|565155682|FG000|Overall Study|Lost to Follow-up|16|||
156564769|NCT01252966|565155683|FG001|Overall Study|Lost to Follow-up|10|||
156564770|NCT01252966|565155682|FG000|Overall Study|Withdrawal by Subject|7|||
156564771|NCT01252966|565155683|FG001|Overall Study|Withdrawal by Subject|3|||
156564772|NCT00398112|565155702|FG000|Overall Study|Adverse Event|4|||
156564773|NCT00398112|565155702|FG000|Overall Study|Disease progression|9|||
156564774|NCT00398112|565155702|FG000|Overall Study|Alternative treatment|1|||
156564775|NCT00398112|565155702|FG000|Overall Study|Withdrawal by Subject|3|||
156564776|NCT00398112|565155702|FG000|Overall Study|Death|1|||
156564777|NCT03932812|565155704|FG000|Overall Study|Lost to Follow-up|12|||
156564778|NCT03932812|565155705|FG001|Overall Study|Lost to Follow-up|14|||
156564779|NCT03932812|565155704|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
156564780|NCT03932812|565155705|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
156564781|NCT00191854|565155712|FG000|Overall Study|Death|26|||
156564782|NCT00191854|565155713|FG001|Overall Study|Death|23|||
156564783|NCT00191854|565155714|FG002|Overall Study|Death|29|||
156564784|NCT00191854|565155712|FG000|Overall Study|Lost to Follow-up|7|||
156564785|NCT00191854|565155713|FG001|Overall Study|Lost to Follow-up|5|||
156564786|NCT00191854|565155714|FG002|Overall Study|Lost to Follow-up|5|||
156564787|NCT00191854|565155712|FG000|Overall Study|Withdrawal by Subject|4|||
156564788|NCT00191854|565155713|FG001|Overall Study|Withdrawal by Subject|2|||
156564789|NCT00191854|565155714|FG002|Overall Study|Withdrawal by Subject|3|||
156564790|NCT00191854|565155712|FG000|Overall Study|Sponsor Decision|0|||
156564791|NCT00191854|565155713|FG001|Overall Study|Sponsor Decision|0|||
156564792|NCT00191854|565155714|FG002|Overall Study|Sponsor Decision|1|||
156564793|NCT00191854|565155712|FG000|Overall Study|Screen Failure|0|||
156564794|NCT00191854|565155713|FG001|Overall Study|Screen Failure|0|||
156564795|NCT00191854|565155714|FG002|Overall Study|Screen Failure|1|||
156564796|NCT01933932|565155715|FG000|Overall Study|Death|173|||
156564797|NCT01933932|565155716|FG001|Overall Study|Death|163|||
156564798|NCT01933932|565155715|FG000|Overall Study|Withdrawal by Subject|11|||
156564799|NCT01933932|565155716|FG001|Overall Study|Withdrawal by Subject|14|||
156564800|NCT01933932|565155715|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156564801|NCT01933932|565155716|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156564802|NCT00934102|565155721|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
156564803|NCT00934102|565155722|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
156564804|NCT00934102|565155723|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
156564805|NCT03304522|565155724|FG000|Overall Study|Adverse Event|0|||
156564806|NCT03304522|565155725|FG001|Overall Study|Adverse Event|4|||
156564807|NCT03304522|565155724|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
156564808|NCT03304522|565155725|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
156564809|NCT03304522|565155724|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
156564810|NCT03304522|565155725|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
156564811|NCT03304522|565155724|FG000|Overall Study|Other|0|||
156564812|NCT03304522|565155725|FG001|Overall Study|Other|1|||
156564813|NCT02649634|565155729|FG000|Overall Study|Withdrawal by Subject|3|||
156564814|NCT02649634|565155730|FG001|Overall Study|Withdrawal by Subject|5|||
156564815|NCT02649634|565155729|FG000|Overall Study|Lost to Follow-up|0|||
156564816|NCT02649634|565155730|FG001|Overall Study|Lost to Follow-up|1|||
156564817|NCT00763009|565155732|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
156564818|NCT01111604|565155733|FG000|Overall Study|Lost to Follow-up|0|||
156564819|NCT01111604|565155734|FG001|Overall Study|Lost to Follow-up|0|||
156564820|NCT01111604|565155735|FG002|Overall Study|Lost to Follow-up|1|||
156564821|NCT01111604|565155733|FG000|Overall Study|Withdrew Consent|3|||
156564822|NCT01111604|565155734|FG001|Overall Study|Withdrew Consent|0|||
156564823|NCT01111604|565155735|FG002|Overall Study|Withdrew Consent|2|||
156564824|NCT01111604|565155733|FG000|Overall Study|Withdrawal by Subject|2|||
156564825|NCT01111604|565155734|FG001|Overall Study|Withdrawal by Subject|0|||
156564826|NCT01111604|565155735|FG002|Overall Study|Withdrawal by Subject|0|||
156564827|NCT01111604|565155733|FG000|Overall Study|Death|1|||
156564828|NCT01111604|565155734|FG001|Overall Study|Death|0|||
156564829|NCT01111604|565155735|FG002|Overall Study|Death|0|||
156564830|NCT01111604|565155733|FG000|Overall Study|Met Exclusion Criteria|2|||
156564831|NCT01111604|565155734|FG001|Overall Study|Met Exclusion Criteria|0|||
156564832|NCT01111604|565155735|FG002|Overall Study|Met Exclusion Criteria|0|||
156564833|NCT01295125|565155737|FG000|Overall Study|Study stopped prematurely|9|||
156564834|NCT01355289|565155738|FG000|Core Study|Adverse Event, Non-Fatal|1|||
156564835|NCT01355289|565155739|FG001|Core Study|Adverse Event, Non-Fatal|0|||
156564836|NCT01355289|565155740|FG002|Core Study|Adverse Event, Non-Fatal|0|||
156564837|NCT01355289|565155741|FG003|Core Study|Adverse Event, Non-Fatal|0|||
156564838|NCT01355289|565155742|FG004|Core Study|Adverse Event, Non-Fatal|0|||
156564839|NCT01355289|565155738|FG000|Core Study|Inadequate Therapeutic Effect|0|||
156564840|NCT01355289|565155739|FG001|Core Study|Inadequate Therapeutic Effect|0|||
156564841|NCT01355289|565155740|FG002|Core Study|Inadequate Therapeutic Effect|0|||
156564842|NCT01355289|565155741|FG003|Core Study|Inadequate Therapeutic Effect|1|||
156564843|NCT01355289|565155742|FG004|Core Study|Inadequate Therapeutic Effect|0|||
156564844|NCT01355289|565155738|FG000|Core Study|Other|0|||
156564845|NCT01355289|565155739|FG001|Core Study|Other|0|||
156564846|NCT01355289|565155740|FG002|Core Study|Other|0|||
156564847|NCT01355289|565155741|FG003|Core Study|Other|1|||
156564848|NCT01355289|565155742|FG004|Core Study|Other|0|||
156564849|NCT01355289|565155738|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
156564850|NCT01355289|565155739|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
156564851|NCT01355289|565155740|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
156564852|NCT01355289|565155741|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
156564853|NCT01355289|565155742|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
156564854|NCT01355289|565155738|FG000|Open Label Extension|Lost to Follow-up|0|||
156564855|NCT01355289|565155739|FG001|Open Label Extension|Lost to Follow-up|0|||
156564856|NCT01355289|565155740|FG002|Open Label Extension|Lost to Follow-up|0|||
156564857|NCT01355289|565155741|FG003|Open Label Extension|Lost to Follow-up|0|||
156564858|NCT01355289|565155742|FG004|Open Label Extension|Lost to Follow-up|1|||
156564859|NCT01355289|565155738|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
156564860|NCT01355289|565155739|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
156564861|NCT01355289|565155740|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
156564862|NCT01355289|565155741|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
156564863|NCT01355289|565155742|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
156564864|NCT01355289|565155738|FG000|Open Label Extension|Other|0|||
156564865|NCT01355289|565155739|FG001|Open Label Extension|Other|0|||
156564866|NCT01355289|565155740|FG002|Open Label Extension|Other|0|||
156564867|NCT01355289|565155741|FG003|Open Label Extension|Other|0|||
156564868|NCT01355289|565155742|FG004|Open Label Extension|Other|3|||
156564869|NCT01756456|565155750|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
156564870|NCT01756456|565155751|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
156564871|NCT01756456|565155752|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
156564872|NCT01756456|565155753|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
156564873|NCT01756456|565155754|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
156564874|NCT01756456|565155755|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
156564875|NCT01756456|565155750|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
156564876|NCT01756456|565155751|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
156564877|NCT01756456|565155752|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
156564878|NCT01756456|565155753|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
156564879|NCT01756456|565155754|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
156564880|NCT01756456|565155755|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
156564881|NCT01756456|565155750|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
156564882|NCT01756456|565155751|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
156564883|NCT01756456|565155752|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
156564884|NCT01756456|565155753|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
156564885|NCT01756456|565155754|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
156564886|NCT01756456|565155755|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
156564887|NCT01756456|565155750|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
156564888|NCT01756456|565155751|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
156564889|NCT01756456|565155752|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
156564890|NCT01756456|565155753|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
156564891|NCT01756456|565155754|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
156564892|NCT01756456|565155755|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
156564893|NCT01756456|565155750|FG000|Treatment Period: Phase I/II|Other causes|0|||
156564894|NCT01756456|565155751|FG001|Treatment Period: Phase I/II|Other causes|0|||
156564895|NCT01756456|565155752|FG002|Treatment Period: Phase I/II|Other causes|0|||
156564896|NCT01756456|565155753|FG003|Treatment Period: Phase I/II|Other causes|1|||
156564897|NCT01756456|565155754|FG004|Treatment Period: Phase I/II|Other causes|2|||
156564898|NCT01756456|565155755|FG005|Treatment Period: Phase I/II|Other causes|2|||
156564899|NCT01756456|565155750|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
156564900|NCT01756456|565155751|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
156564901|NCT01756456|565155752|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
156564902|NCT01756456|565155753|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
156564903|NCT01756456|565155754|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
156564904|NCT01756456|565155755|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
156564905|NCT01756456|565155750|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
156564906|NCT01756456|565155751|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
156564907|NCT01756456|565155752|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
156564908|NCT01756456|565155753|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
156564909|NCT01756456|565155754|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
156564910|NCT01756456|565155755|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
156564911|NCT01756456|565155750|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
156564912|NCT01756456|565155751|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
156564913|NCT01756456|565155752|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
156564914|NCT01756456|565155753|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
156564915|NCT01756456|565155754|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
156564916|NCT01756456|565155755|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
156564917|NCT01756456|565155750|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
156564918|NCT01756456|565155751|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
156564919|NCT01756456|565155752|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
156564920|NCT01756456|565155753|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
156564921|NCT01756456|565155754|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
156564922|NCT01756456|565155755|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
156564923|NCT01756456|565155750|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
156564924|NCT01756456|565155751|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
156564925|NCT01756456|565155752|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
156564926|NCT01756456|565155753|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
156564927|NCT01756456|565155754|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
156564928|NCT01756456|565155755|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
156564929|NCT01756456|565155750|FG000|Follow Up Period Phase I/II|Other causes|0|||
156564930|NCT01756456|565155751|FG001|Follow Up Period Phase I/II|Other causes|0|||
156564931|NCT01756456|565155752|FG002|Follow Up Period Phase I/II|Other causes|0|||
156564932|NCT01756456|565155753|FG003|Follow Up Period Phase I/II|Other causes|1|||
156564933|NCT01756456|565155754|FG004|Follow Up Period Phase I/II|Other causes|3|||
156564934|NCT01756456|565155755|FG005|Follow Up Period Phase I/II|Other causes|5|||
156564935|NCT02706938|565155756|FG000|First Period, 6 Weeks|Adverse Event|8|||
156564936|NCT02706938|565155757|FG001|First Period, 6 Weeks|Adverse Event|0|||
156564937|NCT02706938|565155756|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
156564938|NCT02706938|565155757|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
156564939|NCT02706938|565155756|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
156564940|NCT02706938|565155757|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
156564941|NCT02706938|565155756|FG000|Second Period, 6 Weeks|Adverse Event|0|||
156564942|NCT02706938|565155757|FG001|Second Period, 6 Weeks|Adverse Event|7|||
156564943|NCT02706938|565155756|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
156564944|NCT02706938|565155757|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
156564945|NCT03838484|565155760|FG000|Overall Study|Lost to Follow-up|0|||
156564946|NCT03838484|565155761|FG001|Overall Study|Lost to Follow-up|1|||
156564947|NCT03838484|565155762|FG002|Overall Study|Lost to Follow-up|0|||
156564948|NCT03838484|565155763|FG003|Overall Study|Lost to Follow-up|0|||
156564949|NCT02507349|565155764|FG000|Overall Study|Death|12|||
156564950|NCT02507349|565155765|FG001|Overall Study|Death|16|||
156564951|NCT02507349|565155764|FG000|Overall Study|Withdrawal by Subject|1|||
156564952|NCT02507349|565155765|FG001|Overall Study|Withdrawal by Subject|1|||
156564953|NCT02507349|565155764|FG000|Overall Study|Lost to Follow-up|174|||
156564954|NCT02507349|565155765|FG001|Overall Study|Lost to Follow-up|144|||
156564955|NCT00813995|565155766|FG000|Overall Study|Clinical adverse event|9|||
156564956|NCT00813995|565155767|FG001|Overall Study|Clinical adverse event|3|||
156564957|NCT00813995|565155766|FG000|Overall Study|Laboratory adverse event|0|||
156564958|NCT00813995|565155767|FG001|Overall Study|Laboratory adverse event|2|||
156564959|NCT00813995|565155766|FG000|Overall Study|Lack of Efficacy|1|||
156564960|NCT00813995|565155767|FG001|Overall Study|Lack of Efficacy|0|||
156564961|NCT00813995|565155766|FG000|Overall Study|Lost to Follow-up|4|||
156564962|NCT00813995|565155767|FG001|Overall Study|Lost to Follow-up|2|||
156564963|NCT00813995|565155766|FG000|Overall Study|Other reason|2|||
156564964|NCT00813995|565155767|FG001|Overall Study|Other reason|2|||
156564965|NCT00813995|565155766|FG000|Overall Study|Protocol Violation|3|||
156564966|NCT00813995|565155767|FG001|Overall Study|Protocol Violation|2|||
156564967|NCT00813995|565155766|FG000|Overall Study|Subject moved|4|||
156564968|NCT00813995|565155767|FG001|Overall Study|Subject moved|0|||
156564969|NCT00813995|565155766|FG000|Overall Study|Withdrawal by Subject|0|||
156564970|NCT00813995|565155767|FG001|Overall Study|Withdrawal by Subject|5|||
156564971|NCT01614964|565155768|FG000|Overall Study|Withdrawal by Subject|2|||
156564972|NCT01614964|565155769|FG001|Overall Study|Withdrawal by Subject|0|||
156564973|NCT01614964|565155768|FG000|Overall Study|Lost to Follow-up|3|||
156564974|NCT01614964|565155769|FG001|Overall Study|Lost to Follow-up|0|||
156564975|NCT00860470|565155778|FG000|Overall Study|Death|6|||
156564976|NCT00860470|565155779|FG001|Overall Study|Death|10|||
156564977|NCT00860470|565155778|FG000|Overall Study|Moved away|8|||
156564978|NCT00860470|565155779|FG001|Overall Study|Moved away|10|||
156564979|NCT00860470|565155778|FG000|Overall Study|Lost to Follow-up|34|||
156564980|NCT00860470|565155779|FG001|Overall Study|Lost to Follow-up|39|||
156564981|NCT00888238|565155781|FG000|Washout Period After Period 2|Adverse Event|0|||
156564982|NCT00888238|565155782|FG001|Washout Period After Period 2|Adverse Event|0|||
156564983|NCT00888238|565155783|FG002|Washout Period After Period 2|Adverse Event|1|||
156564984|NCT02700984|565155784|FG000|Overall Study|Death|2|||
156564985|NCT02700984|565155785|FG001|Overall Study|Death|1|||
156564986|NCT02700984|565155784|FG000|Overall Study|Lost to Follow-up|2|||
156564987|NCT02700984|565155785|FG001|Overall Study|Lost to Follow-up|1|||
156564988|NCT02700984|565155784|FG000|Overall Study|Physician Decision|0|||
156564989|NCT02700984|565155785|FG001|Overall Study|Physician Decision|1|||
156564990|NCT02700984|565155784|FG000|Overall Study|Withdrawal by Subject|8|||
156564991|NCT02700984|565155785|FG001|Overall Study|Withdrawal by Subject|9|||
156564992|NCT02700984|565155784|FG000|Overall Study|Reason not specified|3|||
156564993|NCT02700984|565155785|FG001|Overall Study|Reason not specified|2|||
156564994|NCT01032629|565155786|FG000|Overall Study|Closed Site|21|||
156564995|NCT01032629|565155787|FG001|Overall Study|Closed Site|18|||
156564996|NCT01032629|565155788|FG002|Overall Study|Closed Site|16|||
156564997|NCT01032629|565155786|FG000|Overall Study|Withdrawal by Subject|50|||
156564998|NCT01032629|565155787|FG001|Overall Study|Withdrawal by Subject|36|||
156564999|NCT01032629|565155788|FG002|Overall Study|Withdrawal by Subject|35|||
156565000|NCT01032629|565155786|FG000|Overall Study|Lost to Follow-up|74|||
156565001|NCT01032629|565155787|FG001|Overall Study|Lost to Follow-up|47|||
156565002|NCT01032629|565155788|FG002|Overall Study|Lost to Follow-up|37|||
156565003|NCT03371355|565155789|FG000|Overall Study|Investigator judgment|0|||
156565004|NCT03371355|565155790|FG001|Overall Study|Investigator judgment|0|||
156565005|NCT03371355|565155791|FG002|Overall Study|Investigator judgment|1|||
156565006|NCT03371355|565155792|FG003|Overall Study|Investigator judgment|1|||
156565007|NCT03371355|565155789|FG000|Overall Study|Voluntary withdrawal|1|||
156565008|NCT03371355|565155790|FG001|Overall Study|Voluntary withdrawal|0|||
156565009|NCT03371355|565155791|FG002|Overall Study|Voluntary withdrawal|1|||
156565010|NCT03371355|565155792|FG003|Overall Study|Voluntary withdrawal|2|||
156565011|NCT03371355|565155789|FG000|Overall Study|Adverse Event|0|||
156565012|NCT03371355|565155790|FG001|Overall Study|Adverse Event|1|||
156565013|NCT03371355|565155791|FG002|Overall Study|Adverse Event|2|||
156565014|NCT03371355|565155792|FG003|Overall Study|Adverse Event|3|||
156565015|NCT03371355|565155789|FG000|Overall Study|Reason not Specified|0|||
156565016|NCT03371355|565155790|FG001|Overall Study|Reason not Specified|1|||
156565017|NCT03371355|565155791|FG002|Overall Study|Reason not Specified|0|||
156565018|NCT03371355|565155792|FG003|Overall Study|Reason not Specified|1|||
156565019|NCT02868892|565155793|FG000|Overall Study|Investigator left site and no follow-up|6|||
156565020|NCT00619957|565155794|FG000|Month 24 Double-Blind|Adverse Event|9|||
156565021|NCT00619957|565155795|FG001|Month 24 Double-Blind|Adverse Event|7|||
156565022|NCT00619957|565155794|FG000|Month 24 Double-Blind|Protocol Violation|1|||
156565023|NCT00619957|565155795|FG001|Month 24 Double-Blind|Protocol Violation|0|||
156565024|NCT00619957|565155794|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
156565025|NCT00619957|565155795|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
156565026|NCT00619957|565155794|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
156565027|NCT00619957|565155795|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
156565028|NCT00619957|565155794|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
156565029|NCT00619957|565155795|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
156565030|NCT00619957|565155794|FG000|Month 48 Open-Label|Adverse Event|4|||
156565031|NCT00619957|565155795|FG001|Month 48 Open-Label|Adverse Event|4|||
156565032|NCT00619957|565155794|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
156565033|NCT00619957|565155795|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
156565034|NCT00619957|565155794|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
156565035|NCT00619957|565155795|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
156565036|NCT01763164|565155796|FG000|Treatment Phase|Participant/Guardian decision|26|||
156565037|NCT01763164|565155797|FG001|Treatment Phase|Participant/Guardian decision|14|||
156565038|NCT01763164|565155796|FG000|Treatment Phase|Protocol Violation|1|||
156565039|NCT01763164|565155797|FG001|Treatment Phase|Protocol Violation|1|||
156565040|NCT01763164|565155796|FG000|Treatment Phase|Progressive Disease|142|||
156565041|NCT01763164|565155797|FG001|Treatment Phase|Progressive Disease|76|||
156565042|NCT01763164|565155796|FG000|Treatment Phase|Physician Decision|24|||
156565043|NCT01763164|565155797|FG001|Treatment Phase|Physician Decision|13|||
156565044|NCT01763164|565155796|FG000|Treatment Phase|Death|10|||
156565045|NCT01763164|565155797|FG001|Treatment Phase|Death|1|||
156565046|NCT01763164|565155796|FG000|Treatment Phase|Adverse Event|66|||
156565047|NCT01763164|565155797|FG001|Treatment Phase|Adverse Event|8|||
156565048|NCT01763164|565155796|FG000|Treatment Phase|Randomized but not Treated|0|||
156565049|NCT01763164|565155797|FG001|Treatment Phase|Randomized but not Treated|19|||
156565050|NCT01763164|565155796|FG000|Treatment Phase|Other|0|||
156565051|NCT01763164|565155797|FG001|Treatment Phase|Other|1|||
156565052|NCT01763164|565155796|FG000|Follow up Phase|New therapy for study indication|12|||
156565053|NCT01763164|565155797|FG001|Follow up Phase|New therapy for study indication|3|||
156565054|NCT01763164|565155796|FG000|Follow up Phase|Death|21|||
156565055|NCT01763164|565155797|FG001|Follow up Phase|Death|4|||
156565056|NCT01763164|565155796|FG000|Follow up Phase|Subject/guardian decision|9|||
156565057|NCT01763164|565155797|FG001|Follow up Phase|Subject/guardian decision|2|||
156565058|NCT01763164|565155796|FG000|Follow up Phase|Progressive disease|127|||
156565059|NCT01763164|565155797|FG001|Follow up Phase|Progressive disease|62|||
156565060|NCT01763164|565155796|FG000|Follow up Phase|Physician Decision|10|||
156565061|NCT01763164|565155797|FG001|Follow up Phase|Physician Decision|3|||
156565062|NCT01763164|565155796|FG000|Follow up Phase|Lost to Follow-up|1|||
156565063|NCT01763164|565155797|FG001|Follow up Phase|Lost to Follow-up|0|||
156565064|NCT01763164|565155796|FG000|Follow up Phase|Adverse Event|17|||
156565065|NCT01763164|565155797|FG001|Follow up Phase|Adverse Event|1|||
156565066|NCT01526148|565155803|FG000|Overall Study|Adverse Event|6|||
156565067|NCT01526148|565155804|FG001|Overall Study|Adverse Event|5|||
156565068|NCT01526148|565155803|FG000|Overall Study|Lost to Follow-up|3|||
156565069|NCT01526148|565155804|FG001|Overall Study|Lost to Follow-up|6|||
156565070|NCT01526148|565155803|FG000|Overall Study|Withdrawal by Subject|2|||
156565071|NCT01526148|565155804|FG001|Overall Study|Withdrawal by Subject|0|||
156565072|NCT01526148|565155803|FG000|Overall Study|Unstable Medical Condition|1|||
156565073|NCT01526148|565155804|FG001|Overall Study|Unstable Medical Condition|0|||
156565074|NCT01526148|565155803|FG000|Overall Study|Unable to discontinue concomitant med|1|||
156565075|NCT01526148|565155804|FG001|Overall Study|Unable to discontinue concomitant med|0|||
156565076|NCT01526148|565155803|FG000|Overall Study|Moved out of state|1|||
156565077|NCT01526148|565155804|FG001|Overall Study|Moved out of state|0|||
156565078|NCT01526148|565155803|FG000|Overall Study|Incarcerated|0|||
156565079|NCT01526148|565155804|FG001|Overall Study|Incarcerated|2|||
156565080|NCT01173653|565155805|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
156565081|NCT01173653|565155806|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
156565082|NCT03529409|565155815|FG000|Randomized|Lost to Follow-up|0|||
156565083|NCT03529409|565155816|FG001|Randomized|Lost to Follow-up|0|||
156565084|NCT03529409|565155817|FG002|Randomized|Lost to Follow-up|4|||
156565085|NCT03529409|565155815|FG000|Randomized|Excluded|0|||
156565086|NCT03529409|565155816|FG001|Randomized|Excluded|0|||
156565087|NCT03529409|565155817|FG002|Randomized|Excluded|1|||
156565088|NCT03529409|565155815|FG000|Post-treatment Assessment|Death|1|||
156565089|NCT03529409|565155816|FG001|Post-treatment Assessment|Death|0|||
156565090|NCT03529409|565155817|FG002|Post-treatment Assessment|Death|0|||
156565091|NCT03529409|565155815|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
156565092|NCT03529409|565155816|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
156565093|NCT03529409|565155817|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
156565094|NCT03529409|565155815|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
156565095|NCT03529409|565155816|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
156565096|NCT03529409|565155817|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
156565097|NCT03529409|565155815|FG000|Follow-up Assessment|Death|1|||
156565098|NCT03529409|565155816|FG001|Follow-up Assessment|Death|0|||
156565099|NCT03529409|565155817|FG002|Follow-up Assessment|Death|0|||
156565100|NCT03529409|565155815|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
156565101|NCT03529409|565155816|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
156565102|NCT03529409|565155817|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
156565103|NCT01497262|565155818|FG000|Overall Study|Abnormal Lab Values|4|||
156565104|NCT01497262|565155818|FG000|Overall Study|Abnormal Test Procedure Result|1|||
156565105|NCT01497262|565155818|FG000|Overall Study|Physician Decision|1|||
156565106|NCT01497262|565155818|FG000|Overall Study|Withdrawal by Subject|2|||
156565107|NCT01497262|565155818|FG000|Overall Study|Adverse Event|2|||
156565108|NCT01497262|565155818|FG000|Overall Study|Protocol Violation|1|||
156565109|NCT03898063|565155821|FG000|Overall Study|Withdrawal by Subject|10|||
156565110|NCT03898063|565155822|FG001|Overall Study|Withdrawal by Subject|8|||
156565111|NCT01817790|565155832|FG000|Overall Study|Adverse Event|0|||
156565112|NCT01817790|565155833|FG001|Overall Study|Adverse Event|2|||
156565113|NCT01817790|565155832|FG000|Overall Study|Lost to Follow-up|0|||
156565114|NCT01817790|565155833|FG001|Overall Study|Lost to Follow-up|1|||
156565115|NCT01817790|565155832|FG000|Overall Study|Protocol Violation|2|||
156565116|NCT01817790|565155833|FG001|Overall Study|Protocol Violation|1|||
156565117|NCT01817790|565155832|FG000|Overall Study|Withdrawal by Subject|1|||
156565118|NCT01817790|565155833|FG001|Overall Study|Withdrawal by Subject|3|||
156565119|NCT01817790|565155832|FG000|Overall Study|Other: Could not attend appointment|1|||
156565120|NCT01817790|565155833|FG001|Overall Study|Other: Could not attend appointment|1|||
156565121|NCT01671345|565155834|FG000|Overall Study|Lost to Follow-up|10|||
156565122|NCT01671345|565155835|FG001|Overall Study|Lost to Follow-up|6|||
156565123|NCT01671345|565155834|FG000|Overall Study|visit with non-participating physician|3|||
156565124|NCT01671345|565155835|FG001|Overall Study|visit with non-participating physician|3|||
156565125|NCT03636906|565155836|FG000|Overall Study|Adverse Event|0|||
156565126|NCT03636906|565155837|FG001|Overall Study|Adverse Event|0|||
156565127|NCT03636906|565155838|FG002|Overall Study|Adverse Event|1|||
156565128|NCT03636906|565155836|FG000|Overall Study|Lost to Follow-up|1|||
156565129|NCT03636906|565155837|FG001|Overall Study|Lost to Follow-up|0|||
156565130|NCT03636906|565155838|FG002|Overall Study|Lost to Follow-up|0|||
156565131|NCT03636906|565155836|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
156565132|NCT03636906|565155837|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
156565133|NCT03636906|565155838|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
156565134|NCT03636906|565155836|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
156565135|NCT03636906|565155837|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156565136|NCT03636906|565155838|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
156565137|NCT03636906|565155836|FG000|Overall Study|Other|0|||
156565138|NCT03636906|565155837|FG001|Overall Study|Other|0|||
156565139|NCT03636906|565155838|FG002|Overall Study|Other|1|||
156565140|NCT03690869|565155842|FG000|Overall Study|Adverse Event|0|||
156565141|NCT03690869|565155843|FG001|Overall Study|Adverse Event|0|||
156565142|NCT03690869|565155844|FG002|Overall Study|Adverse Event|0|||
156565143|NCT03690869|565155845|FG003|Overall Study|Adverse Event|1|||
156565144|NCT03690869|565155846|FG004|Overall Study|Adverse Event|0|||
156565145|NCT03690869|565155847|FG005|Overall Study|Adverse Event|0|||
156565146|NCT03690869|565155848|FG006|Overall Study|Adverse Event|0|||
156565147|NCT03690869|565155849|FG007|Overall Study|Adverse Event|1|||
156565148|NCT03690869|565155850|FG008|Overall Study|Adverse Event|0|||
156565149|NCT03690869|565155851|FG009|Overall Study|Adverse Event|1|||
156565150|NCT03690869|565155842|FG000|Overall Study|Death|1|||
156565151|NCT03690869|565155843|FG001|Overall Study|Death|1|||
156565152|NCT03690869|565155844|FG002|Overall Study|Death|1|||
156565153|NCT03690869|565155845|FG003|Overall Study|Death|4|||
156565154|NCT03690869|565155846|FG004|Overall Study|Death|2|||
156565155|NCT03690869|565155847|FG005|Overall Study|Death|5|||
156565156|NCT03690869|565155848|FG006|Overall Study|Death|3|||
156565157|NCT03690869|565155849|FG007|Overall Study|Death|2|||
156565158|NCT03690869|565155850|FG008|Overall Study|Death|0|||
156565159|NCT03690869|565155851|FG009|Overall Study|Death|3|||
156565160|NCT03690869|565155842|FG000|Overall Study|Lost to Follow-up|0|||
156565161|NCT03690869|565155843|FG001|Overall Study|Lost to Follow-up|0|||
156565162|NCT03690869|565155844|FG002|Overall Study|Lost to Follow-up|1|||
156565163|NCT03690869|565155845|FG003|Overall Study|Lost to Follow-up|0|||
156565164|NCT03690869|565155846|FG004|Overall Study|Lost to Follow-up|0|||
156565165|NCT03690869|565155847|FG005|Overall Study|Lost to Follow-up|0|||
156565166|NCT03690869|565155848|FG006|Overall Study|Lost to Follow-up|0|||
156565167|NCT03690869|565155849|FG007|Overall Study|Lost to Follow-up|0|||
156565168|NCT03690869|565155850|FG008|Overall Study|Lost to Follow-up|0|||
156565169|NCT03690869|565155851|FG009|Overall Study|Lost to Follow-up|0|||
156565170|NCT03690869|565155842|FG000|Overall Study|Other Treatment|1|||
156565171|NCT03690869|565155843|FG001|Overall Study|Other Treatment|1|||
156565172|NCT03690869|565155844|FG002|Overall Study|Other Treatment|1|||
156565173|NCT03690869|565155845|FG003|Overall Study|Other Treatment|2|||
156565174|NCT03690869|565155846|FG004|Overall Study|Other Treatment|3|||
156565175|NCT03690869|565155847|FG005|Overall Study|Other Treatment|1|||
156565176|NCT03690869|565155848|FG006|Overall Study|Other Treatment|2|||
156565177|NCT03690869|565155849|FG007|Overall Study|Other Treatment|7|||
156565178|NCT03690869|565155850|FG008|Overall Study|Other Treatment|0|||
156565179|NCT03690869|565155851|FG009|Overall Study|Other Treatment|3|||
156565180|NCT03690869|565155842|FG000|Overall Study|Physician Decision|0|||
156565181|NCT03690869|565155843|FG001|Overall Study|Physician Decision|1|||
156565182|NCT03690869|565155844|FG002|Overall Study|Physician Decision|0|||
156565183|NCT03690869|565155845|FG003|Overall Study|Physician Decision|0|||
156565184|NCT03690869|565155846|FG004|Overall Study|Physician Decision|0|||
156565185|NCT03690869|565155847|FG005|Overall Study|Physician Decision|0|||
156565186|NCT03690869|565155848|FG006|Overall Study|Physician Decision|0|||
156565187|NCT03690869|565155849|FG007|Overall Study|Physician Decision|0|||
156565188|NCT03690869|565155850|FG008|Overall Study|Physician Decision|0|||
156565189|NCT03690869|565155851|FG009|Overall Study|Physician Decision|0|||
156565190|NCT03690869|565155842|FG000|Overall Study|Progressive Disease|1|||
156565191|NCT03690869|565155843|FG001|Overall Study|Progressive Disease|2|||
156565192|NCT03690869|565155844|FG002|Overall Study|Progressive Disease|0|||
156565193|NCT03690869|565155845|FG003|Overall Study|Progressive Disease|1|||
156565194|NCT03690869|565155846|FG004|Overall Study|Progressive Disease|0|||
156565195|NCT03690869|565155847|FG005|Overall Study|Progressive Disease|0|||
156565196|NCT03690869|565155848|FG006|Overall Study|Progressive Disease|0|||
156565197|NCT03690869|565155849|FG007|Overall Study|Progressive Disease|0|||
156565198|NCT03690869|565155850|FG008|Overall Study|Progressive Disease|1|||
156565199|NCT03690869|565155851|FG009|Overall Study|Progressive Disease|1|||
156565200|NCT03690869|565155842|FG000|Overall Study|Subject Decision|0|||
156565201|NCT03690869|565155843|FG001|Overall Study|Subject Decision|0|||
156565202|NCT03690869|565155844|FG002|Overall Study|Subject Decision|0|||
156565203|NCT03690869|565155845|FG003|Overall Study|Subject Decision|1|||
156565204|NCT03690869|565155846|FG004|Overall Study|Subject Decision|0|||
156565205|NCT03690869|565155847|FG005|Overall Study|Subject Decision|0|||
156565206|NCT03690869|565155848|FG006|Overall Study|Subject Decision|0|||
156565207|NCT03690869|565155849|FG007|Overall Study|Subject Decision|1|||
156565208|NCT03690869|565155850|FG008|Overall Study|Subject Decision|0|||
156565209|NCT03690869|565155851|FG009|Overall Study|Subject Decision|0|||
156565210|NCT06001307|565157640|FG000|Overall Study|Lost to Follow-up|1|||
156565232|NCT02660580|565157659|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
156565233|NCT02660580|565157660|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
156565234|NCT02660580|565157656|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
156565235|NCT02660580|565157657|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
156565236|NCT02660580|565157658|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
156565237|NCT02660580|565157659|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
156565238|NCT02660580|565157660|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
156565239|NCT02660580|565157656|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
156565240|NCT02660580|565157657|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
156565241|NCT02660580|565157658|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
156565242|NCT02660580|565157659|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
156565243|NCT02660580|565157660|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
156565244|NCT02660580|565157656|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
156565245|NCT02660580|565157657|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
156565246|NCT02660580|565157658|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
156565247|NCT02660580|565157659|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
156565248|NCT02660580|565157660|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
156565249|NCT02660580|565157656|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
156565250|NCT02660580|565157657|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
156565251|NCT02660580|565157658|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
156565252|NCT02660580|565157659|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
156565253|NCT02660580|565157660|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
156565254|NCT02660580|565157656|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
156565255|NCT02660580|565157657|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
156565256|NCT02660580|565157658|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
156565257|NCT02660580|565157659|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
156565258|NCT02660580|565157660|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
156565259|NCT02660580|565157656|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
156565260|NCT02660580|565157657|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
156565261|NCT02660580|565157658|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
156565262|NCT02660580|565157659|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
156565263|NCT02660580|565157660|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
156565264|NCT02660580|565157656|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
156565265|NCT02660580|565157657|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
156565266|NCT02660580|565157658|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
156565267|NCT02660580|565157659|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
156565268|NCT02660580|565157660|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
156565269|NCT02660580|565157656|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
156565270|NCT02660580|565157657|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
156565271|NCT02660580|565157658|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
156565272|NCT02660580|565157659|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
156565273|NCT02660580|565157660|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
156565274|NCT02660580|565157656|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
156565275|NCT02660580|565157657|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
156565276|NCT02660580|565157658|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
156565277|NCT02660580|565157659|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
156565278|NCT02660580|565157660|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
156565279|NCT02660580|565157656|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
156565280|NCT02660580|565157657|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
156565281|NCT02660580|565157658|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
156565282|NCT02660580|565157659|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
156565283|NCT02660580|565157660|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
156565284|NCT05415449|565157661|FG000|Overall Study|Lost to Follow-up|2|||
156565285|NCT05415449|565157661|FG000|Overall Study|Withdrawal by Subject|4|||
156565286|NCT02185521|565157665|FG000|Overall Study|Withdrawal by Subject|1|||
156565287|NCT02185521|565157665|FG000|Overall Study|Protocol Violation|1|||
156565288|NCT03124459|565157667|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
156565289|NCT03124459|565157668|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
156565290|NCT03124459|565157669|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
156565291|NCT03124459|565157670|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
156565292|NCT03124459|565157671|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
156565293|NCT03124459|565157672|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
156565294|NCT03124459|565157667|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
156565295|NCT03124459|565157668|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
156565296|NCT03124459|565157669|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
156565297|NCT03124459|565157670|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
156565298|NCT03124459|565157671|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
156565299|NCT03124459|565157672|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
156565300|NCT03124459|565157667|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
156565301|NCT03124459|565157668|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
156565302|NCT03124459|565157669|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
156565303|NCT03124459|565157670|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
156565304|NCT03124459|565157671|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
156565305|NCT03124459|565157672|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
156565306|NCT03124459|565157667|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
156565307|NCT03124459|565157668|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
156565308|NCT03124459|565157669|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
156565309|NCT03124459|565157670|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
156565310|NCT03124459|565157671|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
156565311|NCT03124459|565157672|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
156565312|NCT03124459|565157667|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
156565313|NCT03124459|565157668|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
156565314|NCT03124459|565157669|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
156565315|NCT03124459|565157670|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
156565316|NCT03124459|565157671|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
156565317|NCT03124459|565157672|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
156565318|NCT03124459|565157667|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
156565319|NCT03124459|565157668|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
156565320|NCT03124459|565157669|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
156565321|NCT03124459|565157670|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
156565322|NCT03124459|565157671|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
156565323|NCT03124459|565157672|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
156565324|NCT01028352|565157673|FG000|Overall Study|Ineligible due to baseline average pain|5|||
156565325|NCT01028352|565157673|FG000|Overall Study|Withdrawal by Subject|1|||
156565326|NCT01903876|565157674|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
156565327|NCT01903876|565157675|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
156565328|NCT01903876|565157674|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
156565329|NCT01903876|565157675|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
156565330|NCT00826748|565157685|FG000|Overall Study|Withdrawal by Subject|0|||
156565331|NCT00826748|565157686|FG001|Overall Study|Withdrawal by Subject|0|||
156565332|NCT00826748|565157687|FG002|Overall Study|Withdrawal by Subject|2|||
156565333|NCT00826748|565157685|FG000|Overall Study|Physician Decision|0|||
156565334|NCT00826748|565157686|FG001|Overall Study|Physician Decision|0|||
156565335|NCT00826748|565157687|FG002|Overall Study|Physician Decision|1|||
156565336|NCT00826748|565157685|FG000|Overall Study|Samples Did Not pass QC|0|||
156565337|NCT00826748|565157686|FG001|Overall Study|Samples Did Not pass QC|0|||
156565338|NCT00826748|565157687|FG002|Overall Study|Samples Did Not pass QC|1|||
156565339|NCT01887912|565157688|FG000|Overall Study|Serious adverse event|400|||
156565340|NCT01887912|565157689|FG001|Overall Study|Serious adverse event|198|||
156565341|NCT01887912|565157688|FG000|Overall Study|Other Adverse Event|34|||
156565342|NCT01887912|565157689|FG001|Overall Study|Other Adverse Event|15|||
156565343|NCT01887912|565157688|FG000|Overall Study|Protocol Violation|67|||
156565344|NCT01887912|565157689|FG001|Overall Study|Protocol Violation|37|||
156565345|NCT01887912|565157688|FG000|Overall Study|Lost to Follow-up|163|||
156565346|NCT01887912|565157689|FG001|Overall Study|Lost to Follow-up|74|||
156565347|NCT01887912|565157688|FG000|Overall Study|Withdrawal by Subject|606|||
156565348|NCT01887912|565157689|FG001|Overall Study|Withdrawal by Subject|349|||
156565349|NCT01887912|565157688|FG000|Overall Study|Other|122|||
156565350|NCT01887912|565157689|FG001|Overall Study|Other|58|||
156565351|NCT04462536|565157690|FG000|Overall Study|Withdrawal by Subject|3|||
156565352|NCT04462536|565157691|FG001|Overall Study|Withdrawal by Subject|9|||
156565353|NCT04462536|565157690|FG000|Overall Study|Lost to Follow-up|2|||
156565354|NCT04462536|565157691|FG001|Overall Study|Lost to Follow-up|4|||
156565355|NCT00450580|565157694|FG000|Overall Study|Adverse Event|5|||
156565356|NCT00450580|565157695|FG001|Overall Study|Adverse Event|7|||
156565357|NCT00450580|565157694|FG000|Overall Study|Lost to Follow-up|4|||
156565358|NCT00450580|565157695|FG001|Overall Study|Lost to Follow-up|5|||
156565359|NCT00450580|565157694|FG000|Overall Study|Withdrawal by Subject|2|||
156565360|NCT00450580|565157695|FG001|Overall Study|Withdrawal by Subject|2|||
156565361|NCT00450580|565157694|FG000|Overall Study|Protocol Violation|1|||
156565362|NCT00450580|565157695|FG001|Overall Study|Protocol Violation|1|||
156565363|NCT00450580|565157694|FG000|Overall Study|Protocol-defined virologic failure|1|||
156565364|NCT00450580|565157695|FG001|Overall Study|Protocol-defined virologic failure|0|||
156565365|NCT00450580|565157694|FG000|Overall Study|Could not comply with scheduled visits|1|||
156565366|NCT00450580|565157695|FG001|Overall Study|Could not comply with scheduled visits|0|||
156565367|NCT00450580|565157694|FG000|Overall Study|Patient went to Brazil|1|||
156565368|NCT00450580|565157695|FG001|Overall Study|Patient went to Brazil|0|||
156565369|NCT00450580|565157694|FG000|Overall Study|Patient could not swallow Norvir|1|||
156565370|NCT00450580|565157695|FG001|Overall Study|Patient could not swallow Norvir|0|||
156565371|NCT00450580|565157694|FG000|Overall Study|Withdrawal due to pregnancy|0|||
156565372|NCT00450580|565157695|FG001|Overall Study|Withdrawal due to pregnancy|1|||
156565373|NCT00332709|565157700|FG000|Overall Study|Adverse Event|11|||
156565374|NCT00332709|565157701|FG001|Overall Study|Adverse Event|14|||
156565375|NCT00332709|565157700|FG000|Overall Study|Withdrawal by Subject|2|||
156565376|NCT00332709|565157701|FG001|Overall Study|Withdrawal by Subject|3|||
156565377|NCT00332709|565157700|FG000|Overall Study|Lost to Follow-up|2|||
156565378|NCT00332709|565157701|FG001|Overall Study|Lost to Follow-up|0|||
156565379|NCT00332709|565157700|FG000|Overall Study|Administrative Problems|0|||
156565380|NCT00332709|565157701|FG001|Overall Study|Administrative Problems|3|||
156565381|NCT00332709|565157700|FG000|Overall Study|Abnormal test procedure result|1|||
156565382|NCT00332709|565157701|FG001|Overall Study|Abnormal test procedure result|0|||
156565383|NCT01169779|565157704|FG000|Overall Study|Adverse Event|3|||
156565384|NCT01169779|565157705|FG001|Overall Study|Adverse Event|11|||
156565385|NCT01169779|565157704|FG000|Overall Study|Lack of Efficacy|1|||
156565386|NCT01169779|565157705|FG001|Overall Study|Lack of Efficacy|0|||
156565387|NCT01169779|565157704|FG000|Overall Study|Protocol Violation|1|||
156565388|NCT01169779|565157705|FG001|Overall Study|Protocol Violation|1|||
156565389|NCT01169779|565157704|FG000|Overall Study|Withdrawal by Subject|3|||
156565390|NCT01169779|565157705|FG001|Overall Study|Withdrawal by Subject|2|||
156565391|NCT01169779|565157704|FG000|Overall Study|Familial and personal reasons|3|||
156565392|NCT01169779|565157705|FG001|Overall Study|Familial and personal reasons|3|||
156565393|NCT03293654|565157708|FG000|Overall Study|Lost to Follow-up|0|||
156565394|NCT03293654|565157709|FG001|Overall Study|Lost to Follow-up|1|||
156565395|NCT03293654|565157710|FG002|Overall Study|Lost to Follow-up|0|||
156565396|NCT03155997|565157712|FG000|Overall Study|Withdrawal by Subject|119|||
156565397|NCT03155997|565157713|FG001|Overall Study|Withdrawal by Subject|134|||
156565398|NCT03155997|565157712|FG000|Overall Study|Lost to Follow-up|12|||
156565399|NCT03155997|565157713|FG001|Overall Study|Lost to Follow-up|13|||
156565400|NCT03155997|565157712|FG000|Overall Study|Missing disposition data|0|||
156565401|NCT03155997|565157713|FG001|Overall Study|Missing disposition data|1|||
156565402|NCT03155997|565157712|FG000|Overall Study|On study treatment|2027|||
156565403|NCT03155997|565157713|FG001|Overall Study|On study treatment|2074|||
156565404|NCT00792298|565157714|FG000|Treatment Period 1|Adverse Event|0|||
156565405|NCT00792298|565157715|FG001|Treatment Period 1|Adverse Event|1|||
156565406|NCT00792298|565157716|FG002|Treatment Period 1|Adverse Event|0|||
156565407|NCT00792298|565157717|FG003|Treatment Period 1|Adverse Event|1|||
156565408|NCT00792298|565157718|FG004|Treatment Period 1|Adverse Event|0|||
156565409|NCT00792298|565157719|FG005|Treatment Period 1|Adverse Event|1|||
156565410|NCT00792298|565157720|FG006|Treatment Period 1|Adverse Event|1|||
156565411|NCT00792298|565157721|FG007|Treatment Period 1|Adverse Event|0|||
156565412|NCT00792298|565157714|FG000|Treatment Period 1|Lack of Efficacy|0|||
156565413|NCT00792298|565157715|FG001|Treatment Period 1|Lack of Efficacy|0|||
156565414|NCT00792298|565157716|FG002|Treatment Period 1|Lack of Efficacy|1|||
156565415|NCT00792298|565157717|FG003|Treatment Period 1|Lack of Efficacy|0|||
156565416|NCT00792298|565157718|FG004|Treatment Period 1|Lack of Efficacy|0|||
156565417|NCT00792298|565157719|FG005|Treatment Period 1|Lack of Efficacy|0|||
156565418|NCT00792298|565157720|FG006|Treatment Period 1|Lack of Efficacy|0|||
156565419|NCT00792298|565157721|FG007|Treatment Period 1|Lack of Efficacy|0|||
156565420|NCT00792298|565157714|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156565421|NCT00792298|565157715|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156565422|NCT00792298|565157716|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156565423|NCT00792298|565157717|FG003|Treatment Period 1|Withdrawal by Subject|2|||
156565424|NCT00792298|565157718|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156565425|NCT00792298|565157719|FG005|Treatment Period 1|Withdrawal by Subject|2|||
156565426|NCT00792298|565157720|FG006|Treatment Period 1|Withdrawal by Subject|1|||
156565427|NCT00792298|565157721|FG007|Treatment Period 1|Withdrawal by Subject|0|||
156565428|NCT00792298|565157714|FG000|Treatment Period 1|Lost to Follow-up|0|||
156565429|NCT00792298|565157715|FG001|Treatment Period 1|Lost to Follow-up|0|||
156565430|NCT00792298|565157716|FG002|Treatment Period 1|Lost to Follow-up|0|||
156565431|NCT00792298|565157717|FG003|Treatment Period 1|Lost to Follow-up|0|||
156565432|NCT00792298|565157718|FG004|Treatment Period 1|Lost to Follow-up|0|||
156565433|NCT00792298|565157719|FG005|Treatment Period 1|Lost to Follow-up|0|||
156565434|NCT00792298|565157720|FG006|Treatment Period 1|Lost to Follow-up|1|||
156565435|NCT00792298|565157721|FG007|Treatment Period 1|Lost to Follow-up|0|||
156565436|NCT00792298|565157714|FG000|Treatment Period 1|Physician Decision|0|||
156565437|NCT00792298|565157715|FG001|Treatment Period 1|Physician Decision|0|||
156565438|NCT00792298|565157716|FG002|Treatment Period 1|Physician Decision|0|||
156565439|NCT00792298|565157717|FG003|Treatment Period 1|Physician Decision|1|||
156565440|NCT00792298|565157718|FG004|Treatment Period 1|Physician Decision|0|||
156565441|NCT00792298|565157719|FG005|Treatment Period 1|Physician Decision|0|||
156565442|NCT00792298|565157720|FG006|Treatment Period 1|Physician Decision|1|||
156565443|NCT00792298|565157721|FG007|Treatment Period 1|Physician Decision|0|||
156565444|NCT00792298|565157714|FG000|Treatment Period 1|Protocol Violation|0|||
156565445|NCT00792298|565157715|FG001|Treatment Period 1|Protocol Violation|0|||
156565446|NCT00792298|565157716|FG002|Treatment Period 1|Protocol Violation|0|||
156565447|NCT00792298|565157717|FG003|Treatment Period 1|Protocol Violation|0|||
156565448|NCT00792298|565157718|FG004|Treatment Period 1|Protocol Violation|0|||
156565449|NCT00792298|565157719|FG005|Treatment Period 1|Protocol Violation|0|||
156565450|NCT00792298|565157720|FG006|Treatment Period 1|Protocol Violation|0|||
156565451|NCT00792298|565157721|FG007|Treatment Period 1|Protocol Violation|1|||
156565452|NCT00792298|565157714|FG000|Washout|Adverse Event|0|||
156565453|NCT00792298|565157715|FG001|Washout|Adverse Event|0|||
156565454|NCT00792298|565157716|FG002|Washout|Adverse Event|0|||
156565455|NCT00792298|565157717|FG003|Washout|Adverse Event|0|||
156565456|NCT00792298|565157718|FG004|Washout|Adverse Event|0|||
156565457|NCT00792298|565157719|FG005|Washout|Adverse Event|1|||
156565458|NCT00792298|565157720|FG006|Washout|Adverse Event|0|||
156565459|NCT00792298|565157721|FG007|Washout|Adverse Event|0|||
156565460|NCT00792298|565157714|FG000|Washout|Withdrawal by Subject|0|||
156565461|NCT00792298|565157715|FG001|Washout|Withdrawal by Subject|0|||
156565462|NCT00792298|565157716|FG002|Washout|Withdrawal by Subject|1|||
156565463|NCT00792298|565157717|FG003|Washout|Withdrawal by Subject|0|||
156565464|NCT00792298|565157718|FG004|Washout|Withdrawal by Subject|0|||
156565465|NCT00792298|565157719|FG005|Washout|Withdrawal by Subject|1|||
156565466|NCT00792298|565157720|FG006|Washout|Withdrawal by Subject|0|||
156565467|NCT00792298|565157721|FG007|Washout|Withdrawal by Subject|0|||
156565468|NCT00792298|565157714|FG000|Treatment Period 2|Lack of Efficacy|0|||
156565469|NCT00792298|565157715|FG001|Treatment Period 2|Lack of Efficacy|0|||
156565470|NCT00792298|565157716|FG002|Treatment Period 2|Lack of Efficacy|0|||
156565471|NCT00792298|565157717|FG003|Treatment Period 2|Lack of Efficacy|0|||
156565472|NCT00792298|565157718|FG004|Treatment Period 2|Lack of Efficacy|1|||
156565473|NCT00792298|565157719|FG005|Treatment Period 2|Lack of Efficacy|0|||
156565474|NCT00792298|565157720|FG006|Treatment Period 2|Lack of Efficacy|0|||
156565475|NCT00792298|565157721|FG007|Treatment Period 2|Lack of Efficacy|0|||
156565476|NCT00792298|565157714|FG000|Treatment Period 2|Physician Decision|0|||
156565477|NCT00792298|565157715|FG001|Treatment Period 2|Physician Decision|0|||
156565478|NCT00792298|565157716|FG002|Treatment Period 2|Physician Decision|0|||
156565479|NCT00792298|565157717|FG003|Treatment Period 2|Physician Decision|0|||
156565480|NCT00792298|565157718|FG004|Treatment Period 2|Physician Decision|0|||
156565481|NCT00792298|565157719|FG005|Treatment Period 2|Physician Decision|0|||
156565482|NCT00792298|565157720|FG006|Treatment Period 2|Physician Decision|1|||
156565483|NCT00792298|565157721|FG007|Treatment Period 2|Physician Decision|0|||
156565484|NCT00792298|565157714|FG000|Treatment Period 2|Pregnancy|0|||
156565485|NCT00792298|565157715|FG001|Treatment Period 2|Pregnancy|0|||
156565486|NCT00792298|565157716|FG002|Treatment Period 2|Pregnancy|1|||
156565487|NCT00792298|565157717|FG003|Treatment Period 2|Pregnancy|0|||
156565488|NCT00792298|565157718|FG004|Treatment Period 2|Pregnancy|0|||
156565489|NCT00792298|565157719|FG005|Treatment Period 2|Pregnancy|0|||
156565490|NCT00792298|565157720|FG006|Treatment Period 2|Pregnancy|0|||
156565491|NCT00792298|565157721|FG007|Treatment Period 2|Pregnancy|0|||
156565492|NCT00792298|565157714|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156565493|NCT00792298|565157715|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156565494|NCT00792298|565157716|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156565495|NCT00792298|565157717|FG003|Treatment Period 2|Withdrawal by Subject|2|||
156565496|NCT00792298|565157718|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156565497|NCT00792298|565157719|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156565498|NCT00792298|565157720|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156565499|NCT00792298|565157721|FG007|Treatment Period 2|Withdrawal by Subject|2|||
156565500|NCT00486603|565157724|FG000|Overall Study|Withdrawal by Subject|1|||
156565501|NCT00486603|565157725|FG001|Overall Study|Withdrawal by Subject|0|||
156565502|NCT00486603|565157726|FG002|Overall Study|Withdrawal by Subject|0|||
156565503|NCT00486603|565157727|FG003|Overall Study|Withdrawal by Subject|0|||
156565504|NCT00486603|565157728|FG004|Overall Study|Withdrawal by Subject|0|||
156565505|NCT00486603|565157724|FG000|Overall Study|Physician Decision|0|||
156565506|NCT00486603|565157725|FG001|Overall Study|Physician Decision|1|||
156565507|NCT00486603|565157726|FG002|Overall Study|Physician Decision|0|||
156565508|NCT00486603|565157727|FG003|Overall Study|Physician Decision|0|||
156565509|NCT00486603|565157728|FG004|Overall Study|Physician Decision|0|||
156565510|NCT01670994|565157730|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
156565511|NCT01670994|565157731|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
156565512|NCT01670994|565157730|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
156565513|NCT01670994|565157731|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
156565514|NCT01670994|565157730|FG000|Overall Study|Patient experienced DLT|0|||
156565515|NCT01670994|565157731|FG001|Overall Study|Patient experienced DLT|1|||
156565516|NCT02013544|565157732|FG000|Overall Study|Adverse Event|5|||
156565517|NCT02013544|565157733|FG001|Overall Study|Adverse Event|5|||
156565518|NCT02013544|565157732|FG000|Overall Study|Lost to Follow-up|2|||
156565519|NCT02013544|565157733|FG001|Overall Study|Lost to Follow-up|3|||
156565520|NCT02013544|565157732|FG000|Overall Study|Withdrawal by Subject|2|||
156565521|NCT02013544|565157733|FG001|Overall Study|Withdrawal by Subject|8|||
156565522|NCT02013544|565157732|FG000|Overall Study|Physician Decision|0|||
156565523|NCT02013544|565157733|FG001|Overall Study|Physician Decision|1|||
156565524|NCT02013544|565157732|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
156565525|NCT02013544|565157733|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
156565526|NCT00891735|565157734|FG000|Overall Study|Adverse Event|2|||
156565527|NCT00891735|565157735|FG001|Overall Study|Adverse Event|0|||
156565528|NCT00891735|565157736|FG002|Overall Study|Adverse Event|2|||
156565529|NCT00891735|565157737|FG003|Overall Study|Adverse Event|0|||
156565530|NCT00891735|565157734|FG000|Overall Study|Death|8|||
156565531|NCT00891735|565157735|FG001|Overall Study|Death|5|||
156565532|NCT00891735|565157736|FG002|Overall Study|Death|4|||
156565533|NCT00891735|565157737|FG003|Overall Study|Death|5|||
156565534|NCT00891735|565157734|FG000|Overall Study|Lost to Follow-up|2|||
156565535|NCT00891735|565157735|FG001|Overall Study|Lost to Follow-up|2|||
156565536|NCT00891735|565157736|FG002|Overall Study|Lost to Follow-up|2|||
156565537|NCT00891735|565157737|FG003|Overall Study|Lost to Follow-up|2|||
156565538|NCT00891735|565157734|FG000|Overall Study|Physician's decision to withdraw patient|1|||
156565539|NCT00891735|565157735|FG001|Overall Study|Physician's decision to withdraw patient|0|||
156565540|NCT00891735|565157736|FG002|Overall Study|Physician's decision to withdraw patient|0|||
156565541|NCT00891735|565157737|FG003|Overall Study|Physician's decision to withdraw patient|0|||
156565542|NCT00891735|565157734|FG000|Overall Study|Patient's decision to withdraw|4|||
156565543|NCT00891735|565157735|FG001|Overall Study|Patient's decision to withdraw|9|||
156565544|NCT00891735|565157736|FG002|Overall Study|Patient's decision to withdraw|4|||
156565545|NCT00891735|565157737|FG003|Overall Study|Patient's decision to withdraw|8|||
156565546|NCT00291551|565157740|FG000|Overall Study|Death|7|||
156565547|NCT00291551|565157740|FG000|Overall Study|Withdrawal by Subject|6|||
156565548|NCT02452762|565157741|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
156565549|NCT02452762|565157742|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
156565550|NCT02452762|565157741|FG000|Overall Study|Withdrawal by Subject|1|||
156565551|NCT02452762|565157742|FG001|Overall Study|Withdrawal by Subject|0|||
156565552|NCT00584870|565157743|FG000|Overall Study|Adverse Event|4|||
156565553|NCT00584870|565157744|FG001|Overall Study|Adverse Event|3|||
156565554|NCT00584870|565157745|FG002|Overall Study|Adverse Event|2|||
156565555|NCT00584870|565157743|FG000|Overall Study|Lost to Follow-up|4|||
156565556|NCT00584870|565157744|FG001|Overall Study|Lost to Follow-up|1|||
156565557|NCT00584870|565157745|FG002|Overall Study|Lost to Follow-up|1|||
156565558|NCT00584870|565157743|FG000|Overall Study|Lack of Efficacy|7|||
156565559|NCT00584870|565157744|FG001|Overall Study|Lack of Efficacy|14|||
156565560|NCT00584870|565157745|FG002|Overall Study|Lack of Efficacy|8|||
156565561|NCT00584870|565157743|FG000|Overall Study|Withdrawal by Subject|10|||
156565562|NCT00584870|565157744|FG001|Overall Study|Withdrawal by Subject|5|||
156565563|NCT00584870|565157745|FG002|Overall Study|Withdrawal by Subject|3|||
156565564|NCT00584870|565157743|FG000|Overall Study|Protocol Violation|1|||
156565565|NCT00584870|565157744|FG001|Overall Study|Protocol Violation|1|||
156565566|NCT00584870|565157745|FG002|Overall Study|Protocol Violation|2|||
156565567|NCT00584870|565157743|FG000|Overall Study|Did not met entrance criteria|1|||
156565568|NCT00584870|565157744|FG001|Overall Study|Did not met entrance criteria|0|||
156565569|NCT00584870|565157745|FG002|Overall Study|Did not met entrance criteria|0|||
156565570|NCT00584870|565157743|FG000|Overall Study|Other|2|||
156565571|NCT00584870|565157744|FG001|Overall Study|Other|0|||
156565572|NCT00584870|565157745|FG002|Overall Study|Other|0|||
156565573|NCT00584870|565157743|FG000|Overall Study|Randomized but not treated|0|||
156565574|NCT00584870|565157744|FG001|Overall Study|Randomized but not treated|1|||
156565575|NCT00584870|565157745|FG002|Overall Study|Randomized but not treated|2|||
156565576|NCT00631137|565157746|FG000|Overall Study|Withdrawal by Subject|1|||
156565577|NCT00631137|565157747|FG001|Overall Study|Withdrawal by Subject|0|||
156565578|NCT03682120|565157748|FG000|Overall Study|Lost to Follow-up|11|||
156565579|NCT03682120|565157749|FG001|Overall Study|Lost to Follow-up|4|||
156565580|NCT03682120|565157750|FG002|Overall Study|Lost to Follow-up|5|||
156565581|NCT03682120|565157751|FG003|Overall Study|Lost to Follow-up|2|||
156565582|NCT03682120|565157748|FG000|Overall Study|Physician Decision|1|||
156565583|NCT03682120|565157749|FG001|Overall Study|Physician Decision|0|||
156565584|NCT03682120|565157750|FG002|Overall Study|Physician Decision|0|||
156565585|NCT03682120|565157751|FG003|Overall Study|Physician Decision|0|||
156565586|NCT03682120|565157748|FG000|Overall Study|Withdrawal by Subject|1|||
156565587|NCT03682120|565157749|FG001|Overall Study|Withdrawal by Subject|2|||
156565588|NCT03682120|565157750|FG002|Overall Study|Withdrawal by Subject|3|||
156565589|NCT03682120|565157751|FG003|Overall Study|Withdrawal by Subject|0|||
156565590|NCT03682120|565157748|FG000|Overall Study|Death|0|||
156565591|NCT03682120|565157749|FG001|Overall Study|Death|1|||
156565592|NCT03682120|565157750|FG002|Overall Study|Death|0|||
156565593|NCT03682120|565157751|FG003|Overall Study|Death|0|||
156565594|NCT03682120|565157748|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
156565595|NCT03682120|565157749|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
156565596|NCT03682120|565157750|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
156565597|NCT03682120|565157751|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
156565598|NCT01015833|565157752|FG000|Overall Study|Death|1|||
156565599|NCT01015833|565157753|FG001|Overall Study|Death|0|||
156565600|NCT01015833|565157752|FG000|Overall Study|Withdrawal by Subject|3|||
156565601|NCT01015833|565157753|FG001|Overall Study|Withdrawal by Subject|2|||
156565602|NCT01015833|565157752|FG000|Overall Study|Adverse Event|0|||
156565603|NCT01015833|565157753|FG001|Overall Study|Adverse Event|1|||
156565604|NCT01015833|565157752|FG000|Overall Study|Physician Decision|2|||
156565605|NCT01015833|565157753|FG001|Overall Study|Physician Decision|0|||
156565606|NCT01015833|565157752|FG000|Overall Study|Symptomatic deterioration|0|||
156565607|NCT01015833|565157753|FG001|Overall Study|Symptomatic deterioration|1|||
156565608|NCT01015833|565157752|FG000|Overall Study|Other|5|||
156565609|NCT01015833|565157753|FG001|Overall Study|Other|1|||
156565610|NCT01015833|565157752|FG000|Overall Study|Motor Vehicle Accidents|1|||
156565611|NCT01015833|565157753|FG001|Overall Study|Motor Vehicle Accidents|0|||
156565612|NCT01015833|565157752|FG000|Overall Study|Did not start treatment|1|||
156565613|NCT01015833|565157753|FG001|Overall Study|Did not start treatment|0|||
156565614|NCT01651780|565157754|FG000|Overall Study|Physician decision: No 30-day visit|2|||
156565615|NCT01651780|565157755|FG001|Overall Study|Physician decision: No 30-day visit|1|||
156565616|NCT01651780|565157754|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
156565617|NCT01651780|565157755|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
156565618|NCT01651780|565157754|FG000|Overall Study|Withdrawal by Subject|2|||
156565619|NCT01651780|565157755|FG001|Overall Study|Withdrawal by Subject|0|||
156565620|NCT01651780|565157754|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
156565621|NCT01651780|565157755|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156565622|NCT01651780|565157754|FG000|Overall Study|Lost to Follow-up|1|||
156565623|NCT01651780|565157755|FG001|Overall Study|Lost to Follow-up|2|||
156565624|NCT01651780|565157754|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
156565625|NCT01651780|565157755|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
156565626|NCT02949830|565157756|FG000|Overall Study|Adverse Event|1|||
156565627|NCT02949830|565157756|FG000|Overall Study|Withdrawal by Subject|1|||
156565628|NCT01290887|565157757|FG000|Overall Study|Adverse Event|6|||
156565629|NCT01290887|565157758|FG001|Overall Study|Adverse Event|11|||
156565630|NCT01290887|565157757|FG000|Overall Study|Lack of Efficacy|4|||
156565631|NCT01290887|565157758|FG001|Overall Study|Lack of Efficacy|5|||
156565632|NCT01290887|565157757|FG000|Overall Study|Withdrawal by Subject|26|||
156565633|NCT01290887|565157758|FG001|Overall Study|Withdrawal by Subject|32|||
156565634|NCT01290887|565157757|FG000|Overall Study|Protocol Violation|2|||
156565635|NCT01290887|565157758|FG001|Overall Study|Protocol Violation|1|||
156565636|NCT01290887|565157757|FG000|Overall Study|Lost to Follow-up|4|||
156565637|NCT01290887|565157758|FG001|Overall Study|Lost to Follow-up|4|||
156565638|NCT01290887|565157757|FG000|Overall Study|Non-compliance to study procedures|0|||
156565639|NCT01290887|565157758|FG001|Overall Study|Non-compliance to study procedures|1|||
156565640|NCT01290887|565157757|FG000|Overall Study|Non-compliance to study medications|1|||
156565641|NCT01290887|565157758|FG001|Overall Study|Non-compliance to study medications|0|||
156565642|NCT01290887|565157757|FG000|Overall Study|Sponsor closure of study|420|||
156565643|NCT01290887|565157758|FG001|Overall Study|Sponsor closure of study|476|||
156565644|NCT01290887|565157757|FG000|Overall Study|Other|3|||
156565645|NCT01290887|565157758|FG001|Overall Study|Other|6|||
156565646|NCT01628926|565157759|FG000|Overall Study|Adverse Event|13|||
156565647|NCT01628926|565157760|FG001|Overall Study|Adverse Event|11|||
156565648|NCT01628926|565157761|FG002|Overall Study|Adverse Event|9|||
156565649|NCT01628926|565157759|FG000|Overall Study|Lack of Efficacy|2|||
156565650|NCT01628926|565157760|FG001|Overall Study|Lack of Efficacy|1|||
156565651|NCT01628926|565157761|FG002|Overall Study|Lack of Efficacy|5|||
156565652|NCT01628926|565157759|FG000|Overall Study|Withdrawal by Subject|6|||
156565653|NCT01628926|565157760|FG001|Overall Study|Withdrawal by Subject|4|||
156565654|NCT01628926|565157761|FG002|Overall Study|Withdrawal by Subject|2|||
156565655|NCT01628926|565157759|FG000|Overall Study|Protocol Violation|0|||
156565656|NCT01628926|565157760|FG001|Overall Study|Protocol Violation|1|||
156565657|NCT01628926|565157761|FG002|Overall Study|Protocol Violation|0|||
156565658|NCT01628926|565157759|FG000|Overall Study|Discontinuation criteria|3|||
156565659|NCT01628926|565157760|FG001|Overall Study|Discontinuation criteria|4|||
156565660|NCT01628926|565157761|FG002|Overall Study|Discontinuation criteria|0|||
156565661|NCT01628926|565157759|FG000|Overall Study|Physician Decision|2|||
156565662|NCT01628926|565157760|FG001|Overall Study|Physician Decision|2|||
156565663|NCT01628926|565157761|FG002|Overall Study|Physician Decision|1|||
156565664|NCT02116621|565157762|FG000|Baseline|Withdrawal by Subject|0|||
156565665|NCT02116621|565157763|FG001|Baseline|Withdrawal by Subject|4|||
156565666|NCT02116621|565157762|FG000|Three Month Follow-up|Death|1|||
156565667|NCT02116621|565157763|FG001|Three Month Follow-up|Death|1|||
156565668|NCT02116621|565157762|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
156565669|NCT02116621|565157763|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
156565670|NCT02116621|565157762|FG000|Three Month Follow-up|Lost to Follow-up|0|||
156565671|NCT02116621|565157763|FG001|Three Month Follow-up|Lost to Follow-up|1|||
156565672|NCT02116621|565157762|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
156565673|NCT02116621|565157763|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
156565674|NCT02116621|565157762|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
156565675|NCT02116621|565157763|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
156565676|NCT02116621|565157762|FG000|Six Month Follow-up|Lost to Follow-up|2|||
156565677|NCT02116621|565157763|FG001|Six Month Follow-up|Lost to Follow-up|1|||
156565678|NCT02116621|565157762|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
156565679|NCT02116621|565157763|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
156565680|NCT02116621|565157762|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
156565681|NCT02116621|565157763|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
156565682|NCT02116621|565157762|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
156565683|NCT02116621|565157763|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
156565684|NCT02116621|565157762|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
156565685|NCT02116621|565157763|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
156565686|NCT02116621|565157762|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
156565687|NCT02116621|565157763|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
156565688|NCT03437447|565157764|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156565689|NCT03437447|565157765|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156565690|NCT03437447|565157766|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156565691|NCT02040142|565157768|FG000|Overall Study|Lost to Follow-up|5|||
156565692|NCT02040142|565157768|FG000|Overall Study|Death|17|||
156565693|NCT02040142|565157768|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
156565694|NCT04752384|565157769|FG000|Overall Study|Withdrawal by Subject|1|||
156565695|NCT04752384|565157769|FG000|Overall Study|Death|1|||
156565696|NCT04439331|565157776|FG000|Overall Study|Never Start Protocol Therapy|2|||
156565697|NCT04439331|565157776|FG000|Overall Study|Ineligible|2|||
156565698|NCT04439331|565157776|FG000|Overall Study|Mutation Status Not Confirmed|1|||
156565699|NCT04439331|565157776|FG000|Overall Study|Adverse Event|1|||
156565700|NCT04439331|565157776|FG000|Overall Study|Death|1|||
156565701|NCT04439331|565157776|FG000|Overall Study|Disease Progression|20|||
156565702|NCT04439331|565157776|FG000|Overall Study|Withdrawal by Subject|6|||
156565703|NCT04439331|565157776|FG000|Overall Study|Physician Decision|1|||
156565704|NCT04439331|565157776|FG000|Overall Study|Other Complicating Disease|1|||
156565705|NCT03726268|565157778|FG000|Overall Study|Physician Decision|2|||
156565706|NCT03726268|565157779|FG001|Overall Study|Physician Decision|8|||
156565707|NCT03726268|565157780|FG002|Overall Study|Physician Decision|6|||
156565708|NCT03726268|565157781|FG003|Overall Study|Physician Decision|3|||
156565709|NCT03726268|565157778|FG000|Overall Study|Withdrawal by Subject|11|||
156565710|NCT03726268|565157779|FG001|Overall Study|Withdrawal by Subject|5|||
156565711|NCT03726268|565157780|FG002|Overall Study|Withdrawal by Subject|9|||
156565712|NCT03726268|565157781|FG003|Overall Study|Withdrawal by Subject|8|||
156565713|NCT00413959|565157783|FG000|Overall Study|Pt had only one cycle.|1|||
156565714|NCT01986062|565157784|FG000|Overall Study|Lost to Follow-up|1|||
156565715|NCT01986062|565157785|FG001|Overall Study|Lost to Follow-up|0|||
156565716|NCT01986062|565157784|FG000|Overall Study|Withdrawal by Subject|0|||
156565717|NCT01986062|565157785|FG001|Overall Study|Withdrawal by Subject|1|||
156565718|NCT03538743|565157786|FG000|Overall Study|Adverse Event|0|||
156565719|NCT03538743|565157787|FG001|Overall Study|Adverse Event|0|||
156565720|NCT03538743|565157788|FG002|Overall Study|Adverse Event|1|||
156565721|NCT03538743|565157789|FG003|Overall Study|Adverse Event|1|||
156565722|NCT03538743|565157790|FG004|Overall Study|Adverse Event|0|||
156565723|NCT03538743|565157791|FG005|Overall Study|Adverse Event|0|||
156565724|NCT03538743|565157792|FG006|Overall Study|Adverse Event|0|||
156565725|NCT03538743|565157793|FG007|Overall Study|Adverse Event|0|||
156565726|NCT03538743|565157794|FG008|Overall Study|Adverse Event|0|||
156565727|NCT03538743|565157786|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
156565728|NCT03538743|565157787|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
156565729|NCT03538743|565157788|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
156565730|NCT03538743|565157789|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
156565731|NCT03538743|565157790|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
156565732|NCT03538743|565157791|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
156565733|NCT03538743|565157792|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
156565734|NCT03538743|565157793|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
156565735|NCT03538743|565157794|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
156565736|NCT03538743|565157786|FG000|Overall Study|Withdrawal by Subject|0|||
156565737|NCT03538743|565157787|FG001|Overall Study|Withdrawal by Subject|0|||
156565738|NCT03538743|565157788|FG002|Overall Study|Withdrawal by Subject|0|||
156565739|NCT03538743|565157789|FG003|Overall Study|Withdrawal by Subject|1|||
156565740|NCT03538743|565157790|FG004|Overall Study|Withdrawal by Subject|0|||
156565741|NCT03538743|565157791|FG005|Overall Study|Withdrawal by Subject|0|||
156565742|NCT03538743|565157792|FG006|Overall Study|Withdrawal by Subject|0|||
156565743|NCT03538743|565157793|FG007|Overall Study|Withdrawal by Subject|0|||
156565744|NCT03538743|565157794|FG008|Overall Study|Withdrawal by Subject|0|||
156565745|NCT01955707|565157797|FG000|Overall Study|Adverse Event|1|||
156565746|NCT01955707|565157798|FG001|Overall Study|Adverse Event|2|||
156565747|NCT01955707|565157797|FG000|Overall Study|Lost to Follow-up|2|||
156565748|NCT01955707|565157798|FG001|Overall Study|Lost to Follow-up|1|||
156565749|NCT01955707|565157797|FG000|Overall Study|Withdrawal by Subject|0|||
156565750|NCT01955707|565157798|FG001|Overall Study|Withdrawal by Subject|3|||
156565751|NCT01955707|565157797|FG000|Overall Study|Death|13|||
156565752|NCT01955707|565157798|FG001|Overall Study|Death|14|||
156565753|NCT01955707|565157797|FG000|Overall Study|Other|4|||
156565754|NCT01955707|565157798|FG001|Overall Study|Other|2|||
156565755|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
156565756|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
156565757|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
156565758|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
156565759|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
156565760|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
156565761|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
156565762|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
156565763|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
156565764|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
156565765|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
156565766|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
156565767|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
156565768|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
156565769|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
156565770|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
156565771|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
156565772|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
156565773|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
156565774|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
156565775|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
156565776|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
156565777|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
156565778|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
156565779|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
156565780|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
156565781|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
156565782|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
156565783|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
156565784|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
156565785|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
156565786|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
156565787|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
156565788|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
156565789|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
156565790|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
156565791|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
156565792|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
156565793|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
156565794|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
156565795|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
156565796|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
156565797|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
156565798|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
156565799|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
156565800|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
156565801|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
156565802|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
156565803|NCT01707992|565157805|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
156565804|NCT01707992|565157806|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
156565805|NCT01707992|565157807|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
156565806|NCT01707992|565157808|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
156565807|NCT01707992|565157809|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
156565808|NCT01707992|565157810|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
156565809|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
156565810|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
156565811|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
156565812|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
156565813|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
156565814|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
156565815|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
156565816|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
156565817|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
156565818|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
156565819|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
156565820|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
156565821|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
156565822|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
156565823|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
156565824|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
156565825|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
156565826|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
156565827|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
156565828|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
156565829|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
156565830|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
156565831|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
156565832|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
156565833|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
156565834|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
156565835|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
156565836|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
156565837|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
156565838|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
156565839|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Death|0|||
156565840|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Death|0|||
156565841|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Death|0|||
156565842|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Death|2|||
156565843|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Death|0|||
156565844|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Death|0|||
156565845|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
156565846|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
156565847|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
156565848|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
156565849|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
156565850|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
156565851|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
156565852|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
156565853|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
156565854|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
156565855|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
156565856|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
156565857|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
156565858|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
156565859|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
156565860|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
156565861|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
156565862|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
156565863|NCT01707992|565157805|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
156565864|NCT01707992|565157806|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
156565865|NCT01707992|565157807|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
156565866|NCT01707992|565157808|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
156565867|NCT01707992|565157809|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
156565868|NCT01707992|565157810|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
156565869|NCT03498521|565157811|FG000|Overall Study|Death|227|||
156565870|NCT03498521|565157812|FG001|Overall Study|Death|79|||
156565871|NCT03498521|565157813|FG002|Overall Study|Death|84|||
156565872|NCT03498521|565157811|FG000|Overall Study|Exclusion criteria|1|||
156565873|NCT03498521|565157812|FG001|Overall Study|Exclusion criteria|0|||
156565874|NCT03498521|565157813|FG002|Overall Study|Exclusion criteria|0|||
156565875|NCT03498521|565157811|FG000|Overall Study|Lost to Follow-up|4|||
156565876|NCT03498521|565157812|FG001|Overall Study|Lost to Follow-up|3|||
156565877|NCT03498521|565157813|FG002|Overall Study|Lost to Follow-up|3|||
156565878|NCT03498521|565157811|FG000|Overall Study|No profile due to technical failure|1|||
156565879|NCT03498521|565157812|FG001|Overall Study|No profile due to technical failure|0|||
156565880|NCT03498521|565157813|FG002|Overall Study|No profile due to technical failure|0|||
156565881|NCT03498521|565157811|FG000|Overall Study|Physician Decision|3|||
156565882|NCT03498521|565157812|FG001|Overall Study|Physician Decision|1|||
156565883|NCT03498521|565157813|FG002|Overall Study|Physician Decision|0|||
156565884|NCT03498521|565157811|FG000|Overall Study|Withdrawal by Subject|11|||
156565885|NCT03498521|565157812|FG001|Overall Study|Withdrawal by Subject|6|||
156565886|NCT03498521|565157813|FG002|Overall Study|Withdrawal by Subject|2|||
156565887|NCT03498521|565157811|FG000|Overall Study|Study terminated by sponsor|79|||
156565888|NCT03498521|565157812|FG001|Overall Study|Study terminated by sponsor|21|||
156565889|NCT03498521|565157813|FG002|Overall Study|Study terminated by sponsor|4|||
156565890|NCT04167345|565157814|FG000|Overall Study|Other|1|||
156565891|NCT04167345|565157815|FG001|Overall Study|Other|1|||
156565892|NCT04167345|565157816|FG002|Overall Study|Other|0|||
156565893|NCT04167345|565157817|FG003|Overall Study|Other|0|||
156565894|NCT04167345|565157818|FG004|Overall Study|Other|0|||
156565895|NCT03532100|565159387|FG000|Overall Study|Intervention malfunction|1|||
156565896|NCT03896581|565159388|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
156565897|NCT03896581|565159389|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
156565898|NCT03896581|565159388|FG000|Overall Study|Withdrawal by Subject|4|||
156565899|NCT03896581|565159389|FG001|Overall Study|Withdrawal by Subject|1|||
156565900|NCT03896581|565159388|FG000|Overall Study|Lost to Follow-up|1|||
156565901|NCT03896581|565159389|FG001|Overall Study|Lost to Follow-up|0|||
156565902|NCT03896581|565159388|FG000|Overall Study|Lack of Efficacy|2|||
156565903|NCT03896581|565159389|FG001|Overall Study|Lack of Efficacy|1|||
156565904|NCT03896581|565159388|FG000|Overall Study|Adverse event, non-fatal|0|||
156565905|NCT03896581|565159389|FG001|Overall Study|Adverse event, non-fatal|2|||
156565906|NCT00960076|565159390|FG000|Overall Study|Adverse Event|1|||
156565907|NCT00960076|565159391|FG001|Overall Study|Adverse Event|7|||
156565908|NCT00960076|565159390|FG000|Overall Study|No longer met study criteria|1|||
156565909|NCT00960076|565159391|FG001|Overall Study|No longer met study criteria|5|||
156565910|NCT00960076|565159390|FG000|Overall Study|Withdrawal by Subject|1|||
156565911|NCT00960076|565159391|FG001|Overall Study|Withdrawal by Subject|2|||
156565912|NCT00960076|565159390|FG000|Overall Study|Lost to Follow-up|3|||
156565913|NCT00960076|565159391|FG001|Overall Study|Lost to Follow-up|3|||
156565914|NCT00960076|565159390|FG000|Overall Study|Severe non-compliance to protocol|1|||
156565915|NCT00960076|565159391|FG001|Overall Study|Severe non-compliance to protocol|2|||
156565916|NCT00960076|565159390|FG000|Overall Study|Hyperglycemia|1|||
156565917|NCT00960076|565159391|FG001|Overall Study|Hyperglycemia|5|||
156565918|NCT00960076|565159390|FG000|Overall Study|Did not attend the termination visit|0|||
156565919|NCT00960076|565159391|FG001|Overall Study|Did not attend the termination visit|1|||
156565920|NCT02029976|565159392|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
156565921|NCT02029976|565159393|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
156565922|NCT02029976|565159392|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
156565923|NCT02029976|565159393|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
156565924|NCT02029976|565159392|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
156565925|NCT02029976|565159393|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
156565926|NCT02029976|565159392|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
156565927|NCT02029976|565159393|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
156565928|NCT01445171|565159394|FG000|Overall Study|Lost to Follow-up|11|||
156565929|NCT01445171|565159394|FG000|Overall Study|Withdrawal by Subject|16|||
156565930|NCT01445171|565159394|FG000|Overall Study|Death|51|||
156565931|NCT01445171|565159394|FG000|Overall Study|Subjects declined to return for followup|9|||
156565932|NCT01445171|565159394|FG000|Overall Study|Consented but did not receive device|8|||
156565933|NCT00162773|565159395|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
156565934|NCT05194345|565159398|FG000|Overall Study|Withdrawal by Subject|6|||
156565935|NCT05194345|565159399|FG001|Overall Study|Withdrawal by Subject|4|||
156565936|NCT05194345|565159400|FG002|Overall Study|Withdrawal by Subject|0|||
156565937|NCT05194345|565159398|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
156565938|NCT05194345|565159399|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
156565939|NCT05194345|565159400|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
156565940|NCT02612909|565159403|FG000|Phase 2|Withdrawal by Subject|2|||
156565941|NCT02612909|565159404|FG001|Phase 2|Withdrawal by Subject|5|||
156565942|NCT02612909|565159405|FG002|Phase 2|Withdrawal by Subject|0|||
156565943|NCT02612909|565159406|FG003|Phase 2|Withdrawal by Subject|0|||
156565944|NCT02612909|565159407|FG004|Phase 2|Withdrawal by Subject|0|||
156565945|NCT02612909|565159403|FG000|Phase 2|Pregnancy|0|||
156565946|NCT02612909|565159404|FG001|Phase 2|Pregnancy|0|||
156565947|NCT02612909|565159405|FG002|Phase 2|Pregnancy|1|||
156565948|NCT02612909|565159406|FG003|Phase 2|Pregnancy|0|||
156565949|NCT02612909|565159407|FG004|Phase 2|Pregnancy|0|||
156565950|NCT02612909|565159403|FG000|Phase 3|Withdrawal by Subject|0|||
156565951|NCT02612909|565159404|FG001|Phase 3|Withdrawal by Subject|0|||
156565952|NCT02612909|565159405|FG002|Phase 3|Withdrawal by Subject|0|||
156565953|NCT02612909|565159406|FG003|Phase 3|Withdrawal by Subject|1|||
156565954|NCT02612909|565159407|FG004|Phase 3|Withdrawal by Subject|0|||
156565955|NCT05067127|565159412|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
156565956|NCT05067127|565159413|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
156565957|NCT05067127|565159414|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
156565958|NCT05067127|565159415|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
156565959|NCT05067127|565159412|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
156565960|NCT05067127|565159413|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
156565961|NCT05067127|565159414|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
156565962|NCT05067127|565159415|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
156565963|NCT05067127|565159412|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
156565964|NCT05067127|565159413|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
156565965|NCT05067127|565159414|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
156565966|NCT05067127|565159415|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
156565967|NCT05067127|565159412|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
156565968|NCT05067127|565159413|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
156565969|NCT05067127|565159414|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
156565970|NCT05067127|565159415|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
156565971|NCT05067127|565159412|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
156565972|NCT05067127|565159413|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
156565973|NCT05067127|565159414|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
156565974|NCT05067127|565159415|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
156565975|NCT05067127|565159412|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
156565976|NCT05067127|565159413|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
156565977|NCT05067127|565159414|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
156565978|NCT05067127|565159415|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
156565979|NCT05067127|565159412|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
156565980|NCT05067127|565159413|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
156565981|NCT05067127|565159414|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
156565982|NCT05067127|565159415|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
156565983|NCT03615222|565159419|FG000|Overall Study|Ineligible|26|||
156565984|NCT03615222|565159419|FG000|Overall Study|Withdrawal by Subject|7|||
156565985|NCT03615222|565159419|FG000|Overall Study|Death|1|||
156565986|NCT04572633|565159422|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
156565987|NCT03480802|565159423|FG000|Overall Study|Lost to Follow-up|5|||
156565988|NCT03480802|565159424|FG001|Overall Study|Lost to Follow-up|1|||
156565989|NCT03480802|565159423|FG000|Overall Study|Withdrawal by Subject|2|||
156565990|NCT03480802|565159424|FG001|Overall Study|Withdrawal by Subject|1|||
156565991|NCT03480802|565159423|FG000|Overall Study|Relocated|0|||
156565992|NCT03480802|565159424|FG001|Overall Study|Relocated|1|||
156565993|NCT02601950|565159429|FG000|Overall Study|Participant enrolled in rollover study|0|||
156565994|NCT02601950|565159430|FG001|Overall Study|Participant enrolled in rollover study|0|||
156565995|NCT02601950|565159431|FG002|Overall Study|Participant enrolled in rollover study|1|||
156565996|NCT02601950|565159432|FG003|Overall Study|Participant enrolled in rollover study|0|||
156565997|NCT02601950|565159433|FG004|Overall Study|Participant enrolled in rollover study|1|||
156565998|NCT02601950|565159434|FG005|Overall Study|Participant enrolled in rollover study|1|||
156565999|NCT02601950|565159435|FG006|Overall Study|Participant enrolled in rollover study|1|||
156566000|NCT02601950|565159436|FG007|Overall Study|Participant enrolled in rollover study|0|||
156566001|NCT02601950|565159429|FG000|Overall Study|Disease progression - radiological|21|||
156566002|NCT02601950|565159430|FG001|Overall Study|Disease progression - radiological|26|||
156566003|NCT02601950|565159431|FG002|Overall Study|Disease progression - radiological|22|||
156566004|NCT02601950|565159432|FG003|Overall Study|Disease progression - radiological|11|||
156566005|NCT02601950|565159433|FG004|Overall Study|Disease progression - radiological|46|||
156566006|NCT02601950|565159434|FG005|Overall Study|Disease progression - radiological|52|||
156566007|NCT02601950|565159435|FG006|Overall Study|Disease progression - radiological|7|||
156566008|NCT02601950|565159436|FG007|Overall Study|Disease progression - radiological|5|||
156566009|NCT02601950|565159429|FG000|Overall Study|Disease progression - clinical|3|||
156566010|NCT02601950|565159430|FG001|Overall Study|Disease progression - clinical|5|||
156566011|NCT02601950|565159431|FG002|Overall Study|Disease progression - clinical|4|||
156566012|NCT02601950|565159432|FG003|Overall Study|Disease progression - clinical|2|||
156566013|NCT02601950|565159433|FG004|Overall Study|Disease progression - clinical|6|||
156566014|NCT02601950|565159434|FG005|Overall Study|Disease progression - clinical|6|||
156566015|NCT02601950|565159435|FG006|Overall Study|Disease progression - clinical|5|||
156566016|NCT02601950|565159436|FG007|Overall Study|Disease progression - clinical|1|||
156566017|NCT02601950|565159429|FG000|Overall Study|Death|6|||
156566018|NCT02601950|565159430|FG001|Overall Study|Death|0|||
156566019|NCT02601950|565159431|FG002|Overall Study|Death|3|||
156566020|NCT02601950|565159432|FG003|Overall Study|Death|1|||
156566021|NCT02601950|565159433|FG004|Overall Study|Death|4|||
156566022|NCT02601950|565159434|FG005|Overall Study|Death|1|||
156566023|NCT02601950|565159435|FG006|Overall Study|Death|0|||
156566024|NCT02601950|565159436|FG007|Overall Study|Death|0|||
156566025|NCT02601950|565159429|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
156566026|NCT02601950|565159430|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
156566027|NCT02601950|565159431|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
156566028|NCT02601950|565159432|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
156566029|NCT02601950|565159433|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
156566030|NCT02601950|565159434|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
156566031|NCT02601950|565159435|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
156566032|NCT02601950|565159436|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
156566033|NCT02601950|565159429|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
156566034|NCT02601950|565159430|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
156566035|NCT02601950|565159431|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
156566036|NCT02601950|565159432|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
156566037|NCT02601950|565159433|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
156566038|NCT02601950|565159434|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
156566039|NCT02601950|565159435|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
156566040|NCT02601950|565159436|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
156566041|NCT02601950|565159429|FG000|Overall Study|Non-compliance|0|||
156566042|NCT02601950|565159430|FG001|Overall Study|Non-compliance|1|||
156566043|NCT02601950|565159431|FG002|Overall Study|Non-compliance|0|||
156566044|NCT02601950|565159432|FG003|Overall Study|Non-compliance|0|||
156566045|NCT02601950|565159433|FG004|Overall Study|Non-compliance|0|||
156566046|NCT02601950|565159434|FG005|Overall Study|Non-compliance|1|||
156566047|NCT02601950|565159435|FG006|Overall Study|Non-compliance|1|||
156566048|NCT02601950|565159436|FG007|Overall Study|Non-compliance|0|||
156566049|NCT02601950|565159429|FG000|Overall Study|Participant refused further study treatment|0|||
156566050|NCT02601950|565159430|FG001|Overall Study|Participant refused further study treatment|1|||
156566051|NCT02601950|565159431|FG002|Overall Study|Participant refused further study treatment|1|||
156566052|NCT02601950|565159432|FG003|Overall Study|Participant refused further study treatment|0|||
156566053|NCT02601950|565159433|FG004|Overall Study|Participant refused further study treatment|2|||
156566054|NCT02601950|565159434|FG005|Overall Study|Participant refused further study treatment|2|||
156566055|NCT02601950|565159435|FG006|Overall Study|Participant refused further study treatment|2|||
156566056|NCT02601950|565159436|FG007|Overall Study|Participant refused further study treatment|1|||
156566057|NCT02601950|565159429|FG000|Overall Study|Investigator discretion|1|||
156566058|NCT02601950|565159430|FG001|Overall Study|Investigator discretion|0|||
156566059|NCT02601950|565159431|FG002|Overall Study|Investigator discretion|1|||
156566060|NCT02601950|565159432|FG003|Overall Study|Investigator discretion|0|||
156566061|NCT02601950|565159433|FG004|Overall Study|Investigator discretion|1|||
156566062|NCT02601950|565159434|FG005|Overall Study|Investigator discretion|1|||
156566063|NCT02601950|565159435|FG006|Overall Study|Investigator discretion|1|||
156566064|NCT02601950|565159436|FG007|Overall Study|Investigator discretion|0|||
156566065|NCT02601950|565159429|FG000|Overall Study|Other|0|||
156566066|NCT02601950|565159430|FG001|Overall Study|Other|0|||
156566067|NCT02601950|565159431|FG002|Overall Study|Other|0|||
156566068|NCT02601950|565159432|FG003|Overall Study|Other|0|||
156566069|NCT02601950|565159433|FG004|Overall Study|Other|2|||
156566070|NCT02601950|565159434|FG005|Overall Study|Other|2|||
156566071|NCT02601950|565159435|FG006|Overall Study|Other|1|||
156566072|NCT02601950|565159436|FG007|Overall Study|Other|0|||
156566073|NCT05540652|565159437|FG000|Overall Study|Withdrawal by Subject|1|||
156566074|NCT05113940|565159440|FG000|Part A (18 Days)|Adverse Event|0|||
156566075|NCT05113940|565159441|FG001|Part A (18 Days)|Adverse Event|0|||
156566076|NCT05113940|565159442|FG002|Part A (18 Days)|Adverse Event|1|||
156566077|NCT05113940|565159443|FG003|Part A (18 Days)|Adverse Event|1|||
156566078|NCT05113940|565159444|FG004|Part A (18 Days)|Adverse Event|1|||
156566079|NCT05113940|565159445|FG005|Part A (18 Days)|Adverse Event|0|||
156566080|NCT05113940|565159446|FG006|Part A (18 Days)|Adverse Event|0|||
156566081|NCT05113940|565159447|FG007|Part A (18 Days)|Adverse Event|0|||
156566082|NCT05113940|565159448|FG008|Part A (18 Days)|Adverse Event|0|||
156566083|NCT05113940|565159449|FG009|Part A (18 Days)|Adverse Event|0|||
156566084|NCT05113940|565159450|FG010|Part A (18 Days)|Adverse Event|0|||
156566085|NCT05113940|565159451|FG011|Part A (18 Days)|Adverse Event|2|||
156566086|NCT05113940|565159452|FG012|Part A (18 Days)|Adverse Event|0|||
156566087|NCT05113940|565159453|FG013|Part A (18 Days)|Adverse Event|0|||
156566088|NCT05113940|565159454|FG014|Part A (18 Days)|Adverse Event|0|||
156566089|NCT05113940|565159440|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566090|NCT05113940|565159441|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566091|NCT05113940|565159442|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566092|NCT05113940|565159443|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566093|NCT05113940|565159444|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566094|NCT05113940|565159445|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566095|NCT05113940|565159446|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566096|NCT05113940|565159447|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566097|NCT05113940|565159448|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566098|NCT05113940|565159449|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566099|NCT05113940|565159450|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566100|NCT05113940|565159451|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566101|NCT05113940|565159452|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566102|NCT05113940|565159453|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
156566103|NCT05113940|565159454|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
156566104|NCT02157883|565159455|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
156566105|NCT02157883|565159455|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
156566106|NCT02157883|565159455|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
156566107|NCT02157883|565159455|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
156566108|NCT02157883|565159455|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
156566109|NCT01701258|565159456|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
156566110|NCT01701258|565159457|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
156566111|NCT01701258|565159458|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
156566112|NCT01701258|565159459|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
156566113|NCT01701258|565159460|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
156566114|NCT01701258|565159461|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
156566115|NCT01701258|565159462|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
156566116|NCT01701258|565159463|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
156566117|NCT01701258|565159464|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
156566118|NCT01701258|565159465|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
156566119|NCT01701258|565159466|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
156566120|NCT01701258|565159467|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
156566121|NCT01701258|565159468|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
156566122|NCT01701258|565159456|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
156566123|NCT01701258|565159457|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
156566124|NCT01701258|565159458|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
156566125|NCT01701258|565159459|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
156566126|NCT01701258|565159460|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
156566127|NCT01701258|565159461|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
156566128|NCT01701258|565159462|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
156566129|NCT01701258|565159463|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
156566130|NCT01701258|565159464|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
156566131|NCT01701258|565159465|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
156566132|NCT01701258|565159466|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
156566133|NCT01701258|565159467|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
156566134|NCT01701258|565159468|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
156566135|NCT01701258|565159456|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
156566136|NCT01701258|565159457|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
156566137|NCT01701258|565159458|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
156566138|NCT01701258|565159459|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
156566139|NCT01701258|565159460|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
156566140|NCT01701258|565159461|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
156566141|NCT01701258|565159462|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
156566142|NCT01701258|565159463|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
156566143|NCT01701258|565159464|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
156566144|NCT01701258|565159465|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
156566145|NCT01701258|565159466|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
156566146|NCT01701258|565159467|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
156566147|NCT01701258|565159468|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
156566148|NCT01701258|565159456|FG000|Assessment and Scheduling|Investigator Terminated|2|||
156566149|NCT01701258|565159457|FG001|Assessment and Scheduling|Investigator Terminated|0|||
156566150|NCT01701258|565159458|FG002|Assessment and Scheduling|Investigator Terminated|0|||
156566151|NCT01701258|565159459|FG003|Assessment and Scheduling|Investigator Terminated|0|||
156566152|NCT01701258|565159460|FG004|Assessment and Scheduling|Investigator Terminated|0|||
156566153|NCT01701258|565159461|FG005|Assessment and Scheduling|Investigator Terminated|0|||
156566154|NCT01701258|565159462|FG006|Assessment and Scheduling|Investigator Terminated|0|||
156566155|NCT01701258|565159463|FG007|Assessment and Scheduling|Investigator Terminated|0|||
156566156|NCT01701258|565159464|FG008|Assessment and Scheduling|Investigator Terminated|0|||
156566157|NCT01701258|565159465|FG009|Assessment and Scheduling|Investigator Terminated|0|||
156566158|NCT01701258|565159466|FG010|Assessment and Scheduling|Investigator Terminated|0|||
156566159|NCT01701258|565159467|FG011|Assessment and Scheduling|Investigator Terminated|0|||
156566160|NCT01701258|565159468|FG012|Assessment and Scheduling|Investigator Terminated|0|||
156566161|NCT01323478|565159469|FG000|Overall Study|Adverse Event|7|||
156566162|NCT01323478|565159469|FG000|Overall Study|Lack of Efficacy|4|||
156566163|NCT01323478|565159469|FG000|Overall Study|Non-compliance With Study Product|3|||
156566164|NCT01323478|565159469|FG000|Overall Study|Protocol Violation|1|||
156566165|NCT01323478|565159469|FG000|Overall Study|Withdrawal of Consent|1|||
156566166|NCT01323478|565159469|FG000|Overall Study|Administrative or Other Reasons|8|||
156566167|NCT01756274|565159473|FG000|Overall Study|Protocol Violation|2|||
156566168|NCT01756274|565159473|FG000|Overall Study|Laboratory error|1|||
156566169|NCT03367871|565159476|FG000|Overall Study|Lost to Follow-up|1|||
156566170|NCT00885365|565159480|FG000|4 Weeks ON Treatment|Adverse Event|2|||
156566171|NCT00885365|565159481|FG001|4 Weeks ON Treatment|Adverse Event|4|||
156566172|NCT00885365|565159480|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
156566173|NCT00885365|565159481|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
156566174|NCT00885365|565159480|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
156566175|NCT00885365|565159481|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
156566176|NCT01824979|565159482|FG000|Overall Study|Withdrawal by Subject|5|||
156566177|NCT01824979|565159483|FG001|Overall Study|Withdrawal by Subject|0|||
156566178|NCT01824979|565159482|FG000|Overall Study|Physician Decision|2|||
156566179|NCT01824979|565159483|FG001|Overall Study|Physician Decision|0|||
156566180|NCT01824979|565159482|FG000|Overall Study|Protocol Violation|6|||
156566181|NCT01824979|565159483|FG001|Overall Study|Protocol Violation|13|||
156566182|NCT00481065|565159487|FG000|Overall Study|Adverse event or death|1|||
156566183|NCT00481065|565159488|FG001|Overall Study|Adverse event or death|1|||
156566184|NCT00481065|565159489|FG002|Overall Study|Adverse event or death|3|||
156566185|NCT00481065|565159490|FG003|Overall Study|Adverse event or death|0|||
156566186|NCT00481065|565159491|FG004|Overall Study|Adverse event or death|2|||
156566187|NCT00481065|565159492|FG005|Overall Study|Adverse event or death|0|||
156566188|NCT00481065|565159493|FG006|Overall Study|Adverse event or death|1|||
156566189|NCT00481065|565159494|FG007|Overall Study|Adverse event or death|1|||
156566190|NCT00481065|565159487|FG000|Overall Study|Withdrawal by Subject|11|||
156566191|NCT00481065|565159488|FG001|Overall Study|Withdrawal by Subject|12|||
156566192|NCT00481065|565159489|FG002|Overall Study|Withdrawal by Subject|7|||
156566193|NCT00481065|565159490|FG003|Overall Study|Withdrawal by Subject|11|||
156566194|NCT00481065|565159491|FG004|Overall Study|Withdrawal by Subject|13|||
156566195|NCT00481065|565159492|FG005|Overall Study|Withdrawal by Subject|12|||
156566196|NCT00481065|565159493|FG006|Overall Study|Withdrawal by Subject|9|||
156566197|NCT00481065|565159494|FG007|Overall Study|Withdrawal by Subject|10|||
156566198|NCT00481065|565159487|FG000|Overall Study|Lost to Follow-up|4|||
156566199|NCT00481065|565159488|FG001|Overall Study|Lost to Follow-up|2|||
156566200|NCT00481065|565159489|FG002|Overall Study|Lost to Follow-up|4|||
156566201|NCT00481065|565159490|FG003|Overall Study|Lost to Follow-up|3|||
156566202|NCT00481065|565159491|FG004|Overall Study|Lost to Follow-up|3|||
156566203|NCT00481065|565159492|FG005|Overall Study|Lost to Follow-up|3|||
156566204|NCT00481065|565159493|FG006|Overall Study|Lost to Follow-up|2|||
156566205|NCT00481065|565159494|FG007|Overall Study|Lost to Follow-up|5|||
156566206|NCT00481065|565159487|FG000|Overall Study|Inappropriate enrollment|4|||
156566207|NCT00481065|565159488|FG001|Overall Study|Inappropriate enrollment|0|||
156566208|NCT00481065|565159489|FG002|Overall Study|Inappropriate enrollment|2|||
156566209|NCT00481065|565159490|FG003|Overall Study|Inappropriate enrollment|0|||
156566210|NCT00481065|565159491|FG004|Overall Study|Inappropriate enrollment|2|||
156566211|NCT00481065|565159492|FG005|Overall Study|Inappropriate enrollment|1|||
156566212|NCT00481065|565159493|FG006|Overall Study|Inappropriate enrollment|0|||
156566213|NCT00481065|565159494|FG007|Overall Study|Inappropriate enrollment|1|||
156566214|NCT00481065|565159487|FG000|Overall Study|Administrative reason|0|||
156566215|NCT00481065|565159488|FG001|Overall Study|Administrative reason|0|||
156566216|NCT00481065|565159489|FG002|Overall Study|Administrative reason|0|||
156566217|NCT00481065|565159490|FG003|Overall Study|Administrative reason|0|||
156566218|NCT00481065|565159491|FG004|Overall Study|Administrative reason|0|||
156566219|NCT00481065|565159492|FG005|Overall Study|Administrative reason|2|||
156566220|NCT00481065|565159493|FG006|Overall Study|Administrative reason|1|||
156566221|NCT00481065|565159494|FG007|Overall Study|Administrative reason|0|||
156566222|NCT00481065|565159487|FG000|Overall Study|Protocol Violation|2|||
156566223|NCT00481065|565159488|FG001|Overall Study|Protocol Violation|1|||
156566224|NCT00481065|565159489|FG002|Overall Study|Protocol Violation|1|||
156566225|NCT00481065|565159490|FG003|Overall Study|Protocol Violation|1|||
156566226|NCT00481065|565159491|FG004|Overall Study|Protocol Violation|2|||
156566227|NCT00481065|565159492|FG005|Overall Study|Protocol Violation|6|||
156566228|NCT00481065|565159493|FG006|Overall Study|Protocol Violation|3|||
156566229|NCT00481065|565159494|FG007|Overall Study|Protocol Violation|2|||
156566230|NCT00481065|565159487|FG000|Overall Study|Unable to classify|0|||
156566231|NCT00481065|565159488|FG001|Overall Study|Unable to classify|1|||
156566232|NCT00481065|565159489|FG002|Overall Study|Unable to classify|2|||
156566233|NCT00481065|565159490|FG003|Overall Study|Unable to classify|0|||
156566234|NCT00481065|565159491|FG004|Overall Study|Unable to classify|1|||
156566235|NCT00481065|565159492|FG005|Overall Study|Unable to classify|0|||
156566236|NCT00481065|565159493|FG006|Overall Study|Unable to classify|0|||
156566237|NCT00481065|565159494|FG007|Overall Study|Unable to classify|0|||
156566238|NCT03094195|565159500|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
156566239|NCT03094195|565159501|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
156566240|NCT03094195|565159502|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
156566241|NCT03094195|565159503|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156566242|NCT03094195|565159504|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156566243|NCT03094195|565159505|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156566244|NCT03094195|565159506|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156566245|NCT03094195|565159507|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156566246|NCT03094195|565159500|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
156566247|NCT03094195|565159501|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
156566248|NCT03094195|565159502|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
156566249|NCT03094195|565159503|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156566250|NCT03094195|565159504|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156566251|NCT03094195|565159505|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156566252|NCT03094195|565159506|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156566253|NCT03094195|565159507|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156566254|NCT03094195|565159500|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156566255|NCT03094195|565159501|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156566256|NCT03094195|565159502|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
156566257|NCT03094195|565159503|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156566258|NCT03094195|565159504|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156566259|NCT03094195|565159505|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156566260|NCT03094195|565159506|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156566261|NCT03094195|565159507|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156566262|NCT03094195|565159500|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156566263|NCT03094195|565159501|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
156566264|NCT03094195|565159502|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
156566265|NCT03094195|565159503|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156566266|NCT03094195|565159504|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156566267|NCT03094195|565159505|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156566268|NCT03094195|565159506|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156566269|NCT03094195|565159507|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156566270|NCT01957137|565159508|FG000|Randomized Portion|Adverse Event|1|||
156566271|NCT01957137|565159508|FG000|Randomized Portion|Withdrawal by Subject|1|||
156566272|NCT00054132|565159509|FG000|Overall Study|Not Treated|1|||
156566273|NCT01795547|565159514|FG000|Overall Study|Adverse Event|16|||
156566274|NCT01795547|565159515|FG001|Overall Study|Adverse Event|27|||
156566275|NCT01795547|565159514|FG000|Overall Study|Lack of Efficacy|8|||
156566276|NCT01795547|565159515|FG001|Overall Study|Lack of Efficacy|3|||
156566277|NCT01795547|565159514|FG000|Overall Study|Protocol Violation|6|||
156566278|NCT01795547|565159515|FG001|Overall Study|Protocol Violation|4|||
156566279|NCT01795547|565159514|FG000|Overall Study|Lost to Follow-up|2|||
156566280|NCT01795547|565159515|FG001|Overall Study|Lost to Follow-up|5|||
156566281|NCT01795547|565159514|FG000|Overall Study|Withdrawal of consent|7|||
156566282|NCT01795547|565159515|FG001|Overall Study|Withdrawal of consent|12|||
156566283|NCT01795547|565159514|FG000|Overall Study|Not Treated|4|||
156566284|NCT01795547|565159515|FG001|Overall Study|Not Treated|10|||
156566285|NCT01795547|565159514|FG000|Overall Study|Non-compliance with IMP|1|||
156566286|NCT01795547|565159515|FG001|Overall Study|Non-compliance with IMP|1|||
156566287|NCT01795547|565159514|FG000|Overall Study|Others|4|||
156566288|NCT01795547|565159515|FG001|Overall Study|Others|1|||
156566289|NCT01795547|565159514|FG000|Overall Study|Not stated|0|||
156566290|NCT01795547|565159515|FG001|Overall Study|Not stated|1|||
156566291|NCT02901431|565159516|FG000|PK Part|Adverse Event|0|||
156566292|NCT02901431|565159517|FG001|PK Part|Adverse Event|1|||
156566293|NCT02901431|565159518|FG002|PK Part|Adverse Event|0|||
156566294|NCT02901431|565159519|FG003|PK Part|Adverse Event|0|||
156566295|NCT02901431|565159520|FG004|PK Part|Adverse Event|0|||
156566296|NCT02901431|565159521|FG005|PK Part|Adverse Event|0|||
156566297|NCT02901431|565159522|FG006|PK Part|Adverse Event|0|||
156566298|NCT02901431|565159523|FG007|PK Part|Adverse Event|0|||
156566299|NCT02901431|565159524|FG008|PK Part|Adverse Event|0|||
156566300|NCT02901431|565159525|FG009|PK Part|Adverse Event|0|||
156566301|NCT02901431|565159526|FG010|PK Part|Adverse Event|0|||
156566302|NCT02901431|565159527|FG011|PK Part|Adverse Event|0|||
156566303|NCT02901431|565159528|FG012|PK Part|Adverse Event|0|||
156566304|NCT02901431|565159516|FG000|PK Part|Lost to Follow-up|0|||
156566305|NCT02901431|565159517|FG001|PK Part|Lost to Follow-up|0|||
156566306|NCT02901431|565159518|FG002|PK Part|Lost to Follow-up|1|||
156566307|NCT02901431|565159519|FG003|PK Part|Lost to Follow-up|0|||
156566308|NCT02901431|565159520|FG004|PK Part|Lost to Follow-up|0|||
156566309|NCT02901431|565159521|FG005|PK Part|Lost to Follow-up|0|||
156566310|NCT02901431|565159522|FG006|PK Part|Lost to Follow-up|0|||
156566311|NCT02901431|565159523|FG007|PK Part|Lost to Follow-up|0|||
156566312|NCT02901431|565159524|FG008|PK Part|Lost to Follow-up|0|||
156566313|NCT02901431|565159525|FG009|PK Part|Lost to Follow-up|0|||
156566314|NCT02901431|565159526|FG010|PK Part|Lost to Follow-up|0|||
156566315|NCT02901431|565159527|FG011|PK Part|Lost to Follow-up|0|||
156566316|NCT02901431|565159528|FG012|PK Part|Lost to Follow-up|0|||
156566317|NCT02901431|565159516|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
156566318|NCT02901431|565159517|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566319|NCT02901431|565159518|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566320|NCT02901431|565159519|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566321|NCT02901431|565159520|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566322|NCT02901431|565159521|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566323|NCT02901431|565159522|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566324|NCT02901431|565159523|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566325|NCT02901431|565159524|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566326|NCT02901431|565159525|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566327|NCT02901431|565159526|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566328|NCT02901431|565159527|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566329|NCT02901431|565159528|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
156566330|NCT02901431|565159516|FG000|PK Part|Pending dose confirmation|0|||
156566331|NCT02901431|565159517|FG001|PK Part|Pending dose confirmation|1|||
156566332|NCT02901431|565159518|FG002|PK Part|Pending dose confirmation|0|||
156566333|NCT02901431|565159519|FG003|PK Part|Pending dose confirmation|0|||
156566334|NCT02901431|565159520|FG004|PK Part|Pending dose confirmation|0|||
156566335|NCT02901431|565159521|FG005|PK Part|Pending dose confirmation|0|||
156566336|NCT02901431|565159522|FG006|PK Part|Pending dose confirmation|0|||
156566337|NCT02901431|565159523|FG007|PK Part|Pending dose confirmation|0|||
156566338|NCT02901431|565159524|FG008|PK Part|Pending dose confirmation|0|||
156566339|NCT02901431|565159525|FG009|PK Part|Pending dose confirmation|0|||
156566340|NCT02901431|565159526|FG010|PK Part|Pending dose confirmation|0|||
156566341|NCT02901431|565159527|FG011|PK Part|Pending dose confirmation|0|||
156566342|NCT02901431|565159528|FG012|PK Part|Pending dose confirmation|0|||
156566343|NCT02901431|565159516|FG000|PK Part|8 weeks of treatment ran out|2|||
156566344|NCT02901431|565159517|FG001|PK Part|8 weeks of treatment ran out|0|||
156566345|NCT02901431|565159518|FG002|PK Part|8 weeks of treatment ran out|0|||
156566346|NCT02901431|565159519|FG003|PK Part|8 weeks of treatment ran out|0|||
156566347|NCT02901431|565159520|FG004|PK Part|8 weeks of treatment ran out|0|||
156566348|NCT02901431|565159521|FG005|PK Part|8 weeks of treatment ran out|0|||
156566349|NCT02901431|565159522|FG006|PK Part|8 weeks of treatment ran out|0|||
156566350|NCT02901431|565159523|FG007|PK Part|8 weeks of treatment ran out|0|||
156566351|NCT02901431|565159524|FG008|PK Part|8 weeks of treatment ran out|0|||
156566352|NCT02901431|565159525|FG009|PK Part|8 weeks of treatment ran out|0|||
156566353|NCT02901431|565159526|FG010|PK Part|8 weeks of treatment ran out|0|||
156566354|NCT02901431|565159527|FG011|PK Part|8 weeks of treatment ran out|0|||
156566355|NCT02901431|565159528|FG012|PK Part|8 weeks of treatment ran out|0|||
156566356|NCT02901431|565159516|FG000|PK Part|Stopped treatment after 8 weeks|1|||
156566357|NCT02901431|565159517|FG001|PK Part|Stopped treatment after 8 weeks|0|||
156566358|NCT02901431|565159518|FG002|PK Part|Stopped treatment after 8 weeks|1|||
156566359|NCT02901431|565159519|FG003|PK Part|Stopped treatment after 8 weeks|0|||
156566360|NCT02901431|565159520|FG004|PK Part|Stopped treatment after 8 weeks|0|||
156566361|NCT02901431|565159521|FG005|PK Part|Stopped treatment after 8 weeks|0|||
156566362|NCT02901431|565159522|FG006|PK Part|Stopped treatment after 8 weeks|0|||
156566363|NCT02901431|565159523|FG007|PK Part|Stopped treatment after 8 weeks|0|||
156566364|NCT02901431|565159524|FG008|PK Part|Stopped treatment after 8 weeks|0|||
156566365|NCT02901431|565159525|FG009|PK Part|Stopped treatment after 8 weeks|0|||
156566366|NCT02901431|565159526|FG010|PK Part|Stopped treatment after 8 weeks|0|||
156566367|NCT02901431|565159527|FG011|PK Part|Stopped treatment after 8 weeks|0|||
156566368|NCT02901431|565159528|FG012|PK Part|Stopped treatment after 8 weeks|0|||
156566369|NCT02901431|565159516|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
156566370|NCT02901431|565159517|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566371|NCT02901431|565159518|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
156566372|NCT02901431|565159519|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566373|NCT02901431|565159520|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566374|NCT02901431|565159521|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566375|NCT02901431|565159522|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566376|NCT02901431|565159523|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566377|NCT02901431|565159524|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566378|NCT02901431|565159525|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566379|NCT02901431|565159526|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566380|NCT02901431|565159527|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566381|NCT02901431|565159528|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156566382|NCT02901431|565159516|FG000|PK Part|Discontinued per Sponsor|0|||
156566383|NCT02901431|565159517|FG001|PK Part|Discontinued per Sponsor|3|||
156566384|NCT02901431|565159518|FG002|PK Part|Discontinued per Sponsor|0|||
156566385|NCT02901431|565159519|FG003|PK Part|Discontinued per Sponsor|0|||
156566386|NCT02901431|565159520|FG004|PK Part|Discontinued per Sponsor|0|||
156566387|NCT02901431|565159521|FG005|PK Part|Discontinued per Sponsor|0|||
156566388|NCT02901431|565159522|FG006|PK Part|Discontinued per Sponsor|0|||
156566389|NCT02901431|565159523|FG007|PK Part|Discontinued per Sponsor|0|||
156566390|NCT02901431|565159524|FG008|PK Part|Discontinued per Sponsor|0|||
156566391|NCT02901431|565159525|FG009|PK Part|Discontinued per Sponsor|0|||
156566392|NCT02901431|565159526|FG010|PK Part|Discontinued per Sponsor|0|||
156566393|NCT02901431|565159527|FG011|PK Part|Discontinued per Sponsor|0|||
156566394|NCT02901431|565159528|FG012|PK Part|Discontinued per Sponsor|0|||
156566395|NCT02901431|565159516|FG000|PK Part|Withdrawal by Subject|1|||
156566396|NCT02901431|565159517|FG001|PK Part|Withdrawal by Subject|1|||
156566397|NCT02901431|565159518|FG002|PK Part|Withdrawal by Subject|3|||
156566398|NCT02901431|565159519|FG003|PK Part|Withdrawal by Subject|0|||
156566399|NCT02901431|565159520|FG004|PK Part|Withdrawal by Subject|0|||
156566400|NCT02901431|565159521|FG005|PK Part|Withdrawal by Subject|0|||
156566401|NCT02901431|565159522|FG006|PK Part|Withdrawal by Subject|0|||
156566402|NCT02901431|565159523|FG007|PK Part|Withdrawal by Subject|0|||
156566403|NCT02901431|565159524|FG008|PK Part|Withdrawal by Subject|0|||
156566404|NCT02901431|565159525|FG009|PK Part|Withdrawal by Subject|0|||
156566405|NCT02901431|565159526|FG010|PK Part|Withdrawal by Subject|0|||
156566406|NCT02901431|565159527|FG011|PK Part|Withdrawal by Subject|0|||
156566407|NCT02901431|565159528|FG012|PK Part|Withdrawal by Subject|0|||
156566408|NCT02901431|565159516|FG000|Main Treatment Part|Adverse Event|0|||
156566409|NCT02901431|565159517|FG001|Main Treatment Part|Adverse Event|0|||
156566410|NCT02901431|565159518|FG002|Main Treatment Part|Adverse Event|0|||
156566411|NCT02901431|565159519|FG003|Main Treatment Part|Adverse Event|3|||
156566412|NCT02901431|565159520|FG004|Main Treatment Part|Adverse Event|3|||
156566413|NCT02901431|565159521|FG005|Main Treatment Part|Adverse Event|4|||
156566414|NCT02901431|565159522|FG006|Main Treatment Part|Adverse Event|1|||
156566415|NCT02901431|565159523|FG007|Main Treatment Part|Adverse Event|0|||
156566416|NCT02901431|565159524|FG008|Main Treatment Part|Adverse Event|0|||
156566417|NCT02901431|565159525|FG009|Main Treatment Part|Adverse Event|0|||
156566418|NCT02901431|565159526|FG010|Main Treatment Part|Adverse Event|0|||
156566419|NCT02901431|565159527|FG011|Main Treatment Part|Adverse Event|0|||
156566420|NCT02901431|565159528|FG012|Main Treatment Part|Adverse Event|0|||
156566421|NCT02901431|565159516|FG000|Main Treatment Part|Lack of Efficacy|0|||
156566422|NCT02901431|565159517|FG001|Main Treatment Part|Lack of Efficacy|0|||
156566423|NCT02901431|565159518|FG002|Main Treatment Part|Lack of Efficacy|0|||
156566424|NCT02901431|565159519|FG003|Main Treatment Part|Lack of Efficacy|1|||
156566425|NCT02901431|565159520|FG004|Main Treatment Part|Lack of Efficacy|0|||
156566426|NCT02901431|565159521|FG005|Main Treatment Part|Lack of Efficacy|0|||
156566427|NCT02901431|565159522|FG006|Main Treatment Part|Lack of Efficacy|0|||
156566428|NCT02901431|565159523|FG007|Main Treatment Part|Lack of Efficacy|0|||
156566429|NCT02901431|565159524|FG008|Main Treatment Part|Lack of Efficacy|0|||
156566430|NCT02901431|565159525|FG009|Main Treatment Part|Lack of Efficacy|0|||
156566431|NCT02901431|565159526|FG010|Main Treatment Part|Lack of Efficacy|0|||
156566432|NCT02901431|565159527|FG011|Main Treatment Part|Lack of Efficacy|0|||
156566433|NCT02901431|565159528|FG012|Main Treatment Part|Lack of Efficacy|0|||
156566434|NCT02901431|565159516|FG000|Main Treatment Part|Lost to Follow-up|0|||
156566435|NCT02901431|565159517|FG001|Main Treatment Part|Lost to Follow-up|0|||
156566436|NCT02901431|565159518|FG002|Main Treatment Part|Lost to Follow-up|0|||
156566437|NCT02901431|565159519|FG003|Main Treatment Part|Lost to Follow-up|3|||
156566438|NCT02901431|565159520|FG004|Main Treatment Part|Lost to Follow-up|1|||
156566439|NCT02901431|565159521|FG005|Main Treatment Part|Lost to Follow-up|2|||
156566440|NCT02901431|565159522|FG006|Main Treatment Part|Lost to Follow-up|3|||
156566441|NCT02901431|565159523|FG007|Main Treatment Part|Lost to Follow-up|0|||
156566442|NCT02901431|565159524|FG008|Main Treatment Part|Lost to Follow-up|0|||
156566443|NCT02901431|565159525|FG009|Main Treatment Part|Lost to Follow-up|0|||
156566444|NCT02901431|565159526|FG010|Main Treatment Part|Lost to Follow-up|0|||
156566445|NCT02901431|565159527|FG011|Main Treatment Part|Lost to Follow-up|0|||
156566446|NCT02901431|565159528|FG012|Main Treatment Part|Lost to Follow-up|0|||
156566447|NCT02901431|565159516|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
156566448|NCT02901431|565159517|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
156566449|NCT02901431|565159518|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
156566450|NCT02901431|565159519|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
156566451|NCT02901431|565159520|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
156566452|NCT02901431|565159521|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
156566453|NCT02901431|565159522|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
156566454|NCT02901431|565159523|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
156566455|NCT02901431|565159524|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
156566456|NCT02901431|565159525|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
156566457|NCT02901431|565159526|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
156566458|NCT02901431|565159527|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
156566459|NCT02901431|565159528|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
156566460|NCT02901431|565159516|FG000|Main Treatment Part|Physician Decision|0|||
156566461|NCT02901431|565159517|FG001|Main Treatment Part|Physician Decision|0|||
156566462|NCT02901431|565159518|FG002|Main Treatment Part|Physician Decision|0|||
156566463|NCT02901431|565159519|FG003|Main Treatment Part|Physician Decision|1|||
156566464|NCT02901431|565159520|FG004|Main Treatment Part|Physician Decision|0|||
156566465|NCT02901431|565159521|FG005|Main Treatment Part|Physician Decision|0|||
156566466|NCT02901431|565159522|FG006|Main Treatment Part|Physician Decision|1|||
156566467|NCT02901431|565159523|FG007|Main Treatment Part|Physician Decision|0|||
156566468|NCT02901431|565159524|FG008|Main Treatment Part|Physician Decision|0|||
156566469|NCT02901431|565159525|FG009|Main Treatment Part|Physician Decision|0|||
156566470|NCT02901431|565159526|FG010|Main Treatment Part|Physician Decision|0|||
156566471|NCT02901431|565159527|FG011|Main Treatment Part|Physician Decision|0|||
156566472|NCT02901431|565159528|FG012|Main Treatment Part|Physician Decision|0|||
156566473|NCT02901431|565159516|FG000|Main Treatment Part|Withdrawal by Subject|0|||
156566474|NCT02901431|565159517|FG001|Main Treatment Part|Withdrawal by Subject|0|||
156566475|NCT02901431|565159518|FG002|Main Treatment Part|Withdrawal by Subject|0|||
156566476|NCT02901431|565159519|FG003|Main Treatment Part|Withdrawal by Subject|18|||
156566477|NCT02901431|565159520|FG004|Main Treatment Part|Withdrawal by Subject|3|||
156566478|NCT02901431|565159521|FG005|Main Treatment Part|Withdrawal by Subject|5|||
156566479|NCT02901431|565159522|FG006|Main Treatment Part|Withdrawal by Subject|6|||
156566480|NCT02901431|565159523|FG007|Main Treatment Part|Withdrawal by Subject|0|||
156566481|NCT02901431|565159524|FG008|Main Treatment Part|Withdrawal by Subject|0|||
156566482|NCT02901431|565159525|FG009|Main Treatment Part|Withdrawal by Subject|0|||
156566483|NCT02901431|565159526|FG010|Main Treatment Part|Withdrawal by Subject|0|||
156566484|NCT02901431|565159527|FG011|Main Treatment Part|Withdrawal by Subject|0|||
156566485|NCT02901431|565159528|FG012|Main Treatment Part|Withdrawal by Subject|0|||
156566486|NCT02901431|565159516|FG000|Open Label Part|Adverse Event|0|||
156566487|NCT02901431|565159517|FG001|Open Label Part|Adverse Event|0|||
156566488|NCT02901431|565159518|FG002|Open Label Part|Adverse Event|0|||
156566489|NCT02901431|565159519|FG003|Open Label Part|Adverse Event|0|||
156566490|NCT02901431|565159520|FG004|Open Label Part|Adverse Event|0|||
156566491|NCT02901431|565159521|FG005|Open Label Part|Adverse Event|0|||
156566492|NCT02901431|565159522|FG006|Open Label Part|Adverse Event|0|||
156566493|NCT02901431|565159523|FG007|Open Label Part|Adverse Event|0|||
156566494|NCT02901431|565159524|FG008|Open Label Part|Adverse Event|4|||
156566495|NCT02901431|565159525|FG009|Open Label Part|Adverse Event|4|||
156566496|NCT02901431|565159526|FG010|Open Label Part|Adverse Event|0|||
156566497|NCT02901431|565159527|FG011|Open Label Part|Adverse Event|4|||
156566498|NCT02901431|565159528|FG012|Open Label Part|Adverse Event|1|||
156566499|NCT02901431|565159516|FG000|Open Label Part|Lost to Follow-up|0|||
156566500|NCT02901431|565159517|FG001|Open Label Part|Lost to Follow-up|0|||
156566501|NCT02901431|565159518|FG002|Open Label Part|Lost to Follow-up|0|||
156566502|NCT02901431|565159519|FG003|Open Label Part|Lost to Follow-up|0|||
156566503|NCT02901431|565159520|FG004|Open Label Part|Lost to Follow-up|0|||
156566504|NCT02901431|565159521|FG005|Open Label Part|Lost to Follow-up|0|||
156566505|NCT02901431|565159522|FG006|Open Label Part|Lost to Follow-up|0|||
156566506|NCT02901431|565159523|FG007|Open Label Part|Lost to Follow-up|0|||
156566507|NCT02901431|565159524|FG008|Open Label Part|Lost to Follow-up|2|||
156566508|NCT02901431|565159525|FG009|Open Label Part|Lost to Follow-up|2|||
156566509|NCT02901431|565159526|FG010|Open Label Part|Lost to Follow-up|1|||
156566510|NCT02901431|565159527|FG011|Open Label Part|Lost to Follow-up|1|||
156566511|NCT02901431|565159528|FG012|Open Label Part|Lost to Follow-up|1|||
156566512|NCT02901431|565159516|FG000|Open Label Part|Physician Decision|0|||
156566513|NCT02901431|565159517|FG001|Open Label Part|Physician Decision|0|||
156566514|NCT02901431|565159518|FG002|Open Label Part|Physician Decision|0|||
156566515|NCT02901431|565159519|FG003|Open Label Part|Physician Decision|0|||
156566516|NCT02901431|565159520|FG004|Open Label Part|Physician Decision|0|||
156566517|NCT02901431|565159521|FG005|Open Label Part|Physician Decision|0|||
156566518|NCT02901431|565159522|FG006|Open Label Part|Physician Decision|0|||
156566519|NCT02901431|565159523|FG007|Open Label Part|Physician Decision|0|||
156566520|NCT02901431|565159524|FG008|Open Label Part|Physician Decision|1|||
156566521|NCT02901431|565159525|FG009|Open Label Part|Physician Decision|1|||
156566522|NCT02901431|565159526|FG010|Open Label Part|Physician Decision|0|||
156566523|NCT02901431|565159527|FG011|Open Label Part|Physician Decision|0|||
156566524|NCT02901431|565159528|FG012|Open Label Part|Physician Decision|0|||
156566525|NCT02901431|565159516|FG000|Open Label Part|Study Terminated By Sponsor|0|||
156566526|NCT02901431|565159517|FG001|Open Label Part|Study Terminated By Sponsor|0|||
156566527|NCT02901431|565159518|FG002|Open Label Part|Study Terminated By Sponsor|0|||
156566528|NCT02901431|565159519|FG003|Open Label Part|Study Terminated By Sponsor|0|||
156566529|NCT02901431|565159520|FG004|Open Label Part|Study Terminated By Sponsor|0|||
156566530|NCT02901431|565159521|FG005|Open Label Part|Study Terminated By Sponsor|0|||
156566531|NCT02901431|565159522|FG006|Open Label Part|Study Terminated By Sponsor|0|||
156566532|NCT02901431|565159523|FG007|Open Label Part|Study Terminated By Sponsor|0|||
156566533|NCT02901431|565159524|FG008|Open Label Part|Study Terminated By Sponsor|35|||
156566534|NCT02901431|565159525|FG009|Open Label Part|Study Terminated By Sponsor|12|||
156566535|NCT02901431|565159526|FG010|Open Label Part|Study Terminated By Sponsor|21|||
156566536|NCT02901431|565159527|FG011|Open Label Part|Study Terminated By Sponsor|31|||
156566537|NCT02901431|565159528|FG012|Open Label Part|Study Terminated By Sponsor|0|||
156566538|NCT02901431|565159516|FG000|Open Label Part|Withdrawal by Subject|0|||
156566539|NCT02901431|565159517|FG001|Open Label Part|Withdrawal by Subject|0|||
156566540|NCT02901431|565159518|FG002|Open Label Part|Withdrawal by Subject|0|||
156566541|NCT02901431|565159519|FG003|Open Label Part|Withdrawal by Subject|0|||
156566542|NCT02901431|565159520|FG004|Open Label Part|Withdrawal by Subject|0|||
156566543|NCT02901431|565159521|FG005|Open Label Part|Withdrawal by Subject|0|||
156566544|NCT02901431|565159522|FG006|Open Label Part|Withdrawal by Subject|0|||
156566545|NCT02901431|565159523|FG007|Open Label Part|Withdrawal by Subject|0|||
156566546|NCT02901431|565159524|FG008|Open Label Part|Withdrawal by Subject|6|||
156566547|NCT02901431|565159525|FG009|Open Label Part|Withdrawal by Subject|5|||
156566548|NCT02901431|565159526|FG010|Open Label Part|Withdrawal by Subject|7|||
156566549|NCT02901431|565159527|FG011|Open Label Part|Withdrawal by Subject|3|||
156566550|NCT02901431|565159528|FG012|Open Label Part|Withdrawal by Subject|1|||
156566551|NCT00591734|565159533|FG000|Overall Study|Lack of Efficacy|35|||
156566552|NCT00591734|565159533|FG000|Overall Study|Adverse Event|5|||
156566553|NCT00591734|565159533|FG000|Overall Study|Physician Decision|5|||
156566554|NCT00591734|565159533|FG000|Overall Study|Intercurrent Illness|8|||
156566555|NCT01661790|565159534|FG000|Overall Study|Lost to Follow-up|0|||
156566556|NCT01661790|565159535|FG001|Overall Study|Lost to Follow-up|2|||
156566557|NCT00784758|565159538|FG000|Overall Study|Withdrawal by Subject|3|||
156566558|NCT00784758|565159539|FG001|Overall Study|Withdrawal by Subject|0|||
156566559|NCT00784758|565159538|FG000|Overall Study|Adverse Event|1|||
156566560|NCT00784758|565159539|FG001|Overall Study|Adverse Event|0|||
156566561|NCT01827384|565159540|FG000|Overall Study|Switched to alternative treatment|0|||
156566562|NCT01827384|565159541|FG001|Overall Study|Switched to alternative treatment|0|||
156566563|NCT01827384|565159542|FG002|Overall Study|Switched to alternative treatment|0|||
156566564|NCT01827384|565159543|FG003|Overall Study|Switched to alternative treatment|0|||
156566565|NCT01827384|565159544|FG004|Overall Study|Switched to alternative treatment|0|||
156566566|NCT01827384|565159545|FG005|Overall Study|Switched to alternative treatment|0|||
156566567|NCT01827384|565159546|FG006|Overall Study|Switched to alternative treatment|0|||
156566568|NCT01827384|565159547|FG007|Overall Study|Switched to alternative treatment|0|||
156566569|NCT01827384|565159548|FG008|Overall Study|Switched to alternative treatment|0|||
156566570|NCT01827384|565159549|FG009|Overall Study|Switched to alternative treatment|0|||
156566571|NCT01827384|565159550|FG010|Overall Study|Switched to alternative treatment|0|||
156566572|NCT01827384|565159551|FG011|Overall Study|Switched to alternative treatment|0|||
156566573|NCT01827384|565159552|FG012|Overall Study|Switched to alternative treatment|0|||
156566574|NCT01827384|565159553|FG013|Overall Study|Switched to alternative treatment|2|||
156566575|NCT01827384|565159540|FG000|Overall Study|Disease progression before treatment|0|||
156566576|NCT01827384|565159541|FG001|Overall Study|Disease progression before treatment|0|||
156566577|NCT01827384|565159542|FG002|Overall Study|Disease progression before treatment|0|||
156566578|NCT01827384|565159543|FG003|Overall Study|Disease progression before treatment|0|||
156566579|NCT01827384|565159544|FG004|Overall Study|Disease progression before treatment|0|||
156566580|NCT01827384|565159545|FG005|Overall Study|Disease progression before treatment|0|||
156566581|NCT01827384|565159546|FG006|Overall Study|Disease progression before treatment|0|||
156566582|NCT01827384|565159547|FG007|Overall Study|Disease progression before treatment|0|||
156566583|NCT01827384|565159548|FG008|Overall Study|Disease progression before treatment|0|||
156566584|NCT01827384|565159549|FG009|Overall Study|Disease progression before treatment|0|||
156566585|NCT01827384|565159550|FG010|Overall Study|Disease progression before treatment|0|||
156566586|NCT01827384|565159551|FG011|Overall Study|Disease progression before treatment|0|||
156566587|NCT01827384|565159552|FG012|Overall Study|Disease progression before treatment|0|||
156566588|NCT01827384|565159553|FG013|Overall Study|Disease progression before treatment|4|||
156566589|NCT01827384|565159540|FG000|Overall Study|Ineligible|0|||
156566590|NCT01827384|565159541|FG001|Overall Study|Ineligible|0|||
156566591|NCT01827384|565159542|FG002|Overall Study|Ineligible|0|||
156566592|NCT01827384|565159543|FG003|Overall Study|Ineligible|0|||
156566593|NCT01827384|565159544|FG004|Overall Study|Ineligible|0|||
156566594|NCT01827384|565159545|FG005|Overall Study|Ineligible|0|||
156566595|NCT01827384|565159546|FG006|Overall Study|Ineligible|0|||
156566596|NCT01827384|565159547|FG007|Overall Study|Ineligible|0|||
156566597|NCT01827384|565159548|FG008|Overall Study|Ineligible|0|||
156566598|NCT01827384|565159549|FG009|Overall Study|Ineligible|0|||
156566599|NCT01827384|565159550|FG010|Overall Study|Ineligible|0|||
156566600|NCT01827384|565159551|FG011|Overall Study|Ineligible|0|||
156566601|NCT01827384|565159552|FG012|Overall Study|Ineligible|0|||
156566602|NCT01827384|565159553|FG013|Overall Study|Ineligible|19|||
156566603|NCT01827384|565159540|FG000|Overall Study|Participant died before treatment|0|||
156566604|NCT01827384|565159541|FG001|Overall Study|Participant died before treatment|0|||
156566605|NCT01827384|565159542|FG002|Overall Study|Participant died before treatment|0|||
156566606|NCT01827384|565159543|FG003|Overall Study|Participant died before treatment|0|||
156566607|NCT01827384|565159544|FG004|Overall Study|Participant died before treatment|0|||
156566608|NCT01827384|565159545|FG005|Overall Study|Participant died before treatment|0|||
156566609|NCT01827384|565159546|FG006|Overall Study|Participant died before treatment|0|||
156566610|NCT01827384|565159547|FG007|Overall Study|Participant died before treatment|0|||
156566611|NCT01827384|565159548|FG008|Overall Study|Participant died before treatment|0|||
156566612|NCT01827384|565159549|FG009|Overall Study|Participant died before treatment|0|||
156566613|NCT01827384|565159550|FG010|Overall Study|Participant died before treatment|0|||
156566614|NCT01827384|565159551|FG011|Overall Study|Participant died before treatment|0|||
156566615|NCT01827384|565159552|FG012|Overall Study|Participant died before treatment|0|||
156566616|NCT01827384|565159553|FG013|Overall Study|Participant died before treatment|5|||
156566617|NCT01827384|565159540|FG000|Overall Study|Insufficient tumor cells|0|||
156566618|NCT01827384|565159541|FG001|Overall Study|Insufficient tumor cells|0|||
156566619|NCT01827384|565159542|FG002|Overall Study|Insufficient tumor cells|0|||
156566620|NCT01827384|565159543|FG003|Overall Study|Insufficient tumor cells|0|||
156566621|NCT01827384|565159544|FG004|Overall Study|Insufficient tumor cells|0|||
156566622|NCT01827384|565159545|FG005|Overall Study|Insufficient tumor cells|0|||
156566623|NCT01827384|565159546|FG006|Overall Study|Insufficient tumor cells|0|||
156566624|NCT01827384|565159547|FG007|Overall Study|Insufficient tumor cells|0|||
156566625|NCT01827384|565159548|FG008|Overall Study|Insufficient tumor cells|0|||
156566626|NCT01827384|565159549|FG009|Overall Study|Insufficient tumor cells|0|||
156566627|NCT01827384|565159550|FG010|Overall Study|Insufficient tumor cells|0|||
156566628|NCT01827384|565159551|FG011|Overall Study|Insufficient tumor cells|0|||
156566629|NCT01827384|565159552|FG012|Overall Study|Insufficient tumor cells|0|||
156566630|NCT01827384|565159553|FG013|Overall Study|Insufficient tumor cells|13|||
156566631|NCT01827384|565159540|FG000|Overall Study|No actionable mutation|0|||
156566632|NCT01827384|565159541|FG001|Overall Study|No actionable mutation|0|||
156566633|NCT01827384|565159542|FG002|Overall Study|No actionable mutation|0|||
156566634|NCT01827384|565159543|FG003|Overall Study|No actionable mutation|0|||
156566635|NCT01827384|565159544|FG004|Overall Study|No actionable mutation|0|||
156566636|NCT01827384|565159545|FG005|Overall Study|No actionable mutation|0|||
156566637|NCT01827384|565159546|FG006|Overall Study|No actionable mutation|0|||
156566638|NCT01827384|565159547|FG007|Overall Study|No actionable mutation|0|||
156566639|NCT01827384|565159548|FG008|Overall Study|No actionable mutation|0|||
156566640|NCT01827384|565159549|FG009|Overall Study|No actionable mutation|0|||
156566641|NCT01827384|565159550|FG010|Overall Study|No actionable mutation|0|||
156566642|NCT01827384|565159551|FG011|Overall Study|No actionable mutation|0|||
156566643|NCT01827384|565159552|FG012|Overall Study|No actionable mutation|0|||
156566644|NCT01827384|565159553|FG013|Overall Study|No actionable mutation|73|||
156566645|NCT01827384|565159540|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
156566646|NCT01827384|565159541|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
156566647|NCT01827384|565159542|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
156566648|NCT01827384|565159543|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
156566649|NCT01827384|565159544|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
156566650|NCT01827384|565159545|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
156566651|NCT01827384|565159546|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
156566652|NCT01827384|565159547|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
156566653|NCT01827384|565159548|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
156566654|NCT01827384|565159549|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
156566655|NCT01827384|565159550|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
156566656|NCT01827384|565159551|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
156566657|NCT01827384|565159552|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
156566658|NCT01827384|565159553|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
156566659|NCT01552057|565161190|FG000|Overall Study|Adverse Event|14|||
156566660|NCT01552057|565161191|FG001|Overall Study|Adverse Event|15|||
156566661|NCT01552057|565161190|FG000|Overall Study|Lack of Efficacy|8|||
156566662|NCT01552057|565161191|FG001|Overall Study|Lack of Efficacy|23|||
156566663|NCT01552057|565161190|FG000|Overall Study|Withdrawal by Subject|5|||
156566664|NCT01552057|565161191|FG001|Overall Study|Withdrawal by Subject|8|||
156566665|NCT01552057|565161190|FG000|Overall Study|Entry Criteria Not Met|2|||
156566666|NCT01552057|565161191|FG001|Overall Study|Entry Criteria Not Met|2|||
156566667|NCT01552057|565161190|FG000|Overall Study|Physician Decision|1|||
156566668|NCT01552057|565161191|FG001|Overall Study|Physician Decision|0|||
156566669|NCT00476086|565161192|FG000|Overall Study|Alternative therapy|1|||
156566670|NCT00476086|565161192|FG000|Overall Study|Progressive Disease|4|||
156566671|NCT02900092|565161193|FG000|Overall Study|Adverse Event|1|||
156566672|NCT03895203|565161194|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
156566673|NCT03895203|565161195|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
156566674|NCT03895203|565161196|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
156566675|NCT03895203|565161197|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
156566676|NCT03895203|565161198|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
156566677|NCT03895203|565161199|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
156566678|NCT03895203|565161194|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
156566679|NCT03895203|565161195|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
156566680|NCT03895203|565161196|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
156566681|NCT03895203|565161197|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
156566682|NCT03895203|565161198|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
156566683|NCT03895203|565161199|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
156566684|NCT03895203|565161194|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
156566685|NCT03895203|565161195|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
156566686|NCT03895203|565161196|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
156566687|NCT03895203|565161197|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
156566688|NCT03895203|565161198|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
156566689|NCT03895203|565161199|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
156566690|NCT03895203|565161194|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
156566691|NCT03895203|565161195|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
156566692|NCT03895203|565161196|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
156566693|NCT03895203|565161197|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
156566694|NCT03895203|565161198|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
156566695|NCT03895203|565161199|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
156566696|NCT03895203|565161194|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
156566697|NCT03895203|565161195|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
156566698|NCT03895203|565161196|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
156566699|NCT03895203|565161197|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
156566700|NCT03895203|565161198|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
156566701|NCT03895203|565161199|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
156566702|NCT03895203|565161194|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
156566703|NCT03895203|565161195|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
156566704|NCT03895203|565161196|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
156566705|NCT03895203|565161197|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
156566706|NCT03895203|565161198|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
156566707|NCT03895203|565161199|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
156566708|NCT03895203|565161194|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156566709|NCT03895203|565161195|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156566710|NCT03895203|565161196|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156566711|NCT03895203|565161197|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
156566712|NCT03895203|565161198|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156566713|NCT03895203|565161199|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156566714|NCT03895203|565161194|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
156566715|NCT03895203|565161195|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
156566716|NCT03895203|565161196|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
156566717|NCT03895203|565161197|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
156566718|NCT03895203|565161198|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
156566719|NCT03895203|565161199|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
156566720|NCT03895203|565161194|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
156566721|NCT03895203|565161195|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
156566722|NCT03895203|565161196|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
156566723|NCT03895203|565161197|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
156566724|NCT03895203|565161198|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
156566725|NCT03895203|565161199|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
156566726|NCT03895203|565161194|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
156566727|NCT03895203|565161195|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
156566728|NCT03895203|565161196|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
156566729|NCT03895203|565161197|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
156566730|NCT03895203|565161198|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
156566731|NCT03895203|565161199|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
156566732|NCT03895203|565161194|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
156566733|NCT03895203|565161195|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
156566734|NCT03895203|565161196|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
156566735|NCT03895203|565161197|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
156566736|NCT03895203|565161198|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
156566737|NCT03895203|565161199|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
156566738|NCT03895203|565161194|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
156566739|NCT03895203|565161195|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
156566740|NCT03895203|565161196|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
156566741|NCT03895203|565161197|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
156566742|NCT03895203|565161198|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
156566743|NCT03895203|565161199|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
156566744|NCT03895203|565161194|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
156566745|NCT03895203|565161195|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
156566746|NCT03895203|565161196|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
156566747|NCT03895203|565161197|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
156566748|NCT03895203|565161198|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
156566749|NCT03895203|565161199|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
156566750|NCT03895203|565161194|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
156566751|NCT03895203|565161195|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
156566752|NCT03895203|565161196|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
156566753|NCT03895203|565161197|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
156566754|NCT03895203|565161198|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
156566755|NCT03895203|565161199|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
156566756|NCT01389245|565161200|FG000|Overall Study|Protocol Violation|10|||
156566757|NCT01389245|565161200|FG000|Overall Study|Lost to Follow-up|3|||
156566758|NCT01389245|565161200|FG000|Overall Study|Withdrawal by Subject|2|||
156566759|NCT00473876|565161205|FG000|Overall Study|Lost to Follow-up|3|||
156566760|NCT00473876|565161206|FG001|Overall Study|Lost to Follow-up|1|||
156566761|NCT01276288|565161207|FG000|Overall Study|Adverse Event|1|||
156566762|NCT01276288|565161208|FG001|Overall Study|Adverse Event|1|||
156566763|NCT01276288|565161209|FG002|Overall Study|Adverse Event|0|||
156566764|NCT01276288|565161210|FG003|Overall Study|Adverse Event|0|||
156566765|NCT01276288|565161207|FG000|Overall Study|not treated|1|||
156566766|NCT01276288|565161208|FG001|Overall Study|not treated|0|||
156566767|NCT01276288|565161209|FG002|Overall Study|not treated|0|||
156566768|NCT01276288|565161210|FG003|Overall Study|not treated|0|||
156566769|NCT03401749|565161215|FG000|Overall Study|Lost to Follow-up|20|||
156566770|NCT03401749|565161216|FG001|Overall Study|Lost to Follow-up|16|||
156566771|NCT03401749|565161217|FG002|Overall Study|Lost to Follow-up|26|||
156566772|NCT01193686|565161218|FG000|Overall Study|Withdrawal by Subject|4|||
156566773|NCT01193686|565161219|FG001|Overall Study|Withdrawal by Subject|1|||
156566774|NCT01193686|565161218|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
156566775|NCT01193686|565161219|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
156566776|NCT03406962|565161224|FG000|Overall Study|Death|2|||
156566777|NCT03406962|565161224|FG000|Overall Study|Adverse Event|1|||
156566778|NCT03853694|565161225|FG000|Overall Study|Protocol Violation|3|||
156566779|NCT03853694|565161226|FG001|Overall Study|Protocol Violation|5|||
156566780|NCT03853694|565161227|FG002|Overall Study|Protocol Violation|3|||
156566781|NCT03853694|565161225|FG000|Overall Study|Delivered early|0|||
156566782|NCT03853694|565161226|FG001|Overall Study|Delivered early|1|||
156566783|NCT03853694|565161227|FG002|Overall Study|Delivered early|0|||
156566784|NCT03853694|565161225|FG000|Overall Study|not suitable to proceed|0|||
156566785|NCT03853694|565161226|FG001|Overall Study|not suitable to proceed|1|||
156566786|NCT03853694|565161227|FG002|Overall Study|not suitable to proceed|0|||
156566787|NCT03853694|565161225|FG000|Overall Study|difficult surgery|0|||
156566788|NCT03853694|565161226|FG001|Overall Study|difficult surgery|0|||
156566789|NCT03853694|565161227|FG002|Overall Study|difficult surgery|1|||
156566790|NCT03853694|565161225|FG000|Overall Study|Lost to Follow-up|0|||
156566791|NCT03853694|565161226|FG001|Overall Study|Lost to Follow-up|1|||
156566792|NCT03853694|565161227|FG002|Overall Study|Lost to Follow-up|0|||
156566793|NCT03853694|565161225|FG000|Overall Study|Withdrawal by Subject|0|||
156566794|NCT03853694|565161226|FG001|Overall Study|Withdrawal by Subject|1|||
156566795|NCT03853694|565161227|FG002|Overall Study|Withdrawal by Subject|0|||
156566796|NCT01818297|565161228|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
156566797|NCT01818297|565161229|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
156566798|NCT01818297|565161228|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
156566799|NCT01818297|565161229|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
156566800|NCT01818297|565161228|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
156566801|NCT01818297|565161229|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
156566802|NCT03896295|565161230|FG000|Overall Study|Adverse Event|0|||
156566803|NCT03896295|565161231|FG001|Overall Study|Adverse Event|1|||
156566804|NCT03896295|565161230|FG000|Overall Study|COVID-19|7|||
156566805|NCT03896295|565161231|FG001|Overall Study|COVID-19|29|||
156566806|NCT03029832|565161232|FG000|Overall Study|Safety Follow-Up Completed|2|||
156566807|NCT03029832|565161233|FG001|Overall Study|Safety Follow-Up Completed|0|||
156566808|NCT03029832|565161232|FG000|Overall Study|Death due to Disease Progression|1|||
156566809|NCT03029832|565161233|FG001|Overall Study|Death due to Disease Progression|0|||
156566810|NCT03029832|565161232|FG000|Overall Study|Study Terminated By Sponsor|1|||
156566811|NCT03029832|565161233|FG001|Overall Study|Study Terminated By Sponsor|1|||
156566812|NCT01412229|565161234|FG000|Overall Study|Physician Decision|1|||
156566813|NCT04373460|565161235|FG000|Overall Study|Did not receive tranfusion|18|||
156566814|NCT04373460|565161236|FG001|Overall Study|Did not receive tranfusion|26|||
156566815|NCT00454207|565161237|FG000|Overall Study|Adverse Event|3|||
156566816|NCT00454207|565161238|FG001|Overall Study|Adverse Event|1|||
156566817|NCT00454207|565161237|FG000|Overall Study|Lack of Efficacy|1|||
156566818|NCT00454207|565161238|FG001|Overall Study|Lack of Efficacy|0|||
156566819|NCT00454207|565161237|FG000|Overall Study|Protocol Violation|0|||
156566820|NCT00454207|565161238|FG001|Overall Study|Protocol Violation|1|||
156566821|NCT01672957|565161239|FG000|Overall Study|Protocol Violation|48|||
156566822|NCT01672957|565161239|FG000|Overall Study|Death|2|||
156566823|NCT01672957|565161239|FG000|Overall Study|ICF Signed After Transplantation|5|||
156566824|NCT00700804|565161240|FG000|Overall Study|Withdrawal by Subject|1|||
156566825|NCT00700804|565161241|FG001|Overall Study|Withdrawal by Subject|2|||
156566826|NCT00700804|565161240|FG000|Overall Study|Protocol Violation|1|||
156566827|NCT00700804|565161241|FG001|Overall Study|Protocol Violation|1|||
156566828|NCT00700804|565161240|FG000|Overall Study|Loose Stools|1|||
156566829|NCT00700804|565161241|FG001|Overall Study|Loose Stools|1|||
156566830|NCT00151892|565161242|FG000|Overall Study|Lack of Efficacy|50|||
156566831|NCT00151892|565161243|FG001|Overall Study|Lack of Efficacy|57|||
156566832|NCT00151892|565161242|FG000|Overall Study|Patient request|10|||
156566833|NCT00151892|565161243|FG001|Overall Study|Patient request|7|||
156566834|NCT00151892|565161242|FG000|Overall Study|Lost to Follow-up|5|||
156566835|NCT00151892|565161243|FG001|Overall Study|Lost to Follow-up|10|||
156566836|NCT00151892|565161242|FG000|Overall Study|Adverse Event|6|||
156566837|NCT00151892|565161243|FG001|Overall Study|Adverse Event|3|||
156566838|NCT00151892|565161242|FG000|Overall Study|Protocol Violation|3|||
156566839|NCT00151892|565161243|FG001|Overall Study|Protocol Violation|3|||
156566840|NCT00151892|565161242|FG000|Overall Study|Non-compliance|0|||
156566841|NCT00151892|565161243|FG001|Overall Study|Non-compliance|1|||
156566842|NCT00151892|565161242|FG000|Overall Study|Pregnancy|0|||
156566843|NCT00151892|565161243|FG001|Overall Study|Pregnancy|1|||
156566844|NCT00151892|565161242|FG000|Overall Study|Did not return for a visit|1|||
156566845|NCT00151892|565161243|FG001|Overall Study|Did not return for a visit|0|||
156566846|NCT00151892|565161242|FG000|Overall Study|Used prohibited corticosteroids|1|||
156566847|NCT00151892|565161243|FG001|Overall Study|Used prohibited corticosteroids|0|||
156566848|NCT00151892|565161242|FG000|Overall Study|Lack of study medication at center|0|||
156566849|NCT00151892|565161243|FG001|Overall Study|Lack of study medication at center|1|||
156566850|NCT04223609|565161244|FG000|Overall Study|Adverse Event|0|||
156566851|NCT04223609|565161245|FG001|Overall Study|Adverse Event|1|||
156566852|NCT04223609|565161244|FG000|Overall Study|Missed last visit|0|||
156566853|NCT04223609|565161245|FG001|Overall Study|Missed last visit|1|||
156566854|NCT03440944|565161246|FG000|Overall Study|Physician Decision|1|||
156566855|NCT03440944|565161247|FG001|Overall Study|Physician Decision|0|||
156566856|NCT03440944|565161246|FG000|Overall Study|No Acceptable Vasculature|0|||
156566857|NCT03440944|565161247|FG001|Overall Study|No Acceptable Vasculature|1|||
156566858|NCT04672083|565161248|FG000|Overall Study|Lost to Follow-up|1|||
156566859|NCT04672083|565161249|FG001|Overall Study|Lost to Follow-up|0|||
156566860|NCT04672083|565161250|FG002|Overall Study|Lost to Follow-up|0|||
156566861|NCT04672083|565161251|FG003|Overall Study|Lost to Follow-up|0|||
156566862|NCT04672083|565161252|FG004|Overall Study|Lost to Follow-up|0|||
156566863|NCT01551745|565161253|FG000|Overall Study|Withdrawal by Subject|1|||
156566864|NCT01551745|565161253|FG000|Overall Study|Disease Progression|2|||
156566865|NCT02764541|565161254|FG000|Overall Study|Withdrawal by Subject|0|||
156566866|NCT02764541|565161255|FG001|Overall Study|Withdrawal by Subject|0|||
156566867|NCT02764541|565161256|FG002|Overall Study|Withdrawal by Subject|0|||
156566868|NCT02764541|565161257|FG003|Overall Study|Withdrawal by Subject|0|||
156566869|NCT02764541|565161258|FG004|Overall Study|Withdrawal by Subject|1|||
156566870|NCT02764541|565161259|FG005|Overall Study|Withdrawal by Subject|1|||
156566871|NCT02764541|565161260|FG006|Overall Study|Withdrawal by Subject|0|||
156566872|NCT02764541|565161261|FG007|Overall Study|Withdrawal by Subject|1|||
156566873|NCT02764541|565161254|FG000|Overall Study|Adverse Event|1|||
156566874|NCT02764541|565161255|FG001|Overall Study|Adverse Event|0|||
156566875|NCT02764541|565161256|FG002|Overall Study|Adverse Event|0|||
156566876|NCT02764541|565161257|FG003|Overall Study|Adverse Event|0|||
156566877|NCT02764541|565161258|FG004|Overall Study|Adverse Event|0|||
156566878|NCT02764541|565161259|FG005|Overall Study|Adverse Event|0|||
156566879|NCT02764541|565161260|FG006|Overall Study|Adverse Event|1|||
156566880|NCT02764541|565161261|FG007|Overall Study|Adverse Event|0|||
156566881|NCT02764541|565161254|FG000|Overall Study|Metastasis|1|||
156566882|NCT02764541|565161255|FG001|Overall Study|Metastasis|0|||
156566883|NCT02764541|565161256|FG002|Overall Study|Metastasis|0|||
156566884|NCT02764541|565161257|FG003|Overall Study|Metastasis|0|||
156566885|NCT02764541|565161258|FG004|Overall Study|Metastasis|0|||
156566886|NCT02764541|565161259|FG005|Overall Study|Metastasis|0|||
156566887|NCT02764541|565161260|FG006|Overall Study|Metastasis|0|||
156566888|NCT02764541|565161261|FG007|Overall Study|Metastasis|0|||
156566889|NCT02764541|565161254|FG000|Overall Study|Disease progression|1|||
156566890|NCT02764541|565161255|FG001|Overall Study|Disease progression|1|||
156566891|NCT02764541|565161256|FG002|Overall Study|Disease progression|0|||
156566892|NCT02764541|565161257|FG003|Overall Study|Disease progression|0|||
156566893|NCT02764541|565161258|FG004|Overall Study|Disease progression|0|||
156566894|NCT02764541|565161259|FG005|Overall Study|Disease progression|0|||
156566895|NCT02764541|565161260|FG006|Overall Study|Disease progression|0|||
156566896|NCT02764541|565161261|FG007|Overall Study|Disease progression|1|||
156566897|NCT02764541|565161254|FG000|Overall Study|Protocol Violation|0|||
156566898|NCT02764541|565161255|FG001|Overall Study|Protocol Violation|0|||
156566899|NCT02764541|565161256|FG002|Overall Study|Protocol Violation|0|||
156566900|NCT02764541|565161257|FG003|Overall Study|Protocol Violation|1|||
156566901|NCT02764541|565161258|FG004|Overall Study|Protocol Violation|0|||
156566902|NCT02764541|565161259|FG005|Overall Study|Protocol Violation|1|||
156566903|NCT02764541|565161260|FG006|Overall Study|Protocol Violation|0|||
156566904|NCT02764541|565161261|FG007|Overall Study|Protocol Violation|0|||
156566905|NCT02764541|565161254|FG000|Overall Study|Physician Decision|0|||
156566906|NCT02764541|565161255|FG001|Overall Study|Physician Decision|0|||
156566907|NCT02764541|565161256|FG002|Overall Study|Physician Decision|0|||
156566908|NCT02764541|565161257|FG003|Overall Study|Physician Decision|1|||
156566909|NCT02764541|565161258|FG004|Overall Study|Physician Decision|0|||
156566910|NCT02764541|565161259|FG005|Overall Study|Physician Decision|0|||
156566911|NCT02764541|565161260|FG006|Overall Study|Physician Decision|0|||
156566912|NCT02764541|565161261|FG007|Overall Study|Physician Decision|1|||
156566913|NCT02764541|565161254|FG000|Overall Study|Three Cycles completed before surgery|0|||
156566914|NCT02764541|565161255|FG001|Overall Study|Three Cycles completed before surgery|0|||
156566915|NCT02764541|565161256|FG002|Overall Study|Three Cycles completed before surgery|0|||
156566916|NCT02764541|565161257|FG003|Overall Study|Three Cycles completed before surgery|1|||
156566917|NCT02764541|565161258|FG004|Overall Study|Three Cycles completed before surgery|0|||
156566918|NCT02764541|565161259|FG005|Overall Study|Three Cycles completed before surgery|0|||
156566919|NCT02764541|565161260|FG006|Overall Study|Three Cycles completed before surgery|0|||
156566920|NCT02764541|565161261|FG007|Overall Study|Three Cycles completed before surgery|0|||
156566921|NCT02764541|565161254|FG000|Overall Study|Patient Compliance|0|||
156566922|NCT02764541|565161255|FG001|Overall Study|Patient Compliance|0|||
156566923|NCT02764541|565161256|FG002|Overall Study|Patient Compliance|1|||
156566924|NCT02764541|565161257|FG003|Overall Study|Patient Compliance|0|||
156566925|NCT02764541|565161258|FG004|Overall Study|Patient Compliance|0|||
156566926|NCT02764541|565161259|FG005|Overall Study|Patient Compliance|0|||
156566927|NCT02764541|565161260|FG006|Overall Study|Patient Compliance|0|||
156566928|NCT02764541|565161261|FG007|Overall Study|Patient Compliance|0|||
156566929|NCT02764541|565161254|FG000|Overall Study|Death|0|||
156566930|NCT02764541|565161255|FG001|Overall Study|Death|0|||
156566931|NCT02764541|565161256|FG002|Overall Study|Death|0|||
156566932|NCT02764541|565161257|FG003|Overall Study|Death|0|||
156566933|NCT02764541|565161258|FG004|Overall Study|Death|0|||
156566934|NCT02764541|565161259|FG005|Overall Study|Death|0|||
156566935|NCT02764541|565161260|FG006|Overall Study|Death|1|||
156566936|NCT02764541|565161261|FG007|Overall Study|Death|0|||
156566937|NCT02764541|565161254|FG000|Overall Study|Insurance reasons|0|||
156566938|NCT02764541|565161255|FG001|Overall Study|Insurance reasons|0|||
156566939|NCT02764541|565161256|FG002|Overall Study|Insurance reasons|0|||
156566940|NCT02764541|565161257|FG003|Overall Study|Insurance reasons|0|||
156566941|NCT02764541|565161258|FG004|Overall Study|Insurance reasons|0|||
156566942|NCT02764541|565161259|FG005|Overall Study|Insurance reasons|0|||
156566943|NCT02764541|565161260|FG006|Overall Study|Insurance reasons|1|||
156566944|NCT02764541|565161261|FG007|Overall Study|Insurance reasons|0|||
156566945|NCT02048904|565161264|FG000|Overall Study|Withdrawal by Subject|7|||
156566946|NCT02048904|565161264|FG000|Overall Study|Physician Decision|70|||
156566947|NCT00749190|565161265|FG000|Overall Study|Adverse Event|0|||
156566948|NCT00749190|565161266|FG001|Overall Study|Adverse Event|2|||
156566949|NCT00749190|565161267|FG002|Overall Study|Adverse Event|0|||
156566950|NCT00749190|565161268|FG003|Overall Study|Adverse Event|4|||
156566951|NCT00749190|565161269|FG004|Overall Study|Adverse Event|0|||
156566952|NCT00749190|565161270|FG005|Overall Study|Adverse Event|3|||
156566953|NCT00749190|565161271|FG006|Overall Study|Adverse Event|0|||
156566954|NCT00749190|565161265|FG000|Overall Study|Lack of Efficacy|3|||
156566955|NCT00749190|565161266|FG001|Overall Study|Lack of Efficacy|1|||
156566956|NCT00749190|565161267|FG002|Overall Study|Lack of Efficacy|1|||
156566957|NCT00749190|565161268|FG003|Overall Study|Lack of Efficacy|0|||
156566958|NCT00749190|565161269|FG004|Overall Study|Lack of Efficacy|0|||
156566959|NCT00749190|565161270|FG005|Overall Study|Lack of Efficacy|1|||
156566960|NCT00749190|565161271|FG006|Overall Study|Lack of Efficacy|0|||
156566961|NCT00749190|565161265|FG000|Overall Study|Withdrawal by Subject|2|||
156566962|NCT00749190|565161266|FG001|Overall Study|Withdrawal by Subject|1|||
156566963|NCT00749190|565161267|FG002|Overall Study|Withdrawal by Subject|0|||
156566964|NCT00749190|565161268|FG003|Overall Study|Withdrawal by Subject|0|||
156566965|NCT00749190|565161269|FG004|Overall Study|Withdrawal by Subject|0|||
156566966|NCT00749190|565161270|FG005|Overall Study|Withdrawal by Subject|1|||
156566967|NCT00749190|565161271|FG006|Overall Study|Withdrawal by Subject|0|||
156566968|NCT00749190|565161265|FG000|Overall Study|Protocol Violation|0|||
156566969|NCT00749190|565161266|FG001|Overall Study|Protocol Violation|1|||
156566970|NCT00749190|565161267|FG002|Overall Study|Protocol Violation|0|||
156566971|NCT00749190|565161268|FG003|Overall Study|Protocol Violation|0|||
156566972|NCT00749190|565161269|FG004|Overall Study|Protocol Violation|0|||
156566973|NCT00749190|565161270|FG005|Overall Study|Protocol Violation|0|||
156566974|NCT00749190|565161271|FG006|Overall Study|Protocol Violation|1|||
156566975|NCT00749190|565161265|FG000|Overall Study|Other reason not defined above|0|||
156566976|NCT00749190|565161266|FG001|Overall Study|Other reason not defined above|0|||
156566977|NCT00749190|565161267|FG002|Overall Study|Other reason not defined above|0|||
156566978|NCT00749190|565161268|FG003|Overall Study|Other reason not defined above|1|||
156566979|NCT00749190|565161269|FG004|Overall Study|Other reason not defined above|0|||
156566980|NCT00749190|565161270|FG005|Overall Study|Other reason not defined above|0|||
156566981|NCT00749190|565161271|FG006|Overall Study|Other reason not defined above|0|||
156566982|NCT05775289|565161272|FG000|Overall Study|Study Ongoing|20|||
156566983|NCT05775289|565161273|FG001|Overall Study|Study Ongoing|53|||
156566984|NCT05775289|565161274|FG002|Overall Study|Study Ongoing|15|||
156566985|NCT05775289|565161275|FG003|Overall Study|Study Ongoing|55|||
156566986|NCT05775289|565161272|FG000|Overall Study|Death|4|||
156566987|NCT05775289|565161273|FG001|Overall Study|Death|11|||
156566988|NCT05775289|565161274|FG002|Overall Study|Death|8|||
156566989|NCT05775289|565161275|FG003|Overall Study|Death|12|||
156566990|NCT05775289|565161272|FG000|Overall Study|Lost to Follow-up|0|||
156566991|NCT05775289|565161273|FG001|Overall Study|Lost to Follow-up|1|||
156566992|NCT05775289|565161274|FG002|Overall Study|Lost to Follow-up|0|||
156566993|NCT05775289|565161275|FG003|Overall Study|Lost to Follow-up|0|||
156566994|NCT05775289|565161272|FG000|Overall Study|Progressive Disease|0|||
156566995|NCT05775289|565161273|FG001|Overall Study|Progressive Disease|0|||
156566996|NCT05775289|565161274|FG002|Overall Study|Progressive Disease|1|||
156566997|NCT05775289|565161275|FG003|Overall Study|Progressive Disease|0|||
156566998|NCT05775289|565161272|FG000|Overall Study|Withdrawal by Subject|1|||
156566999|NCT05775289|565161273|FG001|Overall Study|Withdrawal by Subject|1|||
156567000|NCT05775289|565161274|FG002|Overall Study|Withdrawal by Subject|0|||
156567001|NCT05775289|565161275|FG003|Overall Study|Withdrawal by Subject|0|||
156567002|NCT02330419|565161279|FG000|Overall Study|Lost to Follow-up|3|||
156567003|NCT02330419|565161280|FG001|Overall Study|Lost to Follow-up|7|||
156567004|NCT00490542|565161281|FG000|Overall Study|Lost to Follow-up|3|||
156567005|NCT00490542|565161282|FG001|Overall Study|Lost to Follow-up|0|||
156567006|NCT00490542|565161281|FG000|Overall Study|Adverse Event|3|||
156567007|NCT00490542|565161282|FG001|Overall Study|Adverse Event|3|||
156567008|NCT00490542|565161281|FG000|Overall Study|Lack of Efficacy|1|||
156567009|NCT00490542|565161282|FG001|Overall Study|Lack of Efficacy|1|||
156567010|NCT04370509|565161283|FG000|Overall Study|Adverse Event|1|||
156567011|NCT04370509|565161284|FG001|Overall Study|Adverse Event|0|||
156567012|NCT04370509|565161283|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
156567013|NCT04370509|565161284|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
156567014|NCT04743856|565161285|FG000|Overall Study|Lost to Follow-up|6|||
156567015|NCT04743856|565161286|FG001|Overall Study|Lost to Follow-up|7|||
156567016|NCT04743856|565161285|FG000|Overall Study|Withdrawal by Subject|1|||
156567017|NCT04743856|565161286|FG001|Overall Study|Withdrawal by Subject|0|||
156567018|NCT04696861|565161287|FG000|Overall Study|Death|1|||
156567019|NCT04696861|565161288|FG001|Overall Study|Death|0|||
156567020|NCT04696861|565161287|FG000|Overall Study|Lost to Follow-up|3|||
156567021|NCT04696861|565161288|FG001|Overall Study|Lost to Follow-up|0|||
156567022|NCT04439188|565161289|FG000|Overall Study|Ineligible|3|||
156567023|NCT04439188|565161289|FG000|Overall Study|Adverse Event|4|||
156567024|NCT04439188|565161289|FG000|Overall Study|Death|1|||
156567025|NCT04439188|565161289|FG000|Overall Study|Disease Progression|25|||
156567026|NCT04439188|565161289|FG000|Overall Study|Withdrawal by Subject|2|||
156567027|NCT01813890|565161292|FG000|Overall Study|Adverse Event|0|||
156567028|NCT01813890|565161293|FG001|Overall Study|Adverse Event|3|||
156567029|NCT01813890|565161294|FG002|Overall Study|Adverse Event|4|||
156567030|NCT01813890|565161292|FG000|Overall Study|Lack of Efficacy|9|||
156567031|NCT01813890|565161293|FG001|Overall Study|Lack of Efficacy|1|||
156567032|NCT01813890|565161294|FG002|Overall Study|Lack of Efficacy|2|||
156567033|NCT04482647|565161295|FG000|Overall Study|Time constraints|2|||
156567034|NCT04482647|565161295|FG000|Overall Study|Health issues|1|||
156567035|NCT04482647|565161295|FG000|Overall Study|Death in the family|1|||
156567036|NCT04482647|565161295|FG000|Overall Study|Disliked the intervention|1|||
156567037|NCT04482647|565161295|FG000|Overall Study|No reasons specified|7|||
156567038|NCT03952559|565161296|FG000|Double Blind Treatment Period|Adverse Event|0|||
156567039|NCT03952559|565161297|FG001|Double Blind Treatment Period|Adverse Event|2|||
156567040|NCT03952559|565161298|FG002|Double Blind Treatment Period|Adverse Event|1|||
156567041|NCT03952559|565161299|FG003|Double Blind Treatment Period|Adverse Event|0|||
156567042|NCT03952559|565161300|FG004|Double Blind Treatment Period|Adverse Event|1|||
156567043|NCT03952559|565161296|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
156567044|NCT03952559|565161297|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
156567045|NCT03952559|565161298|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
156567046|NCT03952559|565161299|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
156567047|NCT03952559|565161300|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
156567048|NCT03952559|565161296|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
156567049|NCT03952559|565161297|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
156567050|NCT03952559|565161298|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
156567051|NCT03952559|565161299|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
156567052|NCT03952559|565161300|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
156567053|NCT03952559|565161296|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
156567054|NCT03952559|565161297|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
156567055|NCT03952559|565161298|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
156567056|NCT03952559|565161299|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
156567057|NCT03952559|565161300|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
156567058|NCT02875223|565161301|FG000|Overall Study|Other reasons|0|||
156567059|NCT02875223|565161302|FG001|Overall Study|Other reasons|0|||
156567060|NCT02875223|565161303|FG002|Overall Study|Other reasons|1|||
156567061|NCT02875223|565161304|FG003|Overall Study|Other reasons|0|||
156567062|NCT02875223|565161305|FG004|Overall Study|Other reasons|1|||
156567063|NCT02875223|565161306|FG005|Overall Study|Other reasons|2|||
156567064|NCT02875223|565161307|FG006|Overall Study|Other reasons|0|||
156567065|NCT02875223|565161308|FG007|Overall Study|Other reasons|2|||
156567066|NCT02875223|565161309|FG008|Overall Study|Other reasons|0|||
156567067|NCT02875223|565161310|FG009|Overall Study|Other reasons|0|||
156567068|NCT02875223|565161311|FG010|Overall Study|Other reasons|0|||
156567069|NCT02875223|565161312|FG011|Overall Study|Other reasons|0|||
156567070|NCT02875223|565161313|FG012|Overall Study|Other reasons|0|||
156567071|NCT02875223|565161301|FG000|Overall Study|Withdrawal by Subject|0|||
156567072|NCT02875223|565161302|FG001|Overall Study|Withdrawal by Subject|0|||
156567073|NCT02875223|565161303|FG002|Overall Study|Withdrawal by Subject|0|||
156567074|NCT02875223|565161304|FG003|Overall Study|Withdrawal by Subject|0|||
156567075|NCT02875223|565161305|FG004|Overall Study|Withdrawal by Subject|1|||
156567076|NCT02875223|565161306|FG005|Overall Study|Withdrawal by Subject|1|||
156567077|NCT02875223|565161307|FG006|Overall Study|Withdrawal by Subject|0|||
156567078|NCT02875223|565161308|FG007|Overall Study|Withdrawal by Subject|0|||
156567079|NCT02875223|565161309|FG008|Overall Study|Withdrawal by Subject|1|||
156567080|NCT02875223|565161310|FG009|Overall Study|Withdrawal by Subject|0|||
156567081|NCT02875223|565161311|FG010|Overall Study|Withdrawal by Subject|0|||
156567082|NCT02875223|565161312|FG011|Overall Study|Withdrawal by Subject|0|||
156567083|NCT02875223|565161313|FG012|Overall Study|Withdrawal by Subject|0|||
156567084|NCT02875223|565161301|FG000|Overall Study|Progressive disease|0|||
156567085|NCT02875223|565161302|FG001|Overall Study|Progressive disease|0|||
156567086|NCT02875223|565161303|FG002|Overall Study|Progressive disease|1|||
156567087|NCT02875223|565161304|FG003|Overall Study|Progressive disease|0|||
156567088|NCT02875223|565161305|FG004|Overall Study|Progressive disease|0|||
156567089|NCT02875223|565161306|FG005|Overall Study|Progressive disease|0|||
156567090|NCT02875223|565161307|FG006|Overall Study|Progressive disease|0|||
156567091|NCT02875223|565161308|FG007|Overall Study|Progressive disease|0|||
156567092|NCT02875223|565161309|FG008|Overall Study|Progressive disease|0|||
156567093|NCT02875223|565161310|FG009|Overall Study|Progressive disease|12|||
156567094|NCT02875223|565161311|FG010|Overall Study|Progressive disease|2|||
156567095|NCT02875223|565161312|FG011|Overall Study|Progressive disease|3|||
156567096|NCT02875223|565161313|FG012|Overall Study|Progressive disease|6|||
156567097|NCT02875223|565161301|FG000|Overall Study|Death|4|||
156567098|NCT02875223|565161302|FG001|Overall Study|Death|4|||
156567099|NCT02875223|565161303|FG002|Overall Study|Death|3|||
156567100|NCT02875223|565161304|FG003|Overall Study|Death|4|||
156567101|NCT02875223|565161305|FG004|Overall Study|Death|2|||
156567102|NCT02875223|565161306|FG005|Overall Study|Death|3|||
156567103|NCT02875223|565161307|FG006|Overall Study|Death|5|||
156567104|NCT02875223|565161308|FG007|Overall Study|Death|7|||
156567105|NCT02875223|565161309|FG008|Overall Study|Death|3|||
156567106|NCT02875223|565161310|FG009|Overall Study|Death|2|||
156567107|NCT02875223|565161311|FG010|Overall Study|Death|0|||
156567108|NCT02875223|565161312|FG011|Overall Study|Death|0|||
156567109|NCT02875223|565161313|FG012|Overall Study|Death|0|||
156567110|NCT02875223|565161301|FG000|Overall Study|Lost to Follow-up|0|||
156567111|NCT02875223|565161302|FG001|Overall Study|Lost to Follow-up|1|||
156567112|NCT02875223|565161303|FG002|Overall Study|Lost to Follow-up|1|||
156567113|NCT02875223|565161304|FG003|Overall Study|Lost to Follow-up|0|||
156567114|NCT02875223|565161305|FG004|Overall Study|Lost to Follow-up|1|||
156567115|NCT02875223|565161306|FG005|Overall Study|Lost to Follow-up|0|||
156567116|NCT02875223|565161307|FG006|Overall Study|Lost to Follow-up|1|||
156567117|NCT02875223|565161308|FG007|Overall Study|Lost to Follow-up|1|||
156567118|NCT02875223|565161309|FG008|Overall Study|Lost to Follow-up|0|||
156567119|NCT02875223|565161310|FG009|Overall Study|Lost to Follow-up|0|||
156567120|NCT02875223|565161311|FG010|Overall Study|Lost to Follow-up|0|||
156567121|NCT02875223|565161312|FG011|Overall Study|Lost to Follow-up|0|||
156567122|NCT02875223|565161313|FG012|Overall Study|Lost to Follow-up|0|||
156567123|NCT02847598|565161318|FG000|Overall Study|Adverse Event|0|||
156567124|NCT02847598|565161319|FG001|Overall Study|Adverse Event|0|||
156567125|NCT02847598|565161320|FG002|Overall Study|Adverse Event|0|||
156567126|NCT02847598|565161321|FG003|Overall Study|Adverse Event|0|||
156567127|NCT02847598|565161322|FG004|Overall Study|Adverse Event|0|||
156567128|NCT02847598|565161323|FG005|Overall Study|Adverse Event|0|||
156567129|NCT02847598|565161324|FG006|Overall Study|Adverse Event|0|||
156567130|NCT02847598|565161325|FG007|Overall Study|Adverse Event|1|||
156567131|NCT02847598|565161318|FG000|Overall Study|Consent withdrawn|2|||
156567132|NCT02847598|565161319|FG001|Overall Study|Consent withdrawn|0|||
156567133|NCT02847598|565161320|FG002|Overall Study|Consent withdrawn|0|||
156567134|NCT02847598|565161321|FG003|Overall Study|Consent withdrawn|4|||
156567135|NCT02847598|565161322|FG004|Overall Study|Consent withdrawn|3|||
156567136|NCT02847598|565161323|FG005|Overall Study|Consent withdrawn|2|||
156567137|NCT02847598|565161324|FG006|Overall Study|Consent withdrawn|1|||
156567138|NCT02847598|565161325|FG007|Overall Study|Consent withdrawn|3|||
156567139|NCT02847598|565161318|FG000|Overall Study|Death|3|||
156567140|NCT02847598|565161319|FG001|Overall Study|Death|0|||
156567141|NCT02847598|565161320|FG002|Overall Study|Death|0|||
156567142|NCT02847598|565161321|FG003|Overall Study|Death|0|||
156567143|NCT02847598|565161322|FG004|Overall Study|Death|0|||
156567144|NCT02847598|565161323|FG005|Overall Study|Death|0|||
156567145|NCT02847598|565161324|FG006|Overall Study|Death|0|||
156567146|NCT02847598|565161325|FG007|Overall Study|Death|0|||
156567147|NCT02847598|565161318|FG000|Overall Study|Lost to Follow-up|0|||
156567148|NCT02847598|565161319|FG001|Overall Study|Lost to Follow-up|0|||
156567149|NCT02847598|565161320|FG002|Overall Study|Lost to Follow-up|0|||
156567150|NCT02847598|565161321|FG003|Overall Study|Lost to Follow-up|0|||
156567151|NCT02847598|565161322|FG004|Overall Study|Lost to Follow-up|0|||
156567152|NCT02847598|565161323|FG005|Overall Study|Lost to Follow-up|1|||
156567153|NCT02847598|565161324|FG006|Overall Study|Lost to Follow-up|1|||
156567154|NCT02847598|565161325|FG007|Overall Study|Lost to Follow-up|0|||
156567155|NCT02848833|565161326|FG000|Overall Study|subject who are duplicated|1|||
156567156|NCT02848833|565161326|FG000|Overall Study|have not taken the study drug|11|||
156567157|NCT02848833|565161326|FG000|Overall Study|follow-up failure|6|||
156567158|NCT02848833|565161326|FG000|Overall Study|Protocol Violation|119|||
156567159|NCT04375761|565163048|FG000|Overall Study|Death|1|||
156567160|NCT04375761|565163049|FG001|Overall Study|Death|2|||
156567161|NCT04375761|565163048|FG000|Overall Study|Lost to Follow-up|203|||
156567162|NCT04375761|565163049|FG001|Overall Study|Lost to Follow-up|380|||
156567163|NCT04375761|565163048|FG000|Overall Study|Withdrawal by Subject|47|||
156567164|NCT04375761|565163049|FG001|Overall Study|Withdrawal by Subject|98|||
156567165|NCT04375761|565163048|FG000|Overall Study|Noncompliance with study procedure|121|||
156567166|NCT04375761|565163049|FG001|Overall Study|Noncompliance with study procedure|251|||
156567167|NCT04375761|565163048|FG000|Overall Study|Reimbursement not enough|1|||
156567168|NCT04375761|565163049|FG001|Overall Study|Reimbursement not enough|2|||
156567169|NCT04375761|565163048|FG000|Overall Study|Unforeseen family circumstances|1|||
156567170|NCT04375761|565163049|FG001|Overall Study|Unforeseen family circumstances|3|||
156567171|NCT04375761|565163048|FG000|Overall Study|Test too painful|1|||
156567172|NCT04375761|565163049|FG001|Overall Study|Test too painful|1|||
156567173|NCT04375761|565163048|FG000|Overall Study|Moved|0|||
156567174|NCT04375761|565163049|FG001|Overall Study|Moved|2|||
156567175|NCT04375761|565163048|FG000|Overall Study|Nonresponsive|0|||
156567176|NCT04375761|565163049|FG001|Overall Study|Nonresponsive|5|||
156567177|NCT03797001|565163050|FG000|Overall Study|Withdrawn due to COVID19|4|||
156567178|NCT03797001|565163051|FG001|Overall Study|Withdrawn due to COVID19|0|||
156567179|NCT03797001|565163050|FG000|Overall Study|Withdrawal by Subject|7|||
156567180|NCT03797001|565163051|FG001|Overall Study|Withdrawal by Subject|6|||
156567181|NCT03797001|565163050|FG000|Overall Study|Adverse Event|0|||
156567182|NCT03797001|565163051|FG001|Overall Study|Adverse Event|1|||
156567183|NCT00500266|565163066|FG000|Overall Study|Death|3|||
156567184|NCT00500266|565163066|FG000|Overall Study|Lost to Follow-up|3|||
156567185|NCT00500266|565163066|FG000|Overall Study|Withdrawal by Subject|3|||
156567186|NCT00500266|565163066|FG000|Overall Study|Assigned, not treated|4|||
156567187|NCT01431287|565163067|FG000|Overall Study|not treated|0|||
156567188|NCT01431287|565163068|FG001|Overall Study|not treated|0|||
156567189|NCT01431287|565163069|FG002|Overall Study|not treated|1|||
156567190|NCT01431287|565163070|FG003|Overall Study|not treated|0|||
156567191|NCT01431287|565163071|FG004|Overall Study|not treated|0|||
156567192|NCT01431287|565163067|FG000|Overall Study|Adverse Event|59|||
156567193|NCT01431287|565163068|FG001|Overall Study|Adverse Event|57|||
156567194|NCT01431287|565163069|FG002|Overall Study|Adverse Event|53|||
156567195|NCT01431287|565163070|FG003|Overall Study|Adverse Event|33|||
156567196|NCT01431287|565163071|FG004|Overall Study|Adverse Event|41|||
156567197|NCT01431287|565163067|FG000|Overall Study|Non compliant with protocol|6|||
156567198|NCT01431287|565163068|FG001|Overall Study|Non compliant with protocol|6|||
156567199|NCT01431287|565163069|FG002|Overall Study|Non compliant with protocol|5|||
156567200|NCT01431287|565163070|FG003|Overall Study|Non compliant with protocol|6|||
156567201|NCT01431287|565163071|FG004|Overall Study|Non compliant with protocol|5|||
156567202|NCT01431287|565163067|FG000|Overall Study|Lost to Follow-up|0|||
156567203|NCT01431287|565163068|FG001|Overall Study|Lost to Follow-up|3|||
156567204|NCT01431287|565163069|FG002|Overall Study|Lost to Follow-up|2|||
156567205|NCT01431287|565163070|FG003|Overall Study|Lost to Follow-up|3|||
156567206|NCT01431287|565163071|FG004|Overall Study|Lost to Follow-up|1|||
156567207|NCT01431287|565163067|FG000|Overall Study|Consent withdrawn not due to AE|29|||
156567208|NCT01431287|565163068|FG001|Overall Study|Consent withdrawn not due to AE|30|||
156567209|NCT01431287|565163069|FG002|Overall Study|Consent withdrawn not due to AE|34|||
156567210|NCT01431287|565163070|FG003|Overall Study|Consent withdrawn not due to AE|19|||
156567211|NCT01431287|565163071|FG004|Overall Study|Consent withdrawn not due to AE|29|||
156567212|NCT01431287|565163067|FG000|Overall Study|not stated above|4|||
156567213|NCT01431287|565163068|FG001|Overall Study|not stated above|2|||
156567214|NCT01431287|565163069|FG002|Overall Study|not stated above|2|||
156567215|NCT01431287|565163070|FG003|Overall Study|not stated above|2|||
156567216|NCT01431287|565163071|FG004|Overall Study|not stated above|1|||
156567217|NCT00278629|565163074|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
156567218|NCT05224258|565163075|FG000|Overall Study|Withdrawal by Subject|1|||
156567219|NCT05224258|565163076|FG001|Overall Study|Withdrawal by Subject|1|||
156567220|NCT05224258|565163075|FG000|Overall Study|Physician Decision|1|||
156567221|NCT05224258|565163076|FG001|Overall Study|Physician Decision|1|||
156567222|NCT05224258|565163075|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156567223|NCT05224258|565163076|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156567224|NCT05224258|565163075|FG000|Overall Study|Study Product No Longer in Use|1|||
156567225|NCT05224258|565163076|FG001|Overall Study|Study Product No Longer in Use|0|||
156567226|NCT05224258|565163075|FG000|Overall Study|Adverse Event|0|||
156567227|NCT05224258|565163076|FG001|Overall Study|Adverse Event|1|||
156567228|NCT05224258|565163075|FG000|Overall Study|Protocol Deviation|0|||
156567229|NCT05224258|565163076|FG001|Overall Study|Protocol Deviation|1|||
156567230|NCT04439266|565163078|FG000|Overall Study|Ineligible|1|||
156567231|NCT04439266|565163078|FG000|Overall Study|Adverse Event|1|||
156567232|NCT04439266|565163078|FG000|Overall Study|Death|1|||
156567233|NCT04439266|565163078|FG000|Overall Study|Disease progression|1|||
156567234|NCT04439266|565163078|FG000|Overall Study|Still on treatment|1|||
156567235|NCT06161012|565163080|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
156567236|NCT06161012|565163081|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
156567237|NCT00408005|565163082|FG000|Induction|Adverse Event|19|||
156567238|NCT00408005|565163083|FG001|Induction|Adverse Event|3|||
156567239|NCT00408005|565163084|FG002|Induction|Adverse Event|0|||
156567240|NCT00408005|565163085|FG003|Induction|Adverse Event|0|||
156567241|NCT00408005|565163086|FG004|Induction|Adverse Event|0|||
156567242|NCT00408005|565163087|FG005|Induction|Adverse Event|0|||
156567243|NCT00408005|565163088|FG006|Induction|Adverse Event|0|||
156567244|NCT00408005|565163089|FG007|Induction|Adverse Event|0|||
156567245|NCT00408005|565163082|FG000|Induction|Death|6|||
156567246|NCT00408005|565163083|FG001|Induction|Death|0|||
156567247|NCT00408005|565163084|FG002|Induction|Death|0|||
156567248|NCT00408005|565163085|FG003|Induction|Death|0|||
156567249|NCT00408005|565163086|FG004|Induction|Death|0|||
156567250|NCT00408005|565163087|FG005|Induction|Death|0|||
156567251|NCT00408005|565163088|FG006|Induction|Death|0|||
156567252|NCT00408005|565163089|FG007|Induction|Death|0|||
156567253|NCT00408005|565163082|FG000|Induction|Physician Decision|83|||
156567254|NCT00408005|565163083|FG001|Induction|Physician Decision|9|||
156567255|NCT00408005|565163084|FG002|Induction|Physician Decision|0|||
156567256|NCT00408005|565163085|FG003|Induction|Physician Decision|0|||
156567257|NCT00408005|565163086|FG004|Induction|Physician Decision|0|||
156567258|NCT00408005|565163087|FG005|Induction|Physician Decision|0|||
156567259|NCT00408005|565163088|FG006|Induction|Physician Decision|0|||
156567260|NCT00408005|565163089|FG007|Induction|Physician Decision|0|||
156567261|NCT00408005|565163082|FG000|Induction|Withdrawal by Subject|2|||
156567262|NCT00408005|565163083|FG001|Induction|Withdrawal by Subject|4|||
156567263|NCT00408005|565163084|FG002|Induction|Withdrawal by Subject|0|||
156567264|NCT00408005|565163085|FG003|Induction|Withdrawal by Subject|0|||
156567265|NCT00408005|565163086|FG004|Induction|Withdrawal by Subject|0|||
156567266|NCT00408005|565163087|FG005|Induction|Withdrawal by Subject|0|||
156567267|NCT00408005|565163088|FG006|Induction|Withdrawal by Subject|0|||
156567268|NCT00408005|565163089|FG007|Induction|Withdrawal by Subject|0|||
156567269|NCT00408005|565163082|FG000|Induction|Ineligible|33|||
156567270|NCT00408005|565163083|FG001|Induction|Ineligible|14|||
156567271|NCT00408005|565163084|FG002|Induction|Ineligible|0|||
156567272|NCT00408005|565163085|FG003|Induction|Ineligible|0|||
156567273|NCT00408005|565163086|FG004|Induction|Ineligible|0|||
156567274|NCT00408005|565163087|FG005|Induction|Ineligible|0|||
156567275|NCT00408005|565163088|FG006|Induction|Ineligible|0|||
156567276|NCT00408005|565163089|FG007|Induction|Ineligible|0|||
156567277|NCT00408005|565163082|FG000|Induction|Refusal of Further Protocol Therapy|225|||
156567278|NCT00408005|565163083|FG001|Induction|Refusal of Further Protocol Therapy|44|||
156567279|NCT00408005|565163084|FG002|Induction|Refusal of Further Protocol Therapy|0|||
156567280|NCT00408005|565163085|FG003|Induction|Refusal of Further Protocol Therapy|0|||
156567281|NCT00408005|565163086|FG004|Induction|Refusal of Further Protocol Therapy|0|||
156567282|NCT00408005|565163087|FG005|Induction|Refusal of Further Protocol Therapy|0|||
156567283|NCT00408005|565163088|FG006|Induction|Refusal of Further Protocol Therapy|0|||
156567284|NCT00408005|565163089|FG007|Induction|Refusal of Further Protocol Therapy|0|||
156567285|NCT00408005|565163082|FG000|Induction|Entered another COG therapeutic protocol|4|||
156567286|NCT00408005|565163083|FG001|Induction|Entered another COG therapeutic protocol|0|||
156567287|NCT00408005|565163084|FG002|Induction|Entered another COG therapeutic protocol|0|||
156567288|NCT00408005|565163085|FG003|Induction|Entered another COG therapeutic protocol|0|||
156567289|NCT00408005|565163086|FG004|Induction|Entered another COG therapeutic protocol|0|||
156567290|NCT00408005|565163087|FG005|Induction|Entered another COG therapeutic protocol|0|||
156567291|NCT00408005|565163088|FG006|Induction|Entered another COG therapeutic protocol|0|||
156567292|NCT00408005|565163089|FG007|Induction|Entered another COG therapeutic protocol|0|||
156567293|NCT00408005|565163082|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
156567294|NCT00408005|565163083|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
156567295|NCT00408005|565163084|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
156567296|NCT00408005|565163085|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
156567297|NCT00408005|565163086|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
156567298|NCT00408005|565163087|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
156567299|NCT00408005|565163088|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
156567300|NCT00408005|565163089|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
156567301|NCT00408005|565163082|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
156567302|NCT00408005|565163083|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
156567303|NCT00408005|565163084|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
156567304|NCT00408005|565163085|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
156567305|NCT00408005|565163086|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
156567306|NCT00408005|565163087|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
156567307|NCT00408005|565163088|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
156567308|NCT00408005|565163089|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
156567309|NCT00408005|565163082|FG000|Induction|Progressive Disease|0|||
156567310|NCT00408005|565163083|FG001|Induction|Progressive Disease|1|||
156567311|NCT00408005|565163084|FG002|Induction|Progressive Disease|0|||
156567312|NCT00408005|565163085|FG003|Induction|Progressive Disease|0|||
156567313|NCT00408005|565163086|FG004|Induction|Progressive Disease|0|||
156567314|NCT00408005|565163087|FG005|Induction|Progressive Disease|0|||
156567315|NCT00408005|565163088|FG006|Induction|Progressive Disease|0|||
156567316|NCT00408005|565163089|FG007|Induction|Progressive Disease|0|||
156567317|NCT00408005|565163082|FG000|Induction|Inevaluable|18|||
156567318|NCT00408005|565163083|FG001|Induction|Inevaluable|14|||
156567319|NCT00408005|565163084|FG002|Induction|Inevaluable|0|||
156567320|NCT00408005|565163085|FG003|Induction|Inevaluable|0|||
156567321|NCT00408005|565163086|FG004|Induction|Inevaluable|0|||
156567322|NCT00408005|565163087|FG005|Induction|Inevaluable|0|||
156567323|NCT00408005|565163088|FG006|Induction|Inevaluable|0|||
156567324|NCT00408005|565163089|FG007|Induction|Inevaluable|0|||
156567325|NCT00408005|565163082|FG000|Induction|Failed to Complete Randomization|3|||
156567326|NCT00408005|565163083|FG001|Induction|Failed to Complete Randomization|2|||
156567327|NCT00408005|565163084|FG002|Induction|Failed to Complete Randomization|0|||
156567328|NCT00408005|565163085|FG003|Induction|Failed to Complete Randomization|0|||
156567329|NCT00408005|565163086|FG004|Induction|Failed to Complete Randomization|0|||
156567330|NCT00408005|565163087|FG005|Induction|Failed to Complete Randomization|0|||
156567331|NCT00408005|565163088|FG006|Induction|Failed to Complete Randomization|0|||
156567332|NCT00408005|565163089|FG007|Induction|Failed to Complete Randomization|0|||
156567333|NCT00408005|565163082|FG000|Induction|Protocol Deviation|3|||
156567334|NCT00408005|565163083|FG001|Induction|Protocol Deviation|1|||
156567335|NCT00408005|565163084|FG002|Induction|Protocol Deviation|0|||
156567336|NCT00408005|565163085|FG003|Induction|Protocol Deviation|0|||
156567337|NCT00408005|565163086|FG004|Induction|Protocol Deviation|0|||
156567338|NCT00408005|565163087|FG005|Induction|Protocol Deviation|0|||
156567339|NCT00408005|565163088|FG006|Induction|Protocol Deviation|0|||
156567340|NCT00408005|565163089|FG007|Induction|Protocol Deviation|0|||
156567341|NCT00408005|565163082|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
156567342|NCT00408005|565163083|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
156567343|NCT00408005|565163084|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
156567344|NCT00408005|565163085|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
156567345|NCT00408005|565163086|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
156567346|NCT00408005|565163087|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
156567347|NCT00408005|565163088|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
156567348|NCT00408005|565163089|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
156567349|NCT00408005|565163082|FG000|Induction|Recurrent leukemia|1|||
156567350|NCT00408005|565163083|FG001|Induction|Recurrent leukemia|0|||
156567351|NCT00408005|565163084|FG002|Induction|Recurrent leukemia|0|||
156567352|NCT00408005|565163085|FG003|Induction|Recurrent leukemia|0|||
156567353|NCT00408005|565163086|FG004|Induction|Recurrent leukemia|0|||
156567354|NCT00408005|565163087|FG005|Induction|Recurrent leukemia|0|||
156567355|NCT00408005|565163088|FG006|Induction|Recurrent leukemia|0|||
156567356|NCT00408005|565163089|FG007|Induction|Recurrent leukemia|0|||
156567357|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
156567358|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
156567359|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
156567360|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
156567361|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
156567362|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
156567363|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
156567364|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
156567365|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
156567366|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
156567367|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
156567368|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
156567369|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
156567370|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
156567371|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
156567372|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
156567373|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
156567374|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
156567375|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
156567376|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
156567377|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
156567378|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
156567379|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
156567380|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
156567381|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
156567382|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
156567383|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
156567384|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
156567385|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
156567386|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
156567387|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
156567388|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
156567389|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
156567390|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
156567391|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
156567392|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
156567393|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
156567394|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
156567395|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
156567396|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
156567397|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
156567398|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
156567399|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
156567400|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
156567401|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
156567402|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
156567403|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
156567404|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
156567405|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
156567406|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
156567407|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
156567408|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
156567409|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
156567410|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
156567411|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
156567412|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
156567413|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
156567414|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
156567415|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
156567416|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
156567417|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
156567418|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
156567419|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
156567420|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
156567421|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
156567422|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
156567423|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
156567424|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
156567425|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
156567426|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
156567427|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
156567428|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
156567429|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156567430|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156567431|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156567432|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156567433|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156567434|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
156567435|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156567436|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156567437|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
156567438|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
156567439|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
156567440|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
156567441|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
156567442|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
156567443|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
156567444|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
156567445|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
156567446|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
156567447|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
156567448|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
156567449|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
156567450|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
156567451|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
156567452|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
156567453|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
156567454|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
156567455|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
156567456|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
156567457|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
156567458|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
156567459|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
156567460|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
156567461|NCT00408005|565163082|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
156567462|NCT00408005|565163083|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
156567463|NCT00408005|565163084|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
156567464|NCT00408005|565163085|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
156567465|NCT00408005|565163086|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
156567466|NCT00408005|565163087|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
156567467|NCT00408005|565163088|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
156567468|NCT00408005|565163089|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
156567469|NCT05424276|565163094|FG000|Overall Study|Adverse Event|1|||
156567470|NCT05424276|565163095|FG001|Overall Study|Adverse Event|0|||
156567471|NCT05424276|565163096|FG002|Overall Study|Adverse Event|0|||
156567472|NCT05424276|565163097|FG003|Overall Study|Adverse Event|2|||
156567473|NCT05424276|565163094|FG000|Overall Study|Withdrawal by Subject|0|||
156567474|NCT05424276|565163095|FG001|Overall Study|Withdrawal by Subject|0|||
156567475|NCT05424276|565163096|FG002|Overall Study|Withdrawal by Subject|2|||
156567476|NCT05424276|565163097|FG003|Overall Study|Withdrawal by Subject|0|||
156567477|NCT05424276|565163094|FG000|Overall Study|Protocol Violation|0|||
156567478|NCT05424276|565163095|FG001|Overall Study|Protocol Violation|1|||
156567479|NCT05424276|565163096|FG002|Overall Study|Protocol Violation|0|||
156567480|NCT05424276|565163097|FG003|Overall Study|Protocol Violation|0|||
156567481|NCT05424276|565163094|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
156567482|NCT05424276|565163095|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
156567483|NCT05424276|565163096|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
156567484|NCT05424276|565163097|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
156567485|NCT04454489|565163099|FG000|Overall Study|Disease progression|12|||
156567486|NCT04454489|565163099|FG000|Overall Study|Death|4|||
156567487|NCT04454489|565163099|FG000|Overall Study|Adverse Event|1|||
156567488|NCT04454489|565163099|FG000|Overall Study|Physician Decision|1|||
156567489|NCT00501228|565163101|FG000|Overall Study|Withdrawal by Subject|1|||
156567490|NCT01147926|565163104|FG000|Overall Study|Subject Withdrew Consent|9|||
156567491|NCT01147926|565163105|FG001|Overall Study|Subject Withdrew Consent|10|||
156567492|NCT01147926|565163104|FG000|Overall Study|Adverse Event|7|||
156567493|NCT01147926|565163105|FG001|Overall Study|Adverse Event|6|||
156567494|NCT01147926|565163104|FG000|Overall Study|Subject Non-Compliant|5|||
156567495|NCT01147926|565163105|FG001|Overall Study|Subject Non-Compliant|4|||
156567496|NCT01147926|565163104|FG000|Overall Study|Principal investigator left hospital|1|||
156567497|NCT01147926|565163105|FG001|Overall Study|Principal investigator left hospital|3|||
156567498|NCT01147926|565163104|FG000|Overall Study|Selection criteria not met|3|||
156567499|NCT01147926|565163105|FG001|Overall Study|Selection criteria not met|1|||
156567500|NCT01147926|565163104|FG000|Overall Study|Lost to Follow-up|0|||
156567501|NCT01147926|565163105|FG001|Overall Study|Lost to Follow-up|2|||
156567502|NCT01147926|565163104|FG000|Overall Study|Sponsor's Decision|0|||
156567503|NCT01147926|565163105|FG001|Overall Study|Sponsor's Decision|1|||
156567504|NCT01147926|565163104|FG000|Overall Study|Lack of Efficacy|1|||
156567505|NCT01147926|565163105|FG001|Overall Study|Lack of Efficacy|0|||
156567506|NCT01147926|565163104|FG000|Overall Study|Too busy, no time for study|1|||
156567507|NCT01147926|565163105|FG001|Overall Study|Too busy, no time for study|0|||
156567508|NCT01147926|565163104|FG000|Overall Study|Went on holiday|0|||
156567509|NCT01147926|565163105|FG001|Overall Study|Went on holiday|1|||
156567510|NCT01147926|565163104|FG000|Overall Study|Colonoscopy result|0|||
156567511|NCT01147926|565163105|FG001|Overall Study|Colonoscopy result|1|||
156567512|NCT03514914|565163106|FG000|Overall Study|Death|3|||
156567513|NCT03514914|565163107|FG001|Overall Study|Death|3|||
156567514|NCT03514914|565163106|FG000|Overall Study|Lost to Follow-up|117|||
156567515|NCT03514914|565163107|FG001|Overall Study|Lost to Follow-up|89|||
156567516|NCT03926143|565163109|FG000|Overall Study|Physician Decision|3|||
156567517|NCT03926143|565163109|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
156567518|NCT03926143|565163109|FG000|Overall Study|Adverse Event|2|||
156567519|NCT03926143|565163109|FG000|Overall Study|Progressive disease|3|||
156567520|NCT02561156|565163114|FG000|Part 2|Adverse Event|0|||
156567521|NCT02561156|565163115|FG001|Part 2|Adverse Event|0|||
156567522|NCT02561156|565163116|FG002|Part 2|Adverse Event|0|||
156567523|NCT02561156|565163117|FG003|Part 2|Adverse Event|0|||
156567524|NCT02561156|565163118|FG004|Part 2|Adverse Event|0|||
156567525|NCT02561156|565163119|FG005|Part 2|Adverse Event|0|||
156567526|NCT02561156|565163120|FG006|Part 2|Adverse Event|0|||
156567527|NCT02561156|565163121|FG007|Part 2|Adverse Event|0|||
156567528|NCT02561156|565163122|FG008|Part 2|Adverse Event|0|||
156567529|NCT02561156|565163123|FG009|Part 2|Adverse Event|0|||
156567530|NCT02561156|565163124|FG010|Part 2|Adverse Event|0|||
156567531|NCT02561156|565163125|FG011|Part 2|Adverse Event|1|||
156567532|NCT02561156|565163126|FG012|Part 2|Adverse Event|0|||
156567533|NCT01071070|565163130|FG000|Overall Study|Adverse Event|0|||
156567534|NCT01071070|565163131|FG001|Overall Study|Adverse Event|3|||
156567535|NCT01071070|565163130|FG000|Overall Study|Withdrawal by Subject|1|||
156567536|NCT01071070|565163131|FG001|Overall Study|Withdrawal by Subject|0|||
156567537|NCT01071070|565163130|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
156567538|NCT01071070|565163131|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
156567539|NCT01071070|565163130|FG000|Overall Study|Hypercalcemia|1|||
156567540|NCT01071070|565163131|FG001|Overall Study|Hypercalcemia|0|||
156567541|NCT01478958|565163141|FG000|Overall Study|Withdrawal by Subject|1|||
156567542|NCT01478958|565163142|FG001|Overall Study|Withdrawal by Subject|1|||
156567543|NCT01478958|565163143|FG002|Overall Study|Withdrawal by Subject|1|||
156567544|NCT01478958|565163141|FG000|Overall Study|Weight loss|1|||
156567545|NCT01478958|565163142|FG001|Overall Study|Weight loss|0|||
156567546|NCT01478958|565163143|FG002|Overall Study|Weight loss|0|||
156567547|NCT01478958|565163141|FG000|Overall Study|Re-located|0|||
156567548|NCT01478958|565163142|FG001|Overall Study|Re-located|1|||
156567549|NCT01478958|565163143|FG002|Overall Study|Re-located|0|||
156567550|NCT01478958|565163141|FG000|Overall Study|Unable to comply|0|||
156567551|NCT01478958|565163142|FG001|Overall Study|Unable to comply|0|||
156567552|NCT01478958|565163143|FG002|Overall Study|Unable to comply|2|||
156567553|NCT01147809|565163144|FG000|Phase I (168 Days)|Adverse Event|0|||
156567554|NCT01147809|565163145|FG001|Phase I (168 Days)|Adverse Event|0|||
156567555|NCT01147809|565163146|FG002|Phase I (168 Days)|Adverse Event|0|||
156567556|NCT01147809|565163147|FG003|Phase I (168 Days)|Adverse Event|1|||
156567557|NCT01147809|565163148|FG004|Phase I (168 Days)|Adverse Event|0|||
156567558|NCT01147809|565163149|FG005|Phase I (168 Days)|Adverse Event|0|||
156567559|NCT01147809|565163144|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
156567560|NCT01147809|565163145|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
156567561|NCT01147809|565163146|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
156567562|NCT01147809|565163147|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
156567563|NCT01147809|565163148|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
156567564|NCT01147809|565163149|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
156567565|NCT01147809|565163144|FG000|Phase I (168 Days)|Physician Decision|0|||
156567566|NCT01147809|565163145|FG001|Phase I (168 Days)|Physician Decision|1|||
156567567|NCT01147809|565163146|FG002|Phase I (168 Days)|Physician Decision|2|||
156567568|NCT01147809|565163147|FG003|Phase I (168 Days)|Physician Decision|0|||
156567569|NCT01147809|565163148|FG004|Phase I (168 Days)|Physician Decision|0|||
156567570|NCT01147809|565163149|FG005|Phase I (168 Days)|Physician Decision|0|||
156567571|NCT01147809|565163144|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
156567572|NCT01147809|565163145|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
156567573|NCT01147809|565163146|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
156567574|NCT01147809|565163147|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
156567575|NCT01147809|565163148|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
156567576|NCT01147809|565163149|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
156567577|NCT01147809|565163144|FG000|Phase II (168 Days)|Adverse Event|0|||
156567578|NCT01147809|565163145|FG001|Phase II (168 Days)|Adverse Event|0|||
156567579|NCT01147809|565163146|FG002|Phase II (168 Days)|Adverse Event|0|||
156567580|NCT01147809|565163147|FG003|Phase II (168 Days)|Adverse Event|0|||
156567581|NCT01147809|565163148|FG004|Phase II (168 Days)|Adverse Event|3|||
156567582|NCT01147809|565163149|FG005|Phase II (168 Days)|Adverse Event|6|||
156567583|NCT01147809|565163144|FG000|Phase II (168 Days)|Protocol Violation|0|||
156567584|NCT01147809|565163145|FG001|Phase II (168 Days)|Protocol Violation|0|||
156567585|NCT01147809|565163146|FG002|Phase II (168 Days)|Protocol Violation|0|||
156567586|NCT01147809|565163147|FG003|Phase II (168 Days)|Protocol Violation|0|||
156567587|NCT01147809|565163148|FG004|Phase II (168 Days)|Protocol Violation|0|||
156567588|NCT01147809|565163149|FG005|Phase II (168 Days)|Protocol Violation|1|||
156567589|NCT01147809|565163144|FG000|Phase II (168 Days)|Physician Decision|0|||
156567590|NCT01147809|565163145|FG001|Phase II (168 Days)|Physician Decision|0|||
156567591|NCT01147809|565163146|FG002|Phase II (168 Days)|Physician Decision|0|||
156567592|NCT01147809|565163147|FG003|Phase II (168 Days)|Physician Decision|0|||
156567593|NCT01147809|565163148|FG004|Phase II (168 Days)|Physician Decision|5|||
156567594|NCT01147809|565163149|FG005|Phase II (168 Days)|Physician Decision|11|||
156567595|NCT01147809|565163144|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
156567596|NCT01147809|565163145|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
156567597|NCT01147809|565163146|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
156567598|NCT01147809|565163147|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
156567599|NCT01147809|565163148|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
156567600|NCT01147809|565163149|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
156567601|NCT01147809|565163144|FG000|Phase II (168 Days)|Ongoing|0|||
156567602|NCT01147809|565163145|FG001|Phase II (168 Days)|Ongoing|0|||
156567603|NCT01147809|565163146|FG002|Phase II (168 Days)|Ongoing|0|||
156567604|NCT01147809|565163147|FG003|Phase II (168 Days)|Ongoing|0|||
156567605|NCT01147809|565163148|FG004|Phase II (168 Days)|Ongoing|1|||
156567606|NCT01147809|565163149|FG005|Phase II (168 Days)|Ongoing|0|||
156567607|NCT00805207|565163150|FG000|Overall Study|Protocol Violation|0|||
156567608|NCT00805207|565163151|FG001|Overall Study|Protocol Violation|0|||
156567609|NCT00805207|565163152|FG002|Overall Study|Protocol Violation|1|||
156567610|NCT00805207|565163153|FG003|Overall Study|Protocol Violation|0|||
156567611|NCT00805207|565163154|FG004|Overall Study|Protocol Violation|0|||
156567612|NCT00805207|565163155|FG005|Overall Study|Protocol Violation|0|||
156567613|NCT00805207|565163156|FG006|Overall Study|Protocol Violation|0|||
156567614|NCT00805207|565163157|FG007|Overall Study|Protocol Violation|0|||
156567615|NCT00805207|565163158|FG008|Overall Study|Protocol Violation|0|||
156567616|NCT00805207|565163150|FG000|Overall Study|Physician Decision|0|||
156567617|NCT00805207|565163151|FG001|Overall Study|Physician Decision|1|||
156567618|NCT00805207|565163152|FG002|Overall Study|Physician Decision|0|||
156567619|NCT00805207|565163153|FG003|Overall Study|Physician Decision|0|||
156567620|NCT00805207|565163154|FG004|Overall Study|Physician Decision|0|||
156567621|NCT00805207|565163155|FG005|Overall Study|Physician Decision|1|||
156567622|NCT00805207|565163156|FG006|Overall Study|Physician Decision|0|||
156567623|NCT00805207|565163157|FG007|Overall Study|Physician Decision|0|||
156567624|NCT00805207|565163158|FG008|Overall Study|Physician Decision|0|||
156567625|NCT00805207|565163150|FG000|Overall Study|Withdrawal by Subject|0|||
156567626|NCT00805207|565163151|FG001|Overall Study|Withdrawal by Subject|1|||
156567627|NCT00805207|565163152|FG002|Overall Study|Withdrawal by Subject|0|||
156567628|NCT00805207|565163153|FG003|Overall Study|Withdrawal by Subject|0|||
156567629|NCT00805207|565163154|FG004|Overall Study|Withdrawal by Subject|1|||
156567630|NCT00805207|565163155|FG005|Overall Study|Withdrawal by Subject|2|||
156567631|NCT00805207|565163156|FG006|Overall Study|Withdrawal by Subject|0|||
156567632|NCT00805207|565163157|FG007|Overall Study|Withdrawal by Subject|0|||
156567633|NCT00805207|565163158|FG008|Overall Study|Withdrawal by Subject|0|||
156567634|NCT00064701|565163159|FG000|One Year Post-transplant|Did not receive study drug|7|||
156567635|NCT00064701|565163160|FG001|One Year Post-transplant|Did not receive study drug|12|||
156567636|NCT00064701|565163161|FG002|One Year Post-transplant|Did not receive study drug|11|||
156567637|NCT00064701|565163159|FG000|One Year Post-transplant|Adverse Event|23|||
156567638|NCT00064701|565163160|FG001|One Year Post-transplant|Adverse Event|19|||
156567639|NCT00064701|565163161|FG002|One Year Post-transplant|Adverse Event|37|||
156567640|NCT00064701|565163159|FG000|One Year Post-transplant|Rejection|0|||
156567641|NCT00064701|565163160|FG001|One Year Post-transplant|Rejection|1|||
156567642|NCT00064701|565163161|FG002|One Year Post-transplant|Rejection|16|||
156567643|NCT00064701|565163159|FG000|One Year Post-transplant|Non-compliance|4|||
156567644|NCT00064701|565163160|FG001|One Year Post-transplant|Non-compliance|2|||
156567645|NCT00064701|565163161|FG002|One Year Post-transplant|Non-compliance|5|||
156567646|NCT00064701|565163159|FG000|One Year Post-transplant|Graft Failure|3|||
156567647|NCT00064701|565163160|FG001|One Year Post-transplant|Graft Failure|2|||
156567648|NCT00064701|565163161|FG002|One Year Post-transplant|Graft Failure|1|||
156567649|NCT00064701|565163159|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
156567650|NCT00064701|565163160|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
156567651|NCT00064701|565163161|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
156567652|NCT00064701|565163159|FG000|One Year Post-transplant|Lost to Follow-up|1|||
156567653|NCT00064701|565163160|FG001|One Year Post-transplant|Lost to Follow-up|0|||
156567654|NCT00064701|565163161|FG002|One Year Post-transplant|Lost to Follow-up|0|||
156567655|NCT00064701|565163159|FG000|One Year Post-transplant|Converted to rapamycin|1|||
156567656|NCT00064701|565163160|FG001|One Year Post-transplant|Converted to rapamycin|0|||
156567657|NCT00064701|565163161|FG002|One Year Post-transplant|Converted to rapamycin|0|||
156567658|NCT00064701|565163159|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
156567659|NCT00064701|565163160|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
156567660|NCT00064701|565163161|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
156567661|NCT00064701|565163159|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
156635576|NCT00602667|565409961|FG001|Overall Study|Progressive disease|48|||
156567662|NCT00064701|565163160|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
156567663|NCT00064701|565163161|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
156567664|NCT00064701|565163159|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
156567665|NCT00064701|565163160|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
156567666|NCT00064701|565163161|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
156567667|NCT00064701|565163159|FG000|One Year Post-transplant|Poor absorption|0|||
156567668|NCT00064701|565163160|FG001|One Year Post-transplant|Poor absorption|1|||
156567669|NCT00064701|565163161|FG002|One Year Post-transplant|Poor absorption|0|||
156567670|NCT00064701|565163159|FG000|One Year Post-transplant|Pancreas transplant|0|||
156567671|NCT00064701|565163160|FG001|One Year Post-transplant|Pancreas transplant|0|||
156567672|NCT00064701|565163161|FG002|One Year Post-transplant|Pancreas transplant|1|||
156567673|NCT00064701|565163159|FG000|Clinical Continuation Phase|Adverse Event|12|||
156567674|NCT00064701|565163160|FG001|Clinical Continuation Phase|Adverse Event|21|||
156567675|NCT00064701|565163161|FG002|Clinical Continuation Phase|Adverse Event|14|||
156567676|NCT00064701|565163159|FG000|Clinical Continuation Phase|Non-compliance|8|||
156567677|NCT00064701|565163160|FG001|Clinical Continuation Phase|Non-compliance|6|||
156567678|NCT00064701|565163161|FG002|Clinical Continuation Phase|Non-compliance|7|||
156567679|NCT00064701|565163159|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
156567680|NCT00064701|565163160|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
156567681|NCT00064701|565163161|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
156567682|NCT00064701|565163159|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
156567683|NCT00064701|565163160|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
156567684|NCT00064701|565163161|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
156567685|NCT00064701|565163159|FG000|Clinical Continuation Phase|Graft Failure|5|||
156567686|NCT00064701|565163160|FG001|Clinical Continuation Phase|Graft Failure|5|||
156567687|NCT00064701|565163161|FG002|Clinical Continuation Phase|Graft Failure|2|||
156567688|NCT00064701|565163159|FG000|Clinical Continuation Phase|Rejection|1|||
156567689|NCT00064701|565163160|FG001|Clinical Continuation Phase|Rejection|2|||
156567690|NCT00064701|565163161|FG002|Clinical Continuation Phase|Rejection|2|||
156567691|NCT00064701|565163159|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
156567692|NCT00064701|565163160|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
156567693|NCT00064701|565163161|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
156567694|NCT00064701|565163159|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
156567695|NCT00064701|565163160|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
156567696|NCT00064701|565163161|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
156567697|NCT00064701|565163159|FG000|Clinical Continuation Phase|Physician Decision|1|||
156567698|NCT00064701|565163160|FG001|Clinical Continuation Phase|Physician Decision|3|||
156567699|NCT00064701|565163161|FG002|Clinical Continuation Phase|Physician Decision|0|||
156567700|NCT00064701|565163159|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
156567701|NCT00064701|565163160|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
156567702|NCT00064701|565163161|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
156567703|NCT00064701|565163159|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
156567704|NCT00064701|565163160|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
156567705|NCT00064701|565163161|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
156567706|NCT00064701|565163159|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
156567707|NCT00064701|565163160|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
156567708|NCT00064701|565163161|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
156567709|NCT00064701|565163159|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
156567710|NCT00064701|565163160|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
156567711|NCT00064701|565163161|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
156567712|NCT00064701|565163159|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
156567713|NCT00064701|565163160|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
156567714|NCT00064701|565163161|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
156567715|NCT00064701|565163159|FG000|Clinical Continuation Phase|Patient opted out|0|||
156567716|NCT00064701|565163160|FG001|Clinical Continuation Phase|Patient opted out|0|||
156567717|NCT00064701|565163161|FG002|Clinical Continuation Phase|Patient opted out|1|||
156567718|NCT01791855|565163162|FG000|Overall Study|Adverse Event|0|||
156567719|NCT01791855|565163163|FG001|Overall Study|Adverse Event|0|||
156567720|NCT01791855|565163164|FG002|Overall Study|Adverse Event|0|||
156567721|NCT01791855|565163165|FG003|Overall Study|Adverse Event|1|||
156567722|NCT01791855|565163162|FG000|Overall Study|Randomized, not treated|0|||
156567723|NCT01791855|565163163|FG001|Overall Study|Randomized, not treated|1|||
156567724|NCT01791855|565163164|FG002|Overall Study|Randomized, not treated|0|||
156567725|NCT01791855|565163165|FG003|Overall Study|Randomized, not treated|0|||
156567726|NCT00772447|565163166|FG000|Overall Study|Withdrawal by Subject|9|||
156567727|NCT00772447|565163167|FG001|Overall Study|Withdrawal by Subject|5|||
156567728|NCT00772447|565163166|FG000|Overall Study|Physician Decision|4|||
156567729|NCT00772447|565163167|FG001|Overall Study|Physician Decision|8|||
156567730|NCT00772447|565163166|FG000|Overall Study|Lost to Follow-up|2|||
156567731|NCT00772447|565163167|FG001|Overall Study|Lost to Follow-up|4|||
156567732|NCT00772447|565163166|FG000|Overall Study|incorrect enrolment|3|||
156567733|NCT00772447|565163167|FG001|Overall Study|incorrect enrolment|4|||
156567734|NCT00772447|565163166|FG000|Overall Study|Protocol Violation|0|||
156567735|NCT00772447|565163167|FG001|Overall Study|Protocol Violation|1|||
156567736|NCT00772447|565163166|FG000|Overall Study|all others|2|||
156567737|NCT00772447|565163167|FG001|Overall Study|all others|2|||
156567738|NCT04439344|565163168|FG000|Overall Study|Never started threapy|3|||
156567739|NCT04439344|565163168|FG000|Overall Study|Ineligible|3|||
156567740|NCT04439344|565163168|FG000|Overall Study|Adverse Event|13|||
156567741|NCT04439344|565163168|FG000|Overall Study|Death|2|||
156567742|NCT04439344|565163168|FG000|Overall Study|Disease progression|29|||
156567743|NCT04439344|565163168|FG000|Overall Study|Withdrawal by Subject|2|||
156567744|NCT04439344|565163168|FG000|Overall Study|Alternative therapy|1|||
156567745|NCT03770403|565163169|FG000|Overall Study|Adverse Event|8|||
156567746|NCT03770403|565163169|FG000|Overall Study|Death|5|||
156567747|NCT03770403|565163169|FG000|Overall Study|Physician Decision|1|||
156567748|NCT03770403|565163169|FG000|Overall Study|Sponsor decision|1|||
156567749|NCT03770403|565163169|FG000|Overall Study|Study terminated by Sponsor|1|||
156567750|NCT03770403|565163169|FG000|Overall Study|Withdrawal by Subject|13|||
156567751|NCT03770403|565163169|FG000|Overall Study|Other|88|||
156567752|NCT00642642|565163182|FG000|Treatment & Follow Up|Adverse Event|2|||
156567753|NCT00642642|565163182|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
156567754|NCT00642642|565163182|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
156567755|NCT03832387|565163185|FG000|Overall Study|Protocol Violation|2|||
156567756|NCT03832387|565163186|FG001|Overall Study|Protocol Violation|6|||
156567757|NCT03832387|565163185|FG000|Overall Study|EXCLUSION CRITERIA|3|||
156567758|NCT03832387|565163186|FG001|Overall Study|EXCLUSION CRITERIA|1|||
156567759|NCT00998738|565163188|FG000|Overall Study|Uknown|1|||
156567760|NCT00215150|565165065|FG000|Open Label Phase|Lost to Follow-up|7|||
156567761|NCT00215150|565165065|FG000|Open Label Phase|Withdrawal by Subject|1|||
156567762|NCT00215150|565165065|FG000|Open Label Phase|Did not complete a post base visit|13|||
156567763|NCT00215150|565165065|FG000|Open Label Phase|Did not meet randomization criteria|9|||
156567764|NCT00215150|565165065|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
156567765|NCT00215150|565165065|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
156567766|NCT00215150|565165065|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
156567767|NCT02251743|565165066|FG000|Overall Study|Withdrawal by Subject|1|||
156567768|NCT02251743|565165067|FG001|Overall Study|Withdrawal by Subject|1|||
156567769|NCT02091440|565165071|FG000|Overall Study|Death|2|||
156567770|NCT02443402|565165076|FG000|Overall Study|Withdrawal by Subject|3|||
156567771|NCT02443402|565165077|FG001|Overall Study|Withdrawal by Subject|1|||
156567772|NCT02443402|565165076|FG000|Overall Study|Screen Failure|1|||
156567773|NCT02443402|565165077|FG001|Overall Study|Screen Failure|2|||
156567774|NCT00775021|565165081|FG000|First Intervention|Lost to Follow-up|1|||
156567775|NCT00775021|565165082|FG001|First Intervention|Lost to Follow-up|0|||
156567776|NCT00775021|565165081|FG000|Second Intervention|Adverse Event|0|||
156567777|NCT00775021|565165082|FG001|Second Intervention|Adverse Event|1|||
156567778|NCT02542267|565165083|FG000|Overall Study|Withdrawal by Subject|10|||
156567779|NCT02542267|565165083|FG000|Overall Study|Physician Decision|6|||
156567780|NCT02542267|565165083|FG000|Overall Study|Lost to Follow-up|4|||
156567781|NCT02542267|565165083|FG000|Overall Study|Death|13|||
156567782|NCT02542267|565165083|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
156567783|NCT02542267|565165083|FG000|Overall Study|Other|9|||
156567784|NCT00442598|565165084|FG000|Overall Study|Adverse Event|1|||
156567785|NCT00442598|565165085|FG001|Overall Study|Adverse Event|0|||
156567786|NCT00442598|565165086|FG002|Overall Study|Adverse Event|0|||
156567787|NCT00442598|565165084|FG000|Overall Study|Tumor progression|3|||
156567788|NCT00442598|565165085|FG001|Overall Study|Tumor progression|4|||
156567789|NCT00442598|565165086|FG002|Overall Study|Tumor progression|0|||
156567790|NCT00442598|565165084|FG000|Overall Study|Clinical deterioration|1|||
156567791|NCT00442598|565165085|FG001|Overall Study|Clinical deterioration|2|||
156567792|NCT00442598|565165086|FG002|Overall Study|Clinical deterioration|0|||
156567793|NCT00442598|565165084|FG000|Overall Study|CA125 progression|0|||
156567794|NCT00442598|565165085|FG001|Overall Study|CA125 progression|1|||
156567795|NCT00442598|565165086|FG002|Overall Study|CA125 progression|0|||
156567796|NCT00442598|565165084|FG000|Overall Study|Reduced creatinine clearance|1|||
156567797|NCT00442598|565165085|FG001|Overall Study|Reduced creatinine clearance|0|||
156567798|NCT00442598|565165086|FG002|Overall Study|Reduced creatinine clearance|0|||
156567799|NCT00442598|565165084|FG000|Overall Study|Death|0|||
156567800|NCT00442598|565165085|FG001|Overall Study|Death|1|||
156567801|NCT00442598|565165086|FG002|Overall Study|Death|0|||
156567802|NCT03093402|565165087|FG000|Overall Study|Lost to Follow-up|1|||
156567803|NCT03093402|565165088|FG001|Overall Study|Lost to Follow-up|0|||
156567804|NCT03093402|565165089|FG002|Overall Study|Lost to Follow-up|0|||
156567805|NCT03093402|565165090|FG003|Overall Study|Lost to Follow-up|0|||
156567806|NCT03093402|565165087|FG000|Overall Study|Withdrawal by Subject|3|||
156567807|NCT03093402|565165088|FG001|Overall Study|Withdrawal by Subject|3|||
156567808|NCT03093402|565165089|FG002|Overall Study|Withdrawal by Subject|0|||
156567809|NCT03093402|565165090|FG003|Overall Study|Withdrawal by Subject|1|||
156567810|NCT03093402|565165087|FG000|Overall Study|Withdrew prior to dosing|2|||
156567811|NCT03093402|565165088|FG001|Overall Study|Withdrew prior to dosing|1|||
156567812|NCT03093402|565165089|FG002|Overall Study|Withdrew prior to dosing|2|||
156567813|NCT03093402|565165090|FG003|Overall Study|Withdrew prior to dosing|3|||
156567814|NCT03093402|565165087|FG000|Overall Study|Ineligible for study|1|||
156567815|NCT03093402|565165088|FG001|Overall Study|Ineligible for study|0|||
156567816|NCT03093402|565165089|FG002|Overall Study|Ineligible for study|0|||
156567817|NCT03093402|565165090|FG003|Overall Study|Ineligible for study|0|||
156567818|NCT03093402|565165087|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
156567819|NCT03093402|565165088|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
156567820|NCT03093402|565165089|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
156567821|NCT03093402|565165090|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
156567822|NCT02886702|565165091|FG000|Overall Study|Other|4|||
156567823|NCT02886702|565165092|FG001|Overall Study|Other|3|||
156567824|NCT02886702|565165093|FG002|Overall Study|Other|9|||
156567825|NCT02886702|565165091|FG000|Overall Study|Withdrawal by Subject|24|||
156567826|NCT02886702|565165092|FG001|Overall Study|Withdrawal by Subject|18|||
156567827|NCT02886702|565165093|FG002|Overall Study|Withdrawal by Subject|22|||
156567828|NCT02886702|565165091|FG000|Overall Study|Significant Worsening of Condition|0|||
156567829|NCT02886702|565165092|FG001|Overall Study|Significant Worsening of Condition|1|||
156567830|NCT02886702|565165093|FG002|Overall Study|Significant Worsening of Condition|0|||
156567831|NCT02886702|565165091|FG000|Overall Study|Protocol Violation|2|||
156567832|NCT02886702|565165092|FG001|Overall Study|Protocol Violation|2|||
156567833|NCT02886702|565165093|FG002|Overall Study|Protocol Violation|1|||
156567834|NCT02886702|565165091|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156567835|NCT02886702|565165092|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156567836|NCT02886702|565165093|FG002|Overall Study|Non-Compliance With Study Drug|4|||
156567837|NCT02886702|565165091|FG000|Overall Study|Lost to Follow-up|11|||
156567838|NCT02886702|565165092|FG001|Overall Study|Lost to Follow-up|13|||
156567839|NCT02886702|565165093|FG002|Overall Study|Lost to Follow-up|8|||
156567840|NCT02886702|565165091|FG000|Overall Study|Lack of Efficacy|3|||
156567841|NCT02886702|565165092|FG001|Overall Study|Lack of Efficacy|4|||
156567842|NCT02886702|565165093|FG002|Overall Study|Lack of Efficacy|5|||
156567843|NCT02886702|565165091|FG000|Overall Study|Adverse Event|4|||
156567844|NCT02886702|565165092|FG001|Overall Study|Adverse Event|9|||
156567845|NCT02886702|565165093|FG002|Overall Study|Adverse Event|3|||
156567846|NCT02886702|565165091|FG000|Overall Study|Administrative Reasons|0|||
156567847|NCT02886702|565165092|FG001|Overall Study|Administrative Reasons|0|||
156567848|NCT02886702|565165093|FG002|Overall Study|Administrative Reasons|1|||
156567849|NCT01147497|565165103|FG000|Overall Study|failed insertion|2|||
156567850|NCT01147497|565165104|FG001|Overall Study|failed insertion|0|||
156567851|NCT02731742|565165107|FG000|Overall Study|Death|1|||
156567852|NCT02731742|565165108|FG001|Overall Study|Death|2|||
156567853|NCT02731742|565165109|FG002|Overall Study|Death|5|||
156567854|NCT02731742|565165110|FG003|Overall Study|Death|0|||
156567855|NCT02731742|565165107|FG000|Overall Study|Physician Decision|0|||
156567856|NCT02731742|565165108|FG001|Overall Study|Physician Decision|0|||
156567857|NCT02731742|565165109|FG002|Overall Study|Physician Decision|0|||
156567858|NCT02731742|565165110|FG003|Overall Study|Physician Decision|1|||
156567859|NCT02731742|565165107|FG000|Overall Study|Study Terminated by Sponsor|2|||
156567860|NCT02731742|565165108|FG001|Overall Study|Study Terminated by Sponsor|1|||
156567861|NCT02731742|565165109|FG002|Overall Study|Study Terminated by Sponsor|1|||
156567862|NCT02731742|565165110|FG003|Overall Study|Study Terminated by Sponsor|1|||
156567863|NCT04026568|565165111|FG000|Overall Study|study terminated|0|||
156567864|NCT04026568|565165112|FG001|Overall Study|study terminated|1|||
156567865|NCT00331760|565165113|FG000|Overall Study|Ineligible / no protocol treatment|15|||
156567866|NCT00331760|565165114|FG001|Overall Study|Ineligible / no protocol treatment|8|||
156567867|NCT00461175|565165115|FG000|Overall Study|Protocol Violation|522|||
156567868|NCT00461175|565165116|FG001|Overall Study|Protocol Violation|365|||
156567869|NCT01085682|565165119|FG000|Overall Study|Withdrawal by Subject|25|||
156567870|NCT01085682|565165120|FG001|Overall Study|Withdrawal by Subject|25|||
156567871|NCT02207907|565165122|FG000|Overall Study|Lost to Follow-up|3|||
156567872|NCT02207907|565165123|FG001|Overall Study|Lost to Follow-up|1|||
156567873|NCT02207907|565165122|FG000|Overall Study|Withdrawal by Subject|5|||
156567874|NCT02207907|565165123|FG001|Overall Study|Withdrawal by Subject|6|||
156567875|NCT02207907|565165122|FG000|Overall Study|Did not meet study criteria|3|||
156567876|NCT02207907|565165123|FG001|Overall Study|Did not meet study criteria|0|||
156567877|NCT02207907|565165122|FG000|Overall Study|Pregnancy|0|||
156567878|NCT02207907|565165123|FG001|Overall Study|Pregnancy|1|||
156567879|NCT00158184|565165124|FG000|Overall Study|personal issues|3|||
156567880|NCT00158184|565165125|FG001|Overall Study|personal issues|1|||
156567881|NCT00158184|565165124|FG000|Overall Study|failed for follow unit/study rules|2|||
156567882|NCT00158184|565165125|FG001|Overall Study|failed for follow unit/study rules|0|||
156567883|NCT00158184|565165124|FG000|Overall Study|Adverse Event|1|||
156567884|NCT00158184|565165125|FG001|Overall Study|Adverse Event|1|||
156567885|NCT01025635|565165133|FG000|Overall Study|Withdrawal by Subject|6|||
156567886|NCT01025635|565165134|FG001|Overall Study|Withdrawal by Subject|7|||
156567887|NCT01025635|565165133|FG000|Overall Study|Protocol Violation|4|||
156567888|NCT01025635|565165134|FG001|Overall Study|Protocol Violation|2|||
156567889|NCT01025635|565165133|FG000|Overall Study|Lack of Efficacy|0|||
156567890|NCT01025635|565165134|FG001|Overall Study|Lack of Efficacy|1|||
156567891|NCT01025635|565165133|FG000|Overall Study|Lost to Follow-up|9|||
156567892|NCT01025635|565165134|FG001|Overall Study|Lost to Follow-up|13|||
156567893|NCT01025635|565165133|FG000|Overall Study|Reason not known|4|||
156567894|NCT01025635|565165134|FG001|Overall Study|Reason not known|2|||
156567895|NCT00727402|565165135|FG000|Overall Study|Physician Decision|116|||
156567896|NCT03751111|565165136|FG000|Overall Study|Lack of Efficacy|9|||
156567897|NCT03751111|565165137|FG001|Overall Study|Lack of Efficacy|30|||
156567898|NCT03751111|565165136|FG000|Overall Study|Adverse Event|3|||
156567899|NCT03751111|565165137|FG001|Overall Study|Adverse Event|2|||
156567900|NCT00755079|565165138|FG000|Overall Study|Lost to Follow-up|1|||
156567901|NCT00755079|565165139|FG001|Overall Study|Lost to Follow-up|3|||
156567902|NCT00755079|565165138|FG000|Overall Study|Adverse Event|0|||
156567903|NCT00755079|565165139|FG001|Overall Study|Adverse Event|1|||
156567904|NCT00755079|565165138|FG000|Overall Study|Withdrawal by Subject|0|||
156567905|NCT00755079|565165139|FG001|Overall Study|Withdrawal by Subject|2|||
156567906|NCT03545282|565165140|FG000|Overall Study|Lost to Follow-up|15|||
156567907|NCT03545282|565165141|FG001|Overall Study|Lost to Follow-up|10|||
156567908|NCT03545282|565165140|FG000|Overall Study|Withdrawal by Subject|2|||
156567909|NCT03545282|565165141|FG001|Overall Study|Withdrawal by Subject|2|||
156567910|NCT02209506|565165142|FG000|Overall Study|Withdrawal by Subject|0|||
156567911|NCT02209506|565165143|FG001|Overall Study|Withdrawal by Subject|0|||
156567912|NCT02209506|565165144|FG002|Overall Study|Withdrawal by Subject|0|||
156567913|NCT02209506|565165145|FG003|Overall Study|Withdrawal by Subject|0|||
156567914|NCT02209506|565165146|FG004|Overall Study|Withdrawal by Subject|1|||
156567915|NCT02582671|565165147|FG000|Overall Study|Failure to return|1|||
156567916|NCT02582671|565165147|FG000|Overall Study|Other, not specified|1|||
156567917|NCT01287104|565165152|FG000|Overall Study|Patient developed progressive disease|1|||
156567918|NCT01287104|565165153|FG001|Overall Study|Patient developed progressive disease|1|||
156567919|NCT01287104|565165154|FG002|Overall Study|Patient developed progressive disease|3|||
156567920|NCT01287104|565165155|FG003|Overall Study|Patient developed progressive disease|2|||
156567921|NCT01287104|565165152|FG000|Overall Study|Donor anaphylaxis|0|||
156567922|NCT01287104|565165153|FG001|Overall Study|Donor anaphylaxis|1|||
156567923|NCT01287104|565165154|FG002|Overall Study|Donor anaphylaxis|0|||
156567924|NCT01287104|565165155|FG003|Overall Study|Donor anaphylaxis|1|||
156567925|NCT01287104|565165152|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
156567926|NCT01287104|565165153|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
156567927|NCT01287104|565165154|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
156567928|NCT01287104|565165155|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
156567929|NCT01287104|565165152|FG000|Overall Study|Low donor chimerism|0|||
156567930|NCT01287104|565165153|FG001|Overall Study|Low donor chimerism|1|||
156567931|NCT01287104|565165154|FG002|Overall Study|Low donor chimerism|0|||
156567932|NCT01287104|565165155|FG003|Overall Study|Low donor chimerism|0|||
156567933|NCT01287104|565165152|FG000|Overall Study|NK cells did not meet release criteria|0|||
156567934|NCT01287104|565165153|FG001|Overall Study|NK cells did not meet release criteria|1|||
156567935|NCT01287104|565165154|FG002|Overall Study|NK cells did not meet release criteria|0|||
156567936|NCT01287104|565165155|FG003|Overall Study|NK cells did not meet release criteria|0|||
156567937|NCT00629083|565165158|FG000|Overall Study|Adverse Event|0|||
156567938|NCT00629083|565165159|FG001|Overall Study|Adverse Event|2|||
156567939|NCT00629083|565165158|FG000|Overall Study|Lack of Efficacy|3|||
156567940|NCT00629083|565165159|FG001|Overall Study|Lack of Efficacy|1|||
156567941|NCT00629083|565165158|FG000|Overall Study|Withdrawal by Subject|10|||
156567942|NCT00629083|565165159|FG001|Overall Study|Withdrawal by Subject|2|||
156567943|NCT00629083|565165158|FG000|Overall Study|Lost to Follow-up|12|||
156567944|NCT00629083|565165159|FG001|Overall Study|Lost to Follow-up|8|||
156567945|NCT00629083|565165158|FG000|Overall Study|Moved out of country/state|2|||
156567946|NCT00629083|565165159|FG001|Overall Study|Moved out of country/state|1|||
156567947|NCT00629083|565165158|FG000|Overall Study|Refused to return for 12 month visit|1|||
156567948|NCT00629083|565165159|FG001|Overall Study|Refused to return for 12 month visit|0|||
156567949|NCT01307423|565165160|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
156567950|NCT01307423|565165161|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
156567951|NCT01307423|565165162|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
156567952|NCT01307423|565165163|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156567953|NCT01307423|565165164|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156567954|NCT01307423|565165165|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156567955|NCT01307423|565165166|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156567956|NCT01307423|565165167|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156567957|NCT01307423|565165168|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156567958|NCT01307423|565165160|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
156567959|NCT01307423|565165161|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
156567960|NCT01307423|565165162|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
156567961|NCT01307423|565165163|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156567962|NCT01307423|565165164|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156567963|NCT01307423|565165165|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156567964|NCT01307423|565165166|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156567965|NCT01307423|565165167|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156567966|NCT01307423|565165168|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156567967|NCT01307423|565165160|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
156567968|NCT01307423|565165161|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
156567969|NCT01307423|565165162|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
156567970|NCT01307423|565165163|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156567971|NCT01307423|565165164|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156567972|NCT01307423|565165165|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156567973|NCT01307423|565165166|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156567974|NCT01307423|565165167|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156567975|NCT01307423|565165168|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156567976|NCT01307423|565165160|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156567977|NCT01307423|565165161|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156567978|NCT01307423|565165162|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
156567979|NCT01307423|565165163|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156567980|NCT01307423|565165164|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156567981|NCT01307423|565165165|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156567982|NCT01307423|565165166|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156567983|NCT01307423|565165167|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156567984|NCT01307423|565165168|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
156567985|NCT01307423|565165160|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
156567986|NCT01307423|565165161|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
156567987|NCT01307423|565165162|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
156567988|NCT01307423|565165163|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156567989|NCT01307423|565165164|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156567990|NCT01307423|565165165|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156567991|NCT01307423|565165166|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156567992|NCT01307423|565165167|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156567993|NCT01307423|565165168|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156567994|NCT01307423|565165160|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
156567995|NCT01307423|565165161|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156567996|NCT01307423|565165162|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156567997|NCT01307423|565165163|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156567998|NCT01307423|565165164|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156567999|NCT01307423|565165165|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156568000|NCT01307423|565165166|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156568001|NCT01307423|565165167|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156568002|NCT01307423|565165168|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156568003|NCT01307423|565165160|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
156568004|NCT01307423|565165161|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
156568005|NCT01307423|565165162|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156568006|NCT01307423|565165163|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156568007|NCT01307423|565165164|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156568008|NCT01307423|565165165|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156568009|NCT01307423|565165166|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156568010|NCT01307423|565165167|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156568011|NCT01307423|565165168|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
156568012|NCT01307423|565165160|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156568013|NCT01307423|565165161|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
156568014|NCT01307423|565165162|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
156568015|NCT01307423|565165163|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156568016|NCT01307423|565165164|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156568017|NCT01307423|565165165|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156568018|NCT01307423|565165166|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156568019|NCT01307423|565165167|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156568020|NCT01307423|565165168|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156568021|NCT01307423|565165160|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
156568022|NCT01307423|565165161|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
156568023|NCT01307423|565165162|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
156568024|NCT01307423|565165163|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
156568025|NCT01307423|565165164|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
156568026|NCT01307423|565165165|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
156568027|NCT01307423|565165166|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
156568028|NCT01307423|565165167|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
156568029|NCT01307423|565165168|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
156568030|NCT01307423|565165160|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
156568031|NCT01307423|565165161|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
156568032|NCT01307423|565165162|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
156568033|NCT01307423|565165163|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
156568034|NCT01307423|565165164|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
156568035|NCT01307423|565165165|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
156568036|NCT01307423|565165166|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
156568037|NCT01307423|565165167|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
156568038|NCT01307423|565165168|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
156568039|NCT01307423|565165160|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
156568040|NCT01307423|565165161|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
156568041|NCT01307423|565165162|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
156568042|NCT01307423|565165163|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
156568043|NCT01307423|565165164|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
156568044|NCT01307423|565165165|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
156568045|NCT01307423|565165166|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
156568046|NCT01307423|565165167|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
156568047|NCT01307423|565165168|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
156568048|NCT01307423|565165160|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
156568049|NCT01307423|565165161|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
156568050|NCT01307423|565165162|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
156568051|NCT01307423|565165163|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
156568052|NCT01307423|565165164|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
156568053|NCT01307423|565165165|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
156568054|NCT01307423|565165166|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
156568055|NCT01307423|565165167|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
156568056|NCT01307423|565165168|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
156568057|NCT01307423|565165160|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
156568058|NCT01307423|565165161|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
156568059|NCT01307423|565165162|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
156568060|NCT01307423|565165163|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
156568061|NCT01307423|565165164|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
156568062|NCT01307423|565165165|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
156568063|NCT01307423|565165166|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
156568064|NCT01307423|565165167|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
156568065|NCT01307423|565165168|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
156568066|NCT01307423|565165160|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
156568067|NCT01307423|565165161|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
156568068|NCT01307423|565165162|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
156568069|NCT01307423|565165163|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
156568070|NCT01307423|565165164|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
156568071|NCT01307423|565165165|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
156568072|NCT01307423|565165166|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
156568073|NCT01307423|565165167|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
156568074|NCT01307423|565165168|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
156568075|NCT01307423|565165160|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
156568076|NCT01307423|565165161|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
156568077|NCT01307423|565165162|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
156568078|NCT01307423|565165163|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
156568079|NCT01307423|565165164|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
156568080|NCT01307423|565165165|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
156568081|NCT01307423|565165166|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
156568082|NCT01307423|565165167|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
156568083|NCT01307423|565165168|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
156568084|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156568085|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
156568086|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
156568087|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156568088|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156568089|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156568090|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156568091|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
156568092|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
156568093|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156568094|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
156568095|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
156568096|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156568097|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156568098|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156568099|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156568100|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
156568101|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
156568102|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
156568103|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
156568104|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
156568105|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
156568106|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
156568107|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
156568108|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
156568109|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
156568110|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
156568111|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156568112|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
156568113|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
156568114|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156568115|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156568116|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156568117|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156568118|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
156568119|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
156568120|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156568121|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
156568122|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156568123|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156568124|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156568125|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156568126|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156568127|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
156568128|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
156568129|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156568130|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
156568131|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
156568132|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156568133|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156568134|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156568135|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156568136|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
156568137|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
156568138|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156568139|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
156568140|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
156568141|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156568142|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156568143|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156568144|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156568145|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
156568146|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
156568147|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
156568148|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
156568149|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
156568150|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
156568151|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
156568152|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
156568153|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
156568154|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
156568155|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
156568156|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156568157|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
156568158|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
156568159|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156568160|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156568161|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156568162|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156568163|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
156568164|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
156568165|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156568166|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
156568167|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
156568168|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156568169|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156568170|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156568171|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156568172|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
156568173|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
156568174|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156568175|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
156568176|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156568177|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156568178|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156568179|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156568180|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156568181|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
156568182|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156568183|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156568184|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
156568185|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156568186|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156568187|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156568188|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156568189|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156568190|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156568191|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156568192|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156568193|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
156568194|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156568195|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156568196|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156568197|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156568198|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156568199|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156568200|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
156568201|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156568202|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
156568203|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
156568204|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156568205|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156568206|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156568207|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156568208|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
156568209|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
156568210|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156568211|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156568212|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
156568213|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156568214|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156568215|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156568216|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156568217|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156568218|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156568219|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156568220|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156568221|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156568222|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156568223|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156568224|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156568225|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156568226|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
156568227|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156568228|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156568229|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
156568230|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
156568231|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156568232|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156568233|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156568234|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156568235|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156568236|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
156568237|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156568238|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
156568239|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
156568240|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156568241|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156568242|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156568243|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156568244|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156568245|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156568246|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156568247|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
156568248|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
156568249|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156568250|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156568251|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156568252|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156568253|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156568254|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
156568255|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
156568256|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
156568257|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
156568258|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
156568259|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
156568260|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
156568261|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
156568262|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
156568263|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
156568264|NCT01307423|565165160|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156568265|NCT01307423|565165161|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156568266|NCT01307423|565165162|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
156568267|NCT01307423|565165163|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156568268|NCT01307423|565165164|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156568269|NCT01307423|565165165|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156568270|NCT01307423|565165166|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156568271|NCT01307423|565165167|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
156568272|NCT01307423|565165168|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
156568273|NCT03308188|565165169|FG000|Overall Study|Withdrawal by Subject|0|||
156568274|NCT03308188|565165170|FG001|Overall Study|Withdrawal by Subject|3|||
156568275|NCT03308188|565165169|FG000|Overall Study|Death|0|||
156568276|NCT03308188|565165170|FG001|Overall Study|Death|1|||
156568277|NCT01709331|565165171|FG000|Overall Study|Adverse Event|1|||
156568278|NCT00552110|565165172|FG000|Overall Study|Serious or Life-Threatening AE|0|||
156568279|NCT00552110|565165173|FG001|Overall Study|Serious or Life-Threatening AE|0|||
156568280|NCT00552110|565165174|FG002|Overall Study|Serious or Life-Threatening AE|1|||
156568281|NCT00552110|565165175|FG003|Overall Study|Serious or Life-Threatening AE|0|||
156568282|NCT00552110|565165176|FG004|Overall Study|Serious or Life-Threatening AE|0|||
156568283|NCT00552110|565165172|FG000|Overall Study|Lack of Efficacy|1|||
156568284|NCT00552110|565165173|FG001|Overall Study|Lack of Efficacy|0|||
156568285|NCT00552110|565165174|FG002|Overall Study|Lack of Efficacy|0|||
156568286|NCT00552110|565165175|FG003|Overall Study|Lack of Efficacy|1|||
156568287|NCT00552110|565165176|FG004|Overall Study|Lack of Efficacy|4|||
156568288|NCT00552110|565165172|FG000|Overall Study|Withdrawal by Subject|0|||
156568289|NCT00552110|565165173|FG001|Overall Study|Withdrawal by Subject|2|||
156568290|NCT00552110|565165174|FG002|Overall Study|Withdrawal by Subject|0|||
156568291|NCT00552110|565165175|FG003|Overall Study|Withdrawal by Subject|3|||
156568292|NCT00552110|565165176|FG004|Overall Study|Withdrawal by Subject|2|||
156568293|NCT00552110|565165172|FG000|Overall Study|Lost to Follow-up|0|||
156568294|NCT00552110|565165173|FG001|Overall Study|Lost to Follow-up|0|||
156568295|NCT00552110|565165174|FG002|Overall Study|Lost to Follow-up|0|||
156568296|NCT00552110|565165175|FG003|Overall Study|Lost to Follow-up|1|||
156568297|NCT00552110|565165176|FG004|Overall Study|Lost to Follow-up|1|||
156568298|NCT00552110|565165172|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
156568299|NCT00552110|565165173|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
156568300|NCT00552110|565165174|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
156568301|NCT00552110|565165175|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
156568302|NCT00552110|565165176|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
156568303|NCT00552110|565165172|FG000|Overall Study|Withdrawn per Sponsor|0|||
156568304|NCT00552110|565165173|FG001|Overall Study|Withdrawn per Sponsor|1|||
156568305|NCT00552110|565165174|FG002|Overall Study|Withdrawn per Sponsor|0|||
156568306|NCT00552110|565165175|FG003|Overall Study|Withdrawn per Sponsor|0|||
156568307|NCT00552110|565165176|FG004|Overall Study|Withdrawn per Sponsor|1|||
156568308|NCT00552110|565165172|FG000|Overall Study|Use of Prohibited Medication|1|||
156568309|NCT00552110|565165173|FG001|Overall Study|Use of Prohibited Medication|1|||
156568310|NCT00552110|565165174|FG002|Overall Study|Use of Prohibited Medication|0|||
156568311|NCT00552110|565165175|FG003|Overall Study|Use of Prohibited Medication|0|||
156568312|NCT00552110|565165176|FG004|Overall Study|Use of Prohibited Medication|0|||
156568313|NCT00552110|565165172|FG000|Overall Study|Delay of Study due to Relabeling|0|||
156568314|NCT00552110|565165173|FG001|Overall Study|Delay of Study due to Relabeling|0|||
156568315|NCT00552110|565165174|FG002|Overall Study|Delay of Study due to Relabeling|0|||
156568316|NCT00552110|565165175|FG003|Overall Study|Delay of Study due to Relabeling|1|||
156568317|NCT00552110|565165176|FG004|Overall Study|Delay of Study due to Relabeling|0|||
156568318|NCT00552110|565165172|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
156568319|NCT00552110|565165173|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
156568320|NCT00552110|565165174|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
156568321|NCT00552110|565165175|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
156568322|NCT00552110|565165176|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
156568323|NCT00552110|565165172|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
156568324|NCT00552110|565165173|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
156568325|NCT00552110|565165174|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
156568326|NCT00552110|565165175|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
156568327|NCT00552110|565165176|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
156568328|NCT02500537|565165178|FG000|Overall Study|Death|2|||
156568329|NCT02500537|565165179|FG001|Overall Study|Death|0|||
156568330|NCT02500537|565165178|FG000|Overall Study|Lost to Follow-up|0|||
156568331|NCT02500537|565165179|FG001|Overall Study|Lost to Follow-up|1|||
156568332|NCT02500537|565165178|FG000|Overall Study|Withdrawal by Subject|1|||
156568333|NCT02500537|565165179|FG001|Overall Study|Withdrawal by Subject|0|||
156568334|NCT00355121|565165180|FG000|Overall Study|Did not receive study vaccine|1|||
156568335|NCT00355121|565165181|FG001|Overall Study|Did not receive study vaccine|0|||
156568336|NCT00355121|565165182|FG002|Overall Study|Did not receive study vaccine|1|||
156568337|NCT00355121|565165180|FG000|Overall Study|Adverse Event|0|||
156568338|NCT00355121|565165181|FG001|Overall Study|Adverse Event|1|||
156568339|NCT00355121|565165182|FG002|Overall Study|Adverse Event|0|||
156568340|NCT00355121|565165180|FG000|Overall Study|Protocol Violation|7|||
156568341|NCT00355121|565165181|FG001|Overall Study|Protocol Violation|9|||
156568342|NCT00355121|565165182|FG002|Overall Study|Protocol Violation|1|||
156568343|NCT00355121|565165180|FG000|Overall Study|Lost to Follow-up|4|||
156568344|NCT00355121|565165181|FG001|Overall Study|Lost to Follow-up|7|||
156568345|NCT00355121|565165182|FG002|Overall Study|Lost to Follow-up|1|||
156568346|NCT00355121|565165180|FG000|Overall Study|Withdrawal by Subject|9|||
156568347|NCT00355121|565165181|FG001|Overall Study|Withdrawal by Subject|10|||
156568348|NCT00355121|565165182|FG002|Overall Study|Withdrawal by Subject|2|||
156568349|NCT00355121|565165180|FG000|Overall Study|Serious adverse events|0|||
156568350|NCT00355121|565165181|FG001|Overall Study|Serious adverse events|2|||
156568351|NCT00355121|565165182|FG002|Overall Study|Serious adverse events|0|||
156568352|NCT00655928|565165186|FG000|Overall Study|Withdrawal by Subject|2|||
156568353|NCT00655928|565165187|FG001|Overall Study|Withdrawal by Subject|1|||
156568354|NCT00655928|565165186|FG000|Overall Study|Physician Decision|1|||
156568355|NCT00655928|565165187|FG001|Overall Study|Physician Decision|1|||
156568356|NCT01587989|565165188|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
156568357|NCT01587989|565165189|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
156568358|NCT01587989|565165190|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
156568359|NCT01587989|565165188|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
156568360|NCT01587989|565165189|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
156568361|NCT01587989|565165190|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
156568362|NCT01587989|565165188|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
156568363|NCT01587989|565165189|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
156568364|NCT01587989|565165190|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
156568365|NCT01587989|565165188|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
156568366|NCT01587989|565165189|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
156568367|NCT01587989|565165190|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
156568368|NCT01587989|565165188|FG000|Randomized Study Treatment|Screening failure|0|||
156568369|NCT01587989|565165189|FG001|Randomized Study Treatment|Screening failure|1|||
156568370|NCT01587989|565165190|FG002|Randomized Study Treatment|Screening failure|0|||
156568371|NCT01587989|565165188|FG000|Randomized Study Treatment|Physician Decision|0|||
156568372|NCT01587989|565165189|FG001|Randomized Study Treatment|Physician Decision|0|||
156568373|NCT01587989|565165190|FG002|Randomized Study Treatment|Physician Decision|1|||
156568374|NCT03313050|565165192|FG000|Stage 2: 12 Months|Adverse Event|0|||
156568375|NCT03313050|565165193|FG001|Stage 2: 12 Months|Adverse Event|0|||
156568376|NCT03313050|565165194|FG002|Stage 2: 12 Months|Adverse Event|0|||
156568377|NCT03313050|565165195|FG003|Stage 2: 12 Months|Adverse Event|1|||
156568378|NCT03313050|565165192|FG000|Stage 2: 12 Months|Death|0|||
156568379|NCT03313050|565165193|FG001|Stage 2: 12 Months|Death|0|||
156568380|NCT03313050|565165194|FG002|Stage 2: 12 Months|Death|3|||
156568381|NCT03313050|565165195|FG003|Stage 2: 12 Months|Death|0|||
156568382|NCT03313050|565165192|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
156568383|NCT03313050|565165193|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
156568384|NCT03313050|565165194|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
156568385|NCT03313050|565165195|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
156568386|NCT03313050|565165192|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
156568387|NCT03313050|565165193|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
156568388|NCT03313050|565165194|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
156568389|NCT03313050|565165195|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
156568390|NCT03313050|565165192|FG000|Stage 2: 12 Months|Protocol deviation|0|||
156568391|NCT03313050|565165193|FG001|Stage 2: 12 Months|Protocol deviation|0|||
156568392|NCT03313050|565165194|FG002|Stage 2: 12 Months|Protocol deviation|7|||
156568393|NCT03313050|565165195|FG003|Stage 2: 12 Months|Protocol deviation|7|||
156568394|NCT03313050|565165192|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
156568395|NCT03313050|565165193|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
156568396|NCT03313050|565165194|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
156568397|NCT03313050|565165195|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
156568398|NCT03313050|565165192|FG000|Stage 2: 12 Months|Other|0|||
156568399|NCT03313050|565165193|FG001|Stage 2: 12 Months|Other|0|||
156568400|NCT03313050|565165194|FG002|Stage 2: 12 Months|Other|0|||
156568401|NCT03313050|565165195|FG003|Stage 2: 12 Months|Other|1|||
156568402|NCT04211337|565165196|FG000|Overall Study|On Treatment|175|||
156568403|NCT04211337|565165197|FG001|Overall Study|On Treatment|40|||
156568404|NCT04211337|565165196|FG000|Overall Study|Withdrawal by Subject|0|||
156568405|NCT04211337|565165197|FG001|Overall Study|Withdrawal by Subject|2|||
156568406|NCT01291017|565165204|FG000|Overall Study|Lost to Follow-up|2|||
156568407|NCT01291017|565165204|FG000|Overall Study|Withdrawal by Subject|3|||
156568408|NCT04980391|565165205|FG000|Overall Study|Death|0|||
156568409|NCT04980391|565165206|FG001|Overall Study|Death|0|||
156568410|NCT04980391|565165207|FG002|Overall Study|Death|1|||
156568411|NCT04980391|565165208|FG003|Overall Study|Death|1|||
156568412|NCT04980391|565165205|FG000|Overall Study|Lost to Follow-up|3|||
156568413|NCT04980391|565165206|FG001|Overall Study|Lost to Follow-up|3|||
156568414|NCT04980391|565165207|FG002|Overall Study|Lost to Follow-up|2|||
156568415|NCT04980391|565165208|FG003|Overall Study|Lost to Follow-up|3|||
156568416|NCT04980391|565165205|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
156568417|NCT04980391|565165206|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
156568418|NCT04980391|565165207|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
156568419|NCT04980391|565165208|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
156568420|NCT04980391|565165205|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156568421|NCT04980391|565165206|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156568422|NCT04980391|565165207|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156568423|NCT04980391|565165208|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156568424|NCT04980391|565165205|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
156568425|NCT04980391|565165206|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
156568426|NCT04980391|565165207|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
156568427|NCT04980391|565165208|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
156568428|NCT03323749|565168148|FG000|Double-blind Period|Lost to Follow-up|4|||
156568429|NCT03323749|565168149|FG001|Double-blind Period|Lost to Follow-up|5|||
156568430|NCT03323749|565168148|FG000|Double-blind Period|Adverse Event|3|||
156568431|NCT03323749|565168149|FG001|Double-blind Period|Adverse Event|1|||
156568432|NCT03323749|565168148|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
156568433|NCT03323749|565168149|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
156568434|NCT03323749|565168148|FG000|Open-Label Period|Adverse Event|3|||
156568435|NCT03323749|565168149|FG001|Open-Label Period|Adverse Event|10|||
156568436|NCT03323749|565168148|FG000|Open-Label Period|Withdrawal by Subject|7|||
156568437|NCT03323749|565168149|FG001|Open-Label Period|Withdrawal by Subject|5|||
156568438|NCT01821963|565168150|FG000|Overall Study|Adverse Event|1|||
156568439|NCT00783289|565168151|FG000|Overall Study|Protocol Violation|0|||
156568440|NCT00783289|565168152|FG001|Overall Study|Protocol Violation|1|||
156568441|NCT00783289|565168153|FG002|Overall Study|Protocol Violation|0|||
156568442|NCT00783289|565168154|FG003|Overall Study|Protocol Violation|0|||
156568443|NCT00506389|565168155|FG000|In-treatment Period|Other|3|||
156568444|NCT00506389|565168156|FG001|In-treatment Period|Other|3|||
156568445|NCT00506389|565168157|FG002|In-treatment Period|Other|4|||
156568446|NCT00506389|565168155|FG000|In-treatment Period|Lost to Follow-up|0|||
156568447|NCT00506389|565168156|FG001|In-treatment Period|Lost to Follow-up|0|||
156568448|NCT00506389|565168157|FG002|In-treatment Period|Lost to Follow-up|1|||
156568449|NCT00506389|565168155|FG000|In-treatment Period|Lack of compliance|1|||
156568450|NCT00506389|565168156|FG001|In-treatment Period|Lack of compliance|0|||
156568451|NCT00506389|565168157|FG002|In-treatment Period|Lack of compliance|0|||
156568452|NCT00506389|565168155|FG000|In-treatment Period|Reasons not related to trial|4|||
156568453|NCT00506389|565168156|FG001|In-treatment Period|Reasons not related to trial|1|||
156568454|NCT00506389|565168157|FG002|In-treatment Period|Reasons not related to trial|0|||
156568455|NCT00506389|565168155|FG000|In-treatment Period|Withdrawal by Subject|3|||
156568456|NCT00506389|565168156|FG001|In-treatment Period|Withdrawal by Subject|3|||
156568457|NCT00506389|565168157|FG002|In-treatment Period|Withdrawal by Subject|4|||
156568458|NCT00506389|565168155|FG000|In-treatment Period|Lack of Efficacy|0|||
156568459|NCT00506389|565168156|FG001|In-treatment Period|Lack of Efficacy|2|||
156568460|NCT00506389|565168157|FG002|In-treatment Period|Lack of Efficacy|0|||
156568461|NCT00506389|565168155|FG000|In-treatment Period|Adverse Event|11|||
156568462|NCT00506389|565168156|FG001|In-treatment Period|Adverse Event|5|||
156568463|NCT00506389|565168157|FG002|In-treatment Period|Adverse Event|2|||
156568464|NCT00506389|565168155|FG000|In-treatment Period|Randomized but not treated|4|||
156568465|NCT00506389|565168156|FG001|In-treatment Period|Randomized but not treated|1|||
156568466|NCT00506389|565168157|FG002|In-treatment Period|Randomized but not treated|1|||
156568467|NCT03095703|565168160|FG000|Overall Study|Withdrawal by Subject|1|||
156568468|NCT03539432|565168161|FG000|Overall Study|Lost to Follow-up|0|||
156568469|NCT03539432|565168162|FG001|Overall Study|Lost to Follow-up|1|||
156568470|NCT01381094|565168163|FG000|Overall Study|Adverse Event|1|||
156568471|NCT01381094|565168164|FG001|Overall Study|Adverse Event|2|||
156568472|NCT01381094|565168165|FG002|Overall Study|Adverse Event|0|||
156568473|NCT01381094|565168166|FG003|Overall Study|Adverse Event|1|||
156568474|NCT01381094|565168167|FG004|Overall Study|Adverse Event|0|||
156568475|NCT01381094|565168163|FG000|Overall Study|Lost to Follow-up|0|||
156568476|NCT01381094|565168164|FG001|Overall Study|Lost to Follow-up|0|||
156568477|NCT01381094|565168165|FG002|Overall Study|Lost to Follow-up|0|||
156568478|NCT01381094|565168166|FG003|Overall Study|Lost to Follow-up|0|||
156568479|NCT01381094|565168167|FG004|Overall Study|Lost to Follow-up|1|||
156568480|NCT01381094|565168163|FG000|Overall Study|Withdrawal of informed consent|0|||
156568481|NCT01381094|565168164|FG001|Overall Study|Withdrawal of informed consent|1|||
156568482|NCT01381094|565168165|FG002|Overall Study|Withdrawal of informed consent|0|||
156568483|NCT01381094|565168166|FG003|Overall Study|Withdrawal of informed consent|0|||
156568484|NCT01381094|565168167|FG004|Overall Study|Withdrawal of informed consent|0|||
156568485|NCT01381094|565168163|FG000|Overall Study|Participant given Aranesp injection|1|||
156568486|NCT01381094|565168164|FG001|Overall Study|Participant given Aranesp injection|0|||
156568487|NCT01381094|565168165|FG002|Overall Study|Participant given Aranesp injection|0|||
156568488|NCT01381094|565168166|FG003|Overall Study|Participant given Aranesp injection|0|||
156568489|NCT01381094|565168167|FG004|Overall Study|Participant given Aranesp injection|0|||
156568490|NCT01934504|565168177|FG000|Overall Study|Protocol Deviation|0|||
156568491|NCT01934504|565168178|FG001|Overall Study|Protocol Deviation|0|||
156568492|NCT01934504|565168179|FG002|Overall Study|Protocol Deviation|0|||
156568493|NCT01934504|565168180|FG003|Overall Study|Protocol Deviation|2|||
156568494|NCT01934504|565168177|FG000|Overall Study|Study Terminated by Sponsor|1|||
156568495|NCT01934504|565168178|FG001|Overall Study|Study Terminated by Sponsor|0|||
156568496|NCT01934504|565168179|FG002|Overall Study|Study Terminated by Sponsor|5|||
156568497|NCT01934504|565168180|FG003|Overall Study|Study Terminated by Sponsor|5|||
156568498|NCT02665689|565168181|FG000|Overall Study|Adverse Event|1|||
156568499|NCT02665689|565168182|FG001|Overall Study|Adverse Event|0|||
156568500|NCT02665689|565168181|FG000|Overall Study|Trial termination|1|||
156568501|NCT02665689|565168182|FG001|Overall Study|Trial termination|1|||
156568502|NCT02665689|565168181|FG000|Overall Study|Lost to Follow-up|0|||
156568503|NCT02665689|565168182|FG001|Overall Study|Lost to Follow-up|1|||
156568504|NCT00824564|565168183|FG000|Overall Study|Lost to Follow-up|5|||
156568505|NCT00824564|565168184|FG001|Overall Study|Lost to Follow-up|7|||
156568506|NCT00824564|565168183|FG000|Overall Study|Withdrawal by Subject|1|||
156568507|NCT00824564|565168184|FG001|Overall Study|Withdrawal by Subject|1|||
156568508|NCT00824564|565168183|FG000|Overall Study|Other|1|||
156568509|NCT00824564|565168184|FG001|Overall Study|Other|2|||
156568510|NCT00824564|565168183|FG000|Overall Study|Randomized, but not treated|1|||
156568511|NCT00824564|565168184|FG001|Overall Study|Randomized, but not treated|0|||
156568512|NCT00996840|565168193|FG000|Overall Study|Adverse Event|0|||
156568513|NCT00996840|565168194|FG001|Overall Study|Adverse Event|1|||
156568514|NCT00996840|565168195|FG002|Overall Study|Adverse Event|0|||
156568515|NCT00996840|565168196|FG003|Overall Study|Adverse Event|0|||
156568516|NCT00996840|565168197|FG004|Overall Study|Adverse Event|0|||
156568517|NCT00996840|565168193|FG000|Overall Study|Physician Decision|0|||
156568518|NCT00996840|565168194|FG001|Overall Study|Physician Decision|0|||
156568519|NCT00996840|565168195|FG002|Overall Study|Physician Decision|1|||
156568520|NCT00996840|565168196|FG003|Overall Study|Physician Decision|1|||
156568521|NCT00996840|565168197|FG004|Overall Study|Physician Decision|2|||
156568522|NCT00996840|565168193|FG000|Overall Study|Withdrawal by Subject|1|||
156568523|NCT00996840|565168194|FG001|Overall Study|Withdrawal by Subject|1|||
156568524|NCT00996840|565168195|FG002|Overall Study|Withdrawal by Subject|0|||
156568525|NCT00996840|565168196|FG003|Overall Study|Withdrawal by Subject|0|||
156568526|NCT00996840|565168197|FG004|Overall Study|Withdrawal by Subject|0|||
156568527|NCT00603239|565168198|FG000|Overall Study|Adverse Event|4|||
156568528|NCT00603239|565168199|FG001|Overall Study|Adverse Event|1|||
156568529|NCT00603239|565168198|FG000|Overall Study|Entry criteria not met|0|||
156568530|NCT00603239|565168199|FG001|Overall Study|Entry criteria not met|1|||
156568531|NCT00603239|565168198|FG000|Overall Study|Loss of glucose control|3|||
156568532|NCT00603239|565168199|FG001|Overall Study|Loss of glucose control|0|||
156568533|NCT00603239|565168198|FG000|Overall Study|Lost to Follow-up|2|||
156568534|NCT00603239|565168199|FG001|Overall Study|Lost to Follow-up|1|||
156568535|NCT00603239|565168198|FG000|Overall Study|Physician Decision|2|||
156568536|NCT00603239|565168199|FG001|Overall Study|Physician Decision|0|||
156568537|NCT00603239|565168198|FG000|Overall Study|Protocol Violation|2|||
156568538|NCT00603239|565168199|FG001|Overall Study|Protocol Violation|0|||
156568539|NCT00603239|565168198|FG000|Overall Study|Subject decision|2|||
156568540|NCT00603239|565168199|FG001|Overall Study|Subject decision|1|||
156568541|NCT02292849|565168200|FG000|Overall Study|Lost to Follow-up|0|||
156568542|NCT02292849|565168201|FG001|Overall Study|Lost to Follow-up|2|||
156568543|NCT02292849|565168202|FG002|Overall Study|Lost to Follow-up|2|||
156568544|NCT02292849|565168200|FG000|Overall Study|Physician Decision|4|||
156568545|NCT02292849|565168201|FG001|Overall Study|Physician Decision|0|||
156568546|NCT02292849|565168202|FG002|Overall Study|Physician Decision|0|||
156568547|NCT04125680|565168204|FG000|Overall Study|Lost to Follow-up|15|||
156568548|NCT01562028|565168205|FG000|Overall Study|Withdrawal by Subject|1|||
156568549|NCT01562028|565168206|FG001|Overall Study|Withdrawal by Subject|1|||
156568550|NCT01562028|565168205|FG000|Overall Study|Lost to Follow-up|2|||
156568551|NCT01562028|565168206|FG001|Overall Study|Lost to Follow-up|1|||
156568552|NCT00097539|565168207|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
156568553|NCT00097539|565168208|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
156568554|NCT00097539|565168209|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
156568555|NCT00097539|565168210|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
156568556|NCT00097539|565168211|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
156568557|NCT00097539|565168212|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
156568558|NCT00097539|565168213|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
156568559|NCT00097539|565168207|FG000|Overall Study|Withdrawal by Subject|925|||
156568560|NCT00097539|565168208|FG001|Overall Study|Withdrawal by Subject|323|||
156568561|NCT00097539|565168209|FG002|Overall Study|Withdrawal by Subject|346|||
156568562|NCT00097539|565168210|FG003|Overall Study|Withdrawal by Subject|217|||
156568563|NCT00097539|565168211|FG004|Overall Study|Withdrawal by Subject|68|||
156568564|NCT00097539|565168212|FG005|Overall Study|Withdrawal by Subject|229|||
156568565|NCT00097539|565168213|FG006|Overall Study|Withdrawal by Subject|3|||
156568566|NCT00097539|565168207|FG000|Overall Study|Participant Non-compliant|2140|||
156568567|NCT00097539|565168208|FG001|Overall Study|Participant Non-compliant|567|||
156568568|NCT00097539|565168209|FG002|Overall Study|Participant Non-compliant|1067|||
156568569|NCT00097539|565168210|FG003|Overall Study|Participant Non-compliant|353|||
156568570|NCT00097539|565168211|FG004|Overall Study|Participant Non-compliant|136|||
156568571|NCT00097539|565168212|FG005|Overall Study|Participant Non-compliant|543|||
156568572|NCT00097539|565168213|FG006|Overall Study|Participant Non-compliant|18|||
156568573|NCT00097539|565168207|FG000|Overall Study|Lack of Efficacy|249|||
156568574|NCT00097539|565168208|FG001|Overall Study|Lack of Efficacy|122|||
156568575|NCT00097539|565168209|FG002|Overall Study|Lack of Efficacy|202|||
156568576|NCT00097539|565168210|FG003|Overall Study|Lack of Efficacy|105|||
156568577|NCT00097539|565168211|FG004|Overall Study|Lack of Efficacy|45|||
156568578|NCT00097539|565168212|FG005|Overall Study|Lack of Efficacy|228|||
156568579|NCT00097539|565168213|FG006|Overall Study|Lack of Efficacy|5|||
156568580|NCT00097539|565168207|FG000|Overall Study|Adverse Event|78|||
156568581|NCT00097539|565168208|FG001|Overall Study|Adverse Event|133|||
156568582|NCT00097539|565168209|FG002|Overall Study|Adverse Event|37|||
156568583|NCT00097539|565168210|FG003|Overall Study|Adverse Event|27|||
156568584|NCT00097539|565168211|FG004|Overall Study|Adverse Event|30|||
156568585|NCT00097539|565168212|FG005|Overall Study|Adverse Event|59|||
156568586|NCT00097539|565168213|FG006|Overall Study|Adverse Event|1|||
156568587|NCT00097539|565168207|FG000|Overall Study|Death|2|||
156568588|NCT00097539|565168208|FG001|Overall Study|Death|7|||
156568589|NCT00097539|565168209|FG002|Overall Study|Death|0|||
156568590|NCT00097539|565168210|FG003|Overall Study|Death|0|||
156568591|NCT00097539|565168211|FG004|Overall Study|Death|1|||
156568592|NCT00097539|565168212|FG005|Overall Study|Death|3|||
156568593|NCT00097539|565168213|FG006|Overall Study|Death|0|||
156568594|NCT00097539|565168207|FG000|Overall Study|Reasons Other Than Above|3602|||
156568595|NCT00097539|565168208|FG001|Overall Study|Reasons Other Than Above|1382|||
156568596|NCT00097539|565168209|FG002|Overall Study|Reasons Other Than Above|1757|||
156568597|NCT00097539|565168210|FG003|Overall Study|Reasons Other Than Above|692|||
156568598|NCT00097539|565168211|FG004|Overall Study|Reasons Other Than Above|361|||
156568599|NCT00097539|565168212|FG005|Overall Study|Reasons Other Than Above|1244|||
156568600|NCT00097539|565168213|FG006|Overall Study|Reasons Other Than Above|34|||
156568601|NCT00097539|565168207|FG000|Overall Study|Reason not Specified|111|||
156568602|NCT00097539|565168208|FG001|Overall Study|Reason not Specified|49|||
156568603|NCT00097539|565168209|FG002|Overall Study|Reason not Specified|53|||
156568604|NCT00097539|565168210|FG003|Overall Study|Reason not Specified|21|||
156568605|NCT00097539|565168211|FG004|Overall Study|Reason not Specified|11|||
156568606|NCT00097539|565168212|FG005|Overall Study|Reason not Specified|40|||
156568607|NCT00097539|565168213|FG006|Overall Study|Reason not Specified|2|||
156568608|NCT04938648|565168214|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
156568609|NCT04938648|565168215|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
156568610|NCT04938648|565168214|FG000|Overall Study|Patient too ill|0|||
156568611|NCT04938648|565168215|FG001|Overall Study|Patient too ill|1|||
156568612|NCT04938648|565168214|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
156568613|NCT04938648|565168215|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
156568614|NCT04938648|565168214|FG000|Overall Study|Patient did not have memory problems|1|||
156568615|NCT04938648|565168215|FG001|Overall Study|Patient did not have memory problems|1|||
156568616|NCT04938648|565168214|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
156568617|NCT04938648|565168215|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
156568618|NCT04938648|565168214|FG000|Overall Study|Care partner could not be reached|0|||
156568619|NCT04938648|565168215|FG001|Overall Study|Care partner could not be reached|1|||
156568620|NCT04938648|565168214|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
156568621|NCT04938648|565168215|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
156568622|NCT04938648|565168214|FG000|Overall Study|Withdrawal by Subject|2|||
156568623|NCT04938648|565168215|FG001|Overall Study|Withdrawal by Subject|1|||
156568624|NCT00364793|565168216|FG000|Overall Study|Adverse Event|2|||
156568625|NCT00364793|565168217|FG001|Overall Study|Adverse Event|0|||
156568626|NCT00364793|565168218|FG002|Overall Study|Adverse Event|0|||
156568627|NCT00364793|565168219|FG003|Overall Study|Adverse Event|0|||
156568628|NCT00364793|565168216|FG000|Overall Study|Death|1|||
156568629|NCT00364793|565168217|FG001|Overall Study|Death|0|||
156568630|NCT00364793|565168218|FG002|Overall Study|Death|1|||
156568631|NCT00364793|565168219|FG003|Overall Study|Death|0|||
156568632|NCT00364793|565168216|FG000|Overall Study|Lack of Efficacy|3|||
156568633|NCT00364793|565168217|FG001|Overall Study|Lack of Efficacy|3|||
156568634|NCT00364793|565168218|FG002|Overall Study|Lack of Efficacy|1|||
156568635|NCT00364793|565168219|FG003|Overall Study|Lack of Efficacy|1|||
156568636|NCT00364793|565168216|FG000|Overall Study|Lost to Follow-up|1|||
156568637|NCT00364793|565168217|FG001|Overall Study|Lost to Follow-up|0|||
156568638|NCT00364793|565168218|FG002|Overall Study|Lost to Follow-up|2|||
156568639|NCT00364793|565168219|FG003|Overall Study|Lost to Follow-up|0|||
156568640|NCT00364793|565168216|FG000|Overall Study|Poor or non-compliance|1|||
156568641|NCT00364793|565168217|FG001|Overall Study|Poor or non-compliance|1|||
156568642|NCT00364793|565168218|FG002|Overall Study|Poor or non-compliance|0|||
156568643|NCT00364793|565168219|FG003|Overall Study|Poor or non-compliance|1|||
156568644|NCT00364793|565168216|FG000|Overall Study|No longer meets criteria|0|||
156568645|NCT00364793|565168217|FG001|Overall Study|No longer meets criteria|0|||
156568646|NCT00364793|565168218|FG002|Overall Study|No longer meets criteria|0|||
156568647|NCT00364793|565168219|FG003|Overall Study|No longer meets criteria|1|||
156568648|NCT00364793|565168216|FG000|Overall Study|Withdrawal by Subject|0|||
156568649|NCT00364793|565168217|FG001|Overall Study|Withdrawal by Subject|1|||
156568650|NCT00364793|565168218|FG002|Overall Study|Withdrawal by Subject|0|||
156568651|NCT00364793|565168219|FG003|Overall Study|Withdrawal by Subject|0|||
156568652|NCT00391976|565168220|FG000|Overall Study|Adverse Event|0|||
156568653|NCT00391976|565168221|FG001|Overall Study|Adverse Event|0|||
156568654|NCT00391976|565168222|FG002|Overall Study|Adverse Event|1|||
156568655|NCT00391976|565168220|FG000|Overall Study|Withdrawal of consent|0|||
156568656|NCT00391976|565168221|FG001|Overall Study|Withdrawal of consent|1|||
156568657|NCT00391976|565168222|FG002|Overall Study|Withdrawal of consent|1|||
156568658|NCT00391976|565168220|FG000|Overall Study|Lost to Follow-up|1|||
156568659|NCT00391976|565168221|FG001|Overall Study|Lost to Follow-up|2|||
156568660|NCT00391976|565168222|FG002|Overall Study|Lost to Follow-up|0|||
156568661|NCT00391976|565168220|FG000|Overall Study|Inappropriate enrollment|1|||
156568662|NCT00391976|565168221|FG001|Overall Study|Inappropriate enrollment|1|||
156568663|NCT00391976|565168222|FG002|Overall Study|Inappropriate enrollment|0|||
156568664|NCT00391976|565168220|FG000|Overall Study|Protocol deviation/violation|4|||
156568665|NCT00391976|565168221|FG001|Overall Study|Protocol deviation/violation|2|||
156568666|NCT00391976|565168222|FG002|Overall Study|Protocol deviation/violation|1|||
156568667|NCT00391976|565168220|FG000|Overall Study|Recurrence/no eradication of infection|21|||
156568668|NCT00391976|565168221|FG001|Overall Study|Recurrence/no eradication of infection|19|||
156568669|NCT00391976|565168222|FG002|Overall Study|Recurrence/no eradication of infection|0|||
156568670|NCT00391976|565168220|FG000|Overall Study|Unable to classify|0|||
156568671|NCT00391976|565168221|FG001|Overall Study|Unable to classify|0|||
156568672|NCT00391976|565168222|FG002|Overall Study|Unable to classify|1|||
156568673|NCT00391976|565168220|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
156568674|NCT00391976|565168221|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
156568675|NCT00391976|565168222|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
156568676|NCT05127486|565168223|FG000|Overall Study|Adverse Event|2|||
156568677|NCT05127486|565168224|FG001|Overall Study|Adverse Event|4|||
156568678|NCT05127486|565168223|FG000|Overall Study|Lack of Efficacy|1|||
156568679|NCT05127486|565168224|FG001|Overall Study|Lack of Efficacy|0|||
156568680|NCT05127486|565168223|FG000|Overall Study|Pregnancy|0|||
156568681|NCT05127486|565168224|FG001|Overall Study|Pregnancy|1|||
156568682|NCT05127486|565168223|FG000|Overall Study|Physician Decision|4|||
156568683|NCT05127486|565168224|FG001|Overall Study|Physician Decision|1|||
156568684|NCT05127486|565168223|FG000|Overall Study|Withdrawal by Subject|14|||
156568685|NCT05127486|565168224|FG001|Overall Study|Withdrawal by Subject|13|||
156568686|NCT05127486|565168223|FG000|Overall Study|Lost to Follow-up|5|||
156568687|NCT05127486|565168224|FG001|Overall Study|Lost to Follow-up|8|||
156568688|NCT02582515|565168225|FG000|Overall Study|Withdrawal by Subject|0|||
156568689|NCT02582515|565168226|FG001|Overall Study|Withdrawal by Subject|1|||
156568690|NCT00363415|565168227|FG000|Overall Study|Progressive Disease|196|||
156568691|NCT00363415|565168228|FG001|Overall Study|Progressive Disease|107|||
156568692|NCT00363415|565168227|FG000|Overall Study|Sponsor Decision|67|||
156568693|NCT00363415|565168228|FG001|Overall Study|Sponsor Decision|31|||
156568694|NCT00363415|565168227|FG000|Overall Study|Death|32|||
156568695|NCT00363415|565168228|FG001|Overall Study|Death|29|||
156568696|NCT00363415|565168227|FG000|Overall Study|Adverse Event|24|||
156568697|NCT00363415|565168228|FG001|Overall Study|Adverse Event|15|||
156568698|NCT00363415|565168227|FG000|Overall Study|Physician Decision|18|||
156568699|NCT00363415|565168228|FG001|Overall Study|Physician Decision|35|||
156568700|NCT00363415|565168227|FG000|Overall Study|Entry Criteria Not Met|11|||
156568701|NCT00363415|565168228|FG001|Overall Study|Entry Criteria Not Met|10|||
156568702|NCT00363415|565168227|FG000|Overall Study|Withdrawal by Subject|9|||
156568703|NCT00363415|565168228|FG001|Overall Study|Withdrawal by Subject|15|||
156568704|NCT00363415|565168227|FG000|Overall Study|Lost to Follow-up|3|||
156568705|NCT00363415|565168228|FG001|Overall Study|Lost to Follow-up|3|||
156568706|NCT00363415|565168227|FG000|Overall Study|Protocol Violation|1|||
156568707|NCT00363415|565168228|FG001|Overall Study|Protocol Violation|4|||
156568708|NCT01287754|565168231|FG000|Overall Study|Death|2|||
156568709|NCT01287754|565168232|FG001|Overall Study|Death|12|||
156568710|NCT01287754|565168231|FG000|Overall Study|Lost to Follow-up|1|||
156568711|NCT01287754|565168232|FG001|Overall Study|Lost to Follow-up|6|||
156568712|NCT01287754|565168231|FG000|Overall Study|Protocol Violation|0|||
156568713|NCT01287754|565168232|FG001|Overall Study|Protocol Violation|3|||
156568714|NCT05027802|565168243|FG000|Overall Study|Adverse Event|2|||
156568715|NCT05027802|565168243|FG000|Overall Study|Withdrawal by Subject|18|||
156568716|NCT05027802|565168243|FG000|Overall Study|Death|2|||
156568717|NCT05027802|565168243|FG000|Overall Study|Other|1|||
156568718|NCT00001337|565168250|FG000|Overall Study|Switched to alternate treatment|2|||
156568719|NCT00001337|565168251|FG001|Overall Study|Switched to alternate treatment|2|||
156568720|NCT00001337|565168252|FG002|Overall Study|Switched to alternate treatment|0|||
156568721|NCT00001337|565168250|FG000|Overall Study|Refused further treatment|2|||
156568722|NCT00001337|565168251|FG001|Overall Study|Refused further treatment|1|||
156568723|NCT00001337|565168252|FG002|Overall Study|Refused further treatment|0|||
156568724|NCT00001337|565168250|FG000|Overall Study|Began other Tx|1|||
156568725|NCT00001337|565168251|FG001|Overall Study|Began other Tx|0|||
156568726|NCT00001337|565168252|FG002|Overall Study|Began other Tx|0|||
156568727|NCT00001337|565168250|FG000|Overall Study|Physician Decision|3|||
156568728|NCT00001337|565168251|FG001|Overall Study|Physician Decision|1|||
156568729|NCT00001337|565168252|FG002|Overall Study|Physician Decision|0|||
156568730|NCT00001337|565168250|FG000|Overall Study|Doesn't have NHL|0|||
156568731|NCT00001337|565168251|FG001|Overall Study|Doesn't have NHL|1|||
156568732|NCT00001337|565168252|FG002|Overall Study|Doesn't have NHL|0|||
156568733|NCT00001337|565168250|FG000|Overall Study|Non protocol tx needed|3|||
156568734|NCT00001337|565168251|FG001|Overall Study|Non protocol tx needed|1|||
156568735|NCT00001337|565168252|FG002|Overall Study|Non protocol tx needed|0|||
156568736|NCT00001337|565168250|FG000|Overall Study|Protocol change|1|||
156568737|NCT00001337|565168251|FG001|Overall Study|Protocol change|0|||
156568738|NCT00001337|565168252|FG002|Overall Study|Protocol change|0|||
156568739|NCT00001337|565168250|FG000|Overall Study|2nd primary disease|0|||
156568740|NCT00001337|565168251|FG001|Overall Study|2nd primary disease|0|||
156568741|NCT00001337|565168252|FG002|Overall Study|2nd primary disease|1|||
156568742|NCT00001337|565168250|FG000|Overall Study|Death during follow up period|9|||
156568743|NCT00001337|565168251|FG001|Overall Study|Death during follow up period|4|||
156568744|NCT00001337|565168252|FG002|Overall Study|Death during follow up period|0|||
156568745|NCT00001337|565168250|FG000|Overall Study|Death on study|19|||
156568746|NCT00001337|565168251|FG001|Overall Study|Death on study|9|||
156568747|NCT00001337|565168252|FG002|Overall Study|Death on study|0|||
156568748|NCT00001337|565168250|FG000|Overall Study|Disease progression during follow-up period|3|||
156568749|NCT00001337|565168251|FG001|Overall Study|Disease progression during follow-up period|1|||
156568750|NCT00001337|565168252|FG002|Overall Study|Disease progression during follow-up period|0|||
156568751|NCT00001337|565168250|FG000|Overall Study|Disease progression on study|33|||
156568752|NCT00001337|565168251|FG001|Overall Study|Disease progression on study|41|||
156568753|NCT00001337|565168252|FG002|Overall Study|Disease progression on study|0|||
156568754|NCT00001337|565168250|FG000|Overall Study|Lost to further follow-up|10|||
156568755|NCT00001337|565168251|FG001|Overall Study|Lost to further follow-up|6|||
156568756|NCT00001337|565168252|FG002|Overall Study|Lost to further follow-up|0|||
156568757|NCT00001337|565168250|FG000|Overall Study|2nd malignancy|1|||
156568758|NCT00001337|565168251|FG001|Overall Study|2nd malignancy|0|||
156568759|NCT00001337|565168252|FG002|Overall Study|2nd malignancy|0|||
156568760|NCT00001337|565168250|FG000|Overall Study|Treatment for second lymphoma|0|||
156568761|NCT00001337|565168251|FG001|Overall Study|Treatment for second lymphoma|1|||
156568762|NCT00001337|565168252|FG002|Overall Study|Treatment for second lymphoma|0|||
156568763|NCT00001337|565168250|FG000|Overall Study|Transfer to transplant|0|||
156568764|NCT00001337|565168251|FG001|Overall Study|Transfer to transplant|1|||
156568765|NCT00001337|565168252|FG002|Overall Study|Transfer to transplant|0|||
156568766|NCT05817045|565168257|FG000|Overall Study|Protocol Violation|0|||
156568767|NCT05817045|565168258|FG001|Overall Study|Protocol Violation|3|||
156568768|NCT05817045|565168257|FG000|Overall Study|Withdrawal by Subject|10|||
156568769|NCT05817045|565168258|FG001|Overall Study|Withdrawal by Subject|7|||
156568770|NCT05817045|565168257|FG000|Overall Study|Physician Decision|3|||
156568771|NCT05817045|565168258|FG001|Overall Study|Physician Decision|0|||
156568772|NCT05817045|565168257|FG000|Overall Study|Lost to Follow-up|0|||
156568773|NCT05817045|565168258|FG001|Overall Study|Lost to Follow-up|1|||
156568774|NCT05817045|565168257|FG000|Overall Study|Device Deficiency|1|||
156568775|NCT05817045|565168258|FG001|Overall Study|Device Deficiency|0|||
156568776|NCT05817045|565168257|FG000|Overall Study|System Error|1|||
156568777|NCT05817045|565168258|FG001|Overall Study|System Error|0|||
156568778|NCT01506141|565168259|FG000|Overall Study|Adverse Event|0|||
156568779|NCT01506141|565168260|FG001|Overall Study|Adverse Event|2|||
156568780|NCT01506141|565168259|FG000|Overall Study|Participation Terminated by Investigator|1|||
156568781|NCT01506141|565168260|FG001|Overall Study|Participation Terminated by Investigator|1|||
156568782|NCT01506141|565168259|FG000|Overall Study|Site Terminated by Sponsor|2|||
156568783|NCT01506141|565168260|FG001|Overall Study|Site Terminated by Sponsor|0|||
156568784|NCT01506141|565168259|FG000|Overall Study|Reason Not Specified|4|||
156568785|NCT01506141|565168260|FG001|Overall Study|Reason Not Specified|2|||
156568786|NCT04889209|565168261|FG000|All Cohorts Except 15E|Adverse Event|0|||
156568787|NCT04889209|565168262|FG001|All Cohorts Except 15E|Adverse Event|0|||
156568788|NCT04889209|565168263|FG002|All Cohorts Except 15E|Adverse Event|0|||
156568789|NCT04889209|565168264|FG003|All Cohorts Except 15E|Adverse Event|0|||
156568790|NCT04889209|565168265|FG004|All Cohorts Except 15E|Adverse Event|0|||
156568791|NCT04889209|565168266|FG005|All Cohorts Except 15E|Adverse Event|0|||
156568792|NCT04889209|565168267|FG006|All Cohorts Except 15E|Adverse Event|1|||
156568793|NCT04889209|565168268|FG007|All Cohorts Except 15E|Adverse Event|0|||
156568794|NCT04889209|565168269|FG008|All Cohorts Except 15E|Adverse Event|0|||
156568795|NCT04889209|565168270|FG009|All Cohorts Except 15E|Adverse Event|0|||
156568796|NCT04889209|565168271|FG010|All Cohorts Except 15E|Adverse Event|0|||
156568797|NCT04889209|565168272|FG011|All Cohorts Except 15E|Adverse Event|0|||
156568798|NCT04889209|565168273|FG012|All Cohorts Except 15E|Adverse Event|0|||
156568799|NCT04889209|565168274|FG013|All Cohorts Except 15E|Adverse Event|0|||
156568800|NCT04889209|565168275|FG014|All Cohorts Except 15E|Adverse Event|0|||
156568801|NCT04889209|565168276|FG015|All Cohorts Except 15E|Adverse Event|0|||
156568802|NCT04889209|565168277|FG016|All Cohorts Except 15E|Adverse Event|0|||
156568803|NCT04889209|565168278|FG017|All Cohorts Except 15E|Adverse Event|0|||
156568804|NCT04889209|565168261|FG000|All Cohorts Except 15E|Death|0|||
156568805|NCT04889209|565168262|FG001|All Cohorts Except 15E|Death|1|||
156568806|NCT04889209|565168263|FG002|All Cohorts Except 15E|Death|0|||
156568807|NCT04889209|565168264|FG003|All Cohorts Except 15E|Death|0|||
156568808|NCT04889209|565168265|FG004|All Cohorts Except 15E|Death|0|||
156568809|NCT04889209|565168266|FG005|All Cohorts Except 15E|Death|0|||
156568810|NCT04889209|565168267|FG006|All Cohorts Except 15E|Death|0|||
156568811|NCT04889209|565168268|FG007|All Cohorts Except 15E|Death|0|||
156568812|NCT04889209|565168269|FG008|All Cohorts Except 15E|Death|0|||
156568813|NCT04889209|565168270|FG009|All Cohorts Except 15E|Death|0|||
156568814|NCT04889209|565168271|FG010|All Cohorts Except 15E|Death|0|||
156568815|NCT04889209|565168272|FG011|All Cohorts Except 15E|Death|0|||
156568816|NCT04889209|565168273|FG012|All Cohorts Except 15E|Death|0|||
156568817|NCT04889209|565168274|FG013|All Cohorts Except 15E|Death|0|||
156568818|NCT04889209|565168275|FG014|All Cohorts Except 15E|Death|0|||
156568819|NCT04889209|565168276|FG015|All Cohorts Except 15E|Death|0|||
156568820|NCT04889209|565168277|FG016|All Cohorts Except 15E|Death|0|||
156568821|NCT04889209|565168278|FG017|All Cohorts Except 15E|Death|0|||
156568822|NCT04889209|565168261|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
156568823|NCT04889209|565168262|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
156568824|NCT04889209|565168263|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
156568825|NCT04889209|565168264|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
156568826|NCT04889209|565168265|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
156568827|NCT04889209|565168266|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
156568828|NCT04889209|565168267|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
156568829|NCT04889209|565168268|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
156568830|NCT04889209|565168269|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
156568831|NCT04889209|565168270|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
156568832|NCT04889209|565168271|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
156568833|NCT04889209|565168272|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
156568834|NCT04889209|565168273|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
156568835|NCT04889209|565168274|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
156568836|NCT04889209|565168275|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
156568837|NCT04889209|565168276|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
156568838|NCT04889209|565168277|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
156568839|NCT04889209|565168278|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
156568840|NCT04889209|565168261|FG000|All Cohorts Except 15E|Physician Decision|0|||
156568841|NCT04889209|565168262|FG001|All Cohorts Except 15E|Physician Decision|0|||
156568842|NCT04889209|565168263|FG002|All Cohorts Except 15E|Physician Decision|0|||
156568843|NCT04889209|565168264|FG003|All Cohorts Except 15E|Physician Decision|0|||
156568844|NCT04889209|565168265|FG004|All Cohorts Except 15E|Physician Decision|1|||
156568845|NCT04889209|565168266|FG005|All Cohorts Except 15E|Physician Decision|0|||
156568846|NCT04889209|565168267|FG006|All Cohorts Except 15E|Physician Decision|0|||
156568847|NCT04889209|565168268|FG007|All Cohorts Except 15E|Physician Decision|1|||
156568848|NCT04889209|565168269|FG008|All Cohorts Except 15E|Physician Decision|0|||
156568849|NCT04889209|565168270|FG009|All Cohorts Except 15E|Physician Decision|1|||
156568850|NCT04889209|565168271|FG010|All Cohorts Except 15E|Physician Decision|0|||
156568851|NCT04889209|565168272|FG011|All Cohorts Except 15E|Physician Decision|1|||
156568852|NCT04889209|565168273|FG012|All Cohorts Except 15E|Physician Decision|1|||
156568853|NCT04889209|565168274|FG013|All Cohorts Except 15E|Physician Decision|0|||
156568854|NCT04889209|565168275|FG014|All Cohorts Except 15E|Physician Decision|0|||
156568855|NCT04889209|565168276|FG015|All Cohorts Except 15E|Physician Decision|0|||
156568856|NCT04889209|565168277|FG016|All Cohorts Except 15E|Physician Decision|0|||
156568857|NCT04889209|565168278|FG017|All Cohorts Except 15E|Physician Decision|0|||
156568858|NCT04889209|565168261|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
156568859|NCT04889209|565168262|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
156568860|NCT04889209|565168263|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
156568861|NCT04889209|565168264|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
156568862|NCT04889209|565168265|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
156568863|NCT04889209|565168266|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
156568864|NCT04889209|565168267|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
156568865|NCT04889209|565168268|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
156568866|NCT04889209|565168269|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
156568867|NCT04889209|565168270|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
156568868|NCT04889209|565168271|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
156568869|NCT04889209|565168272|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
156568870|NCT04889209|565168273|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
156568871|NCT04889209|565168274|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
156568872|NCT04889209|565168275|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
156568873|NCT04889209|565168276|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
156568874|NCT04889209|565168277|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
156568875|NCT04889209|565168278|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
156568876|NCT04889209|565168261|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
156568877|NCT04889209|565168262|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
156568878|NCT04889209|565168263|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568879|NCT04889209|565168264|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568880|NCT04889209|565168265|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568881|NCT04889209|565168266|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
156568882|NCT04889209|565168267|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568883|NCT04889209|565168268|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
156568884|NCT04889209|565168269|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568885|NCT04889209|565168270|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
156568886|NCT04889209|565168271|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568887|NCT04889209|565168272|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568888|NCT04889209|565168273|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568889|NCT04889209|565168274|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568890|NCT04889209|565168275|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568891|NCT04889209|565168276|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568892|NCT04889209|565168277|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
156568893|NCT04889209|565168278|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
156568894|NCT04889209|565168261|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568895|NCT04889209|565168262|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568896|NCT04889209|565168263|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568897|NCT04889209|565168264|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
156568898|NCT04889209|565168265|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568899|NCT04889209|565168266|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568900|NCT04889209|565168267|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568901|NCT04889209|565168268|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568902|NCT04889209|565168269|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568903|NCT04889209|565168270|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568904|NCT04889209|565168271|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568905|NCT04889209|565168272|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568906|NCT04889209|565168273|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568907|NCT04889209|565168274|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568908|NCT04889209|565168275|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568909|NCT04889209|565168276|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568910|NCT04889209|565168277|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568911|NCT04889209|565168278|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
156568912|NCT04889209|565168261|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568913|NCT04889209|565168262|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568914|NCT04889209|565168263|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568915|NCT04889209|565168264|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568916|NCT04889209|565168265|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
156568917|NCT04889209|565168266|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568918|NCT04889209|565168267|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
156568919|NCT04889209|565168268|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
156568920|NCT04889209|565168269|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568921|NCT04889209|565168270|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
156568922|NCT04889209|565168271|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
156568923|NCT04889209|565168272|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568924|NCT04889209|565168273|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
156568925|NCT04889209|565168274|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568926|NCT04889209|565168275|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568927|NCT04889209|565168276|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568928|NCT04889209|565168277|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
156568929|NCT04889209|565168278|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
156568930|NCT04889209|565168261|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568931|NCT04889209|565168262|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568932|NCT04889209|565168263|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568933|NCT04889209|565168264|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568934|NCT04889209|565168265|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568935|NCT04889209|565168266|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568936|NCT04889209|565168267|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568937|NCT04889209|565168268|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568938|NCT04889209|565168269|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568939|NCT04889209|565168270|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568940|NCT04889209|565168271|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568941|NCT04889209|565168272|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568942|NCT04889209|565168273|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568943|NCT04889209|565168274|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568944|NCT04889209|565168275|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568945|NCT04889209|565168276|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568946|NCT04889209|565168277|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
156568947|NCT04889209|565168278|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
156568948|NCT04889209|565168261|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568949|NCT04889209|565168262|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568950|NCT04889209|565168263|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568951|NCT04889209|565168264|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568952|NCT04889209|565168265|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568953|NCT04889209|565168266|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568954|NCT04889209|565168267|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568955|NCT04889209|565168268|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568956|NCT04889209|565168269|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568957|NCT04889209|565168270|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568958|NCT04889209|565168271|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568959|NCT04889209|565168272|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568960|NCT04889209|565168273|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568961|NCT04889209|565168274|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568962|NCT04889209|565168275|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568963|NCT04889209|565168276|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568964|NCT04889209|565168277|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
156568965|NCT04889209|565168278|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
156568966|NCT04889209|565168261|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568967|NCT04889209|565168262|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568968|NCT04889209|565168263|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568969|NCT04889209|565168264|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568970|NCT04889209|565168265|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568971|NCT04889209|565168266|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568972|NCT04889209|565168267|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568973|NCT04889209|565168268|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568974|NCT04889209|565168269|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568975|NCT04889209|565168270|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568976|NCT04889209|565168271|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568977|NCT04889209|565168272|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568978|NCT04889209|565168273|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568979|NCT04889209|565168274|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568980|NCT04889209|565168275|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
156568981|NCT04889209|565168276|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568982|NCT04889209|565168277|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568983|NCT04889209|565168278|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156568984|NCT04607408|565168279|FG000|Overall Study|Lost to Follow-up|0|||
156568985|NCT04607408|565168280|FG001|Overall Study|Lost to Follow-up|0|||
156568986|NCT04607408|565168281|FG002|Overall Study|Lost to Follow-up|0|||
156568987|NCT04607408|565168282|FG003|Overall Study|Lost to Follow-up|1|||
156568988|NCT04607408|565168283|FG004|Overall Study|Lost to Follow-up|0|||
156568989|NCT04607408|565168279|FG000|Overall Study|Withdrawal by Subject|0|||
156568990|NCT04607408|565168280|FG001|Overall Study|Withdrawal by Subject|1|||
156568991|NCT04607408|565168281|FG002|Overall Study|Withdrawal by Subject|0|||
156568992|NCT04607408|565168282|FG003|Overall Study|Withdrawal by Subject|1|||
156568993|NCT04607408|565168283|FG004|Overall Study|Withdrawal by Subject|0|||
156568994|NCT01725165|565168286|FG000|Overall Study|Death|11|||
156568995|NCT01725165|565168287|FG001|Overall Study|Death|18|||
156568996|NCT02688647|565168290|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
156568997|NCT02688647|565168291|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
156568998|NCT02688647|565168290|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
156568999|NCT02688647|565168291|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
156569000|NCT02688647|565168290|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
156569001|NCT02688647|565168291|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
156569002|NCT02688647|565168290|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
156569003|NCT02688647|565168291|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
156569004|NCT02688647|565168290|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
156569005|NCT02688647|565168291|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
156569006|NCT02688647|565168290|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
156569007|NCT02688647|565168291|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
156569008|NCT02688647|565168290|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
156569009|NCT02688647|565168291|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
156569010|NCT03619213|565168292|FG000|Overall Study|Lost to Follow-up|2|||
156569011|NCT03619213|565168293|FG001|Overall Study|Lost to Follow-up|1|||
156569012|NCT03619213|565168292|FG000|Overall Study|Withdrawal by Subject|8|||
156569013|NCT03619213|565168293|FG001|Overall Study|Withdrawal by Subject|10|||
156569014|NCT00382967|565168294|FG000|Overall Study|Protocol Violation|1|||
156569015|NCT00382967|565168295|FG001|Overall Study|Protocol Violation|1|||
156569016|NCT03093155|565168297|FG000|Overall Study|Not Eligible|1|||
156569017|NCT03093155|565168298|FG001|Overall Study|Not Eligible|0|||
156569018|NCT03093155|565168297|FG000|Overall Study|Withdrawal by Subject|0|||
156569019|NCT03093155|565168298|FG001|Overall Study|Withdrawal by Subject|1|||
156569020|NCT02786901|565168299|FG000|Overall Study|Adverse Event|1|||
156569021|NCT02786901|565168300|FG001|Overall Study|Adverse Event|1|||
156569022|NCT02786901|565168301|FG002|Overall Study|Adverse Event|2|||
156569023|NCT02786901|565168299|FG000|Overall Study|Physician Decision|1|||
156569024|NCT02786901|565168300|FG001|Overall Study|Physician Decision|0|||
156569025|NCT02786901|565168301|FG002|Overall Study|Physician Decision|0|||
156569026|NCT02786901|565168299|FG000|Overall Study|Rescue Therapy Use|71|||
156569027|NCT02786901|565168300|FG001|Overall Study|Rescue Therapy Use|49|||
156569028|NCT02786901|565168301|FG002|Overall Study|Rescue Therapy Use|33|||
156569029|NCT02786901|565168299|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
156569030|NCT02786901|565168300|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
156569031|NCT02786901|565168301|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
156569032|NCT02786901|565168299|FG000|Overall Study|Disallowed medication|1|||
156569033|NCT02786901|565168300|FG001|Overall Study|Disallowed medication|1|||
156569034|NCT02786901|565168301|FG002|Overall Study|Disallowed medication|0|||
156569035|NCT02786901|565168299|FG000|Overall Study|Randomized in error|2|||
156569036|NCT02786901|565168300|FG001|Overall Study|Randomized in error|0|||
156569037|NCT02786901|565168301|FG002|Overall Study|Randomized in error|1|||
156569038|NCT01075178|565168302|FG000|Subject Matching|eligible but not matched|130|||
156569039|NCT01075178|565168303|FG001|Subject Matching|eligible but not matched|403|||
156569040|NCT01075178|565168302|FG000|Subject Chart Review|died before chart review period|0|||
156569041|NCT01075178|565168303|FG001|Subject Chart Review|died before chart review period|2|||
156569042|NCT01075178|565168302|FG000|Subject Chart Review|no data collected due to site closure|3|||
156569043|NCT01075178|565168303|FG001|Subject Chart Review|no data collected due to site closure|4|||
156569044|NCT01075178|565168302|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
156569045|NCT01075178|565168303|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
156569046|NCT00607048|565168305|FG000|Overall Study|Adverse Event|0|||
156569047|NCT00607048|565168306|FG001|Overall Study|Adverse Event|1|||
156569048|NCT00607048|565168307|FG002|Overall Study|Adverse Event|0|||
156569049|NCT00607048|565168308|FG003|Overall Study|Adverse Event|0|||
156569050|NCT00607048|565168309|FG004|Overall Study|Adverse Event|4|||
156569051|NCT00607048|565168310|FG005|Overall Study|Adverse Event|0|||
156569052|NCT00607048|565168305|FG000|Overall Study|Global deterioration of health|1|||
156569053|NCT00607048|565168306|FG001|Overall Study|Global deterioration of health|0|||
156569054|NCT00607048|565168307|FG002|Overall Study|Global deterioration of health|0|||
156569055|NCT00607048|565168308|FG003|Overall Study|Global deterioration of health|0|||
156569056|NCT00607048|565168309|FG004|Overall Study|Global deterioration of health|0|||
156569057|NCT00607048|565168310|FG005|Overall Study|Global deterioration of health|0|||
156569058|NCT00607048|565168305|FG000|Overall Study|Objective disease progression - relapse|1|||
156569059|NCT00607048|565168306|FG001|Overall Study|Objective disease progression - relapse|2|||
156569060|NCT00607048|565168307|FG002|Overall Study|Objective disease progression - relapse|4|||
156569061|NCT00607048|565168308|FG003|Overall Study|Objective disease progression - relapse|2|||
156569062|NCT00607048|565168309|FG004|Overall Study|Objective disease progression - relapse|2|||
156569063|NCT00607048|565168310|FG005|Overall Study|Objective disease progression - relapse|2|||
156569064|NCT00607048|565168305|FG000|Overall Study|Withdrawal by Subject|0|||
156569065|NCT00607048|565168306|FG001|Overall Study|Withdrawal by Subject|0|||
156569066|NCT00607048|565168307|FG002|Overall Study|Withdrawal by Subject|0|||
156569067|NCT00607048|565168308|FG003|Overall Study|Withdrawal by Subject|1|||
156569068|NCT00607048|565168309|FG004|Overall Study|Withdrawal by Subject|0|||
156569069|NCT00607048|565168310|FG005|Overall Study|Withdrawal by Subject|2|||
156569070|NCT00607048|565168305|FG000|Overall Study|Other|1|||
156569071|NCT00607048|565168306|FG001|Overall Study|Other|1|||
156569072|NCT00607048|565168307|FG002|Overall Study|Other|0|||
156569073|NCT00607048|565168308|FG003|Overall Study|Other|0|||
156569074|NCT00607048|565168309|FG004|Overall Study|Other|0|||
156569075|NCT00607048|565168310|FG005|Overall Study|Other|1|||
156569076|NCT00316264|565168311|FG000|Overall Study|Lost to Follow-up|0|||
156569077|NCT00316264|565168312|FG001|Overall Study|Lost to Follow-up|1|||
156569078|NCT00316264|565168313|FG002|Overall Study|Lost to Follow-up|0|||
156569079|NCT00316264|565168311|FG000|Overall Study|Withdrawal of Consent|3|||
156569080|NCT00316264|565168312|FG001|Overall Study|Withdrawal of Consent|5|||
156569081|NCT00316264|565168313|FG002|Overall Study|Withdrawal of Consent|6|||
156569082|NCT00316264|565168311|FG000|Overall Study|Death|2|||
156569083|NCT00316264|565168312|FG001|Overall Study|Death|0|||
156569084|NCT00316264|565168313|FG002|Overall Study|Death|0|||
156569085|NCT00316264|565168311|FG000|Overall Study|Other|1|||
156569086|NCT00316264|565168312|FG001|Overall Study|Other|1|||
156569087|NCT00316264|565168313|FG002|Overall Study|Other|0|||
156569088|NCT00699192|565168314|FG000|Overall Study|Missing|1|||
156569089|NCT00699192|565168315|FG001|Overall Study|Missing|1|||
156569090|NCT00699192|565168316|FG002|Overall Study|Missing|1|||
156569091|NCT00699192|565168314|FG000|Overall Study|Adverse Event|9|||
156569092|NCT00699192|565168315|FG001|Overall Study|Adverse Event|4|||
156569093|NCT00699192|565168316|FG002|Overall Study|Adverse Event|3|||
156569094|NCT00699192|565168314|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156569095|NCT00699192|565168315|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156569096|NCT00699192|565168316|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156569097|NCT00699192|565168314|FG000|Overall Study|Lack of Efficacy|0|||
156569098|NCT00699192|565168315|FG001|Overall Study|Lack of Efficacy|0|||
156569099|NCT00699192|565168316|FG002|Overall Study|Lack of Efficacy|1|||
156569100|NCT00699192|565168314|FG000|Overall Study|Withdrawal by Subject|3|||
156569101|NCT00699192|565168315|FG001|Overall Study|Withdrawal by Subject|2|||
156569102|NCT00699192|565168316|FG002|Overall Study|Withdrawal by Subject|4|||
156569103|NCT00699192|565168314|FG000|Overall Study|Administrative problems|1|||
156569104|NCT00699192|565168315|FG001|Overall Study|Administrative problems|3|||
156569105|NCT00699192|565168316|FG002|Overall Study|Administrative problems|1|||
156569106|NCT00699192|565168314|FG000|Overall Study|Protocol Violation|2|||
156569107|NCT00699192|565168315|FG001|Overall Study|Protocol Violation|2|||
156569108|NCT00699192|565168316|FG002|Overall Study|Protocol Violation|0|||
156569109|NCT04336163|565168317|FG000|Overall Study|Lost to Follow-up|55|||
156569110|NCT04336163|565168318|FG001|Overall Study|Lost to Follow-up|0|||
156569111|NCT00826514|565168319|FG000|Overall Study|Adverse Event|1|||
156569112|NCT00826514|565168320|FG001|Overall Study|Adverse Event|1|||
156569113|NCT00826514|565168319|FG000|Overall Study|Lack of Efficacy|0|||
156569114|NCT00826514|565168320|FG001|Overall Study|Lack of Efficacy|1|||
156569115|NCT00826514|565168319|FG000|Overall Study|Withdrawal by Subject|2|||
156569116|NCT00826514|565168320|FG001|Overall Study|Withdrawal by Subject|3|||
156569117|NCT01773473|565168321|FG000|Overall Study|Adverse Event|3|||
156569118|NCT01773473|565168322|FG001|Overall Study|Adverse Event|2|||
156569119|NCT01773473|565168321|FG000|Overall Study|Protocol Violation|0|||
156569120|NCT01773473|565168322|FG001|Overall Study|Protocol Violation|4|||
156569121|NCT01773473|565168321|FG000|Overall Study|Physician Decision|3|||
156569122|NCT01773473|565168322|FG001|Overall Study|Physician Decision|5|||
156569123|NCT01773473|565168321|FG000|Overall Study|Sponsor Decision|2|||
156569124|NCT01773473|565168322|FG001|Overall Study|Sponsor Decision|0|||
156569125|NCT01773473|565168321|FG000|Overall Study|Lack of Efficacy|0|||
156569126|NCT01773473|565168322|FG001|Overall Study|Lack of Efficacy|1|||
156569127|NCT01773473|565168321|FG000|Overall Study|Non-Compliance with study drug|1|||
156569128|NCT01773473|565168322|FG001|Overall Study|Non-Compliance with study drug|4|||
156569129|NCT01773473|565168321|FG000|Overall Study|Withdrawal by Subject|5|||
156569130|NCT01773473|565168322|FG001|Overall Study|Withdrawal by Subject|3|||
156569131|NCT01773473|565168321|FG000|Overall Study|Lost to Follow-up|2|||
156569132|NCT01773473|565168322|FG001|Overall Study|Lost to Follow-up|0|||
156569133|NCT03663166|565168325|FG000|Overall Study|Withdrawal by Subject|1|||
156569134|NCT04927312|565168327|FG000|Overall Study|Adverse Event|1|||
156569135|NCT04927312|565168327|FG000|Overall Study|Death|1|||
156569136|NCT04927312|565168327|FG000|Overall Study|Withdrawal by Subject|1|||
156569137|NCT04927312|565168327|FG000|Overall Study|Other|1|||
156569138|NCT02620020|565168329|FG000|Overall Study|Adverse Event|8|||
156569139|NCT02620020|565168330|FG001|Overall Study|Adverse Event|4|||
156569140|NCT02620020|565168331|FG002|Overall Study|Adverse Event|3|||
156569141|NCT02620020|565168332|FG003|Overall Study|Adverse Event|5|||
156569142|NCT02620020|565168329|FG000|Overall Study|Lost to Follow-up|4|||
156569143|NCT02620020|565168330|FG001|Overall Study|Lost to Follow-up|8|||
156569144|NCT02620020|565168331|FG002|Overall Study|Lost to Follow-up|1|||
156569145|NCT02620020|565168332|FG003|Overall Study|Lost to Follow-up|4|||
156569146|NCT02620020|565168329|FG000|Overall Study|Physician Decision|7|||
156569147|NCT02620020|565168330|FG001|Overall Study|Physician Decision|4|||
156569148|NCT02620020|565168331|FG002|Overall Study|Physician Decision|3|||
156569149|NCT02620020|565168332|FG003|Overall Study|Physician Decision|4|||
156569150|NCT02620020|565168329|FG000|Overall Study|Protocol Violation|5|||
156569151|NCT02620020|565168330|FG001|Overall Study|Protocol Violation|2|||
156569152|NCT02620020|565168331|FG002|Overall Study|Protocol Violation|1|||
156569153|NCT02620020|565168332|FG003|Overall Study|Protocol Violation|1|||
156569154|NCT02620020|565168329|FG000|Overall Study|Withdrawal by Subject|20|||
156569155|NCT02620020|565168330|FG001|Overall Study|Withdrawal by Subject|16|||
156569156|NCT02620020|565168331|FG002|Overall Study|Withdrawal by Subject|17|||
156569157|NCT02620020|565168332|FG003|Overall Study|Withdrawal by Subject|12|||
156569158|NCT02620020|565168329|FG000|Overall Study|Death|0|||
156569159|NCT02620020|565168330|FG001|Overall Study|Death|1|||
156569160|NCT02620020|565168331|FG002|Overall Study|Death|0|||
156569161|NCT02620020|565168332|FG003|Overall Study|Death|0|||
156569162|NCT02393209|565168334|FG000|Overall Study|Study Terminated by Sponsor|1|||
156569163|NCT02393209|565168335|FG001|Overall Study|Study Terminated by Sponsor|1|||
156569164|NCT02393209|565168336|FG002|Overall Study|Study Terminated by Sponsor|0|||
156569165|NCT02393209|565168337|FG003|Overall Study|Study Terminated by Sponsor|0|||
156569166|NCT02393209|565168334|FG000|Overall Study|Withdrawal by Patient|1|||
156569167|NCT02393209|565168335|FG001|Overall Study|Withdrawal by Patient|0|||
156569168|NCT02393209|565168336|FG002|Overall Study|Withdrawal by Patient|0|||
156569169|NCT02393209|565168337|FG003|Overall Study|Withdrawal by Patient|0|||
156569170|NCT02393209|565168334|FG000|Overall Study|Death|2|||
156569171|NCT02393209|565168335|FG001|Overall Study|Death|2|||
156569172|NCT02393209|565168336|FG002|Overall Study|Death|0|||
156569173|NCT02393209|565168337|FG003|Overall Study|Death|0|||
156569174|NCT02393209|565168334|FG000|Overall Study|Death due to Disease Progression|2|||
156569175|NCT02393209|565168335|FG001|Overall Study|Death due to Disease Progression|2|||
156569176|NCT02393209|565168336|FG002|Overall Study|Death due to Disease Progression|0|||
156569177|NCT02393209|565168337|FG003|Overall Study|Death due to Disease Progression|0|||
156569178|NCT02393209|565168334|FG000|Overall Study|Death from Legionella Infection|0|||
156569179|NCT02393209|565168335|FG001|Overall Study|Death from Legionella Infection|1|||
156569180|NCT02393209|565168336|FG002|Overall Study|Death from Legionella Infection|0|||
156569181|NCT02393209|565168337|FG003|Overall Study|Death from Legionella Infection|0|||
156569182|NCT02393209|565168334|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
156569183|NCT02393209|565168335|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
156569184|NCT02393209|565168336|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
156569185|NCT02393209|565168337|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
156569186|NCT02393209|565168334|FG000|Overall Study|Lost to Follow-up|0|||
156569187|NCT02393209|565168335|FG001|Overall Study|Lost to Follow-up|1|||
156569188|NCT02393209|565168336|FG002|Overall Study|Lost to Follow-up|0|||
156569189|NCT02393209|565168337|FG003|Overall Study|Lost to Follow-up|0|||
156569190|NCT00929240|565168338|FG000|Initial Treatment Phase|Adverse Event|31|||
156569191|NCT00929240|565168339|FG001|Initial Treatment Phase|Adverse Event|0|||
156569192|NCT00929240|565168340|FG002|Initial Treatment Phase|Adverse Event|0|||
156569193|NCT00929240|565168338|FG000|Initial Treatment Phase|Disease progression|41|||
156569194|NCT00929240|565168339|FG001|Initial Treatment Phase|Disease progression|0|||
156569195|NCT00929240|565168340|FG002|Initial Treatment Phase|Disease progression|0|||
156569196|NCT00929240|565168338|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
156569197|NCT00929240|565168339|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
156569198|NCT00929240|565168340|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
156569199|NCT00929240|565168338|FG000|Initial Treatment Phase|Protocol Violation|5|||
156569200|NCT00929240|565168339|FG001|Initial Treatment Phase|Protocol Violation|0|||
156569201|NCT00929240|565168340|FG002|Initial Treatment Phase|Protocol Violation|0|||
156569202|NCT00929240|565168338|FG000|Initial Treatment Phase|Death|2|||
156569203|NCT00929240|565168339|FG001|Initial Treatment Phase|Death|0|||
156569204|NCT00929240|565168340|FG002|Initial Treatment Phase|Death|0|||
156569205|NCT00929240|565168338|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
156569206|NCT00929240|565168339|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
156569207|NCT00929240|565168340|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
156569208|NCT00929240|565168338|FG000|Initial Treatment Phase|Physician Decision|4|||
156569209|NCT00929240|565168339|FG001|Initial Treatment Phase|Physician Decision|0|||
156569210|NCT00929240|565168340|FG002|Initial Treatment Phase|Physician Decision|0|||
156569211|NCT00929240|565168338|FG000|Maintenance Phase|Disease progression|0|||
156569212|NCT00929240|565168339|FG001|Maintenance Phase|Disease progression|73|||
156569213|NCT00929240|565168340|FG002|Maintenance Phase|Disease progression|60|||
156569214|NCT00929240|565168338|FG000|Maintenance Phase|Adverse Event|0|||
156569215|NCT00929240|565168339|FG001|Maintenance Phase|Adverse Event|9|||
156569216|NCT00929240|565168340|FG002|Maintenance Phase|Adverse Event|12|||
156569217|NCT00929240|565168338|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156569218|NCT00929240|565168339|FG001|Maintenance Phase|Withdrawal by Subject|2|||
156569219|NCT00929240|565168340|FG002|Maintenance Phase|Withdrawal by Subject|6|||
156569220|NCT00929240|565168338|FG000|Maintenance Phase|Protocol Violation|0|||
156569221|NCT00929240|565168339|FG001|Maintenance Phase|Protocol Violation|1|||
156569222|NCT00929240|565168340|FG002|Maintenance Phase|Protocol Violation|0|||
156569223|NCT00929240|565168338|FG000|Maintenance Phase|Health authority/Study termination|0|||
156569224|NCT00929240|565168339|FG001|Maintenance Phase|Health authority/Study termination|1|||
156569225|NCT00929240|565168340|FG002|Maintenance Phase|Health authority/Study termination|2|||
156569226|NCT00929240|565168338|FG000|Maintenance Phase|Physician Decision|0|||
156569227|NCT00929240|565168339|FG001|Maintenance Phase|Physician Decision|2|||
156569228|NCT00929240|565168340|FG002|Maintenance Phase|Physician Decision|1|||
156569229|NCT00929240|565168338|FG000|Maintenance Phase|Change of treatment|0|||
156569230|NCT00929240|565168339|FG001|Maintenance Phase|Change of treatment|4|||
156569231|NCT00929240|565168340|FG002|Maintenance Phase|Change of treatment|0|||
156569232|NCT00929240|565168338|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
156569233|NCT00929240|565168339|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
156569234|NCT00929240|565168340|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
156569235|NCT00929240|565168338|FG000|Maintenance Phase|Participant not treated|0|||
156569236|NCT00929240|565168339|FG001|Maintenance Phase|Participant not treated|2|||
156569237|NCT00929240|565168340|FG002|Maintenance Phase|Participant not treated|0|||
156569238|NCT00098787|565168341|FG000|Overall Study|Never started treatment|3|||
156569239|NCT00098787|565168342|FG001|Overall Study|Never started treatment|2|||
156569240|NCT00098787|565168343|FG002|Overall Study|Never started treatment|1|||
156569241|NCT00098787|565168341|FG000|Overall Study|Ineligible|9|||
156569242|NCT00098787|565168342|FG001|Overall Study|Ineligible|7|||
156569243|NCT00098787|565168343|FG002|Overall Study|Ineligible|3|||
156569244|NCT00098787|565168341|FG000|Overall Study|Disease progression|28|||
156569245|NCT00098787|565168342|FG001|Overall Study|Disease progression|17|||
156569246|NCT00098787|565168343|FG002|Overall Study|Disease progression|23|||
156569247|NCT00098787|565168341|FG000|Overall Study|Adverse Event|8|||
156569248|NCT00098787|565168342|FG001|Overall Study|Adverse Event|17|||
156569249|NCT00098787|565168343|FG002|Overall Study|Adverse Event|8|||
156569250|NCT00098787|565168341|FG000|Overall Study|Death|6|||
156569251|NCT00098787|565168342|FG001|Overall Study|Death|1|||
156569252|NCT00098787|565168343|FG002|Overall Study|Death|0|||
156569253|NCT00098787|565168341|FG000|Overall Study|Withdrawal by Subject|4|||
156569254|NCT00098787|565168342|FG001|Overall Study|Withdrawal by Subject|12|||
156569255|NCT00098787|565168343|FG002|Overall Study|Withdrawal by Subject|6|||
156569256|NCT00098787|565168341|FG000|Overall Study|Alternative therapy|8|||
156569257|NCT00098787|565168342|FG001|Overall Study|Alternative therapy|13|||
156569258|NCT00098787|565168343|FG002|Overall Study|Alternative therapy|13|||
156569259|NCT00098787|565168341|FG000|Overall Study|Other|7|||
156569260|NCT00098787|565168342|FG001|Overall Study|Other|6|||
156569261|NCT00098787|565168343|FG002|Overall Study|Other|9|||
156569262|NCT00684814|565168344|FG000|Washout Period of 7 Days|Adverse Event|1|||
156569263|NCT00684814|565168345|FG001|Washout Period of 7 Days|Adverse Event|2|||
156569264|NCT00684814|565168344|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
156569265|NCT00684814|565168345|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
156569266|NCT00684814|565168344|FG000|Second Intervention|Adverse Event|1|||
156569267|NCT00684814|565168345|FG001|Second Intervention|Adverse Event|0|||
156569268|NCT04348851|565168347|FG000|Post-Test 1|Withdrawal by Subject|0|||
156569269|NCT04348851|565168348|FG001|Post-Test 1|Withdrawal by Subject|1|||
156569270|NCT04348851|565168349|FG002|Post-Test 1|Withdrawal by Subject|0|||
156569271|NCT04348851|565168350|FG003|Post-Test 1|Withdrawal by Subject|0|||
156569272|NCT04348851|565168347|FG000|Post-Test 1|Lost to Follow-up|0|||
156569273|NCT04348851|565168348|FG001|Post-Test 1|Lost to Follow-up|1|||
156569274|NCT04348851|565168349|FG002|Post-Test 1|Lost to Follow-up|0|||
156569275|NCT04348851|565168350|FG003|Post-Test 1|Lost to Follow-up|0|||
156569276|NCT04348851|565168347|FG000|Post-Test 2|Stroke survivor death|0|||
156569277|NCT04348851|565168348|FG001|Post-Test 2|Stroke survivor death|1|||
156569278|NCT04348851|565168349|FG002|Post-Test 2|Stroke survivor death|0|||
156569279|NCT04348851|565168350|FG003|Post-Test 2|Stroke survivor death|1|||
156569280|NCT00195650|565168351|FG000|Overall Study|Adverse Event|194|||
156569281|NCT00195650|565168351|FG000|Overall Study|Lack of Efficacy|99|||
156569282|NCT00195650|565168351|FG000|Overall Study|Withdrawal by Subject|67|||
156569283|NCT00195650|565168351|FG000|Overall Study|Lost to Follow-up|44|||
156569284|NCT00195650|565168351|FG000|Overall Study|Death|23|||
156569285|NCT00195650|565168351|FG000|Overall Study|Protocol Violation|15|||
156569286|NCT00195650|565168351|FG000|Overall Study|Administrative reasons|83|||
156569287|NCT01499290|565168352|FG000|Overall Study|Withdrawal by Subject|22|||
156569288|NCT01499290|565168353|FG001|Overall Study|Withdrawal by Subject|15|||
156569289|NCT01499290|565168352|FG000|Overall Study|Not specified in study report|11|||
156569290|NCT01499290|565168353|FG001|Overall Study|Not specified in study report|5|||
156569291|NCT01499290|565168352|FG000|Overall Study|Condition improved/subject recovered|1|||
156569292|NCT01499290|565168353|FG001|Overall Study|Condition improved/subject recovered|0|||
156569293|NCT01499290|565168352|FG000|Overall Study|Lack of Efficacy|7|||
156569294|NCT01499290|565168353|FG001|Overall Study|Lack of Efficacy|8|||
156569295|NCT01499290|565168352|FG000|Overall Study|Adverse Event|14|||
156569296|NCT01499290|565168353|FG001|Overall Study|Adverse Event|7|||
156569297|NCT04052139|565168354|FG000|Overall Study|Lost to Follow-up|2|||
156569298|NCT04052139|565168355|FG001|Overall Study|Lost to Follow-up|0|||
156569299|NCT04052139|565168356|FG002|Overall Study|Lost to Follow-up|0|||
156569300|NCT04052139|565168354|FG000|Overall Study|Withdrawal by Subject|1|||
156569301|NCT04052139|565168355|FG001|Overall Study|Withdrawal by Subject|0|||
156569302|NCT04052139|565168356|FG002|Overall Study|Withdrawal by Subject|0|||
156569303|NCT00707577|565168357|FG000|Overall Study|Withdrawal by Subject|3|||
156569304|NCT00707577|565168358|FG001|Overall Study|Withdrawal by Subject|2|||
156569305|NCT00707577|565168357|FG000|Overall Study|Lost to Follow-up|34|||
156569306|NCT00707577|565168358|FG001|Overall Study|Lost to Follow-up|25|||
156569307|NCT00707577|565168357|FG000|Overall Study|Left employment|13|||
156569308|NCT00707577|565168358|FG001|Overall Study|Left employment|10|||
156569309|NCT00707577|565168357|FG000|Overall Study|Pregnancy|4|||
156569310|NCT00707577|565168358|FG001|Overall Study|Pregnancy|1|||
156569311|NCT00190775|565168359|FG000|Overall Study|Adverse Event|57|||
156569312|NCT00190775|565168360|FG001|Overall Study|Adverse Event|22|||
156569313|NCT00190775|565168359|FG000|Overall Study|Satisfactory Response|1|||
156569314|NCT00190775|565168360|FG001|Overall Study|Satisfactory Response|0|||
156569315|NCT00190775|565168359|FG000|Overall Study|Lack of Efficacy|28|||
156569316|NCT00190775|565168360|FG001|Overall Study|Lack of Efficacy|32|||
156569317|NCT00190775|565168359|FG000|Overall Study|Lost to Follow-up|31|||
156569318|NCT00190775|565168360|FG001|Overall Study|Lost to Follow-up|23|||
156569319|NCT00190775|565168359|FG000|Overall Study|Participant Moved|0|||
156569320|NCT00190775|565168360|FG001|Overall Study|Participant Moved|1|||
156569321|NCT00190775|565168359|FG000|Overall Study|Withdrawal by Subject|24|||
156569322|NCT00190775|565168360|FG001|Overall Study|Withdrawal by Subject|13|||
156569323|NCT00190775|565168359|FG000|Overall Study|Sponsor Decision|1|||
156569324|NCT00190775|565168360|FG001|Overall Study|Sponsor Decision|0|||
156569325|NCT00190775|565168359|FG000|Overall Study|Physician Decision|3|||
156569326|NCT00190775|565168360|FG001|Overall Study|Physician Decision|0|||
156569327|NCT00190775|565168359|FG000|Overall Study|Noncompliance|3|||
156569328|NCT00190775|565168360|FG001|Overall Study|Noncompliance|5|||
156569329|NCT00190775|565168359|FG000|Overall Study|Protocol Violation|0|||
156569330|NCT00190775|565168360|FG001|Overall Study|Protocol Violation|1|||
156569331|NCT00190775|565168359|FG000|Overall Study|Exclusion Criteria Met|1|||
156569332|NCT00190775|565168360|FG001|Overall Study|Exclusion Criteria Met|3|||
156569333|NCT01794780|565168361|FG000|Overall Study|Adverse Event|0|||
156569334|NCT01794780|565168362|FG001|Overall Study|Adverse Event|1|||
156569335|NCT01794780|565168363|FG002|Overall Study|Adverse Event|2|||
156569336|NCT01794780|565168364|FG003|Overall Study|Adverse Event|0|||
156569337|NCT01794780|565168365|FG004|Overall Study|Adverse Event|0|||
156569338|NCT01794780|565168366|FG005|Overall Study|Adverse Event|0|||
156569339|NCT01794780|565168367|FG006|Overall Study|Adverse Event|0|||
156569340|NCT01794780|565168368|FG007|Overall Study|Adverse Event|0|||
156569341|NCT01794780|565168361|FG000|Overall Study|Death|0|||
156569342|NCT01794780|565168362|FG001|Overall Study|Death|2|||
156569343|NCT01794780|565168363|FG002|Overall Study|Death|14|||
156569344|NCT01794780|565168364|FG003|Overall Study|Death|1|||
156569345|NCT01794780|565168365|FG004|Overall Study|Death|0|||
156569346|NCT01794780|565168366|FG005|Overall Study|Death|9|||
156569347|NCT01794780|565168367|FG006|Overall Study|Death|4|||
156569348|NCT01794780|565168368|FG007|Overall Study|Death|0|||
156569349|NCT01794780|565168361|FG000|Overall Study|Lost to Follow-up|10|||
156569350|NCT01794780|565168362|FG001|Overall Study|Lost to Follow-up|64|||
156569351|NCT01794780|565168363|FG002|Overall Study|Lost to Follow-up|165|||
156569352|NCT01794780|565168364|FG003|Overall Study|Lost to Follow-up|53|||
156569353|NCT01794780|565168365|FG004|Overall Study|Lost to Follow-up|2|||
156569354|NCT01794780|565168366|FG005|Overall Study|Lost to Follow-up|99|||
156569355|NCT01794780|565168367|FG006|Overall Study|Lost to Follow-up|30|||
156569356|NCT01794780|565168368|FG007|Overall Study|Lost to Follow-up|5|||
156569357|NCT01794780|565168361|FG000|Overall Study|Withdrew informed consent|7|||
156569358|NCT01794780|565168362|FG001|Overall Study|Withdrew informed consent|17|||
156569359|NCT01794780|565168363|FG002|Overall Study|Withdrew informed consent|36|||
156569360|NCT01794780|565168364|FG003|Overall Study|Withdrew informed consent|9|||
156569361|NCT01794780|565168365|FG004|Overall Study|Withdrew informed consent|0|||
156569362|NCT01794780|565168366|FG005|Overall Study|Withdrew informed consent|48|||
156569363|NCT01794780|565168367|FG006|Overall Study|Withdrew informed consent|4|||
156569364|NCT01794780|565168368|FG007|Overall Study|Withdrew informed consent|3|||
156569365|NCT01794780|565168361|FG000|Overall Study|Other|0|||
156569366|NCT01794780|565168362|FG001|Overall Study|Other|12|||
156569367|NCT01794780|565168363|FG002|Overall Study|Other|25|||
156569368|NCT01794780|565168364|FG003|Overall Study|Other|20|||
156569369|NCT01794780|565168365|FG004|Overall Study|Other|1|||
156569370|NCT01794780|565168366|FG005|Overall Study|Other|24|||
156569371|NCT01794780|565168367|FG006|Overall Study|Other|4|||
156569372|NCT01794780|565168368|FG007|Overall Study|Other|1|||
156569373|NCT02209766|565168370|FG000|Overall Study|Withdrawal by Subject|0|||
156569374|NCT02209766|565168371|FG001|Overall Study|Withdrawal by Subject|0|||
156569375|NCT02209766|565168372|FG002|Overall Study|Withdrawal by Subject|0|||
156569376|NCT02209766|565168373|FG003|Overall Study|Withdrawal by Subject|1|||
156569377|NCT02209766|565168374|FG004|Overall Study|Withdrawal by Subject|0|||
156569378|NCT00327444|565168375|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
156569379|NCT00327444|565168376|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
156569380|NCT00327444|565168375|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
156569381|NCT00327444|565168376|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
156569382|NCT00327444|565168375|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
156569383|NCT00327444|565168376|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
156569384|NCT00327444|565168375|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
156569385|NCT00327444|565168376|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
156569386|NCT00327444|565168375|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
156569387|NCT00327444|565168376|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
156569388|NCT00327444|565168375|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
156569389|NCT00327444|565168376|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
156569390|NCT00327444|565168375|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
156569391|NCT00327444|565168376|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
156569392|NCT00327444|565168375|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
156569393|NCT00327444|565168376|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
156569394|NCT05630846|565170415|FG000|Overall Study|Death|1|||
156569395|NCT05630846|565170416|FG001|Overall Study|Death|0|||
156569396|NCT05630846|565170417|FG002|Overall Study|Death|0|||
156569397|NCT05630846|565170418|FG003|Overall Study|Death|0|||
156569398|NCT05630846|565170415|FG000|Overall Study|Withdrawal by Subject|3|||
156569399|NCT05630846|565170416|FG001|Overall Study|Withdrawal by Subject|3|||
156569400|NCT05630846|565170417|FG002|Overall Study|Withdrawal by Subject|4|||
156569401|NCT05630846|565170418|FG003|Overall Study|Withdrawal by Subject|1|||
156569402|NCT05630846|565170415|FG000|Overall Study|Lost to Follow-up|6|||
156569403|NCT05630846|565170416|FG001|Overall Study|Lost to Follow-up|5|||
156569404|NCT05630846|565170417|FG002|Overall Study|Lost to Follow-up|2|||
156569405|NCT05630846|565170418|FG003|Overall Study|Lost to Follow-up|5|||
156569406|NCT05630846|565170415|FG000|Overall Study|Other|1|||
156569407|NCT05630846|565170416|FG001|Overall Study|Other|0|||
156569408|NCT05630846|565170417|FG002|Overall Study|Other|0|||
156569409|NCT05630846|565170418|FG003|Overall Study|Other|0|||
156569410|NCT03019549|565170419|FG000|Washout|DId not meet genotype criteria|11|||
156569411|NCT03019549|565170419|FG000|Period 2|Adverse Event|2|||
156569412|NCT03019549|565170419|FG000|Period 2|Physician Decision|2|||
156569413|NCT03019549|565170419|FG000|Period 2|Withdrawal by Subject|1|||
156569414|NCT04030195|565170420|FG000|Overall Study|Withdrawal by Subject|2|||
156569415|NCT04030195|565170421|FG001|Overall Study|Withdrawal by Subject|0|||
156569416|NCT04030195|565170422|FG002|Overall Study|Withdrawal by Subject|0|||
156569417|NCT01412879|565170423|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
156569418|NCT01412879|565170424|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
156569419|NCT01412879|565170425|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
156569420|NCT01412879|565170423|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
156569421|NCT01412879|565170424|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
156569422|NCT01412879|565170425|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
156569423|NCT01412879|565170423|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
156569424|NCT01412879|565170424|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
156569425|NCT01412879|565170425|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
156569426|NCT01412879|565170423|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
156569427|NCT01412879|565170424|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
156569428|NCT01412879|565170425|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
156569429|NCT01412879|565170423|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
156569430|NCT01412879|565170424|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
156569431|NCT01412879|565170425|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
156569432|NCT01056107|565170427|FG000|Overall Study|Withdrawal by Subject|0|||
156569433|NCT01056107|565170428|FG001|Overall Study|Withdrawal by Subject|1|||
156569434|NCT01056107|565170429|FG002|Overall Study|Withdrawal by Subject|3|||
156569435|NCT01056107|565170430|FG003|Overall Study|Withdrawal by Subject|0|||
156569436|NCT00377962|565170431|FG000|Core Study: 0-12 Months|Adverse Event|18|||
156569437|NCT00377962|565170432|FG001|Core Study: 0-12 Months|Adverse Event|2|||
156569438|NCT00377962|565170431|FG000|Core Study: 0-12 Months|Death|3|||
156569439|NCT00377962|565170432|FG001|Core Study: 0-12 Months|Death|0|||
156569440|NCT00377962|565170431|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
156569441|NCT00377962|565170432|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
156569442|NCT00377962|565170431|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
156569443|NCT00377962|565170432|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
156569444|NCT00377962|565170431|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
156569445|NCT00377962|565170432|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
156569446|NCT00377962|565170431|FG000|Extension Study: 12-24 Months|Death|1|||
156569447|NCT00377962|565170432|FG001|Extension Study: 12-24 Months|Death|1|||
156569448|NCT00377962|565170431|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
156569449|NCT00377962|565170432|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
156569450|NCT00377962|565170431|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
156569451|NCT00377962|565170432|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
156569452|NCT00377962|565170431|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
156569453|NCT00377962|565170432|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
156569454|NCT00496366|565170433|FG000|Overall Study|Death|1|||
156569455|NCT00260208|565170434|FG000|Overall Study|Subject withdrew consent|11|||
156569456|NCT00260208|565170435|FG001|Overall Study|Subject withdrew consent|7|||
156569457|NCT00260208|565170434|FG000|Overall Study|Lost to Follow-up|6|||
156569458|NCT00260208|565170435|FG001|Overall Study|Lost to Follow-up|1|||
156569459|NCT00260208|565170434|FG000|Overall Study|Death|12|||
156569460|NCT00260208|565170435|FG001|Overall Study|Death|10|||
156569461|NCT00260208|565170434|FG000|Overall Study|Missing|18|||
156569462|NCT00260208|565170435|FG001|Overall Study|Missing|16|||
156569463|NCT00768222|565170436|FG000|Overall Study|Lost to Follow-up|1|||
156569464|NCT00768222|565170437|FG001|Overall Study|Lost to Follow-up|1|||
156569465|NCT00768222|565170436|FG000|Overall Study|Withdrawal by Subject|3|||
156569466|NCT00768222|565170437|FG001|Overall Study|Withdrawal by Subject|1|||
156569467|NCT00768222|565170436|FG000|Overall Study|Protocol Violation|0|||
156569468|NCT00768222|565170437|FG001|Overall Study|Protocol Violation|2|||
156569469|NCT03263091|565170439|FG000|OL Component|Withdrawal by Subject|1|||
156569470|NCT03263091|565170440|FG001|OL Component|Withdrawal by Subject|1|||
156569471|NCT03263091|565170441|FG002|OL Component|Withdrawal by Subject|0|||
156569472|NCT03263091|565170442|FG003|OL Component|Withdrawal by Subject|0|||
156569473|NCT03263091|565170443|FG004|OL Component|Withdrawal by Subject|0|||
156569474|NCT03263091|565170444|FG005|OL Component|Withdrawal by Subject|0|||
156569475|NCT03263091|565170439|FG000|OL Component|Physician Decision|0|||
156569476|NCT03263091|565170440|FG001|OL Component|Physician Decision|1|||
156569477|NCT03263091|565170441|FG002|OL Component|Physician Decision|2|||
156569478|NCT03263091|565170442|FG003|OL Component|Physician Decision|0|||
156569479|NCT03263091|565170443|FG004|OL Component|Physician Decision|0|||
156569480|NCT03263091|565170444|FG005|OL Component|Physician Decision|0|||
156569481|NCT03263091|565170439|FG000|OL Component|Death|1|||
156569482|NCT03263091|565170440|FG001|OL Component|Death|0|||
156569483|NCT03263091|565170441|FG002|OL Component|Death|0|||
156569484|NCT03263091|565170442|FG003|OL Component|Death|0|||
156569485|NCT03263091|565170443|FG004|OL Component|Death|0|||
156569486|NCT03263091|565170444|FG005|OL Component|Death|0|||
156569487|NCT03263091|565170439|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
156569488|NCT03263091|565170440|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
156569489|NCT03263091|565170441|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
156569490|NCT03263091|565170442|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
156569491|NCT03263091|565170443|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
156569492|NCT03263091|565170444|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
156569493|NCT03263091|565170439|FG000|OL High-EPO Component|Physician Decision|0|||
156569494|NCT03263091|565170440|FG001|OL High-EPO Component|Physician Decision|0|||
156569495|NCT03263091|565170441|FG002|OL High-EPO Component|Physician Decision|0|||
156569496|NCT03263091|565170442|FG003|OL High-EPO Component|Physician Decision|1|||
156569497|NCT03263091|565170443|FG004|OL High-EPO Component|Physician Decision|0|||
156569498|NCT03263091|565170444|FG005|OL High-EPO Component|Physician Decision|0|||
156569499|NCT03263091|565170439|FG000|OL High-EPO Component|Death|0|||
156569500|NCT03263091|565170440|FG001|OL High-EPO Component|Death|0|||
156569501|NCT03263091|565170441|FG002|OL High-EPO Component|Death|0|||
156569502|NCT03263091|565170442|FG003|OL High-EPO Component|Death|3|||
156569503|NCT03263091|565170443|FG004|OL High-EPO Component|Death|0|||
156569504|NCT03263091|565170444|FG005|OL High-EPO Component|Death|0|||
156569505|NCT03263091|565170439|FG000|DB Component|Withdrawal by Subject|0|||
156569506|NCT03263091|565170440|FG001|DB Component|Withdrawal by Subject|0|||
156569507|NCT03263091|565170441|FG002|DB Component|Withdrawal by Subject|0|||
156569508|NCT03263091|565170442|FG003|DB Component|Withdrawal by Subject|0|||
156569509|NCT03263091|565170443|FG004|DB Component|Withdrawal by Subject|22|||
156569510|NCT03263091|565170444|FG005|DB Component|Withdrawal by Subject|8|||
156569511|NCT03263091|565170439|FG000|DB Component|Physician Decision|0|||
156569512|NCT03263091|565170440|FG001|DB Component|Physician Decision|0|||
156569513|NCT03263091|565170441|FG002|DB Component|Physician Decision|0|||
156569514|NCT03263091|565170442|FG003|DB Component|Physician Decision|0|||
156569515|NCT03263091|565170443|FG004|DB Component|Physician Decision|3|||
156569516|NCT03263091|565170444|FG005|DB Component|Physician Decision|1|||
156569517|NCT03263091|565170439|FG000|DB Component|Adverse Event|0|||
156569518|NCT03263091|565170440|FG001|DB Component|Adverse Event|0|||
156569519|NCT03263091|565170441|FG002|DB Component|Adverse Event|0|||
156569520|NCT03263091|565170442|FG003|DB Component|Adverse Event|0|||
156569521|NCT03263091|565170443|FG004|DB Component|Adverse Event|2|||
156569522|NCT03263091|565170444|FG005|DB Component|Adverse Event|1|||
156569523|NCT03263091|565170439|FG000|DB Component|Lost to Follow-up|0|||
156569524|NCT03263091|565170440|FG001|DB Component|Lost to Follow-up|0|||
156569525|NCT03263091|565170441|FG002|DB Component|Lost to Follow-up|0|||
156569526|NCT03263091|565170442|FG003|DB Component|Lost to Follow-up|0|||
156569527|NCT03263091|565170443|FG004|DB Component|Lost to Follow-up|2|||
156569528|NCT03263091|565170444|FG005|DB Component|Lost to Follow-up|1|||
156569529|NCT03263091|565170439|FG000|DB Component|Death|0|||
156569530|NCT03263091|565170440|FG001|DB Component|Death|0|||
156569531|NCT03263091|565170441|FG002|DB Component|Death|0|||
156569532|NCT03263091|565170442|FG003|DB Component|Death|0|||
156569533|NCT03263091|565170443|FG004|DB Component|Death|7|||
156569534|NCT03263091|565170444|FG005|DB Component|Death|4|||
156569535|NCT03263091|565170439|FG000|DB Component|Other than specified|0|||
156569536|NCT03263091|565170440|FG001|DB Component|Other than specified|0|||
156569537|NCT03263091|565170441|FG002|DB Component|Other than specified|0|||
156569538|NCT03263091|565170442|FG003|DB Component|Other than specified|0|||
156569539|NCT03263091|565170443|FG004|DB Component|Other than specified|8|||
156569540|NCT03263091|565170444|FG005|DB Component|Other than specified|6|||
156569541|NCT00265941|565170446|FG000|Overall Study|Protocol Violation|22|||
156569542|NCT00265941|565170447|FG001|Overall Study|Protocol Violation|25|||
156569543|NCT00265941|565170446|FG000|Overall Study|Lost to Follow-up|1|||
156569544|NCT00265941|565170447|FG001|Overall Study|Lost to Follow-up|1|||
156569545|NCT03976401|565170451|FG000|Overall Study|Adverse Event|2|||
156569546|NCT03976401|565170452|FG001|Overall Study|Adverse Event|0|||
156569547|NCT03976401|565170453|FG002|Overall Study|Adverse Event|4|||
156569548|NCT03976401|565170454|FG003|Overall Study|Adverse Event|1|||
156569549|NCT03976401|565170455|FG004|Overall Study|Adverse Event|1|||
156569550|NCT03976401|565170456|FG005|Overall Study|Adverse Event|0|||
156569551|NCT03976401|565170451|FG000|Overall Study|Withdrawal by Subject|0|||
156569552|NCT03976401|565170452|FG001|Overall Study|Withdrawal by Subject|1|||
156569553|NCT03976401|565170453|FG002|Overall Study|Withdrawal by Subject|0|||
156569554|NCT03976401|565170454|FG003|Overall Study|Withdrawal by Subject|0|||
156569555|NCT03976401|565170455|FG004|Overall Study|Withdrawal by Subject|0|||
156569556|NCT03976401|565170456|FG005|Overall Study|Withdrawal by Subject|1|||
156569557|NCT03976401|565170451|FG000|Overall Study|Physician Decision|0|||
156569558|NCT03976401|565170452|FG001|Overall Study|Physician Decision|0|||
156569559|NCT03976401|565170453|FG002|Overall Study|Physician Decision|1|||
156569560|NCT03976401|565170454|FG003|Overall Study|Physician Decision|0|||
156569561|NCT03976401|565170455|FG004|Overall Study|Physician Decision|0|||
156569562|NCT03976401|565170456|FG005|Overall Study|Physician Decision|0|||
156569563|NCT03976401|565170451|FG000|Overall Study|Lost to Follow-up|1|||
156569564|NCT03976401|565170452|FG001|Overall Study|Lost to Follow-up|2|||
156569565|NCT03976401|565170453|FG002|Overall Study|Lost to Follow-up|0|||
156569566|NCT03976401|565170454|FG003|Overall Study|Lost to Follow-up|0|||
156569567|NCT03976401|565170455|FG004|Overall Study|Lost to Follow-up|0|||
156569568|NCT03976401|565170456|FG005|Overall Study|Lost to Follow-up|0|||
156569569|NCT03976401|565170451|FG000|Overall Study|Protocol Violation|0|||
156569570|NCT03976401|565170452|FG001|Overall Study|Protocol Violation|1|||
156569571|NCT03976401|565170453|FG002|Overall Study|Protocol Violation|0|||
156569572|NCT03976401|565170454|FG003|Overall Study|Protocol Violation|0|||
156569573|NCT03976401|565170455|FG004|Overall Study|Protocol Violation|0|||
156569574|NCT03976401|565170456|FG005|Overall Study|Protocol Violation|0|||
156569575|NCT03976401|565170451|FG000|Overall Study|Withdrew Consent|0|||
156569576|NCT03976401|565170452|FG001|Overall Study|Withdrew Consent|0|||
156569577|NCT03976401|565170453|FG002|Overall Study|Withdrew Consent|0|||
156569578|NCT03976401|565170454|FG003|Overall Study|Withdrew Consent|1|||
156569579|NCT03976401|565170455|FG004|Overall Study|Withdrew Consent|0|||
156569580|NCT03976401|565170456|FG005|Overall Study|Withdrew Consent|0|||
156569581|NCT00049127|565170457|FG000|Overall Study|Withdrawal by Subject|0|||
156569582|NCT00049127|565170458|FG001|Overall Study|Withdrawal by Subject|0|||
156569583|NCT00049127|565170459|FG002|Overall Study|Withdrawal by Subject|1|||
156569584|NCT00049127|565170460|FG003|Overall Study|Withdrawal by Subject|0|||
156569585|NCT00049127|565170461|FG004|Overall Study|Withdrawal by Subject|0|||
156569586|NCT00502840|565170470|FG000|Overall Study|Adverse Event|5|||
156569587|NCT00502840|565170470|FG000|Overall Study|Additional or changed therapy|48|||
156569588|NCT00502840|565170470|FG000|Overall Study|Lack of Efficacy|11|||
156569589|NCT00502840|565170470|FG000|Overall Study|Protocol Violation|4|||
156569590|NCT00502840|565170470|FG000|Overall Study|Withdrawal by Subject|5|||
156569591|NCT00502840|565170470|FG000|Overall Study|Lost to Follow-up|6|||
156569592|NCT00502840|565170470|FG000|Overall Study|Administrative problems|1|||
156569593|NCT00502840|565170470|FG000|Overall Study|Other|20|||
156569594|NCT02197377|565170471|FG000|Overall Study|Insertion Failure|0|||
156569595|NCT02197377|565170472|FG001|Overall Study|Insertion Failure|3|||
156569596|NCT01974323|565170473|FG000|Overall Study|Other Reasons|25|||
156569597|NCT01974323|565170474|FG001|Overall Study|Other Reasons|28|||
156569598|NCT01974323|565170473|FG000|Overall Study|Protocol Violation|2|||
156569599|NCT01974323|565170474|FG001|Overall Study|Protocol Violation|2|||
156569600|NCT01974323|565170473|FG000|Overall Study|Personal Reasons|15|||
156569601|NCT01974323|565170474|FG001|Overall Study|Personal Reasons|19|||
156569602|NCT01974323|565170473|FG000|Overall Study|Lost to Follow-up|45|||
156569603|NCT01974323|565170474|FG001|Overall Study|Lost to Follow-up|40|||
156569604|NCT01974323|565170473|FG000|Overall Study|Pregnancy|2|||
156569605|NCT01974323|565170474|FG001|Overall Study|Pregnancy|1|||
156569606|NCT01974323|565170473|FG000|Overall Study|Lack of Efficacy|1|||
156569607|NCT01974323|565170474|FG001|Overall Study|Lack of Efficacy|1|||
156569608|NCT01974323|565170473|FG000|Overall Study|Adverse Event|2|||
156569609|NCT01974323|565170474|FG001|Overall Study|Adverse Event|2|||
156569610|NCT00809133|565170475|FG000|Overall Study|Progressive disease|2|||
156569611|NCT00809133|565170476|FG001|Overall Study|Progressive disease|5|||
156569612|NCT00809133|565170477|FG002|Overall Study|Progressive disease|5|||
156569613|NCT00809133|565170478|FG003|Overall Study|Progressive disease|3|||
156569614|NCT00809133|565170479|FG004|Overall Study|Progressive disease|4|||
156569615|NCT00809133|565170480|FG005|Overall Study|Progressive disease|1|||
156569616|NCT00809133|565170481|FG006|Overall Study|Progressive disease|3|||
156569617|NCT00809133|565170482|FG007|Overall Study|Progressive disease|3|||
156569618|NCT00809133|565170483|FG008|Overall Study|Progressive disease|3|||
156569619|NCT00809133|565170484|FG009|Overall Study|Progressive disease|9|||
156569620|NCT00809133|565170485|FG010|Overall Study|Progressive disease|5|||
156569621|NCT00809133|565170486|FG011|Overall Study|Progressive disease|7|||
156569622|NCT00809133|565170487|FG012|Overall Study|Progressive disease|5|||
156569623|NCT00809133|565170488|FG013|Overall Study|Progressive disease|4|||
156569624|NCT00809133|565170475|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569625|NCT00809133|565170476|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569626|NCT00809133|565170477|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569627|NCT00809133|565170478|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569628|NCT00809133|565170479|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569629|NCT00809133|565170480|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156569630|NCT00809133|565170481|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156569631|NCT00809133|565170482|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156569632|NCT00809133|565170483|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569633|NCT00809133|565170484|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569634|NCT00809133|565170485|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569635|NCT00809133|565170486|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569636|NCT00809133|565170487|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156569637|NCT00809133|565170488|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156569638|NCT00809133|565170475|FG000|Overall Study|Other adverse event|1|||
156569639|NCT00809133|565170476|FG001|Overall Study|Other adverse event|1|||
156569640|NCT00809133|565170477|FG002|Overall Study|Other adverse event|1|||
156569641|NCT00809133|565170478|FG003|Overall Study|Other adverse event|0|||
156569642|NCT00809133|565170479|FG004|Overall Study|Other adverse event|0|||
156569643|NCT00809133|565170480|FG005|Overall Study|Other adverse event|3|||
156569644|NCT00809133|565170481|FG006|Overall Study|Other adverse event|2|||
156569645|NCT00809133|565170482|FG007|Overall Study|Other adverse event|4|||
156569646|NCT00809133|565170483|FG008|Overall Study|Other adverse event|0|||
156569647|NCT00809133|565170484|FG009|Overall Study|Other adverse event|0|||
156569648|NCT00809133|565170485|FG010|Overall Study|Other adverse event|1|||
156569649|NCT00809133|565170486|FG011|Overall Study|Other adverse event|1|||
156569650|NCT00809133|565170487|FG012|Overall Study|Other adverse event|0|||
156569651|NCT00809133|565170488|FG013|Overall Study|Other adverse event|1|||
156569652|NCT00809133|565170475|FG000|Overall Study|Lost to Follow-up|0|||
156569653|NCT00809133|565170476|FG001|Overall Study|Lost to Follow-up|0|||
156569654|NCT00809133|565170477|FG002|Overall Study|Lost to Follow-up|0|||
156569655|NCT00809133|565170478|FG003|Overall Study|Lost to Follow-up|0|||
156569656|NCT00809133|565170479|FG004|Overall Study|Lost to Follow-up|0|||
156569657|NCT00809133|565170480|FG005|Overall Study|Lost to Follow-up|1|||
156569658|NCT00809133|565170481|FG006|Overall Study|Lost to Follow-up|0|||
156569659|NCT00809133|565170482|FG007|Overall Study|Lost to Follow-up|0|||
156569660|NCT00809133|565170483|FG008|Overall Study|Lost to Follow-up|0|||
156569661|NCT00809133|565170484|FG009|Overall Study|Lost to Follow-up|0|||
156569662|NCT00809133|565170485|FG010|Overall Study|Lost to Follow-up|0|||
156569663|NCT00809133|565170486|FG011|Overall Study|Lost to Follow-up|0|||
156569664|NCT00809133|565170487|FG012|Overall Study|Lost to Follow-up|0|||
156569665|NCT00809133|565170488|FG013|Overall Study|Lost to Follow-up|0|||
156569666|NCT00809133|565170475|FG000|Overall Study|Consent withdrawn|0|||
156569667|NCT00809133|565170476|FG001|Overall Study|Consent withdrawn|0|||
156569668|NCT00809133|565170477|FG002|Overall Study|Consent withdrawn|0|||
156569669|NCT00809133|565170478|FG003|Overall Study|Consent withdrawn|0|||
156569670|NCT00809133|565170479|FG004|Overall Study|Consent withdrawn|1|||
156569671|NCT00809133|565170480|FG005|Overall Study|Consent withdrawn|0|||
156569672|NCT00809133|565170481|FG006|Overall Study|Consent withdrawn|0|||
156569673|NCT00809133|565170482|FG007|Overall Study|Consent withdrawn|0|||
156569674|NCT00809133|565170483|FG008|Overall Study|Consent withdrawn|0|||
156569675|NCT00809133|565170484|FG009|Overall Study|Consent withdrawn|0|||
156569676|NCT00809133|565170485|FG010|Overall Study|Consent withdrawn|0|||
156569677|NCT00809133|565170486|FG011|Overall Study|Consent withdrawn|0|||
156569678|NCT00809133|565170487|FG012|Overall Study|Consent withdrawn|0|||
156569679|NCT00809133|565170488|FG013|Overall Study|Consent withdrawn|0|||
156569680|NCT00809133|565170475|FG000|Overall Study|Other not mentioned above|0|||
156569681|NCT00809133|565170476|FG001|Overall Study|Other not mentioned above|1|||
156569682|NCT00809133|565170477|FG002|Overall Study|Other not mentioned above|0|||
156569683|NCT00809133|565170478|FG003|Overall Study|Other not mentioned above|0|||
156569684|NCT00809133|565170479|FG004|Overall Study|Other not mentioned above|0|||
156569685|NCT00809133|565170480|FG005|Overall Study|Other not mentioned above|1|||
156569686|NCT00809133|565170481|FG006|Overall Study|Other not mentioned above|0|||
156569687|NCT00809133|565170482|FG007|Overall Study|Other not mentioned above|0|||
156569688|NCT00809133|565170483|FG008|Overall Study|Other not mentioned above|0|||
156569689|NCT00809133|565170484|FG009|Overall Study|Other not mentioned above|0|||
156569690|NCT00809133|565170485|FG010|Overall Study|Other not mentioned above|0|||
156569691|NCT00809133|565170486|FG011|Overall Study|Other not mentioned above|0|||
156569692|NCT00809133|565170487|FG012|Overall Study|Other not mentioned above|0|||
156569693|NCT00809133|565170488|FG013|Overall Study|Other not mentioned above|0|||
156569694|NCT00833092|565170490|FG000|Overall Study|Withdrawal by Subject|2|||
156569695|NCT00833092|565170491|FG001|Overall Study|Withdrawal by Subject|3|||
156569696|NCT00833092|565170490|FG000|Overall Study|Protocol Violation|2|||
156569697|NCT00833092|565170491|FG001|Overall Study|Protocol Violation|1|||
156569698|NCT00833092|565170490|FG000|Overall Study|Diarrhea|0|||
156569699|NCT00833092|565170491|FG001|Overall Study|Diarrhea|2|||
156569700|NCT00833092|565170490|FG000|Overall Study|constipation|0|||
156569701|NCT00833092|565170491|FG001|Overall Study|constipation|1|||
156569702|NCT00619229|565170492|FG000|Overall Study|Withdrawal by Subject|1|||
156569703|NCT00619229|565170493|FG001|Overall Study|Withdrawal by Subject|1|||
156569704|NCT00619229|565170492|FG000|Overall Study|Lost to Follow-up|1|||
156569705|NCT00619229|565170493|FG001|Overall Study|Lost to Follow-up|0|||
156569706|NCT00619229|565170492|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
156569707|NCT00619229|565170493|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
156569708|NCT00619229|565170492|FG000|Overall Study|Investigator planned Cataract Operation|1|||
156569709|NCT00619229|565170493|FG001|Overall Study|Investigator planned Cataract Operation|0|||
156569710|NCT01700829|565170494|FG000|Overall Study|Withdrawal by Subject|1|||
156569711|NCT01700829|565170495|FG001|Overall Study|Withdrawal by Subject|1|||
156569712|NCT03417440|565170496|FG000|Overall Study|Lost to Follow-up|0|||
156569713|NCT03417440|565170497|FG001|Overall Study|Lost to Follow-up|1|||
156569714|NCT03417440|565170498|FG002|Overall Study|Lost to Follow-up|0|||
156569715|NCT03417440|565170499|FG003|Overall Study|Lost to Follow-up|0|||
156569716|NCT03417440|565170500|FG004|Overall Study|Lost to Follow-up|1|||
156569717|NCT03417440|565170501|FG005|Overall Study|Lost to Follow-up|0|||
156569718|NCT03417440|565170502|FG006|Overall Study|Lost to Follow-up|0|||
156569719|NCT03417440|565170503|FG007|Overall Study|Lost to Follow-up|0|||
156569720|NCT03417440|565170496|FG000|Overall Study|Withdrawal by Subject|2|||
156569721|NCT03417440|565170497|FG001|Overall Study|Withdrawal by Subject|0|||
156569722|NCT03417440|565170498|FG002|Overall Study|Withdrawal by Subject|2|||
156569723|NCT03417440|565170499|FG003|Overall Study|Withdrawal by Subject|1|||
156569724|NCT03417440|565170500|FG004|Overall Study|Withdrawal by Subject|1|||
156569725|NCT03417440|565170501|FG005|Overall Study|Withdrawal by Subject|0|||
156569726|NCT03417440|565170502|FG006|Overall Study|Withdrawal by Subject|0|||
156569727|NCT03417440|565170503|FG007|Overall Study|Withdrawal by Subject|1|||
156569728|NCT02983604|565170504|FG000|Overall Study|Enrolled but not Treated|0|||
156569729|NCT02983604|565170505|FG001|Overall Study|Enrolled but not Treated|0|||
156569730|NCT02983604|565170506|FG002|Overall Study|Enrolled but not Treated|1|||
156569731|NCT02983604|565170507|FG003|Overall Study|Enrolled but not Treated|0|||
156569732|NCT00355264|565170508|FG000|Extension (Variable Duration)|Adverse Event|1|||
156569733|NCT00355264|565170508|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
156569734|NCT00466505|565170509|FG000|Overall Study|disease progression|13|||
156569735|NCT00466505|565170509|FG000|Overall Study|Adverse Event|4|||
156569736|NCT01451645|565170510|FG000|Overall Study|Protocol Violation|1|||
156569737|NCT01451645|565170511|FG001|Overall Study|Protocol Violation|0|||
156569738|NCT01451645|565170510|FG000|Overall Study|Adverse Event|0|||
156569739|NCT01451645|565170511|FG001|Overall Study|Adverse Event|3|||
156569740|NCT01451645|565170510|FG000|Overall Study|Withdrawal by Subject|4|||
156569741|NCT01451645|565170511|FG001|Overall Study|Withdrawal by Subject|2|||
156569742|NCT01451645|565170510|FG000|Overall Study|Lost to Follow-up|4|||
156569743|NCT01451645|565170511|FG001|Overall Study|Lost to Follow-up|3|||
156569744|NCT04919564|565170520|FG000|Overall Study|Lost to Follow-up|1|||
156569745|NCT04919564|565170521|FG001|Overall Study|Lost to Follow-up|0|||
156569746|NCT04919564|565170520|FG000|Overall Study|Physician Decision|1|||
156569747|NCT04919564|565170521|FG001|Overall Study|Physician Decision|1|||
156569748|NCT01241786|565170522|FG000|Overall Study|Lack of Efficacy|5|||
156569749|NCT02203149|565170523|FG000|Part 1|Adverse Event|0|||
156569750|NCT02203149|565170524|FG001|Part 1|Adverse Event|1|||
156569751|NCT02203149|565170525|FG002|Part 1|Adverse Event|0|||
156569752|NCT02203149|565170526|FG003|Part 1|Adverse Event|0|||
156569753|NCT02203149|565170527|FG004|Part 1|Adverse Event|0|||
156569754|NCT02203149|565170523|FG000|Part 2|Death|0|||
156569755|NCT02203149|565170524|FG001|Part 2|Death|0|||
156569756|NCT02203149|565170525|FG002|Part 2|Death|1|||
156569757|NCT02203149|565170526|FG003|Part 2|Death|1|||
156569758|NCT02203149|565170527|FG004|Part 2|Death|0|||
156569759|NCT02203149|565170523|FG000|Part 2|Withdrawal by Subject|0|||
156569760|NCT02203149|565170524|FG001|Part 2|Withdrawal by Subject|0|||
156569761|NCT02203149|565170525|FG002|Part 2|Withdrawal by Subject|0|||
156569762|NCT02203149|565170526|FG003|Part 2|Withdrawal by Subject|1|||
156569763|NCT02203149|565170527|FG004|Part 2|Withdrawal by Subject|0|||
156569764|NCT02203149|565170523|FG000|Part 2|Adverse Event|0|||
156569765|NCT02203149|565170524|FG001|Part 2|Adverse Event|0|||
156569766|NCT02203149|565170525|FG002|Part 2|Adverse Event|0|||
156569767|NCT02203149|565170526|FG003|Part 2|Adverse Event|1|||
156569768|NCT02203149|565170527|FG004|Part 2|Adverse Event|1|||
156569769|NCT02537678|565170528|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
156569770|NCT02537678|565170529|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
156569771|NCT02537678|565170528|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
156569772|NCT02537678|565170529|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
156569773|NCT02537678|565170528|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
156569774|NCT02537678|565170529|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
156569775|NCT02537678|565170528|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
156569776|NCT02537678|565170529|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
156569777|NCT02537678|565170528|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
156569778|NCT02537678|565170529|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
156569779|NCT02537678|565170528|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
156569780|NCT02537678|565170529|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
156569781|NCT02537678|565170528|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
156569782|NCT02537678|565170529|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
156569783|NCT00432809|565170530|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
156569784|NCT00432809|565170531|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
156569785|NCT00432809|565170532|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
156569786|NCT00432809|565170530|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
156569787|NCT00432809|565170531|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
156569788|NCT00432809|565170532|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
156569789|NCT01658514|565170533|FG000|Overall Study|Protocol Violation|1|||
156569790|NCT01658514|565170534|FG001|Overall Study|Protocol Violation|0|||
156569791|NCT01658514|565170535|FG002|Overall Study|Protocol Violation|2|||
156569792|NCT00144170|565170536|FG000|Overall Study|Adverse Event|84|||
156569793|NCT00144170|565170537|FG001|Overall Study|Adverse Event|41|||
156569794|NCT00144170|565170536|FG000|Overall Study|Protocol Violation|23|||
156569795|NCT00144170|565170537|FG001|Overall Study|Protocol Violation|16|||
156569796|NCT00144170|565170536|FG000|Overall Study|Lost to Follow-up|5|||
156569797|NCT00144170|565170537|FG001|Overall Study|Lost to Follow-up|10|||
156569798|NCT00144170|565170536|FG000|Overall Study|Withdrawal by Subject|29|||
156569799|NCT00144170|565170537|FG001|Overall Study|Withdrawal by Subject|13|||
156569800|NCT00144170|565170536|FG000|Overall Study|Other reason not defined above|211|||
156569801|NCT00144170|565170537|FG001|Overall Study|Other reason not defined above|316|||
156569802|NCT00981526|565170538|FG000|Overall Study|Withdrawal by Subject|0|||
156569803|NCT00981526|565170539|FG001|Overall Study|Withdrawal by Subject|2|||
156569804|NCT00981526|565170538|FG000|Overall Study|Physician Decision|4|||
156569805|NCT00981526|565170539|FG001|Overall Study|Physician Decision|4|||
156569806|NCT00332202|565170540|FG000|Overall Study|Adverse Event|72|||
156569807|NCT00332202|565170541|FG001|Overall Study|Adverse Event|28|||
156569808|NCT00332202|565170540|FG000|Overall Study|Lost to Follow-up|2|||
156569809|NCT00332202|565170541|FG001|Overall Study|Lost to Follow-up|1|||
156569810|NCT00332202|565170540|FG000|Overall Study|Physician Decision|6|||
156569811|NCT00332202|565170541|FG001|Overall Study|Physician Decision|8|||
156569812|NCT00332202|565170540|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
156569813|NCT00332202|565170541|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
156569814|NCT00332202|565170540|FG000|Overall Study|Protocol Violation|7|||
156569815|NCT00332202|565170541|FG001|Overall Study|Protocol Violation|2|||
156569816|NCT00332202|565170540|FG000|Overall Study|Sponsor Decision|1|||
156569817|NCT00332202|565170541|FG001|Overall Study|Sponsor Decision|2|||
156569818|NCT00332202|565170540|FG000|Overall Study|Withdrawal by Subject|36|||
156569819|NCT00332202|565170541|FG001|Overall Study|Withdrawal by Subject|17|||
156569820|NCT00332202|565170540|FG000|Overall Study|Progressive Disease|106|||
156569821|NCT00332202|565170541|FG001|Overall Study|Progressive Disease|60|||
156569822|NCT00332202|565170540|FG000|Overall Study|Death|5|||
156569823|NCT00332202|565170541|FG001|Overall Study|Death|2|||
156569824|NCT00957853|565170542|FG000|Overall Study|Withdrawal by Subject|1|||
156569825|NCT00957853|565170543|FG001|Overall Study|Withdrawal by Subject|0|||
156569826|NCT00957853|565170544|FG002|Overall Study|Withdrawal by Subject|0|||
156569827|NCT02495948|565170547|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
156569828|NCT02495948|565170548|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
156569829|NCT02495948|565170547|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
156569830|NCT02495948|565170548|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
156569831|NCT00100048|565170549|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
156569832|NCT00100048|565170550|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
156569833|NCT00100048|565170551|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
156569834|NCT00100048|565170552|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
156569835|NCT00100048|565170553|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
156569836|NCT00100048|565170554|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
156569837|NCT00100048|565170549|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
156569838|NCT00100048|565170550|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
156569839|NCT00100048|565170551|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
156569840|NCT00100048|565170552|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
156569841|NCT00100048|565170553|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
156569842|NCT00100048|565170554|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
156569843|NCT00100048|565170549|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
156569844|NCT00100048|565170550|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
156569845|NCT00100048|565170551|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
156569846|NCT00100048|565170552|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
156569847|NCT00100048|565170553|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
156569848|NCT00100048|565170554|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
156569849|NCT00100048|565170549|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
156569850|NCT00100048|565170550|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
156569851|NCT00100048|565170551|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
156569852|NCT00100048|565170552|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
156569853|NCT00100048|565170553|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
156569854|NCT00100048|565170554|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
156569855|NCT00100048|565170549|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
156569856|NCT00100048|565170550|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
156569857|NCT00100048|565170551|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
156569858|NCT00100048|565170552|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
156569859|NCT00100048|565170553|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
156569860|NCT00100048|565170554|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
156569861|NCT00100048|565170549|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
156569862|NCT00100048|565170550|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
156569863|NCT00100048|565170551|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
156569864|NCT00100048|565170552|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
156635577|NCT00602667|565409962|FG002|Overall Study|Progressive disease|45|||
156569865|NCT00100048|565170553|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
156569866|NCT00100048|565170554|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
156569867|NCT00100048|565170549|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
156569868|NCT00100048|565170550|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
156569869|NCT00100048|565170551|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
156569870|NCT00100048|565170552|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
156569871|NCT00100048|565170553|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
156569872|NCT00100048|565170554|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
156569873|NCT00100048|565170549|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
156569874|NCT00100048|565170550|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
156569875|NCT00100048|565170551|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
156569876|NCT00100048|565170552|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
156569877|NCT00100048|565170553|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
156569878|NCT00100048|565170554|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
156569879|NCT02970929|565170557|FG000|Overall Study|Adverse Event|18|||
156569880|NCT02970929|565170557|FG000|Overall Study|Lack of Efficacy|8|||
156569881|NCT02970929|565170557|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
156569882|NCT02970929|565170557|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
156569883|NCT02970929|565170557|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
156569884|NCT02970929|565170557|FG000|Overall Study|LOST TO FOLLOWUP|6|||
156569885|NCT02970929|565170557|FG000|Overall Study|MOVED OUT OF STATE|1|||
156569886|NCT02970929|565170557|FG000|Overall Study|Withdrawal by Subject|16|||
156569887|NCT02370121|565170562|FG000|Overall Study|Lost to Follow-up|1|||
156569888|NCT02370121|565170563|FG001|Overall Study|Lost to Follow-up|1|||
156569889|NCT02654002|565170570|FG000|Overall Study|Adverse Event|0|||
156569890|NCT02654002|565170571|FG001|Overall Study|Adverse Event|0|||
156569891|NCT02654002|565170572|FG002|Overall Study|Adverse Event|0|||
156569892|NCT02654002|565170573|FG003|Overall Study|Adverse Event|0|||
156569893|NCT02654002|565170574|FG004|Overall Study|Adverse Event|0|||
156569894|NCT02654002|565170575|FG005|Overall Study|Adverse Event|0|||
156569895|NCT02654002|565170576|FG006|Overall Study|Adverse Event|1|||
156569896|NCT02654002|565170577|FG007|Overall Study|Adverse Event|0|||
156569897|NCT02654002|565170578|FG008|Overall Study|Adverse Event|0|||
156569898|NCT02654002|565170570|FG000|Overall Study|Withdrew Consent|0|||
156569899|NCT02654002|565170571|FG001|Overall Study|Withdrew Consent|0|||
156569900|NCT02654002|565170572|FG002|Overall Study|Withdrew Consent|0|||
156569901|NCT02654002|565170573|FG003|Overall Study|Withdrew Consent|0|||
156569902|NCT02654002|565170574|FG004|Overall Study|Withdrew Consent|0|||
156569903|NCT02654002|565170575|FG005|Overall Study|Withdrew Consent|1|||
156569904|NCT02654002|565170576|FG006|Overall Study|Withdrew Consent|0|||
156569905|NCT02654002|565170577|FG007|Overall Study|Withdrew Consent|1|||
156569906|NCT02654002|565170578|FG008|Overall Study|Withdrew Consent|0|||
156569907|NCT01523873|565170579|FG000|Overall Study|Protocol Violation|422|||
156569908|NCT00275561|565170582|FG000|Overall Study|Withdrawal by Subject|0|||
156569909|NCT00275561|565170583|FG001|Overall Study|Withdrawal by Subject|1|||
156569910|NCT00275561|565170582|FG000|Overall Study|Travel|1|||
156569911|NCT00275561|565170583|FG001|Overall Study|Travel|1|||
156569912|NCT00275561|565170582|FG000|Overall Study|Scheduling|1|||
156569913|NCT00275561|565170583|FG001|Overall Study|Scheduling|2|||
156569914|NCT00275561|565170582|FG000|Overall Study|Family Issues|0|||
156569915|NCT00275561|565170583|FG001|Overall Study|Family Issues|2|||
156569916|NCT01769105|565170588|FG000|First Intervention|Protocol Violation|2|||
156569917|NCT01769105|565170589|FG001|First Intervention|Protocol Violation|2|||
156569918|NCT01769105|565170588|FG000|Cross-over|Lost to Follow-up|5|||
156569919|NCT01769105|565170589|FG001|Cross-over|Lost to Follow-up|0|||
156569920|NCT03182738|565171946|FG000|Overall Study|Lost to Follow-up|9|||
156569921|NCT03182738|565171947|FG001|Overall Study|Lost to Follow-up|3|||
156569922|NCT03182738|565171946|FG000|Overall Study|Pregnancy|0|||
156569923|NCT03182738|565171947|FG001|Overall Study|Pregnancy|1|||
156569924|NCT03182738|565171946|FG000|Overall Study|Withdrawal by Subject|0|||
156569925|NCT03182738|565171947|FG001|Overall Study|Withdrawal by Subject|1|||
156569926|NCT00446030|565171948|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
156569927|NCT00446030|565171949|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
156569928|NCT00446030|565171948|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
156569929|NCT00446030|565171949|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
156569930|NCT00446030|565171948|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
156569931|NCT00446030|565171949|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
156569932|NCT00446030|565171948|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
156569933|NCT00446030|565171949|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
156569934|NCT00446030|565171948|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
156569935|NCT00446030|565171949|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
156569936|NCT00446030|565171948|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
156569937|NCT00446030|565171949|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
156569938|NCT00446030|565171948|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
156569939|NCT00446030|565171949|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
156569940|NCT00446030|565171948|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
156569941|NCT00446030|565171949|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
156569942|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
156569943|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
156569944|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
156569945|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
156569946|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
156569947|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
156569948|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
156569949|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
156569950|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
156569951|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
156569952|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
156569953|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
156569954|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
156569955|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
156569956|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
156569957|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
156569958|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
156569959|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
156569960|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
156569961|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
156569962|NCT00446030|565171948|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
156569963|NCT00446030|565171949|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
156569964|NCT02886715|565171950|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156569965|NCT02886715|565171951|FG001|Overall Study|Non-Compliance With Study Drug|2|||
156569966|NCT02886715|565171952|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156569967|NCT02886715|565171950|FG000|Overall Study|Adverse Event|4|||
156569968|NCT02886715|565171951|FG001|Overall Study|Adverse Event|2|||
156569969|NCT02886715|565171952|FG002|Overall Study|Adverse Event|0|||
156569970|NCT02886715|565171950|FG000|Overall Study|Lack of Efficacy|0|||
156569971|NCT02886715|565171951|FG001|Overall Study|Lack of Efficacy|2|||
156569972|NCT02886715|565171952|FG002|Overall Study|Lack of Efficacy|1|||
156569973|NCT02886715|565171950|FG000|Overall Study|Lost to Follow-up|29|||
156569974|NCT02886715|565171951|FG001|Overall Study|Lost to Follow-up|26|||
156569975|NCT02886715|565171952|FG002|Overall Study|Lost to Follow-up|10|||
156569976|NCT02886715|565171950|FG000|Overall Study|Pregnancy|1|||
156569977|NCT02886715|565171951|FG001|Overall Study|Pregnancy|1|||
156569978|NCT02886715|565171952|FG002|Overall Study|Pregnancy|1|||
156569979|NCT02886715|565171950|FG000|Overall Study|Protocol Violation|3|||
156569980|NCT02886715|565171951|FG001|Overall Study|Protocol Violation|2|||
156569981|NCT02886715|565171952|FG002|Overall Study|Protocol Violation|1|||
156569982|NCT02886715|565171950|FG000|Overall Study|Withdrawal by Subject|20|||
156569983|NCT02886715|565171951|FG001|Overall Study|Withdrawal by Subject|18|||
156569984|NCT02886715|565171952|FG002|Overall Study|Withdrawal by Subject|5|||
156569985|NCT02886715|565171950|FG000|Overall Study|missing|7|||
156569986|NCT02886715|565171951|FG001|Overall Study|missing|2|||
156569987|NCT02886715|565171952|FG002|Overall Study|missing|2|||
156569988|NCT00503399|565171953|FG000|Overall Study|Death|2|||
156569989|NCT00503399|565171954|FG001|Overall Study|Death|1|||
156569990|NCT00503399|565171953|FG000|Overall Study|Protocol Violation|1|||
156569991|NCT00503399|565171954|FG001|Overall Study|Protocol Violation|0|||
156569992|NCT00503399|565171953|FG000|Overall Study|Withdrawal by Subject|4|||
156569993|NCT00503399|565171954|FG001|Overall Study|Withdrawal by Subject|2|||
156569994|NCT00503399|565171953|FG000|Overall Study|Adverse Event|0|||
156569995|NCT00503399|565171954|FG001|Overall Study|Adverse Event|3|||
156569996|NCT00503399|565171953|FG000|Overall Study|Lost to Follow-up|0|||
156569997|NCT00503399|565171954|FG001|Overall Study|Lost to Follow-up|2|||
156569998|NCT01676961|565171955|FG000|Overall Study|Death|3|||
156569999|NCT01676961|565171955|FG000|Overall Study|Lost to Follow-up|1|||
156570000|NCT01676961|565171955|FG000|Overall Study|Withdrawal by Subject|1|||
156570001|NCT03168867|565171958|FG000|Overall Study|Withdrawal by Subject|1|||
156570002|NCT03168867|565171959|FG001|Overall Study|Withdrawal by Subject|5|||
156570003|NCT00858832|565171960|FG000|Overall Study|became ineligible: delivered vaginally|1|||
156570004|NCT00858832|565171961|FG001|Overall Study|became ineligible: delivered vaginally|0|||
156570005|NCT00858832|565171960|FG000|Overall Study|Adverse Event|0|||
156570006|NCT00858832|565171961|FG001|Overall Study|Adverse Event|1|||
156570007|NCT05292755|565171962|FG000|Overall Study|Lost to Follow-up|5|||
156570008|NCT05292755|565171963|FG001|Overall Study|Lost to Follow-up|9|||
156570009|NCT00519077|565171968|FG000|Overall Study|Death|6|||
156570010|NCT00519077|565171968|FG000|Overall Study|Other|2|||
156570011|NCT02286102|565171969|FG000|Overall Study|Screen Failure|1|||
156570012|NCT02286102|565171970|FG001|Overall Study|Screen Failure|1|||
156570013|NCT01967225|565171971|FG000|Overall Study|Adverse Event|3|||
156570014|NCT01967225|565171972|FG001|Overall Study|Adverse Event|1|||
156570015|NCT01967225|565171971|FG000|Overall Study|Withdrawal by Subject|2|||
156570016|NCT01967225|565171972|FG001|Overall Study|Withdrawal by Subject|1|||
156570017|NCT01967225|565171971|FG000|Overall Study|Lack of Efficacy|1|||
156570018|NCT01967225|565171972|FG001|Overall Study|Lack of Efficacy|1|||
156570019|NCT01967225|565171971|FG000|Overall Study|Switching to other therapy|2|||
156570020|NCT01967225|565171972|FG001|Overall Study|Switching to other therapy|0|||
156570021|NCT01967225|565171971|FG000|Overall Study|Protocol driven decision point|1|||
156570022|NCT01967225|565171972|FG001|Overall Study|Protocol driven decision point|0|||
156570023|NCT01967225|565171971|FG000|Overall Study|Logistical difficulties|1|||
156570024|NCT01967225|565171972|FG001|Overall Study|Logistical difficulties|0|||
156570025|NCT01967225|565171971|FG000|Overall Study|Protocol Violation|2|||
156570026|NCT01967225|565171972|FG001|Overall Study|Protocol Violation|0|||
156570027|NCT01440101|565171973|FG000|Overall Study|Adverse Event|2|||
156570028|NCT01440101|565171974|FG001|Overall Study|Adverse Event|0|||
156570029|NCT01440101|565171975|FG002|Overall Study|Adverse Event|0|||
156570030|NCT01440101|565171973|FG000|Overall Study|Withdrawal by Subject|0|||
156570031|NCT01440101|565171974|FG001|Overall Study|Withdrawal by Subject|3|||
156570032|NCT01440101|565171975|FG002|Overall Study|Withdrawal by Subject|1|||
156570033|NCT01440101|565171973|FG000|Overall Study|Other|0|||
156570034|NCT01440101|565171974|FG001|Overall Study|Other|1|||
156570035|NCT01440101|565171975|FG002|Overall Study|Other|0|||
156570036|NCT02305563|565171978|FG000|Treatment Period|Disease progression|0|||
156570037|NCT02305563|565171979|FG001|Treatment Period|Disease progression|0|||
156570038|NCT02305563|565171980|FG002|Treatment Period|Disease progression|15|||
156570039|NCT02305563|565171981|FG003|Treatment Period|Disease progression|6|||
156570040|NCT02305563|565171982|FG004|Treatment Period|Disease progression|6|||
156570041|NCT02305563|565171978|FG000|Treatment Period|Study drug toxicity|0|||
156570042|NCT02305563|565171979|FG001|Treatment Period|Study drug toxicity|0|||
156570043|NCT02305563|565171980|FG002|Treatment Period|Study drug toxicity|0|||
156570044|NCT02305563|565171981|FG003|Treatment Period|Study drug toxicity|1|||
156570045|NCT02305563|565171982|FG004|Treatment Period|Study drug toxicity|2|||
156570046|NCT02305563|565171978|FG000|Treatment Period|Death|0|||
156570047|NCT02305563|565171979|FG001|Treatment Period|Death|0|||
156570048|NCT02305563|565171980|FG002|Treatment Period|Death|1|||
156570049|NCT02305563|565171981|FG003|Treatment Period|Death|2|||
156570050|NCT02305563|565171982|FG004|Treatment Period|Death|1|||
156570051|NCT02305563|565171978|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
156570052|NCT02305563|565171979|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
156570053|NCT02305563|565171980|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
156570054|NCT02305563|565171981|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
156570055|NCT02305563|565171982|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
156570056|NCT02305563|565171978|FG000|Treatment Period|Participant request to stop therapy|0|||
156570057|NCT02305563|565171979|FG001|Treatment Period|Participant request to stop therapy|2|||
156570058|NCT02305563|565171980|FG002|Treatment Period|Participant request to stop therapy|0|||
156570059|NCT02305563|565171981|FG003|Treatment Period|Participant request to stop therapy|1|||
156570060|NCT02305563|565171982|FG004|Treatment Period|Participant request to stop therapy|0|||
156570061|NCT02305563|565171978|FG000|Treatment Period|Participant withdrew consent|0|||
156570062|NCT02305563|565171979|FG001|Treatment Period|Participant withdrew consent|0|||
156570063|NCT02305563|565171980|FG002|Treatment Period|Participant withdrew consent|1|||
156570064|NCT02305563|565171981|FG003|Treatment Period|Participant withdrew consent|1|||
156570065|NCT02305563|565171982|FG004|Treatment Period|Participant withdrew consent|1|||
156570066|NCT02305563|565171978|FG000|Treatment Period|Maximum clinical benefit|0|||
156570067|NCT02305563|565171979|FG001|Treatment Period|Maximum clinical benefit|0|||
156570068|NCT02305563|565171980|FG002|Treatment Period|Maximum clinical benefit|0|||
156570069|NCT02305563|565171981|FG003|Treatment Period|Maximum clinical benefit|0|||
156570070|NCT02305563|565171982|FG004|Treatment Period|Maximum clinical benefit|1|||
156570071|NCT02305563|565171978|FG000|Treatment Period|Poor/non-compliance|0|||
156570072|NCT02305563|565171979|FG001|Treatment Period|Poor/non-compliance|0|||
156570073|NCT02305563|565171980|FG002|Treatment Period|Poor/non-compliance|0|||
156570074|NCT02305563|565171981|FG003|Treatment Period|Poor/non-compliance|0|||
156570075|NCT02305563|565171982|FG004|Treatment Period|Poor/non-compliance|1|||
156570076|NCT02305563|565171978|FG000|Treatment Period|Administrative reason by Sponsor|0|||
156570077|NCT02305563|565171979|FG001|Treatment Period|Administrative reason by Sponsor|0|||
156570078|NCT02305563|565171980|FG002|Treatment Period|Administrative reason by Sponsor|0|||
156570079|NCT02305563|565171981|FG003|Treatment Period|Administrative reason by Sponsor|0|||
156570080|NCT02305563|565171982|FG004|Treatment Period|Administrative reason by Sponsor|1|||
156570081|NCT02305563|565171978|FG000|Treatment Period|other reason|2|||
156570082|NCT02305563|565171979|FG001|Treatment Period|other reason|0|||
156570083|NCT02305563|565171980|FG002|Treatment Period|other reason|2|||
156570084|NCT02305563|565171981|FG003|Treatment Period|other reason|2|||
156570085|NCT02305563|565171982|FG004|Treatment Period|other reason|1|||
156570086|NCT02305563|565171978|FG000|Treatment Period|Randomized but not treated|0|||
156570087|NCT02305563|565171979|FG001|Treatment Period|Randomized but not treated|0|||
156570088|NCT02305563|565171980|FG002|Treatment Period|Randomized but not treated|0|||
156570089|NCT02305563|565171981|FG003|Treatment Period|Randomized but not treated|0|||
156570090|NCT02305563|565171982|FG004|Treatment Period|Randomized but not treated|2|||
156570091|NCT02305563|565171978|FG000|Treatment Period|added ULO, then disease progression|0|||
156570092|NCT02305563|565171979|FG001|Treatment Period|added ULO, then disease progression|0|||
156570093|NCT02305563|565171980|FG002|Treatment Period|added ULO, then disease progression|0|||
156570094|NCT02305563|565171981|FG003|Treatment Period|added ULO, then disease progression|0|||
156570095|NCT02305563|565171982|FG004|Treatment Period|added ULO, then disease progression|4|||
156570096|NCT02305563|565171978|FG000|Treatment Period|added ULO; then other reason|0|||
156570097|NCT02305563|565171979|FG001|Treatment Period|added ULO; then other reason|0|||
156570098|NCT02305563|565171980|FG002|Treatment Period|added ULO; then other reason|0|||
156570099|NCT02305563|565171981|FG003|Treatment Period|added ULO; then other reason|0|||
156570100|NCT02305563|565171982|FG004|Treatment Period|added ULO; then other reason|1|||
156570101|NCT02305563|565171978|FG000|Treatment Period|added ULO, then request to stop|0|||
156570102|NCT02305563|565171979|FG001|Treatment Period|added ULO, then request to stop|0|||
156570103|NCT02305563|565171980|FG002|Treatment Period|added ULO, then request to stop|0|||
156570104|NCT02305563|565171981|FG003|Treatment Period|added ULO, then request to stop|0|||
156570105|NCT02305563|565171982|FG004|Treatment Period|added ULO, then request to stop|1|||
156570106|NCT02305563|565171978|FG000|Follow-up Period|Death|0|||
156570107|NCT02305563|565171979|FG001|Follow-up Period|Death|0|||
156570108|NCT02305563|565171980|FG002|Follow-up Period|Death|5|||
156570109|NCT02305563|565171981|FG003|Follow-up Period|Death|4|||
156570110|NCT02305563|565171982|FG004|Follow-up Period|Death|7|||
156570111|NCT02305563|565171978|FG000|Follow-up Period|Participant withdrew consent|0|||
156570112|NCT02305563|565171979|FG001|Follow-up Period|Participant withdrew consent|0|||
156570113|NCT02305563|565171980|FG002|Follow-up Period|Participant withdrew consent|2|||
156570114|NCT02305563|565171981|FG003|Follow-up Period|Participant withdrew consent|1|||
156570115|NCT02305563|565171982|FG004|Follow-up Period|Participant withdrew consent|0|||
156570116|NCT02305563|565171978|FG000|Follow-up Period|other reason|0|||
156570117|NCT02305563|565171979|FG001|Follow-up Period|other reason|0|||
156570118|NCT02305563|565171980|FG002|Follow-up Period|other reason|0|||
156570119|NCT02305563|565171981|FG003|Follow-up Period|other reason|0|||
156570120|NCT02305563|565171982|FG004|Follow-up Period|other reason|1|||
156570121|NCT02305563|565171978|FG000|Follow-up Period|Followup no longer required per protocol|3|||
156570122|NCT02305563|565171979|FG001|Follow-up Period|Followup no longer required per protocol|3|||
156570123|NCT02305563|565171980|FG002|Follow-up Period|Followup no longer required per protocol|4|||
156570124|NCT02305563|565171981|FG003|Follow-up Period|Followup no longer required per protocol|1|||
156570125|NCT02305563|565171982|FG004|Follow-up Period|Followup no longer required per protocol|4|||
156570126|NCT01275222|565171988|FG000|Phase l by Treatment|Adverse Event|1|||
156570127|NCT01275222|565171989|FG001|Phase l by Treatment|Adverse Event|4|||
156570128|NCT01275222|565171990|FG002|Phase l by Treatment|Adverse Event|2|||
156570129|NCT01275222|565171991|FG003|Phase l by Treatment|Adverse Event|3|||
156570130|NCT01275222|565171992|FG004|Phase l by Treatment|Adverse Event|0|||
156570131|NCT01275222|565171993|FG005|Phase l by Treatment|Adverse Event|0|||
156570132|NCT01275222|565171988|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
156570133|NCT01275222|565171989|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
156570134|NCT01275222|565171990|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
156570135|NCT01275222|565171991|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
156570136|NCT01275222|565171992|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
156570137|NCT01275222|565171993|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
156570138|NCT01275222|565171988|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
156570139|NCT01275222|565171989|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
156570140|NCT01275222|565171990|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
156570141|NCT01275222|565171991|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
156570142|NCT01275222|565171992|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
156570143|NCT01275222|565171993|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
156570144|NCT01275222|565171988|FG000|Phase l by Treatment|Disease progression|12|||
156570145|NCT01275222|565171989|FG001|Phase l by Treatment|Disease progression|8|||
156570146|NCT01275222|565171990|FG002|Phase l by Treatment|Disease progression|2|||
156570147|NCT01275222|565171991|FG003|Phase l by Treatment|Disease progression|5|||
156570148|NCT01275222|565171992|FG004|Phase l by Treatment|Disease progression|0|||
156570149|NCT01275222|565171993|FG005|Phase l by Treatment|Disease progression|0|||
156570150|NCT01275222|565171988|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
156570151|NCT01275222|565171989|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
156570152|NCT01275222|565171990|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
156570153|NCT01275222|565171991|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
156570154|NCT01275222|565171992|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
156570155|NCT01275222|565171993|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
156570156|NCT01275222|565171988|FG000|Phase l by Treatment|Death|0|||
156570157|NCT01275222|565171989|FG001|Phase l by Treatment|Death|1|||
156570158|NCT01275222|565171990|FG002|Phase l by Treatment|Death|0|||
156570159|NCT01275222|565171991|FG003|Phase l by Treatment|Death|1|||
156570160|NCT01275222|565171992|FG004|Phase l by Treatment|Death|0|||
156570161|NCT01275222|565171993|FG005|Phase l by Treatment|Death|0|||
156570162|NCT01275222|565171988|FG000|Phase ll by Stratum|Adverse Event|0|||
156570163|NCT01275222|565171989|FG001|Phase ll by Stratum|Adverse Event|0|||
156570164|NCT01275222|565171990|FG002|Phase ll by Stratum|Adverse Event|0|||
156570165|NCT01275222|565171991|FG003|Phase ll by Stratum|Adverse Event|0|||
156570166|NCT01275222|565171992|FG004|Phase ll by Stratum|Adverse Event|2|||
156570167|NCT01275222|565171993|FG005|Phase ll by Stratum|Adverse Event|10|||
156570168|NCT01275222|565171988|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
156570169|NCT01275222|565171989|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
156570170|NCT01275222|565171990|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
156570171|NCT01275222|565171991|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
156570172|NCT01275222|565171992|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
156570173|NCT01275222|565171993|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
156570174|NCT01275222|565171988|FG000|Phase ll by Stratum|Disease progression|0|||
156570175|NCT01275222|565171989|FG001|Phase ll by Stratum|Disease progression|0|||
156570176|NCT01275222|565171990|FG002|Phase ll by Stratum|Disease progression|0|||
156570177|NCT01275222|565171991|FG003|Phase ll by Stratum|Disease progression|0|||
156570178|NCT01275222|565171992|FG004|Phase ll by Stratum|Disease progression|23|||
156570179|NCT01275222|565171993|FG005|Phase ll by Stratum|Disease progression|31|||
156570180|NCT01275222|565171988|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
156570181|NCT01275222|565171989|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
156570182|NCT01275222|565171990|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
156570183|NCT01275222|565171991|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
156570184|NCT01275222|565171992|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
156570185|NCT01275222|565171993|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
156570186|NCT01275222|565171988|FG000|Phase ll by Stratum|Death|0|||
156570187|NCT01275222|565171989|FG001|Phase ll by Stratum|Death|0|||
156570188|NCT01275222|565171990|FG002|Phase ll by Stratum|Death|0|||
156570189|NCT01275222|565171991|FG003|Phase ll by Stratum|Death|0|||
156570190|NCT01275222|565171992|FG004|Phase ll by Stratum|Death|1|||
156570191|NCT01275222|565171993|FG005|Phase ll by Stratum|Death|1|||
156570192|NCT04325503|565171996|FG000|Overall Study|Withdrawal by Subject|1|||
156570193|NCT04325503|565171996|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
156570194|NCT02337387|565171997|FG000|Overall Study|Adverse Event|0|||
156570195|NCT02337387|565171998|FG001|Overall Study|Adverse Event|1|||
156570196|NCT02337387|565171999|FG002|Overall Study|Adverse Event|0|||
156570197|NCT02337387|565172000|FG003|Overall Study|Adverse Event|0|||
156570198|NCT02337387|565171997|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
156570199|NCT02337387|565171998|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
156570200|NCT02337387|565171999|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
156570201|NCT02337387|565172000|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
156570202|NCT01243268|565172001|FG000|Overall Study|Lost to Follow-up|4|||
156570203|NCT01243268|565172001|FG000|Overall Study|Protocol Violation|51|||
156570204|NCT01243268|565172001|FG000|Overall Study|Deviation with contract date|7|||
156570205|NCT01243268|565172001|FG000|Overall Study|Duplicate subject|2|||
156570206|NCT03871491|565172004|FG000|Overall Study|Withdrawal by Subject|14|||
156570207|NCT03871491|565172005|FG001|Overall Study|Withdrawal by Subject|14|||
156570208|NCT03871491|565172006|FG002|Overall Study|Withdrawal by Subject|14|||
156570209|NCT03871491|565172007|FG003|Overall Study|Withdrawal by Subject|14|||
156570210|NCT03871491|565172004|FG000|Overall Study|Physician Decision|0|||
156570211|NCT03871491|565172005|FG001|Overall Study|Physician Decision|0|||
156570212|NCT03871491|565172006|FG002|Overall Study|Physician Decision|1|||
156570213|NCT03871491|565172007|FG003|Overall Study|Physician Decision|1|||
156570214|NCT03871491|565172004|FG000|Overall Study|Lost to Follow-up|50|||
156570215|NCT03871491|565172005|FG001|Overall Study|Lost to Follow-up|15|||
156570216|NCT03871491|565172006|FG002|Overall Study|Lost to Follow-up|36|||
156570217|NCT03871491|565172007|FG003|Overall Study|Lost to Follow-up|11|||
156570218|NCT05202808|565172008|FG000|Overall Study|Lost to Follow-up|3|||
156570219|NCT05202808|565172009|FG001|Overall Study|Lost to Follow-up|1|||
156570220|NCT02793544|565172010|FG000|Overall Study|Death|10|||
156570221|NCT02793544|565172011|FG001|Overall Study|Death|8|||
156570222|NCT02793544|565172010|FG000|Overall Study|Lost to Follow-up|2|||
156570223|NCT02793544|565172011|FG001|Overall Study|Lost to Follow-up|0|||
156570224|NCT02793544|565172010|FG000|Overall Study|Withdrawal by Subject|1|||
156570225|NCT02793544|565172011|FG001|Overall Study|Withdrawal by Subject|0|||
156570226|NCT01822561|565172014|FG000|Overall Study|Withdrawal by Subject|2|||
156570227|NCT02747004|565172015|FG000|Overall Study|Withdrawal by Subject|8|||
156570228|NCT02747004|565172016|FG001|Overall Study|Withdrawal by Subject|5|||
156570229|NCT02747004|565172017|FG002|Overall Study|Withdrawal by Subject|4|||
156570230|NCT02747004|565172015|FG000|Overall Study|Lost to Follow-up|1|||
156570231|NCT02747004|565172016|FG001|Overall Study|Lost to Follow-up|2|||
156570232|NCT02747004|565172017|FG002|Overall Study|Lost to Follow-up|2|||
156570233|NCT02747004|565172015|FG000|Overall Study|on study treatment/follow-up|48|||
156570234|NCT02747004|565172016|FG001|Overall Study|on study treatment/follow-up|42|||
156570235|NCT02747004|565172017|FG002|Overall Study|on study treatment/follow-up|41|||
156570236|NCT01444300|565172018|FG000|Overall Study|Adverse Event|4|||
156570237|NCT01444300|565172019|FG001|Overall Study|Adverse Event|0|||
156570238|NCT02722044|565172020|FG000|Overall Study|Adverse Event|2|||
156570239|NCT02722044|565172020|FG000|Overall Study|Physician Decision|1|||
156570240|NCT02722044|565172020|FG000|Overall Study|Withdrawal by Subject|1|||
156570241|NCT02722044|565172020|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
156570242|NCT04885257|565172024|FG000|Overall Study|Withdrawal by Subject|1|||
156570243|NCT04885257|565172025|FG001|Overall Study|Withdrawal by Subject|0|||
156570244|NCT00818259|565172026|FG000|Part I|Withdrawal by Subject|1|||
156570245|NCT00818259|565172027|FG001|Part I|Withdrawal by Subject|0|||
156570246|NCT00818259|565172028|FG002|Part I|Withdrawal by Subject|0|||
156570247|NCT00818259|565172029|FG003|Part I|Withdrawal by Subject|0|||
156570248|NCT00818259|565172030|FG004|Part I|Withdrawal by Subject|0|||
156570249|NCT00818259|565172031|FG005|Part I|Withdrawal by Subject|0|||
156570250|NCT00818259|565172032|FG006|Part I|Withdrawal by Subject|0|||
156570251|NCT00818259|565172033|FG007|Part I|Withdrawal by Subject|0|||
156570252|NCT00818259|565172034|FG008|Part I|Withdrawal by Subject|0|||
156570253|NCT00818259|565172026|FG000|Part II|Physician Decision|0|||
156570254|NCT00818259|565172027|FG001|Part II|Physician Decision|0|||
156570255|NCT00818259|565172028|FG002|Part II|Physician Decision|1|||
156570256|NCT00818259|565172029|FG003|Part II|Physician Decision|0|||
156570257|NCT00818259|565172030|FG004|Part II|Physician Decision|0|||
156570258|NCT00818259|565172031|FG005|Part II|Physician Decision|0|||
156570259|NCT00818259|565172032|FG006|Part II|Physician Decision|0|||
156570260|NCT00818259|565172033|FG007|Part II|Physician Decision|0|||
156570261|NCT00818259|565172034|FG008|Part II|Physician Decision|0|||
156570262|NCT00818259|565172026|FG000|Part II|Lack of Efficacy|0|||
156570263|NCT00818259|565172027|FG001|Part II|Lack of Efficacy|0|||
156570264|NCT00818259|565172028|FG002|Part II|Lack of Efficacy|0|||
156570265|NCT00818259|565172029|FG003|Part II|Lack of Efficacy|1|||
156570266|NCT00818259|565172030|FG004|Part II|Lack of Efficacy|0|||
156570267|NCT00818259|565172031|FG005|Part II|Lack of Efficacy|0|||
156570268|NCT00818259|565172032|FG006|Part II|Lack of Efficacy|0|||
156570269|NCT00818259|565172033|FG007|Part II|Lack of Efficacy|0|||
156570270|NCT00818259|565172034|FG008|Part II|Lack of Efficacy|0|||
156570271|NCT00818259|565172026|FG000|Part II|Not Treated|0|||
156570272|NCT00818259|565172027|FG001|Part II|Not Treated|0|||
156570273|NCT00818259|565172028|FG002|Part II|Not Treated|0|||
156570274|NCT00818259|565172029|FG003|Part II|Not Treated|1|||
156570275|NCT00818259|565172030|FG004|Part II|Not Treated|0|||
156570276|NCT00818259|565172031|FG005|Part II|Not Treated|0|||
156570277|NCT00818259|565172032|FG006|Part II|Not Treated|0|||
156570278|NCT00818259|565172033|FG007|Part II|Not Treated|0|||
156570279|NCT00818259|565172034|FG008|Part II|Not Treated|0|||
156570280|NCT00818259|565172026|FG000|Part IV|Physician Decision|0|||
156570281|NCT00818259|565172027|FG001|Part IV|Physician Decision|0|||
156570282|NCT00818259|565172028|FG002|Part IV|Physician Decision|0|||
156570283|NCT00818259|565172029|FG003|Part IV|Physician Decision|0|||
156570284|NCT00818259|565172030|FG004|Part IV|Physician Decision|0|||
156570285|NCT00818259|565172031|FG005|Part IV|Physician Decision|1|||
156570286|NCT00818259|565172032|FG006|Part IV|Physician Decision|0|||
156570287|NCT00818259|565172033|FG007|Part IV|Physician Decision|0|||
156570288|NCT00818259|565172034|FG008|Part IV|Physician Decision|0|||
156570289|NCT00818259|565172026|FG000|Part V|Adverse Event|0|||
156570290|NCT00818259|565172027|FG001|Part V|Adverse Event|0|||
156570291|NCT00818259|565172028|FG002|Part V|Adverse Event|0|||
156570292|NCT00818259|565172029|FG003|Part V|Adverse Event|0|||
156570293|NCT00818259|565172030|FG004|Part V|Adverse Event|0|||
156570294|NCT00818259|565172031|FG005|Part V|Adverse Event|0|||
156570295|NCT00818259|565172032|FG006|Part V|Adverse Event|0|||
156570296|NCT00818259|565172033|FG007|Part V|Adverse Event|1|||
156570297|NCT00818259|565172034|FG008|Part V|Adverse Event|0|||
156570298|NCT04640766|565172035|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
156570299|NCT00609622|565172036|FG000|Overall Study|Adverse Event|14|||
156570300|NCT00609622|565172037|FG001|Overall Study|Adverse Event|10|||
156570301|NCT00609622|565172036|FG000|Overall Study|Withdrawal by Subject|4|||
156570302|NCT00609622|565172037|FG001|Overall Study|Withdrawal by Subject|20|||
156570303|NCT00609622|565172036|FG000|Overall Study|Death|1|||
156570304|NCT00609622|565172037|FG001|Overall Study|Death|4|||
156570305|NCT00609622|565172036|FG000|Overall Study|Protocol Violation|1|||
156570306|NCT00609622|565172037|FG001|Overall Study|Protocol Violation|1|||
156570307|NCT00609622|565172036|FG000|Overall Study|Objective progression or relapse|47|||
156570308|NCT00609622|565172037|FG001|Overall Study|Objective progression or relapse|41|||
156570309|NCT00609622|565172036|FG000|Overall Study|Study terminated by sponsor|16|||
156570310|NCT00609622|565172037|FG001|Overall Study|Study terminated by sponsor|3|||
156570311|NCT00609622|565172036|FG000|Overall Study|Other|7|||
156570312|NCT00609622|565172037|FG001|Overall Study|Other|14|||
156570313|NCT00609622|565172036|FG000|Overall Study|Global deterioration of health status|6|||
156570314|NCT00609622|565172037|FG001|Overall Study|Global deterioration of health status|2|||
156570315|NCT01237951|565172038|FG000|Overall Study|Death|1|||
156570316|NCT01708057|565172041|FG000|Overall Study|Withdrawal due to study termination.|1|||
156570317|NCT01708057|565172042|FG001|Overall Study|Withdrawal due to study termination.|1|||
156570318|NCT01708057|565172043|FG002|Overall Study|Withdrawal due to study termination.|1|||
156570319|NCT00666562|565172051|FG000|Overall Study|Withdrawal by Subject|0|||
156570320|NCT00666562|565172052|FG001|Overall Study|Withdrawal by Subject|1|||
156570321|NCT00666562|565172053|FG002|Overall Study|Withdrawal by Subject|0|||
156570322|NCT00666562|565172051|FG000|Overall Study|Concomitant Medication|0|||
156570323|NCT00666562|565172052|FG001|Overall Study|Concomitant Medication|1|||
156570324|NCT00666562|565172053|FG002|Overall Study|Concomitant Medication|0|||
156570325|NCT05262764|565172055|FG000|Overall Study|Case report form not collected|9|||
156570326|NCT05262764|565172055|FG000|Overall Study|No patient visits after entry|23|||
156570327|NCT05262764|565172055|FG000|Overall Study|Registration rule not followed|2|||
156570328|NCT05262764|565172055|FG000|Overall Study|Patient of non-chronic heart failure|1|||
156570329|NCT01392183|565172056|FG000|First Drug Administration|Adverse Event|3|||
156570330|NCT01392183|565172057|FG001|First Drug Administration|Adverse Event|2|||
156570331|NCT01392183|565172056|FG000|First Drug Administration|Death|1|||
156570332|NCT01392183|565172057|FG001|First Drug Administration|Death|0|||
156570333|NCT01392183|565172056|FG000|First Drug Administration|Withdrawal by Subject|10|||
156570334|NCT01392183|565172057|FG001|First Drug Administration|Withdrawal by Subject|17|||
156570335|NCT00963807|565172060|FG000|Overall Study|Physician Decision|2|||
156570336|NCT00963807|565172060|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
156570337|NCT00963807|565172060|FG000|Overall Study|Disease progression|15|||
156570338|NCT00684177|565172063|FG000|Overall Study|Adverse Event|4|||
156570339|NCT00684177|565172064|FG001|Overall Study|Adverse Event|3|||
156570340|NCT00684177|565172063|FG000|Overall Study|Lack of Efficacy|10|||
156570341|NCT00684177|565172064|FG001|Overall Study|Lack of Efficacy|15|||
156570342|NCT00684177|565172063|FG000|Overall Study|Protocol Violation|1|||
156570343|NCT00684177|565172064|FG001|Overall Study|Protocol Violation|0|||
156570344|NCT00684177|565172063|FG000|Overall Study|Lost to Follow-up|2|||
156570345|NCT00684177|565172064|FG001|Overall Study|Lost to Follow-up|1|||
156570346|NCT00684177|565172063|FG000|Overall Study|Physician Decision|2|||
156570347|NCT00684177|565172064|FG001|Overall Study|Physician Decision|0|||
156570348|NCT00684177|565172063|FG000|Overall Study|Withdrawal by Subject|1|||
156570349|NCT00684177|565172064|FG001|Overall Study|Withdrawal by Subject|2|||
156570350|NCT00684177|565172063|FG000|Overall Study|Other|1|||
156570351|NCT00684177|565172064|FG001|Overall Study|Other|2|||
156570352|NCT00075881|565173489|FG000|Overall Study|Lack of Efficacy|18|||
156570353|NCT00075881|565173489|FG000|Overall Study|Adverse Event|7|||
156570354|NCT00075881|565173489|FG000|Overall Study|Death|1|||
156570355|NCT00075881|565173489|FG000|Overall Study|Withdrawal by Subject|2|||
156570356|NCT00075881|565173489|FG000|Overall Study|Protocol Violation|4|||
156570357|NCT00075881|565173489|FG000|Overall Study|other complicating disease|3|||
156570358|NCT00075881|565173489|FG000|Overall Study|other|4|||
156570359|NCT00075881|565173489|FG000|Overall Study|missing data|2|||
156570360|NCT00075881|565173489|FG000|Overall Study|Ineligible|1|||
156570361|NCT00075881|565173489|FG000|Overall Study|never start protocol therapy|1|||
156570362|NCT02224664|565173490|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
156570363|NCT02224664|565173491|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
156570364|NCT02224664|565173492|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
156570365|NCT02224664|565173493|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
156570366|NCT02224664|565173494|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
156570367|NCT02224664|565173490|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
156570368|NCT02224664|565173491|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
156570369|NCT02224664|565173492|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
156570370|NCT02224664|565173493|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
156570371|NCT02224664|565173494|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
156570372|NCT02224664|565173490|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
156570373|NCT02224664|565173491|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
156570374|NCT02224664|565173492|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
156570375|NCT02224664|565173493|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
156570376|NCT02224664|565173494|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
156570377|NCT02109029|565173497|FG000|Part B|Adverse Event|0|||
156570378|NCT02109029|565173498|FG001|Part B|Adverse Event|0|||
156570379|NCT02109029|565173499|FG002|Part B|Adverse Event|0|||
156570380|NCT02109029|565173500|FG003|Part B|Adverse Event|0|||
156570381|NCT02109029|565173501|FG004|Part B|Adverse Event|1|||
156570382|NCT02109029|565173502|FG005|Part B|Adverse Event|1|||
156570383|NCT03195894|565173503|FG000|Overall Study|"An example is Started other treatment."|4|||
156570384|NCT03195894|565173504|FG001|Overall Study|"An example is Started other treatment."|5|||
156570385|NCT03195894|565173503|FG000|Overall Study|Withdrawal by Subject|15|||
156570386|NCT03195894|565173504|FG001|Overall Study|Withdrawal by Subject|4|||
156570387|NCT03195894|565173503|FG000|Overall Study|Lost to Follow-up|14|||
156570388|NCT03195894|565173504|FG001|Overall Study|Lost to Follow-up|19|||
156570389|NCT01024244|565173515|FG000|Overall Study|Adverse Event|1|||
156570390|NCT01024244|565173516|FG001|Overall Study|Adverse Event|2|||
156570391|NCT01024244|565173517|FG002|Overall Study|Adverse Event|0|||
156570392|NCT01024244|565173518|FG003|Overall Study|Adverse Event|1|||
156570393|NCT01024244|565173519|FG004|Overall Study|Adverse Event|2|||
156570394|NCT01024244|565173515|FG000|Overall Study|Entry Criteria Not Met|0|||
156570395|NCT01024244|565173516|FG001|Overall Study|Entry Criteria Not Met|1|||
156570396|NCT01024244|565173517|FG002|Overall Study|Entry Criteria Not Met|0|||
156570397|NCT01024244|565173518|FG003|Overall Study|Entry Criteria Not Met|0|||
156570398|NCT01024244|565173519|FG004|Overall Study|Entry Criteria Not Met|0|||
156570399|NCT01024244|565173515|FG000|Overall Study|Lack of Efficacy|1|||
156570400|NCT01024244|565173516|FG001|Overall Study|Lack of Efficacy|0|||
156570401|NCT01024244|565173517|FG002|Overall Study|Lack of Efficacy|0|||
156570402|NCT01024244|565173518|FG003|Overall Study|Lack of Efficacy|0|||
156570403|NCT01024244|565173519|FG004|Overall Study|Lack of Efficacy|0|||
156570404|NCT01024244|565173515|FG000|Overall Study|Protocol Violation|1|||
156570405|NCT01024244|565173516|FG001|Overall Study|Protocol Violation|0|||
156570406|NCT01024244|565173517|FG002|Overall Study|Protocol Violation|0|||
156570407|NCT01024244|565173518|FG003|Overall Study|Protocol Violation|0|||
156570408|NCT01024244|565173519|FG004|Overall Study|Protocol Violation|2|||
156570409|NCT01024244|565173515|FG000|Overall Study|Sponsor Decision|14|||
156570410|NCT01024244|565173516|FG001|Overall Study|Sponsor Decision|7|||
156570411|NCT01024244|565173517|FG002|Overall Study|Sponsor Decision|14|||
156570412|NCT01024244|565173518|FG003|Overall Study|Sponsor Decision|12|||
156570413|NCT01024244|565173519|FG004|Overall Study|Sponsor Decision|10|||
156570414|NCT01024244|565173515|FG000|Overall Study|Withdrawal by Subject|0|||
156570415|NCT01024244|565173516|FG001|Overall Study|Withdrawal by Subject|1|||
156570416|NCT01024244|565173517|FG002|Overall Study|Withdrawal by Subject|0|||
156570417|NCT01024244|565173518|FG003|Overall Study|Withdrawal by Subject|0|||
156570418|NCT01024244|565173519|FG004|Overall Study|Withdrawal by Subject|0|||
156570419|NCT03874234|565173524|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570420|NCT03874234|565173525|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570421|NCT03874234|565173526|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570422|NCT03874234|565173527|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
156570423|NCT03874234|565173528|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570424|NCT03874234|565173529|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570425|NCT03874234|565173530|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570426|NCT03874234|565173531|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570427|NCT03874234|565173532|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570428|NCT03874234|565173533|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570429|NCT03874234|565173534|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570430|NCT03874234|565173535|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570431|NCT03874234|565173536|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156570432|NCT03874234|565173524|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
156570433|NCT03874234|565173525|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570434|NCT03874234|565173526|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570435|NCT03874234|565173527|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570436|NCT03874234|565173528|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570437|NCT03874234|565173529|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570438|NCT03874234|565173530|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570439|NCT03874234|565173531|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570440|NCT03874234|565173532|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570441|NCT03874234|565173533|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570442|NCT03874234|565173534|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570443|NCT03874234|565173535|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570444|NCT03874234|565173536|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156570445|NCT03874234|565173524|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570446|NCT03874234|565173525|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570447|NCT03874234|565173526|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570448|NCT03874234|565173527|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
156570449|NCT03874234|565173528|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570450|NCT03874234|565173529|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570451|NCT03874234|565173530|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570452|NCT03874234|565173531|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570453|NCT03874234|565173532|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570454|NCT03874234|565173533|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570455|NCT03874234|565173534|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570456|NCT03874234|565173535|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570457|NCT03874234|565173536|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156570458|NCT03874234|565173524|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570459|NCT03874234|565173525|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570460|NCT03874234|565173526|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570461|NCT03874234|565173527|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570462|NCT03874234|565173528|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
156570463|NCT03874234|565173529|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570464|NCT03874234|565173530|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570465|NCT03874234|565173531|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570466|NCT03874234|565173532|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570467|NCT03874234|565173533|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570468|NCT03874234|565173534|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570469|NCT03874234|565173535|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570470|NCT03874234|565173536|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156570471|NCT03874234|565173524|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570472|NCT03874234|565173525|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570473|NCT03874234|565173526|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570474|NCT03874234|565173527|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570475|NCT03874234|565173528|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570476|NCT03874234|565173529|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570477|NCT03874234|565173530|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570478|NCT03874234|565173531|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
156570479|NCT03874234|565173532|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570480|NCT03874234|565173533|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570481|NCT03874234|565173534|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570482|NCT03874234|565173535|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570483|NCT03874234|565173536|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156570484|NCT03874234|565173524|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570485|NCT03874234|565173525|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570486|NCT03874234|565173526|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570487|NCT03874234|565173527|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570488|NCT03874234|565173528|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
156570489|NCT03874234|565173529|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
156570490|NCT03874234|565173530|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570491|NCT03874234|565173531|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570492|NCT03874234|565173532|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570493|NCT03874234|565173533|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570494|NCT03874234|565173534|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570495|NCT03874234|565173535|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570496|NCT03874234|565173536|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156570497|NCT03874234|565173524|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570498|NCT03874234|565173525|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570499|NCT03874234|565173526|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570500|NCT03874234|565173527|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570501|NCT03874234|565173528|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570502|NCT03874234|565173529|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570503|NCT03874234|565173530|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
156570504|NCT03874234|565173531|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570505|NCT03874234|565173532|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570506|NCT03874234|565173533|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570507|NCT03874234|565173534|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570508|NCT03874234|565173535|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570509|NCT03874234|565173536|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156570510|NCT03874234|565173524|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570511|NCT03874234|565173525|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570512|NCT03874234|565173526|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570513|NCT03874234|565173527|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570514|NCT03874234|565173528|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
156570515|NCT03874234|565173529|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570516|NCT03874234|565173530|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570517|NCT03874234|565173531|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570518|NCT03874234|565173532|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570519|NCT03874234|565173533|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570520|NCT03874234|565173534|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570521|NCT03874234|565173535|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570522|NCT03874234|565173536|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
156570523|NCT01896232|565173542|FG000|Overall Study|Death|6|||
156570524|NCT01896232|565173543|FG001|Overall Study|Death|10|||
156570525|NCT01896232|565173542|FG000|Overall Study|Withdrawal by Subject|32|||
156570526|NCT01896232|565173543|FG001|Overall Study|Withdrawal by Subject|31|||
156570527|NCT01896232|565173542|FG000|Overall Study|Sponsor Decision|2|||
156570528|NCT01896232|565173543|FG001|Overall Study|Sponsor Decision|0|||
156570529|NCT01896232|565173542|FG000|Overall Study|Lost to Follow-up|9|||
156570530|NCT01896232|565173543|FG001|Overall Study|Lost to Follow-up|12|||
156570531|NCT00686205|565173552|FG000|Overall Study|Protocol Violation|127|||
156570532|NCT00686205|565173553|FG001|Overall Study|Protocol Violation|0|||
156570533|NCT00686205|565173552|FG000|Overall Study|Withdrawal by Subject|2|||
156570534|NCT00686205|565173553|FG001|Overall Study|Withdrawal by Subject|0|||
156570535|NCT00686205|565173552|FG000|Overall Study|Specimen handling procedure altered|5878|||
156570536|NCT00686205|565173553|FG001|Overall Study|Specimen handling procedure altered|0|||
156570537|NCT00686205|565173552|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
156570538|NCT00686205|565173553|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
156570539|NCT01217606|565173555|FG000|Initial Treatment Phase|Other Reasons|0|||
156570540|NCT01217606|565173556|FG001|Initial Treatment Phase|Other Reasons|2|||
156570541|NCT01217606|565173555|FG000|Initial Treatment Phase|Protocol Violation|3|||
156570542|NCT01217606|565173556|FG001|Initial Treatment Phase|Protocol Violation|2|||
156570543|NCT01217606|565173555|FG000|Initial Treatment Phase|Personal Reasons|0|||
156570544|NCT01217606|565173556|FG001|Initial Treatment Phase|Personal Reasons|2|||
156570545|NCT01217606|565173555|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
156570546|NCT01217606|565173556|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
156570547|NCT01217606|565173555|FG000|Initial Treatment Phase|Adverse Event|10|||
156570548|NCT01217606|565173556|FG001|Initial Treatment Phase|Adverse Event|6|||
156570549|NCT01217606|565173555|FG000|9-Month Masked Extension|Adverse Event|3|||
156570550|NCT01217606|565173556|FG001|9-Month Masked Extension|Adverse Event|6|||
156570551|NCT01217606|565173555|FG000|9-Month Masked Extension|Other Reasons|4|||
156570552|NCT01217606|565173556|FG001|9-Month Masked Extension|Other Reasons|4|||
156570553|NCT01217606|565173555|FG000|9-Month Masked Extension|Personal Reasons|2|||
156570554|NCT01217606|565173556|FG001|9-Month Masked Extension|Personal Reasons|1|||
156570555|NCT01217606|565173555|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
156570556|NCT01217606|565173556|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
156570557|NCT01217606|565173555|FG000|9-Month Masked Extension|Pregnancy|1|||
156570558|NCT01217606|565173556|FG001|9-Month Masked Extension|Pregnancy|0|||
156570559|NCT01217606|565173555|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
156570560|NCT01217606|565173556|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
156570561|NCT02432807|565173560|FG000|Overall Study|Adverse Event|0|||
156570562|NCT02432807|565173561|FG001|Overall Study|Adverse Event|2|||
156570563|NCT02432807|565173560|FG000|Overall Study|Lost to Follow-up|1|||
156570564|NCT02432807|565173561|FG001|Overall Study|Lost to Follow-up|0|||
156570565|NCT02432807|565173560|FG000|Overall Study|Withdrawal by Subject|1|||
156570566|NCT02432807|565173561|FG001|Overall Study|Withdrawal by Subject|1|||
156570567|NCT02432807|565173560|FG000|Overall Study|Other|1|||
156570568|NCT02432807|565173561|FG001|Overall Study|Other|1|||
156570569|NCT02210780|565173564|FG000|Overall Study|Adverse Event|0|||
156570570|NCT02210780|565173565|FG001|Overall Study|Adverse Event|5|||
156570571|NCT02210780|565173564|FG000|Overall Study|Lost to Follow-up|2|||
156570572|NCT02210780|565173565|FG001|Overall Study|Lost to Follow-up|1|||
156570573|NCT02210780|565173564|FG000|Overall Study|Withdrawal by Subject|1|||
156570574|NCT02210780|565173565|FG001|Overall Study|Withdrawal by Subject|1|||
156570575|NCT02210780|565173564|FG000|Overall Study|Physician Decision|1|||
156570576|NCT02210780|565173565|FG001|Overall Study|Physician Decision|0|||
156570577|NCT02210780|565173564|FG000|Overall Study|Protocol Violation|1|||
156570578|NCT02210780|565173565|FG001|Overall Study|Protocol Violation|0|||
156570579|NCT02210780|565173564|FG000|Overall Study|Other than specified above|0|||
156570580|NCT02210780|565173565|FG001|Overall Study|Other than specified above|1|||
156570581|NCT02966314|565173568|FG000|Overall Study|Lost to Follow-up|1|||
156570582|NCT02966314|565173569|FG001|Overall Study|Lost to Follow-up|0|||
156570583|NCT02725788|565173572|FG000|Overall Study|Lost to Follow-up|1|||
156570584|NCT02725788|565173573|FG001|Overall Study|Lost to Follow-up|1|||
156570585|NCT02725788|565173572|FG000|Overall Study|Protocol Violation|0|||
156570586|NCT02725788|565173573|FG001|Overall Study|Protocol Violation|1|||
156570587|NCT00828464|565173574|FG000|Overall Study|Withdrawal by Subject|1|||
156570588|NCT00474240|565173575|FG000|Overall Study|Withdrawal by Subject|1|||
156570589|NCT00474240|565173576|FG001|Overall Study|Withdrawal by Subject|1|||
156570590|NCT00474240|565173577|FG002|Overall Study|Withdrawal by Subject|0|||
156570591|NCT00474240|565173578|FG003|Overall Study|Withdrawal by Subject|2|||
156570592|NCT00474240|565173579|FG004|Overall Study|Withdrawal by Subject|3|||
156570593|NCT00474240|565173580|FG005|Overall Study|Withdrawal by Subject|1|||
156570594|NCT00474240|565173575|FG000|Overall Study|Adverse Event|0|||
156570595|NCT00474240|565173576|FG001|Overall Study|Adverse Event|0|||
156570596|NCT00474240|565173577|FG002|Overall Study|Adverse Event|9|||
156570597|NCT00474240|565173578|FG003|Overall Study|Adverse Event|14|||
156570598|NCT00474240|565173579|FG004|Overall Study|Adverse Event|5|||
156570599|NCT00474240|565173580|FG005|Overall Study|Adverse Event|16|||
156570600|NCT00474240|565173575|FG000|Overall Study|Removed due to lab value|0|||
156570601|NCT00474240|565173576|FG001|Overall Study|Removed due to lab value|0|||
156570602|NCT00474240|565173577|FG002|Overall Study|Removed due to lab value|0|||
156570603|NCT00474240|565173578|FG003|Overall Study|Removed due to lab value|0|||
156570604|NCT00474240|565173579|FG004|Overall Study|Removed due to lab value|0|||
156570605|NCT00474240|565173580|FG005|Overall Study|Removed due to lab value|1|||
156570606|NCT03812510|565173583|FG000|Overall Study|Lost to Follow-up|39|||
156570607|NCT03812510|565173583|FG000|Overall Study|Withdrawal by Subject|42|||
156570608|NCT03812510|565173583|FG000|Overall Study|Physician Decision|2|||
156570609|NCT03812510|565173583|FG000|Overall Study|Study Terminated by Sponsor|9|||
156570610|NCT03812510|565173583|FG000|Overall Study|Did Not Start Study Medication|55|||
156570611|NCT03812510|565173583|FG000|Overall Study|Adverse Event|5|||
156570612|NCT01128387|565173584|FG000|Overall Study|Physician Decision|0|||
156570613|NCT01128387|565173585|FG001|Overall Study|Physician Decision|1|||
156570614|NCT03075839|565173589|FG000|Overall Study|Lost to Follow-up|4|||
156570615|NCT04433117|565173590|FG000|Overall Study|Withdrawal by Subject|1|||
156570616|NCT04433117|565173591|FG001|Overall Study|Withdrawal by Subject|0|||
156570617|NCT00824421|565173593|FG000|Overall Study|Adverse Event|6|||
156570618|NCT00824421|565173594|FG001|Overall Study|Adverse Event|6|||
156570619|NCT00824421|565173595|FG002|Overall Study|Adverse Event|6|||
156570620|NCT00824421|565173593|FG000|Overall Study|Death|0|||
156570621|NCT00824421|565173594|FG001|Overall Study|Death|1|||
156570622|NCT00824421|565173595|FG002|Overall Study|Death|0|||
156570623|NCT00824421|565173593|FG000|Overall Study|Lack of Efficacy|5|||
156570624|NCT00824421|565173594|FG001|Overall Study|Lack of Efficacy|7|||
156570625|NCT00824421|565173595|FG002|Overall Study|Lack of Efficacy|4|||
156570626|NCT00824421|565173593|FG000|Overall Study|Lost to Follow-up|2|||
156570627|NCT00824421|565173594|FG001|Overall Study|Lost to Follow-up|3|||
156570628|NCT00824421|565173595|FG002|Overall Study|Lost to Follow-up|0|||
156570629|NCT00824421|565173593|FG000|Overall Study|Pregnancy|1|||
156570630|NCT00824421|565173594|FG001|Overall Study|Pregnancy|0|||
156570631|NCT00824421|565173595|FG002|Overall Study|Pregnancy|1|||
156570632|NCT00824421|565173593|FG000|Overall Study|Withdrawal by Subject|2|||
156570633|NCT00824421|565173594|FG001|Overall Study|Withdrawal by Subject|3|||
156570634|NCT00824421|565173595|FG002|Overall Study|Withdrawal by Subject|3|||
156570635|NCT00824421|565173593|FG000|Overall Study|Randomized but not Treated|1|||
156570636|NCT00824421|565173594|FG001|Overall Study|Randomized but not Treated|1|||
156570637|NCT00824421|565173595|FG002|Overall Study|Randomized but not Treated|0|||
156570638|NCT00824421|565173593|FG000|Overall Study|Other|0|||
156570639|NCT00824421|565173594|FG001|Overall Study|Other|1|||
156570640|NCT00824421|565173595|FG002|Overall Study|Other|0|||
156570641|NCT02499952|565173596|FG000|Overall Study|Lost to Follow-up|1|||
156570642|NCT02499952|565173596|FG000|Overall Study|Death|9|||
156570643|NCT05089708|565173597|FG000|Overall Study|Lost to Follow-up|9|||
156570644|NCT05089708|565173598|FG001|Overall Study|Lost to Follow-up|7|||
156570645|NCT05089708|565173597|FG000|Overall Study|Withdrawal by Subject|3|||
156570646|NCT05089708|565173598|FG001|Overall Study|Withdrawal by Subject|1|||
156570647|NCT05089708|565173597|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
156570648|NCT05089708|565173598|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
156570649|NCT05089708|565173597|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
156570650|NCT05089708|565173598|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
156570651|NCT02120417|565173599|FG000|Overall Study|Death|5|||
156570652|NCT02120417|565173600|FG001|Overall Study|Death|1|||
156570653|NCT02120417|565173599|FG000|Overall Study|Adverse Event|3|||
156570654|NCT02120417|565173600|FG001|Overall Study|Adverse Event|9|||
156570655|NCT02120417|565173599|FG000|Overall Study|Participant decision|4|||
156570656|NCT02120417|565173600|FG001|Overall Study|Participant decision|4|||
156570657|NCT02120417|565173599|FG000|Overall Study|Disease progression|41|||
156570658|NCT02120417|565173600|FG001|Overall Study|Disease progression|45|||
156570659|NCT02120417|565173599|FG000|Overall Study|Noncompliance with study treatment|0|||
156570660|NCT02120417|565173600|FG001|Overall Study|Noncompliance with study treatment|2|||
156570661|NCT02120417|565173599|FG000|Overall Study|Physician Decision|2|||
156570662|NCT02120417|565173600|FG001|Overall Study|Physician Decision|3|||
156570663|NCT02120417|565173599|FG000|Overall Study|Other unspecified|5|||
156570664|NCT02120417|565173600|FG001|Overall Study|Other unspecified|4|||
156570665|NCT00927485|565173601|FG000|Overall Study|Adverse Event|4|||
156570666|NCT00927485|565173602|FG001|Overall Study|Adverse Event|2|||
156570667|NCT00927485|565173601|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
156570668|NCT00927485|565173602|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
156570669|NCT00702143|565173606|FG000|Overall Study|Lost to Follow-up|0|||
156570670|NCT00702143|565173607|FG001|Overall Study|Lost to Follow-up|0|||
156570671|NCT00702143|565173608|FG002|Overall Study|Lost to Follow-up|1|||
156570672|NCT04996797|565173609|FG000|Overall Study|Adverse Event|0|||
156570673|NCT04996797|565173610|FG001|Overall Study|Adverse Event|2|||
156570674|NCT04996797|565173611|FG002|Overall Study|Adverse Event|0|||
156570675|NCT04996797|565173612|FG003|Overall Study|Adverse Event|1|||
156570676|NCT04996797|565173609|FG000|Overall Study|Lack of Efficacy|0|||
156570677|NCT04996797|565173610|FG001|Overall Study|Lack of Efficacy|2|||
156570678|NCT04996797|565173611|FG002|Overall Study|Lack of Efficacy|0|||
156570679|NCT04996797|565173612|FG003|Overall Study|Lack of Efficacy|0|||
156570680|NCT04996797|565173609|FG000|Overall Study|Prohibited Medication|0|||
156570681|NCT04996797|565173610|FG001|Overall Study|Prohibited Medication|1|||
156570682|NCT04996797|565173611|FG002|Overall Study|Prohibited Medication|0|||
156570683|NCT04996797|565173612|FG003|Overall Study|Prohibited Medication|0|||
156570684|NCT04996797|565173609|FG000|Overall Study|Ongoing|68|||
156570685|NCT04996797|565173610|FG001|Overall Study|Ongoing|60|||
156570686|NCT04996797|565173611|FG002|Overall Study|Ongoing|22|||
156570687|NCT04996797|565173612|FG003|Overall Study|Ongoing|20|||
156570688|NCT04996797|565173609|FG000|Overall Study|Withdrawal by Subject|0|||
156570689|NCT04996797|565173610|FG001|Overall Study|Withdrawal by Subject|2|||
156570690|NCT04996797|565173611|FG002|Overall Study|Withdrawal by Subject|0|||
156570691|NCT04996797|565173612|FG003|Overall Study|Withdrawal by Subject|0|||
156570692|NCT04091217|565173613|FG000|Overall Study|Lost to Follow-up|2|||
156570693|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
156570694|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
156570695|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
156570696|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
156570697|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
156570698|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
156570699|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
156570700|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
156570701|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
156570702|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
156570703|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
156570704|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
156570705|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
156570706|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
156570707|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
156570708|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
156570709|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
156570710|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
156570711|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
156570712|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
156570713|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Death|0|||
156570714|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Death|1|||
156570715|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Death|0|||
156570716|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Death|0|||
156570717|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Death|0|||
156570718|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
156570719|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
156570720|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
156570721|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
156570722|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
156570723|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
156570724|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
156570725|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
156570726|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
156570727|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
156570728|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
156570729|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
156570730|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
156570731|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
156570732|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
156570733|NCT05087030|565173614|FG000|Main Period (Week 0 to Week 52)|Other|1|||
156570734|NCT05087030|565173615|FG001|Main Period (Week 0 to Week 52)|Other|2|||
156570735|NCT05087030|565173616|FG002|Main Period (Week 0 to Week 52)|Other|0|||
156570736|NCT05087030|565173617|FG003|Main Period (Week 0 to Week 52)|Other|0|||
156570737|NCT05087030|565173618|FG004|Main Period (Week 0 to Week 52)|Other|0|||
156570738|NCT05087030|565173614|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156570739|NCT05087030|565173615|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156570740|NCT05087030|565173616|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156570741|NCT05087030|565173617|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156570742|NCT05087030|565173618|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
156570743|NCT02597062|565173619|FG000|Overall Study|Ineligible|1|||
156570744|NCT00741819|565173620|FG000|Overall Study|Adverse Event|3|||
156570745|NCT00741819|565173620|FG000|Overall Study|Withdrawal by Subject|3|||
156570746|NCT00741819|565173620|FG000|Overall Study|Death|1|||
156570747|NCT00741819|565173620|FG000|Overall Study|Disease progression|1|||
156570748|NCT00686543|565173623|FG000|Overall Study|Adverse Event|9|||
156570749|NCT00686543|565173624|FG001|Overall Study|Adverse Event|1|||
156570750|NCT00686543|565173625|FG002|Overall Study|Adverse Event|3|||
156570751|NCT00686543|565173626|FG003|Overall Study|Adverse Event|2|||
156570752|NCT00686543|565173623|FG000|Overall Study|Withdrawal by Subject|2|||
156570753|NCT00686543|565173624|FG001|Overall Study|Withdrawal by Subject|0|||
156570754|NCT00686543|565173625|FG002|Overall Study|Withdrawal by Subject|0|||
156570755|NCT00686543|565173626|FG003|Overall Study|Withdrawal by Subject|0|||
156570756|NCT00686543|565173623|FG000|Overall Study|Protocol Violation|3|||
156570757|NCT00686543|565173624|FG001|Overall Study|Protocol Violation|0|||
156570758|NCT00686543|565173625|FG002|Overall Study|Protocol Violation|2|||
156570759|NCT00686543|565173626|FG003|Overall Study|Protocol Violation|1|||
156570760|NCT00924703|565173627|FG000|Overall Study|Withdrawal by Subject|11|||
156570761|NCT00924703|565173627|FG000|Overall Study|Physician Decision|5|||
156570762|NCT00924703|565173627|FG000|Overall Study|Lost to Follow-up|3|||
156570763|NCT00924703|565173627|FG000|Overall Study|Adverse Event|2|||
156570764|NCT00924703|565173627|FG000|Overall Study|Withdrawal by Sponsor|1|||
156570765|NCT04906707|565173628|FG000|Overall Study|Withdrawal by Subject|2|||
156570766|NCT04906707|565173629|FG001|Overall Study|Withdrawal by Subject|0|||
156570767|NCT04906707|565173628|FG000|Overall Study|Withdrawal due to PI decision|1|||
156570768|NCT04906707|565173629|FG001|Overall Study|Withdrawal due to PI decision|0|||
156570769|NCT04906707|565173628|FG000|Overall Study|Lost to Follow-up|0|||
156570770|NCT04906707|565173629|FG001|Overall Study|Lost to Follow-up|1|||
156570771|NCT01976806|565173630|FG000|Overall Study|Lost to Follow-up|1|||
156570772|NCT01976806|565173631|FG001|Overall Study|Lost to Follow-up|4|||
156570773|NCT01976806|565173630|FG000|Overall Study|Adverse Event|1|||
156570774|NCT01976806|565173631|FG001|Overall Study|Adverse Event|1|||
156570775|NCT01976806|565173630|FG000|Overall Study|Withdrawal by Subject|1|||
156570776|NCT01976806|565173631|FG001|Overall Study|Withdrawal by Subject|1|||
156570777|NCT03929250|565173633|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
156570778|NCT03929250|565173634|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
156570779|NCT04429022|565173636|FG000|Overall Study|Protocol Violation|18|||
156570780|NCT04429022|565173637|FG001|Overall Study|Protocol Violation|1|||
156570781|NCT04909463|565174889|FG000|Overall Study|Withdrawal by Subject|0|||
156570782|NCT04909463|565174890|FG001|Overall Study|Withdrawal by Subject|1|||
156570783|NCT04909463|565174891|FG002|Overall Study|Withdrawal by Subject|0|||
156570784|NCT04909463|565174892|FG003|Overall Study|Withdrawal by Subject|0|||
156570785|NCT04909463|565174889|FG000|Overall Study|Lost to Follow-up|2|||
156570786|NCT04909463|565174890|FG001|Overall Study|Lost to Follow-up|1|||
156570787|NCT04909463|565174891|FG002|Overall Study|Lost to Follow-up|1|||
156570788|NCT04909463|565174892|FG003|Overall Study|Lost to Follow-up|0|||
156570789|NCT01614457|565174903|FG000|Overall Study|Non-Compliance|1|||
156570790|NCT01614457|565174904|FG001|Overall Study|Non-Compliance|0|||
156570791|NCT01614457|565174903|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
156570792|NCT01614457|565174904|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
156570793|NCT03518840|565174905|FG000|Overall Study|Lost to Follow-up|6|||
156570794|NCT02599402|565174908|FG000|Overall Study|Disease progression|153|||
156570795|NCT02599402|565174908|FG000|Overall Study|Study drug toxicity|201|||
156570796|NCT02599402|565174908|FG000|Overall Study|Death|26|||
156570797|NCT02599402|565174908|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
156570798|NCT02599402|565174908|FG000|Overall Study|Participant request to discontinue study treatment|13|||
156570799|NCT02599402|565174908|FG000|Overall Study|Participant withdrew consent|5|||
156570800|NCT02599402|565174908|FG000|Overall Study|Lost to Follow-up|1|||
156570801|NCT02599402|565174908|FG000|Overall Study|Maximum Clinical Benefit|7|||
156570802|NCT02599402|565174908|FG000|Overall Study|Poor/non-compliance|1|||
156570803|NCT02599402|565174908|FG000|Overall Study|Pregnancy|1|||
156570804|NCT02599402|565174908|FG000|Overall Study|Participant no longer met study criteria|7|||
156570805|NCT02599402|565174908|FG000|Overall Study|Other Reasons|95|||
156570806|NCT02945657|565174909|FG000|Overall Study|Adverse Event|1|||
156570807|NCT02945657|565174909|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
156570808|NCT00283387|565174916|FG000|First Intervention|Subject non-compliant|1|||
156570809|NCT00283387|565174917|FG001|First Intervention|Subject non-compliant|1|||
156570810|NCT00283387|565174916|FG000|First Intervention|Withdrawal by Subject|0|||
156570811|NCT00283387|565174917|FG001|First Intervention|Withdrawal by Subject|1|||
156570812|NCT03830281|565174922|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
156570813|NCT03830281|565174923|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
156570814|NCT03830281|565174922|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
156570815|NCT03830281|565174923|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
156570816|NCT03830281|565174922|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
156570817|NCT03830281|565174923|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
156570818|NCT03830281|565174922|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
156570819|NCT03830281|565174923|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
156570820|NCT03830281|565174922|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
156570821|NCT03830281|565174923|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
156570822|NCT03830281|565174922|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
156570823|NCT03830281|565174923|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
156570824|NCT03830281|565174922|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
156570825|NCT03830281|565174923|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
156570826|NCT03830281|565174922|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
156570827|NCT03830281|565174923|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
156570828|NCT03830281|565174922|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
156570829|NCT03830281|565174923|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
156570830|NCT00594399|565174924|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
156570831|NCT00594399|565174925|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
156570832|NCT00594399|565174926|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
156570833|NCT00594399|565174924|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
156570834|NCT00594399|565174925|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
156570835|NCT00594399|565174926|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
156570836|NCT00594399|565174924|FG000|Initial 3 Month Counseling|Personal issues|2|||
156570837|NCT00594399|565174925|FG001|Initial 3 Month Counseling|Personal issues|0|||
156570838|NCT00594399|565174926|FG002|Initial 3 Month Counseling|Personal issues|0|||
156570839|NCT00594399|565174924|FG000|Initial 3 Month Counseling|Too busy|7|||
156570840|NCT00594399|565174925|FG001|Initial 3 Month Counseling|Too busy|1|||
156570841|NCT00594399|565174926|FG002|Initial 3 Month Counseling|Too busy|0|||
156570842|NCT00594399|565174924|FG000|Initial 3 Month Counseling|Pain|2|||
156570843|NCT00594399|565174925|FG001|Initial 3 Month Counseling|Pain|0|||
156570844|NCT00594399|565174926|FG002|Initial 3 Month Counseling|Pain|0|||
156570845|NCT00594399|565174924|FG000|Initial 3 Month Counseling|Moved|1|||
156570846|NCT00594399|565174925|FG001|Initial 3 Month Counseling|Moved|0|||
156570847|NCT00594399|565174926|FG002|Initial 3 Month Counseling|Moved|0|||
156570848|NCT00594399|565174924|FG000|Initial 3 Month Counseling|Family illness|1|||
156570849|NCT00594399|565174925|FG001|Initial 3 Month Counseling|Family illness|0|||
156570850|NCT00594399|565174926|FG002|Initial 3 Month Counseling|Family illness|0|||
156570851|NCT00594399|565174924|FG000|Rerandomization Arm 1 Only|Death|2|||
156570852|NCT00594399|565174925|FG001|Rerandomization Arm 1 Only|Death|1|||
156570853|NCT00594399|565174926|FG002|Rerandomization Arm 1 Only|Death|0|||
156570854|NCT00594399|565174924|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
156570855|NCT00594399|565174925|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
156570856|NCT00594399|565174926|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
156570857|NCT00659438|565174927|FG000|Overall Study|Withdrawal by Subject|2|||
156570858|NCT00659438|565174928|FG001|Overall Study|Withdrawal by Subject|2|||
156570859|NCT00659438|565174927|FG000|Overall Study|Death|11|||
156570860|NCT00659438|565174928|FG001|Overall Study|Death|6|||
156570861|NCT00659438|565174927|FG000|Overall Study|Lost to Follow-up|1|||
156570862|NCT00659438|565174928|FG001|Overall Study|Lost to Follow-up|0|||
156570863|NCT00201851|565174930|FG000|Overall Study|Lost to Follow-up|2|||
156570864|NCT00201851|565174931|FG001|Overall Study|Lost to Follow-up|1|||
156570865|NCT00201851|565174932|FG002|Overall Study|Lost to Follow-up|0|||
156570866|NCT00201851|565174930|FG000|Overall Study|Ineligible post enrollment|6|||
156570867|NCT00201851|565174931|FG001|Overall Study|Ineligible post enrollment|1|||
156570868|NCT00201851|565174932|FG002|Overall Study|Ineligible post enrollment|1|||
156570869|NCT02469246|565174933|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
156570870|NCT02469246|565174934|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
156570871|NCT02469246|565174933|FG000|Double-Blind Phase|Adverse Event|12|||
156570872|NCT02469246|565174934|FG001|Double-Blind Phase|Adverse Event|9|||
156570873|NCT02469246|565174933|FG000|Double-Blind Phase|Death|2|||
156570874|NCT02469246|565174934|FG001|Double-Blind Phase|Death|0|||
156570875|NCT02469246|565174933|FG000|Double-Blind Phase|Lack of Efficacy|2|||
156570876|NCT02469246|565174934|FG001|Double-Blind Phase|Lack of Efficacy|1|||
156570877|NCT02469246|565174933|FG000|Double-Blind Phase|Investigator's Discretion|8|||
156570878|NCT02469246|565174934|FG001|Double-Blind Phase|Investigator's Discretion|8|||
156570879|NCT02469246|565174933|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
156570880|NCT02469246|565174934|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
156570881|NCT02469246|565174933|FG000|Double-Blind Phase|Protocol Violation|1|||
156570882|NCT02469246|565174934|FG001|Double-Blind Phase|Protocol Violation|1|||
156570883|NCT02469246|565174933|FG000|Double-Blind Phase|Withdrew Consent|25|||
156570884|NCT02469246|565174934|FG001|Double-Blind Phase|Withdrew Consent|25|||
156570885|NCT02469246|565174933|FG000|Double-Blind Phase|Lost to Follow-up|9|||
156570886|NCT02469246|565174934|FG001|Double-Blind Phase|Lost to Follow-up|5|||
156570887|NCT00922935|565174938|FG000|Overall Study|Protocol Violation|0|||
156570888|NCT00922935|565174939|FG001|Overall Study|Protocol Violation|3|||
156570889|NCT00922935|565174940|FG002|Overall Study|Protocol Violation|0|||
156570890|NCT00922935|565174938|FG000|Overall Study|Physician Decision|1|||
156570891|NCT00922935|565174939|FG001|Overall Study|Physician Decision|1|||
156570892|NCT00922935|565174940|FG002|Overall Study|Physician Decision|0|||
156570893|NCT00922935|565174938|FG000|Overall Study|Lost to Follow-up|0|||
156570894|NCT00922935|565174939|FG001|Overall Study|Lost to Follow-up|1|||
156570895|NCT00922935|565174940|FG002|Overall Study|Lost to Follow-up|0|||
156570896|NCT01491945|565174941|FG000|Overall Study|Death|30|||
156570897|NCT01491945|565174941|FG000|Overall Study|Withdrwan/LTF|16|||
156570898|NCT01491945|565174941|FG000|Overall Study|Conversion|4|||
156570899|NCT01491945|565174941|FG000|Overall Study|Missed Visit|1|||
156570900|NCT02201940|565174942|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
156570901|NCT02201940|565174943|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
156570902|NCT02201940|565174942|FG000|Overall Study|Lack of Efficacy|2|||
156570903|NCT02201940|565174943|FG001|Overall Study|Lack of Efficacy|113|||
156570904|NCT02201940|565174942|FG000|Overall Study|Lost to Follow-up|5|||
156570905|NCT02201940|565174943|FG001|Overall Study|Lost to Follow-up|0|||
156570906|NCT02201940|565174942|FG000|Overall Study|Withdrew Consent|2|||
156570907|NCT02201940|565174943|FG001|Overall Study|Withdrew Consent|1|||
156570908|NCT02201940|565174942|FG000|Overall Study|Investigator's Discretion|1|||
156570909|NCT02201940|565174943|FG001|Overall Study|Investigator's Discretion|1|||
156570910|NCT02201940|565174942|FG000|Overall Study|Death|1|||
156570911|NCT02201940|565174943|FG001|Overall Study|Death|0|||
156570912|NCT02201940|565174942|FG000|Overall Study|Adverse Event|0|||
156570913|NCT02201940|565174943|FG001|Overall Study|Adverse Event|1|||
156570914|NCT00074958|565174945|FG000|Overall Study|Adverse Event|1|||
156570915|NCT02700451|565174949|FG000|Overall Study|Protocol Violation|2|||
156570916|NCT02700451|565174950|FG001|Overall Study|Protocol Violation|2|||
156570917|NCT02700451|565174951|FG002|Overall Study|Protocol Violation|3|||
156570918|NCT02700451|565174949|FG000|Overall Study|Discontinued intervention|14|||
156570919|NCT02700451|565174950|FG001|Overall Study|Discontinued intervention|15|||
156570920|NCT02700451|565174951|FG002|Overall Study|Discontinued intervention|14|||
156570921|NCT02690701|565174952|FG000|Treatment Period 1|Adverse Event|2|||
156570922|NCT02690701|565174953|FG001|Treatment Period 1|Adverse Event|2|||
156570923|NCT02690701|565174952|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156570924|NCT02690701|565174953|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156570925|NCT02690701|565174952|FG000|Treatment Period 2|Adverse Event|2|||
156570926|NCT02690701|565174953|FG001|Treatment Period 2|Adverse Event|0|||
156570927|NCT02690701|565174952|FG000|Treatment Period 2|Lack of Efficacy|1|||
156570928|NCT02690701|565174953|FG001|Treatment Period 2|Lack of Efficacy|0|||
156570929|NCT02690701|565174952|FG000|Treatment Period 2|Lost to Follow-up|0|||
156570930|NCT02690701|565174953|FG001|Treatment Period 2|Lost to Follow-up|2|||
156570931|NCT02690701|565174952|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156570932|NCT02690701|565174953|FG001|Treatment Period 2|Withdrawal by Subject|2|||
156570933|NCT02690701|565174952|FG000|Treatment Period 2|Protocol Violation|0|||
156570934|NCT02690701|565174953|FG001|Treatment Period 2|Protocol Violation|1|||
156570935|NCT00404092|565174955|FG000|Overall Study|Death|1|||
156570936|NCT00404092|565174956|FG001|Overall Study|Death|0|||
156570937|NCT00404092|565174957|FG002|Overall Study|Death|0|||
156570938|NCT00404092|565174958|FG003|Overall Study|Death|0|||
156570939|NCT00404092|565174955|FG000|Overall Study|Adverse Event|0|||
156570940|NCT00404092|565174956|FG001|Overall Study|Adverse Event|0|||
156570941|NCT00404092|565174957|FG002|Overall Study|Adverse Event|1|||
156570942|NCT00404092|565174958|FG003|Overall Study|Adverse Event|0|||
156570943|NCT01511445|565174959|FG000|Overall Study|Lost to Follow-up|3|||
156570944|NCT01511445|565174960|FG001|Overall Study|Lost to Follow-up|1|||
156570945|NCT01511445|565174959|FG000|Overall Study|Protocol Violation|1|||
156570946|NCT01511445|565174960|FG001|Overall Study|Protocol Violation|3|||
156570947|NCT01511445|565174959|FG000|Overall Study|Protocol Violation|1|||
156570948|NCT01511445|565174960|FG001|Overall Study|Protocol Violation|0|||
156570949|NCT02344576|565174964|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
156570950|NCT02344576|565174965|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
156570951|NCT02344576|565174966|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
156570952|NCT02344576|565174967|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
156570953|NCT02344576|565174964|FG000|1-Month Follow-Up|Death|13|||
156570954|NCT02344576|565174965|FG001|1-Month Follow-Up|Death|8|||
156570955|NCT02344576|565174966|FG002|1-Month Follow-Up|Death|0|||
156570956|NCT02344576|565174967|FG003|1-Month Follow-Up|Death|0|||
156570957|NCT02344576|565174964|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
156570958|NCT02344576|565174965|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
156570959|NCT02344576|565174966|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
156570960|NCT02344576|565174967|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
156570961|NCT02344576|565174964|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
156570962|NCT02344576|565174965|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
156570963|NCT02344576|565174966|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
156570964|NCT02344576|565174967|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
156570965|NCT02344576|565174964|FG000|6-Month Follow-Up|Death|14|||
156570966|NCT02344576|565174965|FG001|6-Month Follow-Up|Death|14|||
156570967|NCT02344576|565174966|FG002|6-Month Follow-Up|Death|0|||
156570968|NCT02344576|565174967|FG003|6-Month Follow-Up|Death|0|||
156570969|NCT02344576|565174964|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
156570970|NCT02344576|565174965|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
156570971|NCT02344576|565174966|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
156570972|NCT02344576|565174967|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
156570973|NCT02344576|565174964|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
156570974|NCT02344576|565174965|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
156570975|NCT02344576|565174966|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
156570976|NCT02344576|565174967|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
156570977|NCT01856114|565174968|FG000|Overall Study|Withdrawal by Subject|1|||
156570978|NCT01856114|565174969|FG001|Overall Study|Withdrawal by Subject|0|||
156570979|NCT01856114|565174968|FG000|Overall Study|Adverse Event|1|||
156570980|NCT01856114|565174969|FG001|Overall Study|Adverse Event|0|||
156570981|NCT02853760|565174970|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
156570982|NCT02853760|565174971|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
156570983|NCT02853760|565174972|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
156570984|NCT02853760|565174973|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
156570985|NCT02853760|565174974|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
156570986|NCT02853760|565174975|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
156570987|NCT01624142|565174976|FG000|Overall Study|Withdrawal by Subject|14|||
156570988|NCT01624142|565174977|FG001|Overall Study|Withdrawal by Subject|4|||
156570989|NCT01624142|565174976|FG000|Overall Study|Death|3|||
156570990|NCT01624142|565174977|FG001|Overall Study|Death|6|||
156570991|NCT01624142|565174976|FG000|Overall Study|Study Closure|12|||
156570992|NCT01624142|565174977|FG001|Overall Study|Study Closure|6|||
156570993|NCT01624142|565174976|FG000|Overall Study|Lost to Follow-up|2|||
156570994|NCT01624142|565174977|FG001|Overall Study|Lost to Follow-up|0|||
156570995|NCT01624142|565174976|FG000|Overall Study|Other|1|||
156570996|NCT01624142|565174977|FG001|Overall Study|Other|0|||
156570997|NCT04826900|565174978|FG000|Overall Study|Family factor|1|||
156570998|NCT04826900|565174979|FG001|Overall Study|Family factor|1|||
156570999|NCT03372941|565174980|FG000|Overall Study|Lost to Follow-up|2|||
156571000|NCT03372941|565174981|FG001|Overall Study|Lost to Follow-up|4|||
156571001|NCT01053429|565174982|FG000|Overall Study|Adverse Event|64|||
156571002|NCT01053429|565174982|FG000|Overall Study|Other|309|||
156571003|NCT00752986|565174983|FG000|Overall Study|Withdrawal by Subject|2|||
156571004|NCT00752986|565174984|FG001|Overall Study|Withdrawal by Subject|1|||
156571005|NCT00752986|565174985|FG002|Overall Study|Withdrawal by Subject|2|||
156571006|NCT00752986|565174983|FG000|Overall Study|Protocol Violation|3|||
156571007|NCT00752986|565174984|FG001|Overall Study|Protocol Violation|0|||
156571008|NCT00752986|565174985|FG002|Overall Study|Protocol Violation|0|||
156571009|NCT01697345|565174986|FG000|Overall Study|Withdrawal by Subject|1|||
156571010|NCT02382133|565174987|FG000|Overall Study|Death|22|||
156571011|NCT02382133|565174987|FG000|Overall Study|transfer out of ICU|4|||
156571012|NCT02382133|565174987|FG000|Overall Study|Physician Decision|2|||
156571013|NCT02382133|565174987|FG000|Overall Study|arterial catheter loss|4|||
156571014|NCT02382133|565174987|FG000|Overall Study|pressure injury both sites|1|||
156571015|NCT03972488|565174991|FG000|Overall Study|Progressive disease|42|||
156571016|NCT03972488|565174992|FG001|Overall Study|Progressive disease|44|||
156571017|NCT03972488|565174991|FG000|Overall Study|Physician Decision|13|||
156571018|NCT03972488|565174992|FG001|Overall Study|Physician Decision|7|||
156571019|NCT03972488|565174991|FG000|Overall Study|Adverse Event|8|||
156571020|NCT03972488|565174992|FG001|Overall Study|Adverse Event|1|||
156571021|NCT03972488|565174991|FG000|Overall Study|Death|4|||
156571022|NCT03972488|565174992|FG001|Overall Study|Death|4|||
156571023|NCT03972488|565174991|FG000|Overall Study|Withdrawal by Subject|3|||
156571024|NCT03972488|565174992|FG001|Overall Study|Withdrawal by Subject|4|||
156571025|NCT03972488|565174991|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
156571026|NCT03972488|565174992|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
156571027|NCT00045032|565175001|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
156571028|NCT00045032|565175002|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
156571029|NCT00045032|565175003|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
156571030|NCT00045032|565175001|FG000|Overall Study|Death|22|||
156571031|NCT00045032|565175002|FG001|Overall Study|Death|24|||
156571032|NCT00045032|565175003|FG002|Overall Study|Death|17|||
156571033|NCT00045032|565175001|FG000|Overall Study|Insufficient Therapeutic Response|542|||
156571034|NCT00045032|565175002|FG001|Overall Study|Insufficient Therapeutic Response|437|||
156571035|NCT00045032|565175003|FG002|Overall Study|Insufficient Therapeutic Response|445|||
156571036|NCT00045032|565175001|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
156571037|NCT00045032|565175002|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
156571038|NCT00045032|565175003|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
156571039|NCT00045032|565175001|FG000|Overall Study|Other Protocol Violation|2|||
156571040|NCT00045032|565175002|FG001|Overall Study|Other Protocol Violation|0|||
156571041|NCT00045032|565175003|FG002|Overall Study|Other Protocol Violation|1|||
156571042|NCT00045032|565175001|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
156571043|NCT00045032|565175002|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
156571044|NCT00045032|565175003|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
156571045|NCT00045032|565175001|FG000|Overall Study|Failure to Return|57|||
156571046|NCT00045032|565175002|FG001|Overall Study|Failure to Return|62|||
156571047|NCT00045032|565175003|FG002|Overall Study|Failure to Return|61|||
156571048|NCT00045032|565175001|FG000|Overall Study|Other|93|||
156571049|NCT00045032|565175002|FG001|Overall Study|Other|84|||
156571050|NCT00045032|565175003|FG002|Overall Study|Other|105|||
156571051|NCT02582658|565175004|FG000|Overall Study|Failure to Return|10|||
156571052|NCT02582658|565175004|FG000|Overall Study|Insufficient Virological Response|2|||
156571053|NCT02582658|565175004|FG000|Overall Study|Withdrawn Consent|1|||
156571054|NCT02582658|565175004|FG000|Overall Study|Death|1|||
156571055|NCT02582658|565175004|FG000|Overall Study|Not further specified|11|||
156571056|NCT02581995|565175005|FG000|Overall Study|Unspecified other|3|||
156571057|NCT02581995|565175005|FG000|Overall Study|Adverse Event|6|||
156571058|NCT02581995|565175005|FG000|Overall Study|Lost to Follow-up|5|||
156571059|NCT02581995|565175005|FG000|Overall Study|Withdrawal by participant|12|||
156571060|NCT02581995|565175005|FG000|Overall Study|Physician Decision|1|||
156571061|NCT02581995|565175005|FG000|Overall Study|Death|4|||
156571062|NCT03277196|565175007|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
156571063|NCT03277196|565175007|FG000|Overall Study|Lost to Follow-up|3|||
156571064|NCT03277196|565175007|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
156571065|NCT03277196|565175007|FG000|Overall Study|Other|2|||
156571066|NCT06119191|565175008|FG000|Overall Study|Adverse Event|0|||
156571067|NCT06119191|565175009|FG001|Overall Study|Adverse Event|1|||
156571068|NCT06119191|565175008|FG000|Overall Study|Protocol Violation|1|||
156571069|NCT06119191|565175009|FG001|Overall Study|Protocol Violation|0|||
156571070|NCT03528681|565176952|FG000|Open-Label Phase|Physician Decision|2|||
156571071|NCT03528681|565176953|FG001|Open-Label Phase|Physician Decision|0|||
156571072|NCT03528681|565176954|FG002|Open-Label Phase|Physician Decision|0|||
156571073|NCT03528681|565176955|FG003|Open-Label Phase|Physician Decision|0|||
156571074|NCT03528681|565176952|FG000|Open-Label Phase|Withdrawal by Subject|8|||
156571075|NCT03528681|565176953|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156571076|NCT03528681|565176954|FG002|Open-Label Phase|Withdrawal by Subject|0|||
156571077|NCT03528681|565176955|FG003|Open-Label Phase|Withdrawal by Subject|0|||
156571078|NCT03528681|565176952|FG000|Open-Label Phase|(Not collected)|4|||
156571079|NCT03528681|565176953|FG001|Open-Label Phase|(Not collected)|0|||
156571080|NCT03528681|565176954|FG002|Open-Label Phase|(Not collected)|0|||
156571081|NCT03528681|565176955|FG003|Open-Label Phase|(Not collected)|0|||
156571082|NCT03528681|565176952|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
156571083|NCT03528681|565176953|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
156571084|NCT03528681|565176954|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
156571085|NCT03528681|565176955|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
156571086|NCT03528681|565176952|FG000|Randomized Treatment Phase|Physician Decision|0|||
156571087|NCT03528681|565176953|FG001|Randomized Treatment Phase|Physician Decision|5|||
156571088|NCT03528681|565176954|FG002|Randomized Treatment Phase|Physician Decision|1|||
156571089|NCT03528681|565176955|FG003|Randomized Treatment Phase|Physician Decision|2|||
156571090|NCT03528681|565176952|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
156571091|NCT03528681|565176953|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
156571092|NCT03528681|565176954|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
156571093|NCT03528681|565176955|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
156571094|NCT03528681|565176952|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
156571095|NCT03528681|565176953|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
156571096|NCT03528681|565176954|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
156571097|NCT03528681|565176955|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
156571098|NCT03528681|565176952|FG000|Randomized Treatment Phase|(Not collected)|0|||
156571099|NCT03528681|565176953|FG001|Randomized Treatment Phase|(Not collected)|4|||
156571100|NCT03528681|565176954|FG002|Randomized Treatment Phase|(Not collected)|6|||
156571101|NCT03528681|565176955|FG003|Randomized Treatment Phase|(Not collected)|5|||
156571102|NCT02017444|565176960|FG000|Overall Study|Physician Decision|1|||
156571103|NCT02017444|565176961|FG001|Overall Study|Physician Decision|0|||
156571104|NCT02017444|565176960|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
156571105|NCT02017444|565176961|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
156571106|NCT00374556|565176966|FG000|Overall Study|Lost to Follow-up|1|||
156571107|NCT00374556|565176967|FG001|Overall Study|Lost to Follow-up|0|||
156571108|NCT00374556|565176966|FG000|Overall Study|Removed at baseline due to medical cond|0|||
156571109|NCT00374556|565176967|FG001|Overall Study|Removed at baseline due to medical cond|1|||
156571110|NCT00473694|565176968|FG000|Overall Study|Adverse Event|0|||
156571111|NCT00473694|565176969|FG001|Overall Study|Adverse Event|1|||
156571112|NCT00473694|565176970|FG002|Overall Study|Adverse Event|0|||
156571113|NCT00473694|565176971|FG003|Overall Study|Adverse Event|0|||
156571114|NCT00473694|565176968|FG000|Overall Study|Participants did not receive treatment|11|||
156571115|NCT00473694|565176969|FG001|Overall Study|Participants did not receive treatment|3|||
156571116|NCT00473694|565176970|FG002|Overall Study|Participants did not receive treatment|5|||
156571117|NCT00473694|565176971|FG003|Overall Study|Participants did not receive treatment|6|||
156571118|NCT00473694|565176968|FG000|Overall Study|Lost to Follow-up|0|||
156571119|NCT00473694|565176969|FG001|Overall Study|Lost to Follow-up|0|||
156571120|NCT00473694|565176970|FG002|Overall Study|Lost to Follow-up|0|||
156571121|NCT00473694|565176971|FG003|Overall Study|Lost to Follow-up|1|||
156571122|NCT02468193|565176972|FG000|Overall Study|Adverse Event|4|||
156571123|NCT02468193|565176972|FG000|Overall Study|Subject/ Guardian decision|2|||
156571124|NCT00742781|565176973|FG000|Overall Study|Withdrawal by Subject|3|||
156571125|NCT01416181|565176974|FG000|Part 1|Other|10|||
156571126|NCT01416181|565176975|FG001|Part 1|Other|24|||
156571127|NCT01416181|565176974|FG000|Part 1|Death|0|||
156571128|NCT01416181|565176975|FG001|Part 1|Death|1|||
156571129|NCT01416181|565176974|FG000|Part 1|Investigator Decision|7|||
156571130|NCT01416181|565176975|FG001|Part 1|Investigator Decision|6|||
156571131|NCT01416181|565176974|FG000|Part 1|Withdrawal by Subject|74|||
156571132|NCT01416181|565176975|FG001|Part 1|Withdrawal by Subject|48|||
156571133|NCT01416181|565176974|FG000|Part 1|Lack of Efficacy|16|||
156571134|NCT01416181|565176975|FG001|Part 1|Lack of Efficacy|8|||
156571135|NCT01416181|565176974|FG000|Part 1|Lost to Follow-up|1|||
156571136|NCT01416181|565176975|FG001|Part 1|Lost to Follow-up|1|||
156571137|NCT01416181|565176974|FG000|Part 1|Adverse Event|15|||
156571138|NCT01416181|565176975|FG001|Part 1|Adverse Event|18|||
156571139|NCT01416181|565176974|FG000|Part 1|Ongoing in Follow-Up|14|||
156571140|NCT01416181|565176975|FG001|Part 1|Ongoing in Follow-Up|8|||
156571141|NCT01416181|565176974|FG000|Part 2|Adverse Event|11|||
156571142|NCT01416181|565176975|FG001|Part 2|Adverse Event|4|||
156571143|NCT01416181|565176974|FG000|Part 2|Other|234|||
156571144|NCT01416181|565176975|FG001|Part 2|Other|267|||
156571145|NCT01416181|565176974|FG000|Part 2|Investigator Decision|6|||
156571146|NCT01416181|565176975|FG001|Part 2|Investigator Decision|7|||
156571147|NCT01416181|565176974|FG000|Part 2|Withdrawal by Subject|14|||
156571148|NCT01416181|565176975|FG001|Part 2|Withdrawal by Subject|5|||
156571149|NCT01416181|565176974|FG000|Part 2|Lack of Efficacy|4|||
156571150|NCT01416181|565176975|FG001|Part 2|Lack of Efficacy|1|||
156571151|NCT01416181|565176974|FG000|Part 2|Lost to Follow-up|2|||
156571152|NCT01416181|565176975|FG001|Part 2|Lost to Follow-up|2|||
156571153|NCT03816995|565176978|FG000|Overall Study|Withdrawal by Subject|3|||
156571154|NCT03816995|565176979|FG001|Overall Study|Withdrawal by Subject|1|||
156571155|NCT03816995|565176978|FG000|Overall Study|Cancelled Surgery|8|||
156571156|NCT03816995|565176979|FG001|Overall Study|Cancelled Surgery|12|||
156571157|NCT03816995|565176978|FG000|Overall Study|No wound protector used|11|||
156571158|NCT03816995|565176979|FG001|Overall Study|No wound protector used|17|||
156571159|NCT03816995|565176978|FG000|Overall Study|Protocol Violation|2|||
156571160|NCT03816995|565176979|FG001|Overall Study|Protocol Violation|3|||
156571161|NCT00486902|565176980|FG000|Overall Study|Withdrawal by Subject|1|||
156571162|NCT00486902|565176981|FG001|Overall Study|Withdrawal by Subject|2|||
156571163|NCT00486902|565176980|FG000|Overall Study|decision for postpartum tubal ligation|3|||
156571164|NCT00486902|565176981|FG001|Overall Study|decision for postpartum tubal ligation|1|||
156571165|NCT00486902|565176980|FG000|Overall Study|spinal anesthetic protocal violation|1|||
156571166|NCT00486902|565176981|FG001|Overall Study|spinal anesthetic protocal violation|1|||
156571167|NCT00486902|565176980|FG000|Overall Study|Did not meet inclusion criteria|1|||
156571168|NCT00486902|565176981|FG001|Overall Study|Did not meet inclusion criteria|0|||
156571169|NCT00486902|565176980|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
156571170|NCT00486902|565176981|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
156571171|NCT00541307|565176982|FG000|Overall Study|Death|5|||
156571172|NCT00541307|565176982|FG000|Overall Study|Physician Decision|3|||
156571173|NCT00541307|565176982|FG000|Overall Study|Withdrawal by Subject|6|||
156571174|NCT00541307|565176982|FG000|Overall Study|Lost to Follow-up|4|||
156571175|NCT00541307|565176982|FG000|Overall Study|Subject returned early (outside window)|1|||
156571176|NCT00541307|565176982|FG000|Overall Study|Surgical Bypass|5|||
156571177|NCT04178590|565176983|FG000|Overall Study|Pregnancy|1|||
156571178|NCT04178590|565176983|FG000|Overall Study|Lost to Follow-up|1|||
156571179|NCT04723537|565176984|FG000|Overall Study|Withdrawal by Subject|3|||
156571180|NCT04723537|565176985|FG001|Overall Study|Withdrawal by Subject|0|||
156571181|NCT04723537|565176986|FG002|Overall Study|Withdrawal by Subject|0|||
156571182|NCT04723537|565176984|FG000|Overall Study|Physician Decision|0|||
156571183|NCT04723537|565176985|FG001|Overall Study|Physician Decision|0|||
156571184|NCT04723537|565176986|FG002|Overall Study|Physician Decision|1|||
156571185|NCT04723537|565176984|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
156571186|NCT04723537|565176985|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
156571187|NCT04723537|565176986|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
156571188|NCT01485614|565176993|FG000|Randomization|Not Treated|1|||
156571189|NCT01485614|565176994|FG001|Randomization|Not Treated|0|||
156571190|NCT01485614|565176995|FG002|Randomization|Not Treated|0|||
156571191|NCT01485614|565176996|FG003|Randomization|Not Treated|0|||
156571192|NCT01485614|565176993|FG000|Weeks 0-20|Lost to Follow-up|2|||
156571193|NCT01485614|565176994|FG001|Weeks 0-20|Lost to Follow-up|0|||
156571194|NCT01485614|565176995|FG002|Weeks 0-20|Lost to Follow-up|0|||
156571195|NCT01485614|565176996|FG003|Weeks 0-20|Lost to Follow-up|0|||
156571196|NCT01485614|565176993|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
156571197|NCT01485614|565176994|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
156571198|NCT01485614|565176995|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
156571199|NCT01485614|565176996|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
156571200|NCT01485614|565176993|FG000|Weeks 0-20|Withdrawal by Subject|3|||
156571201|NCT01485614|565176994|FG001|Weeks 0-20|Withdrawal by Subject|2|||
156571202|NCT01485614|565176995|FG002|Weeks 0-20|Withdrawal by Subject|1|||
156571203|NCT01485614|565176996|FG003|Weeks 0-20|Withdrawal by Subject|0|||
156571204|NCT01485614|565176993|FG000|Weeks 20-54|Lost to Follow-up|4|||
156571205|NCT01485614|565176994|FG001|Weeks 20-54|Lost to Follow-up|3|||
156571206|NCT01485614|565176995|FG002|Weeks 20-54|Lost to Follow-up|1|||
156571207|NCT01485614|565176996|FG003|Weeks 20-54|Lost to Follow-up|0|||
156571208|NCT01485614|565176993|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
156571209|NCT01485614|565176994|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
156571210|NCT01485614|565176995|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
156571211|NCT01485614|565176996|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
156571212|NCT01485614|565176993|FG000|Weeks 20-54|Withdrawal by Subject|5|||
156571213|NCT01485614|565176994|FG001|Weeks 20-54|Withdrawal by Subject|3|||
156571214|NCT01485614|565176995|FG002|Weeks 20-54|Withdrawal by Subject|0|||
156571215|NCT01485614|565176996|FG003|Weeks 20-54|Withdrawal by Subject|0|||
156571216|NCT00733902|565176997|FG000|Overall Study|Death|0|||
156571217|NCT00733902|565176998|FG001|Overall Study|Death|0|||
156571218|NCT00733902|565176999|FG002|Overall Study|Death|0|||
156571219|NCT00733902|565177000|FG003|Overall Study|Death|1|||
156571220|NCT00733902|565176997|FG000|Overall Study|Adverse Event|3|||
156571221|NCT00733902|565176998|FG001|Overall Study|Adverse Event|4|||
156571222|NCT00733902|565176999|FG002|Overall Study|Adverse Event|7|||
156571223|NCT00733902|565177000|FG003|Overall Study|Adverse Event|11|||
156571224|NCT00733902|565176997|FG000|Overall Study|Lack of Efficacy|56|||
156571225|NCT00733902|565176998|FG001|Overall Study|Lack of Efficacy|21|||
156571226|NCT00733902|565176999|FG002|Overall Study|Lack of Efficacy|34|||
156571227|NCT00733902|565177000|FG003|Overall Study|Lack of Efficacy|23|||
156571228|NCT00733902|565176997|FG000|Overall Study|Protocol Violation|4|||
156571229|NCT00733902|565176998|FG001|Overall Study|Protocol Violation|6|||
156571230|NCT00733902|565176999|FG002|Overall Study|Protocol Violation|3|||
156571231|NCT00733902|565177000|FG003|Overall Study|Protocol Violation|3|||
156571232|NCT00733902|565176997|FG000|Overall Study|Withdrawal by Subject|10|||
156571233|NCT00733902|565176998|FG001|Overall Study|Withdrawal by Subject|5|||
156571234|NCT00733902|565176999|FG002|Overall Study|Withdrawal by Subject|4|||
156571235|NCT00733902|565177000|FG003|Overall Study|Withdrawal by Subject|16|||
156571236|NCT00733902|565176997|FG000|Overall Study|Entered extension study|89|||
156571237|NCT00733902|565176998|FG001|Overall Study|Entered extension study|124|||
156571238|NCT00733902|565176999|FG002|Overall Study|Entered extension study|111|||
156571239|NCT00733902|565177000|FG003|Overall Study|Entered extension study|109|||
156571240|NCT00733902|565176997|FG000|Overall Study|Randomized but not treated|2|||
156571241|NCT00733902|565176998|FG001|Overall Study|Randomized but not treated|2|||
156571242|NCT00733902|565176999|FG002|Overall Study|Randomized but not treated|2|||
156571243|NCT00733902|565177000|FG003|Overall Study|Randomized but not treated|1|||
156571244|NCT00942409|565177001|FG000|Overall Study|Lack of Efficacy|1|||
156571245|NCT00942409|565177001|FG000|Overall Study|study drug unavailable|2|||
156571246|NCT01503021|565177006|FG000|Overall Study|Adverse Event|7|||
156571247|NCT01503021|565177007|FG001|Overall Study|Adverse Event|6|||
156571248|NCT01503021|565177006|FG000|Overall Study|Death|0|||
156571249|NCT01503021|565177007|FG001|Overall Study|Death|2|||
156571250|NCT01503021|565177006|FG000|Overall Study|Lost to Follow-up|2|||
156571251|NCT01503021|565177007|FG001|Overall Study|Lost to Follow-up|0|||
156571252|NCT01503021|565177006|FG000|Overall Study|Physician Decision|3|||
156571253|NCT01503021|565177007|FG001|Overall Study|Physician Decision|0|||
156571254|NCT01503021|565177006|FG000|Overall Study|Protocol Violation|1|||
156571255|NCT01503021|565177007|FG001|Overall Study|Protocol Violation|3|||
156571256|NCT01503021|565177006|FG000|Overall Study|Withdrawal by Subject|9|||
156571257|NCT01503021|565177007|FG001|Overall Study|Withdrawal by Subject|8|||
156571258|NCT01503021|565177006|FG000|Overall Study|Moved, received transplant, etc.|5|||
156571259|NCT01503021|565177007|FG001|Overall Study|Moved, received transplant, etc.|7|||
156571260|NCT03941548|565177009|FG000|Overall Study|Adverse Event|0|||
156571261|NCT03941548|565177010|FG001|Overall Study|Adverse Event|1|||
156571262|NCT03941548|565177009|FG000|Overall Study|Lost to Follow-up|0|||
156571263|NCT03941548|565177010|FG001|Overall Study|Lost to Follow-up|1|||
156571264|NCT03941548|565177009|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
156571265|NCT03941548|565177010|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
156571266|NCT01242111|565177011|FG000|Overall Study|Adverse Event|1|||
156571267|NCT01242111|565177011|FG000|Overall Study|Withdrawal by Subject|1|||
156571268|NCT01242111|565177011|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
156571269|NCT00870688|565177012|FG000|Overall Study|Lost to Follow-up|2|||
156571270|NCT00870688|565177012|FG000|Overall Study|Death, Unrelated|1|||
156571271|NCT00870688|565177012|FG000|Overall Study|Granules in the Stools|1|||
156571272|NCT02015819|565177013|FG000|Overall Study|Rickham catheter was misaligned|0|||
156571273|NCT02015819|565177014|FG001|Overall Study|Rickham catheter was misaligned|0|||
156571274|NCT02015819|565177015|FG002|Overall Study|Rickham catheter was misaligned|0|||
156571275|NCT02015819|565177016|FG003|Overall Study|Rickham catheter was misaligned|1|||
156571276|NCT01697215|565177019|FG000|Overall Study|Physician Decision|5|||
156571277|NCT01697215|565177019|FG000|Overall Study|Malfunction|9|||
156571278|NCT01697215|565177019|FG000|Overall Study|CXR not available|9|||
156571279|NCT01929083|565177020|FG000|Intervention 1|Lost to Follow-up|2|||
156571280|NCT01929083|565177021|FG001|Intervention 1|Lost to Follow-up|0|||
156571281|NCT01929083|565177020|FG000|Intervention 1|Nonadherent to study medications|1|||
156571282|NCT01929083|565177021|FG001|Intervention 1|Nonadherent to study medications|0|||
156571283|NCT01929083|565177020|FG000|Intervention 2|Adverse Event|0|||
156571284|NCT01929083|565177021|FG001|Intervention 2|Adverse Event|1|||
156571285|NCT00087438|565177022|FG000|Overall Study|Ineligible / No protocol treatment|4|||
156571286|NCT01486264|565177023|FG000|Overall Study|Death|1|||
156571287|NCT01486264|565177024|FG001|Overall Study|Death|1|||
156571288|NCT01486264|565177023|FG000|Overall Study|Adverse Event|3|||
156571289|NCT01486264|565177024|FG001|Overall Study|Adverse Event|3|||
156571290|NCT01486264|565177023|FG000|Overall Study|Lack of Efficacy|6|||
156571291|NCT01486264|565177024|FG001|Overall Study|Lack of Efficacy|10|||
156571292|NCT01486264|565177023|FG000|Overall Study|Withdrawal by Subject|7|||
156571293|NCT01486264|565177024|FG001|Overall Study|Withdrawal by Subject|18|||
156571294|NCT01486264|565177023|FG000|Overall Study|Physician Decision|1|||
156571295|NCT01486264|565177024|FG001|Overall Study|Physician Decision|1|||
156571296|NCT01486264|565177023|FG000|Overall Study|Protocol Violation|3|||
156571297|NCT01486264|565177024|FG001|Overall Study|Protocol Violation|0|||
156571298|NCT01486264|565177023|FG000|Overall Study|Lost to Follow-up|3|||
156571299|NCT01486264|565177024|FG001|Overall Study|Lost to Follow-up|2|||
156571300|NCT01486264|565177023|FG000|Overall Study|Other|5|||
156571301|NCT01486264|565177024|FG001|Overall Study|Other|11|||
156571302|NCT01486264|565177023|FG000|Overall Study|Not treated|0|||
156571303|NCT01486264|565177024|FG001|Overall Study|Not treated|1|||
156571304|NCT05340504|565177025|FG000|Overall Study|Withdrawal by Subject|1|||
156571305|NCT05340504|565177026|FG001|Overall Study|Withdrawal by Subject|0|||
156571306|NCT03068715|565177037|FG000|Overall Study|No longer met inclusion criteria|1|||
156571307|NCT03068715|565177038|FG001|Overall Study|No longer met inclusion criteria|0|||
156571308|NCT00728416|565177039|FG000|Overall Study|Adverse Event|1|||
156571309|NCT00728416|565177040|FG001|Overall Study|Adverse Event|1|||
156571310|NCT00728416|565177039|FG000|Overall Study|Treatment Failure|0|||
156571311|NCT00728416|565177040|FG001|Overall Study|Treatment Failure|1|||
156571312|NCT00728416|565177039|FG000|Overall Study|Withdrawal by Subject|1|||
156571313|NCT00728416|565177040|FG001|Overall Study|Withdrawal by Subject|0|||
156571314|NCT03584009|565177041|FG000|Overall Study|Death|25|||
156571315|NCT03584009|565177042|FG001|Overall Study|Death|18|||
156571316|NCT03584009|565177041|FG000|Overall Study|Lost to Follow-up|0|||
156571317|NCT03584009|565177042|FG001|Overall Study|Lost to Follow-up|1|||
156571318|NCT03584009|565177041|FG000|Overall Study|Physician Decision|1|||
156571319|NCT03584009|565177042|FG001|Overall Study|Physician Decision|1|||
156571320|NCT03584009|565177041|FG000|Overall Study|Study Terminated by Sponsor|22|||
156571321|NCT03584009|565177042|FG001|Overall Study|Study Terminated by Sponsor|30|||
156571322|NCT03584009|565177041|FG000|Overall Study|Withdrawal by Subject|3|||
156571323|NCT03584009|565177042|FG001|Overall Study|Withdrawal by Subject|2|||
156571324|NCT04112914|565177043|FG000|Overall Study|Lost to Follow-up|13|||
156571325|NCT04112914|565177044|FG001|Overall Study|Lost to Follow-up|9|||
156571326|NCT04112914|565177043|FG000|Overall Study|Withdrawal by Subject|1|||
156571327|NCT04112914|565177044|FG001|Overall Study|Withdrawal by Subject|0|||
156571328|NCT00768560|565177045|FG000|Intervention Set 1|Adverse Event|0|||
156571329|NCT00768560|565177046|FG001|Intervention Set 1|Adverse Event|1|||
156571330|NCT00768560|565177047|FG002|Intervention Set 1|Adverse Event|0|||
156571331|NCT00768560|565177048|FG003|Intervention Set 1|Adverse Event|0|||
156571332|NCT00768560|565177049|FG004|Intervention Set 1|Adverse Event|0|||
156571333|NCT00768560|565177050|FG005|Intervention Set 1|Adverse Event|0|||
156571334|NCT00117312|565177051|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
156571335|NCT00117312|565177052|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
156571336|NCT00117312|565177053|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
156571337|NCT00117312|565177054|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
156571338|NCT00117312|565177051|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
156571339|NCT00117312|565177052|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
156571340|NCT00117312|565177053|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
156571341|NCT00117312|565177054|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
156571342|NCT00117312|565177051|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
156571343|NCT00117312|565177052|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
156571344|NCT00117312|565177053|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
156571345|NCT00117312|565177054|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
156571346|NCT00117312|565177051|FG000|Overall Study|Other|0|||
156571347|NCT00117312|565177052|FG001|Overall Study|Other|1|||
156571348|NCT00117312|565177053|FG002|Overall Study|Other|3|||
156571349|NCT00117312|565177054|FG003|Overall Study|Other|1|||
156571350|NCT00117312|565177051|FG000|Overall Study|Patient choice|0|||
156571351|NCT00117312|565177052|FG001|Overall Study|Patient choice|0|||
156571352|NCT00117312|565177053|FG002|Overall Study|Patient choice|2|||
156571353|NCT00117312|565177054|FG003|Overall Study|Patient choice|1|||
156571354|NCT00117312|565177051|FG000|Overall Study|Adverse Event|0|||
156571355|NCT00117312|565177052|FG001|Overall Study|Adverse Event|2|||
156571356|NCT00117312|565177053|FG002|Overall Study|Adverse Event|0|||
156571357|NCT00117312|565177054|FG003|Overall Study|Adverse Event|0|||
156571358|NCT00117312|565177051|FG000|Overall Study|Protocol Violation|0|||
156571359|NCT00117312|565177052|FG001|Overall Study|Protocol Violation|1|||
156571360|NCT00117312|565177053|FG002|Overall Study|Protocol Violation|3|||
156571361|NCT00117312|565177054|FG003|Overall Study|Protocol Violation|0|||
156571362|NCT00117312|565177051|FG000|Overall Study|PSA decrease <=50%|0|||
156571363|NCT00117312|565177052|FG001|Overall Study|PSA decrease <=50%|2|||
156571364|NCT00117312|565177053|FG002|Overall Study|PSA decrease <=50%|2|||
156571365|NCT00117312|565177054|FG003|Overall Study|PSA decrease <=50%|4|||
156571366|NCT00117312|565177051|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
156571367|NCT00117312|565177052|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
156571368|NCT00117312|565177053|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
156571369|NCT00117312|565177054|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
156571370|NCT00117312|565177051|FG000|Overall Study|Hepatic abnormality|0|||
156571371|NCT00117312|565177052|FG001|Overall Study|Hepatic abnormality|1|||
156571372|NCT00117312|565177053|FG002|Overall Study|Hepatic abnormality|0|||
156571373|NCT00117312|565177054|FG003|Overall Study|Hepatic abnormality|1|||
156571374|NCT00117312|565177051|FG000|Overall Study|Withdrawal by Subject|0|||
156571375|NCT00117312|565177052|FG001|Overall Study|Withdrawal by Subject|2|||
156571376|NCT00117312|565177053|FG002|Overall Study|Withdrawal by Subject|0|||
156571377|NCT00117312|565177054|FG003|Overall Study|Withdrawal by Subject|0|||
156571378|NCT01120626|565177055|FG000|Overall Study|Withdrawal by Subject|1|||
156571379|NCT01120626|565177056|FG001|Overall Study|Withdrawal by Subject|0|||
156571380|NCT02635204|565177057|FG000|Overall Study|Adverse Event|1|||
156571381|NCT02635204|565177058|FG001|Overall Study|Adverse Event|0|||
156571382|NCT02635204|565177057|FG000|Overall Study|Lost to Follow-up|1|||
156571383|NCT02635204|565177058|FG001|Overall Study|Lost to Follow-up|1|||
156571384|NCT01535235|565177060|FG000|Overall Study|Adverse Event|1|||
156571385|NCT01535235|565177061|FG001|Overall Study|Adverse Event|0|||
156571386|NCT00509106|565177064|FG000|Overall Study|Adverse Event|3|||
156571387|NCT00509106|565177065|FG001|Overall Study|Adverse Event|2|||
156571388|NCT00509106|565177064|FG000|Overall Study|Noncompliance|0|||
156571389|NCT00509106|565177065|FG001|Overall Study|Noncompliance|1|||
156571390|NCT00509106|565177064|FG000|Overall Study|At the request of sponsor/investigator|1|||
156571391|NCT00509106|565177065|FG001|Overall Study|At the request of sponsor/investigator|2|||
156571392|NCT00509106|565177064|FG000|Overall Study|Withdrew consent|4|||
156571393|NCT00509106|565177065|FG001|Overall Study|Withdrew consent|8|||
156571394|NCT00509106|565177064|FG000|Overall Study|Lost to Follow-up|16|||
156571395|NCT00509106|565177065|FG001|Overall Study|Lost to Follow-up|10|||
156571396|NCT00509106|565177064|FG000|Overall Study|Other|1|||
156571397|NCT00509106|565177065|FG001|Overall Study|Other|0|||
156571398|NCT00509106|565177064|FG000|Overall Study|Death|6|||
156571399|NCT00509106|565177065|FG001|Overall Study|Death|6|||
156571400|NCT05421754|565177071|FG000|Overall Study|Technical issue with sensor|1|||
156571401|NCT01051739|565177072|FG000|Overall Study|Death|3|||
156571402|NCT01051739|565177073|FG001|Overall Study|Death|3|||
156571403|NCT01051739|565177072|FG000|Overall Study|Withdrawal by Subject|25|||
156571404|NCT01051739|565177073|FG001|Overall Study|Withdrawal by Subject|10|||
156571405|NCT03527043|565177074|FG000|Overall Study|Withdrawal by Subject|1|||
156571406|NCT03527043|565177075|FG001|Overall Study|Withdrawal by Subject|0|||
156571407|NCT00709202|565177076|FG000|Overall Study|Withdrawal by Subject|6|||
156571408|NCT00709202|565177077|FG001|Overall Study|Withdrawal by Subject|6|||
156571409|NCT03133767|565177078|FG000|Overall Study|Lost to Follow-up|38|||
156571410|NCT03133767|565177079|FG001|Overall Study|Lost to Follow-up|24|||
156571411|NCT03133767|565177078|FG000|Overall Study|Protocol Violation|0|||
156571412|NCT03133767|565177079|FG001|Overall Study|Protocol Violation|1|||
156571413|NCT04233424|565177080|FG000|Overall Study|Death|15|||
156571414|NCT04233424|565177081|FG001|Overall Study|Death|16|||
156571415|NCT04233424|565177080|FG000|Overall Study|Withdrawal by Subject|2|||
156571416|NCT04233424|565177081|FG001|Overall Study|Withdrawal by Subject|8|||
156571417|NCT04233424|565177080|FG000|Overall Study|Physician Decision|1|||
156571418|NCT04233424|565177081|FG001|Overall Study|Physician Decision|3|||
156571419|NCT04233424|565177080|FG000|Overall Study|Protocol Violation|3|||
156571420|NCT04233424|565177081|FG001|Overall Study|Protocol Violation|1|||
156571421|NCT04233424|565177080|FG000|Overall Study|Lost to Follow-up|1|||
156571422|NCT04233424|565177081|FG001|Overall Study|Lost to Follow-up|3|||
156571423|NCT04233424|565177080|FG000|Overall Study|subject refuse to visit site|2|||
156571424|NCT04233424|565177081|FG001|Overall Study|subject refuse to visit site|0|||
156571425|NCT02698189|565177082|FG000|Overall Study|Physician Decision|3|||
156571426|NCT02698189|565177083|FG001|Overall Study|Physician Decision|0|||
156571427|NCT02698189|565177082|FG000|Overall Study|Progressive disease|0|||
156571428|NCT02698189|565177083|FG001|Overall Study|Progressive disease|5|||
156571429|NCT02698189|565177082|FG000|Overall Study|Study terminated by sponsor|0|||
156571430|NCT02698189|565177083|FG001|Overall Study|Study terminated by sponsor|1|||
156571431|NCT03301857|565177084|FG000|Overall Study|Death|0|||
156571432|NCT03301857|565177085|FG001|Overall Study|Death|2|||
156571433|NCT03301857|565177084|FG000|Overall Study|Lost to Follow-up|4|||
156571434|NCT03301857|565177085|FG001|Overall Study|Lost to Follow-up|2|||
156571435|NCT03301857|565177084|FG000|Overall Study|Decision by Sponsor|6|||
156571436|NCT03301857|565177085|FG001|Overall Study|Decision by Sponsor|0|||
156571437|NCT03301857|565177084|FG000|Overall Study|Withdrawal by Subject|12|||
156571438|NCT03301857|565177085|FG001|Overall Study|Withdrawal by Subject|4|||
156571439|NCT01642212|565177099|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
156571440|NCT01642212|565177100|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
156571441|NCT01642212|565177101|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
156571442|NCT01642212|565177102|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
156571443|NCT01642212|565177103|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
156571444|NCT01642212|565177099|FG000|Double-blind Treatment|Other|0|||
156571445|NCT01642212|565177100|FG001|Double-blind Treatment|Other|2|||
156571446|NCT01642212|565177101|FG002|Double-blind Treatment|Other|1|||
156571447|NCT01642212|565177102|FG003|Double-blind Treatment|Other|0|||
156571448|NCT01642212|565177103|FG004|Double-blind Treatment|Other|0|||
156571449|NCT01642212|565177099|FG000|Double-blind Treatment|Non-compliance|0|||
156571450|NCT01642212|565177100|FG001|Double-blind Treatment|Non-compliance|1|||
156571451|NCT01642212|565177101|FG002|Double-blind Treatment|Non-compliance|0|||
156571452|NCT01642212|565177102|FG003|Double-blind Treatment|Non-compliance|0|||
156571453|NCT01642212|565177103|FG004|Double-blind Treatment|Non-compliance|0|||
156571454|NCT01642212|565177099|FG000|Double-blind Treatment|Adverse Event|0|||
156571455|NCT01642212|565177100|FG001|Double-blind Treatment|Adverse Event|0|||
156571456|NCT01642212|565177101|FG002|Double-blind Treatment|Adverse Event|1|||
156571457|NCT01642212|565177102|FG003|Double-blind Treatment|Adverse Event|0|||
156571458|NCT01642212|565177103|FG004|Double-blind Treatment|Adverse Event|0|||
156571459|NCT01642212|565177099|FG000|Open-label Extension|Adverse Event|0|||
156571460|NCT01642212|565177100|FG001|Open-label Extension|Adverse Event|0|||
156571461|NCT01642212|565177101|FG002|Open-label Extension|Adverse Event|0|||
156571462|NCT01642212|565177102|FG003|Open-label Extension|Adverse Event|3|||
156571463|NCT01642212|565177103|FG004|Open-label Extension|Adverse Event|0|||
156571464|NCT01642212|565177099|FG000|Open-label Extension|Sponsor Decision|0|||
156571465|NCT01642212|565177100|FG001|Open-label Extension|Sponsor Decision|0|||
156571466|NCT01642212|565177101|FG002|Open-label Extension|Sponsor Decision|0|||
156571467|NCT01642212|565177102|FG003|Open-label Extension|Sponsor Decision|7|||
156571468|NCT01642212|565177103|FG004|Open-label Extension|Sponsor Decision|4|||
156571469|NCT01642212|565177099|FG000|Open-label Extension|Consent Withdrawn|0|||
156571470|NCT01642212|565177100|FG001|Open-label Extension|Consent Withdrawn|0|||
156571471|NCT01642212|565177101|FG002|Open-label Extension|Consent Withdrawn|0|||
156571472|NCT01642212|565177102|FG003|Open-label Extension|Consent Withdrawn|0|||
156571473|NCT01642212|565177103|FG004|Open-label Extension|Consent Withdrawn|2|||
156571474|NCT01642212|565177099|FG000|Open-label Extension|Lost to Follow-up|0|||
156571475|NCT01642212|565177100|FG001|Open-label Extension|Lost to Follow-up|0|||
156571476|NCT01642212|565177101|FG002|Open-label Extension|Lost to Follow-up|0|||
156571477|NCT01642212|565177102|FG003|Open-label Extension|Lost to Follow-up|0|||
156571478|NCT01642212|565177103|FG004|Open-label Extension|Lost to Follow-up|1|||
156571479|NCT01642212|565177099|FG000|Open-label Extension|Other|0|||
156571480|NCT01642212|565177100|FG001|Open-label Extension|Other|0|||
156571481|NCT01642212|565177101|FG002|Open-label Extension|Other|0|||
156571482|NCT01642212|565177102|FG003|Open-label Extension|Other|0|||
156571483|NCT01642212|565177103|FG004|Open-label Extension|Other|1|||
156571484|NCT03430310|565177104|FG000|Overall Study|Protocol Violation|2|||
156571485|NCT03430310|565177105|FG001|Overall Study|Protocol Violation|0|||
156571486|NCT03430310|565177104|FG000|Overall Study|Withdrawal by Subject|3|||
156571487|NCT03430310|565177105|FG001|Overall Study|Withdrawal by Subject|2|||
156571488|NCT03430310|565177104|FG000|Overall Study|COVID shutdown March 2020|0|||
156571489|NCT03430310|565177105|FG001|Overall Study|COVID shutdown March 2020|1|||
156571490|NCT01446809|565177106|FG000|Overall Study|Adverse Event|0|||
156571491|NCT01446809|565177107|FG001|Overall Study|Adverse Event|0|||
156571492|NCT01446809|565177108|FG002|Overall Study|Adverse Event|1|||
156571493|NCT01446809|565177106|FG000|Overall Study|Failure to complete study procedures|0|||
156571494|NCT01446809|565177107|FG001|Overall Study|Failure to complete study procedures|0|||
156571495|NCT01446809|565177108|FG002|Overall Study|Failure to complete study procedures|1|||
156571496|NCT01331161|565177109|FG000|Overall Study|Physician Decision|1|||
156571497|NCT01331161|565177110|FG001|Overall Study|Physician Decision|0|||
156571498|NCT01331161|565177109|FG000|Overall Study|Lost to Follow-up|0|||
156571499|NCT01331161|565177110|FG001|Overall Study|Lost to Follow-up|1|||
156571500|NCT01331161|565177109|FG000|Overall Study|Pregnancy|0|||
156571501|NCT01331161|565177110|FG001|Overall Study|Pregnancy|1|||
156571502|NCT00853632|565179611|FG000|Overall Study|Death|88|||
156571503|NCT00853632|565179611|FG000|Overall Study|Withdrawal by Subject|45|||
156571504|NCT00853632|565179611|FG000|Overall Study|Lost to Follow-up|30|||
156571505|NCT00853632|565179611|FG000|Overall Study|Reoperation/Explant|17|||
156571506|NCT00853632|565179611|FG000|Overall Study|Exit with other reason|22|||
156571507|NCT02342171|565179614|FG000|Overall Study|Death|4|||
156571508|NCT02342171|565179615|FG001|Overall Study|Death|87|||
156571509|NCT02342171|565179614|FG000|Overall Study|Received favipiravir|10|||
156571510|NCT02342171|565179615|FG001|Overall Study|Received favipiravir|0|||
156571511|NCT02342171|565179614|FG000|Overall Study|Missing cycle treshold value|1|||
156571512|NCT02342171|565179615|FG001|Overall Study|Missing cycle treshold value|0|||
156571513|NCT02342171|565179614|FG000|Overall Study|Unknown outcome|0|||
156571514|NCT02342171|565179615|FG001|Overall Study|Unknown outcome|1|||
156571515|NCT02342171|565179614|FG000|Overall Study|Missing age data|0|||
156571516|NCT02342171|565179615|FG001|Overall Study|Missing age data|1|||
156571517|NCT00886821|565179618|FG000|Stage 2|Adverse Event|0|||
156571518|NCT00886821|565179619|FG001|Stage 2|Adverse Event|0|||
156571519|NCT00886821|565179620|FG002|Stage 2|Adverse Event|0|||
156571520|NCT00886821|565179621|FG003|Stage 2|Adverse Event|0|||
156571521|NCT00886821|565179622|FG004|Stage 2|Adverse Event|0|||
156571522|NCT00886821|565179623|FG005|Stage 2|Adverse Event|0|||
156571523|NCT00886821|565179624|FG006|Stage 2|Adverse Event|0|||
156571524|NCT00886821|565179625|FG007|Stage 2|Adverse Event|0|||
156571525|NCT00886821|565179626|FG008|Stage 2|Adverse Event|0|||
156571526|NCT00886821|565179627|FG009|Stage 2|Adverse Event|0|||
156571527|NCT00886821|565179628|FG010|Stage 2|Adverse Event|0|||
156571528|NCT00886821|565179629|FG011|Stage 2|Adverse Event|1|||
156571529|NCT00886821|565179630|FG012|Stage 2|Adverse Event|3|||
156571530|NCT00886821|565179631|FG013|Stage 2|Adverse Event|0|||
156571531|NCT00886821|565179618|FG000|Stage 2|Lost to Follow-up|0|||
156571532|NCT00886821|565179619|FG001|Stage 2|Lost to Follow-up|0|||
156571533|NCT00886821|565179620|FG002|Stage 2|Lost to Follow-up|0|||
156571534|NCT00886821|565179621|FG003|Stage 2|Lost to Follow-up|0|||
156571535|NCT00886821|565179622|FG004|Stage 2|Lost to Follow-up|0|||
156571536|NCT00886821|565179623|FG005|Stage 2|Lost to Follow-up|0|||
156571537|NCT00886821|565179624|FG006|Stage 2|Lost to Follow-up|0|||
156571538|NCT00886821|565179625|FG007|Stage 2|Lost to Follow-up|0|||
156571539|NCT00886821|565179626|FG008|Stage 2|Lost to Follow-up|0|||
156571540|NCT00886821|565179627|FG009|Stage 2|Lost to Follow-up|0|||
156571541|NCT00886821|565179628|FG010|Stage 2|Lost to Follow-up|0|||
156571542|NCT00886821|565179629|FG011|Stage 2|Lost to Follow-up|0|||
156571543|NCT00886821|565179630|FG012|Stage 2|Lost to Follow-up|2|||
156571544|NCT00886821|565179631|FG013|Stage 2|Lost to Follow-up|1|||
156571545|NCT03090191|565179632|FG000|Overall Study|Adverse Event|90|||
156571546|NCT03090191|565179633|FG001|Overall Study|Adverse Event|72|||
156571547|NCT03090191|565179632|FG000|Overall Study|Death|365|||
156571548|NCT03090191|565179633|FG001|Overall Study|Death|358|||
156571549|NCT03090191|565179632|FG000|Overall Study|Lost to Follow-up|382|||
156571550|NCT03090191|565179633|FG001|Overall Study|Lost to Follow-up|394|||
156571551|NCT03090191|565179632|FG000|Overall Study|Physician Decision|77|||
156571552|NCT03090191|565179633|FG001|Overall Study|Physician Decision|66|||
156571553|NCT03090191|565179632|FG000|Overall Study|Protocol Violation|43|||
156571554|NCT03090191|565179633|FG001|Overall Study|Protocol Violation|52|||
156571555|NCT03090191|565179632|FG000|Overall Study|Withdrawal by Subject|2160|||
156571556|NCT03090191|565179633|FG001|Overall Study|Withdrawal by Subject|2133|||
156571557|NCT03090191|565179632|FG000|Overall Study|Site terminated|7|||
156571558|NCT03090191|565179633|FG001|Overall Study|Site terminated|8|||
156571559|NCT03090191|565179632|FG000|Overall Study|Other|66|||
156571560|NCT03090191|565179633|FG001|Overall Study|Other|60|||
156571561|NCT03090191|565179632|FG000|Overall Study|Withdrawn before any study vaccination|43|||
156571562|NCT03090191|565179633|FG001|Overall Study|Withdrawn before any study vaccination|52|||
156571563|NCT04645797|565179634|FG000|Overall Study|Disease Progression|3|||
156571564|NCT04645797|565179635|FG001|Overall Study|Disease Progression|3|||
156571565|NCT04645797|565179636|FG002|Overall Study|Disease Progression|1|||
156571566|NCT04645797|565179637|FG003|Overall Study|Disease Progression|0|||
156571567|NCT04645797|565179638|FG004|Overall Study|Disease Progression|0|||
156571568|NCT04645797|565179639|FG005|Overall Study|Disease Progression|0|||
156571569|NCT04645797|565179640|FG006|Overall Study|Disease Progression|0|||
156571570|NCT04645797|565179634|FG000|Overall Study|Death|3|||
156571571|NCT04645797|565179635|FG001|Overall Study|Death|1|||
156571572|NCT04645797|565179636|FG002|Overall Study|Death|0|||
156571573|NCT04645797|565179637|FG003|Overall Study|Death|0|||
156571574|NCT04645797|565179638|FG004|Overall Study|Death|0|||
156571575|NCT04645797|565179639|FG005|Overall Study|Death|0|||
156571576|NCT04645797|565179640|FG006|Overall Study|Death|0|||
156571577|NCT03596164|565179644|FG000|Overall Study|Adverse Event|0|||
156571578|NCT03596164|565179645|FG001|Overall Study|Adverse Event|1|||
156571579|NCT03596164|565179644|FG000|Overall Study|Death|1|||
156571580|NCT03596164|565179645|FG001|Overall Study|Death|0|||
156571581|NCT00389207|565179646|FG000|Overall Study|Adverse Event|26|||
156571582|NCT00389207|565179647|FG001|Overall Study|Adverse Event|32|||
156571583|NCT00389207|565179648|FG002|Overall Study|Adverse Event|10|||
156571584|NCT00389207|565179646|FG000|Overall Study|Protocol Violation|3|||
156571585|NCT00389207|565179647|FG001|Overall Study|Protocol Violation|1|||
156571586|NCT00389207|565179648|FG002|Overall Study|Protocol Violation|4|||
156571587|NCT00389207|565179646|FG000|Overall Study|Lost to Follow-up|12|||
156571588|NCT00389207|565179647|FG001|Overall Study|Lost to Follow-up|9|||
156571589|NCT00389207|565179648|FG002|Overall Study|Lost to Follow-up|7|||
156571590|NCT00389207|565179646|FG000|Overall Study|Withdrawal by Subject|5|||
156571591|NCT00389207|565179647|FG001|Overall Study|Withdrawal by Subject|7|||
156571592|NCT00389207|565179648|FG002|Overall Study|Withdrawal by Subject|11|||
156571593|NCT00389207|565179646|FG000|Overall Study|Other|17|||
156571594|NCT00389207|565179647|FG001|Overall Study|Other|23|||
156571595|NCT00389207|565179648|FG002|Overall Study|Other|9|||
156571596|NCT01772134|565179655|FG000|Overall Study|Adverse Event|6|||
156571597|NCT01772134|565179656|FG001|Overall Study|Adverse Event|5|||
156571598|NCT01772134|565179657|FG002|Overall Study|Adverse Event|10|||
156571599|NCT01772134|565179655|FG000|Overall Study|Withdrew Consent|3|||
156571600|NCT01772134|565179656|FG001|Overall Study|Withdrew Consent|1|||
156571601|NCT01772134|565179657|FG002|Overall Study|Withdrew Consent|5|||
156571602|NCT01772134|565179655|FG000|Overall Study|Lost to Follow-up|2|||
156571603|NCT01772134|565179656|FG001|Overall Study|Lost to Follow-up|0|||
156571604|NCT01772134|565179657|FG002|Overall Study|Lost to Follow-up|0|||
156571605|NCT01772134|565179655|FG000|Overall Study|Protocol Deviation|4|||
156571606|NCT01772134|565179656|FG001|Overall Study|Protocol Deviation|3|||
156571607|NCT01772134|565179657|FG002|Overall Study|Protocol Deviation|3|||
156571608|NCT01772134|565179655|FG000|Overall Study|Lack of Efficacy|11|||
156571609|NCT01772134|565179656|FG001|Overall Study|Lack of Efficacy|5|||
156571610|NCT01772134|565179657|FG002|Overall Study|Lack of Efficacy|3|||
156571611|NCT01772134|565179655|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
156571612|NCT01772134|565179656|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
156571613|NCT01772134|565179657|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
156571614|NCT01772134|565179655|FG000|Overall Study|Randomized Study Medication Not Received|2|||
156571615|NCT01772134|565179656|FG001|Overall Study|Randomized Study Medication Not Received|0|||
156571616|NCT01772134|565179657|FG002|Overall Study|Randomized Study Medication Not Received|1|||
156571617|NCT02500550|565179662|FG000|Overall Study|Death|7|||
156571618|NCT03293680|565179663|FG000|Overall Study|Death|1|||
156571619|NCT03293680|565179663|FG000|Overall Study|Did not meet inclusion criteria|8|||
156571620|NCT00636818|565179664|FG000|Overall Study|Adverse Event|1|||
156571621|NCT00636818|565179664|FG000|Overall Study|Lost to Follow-up|2|||
156571622|NCT00636818|565179664|FG000|Overall Study|Entry Criteria Exclusion|3|||
156571623|NCT00636818|565179664|FG000|Overall Study|Protocol Violation|1|||
156571624|NCT00636818|565179664|FG000|Overall Study|Withdrawal by Subject|4|||
156571625|NCT02604264|565179667|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
156571626|NCT02604264|565179668|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
156571627|NCT03192904|565179670|FG000|Overall Study|Physician Decision|3|||
156571628|NCT03192904|565179671|FG001|Overall Study|Physician Decision|1|||
156571629|NCT03192904|565179670|FG000|Overall Study|Lost to Follow-up|0|||
156571630|NCT03192904|565179671|FG001|Overall Study|Lost to Follow-up|1|||
156571631|NCT00424398|565179672|FG000|Overall Study|Withdrawal by Subject|2|||
156571632|NCT00424398|565179673|FG001|Overall Study|Withdrawal by Subject|1|||
156571633|NCT00424398|565179674|FG002|Overall Study|Withdrawal by Subject|0|||
156571634|NCT00424398|565179672|FG000|Overall Study|Subject met exclusion criteria|1|||
156571635|NCT00424398|565179673|FG001|Overall Study|Subject met exclusion criteria|0|||
156571636|NCT00424398|565179674|FG002|Overall Study|Subject met exclusion criteria|0|||
156571637|NCT01023789|565179675|FG000|3 - Year Visit|Death|29|||
156571638|NCT01023789|565179675|FG000|3 - Year Visit|Withdrawal of consent|1|||
156571639|NCT01023789|565179675|FG000|3 - Year Visit|Lost to Follow-up|13|||
156571640|NCT02115308|565179686|FG000|Overall Study|Safety Screening|2|||
156571641|NCT02115308|565179687|FG001|Overall Study|Safety Screening|2|||
156571642|NCT01309737|565179688|FG000|Week 0 to 16|Death|1|||
156571643|NCT01309737|565179689|FG001|Week 0 to 16|Death|0|||
156571644|NCT01309737|565179690|FG002|Week 0 to 16|Death|1|||
156571645|NCT01309737|565179691|FG003|Week 0 to 16|Death|0|||
156571646|NCT01309737|565179692|FG004|Week 0 to 16|Death|0|||
156571647|NCT01309737|565179688|FG000|Week 0 to 16|Adverse Event|11|||
156571648|NCT01309737|565179689|FG001|Week 0 to 16|Adverse Event|10|||
156571649|NCT01309737|565179690|FG002|Week 0 to 16|Adverse Event|5|||
156571650|NCT01309737|565179691|FG003|Week 0 to 16|Adverse Event|0|||
156571651|NCT01309737|565179692|FG004|Week 0 to 16|Adverse Event|0|||
156571652|NCT01309737|565179688|FG000|Week 0 to 16|Lack of Efficacy|15|||
156571653|NCT01309737|565179689|FG001|Week 0 to 16|Lack of Efficacy|2|||
156571654|NCT01309737|565179690|FG002|Week 0 to 16|Lack of Efficacy|24|||
156571655|NCT01309737|565179691|FG003|Week 0 to 16|Lack of Efficacy|0|||
156571656|NCT01309737|565179692|FG004|Week 0 to 16|Lack of Efficacy|0|||
156571657|NCT01309737|565179688|FG000|Week 0 to 16|Lost to Follow-up|7|||
156571658|NCT01309737|565179689|FG001|Week 0 to 16|Lost to Follow-up|8|||
156571659|NCT01309737|565179690|FG002|Week 0 to 16|Lost to Follow-up|3|||
156571660|NCT01309737|565179691|FG003|Week 0 to 16|Lost to Follow-up|0|||
156571661|NCT01309737|565179692|FG004|Week 0 to 16|Lost to Follow-up|0|||
156571662|NCT01309737|565179688|FG000|Week 0 to 16|Withdrawal by Subject|7|||
156571663|NCT01309737|565179689|FG001|Week 0 to 16|Withdrawal by Subject|6|||
156571664|NCT01309737|565179690|FG002|Week 0 to 16|Withdrawal by Subject|7|||
156571665|NCT01309737|565179691|FG003|Week 0 to 16|Withdrawal by Subject|0|||
156571666|NCT01309737|565179692|FG004|Week 0 to 16|Withdrawal by Subject|0|||
156571667|NCT01309737|565179688|FG000|Week 0 to 16|Other|10|||
156571668|NCT01309737|565179689|FG001|Week 0 to 16|Other|14|||
156571669|NCT01309737|565179690|FG002|Week 0 to 16|Other|4|||
156571670|NCT01309737|565179691|FG003|Week 0 to 16|Other|0|||
156571671|NCT01309737|565179692|FG004|Week 0 to 16|Other|0|||
156571672|NCT01309737|565179688|FG000|Week 0 to 16|Randomized, but not treated|1|||
156571673|NCT01309737|565179689|FG001|Week 0 to 16|Randomized, but not treated|0|||
156571674|NCT01309737|565179690|FG002|Week 0 to 16|Randomized, but not treated|0|||
156571675|NCT01309737|565179691|FG003|Week 0 to 16|Randomized, but not treated|0|||
156571676|NCT01309737|565179692|FG004|Week 0 to 16|Randomized, but not treated|0|||
156571677|NCT01309737|565179688|FG000|Week 16 to 52|Death|0|||
156571678|NCT01309737|565179689|FG001|Week 16 to 52|Death|0|||
156571679|NCT01309737|565179690|FG002|Week 16 to 52|Death|0|||
156571680|NCT01309737|565179691|FG003|Week 16 to 52|Death|0|||
156571681|NCT01309737|565179692|FG004|Week 16 to 52|Death|1|||
156571682|NCT01309737|565179688|FG000|Week 16 to 52|Adverse Event|7|||
156571683|NCT01309737|565179689|FG001|Week 16 to 52|Adverse Event|7|||
156571684|NCT01309737|565179690|FG002|Week 16 to 52|Adverse Event|0|||
156571685|NCT01309737|565179691|FG003|Week 16 to 52|Adverse Event|6|||
156571686|NCT01309737|565179692|FG004|Week 16 to 52|Adverse Event|5|||
156571687|NCT01309737|565179688|FG000|Week 16 to 52|Lack of Efficacy|107|||
156571688|NCT01309737|565179689|FG001|Week 16 to 52|Lack of Efficacy|76|||
156571689|NCT01309737|565179690|FG002|Week 16 to 52|Lack of Efficacy|0|||
156571690|NCT01309737|565179691|FG003|Week 16 to 52|Lack of Efficacy|25|||
156571691|NCT01309737|565179692|FG004|Week 16 to 52|Lack of Efficacy|21|||
156571692|NCT01309737|565179688|FG000|Week 16 to 52|Lost to Follow-up|4|||
156571693|NCT01309737|565179689|FG001|Week 16 to 52|Lost to Follow-up|2|||
156571694|NCT01309737|565179690|FG002|Week 16 to 52|Lost to Follow-up|0|||
156571695|NCT01309737|565179691|FG003|Week 16 to 52|Lost to Follow-up|1|||
156571696|NCT01309737|565179692|FG004|Week 16 to 52|Lost to Follow-up|4|||
156571697|NCT01309737|565179688|FG000|Week 16 to 52|Withdrawal by Subject|5|||
156571698|NCT01309737|565179689|FG001|Week 16 to 52|Withdrawal by Subject|6|||
156571699|NCT01309737|565179690|FG002|Week 16 to 52|Withdrawal by Subject|0|||
156571700|NCT01309737|565179691|FG003|Week 16 to 52|Withdrawal by Subject|0|||
156571701|NCT01309737|565179692|FG004|Week 16 to 52|Withdrawal by Subject|2|||
156571702|NCT01309737|565179688|FG000|Week 16 to 52|Other|10|||
156571703|NCT01309737|565179689|FG001|Week 16 to 52|Other|12|||
156571704|NCT01309737|565179690|FG002|Week 16 to 52|Other|0|||
156571705|NCT01309737|565179691|FG003|Week 16 to 52|Other|2|||
156571706|NCT01309737|565179692|FG004|Week 16 to 52|Other|0|||
156571707|NCT01442181|565179700|FG000|Overall Study|patient refused surgery|1|||
156571708|NCT01442181|565179701|FG001|Overall Study|patient refused surgery|0|||
156571709|NCT01442181|565179700|FG000|Overall Study|no insurance for surgery|1|||
156571710|NCT01442181|565179701|FG001|Overall Study|no insurance for surgery|0|||
156571711|NCT01442181|565179700|FG000|Overall Study|low ejection factor|0|||
156571712|NCT01442181|565179701|FG001|Overall Study|low ejection factor|1|||
156571713|NCT01442181|565179700|FG000|Overall Study|Lost to Follow-up|1|||
156571714|NCT01442181|565179701|FG001|Overall Study|Lost to Follow-up|1|||
156571715|NCT01442181|565179700|FG000|Overall Study|patient in an additional study|1|||
156571716|NCT01442181|565179701|FG001|Overall Study|patient in an additional study|0|||
156571717|NCT01442181|565179700|FG000|Overall Study|atrial fibrillation not noted|0|||
156571718|NCT01442181|565179701|FG001|Overall Study|atrial fibrillation not noted|1|||
156571719|NCT00749203|565179702|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
156571720|NCT00749203|565179703|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
156571721|NCT00749203|565179702|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
156571722|NCT00749203|565179703|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
156571723|NCT00749203|565179702|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
156571724|NCT00749203|565179703|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
156571725|NCT00749203|565179702|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
156571726|NCT00749203|565179703|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
156571727|NCT00749203|565179702|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
156571728|NCT00749203|565179703|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
156571729|NCT00749203|565179702|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
156571730|NCT00749203|565179703|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
156571731|NCT02034123|565179704|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571732|NCT02034123|565179705|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571733|NCT02034123|565179706|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571734|NCT02034123|565179707|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571735|NCT02034123|565179708|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
156571736|NCT02034123|565179709|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571737|NCT02034123|565179710|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571738|NCT02034123|565179711|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
156571739|NCT02034123|565179712|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
156571740|NCT02034123|565179713|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571741|NCT02034123|565179714|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571742|NCT02034123|565179715|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571743|NCT02034123|565179716|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571744|NCT02034123|565179717|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571745|NCT02034123|565179718|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571746|NCT02034123|565179719|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571747|NCT02034123|565179720|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571748|NCT02034123|565179721|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156571749|NCT02034123|565179704|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571750|NCT02034123|565179705|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571751|NCT02034123|565179706|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571752|NCT02034123|565179707|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
156571753|NCT02034123|565179708|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571754|NCT02034123|565179709|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571755|NCT02034123|565179710|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571756|NCT02034123|565179711|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571757|NCT02034123|565179712|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571758|NCT02034123|565179713|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571759|NCT02034123|565179714|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571760|NCT02034123|565179715|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571761|NCT02034123|565179716|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571762|NCT02034123|565179717|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571763|NCT02034123|565179718|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571764|NCT02034123|565179719|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571765|NCT02034123|565179720|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571766|NCT02034123|565179721|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156571767|NCT02034123|565179704|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571768|NCT02034123|565179705|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571769|NCT02034123|565179706|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571770|NCT02034123|565179707|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571771|NCT02034123|565179708|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571772|NCT02034123|565179709|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571773|NCT02034123|565179710|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571774|NCT02034123|565179711|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571775|NCT02034123|565179712|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
156571776|NCT02034123|565179713|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571777|NCT02034123|565179714|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571778|NCT02034123|565179715|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571779|NCT02034123|565179716|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571780|NCT02034123|565179717|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571781|NCT02034123|565179718|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571782|NCT02034123|565179719|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571783|NCT02034123|565179720|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571784|NCT02034123|565179721|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
156571785|NCT02034123|565179704|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571786|NCT02034123|565179705|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571787|NCT02034123|565179706|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571788|NCT02034123|565179707|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
156571789|NCT02034123|565179708|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
156571790|NCT02034123|565179709|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571791|NCT02034123|565179710|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571792|NCT02034123|565179711|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571793|NCT02034123|565179712|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571794|NCT02034123|565179713|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571795|NCT02034123|565179714|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571796|NCT02034123|565179715|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571797|NCT02034123|565179716|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571798|NCT02034123|565179717|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571799|NCT02034123|565179718|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571800|NCT02034123|565179719|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571801|NCT02034123|565179720|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571802|NCT02034123|565179721|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
156571803|NCT00246259|565179722|FG000|Overall Study|Other|3|||
156571804|NCT00246259|565179723|FG001|Overall Study|Other|3|||
156571805|NCT00246259|565179722|FG000|Overall Study|Not stable by Week 18|2|||
156571806|NCT00246259|565179723|FG001|Overall Study|Not stable by Week 18|1|||
156571807|NCT00246259|565179722|FG000|Overall Study|Participant non-compliant|4|||
156571808|NCT00246259|565179723|FG001|Overall Study|Participant non-compliant|9|||
156571809|NCT00246259|565179722|FG000|Overall Study|Lack of Efficacy|2|||
156571810|NCT00246259|565179723|FG001|Overall Study|Lack of Efficacy|2|||
156571811|NCT00246259|565179722|FG000|Overall Study|Investigator withdrew participant|2|||
156571812|NCT00246259|565179723|FG001|Overall Study|Investigator withdrew participant|0|||
156571813|NCT00246259|565179722|FG000|Overall Study|Adverse Event|5|||
156571814|NCT00246259|565179723|FG001|Overall Study|Adverse Event|0|||
156571815|NCT00246259|565179722|FG000|Overall Study|Lost to Follow-up|3|||
156571816|NCT00246259|565179723|FG001|Overall Study|Lost to Follow-up|4|||
156571817|NCT00246259|565179722|FG000|Overall Study|Withdrawal by Subject|5|||
156571818|NCT00246259|565179723|FG001|Overall Study|Withdrawal by Subject|1|||
156571819|NCT00246259|565179722|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
156571820|NCT00246259|565179723|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
156571821|NCT02240706|565179724|FG000|Overall Study|Lack of Efficacy|2|||
156571822|NCT02240706|565179725|FG001|Overall Study|Lack of Efficacy|2|||
156571823|NCT02240706|565179726|FG002|Overall Study|Lack of Efficacy|2|||
156571824|NCT02240706|565179727|FG003|Overall Study|Lack of Efficacy|2|||
156571825|NCT02240706|565179728|FG004|Overall Study|Lack of Efficacy|5|||
156571826|NCT02240706|565179729|FG005|Overall Study|Lack of Efficacy|0|||
156571827|NCT02240706|565179730|FG006|Overall Study|Lack of Efficacy|0|||
156571828|NCT02240706|565179724|FG000|Overall Study|Adverse Event|1|||
156571829|NCT02240706|565179725|FG001|Overall Study|Adverse Event|0|||
156571830|NCT02240706|565179726|FG002|Overall Study|Adverse Event|1|||
156571831|NCT02240706|565179727|FG003|Overall Study|Adverse Event|0|||
156571832|NCT02240706|565179728|FG004|Overall Study|Adverse Event|2|||
156571833|NCT02240706|565179729|FG005|Overall Study|Adverse Event|0|||
156571834|NCT02240706|565179730|FG006|Overall Study|Adverse Event|0|||
156571835|NCT02240706|565179724|FG000|Overall Study|Progressive disease|0|||
156571836|NCT02240706|565179725|FG001|Overall Study|Progressive disease|0|||
156571837|NCT02240706|565179726|FG002|Overall Study|Progressive disease|0|||
156571838|NCT02240706|565179727|FG003|Overall Study|Progressive disease|0|||
156571839|NCT02240706|565179728|FG004|Overall Study|Progressive disease|1|||
156571840|NCT02240706|565179729|FG005|Overall Study|Progressive disease|0|||
156571841|NCT02240706|565179730|FG006|Overall Study|Progressive disease|0|||
156571842|NCT02240706|565179724|FG000|Overall Study|Dose limiting toxicity|0|||
156571843|NCT02240706|565179725|FG001|Overall Study|Dose limiting toxicity|0|||
156571844|NCT02240706|565179726|FG002|Overall Study|Dose limiting toxicity|0|||
156571845|NCT02240706|565179727|FG003|Overall Study|Dose limiting toxicity|0|||
156571846|NCT02240706|565179728|FG004|Overall Study|Dose limiting toxicity|1|||
156571847|NCT02240706|565179729|FG005|Overall Study|Dose limiting toxicity|0|||
156571848|NCT02240706|565179730|FG006|Overall Study|Dose limiting toxicity|0|||
156571849|NCT02240706|565179724|FG000|Overall Study|Refused to continue taking medication|0|||
156571850|NCT02240706|565179725|FG001|Overall Study|Refused to continue taking medication|1|||
156571851|NCT02240706|565179726|FG002|Overall Study|Refused to continue taking medication|3|||
156571852|NCT02240706|565179727|FG003|Overall Study|Refused to continue taking medication|1|||
156571853|NCT02240706|565179728|FG004|Overall Study|Refused to continue taking medication|2|||
156571854|NCT02240706|565179729|FG005|Overall Study|Refused to continue taking medication|0|||
156571855|NCT02240706|565179730|FG006|Overall Study|Refused to continue taking medication|0|||
156571856|NCT02240706|565179724|FG000|Overall Study|Insurance billing concerns|0|||
156571857|NCT02240706|565179725|FG001|Overall Study|Insurance billing concerns|0|||
156571858|NCT02240706|565179726|FG002|Overall Study|Insurance billing concerns|0|||
156571859|NCT02240706|565179727|FG003|Overall Study|Insurance billing concerns|1|||
156571860|NCT02240706|565179728|FG004|Overall Study|Insurance billing concerns|0|||
156571861|NCT02240706|565179729|FG005|Overall Study|Insurance billing concerns|0|||
156571862|NCT02240706|565179730|FG006|Overall Study|Insurance billing concerns|0|||
156571863|NCT00855439|565179735|FG000|Overall Study|Withdrawal by Subject|2|||
156571864|NCT00855439|565179736|FG001|Overall Study|Withdrawal by Subject|0|||
156571865|NCT00855439|565179735|FG000|Overall Study|Pregnancy|1|||
156571866|NCT00855439|565179736|FG001|Overall Study|Pregnancy|0|||
156571867|NCT05502289|565179737|FG000|Period 1|Out Of Window|1|||
156571868|NCT05502289|565179738|FG001|Period 1|Out Of Window|0|||
156571869|NCT01564784|565179749|FG000|Overall Study|Other|1|||
156571870|NCT01564784|565179750|FG001|Overall Study|Other|0|||
156571871|NCT01564784|565179749|FG000|Overall Study|Subject refused further follow-up|1|||
156571872|NCT01564784|565179750|FG001|Overall Study|Subject refused further follow-up|6|||
156571873|NCT01564784|565179749|FG000|Overall Study|Lost to Follow-up|1|||
156571874|NCT01564784|565179750|FG001|Overall Study|Lost to Follow-up|1|||
156571875|NCT01564784|565179749|FG000|Overall Study|Death|131|||
156571876|NCT01564784|565179750|FG001|Overall Study|Death|126|||
156571877|NCT05300087|565179751|FG000|Overall Study|Withdrawal by Subject|0|||
156571878|NCT05300087|565179752|FG001|Overall Study|Withdrawal by Subject|1|||
156571879|NCT03248128|565179753|FG000|Overall Study|Lost to Follow-up|1|||
156571880|NCT03248128|565179754|FG001|Overall Study|Lost to Follow-up|0|||
156571881|NCT03248128|565179753|FG000|Overall Study|Withdrawal by Subject|16|||
156571882|NCT03248128|565179754|FG001|Overall Study|Withdrawal by Subject|14|||
156571883|NCT03248128|565179753|FG000|Overall Study|Site Closed|4|||
156571884|NCT03248128|565179754|FG001|Overall Study|Site Closed|3|||
156571885|NCT03248128|565179753|FG000|Overall Study|Randomized, but did not receive treatment|1|||
156571886|NCT03248128|565179754|FG001|Overall Study|Randomized, but did not receive treatment|3|||
156571887|NCT01914679|565179755|FG000|Overall Study|Lack of Efficacy|1|||
156571888|NCT01914679|565179755|FG000|Overall Study|Sponsor terminated study|4|||
156571889|NCT00256295|565179759|FG000|Overall Study|Withdrawal by Subject|3|||
156571890|NCT00256295|565179759|FG000|Overall Study|Death|1|||
156571891|NCT01126580|565179760|FG000|Overall Study|Adverse Event|14|||
156571892|NCT01126580|565179761|FG001|Overall Study|Adverse Event|8|||
156571893|NCT01126580|565179762|FG002|Overall Study|Adverse Event|12|||
156571894|NCT01126580|565179760|FG000|Overall Study|Withdrawal by Subject|11|||
156571895|NCT01126580|565179761|FG001|Overall Study|Withdrawal by Subject|19|||
156571896|NCT01126580|565179762|FG002|Overall Study|Withdrawal by Subject|14|||
156571897|NCT01126580|565179760|FG000|Overall Study|Sponsor Decision|5|||
156571898|NCT01126580|565179761|FG001|Overall Study|Sponsor Decision|4|||
156571899|NCT01126580|565179762|FG002|Overall Study|Sponsor Decision|7|||
156571900|NCT01126580|565179760|FG000|Overall Study|Physician Decision|1|||
156571901|NCT01126580|565179761|FG001|Overall Study|Physician Decision|1|||
156571902|NCT01126580|565179762|FG002|Overall Study|Physician Decision|2|||
156571903|NCT01126580|565179760|FG000|Overall Study|Entry Criteria Not Met|1|||
156571904|NCT01126580|565179761|FG001|Overall Study|Entry Criteria Not Met|1|||
156571905|NCT01126580|565179762|FG002|Overall Study|Entry Criteria Not Met|2|||
156571906|NCT01126580|565179760|FG000|Overall Study|Lack of Efficacy|2|||
156571907|NCT01126580|565179761|FG001|Overall Study|Lack of Efficacy|3|||
156571908|NCT01126580|565179762|FG002|Overall Study|Lack of Efficacy|4|||
156571909|NCT01126580|565179760|FG000|Overall Study|Protocol Violation|0|||
156571910|NCT01126580|565179761|FG001|Overall Study|Protocol Violation|1|||
156571911|NCT01126580|565179762|FG002|Overall Study|Protocol Violation|2|||
156571912|NCT01126580|565179760|FG000|Overall Study|Lost to Follow-up|15|||
156571913|NCT01126580|565179761|FG001|Overall Study|Lost to Follow-up|13|||
156571914|NCT01126580|565179762|FG002|Overall Study|Lost to Follow-up|9|||
156571915|NCT01126580|565179760|FG000|Overall Study|Treatment Non-compliance|0|||
156571916|NCT01126580|565179761|FG001|Overall Study|Treatment Non-compliance|2|||
156571917|NCT01126580|565179762|FG002|Overall Study|Treatment Non-compliance|3|||
156571918|NCT01731002|565179772|FG000|Overall Study|Adverse Event|0|||
156571919|NCT01731002|565179773|FG001|Overall Study|Adverse Event|2|||
156571920|NCT01731002|565179774|FG002|Overall Study|Adverse Event|2|||
156571921|NCT01731002|565179772|FG000|Overall Study|Non-Compliant|0|||
156571922|NCT01731002|565179773|FG001|Overall Study|Non-Compliant|1|||
156571923|NCT01731002|565179774|FG002|Overall Study|Non-Compliant|0|||
156571924|NCT01731002|565179772|FG000|Overall Study|Lost to Follow-up|1|||
156571925|NCT01731002|565179773|FG001|Overall Study|Lost to Follow-up|0|||
156571926|NCT01731002|565179774|FG002|Overall Study|Lost to Follow-up|0|||
156571927|NCT01731002|565179772|FG000|Overall Study|Test Agent Discontinuation|0|||
156571928|NCT01731002|565179773|FG001|Overall Study|Test Agent Discontinuation|1|||
156571929|NCT01731002|565179774|FG002|Overall Study|Test Agent Discontinuation|0|||
156571930|NCT01731002|565179772|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
156571931|NCT01731002|565179773|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
156571932|NCT01731002|565179774|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
156571933|NCT01731002|565179772|FG000|Overall Study|Elevated IOP|1|||
156571934|NCT01731002|565179773|FG001|Overall Study|Elevated IOP|0|||
156571935|NCT01731002|565179774|FG002|Overall Study|Elevated IOP|0|||
156571936|NCT01731002|565179772|FG000|Overall Study|Inappropriate use of study medications|0|||
156571937|NCT01731002|565179773|FG001|Overall Study|Inappropriate use of study medications|0|||
156571938|NCT01731002|565179774|FG002|Overall Study|Inappropriate use of study medications|1|||
156571939|NCT00947349|565179777|FG000|Triple Treatment Combination Period|Adverse Event|0|||
156571940|NCT00947349|565179778|FG001|Triple Treatment Combination Period|Adverse Event|1|||
156571941|NCT00947349|565179779|FG002|Triple Treatment Combination Period|Adverse Event|0|||
156571942|NCT00947349|565179780|FG003|Triple Treatment Combination Period|Adverse Event|0|||
156571943|NCT00947349|565179777|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
156571944|NCT00947349|565179778|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
156571945|NCT00947349|565179779|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
156571946|NCT00947349|565179780|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
156571947|NCT00947349|565179777|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
156571948|NCT00947349|565179778|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
156571949|NCT00947349|565179779|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
156571950|NCT00947349|565179780|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
156571951|NCT00947349|565179777|FG000|Overall Study Standard of Care|Other|0|||
156571952|NCT00947349|565179778|FG001|Overall Study Standard of Care|Other|0|||
156571953|NCT00947349|565179779|FG002|Overall Study Standard of Care|Other|0|||
156571954|NCT00947349|565179780|FG003|Overall Study Standard of Care|Other|1|||
156571955|NCT00538681|565179781|FG000|Overall Study|Progressive Disease|7|||
156571956|NCT00538681|565179782|FG001|Overall Study|Progressive Disease|0|||
156571957|NCT00538681|565179783|FG002|Overall Study|Progressive Disease|1|||
156571958|NCT00538681|565179784|FG003|Overall Study|Progressive Disease|0|||
156571959|NCT00538681|565179781|FG000|Overall Study|Sponsor Decision|1|||
156571960|NCT00538681|565179782|FG001|Overall Study|Sponsor Decision|3|||
156571961|NCT00538681|565179783|FG002|Overall Study|Sponsor Decision|8|||
156571962|NCT00538681|565179784|FG003|Overall Study|Sponsor Decision|9|||
156571963|NCT00538681|565179781|FG000|Overall Study|Adverse Event|1|||
156571964|NCT00538681|565179782|FG001|Overall Study|Adverse Event|1|||
156571965|NCT00538681|565179783|FG002|Overall Study|Adverse Event|1|||
156571966|NCT00538681|565179784|FG003|Overall Study|Adverse Event|0|||
156571967|NCT00538681|565179781|FG000|Overall Study|Death|0|||
156571968|NCT00538681|565179782|FG001|Overall Study|Death|0|||
156571969|NCT00538681|565179783|FG002|Overall Study|Death|1|||
156571970|NCT00538681|565179784|FG003|Overall Study|Death|1|||
156571971|NCT00538681|565179781|FG000|Overall Study|Investigator Decision|0|||
156571972|NCT00538681|565179782|FG001|Overall Study|Investigator Decision|0|||
156571973|NCT00538681|565179783|FG002|Overall Study|Investigator Decision|0|||
156571974|NCT00538681|565179784|FG003|Overall Study|Investigator Decision|1|||
156571975|NCT05369806|565179787|FG000|Overall Study|Lost to Follow-up|1|||
156571976|NCT00628355|565179788|FG000|Overall Study|Withdrawal by Subject|1|||
156571977|NCT00628355|565179789|FG001|Overall Study|Withdrawal by Subject|1|||
156571978|NCT04321343|565179794|FG000|Overall Study|Adverse Event|0|||
156571979|NCT04321343|565179795|FG001|Overall Study|Adverse Event|0|||
156571980|NCT04321343|565179796|FG002|Overall Study|Adverse Event|1|||
156571981|NCT04321343|565179797|FG003|Overall Study|Adverse Event|0|||
156571982|NCT04321343|565179794|FG000|Overall Study|Death|0|||
156571983|NCT04321343|565179795|FG001|Overall Study|Death|0|||
156571984|NCT04321343|565179796|FG002|Overall Study|Death|0|||
156571985|NCT04321343|565179797|FG003|Overall Study|Death|1|||
156571986|NCT04321343|565179794|FG000|Overall Study|Pregnancy|1|||
156571987|NCT04321343|565179795|FG001|Overall Study|Pregnancy|0|||
156571988|NCT04321343|565179796|FG002|Overall Study|Pregnancy|0|||
156571989|NCT04321343|565179797|FG003|Overall Study|Pregnancy|0|||
156571990|NCT04321343|565179794|FG000|Overall Study|Protocol Violation|1|||
156571991|NCT04321343|565179795|FG001|Overall Study|Protocol Violation|1|||
156571992|NCT04321343|565179796|FG002|Overall Study|Protocol Violation|1|||
156571993|NCT04321343|565179797|FG003|Overall Study|Protocol Violation|1|||
156571994|NCT04321343|565179794|FG000|Overall Study|Withdrawal by Subject|0|||
156571995|NCT04321343|565179795|FG001|Overall Study|Withdrawal by Subject|6|||
156571996|NCT04321343|565179796|FG002|Overall Study|Withdrawal by Subject|0|||
156571997|NCT04321343|565179797|FG003|Overall Study|Withdrawal by Subject|2|||
156571998|NCT04321343|565179794|FG000|Overall Study|Lost to Follow-up|2|||
156571999|NCT04321343|565179795|FG001|Overall Study|Lost to Follow-up|2|||
156572000|NCT04321343|565179796|FG002|Overall Study|Lost to Follow-up|1|||
156572001|NCT04321343|565179797|FG003|Overall Study|Lost to Follow-up|3|||
156572002|NCT02770807|565179800|FG000|Overall Study|Adverse Event|3|||
156572003|NCT02770807|565179801|FG001|Overall Study|Adverse Event|3|||
156572004|NCT02770807|565179802|FG002|Overall Study|Adverse Event|1|||
156572005|NCT02770807|565179800|FG000|Overall Study|Withdrawal by Subject|7|||
156572006|NCT02770807|565179801|FG001|Overall Study|Withdrawal by Subject|3|||
156572007|NCT02770807|565179802|FG002|Overall Study|Withdrawal by Subject|4|||
156572008|NCT02770807|565179800|FG000|Overall Study|Other|0|||
156572009|NCT02770807|565179801|FG001|Overall Study|Other|1|||
156572010|NCT02770807|565179802|FG002|Overall Study|Other|0|||
156572011|NCT02770807|565179800|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
156572012|NCT02770807|565179801|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
156572013|NCT02770807|565179802|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
156572014|NCT02770807|565179800|FG000|Overall Study|Physician Decision|0|||
156572015|NCT02770807|565179801|FG001|Overall Study|Physician Decision|0|||
156572016|NCT02770807|565179802|FG002|Overall Study|Physician Decision|1|||
156572017|NCT00222105|565179805|FG000|Overall Study|Removed due to wrong diagnosis|1|||
156572018|NCT00222105|565179805|FG000|Overall Study|Withdrawal by Subject|1|||
156572019|NCT00222105|565179805|FG000|Overall Study|Adverse Event|8|||
156572020|NCT00222105|565179805|FG000|Overall Study|Treatment delays|2|||
156572021|NCT00222105|565179805|FG000|Overall Study|Death|2|||
156572022|NCT01084252|565181443|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572023|NCT01084252|565181444|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572024|NCT01084252|565181445|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572025|NCT01084252|565181446|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572026|NCT01084252|565181447|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572027|NCT01084252|565181448|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572028|NCT01084252|565181449|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572029|NCT01084252|565181450|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572030|NCT01084252|565181451|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572031|NCT01084252|565181452|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572032|NCT01084252|565181453|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572033|NCT01084252|565181454|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572034|NCT01084252|565181455|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
156572035|NCT01084252|565181456|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156572036|NCT04364854|565181457|FG000|Overall Study|Withdrawal by Subject|1|||
156572037|NCT04364854|565181458|FG001|Overall Study|Withdrawal by Subject|0|||
156572038|NCT04364854|565181459|FG002|Overall Study|Withdrawal by Subject|1|||
156572039|NCT04364854|565181460|FG003|Overall Study|Withdrawal by Subject|3|||
156572040|NCT04364854|565181457|FG000|Overall Study|Death|1|||
156572041|NCT04364854|565181458|FG001|Overall Study|Death|0|||
156572042|NCT04364854|565181459|FG002|Overall Study|Death|0|||
156572043|NCT04364854|565181460|FG003|Overall Study|Death|0|||
156572044|NCT04364854|565181457|FG000|Overall Study|Lost to Follow-up|0|||
156572045|NCT04364854|565181458|FG001|Overall Study|Lost to Follow-up|0|||
156572046|NCT04364854|565181459|FG002|Overall Study|Lost to Follow-up|0|||
156572047|NCT04364854|565181460|FG003|Overall Study|Lost to Follow-up|1|||
156572048|NCT04493619|565181462|FG000|Overall Study|Death|4|||
156572049|NCT04493619|565181463|FG001|Overall Study|Death|3|||
156572050|NCT04493619|565181464|FG002|Overall Study|Death|3|||
156572051|NCT04493619|565181465|FG003|Overall Study|Death|4|||
156572052|NCT04493619|565181462|FG000|Overall Study|Study discontinued early|10|||
156572053|NCT04493619|565181463|FG001|Overall Study|Study discontinued early|0|||
156572054|NCT04493619|565181464|FG002|Overall Study|Study discontinued early|4|||
156572055|NCT04493619|565181465|FG003|Overall Study|Study discontinued early|8|||
156572056|NCT04493619|565181462|FG000|Overall Study|Lost to Follow-up|0|||
156572057|NCT04493619|565181463|FG001|Overall Study|Lost to Follow-up|0|||
156572058|NCT04493619|565181464|FG002|Overall Study|Lost to Follow-up|0|||
156572059|NCT04493619|565181465|FG003|Overall Study|Lost to Follow-up|1|||
156572060|NCT03368859|565181467|FG000|Overall Study|Withdrew Consent|5|||
156572061|NCT03368859|565181468|FG001|Overall Study|Withdrew Consent|4|||
156572062|NCT03368859|565181467|FG000|Overall Study|Death|12|||
156572063|NCT03368859|565181468|FG001|Overall Study|Death|6|||
156572064|NCT03368859|565181467|FG000|Overall Study|Study terminated by Sponsor|18|||
156572065|NCT03368859|565181468|FG001|Overall Study|Study terminated by Sponsor|23|||
156572066|NCT03368859|565181467|FG000|Overall Study|Other|1|||
156572067|NCT03368859|565181468|FG001|Overall Study|Other|1|||
156572068|NCT01845025|565181471|FG000|Overall Study|Adverse Event|6|||
156572069|NCT01845025|565181472|FG001|Overall Study|Adverse Event|3|||
156572070|NCT01845025|565181471|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156572071|NCT01845025|565181472|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156572072|NCT01845025|565181471|FG000|Overall Study|Withdrawal by Subject|48|||
156572073|NCT01845025|565181472|FG001|Overall Study|Withdrawal by Subject|44|||
156572074|NCT01845025|565181471|FG000|Overall Study|Lost to Follow-up|13|||
156572075|NCT01845025|565181472|FG001|Overall Study|Lost to Follow-up|13|||
156572076|NCT01845025|565181471|FG000|Overall Study|Administrative problems|8|||
156572077|NCT01845025|565181472|FG001|Overall Study|Administrative problems|8|||
156572078|NCT01845025|565181471|FG000|Overall Study|Death|2|||
156572079|NCT01845025|565181472|FG001|Overall Study|Death|0|||
156572080|NCT01845025|565181471|FG000|Overall Study|Protocol deviation|3|||
156572081|NCT01845025|565181472|FG001|Overall Study|Protocol deviation|6|||
156572082|NCT01845025|565181471|FG000|Overall Study|Missing|1|||
156572083|NCT01845025|565181472|FG001|Overall Study|Missing|1|||
156572084|NCT00813748|565181475|FG000|Skin Test Substudy|Physician Decision|0|||
156572085|NCT00813748|565181476|FG001|Skin Test Substudy|Physician Decision|1|||
156572086|NCT01931865|565181479|FG000|Overall Study|Lost to Follow-up|2|||
156572087|NCT01931865|565181479|FG000|Overall Study|Withdrawal by Subject|2|||
156572088|NCT01121406|565181480|FG000|Overall Study|Progressive disease RECIST|44|||
156572089|NCT01121406|565181481|FG001|Overall Study|Progressive disease RECIST|28|||
156572090|NCT01121406|565181480|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
156572091|NCT01121406|565181481|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
156572092|NCT01121406|565181480|FG000|Overall Study|Other AE|3|||
156572093|NCT01121406|565181481|FG001|Overall Study|Other AE|10|||
156572094|NCT01121406|565181480|FG000|Overall Study|Non-compliant with protocol|0|||
156572095|NCT01121406|565181481|FG001|Overall Study|Non-compliant with protocol|2|||
156572096|NCT01121406|565181480|FG000|Overall Study|Lost to Follow-up|0|||
156572097|NCT01121406|565181481|FG001|Overall Study|Lost to Follow-up|1|||
156572098|NCT01121406|565181480|FG000|Overall Study|Refused continuation of study med.|1|||
156572099|NCT01121406|565181481|FG001|Overall Study|Refused continuation of study med.|2|||
156572100|NCT01121406|565181480|FG000|Overall Study|Reason other than specified above|2|||
156572101|NCT01121406|565181481|FG001|Overall Study|Reason other than specified above|6|||
156572102|NCT01121406|565181480|FG000|Overall Study|Not treated|1|||
156572103|NCT01121406|565181481|FG001|Overall Study|Not treated|0|||
156572104|NCT01829048|565181482|FG000|Overall Study|Withdrawal by Subject|0|||
156572105|NCT01829048|565181483|FG001|Overall Study|Withdrawal by Subject|0|||
156572106|NCT01829048|565181484|FG002|Overall Study|Withdrawal by Subject|0|||
156572107|NCT01829048|565181485|FG003|Overall Study|Withdrawal by Subject|2|||
156572108|NCT01829048|565181486|FG004|Overall Study|Withdrawal by Subject|0|||
156572109|NCT00892437|565181487|FG000|Randomized Phase|Randomized but not treated|6|||
156572110|NCT00892437|565181488|FG001|Randomized Phase|Randomized but not treated|0|||
156572111|NCT00892437|565181487|FG000|Randomized Phase|Adverse Event|2|||
156572112|NCT00892437|565181488|FG001|Randomized Phase|Adverse Event|2|||
156572113|NCT00892437|565181487|FG000|Randomized Phase|Lost to Follow-up|1|||
156572114|NCT00892437|565181488|FG001|Randomized Phase|Lost to Follow-up|3|||
156572115|NCT00892437|565181487|FG000|Randomized Phase|Investigator's Discretion|1|||
156572116|NCT00892437|565181488|FG001|Randomized Phase|Investigator's Discretion|0|||
156572117|NCT00892437|565181487|FG000|Randomized Phase|Withdrew Consent|1|||
156572118|NCT00892437|565181488|FG001|Randomized Phase|Withdrew Consent|0|||
156572119|NCT00892437|565181487|FG000|Open-Label Extension Phase|Adverse Event|4|||
156572120|NCT00892437|565181488|FG001|Open-Label Extension Phase|Adverse Event|2|||
156572121|NCT00892437|565181487|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
156572122|NCT00892437|565181488|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
156572123|NCT00892437|565181487|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
156572124|NCT00892437|565181488|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
156572125|NCT00892437|565181487|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
156572126|NCT00892437|565181488|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
156572127|NCT00892437|565181487|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
156572128|NCT00892437|565181488|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
156572129|NCT03185130|565181490|FG000|Overall Study|Withdrawal by Subject|0|||
156572130|NCT03185130|565181491|FG001|Overall Study|Withdrawal by Subject|2|||
156572131|NCT02286960|565181492|FG000|Overall Study|Lost to Follow-up|3|||
156572132|NCT02286960|565181493|FG001|Overall Study|Lost to Follow-up|3|||
156572133|NCT02750410|565181495|FG000|Double-Blind Treatment Period|Adverse Event|2|||
156572134|NCT02750410|565181496|FG001|Double-Blind Treatment Period|Adverse Event|2|||
156572135|NCT02750410|565181495|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156572136|NCT02750410|565181496|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156572137|NCT02750410|565181495|FG000|Open-Label Extension Period|Adverse Event|5|||
156572138|NCT02750410|565181496|FG001|Open-Label Extension Period|Adverse Event|3|||
156572139|NCT02750410|565181495|FG000|Open-Label Extension Period|Protocol Violation|0|||
156572140|NCT02750410|565181496|FG001|Open-Label Extension Period|Protocol Violation|1|||
156572141|NCT02750410|565181495|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
156572142|NCT02750410|565181496|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
156572143|NCT02504541|565181497|FG000|Overall Study|Adverse Event|4|||
156572144|NCT02504541|565181497|FG000|Overall Study|Withdrawal by Subject|4|||
156572145|NCT02504541|565181497|FG000|Overall Study|Lost to Follow-up|1|||
156572146|NCT02504541|565181497|FG000|Overall Study|Met Stopping Criteria|1|||
156572147|NCT02504541|565181497|FG000|Overall Study|Protocol Violation|2|||
156572148|NCT02504541|565181497|FG000|Overall Study|Termination by Sponsor|1|||
156572149|NCT02504541|565181497|FG000|Overall Study|Other|2|||
156572150|NCT02504541|565181497|FG000|Overall Study|Multiple|5|||
156572151|NCT00500071|565181514|FG000|Screening and Washout Phase|Protocol Violation|1|||
156572152|NCT00500071|565181514|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
156572153|NCT00500071|565181514|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
156572154|NCT00500071|565181514|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
156572155|NCT00500071|565181514|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
156572156|NCT00500071|565181514|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
156572157|NCT00500071|565181514|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
156572158|NCT02333227|565181515|FG000|Overall Study|Lost to Follow-up|137|||
156572159|NCT02333227|565181516|FG001|Overall Study|Lost to Follow-up|106|||
156572160|NCT02333227|565181515|FG000|Overall Study|Pregnancy Interrupted|42|||
156572161|NCT02333227|565181516|FG001|Overall Study|Pregnancy Interrupted|89|||
156572162|NCT02333227|565181515|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
156572163|NCT02333227|565181516|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
156572164|NCT02272790|565181517|FG000|Overall Study|Physician Decision|0|||
156572165|NCT02272790|565181518|FG001|Overall Study|Physician Decision|1|||
156572166|NCT02272790|565181519|FG002|Overall Study|Physician Decision|0|||
156572167|NCT02272790|565181520|FG003|Overall Study|Physician Decision|0|||
156572168|NCT02272790|565181521|FG004|Overall Study|Physician Decision|0|||
156572169|NCT02272790|565181522|FG005|Overall Study|Physician Decision|0|||
156572170|NCT04375878|565181525|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
156572171|NCT04375878|565181526|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
156572172|NCT04375878|565181527|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
156572173|NCT04375878|565181528|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
156572174|NCT04375878|565181529|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
156572175|NCT04375878|565181530|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
156572176|NCT04375878|565181525|FG000|Crossover First and Second Interventions|Adverse Event|0|||
156572177|NCT04375878|565181526|FG001|Crossover First and Second Interventions|Adverse Event|0|||
156572178|NCT04375878|565181527|FG002|Crossover First and Second Interventions|Adverse Event|1|||
156572179|NCT04375878|565181528|FG003|Crossover First and Second Interventions|Adverse Event|0|||
156572180|NCT04375878|565181529|FG004|Crossover First and Second Interventions|Adverse Event|0|||
156572181|NCT04375878|565181530|FG005|Crossover First and Second Interventions|Adverse Event|0|||
156572182|NCT04375878|565181525|FG000|Extension Phase|Withdrawal by Subject|0|||
156572183|NCT04375878|565181526|FG001|Extension Phase|Withdrawal by Subject|0|||
156572184|NCT04375878|565181527|FG002|Extension Phase|Withdrawal by Subject|0|||
156572185|NCT04375878|565181528|FG003|Extension Phase|Withdrawal by Subject|0|||
156572186|NCT04375878|565181529|FG004|Extension Phase|Withdrawal by Subject|1|||
156572187|NCT04375878|565181530|FG005|Extension Phase|Withdrawal by Subject|0|||
156572188|NCT01076179|565181531|FG000|Overall Study|Withdrawal by Subject|1|||
156572189|NCT03459040|565181532|FG000|Overall Study|Death|8|||
156572190|NCT03459040|565181532|FG000|Overall Study|Withdrawal by Subject|1|||
156572191|NCT00986349|565181533|FG000|Overall Study|Unsuccessful implant procedure|3|||
156572192|NCT00986349|565181533|FG000|Overall Study|Adverse Event|2|||
156572193|NCT00986349|565181533|FG000|Overall Study|Physician Decision|1|||
156572194|NCT00986349|565181533|FG000|Overall Study|device migration|1|||
156572195|NCT02299934|565181534|FG000|Overall Study|Termination of study|13|||
156572196|NCT00561353|565181535|FG000|Overall Study|Subject reached a virologic endpoint|2|||
156572197|NCT00561353|565181536|FG001|Overall Study|Subject reached a virologic endpoint|1|||
156572198|NCT00561353|565181537|FG002|Overall Study|Subject reached a virologic endpoint|1|||
156572199|NCT00561353|565181538|FG003|Overall Study|Subject reached a virologic endpoint|4|||
156572200|NCT00561353|565181539|FG004|Overall Study|Subject reached a virologic endpoint|1|||
156572201|NCT00561353|565181540|FG005|Overall Study|Subject reached a virologic endpoint|3|||
156572202|NCT00561353|565181541|FG006|Overall Study|Subject reached a virologic endpoint|4|||
156572203|NCT00561353|565181542|FG007|Overall Study|Subject reached a virologic endpoint|4|||
156572204|NCT00561353|565181543|FG008|Overall Study|Subject reached a virologic endpoint|5|||
156572205|NCT00561353|565181544|FG009|Overall Study|Subject reached a virologic endpoint|0|||
156572206|NCT00561353|565181535|FG000|Overall Study|Subject ineligible to continue the trial|0|||
156572207|NCT00561353|565181536|FG001|Overall Study|Subject ineligible to continue the trial|0|||
156572208|NCT00561353|565181537|FG002|Overall Study|Subject ineligible to continue the trial|0|||
156572209|NCT00561353|565181538|FG003|Overall Study|Subject ineligible to continue the trial|0|||
156572210|NCT00561353|565181539|FG004|Overall Study|Subject ineligible to continue the trial|0|||
156572211|NCT00561353|565181540|FG005|Overall Study|Subject ineligible to continue the trial|1|||
156572212|NCT00561353|565181541|FG006|Overall Study|Subject ineligible to continue the trial|1|||
156572213|NCT00561353|565181542|FG007|Overall Study|Subject ineligible to continue the trial|0|||
156572214|NCT00561353|565181543|FG008|Overall Study|Subject ineligible to continue the trial|2|||
156572215|NCT00561353|565181544|FG009|Overall Study|Subject ineligible to continue the trial|1|||
156572216|NCT00561353|565181535|FG000|Overall Study|Other|1|||
156572217|NCT00561353|565181536|FG001|Overall Study|Other|0|||
156572218|NCT00561353|565181537|FG002|Overall Study|Other|1|||
156572219|NCT00561353|565181538|FG003|Overall Study|Other|0|||
156572220|NCT00561353|565181539|FG004|Overall Study|Other|0|||
156572221|NCT00561353|565181540|FG005|Overall Study|Other|2|||
156572222|NCT00561353|565181541|FG006|Overall Study|Other|0|||
156572223|NCT00561353|565181542|FG007|Overall Study|Other|0|||
156572224|NCT00561353|565181543|FG008|Overall Study|Other|0|||
156572225|NCT00561353|565181544|FG009|Overall Study|Other|0|||
156572226|NCT00561353|565181535|FG000|Overall Study|Adverse Event|0|||
156572227|NCT00561353|565181536|FG001|Overall Study|Adverse Event|0|||
156572228|NCT00561353|565181537|FG002|Overall Study|Adverse Event|0|||
156572229|NCT00561353|565181538|FG003|Overall Study|Adverse Event|2|||
156572230|NCT00561353|565181539|FG004|Overall Study|Adverse Event|0|||
156572231|NCT00561353|565181540|FG005|Overall Study|Adverse Event|0|||
156572232|NCT00561353|565181541|FG006|Overall Study|Adverse Event|1|||
156572233|NCT00561353|565181542|FG007|Overall Study|Adverse Event|0|||
156572234|NCT00561353|565181543|FG008|Overall Study|Adverse Event|0|||
156572235|NCT00561353|565181544|FG009|Overall Study|Adverse Event|1|||
156572236|NCT00561353|565181535|FG000|Overall Study|Lost to Follow-up|2|||
156572237|NCT00561353|565181536|FG001|Overall Study|Lost to Follow-up|0|||
156572238|NCT00561353|565181537|FG002|Overall Study|Lost to Follow-up|1|||
156572239|NCT00561353|565181538|FG003|Overall Study|Lost to Follow-up|0|||
156572240|NCT00561353|565181539|FG004|Overall Study|Lost to Follow-up|0|||
156572241|NCT00561353|565181540|FG005|Overall Study|Lost to Follow-up|0|||
156572242|NCT00561353|565181541|FG006|Overall Study|Lost to Follow-up|0|||
156572243|NCT00561353|565181542|FG007|Overall Study|Lost to Follow-up|0|||
156572244|NCT00561353|565181543|FG008|Overall Study|Lost to Follow-up|0|||
156572245|NCT00561353|565181544|FG009|Overall Study|Lost to Follow-up|0|||
156572246|NCT00561353|565181535|FG000|Overall Study|Withdrawal by Subject|0|||
156572247|NCT00561353|565181536|FG001|Overall Study|Withdrawal by Subject|2|||
156572248|NCT00561353|565181537|FG002|Overall Study|Withdrawal by Subject|0|||
156572249|NCT00561353|565181538|FG003|Overall Study|Withdrawal by Subject|0|||
156572250|NCT00561353|565181539|FG004|Overall Study|Withdrawal by Subject|0|||
156572251|NCT00561353|565181540|FG005|Overall Study|Withdrawal by Subject|0|||
156572252|NCT00561353|565181541|FG006|Overall Study|Withdrawal by Subject|0|||
156572253|NCT00561353|565181542|FG007|Overall Study|Withdrawal by Subject|0|||
156572254|NCT00561353|565181543|FG008|Overall Study|Withdrawal by Subject|0|||
156572255|NCT00561353|565181544|FG009|Overall Study|Withdrawal by Subject|0|||
156572256|NCT01273818|565181545|FG000|Overall Study|Physician Decision|13|||
156572257|NCT01273818|565181546|FG001|Overall Study|Physician Decision|2|||
156572258|NCT01273818|565181547|FG002|Overall Study|Physician Decision|9|||
156572259|NCT03815175|565181548|FG000|Overall Study|Subject Lost to Follow-up|6|||
156572260|NCT03815175|565181548|FG000|Overall Study|Subject Withdrew Consent|48|||
156572261|NCT03815175|565181548|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
156572262|NCT03815175|565181548|FG000|Overall Study|Death|86|||
156572263|NCT03815175|565181548|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
156572264|NCT03815175|565181548|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
156572265|NCT03815175|565181548|FG000|Overall Study|Other Status Change Reason|1|||
156572266|NCT03815175|565181548|FG000|Overall Study|Missed Visit|12|||
156572267|NCT03577990|565181549|FG000|Overall Study|Lost to Follow-up|4|||
156572268|NCT03577990|565181550|FG001|Overall Study|Lost to Follow-up|6|||
156572269|NCT03577990|565181549|FG000|Overall Study|Withdrawal by Subject|4|||
156572270|NCT03577990|565181550|FG001|Overall Study|Withdrawal by Subject|7|||
156572271|NCT03934684|565181555|FG000|Overall Study|Participants continuing in study|11|||
156572272|NCT03934684|565181556|FG001|Overall Study|Participants continuing in study|4|||
156572273|NCT03934684|565181555|FG000|Overall Study|Discontinuation of carfilzomib|20|||
156572274|NCT03934684|565181556|FG001|Overall Study|Discontinuation of carfilzomib|30|||
156572275|NCT03934684|565181555|FG000|Overall Study|Death|2|||
156572276|NCT03934684|565181556|FG001|Overall Study|Death|2|||
156572277|NCT03934684|565181555|FG000|Overall Study|Lost to Follow-up|2|||
156572278|NCT03934684|565181556|FG001|Overall Study|Lost to Follow-up|5|||
156572279|NCT03934684|565181555|FG000|Overall Study|Withdrawal by Subject|7|||
156572280|NCT03934684|565181556|FG001|Overall Study|Withdrawal by Subject|8|||
156572281|NCT01073943|565181557|FG000|Overall Study|Withdrawal by Subject|8|||
156572282|NCT01073943|565181558|FG001|Overall Study|Withdrawal by Subject|2|||
156572283|NCT01073943|565181557|FG000|Overall Study|Protocol Violation|2|||
156572284|NCT01073943|565181558|FG001|Overall Study|Protocol Violation|1|||
156572285|NCT01073943|565181557|FG000|Overall Study|Adverse Event|1|||
156572286|NCT01073943|565181558|FG001|Overall Study|Adverse Event|1|||
156572287|NCT01073943|565181557|FG000|Overall Study|Lost to Follow-up|0|||
156572288|NCT01073943|565181558|FG001|Overall Study|Lost to Follow-up|2|||
156572289|NCT01073943|565181557|FG000|Overall Study|Power outage; colonoscopy not done|1|||
156572290|NCT01073943|565181558|FG001|Overall Study|Power outage; colonoscopy not done|0|||
156572291|NCT01073943|565181557|FG000|Overall Study|Subject forgot|0|||
156572292|NCT01073943|565181558|FG001|Overall Study|Subject forgot|1|||
156572293|NCT01073943|565181557|FG000|Overall Study|Unable to return for follow-up|0|||
156572294|NCT01073943|565181558|FG001|Overall Study|Unable to return for follow-up|1|||
156572295|NCT01073943|565181557|FG000|Overall Study|Could not tolerate prep|1|||
156572296|NCT01073943|565181558|FG001|Overall Study|Could not tolerate prep|0|||
156572297|NCT00488631|565181564|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
156572298|NCT00488631|565181565|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
156572299|NCT00488631|565181566|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
156572300|NCT00488631|565181567|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
156572301|NCT00488631|565181568|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
156572302|NCT00488631|565181569|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
156572303|NCT00488631|565181570|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
156572304|NCT00488631|565181571|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
156572305|NCT00488631|565181572|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
156572306|NCT00488631|565181573|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
156572307|NCT00488631|565181564|FG000|Double Blind Period (Week 0-54)|Death|0|||
156572308|NCT00488631|565181565|FG001|Double Blind Period (Week 0-54)|Death|0|||
156572309|NCT00488631|565181566|FG002|Double Blind Period (Week 0-54)|Death|0|||
156572310|NCT00488631|565181567|FG003|Double Blind Period (Week 0-54)|Death|0|||
156572311|NCT00488631|565181568|FG004|Double Blind Period (Week 0-54)|Death|0|||
156572312|NCT00488631|565181569|FG005|Double Blind Period (Week 0-54)|Death|1|||
156572313|NCT00488631|565181570|FG006|Double Blind Period (Week 0-54)|Death|0|||
156572314|NCT00488631|565181571|FG007|Double Blind Period (Week 0-54)|Death|0|||
156572315|NCT00488631|565181572|FG008|Double Blind Period (Week 0-54)|Death|0|||
156572316|NCT00488631|565181573|FG009|Double Blind Period (Week 0-54)|Death|0|||
156572317|NCT00488631|565181564|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
156572318|NCT00488631|565181565|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
156572319|NCT00488631|565181566|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
156572320|NCT00488631|565181567|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
156572321|NCT00488631|565181568|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
156572322|NCT00488631|565181569|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
156572323|NCT00488631|565181570|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
156572324|NCT00488631|565181571|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
156572325|NCT00488631|565181572|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
156572326|NCT00488631|565181573|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
156572327|NCT00488631|565181564|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
156572328|NCT00488631|565181565|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
156572329|NCT00488631|565181566|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
156572330|NCT00488631|565181567|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
156572331|NCT00488631|565181568|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
156572332|NCT00488631|565181569|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
156572333|NCT00488631|565181570|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
156572334|NCT00488631|565181571|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
156572335|NCT00488631|565181572|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
156572336|NCT00488631|565181573|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
156572337|NCT00488631|565181564|FG000|Double Blind Period (Week 0-54)|Other|6|||
156572338|NCT00488631|565181565|FG001|Double Blind Period (Week 0-54)|Other|12|||
156572339|NCT00488631|565181566|FG002|Double Blind Period (Week 0-54)|Other|10|||
156572340|NCT00488631|565181567|FG003|Double Blind Period (Week 0-54)|Other|11|||
156572341|NCT00488631|565181568|FG004|Double Blind Period (Week 0-54)|Other|14|||
156572342|NCT00488631|565181569|FG005|Double Blind Period (Week 0-54)|Other|34|||
156572343|NCT00488631|565181570|FG006|Double Blind Period (Week 0-54)|Other|0|||
156572344|NCT00488631|565181571|FG007|Double Blind Period (Week 0-54)|Other|0|||
156572345|NCT00488631|565181572|FG008|Double Blind Period (Week 0-54)|Other|0|||
156572346|NCT00488631|565181573|FG009|Double Blind Period (Week 0-54)|Other|0|||
156572347|NCT00488631|565181564|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
156572348|NCT00488631|565181565|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
156572349|NCT00488631|565181566|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
156572350|NCT00488631|565181567|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
156572351|NCT00488631|565181568|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
156572352|NCT00488631|565181569|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
156572353|NCT00488631|565181570|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
156572354|NCT00488631|565181571|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
156572355|NCT00488631|565181572|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
156572356|NCT00488631|565181573|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
156572357|NCT00488631|565181564|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
156572358|NCT00488631|565181565|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
156572359|NCT00488631|565181566|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
156572360|NCT00488631|565181567|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
156572361|NCT00488631|565181568|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
156572362|NCT00488631|565181569|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
156572363|NCT00488631|565181570|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
156572364|NCT00488631|565181571|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
156572365|NCT00488631|565181572|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
156572366|NCT00488631|565181573|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
156572367|NCT00488631|565181564|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
156572368|NCT00488631|565181565|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
156572369|NCT00488631|565181566|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
156572370|NCT00488631|565181567|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
156572371|NCT00488631|565181568|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
156572372|NCT00488631|565181569|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
156572373|NCT00488631|565181570|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
156572374|NCT00488631|565181571|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
156572375|NCT00488631|565181572|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
156572376|NCT00488631|565181573|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
156572377|NCT00488631|565181564|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
156572378|NCT00488631|565181565|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
156572379|NCT00488631|565181566|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
156572380|NCT00488631|565181567|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
156572381|NCT00488631|565181568|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
156572382|NCT00488631|565181569|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
156572383|NCT00488631|565181570|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
156572384|NCT00488631|565181571|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
156572385|NCT00488631|565181572|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
156572386|NCT00488631|565181573|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
156572387|NCT00488631|565181564|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
156572388|NCT00488631|565181565|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
156572389|NCT00488631|565181566|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
156572390|NCT00488631|565181567|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
156572391|NCT00488631|565181568|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
156572392|NCT00488631|565181569|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
156572393|NCT00488631|565181570|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
156572394|NCT00488631|565181571|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
156572395|NCT00488631|565181572|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
156572396|NCT00488631|565181573|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
156572397|NCT00761215|565181574|FG000|Overall Study|Randomized but didn't receive drug|1|||
156572398|NCT00761215|565181575|FG001|Overall Study|Randomized but didn't receive drug|1|||
156572399|NCT00761215|565181576|FG002|Overall Study|Randomized but didn't receive drug|2|||
156572400|NCT00761215|565181574|FG000|Overall Study|Lost to Follow-up|6|||
156572401|NCT00761215|565181575|FG001|Overall Study|Lost to Follow-up|3|||
156572402|NCT00761215|565181576|FG002|Overall Study|Lost to Follow-up|6|||
156572403|NCT00761215|565181574|FG000|Overall Study|Withdrawal by Subject|1|||
156572404|NCT00761215|565181575|FG001|Overall Study|Withdrawal by Subject|0|||
156572405|NCT00761215|565181576|FG002|Overall Study|Withdrawal by Subject|0|||
156572406|NCT00761215|565181574|FG000|Overall Study|Bacteremia|1|||
156572407|NCT00761215|565181575|FG001|Overall Study|Bacteremia|0|||
156572408|NCT00761215|565181576|FG002|Overall Study|Bacteremia|0|||
156572409|NCT05662332|565181577|FG000|Overall Study|Death|3|||
156572410|NCT05662332|565181578|FG001|Overall Study|Death|3|||
156572411|NCT05662332|565181577|FG000|Overall Study|Lost to Follow-up|3|||
156572412|NCT05662332|565181578|FG001|Overall Study|Lost to Follow-up|8|||
156572413|NCT05662332|565181577|FG000|Overall Study|Physician Decision|1|||
156572414|NCT05662332|565181578|FG001|Overall Study|Physician Decision|2|||
156572415|NCT05662332|565181577|FG000|Overall Study|Protocol Deviation|2|||
156572416|NCT05662332|565181578|FG001|Overall Study|Protocol Deviation|1|||
156572417|NCT05662332|565181577|FG000|Overall Study|Withdrawal by Subject|14|||
156572418|NCT05662332|565181578|FG001|Overall Study|Withdrawal by Subject|14|||
156572419|NCT05662332|565181577|FG000|Overall Study|Assigned Treatment by Mistake|5|||
156572420|NCT05662332|565181578|FG001|Overall Study|Assigned Treatment by Mistake|7|||
156572421|NCT05662332|565181577|FG000|Overall Study|Non-compliance with study drug|4|||
156572422|NCT05662332|565181578|FG001|Overall Study|Non-compliance with study drug|1|||
156572423|NCT05662332|565181577|FG000|Overall Study|Due to Bariatric surgery|1|||
156572424|NCT05662332|565181578|FG001|Overall Study|Due to Bariatric surgery|0|||
156572425|NCT05662332|565181577|FG000|Overall Study|Subject Moving out of State|0|||
156572426|NCT05662332|565181578|FG001|Overall Study|Subject Moving out of State|1|||
156572427|NCT05662332|565181577|FG000|Overall Study|Subject Missed the Schedule|1|||
156572428|NCT05662332|565181578|FG001|Overall Study|Subject Missed the Schedule|0|||
156572429|NCT05662332|565181577|FG000|Overall Study|The Patient Moved to Another City|1|||
156572430|NCT05662332|565181578|FG001|Overall Study|The Patient Moved to Another City|0|||
156572431|NCT00667277|565181579|FG000|Overall Study|Withdrawal by Subject|2|||
156572432|NCT00140855|565181580|FG000|Overall Study|Progressive disease|2|||
156572433|NCT03542682|565181581|FG000|Overall Study|COVID-19 Protocol|0|||
156572434|NCT03542682|565181582|FG001|Overall Study|COVID-19 Protocol|1|||
156572435|NCT01097044|565181587|FG000|Overall Study|Withdrawal by Subject|4|||
156572436|NCT01097044|565181588|FG001|Overall Study|Withdrawal by Subject|4|||
156572437|NCT01097044|565181587|FG000|Overall Study|Lost to Follow-up|1|||
156572438|NCT01097044|565181588|FG001|Overall Study|Lost to Follow-up|0|||
156572439|NCT01097044|565181587|FG000|Overall Study|Withdrawal by Sponsor|0|||
156572440|NCT01097044|565181588|FG001|Overall Study|Withdrawal by Sponsor|1|||
156572441|NCT01682044|565181592|FG000|Overall Study|Death|1|||
156572442|NCT01682044|565181592|FG000|Overall Study|Progression|3|||
156572443|NCT04865731|565181596|FG000|Overall Study|Physician Decision|2|||
156572444|NCT04865731|565181597|FG001|Overall Study|Physician Decision|1|||
156572445|NCT04865731|565181596|FG000|Overall Study|Adverse Event|1|||
156572446|NCT04865731|565181597|FG001|Overall Study|Adverse Event|0|||
156572447|NCT04865731|565181596|FG000|Overall Study|Withdrawal by Subject|0|||
156572448|NCT04865731|565181597|FG001|Overall Study|Withdrawal by Subject|1|||
156572449|NCT00875420|565183829|FG000|Overall Study|Adverse Event|0|||
156572450|NCT00875420|565183830|FG001|Overall Study|Adverse Event|1|||
156572451|NCT00875420|565183831|FG002|Overall Study|Adverse Event|1|||
156572452|NCT00875420|565183832|FG003|Overall Study|Adverse Event|0|||
156572453|NCT00875420|565183833|FG004|Overall Study|Adverse Event|0|||
156572454|NCT00875420|565183829|FG000|Overall Study|Inability to complete study procedures|1|||
156572455|NCT00875420|565183830|FG001|Overall Study|Inability to complete study procedures|0|||
156572456|NCT00875420|565183831|FG002|Overall Study|Inability to complete study procedures|1|||
156572457|NCT00875420|565183832|FG003|Overall Study|Inability to complete study procedures|1|||
156572458|NCT00875420|565183833|FG004|Overall Study|Inability to complete study procedures|1|||
156572459|NCT00875420|565183829|FG000|Overall Study|Lost to Follow-up|1|||
156572460|NCT00875420|565183830|FG001|Overall Study|Lost to Follow-up|0|||
156572461|NCT00875420|565183831|FG002|Overall Study|Lost to Follow-up|0|||
156572462|NCT00875420|565183832|FG003|Overall Study|Lost to Follow-up|0|||
156572463|NCT00875420|565183833|FG004|Overall Study|Lost to Follow-up|0|||
156572464|NCT00875420|565183829|FG000|Overall Study|Personal reason|0|||
156572465|NCT00875420|565183830|FG001|Overall Study|Personal reason|0|||
156572466|NCT00875420|565183831|FG002|Overall Study|Personal reason|0|||
156572467|NCT00875420|565183832|FG003|Overall Study|Personal reason|0|||
156572468|NCT00875420|565183833|FG004|Overall Study|Personal reason|1|||
156572469|NCT00875420|565183829|FG000|Overall Study|Prohibited medication|0|||
156572470|NCT00875420|565183830|FG001|Overall Study|Prohibited medication|0|||
156572471|NCT00875420|565183831|FG002|Overall Study|Prohibited medication|0|||
156572472|NCT00875420|565183832|FG003|Overall Study|Prohibited medication|1|||
156572473|NCT00875420|565183833|FG004|Overall Study|Prohibited medication|0|||
156572474|NCT00875420|565183829|FG000|Overall Study|Sponsor decision|0|||
156572475|NCT00875420|565183830|FG001|Overall Study|Sponsor decision|1|||
156572476|NCT00875420|565183831|FG002|Overall Study|Sponsor decision|0|||
156572477|NCT00875420|565183832|FG003|Overall Study|Sponsor decision|0|||
156572478|NCT00875420|565183833|FG004|Overall Study|Sponsor decision|0|||
156572479|NCT00875420|565183829|FG000|Overall Study|Withdrawal by Subject|0|||
156572480|NCT00875420|565183830|FG001|Overall Study|Withdrawal by Subject|0|||
156572481|NCT00875420|565183831|FG002|Overall Study|Withdrawal by Subject|1|||
156572482|NCT00875420|565183832|FG003|Overall Study|Withdrawal by Subject|0|||
156572483|NCT00875420|565183833|FG004|Overall Study|Withdrawal by Subject|0|||
156572484|NCT00914628|565183834|FG000|Overall Study|Death|35|||
156572485|NCT00914628|565183835|FG001|Overall Study|Death|17|||
156572486|NCT00914628|565183834|FG000|Overall Study|Medical decision|4|||
156572487|NCT00914628|565183835|FG001|Overall Study|Medical decision|0|||
156572488|NCT00914628|565183834|FG000|Overall Study|Protocol Violation|1|||
156572489|NCT00914628|565183835|FG001|Overall Study|Protocol Violation|0|||
156572490|NCT00914628|565183834|FG000|Overall Study|Lack of Efficacy|1|||
156572491|NCT00914628|565183835|FG001|Overall Study|Lack of Efficacy|0|||
156572492|NCT00914628|565183834|FG000|Overall Study|non-randomized|1|||
156572493|NCT00914628|565183835|FG001|Overall Study|non-randomized|0|||
156572494|NCT00914628|565183834|FG000|Overall Study|Relapse|1|||
156572495|NCT00914628|565183835|FG001|Overall Study|Relapse|2|||
156572496|NCT00914628|565183834|FG000|Overall Study|Study terminated by Sponsor|14|||
156572497|NCT00914628|565183835|FG001|Overall Study|Study terminated by Sponsor|8|||
156572498|NCT00914628|565183834|FG000|Overall Study|Patients who did not receive a single dose|7|||
156572499|NCT00914628|565183835|FG001|Overall Study|Patients who did not receive a single dose|1|||
156572500|NCT03716726|565183836|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
156572501|NCT03716726|565183837|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
156572502|NCT03716726|565183836|FG000|12 Months Followup|Lost to Follow-up|10|||
156572503|NCT03716726|565183837|FG001|12 Months Followup|Lost to Follow-up|17|||
156572504|NCT02579603|565183838|FG000|Overall Study|Not treated|1|||
156572505|NCT02579603|565183839|FG001|Overall Study|Not treated|0|||
156572506|NCT02579603|565183838|FG000|Overall Study|Adverse Event|2|||
156572507|NCT02579603|565183839|FG001|Overall Study|Adverse Event|2|||
156572508|NCT02579603|565183838|FG000|Overall Study|Other than stated|1|||
156572509|NCT02579603|565183839|FG001|Overall Study|Other than stated|0|||
156572510|NCT00469079|565183840|FG000|Overall Study|Lack of Efficacy|3|||
156572511|NCT00469079|565183841|FG001|Overall Study|Lack of Efficacy|8|||
156572512|NCT00469079|565183842|FG002|Overall Study|Lack of Efficacy|5|||
156572513|NCT00469079|565183840|FG000|Overall Study|Adverse Event|1|||
156572514|NCT00469079|565183841|FG001|Overall Study|Adverse Event|3|||
156572515|NCT00469079|565183842|FG002|Overall Study|Adverse Event|2|||
156572516|NCT00469079|565183840|FG000|Overall Study|Lost to Follow-up|4|||
156572517|NCT00469079|565183841|FG001|Overall Study|Lost to Follow-up|8|||
156572518|NCT00469079|565183842|FG002|Overall Study|Lost to Follow-up|10|||
156572519|NCT00469079|565183840|FG000|Overall Study|Withdrawal by Subject|1|||
156572520|NCT00469079|565183841|FG001|Overall Study|Withdrawal by Subject|2|||
156572521|NCT00469079|565183842|FG002|Overall Study|Withdrawal by Subject|2|||
156572522|NCT00469079|565183840|FG000|Overall Study|Ineligible|0|||
156572523|NCT00469079|565183841|FG001|Overall Study|Ineligible|1|||
156572524|NCT00469079|565183842|FG002|Overall Study|Ineligible|0|||
156572525|NCT00942162|565183843|FG000|Overall Study|Death|45|||
156572526|NCT00942162|565183844|FG001|Overall Study|Death|35|||
156572527|NCT00942162|565183845|FG002|Overall Study|Death|0|||
156572528|NCT00942162|565183843|FG000|Overall Study|Withdrawal by Subject|7|||
156572529|NCT00942162|565183844|FG001|Overall Study|Withdrawal by Subject|2|||
156572530|NCT00942162|565183845|FG002|Overall Study|Withdrawal by Subject|0|||
156572531|NCT00942162|565183843|FG000|Overall Study|Lost to Follow-up|4|||
156572532|NCT00942162|565183844|FG001|Overall Study|Lost to Follow-up|0|||
156572533|NCT00942162|565183845|FG002|Overall Study|Lost to Follow-up|0|||
156572534|NCT00942162|565183843|FG000|Overall Study|Other|14|||
156572535|NCT00942162|565183844|FG001|Overall Study|Other|13|||
156572536|NCT00942162|565183845|FG002|Overall Study|Other|2|||
156572537|NCT01006356|565183849|FG000|Overall Study|Adverse Event|6|||
156572538|NCT01006356|565183849|FG000|Overall Study|Physician Decision|1|||
156572539|NCT01006356|565183849|FG000|Overall Study|Paticipants did not cooperate|6|||
156572540|NCT01006356|565183849|FG000|Overall Study|Withdrawal by Subject|1|||
156572541|NCT01006356|565183849|FG000|Overall Study|Choice by participants|2|||
156572542|NCT01006356|565183849|FG000|Overall Study|Protocol Violation|3|||
156572543|NCT01006356|565183849|FG000|Overall Study|Other|23|||
156572544|NCT02981472|565183851|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
156572545|NCT02981472|565183852|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
156572546|NCT02981472|565183851|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156572547|NCT02981472|565183852|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156572548|NCT02981472|565183851|FG000|Treatment Period|Adverse Event|6|||
156572549|NCT02981472|565183852|FG001|Treatment Period|Adverse Event|1|||
156572550|NCT02981472|565183851|FG000|Treatment Period|Participant withdrew consent|1|||
156572551|NCT02981472|565183852|FG001|Treatment Period|Participant withdrew consent|0|||
156572552|NCT02981472|565183851|FG000|Treatment Period|Lost to Follow-up|0|||
156572553|NCT02981472|565183852|FG001|Treatment Period|Lost to Follow-up|1|||
156572554|NCT01756157|565183855|FG000|First Intervention Period|Withdrawal by Subject|1|||
156572555|NCT01756157|565183856|FG001|First Intervention Period|Withdrawal by Subject|0|||
156572556|NCT01756157|565183855|FG000|First Intervention Period|Lost to Follow-up|0|||
156572557|NCT01756157|565183856|FG001|First Intervention Period|Lost to Follow-up|2|||
156572558|NCT02799381|565183859|FG000|Overall Study|Withdrew consent|3|||
156572559|NCT02799381|565183860|FG001|Overall Study|Withdrew consent|2|||
156572560|NCT02799381|565183859|FG000|Overall Study|Adverse Event|0|||
156572561|NCT02799381|565183860|FG001|Overall Study|Adverse Event|1|||
156572562|NCT02799381|565183859|FG000|Overall Study|Participant did not take any study drug|1|||
156572563|NCT02799381|565183860|FG001|Overall Study|Participant did not take any study drug|0|||
156572564|NCT02698410|565183863|FG000|Overall Study|Adverse Event|2|||
156572565|NCT02698410|565183863|FG000|Overall Study|Withdrawal by Subject|1|||
156572566|NCT02698410|565183863|FG000|Overall Study|Other|1|||
156572567|NCT03952130|565183864|FG000|Overall Study|Adverse Event|0|||
156572568|NCT03952130|565183865|FG001|Overall Study|Adverse Event|1|||
156572569|NCT03952130|565183864|FG000|Overall Study|Lost to Follow-up|1|||
156572570|NCT03952130|565183865|FG001|Overall Study|Lost to Follow-up|0|||
156572571|NCT03952130|565183864|FG000|Overall Study|Withdrawal by Subject|1|||
156572572|NCT03952130|565183865|FG001|Overall Study|Withdrawal by Subject|5|||
156572573|NCT01713348|565183866|FG000|Overall Study|Withdrawal by Subject|3|||
156572574|NCT01713348|565183867|FG001|Overall Study|Withdrawal by Subject|2|||
156572575|NCT01713348|565183868|FG002|Overall Study|Withdrawal by Subject|2|||
156572576|NCT01713348|565183869|FG003|Overall Study|Withdrawal by Subject|0|||
156572577|NCT01713348|565183866|FG000|Overall Study|Lost to Follow-up|1|||
156572578|NCT01713348|565183867|FG001|Overall Study|Lost to Follow-up|0|||
156572579|NCT01713348|565183868|FG002|Overall Study|Lost to Follow-up|0|||
156572580|NCT01713348|565183869|FG003|Overall Study|Lost to Follow-up|0|||
156572581|NCT02638012|565183872|FG000|Overall Study|Lost to Follow-up|1|||
156572582|NCT00621023|565183874|FG000|Overall Study|Death|5|||
156572583|NCT00621023|565183874|FG000|Overall Study|Follow up discontinued|1|||
156572584|NCT03199911|565183881|FG000|Overall Study|Lost to Follow-up|5|||
156572585|NCT03199911|565183882|FG001|Overall Study|Lost to Follow-up|5|||
156572586|NCT03199911|565183881|FG000|Overall Study|Did not proceed with surgery|2|||
156572587|NCT03199911|565183882|FG001|Overall Study|Did not proceed with surgery|1|||
156572588|NCT02559505|565183883|FG000|Overall Study|Lost to Follow-up|23|||
156572589|NCT02559505|565183884|FG001|Overall Study|Lost to Follow-up|20|||
156572590|NCT02559505|565183883|FG000|Overall Study|Withdrawal by Subject|4|||
156572591|NCT02559505|565183884|FG001|Overall Study|Withdrawal by Subject|2|||
156572592|NCT03523585|565183885|FG000|Overall Study|Progressive Disease|174|||
156572593|NCT03523585|565183886|FG001|Overall Study|Progressive Disease|64|||
156572594|NCT03523585|565183887|FG002|Overall Study|Progressive Disease|77|||
156572595|NCT03523585|565183885|FG000|Overall Study|Adverse Event|74|||
156572596|NCT03523585|565183886|FG001|Overall Study|Adverse Event|5|||
156572597|NCT03523585|565183887|FG002|Overall Study|Adverse Event|9|||
156572598|NCT03523585|565183885|FG000|Overall Study|Withdrawal by Subject|30|||
156572599|NCT03523585|565183886|FG001|Overall Study|Withdrawal by Subject|11|||
156572600|NCT03523585|565183887|FG002|Overall Study|Withdrawal by Subject|6|||
156572601|NCT03523585|565183885|FG000|Overall Study|Clinical Progression|23|||
156572602|NCT03523585|565183886|FG001|Overall Study|Clinical Progression|5|||
156572603|NCT03523585|565183887|FG002|Overall Study|Clinical Progression|10|||
156572604|NCT03523585|565183885|FG000|Overall Study|Death|4|||
156572605|NCT03523585|565183886|FG001|Overall Study|Death|0|||
156572606|NCT03523585|565183887|FG002|Overall Study|Death|1|||
156572607|NCT03523585|565183885|FG000|Overall Study|Physician Decision|2|||
156572608|NCT03523585|565183886|FG001|Overall Study|Physician Decision|1|||
156572609|NCT03523585|565183887|FG002|Overall Study|Physician Decision|0|||
156572610|NCT03523585|565183885|FG000|Overall Study|Lost to Follow-up|1|||
156572611|NCT03523585|565183886|FG001|Overall Study|Lost to Follow-up|0|||
156572612|NCT03523585|565183887|FG002|Overall Study|Lost to Follow-up|0|||
156572613|NCT03523585|565183885|FG000|Overall Study|Miscellaneous|1|||
156572614|NCT03523585|565183886|FG001|Overall Study|Miscellaneous|0|||
156572615|NCT03523585|565183887|FG002|Overall Study|Miscellaneous|0|||
156572616|NCT03523585|565183885|FG000|Overall Study|Protocol Deviation|1|||
156572617|NCT03523585|565183886|FG001|Overall Study|Protocol Deviation|0|||
156572618|NCT03523585|565183887|FG002|Overall Study|Protocol Deviation|1|||
156572619|NCT03523585|565183885|FG000|Overall Study|Randomized But Not Treated|2|||
156572620|NCT03523585|565183886|FG001|Overall Study|Randomized But Not Treated|4|||
156572621|NCT03523585|565183887|FG002|Overall Study|Randomized But Not Treated|3|||
156572622|NCT00698516|565183888|FG000|Overall Study|Study Termination|2|||
156572623|NCT00698516|565183888|FG000|Overall Study|Withdrawal by Subject|3|||
156572624|NCT05882890|565183889|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
156572625|NCT04331899|565183900|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
156572626|NCT04331899|565183901|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
156572627|NCT01062399|565183904|FG000|Overall Study|Protocol Violation|0|||
156572628|NCT01062399|565183905|FG001|Overall Study|Protocol Violation|1|||
156572629|NCT01062399|565183906|FG002|Overall Study|Protocol Violation|0|||
156572630|NCT01062399|565183907|FG003|Overall Study|Protocol Violation|6|||
156572631|NCT01062399|565183908|FG004|Overall Study|Protocol Violation|4|||
156572632|NCT02424539|565183909|FG000|Overall Study|Adverse Event|0|||
156572633|NCT02424539|565183910|FG001|Overall Study|Adverse Event|0|||
156572634|NCT02424539|565183911|FG002|Overall Study|Adverse Event|1|||
156572635|NCT02424539|565183909|FG000|Overall Study|Physician Decision|0|||
156572636|NCT02424539|565183910|FG001|Overall Study|Physician Decision|0|||
156572637|NCT02424539|565183911|FG002|Overall Study|Physician Decision|1|||
156572638|NCT02424539|565183909|FG000|Overall Study|Withdrawal by Subject|3|||
156572639|NCT02424539|565183910|FG001|Overall Study|Withdrawal by Subject|1|||
156572640|NCT02424539|565183911|FG002|Overall Study|Withdrawal by Subject|0|||
156572641|NCT02424539|565183909|FG000|Overall Study|Other: Reached stopping criteria|11|||
156572642|NCT02424539|565183910|FG001|Overall Study|Other: Reached stopping criteria|7|||
156572643|NCT02424539|565183911|FG002|Overall Study|Other: Reached stopping criteria|6|||
156572644|NCT00719810|565183912|FG000|Overall Study|Adverse Event|0|||
156572645|NCT00719810|565183913|FG001|Overall Study|Adverse Event|2|||
156572646|NCT00719810|565183914|FG002|Overall Study|Adverse Event|3|||
156572647|NCT00719810|565183912|FG000|Overall Study|Lost to Follow-up|2|||
156572648|NCT00719810|565183913|FG001|Overall Study|Lost to Follow-up|0|||
156572649|NCT00719810|565183914|FG002|Overall Study|Lost to Follow-up|3|||
156572650|NCT00719810|565183912|FG000|Overall Study|Physician Decision|0|||
156572651|NCT00719810|565183913|FG001|Overall Study|Physician Decision|1|||
156572652|NCT00719810|565183914|FG002|Overall Study|Physician Decision|0|||
156572653|NCT00719810|565183912|FG000|Overall Study|Withdrawal by Subject|1|||
156572654|NCT00719810|565183913|FG001|Overall Study|Withdrawal by Subject|1|||
156572655|NCT00719810|565183914|FG002|Overall Study|Withdrawal by Subject|2|||
156572656|NCT04893265|565183937|FG000|Overall Study|Withdrawal by Subject|2|||
156572657|NCT04893265|565183938|FG001|Overall Study|Withdrawal by Subject|5|||
156572658|NCT04893265|565183937|FG000|Overall Study|Lost to Follow-up|0|||
156572659|NCT04893265|565183938|FG001|Overall Study|Lost to Follow-up|4|||
156572660|NCT02465034|565183939|FG000|Overall Study|Withdrawal by Subject|1|||
156572661|NCT02465034|565183940|FG001|Overall Study|Withdrawal by Subject|1|||
156572662|NCT02465034|565183939|FG000|Overall Study|Screen fail|2|||
156572663|NCT02465034|565183940|FG001|Overall Study|Screen fail|0|||
156572664|NCT02465034|565183939|FG000|Overall Study|Could not be scheduled for study visit|0|||
156572665|NCT02465034|565183940|FG001|Overall Study|Could not be scheduled for study visit|5|||
156572666|NCT00573131|565183941|FG000|Overall Study|Withdrawal by Subject|10|||
156572667|NCT00573131|565183942|FG001|Overall Study|Withdrawal by Subject|8|||
156572668|NCT02401256|565183947|FG000|Overall Study|Adverse Event|5|||
156572669|NCT02401256|565183947|FG000|Overall Study|Withdrawal by Subject|12|||
156572670|NCT00893789|565183949|FG000|Overall Study|Withdrawal by Subject|3|||
156572671|NCT00893789|565183950|FG001|Overall Study|Withdrawal by Subject|1|||
156572672|NCT00893789|565183951|FG002|Overall Study|Withdrawal by Subject|3|||
156572673|NCT00893789|565183952|FG003|Overall Study|Withdrawal by Subject|1|||
156572674|NCT00893789|565183949|FG000|Overall Study|Noncompliance With Study Drug|1|||
156572675|NCT00893789|565183950|FG001|Overall Study|Noncompliance With Study Drug|0|||
156572676|NCT00893789|565183951|FG002|Overall Study|Noncompliance With Study Drug|1|||
156572677|NCT00893789|565183952|FG003|Overall Study|Noncompliance With Study Drug|2|||
156572678|NCT00893789|565183949|FG000|Overall Study|Noncompliance With Study Procedures|1|||
156572679|NCT00893789|565183950|FG001|Overall Study|Noncompliance With Study Procedures|0|||
156572680|NCT00893789|565183951|FG002|Overall Study|Noncompliance With Study Procedures|0|||
156572681|NCT00893789|565183952|FG003|Overall Study|Noncompliance With Study Procedures|0|||
156572682|NCT00893789|565183949|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
156572683|NCT00893789|565183950|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
156572684|NCT00893789|565183951|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
156572685|NCT00893789|565183952|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
156572686|NCT00893789|565183949|FG000|Overall Study|Adverse Event|0|||
156572687|NCT00893789|565183950|FG001|Overall Study|Adverse Event|2|||
156572688|NCT00893789|565183951|FG002|Overall Study|Adverse Event|1|||
156572689|NCT00893789|565183952|FG003|Overall Study|Adverse Event|5|||
156572690|NCT00893789|565183949|FG000|Overall Study|Protocol Violation|0|||
156572691|NCT00893789|565183950|FG001|Overall Study|Protocol Violation|1|||
156572692|NCT00893789|565183951|FG002|Overall Study|Protocol Violation|1|||
156572693|NCT00893789|565183952|FG003|Overall Study|Protocol Violation|4|||
156572694|NCT00893789|565183949|FG000|Overall Study|Lost to Follow-up|0|||
156572695|NCT00893789|565183950|FG001|Overall Study|Lost to Follow-up|0|||
156572696|NCT00893789|565183951|FG002|Overall Study|Lost to Follow-up|0|||
156572697|NCT00893789|565183952|FG003|Overall Study|Lost to Follow-up|1|||
156572698|NCT02024464|565183953|FG000|Overall Study|Discontinued|5|||
156572699|NCT02024464|565183954|FG001|Overall Study|Discontinued|4|||
156572700|NCT02024464|565183953|FG000|Overall Study|Missed Visits|1|||
156572701|NCT02024464|565183954|FG001|Overall Study|Missed Visits|0|||
156572702|NCT02024464|565183953|FG000|Overall Study|Lost to Follow-up|4|||
156572703|NCT02024464|565183954|FG001|Overall Study|Lost to Follow-up|7|||
156572704|NCT02586805|565183967|FG000|Overall Study|Withdrawal by Subject|3|||
156572705|NCT02586805|565183968|FG001|Overall Study|Withdrawal by Subject|1|||
156572706|NCT02586805|565183969|FG002|Overall Study|Withdrawal by Subject|1|||
156572707|NCT02586805|565183970|FG003|Overall Study|Withdrawal by Subject|2|||
156572708|NCT02586805|565183967|FG000|Overall Study|Adverse Event|2|||
156572709|NCT02586805|565183968|FG001|Overall Study|Adverse Event|0|||
156572710|NCT02586805|565183969|FG002|Overall Study|Adverse Event|1|||
156572711|NCT02586805|565183970|FG003|Overall Study|Adverse Event|0|||
156572712|NCT02586805|565183967|FG000|Overall Study|Lost to Follow-up|0|||
156572713|NCT02586805|565183968|FG001|Overall Study|Lost to Follow-up|0|||
156572714|NCT02586805|565183969|FG002|Overall Study|Lost to Follow-up|1|||
156572715|NCT02586805|565183970|FG003|Overall Study|Lost to Follow-up|0|||
156572716|NCT02586805|565183967|FG000|Overall Study|Physician Decision|1|||
156572717|NCT02586805|565183968|FG001|Overall Study|Physician Decision|0|||
156572718|NCT02586805|565183969|FG002|Overall Study|Physician Decision|0|||
156572719|NCT02586805|565183970|FG003|Overall Study|Physician Decision|0|||
156572720|NCT01859403|565183971|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
156572721|NCT01859403|565183972|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
156572722|NCT01859403|565183971|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
156572723|NCT01859403|565183972|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
156572724|NCT01859403|565183971|FG000|Primary Endpoint Measure|Physician Decision|0|||
156572725|NCT01859403|565183972|FG001|Primary Endpoint Measure|Physician Decision|1|||
156572726|NCT01859403|565183971|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
156572727|NCT01859403|565183972|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
156572728|NCT01157117|565183973|FG000|Overall Study|Dosing Symptoms|0|||
156572729|NCT01157117|565183974|FG001|Overall Study|Dosing Symptoms|4|||
156572730|NCT01157117|565183975|FG002|Overall Study|Dosing Symptoms|0|||
156572731|NCT01157117|565183973|FG000|Overall Study|Withdrawal by Subject|4|||
156572732|NCT01157117|565183974|FG001|Overall Study|Withdrawal by Subject|1|||
156572733|NCT01157117|565183975|FG002|Overall Study|Withdrawal by Subject|1|||
156572734|NCT01157117|565183973|FG000|Overall Study|Lack of Efficacy|1|||
156572735|NCT01157117|565183974|FG001|Overall Study|Lack of Efficacy|1|||
156572736|NCT01157117|565183975|FG002|Overall Study|Lack of Efficacy|0|||
156572737|NCT01157117|565183973|FG000|Overall Study|Lost to Follow-up|0|||
156572738|NCT01157117|565183974|FG001|Overall Study|Lost to Follow-up|0|||
156572739|NCT01157117|565183975|FG002|Overall Study|Lost to Follow-up|1|||
156572740|NCT01157117|565183973|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
156572741|NCT01157117|565183974|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
156572742|NCT01157117|565183975|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
156572743|NCT00811252|565183976|FG000|Overall Study|Adverse Event|6|||
156572744|NCT00811252|565183977|FG001|Overall Study|Adverse Event|10|||
156572745|NCT00811252|565183978|FG002|Overall Study|Adverse Event|15|||
156572746|NCT00811252|565183976|FG000|Overall Study|Lack of Efficacy|7|||
156572747|NCT00811252|565183977|FG001|Overall Study|Lack of Efficacy|2|||
156572748|NCT00811252|565183978|FG002|Overall Study|Lack of Efficacy|0|||
156572749|NCT00811252|565183976|FG000|Overall Study|Protocol Violation|3|||
156572750|NCT00811252|565183977|FG001|Overall Study|Protocol Violation|3|||
156572751|NCT00811252|565183978|FG002|Overall Study|Protocol Violation|2|||
156572752|NCT00811252|565183976|FG000|Overall Study|Withdrawal of Consent|1|||
156572753|NCT00811252|565183977|FG001|Overall Study|Withdrawal of Consent|2|||
156572754|NCT00811252|565183978|FG002|Overall Study|Withdrawal of Consent|2|||
156572755|NCT00811252|565183976|FG000|Overall Study|Lost to Follow-up|0|||
156572756|NCT00811252|565183977|FG001|Overall Study|Lost to Follow-up|0|||
156572757|NCT00811252|565183978|FG002|Overall Study|Lost to Follow-up|2|||
156572758|NCT00811252|565183976|FG000|Overall Study|Administrative or Other Reasons|0|||
156572759|NCT00811252|565183977|FG001|Overall Study|Administrative or Other Reasons|3|||
156572760|NCT00811252|565183978|FG002|Overall Study|Administrative or Other Reasons|2|||
156572761|NCT00504257|565183980|FG000|Overall Study|Withdrawal by Subject|2|||
156572762|NCT00504257|565183980|FG000|Overall Study|ineligible histology|2|||
156572763|NCT01531725|565183981|FG000|Overall Study|Protocol Violation|5|||
156572764|NCT03215277|565183982|FG000|Overall Study|Adverse Event|2|||
156572765|NCT03215277|565183983|FG001|Overall Study|Adverse Event|3|||
156572766|NCT03215277|565183982|FG000|Overall Study|Death|1|||
156572767|NCT03215277|565183983|FG001|Overall Study|Death|0|||
156572768|NCT03215277|565183982|FG000|Overall Study|Lost to Follow-up|0|||
156572769|NCT03215277|565183983|FG001|Overall Study|Lost to Follow-up|1|||
156572770|NCT03215277|565183982|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
156572771|NCT03215277|565183983|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
156572772|NCT02317510|565183984|FG000|Overall Study|Adverse Event|0|||
156572773|NCT02317510|565183985|FG001|Overall Study|Adverse Event|1|||
156572774|NCT00472303|565183986|FG000|Titration Phase|Adverse Event|22|||
156572775|NCT00472303|565183987|FG001|Titration Phase|Adverse Event|12|||
156572776|NCT00472303|565183988|FG002|Titration Phase|Adverse Event|0|||
156572777|NCT00472303|565183986|FG000|Titration Phase|Death|4|||
156572778|NCT00472303|565183987|FG001|Titration Phase|Death|2|||
156572779|NCT00472303|565183988|FG002|Titration Phase|Death|0|||
156572780|NCT00472303|565183986|FG000|Titration Phase|Lack of Efficacy|10|||
156572781|NCT00472303|565183987|FG001|Titration Phase|Lack of Efficacy|0|||
156572782|NCT00472303|565183988|FG002|Titration Phase|Lack of Efficacy|0|||
156572783|NCT00472303|565183986|FG000|Titration Phase|Withdrawal by Subject|16|||
156572784|NCT00472303|565183987|FG001|Titration Phase|Withdrawal by Subject|13|||
156572785|NCT00472303|565183988|FG002|Titration Phase|Withdrawal by Subject|0|||
156572786|NCT00472303|565183986|FG000|Titration Phase|Trial Medication non-compliant|4|||
156572787|NCT00472303|565183987|FG001|Titration Phase|Trial Medication non-compliant|1|||
156572788|NCT00472303|565183988|FG002|Titration Phase|Trial Medication non-compliant|0|||
156572789|NCT00472303|565183986|FG000|Titration Phase|Other|3|||
156572790|NCT00472303|565183987|FG001|Titration Phase|Other|1|||
156572791|NCT00472303|565183988|FG002|Titration Phase|Other|0|||
156572792|NCT00472303|565183986|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
156572793|NCT00472303|565183987|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
156572794|NCT00472303|565183988|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
156572795|NCT00472303|565183986|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
156572796|NCT00472303|565183987|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
156572797|NCT00472303|565183988|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
156572798|NCT00472303|565183986|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
156572799|NCT00472303|565183987|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
156572800|NCT00472303|565183988|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
156572801|NCT00472303|565183986|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
156572802|NCT00472303|565183987|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
156572803|NCT00472303|565183988|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
156572804|NCT00472303|565183986|FG000|Discontinuations After Titration Phase|Other|5|||
156572805|NCT00472303|565183987|FG001|Discontinuations After Titration Phase|Other|0|||
156572806|NCT00472303|565183988|FG002|Discontinuations After Titration Phase|Other|0|||
156572807|NCT00472303|565183986|FG000|Maintenance Phase|Adverse Event|5|||
156572808|NCT00472303|565183987|FG001|Maintenance Phase|Adverse Event|6|||
156572809|NCT00472303|565183988|FG002|Maintenance Phase|Adverse Event|6|||
156572810|NCT00472303|565183986|FG000|Maintenance Phase|Death|3|||
156572811|NCT00472303|565183987|FG001|Maintenance Phase|Death|0|||
156572812|NCT00472303|565183988|FG002|Maintenance Phase|Death|2|||
156572813|NCT00472303|565183986|FG000|Maintenance Phase|Lack of Efficacy|2|||
156572814|NCT00472303|565183987|FG001|Maintenance Phase|Lack of Efficacy|2|||
156572815|NCT00472303|565183988|FG002|Maintenance Phase|Lack of Efficacy|4|||
156572816|NCT00472303|565183986|FG000|Maintenance Phase|Withdrawal by Subject|6|||
156572817|NCT00472303|565183987|FG001|Maintenance Phase|Withdrawal by Subject|7|||
156572818|NCT00472303|565183988|FG002|Maintenance Phase|Withdrawal by Subject|3|||
156572819|NCT00472303|565183986|FG000|Maintenance Phase|Trial medication non-compliant|0|||
156572820|NCT00472303|565183987|FG001|Maintenance Phase|Trial medication non-compliant|0|||
156572821|NCT00472303|565183988|FG002|Maintenance Phase|Trial medication non-compliant|1|||
156572822|NCT00472303|565183986|FG000|Maintenance Phase|Resolution of pain|0|||
156572823|NCT00472303|565183987|FG001|Maintenance Phase|Resolution of pain|0|||
156572824|NCT00472303|565183988|FG002|Maintenance Phase|Resolution of pain|1|||
156572825|NCT00472303|565183986|FG000|Maintenance Phase|Other|1|||
156572826|NCT00472303|565183987|FG001|Maintenance Phase|Other|1|||
156572827|NCT00472303|565183988|FG002|Maintenance Phase|Other|0|||
156572828|NCT01122927|565183989|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
156572829|NCT01122927|565183990|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
156572830|NCT01122927|565183989|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
156572831|NCT01122927|565183990|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
156572832|NCT01122927|565183989|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
156572833|NCT01122927|565183990|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
156572834|NCT01122927|565183989|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
156572835|NCT01122927|565183990|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
156572836|NCT01122927|565183989|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
156572837|NCT01122927|565183990|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
156572838|NCT01122927|565183989|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
156572839|NCT01122927|565183990|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
156572840|NCT01122927|565183989|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
156572841|NCT01122927|565183990|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
156572842|NCT01122927|565183989|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
156572843|NCT01122927|565183990|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
156572844|NCT01122927|565183989|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
156572845|NCT01122927|565183990|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
156572846|NCT01122927|565183989|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
156572847|NCT01122927|565183990|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
156572848|NCT01122927|565183989|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
156572849|NCT01122927|565183990|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
156572850|NCT01122927|565183989|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
156572851|NCT01122927|565183990|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
156572852|NCT03427073|565183998|FG000|Overall Study|Disease Progression|1|||
156572853|NCT03427073|565183999|FG001|Overall Study|Disease Progression|1|||
156572854|NCT03427073|565184000|FG002|Overall Study|Disease Progression|1|||
156572855|NCT03427073|565184001|FG003|Overall Study|Disease Progression|3|||
156572856|NCT03427073|565184002|FG004|Overall Study|Disease Progression|3|||
156572857|NCT03427073|565184003|FG005|Overall Study|Disease Progression|4|||
156572858|NCT03427073|565184004|FG006|Overall Study|Disease Progression|2|||
156572859|NCT03427073|565184005|FG007|Overall Study|Disease Progression|3|||
156572860|NCT03427073|565183998|FG000|Overall Study|Physician Decision|0|||
156572861|NCT03427073|565183999|FG001|Overall Study|Physician Decision|0|||
156572862|NCT03427073|565184000|FG002|Overall Study|Physician Decision|0|||
156572863|NCT03427073|565184001|FG003|Overall Study|Physician Decision|0|||
156572864|NCT03427073|565184002|FG004|Overall Study|Physician Decision|0|||
156572865|NCT03427073|565184003|FG005|Overall Study|Physician Decision|0|||
156572866|NCT03427073|565184004|FG006|Overall Study|Physician Decision|1|||
156572867|NCT03427073|565184005|FG007|Overall Study|Physician Decision|1|||
156572868|NCT01244737|565184006|FG000|Overall Study|Physician Decision|2|||
156572869|NCT01244737|565184007|FG001|Overall Study|Physician Decision|18|||
156572870|NCT01244737|565184008|FG002|Overall Study|Physician Decision|5|||
156572871|NCT01244737|565184006|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
156572872|NCT01244737|565184007|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
156572873|NCT01244737|565184008|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
156572874|NCT01244737|565184006|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
156572875|NCT01244737|565184007|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
156572876|NCT01244737|565184008|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
156572877|NCT01244737|565184006|FG000|Overall Study|MIB immunopathology results not available|3|||
156572878|NCT01244737|565184007|FG001|Overall Study|MIB immunopathology results not available|2|||
156572879|NCT01244737|565184008|FG002|Overall Study|MIB immunopathology results not available|0|||
156572880|NCT01244737|565184006|FG000|Overall Study|PET data failure|0|||
156572881|NCT01244737|565184007|FG001|Overall Study|PET data failure|1|||
156572882|NCT01244737|565184008|FG002|Overall Study|PET data failure|0|||
156572883|NCT01244737|565184006|FG000|Overall Study|Withdrawal by Subject|0|||
156572884|NCT01244737|565184007|FG001|Overall Study|Withdrawal by Subject|0|||
156572885|NCT01244737|565184008|FG002|Overall Study|Withdrawal by Subject|1|||
156572886|NCT02835495|565184013|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
156572887|NCT02835495|565184014|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
156572888|NCT02835495|565184013|FG000|Overall Study|Declined in-person follow-up visit|4|||
156572889|NCT02835495|565184014|FG001|Overall Study|Declined in-person follow-up visit|2|||
156572890|NCT00356915|565184015|FG000|Overall Study|Non compliance|1|||
156572891|NCT00356915|565184016|FG001|Overall Study|Non compliance|2|||
156572892|NCT00356915|565184017|FG002|Overall Study|Non compliance|1|||
156572893|NCT00356915|565184015|FG000|Overall Study|Protocol Violation|2|||
156572894|NCT00356915|565184016|FG001|Overall Study|Protocol Violation|3|||
156572895|NCT00356915|565184017|FG002|Overall Study|Protocol Violation|2|||
156572896|NCT00356915|565184015|FG000|Overall Study|Withdrawal by Subject|14|||
156572897|NCT00356915|565184016|FG001|Overall Study|Withdrawal by Subject|14|||
156572898|NCT00356915|565184017|FG002|Overall Study|Withdrawal by Subject|10|||
156572899|NCT00356915|565184015|FG000|Overall Study|Lack of Efficacy|0|||
156572900|NCT00356915|565184016|FG001|Overall Study|Lack of Efficacy|0|||
156572901|NCT00356915|565184017|FG002|Overall Study|Lack of Efficacy|3|||
156572902|NCT00356915|565184015|FG000|Overall Study|Lost to Follow-up|27|||
156572903|NCT00356915|565184016|FG001|Overall Study|Lost to Follow-up|34|||
156572904|NCT00356915|565184017|FG002|Overall Study|Lost to Follow-up|14|||
156572905|NCT00356915|565184015|FG000|Overall Study|Administrative Decision|0|||
156572906|NCT00356915|565184016|FG001|Overall Study|Administrative Decision|0|||
156572907|NCT00356915|565184017|FG002|Overall Study|Administrative Decision|1|||
156572908|NCT00356915|565184015|FG000|Overall Study|Physician Decision|0|||
156572909|NCT00356915|565184016|FG001|Overall Study|Physician Decision|2|||
156572910|NCT00356915|565184017|FG002|Overall Study|Physician Decision|0|||
156572911|NCT00356915|565184015|FG000|Overall Study|Adverse Event|21|||
156572912|NCT00356915|565184016|FG001|Overall Study|Adverse Event|31|||
156572913|NCT00356915|565184017|FG002|Overall Study|Adverse Event|8|||
156572914|NCT00356915|565184015|FG000|Overall Study|Miscellaneous reasons|11|||
156572915|NCT00356915|565184016|FG001|Overall Study|Miscellaneous reasons|8|||
156572916|NCT00356915|565184017|FG002|Overall Study|Miscellaneous reasons|3|||
156572917|NCT02580058|565184027|FG000|Overall Study|Adverse Event|16|||
156572918|NCT02580058|565184028|FG001|Overall Study|Adverse Event|30|||
156572919|NCT02580058|565184029|FG002|Overall Study|Adverse Event|20|||
156572920|NCT02580058|565184027|FG000|Overall Study|Death|4|||
156572921|NCT02580058|565184028|FG001|Overall Study|Death|4|||
156572922|NCT02580058|565184029|FG002|Overall Study|Death|5|||
156572923|NCT02580058|565184027|FG000|Overall Study|Physician Decision|1|||
156572924|NCT02580058|565184028|FG001|Overall Study|Physician Decision|3|||
156572925|NCT02580058|565184029|FG002|Overall Study|Physician Decision|11|||
156572926|NCT02580058|565184027|FG000|Overall Study|Other|5|||
156572927|NCT02580058|565184028|FG001|Overall Study|Other|1|||
156572928|NCT02580058|565184029|FG002|Overall Study|Other|3|||
156572929|NCT02580058|565184027|FG000|Overall Study|Withdrawal by Subject|4|||
156572930|NCT02580058|565184028|FG001|Overall Study|Withdrawal by Subject|7|||
156572931|NCT02580058|565184029|FG002|Overall Study|Withdrawal by Subject|31|||
156572932|NCT02580058|565184027|FG000|Overall Study|Global Deterioration of Health Status|19|||
156572933|NCT02580058|565184028|FG001|Overall Study|Global Deterioration of Health Status|18|||
156572934|NCT02580058|565184029|FG002|Overall Study|Global Deterioration of Health Status|24|||
156572935|NCT02580058|565184027|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
156572936|NCT02580058|565184028|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156572937|NCT02580058|565184029|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
156572938|NCT02580058|565184027|FG000|Overall Study|Progressive Disease|137|||
156572939|NCT02580058|565184028|FG001|Overall Study|Progressive Disease|125|||
156572940|NCT02580058|565184029|FG002|Overall Study|Progressive Disease|94|||
156572941|NCT02580058|565184027|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156572942|NCT02580058|565184028|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156572943|NCT02580058|565184029|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156572944|NCT03022461|565184030|FG000|Overall Study|Death|3|||
156572945|NCT01982630|565184031|FG000|Overall Study|Adverse Event|2|||
156572946|NCT01982630|565184032|FG001|Overall Study|Adverse Event|0|||
156572947|NCT01982630|565184033|FG002|Overall Study|Adverse Event|1|||
156572948|NCT01982630|565184034|FG003|Overall Study|Adverse Event|0|||
156572949|NCT01982630|565184035|FG004|Overall Study|Adverse Event|1|||
156572950|NCT01982630|565184036|FG005|Overall Study|Adverse Event|2|||
156572951|NCT01982630|565184037|FG006|Overall Study|Adverse Event|1|||
156572952|NCT01982630|565184038|FG007|Overall Study|Adverse Event|0|||
156572953|NCT01982630|565184031|FG000|Overall Study|Physician Decision|1|||
156572954|NCT01982630|565184032|FG001|Overall Study|Physician Decision|0|||
156572955|NCT01982630|565184033|FG002|Overall Study|Physician Decision|2|||
156572956|NCT01982630|565184034|FG003|Overall Study|Physician Decision|1|||
156572957|NCT01982630|565184035|FG004|Overall Study|Physician Decision|2|||
156572958|NCT01982630|565184036|FG005|Overall Study|Physician Decision|0|||
156572959|NCT01982630|565184037|FG006|Overall Study|Physician Decision|0|||
156572960|NCT01982630|565184038|FG007|Overall Study|Physician Decision|0|||
156572961|NCT01982630|565184031|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156572962|NCT01982630|565184032|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156572963|NCT01982630|565184033|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
156572964|NCT01982630|565184034|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156572965|NCT01982630|565184035|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156572966|NCT01982630|565184036|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156572967|NCT01982630|565184037|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156572968|NCT01982630|565184038|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156572969|NCT01982630|565184031|FG000|Overall Study|Withdrawal by Subject|0|||
156572970|NCT01982630|565184032|FG001|Overall Study|Withdrawal by Subject|0|||
156572971|NCT01982630|565184033|FG002|Overall Study|Withdrawal by Subject|0|||
156572972|NCT01982630|565184034|FG003|Overall Study|Withdrawal by Subject|0|||
156572973|NCT01982630|565184035|FG004|Overall Study|Withdrawal by Subject|0|||
156572974|NCT01982630|565184036|FG005|Overall Study|Withdrawal by Subject|1|||
156572975|NCT01982630|565184037|FG006|Overall Study|Withdrawal by Subject|0|||
156572976|NCT01982630|565184038|FG007|Overall Study|Withdrawal by Subject|0|||
156572977|NCT05738486|565185647|FG000|Overall Study|Continuing Study|194|||
156572978|NCT05738486|565185648|FG001|Overall Study|Continuing Study|196|||
156572979|NCT05738486|565185649|FG002|Overall Study|Continuing Study|193|||
156572980|NCT05738486|565185650|FG003|Overall Study|Continuing Study|191|||
156572981|NCT05738486|565185647|FG000|Overall Study|Withdrawal by Subject|8|||
156572982|NCT05738486|565185648|FG001|Overall Study|Withdrawal by Subject|5|||
156572983|NCT05738486|565185649|FG002|Overall Study|Withdrawal by Subject|7|||
156572984|NCT05738486|565185650|FG003|Overall Study|Withdrawal by Subject|13|||
156572985|NCT05738486|565185647|FG000|Overall Study|Adverse Event|4|||
156572986|NCT05738486|565185648|FG001|Overall Study|Adverse Event|6|||
156572987|NCT05738486|565185649|FG002|Overall Study|Adverse Event|4|||
156572988|NCT05738486|565185650|FG003|Overall Study|Adverse Event|5|||
156572989|NCT05738486|565185647|FG000|Overall Study|Physician Decision|0|||
156572990|NCT05738486|565185648|FG001|Overall Study|Physician Decision|2|||
156572991|NCT05738486|565185649|FG002|Overall Study|Physician Decision|4|||
156572992|NCT05738486|565185650|FG003|Overall Study|Physician Decision|1|||
156572993|NCT05738486|565185647|FG000|Overall Study|Lost to Follow-up|1|||
156572994|NCT05738486|565185648|FG001|Overall Study|Lost to Follow-up|1|||
156572995|NCT05738486|565185649|FG002|Overall Study|Lost to Follow-up|2|||
156572996|NCT05738486|565185650|FG003|Overall Study|Lost to Follow-up|1|||
156572997|NCT05738486|565185647|FG000|Overall Study|Participant was Non-ambulatory|0|||
156572998|NCT05738486|565185648|FG001|Overall Study|Participant was Non-ambulatory|0|||
156572999|NCT05738486|565185649|FG002|Overall Study|Participant was Non-ambulatory|1|||
156573000|NCT05738486|565185650|FG003|Overall Study|Participant was Non-ambulatory|0|||
156573001|NCT05738486|565185647|FG000|Overall Study|Participant had Poor Venous Access|0|||
156573002|NCT05738486|565185648|FG001|Overall Study|Participant had Poor Venous Access|0|||
156573003|NCT05738486|565185649|FG002|Overall Study|Participant had Poor Venous Access|0|||
156573004|NCT05738486|565185650|FG003|Overall Study|Participant had Poor Venous Access|1|||
156573005|NCT05738486|565185647|FG000|Overall Study|Assigned Treatment by Mistake|0|||
156573006|NCT05738486|565185648|FG001|Overall Study|Assigned Treatment by Mistake|0|||
156573007|NCT05738486|565185649|FG002|Overall Study|Assigned Treatment by Mistake|0|||
156573008|NCT05738486|565185650|FG003|Overall Study|Assigned Treatment by Mistake|1|||
156573009|NCT05738486|565185647|FG000|Overall Study|Death|0|||
156573010|NCT05738486|565185648|FG001|Overall Study|Death|0|||
156573011|NCT05738486|565185649|FG002|Overall Study|Death|1|||
156573012|NCT05738486|565185650|FG003|Overall Study|Death|0|||
156573013|NCT05738486|565185647|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
156573014|NCT05738486|565185648|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
156573015|NCT05738486|565185649|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
156573016|NCT05738486|565185650|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
156573017|NCT03395210|565185651|FG000|Overall Study|Other|0|||
156573018|NCT03395210|565185652|FG001|Overall Study|Other|0|||
156573019|NCT03395210|565185653|FG002|Overall Study|Other|0|||
156573020|NCT03395210|565185654|FG003|Overall Study|Other|0|||
156573021|NCT03395210|565185655|FG004|Overall Study|Other|1|||
156573022|NCT03395210|565185651|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
156573023|NCT03395210|565185652|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
156573024|NCT03395210|565185653|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
156573025|NCT03395210|565185654|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
156573026|NCT03395210|565185655|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
156573027|NCT03395210|565185651|FG000|Overall Study|Adverse Event|1|||
156573028|NCT03395210|565185652|FG001|Overall Study|Adverse Event|0|||
156573029|NCT03395210|565185653|FG002|Overall Study|Adverse Event|2|||
156573030|NCT03395210|565185654|FG003|Overall Study|Adverse Event|4|||
156573031|NCT03395210|565185655|FG004|Overall Study|Adverse Event|3|||
156573032|NCT03395210|565185651|FG000|Overall Study|Need of Rescue Medication|1|||
156573033|NCT03395210|565185652|FG001|Overall Study|Need of Rescue Medication|0|||
156573034|NCT03395210|565185653|FG002|Overall Study|Need of Rescue Medication|1|||
156573035|NCT03395210|565185654|FG003|Overall Study|Need of Rescue Medication|4|||
156573036|NCT03395210|565185655|FG004|Overall Study|Need of Rescue Medication|0|||
156573037|NCT03395210|565185651|FG000|Overall Study|Lack of Response|0|||
156573038|NCT03395210|565185652|FG001|Overall Study|Lack of Response|0|||
156573039|NCT03395210|565185653|FG002|Overall Study|Lack of Response|0|||
156573040|NCT03395210|565185654|FG003|Overall Study|Lack of Response|5|||
156573041|NCT03395210|565185655|FG004|Overall Study|Lack of Response|5|||
156573042|NCT03395210|565185651|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
156573043|NCT03395210|565185652|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
156573044|NCT03395210|565185653|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
156573045|NCT03395210|565185654|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
156573046|NCT03395210|565185655|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
156573047|NCT03395210|565185651|FG000|Overall Study|Participant Decision|1|||
156573048|NCT03395210|565185652|FG001|Overall Study|Participant Decision|1|||
156573049|NCT03395210|565185653|FG002|Overall Study|Participant Decision|0|||
156573050|NCT03395210|565185654|FG003|Overall Study|Participant Decision|4|||
156573051|NCT03395210|565185655|FG004|Overall Study|Participant Decision|0|||
156573052|NCT03395210|565185651|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
156573053|NCT03395210|565185652|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
156573054|NCT03395210|565185653|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
156573055|NCT03395210|565185654|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
156573056|NCT03395210|565185655|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
156573057|NCT01672892|565185656|FG000|Overall Study|Protocol Violation|7|||
156573058|NCT01672892|565185657|FG001|Overall Study|Protocol Violation|3|||
156573059|NCT02874794|565185670|FG000|Overall Study|Physician Decision|3|||
156573060|NCT02874794|565185671|FG001|Overall Study|Physician Decision|2|||
156573061|NCT02874794|565185670|FG000|Overall Study|Withdrawal by Subject|2|||
156573062|NCT02874794|565185671|FG001|Overall Study|Withdrawal by Subject|8|||
156573063|NCT02874794|565185670|FG000|Overall Study|Death|2|||
156573064|NCT02874794|565185671|FG001|Overall Study|Death|1|||
156573065|NCT01473004|565185672|FG000|Overall Study|Incomplete Lobar Treatment|1|||
156573066|NCT01473004|565185673|FG001|Overall Study|Incomplete Lobar Treatment|0|||
156573067|NCT00613314|565185677|FG000|Overall Study|Adverse Event|5|||
156573068|NCT00613314|565185677|FG000|Overall Study|Protocol Violation|14|||
156573069|NCT00613314|565185677|FG000|Overall Study|Lost to Follow-up|46|||
156573070|NCT00613314|565185677|FG000|Overall Study|Other reason not defined above|90|||
156573071|NCT01584024|565185678|FG000|Overall Study|Lost to Follow-up|10|||
156573072|NCT01584024|565185678|FG000|Overall Study|Withdrawal by Subject|3|||
156573073|NCT00345605|565185682|FG000|Arm 1|Adverse Event|0|||
156573074|NCT00345605|565185683|FG001|Arm 1|Adverse Event|1|||
156573075|NCT00345605|565185682|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
156573076|NCT00345605|565185683|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
156573077|NCT01324830|565185684|FG000|Overall Study|Progressive Disease|3|||
156573078|NCT01324830|565185685|FG001|Overall Study|Progressive Disease|2|||
156573079|NCT01324830|565185686|FG002|Overall Study|Progressive Disease|3|||
156573080|NCT01324830|565185687|FG003|Overall Study|Progressive Disease|3|||
156573081|NCT01324830|565185688|FG004|Overall Study|Progressive Disease|6|||
156863436|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
156573082|NCT01324830|565185689|FG005|Overall Study|Progressive Disease|6|||
156573083|NCT01324830|565185690|FG006|Overall Study|Progressive Disease|3|||
156573084|NCT01324830|565185691|FG007|Overall Study|Progressive Disease|3|||
156573085|NCT01324830|565185692|FG008|Overall Study|Progressive Disease|3|||
156573086|NCT01324830|565185693|FG009|Overall Study|Progressive Disease|6|||
156573087|NCT01324830|565185694|FG010|Overall Study|Progressive Disease|2|||
156573088|NCT01324830|565185695|FG011|Overall Study|Progressive Disease|1|||
156573089|NCT01324830|565185696|FG012|Overall Study|Progressive Disease|1|||
156573090|NCT01324830|565185697|FG013|Overall Study|Progressive Disease|1|||
156573091|NCT01324830|565185698|FG014|Overall Study|Progressive Disease|1|||
156573092|NCT01324830|565185699|FG015|Overall Study|Progressive Disease|3|||
156573093|NCT01324830|565185700|FG016|Overall Study|Progressive Disease|2|||
156573094|NCT01324830|565185701|FG017|Overall Study|Progressive Disease|3|||
156573095|NCT01324830|565185702|FG018|Overall Study|Progressive Disease|4|||
156573096|NCT01324830|565185684|FG000|Overall Study|Dose limiting toxicity|0|||
156573097|NCT01324830|565185685|FG001|Overall Study|Dose limiting toxicity|0|||
156573098|NCT01324830|565185686|FG002|Overall Study|Dose limiting toxicity|0|||
156573099|NCT01324830|565185687|FG003|Overall Study|Dose limiting toxicity|0|||
156573100|NCT01324830|565185688|FG004|Overall Study|Dose limiting toxicity|1|||
156573101|NCT01324830|565185689|FG005|Overall Study|Dose limiting toxicity|0|||
156573102|NCT01324830|565185690|FG006|Overall Study|Dose limiting toxicity|0|||
156573103|NCT01324830|565185691|FG007|Overall Study|Dose limiting toxicity|0|||
156573104|NCT01324830|565185692|FG008|Overall Study|Dose limiting toxicity|0|||
156573105|NCT01324830|565185693|FG009|Overall Study|Dose limiting toxicity|0|||
156573106|NCT01324830|565185694|FG010|Overall Study|Dose limiting toxicity|0|||
156573107|NCT01324830|565185695|FG011|Overall Study|Dose limiting toxicity|0|||
156573108|NCT01324830|565185696|FG012|Overall Study|Dose limiting toxicity|0|||
156573109|NCT01324830|565185697|FG013|Overall Study|Dose limiting toxicity|0|||
156573110|NCT01324830|565185698|FG014|Overall Study|Dose limiting toxicity|0|||
156573111|NCT01324830|565185699|FG015|Overall Study|Dose limiting toxicity|0|||
156573112|NCT01324830|565185700|FG016|Overall Study|Dose limiting toxicity|1|||
156573113|NCT01324830|565185701|FG017|Overall Study|Dose limiting toxicity|1|||
156573114|NCT01324830|565185702|FG018|Overall Study|Dose limiting toxicity|1|||
156573115|NCT01324830|565185684|FG000|Overall Study|Reason not mentioned above|0|||
156573116|NCT01324830|565185685|FG001|Overall Study|Reason not mentioned above|0|||
156573117|NCT01324830|565185686|FG002|Overall Study|Reason not mentioned above|0|||
156573118|NCT01324830|565185687|FG003|Overall Study|Reason not mentioned above|0|||
156573119|NCT01324830|565185688|FG004|Overall Study|Reason not mentioned above|0|||
156573120|NCT01324830|565185689|FG005|Overall Study|Reason not mentioned above|0|||
156573121|NCT01324830|565185690|FG006|Overall Study|Reason not mentioned above|0|||
156573122|NCT01324830|565185691|FG007|Overall Study|Reason not mentioned above|0|||
156573123|NCT01324830|565185692|FG008|Overall Study|Reason not mentioned above|0|||
156573124|NCT01324830|565185693|FG009|Overall Study|Reason not mentioned above|0|||
156573125|NCT01324830|565185694|FG010|Overall Study|Reason not mentioned above|0|||
156573126|NCT01324830|565185695|FG011|Overall Study|Reason not mentioned above|0|||
156573127|NCT01324830|565185696|FG012|Overall Study|Reason not mentioned above|0|||
156573128|NCT01324830|565185697|FG013|Overall Study|Reason not mentioned above|0|||
156573129|NCT01324830|565185698|FG014|Overall Study|Reason not mentioned above|0|||
156573130|NCT01324830|565185699|FG015|Overall Study|Reason not mentioned above|0|||
156573131|NCT01324830|565185700|FG016|Overall Study|Reason not mentioned above|0|||
156573132|NCT01324830|565185701|FG017|Overall Study|Reason not mentioned above|1|||
156573133|NCT01324830|565185702|FG018|Overall Study|Reason not mentioned above|0|||
156573134|NCT01324830|565185684|FG000|Overall Study|Adverse Event, serious fatal|0|||
156573135|NCT01324830|565185685|FG001|Overall Study|Adverse Event, serious fatal|1|||
156573136|NCT01324830|565185686|FG002|Overall Study|Adverse Event, serious fatal|0|||
156573137|NCT01324830|565185687|FG003|Overall Study|Adverse Event, serious fatal|0|||
156573138|NCT01324830|565185688|FG004|Overall Study|Adverse Event, serious fatal|0|||
156573139|NCT01324830|565185689|FG005|Overall Study|Adverse Event, serious fatal|0|||
156573140|NCT01324830|565185690|FG006|Overall Study|Adverse Event, serious fatal|0|||
156573141|NCT01324830|565185691|FG007|Overall Study|Adverse Event, serious fatal|0|||
156573142|NCT01324830|565185692|FG008|Overall Study|Adverse Event, serious fatal|0|||
156573143|NCT01324830|565185693|FG009|Overall Study|Adverse Event, serious fatal|0|||
156573144|NCT01324830|565185694|FG010|Overall Study|Adverse Event, serious fatal|0|||
156573145|NCT01324830|565185695|FG011|Overall Study|Adverse Event, serious fatal|0|||
156573146|NCT01324830|565185696|FG012|Overall Study|Adverse Event, serious fatal|0|||
156573147|NCT01324830|565185697|FG013|Overall Study|Adverse Event, serious fatal|0|||
156573148|NCT01324830|565185698|FG014|Overall Study|Adverse Event, serious fatal|0|||
156573149|NCT01324830|565185699|FG015|Overall Study|Adverse Event, serious fatal|0|||
156573150|NCT01324830|565185700|FG016|Overall Study|Adverse Event, serious fatal|0|||
156573151|NCT01324830|565185701|FG017|Overall Study|Adverse Event, serious fatal|0|||
156573152|NCT01324830|565185702|FG018|Overall Study|Adverse Event, serious fatal|0|||
156573153|NCT01324830|565185684|FG000|Overall Study|Adverse Event, non-fatal|0|||
156573154|NCT01324830|565185685|FG001|Overall Study|Adverse Event, non-fatal|0|||
156573155|NCT01324830|565185686|FG002|Overall Study|Adverse Event, non-fatal|0|||
156573156|NCT01324830|565185687|FG003|Overall Study|Adverse Event, non-fatal|0|||
156573157|NCT01324830|565185688|FG004|Overall Study|Adverse Event, non-fatal|0|||
156573158|NCT01324830|565185689|FG005|Overall Study|Adverse Event, non-fatal|0|||
156573159|NCT01324830|565185690|FG006|Overall Study|Adverse Event, non-fatal|0|||
156573160|NCT01324830|565185691|FG007|Overall Study|Adverse Event, non-fatal|0|||
156573161|NCT01324830|565185692|FG008|Overall Study|Adverse Event, non-fatal|2|||
156573162|NCT01324830|565185693|FG009|Overall Study|Adverse Event, non-fatal|0|||
156573163|NCT01324830|565185694|FG010|Overall Study|Adverse Event, non-fatal|1|||
156573164|NCT01324830|565185695|FG011|Overall Study|Adverse Event, non-fatal|0|||
156573165|NCT01324830|565185696|FG012|Overall Study|Adverse Event, non-fatal|0|||
156573166|NCT01324830|565185697|FG013|Overall Study|Adverse Event, non-fatal|0|||
156573167|NCT01324830|565185698|FG014|Overall Study|Adverse Event, non-fatal|0|||
156573168|NCT01324830|565185699|FG015|Overall Study|Adverse Event, non-fatal|0|||
156573169|NCT01324830|565185700|FG016|Overall Study|Adverse Event, non-fatal|0|||
156573170|NCT01324830|565185701|FG017|Overall Study|Adverse Event, non-fatal|1|||
156573171|NCT01324830|565185702|FG018|Overall Study|Adverse Event, non-fatal|0|||
156573172|NCT01324830|565185684|FG000|Overall Study|Withdrawal by Subject|0|||
156573173|NCT01324830|565185685|FG001|Overall Study|Withdrawal by Subject|0|||
156573174|NCT01324830|565185686|FG002|Overall Study|Withdrawal by Subject|0|||
156573175|NCT01324830|565185687|FG003|Overall Study|Withdrawal by Subject|0|||
156573176|NCT01324830|565185688|FG004|Overall Study|Withdrawal by Subject|0|||
156573177|NCT01324830|565185689|FG005|Overall Study|Withdrawal by Subject|1|||
156573178|NCT01324830|565185690|FG006|Overall Study|Withdrawal by Subject|0|||
156573179|NCT01324830|565185691|FG007|Overall Study|Withdrawal by Subject|0|||
156573180|NCT01324830|565185692|FG008|Overall Study|Withdrawal by Subject|0|||
156573181|NCT01324830|565185693|FG009|Overall Study|Withdrawal by Subject|0|||
156573182|NCT01324830|565185694|FG010|Overall Study|Withdrawal by Subject|1|||
156573183|NCT01324830|565185695|FG011|Overall Study|Withdrawal by Subject|0|||
156573184|NCT01324830|565185696|FG012|Overall Study|Withdrawal by Subject|0|||
156573185|NCT01324830|565185697|FG013|Overall Study|Withdrawal by Subject|0|||
156573186|NCT01324830|565185698|FG014|Overall Study|Withdrawal by Subject|0|||
156573187|NCT01324830|565185699|FG015|Overall Study|Withdrawal by Subject|0|||
156573188|NCT01324830|565185700|FG016|Overall Study|Withdrawal by Subject|0|||
156573189|NCT01324830|565185701|FG017|Overall Study|Withdrawal by Subject|0|||
156573190|NCT01324830|565185702|FG018|Overall Study|Withdrawal by Subject|1|||
156573191|NCT01973283|565185703|FG000|Overall Study|Lost to Follow-up|4|||
156573192|NCT00817414|565185704|FG000|Overall Study|Adverse Event|1|||
156573193|NCT00817414|565185705|FG001|Overall Study|Adverse Event|1|||
156573194|NCT00817414|565185706|FG002|Overall Study|Adverse Event|1|||
156573195|NCT00817414|565185707|FG003|Overall Study|Adverse Event|0|||
156573196|NCT00817414|565185708|FG004|Overall Study|Adverse Event|0|||
156573197|NCT00817414|565185704|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
156573198|NCT00817414|565185705|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
156573199|NCT00817414|565185706|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
156573200|NCT00817414|565185707|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
156573201|NCT00817414|565185708|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
156573202|NCT00817414|565185704|FG000|Overall Study|Withdrawal by Subject|1|||
156573203|NCT00817414|565185705|FG001|Overall Study|Withdrawal by Subject|1|||
156573204|NCT00817414|565185706|FG002|Overall Study|Withdrawal by Subject|0|||
156573205|NCT00817414|565185707|FG003|Overall Study|Withdrawal by Subject|0|||
156573206|NCT00817414|565185708|FG004|Overall Study|Withdrawal by Subject|0|||
156573207|NCT00817414|565185704|FG000|Overall Study|Lost to Follow-up|0|||
156573208|NCT00817414|565185705|FG001|Overall Study|Lost to Follow-up|0|||
156573209|NCT00817414|565185706|FG002|Overall Study|Lost to Follow-up|1|||
156573210|NCT00817414|565185707|FG003|Overall Study|Lost to Follow-up|1|||
156573211|NCT00817414|565185708|FG004|Overall Study|Lost to Follow-up|1|||
156573212|NCT00817414|565185704|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
156573213|NCT00817414|565185705|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
156573214|NCT00817414|565185706|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
156573215|NCT00817414|565185707|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
156573216|NCT00817414|565185708|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
156573217|NCT00817414|565185704|FG000|Overall Study|Protocol Violation|0|||
156573218|NCT00817414|565185705|FG001|Overall Study|Protocol Violation|0|||
156573219|NCT00817414|565185706|FG002|Overall Study|Protocol Violation|0|||
156573220|NCT00817414|565185707|FG003|Overall Study|Protocol Violation|0|||
156573221|NCT00817414|565185708|FG004|Overall Study|Protocol Violation|1|||
156573222|NCT00886938|565185709|FG000|Overall Study|Adverse Event|1|||
156573223|NCT00886938|565185709|FG000|Overall Study|Withdrawal by Subject|1|||
156573224|NCT03872180|565185716|FG000|Overall Study|Adverse Event|4|||
156573225|NCT03872180|565185716|FG000|Overall Study|Lack of Efficacy|2|||
156573226|NCT01126619|565185717|FG000|Overall Study|Not eligible for the study|2|||
156573227|NCT01126619|565185717|FG000|Overall Study|Investigator decision|4|||
156573228|NCT01126619|565185717|FG000|Overall Study|Serious adverse event|1|||
156573229|NCT01126619|565185717|FG000|Overall Study|Withdrawal by Subject|9|||
156573230|NCT01126619|565185717|FG000|Overall Study|Non-compliance|1|||
156573231|NCT00947154|565185718|FG000|Overall Study|Lost to Follow-up|1|||
156573232|NCT04876391|565185719|FG000|Overall Study|Withdrawal by Subject|1|||
156573233|NCT04876391|565185720|FG001|Overall Study|Withdrawal by Subject|10|||
156573234|NCT04876391|565185719|FG000|Overall Study|Lost to Follow-up|2|||
156573235|NCT04876391|565185720|FG001|Overall Study|Lost to Follow-up|4|||
156573236|NCT04876391|565185719|FG000|Overall Study|Lack of Efficacy|0|||
156573237|NCT04876391|565185720|FG001|Overall Study|Lack of Efficacy|2|||
156573238|NCT04876391|565185719|FG000|Overall Study|Adverse Event|3|||
156573239|NCT04876391|565185720|FG001|Overall Study|Adverse Event|1|||
156573240|NCT04876391|565185719|FG000|Overall Study|Patient non-compliance|0|||
156573241|NCT04876391|565185720|FG001|Overall Study|Patient non-compliance|1|||
156573242|NCT04876391|565185719|FG000|Overall Study|Personal reasons|0|||
156573243|NCT04876391|565185720|FG001|Overall Study|Personal reasons|1|||
156573244|NCT04876391|565185719|FG000|Overall Study|Withdrawn as per protocol|2|||
156573245|NCT04876391|565185720|FG001|Overall Study|Withdrawn as per protocol|2|||
156573246|NCT00900796|565185721|FG000|Phase 1|Lacked sufficient information|4|||
156573247|NCT00900796|565185721|FG000|Phase 1|Missing information at Week 16|7|||
156573248|NCT00900796|565185721|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
156573249|NCT00900796|565185721|FG000|Phase 2|Lost to Follow-up|5|||
156573250|NCT02371629|565185724|FG000|Overall Study|Patient decision|14|||
156573251|NCT02371629|565185725|FG001|Overall Study|Patient decision|10|||
156573252|NCT02371629|565185724|FG000|Overall Study|Adverse Event|8|||
156573253|NCT02371629|565185725|FG001|Overall Study|Adverse Event|8|||
156573254|NCT02371629|565185724|FG000|Overall Study|Physician Decision|2|||
156573255|NCT02371629|565185725|FG001|Overall Study|Physician Decision|3|||
156573256|NCT02371629|565185724|FG000|Overall Study|Death|1|||
156573257|NCT02371629|565185725|FG001|Overall Study|Death|1|||
156573258|NCT02371629|565185724|FG000|Overall Study|Noncompliance with study treatment|1|||
156573259|NCT02371629|565185725|FG001|Overall Study|Noncompliance with study treatment|0|||
156573260|NCT02371629|565185724|FG000|Overall Study|Lack of Efficacy|0|||
156573261|NCT02371629|565185725|FG001|Overall Study|Lack of Efficacy|2|||
156573262|NCT02371629|565185724|FG000|Overall Study|Protocol deviation|0|||
156573263|NCT02371629|565185725|FG001|Overall Study|Protocol deviation|1|||
156573264|NCT03486314|565185726|FG000|Part A|Adverse Event|1|||
156573265|NCT03486314|565185727|FG001|Part A|Adverse Event|0|||
156573266|NCT03486314|565185728|FG002|Part A|Adverse Event|0|||
156573267|NCT03486314|565185726|FG000|Part A|Symptomatic Deterioration|2|||
156573268|NCT03486314|565185727|FG001|Part A|Symptomatic Deterioration|0|||
156573269|NCT03486314|565185728|FG002|Part A|Symptomatic Deterioration|0|||
156573270|NCT00542828|565185733|FG000|Overall Study|Physician Decision|1|||
156573271|NCT00542828|565185733|FG000|Overall Study|Need for Prohibited Treatment|3|||
156573272|NCT00542828|565185733|FG000|Overall Study|Study Prematurely Discontinued|7|||
156573273|NCT00542828|565185733|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
156573274|NCT01364467|565185736|FG000|Overall Study|Lost to Follow-up|1|||
156573275|NCT01364467|565185737|FG001|Overall Study|Lost to Follow-up|2|||
156573276|NCT03228186|565185738|FG000|Overall Study|Patient never started treatment|1|||
156573277|NCT01634243|565185739|FG000|Overall Study|Adverse Event|5|||
156573278|NCT01634243|565185740|FG001|Overall Study|Adverse Event|5|||
156573279|NCT01634243|565185739|FG000|Overall Study|Lack of Efficacy|1|||
156573280|NCT01634243|565185740|FG001|Overall Study|Lack of Efficacy|0|||
156573281|NCT04283461|565185743|FG000|Overall Study|Enrolled in separate trial|0|||
156573282|NCT04283461|565185744|FG001|Overall Study|Enrolled in separate trial|0|||
156573283|NCT04283461|565185745|FG002|Overall Study|Enrolled in separate trial|8|||
156573284|NCT04283461|565185746|FG003|Overall Study|Enrolled in separate trial|13|||
156573285|NCT04283461|565185747|FG004|Overall Study|Enrolled in separate trial|12|||
156573286|NCT04283461|565185748|FG005|Overall Study|Enrolled in separate trial|0|||
156573287|NCT04283461|565185749|FG006|Overall Study|Enrolled in separate trial|0|||
156573288|NCT04283461|565185750|FG007|Overall Study|Enrolled in separate trial|8|||
156573289|NCT04283461|565185751|FG008|Overall Study|Enrolled in separate trial|0|||
156573290|NCT04283461|565185752|FG009|Overall Study|Enrolled in separate trial|0|||
156573291|NCT04283461|565185753|FG010|Overall Study|Enrolled in separate trial|0|||
156573292|NCT04283461|565185754|FG011|Overall Study|Enrolled in separate trial|7|||
156573293|NCT04283461|565185755|FG012|Overall Study|Enrolled in separate trial|0|||
156573294|NCT00258154|565185756|FG000|Overall Study|Adverse Event|1|||
156573295|NCT00258154|565185757|FG001|Overall Study|Adverse Event|0|||
156573296|NCT00258154|565185756|FG000|Overall Study|Lost to Follow-up|0|||
156573297|NCT00258154|565185757|FG001|Overall Study|Lost to Follow-up|1|||
156573298|NCT00258154|565185756|FG000|Overall Study|Protocol Violation|2|||
156573299|NCT00258154|565185757|FG001|Overall Study|Protocol Violation|1|||
156573300|NCT00258154|565185756|FG000|Overall Study|Withdrawal by Subject|3|||
156573301|NCT00258154|565185757|FG001|Overall Study|Withdrawal by Subject|4|||
156573302|NCT00258154|565185756|FG000|Overall Study|Patient Moved|3|||
156573303|NCT00258154|565185757|FG001|Overall Study|Patient Moved|1|||
156573304|NCT05490771|565185758|FG000|Overall Study|Disease progression|18|||
156573305|NCT05490771|565185758|FG000|Overall Study|Adverse Event|3|||
156573306|NCT05490771|565185758|FG000|Overall Study|Other complicating disease|1|||
156573307|NCT05490771|565185758|FG000|Overall Study|Withdrawal by Subject|3|||
156573308|NCT05490771|565185758|FG000|Overall Study|Physician Decision|1|||
156573309|NCT05490771|565185758|FG000|Overall Study|Still on treatment|2|||
156573310|NCT05490771|565185758|FG000|Overall Study|Never start protocol therapy|5|||
156573311|NCT05490771|565185758|FG000|Overall Study|Ineligible|2|||
156573312|NCT02502864|565185766|FG000|Overall Study|Withdrawal by Subject|1|||
156573313|NCT00613626|565185770|FG000|Overall Study|Ineligible|0|||
156573314|NCT00613626|565185771|FG001|Overall Study|Ineligible|1|||
156573315|NCT00613626|565185772|FG002|Overall Study|Ineligible|0|||
156573316|NCT00816036|565185775|FG000|Overall Study|Death|47|||
156573317|NCT00816036|565185776|FG001|Overall Study|Death|28|||
156573318|NCT00816036|565185775|FG000|Overall Study|Lost to Follow-up|75|||
156573319|NCT00816036|565185776|FG001|Overall Study|Lost to Follow-up|57|||
156573320|NCT00816036|565185775|FG000|Overall Study|Withdrawal by Subject|54|||
156573321|NCT00816036|565185776|FG001|Overall Study|Withdrawal by Subject|23|||
156573322|NCT01299025|565185777|FG000|Overall Study|Withdrawal by Subject|2|||
156573323|NCT01299025|565185778|FG001|Overall Study|Withdrawal by Subject|1|||
156573324|NCT01299025|565185777|FG000|Overall Study|Lost to Follow-up|1|||
156573325|NCT01299025|565185778|FG001|Overall Study|Lost to Follow-up|0|||
156573326|NCT00004980|565185779|FG000|Overall Study|Withdrawal by Subject|1|||
156573327|NCT00004980|565185780|FG001|Overall Study|Withdrawal by Subject|0|||
156573328|NCT00004980|565185779|FG000|Overall Study|memory difficulties|1|||
156573329|NCT00004980|565185780|FG001|Overall Study|memory difficulties|1|||
156573330|NCT00004980|565185779|FG000|Overall Study|Physician Decision|0|||
156573331|NCT00004980|565185780|FG001|Overall Study|Physician Decision|1|||
156573332|NCT01624194|565185781|FG000|Overall Study|Lost to Follow-up|1|||
156573333|NCT01624194|565185782|FG001|Overall Study|Lost to Follow-up|0|||
156573334|NCT01624194|565185781|FG000|Overall Study|Withdrawal by Subject|1|||
156573335|NCT01624194|565185782|FG001|Overall Study|Withdrawal by Subject|0|||
156573336|NCT03212261|565185783|FG000|Overall Study|Became ineligible d/t tech|2|||
156573337|NCT03212261|565185783|FG000|Overall Study|Tech Trouble- No first study visit|1|||
156573338|NCT03212261|565185783|FG000|Overall Study|Lost to Follow-up|7|||
156573339|NCT03212261|565185783|FG000|Overall Study|Family Emergency|1|||
156573340|NCT03212261|565185783|FG000|Overall Study|Too busy/ No time|5|||
156573341|NCT05480514|565185784|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
156573342|NCT05480514|565185785|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
156573343|NCT05480514|565185784|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
156573344|NCT05480514|565185785|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
156573345|NCT05480514|565185784|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156573346|NCT05480514|565185785|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
156573347|NCT05480514|565185784|FG000|Period 1|Covid-19 Related|1|||
156573348|NCT05480514|565185785|FG001|Period 1|Covid-19 Related|0|||
156573349|NCT05480514|565185784|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
156573350|NCT05480514|565185785|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
156573351|NCT00184054|565185789|FG000|Overall Study|Adverse Event|1|||
156573352|NCT02296840|565185790|FG000|Overall Study|Adverse Event|1|||
156573353|NCT02296840|565185791|FG001|Overall Study|Adverse Event|1|||
156573354|NCT02296840|565185790|FG000|Overall Study|Protocol Violation|2|||
156573355|NCT02296840|565185791|FG001|Overall Study|Protocol Violation|1|||
156573356|NCT02296840|565185790|FG000|Overall Study|Lost to Follow-up|6|||
156573357|NCT02296840|565185791|FG001|Overall Study|Lost to Follow-up|17|||
156573358|NCT02485717|565185792|FG000|Overall Study|Lost to Follow-up|6|||
156573359|NCT02485717|565185793|FG001|Overall Study|Lost to Follow-up|0|||
156573360|NCT02485717|565185794|FG002|Overall Study|Lost to Follow-up|0|||
156573361|NCT02485717|565185792|FG000|Overall Study|Withdrawal by Subject|0|||
156573362|NCT02485717|565185793|FG001|Overall Study|Withdrawal by Subject|0|||
156573363|NCT02485717|565185794|FG002|Overall Study|Withdrawal by Subject|1|||
156573364|NCT02485717|565185792|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
156573365|NCT02485717|565185793|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
156573366|NCT02485717|565185794|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
156573367|NCT02485717|565185792|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
156573368|NCT02485717|565185793|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
156573369|NCT02485717|565185794|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
156573370|NCT02827877|565185795|FG000|Overall Study|Withdrawal by Subject|1|||
156573371|NCT00814710|565185798|FG000|Overall Study|Adverse Event|1|||
156573372|NCT00814710|565185799|FG001|Overall Study|Adverse Event|0|||
156573373|NCT00814710|565185798|FG000|Overall Study|Lost to Follow-up|7|||
156573374|NCT00814710|565185799|FG001|Overall Study|Lost to Follow-up|3|||
156573375|NCT03885284|565185800|FG000|Overall Study|Disease Progression|1|||
156573376|NCT03885284|565185801|FG001|Overall Study|Disease Progression|3|||
156573377|NCT03885284|565185800|FG000|Overall Study|Physician Decision|0|||
156573378|NCT03885284|565185801|FG001|Overall Study|Physician Decision|1|||
156573379|NCT00002850|565185802|FG000|Overall Study|Death|4|||
156573380|NCT00002850|565185803|FG001|Overall Study|Death|1|||
156573381|NCT00002850|565185804|FG002|Overall Study|Death|3|||
156573382|NCT00002850|565185802|FG000|Overall Study|Protocol Violation|1|||
156573383|NCT00002850|565185803|FG001|Overall Study|Protocol Violation|0|||
156573384|NCT00002850|565185804|FG002|Overall Study|Protocol Violation|1|||
156573385|NCT00002850|565185802|FG000|Overall Study|Withdrawal by Subject|0|||
156573386|NCT00002850|565185803|FG001|Overall Study|Withdrawal by Subject|1|||
156573387|NCT00002850|565185804|FG002|Overall Study|Withdrawal by Subject|0|||
156573388|NCT04090164|565185805|FG000|Overall Study|incomplete data on file|245|||
156573389|NCT04090164|565185806|FG001|Overall Study|incomplete data on file|0|||
156573390|NCT02452359|565185809|FG000|Overall Study|Adverse Event|1|||
156573391|NCT02452359|565185809|FG000|Overall Study|Lost to Follow-up|15|||
156573392|NCT02452359|565185809|FG000|Overall Study|Pregnancy|1|||
156573393|NCT02452359|565185809|FG000|Overall Study|Withdrawal by Subject|4|||
156573394|NCT03414359|565185810|FG000|Overall Study|Lack of Efficacy|1|||
156573395|NCT03414359|565185811|FG001|Overall Study|Lack of Efficacy|1|||
156573396|NCT03414359|565185810|FG000|Overall Study|Protocol Violation|0|||
156573397|NCT03414359|565185811|FG001|Overall Study|Protocol Violation|1|||
156573398|NCT03439345|565187283|FG000|Overall Study|Lost to Follow-up|0|||
156573399|NCT03439345|565187284|FG001|Overall Study|Lost to Follow-up|1|||
156573400|NCT03439345|565187283|FG000|Overall Study|Consent withdrawn|0|||
156573401|NCT03439345|565187284|FG001|Overall Study|Consent withdrawn|1|||
156573402|NCT05405166|565187285|FG000|Overall Study|Death|49|||
156573403|NCT05405166|565187286|FG001|Overall Study|Death|50|||
156573404|NCT05405166|565187285|FG000|Overall Study|Withdrawal by Subject|10|||
156573405|NCT05405166|565187286|FG001|Overall Study|Withdrawal by Subject|3|||
156573406|NCT05405166|565187285|FG000|Overall Study|Ongoing at the time of PCD|209|||
156573407|NCT05405166|565187286|FG001|Overall Study|Ongoing at the time of PCD|210|||
156573408|NCT01386385|565187287|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
156573409|NCT01386385|565187288|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
156573410|NCT01386385|565187289|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
156573411|NCT01386385|565187290|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
156573412|NCT01386385|565187291|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
156573413|NCT01386385|565187292|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
156573414|NCT01386385|565187293|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
156573415|NCT01386385|565187294|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
156573416|NCT01386385|565187287|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
156573417|NCT01386385|565187288|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
156573418|NCT01386385|565187289|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
156573419|NCT01386385|565187290|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
156573420|NCT01386385|565187291|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
156573421|NCT01386385|565187292|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
156573422|NCT01386385|565187293|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
156573423|NCT01386385|565187294|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
156573424|NCT01386385|565187287|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
156573425|NCT01386385|565187288|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
156573426|NCT01386385|565187289|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
156573427|NCT01386385|565187290|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
156573428|NCT01386385|565187291|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
156573429|NCT01386385|565187292|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
156573430|NCT01386385|565187293|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
156573431|NCT01386385|565187294|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
156573432|NCT01386385|565187287|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
156573433|NCT01386385|565187288|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
156573434|NCT01386385|565187289|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
156573435|NCT01386385|565187290|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
156573436|NCT01386385|565187291|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
156573437|NCT01386385|565187292|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
156573438|NCT01386385|565187293|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
156573439|NCT01386385|565187294|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
156573440|NCT01386385|565187287|FG000|Phase II Concurrent CRT|Adverse Event|0|||
156573441|NCT01386385|565187288|FG001|Phase II Concurrent CRT|Adverse Event|0|||
156573442|NCT01386385|565187289|FG002|Phase II Concurrent CRT|Adverse Event|0|||
156573443|NCT01386385|565187290|FG003|Phase II Concurrent CRT|Adverse Event|0|||
156573444|NCT01386385|565187291|FG004|Phase II Concurrent CRT|Adverse Event|0|||
156573445|NCT01386385|565187292|FG005|Phase II Concurrent CRT|Adverse Event|0|||
156573446|NCT01386385|565187293|FG006|Phase II Concurrent CRT|Adverse Event|3|||
156573447|NCT01386385|565187294|FG007|Phase II Concurrent CRT|Adverse Event|3|||
156573448|NCT01386385|565187287|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
156573449|NCT01386385|565187288|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
156573450|NCT01386385|565187289|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
156573451|NCT01386385|565187290|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
156573452|NCT01386385|565187291|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
156573453|NCT01386385|565187292|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
156573454|NCT01386385|565187293|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
156573455|NCT01386385|565187294|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
156573456|NCT01386385|565187287|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
156573457|NCT01386385|565187288|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
156573458|NCT01386385|565187289|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
156573459|NCT01386385|565187290|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
156573460|NCT01386385|565187291|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
156573461|NCT01386385|565187292|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
156573462|NCT01386385|565187293|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
156573463|NCT01386385|565187294|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
156573464|NCT01386385|565187287|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
156573465|NCT01386385|565187288|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
156573466|NCT01386385|565187289|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
156573467|NCT01386385|565187290|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
156573468|NCT01386385|565187291|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
156573469|NCT01386385|565187292|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
156573470|NCT01386385|565187293|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
156573471|NCT01386385|565187294|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
156573472|NCT01386385|565187287|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
156573473|NCT01386385|565187288|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
156573474|NCT01386385|565187289|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
156573475|NCT01386385|565187290|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
156573476|NCT01386385|565187291|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
156573477|NCT01386385|565187292|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
156573478|NCT01386385|565187293|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
156573479|NCT01386385|565187294|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
156573480|NCT03746080|565187296|FG000|Overall Study|In follow up|2|||
156573481|NCT03746080|565187296|FG000|Overall Study|Death|15|||
156573482|NCT02128490|565187300|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156573483|NCT02128490|565187301|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
156573484|NCT02128490|565187302|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
156573485|NCT02128490|565187303|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
156573486|NCT02128490|565187304|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
156573487|NCT02128490|565187300|FG000|Overall Study|Major Protocol Deviation|1|||
156573488|NCT02128490|565187301|FG001|Overall Study|Major Protocol Deviation|2|||
156573489|NCT02128490|565187302|FG002|Overall Study|Major Protocol Deviation|0|||
156573490|NCT02128490|565187303|FG003|Overall Study|Major Protocol Deviation|2|||
156573491|NCT02128490|565187304|FG004|Overall Study|Major Protocol Deviation|2|||
156573492|NCT02128490|565187300|FG000|Overall Study|Lost to Follow-up|0|||
156573493|NCT02128490|565187301|FG001|Overall Study|Lost to Follow-up|0|||
156573494|NCT02128490|565187302|FG002|Overall Study|Lost to Follow-up|1|||
156573495|NCT02128490|565187303|FG003|Overall Study|Lost to Follow-up|1|||
156573496|NCT02128490|565187304|FG004|Overall Study|Lost to Follow-up|1|||
156573497|NCT02128490|565187300|FG000|Overall Study|Voluntary Withdrawal|3|||
156573498|NCT02128490|565187301|FG001|Overall Study|Voluntary Withdrawal|3|||
156573499|NCT02128490|565187302|FG002|Overall Study|Voluntary Withdrawal|1|||
156573500|NCT02128490|565187303|FG003|Overall Study|Voluntary Withdrawal|1|||
156573501|NCT02128490|565187304|FG004|Overall Study|Voluntary Withdrawal|2|||
156573502|NCT02128490|565187300|FG000|Overall Study|Lack of Efficacy|0|||
156573503|NCT02128490|565187301|FG001|Overall Study|Lack of Efficacy|1|||
156573504|NCT02128490|565187302|FG002|Overall Study|Lack of Efficacy|0|||
156573505|NCT02128490|565187303|FG003|Overall Study|Lack of Efficacy|0|||
156573506|NCT02128490|565187304|FG004|Overall Study|Lack of Efficacy|0|||
156573507|NCT02128490|565187300|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
156573508|NCT02128490|565187301|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
156573509|NCT02128490|565187302|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
156573510|NCT02128490|565187303|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
156573511|NCT02128490|565187304|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
156573512|NCT02128490|565187300|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156573513|NCT02128490|565187301|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156573514|NCT02128490|565187302|FG002|Overall Study|Other Miscellaneous Reasons|2|||
156573515|NCT02128490|565187303|FG003|Overall Study|Other Miscellaneous Reasons|1|||
156573516|NCT02128490|565187304|FG004|Overall Study|Other Miscellaneous Reasons|1|||
156573517|NCT02243176|565187305|FG000|Overall Study|Other reason|1|||
156573518|NCT02243176|565187306|FG001|Overall Study|Other reason|2|||
156573519|NCT02243176|565187305|FG000|Overall Study|protocol specified withdrawal critera|1|||
156573520|NCT02243176|565187306|FG001|Overall Study|protocol specified withdrawal critera|3|||
156573521|NCT02243176|565187305|FG000|Overall Study|Protocol Violation|2|||
156573522|NCT02243176|565187306|FG001|Overall Study|Protocol Violation|1|||
156573523|NCT02243176|565187305|FG000|Overall Study|Withdrawal by Subject|8|||
156573524|NCT02243176|565187306|FG001|Overall Study|Withdrawal by Subject|7|||
156573525|NCT02243176|565187305|FG000|Overall Study|Adverse Event|2|||
156573526|NCT02243176|565187306|FG001|Overall Study|Adverse Event|2|||
156573527|NCT03311126|565187308|FG000|Induction|Death|1|||
156573528|NCT03311126|565187308|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
156573529|NCT03113500|565187309|FG000|Overall Study|Withdrawal by Subject|1|||
156573530|NCT01348919|565187310|FG000|Overall Study|Adverse Event|3|||
156573531|NCT01348919|565187311|FG001|Overall Study|Adverse Event|1|||
156573532|NCT01348919|565187312|FG002|Overall Study|Adverse Event|0|||
156573533|NCT01348919|565187310|FG000|Overall Study|Withdrawal by Subject|0|||
156573534|NCT01348919|565187311|FG001|Overall Study|Withdrawal by Subject|1|||
156573535|NCT01348919|565187312|FG002|Overall Study|Withdrawal by Subject|0|||
156573536|NCT01348919|565187310|FG000|Overall Study|Disease progression|0|||
156573537|NCT01348919|565187311|FG001|Overall Study|Disease progression|1|||
156573538|NCT01348919|565187312|FG002|Overall Study|Disease progression|1|||
156573539|NCT02517515|565187315|FG000|Overall Study|Adverse Event|0|||
156573540|NCT02517515|565187316|FG001|Overall Study|Adverse Event|1|||
156573541|NCT02517515|565187315|FG000|Overall Study|Withdrew Consent|0|||
156573542|NCT02517515|565187316|FG001|Overall Study|Withdrew Consent|1|||
156573543|NCT02517515|565187315|FG000|Overall Study|Lost to Follow-up|1|||
156573544|NCT02517515|565187316|FG001|Overall Study|Lost to Follow-up|0|||
156573545|NCT02517515|565187315|FG000|Overall Study|Other|1|||
156573546|NCT02517515|565187316|FG001|Overall Study|Other|0|||
156573547|NCT06400238|565187319|FG000|Overall Study|Started Protocol Therapy|2|||
156573548|NCT06400238|565187319|FG000|Overall Study|Adverse Event|1|||
156573549|NCT06400238|565187319|FG000|Overall Study|Death|1|||
156573550|NCT06400238|565187319|FG000|Overall Study|Disease Progression|27|||
156573551|NCT06400238|565187319|FG000|Overall Study|Withdrawal by Subject|2|||
156573552|NCT06400238|565187319|FG000|Overall Study|Physician Decision|2|||
156573553|NCT01009463|565187324|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
156573554|NCT01009463|565187325|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
156573555|NCT01009463|565187326|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
156573556|NCT01009463|565187327|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
156573557|NCT01009463|565187328|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
156573558|NCT01009463|565187324|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
156573559|NCT01009463|565187325|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
156573560|NCT01009463|565187326|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
156573561|NCT01009463|565187327|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
156573562|NCT01009463|565187328|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
156573563|NCT01009463|565187324|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
156573564|NCT01009463|565187325|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
156573565|NCT01009463|565187326|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
156573566|NCT01009463|565187327|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
156573567|NCT01009463|565187328|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
156573568|NCT01009463|565187324|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
156573569|NCT01009463|565187325|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
156573570|NCT01009463|565187326|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
156573571|NCT01009463|565187327|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
156573572|NCT01009463|565187328|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
156573573|NCT01009463|565187324|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
156573574|NCT01009463|565187325|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
156573575|NCT01009463|565187326|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
156573576|NCT01009463|565187327|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
156573577|NCT01009463|565187328|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
156573578|NCT01009463|565187324|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
156573579|NCT01009463|565187325|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
156573580|NCT01009463|565187326|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
156573581|NCT01009463|565187327|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
156573582|NCT01009463|565187328|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
156573583|NCT01009463|565187324|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156573584|NCT01009463|565187325|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
156573585|NCT01009463|565187326|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
156573586|NCT01009463|565187327|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
156573587|NCT01009463|565187328|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
156573588|NCT01009463|565187324|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
156573589|NCT01009463|565187325|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
156573590|NCT01009463|565187326|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
156573591|NCT01009463|565187327|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
156573592|NCT01009463|565187328|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
156573593|NCT01009463|565187324|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
156573594|NCT01009463|565187325|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
156573595|NCT01009463|565187326|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
156573596|NCT01009463|565187327|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
156573597|NCT01009463|565187328|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
156573598|NCT01009463|565187324|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
156573599|NCT01009463|565187325|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
156573600|NCT01009463|565187326|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
156573601|NCT01009463|565187327|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
156573602|NCT01009463|565187328|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
156573603|NCT01009463|565187324|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
156573604|NCT01009463|565187325|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
156573605|NCT01009463|565187326|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
156573606|NCT01009463|565187327|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
156573607|NCT01009463|565187328|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
156573608|NCT01009463|565187324|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156573609|NCT01009463|565187325|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
156573610|NCT01009463|565187326|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
156573611|NCT01009463|565187327|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
156573612|NCT01009463|565187328|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
156573613|NCT01009463|565187324|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
156573614|NCT01009463|565187325|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
156573615|NCT01009463|565187326|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
156573616|NCT01009463|565187327|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
156573617|NCT01009463|565187328|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
156573618|NCT04430348|565187331|FG000|Overall Study|Death|3|||
156573619|NCT04430348|565187332|FG001|Overall Study|Death|2|||
156573620|NCT04430348|565187333|FG002|Overall Study|Death|2|||
156573621|NCT04430348|565187334|FG003|Overall Study|Death|2|||
156573622|NCT04430348|565187335|FG004|Overall Study|Death|2|||
156573623|NCT04430348|565187336|FG005|Overall Study|Death|3|||
156573624|NCT04430348|565187331|FG000|Overall Study|Lost to Follow-up|0|||
156573625|NCT04430348|565187332|FG001|Overall Study|Lost to Follow-up|0|||
156573626|NCT04430348|565187333|FG002|Overall Study|Lost to Follow-up|0|||
156573627|NCT04430348|565187334|FG003|Overall Study|Lost to Follow-up|1|||
156573628|NCT04430348|565187335|FG004|Overall Study|Lost to Follow-up|0|||
156573629|NCT04430348|565187336|FG005|Overall Study|Lost to Follow-up|0|||
156573630|NCT04430348|565187331|FG000|Overall Study|Adverse Event|0|||
156573631|NCT04430348|565187332|FG001|Overall Study|Adverse Event|0|||
156573632|NCT04430348|565187333|FG002|Overall Study|Adverse Event|0|||
156573633|NCT04430348|565187334|FG003|Overall Study|Adverse Event|0|||
156573634|NCT04430348|565187335|FG004|Overall Study|Adverse Event|0|||
156573635|NCT04430348|565187336|FG005|Overall Study|Adverse Event|1|||
156573636|NCT04430348|565187331|FG000|Overall Study|Withdrawal by Subject|0|||
156573637|NCT04430348|565187332|FG001|Overall Study|Withdrawal by Subject|1|||
156573638|NCT04430348|565187333|FG002|Overall Study|Withdrawal by Subject|0|||
156573639|NCT04430348|565187334|FG003|Overall Study|Withdrawal by Subject|0|||
156573640|NCT04430348|565187335|FG004|Overall Study|Withdrawal by Subject|0|||
156573641|NCT04430348|565187336|FG005|Overall Study|Withdrawal by Subject|1|||
156573642|NCT04430348|565187331|FG000|Overall Study|Study Terminated by Sponsor|0|||
156573643|NCT04430348|565187332|FG001|Overall Study|Study Terminated by Sponsor|0|||
156573644|NCT04430348|565187333|FG002|Overall Study|Study Terminated by Sponsor|2|||
156573645|NCT04430348|565187334|FG003|Overall Study|Study Terminated by Sponsor|0|||
156573646|NCT04430348|565187335|FG004|Overall Study|Study Terminated by Sponsor|1|||
156573647|NCT04430348|565187336|FG005|Overall Study|Study Terminated by Sponsor|1|||
156573648|NCT03839524|565187339|FG000|Overall Study|Adverse Event|1|||
156573649|NCT04419506|565187346|FG000|Overall Study|Adverse Event|0|||
156573650|NCT04419506|565187347|FG001|Overall Study|Adverse Event|10|||
156573651|NCT04419506|565187348|FG002|Overall Study|Adverse Event|0|||
156573652|NCT04419506|565187349|FG003|Overall Study|Adverse Event|3|||
156573653|NCT04419506|565187346|FG000|Overall Study|Withdrawal by Subject|0|||
156573654|NCT04419506|565187347|FG001|Overall Study|Withdrawal by Subject|0|||
156573655|NCT04419506|565187348|FG002|Overall Study|Withdrawal by Subject|0|||
156573656|NCT04419506|565187349|FG003|Overall Study|Withdrawal by Subject|1|||
156573657|NCT04419506|565187346|FG000|Overall Study|poor-compliance|0|||
156573658|NCT04419506|565187347|FG001|Overall Study|poor-compliance|0|||
156573659|NCT04419506|565187348|FG002|Overall Study|poor-compliance|0|||
156573660|NCT04419506|565187349|FG003|Overall Study|poor-compliance|1|||
156573661|NCT04329949|565187350|FG000|Overall Study|Death|36|||
156573662|NCT04329949|565187350|FG000|Overall Study|Withdrawal by Subject|4|||
156573663|NCT04329949|565187350|FG000|Overall Study|Termination of study by sponsor|3|||
156573664|NCT02037919|565187351|FG000|Overall Study|Lost to Follow-up|30|||
156573665|NCT02037919|565187352|FG001|Overall Study|Lost to Follow-up|45|||
156573666|NCT00917384|565187355|FG000|Overall Study|Lost to Follow-up|4|||
156573667|NCT00917384|565187356|FG001|Overall Study|Lost to Follow-up|2|||
156573668|NCT00917384|565187355|FG000|Overall Study|Withdrawal by Subject|10|||
156573669|NCT00917384|565187356|FG001|Overall Study|Withdrawal by Subject|2|||
156573670|NCT03717922|565187359|FG000|Overall Study|Lost to Follow-up|2|||
156573671|NCT03717922|565187360|FG001|Overall Study|Lost to Follow-up|2|||
156573672|NCT01458340|565187361|FG000|Overall Study|Adverse Event|5|||
156573673|NCT01458340|565187362|FG001|Overall Study|Adverse Event|4|||
156573674|NCT01458340|565187363|FG002|Overall Study|Adverse Event|2|||
156573675|NCT01458340|565187361|FG000|Overall Study|Lost to Follow-up|3|||
156573676|NCT01458340|565187362|FG001|Overall Study|Lost to Follow-up|3|||
156573677|NCT01458340|565187363|FG002|Overall Study|Lost to Follow-up|10|||
156573678|NCT01458340|565187361|FG000|Overall Study|Miscellaneous|0|||
156573679|NCT01458340|565187362|FG001|Overall Study|Miscellaneous|1|||
156573680|NCT01458340|565187363|FG002|Overall Study|Miscellaneous|0|||
156573681|NCT01458340|565187361|FG000|Overall Study|Physician Decision|1|||
156573682|NCT01458340|565187362|FG001|Overall Study|Physician Decision|1|||
156573683|NCT01458340|565187363|FG002|Overall Study|Physician Decision|2|||
156573684|NCT01458340|565187361|FG000|Overall Study|Protocol Violation|6|||
156573685|NCT01458340|565187362|FG001|Overall Study|Protocol Violation|6|||
156573686|NCT01458340|565187363|FG002|Overall Study|Protocol Violation|5|||
156573687|NCT01458340|565187361|FG000|Overall Study|Withdrawal by Subject|12|||
156573688|NCT01458340|565187362|FG001|Overall Study|Withdrawal by Subject|6|||
156573689|NCT01458340|565187363|FG002|Overall Study|Withdrawal by Subject|4|||
156573690|NCT03126227|565187364|FG000|Overall Study|Adverse Event|43|||
156573691|NCT03126227|565187365|FG001|Overall Study|Adverse Event|4|||
156573692|NCT03126227|565187364|FG000|Overall Study|Death|0|||
156573693|NCT03126227|565187365|FG001|Overall Study|Death|1|||
156573694|NCT03126227|565187364|FG000|Overall Study|Lost to Follow-up|0|||
156573695|NCT03126227|565187365|FG001|Overall Study|Lost to Follow-up|1|||
156573696|NCT03126227|565187364|FG000|Overall Study|Physician Decision|2|||
156573697|NCT03126227|565187365|FG001|Overall Study|Physician Decision|0|||
156573698|NCT03126227|565187364|FG000|Overall Study|Protocol Violation|1|||
156573699|NCT03126227|565187365|FG001|Overall Study|Protocol Violation|0|||
156573700|NCT03126227|565187364|FG000|Overall Study|Withdrawal by Subject|19|||
156573701|NCT03126227|565187365|FG001|Overall Study|Withdrawal by Subject|3|||
156573702|NCT03126227|565187364|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
156573703|NCT03126227|565187365|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
156573704|NCT03126227|565187364|FG000|Overall Study|Lack of dosing compliance|2|||
156573705|NCT03126227|565187365|FG001|Overall Study|Lack of dosing compliance|0|||
156573706|NCT03126227|565187364|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
156573707|NCT03126227|565187365|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
156573708|NCT03126227|565187364|FG000|Overall Study|Scheduling conflict|1|||
156573709|NCT03126227|565187365|FG001|Overall Study|Scheduling conflict|0|||
156573710|NCT01021007|565187368|FG000|Overall Study|Lost to Follow-up|1|||
156573711|NCT01021007|565187369|FG001|Overall Study|Lost to Follow-up|1|||
156573712|NCT01021007|565187368|FG000|Overall Study|Adverse Event|1|||
156573713|NCT01021007|565187369|FG001|Overall Study|Adverse Event|3|||
156573714|NCT03293030|565187372|FG000|Overall Study|Withdrawal by Subject|3|||
156573715|NCT04899271|565187373|FG000|Overall Study|Lost to Follow-up|1|||
156573716|NCT04899271|565187374|FG001|Overall Study|Lost to Follow-up|0|||
156573717|NCT04899271|565187373|FG000|Overall Study|Subject request/consent withdrawal|2|||
156573718|NCT04899271|565187374|FG001|Overall Study|Subject request/consent withdrawal|0|||
156573719|NCT02318602|565187379|FG000|Overall Study|Adverse Event|0|||
156573720|NCT02318602|565187380|FG001|Overall Study|Adverse Event|1|||
156573721|NCT02318602|565187381|FG002|Overall Study|Adverse Event|1|||
156573722|NCT02318602|565187379|FG000|Overall Study|Withdrawal by Subject|0|||
156573723|NCT02318602|565187380|FG001|Overall Study|Withdrawal by Subject|3|||
156573724|NCT02318602|565187381|FG002|Overall Study|Withdrawal by Subject|0|||
156573725|NCT02318602|565187379|FG000|Overall Study|Death|1|||
156573726|NCT02318602|565187380|FG001|Overall Study|Death|0|||
156573727|NCT02318602|565187381|FG002|Overall Study|Death|0|||
156573728|NCT02318602|565187379|FG000|Overall Study|Guardian decision to withdraw|0|||
156573729|NCT02318602|565187380|FG001|Overall Study|Guardian decision to withdraw|0|||
156573730|NCT02318602|565187381|FG002|Overall Study|Guardian decision to withdraw|1|||
156573731|NCT01193335|565187385|FG000|After Infant Series|Lost to Follow-up|1|||
156573732|NCT01193335|565187386|FG001|After Infant Series|Lost to Follow-up|2|||
156573733|NCT01193335|565187385|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
156573734|NCT01193335|565187386|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
156573735|NCT01193335|565187385|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
156573736|NCT01193335|565187386|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
156573737|NCT01193335|565187385|FG000|1-Year Follow-up|Lost to Follow-up|4|||
156573738|NCT01193335|565187386|FG001|1-Year Follow-up|Lost to Follow-up|0|||
156573739|NCT01193335|565187385|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
156573740|NCT01193335|565187386|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
156573741|NCT01193335|565187385|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
156573742|NCT01193335|565187386|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
156573743|NCT01733329|565187387|FG000|Overall Study|Protocol Violation|1|||
156573744|NCT01733329|565187388|FG001|Overall Study|Protocol Violation|1|||
156573745|NCT01733329|565187387|FG000|Overall Study|Uterine artery injury|1|||
156573746|NCT01733329|565187388|FG001|Overall Study|Uterine artery injury|0|||
156573747|NCT00095303|565187389|FG000|Main Study|Lost to Follow-up|91|||
156573748|NCT00095303|565187390|FG001|Main Study|Lost to Follow-up|87|||
156573749|NCT00095303|565187389|FG000|Follow Up Study|Lost to Follow-up|59|||
156573750|NCT00095303|565187390|FG001|Follow Up Study|Lost to Follow-up|58|||
156573751|NCT03953118|565187391|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
156573752|NCT03953118|565187392|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
156573753|NCT05139030|565187395|FG000|Overall Study|Withdrawal by Subject|1|||
156573754|NCT05139030|565187396|FG001|Overall Study|Withdrawal by Subject|3|||
156573755|NCT05139030|565187395|FG000|Overall Study|Adverse Event|0|||
156573756|NCT05139030|565187396|FG001|Overall Study|Adverse Event|1|||
156573757|NCT05139030|565187395|FG000|Overall Study|Failure to meet continuation criteria|0|||
156573758|NCT05139030|565187396|FG001|Overall Study|Failure to meet continuation criteria|1|||
156573759|NCT03772327|565187397|FG000|Overall Study|Lost to Follow-up|3|||
156573760|NCT03772327|565187398|FG001|Overall Study|Lost to Follow-up|4|||
156573761|NCT03772327|565187397|FG000|Overall Study|Withdrawal by Subject|2|||
156573762|NCT03772327|565187398|FG001|Overall Study|Withdrawal by Subject|3|||
156573763|NCT00820040|565187401|FG000|Overall Study|Death|1|||
156573764|NCT00820040|565187401|FG000|Overall Study|Sponsor terminated study|1|||
156573765|NCT00820040|565187401|FG000|Overall Study|Screen failure|1|||
156573766|NCT01259466|565187406|FG000|Overall Study|Withdrawal by Subject|1|||
156573767|NCT01259466|565187407|FG001|Overall Study|Withdrawal by Subject|9|||
156573768|NCT01824602|565187412|FG000|Overall Study|Withdrawal by Subject|0|||
156573769|NCT01824602|565187413|FG001|Overall Study|Withdrawal by Subject|0|||
156573770|NCT01824602|565187414|FG002|Overall Study|Withdrawal by Subject|1|||
156573771|NCT01824602|565187415|FG003|Overall Study|Withdrawal by Subject|2|||
156573772|NCT01824602|565187412|FG000|Overall Study|Patient non-compliance|0|||
156573773|NCT01824602|565187413|FG001|Overall Study|Patient non-compliance|0|||
156573774|NCT01824602|565187414|FG002|Overall Study|Patient non-compliance|1|||
156573775|NCT01824602|565187415|FG003|Overall Study|Patient non-compliance|0|||
156573776|NCT01824602|565187412|FG000|Overall Study|Adverse Event|1|||
156573777|NCT01824602|565187413|FG001|Overall Study|Adverse Event|0|||
156573778|NCT01824602|565187414|FG002|Overall Study|Adverse Event|2|||
156573779|NCT01824602|565187415|FG003|Overall Study|Adverse Event|2|||
156573780|NCT01824602|565187412|FG000|Overall Study|Treatment failure|0|||
156573781|NCT01824602|565187413|FG001|Overall Study|Treatment failure|0|||
156573782|NCT01824602|565187414|FG002|Overall Study|Treatment failure|0|||
156573783|NCT01824602|565187415|FG003|Overall Study|Treatment failure|1|||
156573784|NCT01450540|565187418|FG000|Overall Study|Withdrawal by Subject|19|||
156573785|NCT01450540|565187419|FG001|Overall Study|Withdrawal by Subject|13|||
156573786|NCT01450540|565187418|FG000|Overall Study|protocol deviation|3|||
156573787|NCT01450540|565187419|FG001|Overall Study|protocol deviation|23|||
156573788|NCT01887210|565187423|FG000|Overall Study|Withdrawal by Subject|1|||
156573789|NCT01887210|565187424|FG001|Overall Study|Withdrawal by Subject|3|||
156573790|NCT01887210|565187423|FG000|Overall Study|Lost to Follow-up|0|||
156573791|NCT01887210|565187424|FG001|Overall Study|Lost to Follow-up|1|||
156573792|NCT00840463|565187425|FG000|Overall Study|Adverse Event|1|||
156573793|NCT00840463|565187426|FG001|Overall Study|Adverse Event|0|||
156573794|NCT00957372|565187433|FG000|PART I|Lost to Follow-up|0|||
156573795|NCT00957372|565187434|FG001|PART I|Lost to Follow-up|0|||
156573796|NCT00957372|565187435|FG002|PART I|Lost to Follow-up|1|||
156573797|NCT00957372|565187436|FG003|PART I|Lost to Follow-up|0|||
156573798|NCT00957372|565187433|FG000|PART II|Withdrawal by Subject|0|||
156573799|NCT00957372|565187434|FG001|PART II|Withdrawal by Subject|0|||
156573800|NCT00957372|565187435|FG002|PART II|Withdrawal by Subject|0|||
156573801|NCT00957372|565187436|FG003|PART II|Withdrawal by Subject|8|||
156573802|NCT00957372|565187433|FG000|PART II|Physician Decision|0|||
156573803|NCT00957372|565187434|FG001|PART II|Physician Decision|0|||
156573804|NCT00957372|565187435|FG002|PART II|Physician Decision|0|||
156573805|NCT00957372|565187436|FG003|PART II|Physician Decision|1|||
156573806|NCT00957372|565187433|FG000|PART II|Pregnancy|0|||
156573807|NCT00957372|565187434|FG001|PART II|Pregnancy|0|||
156573808|NCT00957372|565187435|FG002|PART II|Pregnancy|0|||
156573809|NCT00957372|565187436|FG003|PART II|Pregnancy|1|||
156573810|NCT00957372|565187433|FG000|PART II|Not Know|0|||
156573811|NCT00957372|565187434|FG001|PART II|Not Know|0|||
156573812|NCT00957372|565187435|FG002|PART II|Not Know|0|||
156573813|NCT00957372|565187436|FG003|PART II|Not Know|20|||
156573814|NCT00957372|565187433|FG000|PART II|Adverse Event|0|||
156573815|NCT00957372|565187434|FG001|PART II|Adverse Event|0|||
156573816|NCT00957372|565187435|FG002|PART II|Adverse Event|0|||
156573817|NCT00957372|565187436|FG003|PART II|Adverse Event|10|||
156573818|NCT00957372|565187433|FG000|PART II|Patient non-compliance|0|||
156573819|NCT00957372|565187434|FG001|PART II|Patient non-compliance|0|||
156573820|NCT00957372|565187435|FG002|PART II|Patient non-compliance|0|||
156573821|NCT00957372|565187436|FG003|PART II|Patient non-compliance|4|||
156573822|NCT01444391|565187439|FG000|Overall Study|Death|1|||
156573823|NCT00630032|565187442|FG000|Overall Study|Death|55|||
156573824|NCT00630032|565187443|FG001|Overall Study|Death|49|||
156573825|NCT00630032|565187442|FG000|Overall Study|Withdrawal by Subject|3|||
156573826|NCT00630032|565187443|FG001|Overall Study|Withdrawal by Subject|2|||
156573827|NCT00630032|565187442|FG000|Overall Study|Lost to Follow-up|18|||
156573828|NCT00630032|565187443|FG001|Overall Study|Lost to Follow-up|31|||
156573829|NCT00630032|565187442|FG000|Overall Study|Protocol Violation|1|||
156573830|NCT00630032|565187443|FG001|Overall Study|Protocol Violation|0|||
156573831|NCT00630032|565187442|FG000|Overall Study|Patient has moved|1|||
156573832|NCT00630032|565187443|FG001|Overall Study|Patient has moved|1|||
156573833|NCT00630032|565187442|FG000|Overall Study|Disease progression|1|||
156573834|NCT00630032|565187443|FG001|Overall Study|Disease progression|1|||
156573835|NCT00630032|565187442|FG000|Overall Study|End of monitoring in US centers|11|||
156573836|NCT00630032|565187443|FG001|Overall Study|End of monitoring in US centers|11|||
156573837|NCT02332915|565187444|FG000|Overall Study|Moved out of region|3|||
156573838|NCT02332915|565187445|FG001|Overall Study|Moved out of region|0|||
156573839|NCT02332915|565187444|FG000|Overall Study|Unrelated illness|1|||
156573840|NCT02332915|565187445|FG001|Overall Study|Unrelated illness|1|||
156573841|NCT02332915|565187444|FG000|Overall Study|Travel distance prohibitive|0|||
156573842|NCT02332915|565187445|FG001|Overall Study|Travel distance prohibitive|1|||
156573843|NCT02332915|565187444|FG000|Overall Study|did not meet inclusion criteria|2|||
156573844|NCT02332915|565187445|FG001|Overall Study|did not meet inclusion criteria|4|||
156573845|NCT01901328|565187446|FG000|Overall Study|Lost to Follow-up|1|||
156573846|NCT01901328|565187447|FG001|Overall Study|Lost to Follow-up|0|||
156573847|NCT01901328|565187446|FG000|Overall Study|Physician Decision|0|||
156573848|NCT01901328|565187447|FG001|Overall Study|Physician Decision|1|||
156573849|NCT01901328|565187446|FG000|Overall Study|Protocol Violation|1|||
156573850|NCT01901328|565187447|FG001|Overall Study|Protocol Violation|1|||
156573851|NCT01901328|565187446|FG000|Overall Study|Study Terminated by Sponsor|19|||
156573852|NCT01901328|565187447|FG001|Overall Study|Study Terminated by Sponsor|16|||
156573853|NCT01901328|565187446|FG000|Overall Study|Withdrawal by Subject|1|||
156573854|NCT01901328|565187447|FG001|Overall Study|Withdrawal by Subject|2|||
156573855|NCT01901328|565187446|FG000|Overall Study|Lack of Efficacy|0|||
156573856|NCT01901328|565187447|FG001|Overall Study|Lack of Efficacy|1|||
156573857|NCT02462889|565187448|FG000|Overall Study|Withdrawal by Subject|2|||
156573858|NCT02462889|565187449|FG001|Overall Study|Withdrawal by Subject|6|||
156573859|NCT02462889|565187448|FG000|Overall Study|Death|1|||
156573860|NCT02462889|565187449|FG001|Overall Study|Death|5|||
156573861|NCT01575548|565188740|FG000|Overall Study|Adverse Event|15|||
156573862|NCT01575548|565188741|FG001|Overall Study|Adverse Event|2|||
156573863|NCT01575548|565188740|FG000|Overall Study|Disease progression|12|||
156573864|NCT01575548|565188741|FG001|Overall Study|Disease progression|25|||
156573865|NCT01575548|565188740|FG000|Overall Study|Death|1|||
156573866|NCT01575548|565188741|FG001|Overall Study|Death|0|||
156573867|NCT01575548|565188740|FG000|Overall Study|Other complicating disease|1|||
156573868|NCT01575548|565188741|FG001|Overall Study|Other complicating disease|0|||
156573869|NCT01575548|565188740|FG000|Overall Study|Withdrawal by Subject|7|||
156573870|NCT01575548|565188741|FG001|Overall Study|Withdrawal by Subject|3|||
156573871|NCT01575548|565188740|FG000|Overall Study|Noncompliance|1|||
156573872|NCT01575548|565188741|FG001|Overall Study|Noncompliance|0|||
156573873|NCT01575548|565188740|FG000|Overall Study|Anticipated surgery|0|||
156573874|NCT01575548|565188741|FG001|Overall Study|Anticipated surgery|1|||
156573875|NCT01575548|565188740|FG000|Overall Study|Never started protocol therapy|3|||
156573876|NCT01575548|565188741|FG001|Overall Study|Never started protocol therapy|2|||
156573877|NCT00693706|565188744|FG000|Overall Study|Protocol Violation|0|||
156573878|NCT00693706|565188745|FG001|Overall Study|Protocol Violation|1|||
156573879|NCT02498652|565188746|FG000|Overall Study|Protocol Violation|0|||
156573880|NCT02498652|565188747|FG001|Overall Study|Protocol Violation|1|||
156573881|NCT00730236|565188748|FG000|Overall Study|Adverse Event|4|||
156573882|NCT00730236|565188748|FG000|Overall Study|Withdrawal by Subject|1|||
156573883|NCT00730236|565188748|FG000|Overall Study|Non-compliance|1|||
156573884|NCT01184989|565188754|FG000|Overall Study|Adverse Event|11|||
156573885|NCT01184989|565188754|FG000|Overall Study|Withdrawal by Subject|1|||
156573886|NCT00465569|565188755|FG000|Overall Study|persistent eczema during dose escalation|1|||
156573887|NCT00465569|565188756|FG001|Overall Study|persistent eczema during dose escalation|0|||
156573888|NCT01985321|565188758|FG000|Overall Study|Protocol Violation|4|||
156573889|NCT01985321|565188759|FG001|Overall Study|Protocol Violation|3|||
156573890|NCT01985321|565188758|FG000|Overall Study|Withdrawal by Subject|1|||
156573891|NCT01985321|565188759|FG001|Overall Study|Withdrawal by Subject|0|||
156573892|NCT01985321|565188758|FG000|Overall Study|Lost to Follow-up|5|||
156573893|NCT01985321|565188759|FG001|Overall Study|Lost to Follow-up|2|||
156573894|NCT01985321|565188758|FG000|Overall Study|Subject treated wrong type of sore|1|||
156573895|NCT01985321|565188759|FG001|Overall Study|Subject treated wrong type of sore|0|||
156573896|NCT00482001|565188760|FG000|Overall Study|Protocol Violation|1|||
156573897|NCT00482001|565188761|FG001|Overall Study|Protocol Violation|1|||
156573898|NCT02388776|565188762|FG000|Overall Study|Death|1|||
156573899|NCT02388776|565188762|FG000|Overall Study|Lost to Follow-up|1|||
156573900|NCT04786210|565188763|FG000|Overall Study|Lost to Follow-up|2|||
156573901|NCT04786210|565188763|FG000|Overall Study|Withdrawal by Subject|4|||
156573902|NCT03826914|565188764|FG000|Overall Study|Withdrawal by Subject|1|||
156573903|NCT03826914|565188765|FG001|Overall Study|Withdrawal by Subject|1|||
156573904|NCT04334148|565188767|FG000|Overall Study|positive nasal swab at baseline|0|||
156573905|NCT04334148|565188768|FG001|Overall Study|positive nasal swab at baseline|1|||
156573906|NCT05370157|565188771|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
156573907|NCT05370157|565188772|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
156573908|NCT05370157|565188771|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
156573909|NCT05370157|565188772|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
156573910|NCT01508676|565188773|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
156573911|NCT01508676|565188774|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
156573912|NCT01508676|565188773|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
156573913|NCT01508676|565188774|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
156573914|NCT01508676|565188773|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
156573915|NCT01508676|565188774|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
156573916|NCT01508676|565188773|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
156573917|NCT01508676|565188774|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
156573918|NCT01508676|565188773|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
156573919|NCT01508676|565188774|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
156573920|NCT00498173|565188775|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
156573921|NCT00498173|565188776|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
156573922|NCT00498173|565188777|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
156573923|NCT04689828|565188778|FG000|Overall Study|Subject decision|5|||
156573924|NCT04689828|565188779|FG001|Overall Study|Subject decision|5|||
156573925|NCT04689828|565188778|FG000|Overall Study|Adverse Event|12|||
156573926|NCT04689828|565188779|FG001|Overall Study|Adverse Event|12|||
156573927|NCT04689828|565188778|FG000|Overall Study|Physician Decision|24|||
156573928|NCT04689828|565188779|FG001|Overall Study|Physician Decision|32|||
156573929|NCT04689828|565188778|FG000|Overall Study|Progressive disease|54|||
156573930|NCT04689828|565188779|FG001|Overall Study|Progressive disease|173|||
156573931|NCT04689828|565188778|FG000|Overall Study|Death|0|||
156573932|NCT04689828|565188779|FG001|Overall Study|Death|1|||
156573933|NCT04689828|565188778|FG000|Overall Study|Lost to Follow-up|1|||
156573934|NCT04689828|565188779|FG001|Overall Study|Lost to Follow-up|0|||
156573935|NCT04689828|565188778|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
156573936|NCT04689828|565188779|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
156573937|NCT04689828|565188778|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
156573938|NCT04689828|565188779|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
156573939|NCT04689828|565188778|FG000|Overall Study|Participants not treated|7|||
156573940|NCT04689828|565188779|FG001|Overall Study|Participants not treated|2|||
156573941|NCT00104871|565188786|FG000|Overall Study|Not evaluable|1|||
156573942|NCT00519532|565188791|FG000|Overall Study|Adverse Event|11|||
156573943|NCT00519532|565188791|FG000|Overall Study|Withdrawal by Subject|5|||
156573944|NCT00519532|565188791|FG000|Overall Study|Lost to Follow-up|2|||
156573945|NCT00457639|565188794|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
156573946|NCT00457639|565188795|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
156573947|NCT00457639|565188794|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
156573948|NCT00457639|565188795|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
156573949|NCT00457639|565188794|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
156573950|NCT00457639|565188795|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
156573951|NCT02117687|565188798|FG000|Overall Study|Lost to Follow-up|0|||
156573952|NCT02117687|565188799|FG001|Overall Study|Lost to Follow-up|1|||
156573953|NCT02117687|565188798|FG000|Overall Study|Adverse Event|0|||
156573954|NCT02117687|565188799|FG001|Overall Study|Adverse Event|2|||
156573955|NCT02117687|565188798|FG000|Overall Study|Other Reasons|1|||
156573956|NCT02117687|565188799|FG001|Overall Study|Other Reasons|1|||
156573957|NCT02932267|565188806|FG000|Overall Study|Withdrawal by Subject|3|||
156573958|NCT02932267|565188806|FG000|Overall Study|Lost to Follow-up|4|||
156573959|NCT02932267|565188806|FG000|Overall Study|Pregnancy|1|||
156573960|NCT01687673|565188812|FG000|Overall Study|Physician Decision|1|||
156573961|NCT02234622|565188813|FG000|Overall Study|Withdrawal by Subject|16|||
156573962|NCT02234622|565188814|FG001|Overall Study|Withdrawal by Subject|22|||
156573963|NCT02234622|565188813|FG000|Overall Study|Lost to Follow-up|27|||
156573964|NCT02234622|565188814|FG001|Overall Study|Lost to Follow-up|14|||
156573965|NCT03476239|565188815|FG000|Overall Study|Withdrawal by Subject|10|||
156573966|NCT03476239|565188815|FG000|Overall Study|Death|80|||
156573967|NCT03476239|565188815|FG000|Overall Study|Lost to Follow-up|8|||
156573968|NCT00618956|565188816|FG000|Overall Study|Adverse Event|10|||
156573969|NCT00618956|565188817|FG001|Overall Study|Adverse Event|34|||
156573970|NCT00618956|565188816|FG000|Overall Study|Lack of Efficacy|2|||
156573971|NCT00618956|565188817|FG001|Overall Study|Lack of Efficacy|1|||
156573972|NCT00618956|565188816|FG000|Overall Study|Withdrawal by Subject|5|||
156573973|NCT00618956|565188817|FG001|Overall Study|Withdrawal by Subject|7|||
156573974|NCT00618956|565188816|FG000|Overall Study|Lost to Follow-up|4|||
156573975|NCT00618956|565188817|FG001|Overall Study|Lost to Follow-up|5|||
156573976|NCT00618956|565188816|FG000|Overall Study|Protocol Violation|2|||
156573977|NCT00618956|565188817|FG001|Overall Study|Protocol Violation|2|||
156573978|NCT00618956|565188816|FG000|Overall Study|did not meet criteria, non-compliance|2|||
156573979|NCT00618956|565188817|FG001|Overall Study|did not meet criteria, non-compliance|1|||
156573980|NCT03598777|565188818|FG000|Overall Study|Study Terminated by Sponsor|3|||
156573981|NCT03598777|565188819|FG001|Overall Study|Study Terminated by Sponsor|0|||
156573982|NCT03598777|565188820|FG002|Overall Study|Study Terminated by Sponsor|0|||
156573983|NCT03598777|565188821|FG003|Overall Study|Study Terminated by Sponsor|0|||
156573984|NCT03598777|565188822|FG004|Overall Study|Study Terminated by Sponsor|15|||
156573985|NCT03598777|565188818|FG000|Overall Study|Withdrawal by Subject|1|||
156573986|NCT03598777|565188819|FG001|Overall Study|Withdrawal by Subject|1|||
156573987|NCT03598777|565188820|FG002|Overall Study|Withdrawal by Subject|0|||
156573988|NCT03598777|565188821|FG003|Overall Study|Withdrawal by Subject|0|||
156573989|NCT03598777|565188822|FG004|Overall Study|Withdrawal by Subject|0|||
156573990|NCT03598777|565188818|FG000|Overall Study|Adverse Event|1|||
156573991|NCT03598777|565188819|FG001|Overall Study|Adverse Event|0|||
156573992|NCT03598777|565188820|FG002|Overall Study|Adverse Event|0|||
156573993|NCT03598777|565188821|FG003|Overall Study|Adverse Event|0|||
156573994|NCT03598777|565188822|FG004|Overall Study|Adverse Event|0|||
156573995|NCT03598777|565188818|FG000|Overall Study|Lost to Follow-up|1|||
156573996|NCT03598777|565188819|FG001|Overall Study|Lost to Follow-up|0|||
156573997|NCT03598777|565188820|FG002|Overall Study|Lost to Follow-up|0|||
156573998|NCT03598777|565188821|FG003|Overall Study|Lost to Follow-up|0|||
156573999|NCT03598777|565188822|FG004|Overall Study|Lost to Follow-up|0|||
156574000|NCT02006576|565188823|FG000|Overall Study|Withdrawal by Subject|4|||
156574001|NCT02006576|565188824|FG001|Overall Study|Withdrawal by Subject|6|||
156574002|NCT02006576|565188825|FG002|Overall Study|Withdrawal by Subject|2|||
156574003|NCT02006576|565188823|FG000|Overall Study|Death|0|||
156574004|NCT02006576|565188824|FG001|Overall Study|Death|0|||
156574005|NCT02006576|565188825|FG002|Overall Study|Death|1|||
156574006|NCT02006576|565188823|FG000|Overall Study|Lost to Follow-up|1|||
156574007|NCT02006576|565188824|FG001|Overall Study|Lost to Follow-up|0|||
156574008|NCT02006576|565188825|FG002|Overall Study|Lost to Follow-up|1|||
156574009|NCT02006576|565188823|FG000|Overall Study|Screen Failure, too sick, other|13|||
156574010|NCT02006576|565188824|FG001|Overall Study|Screen Failure, too sick, other|1|||
156574011|NCT02006576|565188825|FG002|Overall Study|Screen Failure, too sick, other|13|||
156574012|NCT00785577|565188826|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
156574013|NCT00785577|565188827|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
156574014|NCT00785577|565188828|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
156574015|NCT00785577|565188829|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
156574016|NCT00785577|565188830|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
156574017|NCT00785577|565188826|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
156574018|NCT00785577|565188827|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
156574019|NCT00785577|565188828|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
156574020|NCT00785577|565188829|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
156574021|NCT00785577|565188830|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
156574022|NCT00785577|565188826|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
156574023|NCT00785577|565188827|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
156574024|NCT00785577|565188828|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
156574025|NCT00785577|565188829|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
156574026|NCT00785577|565188830|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
156574027|NCT00785577|565188826|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
156574028|NCT00785577|565188827|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
156574029|NCT00785577|565188828|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
156574030|NCT00785577|565188829|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
156574031|NCT00785577|565188830|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
156574032|NCT00785577|565188826|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
156574033|NCT00785577|565188827|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
156574034|NCT00785577|565188828|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
156574035|NCT00785577|565188829|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
156574036|NCT00785577|565188830|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
156574037|NCT00785577|565188826|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
156574038|NCT00785577|565188827|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
156574039|NCT00785577|565188828|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
156574040|NCT00785577|565188829|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
156574041|NCT00785577|565188830|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
156574042|NCT00785577|565188826|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
156574043|NCT00785577|565188827|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
156574044|NCT00785577|565188828|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
156574045|NCT00785577|565188829|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
156574046|NCT00785577|565188830|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
156574047|NCT00785577|565188826|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
156574048|NCT00785577|565188827|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
156574049|NCT00785577|565188828|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
156574050|NCT00785577|565188829|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
156574051|NCT00785577|565188830|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
156574052|NCT00785577|565188826|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
156574053|NCT00785577|565188827|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
156574054|NCT00785577|565188828|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
156574055|NCT00785577|565188829|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
156574056|NCT00785577|565188830|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
156574057|NCT00785577|565188826|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
156574058|NCT00785577|565188827|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
156574059|NCT00785577|565188828|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
156574060|NCT00785577|565188829|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
156574061|NCT00785577|565188830|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
156574062|NCT01650805|565188833|FG000|Overall Study|Withdrawal by Subject|1|||
156574063|NCT01650805|565188834|FG001|Overall Study|Withdrawal by Subject|0|||
156574064|NCT02515669|565188837|FG000|228 Week Open-Label Phase|Other|0|||
156574065|NCT02515669|565188838|FG001|228 Week Open-Label Phase|Other|0|||
156574066|NCT02515669|565188839|FG002|228 Week Open-Label Phase|Other|1|||
156574067|NCT02515669|565188840|FG003|228 Week Open-Label Phase|Other|4|||
156574068|NCT02515669|565188837|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
156574069|NCT02515669|565188838|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
156574070|NCT02515669|565188839|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
156574071|NCT02515669|565188840|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
156574072|NCT02515669|565188837|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
156574073|NCT02515669|565188838|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
156574074|NCT02515669|565188839|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
156574075|NCT02515669|565188840|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
156574076|NCT02515669|565188837|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
156574077|NCT02515669|565188838|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
156574078|NCT02515669|565188839|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
156574079|NCT02515669|565188840|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
156574080|NCT02515669|565188837|FG000|228 Week Open-Label Phase|Missing|0|||
156574081|NCT02515669|565188838|FG001|228 Week Open-Label Phase|Missing|2|||
156574082|NCT02515669|565188839|FG002|228 Week Open-Label Phase|Missing|2|||
156574083|NCT02515669|565188840|FG003|228 Week Open-Label Phase|Missing|2|||
156574084|NCT03750838|565188841|FG000|Overall Study|Lost to Follow-up|10|||
156574085|NCT03750838|565188842|FG001|Overall Study|Lost to Follow-up|6|||
156574086|NCT04070378|565188846|FG000|Overall Study|Withdrawal by Subject|2|||
156574087|NCT04070378|565188846|FG000|Overall Study|Screen Failure|6|||
156574088|NCT04070378|565188846|FG000|Overall Study|Physician Decision|1|||
156574089|NCT04070378|565188846|FG000|Overall Study|Adverse Event|1|||
156574090|NCT03232073|565188849|FG000|Overall Study|Death|1|||
156574091|NCT03232073|565188850|FG001|Overall Study|Death|0|||
156574092|NCT03232073|565188849|FG000|Overall Study|Adverse Event|7|||
156574093|NCT03232073|565188850|FG001|Overall Study|Adverse Event|12|||
156574094|NCT03232073|565188849|FG000|Overall Study|Lost to Follow-up|6|||
156574095|NCT03232073|565188850|FG001|Overall Study|Lost to Follow-up|6|||
156574096|NCT03232073|565188849|FG000|Overall Study|Lack of Efficacy|10|||
156574097|NCT03232073|565188850|FG001|Overall Study|Lack of Efficacy|8|||
156574098|NCT03232073|565188849|FG000|Overall Study|Physician Decision|9|||
156574099|NCT03232073|565188850|FG001|Overall Study|Physician Decision|2|||
156574100|NCT03232073|565188849|FG000|Overall Study|Withdrawal by Subject|54|||
156574101|NCT03232073|565188850|FG001|Overall Study|Withdrawal by Subject|39|||
156574102|NCT02032875|565188851|FG000|Treatment Period|Adverse Event|1|||
156574103|NCT02032875|565188852|FG001|Treatment Period|Adverse Event|0|||
156574104|NCT02032875|565188851|FG000|Treatment Period|Liver transplant, No extension needed|0|||
156574105|NCT02032875|565188852|FG001|Treatment Period|Liver transplant, No extension needed|1|||
156574106|NCT02032875|565188851|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
156574107|NCT02032875|565188852|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
156574108|NCT02032875|565188851|FG000|Follow-up Period|Death|0|||
156574109|NCT02032875|565188852|FG001|Follow-up Period|Death|1|||
156574110|NCT02032875|565188851|FG000|Follow-up Period|Virologic Relapse|3|||
156574111|NCT02032875|565188852|FG001|Follow-up Period|Virologic Relapse|10|||
156574112|NCT03191786|565188857|FG000|Overall Study|Death|236|||
156574113|NCT03191786|565188858|FG001|Overall Study|Death|127|||
156574114|NCT03191786|565188857|FG000|Overall Study|Lost to Follow-up|9|||
156574115|NCT03191786|565188858|FG001|Overall Study|Lost to Follow-up|3|||
156574116|NCT03191786|565188857|FG000|Overall Study|Physician Decision|1|||
156574117|NCT03191786|565188858|FG001|Overall Study|Physician Decision|0|||
156574118|NCT03191786|565188857|FG000|Overall Study|Moved to Post Trial Access Program|30|||
156574119|NCT03191786|565188858|FG001|Overall Study|Moved to Post Trial Access Program|5|||
156574120|NCT03191786|565188857|FG000|Overall Study|Withdrawal by Subject|26|||
156574121|NCT03191786|565188858|FG001|Overall Study|Withdrawal by Subject|16|||
156574122|NCT05847881|565188859|FG000|Overall Study|Principal Investigator Decision|8|||
156574123|NCT05847881|565188859|FG000|Overall Study|Withdrawal by Subject|2|||
156574124|NCT05781542|565190599|FG000|Overall Study|Lost to Follow-up|1|||
156574125|NCT05781542|565190600|FG001|Overall Study|Lost to Follow-up|0|||
156574126|NCT05781542|565190601|FG002|Overall Study|Lost to Follow-up|1|||
156574127|NCT00955110|565190602|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
156574128|NCT00955110|565190602|FG000|Treatment Phase|Adverse Event|2|||
156574129|NCT00955110|565190602|FG000|Treatment Phase|Administrative reasons|2|||
156574130|NCT00955110|565190602|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
156574131|NCT00955110|565190602|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
156574132|NCT01981187|565190603|FG000|Overall Study|Participant/guardian decision|2|||
156574133|NCT01981187|565190603|FG000|Overall Study|Physician Decision|1|||
156574134|NCT01981187|565190603|FG000|Overall Study|Disease progression|2|||
156574135|NCT01981187|565190603|FG000|Overall Study|Adverse Event|7|||
156574136|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
156574137|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
156574138|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
156574139|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
156574140|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
156574141|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
156574142|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
156574143|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
156574144|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
156574145|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
156574146|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
156574147|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
156574148|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
156574149|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
156574150|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
156574151|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
156574152|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
156574153|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
156574154|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Death|0|||
156574155|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Death|1|||
156574156|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Death|0|||
156574157|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
156574158|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
156574159|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
156574160|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
156574161|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
156574162|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
156574163|NCT00430781|565190605|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
156574164|NCT00430781|565190606|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
156574165|NCT00430781|565190607|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
156574166|NCT00430781|565190605|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
156574167|NCT00430781|565190606|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
156574168|NCT00430781|565190607|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
156574169|NCT00430781|565190605|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
156574170|NCT00430781|565190606|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
156574171|NCT00430781|565190607|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
156574172|NCT00430781|565190605|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
156574173|NCT00430781|565190606|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
156574174|NCT00430781|565190607|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
156574175|NCT00430781|565190605|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
156574176|NCT00430781|565190606|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
156574177|NCT00430781|565190607|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
156574178|NCT00430781|565190605|FG000|Final Analysis; 31 July 2008|Other|0|||
156574179|NCT00430781|565190606|FG001|Final Analysis; 31 July 2008|Other|1|||
156574180|NCT00430781|565190607|FG002|Final Analysis; 31 July 2008|Other|0|||
156574181|NCT00430781|565190605|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
156574182|NCT00430781|565190606|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
156574183|NCT00430781|565190607|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
156574184|NCT00430781|565190605|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
156574185|NCT00430781|565190606|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
156574186|NCT00430781|565190607|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
156574187|NCT00430781|565190605|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
156574188|NCT00430781|565190606|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
156574189|NCT00430781|565190607|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
156574190|NCT00430781|565190605|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
156574191|NCT00430781|565190606|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
156574192|NCT00430781|565190607|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
156574193|NCT00430781|565190605|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
156574194|NCT00430781|565190606|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
156574195|NCT00430781|565190607|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
156574196|NCT00430781|565190605|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
156574197|NCT00430781|565190606|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
156574198|NCT00430781|565190607|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
156574199|NCT00430781|565190605|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
156574200|NCT00430781|565190606|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
156574201|NCT00430781|565190607|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
156574202|NCT05408858|565190608|FG000|Overall Study|no longer met eligibility criteria|1|||
156574203|NCT01451515|565190616|FG000|Overall Study|Death|0|||
156574204|NCT01451515|565190617|FG001|Overall Study|Death|1|||
156574205|NCT01451515|565190618|FG002|Overall Study|Death|0|||
156574206|NCT01451515|565190616|FG000|Overall Study|Withdrawal by Subject|0|||
156574207|NCT01451515|565190617|FG001|Overall Study|Withdrawal by Subject|1|||
156574208|NCT01451515|565190618|FG002|Overall Study|Withdrawal by Subject|0|||
156574209|NCT01451515|565190616|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
156574210|NCT01451515|565190617|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
156574211|NCT01451515|565190618|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
156574212|NCT01451515|565190616|FG000|Overall Study|Relapse (except CNS)|1|||
156574213|NCT01451515|565190617|FG001|Overall Study|Relapse (except CNS)|1|||
156574214|NCT01451515|565190618|FG002|Overall Study|Relapse (except CNS)|0|||
156574215|NCT03230097|565190624|FG000|Overall Study|Adverse Event|2|||
156574216|NCT03230097|565190625|FG001|Overall Study|Adverse Event|1|||
156574217|NCT03230097|565190624|FG000|Overall Study|non-compliance|0|||
156574218|NCT03230097|565190625|FG001|Overall Study|non-compliance|1|||
156574219|NCT03230097|565190624|FG000|Overall Study|Lost to Follow-up|2|||
156574220|NCT03230097|565190625|FG001|Overall Study|Lost to Follow-up|4|||
156574221|NCT03230097|565190624|FG000|Overall Study|Withdrawal by Subject|7|||
156574222|NCT03230097|565190625|FG001|Overall Study|Withdrawal by Subject|3|||
156574223|NCT03230097|565190624|FG000|Overall Study|Trial termination|4|||
156574224|NCT03230097|565190625|FG001|Overall Study|Trial termination|5|||
156574225|NCT03230097|565190624|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
156574226|NCT03230097|565190625|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
156574227|NCT03230097|565190624|FG000|Overall Study|outcome event|0|||
156574228|NCT03230097|565190625|FG001|Overall Study|outcome event|1|||
156574229|NCT01702805|565190632|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
156574230|NCT01702805|565190633|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
156574231|NCT01702805|565190632|FG000|Overall Study|Incomplete Follow-up|18|||
156574232|NCT01702805|565190633|FG001|Overall Study|Incomplete Follow-up|15|||
156574233|NCT01702805|565190632|FG000|Overall Study|Vital Status Assessment Only|40|||
156574234|NCT01702805|565190633|FG001|Overall Study|Vital Status Assessment Only|39|||
156574235|NCT01702805|565190632|FG000|Overall Study|Lost to Follow-up|5|||
156574236|NCT01702805|565190633|FG001|Overall Study|Lost to Follow-up|5|||
156574237|NCT00635102|565190646|FG000|Overall Study|Withdrawal by Subject|7|||
156574238|NCT00635102|565190647|FG001|Overall Study|Withdrawal by Subject|8|||
156574239|NCT00440401|565190649|FG000|Overall Study|Adverse Event|2|||
156574240|NCT00440401|565190650|FG001|Overall Study|Adverse Event|1|||
156574241|NCT00440401|565190649|FG000|Overall Study|Other|2|||
156574242|NCT00440401|565190650|FG001|Overall Study|Other|5|||
156574243|NCT01925703|565190651|FG000|Overall Study|Physician Decision|1|||
156574244|NCT01925703|565190651|FG000|Overall Study|Lost to Follow-up|2|||
156574245|NCT01925703|565190651|FG000|Overall Study|Discharge prior to full iron repletion|1|||
156574246|NCT01938625|565190652|FG000|Overall Study|Withdrawal by Subject|0|||
156574247|NCT01938625|565190653|FG001|Overall Study|Withdrawal by Subject|1|||
156574248|NCT01938625|565190652|FG000|Overall Study|Adverse Event|0|||
156574249|NCT01938625|565190653|FG001|Overall Study|Adverse Event|1|||
156574250|NCT01937312|565190654|FG000|Overall Study|Adverse Event|10|||
156574251|NCT01937312|565190655|FG001|Overall Study|Adverse Event|1|||
156574252|NCT01937312|565190654|FG000|Overall Study|Lack of Efficacy|0|||
156574253|NCT01937312|565190655|FG001|Overall Study|Lack of Efficacy|1|||
156574254|NCT01937312|565190654|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
156574255|NCT01937312|565190655|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
156574256|NCT00091793|565190656|FG000|Overall Study|Adverse Event|1|||
156574257|NCT00091793|565190657|FG001|Overall Study|Adverse Event|2|||
156574258|NCT00091793|565190656|FG000|Overall Study|Withdrawal by Subject|10|||
156574259|NCT00091793|565190657|FG001|Overall Study|Withdrawal by Subject|15|||
156574260|NCT00091793|565190656|FG000|Overall Study|Ineligibility determined|2|||
156574261|NCT00091793|565190657|FG001|Overall Study|Ineligibility determined|0|||
156574262|NCT00091793|565190656|FG000|Overall Study|Lost to Follow-up|7|||
156574263|NCT00091793|565190657|FG001|Overall Study|Lost to Follow-up|5|||
156574264|NCT00091793|565190656|FG000|Overall Study|Noncompliance|2|||
156574265|NCT00091793|565190657|FG001|Overall Study|Noncompliance|0|||
156574266|NCT00091793|565190656|FG000|Overall Study|Other|2|||
156574267|NCT00091793|565190657|FG001|Overall Study|Other|0|||
156574268|NCT05309083|565190659|FG000|Overall Study|Withdrawal by Subject|2|||
156574269|NCT01238120|565190660|FG000|Overall Study|Withdrawal by Subject|4|||
156574270|NCT01238120|565190661|FG001|Overall Study|Withdrawal by Subject|1|||
156574271|NCT01238120|565190662|FG002|Overall Study|Withdrawal by Subject|2|||
156574272|NCT01238120|565190663|FG003|Overall Study|Withdrawal by Subject|5|||
156574273|NCT01238120|565190660|FG000|Overall Study|Lost to Follow-up|2|||
156574274|NCT01238120|565190661|FG001|Overall Study|Lost to Follow-up|0|||
156574275|NCT01238120|565190662|FG002|Overall Study|Lost to Follow-up|1|||
156574276|NCT01238120|565190663|FG003|Overall Study|Lost to Follow-up|1|||
156574277|NCT01238120|565190660|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
156574278|NCT01238120|565190661|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
156574279|NCT01238120|565190662|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
156574280|NCT01238120|565190663|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
156574281|NCT00881205|565190664|FG000|Overall Study|Adverse Event|8|||
156574282|NCT00881205|565190665|FG001|Overall Study|Adverse Event|3|||
156574283|NCT00881205|565190664|FG000|Overall Study|Withdrawal by Subject|1|||
156574284|NCT00881205|565190665|FG001|Overall Study|Withdrawal by Subject|2|||
156574285|NCT00881205|565190664|FG000|Overall Study|Lost to Follow-up|0|||
156574286|NCT00881205|565190665|FG001|Overall Study|Lost to Follow-up|1|||
156574287|NCT00881205|565190664|FG000|Overall Study|Administrative problems|1|||
156574288|NCT00881205|565190665|FG001|Overall Study|Administrative problems|1|||
156574289|NCT00881205|565190664|FG000|Overall Study|Condition no longer requires drug|1|||
156574290|NCT00881205|565190665|FG001|Overall Study|Condition no longer requires drug|0|||
156574291|NCT06129487|565190668|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
156574292|NCT06129487|565190669|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
156574293|NCT04246047|565190670|FG000|Overall Study|Death|50|||
156574294|NCT04246047|565190671|FG001|Overall Study|Death|77|||
156574295|NCT04246047|565190670|FG000|Overall Study|Lost to Follow-up|1|||
156574296|NCT04246047|565190671|FG001|Overall Study|Lost to Follow-up|3|||
156574297|NCT04246047|565190670|FG000|Overall Study|Physician Decision|4|||
156574298|NCT04246047|565190671|FG001|Overall Study|Physician Decision|10|||
156574299|NCT04246047|565190670|FG000|Overall Study|Withdrawal by Subject|19|||
156574300|NCT04246047|565190671|FG001|Overall Study|Withdrawal by Subject|26|||
156574301|NCT04246047|565190670|FG000|Overall Study|Ongoing|169|||
156574302|NCT04246047|565190671|FG001|Overall Study|Ongoing|135|||
156574303|NCT00587223|565190681|FG000|Overall Study|Adverse Event|1|||
156574304|NCT00195351|565190682|FG000|Overall Study|Lost to Follow-up|9|||
156574305|NCT00195351|565190683|FG001|Overall Study|Lost to Follow-up|9|||
156574306|NCT00195351|565190682|FG000|Overall Study|Withdrawal by Subject|6|||
156574307|NCT00195351|565190683|FG001|Overall Study|Withdrawal by Subject|3|||
156574308|NCT00195351|565190682|FG000|Overall Study|Protocol Deviation|3|||
156574309|NCT00195351|565190683|FG001|Overall Study|Protocol Deviation|2|||
156574310|NCT00195351|565190682|FG000|Overall Study|Death|3|||
156574311|NCT00195351|565190683|FG001|Overall Study|Death|1|||
156574312|NCT00195351|565190682|FG000|Overall Study|Lack of Efficacy|0|||
156574313|NCT00195351|565190683|FG001|Overall Study|Lack of Efficacy|1|||
156574314|NCT04332419|565190686|FG000|Overall Study|Withdrawal by Subject|1|||
156574315|NCT02493751|565190687|FG000|Overall Study|Withdrawal by Subject|2|||
156574316|NCT02493751|565190688|FG001|Overall Study|Withdrawal by Subject|8|||
156574317|NCT02493751|565190687|FG000|Overall Study|Death|6|||
156574318|NCT02493751|565190688|FG001|Overall Study|Death|13|||
156574319|NCT02493751|565190687|FG000|Overall Study|Lost to Follow-up|2|||
156574320|NCT02493751|565190688|FG001|Overall Study|Lost to Follow-up|3|||
156574321|NCT02493751|565190687|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
156574322|NCT02493751|565190688|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
156574323|NCT00519623|565190689|FG000|Overall Study|Adverse Event|1|||
156574324|NCT03819140|565190692|FG000|Overall Study|Lost to Follow-up|1|||
156574325|NCT03819140|565190693|FG001|Overall Study|Lost to Follow-up|2|||
156574326|NCT03819140|565190692|FG000|Overall Study|Withdrawal by Subject|3|||
156574327|NCT03819140|565190693|FG001|Overall Study|Withdrawal by Subject|2|||
156574328|NCT03819140|565190692|FG000|Overall Study|Adverse Event|0|||
156574329|NCT03819140|565190693|FG001|Overall Study|Adverse Event|1|||
156574330|NCT03819140|565190692|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
156574331|NCT03819140|565190693|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
156574332|NCT03819140|565190692|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
156574333|NCT03819140|565190693|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
156574334|NCT02192359|565190694|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
156574335|NCT02192359|565190695|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
156574336|NCT02192359|565190696|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
156574337|NCT02192359|565190697|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
156574338|NCT02192359|565190694|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
156574339|NCT02192359|565190695|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
156574340|NCT02192359|565190696|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
156574341|NCT02192359|565190697|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
156574342|NCT02192359|565190694|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
156574343|NCT02192359|565190695|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
156574344|NCT02192359|565190696|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
156574345|NCT02192359|565190697|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
156574346|NCT00828451|565190698|FG000|Overall Study|Death|2|||
156574347|NCT00828451|565190698|FG000|Overall Study|Lack of intravenous line|7|||
156574348|NCT00828451|565190698|FG000|Overall Study|Withdrawal by Subject|1|||
156574349|NCT00828451|565190698|FG000|Overall Study|Deterioration in clinical status|1|||
156574350|NCT03914300|565190700|FG000|Overall Study|Adverse Event|1|||
156574351|NCT00624338|565190704|FG000|Overall Study|Adverse Event|14|||
156574352|NCT00624338|565190705|FG001|Overall Study|Adverse Event|14|||
156574353|NCT00624338|565190706|FG002|Overall Study|Adverse Event|18|||
156574354|NCT00624338|565190704|FG000|Overall Study|Lost to Follow-up|1|||
156574355|NCT00624338|565190705|FG001|Overall Study|Lost to Follow-up|0|||
156574356|NCT00624338|565190706|FG002|Overall Study|Lost to Follow-up|0|||
156574357|NCT00624338|565190704|FG000|Overall Study|Lack of Efficacy|11|||
156574358|NCT00624338|565190705|FG001|Overall Study|Lack of Efficacy|3|||
156574359|NCT00624338|565190706|FG002|Overall Study|Lack of Efficacy|14|||
156574360|NCT00624338|565190704|FG000|Overall Study|Protocol Violation|3|||
156574361|NCT00624338|565190705|FG001|Overall Study|Protocol Violation|3|||
156574362|NCT00624338|565190706|FG002|Overall Study|Protocol Violation|2|||
156574363|NCT00624338|565190704|FG000|Overall Study|Death|0|||
156574364|NCT00624338|565190705|FG001|Overall Study|Death|2|||
156574365|NCT00624338|565190706|FG002|Overall Study|Death|0|||
156574366|NCT00624338|565190704|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
156574367|NCT00624338|565190705|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
156574368|NCT00624338|565190706|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
156574369|NCT00624338|565190704|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
156574370|NCT00624338|565190705|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
156574371|NCT00624338|565190706|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
156574372|NCT00624338|565190704|FG000|Overall Study|Other|15|||
156574373|NCT00624338|565190705|FG001|Overall Study|Other|5|||
156574374|NCT00624338|565190706|FG002|Overall Study|Other|9|||
156574375|NCT00624338|565190704|FG000|Overall Study|Randomized but not treated|2|||
156574376|NCT00624338|565190705|FG001|Overall Study|Randomized but not treated|1|||
156574377|NCT00624338|565190706|FG002|Overall Study|Randomized but not treated|3|||
156574378|NCT04358458|565190719|FG000|Overall Study|Death|1|||
156574379|NCT04358458|565190720|FG001|Overall Study|Death|1|||
156574380|NCT04358458|565190721|FG002|Overall Study|Death|3|||
156574381|NCT04358458|565190722|FG003|Overall Study|Death|8|||
156574382|NCT04358458|565190723|FG004|Overall Study|Death|1|||
156574383|NCT04358458|565190724|FG005|Overall Study|Death|6|||
156574384|NCT04358458|565190725|FG006|Overall Study|Death|2|||
156574385|NCT04358458|565190726|FG007|Overall Study|Death|3|||
156574386|NCT04358458|565190719|FG000|Overall Study|Lost to Follow-up|0|||
156574387|NCT04358458|565190720|FG001|Overall Study|Lost to Follow-up|0|||
156574388|NCT04358458|565190721|FG002|Overall Study|Lost to Follow-up|0|||
156574389|NCT04358458|565190722|FG003|Overall Study|Lost to Follow-up|0|||
156574390|NCT04358458|565190723|FG004|Overall Study|Lost to Follow-up|0|||
156574391|NCT04358458|565190724|FG005|Overall Study|Lost to Follow-up|0|||
156574392|NCT04358458|565190725|FG006|Overall Study|Lost to Follow-up|0|||
156574393|NCT04358458|565190726|FG007|Overall Study|Lost to Follow-up|1|||
156574394|NCT04358458|565190719|FG000|Overall Study|Site is closing study participation|0|||
156574395|NCT04358458|565190720|FG001|Overall Study|Site is closing study participation|0|||
156574396|NCT04358458|565190721|FG002|Overall Study|Site is closing study participation|0|||
156574397|NCT04358458|565190722|FG003|Overall Study|Site is closing study participation|1|||
156574398|NCT04358458|565190723|FG004|Overall Study|Site is closing study participation|0|||
156574399|NCT04358458|565190724|FG005|Overall Study|Site is closing study participation|0|||
156574400|NCT04358458|565190725|FG006|Overall Study|Site is closing study participation|0|||
156574401|NCT04358458|565190726|FG007|Overall Study|Site is closing study participation|0|||
156574402|NCT04358458|565190719|FG000|Overall Study|Sponsor request|2|||
156574403|NCT04358458|565190720|FG001|Overall Study|Sponsor request|3|||
156574404|NCT04358458|565190721|FG002|Overall Study|Sponsor request|3|||
156574405|NCT04358458|565190722|FG003|Overall Study|Sponsor request|0|||
156574406|NCT04358458|565190723|FG004|Overall Study|Sponsor request|2|||
156574407|NCT04358458|565190724|FG005|Overall Study|Sponsor request|3|||
156574408|NCT04358458|565190725|FG006|Overall Study|Sponsor request|1|||
156574409|NCT04358458|565190726|FG007|Overall Study|Sponsor request|1|||
156574410|NCT04358458|565190719|FG000|Overall Study|Withdrawal by Subject|0|||
156574411|NCT04358458|565190720|FG001|Overall Study|Withdrawal by Subject|0|||
156574412|NCT04358458|565190721|FG002|Overall Study|Withdrawal by Subject|1|||
156574413|NCT04358458|565190722|FG003|Overall Study|Withdrawal by Subject|1|||
156574414|NCT04358458|565190723|FG004|Overall Study|Withdrawal by Subject|0|||
156574415|NCT04358458|565190724|FG005|Overall Study|Withdrawal by Subject|1|||
156574416|NCT04358458|565190725|FG006|Overall Study|Withdrawal by Subject|0|||
156574417|NCT04358458|565190726|FG007|Overall Study|Withdrawal by Subject|1|||
156574418|NCT01843374|565192339|FG000|Overall Study|Death|155|||
156574419|NCT01843374|565192340|FG001|Overall Study|Death|313|||
156574420|NCT01843374|565192339|FG000|Overall Study|Withdrawal by Subject|14|||
156574421|NCT01843374|565192340|FG001|Overall Study|Withdrawal by Subject|20|||
156574422|NCT01843374|565192339|FG000|Overall Study|Withdrawing due to Other reason|20|||
156574423|NCT01843374|565192340|FG001|Overall Study|Withdrawing due to Other reason|46|||
156574424|NCT01826214|565192341|FG000|Overall Study|Adverse Event|7|||
156574425|NCT01826214|565192342|FG001|Overall Study|Adverse Event|6|||
156574426|NCT01826214|565192341|FG000|Overall Study|Death|3|||
156574427|NCT01826214|565192342|FG001|Overall Study|Death|1|||
156574428|NCT01826214|565192341|FG000|Overall Study|Lost to Follow-up|1|||
156574429|NCT01826214|565192342|FG001|Overall Study|Lost to Follow-up|0|||
156574430|NCT01826214|565192341|FG000|Overall Study|Physician Decision|0|||
156574431|NCT01826214|565192342|FG001|Overall Study|Physician Decision|2|||
156574432|NCT01826214|565192341|FG000|Overall Study|Progressive disease|22|||
156574433|NCT01826214|565192342|FG001|Overall Study|Progressive disease|21|||
156574434|NCT01826214|565192341|FG000|Overall Study|Study terminated by Sponsor|0|||
156574435|NCT01826214|565192342|FG001|Overall Study|Study terminated by Sponsor|1|||
156574436|NCT01826214|565192341|FG000|Overall Study|Subject/guardian decision|2|||
156574437|NCT01826214|565192342|FG001|Overall Study|Subject/guardian decision|3|||
156574438|NCT03704051|565192347|FG000|Overall Study|Withdrawal by Subject|4|||
156574439|NCT03704051|565192348|FG001|Overall Study|Withdrawal by Subject|0|||
156574440|NCT03167619|565192357|FG000|Overall Study|Death|11|||
156574441|NCT03167619|565192358|FG001|Overall Study|Death|8|||
156574442|NCT03167619|565192357|FG000|Overall Study|Withdrawal by Subject|1|||
156574443|NCT03167619|565192358|FG001|Overall Study|Withdrawal by Subject|2|||
156574444|NCT03167619|565192357|FG000|Overall Study|Physician Decision|0|||
156574445|NCT03167619|565192358|FG001|Overall Study|Physician Decision|1|||
156574446|NCT02082184|565192362|FG000|Overall Study|Adverse Event|1|||
156574447|NCT02082184|565192363|FG001|Overall Study|Adverse Event|0|||
156574448|NCT02082184|565192362|FG000|Overall Study|Medical diagnosis|1|||
156574449|NCT02082184|565192363|FG001|Overall Study|Medical diagnosis|2|||
156574450|NCT02082184|565192362|FG000|Overall Study|Device associated symptoms|5|||
156574451|NCT02082184|565192363|FG001|Overall Study|Device associated symptoms|0|||
156574452|NCT02082184|565192362|FG000|Overall Study|Withdrawal by Subject|3|||
156574453|NCT02082184|565192363|FG001|Overall Study|Withdrawal by Subject|2|||
156574454|NCT02082184|565192362|FG000|Overall Study|Protocol Violation|0|||
156574455|NCT02082184|565192363|FG001|Overall Study|Protocol Violation|6|||
156574456|NCT02082184|565192362|FG000|Overall Study|Lost to Follow-up|0|||
156574457|NCT02082184|565192363|FG001|Overall Study|Lost to Follow-up|2|||
156574458|NCT02082184|565192362|FG000|Overall Study|Subject non-compliance|0|||
156574459|NCT02082184|565192363|FG001|Overall Study|Subject non-compliance|1|||
156574460|NCT01362322|565192366|FG000|Overall Study|Withdrawal by Subject|3|||
156574461|NCT01362322|565192367|FG001|Overall Study|Withdrawal by Subject|1|||
156574462|NCT01362322|565192366|FG000|Overall Study|Lost to Follow-up|2|||
156574463|NCT01362322|565192367|FG001|Overall Study|Lost to Follow-up|6|||
156574464|NCT01943539|565192368|FG000|Overall Study|Non-compliance with at-home intervention|4|||
156574465|NCT01943539|565192369|FG001|Overall Study|Non-compliance with at-home intervention|0|||
156574466|NCT02413398|565192372|FG000|Overall Study|Lost to Follow-up|2|||
156574467|NCT02413398|565192373|FG001|Overall Study|Lost to Follow-up|4|||
156574468|NCT02413398|565192372|FG000|Overall Study|Withdrawal by Subject|1|||
156574469|NCT02413398|565192373|FG001|Overall Study|Withdrawal by Subject|1|||
156574470|NCT02413398|565192372|FG000|Overall Study|Other Eligibility criteria|1|||
156574471|NCT02413398|565192373|FG001|Overall Study|Other Eligibility criteria|2|||
156574472|NCT00537940|565192376|FG000|Overall Study|Adverse Event|20|||
156574473|NCT00537940|565192377|FG001|Overall Study|Adverse Event|19|||
156574474|NCT00537940|565192376|FG000|Overall Study|Lack of Efficacy|8|||
156574475|NCT00537940|565192377|FG001|Overall Study|Lack of Efficacy|16|||
156574476|NCT00537940|565192376|FG000|Overall Study|Lost to Follow-up|23|||
156574477|NCT00537940|565192377|FG001|Overall Study|Lost to Follow-up|29|||
156574478|NCT00537940|565192376|FG000|Overall Study|Withdrawal by Subject|113|||
156574479|NCT00537940|565192377|FG001|Overall Study|Withdrawal by Subject|95|||
156574480|NCT00537940|565192376|FG000|Overall Study|Protocol Violation|6|||
156574481|NCT00537940|565192377|FG001|Overall Study|Protocol Violation|4|||
156574482|NCT00537940|565192376|FG000|Overall Study|Pregnancy|1|||
156574483|NCT00537940|565192377|FG001|Overall Study|Pregnancy|1|||
156574484|NCT00537940|565192376|FG000|Overall Study|Study terminated by sponsor|2|||
156574485|NCT00537940|565192377|FG001|Overall Study|Study terminated by sponsor|3|||
156574486|NCT00537940|565192376|FG000|Overall Study|Other|10|||
156574487|NCT00537940|565192377|FG001|Overall Study|Other|12|||
156574488|NCT03715465|565192381|FG000|Overall Study|Withdrawal by Subject|1|||
156574489|NCT03715465|565192382|FG001|Overall Study|Withdrawal by Subject|2|||
156574490|NCT02158533|565192386|FG000|Stage 1|Adverse Event|6|||
156574491|NCT02158533|565192387|FG001|Stage 1|Adverse Event|4|||
156574492|NCT02158533|565192388|FG002|Stage 1|Adverse Event|7|||
156574493|NCT02158533|565192389|FG003|Stage 1|Adverse Event|0|||
156574494|NCT02158533|565192390|FG004|Stage 1|Adverse Event|0|||
156574495|NCT02158533|565192391|FG005|Stage 1|Adverse Event|0|||
156574496|NCT02158533|565192386|FG000|Stage 1|Withdrawal by Subject|3|||
156574497|NCT02158533|565192387|FG001|Stage 1|Withdrawal by Subject|2|||
156574498|NCT02158533|565192388|FG002|Stage 1|Withdrawal by Subject|1|||
156574499|NCT02158533|565192389|FG003|Stage 1|Withdrawal by Subject|0|||
156574500|NCT02158533|565192390|FG004|Stage 1|Withdrawal by Subject|0|||
156574501|NCT02158533|565192391|FG005|Stage 1|Withdrawal by Subject|0|||
156574502|NCT02158533|565192386|FG000|Stage 1|Lack of Efficacy|1|||
156574503|NCT02158533|565192387|FG001|Stage 1|Lack of Efficacy|0|||
156574504|NCT02158533|565192388|FG002|Stage 1|Lack of Efficacy|0|||
156574505|NCT02158533|565192389|FG003|Stage 1|Lack of Efficacy|0|||
156574506|NCT02158533|565192390|FG004|Stage 1|Lack of Efficacy|0|||
156574507|NCT02158533|565192391|FG005|Stage 1|Lack of Efficacy|0|||
156574508|NCT02158533|565192386|FG000|Stage 1|Lost to Follow-up|3|||
156574509|NCT02158533|565192387|FG001|Stage 1|Lost to Follow-up|1|||
156574510|NCT02158533|565192388|FG002|Stage 1|Lost to Follow-up|0|||
156574511|NCT02158533|565192389|FG003|Stage 1|Lost to Follow-up|0|||
156574512|NCT02158533|565192390|FG004|Stage 1|Lost to Follow-up|0|||
156574513|NCT02158533|565192391|FG005|Stage 1|Lost to Follow-up|0|||
156574514|NCT02158533|565192386|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
156574515|NCT02158533|565192387|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
156574516|NCT02158533|565192388|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
156574517|NCT02158533|565192389|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
156574518|NCT02158533|565192390|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
156574519|NCT02158533|565192391|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
156574520|NCT02158533|565192386|FG000|Stage 1|Non-compliance with study visits|1|||
156574521|NCT02158533|565192387|FG001|Stage 1|Non-compliance with study visits|0|||
156574522|NCT02158533|565192388|FG002|Stage 1|Non-compliance with study visits|0|||
156574523|NCT02158533|565192389|FG003|Stage 1|Non-compliance with study visits|0|||
156574524|NCT02158533|565192390|FG004|Stage 1|Non-compliance with study visits|0|||
156574525|NCT02158533|565192391|FG005|Stage 1|Non-compliance with study visits|0|||
156574526|NCT02158533|565192386|FG000|Stage 2|Adverse Event|0|||
156574527|NCT02158533|565192387|FG001|Stage 2|Adverse Event|0|||
156574528|NCT02158533|565192388|FG002|Stage 2|Adverse Event|0|||
156574529|NCT02158533|565192389|FG003|Stage 2|Adverse Event|0|||
156574530|NCT02158533|565192390|FG004|Stage 2|Adverse Event|0|||
156574531|NCT02158533|565192391|FG005|Stage 2|Adverse Event|1|||
156574532|NCT02158533|565192386|FG000|Stage 2|Lack of Efficacy|0|||
156574533|NCT02158533|565192387|FG001|Stage 2|Lack of Efficacy|0|||
156574534|NCT02158533|565192388|FG002|Stage 2|Lack of Efficacy|0|||
156574535|NCT02158533|565192389|FG003|Stage 2|Lack of Efficacy|0|||
156574536|NCT02158533|565192390|FG004|Stage 2|Lack of Efficacy|1|||
156574537|NCT02158533|565192391|FG005|Stage 2|Lack of Efficacy|0|||
156574538|NCT02158533|565192386|FG000|Stage 2|Lost to Follow-up|0|||
156574539|NCT02158533|565192387|FG001|Stage 2|Lost to Follow-up|0|||
156574540|NCT02158533|565192388|FG002|Stage 2|Lost to Follow-up|0|||
156574541|NCT02158533|565192389|FG003|Stage 2|Lost to Follow-up|1|||
156574542|NCT02158533|565192390|FG004|Stage 2|Lost to Follow-up|1|||
156574543|NCT02158533|565192391|FG005|Stage 2|Lost to Follow-up|2|||
156574544|NCT02158533|565192386|FG000|Stage 2|Withdrawal by Subject|0|||
156574545|NCT02158533|565192387|FG001|Stage 2|Withdrawal by Subject|0|||
156574546|NCT02158533|565192388|FG002|Stage 2|Withdrawal by Subject|0|||
156574547|NCT02158533|565192389|FG003|Stage 2|Withdrawal by Subject|0|||
156574548|NCT02158533|565192390|FG004|Stage 2|Withdrawal by Subject|1|||
156574549|NCT02158533|565192391|FG005|Stage 2|Withdrawal by Subject|2|||
156574550|NCT02158533|565192386|FG000|Stage 2|Physician Decision|0|||
156574551|NCT02158533|565192387|FG001|Stage 2|Physician Decision|0|||
156574552|NCT02158533|565192388|FG002|Stage 2|Physician Decision|0|||
156574553|NCT02158533|565192389|FG003|Stage 2|Physician Decision|0|||
156574554|NCT02158533|565192390|FG004|Stage 2|Physician Decision|1|||
156574555|NCT02158533|565192391|FG005|Stage 2|Physician Decision|0|||
156574556|NCT02158533|565192386|FG000|Stage 2|Pregnancy|0|||
156574557|NCT02158533|565192387|FG001|Stage 2|Pregnancy|0|||
156574558|NCT02158533|565192388|FG002|Stage 2|Pregnancy|0|||
156574559|NCT02158533|565192389|FG003|Stage 2|Pregnancy|1|||
156574560|NCT02158533|565192390|FG004|Stage 2|Pregnancy|0|||
156574561|NCT02158533|565192391|FG005|Stage 2|Pregnancy|0|||
156574562|NCT02158533|565192386|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
156574563|NCT02158533|565192387|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
156574564|NCT02158533|565192388|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
156574565|NCT02158533|565192389|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
156574566|NCT02158533|565192390|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
156574567|NCT02158533|565192391|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
156574568|NCT02158533|565192386|FG000|Stage 2|Non-adherence with study visits|0|||
156574569|NCT02158533|565192387|FG001|Stage 2|Non-adherence with study visits|0|||
156574570|NCT02158533|565192388|FG002|Stage 2|Non-adherence with study visits|0|||
156574571|NCT02158533|565192389|FG003|Stage 2|Non-adherence with study visits|0|||
156574572|NCT02158533|565192390|FG004|Stage 2|Non-adherence with study visits|0|||
156574573|NCT02158533|565192391|FG005|Stage 2|Non-adherence with study visits|1|||
156574574|NCT00384956|565192392|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
156574575|NCT01389128|565192394|FG000|Overall Study|Fetal distress|1|||
156574576|NCT01389128|565192395|FG001|Overall Study|Fetal distress|0|||
156574577|NCT01389128|565192394|FG000|Overall Study|Cervix dilation stop|1|||
156574578|NCT01389128|565192395|FG001|Overall Study|Cervix dilation stop|2|||
156574579|NCT01389128|565192394|FG000|Overall Study|Rapid labor evolution|3|||
156574580|NCT01389128|565192395|FG001|Overall Study|Rapid labor evolution|2|||
156574581|NCT01389128|565192394|FG000|Overall Study|Intolerance to procedure|0|||
156574582|NCT01389128|565192395|FG001|Overall Study|Intolerance to procedure|2|||
156574583|NCT00174941|565192399|FG000|Overall Study|Adverse Event|1|||
156574584|NCT00174941|565192400|FG001|Overall Study|Adverse Event|10|||
156574585|NCT00174941|565192401|FG002|Overall Study|Adverse Event|2|||
156574586|NCT00174941|565192402|FG003|Overall Study|Adverse Event|13|||
156574587|NCT00174941|565192399|FG000|Overall Study|Protocol Violation|0|||
156574588|NCT00174941|565192400|FG001|Overall Study|Protocol Violation|1|||
156574589|NCT00174941|565192401|FG002|Overall Study|Protocol Violation|0|||
156574590|NCT00174941|565192402|FG003|Overall Study|Protocol Violation|1|||
156574591|NCT00174941|565192399|FG000|Overall Study|Lost to Follow-up|0|||
156574592|NCT00174941|565192400|FG001|Overall Study|Lost to Follow-up|3|||
156574593|NCT00174941|565192401|FG002|Overall Study|Lost to Follow-up|2|||
156574594|NCT00174941|565192402|FG003|Overall Study|Lost to Follow-up|5|||
156574595|NCT00174941|565192399|FG000|Overall Study|Personal Reason(s)|0|||
156574596|NCT00174941|565192400|FG001|Overall Study|Personal Reason(s)|14|||
156574597|NCT00174941|565192401|FG002|Overall Study|Personal Reason(s)|8|||
156574598|NCT00174941|565192402|FG003|Overall Study|Personal Reason(s)|22|||
156574599|NCT00174941|565192399|FG000|Overall Study|Gout Flare|0|||
156574600|NCT00174941|565192400|FG001|Overall Study|Gout Flare|4|||
156574601|NCT00174941|565192401|FG002|Overall Study|Gout Flare|4|||
156574602|NCT00174941|565192402|FG003|Overall Study|Gout Flare|8|||
156574603|NCT00174941|565192399|FG000|Overall Study|Reason Not Specified|1|||
156574604|NCT00174941|565192400|FG001|Overall Study|Reason Not Specified|6|||
156574605|NCT00174941|565192401|FG002|Overall Study|Reason Not Specified|2|||
156574606|NCT00174941|565192402|FG003|Overall Study|Reason Not Specified|9|||
156574607|NCT01588197|565192409|FG000|Overall Study|Lack of Efficacy|0|||
156574608|NCT01588197|565192410|FG001|Overall Study|Lack of Efficacy|1|||
156574609|NCT01588197|565192409|FG000|Overall Study|No MRI|1|||
156574610|NCT01588197|565192410|FG001|Overall Study|No MRI|0|||
156574611|NCT02111369|565192414|FG000|Overall Study|Lost to Follow-up|2|||
156574612|NCT02111369|565192414|FG000|Overall Study|Withdrawal by Subject|1|||
156574613|NCT01480180|565192415|FG000|Main Phase|Withdrawal criteria|12|||
156574614|NCT01480180|565192416|FG001|Main Phase|Withdrawal criteria|1|||
156574615|NCT01480180|565192417|FG002|Main Phase|Withdrawal criteria|0|||
156574616|NCT01480180|565192418|FG003|Main Phase|Withdrawal criteria|0|||
156574617|NCT01480180|565192419|FG004|Main Phase|Withdrawal criteria|0|||
156574618|NCT01480180|565192420|FG005|Main Phase|Withdrawal criteria|0|||
156574619|NCT01480180|565192415|FG000|Main Phase|Lack of Efficacy|1|||
156574620|NCT01480180|565192416|FG001|Main Phase|Lack of Efficacy|0|||
156574621|NCT01480180|565192417|FG002|Main Phase|Lack of Efficacy|0|||
156574622|NCT01480180|565192418|FG003|Main Phase|Lack of Efficacy|0|||
156574623|NCT01480180|565192419|FG004|Main Phase|Lack of Efficacy|0|||
156574624|NCT01480180|565192420|FG005|Main Phase|Lack of Efficacy|0|||
156574625|NCT01480180|565192415|FG000|Main Phase|Non-compliance|3|||
156574626|NCT01480180|565192416|FG001|Main Phase|Non-compliance|0|||
156574627|NCT01480180|565192417|FG002|Main Phase|Non-compliance|0|||
156574628|NCT01480180|565192418|FG003|Main Phase|Non-compliance|0|||
156574629|NCT01480180|565192419|FG004|Main Phase|Non-compliance|0|||
156574630|NCT01480180|565192420|FG005|Main Phase|Non-compliance|0|||
156574631|NCT01480180|565192415|FG000|Main Phase|Unclassified|3|||
156574632|NCT01480180|565192416|FG001|Main Phase|Unclassified|0|||
156574633|NCT01480180|565192417|FG002|Main Phase|Unclassified|0|||
156574634|NCT01480180|565192418|FG003|Main Phase|Unclassified|0|||
156574635|NCT01480180|565192419|FG004|Main Phase|Unclassified|0|||
156574636|NCT01480180|565192420|FG005|Main Phase|Unclassified|0|||
156574637|NCT01480180|565192415|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
156574638|NCT01480180|565192416|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
156574639|NCT01480180|565192417|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
156574640|NCT01480180|565192418|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
156574641|NCT01480180|565192419|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
156574642|NCT01480180|565192420|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
156574643|NCT01480180|565192415|FG000|Extension Phase, Part 1|Unclassified|0|||
156574644|NCT01480180|565192416|FG001|Extension Phase, Part 1|Unclassified|0|||
156574645|NCT01480180|565192417|FG002|Extension Phase, Part 1|Unclassified|1|||
156574646|NCT01480180|565192418|FG003|Extension Phase, Part 1|Unclassified|0|||
156574647|NCT01480180|565192419|FG004|Extension Phase, Part 1|Unclassified|0|||
156574648|NCT01480180|565192420|FG005|Extension Phase, Part 1|Unclassified|0|||
156574649|NCT01480180|565192415|FG000|Extension Phase, Part 1|Adverse Event|0|||
156574650|NCT01480180|565192416|FG001|Extension Phase, Part 1|Adverse Event|0|||
156574651|NCT01480180|565192417|FG002|Extension Phase, Part 1|Adverse Event|4|||
156574652|NCT01480180|565192418|FG003|Extension Phase, Part 1|Adverse Event|1|||
156574653|NCT01480180|565192419|FG004|Extension Phase, Part 1|Adverse Event|0|||
156574654|NCT01480180|565192420|FG005|Extension Phase, Part 1|Adverse Event|0|||
156574655|NCT01480180|565192415|FG000|Extension Phase, Part 1|Change of treatment|0|||
156574656|NCT01480180|565192416|FG001|Extension Phase, Part 1|Change of treatment|0|||
156574657|NCT01480180|565192417|FG002|Extension Phase, Part 1|Change of treatment|0|||
156574658|NCT01480180|565192418|FG003|Extension Phase, Part 1|Change of treatment|9|||
156574659|NCT01480180|565192419|FG004|Extension Phase, Part 1|Change of treatment|0|||
156574660|NCT01480180|565192420|FG005|Extension Phase, Part 1|Change of treatment|0|||
156574661|NCT01480180|565192415|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
156574662|NCT01480180|565192416|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
156574663|NCT01480180|565192417|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
156574664|NCT01480180|565192418|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
156574665|NCT01480180|565192419|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
156574666|NCT01480180|565192420|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
156574667|NCT01480180|565192415|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
156574668|NCT01480180|565192416|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
156574669|NCT01480180|565192417|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
156574670|NCT01480180|565192418|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
156574671|NCT01480180|565192419|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
156574672|NCT01480180|565192420|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
156574673|NCT01480180|565192415|FG000|Extension Phase, Part 2|Unclassified|0|||
156574674|NCT01480180|565192416|FG001|Extension Phase, Part 2|Unclassified|0|||
156574675|NCT01480180|565192417|FG002|Extension Phase, Part 2|Unclassified|3|||
156574676|NCT01480180|565192418|FG003|Extension Phase, Part 2|Unclassified|1|||
156574677|NCT01480180|565192419|FG004|Extension Phase, Part 2|Unclassified|1|||
156574678|NCT01480180|565192420|FG005|Extension Phase, Part 2|Unclassified|0|||
156574679|NCT00658333|565192421|FG000|Overall Study|Adverse Event|2|||
156574680|NCT00658333|565192422|FG001|Overall Study|Adverse Event|1|||
156574681|NCT03519178|565192423|FG000|PF-06873600 Treatment|Adverse Event|0|||
156574682|NCT03519178|565192424|FG001|PF-06873600 Treatment|Adverse Event|0|||
156574683|NCT03519178|565192425|FG002|PF-06873600 Treatment|Adverse Event|0|||
156574684|NCT03519178|565192426|FG003|PF-06873600 Treatment|Adverse Event|0|||
156574685|NCT03519178|565192427|FG004|PF-06873600 Treatment|Adverse Event|0|||
156574686|NCT03519178|565192428|FG005|PF-06873600 Treatment|Adverse Event|0|||
156574687|NCT03519178|565192429|FG006|PF-06873600 Treatment|Adverse Event|0|||
156574688|NCT03519178|565192430|FG007|PF-06873600 Treatment|Adverse Event|2|||
156574689|NCT03519178|565192431|FG008|PF-06873600 Treatment|Adverse Event|1|||
156574690|NCT03519178|565192432|FG009|PF-06873600 Treatment|Adverse Event|0|||
156574691|NCT03519178|565192433|FG010|PF-06873600 Treatment|Adverse Event|0|||
156574692|NCT03519178|565192434|FG011|PF-06873600 Treatment|Adverse Event|0|||
156574693|NCT03519178|565192435|FG012|PF-06873600 Treatment|Adverse Event|1|||
156574694|NCT03519178|565192436|FG013|PF-06873600 Treatment|Adverse Event|3|||
156574695|NCT03519178|565192437|FG014|PF-06873600 Treatment|Adverse Event|2|||
156574696|NCT03519178|565192423|FG000|PF-06873600 Treatment|Death|0|||
156574697|NCT03519178|565192424|FG001|PF-06873600 Treatment|Death|0|||
156574698|NCT03519178|565192425|FG002|PF-06873600 Treatment|Death|0|||
156574699|NCT03519178|565192426|FG003|PF-06873600 Treatment|Death|0|||
156574700|NCT03519178|565192427|FG004|PF-06873600 Treatment|Death|0|||
156574701|NCT03519178|565192428|FG005|PF-06873600 Treatment|Death|0|||
156574702|NCT03519178|565192429|FG006|PF-06873600 Treatment|Death|0|||
156574703|NCT03519178|565192430|FG007|PF-06873600 Treatment|Death|0|||
156574704|NCT03519178|565192431|FG008|PF-06873600 Treatment|Death|1|||
156574705|NCT03519178|565192432|FG009|PF-06873600 Treatment|Death|1|||
156574706|NCT03519178|565192433|FG010|PF-06873600 Treatment|Death|0|||
156574707|NCT03519178|565192434|FG011|PF-06873600 Treatment|Death|0|||
156574708|NCT03519178|565192435|FG012|PF-06873600 Treatment|Death|0|||
156574709|NCT03519178|565192436|FG013|PF-06873600 Treatment|Death|0|||
156574710|NCT03519178|565192437|FG014|PF-06873600 Treatment|Death|1|||
156574711|NCT03519178|565192423|FG000|PF-06873600 Treatment|Physician Decision|0|||
156574712|NCT03519178|565192424|FG001|PF-06873600 Treatment|Physician Decision|0|||
156574713|NCT03519178|565192425|FG002|PF-06873600 Treatment|Physician Decision|0|||
156574714|NCT03519178|565192426|FG003|PF-06873600 Treatment|Physician Decision|0|||
156574715|NCT03519178|565192427|FG004|PF-06873600 Treatment|Physician Decision|0|||
156574716|NCT03519178|565192428|FG005|PF-06873600 Treatment|Physician Decision|0|||
156574717|NCT03519178|565192429|FG006|PF-06873600 Treatment|Physician Decision|0|||
156574718|NCT03519178|565192430|FG007|PF-06873600 Treatment|Physician Decision|1|||
156574719|NCT03519178|565192431|FG008|PF-06873600 Treatment|Physician Decision|0|||
156574720|NCT03519178|565192432|FG009|PF-06873600 Treatment|Physician Decision|0|||
156574721|NCT03519178|565192433|FG010|PF-06873600 Treatment|Physician Decision|1|||
156574722|NCT03519178|565192434|FG011|PF-06873600 Treatment|Physician Decision|0|||
156574723|NCT03519178|565192435|FG012|PF-06873600 Treatment|Physician Decision|0|||
156574724|NCT03519178|565192436|FG013|PF-06873600 Treatment|Physician Decision|4|||
156574725|NCT03519178|565192437|FG014|PF-06873600 Treatment|Physician Decision|1|||
156574726|NCT03519178|565192423|FG000|PF-06873600 Treatment|Progressive disease|1|||
156574727|NCT03519178|565192424|FG001|PF-06873600 Treatment|Progressive disease|1|||
156574728|NCT03519178|565192425|FG002|PF-06873600 Treatment|Progressive disease|1|||
156574729|NCT03519178|565192426|FG003|PF-06873600 Treatment|Progressive disease|1|||
156574730|NCT03519178|565192427|FG004|PF-06873600 Treatment|Progressive disease|6|||
156574731|NCT03519178|565192428|FG005|PF-06873600 Treatment|Progressive disease|7|||
156574732|NCT03519178|565192429|FG006|PF-06873600 Treatment|Progressive disease|3|||
156574733|NCT03519178|565192430|FG007|PF-06873600 Treatment|Progressive disease|7|||
156574734|NCT03519178|565192431|FG008|PF-06873600 Treatment|Progressive disease|3|||
156574735|NCT03519178|565192432|FG009|PF-06873600 Treatment|Progressive disease|5|||
156574736|NCT03519178|565192433|FG010|PF-06873600 Treatment|Progressive disease|4|||
156574737|NCT03519178|565192434|FG011|PF-06873600 Treatment|Progressive disease|3|||
156574738|NCT03519178|565192435|FG012|PF-06873600 Treatment|Progressive disease|4|||
156574739|NCT03519178|565192436|FG013|PF-06873600 Treatment|Progressive disease|28|||
156574740|NCT03519178|565192437|FG014|PF-06873600 Treatment|Progressive disease|8|||
156574741|NCT03519178|565192423|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
156574742|NCT03519178|565192424|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
156574743|NCT03519178|565192425|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
156574744|NCT03519178|565192426|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
156574745|NCT03519178|565192427|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
156574746|NCT03519178|565192428|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
156574747|NCT03519178|565192429|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
156574748|NCT03519178|565192430|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
156574749|NCT03519178|565192431|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
156574750|NCT03519178|565192432|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
156574751|NCT03519178|565192433|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
156574752|NCT03519178|565192434|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
156574753|NCT03519178|565192435|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
156574754|NCT03519178|565192436|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
156574755|NCT03519178|565192437|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
156574756|NCT03519178|565192423|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
156574757|NCT03519178|565192424|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
156574758|NCT03519178|565192425|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
156574759|NCT03519178|565192426|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
156574760|NCT03519178|565192427|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
156574761|NCT03519178|565192428|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
156574762|NCT03519178|565192429|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
156574763|NCT03519178|565192430|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
156574764|NCT03519178|565192431|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
156574765|NCT03519178|565192432|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
156574766|NCT03519178|565192433|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
156574767|NCT03519178|565192434|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
156574768|NCT03519178|565192435|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
156574769|NCT03519178|565192436|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
156574770|NCT03519178|565192437|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
156574771|NCT03519178|565192423|FG000|PF-06873600 Treatment|Refused further treatment|0|||
156574772|NCT03519178|565192424|FG001|PF-06873600 Treatment|Refused further treatment|1|||
156574773|NCT03519178|565192425|FG002|PF-06873600 Treatment|Refused further treatment|0|||
156574774|NCT03519178|565192426|FG003|PF-06873600 Treatment|Refused further treatment|0|||
156574775|NCT03519178|565192427|FG004|PF-06873600 Treatment|Refused further treatment|1|||
156574776|NCT03519178|565192428|FG005|PF-06873600 Treatment|Refused further treatment|0|||
156574777|NCT03519178|565192429|FG006|PF-06873600 Treatment|Refused further treatment|0|||
156574778|NCT03519178|565192430|FG007|PF-06873600 Treatment|Refused further treatment|0|||
156574779|NCT03519178|565192431|FG008|PF-06873600 Treatment|Refused further treatment|0|||
156574780|NCT03519178|565192432|FG009|PF-06873600 Treatment|Refused further treatment|0|||
156574781|NCT03519178|565192433|FG010|PF-06873600 Treatment|Refused further treatment|0|||
156574782|NCT03519178|565192434|FG011|PF-06873600 Treatment|Refused further treatment|0|||
156574783|NCT03519178|565192435|FG012|PF-06873600 Treatment|Refused further treatment|0|||
156574784|NCT03519178|565192436|FG013|PF-06873600 Treatment|Refused further treatment|0|||
156574785|NCT03519178|565192437|FG014|PF-06873600 Treatment|Refused further treatment|1|||
156574786|NCT03519178|565192423|FG000|PF-06873600 Treatment|Other|0|||
156574787|NCT03519178|565192424|FG001|PF-06873600 Treatment|Other|0|||
156574788|NCT03519178|565192425|FG002|PF-06873600 Treatment|Other|0|||
156574789|NCT03519178|565192426|FG003|PF-06873600 Treatment|Other|0|||
156574790|NCT03519178|565192427|FG004|PF-06873600 Treatment|Other|0|||
156574791|NCT03519178|565192428|FG005|PF-06873600 Treatment|Other|0|||
156574792|NCT03519178|565192429|FG006|PF-06873600 Treatment|Other|0|||
156574793|NCT03519178|565192430|FG007|PF-06873600 Treatment|Other|0|||
156574794|NCT03519178|565192431|FG008|PF-06873600 Treatment|Other|1|||
156574795|NCT03519178|565192432|FG009|PF-06873600 Treatment|Other|0|||
156574796|NCT03519178|565192433|FG010|PF-06873600 Treatment|Other|0|||
156574797|NCT03519178|565192434|FG011|PF-06873600 Treatment|Other|0|||
156574798|NCT03519178|565192435|FG012|PF-06873600 Treatment|Other|0|||
156574799|NCT03519178|565192436|FG013|PF-06873600 Treatment|Other|1|||
156574800|NCT03519178|565192437|FG014|PF-06873600 Treatment|Other|3|||
156574801|NCT03519178|565192423|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
156574802|NCT03519178|565192424|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
156574803|NCT03519178|565192425|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
156574804|NCT03519178|565192426|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
156574805|NCT03519178|565192427|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
156574806|NCT03519178|565192428|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
156574807|NCT03519178|565192429|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
156574808|NCT03519178|565192430|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
156574809|NCT03519178|565192431|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
156574810|NCT03519178|565192432|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
156574811|NCT03519178|565192433|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
156574812|NCT03519178|565192434|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
156574813|NCT03519178|565192435|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
156574814|NCT03519178|565192436|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
156574815|NCT03519178|565192437|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
156574816|NCT03519178|565192423|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574817|NCT03519178|565192424|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574818|NCT03519178|565192425|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574819|NCT03519178|565192426|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574820|NCT03519178|565192427|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574821|NCT03519178|565192428|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574822|NCT03519178|565192429|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574823|NCT03519178|565192430|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574824|NCT03519178|565192431|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574825|NCT03519178|565192432|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574826|NCT03519178|565192433|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574827|NCT03519178|565192434|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574828|NCT03519178|565192435|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
156574829|NCT03519178|565192436|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
156574830|NCT03519178|565192437|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
156574831|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Adverse Event|0|||
156574832|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Adverse Event|0|||
156574833|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Adverse Event|0|||
156574834|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Adverse Event|0|||
156574835|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Adverse Event|0|||
156574836|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Adverse Event|0|||
156574837|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Adverse Event|0|||
156574838|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Adverse Event|0|||
156574839|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Adverse Event|0|||
156574840|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Adverse Event|0|||
156574841|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Adverse Event|0|||
156574842|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Adverse Event|0|||
156574843|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Adverse Event|0|||
156574844|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Adverse Event|1|||
156574845|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Adverse Event|0|||
156574846|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Death|0|||
156574847|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Death|0|||
156574848|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Death|0|||
156574849|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Death|0|||
156574850|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Death|0|||
156574851|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Death|0|||
156574852|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Death|0|||
156574853|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Death|0|||
156574854|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Death|0|||
156574855|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Death|1|||
156574856|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Death|0|||
156574857|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Death|0|||
156574858|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Death|0|||
156574859|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Death|0|||
156574860|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Death|1|||
156574861|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574862|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574863|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574864|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574865|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574866|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574867|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574868|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574869|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574870|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574871|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574872|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574873|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574874|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
156574875|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
156574876|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Physician Decision|0|||
156574877|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Physician Decision|0|||
156574878|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Physician Decision|0|||
156574879|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Physician Decision|0|||
156574880|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Physician Decision|0|||
156574881|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Physician Decision|0|||
156574882|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Physician Decision|0|||
156574883|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Physician Decision|0|||
156574884|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Physician Decision|0|||
156574885|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Physician Decision|0|||
156574886|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Physician Decision|0|||
156574887|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Physician Decision|0|||
156574888|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Physician Decision|0|||
156574889|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Physician Decision|4|||
156574890|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Physician Decision|2|||
156574891|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Progressive disease|0|||
156574892|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Progressive disease|0|||
156574893|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Progressive disease|0|||
156574894|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Progressive disease|0|||
156574895|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Progressive disease|0|||
156574896|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Progressive disease|0|||
156574897|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Progressive disease|0|||
156574898|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Progressive disease|0|||
156574899|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Progressive disease|0|||
156574900|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Progressive disease|5|||
156574901|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Progressive disease|0|||
156574902|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Progressive disease|0|||
156574903|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Progressive disease|0|||
156574904|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Progressive disease|30|||
156574905|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Progressive disease|8|||
156574906|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574907|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574908|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574909|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574910|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574911|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574912|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574913|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574914|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574915|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574916|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574917|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574918|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
156574919|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
156574920|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
156574921|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574922|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574923|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574924|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574925|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574926|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574927|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574928|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574929|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574930|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
156574931|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574932|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574933|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
156574934|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
156574935|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
156574936|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574937|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574938|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574939|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574940|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574941|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574942|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574943|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574944|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574945|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
156574946|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574947|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574948|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574949|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
156574950|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
156574951|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
156574952|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
156574953|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
156574954|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
156574955|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
156574956|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
156574957|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
156574958|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
156574959|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
156574960|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
156574961|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
156574962|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
156574963|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
156574964|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
156574965|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
156574966|NCT03519178|565192423|FG000|Fulvestrant. Treatment|Other|0|||
156574967|NCT03519178|565192424|FG001|Fulvestrant. Treatment|Other|0|||
156574968|NCT03519178|565192425|FG002|Fulvestrant. Treatment|Other|0|||
156574969|NCT03519178|565192426|FG003|Fulvestrant. Treatment|Other|0|||
156574970|NCT03519178|565192427|FG004|Fulvestrant. Treatment|Other|0|||
156574971|NCT03519178|565192428|FG005|Fulvestrant. Treatment|Other|0|||
156574972|NCT03519178|565192429|FG006|Fulvestrant. Treatment|Other|0|||
156574973|NCT03519178|565192430|FG007|Fulvestrant. Treatment|Other|0|||
156574974|NCT03519178|565192431|FG008|Fulvestrant. Treatment|Other|0|||
156574975|NCT03519178|565192432|FG009|Fulvestrant. Treatment|Other|0|||
156574976|NCT03519178|565192433|FG010|Fulvestrant. Treatment|Other|0|||
156574977|NCT03519178|565192434|FG011|Fulvestrant. Treatment|Other|0|||
156574978|NCT03519178|565192435|FG012|Fulvestrant. Treatment|Other|0|||
156574979|NCT03519178|565192436|FG013|Fulvestrant. Treatment|Other|1|||
156574980|NCT03519178|565192437|FG014|Fulvestrant. Treatment|Other|3|||
156574981|NCT03519178|565192423|FG000|Letrozole Treatment|Physician Decision|0|||
156574982|NCT03519178|565192424|FG001|Letrozole Treatment|Physician Decision|0|||
156574983|NCT03519178|565192425|FG002|Letrozole Treatment|Physician Decision|0|||
156574984|NCT03519178|565192426|FG003|Letrozole Treatment|Physician Decision|0|||
156574985|NCT03519178|565192427|FG004|Letrozole Treatment|Physician Decision|0|||
156574986|NCT03519178|565192428|FG005|Letrozole Treatment|Physician Decision|0|||
156574987|NCT03519178|565192429|FG006|Letrozole Treatment|Physician Decision|0|||
156574988|NCT03519178|565192430|FG007|Letrozole Treatment|Physician Decision|0|||
156574989|NCT03519178|565192431|FG008|Letrozole Treatment|Physician Decision|0|||
156574990|NCT03519178|565192432|FG009|Letrozole Treatment|Physician Decision|0|||
156574991|NCT03519178|565192433|FG010|Letrozole Treatment|Physician Decision|1|||
156574992|NCT03519178|565192434|FG011|Letrozole Treatment|Physician Decision|0|||
156574993|NCT03519178|565192435|FG012|Letrozole Treatment|Physician Decision|0|||
156574994|NCT03519178|565192436|FG013|Letrozole Treatment|Physician Decision|0|||
156574995|NCT03519178|565192437|FG014|Letrozole Treatment|Physician Decision|0|||
156574996|NCT03519178|565192423|FG000|Letrozole Treatment|Progressive disease|0|||
156574997|NCT03519178|565192424|FG001|Letrozole Treatment|Progressive disease|0|||
156574998|NCT03519178|565192425|FG002|Letrozole Treatment|Progressive disease|0|||
156574999|NCT03519178|565192426|FG003|Letrozole Treatment|Progressive disease|0|||
156575000|NCT03519178|565192427|FG004|Letrozole Treatment|Progressive disease|0|||
156575001|NCT03519178|565192428|FG005|Letrozole Treatment|Progressive disease|0|||
156575002|NCT03519178|565192429|FG006|Letrozole Treatment|Progressive disease|0|||
156575003|NCT03519178|565192430|FG007|Letrozole Treatment|Progressive disease|0|||
156575004|NCT03519178|565192431|FG008|Letrozole Treatment|Progressive disease|0|||
156575005|NCT03519178|565192432|FG009|Letrozole Treatment|Progressive disease|0|||
156575006|NCT03519178|565192433|FG010|Letrozole Treatment|Progressive disease|4|||
156575007|NCT03519178|565192434|FG011|Letrozole Treatment|Progressive disease|0|||
156575008|NCT03519178|565192435|FG012|Letrozole Treatment|Progressive disease|0|||
156575009|NCT03519178|565192436|FG013|Letrozole Treatment|Progressive disease|0|||
156575010|NCT03519178|565192437|FG014|Letrozole Treatment|Progressive disease|0|||
156575011|NCT03519178|565192423|FG000|Letrozole Treatment|Global deterioration of health status|0|||
156575012|NCT03519178|565192424|FG001|Letrozole Treatment|Global deterioration of health status|0|||
156575013|NCT03519178|565192425|FG002|Letrozole Treatment|Global deterioration of health status|0|||
156575014|NCT03519178|565192426|FG003|Letrozole Treatment|Global deterioration of health status|0|||
156575015|NCT03519178|565192427|FG004|Letrozole Treatment|Global deterioration of health status|0|||
156575016|NCT03519178|565192428|FG005|Letrozole Treatment|Global deterioration of health status|0|||
156575017|NCT03519178|565192429|FG006|Letrozole Treatment|Global deterioration of health status|0|||
156575018|NCT03519178|565192430|FG007|Letrozole Treatment|Global deterioration of health status|0|||
156575019|NCT03519178|565192431|FG008|Letrozole Treatment|Global deterioration of health status|0|||
156575020|NCT03519178|565192432|FG009|Letrozole Treatment|Global deterioration of health status|0|||
156575021|NCT03519178|565192433|FG010|Letrozole Treatment|Global deterioration of health status|2|||
156575022|NCT03519178|565192434|FG011|Letrozole Treatment|Global deterioration of health status|0|||
156575023|NCT03519178|565192435|FG012|Letrozole Treatment|Global deterioration of health status|0|||
156575024|NCT03519178|565192436|FG013|Letrozole Treatment|Global deterioration of health status|0|||
156575025|NCT03519178|565192437|FG014|Letrozole Treatment|Global deterioration of health status|0|||
156575026|NCT03519178|565192423|FG000|Follow-Up|Death|0|||
156575027|NCT03519178|565192424|FG001|Follow-Up|Death|0|||
156575028|NCT03519178|565192425|FG002|Follow-Up|Death|0|||
156575029|NCT03519178|565192426|FG003|Follow-Up|Death|0|||
156575030|NCT03519178|565192427|FG004|Follow-Up|Death|0|||
156575031|NCT03519178|565192428|FG005|Follow-Up|Death|0|||
156575032|NCT03519178|565192429|FG006|Follow-Up|Death|0|||
156575033|NCT03519178|565192430|FG007|Follow-Up|Death|0|||
156575034|NCT03519178|565192431|FG008|Follow-Up|Death|3|||
156575035|NCT03519178|565192432|FG009|Follow-Up|Death|1|||
156575036|NCT03519178|565192433|FG010|Follow-Up|Death|0|||
156575037|NCT03519178|565192434|FG011|Follow-Up|Death|0|||
156575038|NCT03519178|565192435|FG012|Follow-Up|Death|2|||
156575039|NCT03519178|565192436|FG013|Follow-Up|Death|0|||
156575040|NCT03519178|565192437|FG014|Follow-Up|Death|0|||
156575041|NCT03519178|565192423|FG000|Follow-Up|Lost to Follow-up|0|||
156575042|NCT03519178|565192424|FG001|Follow-Up|Lost to Follow-up|0|||
156575043|NCT03519178|565192425|FG002|Follow-Up|Lost to Follow-up|0|||
156575044|NCT03519178|565192426|FG003|Follow-Up|Lost to Follow-up|0|||
156575045|NCT03519178|565192427|FG004|Follow-Up|Lost to Follow-up|0|||
156575046|NCT03519178|565192428|FG005|Follow-Up|Lost to Follow-up|3|||
156575047|NCT03519178|565192429|FG006|Follow-Up|Lost to Follow-up|1|||
156575048|NCT03519178|565192430|FG007|Follow-Up|Lost to Follow-up|4|||
156575049|NCT03519178|565192431|FG008|Follow-Up|Lost to Follow-up|1|||
156575050|NCT03519178|565192432|FG009|Follow-Up|Lost to Follow-up|0|||
156575051|NCT03519178|565192433|FG010|Follow-Up|Lost to Follow-up|0|||
156575052|NCT03519178|565192434|FG011|Follow-Up|Lost to Follow-up|0|||
156575053|NCT03519178|565192435|FG012|Follow-Up|Lost to Follow-up|0|||
156575054|NCT03519178|565192436|FG013|Follow-Up|Lost to Follow-up|0|||
156575055|NCT03519178|565192437|FG014|Follow-Up|Lost to Follow-up|0|||
156575056|NCT03519178|565192423|FG000|Follow-Up|Withdrawal by Subject|1|||
156575057|NCT03519178|565192424|FG001|Follow-Up|Withdrawal by Subject|2|||
156575058|NCT03519178|565192425|FG002|Follow-Up|Withdrawal by Subject|2|||
156575059|NCT03519178|565192426|FG003|Follow-Up|Withdrawal by Subject|3|||
156575060|NCT03519178|565192427|FG004|Follow-Up|Withdrawal by Subject|5|||
156575061|NCT03519178|565192428|FG005|Follow-Up|Withdrawal by Subject|1|||
156575062|NCT03519178|565192429|FG006|Follow-Up|Withdrawal by Subject|2|||
156575063|NCT03519178|565192430|FG007|Follow-Up|Withdrawal by Subject|6|||
156575064|NCT03519178|565192431|FG008|Follow-Up|Withdrawal by Subject|5|||
156575065|NCT03519178|565192432|FG009|Follow-Up|Withdrawal by Subject|2|||
156575066|NCT03519178|565192433|FG010|Follow-Up|Withdrawal by Subject|3|||
156575067|NCT03519178|565192434|FG011|Follow-Up|Withdrawal by Subject|5|||
156575068|NCT03519178|565192435|FG012|Follow-Up|Withdrawal by Subject|2|||
156575069|NCT03519178|565192436|FG013|Follow-Up|Withdrawal by Subject|0|||
156575070|NCT03519178|565192437|FG014|Follow-Up|Withdrawal by Subject|0|||
156575071|NCT03519178|565192423|FG000|Follow-Up|Other|0|||
156575072|NCT03519178|565192424|FG001|Follow-Up|Other|0|||
156575073|NCT03519178|565192425|FG002|Follow-Up|Other|0|||
156575074|NCT03519178|565192426|FG003|Follow-Up|Other|0|||
156575075|NCT03519178|565192427|FG004|Follow-Up|Other|0|||
156575076|NCT03519178|565192428|FG005|Follow-Up|Other|0|||
156575077|NCT03519178|565192429|FG006|Follow-Up|Other|0|||
156575078|NCT03519178|565192430|FG007|Follow-Up|Other|1|||
156575079|NCT03519178|565192431|FG008|Follow-Up|Other|0|||
156575080|NCT03519178|565192432|FG009|Follow-Up|Other|0|||
156575081|NCT03519178|565192433|FG010|Follow-Up|Other|0|||
156575082|NCT03519178|565192434|FG011|Follow-Up|Other|0|||
156575083|NCT03519178|565192435|FG012|Follow-Up|Other|0|||
156575084|NCT03519178|565192436|FG013|Follow-Up|Other|0|||
156575085|NCT03519178|565192437|FG014|Follow-Up|Other|0|||
156575086|NCT03519178|565192423|FG000|Long-term Follow-up|Death|0|||
156575087|NCT03519178|565192424|FG001|Long-term Follow-up|Death|0|||
156575088|NCT03519178|565192425|FG002|Long-term Follow-up|Death|0|||
156575089|NCT03519178|565192426|FG003|Long-term Follow-up|Death|0|||
156575090|NCT03519178|565192427|FG004|Long-term Follow-up|Death|0|||
156575091|NCT03519178|565192428|FG005|Long-term Follow-up|Death|0|||
156575092|NCT03519178|565192429|FG006|Long-term Follow-up|Death|0|||
156575093|NCT03519178|565192430|FG007|Long-term Follow-up|Death|0|||
156575094|NCT03519178|565192431|FG008|Long-term Follow-up|Death|0|||
156575095|NCT03519178|565192432|FG009|Long-term Follow-up|Death|0|||
156575096|NCT03519178|565192433|FG010|Long-term Follow-up|Death|0|||
156575097|NCT03519178|565192434|FG011|Long-term Follow-up|Death|0|||
156575098|NCT03519178|565192435|FG012|Long-term Follow-up|Death|0|||
156575099|NCT03519178|565192436|FG013|Long-term Follow-up|Death|4|||
156575100|NCT03519178|565192437|FG014|Long-term Follow-up|Death|4|||
156575101|NCT03519178|565192423|FG000|Long-term Follow-up|Lost to Follow-up|0|||
156575102|NCT03519178|565192424|FG001|Long-term Follow-up|Lost to Follow-up|0|||
156575103|NCT03519178|565192425|FG002|Long-term Follow-up|Lost to Follow-up|0|||
156575104|NCT03519178|565192426|FG003|Long-term Follow-up|Lost to Follow-up|0|||
156575105|NCT03519178|565192427|FG004|Long-term Follow-up|Lost to Follow-up|0|||
156575106|NCT03519178|565192428|FG005|Long-term Follow-up|Lost to Follow-up|0|||
156575107|NCT03519178|565192429|FG006|Long-term Follow-up|Lost to Follow-up|0|||
156575108|NCT03519178|565192430|FG007|Long-term Follow-up|Lost to Follow-up|0|||
156575109|NCT03519178|565192431|FG008|Long-term Follow-up|Lost to Follow-up|0|||
156575110|NCT03519178|565192432|FG009|Long-term Follow-up|Lost to Follow-up|0|||
156575111|NCT03519178|565192433|FG010|Long-term Follow-up|Lost to Follow-up|0|||
156575112|NCT03519178|565192434|FG011|Long-term Follow-up|Lost to Follow-up|0|||
156575113|NCT03519178|565192435|FG012|Long-term Follow-up|Lost to Follow-up|0|||
156575114|NCT03519178|565192436|FG013|Long-term Follow-up|Lost to Follow-up|1|||
156575115|NCT03519178|565192437|FG014|Long-term Follow-up|Lost to Follow-up|1|||
156575116|NCT03519178|565192423|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
156575117|NCT03519178|565192424|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
156575118|NCT03519178|565192425|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
156575119|NCT03519178|565192426|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
156575120|NCT03519178|565192427|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
156575121|NCT03519178|565192428|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
156575122|NCT03519178|565192429|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
156575123|NCT03519178|565192430|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
156575124|NCT03519178|565192431|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
156575125|NCT03519178|565192432|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
156575126|NCT03519178|565192433|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
156575127|NCT03519178|565192434|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
156575128|NCT03519178|565192435|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
156575129|NCT03519178|565192436|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
156575130|NCT03519178|565192437|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
156575131|NCT03519178|565192423|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
156575132|NCT03519178|565192424|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
156575133|NCT03519178|565192425|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
156575134|NCT03519178|565192426|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
156575135|NCT03519178|565192427|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
156575136|NCT03519178|565192428|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
156575137|NCT03519178|565192429|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
156575138|NCT03519178|565192430|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
156575139|NCT03519178|565192431|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
156575140|NCT03519178|565192432|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
156575141|NCT03519178|565192433|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
156575142|NCT03519178|565192434|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
156575143|NCT03519178|565192435|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
156575144|NCT03519178|565192436|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
156575145|NCT03519178|565192437|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
156575146|NCT03519178|565192423|FG000|Long-term Follow-up|Other|0|||
156575147|NCT03519178|565192424|FG001|Long-term Follow-up|Other|0|||
156575148|NCT03519178|565192425|FG002|Long-term Follow-up|Other|0|||
156575149|NCT03519178|565192426|FG003|Long-term Follow-up|Other|0|||
156575150|NCT03519178|565192427|FG004|Long-term Follow-up|Other|0|||
156575151|NCT03519178|565192428|FG005|Long-term Follow-up|Other|0|||
156575152|NCT03519178|565192429|FG006|Long-term Follow-up|Other|0|||
156575153|NCT03519178|565192430|FG007|Long-term Follow-up|Other|0|||
156575154|NCT03519178|565192431|FG008|Long-term Follow-up|Other|0|||
156575155|NCT03519178|565192432|FG009|Long-term Follow-up|Other|0|||
156575156|NCT03519178|565192433|FG010|Long-term Follow-up|Other|0|||
156575157|NCT03519178|565192434|FG011|Long-term Follow-up|Other|0|||
156575158|NCT03519178|565192435|FG012|Long-term Follow-up|Other|0|||
156575159|NCT03519178|565192436|FG013|Long-term Follow-up|Other|0|||
156575160|NCT03519178|565192437|FG014|Long-term Follow-up|Other|1|||
156575161|NCT03519178|565192423|FG000|Long-term Follow-up|Global deterioration of health status|0|||
156575162|NCT03519178|565192424|FG001|Long-term Follow-up|Global deterioration of health status|0|||
156575163|NCT03519178|565192425|FG002|Long-term Follow-up|Global deterioration of health status|0|||
156575164|NCT03519178|565192426|FG003|Long-term Follow-up|Global deterioration of health status|0|||
156575165|NCT03519178|565192427|FG004|Long-term Follow-up|Global deterioration of health status|0|||
156575166|NCT03519178|565192428|FG005|Long-term Follow-up|Global deterioration of health status|0|||
156575167|NCT03519178|565192429|FG006|Long-term Follow-up|Global deterioration of health status|0|||
156575168|NCT03519178|565192430|FG007|Long-term Follow-up|Global deterioration of health status|0|||
156575169|NCT03519178|565192431|FG008|Long-term Follow-up|Global deterioration of health status|0|||
156575170|NCT03519178|565192432|FG009|Long-term Follow-up|Global deterioration of health status|0|||
156575171|NCT03519178|565192433|FG010|Long-term Follow-up|Global deterioration of health status|0|||
156575172|NCT03519178|565192434|FG011|Long-term Follow-up|Global deterioration of health status|0|||
156575173|NCT03519178|565192435|FG012|Long-term Follow-up|Global deterioration of health status|0|||
156575174|NCT03519178|565192436|FG013|Long-term Follow-up|Global deterioration of health status|1|||
156575175|NCT03519178|565192437|FG014|Long-term Follow-up|Global deterioration of health status|0|||
156575176|NCT03256539|565192442|FG000|Overall Study|Withdrawal by Subject|0|||
156575177|NCT03256539|565192443|FG001|Overall Study|Withdrawal by Subject|3|||
156575178|NCT03256539|565192442|FG000|Overall Study|Unexpected closure of study components|8|||
156575179|NCT03256539|565192443|FG001|Overall Study|Unexpected closure of study components|4|||
156575180|NCT05755438|565192446|FG000|12-week DBVC Period|Adverse Event|4|||
156575181|NCT05755438|565192447|FG001|12-week DBVC Period|Adverse Event|1|||
156575182|NCT05755438|565192446|FG000|12-week DBVC Period|Physician Decision|1|||
156575183|NCT05755438|565192447|FG001|12-week DBVC Period|Physician Decision|1|||
156575184|NCT05755438|565192446|FG000|12-week DBVC Period|Protocol Violation|4|||
156575185|NCT05755438|565192447|FG001|12-week DBVC Period|Protocol Violation|2|||
156575186|NCT05755438|565192446|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
156575187|NCT05755438|565192447|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
156575188|NCT05755438|565192446|FG000|12-week DBVC Period|Sponsor Decision|1|||
156575189|NCT05755438|565192447|FG001|12-week DBVC Period|Sponsor Decision|0|||
156575190|NCT05755438|565192446|FG000|40-week OLE Period|Adverse Event|0|||
156575191|NCT05755438|565192447|FG001|40-week OLE Period|Adverse Event|2|||
156575192|NCT05755438|565192446|FG000|40-week OLE Period|Lack of Efficacy|1|||
156575193|NCT05755438|565192447|FG001|40-week OLE Period|Lack of Efficacy|1|||
156575194|NCT05755438|565192446|FG000|40-week OLE Period|Lost to Follow-up|1|||
156575195|NCT05755438|565192447|FG001|40-week OLE Period|Lost to Follow-up|0|||
156575196|NCT05755438|565192446|FG000|40-week OLE Period|Physician Decision|1|||
156575197|NCT05755438|565192447|FG001|40-week OLE Period|Physician Decision|1|||
156575198|NCT05755438|565192446|FG000|40-week OLE Period|Protocol Violation|1|||
156575199|NCT05755438|565192447|FG001|40-week OLE Period|Protocol Violation|1|||
156575200|NCT05755438|565192446|FG000|40-week OLE Period|Withdrawal by Subject|6|||
156575201|NCT05755438|565192447|FG001|40-week OLE Period|Withdrawal by Subject|6|||
156575202|NCT05755438|565192446|FG000|40-week OLE Period|Sponsor Decision|3|||
156575203|NCT05755438|565192447|FG001|40-week OLE Period|Sponsor Decision|0|||
156575204|NCT05755438|565192446|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
156575205|NCT05755438|565192447|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
156575206|NCT05755438|565192446|FG000|40-week OLE Period|Ongoing|46|||
156575207|NCT05755438|565192447|FG001|40-week OLE Period|Ongoing|58|||
156575208|NCT01476787|565192455|FG000|Treatment|Progression|64|||
156575209|NCT01476787|565192456|FG001|Treatment|Progression|71|||
156575210|NCT01476787|565192455|FG000|Treatment|Toxicity|44|||
156575211|NCT01476787|565192456|FG001|Treatment|Toxicity|16|||
156575212|NCT01476787|565192455|FG000|Treatment|Death|0|||
156575213|NCT01476787|565192456|FG001|Treatment|Death|1|||
156575214|NCT01476787|565192455|FG000|Treatment|Withdrawal by Subject|3|||
156575215|NCT01476787|565192456|FG001|Treatment|Withdrawal by Subject|14|||
156575216|NCT01476787|565192455|FG000|Treatment|Major protocol violation|1|||
156575217|NCT01476787|565192456|FG001|Treatment|Major protocol violation|6|||
156575218|NCT01476787|565192455|FG000|Treatment|Other reasons|10|||
156575219|NCT01476787|565192456|FG001|Treatment|Other reasons|22|||
156575220|NCT01476787|565192455|FG000|Treatment|Concurrent illness|12|||
156575221|NCT01476787|565192456|FG001|Treatment|Concurrent illness|9|||
156575222|NCT01476787|565192455|FG000|Treatment|Insufficient response|15|||
156575223|NCT01476787|565192456|FG001|Treatment|Insufficient response|3|||
156575224|NCT01476787|565192455|FG000|Treatment|Voluntary treatment discontinuation|8|||
156575225|NCT01476787|565192456|FG001|Treatment|Voluntary treatment discontinuation|4|||
156575226|NCT01591330|565192457|FG000|Period 1|Adverse Event|1|||
156575227|NCT01591330|565192458|FG001|Period 1|Adverse Event|0|||
156575228|NCT01591330|565192459|FG002|Period 1|Adverse Event|0|||
156575229|NCT01591330|565192460|FG003|Period 1|Adverse Event|0|||
156575230|NCT01591330|565192457|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
156575231|NCT01591330|565192458|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
156575232|NCT01591330|565192459|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
156575233|NCT01591330|565192460|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
156575234|NCT01591330|565192457|FG000|Period 2|Adverse Event|1|||
156575235|NCT01591330|565192458|FG001|Period 2|Adverse Event|0|||
156575236|NCT01591330|565192459|FG002|Period 2|Adverse Event|0|||
156575237|NCT01591330|565192460|FG003|Period 2|Adverse Event|0|||
156575238|NCT01919411|565192467|FG000|Overall Study|Lost to Follow-up|2|||
156575239|NCT01919411|565192468|FG001|Overall Study|Lost to Follow-up|4|||
156575240|NCT01919411|565192467|FG000|Overall Study|Physician Decision|1|||
156575241|NCT01919411|565192468|FG001|Overall Study|Physician Decision|0|||
156575242|NCT01919411|565192467|FG000|Overall Study|Protocol Violation|2|||
156575243|NCT01919411|565192468|FG001|Overall Study|Protocol Violation|1|||
156575244|NCT00144300|565192469|FG000|Overall Study|Adverse Event|18|||
156575245|NCT00144300|565192470|FG001|Overall Study|Adverse Event|16|||
156575246|NCT00144300|565192469|FG000|Overall Study|Protocol Violation|1|||
156575247|NCT00144300|565192470|FG001|Overall Study|Protocol Violation|3|||
156575248|NCT00144300|565192469|FG000|Overall Study|Lost to Follow-up|3|||
156575249|NCT00144300|565192470|FG001|Overall Study|Lost to Follow-up|0|||
156575250|NCT00144300|565192469|FG000|Overall Study|Withdrawal by Subject|6|||
156575251|NCT00144300|565192470|FG001|Overall Study|Withdrawal by Subject|6|||
156575252|NCT00144300|565192469|FG000|Overall Study|Other reason (not specified)|1|||
156575253|NCT00144300|565192470|FG001|Overall Study|Other reason (not specified)|3|||
156575254|NCT00095121|565192471|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
156575255|NCT00095121|565192472|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
156575256|NCT00095121|565192471|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
156575257|NCT00095121|565192472|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
156575258|NCT04636177|565192476|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
156575259|NCT04636177|565192477|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
156575260|NCT04636177|565192476|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
156575261|NCT04636177|565192477|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
156575262|NCT04636177|565192476|FG000|Single-arm portion|Withdrawal by Subject|1|||
156575263|NCT04636177|565192477|FG001|Single-arm portion|Withdrawal by Subject|0|||
156575264|NCT04636177|565192476|FG000|Single-arm portion|Adverse Event|1|||
156575265|NCT04636177|565192477|FG001|Single-arm portion|Adverse Event|0|||
156575266|NCT02495077|565194093|FG000|Overall Study|Adverse Event|0|||
156575267|NCT02495077|565194094|FG001|Overall Study|Adverse Event|1|||
156575268|NCT02495077|565194095|FG002|Overall Study|Adverse Event|1|||
156575269|NCT02495077|565194096|FG003|Overall Study|Adverse Event|0|||
156575270|NCT02495077|565194093|FG000|Overall Study|Death|3|||
156575271|NCT02495077|565194094|FG001|Overall Study|Death|5|||
156575272|NCT02495077|565194095|FG002|Overall Study|Death|0|||
156575273|NCT02495077|565194096|FG003|Overall Study|Death|0|||
156575274|NCT02495077|565194093|FG000|Overall Study|Lost to Follow-up|6|||
156575275|NCT02495077|565194094|FG001|Overall Study|Lost to Follow-up|4|||
156575276|NCT02495077|565194095|FG002|Overall Study|Lost to Follow-up|0|||
156575277|NCT02495077|565194096|FG003|Overall Study|Lost to Follow-up|0|||
156575278|NCT02495077|565194093|FG000|Overall Study|Physician Decision|2|||
156575279|NCT02495077|565194094|FG001|Overall Study|Physician Decision|1|||
156575280|NCT02495077|565194095|FG002|Overall Study|Physician Decision|4|||
156575281|NCT02495077|565194096|FG003|Overall Study|Physician Decision|0|||
156575282|NCT02495077|565194093|FG000|Overall Study|Protocol Violation|0|||
156575283|NCT02495077|565194094|FG001|Overall Study|Protocol Violation|1|||
156575284|NCT02495077|565194095|FG002|Overall Study|Protocol Violation|0|||
156575285|NCT02495077|565194096|FG003|Overall Study|Protocol Violation|0|||
156575286|NCT02495077|565194093|FG000|Overall Study|Screen Failure|0|||
156575287|NCT02495077|565194094|FG001|Overall Study|Screen Failure|0|||
156575288|NCT02495077|565194095|FG002|Overall Study|Screen Failure|0|||
156575289|NCT02495077|565194096|FG003|Overall Study|Screen Failure|48|||
156575290|NCT02495077|565194093|FG000|Overall Study|Withdrawal by Subject|7|||
156575291|NCT02495077|565194094|FG001|Overall Study|Withdrawal by Subject|7|||
156575292|NCT02495077|565194095|FG002|Overall Study|Withdrawal by Subject|7|||
156575293|NCT02495077|565194096|FG003|Overall Study|Withdrawal by Subject|0|||
156575294|NCT02495077|565194093|FG000|Overall Study|Covid-19 research restrictions|1|||
156575295|NCT02495077|565194094|FG001|Overall Study|Covid-19 research restrictions|0|||
156575296|NCT02495077|565194095|FG002|Overall Study|Covid-19 research restrictions|0|||
156575297|NCT02495077|565194096|FG003|Overall Study|Covid-19 research restrictions|0|||
156575298|NCT02495077|565194093|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
156575299|NCT02495077|565194094|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
156575300|NCT02495077|565194095|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
156575301|NCT02495077|565194096|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
156575302|NCT02495077|565194093|FG000|Overall Study|Incarcerated|0|||
156575303|NCT02495077|565194094|FG001|Overall Study|Incarcerated|1|||
156575304|NCT02495077|565194095|FG002|Overall Study|Incarcerated|0|||
156575305|NCT02495077|565194096|FG003|Overall Study|Incarcerated|0|||
156575306|NCT02495077|565194093|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
156575307|NCT02495077|565194094|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
156575308|NCT02495077|565194095|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
156575309|NCT02495077|565194096|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
156575310|NCT02495077|565194093|FG000|Overall Study|Timing of transplant and randomization|0|||
156575311|NCT02495077|565194094|FG001|Overall Study|Timing of transplant and randomization|0|||
156575312|NCT02495077|565194095|FG002|Overall Study|Timing of transplant and randomization|5|||
156575313|NCT02495077|565194096|FG003|Overall Study|Timing of transplant and randomization|0|||
156575314|NCT02742649|565194097|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
156575315|NCT02742649|565194098|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
156575316|NCT02742649|565194099|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
156575317|NCT02742649|565194100|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
156575318|NCT02742649|565194101|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
156575319|NCT02742649|565194097|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156575320|NCT02742649|565194098|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156575321|NCT02742649|565194099|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156575322|NCT02742649|565194100|FG003|Double-Blind Treatment Period|Adverse Event|0|||
156575323|NCT02742649|565194101|FG004|Double-Blind Treatment Period|Adverse Event|0|||
156575324|NCT02742649|565194097|FG000|Open-Label Period|Lost to Follow-up|0|||
156575325|NCT02742649|565194098|FG001|Open-Label Period|Lost to Follow-up|0|||
156575326|NCT02742649|565194099|FG002|Open-Label Period|Lost to Follow-up|0|||
156575327|NCT02742649|565194100|FG003|Open-Label Period|Lost to Follow-up|0|||
156575328|NCT02742649|565194101|FG004|Open-Label Period|Lost to Follow-up|1|||
156575329|NCT00443560|565194102|FG000|Overall Study|No intrathecal dose|58|||
156575330|NCT00443560|565194103|FG001|Overall Study|No intrathecal dose|26|||
156575331|NCT00443560|565194102|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
156575332|NCT00443560|565194103|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
156575333|NCT01059812|565194108|FG000|Overall Study|Adverse Event|9|||
156575334|NCT01059812|565194109|FG001|Overall Study|Adverse Event|5|||
156575335|NCT01059812|565194108|FG000|Overall Study|Lack of Efficacy|2|||
156575336|NCT01059812|565194109|FG001|Overall Study|Lack of Efficacy|2|||
156575337|NCT01059812|565194108|FG000|Overall Study|Protocol Violation|3|||
156575338|NCT01059812|565194109|FG001|Overall Study|Protocol Violation|1|||
156575339|NCT01059812|565194108|FG000|Overall Study|Withdrawal Criteria|9|||
156575340|NCT01059812|565194109|FG001|Overall Study|Withdrawal Criteria|4|||
156575341|NCT01059812|565194108|FG000|Overall Study|Unclassified|14|||
156575342|NCT01059812|565194109|FG001|Overall Study|Unclassified|4|||
156575343|NCT00756002|565194113|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
156575344|NCT00756002|565194114|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
156575345|NCT00756002|565194113|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156575346|NCT00756002|565194114|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
156575347|NCT00756002|565194113|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
156575348|NCT00756002|565194114|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
156575349|NCT00756002|565194113|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
156575350|NCT00756002|565194114|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
156575351|NCT00756002|565194113|FG000|Double-Blind Treatment Period|Other|2|||
156575352|NCT00756002|565194114|FG001|Double-Blind Treatment Period|Other|2|||
156575353|NCT04329923|565194118|FG000|Overall Study|Withdrawal by Subject|1|||
156575354|NCT04329923|565194119|FG001|Overall Study|Withdrawal by Subject|4|||
156575355|NCT04329923|565194120|FG002|Overall Study|Withdrawal by Subject|1|||
156575356|NCT04329923|565194121|FG003|Overall Study|Withdrawal by Subject|1|||
156575357|NCT04329923|565194122|FG004|Overall Study|Withdrawal by Subject|1|||
156575358|NCT04329923|565194123|FG005|Overall Study|Withdrawal by Subject|1|||
156575359|NCT04329923|565194118|FG000|Overall Study|early termination of study|0|||
156575360|NCT04329923|565194119|FG001|Overall Study|early termination of study|0|||
156575361|NCT04329923|565194120|FG002|Overall Study|early termination of study|0|||
156575362|NCT04329923|565194121|FG003|Overall Study|early termination of study|0|||
156575363|NCT04329923|565194122|FG004|Overall Study|early termination of study|1|||
156575364|NCT04329923|565194123|FG005|Overall Study|early termination of study|2|||
156575365|NCT04329923|565194118|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
156575366|NCT04329923|565194119|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
156575367|NCT04329923|565194120|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
156575368|NCT04329923|565194121|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
156575369|NCT04329923|565194122|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
156575370|NCT04329923|565194123|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
156575371|NCT03334214|565194124|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
156575372|NCT03334214|565194125|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
156575373|NCT03334214|565194124|FG000|Overall Study|Withdrawal by Subject|0|||
156575374|NCT03334214|565194125|FG001|Overall Study|Withdrawal by Subject|1|||
156575375|NCT03334214|565194124|FG000|Overall Study|Other|1|||
156575376|NCT03334214|565194125|FG001|Overall Study|Other|0|||
156575377|NCT01260181|565194130|FG000|Overall Study|Decision of Investigator|1|||
156575378|NCT01844076|565194131|FG000|Overall Study|Adverse Event|1|||
156575379|NCT01844076|565194132|FG001|Overall Study|Adverse Event|0|||
156575380|NCT01844076|565194133|FG002|Overall Study|Adverse Event|0|||
156575381|NCT01844076|565194134|FG003|Overall Study|Adverse Event|0|||
156575382|NCT01844076|565194131|FG000|Overall Study|Withdrawal by Subject|1|||
156575383|NCT01844076|565194132|FG001|Overall Study|Withdrawal by Subject|0|||
156575384|NCT01844076|565194133|FG002|Overall Study|Withdrawal by Subject|0|||
156575385|NCT01844076|565194134|FG003|Overall Study|Withdrawal by Subject|0|||
156575386|NCT02088034|565194139|FG000|Overall Study|Lost to Follow-up|1|||
156575387|NCT02088034|565194140|FG001|Overall Study|Lost to Follow-up|1|||
156575388|NCT02088034|565194141|FG002|Overall Study|Lost to Follow-up|0|||
156575389|NCT02088034|565194139|FG000|Overall Study|Pregnancy|2|||
156575390|NCT02088034|565194140|FG001|Overall Study|Pregnancy|1|||
156575391|NCT02088034|565194141|FG002|Overall Study|Pregnancy|2|||
156575392|NCT00308620|565194144|FG000|Overall Study|Death|1|||
156575393|NCT00308620|565194145|FG001|Overall Study|Death|1|||
156575394|NCT00308620|565194146|FG002|Overall Study|Death|0|||
156575395|NCT00308620|565194144|FG000|Overall Study|Lost to Follow-up|0|||
156575396|NCT00308620|565194145|FG001|Overall Study|Lost to Follow-up|0|||
156575397|NCT00308620|565194146|FG002|Overall Study|Lost to Follow-up|1|||
156575398|NCT00550238|565194151|FG000|Overall Study|Adverse Event|88|||
156575399|NCT00550238|565194151|FG000|Overall Study|Death|34|||
156575400|NCT00550238|565194151|FG000|Overall Study|Disease progression|46|||
156575401|NCT00550238|565194151|FG000|Overall Study|Withdrawal by Subject|167|||
156575402|NCT00550238|565194151|FG000|Overall Study|Physician Decision|31|||
156575403|NCT00550238|565194151|FG000|Overall Study|Patient noncompliance|25|||
156575404|NCT00550238|565194151|FG000|Overall Study|Lost to Follow-up|13|||
156575405|NCT00550238|565194151|FG000|Overall Study|Sponsor decision|55|||
156575406|NCT03133481|565194152|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
156575407|NCT03133481|565194153|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
156575408|NCT01486238|565194159|FG000|Overall Study|Death|0|||
156575409|NCT01486238|565194160|FG001|Overall Study|Death|2|||
156575410|NCT01486238|565194159|FG000|Overall Study|Withdrawal by Subject|2|||
156575411|NCT01486238|565194160|FG001|Overall Study|Withdrawal by Subject|1|||
156575412|NCT01486238|565194159|FG000|Overall Study|Lost to Follow-up|0|||
156575413|NCT01486238|565194160|FG001|Overall Study|Lost to Follow-up|3|||
156575414|NCT00637728|565194161|FG000|Double-blind Phase|Adverse Event|1|||
156575415|NCT00637728|565194162|FG001|Double-blind Phase|Adverse Event|0|||
156575416|NCT00637728|565194163|FG002|Double-blind Phase|Adverse Event|0|||
156575417|NCT00637728|565194161|FG000|Double-blind Phase|Non-compliance|2|||
156575418|NCT00637728|565194162|FG001|Double-blind Phase|Non-compliance|0|||
156575419|NCT00637728|565194163|FG002|Double-blind Phase|Non-compliance|0|||
156575420|NCT00637728|565194161|FG000|Double-blind Phase|Study Discontinued|1|||
156575421|NCT00637728|565194162|FG001|Double-blind Phase|Study Discontinued|1|||
156575422|NCT00637728|565194163|FG002|Double-blind Phase|Study Discontinued|0|||
156575423|NCT01050062|565194164|FG000|Overall Study|Adverse Event|75|||
156575424|NCT01050062|565194165|FG001|Overall Study|Adverse Event|22|||
156575425|NCT01050062|565194164|FG000|Overall Study|Lost to Follow-up|83|||
156575426|NCT01050062|565194165|FG001|Overall Study|Lost to Follow-up|35|||
156575427|NCT01050062|565194164|FG000|Overall Study|Lack of Efficacy|22|||
156575428|NCT01050062|565194165|FG001|Overall Study|Lack of Efficacy|35|||
156575429|NCT01050062|565194164|FG000|Overall Study|Physician Decision|74|||
156575430|NCT01050062|565194165|FG001|Overall Study|Physician Decision|9|||
156575431|NCT01050062|565194164|FG000|Overall Study|Others|17|||
156575432|NCT01050062|565194165|FG001|Overall Study|Others|11|||
156575433|NCT01873950|565194166|FG000|Period 5|Withdrawal by Subject|0|||
156575434|NCT01873950|565194167|FG001|Period 5|Withdrawal by Subject|0|||
156575435|NCT01873950|565194168|FG002|Period 5|Withdrawal by Subject|0|||
156575436|NCT01873950|565194169|FG003|Period 5|Withdrawal by Subject|1|||
156575437|NCT01873950|565194170|FG004|Period 5|Withdrawal by Subject|0|||
156575438|NCT03894540|565194172|FG000|Overall Study|Adverse Event|0|||
156575439|NCT03894540|565194173|FG001|Overall Study|Adverse Event|0|||
156575440|NCT03894540|565194174|FG002|Overall Study|Adverse Event|0|||
156575441|NCT03894540|565194175|FG003|Overall Study|Adverse Event|0|||
156575442|NCT03894540|565194176|FG004|Overall Study|Adverse Event|1|||
156575443|NCT03894540|565194177|FG005|Overall Study|Adverse Event|0|||
156575444|NCT03894540|565194172|FG000|Overall Study|Withdrawal by Subject|0|||
156575445|NCT03894540|565194173|FG001|Overall Study|Withdrawal by Subject|0|||
156575446|NCT03894540|565194174|FG002|Overall Study|Withdrawal by Subject|0|||
156575447|NCT03894540|565194175|FG003|Overall Study|Withdrawal by Subject|0|||
156575448|NCT03894540|565194176|FG004|Overall Study|Withdrawal by Subject|1|||
156575449|NCT03894540|565194177|FG005|Overall Study|Withdrawal by Subject|0|||
156575450|NCT03894540|565194172|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
156575451|NCT03894540|565194173|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
156575452|NCT03894540|565194174|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
156575453|NCT03894540|565194175|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
156575454|NCT03894540|565194176|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
156575455|NCT03894540|565194177|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
156575456|NCT03894540|565194172|FG000|Overall Study|Progressive Disease Clinical|1|||
156575457|NCT03894540|565194173|FG001|Overall Study|Progressive Disease Clinical|1|||
156575458|NCT03894540|565194174|FG002|Overall Study|Progressive Disease Clinical|0|||
156575459|NCT03894540|565194175|FG003|Overall Study|Progressive Disease Clinical|1|||
156575460|NCT03894540|565194176|FG004|Overall Study|Progressive Disease Clinical|5|||
156575461|NCT03894540|565194177|FG005|Overall Study|Progressive Disease Clinical|1|||
156575462|NCT03894540|565194172|FG000|Overall Study|Study termination by sponsor|0|||
156575463|NCT03894540|565194173|FG001|Overall Study|Study termination by sponsor|0|||
156575464|NCT03894540|565194174|FG002|Overall Study|Study termination by sponsor|0|||
156575465|NCT03894540|565194175|FG003|Overall Study|Study termination by sponsor|0|||
156575466|NCT03894540|565194176|FG004|Overall Study|Study termination by sponsor|2|||
156575467|NCT03894540|565194177|FG005|Overall Study|Study termination by sponsor|0|||
156575468|NCT03000452|565194178|FG000|Treatment Period|Death|1|||
156575469|NCT03000452|565194178|FG000|Treatment Period|Progressive Disease (PD)|14|||
156575470|NCT03000452|565194178|FG000|Treatment Period|Physician Decision|1|||
156575471|NCT03000452|565194178|FG000|Treatment Period|Miscellaneous|2|||
156575472|NCT03000452|565194178|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
156575473|NCT03000452|565194178|FG000|Follow-Up Period|Death|3|||
156575474|NCT03000452|565194178|FG000|Follow-Up Period|Withdrawal by Subject|3|||
156575475|NCT00593112|565194179|FG000|Overall Study|Scan Anxiety|3|||
156575476|NCT00593112|565194180|FG001|Overall Study|Scan Anxiety|0|||
156575477|NCT00593112|565194179|FG000|Overall Study|Abnormal Scan|1|||
156575478|NCT00593112|565194180|FG001|Overall Study|Abnormal Scan|0|||
156575479|NCT00593112|565194179|FG000|Overall Study|Unreadable Scan|1|||
156575480|NCT00593112|565194180|FG001|Overall Study|Unreadable Scan|0|||
156575481|NCT00593112|565194179|FG000|Overall Study|Withdrawal by Subject|5|||
156575482|NCT00593112|565194180|FG001|Overall Study|Withdrawal by Subject|0|||
156575483|NCT03043365|565194181|FG000|Weeks 0 to Week 8|Adverse Event|1|||
156575484|NCT03043365|565194182|FG001|Weeks 0 to Week 8|Adverse Event|3|||
156575485|NCT03043365|565194181|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
156575486|NCT03043365|565194182|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
156575487|NCT03043365|565194181|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
156575488|NCT03043365|565194182|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
156575489|NCT02723630|565194183|FG000|Intervention Period 1|Adverse Event|1|||
156575490|NCT02723630|565194184|FG001|Intervention Period 1|Adverse Event|0|||
156575491|NCT02723630|565194185|FG002|Intervention Period 1|Adverse Event|0|||
156575492|NCT02723630|565194186|FG003|Intervention Period 1|Adverse Event|0|||
156575493|NCT02723630|565194187|FG004|Intervention Period 1|Adverse Event|0|||
156575494|NCT02723630|565194188|FG005|Intervention Period 1|Adverse Event|0|||
156575495|NCT02723630|565194183|FG000|Intervention Period 3|consumption of restricted item|0|||
156575496|NCT02723630|565194184|FG001|Intervention Period 3|consumption of restricted item|1|||
156575497|NCT02723630|565194185|FG002|Intervention Period 3|consumption of restricted item|0|||
156575498|NCT02723630|565194186|FG003|Intervention Period 3|consumption of restricted item|0|||
156575499|NCT02723630|565194187|FG004|Intervention Period 3|consumption of restricted item|0|||
156575500|NCT02723630|565194188|FG005|Intervention Period 3|consumption of restricted item|0|||
156575501|NCT00537745|565194189|FG000|Overall Study|Did not meet eligibility criteria|2|||
156575502|NCT00537745|565194189|FG000|Overall Study|Withdrawal by Subject|2|||
156575503|NCT00537745|565194189|FG000|Overall Study|Subject unable to provide Interlock info|1|||
156575504|NCT01570491|565194190|FG000|Overall Study|Lost to Follow-up|3|||
156575505|NCT01570491|565194191|FG001|Overall Study|Lost to Follow-up|1|||
156575506|NCT01570491|565194190|FG000|Overall Study|treatment: not given or discontinued|2|||
156575507|NCT01570491|565194191|FG001|Overall Study|treatment: not given or discontinued|0|||
156575508|NCT03700892|565194195|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
156575509|NCT03700892|565194196|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
156575510|NCT03700892|565194197|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
156575511|NCT00849212|565194198|FG000|Overall Study|Lack of Efficacy|1|||
156575512|NCT00849212|565194198|FG000|Overall Study|Withdrawal by Subject|3|||
156575513|NCT00849212|565194198|FG000|Overall Study|Adverse Event|2|||
156575514|NCT00849212|565194198|FG000|Overall Study|Miscellaneous|1|||
156575515|NCT04407507|565194199|FG000|Overall Study|Withdrawal by Subject|0|||
156575516|NCT04407507|565194200|FG001|Overall Study|Withdrawal by Subject|1|||
156575517|NCT01499576|565194201|FG000|Overall Study|Physician Decision|12|||
156575518|NCT01499576|565194201|FG000|Overall Study|Withdrawal by Subject|9|||
156575519|NCT03396471|565194204|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
156575520|NCT03396471|565194204|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
156575521|NCT03396471|565194204|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
156575522|NCT03396471|565194204|FG000|Study Treatment - Up to 22 Months|Death|2|||
156575523|NCT03396471|565194204|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
156575524|NCT03396471|565194204|FG000|Follow up - Up to 2 Years|Death|9|||
156575525|NCT03396471|565194204|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
156575526|NCT03396471|565194204|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
156575527|NCT03396471|565194204|FG000|Follow up - Up to 2 Years|study terminated|1|||
156575528|NCT03396471|565194204|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
156575529|NCT03396471|565194204|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
156575530|NCT00923091|565194205|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
156575531|NCT00923091|565194206|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
156575532|NCT00923091|565194207|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
156575533|NCT00923091|565194208|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
156575534|NCT00923091|565194209|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
156575535|NCT00923091|565194210|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
156575536|NCT00923091|565194211|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
156575537|NCT00923091|565194212|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
156575538|NCT00923091|565194213|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
156575539|NCT00923091|565194214|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
156575540|NCT00923091|565194215|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
156575541|NCT00923091|565194216|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
156575542|NCT00923091|565194217|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
156575543|NCT00923091|565194205|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
156575544|NCT00923091|565194206|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
156575545|NCT00923091|565194207|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
156575546|NCT00923091|565194208|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
156575547|NCT00923091|565194209|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
156575548|NCT00923091|565194210|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
156575549|NCT00923091|565194211|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
156575550|NCT00923091|565194212|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
156575551|NCT00923091|565194213|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
156575552|NCT00923091|565194214|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
156575553|NCT00923091|565194215|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
156575554|NCT00923091|565194216|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
156575555|NCT00923091|565194217|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
156575556|NCT00923091|565194205|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
156575557|NCT00923091|565194206|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
156575558|NCT00923091|565194207|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
156575559|NCT00923091|565194208|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
156575560|NCT00923091|565194209|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
156575561|NCT00923091|565194210|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
156575562|NCT00923091|565194211|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
156575563|NCT00923091|565194212|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
156575564|NCT00923091|565194213|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
156575565|NCT00923091|565194214|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
156575566|NCT00923091|565194215|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
156575567|NCT00923091|565194216|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
156575568|NCT00923091|565194217|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
156575569|NCT00923091|565194205|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575570|NCT00923091|565194206|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575571|NCT00923091|565194207|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575572|NCT00923091|565194208|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575573|NCT00923091|565194209|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575574|NCT00923091|565194210|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
156575575|NCT00923091|565194211|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575576|NCT00923091|565194212|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575577|NCT00923091|565194213|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575578|NCT00923091|565194214|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575579|NCT00923091|565194215|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575580|NCT00923091|565194216|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575581|NCT00923091|565194217|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156575582|NCT00923091|565194205|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575583|NCT00923091|565194206|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
156575584|NCT00923091|565194207|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575585|NCT00923091|565194208|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
156575586|NCT00923091|565194209|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575587|NCT00923091|565194210|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
156575588|NCT00923091|565194211|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575589|NCT00923091|565194212|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575590|NCT00923091|565194213|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575591|NCT00923091|565194214|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575592|NCT00923091|565194215|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575593|NCT00923091|565194216|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575594|NCT00923091|565194217|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
156575595|NCT00923091|565194205|FG000|Period III (Single-Blind)|Adverse Event|5|||
156575596|NCT00923091|565194206|FG001|Period III (Single-Blind)|Adverse Event|0|||
156575597|NCT00923091|565194207|FG002|Period III (Single-Blind)|Adverse Event|0|||
156575598|NCT00923091|565194208|FG003|Period III (Single-Blind)|Adverse Event|0|||
156575599|NCT00923091|565194209|FG004|Period III (Single-Blind)|Adverse Event|0|||
156575600|NCT00923091|565194210|FG005|Period III (Single-Blind)|Adverse Event|0|||
156575601|NCT00923091|565194211|FG006|Period III (Single-Blind)|Adverse Event|0|||
156575602|NCT00923091|565194212|FG007|Period III (Single-Blind)|Adverse Event|0|||
156575603|NCT00923091|565194213|FG008|Period III (Single-Blind)|Adverse Event|0|||
156575604|NCT00923091|565194214|FG009|Period III (Single-Blind)|Adverse Event|0|||
156575605|NCT00923091|565194215|FG010|Period III (Single-Blind)|Adverse Event|0|||
156575606|NCT00923091|565194216|FG011|Period III (Single-Blind)|Adverse Event|0|||
156575607|NCT00923091|565194217|FG012|Period III (Single-Blind)|Adverse Event|0|||
156575608|NCT00923091|565194205|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
156575609|NCT00923091|565194206|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575610|NCT00923091|565194207|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575611|NCT00923091|565194208|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575612|NCT00923091|565194209|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575613|NCT00923091|565194210|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575614|NCT00923091|565194211|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575615|NCT00923091|565194212|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575616|NCT00923091|565194213|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575617|NCT00923091|565194214|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575618|NCT00923091|565194215|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575619|NCT00923091|565194216|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575620|NCT00923091|565194217|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
156575621|NCT00923091|565194205|FG000|Period III (Single-Blind)|Protocol Violation|3|||
156575622|NCT00923091|565194206|FG001|Period III (Single-Blind)|Protocol Violation|0|||
156575623|NCT00923091|565194207|FG002|Period III (Single-Blind)|Protocol Violation|0|||
156575624|NCT00923091|565194208|FG003|Period III (Single-Blind)|Protocol Violation|0|||
156575625|NCT00923091|565194209|FG004|Period III (Single-Blind)|Protocol Violation|0|||
156575626|NCT00923091|565194210|FG005|Period III (Single-Blind)|Protocol Violation|0|||
156575627|NCT00923091|565194211|FG006|Period III (Single-Blind)|Protocol Violation|0|||
156575628|NCT00923091|565194212|FG007|Period III (Single-Blind)|Protocol Violation|0|||
156575629|NCT00923091|565194213|FG008|Period III (Single-Blind)|Protocol Violation|0|||
156575630|NCT00923091|565194214|FG009|Period III (Single-Blind)|Protocol Violation|0|||
156575631|NCT00923091|565194215|FG010|Period III (Single-Blind)|Protocol Violation|0|||
156575632|NCT00923091|565194216|FG011|Period III (Single-Blind)|Protocol Violation|0|||
156575633|NCT00923091|565194217|FG012|Period III (Single-Blind)|Protocol Violation|0|||
156575634|NCT00923091|565194205|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
156575635|NCT00923091|565194206|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
156575636|NCT00923091|565194207|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
156575637|NCT00923091|565194208|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
156575638|NCT00923091|565194209|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
156575639|NCT00923091|565194210|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
156575640|NCT00923091|565194211|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
156575641|NCT00923091|565194212|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
156575642|NCT00923091|565194213|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
156575643|NCT00923091|565194214|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
156575644|NCT00923091|565194215|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
156575645|NCT00923091|565194216|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
156575646|NCT00923091|565194217|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
156575647|NCT00923091|565194205|FG000|Period IV (Double-Blind)|Adverse Event|2|||
156575648|NCT00923091|565194206|FG001|Period IV (Double-Blind)|Adverse Event|0|||
156575649|NCT00923091|565194207|FG002|Period IV (Double-Blind)|Adverse Event|0|||
156575650|NCT00923091|565194208|FG003|Period IV (Double-Blind)|Adverse Event|0|||
156575651|NCT00923091|565194209|FG004|Period IV (Double-Blind)|Adverse Event|0|||
156575652|NCT00923091|565194210|FG005|Period IV (Double-Blind)|Adverse Event|0|||
156575653|NCT00923091|565194211|FG006|Period IV (Double-Blind)|Adverse Event|0|||
156575654|NCT00923091|565194212|FG007|Period IV (Double-Blind)|Adverse Event|0|||
156575655|NCT00923091|565194213|FG008|Period IV (Double-Blind)|Adverse Event|0|||
156575656|NCT00923091|565194214|FG009|Period IV (Double-Blind)|Adverse Event|0|||
156575657|NCT00923091|565194215|FG010|Period IV (Double-Blind)|Adverse Event|0|||
156575658|NCT00923091|565194216|FG011|Period IV (Double-Blind)|Adverse Event|0|||
156863437|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
156863438|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156863439|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156863440|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
156863441|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
156863442|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
156863443|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
156863444|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
156863445|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
156863446|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
156863447|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
156863448|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
156863449|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156863450|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
156863451|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
156863452|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
156863453|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
156863454|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
156863455|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
156863456|NCT03137381|566258642|FG000|Overall Study|Adverse Event|3|||
156863457|NCT03137381|566258643|FG001|Overall Study|Adverse Event|0|||
156863458|NCT03137381|566258644|FG002|Overall Study|Adverse Event|2|||
156863459|NCT03137381|566258645|FG003|Overall Study|Adverse Event|0|||
156863460|NCT03137381|566258642|FG000|Overall Study|Lost to Follow-up|2|||
156575659|NCT00923091|565194217|FG012|Period IV (Double-Blind)|Adverse Event|0|||
156863461|NCT03137381|566258643|FG001|Overall Study|Lost to Follow-up|1|||
156863462|NCT03137381|566258644|FG002|Overall Study|Lost to Follow-up|1|||
156575660|NCT00923091|565194205|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575661|NCT00923091|565194206|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
156575662|NCT00923091|565194207|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575663|NCT00923091|565194208|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575664|NCT00923091|565194209|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575665|NCT00923091|565194210|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575666|NCT00923091|565194211|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575667|NCT00923091|565194212|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575668|NCT00923091|565194213|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575669|NCT00923091|565194214|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575670|NCT00923091|565194215|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575671|NCT00923091|565194216|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575672|NCT00923091|565194217|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156575673|NCT00923091|565194205|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
156575674|NCT00923091|565194206|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
156575675|NCT00923091|565194207|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
156575676|NCT00923091|565194208|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
156575677|NCT00923091|565194209|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
156575678|NCT00923091|565194210|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
156575679|NCT00923091|565194211|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
156575680|NCT00923091|565194212|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
156575681|NCT00923091|565194213|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
156575682|NCT00923091|565194214|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
156575683|NCT00923091|565194215|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
156575684|NCT00923091|565194216|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
156575685|NCT00923091|565194217|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
156575686|NCT00923091|565194205|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575687|NCT00923091|565194206|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575688|NCT00923091|565194207|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575689|NCT00923091|565194208|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575690|NCT00923091|565194209|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575691|NCT00923091|565194210|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575692|NCT00923091|565194211|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575693|NCT00923091|565194212|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575694|NCT00923091|565194213|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
156575695|NCT00923091|565194214|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575696|NCT00923091|565194215|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575697|NCT00923091|565194216|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
156575698|NCT00923091|565194217|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
156575699|NCT00923091|565194205|FG000|Period V (Double -Blind)|Protocol Violation|0|||
156575700|NCT00923091|565194206|FG001|Period V (Double -Blind)|Protocol Violation|0|||
156575701|NCT00923091|565194207|FG002|Period V (Double -Blind)|Protocol Violation|0|||
156575702|NCT00923091|565194208|FG003|Period V (Double -Blind)|Protocol Violation|0|||
156575703|NCT00923091|565194209|FG004|Period V (Double -Blind)|Protocol Violation|0|||
156575704|NCT00923091|565194210|FG005|Period V (Double -Blind)|Protocol Violation|0|||
156575705|NCT00923091|565194211|FG006|Period V (Double -Blind)|Protocol Violation|0|||
156575706|NCT00923091|565194212|FG007|Period V (Double -Blind)|Protocol Violation|0|||
156575707|NCT00923091|565194213|FG008|Period V (Double -Blind)|Protocol Violation|0|||
156575708|NCT00923091|565194214|FG009|Period V (Double -Blind)|Protocol Violation|0|||
156575709|NCT00923091|565194215|FG010|Period V (Double -Blind)|Protocol Violation|0|||
156575710|NCT00923091|565194216|FG011|Period V (Double -Blind)|Protocol Violation|0|||
156575711|NCT00923091|565194217|FG012|Period V (Double -Blind)|Protocol Violation|1|||
156575712|NCT00923091|565194205|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
156575713|NCT00923091|565194206|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
156575714|NCT00923091|565194207|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
156575715|NCT00923091|565194208|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
156575716|NCT00923091|565194209|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
156575717|NCT00923091|565194210|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
156575718|NCT00923091|565194211|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
156575719|NCT00923091|565194212|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
156575720|NCT00923091|565194213|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
156575721|NCT00923091|565194214|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
156575722|NCT00923091|565194215|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
156575723|NCT00923091|565194216|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
156575724|NCT00923091|565194217|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
156575725|NCT00923091|565194205|FG000|Period VI (Open-Label)|Adverse Event|17|||
156575726|NCT00923091|565194206|FG001|Period VI (Open-Label)|Adverse Event|0|||
156575727|NCT00923091|565194207|FG002|Period VI (Open-Label)|Adverse Event|4|||
156575728|NCT00923091|565194208|FG003|Period VI (Open-Label)|Adverse Event|1|||
156575729|NCT00923091|565194209|FG004|Period VI (Open-Label)|Adverse Event|1|||
156575730|NCT00923091|565194210|FG005|Period VI (Open-Label)|Adverse Event|0|||
156575731|NCT00923091|565194211|FG006|Period VI (Open-Label)|Adverse Event|0|||
156575732|NCT00923091|565194212|FG007|Period VI (Open-Label)|Adverse Event|0|||
156575733|NCT00923091|565194213|FG008|Period VI (Open-Label)|Adverse Event|0|||
156575734|NCT00923091|565194214|FG009|Period VI (Open-Label)|Adverse Event|0|||
156575735|NCT00923091|565194215|FG010|Period VI (Open-Label)|Adverse Event|0|||
156575736|NCT00923091|565194216|FG011|Period VI (Open-Label)|Adverse Event|0|||
156575737|NCT00923091|565194217|FG012|Period VI (Open-Label)|Adverse Event|0|||
156575738|NCT00923091|565194205|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
156575739|NCT00923091|565194206|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
156575740|NCT00923091|565194207|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
156575741|NCT00923091|565194208|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575742|NCT00923091|565194209|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
156575743|NCT00923091|565194210|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575744|NCT00923091|565194211|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575745|NCT00923091|565194212|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575746|NCT00923091|565194213|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575747|NCT00923091|565194214|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575748|NCT00923091|565194215|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575749|NCT00923091|565194216|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575750|NCT00923091|565194217|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
156575751|NCT00923091|565194205|FG000|Period VI (Open-Label)|Protocol Violation|6|||
156575752|NCT00923091|565194206|FG001|Period VI (Open-Label)|Protocol Violation|1|||
156575753|NCT00923091|565194207|FG002|Period VI (Open-Label)|Protocol Violation|3|||
156575754|NCT00923091|565194208|FG003|Period VI (Open-Label)|Protocol Violation|1|||
156575755|NCT00923091|565194209|FG004|Period VI (Open-Label)|Protocol Violation|4|||
156575756|NCT00923091|565194210|FG005|Period VI (Open-Label)|Protocol Violation|0|||
156575757|NCT00923091|565194211|FG006|Period VI (Open-Label)|Protocol Violation|0|||
156575758|NCT00923091|565194212|FG007|Period VI (Open-Label)|Protocol Violation|0|||
156575759|NCT00923091|565194213|FG008|Period VI (Open-Label)|Protocol Violation|0|||
156575760|NCT00923091|565194214|FG009|Period VI (Open-Label)|Protocol Violation|0|||
156575761|NCT00923091|565194215|FG010|Period VI (Open-Label)|Protocol Violation|0|||
156575762|NCT00923091|565194216|FG011|Period VI (Open-Label)|Protocol Violation|0|||
156575763|NCT00923091|565194217|FG012|Period VI (Open-Label)|Protocol Violation|0|||
156575764|NCT00923091|565194205|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
156575765|NCT00923091|565194206|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
156575766|NCT00923091|565194207|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
156575767|NCT00923091|565194208|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
156575768|NCT00923091|565194209|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
156575769|NCT00923091|565194210|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
156575770|NCT00923091|565194211|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
156575771|NCT00923091|565194212|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
156575772|NCT00923091|565194213|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
156575773|NCT00923091|565194214|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
156575774|NCT00923091|565194215|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
156575775|NCT00923091|565194216|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
156575776|NCT00923091|565194217|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
156575777|NCT00923091|565194205|FG000|Period VI (Open-Label)|Other Reason|0|||
156575778|NCT00923091|565194206|FG001|Period VI (Open-Label)|Other Reason|0|||
156575779|NCT00923091|565194207|FG002|Period VI (Open-Label)|Other Reason|0|||
156575780|NCT00923091|565194208|FG003|Period VI (Open-Label)|Other Reason|1|||
156575781|NCT00923091|565194209|FG004|Period VI (Open-Label)|Other Reason|1|||
156575782|NCT00923091|565194210|FG005|Period VI (Open-Label)|Other Reason|0|||
156575783|NCT00923091|565194211|FG006|Period VI (Open-Label)|Other Reason|0|||
156575784|NCT00923091|565194212|FG007|Period VI (Open-Label)|Other Reason|0|||
156575785|NCT00923091|565194213|FG008|Period VI (Open-Label)|Other Reason|0|||
156575786|NCT00923091|565194214|FG009|Period VI (Open-Label)|Other Reason|0|||
156575787|NCT00923091|565194215|FG010|Period VI (Open-Label)|Other Reason|0|||
156575788|NCT00923091|565194216|FG011|Period VI (Open-Label)|Other Reason|0|||
156575789|NCT00923091|565194217|FG012|Period VI (Open-Label)|Other Reason|0|||
156575790|NCT03237845|565194221|FG000|Overall Study|Adverse Event|0|||
156575791|NCT03237845|565194222|FG001|Overall Study|Adverse Event|1|||
156575792|NCT03237845|565194221|FG000|Overall Study|Lost to Follow-up|13|||
156575793|NCT03237845|565194222|FG001|Overall Study|Lost to Follow-up|10|||
156575794|NCT03237845|565194221|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
156575795|NCT03237845|565194222|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
156575796|NCT03237845|565194221|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
156575797|NCT03237845|565194222|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
156575798|NCT03237845|565194221|FG000|Overall Study|Physician Decision|1|||
156575799|NCT03237845|565194222|FG001|Overall Study|Physician Decision|2|||
156575800|NCT03237845|565194221|FG000|Overall Study|Pregnancy|1|||
156575801|NCT03237845|565194222|FG001|Overall Study|Pregnancy|0|||
156575802|NCT03237845|565194221|FG000|Overall Study|Protocol Deviation|0|||
156575803|NCT03237845|565194222|FG001|Overall Study|Protocol Deviation|1|||
156575804|NCT03237845|565194221|FG000|Overall Study|Technical Problems|8|||
156575805|NCT03237845|565194222|FG001|Overall Study|Technical Problems|1|||
156575806|NCT03237845|565194221|FG000|Overall Study|Withdrawal by Subject|3|||
156575807|NCT03237845|565194222|FG001|Overall Study|Withdrawal by Subject|3|||
156575808|NCT03237845|565194221|FG000|Overall Study|Other Reasons|4|||
156575809|NCT03237845|565194222|FG001|Overall Study|Other Reasons|0|||
156575810|NCT02460822|565194227|FG000|Overall Study|Withdrawal by Subject|1|||
156575811|NCT00754390|565194231|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
156575812|NCT00754390|565194231|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
156575813|NCT00754390|565194231|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
156575814|NCT00754390|565194231|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
156575815|NCT00847613|565194232|FG000|Overall Study|Ongoing at cut-off date|250|||
156575816|NCT00847613|565194233|FG001|Overall Study|Ongoing at cut-off date|265|||
156575817|NCT00847613|565194234|FG002|Overall Study|Ongoing at cut-off date|64|||
156575818|NCT00847613|565194235|FG003|Overall Study|Ongoing at cut-off date|64|||
156575819|NCT00847613|565194232|FG000|Overall Study|Death|1|||
156575820|NCT00847613|565194233|FG001|Overall Study|Death|1|||
156575821|NCT00847613|565194234|FG002|Overall Study|Death|0|||
156575822|NCT00847613|565194235|FG003|Overall Study|Death|0|||
156575823|NCT00847613|565194232|FG000|Overall Study|Adverse Event|36|||
156575824|NCT00847613|565194233|FG001|Overall Study|Adverse Event|26|||
156575825|NCT00847613|565194234|FG002|Overall Study|Adverse Event|5|||
156575826|NCT00847613|565194235|FG003|Overall Study|Adverse Event|6|||
156575827|NCT00847613|565194232|FG000|Overall Study|Lack of Efficacy|7|||
156575828|NCT00847613|565194233|FG001|Overall Study|Lack of Efficacy|3|||
156575829|NCT00847613|565194234|FG002|Overall Study|Lack of Efficacy|3|||
156575830|NCT00847613|565194235|FG003|Overall Study|Lack of Efficacy|1|||
156575831|NCT00847613|565194232|FG000|Overall Study|Study terminated by Sponsor|1|||
156575832|NCT00847613|565194233|FG001|Overall Study|Study terminated by Sponsor|0|||
156575833|NCT00847613|565194234|FG002|Overall Study|Study terminated by Sponsor|2|||
156575834|NCT00847613|565194235|FG003|Overall Study|Study terminated by Sponsor|1|||
156575835|NCT00847613|565194232|FG000|Overall Study|Lost to Follow-up|5|||
156575836|NCT00847613|565194233|FG001|Overall Study|Lost to Follow-up|0|||
156575837|NCT00847613|565194234|FG002|Overall Study|Lost to Follow-up|0|||
156575838|NCT00847613|565194235|FG003|Overall Study|Lost to Follow-up|3|||
156575839|NCT00847613|565194232|FG000|Overall Study|Protocol Violation|6|||
156575840|NCT00847613|565194233|FG001|Overall Study|Protocol Violation|6|||
156575841|NCT00847613|565194234|FG002|Overall Study|Protocol Violation|3|||
156575842|NCT00847613|565194235|FG003|Overall Study|Protocol Violation|1|||
156575843|NCT00847613|565194232|FG000|Overall Study|Pregnancy|1|||
156575844|NCT00847613|565194233|FG001|Overall Study|Pregnancy|1|||
156575845|NCT00847613|565194234|FG002|Overall Study|Pregnancy|0|||
156575846|NCT00847613|565194235|FG003|Overall Study|Pregnancy|0|||
156575847|NCT00847613|565194232|FG000|Overall Study|Site closure|1|||
156575848|NCT00847613|565194233|FG001|Overall Study|Site closure|0|||
156575849|NCT00847613|565194234|FG002|Overall Study|Site closure|0|||
156575850|NCT00847613|565194235|FG003|Overall Study|Site closure|1|||
156575851|NCT00847613|565194232|FG000|Overall Study|Withdrawal by Subject|8|||
156575852|NCT00847613|565194233|FG001|Overall Study|Withdrawal by Subject|11|||
156575853|NCT00847613|565194234|FG002|Overall Study|Withdrawal by Subject|2|||
156575854|NCT00847613|565194235|FG003|Overall Study|Withdrawal by Subject|2|||
156575855|NCT00847613|565194232|FG000|Overall Study|Participant moved|4|||
156575856|NCT00847613|565194233|FG001|Overall Study|Participant moved|1|||
156575857|NCT00847613|565194234|FG002|Overall Study|Participant moved|0|||
156575858|NCT00847613|565194235|FG003|Overall Study|Participant moved|0|||
156575859|NCT00847613|565194232|FG000|Overall Study|Sponsor request|0|||
156575860|NCT00847613|565194233|FG001|Overall Study|Sponsor request|1|||
156575861|NCT00847613|565194234|FG002|Overall Study|Sponsor request|0|||
156575862|NCT00847613|565194235|FG003|Overall Study|Sponsor request|0|||
156575863|NCT00847613|565194232|FG000|Overall Study|Randomized, but not treated|0|||
156575864|NCT00847613|565194233|FG001|Overall Study|Randomized, but not treated|3|||
156575865|NCT00847613|565194234|FG002|Overall Study|Randomized, but not treated|0|||
156575866|NCT00847613|565194235|FG003|Overall Study|Randomized, but not treated|0|||
156575867|NCT00847613|565194232|FG000|Overall Study|Other|1|||
156575868|NCT00847613|565194233|FG001|Overall Study|Other|1|||
156575869|NCT00847613|565194234|FG002|Overall Study|Other|2|||
156575870|NCT00847613|565194235|FG003|Overall Study|Other|0|||
156575871|NCT00845429|565194236|FG000|Overall Study|Protocol Violation|5|||
156575872|NCT00845429|565194237|FG001|Overall Study|Protocol Violation|4|||
156575873|NCT00845429|565194238|FG002|Overall Study|Protocol Violation|7|||
156575874|NCT00845429|565194236|FG000|Overall Study|Lost to Follow-up|7|||
156575875|NCT00845429|565194237|FG001|Overall Study|Lost to Follow-up|9|||
156575876|NCT00845429|565194238|FG002|Overall Study|Lost to Follow-up|10|||
156575877|NCT00845429|565194236|FG000|Overall Study|Withdrawal by Subject|2|||
156575878|NCT00845429|565194237|FG001|Overall Study|Withdrawal by Subject|2|||
156575879|NCT00845429|565194238|FG002|Overall Study|Withdrawal by Subject|2|||
156575880|NCT00845429|565194236|FG000|Overall Study|Serious adverse event|0|||
156575881|NCT00845429|565194237|FG001|Overall Study|Serious adverse event|0|||
156575882|NCT00845429|565194238|FG002|Overall Study|Serious adverse event|1|||
156575883|NCT04222725|565194239|FG000|Overall Study|Adverse Event|0|||
156575884|NCT04222725|565194240|FG001|Overall Study|Adverse Event|1|||
156575885|NCT04222725|565194241|FG002|Overall Study|Adverse Event|0|||
156575886|NCT04222725|565194242|FG003|Overall Study|Adverse Event|0|||
156575887|NCT01548638|565194244|FG000|Overall Study|Protocol Violation|3|||
156575888|NCT01548638|565194244|FG000|Overall Study|Withdrawal by Subject|1|||
156575889|NCT02782715|565194245|FG000|Overall Study|Withdrawal by Subject|1|||
156575890|NCT02403206|565194249|FG000|Overall Study|Lost to Follow-up|4|||
156575891|NCT02403206|565194250|FG001|Overall Study|Lost to Follow-up|3|||
156575892|NCT02403206|565194249|FG000|Overall Study|Physician Decision|2|||
156575893|NCT02403206|565194250|FG001|Overall Study|Physician Decision|0|||
156575894|NCT02403206|565194249|FG000|Overall Study|Withdrawal by Subject|3|||
156575895|NCT02403206|565194250|FG001|Overall Study|Withdrawal by Subject|3|||
156575896|NCT02403206|565194249|FG000|Overall Study|Reason not given|2|||
156575897|NCT02403206|565194250|FG001|Overall Study|Reason not given|4|||
156575898|NCT01676116|565194251|FG000|Overall Study|Withdrawal criteria|2|||
156575899|NCT01676116|565194252|FG001|Overall Study|Withdrawal criteria|14|||
156575900|NCT01676116|565194251|FG000|Overall Study|Adverse Event|1|||
156575901|NCT01676116|565194252|FG001|Overall Study|Adverse Event|2|||
156575902|NCT01676116|565194251|FG000|Overall Study|Unclassified|4|||
156575903|NCT01676116|565194252|FG001|Overall Study|Unclassified|10|||
156575904|NCT01676116|565194251|FG000|Overall Study|Protocol Violation|9|||
156575905|NCT01676116|565194252|FG001|Overall Study|Protocol Violation|3|||
156575906|NCT01877655|565194253|FG000|Overall Study|Death|57|||
156575907|NCT01877655|565194254|FG001|Overall Study|Death|52|||
156575908|NCT01877655|565194253|FG000|Overall Study|Withdrawal by Subject|18|||
156575909|NCT01877655|565194254|FG001|Overall Study|Withdrawal by Subject|26|||
156575910|NCT01877655|565194253|FG000|Overall Study|Physician Decision|11|||
156575911|NCT01877655|565194254|FG001|Overall Study|Physician Decision|10|||
156575912|NCT01877655|565194253|FG000|Overall Study|Miscellaneous|4|||
156575913|NCT01877655|565194254|FG001|Overall Study|Miscellaneous|4|||
156575914|NCT01877655|565194253|FG000|Overall Study|Randomized but Never Received Drug|8|||
156575915|NCT01877655|565194254|FG001|Overall Study|Randomized but Never Received Drug|5|||
156575916|NCT01821677|565194257|FG000|Overall Study|Adverse Event|4|||
156575917|NCT01821677|565194258|FG001|Overall Study|Adverse Event|6|||
156575918|NCT01821677|565194259|FG002|Overall Study|Adverse Event|5|||
156575919|NCT01821677|565194257|FG000|Overall Study|Physician Decision|1|||
156575920|NCT01821677|565194258|FG001|Overall Study|Physician Decision|4|||
156575921|NCT01821677|565194259|FG002|Overall Study|Physician Decision|1|||
156575922|NCT01821677|565194257|FG000|Overall Study|Non-compliance|0|||
156575923|NCT01821677|565194258|FG001|Overall Study|Non-compliance|1|||
156575924|NCT01821677|565194259|FG002|Overall Study|Non-compliance|2|||
156575925|NCT01821677|565194257|FG000|Overall Study|Lost to Follow-up|2|||
156575926|NCT01821677|565194258|FG001|Overall Study|Lost to Follow-up|1|||
156575927|NCT01821677|565194259|FG002|Overall Study|Lost to Follow-up|3|||
156575928|NCT01821677|565194257|FG000|Overall Study|Protocol Violation|0|||
156575929|NCT01821677|565194258|FG001|Overall Study|Protocol Violation|0|||
156575930|NCT01821677|565194259|FG002|Overall Study|Protocol Violation|2|||
156575931|NCT01821677|565194257|FG000|Overall Study|Withdrawal by Subject|7|||
156575932|NCT01821677|565194258|FG001|Overall Study|Withdrawal by Subject|3|||
156575933|NCT01821677|565194259|FG002|Overall Study|Withdrawal by Subject|2|||
156575934|NCT01821677|565194257|FG000|Overall Study|Other|9|||
156575935|NCT01821677|565194258|FG001|Overall Study|Other|0|||
156575936|NCT01821677|565194259|FG002|Overall Study|Other|0|||
156575937|NCT00538733|565194260|FG000|Overall Study|Adverse Event|8|||
156575938|NCT00538733|565194260|FG000|Overall Study|Death|1|||
156575939|NCT00538733|565194260|FG000|Overall Study|declined to participate|2|||
156575940|NCT00538733|565194260|FG000|Overall Study|still on therapy|1|||
156575941|NCT03497689|565194263|FG000|Overall Study|Adverse Event|2|||
156575942|NCT03497689|565194263|FG000|Overall Study|Death|1|||
156575943|NCT03497689|565194263|FG000|Overall Study|Physician Decision|1|||
156575944|NCT03497689|565194263|FG000|Overall Study|Withdrawal by Subject|1|||
156575945|NCT03497689|565194263|FG000|Overall Study|Protocol Violation|2|||
156575946|NCT03567187|565194264|FG000|Overall Study|Lost to Follow-up|18|||
156575947|NCT03596645|565194267|FG000|Overall Study|Adverse Event|17|||
156575948|NCT03596645|565194268|FG001|Overall Study|Adverse Event|0|||
156575949|NCT03596645|565194267|FG000|Overall Study|Lack of Efficacy|8|||
156575950|NCT03596645|565194268|FG001|Overall Study|Lack of Efficacy|0|||
156575951|NCT03596645|565194267|FG000|Overall Study|Lost to Follow-up|1|||
156575952|NCT03596645|565194268|FG001|Overall Study|Lost to Follow-up|1|||
156575953|NCT03596645|565194267|FG000|Overall Study|Physician Decision|1|||
156575954|NCT03596645|565194268|FG001|Overall Study|Physician Decision|1|||
156575955|NCT03596645|565194267|FG000|Overall Study|Protocol Violation|1|||
156575956|NCT03596645|565194268|FG001|Overall Study|Protocol Violation|0|||
156575957|NCT03596645|565194267|FG000|Overall Study|Initiated Prohibited Medication|1|||
156575958|NCT03596645|565194268|FG001|Overall Study|Initiated Prohibited Medication|0|||
156575959|NCT03596645|565194267|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156575960|NCT03596645|565194268|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156575961|NCT03596645|565194267|FG000|Overall Study|No mucosal healing achieved|1|||
156575962|NCT03596645|565194268|FG001|Overall Study|No mucosal healing achieved|0|||
156575963|NCT03596645|565194267|FG000|Overall Study|Disease progression|1|||
156575964|NCT03596645|565194268|FG001|Overall Study|Disease progression|0|||
156575965|NCT03596645|565194267|FG000|Overall Study|Ongoing|37|||
156575966|NCT03596645|565194268|FG001|Overall Study|Ongoing|12|||
156575967|NCT03596645|565194267|FG000|Overall Study|Randomized but not treated|0|||
156575968|NCT03596645|565194268|FG001|Overall Study|Randomized but not treated|1|||
156575969|NCT05165394|565195715|FG000|Overall Study|Withdrawal by Subject|5|||
156575970|NCT05165394|565195716|FG001|Overall Study|Withdrawal by Subject|1|||
156575971|NCT05165394|565195715|FG000|Overall Study|Lost to Follow-up|1|||
156575972|NCT05165394|565195716|FG001|Overall Study|Lost to Follow-up|2|||
156575973|NCT05165394|565195715|FG000|Overall Study|Other Than Specified|0|||
156575974|NCT05165394|565195716|FG001|Overall Study|Other Than Specified|1|||
156575975|NCT02089737|565195718|FG000|Overall Study|Survey form not completed|5|||
156575976|NCT02089737|565195718|FG000|Overall Study|Not treated|1|||
156575977|NCT01123889|565195719|FG000|Overall Study|Lost to Follow-up|3|||
156575978|NCT01123889|565195720|FG001|Overall Study|Lost to Follow-up|1|||
156575979|NCT02333331|565195725|FG000|Overall Study|Adverse Event|1|||
156575980|NCT02333331|565195726|FG001|Overall Study|Adverse Event|0|||
156575981|NCT02333331|565195727|FG002|Overall Study|Adverse Event|4|||
156575982|NCT02333331|565195728|FG003|Overall Study|Adverse Event|1|||
156575983|NCT02333331|565195725|FG000|Overall Study|Death|0|||
156575984|NCT02333331|565195726|FG001|Overall Study|Death|0|||
156575985|NCT02333331|565195727|FG002|Overall Study|Death|2|||
156575986|NCT02333331|565195728|FG003|Overall Study|Death|0|||
156575987|NCT02333331|565195725|FG000|Overall Study|Lost to Follow-up|0|||
156575988|NCT02333331|565195726|FG001|Overall Study|Lost to Follow-up|0|||
156575989|NCT02333331|565195727|FG002|Overall Study|Lost to Follow-up|1|||
156575990|NCT02333331|565195728|FG003|Overall Study|Lost to Follow-up|0|||
156575991|NCT02333331|565195725|FG000|Overall Study|Physician Decision|0|||
156575992|NCT02333331|565195726|FG001|Overall Study|Physician Decision|1|||
156575993|NCT02333331|565195727|FG002|Overall Study|Physician Decision|0|||
156575994|NCT02333331|565195728|FG003|Overall Study|Physician Decision|0|||
156575995|NCT02333331|565195725|FG000|Overall Study|Protocol Deviation|0|||
156575996|NCT02333331|565195726|FG001|Overall Study|Protocol Deviation|3|||
156575997|NCT02333331|565195727|FG002|Overall Study|Protocol Deviation|2|||
156575998|NCT02333331|565195728|FG003|Overall Study|Protocol Deviation|1|||
156575999|NCT02333331|565195725|FG000|Overall Study|Patient/Guardian Decision|1|||
156576000|NCT02333331|565195726|FG001|Overall Study|Patient/Guardian Decision|2|||
156576001|NCT02333331|565195727|FG002|Overall Study|Patient/Guardian Decision|9|||
156576002|NCT02333331|565195728|FG003|Overall Study|Patient/Guardian Decision|1|||
156576003|NCT01494038|565195729|FG000|Overall Study|Protocol Violation|1|||
156576004|NCT01494038|565195730|FG001|Overall Study|Protocol Violation|1|||
156576005|NCT01494038|565195729|FG000|Overall Study|Lost to Follow-up|18|||
156576006|NCT01494038|565195730|FG001|Overall Study|Lost to Follow-up|20|||
156576007|NCT01494038|565195729|FG000|Overall Study|Withdrawal by Subject|44|||
156576008|NCT01494038|565195730|FG001|Overall Study|Withdrawal by Subject|34|||
156576009|NCT01494038|565195729|FG000|Overall Study|Not able to get to clinic|21|||
156576010|NCT01494038|565195730|FG001|Overall Study|Not able to get to clinic|15|||
156576011|NCT01494038|565195729|FG000|Overall Study|Not willing to adhere to reqs|2|||
156576012|NCT01494038|565195730|FG001|Overall Study|Not willing to adhere to reqs|9|||
156576013|NCT01494038|565195729|FG000|Overall Study|Death|2|||
156576014|NCT01494038|565195730|FG001|Overall Study|Death|4|||
156576015|NCT00685178|565195737|FG000|Overall Study|Adverse Event|1|||
156576016|NCT00685178|565195738|FG001|Overall Study|Adverse Event|5|||
156576017|NCT00685178|565195739|FG002|Overall Study|Adverse Event|2|||
156576018|NCT00685178|565195740|FG003|Overall Study|Adverse Event|4|||
156576019|NCT00685178|565195737|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
156576020|NCT00685178|565195738|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
156576021|NCT00685178|565195739|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
156576022|NCT00685178|565195740|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
156576023|NCT00685178|565195737|FG000|Overall Study|voluntary study discharge|4|||
156576024|NCT00685178|565195738|FG001|Overall Study|voluntary study discharge|5|||
156576025|NCT00685178|565195739|FG002|Overall Study|voluntary study discharge|1|||
156576026|NCT00685178|565195740|FG003|Overall Study|voluntary study discharge|1|||
156576027|NCT00685178|565195737|FG000|Overall Study|incarcerated|1|||
156576028|NCT00685178|565195738|FG001|Overall Study|incarcerated|3|||
156576029|NCT00685178|565195739|FG002|Overall Study|incarcerated|7|||
156576030|NCT00685178|565195740|FG003|Overall Study|incarcerated|0|||
156576031|NCT00685178|565195737|FG000|Overall Study|administrative (disciplinary) discharge|0|||
156576032|NCT00685178|565195738|FG001|Overall Study|administrative (disciplinary) discharge|1|||
156576033|NCT00685178|565195739|FG002|Overall Study|administrative (disciplinary) discharge|0|||
156576034|NCT00685178|565195740|FG003|Overall Study|administrative (disciplinary) discharge|2|||
156576035|NCT00685178|565195737|FG000|Overall Study|Pregnancy|0|||
156576036|NCT00685178|565195738|FG001|Overall Study|Pregnancy|0|||
156576037|NCT00685178|565195739|FG002|Overall Study|Pregnancy|0|||
156576038|NCT00685178|565195740|FG003|Overall Study|Pregnancy|1|||
156576039|NCT00077623|565195746|FG000|Overall Study|Adverse Event|1|||
156576040|NCT00077623|565195747|FG001|Overall Study|Adverse Event|0|||
156576041|NCT00077623|565195748|FG002|Overall Study|Adverse Event|1|||
156576042|NCT00077623|565195746|FG000|Overall Study|Withdrawal by Subject|2|||
156576043|NCT00077623|565195747|FG001|Overall Study|Withdrawal by Subject|10|||
156576044|NCT00077623|565195748|FG002|Overall Study|Withdrawal by Subject|1|||
156576045|NCT00077623|565195746|FG000|Overall Study|Other-Non safety reason|18|||
156576046|NCT00077623|565195747|FG001|Overall Study|Other-Non safety reason|15|||
156576047|NCT00077623|565195748|FG002|Overall Study|Other-Non safety reason|19|||
156576048|NCT00077623|565195746|FG000|Overall Study|Insufficient therapeutic response|2|||
156576049|NCT00077623|565195747|FG001|Overall Study|Insufficient therapeutic response|0|||
156576050|NCT00077623|565195748|FG002|Overall Study|Insufficient therapeutic response|0|||
156576051|NCT00077623|565195746|FG000|Overall Study|Death|12|||
156576052|NCT00077623|565195747|FG001|Overall Study|Death|18|||
156576053|NCT00077623|565195748|FG002|Overall Study|Death|11|||
156576054|NCT00077623|565195746|FG000|Overall Study|Failure to return|1|||
156576055|NCT00077623|565195747|FG001|Overall Study|Failure to return|0|||
156576056|NCT00077623|565195748|FG002|Overall Study|Failure to return|0|||
156576057|NCT01334125|565195749|FG000|Overall Study|Lost to Follow-up|3|||
156576058|NCT01334125|565195750|FG001|Overall Study|Lost to Follow-up|3|||
156576059|NCT02138110|565195753|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
156576060|NCT02138110|565195753|FG000|Overall Scaffold Implantation|Death|3|||
156576061|NCT00882713|565195754|FG000|Overall Study|Adverse Event|2|||
156576062|NCT00882713|565195754|FG000|Overall Study|Death|3|||
156576063|NCT00882713|565195754|FG000|Overall Study|Administrative reasons|4|||
156576064|NCT00882713|565195754|FG000|Overall Study|refused treatment/withdrew consent|4|||
156576065|NCT00882713|565195754|FG000|Overall Study|Blood transfusion|2|||
156576066|NCT00882713|565195754|FG000|Overall Study|Insufficient therapeutic response|3|||
156576067|NCT00882713|565195754|FG000|Overall Study|Failure to return|2|||
156576068|NCT00882713|565195754|FG000|Overall Study|Other - Reasons|2|||
156576069|NCT00401973|565195757|FG000|Overall Study|Adverse Event|2|||
156576070|NCT00401973|565195758|FG001|Overall Study|Adverse Event|8|||
156576071|NCT00401973|565195759|FG002|Overall Study|Adverse Event|4|||
156576072|NCT00401973|565195757|FG000|Overall Study|Clinical Relapse|0|||
156576073|NCT00401973|565195758|FG001|Overall Study|Clinical Relapse|1|||
156576074|NCT00401973|565195759|FG002|Overall Study|Clinical Relapse|1|||
156576075|NCT00401973|565195757|FG000|Overall Study|Lack of Efficacy|0|||
156576076|NCT00401973|565195758|FG001|Overall Study|Lack of Efficacy|0|||
156576077|NCT00401973|565195759|FG002|Overall Study|Lack of Efficacy|3|||
156576078|NCT00401973|565195757|FG000|Overall Study|Lost to Follow-up|2|||
156576079|NCT00401973|565195758|FG001|Overall Study|Lost to Follow-up|2|||
156576080|NCT00401973|565195759|FG002|Overall Study|Lost to Follow-up|2|||
156576081|NCT00401973|565195757|FG000|Overall Study|Physician Decision|2|||
156576082|NCT00401973|565195758|FG001|Overall Study|Physician Decision|0|||
156576083|NCT00401973|565195759|FG002|Overall Study|Physician Decision|1|||
156576084|NCT00401973|565195757|FG000|Overall Study|Protocol Violation|1|||
156576085|NCT00401973|565195758|FG001|Overall Study|Protocol Violation|2|||
156576086|NCT00401973|565195759|FG002|Overall Study|Protocol Violation|3|||
156576087|NCT00401973|565195757|FG000|Overall Study|Sponsor Decision|0|||
156576088|NCT00401973|565195758|FG001|Overall Study|Sponsor Decision|1|||
156576089|NCT00401973|565195759|FG002|Overall Study|Sponsor Decision|0|||
156576090|NCT00401973|565195757|FG000|Overall Study|Withdrawal by Subject|4|||
156576091|NCT00401973|565195758|FG001|Overall Study|Withdrawal by Subject|12|||
156576092|NCT00401973|565195759|FG002|Overall Study|Withdrawal by Subject|9|||
156576093|NCT02760602|565195766|FG000|Overall Study|Withdrawal by Subject|1|||
156576094|NCT02760602|565195767|FG001|Overall Study|Withdrawal by Subject|0|||
156576095|NCT02760602|565195766|FG000|Overall Study|Terminated by sponsor|12|||
156576096|NCT02760602|565195767|FG001|Overall Study|Terminated by sponsor|13|||
156576097|NCT01335971|565195772|FG000|Overall Study|Withdrawal by Subject|1|||
156576098|NCT01335971|565195773|FG001|Overall Study|Withdrawal by Subject|0|||
156576099|NCT01335971|565195774|FG002|Overall Study|Withdrawal by Subject|0|||
156576100|NCT01335971|565195772|FG000|Overall Study|Did not complete bronchoscopy|1|||
156576101|NCT01335971|565195773|FG001|Overall Study|Did not complete bronchoscopy|1|||
156576102|NCT01335971|565195774|FG002|Overall Study|Did not complete bronchoscopy|1|||
156576103|NCT05299892|565195775|FG000|Overall Study|Withdrawal by Subject|2|||
156576104|NCT00149214|565195776|FG000|Overall Study|Adverse Event|12|||
156576105|NCT00149214|565195777|FG001|Overall Study|Adverse Event|9|||
156576106|NCT00149214|565195776|FG000|Overall Study|Withdrawal by Subject|4|||
156576107|NCT00149214|565195777|FG001|Overall Study|Withdrawal by Subject|1|||
156576108|NCT00149214|565195776|FG000|Overall Study|Physician Decision|3|||
156576109|NCT00149214|565195777|FG001|Overall Study|Physician Decision|3|||
156576110|NCT00149214|565195776|FG000|Overall Study|Sponsor Decision|0|||
156576111|NCT00149214|565195777|FG001|Overall Study|Sponsor Decision|1|||
156576112|NCT00149214|565195776|FG000|Overall Study|Progressive Disease|7|||
156576113|NCT00149214|565195777|FG001|Overall Study|Progressive Disease|3|||
156576114|NCT01272180|565195778|FG000|Overall Study|Adverse Event|0|||
156576115|NCT01272180|565195779|FG001|Overall Study|Adverse Event|0|||
156576116|NCT01272180|565195780|FG002|Overall Study|Adverse Event|1|||
156576117|NCT01272180|565195781|FG003|Overall Study|Adverse Event|0|||
156576118|NCT01272180|565195778|FG000|Overall Study|Withdrawal by Subject|2|||
156576119|NCT01272180|565195779|FG001|Overall Study|Withdrawal by Subject|6|||
156576120|NCT01272180|565195780|FG002|Overall Study|Withdrawal by Subject|3|||
156576121|NCT01272180|565195781|FG003|Overall Study|Withdrawal by Subject|2|||
156576122|NCT01272180|565195778|FG000|Overall Study|Lost to Follow-up|15|||
156576123|NCT01272180|565195779|FG001|Overall Study|Lost to Follow-up|14|||
156576124|NCT01272180|565195780|FG002|Overall Study|Lost to Follow-up|8|||
156576125|NCT01272180|565195781|FG003|Overall Study|Lost to Follow-up|10|||
156576126|NCT01272180|565195778|FG000|Overall Study|Inappropriate enrollment|0|||
156576127|NCT01272180|565195779|FG001|Overall Study|Inappropriate enrollment|0|||
156576128|NCT01272180|565195780|FG002|Overall Study|Inappropriate enrollment|1|||
156576129|NCT01272180|565195781|FG003|Overall Study|Inappropriate enrollment|1|||
156576130|NCT01272180|565195778|FG000|Overall Study|Protocol Violation|0|||
156576131|NCT01272180|565195779|FG001|Overall Study|Protocol Violation|1|||
156576132|NCT01272180|565195780|FG002|Overall Study|Protocol Violation|0|||
156576133|NCT01272180|565195781|FG003|Overall Study|Protocol Violation|1|||
156576134|NCT03351244|565195782|FG000|Overall Study|Adverse Event|7|||
156576135|NCT03351244|565195783|FG001|Overall Study|Adverse Event|11|||
156576136|NCT03351244|565195784|FG002|Overall Study|Adverse Event|12|||
156576137|NCT03351244|565195782|FG000|Overall Study|Investigator's decision|0|||
156576138|NCT03351244|565195783|FG001|Overall Study|Investigator's decision|0|||
156576139|NCT03351244|565195784|FG002|Overall Study|Investigator's decision|2|||
156576140|NCT03351244|565195782|FG000|Overall Study|System error|0|||
156576141|NCT03351244|565195783|FG001|Overall Study|System error|0|||
156576142|NCT03351244|565195784|FG002|Overall Study|System error|2|||
156576143|NCT03351244|565195782|FG000|Overall Study|COVID-19 restrictions|3|||
156576144|NCT03351244|565195783|FG001|Overall Study|COVID-19 restrictions|0|||
156576145|NCT03351244|565195784|FG002|Overall Study|COVID-19 restrictions|1|||
156576146|NCT03351244|565195782|FG000|Overall Study|Non-compliance|2|||
156576147|NCT03351244|565195783|FG001|Overall Study|Non-compliance|5|||
156576148|NCT03351244|565195784|FG002|Overall Study|Non-compliance|0|||
156576149|NCT03351244|565195782|FG000|Overall Study|Withdrawal by Subject|11|||
156576150|NCT03351244|565195783|FG001|Overall Study|Withdrawal by Subject|16|||
156576151|NCT03351244|565195784|FG002|Overall Study|Withdrawal by Subject|13|||
156576152|NCT03351244|565195782|FG000|Overall Study|Lost to Follow-up|2|||
156576153|NCT03351244|565195783|FG001|Overall Study|Lost to Follow-up|6|||
156576154|NCT03351244|565195784|FG002|Overall Study|Lost to Follow-up|4|||
156576155|NCT03351244|565195782|FG000|Overall Study|Protocol Violation|2|||
156576156|NCT03351244|565195783|FG001|Overall Study|Protocol Violation|2|||
156576157|NCT03351244|565195784|FG002|Overall Study|Protocol Violation|0|||
156576158|NCT02424149|565195794|FG000|Overall Study|surgery cancelled|2|||
156576159|NCT02424149|565195795|FG001|Overall Study|surgery cancelled|0|||
156576160|NCT02424149|565195794|FG000|Overall Study|Withdrawal by Subject|0|||
156576161|NCT02424149|565195795|FG001|Overall Study|Withdrawal by Subject|1|||
156576162|NCT01025336|565195796|FG000|Overall Study|Protocol Violation|0|||
156576163|NCT01025336|565195797|FG001|Overall Study|Protocol Violation|0|||
156576164|NCT01025336|565195798|FG002|Overall Study|Protocol Violation|0|||
156576165|NCT01025336|565195799|FG003|Overall Study|Protocol Violation|2|||
156576166|NCT01025336|565195800|FG004|Overall Study|Protocol Violation|0|||
156576167|NCT03794986|565195803|FG000|Overall Study|0 Sessions Attended|34|||
156576168|NCT03794986|565195804|FG001|Overall Study|0 Sessions Attended|37|||
156576169|NCT03794986|565195803|FG000|Overall Study|Withdrawal by Subject|4|||
156576170|NCT03794986|565195804|FG001|Overall Study|Withdrawal by Subject|6|||
156576171|NCT03794986|565195803|FG000|Overall Study|Protocol Violation|1|||
156576172|NCT03794986|565195804|FG001|Overall Study|Protocol Violation|0|||
156576173|NCT01165229|565195807|FG000|Overall Study|Serious Adverse Event|456|||
156576174|NCT01165229|565195808|FG001|Overall Study|Serious Adverse Event|487|||
156576175|NCT01165229|565195807|FG000|Overall Study|Non-Serious Adverse Event|47|||
156576176|NCT01165229|565195808|FG001|Overall Study|Non-Serious Adverse Event|15|||
156576177|NCT01165229|565195807|FG000|Overall Study|Protocol Violation|6|||
156576178|NCT01165229|565195808|FG001|Overall Study|Protocol Violation|8|||
156576179|NCT01165229|565195807|FG000|Overall Study|Withdrawal by Subject|387|||
156576180|NCT01165229|565195808|FG001|Overall Study|Withdrawal by Subject|396|||
156576181|NCT01165229|565195807|FG000|Overall Study|Migrated/moved from study area|51|||
156576182|NCT01165229|565195808|FG001|Overall Study|Migrated/moved from study area|46|||
156576183|NCT01165229|565195807|FG000|Overall Study|Lost to Follow-up|123|||
156576184|NCT01165229|565195808|FG001|Overall Study|Lost to Follow-up|133|||
156576185|NCT01165229|565195807|FG000|Overall Study|Suspected HZ Episode|2|||
156576186|NCT01165229|565195808|FG001|Overall Study|Suspected HZ Episode|2|||
156576187|NCT01165229|565195807|FG000|Overall Study|No reason from the subject|108|||
156576188|NCT01165229|565195808|FG001|Overall Study|No reason from the subject|102|||
156576189|NCT01165229|565195807|FG000|Overall Study|Unknown completion status|0|||
156576190|NCT01165229|565195808|FG001|Overall Study|Unknown completion status|1|||
156576191|NCT00474253|565195809|FG000|Overall Study|Withdrew consent|2|||
156576192|NCT00474253|565195810|FG001|Overall Study|Withdrew consent|0|||
156576193|NCT00474253|565195809|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
156576194|NCT00474253|565195810|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
156576195|NCT00474253|565195809|FG000|Overall Study|Lost to Follow-up|1|||
156576196|NCT00474253|565195810|FG001|Overall Study|Lost to Follow-up|0|||
156576197|NCT00474253|565195809|FG000|Overall Study|Discharged prior to study completion|0|||
156576198|NCT00474253|565195810|FG001|Overall Study|Discharged prior to study completion|1|||
156576199|NCT01357239|565195811|FG000|Stratum: All Patients|Adverse Event|0|||
156576200|NCT01357239|565195812|FG001|Stratum: All Patients|Adverse Event|0|||
156576201|NCT01357239|565195813|FG002|Stratum: All Patients|Adverse Event|1|||
156576202|NCT01357239|565195814|FG003|Stratum: All Patients|Adverse Event|1|||
156576203|NCT01357239|565195811|FG000|Stratum: All Patients|Subject withdrew consent|0|||
156576204|NCT01357239|565195812|FG001|Stratum: All Patients|Subject withdrew consent|0|||
156576205|NCT01357239|565195813|FG002|Stratum: All Patients|Subject withdrew consent|1|||
156576206|NCT01357239|565195814|FG003|Stratum: All Patients|Subject withdrew consent|1|||
156576207|NCT01357239|565195811|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
156576208|NCT01357239|565195812|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
156576209|NCT01357239|565195813|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
156576210|NCT01357239|565195814|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
156576211|NCT01357239|565195811|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
156576212|NCT01357239|565195812|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
156576213|NCT01357239|565195813|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
156576214|NCT01357239|565195814|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
156576215|NCT01357239|565195811|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
156576216|NCT01357239|565195812|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
156576217|NCT01357239|565195813|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
156576218|NCT01357239|565195814|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
156576219|NCT00852930|565195822|FG000|Overall Study|Withdrawal by Subject|1|||
156576220|NCT00852930|565195823|FG001|Overall Study|Withdrawal by Subject|1|||
156576221|NCT00852930|565195824|FG002|Overall Study|Withdrawal by Subject|1|||
156576222|NCT00852930|565195822|FG000|Overall Study|Physician Decision|0|||
156576223|NCT00852930|565195823|FG001|Overall Study|Physician Decision|0|||
156576224|NCT00852930|565195824|FG002|Overall Study|Physician Decision|1|||
156576225|NCT01512368|565195827|FG000|Overall Study|Protocol Violation|3|||
156576226|NCT01319929|565195828|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
156576227|NCT01319929|565195829|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
156576228|NCT01319929|565195828|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
156576229|NCT01319929|565195829|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
156576230|NCT01319929|565195828|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
156576231|NCT01319929|565195829|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
156576232|NCT01319929|565195828|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
156576233|NCT01319929|565195829|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
156576234|NCT01319929|565195828|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
156576235|NCT01319929|565195829|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
156576236|NCT01221233|565195830|FG000|Overall Study|Withdrawal by Subject|3|||
156576237|NCT01221233|565195831|FG001|Overall Study|Withdrawal by Subject|1|||
156576238|NCT02117050|565195833|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
156576239|NCT00971321|565195835|FG000|Up to Month 7|Withdrawal by Subject|1|||
156576240|NCT00971321|565195836|FG001|Up to Month 7|Withdrawal by Subject|0|||
156576241|NCT00971321|565195835|FG000|Up to Month 7|Migrated/moved from study area|3|||
156576242|NCT00971321|565195836|FG001|Up to Month 7|Migrated/moved from study area|2|||
156576243|NCT00971321|565195835|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
156576244|NCT00971321|565195836|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
156576245|NCT00971321|565195835|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
156576246|NCT00971321|565195836|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
156576247|NCT00971321|565195835|FG000|Up to Month 11-12|Lost to Follow-up|1|||
156576248|NCT00971321|565195836|FG001|Up to Month 11-12|Lost to Follow-up|0|||
156576249|NCT01662999|565195839|FG000|Period 3|Withdrawal by Subject|0|||
156576250|NCT01662999|565195840|FG001|Period 3|Withdrawal by Subject|1|||
156576251|NCT01662999|565195841|FG002|Period 3|Withdrawal by Subject|0|||
156576252|NCT01662999|565195842|FG003|Period 3|Withdrawal by Subject|0|||
156576253|NCT01662999|565195843|FG004|Period 3|Withdrawal by Subject|0|||
156576254|NCT01662999|565195844|FG005|Period 3|Withdrawal by Subject|0|||
156576255|NCT02190591|565195845|FG000|Overall Study|Withdrawal by Subject|1|||
156576256|NCT02190591|565195846|FG001|Overall Study|Withdrawal by Subject|8|||
156576257|NCT02190591|565195845|FG000|Overall Study|Protocol Violation|1|||
156576258|NCT02190591|565195846|FG001|Overall Study|Protocol Violation|0|||
156576259|NCT02190591|565195845|FG000|Overall Study|did not use peanut ball as instructed|0|||
156576260|NCT02190591|565195846|FG001|Overall Study|did not use peanut ball as instructed|2|||
156576261|NCT02190591|565195845|FG000|Overall Study|face presentation so she was ineligible|0|||
156576262|NCT02190591|565195846|FG001|Overall Study|face presentation so she was ineligible|1|||
156576263|NCT01933672|565195847|FG000|Metformin Run-in Period|Adverse Event|1|||
156576264|NCT01933672|565195848|FG001|Metformin Run-in Period|Adverse Event|0|||
156576265|NCT01933672|565195849|FG002|Metformin Run-in Period|Adverse Event|0|||
156576266|NCT01933672|565195850|FG003|Metformin Run-in Period|Adverse Event|0|||
156576267|NCT01933672|565195851|FG004|Metformin Run-in Period|Adverse Event|0|||
156576268|NCT01933672|565195852|FG005|Metformin Run-in Period|Adverse Event|0|||
156576269|NCT01933672|565195853|FG006|Metformin Run-in Period|Adverse Event|0|||
156863463|NCT03137381|566258645|FG003|Overall Study|Lost to Follow-up|0|||
156576270|NCT01933672|565195847|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
156576271|NCT01933672|565195848|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
156576272|NCT01933672|565195849|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
156576273|NCT01933672|565195850|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
156576274|NCT01933672|565195851|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
156576275|NCT01933672|565195852|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
156576276|NCT01933672|565195853|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
156576277|NCT01933672|565195847|FG000|Metformin Run-in Period|Other|5|||
156576278|NCT01933672|565195848|FG001|Metformin Run-in Period|Other|0|||
156576279|NCT01933672|565195849|FG002|Metformin Run-in Period|Other|0|||
156576280|NCT01933672|565195850|FG003|Metformin Run-in Period|Other|0|||
156576281|NCT01933672|565195851|FG004|Metformin Run-in Period|Other|0|||
156576282|NCT01933672|565195852|FG005|Metformin Run-in Period|Other|0|||
156576283|NCT01933672|565195853|FG006|Metformin Run-in Period|Other|0|||
156576284|NCT01933672|565195847|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576285|NCT01933672|565195848|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576286|NCT01933672|565195849|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576287|NCT01933672|565195850|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576288|NCT01933672|565195851|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
156576289|NCT01933672|565195852|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576290|NCT01933672|565195853|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576291|NCT01933672|565195847|FG000|First Intervention Period (12-16 Days)|Other|0|||
156576292|NCT01933672|565195848|FG001|First Intervention Period (12-16 Days)|Other|0|||
156576293|NCT01933672|565195849|FG002|First Intervention Period (12-16 Days)|Other|1|||
156576294|NCT01933672|565195850|FG003|First Intervention Period (12-16 Days)|Other|0|||
156576295|NCT01933672|565195851|FG004|First Intervention Period (12-16 Days)|Other|0|||
156576296|NCT01933672|565195852|FG005|First Intervention Period (12-16 Days)|Other|1|||
156576297|NCT01933672|565195853|FG006|First Intervention Period (12-16 Days)|Other|0|||
156576298|NCT01933672|565195847|FG000|Second Intervention Period (12-16 Days)|Other|0|||
156576299|NCT01933672|565195848|FG001|Second Intervention Period (12-16 Days)|Other|1|||
156576300|NCT01933672|565195849|FG002|Second Intervention Period (12-16 Days)|Other|1|||
156576301|NCT01933672|565195850|FG003|Second Intervention Period (12-16 Days)|Other|0|||
156576302|NCT01933672|565195851|FG004|Second Intervention Period (12-16 Days)|Other|0|||
156576303|NCT01933672|565195852|FG005|Second Intervention Period (12-16 Days)|Other|0|||
156576304|NCT01933672|565195853|FG006|Second Intervention Period (12-16 Days)|Other|0|||
156576305|NCT01933672|565195847|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576306|NCT01933672|565195848|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576307|NCT01933672|565195849|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576308|NCT01933672|565195850|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
156576309|NCT01933672|565195851|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576310|NCT01933672|565195852|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576311|NCT01933672|565195853|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
156576312|NCT01933672|565195847|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
156576313|NCT01933672|565195848|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
156576314|NCT01933672|565195849|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
156576315|NCT01933672|565195850|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
156576316|NCT01933672|565195851|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
156576317|NCT01933672|565195852|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
156576318|NCT01933672|565195853|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
156576319|NCT00001259|565198168|FG000|Study 2|Adverse Event|0|||
156576320|NCT00001259|565198169|FG001|Study 2|Adverse Event|0|||
156576321|NCT00001259|565198170|FG002|Study 2|Adverse Event|0|||
156576322|NCT00001259|565198171|FG003|Study 2|Adverse Event|0|||
156576323|NCT00001259|565198172|FG004|Study 2|Adverse Event|2|||
156576324|NCT00001259|565198173|FG005|Study 2|Adverse Event|0|||
156576325|NCT00001259|565198174|FG006|Study 2|Adverse Event|0|||
156576326|NCT03705494|565198175|FG000|Overall Study|Lost to Follow-up|2|||
156576327|NCT03705494|565198176|FG001|Overall Study|Lost to Follow-up|1|||
156576328|NCT03705494|565198175|FG000|Overall Study|Withdrawal by Subject|5|||
156576329|NCT03705494|565198176|FG001|Overall Study|Withdrawal by Subject|2|||
156576330|NCT01582282|565198177|FG000|Overall Study|Adverse Event|1|||
156576331|NCT01582282|565198178|FG001|Overall Study|Adverse Event|1|||
156576332|NCT01582282|565198179|FG002|Overall Study|Adverse Event|0|||
156576333|NCT01582282|565198177|FG000|Overall Study|Lost to Follow-up|1|||
156576334|NCT01582282|565198178|FG001|Overall Study|Lost to Follow-up|0|||
156576335|NCT01582282|565198179|FG002|Overall Study|Lost to Follow-up|0|||
156576336|NCT01582282|565198177|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
156576337|NCT01582282|565198178|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
156576338|NCT01582282|565198179|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
156576339|NCT03937986|565198181|FG000|Overall Study|COVID-19 Pandemic|1|||
156576340|NCT02839746|565198182|FG000|Overall Study|Not met selection criteria|12|||
156576341|NCT01330381|565198183|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
156576342|NCT01330381|565198184|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
156576343|NCT01330381|565198185|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
156576344|NCT01330381|565198183|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
156576345|NCT01330381|565198184|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
156576346|NCT01330381|565198185|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
156576347|NCT01330381|565198183|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
156576348|NCT01330381|565198184|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
156576349|NCT01330381|565198185|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
156576350|NCT01330381|565198183|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
156576351|NCT01330381|565198184|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
156576352|NCT01330381|565198185|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
156576353|NCT01330381|565198183|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
156576354|NCT01330381|565198184|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
156576355|NCT01330381|565198185|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
156576356|NCT01330381|565198183|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
156576357|NCT01330381|565198184|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
156576358|NCT01330381|565198185|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
156576359|NCT01330381|565198183|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
156576360|NCT01330381|565198184|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
156576361|NCT01330381|565198185|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
156576362|NCT01330381|565198183|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
156576363|NCT01330381|565198184|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
156576364|NCT01330381|565198185|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
156576365|NCT01330381|565198183|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
156576366|NCT01330381|565198184|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
156576367|NCT01330381|565198185|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
156576368|NCT01330381|565198183|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
156576369|NCT01330381|565198184|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
156576370|NCT01330381|565198185|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
156576371|NCT03056287|565198186|FG000|Overall Study|Withdrawal by Subject|0|||
156576372|NCT03056287|565198187|FG001|Overall Study|Withdrawal by Subject|1|||
156576373|NCT03056287|565198188|FG002|Overall Study|Withdrawal by Subject|0|||
156576374|NCT03056287|565198189|FG003|Overall Study|Withdrawal by Subject|0|||
156863464|NCT03137381|566258642|FG000|Overall Study|Protocol deviation|1|||
156863465|NCT03137381|566258643|FG001|Overall Study|Protocol deviation|1|||
156863466|NCT03137381|566258644|FG002|Overall Study|Protocol deviation|0|||
156863467|NCT03137381|566258645|FG003|Overall Study|Protocol deviation|1|||
156863468|NCT03137381|566258642|FG000|Overall Study|Withdrawal by Investigator|0|||
156863469|NCT03137381|566258643|FG001|Overall Study|Withdrawal by Investigator|1|||
156863470|NCT03137381|566258644|FG002|Overall Study|Withdrawal by Investigator|1|||
156863471|NCT03137381|566258645|FG003|Overall Study|Withdrawal by Investigator|0|||
156863472|NCT03137381|566258642|FG000|Overall Study|Withdrawal by Subject|3|||
156863473|NCT03137381|566258643|FG001|Overall Study|Withdrawal by Subject|4|||
156863474|NCT03137381|566258644|FG002|Overall Study|Withdrawal by Subject|3|||
156863475|NCT03137381|566258645|FG003|Overall Study|Withdrawal by Subject|0|||
156863476|NCT03137381|566258642|FG000|Overall Study|Pregnancy|0|||
156863477|NCT03137381|566258643|FG001|Overall Study|Pregnancy|0|||
156863478|NCT03137381|566258644|FG002|Overall Study|Pregnancy|1|||
156863479|NCT03137381|566258645|FG003|Overall Study|Pregnancy|0|||
156863480|NCT01980017|566258646|FG000|Overall Study|Lost to Follow-up|30|||
156863481|NCT01980017|566258647|FG001|Overall Study|Lost to Follow-up|21|||
156863482|NCT01980017|566258646|FG000|Overall Study|Death|0|||
156863483|NCT01980017|566258647|FG001|Overall Study|Death|1|||
156863484|NCT03044106|566258648|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
156863485|NCT03044106|566258649|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
156863486|NCT02057250|566258651|FG000|AID Assessment Phase|Adverse Event|3|||
156863487|NCT02057250|566258652|FG001|AID Assessment Phase|Adverse Event|2|||
156863488|NCT02057250|566258653|FG002|AID Assessment Phase|Adverse Event|6|||
156863489|NCT02057250|566258654|FG003|AID Assessment Phase|Adverse Event|1|||
156863490|NCT02057250|566258655|FG004|AID Assessment Phase|Adverse Event|0|||
156863491|NCT02057250|566258651|FG000|AID Assessment Phase|Other than specified above|1|||
156863492|NCT02057250|566258652|FG001|AID Assessment Phase|Other than specified above|1|||
156863493|NCT02057250|566258653|FG002|AID Assessment Phase|Other than specified above|1|||
156863494|NCT02057250|566258654|FG003|AID Assessment Phase|Other than specified above|1|||
156863495|NCT02057250|566258655|FG004|AID Assessment Phase|Other than specified above|0|||
156863496|NCT02057250|566258651|FG000|Extension Phase|Adverse Event|0|||
156863497|NCT02057250|566258652|FG001|Extension Phase|Adverse Event|0|||
156863498|NCT02057250|566258653|FG002|Extension Phase|Adverse Event|0|||
156863499|NCT02057250|566258654|FG003|Extension Phase|Adverse Event|0|||
156863500|NCT02057250|566258655|FG004|Extension Phase|Adverse Event|15|||
156576375|NCT03056287|565198186|FG000|Overall Study|move out of area|0|||
156576376|NCT03056287|565198187|FG001|Overall Study|move out of area|0|||
156576377|NCT03056287|565198188|FG002|Overall Study|move out of area|1|||
156576378|NCT03056287|565198189|FG003|Overall Study|move out of area|1|||
156576379|NCT00328198|565198190|FG000|Treatment|Adverse Event|21|||
156576380|NCT00328198|565198190|FG000|Treatment|Death|1|||
156576381|NCT00328198|565198190|FG000|Treatment|Physician Decision|5|||
156576382|NCT00328198|565198190|FG000|Treatment|Withdrawal by Subject|5|||
156576383|NCT00328198|565198190|FG000|Treatment|Evidence of disease progression|2|||
156576384|NCT00328198|565198190|FG000|Treatment|Non-compliance|1|||
156576385|NCT00328198|565198190|FG000|Treatment|Confirmed complete response, MRD -|3|||
156576386|NCT00328198|565198190|FG000|Follow-up|Lost to Follow-up|4|||
156576387|NCT00328198|565198190|FG000|Follow-up|Death|31|||
156576388|NCT00650585|565198191|FG000|Overall Study|Lost to Follow-up|505|||
156576389|NCT00650585|565198192|FG001|Overall Study|Lost to Follow-up|482|||
156576390|NCT00650585|565198191|FG000|Overall Study|No parental consent|935|||
156576391|NCT00650585|565198192|FG001|Overall Study|No parental consent|866|||
156576392|NCT00650585|565198191|FG000|Overall Study|Excluded/ruled ineligible|357|||
156576393|NCT00650585|565198192|FG001|Overall Study|Excluded/ruled ineligible|129|||
156576394|NCT02532543|565198193|FG000|Overall Study|Lost to Follow-up|0|||
156576395|NCT02532543|565198194|FG001|Overall Study|Lost to Follow-up|0|||
156576396|NCT02532543|565198195|FG002|Overall Study|Lost to Follow-up|1|||
156576397|NCT02532543|565198196|FG003|Overall Study|Lost to Follow-up|0|||
156576398|NCT02640612|565198199|FG000|Overall Study|Adverse Event|6|||
156576399|NCT02640612|565198200|FG001|Overall Study|Adverse Event|7|||
156576400|NCT02640612|565198201|FG002|Overall Study|Adverse Event|2|||
156576401|NCT02640612|565198199|FG000|Overall Study|Death|1|||
156576402|NCT02640612|565198200|FG001|Overall Study|Death|0|||
156576403|NCT02640612|565198201|FG002|Overall Study|Death|0|||
156576404|NCT02640612|565198199|FG000|Overall Study|Withdrawal by Subject|10|||
156576405|NCT02640612|565198200|FG001|Overall Study|Withdrawal by Subject|3|||
156576406|NCT02640612|565198201|FG002|Overall Study|Withdrawal by Subject|3|||
156576407|NCT02640612|565198199|FG000|Overall Study|Lost to Follow-up|4|||
156576408|NCT02640612|565198200|FG001|Overall Study|Lost to Follow-up|1|||
156576409|NCT02640612|565198201|FG002|Overall Study|Lost to Follow-up|1|||
156576410|NCT02640612|565198199|FG000|Overall Study|Protocol Violation|0|||
156576411|NCT02640612|565198200|FG001|Overall Study|Protocol Violation|2|||
156576412|NCT02640612|565198201|FG002|Overall Study|Protocol Violation|0|||
156576413|NCT02640612|565198199|FG000|Overall Study|Lack of Efficacy|1|||
156863501|NCT02057250|566258651|FG000|Extension Phase|Lack of Efficacy|0|||
156863502|NCT02057250|566258652|FG001|Extension Phase|Lack of Efficacy|0|||
156863503|NCT02057250|566258653|FG002|Extension Phase|Lack of Efficacy|0|||
156863504|NCT02057250|566258654|FG003|Extension Phase|Lack of Efficacy|0|||
156863505|NCT02057250|566258655|FG004|Extension Phase|Lack of Efficacy|10|||
156863506|NCT02057250|566258651|FG000|Extension Phase|Entered in this period but not treated|0|||
156863507|NCT02057250|566258652|FG001|Extension Phase|Entered in this period but not treated|0|||
156863508|NCT02057250|566258653|FG002|Extension Phase|Entered in this period but not treated|0|||
156863509|NCT02057250|566258654|FG003|Extension Phase|Entered in this period but not treated|0|||
156863510|NCT02057250|566258655|FG004|Extension Phase|Entered in this period but not treated|4|||
156863511|NCT02057250|566258651|FG000|Extension Phase|Other than specified above|0|||
156863512|NCT02057250|566258652|FG001|Extension Phase|Other than specified above|0|||
156863513|NCT02057250|566258653|FG002|Extension Phase|Other than specified above|0|||
156863514|NCT02057250|566258654|FG003|Extension Phase|Other than specified above|0|||
156863515|NCT02057250|566258655|FG004|Extension Phase|Other than specified above|7|||
156863516|NCT03379818|566258656|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
156863517|NCT03379818|566258657|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
156863518|NCT03379818|566258656|FG000|Overall Study|Withdrawal by Subject|2|||
156863519|NCT03379818|566258657|FG001|Overall Study|Withdrawal by Subject|3|||
156863520|NCT03379818|566258656|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
156863521|NCT03379818|566258657|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
156863522|NCT03367793|566258658|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156863523|NCT03367793|566258659|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156863524|NCT03367793|566258660|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
156863525|NCT03367793|566258661|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156576414|NCT02640612|565198200|FG001|Overall Study|Lack of Efficacy|1|||
156576415|NCT02640612|565198201|FG002|Overall Study|Lack of Efficacy|0|||
156576416|NCT03865407|565198216|FG000|Overall Study|Adverse Event|1|||
156576417|NCT03865407|565198217|FG001|Overall Study|Adverse Event|0|||
156576418|NCT03865407|565198216|FG000|Overall Study|Withdrawal by Subject|1|||
156576419|NCT03865407|565198217|FG001|Overall Study|Withdrawal by Subject|0|||
156576420|NCT03865407|565198216|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
156863526|NCT03367793|566258662|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156576421|NCT03865407|565198217|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
156576422|NCT01645280|565198218|FG000|Overall Study|Death|0|||
156863527|NCT03367793|566258663|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156576423|NCT01645280|565198219|FG001|Overall Study|Death|1|||
156576424|NCT01645280|565198220|FG002|Overall Study|Death|0|||
156576425|NCT01645280|565198221|FG003|Overall Study|Death|0|||
156576426|NCT01645280|565198222|FG004|Overall Study|Death|0|||
156576427|NCT01645280|565198218|FG000|Overall Study|Withdrawal by Subject|4|||
156576428|NCT01645280|565198219|FG001|Overall Study|Withdrawal by Subject|0|||
156576429|NCT01645280|565198220|FG002|Overall Study|Withdrawal by Subject|2|||
156576430|NCT01645280|565198221|FG003|Overall Study|Withdrawal by Subject|4|||
156576431|NCT01645280|565198222|FG004|Overall Study|Withdrawal by Subject|5|||
156576432|NCT01645280|565198218|FG000|Overall Study|Lost to Follow-up|0|||
156576433|NCT01645280|565198219|FG001|Overall Study|Lost to Follow-up|0|||
156576434|NCT01645280|565198220|FG002|Overall Study|Lost to Follow-up|0|||
156576435|NCT01645280|565198221|FG003|Overall Study|Lost to Follow-up|2|||
156576436|NCT01645280|565198222|FG004|Overall Study|Lost to Follow-up|1|||
156576437|NCT01645280|565198218|FG000|Overall Study|Other|1|||
156576438|NCT01645280|565198219|FG001|Overall Study|Other|1|||
156576439|NCT01645280|565198220|FG002|Overall Study|Other|2|||
156576440|NCT01645280|565198221|FG003|Overall Study|Other|0|||
156576441|NCT01645280|565198222|FG004|Overall Study|Other|0|||
156576442|NCT01645280|565198218|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
156576443|NCT01645280|565198219|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
156576444|NCT01645280|565198220|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
156576445|NCT01645280|565198221|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
156576446|NCT01645280|565198222|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
156576447|NCT00546819|565198227|FG000|Overall Study|Adverse Event|2|||
156576448|NCT00546819|565198228|FG001|Overall Study|Adverse Event|3|||
156576449|NCT00546819|565198227|FG000|Overall Study|Lost to Follow-up|2|||
156576450|NCT00546819|565198228|FG001|Overall Study|Lost to Follow-up|1|||
156576451|NCT00546819|565198227|FG000|Overall Study|Withdrawal by Subject|4|||
156576452|NCT00546819|565198228|FG001|Overall Study|Withdrawal by Subject|2|||
156576453|NCT03849560|565198229|FG000|Overall Study|Withdrawal by Subject|1|||
156576454|NCT03849560|565198230|FG001|Overall Study|Withdrawal by Subject|0|||
156576455|NCT03849560|565198231|FG002|Overall Study|Withdrawal by Subject|0|||
156576456|NCT01254344|565198238|FG000|Overall Study|Adverse Event|2|||
156576457|NCT01254344|565198239|FG001|Overall Study|Adverse Event|5|||
156576458|NCT01254344|565198238|FG000|Overall Study|Physician Decision|7|||
156576459|NCT01254344|565198239|FG001|Overall Study|Physician Decision|4|||
156576460|NCT01254344|565198238|FG000|Overall Study|Protocol Violation|1|||
156576461|NCT01254344|565198239|FG001|Overall Study|Protocol Violation|4|||
156576462|NCT01254344|565198238|FG000|Overall Study|Withdrawal by Subject|3|||
156576463|NCT01254344|565198239|FG001|Overall Study|Withdrawal by Subject|6|||
156576464|NCT00467649|565198240|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
156576465|NCT00467649|565198241|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
156576466|NCT00467649|565198242|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
156576467|NCT00467649|565198243|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
156576468|NCT00467649|565198244|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
156576469|NCT00467649|565198245|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
156576470|NCT00467649|565198240|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
156576471|NCT00467649|565198241|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
156576472|NCT00467649|565198242|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
156576473|NCT00467649|565198243|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
156576474|NCT00467649|565198244|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
156576475|NCT00467649|565198245|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
156576476|NCT00467649|565198240|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
156576477|NCT00467649|565198241|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
156576478|NCT00467649|565198242|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
156576479|NCT00467649|565198243|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
156576480|NCT00467649|565198244|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
156576481|NCT00467649|565198245|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
156576482|NCT00467649|565198240|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
156576483|NCT00467649|565198241|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
156576484|NCT00467649|565198242|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
156576485|NCT00467649|565198243|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
156576486|NCT00467649|565198244|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
156576487|NCT00467649|565198245|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
156576488|NCT00467649|565198240|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
156576489|NCT00467649|565198241|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
156576490|NCT00467649|565198242|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
156576491|NCT00467649|565198243|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
156576492|NCT00467649|565198244|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
156576493|NCT00467649|565198245|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
156576494|NCT00467649|565198240|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
156576495|NCT00467649|565198241|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
156576496|NCT00467649|565198242|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
156576497|NCT00467649|565198243|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
156576498|NCT00467649|565198244|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
156576499|NCT00467649|565198245|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
156576500|NCT00467649|565198240|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
156576501|NCT00467649|565198241|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
156576502|NCT00467649|565198242|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
156576503|NCT00467649|565198243|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
156576504|NCT00467649|565198244|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
156576505|NCT00467649|565198245|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
156576506|NCT01633060|565198246|FG000|Randomization Phase|Protocol deviation|1|||
156576507|NCT01633060|565198247|FG001|Randomization Phase|Protocol deviation|2|||
156576508|NCT01633060|565198246|FG000|Randomization Phase|Technical problem|0|||
156576509|NCT01633060|565198247|FG001|Randomization Phase|Technical problem|1|||
156576510|NCT01633060|565198246|FG000|Treatment Phase|Adverse Event|24|||
156576511|NCT01633060|565198247|FG001|Treatment Phase|Adverse Event|3|||
156576512|NCT01633060|565198246|FG000|Treatment Phase|Lost to Follow-up|1|||
156576513|NCT01633060|565198247|FG001|Treatment Phase|Lost to Follow-up|0|||
156576514|NCT01633060|565198246|FG000|Treatment Phase|Physician Decision|16|||
156576515|NCT01633060|565198247|FG001|Treatment Phase|Physician Decision|7|||
156576516|NCT01633060|565198246|FG000|Treatment Phase|Progressive Disease|210|||
156576517|NCT01633060|565198247|FG001|Treatment Phase|Progressive Disease|120|||
156576518|NCT01633060|565198246|FG000|Treatment Phase|Protocol Deviation|1|||
156576519|NCT01633060|565198247|FG001|Treatment Phase|Protocol Deviation|0|||
156576520|NCT01633060|565198246|FG000|Treatment Phase|Study Terminated by sponsor|7|||
156576521|NCT01633060|565198247|FG001|Treatment Phase|Study Terminated by sponsor|3|||
156576522|NCT01633060|565198246|FG000|Treatment Phase|Subject/guardian decision|25|||
156576523|NCT01633060|565198247|FG001|Treatment Phase|Subject/guardian decision|4|||
156576524|NCT01633060|565198246|FG000|Treatment Phase|Death|4|||
156576525|NCT01633060|565198247|FG001|Treatment Phase|Death|3|||
156576526|NCT01633060|565198246|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
156576527|NCT01633060|565198247|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156576528|NCT01633060|565198246|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
156576529|NCT01633060|565198247|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
156576530|NCT01633060|565198246|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
156576531|NCT01633060|565198247|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
156576532|NCT01633060|565198246|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
156576533|NCT01633060|565198247|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
156576534|NCT01633060|565198246|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
156576535|NCT01633060|565198247|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
156576536|NCT01633060|565198246|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
156576537|NCT01633060|565198247|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
156576538|NCT03233048|565198248|FG000|Overall Study|Withdrawal by Subject|1|||
156576539|NCT00491530|565198249|FG000|Overall Study|Adverse Event|6|||
156576540|NCT00491530|565198250|FG001|Overall Study|Adverse Event|1|||
156576541|NCT00491530|565198251|FG002|Overall Study|Adverse Event|2|||
156576542|NCT00491530|565198249|FG000|Overall Study|Withdrawal by Subject|3|||
156576543|NCT00491530|565198250|FG001|Overall Study|Withdrawal by Subject|0|||
156576544|NCT00491530|565198251|FG002|Overall Study|Withdrawal by Subject|0|||
156576545|NCT00491530|565198249|FG000|Overall Study|Lost to Follow-up|3|||
156576546|NCT00491530|565198250|FG001|Overall Study|Lost to Follow-up|2|||
156576547|NCT00491530|565198251|FG002|Overall Study|Lost to Follow-up|2|||
156576548|NCT00491530|565198249|FG000|Overall Study|Lack of Efficacy|0|||
156576549|NCT00491530|565198250|FG001|Overall Study|Lack of Efficacy|1|||
156576550|NCT00491530|565198251|FG002|Overall Study|Lack of Efficacy|0|||
156576551|NCT00491530|565198249|FG000|Overall Study|Investigator Discretion|0|||
156576552|NCT00491530|565198250|FG001|Overall Study|Investigator Discretion|1|||
156576553|NCT00491530|565198251|FG002|Overall Study|Investigator Discretion|0|||
156576554|NCT00491530|565198249|FG000|Overall Study|Patient Request|0|||
156576555|NCT00491530|565198250|FG001|Overall Study|Patient Request|1|||
156576556|NCT00491530|565198251|FG002|Overall Study|Patient Request|0|||
156576557|NCT00491530|565198249|FG000|Overall Study|Use of Prohibited Medication|0|||
156576558|NCT00491530|565198250|FG001|Overall Study|Use of Prohibited Medication|0|||
156576559|NCT00491530|565198251|FG002|Overall Study|Use of Prohibited Medication|1|||
156576560|NCT02859415|565198252|FG000|Overall Study|Physician Decision|1|||
156576561|NCT02859415|565198253|FG001|Overall Study|Physician Decision|0|||
156576562|NCT02859415|565198252|FG000|Overall Study|Off treatment due to cardiac event|0|||
156576563|NCT02859415|565198253|FG001|Overall Study|Off treatment due to cardiac event|1|||
156576564|NCT01396525|565198256|FG000|Overall Study|Withdrawal by Subject|8|||
156576565|NCT01396525|565198256|FG000|Overall Study|Death|14|||
156576566|NCT01396525|565198256|FG000|Overall Study|Lost to Follow-up|4|||
156576567|NCT03114969|565198257|FG000|Overall Study|Lost to Follow-up|0|||
156576568|NCT03114969|565198258|FG001|Overall Study|Lost to Follow-up|0|||
156576569|NCT03114969|565198259|FG002|Overall Study|Lost to Follow-up|3|||
156576570|NCT03114969|565198260|FG003|Overall Study|Lost to Follow-up|2|||
156576571|NCT03114969|565198261|FG004|Overall Study|Lost to Follow-up|0|||
156576572|NCT03114969|565198262|FG005|Overall Study|Lost to Follow-up|0|||
156576573|NCT03114969|565198263|FG006|Overall Study|Lost to Follow-up|0|||
156576574|NCT03114969|565198264|FG007|Overall Study|Lost to Follow-up|0|||
156576575|NCT03114969|565198265|FG008|Overall Study|Lost to Follow-up|0|||
156576576|NCT03114969|565198257|FG000|Overall Study|Adverse Event|0|||
156576577|NCT03114969|565198258|FG001|Overall Study|Adverse Event|0|||
156576578|NCT03114969|565198259|FG002|Overall Study|Adverse Event|1|||
156576579|NCT03114969|565198260|FG003|Overall Study|Adverse Event|0|||
156576580|NCT03114969|565198261|FG004|Overall Study|Adverse Event|0|||
156576581|NCT03114969|565198262|FG005|Overall Study|Adverse Event|1|||
156576582|NCT03114969|565198263|FG006|Overall Study|Adverse Event|1|||
156576583|NCT03114969|565198264|FG007|Overall Study|Adverse Event|0|||
156576584|NCT03114969|565198265|FG008|Overall Study|Adverse Event|2|||
156576585|NCT02436239|565198268|FG000|Open-Lable Treatment Period|Adverse Event|12|||
156576586|NCT02436239|565198269|FG001|Open-Lable Treatment Period|Adverse Event|3|||
156576587|NCT02436239|565198270|FG002|Open-Lable Treatment Period|Adverse Event|4|||
156576588|NCT02436239|565198271|FG003|Open-Lable Treatment Period|Adverse Event|2|||
156576589|NCT02436239|565198268|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
156576590|NCT02436239|565198269|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
156576591|NCT02436239|565198270|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
156576592|NCT02436239|565198271|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
156576593|NCT02436239|565198268|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
156576594|NCT02436239|565198269|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
156576595|NCT02436239|565198270|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
156576596|NCT02436239|565198271|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
156576597|NCT02436239|565198268|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
156576598|NCT02436239|565198269|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
156576599|NCT02436239|565198270|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
156576600|NCT02436239|565198271|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
156576601|NCT02436239|565198268|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
156576602|NCT02436239|565198269|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
156576603|NCT02436239|565198270|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
156576604|NCT02436239|565198271|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
156576605|NCT02436239|565198268|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
156576606|NCT02436239|565198269|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
156576607|NCT02436239|565198270|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
156576608|NCT02436239|565198271|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
156576609|NCT02436239|565198268|FG000|Open-Lable Treatment Period|Other Reason|1|||
156576610|NCT02436239|565198269|FG001|Open-Lable Treatment Period|Other Reason|1|||
156576611|NCT02436239|565198270|FG002|Open-Lable Treatment Period|Other Reason|0|||
156576612|NCT02436239|565198271|FG003|Open-Lable Treatment Period|Other Reason|0|||
156576613|NCT02436239|565198268|FG000|Down-Taper Period|Withdrawal by Subject|4|||
156576614|NCT02436239|565198269|FG001|Down-Taper Period|Withdrawal by Subject|4|||
156576615|NCT02436239|565198270|FG002|Down-Taper Period|Withdrawal by Subject|1|||
156576616|NCT02436239|565198271|FG003|Down-Taper Period|Withdrawal by Subject|2|||
156576617|NCT02168946|565198272|FG000|Overall Study|Adverse Event|8|||
156576618|NCT02168946|565198273|FG001|Overall Study|Adverse Event|5|||
156576619|NCT02168946|565198272|FG000|Overall Study|Lost to Follow-up|3|||
156576620|NCT02168946|565198273|FG001|Overall Study|Lost to Follow-up|0|||
156576621|NCT02168946|565198272|FG000|Overall Study|Subject unable to come back for visits|1|||
156576622|NCT02168946|565198273|FG001|Overall Study|Subject unable to come back for visits|0|||
156576623|NCT00450866|565198277|FG000|Overall Study|Adverse Event|0|||
156576624|NCT00450866|565198278|FG001|Overall Study|Adverse Event|1|||
156576625|NCT00450866|565198277|FG000|Overall Study|Withdrawal by Subject|5|||
156576626|NCT00450866|565198278|FG001|Overall Study|Withdrawal by Subject|2|||
156576627|NCT00450866|565198277|FG000|Overall Study|Death|1|||
156576628|NCT00450866|565198278|FG001|Overall Study|Death|0|||
156576629|NCT00450866|565198277|FG000|Overall Study|Physician Decision|1|||
156576630|NCT00450866|565198278|FG001|Overall Study|Physician Decision|0|||
156576631|NCT01743027|565198279|FG000|Overall Study|Adverse Event|2|||
156576632|NCT01743027|565198280|FG001|Overall Study|Adverse Event|0|||
156576633|NCT01743027|565198281|FG002|Overall Study|Adverse Event|0|||
156576634|NCT01743027|565198282|FG003|Overall Study|Adverse Event|0|||
156576635|NCT01743027|565198279|FG000|Overall Study|Lost to Follow-up|0|||
156576636|NCT01743027|565198280|FG001|Overall Study|Lost to Follow-up|0|||
156576637|NCT01743027|565198281|FG002|Overall Study|Lost to Follow-up|2|||
156576638|NCT01743027|565198282|FG003|Overall Study|Lost to Follow-up|0|||
156576639|NCT01743027|565198279|FG000|Overall Study|Progressive Disease|1|||
156576640|NCT01743027|565198280|FG001|Overall Study|Progressive Disease|4|||
156576641|NCT01743027|565198281|FG002|Overall Study|Progressive Disease|3|||
156576642|NCT01743027|565198282|FG003|Overall Study|Progressive Disease|0|||
156576643|NCT01743027|565198279|FG000|Overall Study|Protocol Violation|1|||
156576644|NCT01743027|565198280|FG001|Overall Study|Protocol Violation|1|||
156576645|NCT01743027|565198281|FG002|Overall Study|Protocol Violation|1|||
156576646|NCT01743027|565198282|FG003|Overall Study|Protocol Violation|0|||
156576647|NCT01743027|565198279|FG000|Overall Study|Withdrawal by Subject|1|||
156576648|NCT01743027|565198280|FG001|Overall Study|Withdrawal by Subject|0|||
156576649|NCT01743027|565198281|FG002|Overall Study|Withdrawal by Subject|3|||
156576650|NCT01743027|565198282|FG003|Overall Study|Withdrawal by Subject|1|||
156576651|NCT01753518|565198283|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
156576652|NCT01753518|565198284|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
156576653|NCT01753518|565198283|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
156576654|NCT01753518|565198284|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
156576655|NCT01753518|565198283|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
156576656|NCT01753518|565198284|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
156576657|NCT01753518|565198283|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
156576658|NCT01753518|565198284|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
156576659|NCT01971476|565198285|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
156576660|NCT01971476|565198286|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
156576661|NCT01971476|565198287|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
156576662|NCT01971476|565198285|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
156576663|NCT01971476|565198286|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
156576664|NCT01971476|565198287|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
156576665|NCT01971476|565198285|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
156576666|NCT01971476|565198286|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
156576667|NCT01971476|565198287|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
156576668|NCT00138151|565198288|FG000|Overall Study|Withdrawal by Subject|3|||
156576669|NCT00138151|565198288|FG000|Overall Study|Physician Decision|1|||
156576670|NCT04925570|565198291|FG000|Overall Study|Protocol Violation|24|||
156576671|NCT04925570|565198292|FG001|Overall Study|Protocol Violation|30|||
156576672|NCT04925570|565198291|FG000|Overall Study|Withdrawal by Subject|0|||
156576673|NCT04925570|565198292|FG001|Overall Study|Withdrawal by Subject|2|||
156576674|NCT02675517|565198293|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
156576675|NCT02675517|565198293|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
156576676|NCT03249350|565198296|FG000|Overall Study|Participant did not initiate treatment|5|||
156576677|NCT03249350|565198297|FG001|Overall Study|Participant did not initiate treatment|8|||
156576678|NCT03368404|565198309|FG000|Overall Study|Adverse Event|2|||
156576679|NCT03368404|565198310|FG001|Overall Study|Adverse Event|1|||
156576680|NCT03368404|565198309|FG000|Overall Study|Withdrawal by Subject|1|||
156576681|NCT03368404|565198310|FG001|Overall Study|Withdrawal by Subject|1|||
156576682|NCT01751646|565198316|FG000|Overall Study|Lost to Follow-up|5|||
156576683|NCT01751646|565198317|FG001|Overall Study|Lost to Follow-up|1|||
156576684|NCT01751646|565198316|FG000|Overall Study|Withdrawal by Subject|0|||
156576685|NCT01751646|565198317|FG001|Overall Study|Withdrawal by Subject|4|||
156576686|NCT01751646|565198316|FG000|Overall Study|Starting hormone therapy|1|||
156576687|NCT01751646|565198317|FG001|Overall Study|Starting hormone therapy|0|||
156576688|NCT01751646|565198316|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
156576689|NCT01751646|565198317|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
156576690|NCT01751646|565198316|FG000|Overall Study|Inadvertent enrollment|1|||
156576691|NCT01751646|565198317|FG001|Overall Study|Inadvertent enrollment|1|||
156576692|NCT01751646|565198316|FG000|Overall Study|Moved out of the area|1|||
156576693|NCT01751646|565198317|FG001|Overall Study|Moved out of the area|5|||
156576694|NCT01751646|565198316|FG000|Overall Study|Inability to attend required visits|0|||
156576695|NCT01751646|565198317|FG001|Overall Study|Inability to attend required visits|1|||
156576696|NCT01751646|565198316|FG000|Overall Study|Off study due to multiple obligations|0|||
156576697|NCT01751646|565198317|FG001|Overall Study|Off study due to multiple obligations|1|||
156576698|NCT01751646|565198316|FG000|Overall Study|Fails to comply with study requirements|0|||
156576699|NCT01751646|565198317|FG001|Overall Study|Fails to comply with study requirements|1|||
156576700|NCT01751646|565198316|FG000|Overall Study|Childcare issues|1|||
156576701|NCT01751646|565198317|FG001|Overall Study|Childcare issues|1|||
156576702|NCT00857246|565198318|FG000|Induction Regimen|Adverse Event|1|||
156576703|NCT00857246|565198318|FG000|Induction Regimen|disease-related complications|1|||
156576704|NCT00857246|565198318|FG000|Induction Regimen|Withdrawal by Subject|1|||
156576705|NCT00857246|565198318|FG000|Surgery (Curative)|disease progression|6|||
156576706|NCT00857246|565198318|FG000|ChemoRT|Withdrawal by Subject|1|||
156576707|NCT00857246|565198318|FG000|ChemoRT|Adverse Event|2|||
156576708|NCT02973815|565198319|FG000|Post Intervention|Death|1|||
156576709|NCT02973815|565198320|FG001|Post Intervention|Death|0|||
156576710|NCT02973815|565198319|FG000|Post Intervention|Lost to Follow-up|7|||
156576711|NCT02973815|565198320|FG001|Post Intervention|Lost to Follow-up|24|||
156576712|NCT02973815|565198319|FG000|Follow-up|Lost to Follow-up|2|||
156576713|NCT02973815|565198320|FG001|Follow-up|Lost to Follow-up|0|||
156576714|NCT02426086|565198321|FG000|Overall Study|Death|33|||
156576715|NCT02426086|565198322|FG001|Overall Study|Death|36|||
156576716|NCT02426086|565198321|FG000|Overall Study|Lost to Follow-up|2|||
156576717|NCT02426086|565198322|FG001|Overall Study|Lost to Follow-up|0|||
156576718|NCT02426086|565198321|FG000|Overall Study|Study Terminated by Sponsor|5|||
156576719|NCT02426086|565198322|FG001|Overall Study|Study Terminated by Sponsor|14|||
156576720|NCT02426086|565198321|FG000|Overall Study|Withdrawal by Subject|8|||
156576721|NCT02426086|565198322|FG001|Overall Study|Withdrawal by Subject|9|||
156576722|NCT04542291|565198323|FG000|Overall Study|Adverse Event|1|||
156576723|NCT04542291|565198323|FG000|Overall Study|Physician Decision|2|||
156576724|NCT03478683|565198324|FG000|Overall Study|Adverse Event|5|||
156576725|NCT03478683|565198325|FG001|Overall Study|Adverse Event|3|||
156576726|NCT03478683|565198324|FG000|Overall Study|Lost to Follow-up|0|||
156576727|NCT03478683|565198325|FG001|Overall Study|Lost to Follow-up|5|||
156576728|NCT03478683|565198324|FG000|Overall Study|Physician Decision|1|||
156576729|NCT03478683|565198325|FG001|Overall Study|Physician Decision|3|||
156576730|NCT03478683|565198324|FG000|Overall Study|Withdrawal by Subject|7|||
156576731|NCT03478683|565198325|FG001|Overall Study|Withdrawal by Subject|7|||
156576732|NCT00524303|565198326|FG000|Overall Study|Lost to Follow-up|6|||
156576733|NCT00524303|565198327|FG001|Overall Study|Lost to Follow-up|0|||
156576734|NCT00524303|565198328|FG002|Overall Study|Lost to Follow-up|3|||
156576735|NCT00524303|565198326|FG000|Overall Study|Protocol Violation|0|||
156576736|NCT00524303|565198327|FG001|Overall Study|Protocol Violation|1|||
156576737|NCT00524303|565198328|FG002|Overall Study|Protocol Violation|1|||
156576738|NCT00524303|565198326|FG000|Overall Study|Withdrawal by Subject|3|||
156576739|NCT00524303|565198327|FG001|Overall Study|Withdrawal by Subject|0|||
156576740|NCT00524303|565198328|FG002|Overall Study|Withdrawal by Subject|4|||
156576741|NCT00524303|565198326|FG000|Overall Study|Death|0|||
156576742|NCT00524303|565198327|FG001|Overall Study|Death|2|||
156576743|NCT00524303|565198328|FG002|Overall Study|Death|3|||
156576744|NCT00524303|565198326|FG000|Overall Study|Adverse Event|1|||
156576745|NCT00524303|565198327|FG001|Overall Study|Adverse Event|2|||
156576746|NCT00524303|565198328|FG002|Overall Study|Adverse Event|3|||
156576747|NCT00524303|565198326|FG000|Overall Study|Did not Complete Study Dosing|1|||
156576748|NCT00524303|565198327|FG001|Overall Study|Did not Complete Study Dosing|0|||
156576749|NCT00524303|565198328|FG002|Overall Study|Did not Complete Study Dosing|0|||
156576750|NCT00524303|565198326|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
156576751|NCT00524303|565198327|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
156576752|NCT00524303|565198328|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
156576753|NCT00524303|565198326|FG000|Overall Study|Disease Progression|0|||
156576754|NCT00524303|565198327|FG001|Overall Study|Disease Progression|4|||
156576755|NCT00524303|565198328|FG002|Overall Study|Disease Progression|1|||
156576756|NCT00524303|565198326|FG000|Overall Study|Disease Recurrence|0|||
156576757|NCT00524303|565198327|FG001|Overall Study|Disease Recurrence|1|||
156576758|NCT00524303|565198328|FG002|Overall Study|Disease Recurrence|0|||
156576759|NCT00524303|565198326|FG000|Overall Study|Sponsor Request|0|||
156576760|NCT00524303|565198327|FG001|Overall Study|Sponsor Request|0|||
156576761|NCT00524303|565198328|FG002|Overall Study|Sponsor Request|1|||
156576762|NCT00524303|565198326|FG000|Overall Study|Physician Decision|0|||
156576763|NCT00524303|565198327|FG001|Overall Study|Physician Decision|0|||
156576764|NCT00524303|565198328|FG002|Overall Study|Physician Decision|1|||
156576765|NCT00524303|565198326|FG000|Overall Study|Completed 5 years|0|||
156576766|NCT00524303|565198327|FG001|Overall Study|Completed 5 years|0|||
156576767|NCT00524303|565198328|FG002|Overall Study|Completed 5 years|1|||
156576768|NCT01607892|565198334|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
156576769|NCT01607892|565198335|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
156576770|NCT01607892|565198336|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
156576771|NCT01607892|565198337|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
156576772|NCT01607892|565198338|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
156576773|NCT01607892|565198334|FG000|Overall Study|Death|4|||
156576774|NCT01607892|565198335|FG001|Overall Study|Death|2|||
156576775|NCT01607892|565198336|FG002|Overall Study|Death|8|||
156576776|NCT01607892|565198337|FG003|Overall Study|Death|10|||
156576777|NCT01607892|565198338|FG004|Overall Study|Death|3|||
156576778|NCT01607892|565198334|FG000|Overall Study|Investigator discretion|2|||
156576779|NCT01607892|565198335|FG001|Overall Study|Investigator discretion|4|||
156576780|NCT01607892|565198336|FG002|Overall Study|Investigator discretion|4|||
156576781|NCT01607892|565198337|FG003|Overall Study|Investigator discretion|8|||
156576782|NCT01607892|565198338|FG004|Overall Study|Investigator discretion|0|||
156576783|NCT01607892|565198334|FG000|Overall Study|Other treatments became available|1|||
156576784|NCT01607892|565198335|FG001|Overall Study|Other treatments became available|1|||
156576785|NCT01607892|565198336|FG002|Overall Study|Other treatments became available|0|||
156576786|NCT01607892|565198337|FG003|Overall Study|Other treatments became available|0|||
156576787|NCT01607892|565198338|FG004|Overall Study|Other treatments became available|2|||
156576788|NCT01607892|565198334|FG000|Overall Study|Intercurrent illness|1|||
156576789|NCT01607892|565198335|FG001|Overall Study|Intercurrent illness|0|||
156576790|NCT01607892|565198336|FG002|Overall Study|Intercurrent illness|0|||
156576791|NCT01607892|565198337|FG003|Overall Study|Intercurrent illness|3|||
156576792|NCT01607892|565198338|FG004|Overall Study|Intercurrent illness|0|||
156576793|NCT01607892|565198334|FG000|Overall Study|Non-Compliance with study procedures|0|||
156576794|NCT01607892|565198335|FG001|Overall Study|Non-Compliance with study procedures|0|||
156576795|NCT01607892|565198336|FG002|Overall Study|Non-Compliance with study procedures|1|||
156576796|NCT01607892|565198337|FG003|Overall Study|Non-Compliance with study procedures|0|||
156576797|NCT01607892|565198338|FG004|Overall Study|Non-Compliance with study procedures|0|||
156576798|NCT01607892|565198334|FG000|Overall Study|Consent withdrawn by participant|9|||
156576799|NCT01607892|565198335|FG001|Overall Study|Consent withdrawn by participant|4|||
156576800|NCT01607892|565198336|FG002|Overall Study|Consent withdrawn by participant|24|||
156576801|NCT01607892|565198337|FG003|Overall Study|Consent withdrawn by participant|14|||
156576802|NCT01607892|565198338|FG004|Overall Study|Consent withdrawn by participant|4|||
156576803|NCT01607892|565198334|FG000|Overall Study|Disease progression|38|||
156576804|NCT01607892|565198335|FG001|Overall Study|Disease progression|13|||
156576805|NCT01607892|565198336|FG002|Overall Study|Disease progression|37|||
156576806|NCT01607892|565198337|FG003|Overall Study|Disease progression|57|||
156576807|NCT01607892|565198338|FG004|Overall Study|Disease progression|9|||
156576808|NCT01607892|565198334|FG000|Overall Study|Incidence or severity of Adverse events|3|||
156576809|NCT01607892|565198335|FG001|Overall Study|Incidence or severity of Adverse events|3|||
156576810|NCT01607892|565198336|FG002|Overall Study|Incidence or severity of Adverse events|7|||
156576811|NCT01607892|565198337|FG003|Overall Study|Incidence or severity of Adverse events|2|||
156576812|NCT01607892|565198338|FG004|Overall Study|Incidence or severity of Adverse events|6|||
156576813|NCT02273973|565198341|FG000|Overall Study|Adverse Event|4|||
156576814|NCT02273973|565198342|FG001|Overall Study|Adverse Event|0|||
156576815|NCT02273973|565198341|FG000|Overall Study|Withdrawal by Subject|2|||
156576816|NCT02273973|565198342|FG001|Overall Study|Withdrawal by Subject|3|||
156576817|NCT02273973|565198341|FG000|Overall Study|Death|1|||
156576818|NCT02273973|565198342|FG001|Overall Study|Death|0|||
156576819|NCT02273973|565198341|FG000|Overall Study|Non-compliance|1|||
156576820|NCT02273973|565198342|FG001|Overall Study|Non-compliance|0|||
156576821|NCT02273973|565198341|FG000|Overall Study|Protocol Violation|1|||
156576822|NCT02273973|565198342|FG001|Overall Study|Protocol Violation|0|||
156576823|NCT02273973|565198341|FG000|Overall Study|Progression of disease|0|||
156576824|NCT02273973|565198342|FG001|Overall Study|Progression of disease|2|||
156576825|NCT02273973|565198341|FG000|Overall Study|Lost to Follow-up|0|||
156576826|NCT02273973|565198342|FG001|Overall Study|Lost to Follow-up|1|||
156576827|NCT02273973|565198341|FG000|Overall Study|Physician Decision|0|||
156576828|NCT02273973|565198342|FG001|Overall Study|Physician Decision|1|||
156576829|NCT02273973|565198341|FG000|Overall Study|Reason not specified|0|||
156576830|NCT02273973|565198342|FG001|Overall Study|Reason not specified|1|||
156576831|NCT03022422|565198343|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
156576832|NCT03022422|565198344|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
156576833|NCT03022422|565198345|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
156576834|NCT03022422|565198346|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
156576835|NCT03022422|565198347|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
156576836|NCT03022422|565198348|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
156576837|NCT01287117|565198349|FG000|Overall Study|Adverse Event|2|||
156576838|NCT01287117|565198350|FG001|Overall Study|Adverse Event|1|||
156576839|NCT01287117|565198351|FG002|Overall Study|Adverse Event|1|||
156576840|NCT01287117|565198352|FG003|Overall Study|Adverse Event|1|||
156576841|NCT01287117|565198349|FG000|Overall Study|Lost to Follow-up|1|||
156576842|NCT01287117|565198350|FG001|Overall Study|Lost to Follow-up|1|||
156576843|NCT01287117|565198351|FG002|Overall Study|Lost to Follow-up|0|||
156576844|NCT01287117|565198352|FG003|Overall Study|Lost to Follow-up|0|||
156576845|NCT01287117|565198349|FG000|Overall Study|Physician Decision|0|||
156576846|NCT01287117|565198350|FG001|Overall Study|Physician Decision|1|||
156576847|NCT01287117|565198351|FG002|Overall Study|Physician Decision|1|||
156576848|NCT01287117|565198352|FG003|Overall Study|Physician Decision|1|||
156576849|NCT01287117|565198349|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
156576850|NCT01287117|565198350|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
156576851|NCT01287117|565198351|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
156576852|NCT01287117|565198352|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
156576853|NCT01287117|565198349|FG000|Overall Study|Disease Progression|10|||
156576854|NCT01287117|565198350|FG001|Overall Study|Disease Progression|5|||
156576855|NCT01287117|565198351|FG002|Overall Study|Disease Progression|6|||
156576856|NCT01287117|565198352|FG003|Overall Study|Disease Progression|5|||
156576857|NCT01769404|565198358|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
156576858|NCT01769404|565198359|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
156576859|NCT01769404|565198358|FG000|Treatment Period 1|Withdrawal by Subject|3|||
156576860|NCT01769404|565198359|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156576861|NCT01769404|565198358|FG000|Treatment Period 1|Sponsor decision|1|||
156576862|NCT01769404|565198359|FG001|Treatment Period 1|Sponsor decision|0|||
156576863|NCT01769404|565198358|FG000|Treatment Period 2|Sponsor decision|7|||
156576864|NCT01769404|565198359|FG001|Treatment Period 2|Sponsor decision|0|||
156576865|NCT02606877|565198374|FG000|Overall Study|Adverse Event|3|||
156576866|NCT02606877|565198375|FG001|Overall Study|Adverse Event|0|||
156576867|NCT02606877|565198374|FG000|Overall Study|Non-compliance with protocol|0|||
156576868|NCT02606877|565198375|FG001|Overall Study|Non-compliance with protocol|1|||
156576869|NCT02606877|565198374|FG000|Overall Study|Other than listed above|1|||
156576870|NCT02606877|565198375|FG001|Overall Study|Other than listed above|0|||
156576871|NCT00778999|565198376|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
156576872|NCT00778999|565198377|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
156576873|NCT00778999|565198376|FG000|Overall Study|Did not receive recFSH|14|||
156576874|NCT00778999|565198377|FG001|Overall Study|Did not receive recFSH|20|||
156576875|NCT02032524|565198378|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
156576876|NCT02032524|565198379|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
156576877|NCT02032524|565198380|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
156576878|NCT02032524|565198381|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
156576879|NCT02032524|565198382|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
156576880|NCT02032524|565198383|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
156576881|NCT02032524|565198378|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
156576882|NCT02032524|565198379|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
156576883|NCT02032524|565198380|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
156576884|NCT02032524|565198381|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
156576885|NCT02032524|565198382|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
156576886|NCT02032524|565198383|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
156576887|NCT02032524|565198378|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
156576888|NCT02032524|565198379|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
156576889|NCT02032524|565198380|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
156576890|NCT02032524|565198381|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
156576891|NCT02032524|565198382|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
156576892|NCT02032524|565198383|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
156576893|NCT02032524|565198378|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
156576894|NCT02032524|565198379|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
156576895|NCT02032524|565198380|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
156576896|NCT02032524|565198381|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
156576897|NCT02032524|565198382|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
156576898|NCT02032524|565198383|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
156576899|NCT02032524|565198378|FG000|Period 2: LTS13769 Study|Other|0|||
156576900|NCT02032524|565198379|FG001|Period 2: LTS13769 Study|Other|0|||
156576901|NCT02032524|565198380|FG002|Period 2: LTS13769 Study|Other|0|||
156576902|NCT02032524|565198381|FG003|Period 2: LTS13769 Study|Other|0|||
156576903|NCT02032524|565198382|FG004|Period 2: LTS13769 Study|Other|0|||
156576904|NCT02032524|565198383|FG005|Period 2: LTS13769 Study|Other|1|||
156576905|NCT02277444|565198387|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
156576906|NCT02277444|565198387|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
156576907|NCT02277444|565198387|FG000|Treatment Period (Week 0-52)|Other|1|||
156576908|NCT02277444|565198387|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
156576909|NCT02277444|565198387|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
156576910|NCT02277444|565198387|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
156576911|NCT02277444|565198387|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
156576912|NCT02277444|565198387|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
156576913|NCT02277444|565198387|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
156576914|NCT04513158|565198388|FG000|Overall Study|Screen Failure|1|||
156576915|NCT05278104|565198389|FG000|Overall Study|Not treated|1|||
156576916|NCT05278104|565198390|FG001|Overall Study|Not treated|0|||
156576917|NCT05278104|565198389|FG000|Overall Study|Adverse Event|2|||
156576918|NCT05278104|565198390|FG001|Overall Study|Adverse Event|1|||
156576919|NCT05278104|565198389|FG000|Overall Study|Exclusion criteria not met|1|||
156576920|NCT05278104|565198390|FG001|Overall Study|Exclusion criteria not met|0|||
156576921|NCT05635838|565199928|FG000|16-Week DBVC Period|Adverse Event|2|||
156576922|NCT05635838|565199929|FG001|16-Week DBVC Period|Adverse Event|0|||
156576923|NCT05635838|565199930|FG002|16-Week DBVC Period|Adverse Event|0|||
156576924|NCT05635838|565199931|FG003|16-Week DBVC Period|Adverse Event|0|||
156576925|NCT05635838|565199928|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
156576926|NCT05635838|565199929|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
156576927|NCT05635838|565199930|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
156576928|NCT05635838|565199931|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
156576929|NCT05635838|565199928|FG000|16-Week DBVC Period|Physician Decision|0|||
156576930|NCT05635838|565199929|FG001|16-Week DBVC Period|Physician Decision|1|||
156576931|NCT05635838|565199930|FG002|16-Week DBVC Period|Physician Decision|0|||
156576932|NCT05635838|565199931|FG003|16-Week DBVC Period|Physician Decision|0|||
156576933|NCT05635838|565199928|FG000|16-Week DBVC Period|Protocol Violation|1|||
156576934|NCT05635838|565199929|FG001|16-Week DBVC Period|Protocol Violation|0|||
156576935|NCT05635838|565199930|FG002|16-Week DBVC Period|Protocol Violation|0|||
156576936|NCT05635838|565199931|FG003|16-Week DBVC Period|Protocol Violation|0|||
156576937|NCT05635838|565199928|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
156576938|NCT05635838|565199929|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
156576939|NCT05635838|565199930|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
156576940|NCT05635838|565199931|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
156576941|NCT05635838|565199928|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
156576942|NCT05635838|565199929|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
156576943|NCT05635838|565199930|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
156576944|NCT05635838|565199931|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
156576945|NCT05635838|565199928|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
156576946|NCT05635838|565199929|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
156576947|NCT05635838|565199930|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
156576948|NCT05635838|565199931|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
156576949|NCT05635838|565199928|FG000|16-Week OLE Period|Adverse Event|0|||
156576950|NCT05635838|565199929|FG001|16-Week OLE Period|Adverse Event|0|||
156576951|NCT05635838|565199930|FG002|16-Week OLE Period|Adverse Event|0|||
156576952|NCT05635838|565199931|FG003|16-Week OLE Period|Adverse Event|2|||
156576953|NCT05635838|565199928|FG000|16-Week OLE Period|Lost to Follow-up|0|||
156576954|NCT05635838|565199929|FG001|16-Week OLE Period|Lost to Follow-up|0|||
156576955|NCT05635838|565199930|FG002|16-Week OLE Period|Lost to Follow-up|1|||
156576956|NCT05635838|565199931|FG003|16-Week OLE Period|Lost to Follow-up|3|||
156863528|NCT00260533|566258664|FG000|Overall Study|Other|3|||
156863529|NCT00260533|566258665|FG001|Overall Study|Other|3|||
156863530|NCT01310777|566258666|FG000|Overall Study|Adverse Event|23|||
156863531|NCT01310777|566258667|FG001|Overall Study|Adverse Event|1|||
156863532|NCT01310777|566258668|FG002|Overall Study|Adverse Event|15|||
156863533|NCT01310777|566258666|FG000|Overall Study|Lost to Follow-up|0|||
156863534|NCT01310777|566258667|FG001|Overall Study|Lost to Follow-up|4|||
156863535|NCT01310777|566258668|FG002|Overall Study|Lost to Follow-up|1|||
156863536|NCT01310777|566258666|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
156863537|NCT01310777|566258667|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
156863538|NCT01310777|566258668|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
156863539|NCT01310777|566258666|FG000|Overall Study|Inadequate Control of IOP|5|||
156863540|NCT01310777|566258667|FG001|Overall Study|Inadequate Control of IOP|7|||
156863541|NCT01310777|566258668|FG002|Overall Study|Inadequate Control of IOP|10|||
156863542|NCT01310777|566258666|FG000|Overall Study|Other|4|||
156863543|NCT01310777|566258667|FG001|Overall Study|Other|1|||
156863544|NCT01310777|566258668|FG002|Overall Study|Other|2|||
156863545|NCT04218240|566258670|FG000|Overall Study|Withdrawal by Subject|6|||
156863546|NCT04218240|566258671|FG001|Overall Study|Withdrawal by Subject|0|||
156863547|NCT04218240|566258670|FG000|Overall Study|Lack of Efficacy|24|||
156863548|NCT04218240|566258671|FG001|Overall Study|Lack of Efficacy|19|||
156863549|NCT04218240|566258670|FG000|Overall Study|Physician Decision|0|||
156863550|NCT04218240|566258671|FG001|Overall Study|Physician Decision|1|||
156863551|NCT04218240|566258670|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
156863552|NCT04218240|566258671|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
156863553|NCT02738801|566258696|FG000|Overall Study|Adverse Event|1|||
156863554|NCT02738801|566258697|FG001|Overall Study|Adverse Event|1|||
156863555|NCT02738801|566258696|FG000|Overall Study|Withdrawal by Subject|0|||
156863556|NCT02738801|566258697|FG001|Overall Study|Withdrawal by Subject|1|||
156863557|NCT03279081|566258698|FG000|Overall Study|Withdrawal by Subject|12|||
156863558|NCT03279081|566258699|FG001|Overall Study|Withdrawal by Subject|20|||
156863559|NCT03279081|566258698|FG000|Overall Study|Physician Decision|4|||
156863560|NCT03279081|566258699|FG001|Overall Study|Physician Decision|1|||
156863561|NCT03279081|566258698|FG000|Overall Study|Lost to Follow-up|8|||
156863562|NCT03279081|566258699|FG001|Overall Study|Lost to Follow-up|8|||
156863563|NCT03279081|566258698|FG000|Overall Study|Death|0|||
156863564|NCT03279081|566258699|FG001|Overall Study|Death|1|||
156863565|NCT03279081|566258698|FG000|Overall Study|Adverse Event|1|||
156863566|NCT03279081|566258699|FG001|Overall Study|Adverse Event|0|||
156863567|NCT03279081|566258698|FG000|Overall Study|Reason not Specified|14|||
156863568|NCT03279081|566258699|FG001|Overall Study|Reason not Specified|4|||
156863569|NCT00771914|566258702|FG000|Overall Study|Physician Decision|0|||
156863570|NCT00771914|566258703|FG001|Overall Study|Physician Decision|0|||
156863571|NCT00771914|566258704|FG002|Overall Study|Physician Decision|0|||
156863572|NCT00771914|566258705|FG003|Overall Study|Physician Decision|1|||
156863573|NCT00771914|566258702|FG000|Overall Study|Lost to Follow-up|0|||
156863574|NCT00771914|566258703|FG001|Overall Study|Lost to Follow-up|0|||
156863575|NCT00771914|566258704|FG002|Overall Study|Lost to Follow-up|0|||
156863576|NCT00771914|566258705|FG003|Overall Study|Lost to Follow-up|1|||
156863577|NCT04842747|566258706|FG000|Overall Study|Withdrawal by Subject|6|||
156863578|NCT04842747|566258707|FG001|Overall Study|Withdrawal by Subject|2|||
156863579|NCT04842747|566258706|FG000|Overall Study|Lost to Follow-up|1|||
156863580|NCT04842747|566258707|FG001|Overall Study|Lost to Follow-up|2|||
156863581|NCT04842747|566258706|FG000|Overall Study|Physician Decision|1|||
156863582|NCT04842747|566258707|FG001|Overall Study|Physician Decision|0|||
156863583|NCT04842747|566258706|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
156863584|NCT04842747|566258707|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
156863585|NCT01743469|566258708|FG000|Active Treatment Phase|Adverse Event|10|||
156863586|NCT01743469|566258709|FG001|Active Treatment Phase|Adverse Event|5|||
156863587|NCT01743469|566258710|FG002|Active Treatment Phase|Adverse Event|8|||
156863588|NCT01743469|566258711|FG003|Active Treatment Phase|Adverse Event|1|||
156863589|NCT01743469|566258708|FG000|Active Treatment Phase|Disease Progression|40|||
156863590|NCT01743469|566258709|FG001|Active Treatment Phase|Disease Progression|47|||
156863591|NCT01743469|566258710|FG002|Active Treatment Phase|Disease Progression|30|||
156576957|NCT05635838|565199928|FG000|16-Week OLE Period|Physician Decision|0|||
156576958|NCT05635838|565199929|FG001|16-Week OLE Period|Physician Decision|0|||
156576959|NCT05635838|565199930|FG002|16-Week OLE Period|Physician Decision|0|||
156576960|NCT05635838|565199931|FG003|16-Week OLE Period|Physician Decision|1|||
156576961|NCT05635838|565199928|FG000|16-Week OLE Period|Protocol Violation|0|||
156576962|NCT05635838|565199929|FG001|16-Week OLE Period|Protocol Violation|0|||
156576963|NCT05635838|565199930|FG002|16-Week OLE Period|Protocol Violation|1|||
156576964|NCT05635838|565199931|FG003|16-Week OLE Period|Protocol Violation|1|||
156576965|NCT05635838|565199928|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
156576966|NCT05635838|565199929|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
156576967|NCT05635838|565199930|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
156576968|NCT05635838|565199931|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
156576969|NCT05635838|565199928|FG000|16-Week OLE Period|Pregnancy|0|||
156576970|NCT05635838|565199929|FG001|16-Week OLE Period|Pregnancy|0|||
156576971|NCT05635838|565199930|FG002|16-Week OLE Period|Pregnancy|1|||
156576972|NCT05635838|565199931|FG003|16-Week OLE Period|Pregnancy|0|||
156576973|NCT02031146|565199933|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
156576974|NCT02031146|565199934|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
156576975|NCT02031146|565199935|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
156576976|NCT02031146|565199936|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
156576977|NCT02031146|565199937|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
156576978|NCT02031146|565199938|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
156576979|NCT02031146|565199939|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
156576980|NCT02452970|565199942|FG000|Overall Study|Adverse Event|1|||
156576981|NCT02629393|565199943|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
156576982|NCT02629393|565199943|FG000|Overall Study|Physician Decision|1|||
156576983|NCT01040832|565199947|FG000|Overall Study|Adverse Event|4|||
156576984|NCT01040832|565199948|FG001|Overall Study|Adverse Event|5|||
156576985|NCT01040832|565199947|FG000|Overall Study|Death|4|||
156576986|NCT01040832|565199948|FG001|Overall Study|Death|6|||
156576987|NCT01040832|565199947|FG000|Overall Study|Withdrawal by Subject|2|||
156576988|NCT01040832|565199948|FG001|Overall Study|Withdrawal by Subject|3|||
156576989|NCT01040832|565199947|FG000|Overall Study|Progressive disease|32|||
156576990|NCT01040832|565199948|FG001|Overall Study|Progressive disease|17|||
156576991|NCT01040832|565199947|FG000|Overall Study|Symptomatic deterioration|2|||
156576992|NCT01040832|565199948|FG001|Overall Study|Symptomatic deterioration|5|||
156576993|NCT01040832|565199947|FG000|Overall Study|Other|2|||
156576994|NCT01040832|565199948|FG001|Overall Study|Other|1|||
156576995|NCT00744055|565199949|FG000|Overall Study|Withdrawal by Subject|6|||
156576996|NCT00744055|565199950|FG001|Overall Study|Withdrawal by Subject|9|||
156576997|NCT00744055|565199949|FG000|Overall Study|Lack of Efficacy|0|||
156576998|NCT00744055|565199950|FG001|Overall Study|Lack of Efficacy|1|||
156576999|NCT00744055|565199949|FG000|Overall Study|Physician Decision|0|||
156577000|NCT00744055|565199950|FG001|Overall Study|Physician Decision|2|||
156577001|NCT00744055|565199949|FG000|Overall Study|Protocol Violation|1|||
156577002|NCT00744055|565199950|FG001|Overall Study|Protocol Violation|1|||
156577003|NCT00744055|565199949|FG000|Overall Study|Lost to Follow-up|0|||
156577004|NCT00744055|565199950|FG001|Overall Study|Lost to Follow-up|1|||
156577005|NCT04426630|565199951|FG000|Overall Study|Death|4|||
156577006|NCT04426630|565199951|FG000|Overall Study|Lost to Follow-up|2|||
156577007|NCT02413255|565199954|FG000|Overall Study|Voluntary Withdrawal|0|||
156577008|NCT02413255|565199955|FG001|Overall Study|Voluntary Withdrawal|0|||
156577009|NCT02413255|565199956|FG002|Overall Study|Voluntary Withdrawal|0|||
156577010|NCT02413255|565199957|FG003|Overall Study|Voluntary Withdrawal|0|||
156577011|NCT02413255|565199958|FG004|Overall Study|Voluntary Withdrawal|0|||
156577012|NCT02413255|565199959|FG005|Overall Study|Voluntary Withdrawal|0|||
156577013|NCT02413255|565199960|FG006|Overall Study|Voluntary Withdrawal|0|||
156577014|NCT02413255|565199961|FG007|Overall Study|Voluntary Withdrawal|0|||
156577015|NCT02413255|565199962|FG008|Overall Study|Voluntary Withdrawal|0|||
156577016|NCT02413255|565199963|FG009|Overall Study|Voluntary Withdrawal|0|||
156577017|NCT02413255|565199964|FG010|Overall Study|Voluntary Withdrawal|0|||
156577018|NCT02413255|565199965|FG011|Overall Study|Voluntary Withdrawal|0|||
156577019|NCT02413255|565199966|FG012|Overall Study|Voluntary Withdrawal|0|||
156577020|NCT02413255|565199967|FG013|Overall Study|Voluntary Withdrawal|0|||
156577021|NCT02413255|565199968|FG014|Overall Study|Voluntary Withdrawal|1|||
156577022|NCT02413255|565199969|FG015|Overall Study|Voluntary Withdrawal|0|||
156577023|NCT02413255|565199970|FG016|Overall Study|Voluntary Withdrawal|0|||
156577024|NCT00779038|565199974|FG000|Overall Study|Study Prematurely Terminated|13|||
156577025|NCT05372315|565199975|FG000|Overall Study|Withdrawal by Subject|1|||
156577026|NCT05372315|565199976|FG001|Overall Study|Withdrawal by Subject|0|||
156577027|NCT03472534|565199977|FG000|Overall Study|Withdrawal by Subject|9|||
156577028|NCT03472534|565199977|FG000|Overall Study|Adverse Event|2|||
156577029|NCT01856673|565199983|FG000|Overall Study|Withdrawal by Subject|44|||
156577030|NCT01856673|565199984|FG001|Overall Study|Withdrawal by Subject|50|||
156577031|NCT01856673|565199985|FG002|Overall Study|Withdrawal by Subject|33|||
156577032|NCT01856673|565199983|FG000|Overall Study|Lost to Follow-up|31|||
156577033|NCT01856673|565199984|FG001|Overall Study|Lost to Follow-up|34|||
156577034|NCT01856673|565199985|FG002|Overall Study|Lost to Follow-up|0|||
156577035|NCT01856673|565199983|FG000|Overall Study|Unknown reasons|9|||
156577036|NCT01856673|565199984|FG001|Overall Study|Unknown reasons|0|||
156577037|NCT01856673|565199985|FG002|Overall Study|Unknown reasons|0|||
156577038|NCT01856673|565199983|FG000|Overall Study|Psychologist decision|1|||
156577039|NCT01856673|565199984|FG001|Overall Study|Psychologist decision|0|||
156577040|NCT01856673|565199985|FG002|Overall Study|Psychologist decision|0|||
156577041|NCT01856673|565199983|FG000|Overall Study|Paperwork errors|8|||
156577042|NCT01856673|565199984|FG001|Overall Study|Paperwork errors|0|||
156577043|NCT01856673|565199985|FG002|Overall Study|Paperwork errors|0|||
156577044|NCT01856673|565199983|FG000|Overall Study|Death|1|||
156577045|NCT01856673|565199984|FG001|Overall Study|Death|1|||
156577046|NCT01856673|565199985|FG002|Overall Study|Death|0|||
156577047|NCT01856673|565199983|FG000|Overall Study|Protocol Violation|1|||
156577048|NCT01856673|565199984|FG001|Overall Study|Protocol Violation|0|||
156577049|NCT01856673|565199985|FG002|Overall Study|Protocol Violation|1|||
156577050|NCT03240081|565199986|FG000|Overall Study|Withdrawal by Subject|0|||
156577051|NCT03240081|565199987|FG001|Overall Study|Withdrawal by Subject|2|||
156577052|NCT03240081|565199986|FG000|Overall Study|Lost to Follow-up|0|||
156577053|NCT03240081|565199987|FG001|Overall Study|Lost to Follow-up|1|||
156577054|NCT00883753|565199988|FG000|Overall Study|Adverse Event|37|||
156577055|NCT00883753|565199988|FG000|Overall Study|Death|2|||
156577056|NCT00883753|565199988|FG000|Overall Study|Insufficient therapeutic response|16|||
156577057|NCT00883753|565199988|FG000|Overall Study|Lost to Follow-up|4|||
156577058|NCT00883753|565199988|FG000|Overall Study|Violation of selection criteria at entry|7|||
156577059|NCT00883753|565199988|FG000|Overall Study|Protocol Violation|2|||
156577060|NCT00883753|565199988|FG000|Overall Study|Refused treatment|4|||
156577061|NCT00883753|565199988|FG000|Overall Study|Withdrew consent|10|||
156577062|NCT00883753|565199988|FG000|Overall Study|Investigator's decision|17|||
156577063|NCT00883753|565199988|FG000|Overall Study|Administrative/Other|8|||
156577064|NCT00940342|565199994|FG000|Overall Study|Adverse Event|0|||
156577065|NCT00940342|565199995|FG001|Overall Study|Adverse Event|2|||
156577066|NCT00940342|565199996|FG002|Overall Study|Adverse Event|1|||
156577067|NCT00793104|565199997|FG000|Overall Study|Lost to Follow-up|1|||
156577068|NCT03494725|565200000|FG000|Overall Study|Withdrawal by Subject|0|||
156577069|NCT03494725|565200001|FG001|Overall Study|Withdrawal by Subject|2|||
156577070|NCT03494725|565200000|FG000|Overall Study|Antibiotic use|1|||
156577071|NCT03494725|565200001|FG001|Overall Study|Antibiotic use|0|||
156577072|NCT02111811|565200002|FG000|Treatment Phase|Lost to Follow-up|22|||
156577073|NCT02111811|565200003|FG001|Treatment Phase|Lost to Follow-up|18|||
156577074|NCT02111811|565200002|FG000|Treatment Phase|Death|2|||
156577075|NCT02111811|565200003|FG001|Treatment Phase|Death|0|||
156577076|NCT02111811|565200002|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
156577077|NCT02111811|565200003|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
156577078|NCT02111811|565200002|FG000|Follow up Period (Aim 2)|Death|2|||
156577079|NCT02111811|565200003|FG001|Follow up Period (Aim 2)|Death|0|||
156577080|NCT03443024|565200006|FG000|Overall Study|Adverse Event|2|||
156577081|NCT03443024|565200007|FG001|Overall Study|Adverse Event|4|||
156577082|NCT03443024|565200008|FG002|Overall Study|Adverse Event|3|||
156577083|NCT03443024|565200009|FG003|Overall Study|Adverse Event|1|||
156577084|NCT03443024|565200006|FG000|Overall Study|Lost to Follow-up|9|||
156577085|NCT03443024|565200007|FG001|Overall Study|Lost to Follow-up|9|||
156577086|NCT03443024|565200008|FG002|Overall Study|Lost to Follow-up|7|||
156577087|NCT03443024|565200009|FG003|Overall Study|Lost to Follow-up|5|||
156577088|NCT03443024|565200006|FG000|Overall Study|Withdrawal by Subject|8|||
156577089|NCT03443024|565200007|FG001|Overall Study|Withdrawal by Subject|15|||
156577090|NCT03443024|565200008|FG002|Overall Study|Withdrawal by Subject|9|||
156577091|NCT03443024|565200009|FG003|Overall Study|Withdrawal by Subject|23|||
156577092|NCT03443024|565200006|FG000|Overall Study|Physician Decision|1|||
156577093|NCT03443024|565200007|FG001|Overall Study|Physician Decision|2|||
156577094|NCT03443024|565200008|FG002|Overall Study|Physician Decision|0|||
156577095|NCT03443024|565200009|FG003|Overall Study|Physician Decision|1|||
156577096|NCT03443024|565200006|FG000|Overall Study|Sponsor Decision|1|||
156577097|NCT03443024|565200007|FG001|Overall Study|Sponsor Decision|1|||
156577098|NCT03443024|565200008|FG002|Overall Study|Sponsor Decision|0|||
156577099|NCT03443024|565200009|FG003|Overall Study|Sponsor Decision|0|||
156577100|NCT03443024|565200006|FG000|Overall Study|Protocol Deviation|0|||
156577101|NCT03443024|565200007|FG001|Overall Study|Protocol Deviation|0|||
156577102|NCT03443024|565200008|FG002|Overall Study|Protocol Deviation|0|||
156577103|NCT03443024|565200009|FG003|Overall Study|Protocol Deviation|2|||
156577104|NCT00149825|565200010|FG000|Overall Study|Intolerance to medication side effects|1|||
156577105|NCT00149825|565200011|FG001|Overall Study|Intolerance to medication side effects|2|||
156577106|NCT00149825|565200010|FG000|Overall Study|Time commitments|2|||
156577107|NCT00149825|565200011|FG001|Overall Study|Time commitments|1|||
156577108|NCT00149825|565200010|FG000|Overall Study|Not liking insomnia therapy|1|||
156577109|NCT00149825|565200011|FG001|Overall Study|Not liking insomnia therapy|0|||
156577110|NCT00149825|565200010|FG000|Overall Study|Other|1|||
156577111|NCT00149825|565200011|FG001|Overall Study|Other|0|||
156577112|NCT05897853|565200012|FG000|Overall Study|Lost to Follow-up|2|||
156577113|NCT05897853|565200013|FG001|Overall Study|Lost to Follow-up|0|||
156577114|NCT05897853|565200012|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
156577115|NCT05897853|565200013|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
156577116|NCT01450137|565200014|FG000|Up to Week 12|Adverse Event|2|||
156577117|NCT01450137|565200015|FG001|Up to Week 12|Adverse Event|1|||
156577118|NCT01450137|565200014|FG000|Up to Week 12|Withdrawal by Subject|0|||
156577119|NCT01450137|565200015|FG001|Up to Week 12|Withdrawal by Subject|2|||
156577120|NCT01450137|565200014|FG000|Week 12 to Study End|Death|0|||
156577121|NCT01450137|565200015|FG001|Week 12 to Study End|Death|1|||
156577122|NCT01450137|565200014|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
156577123|NCT01450137|565200015|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
156577124|NCT01926886|565200016|FG000|Overall Study|Administrative/other|1|||
156577125|NCT01926886|565200017|FG001|Overall Study|Administrative/other|0|||
156577126|NCT01926886|565200016|FG000|Overall Study|Adverse event/intercurrent illness|4|||
156577127|NCT01926886|565200017|FG001|Overall Study|Adverse event/intercurrent illness|0|||
156577128|NCT01926886|565200016|FG000|Overall Study|Disease progression/recurrence|4|||
156577129|NCT01926886|565200017|FG001|Overall Study|Disease progression/recurrence|0|||
156577130|NCT01926886|565200016|FG000|Overall Study|Withdrawal by Subject|15|||
156577131|NCT01926886|565200017|FG001|Overall Study|Withdrawal by Subject|0|||
156577132|NCT01926886|565200016|FG000|Overall Study|Failure to return|3|||
156577133|NCT01926886|565200017|FG001|Overall Study|Failure to return|0|||
156577134|NCT01926886|565200016|FG000|Overall Study|Recurrence of disease|1|||
156577135|NCT01926886|565200017|FG001|Overall Study|Recurrence of disease|0|||
156577136|NCT01926886|565200016|FG000|Overall Study|Progression of disease|2|||
156577137|NCT01926886|565200017|FG001|Overall Study|Progression of disease|0|||
156577138|NCT01926886|565200016|FG000|Overall Study|Death|1|||
156577139|NCT01926886|565200017|FG001|Overall Study|Death|0|||
156577140|NCT01926886|565200016|FG000|Overall Study|Did not cooperate|1|||
156577141|NCT01926886|565200017|FG001|Overall Study|Did not cooperate|0|||
156577142|NCT04458857|565200021|FG000|Overall Study|Adverse Event|0|||
156577143|NCT04458857|565200022|FG001|Overall Study|Adverse Event|1|||
156577144|NCT04458857|565200023|FG002|Overall Study|Adverse Event|0|||
156577145|NCT04458857|565200021|FG000|Overall Study|Withdrawal by Subject|2|||
156577146|NCT04458857|565200022|FG001|Overall Study|Withdrawal by Subject|0|||
156577147|NCT04458857|565200023|FG002|Overall Study|Withdrawal by Subject|0|||
156577148|NCT04458857|565200021|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156577149|NCT04458857|565200022|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156577150|NCT04458857|565200023|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156577151|NCT04458857|565200021|FG000|Overall Study|Non-compliance with study drug|0|||
156577152|NCT04458857|565200022|FG001|Overall Study|Non-compliance with study drug|1|||
156577153|NCT04458857|565200023|FG002|Overall Study|Non-compliance with study drug|0|||
156577154|NCT04458857|565200021|FG000|Overall Study|Lost to Follow-up|4|||
156577155|NCT04458857|565200022|FG001|Overall Study|Lost to Follow-up|1|||
156577156|NCT04458857|565200023|FG002|Overall Study|Lost to Follow-up|0|||
156577157|NCT02609399|565200024|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
156577158|NCT02609399|565200025|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
156577159|NCT02609399|565200024|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
156577160|NCT02609399|565200025|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
156577161|NCT02609399|565200024|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
156577162|NCT02609399|565200025|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
156577163|NCT00069121|565200026|FG000|Overall Study|Death|286|||
156577164|NCT00069121|565200027|FG001|Overall Study|Death|242|||
156577165|NCT00069121|565200026|FG000|Overall Study|Withdrawal by Subject|18|||
156577166|NCT00069121|565200027|FG001|Overall Study|Withdrawal by Subject|20|||
156577167|NCT00069121|565200026|FG000|Overall Study|Lost to Follow-up|63|||
156577168|NCT00069121|565200027|FG001|Overall Study|Lost to Follow-up|63|||
156577169|NCT02986373|565200028|FG000|Overall Study|Adverse Event|4|||
156577170|NCT02986373|565200028|FG000|Overall Study|Lost to Follow-up|1|||
156577171|NCT02986373|565200028|FG000|Overall Study|Withdrawal by Subject|10|||
156577172|NCT02986373|565200028|FG000|Overall Study|Other|24|||
156577173|NCT04800315|565200029|FG000|Randomization|Did not receive study treatment|1|||
156577174|NCT04800315|565200030|FG001|Randomization|Did not receive study treatment|0|||
156577175|NCT04800315|565200031|FG002|Randomization|Did not receive study treatment|0|||
156577176|NCT04800315|565200032|FG003|Randomization|Did not receive study treatment|0|||
156577177|NCT04800315|565200029|FG000|Treatment Period|Adverse Event|4|||
156577178|NCT04800315|565200030|FG001|Treatment Period|Adverse Event|2|||
156577179|NCT04800315|565200031|FG002|Treatment Period|Adverse Event|1|||
156577180|NCT04800315|565200032|FG003|Treatment Period|Adverse Event|2|||
156577181|NCT04800315|565200029|FG000|Treatment Period|Lack of Efficacy|1|||
156577182|NCT04800315|565200030|FG001|Treatment Period|Lack of Efficacy|0|||
156577183|NCT04800315|565200031|FG002|Treatment Period|Lack of Efficacy|0|||
156577184|NCT04800315|565200032|FG003|Treatment Period|Lack of Efficacy|3|||
156577185|NCT04800315|565200029|FG000|Treatment Period|Lost to Follow-up|0|||
156577186|NCT04800315|565200030|FG001|Treatment Period|Lost to Follow-up|1|||
156577187|NCT04800315|565200031|FG002|Treatment Period|Lost to Follow-up|2|||
156577188|NCT04800315|565200032|FG003|Treatment Period|Lost to Follow-up|2|||
156577189|NCT04800315|565200029|FG000|Treatment Period|Withdrawal by participant|0|||
156577190|NCT04800315|565200030|FG001|Treatment Period|Withdrawal by participant|0|||
156577191|NCT04800315|565200031|FG002|Treatment Period|Withdrawal by participant|0|||
156577192|NCT04800315|565200032|FG003|Treatment Period|Withdrawal by participant|4|||
156577193|NCT04800315|565200029|FG000|Treatment Period|Other Reasons|0|||
156577194|NCT04800315|565200030|FG001|Treatment Period|Other Reasons|2|||
156577195|NCT04800315|565200031|FG002|Treatment Period|Other Reasons|0|||
156577196|NCT04800315|565200032|FG003|Treatment Period|Other Reasons|1|||
156577197|NCT00753922|565200033|FG000|Overall Study|Lost to Follow-up|155|||
156577198|NCT00753922|565200034|FG001|Overall Study|Lost to Follow-up|24|||
156577199|NCT00753922|565200035|FG002|Overall Study|Lost to Follow-up|28|||
156577200|NCT00753922|565200036|FG003|Overall Study|Lost to Follow-up|5|||
156577201|NCT00753922|565200033|FG000|Overall Study|Withdrawal by Subject|9|||
156577202|NCT00753922|565200034|FG001|Overall Study|Withdrawal by Subject|11|||
156577203|NCT00753922|565200035|FG002|Overall Study|Withdrawal by Subject|4|||
156577204|NCT00753922|565200036|FG003|Overall Study|Withdrawal by Subject|2|||
156577205|NCT00753922|565200033|FG000|Overall Study|Patient Non-compliance|55|||
156577206|NCT00753922|565200034|FG001|Overall Study|Patient Non-compliance|22|||
156577207|NCT00753922|565200035|FG002|Overall Study|Patient Non-compliance|14|||
156577208|NCT00753922|565200036|FG003|Overall Study|Patient Non-compliance|11|||
156577209|NCT00753922|565200033|FG000|Overall Study|Patients Not Completing Visit|11|||
156577210|NCT00753922|565200034|FG001|Overall Study|Patients Not Completing Visit|0|||
156577211|NCT00753922|565200035|FG002|Overall Study|Patients Not Completing Visit|1|||
156577212|NCT00753922|565200036|FG003|Overall Study|Patients Not Completing Visit|0|||
156577213|NCT00753922|565200033|FG000|Overall Study|Death|2|||
156577214|NCT00753922|565200034|FG001|Overall Study|Death|23|||
156577215|NCT00753922|565200035|FG002|Overall Study|Death|2|||
156577216|NCT00753922|565200036|FG003|Overall Study|Death|1|||
156577217|NCT00753922|565200033|FG000|Overall Study|Discontinuation Due to Explantation|14|||
156577218|NCT00753922|565200034|FG001|Overall Study|Discontinuation Due to Explantation|14|||
156577219|NCT00753922|565200035|FG002|Overall Study|Discontinuation Due to Explantation|14|||
156577220|NCT00753922|565200036|FG003|Overall Study|Discontinuation Due to Explantation|4|||
156577221|NCT00196937|565200037|FG000|Overall Study|Serious Adverse Event|1|||
156577222|NCT00196937|565200038|FG001|Overall Study|Serious Adverse Event|0|||
156577223|NCT00196937|565200039|FG002|Overall Study|Serious Adverse Event|0|||
156577224|NCT00196937|565200037|FG000|Overall Study|Non-serious adverse event|1|||
156577225|NCT00196937|565200038|FG001|Overall Study|Non-serious adverse event|1|||
156577226|NCT00196937|565200039|FG002|Overall Study|Non-serious adverse event|1|||
156577227|NCT00196937|565200037|FG000|Overall Study|Withdrawal by Subject|0|||
156577228|NCT00196937|565200038|FG001|Overall Study|Withdrawal by Subject|0|||
156577229|NCT00196937|565200039|FG002|Overall Study|Withdrawal by Subject|2|||
156577230|NCT00196937|565200037|FG000|Overall Study|Lost to Follow-up|4|||
156577231|NCT00196937|565200038|FG001|Overall Study|Lost to Follow-up|3|||
156577232|NCT00196937|565200039|FG002|Overall Study|Lost to Follow-up|3|||
156577233|NCT00196937|565200037|FG000|Overall Study|Other|3|||
156577234|NCT00196937|565200038|FG001|Overall Study|Other|1|||
156577235|NCT00196937|565200039|FG002|Overall Study|Other|1|||
156577236|NCT02983292|565200047|FG000|Overall Study|Participant unwell & cannot travel|2|||
156577237|NCT02983292|565200047|FG000|Overall Study|Lost to Follow-up|3|||
156577238|NCT02983292|565200047|FG000|Overall Study|Participant withdrew consent|2|||
156577239|NCT02983292|565200047|FG000|Overall Study|Revision|7|||
156577240|NCT02983292|565200047|FG000|Overall Study|Death|1|||
156577241|NCT02983292|565200047|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
156577242|NCT02983292|565200047|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
156577243|NCT02983292|565200047|FG000|Overall Study|Participant relocation|1|||
156577244|NCT04725682|565200048|FG000|Overall Study|Withdrawal by Subject|7|||
156577245|NCT04725682|565200049|FG001|Overall Study|Withdrawal by Subject|5|||
156577246|NCT04725682|565200048|FG000|Overall Study|Failed to comply with the requirements|2|||
156577247|NCT04725682|565200049|FG001|Overall Study|Failed to comply with the requirements|1|||
156577248|NCT04725682|565200048|FG000|Overall Study|Adverse Event|1|||
156577249|NCT04725682|565200049|FG001|Overall Study|Adverse Event|1|||
156577250|NCT04725682|565200048|FG000|Overall Study|Death|0|||
156577251|NCT04725682|565200049|FG001|Overall Study|Death|1|||
156577252|NCT00964795|565200050|FG000|Overall Study|Withdrawal by Subject|79|||
156577253|NCT00964795|565200050|FG000|Overall Study|Adverse Event|12|||
156577254|NCT00964795|565200050|FG000|Overall Study|Death|14|||
156577255|NCT00964795|565200050|FG000|Overall Study|Lost to Follow-up|7|||
156577256|NCT00964795|565200050|FG000|Overall Study|Termination of Study by Sponsor|169|||
156577257|NCT00964795|565200050|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
156577258|NCT00964795|565200050|FG000|Overall Study|Other|23|||
156577259|NCT02453841|565200055|FG000|Overall Study|Protocol Violation|1|||
156577260|NCT02453841|565200055|FG000|Overall Study|Unable to obtain blood samples|2|||
156577261|NCT00586690|565200056|FG000|Overall Study|Death|2|||
156577262|NCT00586690|565200057|FG001|Overall Study|Death|0|||
156577263|NCT00586690|565200056|FG000|Overall Study|Disease Progression|10|||
156577264|NCT00586690|565200057|FG001|Overall Study|Disease Progression|0|||
156577265|NCT00586690|565200056|FG000|Overall Study|Adverse Event|1|||
156577266|NCT00586690|565200057|FG001|Overall Study|Adverse Event|0|||
156577267|NCT00586690|565200056|FG000|Overall Study|Lack of Efficacy|2|||
156577268|NCT00586690|565200057|FG001|Overall Study|Lack of Efficacy|0|||
156577269|NCT00586690|565200056|FG000|Overall Study|Lab can't accommodate|1|||
156577270|NCT00586690|565200057|FG001|Overall Study|Lab can't accommodate|0|||
156577271|NCT03851510|565200058|FG000|Overall Study|Screen Fail|1|||
156577272|NCT03851510|565200058|FG000|Overall Study|Adverse Event|1|||
156577273|NCT03851510|565200058|FG000|Overall Study|Withdrawal by Subject|1|||
156577274|NCT01151137|565200061|FG000|Overall Study|Death|15|||
156577275|NCT01151137|565200062|FG001|Overall Study|Death|27|||
156577276|NCT01151137|565200061|FG000|Overall Study|Lost to Follow-up|1|||
156577277|NCT01151137|565200062|FG001|Overall Study|Lost to Follow-up|1|||
156577278|NCT00072189|565200063|FG000|Overall Study|Withdrawal by Subject|1|||
156577279|NCT00970294|565200066|FG000|Overall Study|Physician Decision|4|||
156577280|NCT00970294|565200066|FG000|Overall Study|Withdrawal by Subject|1|||
156577281|NCT01333189|565200067|FG000|Overall Study|Time constraints|1|||
156577282|NCT01333189|565200068|FG001|Overall Study|Time constraints|0|||
156577283|NCT01333189|565200067|FG000|Overall Study|Adverse Event|1|||
156577284|NCT01333189|565200068|FG001|Overall Study|Adverse Event|0|||
156577285|NCT01333189|565200067|FG000|Overall Study|Transportation difficulties|0|||
156577286|NCT01333189|565200068|FG001|Overall Study|Transportation difficulties|1|||
156577287|NCT01333189|565200067|FG000|Overall Study|Moved from region|0|||
156577288|NCT01333189|565200068|FG001|Overall Study|Moved from region|1|||
156577289|NCT01739595|565200069|FG000|Overall Study|Adverse Event|3|||
156577290|NCT01739595|565200070|FG001|Overall Study|Adverse Event|0|||
156577291|NCT01739595|565200071|FG002|Overall Study|Adverse Event|0|||
156577292|NCT01739595|565200069|FG000|Overall Study|Lost to Follow-up|2|||
156577293|NCT01739595|565200070|FG001|Overall Study|Lost to Follow-up|0|||
156577294|NCT01739595|565200071|FG002|Overall Study|Lost to Follow-up|0|||
156577295|NCT01739595|565200069|FG000|Overall Study|Withdrawal by Subject|2|||
156577296|NCT01739595|565200070|FG001|Overall Study|Withdrawal by Subject|1|||
156577297|NCT01739595|565200071|FG002|Overall Study|Withdrawal by Subject|2|||
156577298|NCT01739595|565200069|FG000|Overall Study|Eligibility issue|3|||
156577299|NCT01739595|565200070|FG001|Overall Study|Eligibility issue|0|||
156577300|NCT01739595|565200071|FG002|Overall Study|Eligibility issue|0|||
156577301|NCT01739595|565200069|FG000|Overall Study|Protocol Violation|1|||
156577302|NCT01739595|565200070|FG001|Overall Study|Protocol Violation|0|||
156577303|NCT01739595|565200071|FG002|Overall Study|Protocol Violation|0|||
156577304|NCT01739595|565200069|FG000|Overall Study|Lab assessment|1|||
156577305|NCT01739595|565200070|FG001|Overall Study|Lab assessment|0|||
156577306|NCT01739595|565200071|FG002|Overall Study|Lab assessment|0|||
156577307|NCT01739595|565200069|FG000|Overall Study|Drug discrepancy|1|||
156577308|NCT01739595|565200070|FG001|Overall Study|Drug discrepancy|0|||
156577309|NCT01739595|565200071|FG002|Overall Study|Drug discrepancy|0|||
156577310|NCT02104180|565200072|FG000|Overall Study|Protocol Violation|1|||
156577311|NCT02104180|565200073|FG001|Overall Study|Protocol Violation|0|||
156577312|NCT00793585|565200074|FG000|Overall Study|Adverse Event|1|||
156577313|NCT00793585|565200075|FG001|Overall Study|Adverse Event|1|||
156577314|NCT00793585|565200074|FG000|Overall Study|Protocol Violation|1|||
156577315|NCT00793585|565200075|FG001|Overall Study|Protocol Violation|2|||
156577316|NCT00035815|565200076|FG000|Overall Study|Withdrawal by Subject|17|||
156577317|NCT00035815|565200077|FG001|Overall Study|Withdrawal by Subject|11|||
156577318|NCT04952389|565200079|FG000|Overall Study|Withdrawal by Subject|8|||
156577319|NCT04952389|565200080|FG001|Overall Study|Withdrawal by Subject|4|||
156577320|NCT01894516|565201802|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
156577321|NCT01894516|565201803|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
156577322|NCT01894516|565201804|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
156577323|NCT01894516|565201805|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
156577324|NCT01894516|565201802|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
156577325|NCT01894516|565201803|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156577326|NCT01894516|565201804|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156577327|NCT01894516|565201805|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
156577328|NCT01894516|565201802|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
156577329|NCT01894516|565201803|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
156577330|NCT01894516|565201804|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
156577331|NCT01894516|565201805|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
156577332|NCT01894516|565201802|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
156577333|NCT01894516|565201803|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
156577334|NCT01894516|565201804|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
156577335|NCT01894516|565201805|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
156577336|NCT01894516|565201802|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
156577337|NCT01894516|565201803|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
156577338|NCT01894516|565201804|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
156577339|NCT01894516|565201805|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
156577340|NCT01894516|565201802|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
156577341|NCT01894516|565201803|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
156577342|NCT01894516|565201804|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
156577343|NCT01894516|565201805|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
156577344|NCT01894516|565201802|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
156577345|NCT01894516|565201803|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
156577346|NCT01894516|565201804|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
156577347|NCT01894516|565201805|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
156577348|NCT01894516|565201802|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
156577349|NCT01894516|565201803|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
156577350|NCT01894516|565201804|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
156577351|NCT01894516|565201805|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
156577352|NCT01266148|565201808|FG000|Overall Study|Adverse Event|2|||
156577353|NCT01266148|565201809|FG001|Overall Study|Adverse Event|0|||
156577354|NCT01266148|565201808|FG000|Overall Study|Ongoing rejection|1|||
156577355|NCT01266148|565201809|FG001|Overall Study|Ongoing rejection|0|||
156577356|NCT01266148|565201808|FG000|Overall Study|2 2R rejections|1|||
156577357|NCT01266148|565201809|FG001|Overall Study|2 2R rejections|0|||
156577358|NCT01266148|565201808|FG000|Overall Study|Death|2|||
156577359|NCT01266148|565201809|FG001|Overall Study|Death|3|||
156577360|NCT01266148|565201808|FG000|Overall Study|missing mGFR value + AE|1|||
156577361|NCT01266148|565201809|FG001|Overall Study|missing mGFR value + AE|0|||
156577362|NCT01853228|565201810|FG000|Phase 1|Lack of Efficacy|8|||
156577363|NCT01853228|565201811|FG001|Phase 1|Lack of Efficacy|0|||
156577364|NCT01853228|565201810|FG000|Phase 1|Other|1|||
156577365|NCT01853228|565201811|FG001|Phase 1|Other|0|||
156577366|NCT01853228|565201810|FG000|Phase 2|Physician Decision|0|||
156577367|NCT01853228|565201811|FG001|Phase 2|Physician Decision|1|||
156577368|NCT01853228|565201810|FG000|Phase 2|Proceed To Transplant|0|||
156577369|NCT01853228|565201811|FG001|Phase 2|Proceed To Transplant|3|||
156577370|NCT01853228|565201810|FG000|Phase 2|Lack of Efficacy|0|||
156577371|NCT01853228|565201811|FG001|Phase 2|Lack of Efficacy|4|||
156577372|NCT01269125|565201812|FG000|Overall Study|Adverse Event|3|||
156577373|NCT01269125|565201813|FG001|Overall Study|Adverse Event|5|||
156577374|NCT01269125|565201814|FG002|Overall Study|Adverse Event|0|||
156577375|NCT01269125|565201812|FG000|Overall Study|Lost to Follow-up|4|||
156577376|NCT01269125|565201813|FG001|Overall Study|Lost to Follow-up|0|||
156577377|NCT01269125|565201814|FG002|Overall Study|Lost to Follow-up|0|||
156577378|NCT01300286|565201815|FG000|Overall Study|did not get dosed|1|||
156577379|NCT03635190|565201816|FG000|Overall Study|Lost to Follow-up|4|||
156577380|NCT03635190|565201816|FG000|Overall Study|Death|3|||
156577381|NCT03635190|565201816|FG000|Overall Study|Withdrawal by Subject|1|||
156577382|NCT03635190|565201816|FG000|Overall Study|Patient moved and did not return for follow up|1|||
156577383|NCT02767570|565201819|FG000|Overall Study|Lost to Follow-up|3|||
156577384|NCT02767570|565201820|FG001|Overall Study|Lost to Follow-up|0|||
156577385|NCT02767570|565201819|FG000|Overall Study|COVID shutdown|2|||
156577386|NCT02767570|565201820|FG001|Overall Study|COVID shutdown|5|||
156577387|NCT02767570|565201819|FG000|Overall Study|Increased pain|2|||
156577388|NCT02767570|565201820|FG001|Overall Study|Increased pain|0|||
156577389|NCT02767570|565201819|FG000|Overall Study|Withdrawal by Subject|1|||
156577390|NCT02767570|565201820|FG001|Overall Study|Withdrawal by Subject|3|||
156577391|NCT02767570|565201819|FG000|Overall Study|Unrelated medical issue|1|||
156577392|NCT02767570|565201820|FG001|Overall Study|Unrelated medical issue|1|||
156577393|NCT02767570|565201819|FG000|Overall Study|Received intra-articular injection|0|||
156577394|NCT02767570|565201820|FG001|Overall Study|Received intra-articular injection|1|||
156577395|NCT00417612|565201821|FG000|Overall Study|Errant diagnosis|0|||
156577396|NCT00417612|565201822|FG001|Overall Study|Errant diagnosis|1|||
156577397|NCT00417612|565201821|FG000|Overall Study|Adverse Event|2|||
156577398|NCT00417612|565201822|FG001|Overall Study|Adverse Event|0|||
156577399|NCT00417612|565201821|FG000|Overall Study|Protocol Violation|0|||
156577400|NCT00417612|565201822|FG001|Overall Study|Protocol Violation|2|||
156577401|NCT00417612|565201821|FG000|Overall Study|Lost to Follow-up|1|||
156577402|NCT00417612|565201822|FG001|Overall Study|Lost to Follow-up|0|||
156577403|NCT01712438|565201825|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
156577404|NCT01712438|565201825|FG000|Overall Study|Ongoing ITI treatment|6|||
156577405|NCT01712438|565201825|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
156577406|NCT01712438|565201825|FG000|Overall Study|Prematurely Discontinued|25|||
156577407|NCT02786537|565201826|FG000|As Randomized|Adverse Event|0|||
156577408|NCT02786537|565201827|FG001|As Randomized|Adverse Event|11|||
156577409|NCT02786537|565201828|FG002|As Randomized|Adverse Event|0|||
156577410|NCT02786537|565201829|FG003|As Randomized|Adverse Event|4|||
156577411|NCT02786537|565201830|FG004|As Randomized|Adverse Event|6|||
156577412|NCT02786537|565201831|FG005|As Randomized|Adverse Event|2|||
156577413|NCT02786537|565201826|FG000|As Randomized|Lack of Efficacy|0|||
156577414|NCT02786537|565201827|FG001|As Randomized|Lack of Efficacy|0|||
156577415|NCT02786537|565201828|FG002|As Randomized|Lack of Efficacy|0|||
156577416|NCT02786537|565201829|FG003|As Randomized|Lack of Efficacy|1|||
156577417|NCT02786537|565201830|FG004|As Randomized|Lack of Efficacy|0|||
156577418|NCT02786537|565201831|FG005|As Randomized|Lack of Efficacy|0|||
156577419|NCT02786537|565201826|FG000|As Randomized|Withdrawal by Subject|1|||
156577420|NCT02786537|565201827|FG001|As Randomized|Withdrawal by Subject|2|||
156577421|NCT02786537|565201828|FG002|As Randomized|Withdrawal by Subject|0|||
156577422|NCT02786537|565201829|FG003|As Randomized|Withdrawal by Subject|1|||
156577423|NCT02786537|565201830|FG004|As Randomized|Withdrawal by Subject|1|||
156577424|NCT02786537|565201831|FG005|As Randomized|Withdrawal by Subject|0|||
156577425|NCT02786537|565201826|FG000|As Randomized|Death|0|||
156577426|NCT02786537|565201827|FG001|As Randomized|Death|2|||
156577427|NCT02786537|565201828|FG002|As Randomized|Death|0|||
156577428|NCT02786537|565201829|FG003|As Randomized|Death|3|||
156577429|NCT02786537|565201830|FG004|As Randomized|Death|1|||
156577430|NCT02786537|565201831|FG005|As Randomized|Death|0|||
156577431|NCT02786537|565201826|FG000|As Randomized|Non-compliance with study drug|1|||
156577432|NCT02786537|565201827|FG001|As Randomized|Non-compliance with study drug|11|||
156577433|NCT02786537|565201828|FG002|As Randomized|Non-compliance with study drug|0|||
156577434|NCT02786537|565201829|FG003|As Randomized|Non-compliance with study drug|1|||
156577435|NCT02786537|565201830|FG004|As Randomized|Non-compliance with study drug|0|||
156577436|NCT02786537|565201831|FG005|As Randomized|Non-compliance with study drug|1|||
156577437|NCT02786537|565201826|FG000|As Randomized|Lost to treatment follow-up|4|||
156577438|NCT02786537|565201827|FG001|As Randomized|Lost to treatment follow-up|32|||
156577439|NCT02786537|565201828|FG002|As Randomized|Lost to treatment follow-up|0|||
156577440|NCT02786537|565201829|FG003|As Randomized|Lost to treatment follow-up|24|||
156577441|NCT02786537|565201830|FG004|As Randomized|Lost to treatment follow-up|4|||
156577442|NCT02786537|565201831|FG005|As Randomized|Lost to treatment follow-up|4|||
156577443|NCT02786537|565201826|FG000|As Randomized|Incarceration|0|||
156577444|NCT02786537|565201827|FG001|As Randomized|Incarceration|1|||
156577445|NCT02786537|565201828|FG002|As Randomized|Incarceration|0|||
156577446|NCT02786537|565201829|FG003|As Randomized|Incarceration|0|||
156577447|NCT02786537|565201830|FG004|As Randomized|Incarceration|0|||
156577448|NCT02786537|565201831|FG005|As Randomized|Incarceration|0|||
156577449|NCT02786537|565201826|FG000|As Randomized|Opiate Dependency Relapse|0|||
156577450|NCT02786537|565201827|FG001|As Randomized|Opiate Dependency Relapse|1|||
156577451|NCT02786537|565201828|FG002|As Randomized|Opiate Dependency Relapse|0|||
156577452|NCT02786537|565201829|FG003|As Randomized|Opiate Dependency Relapse|0|||
156577453|NCT02786537|565201830|FG004|As Randomized|Opiate Dependency Relapse|0|||
156577454|NCT02786537|565201831|FG005|As Randomized|Opiate Dependency Relapse|0|||
156577455|NCT02786537|565201826|FG000|As Randomized|HCV drugs stolen from pt|0|||
156577456|NCT02786537|565201827|FG001|As Randomized|HCV drugs stolen from pt|1|||
156577457|NCT02786537|565201828|FG002|As Randomized|HCV drugs stolen from pt|0|||
156577458|NCT02786537|565201829|FG003|As Randomized|HCV drugs stolen from pt|0|||
156577459|NCT02786537|565201830|FG004|As Randomized|HCV drugs stolen from pt|0|||
156577460|NCT02786537|565201831|FG005|As Randomized|HCV drugs stolen from pt|0|||
156577461|NCT02786537|565201826|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
156577462|NCT02786537|565201827|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
156577463|NCT02786537|565201828|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
156577464|NCT02786537|565201829|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
156577465|NCT02786537|565201830|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
156577466|NCT02786537|565201831|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
156577467|NCT02786537|565201826|FG000|As Randomized|Subject lost insurance|0|||
156577468|NCT02786537|565201827|FG001|As Randomized|Subject lost insurance|0|||
156577469|NCT02786537|565201828|FG002|As Randomized|Subject lost insurance|0|||
156577470|NCT02786537|565201829|FG003|As Randomized|Subject lost insurance|1|||
156577471|NCT02786537|565201830|FG004|As Randomized|Subject lost insurance|0|||
156577472|NCT02786537|565201831|FG005|As Randomized|Subject lost insurance|0|||
156577473|NCT02786537|565201826|FG000|As Treated|Adverse Event|0|||
156577474|NCT02786537|565201827|FG001|As Treated|Adverse Event|11|||
156577475|NCT02786537|565201828|FG002|As Treated|Adverse Event|0|||
156577476|NCT02786537|565201829|FG003|As Treated|Adverse Event|4|||
156577477|NCT02786537|565201830|FG004|As Treated|Adverse Event|6|||
156577478|NCT02786537|565201831|FG005|As Treated|Adverse Event|2|||
156577479|NCT02786537|565201826|FG000|As Treated|Death|0|||
156577480|NCT02786537|565201827|FG001|As Treated|Death|2|||
156577481|NCT02786537|565201828|FG002|As Treated|Death|0|||
156577482|NCT02786537|565201829|FG003|As Treated|Death|3|||
156577483|NCT02786537|565201830|FG004|As Treated|Death|1|||
156577484|NCT02786537|565201831|FG005|As Treated|Death|0|||
156577485|NCT02786537|565201826|FG000|As Treated|Lack of Efficacy|0|||
156577486|NCT02786537|565201827|FG001|As Treated|Lack of Efficacy|0|||
156577487|NCT02786537|565201828|FG002|As Treated|Lack of Efficacy|0|||
156577488|NCT02786537|565201829|FG003|As Treated|Lack of Efficacy|1|||
156577489|NCT02786537|565201830|FG004|As Treated|Lack of Efficacy|0|||
156863592|NCT01743469|566258711|FG003|Active Treatment Phase|Disease Progression|20|||
156577490|NCT02786537|565201831|FG005|As Treated|Lack of Efficacy|0|||
156577491|NCT02786537|565201826|FG000|As Treated|Lost to Follow-up|4|||
156577492|NCT02786537|565201827|FG001|As Treated|Lost to Follow-up|32|||
156577493|NCT02786537|565201828|FG002|As Treated|Lost to Follow-up|0|||
156577494|NCT02786537|565201829|FG003|As Treated|Lost to Follow-up|25|||
156577495|NCT02786537|565201830|FG004|As Treated|Lost to Follow-up|4|||
156577496|NCT02786537|565201831|FG005|As Treated|Lost to Follow-up|4|||
156577497|NCT02786537|565201826|FG000|As Treated|Non-compliance with study drug|1|||
156577498|NCT02786537|565201827|FG001|As Treated|Non-compliance with study drug|11|||
156577499|NCT02786537|565201828|FG002|As Treated|Non-compliance with study drug|0|||
156577500|NCT02786537|565201829|FG003|As Treated|Non-compliance with study drug|1|||
156577501|NCT02786537|565201830|FG004|As Treated|Non-compliance with study drug|0|||
156577502|NCT02786537|565201831|FG005|As Treated|Non-compliance with study drug|1|||
156577503|NCT02786537|565201826|FG000|As Treated|Lost insurance|0|||
156577504|NCT02786537|565201827|FG001|As Treated|Lost insurance|0|||
156577505|NCT02786537|565201828|FG002|As Treated|Lost insurance|0|||
156577506|NCT02786537|565201829|FG003|As Treated|Lost insurance|1|||
156577507|NCT02786537|565201830|FG004|As Treated|Lost insurance|0|||
156577508|NCT02786537|565201831|FG005|As Treated|Lost insurance|0|||
156577509|NCT02786537|565201826|FG000|As Treated|Withdrawal by Subject|1|||
156577510|NCT02786537|565201827|FG001|As Treated|Withdrawal by Subject|2|||
156577511|NCT02786537|565201828|FG002|As Treated|Withdrawal by Subject|0|||
156577512|NCT02786537|565201829|FG003|As Treated|Withdrawal by Subject|0|||
156577513|NCT02786537|565201830|FG004|As Treated|Withdrawal by Subject|1|||
156577514|NCT02786537|565201831|FG005|As Treated|Withdrawal by Subject|0|||
156577515|NCT02786537|565201826|FG000|As Treated|Incarceration|0|||
156577516|NCT02786537|565201827|FG001|As Treated|Incarceration|1|||
156577517|NCT02786537|565201828|FG002|As Treated|Incarceration|0|||
156577518|NCT02786537|565201829|FG003|As Treated|Incarceration|0|||
156577519|NCT02786537|565201830|FG004|As Treated|Incarceration|0|||
156577520|NCT02786537|565201831|FG005|As Treated|Incarceration|0|||
156577521|NCT02786537|565201826|FG000|As Treated|Opiate dependency relapse|0|||
156577522|NCT02786537|565201827|FG001|As Treated|Opiate dependency relapse|1|||
156577523|NCT02786537|565201828|FG002|As Treated|Opiate dependency relapse|0|||
156577524|NCT02786537|565201829|FG003|As Treated|Opiate dependency relapse|0|||
156577525|NCT02786537|565201830|FG004|As Treated|Opiate dependency relapse|0|||
156577526|NCT02786537|565201831|FG005|As Treated|Opiate dependency relapse|0|||
156577527|NCT02786537|565201826|FG000|As Treated|Drugs stolen from patient|0|||
156577528|NCT02786537|565201827|FG001|As Treated|Drugs stolen from patient|1|||
156577529|NCT02786537|565201828|FG002|As Treated|Drugs stolen from patient|0|||
156577530|NCT02786537|565201829|FG003|As Treated|Drugs stolen from patient|0|||
156577531|NCT02786537|565201830|FG004|As Treated|Drugs stolen from patient|0|||
156577532|NCT02786537|565201831|FG005|As Treated|Drugs stolen from patient|0|||
156577533|NCT02786537|565201826|FG000|As Treated|Advised to stop tx after loss of meds|0|||
156577534|NCT02786537|565201827|FG001|As Treated|Advised to stop tx after loss of meds|1|||
156577535|NCT02786537|565201828|FG002|As Treated|Advised to stop tx after loss of meds|0|||
156577536|NCT02786537|565201829|FG003|As Treated|Advised to stop tx after loss of meds|0|||
156577537|NCT02786537|565201830|FG004|As Treated|Advised to stop tx after loss of meds|0|||
156577538|NCT02786537|565201831|FG005|As Treated|Advised to stop tx after loss of meds|0|||
156577539|NCT03060577|565201832|FG000|Overall Study|Withdrawal by Subject|25|||
156577540|NCT03060577|565201833|FG001|Overall Study|Withdrawal by Subject|5|||
156577541|NCT03060577|565201832|FG000|Overall Study|Physician Decision|4|||
156577542|NCT03060577|565201833|FG001|Overall Study|Physician Decision|3|||
156577543|NCT03060577|565201832|FG000|Overall Study|Lost to Follow-up|3|||
156577544|NCT03060577|565201833|FG001|Overall Study|Lost to Follow-up|0|||
156577545|NCT03060577|565201832|FG000|Overall Study|Death|7|||
156577546|NCT03060577|565201833|FG001|Overall Study|Death|1|||
156577547|NCT03060577|565201832|FG000|Overall Study|Adverse Event|9|||
156577548|NCT03060577|565201833|FG001|Overall Study|Adverse Event|1|||
156577549|NCT03060577|565201832|FG000|Overall Study|Inclusion/Exclusion|1|||
156577550|NCT03060577|565201833|FG001|Overall Study|Inclusion/Exclusion|0|||
156577551|NCT03060577|565201832|FG000|Overall Study|Other|8|||
156577552|NCT03060577|565201833|FG001|Overall Study|Other|2|||
156577553|NCT03216265|565201834|FG000|Overall Study|Adverse Event|2|||
156577554|NCT03216265|565201835|FG001|Overall Study|Adverse Event|0|||
156577555|NCT03216265|565201836|FG002|Overall Study|Adverse Event|2|||
156577556|NCT03216265|565201834|FG000|Overall Study|Lost to Follow-up|0|||
156577557|NCT03216265|565201835|FG001|Overall Study|Lost to Follow-up|1|||
156577558|NCT03216265|565201836|FG002|Overall Study|Lost to Follow-up|0|||
156577559|NCT03216265|565201834|FG000|Overall Study|Withdrawal by Subject|0|||
156863593|NCT01743469|566258708|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
156863594|NCT01743469|566258709|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
156577560|NCT03216265|565201835|FG001|Overall Study|Withdrawal by Subject|0|||
156577561|NCT03216265|565201836|FG002|Overall Study|Withdrawal by Subject|1|||
156577562|NCT01306058|565201837|FG000|Overall Study|Death|1|||
156577563|NCT01306058|565201837|FG000|Overall Study|Enrolled but did not get treatment|1|||
156577564|NCT01539837|565201838|FG000|Overall Study|reduce neutrophil level|0|||
156577565|NCT01539837|565201839|FG001|Overall Study|reduce neutrophil level|1|||
156577566|NCT01539837|565201840|FG002|Overall Study|reduce neutrophil level|1|||
156577567|NCT01539837|565201838|FG000|Overall Study|bad compliance|0|||
156577568|NCT01539837|565201839|FG001|Overall Study|bad compliance|0|||
156577569|NCT01539837|565201840|FG002|Overall Study|bad compliance|1|||
156577570|NCT00849693|565201841|FG000|Acute Treatment Phase|Adverse Event|12|||
156577571|NCT00849693|565201842|FG001|Acute Treatment Phase|Adverse Event|7|||
156577572|NCT00849693|565201843|FG002|Acute Treatment Phase|Adverse Event|6|||
156577573|NCT00849693|565201844|FG003|Acute Treatment Phase|Adverse Event|4|||
156577574|NCT00849693|565201841|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
156577575|NCT00849693|565201842|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
156577576|NCT00849693|565201843|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
156577577|NCT00849693|565201844|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
156577578|NCT00849693|565201841|FG000|Acute Treatment Phase|Protocol Violation|1|||
156577579|NCT00849693|565201842|FG001|Acute Treatment Phase|Protocol Violation|5|||
156577580|NCT00849693|565201843|FG002|Acute Treatment Phase|Protocol Violation|2|||
156577581|NCT00849693|565201844|FG003|Acute Treatment Phase|Protocol Violation|6|||
156577582|NCT00849693|565201841|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
156577583|NCT00849693|565201842|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
156577584|NCT00849693|565201843|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
156577585|NCT00849693|565201844|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
156577586|NCT00849693|565201841|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
156577587|NCT00849693|565201842|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
156577588|NCT00849693|565201843|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
156577589|NCT00849693|565201844|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
156577590|NCT00849693|565201841|FG000|Acute Treatment Phase|Physician Decision|2|||
156577591|NCT00849693|565201842|FG001|Acute Treatment Phase|Physician Decision|1|||
156577592|NCT00849693|565201843|FG002|Acute Treatment Phase|Physician Decision|2|||
156577593|NCT00849693|565201844|FG003|Acute Treatment Phase|Physician Decision|1|||
156577594|NCT00849693|565201841|FG000|Acute Treatment Phase|Sponsor decision|0|||
156577595|NCT00849693|565201842|FG001|Acute Treatment Phase|Sponsor decision|0|||
156577596|NCT00849693|565201843|FG002|Acute Treatment Phase|Sponsor decision|1|||
156577597|NCT00849693|565201844|FG003|Acute Treatment Phase|Sponsor decision|0|||
156577598|NCT00849693|565201841|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
156577599|NCT00849693|565201842|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
156577600|NCT00849693|565201843|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
156577601|NCT00849693|565201844|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
156577602|NCT00849693|565201841|FG000|Extension Phase|Adverse Event|4|||
156577603|NCT00849693|565201842|FG001|Extension Phase|Adverse Event|6|||
156577604|NCT00849693|565201843|FG002|Extension Phase|Adverse Event|3|||
156577605|NCT00849693|565201844|FG003|Extension Phase|Adverse Event|7|||
156577606|NCT00849693|565201841|FG000|Extension Phase|Lost to Follow-up|7|||
156577607|NCT00849693|565201842|FG001|Extension Phase|Lost to Follow-up|5|||
156577608|NCT00849693|565201843|FG002|Extension Phase|Lost to Follow-up|6|||
156577609|NCT00849693|565201844|FG003|Extension Phase|Lost to Follow-up|6|||
156577610|NCT00849693|565201841|FG000|Extension Phase|Protocol Violation|0|||
156577611|NCT00849693|565201842|FG001|Extension Phase|Protocol Violation|3|||
156577612|NCT00849693|565201843|FG002|Extension Phase|Protocol Violation|2|||
156577613|NCT00849693|565201844|FG003|Extension Phase|Protocol Violation|3|||
156577614|NCT00849693|565201841|FG000|Extension Phase|Withdrawal by Subject|6|||
156577615|NCT00849693|565201842|FG001|Extension Phase|Withdrawal by Subject|9|||
156577616|NCT00849693|565201843|FG002|Extension Phase|Withdrawal by Subject|10|||
156577617|NCT00849693|565201844|FG003|Extension Phase|Withdrawal by Subject|15|||
156577618|NCT00849693|565201841|FG000|Extension Phase|Parent or caregiver decision|9|||
156577619|NCT00849693|565201842|FG001|Extension Phase|Parent or caregiver decision|4|||
156577620|NCT00849693|565201843|FG002|Extension Phase|Parent or caregiver decision|10|||
156577621|NCT00849693|565201844|FG003|Extension Phase|Parent or caregiver decision|5|||
156577622|NCT00849693|565201841|FG000|Extension Phase|Physician Decision|1|||
156577623|NCT00849693|565201842|FG001|Extension Phase|Physician Decision|1|||
156577624|NCT00849693|565201843|FG002|Extension Phase|Physician Decision|2|||
156577625|NCT00849693|565201844|FG003|Extension Phase|Physician Decision|0|||
156577626|NCT00849693|565201841|FG000|Extension Phase|Sponsor decision|1|||
156577627|NCT00849693|565201842|FG001|Extension Phase|Sponsor decision|0|||
156577628|NCT00849693|565201843|FG002|Extension Phase|Sponsor decision|0|||
156577629|NCT00849693|565201844|FG003|Extension Phase|Sponsor decision|1|||
156577630|NCT00849693|565201841|FG000|Extension Phase|Lack of Efficacy|2|||
156577631|NCT00849693|565201842|FG001|Extension Phase|Lack of Efficacy|2|||
156577632|NCT00849693|565201843|FG002|Extension Phase|Lack of Efficacy|2|||
156577633|NCT00849693|565201844|FG003|Extension Phase|Lack of Efficacy|1|||
156577634|NCT01978912|565201847|FG000|Overall Study|Adverse Event|0|||
156577635|NCT01978912|565201848|FG001|Overall Study|Adverse Event|1|||
156577636|NCT01978912|565201849|FG002|Overall Study|Adverse Event|0|||
156577637|NCT01978912|565201850|FG003|Overall Study|Adverse Event|0|||
156577638|NCT01978912|565201847|FG000|Overall Study|Lost to Follow-up|1|||
156577639|NCT01978912|565201848|FG001|Overall Study|Lost to Follow-up|1|||
156577640|NCT01978912|565201849|FG002|Overall Study|Lost to Follow-up|0|||
156577641|NCT01978912|565201850|FG003|Overall Study|Lost to Follow-up|1|||
156577642|NCT01978912|565201847|FG000|Overall Study|Withdrawal by Subject|1|||
156577643|NCT01978912|565201848|FG001|Overall Study|Withdrawal by Subject|0|||
156577644|NCT01978912|565201849|FG002|Overall Study|Withdrawal by Subject|2|||
156577645|NCT01978912|565201850|FG003|Overall Study|Withdrawal by Subject|2|||
156577646|NCT01978912|565201847|FG000|Overall Study|Lumbar Surgery|1|||
156577647|NCT01978912|565201848|FG001|Overall Study|Lumbar Surgery|0|||
156577648|NCT01978912|565201849|FG002|Overall Study|Lumbar Surgery|1|||
156577649|NCT01978912|565201850|FG003|Overall Study|Lumbar Surgery|0|||
156577650|NCT01978912|565201847|FG000|Overall Study|Intradiscal Steroid Injection|0|||
156577651|NCT01978912|565201848|FG001|Overall Study|Intradiscal Steroid Injection|1|||
156577652|NCT01978912|565201849|FG002|Overall Study|Intradiscal Steroid Injection|0|||
156577653|NCT01978912|565201850|FG003|Overall Study|Intradiscal Steroid Injection|0|||
156577654|NCT00224107|565201851|FG000|Overall Study|Adverse Event|20|||
156577655|NCT00224107|565201852|FG001|Overall Study|Adverse Event|6|||
156577656|NCT00224107|565201851|FG000|Overall Study|Protocol Violation|2|||
156577657|NCT00224107|565201852|FG001|Overall Study|Protocol Violation|3|||
156577658|NCT00224107|565201851|FG000|Overall Study|Withdrawal by Subject|1|||
156577659|NCT00224107|565201852|FG001|Overall Study|Withdrawal by Subject|4|||
156577660|NCT00224107|565201851|FG000|Overall Study|Lack of Efficacy|2|||
156577661|NCT00224107|565201852|FG001|Overall Study|Lack of Efficacy|0|||
156577662|NCT00224107|565201851|FG000|Overall Study|Lost to Follow-up|4|||
156577663|NCT00224107|565201852|FG001|Overall Study|Lost to Follow-up|0|||
156577664|NCT00224107|565201851|FG000|Overall Study|Physician Decision|1|||
156577665|NCT00224107|565201852|FG001|Overall Study|Physician Decision|0|||
156577666|NCT00224107|565201851|FG000|Overall Study|Other|1|||
156577667|NCT00224107|565201852|FG001|Overall Study|Other|1|||
156577668|NCT01408537|565201853|FG000|Overall Study|Withdrawal by Subject|2|||
156577669|NCT01408537|565201853|FG000|Overall Study|Protocol Violation|3|||
156577670|NCT01408537|565201853|FG000|Overall Study|Lost to Follow-up|3|||
156577671|NCT05523362|565201854|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
156577672|NCT05523362|565201854|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
156577673|NCT05523362|565201854|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
156577674|NCT05523362|565201854|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
156577675|NCT02584634|565201855|FG000|Overall Study|Adverse Event|3|||
156577676|NCT02584634|565201856|FG001|Overall Study|Adverse Event|5|||
156577677|NCT02584634|565201855|FG000|Overall Study|Death|0|||
156577678|NCT02584634|565201856|FG001|Overall Study|Death|1|||
156577679|NCT02584634|565201855|FG000|Overall Study|Lost to Follow-up|0|||
156577680|NCT02584634|565201856|FG001|Overall Study|Lost to Follow-up|1|||
156577681|NCT02584634|565201855|FG000|Overall Study|Physician Decision|1|||
156577682|NCT02584634|565201856|FG001|Overall Study|Physician Decision|2|||
156577683|NCT02584634|565201855|FG000|Overall Study|Progressive disease|7|||
156577684|NCT02584634|565201856|FG001|Overall Study|Progressive disease|15|||
156577685|NCT02584634|565201855|FG000|Overall Study|Withdrawal by Subject|1|||
156577686|NCT02584634|565201856|FG001|Overall Study|Withdrawal by Subject|1|||
156577687|NCT02584634|565201855|FG000|Overall Study|Other|0|||
156577688|NCT02584634|565201856|FG001|Overall Study|Other|6|||
156577689|NCT04075604|565201860|FG000|Overall Study|Adverse Event|0|||
156577690|NCT04075604|565201861|FG001|Overall Study|Adverse Event|0|||
156577691|NCT04075604|565201862|FG002|Overall Study|Adverse Event|3|||
156577692|NCT04075604|565201860|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156577693|NCT04075604|565201861|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156577694|NCT04075604|565201862|FG002|Overall Study|Participant request to discontinue study treatment|1|||
156577695|NCT04075604|565201860|FG000|Overall Study|Participant withdrew consent|0|||
156577696|NCT04075604|565201861|FG001|Overall Study|Participant withdrew consent|0|||
156577697|NCT04075604|565201862|FG002|Overall Study|Participant withdrew consent|1|||
156577698|NCT04075604|565201860|FG000|Overall Study|Other reasons|1|||
156577699|NCT04075604|565201861|FG001|Overall Study|Other reasons|0|||
156577700|NCT04075604|565201862|FG002|Overall Study|Other reasons|0|||
156577701|NCT04075604|565201860|FG000|Overall Study|Disease progression|0|||
156577702|NCT04075604|565201861|FG001|Overall Study|Disease progression|1|||
156577703|NCT04075604|565201862|FG002|Overall Study|Disease progression|0|||
156577704|NCT04075604|565201860|FG000|Overall Study|Study drug toxicity|0|||
156577705|NCT04075604|565201861|FG001|Overall Study|Study drug toxicity|5|||
156577706|NCT04075604|565201862|FG002|Overall Study|Study drug toxicity|1|||
156577707|NCT00098345|565201863|FG000|Overall Study|Adverse Event|7|||
156577708|NCT00098345|565201863|FG000|Overall Study|Withdrawal by Subject|2|||
156577709|NCT00098345|565201863|FG000|Overall Study|progression|4|||
156577710|NCT01183858|565201864|FG000|Overall Study|Death not related to Progressive Disease|5|||
156577711|NCT01183858|565201865|FG001|Overall Study|Death not related to Progressive Disease|6|||
156577712|NCT01183858|565201864|FG000|Overall Study|Adverse Event|14|||
156577713|NCT01183858|565201865|FG001|Overall Study|Adverse Event|11|||
156577714|NCT01183858|565201864|FG000|Overall Study|Investigator's Decision|0|||
156577715|NCT01183858|565201865|FG001|Overall Study|Investigator's Decision|3|||
156577716|NCT01183858|565201864|FG000|Overall Study|Insufficient Therapeutic Response|2|||
156577717|NCT01183858|565201865|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156577718|NCT01183858|565201864|FG000|Overall Study|Refused Treatment|1|||
156577719|NCT01183858|565201865|FG001|Overall Study|Refused Treatment|4|||
156577720|NCT01183858|565201864|FG000|Overall Study|Withdrew Consent|4|||
156577721|NCT01183858|565201865|FG001|Overall Study|Withdrew Consent|4|||
156577722|NCT01183858|565201864|FG000|Overall Study|Discontinued Smoking|3|||
156577723|NCT01183858|565201865|FG001|Overall Study|Discontinued Smoking|1|||
156577724|NCT01183858|565201864|FG000|Overall Study|Protocol Violation|1|||
156577725|NCT01183858|565201865|FG001|Overall Study|Protocol Violation|0|||
156577726|NCT01183858|565201864|FG000|Overall Study|Administrative/Other|6|||
156577727|NCT01183858|565201865|FG001|Overall Study|Administrative/Other|6|||
156577728|NCT01183858|565201864|FG000|Overall Study|Progressive Disease|112|||
156577729|NCT01183858|565201865|FG001|Overall Study|Progressive Disease|115|||
156577730|NCT01183858|565201864|FG000|Overall Study|Death related to Progressive Disease|4|||
156577731|NCT01183858|565201865|FG001|Overall Study|Death related to Progressive Disease|5|||
156577732|NCT01183858|565201864|FG000|Overall Study|Lost to Follow-up|1|||
156577733|NCT01183858|565201865|FG001|Overall Study|Lost to Follow-up|1|||
156577734|NCT03707977|565201868|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
156577735|NCT03707977|565201869|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
156577736|NCT03707977|565201870|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
156577737|NCT03707977|565201868|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
156577738|NCT03707977|565201869|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
156577739|NCT03707977|565201870|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
156577740|NCT03069690|565201871|FG000|Pregnancy Intervention|Pregnancy loss|9|||
156577741|NCT03069690|565201872|FG001|Pregnancy Intervention|Pregnancy loss|4|||
156577742|NCT03069690|565201873|FG002|Pregnancy Intervention|Pregnancy loss|0|||
156577743|NCT03069690|565201874|FG003|Pregnancy Intervention|Pregnancy loss|0|||
156577744|NCT03069690|565201875|FG004|Pregnancy Intervention|Pregnancy loss|0|||
156577745|NCT03069690|565201876|FG005|Pregnancy Intervention|Pregnancy loss|0|||
156577746|NCT03069690|565201871|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
156577747|NCT03069690|565201872|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
156577748|NCT03069690|565201873|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
156577749|NCT03069690|565201874|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
156577750|NCT03069690|565201875|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
156577751|NCT03069690|565201876|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
156577752|NCT03069690|565201871|FG000|Postpartum Intervention|Lost to Follow-up|0|||
156577753|NCT03069690|565201872|FG001|Postpartum Intervention|Lost to Follow-up|0|||
156577754|NCT03069690|565201873|FG002|Postpartum Intervention|Lost to Follow-up|5|||
156577755|NCT03069690|565201874|FG003|Postpartum Intervention|Lost to Follow-up|5|||
156577756|NCT03069690|565201875|FG004|Postpartum Intervention|Lost to Follow-up|2|||
156577757|NCT03069690|565201876|FG005|Postpartum Intervention|Lost to Follow-up|4|||
156577758|NCT02564120|565201877|FG000|Overall Study|Did not return release forms|160|||
156577759|NCT02564120|565201877|FG000|Overall Study|Death|58|||
156577760|NCT02564120|565201877|FG000|Overall Study|Withdrawal by Subject|204|||
156577761|NCT02564120|565201877|FG000|Overall Study|Other medical condition|24|||
156577762|NCT03842709|565201878|FG000|Overall Study|Withdrawal by Subject|3|||
156577763|NCT03842709|565201879|FG001|Overall Study|Withdrawal by Subject|3|||
156577764|NCT03842709|565201878|FG000|Overall Study|Lost to Follow-up|1|||
156577765|NCT03842709|565201879|FG001|Overall Study|Lost to Follow-up|0|||
156577766|NCT00641147|565201880|FG000|Completed 4 Months.|Physician Decision|1|||
156577767|NCT00641147|565201881|FG001|Completed 4 Months.|Physician Decision|0|||
156577768|NCT00641147|565201880|FG000|Completed 4 Months.|Adverse Event|1|||
156577769|NCT00641147|565201881|FG001|Completed 4 Months.|Adverse Event|0|||
156577770|NCT00641147|565201880|FG000|Completed 8 Months.|Physician Decision|2|||
156577771|NCT00641147|565201881|FG001|Completed 8 Months.|Physician Decision|1|||
156577772|NCT00641147|565201880|FG000|Completed 8 Months.|non compliance|1|||
156577773|NCT00641147|565201881|FG001|Completed 8 Months.|non compliance|0|||
156577774|NCT00641147|565201880|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
156577775|NCT00641147|565201881|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
156577776|NCT00641147|565201880|FG000|Completed 12 Months.|Physician Decision|1|||
156577777|NCT00641147|565201881|FG001|Completed 12 Months.|Physician Decision|1|||
156577778|NCT00641147|565201880|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
156577779|NCT00641147|565201881|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
156577780|NCT00641147|565201880|FG000|Completed 16 Months.|Physician Decision|1|||
156577781|NCT00641147|565201881|FG001|Completed 16 Months.|Physician Decision|0|||
156577782|NCT00641147|565201880|FG000|Completed 16 Months.|Lost to Follow-up|1|||
156577783|NCT00641147|565201881|FG001|Completed 16 Months.|Lost to Follow-up|0|||
156577784|NCT00791128|565201882|FG000|Overall Study|Adverse Event|4|||
156577785|NCT00791128|565201882|FG000|Overall Study|Device migration|2|||
156577786|NCT00791128|565201882|FG000|Overall Study|non-compliance by subject|2|||
156577787|NCT00791128|565201882|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
156577788|NCT01629667|565201883|FG000|Overall Study|Lost to Follow-up|0|||
156577789|NCT01629667|565201884|FG001|Overall Study|Lost to Follow-up|1|||
156577790|NCT01629667|565201885|FG002|Overall Study|Lost to Follow-up|1|||
156577791|NCT01629667|565201883|FG000|Overall Study|Withdrawal by Subject|31|||
156577792|NCT01629667|565201884|FG001|Overall Study|Withdrawal by Subject|20|||
156577793|NCT01629667|565201885|FG002|Overall Study|Withdrawal by Subject|28|||
156577794|NCT01629667|565201883|FG000|Overall Study|Death|1|||
156577795|NCT01629667|565201884|FG001|Overall Study|Death|5|||
156577796|NCT01629667|565201885|FG002|Overall Study|Death|3|||
156577797|NCT01629667|565201883|FG000|Overall Study|Randomized, not treated|2|||
156577798|NCT01629667|565201884|FG001|Overall Study|Randomized, not treated|1|||
156577799|NCT01629667|565201885|FG002|Overall Study|Randomized, not treated|0|||
156577800|NCT01629667|565201883|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
156577801|NCT01629667|565201884|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
156577802|NCT01629667|565201885|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
156577803|NCT01629667|565201883|FG000|Overall Study|Requiring lung transplant|2|||
156577804|NCT01629667|565201884|FG001|Overall Study|Requiring lung transplant|1|||
156577805|NCT01629667|565201885|FG002|Overall Study|Requiring lung transplant|3|||
156577806|NCT01629667|565201883|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
156577807|NCT01629667|565201884|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
156577808|NCT01629667|565201885|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
156577809|NCT01629667|565201883|FG000|Overall Study|Started other medicine|1|||
156577810|NCT01629667|565201884|FG001|Overall Study|Started other medicine|0|||
156577811|NCT01629667|565201885|FG002|Overall Study|Started other medicine|1|||
156577812|NCT01629667|565201883|FG000|Overall Study|Site error in safety follow-up|0|||
156577813|NCT01629667|565201884|FG001|Overall Study|Site error in safety follow-up|0|||
156577814|NCT01629667|565201885|FG002|Overall Study|Site error in safety follow-up|1|||
156577815|NCT01629667|565201883|FG000|Overall Study|Enrolled in another clinical study|0|||
156577816|NCT01629667|565201884|FG001|Overall Study|Enrolled in another clinical study|1|||
156577817|NCT01629667|565201885|FG002|Overall Study|Enrolled in another clinical study|0|||
156577818|NCT01629667|565201883|FG000|Overall Study|Code break|1|||
156577819|NCT01629667|565201884|FG001|Overall Study|Code break|0|||
156577820|NCT01629667|565201885|FG002|Overall Study|Code break|0|||
156577821|NCT00984659|565201886|FG000|2-week Run-in Period|Adverse Event|8|||
156577822|NCT00984659|565201887|FG001|2-week Run-in Period|Adverse Event|0|||
156577823|NCT00984659|565201888|FG002|2-week Run-in Period|Adverse Event|0|||
156577824|NCT00984659|565201889|FG003|2-week Run-in Period|Adverse Event|0|||
156577825|NCT00984659|565201886|FG000|2-week Run-in Period|Protocol Violation|5|||
156577826|NCT00984659|565201887|FG001|2-week Run-in Period|Protocol Violation|0|||
156577827|NCT00984659|565201888|FG002|2-week Run-in Period|Protocol Violation|0|||
156577828|NCT00984659|565201889|FG003|2-week Run-in Period|Protocol Violation|0|||
156577829|NCT00984659|565201886|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
156577830|NCT00984659|565201887|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
156577831|NCT00984659|565201888|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
156577832|NCT00984659|565201889|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
156577833|NCT00984659|565201886|FG000|2-week Run-in Period|Lost to Follow-up|3|||
156577834|NCT00984659|565201887|FG001|2-week Run-in Period|Lost to Follow-up|0|||
156577835|NCT00984659|565201888|FG002|2-week Run-in Period|Lost to Follow-up|0|||
156577836|NCT00984659|565201889|FG003|2-week Run-in Period|Lost to Follow-up|0|||
156577837|NCT00984659|565201886|FG000|2-week Run-in Period|Physician Decision|10|||
156577838|NCT00984659|565201887|FG001|2-week Run-in Period|Physician Decision|0|||
156577839|NCT00984659|565201888|FG002|2-week Run-in Period|Physician Decision|0|||
156577840|NCT00984659|565201889|FG003|2-week Run-in Period|Physician Decision|0|||
156577841|NCT00984659|565201886|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
156577842|NCT00984659|565201887|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156577843|NCT00984659|565201888|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156577844|NCT00984659|565201889|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
156577845|NCT00984659|565201886|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
156577846|NCT00984659|565201887|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156577847|NCT00984659|565201888|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156577848|NCT00984659|565201889|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156577849|NCT00984659|565201886|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
156577850|NCT00984659|565201887|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
156577851|NCT00984659|565201888|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
156577852|NCT00984659|565201889|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
156577853|NCT00984659|565201886|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
156577854|NCT00984659|565201887|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
156577855|NCT00984659|565201888|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
156577856|NCT00984659|565201889|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
156577857|NCT00984659|565201886|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
156577858|NCT00984659|565201887|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
156577859|NCT00984659|565201888|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
156577860|NCT00984659|565201889|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
156577861|NCT00984659|565201886|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
156577862|NCT00984659|565201887|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
156577863|NCT00984659|565201888|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
156577864|NCT00984659|565201889|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
156577865|NCT00984659|565201886|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156577866|NCT00984659|565201887|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
156577867|NCT00984659|565201888|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
156577868|NCT00984659|565201889|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
156577869|NCT00891657|565201891|FG000|Overall Study|Withdrawal by Subject|1|||
156577870|NCT00891657|565201892|FG001|Overall Study|Withdrawal by Subject|1|||
156577871|NCT03455543|565201898|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
156577872|NCT03455543|565201899|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
156577873|NCT03455543|565201900|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
156577874|NCT03455543|565201898|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
156577875|NCT03455543|565201899|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
156577876|NCT03455543|565201900|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
156577877|NCT03455543|565201898|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
156577878|NCT03455543|565201899|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
156577879|NCT03455543|565201900|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
156577880|NCT03455543|565201898|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
156577881|NCT03455543|565201899|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
156577882|NCT03455543|565201900|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
156577883|NCT03455543|565201898|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
156577884|NCT03455543|565201899|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
156577885|NCT03455543|565201900|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
156577886|NCT03455543|565201898|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
156577887|NCT03455543|565201899|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
156577888|NCT03455543|565201900|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
156577889|NCT03455543|565201898|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
156577890|NCT03455543|565201899|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
156577891|NCT03455543|565201900|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
156577892|NCT03455543|565201898|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
156577893|NCT03455543|565201899|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
156577894|NCT03455543|565201900|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
156577895|NCT03455543|565201898|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
156577896|NCT03455543|565201899|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
156577897|NCT03455543|565201900|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
156577898|NCT01720667|565201908|FG000|Overall Study|Adverse Event|1|||
156577899|NCT01720667|565201909|FG001|Overall Study|Adverse Event|1|||
156577900|NCT01720667|565201908|FG000|Overall Study|Withdrawal by Subject|3|||
156577901|NCT01720667|565201909|FG001|Overall Study|Withdrawal by Subject|0|||
156577902|NCT02614794|565201910|FG000|Overall Study|Death|258|||
156577903|NCT02614794|565201911|FG001|Overall Study|Death|151|||
156577904|NCT02614794|565201910|FG000|Overall Study|Study closure by Sponsor|119|||
156577905|NCT02614794|565201911|FG001|Overall Study|Study closure by Sponsor|45|||
156577906|NCT02614794|565201910|FG000|Overall Study|Withdrawal by Subject|24|||
156577907|NCT02614794|565201911|FG001|Overall Study|Withdrawal by Subject|5|||
156577908|NCT02614794|565201910|FG000|Overall Study|Lost to Follow-up|7|||
156577909|NCT02614794|565201911|FG001|Overall Study|Lost to Follow-up|0|||
156577910|NCT02614794|565201910|FG000|Overall Study|Physician Decision|1|||
156577911|NCT02614794|565201911|FG001|Overall Study|Physician Decision|1|||
156577912|NCT02614794|565201910|FG000|Overall Study|Hospital closure|1|||
156577913|NCT02614794|565201911|FG001|Overall Study|Hospital closure|0|||
156577914|NCT00234104|565201912|FG000|Overall Study|Adverse Event|4|||
156577915|NCT00234104|565201913|FG001|Overall Study|Adverse Event|0|||
156577916|NCT00234104|565201914|FG002|Overall Study|Adverse Event|3|||
156577917|NCT00234104|565201915|FG003|Overall Study|Adverse Event|5|||
156577918|NCT00234104|565201912|FG000|Overall Study|Protocol Violation|0|||
156577919|NCT00234104|565201913|FG001|Overall Study|Protocol Violation|0|||
156577920|NCT00234104|565201914|FG002|Overall Study|Protocol Violation|0|||
156577921|NCT00234104|565201915|FG003|Overall Study|Protocol Violation|1|||
156577922|NCT00234104|565201912|FG000|Overall Study|Physician Decision|0|||
156577923|NCT00234104|565201913|FG001|Overall Study|Physician Decision|1|||
156577924|NCT00234104|565201914|FG002|Overall Study|Physician Decision|2|||
156577925|NCT00234104|565201915|FG003|Overall Study|Physician Decision|2|||
156577926|NCT02052960|565201917|FG000|Overall Study|Adverse Event|19|||
156577927|NCT02052960|565201918|FG001|Overall Study|Adverse Event|17|||
156577928|NCT02052960|565201917|FG000|Overall Study|Protocol Violation|4|||
156577929|NCT02052960|565201918|FG001|Overall Study|Protocol Violation|3|||
156577930|NCT02052960|565201917|FG000|Overall Study|Withdrawal by Subject|6|||
156577931|NCT02052960|565201918|FG001|Overall Study|Withdrawal by Subject|11|||
156577932|NCT02052960|565201917|FG000|Overall Study|Other|25|||
156577933|NCT02052960|565201918|FG001|Overall Study|Other|15|||
156577934|NCT04045613|565201919|FG000|Overall Study|Adverse Event|2|||
156577935|NCT04045613|565201920|FG001|Overall Study|Adverse Event|2|||
156577936|NCT04045613|565201921|FG002|Overall Study|Adverse Event|1|||
156577937|NCT04045613|565201922|FG003|Overall Study|Adverse Event|1|||
156577938|NCT04045613|565201923|FG004|Overall Study|Adverse Event|0|||
156577939|NCT04045613|565201924|FG005|Overall Study|Adverse Event|0|||
156577940|NCT04045613|565201925|FG006|Overall Study|Adverse Event|1|||
156577941|NCT04045613|565201919|FG000|Overall Study|Withdrawal by Subject|0|||
156577942|NCT04045613|565201920|FG001|Overall Study|Withdrawal by Subject|5|||
156577943|NCT04045613|565201921|FG002|Overall Study|Withdrawal by Subject|0|||
156577944|NCT04045613|565201922|FG003|Overall Study|Withdrawal by Subject|0|||
156577945|NCT04045613|565201923|FG004|Overall Study|Withdrawal by Subject|0|||
156577946|NCT04045613|565201924|FG005|Overall Study|Withdrawal by Subject|1|||
156577947|NCT04045613|565201925|FG006|Overall Study|Withdrawal by Subject|0|||
156577948|NCT04045613|565201919|FG000|Overall Study|Physician Decision|2|||
156577949|NCT04045613|565201920|FG001|Overall Study|Physician Decision|0|||
156577950|NCT04045613|565201921|FG002|Overall Study|Physician Decision|0|||
156577951|NCT04045613|565201922|FG003|Overall Study|Physician Decision|0|||
156577952|NCT04045613|565201923|FG004|Overall Study|Physician Decision|1|||
156577953|NCT04045613|565201924|FG005|Overall Study|Physician Decision|0|||
156577954|NCT04045613|565201925|FG006|Overall Study|Physician Decision|0|||
156577955|NCT04045613|565201919|FG000|Overall Study|Death|3|||
156577956|NCT04045613|565201920|FG001|Overall Study|Death|0|||
156577957|NCT04045613|565201921|FG002|Overall Study|Death|0|||
156577958|NCT04045613|565201922|FG003|Overall Study|Death|0|||
156577959|NCT04045613|565201923|FG004|Overall Study|Death|0|||
156577960|NCT04045613|565201924|FG005|Overall Study|Death|0|||
156577961|NCT04045613|565201925|FG006|Overall Study|Death|1|||
156577962|NCT04045613|565201919|FG000|Overall Study|Other reasons|0|||
156577963|NCT04045613|565201920|FG001|Overall Study|Other reasons|1|||
156577964|NCT04045613|565201921|FG002|Overall Study|Other reasons|0|||
156577965|NCT04045613|565201922|FG003|Overall Study|Other reasons|0|||
156577966|NCT04045613|565201923|FG004|Overall Study|Other reasons|0|||
156577967|NCT04045613|565201924|FG005|Overall Study|Other reasons|0|||
156577968|NCT04045613|565201925|FG006|Overall Study|Other reasons|1|||
156577969|NCT04045613|565201919|FG000|Overall Study|Progressive disease: Clinical progression|1|||
156577970|NCT04045613|565201920|FG001|Overall Study|Progressive disease: Clinical progression|0|||
156577971|NCT04045613|565201921|FG002|Overall Study|Progressive disease: Clinical progression|3|||
156577972|NCT04045613|565201922|FG003|Overall Study|Progressive disease: Clinical progression|1|||
156577973|NCT04045613|565201923|FG004|Overall Study|Progressive disease: Clinical progression|1|||
156577974|NCT04045613|565201924|FG005|Overall Study|Progressive disease: Clinical progression|3|||
156577975|NCT04045613|565201925|FG006|Overall Study|Progressive disease: Clinical progression|3|||
156577976|NCT04045613|565201919|FG000|Overall Study|Progressive disease: Radiological progression|24|||
156577977|NCT04045613|565201920|FG001|Overall Study|Progressive disease: Radiological progression|6|||
156577978|NCT04045613|565201921|FG002|Overall Study|Progressive disease: Radiological progression|8|||
156577979|NCT04045613|565201922|FG003|Overall Study|Progressive disease: Radiological progression|0|||
156577980|NCT04045613|565201923|FG004|Overall Study|Progressive disease: Radiological progression|6|||
156577981|NCT04045613|565201924|FG005|Overall Study|Progressive disease: Radiological progression|6|||
156577982|NCT04045613|565201925|FG006|Overall Study|Progressive disease: Radiological progression|11|||
156577983|NCT03633331|565201936|FG000|Overall Study|Withdrawal by Subject|1|||
156577984|NCT00949650|565201937|FG000|Overall Study|Progressive disease|188|||
156577985|NCT00949650|565201938|FG001|Overall Study|Progressive disease|19|||
156577986|NCT00949650|565201937|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
156577987|NCT00949650|565201938|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
156577988|NCT00949650|565201937|FG000|Overall Study|Other Adverse Event (AE)|28|||
156577989|NCT00949650|565201938|FG001|Overall Study|Other Adverse Event (AE)|17|||
156577990|NCT00949650|565201937|FG000|Overall Study|Protocol Violation|1|||
156577991|NCT00949650|565201938|FG001|Overall Study|Protocol Violation|4|||
156577992|NCT00949650|565201937|FG000|Overall Study|Refusal to continue medication|7|||
156577993|NCT00949650|565201938|FG001|Overall Study|Refusal to continue medication|11|||
156577994|NCT00949650|565201937|FG000|Overall Study|Not treated|1|||
156577995|NCT00949650|565201938|FG001|Overall Study|Not treated|4|||
156577996|NCT00949650|565201937|FG000|Overall Study|Other not specified above|5|||
156577997|NCT00949650|565201938|FG001|Overall Study|Other not specified above|0|||
156577998|NCT03671369|565201941|FG000|Overall Study|Other|1|||
156577999|NCT03671369|565201941|FG000|Overall Study|Withdrawal by Subject|289|||
156578000|NCT03671369|565201941|FG000|Overall Study|Not willing to be vaccinated|1|||
156578001|NCT01507545|565201946|FG000|Overall Study|Withdrawal by Subject|6|||
156578002|NCT01507545|565201947|FG001|Overall Study|Withdrawal by Subject|2|||
156578003|NCT01507545|565201946|FG000|Overall Study|Lost to Follow-up|1|||
156578004|NCT01507545|565201947|FG001|Overall Study|Lost to Follow-up|0|||
156578005|NCT01507545|565201946|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
156578006|NCT01507545|565201947|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
156578007|NCT01507545|565201946|FG000|Overall Study|Progressive disease|60|||
156578008|NCT01507545|565201947|FG001|Overall Study|Progressive disease|27|||
156578009|NCT01507545|565201946|FG000|Overall Study|Other|6|||
156578010|NCT01507545|565201947|FG001|Overall Study|Other|4|||
156578011|NCT00790296|565201948|FG000|Overall Study|Did not meet study eligibility criteria|1|||
156578012|NCT00790296|565201949|FG001|Overall Study|Did not meet study eligibility criteria|1|||
156578013|NCT00790296|565201948|FG000|Overall Study|Adverse Event|0|||
156578014|NCT00790296|565201949|FG001|Overall Study|Adverse Event|1|||
156578015|NCT01716169|565201951|FG000|Overall Study|Adverse Event|1|||
156578016|NCT01716169|565201951|FG000|Overall Study|Lost to Follow-up|1|||
156578017|NCT01716169|565201951|FG000|Overall Study|Withdrawal by Subject|1|||
156578018|NCT01716169|565201951|FG000|Overall Study|inconsistent dressing application|1|||
156578019|NCT00553787|565201952|FG000|Overall Study|Adverse Event|34|||
156578020|NCT00553787|565201953|FG001|Overall Study|Adverse Event|21|||
156578021|NCT00553787|565201954|FG002|Overall Study|Adverse Event|67|||
156578022|NCT00553787|565201952|FG000|Overall Study|Lost to Follow-up|132|||
156578023|NCT00553787|565201953|FG001|Overall Study|Lost to Follow-up|44|||
156578024|NCT00553787|565201954|FG002|Overall Study|Lost to Follow-up|78|||
156578025|NCT00553787|565201952|FG000|Overall Study|Withdrawal by Subject|151|||
156578026|NCT00553787|565201953|FG001|Overall Study|Withdrawal by Subject|40|||
156578027|NCT00553787|565201954|FG002|Overall Study|Withdrawal by Subject|83|||
156578028|NCT00553787|565201952|FG000|Overall Study|Lack of Efficacy|31|||
156578029|NCT00553787|565201953|FG001|Overall Study|Lack of Efficacy|1|||
156578030|NCT00553787|565201954|FG002|Overall Study|Lack of Efficacy|3|||
156578031|NCT00553787|565201952|FG000|Overall Study|Pregnancy|0|||
156578032|NCT00553787|565201953|FG001|Overall Study|Pregnancy|1|||
156578033|NCT00553787|565201954|FG002|Overall Study|Pregnancy|2|||
156578034|NCT00553787|565201952|FG000|Overall Study|non compliance|4|||
156578035|NCT00553787|565201953|FG001|Overall Study|non compliance|0|||
156578036|NCT00553787|565201954|FG002|Overall Study|non compliance|11|||
156578037|NCT00553787|565201952|FG000|Overall Study|Requirement for restricted medication|8|||
156578038|NCT00553787|565201953|FG001|Overall Study|Requirement for restricted medication|7|||
156863595|NCT01743469|566258710|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
156863596|NCT01743469|566258711|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
156863597|NCT01743469|566258708|FG000|Active Treatment Phase|Missing|1|||
156863598|NCT01743469|566258709|FG001|Active Treatment Phase|Missing|0|||
156863599|NCT01743469|566258710|FG002|Active Treatment Phase|Missing|0|||
156863600|NCT01743469|566258711|FG003|Active Treatment Phase|Missing|0|||
156863601|NCT01743469|566258708|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
156863602|NCT01743469|566258709|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
156863603|NCT01743469|566258710|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
156863604|NCT01743469|566258711|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
156863605|NCT01743469|566258708|FG000|Follow-up Period - Post-Treatment|Death|43|||
156863606|NCT01743469|566258709|FG001|Follow-up Period - Post-Treatment|Death|47|||
156863607|NCT01743469|566258710|FG002|Follow-up Period - Post-Treatment|Death|22|||
156863608|NCT01743469|566258711|FG003|Follow-up Period - Post-Treatment|Death|16|||
156863609|NCT01743469|566258708|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
156863610|NCT01743469|566258709|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
156863611|NCT01743469|566258710|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
156863612|NCT01743469|566258711|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
156863613|NCT00317473|566258712|FG000|Overall Study|Withdrawal by Subject|2|||
156863614|NCT00317473|566258713|FG001|Overall Study|Withdrawal by Subject|1|||
156863615|NCT00317473|566258714|FG002|Overall Study|Withdrawal by Subject|2|||
156863616|NCT00317473|566258715|FG003|Overall Study|Withdrawal by Subject|1|||
156863617|NCT00317473|566258716|FG004|Overall Study|Withdrawal by Subject|3|||
156863618|NCT00317473|566258717|FG005|Overall Study|Withdrawal by Subject|1|||
156863619|NCT00317473|566258712|FG000|Overall Study|Relocation|1|||
156863620|NCT00317473|566258713|FG001|Overall Study|Relocation|0|||
156863621|NCT00317473|566258714|FG002|Overall Study|Relocation|1|||
156863622|NCT00317473|566258715|FG003|Overall Study|Relocation|1|||
156863623|NCT00317473|566258716|FG004|Overall Study|Relocation|5|||
156863624|NCT00317473|566258717|FG005|Overall Study|Relocation|2|||
156863625|NCT00317473|566258712|FG000|Overall Study|Death|1|||
156863626|NCT00317473|566258713|FG001|Overall Study|Death|0|||
156863627|NCT00317473|566258714|FG002|Overall Study|Death|0|||
156863628|NCT00317473|566258715|FG003|Overall Study|Death|0|||
156863629|NCT00317473|566258716|FG004|Overall Study|Death|0|||
156863630|NCT00317473|566258717|FG005|Overall Study|Death|0|||
156863631|NCT00317473|566258712|FG000|Overall Study|Other|0|||
156863632|NCT00317473|566258713|FG001|Overall Study|Other|2|||
156863633|NCT00317473|566258714|FG002|Overall Study|Other|0|||
156863634|NCT00317473|566258715|FG003|Overall Study|Other|0|||
156578039|NCT00553787|565201954|FG002|Overall Study|Requirement for restricted medication|5|||
156578040|NCT00553787|565201952|FG000|Overall Study|Other|18|||
156578041|NCT00553787|565201953|FG001|Overall Study|Other|10|||
156578042|NCT00553787|565201954|FG002|Overall Study|Other|13|||
156578043|NCT01088412|565201955|FG000|Overall Study|Adverse Event|38|||
156578044|NCT01088412|565201956|FG001|Overall Study|Adverse Event|0|||
156578045|NCT01088412|565201957|FG002|Overall Study|Adverse Event|0|||
156578046|NCT01088412|565201955|FG000|Overall Study|Death|42|||
156578047|NCT01088412|565201956|FG001|Overall Study|Death|6|||
156578048|NCT01088412|565201957|FG002|Overall Study|Death|0|||
156578049|NCT01088412|565201955|FG000|Overall Study|Other Reason per Case Report Form|2089|||
156578050|NCT01088412|565201956|FG001|Overall Study|Other Reason per Case Report Form|103|||
156578051|NCT01088412|565201957|FG002|Overall Study|Other Reason per Case Report Form|9|||
156578052|NCT01088412|565201955|FG000|Overall Study|Withdrawal by Subject|1761|||
156578053|NCT01088412|565201956|FG001|Overall Study|Withdrawal by Subject|25|||
156578054|NCT01088412|565201957|FG002|Overall Study|Withdrawal by Subject|1|||
156578055|NCT01088412|565201955|FG000|Overall Study|Received Another GH Product|79|||
156578056|NCT01088412|565201956|FG001|Overall Study|Received Another GH Product|0|||
156578057|NCT01088412|565201957|FG002|Overall Study|Received Another GH Product|0|||
156578058|NCT01088412|565201955|FG000|Overall Study|Participant Moved|601|||
156578059|NCT01088412|565201956|FG001|Overall Study|Participant Moved|21|||
156578060|NCT01088412|565201957|FG002|Overall Study|Participant Moved|2|||
156578061|NCT01088412|565201955|FG000|Overall Study|Physician Decision|1041|||
156578062|NCT01088412|565201956|FG001|Overall Study|Physician Decision|8|||
156578063|NCT01088412|565201957|FG002|Overall Study|Physician Decision|4|||
156578064|NCT01088412|565201955|FG000|Overall Study|Sponsor Decision|4467|||
156578065|NCT01088412|565201956|FG001|Overall Study|Sponsor Decision|79|||
156578066|NCT01088412|565201957|FG002|Overall Study|Sponsor Decision|23|||
156578067|NCT01088412|565201955|FG000|Overall Study|Third Party Required to Change Brand|487|||
156578068|NCT01088412|565201956|FG001|Overall Study|Third Party Required to Change Brand|0|||
156578069|NCT01088412|565201957|FG002|Overall Study|Third Party Required to Change Brand|0|||
156578070|NCT01088412|565201955|FG000|Overall Study|Lost to Follow-up|3052|||
156578071|NCT01088412|565201956|FG001|Overall Study|Lost to Follow-up|130|||
156578072|NCT01088412|565201957|FG002|Overall Study|Lost to Follow-up|11|||
156578073|NCT01088412|565201955|FG000|Overall Study|Study Summary Not Completed|4360|||
156578074|NCT01088412|565201956|FG001|Overall Study|Study Summary Not Completed|64|||
156578075|NCT01088412|565201957|FG002|Overall Study|Study Summary Not Completed|22|||
156578076|NCT05121103|565201958|FG000|Overall Study|Progressive disease|2|||
156578077|NCT05121103|565201959|FG001|Overall Study|Progressive disease|1|||
156578078|NCT05121103|565201960|FG002|Overall Study|Progressive disease|6|||
156578079|NCT05121103|565201958|FG000|Overall Study|Physician Decision|2|||
156578080|NCT05121103|565201959|FG001|Overall Study|Physician Decision|1|||
156578081|NCT05121103|565201960|FG002|Overall Study|Physician Decision|0|||
156578082|NCT05121103|565201958|FG000|Overall Study|Withdrawal by Subject|0|||
156578083|NCT05121103|565201959|FG001|Overall Study|Withdrawal by Subject|1|||
156578084|NCT05121103|565201960|FG002|Overall Study|Withdrawal by Subject|0|||
156578085|NCT02619253|565201963|FG000|Overall Study|Adverse Event|0|||
156578086|NCT02619253|565201964|FG001|Overall Study|Adverse Event|0|||
156578087|NCT02619253|565201965|FG002|Overall Study|Adverse Event|1|||
156578088|NCT02619253|565201966|FG003|Overall Study|Adverse Event|1|||
156578089|NCT02619253|565201967|FG004|Overall Study|Adverse Event|3|||
156578090|NCT02619253|565201963|FG000|Overall Study|Alternative Therapy|0|||
156578091|NCT02619253|565201964|FG001|Overall Study|Alternative Therapy|0|||
156578092|NCT02619253|565201965|FG002|Overall Study|Alternative Therapy|1|||
156578093|NCT02619253|565201966|FG003|Overall Study|Alternative Therapy|0|||
156578094|NCT02619253|565201967|FG004|Overall Study|Alternative Therapy|0|||
156578095|NCT02619253|565201963|FG000|Overall Study|Death|0|||
156578096|NCT02619253|565201964|FG001|Overall Study|Death|0|||
156578097|NCT02619253|565201965|FG002|Overall Study|Death|0|||
156578098|NCT02619253|565201966|FG003|Overall Study|Death|1|||
156578099|NCT02619253|565201967|FG004|Overall Study|Death|0|||
156578100|NCT02619253|565201963|FG000|Overall Study|Disease Progression|4|||
156578101|NCT02619253|565201964|FG001|Overall Study|Disease Progression|2|||
156578102|NCT02619253|565201965|FG002|Overall Study|Disease Progression|8|||
156578103|NCT02619253|565201966|FG003|Overall Study|Disease Progression|9|||
156578104|NCT02619253|565201967|FG004|Overall Study|Disease Progression|10|||
156578105|NCT02619253|565201963|FG000|Overall Study|Needed a disqualifying therapy|0|||
156578106|NCT02619253|565201964|FG001|Overall Study|Needed a disqualifying therapy|0|||
156578107|NCT02619253|565201965|FG002|Overall Study|Needed a disqualifying therapy|1|||
156578108|NCT02619253|565201966|FG003|Overall Study|Needed a disqualifying therapy|0|||
156578109|NCT02619253|565201967|FG004|Overall Study|Needed a disqualifying therapy|0|||
156578110|NCT02619253|565201963|FG000|Overall Study|Transferred to hospice|0|||
156863635|NCT00317473|566258716|FG004|Overall Study|Other|0|||
156578111|NCT02619253|565201964|FG001|Overall Study|Transferred to hospice|0|||
156578112|NCT02619253|565201965|FG002|Overall Study|Transferred to hospice|1|||
156578113|NCT02619253|565201966|FG003|Overall Study|Transferred to hospice|0|||
156578114|NCT02619253|565201967|FG004|Overall Study|Transferred to hospice|0|||
156578115|NCT02619253|565201963|FG000|Overall Study|Physician Decision|0|||
156578116|NCT02619253|565201964|FG001|Overall Study|Physician Decision|1|||
156578117|NCT02619253|565201965|FG002|Overall Study|Physician Decision|2|||
156578118|NCT02619253|565201966|FG003|Overall Study|Physician Decision|3|||
156578119|NCT02619253|565201967|FG004|Overall Study|Physician Decision|0|||
156578120|NCT02619253|565201963|FG000|Overall Study|Withdrawal by Subject|0|||
156578121|NCT02619253|565201964|FG001|Overall Study|Withdrawal by Subject|1|||
156578122|NCT02619253|565201965|FG002|Overall Study|Withdrawal by Subject|0|||
156578123|NCT02619253|565201966|FG003|Overall Study|Withdrawal by Subject|0|||
156578124|NCT02619253|565201967|FG004|Overall Study|Withdrawal by Subject|2|||
156578125|NCT00301067|565201968|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
156578126|NCT00301067|565201969|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
156578127|NCT00301067|565201970|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
156578128|NCT00301067|565201971|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
156578129|NCT00301067|565201968|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
156578130|NCT00301067|565201969|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
156578131|NCT00301067|565201970|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
156578132|NCT00301067|565201971|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
156578133|NCT00301067|565201968|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
156578134|NCT00301067|565201969|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
156578135|NCT00301067|565201970|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
156578136|NCT00301067|565201971|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
156578137|NCT00301067|565201968|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
156578138|NCT00301067|565201969|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
156578139|NCT00301067|565201970|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
156578140|NCT00301067|565201971|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
156578141|NCT00301067|565201968|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
156578142|NCT00301067|565201969|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
156578143|NCT00301067|565201970|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
156578144|NCT00301067|565201971|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
156578145|NCT00301067|565201968|FG000|Follow up Until Death|Alive at last data cut point|1|||
156578146|NCT00301067|565201969|FG001|Follow up Until Death|Alive at last data cut point|0|||
156578147|NCT00301067|565201970|FG002|Follow up Until Death|Alive at last data cut point|0|||
156578148|NCT00301067|565201971|FG003|Follow up Until Death|Alive at last data cut point|1|||
156578149|NCT05593432|565201972|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
156578150|NCT05593432|565201973|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
156578151|NCT05593432|565201974|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
156578152|NCT05593432|565201975|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
156578153|NCT05593432|565201972|FG000|16-Week OLE Period|Lack of Efficacy|0|||
156578154|NCT05593432|565201973|FG001|16-Week OLE Period|Lack of Efficacy|0|||
156578155|NCT05593432|565201974|FG002|16-Week OLE Period|Lack of Efficacy|0|||
156578156|NCT05593432|565201975|FG003|16-Week OLE Period|Lack of Efficacy|1|||
156578157|NCT05593432|565201972|FG000|16-Week OLE Period|Lost to Follow-up|0|||
156578158|NCT05593432|565201973|FG001|16-Week OLE Period|Lost to Follow-up|0|||
156578159|NCT05593432|565201974|FG002|16-Week OLE Period|Lost to Follow-up|1|||
156578160|NCT05593432|565201975|FG003|16-Week OLE Period|Lost to Follow-up|2|||
156578161|NCT05593432|565201972|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
156578162|NCT05593432|565201973|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
156578163|NCT05593432|565201974|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
156578164|NCT05593432|565201975|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
156578165|NCT02100657|565203061|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
156578166|NCT02100657|565203062|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
156578167|NCT02100657|565203063|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
156578168|NCT02100657|565203061|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
156578169|NCT02100657|565203062|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
156578170|NCT02100657|565203063|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
156578171|NCT02100657|565203061|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
156578172|NCT02100657|565203062|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
156578173|NCT02100657|565203063|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
156578174|NCT02100657|565203061|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
156578175|NCT02100657|565203062|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
156578176|NCT02100657|565203063|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
156578177|NCT02100657|565203061|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
156578178|NCT02100657|565203062|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
156578179|NCT02100657|565203063|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
156578180|NCT02100657|565203061|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
156578181|NCT02100657|565203062|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
156578182|NCT02100657|565203063|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
156578183|NCT02100657|565203061|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
156578184|NCT02100657|565203062|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
156578185|NCT02100657|565203063|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
156578186|NCT02100657|565203061|FG000|Cohort 3: Dose Level 3|Death|0|||
156578187|NCT02100657|565203062|FG001|Cohort 3: Dose Level 3|Death|0|||
156578188|NCT02100657|565203063|FG002|Cohort 3: Dose Level 3|Death|1|||
156578189|NCT02100657|565203061|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
156578190|NCT02100657|565203062|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
156578191|NCT02100657|565203063|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
156578192|NCT02100657|565203061|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
156578193|NCT02100657|565203062|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
156578194|NCT02100657|565203063|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
156578195|NCT02100657|565203061|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
156578196|NCT02100657|565203062|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
156578197|NCT02100657|565203063|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
156578198|NCT02100657|565203061|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
156578199|NCT02100657|565203062|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
156578200|NCT02100657|565203063|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
156578201|NCT02100657|565203061|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
156578202|NCT02100657|565203062|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
156578203|NCT02100657|565203063|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
156578204|NCT01543490|565203070|FG000|Overall Study|Adverse Event|4|||
156578205|NCT01543490|565203071|FG001|Overall Study|Adverse Event|0|||
156578206|NCT01543490|565203070|FG000|Overall Study|Physician Decision|1|||
156578207|NCT01543490|565203071|FG001|Overall Study|Physician Decision|0|||
156578208|NCT01543490|565203070|FG000|Overall Study|Lack of Efficacy|3|||
156578209|NCT01543490|565203071|FG001|Overall Study|Lack of Efficacy|3|||
156578210|NCT01543490|565203070|FG000|Overall Study|Lost to Follow-up|5|||
156578211|NCT01543490|565203071|FG001|Overall Study|Lost to Follow-up|0|||
156578212|NCT01543490|565203070|FG000|Overall Study|Withdrawal by Subject|2|||
156578213|NCT01543490|565203071|FG001|Overall Study|Withdrawal by Subject|0|||
156578214|NCT01543490|565203070|FG000|Overall Study|Other-Various Administrative Reasons|1|||
156578215|NCT01543490|565203071|FG001|Overall Study|Other-Various Administrative Reasons|2|||
156578216|NCT04168645|565203073|FG000|Overall Study|Lost to Follow-up|23|||
156578217|NCT04168645|565203074|FG001|Overall Study|Lost to Follow-up|28|||
156578218|NCT04168645|565203075|FG002|Overall Study|Lost to Follow-up|15|||
156578219|NCT04168645|565203076|FG003|Overall Study|Lost to Follow-up|12|||
156578220|NCT04168645|565203073|FG000|Overall Study|Death|1|||
156578221|NCT04168645|565203074|FG001|Overall Study|Death|1|||
156578222|NCT04168645|565203075|FG002|Overall Study|Death|0|||
156578223|NCT04168645|565203076|FG003|Overall Study|Death|0|||
156578224|NCT04168645|565203073|FG000|Overall Study|Withdrawal by Subject|5|||
156578225|NCT04168645|565203074|FG001|Overall Study|Withdrawal by Subject|2|||
156578226|NCT04168645|565203075|FG002|Overall Study|Withdrawal by Subject|2|||
156578227|NCT04168645|565203076|FG003|Overall Study|Withdrawal by Subject|2|||
156578228|NCT04168645|565203073|FG000|Overall Study|Administrative Withdrawal|3|||
156578229|NCT04168645|565203074|FG001|Overall Study|Administrative Withdrawal|1|||
156578230|NCT04168645|565203075|FG002|Overall Study|Administrative Withdrawal|1|||
156578231|NCT04168645|565203076|FG003|Overall Study|Administrative Withdrawal|3|||
156578232|NCT03692910|565203084|FG000|Overall Study|Lost to Follow-up|4|||
156578233|NCT03692910|565203085|FG001|Overall Study|Lost to Follow-up|0|||
156578234|NCT03692910|565203086|FG002|Overall Study|Lost to Follow-up|0|||
156578235|NCT03692910|565203084|FG000|Overall Study|Withdrawal by Subject|2|||
156578236|NCT03692910|565203085|FG001|Overall Study|Withdrawal by Subject|0|||
156578237|NCT03692910|565203086|FG002|Overall Study|Withdrawal by Subject|0|||
156578238|NCT00151411|565203089|FG000|Overall Study|Lost to Follow-up|15|||
156578239|NCT00151411|565203090|FG001|Overall Study|Lost to Follow-up|19|||
156578240|NCT00151411|565203089|FG000|Overall Study|Withdrawal by Subject|12|||
156578241|NCT00151411|565203090|FG001|Overall Study|Withdrawal by Subject|20|||
156578242|NCT00151411|565203089|FG000|Overall Study|Adverse Event|6|||
156578243|NCT00151411|565203090|FG001|Overall Study|Adverse Event|0|||
156578244|NCT00151411|565203089|FG000|Overall Study|Pregnancy|0|||
156578245|NCT00151411|565203090|FG001|Overall Study|Pregnancy|4|||
156578246|NCT01283581|565203091|FG000|Overall Study|Lost to Follow-up|8|||
156578247|NCT01283581|565203092|FG001|Overall Study|Lost to Follow-up|6|||
156578248|NCT01283581|565203093|FG002|Overall Study|Lost to Follow-up|8|||
156578249|NCT01283581|565203091|FG000|Overall Study|Withdrawal by Subject|2|||
156578250|NCT01283581|565203092|FG001|Overall Study|Withdrawal by Subject|5|||
156578251|NCT01283581|565203093|FG002|Overall Study|Withdrawal by Subject|2|||
156578252|NCT01283581|565203091|FG000|Overall Study|Adverse Event|1|||
156578253|NCT01283581|565203092|FG001|Overall Study|Adverse Event|1|||
156578254|NCT01283581|565203093|FG002|Overall Study|Adverse Event|4|||
156578255|NCT01283581|565203091|FG000|Overall Study|Physician Decision|0|||
156578256|NCT01283581|565203092|FG001|Overall Study|Physician Decision|1|||
156578257|NCT01283581|565203093|FG002|Overall Study|Physician Decision|2|||
156578258|NCT01283581|565203091|FG000|Overall Study|Protocol Violation|0|||
156578259|NCT01283581|565203092|FG001|Overall Study|Protocol Violation|1|||
156578260|NCT01283581|565203093|FG002|Overall Study|Protocol Violation|2|||
156578261|NCT01283581|565203091|FG000|Overall Study|Noncompliance|1|||
156578262|NCT01283581|565203092|FG001|Overall Study|Noncompliance|0|||
156578263|NCT01283581|565203093|FG002|Overall Study|Noncompliance|0|||
156578264|NCT01283581|565203091|FG000|Overall Study|Investigator unblinded|0|||
156578265|NCT01283581|565203092|FG001|Overall Study|Investigator unblinded|0|||
156578266|NCT01283581|565203093|FG002|Overall Study|Investigator unblinded|1|||
156578267|NCT01283581|565203091|FG000|Overall Study|"Early termination"|0|||
156578268|NCT01283581|565203092|FG001|Overall Study|"Early termination"|0|||
156578269|NCT01283581|565203093|FG002|Overall Study|"Early termination"|1|||
156578270|NCT01259492|565203094|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
156578271|NCT01259492|565203095|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
156578272|NCT01259492|565203096|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
156578273|NCT01259492|565203097|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
156578274|NCT01259492|565203094|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
156578275|NCT01259492|565203095|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
156578276|NCT01259492|565203096|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
156578277|NCT01259492|565203097|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
156578278|NCT01259492|565203094|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
156578279|NCT01259492|565203095|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
156578280|NCT01259492|565203096|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
156578281|NCT01259492|565203097|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
156578282|NCT01259492|565203094|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
156578283|NCT01259492|565203095|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
156578284|NCT01259492|565203096|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
156578285|NCT01259492|565203097|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
156578286|NCT01259492|565203094|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
156578287|NCT01259492|565203095|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
156578288|NCT01259492|565203096|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
156578289|NCT01259492|565203097|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
156578290|NCT01259492|565203094|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
156578291|NCT01259492|565203095|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
156578292|NCT01259492|565203096|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
156578293|NCT01259492|565203097|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
156578294|NCT01259492|565203094|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
156578295|NCT01259492|565203095|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
156578296|NCT01259492|565203096|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
156578297|NCT01259492|565203097|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
156578298|NCT01259492|565203094|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
156578299|NCT01259492|565203095|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
156578300|NCT01259492|565203096|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
156578301|NCT01259492|565203097|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
156578302|NCT01259492|565203094|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
156578303|NCT01259492|565203095|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
156578304|NCT01259492|565203096|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
156578305|NCT01259492|565203097|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
156578306|NCT01259492|565203094|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
156578307|NCT01259492|565203095|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
156578308|NCT01259492|565203096|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
156578309|NCT01259492|565203097|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
156578310|NCT01259492|565203094|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
156578311|NCT01259492|565203095|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
156578312|NCT01259492|565203096|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
156578313|NCT01259492|565203097|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
156578314|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
156578315|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
156578316|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
156578317|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
156578318|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
156578319|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
156578320|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
156578321|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
156578322|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
156578323|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
156578324|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
156578325|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
156578326|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
156578327|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
156578328|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
156578329|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
156578330|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
156578331|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
156578332|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
156578333|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
156578334|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
156578335|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
156578336|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
156578337|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
156578338|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
156578339|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
156578340|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
156578341|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
156578342|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
156578343|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
156578344|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
156578345|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
156578346|NCT01259492|565203094|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
156578347|NCT01259492|565203095|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
156578348|NCT01259492|565203096|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
156578349|NCT01259492|565203097|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
156578350|NCT00089843|565203098|FG000|Overall Study|Withdrawal by Subject|1|||
156578351|NCT00089843|565203099|FG001|Overall Study|Withdrawal by Subject|4|||
156578352|NCT00089843|565203100|FG002|Overall Study|Withdrawal by Subject|5|||
156578353|NCT00089843|565203101|FG003|Overall Study|Withdrawal by Subject|6|||
156578354|NCT00089843|565203098|FG000|Overall Study|Physician Decision|1|||
156578355|NCT00089843|565203099|FG001|Overall Study|Physician Decision|0|||
156578356|NCT00089843|565203100|FG002|Overall Study|Physician Decision|0|||
156578357|NCT00089843|565203101|FG003|Overall Study|Physician Decision|1|||
156578358|NCT03846947|565203102|FG000|Overall Study|technical issues with imaging sequence|2|||
156578359|NCT01295905|565203107|FG000|Overall Study|Did not meet inclusion criteria|1|||
156578360|NCT01295905|565203108|FG001|Overall Study|Did not meet inclusion criteria|0|||
156578361|NCT01295905|565203107|FG000|Overall Study|Met exclusion criteria|1|||
156578362|NCT01295905|565203108|FG001|Overall Study|Met exclusion criteria|0|||
156578363|NCT02717546|565203109|FG000|Overall Study|Lost to Follow-up|12|||
156578364|NCT00909090|565203110|FG000|Overall Study|Lost to Follow-up|17|||
156578365|NCT00909090|565203111|FG001|Overall Study|Lost to Follow-up|17|||
156578366|NCT01009294|565203112|FG000|Overall Study|Study discontinued by Sponsor|6|||
156578367|NCT00414440|565203115|FG000|Core Period|Withdrawal by Subject|70|||
156578368|NCT00414440|565203116|FG001|Core Period|Withdrawal by Subject|32|||
156578369|NCT00414440|565203115|FG000|Extension Period|Lost to Follow-up|44|||
156578370|NCT00414440|565203116|FG001|Extension Period|Lost to Follow-up|52|||
156578371|NCT00414440|565203115|FG000|Extension Period|Did not consent to continue follow up|61|||
156578372|NCT00414440|565203116|FG001|Extension Period|Did not consent to continue follow up|54|||
156578373|NCT00414440|565203115|FG000|Extension Period|Other|1|||
156578374|NCT00414440|565203116|FG001|Extension Period|Other|1|||
156578375|NCT00414440|565203115|FG000|Extension Period|Administrative|16|||
156578376|NCT00414440|565203116|FG001|Extension Period|Administrative|16|||
156578377|NCT00414440|565203115|FG000|Extension Period|Death|1|||
156578378|NCT00414440|565203116|FG001|Extension Period|Death|2|||
156578379|NCT00414440|565203115|FG000|Extension Period|Withdrawal by Subject|9|||
156578380|NCT00414440|565203116|FG001|Extension Period|Withdrawal by Subject|7|||
156578381|NCT00414440|565203115|FG000|Extension Period|Not included in follow up period|18|||
156578382|NCT00414440|565203116|FG001|Extension Period|Not included in follow up period|8|||
156578383|NCT04382651|565203117|FG000|Overall Study|Death|26|||
156578384|NCT04382651|565203118|FG001|Overall Study|Death|23|||
156578385|NCT04382651|565203117|FG000|Overall Study|Lost to Follow-up|3|||
156578386|NCT04382651|565203118|FG001|Overall Study|Lost to Follow-up|4|||
156578387|NCT04382651|565203117|FG000|Overall Study|Withdrawal by Subject|2|||
156578388|NCT04382651|565203118|FG001|Overall Study|Withdrawal by Subject|0|||
156578389|NCT04382651|565203117|FG000|Overall Study|Physician Decision|0|||
156578390|NCT04382651|565203118|FG001|Overall Study|Physician Decision|1|||
156578391|NCT02612077|565203120|FG000|Overall Study|Adverse Event|3|||
156578392|NCT02612077|565203120|FG000|Overall Study|Withdrawal by Subject|9|||
156578393|NCT02612077|565203120|FG000|Overall Study|Protocol Violation|28|||
156578394|NCT02612077|565203120|FG000|Overall Study|Lost to Follow-up|20|||
156578395|NCT02612077|565203120|FG000|Overall Study|Death|377|||
156578396|NCT02612077|565203120|FG000|Overall Study|Moved or Changed Medical Team|23|||
156578397|NCT02612077|565203120|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
156578398|NCT02612077|565203120|FG000|Overall Study|Disease Progression|3|||
156578399|NCT02612077|565203120|FG000|Overall Study|Unknown reason|2|||
156578400|NCT00514449|565203121|FG000|Overall Study|Withdrawal by Subject|1|||
156578401|NCT00514449|565203122|FG001|Overall Study|Withdrawal by Subject|2|||
156578402|NCT00514449|565203121|FG000|Overall Study|Protocol Violation|1|||
156578403|NCT00514449|565203122|FG001|Overall Study|Protocol Violation|2|||
156578404|NCT00514449|565203121|FG000|Overall Study|Lost to Follow-up|1|||
156578405|NCT00514449|565203122|FG001|Overall Study|Lost to Follow-up|0|||
156578406|NCT01359982|565203130|FG000|Overall Study|Adverse Event|2|||
156578407|NCT01359982|565203131|FG001|Overall Study|Adverse Event|0|||
156863636|NCT00317473|566258717|FG005|Overall Study|Other|0|||
156863637|NCT02285855|566258718|FG000|Overall Study|Withdrawal by Subject|2|||
156578408|NCT01359982|565203132|FG002|Overall Study|Adverse Event|0|||
156578409|NCT01359982|565203133|FG003|Overall Study|Adverse Event|1|||
156578410|NCT01359982|565203134|FG004|Overall Study|Adverse Event|0|||
156578411|NCT01359982|565203135|FG005|Overall Study|Adverse Event|0|||
156578412|NCT01359982|565203130|FG000|Overall Study|Death|1|||
156578413|NCT01359982|565203131|FG001|Overall Study|Death|0|||
156578414|NCT01359982|565203132|FG002|Overall Study|Death|0|||
156578415|NCT01359982|565203133|FG003|Overall Study|Death|0|||
156578416|NCT01359982|565203134|FG004|Overall Study|Death|0|||
156578417|NCT01359982|565203135|FG005|Overall Study|Death|0|||
156578418|NCT00306891|565203139|FG000|Part A|Withdrawal by Subject|1|||
156578419|NCT00306891|565203140|FG001|Part A|Withdrawal by Subject|1|||
156578420|NCT00306891|565203141|FG002|Part A|Withdrawal by Subject|0|||
156578421|NCT00306891|565203142|FG003|Part A|Withdrawal by Subject|0|||
156578422|NCT00306891|565203139|FG000|Part A|Condition under investigation worsened|2|||
156578423|NCT00306891|565203140|FG001|Part A|Condition under investigation worsened|2|||
156578424|NCT00306891|565203141|FG002|Part A|Condition under investigation worsened|0|||
156578425|NCT00306891|565203142|FG003|Part A|Condition under investigation worsened|0|||
156578426|NCT00306891|565203139|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
156578427|NCT00306891|565203140|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
156578428|NCT00306891|565203141|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
156578429|NCT00306891|565203142|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
156578430|NCT00306891|565203139|FG000|Part A|Partial bowel obstruction|1|||
156578431|NCT00306891|565203140|FG001|Part A|Partial bowel obstruction|0|||
156578432|NCT00306891|565203141|FG002|Part A|Partial bowel obstruction|0|||
156578433|NCT00306891|565203142|FG003|Part A|Partial bowel obstruction|0|||
156578434|NCT00306891|565203139|FG000|Part A|Reaccumul. of ascites following drainage|0|||
156578435|NCT00306891|565203140|FG001|Part A|Reaccumul. of ascites following drainage|1|||
156578436|NCT00306891|565203141|FG002|Part A|Reaccumul. of ascites following drainage|0|||
156578437|NCT00306891|565203142|FG003|Part A|Reaccumul. of ascites following drainage|0|||
156578438|NCT00306891|565203139|FG000|Part A|Suspicion of second malignancy|0|||
156578439|NCT00306891|565203140|FG001|Part A|Suspicion of second malignancy|1|||
156578440|NCT00306891|565203141|FG002|Part A|Suspicion of second malignancy|0|||
156578441|NCT00306891|565203142|FG003|Part A|Suspicion of second malignancy|0|||
156578442|NCT00306891|565203139|FG000|Part A|QTC interval outwith elig. criteria|1|||
156578443|NCT00306891|565203140|FG001|Part A|QTC interval outwith elig. criteria|0|||
156578444|NCT00306891|565203141|FG002|Part A|QTC interval outwith elig. criteria|0|||
156578445|NCT00306891|565203142|FG003|Part A|QTC interval outwith elig. criteria|0|||
156578446|NCT00306891|565203139|FG000|Part B|Death|0|||
156578447|NCT00306891|565203140|FG001|Part B|Death|0|||
156578448|NCT00306891|565203141|FG002|Part B|Death|1|||
156578449|NCT00306891|565203142|FG003|Part B|Death|2|||
156578450|NCT00306891|565203139|FG000|Part B|Adverse Event|0|||
156578451|NCT00306891|565203140|FG001|Part B|Adverse Event|0|||
156578452|NCT00306891|565203141|FG002|Part B|Adverse Event|5|||
156578453|NCT00306891|565203142|FG003|Part B|Adverse Event|5|||
156578454|NCT00306891|565203139|FG000|Part B|Withdrawal by Subject|0|||
156578455|NCT00306891|565203140|FG001|Part B|Withdrawal by Subject|0|||
156578456|NCT00306891|565203141|FG002|Part B|Withdrawal by Subject|3|||
156578457|NCT00306891|565203142|FG003|Part B|Withdrawal by Subject|1|||
156578458|NCT00306891|565203139|FG000|Part B|Condition under investigation worsened|0|||
156578459|NCT00306891|565203140|FG001|Part B|Condition under investigation worsened|0|||
156578460|NCT00306891|565203141|FG002|Part B|Condition under investigation worsened|2|||
156578461|NCT00306891|565203142|FG003|Part B|Condition under investigation worsened|8|||
156578462|NCT00306891|565203139|FG000|Part B|Development of study specific disc crit.|0|||
156578463|NCT00306891|565203140|FG001|Part B|Development of study specific disc crit.|0|||
156578464|NCT00306891|565203141|FG002|Part B|Development of study specific disc crit.|0|||
156578465|NCT00306891|565203142|FG003|Part B|Development of study specific disc crit.|1|||
156578466|NCT00206518|565203144|FG000|Overall Study|Lack of Efficacy|6|||
156578467|NCT00206518|565203145|FG001|Overall Study|Lack of Efficacy|4|||
156578468|NCT00206518|565203144|FG000|Overall Study|Adverse Event|2|||
156578469|NCT00206518|565203145|FG001|Overall Study|Adverse Event|1|||
156578470|NCT00206518|565203144|FG000|Overall Study|Physician Decision|1|||
156578471|NCT00206518|565203145|FG001|Overall Study|Physician Decision|0|||
156578472|NCT00206518|565203144|FG000|Overall Study|Protocol Violation|1|||
156578473|NCT00206518|565203145|FG001|Overall Study|Protocol Violation|1|||
156578474|NCT02335450|565203146|FG000|Overall Study|Pregnancy|1|||
156578475|NCT02613572|565203147|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
156578476|NCT02613572|565203148|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
156578477|NCT02613572|565203149|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
156578478|NCT02613572|565203147|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
156578479|NCT02613572|565203148|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
156578480|NCT02613572|565203149|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
156578481|NCT04538950|565203151|FG000|Overall Study|Pulmonary Issues|2|||
156578482|NCT04538950|565203151|FG000|Overall Study|illness|2|||
156578483|NCT00231478|565203152|FG000|Overall Study|Protocol Violation|3|||
156578484|NCT00231478|565203153|FG001|Overall Study|Protocol Violation|2|||
156578485|NCT00231478|565203152|FG000|Overall Study|Refused Treatment|1|||
156578486|NCT00231478|565203153|FG001|Overall Study|Refused Treatment|1|||
156578487|NCT00231478|565203152|FG000|Overall Study|Withdrawal by Subject|1|||
156578488|NCT00231478|565203153|FG001|Overall Study|Withdrawal by Subject|0|||
156578489|NCT00231478|565203152|FG000|Overall Study|Adverse Event|0|||
156578490|NCT00231478|565203153|FG001|Overall Study|Adverse Event|1|||
156578491|NCT00231478|565203152|FG000|Overall Study|Administrative|3|||
156578492|NCT00231478|565203153|FG001|Overall Study|Administrative|2|||
156578493|NCT00853905|565203154|FG000|Overall Study|Lost to Follow-up|1|||
156578494|NCT00853905|565203155|FG001|Overall Study|Lost to Follow-up|3|||
156578495|NCT00853905|565203154|FG000|Overall Study|Withdrawal by Subject|0|||
156578496|NCT00853905|565203155|FG001|Overall Study|Withdrawal by Subject|1|||
156578497|NCT00853905|565203154|FG000|Overall Study|never had surgery|1|||
156578498|NCT00853905|565203155|FG001|Overall Study|never had surgery|0|||
156578499|NCT00847561|565203156|FG000|Overall Study|Withdrawal by Subject|4|||
156578500|NCT00847561|565203157|FG001|Overall Study|Withdrawal by Subject|3|||
156578501|NCT00847561|565203156|FG000|Overall Study|Unable to schedule|9|||
156578502|NCT00847561|565203157|FG001|Overall Study|Unable to schedule|1|||
156578503|NCT00393458|565203159|FG000|Overall Study|Adverse Event|35|||
156578504|NCT00393458|565203160|FG001|Overall Study|Adverse Event|24|||
156578505|NCT00393458|565203161|FG002|Overall Study|Adverse Event|40|||
156578506|NCT00393458|565203162|FG003|Overall Study|Adverse Event|35|||
156578507|NCT00393458|565203159|FG000|Overall Study|Subject withdrew consent|27|||
156578508|NCT00393458|565203160|FG001|Overall Study|Subject withdrew consent|40|||
156578509|NCT00393458|565203161|FG002|Overall Study|Subject withdrew consent|33|||
156578510|NCT00393458|565203162|FG003|Overall Study|Subject withdrew consent|50|||
156578511|NCT00393458|565203159|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
156578512|NCT00393458|565203160|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
156578513|NCT00393458|565203161|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
156578514|NCT00393458|565203162|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
156578515|NCT00393458|565203159|FG000|Overall Study|Protocol deviation|11|||
156578516|NCT00393458|565203160|FG001|Overall Study|Protocol deviation|11|||
156578517|NCT00393458|565203161|FG002|Overall Study|Protocol deviation|11|||
156578518|NCT00393458|565203162|FG003|Overall Study|Protocol deviation|10|||
156578519|NCT00393458|565203159|FG000|Overall Study|Administrative problems|7|||
156578520|NCT00393458|565203160|FG001|Overall Study|Administrative problems|8|||
156578521|NCT00393458|565203161|FG002|Overall Study|Administrative problems|5|||
156578522|NCT00393458|565203162|FG003|Overall Study|Administrative problems|2|||
156578523|NCT00393458|565203159|FG000|Overall Study|Lost to Follow-up|5|||
156578524|NCT00393458|565203160|FG001|Overall Study|Lost to Follow-up|6|||
156578525|NCT00393458|565203161|FG002|Overall Study|Lost to Follow-up|5|||
156578526|NCT00393458|565203162|FG003|Overall Study|Lost to Follow-up|3|||
156578527|NCT00393458|565203159|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156578528|NCT00393458|565203160|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156578529|NCT00393458|565203161|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156578530|NCT00393458|565203162|FG003|Overall Study|Abnormal laboratory value(s)|0|||
156578531|NCT00393458|565203159|FG000|Overall Study|Death|1|||
156578532|NCT00393458|565203160|FG001|Overall Study|Death|1|||
156578533|NCT00393458|565203161|FG002|Overall Study|Death|5|||
156578534|NCT00393458|565203162|FG003|Overall Study|Death|5|||
156578535|NCT00393458|565203159|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156578536|NCT00393458|565203160|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156578537|NCT00393458|565203161|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156578538|NCT00393458|565203162|FG003|Overall Study|Abnormal test procedure result(s)|2|||
156578539|NCT00393458|565203159|FG000|Overall Study|Subject no longer requires study drug|0|||
156578540|NCT00393458|565203160|FG001|Overall Study|Subject no longer requires study drug|1|||
156578541|NCT00393458|565203161|FG002|Overall Study|Subject no longer requires study drug|0|||
156578542|NCT00393458|565203162|FG003|Overall Study|Subject no longer requires study drug|0|||
156578543|NCT02519231|565203173|FG000|Overall Study|Lost to Follow-up|2|||
156578544|NCT02519231|565203174|FG001|Overall Study|Lost to Follow-up|5|||
156578545|NCT02519231|565203173|FG000|Overall Study|Withdrawal by Subject|0|||
156578546|NCT02519231|565203174|FG001|Overall Study|Withdrawal by Subject|1|||
156578547|NCT00447421|565203176|FG000|Overall Study|Lack of Efficacy|1|||
156578548|NCT00447421|565203176|FG000|Overall Study|Adverse Event|3|||
156578549|NCT00447421|565203176|FG000|Overall Study|Sponsor Decision|2|||
156578550|NCT01707147|565203177|FG000|Overall Study|Administered Trajenta prior to contract|5|||
156578551|NCT01707147|565203177|FG000|Overall Study|Patients who have not taken Trajenta|1|||
156578552|NCT01707147|565203177|FG000|Overall Study|Follow-up failure|17|||
156578553|NCT01707147|565203177|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
156578554|NCT02725177|565203178|FG000|Overall Study|Physician Decision|4|||
156578555|NCT02725177|565203178|FG000|Overall Study|Adverse Event|1|||
156578556|NCT02050048|565203181|FG000|Overall Study|Lost to Follow-up|0|||
156578557|NCT02050048|565203182|FG001|Overall Study|Lost to Follow-up|1|||
156578558|NCT02050048|565203181|FG000|Overall Study|Death|1|||
156578559|NCT02050048|565203182|FG001|Overall Study|Death|0|||
156578560|NCT02050048|565203181|FG000|Overall Study|Ineligible after ERCP|4|||
156578561|NCT02050048|565203182|FG001|Overall Study|Ineligible after ERCP|1|||
156578562|NCT04285723|565203188|FG000|Overall Study|Subject decision|1|||
156578563|NCT04285723|565203189|FG001|Overall Study|Subject decision|2|||
156578564|NCT04285723|565203188|FG000|Overall Study|Physician Decision|1|||
156578565|NCT04285723|565203189|FG001|Overall Study|Physician Decision|0|||
156578566|NCT04285723|565203188|FG000|Overall Study|No efficiency|1|||
156578567|NCT04285723|565203189|FG001|Overall Study|No efficiency|0|||
156578568|NCT03067311|565203190|FG000|Overall Study|Lost to Follow-up|1|||
156578569|NCT03067311|565203191|FG001|Overall Study|Lost to Follow-up|1|||
156578570|NCT03067311|565203190|FG000|Overall Study|Moved away|1|||
156578571|NCT03067311|565203191|FG001|Overall Study|Moved away|1|||
156578572|NCT02903511|565203195|FG000|Overall Study|Withdrawal by Subject|1|||
156578573|NCT02903511|565203196|FG001|Overall Study|Withdrawal by Subject|0|||
156578574|NCT02903511|565203195|FG000|Overall Study|Lost to Follow-up|3|||
156578575|NCT02903511|565203196|FG001|Overall Study|Lost to Follow-up|2|||
156578576|NCT02699515|565204680|FG000|Overall Study|Death|3|||
156578577|NCT02699515|565204681|FG001|Overall Study|Death|3|||
156578578|NCT02699515|565204682|FG002|Overall Study|Death|3|||
156578579|NCT02699515|565204683|FG003|Overall Study|Death|23|||
156578580|NCT02699515|565204684|FG004|Overall Study|Death|22|||
156578581|NCT02699515|565204685|FG005|Overall Study|Death|23|||
156578582|NCT02699515|565204686|FG006|Overall Study|Death|3|||
156578583|NCT02699515|565204687|FG007|Overall Study|Death|5|||
156578584|NCT02699515|565204680|FG000|Overall Study|Withdrawal by Subject|0|||
156578585|NCT02699515|565204681|FG001|Overall Study|Withdrawal by Subject|0|||
156578586|NCT02699515|565204682|FG002|Overall Study|Withdrawal by Subject|3|||
156578587|NCT02699515|565204683|FG003|Overall Study|Withdrawal by Subject|1|||
156578588|NCT02699515|565204684|FG004|Overall Study|Withdrawal by Subject|5|||
156578589|NCT02699515|565204685|FG005|Overall Study|Withdrawal by Subject|3|||
156578590|NCT02699515|565204686|FG006|Overall Study|Withdrawal by Subject|0|||
156578591|NCT02699515|565204687|FG007|Overall Study|Withdrawal by Subject|1|||
156578592|NCT02699515|565204680|FG000|Overall Study|Other|1|||
156578593|NCT02699515|565204681|FG001|Overall Study|Other|0|||
156578594|NCT02699515|565204682|FG002|Overall Study|Other|1|||
156578595|NCT02699515|565204683|FG003|Overall Study|Other|6|||
156578596|NCT02699515|565204684|FG004|Overall Study|Other|4|||
156578597|NCT02699515|565204685|FG005|Overall Study|Other|3|||
156578598|NCT02699515|565204686|FG006|Overall Study|Other|0|||
156578599|NCT02699515|565204687|FG007|Overall Study|Other|0|||
156578600|NCT05243550|565204688|FG000|Overall Study|Ongoing in the Study|171|||
156578601|NCT05243550|565204688|FG000|Overall Study|Withdrawal by Subject|10|||
156578602|NCT05243550|565204688|FG000|Overall Study|Lost to Follow-up|7|||
156578603|NCT05243550|565204688|FG000|Overall Study|Adverse Event|3|||
156578604|NCT05243550|565204688|FG000|Overall Study|Noncompliance|1|||
156578605|NCT05243550|565204688|FG000|Overall Study|Physician Decision|1|||
156578606|NCT05243550|565204688|FG000|Overall Study|Other Reason|4|||
156578607|NCT01486316|565204689|FG000|Overall Study|Device explanted with/without re-implant|3|||
156578608|NCT01486316|565204690|FG001|Overall Study|Device explanted with/without re-implant|2|||
156578609|NCT01486316|565204691|FG002|Overall Study|Device explanted with/without re-implant|0|||
156578610|NCT01486316|565204692|FG003|Overall Study|Device explanted with/without re-implant|2|||
156578611|NCT01486316|565204689|FG000|Overall Study|Not meeting eligibility criteria|0|||
156578612|NCT01486316|565204690|FG001|Overall Study|Not meeting eligibility criteria|0|||
156578613|NCT01486316|565204691|FG002|Overall Study|Not meeting eligibility criteria|1|||
156578614|NCT01486316|565204692|FG003|Overall Study|Not meeting eligibility criteria|0|||
156578615|NCT01486316|565204689|FG000|Overall Study|Withdrawal by Subject|1|||
156578616|NCT01486316|565204690|FG001|Overall Study|Withdrawal by Subject|0|||
156578617|NCT01486316|565204691|FG002|Overall Study|Withdrawal by Subject|3|||
156578618|NCT01486316|565204692|FG003|Overall Study|Withdrawal by Subject|0|||
156578619|NCT01486316|565204689|FG000|Overall Study|Physician Decision|0|||
156578620|NCT01486316|565204690|FG001|Overall Study|Physician Decision|0|||
156578621|NCT01486316|565204691|FG002|Overall Study|Physician Decision|1|||
156578622|NCT01486316|565204692|FG003|Overall Study|Physician Decision|0|||
156578623|NCT01486316|565204689|FG000|Overall Study|Death|0|||
156578624|NCT01486316|565204690|FG001|Overall Study|Death|1|||
156578625|NCT01486316|565204691|FG002|Overall Study|Death|0|||
156578626|NCT01486316|565204692|FG003|Overall Study|Death|0|||
156578627|NCT00375934|565204702|FG000|Overall Study|Adverse Event|1|||
156578628|NCT00375934|565204703|FG001|Overall Study|Adverse Event|1|||
156578629|NCT00375934|565204702|FG000|Overall Study|Withdrawal by Subject|2|||
156578630|NCT00375934|565204703|FG001|Overall Study|Withdrawal by Subject|2|||
156578631|NCT00375934|565204702|FG000|Overall Study|Lack of Efficacy|0|||
156578632|NCT00375934|565204703|FG001|Overall Study|Lack of Efficacy|2|||
156578633|NCT00375934|565204702|FG000|Overall Study|Physician Decision|0|||
156578634|NCT00375934|565204703|FG001|Overall Study|Physician Decision|1|||
156578635|NCT03191396|565204704|FG000|Overall Study|Lost to Follow-up|0|||
156578636|NCT03191396|565204705|FG001|Overall Study|Lost to Follow-up|3|||
156578637|NCT03191396|565204704|FG000|Overall Study|Withdrawal by Subject|3|||
156578638|NCT03191396|565204705|FG001|Overall Study|Withdrawal by Subject|2|||
156578639|NCT05094154|565204706|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
156578640|NCT05094154|565204707|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
156578641|NCT05094154|565204706|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
156578642|NCT05094154|565204707|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
156578643|NCT00893113|565204708|FG000|Overall Study|Lost to Follow-up|4|||
156578644|NCT00893113|565204709|FG001|Overall Study|Lost to Follow-up|8|||
156578645|NCT00893113|565204708|FG000|Overall Study|Early Termination|1|||
156578646|NCT00893113|565204709|FG001|Overall Study|Early Termination|1|||
156578647|NCT00893113|565204708|FG000|Overall Study|Withdrew Consent|8|||
156578648|NCT00893113|565204709|FG001|Overall Study|Withdrew Consent|7|||
156578649|NCT02531035|565204718|FG000|Overall Study|Death|0|||
156578650|NCT02531035|565204719|FG001|Overall Study|Death|1|||
156578651|NCT02531035|565204718|FG000|Overall Study|Protocol Violation|1|||
156578652|NCT02531035|565204719|FG001|Overall Study|Protocol Violation|1|||
156578653|NCT02531035|565204718|FG000|Overall Study|Noncompliance with study drug|8|||
156578654|NCT02531035|565204719|FG001|Overall Study|Noncompliance with study drug|3|||
156578655|NCT02531035|565204718|FG000|Overall Study|Physician Decision|1|||
156578656|NCT02531035|565204719|FG001|Overall Study|Physician Decision|0|||
156578657|NCT02531035|565204718|FG000|Overall Study|Adverse Event|16|||
156578658|NCT02531035|565204719|FG001|Overall Study|Adverse Event|45|||
156578659|NCT02531035|565204718|FG000|Overall Study|Other|3|||
156578660|NCT02531035|565204719|FG001|Overall Study|Other|2|||
156578661|NCT02531035|565204718|FG000|Overall Study|Withdrawal by Subject|42|||
156578662|NCT02531035|565204719|FG001|Overall Study|Withdrawal by Subject|32|||
156578663|NCT02531035|565204718|FG000|Overall Study|Lost to Follow-up|8|||
156578664|NCT02531035|565204719|FG001|Overall Study|Lost to Follow-up|10|||
156578665|NCT02531035|565204718|FG000|Overall Study|Randomized, not treated|2|||
156578666|NCT02531035|565204719|FG001|Overall Study|Randomized, not treated|1|||
156578667|NCT01240811|565204720|FG000|Overall Study|Physician Decision|0|||
156578668|NCT01240811|565204721|FG001|Overall Study|Physician Decision|1|||
156578669|NCT01240811|565204722|FG002|Overall Study|Physician Decision|0|||
156578670|NCT01240811|565204720|FG000|Overall Study|Withdrawal by Subject|0|||
156578671|NCT01240811|565204721|FG001|Overall Study|Withdrawal by Subject|0|||
156578672|NCT01240811|565204722|FG002|Overall Study|Withdrawal by Subject|1|||
156578673|NCT02400346|565204737|FG000|Overall Study|Adverse Event|24|||
156578674|NCT02400346|565204737|FG000|Overall Study|Lack of Efficacy|9|||
156578675|NCT02400346|565204737|FG000|Overall Study|Non-compliance with IMP|1|||
156578676|NCT02400346|565204737|FG000|Overall Study|Withdrawal by Subject|7|||
156578677|NCT02400346|565204737|FG000|Overall Study|Administrative or other reason(s)|2|||
156578678|NCT02400346|565204737|FG000|Overall Study|Lost to Follow-up|1|||
156578679|NCT02114203|565204738|FG000|Overall Study|Adverse Event|0|||
156578680|NCT02114203|565204739|FG001|Overall Study|Adverse Event|1|||
156578681|NCT02114203|565204740|FG002|Overall Study|Adverse Event|0|||
156578682|NCT02114203|565204738|FG000|Overall Study|Withdrawal by Subject|0|||
156578683|NCT02114203|565204739|FG001|Overall Study|Withdrawal by Subject|1|||
156578684|NCT02114203|565204740|FG002|Overall Study|Withdrawal by Subject|0|||
156578685|NCT01518699|565204741|FG000|Period 2|Protocol Violation|1|||
156578686|NCT01518699|565204742|FG001|Period 2|Protocol Violation|1|||
156578687|NCT01518699|565204743|FG002|Period 2|Protocol Violation|0|||
156578688|NCT01518699|565204744|FG003|Period 2|Protocol Violation|0|||
156578689|NCT01518699|565204745|FG004|Period 2|Protocol Violation|0|||
156578690|NCT01518699|565204746|FG005|Period 2|Protocol Violation|0|||
156578691|NCT01518699|565204741|FG000|Period 2|Lost to Follow-up|0|||
156578692|NCT01518699|565204742|FG001|Period 2|Lost to Follow-up|1|||
156578693|NCT01518699|565204743|FG002|Period 2|Lost to Follow-up|0|||
156578694|NCT01518699|565204744|FG003|Period 2|Lost to Follow-up|0|||
156578695|NCT01518699|565204745|FG004|Period 2|Lost to Follow-up|0|||
156578696|NCT01518699|565204746|FG005|Period 2|Lost to Follow-up|0|||
156578697|NCT01518699|565204741|FG000|Period 2|Adverse Event|1|||
156578698|NCT01518699|565204742|FG001|Period 2|Adverse Event|0|||
156578699|NCT01518699|565204743|FG002|Period 2|Adverse Event|0|||
156578700|NCT01518699|565204744|FG003|Period 2|Adverse Event|0|||
156578701|NCT01518699|565204745|FG004|Period 2|Adverse Event|0|||
156578702|NCT01518699|565204746|FG005|Period 2|Adverse Event|0|||
156578703|NCT00486226|565204751|FG000|Overall Study|Death|3|||
156578704|NCT00486226|565204751|FG000|Overall Study|Adverse Event|1|||
156578705|NCT00486226|565204751|FG000|Overall Study|Withdrawal by Subject|1|||
156578706|NCT00486226|565204751|FG000|Overall Study|Lost to Follow-up|8|||
156578707|NCT01981122|565204756|FG000|Overall Study|Withdrawal by Subject|0|||
156578708|NCT01981122|565204757|FG001|Overall Study|Withdrawal by Subject|2|||
156578709|NCT01981122|565204756|FG000|Overall Study|Protocol Violation|0|||
156578710|NCT01981122|565204757|FG001|Overall Study|Protocol Violation|1|||
156578711|NCT01981122|565204756|FG000|Overall Study|Lost to Follow-up|0|||
156578712|NCT01981122|565204757|FG001|Overall Study|Lost to Follow-up|1|||
156578713|NCT01981122|565204756|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
156578714|NCT01981122|565204757|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
156578715|NCT01981122|565204756|FG000|Overall Study|Death|14|||
156578716|NCT01981122|565204757|FG001|Overall Study|Death|15|||
156578717|NCT02926573|565204759|FG000|Overall Study|Nausea|1|||
156578718|NCT02926573|565204760|FG001|Overall Study|Nausea|0|||
156578719|NCT02926573|565204759|FG000|Overall Study|Remain intubated|2|||
156578720|NCT02926573|565204760|FG001|Overall Study|Remain intubated|2|||
156578721|NCT02926573|565204759|FG000|Overall Study|Change in surgery plan|3|||
156578722|NCT02926573|565204760|FG001|Overall Study|Change in surgery plan|1|||
156578723|NCT02926573|565204759|FG000|Overall Study|Change to outpatient status|5|||
156578724|NCT02926573|565204760|FG001|Overall Study|Change to outpatient status|1|||
156578725|NCT02926573|565204759|FG000|Overall Study|Withdrawal by Subject|0|||
156578726|NCT02926573|565204760|FG001|Overall Study|Withdrawal by Subject|2|||
156578727|NCT02926573|565204759|FG000|Overall Study|Return to operating room|0|||
156578728|NCT02926573|565204760|FG001|Overall Study|Return to operating room|2|||
156578729|NCT02926573|565204759|FG000|Overall Study|Delirium|0|||
156578730|NCT02926573|565204760|FG001|Overall Study|Delirium|1|||
156578731|NCT00611455|565204763|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
156578732|NCT00611455|565204764|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
156578733|NCT00611455|565204765|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156578734|NCT00611455|565204763|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
156578735|NCT00611455|565204764|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
156578736|NCT00611455|565204765|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
156578737|NCT00611455|565204763|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
156578738|NCT00611455|565204764|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
156578739|NCT00611455|565204765|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156578740|NCT00611455|565204763|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
156578741|NCT00611455|565204764|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
156578742|NCT00611455|565204765|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156578743|NCT00611455|565204763|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
156578744|NCT00611455|565204764|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
156578745|NCT00611455|565204765|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
156578746|NCT00611455|565204763|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
156578747|NCT00611455|565204764|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
156578748|NCT00611455|565204765|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
156578749|NCT00611455|565204763|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
156578750|NCT00611455|565204764|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
156578751|NCT00611455|565204765|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
156578752|NCT00611455|565204763|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
156578753|NCT00611455|565204764|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
156578754|NCT00611455|565204765|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
156578755|NCT00611455|565204763|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
156578756|NCT00611455|565204764|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
156578757|NCT00611455|565204765|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
156578758|NCT00611455|565204763|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
156578759|NCT00611455|565204764|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
156578760|NCT00611455|565204765|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
156578761|NCT00611455|565204763|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
156578762|NCT00611455|565204764|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
156578763|NCT00611455|565204765|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
156578764|NCT00611455|565204763|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
156578765|NCT00611455|565204764|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
156578766|NCT00611455|565204765|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
156578767|NCT00611455|565204763|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
156578768|NCT00611455|565204764|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
156578769|NCT00611455|565204765|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
156578770|NCT00611455|565204763|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
156578771|NCT00611455|565204764|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
156578772|NCT00611455|565204765|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
156578773|NCT00611455|565204763|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
156578774|NCT00611455|565204764|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
156578775|NCT00611455|565204765|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
156578776|NCT00611455|565204763|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
156578777|NCT00611455|565204764|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
156578778|NCT00611455|565204765|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
156578779|NCT00611455|565204763|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
156578780|NCT00611455|565204764|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
156578781|NCT00611455|565204765|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
156578782|NCT00611455|565204763|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
156578783|NCT00611455|565204764|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
156578784|NCT00611455|565204765|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
156578785|NCT00611455|565204763|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
156578786|NCT00611455|565204764|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
156578787|NCT00611455|565204765|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
156578788|NCT00611455|565204763|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
156578789|NCT00611455|565204764|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
156578790|NCT00611455|565204765|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
156578791|NCT00611455|565204763|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
156578792|NCT00611455|565204764|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
156578793|NCT00611455|565204765|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
156578794|NCT04601272|565204766|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
156578795|NCT04601272|565204767|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
156578796|NCT04601272|565204768|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
156578797|NCT00942708|565204770|FG000|Overall Study|Withdrawal by Subject|1|||
156578798|NCT00995371|565204771|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
156578799|NCT00995371|565204772|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
156578800|NCT00673673|565204773|FG000|Overall Study|Progressive disease|27|||
156578801|NCT00673673|565204773|FG000|Overall Study|Adverse Event|4|||
156578802|NCT00673673|565204773|FG000|Overall Study|Withdrawal by Subject|3|||
156578803|NCT00673673|565204773|FG000|Overall Study|Investigators' discretion|2|||
156578804|NCT04579393|565204786|FG000|Overall Study|Withdrawal by Subject|2|||
156578805|NCT04579393|565204787|FG001|Overall Study|Withdrawal by Subject|2|||
156578806|NCT04579393|565204786|FG000|Overall Study|Death|1|||
156578807|NCT04579393|565204787|FG001|Overall Study|Death|3|||
156578808|NCT01282814|565204788|FG000|First Intervention|Emesis During Dosing Interval|0|||
156578809|NCT01282814|565204789|FG001|First Intervention|Emesis During Dosing Interval|3|||
156578810|NCT01282814|565204788|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
156578811|NCT01282814|565204789|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156578812|NCT01524289|565204790|FG000|Overall Study|Lost to Follow-up|0|||
156578813|NCT01524289|565204791|FG001|Overall Study|Lost to Follow-up|1|||
156578814|NCT01524289|565204790|FG000|Overall Study|Physician Decision|1|||
156578815|NCT01524289|565204791|FG001|Overall Study|Physician Decision|0|||
156578816|NCT01524289|565204790|FG000|Overall Study|Protocol Violation|5|||
156578817|NCT01524289|565204791|FG001|Overall Study|Protocol Violation|1|||
156578818|NCT01524289|565204790|FG000|Overall Study|Withdrawal by Subject|11|||
156578819|NCT01524289|565204791|FG001|Overall Study|Withdrawal by Subject|7|||
156578820|NCT01524289|565204790|FG000|Overall Study|Adverse Event|12|||
156578821|NCT01524289|565204791|FG001|Overall Study|Adverse Event|5|||
156578822|NCT01524289|565204790|FG000|Overall Study|Did not take study medication|1|||
156578823|NCT01524289|565204791|FG001|Overall Study|Did not take study medication|0|||
156578824|NCT02704429|565204792|FG000|Part A: 24 Weeks|Adverse Event|3|||
156578825|NCT02704429|565204793|FG001|Part A: 24 Weeks|Adverse Event|0|||
156578826|NCT02704429|565204792|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
156578827|NCT02704429|565204793|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
156578828|NCT00104104|565204794|FG000|Overall Study|Adverse Event|8|||
156578829|NCT00104104|565204795|FG001|Overall Study|Adverse Event|8|||
156578830|NCT00104104|565204794|FG000|Overall Study|Abnormal laboratory value(s)|20|||
156578831|NCT00104104|565204795|FG001|Overall Study|Abnormal laboratory value(s)|14|||
156578832|NCT00104104|565204794|FG000|Overall Study|Lack of Efficacy|0|||
156578833|NCT00104104|565204795|FG001|Overall Study|Lack of Efficacy|3|||
156578834|NCT00104104|565204794|FG000|Overall Study|Condition no longer requires study drug|7|||
156578835|NCT00104104|565204795|FG001|Overall Study|Condition no longer requires study drug|4|||
156578836|NCT00104104|565204794|FG000|Overall Study|Protocol Violation|5|||
156578837|NCT00104104|565204795|FG001|Overall Study|Protocol Violation|2|||
156578838|NCT00104104|565204794|FG000|Overall Study|Withdrawal by Subject|11|||
156578839|NCT00104104|565204795|FG001|Overall Study|Withdrawal by Subject|15|||
156578840|NCT00104104|565204794|FG000|Overall Study|Lost to Follow-up|3|||
156578841|NCT00104104|565204795|FG001|Overall Study|Lost to Follow-up|7|||
156578842|NCT00104104|565204794|FG000|Overall Study|Administrative problems|12|||
156578843|NCT00104104|565204795|FG001|Overall Study|Administrative problems|13|||
156578844|NCT00104104|565204794|FG000|Overall Study|Death|9|||
156578845|NCT00104104|565204795|FG001|Overall Study|Death|6|||
156578846|NCT01326962|565204799|FG000|Overall Study|Adverse Event|1|||
156578847|NCT01326962|565204799|FG000|Overall Study|Withdrawal by Subject|1|||
156578848|NCT01326962|565204799|FG000|Overall Study|Lost to Follow-up|3|||
156578849|NCT01326962|565204799|FG000|Overall Study|Other|2|||
156578850|NCT02053246|565204800|FG000|Overall Study|Withdrawal by Subject|3|||
156578851|NCT02053246|565204800|FG000|Overall Study|Physician Decision|1|||
156578852|NCT02707757|565204801|FG000|Overall Study|Protocol Violation|3|||
156578853|NCT02707757|565204802|FG001|Overall Study|Protocol Violation|2|||
156578854|NCT02707757|565204801|FG000|Overall Study|Withdrawal by Subject|2|||
156578855|NCT02707757|565204802|FG001|Overall Study|Withdrawal by Subject|0|||
156578856|NCT02707757|565204801|FG000|Overall Study|Death|0|||
156578857|NCT02707757|565204802|FG001|Overall Study|Death|1|||
156578858|NCT02707757|565204801|FG000|Overall Study|Adverse Event|6|||
156578859|NCT02707757|565204802|FG001|Overall Study|Adverse Event|4|||
156578860|NCT02707757|565204801|FG000|Overall Study|Renal transplant/elective operation|1|||
156578861|NCT02707757|565204802|FG001|Overall Study|Renal transplant/elective operation|5|||
156578862|NCT01056523|565204803|FG000|Overall Study|Death|1|||
156578863|NCT01056523|565204804|FG001|Overall Study|Death|0|||
156578864|NCT01056523|565204805|FG002|Overall Study|Death|2|||
156578865|NCT01056523|565204806|FG003|Overall Study|Death|3|||
156578866|NCT01056523|565204807|FG004|Overall Study|Death|0|||
156578867|NCT01056523|565204808|FG005|Overall Study|Death|0|||
156578868|NCT01056523|565204809|FG006|Overall Study|Death|1|||
156578869|NCT03429556|565204810|FG000|Overall Study|Lost to Follow-up|0|||
156578870|NCT03429556|565204811|FG001|Overall Study|Lost to Follow-up|1|||
156578871|NCT03429556|565204812|FG002|Overall Study|Lost to Follow-up|0|||
156578872|NCT03429556|565204813|FG003|Overall Study|Lost to Follow-up|0|||
156578873|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Adverse Event|37|||
156578874|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Adverse Event|0|||
156578875|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Adverse Event|0|||
156578876|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Adverse Event|0|||
156578877|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Death|2|||
156578878|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Death|0|||
156578879|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Death|0|||
156578880|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Death|0|||
156578881|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
156578882|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
156578883|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
156578884|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
156578885|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
156578886|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
156578887|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
156578888|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
156578889|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
156578890|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
156578891|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
156578892|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
156578893|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
156578894|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
156578895|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
156578896|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
156578897|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Physician Decision|4|||
156578898|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Physician Decision|0|||
156578899|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Physician Decision|0|||
156578900|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Physician Decision|0|||
156578901|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Pregnancy|1|||
156578902|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Pregnancy|0|||
156578903|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Pregnancy|0|||
156578904|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Pregnancy|0|||
156578905|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
156578906|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
156578907|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
156578908|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
156578909|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
156578910|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
156578911|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
156578912|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
156578913|NCT01855789|565204819|FG000|1) Baseline up to Week 24|Other|4|||
156578914|NCT01855789|565204820|FG001|1) Baseline up to Week 24|Other|0|||
156578915|NCT01855789|565204821|FG002|1) Baseline up to Week 24|Other|0|||
156578916|NCT01855789|565204822|FG003|1) Baseline up to Week 24|Other|0|||
156578917|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
156578918|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
156578919|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
156578920|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
156578921|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
156578922|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
156578923|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
156578924|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
156578925|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
156578926|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
156578927|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
156578928|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
156578929|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
156578930|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
156578931|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
156578932|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
156578933|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
156578934|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
156578935|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
156578936|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
156578937|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
156578938|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
156578939|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
156578940|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
156578941|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
156578942|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
156578943|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
156578944|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
156578945|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
156578946|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
156578947|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
156578948|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
156578949|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
156578950|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
156578951|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
156578952|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
156578953|NCT01855789|565204819|FG000|2) Week 24 up to End of Study|Other|0|||
156578954|NCT01855789|565204820|FG001|2) Week 24 up to End of Study|Other|0|||
156578955|NCT01855789|565204821|FG002|2) Week 24 up to End of Study|Other|0|||
156578956|NCT01855789|565204822|FG003|2) Week 24 up to End of Study|Other|1|||
156578957|NCT01863758|565204823|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
156578958|NCT01863758|565204823|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
156578959|NCT02369510|565204824|FG000|Overall Study|Spilled Medication|1|||
156578960|NCT02369510|565204825|FG001|Overall Study|Spilled Medication|2|||
156578961|NCT02369510|565204826|FG002|Overall Study|Spilled Medication|1|||
156578962|NCT02369510|565204824|FG000|Overall Study|Epidural Activation|1|||
156578963|NCT02369510|565204825|FG001|Overall Study|Epidural Activation|1|||
156578964|NCT02369510|565204826|FG002|Overall Study|Epidural Activation|5|||
156578965|NCT01089725|565204834|FG000|Overall Study|Adverse Event|1|||
156578966|NCT01089725|565204835|FG001|Overall Study|Adverse Event|1|||
156578967|NCT01089725|565204836|FG002|Overall Study|Adverse Event|0|||
156578968|NCT01089725|565204837|FG003|Overall Study|Adverse Event|0|||
156578969|NCT01089725|565204838|FG004|Overall Study|Adverse Event|2|||
156578970|NCT01089725|565204834|FG000|Overall Study|Lack of Efficacy|4|||
156578971|NCT01089725|565204835|FG001|Overall Study|Lack of Efficacy|3|||
156578972|NCT01089725|565204836|FG002|Overall Study|Lack of Efficacy|1|||
156578973|NCT01089725|565204837|FG003|Overall Study|Lack of Efficacy|0|||
156578974|NCT01089725|565204838|FG004|Overall Study|Lack of Efficacy|4|||
156578975|NCT01089725|565204834|FG000|Overall Study|Lost to Follow-up|2|||
156578976|NCT01089725|565204835|FG001|Overall Study|Lost to Follow-up|2|||
156578977|NCT01089725|565204836|FG002|Overall Study|Lost to Follow-up|0|||
156578978|NCT01089725|565204837|FG003|Overall Study|Lost to Follow-up|3|||
156578979|NCT01089725|565204838|FG004|Overall Study|Lost to Follow-up|0|||
156578980|NCT01089725|565204834|FG000|Overall Study|Protocol Violation|0|||
156578981|NCT01089725|565204835|FG001|Overall Study|Protocol Violation|0|||
156578982|NCT01089725|565204836|FG002|Overall Study|Protocol Violation|1|||
156578983|NCT01089725|565204837|FG003|Overall Study|Protocol Violation|1|||
156578984|NCT01089725|565204838|FG004|Overall Study|Protocol Violation|0|||
156578985|NCT01089725|565204834|FG000|Overall Study|Withdrawal by Subject|5|||
156578986|NCT01089725|565204835|FG001|Overall Study|Withdrawal by Subject|5|||
156578987|NCT01089725|565204836|FG002|Overall Study|Withdrawal by Subject|4|||
156578988|NCT01089725|565204837|FG003|Overall Study|Withdrawal by Subject|5|||
156578989|NCT01089725|565204838|FG004|Overall Study|Withdrawal by Subject|4|||
156578990|NCT01089725|565204834|FG000|Overall Study|Study Terminated by Sponsor|51|||
156578991|NCT01089725|565204835|FG001|Overall Study|Study Terminated by Sponsor|56|||
156578992|NCT01089725|565204836|FG002|Overall Study|Study Terminated by Sponsor|53|||
156578993|NCT01089725|565204837|FG003|Overall Study|Study Terminated by Sponsor|68|||
156578994|NCT01089725|565204838|FG004|Overall Study|Study Terminated by Sponsor|68|||
156578995|NCT01089725|565204834|FG000|Overall Study|Randomized, but not treated|0|||
156578996|NCT01089725|565204835|FG001|Overall Study|Randomized, but not treated|1|||
156578997|NCT01089725|565204836|FG002|Overall Study|Randomized, but not treated|2|||
156578998|NCT01089725|565204837|FG003|Overall Study|Randomized, but not treated|1|||
156578999|NCT01089725|565204838|FG004|Overall Study|Randomized, but not treated|2|||
156579000|NCT01089725|565204834|FG000|Overall Study|Other|3|||
156579001|NCT01089725|565204835|FG001|Overall Study|Other|0|||
156579002|NCT01089725|565204836|FG002|Overall Study|Other|0|||
156579003|NCT01089725|565204837|FG003|Overall Study|Other|1|||
156579004|NCT01089725|565204838|FG004|Overall Study|Other|0|||
156579005|NCT00500149|565206209|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
156579006|NCT00500149|565206210|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
156579007|NCT00500149|565206209|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
156579008|NCT00500149|565206210|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
156579009|NCT00500149|565206209|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
156579010|NCT00500149|565206210|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
156579011|NCT00500149|565206209|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
156579012|NCT00500149|565206210|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
156579013|NCT00500149|565206209|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
156579014|NCT00500149|565206210|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
156579015|NCT00500149|565206209|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
156579016|NCT00500149|565206210|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
156579017|NCT00500149|565206209|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
156579018|NCT00500149|565206210|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
156579019|NCT03666143|565206213|FG000|Overall Study|Death|158|||
156579020|NCT03666143|565206213|FG000|Overall Study|Sponsor Decision|31|||
156579021|NCT03666143|565206213|FG000|Overall Study|Withdrawal by Subject|11|||
156579022|NCT03666143|565206213|FG000|Overall Study|Lost to Follow-up|5|||
156579023|NCT03666143|565206213|FG000|Overall Study|Physician Decision|1|||
156579024|NCT03666143|565206213|FG000|Overall Study|Rolled into extension study|9|||
156579025|NCT03666143|565206213|FG000|Overall Study|Progressive Disease|1|||
156579026|NCT00915005|565206215|FG000|Overall Study|Withdrawal by Subject|4|||
156579027|NCT00915005|565206216|FG001|Overall Study|Withdrawal by Subject|4|||
156579028|NCT00915005|565206215|FG000|Overall Study|Patient preferred protons therapy|6|||
156579029|NCT00915005|565206216|FG001|Overall Study|Patient preferred protons therapy|0|||
156579030|NCT00915005|565206215|FG000|Overall Study|Insurance denial|3|||
156579031|NCT00915005|565206216|FG001|Overall Study|Insurance denial|15|||
156579032|NCT02397655|565206219|FG000|Overall Study|data not completed|1301|||
156579033|NCT01736683|565206220|FG000|Overall Study|Disease Relapse|0|||
156579034|NCT01736683|565206221|FG001|Overall Study|Disease Relapse|0|||
156579035|NCT01736683|565206222|FG002|Overall Study|Disease Relapse|2|||
156579036|NCT01736683|565206223|FG003|Overall Study|Disease Relapse|1|||
156579037|NCT01736683|565206224|FG004|Overall Study|Disease Relapse|0|||
156579038|NCT01736683|565206220|FG000|Overall Study|Adverse Event|0|||
156579039|NCT01736683|565206221|FG001|Overall Study|Adverse Event|2|||
156579040|NCT01736683|565206222|FG002|Overall Study|Adverse Event|2|||
156579041|NCT01736683|565206223|FG003|Overall Study|Adverse Event|3|||
156579042|NCT01736683|565206224|FG004|Overall Study|Adverse Event|2|||
156579043|NCT01736683|565206220|FG000|Overall Study|Withdrawal by Subject|0|||
156579044|NCT01736683|565206221|FG001|Overall Study|Withdrawal by Subject|0|||
156579045|NCT01736683|565206222|FG002|Overall Study|Withdrawal by Subject|3|||
156579046|NCT01736683|565206223|FG003|Overall Study|Withdrawal by Subject|1|||
156579047|NCT01736683|565206224|FG004|Overall Study|Withdrawal by Subject|1|||
156579048|NCT01736683|565206220|FG000|Overall Study|Lack of Therapeutic Effect|7|||
156579049|NCT01736683|565206221|FG001|Overall Study|Lack of Therapeutic Effect|4|||
156579050|NCT01736683|565206222|FG002|Overall Study|Lack of Therapeutic Effect|13|||
156579051|NCT01736683|565206223|FG003|Overall Study|Lack of Therapeutic Effect|20|||
156579052|NCT01736683|565206224|FG004|Overall Study|Lack of Therapeutic Effect|1|||
156579053|NCT01736683|565206220|FG000|Overall Study|Progressive Disease|0|||
156579054|NCT01736683|565206221|FG001|Overall Study|Progressive Disease|0|||
156579055|NCT01736683|565206222|FG002|Overall Study|Progressive Disease|0|||
156579056|NCT01736683|565206223|FG003|Overall Study|Progressive Disease|1|||
156579057|NCT01736683|565206224|FG004|Overall Study|Progressive Disease|0|||
156579058|NCT01736683|565206220|FG000|Overall Study|Other|0|||
156579059|NCT01736683|565206221|FG001|Overall Study|Other|0|||
156579060|NCT01736683|565206222|FG002|Overall Study|Other|1|||
156579061|NCT01736683|565206223|FG003|Overall Study|Other|9|||
156579062|NCT01736683|565206224|FG004|Overall Study|Other|1|||
156579063|NCT00283712|565206226|FG000|Overall Study|Death|0|||
156579064|NCT00283712|565206227|FG001|Overall Study|Death|1|||
156579065|NCT02747043|565206232|FG000|Overall Study|Other|1|||
156579066|NCT02747043|565206233|FG001|Overall Study|Other|1|||
156579067|NCT02747043|565206232|FG000|Overall Study|Adverse Event|3|||
156579068|NCT02747043|565206233|FG001|Overall Study|Adverse Event|1|||
156579069|NCT02747043|565206232|FG000|Overall Study|Withdrawal by Subject|1|||
156579070|NCT02747043|565206233|FG001|Overall Study|Withdrawal by Subject|1|||
156579071|NCT02747043|565206232|FG000|Overall Study|Physician Decision|1|||
156579072|NCT02747043|565206233|FG001|Overall Study|Physician Decision|1|||
156579073|NCT02747043|565206232|FG000|Overall Study|Protocol Violation|0|||
156579074|NCT02747043|565206233|FG001|Overall Study|Protocol Violation|1|||
156579075|NCT02747043|565206232|FG000|Overall Study|Disease progression|4|||
156579076|NCT02747043|565206233|FG001|Overall Study|Disease progression|0|||
156579077|NCT02046564|565206234|FG000|Overall Study|Adverse Event|6|||
156579078|NCT02046564|565206235|FG001|Overall Study|Adverse Event|3|||
156579079|NCT02046564|565206234|FG000|Overall Study|Physician Decision|0|||
156579080|NCT02046564|565206235|FG001|Overall Study|Physician Decision|1|||
156579081|NCT02046564|565206234|FG000|Overall Study|Protocol Violation|3|||
156579082|NCT02046564|565206235|FG001|Overall Study|Protocol Violation|1|||
156579083|NCT02046564|565206234|FG000|Overall Study|Withdrawal by Subject|4|||
156579084|NCT02046564|565206235|FG001|Overall Study|Withdrawal by Subject|10|||
156579085|NCT02046564|565206234|FG000|Overall Study|Subject met withdrawal criteria|2|||
156579086|NCT02046564|565206235|FG001|Overall Study|Subject met withdrawal criteria|5|||
156579087|NCT00553059|565206237|FG000|Overall Study|Deemed ineligible|1|||
156579088|NCT00553059|565206238|FG001|Overall Study|Deemed ineligible|1|||
156579089|NCT00553059|565206237|FG000|Overall Study|Drug supply not available|0|||
156579090|NCT00553059|565206238|FG001|Overall Study|Drug supply not available|1|||
156579091|NCT01966731|565206239|FG000|Overall Study|Death|2|||
156579092|NCT01966731|565206239|FG000|Overall Study|Lost to Follow-up|1|||
156579093|NCT01966731|565206239|FG000|Overall Study|Physician Decision|2|||
156579094|NCT01966731|565206239|FG000|Overall Study|Follow up is not complete|600|||
156579095|NCT01966731|565206239|FG000|Overall Study|Screening Failure|29|||
156579096|NCT01966731|565206239|FG000|Overall Study|Found to be ineligible|1|||
156579097|NCT00592683|565206240|FG000|Overall Study|Found ineligible|0|||
156579098|NCT00592683|565206241|FG001|Overall Study|Found ineligible|1|||
156579099|NCT00592683|565206240|FG000|Overall Study|Withdrawal by Subject|1|||
156579100|NCT00592683|565206241|FG001|Overall Study|Withdrawal by Subject|0|||
156579101|NCT00592683|565206240|FG000|Overall Study|Adverse Event|0|||
156579102|NCT00592683|565206241|FG001|Overall Study|Adverse Event|2|||
156579103|NCT00592683|565206240|FG000|Overall Study|Protocol Violation|1|||
156579104|NCT00592683|565206241|FG001|Overall Study|Protocol Violation|0|||
156579105|NCT00592683|565206240|FG000|Overall Study|Study drug expired|1|||
156579106|NCT00592683|565206241|FG001|Overall Study|Study drug expired|0|||
156579107|NCT00592683|565206240|FG000|Overall Study|Other|1|||
156579108|NCT00592683|565206241|FG001|Overall Study|Other|0|||
156579109|NCT00592683|565206240|FG000|Overall Study|Lost to Follow-up|0|||
156579110|NCT00592683|565206241|FG001|Overall Study|Lost to Follow-up|1|||
156579111|NCT00201201|565206242|FG000|Overall Study|Death|0|||
156579112|NCT00201201|565206243|FG001|Overall Study|Death|2|||
156579113|NCT00201201|565206242|FG000|Overall Study|Withdrawal by Subject|5|||
156579114|NCT00201201|565206243|FG001|Overall Study|Withdrawal by Subject|5|||
156579115|NCT00545818|565206249|FG000|Overall Study|Protocol Violation|1|||
156579116|NCT00545818|565206250|FG001|Overall Study|Protocol Violation|0|||
156579117|NCT00545818|565206249|FG000|Overall Study|Adverse Event|1|||
156579118|NCT00545818|565206250|FG001|Overall Study|Adverse Event|1|||
156579119|NCT00545818|565206249|FG000|Overall Study|Lost to Follow-up|1|||
156579120|NCT00545818|565206250|FG001|Overall Study|Lost to Follow-up|6|||
156579121|NCT00670111|565206251|FG000|Enrollment to One Month|Testing Failure|0|||
156579122|NCT00670111|565206252|FG001|Enrollment to One Month|Testing Failure|0|||
156579123|NCT00670111|565206253|FG002|Enrollment to One Month|Testing Failure|13|||
156579124|NCT00670111|565206251|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
156579125|NCT00670111|565206252|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
156579126|NCT00670111|565206253|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
156579127|NCT00670111|565206251|FG000|Enrollment to One Month|Physician Decision|1|||
156579128|NCT00670111|565206252|FG001|Enrollment to One Month|Physician Decision|0|||
156579129|NCT00670111|565206253|FG002|Enrollment to One Month|Physician Decision|0|||
156579130|NCT02623361|565206254|FG000|Overall Study|Protocol Violation|0|||
156579131|NCT02623361|565206255|FG001|Overall Study|Protocol Violation|1|||
156579132|NCT02623361|565206254|FG000|Overall Study|Withdrawal by Subject|0|||
156579133|NCT02623361|565206255|FG001|Overall Study|Withdrawal by Subject|1|||
156579134|NCT02441803|565206258|FG000|Overall Study|Physician Decision|0|||
156579135|NCT02441803|565206259|FG001|Overall Study|Physician Decision|2|||
156579136|NCT02441803|565206260|FG002|Overall Study|Physician Decision|2|||
156579137|NCT00537823|565206261|FG000|Overall Study|Adverse Event|2|||
156579138|NCT00537823|565206262|FG001|Overall Study|Adverse Event|0|||
156579139|NCT02873221|565206263|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
156579140|NCT02873221|565206264|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
156579141|NCT02873221|565206265|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
156579142|NCT02873221|565206263|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
156579143|NCT02873221|565206264|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
156579144|NCT02873221|565206265|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
156579145|NCT02873221|565206263|FG000|Treatment Period|Protocol Violation|2|||
156579146|NCT02873221|565206264|FG001|Treatment Period|Protocol Violation|5|||
156579147|NCT02873221|565206265|FG002|Treatment Period|Protocol Violation|8|||
156579148|NCT02873221|565206263|FG000|Treatment Period|Pregnancy|4|||
156579149|NCT02873221|565206264|FG001|Treatment Period|Pregnancy|6|||
156579150|NCT02873221|565206265|FG002|Treatment Period|Pregnancy|3|||
156579151|NCT02873221|565206263|FG000|Treatment Period|Lack of Qualifying Event|0|||
156579152|NCT02873221|565206264|FG001|Treatment Period|Lack of Qualifying Event|3|||
156579153|NCT02873221|565206265|FG002|Treatment Period|Lack of Qualifying Event|1|||
156579154|NCT02873221|565206263|FG000|Treatment Period|Withdrawal of Consent|52|||
156579155|NCT02873221|565206264|FG001|Treatment Period|Withdrawal of Consent|51|||
156579156|NCT02873221|565206265|FG002|Treatment Period|Withdrawal of Consent|41|||
156579157|NCT02873221|565206263|FG000|Treatment Period|Lack of Efficacy|0|||
156579158|NCT02873221|565206264|FG001|Treatment Period|Lack of Efficacy|17|||
156579159|NCT02873221|565206265|FG002|Treatment Period|Lack of Efficacy|12|||
156579160|NCT02873221|565206263|FG000|Treatment Period|Adverse Event|4|||
156579161|NCT02873221|565206264|FG001|Treatment Period|Adverse Event|9|||
156579162|NCT02873221|565206265|FG002|Treatment Period|Adverse Event|11|||
156579163|NCT02873221|565206263|FG000|Treatment Period|Lost to Follow-up|26|||
156579164|NCT02873221|565206264|FG001|Treatment Period|Lost to Follow-up|30|||
156579165|NCT02873221|565206265|FG002|Treatment Period|Lost to Follow-up|26|||
156579166|NCT02873221|565206263|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
156579167|NCT02873221|565206264|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
156579168|NCT02873221|565206265|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
156579169|NCT02873221|565206263|FG000|Safety Follow-up Period|Protocol Violation|0|||
156579170|NCT02873221|565206264|FG001|Safety Follow-up Period|Protocol Violation|0|||
156579171|NCT02873221|565206265|FG002|Safety Follow-up Period|Protocol Violation|1|||
156579172|NCT02873221|565206263|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
156579173|NCT02873221|565206264|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
156579174|NCT02873221|565206265|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
156579175|NCT02873221|565206263|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
156579176|NCT02873221|565206264|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
156579177|NCT02873221|565206265|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
156579178|NCT01325493|565206266|FG000|Overall Study|Protocol Violation|0|||
156579179|NCT01325493|565206267|FG001|Overall Study|Protocol Violation|1|||
156579180|NCT01325493|565206266|FG000|Overall Study|loss of neuromonitoring signals|0|||
156579181|NCT01325493|565206267|FG001|Overall Study|loss of neuromonitoring signals|2|||
156579182|NCT01325493|565206266|FG000|Overall Study|Allergy|1|||
156579183|NCT01325493|565206267|FG001|Overall Study|Allergy|0|||
156579184|NCT02240628|565206268|FG000|Overall Study|Physician Decision|6|||
156579185|NCT02240628|565206269|FG001|Overall Study|Physician Decision|5|||
156579186|NCT01749735|565206270|FG000|Overall Study|Withdrawal by Subject|1|||
156579187|NCT01749735|565206271|FG001|Overall Study|Withdrawal by Subject|0|||
156579188|NCT02732912|565206272|FG000|Overall Study|Discharged before night|2|||
156579189|NCT02732912|565206273|FG001|Overall Study|Discharged before night|6|||
156579190|NCT02732912|565206272|FG000|Overall Study|Incomplete completion of questionnaire|2|||
156579191|NCT02732912|565206273|FG001|Overall Study|Incomplete completion of questionnaire|3|||
156579192|NCT02732912|565206272|FG000|Overall Study|No outcome; discharged or refused|6|||
156579193|NCT02732912|565206273|FG001|Overall Study|No outcome; discharged or refused|9|||
156579194|NCT01873742|565206274|FG000|Overall Study|Lost to Follow-up|68|||
156579195|NCT01873742|565206275|FG001|Overall Study|Lost to Follow-up|76|||
156579196|NCT02498821|565206276|FG000|Overall Study|Screen failure|3|||
156579197|NCT02498821|565206277|FG001|Overall Study|Screen failure|5|||
156579198|NCT02285010|565206278|FG000|Overall Study|not abdominal hysterectomy|2|||
156579199|NCT02285010|565206279|FG001|Overall Study|not abdominal hysterectomy|0|||
156579200|NCT02285010|565206278|FG000|Overall Study|Not spinal anesthesia|3|||
156579201|NCT02285010|565206279|FG001|Overall Study|Not spinal anesthesia|1|||
156579202|NCT01457339|565206286|FG000|Period 3 (100 mg)|Adverse Event|0|||
156579203|NCT01457339|565206287|FG001|Period 3 (100 mg)|Adverse Event|1|||
156579204|NCT01457339|565206286|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
156579205|NCT01457339|565206287|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
156579206|NCT01457339|565206286|FG000|Period 6 (250 mg)|Family Emergency|1|||
156579207|NCT01457339|565206287|FG001|Period 6 (250 mg)|Family Emergency|0|||
156579208|NCT01457339|565206286|FG000|Period 6 (250 mg)|Personal appointment|0|||
156579209|NCT01457339|565206287|FG001|Period 6 (250 mg)|Personal appointment|1|||
156579210|NCT01164501|565206289|FG000|Overall Study|Not treated|2|||
156579211|NCT01164501|565206290|FG001|Overall Study|Not treated|0|||
156579212|NCT01164501|565206291|FG002|Overall Study|Not treated|1|||
156579213|NCT01164501|565206289|FG000|Overall Study|Adverse Event|18|||
156579214|NCT01164501|565206290|FG001|Overall Study|Adverse Event|4|||
156579215|NCT01164501|565206291|FG002|Overall Study|Adverse Event|21|||
156579216|NCT01164501|565206289|FG000|Overall Study|Lack of Efficacy|0|||
156579217|NCT01164501|565206290|FG001|Overall Study|Lack of Efficacy|0|||
156579218|NCT01164501|565206291|FG002|Overall Study|Lack of Efficacy|1|||
156579219|NCT01164501|565206289|FG000|Overall Study|Non compliant with protocol|1|||
156579220|NCT01164501|565206290|FG001|Overall Study|Non compliant with protocol|1|||
156579221|NCT01164501|565206291|FG002|Overall Study|Non compliant with protocol|4|||
156579222|NCT01164501|565206289|FG000|Overall Study|Lost to Follow-up|3|||
156579223|NCT01164501|565206290|FG001|Overall Study|Lost to Follow-up|0|||
156579224|NCT01164501|565206291|FG002|Overall Study|Lost to Follow-up|3|||
156579225|NCT01164501|565206289|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
156579226|NCT01164501|565206290|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
156579227|NCT01164501|565206291|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
156579228|NCT01164501|565206289|FG000|Overall Study|Other reason not defined above|9|||
156579229|NCT01164501|565206290|FG001|Overall Study|Other reason not defined above|1|||
156579230|NCT01164501|565206291|FG002|Overall Study|Other reason not defined above|4|||
156579231|NCT01845077|565206292|FG000|Washout Period|Lost to Follow-up|0|||
156579232|NCT01845077|565206293|FG001|Washout Period|Lost to Follow-up|1|||
156579233|NCT01845077|565206294|FG002|Washout Period|Lost to Follow-up|0|||
156579234|NCT01845077|565206295|FG003|Washout Period|Lost to Follow-up|1|||
156579235|NCT01845077|565206296|FG004|Washout Period|Lost to Follow-up|0|||
156579236|NCT01845077|565206297|FG005|Washout Period|Lost to Follow-up|1|||
156579237|NCT01845077|565206292|FG000|Washout Period|Adverse Event|1|||
156579238|NCT01845077|565206293|FG001|Washout Period|Adverse Event|0|||
156579239|NCT01845077|565206294|FG002|Washout Period|Adverse Event|0|||
156579240|NCT01845077|565206295|FG003|Washout Period|Adverse Event|0|||
156579241|NCT01845077|565206296|FG004|Washout Period|Adverse Event|0|||
156579242|NCT01845077|565206297|FG005|Washout Period|Adverse Event|0|||
156579243|NCT01845077|565206292|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
156579244|NCT01845077|565206293|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
156579245|NCT01845077|565206294|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
156579246|NCT01845077|565206295|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
156579247|NCT01845077|565206296|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
156579248|NCT01845077|565206297|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
156579249|NCT01845077|565206292|FG000|Washout Period|Protocol Violation|0|||
156579250|NCT01845077|565206293|FG001|Washout Period|Protocol Violation|0|||
156579251|NCT01845077|565206294|FG002|Washout Period|Protocol Violation|0|||
156579252|NCT01845077|565206295|FG003|Washout Period|Protocol Violation|1|||
156579253|NCT01845077|565206296|FG004|Washout Period|Protocol Violation|1|||
156579254|NCT01845077|565206297|FG005|Washout Period|Protocol Violation|0|||
156579255|NCT00312377|565206299|FG000|Overall Study|Death|403|||
156579256|NCT00312377|565206300|FG001|Overall Study|Death|418|||
156579257|NCT00312377|565206299|FG000|Overall Study|Withdrawal by Subject|23|||
156579258|NCT00312377|565206300|FG001|Overall Study|Withdrawal by Subject|30|||
156579259|NCT00312377|565206299|FG000|Overall Study|Lost to Follow-up|9|||
156579260|NCT00312377|565206300|FG001|Overall Study|Lost to Follow-up|12|||
156579261|NCT00312377|565206299|FG000|Overall Study|Non-compliance|0|||
156579262|NCT00312377|565206300|FG001|Overall Study|Non-compliance|2|||
156579263|NCT00312377|565206299|FG000|Overall Study|Randomised but never received treatment|6|||
156579264|NCT00312377|565206300|FG001|Overall Study|Randomised but never received treatment|6|||
156579265|NCT00312377|565206299|FG000|Overall Study|Discontinue treatment survival follow up|202|||
156579266|NCT00312377|565206300|FG001|Overall Study|Discontinue treatment survival follow up|200|||
156579267|NCT00312377|565206299|FG000|Overall Study|Site ended participation in study|1|||
156579268|NCT00312377|565206300|FG001|Overall Study|Site ended participation in study|0|||
156579269|NCT05258058|565206301|FG000|Overall Study|Withdrawal by Subject|2|||
156579270|NCT00408681|565206304|FG000|Overall Study|Lack of Efficacy|2|||
156579271|NCT00408681|565206304|FG000|Overall Study|Adverse Event|7|||
156579272|NCT01787591|565206306|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
156579273|NCT01787591|565206307|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
156579274|NCT01787591|565206308|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
156579275|NCT01787591|565206309|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
156579276|NCT02489630|565206312|FG000|Overall Study|Oversedation|1|||
156579277|NCT02489630|565206313|FG001|Overall Study|Oversedation|1|||
156579278|NCT02489630|565206312|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
156579279|NCT02489630|565206313|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
156579280|NCT00815308|565206314|FG000|Overall Study|Adverse Event|4|||
156579281|NCT00815308|565206314|FG000|Overall Study|Withdrawal by Subject|0|||
156579282|NCT00815308|565206314|FG000|Overall Study|Protocol Violation|6|||
156579283|NCT00377299|565206315|FG000|Overall Study|Lost to Follow-up|14|||
156579284|NCT00377299|565206316|FG001|Overall Study|Lost to Follow-up|19|||
156579285|NCT00377299|565206315|FG000|Overall Study|Adverse Event|0|||
156579286|NCT00377299|565206316|FG001|Overall Study|Adverse Event|1|||
156579287|NCT00377299|565206315|FG000|Overall Study|Withdrawal by Subject|5|||
156579288|NCT00377299|565206316|FG001|Overall Study|Withdrawal by Subject|4|||
156579289|NCT02209597|565206317|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
156579290|NCT02209597|565206317|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
156579291|NCT02209597|565206317|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
156579292|NCT02209597|565206317|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
156579293|NCT04799782|565206321|FG000|Washout|Physician Decision|2|||
156579294|NCT04799782|565206322|FG001|Washout|Physician Decision|0|||
156579295|NCT04799782|565206321|FG000|Washout|Withdrawal by Subject|0|||
156579296|NCT04799782|565206322|FG001|Washout|Withdrawal by Subject|2|||
156579297|NCT04799782|565206321|FG000|Washout|Lost to Follow-up|0|||
156579298|NCT04799782|565206322|FG001|Washout|Lost to Follow-up|1|||
156579299|NCT01589094|565206325|FG000|Overall Study|Did not receive treatment|2|||
156579300|NCT02975349|565206326|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156579301|NCT02975349|565206327|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156579302|NCT02975349|565206328|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156579303|NCT02975349|565206329|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
156579304|NCT02975349|565206330|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
156579305|NCT02975349|565206331|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156579306|NCT02975349|565206332|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156579307|NCT02975349|565206326|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156579308|NCT02975349|565206327|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156863638|NCT02285855|566258719|FG001|Overall Study|Withdrawal by Subject|1|||
156863639|NCT00627393|566258730|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
156579309|NCT02975349|565206328|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156579310|NCT02975349|565206329|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156579311|NCT02975349|565206330|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156579312|NCT02975349|565206331|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156579313|NCT02975349|565206332|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156579314|NCT02975349|565206326|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
156579315|NCT02975349|565206327|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
156579316|NCT02975349|565206328|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
156579317|NCT02975349|565206329|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
156579318|NCT02975349|565206330|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
156579319|NCT02975349|565206331|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
156579320|NCT02975349|565206332|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
156579321|NCT02975349|565206326|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
156579322|NCT02975349|565206327|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
156579323|NCT02975349|565206328|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
156579324|NCT02975349|565206329|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
156579325|NCT02975349|565206330|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
156579326|NCT02975349|565206331|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
156579327|NCT02975349|565206332|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
156579328|NCT02975349|565206326|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
156579329|NCT02975349|565206327|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
156579330|NCT02975349|565206328|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
156579331|NCT02975349|565206329|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
156579332|NCT02975349|565206330|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
156579333|NCT02975349|565206331|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
156579334|NCT02975349|565206332|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
156579335|NCT02975349|565206326|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
156579336|NCT02975349|565206327|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
156579337|NCT02975349|565206328|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
156579338|NCT02975349|565206329|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
156579339|NCT02975349|565206330|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
156579340|NCT02975349|565206331|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
156579341|NCT02975349|565206332|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
156579342|NCT02975349|565206326|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
156579343|NCT02975349|565206327|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
156579344|NCT02975349|565206328|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
156579345|NCT02975349|565206329|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
156579346|NCT02975349|565206330|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
156579347|NCT02975349|565206331|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
156579348|NCT02975349|565206332|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
156579349|NCT02975349|565206326|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
156579350|NCT02975349|565206327|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
156579351|NCT02975349|565206328|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
156579352|NCT02975349|565206329|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
156579353|NCT02975349|565206330|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
156579354|NCT02975349|565206331|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
156579355|NCT02975349|565206332|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
156579356|NCT02975349|565206326|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
156579357|NCT02975349|565206327|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
156579358|NCT02975349|565206328|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
156579359|NCT02975349|565206329|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
156579360|NCT02975349|565206330|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
156579361|NCT02975349|565206331|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
156579362|NCT02975349|565206332|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
156579363|NCT02975349|565206326|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
156579364|NCT02975349|565206327|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
156579365|NCT02975349|565206328|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
156579366|NCT02975349|565206329|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
156579367|NCT02975349|565206330|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
156579368|NCT02975349|565206331|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
156579369|NCT02975349|565206332|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
156579370|NCT02975349|565206326|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
156579371|NCT02975349|565206327|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
156579372|NCT02975349|565206328|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
156579373|NCT02975349|565206329|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
156579374|NCT02975349|565206330|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
156579375|NCT02975349|565206331|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
156579376|NCT02975349|565206332|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
156579377|NCT02975349|565206326|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
156579378|NCT02975349|565206327|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
156579379|NCT02975349|565206328|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
156579380|NCT02975349|565206329|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
156579381|NCT02975349|565206330|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
156579382|NCT02975349|565206331|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
156579383|NCT02975349|565206332|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
156579384|NCT02975349|565206326|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
156579385|NCT02975349|565206327|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
156579386|NCT02975349|565206328|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
156579387|NCT02975349|565206329|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
156579388|NCT02975349|565206330|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
156579389|NCT02975349|565206331|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
156579390|NCT02975349|565206332|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
156579391|NCT02975349|565206326|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
156579392|NCT02975349|565206327|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
156579393|NCT02975349|565206328|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
156579394|NCT02975349|565206329|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
156579395|NCT02975349|565206330|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
156579396|NCT02975349|565206331|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
156579397|NCT02975349|565206332|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
156579398|NCT02975349|565206326|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
156579399|NCT02975349|565206327|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
156579400|NCT02975349|565206328|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
156579401|NCT02975349|565206329|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
156579402|NCT02975349|565206330|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
156579403|NCT02975349|565206331|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
156579404|NCT02975349|565206332|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
156579405|NCT00969618|565206338|FG000|Overall Study|Adverse Event|29|||
156579406|NCT00969618|565206338|FG000|Overall Study|Entry Criteria Not Met|3|||
156579407|NCT00969618|565206338|FG000|Overall Study|Lack of Efficacy|2|||
156579408|NCT00969618|565206338|FG000|Overall Study|Lost to Follow-up|7|||
156579409|NCT00969618|565206338|FG000|Overall Study|Physician Decision|1|||
156579410|NCT00969618|565206338|FG000|Overall Study|Protocol Violation|9|||
156579411|NCT00969618|565206338|FG000|Overall Study|Withdrawal by Subject|27|||
156579412|NCT00907738|565206341|FG000|Overall Study|Adverse Event|2|||
156579413|NCT00907738|565206342|FG001|Overall Study|Adverse Event|0|||
156579414|NCT00907738|565206343|FG002|Overall Study|Adverse Event|1|||
156579415|NCT00907738|565206344|FG003|Overall Study|Adverse Event|0|||
156579416|NCT00907738|565206345|FG004|Overall Study|Adverse Event|0|||
156579417|NCT00907738|565206341|FG000|Overall Study|not specified or withdrew consent|3|||
156579418|NCT00907738|565206342|FG001|Overall Study|not specified or withdrew consent|0|||
156579419|NCT00907738|565206343|FG002|Overall Study|not specified or withdrew consent|0|||
156579420|NCT00907738|565206344|FG003|Overall Study|not specified or withdrew consent|0|||
156579421|NCT00907738|565206345|FG004|Overall Study|not specified or withdrew consent|0|||
156579422|NCT00907738|565206341|FG000|Overall Study|Disease progression|8|||
156579423|NCT00907738|565206342|FG001|Overall Study|Disease progression|1|||
156579424|NCT00907738|565206343|FG002|Overall Study|Disease progression|6|||
156579425|NCT00907738|565206344|FG003|Overall Study|Disease progression|4|||
156579426|NCT00907738|565206345|FG004|Overall Study|Disease progression|2|||
156579427|NCT05363293|565206346|FG000|Overall Study|Withdrawal by Subject|1|||
156579428|NCT05363293|565206347|FG001|Overall Study|Withdrawal by Subject|0|||
156579429|NCT05363293|565206348|FG002|Overall Study|Withdrawal by Subject|0|||
156579430|NCT05363293|565206349|FG003|Overall Study|Withdrawal by Subject|0|||
156579431|NCT05363293|565206350|FG004|Overall Study|Withdrawal by Subject|0|||
156579432|NCT05363293|565206351|FG005|Overall Study|Withdrawal by Subject|0|||
156579433|NCT05363293|565206352|FG006|Overall Study|Withdrawal by Subject|0|||
156579434|NCT05363293|565206353|FG007|Overall Study|Withdrawal by Subject|0|||
156579435|NCT05363293|565206354|FG008|Overall Study|Withdrawal by Subject|0|||
156579436|NCT05363293|565206355|FG009|Overall Study|Withdrawal by Subject|0|||
156579437|NCT04773041|565206356|FG000|Overall Study|Unable to data match|1|||
156579438|NCT04773041|565206357|FG001|Overall Study|Unable to data match|0|||
156579439|NCT04773041|565206358|FG002|Overall Study|Unable to data match|0|||
156634712|NCT03426995|565407776|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634713|NCT03426995|565407777|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634714|NCT03426995|565407778|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156863640|NCT00627393|566258731|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
156634715|NCT03426995|565407779|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156579440|NCT01988012|565208317|FG000|Overall Study|Adverse Event|5|||
156579441|NCT01988012|565208317|FG000|Overall Study|Insufficient Therapeutic Response|3|||
156579442|NCT01988012|565208317|FG000|Overall Study|Patient Withdrawal of Consent|4|||
156579443|NCT01988012|565208317|FG000|Overall Study|Lost to Follow-up|1|||
156579444|NCT01988012|565208317|FG000|Overall Study|Physician Decision|1|||
156579445|NCT01988012|565208317|FG000|Overall Study|Protocol Violation|1|||
156579446|NCT00521339|565208318|FG000|Treatment Phase|Adverse Event|2|||
156579447|NCT00521339|565208319|FG001|Treatment Phase|Adverse Event|0|||
156579448|NCT00521339|565208320|FG002|Treatment Phase|Adverse Event|0|||
156579449|NCT00521339|565208318|FG000|Treatment Phase|Intolerability to study drug|2|||
156579450|NCT00521339|565208319|FG001|Treatment Phase|Intolerability to study drug|0|||
156579451|NCT00521339|565208320|FG002|Treatment Phase|Intolerability to study drug|0|||
156579452|NCT00521339|565208318|FG000|Treatment Phase|Lack of Efficacy|3|||
156579453|NCT00521339|565208319|FG001|Treatment Phase|Lack of Efficacy|0|||
156579454|NCT00521339|565208320|FG002|Treatment Phase|Lack of Efficacy|0|||
156579455|NCT00521339|565208318|FG000|Treatment Phase|Withdrawal by Subject|3|||
156579456|NCT00521339|565208319|FG001|Treatment Phase|Withdrawal by Subject|0|||
156579457|NCT00521339|565208320|FG002|Treatment Phase|Withdrawal by Subject|0|||
156579458|NCT00521339|565208318|FG000|Treatment Phase|Lost to Follow-up|1|||
156579459|NCT00521339|565208319|FG001|Treatment Phase|Lost to Follow-up|0|||
156579460|NCT00521339|565208320|FG002|Treatment Phase|Lost to Follow-up|0|||
156579461|NCT00521339|565208318|FG000|Treatment Phase|Protocol Violation|1|||
156579462|NCT00521339|565208319|FG001|Treatment Phase|Protocol Violation|0|||
156579463|NCT00521339|565208320|FG002|Treatment Phase|Protocol Violation|0|||
156579464|NCT00521339|565208318|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
156579465|NCT00521339|565208319|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
156579466|NCT00521339|565208320|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
156579467|NCT00521339|565208318|FG000|Treatment Extension Phase|Death|0|||
156579468|NCT00521339|565208319|FG001|Treatment Extension Phase|Death|0|||
156579469|NCT00521339|565208320|FG002|Treatment Extension Phase|Death|1|||
156579470|NCT01058369|565208321|FG000|Overall Study|Adverse Event|1|||
156579471|NCT01058369|565208321|FG000|Overall Study|Early termination study|1|||
156579472|NCT03314519|565208322|FG000|Overall Study|Protocol Violation|3|||
156579473|NCT03314519|565208323|FG001|Overall Study|Protocol Violation|2|||
156579474|NCT01157169|565208326|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
156579475|NCT01157169|565208327|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
156579476|NCT01157169|565208326|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
156579477|NCT01157169|565208327|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
156579478|NCT00663858|565208330|FG000|Overall Study|Adverse Event|9|||
156579479|NCT00663858|565208331|FG001|Overall Study|Adverse Event|1|||
156579480|NCT00663858|565208332|FG002|Overall Study|Adverse Event|6|||
156579481|NCT00663858|565208330|FG000|Overall Study|Lack of Efficacy|5|||
156579482|NCT00663858|565208331|FG001|Overall Study|Lack of Efficacy|1|||
156579483|NCT00663858|565208332|FG002|Overall Study|Lack of Efficacy|3|||
156579484|NCT00663858|565208330|FG000|Overall Study|Withdrawal by Subject|7|||
156579485|NCT00663858|565208331|FG001|Overall Study|Withdrawal by Subject|3|||
156579486|NCT00663858|565208332|FG002|Overall Study|Withdrawal by Subject|3|||
156579487|NCT00663858|565208330|FG000|Overall Study|Protocol Violation|5|||
156579488|NCT00663858|565208331|FG001|Overall Study|Protocol Violation|3|||
156579489|NCT00663858|565208332|FG002|Overall Study|Protocol Violation|4|||
156579490|NCT00663858|565208330|FG000|Overall Study|Other|8|||
156579491|NCT00663858|565208331|FG001|Overall Study|Other|2|||
156579492|NCT00663858|565208332|FG002|Overall Study|Other|4|||
156579493|NCT02940886|565208333|FG000|Overall Study|Adverse Event|7|||
156579494|NCT02940886|565208334|FG001|Overall Study|Adverse Event|3|||
156579495|NCT02940886|565208333|FG000|Overall Study|Protocol Violation|0|||
156579496|NCT02940886|565208334|FG001|Overall Study|Protocol Violation|2|||
156579497|NCT02940886|565208333|FG000|Overall Study|Withdrawal by Subject|28|||
156579498|NCT02940886|565208334|FG001|Overall Study|Withdrawal by Subject|20|||
156579499|NCT02940886|565208333|FG000|Overall Study|Death|1|||
156579500|NCT02940886|565208334|FG001|Overall Study|Death|0|||
156579501|NCT02940886|565208333|FG000|Overall Study|Lack of Efficacy|1|||
156579502|NCT02940886|565208334|FG001|Overall Study|Lack of Efficacy|0|||
156579503|NCT02940886|565208333|FG000|Overall Study|Lost to Follow-up|49|||
156579504|NCT02940886|565208334|FG001|Overall Study|Lost to Follow-up|21|||
156579505|NCT02940886|565208333|FG000|Overall Study|Physician Decision|9|||
156579506|NCT02940886|565208334|FG001|Overall Study|Physician Decision|4|||
156579507|NCT02940886|565208333|FG000|Overall Study|Sponsor decision|0|||
156579508|NCT02940886|565208334|FG001|Overall Study|Sponsor decision|1|||
156579509|NCT02940886|565208333|FG000|Overall Study|No treatment|7|||
156579510|NCT02940886|565208334|FG001|Overall Study|No treatment|2|||
156579511|NCT02940886|565208333|FG000|Overall Study|Enrolment error|0|||
156579512|NCT02940886|565208334|FG001|Overall Study|Enrolment error|1|||
156579513|NCT03042611|565208335|FG000|Core Phase|Withdrawal by Subject|13|||
156579514|NCT03042611|565208336|FG001|Core Phase|Withdrawal by Subject|4|||
156579515|NCT03042611|565208337|FG002|Core Phase|Withdrawal by Subject|0|||
156579516|NCT03042611|565208338|FG003|Core Phase|Withdrawal by Subject|0|||
156579517|NCT03042611|565208335|FG000|Core Phase|Death|232|||
156579518|NCT03042611|565208336|FG001|Core Phase|Death|110|||
156579519|NCT03042611|565208337|FG002|Core Phase|Death|0|||
156579520|NCT03042611|565208338|FG003|Core Phase|Death|0|||
156579521|NCT03042611|565208335|FG000|Core Phase|Lost to Follow-up|4|||
156579522|NCT03042611|565208336|FG001|Core Phase|Lost to Follow-up|7|||
156579523|NCT03042611|565208337|FG002|Core Phase|Lost to Follow-up|0|||
156579524|NCT03042611|565208338|FG003|Core Phase|Lost to Follow-up|0|||
156579525|NCT03042611|565208335|FG000|Core Phase|Physician Decision|7|||
156579526|NCT03042611|565208336|FG001|Core Phase|Physician Decision|2|||
156579527|NCT03042611|565208337|FG002|Core Phase|Physician Decision|0|||
156579528|NCT03042611|565208338|FG003|Core Phase|Physician Decision|0|||
156579529|NCT03042611|565208335|FG000|Core Phase|Study Closed|0|||
156579530|NCT03042611|565208336|FG001|Core Phase|Study Closed|1|||
156579531|NCT03042611|565208337|FG002|Core Phase|Study Closed|0|||
156579532|NCT03042611|565208338|FG003|Core Phase|Study Closed|0|||
156579533|NCT03042611|565208335|FG000|Extension Phase|Death|0|||
156579534|NCT03042611|565208336|FG001|Extension Phase|Death|0|||
156579535|NCT03042611|565208337|FG002|Extension Phase|Death|34|||
156579536|NCT03042611|565208338|FG003|Extension Phase|Death|16|||
156579537|NCT03042611|565208335|FG000|Extension Phase|Lost to Follow-up|0|||
156579538|NCT03042611|565208336|FG001|Extension Phase|Lost to Follow-up|0|||
156579539|NCT03042611|565208337|FG002|Extension Phase|Lost to Follow-up|1|||
156579540|NCT03042611|565208338|FG003|Extension Phase|Lost to Follow-up|1|||
156579541|NCT03042611|565208335|FG000|Extension Phase|Study Closed|0|||
156579542|NCT03042611|565208336|FG001|Extension Phase|Study Closed|0|||
156579543|NCT03042611|565208337|FG002|Extension Phase|Study Closed|17|||
156579544|NCT03042611|565208338|FG003|Extension Phase|Study Closed|11|||
156579545|NCT01277289|565208340|FG000|Overall Study|fragile vein|1|||
156579546|NCT01277289|565208341|FG001|Overall Study|fragile vein|0|||
156579547|NCT01277289|565208340|FG000|Overall Study|Physician Decision|1|||
156579548|NCT01277289|565208341|FG001|Overall Study|Physician Decision|0|||
156579549|NCT01277289|565208340|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
156579550|NCT01277289|565208341|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
156579551|NCT01277289|565208340|FG000|Overall Study|Protocol Violation|1|||
156579552|NCT01277289|565208341|FG001|Overall Study|Protocol Violation|1|||
156579553|NCT01277289|565208340|FG000|Overall Study|Adverse Event|2|||
156579554|NCT01277289|565208341|FG001|Overall Study|Adverse Event|1|||
156579555|NCT01277289|565208340|FG000|Overall Study|consent withdrawn|1|||
156579556|NCT01277289|565208341|FG001|Overall Study|consent withdrawn|1|||
156579557|NCT01277289|565208340|FG000|Overall Study|premature closure of the study|4|||
156579558|NCT01277289|565208341|FG001|Overall Study|premature closure of the study|2|||
156579559|NCT01666444|565208342|FG000|Overall Study|Did not initiate treatment|2|||
156579560|NCT01666444|565208343|FG001|Overall Study|Did not initiate treatment|1|||
156579561|NCT00950690|565208344|FG000|Overall Study|Death|4|||
156579562|NCT00950690|565208344|FG000|Overall Study|Adverse Event|15|||
156579563|NCT00950690|565208344|FG000|Overall Study|Lack of Efficacy|22|||
156579564|NCT00950690|565208344|FG000|Overall Study|Lost to Follow-up|40|||
156579565|NCT00950690|565208344|FG000|Overall Study|Other|163|||
156579566|NCT01713036|565208349|FG000|Overall Study|Death|1|||
156579567|NCT00592358|565208350|FG000|Overall Study|Withdrawal by Subject|2|||
156579568|NCT00592358|565208350|FG000|Overall Study|Adverse Event|1|||
156579569|NCT00592358|565208350|FG000|Overall Study|Lack of Efficacy|2|||
156579570|NCT00592358|565208350|FG000|Overall Study|Inability to swallow pills|1|||
156579571|NCT00092547|565208351|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
156579572|NCT00092547|565208352|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
156579573|NCT00092547|565208353|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
156579574|NCT00092547|565208351|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
156579575|NCT00092547|565208352|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
156579576|NCT00092547|565208353|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
156579577|NCT00092547|565208351|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
156579578|NCT00092547|565208352|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
156579579|NCT00092547|565208353|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
156579580|NCT00092547|565208351|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
156579581|NCT00092547|565208352|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
156579582|NCT00092547|565208353|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
156579583|NCT00092547|565208351|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
156579584|NCT00092547|565208352|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
156579585|NCT00092547|565208353|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
156579586|NCT00092547|565208351|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
156579587|NCT00092547|565208352|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
156579588|NCT00092547|565208353|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
156579589|NCT00092547|565208351|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
156579590|NCT00092547|565208352|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
156579591|NCT00092547|565208353|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
156579592|NCT00092547|565208351|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
156579593|NCT00092547|565208352|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
156579594|NCT00092547|565208353|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
156579595|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
156579596|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
156579597|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
156579598|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
156579599|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
156579600|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
156579601|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
156579602|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
156579603|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
156579604|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
156579605|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
156579606|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
156579607|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
156579608|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
156579609|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
156579610|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
156579611|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
156579612|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
156579613|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
156579614|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
156579615|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
156579616|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
156579617|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
156579618|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
156579619|NCT00092547|565208351|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
156579620|NCT00092547|565208352|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
156579621|NCT00092547|565208353|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
156579622|NCT00092547|565208351|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
156579623|NCT00092547|565208352|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
156579624|NCT00092547|565208353|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
156579625|NCT00092547|565208351|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
156579626|NCT00092547|565208352|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
156579627|NCT00092547|565208353|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
156579628|NCT00092547|565208351|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
156579629|NCT00092547|565208352|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
156579630|NCT00092547|565208353|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
156579631|NCT00092547|565208351|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
156579632|NCT00092547|565208352|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
156579633|NCT00092547|565208353|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
156579634|NCT00084682|565208354|FG000|Overall Study|Withdrawal by Subject|1|||
156579635|NCT01166659|565208355|FG000|Overall Study|Subject Decision|8|||
156579636|NCT01166659|565208355|FG000|Overall Study|Investigator Decision|2|||
156579637|NCT01166659|565208355|FG000|Overall Study|Death|1|||
156579638|NCT01166659|565208355|FG000|Overall Study|Lost to Follow-up|1|||
156579639|NCT01166659|565208355|FG000|Overall Study|Study Closed at Site|1|||
156579640|NCT00634543|565208363|FG000|Overall Study|Other|1|||
156579641|NCT00634543|565208364|FG001|Overall Study|Other|2|||
156579642|NCT00634543|565208363|FG000|Overall Study|Protocol Violation|3|||
156579643|NCT00634543|565208364|FG001|Overall Study|Protocol Violation|3|||
156579644|NCT00634543|565208363|FG000|Overall Study|Adverse Event|11|||
156579645|NCT00634543|565208364|FG001|Overall Study|Adverse Event|11|||
156579646|NCT00634543|565208363|FG000|Overall Study|Withdrawal by Subject|4|||
156579647|NCT00634543|565208364|FG001|Overall Study|Withdrawal by Subject|4|||
156579648|NCT00634543|565208363|FG000|Overall Study|Lost to Follow-up|0|||
156579649|NCT00634543|565208364|FG001|Overall Study|Lost to Follow-up|1|||
156579650|NCT01371838|565208365|FG000|Overall Study|Withdrawal by Subject|27|||
156579651|NCT01371838|565208366|FG001|Overall Study|Withdrawal by Subject|33|||
156579652|NCT01371838|565208365|FG000|Overall Study|Lost to Follow-up|10|||
156579653|NCT01371838|565208366|FG001|Overall Study|Lost to Follow-up|20|||
156579654|NCT01371838|565208365|FG000|Overall Study|Death|3|||
156579655|NCT01371838|565208366|FG001|Overall Study|Death|4|||
156579656|NCT01371838|565208365|FG000|Overall Study|Protocol Violation|3|||
156579657|NCT01371838|565208366|FG001|Overall Study|Protocol Violation|0|||
156579658|NCT01371838|565208365|FG000|Overall Study|Investigator Decision|3|||
156579659|NCT01371838|565208366|FG001|Overall Study|Investigator Decision|8|||
156579660|NCT01371838|565208365|FG000|Overall Study|Last follow-up visit not conducted|2|||
156579661|NCT01371838|565208366|FG001|Overall Study|Last follow-up visit not conducted|0|||
156579662|NCT01371838|565208365|FG000|Overall Study|Lack of therapeutic response|0|||
156579663|NCT01371838|565208366|FG001|Overall Study|Lack of therapeutic response|1|||
156579664|NCT01371838|565208365|FG000|Overall Study|Surgery|1|||
156579665|NCT01371838|565208366|FG001|Overall Study|Surgery|0|||
156579666|NCT00641043|565208373|FG000|Overall Study|Adverse Event|6|||
156579667|NCT00641043|565208374|FG001|Overall Study|Adverse Event|4|||
156579668|NCT00641043|565208373|FG000|Overall Study|Protocol Violation|2|||
156579669|NCT00641043|565208374|FG001|Overall Study|Protocol Violation|3|||
156579670|NCT00641043|565208373|FG000|Overall Study|Lost to Follow-up|3|||
156579671|NCT00641043|565208374|FG001|Overall Study|Lost to Follow-up|2|||
156579672|NCT00641043|565208373|FG000|Overall Study|Withdrawal by Subject|4|||
156579673|NCT00641043|565208374|FG001|Overall Study|Withdrawal by Subject|4|||
156579674|NCT00641043|565208373|FG000|Overall Study|Other incl. lack of efficacy|4|||
156579675|NCT00641043|565208374|FG001|Overall Study|Other incl. lack of efficacy|2|||
156579676|NCT00474630|565208377|FG000|Overall Study|Adverse Event|98|||
156579677|NCT00474630|565208378|FG001|Overall Study|Adverse Event|26|||
156579678|NCT00474630|565208377|FG000|Overall Study|Lost to Follow-up|22|||
156579679|NCT00474630|565208378|FG001|Overall Study|Lost to Follow-up|15|||
156579680|NCT00474630|565208377|FG000|Overall Study|Withdrawal by Subject|21|||
156579681|NCT00474630|565208378|FG001|Overall Study|Withdrawal by Subject|15|||
156579682|NCT00474630|565208377|FG000|Overall Study|Protocol Violation|3|||
156579683|NCT00474630|565208378|FG001|Overall Study|Protocol Violation|4|||
156579684|NCT00474630|565208377|FG000|Overall Study|Lack of Efficacy|5|||
156579685|NCT00474630|565208378|FG001|Overall Study|Lack of Efficacy|6|||
156579686|NCT00474630|565208377|FG000|Overall Study|Drug noncompliance, other|11|||
156579687|NCT00474630|565208378|FG001|Overall Study|Drug noncompliance, other|4|||
156579688|NCT03515538|565208379|FG000|Overall Study|Lack of Efficacy|2|||
156579689|NCT03515538|565208380|FG001|Overall Study|Lack of Efficacy|0|||
156579690|NCT03515538|565208381|FG002|Overall Study|Lack of Efficacy|2|||
156579691|NCT03515538|565208382|FG003|Overall Study|Lack of Efficacy|0|||
156579692|NCT03515538|565208379|FG000|Overall Study|Death|0|||
156579693|NCT03515538|565208380|FG001|Overall Study|Death|0|||
156579694|NCT03515538|565208381|FG002|Overall Study|Death|1|||
156579695|NCT03515538|565208382|FG003|Overall Study|Death|0|||
156579696|NCT03515538|565208379|FG000|Overall Study|Protocol Violation|0|||
156579697|NCT03515538|565208380|FG001|Overall Study|Protocol Violation|0|||
156579698|NCT03515538|565208381|FG002|Overall Study|Protocol Violation|0|||
156579699|NCT03515538|565208382|FG003|Overall Study|Protocol Violation|1|||
156579700|NCT03515538|565208379|FG000|Overall Study|Screen failure (baseline dropout)|0|||
156579701|NCT03515538|565208380|FG001|Overall Study|Screen failure (baseline dropout)|1|||
156579702|NCT03515538|565208381|FG002|Overall Study|Screen failure (baseline dropout)|0|||
156579703|NCT03515538|565208382|FG003|Overall Study|Screen failure (baseline dropout)|0|||
156579704|NCT03515538|565208379|FG000|Overall Study|Withdrawal by Subject|2|||
156579705|NCT03515538|565208380|FG001|Overall Study|Withdrawal by Subject|2|||
156579706|NCT03515538|565208381|FG002|Overall Study|Withdrawal by Subject|1|||
156579707|NCT03515538|565208382|FG003|Overall Study|Withdrawal by Subject|3|||
156579708|NCT03515538|565208379|FG000|Overall Study|Physician Decision|1|||
156579709|NCT03515538|565208380|FG001|Overall Study|Physician Decision|0|||
156579710|NCT03515538|565208381|FG002|Overall Study|Physician Decision|0|||
156579711|NCT03515538|565208382|FG003|Overall Study|Physician Decision|1|||
156579712|NCT03088605|565208385|FG000|Overall Study|Withdrawal by Subject|1|||
156579713|NCT03088605|565208386|FG001|Overall Study|Withdrawal by Subject|0|||
156579714|NCT02225223|565208392|FG000|Overall Study|Death|10|||
156579715|NCT02225223|565208393|FG001|Overall Study|Death|1|||
156579716|NCT02225223|565208392|FG000|Overall Study|Lost to Follow-up|5|||
156579717|NCT02225223|565208393|FG001|Overall Study|Lost to Follow-up|0|||
156579718|NCT02225223|565208392|FG000|Overall Study|Other|1|||
156579719|NCT02225223|565208393|FG001|Overall Study|Other|2|||
156579720|NCT02225223|565208392|FG000|Overall Study|Physician Decision|1|||
156579721|NCT02225223|565208393|FG001|Overall Study|Physician Decision|0|||
156579722|NCT02225223|565208392|FG000|Overall Study|Withdrawal by Subject|2|||
156579723|NCT02225223|565208393|FG001|Overall Study|Withdrawal by Subject|2|||
156579724|NCT01650779|565208394|FG000|Overall Study|Withdrawal by Subject|1|||
156579725|NCT03567291|565208395|FG000|Period I|Adverse Event|14|||
156579726|NCT03567291|565208396|FG001|Period I|Adverse Event|0|||
156579727|NCT03567291|565208397|FG002|Period I|Adverse Event|0|||
156579728|NCT03567291|565208398|FG003|Period I|Adverse Event|0|||
156579729|NCT03567291|565208395|FG000|Period I|Protocol Violation|1|||
156579730|NCT03567291|565208396|FG001|Period I|Protocol Violation|0|||
156579731|NCT03567291|565208397|FG002|Period I|Protocol Violation|0|||
156579732|NCT03567291|565208398|FG003|Period I|Protocol Violation|0|||
156579733|NCT03567291|565208395|FG000|Period I|Withdrawal by Subject|23|||
156579734|NCT03567291|565208396|FG001|Period I|Withdrawal by Subject|0|||
156579735|NCT03567291|565208397|FG002|Period I|Withdrawal by Subject|0|||
156579736|NCT03567291|565208398|FG003|Period I|Withdrawal by Subject|0|||
156579737|NCT03567291|565208395|FG000|Period I|Lost to Follow-up|2|||
156579738|NCT03567291|565208396|FG001|Period I|Lost to Follow-up|0|||
156579739|NCT03567291|565208397|FG002|Period I|Lost to Follow-up|0|||
156579740|NCT03567291|565208398|FG003|Period I|Lost to Follow-up|0|||
156579741|NCT03567291|565208395|FG000|Period I|Terminated by sponsor|44|||
156579742|NCT03567291|565208396|FG001|Period I|Terminated by sponsor|0|||
156579743|NCT03567291|565208397|FG002|Period I|Terminated by sponsor|0|||
156579744|NCT03567291|565208398|FG003|Period I|Terminated by sponsor|0|||
156579745|NCT03567291|565208395|FG000|Period I|Missing or unknown|7|||
156579746|NCT03567291|565208396|FG001|Period I|Missing or unknown|0|||
156579747|NCT03567291|565208397|FG002|Period I|Missing or unknown|0|||
156579748|NCT03567291|565208398|FG003|Period I|Missing or unknown|0|||
156579749|NCT03567291|565208395|FG000|Period II|Adverse Event|0|||
156579750|NCT03567291|565208396|FG001|Period II|Adverse Event|1|||
156579751|NCT03567291|565208397|FG002|Period II|Adverse Event|0|||
156579752|NCT03567291|565208398|FG003|Period II|Adverse Event|0|||
156579753|NCT03567291|565208395|FG000|Period II|Missing or unknown|0|||
156579754|NCT03567291|565208396|FG001|Period II|Missing or unknown|2|||
156579755|NCT03567291|565208397|FG002|Period II|Missing or unknown|1|||
156579756|NCT03567291|565208398|FG003|Period II|Missing or unknown|0|||
156579757|NCT03567291|565208395|FG000|Period III|Adverse Event|0|||
156579758|NCT03567291|565208396|FG001|Period III|Adverse Event|0|||
156579759|NCT03567291|565208397|FG002|Period III|Adverse Event|0|||
156579760|NCT03567291|565208398|FG003|Period III|Adverse Event|4|||
156579761|NCT03567291|565208395|FG000|Period III|Withdrawal by Subject|0|||
156579762|NCT03567291|565208396|FG001|Period III|Withdrawal by Subject|0|||
156579763|NCT03567291|565208397|FG002|Period III|Withdrawal by Subject|0|||
156579764|NCT03567291|565208398|FG003|Period III|Withdrawal by Subject|4|||
156579765|NCT03567291|565208395|FG000|Period III|Lost to Follow-up|0|||
156579766|NCT03567291|565208396|FG001|Period III|Lost to Follow-up|0|||
156579767|NCT03567291|565208397|FG002|Period III|Lost to Follow-up|0|||
156579768|NCT03567291|565208398|FG003|Period III|Lost to Follow-up|1|||
156579769|NCT03567291|565208395|FG000|Period III|Terminated by sponsor|0|||
156579770|NCT03567291|565208396|FG001|Period III|Terminated by sponsor|0|||
156579771|NCT03567291|565208397|FG002|Period III|Terminated by sponsor|0|||
156579772|NCT03567291|565208398|FG003|Period III|Terminated by sponsor|68|||
156579773|NCT03567291|565208395|FG000|Period III|Missing or unknown|0|||
156579774|NCT03567291|565208396|FG001|Period III|Missing or unknown|0|||
156579775|NCT03567291|565208397|FG002|Period III|Missing or unknown|0|||
156579776|NCT03567291|565208398|FG003|Period III|Missing or unknown|8|||
156579777|NCT01103349|565208401|FG000|Overall Study|Adverse Event|8|||
156579778|NCT01103349|565208402|FG001|Overall Study|Adverse Event|5|||
156579779|NCT01103349|565208403|FG002|Overall Study|Adverse Event|3|||
156579780|NCT01103349|565208401|FG000|Overall Study|Consent withdrawn|1|||
156579781|NCT01103349|565208402|FG001|Overall Study|Consent withdrawn|0|||
156579782|NCT01103349|565208403|FG002|Overall Study|Consent withdrawn|0|||
156579783|NCT01103349|565208401|FG000|Overall Study|Incorrectly included in the trial|1|||
156579784|NCT01103349|565208402|FG001|Overall Study|Incorrectly included in the trial|0|||
156579785|NCT01103349|565208403|FG002|Overall Study|Incorrectly included in the trial|0|||
156579786|NCT01103349|565208401|FG000|Overall Study|Withdrawal by Subject|1|||
156579787|NCT01103349|565208402|FG001|Overall Study|Withdrawal by Subject|1|||
156579788|NCT01103349|565208403|FG002|Overall Study|Withdrawal by Subject|0|||
156579789|NCT01103349|565208401|FG000|Overall Study|did not want to take trial medication|0|||
156579790|NCT01103349|565208402|FG001|Overall Study|did not want to take trial medication|1|||
156579791|NCT01103349|565208403|FG002|Overall Study|did not want to take trial medication|0|||
156579792|NCT01103349|565208401|FG000|Overall Study|forgot to take medication|0|||
156579793|NCT01103349|565208402|FG001|Overall Study|forgot to take medication|0|||
156579794|NCT01103349|565208403|FG002|Overall Study|forgot to take medication|1|||
156579795|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
156579796|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
156579797|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
156579798|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
156579799|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
156579800|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
156579801|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
156579802|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
156579803|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
156579804|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
156579805|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
156579806|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
156579807|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
156579808|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
156579809|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
156579810|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
156579811|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
156579812|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
156579813|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
156579814|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
156579815|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
156579816|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
156579817|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
156579818|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
156579819|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
156579820|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
156579821|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
156579822|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
156579823|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
156579824|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
156579825|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
156579826|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
156579827|NCT00958568|565208407|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
156579828|NCT00958568|565208408|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
156579829|NCT00958568|565208409|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
156579830|NCT00958568|565208410|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
156579831|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
156579832|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
156579833|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
156579834|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
156579835|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
156579836|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
156579837|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
156579838|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
156579839|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
156579840|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
156579841|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
156579842|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
156579843|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
156579844|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
156579845|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
156579846|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
156579847|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
156579848|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
156579849|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
156579850|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
156579851|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
156579852|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
156579853|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
156579854|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
156579855|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
156579856|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
156579857|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
156579858|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
156579859|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
156579860|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
156579861|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
156579862|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
156579863|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
156579864|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
156579865|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
156579866|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
156579867|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
156579868|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
156579869|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
156579870|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
156579871|NCT00958568|565208407|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
156579872|NCT00958568|565208408|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
156579873|NCT00958568|565208409|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
156579874|NCT00958568|565208410|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
156579875|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
156579876|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
156579877|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
156579878|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
156579879|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
156579880|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
156579881|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
156579882|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
156579883|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
156579884|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
156579885|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
156579886|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
156579887|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
156579888|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
156579889|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
156579890|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
156579891|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
156579892|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
156579893|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
156579894|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
156579895|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
156579896|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
156579897|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
156579898|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
156579899|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
156579900|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
156579901|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
156579902|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
156579903|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
156579904|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
156579905|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
156579906|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
156579907|NCT00958568|565208407|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
156579908|NCT00958568|565208408|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
156579909|NCT00958568|565208409|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
156579910|NCT00958568|565208410|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
156579911|NCT00090285|565208416|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
156579912|NCT00090285|565208417|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
156579913|NCT00090285|565208418|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
156579914|NCT00090285|565208419|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
156579915|NCT00090285|565208420|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
156579916|NCT00090285|565208421|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
156579917|NCT00090285|565208416|FG000|Base Study Vaccination Period|Adverse Event|2|||
156579918|NCT00090285|565208417|FG001|Base Study Vaccination Period|Adverse Event|4|||
156579919|NCT00090285|565208418|FG002|Base Study Vaccination Period|Adverse Event|0|||
156579920|NCT00090285|565208419|FG003|Base Study Vaccination Period|Adverse Event|0|||
156579921|NCT00090285|565208420|FG004|Base Study Vaccination Period|Adverse Event|0|||
156579922|NCT00090285|565208421|FG005|Base Study Vaccination Period|Adverse Event|0|||
156579923|NCT00090285|565208416|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
156579924|NCT00090285|565208417|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
156579925|NCT00090285|565208418|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
156579926|NCT00090285|565208419|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
156579927|NCT00090285|565208420|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
156579928|NCT00090285|565208421|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
156579929|NCT00090285|565208416|FG000|Base Study Vaccination Period|Protocol Violation|2|||
156579930|NCT00090285|565208417|FG001|Base Study Vaccination Period|Protocol Violation|3|||
156579931|NCT00090285|565208418|FG002|Base Study Vaccination Period|Protocol Violation|0|||
156579932|NCT00090285|565208419|FG003|Base Study Vaccination Period|Protocol Violation|0|||
156579933|NCT00090285|565208420|FG004|Base Study Vaccination Period|Protocol Violation|0|||
156579934|NCT00090285|565208421|FG005|Base Study Vaccination Period|Protocol Violation|0|||
156579935|NCT00090285|565208416|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
156579936|NCT00090285|565208417|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
156579937|NCT00090285|565208418|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
156579938|NCT00090285|565208419|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
156579939|NCT00090285|565208420|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
156579940|NCT00090285|565208421|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
156579941|NCT00090285|565208416|FG000|Base Study Vaccination Period|Uncooperative|2|||
156579942|NCT00090285|565208417|FG001|Base Study Vaccination Period|Uncooperative|2|||
156579943|NCT00090285|565208418|FG002|Base Study Vaccination Period|Uncooperative|0|||
156579944|NCT00090285|565208419|FG003|Base Study Vaccination Period|Uncooperative|0|||
156579945|NCT00090285|565208420|FG004|Base Study Vaccination Period|Uncooperative|0|||
156579946|NCT00090285|565208421|FG005|Base Study Vaccination Period|Uncooperative|0|||
156579947|NCT00090285|565208416|FG000|Base Study Vaccination Period|Moved|20|||
156579948|NCT00090285|565208417|FG001|Base Study Vaccination Period|Moved|21|||
156579949|NCT00090285|565208418|FG002|Base Study Vaccination Period|Moved|0|||
156579950|NCT00090285|565208419|FG003|Base Study Vaccination Period|Moved|0|||
156579951|NCT00090285|565208420|FG004|Base Study Vaccination Period|Moved|0|||
156579952|NCT00090285|565208421|FG005|Base Study Vaccination Period|Moved|0|||
156579953|NCT00090285|565208416|FG000|Base Study Vaccination Period|Site Terminated|1|||
156579954|NCT00090285|565208417|FG001|Base Study Vaccination Period|Site Terminated|0|||
156579955|NCT00090285|565208418|FG002|Base Study Vaccination Period|Site Terminated|0|||
156579956|NCT00090285|565208419|FG003|Base Study Vaccination Period|Site Terminated|0|||
156579957|NCT00090285|565208420|FG004|Base Study Vaccination Period|Site Terminated|0|||
156579958|NCT00090285|565208421|FG005|Base Study Vaccination Period|Site Terminated|0|||
156579959|NCT00090285|565208416|FG000|Base Study Vaccination Period|Other|2|||
156579960|NCT00090285|565208417|FG001|Base Study Vaccination Period|Other|2|||
156579961|NCT00090285|565208418|FG002|Base Study Vaccination Period|Other|0|||
156579962|NCT00090285|565208419|FG003|Base Study Vaccination Period|Other|0|||
156579963|NCT00090285|565208420|FG004|Base Study Vaccination Period|Other|0|||
156579964|NCT00090285|565208421|FG005|Base Study Vaccination Period|Other|0|||
156579965|NCT00090285|565208416|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
156579966|NCT00090285|565208417|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
156579967|NCT00090285|565208418|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
156579968|NCT00090285|565208419|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
156579969|NCT00090285|565208420|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
156579970|NCT00090285|565208421|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
156579971|NCT00090285|565208416|FG000|Base Study Vaccination Period|HIV positive|1|||
156579972|NCT00090285|565208417|FG001|Base Study Vaccination Period|HIV positive|1|||
156579973|NCT00090285|565208418|FG002|Base Study Vaccination Period|HIV positive|0|||
156579974|NCT00090285|565208419|FG003|Base Study Vaccination Period|HIV positive|0|||
156579975|NCT00090285|565208420|FG004|Base Study Vaccination Period|HIV positive|0|||
156579976|NCT00090285|565208421|FG005|Base Study Vaccination Period|HIV positive|0|||
156579977|NCT00090285|565208416|FG000|Base Study Follow-up Period|Adverse Event|3|||
156579978|NCT00090285|565208417|FG001|Base Study Follow-up Period|Adverse Event|10|||
156579979|NCT00090285|565208418|FG002|Base Study Follow-up Period|Adverse Event|0|||
156579980|NCT00090285|565208419|FG003|Base Study Follow-up Period|Adverse Event|0|||
156579981|NCT00090285|565208420|FG004|Base Study Follow-up Period|Adverse Event|0|||
156579982|NCT00090285|565208421|FG005|Base Study Follow-up Period|Adverse Event|0|||
156579983|NCT00090285|565208416|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
156579984|NCT00090285|565208417|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
156579985|NCT00090285|565208418|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
156579986|NCT00090285|565208419|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
156579987|NCT00090285|565208420|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
156579988|NCT00090285|565208421|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
156579989|NCT00090285|565208416|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
156579990|NCT00090285|565208417|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
156579991|NCT00090285|565208418|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
156579992|NCT00090285|565208419|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
156579993|NCT00090285|565208420|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
156579994|NCT00090285|565208421|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
156579995|NCT00090285|565208416|FG000|Base Study Follow-up Period|Moved|41|||
156579996|NCT00090285|565208417|FG001|Base Study Follow-up Period|Moved|36|||
156579997|NCT00090285|565208418|FG002|Base Study Follow-up Period|Moved|0|||
156579998|NCT00090285|565208419|FG003|Base Study Follow-up Period|Moved|0|||
156579999|NCT00090285|565208420|FG004|Base Study Follow-up Period|Moved|0|||
156580000|NCT00090285|565208421|FG005|Base Study Follow-up Period|Moved|0|||
156580001|NCT00090285|565208416|FG000|Base Study Follow-up Period|Other|2|||
156580002|NCT00090285|565208417|FG001|Base Study Follow-up Period|Other|0|||
156580003|NCT00090285|565208418|FG002|Base Study Follow-up Period|Other|0|||
156580004|NCT00090285|565208419|FG003|Base Study Follow-up Period|Other|0|||
156580005|NCT00090285|565208420|FG004|Base Study Follow-up Period|Other|0|||
156580006|NCT00090285|565208421|FG005|Base Study Follow-up Period|Other|0|||
156580007|NCT00090285|565208416|FG000|Base Study Follow-up Period|Protocol Violation|1|||
156580008|NCT00090285|565208417|FG001|Base Study Follow-up Period|Protocol Violation|0|||
156580009|NCT00090285|565208418|FG002|Base Study Follow-up Period|Protocol Violation|0|||
156580010|NCT00090285|565208419|FG003|Base Study Follow-up Period|Protocol Violation|0|||
156580011|NCT00090285|565208420|FG004|Base Study Follow-up Period|Protocol Violation|0|||
156580012|NCT00090285|565208421|FG005|Base Study Follow-up Period|Protocol Violation|0|||
156580013|NCT00090285|565208416|FG000|Base Study Follow-up Period|Uncooperative|3|||
156580014|NCT00090285|565208417|FG001|Base Study Follow-up Period|Uncooperative|4|||
156580015|NCT00090285|565208418|FG002|Base Study Follow-up Period|Uncooperative|0|||
156580016|NCT00090285|565208419|FG003|Base Study Follow-up Period|Uncooperative|0|||
156580017|NCT00090285|565208420|FG004|Base Study Follow-up Period|Uncooperative|0|||
156580018|NCT00090285|565208421|FG005|Base Study Follow-up Period|Uncooperative|0|||
156580019|NCT00090285|565208416|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
156580020|NCT00090285|565208417|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
156580021|NCT00090285|565208418|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
156580022|NCT00090285|565208419|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
156580023|NCT00090285|565208420|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
156580024|NCT00090285|565208421|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
156580025|NCT00090285|565208416|FG000|Extension 1|Adverse Event|0|||
156580026|NCT00090285|565208417|FG001|Extension 1|Adverse Event|0|||
156580027|NCT00090285|565208418|FG002|Extension 1|Adverse Event|2|||
156580028|NCT00090285|565208419|FG003|Extension 1|Adverse Event|0|||
156580029|NCT00090285|565208420|FG004|Extension 1|Adverse Event|0|||
156580030|NCT00090285|565208421|FG005|Extension 1|Adverse Event|0|||
156580031|NCT00090285|565208416|FG000|Extension 1|Lost to Follow-up|0|||
156580032|NCT00090285|565208417|FG001|Extension 1|Lost to Follow-up|0|||
156580033|NCT00090285|565208418|FG002|Extension 1|Lost to Follow-up|35|||
156580034|NCT00090285|565208419|FG003|Extension 1|Lost to Follow-up|0|||
156580035|NCT00090285|565208420|FG004|Extension 1|Lost to Follow-up|0|||
156580036|NCT00090285|565208421|FG005|Extension 1|Lost to Follow-up|0|||
156580037|NCT00090285|565208416|FG000|Extension 1|Withdrawal by Subject|0|||
156580038|NCT00090285|565208417|FG001|Extension 1|Withdrawal by Subject|0|||
156580039|NCT00090285|565208418|FG002|Extension 1|Withdrawal by Subject|13|||
156580040|NCT00090285|565208419|FG003|Extension 1|Withdrawal by Subject|1|||
156580041|NCT00090285|565208420|FG004|Extension 1|Withdrawal by Subject|0|||
156580042|NCT00090285|565208421|FG005|Extension 1|Withdrawal by Subject|0|||
156580043|NCT00090285|565208416|FG000|Extension 1|Other|0|||
156580044|NCT00090285|565208417|FG001|Extension 1|Other|0|||
156580045|NCT00090285|565208418|FG002|Extension 1|Other|4|||
156580046|NCT00090285|565208419|FG003|Extension 1|Other|0|||
156580047|NCT00090285|565208420|FG004|Extension 1|Other|0|||
156580048|NCT00090285|565208421|FG005|Extension 1|Other|0|||
156580049|NCT00090285|565208416|FG000|Extension 1|Moved|0|||
156580050|NCT00090285|565208417|FG001|Extension 1|Moved|0|||
156580051|NCT00090285|565208418|FG002|Extension 1|Moved|3|||
156580052|NCT00090285|565208419|FG003|Extension 1|Moved|0|||
156580053|NCT00090285|565208420|FG004|Extension 1|Moved|0|||
156580054|NCT00090285|565208421|FG005|Extension 1|Moved|0|||
156580055|NCT00090285|565208416|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
156580056|NCT00090285|565208417|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
156580057|NCT00090285|565208418|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
156580058|NCT00090285|565208419|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
156580059|NCT00090285|565208420|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
156580060|NCT00090285|565208421|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
156580061|NCT00090285|565208416|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156580062|NCT00090285|565208417|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156580063|NCT00090285|565208418|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156580064|NCT00090285|565208419|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156580065|NCT00090285|565208420|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
156580066|NCT00090285|565208421|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
156580067|NCT00090285|565208416|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156580068|NCT00090285|565208417|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156580069|NCT00090285|565208418|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156580070|NCT00090285|565208419|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156580071|NCT00090285|565208420|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
156580072|NCT00090285|565208421|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
156580073|NCT00090285|565208416|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
156580074|NCT00090285|565208417|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
156580075|NCT00090285|565208418|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
156580076|NCT00090285|565208419|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
156580077|NCT00090285|565208420|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
156580078|NCT00090285|565208421|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
156580079|NCT00907478|565208424|FG000|Overall Study|Ineligibility determined|0|||
156580080|NCT00907478|565208425|FG001|Overall Study|Ineligibility determined|0|||
156580081|NCT00907478|565208426|FG002|Overall Study|Ineligibility determined|1|||
156580082|NCT00907478|565208424|FG000|Overall Study|Noncompliance|0|||
156580083|NCT00907478|565208425|FG001|Overall Study|Noncompliance|0|||
156580084|NCT00907478|565208426|FG002|Overall Study|Noncompliance|1|||
156580085|NCT00907478|565208424|FG000|Overall Study|Adverse Event|3|||
156580086|NCT00907478|565208425|FG001|Overall Study|Adverse Event|1|||
156580087|NCT00907478|565208426|FG002|Overall Study|Adverse Event|2|||
156580088|NCT00907478|565208424|FG000|Overall Study|Withdrawal by Subject|8|||
156580089|NCT00907478|565208425|FG001|Overall Study|Withdrawal by Subject|9|||
156580090|NCT00907478|565208426|FG002|Overall Study|Withdrawal by Subject|6|||
156580091|NCT00907478|565208424|FG000|Overall Study|Requirement for alternative therapy|1|||
156580092|NCT00907478|565208425|FG001|Overall Study|Requirement for alternative therapy|2|||
156580093|NCT00907478|565208426|FG002|Overall Study|Requirement for alternative therapy|3|||
156580094|NCT00907478|565208424|FG000|Overall Study|Physician Decision|2|||
156580095|NCT00907478|565208425|FG001|Overall Study|Physician Decision|0|||
156580096|NCT00907478|565208426|FG002|Overall Study|Physician Decision|3|||
156580097|NCT00907478|565208424|FG000|Overall Study|Death|4|||
156580098|NCT00907478|565208425|FG001|Overall Study|Death|2|||
156580099|NCT00907478|565208426|FG002|Overall Study|Death|1|||
156580100|NCT00907478|565208424|FG000|Overall Study|Protocol-specified criteria|5|||
156580101|NCT00907478|565208425|FG001|Overall Study|Protocol-specified criteria|2|||
156580102|NCT00907478|565208426|FG002|Overall Study|Protocol-specified criteria|3|||
156580103|NCT00907478|565208424|FG000|Overall Study|Pregnancy|0|||
156580104|NCT00907478|565208425|FG001|Overall Study|Pregnancy|1|||
156580105|NCT00907478|565208426|FG002|Overall Study|Pregnancy|1|||
156580106|NCT00907478|565208424|FG000|Overall Study|Lost to Follow-up|1|||
156580107|NCT00907478|565208425|FG001|Overall Study|Lost to Follow-up|0|||
156580108|NCT00907478|565208426|FG002|Overall Study|Lost to Follow-up|0|||
156580109|NCT00907478|565208424|FG000|Overall Study|Other|3|||
156580110|NCT00907478|565208425|FG001|Overall Study|Other|0|||
156580111|NCT00907478|565208426|FG002|Overall Study|Other|1|||
156580112|NCT01936649|565208433|FG000|Overall Study|Withdrawal by Subject|4|||
156580113|NCT01936649|565208433|FG000|Overall Study|Physician Decision|2|||
156580114|NCT01936649|565208433|FG000|Overall Study|Protocol Violation|2|||
156580115|NCT01936649|565208433|FG000|Overall Study|Other than specified above|5|||
156580116|NCT00631488|565208438|FG000|Overall Study|Adverse Event|1|||
156580117|NCT00631488|565208439|FG001|Overall Study|Adverse Event|0|||
156580118|NCT00631488|565208440|FG002|Overall Study|Adverse Event|0|||
156580119|NCT00631488|565208438|FG000|Overall Study|Lost to Follow-up|2|||
156580120|NCT00631488|565208439|FG001|Overall Study|Lost to Follow-up|2|||
156580121|NCT00631488|565208440|FG002|Overall Study|Lost to Follow-up|0|||
156580122|NCT00631488|565208438|FG000|Overall Study|Physician Decision|1|||
156580123|NCT00631488|565208439|FG001|Overall Study|Physician Decision|0|||
156580124|NCT00631488|565208440|FG002|Overall Study|Physician Decision|1|||
156580125|NCT00631488|565208438|FG000|Overall Study|Protocol Violation|0|||
156580126|NCT00631488|565208439|FG001|Overall Study|Protocol Violation|0|||
156580127|NCT00631488|565208440|FG002|Overall Study|Protocol Violation|1|||
156580128|NCT03648476|565208442|FG000|Overall Study|Withdrawal by Subject|2|||
156580129|NCT03648476|565208443|FG001|Overall Study|Withdrawal by Subject|1|||
156580130|NCT02855411|565208448|FG000|Overall Study|Study terminated by sponsor|21|||
156580131|NCT02855411|565208448|FG000|Overall Study|Does not meet entrance criteria|14|||
156580132|NCT01097616|565208451|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
156580133|NCT01097616|565208452|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
156580134|NCT01097616|565208453|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
156580135|NCT01097616|565208454|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156580136|NCT01097616|565208455|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156580137|NCT01097616|565208456|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156580138|NCT01097616|565208457|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156580139|NCT01097616|565208458|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156580140|NCT01097616|565208451|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
156580141|NCT01097616|565208452|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
156580142|NCT01097616|565208453|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
156580143|NCT01097616|565208454|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156580144|NCT01097616|565208455|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156580145|NCT01097616|565208456|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156580146|NCT01097616|565208457|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156580147|NCT01097616|565208458|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
156580148|NCT01097616|565208451|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
156580149|NCT01097616|565208452|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
156580150|NCT01097616|565208453|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
156580151|NCT01097616|565208454|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156580152|NCT01097616|565208455|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156580153|NCT01097616|565208456|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156580154|NCT01097616|565208457|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156580155|NCT01097616|565208458|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156580156|NCT01097616|565208451|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
156580157|NCT01097616|565208452|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
156580158|NCT01097616|565208453|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156580159|NCT01097616|565208454|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156580160|NCT01097616|565208455|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156580161|NCT01097616|565208456|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156580162|NCT01097616|565208457|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156580163|NCT01097616|565208458|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
156580164|NCT01097616|565208451|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
156580165|NCT01097616|565208452|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
156580166|NCT01097616|565208453|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
156580167|NCT01097616|565208454|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156580168|NCT01097616|565208455|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156580169|NCT01097616|565208456|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156580170|NCT01097616|565208457|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156580171|NCT01097616|565208458|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
156580172|NCT01097616|565208451|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
156580173|NCT01097616|565208452|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
156580174|NCT01097616|565208453|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
156580175|NCT01097616|565208454|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
156580176|NCT01097616|565208455|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
156580177|NCT01097616|565208456|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
156580178|NCT01097616|565208457|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
156580179|NCT01097616|565208458|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
156580180|NCT01097616|565208451|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
156580181|NCT01097616|565208452|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
156580182|NCT01097616|565208453|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156580183|NCT01097616|565208454|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156580184|NCT01097616|565208455|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156580185|NCT01097616|565208456|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156580186|NCT01097616|565208457|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156580187|NCT01097616|565208458|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
156580188|NCT01097616|565208451|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156580189|NCT01097616|565208452|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156580190|NCT01097616|565208453|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
156580191|NCT01097616|565208454|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156580192|NCT01097616|565208455|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156580193|NCT01097616|565208456|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156580194|NCT01097616|565208457|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156580195|NCT01097616|565208458|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156580196|NCT01097616|565208451|FG000|Optional DB EXT Phase|Adverse Event|0|||
156580197|NCT01097616|565208452|FG001|Optional DB EXT Phase|Adverse Event|7|||
156580198|NCT01097616|565208453|FG002|Optional DB EXT Phase|Adverse Event|2|||
156580199|NCT01097616|565208454|FG003|Optional DB EXT Phase|Adverse Event|0|||
156580200|NCT01097616|565208455|FG004|Optional DB EXT Phase|Adverse Event|0|||
156580201|NCT01097616|565208456|FG005|Optional DB EXT Phase|Adverse Event|0|||
156580202|NCT01097616|565208457|FG006|Optional DB EXT Phase|Adverse Event|0|||
156580203|NCT01097616|565208458|FG007|Optional DB EXT Phase|Adverse Event|0|||
156580204|NCT01097616|565208451|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
156580205|NCT01097616|565208452|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
156580206|NCT01097616|565208453|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
156580207|NCT01097616|565208454|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
156580208|NCT01097616|565208455|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
156580209|NCT01097616|565208456|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
156580210|NCT01097616|565208457|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
156580211|NCT01097616|565208458|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
156580212|NCT01097616|565208451|FG000|Optional DB EXT Phase|Protocol Violation|0|||
156580213|NCT01097616|565208452|FG001|Optional DB EXT Phase|Protocol Violation|2|||
156580214|NCT01097616|565208453|FG002|Optional DB EXT Phase|Protocol Violation|3|||
156580215|NCT01097616|565208454|FG003|Optional DB EXT Phase|Protocol Violation|0|||
156580216|NCT01097616|565208455|FG004|Optional DB EXT Phase|Protocol Violation|0|||
156580217|NCT01097616|565208456|FG005|Optional DB EXT Phase|Protocol Violation|0|||
156580218|NCT01097616|565208457|FG006|Optional DB EXT Phase|Protocol Violation|0|||
156580219|NCT01097616|565208458|FG007|Optional DB EXT Phase|Protocol Violation|0|||
156580220|NCT01097616|565208451|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
156580221|NCT01097616|565208452|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
156580222|NCT01097616|565208453|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
156580223|NCT01097616|565208454|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
156580224|NCT01097616|565208455|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
156580225|NCT01097616|565208456|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
156580226|NCT01097616|565208457|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
156580227|NCT01097616|565208458|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
156580228|NCT01097616|565208451|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
156580229|NCT01097616|565208452|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
156580230|NCT01097616|565208453|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
156580231|NCT01097616|565208454|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
156580232|NCT01097616|565208455|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
156580233|NCT01097616|565208456|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
156580234|NCT01097616|565208457|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
156580235|NCT01097616|565208458|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
156580236|NCT01097616|565208451|FG000|Optional DB EXT Phase|Physician Decision|1|||
156580237|NCT01097616|565208452|FG001|Optional DB EXT Phase|Physician Decision|0|||
156580238|NCT01097616|565208453|FG002|Optional DB EXT Phase|Physician Decision|0|||
156580239|NCT01097616|565208454|FG003|Optional DB EXT Phase|Physician Decision|0|||
156580240|NCT01097616|565208455|FG004|Optional DB EXT Phase|Physician Decision|0|||
156580241|NCT01097616|565208456|FG005|Optional DB EXT Phase|Physician Decision|0|||
156580242|NCT01097616|565208457|FG006|Optional DB EXT Phase|Physician Decision|0|||
156580243|NCT01097616|565208458|FG007|Optional DB EXT Phase|Physician Decision|0|||
156580244|NCT01097616|565208451|FG000|DB RO Phase|Adverse Event|0|||
156580245|NCT01097616|565208452|FG001|DB RO Phase|Adverse Event|0|||
156580246|NCT01097616|565208453|FG002|DB RO Phase|Adverse Event|0|||
156580247|NCT01097616|565208454|FG003|DB RO Phase|Adverse Event|0|||
156580248|NCT01097616|565208455|FG004|DB RO Phase|Adverse Event|0|||
156580249|NCT01097616|565208456|FG005|DB RO Phase|Adverse Event|0|||
156580250|NCT01097616|565208457|FG006|DB RO Phase|Adverse Event|1|||
156580251|NCT01097616|565208458|FG007|DB RO Phase|Adverse Event|0|||
156580252|NCT01097616|565208451|FG000|DB RO Phase|Withdrawal by Subject|0|||
156580253|NCT01097616|565208452|FG001|DB RO Phase|Withdrawal by Subject|0|||
156580254|NCT01097616|565208453|FG002|DB RO Phase|Withdrawal by Subject|0|||
156580255|NCT01097616|565208454|FG003|DB RO Phase|Withdrawal by Subject|0|||
156580256|NCT01097616|565208455|FG004|DB RO Phase|Withdrawal by Subject|0|||
156580257|NCT01097616|565208456|FG005|DB RO Phase|Withdrawal by Subject|1|||
156580258|NCT01097616|565208457|FG006|DB RO Phase|Withdrawal by Subject|0|||
156580259|NCT01097616|565208458|FG007|DB RO Phase|Withdrawal by Subject|0|||
156580260|NCT01097616|565208451|FG000|DB RO Phase|Lost to Follow-up|0|||
156580261|NCT01097616|565208452|FG001|DB RO Phase|Lost to Follow-up|0|||
156580262|NCT01097616|565208453|FG002|DB RO Phase|Lost to Follow-up|0|||
156580263|NCT01097616|565208454|FG003|DB RO Phase|Lost to Follow-up|1|||
156580264|NCT01097616|565208455|FG004|DB RO Phase|Lost to Follow-up|1|||
156580265|NCT01097616|565208456|FG005|DB RO Phase|Lost to Follow-up|0|||
156580266|NCT01097616|565208457|FG006|DB RO Phase|Lost to Follow-up|0|||
156580267|NCT01097616|565208458|FG007|DB RO Phase|Lost to Follow-up|1|||
156580268|NCT01097616|565208451|FG000|DB RO Phase|Not Treated in RO|0|||
156580269|NCT01097616|565208452|FG001|DB RO Phase|Not Treated in RO|0|||
156580270|NCT01097616|565208453|FG002|DB RO Phase|Not Treated in RO|0|||
156580271|NCT01097616|565208454|FG003|DB RO Phase|Not Treated in RO|0|||
156580272|NCT01097616|565208455|FG004|DB RO Phase|Not Treated in RO|0|||
156580273|NCT01097616|565208456|FG005|DB RO Phase|Not Treated in RO|1|||
156580274|NCT01097616|565208457|FG006|DB RO Phase|Not Treated in RO|0|||
156580275|NCT01097616|565208458|FG007|DB RO Phase|Not Treated in RO|0|||
156580276|NCT03952650|565208461|FG000|Overall Study|TRAVEL|0|||
156580277|NCT03952650|565208462|FG001|Overall Study|TRAVEL|4|||
156580278|NCT03952650|565208463|FG002|Overall Study|TRAVEL|0|||
156580279|NCT03952650|565208464|FG003|Overall Study|TRAVEL|4|||
156580280|NCT03952650|565208465|FG004|Overall Study|TRAVEL|0|||
156580281|NCT03952650|565208466|FG005|Overall Study|TRAVEL|3|||
156580282|NCT03952650|565208467|FG006|Overall Study|TRAVEL|2|||
156580283|NCT03952650|565208461|FG000|Overall Study|Withdrawal by Subject|0|||
156580284|NCT03952650|565208462|FG001|Overall Study|Withdrawal by Subject|2|||
156580285|NCT03952650|565208463|FG002|Overall Study|Withdrawal by Subject|0|||
156580286|NCT03952650|565208464|FG003|Overall Study|Withdrawal by Subject|3|||
156580287|NCT03952650|565208465|FG004|Overall Study|Withdrawal by Subject|0|||
156580288|NCT03952650|565208466|FG005|Overall Study|Withdrawal by Subject|1|||
156580289|NCT03952650|565208467|FG006|Overall Study|Withdrawal by Subject|1|||
156580290|NCT03952650|565208461|FG000|Overall Study|Lost to Follow-up|0|||
156580291|NCT03952650|565208462|FG001|Overall Study|Lost to Follow-up|1|||
156580292|NCT03952650|565208463|FG002|Overall Study|Lost to Follow-up|0|||
156580293|NCT03952650|565208464|FG003|Overall Study|Lost to Follow-up|0|||
156580294|NCT03952650|565208465|FG004|Overall Study|Lost to Follow-up|0|||
156580295|NCT03952650|565208466|FG005|Overall Study|Lost to Follow-up|1|||
156580296|NCT03952650|565208467|FG006|Overall Study|Lost to Follow-up|1|||
156580297|NCT03952650|565208461|FG000|Overall Study|Received wrong vaccine and travelled|0|||
156580298|NCT03952650|565208462|FG001|Overall Study|Received wrong vaccine and travelled|0|||
156580299|NCT03952650|565208463|FG002|Overall Study|Received wrong vaccine and travelled|0|||
156580300|NCT03952650|565208464|FG003|Overall Study|Received wrong vaccine and travelled|0|||
156580301|NCT03952650|565208465|FG004|Overall Study|Received wrong vaccine and travelled|0|||
156580302|NCT03952650|565208466|FG005|Overall Study|Received wrong vaccine and travelled|1|||
156580303|NCT03952650|565208467|FG006|Overall Study|Received wrong vaccine and travelled|0|||
156580304|NCT03952650|565208461|FG000|Overall Study|Unable to make study visit|0|||
156580305|NCT03952650|565208462|FG001|Overall Study|Unable to make study visit|0|||
156580306|NCT03952650|565208463|FG002|Overall Study|Unable to make study visit|0|||
156580307|NCT03952650|565208464|FG003|Overall Study|Unable to make study visit|0|||
156580308|NCT03952650|565208465|FG004|Overall Study|Unable to make study visit|0|||
156580309|NCT03952650|565208466|FG005|Overall Study|Unable to make study visit|1|||
156580310|NCT03952650|565208467|FG006|Overall Study|Unable to make study visit|0|||
156580311|NCT01342640|565208468|FG000|Overall Study|Adverse Event|3|||
156580312|NCT01342640|565208468|FG000|Overall Study|Protocol Violation|16|||
156580313|NCT01342640|565208468|FG000|Overall Study|Lost to Follow-up|21|||
156580314|NCT01342640|565208468|FG000|Overall Study|Other|1|||
156580315|NCT01208181|565208475|FG000|Part 1|Withdrawal by Subject|11|||
156580316|NCT01208181|565208476|FG001|Part 1|Withdrawal by Subject|10|||
156580317|NCT01208181|565208477|FG002|Part 1|Withdrawal by Subject|0|||
156580318|NCT01208181|565208478|FG003|Part 1|Withdrawal by Subject|0|||
156580319|NCT01208181|565208479|FG004|Part 1|Withdrawal by Subject|0|||
156580320|NCT01208181|565208475|FG000|Part 1|Technical problem|5|||
156580321|NCT01208181|565208476|FG001|Part 1|Technical problem|0|||
156580322|NCT01208181|565208477|FG002|Part 1|Technical problem|0|||
156580323|NCT01208181|565208478|FG003|Part 1|Technical problem|0|||
156580324|NCT01208181|565208479|FG004|Part 1|Technical problem|0|||
156580325|NCT01208181|565208475|FG000|Part 1|Protocol Violation|10|||
156580326|NCT01208181|565208476|FG001|Part 1|Protocol Violation|5|||
156580327|NCT01208181|565208477|FG002|Part 1|Protocol Violation|0|||
156580328|NCT01208181|565208478|FG003|Part 1|Protocol Violation|0|||
156580329|NCT01208181|565208479|FG004|Part 1|Protocol Violation|0|||
156580330|NCT01208181|565208475|FG000|Part 1|Physician Decision|4|||
156580331|NCT01208181|565208476|FG001|Part 1|Physician Decision|0|||
156580332|NCT01208181|565208477|FG002|Part 1|Physician Decision|0|||
156580333|NCT01208181|565208478|FG003|Part 1|Physician Decision|0|||
156580334|NCT01208181|565208479|FG004|Part 1|Physician Decision|0|||
156580335|NCT01208181|565208475|FG000|Part 1|Non-compliance with study drug|1|||
156580336|NCT01208181|565208476|FG001|Part 1|Non-compliance with study drug|1|||
156580337|NCT01208181|565208477|FG002|Part 1|Non-compliance with study drug|0|||
156580338|NCT01208181|565208478|FG003|Part 1|Non-compliance with study drug|0|||
156580339|NCT01208181|565208479|FG004|Part 1|Non-compliance with study drug|0|||
156580340|NCT01208181|565208475|FG000|Part 1|Lost to Follow-up|5|||
156580341|NCT01208181|565208476|FG001|Part 1|Lost to Follow-up|3|||
156580342|NCT01208181|565208477|FG002|Part 1|Lost to Follow-up|0|||
156580343|NCT01208181|565208478|FG003|Part 1|Lost to Follow-up|0|||
156580344|NCT01208181|565208479|FG004|Part 1|Lost to Follow-up|1|||
156580345|NCT01208181|565208475|FG000|Part 1|Lack of Efficacy|37|||
156580346|NCT01208181|565208476|FG001|Part 1|Lack of Efficacy|12|||
156580347|NCT01208181|565208477|FG002|Part 1|Lack of Efficacy|0|||
156580348|NCT01208181|565208478|FG003|Part 1|Lack of Efficacy|0|||
156580349|NCT01208181|565208479|FG004|Part 1|Lack of Efficacy|17|||
156580350|NCT01208181|565208475|FG000|Part 1|Adverse Event|26|||
156580351|NCT01208181|565208476|FG001|Part 1|Adverse Event|24|||
156580352|NCT01208181|565208477|FG002|Part 1|Adverse Event|0|||
156580353|NCT01208181|565208478|FG003|Part 1|Adverse Event|0|||
156580354|NCT01208181|565208479|FG004|Part 1|Adverse Event|4|||
156580355|NCT01208181|565208475|FG000|Part 2|Adverse Event|0|||
156580356|NCT01208181|565208476|FG001|Part 2|Adverse Event|0|||
156580357|NCT01208181|565208477|FG002|Part 2|Adverse Event|6|||
156580358|NCT01208181|565208478|FG003|Part 2|Adverse Event|7|||
156580359|NCT01208181|565208479|FG004|Part 2|Adverse Event|0|||
156580360|NCT01208181|565208475|FG000|Part 2|Withdrawal by Subject|0|||
156580361|NCT01208181|565208476|FG001|Part 2|Withdrawal by Subject|0|||
156580362|NCT01208181|565208477|FG002|Part 2|Withdrawal by Subject|1|||
156580363|NCT01208181|565208478|FG003|Part 2|Withdrawal by Subject|1|||
156580364|NCT01208181|565208479|FG004|Part 2|Withdrawal by Subject|0|||
156580365|NCT01208181|565208475|FG000|Part 2|Protocol Violation|0|||
156580366|NCT01208181|565208476|FG001|Part 2|Protocol Violation|0|||
156580367|NCT01208181|565208477|FG002|Part 2|Protocol Violation|1|||
156580368|NCT01208181|565208478|FG003|Part 2|Protocol Violation|0|||
156580369|NCT01208181|565208479|FG004|Part 2|Protocol Violation|0|||
156580370|NCT01208181|565208475|FG000|Part 2|Physician Decision|0|||
156580371|NCT01208181|565208476|FG001|Part 2|Physician Decision|0|||
156580372|NCT01208181|565208477|FG002|Part 2|Physician Decision|1|||
156580373|NCT01208181|565208478|FG003|Part 2|Physician Decision|2|||
156580374|NCT01208181|565208479|FG004|Part 2|Physician Decision|0|||
156580375|NCT01208181|565208475|FG000|Part 2|Non-compliance with study drug|0|||
156580376|NCT01208181|565208476|FG001|Part 2|Non-compliance with study drug|0|||
156580377|NCT01208181|565208477|FG002|Part 2|Non-compliance with study drug|1|||
156580378|NCT01208181|565208478|FG003|Part 2|Non-compliance with study drug|1|||
156580379|NCT01208181|565208479|FG004|Part 2|Non-compliance with study drug|0|||
156580380|NCT01208181|565208475|FG000|Part 2|Lost to Follow-up|0|||
156580381|NCT01208181|565208476|FG001|Part 2|Lost to Follow-up|0|||
156580382|NCT01208181|565208477|FG002|Part 2|Lost to Follow-up|1|||
156580383|NCT01208181|565208478|FG003|Part 2|Lost to Follow-up|2|||
156580384|NCT01208181|565208479|FG004|Part 2|Lost to Follow-up|0|||
156580385|NCT01208181|565208475|FG000|Part 2|Lack of Efficacy|0|||
156580386|NCT01208181|565208476|FG001|Part 2|Lack of Efficacy|0|||
156580387|NCT01208181|565208477|FG002|Part 2|Lack of Efficacy|5|||
156580388|NCT01208181|565208478|FG003|Part 2|Lack of Efficacy|7|||
156580389|NCT01208181|565208479|FG004|Part 2|Lack of Efficacy|0|||
156580390|NCT01096667|565208482|FG000|Overall Study|Lost to Follow-up|1|||
156580391|NCT01096667|565208483|FG001|Overall Study|Lost to Follow-up|1|||
156580392|NCT01096667|565208484|FG002|Overall Study|Lost to Follow-up|1|||
156580393|NCT01096667|565208485|FG003|Overall Study|Lost to Follow-up|0|||
156580394|NCT01096667|565208486|FG004|Overall Study|Lost to Follow-up|0|||
156580395|NCT01096667|565208482|FG000|Overall Study|Withdrawal by Subject|1|||
156580396|NCT01096667|565208483|FG001|Overall Study|Withdrawal by Subject|0|||
156580397|NCT01096667|565208484|FG002|Overall Study|Withdrawal by Subject|0|||
156580398|NCT01096667|565208485|FG003|Overall Study|Withdrawal by Subject|1|||
156580399|NCT01096667|565208486|FG004|Overall Study|Withdrawal by Subject|0|||
156580400|NCT01096667|565208482|FG000|Overall Study|Reason not available|0|||
156580401|NCT01096667|565208483|FG001|Overall Study|Reason not available|1|||
156580402|NCT01096667|565208484|FG002|Overall Study|Reason not available|1|||
156580403|NCT01096667|565208485|FG003|Overall Study|Reason not available|1|||
156580404|NCT01096667|565208486|FG004|Overall Study|Reason not available|0|||
156580405|NCT01096667|565208482|FG000|Overall Study|Protocol Violation|0|||
156580406|NCT01096667|565208483|FG001|Overall Study|Protocol Violation|0|||
156580407|NCT01096667|565208484|FG002|Overall Study|Protocol Violation|0|||
156580408|NCT01096667|565208485|FG003|Overall Study|Protocol Violation|1|||
156580409|NCT01096667|565208486|FG004|Overall Study|Protocol Violation|0|||
156580410|NCT01096667|565208482|FG000|Overall Study|Not treated|1|||
156580411|NCT01096667|565208483|FG001|Overall Study|Not treated|0|||
156580412|NCT01096667|565208484|FG002|Overall Study|Not treated|0|||
156580413|NCT01096667|565208485|FG003|Overall Study|Not treated|0|||
156580414|NCT01096667|565208486|FG004|Overall Study|Not treated|0|||
156580415|NCT00394914|565208489|FG000|Treatment Period|Adverse Event|0|||
156580416|NCT00394914|565208490|FG001|Treatment Period|Adverse Event|3|||
156580417|NCT00394914|565208491|FG002|Treatment Period|Adverse Event|1|||
156580418|NCT00394914|565208489|FG000|Treatment Period|Lost to Follow-up|0|||
156580419|NCT00394914|565208490|FG001|Treatment Period|Lost to Follow-up|1|||
156580420|NCT00394914|565208491|FG002|Treatment Period|Lost to Follow-up|0|||
156580421|NCT00394914|565208489|FG000|Treatment Period|Withdrawal by Subject|0|||
156580422|NCT00394914|565208490|FG001|Treatment Period|Withdrawal by Subject|2|||
156580423|NCT00394914|565208491|FG002|Treatment Period|Withdrawal by Subject|2|||
156580424|NCT00394914|565208489|FG000|Treatment Period|Noncompliance with protocol|0|||
156580425|NCT00394914|565208490|FG001|Treatment Period|Noncompliance with protocol|3|||
156580426|NCT00394914|565208491|FG002|Treatment Period|Noncompliance with protocol|2|||
156580427|NCT00394914|565208489|FG000|Treatment Period|Did not meet protocol eligibility|0|||
156580428|NCT00394914|565208490|FG001|Treatment Period|Did not meet protocol eligibility|1|||
156580429|NCT00394914|565208491|FG002|Treatment Period|Did not meet protocol eligibility|1|||
156580430|NCT02179398|565208501|FG000|Overall Study|Lack of obligatory data|3|||
156580431|NCT02179398|565208502|FG001|Overall Study|Lack of obligatory data|3|||
156580432|NCT02179398|565208501|FG000|Overall Study|Lost to Follow-up|0|||
156580433|NCT02179398|565208502|FG001|Overall Study|Lost to Follow-up|1|||
156580434|NCT00465738|565208509|FG000|Overall Study|Lost to Follow-up|2|||
156580435|NCT00465738|565208510|FG001|Overall Study|Lost to Follow-up|0|||
156580436|NCT00465738|565208509|FG000|Overall Study|Adverse Event|0|||
156580437|NCT00465738|565208510|FG001|Overall Study|Adverse Event|1|||
156580438|NCT00465738|565208509|FG000|Overall Study|Withdrawal by Subject|2|||
156580439|NCT00465738|565208510|FG001|Overall Study|Withdrawal by Subject|0|||
156580440|NCT00465738|565208509|FG000|Overall Study|Other|2|||
156580441|NCT00465738|565208510|FG001|Overall Study|Other|5|||
156580442|NCT01318902|565208511|FG000|Overall Study|Symptomatic Deterioration|0|||
156580443|NCT01318902|565208512|FG001|Overall Study|Symptomatic Deterioration|1|||
156580444|NCT01318902|565208513|FG002|Overall Study|Symptomatic Deterioration|1|||
156580445|NCT01318902|565208514|FG003|Overall Study|Symptomatic Deterioration|2|||
156580446|NCT01318902|565208511|FG000|Overall Study|Withdrawal by Patient|0|||
156580447|NCT01318902|565208512|FG001|Overall Study|Withdrawal by Patient|1|||
156580448|NCT01318902|565208513|FG002|Overall Study|Withdrawal by Patient|0|||
156580449|NCT01318902|565208514|FG003|Overall Study|Withdrawal by Patient|3|||
156580450|NCT01318902|565208511|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
156580451|NCT01318902|565208512|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
156580452|NCT01318902|565208513|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
156580453|NCT01318902|565208514|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
156580454|NCT01318902|565208511|FG000|Overall Study|Adverse Event|0|||
156580455|NCT01318902|565208512|FG001|Overall Study|Adverse Event|1|||
156580456|NCT01318902|565208513|FG002|Overall Study|Adverse Event|0|||
156580457|NCT01318902|565208514|FG003|Overall Study|Adverse Event|0|||
156580458|NCT01318902|565208511|FG000|Overall Study|Terminated by Sponsor|0|||
156580459|NCT01318902|565208512|FG001|Overall Study|Terminated by Sponsor|0|||
156580460|NCT01318902|565208513|FG002|Overall Study|Terminated by Sponsor|1|||
156580461|NCT01318902|565208514|FG003|Overall Study|Terminated by Sponsor|0|||
156580462|NCT03270085|565210917|FG000|Overall Study|Withdrawal by Subject|1|||
156580463|NCT03270085|565210918|FG001|Overall Study|Withdrawal by Subject|0|||
156580464|NCT03825042|565210919|FG000|Overall Study|Adverse Event|1|||
156580465|NCT03825042|565210920|FG001|Overall Study|Adverse Event|0|||
156580466|NCT03825042|565210919|FG000|Overall Study|Withdrawal by Subject|1|||
156580467|NCT03825042|565210920|FG001|Overall Study|Withdrawal by Subject|0|||
156580468|NCT01158534|565210927|FG000|Overall Study|Withdrawal by Subject|1|||
156580469|NCT01158534|565210927|FG000|Overall Study|Death|1|||
156580470|NCT01158534|565210927|FG000|Overall Study|Other|1|||
156580471|NCT04003155|565210928|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
156580472|NCT04003155|565210929|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
156580473|NCT04003155|565210930|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
156580474|NCT04003155|565210931|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
156580475|NCT04003155|565210932|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
156580476|NCT04003155|565210928|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
156580477|NCT04003155|565210929|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
156580478|NCT04003155|565210930|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
156580479|NCT04003155|565210931|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
156580480|NCT04003155|565210932|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
156580481|NCT04003155|565210928|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
156580482|NCT04003155|565210929|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
156580483|NCT04003155|565210930|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
156580484|NCT04003155|565210931|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
156580485|NCT04003155|565210932|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
156580486|NCT04003155|565210928|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
156580487|NCT04003155|565210929|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
156580488|NCT04003155|565210930|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
156580489|NCT04003155|565210931|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
156580490|NCT04003155|565210932|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
156580491|NCT04003155|565210928|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
156580492|NCT04003155|565210929|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
156580493|NCT04003155|565210930|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
156580494|NCT04003155|565210931|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
156580495|NCT04003155|565210932|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
156580496|NCT04003155|565210928|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
156580497|NCT04003155|565210929|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
156580498|NCT04003155|565210930|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
156580499|NCT04003155|565210931|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
156580500|NCT04003155|565210932|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
156580501|NCT04003155|565210928|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
156580502|NCT04003155|565210929|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
156580503|NCT04003155|565210930|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
156580504|NCT04003155|565210931|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
156580505|NCT04003155|565210932|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
156580506|NCT04003155|565210928|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
156580507|NCT04003155|565210929|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
156580508|NCT04003155|565210930|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
156580509|NCT04003155|565210931|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
156580510|NCT04003155|565210932|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
156580511|NCT04003155|565210928|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
156580512|NCT04003155|565210929|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
156580513|NCT04003155|565210930|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
156580514|NCT04003155|565210931|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
156580515|NCT04003155|565210932|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
156580516|NCT01912872|565210936|FG000|Overall Study|Lost to Follow-up|2|||
156580517|NCT01912872|565210937|FG001|Overall Study|Lost to Follow-up|3|||
156580518|NCT01912872|565210938|FG002|Overall Study|Lost to Follow-up|5|||
156580519|NCT01912872|565210939|FG003|Overall Study|Lost to Follow-up|5|||
156580520|NCT01912872|565210936|FG000|Overall Study|Other unspecified|3|||
156580521|NCT01912872|565210937|FG001|Overall Study|Other unspecified|1|||
156580522|NCT01912872|565210938|FG002|Overall Study|Other unspecified|3|||
156580523|NCT01912872|565210939|FG003|Overall Study|Other unspecified|0|||
156580524|NCT01912872|565210936|FG000|Overall Study|Informed consent withdrawn|0|||
156580525|NCT01912872|565210937|FG001|Overall Study|Informed consent withdrawn|0|||
156580526|NCT01912872|565210938|FG002|Overall Study|Informed consent withdrawn|1|||
156580527|NCT01912872|565210939|FG003|Overall Study|Informed consent withdrawn|1|||
156580528|NCT01912872|565210936|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
156580529|NCT01912872|565210937|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
156580530|NCT01912872|565210938|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
156580531|NCT01912872|565210939|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
156580532|NCT01912872|565210936|FG000|Overall Study|Protocol Violation|0|||
156580533|NCT01912872|565210937|FG001|Overall Study|Protocol Violation|0|||
156580534|NCT01912872|565210938|FG002|Overall Study|Protocol Violation|1|||
156580535|NCT01912872|565210939|FG003|Overall Study|Protocol Violation|0|||
156580536|NCT01912872|565210936|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156580537|NCT01912872|565210937|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156580538|NCT01912872|565210938|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156580539|NCT01912872|565210939|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
156580540|NCT01912872|565210936|FG000|Overall Study|Withdrawal of study medication|0|||
156580541|NCT01912872|565210937|FG001|Overall Study|Withdrawal of study medication|0|||
156580542|NCT01912872|565210938|FG002|Overall Study|Withdrawal of study medication|0|||
156580543|NCT01912872|565210939|FG003|Overall Study|Withdrawal of study medication|2|||
156580544|NCT01912872|565210936|FG000|Overall Study|Missing|0|||
156580545|NCT01912872|565210937|FG001|Overall Study|Missing|0|||
156580546|NCT01912872|565210938|FG002|Overall Study|Missing|0|||
156580547|NCT01912872|565210939|FG003|Overall Study|Missing|1|||
156580548|NCT04760314|565210945|FG000|Induction Period|Withdrawal by Subject|0|||
156580549|NCT04760314|565210946|FG001|Induction Period|Withdrawal by Subject|1|||
156580550|NCT04760314|565210947|FG002|Induction Period|Withdrawal by Subject|1|||
156580551|NCT04760314|565210948|FG003|Induction Period|Withdrawal by Subject|0|||
156580552|NCT04760314|565210949|FG004|Induction Period|Withdrawal by Subject|0|||
156580553|NCT04760314|565210950|FG005|Induction Period|Withdrawal by Subject|0|||
156580554|NCT04760314|565210951|FG006|Induction Period|Withdrawal by Subject|0|||
156580555|NCT04760314|565210952|FG007|Induction Period|Withdrawal by Subject|0|||
156580556|NCT04760314|565210953|FG008|Induction Period|Withdrawal by Subject|0|||
156580557|NCT04760314|565210954|FG009|Induction Period|Withdrawal by Subject|0|||
156580558|NCT04760314|565210955|FG010|Induction Period|Withdrawal by Subject|0|||
156580559|NCT04760314|565210945|FG000|Induction Period|Adverse Event|0|||
156580560|NCT04760314|565210946|FG001|Induction Period|Adverse Event|0|||
156580561|NCT04760314|565210947|FG002|Induction Period|Adverse Event|2|||
156580562|NCT04760314|565210948|FG003|Induction Period|Adverse Event|0|||
156580563|NCT04760314|565210949|FG004|Induction Period|Adverse Event|0|||
156580564|NCT04760314|565210950|FG005|Induction Period|Adverse Event|0|||
156580565|NCT04760314|565210951|FG006|Induction Period|Adverse Event|0|||
156580566|NCT04760314|565210952|FG007|Induction Period|Adverse Event|0|||
156580567|NCT04760314|565210953|FG008|Induction Period|Adverse Event|0|||
156580568|NCT04760314|565210954|FG009|Induction Period|Adverse Event|0|||
156580569|NCT04760314|565210955|FG010|Induction Period|Adverse Event|0|||
156580570|NCT04760314|565210945|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
156580571|NCT04760314|565210946|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
156580572|NCT04760314|565210947|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
156580573|NCT04760314|565210948|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
156580574|NCT04760314|565210949|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
156580575|NCT04760314|565210950|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
156580576|NCT04760314|565210951|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
156580577|NCT04760314|565210952|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
156580578|NCT04760314|565210953|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
156580579|NCT04760314|565210954|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
156580580|NCT04760314|565210955|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
156580581|NCT04760314|565210945|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
156580582|NCT04760314|565210946|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
156580583|NCT04760314|565210947|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
156580584|NCT04760314|565210948|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
156580585|NCT04760314|565210949|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
156580586|NCT04760314|565210950|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
156580587|NCT04760314|565210951|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
156580588|NCT04760314|565210952|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
156580589|NCT04760314|565210953|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
156580590|NCT04760314|565210954|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
156580591|NCT04760314|565210955|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
156580592|NCT04760314|565210945|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580593|NCT04760314|565210946|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580594|NCT04760314|565210947|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580595|NCT04760314|565210948|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580596|NCT04760314|565210949|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
156580597|NCT04760314|565210950|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580598|NCT04760314|565210951|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580599|NCT04760314|565210952|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580600|NCT04760314|565210953|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580601|NCT04760314|565210954|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580602|NCT04760314|565210955|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
156580603|NCT04760314|565210945|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
156580604|NCT04760314|565210946|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
156580605|NCT04760314|565210947|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
156580606|NCT04760314|565210948|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
156580607|NCT04760314|565210949|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
156580608|NCT04760314|565210950|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
156580609|NCT04760314|565210951|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
156580610|NCT04760314|565210952|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
156580611|NCT04760314|565210953|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
156580612|NCT04760314|565210954|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
156580613|NCT04760314|565210955|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
156580614|NCT04760314|565210945|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156580615|NCT04760314|565210946|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156580616|NCT04760314|565210947|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156580617|NCT04760314|565210948|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156580618|NCT04760314|565210949|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156580619|NCT04760314|565210950|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156580620|NCT04760314|565210951|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156580621|NCT04760314|565210952|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
156580622|NCT04760314|565210953|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156580623|NCT04760314|565210954|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
156580624|NCT04760314|565210955|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
156580625|NCT04760314|565210945|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156580626|NCT04760314|565210946|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156580627|NCT04760314|565210947|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156580628|NCT04760314|565210948|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156580629|NCT04760314|565210949|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156580630|NCT04760314|565210950|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156580631|NCT04760314|565210951|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156580632|NCT04760314|565210952|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
156580633|NCT04760314|565210953|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
156580634|NCT04760314|565210954|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
156580635|NCT04760314|565210955|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156580636|NCT04760314|565210945|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580637|NCT04760314|565210946|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580638|NCT04760314|565210947|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580639|NCT04760314|565210948|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580640|NCT04760314|565210949|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580641|NCT04760314|565210950|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580642|NCT04760314|565210951|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580643|NCT04760314|565210952|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
156580644|NCT04760314|565210953|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580645|NCT04760314|565210954|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580646|NCT04760314|565210955|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156580647|NCT04760314|565210945|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580648|NCT04760314|565210946|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580649|NCT04760314|565210947|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580650|NCT04760314|565210948|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580651|NCT04760314|565210949|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580652|NCT04760314|565210950|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580653|NCT04760314|565210951|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580654|NCT04760314|565210952|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580655|NCT04760314|565210953|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
156580656|NCT04760314|565210954|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
156580657|NCT04760314|565210955|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
156580658|NCT01013883|565210958|FG000|Overall Study|Lost to Follow-up|2|||
156580659|NCT01013883|565210959|FG001|Overall Study|Lost to Follow-up|2|||
156580660|NCT04275310|565210960|FG000|Overall Study|Non-randomized due to running out of funding|4|||
156580661|NCT04275310|565210961|FG001|Overall Study|Non-randomized due to running out of funding|0|||
156580662|NCT02345161|565210962|FG000|Overall Study|Withdrawal by Subject|25|||
156580663|NCT02345161|565210963|FG001|Overall Study|Withdrawal by Subject|33|||
156580664|NCT02345161|565210962|FG000|Overall Study|Adverse Event|16|||
156580665|NCT02345161|565210963|FG001|Overall Study|Adverse Event|19|||
156580666|NCT02345161|565210962|FG000|Overall Study|Physician Decision|4|||
156580667|NCT02345161|565210963|FG001|Overall Study|Physician Decision|4|||
156580668|NCT02345161|565210962|FG000|Overall Study|Lost to Follow-up|0|||
156580669|NCT02345161|565210963|FG001|Overall Study|Lost to Follow-up|1|||
156580670|NCT00972244|565210964|FG000|Overall Study|Incorrect Enrolment|1|||
156580671|NCT00972244|565210965|FG001|Overall Study|Incorrect Enrolment|0|||
156580672|NCT00972244|565210966|FG002|Overall Study|Incorrect Enrolment|0|||
156580673|NCT00972244|565210967|FG003|Overall Study|Incorrect Enrolment|0|||
156580674|NCT00972244|565210968|FG004|Overall Study|Incorrect Enrolment|0|||
156580675|NCT00972244|565210964|FG000|Overall Study|Adverse Event|0|||
156580676|NCT00972244|565210965|FG001|Overall Study|Adverse Event|1|||
156580677|NCT00972244|565210966|FG002|Overall Study|Adverse Event|1|||
156580678|NCT00972244|565210967|FG003|Overall Study|Adverse Event|0|||
156580679|NCT00972244|565210968|FG004|Overall Study|Adverse Event|0|||
156580680|NCT00972244|565210964|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
156580681|NCT00972244|565210965|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
156580682|NCT00972244|565210966|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
156580683|NCT00972244|565210967|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
156580684|NCT00972244|565210968|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
156580685|NCT00972244|565210964|FG000|Overall Study|Withdrawal by Subject|1|||
156580686|NCT00972244|565210965|FG001|Overall Study|Withdrawal by Subject|2|||
156580687|NCT00972244|565210966|FG002|Overall Study|Withdrawal by Subject|1|||
156580688|NCT00972244|565210967|FG003|Overall Study|Withdrawal by Subject|0|||
156580689|NCT00972244|565210968|FG004|Overall Study|Withdrawal by Subject|1|||
156580690|NCT00972244|565210964|FG000|Overall Study|Safety|0|||
156580691|NCT00972244|565210965|FG001|Overall Study|Safety|0|||
156580692|NCT00972244|565210966|FG002|Overall Study|Safety|0|||
156580693|NCT00972244|565210967|FG003|Overall Study|Safety|0|||
156580694|NCT00972244|565210968|FG004|Overall Study|Safety|1|||
156580695|NCT00972244|565210964|FG000|Overall Study|Death|1|||
156580696|NCT00972244|565210965|FG001|Overall Study|Death|0|||
156580697|NCT00972244|565210966|FG002|Overall Study|Death|0|||
156580698|NCT00972244|565210967|FG003|Overall Study|Death|0|||
156580699|NCT00972244|565210968|FG004|Overall Study|Death|0|||
156580700|NCT00972244|565210964|FG000|Overall Study|Various|0|||
156580701|NCT00972244|565210965|FG001|Overall Study|Various|0|||
156580702|NCT00972244|565210966|FG002|Overall Study|Various|0|||
156580703|NCT00972244|565210967|FG003|Overall Study|Various|0|||
156580704|NCT00972244|565210968|FG004|Overall Study|Various|2|||
156580705|NCT03554005|565210971|FG000|Overall Study|Not in participant's best interest|0|||
156580706|NCT03554005|565210972|FG001|Overall Study|Not in participant's best interest|0|||
156580707|NCT03554005|565210973|FG002|Overall Study|Not in participant's best interest|0|||
156580708|NCT03554005|565210974|FG003|Overall Study|Not in participant's best interest|0|||
156580709|NCT03554005|565210975|FG004|Overall Study|Not in participant's best interest|0|||
156580710|NCT03554005|565210976|FG005|Overall Study|Not in participant's best interest|1|||
156580711|NCT03554005|565210971|FG000|Overall Study|Disease Progression|1|||
156580712|NCT03554005|565210972|FG001|Overall Study|Disease Progression|1|||
156580713|NCT03554005|565210973|FG002|Overall Study|Disease Progression|1|||
156580714|NCT03554005|565210974|FG003|Overall Study|Disease Progression|1|||
156580715|NCT03554005|565210975|FG004|Overall Study|Disease Progression|5|||
156580716|NCT03554005|565210976|FG005|Overall Study|Disease Progression|6|||
156580717|NCT03554005|565210971|FG000|Overall Study|Adverse Event|0|||
156580718|NCT03554005|565210972|FG001|Overall Study|Adverse Event|0|||
156580719|NCT03554005|565210973|FG002|Overall Study|Adverse Event|0|||
156580720|NCT03554005|565210974|FG003|Overall Study|Adverse Event|0|||
156580721|NCT03554005|565210975|FG004|Overall Study|Adverse Event|0|||
156580722|NCT03554005|565210976|FG005|Overall Study|Adverse Event|3|||
156580723|NCT03554005|565210971|FG000|Overall Study|Physician Decision|0|||
156580724|NCT03554005|565210972|FG001|Overall Study|Physician Decision|0|||
156580725|NCT03554005|565210973|FG002|Overall Study|Physician Decision|0|||
156580726|NCT03554005|565210974|FG003|Overall Study|Physician Decision|0|||
156580727|NCT03554005|565210975|FG004|Overall Study|Physician Decision|1|||
156580728|NCT03554005|565210976|FG005|Overall Study|Physician Decision|0|||
156580729|NCT03554005|565210971|FG000|Overall Study|Other|0|||
156580730|NCT03554005|565210972|FG001|Overall Study|Other|0|||
156580731|NCT03554005|565210973|FG002|Overall Study|Other|0|||
156580732|NCT03554005|565210974|FG003|Overall Study|Other|0|||
156580733|NCT03554005|565210975|FG004|Overall Study|Other|0|||
156580734|NCT03554005|565210976|FG005|Overall Study|Other|1|||
156580735|NCT02639182|565210980|FG000|Overall Study|Disease Progression|50|||
156580736|NCT02639182|565210981|FG001|Overall Study|Disease Progression|49|||
156580737|NCT02639182|565210980|FG000|Overall Study|Adverse Event|7|||
156580738|NCT02639182|565210981|FG001|Overall Study|Adverse Event|5|||
156580739|NCT02639182|565210980|FG000|Overall Study|Physician Decision|3|||
156580740|NCT02639182|565210981|FG001|Overall Study|Physician Decision|3|||
156580741|NCT02639182|565210980|FG000|Overall Study|Withdrew Consent|5|||
156580742|NCT02639182|565210981|FG001|Overall Study|Withdrew Consent|4|||
156580743|NCT02639182|565210980|FG000|Overall Study|Lost to Follow-up|0|||
156580744|NCT02639182|565210981|FG001|Overall Study|Lost to Follow-up|1|||
156580745|NCT02639182|565210980|FG000|Overall Study|Study Closure|1|||
156580746|NCT02639182|565210981|FG001|Overall Study|Study Closure|2|||
156580747|NCT02639182|565210980|FG000|Overall Study|Sponsor Ended Study|0|||
156580748|NCT02639182|565210981|FG001|Overall Study|Sponsor Ended Study|1|||
156580749|NCT02639182|565210980|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
156580750|NCT02639182|565210981|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
156580751|NCT00907881|565210982|FG000|Overall Study|Lost to Follow-up|59|||
156580752|NCT00907881|565210982|FG000|Overall Study|Noncompliance|5|||
156580753|NCT00907881|565210982|FG000|Overall Study|Withdrawal by Subject|5|||
156580754|NCT00907881|565210982|FG000|Overall Study|Protocol Violation|1|||
156580755|NCT00907881|565210982|FG000|Overall Study|Missing discontinuation information|15|||
156580756|NCT02546856|565210985|FG000|4 Months Evaluation|Death|2|||
156580757|NCT02546856|565210986|FG001|4 Months Evaluation|Death|3|||
156580758|NCT02546856|565210985|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
156580759|NCT02546856|565210986|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
156580760|NCT02546856|565210985|FG000|4 Months Evaluation|Lost to Follow-up|3|||
156580761|NCT02546856|565210986|FG001|4 Months Evaluation|Lost to Follow-up|3|||
156580762|NCT02546856|565210985|FG000|4 Months Evaluation|Physician Decision|3|||
156580763|NCT02546856|565210986|FG001|4 Months Evaluation|Physician Decision|0|||
156580764|NCT02546856|565210985|FG000|4 Months Evaluation|Working or living abroad|5|||
156580765|NCT02546856|565210986|FG001|4 Months Evaluation|Working or living abroad|1|||
156580766|NCT02546856|565210985|FG000|4 Months Evaluation|reasons not due to titration|4|||
156580767|NCT02546856|565210986|FG001|4 Months Evaluation|reasons not due to titration|1|||
156580768|NCT02546856|565210985|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
156580769|NCT02546856|565210986|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
156580770|NCT02546856|565210985|FG000|6 Months Evaluation|Death|1|||
156580771|NCT02546856|565210986|FG001|6 Months Evaluation|Death|1|||
156580772|NCT02546856|565210985|FG000|6 Months Evaluation|Lost to Follow-up|1|||
156580773|NCT02546856|565210986|FG001|6 Months Evaluation|Lost to Follow-up|1|||
156580774|NCT02546856|565210985|FG000|6 Months Evaluation|Working or living abroad|6|||
156580775|NCT02546856|565210986|FG001|6 Months Evaluation|Working or living abroad|4|||
156580776|NCT02546856|565210985|FG000|6 Months Evaluation|reasons not due to titration|0|||
156580777|NCT02546856|565210986|FG001|6 Months Evaluation|reasons not due to titration|1|||
156580778|NCT00130208|565210991|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
156580779|NCT00130208|565210992|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
156580780|NCT00130208|565210991|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
156580781|NCT00130208|565210992|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
156580782|NCT00130208|565210991|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
156580783|NCT00130208|565210992|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
156580784|NCT00130208|565210991|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
156580785|NCT00130208|565210992|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
156580786|NCT00130208|565210991|FG000|Maintenance Period (26 Weeks)|Other|1|||
156580787|NCT00130208|565210992|FG001|Maintenance Period (26 Weeks)|Other|1|||
156580788|NCT00130208|565210991|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
156580789|NCT00130208|565210992|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
156580790|NCT00130208|565210991|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
156580791|NCT00130208|565210992|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
156580792|NCT00130208|565210991|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
156580793|NCT00130208|565210992|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
156580794|NCT00130208|565210991|FG000|Washout Period (8 Weeks)|Other|1|||
156580795|NCT00130208|565210992|FG001|Washout Period (8 Weeks)|Other|1|||
156580796|NCT04655586|565210995|FG000|Overall Study|Physician Decision|1|||
156580797|NCT04655586|565210996|FG001|Overall Study|Physician Decision|3|||
156580798|NCT04655586|565210997|FG002|Overall Study|Physician Decision|4|||
156580799|NCT04655586|565210995|FG000|Overall Study|Withdrawal by Subject|1|||
156580800|NCT04655586|565210996|FG001|Overall Study|Withdrawal by Subject|3|||
156580801|NCT04655586|565210997|FG002|Overall Study|Withdrawal by Subject|1|||
156580802|NCT00589472|565211004|FG000|Overall Study|Adverse Event|1|||
156580803|NCT01372878|565211005|FG000|Overall Study|Withdrawal by Subject|63|||
156580804|NCT01372878|565211005|FG000|Overall Study|Protocol Violation|17|||
156580805|NCT01372878|565211005|FG000|Overall Study|incomplete study procedure|104|||
156580806|NCT00117338|565211006|FG000|Overall Study|Adverse Event|0|||
156580807|NCT00117338|565211007|FG001|Overall Study|Adverse Event|1|||
156580808|NCT00117338|565211006|FG000|Overall Study|Protocol Violation|3|||
156580809|NCT00117338|565211007|FG001|Overall Study|Protocol Violation|2|||
156580810|NCT00117338|565211006|FG000|Overall Study|Withdrawal by Subject|1|||
156580811|NCT00117338|565211007|FG001|Overall Study|Withdrawal by Subject|0|||
156580812|NCT00117338|565211006|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
156580813|NCT00117338|565211007|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
156580814|NCT00117338|565211006|FG000|Overall Study|Lack of Efficacy|0|||
156580815|NCT00117338|565211007|FG001|Overall Study|Lack of Efficacy|1|||
156580816|NCT01380093|565211008|FG000|Naloxone Challenge Phase|Screen failures|21|||
156580817|NCT01380093|565211009|FG001|Naloxone Challenge Phase|Screen failures|0|||
156580818|NCT01380093|565211010|FG002|Naloxone Challenge Phase|Screen failures|0|||
156580819|NCT01380093|565211011|FG003|Naloxone Challenge Phase|Screen failures|0|||
156580820|NCT01380093|565211012|FG004|Naloxone Challenge Phase|Screen failures|0|||
156580821|NCT01380093|565211013|FG005|Naloxone Challenge Phase|Screen failures|0|||
156580822|NCT01380093|565211014|FG006|Naloxone Challenge Phase|Screen failures|0|||
156580823|NCT01380093|565211015|FG007|Naloxone Challenge Phase|Screen failures|0|||
156580824|NCT01380093|565211016|FG008|Naloxone Challenge Phase|Screen failures|0|||
156580825|NCT01380093|565211008|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
156580826|NCT01380093|565211009|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
156580827|NCT01380093|565211010|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
156580828|NCT01380093|565211011|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
156580829|NCT01380093|565211012|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
156580830|NCT01380093|565211013|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
156580831|NCT01380093|565211014|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
156580832|NCT01380093|565211015|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
156580833|NCT01380093|565211016|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
156580834|NCT01380093|565211008|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
156580835|NCT01380093|565211009|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
156580836|NCT01380093|565211010|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
156580837|NCT01380093|565211011|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
156580838|NCT01380093|565211012|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
156580839|NCT01380093|565211013|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
156580840|NCT01380093|565211014|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
156580841|NCT01380093|565211015|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
156580842|NCT01380093|565211016|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
156580843|NCT01380093|565211008|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
156580844|NCT01380093|565211009|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
156580845|NCT01380093|565211010|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
156580846|NCT01380093|565211011|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
156580847|NCT01380093|565211012|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
156580848|NCT01380093|565211013|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
156580849|NCT01380093|565211014|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
156580850|NCT01380093|565211015|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
156580851|NCT01380093|565211016|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
156580852|NCT01380093|565211008|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
156580853|NCT01380093|565211009|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
156580854|NCT01380093|565211010|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
156580855|NCT01380093|565211011|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
156580856|NCT01380093|565211012|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
156580857|NCT01380093|565211013|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
156580858|NCT01380093|565211014|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
156580859|NCT01380093|565211015|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
156580860|NCT01380093|565211016|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
156580861|NCT01380093|565211008|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
156580862|NCT01380093|565211009|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
156580863|NCT01380093|565211010|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
156580864|NCT01380093|565211011|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
156580865|NCT01380093|565211012|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
156580866|NCT01380093|565211013|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
156580867|NCT01380093|565211014|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
156580868|NCT01380093|565211015|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
156580869|NCT01380093|565211016|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
156580870|NCT01380093|565211008|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
156580871|NCT01380093|565211009|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
156580872|NCT01380093|565211010|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
156580873|NCT01380093|565211011|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
156580874|NCT01380093|565211012|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
156580875|NCT01380093|565211013|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
156580876|NCT01380093|565211014|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
156580877|NCT01380093|565211015|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
156580878|NCT01380093|565211016|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
156580879|NCT01380093|565211008|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
156580880|NCT01380093|565211009|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
156580881|NCT01380093|565211010|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
156580882|NCT01380093|565211011|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
156580883|NCT01380093|565211012|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
156580884|NCT01380093|565211013|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
156580885|NCT01380093|565211014|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
156580886|NCT01380093|565211015|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
156580887|NCT01380093|565211016|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
156580888|NCT01380093|565211008|FG000|Treatment Phase: Second Intervention|Other|0|||
156580889|NCT01380093|565211009|FG001|Treatment Phase: Second Intervention|Other|0|||
156580890|NCT01380093|565211010|FG002|Treatment Phase: Second Intervention|Other|0|||
156580891|NCT01380093|565211011|FG003|Treatment Phase: Second Intervention|Other|1|||
156580892|NCT01380093|565211012|FG004|Treatment Phase: Second Intervention|Other|0|||
156580893|NCT01380093|565211013|FG005|Treatment Phase: Second Intervention|Other|0|||
156580894|NCT01380093|565211014|FG006|Treatment Phase: Second Intervention|Other|0|||
156580895|NCT01380093|565211015|FG007|Treatment Phase: Second Intervention|Other|0|||
156580896|NCT01380093|565211016|FG008|Treatment Phase: Second Intervention|Other|0|||
156580897|NCT01380093|565211008|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
156580898|NCT01380093|565211009|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
156580899|NCT01380093|565211010|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
156580900|NCT01380093|565211011|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
156580901|NCT01380093|565211012|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
156580902|NCT01380093|565211013|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
156580903|NCT01380093|565211014|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
156580904|NCT01380093|565211015|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
156580905|NCT01380093|565211016|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
156580906|NCT01380093|565211008|FG000|Treatment Phase: Third Intervention|Other|0|||
156580907|NCT01380093|565211009|FG001|Treatment Phase: Third Intervention|Other|0|||
156580908|NCT01380093|565211010|FG002|Treatment Phase: Third Intervention|Other|0|||
156580909|NCT01380093|565211011|FG003|Treatment Phase: Third Intervention|Other|0|||
156580910|NCT01380093|565211012|FG004|Treatment Phase: Third Intervention|Other|0|||
156580911|NCT01380093|565211013|FG005|Treatment Phase: Third Intervention|Other|0|||
156580912|NCT01380093|565211014|FG006|Treatment Phase: Third Intervention|Other|0|||
156580913|NCT01380093|565211015|FG007|Treatment Phase: Third Intervention|Other|0|||
156580914|NCT01380093|565211016|FG008|Treatment Phase: Third Intervention|Other|1|||
156580915|NCT00546351|565211017|FG000|Overall Study|Adverse Event|76|||
156580916|NCT00546351|565211017|FG000|Overall Study|Lack of Efficacy|15|||
156580917|NCT00546351|565211017|FG000|Overall Study|Withdrawal by Subject|109|||
156580918|NCT00546351|565211017|FG000|Overall Study|Lost to Follow-up|9|||
156580919|NCT00546351|565211017|FG000|Overall Study|Protocol Deviation|1|||
156580920|NCT00546351|565211017|FG000|Overall Study|Unsatisfactory compliance|9|||
156580921|NCT00546351|565211017|FG000|Overall Study|Other reasons for premature termination|17|||
156580922|NCT04734873|565211018|FG000|Overall Study|Lost to Follow-up|1|||
156580923|NCT04734873|565211019|FG001|Overall Study|Lost to Follow-up|3|||
156580924|NCT04734873|565211020|FG002|Overall Study|Lost to Follow-up|2|||
156580925|NCT04734873|565211018|FG000|Overall Study|Randomized but not dosed|1|||
156580926|NCT04734873|565211019|FG001|Overall Study|Randomized but not dosed|0|||
156580927|NCT04734873|565211020|FG002|Overall Study|Randomized but not dosed|1|||
156580928|NCT02616029|565211022|FG000|Overall Study|Adverse Event|1|||
156580929|NCT02616029|565211023|FG001|Overall Study|Adverse Event|0|||
156580930|NCT02616029|565211022|FG000|Overall Study|Death|0|||
156580931|NCT02616029|565211023|FG001|Overall Study|Death|1|||
156580932|NCT02616029|565211022|FG000|Overall Study|Protocol Violation|1|||
156580933|NCT02616029|565211023|FG001|Overall Study|Protocol Violation|0|||
156580934|NCT02616029|565211022|FG000|Overall Study|Withdrew Consent|1|||
156580935|NCT02616029|565211023|FG001|Overall Study|Withdrew Consent|0|||
156580936|NCT02616029|565211022|FG000|Overall Study|Enrolled and Never Treated|1|||
156580937|NCT02616029|565211023|FG001|Overall Study|Enrolled and Never Treated|1|||
156580938|NCT00609609|565211024|FG000|Overall Study|Withdrawal by Subject|2|||
156580939|NCT00609609|565211025|FG001|Overall Study|Withdrawal by Subject|0|||
156580940|NCT00609609|565211024|FG000|Overall Study|Progression|4|||
156580941|NCT00609609|565211025|FG001|Overall Study|Progression|2|||
156580942|NCT03988751|565211026|FG000|Overall Study|Withdrawal by Subject|1|||
156580943|NCT03988751|565211027|FG001|Overall Study|Withdrawal by Subject|0|||
156580944|NCT03988751|565211026|FG000|Overall Study|Protocol Violation|0|||
156580945|NCT03988751|565211027|FG001|Overall Study|Protocol Violation|1|||
156580946|NCT00844883|565211028|FG000|Overall Study|Bridged to liver transplant|3|||
156580947|NCT00844883|565211028|FG000|Overall Study|Bridged to resection|1|||
156580948|NCT03065530|565211033|FG000|Overall Study|Lack of Efficacy|1|||
156580949|NCT03065530|565211034|FG001|Overall Study|Lack of Efficacy|1|||
156580950|NCT03065530|565211035|FG002|Overall Study|Lack of Efficacy|0|||
156580951|NCT03065530|565211036|FG003|Overall Study|Lack of Efficacy|1|||
156580952|NCT03065530|565211033|FG000|Overall Study|Protocol Violation|1|||
156580953|NCT03065530|565211034|FG001|Overall Study|Protocol Violation|0|||
156580954|NCT03065530|565211035|FG002|Overall Study|Protocol Violation|1|||
156580955|NCT03065530|565211036|FG003|Overall Study|Protocol Violation|1|||
156580956|NCT00479466|565211039|FG000|Overall Study|Adverse Event|5|||
156580957|NCT00479466|565211040|FG001|Overall Study|Adverse Event|1|||
156580958|NCT00479466|565211041|FG002|Overall Study|Adverse Event|0|||
156580959|NCT00479466|565211042|FG003|Overall Study|Adverse Event|1|||
156580960|NCT00479466|565211043|FG004|Overall Study|Adverse Event|2|||
156580961|NCT00479466|565211044|FG005|Overall Study|Adverse Event|0|||
156580962|NCT00479466|565211039|FG000|Overall Study|Hyperglycemia|0|||
156580963|NCT00479466|565211040|FG001|Overall Study|Hyperglycemia|0|||
156580964|NCT00479466|565211041|FG002|Overall Study|Hyperglycemia|0|||
156580965|NCT00479466|565211042|FG003|Overall Study|Hyperglycemia|0|||
156580966|NCT00479466|565211043|FG004|Overall Study|Hyperglycemia|0|||
156580967|NCT00479466|565211044|FG005|Overall Study|Hyperglycemia|1|||
156580968|NCT00479466|565211039|FG000|Overall Study|Lack of Efficacy|2|||
156580969|NCT00479466|565211040|FG001|Overall Study|Lack of Efficacy|0|||
156580970|NCT00479466|565211041|FG002|Overall Study|Lack of Efficacy|1|||
156580971|NCT00479466|565211042|FG003|Overall Study|Lack of Efficacy|0|||
156580972|NCT00479466|565211043|FG004|Overall Study|Lack of Efficacy|0|||
156580973|NCT00479466|565211044|FG005|Overall Study|Lack of Efficacy|0|||
156580974|NCT00479466|565211039|FG000|Overall Study|Lost to Follow-up|0|||
156580975|NCT00479466|565211040|FG001|Overall Study|Lost to Follow-up|1|||
156580976|NCT00479466|565211041|FG002|Overall Study|Lost to Follow-up|1|||
156580977|NCT00479466|565211042|FG003|Overall Study|Lost to Follow-up|0|||
156580978|NCT00479466|565211043|FG004|Overall Study|Lost to Follow-up|2|||
156580979|NCT00479466|565211044|FG005|Overall Study|Lost to Follow-up|2|||
156580980|NCT00479466|565211039|FG000|Overall Study|Physician Decision|2|||
156580981|NCT00479466|565211040|FG001|Overall Study|Physician Decision|1|||
156580982|NCT00479466|565211041|FG002|Overall Study|Physician Decision|1|||
156580983|NCT00479466|565211042|FG003|Overall Study|Physician Decision|0|||
156580984|NCT00479466|565211043|FG004|Overall Study|Physician Decision|0|||
156580985|NCT00479466|565211044|FG005|Overall Study|Physician Decision|0|||
156580986|NCT00479466|565211039|FG000|Overall Study|Pregnancy|0|||
156580987|NCT00479466|565211040|FG001|Overall Study|Pregnancy|0|||
156580988|NCT00479466|565211041|FG002|Overall Study|Pregnancy|0|||
156580989|NCT00479466|565211042|FG003|Overall Study|Pregnancy|0|||
156580990|NCT00479466|565211043|FG004|Overall Study|Pregnancy|1|||
156580991|NCT00479466|565211044|FG005|Overall Study|Pregnancy|0|||
156580992|NCT00479466|565211039|FG000|Overall Study|Protocol Violation|1|||
156580993|NCT00479466|565211040|FG001|Overall Study|Protocol Violation|0|||
156580994|NCT00479466|565211041|FG002|Overall Study|Protocol Violation|0|||
156580995|NCT00479466|565211042|FG003|Overall Study|Protocol Violation|0|||
156580996|NCT00479466|565211043|FG004|Overall Study|Protocol Violation|0|||
156580997|NCT00479466|565211044|FG005|Overall Study|Protocol Violation|0|||
156580998|NCT00479466|565211039|FG000|Overall Study|Withdrawal by Subject|3|||
156580999|NCT00479466|565211040|FG001|Overall Study|Withdrawal by Subject|5|||
156581000|NCT00479466|565211041|FG002|Overall Study|Withdrawal by Subject|0|||
156581001|NCT00479466|565211042|FG003|Overall Study|Withdrawal by Subject|2|||
156581002|NCT00479466|565211043|FG004|Overall Study|Withdrawal by Subject|3|||
156581003|NCT00479466|565211044|FG005|Overall Study|Withdrawal by Subject|1|||
156581004|NCT02927171|565211045|FG000|Overall Study|Lost to Follow-up|0|||
156581005|NCT02927171|565211046|FG001|Overall Study|Lost to Follow-up|1|||
156581006|NCT04530825|565211051|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
156581007|NCT04530825|565211052|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
156581008|NCT04530825|565211053|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
156581009|NCT04530825|565211054|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
156581010|NCT04530825|565211051|FG000|Overall Study|Did not complete follow-up|3|||
156581011|NCT04530825|565211052|FG001|Overall Study|Did not complete follow-up|0|||
156581012|NCT04530825|565211053|FG002|Overall Study|Did not complete follow-up|0|||
156581013|NCT04530825|565211054|FG003|Overall Study|Did not complete follow-up|0|||
156581014|NCT04101422|565211056|FG000|Overall Study|Ineligible|1|||
156581015|NCT04101422|565211057|FG001|Overall Study|Ineligible|0|||
156581016|NCT04101422|565211058|FG002|Overall Study|Ineligible|9|||
156581017|NCT04101422|565211059|FG003|Overall Study|Ineligible|0|||
156581018|NCT04101422|565211056|FG000|Overall Study|Withdrawal by Subject|0|||
156581019|NCT04101422|565211057|FG001|Overall Study|Withdrawal by Subject|0|||
156581020|NCT04101422|565211058|FG002|Overall Study|Withdrawal by Subject|1|||
156581021|NCT04101422|565211059|FG003|Overall Study|Withdrawal by Subject|0|||
156581022|NCT04101422|565211056|FG000|Overall Study|Not attending to the stimuli|0|||
156581023|NCT04101422|565211057|FG001|Overall Study|Not attending to the stimuli|0|||
156581024|NCT04101422|565211058|FG002|Overall Study|Not attending to the stimuli|4|||
156581025|NCT04101422|565211059|FG003|Overall Study|Not attending to the stimuli|0|||
156581026|NCT04101422|565211056|FG000|Overall Study|Did not download app|0|||
156581027|NCT04101422|565211057|FG001|Overall Study|Did not download app|0|||
156581028|NCT04101422|565211058|FG002|Overall Study|Did not download app|0|||
156581029|NCT04101422|565211059|FG003|Overall Study|Did not download app|17|||
156581030|NCT04101422|565211056|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
156581031|NCT04101422|565211057|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
156581032|NCT04101422|565211058|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
156581033|NCT04101422|565211059|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
156581034|NCT00850499|565211060|FG000|Overall Study|Adverse Event|3|||
156581035|NCT00850499|565211061|FG001|Overall Study|Adverse Event|1|||
156581036|NCT00850499|565211060|FG000|Overall Study|Lack of Efficacy|0|||
156581037|NCT00850499|565211061|FG001|Overall Study|Lack of Efficacy|1|||
156581038|NCT00552305|565211062|FG000|Overall Study|Adverse Event|43|||
156581039|NCT00552305|565211062|FG000|Overall Study|Lack of Efficacy|120|||
156581040|NCT00552305|565211062|FG000|Overall Study|Lost to Follow-up|4|||
156581041|NCT00552305|565211062|FG000|Overall Study|Protocol Violation|3|||
156581042|NCT00552305|565211062|FG000|Overall Study|Withdrawal by Subject|44|||
156581043|NCT00552305|565211062|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
156581044|NCT00552305|565211062|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
156581045|NCT00552305|565211062|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
156581046|NCT00552305|565211062|FG000|Overall Study|Unsatisfactory compliance|11|||
156581047|NCT00552305|565211062|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
156581048|NCT00552305|565211062|FG000|Overall Study|AE/Other: prohibited drug required|1|||
156581049|NCT00552305|565211062|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
156581050|NCT00552305|565211062|FG000|Overall Study|Other: Site closed|4|||
156581051|NCT00552305|565211062|FG000|Overall Study|Other: Personal problems|1|||
156581052|NCT00552305|565211062|FG000|Overall Study|Other: Unable to attend visits|1|||
156581053|NCT00552305|565211062|FG000|Overall Study|Other: Subject underwent surgery|4|||
156581054|NCT00552305|565211062|FG000|Overall Study|Other: Subject became pregnant|1|||
156581055|NCT00552305|565211062|FG000|Overall Study|Other: Health problems, not drug related|1|||
156581056|NCT00552305|565211062|FG000|Overall Study|Other: Subject moved from area|2|||
156581057|NCT00552305|565211062|FG000|Overall Study|Other: Subject incarcerated|1|||
156581058|NCT00552305|565211062|FG000|Overall Study|Other: Subject went to rehab|1|||
156581059|NCT00718861|565211063|FG000|Overall Study|Withdrawal by Subject|15|||
156581060|NCT00718861|565211064|FG001|Overall Study|Withdrawal by Subject|10|||
156581061|NCT00718861|565211063|FG000|Overall Study|Adverse Event|2|||
156581062|NCT00718861|565211064|FG001|Overall Study|Adverse Event|1|||
156581063|NCT00718861|565211063|FG000|Overall Study|Lost to Follow-up|2|||
156581064|NCT00718861|565211064|FG001|Overall Study|Lost to Follow-up|1|||
156581065|NCT00718861|565211063|FG000|Overall Study|Administrative Problems|1|||
156581066|NCT00718861|565211064|FG001|Overall Study|Administrative Problems|1|||
156581067|NCT00718861|565211063|FG000|Overall Study|Death|1|||
156581068|NCT00718861|565211064|FG001|Overall Study|Death|5|||
156581069|NCT01703819|565211065|FG000|Overall Study|Adverse Event|0|||
156581070|NCT01703819|565211066|FG001|Overall Study|Adverse Event|1|||
156581071|NCT01703819|565211065|FG000|Overall Study|Withdrawal by Subject|0|||
156581072|NCT01703819|565211066|FG001|Overall Study|Withdrawal by Subject|1|||
156581073|NCT04230486|565211073|FG000|Overall Study|Screen Failure|1|||
156581074|NCT01302041|565211074|FG000|Overall Study|Death|5|||
156581075|NCT01302041|565211074|FG000|Overall Study|Withdrawal by Subject|4|||
156581076|NCT01302041|565211074|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
156581077|NCT01302041|565211074|FG000|Overall Study|Other-Miscellaneous Reason|2|||
156581078|NCT02234583|565211079|FG000|Overall Study|Adverse Event|172|||
156581079|NCT02234583|565211080|FG001|Overall Study|Adverse Event|156|||
156581080|NCT02234583|565211079|FG000|Overall Study|Withdrawal by Subject|109|||
156581081|NCT02234583|565211080|FG001|Overall Study|Withdrawal by Subject|157|||
156581082|NCT02234583|565211079|FG000|Overall Study|Lost to Follow-up|0|||
156581083|NCT02234583|565211080|FG001|Overall Study|Lost to Follow-up|1|||
156581084|NCT02234583|565211079|FG000|Overall Study|Lack of Efficacy|58|||
156581085|NCT02234583|565211080|FG001|Overall Study|Lack of Efficacy|103|||
156581086|NCT02234583|565211079|FG000|Overall Study|Protocol Violation|35|||
156581087|NCT02234583|565211080|FG001|Overall Study|Protocol Violation|42|||
156581088|NCT02234583|565211079|FG000|Overall Study|Other|39|||
156581089|NCT02234583|565211080|FG001|Overall Study|Other|97|||
156581090|NCT01849250|565211081|FG000|Overall Study|Withdrawal by Subject|1|||
156581091|NCT01849250|565211082|FG001|Overall Study|Withdrawal by Subject|0|||
156581092|NCT01849250|565211081|FG000|Overall Study|Not Evaluable|5|||
156581093|NCT01849250|565211082|FG001|Overall Study|Not Evaluable|3|||
156581094|NCT01849250|565211081|FG000|Overall Study|Screen Failure|1|||
156581095|NCT01849250|565211082|FG001|Overall Study|Screen Failure|0|||
156581096|NCT04504032|565211085|FG000|Overall Study|Adverse Event|1|||
156581097|NCT04504032|565211086|FG001|Overall Study|Adverse Event|2|||
156581098|NCT04504032|565211085|FG000|Overall Study|Lost to Follow-up|6|||
156581099|NCT04504032|565211086|FG001|Overall Study|Lost to Follow-up|9|||
156581100|NCT04504032|565211085|FG000|Overall Study|Protocol Violation|2|||
156581101|NCT04504032|565211086|FG001|Overall Study|Protocol Violation|0|||
156581102|NCT04504032|565211085|FG000|Overall Study|Study terminated by sponsor|1|||
156581103|NCT04504032|565211086|FG001|Overall Study|Study terminated by sponsor|2|||
156581104|NCT04504032|565211085|FG000|Overall Study|Withdrawal by Subject|9|||
156581105|NCT04504032|565211086|FG001|Overall Study|Withdrawal by Subject|11|||
156581106|NCT04504032|565211085|FG000|Overall Study|Disease progression prior to dosing|15|||
156581107|NCT04504032|565211086|FG001|Overall Study|Disease progression prior to dosing|3|||
156581108|NCT04504032|565211085|FG000|Overall Study|Drug supply issues|1|||
156581109|NCT04504032|565211086|FG001|Overall Study|Drug supply issues|1|||
156581110|NCT04504032|565211085|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
156581111|NCT04504032|565211086|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
156581112|NCT00771030|565211087|FG000|Overall Study|Adverse Event|0|||
156581113|NCT00771030|565211088|FG001|Overall Study|Adverse Event|1|||
156581114|NCT00771030|565211089|FG002|Overall Study|Adverse Event|0|||
156581115|NCT00771030|565211090|FG003|Overall Study|Adverse Event|0|||
156581116|NCT00771030|565211091|FG004|Overall Study|Adverse Event|0|||
156581117|NCT00771030|565211092|FG005|Overall Study|Adverse Event|0|||
156581118|NCT00771030|565211093|FG006|Overall Study|Adverse Event|0|||
156581119|NCT01839188|565211094|FG000|Overall Study|Withdrawal by Subject|1|||
156581120|NCT04983901|565211095|FG000|Overall Study|Death|1|||
156581121|NCT04983901|565211096|FG001|Overall Study|Death|4|||
156581122|NCT04983901|565211095|FG000|Overall Study|Lost to Follow-up|3|||
156581123|NCT04983901|565211096|FG001|Overall Study|Lost to Follow-up|0|||
156581124|NCT04983901|565211095|FG000|Overall Study|Protocol Violation|1|||
156581125|NCT04983901|565211096|FG001|Overall Study|Protocol Violation|0|||
156581126|NCT04983901|565211095|FG000|Overall Study|Withdrawal by Subject|1|||
156581127|NCT04983901|565211096|FG001|Overall Study|Withdrawal by Subject|2|||
156581128|NCT01174784|565211097|FG000|Overall Study|Screen fails|4|||
156581129|NCT04156646|565211098|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
156581130|NCT04156646|565211099|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
156581131|NCT03268746|565212667|FG000|Overall Study|Withdrawal by Subject|1|||
156581132|NCT02345434|565212675|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
156581133|NCT02345434|565212676|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
156581134|NCT02805907|565212682|FG000|Overall Study|Lost to Follow-up|3|||
156581135|NCT02805907|565212683|FG001|Overall Study|Lost to Follow-up|3|||
156581136|NCT01671488|565212705|FG000|Overall Study|Withdrawal by Subject|1|||
156581137|NCT01022853|565212706|FG000|Overall Study|Progressive disease|2|||
156581138|NCT01022853|565212707|FG001|Overall Study|Progressive disease|3|||
156581139|NCT01022853|565212708|FG002|Overall Study|Progressive disease|11|||
156581140|NCT01022853|565212709|FG003|Overall Study|Progressive disease|7|||
156581141|NCT01022853|565212710|FG004|Overall Study|Progressive disease|1|||
156581142|NCT01022853|565212706|FG000|Overall Study|Dose-limiting toxicity|0|||
156581143|NCT01022853|565212707|FG001|Overall Study|Dose-limiting toxicity|0|||
156581144|NCT01022853|565212708|FG002|Overall Study|Dose-limiting toxicity|0|||
156581145|NCT01022853|565212709|FG003|Overall Study|Dose-limiting toxicity|0|||
156581146|NCT01022853|565212710|FG004|Overall Study|Dose-limiting toxicity|1|||
156581147|NCT01022853|565212706|FG000|Overall Study|Withdrawal by Subject|0|||
156581148|NCT01022853|565212707|FG001|Overall Study|Withdrawal by Subject|1|||
156581149|NCT01022853|565212708|FG002|Overall Study|Withdrawal by Subject|1|||
156581150|NCT01022853|565212709|FG003|Overall Study|Withdrawal by Subject|1|||
156581151|NCT01022853|565212710|FG004|Overall Study|Withdrawal by Subject|0|||
156581152|NCT01022853|565212706|FG000|Overall Study|Other not stated above|1|||
156581153|NCT01022853|565212707|FG001|Overall Study|Other not stated above|0|||
156581154|NCT01022853|565212708|FG002|Overall Study|Other not stated above|1|||
156581155|NCT01022853|565212709|FG003|Overall Study|Other not stated above|0|||
156581156|NCT01022853|565212710|FG004|Overall Study|Other not stated above|0|||
156581157|NCT02416908|565212711|FG000|Dose Escalation Phase|Adverse Event|0|||
156581158|NCT02416908|565212712|FG001|Dose Escalation Phase|Adverse Event|0|||
156581159|NCT02416908|565212713|FG002|Dose Escalation Phase|Adverse Event|3|||
156581160|NCT02416908|565212714|FG003|Dose Escalation Phase|Adverse Event|0|||
156581161|NCT02416908|565212711|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
156581162|NCT02416908|565212712|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
156581163|NCT02416908|565212713|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
156581164|NCT02416908|565212714|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156581165|NCT00532883|565212715|FG000|Overall Study|Adverse Event|1|||
156581166|NCT00532883|565212716|FG001|Overall Study|Adverse Event|0|||
156581167|NCT00532883|565212717|FG002|Overall Study|Adverse Event|0|||
156581168|NCT00532883|565212718|FG003|Overall Study|Adverse Event|1|||
156581169|NCT00532883|565212715|FG000|Overall Study|Lost to Follow-up|1|||
156581170|NCT00532883|565212716|FG001|Overall Study|Lost to Follow-up|1|||
156581171|NCT00532883|565212717|FG002|Overall Study|Lost to Follow-up|1|||
156581172|NCT00532883|565212718|FG003|Overall Study|Lost to Follow-up|0|||
156581173|NCT00532883|565212715|FG000|Overall Study|Withdrawal by Subject|0|||
156581174|NCT00532883|565212716|FG001|Overall Study|Withdrawal by Subject|1|||
156581175|NCT00532883|565212717|FG002|Overall Study|Withdrawal by Subject|1|||
156581176|NCT00532883|565212718|FG003|Overall Study|Withdrawal by Subject|0|||
156581177|NCT00532883|565212715|FG000|Overall Study|Subject was Nonadherent|0|||
156581178|NCT00532883|565212716|FG001|Overall Study|Subject was Nonadherent|1|||
156581179|NCT00532883|565212717|FG002|Overall Study|Subject was Nonadherent|1|||
156581180|NCT00532883|565212718|FG003|Overall Study|Subject was Nonadherent|0|||
156581181|NCT00532883|565212715|FG000|Overall Study|Early Study Termination|4|||
156581182|NCT00532883|565212716|FG001|Overall Study|Early Study Termination|4|||
156581183|NCT00532883|565212717|FG002|Overall Study|Early Study Termination|1|||
156581184|NCT00532883|565212718|FG003|Overall Study|Early Study Termination|4|||
156581185|NCT01214434|565212721|FG000|Overall Study|Withdrawal by Subject|1|||
156581186|NCT01214434|565212722|FG001|Overall Study|Withdrawal by Subject|0|||
156581187|NCT01214434|565212721|FG000|Overall Study|Lost to Follow-up|2|||
156581188|NCT01214434|565212722|FG001|Overall Study|Lost to Follow-up|2|||
156581189|NCT01214434|565212721|FG000|Overall Study|Site error|1|||
156581190|NCT01214434|565212722|FG001|Overall Study|Site error|0|||
156581191|NCT03799718|565212723|FG000|Overall Study|Adverse Event|2|||
156581192|NCT02075255|565212725|FG000|Overall Study|Study specific withdrawal criteria|0|||
156581193|NCT02075255|565212726|FG001|Overall Study|Study specific withdrawal criteria|1|||
156581194|NCT02075255|565212727|FG002|Overall Study|Study specific withdrawal criteria|1|||
156581195|NCT02075255|565212725|FG000|Overall Study|Withdrawal by Subject|4|||
156581196|NCT02075255|565212726|FG001|Overall Study|Withdrawal by Subject|1|||
156581197|NCT02075255|565212727|FG002|Overall Study|Withdrawal by Subject|0|||
156581198|NCT02075255|565212725|FG000|Overall Study|Lost to Follow-up|0|||
156581199|NCT02075255|565212726|FG001|Overall Study|Lost to Follow-up|0|||
156581200|NCT02075255|565212727|FG002|Overall Study|Lost to Follow-up|1|||
156581201|NCT02075255|565212725|FG000|Overall Study|Adverse Event|0|||
156581202|NCT02075255|565212726|FG001|Overall Study|Adverse Event|0|||
156581203|NCT02075255|565212727|FG002|Overall Study|Adverse Event|1|||
156581204|NCT02075255|565212725|FG000|Overall Study|Death|0|||
156581205|NCT02075255|565212726|FG001|Overall Study|Death|2|||
156581206|NCT02075255|565212727|FG002|Overall Study|Death|0|||
156581207|NCT03792750|565212728|FG000|Overall Study|Death|3|||
156581208|NCT01651052|565212729|FG000|Overall Study|Death|21|||
156581209|NCT01651052|565212729|FG000|Overall Study|Explant|1|||
156581210|NCT01651052|565212729|FG000|Overall Study|Withdrawal by Subject|1|||
156581211|NCT01651052|565212729|FG000|Overall Study|Lost to Follow-up|3|||
156581212|NCT03503773|565212730|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
156581213|NCT03503773|565212731|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
156581214|NCT03503773|565212730|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
156581215|NCT03503773|565212731|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
156581216|NCT03503773|565212730|FG000|Overall Study|Not completing the primary ABPM|3|||
156581217|NCT03503773|565212731|FG001|Overall Study|Not completing the primary ABPM|1|||
156581218|NCT03503773|565212730|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
156581219|NCT03503773|565212731|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
156581220|NCT00425438|565212735|FG000|Overall Study|Termination by Sponsor|25|||
156581221|NCT00425438|565212736|FG001|Overall Study|Termination by Sponsor|27|||
156581222|NCT02902809|565212739|FG000|Overall Study|Discontinuation of asthma program|28|||
156581223|NCT00532259|565212740|FG000|Overall Study|Withdrawal by Subject|2|||
156581224|NCT00532259|565212740|FG000|Overall Study|Adverse Event|1|||
156581225|NCT00532259|565212740|FG000|Overall Study|Death|1|||
156581226|NCT00532259|565212740|FG000|Overall Study|Lack of Efficacy|21|||
156581227|NCT00532259|565212740|FG000|Overall Study|Lost to Follow-up|3|||
156581228|NCT00532259|565212740|FG000|Overall Study|Physician Decision|3|||
156581229|NCT00532259|565212740|FG000|Overall Study|Protocol Violation|1|||
156581230|NCT01188798|565212741|FG000|Overall Study|Death|0|||
156581231|NCT01188798|565212742|FG001|Overall Study|Death|1|||
156581232|NCT01188798|565212741|FG000|Overall Study|Required additional transplant|1|||
156581233|NCT01188798|565212742|FG001|Overall Study|Required additional transplant|1|||
156581234|NCT01188798|565212741|FG000|Overall Study|Protocol closure|1|||
156581235|NCT01188798|565212742|FG001|Overall Study|Protocol closure|1|||
156581236|NCT02795767|565212743|FG000|Overall Study|Received Commercial Emicizumab|1|||
156581237|NCT02795767|565212744|FG001|Overall Study|Received Commercial Emicizumab|0|||
156581238|NCT02795767|565212745|FG002|Overall Study|Received Commercial Emicizumab|0|||
156581239|NCT03964415|565212750|FG000|Overall Study|Sponsor's decision|1563|||
156581240|NCT03964415|565212751|FG001|Overall Study|Sponsor's decision|1528|||
156581241|NCT03964415|565212750|FG000|Overall Study|Lost to Follow-up|139|||
156581242|NCT03964415|565212751|FG001|Overall Study|Lost to Follow-up|146|||
156581243|NCT03964415|565212750|FG000|Overall Study|Withdrawal by Subject|68|||
156581244|NCT03964415|565212751|FG001|Overall Study|Withdrawal by Subject|72|||
156581245|NCT03964415|565212750|FG000|Overall Study|Physician Decision|34|||
156581246|NCT03964415|565212751|FG001|Overall Study|Physician Decision|48|||
156581247|NCT03964415|565212750|FG000|Overall Study|Adverse Event|3|||
156581248|NCT03964415|565212751|FG001|Overall Study|Adverse Event|0|||
156581249|NCT03964415|565212750|FG000|Overall Study|Death|4|||
156581250|NCT03964415|565212751|FG001|Overall Study|Death|6|||
156581251|NCT03964415|565212750|FG000|Overall Study|Protocol Violation|1|||
156581252|NCT03964415|565212751|FG001|Overall Study|Protocol Violation|4|||
156581253|NCT03964415|565212750|FG000|Overall Study|Other|35|||
156581254|NCT03964415|565212751|FG001|Overall Study|Other|38|||
156581255|NCT03964415|565212750|FG000|Overall Study|Randomized but not treated|6|||
156581256|NCT03964415|565212751|FG001|Overall Study|Randomized but not treated|7|||
156581257|NCT03662334|565212752|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
156581258|NCT03662334|565212753|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
156581259|NCT01097330|565212758|FG000|Overall Study|Study terminated early|7|||
156581260|NCT01097330|565212759|FG001|Overall Study|Study terminated early|5|||
156581261|NCT04983940|565212760|FG000|Overall Study|Lost to Follow-up|14|||
156581262|NCT04983940|565212760|FG000|Overall Study|Lack of Efficacy|2|||
156581263|NCT01478347|565212766|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
156581264|NCT01478347|565212766|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
156581265|NCT01478347|565212766|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
156581266|NCT01645930|565212767|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
156581267|NCT01645930|565212767|FG000|Overall Study|Progressive Disease|12|||
156581268|NCT01645930|565212767|FG000|Overall Study|Adverse Event|4|||
156581269|NCT01645930|565212767|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
156581270|NCT01645930|565212767|FG000|Overall Study|Withdrawal by Participant|2|||
156581271|NCT01645930|565212767|FG000|Overall Study|Reason not Defined|1|||
156581272|NCT01748760|565212768|FG000|Overall Study|Withdrawal by Subject|1|||
156581273|NCT01748760|565212769|FG001|Overall Study|Withdrawal by Subject|1|||
156581274|NCT01748760|565212768|FG000|Overall Study|Lost to Follow-up|5|||
156581275|NCT01748760|565212769|FG001|Overall Study|Lost to Follow-up|1|||
156581276|NCT03245814|565212770|FG000|Overall Study|Lost to Follow-up|5|||
156581277|NCT03245814|565212771|FG001|Overall Study|Lost to Follow-up|8|||
156581278|NCT03245814|565212770|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
156581279|NCT03245814|565212771|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
156581280|NCT02263365|565212776|FG000|Overall Study|Physician Decision|22|||
156581281|NCT02263365|565212777|FG001|Overall Study|Physician Decision|18|||
156581282|NCT00510692|565212778|FG000|Overall Study|Adverse Event|1|||
156581283|NCT00510692|565212779|FG001|Overall Study|Adverse Event|3|||
156581284|NCT00510692|565212778|FG000|Overall Study|Withdrawal by Subject|1|||
156581285|NCT00510692|565212779|FG001|Overall Study|Withdrawal by Subject|0|||
156581286|NCT00945191|565212780|FG000|Overall Study|Did not achieve a complete response|18|||
156581287|NCT00945191|565212780|FG000|Overall Study|Participant relocated to another state|1|||
156581288|NCT00945191|565212780|FG000|Overall Study|Disease progression|3|||
156581289|NCT00945191|565212780|FG000|Overall Study|Serious adverse event or adverse event|1|||
156581290|NCT00945191|565212780|FG000|Overall Study|Investigator's discretion|1|||
156581291|NCT02116972|565212781|FG000|Overall Study|Adverse Event|4|||
156581292|NCT02116972|565212782|FG001|Overall Study|Adverse Event|4|||
156581293|NCT02116972|565212783|FG002|Overall Study|Adverse Event|1|||
156581294|NCT02116972|565212781|FG000|Overall Study|Withdrawal by Subject|1|||
156581295|NCT02116972|565212782|FG001|Overall Study|Withdrawal by Subject|1|||
156581296|NCT02116972|565212783|FG002|Overall Study|Withdrawal by Subject|5|||
156581297|NCT02116972|565212781|FG000|Overall Study|Protocol Violation|1|||
156581298|NCT02116972|565212782|FG001|Overall Study|Protocol Violation|0|||
156581299|NCT02116972|565212783|FG002|Overall Study|Protocol Violation|1|||
156581300|NCT02116972|565212781|FG000|Overall Study|Lost to Follow-up|4|||
156581301|NCT02116972|565212782|FG001|Overall Study|Lost to Follow-up|3|||
156581302|NCT02116972|565212783|FG002|Overall Study|Lost to Follow-up|1|||
156581303|NCT02116972|565212781|FG000|Overall Study|Lack of Efficacy|6|||
156581304|NCT02116972|565212782|FG001|Overall Study|Lack of Efficacy|6|||
156581305|NCT02116972|565212783|FG002|Overall Study|Lack of Efficacy|5|||
156581306|NCT02116972|565212781|FG000|Overall Study|scheduling conflicts and relocation|3|||
156581307|NCT02116972|565212782|FG001|Overall Study|scheduling conflicts and relocation|3|||
156581308|NCT02116972|565212783|FG002|Overall Study|scheduling conflicts and relocation|6|||
156581309|NCT00784784|565212786|FG000|Overall Study|Withdrawal by Subject|2|||
156581310|NCT00784784|565212787|FG001|Overall Study|Withdrawal by Subject|2|||
156581311|NCT01879618|565212788|FG000|Overall Study|Does not meet entrance criteria|1|||
156581312|NCT01879618|565212788|FG000|Overall Study|Withdrawal by Subject|1|||
156581313|NCT01879618|565212788|FG000|Overall Study|Surgery;changed schedule; not available|8|||
156581314|NCT01879618|565212788|FG000|Overall Study|Protocol Violation|6|||
156581315|NCT01879618|565212788|FG000|Overall Study|Adverse Event|5|||
156581316|NCT01004146|565212793|FG000|Overall Study|Withdrawal by Subject|4|||
156581317|NCT01004146|565212794|FG001|Overall Study|Withdrawal by Subject|5|||
156581318|NCT01001494|565212801|FG000|Overall Study|Adverse Event|8|||
156581319|NCT01001494|565212802|FG001|Overall Study|Adverse Event|4|||
156581320|NCT01001494|565212803|FG002|Overall Study|Adverse Event|6|||
156581321|NCT01001494|565212801|FG000|Overall Study|Protocol Violation|0|||
156581322|NCT01001494|565212802|FG001|Overall Study|Protocol Violation|1|||
156581323|NCT01001494|565212803|FG002|Overall Study|Protocol Violation|1|||
156581324|NCT01001494|565212801|FG000|Overall Study|Lost to Follow-up|2|||
156581325|NCT01001494|565212802|FG001|Overall Study|Lost to Follow-up|0|||
156581326|NCT01001494|565212803|FG002|Overall Study|Lost to Follow-up|1|||
156581327|NCT01001494|565212801|FG000|Overall Study|Withdrawal by Subject|9|||
156581328|NCT01001494|565212802|FG001|Overall Study|Withdrawal by Subject|7|||
156581329|NCT01001494|565212803|FG002|Overall Study|Withdrawal by Subject|17|||
156581330|NCT01001494|565212801|FG000|Overall Study|COPD exacerbation|3|||
156581331|NCT01001494|565212802|FG001|Overall Study|COPD exacerbation|4|||
156581332|NCT01001494|565212803|FG002|Overall Study|COPD exacerbation|5|||
156581333|NCT01001494|565212801|FG000|Overall Study|Lack of Efficacy|2|||
156581334|NCT01001494|565212802|FG001|Overall Study|Lack of Efficacy|0|||
156581335|NCT01001494|565212803|FG002|Overall Study|Lack of Efficacy|8|||
156581336|NCT01001494|565212801|FG000|Overall Study|Other|0|||
156581337|NCT01001494|565212802|FG001|Overall Study|Other|1|||
156581338|NCT01001494|565212803|FG002|Overall Study|Other|3|||
156581339|NCT05270694|565213984|FG000|Overall Study|Death|1|||
156581340|NCT05270694|565213984|FG000|Overall Study|Medical issues impacted ability to participate|2|||
156581341|NCT05270694|565213984|FG000|Overall Study|Lost to Follow-up|3|||
156581342|NCT05270694|565213984|FG000|Overall Study|Withdrawal by Subject|3|||
156581343|NCT04267562|565213985|FG000|Assessed for Eligibility|Screen Failure|64|||
156581344|NCT04267562|565213985|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
156581345|NCT04267562|565213985|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
156581346|NCT04267562|565213985|FG000|Assessed for Eligibility|Site closure|6|||
156581347|NCT04267562|565213985|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
156581348|NCT04267562|565213985|FG000|Assessed for Eligibility|Physician Decision|1|||
156581349|NCT04267562|565213985|FG000|Month 24|Elective hysterectomy|1|||
156581350|NCT04267562|565213985|FG000|Month 24|Lost to Follow-up|1|||
156581351|NCT04267562|565213985|FG000|Month 36|Elective hysterectomy|2|||
156581352|NCT04267562|565213985|FG000|Month 36|Lost to Follow-up|3|||
156581353|NCT00710034|565213989|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
156581354|NCT00710034|565213990|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
156581355|NCT00710034|565213989|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
156581356|NCT00710034|565213990|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
156581357|NCT00710034|565213989|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
156581358|NCT00710034|565213990|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
156581359|NCT00710034|565213989|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
156581360|NCT00710034|565213990|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
156581361|NCT00710034|565213989|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
156581362|NCT00710034|565213990|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
156581363|NCT00710034|565213989|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
156581364|NCT00710034|565213990|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
156581365|NCT00710034|565213989|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
156581366|NCT00710034|565213990|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
156581367|NCT00710034|565213989|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
156581368|NCT00710034|565213990|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
156581369|NCT00710034|565213989|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
156581370|NCT00710034|565213990|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
156581371|NCT00710034|565213989|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
156581372|NCT00710034|565213990|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
156581373|NCT00710034|565213989|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
156581374|NCT00710034|565213990|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
156581375|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
156581376|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
156581377|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
156581378|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
156581379|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Death|8|||
156581380|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Death|3|||
156581381|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
156581382|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
156581383|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
156581384|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
156581385|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
156581386|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
156581387|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
156581388|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
156581389|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
156581390|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
156581391|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
156581392|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
156581393|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
156581394|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
156581395|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
156581396|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
156581397|NCT00494871|565213991|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
156581398|NCT00494871|565213992|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
156581399|NCT00494871|565213991|FG000|Follow-up (FU) Period|Adverse Event|1|||
156581400|NCT00494871|565213992|FG001|Follow-up (FU) Period|Adverse Event|1|||
156581401|NCT00494871|565213991|FG000|Follow-up (FU) Period|Death|13|||
156581402|NCT00494871|565213992|FG001|Follow-up (FU) Period|Death|12|||
156581403|NCT00494871|565213991|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
156581404|NCT00494871|565213992|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
156581405|NCT00494871|565213991|FG000|Follow-up (FU) Period|Physician Decision|0|||
156581406|NCT00494871|565213992|FG001|Follow-up (FU) Period|Physician Decision|1|||
156581407|NCT00494871|565213991|FG000|Follow-up (FU) Period|Protocol Violation|1|||
156581408|NCT00494871|565213992|FG001|Follow-up (FU) Period|Protocol Violation|0|||
156581409|NCT00494871|565213991|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
156581410|NCT00494871|565213992|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
156581411|NCT00494871|565213991|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
156581412|NCT00494871|565213992|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
156581413|NCT03238248|565213993|FG000|Overall Study|Death|5|||
156581414|NCT03238248|565213993|FG000|Overall Study|Withdrawal by Subject|7|||
156581415|NCT03238248|565213993|FG000|Overall Study|Participant proceeding to transplant|10|||
156581416|NCT03238248|565213993|FG000|Overall Study|Lack of Efficacy|4|||
156581417|NCT03238248|565213993|FG000|Overall Study|Physician Decision|3|||
156581418|NCT03238248|565213993|FG000|Overall Study|Transitioning to another study|1|||
156581419|NCT03238248|565213993|FG000|Overall Study|No longer benefiting|1|||
156581420|NCT03238248|565213993|FG000|Overall Study|Other complicating disease|1|||
156581421|NCT03238248|565213993|FG000|Overall Study|Adverse Event|5|||
156581422|NCT03238248|565213993|FG000|Overall Study|Disease progression|26|||
156581423|NCT03238248|565213993|FG000|Overall Study|N/A participant is still on treatment|1|||
156581424|NCT03238248|565213993|FG000|Overall Study|Decline in condition|1|||
156581425|NCT03238248|565213993|FG000|Overall Study|Alternative therapy|2|||
156581426|NCT02241512|565214000|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
156581427|NCT02241512|565214001|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
156581428|NCT02385123|565214007|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
156581429|NCT04498910|565214008|FG000|Overall Study|Lost to Follow-up|0|||
156581430|NCT04498910|565214009|FG001|Overall Study|Lost to Follow-up|1|||
156581431|NCT04498910|565214008|FG000|Overall Study|Withdrawal by Subject|2|||
156581432|NCT04498910|565214009|FG001|Overall Study|Withdrawal by Subject|1|||
156581433|NCT04498910|565214008|FG000|Overall Study|Adverse Event|1|||
156581434|NCT04498910|565214009|FG001|Overall Study|Adverse Event|0|||
156581435|NCT01070303|565214010|FG000|Overall Study|Adverse Event|39|||
156581436|NCT01070303|565214010|FG000|Overall Study|Withdrawal by Subject|20|||
156581437|NCT01070303|565214010|FG000|Overall Study|Lost to Follow-up|9|||
156581438|NCT01070303|565214010|FG000|Overall Study|Protocol Violation|0|||
156581439|NCT01070303|565214010|FG000|Overall Study|Lack of Efficacy|2|||
156581440|NCT01070303|565214010|FG000|Overall Study|Administrative Reason|1|||
156581441|NCT01070303|565214010|FG000|Overall Study|Other|18|||
156581442|NCT02064439|565214013|FG000|Overall Study|Adverse Event|51|||
156581443|NCT02064439|565214014|FG001|Overall Study|Adverse Event|47|||
156581444|NCT02064439|565214015|FG002|Overall Study|Adverse Event|46|||
156581445|NCT02064439|565214013|FG000|Overall Study|Death|0|||
156581446|NCT02064439|565214014|FG001|Overall Study|Death|2|||
156581447|NCT02064439|565214015|FG002|Overall Study|Death|3|||
156581448|NCT02064439|565214013|FG000|Overall Study|Withdrawal by Subject|29|||
156581449|NCT02064439|565214014|FG001|Overall Study|Withdrawal by Subject|18|||
156581450|NCT02064439|565214015|FG002|Overall Study|Withdrawal by Subject|26|||
156581451|NCT02064439|565214013|FG000|Overall Study|Protocol Violation|3|||
156581452|NCT02064439|565214014|FG001|Overall Study|Protocol Violation|5|||
156581453|NCT02064439|565214015|FG002|Overall Study|Protocol Violation|3|||
156581454|NCT02064439|565214013|FG000|Overall Study|Lost to Follow-up|1|||
156581455|NCT02064439|565214014|FG001|Overall Study|Lost to Follow-up|3|||
156581456|NCT02064439|565214015|FG002|Overall Study|Lost to Follow-up|4|||
156581457|NCT02064439|565214013|FG000|Overall Study|Non-compliance with study medication|21|||
156581458|NCT02064439|565214014|FG001|Overall Study|Non-compliance with study medication|19|||
156581459|NCT02064439|565214015|FG002|Overall Study|Non-compliance with study medication|23|||
156581460|NCT02064439|565214013|FG000|Overall Study|Physician Decision|0|||
156581461|NCT02064439|565214014|FG001|Overall Study|Physician Decision|1|||
156581462|NCT02064439|565214015|FG002|Overall Study|Physician Decision|1|||
156581463|NCT02064439|565214013|FG000|Overall Study|Logistical difficulties|6|||
156581464|NCT02064439|565214014|FG001|Overall Study|Logistical difficulties|5|||
156581465|NCT02064439|565214015|FG002|Overall Study|Logistical difficulties|2|||
156581466|NCT02064439|565214013|FG000|Overall Study|Efficacy outcome reached|18|||
156581467|NCT02064439|565214014|FG001|Overall Study|Efficacy outcome reached|16|||
156581468|NCT02064439|565214015|FG002|Overall Study|Efficacy outcome reached|57|||
156581469|NCT02064439|565214013|FG000|Overall Study|Safety outcome reached|12|||
156581470|NCT02064439|565214014|FG001|Overall Study|Safety outcome reached|20|||
156581471|NCT02064439|565214015|FG002|Overall Study|Safety outcome reached|10|||
156581472|NCT02064439|565214013|FG000|Overall Study|Other|2|||
156581473|NCT02064439|565214014|FG001|Overall Study|Other|2|||
156581474|NCT02064439|565214015|FG002|Overall Study|Other|7|||
156581475|NCT02433288|565214016|FG000|Overall Study|Severe non-compliance to protocol|13|||
156581476|NCT02433288|565214017|FG001|Overall Study|Severe non-compliance to protocol|7|||
156581477|NCT02433288|565214016|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
156581478|NCT02433288|565214017|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
156581479|NCT02433288|565214016|FG000|Overall Study|Withdrawal by Subject|101|||
156581480|NCT02433288|565214017|FG001|Overall Study|Withdrawal by Subject|99|||
156581481|NCT02433288|565214016|FG000|Overall Study|Lost to Follow-up|2|||
156581482|NCT02433288|565214017|FG001|Overall Study|Lost to Follow-up|14|||
156581483|NCT02433288|565214016|FG000|Overall Study|Death|0|||
156581484|NCT02433288|565214017|FG001|Overall Study|Death|3|||
156581485|NCT00858702|565214020|FG000|Overall Study|Lack of Efficacy|1|||
156581486|NCT00858702|565214021|FG001|Overall Study|Lack of Efficacy|0|||
156581487|NCT00858702|565214020|FG000|Overall Study|Protocol Violation|1|||
156581488|NCT00858702|565214021|FG001|Overall Study|Protocol Violation|1|||
156581489|NCT00858702|565214020|FG000|Overall Study|Other|2|||
156581490|NCT00858702|565214021|FG001|Overall Study|Other|1|||
156581491|NCT00858702|565214020|FG000|Overall Study|Withdrawal by Subject|1|||
156581492|NCT00858702|565214021|FG001|Overall Study|Withdrawal by Subject|0|||
156581493|NCT00367640|565214022|FG000|Overall Study|Adverse Event|3|||
156581494|NCT00367640|565214023|FG001|Overall Study|Adverse Event|6|||
156581495|NCT00367640|565214024|FG002|Overall Study|Adverse Event|8|||
156581496|NCT00367640|565214025|FG003|Overall Study|Adverse Event|0|||
156581497|NCT00367640|565214022|FG000|Overall Study|Withdrawal by Subject|8|||
156581498|NCT00367640|565214023|FG001|Overall Study|Withdrawal by Subject|11|||
156581499|NCT00367640|565214024|FG002|Overall Study|Withdrawal by Subject|8|||
156581500|NCT00367640|565214025|FG003|Overall Study|Withdrawal by Subject|6|||
156581501|NCT00367640|565214022|FG000|Overall Study|Any other reason not above-mentioned|7|||
156581502|NCT00367640|565214023|FG001|Overall Study|Any other reason not above-mentioned|5|||
156581503|NCT00367640|565214024|FG002|Overall Study|Any other reason not above-mentioned|3|||
156581504|NCT00367640|565214025|FG003|Overall Study|Any other reason not above-mentioned|4|||
156581505|NCT02417233|565214026|FG000|Overall Study|Death|4|||
156581506|NCT02417233|565214027|FG001|Overall Study|Death|10|||
156581507|NCT02417233|565214028|FG002|Overall Study|Death|14|||
156581508|NCT02417233|565214026|FG000|Overall Study|Lost to Follow-up|27|||
156581509|NCT02417233|565214027|FG001|Overall Study|Lost to Follow-up|39|||
156581510|NCT02417233|565214028|FG002|Overall Study|Lost to Follow-up|34|||
156581511|NCT02417233|565214026|FG000|Overall Study|Protocol Violation|2|||
156581512|NCT02417233|565214027|FG001|Overall Study|Protocol Violation|0|||
156581513|NCT02417233|565214028|FG002|Overall Study|Protocol Violation|2|||
156581514|NCT02417233|565214026|FG000|Overall Study|Withdrawal by Subject|2|||
156581515|NCT02417233|565214027|FG001|Overall Study|Withdrawal by Subject|1|||
156581516|NCT02417233|565214028|FG002|Overall Study|Withdrawal by Subject|8|||
156581517|NCT02417233|565214026|FG000|Overall Study|Relocation out of study area|1|||
156581518|NCT02417233|565214027|FG001|Overall Study|Relocation out of study area|0|||
156581519|NCT02417233|565214028|FG002|Overall Study|Relocation out of study area|1|||
156581520|NCT02417233|565214026|FG000|Overall Study|Mentally unstable|0|||
156581521|NCT02417233|565214027|FG001|Overall Study|Mentally unstable|1|||
156581522|NCT02417233|565214028|FG002|Overall Study|Mentally unstable|0|||
156581523|NCT01063751|565214030|FG000|Overall Study|Censored from analyses|42|||
156581524|NCT01063751|565214030|FG000|Overall Study|Withdrawal by Subject|34|||
156581525|NCT01063751|565214030|FG000|Overall Study|Lost to Follow-up|30|||
156581526|NCT01063751|565214030|FG000|Overall Study|Death|13|||
156581527|NCT01063751|565214030|FG000|Overall Study|Sponsored Terminated Study|60|||
156581528|NCT01063751|565214030|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
156581529|NCT01063751|565214030|FG000|Overall Study|Investigator site closed|10|||
156581530|NCT01063751|565214030|FG000|Overall Study|Revision|6|||
156581531|NCT01063751|565214030|FG000|Overall Study|Physician Decision|4|||
156581532|NCT00872898|565214032|FG000|Part Two - Double Blind|Adverse Event|4|||
156581533|NCT00872898|565214033|FG001|Part Two - Double Blind|Adverse Event|3|||
156581534|NCT00872898|565214032|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
156581535|NCT00872898|565214033|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
156581536|NCT00872898|565214032|FG000|Part Two - Double Blind|Protocol Violation|1|||
156581537|NCT00872898|565214033|FG001|Part Two - Double Blind|Protocol Violation|0|||
156581538|NCT00872898|565214032|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
156581539|NCT00872898|565214033|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
156581540|NCT00872898|565214032|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
156581541|NCT00872898|565214033|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
156581542|NCT00872898|565214032|FG000|Part Two - Double Blind|Other reasons|2|||
156581543|NCT00872898|565214033|FG001|Part Two - Double Blind|Other reasons|0|||
156581544|NCT00863928|565214036|FG000|Overall Study|Protocol Violation|26|||
156581545|NCT00863928|565214037|FG001|Overall Study|Protocol Violation|0|||
156581546|NCT00863928|565214036|FG000|Overall Study|Withdrawal by Subject|3|||
156581547|NCT00863928|565214037|FG001|Overall Study|Withdrawal by Subject|0|||
156581548|NCT00863928|565214036|FG000|Overall Study|surgery cancellation|4|||
156581549|NCT00863928|565214037|FG001|Overall Study|surgery cancellation|0|||
156581550|NCT00863928|565214036|FG000|Overall Study|medication allergy|3|||
156581551|NCT00863928|565214037|FG001|Overall Study|medication allergy|0|||
156581552|NCT02795156|565214039|FG000|Overall Study|Progressive Disease|22|||
156581553|NCT02795156|565214040|FG001|Overall Study|Progressive Disease|7|||
156581554|NCT02795156|565214041|FG002|Overall Study|Progressive Disease|34|||
156581555|NCT02795156|565214042|FG003|Overall Study|Progressive Disease|7|||
156581556|NCT02795156|565214039|FG000|Overall Study|Adverse Event|13|||
156581557|NCT02795156|565214040|FG001|Overall Study|Adverse Event|2|||
156581558|NCT02795156|565214041|FG002|Overall Study|Adverse Event|3|||
156581559|NCT02795156|565214042|FG003|Overall Study|Adverse Event|2|||
156581560|NCT02795156|565214039|FG000|Overall Study|Death|1|||
156581561|NCT02795156|565214040|FG001|Overall Study|Death|1|||
156581562|NCT02795156|565214041|FG002|Overall Study|Death|1|||
156581563|NCT02795156|565214042|FG003|Overall Study|Death|0|||
156581564|NCT02795156|565214039|FG000|Overall Study|Physician Decision|1|||
156581565|NCT02795156|565214040|FG001|Overall Study|Physician Decision|0|||
156581566|NCT02795156|565214041|FG002|Overall Study|Physician Decision|1|||
156581567|NCT02795156|565214042|FG003|Overall Study|Physician Decision|0|||
156581568|NCT02795156|565214039|FG000|Overall Study|Withdrawal by Subject|2|||
156581569|NCT02795156|565214040|FG001|Overall Study|Withdrawal by Subject|0|||
156581570|NCT02795156|565214041|FG002|Overall Study|Withdrawal by Subject|3|||
156581571|NCT02795156|565214042|FG003|Overall Study|Withdrawal by Subject|0|||
156581572|NCT00734929|565214046|FG000|Overall Study|Lost to Follow-up|1|||
156581573|NCT00734929|565214047|FG001|Overall Study|Lost to Follow-up|2|||
156581574|NCT00734929|565214046|FG000|Overall Study|No intervention/ screen fail|5|||
156581575|NCT00734929|565214047|FG001|Overall Study|No intervention/ screen fail|3|||
156581576|NCT02961764|565214051|FG000|Overall Study|Protocol Violation|0|||
156581577|NCT02961764|565214052|FG001|Overall Study|Protocol Violation|1|||
156581578|NCT02961764|565214051|FG000|Overall Study|Death|2|||
156581579|NCT02961764|565214052|FG001|Overall Study|Death|0|||
156581580|NCT02961764|565214051|FG000|Overall Study|Lost to Follow-up|35|||
156581581|NCT02961764|565214052|FG001|Overall Study|Lost to Follow-up|24|||
156581582|NCT02961764|565214051|FG000|Overall Study|Withdrawal by Subject|2|||
156581583|NCT02961764|565214052|FG001|Overall Study|Withdrawal by Subject|0|||
156581584|NCT01903434|565214060|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
156581585|NCT01903434|565214061|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
156581586|NCT01903434|565214060|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
156581587|NCT01903434|565214061|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
156581588|NCT01507246|565214062|FG000|Overall Study|Required different surgical procedures|2|||
156581589|NCT01507246|565214063|FG001|Overall Study|Required different surgical procedures|1|||
156581590|NCT03103750|565214064|FG000|Overall Study|Adverse Event|1|||
156581591|NCT03103750|565214065|FG001|Overall Study|Adverse Event|0|||
156581592|NCT03103750|565214064|FG000|Overall Study|Lost to Follow-up|1|||
156581593|NCT03103750|565214065|FG001|Overall Study|Lost to Follow-up|0|||
156581594|NCT03103750|565214064|FG000|Overall Study|PET Equipment Related|2|||
156581595|NCT03103750|565214065|FG001|Overall Study|PET Equipment Related|2|||
156581596|NCT01663740|565214067|FG000|Overall Study|Lost to Follow-up|1|||
156581597|NCT01663740|565214068|FG001|Overall Study|Lost to Follow-up|4|||
156581598|NCT01663740|565214067|FG000|Overall Study|Other|9|||
156581599|NCT01663740|565214068|FG001|Overall Study|Other|2|||
156581600|NCT01663740|565214067|FG000|Overall Study|Inclusion/Exclusion not met|1|||
156581601|NCT01663740|565214068|FG001|Overall Study|Inclusion/Exclusion not met|0|||
156581602|NCT01663740|565214067|FG000|Overall Study|Death|0|||
156581603|NCT01663740|565214068|FG001|Overall Study|Death|1|||
156581604|NCT01663740|565214067|FG000|Overall Study|Withdrawal by Subject|2|||
156581605|NCT01663740|565214068|FG001|Overall Study|Withdrawal by Subject|1|||
156581606|NCT01663740|565214067|FG000|Overall Study|No end of study status|3|||
156581607|NCT01663740|565214068|FG001|Overall Study|No end of study status|0|||
156581608|NCT00404768|565214071|FG000|Part A and B|Withdrawn due to labor progression|1|||
156581609|NCT00404768|565214072|FG001|Part A and B|Withdrawn due to labor progression|0|||
156581610|NCT00404768|565214073|FG002|Part A and B|Withdrawn due to labor progression|0|||
156581611|NCT00404768|565214074|FG003|Part A and B|Withdrawn due to labor progression|0|||
156581612|NCT00404768|565214071|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
156581613|NCT00404768|565214072|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
156581614|NCT00404768|565214073|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
156581615|NCT00404768|565214074|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
156581616|NCT00404768|565214071|FG000|Part C|Adverse Event|0|||
156581617|NCT00404768|565214072|FG001|Part C|Adverse Event|0|||
156581618|NCT00404768|565214073|FG002|Part C|Adverse Event|0|||
156581619|NCT00404768|565214074|FG003|Part C|Adverse Event|3|||
156581620|NCT00404768|565214071|FG000|Part C|Lost to Follow-up|0|||
156581621|NCT00404768|565214072|FG001|Part C|Lost to Follow-up|0|||
156581622|NCT00404768|565214073|FG002|Part C|Lost to Follow-up|3|||
156581623|NCT00404768|565214074|FG003|Part C|Lost to Follow-up|1|||
156581624|NCT00404768|565214071|FG000|Part C|Withdrawal by Subject|0|||
156581625|NCT00404768|565214072|FG001|Part C|Withdrawal by Subject|0|||
156581626|NCT00404768|565214073|FG002|Part C|Withdrawal by Subject|2|||
156581627|NCT00404768|565214074|FG003|Part C|Withdrawal by Subject|1|||
156581628|NCT00404768|565214071|FG000|Part C|Early withdrawal from study medication|0|||
156581629|NCT00404768|565214072|FG001|Part C|Early withdrawal from study medication|0|||
156581630|NCT00404768|565214073|FG002|Part C|Early withdrawal from study medication|1|||
156581631|NCT00404768|565214074|FG003|Part C|Early withdrawal from study medication|0|||
156581632|NCT00404768|565214071|FG000|Part C|Participant did not respond to therapy|0|||
156581633|NCT00404768|565214072|FG001|Part C|Participant did not respond to therapy|0|||
156581634|NCT00404768|565214073|FG002|Part C|Participant did not respond to therapy|1|||
156581635|NCT00404768|565214074|FG003|Part C|Participant did not respond to therapy|1|||
156581636|NCT00404768|565214071|FG000|Part C|Physician withdrew the study medication|0|||
156581637|NCT00404768|565214072|FG001|Part C|Physician withdrew the study medication|0|||
156581638|NCT00404768|565214073|FG002|Part C|Physician withdrew the study medication|1|||
156581639|NCT00404768|565214074|FG003|Part C|Physician withdrew the study medication|0|||
156581640|NCT00404768|565214071|FG000|Part C|Participant delivered baby|0|||
156581641|NCT00404768|565214072|FG001|Part C|Participant delivered baby|0|||
156581642|NCT00404768|565214073|FG002|Part C|Participant delivered baby|0|||
156581643|NCT00404768|565214074|FG003|Part C|Participant delivered baby|1|||
156581644|NCT00404768|565214071|FG000|Part C|Unsatisfactory uterine response to IP|0|||
156581645|NCT00404768|565214072|FG001|Part C|Unsatisfactory uterine response to IP|0|||
156581646|NCT00404768|565214073|FG002|Part C|Unsatisfactory uterine response to IP|0|||
156581647|NCT00404768|565214074|FG003|Part C|Unsatisfactory uterine response to IP|1|||
156581648|NCT00404768|565214071|FG000|Part C|Active labor|0|||
156581649|NCT00404768|565214072|FG001|Part C|Active labor|0|||
156581650|NCT00404768|565214073|FG002|Part C|Active labor|0|||
156581651|NCT00404768|565214074|FG003|Part C|Active labor|1|||
156581652|NCT00404768|565214071|FG000|Part C|Lack of Efficacy|0|||
156581653|NCT00404768|565214072|FG001|Part C|Lack of Efficacy|0|||
156581654|NCT00404768|565214073|FG002|Part C|Lack of Efficacy|0|||
156581655|NCT00404768|565214074|FG003|Part C|Lack of Efficacy|2|||
156581656|NCT00404768|565214071|FG000|Part C|Treatment failure|0|||
156581657|NCT00404768|565214072|FG001|Part C|Treatment failure|0|||
156581658|NCT00404768|565214073|FG002|Part C|Treatment failure|0|||
156581659|NCT00404768|565214074|FG003|Part C|Treatment failure|1|||
156581660|NCT00404768|565214071|FG000|Part C|Investigator discretion|0|||
156581661|NCT00404768|565214072|FG001|Part C|Investigator discretion|0|||
156581662|NCT00404768|565214073|FG002|Part C|Investigator discretion|0|||
156581663|NCT00404768|565214074|FG003|Part C|Investigator discretion|1|||
156581664|NCT00404768|565214071|FG000|Part C|Researcher suspended study medication|0|||
156581665|NCT00404768|565214072|FG001|Part C|Researcher suspended study medication|0|||
156581666|NCT00404768|565214073|FG002|Part C|Researcher suspended study medication|0|||
156581667|NCT00404768|565214074|FG003|Part C|Researcher suspended study medication|1|||
156581668|NCT03575468|565214075|FG000|Overall Study|Withdrawal by Subject|3|||
156581669|NCT03575468|565214076|FG001|Overall Study|Withdrawal by Subject|0|||
156581670|NCT03575468|565214075|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
156581671|NCT03575468|565214076|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
156581672|NCT03575468|565214075|FG000|Overall Study|Lost to Follow-up|13|||
156581673|NCT03575468|565214076|FG001|Overall Study|Lost to Follow-up|17|||
156581674|NCT01522651|565214079|FG000|Overall Study|Adverse Event|3|||
156581675|NCT01522651|565214080|FG001|Overall Study|Adverse Event|4|||
156581676|NCT01522651|565214081|FG002|Overall Study|Adverse Event|4|||
156581677|NCT01522651|565214082|FG003|Overall Study|Adverse Event|5|||
156581678|NCT01522651|565214083|FG004|Overall Study|Adverse Event|4|||
156581679|NCT01522651|565214079|FG000|Overall Study|Cardioversion|1|||
156581680|NCT01522651|565214080|FG001|Overall Study|Cardioversion|0|||
156581681|NCT01522651|565214081|FG002|Overall Study|Cardioversion|0|||
156581682|NCT01522651|565214082|FG003|Overall Study|Cardioversion|0|||
156581683|NCT01522651|565214083|FG004|Overall Study|Cardioversion|0|||
156581684|NCT01522651|565214079|FG000|Overall Study|Device Malfunction|0|||
156581685|NCT01522651|565214080|FG001|Overall Study|Device Malfunction|1|||
156581686|NCT01522651|565214081|FG002|Overall Study|Device Malfunction|0|||
156581687|NCT01522651|565214082|FG003|Overall Study|Device Malfunction|0|||
156581688|NCT01522651|565214083|FG004|Overall Study|Device Malfunction|0|||
156581689|NCT01522651|565214079|FG000|Overall Study|Investigator's Discretion|0|||
156581690|NCT01522651|565214080|FG001|Overall Study|Investigator's Discretion|1|||
156581691|NCT01522651|565214081|FG002|Overall Study|Investigator's Discretion|0|||
156581692|NCT01522651|565214082|FG003|Overall Study|Investigator's Discretion|0|||
156581693|NCT01522651|565214083|FG004|Overall Study|Investigator's Discretion|0|||
156581694|NCT01522651|565214079|FG000|Overall Study|Protocol Violation|3|||
156581695|NCT01522651|565214080|FG001|Overall Study|Protocol Violation|0|||
156581696|NCT01522651|565214081|FG002|Overall Study|Protocol Violation|0|||
156581697|NCT01522651|565214082|FG003|Overall Study|Protocol Violation|0|||
156581698|NCT01522651|565214083|FG004|Overall Study|Protocol Violation|0|||
156581699|NCT01522651|565214079|FG000|Overall Study|Reason Not Specified|0|||
156581700|NCT01522651|565214080|FG001|Overall Study|Reason Not Specified|0|||
156581701|NCT01522651|565214081|FG002|Overall Study|Reason Not Specified|0|||
156581702|NCT01522651|565214082|FG003|Overall Study|Reason Not Specified|1|||
156581703|NCT01522651|565214083|FG004|Overall Study|Reason Not Specified|0|||
156581704|NCT01522651|565214079|FG000|Overall Study|Participant Non-Compliance|1|||
156581705|NCT01522651|565214080|FG001|Overall Study|Participant Non-Compliance|0|||
156581706|NCT01522651|565214081|FG002|Overall Study|Participant Non-Compliance|0|||
156581707|NCT01522651|565214082|FG003|Overall Study|Participant Non-Compliance|0|||
156581708|NCT01522651|565214083|FG004|Overall Study|Participant Non-Compliance|0|||
156581709|NCT01522651|565214079|FG000|Overall Study|Withdrew Consent|1|||
156581710|NCT01522651|565214080|FG001|Overall Study|Withdrew Consent|1|||
156581711|NCT01522651|565214081|FG002|Overall Study|Withdrew Consent|0|||
156581712|NCT01522651|565214082|FG003|Overall Study|Withdrew Consent|1|||
156581713|NCT01522651|565214083|FG004|Overall Study|Withdrew Consent|1|||
156581714|NCT01522651|565214079|FG000|Overall Study|Randomized but Never Treated|0|||
156581715|NCT01522651|565214080|FG001|Overall Study|Randomized but Never Treated|1|||
156581716|NCT01522651|565214081|FG002|Overall Study|Randomized but Never Treated|0|||
156581717|NCT01522651|565214082|FG003|Overall Study|Randomized but Never Treated|1|||
156581718|NCT01522651|565214083|FG004|Overall Study|Randomized but Never Treated|1|||
156581719|NCT02658656|565214084|FG000|Screening|Failed eligibility criteria|0|||
156581720|NCT02658656|565214085|FG001|Screening|Failed eligibility criteria|0|||
156581721|NCT02658656|565214086|FG002|Screening|Failed eligibility criteria|263|||
156581722|NCT02658656|565214084|FG000|Randomization|Withdrawal by Subject|8|||
156581723|NCT02658656|565214085|FG001|Randomization|Withdrawal by Subject|7|||
156581724|NCT02658656|565214086|FG002|Randomization|Withdrawal by Subject|0|||
156581725|NCT02658656|565214084|FG000|Randomization|Lost to Follow-up|1|||
156581726|NCT02658656|565214085|FG001|Randomization|Lost to Follow-up|3|||
156581727|NCT02658656|565214086|FG002|Randomization|Lost to Follow-up|0|||
156581728|NCT02658656|565214084|FG000|Randomization|Adverse Event|4|||
156581729|NCT02658656|565214085|FG001|Randomization|Adverse Event|0|||
156581730|NCT02658656|565214086|FG002|Randomization|Adverse Event|0|||
156581731|NCT02658656|565214084|FG000|Randomization|Administrative Termination|3|||
156581732|NCT02658656|565214085|FG001|Randomization|Administrative Termination|1|||
156581733|NCT02658656|565214086|FG002|Randomization|Administrative Termination|0|||
156581734|NCT02658656|565214084|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
156581735|NCT02658656|565214085|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
156581736|NCT02658656|565214086|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
156581737|NCT02658656|565214084|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
156581738|NCT02658656|565214085|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
156581739|NCT02658656|565214086|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
156581740|NCT02658656|565214084|FG000|Randomization|Not eligible for Randomization|1|||
156581741|NCT02658656|565214085|FG001|Randomization|Not eligible for Randomization|0|||
156581742|NCT02658656|565214086|FG002|Randomization|Not eligible for Randomization|0|||
156581743|NCT02658656|565214084|FG000|Randomization|Protocol Violation|1|||
156581744|NCT02658656|565214085|FG001|Randomization|Protocol Violation|0|||
156581745|NCT02658656|565214086|FG002|Randomization|Protocol Violation|0|||
156581746|NCT01118143|565214087|FG000|Overall Study|Withdrawal by Subject|2|||
156581747|NCT01118143|565214088|FG001|Overall Study|Withdrawal by Subject|5|||
156581748|NCT02112448|565214089|FG000|Overall Study|lab values precluding use of ketorolac|2|||
156581749|NCT02112448|565214090|FG001|Overall Study|lab values precluding use of ketorolac|2|||
156581750|NCT02112448|565214089|FG000|Overall Study|Protocol Violation|1|||
156581751|NCT02112448|565214090|FG001|Overall Study|Protocol Violation|2|||
156581752|NCT02112448|565214089|FG000|Overall Study|Physician Decision|4|||
156581753|NCT02112448|565214090|FG001|Overall Study|Physician Decision|6|||
156581754|NCT02112448|565214089|FG000|Overall Study|required heparin so could not use ketoro|1|||
156581755|NCT02112448|565214090|FG001|Overall Study|required heparin so could not use ketoro|0|||
156581756|NCT00128206|565215667|FG000|Overall Study|Lost to Follow-up|137|||
156581757|NCT00128206|565215668|FG001|Overall Study|Lost to Follow-up|118|||
156581758|NCT00128206|565215667|FG000|Overall Study|Adverse Event|0|||
156581759|NCT00128206|565215668|FG001|Overall Study|Adverse Event|2|||
156581760|NCT03032068|565215677|FG000|Overall Study|Adverse Event|1|||
156581761|NCT01597622|565215678|FG000|Overall Study|Adverse Event|7|||
156581762|NCT01597622|565215678|FG000|Overall Study|Lack of Efficacy|3|||
156581763|NCT01597622|565215678|FG000|Overall Study|Protocol Violation|1|||
156581764|NCT01597622|565215678|FG000|Overall Study|Lost to Follow-up|1|||
156581765|NCT01597622|565215678|FG000|Overall Study|Investigator Discretion|5|||
156581766|NCT01597622|565215678|FG000|Overall Study|Withdrawal by Subject|20|||
156581767|NCT01597622|565215678|FG000|Overall Study|Death|1|||
156581768|NCT00408421|565215679|FG000|Treatment Initial Randomization|Adverse Event|5|||
156581769|NCT00408421|565215680|FG001|Treatment Initial Randomization|Adverse Event|9|||
156581770|NCT00408421|565215681|FG002|Treatment Initial Randomization|Adverse Event|0|||
156581771|NCT00408421|565215679|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
156581772|NCT00408421|565215680|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
156581773|NCT00408421|565215681|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
156581774|NCT00408421|565215679|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
156581775|NCT00408421|565215680|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
156581776|NCT00408421|565215681|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
156581777|NCT00408421|565215679|FG000|Treatment Initial Randomization|Physician Decision|1|||
156581778|NCT00408421|565215680|FG001|Treatment Initial Randomization|Physician Decision|0|||
156581779|NCT00408421|565215681|FG002|Treatment Initial Randomization|Physician Decision|0|||
156581780|NCT00408421|565215679|FG000|Treatment Initial Randomization|Protocol Violation|0|||
156581781|NCT00408421|565215680|FG001|Treatment Initial Randomization|Protocol Violation|1|||
156581782|NCT00408421|565215681|FG002|Treatment Initial Randomization|Protocol Violation|0|||
156581783|NCT00408421|565215679|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
156581784|NCT00408421|565215680|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
156581785|NCT00408421|565215681|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
156581786|NCT00408421|565215679|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
156581787|NCT00408421|565215680|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
156581788|NCT00408421|565215681|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
156581789|NCT00408421|565215679|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
156581790|NCT00408421|565215680|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
156581791|NCT00408421|565215681|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
156581792|NCT00408421|565215679|FG000|Treatment Re-Randomization|Adverse Event|2|||
156581793|NCT00408421|565215680|FG001|Treatment Re-Randomization|Adverse Event|2|||
156581794|NCT00408421|565215681|FG002|Treatment Re-Randomization|Adverse Event|4|||
156581795|NCT00408421|565215679|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
156581796|NCT00408421|565215680|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
156581797|NCT00408421|565215681|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
156581798|NCT00408421|565215679|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
156581799|NCT00408421|565215680|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
156581800|NCT00408421|565215681|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
156581801|NCT00408421|565215679|FG000|Treatment Re-Randomization|Physician Decision|1|||
156581802|NCT00408421|565215680|FG001|Treatment Re-Randomization|Physician Decision|3|||
156581803|NCT00408421|565215681|FG002|Treatment Re-Randomization|Physician Decision|0|||
156581804|NCT00408421|565215679|FG000|Treatment Re-Randomization|Protocol Violation|1|||
156581805|NCT00408421|565215680|FG001|Treatment Re-Randomization|Protocol Violation|1|||
156581806|NCT00408421|565215681|FG002|Treatment Re-Randomization|Protocol Violation|0|||
156581807|NCT00408421|565215679|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
156581808|NCT00408421|565215680|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
156581809|NCT00408421|565215681|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
156581810|NCT03132805|565215684|FG000|Overall Study|Lost to Follow-up|142|||
156581811|NCT03132805|565215685|FG001|Overall Study|Lost to Follow-up|141|||
156581812|NCT03132805|565215686|FG002|Overall Study|Lost to Follow-up|113|||
156581813|NCT03009539|565215689|FG000|Overall Study|Lost to Follow-up|132|||
156581814|NCT03009539|565215690|FG001|Overall Study|Lost to Follow-up|113|||
156581815|NCT03009539|565215691|FG002|Overall Study|Lost to Follow-up|132|||
156581816|NCT03009539|565215692|FG003|Overall Study|Lost to Follow-up|113|||
156581817|NCT03151148|565215693|FG000|Overall Study|Lost to Follow-up|1|||
156581818|NCT03151148|565215694|FG001|Overall Study|Lost to Follow-up|0|||
156581819|NCT03151148|565215693|FG000|Overall Study|Withdrawal by Subject|1|||
156581820|NCT03151148|565215694|FG001|Overall Study|Withdrawal by Subject|0|||
156581821|NCT03918642|565215695|FG000|Overall Study|Lost to Follow-up|12|||
156581822|NCT03918642|565215696|FG001|Overall Study|Lost to Follow-up|10|||
156581823|NCT01115569|565215701|FG000|Conversion/Titration Phase|Adverse Event|59|||
156581824|NCT01115569|565215702|FG001|Conversion/Titration Phase|Adverse Event|0|||
156581825|NCT01115569|565215701|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
156581826|NCT01115569|565215702|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
156581827|NCT01115569|565215701|FG000|Conversion/Titration Phase|Physician Decision|5|||
156581828|NCT01115569|565215702|FG001|Conversion/Titration Phase|Physician Decision|0|||
156581829|NCT01115569|565215701|FG000|Conversion/Titration Phase|Protocol Violation|68|||
156581830|NCT01115569|565215702|FG001|Conversion/Titration Phase|Protocol Violation|0|||
156581831|NCT01115569|565215701|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
156581832|NCT01115569|565215702|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
156581833|NCT01115569|565215701|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
156581834|NCT01115569|565215702|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
156581835|NCT01115569|565215701|FG000|Maintenance Phase|Adverse Event|0|||
156581836|NCT01115569|565215702|FG001|Maintenance Phase|Adverse Event|43|||
156581837|NCT01115569|565215701|FG000|Maintenance Phase|Lost to Follow-up|0|||
156581838|NCT01115569|565215702|FG001|Maintenance Phase|Lost to Follow-up|8|||
156581839|NCT01115569|565215701|FG000|Maintenance Phase|Physician Decision|0|||
156581840|NCT01115569|565215702|FG001|Maintenance Phase|Physician Decision|3|||
156581841|NCT01115569|565215701|FG000|Maintenance Phase|Protocol Violation|0|||
156581842|NCT01115569|565215702|FG001|Maintenance Phase|Protocol Violation|9|||
156581843|NCT01115569|565215701|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156581844|NCT01115569|565215702|FG001|Maintenance Phase|Withdrawal by Subject|27|||
156581845|NCT01115569|565215701|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
156581846|NCT01115569|565215702|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
156581847|NCT01115569|565215701|FG000|Maintenance Phase|Administrative|0|||
156581848|NCT01115569|565215702|FG001|Maintenance Phase|Administrative|1|||
156581849|NCT03242928|565215704|FG000|Overall Study|Adverse Event|2|||
156581850|NCT03242928|565215705|FG001|Overall Study|Adverse Event|1|||
156581851|NCT03242928|565215704|FG000|Overall Study|Lost to Follow-up|2|||
156581852|NCT03242928|565215705|FG001|Overall Study|Lost to Follow-up|0|||
156581853|NCT03242928|565215704|FG000|Overall Study|Physician Decision|0|||
156581854|NCT03242928|565215705|FG001|Overall Study|Physician Decision|1|||
156581855|NCT03242928|565215704|FG000|Overall Study|Withdrawal by Subject|5|||
156581856|NCT03242928|565215705|FG001|Overall Study|Withdrawal by Subject|3|||
156581857|NCT00960440|565215706|FG000|Overall Study|Death|0|||
156581858|NCT00960440|565215707|FG001|Overall Study|Death|0|||
156581859|NCT00960440|565215708|FG002|Overall Study|Death|0|||
156581860|NCT00960440|565215709|FG003|Overall Study|Death|1|||
156581861|NCT00960440|565215706|FG000|Overall Study|Adverse Event|12|||
156581862|NCT00960440|565215707|FG001|Overall Study|Adverse Event|12|||
156581863|NCT00960440|565215708|FG002|Overall Study|Adverse Event|4|||
156581864|NCT00960440|565215709|FG003|Overall Study|Adverse Event|4|||
156581865|NCT00960440|565215706|FG000|Overall Study|Lack of Efficacy|2|||
156581866|NCT00960440|565215707|FG001|Overall Study|Lack of Efficacy|5|||
156581867|NCT00960440|565215708|FG002|Overall Study|Lack of Efficacy|3|||
156581868|NCT00960440|565215709|FG003|Overall Study|Lack of Efficacy|8|||
156581869|NCT00960440|565215706|FG000|Overall Study|Protocol Violation|2|||
156581870|NCT00960440|565215707|FG001|Overall Study|Protocol Violation|8|||
156581871|NCT00960440|565215708|FG002|Overall Study|Protocol Violation|3|||
156581872|NCT00960440|565215709|FG003|Overall Study|Protocol Violation|4|||
156581873|NCT00960440|565215706|FG000|Overall Study|Withdrawal by Subject|9|||
156581874|NCT00960440|565215707|FG001|Overall Study|Withdrawal by Subject|5|||
156581875|NCT00960440|565215708|FG002|Overall Study|Withdrawal by Subject|2|||
156581876|NCT00960440|565215709|FG003|Overall Study|Withdrawal by Subject|1|||
156581877|NCT00960440|565215706|FG000|Overall Study|Other|1|||
156581878|NCT00960440|565215707|FG001|Overall Study|Other|1|||
156581879|NCT00960440|565215708|FG002|Overall Study|Other|1|||
156581880|NCT00960440|565215709|FG003|Overall Study|Other|0|||
156581881|NCT03504774|565215713|FG000|Overall Study|Adverse Event|2|||
156581882|NCT03504774|565215714|FG001|Overall Study|Adverse Event|0|||
156581883|NCT03504774|565215713|FG000|Overall Study|Lost to Follow-up|0|||
156581884|NCT03504774|565215714|FG001|Overall Study|Lost to Follow-up|1|||
156581885|NCT03504774|565215713|FG000|Overall Study|Protocol Violation|11|||
156581886|NCT03504774|565215714|FG001|Overall Study|Protocol Violation|3|||
156581887|NCT03504774|565215713|FG000|Overall Study|failed wk 52 DBPCFC|1|||
156581888|NCT03504774|565215714|FG001|Overall Study|failed wk 52 DBPCFC|0|||
156581889|NCT00625365|565215715|FG000|Overall Study|Withdrawal by Subject|1|||
156581890|NCT00625365|565215715|FG000|Overall Study|No IV access|5|||
156581891|NCT00625365|565215715|FG000|Overall Study|VSD|1|||
156581892|NCT01781429|565215716|FG000|Overall Study|Death|0|||
156581893|NCT01781429|565215717|FG001|Overall Study|Death|0|||
156581894|NCT01781429|565215718|FG002|Overall Study|Death|0|||
156581895|NCT01781429|565215719|FG003|Overall Study|Death|0|||
156581896|NCT01781429|565215720|FG004|Overall Study|Death|0|||
156581897|NCT01781429|565215721|FG005|Overall Study|Death|0|||
156581898|NCT01781429|565215722|FG006|Overall Study|Death|0|||
156581899|NCT01781429|565215723|FG007|Overall Study|Death|0|||
156581900|NCT01781429|565215724|FG008|Overall Study|Death|0|||
156581901|NCT01781429|565215725|FG009|Overall Study|Death|1|||
156581902|NCT01781429|565215726|FG010|Overall Study|Death|0|||
156581903|NCT01781429|565215727|FG011|Overall Study|Death|0|||
156581904|NCT01781429|565215728|FG012|Overall Study|Death|1|||
156581905|NCT01781429|565215729|FG013|Overall Study|Death|0|||
156581906|NCT01781429|565215730|FG014|Overall Study|Death|1|||
156581907|NCT01781429|565215731|FG015|Overall Study|Death|0|||
156581908|NCT01781429|565215716|FG000|Overall Study|Withdrawal by Subject|0|||
156581909|NCT01781429|565215717|FG001|Overall Study|Withdrawal by Subject|0|||
156581910|NCT01781429|565215718|FG002|Overall Study|Withdrawal by Subject|0|||
156581911|NCT01781429|565215719|FG003|Overall Study|Withdrawal by Subject|0|||
156581912|NCT01781429|565215720|FG004|Overall Study|Withdrawal by Subject|0|||
156581913|NCT01781429|565215721|FG005|Overall Study|Withdrawal by Subject|0|||
156581914|NCT01781429|565215722|FG006|Overall Study|Withdrawal by Subject|0|||
156581915|NCT01781429|565215723|FG007|Overall Study|Withdrawal by Subject|0|||
156581916|NCT01781429|565215724|FG008|Overall Study|Withdrawal by Subject|1|||
156581917|NCT01781429|565215725|FG009|Overall Study|Withdrawal by Subject|3|||
156581918|NCT01781429|565215726|FG010|Overall Study|Withdrawal by Subject|1|||
156581919|NCT01781429|565215727|FG011|Overall Study|Withdrawal by Subject|1|||
156581920|NCT01781429|565215728|FG012|Overall Study|Withdrawal by Subject|5|||
156581921|NCT01781429|565215729|FG013|Overall Study|Withdrawal by Subject|2|||
156581922|NCT01781429|565215730|FG014|Overall Study|Withdrawal by Subject|3|||
156581923|NCT01781429|565215731|FG015|Overall Study|Withdrawal by Subject|0|||
156581924|NCT01781429|565215716|FG000|Overall Study|Disease Progression|1|||
156581925|NCT01781429|565215717|FG001|Overall Study|Disease Progression|0|||
156581926|NCT01781429|565215718|FG002|Overall Study|Disease Progression|1|||
156581927|NCT01781429|565215719|FG003|Overall Study|Disease Progression|1|||
156581928|NCT01781429|565215720|FG004|Overall Study|Disease Progression|1|||
156581929|NCT01781429|565215721|FG005|Overall Study|Disease Progression|4|||
156581930|NCT01781429|565215722|FG006|Overall Study|Disease Progression|7|||
156581931|NCT01781429|565215723|FG007|Overall Study|Disease Progression|4|||
156581932|NCT01781429|565215724|FG008|Overall Study|Disease Progression|6|||
156581933|NCT01781429|565215725|FG009|Overall Study|Disease Progression|15|||
156581934|NCT01781429|565215726|FG010|Overall Study|Disease Progression|15|||
156581935|NCT01781429|565215727|FG011|Overall Study|Disease Progression|15|||
156581936|NCT01781429|565215728|FG012|Overall Study|Disease Progression|15|||
156581937|NCT01781429|565215729|FG013|Overall Study|Disease Progression|4|||
156581938|NCT01781429|565215730|FG014|Overall Study|Disease Progression|11|||
156581939|NCT01781429|565215731|FG015|Overall Study|Disease Progression|0|||
156581940|NCT01781429|565215716|FG000|Overall Study|Unacceptable Toxicity|0|||
156581941|NCT01781429|565215717|FG001|Overall Study|Unacceptable Toxicity|0|||
156581942|NCT01781429|565215718|FG002|Overall Study|Unacceptable Toxicity|0|||
156581943|NCT01781429|565215719|FG003|Overall Study|Unacceptable Toxicity|0|||
156581944|NCT01781429|565215720|FG004|Overall Study|Unacceptable Toxicity|0|||
156581945|NCT01781429|565215721|FG005|Overall Study|Unacceptable Toxicity|0|||
156581946|NCT01781429|565215722|FG006|Overall Study|Unacceptable Toxicity|0|||
156581947|NCT01781429|565215723|FG007|Overall Study|Unacceptable Toxicity|0|||
156581948|NCT01781429|565215724|FG008|Overall Study|Unacceptable Toxicity|0|||
156581949|NCT01781429|565215725|FG009|Overall Study|Unacceptable Toxicity|0|||
156581950|NCT01781429|565215726|FG010|Overall Study|Unacceptable Toxicity|0|||
156581951|NCT01781429|565215727|FG011|Overall Study|Unacceptable Toxicity|2|||
156581952|NCT01781429|565215728|FG012|Overall Study|Unacceptable Toxicity|0|||
156581953|NCT01781429|565215729|FG013|Overall Study|Unacceptable Toxicity|0|||
156581954|NCT01781429|565215730|FG014|Overall Study|Unacceptable Toxicity|0|||
156581955|NCT01781429|565215731|FG015|Overall Study|Unacceptable Toxicity|0|||
156581956|NCT01781429|565215716|FG000|Overall Study|Patient Condition Changed|0|||
156581957|NCT01781429|565215717|FG001|Overall Study|Patient Condition Changed|0|||
156581958|NCT01781429|565215718|FG002|Overall Study|Patient Condition Changed|0|||
156581959|NCT01781429|565215719|FG003|Overall Study|Patient Condition Changed|0|||
156581960|NCT01781429|565215720|FG004|Overall Study|Patient Condition Changed|0|||
156581961|NCT01781429|565215721|FG005|Overall Study|Patient Condition Changed|0|||
156581962|NCT01781429|565215722|FG006|Overall Study|Patient Condition Changed|0|||
156581963|NCT01781429|565215723|FG007|Overall Study|Patient Condition Changed|0|||
156581964|NCT01781429|565215724|FG008|Overall Study|Patient Condition Changed|0|||
156581965|NCT01781429|565215725|FG009|Overall Study|Patient Condition Changed|4|||
156581966|NCT01781429|565215726|FG010|Overall Study|Patient Condition Changed|0|||
156581967|NCT01781429|565215727|FG011|Overall Study|Patient Condition Changed|1|||
156581968|NCT01781429|565215728|FG012|Overall Study|Patient Condition Changed|0|||
156581969|NCT01781429|565215729|FG013|Overall Study|Patient Condition Changed|1|||
156581970|NCT01781429|565215730|FG014|Overall Study|Patient Condition Changed|0|||
156581971|NCT01781429|565215731|FG015|Overall Study|Patient Condition Changed|0|||
156581972|NCT01781429|565215716|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
156581973|NCT01781429|565215717|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
156581974|NCT01781429|565215718|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
156581975|NCT01781429|565215719|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
156581976|NCT01781429|565215720|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
156581977|NCT01781429|565215721|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
156581978|NCT01781429|565215722|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
156581979|NCT01781429|565215723|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
156581980|NCT01781429|565215724|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
156581981|NCT01781429|565215725|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
156581982|NCT01781429|565215726|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
156581983|NCT01781429|565215727|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
156581984|NCT01781429|565215728|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
156581985|NCT01781429|565215729|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
156581986|NCT01781429|565215730|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
156581987|NCT01781429|565215731|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
156581988|NCT01781429|565215716|FG000|Overall Study|Enrolled, but not treated|0|||
156581989|NCT01781429|565215717|FG001|Overall Study|Enrolled, but not treated|0|||
156581990|NCT01781429|565215718|FG002|Overall Study|Enrolled, but not treated|0|||
156581991|NCT01781429|565215719|FG003|Overall Study|Enrolled, but not treated|0|||
156581992|NCT01781429|565215720|FG004|Overall Study|Enrolled, but not treated|0|||
156581993|NCT01781429|565215721|FG005|Overall Study|Enrolled, but not treated|0|||
156581994|NCT01781429|565215722|FG006|Overall Study|Enrolled, but not treated|0|||
156581995|NCT01781429|565215723|FG007|Overall Study|Enrolled, but not treated|0|||
156581996|NCT01781429|565215724|FG008|Overall Study|Enrolled, but not treated|0|||
156581997|NCT01781429|565215725|FG009|Overall Study|Enrolled, but not treated|0|||
156581998|NCT01781429|565215726|FG010|Overall Study|Enrolled, but not treated|1|||
156581999|NCT01781429|565215727|FG011|Overall Study|Enrolled, but not treated|0|||
156582000|NCT01781429|565215728|FG012|Overall Study|Enrolled, but not treated|0|||
156582001|NCT01781429|565215729|FG013|Overall Study|Enrolled, but not treated|0|||
156582002|NCT01781429|565215730|FG014|Overall Study|Enrolled, but not treated|0|||
156582003|NCT01781429|565215731|FG015|Overall Study|Enrolled, but not treated|0|||
156582004|NCT01703286|565215733|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
156582005|NCT01703286|565215734|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
156582006|NCT01703286|565215735|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
156582007|NCT01703286|565215736|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
156582008|NCT01703286|565215737|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
156582009|NCT01703286|565215738|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
156582010|NCT01703286|565215733|FG000|Period 2 Including Washout|Adverse Event|0|||
156582011|NCT01703286|565215734|FG001|Period 2 Including Washout|Adverse Event|0|||
156582012|NCT01703286|565215735|FG002|Period 2 Including Washout|Adverse Event|0|||
156582013|NCT01703286|565215736|FG003|Period 2 Including Washout|Adverse Event|1|||
156582014|NCT01703286|565215737|FG004|Period 2 Including Washout|Adverse Event|0|||
156582015|NCT01703286|565215738|FG005|Period 2 Including Washout|Adverse Event|0|||
156582016|NCT00931892|565215739|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
156582017|NCT00931892|565215740|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
156582018|NCT02207530|565215743|FG000|Overall Study|Worsening condition under investigation|78|||
156582019|NCT02207530|565215743|FG000|Overall Study|Patient decision to stop study treatment|5|||
156582020|NCT02207530|565215743|FG000|Overall Study|Adverse Event|8|||
156582021|NCT00859898|565215747|FG000|Overall Study|Lack of Efficacy|0|||
156582022|NCT00859898|565215748|FG001|Overall Study|Lack of Efficacy|1|||
156582023|NCT00859898|565215749|FG002|Overall Study|Lack of Efficacy|1|||
156582024|NCT00859898|565215747|FG000|Overall Study|Adverse Event|4|||
156582025|NCT00859898|565215748|FG001|Overall Study|Adverse Event|9|||
156582026|NCT00859898|565215749|FG002|Overall Study|Adverse Event|8|||
156582027|NCT00859898|565215747|FG000|Overall Study|Withdrawal by Subject|11|||
156582028|NCT00859898|565215748|FG001|Overall Study|Withdrawal by Subject|8|||
156582029|NCT00859898|565215749|FG002|Overall Study|Withdrawal by Subject|11|||
156582030|NCT00859898|565215747|FG000|Overall Study|Death|0|||
156582031|NCT00859898|565215748|FG001|Overall Study|Death|0|||
156582032|NCT00859898|565215749|FG002|Overall Study|Death|1|||
156582033|NCT00859898|565215747|FG000|Overall Study|Lost to Follow-up|10|||
156582034|NCT00859898|565215748|FG001|Overall Study|Lost to Follow-up|11|||
156582035|NCT00859898|565215749|FG002|Overall Study|Lost to Follow-up|5|||
156582036|NCT00859898|565215747|FG000|Overall Study|poor/non-compliance|2|||
156582037|NCT00859898|565215748|FG001|Overall Study|poor/non-compliance|0|||
156582038|NCT00859898|565215749|FG002|Overall Study|poor/non-compliance|0|||
156582039|NCT00859898|565215747|FG000|Overall Study|No longer meets criteria|0|||
156582040|NCT00859898|565215748|FG001|Overall Study|No longer meets criteria|1|||
156582041|NCT00859898|565215749|FG002|Overall Study|No longer meets criteria|0|||
156582042|NCT00859898|565215747|FG000|Overall Study|non-specified|1|||
156582043|NCT00859898|565215748|FG001|Overall Study|non-specified|1|||
156582044|NCT00859898|565215749|FG002|Overall Study|non-specified|1|||
156582045|NCT03215264|565215750|FG000|Dose Level 2|Adverse Event|0|||
156582046|NCT03215264|565215751|FG001|Dose Level 2|Adverse Event|1|||
156582047|NCT03215264|565215752|FG002|Dose Level 2|Adverse Event|0|||
156582048|NCT03215264|565215750|FG000|Dose Level 3|Withdrawal by Subject|0|||
156582049|NCT03215264|565215751|FG001|Dose Level 3|Withdrawal by Subject|0|||
156582050|NCT03215264|565215752|FG002|Dose Level 3|Withdrawal by Subject|1|||
156582051|NCT02145156|565215754|FG000|Overall Study|No match to vaccination records|60|||
156582052|NCT02145156|565215755|FG001|Overall Study|No match to vaccination records|52|||
156582053|NCT02145156|565215756|FG002|Overall Study|No match to vaccination records|41|||
156582054|NCT03350750|565215757|FG000|Overall Study|Death|1|||
156582055|NCT03350750|565215758|FG001|Overall Study|Death|1|||
156582056|NCT01740440|565215761|FG000|Overall Study|Lost to Follow-up|3|||
156582057|NCT03408873|565215765|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
156582058|NCT03408873|565215765|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
156582059|NCT03408873|565215765|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
156582060|NCT03408873|565215765|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
156582061|NCT03408873|565215765|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
156582062|NCT03408873|565215765|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
156582063|NCT01264965|565215766|FG000|Overall Study|Withdrawal by Subject|10|||
156582064|NCT00406315|565215768|FG000|Overall Study|Death|1|||
156582065|NCT00406315|565215768|FG000|Overall Study|Adverse Event|39|||
156582066|NCT00406315|565215768|FG000|Overall Study|Laboratory Abnormality|4|||
156582067|NCT00406315|565215768|FG000|Overall Study|Lack of Efficacy|13|||
156582068|NCT00406315|565215768|FG000|Overall Study|Other|33|||
156582069|NCT00406315|565215768|FG000|Overall Study|Lost to Follow-up|21|||
156582070|NCT00406315|565215768|FG000|Overall Study|Withdrawal by Subject|30|||
156582071|NCT01469013|565215770|FG000|Part A (Treatment Period)|Adverse Event|1|||
156582072|NCT01469013|565215771|FG001|Part A (Treatment Period)|Adverse Event|0|||
156582073|NCT01469013|565215772|FG002|Part A (Treatment Period)|Adverse Event|0|||
156582074|NCT01469013|565215773|FG003|Part A (Treatment Period)|Adverse Event|0|||
156582075|NCT01469013|565215774|FG004|Part A (Treatment Period)|Adverse Event|1|||
156582076|NCT01469013|565215775|FG005|Part A (Treatment Period)|Adverse Event|0|||
156582077|NCT01469013|565215776|FG006|Part A (Treatment Period)|Adverse Event|0|||
156582078|NCT01469013|565215777|FG007|Part A (Treatment Period)|Adverse Event|0|||
156582079|NCT01469013|565215778|FG008|Part A (Treatment Period)|Adverse Event|0|||
156582080|NCT01469013|565215779|FG009|Part A (Treatment Period)|Adverse Event|0|||
156582081|NCT01469013|565215780|FG010|Part A (Treatment Period)|Adverse Event|0|||
156582082|NCT01469013|565215781|FG011|Part A (Treatment Period)|Adverse Event|0|||
156582083|NCT01469013|565215782|FG012|Part A (Treatment Period)|Adverse Event|0|||
156582084|NCT01469013|565215770|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582085|NCT01469013|565215771|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582086|NCT01469013|565215772|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
156582087|NCT01469013|565215773|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582088|NCT01469013|565215774|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582089|NCT01469013|565215775|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582090|NCT01469013|565215776|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582091|NCT01469013|565215777|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582092|NCT01469013|565215778|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582093|NCT01469013|565215779|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582094|NCT01469013|565215780|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582095|NCT01469013|565215781|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582096|NCT01469013|565215782|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
156582097|NCT01469013|565215770|FG000|Part B (Extension Period)|Adverse Event|0|||
156582098|NCT01469013|565215771|FG001|Part B (Extension Period)|Adverse Event|0|||
156582099|NCT01469013|565215772|FG002|Part B (Extension Period)|Adverse Event|0|||
156582100|NCT01469013|565215773|FG003|Part B (Extension Period)|Adverse Event|0|||
156582101|NCT01469013|565215774|FG004|Part B (Extension Period)|Adverse Event|0|||
156582102|NCT01469013|565215775|FG005|Part B (Extension Period)|Adverse Event|2|||
156582103|NCT01469013|565215776|FG006|Part B (Extension Period)|Adverse Event|5|||
156582104|NCT01469013|565215777|FG007|Part B (Extension Period)|Adverse Event|5|||
156582105|NCT01469013|565215778|FG008|Part B (Extension Period)|Adverse Event|3|||
156582106|NCT01469013|565215779|FG009|Part B (Extension Period)|Adverse Event|3|||
156582107|NCT01469013|565215780|FG010|Part B (Extension Period)|Adverse Event|1|||
156582108|NCT01469013|565215781|FG011|Part B (Extension Period)|Adverse Event|6|||
156582109|NCT01469013|565215782|FG012|Part B (Extension Period)|Adverse Event|3|||
156582110|NCT01469013|565215770|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
156582111|NCT01469013|565215771|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
156582112|NCT01469013|565215772|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
156582113|NCT01469013|565215773|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
156582114|NCT01469013|565215774|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
156582115|NCT01469013|565215775|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
156582116|NCT01469013|565215776|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
156582117|NCT01469013|565215777|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
156582118|NCT01469013|565215778|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
156582119|NCT01469013|565215779|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
156582120|NCT01469013|565215780|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
156582121|NCT01469013|565215781|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
156582122|NCT01469013|565215782|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
156582123|NCT05232097|565215783|FG000|Overall Study|Physician Decision|1|||
156582124|NCT01172288|565215786|FG000|Overall Study|Adverse Event|1|||
156582125|NCT01172288|565215787|FG001|Overall Study|Adverse Event|0|||
156582126|NCT01172288|565215786|FG000|Overall Study|Protocol Violation|0|||
156582127|NCT01172288|565215787|FG001|Overall Study|Protocol Violation|1|||
156582128|NCT01327339|565215788|FG000|Overall Study|Protocol Violation|8|||
156582129|NCT00871858|565215789|FG000|Overall Study|Protocol Violation|3|||
156582130|NCT00871858|565215790|FG001|Overall Study|Protocol Violation|4|||
156582131|NCT00871858|565215789|FG000|Overall Study|Adverse Event|1|||
156582132|NCT00871858|565215790|FG001|Overall Study|Adverse Event|1|||
156582133|NCT00871858|565215789|FG000|Overall Study|Withdrawal by Subject|1|||
156582134|NCT00871858|565215790|FG001|Overall Study|Withdrawal by Subject|1|||
156582135|NCT00871858|565215789|FG000|Overall Study|Lost to Follow-up|0|||
156582136|NCT00871858|565215790|FG001|Overall Study|Lost to Follow-up|1|||
156582137|NCT00700752|565215796|FG000|First Intervention|Withdrawal by Subject|0|||
156582138|NCT00700752|565215797|FG001|First Intervention|Withdrawal by Subject|2|||
156582139|NCT01302769|565215798|FG000|Overall Study|Lost to Follow-up|1|||
156582140|NCT01302769|565215799|FG001|Overall Study|Lost to Follow-up|1|||
156582141|NCT01734993|565215803|FG000|Overall Study|Adverse Event|1|||
156582142|NCT01734993|565215803|FG000|Overall Study|Lack of Efficacy|1|||
156582143|NCT01426386|565215804|FG000|Overall Study|Adverse Event|0|||
156582144|NCT01426386|565215805|FG001|Overall Study|Adverse Event|1|||
156582145|NCT01426386|565215806|FG002|Overall Study|Adverse Event|0|||
156582146|NCT01426386|565215807|FG003|Overall Study|Adverse Event|0|||
156582147|NCT01426386|565215808|FG004|Overall Study|Adverse Event|0|||
156582148|NCT01426386|565215809|FG005|Overall Study|Adverse Event|0|||
156582149|NCT01426386|565215804|FG000|Overall Study|Did not attend scheduled visit|1|||
156582150|NCT01426386|565215805|FG001|Overall Study|Did not attend scheduled visit|4|||
156582151|NCT01426386|565215806|FG002|Overall Study|Did not attend scheduled visit|0|||
156582152|NCT01426386|565215807|FG003|Overall Study|Did not attend scheduled visit|0|||
156582153|NCT01426386|565215808|FG004|Overall Study|Did not attend scheduled visit|2|||
156582154|NCT01426386|565215809|FG005|Overall Study|Did not attend scheduled visit|1|||
156582155|NCT01426386|565215804|FG000|Overall Study|Poor response|2|||
156582156|NCT01426386|565215805|FG001|Overall Study|Poor response|1|||
156582157|NCT01426386|565215806|FG002|Overall Study|Poor response|2|||
156582158|NCT01426386|565215807|FG003|Overall Study|Poor response|0|||
156582159|NCT01426386|565215808|FG004|Overall Study|Poor response|1|||
156582160|NCT01426386|565215809|FG005|Overall Study|Poor response|0|||
156582161|NCT01426386|565215804|FG000|Overall Study|Personal reasons|0|||
156582162|NCT01426386|565215805|FG001|Overall Study|Personal reasons|0|||
156582163|NCT01426386|565215806|FG002|Overall Study|Personal reasons|0|||
156582164|NCT01426386|565215807|FG003|Overall Study|Personal reasons|0|||
156582165|NCT01426386|565215808|FG004|Overall Study|Personal reasons|1|||
156582166|NCT01426386|565215809|FG005|Overall Study|Personal reasons|0|||
156582167|NCT01797432|565215812|FG000|Overall Study|Lost to Follow-up|1|||
156582168|NCT01797432|565215812|FG000|Overall Study|Adverse Event|1|||
156582169|NCT01797432|565215812|FG000|Overall Study|Withdrawal by Subject|1|||
156582170|NCT01797432|565215812|FG000|Overall Study|lived too far from study site|1|||
156582171|NCT02792777|565215813|FG000|Overall Study|Withdrawal by Subject|2|||
156582172|NCT02792777|565215814|FG001|Overall Study|Withdrawal by Subject|0|||
156582173|NCT02792777|565215813|FG000|Overall Study|Recording malfunction|2|||
156582174|NCT02792777|565215814|FG001|Overall Study|Recording malfunction|0|||
156582175|NCT02792777|565215813|FG000|Overall Study|Later determined to be ineligible|2|||
156582176|NCT02792777|565215814|FG001|Overall Study|Later determined to be ineligible|0|||
156582177|NCT02792777|565215813|FG000|Overall Study|Participant interviewed twice|1|||
156582178|NCT02792777|565215814|FG001|Overall Study|Participant interviewed twice|0|||
156582179|NCT00638846|565215815|FG000|Overall Study|Adverse Event|0|||
156582180|NCT00638846|565215816|FG001|Overall Study|Adverse Event|1|||
156582181|NCT00638846|565215815|FG000|Overall Study|Lost to Follow-up|3|||
156582182|NCT00638846|565215816|FG001|Overall Study|Lost to Follow-up|2|||
156582183|NCT00638846|565215815|FG000|Overall Study|lens issue|1|||
156582184|NCT00638846|565215816|FG001|Overall Study|lens issue|3|||
156582185|NCT03176966|565215820|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
156582186|NCT03176966|565215821|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
156582187|NCT03176966|565215820|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
156582188|NCT03176966|565215821|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
156582189|NCT03176966|565215820|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
156582190|NCT03176966|565215821|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
156582191|NCT03176966|565215820|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
156582192|NCT03176966|565215821|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
156582193|NCT03176966|565215820|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
156582194|NCT03176966|565215821|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
156582195|NCT03176966|565215820|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
156582196|NCT03176966|565215821|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
156582197|NCT03176966|565215820|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
156582198|NCT03176966|565215821|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
156582199|NCT00633139|565215829|FG000|Overall Study|Non compliance|0|||
156582200|NCT00633139|565215830|FG001|Overall Study|Non compliance|0|||
156582201|NCT00633139|565215831|FG002|Overall Study|Non compliance|1|||
156582202|NCT00633139|565215829|FG000|Overall Study|Withdrawal by Subject|0|||
156582203|NCT00633139|565215830|FG001|Overall Study|Withdrawal by Subject|1|||
156582204|NCT00633139|565215831|FG002|Overall Study|Withdrawal by Subject|0|||
156582205|NCT02160977|565215832|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
156582206|NCT02160977|565215833|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
156582207|NCT02160977|565215832|FG000|Three Months After Surgery|Lost to Follow-up|0|||
156582208|NCT02160977|565215833|FG001|Three Months After Surgery|Lost to Follow-up|2|||
156582209|NCT02160977|565215832|FG000|Six Months After Surgery|Lost to Follow-up|2|||
156582210|NCT02160977|565215833|FG001|Six Months After Surgery|Lost to Follow-up|1|||
156582211|NCT02269319|565215834|FG000|Overall Study|Lost to Follow-up|4|||
156582212|NCT02269319|565215835|FG001|Overall Study|Lost to Follow-up|3|||
156582213|NCT02269319|565215834|FG000|Overall Study|Adverse Event|0|||
156582214|NCT02269319|565215835|FG001|Overall Study|Adverse Event|1|||
156582215|NCT02269319|565215834|FG000|Overall Study|Instructions not followed|1|||
156582216|NCT02269319|565215835|FG001|Overall Study|Instructions not followed|0|||
156582217|NCT03625986|565217601|FG000|Randomization Period|Lost to Follow-up|7|||
156582218|NCT03625986|565217602|FG001|Randomization Period|Lost to Follow-up|12|||
156582219|NCT03625986|565217601|FG000|Randomization Period|Withdrawal by Subject|10|||
156582220|NCT03625986|565217602|FG001|Randomization Period|Withdrawal by Subject|6|||
156582221|NCT01850563|565217603|FG000|Overall Study|Not eligible|3|||
156582222|NCT01850563|565217604|FG001|Overall Study|Not eligible|0|||
156582223|NCT04359823|565217605|FG000|Overall Study|Lost to Follow-up|0|||
156582224|NCT04359823|565217606|FG001|Overall Study|Lost to Follow-up|1|||
156582225|NCT04359823|565217605|FG000|Overall Study|Withdrawal by Subject|0|||
156582226|NCT04359823|565217606|FG001|Overall Study|Withdrawal by Subject|1|||
156582227|NCT04543955|565217607|FG000|Overall Study|Company cancelled study|1|||
156582228|NCT04543955|565217608|FG001|Overall Study|Company cancelled study|0|||
156582229|NCT06094296|565217609|FG000|Overall Study|Progressive Disease|1|||
156582230|NCT06094296|565217610|FG001|Overall Study|Progressive Disease|0|||
156582231|NCT06094296|565217611|FG002|Overall Study|Progressive Disease|0|||
156582232|NCT06094296|565217612|FG003|Overall Study|Progressive Disease|0|||
156582233|NCT00986258|565217613|FG000|Observation Period|Not eligible to be dosed|11|||
156582234|NCT00986258|565217613|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
156582235|NCT00986258|565217613|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
156582236|NCT00986258|565217613|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
156582237|NCT00986258|565217613|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
156582238|NCT00986258|565217613|FG000|Titration and Optimal Dose Period|Other|1|||
156582239|NCT00986258|565217613|FG000|Maintenance Period|Adverse Event|5|||
156582240|NCT00986258|565217613|FG000|Maintenance Period|Lack of Efficacy|2|||
156582241|NCT00986258|565217613|FG000|Maintenance Period|Withdrawal by Subject|2|||
156582242|NCT03332667|565217614|FG000|Overall Study|Adverse Event|0|||
156582243|NCT03332667|565217615|FG001|Overall Study|Adverse Event|0|||
156582244|NCT03332667|565217616|FG002|Overall Study|Adverse Event|2|||
156582245|NCT03332667|565217617|FG003|Overall Study|Adverse Event|1|||
156582246|NCT03332667|565217614|FG000|Overall Study|Withdrawal by Subject|2|||
156582247|NCT03332667|565217615|FG001|Overall Study|Withdrawal by Subject|1|||
156582248|NCT03332667|565217616|FG002|Overall Study|Withdrawal by Subject|5|||
156582249|NCT03332667|565217617|FG003|Overall Study|Withdrawal by Subject|1|||
156582250|NCT03332667|565217614|FG000|Overall Study|Disease Progression or Relapse|2|||
156582251|NCT03332667|565217615|FG001|Overall Study|Disease Progression or Relapse|1|||
156582252|NCT03332667|565217616|FG002|Overall Study|Disease Progression or Relapse|3|||
156582253|NCT03332667|565217617|FG003|Overall Study|Disease Progression or Relapse|0|||
156582254|NCT03332667|565217614|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
156582255|NCT03332667|565217615|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
156582256|NCT03332667|565217616|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
156582257|NCT03332667|565217617|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
156582258|NCT03332667|565217614|FG000|Overall Study|No Treatment Received|0|||
156582259|NCT03332667|565217615|FG001|Overall Study|No Treatment Received|0|||
156582260|NCT03332667|565217616|FG002|Overall Study|No Treatment Received|1|||
156582261|NCT03332667|565217617|FG003|Overall Study|No Treatment Received|0|||
156582262|NCT01035606|565217618|FG000|Overall Study|change in health, job demands,family|3|||
156582263|NCT01035606|565217619|FG001|Overall Study|change in health, job demands,family|3|||
156582264|NCT01035606|565217620|FG002|Overall Study|change in health, job demands,family|4|||
156582265|NCT01809262|565217621|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582266|NCT01809262|565217622|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582267|NCT01809262|565217623|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582268|NCT01809262|565217624|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582269|NCT01809262|565217625|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
156582270|NCT01809262|565217626|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582271|NCT01809262|565217627|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582272|NCT01809262|565217628|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582273|NCT01809262|565217629|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582274|NCT01809262|565217630|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
156582275|NCT01809262|565217621|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582276|NCT01809262|565217622|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
156582277|NCT01809262|565217623|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582278|NCT01809262|565217624|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582279|NCT01809262|565217625|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582280|NCT01809262|565217626|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582281|NCT01809262|565217627|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582282|NCT01809262|565217628|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582283|NCT01809262|565217629|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582284|NCT01809262|565217630|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
156582285|NCT01505491|565217631|FG000|Overall Study|Other reason not listed|1|||
156582286|NCT01505491|565217632|FG001|Overall Study|Other reason not listed|0|||
156582287|NCT01505491|565217633|FG002|Overall Study|Other reason not listed|0|||
156582288|NCT01505491|565217631|FG000|Overall Study|Withdrawal by Subject|1|||
156582289|NCT01505491|565217632|FG001|Overall Study|Withdrawal by Subject|1|||
156582290|NCT01505491|565217633|FG002|Overall Study|Withdrawal by Subject|4|||
156582291|NCT01505491|565217631|FG000|Overall Study|Lost to Follow-up|0|||
156582292|NCT01505491|565217632|FG001|Overall Study|Lost to Follow-up|0|||
156582293|NCT01505491|565217633|FG002|Overall Study|Lost to Follow-up|1|||
156582294|NCT01797783|565217637|FG000|Overall Study|Adverse Event|1|||
156582295|NCT01797783|565217638|FG001|Overall Study|Adverse Event|1|||
156582296|NCT01797783|565217637|FG000|Overall Study|Withdrawal by Subject|1|||
156582297|NCT01797783|565217638|FG001|Overall Study|Withdrawal by Subject|0|||
156582298|NCT02202031|565217640|FG000|Overall Study|Lost to Follow-up|1|||
156582299|NCT02202031|565217641|FG001|Overall Study|Lost to Follow-up|0|||
156582300|NCT02202031|565217640|FG000|Overall Study|Too Busy|1|||
156582301|NCT02202031|565217641|FG001|Overall Study|Too Busy|3|||
156582302|NCT02202031|565217640|FG000|Overall Study|Illness/Medical Reason|0|||
156582303|NCT02202031|565217641|FG001|Overall Study|Illness/Medical Reason|2|||
156582304|NCT02202031|565217640|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
156582305|NCT02202031|565217641|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
156582306|NCT02184143|565217642|FG000|Overall Study|Withdrawal by Subject|4|||
156582307|NCT02184143|565217643|FG001|Overall Study|Withdrawal by Subject|4|||
156582308|NCT02184143|565217642|FG000|Overall Study|Lost to Follow-up|5|||
156582309|NCT02184143|565217643|FG001|Overall Study|Lost to Follow-up|3|||
156582310|NCT02184143|565217642|FG000|Overall Study|Death|1|||
156582311|NCT02184143|565217643|FG001|Overall Study|Death|0|||
156582312|NCT00321984|565217645|FG000|Overall Study|Adverse Event|9|||
156582313|NCT00321984|565217646|FG001|Overall Study|Adverse Event|6|||
156582314|NCT00321984|565217647|FG002|Overall Study|Adverse Event|8|||
156582315|NCT00321984|565217645|FG000|Overall Study|Protocol Violation|0|||
156582316|NCT00321984|565217646|FG001|Overall Study|Protocol Violation|1|||
156582317|NCT00321984|565217647|FG002|Overall Study|Protocol Violation|1|||
156582318|NCT00321984|565217645|FG000|Overall Study|Lost to Follow-up|2|||
156582319|NCT00321984|565217646|FG001|Overall Study|Lost to Follow-up|4|||
156582320|NCT00321984|565217647|FG002|Overall Study|Lost to Follow-up|2|||
156582321|NCT00321984|565217645|FG000|Overall Study|Withdrawal by Subject|8|||
156582322|NCT00321984|565217646|FG001|Overall Study|Withdrawal by Subject|6|||
156582323|NCT00321984|565217647|FG002|Overall Study|Withdrawal by Subject|5|||
156582324|NCT00321984|565217645|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
156582325|NCT00321984|565217646|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
156582326|NCT00321984|565217647|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
156582327|NCT00321984|565217645|FG000|Overall Study|Lack of Efficacy|3|||
156582328|NCT00321984|565217646|FG001|Overall Study|Lack of Efficacy|1|||
156582329|NCT00321984|565217647|FG002|Overall Study|Lack of Efficacy|3|||
156582330|NCT00321984|565217645|FG000|Overall Study|Noncompliant|0|||
156582331|NCT00321984|565217646|FG001|Overall Study|Noncompliant|0|||
156582332|NCT00321984|565217647|FG002|Overall Study|Noncompliant|2|||
156582333|NCT00321984|565217645|FG000|Overall Study|Pregnancy|0|||
156582334|NCT00321984|565217646|FG001|Overall Study|Pregnancy|1|||
156582335|NCT00321984|565217647|FG002|Overall Study|Pregnancy|0|||
156582336|NCT00321984|565217645|FG000|Overall Study|Per Subject Request|1|||
156582337|NCT00321984|565217646|FG001|Overall Study|Per Subject Request|0|||
156582338|NCT00321984|565217647|FG002|Overall Study|Per Subject Request|0|||
156582339|NCT00321984|565217645|FG000|Overall Study|Per Investigator Request|1|||
156582340|NCT00321984|565217646|FG001|Overall Study|Per Investigator Request|0|||
156582341|NCT00321984|565217647|FG002|Overall Study|Per Investigator Request|0|||
156582342|NCT00321984|565217645|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
156582343|NCT00321984|565217646|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
156582344|NCT00321984|565217647|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
156582345|NCT02214186|565217650|FG000|Overall Study|Lost to Follow-up|1|||
156582346|NCT02214186|565217651|FG001|Overall Study|Lost to Follow-up|1|||
156582347|NCT02214186|565217650|FG000|Overall Study|Protocol Violation|1|||
156582348|NCT02214186|565217651|FG001|Overall Study|Protocol Violation|1|||
156582349|NCT01525849|565217652|FG000|Overall Study|Lost to Follow-up|3|||
156582350|NCT01525849|565217653|FG001|Overall Study|Lost to Follow-up|2|||
156582351|NCT01525849|565217652|FG000|Overall Study|Withdrawal by Subject|1|||
156582352|NCT01525849|565217653|FG001|Overall Study|Withdrawal by Subject|9|||
156582353|NCT01525849|565217652|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
156582354|NCT01525849|565217653|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
156582355|NCT01525849|565217652|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
156582356|NCT01525849|565217653|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
156582357|NCT00611130|565217660|FG000|Overall Study|Lost to Follow-up|25|||
156582358|NCT00611130|565217661|FG001|Overall Study|Lost to Follow-up|29|||
156582359|NCT00611130|565217660|FG000|Overall Study|Protocol noncompliance|7|||
156582360|NCT00611130|565217661|FG001|Overall Study|Protocol noncompliance|6|||
156582361|NCT00611130|565217660|FG000|Overall Study|Withdrawal by Subject|6|||
156582362|NCT00611130|565217661|FG001|Overall Study|Withdrawal by Subject|5|||
156582363|NCT00611130|565217660|FG000|Overall Study|Other|5|||
156582364|NCT00611130|565217661|FG001|Overall Study|Other|4|||
156582365|NCT00611130|565217660|FG000|Overall Study|Incarceration|3|||
156582366|NCT00611130|565217661|FG001|Overall Study|Incarceration|2|||
156582367|NCT00611130|565217660|FG000|Overall Study|Administrative|1|||
156582368|NCT00611130|565217661|FG001|Overall Study|Administrative|1|||
156582369|NCT00611130|565217660|FG000|Overall Study|Adverse Event|1|||
156582370|NCT00611130|565217661|FG001|Overall Study|Adverse Event|0|||
156582371|NCT00611130|565217660|FG000|Overall Study|Death|1|||
156582372|NCT00611130|565217661|FG001|Overall Study|Death|0|||
156582373|NCT01024465|565217666|FG000|Overall Study|Adverse Event|2|||
156582374|NCT01024465|565217666|FG000|Overall Study|Physician Decision|1|||
156582375|NCT03078608|565217669|FG000|Overall Study|Death|1|||
156582376|NCT03078608|565217670|FG001|Overall Study|Death|2|||
156582377|NCT03078608|565217671|FG002|Overall Study|Death|0|||
156582378|NCT03078608|565217672|FG003|Overall Study|Death|0|||
156582379|NCT03078608|565217669|FG000|Overall Study|Withdrawal by Subject|8|||
156582380|NCT03078608|565217670|FG001|Overall Study|Withdrawal by Subject|1|||
156582381|NCT03078608|565217671|FG002|Overall Study|Withdrawal by Subject|0|||
156582382|NCT03078608|565217672|FG003|Overall Study|Withdrawal by Subject|0|||
156582383|NCT03078608|565217669|FG000|Overall Study|Lost to Follow-up|5|||
156582384|NCT03078608|565217670|FG001|Overall Study|Lost to Follow-up|8|||
156582385|NCT03078608|565217671|FG002|Overall Study|Lost to Follow-up|4|||
156582386|NCT03078608|565217672|FG003|Overall Study|Lost to Follow-up|1|||
156582387|NCT00723840|565217673|FG000|Overall Study|Lost to Follow-up|2|||
156582388|NCT00723840|565217673|FG000|Overall Study|Failure to return|18|||
156582389|NCT00723840|565217673|FG000|Overall Study|Withdrawal by Subject|55|||
156582390|NCT00723840|565217673|FG000|Overall Study|Serious Adverse Events|3|||
156582391|NCT00723840|565217673|FG000|Overall Study|Other Medical Event|2|||
156582392|NCT00723840|565217673|FG000|Overall Study|Unspecified reason|2|||
156582393|NCT03303339|565217674|FG000|Overall Study|Death|2|||
156582394|NCT03303339|565217675|FG001|Overall Study|Death|2|||
156582395|NCT03303339|565217676|FG002|Overall Study|Death|2|||
156582396|NCT03303339|565217677|FG003|Overall Study|Death|1|||
156582397|NCT03303339|565217678|FG004|Overall Study|Death|4|||
156582398|NCT03303339|565217679|FG005|Overall Study|Death|2|||
156582399|NCT03303339|565217680|FG006|Overall Study|Death|2|||
156582400|NCT03303339|565217681|FG007|Overall Study|Death|2|||
156582401|NCT03303339|565217682|FG008|Overall Study|Death|3|||
156582402|NCT03303339|565217683|FG009|Overall Study|Death|3|||
156582403|NCT03303339|565217684|FG010|Overall Study|Death|4|||
156582404|NCT03303339|565217685|FG011|Overall Study|Death|24|||
156582405|NCT03303339|565217674|FG000|Overall Study|Study Terminated by Sponsor|0|||
156582406|NCT03303339|565217675|FG001|Overall Study|Study Terminated by Sponsor|0|||
156582407|NCT03303339|565217676|FG002|Overall Study|Study Terminated by Sponsor|0|||
156582408|NCT03303339|565217677|FG003|Overall Study|Study Terminated by Sponsor|0|||
156582409|NCT03303339|565217678|FG004|Overall Study|Study Terminated by Sponsor|0|||
156582410|NCT03303339|565217679|FG005|Overall Study|Study Terminated by Sponsor|0|||
156582411|NCT03303339|565217680|FG006|Overall Study|Study Terminated by Sponsor|0|||
156582412|NCT03303339|565217681|FG007|Overall Study|Study Terminated by Sponsor|0|||
156582413|NCT03303339|565217682|FG008|Overall Study|Study Terminated by Sponsor|1|||
156582414|NCT03303339|565217683|FG009|Overall Study|Study Terminated by Sponsor|0|||
156582415|NCT03303339|565217684|FG010|Overall Study|Study Terminated by Sponsor|1|||
156582416|NCT03303339|565217685|FG011|Overall Study|Study Terminated by Sponsor|1|||
156582417|NCT03303339|565217674|FG000|Overall Study|Withdrawal by Subject|1|||
156582418|NCT03303339|565217675|FG001|Overall Study|Withdrawal by Subject|0|||
156582419|NCT03303339|565217676|FG002|Overall Study|Withdrawal by Subject|0|||
156582420|NCT03303339|565217677|FG003|Overall Study|Withdrawal by Subject|0|||
156582421|NCT03303339|565217678|FG004|Overall Study|Withdrawal by Subject|0|||
156582422|NCT03303339|565217679|FG005|Overall Study|Withdrawal by Subject|1|||
156582423|NCT03303339|565217680|FG006|Overall Study|Withdrawal by Subject|1|||
156582424|NCT03303339|565217681|FG007|Overall Study|Withdrawal by Subject|0|||
156582425|NCT03303339|565217682|FG008|Overall Study|Withdrawal by Subject|0|||
156582426|NCT03303339|565217683|FG009|Overall Study|Withdrawal by Subject|0|||
156582427|NCT03303339|565217684|FG010|Overall Study|Withdrawal by Subject|0|||
156582428|NCT03303339|565217685|FG011|Overall Study|Withdrawal by Subject|2|||
156582429|NCT03303339|565217674|FG000|Overall Study|Physician Decision|0|||
156582430|NCT03303339|565217675|FG001|Overall Study|Physician Decision|0|||
156582431|NCT03303339|565217676|FG002|Overall Study|Physician Decision|0|||
156582432|NCT03303339|565217677|FG003|Overall Study|Physician Decision|0|||
156582433|NCT03303339|565217678|FG004|Overall Study|Physician Decision|1|||
156582434|NCT03303339|565217679|FG005|Overall Study|Physician Decision|0|||
156582435|NCT03303339|565217680|FG006|Overall Study|Physician Decision|0|||
156582436|NCT03303339|565217681|FG007|Overall Study|Physician Decision|0|||
156582437|NCT03303339|565217682|FG008|Overall Study|Physician Decision|0|||
156582438|NCT03303339|565217683|FG009|Overall Study|Physician Decision|0|||
156582439|NCT03303339|565217684|FG010|Overall Study|Physician Decision|0|||
156582440|NCT03303339|565217685|FG011|Overall Study|Physician Decision|0|||
156582441|NCT03303339|565217674|FG000|Overall Study|Safety/Non-compliance|0|||
156582442|NCT03303339|565217675|FG001|Overall Study|Safety/Non-compliance|0|||
156582443|NCT03303339|565217676|FG002|Overall Study|Safety/Non-compliance|0|||
156582444|NCT03303339|565217677|FG003|Overall Study|Safety/Non-compliance|0|||
156582445|NCT03303339|565217678|FG004|Overall Study|Safety/Non-compliance|0|||
156582446|NCT03303339|565217679|FG005|Overall Study|Safety/Non-compliance|0|||
156582447|NCT03303339|565217680|FG006|Overall Study|Safety/Non-compliance|0|||
156582448|NCT03303339|565217681|FG007|Overall Study|Safety/Non-compliance|0|||
156582449|NCT03303339|565217682|FG008|Overall Study|Safety/Non-compliance|0|||
156582450|NCT03303339|565217683|FG009|Overall Study|Safety/Non-compliance|0|||
156582451|NCT03303339|565217684|FG010|Overall Study|Safety/Non-compliance|0|||
156582452|NCT03303339|565217685|FG011|Overall Study|Safety/Non-compliance|1|||
156582453|NCT03694522|565217686|FG000|Overall Study|Withdrawal by Subject|8|||
156582454|NCT03694522|565217687|FG001|Overall Study|Withdrawal by Subject|10|||
156582455|NCT03694522|565217686|FG000|Overall Study|Physician Decision|53|||
156582456|NCT03694522|565217687|FG001|Overall Study|Physician Decision|54|||
156582457|NCT03694522|565217686|FG000|Overall Study|Other|1|||
156582458|NCT03694522|565217687|FG001|Overall Study|Other|1|||
156582459|NCT03694522|565217686|FG000|Overall Study|Lost to Follow-up|0|||
156582460|NCT03694522|565217687|FG001|Overall Study|Lost to Follow-up|1|||
156582461|NCT02760407|565217688|FG000|Overall Study|Death|2|||
156582462|NCT02760407|565217689|FG001|Overall Study|Death|3|||
156582463|NCT02760407|565217690|FG002|Overall Study|Death|1|||
156582464|NCT02760407|565217691|FG003|Overall Study|Death|1|||
156582465|NCT02760407|565217688|FG000|Overall Study|Lost to Follow-up|1|||
156582466|NCT02760407|565217689|FG001|Overall Study|Lost to Follow-up|7|||
156582467|NCT02760407|565217690|FG002|Overall Study|Lost to Follow-up|4|||
156582468|NCT02760407|565217691|FG003|Overall Study|Lost to Follow-up|6|||
156582469|NCT02760407|565217688|FG000|Overall Study|Withdrawal by Subject|25|||
156582470|NCT02760407|565217689|FG001|Overall Study|Withdrawal by Subject|31|||
156582471|NCT02760407|565217690|FG002|Overall Study|Withdrawal by Subject|37|||
156582472|NCT02760407|565217691|FG003|Overall Study|Withdrawal by Subject|25|||
156582473|NCT02760407|565217688|FG000|Overall Study|Violation of Eligibility criteria|0|||
156582474|NCT02760407|565217689|FG001|Overall Study|Violation of Eligibility criteria|0|||
156582475|NCT02760407|565217690|FG002|Overall Study|Violation of Eligibility criteria|1|||
156582476|NCT02760407|565217691|FG003|Overall Study|Violation of Eligibility criteria|1|||
156582477|NCT02760407|565217688|FG000|Overall Study|Personal reasons|0|||
156582478|NCT02760407|565217689|FG001|Overall Study|Personal reasons|0|||
156582479|NCT02760407|565217690|FG002|Overall Study|Personal reasons|0|||
156582480|NCT02760407|565217691|FG003|Overall Study|Personal reasons|1|||
156582481|NCT02760407|565217688|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
156582482|NCT02760407|565217689|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
156582483|NCT02760407|565217690|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
156582484|NCT02760407|565217691|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
156582485|NCT02760407|565217688|FG000|Overall Study|Use of prohibited Medication|0|||
156582486|NCT02760407|565217689|FG001|Overall Study|Use of prohibited Medication|0|||
156582487|NCT02760407|565217690|FG002|Overall Study|Use of prohibited Medication|1|||
156582488|NCT02760407|565217691|FG003|Overall Study|Use of prohibited Medication|0|||
156634749|NCT03426995|565407775|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156582489|NCT02760407|565217688|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
156582490|NCT02760407|565217689|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
156582491|NCT02760407|565217690|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
156582492|NCT02760407|565217691|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
156582493|NCT02760407|565217688|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
156582494|NCT02760407|565217689|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
156582495|NCT02760407|565217690|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
156582496|NCT02760407|565217691|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
156582497|NCT02760407|565217688|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
156582498|NCT02760407|565217689|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
156582499|NCT02760407|565217690|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
156582500|NCT02760407|565217691|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
156582501|NCT02760407|565217688|FG000|Overall Study|Inadequately Enrolled|0|||
156582502|NCT02760407|565217689|FG001|Overall Study|Inadequately Enrolled|0|||
156582503|NCT02760407|565217690|FG002|Overall Study|Inadequately Enrolled|0|||
156582504|NCT02760407|565217691|FG003|Overall Study|Inadequately Enrolled|1|||
156582505|NCT02760407|565217688|FG000|Overall Study|Withdrawal By PI's Decision|0|||
156582506|NCT02760407|565217689|FG001|Overall Study|Withdrawal By PI's Decision|1|||
156582507|NCT02760407|565217690|FG002|Overall Study|Withdrawal By PI's Decision|0|||
156582508|NCT02760407|565217691|FG003|Overall Study|Withdrawal By PI's Decision|0|||
156582509|NCT02760407|565217688|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
156582510|NCT02760407|565217689|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
156582511|NCT02760407|565217690|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
156582512|NCT02760407|565217691|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
156582513|NCT02760407|565217688|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
156582514|NCT02760407|565217689|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
156582515|NCT02760407|565217690|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
156582516|NCT02760407|565217691|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
156582517|NCT02760407|565217688|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
156582518|NCT02760407|565217689|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
156582519|NCT02760407|565217690|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
156582520|NCT02760407|565217691|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
156582521|NCT02760407|565217688|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
156582522|NCT02760407|565217689|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
156582523|NCT02760407|565217690|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
156582524|NCT02760407|565217691|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
156582525|NCT02760407|565217688|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
156582526|NCT02760407|565217689|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
156582527|NCT02760407|565217690|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
156582528|NCT02760407|565217691|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
156582529|NCT02760407|565217688|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
156582530|NCT02760407|565217689|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
156582531|NCT02760407|565217690|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
156582532|NCT02760407|565217691|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
156582533|NCT02760407|565217688|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
156582534|NCT02760407|565217689|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
156582535|NCT02760407|565217690|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
156582536|NCT02760407|565217691|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
156582537|NCT02760407|565217688|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
156582538|NCT02760407|565217689|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
156582539|NCT02760407|565217690|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
156582540|NCT02760407|565217691|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
156582541|NCT02760407|565217688|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
156582542|NCT02760407|565217689|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
156582543|NCT02760407|565217690|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
156582544|NCT02760407|565217691|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
156582545|NCT02522377|565217692|FG000|Overall Study|Withdrawal by Subject|1|||
156582546|NCT02522377|565217693|FG001|Overall Study|Withdrawal by Subject|0|||
156582547|NCT02522377|565217692|FG000|Overall Study|Remission Achieved|3|||
156582548|NCT02522377|565217693|FG001|Overall Study|Remission Achieved|0|||
156582549|NCT01158950|565217694|FG000|1st Intervention (1 Day)|Physician Decision|1|||
156582550|NCT01158950|565217695|FG001|1st Intervention (1 Day)|Physician Decision|2|||
156582551|NCT02137772|565217698|FG000|Overall Study|Adverse Event|6|||
156582552|NCT02137772|565217699|FG001|Overall Study|Adverse Event|3|||
156582553|NCT02137772|565217698|FG000|Overall Study|Death|71|||
156582554|NCT02137772|565217699|FG001|Overall Study|Death|44|||
156582555|NCT02137772|565217698|FG000|Overall Study|Lost to Follow-up|8|||
156582556|NCT02137772|565217699|FG001|Overall Study|Lost to Follow-up|4|||
156582557|NCT02137772|565217698|FG000|Overall Study|Physician Decision|15|||
156582558|NCT02137772|565217699|FG001|Overall Study|Physician Decision|5|||
156582559|NCT02137772|565217698|FG000|Overall Study|Withdrawal by Subject|28|||
156582560|NCT02137772|565217699|FG001|Overall Study|Withdrawal by Subject|17|||
156582561|NCT02137772|565217698|FG000|Overall Study|Non-compliance with study drug|1|||
156582562|NCT02137772|565217699|FG001|Overall Study|Non-compliance with study drug|0|||
156582563|NCT02137772|565217698|FG000|Overall Study|Not treated|3|||
156582564|NCT02137772|565217699|FG001|Overall Study|Not treated|2|||
156582565|NCT01844700|565217700|FG000|Overall Study|Lack of Efficacy|1|||
156582566|NCT01844700|565217701|FG001|Overall Study|Lack of Efficacy|0|||
156582567|NCT01844700|565217700|FG000|Overall Study|refused medication switch|1|||
156582568|NCT01844700|565217701|FG001|Overall Study|refused medication switch|0|||
156582569|NCT01844700|565217700|FG000|Overall Study|Withdrawal by Subject|1|||
156582570|NCT01844700|565217701|FG001|Overall Study|Withdrawal by Subject|0|||
156582571|NCT01844700|565217700|FG000|Overall Study|stopped taking meds|0|||
156582572|NCT01844700|565217701|FG001|Overall Study|stopped taking meds|1|||
156582573|NCT03290300|565217702|FG000|Overall Study|Lost to Follow-up|3|||
156582574|NCT00864227|565217703|FG000|Overall Study|Withdrawal by Subject|1|||
156582575|NCT00864227|565217703|FG000|Overall Study|Disease Relapse/Progression|3|||
156582576|NCT02124798|565217704|FG000|Overall Study|Adverse Event|3|||
156582577|NCT02124798|565217704|FG000|Overall Study|Lost to Follow-up|1|||
156582578|NCT02746679|565217712|FG000|Overall Study|Lost to Follow-up|4|||
156582579|NCT02746679|565217713|FG001|Overall Study|Lost to Follow-up|6|||
156582580|NCT00487279|565217714|FG000|Overall Study|Death|1|||
156582581|NCT00487279|565217715|FG001|Overall Study|Death|0|||
156582582|NCT00487279|565217714|FG000|Overall Study|Withdrawal by Subject|0|||
156582583|NCT00487279|565217715|FG001|Overall Study|Withdrawal by Subject|2|||
156582584|NCT00501852|565217716|FG000|Overall Study|Adverse Event|3|||
156582585|NCT00501852|565217716|FG000|Overall Study|Withdrawal by Subject|2|||
156582586|NCT01171521|565217720|FG000|Overall Study|Lost to Follow-up|5|||
156582587|NCT01171521|565217720|FG000|Overall Study|screen failure|1|||
156582588|NCT01416610|565217721|FG000|Overall Study|Adverse Event|4|||
156582589|NCT01416610|565217721|FG000|Overall Study|Adverse Event -Patient decision|3|||
156582590|NCT01416610|565217721|FG000|Overall Study|Lack of Efficacy|4|||
156582591|NCT01416610|565217721|FG000|Overall Study|No reason given|5|||
156582592|NCT01416610|565217721|FG000|Overall Study|Withdrawal by Subject|13|||
156582593|NCT01416610|565217721|FG000|Overall Study|Lost to Follow-up|7|||
156582594|NCT01416610|565217721|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
156582595|NCT00492921|565217722|FG000|Overall Study|Death|1|||
156582596|NCT00492921|565217723|FG001|Overall Study|Death|0|||
156582597|NCT00492921|565217724|FG002|Overall Study|Death|1|||
156582598|NCT01520922|565217725|FG000|Treatment Phase|Physician Decision|2|||
156582599|NCT01520922|565217726|FG001|Treatment Phase|Physician Decision|1|||
156582600|NCT01520922|565217725|FG000|Treatment Phase|Progression|0|||
156582601|NCT01520922|565217726|FG001|Treatment Phase|Progression|2|||
156582602|NCT01520922|565217725|FG000|Treatment Phase|Adverse Event|3|||
156582603|NCT01520922|565217726|FG001|Treatment Phase|Adverse Event|5|||
156582604|NCT01520922|565217725|FG000|Follow up|Lost to Follow-up|0|||
156582605|NCT01520922|565217726|FG001|Follow up|Lost to Follow-up|1|||
156582606|NCT01520922|565217725|FG000|Survival Follow-up|Withdrawal by Subject|1|||
156582607|NCT01520922|565217726|FG001|Survival Follow-up|Withdrawal by Subject|0|||
156582608|NCT01696877|565217729|FG000|Overall Study|Adverse Event|0|||
156582609|NCT01696877|565217730|FG001|Overall Study|Adverse Event|1|||
156582610|NCT01422304|565217731|FG000|Overall Study|Adverse Event|0|||
156582611|NCT01422304|565217732|FG001|Overall Study|Adverse Event|1|||
156582612|NCT01422304|565217731|FG000|Overall Study|Lost to Follow-up|14|||
156582613|NCT01422304|565217732|FG001|Overall Study|Lost to Follow-up|20|||
156582614|NCT01422304|565217731|FG000|Overall Study|Never Entered Follow-up|2|||
156582615|NCT01422304|565217732|FG001|Overall Study|Never Entered Follow-up|1|||
156582616|NCT01422304|565217731|FG000|Overall Study|Protocol Violation|1|||
156582617|NCT01422304|565217732|FG001|Overall Study|Protocol Violation|0|||
156582618|NCT01422304|565217731|FG000|Overall Study|Withdrawal by Subject|4|||
156582619|NCT01422304|565217732|FG001|Overall Study|Withdrawal by Subject|2|||
156582620|NCT01422304|565217731|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
156582621|NCT01422304|565217732|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
156582622|NCT01422304|565217731|FG000|Overall Study|Not Treated|3|||
156582623|NCT01422304|565217732|FG001|Overall Study|Not Treated|11|||
156582624|NCT00469014|565217737|FG000|Initial Phase Randomization|Disease Progression|0|||
156582625|NCT00469014|565217738|FG001|Initial Phase Randomization|Disease Progression|1|||
156582626|NCT00469014|565217739|FG002|Initial Phase Randomization|Disease Progression|1|||
156582627|NCT00469014|565217740|FG003|Initial Phase Randomization|Disease Progression|0|||
156582628|NCT00469014|565217737|FG000|Initial Phase Randomization|No Response|1|||
156582629|NCT00469014|565217738|FG001|Initial Phase Randomization|No Response|0|||
156582630|NCT00469014|565217739|FG002|Initial Phase Randomization|No Response|0|||
156582631|NCT00469014|565217740|FG003|Initial Phase Randomization|No Response|1|||
156582632|NCT00469014|565217737|FG000|Adaptive Randomization|Not Evaluable|1|||
156582633|NCT00469014|565217738|FG001|Adaptive Randomization|Not Evaluable|0|||
156582634|NCT00469014|565217739|FG002|Adaptive Randomization|Not Evaluable|0|||
156582635|NCT00469014|565217740|FG003|Adaptive Randomization|Not Evaluable|1|||
156582636|NCT00469014|565217737|FG000|Adaptive Randomization|No Response|0|||
156582637|NCT00469014|565217738|FG001|Adaptive Randomization|No Response|1|||
156582638|NCT00469014|565217739|FG002|Adaptive Randomization|No Response|0|||
156582639|NCT00469014|565217740|FG003|Adaptive Randomization|No Response|0|||
156582640|NCT00469014|565217737|FG000|Adaptive Randomization|Death|0|||
156582641|NCT00469014|565217738|FG001|Adaptive Randomization|Death|0|||
156582642|NCT00469014|565217739|FG002|Adaptive Randomization|Death|1|||
156582643|NCT00469014|565217740|FG003|Adaptive Randomization|Death|0|||
156582644|NCT03461289|565217744|FG000|Overall Study|Death|1|||
156582645|NCT00866294|565217745|FG000|Overall Study|Adverse Event|12|||
156582646|NCT00866294|565217746|FG001|Overall Study|Adverse Event|13|||
156582647|NCT00866294|565217747|FG002|Overall Study|Adverse Event|9|||
156582648|NCT00866294|565217745|FG000|Overall Study|Lack of Efficacy|7|||
156582649|NCT00866294|565217746|FG001|Overall Study|Lack of Efficacy|1|||
156582650|NCT00866294|565217747|FG002|Overall Study|Lack of Efficacy|0|||
156582651|NCT00866294|565217745|FG000|Overall Study|Protocol Violation|2|||
156582652|NCT00866294|565217746|FG001|Overall Study|Protocol Violation|0|||
156582653|NCT00866294|565217747|FG002|Overall Study|Protocol Violation|0|||
156582654|NCT00866294|565217745|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
156582655|NCT00866294|565217746|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156582656|NCT00866294|565217747|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156582657|NCT00866294|565217745|FG000|Overall Study|Lost to Follow-up|1|||
156582658|NCT00866294|565217746|FG001|Overall Study|Lost to Follow-up|3|||
156582659|NCT00866294|565217747|FG002|Overall Study|Lost to Follow-up|0|||
156582660|NCT00866294|565217745|FG000|Overall Study|Physician Decision|6|||
156582661|NCT00866294|565217746|FG001|Overall Study|Physician Decision|2|||
156582662|NCT00866294|565217747|FG002|Overall Study|Physician Decision|1|||
156582663|NCT03241173|565217748|FG000|Overall Study|Death|3|||
156582664|NCT03241173|565217749|FG001|Overall Study|Death|2|||
156582665|NCT03241173|565217750|FG002|Overall Study|Death|4|||
156582666|NCT03241173|565217751|FG003|Overall Study|Death|4|||
156582667|NCT03241173|565217752|FG004|Overall Study|Death|2|||
156582668|NCT03241173|565217753|FG005|Overall Study|Death|2|||
156582669|NCT03241173|565217754|FG006|Overall Study|Death|3|||
156582670|NCT03241173|565217755|FG007|Overall Study|Death|1|||
156582671|NCT03241173|565217756|FG008|Overall Study|Death|0|||
156582672|NCT03241173|565217757|FG009|Overall Study|Death|5|||
156582673|NCT03241173|565217758|FG010|Overall Study|Death|4|||
156582674|NCT03241173|565217759|FG011|Overall Study|Death|3|||
156582675|NCT03241173|565217760|FG012|Overall Study|Death|0|||
156582676|NCT03241173|565217761|FG013|Overall Study|Death|0|||
156582677|NCT03241173|565217762|FG014|Overall Study|Death|0|||
156582678|NCT03241173|565217748|FG000|Overall Study|Withdrawal by Subject|0|||
156582679|NCT03241173|565217749|FG001|Overall Study|Withdrawal by Subject|0|||
156582680|NCT03241173|565217750|FG002|Overall Study|Withdrawal by Subject|1|||
156582681|NCT03241173|565217751|FG003|Overall Study|Withdrawal by Subject|0|||
156582682|NCT03241173|565217752|FG004|Overall Study|Withdrawal by Subject|0|||
156582683|NCT03241173|565217753|FG005|Overall Study|Withdrawal by Subject|1|||
156582684|NCT03241173|565217754|FG006|Overall Study|Withdrawal by Subject|0|||
156582685|NCT03241173|565217755|FG007|Overall Study|Withdrawal by Subject|0|||
156582686|NCT03241173|565217756|FG008|Overall Study|Withdrawal by Subject|0|||
156582687|NCT03241173|565217757|FG009|Overall Study|Withdrawal by Subject|0|||
156582688|NCT03241173|565217758|FG010|Overall Study|Withdrawal by Subject|0|||
156582689|NCT03241173|565217759|FG011|Overall Study|Withdrawal by Subject|0|||
156582690|NCT03241173|565217760|FG012|Overall Study|Withdrawal by Subject|0|||
156582691|NCT03241173|565217761|FG013|Overall Study|Withdrawal by Subject|0|||
156582692|NCT03241173|565217762|FG014|Overall Study|Withdrawal by Subject|0|||
156582693|NCT03241173|565217748|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
156582694|NCT03241173|565217749|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
156582695|NCT03241173|565217750|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
156582696|NCT03241173|565217751|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
156582697|NCT03241173|565217752|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
156582698|NCT03241173|565217753|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
156582699|NCT03241173|565217754|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
156582700|NCT03241173|565217755|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
156582701|NCT03241173|565217756|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
156582702|NCT03241173|565217757|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
156582703|NCT03241173|565217758|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
156582704|NCT03241173|565217759|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
156582705|NCT03241173|565217760|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
156582706|NCT03241173|565217761|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
156582707|NCT03241173|565217762|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
156582708|NCT03241173|565217748|FG000|Overall Study|Lost to Follow-up|0|||
156582709|NCT03241173|565217749|FG001|Overall Study|Lost to Follow-up|0|||
156582710|NCT03241173|565217750|FG002|Overall Study|Lost to Follow-up|0|||
156582711|NCT03241173|565217751|FG003|Overall Study|Lost to Follow-up|0|||
156582712|NCT03241173|565217752|FG004|Overall Study|Lost to Follow-up|1|||
156582713|NCT03241173|565217753|FG005|Overall Study|Lost to Follow-up|0|||
156582714|NCT03241173|565217754|FG006|Overall Study|Lost to Follow-up|0|||
156582715|NCT03241173|565217755|FG007|Overall Study|Lost to Follow-up|0|||
156582716|NCT03241173|565217756|FG008|Overall Study|Lost to Follow-up|0|||
156582717|NCT03241173|565217757|FG009|Overall Study|Lost to Follow-up|1|||
156582718|NCT03241173|565217758|FG010|Overall Study|Lost to Follow-up|0|||
156582719|NCT03241173|565217759|FG011|Overall Study|Lost to Follow-up|0|||
156582720|NCT03241173|565217760|FG012|Overall Study|Lost to Follow-up|0|||
156582721|NCT03241173|565217761|FG013|Overall Study|Lost to Follow-up|0|||
156582722|NCT03241173|565217762|FG014|Overall Study|Lost to Follow-up|0|||
156582723|NCT00564629|565217763|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
156582724|NCT00564629|565217764|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
156582725|NCT00515463|565217765|FG000|Overall Study|Physician Decision|4|||
156582726|NCT00515463|565217766|FG001|Overall Study|Physician Decision|2|||
156582727|NCT00515463|565217765|FG000|Overall Study|Adverse Event|1|||
156582728|NCT00515463|565217766|FG001|Overall Study|Adverse Event|2|||
156582729|NCT00515463|565217765|FG000|Overall Study|Withdrawal by Subject|3|||
156582730|NCT00515463|565217766|FG001|Overall Study|Withdrawal by Subject|4|||
156582731|NCT00515463|565217765|FG000|Overall Study|Lost to Follow-up|6|||
156582732|NCT00515463|565217766|FG001|Overall Study|Lost to Follow-up|5|||
156582733|NCT00515463|565217765|FG000|Overall Study|Other|0|||
156582734|NCT00515463|565217766|FG001|Overall Study|Other|1|||
156582735|NCT00916721|565217767|FG000|Overall Study|Lost to Follow-up|0|||
156582736|NCT00916721|565217768|FG001|Overall Study|Lost to Follow-up|1|||
156582737|NCT00916721|565217767|FG000|Overall Study|Adverse Event|6|||
156582738|NCT00916721|565217768|FG001|Overall Study|Adverse Event|3|||
156582739|NCT00916721|565217767|FG000|Overall Study|Withdrawal by Subject|2|||
156582740|NCT00916721|565217768|FG001|Overall Study|Withdrawal by Subject|2|||
156582741|NCT00916721|565217767|FG000|Overall Study|Protocol Violation|2|||
156582742|NCT00916721|565217768|FG001|Overall Study|Protocol Violation|4|||
156582743|NCT01469052|565217771|FG000|Overall Study|Adverse Event|2|||
156582744|NCT01469052|565217772|FG001|Overall Study|Adverse Event|3|||
156582745|NCT01469052|565217773|FG002|Overall Study|Adverse Event|0|||
156582746|NCT01469052|565217774|FG003|Overall Study|Adverse Event|2|||
156582747|NCT01469052|565217775|FG004|Overall Study|Adverse Event|0|||
156582748|NCT01469052|565217776|FG005|Overall Study|Adverse Event|1|||
156582749|NCT01469052|565217771|FG000|Overall Study|Progressive disease|3|||
156582750|NCT01469052|565217772|FG001|Overall Study|Progressive disease|0|||
156582751|NCT01469052|565217773|FG002|Overall Study|Progressive disease|5|||
156582752|NCT01469052|565217774|FG003|Overall Study|Progressive disease|3|||
156582753|NCT01469052|565217775|FG004|Overall Study|Progressive disease|7|||
156582754|NCT01469052|565217776|FG005|Overall Study|Progressive disease|2|||
156582755|NCT01469052|565217771|FG000|Overall Study|Lack of Efficacy|0|||
156582756|NCT01469052|565217772|FG001|Overall Study|Lack of Efficacy|0|||
156582757|NCT01469052|565217773|FG002|Overall Study|Lack of Efficacy|0|||
156582758|NCT01469052|565217774|FG003|Overall Study|Lack of Efficacy|0|||
156582759|NCT01469052|565217775|FG004|Overall Study|Lack of Efficacy|0|||
156582760|NCT01469052|565217776|FG005|Overall Study|Lack of Efficacy|2|||
156582761|NCT01469052|565217771|FG000|Overall Study|Moved to rollover protocol|1|||
156582762|NCT01469052|565217772|FG001|Overall Study|Moved to rollover protocol|0|||
156582763|NCT01469052|565217773|FG002|Overall Study|Moved to rollover protocol|1|||
156582764|NCT01469052|565217774|FG003|Overall Study|Moved to rollover protocol|0|||
156582765|NCT01469052|565217775|FG004|Overall Study|Moved to rollover protocol|0|||
156582766|NCT01469052|565217776|FG005|Overall Study|Moved to rollover protocol|1|||
156582767|NCT01469052|565217771|FG000|Overall Study|Other|0|||
156582768|NCT01469052|565217772|FG001|Overall Study|Other|1|||
156582769|NCT01469052|565217773|FG002|Overall Study|Other|0|||
156582770|NCT01469052|565217774|FG003|Overall Study|Other|0|||
156582771|NCT01469052|565217775|FG004|Overall Study|Other|1|||
156582772|NCT01469052|565217776|FG005|Overall Study|Other|0|||
156582773|NCT03648996|565217778|FG000|Overall Study|Withdrawal by Subject|0|||
156582774|NCT03648996|565217779|FG001|Overall Study|Withdrawal by Subject|2|||
156582775|NCT03648996|565217780|FG002|Overall Study|Withdrawal by Subject|2|||
156582776|NCT03648996|565217778|FG000|Overall Study|Physician Decision|2|||
156582777|NCT03648996|565217779|FG001|Overall Study|Physician Decision|0|||
156582778|NCT03648996|565217780|FG002|Overall Study|Physician Decision|0|||
156582779|NCT02749370|565217782|FG000|Overall Study|Withdrawal by Subject|11|||
156582780|NCT02749370|565217782|FG000|Overall Study|Lost to Follow-up|3|||
156582781|NCT01519427|565217786|FG000|Overall Study|disease progression|2|||
156582782|NCT03894904|565217787|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
156582783|NCT03894904|565217788|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
156582784|NCT03894904|565217787|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
156582785|NCT03894904|565217788|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
156582786|NCT00365976|565217795|FG000|Overall Study|Withdrawal by Subject|1|||
156582787|NCT00365976|565217796|FG001|Overall Study|Withdrawal by Subject|5|||
156582788|NCT01780389|565217797|FG000|Overall Study|Adverse Event|1|||
156582789|NCT01614769|565219738|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
156582790|NCT01614769|565219739|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
156582791|NCT01614769|565219740|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
156582792|NCT01614769|565219741|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
156582793|NCT01614769|565219742|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
156582794|NCT01614769|565219743|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
156582795|NCT01614769|565219738|FG000|Period 1|Protocol Violation|0|||
156582796|NCT01614769|565219739|FG001|Period 1|Protocol Violation|0|||
156582797|NCT01614769|565219740|FG002|Period 1|Protocol Violation|0|||
156582798|NCT01614769|565219741|FG003|Period 1|Protocol Violation|1|||
156582799|NCT01614769|565219742|FG004|Period 1|Protocol Violation|0|||
156582800|NCT01614769|565219743|FG005|Period 1|Protocol Violation|0|||
156582801|NCT01614769|565219738|FG000|Period 1|Withdrawal by Subject|1|||
156582802|NCT01614769|565219739|FG001|Period 1|Withdrawal by Subject|0|||
156582803|NCT01614769|565219740|FG002|Period 1|Withdrawal by Subject|0|||
156582804|NCT01614769|565219741|FG003|Period 1|Withdrawal by Subject|0|||
156582805|NCT01614769|565219742|FG004|Period 1|Withdrawal by Subject|0|||
156582806|NCT01614769|565219743|FG005|Period 1|Withdrawal by Subject|0|||
156582807|NCT01614769|565219738|FG000|Period 3|Withdrawal by Subject|0|||
156582808|NCT01614769|565219739|FG001|Period 3|Withdrawal by Subject|0|||
156582809|NCT01614769|565219740|FG002|Period 3|Withdrawal by Subject|1|||
156582810|NCT01614769|565219741|FG003|Period 3|Withdrawal by Subject|0|||
156582811|NCT01614769|565219742|FG004|Period 3|Withdrawal by Subject|0|||
156582812|NCT01614769|565219743|FG005|Period 3|Withdrawal by Subject|0|||
156582813|NCT02115815|565219744|FG000|Overall Study|Withdrawal by Subject|2|||
156582814|NCT02115815|565219745|FG001|Overall Study|Withdrawal by Subject|0|||
156582815|NCT02115815|565219746|FG002|Overall Study|Withdrawal by Subject|0|||
156582816|NCT02115815|565219747|FG003|Overall Study|Withdrawal by Subject|0|||
156582817|NCT02115815|565219748|FG004|Overall Study|Withdrawal by Subject|0|||
156582818|NCT02115815|565219749|FG005|Overall Study|Withdrawal by Subject|0|||
156582819|NCT02115815|565219750|FG006|Overall Study|Withdrawal by Subject|0|||
156582820|NCT02115815|565219744|FG000|Overall Study|Not enough drug to dose participant|0|||
156582821|NCT02115815|565219745|FG001|Overall Study|Not enough drug to dose participant|0|||
156582822|NCT02115815|565219746|FG002|Overall Study|Not enough drug to dose participant|0|||
156582823|NCT02115815|565219747|FG003|Overall Study|Not enough drug to dose participant|0|||
156582824|NCT02115815|565219748|FG004|Overall Study|Not enough drug to dose participant|0|||
156582825|NCT02115815|565219749|FG005|Overall Study|Not enough drug to dose participant|1|||
156582826|NCT02115815|565219750|FG006|Overall Study|Not enough drug to dose participant|0|||
156582827|NCT02115815|565219744|FG000|Overall Study|Missed appointment, randomized in error|0|||
156582828|NCT02115815|565219745|FG001|Overall Study|Missed appointment, randomized in error|0|||
156582829|NCT02115815|565219746|FG002|Overall Study|Missed appointment, randomized in error|0|||
156582830|NCT02115815|565219747|FG003|Overall Study|Missed appointment, randomized in error|0|||
156582831|NCT02115815|565219748|FG004|Overall Study|Missed appointment, randomized in error|0|||
156582832|NCT02115815|565219749|FG005|Overall Study|Missed appointment, randomized in error|1|||
156582833|NCT02115815|565219750|FG006|Overall Study|Missed appointment, randomized in error|0|||
156582834|NCT01228071|565219751|FG000|Overall Study|Protocol Violation|1|||
156582835|NCT01228071|565219751|FG000|Overall Study|Withdrawal by Subject|1|||
156582836|NCT01989546|565219752|FG000|Overall Study|Clinical Progression|1|||
156582837|NCT01989546|565219752|FG000|Overall Study|Disease progression on study|8|||
156582838|NCT02819310|565219755|FG000|Overall Study|Withdrawal by Subject|37|||
156582839|NCT02819310|565219755|FG000|Overall Study|Lost to Follow-up|16|||
156582840|NCT02819310|565219755|FG000|Overall Study|Adverse Event|13|||
156582841|NCT02819310|565219755|FG000|Overall Study|Lack of Efficacy|5|||
156582842|NCT02819310|565219755|FG000|Overall Study|Physician Decision|8|||
156582843|NCT02819310|565219755|FG000|Overall Study|Protocol Violation|30|||
156582844|NCT01793051|565219760|FG000|Overall Study|Withdrawal by Subject|6|||
156582845|NCT01793051|565219761|FG001|Overall Study|Withdrawal by Subject|4|||
156582846|NCT01793051|565219760|FG000|Overall Study|Adverse Event|0|||
156582847|NCT01793051|565219761|FG001|Overall Study|Adverse Event|2|||
156582848|NCT01793051|565219760|FG000|Overall Study|Too ill to continue|1|||
156582849|NCT01793051|565219761|FG001|Overall Study|Too ill to continue|0|||
156582850|NCT01793051|565219760|FG000|Overall Study|Switched chemo|1|||
156582851|NCT01793051|565219761|FG001|Overall Study|Switched chemo|1|||
156582852|NCT01793051|565219760|FG000|Overall Study|Lack of compliance|1|||
156582853|NCT01793051|565219761|FG001|Overall Study|Lack of compliance|0|||
156582854|NCT01793051|565219760|FG000|Overall Study|Requested to be removed from the study|1|||
156582855|NCT01793051|565219761|FG001|Overall Study|Requested to be removed from the study|1|||
156582856|NCT00059215|565219765|FG000|Overall Study|Adverse Event|5|||
156582857|NCT00059215|565219766|FG001|Overall Study|Adverse Event|5|||
156582858|NCT00059215|565219767|FG002|Overall Study|Adverse Event|9|||
156582859|NCT00059215|565219768|FG003|Overall Study|Adverse Event|9|||
156582860|NCT00059215|565219765|FG000|Overall Study|Death|0|||
156582861|NCT00059215|565219766|FG001|Overall Study|Death|0|||
156582862|NCT00059215|565219767|FG002|Overall Study|Death|3|||
156582863|NCT00059215|565219768|FG003|Overall Study|Death|0|||
156582864|NCT00059215|565219765|FG000|Overall Study|Lost to Follow-up|1|||
156582865|NCT00059215|565219766|FG001|Overall Study|Lost to Follow-up|2|||
156582866|NCT00059215|565219767|FG002|Overall Study|Lost to Follow-up|0|||
156582867|NCT00059215|565219768|FG003|Overall Study|Lost to Follow-up|0|||
156582868|NCT00059215|565219765|FG000|Overall Study|Withdrawal by Subject|4|||
156582869|NCT00059215|565219766|FG001|Overall Study|Withdrawal by Subject|4|||
156582870|NCT00059215|565219767|FG002|Overall Study|Withdrawal by Subject|1|||
156582871|NCT00059215|565219768|FG003|Overall Study|Withdrawal by Subject|3|||
156582872|NCT00059215|565219765|FG000|Overall Study|Protocol Violation|1|||
156582873|NCT00059215|565219766|FG001|Overall Study|Protocol Violation|0|||
156582874|NCT00059215|565219767|FG002|Overall Study|Protocol Violation|1|||
156582875|NCT00059215|565219768|FG003|Overall Study|Protocol Violation|0|||
156582876|NCT00059215|565219765|FG000|Overall Study|Protocol entry criteria not met|1|||
156582877|NCT00059215|565219766|FG001|Overall Study|Protocol entry criteria not met|1|||
156582878|NCT00059215|565219767|FG002|Overall Study|Protocol entry criteria not met|0|||
156582879|NCT00059215|565219768|FG003|Overall Study|Protocol entry criteria not met|2|||
156582880|NCT00059215|565219765|FG000|Overall Study|Physician Decision|1|||
156582881|NCT00059215|565219766|FG001|Overall Study|Physician Decision|2|||
156582882|NCT00059215|565219767|FG002|Overall Study|Physician Decision|1|||
156582883|NCT00059215|565219768|FG003|Overall Study|Physician Decision|1|||
156582884|NCT04439838|565219769|FG000|Overall Study|Withdrawal by Subject|0|||
156582885|NCT04439838|565219770|FG001|Overall Study|Withdrawal by Subject|0|||
156582886|NCT04439838|565219771|FG002|Overall Study|Withdrawal by Subject|0|||
156582887|NCT04439838|565219772|FG003|Overall Study|Withdrawal by Subject|0|||
156582888|NCT04439838|565219773|FG004|Overall Study|Withdrawal by Subject|0|||
156582889|NCT04439838|565219774|FG005|Overall Study|Withdrawal by Subject|0|||
156582890|NCT04439838|565219775|FG006|Overall Study|Withdrawal by Subject|0|||
156582891|NCT04439838|565219776|FG007|Overall Study|Withdrawal by Subject|0|||
156582892|NCT04439838|565219777|FG008|Overall Study|Withdrawal by Subject|1|||
156582893|NCT04494633|565219782|FG000|Overall Study|Lost to Follow-up|5|||
156582894|NCT04494633|565219783|FG001|Overall Study|Lost to Follow-up|3|||
156582895|NCT04494633|565219782|FG000|Overall Study|Protocol Violation|1|||
156582896|NCT04494633|565219783|FG001|Overall Study|Protocol Violation|1|||
156582897|NCT01254604|565219786|FG000|Overall Study|Lost to Follow-up|1|||
156582898|NCT01254604|565219787|FG001|Overall Study|Lost to Follow-up|1|||
156582899|NCT01254604|565219786|FG000|Overall Study|Protocol Violation|2|||
156582900|NCT01254604|565219787|FG001|Overall Study|Protocol Violation|2|||
156582901|NCT01254604|565219786|FG000|Overall Study|Withdrawal by Subject|2|||
156582902|NCT01254604|565219787|FG001|Overall Study|Withdrawal by Subject|4|||
156582903|NCT01254604|565219786|FG000|Overall Study|Adverse Event|3|||
156582904|NCT01254604|565219787|FG001|Overall Study|Adverse Event|2|||
156582905|NCT03074162|565219788|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
156582906|NCT03074162|565219789|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
156582907|NCT03074162|565219790|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
156582908|NCT03074162|565219791|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
156582909|NCT03074162|565219792|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
156582910|NCT03074162|565219793|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
156582911|NCT03074162|565219788|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
156582912|NCT03074162|565219789|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
156582913|NCT03074162|565219790|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
156582914|NCT03074162|565219791|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
156582915|NCT03074162|565219792|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
156582916|NCT03074162|565219793|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
156582917|NCT03074162|565219788|FG000|Period 3|Withdrawal by Subject|1|||
156582918|NCT03074162|565219789|FG001|Period 3|Withdrawal by Subject|0|||
156582919|NCT03074162|565219790|FG002|Period 3|Withdrawal by Subject|0|||
156582920|NCT03074162|565219791|FG003|Period 3|Withdrawal by Subject|0|||
156582921|NCT03074162|565219792|FG004|Period 3|Withdrawal by Subject|1|||
156582922|NCT03074162|565219793|FG005|Period 3|Withdrawal by Subject|0|||
156582923|NCT01958671|565219794|FG000|Overall Study|Adverse Event|1|||
156582924|NCT01958671|565219795|FG001|Overall Study|Adverse Event|1|||
156582925|NCT01958671|565219796|FG002|Overall Study|Adverse Event|5|||
156582926|NCT01958671|565219794|FG000|Overall Study|Death|1|||
156582927|NCT01958671|565219795|FG001|Overall Study|Death|0|||
156582928|NCT01958671|565219796|FG002|Overall Study|Death|0|||
156582929|NCT01958671|565219794|FG000|Overall Study|Excluded medication|0|||
156582930|NCT01958671|565219795|FG001|Overall Study|Excluded medication|0|||
156582931|NCT01958671|565219796|FG002|Overall Study|Excluded medication|1|||
156582932|NCT01958671|565219794|FG000|Overall Study|Hyperglycemia|0|||
156582933|NCT01958671|565219795|FG001|Overall Study|Hyperglycemia|0|||
156582934|NCT01958671|565219796|FG002|Overall Study|Hyperglycemia|2|||
156582935|NCT01958671|565219794|FG000|Overall Study|Lost to Follow-up|7|||
156582936|NCT01958671|565219795|FG001|Overall Study|Lost to Follow-up|11|||
156582937|NCT01958671|565219796|FG002|Overall Study|Lost to Follow-up|7|||
156582938|NCT01958671|565219794|FG000|Overall Study|Non-compliance with study drug|1|||
156582939|NCT01958671|565219795|FG001|Overall Study|Non-compliance with study drug|1|||
156582940|NCT01958671|565219796|FG002|Overall Study|Non-compliance with study drug|1|||
156582941|NCT01958671|565219794|FG000|Overall Study|Pregnancy|0|||
156582942|NCT01958671|565219795|FG001|Overall Study|Pregnancy|0|||
156582943|NCT01958671|565219796|FG002|Overall Study|Pregnancy|1|||
156582944|NCT01958671|565219794|FG000|Overall Study|Protocol Violation|0|||
156582945|NCT01958671|565219795|FG001|Overall Study|Protocol Violation|1|||
156582946|NCT01958671|565219796|FG002|Overall Study|Protocol Violation|0|||
156582947|NCT01958671|565219794|FG000|Overall Study|Study site terminated by sponsor|1|||
156582948|NCT01958671|565219795|FG001|Overall Study|Study site terminated by sponsor|0|||
156582949|NCT01958671|565219796|FG002|Overall Study|Study site terminated by sponsor|1|||
156582950|NCT01958671|565219794|FG000|Overall Study|Participant moved|0|||
156582951|NCT01958671|565219795|FG001|Overall Study|Participant moved|0|||
156582952|NCT01958671|565219796|FG002|Overall Study|Participant moved|1|||
156582953|NCT01958671|565219794|FG000|Overall Study|Withdrawal by Subject|8|||
156582954|NCT01958671|565219795|FG001|Overall Study|Withdrawal by Subject|10|||
156582955|NCT01958671|565219796|FG002|Overall Study|Withdrawal by Subject|13|||
156582956|NCT02778867|565219802|FG000|Phase 1|Withdrawal by Subject|2|||
156582957|NCT02778867|565219803|FG001|Phase 1|Withdrawal by Subject|3|||
156582958|NCT02778867|565219804|FG002|Phase 1|Withdrawal by Subject|0|||
156582959|NCT02778867|565219805|FG003|Phase 1|Withdrawal by Subject|0|||
156582960|NCT02778867|565219802|FG000|Phase 2|Withdrawal by Subject|0|||
156582961|NCT02778867|565219803|FG001|Phase 2|Withdrawal by Subject|0|||
156582962|NCT02778867|565219804|FG002|Phase 2|Withdrawal by Subject|1|||
156582963|NCT02778867|565219805|FG003|Phase 2|Withdrawal by Subject|0|||
156582964|NCT02778867|565219802|FG000|Phase 2|Physician Decision|0|||
156582965|NCT02778867|565219803|FG001|Phase 2|Physician Decision|0|||
156582966|NCT02778867|565219804|FG002|Phase 2|Physician Decision|0|||
156582967|NCT02778867|565219805|FG003|Phase 2|Physician Decision|1|||
156582968|NCT02778867|565219802|FG000|Phase 2|Adverse Event|0|||
156582969|NCT02778867|565219803|FG001|Phase 2|Adverse Event|0|||
156582970|NCT02778867|565219804|FG002|Phase 2|Adverse Event|0|||
156582971|NCT02778867|565219805|FG003|Phase 2|Adverse Event|1|||
156582972|NCT02948777|565219806|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
156582973|NCT00623467|565219809|FG000|Overall Study|Lost to Follow-up|1|||
156582974|NCT00623467|565219809|FG000|Overall Study|Protocol Violation|4|||
156582975|NCT00623467|565219809|FG000|Overall Study|Withdrawal by Subject|2|||
156582976|NCT01070550|565219823|FG000|Overall Study|Adverse Event|43|||
156582977|NCT01070550|565219824|FG001|Overall Study|Adverse Event|1|||
156582978|NCT01070550|565219825|FG002|Overall Study|Adverse Event|3|||
156582979|NCT01070550|565219826|FG003|Overall Study|Adverse Event|0|||
156582980|NCT01070550|565219827|FG004|Overall Study|Adverse Event|0|||
156582981|NCT01070550|565219828|FG005|Overall Study|Adverse Event|0|||
156582982|NCT01070550|565219823|FG000|Overall Study|Death|20|||
156582983|NCT01070550|565219824|FG001|Overall Study|Death|4|||
156582984|NCT01070550|565219825|FG002|Overall Study|Death|3|||
156582985|NCT01070550|565219826|FG003|Overall Study|Death|0|||
156582986|NCT01070550|565219827|FG004|Overall Study|Death|0|||
156582987|NCT01070550|565219828|FG005|Overall Study|Death|0|||
156582988|NCT01070550|565219823|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
156582989|NCT01070550|565219824|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
156582990|NCT01070550|565219825|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
156582991|NCT01070550|565219826|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
156582992|NCT01070550|565219827|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
156582993|NCT01070550|565219828|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
156582994|NCT01070550|565219823|FG000|Overall Study|Early termination|3|||
156582995|NCT01070550|565219824|FG001|Overall Study|Early termination|0|||
156582996|NCT01070550|565219825|FG002|Overall Study|Early termination|0|||
156582997|NCT01070550|565219826|FG003|Overall Study|Early termination|0|||
156582998|NCT01070550|565219827|FG004|Overall Study|Early termination|0|||
156582999|NCT01070550|565219828|FG005|Overall Study|Early termination|0|||
156583000|NCT01070550|565219823|FG000|Overall Study|Failed to return|450|||
156583001|NCT01070550|565219824|FG001|Overall Study|Failed to return|33|||
156583002|NCT01070550|565219825|FG002|Overall Study|Failed to return|144|||
156583003|NCT01070550|565219826|FG003|Overall Study|Failed to return|40|||
156583004|NCT01070550|565219827|FG004|Overall Study|Failed to return|1|||
156583005|NCT01070550|565219828|FG005|Overall Study|Failed to return|2|||
156583006|NCT01070550|565219823|FG000|Overall Study|Incomplete treatment|2|||
156583007|NCT01070550|565219824|FG001|Overall Study|Incomplete treatment|0|||
156583008|NCT01070550|565219825|FG002|Overall Study|Incomplete treatment|0|||
156583009|NCT01070550|565219826|FG003|Overall Study|Incomplete treatment|0|||
156583010|NCT01070550|565219827|FG004|Overall Study|Incomplete treatment|0|||
156583011|NCT01070550|565219828|FG005|Overall Study|Incomplete treatment|0|||
156583012|NCT01070550|565219823|FG000|Overall Study|Lab test not done|22|||
156583013|NCT01070550|565219824|FG001|Overall Study|Lab test not done|3|||
156583014|NCT01070550|565219825|FG002|Overall Study|Lab test not done|4|||
156583015|NCT01070550|565219826|FG003|Overall Study|Lab test not done|1|||
156583016|NCT01070550|565219827|FG004|Overall Study|Lab test not done|0|||
156583017|NCT01070550|565219828|FG005|Overall Study|Lab test not done|1|||
156583018|NCT01070550|565219823|FG000|Overall Study|Lack of Efficacy|65|||
156583019|NCT01070550|565219824|FG001|Overall Study|Lack of Efficacy|1|||
156583020|NCT01070550|565219825|FG002|Overall Study|Lack of Efficacy|5|||
156583021|NCT01070550|565219826|FG003|Overall Study|Lack of Efficacy|5|||
156583022|NCT01070550|565219827|FG004|Overall Study|Lack of Efficacy|0|||
156583023|NCT01070550|565219828|FG005|Overall Study|Lack of Efficacy|1|||
156583024|NCT01070550|565219823|FG000|Overall Study|Miscellaneous|12|||
156583025|NCT01070550|565219824|FG001|Overall Study|Miscellaneous|2|||
156583026|NCT01070550|565219825|FG002|Overall Study|Miscellaneous|3|||
156583027|NCT01070550|565219826|FG003|Overall Study|Miscellaneous|1|||
156583028|NCT01070550|565219827|FG004|Overall Study|Miscellaneous|0|||
156583029|NCT01070550|565219828|FG005|Overall Study|Miscellaneous|0|||
156583030|NCT01070550|565219823|FG000|Overall Study|New treatment started|3|||
156583031|NCT01070550|565219824|FG001|Overall Study|New treatment started|1|||
156583032|NCT01070550|565219825|FG002|Overall Study|New treatment started|0|||
156583033|NCT01070550|565219826|FG003|Overall Study|New treatment started|2|||
156583034|NCT01070550|565219827|FG004|Overall Study|New treatment started|0|||
156583035|NCT01070550|565219828|FG005|Overall Study|New treatment started|0|||
156583036|NCT01070550|565219823|FG000|Overall Study|Non-responders|493|||
156583037|NCT01070550|565219824|FG001|Overall Study|Non-responders|4|||
156583038|NCT01070550|565219825|FG002|Overall Study|Non-responders|21|||
156583039|NCT01070550|565219826|FG003|Overall Study|Non-responders|20|||
156583040|NCT01070550|565219827|FG004|Overall Study|Non-responders|0|||
156583041|NCT01070550|565219828|FG005|Overall Study|Non-responders|2|||
156583042|NCT01070550|565219823|FG000|Overall Study|Not categorized|33|||
156583043|NCT01070550|565219824|FG001|Overall Study|Not categorized|2|||
156583044|NCT01070550|565219825|FG002|Overall Study|Not categorized|6|||
156583045|NCT01070550|565219826|FG003|Overall Study|Not categorized|1|||
156583046|NCT01070550|565219827|FG004|Overall Study|Not categorized|0|||
156583047|NCT01070550|565219828|FG005|Overall Study|Not categorized|1|||
156583048|NCT01070550|565219823|FG000|Overall Study|Protocol Violation|15|||
156583049|NCT01070550|565219824|FG001|Overall Study|Protocol Violation|1|||
156583050|NCT01070550|565219825|FG002|Overall Study|Protocol Violation|1|||
156583051|NCT01070550|565219826|FG003|Overall Study|Protocol Violation|1|||
156583052|NCT01070550|565219827|FG004|Overall Study|Protocol Violation|0|||
156583053|NCT01070550|565219828|FG005|Overall Study|Protocol Violation|0|||
156583054|NCT01070550|565219823|FG000|Overall Study|Relapse|44|||
156583055|NCT01070550|565219824|FG001|Overall Study|Relapse|5|||
156583056|NCT01070550|565219825|FG002|Overall Study|Relapse|14|||
156583057|NCT01070550|565219826|FG003|Overall Study|Relapse|4|||
156583058|NCT01070550|565219827|FG004|Overall Study|Relapse|0|||
156583059|NCT01070550|565219828|FG005|Overall Study|Relapse|0|||
156583060|NCT01070550|565219823|FG000|Overall Study|Result not available|3|||
156583061|NCT01070550|565219824|FG001|Overall Study|Result not available|1|||
156583062|NCT01070550|565219825|FG002|Overall Study|Result not available|3|||
156583063|NCT01070550|565219826|FG003|Overall Study|Result not available|0|||
156583064|NCT01070550|565219827|FG004|Overall Study|Result not available|0|||
156583065|NCT01070550|565219828|FG005|Overall Study|Result not available|0|||
156583066|NCT01070550|565219823|FG000|Overall Study|Screen failure|1|||
156583067|NCT01070550|565219824|FG001|Overall Study|Screen failure|0|||
156583068|NCT01070550|565219825|FG002|Overall Study|Screen failure|0|||
156583069|NCT01070550|565219826|FG003|Overall Study|Screen failure|0|||
156583070|NCT01070550|565219827|FG004|Overall Study|Screen failure|0|||
156583071|NCT01070550|565219828|FG005|Overall Study|Screen failure|0|||
156583072|NCT01070550|565219823|FG000|Overall Study|Sponsor decision|1|||
156583073|NCT01070550|565219824|FG001|Overall Study|Sponsor decision|0|||
156583074|NCT01070550|565219825|FG002|Overall Study|Sponsor decision|0|||
156583075|NCT01070550|565219826|FG003|Overall Study|Sponsor decision|0|||
156583076|NCT01070550|565219827|FG004|Overall Study|Sponsor decision|0|||
156583077|NCT01070550|565219828|FG005|Overall Study|Sponsor decision|0|||
156583078|NCT01070550|565219823|FG000|Overall Study|Treatment duration shortened|1|||
156583079|NCT01070550|565219824|FG001|Overall Study|Treatment duration shortened|0|||
156583080|NCT01070550|565219825|FG002|Overall Study|Treatment duration shortened|0|||
156583081|NCT01070550|565219826|FG003|Overall Study|Treatment duration shortened|0|||
156583082|NCT01070550|565219827|FG004|Overall Study|Treatment duration shortened|0|||
156583083|NCT01070550|565219828|FG005|Overall Study|Treatment duration shortened|0|||
156583084|NCT01070550|565219823|FG000|Overall Study|Treatment interrupted|7|||
156583085|NCT01070550|565219824|FG001|Overall Study|Treatment interrupted|0|||
156583086|NCT01070550|565219825|FG002|Overall Study|Treatment interrupted|1|||
156583087|NCT01070550|565219826|FG003|Overall Study|Treatment interrupted|1|||
156583088|NCT01070550|565219827|FG004|Overall Study|Treatment interrupted|0|||
156583089|NCT01070550|565219828|FG005|Overall Study|Treatment interrupted|0|||
156583090|NCT01070550|565219823|FG000|Overall Study|Treatment not started|14|||
156583091|NCT01070550|565219824|FG001|Overall Study|Treatment not started|2|||
156583092|NCT01070550|565219825|FG002|Overall Study|Treatment not started|4|||
156583093|NCT01070550|565219826|FG003|Overall Study|Treatment not started|0|||
156583094|NCT01070550|565219827|FG004|Overall Study|Treatment not started|0|||
156583095|NCT01070550|565219828|FG005|Overall Study|Treatment not started|0|||
156583096|NCT01070550|565219823|FG000|Overall Study|Treatment restarted|0|||
156583097|NCT01070550|565219824|FG001|Overall Study|Treatment restarted|1|||
156583098|NCT01070550|565219825|FG002|Overall Study|Treatment restarted|0|||
156583099|NCT01070550|565219826|FG003|Overall Study|Treatment restarted|0|||
156583100|NCT01070550|565219827|FG004|Overall Study|Treatment restarted|0|||
156583101|NCT01070550|565219828|FG005|Overall Study|Treatment restarted|0|||
156583102|NCT01070550|565219823|FG000|Overall Study|Treatment stopped|3|||
156583103|NCT01070550|565219824|FG001|Overall Study|Treatment stopped|0|||
156583104|NCT01070550|565219825|FG002|Overall Study|Treatment stopped|0|||
156583105|NCT01070550|565219826|FG003|Overall Study|Treatment stopped|0|||
156583106|NCT01070550|565219827|FG004|Overall Study|Treatment stopped|0|||
156583107|NCT01070550|565219828|FG005|Overall Study|Treatment stopped|0|||
156583108|NCT01070550|565219823|FG000|Overall Study|Treatment unavailable|1|||
156583109|NCT01070550|565219824|FG001|Overall Study|Treatment unavailable|0|||
156583110|NCT01070550|565219825|FG002|Overall Study|Treatment unavailable|0|||
156583111|NCT01070550|565219826|FG003|Overall Study|Treatment unavailable|0|||
156583112|NCT01070550|565219827|FG004|Overall Study|Treatment unavailable|0|||
156583113|NCT01070550|565219828|FG005|Overall Study|Treatment unavailable|0|||
156583114|NCT01070550|565219823|FG000|Overall Study|Treatment was stopped early|7|||
156583115|NCT01070550|565219824|FG001|Overall Study|Treatment was stopped early|0|||
156583116|NCT01070550|565219825|FG002|Overall Study|Treatment was stopped early|0|||
156583117|NCT01070550|565219826|FG003|Overall Study|Treatment was stopped early|0|||
156583118|NCT01070550|565219827|FG004|Overall Study|Treatment was stopped early|0|||
156583119|NCT01070550|565219828|FG005|Overall Study|Treatment was stopped early|0|||
156583120|NCT01070550|565219823|FG000|Overall Study|Other|5|||
156583121|NCT01070550|565219824|FG001|Overall Study|Other|0|||
156583122|NCT01070550|565219825|FG002|Overall Study|Other|0|||
156583123|NCT01070550|565219826|FG003|Overall Study|Other|1|||
156583124|NCT01070550|565219827|FG004|Overall Study|Other|0|||
156583125|NCT01070550|565219828|FG005|Overall Study|Other|0|||
156583126|NCT01070550|565219823|FG000|Overall Study|Withdrawal by Subject|35|||
156583127|NCT01070550|565219824|FG001|Overall Study|Withdrawal by Subject|0|||
156583128|NCT01070550|565219825|FG002|Overall Study|Withdrawal by Subject|3|||
156583129|NCT01070550|565219826|FG003|Overall Study|Withdrawal by Subject|0|||
156583130|NCT01070550|565219827|FG004|Overall Study|Withdrawal by Subject|0|||
156583131|NCT01070550|565219828|FG005|Overall Study|Withdrawal by Subject|0|||
156583132|NCT03952468|565219829|FG000|Overall Study|Death|0|||
156583133|NCT03952468|565219830|FG001|Overall Study|Death|1|||
156583134|NCT03952468|565219829|FG000|Overall Study|Adverse Event|0|||
156583135|NCT03952468|565219830|FG001|Overall Study|Adverse Event|1|||
156583136|NCT03952468|565219829|FG000|Overall Study|Physician Decision|1|||
156583137|NCT03952468|565219830|FG001|Overall Study|Physician Decision|0|||
156583138|NCT03952468|565219829|FG000|Overall Study|Lost to Follow-up|3|||
156583139|NCT03952468|565219830|FG001|Overall Study|Lost to Follow-up|4|||
156583140|NCT03952468|565219829|FG000|Overall Study|Withdrawal by Subject|2|||
156583141|NCT03952468|565219830|FG001|Overall Study|Withdrawal by Subject|1|||
156583142|NCT04964063|565219831|FG000|Overall Study|Adverse Event|4|||
156583143|NCT04964063|565219831|FG000|Overall Study|Lost to Follow-up|47|||
156583144|NCT04964063|565219831|FG000|Overall Study|Withdrawal by Subject|5|||
156583145|NCT04964063|565219831|FG000|Overall Study|Baseline Tasks Expired|41|||
156583146|NCT04964063|565219831|FG000|Overall Study|Participant withdrawn in error|1|||
156583147|NCT01702363|565219834|FG000|Overall Study|Adverse Event|14|||
156583148|NCT01702363|565219834|FG000|Overall Study|Lack of Efficacy|4|||
156583149|NCT01702363|565219834|FG000|Overall Study|Withdrawal by Subject|2|||
156583150|NCT01312428|565219835|FG000|Overall Study|Study Termination|3|||
156583151|NCT01312428|565219836|FG001|Overall Study|Study Termination|4|||
156583152|NCT00431847|565219842|FG000|Overall Study|completion of less than two study visits|6|||
156583153|NCT00431847|565219843|FG001|Overall Study|completion of less than two study visits|3|||
156583154|NCT00431847|565219844|FG002|Overall Study|completion of less than two study visits|4|||
156583155|NCT00431847|565219845|FG003|Overall Study|completion of less than two study visits|14|||
156583156|NCT00431847|565219846|FG004|Overall Study|completion of less than two study visits|0|||
156583157|NCT00431847|565219842|FG000|Overall Study|Protocol Violation|0|||
156583158|NCT00431847|565219843|FG001|Overall Study|Protocol Violation|0|||
156583159|NCT00431847|565219844|FG002|Overall Study|Protocol Violation|0|||
156583160|NCT00431847|565219845|FG003|Overall Study|Protocol Violation|0|||
156583161|NCT00431847|565219846|FG004|Overall Study|Protocol Violation|1|||
156583162|NCT00339183|565219849|FG000|Overall Study|Adverse Event|5|||
156583163|NCT00339183|565219850|FG001|Overall Study|Adverse Event|3|||
156583164|NCT00339183|565219849|FG000|Overall Study|Withdrawal by Subject|16|||
156583165|NCT00339183|565219850|FG001|Overall Study|Withdrawal by Subject|19|||
156583166|NCT00339183|565219849|FG000|Overall Study|Physician Decision|2|||
156583167|NCT00339183|565219850|FG001|Overall Study|Physician Decision|4|||
156583168|NCT00339183|565219849|FG000|Overall Study|Lost to Follow-up|17|||
156583169|NCT00339183|565219850|FG001|Overall Study|Lost to Follow-up|17|||
156583170|NCT00339183|565219849|FG000|Overall Study|Protocol-specified criteria|12|||
156583171|NCT00339183|565219850|FG001|Overall Study|Protocol-specified criteria|8|||
156583172|NCT00339183|565219849|FG000|Overall Study|Missing reason|3|||
156583173|NCT00339183|565219850|FG001|Overall Study|Missing reason|1|||
156583174|NCT00339183|565219849|FG000|Overall Study|Other|46|||
156583175|NCT00339183|565219850|FG001|Overall Study|Other|40|||
156583176|NCT00339183|565219849|FG000|Overall Study|Ongoing|20|||
156583177|NCT00339183|565219850|FG001|Overall Study|Ongoing|13|||
156583178|NCT00793819|565219851|FG000|Overall Study|Adverse Event|8|||
156583179|NCT00793819|565219852|FG001|Overall Study|Adverse Event|4|||
156583180|NCT00793819|565219851|FG000|Overall Study|Lack of Efficacy|1|||
156583181|NCT00793819|565219852|FG001|Overall Study|Lack of Efficacy|1|||
156583182|NCT00793819|565219851|FG000|Overall Study|Withdrawal by Subject|4|||
156583183|NCT00793819|565219852|FG001|Overall Study|Withdrawal by Subject|3|||
156583184|NCT00793819|565219851|FG000|Overall Study|Lost to Follow-up|1|||
156583185|NCT00793819|565219852|FG001|Overall Study|Lost to Follow-up|1|||
156583186|NCT00002663|565219853|FG000|Overall Study|Death|4|||
156583187|NCT00002663|565219854|FG001|Overall Study|Death|1|||
156583188|NCT00002663|565219855|FG002|Overall Study|Death|1|||
156583189|NCT00002663|565219856|FG003|Overall Study|Death|0|||
156583190|NCT00002663|565219857|FG004|Overall Study|Death|0|||
156583191|NCT00002663|565219858|FG005|Overall Study|Death|13|||
156583192|NCT00002663|565219859|FG006|Overall Study|Death|0|||
156583193|NCT00002663|565219860|FG007|Overall Study|Death|1|||
156583194|NCT00002663|565219861|FG008|Overall Study|Death|1|||
156583195|NCT00002663|565219862|FG009|Overall Study|Death|1|||
156583196|NCT00002663|565219853|FG000|Overall Study|Lost to Follow-up|3|||
156583197|NCT00002663|565219854|FG001|Overall Study|Lost to Follow-up|0|||
156583198|NCT00002663|565219855|FG002|Overall Study|Lost to Follow-up|0|||
156583199|NCT00002663|565219856|FG003|Overall Study|Lost to Follow-up|1|||
156583200|NCT00002663|565219857|FG004|Overall Study|Lost to Follow-up|0|||
156583201|NCT00002663|565219858|FG005|Overall Study|Lost to Follow-up|1|||
156583202|NCT00002663|565219859|FG006|Overall Study|Lost to Follow-up|0|||
156583203|NCT00002663|565219860|FG007|Overall Study|Lost to Follow-up|0|||
156583204|NCT00002663|565219861|FG008|Overall Study|Lost to Follow-up|0|||
156583205|NCT00002663|565219862|FG009|Overall Study|Lost to Follow-up|0|||
156583206|NCT00002663|565219853|FG000|Overall Study|Other|0|||
156583207|NCT00002663|565219854|FG001|Overall Study|Other|1|||
156583208|NCT00002663|565219855|FG002|Overall Study|Other|0|||
156583209|NCT00002663|565219856|FG003|Overall Study|Other|0|||
156583210|NCT00002663|565219857|FG004|Overall Study|Other|0|||
156583211|NCT00002663|565219858|FG005|Overall Study|Other|1|||
156583212|NCT00002663|565219859|FG006|Overall Study|Other|1|||
156583213|NCT00002663|565219860|FG007|Overall Study|Other|0|||
156583214|NCT00002663|565219861|FG008|Overall Study|Other|0|||
156583215|NCT00002663|565219862|FG009|Overall Study|Other|0|||
156583216|NCT00002663|565219853|FG000|Overall Study|Physician Decision|0|||
156583217|NCT00002663|565219854|FG001|Overall Study|Physician Decision|0|||
156583218|NCT00002663|565219855|FG002|Overall Study|Physician Decision|0|||
156583219|NCT00002663|565219856|FG003|Overall Study|Physician Decision|0|||
156583220|NCT00002663|565219857|FG004|Overall Study|Physician Decision|1|||
156583221|NCT00002663|565219858|FG005|Overall Study|Physician Decision|0|||
156583222|NCT00002663|565219859|FG006|Overall Study|Physician Decision|0|||
156583223|NCT00002663|565219860|FG007|Overall Study|Physician Decision|0|||
156583224|NCT00002663|565219861|FG008|Overall Study|Physician Decision|1|||
156583225|NCT00002663|565219862|FG009|Overall Study|Physician Decision|1|||
156583226|NCT00002663|565219853|FG000|Overall Study|Adverse Event|0|||
156583227|NCT00002663|565219854|FG001|Overall Study|Adverse Event|0|||
156583228|NCT00002663|565219855|FG002|Overall Study|Adverse Event|0|||
156583229|NCT00002663|565219856|FG003|Overall Study|Adverse Event|1|||
156583230|NCT00002663|565219857|FG004|Overall Study|Adverse Event|0|||
156583231|NCT00002663|565219858|FG005|Overall Study|Adverse Event|0|||
156583232|NCT00002663|565219859|FG006|Overall Study|Adverse Event|0|||
156583233|NCT00002663|565219860|FG007|Overall Study|Adverse Event|1|||
156583234|NCT00002663|565219861|FG008|Overall Study|Adverse Event|0|||
156583235|NCT00002663|565219862|FG009|Overall Study|Adverse Event|0|||
156583236|NCT00446446|565219864|FG000|Overall Study|Death|10|||
156583237|NCT00446446|565219864|FG000|Overall Study|Withdrawal by Subject|6|||
156583238|NCT00446446|565219864|FG000|Overall Study|Other|4|||
156583239|NCT00446446|565219864|FG000|Overall Study|Disease Progession|2|||
156583240|NCT00446446|565219864|FG000|Overall Study|Adverse Event|1|||
156583241|NCT00446446|565219864|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
156583242|NCT02142894|565219865|FG000|Overall Study|Protocol Violation|8|||
156583243|NCT01137435|565219875|FG000|Overall Study|Lost to Follow-up|24|||
156583244|NCT01137435|565219875|FG000|Overall Study|Off label usage|4|||
156583245|NCT00652093|565219876|FG000|Overall Study|Withdrawal by Subject|0|||
156583246|NCT00652093|565219877|FG001|Overall Study|Withdrawal by Subject|0|||
156583247|NCT00652093|565219878|FG002|Overall Study|Withdrawal by Subject|1|||
156583248|NCT00652093|565219879|FG003|Overall Study|Withdrawal by Subject|0|||
156583249|NCT00652093|565219880|FG004|Overall Study|Withdrawal by Subject|1|||
156583250|NCT00652093|565219881|FG005|Overall Study|Withdrawal by Subject|0|||
156583251|NCT00652093|565219876|FG000|Overall Study|Physician Decision|0|||
156583252|NCT00652093|565219877|FG001|Overall Study|Physician Decision|0|||
156583253|NCT00652093|565219878|FG002|Overall Study|Physician Decision|0|||
156583254|NCT00652093|565219879|FG003|Overall Study|Physician Decision|0|||
156583255|NCT00652093|565219880|FG004|Overall Study|Physician Decision|1|||
156583256|NCT00652093|565219881|FG005|Overall Study|Physician Decision|0|||
156583257|NCT03117049|565219884|FG000|Overall Study|Continued the follow-up period|109|||
156583258|NCT03117049|565219885|FG001|Overall Study|Continued the follow-up period|129|||
156583259|NCT03117049|565219884|FG000|Overall Study|Died|82|||
156583260|NCT03117049|565219885|FG001|Overall Study|Died|93|||
156583261|NCT03117049|565219884|FG000|Overall Study|Consent withdrawal|7|||
156583262|NCT03117049|565219885|FG001|Overall Study|Consent withdrawal|6|||
156583263|NCT03117049|565219884|FG000|Overall Study|Missing contact|3|||
156583264|NCT03117049|565219885|FG001|Overall Study|Missing contact|3|||
156583265|NCT00651118|565219886|FG000|Overall Study|Adverse Event|4|||
156583266|NCT00651118|565219887|FG001|Overall Study|Adverse Event|0|||
156583267|NCT00651118|565219888|FG002|Overall Study|Adverse Event|1|||
156583268|NCT00651118|565219889|FG003|Overall Study|Adverse Event|1|||
156583269|NCT00651118|565219886|FG000|Overall Study|Protocol Violation|2|||
156583270|NCT00651118|565219887|FG001|Overall Study|Protocol Violation|2|||
156583271|NCT00651118|565219888|FG002|Overall Study|Protocol Violation|6|||
156583272|NCT00651118|565219889|FG003|Overall Study|Protocol Violation|2|||
156583273|NCT00651118|565219886|FG000|Overall Study|Lost to Follow-up|2|||
156583274|NCT00651118|565219887|FG001|Overall Study|Lost to Follow-up|0|||
156583275|NCT00651118|565219888|FG002|Overall Study|Lost to Follow-up|1|||
156583276|NCT00651118|565219889|FG003|Overall Study|Lost to Follow-up|2|||
156583277|NCT00651118|565219886|FG000|Overall Study|administrative|1|||
156583278|NCT00651118|565219887|FG001|Overall Study|administrative|4|||
156583279|NCT00651118|565219888|FG002|Overall Study|administrative|2|||
156583280|NCT00651118|565219889|FG003|Overall Study|administrative|1|||
156583281|NCT00651118|565219886|FG000|Overall Study|Withdrawal by Subject|0|||
156583282|NCT00651118|565219887|FG001|Overall Study|Withdrawal by Subject|1|||
156583283|NCT00651118|565219888|FG002|Overall Study|Withdrawal by Subject|1|||
156583284|NCT00651118|565219889|FG003|Overall Study|Withdrawal by Subject|1|||
156583285|NCT00839098|565219890|FG000|Overall Study|Withdrawal by Subject|2|||
156583286|NCT00839098|565219891|FG001|Overall Study|Withdrawal by Subject|1|||
156583287|NCT00839098|565219892|FG002|Overall Study|Withdrawal by Subject|7|||
156583288|NCT02190435|565219893|FG000|Overall Study|First 12 patients were lead-ins|12|||
156583289|NCT02190435|565219894|FG001|Overall Study|First 12 patients were lead-ins|0|||
156583290|NCT02190435|565219893|FG000|Overall Study|3 consented screen fails|3|||
156583291|NCT02190435|565219894|FG001|Overall Study|3 consented screen fails|0|||
156583292|NCT02399475|565219903|FG000|Overall Study|Physician Decision|1|||
156583293|NCT02399475|565219904|FG001|Overall Study|Physician Decision|0|||
156583294|NCT02260193|565219905|FG000|Overall Study|Lack of Efficacy|0|||
156583295|NCT02260193|565219906|FG001|Overall Study|Lack of Efficacy|1|||
156583296|NCT02260193|565219907|FG002|Overall Study|Lack of Efficacy|6|||
156583297|NCT02260193|565219905|FG000|Overall Study|Adverse Event|3|||
156583298|NCT02260193|565219906|FG001|Overall Study|Adverse Event|4|||
156583299|NCT02260193|565219907|FG002|Overall Study|Adverse Event|1|||
156583300|NCT02260193|565219905|FG000|Overall Study|Protocol Violation|0|||
156583301|NCT02260193|565219906|FG001|Overall Study|Protocol Violation|4|||
156583302|NCT02260193|565219907|FG002|Overall Study|Protocol Violation|0|||
156583303|NCT02260193|565219905|FG000|Overall Study|Withdrawal by Subject|3|||
156583304|NCT02260193|565219906|FG001|Overall Study|Withdrawal by Subject|0|||
156583305|NCT02260193|565219907|FG002|Overall Study|Withdrawal by Subject|2|||
156583306|NCT02260193|565219905|FG000|Overall Study|Kidney Transplantation|0|||
156583307|NCT02260193|565219906|FG001|Overall Study|Kidney Transplantation|0|||
156583308|NCT02260193|565219907|FG002|Overall Study|Kidney Transplantation|1|||
156583309|NCT00935220|565219908|FG000|Overall Study|Adverse Event|1|||
156583310|NCT00935220|565219908|FG000|Overall Study|Other reason (not specified)|1|||
156583311|NCT01000064|565219909|FG000|Overall Study|Withdrawal by Subject|1|||
156583312|NCT01000064|565219910|FG001|Overall Study|Withdrawal by Subject|1|||
156583313|NCT02518620|565219911|FG000|Overall Study|Adverse Event|23|||
156583314|NCT02518620|565219912|FG001|Overall Study|Adverse Event|11|||
156583315|NCT02518620|565219911|FG000|Overall Study|Lack of Efficacy|2|||
156583316|NCT02518620|565219912|FG001|Overall Study|Lack of Efficacy|0|||
156583317|NCT02518620|565219911|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156583318|NCT02518620|565219912|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156583319|NCT02518620|565219911|FG000|Overall Study|Physician Decision|1|||
156583320|NCT02518620|565219912|FG001|Overall Study|Physician Decision|1|||
156583321|NCT02518620|565219911|FG000|Overall Study|Sponsor's Decision|0|||
156583322|NCT02518620|565219912|FG001|Overall Study|Sponsor's Decision|3|||
156583323|NCT02518620|565219911|FG000|Overall Study|Lost to Follow-up|1|||
156583324|NCT02518620|565219912|FG001|Overall Study|Lost to Follow-up|1|||
156583325|NCT02518620|565219911|FG000|Overall Study|Withdrawal by Subject|17|||
156583326|NCT02518620|565219912|FG001|Overall Study|Withdrawal by Subject|9|||
156583327|NCT02518620|565219911|FG000|Overall Study|Death|1|||
156583328|NCT02518620|565219912|FG001|Overall Study|Death|0|||
156583329|NCT02518620|565219911|FG000|Overall Study|Pregnancy Wish|3|||
156583330|NCT02518620|565219912|FG001|Overall Study|Pregnancy Wish|0|||
156583331|NCT02518620|565219911|FG000|Overall Study|Pregnancy|1|||
156583332|NCT02518620|565219912|FG001|Overall Study|Pregnancy|0|||
156583333|NCT02518620|565219911|FG000|Overall Study|Relocation|2|||
156583334|NCT02518620|565219912|FG001|Overall Study|Relocation|1|||
156583335|NCT00798967|565219913|FG000|Overall Study|Adverse Event|2|||
156583336|NCT00798967|565219914|FG001|Overall Study|Adverse Event|3|||
156583337|NCT00798967|565219913|FG000|Overall Study|Withdrawal by Subject|0|||
156583338|NCT00798967|565219914|FG001|Overall Study|Withdrawal by Subject|1|||
156583339|NCT00798967|565219913|FG000|Overall Study|Physician Decision|1|||
156583340|NCT00798967|565219914|FG001|Overall Study|Physician Decision|0|||
156583341|NCT00798967|565219913|FG000|Overall Study|Randomized in error by site|1|||
156583342|NCT00798967|565219914|FG001|Overall Study|Randomized in error by site|0|||
156583343|NCT01415440|565219915|FG000|Overall Study|Lost to Follow-up|0|||
156583344|NCT01415440|565219916|FG001|Overall Study|Lost to Follow-up|1|||
156583345|NCT01415440|565219917|FG002|Overall Study|Lost to Follow-up|2|||
156583346|NCT01415440|565219915|FG000|Overall Study|Physician Decision|3|||
156583347|NCT01415440|565219916|FG001|Overall Study|Physician Decision|0|||
156583348|NCT01415440|565219917|FG002|Overall Study|Physician Decision|0|||
156583349|NCT01415440|565219915|FG000|Overall Study|Withdrawal by Subject|1|||
156583350|NCT01415440|565219916|FG001|Overall Study|Withdrawal by Subject|0|||
156583351|NCT01415440|565219917|FG002|Overall Study|Withdrawal by Subject|0|||
156583352|NCT00336492|565219918|FG000|Overall Study|Adverse Event|4|||
156583353|NCT00336492|565219919|FG001|Overall Study|Adverse Event|3|||
156583354|NCT00336492|565219920|FG002|Overall Study|Adverse Event|6|||
156583355|NCT00336492|565219918|FG000|Overall Study|Lack of Efficacy|6|||
156583356|NCT00336492|565219919|FG001|Overall Study|Lack of Efficacy|1|||
156583357|NCT00336492|565219920|FG002|Overall Study|Lack of Efficacy|4|||
156583358|NCT00336492|565219918|FG000|Overall Study|Other|5|||
156583359|NCT00336492|565219919|FG001|Overall Study|Other|0|||
156583360|NCT00336492|565219920|FG002|Overall Study|Other|1|||
156583361|NCT01781026|565219923|FG000|Overall Study|Lack of Efficacy|2|||
156583362|NCT00227877|565219926|FG000|Pre-visit Assessment|Technical difficulties|7|||
156583363|NCT00227877|565219927|FG001|Pre-visit Assessment|Technical difficulties|3|||
156583364|NCT00227877|565219928|FG002|Pre-visit Assessment|Technical difficulties|0|||
156583365|NCT00227877|565219929|FG003|Pre-visit Assessment|Technical difficulties|0|||
156583366|NCT00227877|565219926|FG000|Post-visit Checklist|Lost to Follow-up|24|||
156583367|NCT00227877|565219927|FG001|Post-visit Checklist|Lost to Follow-up|13|||
156583368|NCT00227877|565219928|FG002|Post-visit Checklist|Lost to Follow-up|1|||
156583369|NCT00227877|565219929|FG003|Post-visit Checklist|Lost to Follow-up|0|||
156583370|NCT00227877|565219926|FG000|3-months Follow-up|Completed late|135|||
156583371|NCT00227877|565219927|FG001|3-months Follow-up|Completed late|128|||
156583372|NCT00227877|565219928|FG002|3-months Follow-up|Completed late|34|||
156583373|NCT00227877|565219929|FG003|3-months Follow-up|Completed late|8|||
156583374|NCT00227877|565219926|FG000|3-months Follow-up|Lost to Follow-up|178|||
156583375|NCT00227877|565219927|FG001|3-months Follow-up|Lost to Follow-up|139|||
156583376|NCT00227877|565219928|FG002|3-months Follow-up|Lost to Follow-up|18|||
156583377|NCT00227877|565219929|FG003|3-months Follow-up|Lost to Follow-up|13|||
156583378|NCT00227877|565219926|FG000|12-months Follow-up|Completed late|78|||
156583379|NCT00227877|565219927|FG001|12-months Follow-up|Completed late|74|||
156583380|NCT00227877|565219928|FG002|12-months Follow-up|Completed late|1|||
156583381|NCT00227877|565219929|FG003|12-months Follow-up|Completed late|0|||
156583382|NCT00227877|565219926|FG000|12-months Follow-up|Lost to Follow-up|232|||
156583383|NCT00227877|565219927|FG001|12-months Follow-up|Lost to Follow-up|189|||
156583384|NCT00227877|565219928|FG002|12-months Follow-up|Lost to Follow-up|30|||
156583385|NCT00227877|565219929|FG003|12-months Follow-up|Lost to Follow-up|26|||
156583386|NCT03141307|565219930|FG000|In-Hospital|Withdrawal by Subject|0|||
156583387|NCT03141307|565219931|FG001|In-Hospital|Withdrawal by Subject|2|||
156583388|NCT03141307|565219930|FG000|In-Hospital|Protocol Violation|4|||
156583389|NCT03141307|565219931|FG001|In-Hospital|Protocol Violation|0|||
156583390|NCT03141307|565219930|FG000|Follow-Up|Lost to Follow-up|97|||
156583391|NCT03141307|565219931|FG001|Follow-Up|Lost to Follow-up|54|||
156583392|NCT03090737|565219932|FG000|Overall Study|Other reasons|1|||
156583393|NCT03090737|565219932|FG000|Overall Study|Completed treatment as per protocol|17|||
156583394|NCT03090737|565219932|FG000|Overall Study|Maximum clinical benefit|2|||
156583395|NCT03090737|565219932|FG000|Overall Study|Adverse event unrelated to study drug|7|||
156583396|NCT03090737|565219932|FG000|Overall Study|Study drug toxicity|4|||
156583397|NCT03090737|565219932|FG000|Overall Study|Disease progression|98|||
156583398|NCT03596177|565219935|FG000|Single Blind Period|Withdrawal by Subject|1|||
156583399|NCT03596177|565219936|FG001|Single Blind Period|Withdrawal by Subject|1|||
156583400|NCT03596177|565219935|FG000|Single Blind Period|Other|1|||
156583401|NCT03596177|565219936|FG001|Single Blind Period|Other|0|||
156583402|NCT03596177|565219935|FG000|Double Blind Period|Withdrawal by Subject|0|||
156583403|NCT03596177|565219936|FG001|Double Blind Period|Withdrawal by Subject|1|||
156583404|NCT03596177|565219935|FG000|Double Blind Period|Other|0|||
156583405|NCT03596177|565219936|FG001|Double Blind Period|Other|4|||
156583406|NCT03596177|565219935|FG000|Double Blind Period|Death during safety follow-up|0|||
156583407|NCT03596177|565219936|FG001|Double Blind Period|Death during safety follow-up|1|||
156583408|NCT02522481|565219939|FG000|Overall Study|discontinued|1|||
156583409|NCT02522481|565219939|FG000|Overall Study|Not dosed|2|||
156583410|NCT03123939|565219940|FG000|Overall Study|Lack of Efficacy|6|||
156583411|NCT03123939|565219940|FG000|Overall Study|Death|5|||
156583412|NCT03123939|565219940|FG000|Overall Study|Physician Decision|2|||
156583413|NCT03123939|565219940|FG000|Overall Study|Subject/guardian decision|2|||
156583414|NCT03123939|565219940|FG000|Overall Study|Lost to Follow-up|1|||
156583415|NCT03123939|565219940|FG000|Overall Study|New therapy for study indication|1|||
156583416|NCT03123939|565219940|FG000|Overall Study|Protocol deviation|1|||
156583417|NCT03123939|565219940|FG000|Overall Study|Progressive disease|18|||
156583418|NCT03123939|565219940|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
156583419|NCT03123939|565219940|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
156583420|NCT02078713|565221535|FG000|Overall Study|Lost to Follow-up|49|||
156583421|NCT02078713|565221536|FG001|Overall Study|Lost to Follow-up|55|||
156583422|NCT02078713|565221537|FG002|Overall Study|Lost to Follow-up|0|||
156583423|NCT02078713|565221538|FG003|Overall Study|Lost to Follow-up|0|||
156583424|NCT02078713|565221535|FG000|Overall Study|Pregnant at baseline|3|||
156583425|NCT02078713|565221536|FG001|Overall Study|Pregnant at baseline|5|||
156583426|NCT02078713|565221537|FG002|Overall Study|Pregnant at baseline|0|||
156583427|NCT02078713|565221538|FG003|Overall Study|Pregnant at baseline|0|||
156583428|NCT02078713|565221535|FG000|Overall Study|Enrolled twice|0|||
156583429|NCT02078713|565221536|FG001|Overall Study|Enrolled twice|1|||
156583430|NCT02078713|565221537|FG002|Overall Study|Enrolled twice|0|||
156583431|NCT02078713|565221538|FG003|Overall Study|Enrolled twice|0|||
156583432|NCT01931462|565221546|FG000|Overall Study|Withdrawal by Subject|1|||
156583433|NCT01701583|565221547|FG000|Overall Study|Withdrawal by Subject|2|||
156583434|NCT01701583|565221548|FG001|Overall Study|Withdrawal by Subject|0|||
156583435|NCT02311478|565221549|FG000|Overall Study|Withdrawal by Subject|1|||
156583436|NCT02311478|565221549|FG000|Overall Study|Lost to Follow-up|5|||
156583437|NCT02311478|565221549|FG000|Overall Study|Failed IUD Insertion|1|||
156583438|NCT03276936|565221550|FG000|Overall Study|Adverse Event|4|||
156583439|NCT03276936|565221551|FG001|Overall Study|Adverse Event|2|||
156583440|NCT03276936|565221550|FG000|Overall Study|Lost to Follow-up|16|||
156583441|NCT03276936|565221551|FG001|Overall Study|Lost to Follow-up|13|||
156583442|NCT03276936|565221550|FG000|Overall Study|Withdrawal by Subject|30|||
156583443|NCT03276936|565221551|FG001|Overall Study|Withdrawal by Subject|20|||
156583444|NCT03276936|565221550|FG000|Overall Study|Not mentioned|6|||
156583445|NCT03276936|565221551|FG001|Overall Study|Not mentioned|3|||
156583446|NCT00943319|565221552|FG000|Overall Study|Death|1|||
156583447|NCT02043301|565221553|FG000|Overall Study|Discontinued|0|||
156583448|NCT02043301|565221554|FG001|Overall Study|Discontinued|1|||
156583449|NCT02043301|565221555|FG002|Overall Study|Discontinued|0|||
156583450|NCT02653976|565221556|FG000|Overall Study|Withdrawal by Subject|5|||
156583451|NCT02653976|565221556|FG000|Overall Study|Death|4|||
156583452|NCT03703375|565221557|FG000|Randomization Period|Withdrawal by Subject|0|||
156583453|NCT03703375|565221558|FG001|Randomization Period|Withdrawal by Subject|0|||
156583454|NCT03703375|565221559|FG002|Randomization Period|Withdrawal by Subject|0|||
156583455|NCT03703375|565221560|FG003|Randomization Period|Withdrawal by Subject|1|||
156583456|NCT03703375|565221557|FG000|Randomization Period|Completed safety run-in treatment|7|||
156583457|NCT03703375|565221558|FG001|Randomization Period|Completed safety run-in treatment|0|||
156583458|NCT03703375|565221559|FG002|Randomization Period|Completed safety run-in treatment|0|||
156583459|NCT03703375|565221560|FG003|Randomization Period|Completed safety run-in treatment|0|||
156583460|NCT03703375|565221557|FG000|Treatment Period|Other Reasons|0|||
156583461|NCT03703375|565221558|FG001|Treatment Period|Other Reasons|1|||
156583462|NCT03703375|565221559|FG002|Treatment Period|Other Reasons|0|||
156583463|NCT03703375|565221560|FG003|Treatment Period|Other Reasons|3|||
156583464|NCT03703375|565221557|FG000|Treatment Period|Consent Withdrawal|0|||
156583465|NCT03703375|565221558|FG001|Treatment Period|Consent Withdrawal|0|||
156583466|NCT03703375|565221559|FG002|Treatment Period|Consent Withdrawal|0|||
156583467|NCT03703375|565221560|FG003|Treatment Period|Consent Withdrawal|1|||
156583468|NCT03703375|565221557|FG000|Treatment Period|Death|1|||
156583469|NCT03703375|565221558|FG001|Treatment Period|Death|0|||
156583470|NCT03703375|565221559|FG002|Treatment Period|Death|1|||
156583471|NCT03703375|565221560|FG003|Treatment Period|Death|2|||
156583472|NCT03703375|565221557|FG000|Treatment Period|Toxicity of Study Treatment|2|||
156583473|NCT03703375|565221558|FG001|Treatment Period|Toxicity of Study Treatment|0|||
156583474|NCT03703375|565221559|FG002|Treatment Period|Toxicity of Study Treatment|4|||
156583475|NCT03703375|565221560|FG003|Treatment Period|Toxicity of Study Treatment|1|||
156583476|NCT03703375|565221557|FG000|Treatment Period|Progression|32|||
156583477|NCT03703375|565221558|FG001|Treatment Period|Progression|1|||
156583478|NCT03703375|565221559|FG002|Treatment Period|Progression|7|||
156583479|NCT03703375|565221560|FG003|Treatment Period|Progression|11|||
156583480|NCT03703375|565221557|FG000|Treatment Period|Completed treatment|7|||
156583481|NCT03703375|565221558|FG001|Treatment Period|Completed treatment|2|||
156583482|NCT03703375|565221559|FG002|Treatment Period|Completed treatment|0|||
156583483|NCT03703375|565221560|FG003|Treatment Period|Completed treatment|0|||
156583484|NCT01675011|565221561|FG000|Overall Study|Trial terminated by Sponsor|3|||
156583485|NCT01675011|565221562|FG001|Overall Study|Trial terminated by Sponsor|1|||
156583486|NCT00366548|565221563|FG000|Infant Series|Adverse Event|1|||
156583487|NCT00366548|565221564|FG001|Infant Series|Adverse Event|3|||
156583488|NCT00366548|565221563|FG000|Infant Series|Protocol Violation|0|||
156583489|NCT00366548|565221564|FG001|Infant Series|Protocol Violation|1|||
156583490|NCT00366548|565221563|FG000|Infant Series|Withdrawal by Subject|3|||
156583491|NCT00366548|565221564|FG001|Infant Series|Withdrawal by Subject|1|||
156583492|NCT00366548|565221563|FG000|After Infant Series|Withdrawal by Subject|3|||
156583493|NCT00366548|565221564|FG001|After Infant Series|Withdrawal by Subject|1|||
156583494|NCT00366548|565221563|FG000|After Infant Series|Adverse Event|2|||
156583495|NCT00366548|565221564|FG001|After Infant Series|Adverse Event|0|||
156583496|NCT00366548|565221563|FG000|After Infant Series|Lost to Follow-up|1|||
156583497|NCT00366548|565221564|FG001|After Infant Series|Lost to Follow-up|0|||
156583498|NCT02849990|565221565|FG000|Overall Study|Adverse Event|1|||
156583499|NCT02849990|565221565|FG000|Overall Study|Withdrawal by Subject|1|||
156583500|NCT01252134|565221566|FG000|Period 1, 8 Hours|Personal Reasons|0|||
156583501|NCT01252134|565221567|FG001|Period 1, 8 Hours|Personal Reasons|1|||
156583502|NCT01252134|565221568|FG002|Period 1, 8 Hours|Personal Reasons|1|||
156583503|NCT01252134|565221569|FG003|Period 1, 8 Hours|Personal Reasons|0|||
156583504|NCT01252134|565221570|FG004|Period 1, 8 Hours|Personal Reasons|0|||
156583505|NCT01252134|565221571|FG005|Period 1, 8 Hours|Personal Reasons|0|||
156583506|NCT02678741|565221573|FG000|Overall Study|Death|4|||
156583507|NCT02678741|565221573|FG000|Overall Study|Withdrawal by Subject|1|||
156583508|NCT02678741|565221573|FG000|Overall Study|ineligible|3|||
156583509|NCT02678741|565221573|FG000|Overall Study|Not RECIST Measurable|2|||
156583510|NCT02678741|565221573|FG000|Overall Study|Lack of Efficacy|10|||
156583511|NCT01795898|565221574|FG000|Overall Study|Adverse Event|27|||
156583512|NCT01795898|565221574|FG000|Overall Study|Lost to Follow-up|20|||
156583513|NCT01795898|565221574|FG000|Overall Study|Withdrawal of consent|6|||
156583514|NCT01795898|565221574|FG000|Overall Study|Diagnosed with metastasis|1|||
156583515|NCT01795898|565221574|FG000|Overall Study|No pain|1|||
156583516|NCT01795898|565221574|FG000|Overall Study|Death|1|||
156583517|NCT01795898|565221574|FG000|Overall Study|Withdrew consent & had adverse events|3|||
156583518|NCT01795898|565221574|FG000|Overall Study|Physician Decision|1|||
156583519|NCT02421120|565221583|FG000|Overall Study|Adverse Event|1|||
156583520|NCT00372190|565221584|FG000|Overall Study|Lost to Follow-up|3|||
156583521|NCT00372190|565221585|FG001|Overall Study|Lost to Follow-up|1|||
156583522|NCT00273858|565221592|FG000|Overall Study|Not completed 24 month observation time|334|||
156583523|NCT00273858|565221592|FG000|Overall Study|Lost to Follow-up|101|||
156583524|NCT00273858|565221592|FG000|Overall Study|Withdrawal by Subject|21|||
156583525|NCT00273858|565221592|FG000|Overall Study|Adverse Event|81|||
156583526|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
156583527|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
156583528|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
156583529|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
156583530|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
156583531|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
156583532|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
156583533|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
156583534|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
156583535|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
156583536|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
156583537|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
156583538|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
156583539|NCT02232516|565221593|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
156583540|NCT02232516|565221593|FG000|Survival Follow-up|Death|15|||
156583541|NCT02232516|565221593|FG000|Survival Follow-up|Withdrawal by Subject|3|||
156583542|NCT02232516|565221593|FG000|Survival Follow-up|Lost to Follow-up|1|||
156583543|NCT02232516|565221593|FG000|Survival Follow-up|Still in follow-up|5|||
156583544|NCT01258348|565221595|FG000|Overall Study|Adverse Event|1|||
156583545|NCT01258348|565221596|FG001|Overall Study|Adverse Event|1|||
156583546|NCT01258348|565221597|FG002|Overall Study|Adverse Event|3|||
156583547|NCT01258348|565221598|FG003|Overall Study|Adverse Event|2|||
156583548|NCT01258348|565221599|FG004|Overall Study|Adverse Event|4|||
156583549|NCT01258348|565221595|FG000|Overall Study|Progressive Disease|0|||
156583550|NCT01258348|565221596|FG001|Overall Study|Progressive Disease|3|||
156583551|NCT01258348|565221597|FG002|Overall Study|Progressive Disease|0|||
156583552|NCT01258348|565221598|FG003|Overall Study|Progressive Disease|2|||
156583553|NCT01258348|565221599|FG004|Overall Study|Progressive Disease|2|||
156583554|NCT01258348|565221595|FG000|Overall Study|Physician Decision|0|||
156583555|NCT01258348|565221596|FG001|Overall Study|Physician Decision|0|||
156583556|NCT01258348|565221597|FG002|Overall Study|Physician Decision|0|||
156583557|NCT01258348|565221598|FG003|Overall Study|Physician Decision|2|||
156583558|NCT01258348|565221599|FG004|Overall Study|Physician Decision|0|||
156583559|NCT01258348|565221595|FG000|Overall Study|Withdrawal by Subject|0|||
156583560|NCT01258348|565221596|FG001|Overall Study|Withdrawal by Subject|1|||
156583561|NCT01258348|565221597|FG002|Overall Study|Withdrawal by Subject|0|||
156583562|NCT01258348|565221598|FG003|Overall Study|Withdrawal by Subject|0|||
156583563|NCT01258348|565221599|FG004|Overall Study|Withdrawal by Subject|0|||
156583564|NCT00305006|565221600|FG000|Overall Study|Withdrawal by Subject|1|||
156583565|NCT00305006|565221601|FG001|Overall Study|Withdrawal by Subject|0|||
156583566|NCT00305006|565221600|FG000|Overall Study|Failure to complete pretest|0|||
156583567|NCT00305006|565221601|FG001|Overall Study|Failure to complete pretest|1|||
156583568|NCT01849848|565221602|FG000|Overall Study|Physician Decision|1|||
156583569|NCT01849848|565221602|FG000|Overall Study|Progression of the primary disease|3|||
156583570|NCT03649321|565221603|FG000|Overall Study|Withdrawal by Subject|1|||
156583571|NCT03649321|565221604|FG001|Overall Study|Withdrawal by Subject|0|||
156583572|NCT03649321|565221603|FG000|Overall Study|Death|1|||
156583573|NCT03649321|565221604|FG001|Overall Study|Death|0|||
156583574|NCT05100199|565221605|FG000|Overall Study|Lost to Follow-up|5|||
156583575|NCT05100199|565221606|FG001|Overall Study|Lost to Follow-up|8|||
156583576|NCT05100199|565221607|FG002|Overall Study|Lost to Follow-up|3|||
156583577|NCT05100199|565221608|FG003|Overall Study|Lost to Follow-up|6|||
156583578|NCT05100199|565221605|FG000|Overall Study|Withdrawal by Subject|3|||
156583579|NCT05100199|565221606|FG001|Overall Study|Withdrawal by Subject|3|||
156583580|NCT05100199|565221607|FG002|Overall Study|Withdrawal by Subject|9|||
156583581|NCT05100199|565221608|FG003|Overall Study|Withdrawal by Subject|7|||
156583582|NCT05100199|565221605|FG000|Overall Study|Other|0|||
156583583|NCT05100199|565221606|FG001|Overall Study|Other|0|||
156583584|NCT05100199|565221607|FG002|Overall Study|Other|1|||
156583585|NCT05100199|565221608|FG003|Overall Study|Other|1|||
156583586|NCT02853331|565221609|FG000|Overall Study|Death|59|||
156583587|NCT02853331|565221610|FG001|Overall Study|Death|95|||
156583588|NCT02853331|565221609|FG000|Overall Study|Withdrawal by Subject|5|||
156583589|NCT02853331|565221610|FG001|Overall Study|Withdrawal by Subject|9|||
156583590|NCT02853331|565221609|FG000|Overall Study|Ongoing in study|368|||
156583591|NCT02853331|565221610|FG001|Overall Study|Ongoing in study|325|||
156583592|NCT01455428|565221611|FG000|Overall Study|Protocol Violation|2|||
156583593|NCT01455428|565221612|FG001|Overall Study|Protocol Violation|1|||
156583594|NCT01455428|565221611|FG000|Overall Study|Adverse Event|6|||
156583595|NCT01455428|565221612|FG001|Overall Study|Adverse Event|2|||
156583596|NCT01455428|565221611|FG000|Overall Study|Lost to Follow-up|1|||
156583597|NCT01455428|565221612|FG001|Overall Study|Lost to Follow-up|1|||
156583598|NCT01455428|565221611|FG000|Overall Study|Withdrawal by Subject|2|||
156583599|NCT01455428|565221612|FG001|Overall Study|Withdrawal by Subject|5|||
156583600|NCT01455428|565221611|FG000|Overall Study|Did not meet entrance criteria|0|||
156583601|NCT01455428|565221612|FG001|Overall Study|Did not meet entrance criteria|2|||
156583602|NCT01455428|565221611|FG000|Overall Study|Insufficient clinical response|0|||
156583603|NCT01455428|565221612|FG001|Overall Study|Insufficient clinical response|2|||
156583604|NCT01455428|565221611|FG000|Overall Study|Did not receive treatment|1|||
156583605|NCT01455428|565221612|FG001|Overall Study|Did not receive treatment|1|||
156583606|NCT01455428|565221611|FG000|Overall Study|Other|2|||
156583607|NCT01455428|565221612|FG001|Overall Study|Other|4|||
156583608|NCT00257192|565221616|FG000|Overall Study|Adverse Event|21|||
156583609|NCT00257192|565221617|FG001|Overall Study|Adverse Event|10|||
156583610|NCT00257192|565221616|FG000|Overall Study|Laboratory abnormality|1|||
156583611|NCT00257192|565221617|FG001|Overall Study|Laboratory abnormality|1|||
156583612|NCT00257192|565221616|FG000|Overall Study|Lost to Follow-up|3|||
156583613|NCT00257192|565221617|FG001|Overall Study|Lost to Follow-up|3|||
156583614|NCT00257192|565221616|FG000|Overall Study|Insufficient clinical response|18|||
156583615|NCT00257192|565221617|FG001|Overall Study|Insufficient clinical response|18|||
156583616|NCT00257192|565221616|FG000|Overall Study|Withdrawal by Subject|14|||
156583617|NCT00257192|565221617|FG001|Overall Study|Withdrawal by Subject|2|||
156583618|NCT00257192|565221616|FG000|Overall Study|Randomized but not treated|0|||
156583619|NCT00257192|565221617|FG001|Overall Study|Randomized but not treated|1|||
156583620|NCT00257192|565221616|FG000|Overall Study|Study terminated by sponsor|1|||
156583621|NCT00257192|565221617|FG001|Overall Study|Study terminated by sponsor|0|||
156583622|NCT00257192|565221616|FG000|Overall Study|Miscellaneous|0|||
156583623|NCT00257192|565221617|FG001|Overall Study|Miscellaneous|4|||
156583624|NCT02062151|565221618|FG000|Overall Study|screen failure|1|||
156583625|NCT00751101|565221621|FG000|Overall Study|Withdrawal by Subject|1|||
156583626|NCT00751101|565221622|FG001|Overall Study|Withdrawal by Subject|0|||
156583627|NCT00751101|565221621|FG000|Overall Study|No HFS / Never Started Patch/|0|||
156583628|NCT00751101|565221622|FG001|Overall Study|No HFS / Never Started Patch/|4|||
156583629|NCT00751101|565221621|FG000|Overall Study|Never began capecitabine|1|||
156583630|NCT00751101|565221622|FG001|Overall Study|Never began capecitabine|0|||
156583631|NCT00751101|565221621|FG000|Overall Study|Physician Decision|0|||
156583632|NCT00751101|565221622|FG001|Overall Study|Physician Decision|1|||
156583633|NCT01905397|565221623|FG000|Overall Study|Death|0|||
156583634|NCT01905397|565221624|FG001|Overall Study|Death|1|||
156583635|NCT01905397|565221623|FG000|Overall Study|Withdrawal by Subject|2|||
156583636|NCT01905397|565221624|FG001|Overall Study|Withdrawal by Subject|0|||
156583637|NCT01905397|565221623|FG000|Overall Study|Surgery canceled/aborted|9|||
156583638|NCT01905397|565221624|FG001|Overall Study|Surgery canceled/aborted|5|||
156583639|NCT01905397|565221623|FG000|Overall Study|Incision < 7 cm|2|||
156583640|NCT01905397|565221624|FG001|Overall Study|Incision < 7 cm|0|||
156583641|NCT01905397|565221623|FG000|Overall Study|Wrong treatment|1|||
156583642|NCT01905397|565221624|FG001|Overall Study|Wrong treatment|1|||
156583643|NCT01905397|565221623|FG000|Overall Study|Device not applied|3|||
156583644|NCT01905397|565221624|FG001|Overall Study|Device not applied|0|||
156583645|NCT01905397|565221623|FG000|Overall Study|Dressing not applied in operating room|1|||
156583646|NCT01905397|565221624|FG001|Overall Study|Dressing not applied in operating room|0|||
156583647|NCT01905397|565221623|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
156583648|NCT01905397|565221624|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
156583649|NCT01921270|565221628|FG000|Overall Study|Withdrawal by Subject|1|||
156583650|NCT00844428|565221629|FG000|Screening Period|Screen Failure|3|||
156583651|NCT00844428|565221629|FG000|Extension Treatment Period|Death|1|||
156583652|NCT00844428|565221629|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
156583653|NCT00455858|565221630|FG000|Overall Study|Lost to Follow-up|2|||
156583654|NCT00455858|565221630|FG000|Overall Study|Protocol Violation|1|||
156583655|NCT00455858|565221630|FG000|Overall Study|Lack of Efficacy|1|||
156583656|NCT00455858|565221630|FG000|Overall Study|Well controlled FPG without insulin|1|||
156583657|NCT00455858|565221630|FG000|Overall Study|Withdrawal|1|||
156583658|NCT02092389|565221631|FG000|Overall Study|Adverse Event|1|||
156583659|NCT02092389|565221631|FG000|Overall Study|Other|5|||
156583660|NCT01242020|565221632|FG000|Overall Study|Withdrawal by Subject|2|||
156583661|NCT01242020|565221633|FG001|Overall Study|Withdrawal by Subject|0|||
156583662|NCT01242020|565221632|FG000|Overall Study|Failed screening|1|||
156583663|NCT01242020|565221633|FG001|Overall Study|Failed screening|0|||
156583664|NCT02680847|565221634|FG000|Overall Study|Other|2|||
156583665|NCT02680847|565221635|FG001|Overall Study|Other|0|||
156583666|NCT02680847|565221636|FG002|Overall Study|Other|0|||
156583667|NCT02680847|565221634|FG000|Overall Study|No longer met eligibility criteria|2|||
156583668|NCT02680847|565221635|FG001|Overall Study|No longer met eligibility criteria|2|||
156583669|NCT02680847|565221636|FG002|Overall Study|No longer met eligibility criteria|0|||
156583670|NCT02680847|565221634|FG000|Overall Study|Unwilling to participate in study|1|||
156583671|NCT02680847|565221635|FG001|Overall Study|Unwilling to participate in study|1|||
156583672|NCT02680847|565221636|FG002|Overall Study|Unwilling to participate in study|0|||
156583673|NCT02680847|565221634|FG000|Overall Study|Lack of Efficacy|0|||
156583674|NCT02680847|565221635|FG001|Overall Study|Lack of Efficacy|0|||
156583675|NCT02680847|565221636|FG002|Overall Study|Lack of Efficacy|2|||
156583676|NCT02680847|565221634|FG000|Overall Study|Adverse Event|0|||
156583677|NCT02680847|565221635|FG001|Overall Study|Adverse Event|0|||
156583678|NCT02680847|565221636|FG002|Overall Study|Adverse Event|1|||
156583679|NCT01161524|565221642|FG000|Core Study (23 Weeks)|Adverse Event|3|||
156583680|NCT01161524|565221643|FG001|Core Study (23 Weeks)|Adverse Event|0|||
156583681|NCT01161524|565221644|FG002|Core Study (23 Weeks)|Adverse Event|0|||
156583682|NCT01161524|565221642|FG000|Core Study (23 Weeks)|Other|1|||
156583683|NCT01161524|565221643|FG001|Core Study (23 Weeks)|Other|0|||
156583684|NCT01161524|565221644|FG002|Core Study (23 Weeks)|Other|0|||
156583685|NCT01161524|565221642|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
156583686|NCT01161524|565221643|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
156583687|NCT01161524|565221644|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
156583688|NCT01161524|565221642|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
156583689|NCT01161524|565221643|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
156583690|NCT01161524|565221644|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
156583691|NCT01161524|565221642|FG000|Core Study (23 Weeks)|Subject Choice|3|||
156583692|NCT01161524|565221643|FG001|Core Study (23 Weeks)|Subject Choice|2|||
156583693|NCT01161524|565221644|FG002|Core Study (23 Weeks)|Subject Choice|0|||
156583694|NCT01161524|565221642|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
156583695|NCT01161524|565221643|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
156583696|NCT01161524|565221644|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
156583697|NCT01161524|565221642|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
156583698|NCT01161524|565221643|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
156583699|NCT01161524|565221644|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
156583700|NCT01161524|565221642|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
156583701|NCT01161524|565221643|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
156583702|NCT01161524|565221644|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
156583703|NCT01161524|565221642|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
156583704|NCT01161524|565221643|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
156583705|NCT01161524|565221644|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
156583706|NCT01161524|565221642|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
156583707|NCT01161524|565221643|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
156583708|NCT01161524|565221644|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
156583709|NCT00399802|565221645|FG000|Overall Study|Adverse Event|0|||
156583710|NCT00399802|565221646|FG001|Overall Study|Adverse Event|2|||
156583711|NCT00399802|565221645|FG000|Overall Study|Participant discontinued by mistake|0|||
156583712|NCT00399802|565221646|FG001|Overall Study|Participant discontinued by mistake|1|||
156583713|NCT04172831|565221649|FG000|Overall Study|Adverse Event|21|||
156583714|NCT04172831|565221650|FG001|Overall Study|Adverse Event|9|||
156583715|NCT04172831|565221649|FG000|Overall Study|Lack of Efficacy|2|||
156583716|NCT04172831|565221650|FG001|Overall Study|Lack of Efficacy|8|||
156583717|NCT04172831|565221649|FG000|Overall Study|Physician Decision|0|||
156583718|NCT04172831|565221650|FG001|Overall Study|Physician Decision|1|||
156583719|NCT04172831|565221649|FG000|Overall Study|Withdrawal by Subject|12|||
156583720|NCT04172831|565221650|FG001|Overall Study|Withdrawal by Subject|11|||
156583721|NCT04172831|565221649|FG000|Overall Study|Lost to Follow-up|4|||
156583722|NCT04172831|565221650|FG001|Overall Study|Lost to Follow-up|9|||
156583723|NCT04172831|565221649|FG000|Overall Study|COVID-19 related crisis|3|||
156583724|NCT04172831|565221650|FG001|Overall Study|COVID-19 related crisis|3|||
156583725|NCT04172831|565221649|FG000|Overall Study|Subject non-compliance|1|||
156583726|NCT04172831|565221650|FG001|Overall Study|Subject non-compliance|1|||
156583727|NCT04172831|565221649|FG000|Overall Study|Family emergency|1|||
156583728|NCT04172831|565221650|FG001|Overall Study|Family emergency|0|||
156583729|NCT01276847|565221652|FG000|Overall Study|Withdrawal by Subject|1|||
156583730|NCT01276847|565221653|FG001|Overall Study|Withdrawal by Subject|0|||
156583731|NCT01276847|565221654|FG002|Overall Study|Withdrawal by Subject|0|||
156583732|NCT01618656|565221655|FG000|Overall Study|Withdrawal by Subject|7|||
156583733|NCT01618656|565221656|FG001|Overall Study|Withdrawal by Subject|3|||
156583734|NCT01618656|565221655|FG000|Overall Study|Physician Decision|1|||
156583735|NCT01618656|565221656|FG001|Overall Study|Physician Decision|1|||
156583736|NCT01899144|565221657|FG000|Treatment Period 2|Other|1|||
156583737|NCT01899144|565221657|FG000|Treatment Period 3|Other|2|||
156583738|NCT01899144|565221657|FG000|Treatment Period 5|Other|1|||
156583739|NCT02021812|565221658|FG000|Overall Study|Death|8|||
156583740|NCT02021812|565221658|FG000|Overall Study|Withdrawal by Subject|3|||
156583741|NCT02021812|565221658|FG000|Overall Study|Lost to Follow-up|2|||
156583742|NCT02021812|565221658|FG000|Overall Study|Refuse to return, COVD 19|2|||
156583743|NCT02119104|565221660|FG000|Overall Study|Protocol Violation|16|||
156583744|NCT00081289|565221661|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
156583745|NCT00081289|565221662|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
156583746|NCT00081289|565221661|FG000|Overall Study|Ineligible / no protocol treatment|3|||
156583747|NCT00081289|565221662|FG001|Overall Study|Ineligible / no protocol treatment|4|||
156583748|NCT01651260|565221665|FG000|Overall Study|unable to apply product|3|||
156583749|NCT01952015|565221668|FG000|Induction|Protocol Violation|1|||
156583750|NCT01952015|565221668|FG000|Maintenance|Adverse Event|2|||
156583751|NCT01952015|565221668|FG000|Treatment Period 3|Physician Decision|9|||
156583752|NCT02239094|565221669|FG000|Overall Study|Withdrawal by Subject|1|||
156583753|NCT02239094|565221669|FG000|Overall Study|Remitted before started|1|||
156583754|NCT02508701|565221672|FG000|Overall Study|Lost to Follow-up|9|||
156583755|NCT02508701|565221673|FG001|Overall Study|Lost to Follow-up|5|||
156583756|NCT02508701|565221674|FG002|Overall Study|Lost to Follow-up|5|||
156583757|NCT02508701|565221675|FG003|Overall Study|Lost to Follow-up|3|||
156583758|NCT00530712|565221680|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
156583759|NCT00530712|565221680|FG000|30 Day Follow-up Visit|Missed Visit|5|||
156583760|NCT00530712|565221680|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
156583761|NCT00530712|565221680|FG000|6 Month Follow-up Visit|Missed Visit|3|||
156583762|NCT00530712|565221680|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
156583763|NCT00530712|565221680|FG000|6 Month Follow-up Visit|Death|2|||
156583764|NCT00530712|565221680|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
156583765|NCT00530712|565221680|FG000|12 Month Follow-up Visit|Missed Visit|3|||
156583766|NCT00530712|565221680|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
156583767|NCT00530712|565221680|FG000|12 Month Follow-up Visit|Death|9|||
156583768|NCT03242759|565221683|FG000|Overall Study|Adverse Event|5|||
156583769|NCT03242759|565221684|FG001|Overall Study|Adverse Event|1|||
156583770|NCT03242759|565221683|FG000|Overall Study|Withdrawal by Subject|4|||
156583771|NCT03242759|565221684|FG001|Overall Study|Withdrawal by Subject|3|||
156583772|NCT03242759|565221683|FG000|Overall Study|Lost to Follow-up|3|||
156583773|NCT03242759|565221684|FG001|Overall Study|Lost to Follow-up|1|||
156583774|NCT03242759|565221683|FG000|Overall Study|Administrative problems|1|||
156583775|NCT03242759|565221684|FG001|Overall Study|Administrative problems|1|||
156583776|NCT03242759|565221683|FG000|Overall Study|Death|22|||
156583777|NCT03242759|565221684|FG001|Overall Study|Death|0|||
156583778|NCT03242759|565221683|FG000|Overall Study|Change visit schedule|0|||
156583779|NCT03242759|565221684|FG001|Overall Study|Change visit schedule|1|||
156583780|NCT01095250|565221685|FG000|Overall Study|administrative reasons|8|||
156583781|NCT01095250|565221686|FG001|Overall Study|administrative reasons|10|||
156583782|NCT01095250|565221687|FG002|Overall Study|administrative reasons|7|||
156583783|NCT01095250|565221688|FG003|Overall Study|administrative reasons|5|||
156583784|NCT01095250|565221685|FG000|Overall Study|Withdrawal by Subject|0|||
156583785|NCT01095250|565221686|FG001|Overall Study|Withdrawal by Subject|0|||
156583786|NCT01095250|565221687|FG002|Overall Study|Withdrawal by Subject|1|||
156583787|NCT01095250|565221688|FG003|Overall Study|Withdrawal by Subject|0|||
156583788|NCT04400318|565223388|FG000|Overall Study|Adverse Event|1|||
156583789|NCT04400318|565223389|FG001|Overall Study|Adverse Event|0|||
156583790|NCT04400318|565223388|FG000|Overall Study|Withdrawal by Subject|1|||
156583791|NCT04400318|565223389|FG001|Overall Study|Withdrawal by Subject|1|||
156583792|NCT04400318|565223388|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
156583793|NCT04400318|565223389|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
156583794|NCT00165646|565223390|FG000|Overall Study|Adverse Event|1|||
156583795|NCT00165646|565223391|FG001|Overall Study|Adverse Event|1|||
156583796|NCT00165646|565223392|FG002|Overall Study|Adverse Event|1|||
156583797|NCT00165646|565223390|FG000|Overall Study|Lack of Efficacy|1|||
156583798|NCT00165646|565223391|FG001|Overall Study|Lack of Efficacy|2|||
156583799|NCT00165646|565223392|FG002|Overall Study|Lack of Efficacy|0|||
156583800|NCT00165646|565223390|FG000|Overall Study|Withdrawal by Subject|0|||
156583801|NCT00165646|565223391|FG001|Overall Study|Withdrawal by Subject|2|||
156583802|NCT00165646|565223392|FG002|Overall Study|Withdrawal by Subject|1|||
156583803|NCT00165646|565223390|FG000|Overall Study|Physician Decision|2|||
156583804|NCT00165646|565223391|FG001|Overall Study|Physician Decision|0|||
156583805|NCT00165646|565223392|FG002|Overall Study|Physician Decision|2|||
156583806|NCT00165646|565223390|FG000|Overall Study|Protocol Violation|1|||
156583807|NCT00165646|565223391|FG001|Overall Study|Protocol Violation|0|||
156583808|NCT00165646|565223392|FG002|Overall Study|Protocol Violation|0|||
156583809|NCT01790438|565223393|FG000|Overall Study|Adverse Event|3|||
156583810|NCT01790438|565223394|FG001|Overall Study|Adverse Event|2|||
156583811|NCT01790438|565223393|FG000|Overall Study|Death|4|||
156583812|NCT01790438|565223394|FG001|Overall Study|Death|0|||
156583813|NCT01790438|565223393|FG000|Overall Study|Lost to Follow-up|5|||
156583814|NCT01790438|565223394|FG001|Overall Study|Lost to Follow-up|2|||
156583815|NCT01790438|565223393|FG000|Overall Study|Withdrawal by Subject|13|||
156583816|NCT01790438|565223394|FG001|Overall Study|Withdrawal by Subject|2|||
156583817|NCT01790438|565223393|FG000|Overall Study|Physician Decision|3|||
156583818|NCT01790438|565223394|FG001|Overall Study|Physician Decision|1|||
156583819|NCT01790438|565223393|FG000|Overall Study|Sponsor Decision|0|||
156583820|NCT01790438|565223394|FG001|Overall Study|Sponsor Decision|3|||
156583821|NCT01790438|565223393|FG000|Overall Study|Protocol Required Discontinuation|7|||
156583822|NCT01790438|565223394|FG001|Overall Study|Protocol Required Discontinuation|1|||
156583823|NCT02433210|565223397|FG000|Overall Study|Physician Decision|1|||
156583824|NCT02433210|565223398|FG001|Overall Study|Physician Decision|0|||
156583825|NCT02433210|565223399|FG002|Overall Study|Physician Decision|0|||
156583826|NCT04907539|565223400|FG000|Overall Study|Consent withdrawn|1|||
156583827|NCT04907539|565223401|FG001|Overall Study|Consent withdrawn|0|||
156583828|NCT04907539|565223400|FG000|Overall Study|Death|14|||
156583829|NCT04907539|565223401|FG001|Overall Study|Death|3|||
156583830|NCT05070429|565223402|FG000|Overall Study|Death|0|||
156583831|NCT05070429|565223403|FG001|Overall Study|Death|4|||
156583832|NCT05070429|565223402|FG000|Overall Study|Withdrawal by Subject|2|||
156583833|NCT05070429|565223403|FG001|Overall Study|Withdrawal by Subject|1|||
156583834|NCT05070429|565223402|FG000|Overall Study|Other|15|||
156583835|NCT05070429|565223403|FG001|Overall Study|Other|5|||
156583836|NCT03041116|565223404|FG000|Double-blind|Death|0|||
156583837|NCT03041116|565223405|FG001|Double-blind|Death|2|||
156583838|NCT03041116|565223404|FG000|Double-blind|Withdrawal by Subject|0|||
156583839|NCT03041116|565223405|FG001|Double-blind|Withdrawal by Subject|4|||
156583840|NCT03041116|565223404|FG000|Open-label|Death|1|||
156583841|NCT03041116|565223405|FG001|Open-label|Death|0|||
156583842|NCT03041116|565223404|FG000|Open-label|Termination of the study by Sponsor|39|||
156583843|NCT03041116|565223405|FG001|Open-label|Termination of the study by Sponsor|37|||
156583844|NCT03041116|565223404|FG000|Open-label|Withdrawal by Subject|1|||
156583845|NCT03041116|565223405|FG001|Open-label|Withdrawal by Subject|0|||
156583846|NCT01798134|565223406|FG000|Overall Study|Lost to Follow-up|1|||
156583847|NCT01798134|565223406|FG000|Overall Study|Withdrawal by Subject|3|||
156583848|NCT01798134|565223406|FG000|Overall Study|Death|2|||
156583849|NCT01798134|565223406|FG000|Overall Study|Adverse Event|3|||
156583850|NCT01798134|565223406|FG000|Overall Study|Physician Decision|3|||
156583851|NCT01798134|565223406|FG000|Overall Study|Liver transplant/surgery|4|||
156583852|NCT02023164|565223407|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
156583853|NCT02023164|565223408|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
156583854|NCT02436577|565223409|FG000|Overall Study|Protocol Deviation|0|||
156583855|NCT02436577|565223410|FG001|Overall Study|Protocol Deviation|1|||
156583856|NCT02436577|565223411|FG002|Overall Study|Protocol Deviation|0|||
156583857|NCT02436577|565223412|FG003|Overall Study|Protocol Deviation|0|||
156583858|NCT02436577|565223413|FG004|Overall Study|Protocol Deviation|0|||
156583859|NCT02436577|565223414|FG005|Overall Study|Protocol Deviation|0|||
156583860|NCT00615290|565223415|FG000|Overall Study|Adverse Event|2|||
156583861|NCT00615290|565223415|FG000|Overall Study|Lost to Follow-up|3|||
156583862|NCT00615290|565223415|FG000|Overall Study|Withdrawal by Subject|1|||
156583863|NCT00615290|565223415|FG000|Overall Study|Other|2|||
156583864|NCT02531373|565223418|FG000|Overall Study|Lack of Efficacy|0|||
156583865|NCT02531373|565223419|FG001|Overall Study|Lack of Efficacy|0|||
156583866|NCT02531373|565223420|FG002|Overall Study|Lack of Efficacy|0|||
156583867|NCT02531373|565223421|FG003|Overall Study|Lack of Efficacy|0|||
156583868|NCT02531373|565223422|FG004|Overall Study|Lack of Efficacy|3|||
156583869|NCT02531373|565223423|FG005|Overall Study|Lack of Efficacy|2|||
156583870|NCT02531373|565223424|FG006|Overall Study|Lack of Efficacy|4|||
156583871|NCT02531373|565223425|FG007|Overall Study|Lack of Efficacy|8|||
156583872|NCT02531373|565223426|FG008|Overall Study|Lack of Efficacy|5|||
156583873|NCT02531373|565223418|FG000|Overall Study|Lost to Follow-up|0|||
156583874|NCT02531373|565223419|FG001|Overall Study|Lost to Follow-up|0|||
156583875|NCT02531373|565223420|FG002|Overall Study|Lost to Follow-up|0|||
156583876|NCT02531373|565223421|FG003|Overall Study|Lost to Follow-up|0|||
156583877|NCT02531373|565223422|FG004|Overall Study|Lost to Follow-up|0|||
156583878|NCT02531373|565223423|FG005|Overall Study|Lost to Follow-up|2|||
156583879|NCT02531373|565223424|FG006|Overall Study|Lost to Follow-up|2|||
156583880|NCT02531373|565223425|FG007|Overall Study|Lost to Follow-up|0|||
156583881|NCT02531373|565223426|FG008|Overall Study|Lost to Follow-up|0|||
156583882|NCT02531373|565223418|FG000|Overall Study|Physician Decision|0|||
156583883|NCT02531373|565223419|FG001|Overall Study|Physician Decision|0|||
156583884|NCT02531373|565223420|FG002|Overall Study|Physician Decision|0|||
156583885|NCT02531373|565223421|FG003|Overall Study|Physician Decision|0|||
156583886|NCT02531373|565223422|FG004|Overall Study|Physician Decision|2|||
156583887|NCT02531373|565223423|FG005|Overall Study|Physician Decision|1|||
156583888|NCT02531373|565223424|FG006|Overall Study|Physician Decision|0|||
156583889|NCT02531373|565223425|FG007|Overall Study|Physician Decision|0|||
156583890|NCT02531373|565223426|FG008|Overall Study|Physician Decision|0|||
156583891|NCT02531373|565223418|FG000|Overall Study|Protocol Violation|0|||
156583892|NCT02531373|565223419|FG001|Overall Study|Protocol Violation|0|||
156583893|NCT02531373|565223420|FG002|Overall Study|Protocol Violation|0|||
156583894|NCT02531373|565223421|FG003|Overall Study|Protocol Violation|0|||
156583895|NCT02531373|565223422|FG004|Overall Study|Protocol Violation|0|||
156583896|NCT02531373|565223423|FG005|Overall Study|Protocol Violation|1|||
156583897|NCT02531373|565223424|FG006|Overall Study|Protocol Violation|1|||
156583898|NCT02531373|565223425|FG007|Overall Study|Protocol Violation|0|||
156583899|NCT02531373|565223426|FG008|Overall Study|Protocol Violation|1|||
156583900|NCT02531373|565223418|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156583901|NCT02531373|565223419|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156583902|NCT02531373|565223420|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156583903|NCT02531373|565223421|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156583904|NCT02531373|565223422|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156583905|NCT02531373|565223423|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
156583906|NCT02531373|565223424|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
156583907|NCT02531373|565223425|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
156583908|NCT02531373|565223426|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
156583909|NCT02531373|565223418|FG000|Overall Study|Withdrawal by Subject|0|||
156583910|NCT02531373|565223419|FG001|Overall Study|Withdrawal by Subject|0|||
156583911|NCT02531373|565223420|FG002|Overall Study|Withdrawal by Subject|0|||
156583912|NCT02531373|565223421|FG003|Overall Study|Withdrawal by Subject|0|||
156583913|NCT02531373|565223422|FG004|Overall Study|Withdrawal by Subject|3|||
156583914|NCT02531373|565223423|FG005|Overall Study|Withdrawal by Subject|0|||
156583915|NCT02531373|565223424|FG006|Overall Study|Withdrawal by Subject|0|||
156583916|NCT02531373|565223425|FG007|Overall Study|Withdrawal by Subject|0|||
156583917|NCT02531373|565223426|FG008|Overall Study|Withdrawal by Subject|0|||
156583918|NCT01623531|565223427|FG000|Overall Study|Death|1|||
156583919|NCT01623531|565223428|FG001|Overall Study|Death|0|||
156583920|NCT01623531|565223427|FG000|Overall Study|Protocol Violation|2|||
156583921|NCT01623531|565223428|FG001|Overall Study|Protocol Violation|1|||
156583922|NCT01623531|565223427|FG000|Overall Study|Missing data at primary outcome time poi|1|||
156583923|NCT01623531|565223428|FG001|Overall Study|Missing data at primary outcome time poi|1|||
156583924|NCT02834403|565223433|FG000|Overall Study|Physician Decision|2|||
156583925|NCT02834403|565223434|FG001|Overall Study|Physician Decision|1|||
156583926|NCT02834403|565223435|FG002|Overall Study|Physician Decision|2|||
156583927|NCT02834403|565223436|FG003|Overall Study|Physician Decision|1|||
156583928|NCT02834403|565223437|FG004|Overall Study|Physician Decision|1|||
156583929|NCT02834403|565223438|FG005|Overall Study|Physician Decision|2|||
156583930|NCT02834403|565223439|FG006|Overall Study|Physician Decision|12|||
156583931|NCT02834403|565223433|FG000|Overall Study|Adverse Event|0|||
156583932|NCT02834403|565223434|FG001|Overall Study|Adverse Event|0|||
156583933|NCT02834403|565223435|FG002|Overall Study|Adverse Event|0|||
156583934|NCT02834403|565223436|FG003|Overall Study|Adverse Event|0|||
156583935|NCT02834403|565223437|FG004|Overall Study|Adverse Event|1|||
156583936|NCT02834403|565223438|FG005|Overall Study|Adverse Event|1|||
156583937|NCT02834403|565223439|FG006|Overall Study|Adverse Event|3|||
156583938|NCT02834403|565223433|FG000|Overall Study|Withdrawal by Subject|0|||
156583939|NCT02834403|565223434|FG001|Overall Study|Withdrawal by Subject|1|||
156583940|NCT02834403|565223435|FG002|Overall Study|Withdrawal by Subject|0|||
156583941|NCT02834403|565223436|FG003|Overall Study|Withdrawal by Subject|0|||
156583942|NCT02834403|565223437|FG004|Overall Study|Withdrawal by Subject|1|||
156583943|NCT02834403|565223438|FG005|Overall Study|Withdrawal by Subject|0|||
156583944|NCT02834403|565223439|FG006|Overall Study|Withdrawal by Subject|0|||
156583945|NCT02834403|565223433|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
156583946|NCT02834403|565223434|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
156583947|NCT02834403|565223435|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
156583948|NCT02834403|565223436|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
156583949|NCT02834403|565223437|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
156583950|NCT02834403|565223438|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
156583951|NCT02834403|565223439|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
156583952|NCT04705597|565223440|FG000|Overall Study|Death|16|||
156583953|NCT04705597|565223441|FG001|Overall Study|Death|9|||
156583954|NCT04705597|565223440|FG000|Overall Study|Lost to Follow-up|1|||
156583955|NCT04705597|565223441|FG001|Overall Study|Lost to Follow-up|0|||
156583956|NCT04705597|565223440|FG000|Overall Study|Withdrawal by Subject|1|||
156583957|NCT04705597|565223441|FG001|Overall Study|Withdrawal by Subject|2|||
156583958|NCT00390780|565223442|FG000|Overall Study|Not completed|10|||
156583959|NCT00390780|565223443|FG001|Overall Study|Not completed|4|||
156583960|NCT00390780|565223442|FG000|Overall Study|Protocol Violation|6|||
156583961|NCT00390780|565223443|FG001|Overall Study|Protocol Violation|4|||
156583962|NCT00390780|565223442|FG000|Overall Study|Lost to Follow-up|3|||
156583963|NCT00390780|565223443|FG001|Overall Study|Lost to Follow-up|6|||
156583964|NCT00390780|565223442|FG000|Overall Study|Adverse Event|2|||
156583965|NCT00390780|565223443|FG001|Overall Study|Adverse Event|3|||
156583966|NCT00390780|565223442|FG000|Overall Study|Death|1|||
156583967|NCT00390780|565223443|FG001|Overall Study|Death|3|||
156583968|NCT00390780|565223442|FG000|Overall Study|Withdrawal by Subject|1|||
156583969|NCT00390780|565223443|FG001|Overall Study|Withdrawal by Subject|2|||
156583970|NCT00390780|565223442|FG000|Overall Study|Inclusion criteria not satisfied|0|||
156583971|NCT00390780|565223443|FG001|Overall Study|Inclusion criteria not satisfied|2|||
156583972|NCT00390780|565223442|FG000|Overall Study|Lost to follow up and other reasons|0|||
156583973|NCT00390780|565223443|FG001|Overall Study|Lost to follow up and other reasons|1|||
156583974|NCT00390780|565223442|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
156583975|NCT00390780|565223443|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
156583976|NCT00390780|565223442|FG000|Overall Study|SAE, death|0|||
156583977|NCT00390780|565223443|FG001|Overall Study|SAE, death|1|||
156583978|NCT01585961|565223444|FG000|Overall Study|Death|6|||
156583979|NCT01585961|565223444|FG000|Overall Study|Physician Decision|1|||
156583980|NCT01585961|565223444|FG000|Overall Study|Decision to use non-study catheter|1|||
156583981|NCT01585961|565223444|FG000|Overall Study|Withdrawal by Subject|1|||
156583982|NCT01585961|565223444|FG000|Overall Study|Lost to Follow-up|23|||
156583983|NCT01585961|565223444|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
156583984|NCT02606045|565223445|FG000|Overall Study|Study closed before treament could begin|1|||
156583985|NCT02606045|565223446|FG001|Overall Study|Study closed before treament could begin|2|||
156583986|NCT01996319|565223447|FG000|Overall Study|Protocol Violation|1|||
156583987|NCT01996319|565223448|FG001|Overall Study|Protocol Violation|0|||
156583988|NCT01996319|565223447|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
156583989|NCT01996319|565223448|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
156583990|NCT01996319|565223447|FG000|Overall Study|Adverse Event|2|||
156583991|NCT01996319|565223448|FG001|Overall Study|Adverse Event|2|||
156583992|NCT01671085|565223450|FG000|Overall Study|Withdrawal by Subject|1|||
156583993|NCT01671085|565223451|FG001|Overall Study|Withdrawal by Subject|0|||
156583994|NCT00637273|565223452|FG000|Overall Study|Adverse Event|11|||
156583995|NCT00637273|565223453|FG001|Overall Study|Adverse Event|5|||
156583996|NCT00637273|565223454|FG002|Overall Study|Adverse Event|7|||
156583997|NCT00637273|565223452|FG000|Overall Study|Lost to Follow-up|8|||
156583998|NCT00637273|565223453|FG001|Overall Study|Lost to Follow-up|9|||
156583999|NCT00637273|565223454|FG002|Overall Study|Lost to Follow-up|13|||
156584000|NCT00637273|565223452|FG000|Overall Study|Protocol Violation|2|||
156584001|NCT00637273|565223453|FG001|Overall Study|Protocol Violation|4|||
156584002|NCT00637273|565223454|FG002|Overall Study|Protocol Violation|1|||
156584003|NCT00637273|565223452|FG000|Overall Study|Withdrawal of Consent|18|||
156584004|NCT00637273|565223453|FG001|Overall Study|Withdrawal of Consent|6|||
156584005|NCT00637273|565223454|FG002|Overall Study|Withdrawal of Consent|18|||
156584006|NCT00637273|565223452|FG000|Overall Study|Investigator Decision|1|||
156584007|NCT00637273|565223453|FG001|Overall Study|Investigator Decision|3|||
156584008|NCT00637273|565223454|FG002|Overall Study|Investigator Decision|1|||
156584009|NCT00637273|565223452|FG000|Overall Study|Administrative|2|||
156584010|NCT00637273|565223453|FG001|Overall Study|Administrative|0|||
156584011|NCT00637273|565223454|FG002|Overall Study|Administrative|0|||
156584012|NCT00637273|565223452|FG000|Overall Study|Loss of Glucose Control|1|||
156584013|NCT00637273|565223453|FG001|Overall Study|Loss of Glucose Control|1|||
156584014|NCT00637273|565223454|FG002|Overall Study|Loss of Glucose Control|1|||
156584015|NCT00365716|565223455|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
156584016|NCT00365716|565223456|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
156584017|NCT00365716|565223457|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
156584018|NCT00365716|565223458|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
156584019|NCT00365716|565223459|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
156584020|NCT00365716|565223460|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
156584021|NCT00365716|565223461|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
156584022|NCT00365716|565223455|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
156584023|NCT00365716|565223456|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
156584024|NCT00365716|565223457|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
156584025|NCT00365716|565223458|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
156584026|NCT00365716|565223459|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
156584027|NCT00365716|565223460|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
156584028|NCT00365716|565223461|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
156584029|NCT00365716|565223455|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
156584030|NCT00365716|565223456|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
156584031|NCT00365716|565223457|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
156584032|NCT00365716|565223458|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
156584033|NCT00365716|565223459|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
156584034|NCT00365716|565223460|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
156584035|NCT00365716|565223461|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
156584036|NCT00365716|565223455|FG000|Base Study (Day 1 to Month 7)|Other|0|||
156584037|NCT00365716|565223456|FG001|Base Study (Day 1 to Month 7)|Other|1|||
156584038|NCT00365716|565223457|FG002|Base Study (Day 1 to Month 7)|Other|0|||
156584039|NCT00365716|565223458|FG003|Base Study (Day 1 to Month 7)|Other|0|||
156584040|NCT00365716|565223459|FG004|Base Study (Day 1 to Month 7)|Other|0|||
156584041|NCT00365716|565223460|FG005|Base Study (Day 1 to Month 7)|Other|0|||
156584042|NCT00365716|565223461|FG006|Base Study (Day 1 to Month 7)|Other|0|||
156584043|NCT00365716|565223455|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
156584044|NCT00365716|565223456|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
156584045|NCT00365716|565223457|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
156584046|NCT00365716|565223458|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
156584047|NCT00365716|565223459|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
156584048|NCT00365716|565223460|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
156584049|NCT00365716|565223461|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
156584050|NCT00365716|565223455|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
156584051|NCT00365716|565223456|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
156584052|NCT00365716|565223457|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
156584053|NCT00365716|565223458|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
156584054|NCT00365716|565223459|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
156584055|NCT00365716|565223460|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
156584056|NCT00365716|565223461|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
156584057|NCT00365716|565223455|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
156584058|NCT00365716|565223456|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
156584059|NCT00365716|565223457|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
156584060|NCT00365716|565223458|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
156584061|NCT00365716|565223459|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
156584062|NCT00365716|565223460|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
156584063|NCT00365716|565223461|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
156584064|NCT00365716|565223455|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
156584065|NCT00365716|565223456|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
156584066|NCT00365716|565223457|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
156584067|NCT00365716|565223458|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
156584068|NCT00365716|565223459|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
156584069|NCT00365716|565223460|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
156584070|NCT00365716|565223461|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
156584071|NCT00365716|565223455|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
156584072|NCT00365716|565223456|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
156584073|NCT00365716|565223457|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
156584074|NCT00365716|565223458|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
156584075|NCT00365716|565223459|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
156584076|NCT00365716|565223460|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
156584077|NCT00365716|565223461|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
156584078|NCT00365716|565223455|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
156584079|NCT00365716|565223456|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
156584080|NCT00365716|565223457|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
156584081|NCT00365716|565223458|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
156584082|NCT00365716|565223459|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
156584083|NCT00365716|565223460|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
156584084|NCT00365716|565223461|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
156584085|NCT00365716|565223455|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
156584086|NCT00365716|565223456|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
156584087|NCT00365716|565223457|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
156584088|NCT00365716|565223458|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
156584089|NCT00365716|565223459|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
156584090|NCT00365716|565223460|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
156584091|NCT00365716|565223461|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
156584092|NCT00365716|565223455|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
156584093|NCT00365716|565223456|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
156584094|NCT00365716|565223457|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
156584095|NCT00365716|565223458|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
156584096|NCT00365716|565223459|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
156584097|NCT00365716|565223460|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
156584098|NCT00365716|565223461|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
156584099|NCT00365716|565223455|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
156584100|NCT00365716|565223456|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
156584101|NCT00365716|565223457|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
156584102|NCT00365716|565223458|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
156584103|NCT00365716|565223459|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
156584104|NCT00365716|565223460|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
156584105|NCT00365716|565223461|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
156584106|NCT00365716|565223455|FG000|Extension 1|Lost to Follow-up|0|||
156584107|NCT00365716|565223456|FG001|Extension 1|Lost to Follow-up|0|||
156584108|NCT00365716|565223457|FG002|Extension 1|Lost to Follow-up|0|||
156584109|NCT00365716|565223458|FG003|Extension 1|Lost to Follow-up|0|||
156584110|NCT00365716|565223459|FG004|Extension 1|Lost to Follow-up|0|||
156584111|NCT00365716|565223460|FG005|Extension 1|Lost to Follow-up|1|||
156584112|NCT00365716|565223461|FG006|Extension 1|Lost to Follow-up|0|||
156584113|NCT00365716|565223455|FG000|Extension 1|Other|0|||
156584114|NCT00365716|565223456|FG001|Extension 1|Other|0|||
156584115|NCT00365716|565223457|FG002|Extension 1|Other|0|||
156584116|NCT00365716|565223458|FG003|Extension 1|Other|0|||
156584117|NCT00365716|565223459|FG004|Extension 1|Other|0|||
156584118|NCT00365716|565223460|FG005|Extension 1|Other|9|||
156584119|NCT00365716|565223461|FG006|Extension 1|Other|0|||
156584120|NCT00365716|565223455|FG000|Extension 1|Moved|0|||
156584121|NCT00365716|565223456|FG001|Extension 1|Moved|0|||
156584122|NCT00365716|565223457|FG002|Extension 1|Moved|0|||
156584123|NCT00365716|565223458|FG003|Extension 1|Moved|0|||
156584124|NCT00365716|565223459|FG004|Extension 1|Moved|0|||
156584125|NCT00365716|565223460|FG005|Extension 1|Moved|4|||
156584126|NCT00365716|565223461|FG006|Extension 1|Moved|0|||
156584127|NCT00365716|565223455|FG000|Extension 1|Withdrawal by Subject|0|||
156584128|NCT00365716|565223456|FG001|Extension 1|Withdrawal by Subject|0|||
156584129|NCT00365716|565223457|FG002|Extension 1|Withdrawal by Subject|0|||
156584130|NCT00365716|565223458|FG003|Extension 1|Withdrawal by Subject|0|||
156584131|NCT00365716|565223459|FG004|Extension 1|Withdrawal by Subject|0|||
156584132|NCT00365716|565223460|FG005|Extension 1|Withdrawal by Subject|3|||
156584133|NCT00365716|565223461|FG006|Extension 1|Withdrawal by Subject|0|||
156584134|NCT00365716|565223455|FG000|Extension 1|Pregnancy|0|||
156584135|NCT00365716|565223456|FG001|Extension 1|Pregnancy|0|||
156584136|NCT00365716|565223457|FG002|Extension 1|Pregnancy|0|||
156584137|NCT00365716|565223458|FG003|Extension 1|Pregnancy|0|||
156584138|NCT00365716|565223459|FG004|Extension 1|Pregnancy|0|||
156584139|NCT00365716|565223460|FG005|Extension 1|Pregnancy|4|||
156584140|NCT00365716|565223461|FG006|Extension 1|Pregnancy|0|||
156584141|NCT00365716|565223455|FG000|Extension 1|Protocol Violation|0|||
156584142|NCT00365716|565223456|FG001|Extension 1|Protocol Violation|0|||
156584143|NCT00365716|565223457|FG002|Extension 1|Protocol Violation|0|||
156584144|NCT00365716|565223458|FG003|Extension 1|Protocol Violation|0|||
156584145|NCT00365716|565223459|FG004|Extension 1|Protocol Violation|0|||
156584146|NCT00365716|565223460|FG005|Extension 1|Protocol Violation|1|||
156584147|NCT00365716|565223461|FG006|Extension 1|Protocol Violation|0|||
156584148|NCT00365716|565223455|FG000|Extension 2|Lost to Follow-up|0|||
156584149|NCT00365716|565223456|FG001|Extension 2|Lost to Follow-up|0|||
156584150|NCT00365716|565223457|FG002|Extension 2|Lost to Follow-up|0|||
156584151|NCT00365716|565223458|FG003|Extension 2|Lost to Follow-up|0|||
156584152|NCT00365716|565223459|FG004|Extension 2|Lost to Follow-up|0|||
156584153|NCT00365716|565223460|FG005|Extension 2|Lost to Follow-up|0|||
156584154|NCT00365716|565223461|FG006|Extension 2|Lost to Follow-up|2|||
156584155|NCT00365716|565223455|FG000|Extension 2|Other|0|||
156584156|NCT00365716|565223456|FG001|Extension 2|Other|0|||
156584157|NCT00365716|565223457|FG002|Extension 2|Other|0|||
156584158|NCT00365716|565223458|FG003|Extension 2|Other|0|||
156584159|NCT00365716|565223459|FG004|Extension 2|Other|0|||
156584160|NCT00365716|565223460|FG005|Extension 2|Other|0|||
156584161|NCT00365716|565223461|FG006|Extension 2|Other|3|||
156584162|NCT00365716|565223455|FG000|Extension 2|Withdrawal by Subject|0|||
156584163|NCT00365716|565223456|FG001|Extension 2|Withdrawal by Subject|0|||
156584164|NCT00365716|565223457|FG002|Extension 2|Withdrawal by Subject|0|||
156584165|NCT00365716|565223458|FG003|Extension 2|Withdrawal by Subject|0|||
156584166|NCT00365716|565223459|FG004|Extension 2|Withdrawal by Subject|0|||
156584167|NCT00365716|565223460|FG005|Extension 2|Withdrawal by Subject|0|||
156584168|NCT00365716|565223461|FG006|Extension 2|Withdrawal by Subject|5|||
156584169|NCT01120093|565223471|FG000|Treatment Period 1|Adverse Event|0|||
156584170|NCT01120093|565223472|FG001|Treatment Period 1|Adverse Event|0|||
156584171|NCT01120093|565223473|FG002|Treatment Period 1|Adverse Event|1|||
156584172|NCT01120093|565223474|FG003|Treatment Period 1|Adverse Event|0|||
156584173|NCT01120093|565223475|FG004|Treatment Period 1|Adverse Event|1|||
156584174|NCT01120093|565223471|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156584175|NCT01120093|565223472|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156584176|NCT01120093|565223473|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156584177|NCT01120093|565223474|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156584178|NCT01120093|565223475|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156584179|NCT01120093|565223471|FG000|Treatment Period 2|Adverse Event|0|||
156584180|NCT01120093|565223472|FG001|Treatment Period 2|Adverse Event|0|||
156584181|NCT01120093|565223473|FG002|Treatment Period 2|Adverse Event|0|||
156584182|NCT01120093|565223474|FG003|Treatment Period 2|Adverse Event|1|||
156584183|NCT01120093|565223475|FG004|Treatment Period 2|Adverse Event|0|||
156584184|NCT01120093|565223471|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156584185|NCT01120093|565223472|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156584186|NCT01120093|565223473|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156584187|NCT01120093|565223474|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156584188|NCT01120093|565223475|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156584189|NCT01120093|565223471|FG000|Treatment Period 3|Lack of Efficacy|0|||
156584190|NCT01120093|565223472|FG001|Treatment Period 3|Lack of Efficacy|0|||
156584191|NCT01120093|565223473|FG002|Treatment Period 3|Lack of Efficacy|0|||
156584192|NCT01120093|565223474|FG003|Treatment Period 3|Lack of Efficacy|1|||
156584193|NCT01120093|565223475|FG004|Treatment Period 3|Lack of Efficacy|0|||
156584194|NCT01120093|565223471|FG000|Treatment Period 3|Adverse Event|0|||
156584195|NCT01120093|565223472|FG001|Treatment Period 3|Adverse Event|0|||
156584196|NCT01120093|565223473|FG002|Treatment Period 3|Adverse Event|0|||
156584197|NCT01120093|565223474|FG003|Treatment Period 3|Adverse Event|0|||
156584198|NCT01120093|565223475|FG004|Treatment Period 3|Adverse Event|1|||
156584199|NCT01120093|565223471|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156584200|NCT01120093|565223472|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156584201|NCT01120093|565223473|FG002|Treatment Period 3|Withdrawal by Subject|1|||
156584202|NCT01120093|565223474|FG003|Treatment Period 3|Withdrawal by Subject|0|||
156584203|NCT01120093|565223475|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156584204|NCT01120093|565223471|FG000|Treatment Period 4|Adverse Event|1|||
156584205|NCT01120093|565223472|FG001|Treatment Period 4|Adverse Event|0|||
156584206|NCT01120093|565223473|FG002|Treatment Period 4|Adverse Event|0|||
156584207|NCT01120093|565223474|FG003|Treatment Period 4|Adverse Event|0|||
156584208|NCT01120093|565223475|FG004|Treatment Period 4|Adverse Event|0|||
156584209|NCT01120093|565223471|FG000|Treatment Period 5|Adverse Event|0|||
156584210|NCT01120093|565223472|FG001|Treatment Period 5|Adverse Event|1|||
156584211|NCT01120093|565223473|FG002|Treatment Period 5|Adverse Event|0|||
156584212|NCT01120093|565223474|FG003|Treatment Period 5|Adverse Event|1|||
156584213|NCT01120093|565223475|FG004|Treatment Period 5|Adverse Event|0|||
156584214|NCT00525148|565223478|FG000|Overall Study|Other Adverse Event|3|||
156584215|NCT00525148|565223479|FG001|Overall Study|Other Adverse Event|5|||
156584216|NCT00525148|565223480|FG002|Overall Study|Other Adverse Event|1|||
156584217|NCT00525148|565223481|FG003|Overall Study|Other Adverse Event|8|||
156584218|NCT00525148|565223478|FG000|Overall Study|Progressive disease|18|||
156584219|NCT00525148|565223479|FG001|Overall Study|Progressive disease|30|||
156584220|NCT00525148|565223480|FG002|Overall Study|Progressive disease|6|||
156584221|NCT00525148|565223481|FG003|Overall Study|Progressive disease|49|||
156584222|NCT00525148|565223478|FG000|Overall Study|Refused continuation of study medication|0|||
156584223|NCT00525148|565223479|FG001|Overall Study|Refused continuation of study medication|2|||
156584224|NCT00525148|565223480|FG002|Overall Study|Refused continuation of study medication|0|||
156584225|NCT00525148|565223481|FG003|Overall Study|Refused continuation of study medication|1|||
156584226|NCT00525148|565223478|FG000|Overall Study|Other than stated|2|||
156584227|NCT00525148|565223479|FG001|Overall Study|Other than stated|1|||
156584228|NCT00525148|565223480|FG002|Overall Study|Other than stated|0|||
156584229|NCT00525148|565223481|FG003|Overall Study|Other than stated|3|||
156584230|NCT00570739|565223482|FG000|Overall Study|Adverse Event|8|||
156584231|NCT00570739|565223483|FG001|Overall Study|Adverse Event|6|||
156584232|NCT00570739|565223484|FG002|Overall Study|Adverse Event|2|||
156584233|NCT00570739|565223485|FG003|Overall Study|Adverse Event|2|||
156584234|NCT00570739|565223482|FG000|Overall Study|Lost to Follow-up|4|||
156584235|NCT00570739|565223483|FG001|Overall Study|Lost to Follow-up|5|||
156584236|NCT00570739|565223484|FG002|Overall Study|Lost to Follow-up|4|||
156584237|NCT00570739|565223485|FG003|Overall Study|Lost to Follow-up|1|||
156584238|NCT00570739|565223482|FG000|Overall Study|Physician Decision|1|||
156584239|NCT00570739|565223483|FG001|Overall Study|Physician Decision|1|||
156584240|NCT00570739|565223484|FG002|Overall Study|Physician Decision|0|||
156584241|NCT00570739|565223485|FG003|Overall Study|Physician Decision|0|||
156584242|NCT00570739|565223482|FG000|Overall Study|Withdrawal by Subject|7|||
156634891|NCT03917654|565407815|FG000|Year 1|Withdrawal by Subject|1|||
156584243|NCT00570739|565223483|FG001|Overall Study|Withdrawal by Subject|7|||
156584244|NCT00570739|565223484|FG002|Overall Study|Withdrawal by Subject|3|||
156584245|NCT00570739|565223485|FG003|Overall Study|Withdrawal by Subject|5|||
156584246|NCT00570739|565223482|FG000|Overall Study|Required restricted medication|0|||
156584247|NCT00570739|565223483|FG001|Overall Study|Required restricted medication|0|||
156584248|NCT00570739|565223484|FG002|Overall Study|Required restricted medication|1|||
156584249|NCT00570739|565223485|FG003|Overall Study|Required restricted medication|0|||
156584250|NCT00570739|565223482|FG000|Overall Study|Met discontinuation criteria|1|||
156584251|NCT00570739|565223483|FG001|Overall Study|Met discontinuation criteria|0|||
156584252|NCT00570739|565223484|FG002|Overall Study|Met discontinuation criteria|1|||
156584253|NCT00570739|565223485|FG003|Overall Study|Met discontinuation criteria|1|||
156584254|NCT00570739|565223482|FG000|Overall Study|Other|0|||
156584255|NCT00570739|565223483|FG001|Overall Study|Other|2|||
156584256|NCT00570739|565223484|FG002|Overall Study|Other|5|||
156584257|NCT00570739|565223485|FG003|Overall Study|Other|3|||
156584258|NCT02086565|565223487|FG000|Overall Study|Lost to Follow-up|9|||
156584259|NCT02086565|565223488|FG001|Overall Study|Lost to Follow-up|7|||
156584260|NCT02086565|565223487|FG000|Overall Study|Withdrawal by Subject|2|||
156584261|NCT02086565|565223488|FG001|Overall Study|Withdrawal by Subject|1|||
156584262|NCT02086565|565223487|FG000|Overall Study|Death|3|||
156584263|NCT02086565|565223488|FG001|Overall Study|Death|2|||
156584264|NCT02086565|565223487|FG000|Overall Study|withdrawn by research team|2|||
156584265|NCT02086565|565223488|FG001|Overall Study|withdrawn by research team|2|||
156584266|NCT00739297|565223489|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
156584267|NCT00739297|565223490|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
156584268|NCT00739297|565223491|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
156584269|NCT00739297|565223492|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
156584270|NCT00739297|565223493|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
156584271|NCT00739297|565223494|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
156584272|NCT00739297|565223495|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
156584273|NCT00739297|565223489|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
156584274|NCT00739297|565223490|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
156584275|NCT00739297|565223491|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
156584276|NCT00739297|565223492|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
156584277|NCT00739297|565223493|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
156584278|NCT00739297|565223494|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
156584279|NCT00739297|565223495|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
156584280|NCT01400971|565223496|FG000|Overall Study|Death|82|||
156584281|NCT01400971|565223496|FG000|Overall Study|Lost to Follow-up|196|||
156584282|NCT01400971|565223496|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
156584283|NCT01400971|565223496|FG000|Overall Study|Physician Decision|57|||
156584284|NCT01400971|565223496|FG000|Overall Study|Withdrawal by Subject|158|||
156584285|NCT01400971|565223496|FG000|Overall Study|Other|422|||
156584286|NCT00789477|565223501|FG000|Overall Study|Withdrawal by Subject|2|||
156584287|NCT00789477|565223502|FG001|Overall Study|Withdrawal by Subject|1|||
156584288|NCT00789477|565223503|FG002|Overall Study|Withdrawal by Subject|3|||
156584289|NCT00789477|565223504|FG003|Overall Study|Withdrawal by Subject|2|||
156584290|NCT00789477|565223505|FG004|Overall Study|Withdrawal by Subject|3|||
156584291|NCT00789477|565223501|FG000|Overall Study|Protocol Violation|1|||
156584292|NCT00789477|565223502|FG001|Overall Study|Protocol Violation|0|||
156584293|NCT00789477|565223503|FG002|Overall Study|Protocol Violation|0|||
156584294|NCT00789477|565223504|FG003|Overall Study|Protocol Violation|1|||
156584295|NCT00789477|565223505|FG004|Overall Study|Protocol Violation|0|||
156584296|NCT00789477|565223501|FG000|Overall Study|Adverse Event|3|||
156584297|NCT00789477|565223502|FG001|Overall Study|Adverse Event|3|||
156584298|NCT00789477|565223503|FG002|Overall Study|Adverse Event|1|||
156584299|NCT00789477|565223504|FG003|Overall Study|Adverse Event|0|||
156584300|NCT00789477|565223505|FG004|Overall Study|Adverse Event|0|||
156584301|NCT00789477|565223501|FG000|Overall Study|Death|1|||
156584302|NCT00789477|565223502|FG001|Overall Study|Death|1|||
156584303|NCT00789477|565223503|FG002|Overall Study|Death|2|||
156584304|NCT00789477|565223504|FG003|Overall Study|Death|2|||
156584305|NCT00789477|565223505|FG004|Overall Study|Death|0|||
156584306|NCT00789477|565223501|FG000|Overall Study|Lost to Follow-up|0|||
156584307|NCT00789477|565223502|FG001|Overall Study|Lost to Follow-up|1|||
156584308|NCT00789477|565223503|FG002|Overall Study|Lost to Follow-up|4|||
156584309|NCT00789477|565223504|FG003|Overall Study|Lost to Follow-up|2|||
156584310|NCT00789477|565223505|FG004|Overall Study|Lost to Follow-up|4|||
156584311|NCT00789477|565223501|FG000|Overall Study|Lack of Efficacy|2|||
156584312|NCT00789477|565223502|FG001|Overall Study|Lack of Efficacy|0|||
156584313|NCT00789477|565223503|FG002|Overall Study|Lack of Efficacy|0|||
156584314|NCT00789477|565223504|FG003|Overall Study|Lack of Efficacy|0|||
156584315|NCT00789477|565223505|FG004|Overall Study|Lack of Efficacy|0|||
156584316|NCT00789477|565223501|FG000|Overall Study|Other|2|||
156584317|NCT00789477|565223502|FG001|Overall Study|Other|0|||
156584318|NCT00789477|565223503|FG002|Overall Study|Other|1|||
156584319|NCT00789477|565223504|FG003|Overall Study|Other|3|||
156584320|NCT00789477|565223505|FG004|Overall Study|Other|0|||
156584321|NCT01927562|565223506|FG000|Overall Study|Lost to Follow-up|30|||
156584322|NCT01927562|565223506|FG000|Overall Study|Withdrawal by Subject|3|||
156584323|NCT01927562|565223506|FG000|Overall Study|Physician Decision|5|||
156584324|NCT00642616|565223507|FG000|Overall Study|Adverse Event|2|||
156584325|NCT00642616|565223508|FG001|Overall Study|Adverse Event|0|||
156584326|NCT00642616|565223509|FG002|Overall Study|Adverse Event|1|||
156584327|NCT00642616|565223510|FG003|Overall Study|Adverse Event|0|||
156584328|NCT00642616|565223507|FG000|Overall Study|Study Terminated by Sponsor|7|||
156584329|NCT00642616|565223508|FG001|Overall Study|Study Terminated by Sponsor|6|||
156584330|NCT00642616|565223509|FG002|Overall Study|Study Terminated by Sponsor|4|||
156584331|NCT00642616|565223510|FG003|Overall Study|Study Terminated by Sponsor|5|||
156584332|NCT00642616|565223507|FG000|Overall Study|Withdrawal by Subject|0|||
156584333|NCT00642616|565223508|FG001|Overall Study|Withdrawal by Subject|1|||
156584334|NCT00642616|565223509|FG002|Overall Study|Withdrawal by Subject|1|||
156584335|NCT00642616|565223510|FG003|Overall Study|Withdrawal by Subject|1|||
156584336|NCT00642616|565223507|FG000|Overall Study|Protocol Violation|0|||
156584337|NCT00642616|565223508|FG001|Overall Study|Protocol Violation|0|||
156584338|NCT00642616|565223509|FG002|Overall Study|Protocol Violation|2|||
156584339|NCT00642616|565223510|FG003|Overall Study|Protocol Violation|0|||
156584340|NCT00642616|565223507|FG000|Overall Study|Physician Decision|0|||
156584341|NCT00642616|565223508|FG001|Overall Study|Physician Decision|0|||
156584342|NCT00642616|565223509|FG002|Overall Study|Physician Decision|1|||
156584343|NCT00642616|565223510|FG003|Overall Study|Physician Decision|1|||
156584344|NCT00542815|565223511|FG000|Overall Study|Adverse Event|19|||
156584345|NCT00542815|565223512|FG001|Overall Study|Adverse Event|6|||
156584346|NCT00542815|565223513|FG002|Overall Study|Adverse Event|9|||
156584347|NCT00542815|565223511|FG000|Overall Study|Death|10|||
156584348|NCT00542815|565223512|FG001|Overall Study|Death|7|||
156584349|NCT00542815|565223513|FG002|Overall Study|Death|3|||
156584350|NCT00542815|565223511|FG000|Overall Study|Lack of Efficacy|9|||
156584351|NCT00542815|565223512|FG001|Overall Study|Lack of Efficacy|2|||
156584352|NCT00542815|565223513|FG002|Overall Study|Lack of Efficacy|0|||
156584353|NCT00542815|565223511|FG000|Overall Study|Physician Decision|2|||
156584354|NCT00542815|565223512|FG001|Overall Study|Physician Decision|1|||
156584355|NCT00542815|565223513|FG002|Overall Study|Physician Decision|0|||
156584356|NCT00542815|565223511|FG000|Overall Study|Protocol Violation|1|||
156584357|NCT00542815|565223512|FG001|Overall Study|Protocol Violation|1|||
156584358|NCT00542815|565223513|FG002|Overall Study|Protocol Violation|2|||
156584359|NCT00542815|565223511|FG000|Overall Study|Withdrawal by Subject|41|||
156584360|NCT00542815|565223512|FG001|Overall Study|Withdrawal by Subject|5|||
156584361|NCT00542815|565223513|FG002|Overall Study|Withdrawal by Subject|8|||
156584362|NCT00542815|565223511|FG000|Overall Study|Other reasons|24|||
156584363|NCT00542815|565223512|FG001|Overall Study|Other reasons|10|||
156584364|NCT00542815|565223513|FG002|Overall Study|Other reasons|10|||
156584365|NCT01041573|565223514|FG000|Overall Study|Withdrawal by Subject|2|||
156584366|NCT01041573|565223515|FG001|Overall Study|Withdrawal by Subject|5|||
156584367|NCT01041573|565223516|FG002|Overall Study|Withdrawal by Subject|2|||
156584368|NCT01041573|565223517|FG003|Overall Study|Withdrawal by Subject|0|||
156584369|NCT01041573|565223514|FG000|Overall Study|Death|1|||
156584370|NCT01041573|565223515|FG001|Overall Study|Death|0|||
156584371|NCT01041573|565223516|FG002|Overall Study|Death|0|||
156584372|NCT01041573|565223517|FG003|Overall Study|Death|0|||
156584373|NCT01041573|565223514|FG000|Overall Study|Lost to Follow-up|0|||
156584374|NCT01041573|565223515|FG001|Overall Study|Lost to Follow-up|1|||
156584375|NCT01041573|565223516|FG002|Overall Study|Lost to Follow-up|2|||
156584376|NCT01041573|565223517|FG003|Overall Study|Lost to Follow-up|1|||
156584377|NCT01041573|565223514|FG000|Overall Study|Adverse Event|0|||
156584378|NCT01041573|565223515|FG001|Overall Study|Adverse Event|2|||
156584379|NCT01041573|565223516|FG002|Overall Study|Adverse Event|0|||
156584380|NCT01041573|565223517|FG003|Overall Study|Adverse Event|0|||
156584381|NCT01041573|565223514|FG000|Overall Study|relocation|1|||
156584382|NCT01041573|565223515|FG001|Overall Study|relocation|4|||
156584383|NCT01041573|565223516|FG002|Overall Study|relocation|3|||
156584384|NCT01041573|565223517|FG003|Overall Study|relocation|1|||
156584385|NCT01041573|565223514|FG000|Overall Study|further blood extraction|0|||
156584386|NCT01041573|565223515|FG001|Overall Study|further blood extraction|1|||
156584387|NCT01041573|565223516|FG002|Overall Study|further blood extraction|0|||
156584388|NCT01041573|565223517|FG003|Overall Study|further blood extraction|0|||
156584389|NCT01041573|565223514|FG000|Overall Study|positive to anti-HCV|1|||
156584390|NCT01041573|565223515|FG001|Overall Study|positive to anti-HCV|0|||
156584391|NCT01041573|565223516|FG002|Overall Study|positive to anti-HCV|0|||
156584392|NCT01041573|565223517|FG003|Overall Study|positive to anti-HCV|0|||
156584393|NCT02955186|565223518|FG000|Overall Study|Withdrawal by Subject|6|||
156584394|NCT02955186|565223519|FG001|Overall Study|Withdrawal by Subject|2|||
156584395|NCT02955186|565223518|FG000|Overall Study|Protocol Violation|1|||
156584396|NCT02955186|565223519|FG001|Overall Study|Protocol Violation|0|||
156584397|NCT02698423|565223524|FG000|Overall Study|Lost to Follow-up|19|||
156584398|NCT02698423|565223525|FG001|Overall Study|Lost to Follow-up|24|||
156584399|NCT00064662|565223529|FG000|Overall Study|Death|1|||
156584400|NCT00064662|565223530|FG001|Overall Study|Death|1|||
156584401|NCT00064662|565223529|FG000|Overall Study|Lost to Follow-up|57|||
156584402|NCT00064662|565223530|FG001|Overall Study|Lost to Follow-up|44|||
156584403|NCT00064662|565223529|FG000|Overall Study|Withdrawal by Subject|14|||
156584404|NCT00064662|565223530|FG001|Overall Study|Withdrawal by Subject|14|||
156584405|NCT00064662|565223529|FG000|Overall Study|Administratively withdrawn|2|||
156584406|NCT00064662|565223530|FG001|Overall Study|Administratively withdrawn|2|||
156584407|NCT00504166|565223535|FG000|Overall Study|Adverse Event|1|||
156584408|NCT00504166|565223536|FG001|Overall Study|Adverse Event|4|||
156584409|NCT00504166|565223535|FG000|Overall Study|Withdrawal by Subject|3|||
156584410|NCT00504166|565223536|FG001|Overall Study|Withdrawal by Subject|6|||
156584411|NCT00504166|565223535|FG000|Overall Study|Physician Decision|1|||
156584412|NCT00504166|565223536|FG001|Overall Study|Physician Decision|1|||
156584413|NCT00504166|565223535|FG000|Overall Study|Lost to Follow-up|1|||
156584414|NCT00504166|565223536|FG001|Overall Study|Lost to Follow-up|3|||
156584415|NCT01096550|565223537|FG000|Overall Study|discontinued site|10|||
156584416|NCT01096550|565223538|FG001|Overall Study|discontinued site|11|||
156584417|NCT01096550|565223537|FG000|Overall Study|non-regular treatment track at clinic|1|||
156584418|NCT01096550|565223538|FG001|Overall Study|non-regular treatment track at clinic|1|||
156584419|NCT01096550|565223537|FG000|Overall Study|clinic readmission|1|||
156584420|NCT01096550|565223538|FG001|Overall Study|clinic readmission|1|||
156584421|NCT01096550|565223537|FG000|Overall Study|Withdrawal by Subject|0|||
156584422|NCT01096550|565223538|FG001|Overall Study|Withdrawal by Subject|1|||
156584423|NCT01096550|565223537|FG000|Overall Study|non-African American participant|13|||
156584424|NCT01096550|565223538|FG001|Overall Study|non-African American participant|6|||
156584425|NCT01096550|565223537|FG000|Overall Study|Lost to Follow-up|12|||
156584426|NCT01096550|565223538|FG001|Overall Study|Lost to Follow-up|9|||
156584427|NCT01345786|565223543|FG000|Overall Study|Adverse Event|0|||
156584428|NCT01345786|565223544|FG001|Overall Study|Adverse Event|1|||
156584429|NCT01345786|565223545|FG002|Overall Study|Adverse Event|3|||
156584430|NCT01345786|565223546|FG003|Overall Study|Adverse Event|1|||
156584431|NCT01345786|565223543|FG000|Overall Study|Subject withdrew consent|2|||
156584432|NCT01345786|565223544|FG001|Overall Study|Subject withdrew consent|2|||
156584433|NCT01345786|565223545|FG002|Overall Study|Subject withdrew consent|1|||
156584434|NCT01345786|565223546|FG003|Overall Study|Subject withdrew consent|0|||
156584435|NCT01345786|565223543|FG000|Overall Study|Noncompliance with protocol|1|||
156584436|NCT01345786|565223544|FG001|Overall Study|Noncompliance with protocol|0|||
156584437|NCT01345786|565223545|FG002|Overall Study|Noncompliance with protocol|1|||
156584438|NCT01345786|565223546|FG003|Overall Study|Noncompliance with protocol|0|||
156584439|NCT01345786|565223543|FG000|Overall Study|Administrative|3|||
156584440|NCT01345786|565223544|FG001|Overall Study|Administrative|5|||
156584441|NCT01345786|565223545|FG002|Overall Study|Administrative|0|||
156584442|NCT01345786|565223546|FG003|Overall Study|Administrative|0|||
156584443|NCT01345786|565223543|FG000|Overall Study|Lost to Follow-up|0|||
156584444|NCT01345786|565223544|FG001|Overall Study|Lost to Follow-up|0|||
156584445|NCT01345786|565223545|FG002|Overall Study|Lost to Follow-up|0|||
156584446|NCT01345786|565223546|FG003|Overall Study|Lost to Follow-up|2|||
156584447|NCT01963117|565223549|FG000|Overall Study|Death|1|||
156584448|NCT01070784|565223550|FG000|Overall Study|Withdrawal by Subject|6|||
156584449|NCT01070784|565223551|FG001|Overall Study|Withdrawal by Subject|9|||
156584450|NCT01070784|565223550|FG000|Overall Study|Adverse Event|14|||
156584451|NCT01070784|565223551|FG001|Overall Study|Adverse Event|9|||
156584452|NCT01323673|565223553|FG000|Overall Study|Adverse Event|0|||
156584453|NCT01323673|565223554|FG001|Overall Study|Adverse Event|1|||
156584454|NCT01323673|565223553|FG000|Overall Study|Lost to Follow-up|0|||
156584455|NCT01323673|565223554|FG001|Overall Study|Lost to Follow-up|1|||
156584456|NCT01323673|565223553|FG000|Overall Study|Protocol Violation|1|||
156584457|NCT01323673|565223554|FG001|Overall Study|Protocol Violation|0|||
156584458|NCT01323673|565223553|FG000|Overall Study|Withdrawal by Subject|2|||
156584459|NCT01323673|565223554|FG001|Overall Study|Withdrawal by Subject|3|||
156584460|NCT03844633|565223555|FG000|1 Week FU|Lost to Follow-up|0|||
156584461|NCT03844633|565223556|FG001|1 Week FU|Lost to Follow-up|1|||
156584462|NCT03844633|565223557|FG002|1 Week FU|Lost to Follow-up|4|||
156584463|NCT03844633|565223555|FG000|12-month Follow-up|Lost to Follow-up|7|||
156584464|NCT03844633|565223556|FG001|12-month Follow-up|Lost to Follow-up|5|||
156584465|NCT03844633|565223557|FG002|12-month Follow-up|Lost to Follow-up|8|||
156584466|NCT02588248|565223560|FG000|Overall Study|Physician Decision|4|||
156584467|NCT02588248|565223561|FG001|Overall Study|Physician Decision|3|||
156584468|NCT01355068|565223562|FG000|First Intervention Period|Adverse Event|0|||
156584469|NCT01355068|565223563|FG001|First Intervention Period|Adverse Event|1|||
156584470|NCT01355068|565223562|FG000|First Intervention Period|Withdrawal by Subject|0|||
156584471|NCT01355068|565223563|FG001|First Intervention Period|Withdrawal by Subject|1|||
156584472|NCT04229446|565223564|FG000|Overall Study|Death|12|||
156584473|NCT04229446|565223565|FG001|Overall Study|Death|10|||
156584474|NCT04229446|565223564|FG000|Overall Study|Lost to Follow-up|5|||
156584475|NCT04229446|565223565|FG001|Overall Study|Lost to Follow-up|8|||
156584476|NCT04083222|565223567|FG000|Overall Study|Voluntary Withdrawal|0|||
156584477|NCT04083222|565223568|FG001|Overall Study|Voluntary Withdrawal|1|||
156584478|NCT04083222|565223567|FG000|Overall Study|Reason not Specified|0|||
156584479|NCT04083222|565223568|FG001|Overall Study|Reason not Specified|1|||
156584480|NCT01937130|565225457|FG000|Overall Study|Withdrawal by Subject|0|||
156584481|NCT01937130|565225458|FG001|Overall Study|Withdrawal by Subject|0|||
156584482|NCT01937130|565225459|FG002|Overall Study|Withdrawal by Subject|0|||
156584483|NCT01937130|565225460|FG003|Overall Study|Withdrawal by Subject|1|||
156584484|NCT01937130|565225457|FG000|Overall Study|Adverse Event|0|||
156584485|NCT01937130|565225458|FG001|Overall Study|Adverse Event|1|||
156584486|NCT01937130|565225459|FG002|Overall Study|Adverse Event|0|||
156584487|NCT01937130|565225460|FG003|Overall Study|Adverse Event|1|||
156584488|NCT01937130|565225457|FG000|Overall Study|Death|1|||
156584489|NCT01937130|565225458|FG001|Overall Study|Death|1|||
156584490|NCT01937130|565225459|FG002|Overall Study|Death|1|||
156584491|NCT01937130|565225460|FG003|Overall Study|Death|0|||
156584492|NCT01937130|565225457|FG000|Overall Study|Lost to Follow-up|2|||
156584493|NCT01937130|565225458|FG001|Overall Study|Lost to Follow-up|0|||
156584494|NCT01937130|565225459|FG002|Overall Study|Lost to Follow-up|2|||
156584495|NCT01937130|565225460|FG003|Overall Study|Lost to Follow-up|0|||
156584496|NCT01937130|565225457|FG000|Overall Study|Physician Decision|0|||
156584497|NCT01937130|565225458|FG001|Overall Study|Physician Decision|1|||
156584498|NCT01937130|565225459|FG002|Overall Study|Physician Decision|0|||
156584499|NCT01937130|565225460|FG003|Overall Study|Physician Decision|0|||
156584500|NCT01937130|565225457|FG000|Overall Study|Patients unable to swallow|0|||
156584501|NCT01937130|565225458|FG001|Overall Study|Patients unable to swallow|1|||
156584502|NCT01937130|565225459|FG002|Overall Study|Patients unable to swallow|0|||
156584503|NCT01937130|565225460|FG003|Overall Study|Patients unable to swallow|0|||
156584504|NCT01937130|565225457|FG000|Overall Study|Patient lost to FU due to death|2|||
156584505|NCT01937130|565225458|FG001|Overall Study|Patient lost to FU due to death|0|||
156584506|NCT01937130|565225459|FG002|Overall Study|Patient lost to FU due to death|0|||
156584507|NCT01937130|565225460|FG003|Overall Study|Patient lost to FU due to death|0|||
156584508|NCT04191967|565225461|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
156584509|NCT04191967|565225461|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
156584510|NCT01431144|565225462|FG000|Overall Study|Implant mobility and removal|2|||
156584511|NCT01431144|565225463|FG001|Overall Study|Implant mobility and removal|0|||
156584512|NCT00953043|565225469|FG000|Overall Study|Withdrawal by Subject|4|||
156584513|NCT00953043|565225470|FG001|Overall Study|Withdrawal by Subject|0|||
156584514|NCT00953043|565225469|FG000|Overall Study|Physician Decision|0|||
156584515|NCT00953043|565225470|FG001|Overall Study|Physician Decision|2|||
156584516|NCT02322892|565225472|FG000|Overall Study|Surgery cancelled|1|||
156584517|NCT02322892|565225473|FG001|Overall Study|Surgery cancelled|2|||
156584518|NCT02322892|565225472|FG000|Overall Study|Met exclusion criteria|0|||
156584519|NCT02322892|565225473|FG001|Overall Study|Met exclusion criteria|1|||
156584520|NCT02322892|565225472|FG000|Overall Study|Protocol Violation|1|||
156584521|NCT02322892|565225473|FG001|Overall Study|Protocol Violation|0|||
156584522|NCT00747617|565225474|FG000|Overall Study|Lost to Follow-up|3|||
156584523|NCT00747617|565225475|FG001|Overall Study|Lost to Follow-up|1|||
156584524|NCT03509207|565225476|FG000|Overall Study|Death|2|||
156584525|NCT02125331|565225477|FG000|Overall Study|Protocol Violation|1|||
156584526|NCT02125331|565225478|FG001|Overall Study|Protocol Violation|0|||
156584527|NCT02125331|565225477|FG000|Overall Study|technical problem|2|||
156584528|NCT02125331|565225478|FG001|Overall Study|technical problem|0|||
156584529|NCT02125331|565225477|FG000|Overall Study|screen failure|2|||
156584530|NCT02125331|565225478|FG001|Overall Study|screen failure|0|||
156584531|NCT01432262|565225479|FG000|Overall Study|Withdrawal by Subject|2|||
156584532|NCT01432262|565225480|FG001|Overall Study|Withdrawal by Subject|1|||
156584533|NCT04657016|565225481|FG000|Overall Study|Adverse Event|2|||
156584534|NCT04657016|565225482|FG001|Overall Study|Adverse Event|4|||
156584535|NCT04657016|565225481|FG000|Overall Study|Death|1|||
156584536|NCT04657016|565225482|FG001|Overall Study|Death|1|||
156584537|NCT04657016|565225481|FG000|Overall Study|Lost to Follow-up|24|||
156584538|NCT04657016|565225482|FG001|Overall Study|Lost to Follow-up|12|||
156584539|NCT04657016|565225481|FG000|Overall Study|Physician Decision|1|||
156584540|NCT04657016|565225482|FG001|Overall Study|Physician Decision|2|||
156584541|NCT04657016|565225481|FG000|Overall Study|Pregnancy|2|||
156584542|NCT04657016|565225482|FG001|Overall Study|Pregnancy|2|||
156584543|NCT04657016|565225481|FG000|Overall Study|Protocol Deviation|1|||
156584544|NCT04657016|565225482|FG001|Overall Study|Protocol Deviation|0|||
156584545|NCT04657016|565225481|FG000|Overall Study|Withdrawal by Subject|28|||
156584546|NCT04657016|565225482|FG001|Overall Study|Withdrawal by Subject|14|||
156584547|NCT04657016|565225481|FG000|Overall Study|Other - as reported by the investigator|6|||
156584548|NCT04657016|565225482|FG001|Overall Study|Other - as reported by the investigator|0|||
156584549|NCT01104558|565225485|FG000|Overall Study|Protocol Violation|6|||
156584550|NCT01104558|565225485|FG000|Overall Study|Missing of primary efficacy assessment|10|||
156584551|NCT01104558|565225485|FG000|Overall Study|Missing of genetic analysis results|1|||
156584552|NCT00696657|565225486|FG000|Overall Study|Protocol Violation|0|||
156584553|NCT00696657|565225487|FG001|Overall Study|Protocol Violation|0|||
156584554|NCT00696657|565225488|FG002|Overall Study|Protocol Violation|0|||
156584555|NCT00696657|565225489|FG003|Overall Study|Protocol Violation|0|||
156584556|NCT00696657|565225490|FG004|Overall Study|Protocol Violation|0|||
156584557|NCT00696657|565225491|FG005|Overall Study|Protocol Violation|1|||
156584558|NCT00696657|565225492|FG006|Overall Study|Protocol Violation|0|||
156584559|NCT00696657|565225493|FG007|Overall Study|Protocol Violation|0|||
156584560|NCT00696657|565225494|FG008|Overall Study|Protocol Violation|1|||
156584561|NCT00696657|565225486|FG000|Overall Study|Lack of Efficacy|0|||
156584562|NCT00696657|565225487|FG001|Overall Study|Lack of Efficacy|1|||
156584563|NCT00696657|565225488|FG002|Overall Study|Lack of Efficacy|0|||
156584564|NCT00696657|565225489|FG003|Overall Study|Lack of Efficacy|0|||
156584565|NCT00696657|565225490|FG004|Overall Study|Lack of Efficacy|0|||
156584566|NCT00696657|565225491|FG005|Overall Study|Lack of Efficacy|0|||
156584567|NCT00696657|565225492|FG006|Overall Study|Lack of Efficacy|0|||
156584568|NCT00696657|565225493|FG007|Overall Study|Lack of Efficacy|0|||
156584569|NCT00696657|565225494|FG008|Overall Study|Lack of Efficacy|0|||
156584570|NCT00696657|565225486|FG000|Overall Study|Withdrawal criteria|1|||
156584571|NCT00696657|565225487|FG001|Overall Study|Withdrawal criteria|3|||
156584572|NCT00696657|565225488|FG002|Overall Study|Withdrawal criteria|2|||
156584573|NCT00696657|565225489|FG003|Overall Study|Withdrawal criteria|2|||
156584574|NCT00696657|565225490|FG004|Overall Study|Withdrawal criteria|0|||
156584575|NCT00696657|565225491|FG005|Overall Study|Withdrawal criteria|0|||
156584576|NCT00696657|565225492|FG006|Overall Study|Withdrawal criteria|1|||
156584577|NCT00696657|565225493|FG007|Overall Study|Withdrawal criteria|1|||
156584578|NCT00696657|565225494|FG008|Overall Study|Withdrawal criteria|2|||
156584579|NCT00696657|565225486|FG000|Overall Study|Unclassified|0|||
156584580|NCT00696657|565225487|FG001|Overall Study|Unclassified|1|||
156584581|NCT00696657|565225488|FG002|Overall Study|Unclassified|3|||
156584582|NCT00696657|565225489|FG003|Overall Study|Unclassified|2|||
156584583|NCT00696657|565225490|FG004|Overall Study|Unclassified|4|||
156584584|NCT00696657|565225491|FG005|Overall Study|Unclassified|2|||
156584585|NCT00696657|565225492|FG006|Overall Study|Unclassified|0|||
156584586|NCT00696657|565225493|FG007|Overall Study|Unclassified|0|||
156584587|NCT00696657|565225494|FG008|Overall Study|Unclassified|1|||
156584588|NCT00696657|565225486|FG000|Overall Study|Adverse Event|0|||
156584589|NCT00696657|565225487|FG001|Overall Study|Adverse Event|0|||
156584590|NCT00696657|565225488|FG002|Overall Study|Adverse Event|3|||
156584591|NCT00696657|565225489|FG003|Overall Study|Adverse Event|7|||
156584592|NCT00696657|565225490|FG004|Overall Study|Adverse Event|6|||
156584593|NCT00696657|565225491|FG005|Overall Study|Adverse Event|9|||
156584594|NCT00696657|565225492|FG006|Overall Study|Adverse Event|14|||
156584595|NCT00696657|565225493|FG007|Overall Study|Adverse Event|2|||
156584596|NCT00696657|565225494|FG008|Overall Study|Adverse Event|5|||
156584597|NCT00523341|565225498|FG000|Overall Study|Withdrawal by Subject|399|||
156584598|NCT00523341|565225499|FG001|Overall Study|Withdrawal by Subject|427|||
156584599|NCT00523341|565225498|FG000|Overall Study|Other|181|||
156584600|NCT00523341|565225499|FG001|Overall Study|Other|198|||
156584601|NCT00523341|565225498|FG000|Overall Study|Adverse Event|122|||
156584602|NCT00523341|565225499|FG001|Overall Study|Adverse Event|155|||
156584603|NCT00523341|565225498|FG000|Overall Study|Death|101|||
156584604|NCT00523341|565225499|FG001|Overall Study|Death|110|||
156584605|NCT00523341|565225498|FG000|Overall Study|Lost to Follow-up|73|||
156584606|NCT00523341|565225499|FG001|Overall Study|Lost to Follow-up|61|||
156584607|NCT00523341|565225498|FG000|Overall Study|Non-compliance|20|||
156584608|NCT00523341|565225499|FG001|Overall Study|Non-compliance|13|||
156584609|NCT00523341|565225498|FG000|Overall Study|Physician Decision|14|||
156584610|NCT00523341|565225499|FG001|Overall Study|Physician Decision|13|||
156584611|NCT00523341|565225498|FG000|Overall Study|Requirement for Alternative Therapy|4|||
156584612|NCT00523341|565225499|FG001|Overall Study|Requirement for Alternative Therapy|14|||
156584613|NCT00523341|565225498|FG000|Overall Study|Protocol Deviation|6|||
156584614|NCT00523341|565225499|FG001|Overall Study|Protocol Deviation|5|||
156584615|NCT00523341|565225498|FG000|Overall Study|Ineligibility Determined|3|||
156584616|NCT00523341|565225499|FG001|Overall Study|Ineligibility Determined|4|||
156584617|NCT00523341|565225498|FG000|Overall Study|Disease Progression|1|||
156584618|NCT00523341|565225499|FG001|Overall Study|Disease Progression|0|||
156584619|NCT02601001|565225502|FG000|Dosing Period 2|Adverse Event|0|||
156584620|NCT02601001|565225503|FG001|Dosing Period 2|Adverse Event|0|||
156584621|NCT02601001|565225504|FG002|Dosing Period 2|Adverse Event|0|||
156584622|NCT02601001|565225505|FG003|Dosing Period 2|Adverse Event|0|||
156584623|NCT02601001|565225506|FG004|Dosing Period 2|Adverse Event|0|||
156584624|NCT02601001|565225507|FG005|Dosing Period 2|Adverse Event|0|||
156863641|NCT00627393|566258730|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
156584625|NCT02601001|565225508|FG006|Dosing Period 2|Adverse Event|1|||
156584626|NCT01356602|565225509|FG000|Overall Study|Protocol Deviation|0|||
156584627|NCT01356602|565225510|FG001|Overall Study|Protocol Deviation|1|||
156584628|NCT01356602|565225511|FG002|Overall Study|Protocol Deviation|1|||
156584629|NCT01356602|565225509|FG000|Overall Study|Administrative Problems|1|||
156584630|NCT01356602|565225510|FG001|Overall Study|Administrative Problems|4|||
156584631|NCT01356602|565225511|FG002|Overall Study|Administrative Problems|5|||
156584632|NCT01356602|565225509|FG000|Overall Study|Lost to Follow-up|4|||
156584633|NCT01356602|565225510|FG001|Overall Study|Lost to Follow-up|5|||
156584634|NCT01356602|565225511|FG002|Overall Study|Lost to Follow-up|6|||
156584635|NCT01356602|565225509|FG000|Overall Study|Withdrawal by Subject|4|||
156584636|NCT01356602|565225510|FG001|Overall Study|Withdrawal by Subject|3|||
156584637|NCT01356602|565225511|FG002|Overall Study|Withdrawal by Subject|7|||
156584638|NCT01356602|565225509|FG000|Overall Study|Lack of Efficacy|0|||
156584639|NCT01356602|565225510|FG001|Overall Study|Lack of Efficacy|1|||
156584640|NCT01356602|565225511|FG002|Overall Study|Lack of Efficacy|4|||
156584641|NCT01356602|565225509|FG000|Overall Study|Adverse Event|0|||
156584642|NCT01356602|565225510|FG001|Overall Study|Adverse Event|1|||
156584643|NCT01356602|565225511|FG002|Overall Study|Adverse Event|1|||
156584644|NCT03123354|565225512|FG000|Overall Study|Physician Decision|6|||
156584645|NCT01345123|565225513|FG000|Overall Study|participants no longer with health plan|79|||
156584646|NCT01345123|565225514|FG001|Overall Study|participants no longer with health plan|85|||
156584647|NCT01345123|565225515|FG002|Overall Study|participants no longer with health plan|88|||
156584648|NCT03097328|565225516|FG000|Overall Study|Still on Therapy|2|||
156584649|NCT03097328|565225516|FG000|Overall Study|Progressive Disease|29|||
156584650|NCT03097328|565225516|FG000|Overall Study|Adverse Event|4|||
156584651|NCT03097328|565225516|FG000|Overall Study|Withdrawal by Subject|1|||
156584652|NCT03097328|565225516|FG000|Overall Study|Physician Decision|1|||
156584653|NCT03097328|565225516|FG000|Overall Study|Patient Decision|1|||
156584654|NCT03097328|565225516|FG000|Overall Study|Ineligible for Study Drug|1|||
156584655|NCT03539458|565225518|FG000|Overall Study|Death|1|||
156584656|NCT01984346|565225520|FG000|Overall Study|Physician Decision|4|||
156584657|NCT01984346|565225521|FG001|Overall Study|Physician Decision|2|||
156584658|NCT01984346|565225520|FG000|Overall Study|Withdrawal by Subject|2|||
156584659|NCT01984346|565225521|FG001|Overall Study|Withdrawal by Subject|2|||
156584660|NCT01984346|565225520|FG000|Overall Study|Enrollment Closed|8|||
156584661|NCT01984346|565225521|FG001|Overall Study|Enrollment Closed|1|||
156584662|NCT01984346|565225520|FG000|Overall Study|Insurance Coverage|1|||
156584663|NCT01984346|565225521|FG001|Overall Study|Insurance Coverage|0|||
156584664|NCT01984346|565225520|FG000|Overall Study|Intra-operative Exclusion|2|||
156584665|NCT01984346|565225521|FG001|Overall Study|Intra-operative Exclusion|0|||
156584666|NCT04184622|565225522|FG000|Primary Treatment Period|Adverse Event|6|||
156584667|NCT04184622|565225523|FG001|Primary Treatment Period|Adverse Event|4|||
156584668|NCT04184622|565225524|FG002|Primary Treatment Period|Adverse Event|8|||
156584669|NCT04184622|565225525|FG003|Primary Treatment Period|Adverse Event|6|||
156584670|NCT04184622|565225522|FG000|Primary Treatment Period|Death|4|||
156584671|NCT04184622|565225523|FG001|Primary Treatment Period|Death|4|||
156584672|NCT04184622|565225524|FG002|Primary Treatment Period|Death|2|||
156584673|NCT04184622|565225525|FG003|Primary Treatment Period|Death|1|||
156584674|NCT04184622|565225522|FG000|Primary Treatment Period|Lost to Follow-up|41|||
156584675|NCT04184622|565225523|FG001|Primary Treatment Period|Lost to Follow-up|17|||
156584676|NCT04184622|565225524|FG002|Primary Treatment Period|Lost to Follow-up|15|||
156584677|NCT04184622|565225525|FG003|Primary Treatment Period|Lost to Follow-up|13|||
156584678|NCT04184622|565225522|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
156584679|NCT04184622|565225523|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
156584680|NCT04184622|565225524|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
156584681|NCT04184622|565225525|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
156584682|NCT04184622|565225522|FG000|Primary Treatment Period|Physician Decision|0|||
156584683|NCT04184622|565225523|FG001|Primary Treatment Period|Physician Decision|0|||
156584684|NCT04184622|565225524|FG002|Primary Treatment Period|Physician Decision|3|||
156584685|NCT04184622|565225525|FG003|Primary Treatment Period|Physician Decision|1|||
156584686|NCT04184622|565225522|FG000|Primary Treatment Period|Pregnancy|4|||
156584687|NCT04184622|565225523|FG001|Primary Treatment Period|Pregnancy|3|||
156584688|NCT04184622|565225524|FG002|Primary Treatment Period|Pregnancy|4|||
156584689|NCT04184622|565225525|FG003|Primary Treatment Period|Pregnancy|1|||
156584690|NCT04184622|565225522|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
156584691|NCT04184622|565225523|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
156584692|NCT04184622|565225524|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
156584693|NCT04184622|565225525|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
156584694|NCT04184622|565225522|FG000|Additional Treatment Period|Adverse Event|1|||
156584695|NCT04184622|565225523|FG001|Additional Treatment Period|Adverse Event|2|||
156584696|NCT04184622|565225524|FG002|Additional Treatment Period|Adverse Event|1|||
156584697|NCT04184622|565225525|FG003|Additional Treatment Period|Adverse Event|0|||
156584698|NCT04184622|565225522|FG000|Additional Treatment Period|Death|0|||
156584699|NCT04184622|565225523|FG001|Additional Treatment Period|Death|0|||
156584700|NCT04184622|565225524|FG002|Additional Treatment Period|Death|1|||
156863642|NCT00627393|566258731|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
156584701|NCT04184622|565225525|FG003|Additional Treatment Period|Death|1|||
156584702|NCT04184622|565225522|FG000|Additional Treatment Period|Lost to Follow-up|6|||
156584703|NCT04184622|565225523|FG001|Additional Treatment Period|Lost to Follow-up|4|||
156584704|NCT04184622|565225524|FG002|Additional Treatment Period|Lost to Follow-up|8|||
156584705|NCT04184622|565225525|FG003|Additional Treatment Period|Lost to Follow-up|6|||
156584706|NCT04184622|565225522|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
156584707|NCT04184622|565225523|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
156584708|NCT04184622|565225524|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
156584709|NCT04184622|565225525|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
156584710|NCT04184622|565225522|FG000|Additional Treatment Period|Physician Decision|0|||
156584711|NCT04184622|565225523|FG001|Additional Treatment Period|Physician Decision|0|||
156584712|NCT04184622|565225524|FG002|Additional Treatment Period|Physician Decision|1|||
156584713|NCT04184622|565225525|FG003|Additional Treatment Period|Physician Decision|0|||
156584714|NCT04184622|565225522|FG000|Additional Treatment Period|Pregnancy|0|||
156584715|NCT04184622|565225523|FG001|Additional Treatment Period|Pregnancy|0|||
156584716|NCT04184622|565225524|FG002|Additional Treatment Period|Pregnancy|0|||
156584717|NCT04184622|565225525|FG003|Additional Treatment Period|Pregnancy|1|||
156584718|NCT04184622|565225522|FG000|Additional Treatment Period|Protocol deviation|0|||
156584719|NCT04184622|565225523|FG001|Additional Treatment Period|Protocol deviation|0|||
156584720|NCT04184622|565225524|FG002|Additional Treatment Period|Protocol deviation|1|||
156584721|NCT04184622|565225525|FG003|Additional Treatment Period|Protocol deviation|0|||
156584722|NCT04184622|565225522|FG000|Additional Treatment Period|Site closed|1|||
156584723|NCT04184622|565225523|FG001|Additional Treatment Period|Site closed|0|||
156584724|NCT04184622|565225524|FG002|Additional Treatment Period|Site closed|1|||
156584725|NCT04184622|565225525|FG003|Additional Treatment Period|Site closed|0|||
156584726|NCT04184622|565225522|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
156584727|NCT04184622|565225523|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
156584728|NCT04184622|565225524|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
156584729|NCT04184622|565225525|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
156584730|NCT04184622|565225522|FG000|Safety Follow-up Period|Adverse Event|6|||
156584731|NCT04184622|565225523|FG001|Safety Follow-up Period|Adverse Event|8|||
156584732|NCT04184622|565225524|FG002|Safety Follow-up Period|Adverse Event|9|||
156584733|NCT04184622|565225525|FG003|Safety Follow-up Period|Adverse Event|16|||
156584734|NCT04184622|565225522|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
156584735|NCT04184622|565225523|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
156584736|NCT04184622|565225524|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
156584737|NCT04184622|565225525|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
156584738|NCT04184622|565225522|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
156584739|NCT04184622|565225523|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
156584740|NCT04184622|565225524|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
156584741|NCT04184622|565225525|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
156584742|NCT04184622|565225522|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
156584743|NCT04184622|565225523|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
156584744|NCT04184622|565225524|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
156584745|NCT04184622|565225525|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
156584746|NCT04184622|565225522|FG000|Safety Follow-up Period|Physician Decision|1|||
156584747|NCT04184622|565225523|FG001|Safety Follow-up Period|Physician Decision|0|||
156584748|NCT04184622|565225524|FG002|Safety Follow-up Period|Physician Decision|0|||
156584749|NCT04184622|565225525|FG003|Safety Follow-up Period|Physician Decision|1|||
156584750|NCT04184622|565225522|FG000|Safety Follow-up Period|Pregnancy|1|||
156584751|NCT04184622|565225523|FG001|Safety Follow-up Period|Pregnancy|3|||
156584752|NCT04184622|565225524|FG002|Safety Follow-up Period|Pregnancy|0|||
156584753|NCT04184622|565225525|FG003|Safety Follow-up Period|Pregnancy|6|||
156584754|NCT04184622|565225522|FG000|Safety Follow-up Period|Protocol deviation|1|||
156584755|NCT04184622|565225523|FG001|Safety Follow-up Period|Protocol deviation|0|||
156584756|NCT04184622|565225524|FG002|Safety Follow-up Period|Protocol deviation|0|||
156584757|NCT04184622|565225525|FG003|Safety Follow-up Period|Protocol deviation|0|||
156584758|NCT04184622|565225522|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
156584759|NCT04184622|565225523|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
156584760|NCT04184622|565225524|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
156584761|NCT04184622|565225525|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
156584762|NCT02795988|565225526|FG000|Phase 1b|Withdrawal by Subject|0|||
156584763|NCT02795988|565225527|FG001|Phase 1b|Withdrawal by Subject|1|||
156584764|NCT02795988|565225528|FG002|Phase 1b|Withdrawal by Subject|0|||
156584765|NCT02795988|565225529|FG003|Phase 1b|Withdrawal by Subject|0|||
156584766|NCT02795988|565225530|FG004|Phase 1b|Withdrawal by Subject|0|||
156584767|NCT02795988|565225531|FG005|Phase 1b|Withdrawal by Subject|0|||
156584768|NCT02795988|565225532|FG006|Phase 1b|Withdrawal by Subject|0|||
156584769|NCT02795988|565225526|FG000|Phase 1b|Death|1|||
156584770|NCT02795988|565225527|FG001|Phase 1b|Death|2|||
156584771|NCT02795988|565225528|FG002|Phase 1b|Death|1|||
156584772|NCT02795988|565225529|FG003|Phase 1b|Death|0|||
156584773|NCT02795988|565225530|FG004|Phase 1b|Death|0|||
156584774|NCT02795988|565225531|FG005|Phase 1b|Death|0|||
156584775|NCT02795988|565225532|FG006|Phase 1b|Death|0|||
156584776|NCT02795988|565225526|FG000|Phase 1b|Physician Decision|0|||
156584777|NCT02795988|565225527|FG001|Phase 1b|Physician Decision|0|||
156584778|NCT02795988|565225528|FG002|Phase 1b|Physician Decision|1|||
156584779|NCT02795988|565225529|FG003|Phase 1b|Physician Decision|0|||
156584780|NCT02795988|565225530|FG004|Phase 1b|Physician Decision|0|||
156584781|NCT02795988|565225531|FG005|Phase 1b|Physician Decision|0|||
156584782|NCT02795988|565225532|FG006|Phase 1b|Physician Decision|0|||
156584783|NCT02795988|565225526|FG000|Phase 1b|Progressive Disease|2|||
156584784|NCT02795988|565225527|FG001|Phase 1b|Progressive Disease|2|||
156584785|NCT02795988|565225528|FG002|Phase 1b|Progressive Disease|0|||
156584786|NCT02795988|565225529|FG003|Phase 1b|Progressive Disease|0|||
156584787|NCT02795988|565225530|FG004|Phase 1b|Progressive Disease|0|||
156584788|NCT02795988|565225531|FG005|Phase 1b|Progressive Disease|0|||
156584789|NCT02795988|565225532|FG006|Phase 1b|Progressive Disease|0|||
156584790|NCT02795988|565225526|FG000|Phase 2|Withdrawal by Subject|0|||
156584791|NCT02795988|565225527|FG001|Phase 2|Withdrawal by Subject|0|||
156584792|NCT02795988|565225528|FG002|Phase 2|Withdrawal by Subject|0|||
156584793|NCT02795988|565225529|FG003|Phase 2|Withdrawal by Subject|1|||
156584794|NCT02795988|565225530|FG004|Phase 2|Withdrawal by Subject|0|||
156584795|NCT02795988|565225531|FG005|Phase 2|Withdrawal by Subject|0|||
156584796|NCT02795988|565225532|FG006|Phase 2|Withdrawal by Subject|0|||
156584797|NCT02795988|565225526|FG000|Phase 2|Death|0|||
156584798|NCT02795988|565225527|FG001|Phase 2|Death|0|||
156584799|NCT02795988|565225528|FG002|Phase 2|Death|0|||
156584800|NCT02795988|565225529|FG003|Phase 2|Death|17|||
156584801|NCT02795988|565225530|FG004|Phase 2|Death|17|||
156584802|NCT02795988|565225531|FG005|Phase 2|Death|0|||
156584803|NCT02795988|565225532|FG006|Phase 2|Death|0|||
156584804|NCT02795988|565225526|FG000|Phase 2|Other|0|||
156584805|NCT02795988|565225527|FG001|Phase 2|Other|0|||
156584806|NCT02795988|565225528|FG002|Phase 2|Other|0|||
156584807|NCT02795988|565225529|FG003|Phase 2|Other|1|||
156584808|NCT02795988|565225530|FG004|Phase 2|Other|0|||
156584809|NCT02795988|565225531|FG005|Phase 2|Other|0|||
156584810|NCT02795988|565225532|FG006|Phase 2|Other|0|||
156584811|NCT02795988|565225526|FG000|Phase 2 Extension|Death|0|||
156584812|NCT02795988|565225527|FG001|Phase 2 Extension|Death|0|||
156584813|NCT02795988|565225528|FG002|Phase 2 Extension|Death|0|||
156584814|NCT02795988|565225529|FG003|Phase 2 Extension|Death|0|||
156584815|NCT02795988|565225530|FG004|Phase 2 Extension|Death|0|||
156584816|NCT02795988|565225531|FG005|Phase 2 Extension|Death|5|||
156584817|NCT02795988|565225532|FG006|Phase 2 Extension|Death|6|||
156584818|NCT02795988|565225526|FG000|Phase 2 Extension|Other reasons|0|||
156584819|NCT02795988|565225527|FG001|Phase 2 Extension|Other reasons|0|||
156584820|NCT02795988|565225528|FG002|Phase 2 Extension|Other reasons|0|||
156584821|NCT02795988|565225529|FG003|Phase 2 Extension|Other reasons|0|||
156584822|NCT02795988|565225530|FG004|Phase 2 Extension|Other reasons|0|||
156584823|NCT02795988|565225531|FG005|Phase 2 Extension|Other reasons|2|||
156584824|NCT02795988|565225532|FG006|Phase 2 Extension|Other reasons|1|||
156584825|NCT02341014|565225533|FG000|Overall Study|Adverse Event|0|||
156584826|NCT02341014|565225534|FG001|Overall Study|Adverse Event|1|||
156584827|NCT02341014|565225535|FG002|Overall Study|Adverse Event|0|||
156584828|NCT02341014|565225536|FG003|Overall Study|Adverse Event|0|||
156584829|NCT02341014|565225537|FG004|Overall Study|Adverse Event|2|||
156584830|NCT00726323|565225538|FG000|Overall Study|Withdrawal by Subject|3|||
156584831|NCT00726323|565225539|FG001|Overall Study|Withdrawal by Subject|1|||
156584832|NCT00726323|565225538|FG000|Overall Study|Physician Decision|1|||
156584833|NCT00726323|565225539|FG001|Overall Study|Physician Decision|0|||
156584834|NCT00726323|565225538|FG000|Overall Study|Progressive disease|23|||
156584835|NCT00726323|565225539|FG001|Overall Study|Progressive disease|16|||
156584836|NCT00726323|565225538|FG000|Overall Study|Clinical progression|0|||
156584837|NCT00726323|565225539|FG001|Overall Study|Clinical progression|3|||
156584838|NCT00726323|565225538|FG000|Overall Study|Adverse Event|9|||
156584839|NCT00726323|565225539|FG001|Overall Study|Adverse Event|9|||
156584840|NCT00726323|565225538|FG000|Overall Study|Death|1|||
156584841|NCT00726323|565225539|FG001|Overall Study|Death|0|||
156584842|NCT00726323|565225538|FG000|Overall Study|Participant wished to discontinue|0|||
156584843|NCT00726323|565225539|FG001|Overall Study|Participant wished to discontinue|1|||
156584844|NCT00726323|565225538|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
156584845|NCT00726323|565225539|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
156584846|NCT05058664|565225540|FG000|Overall Study|No follow-up data provided|4|||
156584847|NCT05058664|565225541|FG001|Overall Study|No follow-up data provided|0|||
156584848|NCT05058664|565225542|FG002|Overall Study|No follow-up data provided|2|||
156584849|NCT05058664|565225540|FG000|Overall Study|Withdrawal by Subject|0|||
156584850|NCT05058664|565225541|FG001|Overall Study|Withdrawal by Subject|0|||
156584851|NCT05058664|565225542|FG002|Overall Study|Withdrawal by Subject|1|||
156584852|NCT01617681|565225543|FG000|Period 1 Double Blind|Adverse Event|2|||
156584853|NCT01617681|565225544|FG001|Period 1 Double Blind|Adverse Event|0|||
156584854|NCT01617681|565225545|FG002|Period 1 Double Blind|Adverse Event|0|||
156584855|NCT01617681|565225546|FG003|Period 1 Double Blind|Adverse Event|2|||
156584856|NCT01617681|565225547|FG004|Period 1 Double Blind|Adverse Event|0|||
156584857|NCT01617681|565225543|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
156584858|NCT01617681|565225544|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
156584859|NCT01617681|565225545|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
156584860|NCT01617681|565225546|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
156584861|NCT01617681|565225547|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
156584862|NCT01617681|565225543|FG000|Period 2 Open Label|Adverse Event|0|||
156584863|NCT01617681|565225544|FG001|Period 2 Open Label|Adverse Event|0|||
156584864|NCT01617681|565225545|FG002|Period 2 Open Label|Adverse Event|0|||
156584865|NCT01617681|565225546|FG003|Period 2 Open Label|Adverse Event|0|||
156584866|NCT01617681|565225547|FG004|Period 2 Open Label|Adverse Event|3|||
156584867|NCT01617681|565225543|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
156584868|NCT01617681|565225544|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
156584869|NCT01617681|565225545|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
156584870|NCT01617681|565225546|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
156584871|NCT01617681|565225547|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
156584872|NCT00109733|565225555|FG000|Overall Study|Protocol Violation|0|||
156584873|NCT00109733|565225556|FG001|Overall Study|Protocol Violation|1|||
156584874|NCT00109733|565225555|FG000|Overall Study|Stopped taking study drug|1|||
156584875|NCT00109733|565225556|FG001|Overall Study|Stopped taking study drug|1|||
156584876|NCT00109733|565225555|FG000|Overall Study|Non-compliant|0|||
156584877|NCT00109733|565225556|FG001|Overall Study|Non-compliant|1|||
156584878|NCT00109733|565225555|FG000|Overall Study|Could not commit time for study|1|||
156584879|NCT00109733|565225556|FG001|Overall Study|Could not commit time for study|1|||
156584880|NCT00316303|565225565|FG000|Overall Study|Lost to Follow-up|11|||
156584881|NCT00316303|565225566|FG001|Overall Study|Lost to Follow-up|16|||
156584882|NCT03838367|565225567|FG000|Overall Study|Early termination of study|3|||
156584883|NCT03838367|565225568|FG001|Overall Study|Early termination of study|4|||
156584884|NCT03838367|565225569|FG002|Overall Study|Early termination of study|3|||
156584885|NCT03838367|565225570|FG003|Overall Study|Early termination of study|0|||
156584886|NCT03015610|565225573|FG000|Overall Study|Lost to Follow-up|1|||
156584887|NCT03015610|565225574|FG001|Overall Study|Lost to Follow-up|5|||
156584888|NCT02375698|565225578|FG000|Overall Study|Withdrawal by Subject|0|||
156584889|NCT02375698|565225579|FG001|Overall Study|Withdrawal by Subject|2|||
156584890|NCT02375698|565225578|FG000|Overall Study|Physician Decision|2|||
156584891|NCT02375698|565225579|FG001|Overall Study|Physician Decision|0|||
156584892|NCT01595646|565225581|FG000|Overall Study|Withdrawal by Subject|1|||
156584893|NCT01595646|565225582|FG001|Overall Study|Withdrawal by Subject|0|||
156584894|NCT01595646|565225583|FG002|Overall Study|Withdrawal by Subject|0|||
156584895|NCT00751881|565225589|FG000|Core Treatment Period|Not treated|1|||
156584896|NCT00751881|565225590|FG001|Core Treatment Period|Not treated|1|||
156584897|NCT00751881|565225591|FG002|Core Treatment Period|Not treated|2|||
156584898|NCT00751881|565225589|FG000|Core Treatment Period|Adverse Event|26|||
156584899|NCT00751881|565225590|FG001|Core Treatment Period|Adverse Event|54|||
156584900|NCT00751881|565225591|FG002|Core Treatment Period|Adverse Event|58|||
156584901|NCT00751881|565225589|FG000|Core Treatment Period|Lack of Efficacy|37|||
156584902|NCT00751881|565225590|FG001|Core Treatment Period|Lack of Efficacy|30|||
156584903|NCT00751881|565225591|FG002|Core Treatment Period|Lack of Efficacy|20|||
156584904|NCT00751881|565225589|FG000|Core Treatment Period|Poor compliance to protocol|15|||
156584905|NCT00751881|565225590|FG001|Core Treatment Period|Poor compliance to protocol|3|||
156584906|NCT00751881|565225591|FG002|Core Treatment Period|Poor compliance to protocol|4|||
156584907|NCT00751881|565225589|FG000|Core Treatment Period|Lost to Follow-up|6|||
156584908|NCT00751881|565225590|FG001|Core Treatment Period|Lost to Follow-up|4|||
156584909|NCT00751881|565225591|FG002|Core Treatment Period|Lost to Follow-up|3|||
156584910|NCT00751881|565225589|FG000|Core Treatment Period|Other: protocol deviation|3|||
156584911|NCT00751881|565225590|FG001|Core Treatment Period|Other: protocol deviation|3|||
156584912|NCT00751881|565225591|FG002|Core Treatment Period|Other: protocol deviation|7|||
156584913|NCT00751881|565225589|FG000|Core Treatment Period|Other: wish to parent|5|||
156584914|NCT00751881|565225590|FG001|Core Treatment Period|Other: wish to parent|7|||
156584915|NCT00751881|565225591|FG002|Core Treatment Period|Other: wish to parent|4|||
156584916|NCT00751881|565225589|FG000|Core Treatment Period|Other: personal/family constraints|6|||
156584917|NCT00751881|565225590|FG001|Core Treatment Period|Other: personal/family constraints|7|||
156584918|NCT00751881|565225591|FG002|Core Treatment Period|Other: personal/family constraints|10|||
156584919|NCT00751881|565225589|FG000|Core Treatment Period|Other: MS treatment change|6|||
156584920|NCT00751881|565225590|FG001|Core Treatment Period|Other: MS treatment change|4|||
156584921|NCT00751881|565225591|FG002|Core Treatment Period|Other: MS treatment change|4|||
156584922|NCT00751881|565225589|FG000|Core Treatment Period|Other: tolerability complaints|2|||
156584923|NCT00751881|565225590|FG001|Core Treatment Period|Other: tolerability complaints|0|||
156584924|NCT00751881|565225591|FG002|Core Treatment Period|Other: tolerability complaints|0|||
156584925|NCT00751881|565225589|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
156584926|NCT00751881|565225590|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
156584927|NCT00751881|565225591|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
156584928|NCT00751881|565225589|FG000|Extension Study Period|Adverse Event|18|||
156584929|NCT00751881|565225590|FG001|Extension Study Period|Adverse Event|20|||
156584930|NCT00751881|565225591|FG002|Extension Study Period|Adverse Event|21|||
156584931|NCT00751881|565225589|FG000|Extension Study Period|Lack of Efficacy|14|||
156584932|NCT00751881|565225590|FG001|Extension Study Period|Lack of Efficacy|10|||
156584933|NCT00751881|565225591|FG002|Extension Study Period|Lack of Efficacy|20|||
156584934|NCT00751881|565225589|FG000|Extension Study Period|Lost to Follow-up|4|||
156584935|NCT00751881|565225590|FG001|Extension Study Period|Lost to Follow-up|9|||
156584936|NCT00751881|565225591|FG002|Extension Study Period|Lost to Follow-up|6|||
156584937|NCT00751881|565225589|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
156584938|NCT00751881|565225590|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
156584939|NCT00751881|565225591|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
156584940|NCT00751881|565225589|FG000|Extension Study Period|Other than specified above|26|||
156584941|NCT00751881|565225590|FG001|Extension Study Period|Other than specified above|30|||
156584942|NCT00751881|565225591|FG002|Extension Study Period|Other than specified above|18|||
156584943|NCT04770155|565225592|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
156584944|NCT04770155|565225593|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
156584945|NCT04770155|565225594|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
156584946|NCT04770155|565225595|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
156584947|NCT04770155|565225596|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
156584948|NCT04770155|565225597|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
156584949|NCT04770155|565225598|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
156584950|NCT04770155|565225599|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
156584951|NCT01632878|565225600|FG000|Screening|Physician Decision|268|||
156584952|NCT01632878|565225600|FG000|Treatment|Lost to Follow-up|41|||
156584953|NCT01632878|565225600|FG000|Treatment|Withdrawal by Subject|36|||
156584954|NCT01632878|565225600|FG000|Treatment|Physician Decision|34|||
156584955|NCT01632878|565225600|FG000|Treatment|missing information|4|||
156584956|NCT01632878|565225600|FG000|Treatment|no information on study completion|43|||
156584957|NCT03634072|565225601|FG000|Overall Study|Early termination of overall study|1|||
156584958|NCT03634072|565225602|FG001|Overall Study|Early termination of overall study|0|||
156584959|NCT01765764|565225603|FG000|Treatment Period|Adverse Event|1|||
156584960|NCT01765764|565225604|FG001|Treatment Period|Adverse Event|2|||
156584961|NCT01765764|565225605|FG002|Treatment Period|Adverse Event|1|||
156584962|NCT01765764|565225603|FG000|Treatment Period|Lost to Follow-up|0|||
156584963|NCT01765764|565225604|FG001|Treatment Period|Lost to Follow-up|3|||
156584964|NCT01765764|565225605|FG002|Treatment Period|Lost to Follow-up|2|||
156584965|NCT01765764|565225603|FG000|Treatment Period|Personal Reasons|1|||
156584966|NCT01765764|565225604|FG001|Treatment Period|Personal Reasons|2|||
156584967|NCT01765764|565225605|FG002|Treatment Period|Personal Reasons|1|||
156584968|NCT01765764|565225603|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
156584969|NCT01765764|565225604|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
156584970|NCT01765764|565225605|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
156584971|NCT01597193|565225608|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
156584972|NCT01597193|565225609|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
156584973|NCT01597193|565225610|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
156584974|NCT01597193|565225611|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
156584975|NCT01597193|565225612|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
156584976|NCT01597193|565225613|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
156584977|NCT01597193|565225614|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
156584978|NCT01597193|565225608|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
156584979|NCT01597193|565225609|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
156584980|NCT01597193|565225610|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
156584981|NCT01597193|565225611|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
156584982|NCT01597193|565225612|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
156584983|NCT01597193|565225613|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
156584984|NCT01597193|565225614|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
156584985|NCT01597193|565225608|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
156584986|NCT01597193|565225609|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
156584987|NCT01597193|565225610|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
156584988|NCT01597193|565225611|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
156584989|NCT01597193|565225612|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
156584990|NCT01597193|565225613|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
156584991|NCT01597193|565225614|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
156584992|NCT01597193|565225608|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
156584993|NCT01597193|565225609|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
156584994|NCT01597193|565225610|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
156584995|NCT01597193|565225611|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
156584996|NCT01597193|565225612|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
156584997|NCT01597193|565225613|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
156584998|NCT01597193|565225614|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
156584999|NCT01597193|565225608|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
156585000|NCT01597193|565225609|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
156585001|NCT01597193|565225610|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
156585002|NCT01597193|565225611|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
156585003|NCT01597193|565225612|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
156585004|NCT01597193|565225613|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
156585005|NCT01597193|565225614|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
156585006|NCT03184701|565225616|FG000|Overall Study|Death|3|||
156585007|NCT03184701|565225616|FG000|Overall Study|Physician Decision|3|||
156585008|NCT03184701|565225616|FG000|Overall Study|Withdrawal by Subject|6|||
156585009|NCT03184701|565225616|FG000|Overall Study|Lost to Follow-up|5|||
156585010|NCT01259297|565225619|FG000|Double Blind Randomized Period|Death|1|||
156585011|NCT01259297|565225620|FG001|Double Blind Randomized Period|Death|1|||
156585012|NCT01259297|565225621|FG002|Double Blind Randomized Period|Death|1|||
156585013|NCT01259297|565225622|FG003|Double Blind Randomized Period|Death|2|||
156585014|NCT01259297|565225623|FG004|Double Blind Randomized Period|Death|1|||
156585015|NCT01259297|565225624|FG005|Double Blind Randomized Period|Death|5|||
156585016|NCT01259297|565225625|FG006|Double Blind Randomized Period|Death|2|||
156585017|NCT01259297|565225626|FG007|Double Blind Randomized Period|Death|1|||
156585018|NCT01259297|565225619|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
156585019|NCT01259297|565225620|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
156585020|NCT01259297|565225621|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
156585021|NCT01259297|565225622|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
156585022|NCT01259297|565225623|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
156585023|NCT01259297|565225624|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
156585024|NCT01259297|565225625|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
156585025|NCT01259297|565225626|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
156585026|NCT01259297|565225619|FG000|Double Blind Randomized Period|Other reasons|0|||
156585027|NCT01259297|565225620|FG001|Double Blind Randomized Period|Other reasons|1|||
156585028|NCT01259297|565225621|FG002|Double Blind Randomized Period|Other reasons|0|||
156585029|NCT01259297|565225622|FG003|Double Blind Randomized Period|Other reasons|0|||
156585030|NCT01259297|565225623|FG004|Double Blind Randomized Period|Other reasons|1|||
156585031|NCT01259297|565225624|FG005|Double Blind Randomized Period|Other reasons|2|||
156585032|NCT01259297|565225625|FG006|Double Blind Randomized Period|Other reasons|3|||
156585033|NCT01259297|565225626|FG007|Double Blind Randomized Period|Other reasons|1|||
156585034|NCT00705224|565225627|FG000|Overall Study|Adverse Event|1|||
156585035|NCT00705224|565225627|FG000|Overall Study|Lack of Efficacy|2|||
156585036|NCT00705224|565225627|FG000|Overall Study|Withdrawal by Subject|3|||
156585037|NCT00705224|565225627|FG000|Overall Study|Lost to Follow-up|5|||
156585038|NCT03283163|565225628|FG000|Overall Study|Lost to Follow-up|1|||
156585039|NCT03283163|565225628|FG000|Overall Study|other life commitments|6|||
156585040|NCT03283163|565225628|FG000|Overall Study|COVID-19 institution wide halting|1|||
156585041|NCT03283163|565225628|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
156585042|NCT03283163|565225628|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
156585043|NCT02566525|565225629|FG000|Overall Study|Protocol Violation|3|||
156585044|NCT02566525|565225630|FG001|Overall Study|Protocol Violation|5|||
156585045|NCT03141086|565225631|FG000|Overall Study|Study Terminated By Sponsor|1|||
156585046|NCT03141086|565225632|FG001|Overall Study|Study Terminated By Sponsor|1|||
156585047|NCT03141086|565225631|FG000|Overall Study|Withdrawal by Subject|0|||
156585048|NCT03141086|565225632|FG001|Overall Study|Withdrawal by Subject|1|||
156585049|NCT03141086|565225631|FG000|Overall Study|Protocol Violation|0|||
156585050|NCT03141086|565225632|FG001|Overall Study|Protocol Violation|1|||
156585051|NCT03141086|565225631|FG000|Overall Study|Adverse Event|0|||
156585052|NCT03141086|565225632|FG001|Overall Study|Adverse Event|2|||
156585053|NCT00620321|565227397|FG000|Overall Study|Adverse Event|1|||
156585054|NCT00620321|565227398|FG001|Overall Study|Adverse Event|1|||
156585055|NCT00620321|565227397|FG000|Overall Study|Death|1|||
156585056|NCT00620321|565227398|FG001|Overall Study|Death|1|||
156585057|NCT00620321|565227397|FG000|Overall Study|Physician Decision|0|||
156585058|NCT00620321|565227398|FG001|Overall Study|Physician Decision|7|||
156585059|NCT00620321|565227397|FG000|Overall Study|Progressive Disease|5|||
156585060|NCT00620321|565227398|FG001|Overall Study|Progressive Disease|5|||
156585061|NCT00620321|565227397|FG000|Overall Study|Sponsor Decision|0|||
156585062|NCT00620321|565227398|FG001|Overall Study|Sponsor Decision|1|||
156863643|NCT00627393|566258730|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
156585063|NCT00620321|565227397|FG000|Overall Study|Withdrawal by Subject|1|||
156585064|NCT00620321|565227398|FG001|Overall Study|Withdrawal by Subject|1|||
156585065|NCT02410902|565227402|FG000|Overall Study|Adverse Event|2|||
156585066|NCT02410902|565227403|FG001|Overall Study|Adverse Event|3|||
156585067|NCT02410902|565227402|FG000|Overall Study|Lost to Follow-up|4|||
156585068|NCT02410902|565227403|FG001|Overall Study|Lost to Follow-up|1|||
156585069|NCT02410902|565227402|FG000|Overall Study|Protocol Violation|1|||
156585070|NCT02410902|565227403|FG001|Overall Study|Protocol Violation|4|||
156585071|NCT02410902|565227402|FG000|Overall Study|Withdrawal by Subject|6|||
156585072|NCT02410902|565227403|FG001|Overall Study|Withdrawal by Subject|8|||
156585073|NCT02410902|565227402|FG000|Overall Study|Non-Compliance|8|||
156585074|NCT02410902|565227403|FG001|Overall Study|Non-Compliance|2|||
156585075|NCT02279524|565227405|FG000|Overall Study|Withdrawal by Subject|3|||
156585076|NCT02279524|565227406|FG001|Overall Study|Withdrawal by Subject|6|||
156585077|NCT02279524|565227407|FG002|Overall Study|Withdrawal by Subject|3|||
156585078|NCT02279524|565227405|FG000|Overall Study|Adverse Event|4|||
156585079|NCT02279524|565227406|FG001|Overall Study|Adverse Event|3|||
156585080|NCT02279524|565227407|FG002|Overall Study|Adverse Event|2|||
156585081|NCT02279524|565227405|FG000|Overall Study|Lost to Follow-up|1|||
156585082|NCT02279524|565227406|FG001|Overall Study|Lost to Follow-up|1|||
156585083|NCT02279524|565227407|FG002|Overall Study|Lost to Follow-up|0|||
156585084|NCT02279524|565227405|FG000|Overall Study|Disallowed medication|1|||
156585085|NCT02279524|565227406|FG001|Overall Study|Disallowed medication|1|||
156585086|NCT02279524|565227407|FG002|Overall Study|Disallowed medication|2|||
156585087|NCT02279524|565227405|FG000|Overall Study|Bariatric surgery|1|||
156585088|NCT02279524|565227406|FG001|Overall Study|Bariatric surgery|0|||
156585089|NCT02279524|565227407|FG002|Overall Study|Bariatric surgery|0|||
156585090|NCT01746732|565227408|FG000|Lead-In Period|Withdrawal by Subject|1|||
156585091|NCT01746732|565227409|FG001|Lead-In Period|Withdrawal by Subject|0|||
156585092|NCT01746732|565227410|FG002|Lead-In Period|Withdrawal by Subject|0|||
156585093|NCT01746732|565227408|FG000|Period 1|Physician Decision|0|||
156585094|NCT01746732|565227409|FG001|Period 1|Physician Decision|1|||
156585095|NCT01746732|565227410|FG002|Period 1|Physician Decision|0|||
156585096|NCT01746732|565227408|FG000|Period 2|Withdrawal by Subject|0|||
156585097|NCT01746732|565227409|FG001|Period 2|Withdrawal by Subject|0|||
156585098|NCT01746732|565227410|FG002|Period 2|Withdrawal by Subject|2|||
156585099|NCT01746732|565227408|FG000|Period 2|Adverse Event|0|||
156585100|NCT01746732|565227409|FG001|Period 2|Adverse Event|0|||
156585101|NCT01746732|565227410|FG002|Period 2|Adverse Event|1|||
156585102|NCT01746732|565227408|FG000|Period 2|Lost to Follow-up|0|||
156585103|NCT01746732|565227409|FG001|Period 2|Lost to Follow-up|0|||
156585104|NCT01746732|565227410|FG002|Period 2|Lost to Follow-up|1|||
156585105|NCT02817555|565227411|FG000|Overall Study|Death|1|||
156585106|NCT02817555|565227412|FG001|Overall Study|Death|3|||
156585107|NCT02817555|565227411|FG000|Overall Study|moved away|1|||
156585108|NCT02817555|565227412|FG001|Overall Study|moved away|0|||
156585109|NCT02817555|565227411|FG000|Overall Study|transplant|1|||
156585110|NCT02817555|565227412|FG001|Overall Study|transplant|1|||
156585111|NCT02817555|565227411|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
156585112|NCT02817555|565227412|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
156585113|NCT00137436|565227413|FG000|Overall Study|Adverse Event|13|||
156585114|NCT00137436|565227413|FG000|Overall Study|Death|2|||
156585115|NCT00137436|565227413|FG000|Overall Study|Lack of Efficacy|17|||
156585116|NCT00137436|565227413|FG000|Overall Study|Withdrawal by Subject|6|||
156585117|NCT00137436|565227413|FG000|Overall Study|Other|5|||
156585118|NCT00701727|565227414|FG000|First Treatment Period|Adverse Event|0|||
156585119|NCT00701727|565227415|FG001|First Treatment Period|Adverse Event|0|||
156585120|NCT00701727|565227414|FG000|First Treatment Period|Withdrawal by Subject|1|||
156585121|NCT00701727|565227415|FG001|First Treatment Period|Withdrawal by Subject|0|||
156585122|NCT00701727|565227414|FG000|First Treatment Period|sponsor decision|0|||
156585123|NCT00701727|565227415|FG001|First Treatment Period|sponsor decision|1|||
156585124|NCT00701727|565227414|FG000|First Treatment Period|Lost to Follow-up|0|||
156585125|NCT00701727|565227415|FG001|First Treatment Period|Lost to Follow-up|1|||
156585126|NCT00701727|565227414|FG000|Second Treatment Period|Withdrawal by Subject|2|||
156585127|NCT00701727|565227415|FG001|Second Treatment Period|Withdrawal by Subject|0|||
156585128|NCT02090114|565227416|FG000|Overall Study|Withdrawal by Subject|3|||
156585129|NCT02090114|565227417|FG001|Overall Study|Withdrawal by Subject|6|||
156585130|NCT02090114|565227418|FG002|Overall Study|Withdrawal by Subject|2|||
156585131|NCT02090114|565227419|FG003|Overall Study|Withdrawal by Subject|1|||
156585132|NCT02090114|565227416|FG000|Overall Study|Physician Decision|5|||
156585133|NCT02090114|565227417|FG001|Overall Study|Physician Decision|0|||
156585134|NCT02090114|565227418|FG002|Overall Study|Physician Decision|1|||
156585135|NCT02090114|565227419|FG003|Overall Study|Physician Decision|1|||
156585136|NCT02090114|565227416|FG000|Overall Study|Adverse Event|1|||
156585137|NCT02090114|565227417|FG001|Overall Study|Adverse Event|2|||
156585138|NCT02090114|565227418|FG002|Overall Study|Adverse Event|2|||
156585139|NCT02090114|565227419|FG003|Overall Study|Adverse Event|0|||
156585140|NCT02090114|565227416|FG000|Overall Study|Progressive Disease|20|||
156585141|NCT02090114|565227417|FG001|Overall Study|Progressive Disease|21|||
156585142|NCT02090114|565227418|FG002|Overall Study|Progressive Disease|23|||
156585143|NCT02090114|565227419|FG003|Overall Study|Progressive Disease|6|||
156585144|NCT02090114|565227416|FG000|Overall Study|Death|1|||
156585145|NCT02090114|565227417|FG001|Overall Study|Death|0|||
156585146|NCT02090114|565227418|FG002|Overall Study|Death|1|||
156585147|NCT02090114|565227419|FG003|Overall Study|Death|0|||
156585148|NCT00392171|565227420|FG000|Overall Study|Did not meet inclusion criteria|4|||
156585149|NCT00392171|565227420|FG000|Overall Study|Disease progression|101|||
156634892|NCT03917654|565407816|FG001|Year 1|Withdrawal by Subject|0|||
156585150|NCT01605071|565227421|FG000|Overall Study|Withdrawal by Subject|3|||
156585151|NCT01605071|565227422|FG001|Overall Study|Withdrawal by Subject|2|||
156585152|NCT00051558|565227425|FG000|Overall Study|Adverse Event|30|||
156585153|NCT00051558|565227426|FG001|Overall Study|Adverse Event|18|||
156585154|NCT00051558|565227425|FG000|Overall Study|Withdrawal by Subject|29|||
156585155|NCT00051558|565227426|FG001|Overall Study|Withdrawal by Subject|42|||
156585156|NCT00051558|565227425|FG000|Overall Study|Death|9|||
156585157|NCT00051558|565227426|FG001|Overall Study|Death|15|||
156585158|NCT00051558|565227425|FG000|Overall Study|Lost to Follow-up|4|||
156585159|NCT00051558|565227426|FG001|Overall Study|Lost to Follow-up|13|||
156585160|NCT00051558|565227425|FG000|Overall Study|Protocol Violation|3|||
156585161|NCT00051558|565227426|FG001|Overall Study|Protocol Violation|4|||
156585162|NCT00051558|565227425|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
156585163|NCT00051558|565227426|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
156585164|NCT00051558|565227425|FG000|Overall Study|Sponsor Decision|6|||
156585165|NCT00051558|565227426|FG001|Overall Study|Sponsor Decision|1|||
156585166|NCT00051558|565227425|FG000|Overall Study|Other|2|||
156585167|NCT00051558|565227426|FG001|Overall Study|Other|1|||
156585168|NCT00051558|565227425|FG000|Overall Study|Significant Lab Value|2|||
156585169|NCT00051558|565227426|FG001|Overall Study|Significant Lab Value|0|||
156585170|NCT00051558|565227425|FG000|Overall Study|Physician Decision|5|||
156585171|NCT00051558|565227426|FG001|Overall Study|Physician Decision|0|||
156585172|NCT02163993|565227428|FG000|Treatment Period|Adverse Event|0|||
156585173|NCT02163993|565227429|FG001|Treatment Period|Adverse Event|1|||
156585174|NCT02163993|565227430|FG002|Treatment Period|Adverse Event|0|||
156585175|NCT02163993|565227431|FG003|Treatment Period|Adverse Event|0|||
156585176|NCT02163993|565227432|FG004|Treatment Period|Adverse Event|1|||
156585177|NCT02163993|565227428|FG000|Treatment Period|Lost to Follow-up|2|||
156585178|NCT02163993|565227429|FG001|Treatment Period|Lost to Follow-up|3|||
156585179|NCT02163993|565227430|FG002|Treatment Period|Lost to Follow-up|1|||
156585180|NCT02163993|565227431|FG003|Treatment Period|Lost to Follow-up|3|||
156585181|NCT02163993|565227432|FG004|Treatment Period|Lost to Follow-up|1|||
156585182|NCT02163993|565227428|FG000|Treatment Period|Physician Decision|1|||
156585183|NCT02163993|565227429|FG001|Treatment Period|Physician Decision|0|||
156585184|NCT02163993|565227430|FG002|Treatment Period|Physician Decision|0|||
156585185|NCT02163993|565227431|FG003|Treatment Period|Physician Decision|0|||
156585186|NCT02163993|565227432|FG004|Treatment Period|Physician Decision|0|||
156585187|NCT02163993|565227428|FG000|Treatment Period|Protocol Violation|2|||
156585188|NCT02163993|565227429|FG001|Treatment Period|Protocol Violation|1|||
156585189|NCT02163993|565227430|FG002|Treatment Period|Protocol Violation|0|||
156585190|NCT02163993|565227431|FG003|Treatment Period|Protocol Violation|1|||
156585191|NCT02163993|565227432|FG004|Treatment Period|Protocol Violation|2|||
156585192|NCT02163993|565227428|FG000|Treatment Period|Withdrawal by Subject|6|||
156585193|NCT02163993|565227429|FG001|Treatment Period|Withdrawal by Subject|4|||
156585194|NCT02163993|565227430|FG002|Treatment Period|Withdrawal by Subject|1|||
156585195|NCT02163993|565227431|FG003|Treatment Period|Withdrawal by Subject|4|||
156585196|NCT02163993|565227432|FG004|Treatment Period|Withdrawal by Subject|1|||
156585197|NCT02163993|565227428|FG000|Treatment Period|Not treated|1|||
156585198|NCT02163993|565227429|FG001|Treatment Period|Not treated|0|||
156585199|NCT02163993|565227430|FG002|Treatment Period|Not treated|0|||
156585200|NCT02163993|565227431|FG003|Treatment Period|Not treated|1|||
156585201|NCT02163993|565227432|FG004|Treatment Period|Not treated|2|||
156585202|NCT02163993|565227428|FG000|Post-treatment Period|Adverse Event|0|||
156585203|NCT02163993|565227429|FG001|Post-treatment Period|Adverse Event|0|||
156585204|NCT02163993|565227430|FG002|Post-treatment Period|Adverse Event|1|||
156585205|NCT02163993|565227431|FG003|Post-treatment Period|Adverse Event|0|||
156585206|NCT02163993|565227432|FG004|Post-treatment Period|Adverse Event|0|||
156585207|NCT02163993|565227428|FG000|Post-treatment Period|Lost to Follow-up|2|||
156585208|NCT02163993|565227429|FG001|Post-treatment Period|Lost to Follow-up|2|||
156585209|NCT02163993|565227430|FG002|Post-treatment Period|Lost to Follow-up|3|||
156585210|NCT02163993|565227431|FG003|Post-treatment Period|Lost to Follow-up|1|||
156585211|NCT02163993|565227432|FG004|Post-treatment Period|Lost to Follow-up|0|||
156585212|NCT02163993|565227428|FG000|Post-treatment Period|Protocol Violation|0|||
156585213|NCT02163993|565227429|FG001|Post-treatment Period|Protocol Violation|0|||
156585214|NCT02163993|565227430|FG002|Post-treatment Period|Protocol Violation|0|||
156585215|NCT02163993|565227431|FG003|Post-treatment Period|Protocol Violation|0|||
156585216|NCT02163993|565227432|FG004|Post-treatment Period|Protocol Violation|1|||
156585217|NCT02163993|565227428|FG000|Post-treatment Period|Withdrawal by Subject|2|||
156585218|NCT02163993|565227429|FG001|Post-treatment Period|Withdrawal by Subject|4|||
156585219|NCT02163993|565227430|FG002|Post-treatment Period|Withdrawal by Subject|0|||
156585220|NCT02163993|565227431|FG003|Post-treatment Period|Withdrawal by Subject|1|||
156585221|NCT02163993|565227432|FG004|Post-treatment Period|Withdrawal by Subject|2|||
156585222|NCT00414310|565227435|FG000|Overall Study|Not treated|1|||
156585223|NCT00414310|565227436|FG001|Overall Study|Not treated|0|||
156585224|NCT01808118|565227437|FG000|Period 1|Adverse Event|15|||
156585225|NCT01808118|565227438|FG001|Period 1|Adverse Event|0|||
156585226|NCT01808118|565227439|FG002|Period 1|Adverse Event|0|||
156585227|NCT01808118|565227437|FG000|Period 1|Withdrew consent|24|||
156585228|NCT01808118|565227438|FG001|Period 1|Withdrew consent|0|||
156585229|NCT01808118|565227439|FG002|Period 1|Withdrew consent|0|||
156585230|NCT01808118|565227437|FG000|Period 1|Lost to Follow-up|9|||
156585231|NCT01808118|565227438|FG001|Period 1|Lost to Follow-up|0|||
156585232|NCT01808118|565227439|FG002|Period 1|Lost to Follow-up|0|||
156585233|NCT01808118|565227437|FG000|Period 1|Did not meet criteria for remission|303|||
156585234|NCT01808118|565227438|FG001|Period 1|Did not meet criteria for remission|0|||
156585235|NCT01808118|565227439|FG002|Period 1|Did not meet criteria for remission|0|||
156585236|NCT01808118|565227437|FG000|Period 1|Enrolled in error|7|||
156585237|NCT01808118|565227438|FG001|Period 1|Enrolled in error|0|||
156585238|NCT01808118|565227439|FG002|Period 1|Enrolled in error|0|||
156585239|NCT01808118|565227437|FG000|Period 1|Did not meet inclusion criteria|3|||
156585240|NCT01808118|565227438|FG001|Period 1|Did not meet inclusion criteria|0|||
156585241|NCT01808118|565227439|FG002|Period 1|Did not meet inclusion criteria|0|||
156585242|NCT01808118|565227437|FG000|Period 1|Non-conformance with inclusion criteria|3|||
156585243|NCT01808118|565227438|FG001|Period 1|Non-conformance with inclusion criteria|0|||
156585244|NCT01808118|565227439|FG002|Period 1|Non-conformance with inclusion criteria|0|||
156585245|NCT01808118|565227437|FG000|Period 1|Investigator decision: site closure|2|||
156585246|NCT01808118|565227438|FG001|Period 1|Investigator decision: site closure|0|||
156585247|NCT01808118|565227439|FG002|Period 1|Investigator decision: site closure|0|||
156585248|NCT01808118|565227437|FG000|Period 1|Non-compliance per sponsor|1|||
156585249|NCT01808118|565227438|FG001|Period 1|Non-compliance per sponsor|0|||
156585250|NCT01808118|565227439|FG002|Period 1|Non-compliance per sponsor|0|||
156585251|NCT01808118|565227437|FG000|Period 1|Lack of Efficacy|1|||
156585252|NCT01808118|565227438|FG001|Period 1|Lack of Efficacy|0|||
156585253|NCT01808118|565227439|FG002|Period 1|Lack of Efficacy|0|||
156585254|NCT01808118|565227437|FG000|Period 2|Adverse Event|0|||
156585255|NCT01808118|565227438|FG001|Period 2|Adverse Event|4|||
156585256|NCT01808118|565227439|FG002|Period 2|Adverse Event|0|||
156585257|NCT01808118|565227437|FG000|Period 2|Withdrew consent|0|||
156585258|NCT01808118|565227438|FG001|Period 2|Withdrew consent|7|||
156585259|NCT01808118|565227439|FG002|Period 2|Withdrew consent|6|||
156585260|NCT01808118|565227437|FG000|Period 2|Lost to Follow-up|0|||
156585261|NCT01808118|565227438|FG001|Period 2|Lost to Follow-up|0|||
156585262|NCT01808118|565227439|FG002|Period 2|Lost to Follow-up|2|||
156585263|NCT01808118|565227437|FG000|Period 2|Investigator no longer conducting trials|0|||
156585264|NCT01808118|565227438|FG001|Period 2|Investigator no longer conducting trials|1|||
156585265|NCT01808118|565227439|FG002|Period 2|Investigator no longer conducting trials|0|||
156585266|NCT01808118|565227437|FG000|Period 2|Switched to other therapy|0|||
156585267|NCT01808118|565227438|FG001|Period 2|Switched to other therapy|1|||
156585268|NCT01808118|565227439|FG002|Period 2|Switched to other therapy|0|||
156585269|NCT01441440|565227448|FG000|Overall Study|Death|1|||
156585270|NCT01441440|565227449|FG001|Overall Study|Death|0|||
156585271|NCT01441440|565227450|FG002|Overall Study|Death|1|||
156585272|NCT01441440|565227448|FG000|Overall Study|Adverse Event|2|||
156585273|NCT01441440|565227449|FG001|Overall Study|Adverse Event|9|||
156585274|NCT01441440|565227450|FG002|Overall Study|Adverse Event|9|||
156585275|NCT01441440|565227448|FG000|Overall Study|Lost to Follow-up|0|||
156585276|NCT01441440|565227449|FG001|Overall Study|Lost to Follow-up|2|||
156585277|NCT01441440|565227450|FG002|Overall Study|Lost to Follow-up|1|||
156585278|NCT01441440|565227448|FG000|Overall Study|Withdrawal by Subject|11|||
156585279|NCT01441440|565227449|FG001|Overall Study|Withdrawal by Subject|9|||
156585280|NCT01441440|565227450|FG002|Overall Study|Withdrawal by Subject|9|||
156585281|NCT01441440|565227448|FG000|Overall Study|Pregnancy|1|||
156585282|NCT01441440|565227449|FG001|Overall Study|Pregnancy|0|||
156585283|NCT01441440|565227450|FG002|Overall Study|Pregnancy|0|||
156585284|NCT01441440|565227448|FG000|Overall Study|Lack of Efficacy|1|||
156585285|NCT01441440|565227449|FG001|Overall Study|Lack of Efficacy|0|||
156585286|NCT01441440|565227450|FG002|Overall Study|Lack of Efficacy|1|||
156585287|NCT01441440|565227448|FG000|Overall Study|Moving|0|||
156585288|NCT01441440|565227449|FG001|Overall Study|Moving|1|||
156585289|NCT01441440|565227450|FG002|Overall Study|Moving|1|||
156585290|NCT01441440|565227448|FG000|Overall Study|Work-related matter|0|||
156585291|NCT01441440|565227449|FG001|Overall Study|Work-related matter|1|||
156585292|NCT01441440|565227450|FG002|Overall Study|Work-related matter|0|||
156585293|NCT01441440|565227448|FG000|Overall Study|Difficllty in keeping the schedule|1|||
156585294|NCT01441440|565227449|FG001|Overall Study|Difficllty in keeping the schedule|1|||
156585295|NCT01441440|565227450|FG002|Overall Study|Difficllty in keeping the schedule|0|||
156585296|NCT01993329|565227451|FG000|Period 2|Adverse Event|0|||
156585297|NCT01993329|565227452|FG001|Period 2|Adverse Event|0|||
156585298|NCT01993329|565227453|FG002|Period 2|Adverse Event|0|||
156585299|NCT01993329|565227454|FG003|Period 2|Adverse Event|0|||
156585300|NCT01993329|565227455|FG004|Period 2|Adverse Event|0|||
156585301|NCT01993329|565227456|FG005|Period 2|Adverse Event|1|||
156585302|NCT01993329|565227451|FG000|Wash-out|Personal reasons|0|||
156585303|NCT01993329|565227452|FG001|Wash-out|Personal reasons|1|||
156585304|NCT01993329|565227453|FG002|Wash-out|Personal reasons|0|||
156585305|NCT01993329|565227454|FG003|Wash-out|Personal reasons|0|||
156585306|NCT01993329|565227455|FG004|Wash-out|Personal reasons|0|||
156585307|NCT01993329|565227456|FG005|Wash-out|Personal reasons|0|||
156585308|NCT00883558|565227457|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
156585309|NCT00883558|565227458|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
156585310|NCT00883558|565227459|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
156585311|NCT00883558|565227457|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
156585312|NCT00883558|565227458|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
156585313|NCT00883558|565227459|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
156585314|NCT00883558|565227457|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
156585315|NCT00883558|565227458|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
156585316|NCT00883558|565227459|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
156585317|NCT00883558|565227457|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
156585318|NCT00883558|565227458|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
156585319|NCT00883558|565227459|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
156585320|NCT00883558|565227457|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
156585321|NCT00883558|565227458|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
156585322|NCT00883558|565227459|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
156585323|NCT03650452|565227460|FG000|Overall Study|Physician Decision|1|||
156585324|NCT03650452|565227461|FG001|Overall Study|Physician Decision|0|||
156585325|NCT03650452|565227460|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
156585326|NCT03650452|565227461|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156585327|NCT03650452|565227460|FG000|Overall Study|Adverse Event|3|||
156585328|NCT03650452|565227461|FG001|Overall Study|Adverse Event|4|||
156585329|NCT03650452|565227460|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
156585330|NCT03650452|565227461|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
156585331|NCT02042404|565227465|FG000|Overall Study|Death|1|||
156585332|NCT02042404|565227466|FG001|Overall Study|Death|0|||
156585333|NCT02042404|565227465|FG000|Overall Study|Unrelated Adverse Event|3|||
156585334|NCT02042404|565227466|FG001|Overall Study|Unrelated Adverse Event|0|||
156585335|NCT02042404|565227465|FG000|Overall Study|Inability to meet time requirements|1|||
156585336|NCT02042404|565227466|FG001|Overall Study|Inability to meet time requirements|0|||
156585337|NCT03100942|565227467|FG000|Randomized Treatment Period|Withdrew Consent|4|||
156585338|NCT03100942|565227468|FG001|Randomized Treatment Period|Withdrew Consent|5|||
156585339|NCT03100942|565227469|FG002|Randomized Treatment Period|Withdrew Consent|3|||
156585340|NCT03100942|565227470|FG003|Randomized Treatment Period|Withdrew Consent|3|||
156585341|NCT03100942|565227471|FG004|Randomized Treatment Period|Withdrew Consent|0|||
156585342|NCT03100942|565227472|FG005|Randomized Treatment Period|Withdrew Consent|0|||
156585343|NCT03100942|565227473|FG006|Randomized Treatment Period|Withdrew Consent|0|||
156585344|NCT03100942|565227467|FG000|Randomized Treatment Period|Adverse Event|5|||
156585345|NCT03100942|565227468|FG001|Randomized Treatment Period|Adverse Event|2|||
156585346|NCT03100942|565227469|FG002|Randomized Treatment Period|Adverse Event|1|||
156585347|NCT03100942|565227470|FG003|Randomized Treatment Period|Adverse Event|0|||
156585348|NCT03100942|565227471|FG004|Randomized Treatment Period|Adverse Event|0|||
156585349|NCT03100942|565227472|FG005|Randomized Treatment Period|Adverse Event|0|||
156585350|NCT03100942|565227473|FG006|Randomized Treatment Period|Adverse Event|0|||
156585351|NCT03100942|565227467|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
156585352|NCT03100942|565227468|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
156585353|NCT03100942|565227469|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
156585354|NCT03100942|565227470|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
156585355|NCT03100942|565227471|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
156585356|NCT03100942|565227472|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
156585357|NCT03100942|565227473|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
156585358|NCT03100942|565227467|FG000|Randomized Treatment Period|Protocol Violation|0|||
156585359|NCT03100942|565227468|FG001|Randomized Treatment Period|Protocol Violation|1|||
156585360|NCT03100942|565227469|FG002|Randomized Treatment Period|Protocol Violation|1|||
156585361|NCT03100942|565227470|FG003|Randomized Treatment Period|Protocol Violation|1|||
156585362|NCT03100942|565227471|FG004|Randomized Treatment Period|Protocol Violation|0|||
156585363|NCT03100942|565227472|FG005|Randomized Treatment Period|Protocol Violation|0|||
156585364|NCT03100942|565227473|FG006|Randomized Treatment Period|Protocol Violation|0|||
156585365|NCT03100942|565227467|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
156585366|NCT03100942|565227468|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
156585367|NCT03100942|565227469|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
156585368|NCT03100942|565227470|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
156585369|NCT03100942|565227471|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
156585370|NCT03100942|565227472|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
156585371|NCT03100942|565227473|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
156585372|NCT03100942|565227467|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
156585373|NCT03100942|565227468|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
156585374|NCT03100942|565227469|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
156585375|NCT03100942|565227470|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
156634893|NCT03917654|565407817|FG002|Year 1|Withdrawal by Subject|0|||
156585376|NCT03100942|565227471|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
156585377|NCT03100942|565227472|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
156585378|NCT03100942|565227473|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
156585379|NCT03100942|565227467|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
156585380|NCT03100942|565227468|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
156585381|NCT03100942|565227469|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
156585382|NCT03100942|565227470|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
156585383|NCT03100942|565227471|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
156585384|NCT03100942|565227472|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
156585385|NCT03100942|565227473|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
156585386|NCT01876732|565227478|FG000|Overall Study|MMA was not over 800mg/dL|75|||
156585387|NCT00536731|565227479|FG000|Overall Study|Adverse Event|3|||
156585388|NCT00536731|565227480|FG001|Overall Study|Adverse Event|2|||
156585389|NCT00536731|565227481|FG002|Overall Study|Adverse Event|3|||
156585390|NCT00536731|565227479|FG000|Overall Study|Withdrawal by Subject|0|||
156585391|NCT00536731|565227480|FG001|Overall Study|Withdrawal by Subject|2|||
156585392|NCT00536731|565227481|FG002|Overall Study|Withdrawal by Subject|0|||
156585393|NCT00536731|565227479|FG000|Overall Study|Intake of prohibited conc. medication|0|||
156585394|NCT00536731|565227480|FG001|Overall Study|Intake of prohibited conc. medication|0|||
156585395|NCT00536731|565227481|FG002|Overall Study|Intake of prohibited conc. medication|1|||
156585396|NCT00536731|565227479|FG000|Overall Study|Safety reasons|0|||
156585397|NCT00536731|565227480|FG001|Overall Study|Safety reasons|0|||
156585398|NCT00536731|565227481|FG002|Overall Study|Safety reasons|1|||
156585399|NCT00536731|565227479|FG000|Overall Study|Other|1|||
156585400|NCT00536731|565227480|FG001|Overall Study|Other|1|||
156585401|NCT00536731|565227481|FG002|Overall Study|Other|0|||
156585402|NCT00718419|565227482|FG000|Overall Study|Adverse Event|2|||
156585403|NCT00718419|565227483|FG001|Overall Study|Adverse Event|1|||
156585404|NCT00718419|565227482|FG000|Overall Study|Physician Decision|1|||
156585405|NCT00718419|565227483|FG001|Overall Study|Physician Decision|6|||
156585406|NCT00718419|565227482|FG000|Overall Study|Sponsor decision|0|||
156585407|NCT00718419|565227483|FG001|Overall Study|Sponsor decision|1|||
156585408|NCT00718419|565227482|FG000|Overall Study|Withdrawal by Subject|0|||
156585409|NCT00718419|565227483|FG001|Overall Study|Withdrawal by Subject|5|||
156585410|NCT00718419|565227482|FG000|Overall Study|Progressive Disease|7|||
156585411|NCT00718419|565227483|FG001|Overall Study|Progressive Disease|25|||
156585412|NCT00718419|565227482|FG000|Overall Study|Death Due to Progressive Disease|2|||
156585413|NCT00718419|565227483|FG001|Overall Study|Death Due to Progressive Disease|0|||
156585414|NCT00718419|565227482|FG000|Overall Study|Death Due to Study Drug Related|0|||
156585415|NCT00718419|565227483|FG001|Overall Study|Death Due to Study Drug Related|1|||
156585416|NCT00718419|565227482|FG000|Overall Study|Death Due to Adverse Events|1|||
156585417|NCT00718419|565227483|FG001|Overall Study|Death Due to Adverse Events|0|||
156585418|NCT01675531|565227486|FG000|Overall Study|Adverse Event|9|||
156585419|NCT01675531|565227486|FG000|Overall Study|Withdrawal by Subject|7|||
156585420|NCT01675531|565227486|FG000|Overall Study|Lack of Efficacy|1|||
156585421|NCT01675531|565227486|FG000|Overall Study|Protocol Violation|8|||
156585422|NCT00630812|565227491|FG000|Randomisation to First Dose|Adverse Event|1|||
156585423|NCT00630812|565227492|FG001|Randomisation to First Dose|Adverse Event|1|||
156585424|NCT00630812|565227491|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
156585425|NCT00630812|565227492|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
156585426|NCT00630812|565227491|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
156585427|NCT00630812|565227492|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
156585428|NCT00630812|565227491|FG000|Randomisation to First Dose|Protocol Violation|4|||
156585429|NCT00630812|565227492|FG001|Randomisation to First Dose|Protocol Violation|1|||
156585430|NCT00630812|565227491|FG000|Double Blind Treatment Period|Adverse Event|13|||
156585431|NCT00630812|565227492|FG001|Double Blind Treatment Period|Adverse Event|5|||
156585432|NCT00630812|565227491|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
156585433|NCT00630812|565227492|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
156585434|NCT00630812|565227491|FG000|Double Blind Treatment Period|Physician Decision|2|||
156585435|NCT00630812|565227492|FG001|Double Blind Treatment Period|Physician Decision|1|||
156585436|NCT00630812|565227491|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156585437|NCT00630812|565227492|FG001|Double Blind Treatment Period|Protocol Violation|0|||
156585438|NCT00630812|565227491|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
156585439|NCT00630812|565227492|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
156585440|NCT00630812|565227491|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
156585441|NCT00630812|565227492|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
156585442|NCT00630812|565227491|FG000|Double Blind Treatment Period|Non-compliance|0|||
156585443|NCT00630812|565227492|FG001|Double Blind Treatment Period|Non-compliance|1|||
156585444|NCT00972478|565227493|FG000|Overall Study|Adverse Event|3|||
156585445|NCT00972478|565227494|FG001|Overall Study|Adverse Event|16|||
156585446|NCT00972478|565227493|FG000|Overall Study|Withdrawal by Subject|1|||
156585447|NCT00972478|565227494|FG001|Overall Study|Withdrawal by Subject|8|||
156585448|NCT00972478|565227493|FG000|Overall Study|Progression/Relapse|0|||
156585449|NCT00972478|565227494|FG001|Overall Study|Progression/Relapse|2|||
156585450|NCT00972478|565227493|FG000|Overall Study|Death|0|||
156585451|NCT00972478|565227494|FG001|Overall Study|Death|2|||
156585452|NCT00972478|565227493|FG000|Overall Study|Not protocol specified|1|||
156585453|NCT00972478|565227494|FG001|Overall Study|Not protocol specified|1|||
156585454|NCT00972478|565227493|FG000|Overall Study|Ineligible|1|||
156585455|NCT00972478|565227494|FG001|Overall Study|Ineligible|7|||
156585456|NCT00972478|565227493|FG000|Overall Study|Not start protocol treatment|1|||
156585457|NCT00972478|565227494|FG001|Overall Study|Not start protocol treatment|2|||
156585458|NCT02561000|565227495|FG000|Overall Study|Withdrawal by Subject|2|||
156585459|NCT02561000|565227496|FG001|Overall Study|Withdrawal by Subject|3|||
156585460|NCT02561000|565227497|FG002|Overall Study|Withdrawal by Subject|0|||
156585461|NCT02561000|565227495|FG000|Overall Study|Adverse Event|0|||
156585462|NCT02561000|565227496|FG001|Overall Study|Adverse Event|1|||
156585463|NCT02561000|565227497|FG002|Overall Study|Adverse Event|0|||
156585464|NCT01234402|565227498|FG000|Overall Study|Lost to Follow-up|0|||
156585465|NCT01234402|565227499|FG001|Overall Study|Lost to Follow-up|1|||
156585466|NCT01234402|565227500|FG002|Overall Study|Lost to Follow-up|3|||
156585467|NCT01234402|565227498|FG000|Overall Study|Withdrawal by Subject|1|||
156585468|NCT01234402|565227499|FG001|Overall Study|Withdrawal by Subject|3|||
156585469|NCT01234402|565227500|FG002|Overall Study|Withdrawal by Subject|4|||
156585470|NCT01234402|565227498|FG000|Overall Study|Never treated: Death|0|||
156585471|NCT01234402|565227499|FG001|Overall Study|Never treated: Death|0|||
156585472|NCT01234402|565227500|FG002|Overall Study|Never treated: Death|1|||
156585473|NCT01234402|565227498|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
156585474|NCT01234402|565227499|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
156585475|NCT01234402|565227500|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
156585476|NCT01234402|565227498|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
156585477|NCT01234402|565227499|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
156585478|NCT01234402|565227500|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
156585479|NCT02280291|565227502|FG000|Overall Study|Lost to Follow-up|2|||
156585480|NCT02280291|565227503|FG001|Overall Study|Lost to Follow-up|1|||
156585481|NCT02280291|565227504|FG002|Overall Study|Lost to Follow-up|3|||
156585482|NCT02280291|565227505|FG003|Overall Study|Lost to Follow-up|8|||
156585483|NCT02280291|565227502|FG000|Overall Study|Protocol Violation|1|||
156585484|NCT02280291|565227503|FG001|Overall Study|Protocol Violation|0|||
156585485|NCT02280291|565227504|FG002|Overall Study|Protocol Violation|0|||
156585486|NCT02280291|565227505|FG003|Overall Study|Protocol Violation|0|||
156585487|NCT02280291|565227502|FG000|Overall Study|Other|1|||
156585488|NCT02280291|565227503|FG001|Overall Study|Other|1|||
156585489|NCT02280291|565227504|FG002|Overall Study|Other|0|||
156585490|NCT02280291|565227505|FG003|Overall Study|Other|0|||
156585491|NCT00506077|565227507|FG000|Treatment Period 1|Adverse Event|2|||
156585492|NCT00506077|565227508|FG001|Treatment Period 1|Adverse Event|1|||
156585493|NCT00506077|565227507|FG000|Treatment Period 1|Lost to Follow-up|0|||
156585494|NCT00506077|565227508|FG001|Treatment Period 1|Lost to Follow-up|2|||
156585495|NCT00506077|565227507|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156585496|NCT00506077|565227508|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156585497|NCT00506077|565227507|FG000|Treatment Period 2|Adverse Event|0|||
156585498|NCT00506077|565227508|FG001|Treatment Period 2|Adverse Event|1|||
156585499|NCT00506077|565227507|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156585500|NCT00506077|565227508|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156585501|NCT02918266|565227509|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
156585502|NCT02918266|565227510|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156585503|NCT02918266|565227511|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156585504|NCT02918266|565227512|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156585505|NCT02918266|565227513|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156585506|NCT02918266|565227514|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156585507|NCT02918266|565227515|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
156585508|NCT02918266|565227516|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156585509|NCT02918266|565227517|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
156585510|NCT02918266|565227518|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156585511|NCT02918266|565227519|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156585512|NCT01293032|565227520|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
156585513|NCT01293032|565227521|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
156585514|NCT01293032|565227522|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
156585515|NCT01293032|565227523|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
156585516|NCT01293032|565227520|FG000|Treatment|Adverse Event|0|||
156585517|NCT01293032|565227521|FG001|Treatment|Adverse Event|0|||
156585518|NCT01293032|565227522|FG002|Treatment|Adverse Event|1|||
156585519|NCT01293032|565227523|FG003|Treatment|Adverse Event|1|||
156585520|NCT01293032|565227520|FG000|Treatment|Withdrawal by Subject|2|||
156585521|NCT01293032|565227521|FG001|Treatment|Withdrawal by Subject|4|||
156585522|NCT01293032|565227522|FG002|Treatment|Withdrawal by Subject|0|||
156585523|NCT01293032|565227523|FG003|Treatment|Withdrawal by Subject|0|||
156585524|NCT01293032|565227520|FG000|Treatment|Disease Progression, relapse|0|||
156585525|NCT01293032|565227521|FG001|Treatment|Disease Progression, relapse|1|||
156585526|NCT01293032|565227522|FG002|Treatment|Disease Progression, relapse|0|||
156585527|NCT01293032|565227523|FG003|Treatment|Disease Progression, relapse|0|||
156585528|NCT01106534|565227524|FG000|Overall Study|Withdrawal by Subject|18|||
156585529|NCT01106534|565227524|FG000|Overall Study|Lost to Follow-up|2|||
156585530|NCT01106534|565227524|FG000|Overall Study|Death|16|||
156585531|NCT01106534|565227524|FG000|Overall Study|Physician Decision|1|||
156585532|NCT01603641|565227525|FG000|Overall Study|Did not Receive Treatment|3|||
156585533|NCT01603641|565227525|FG000|Overall Study|Adverse Event|1|||
156585534|NCT01603641|565227525|FG000|Overall Study|Lack of Efficacy|1|||
156585535|NCT01603641|565227525|FG000|Overall Study|Lost to Follow-up|6|||
156585536|NCT01603641|565227525|FG000|Overall Study|Personal Reasons|18|||
156585537|NCT01603641|565227525|FG000|Overall Study|Other Miscellaneous Reasons|6|||
156585538|NCT00114972|565227526|FG000|Overall Study|Withdrawal by Subject|40|||
156585539|NCT00114972|565227527|FG001|Overall Study|Withdrawal by Subject|7|||
156585540|NCT00114972|565227526|FG000|Overall Study|Lost to Follow-up|8|||
156585541|NCT00114972|565227527|FG001|Overall Study|Lost to Follow-up|5|||
156585542|NCT00358917|565227528|FG000|Overall Study|Adverse Event|14|||
156585543|NCT00358917|565227529|FG001|Overall Study|Adverse Event|21|||
156585544|NCT00358917|565227528|FG000|Overall Study|Withdrawal by Subject|5|||
156585545|NCT00358917|565227529|FG001|Overall Study|Withdrawal by Subject|7|||
156585546|NCT00358917|565227528|FG000|Overall Study|Lost to Follow-up|20|||
156585547|NCT00358917|565227529|FG001|Overall Study|Lost to Follow-up|17|||
156585548|NCT00358917|565227528|FG000|Overall Study|Noncompliance|12|||
156585549|NCT00358917|565227529|FG001|Overall Study|Noncompliance|11|||
156585550|NCT00358917|565227528|FG000|Overall Study|Death|2|||
156585551|NCT00358917|565227529|FG001|Overall Study|Death|3|||
156585552|NCT00358917|565227528|FG000|Overall Study|Virologic failure|11|||
156585553|NCT00358917|565227529|FG001|Overall Study|Virologic failure|8|||
156585554|NCT00358917|565227528|FG000|Overall Study|Unable to Continue Participation|2|||
156585555|NCT00358917|565227529|FG001|Overall Study|Unable to Continue Participation|2|||
156585556|NCT01555463|565227535|FG000|Treatment|Adverse Event|6|||
156585557|NCT01555463|565227536|FG001|Treatment|Adverse Event|12|||
156585558|NCT01555463|565227535|FG000|Treatment|Withdrawal by Subject|24|||
156585559|NCT01555463|565227536|FG001|Treatment|Withdrawal by Subject|36|||
156585560|NCT01555463|565227535|FG000|Treatment|Lost to Follow-up|28|||
156585561|NCT01555463|565227536|FG001|Treatment|Lost to Follow-up|23|||
156585562|NCT01555463|565227535|FG000|Treatment|Protocol Violation|4|||
156585563|NCT01555463|565227536|FG001|Treatment|Protocol Violation|5|||
156585564|NCT01555463|565227535|FG000|Treatment|Other reason|2|||
156585565|NCT01555463|565227536|FG001|Treatment|Other reason|3|||
156585566|NCT01555463|565227535|FG000|Follow up|Adverse Event|2|||
156585567|NCT01555463|565227536|FG001|Follow up|Adverse Event|5|||
156585568|NCT01555463|565227535|FG000|Follow up|Death|0|||
156585569|NCT01555463|565227536|FG001|Follow up|Death|1|||
156585570|NCT01555463|565227535|FG000|Follow up|Withdrawal by Subject|22|||
156585571|NCT01555463|565227536|FG001|Follow up|Withdrawal by Subject|22|||
156585572|NCT01555463|565227535|FG000|Follow up|Lost to Follow-up|9|||
156585573|NCT01555463|565227536|FG001|Follow up|Lost to Follow-up|10|||
156585574|NCT01555463|565227535|FG000|Follow up|Protocol Violation|2|||
156585575|NCT01555463|565227536|FG001|Follow up|Protocol Violation|4|||
156585576|NCT01555463|565227535|FG000|Follow up|Other reason|3|||
156585577|NCT01555463|565227536|FG001|Follow up|Other reason|3|||
156585578|NCT01165203|565227537|FG000|Active Phase|Serious Adverse Event|1|||
156585579|NCT01165203|565227538|FG001|Active Phase|Serious Adverse Event|0|||
156585580|NCT01165203|565227537|FG000|Active Phase|Withdrawal by Subject|2|||
156585581|NCT01165203|565227538|FG001|Active Phase|Withdrawal by Subject|1|||
156585582|NCT01165203|565227537|FG000|Active Phase|Migrated/moved from study area|0|||
156585583|NCT01165203|565227538|FG001|Active Phase|Migrated/moved from study area|1|||
156585584|NCT01165203|565227537|FG000|Active Phase|Lost to Follow-up|2|||
156585585|NCT01165203|565227538|FG001|Active Phase|Lost to Follow-up|0|||
156585586|NCT01165203|565227537|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
156585587|NCT01165203|565227538|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
156585588|NCT01165203|565227537|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
156585589|NCT01165203|565227538|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
156585590|NCT01165203|565227537|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
156585591|NCT01165203|565227538|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
156585592|NCT01165203|565227537|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
156585593|NCT01165203|565227538|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
156585594|NCT01165203|565227537|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
156585595|NCT01165203|565227538|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
156585596|NCT02815397|565227542|FG000|Overall Study|Physician Decision|2|||
156585597|NCT00085540|565227543|FG000|Overall Study|Withdrawal by Subject|0|||
156585598|NCT00085540|565227544|FG001|Overall Study|Withdrawal by Subject|1|||
156585599|NCT00085540|565227543|FG000|Overall Study|Protocol Violation|0|||
156585600|NCT00085540|565227544|FG001|Overall Study|Protocol Violation|1|||
156585601|NCT01605396|565227547|FG000|Overall Study|Adverse Event|5|||
156585602|NCT01605396|565227548|FG001|Overall Study|Adverse Event|3|||
156585603|NCT01605396|565227547|FG000|Overall Study|Lost to Follow-up|1|||
156585604|NCT01605396|565227548|FG001|Overall Study|Lost to Follow-up|0|||
156585605|NCT01605396|565227547|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156585606|NCT01605396|565227548|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156585607|NCT01605396|565227547|FG000|Overall Study|Physician Decision|2|||
156585608|NCT01605396|565227548|FG001|Overall Study|Physician Decision|2|||
156585609|NCT01605396|565227547|FG000|Overall Study|Progressive Disease|23|||
156585610|NCT01605396|565227548|FG001|Overall Study|Progressive Disease|27|||
156585611|NCT01605396|565227547|FG000|Overall Study|Withdrawal by Subject|4|||
156585612|NCT01605396|565227548|FG001|Overall Study|Withdrawal by Subject|2|||
156585613|NCT01605396|565227547|FG000|Overall Study|Transfer Off Study|4|||
156585614|NCT01605396|565227548|FG001|Overall Study|Transfer Off Study|5|||
156585615|NCT04598165|565227549|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
156585616|NCT04598165|565227550|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
156585617|NCT04598165|565227549|FG000|Completed 6-week Follow-up|Death|2|||
156585618|NCT04598165|565227550|FG001|Completed 6-week Follow-up|Death|1|||
156585619|NCT04598165|565227549|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
156585620|NCT04598165|565227550|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
156585621|NCT04598165|565227549|FG000|Completed 6-week Follow-up|Ineligible|4|||
156585622|NCT04598165|565227550|FG001|Completed 6-week Follow-up|Ineligible|3|||
156585623|NCT04598165|565227549|FG000|Completed 6-week Follow-up|Partner refusal|0|||
156585624|NCT04598165|565227550|FG001|Completed 6-week Follow-up|Partner refusal|1|||
156585625|NCT04598165|565227549|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
156585626|NCT04598165|565227550|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
156585627|NCT00426751|565227553|FG000|Overall Study|Adverse Event|8|||
156585628|NCT00426751|565227554|FG001|Overall Study|Adverse Event|1|||
156585629|NCT00426751|565227553|FG000|Overall Study|Lost to Follow-up|7|||
156585630|NCT00426751|565227554|FG001|Overall Study|Lost to Follow-up|6|||
156585631|NCT00426751|565227553|FG000|Overall Study|Consent Withdrawn|0|||
156585632|NCT00426751|565227554|FG001|Overall Study|Consent Withdrawn|1|||
156585633|NCT00426751|565227553|FG000|Overall Study|Other Reasons|7|||
156585634|NCT00426751|565227554|FG001|Overall Study|Other Reasons|12|||
156585635|NCT01413178|565227555|FG000|Overall Study|Toxicity|1|||
156585636|NCT01413178|565227556|FG001|Overall Study|Toxicity|0|||
156585637|NCT01413178|565227555|FG000|Overall Study|Ineligible|0|||
156585638|NCT01413178|565227556|FG001|Overall Study|Ineligible|2|||
156585639|NCT00576693|565227557|FG000|Overall Study|Lost to Follow-up|7|||
156585640|NCT00576693|565227558|FG001|Overall Study|Lost to Follow-up|11|||
156585641|NCT00576693|565227557|FG000|Overall Study|Withdrawal by Subject|3|||
156585642|NCT00576693|565227558|FG001|Overall Study|Withdrawal by Subject|13|||
156585643|NCT04238663|565227559|FG000|Overall Study|Lost to Follow-up|0|||
156585644|NCT04238663|565227560|FG001|Overall Study|Lost to Follow-up|1|||
156585645|NCT04238663|565227561|FG002|Overall Study|Lost to Follow-up|0|||
156585646|NCT00337467|565227562|FG000|Overall Study|Adverse Event|3|||
156585647|NCT00337467|565227562|FG000|Overall Study|Subject Withdrew Consent|2|||
156585648|NCT00337467|565227562|FG000|Overall Study|Pregnancy|1|||
156585649|NCT00337467|565227562|FG000|Overall Study|Lost to Follow-up|2|||
156585650|NCT00337467|565227562|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
156585651|NCT04430582|565227566|FG000|Overall Study|Found to meet exclusionary criteria|1|||
156585652|NCT04430582|565227567|FG001|Overall Study|Found to meet exclusionary criteria|0|||
156585653|NCT04430582|565227566|FG000|Overall Study|Withdrawal by Subject|0|||
156585654|NCT04430582|565227567|FG001|Overall Study|Withdrawal by Subject|1|||
156585655|NCT03607682|565227568|FG000|Overall Study|Withdrawal by Subject|1|||
156585656|NCT03607682|565227568|FG000|Overall Study|Disease progression|1|||
156585657|NCT01770353|565227569|FG000|Overall Study|Progressive disease|2|||
156585658|NCT01770353|565227570|FG001|Overall Study|Progressive disease|1|||
156585659|NCT01770353|565227569|FG000|Overall Study|Adverse Event|0|||
156585660|NCT01770353|565227570|FG001|Overall Study|Adverse Event|1|||
156585661|NCT01770353|565227569|FG000|Overall Study|Protocol Violation|1|||
156585662|NCT01770353|565227570|FG001|Overall Study|Protocol Violation|0|||
156585663|NCT01770353|565227569|FG000|Overall Study|Physician Decision|0|||
156585664|NCT01770353|565227570|FG001|Overall Study|Physician Decision|3|||
156585665|NCT01770353|565227569|FG000|Overall Study|Clinical deterioration|3|||
156585666|NCT01770353|565227570|FG001|Overall Study|Clinical deterioration|6|||
156585667|NCT01770353|565227569|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
156585668|NCT01770353|565227570|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
156585669|NCT05128162|565227571|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
156585670|NCT05128162|565227571|FG000|Overall Study|Physician Decision|1|||
156585671|NCT00912015|565228845|FG000|Overall Study|Lack of Efficacy|1|||
156585672|NCT00912015|565228846|FG001|Overall Study|Lack of Efficacy|0|||
156585673|NCT00912015|565228847|FG002|Overall Study|Lack of Efficacy|0|||
156585674|NCT00912015|565228848|FG003|Overall Study|Lack of Efficacy|0|||
156585675|NCT00912015|565228845|FG000|Overall Study|Withdrawal by Subject|8|||
156585676|NCT00912015|565228846|FG001|Overall Study|Withdrawal by Subject|8|||
156585677|NCT00912015|565228847|FG002|Overall Study|Withdrawal by Subject|3|||
156585678|NCT00912015|565228848|FG003|Overall Study|Withdrawal by Subject|0|||
156585679|NCT00912015|565228845|FG000|Overall Study|Protocol Violation|1|||
156585680|NCT00912015|565228846|FG001|Overall Study|Protocol Violation|0|||
156585681|NCT00912015|565228847|FG002|Overall Study|Protocol Violation|0|||
156585682|NCT00912015|565228848|FG003|Overall Study|Protocol Violation|1|||
156585683|NCT00912015|565228845|FG000|Overall Study|Adverse Event|6|||
156585684|NCT00912015|565228846|FG001|Overall Study|Adverse Event|0|||
156585685|NCT00912015|565228847|FG002|Overall Study|Adverse Event|0|||
156585686|NCT00912015|565228848|FG003|Overall Study|Adverse Event|1|||
156585687|NCT05137041|565228851|FG000|Overall Study|Lost to Follow-up|1|||
156585688|NCT05137041|565228852|FG001|Overall Study|Lost to Follow-up|1|||
156585689|NCT05137041|565228851|FG000|Overall Study|Withdrawal by Subject|0|||
156585690|NCT05137041|565228852|FG001|Overall Study|Withdrawal by Subject|2|||
156585691|NCT05137041|565228851|FG000|Overall Study|Reason not Specified|0|||
156585692|NCT05137041|565228852|FG001|Overall Study|Reason not Specified|1|||
156585693|NCT01881620|565228854|FG000|Overall Study|Protocol Violation|4|||
156585694|NCT00879814|565228855|FG000|Overall Study|Adverse Event|0|||
156585695|NCT00879814|565228856|FG001|Overall Study|Adverse Event|1|||
156585696|NCT00879814|565228857|FG002|Overall Study|Adverse Event|0|||
156585697|NCT00879814|565228858|FG003|Overall Study|Adverse Event|0|||
156585698|NCT00879814|565228855|FG000|Overall Study|Lost to Follow-up|1|||
156585699|NCT00879814|565228856|FG001|Overall Study|Lost to Follow-up|0|||
156585700|NCT00879814|565228857|FG002|Overall Study|Lost to Follow-up|0|||
156585701|NCT00879814|565228858|FG003|Overall Study|Lost to Follow-up|2|||
156585702|NCT00879814|565228855|FG000|Overall Study|Participant Failed to Return|0|||
156585703|NCT00879814|565228856|FG001|Overall Study|Participant Failed to Return|0|||
156585704|NCT00879814|565228857|FG002|Overall Study|Participant Failed to Return|0|||
156585705|NCT00879814|565228858|FG003|Overall Study|Participant Failed to Return|1|||
156585706|NCT00879814|565228855|FG000|Overall Study|Withdrawal by Subject|3|||
156585707|NCT00879814|565228856|FG001|Overall Study|Withdrawal by Subject|1|||
156585708|NCT00879814|565228857|FG002|Overall Study|Withdrawal by Subject|1|||
156585709|NCT00879814|565228858|FG003|Overall Study|Withdrawal by Subject|2|||
156585710|NCT00879814|565228855|FG000|Overall Study|Physician Decision|0|||
156585711|NCT00879814|565228856|FG001|Overall Study|Physician Decision|0|||
156585712|NCT00879814|565228857|FG002|Overall Study|Physician Decision|1|||
156585713|NCT00879814|565228858|FG003|Overall Study|Physician Decision|0|||
156585714|NCT00879814|565228855|FG000|Overall Study|Other|0|||
156585715|NCT00879814|565228856|FG001|Overall Study|Other|0|||
156585716|NCT00879814|565228857|FG002|Overall Study|Other|1|||
156585717|NCT00879814|565228858|FG003|Overall Study|Other|0|||
156585718|NCT02985450|565228870|FG000|Overall Study|Lost to Follow-up|7|||
156585719|NCT00069576|565228871|FG000|Original Trial|Lost to Follow-up|25|||
156585720|NCT00069576|565228872|FG001|Original Trial|Lost to Follow-up|33|||
156585721|NCT00069576|565228871|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
156585722|NCT00069576|565228872|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
156585723|NCT00905307|565228873|FG000|Overall Study|Switched to Open Label Rescue|7|||
156585724|NCT00905307|565228874|FG001|Overall Study|Switched to Open Label Rescue|17|||
156585725|NCT00905307|565228875|FG002|Overall Study|Switched to Open Label Rescue|11|||
156585726|NCT00905307|565228876|FG003|Overall Study|Switched to Open Label Rescue|11|||
156585727|NCT00905307|565228877|FG004|Overall Study|Switched to Open Label Rescue|4|||
156585728|NCT00905307|565228878|FG005|Overall Study|Switched to Open Label Rescue|15|||
156585729|NCT00905307|565228873|FG000|Overall Study|Lost to Follow-up|0|||
156585730|NCT00905307|565228874|FG001|Overall Study|Lost to Follow-up|0|||
156585731|NCT00905307|565228875|FG002|Overall Study|Lost to Follow-up|0|||
156585732|NCT00905307|565228876|FG003|Overall Study|Lost to Follow-up|0|||
156585733|NCT00905307|565228877|FG004|Overall Study|Lost to Follow-up|1|||
156585734|NCT00905307|565228878|FG005|Overall Study|Lost to Follow-up|1|||
156585735|NCT00905307|565228873|FG000|Overall Study|Adverse Event|3|||
156585736|NCT00905307|565228874|FG001|Overall Study|Adverse Event|4|||
156585737|NCT00905307|565228875|FG002|Overall Study|Adverse Event|5|||
156585738|NCT00905307|565228876|FG003|Overall Study|Adverse Event|11|||
156585739|NCT00905307|565228877|FG004|Overall Study|Adverse Event|3|||
156585740|NCT00905307|565228878|FG005|Overall Study|Adverse Event|5|||
156585741|NCT00905307|565228873|FG000|Overall Study|Withdrawal by Subject|5|||
156585742|NCT00905307|565228874|FG001|Overall Study|Withdrawal by Subject|13|||
156585743|NCT00905307|565228875|FG002|Overall Study|Withdrawal by Subject|15|||
156585744|NCT00905307|565228876|FG003|Overall Study|Withdrawal by Subject|11|||
156585745|NCT00905307|565228877|FG004|Overall Study|Withdrawal by Subject|4|||
156585746|NCT00905307|565228878|FG005|Overall Study|Withdrawal by Subject|13|||
156585747|NCT00905307|565228873|FG000|Overall Study|Protocol Violation|1|||
156585748|NCT00905307|565228874|FG001|Overall Study|Protocol Violation|0|||
156585749|NCT00905307|565228875|FG002|Overall Study|Protocol Violation|1|||
156585750|NCT00905307|565228876|FG003|Overall Study|Protocol Violation|0|||
156585751|NCT00905307|565228877|FG004|Overall Study|Protocol Violation|0|||
156585752|NCT00905307|565228878|FG005|Overall Study|Protocol Violation|0|||
156585753|NCT00905307|565228873|FG000|Overall Study|Lack of Efficacy|6|||
156585754|NCT00905307|565228874|FG001|Overall Study|Lack of Efficacy|3|||
156585755|NCT00905307|565228875|FG002|Overall Study|Lack of Efficacy|5|||
156585756|NCT00905307|565228876|FG003|Overall Study|Lack of Efficacy|4|||
156585757|NCT00905307|565228877|FG004|Overall Study|Lack of Efficacy|4|||
156585758|NCT00905307|565228878|FG005|Overall Study|Lack of Efficacy|8|||
156585759|NCT05590793|565228879|FG000|Overall Study|Withdrawal by Subject|6|||
156585760|NCT05590793|565228879|FG000|Overall Study|Physician Decision|1|||
156585761|NCT04060667|565228880|FG000|Overall Study|Lost to Follow-up|75|||
156585762|NCT04060667|565228881|FG001|Overall Study|Lost to Follow-up|10|||
156585763|NCT04488822|565228882|FG000|Overall Study|Adverse Event|8|||
156585764|NCT04488822|565228882|FG000|Overall Study|Withdrawal by Subject|1|||
156585765|NCT03406104|565228883|FG000|Overall Study|Lost to Follow-up|2|||
156585766|NCT03406104|565228883|FG000|Overall Study|Withdrawal by Subject|2|||
156585767|NCT03406104|565228883|FG000|Overall Study|due to Covid patient did not want to travel|1|||
156585768|NCT03406104|565228883|FG000|Overall Study|Death|2|||
156585769|NCT01757704|565228891|FG000|Overall Study|Protocol Violation|1|||
156585770|NCT01757704|565228892|FG001|Overall Study|Protocol Violation|3|||
156585771|NCT00772967|565228896|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
156585772|NCT00772967|565228897|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
156585773|NCT00772967|565228898|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
156585774|NCT00772967|565228899|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
156585775|NCT00772967|565228900|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
156585776|NCT00772967|565228901|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
156585777|NCT00772967|565228896|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
156585778|NCT00772967|565228897|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
156585779|NCT00772967|565228898|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
156585780|NCT00772967|565228899|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
156585781|NCT00772967|565228900|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
156585782|NCT00772967|565228901|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
156585783|NCT00772967|565228896|FG000|Crossover Treatment 3|Adverse Event|0|||
156585784|NCT00772967|565228897|FG001|Crossover Treatment 3|Adverse Event|0|||
156585785|NCT00772967|565228898|FG002|Crossover Treatment 3|Adverse Event|0|||
156585786|NCT00772967|565228899|FG003|Crossover Treatment 3|Adverse Event|0|||
156585787|NCT00772967|565228900|FG004|Crossover Treatment 3|Adverse Event|1|||
156585788|NCT00772967|565228901|FG005|Crossover Treatment 3|Adverse Event|0|||
156585789|NCT00231062|565228902|FG000|Overall Study|Physician Decision|6|||
156585790|NCT00803244|565228903|FG000|Overall Study|Adverse Event|1|||
156585791|NCT00803244|565228904|FG001|Overall Study|Adverse Event|2|||
156585792|NCT00803244|565228903|FG000|Overall Study|Withdrawal by Subject|2|||
156585793|NCT00803244|565228904|FG001|Overall Study|Withdrawal by Subject|3|||
156585794|NCT00803244|565228903|FG000|Overall Study|Any other reason not above-mentioned|4|||
156585795|NCT00803244|565228904|FG001|Overall Study|Any other reason not above-mentioned|10|||
156585796|NCT03321929|565228906|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
156585797|NCT00616239|565228907|FG000|Overall Study|Withdrawal by Subject|2|||
156585798|NCT02873715|565228908|FG000|Overall Study|Lost to Follow-up|84|||
156585799|NCT02873715|565228909|FG001|Overall Study|Lost to Follow-up|94|||
156585800|NCT02873715|565228908|FG000|Overall Study|Withdrawal by Subject|7|||
156585801|NCT02873715|565228909|FG001|Overall Study|Withdrawal by Subject|26|||
156585802|NCT02144220|565228915|FG000|Overall Study|technology incompatibility|9|||
156585803|NCT02144220|565228915|FG000|Overall Study|Lack of Efficacy|4|||
156585804|NCT02144220|565228915|FG000|Overall Study|Physician Decision|3|||
156585805|NCT02144220|565228915|FG000|Overall Study|Withdrawal by Subject|2|||
156585806|NCT02144220|565228915|FG000|Overall Study|Protocol Violation|1|||
156585807|NCT01558089|565228916|FG000|Overall Study|Adverse Event|1|||
156585808|NCT01558089|565228916|FG000|Overall Study|Lack of Efficacy|1|||
156585809|NCT01558089|565228916|FG000|Overall Study|Lost to Follow-up|5|||
156585810|NCT01558089|565228916|FG000|Overall Study|Withdrawal by Subject|6|||
156585811|NCT00590681|565228917|FG000|Overall Study|Withdrawal by Subject|7|||
156585812|NCT00590681|565228917|FG000|Overall Study|Adverse Event|8|||
156585813|NCT00590681|565228917|FG000|Overall Study|Death|3|||
156585814|NCT00590681|565228917|FG000|Overall Study|Lost to Follow-up|1|||
156585815|NCT00590681|565228917|FG000|Overall Study|disease progression|1|||
156585816|NCT00443430|565228920|FG000|Overall Study|Lack of Efficacy|3|||
156585817|NCT00443430|565228921|FG001|Overall Study|Lack of Efficacy|3|||
156585818|NCT00443430|565228920|FG000|Overall Study|Adverse Event|1|||
156585819|NCT00443430|565228921|FG001|Overall Study|Adverse Event|1|||
156585820|NCT00053846|565228922|FG000|Overall Study|Changed mind|8|||
156585821|NCT00053846|565228923|FG001|Overall Study|Changed mind|13|||
156585822|NCT00053846|565228922|FG000|Overall Study|Became too ill|8|||
156585823|NCT00053846|565228923|FG001|Overall Study|Became too ill|7|||
156585824|NCT00053846|565228922|FG000|Overall Study|Expired|5|||
156585825|NCT00053846|565228923|FG001|Overall Study|Expired|0|||
156585826|NCT00053846|565228922|FG000|Overall Study|Became ineligible|3|||
156585827|NCT00053846|565228923|FG001|Overall Study|Became ineligible|1|||
156585828|NCT00053846|565228922|FG000|Overall Study|Did not return data|1|||
156585829|NCT00053846|565228923|FG001|Overall Study|Did not return data|2|||
156585830|NCT00053846|565228922|FG000|Overall Study|Quit due to side effects|1|||
156585831|NCT00053846|565228923|FG001|Overall Study|Quit due to side effects|3|||
156585832|NCT00053846|565228922|FG000|Overall Study|Pills too large|0|||
156585833|NCT00053846|565228923|FG001|Overall Study|Pills too large|1|||
156585834|NCT00592501|565228924|FG000|Overall Study|Withdrawal by Subject|1|||
156585835|NCT00592501|565228924|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
156585836|NCT00933335|565228925|FG000|Overall Study|Lost to Follow-up|1|||
156585837|NCT00933335|565228926|FG001|Overall Study|Lost to Follow-up|3|||
156585838|NCT00933335|565228925|FG000|Overall Study|Withdrawal by Subject|0|||
156585839|NCT00933335|565228926|FG001|Overall Study|Withdrawal by Subject|1|||
156585840|NCT00933335|565228925|FG000|Overall Study|Progressive Disease|0|||
156585841|NCT00933335|565228926|FG001|Overall Study|Progressive Disease|11|||
156585842|NCT00933335|565228925|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
156585843|NCT00933335|565228926|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
156585844|NCT00933335|565228925|FG000|Overall Study|Co-morbid Illness|1|||
156585845|NCT00933335|565228926|FG001|Overall Study|Co-morbid Illness|0|||
156585846|NCT02229864|565228927|FG000|Overall Study|Death|2|||
156585847|NCT02229864|565228927|FG000|Overall Study|Lost to Follow-up|1|||
156585848|NCT02650284|565228930|FG000|Overall Study|Lost to Follow-up|3|||
156585849|NCT02650284|565228931|FG001|Overall Study|Lost to Follow-up|3|||
156585850|NCT02650284|565228930|FG000|Overall Study|Consent incorrectly taken|0|||
156585851|NCT02650284|565228931|FG001|Overall Study|Consent incorrectly taken|1|||
156585852|NCT04590937|565228932|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
156585853|NCT02084134|565228941|FG000|Overall Study|Protocol Violation|4|||
156585854|NCT02084134|565228942|FG001|Overall Study|Protocol Violation|2|||
156585855|NCT02084134|565228941|FG000|Overall Study|Death|0|||
156585856|NCT02084134|565228942|FG001|Overall Study|Death|1|||
156585857|NCT02026271|565228943|FG000|Overall Study|Adverse Event|2|||
156585858|NCT02026271|565228944|FG001|Overall Study|Adverse Event|3|||
156585859|NCT02026271|565228945|FG002|Overall Study|Adverse Event|2|||
156585860|NCT02026271|565228946|FG003|Overall Study|Adverse Event|3|||
156585861|NCT02026271|565228947|FG004|Overall Study|Adverse Event|0|||
156585862|NCT02026271|565228943|FG000|Overall Study|Withdrawal by Subject|0|||
156585863|NCT02026271|565228944|FG001|Overall Study|Withdrawal by Subject|0|||
156585864|NCT02026271|565228945|FG002|Overall Study|Withdrawal by Subject|0|||
156585865|NCT02026271|565228946|FG003|Overall Study|Withdrawal by Subject|0|||
156585866|NCT02026271|565228947|FG004|Overall Study|Withdrawal by Subject|1|||
156585867|NCT02807454|565228948|FG000|Overall Study|Adverse Event|1|||
156585868|NCT02807454|565228949|FG001|Overall Study|Adverse Event|0|||
156585869|NCT02807454|565228948|FG000|Overall Study|Withdrawal by Subject|0|||
156585870|NCT02807454|565228949|FG001|Overall Study|Withdrawal by Subject|1|||
156585871|NCT02807454|565228948|FG000|Overall Study|Progressive Disease|30|||
156585872|NCT02807454|565228949|FG001|Overall Study|Progressive Disease|3|||
156585873|NCT02807454|565228948|FG000|Overall Study|Other Reasons|1|||
156585874|NCT02807454|565228949|FG001|Overall Study|Other Reasons|1|||
156585875|NCT02275026|565228952|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
156585876|NCT02275026|565228952|FG000|Overall Study|Withdrawal by Subject|4|||
156585877|NCT02275026|565228952|FG000|Overall Study|Ineligible due to medical history|13|||
156585878|NCT02275026|565228952|FG000|Overall Study|MRI malfunction precluded testing|1|||
156585879|NCT02275026|565228952|FG000|Overall Study|Ineligible after MRI findings|1|||
156585880|NCT02275026|565228952|FG000|Overall Study|Lost to Follow-up|2|||
156585881|NCT02275026|565228952|FG000|Overall Study|Scanner failure|1|||
156585882|NCT05468086|565228953|FG000|Overall Study|Withdrawal by Subject|3|||
156585883|NCT05468086|565228953|FG000|Overall Study|Subject was found ineligible after consent|1|||
156585884|NCT00374907|565228954|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
156585885|NCT00374907|565228955|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
156585886|NCT00374907|565228954|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
156585887|NCT00374907|565228955|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
156585888|NCT00374907|565228954|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
156585889|NCT00374907|565228955|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
156585890|NCT00374907|565228954|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
156585891|NCT00374907|565228955|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
156585892|NCT00374907|565228954|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
156585893|NCT00374907|565228955|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
156585894|NCT01200511|565228959|FG000|Overall Study|Lost to Follow-up|3|||
156585895|NCT01200511|565228959|FG000|Overall Study|Withdrawal by Subject|1|||
156585896|NCT01200511|565228959|FG000|Overall Study|Adverse Event|1|||
156585897|NCT03382899|565228964|FG000|Overall Study|Ineligibility Determined|0|||
156585898|NCT03382899|565228965|FG001|Overall Study|Ineligibility Determined|1|||
156585899|NCT03382899|565228964|FG000|Overall Study|Lost to Follow-up|0|||
156585900|NCT03382899|565228965|FG001|Overall Study|Lost to Follow-up|1|||
156585901|NCT03382899|565228964|FG000|Overall Study|Sponsor's decision|31|||
156585902|NCT03382899|565228965|FG001|Overall Study|Sponsor's decision|28|||
156585903|NCT03382899|565228964|FG000|Overall Study|Withdrawal by Subject|0|||
156585904|NCT03382899|565228965|FG001|Overall Study|Withdrawal by Subject|5|||
156585905|NCT02504892|565228967|FG000|Overall Study|Adverse event-pneumonitis|2|||
156585906|NCT00524745|565228968|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
156585907|NCT00524745|565228969|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
156585908|NCT00524745|565228970|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
156585909|NCT00524745|565228971|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
156585910|NCT00540449|565228972|FG000|Overall Study|Adverse Event|12|||
156585911|NCT00540449|565228973|FG001|Overall Study|Adverse Event|32|||
156585912|NCT00540449|565228972|FG000|Overall Study|Sponsor's Decision|1|||
156585913|NCT00540449|565228973|FG001|Overall Study|Sponsor's Decision|1|||
156585914|NCT00540449|565228972|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
156585915|NCT00540449|565228973|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
156585916|NCT00540449|565228972|FG000|Overall Study|Lost to Follow-up|19|||
156585917|NCT00540449|565228973|FG001|Overall Study|Lost to Follow-up|17|||
156585918|NCT00540449|565228972|FG000|Overall Study|Subject Non-Compliant|7|||
156585919|NCT00540449|565228973|FG001|Overall Study|Subject Non-Compliant|5|||
156585920|NCT00540449|565228972|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
156585921|NCT00540449|565228973|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
156585922|NCT00540449|565228972|FG000|Overall Study|Withdrawal by Subject|10|||
156585923|NCT00540449|565228973|FG001|Overall Study|Withdrawal by Subject|10|||
156585924|NCT00540449|565228972|FG000|Overall Study|Other|1|||
156585925|NCT00540449|565228973|FG001|Overall Study|Other|4|||
156585926|NCT01721408|565228974|FG000|Overall Study|Adverse Event|6|||
156585927|NCT01721408|565228975|FG001|Overall Study|Adverse Event|1|||
156585928|NCT01721408|565228974|FG000|Overall Study|Death|1|||
156585929|NCT01721408|565228975|FG001|Overall Study|Death|0|||
156585930|NCT01721408|565228974|FG000|Overall Study|Insufficient clinical response|15|||
156585931|NCT01721408|565228975|FG001|Overall Study|Insufficient clinical response|6|||
156585932|NCT01721408|565228974|FG000|Overall Study|No longer willing to participate study|9|||
156585933|NCT01721408|565228975|FG001|Overall Study|No longer willing to participate study|10|||
156585934|NCT01721408|565228974|FG000|Overall Study|Protocol Violation|0|||
156585935|NCT01721408|565228975|FG001|Overall Study|Protocol Violation|2|||
156585936|NCT01721408|565228974|FG000|Overall Study|Other|3|||
156585937|NCT01721408|565228975|FG001|Overall Study|Other|3|||
156585938|NCT01721408|565228974|FG000|Overall Study|Lost to Follow-up|1|||
156585939|NCT01721408|565228975|FG001|Overall Study|Lost to Follow-up|2|||
156585940|NCT01721408|565228974|FG000|Overall Study|Does not meet entrance criteria|1|||
156585941|NCT01721408|565228975|FG001|Overall Study|Does not meet entrance criteria|0|||
156585942|NCT04160468|565228978|FG000|Overall Study|Lost to Follow-up|19|||
156585943|NCT04160468|565228979|FG001|Overall Study|Lost to Follow-up|4|||
156585944|NCT04160468|565228978|FG000|Overall Study|Randomized but not dosed|6|||
156585945|NCT04160468|565228979|FG001|Overall Study|Randomized but not dosed|0|||
156585946|NCT04160468|565228978|FG000|Overall Study|Withdrawal by Subject|4|||
156585947|NCT04160468|565228979|FG001|Overall Study|Withdrawal by Subject|1|||
156585948|NCT04160468|565228978|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
156585949|NCT04160468|565228979|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
156585950|NCT04160468|565228978|FG000|Overall Study|Participant incarcerated|1|||
156585951|NCT04160468|565228979|FG001|Overall Study|Participant incarcerated|0|||
156585952|NCT01187901|565228980|FG000|Overall Study|Protocol Violation|1|||
156585953|NCT01187901|565228981|FG001|Overall Study|Protocol Violation|0|||
156585954|NCT01187901|565228980|FG000|Overall Study|Lost to Follow-up|1|||
156585955|NCT01187901|565228981|FG001|Overall Study|Lost to Follow-up|2|||
156585956|NCT01187901|565228980|FG000|Overall Study|Unrelated Health Reasons|1|||
156585957|NCT01187901|565228981|FG001|Overall Study|Unrelated Health Reasons|2|||
156585958|NCT01187901|565228980|FG000|Overall Study|Suspected Allergic Reaction|1|||
156585959|NCT01187901|565228981|FG001|Overall Study|Suspected Allergic Reaction|1|||
156585960|NCT01187901|565228980|FG000|Overall Study|Adverse Event|3|||
156585961|NCT01187901|565228981|FG001|Overall Study|Adverse Event|0|||
156585962|NCT01187901|565228980|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
156585963|NCT01187901|565228981|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
156585964|NCT01187901|565228980|FG000|Overall Study|Pregnancy|0|||
156585965|NCT01187901|565228981|FG001|Overall Study|Pregnancy|2|||
156585966|NCT03987620|565228982|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
156585967|NCT03987620|565228983|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
156585968|NCT03987620|565228982|FG000|Overall Study|Adverse Event|3|||
156585969|NCT03987620|565228983|FG001|Overall Study|Adverse Event|0|||
156585970|NCT03987620|565228982|FG000|Overall Study|Lost to Follow-up|1|||
156585971|NCT03987620|565228983|FG001|Overall Study|Lost to Follow-up|2|||
156585972|NCT03987620|565228982|FG000|Overall Study|Physician Decision|0|||
156585973|NCT03987620|565228983|FG001|Overall Study|Physician Decision|1|||
156585974|NCT03987620|565228982|FG000|Overall Study|Pregnancy|1|||
156585975|NCT03987620|565228983|FG001|Overall Study|Pregnancy|0|||
156585976|NCT03987620|565228982|FG000|Overall Study|Withdrawal by Subject|7|||
156585977|NCT03987620|565228983|FG001|Overall Study|Withdrawal by Subject|1|||
156585978|NCT03987620|565228982|FG000|Overall Study|Other|2|||
156585979|NCT03987620|565228983|FG001|Overall Study|Other|5|||
156585980|NCT02149836|565228984|FG000|Overall Study|Withdrawal by Subject|1|||
156585981|NCT00376688|565228985|FG000|Overall Study|Adverse Event|3|||
156585982|NCT00376688|565228985|FG000|Overall Study|Death|1|||
156585983|NCT00370149|565228986|FG000|Overall Study|Physician Decision|16|||
156585984|NCT00370149|565228987|FG001|Overall Study|Physician Decision|16|||
156585985|NCT00370149|565228986|FG000|Overall Study|Protocol Violation|1|||
156585986|NCT00370149|565228987|FG001|Overall Study|Protocol Violation|0|||
156585987|NCT00370149|565228986|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
156585988|NCT00370149|565228987|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
156585989|NCT00370149|565228986|FG000|Overall Study|Pre-existing infection|0|||
156585990|NCT00370149|565228987|FG001|Overall Study|Pre-existing infection|1|||
156585991|NCT00370149|565228986|FG000|Overall Study|Antibiotic coated dressing placed|0|||
156585992|NCT00370149|565228987|FG001|Overall Study|Antibiotic coated dressing placed|1|||
156585993|NCT03488472|565230148|FG000|Overall Study|disease progression additional mets|1|||
156585994|NCT00028002|565230149|FG000|Overall Study|Withdrawal by Subject|3|||
156585995|NCT00028002|565230149|FG000|Overall Study|Ineligible|8|||
156585996|NCT04467164|565230152|FG000|Washout (1 Week)|Lost to Follow-up|2|||
156585997|NCT04467164|565230153|FG001|Washout (1 Week)|Lost to Follow-up|0|||
156585998|NCT05628181|565230154|FG000|Overall Study|Death|2|||
156585999|NCT05628181|565230155|FG001|Overall Study|Death|4|||
156586000|NCT05628181|565230156|FG002|Overall Study|Death|0|||
156586001|NCT04742907|565230157|FG000|Overall Study|Adverse Event|1|||
156586002|NCT04742907|565230158|FG001|Overall Study|Adverse Event|0|||
156586003|NCT04742907|565230159|FG002|Overall Study|Adverse Event|1|||
156586004|NCT04742907|565230157|FG000|Overall Study|Lost to Follow-up|3|||
156586005|NCT04742907|565230158|FG001|Overall Study|Lost to Follow-up|3|||
156586006|NCT04742907|565230159|FG002|Overall Study|Lost to Follow-up|2|||
156586007|NCT04742907|565230157|FG000|Overall Study|Physician Decision|0|||
156586008|NCT04742907|565230158|FG001|Overall Study|Physician Decision|1|||
156586009|NCT04742907|565230159|FG002|Overall Study|Physician Decision|0|||
156586010|NCT04742907|565230157|FG000|Overall Study|Protocol Violation|1|||
156586011|NCT04742907|565230158|FG001|Overall Study|Protocol Violation|1|||
156586012|NCT04742907|565230159|FG002|Overall Study|Protocol Violation|1|||
156586013|NCT04742907|565230157|FG000|Overall Study|Withdrawal by Subject|5|||
156586014|NCT04742907|565230158|FG001|Overall Study|Withdrawal by Subject|6|||
156586015|NCT04742907|565230159|FG002|Overall Study|Withdrawal by Subject|4|||
156586016|NCT04742907|565230157|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
156586017|NCT04742907|565230158|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
156586018|NCT04742907|565230159|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
156586019|NCT04742907|565230157|FG000|Overall Study|Did Not Receive the Study Drug|2|||
156586020|NCT04742907|565230158|FG001|Overall Study|Did Not Receive the Study Drug|4|||
156586021|NCT04742907|565230159|FG002|Overall Study|Did Not Receive the Study Drug|4|||
156586022|NCT01428063|565230160|FG000|Overall Study|Lack of Efficacy|8|||
156586023|NCT01428063|565230161|FG001|Overall Study|Lack of Efficacy|4|||
156586024|NCT01428063|565230162|FG002|Overall Study|Lack of Efficacy|1|||
156586025|NCT01428063|565230160|FG000|Overall Study|Adverse Event|2|||
156586026|NCT01428063|565230161|FG001|Overall Study|Adverse Event|3|||
156586027|NCT01428063|565230162|FG002|Overall Study|Adverse Event|0|||
156586028|NCT01428063|565230160|FG000|Overall Study|Lost to Follow-up|0|||
156586029|NCT01428063|565230161|FG001|Overall Study|Lost to Follow-up|2|||
156586030|NCT01428063|565230162|FG002|Overall Study|Lost to Follow-up|0|||
156586031|NCT01428063|565230160|FG000|Overall Study|No longer meets study criteria|0|||
156586032|NCT01428063|565230161|FG001|Overall Study|No longer meets study criteria|1|||
156586033|NCT01428063|565230162|FG002|Overall Study|No longer meets study criteria|0|||
156586034|NCT05761444|565230163|FG000|Overall Study|Protocol Violation|2|||
156586035|NCT05761444|565230164|FG001|Overall Study|Protocol Violation|1|||
156586036|NCT05761444|565230163|FG000|Overall Study|Adverse Event|2|||
156586037|NCT05761444|565230164|FG001|Overall Study|Adverse Event|2|||
156586038|NCT05761444|565230163|FG000|Overall Study|Withdrawal by Subject|3|||
156586039|NCT05761444|565230164|FG001|Overall Study|Withdrawal by Subject|2|||
156586040|NCT05761444|565230163|FG000|Overall Study|Other|1|||
156586041|NCT05761444|565230164|FG001|Overall Study|Other|0|||
156586042|NCT03508622|565230165|FG000|Overall Study|Protocol Violation|1|||
156586043|NCT03508622|565230166|FG001|Overall Study|Protocol Violation|0|||
156586044|NCT03508622|565230165|FG000|Overall Study|Withdrawal by Subject|1|||
156586045|NCT03508622|565230166|FG001|Overall Study|Withdrawal by Subject|0|||
156586046|NCT03508622|565230165|FG000|Overall Study|Lost to Follow-up|16|||
156586047|NCT03508622|565230166|FG001|Overall Study|Lost to Follow-up|0|||
156586048|NCT03508622|565230165|FG000|Overall Study|Incomplete data|0|||
156586049|NCT03508622|565230166|FG001|Overall Study|Incomplete data|24|||
156586050|NCT03196505|565230169|FG000|Overall Study|Physician Decision|26|||
156586051|NCT03196505|565230170|FG001|Overall Study|Physician Decision|26|||
156586052|NCT01005719|565230171|FG000|Period 1|Adverse Event|0|||
156586053|NCT01005719|565230172|FG001|Period 1|Adverse Event|0|||
156586054|NCT01005719|565230173|FG002|Period 1|Adverse Event|0|||
156586055|NCT01005719|565230174|FG003|Period 1|Adverse Event|1|||
156586056|NCT01005719|565230175|FG004|Period 1|Adverse Event|0|||
156586057|NCT01005719|565230176|FG005|Period 1|Adverse Event|0|||
156586058|NCT01005719|565230171|FG000|Period 1|Delay in completing study procedures|0|||
156586059|NCT01005719|565230172|FG001|Period 1|Delay in completing study procedures|0|||
156586060|NCT01005719|565230173|FG002|Period 1|Delay in completing study procedures|0|||
156586061|NCT01005719|565230174|FG003|Period 1|Delay in completing study procedures|0|||
156586062|NCT01005719|565230175|FG004|Period 1|Delay in completing study procedures|0|||
156586063|NCT01005719|565230176|FG005|Period 1|Delay in completing study procedures|1|||
156586064|NCT01005719|565230171|FG000|Period 2|Adverse Event|0|||
156586065|NCT01005719|565230172|FG001|Period 2|Adverse Event|0|||
156586066|NCT01005719|565230173|FG002|Period 2|Adverse Event|0|||
156586067|NCT01005719|565230174|FG003|Period 2|Adverse Event|0|||
156586068|NCT01005719|565230175|FG004|Period 2|Adverse Event|1|||
156586069|NCT01005719|565230176|FG005|Period 2|Adverse Event|1|||
156586070|NCT01753076|565230177|FG000|Overall Study|Adverse Event|17|||
156586071|NCT01753076|565230178|FG001|Overall Study|Adverse Event|18|||
156586072|NCT01753076|565230177|FG000|Overall Study|Lack of Efficacy|3|||
156586073|NCT01753076|565230178|FG001|Overall Study|Lack of Efficacy|1|||
156586074|NCT01753076|565230177|FG000|Overall Study|Lost to Follow-up|2|||
156586075|NCT01753076|565230178|FG001|Overall Study|Lost to Follow-up|1|||
156586076|NCT01753076|565230177|FG000|Overall Study|Physician Decision|4|||
156586077|NCT01753076|565230178|FG001|Overall Study|Physician Decision|2|||
156586078|NCT01753076|565230177|FG000|Overall Study|Withdrawal by Subject|14|||
156586079|NCT01753076|565230178|FG001|Overall Study|Withdrawal by Subject|24|||
156586080|NCT01753076|565230177|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
156586081|NCT01753076|565230178|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
156586082|NCT02575079|565230179|FG000|Overall Study|Death|3|||
156586083|NCT02575079|565230180|FG001|Overall Study|Death|0|||
156586084|NCT02575079|565230179|FG000|Overall Study|Withdrawal by Subject|3|||
156586085|NCT02575079|565230180|FG001|Overall Study|Withdrawal by Subject|0|||
156586086|NCT01259856|565230181|FG000|Overall Study|Adverse Event|12|||
156586087|NCT01259856|565230182|FG001|Overall Study|Adverse Event|9|||
156586088|NCT01259856|565230181|FG000|Overall Study|Death|0|||
156586089|NCT01259856|565230182|FG001|Overall Study|Death|1|||
156586090|NCT01259856|565230181|FG000|Overall Study|Lack of Efficacy|3|||
156586091|NCT01259856|565230182|FG001|Overall Study|Lack of Efficacy|1|||
156586092|NCT01259856|565230181|FG000|Overall Study|Lost to Follow-up|1|||
156586093|NCT01259856|565230182|FG001|Overall Study|Lost to Follow-up|1|||
156586094|NCT01259856|565230181|FG000|Overall Study|Physician Decision|2|||
156586095|NCT01259856|565230182|FG001|Overall Study|Physician Decision|1|||
156586096|NCT01259856|565230181|FG000|Overall Study|Withdrawal by Subject|9|||
156586097|NCT01259856|565230182|FG001|Overall Study|Withdrawal by Subject|10|||
156586098|NCT01259856|565230181|FG000|Overall Study|Treatment never started|0|||
156586099|NCT01259856|565230182|FG001|Overall Study|Treatment never started|6|||
156586100|NCT01259856|565230181|FG000|Overall Study|Study closure by sponsor|40|||
156586101|NCT01259856|565230182|FG001|Overall Study|Study closure by sponsor|41|||
156586102|NCT01259856|565230181|FG000|Overall Study|Patient developed other disease|0|||
156586103|NCT01259856|565230182|FG001|Overall Study|Patient developed other disease|1|||
156586104|NCT01259856|565230181|FG000|Overall Study|Transfer to another study|0|||
156586105|NCT01259856|565230182|FG001|Overall Study|Transfer to another study|1|||
156586106|NCT01259856|565230181|FG000|Overall Study|Unknown/missing|2|||
156586107|NCT01259856|565230182|FG001|Overall Study|Unknown/missing|2|||
156586108|NCT00788775|565230185|FG000|Overall Study|Progressive Disease|8|||
156586109|NCT00788775|565230186|FG001|Overall Study|Progressive Disease|6|||
156586110|NCT00788775|565230185|FG000|Overall Study|Withdrawal by Subject|0|||
156586111|NCT00788775|565230186|FG001|Overall Study|Withdrawal by Subject|2|||
156586112|NCT00788775|565230185|FG000|Overall Study|Patient Non-Compliance|1|||
156586113|NCT00788775|565230186|FG001|Overall Study|Patient Non-Compliance|0|||
156586114|NCT00788775|565230185|FG000|Overall Study|Patient's measurable disease resected.|1|||
156586115|NCT00788775|565230186|FG001|Overall Study|Patient's measurable disease resected.|0|||
156586116|NCT02890329|565230192|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
156586117|NCT02890329|565230193|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
156586118|NCT02890329|565230194|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
156586119|NCT02890329|565230195|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
156586120|NCT02890329|565230196|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
156586121|NCT02890329|565230197|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
156586122|NCT02890329|565230192|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
156586123|NCT02890329|565230193|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
156586124|NCT02890329|565230194|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
156586125|NCT02890329|565230195|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
156586126|NCT02890329|565230196|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
156586127|NCT02890329|565230197|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
156586128|NCT02890329|565230192|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
156586129|NCT02890329|565230193|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
156586130|NCT02890329|565230194|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
156586131|NCT02890329|565230195|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
156586132|NCT02890329|565230196|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
156586133|NCT02890329|565230197|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
156586134|NCT02890329|565230192|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
156586135|NCT02890329|565230193|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
156586136|NCT02890329|565230194|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
156586137|NCT02890329|565230195|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
156586138|NCT02890329|565230196|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
156586139|NCT02890329|565230197|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
156586140|NCT01035255|565230199|FG000|Overall Study|Death|724|||
156586141|NCT01035255|565230200|FG001|Overall Study|Death|844|||
156586142|NCT01035255|565230199|FG000|Overall Study|Lost to Follow-up|2|||
156586143|NCT01035255|565230200|FG001|Overall Study|Lost to Follow-up|5|||
156586144|NCT01035255|565230199|FG000|Overall Study|patient's request|15|||
156586145|NCT01035255|565230200|FG001|Overall Study|patient's request|13|||
156586146|NCT00195260|565230203|FG000|Part 1: Dose Escalation|Adverse Event|0|||
156586147|NCT00195260|565230204|FG001|Part 1: Dose Escalation|Adverse Event|1|||
156586148|NCT00195260|565230205|FG002|Part 1: Dose Escalation|Adverse Event|0|||
156586149|NCT00195260|565230206|FG003|Part 1: Dose Escalation|Adverse Event|1|||
156586150|NCT00195260|565230207|FG004|Part 1: Dose Escalation|Adverse Event|1|||
156586151|NCT00195260|565230208|FG005|Part 1: Dose Escalation|Adverse Event|0|||
156586152|NCT00195260|565230209|FG006|Part 1: Dose Escalation|Adverse Event|3|||
156586153|NCT00195260|565230210|FG007|Part 1: Dose Escalation|Adverse Event|0|||
156586154|NCT00195260|565230211|FG008|Part 1: Dose Escalation|Adverse Event|0|||
156586155|NCT00195260|565230212|FG009|Part 1: Dose Escalation|Adverse Event|0|||
156586156|NCT00195260|565230213|FG010|Part 1: Dose Escalation|Adverse Event|0|||
156586157|NCT00195260|565230203|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586158|NCT00195260|565230204|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586159|NCT00195260|565230205|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586160|NCT00195260|565230206|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586161|NCT00195260|565230207|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
156586162|NCT00195260|565230208|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586163|NCT00195260|565230209|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586164|NCT00195260|565230210|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
156586165|NCT00195260|565230211|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586166|NCT00195260|565230212|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586167|NCT00195260|565230213|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156586168|NCT00195260|565230203|FG000|Part 1: Dose Escalation|Death|0|||
156586169|NCT00195260|565230204|FG001|Part 1: Dose Escalation|Death|0|||
156586170|NCT00195260|565230205|FG002|Part 1: Dose Escalation|Death|0|||
156586171|NCT00195260|565230206|FG003|Part 1: Dose Escalation|Death|0|||
156586172|NCT00195260|565230207|FG004|Part 1: Dose Escalation|Death|0|||
156586173|NCT00195260|565230208|FG005|Part 1: Dose Escalation|Death|0|||
156586174|NCT00195260|565230209|FG006|Part 1: Dose Escalation|Death|0|||
156586175|NCT00195260|565230210|FG007|Part 1: Dose Escalation|Death|1|||
156586176|NCT00195260|565230211|FG008|Part 1: Dose Escalation|Death|0|||
156586177|NCT00195260|565230212|FG009|Part 1: Dose Escalation|Death|0|||
156586178|NCT00195260|565230213|FG010|Part 1: Dose Escalation|Death|0|||
156586179|NCT00195260|565230203|FG000|Part 1: Dose Escalation|Disease Progression|3|||
156586180|NCT00195260|565230204|FG001|Part 1: Dose Escalation|Disease Progression|2|||
156586181|NCT00195260|565230205|FG002|Part 1: Dose Escalation|Disease Progression|5|||
156586182|NCT00195260|565230206|FG003|Part 1: Dose Escalation|Disease Progression|6|||
156586183|NCT00195260|565230207|FG004|Part 1: Dose Escalation|Disease Progression|4|||
156586184|NCT00195260|565230208|FG005|Part 1: Dose Escalation|Disease Progression|6|||
156586185|NCT00195260|565230209|FG006|Part 1: Dose Escalation|Disease Progression|7|||
156586186|NCT00195260|565230210|FG007|Part 1: Dose Escalation|Disease Progression|4|||
156586187|NCT00195260|565230211|FG008|Part 1: Dose Escalation|Disease Progression|0|||
156586188|NCT00195260|565230212|FG009|Part 1: Dose Escalation|Disease Progression|0|||
156586189|NCT00195260|565230213|FG010|Part 1: Dose Escalation|Disease Progression|0|||
156586190|NCT00195260|565230203|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
156586191|NCT00195260|565230204|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
156586192|NCT00195260|565230205|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
156586193|NCT00195260|565230206|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
156586194|NCT00195260|565230207|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
156586195|NCT00195260|565230208|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
156586196|NCT00195260|565230209|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
156586197|NCT00195260|565230210|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
156586198|NCT00195260|565230211|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
156586199|NCT00195260|565230212|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
156586200|NCT00195260|565230213|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
156586201|NCT00195260|565230203|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
156586202|NCT00195260|565230204|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
156586203|NCT00195260|565230205|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
156586204|NCT00195260|565230206|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
156586205|NCT00195260|565230207|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
156586206|NCT00195260|565230208|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
156586207|NCT00195260|565230209|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
156586208|NCT00195260|565230210|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
156586209|NCT00195260|565230211|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
156586210|NCT00195260|565230212|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
156586211|NCT00195260|565230213|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
156586212|NCT00195260|565230203|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
156586213|NCT00195260|565230204|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
156586214|NCT00195260|565230205|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
156586215|NCT00195260|565230206|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
156586216|NCT00195260|565230207|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
156586217|NCT00195260|565230208|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
156586218|NCT00195260|565230209|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
156586219|NCT00195260|565230210|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
156586220|NCT00195260|565230211|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
156586221|NCT00195260|565230212|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
156586222|NCT00195260|565230213|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
156586223|NCT00195260|565230203|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
156586224|NCT00195260|565230204|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
156586225|NCT00195260|565230205|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
156586226|NCT00195260|565230206|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
156586227|NCT00195260|565230207|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
156586228|NCT00195260|565230208|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
156586229|NCT00195260|565230209|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
156586230|NCT00195260|565230210|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
156586231|NCT00195260|565230211|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
156586232|NCT00195260|565230212|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
156586233|NCT00195260|565230213|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
156586234|NCT00195260|565230203|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
156586235|NCT00195260|565230204|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
156586236|NCT00195260|565230205|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
156586237|NCT00195260|565230206|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
156586238|NCT00195260|565230207|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
156586239|NCT00195260|565230208|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
156586240|NCT00195260|565230209|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
156586241|NCT00195260|565230210|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
156586242|NCT00195260|565230211|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
156586243|NCT00195260|565230212|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
156586244|NCT00195260|565230213|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
156586245|NCT02749721|565230214|FG000|Screening|Withdrawal by Subject|1|||
156586246|NCT02749721|565230214|FG000|Screening|Lost to Follow-up|2|||
156586247|NCT02749721|565230214|FG000|Screening|Protocol Violation|3|||
156586248|NCT02749721|565230214|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
156586249|NCT02749721|565230214|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
156586250|NCT01379534|565230215|FG000|Treatment Phase|Withdrawal by Subject|2|||
156586251|NCT01379534|565230216|FG001|Treatment Phase|Withdrawal by Subject|2|||
156586252|NCT01379534|565230215|FG000|Treatment Phase|Progressive disease|13|||
156586253|NCT01379534|565230216|FG001|Treatment Phase|Progressive disease|22|||
156586254|NCT01379534|565230215|FG000|Treatment Phase|Adverse Event|7|||
156586255|NCT01379534|565230216|FG001|Treatment Phase|Adverse Event|7|||
156586256|NCT01379534|565230215|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
156586257|NCT01379534|565230216|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
156586258|NCT01379534|565230215|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
156586259|NCT01379534|565230216|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
156586260|NCT01379534|565230215|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
156586261|NCT01379534|565230216|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
156586262|NCT01379534|565230215|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
156586263|NCT01379534|565230216|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
156586264|NCT02691247|565230217|FG000|Overall Study|Withdrawal by Subject|1|||
156586265|NCT02691247|565230218|FG001|Overall Study|Withdrawal by Subject|2|||
156586266|NCT02691247|565230219|FG002|Overall Study|Withdrawal by Subject|2|||
156586267|NCT02691247|565230217|FG000|Overall Study|Lost to Follow-up|2|||
156586268|NCT02691247|565230218|FG001|Overall Study|Lost to Follow-up|0|||
156586269|NCT02691247|565230219|FG002|Overall Study|Lost to Follow-up|1|||
156586270|NCT01519245|565230220|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
156586271|NCT01519245|565230221|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
156586272|NCT03880227|565230228|FG000|First Visit|Withdrawal by Subject|1|||
156586273|NCT03880227|565230229|FG001|First Visit|Withdrawal by Subject|0|||
156586274|NCT03880227|565230230|FG002|First Visit|Withdrawal by Subject|0|||
156586275|NCT03880227|565230231|FG003|First Visit|Withdrawal by Subject|0|||
156586276|NCT03880227|565230228|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
156586277|NCT03880227|565230229|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
156586278|NCT03880227|565230230|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
156586279|NCT03880227|565230231|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
156586280|NCT03880227|565230228|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
156586281|NCT03880227|565230229|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
156586282|NCT03880227|565230230|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
156586283|NCT03880227|565230231|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
156586284|NCT03880227|565230228|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
156586285|NCT03880227|565230229|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
156586286|NCT03880227|565230230|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
156586287|NCT03880227|565230231|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
156586288|NCT01635933|565230232|FG000|Overall Study|Adverse Event|1|||
156586289|NCT01635933|565230233|FG001|Overall Study|Adverse Event|0|||
156586290|NCT01635933|565230232|FG000|Overall Study|Lost to Follow-up|0|||
156586291|NCT01635933|565230233|FG001|Overall Study|Lost to Follow-up|5|||
156586292|NCT01635933|565230232|FG000|Overall Study|Subject decision|1|||
156586293|NCT01635933|565230233|FG001|Overall Study|Subject decision|1|||
156586294|NCT01635933|565230232|FG000|Overall Study|Noncompliance|0|||
156586295|NCT01635933|565230233|FG001|Overall Study|Noncompliance|1|||
156586296|NCT01635933|565230232|FG000|Overall Study|No longer had transportation|0|||
156586297|NCT01635933|565230233|FG001|Overall Study|No longer had transportation|1|||
156586298|NCT01544595|565230234|FG000|Status at Week 68|Adverse Event|3|||
156586299|NCT01544595|565230235|FG001|Status at Week 68|Adverse Event|2|||
156586300|NCT01544595|565230236|FG002|Status at Week 68|Adverse Event|1|||
156586301|NCT01544595|565230237|FG003|Status at Week 68|Adverse Event|0|||
156586302|NCT01544595|565230238|FG004|Status at Week 68|Adverse Event|0|||
156586303|NCT01544595|565230239|FG005|Status at Week 68|Adverse Event|0|||
156586304|NCT01544595|565230234|FG000|Status at Week 68|Lack of Efficacy|1|||
156586305|NCT01544595|565230235|FG001|Status at Week 68|Lack of Efficacy|0|||
156586306|NCT01544595|565230236|FG002|Status at Week 68|Lack of Efficacy|0|||
156586307|NCT01544595|565230237|FG003|Status at Week 68|Lack of Efficacy|0|||
156586308|NCT01544595|565230238|FG004|Status at Week 68|Lack of Efficacy|0|||
156586309|NCT01544595|565230239|FG005|Status at Week 68|Lack of Efficacy|0|||
156586310|NCT01544595|565230234|FG000|Status at Week 68|Lost to Follow-up|1|||
156586311|NCT01544595|565230235|FG001|Status at Week 68|Lost to Follow-up|1|||
156586312|NCT01544595|565230236|FG002|Status at Week 68|Lost to Follow-up|0|||
156586313|NCT01544595|565230237|FG003|Status at Week 68|Lost to Follow-up|0|||
156586314|NCT01544595|565230238|FG004|Status at Week 68|Lost to Follow-up|0|||
156586315|NCT01544595|565230239|FG005|Status at Week 68|Lost to Follow-up|0|||
156586316|NCT01544595|565230234|FG000|Status at Week 68|Non-compliance with study treatment|1|||
156586317|NCT01544595|565230235|FG001|Status at Week 68|Non-compliance with study treatment|0|||
156586318|NCT01544595|565230236|FG002|Status at Week 68|Non-compliance with study treatment|0|||
156586319|NCT01544595|565230237|FG003|Status at Week 68|Non-compliance with study treatment|1|||
156586320|NCT01544595|565230238|FG004|Status at Week 68|Non-compliance with study treatment|0|||
156586321|NCT01544595|565230239|FG005|Status at Week 68|Non-compliance with study treatment|0|||
156586322|NCT01544595|565230234|FG000|Status at Week 68|Protocol Violation|2|||
156586323|NCT01544595|565230235|FG001|Status at Week 68|Protocol Violation|0|||
156586324|NCT01544595|565230236|FG002|Status at Week 68|Protocol Violation|1|||
156586325|NCT01544595|565230237|FG003|Status at Week 68|Protocol Violation|1|||
156586326|NCT01544595|565230238|FG004|Status at Week 68|Protocol Violation|0|||
156586327|NCT01544595|565230239|FG005|Status at Week 68|Protocol Violation|0|||
156586328|NCT01544595|565230234|FG000|Status at Week 68|Technical problems|1|||
156586329|NCT01544595|565230235|FG001|Status at Week 68|Technical problems|0|||
156586330|NCT01544595|565230236|FG002|Status at Week 68|Technical problems|0|||
156586331|NCT01544595|565230237|FG003|Status at Week 68|Technical problems|1|||
156586332|NCT01544595|565230238|FG004|Status at Week 68|Technical problems|0|||
156586333|NCT01544595|565230239|FG005|Status at Week 68|Technical problems|0|||
156586334|NCT01544595|565230234|FG000|Status at Week 68|Withdrawal by Subject|0|||
156586335|NCT01544595|565230235|FG001|Status at Week 68|Withdrawal by Subject|1|||
156586336|NCT01544595|565230236|FG002|Status at Week 68|Withdrawal by Subject|1|||
156586337|NCT01544595|565230237|FG003|Status at Week 68|Withdrawal by Subject|2|||
156586338|NCT01544595|565230238|FG004|Status at Week 68|Withdrawal by Subject|0|||
156586339|NCT01544595|565230239|FG005|Status at Week 68|Withdrawal by Subject|0|||
156586340|NCT01544595|565230234|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
156586341|NCT01544595|565230235|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
156586342|NCT01544595|565230236|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
156586343|NCT01544595|565230237|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
156586344|NCT01544595|565230238|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
156586345|NCT01544595|565230239|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
156586346|NCT01544595|565230234|FG000|Status at Week 156|Withdrawal by Subject|9|||
156586347|NCT01544595|565230235|FG001|Status at Week 156|Withdrawal by Subject|10|||
156634894|NCT03917654|565407818|FG003|Year 1|Withdrawal by Subject|0|||
156586348|NCT01544595|565230236|FG002|Status at Week 156|Withdrawal by Subject|4|||
156586349|NCT01544595|565230237|FG003|Status at Week 156|Withdrawal by Subject|9|||
156586350|NCT01544595|565230238|FG004|Status at Week 156|Withdrawal by Subject|20|||
156586351|NCT01544595|565230239|FG005|Status at Week 156|Withdrawal by Subject|6|||
156586352|NCT01544595|565230234|FG000|Status at Week 156|Adverse Event|9|||
156586353|NCT01544595|565230235|FG001|Status at Week 156|Adverse Event|11|||
156586354|NCT01544595|565230236|FG002|Status at Week 156|Adverse Event|1|||
156586355|NCT01544595|565230237|FG003|Status at Week 156|Adverse Event|3|||
156586356|NCT01544595|565230238|FG004|Status at Week 156|Adverse Event|4|||
156586357|NCT01544595|565230239|FG005|Status at Week 156|Adverse Event|2|||
156586358|NCT01544595|565230234|FG000|Status at Week 156|Lost to Follow-up|4|||
156586359|NCT01544595|565230235|FG001|Status at Week 156|Lost to Follow-up|4|||
156586360|NCT01544595|565230236|FG002|Status at Week 156|Lost to Follow-up|0|||
156586361|NCT01544595|565230237|FG003|Status at Week 156|Lost to Follow-up|1|||
156586362|NCT01544595|565230238|FG004|Status at Week 156|Lost to Follow-up|4|||
156586363|NCT01544595|565230239|FG005|Status at Week 156|Lost to Follow-up|1|||
156586364|NCT01544595|565230234|FG000|Status at Week 156|Non-compliance with study treatement|0|||
156586365|NCT01544595|565230235|FG001|Status at Week 156|Non-compliance with study treatement|1|||
156586366|NCT01544595|565230236|FG002|Status at Week 156|Non-compliance with study treatement|0|||
156586367|NCT01544595|565230237|FG003|Status at Week 156|Non-compliance with study treatement|1|||
156586368|NCT01544595|565230238|FG004|Status at Week 156|Non-compliance with study treatement|0|||
156586369|NCT01544595|565230239|FG005|Status at Week 156|Non-compliance with study treatement|1|||
156586370|NCT01544595|565230234|FG000|Status at Week 156|Physician Decision|0|||
156586371|NCT01544595|565230235|FG001|Status at Week 156|Physician Decision|3|||
156586372|NCT01544595|565230236|FG002|Status at Week 156|Physician Decision|1|||
156586373|NCT01544595|565230237|FG003|Status at Week 156|Physician Decision|0|||
156586374|NCT01544595|565230238|FG004|Status at Week 156|Physician Decision|0|||
156586375|NCT01544595|565230239|FG005|Status at Week 156|Physician Decision|0|||
156586376|NCT01544595|565230234|FG000|Status at Week 156|Pregnancy|2|||
156586377|NCT01544595|565230235|FG001|Status at Week 156|Pregnancy|3|||
156586378|NCT01544595|565230236|FG002|Status at Week 156|Pregnancy|0|||
156586379|NCT01544595|565230237|FG003|Status at Week 156|Pregnancy|0|||
156586380|NCT01544595|565230238|FG004|Status at Week 156|Pregnancy|0|||
156586381|NCT01544595|565230239|FG005|Status at Week 156|Pregnancy|0|||
156586382|NCT01544595|565230234|FG000|Status at Week 156|Protocol Violation|3|||
156586383|NCT01544595|565230235|FG001|Status at Week 156|Protocol Violation|1|||
156586384|NCT01544595|565230236|FG002|Status at Week 156|Protocol Violation|2|||
156586385|NCT01544595|565230237|FG003|Status at Week 156|Protocol Violation|2|||
156586386|NCT01544595|565230238|FG004|Status at Week 156|Protocol Violation|0|||
156586387|NCT01544595|565230239|FG005|Status at Week 156|Protocol Violation|0|||
156586388|NCT01544595|565230234|FG000|Status at Week 156|Technical problems|3|||
156586389|NCT01544595|565230235|FG001|Status at Week 156|Technical problems|1|||
156586390|NCT01544595|565230236|FG002|Status at Week 156|Technical problems|0|||
156586391|NCT01544595|565230237|FG003|Status at Week 156|Technical problems|1|||
156586392|NCT01544595|565230238|FG004|Status at Week 156|Technical problems|0|||
156586393|NCT01544595|565230239|FG005|Status at Week 156|Technical problems|0|||
156586394|NCT01544595|565230234|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
156586395|NCT01544595|565230235|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
156586396|NCT01544595|565230236|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
156586397|NCT01544595|565230237|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
156586398|NCT01544595|565230238|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
156586399|NCT01544595|565230239|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
156586400|NCT01544595|565230234|FG000|Status at Week 156|Lack of Efficacy|1|||
156586401|NCT01544595|565230235|FG001|Status at Week 156|Lack of Efficacy|0|||
156586402|NCT01544595|565230236|FG002|Status at Week 156|Lack of Efficacy|1|||
156586403|NCT01544595|565230237|FG003|Status at Week 156|Lack of Efficacy|4|||
156586404|NCT01544595|565230238|FG004|Status at Week 156|Lack of Efficacy|10|||
156586405|NCT01544595|565230239|FG005|Status at Week 156|Lack of Efficacy|5|||
156586406|NCT01929044|565230242|FG000|Overall Study|Adverse Event|1|||
156586407|NCT01929044|565230243|FG001|Overall Study|Adverse Event|0|||
156586408|NCT01929044|565230242|FG000|Overall Study|Protocol Violation|9|||
156586409|NCT01929044|565230243|FG001|Overall Study|Protocol Violation|14|||
156586410|NCT01929044|565230242|FG000|Overall Study|Not Treated|1|||
156586411|NCT01929044|565230243|FG001|Overall Study|Not Treated|3|||
156586412|NCT04333433|565230244|FG000|Overall Study|Withdrawal by Subject|6|||
156586413|NCT04333433|565230245|FG001|Overall Study|Withdrawal by Subject|3|||
156586414|NCT04333433|565230244|FG000|Overall Study|Death|3|||
156586415|NCT04333433|565230245|FG001|Overall Study|Death|0|||
156586416|NCT04333433|565230244|FG000|Overall Study|Lost to Follow-up|6|||
156586417|NCT04333433|565230245|FG001|Overall Study|Lost to Follow-up|1|||
156586418|NCT04333433|565230244|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
156586419|NCT04333433|565230245|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
156586420|NCT00878072|565230247|FG000|Overall Study|Withdrew consent|2|||
156586421|NCT03288779|565230253|FG000|Overall Study|Withdrawal by Subject|3|||
156634895|NCT03917654|565407819|FG004|Year 1|Withdrawal by Subject|0|||
156586422|NCT00237796|565230254|FG000|Overall Study|Baseline and one other ILSS required|10|||
156586423|NCT00237796|565230255|FG001|Overall Study|Baseline and one other ILSS required|5|||
156586424|NCT00968253|565230256|FG000|Overall Study|Death|0|||
156586425|NCT00968253|565230257|FG001|Overall Study|Death|0|||
156586426|NCT00968253|565230258|FG002|Overall Study|Death|2|||
156586427|NCT00968253|565230256|FG000|Overall Study|Withdrawal by Subject|0|||
156586428|NCT00968253|565230257|FG001|Overall Study|Withdrawal by Subject|0|||
156586429|NCT00968253|565230258|FG002|Overall Study|Withdrawal by Subject|1|||
156586430|NCT00968253|565230256|FG000|Overall Study|Disease Progression|0|||
156586431|NCT00968253|565230257|FG001|Overall Study|Disease Progression|3|||
156586432|NCT00968253|565230258|FG002|Overall Study|Disease Progression|3|||
156586433|NCT00968253|565230256|FG000|Overall Study|Adverse Event|0|||
156586434|NCT00968253|565230257|FG001|Overall Study|Adverse Event|0|||
156586435|NCT00968253|565230258|FG002|Overall Study|Adverse Event|1|||
156586436|NCT02488759|565230264|FG000|Overall Study|Disease progression|73|||
156586437|NCT02488759|565230265|FG001|Overall Study|Disease progression|111|||
156586438|NCT02488759|565230266|FG002|Overall Study|Disease progression|62|||
156586439|NCT02488759|565230267|FG003|Overall Study|Disease progression|7|||
156586440|NCT02488759|565230268|FG004|Overall Study|Disease progression|4|||
156586441|NCT02488759|565230269|FG005|Overall Study|Disease progression|2|||
156586442|NCT02488759|565230264|FG000|Overall Study|Study drug toxicity|11|||
156586443|NCT02488759|565230265|FG001|Overall Study|Study drug toxicity|33|||
156586444|NCT02488759|565230266|FG002|Overall Study|Study drug toxicity|31|||
156586445|NCT02488759|565230267|FG003|Overall Study|Study drug toxicity|0|||
156586446|NCT02488759|565230268|FG004|Overall Study|Study drug toxicity|0|||
156586447|NCT02488759|565230269|FG005|Overall Study|Study drug toxicity|2|||
156586448|NCT02488759|565230264|FG000|Overall Study|Adverse event unrelated to study drug|9|||
156586449|NCT02488759|565230265|FG001|Overall Study|Adverse event unrelated to study drug|11|||
156586450|NCT02488759|565230266|FG002|Overall Study|Adverse event unrelated to study drug|7|||
156586451|NCT02488759|565230267|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156586452|NCT02488759|565230268|FG004|Overall Study|Adverse event unrelated to study drug|1|||
156586453|NCT02488759|565230269|FG005|Overall Study|Adverse event unrelated to study drug|0|||
156586454|NCT02488759|565230264|FG000|Overall Study|Participant request to discontinue study treatment|6|||
156586455|NCT02488759|565230265|FG001|Overall Study|Participant request to discontinue study treatment|8|||
156586456|NCT02488759|565230266|FG002|Overall Study|Participant request to discontinue study treatment|4|||
156586457|NCT02488759|565230267|FG003|Overall Study|Participant request to discontinue study treatment|0|||
156586458|NCT02488759|565230268|FG004|Overall Study|Participant request to discontinue study treatment|0|||
156586459|NCT02488759|565230269|FG005|Overall Study|Participant request to discontinue study treatment|0|||
156586460|NCT02488759|565230264|FG000|Overall Study|Withdrawal by Subject|4|||
156586461|NCT02488759|565230265|FG001|Overall Study|Withdrawal by Subject|0|||
156586462|NCT02488759|565230266|FG002|Overall Study|Withdrawal by Subject|3|||
156586463|NCT02488759|565230267|FG003|Overall Study|Withdrawal by Subject|0|||
156586464|NCT02488759|565230268|FG004|Overall Study|Withdrawal by Subject|0|||
156586465|NCT02488759|565230269|FG005|Overall Study|Withdrawal by Subject|2|||
156586466|NCT02488759|565230264|FG000|Overall Study|Lost to Follow-up|0|||
156586467|NCT02488759|565230265|FG001|Overall Study|Lost to Follow-up|0|||
156586468|NCT02488759|565230266|FG002|Overall Study|Lost to Follow-up|2|||
156586469|NCT02488759|565230267|FG003|Overall Study|Lost to Follow-up|0|||
156586470|NCT02488759|565230268|FG004|Overall Study|Lost to Follow-up|0|||
156586471|NCT02488759|565230269|FG005|Overall Study|Lost to Follow-up|0|||
156586472|NCT02488759|565230264|FG000|Overall Study|Maximum clinical benefit|3|||
156586473|NCT02488759|565230265|FG001|Overall Study|Maximum clinical benefit|0|||
156586474|NCT02488759|565230266|FG002|Overall Study|Maximum clinical benefit|1|||
156586475|NCT02488759|565230267|FG003|Overall Study|Maximum clinical benefit|0|||
156586476|NCT02488759|565230268|FG004|Overall Study|Maximum clinical benefit|0|||
156586477|NCT02488759|565230269|FG005|Overall Study|Maximum clinical benefit|0|||
156586478|NCT02488759|565230264|FG000|Overall Study|Other reasons|7|||
156586479|NCT02488759|565230265|FG001|Overall Study|Other reasons|32|||
156586480|NCT02488759|565230266|FG002|Overall Study|Other reasons|23|||
156586481|NCT02488759|565230267|FG003|Overall Study|Other reasons|1|||
156586482|NCT02488759|565230268|FG004|Overall Study|Other reasons|1|||
156586483|NCT02488759|565230269|FG005|Overall Study|Other reasons|1|||
156586484|NCT03860844|565230270|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
156586485|NCT03860844|565230271|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
156586486|NCT03860844|565230272|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
156586487|NCT03860844|565230270|FG000|Overall Study|Progressive disease|5|||
156586488|NCT03860844|565230271|FG001|Overall Study|Progressive disease|3|||
156586489|NCT03860844|565230272|FG002|Overall Study|Progressive disease|4|||
156586490|NCT03860844|565230270|FG000|Overall Study|Other, Not related to COVID-19|0|||
156586491|NCT03860844|565230271|FG001|Overall Study|Other, Not related to COVID-19|1|||
156586492|NCT03860844|565230272|FG002|Overall Study|Other, Not related to COVID-19|0|||
156586493|NCT05306873|565231777|FG000|Stage 2|Study stopped|1|||
156586494|NCT05306873|565231778|FG001|Stage 2|Study stopped|1|||
156586495|NCT05306873|565231779|FG002|Stage 2|Study stopped|0|||
156586496|NCT05306873|565231780|FG003|Stage 2|Study stopped|0|||
156586497|NCT05306873|565231777|FG000|Stage 2|Stage 2 Treatment Failure|2|||
156586498|NCT05306873|565231778|FG001|Stage 2|Stage 2 Treatment Failure|3|||
156586499|NCT05306873|565231779|FG002|Stage 2|Stage 2 Treatment Failure|0|||
156586500|NCT05306873|565231780|FG003|Stage 2|Stage 2 Treatment Failure|0|||
156586501|NCT05306873|565231777|FG000|Stage 2|Logistical issues due to participant moving|1|||
156586502|NCT05306873|565231778|FG001|Stage 2|Logistical issues due to participant moving|0|||
156586503|NCT05306873|565231779|FG002|Stage 2|Logistical issues due to participant moving|0|||
156586504|NCT05306873|565231780|FG003|Stage 2|Logistical issues due to participant moving|0|||
156586505|NCT05306873|565231777|FG000|Stage 3|Stage 3 Treatment Failure|0|||
156586506|NCT05306873|565231778|FG001|Stage 3|Stage 3 Treatment Failure|0|||
156586507|NCT05306873|565231779|FG002|Stage 3|Stage 3 Treatment Failure|0|||
156586508|NCT05306873|565231780|FG003|Stage 3|Stage 3 Treatment Failure|1|||
156586509|NCT05306873|565231777|FG000|Stage 3|Study Stopped|0|||
156586510|NCT05306873|565231778|FG001|Stage 3|Study Stopped|0|||
156586511|NCT05306873|565231779|FG002|Stage 3|Study Stopped|1|||
156586512|NCT05306873|565231780|FG003|Stage 3|Study Stopped|0|||
156586513|NCT04920084|565231786|FG000|Overall Study|Adverse Event|1|||
156586514|NCT04920084|565231786|FG000|Overall Study|Lost to Follow-up|2|||
156586515|NCT04920084|565231786|FG000|Overall Study|Withdrawal by Subject|2|||
156586516|NCT01096446|565231787|FG000|Overall Study|Death|1|||
156586517|NCT01096446|565231788|FG001|Overall Study|Death|0|||
156586518|NCT01096446|565231787|FG000|Overall Study|Protocol Violation|2|||
156586519|NCT01096446|565231788|FG001|Overall Study|Protocol Violation|0|||
156586520|NCT00074412|565231789|FG000|Overall Study|Death|30|||
156586521|NCT00074412|565231790|FG001|Overall Study|Death|26|||
156586522|NCT00074412|565231789|FG000|Overall Study|Lost to Follow-up|52|||
156586523|NCT00074412|565231790|FG001|Overall Study|Lost to Follow-up|58|||
156586524|NCT01043185|565231791|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
156586525|NCT01043185|565231792|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
156586526|NCT01043185|565231793|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
156586527|NCT01043185|565231794|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
156586528|NCT01043185|565231795|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
156586529|NCT01043185|565231796|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
156586530|NCT01043185|565231797|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
156586531|NCT01043185|565231798|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
156586532|NCT01043185|565231799|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
156586533|NCT01043185|565231800|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
156586534|NCT00418834|565231803|FG000|Overall Study|Adverse Event|16|||
156586535|NCT00418834|565231804|FG001|Overall Study|Adverse Event|9|||
156586536|NCT00418834|565231803|FG000|Overall Study|Lost to Follow-up|0|||
156586537|NCT00418834|565231804|FG001|Overall Study|Lost to Follow-up|1|||
156586538|NCT00418834|565231803|FG000|Overall Study|Protocol Violation|4|||
156586539|NCT00418834|565231804|FG001|Overall Study|Protocol Violation|3|||
156586540|NCT00418834|565231803|FG000|Overall Study|Withdrawal by Subject|3|||
156586541|NCT00418834|565231804|FG001|Overall Study|Withdrawal by Subject|7|||
156586542|NCT01755195|565231807|FG000|Overall Study|Participant noncompliance|2|||
156586543|NCT01755195|565231807|FG000|Overall Study|Switched to alternative treatment|4|||
156586544|NCT01755195|565231807|FG000|Overall Study|Withdrawal by Subject|1|||
156586545|NCT01755195|565231807|FG000|Overall Study|Participant refused to start treatment|1|||
156586546|NCT01755195|565231807|FG000|Overall Study|Participant has been consented for another trial|1|||
156586547|NCT01755195|565231807|FG000|Overall Study|Refused further treatment|3|||
156586548|NCT01755195|565231807|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
156586549|NCT05113953|565231808|FG000|Overall Study|Adverse Event|5|||
156586550|NCT05113953|565231809|FG001|Overall Study|Adverse Event|0|||
156586551|NCT05113953|565231810|FG002|Overall Study|Adverse Event|3|||
156586552|NCT05113953|565231808|FG000|Overall Study|Lost to Follow-up|3|||
156586553|NCT05113953|565231809|FG001|Overall Study|Lost to Follow-up|4|||
156586554|NCT05113953|565231810|FG002|Overall Study|Lost to Follow-up|2|||
156586555|NCT05113953|565231808|FG000|Overall Study|Non-compliance with Study Drug|1|||
156586556|NCT05113953|565231809|FG001|Overall Study|Non-compliance with Study Drug|0|||
156586557|NCT05113953|565231810|FG002|Overall Study|Non-compliance with Study Drug|0|||
156586558|NCT05113953|565231808|FG000|Overall Study|Withdrawal by Subject|2|||
156586559|NCT05113953|565231809|FG001|Overall Study|Withdrawal by Subject|6|||
156586560|NCT05113953|565231810|FG002|Overall Study|Withdrawal by Subject|4|||
156586561|NCT05113953|565231808|FG000|Overall Study|Reason not Specified|2|||
156586562|NCT05113953|565231809|FG001|Overall Study|Reason not Specified|0|||
156586563|NCT05113953|565231810|FG002|Overall Study|Reason not Specified|0|||
156586564|NCT03470922|565231815|FG000|Overall Study|Death|107|||
156586565|NCT03470922|565231816|FG001|Overall Study|Death|118|||
156586566|NCT03470922|565231815|FG000|Overall Study|Lost to Follow-up|5|||
156586567|NCT03470922|565231816|FG001|Overall Study|Lost to Follow-up|5|||
156586568|NCT03470922|565231815|FG000|Overall Study|Participant Withdrew Consent|4|||
156586569|NCT03470922|565231816|FG001|Overall Study|Participant Withdrew Consent|9|||
156586570|NCT03470922|565231815|FG000|Overall Study|Other reasons|1|||
156586571|NCT03470922|565231816|FG001|Overall Study|Other reasons|0|||
156586572|NCT03470922|565231815|FG000|Overall Study|Not reported|1|||
156586573|NCT03470922|565231816|FG001|Overall Study|Not reported|0|||
156586574|NCT02340819|565231817|FG000|Overall Study|Adverse Event|1|||
156586575|NCT02340819|565231817|FG000|Overall Study|Withdrawal by Subject|2|||
156586576|NCT02340819|565231817|FG000|Overall Study|Discontinued with other reason|1|||
156586577|NCT02626819|565231818|FG000|Overall Study|Lost to Follow-up|3|||
156586578|NCT02626819|565231819|FG001|Overall Study|Lost to Follow-up|2|||
156586579|NCT02626819|565231818|FG000|Overall Study|Withdrawal by Subject|1|||
156586580|NCT02626819|565231819|FG001|Overall Study|Withdrawal by Subject|0|||
156586581|NCT02626819|565231818|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
156586582|NCT02626819|565231819|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
156586583|NCT01763905|565231824|FG000|Overall Study|Withdrawal by Subject|1|||
156586584|NCT01763905|565231825|FG001|Overall Study|Withdrawal by Subject|1|||
156586585|NCT01763905|565231826|FG002|Overall Study|Withdrawal by Subject|0|||
156586586|NCT01763905|565231827|FG003|Overall Study|Withdrawal by Subject|1|||
156586587|NCT01763905|565231824|FG000|Overall Study|Decision by sponsor|5|||
156586588|NCT01763905|565231825|FG001|Overall Study|Decision by sponsor|0|||
156586589|NCT01763905|565231826|FG002|Overall Study|Decision by sponsor|8|||
156586590|NCT01763905|565231827|FG003|Overall Study|Decision by sponsor|0|||
156586591|NCT01763905|565231824|FG000|Overall Study|Lost to Follow-up|0|||
156586592|NCT01763905|565231825|FG001|Overall Study|Lost to Follow-up|0|||
156586593|NCT01763905|565231826|FG002|Overall Study|Lost to Follow-up|1|||
156586594|NCT01763905|565231827|FG003|Overall Study|Lost to Follow-up|0|||
156586595|NCT04346628|565231828|FG000|Overall Study|Lost to Follow-up|4|||
156586596|NCT04346628|565231829|FG001|Overall Study|Lost to Follow-up|4|||
156586597|NCT04346628|565231828|FG000|Overall Study|Withdrew (had personal reasons)|2|||
156586598|NCT04346628|565231829|FG001|Overall Study|Withdrew (had personal reasons)|5|||
156586599|NCT04346628|565231828|FG000|Overall Study|Withdrew (medication intolerant)|0|||
156586600|NCT04346628|565231829|FG001|Overall Study|Withdrew (medication intolerant)|3|||
156586601|NCT04346628|565231828|FG000|Overall Study|Withdrew (declined intervention)|0|||
156586602|NCT04346628|565231829|FG001|Overall Study|Withdrew (declined intervention)|1|||
156586603|NCT02750800|565231836|FG000|Overall Study|Adverse Event|18|||
156586604|NCT02750800|565231836|FG000|Overall Study|Lost to Follow-up|12|||
156586605|NCT02750800|565231836|FG000|Overall Study|Investigator decision|53|||
156586606|NCT02750800|565231836|FG000|Overall Study|Patient request|12|||
156586607|NCT02750800|565231836|FG000|Overall Study|Other, not specified|3|||
156586608|NCT00643487|565231840|FG000|Overall Study|Technical difficulty|3|||
156586609|NCT03430245|565231856|FG000|Overall Study|Withdrawal by Subject|6|||
156586610|NCT03430245|565231856|FG000|Overall Study|Lost to Follow-up|1|||
156586611|NCT01087528|565231863|FG000|Overall Study|Withdrawal by Subject|1|||
156586612|NCT01087528|565231863|FG000|Overall Study|Incomplete CE procedure|6|||
156586613|NCT03116399|565231866|FG000|Overall Study|Death|8|||
156586614|NCT03116399|565231867|FG001|Overall Study|Death|3|||
156586615|NCT03116399|565231866|FG000|Overall Study|Lost to Follow-up|7|||
156586616|NCT03116399|565231867|FG001|Overall Study|Lost to Follow-up|11|||
156586617|NCT03116399|565231866|FG000|Overall Study|Investigator Decision|1|||
156586618|NCT03116399|565231867|FG001|Overall Study|Investigator Decision|1|||
156586619|NCT03116399|565231866|FG000|Overall Study|Withdrawal by Subject|24|||
156586620|NCT03116399|565231867|FG001|Overall Study|Withdrawal by Subject|9|||
156586621|NCT02868216|565231869|FG000|Overall Study|Death|0|||
156586622|NCT02868216|565231870|FG001|Overall Study|Death|1|||
156586623|NCT02868216|565231869|FG000|Overall Study|coronary artery bypass|1|||
156586624|NCT02868216|565231870|FG001|Overall Study|coronary artery bypass|0|||
156586625|NCT02868216|565231869|FG000|Overall Study|Withdrawal by Subject|7|||
156586626|NCT02868216|565231870|FG001|Overall Study|Withdrawal by Subject|5|||
156586627|NCT00987623|565231871|FG000|Overall Study|Lost to Follow-up|2|||
156586628|NCT00987623|565231872|FG001|Overall Study|Lost to Follow-up|1|||
156586629|NCT00987623|565231871|FG000|Overall Study|Time/job conflict|2|||
156586630|NCT00987623|565231872|FG001|Overall Study|Time/job conflict|0|||
156586631|NCT00987623|565231871|FG000|Overall Study|Discomfort|1|||
156586632|NCT00987623|565231872|FG001|Overall Study|Discomfort|0|||
156586633|NCT00987623|565231871|FG000|Overall Study|Biomicroscopy|0|||
156586634|NCT00987623|565231872|FG001|Overall Study|Biomicroscopy|1|||
156586635|NCT00987623|565231871|FG000|Overall Study|Influenza|0|||
156586636|NCT00987623|565231872|FG001|Overall Study|Influenza|1|||
156586637|NCT03161678|565231875|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
156586638|NCT03161678|565231876|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
156586639|NCT03161678|565231877|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156586640|NCT03161678|565231878|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
156586641|NCT03161678|565231879|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
156586642|NCT03161678|565231880|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156586643|NCT03161678|565231875|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
156586644|NCT03161678|565231876|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
156586645|NCT03161678|565231877|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
156586646|NCT03161678|565231878|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
156586647|NCT03161678|565231879|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
156586648|NCT03161678|565231880|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
156586649|NCT03161678|565231875|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
156586650|NCT03161678|565231876|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
156586651|NCT03161678|565231877|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
156586652|NCT03161678|565231878|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
156586653|NCT03161678|565231879|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
156586654|NCT03161678|565231880|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
156586655|NCT03161678|565231875|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
156586656|NCT03161678|565231876|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
156586657|NCT03161678|565231877|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
156586658|NCT03161678|565231878|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
156586659|NCT03161678|565231879|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
156586660|NCT03161678|565231880|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
156586661|NCT00752609|565231881|FG000|Overall Study|Adverse Event|2|||
156586662|NCT00752609|565231882|FG001|Overall Study|Adverse Event|2|||
156586663|NCT00752609|565231881|FG000|Overall Study|Withdrawal by Subject|3|||
156586664|NCT00752609|565231882|FG001|Overall Study|Withdrawal by Subject|0|||
156586665|NCT00752609|565231881|FG000|Overall Study|Physician Decision|1|||
156586666|NCT00752609|565231882|FG001|Overall Study|Physician Decision|0|||
156586667|NCT00752609|565231881|FG000|Overall Study|Death|1|||
156586668|NCT00752609|565231882|FG001|Overall Study|Death|0|||
156586669|NCT00752609|565231881|FG000|Overall Study|Met exclusion criteria|1|||
156586670|NCT00752609|565231882|FG001|Overall Study|Met exclusion criteria|0|||
156586671|NCT00752609|565231881|FG000|Overall Study|Received Aranesp in error|1|||
156586672|NCT00752609|565231882|FG001|Overall Study|Received Aranesp in error|0|||
156586673|NCT05114590|565231883|FG000|Overall Study|Adverse Event|1|||
156586674|NCT05114590|565231883|FG000|Overall Study|Investigator decision|1|||
156586675|NCT05114590|565231883|FG000|Overall Study|Lost to Follow-up|5|||
156586676|NCT05114590|565231883|FG000|Overall Study|Withdrawal by Subject|5|||
156586677|NCT05114590|565231883|FG000|Overall Study|Other|2|||
156586678|NCT00938327|565231884|FG000|Overall Study|Adverse Event|2|||
156586679|NCT00938327|565231884|FG000|Overall Study|Protocol Violation|1|||
156586680|NCT00938327|565231884|FG000|Overall Study|Withdrawal by Subject|4|||
156586681|NCT00938327|565231884|FG000|Overall Study|Lost to Follow-up|37|||
156586682|NCT00938327|565231884|FG000|Overall Study|2nd dose received outside of the study|7|||
156586683|NCT00938327|565231884|FG000|Overall Study|Vaccine not received as out of stock|9|||
156586684|NCT01108809|565231885|FG000|Overall Study|Adverse Event|3|||
156586685|NCT01108809|565231885|FG000|Overall Study|Lost to Follow-up|1|||
156586686|NCT02379923|565231891|FG000|Overall Study|Death|5|||
156586687|NCT03643432|565231892|FG000|Overall Study|Lost to Follow-up|1|||
156586688|NCT03643432|565231893|FG001|Overall Study|Lost to Follow-up|0|||
156586689|NCT00804193|565231894|FG000|Overall Study|Lack of baseline fungus|32|||
156586690|NCT00804193|565231895|FG001|Overall Study|Lack of baseline fungus|31|||
156586691|NCT00804193|565231896|FG002|Overall Study|Lack of baseline fungus|19|||
156586692|NCT00804193|565231894|FG000|Overall Study|Adverse Event|0|||
156586693|NCT00804193|565231895|FG001|Overall Study|Adverse Event|0|||
156586694|NCT00804193|565231896|FG002|Overall Study|Adverse Event|2|||
156586695|NCT00804193|565231894|FG000|Overall Study|Lack of Efficacy|1|||
156586696|NCT00804193|565231895|FG001|Overall Study|Lack of Efficacy|1|||
156586697|NCT00804193|565231896|FG002|Overall Study|Lack of Efficacy|3|||
156586698|NCT00804193|565231894|FG000|Overall Study|Protocol Violation|0|||
156586699|NCT00804193|565231895|FG001|Overall Study|Protocol Violation|8|||
156586700|NCT00804193|565231896|FG002|Overall Study|Protocol Violation|2|||
156586701|NCT00804193|565231894|FG000|Overall Study|Lost to Follow-up|3|||
156586702|NCT00804193|565231895|FG001|Overall Study|Lost to Follow-up|3|||
156586703|NCT00804193|565231896|FG002|Overall Study|Lost to Follow-up|4|||
156586704|NCT00804193|565231894|FG000|Overall Study|Withdrawal by Subject|3|||
156586705|NCT00804193|565231895|FG001|Overall Study|Withdrawal by Subject|1|||
156586706|NCT00804193|565231896|FG002|Overall Study|Withdrawal by Subject|2|||
156586707|NCT01193348|565231899|FG000|Screening Period|Screen Failure|5|||
156586708|NCT01193348|565231899|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
156586709|NCT01193348|565231899|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
156586710|NCT01193348|565231899|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
156586711|NCT01193348|565231899|FG000|Extension Treatment Period|Physician Decision|1|||
156586712|NCT01193348|565231899|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
156586713|NCT01402284|565231900|FG000|Overall Study|Withdrawal consent|2|||
156586714|NCT01402284|565231900|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
156586715|NCT01402284|565231900|FG000|Overall Study|Physician Decision|1|||
156586716|NCT01402284|565231900|FG000|Overall Study|Disease progression on study|10|||
156586717|NCT02928406|565231901|FG000|Overall Study|Death|780|||
156586718|NCT02928406|565231901|FG000|Overall Study|Progressive disease|3|||
156586719|NCT02928406|565231901|FG000|Overall Study|Lost to Follow-up|49|||
156586720|NCT02928406|565231901|FG000|Overall Study|Non-compliance|2|||
156586721|NCT02928406|565231901|FG000|Overall Study|Withdrawal by Subject|40|||
156586722|NCT02928406|565231901|FG000|Overall Study|Study terminated by sponsor|57|||
156586723|NCT02928406|565231901|FG000|Overall Study|Physician Decision|1|||
156586724|NCT02928406|565231901|FG000|Overall Study|Various reasons|72|||
156586725|NCT01745393|565231903|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
156586726|NCT01745393|565231904|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
156586727|NCT01745393|565231903|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
156586728|NCT01745393|565231904|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
156586729|NCT01745393|565231903|FG000|12-month Follow-up|Lost to Follow-up|6|||
156586730|NCT01745393|565231904|FG001|12-month Follow-up|Lost to Follow-up|5|||
156586731|NCT00905021|565231905|FG000|Overall Study|Adverse Event|2|||
156586732|NCT00786838|565231906|FG000|Overall Study|Physician Decision|4|||
156586733|NCT00786838|565231906|FG000|Overall Study|Death|4|||
156586734|NCT00786838|565231906|FG000|Overall Study|Adverse Event|6|||
156586735|NCT00786838|565231906|FG000|Overall Study|Progressive disease|31|||
156586736|NCT00786838|565231906|FG000|Overall Study|Withdrawal by Subject|4|||
156586737|NCT04937816|565231907|FG000|Overall Study|Study drug stopped, reason missing|5|||
156586738|NCT04937816|565231908|FG001|Overall Study|Study drug stopped, reason missing|3|||
156586739|NCT04937816|565231909|FG002|Overall Study|Study drug stopped, reason missing|4|||
156586740|NCT04937816|565231910|FG003|Overall Study|Study drug stopped, reason missing|6|||
156586741|NCT04937816|565231911|FG004|Overall Study|Study drug stopped, reason missing|1|||
156586742|NCT04937816|565231912|FG005|Overall Study|Study drug stopped, reason missing|0|||
156586743|NCT04937816|565231913|FG006|Overall Study|Study drug stopped, reason missing|0|||
156586744|NCT04937816|565231907|FG000|Overall Study|Other than stated below|173|||
156586745|NCT04937816|565231908|FG001|Overall Study|Other than stated below|143|||
156586746|NCT04937816|565231909|FG002|Overall Study|Other than stated below|125|||
156586747|NCT04937816|565231910|FG003|Overall Study|Other than stated below|44|||
156586748|NCT04937816|565231911|FG004|Overall Study|Other than stated below|45|||
156586749|NCT04937816|565231912|FG005|Overall Study|Other than stated below|28|||
156586750|NCT04937816|565231913|FG006|Overall Study|Other than stated below|31|||
156586751|NCT04937816|565231907|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
156586752|NCT04937816|565231908|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
156586753|NCT04937816|565231909|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
156586754|NCT04937816|565231910|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
156586755|NCT04937816|565231911|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
156586756|NCT04937816|565231912|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
156586757|NCT04937816|565231913|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
156586758|NCT04937816|565231907|FG000|Overall Study|Lost to Follow-up|15|||
156586759|NCT04937816|565231908|FG001|Overall Study|Lost to Follow-up|9|||
156586760|NCT04937816|565231909|FG002|Overall Study|Lost to Follow-up|6|||
156586761|NCT04937816|565231910|FG003|Overall Study|Lost to Follow-up|6|||
156586762|NCT04937816|565231911|FG004|Overall Study|Lost to Follow-up|16|||
156586763|NCT04937816|565231912|FG005|Overall Study|Lost to Follow-up|11|||
156586764|NCT04937816|565231913|FG006|Overall Study|Lost to Follow-up|17|||
156586765|NCT04937816|565231907|FG000|Overall Study|Protocol Violation|15|||
156586766|NCT04937816|565231908|FG001|Overall Study|Protocol Violation|15|||
156586767|NCT04937816|565231909|FG002|Overall Study|Protocol Violation|12|||
156586768|NCT04937816|565231910|FG003|Overall Study|Protocol Violation|30|||
156586769|NCT04937816|565231911|FG004|Overall Study|Protocol Violation|24|||
156586770|NCT04937816|565231912|FG005|Overall Study|Protocol Violation|5|||
156586771|NCT04937816|565231913|FG006|Overall Study|Protocol Violation|5|||
156586772|NCT04937816|565231907|FG000|Overall Study|Adverse Event|303|||
156586773|NCT04937816|565231908|FG001|Overall Study|Adverse Event|267|||
156586774|NCT04937816|565231909|FG002|Overall Study|Adverse Event|273|||
156586775|NCT04937816|565231910|FG003|Overall Study|Adverse Event|553|||
156586776|NCT04937816|565231911|FG004|Overall Study|Adverse Event|575|||
156586777|NCT04937816|565231912|FG005|Overall Study|Adverse Event|343|||
156586778|NCT04937816|565231913|FG006|Overall Study|Adverse Event|337|||
156586779|NCT04937816|565231907|FG000|Overall Study|Not treated|4|||
156586780|NCT04937816|565231908|FG001|Overall Study|Not treated|2|||
156586781|NCT04937816|565231909|FG002|Overall Study|Not treated|2|||
156586782|NCT04937816|565231910|FG003|Overall Study|Not treated|2|||
156586783|NCT04937816|565231911|FG004|Overall Study|Not treated|1|||
156586784|NCT04937816|565231912|FG005|Overall Study|Not treated|4|||
156586785|NCT04937816|565231913|FG006|Overall Study|Not treated|0|||
156586786|NCT01678807|565231919|FG000|Overall Study|Adverse Event|4|||
156586787|NCT01678807|565231920|FG001|Overall Study|Adverse Event|4|||
156586788|NCT01678807|565231921|FG002|Overall Study|Adverse Event|0|||
156586789|NCT01678807|565231919|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
156586790|NCT01678807|565231920|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
156586791|NCT01678807|565231921|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
156586792|NCT02574312|565231922|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
156863644|NCT00627393|566258731|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
156586793|NCT02574312|565231923|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
156586794|NCT02361762|565233438|FG000|Overall Study|Withdrawal by Subject|0|||
156586795|NCT02361762|565233439|FG001|Overall Study|Withdrawal by Subject|1|||
156586796|NCT02361762|565233438|FG000|Overall Study|Lost to Follow-up|0|||
156586797|NCT02361762|565233439|FG001|Overall Study|Lost to Follow-up|1|||
156586798|NCT00502307|565233440|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
156586799|NCT00502307|565233441|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
156586800|NCT00502307|565233442|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
156586801|NCT00502307|565233440|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
156586802|NCT00502307|565233441|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
156586803|NCT00502307|565233442|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
156586804|NCT00502307|565233440|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
156586805|NCT00502307|565233441|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
156586806|NCT00502307|565233442|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
156586807|NCT00502307|565233440|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
156586808|NCT00502307|565233441|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
156586809|NCT00502307|565233442|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
156586810|NCT00502307|565233440|FG000|Maintenance Period|Progressive disease|80|||
156586811|NCT00502307|565233441|FG001|Maintenance Period|Progressive disease|0|||
156586812|NCT00502307|565233442|FG002|Maintenance Period|Progressive disease|0|||
156586813|NCT00502307|565233440|FG000|Maintenance Period|Discontinued due to other reasons|68|||
156586814|NCT00502307|565233441|FG001|Maintenance Period|Discontinued due to other reasons|0|||
156586815|NCT00502307|565233442|FG002|Maintenance Period|Discontinued due to other reasons|0|||
156586816|NCT02750813|565233443|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
156586817|NCT02750813|565233444|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
156586818|NCT02750813|565233443|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
156586819|NCT02750813|565233444|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
156586820|NCT01998581|565233445|FG000|Overall Study|Refused repeat treatment|20|||
156586821|NCT01998581|565233446|FG001|Overall Study|Refused repeat treatment|4|||
156586822|NCT01998581|565233445|FG000|Overall Study|Protocol Violation|1|||
156586823|NCT01998581|565233446|FG001|Overall Study|Protocol Violation|0|||
156586824|NCT01998581|565233445|FG000|Overall Study|Withdrawal by Subject|8|||
156586825|NCT01998581|565233446|FG001|Overall Study|Withdrawal by Subject|1|||
156586826|NCT01998581|565233445|FG000|Overall Study|Lost to Follow-up|12|||
156586827|NCT01998581|565233446|FG001|Overall Study|Lost to Follow-up|4|||
156586828|NCT01998581|565233445|FG000|Overall Study|Adverse Event|1|||
156586829|NCT01998581|565233446|FG001|Overall Study|Adverse Event|1|||
156586830|NCT01998581|565233445|FG000|Overall Study|Other reasons|3|||
156586831|NCT01998581|565233446|FG001|Overall Study|Other reasons|2|||
156586832|NCT01998581|565233445|FG000|Overall Study|Randomized but withdrew before treatment|1|||
156586833|NCT01998581|565233446|FG001|Overall Study|Randomized but withdrew before treatment|0|||
156586834|NCT02273050|565233449|FG000|Overall Study|Adverse Event|4|||
156586835|NCT02273050|565233450|FG001|Overall Study|Adverse Event|3|||
156586836|NCT02273050|565233451|FG002|Overall Study|Adverse Event|3|||
156586837|NCT02273050|565233449|FG000|Overall Study|Death|0|||
156586838|NCT02273050|565233450|FG001|Overall Study|Death|0|||
156586839|NCT02273050|565233451|FG002|Overall Study|Death|1|||
156586840|NCT02273050|565233449|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
156586841|NCT02273050|565233450|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
156586842|NCT02273050|565233451|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
156586843|NCT02273050|565233449|FG000|Overall Study|Lack of Efficacy|0|||
156586844|NCT02273050|565233450|FG001|Overall Study|Lack of Efficacy|1|||
156586845|NCT02273050|565233451|FG002|Overall Study|Lack of Efficacy|1|||
156586846|NCT02273050|565233449|FG000|Overall Study|Withdrawal by Subject|17|||
156586847|NCT02273050|565233450|FG001|Overall Study|Withdrawal by Subject|14|||
156586848|NCT02273050|565233451|FG002|Overall Study|Withdrawal by Subject|16|||
156586849|NCT02273050|565233449|FG000|Overall Study|Lost to Follow-up|0|||
156586850|NCT02273050|565233450|FG001|Overall Study|Lost to Follow-up|2|||
156586851|NCT02273050|565233451|FG002|Overall Study|Lost to Follow-up|3|||
156586852|NCT02273050|565233449|FG000|Overall Study|Protocol Violation|3|||
156586853|NCT02273050|565233450|FG001|Overall Study|Protocol Violation|1|||
156586854|NCT02273050|565233451|FG002|Overall Study|Protocol Violation|4|||
156586855|NCT02273752|565233452|FG000|Overall Study|Trial was terminated early|2|||
156586856|NCT00903032|565233453|FG000|Overall Study|Withdrawal by Subject|5|||
156586857|NCT00903032|565233454|FG001|Overall Study|Withdrawal by Subject|3|||
156586858|NCT00903032|565233453|FG000|Overall Study|Lost to Follow-up|2|||
156586859|NCT00903032|565233454|FG001|Overall Study|Lost to Follow-up|2|||
156586860|NCT01429792|565233455|FG000|Overall Study|Other Reasons|67|||
156586861|NCT01429792|565233455|FG000|Overall Study|Unknown Disposition|94|||
156586862|NCT01429792|565233455|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
156586863|NCT01429792|565233455|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
156586864|NCT01429792|565233455|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
156586865|NCT01429792|565233455|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
156586866|NCT01429792|565233455|FG000|Overall Study|Withdrawal by Subject|70|||
156586867|NCT01429792|565233455|FG000|Overall Study|Lost to Follow-up|88|||
156586868|NCT02324842|565233456|FG000|Overall Study|Lost to Follow-up|1|||
156586869|NCT02324842|565233457|FG001|Overall Study|Lost to Follow-up|1|||
156586870|NCT02324842|565233458|FG002|Overall Study|Lost to Follow-up|2|||
156586871|NCT03298412|565233461|FG000|Run-in Period|Other, Not Specified|1|||
156586872|NCT03298412|565233461|FG000|Run-in Period|Disease Progression|1|||
156586873|NCT03298412|565233461|FG000|Run-in Period|Ineligibility Determined|1|||
156586874|NCT03298412|565233461|FG000|Run-in Period|Decision by Sponsor|6|||
156586875|NCT03456713|565233464|FG000|Overall Study|Lost to Follow-up|1|||
156586876|NCT03456713|565233465|FG001|Overall Study|Lost to Follow-up|0|||
156586877|NCT03456713|565233466|FG002|Overall Study|Lost to Follow-up|0|||
156586878|NCT03456713|565233467|FG003|Overall Study|Lost to Follow-up|0|||
156586879|NCT01263691|565233468|FG000|Overall Study|Lost to Follow-up|1|||
156586880|NCT01263691|565233469|FG001|Overall Study|Lost to Follow-up|0|||
156586881|NCT01263691|565233470|FG002|Overall Study|Lost to Follow-up|1|||
156586882|NCT01263691|565233471|FG003|Overall Study|Lost to Follow-up|1|||
156586883|NCT01263691|565233472|FG004|Overall Study|Lost to Follow-up|0|||
156586884|NCT01263691|565233473|FG005|Overall Study|Lost to Follow-up|0|||
156586885|NCT01263691|565233468|FG000|Overall Study|Withdrawal by Subject|1|||
156586886|NCT01263691|565233469|FG001|Overall Study|Withdrawal by Subject|0|||
156586887|NCT01263691|565233470|FG002|Overall Study|Withdrawal by Subject|0|||
156586888|NCT01263691|565233471|FG003|Overall Study|Withdrawal by Subject|0|||
156586889|NCT01263691|565233472|FG004|Overall Study|Withdrawal by Subject|0|||
156586890|NCT01263691|565233473|FG005|Overall Study|Withdrawal by Subject|0|||
156586891|NCT01263691|565233468|FG000|Overall Study|Adverse Event|1|||
156586892|NCT01263691|565233469|FG001|Overall Study|Adverse Event|0|||
156586893|NCT01263691|565233470|FG002|Overall Study|Adverse Event|0|||
156586894|NCT01263691|565233471|FG003|Overall Study|Adverse Event|0|||
156586895|NCT01263691|565233472|FG004|Overall Study|Adverse Event|0|||
156586896|NCT01263691|565233473|FG005|Overall Study|Adverse Event|0|||
156586897|NCT01202227|565233474|FG000|Overall Study|Adverse Event|16|||
156586898|NCT01202227|565233474|FG000|Overall Study|Withdrawal by Subject|2|||
156586899|NCT01202227|565233474|FG000|Overall Study|Lack of Efficacy|1|||
156586900|NCT01894477|565233475|FG000|Overall Study|Protocol Violation|0|||
156586901|NCT01894477|565233476|FG001|Overall Study|Protocol Violation|1|||
156586902|NCT01894477|565233475|FG000|Overall Study|protocol changed due SC changed to cord|0|||
156586903|NCT01894477|565233476|FG001|Overall Study|protocol changed due SC changed to cord|1|||
156586904|NCT03656926|565233478|FG000|Overall Study|Adverse Event|5|||
156586905|NCT03656926|565233479|FG001|Overall Study|Adverse Event|4|||
156586906|NCT03656926|565233478|FG000|Overall Study|Withdrawal by Subject|7|||
156586907|NCT03656926|565233479|FG001|Overall Study|Withdrawal by Subject|2|||
156586908|NCT03656926|565233478|FG000|Overall Study|Screen fail after randomization|1|||
156586909|NCT03656926|565233479|FG001|Overall Study|Screen fail after randomization|0|||
156586910|NCT03656926|565233478|FG000|Overall Study|PI decision due to patient condition|1|||
156586911|NCT03656926|565233479|FG001|Overall Study|PI decision due to patient condition|0|||
156586912|NCT03656926|565233478|FG000|Overall Study|Patient unresponsiveness|1|||
156586913|NCT03656926|565233479|FG001|Overall Study|Patient unresponsiveness|0|||
156586914|NCT00069095|565233480|FG000|Primary Treatment Phase|Ongoing|0|||
156586915|NCT00069095|565233481|FG001|Primary Treatment Phase|Ongoing|0|||
156586916|NCT00069095|565233482|FG002|Primary Treatment Phase|Ongoing|5|||
156586917|NCT00069095|565233483|FG003|Primary Treatment Phase|Ongoing|7|||
156586918|NCT00069095|565233484|FG004|Primary Treatment Phase|Ongoing|7|||
156586919|NCT00069095|565233485|FG005|Primary Treatment Phase|Ongoing|4|||
156586920|NCT00069095|565233480|FG000|Primary Treatment Phase|Admin/Other|29|||
156586921|NCT00069095|565233481|FG001|Primary Treatment Phase|Admin/Other|38|||
156586922|NCT00069095|565233482|FG002|Primary Treatment Phase|Admin/Other|31|||
156586923|NCT00069095|565233483|FG003|Primary Treatment Phase|Admin/Other|45|||
156586924|NCT00069095|565233484|FG004|Primary Treatment Phase|Admin/Other|48|||
156586925|NCT00069095|565233485|FG005|Primary Treatment Phase|Admin/Other|42|||
156586926|NCT00069095|565233480|FG000|Primary Treatment Phase|Adverse Event|99|||
156586927|NCT00069095|565233481|FG001|Primary Treatment Phase|Adverse Event|92|||
156586928|NCT00069095|565233482|FG002|Primary Treatment Phase|Adverse Event|71|||
156586929|NCT00069095|565233483|FG003|Primary Treatment Phase|Adverse Event|72|||
156586930|NCT00069095|565233484|FG004|Primary Treatment Phase|Adverse Event|109|||
156586931|NCT00069095|565233485|FG005|Primary Treatment Phase|Adverse Event|101|||
156586932|NCT00069095|565233480|FG000|Primary Treatment Phase|Death|14|||
156586933|NCT00069095|565233481|FG001|Primary Treatment Phase|Death|8|||
156586934|NCT00069095|565233482|FG002|Primary Treatment Phase|Death|2|||
156586935|NCT00069095|565233483|FG003|Primary Treatment Phase|Death|5|||
156586936|NCT00069095|565233484|FG004|Primary Treatment Phase|Death|8|||
156586937|NCT00069095|565233485|FG005|Primary Treatment Phase|Death|8|||
156586938|NCT00069095|565233480|FG000|Primary Treatment Phase|Failure to return|5|||
156586939|NCT00069095|565233481|FG001|Primary Treatment Phase|Failure to return|5|||
156586940|NCT00069095|565233482|FG002|Primary Treatment Phase|Failure to return|0|||
156586941|NCT00069095|565233483|FG003|Primary Treatment Phase|Failure to return|0|||
156586942|NCT00069095|565233484|FG004|Primary Treatment Phase|Failure to return|0|||
156586943|NCT00069095|565233485|FG005|Primary Treatment Phase|Failure to return|2|||
156586944|NCT00069095|565233480|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
156586945|NCT00069095|565233481|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
156586946|NCT00069095|565233482|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
156586947|NCT00069095|565233483|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
156586948|NCT00069095|565233484|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
156586949|NCT00069095|565233485|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
156586950|NCT00069095|565233480|FG000|Primary Treatment Phase|Refused treatment|15|||
156586951|NCT00069095|565233481|FG001|Primary Treatment Phase|Refused treatment|26|||
156586952|NCT00069095|565233482|FG002|Primary Treatment Phase|Refused treatment|17|||
156586953|NCT00069095|565233483|FG003|Primary Treatment Phase|Refused treatment|31|||
156586954|NCT00069095|565233484|FG004|Primary Treatment Phase|Refused treatment|24|||
156586955|NCT00069095|565233485|FG005|Primary Treatment Phase|Refused treatment|27|||
156586956|NCT00069095|565233480|FG000|Primary Treatment Phase|Withdrew|2|||
156586957|NCT00069095|565233481|FG001|Primary Treatment Phase|Withdrew|3|||
156586958|NCT00069095|565233482|FG002|Primary Treatment Phase|Withdrew|8|||
156586959|NCT00069095|565233483|FG003|Primary Treatment Phase|Withdrew|2|||
156586960|NCT00069095|565233484|FG004|Primary Treatment Phase|Withdrew|4|||
156586961|NCT00069095|565233485|FG005|Primary Treatment Phase|Withdrew|9|||
156586962|NCT00069095|565233480|FG000|Primary Treatment Phase|Other Violation|0|||
156586963|NCT00069095|565233481|FG001|Primary Treatment Phase|Other Violation|1|||
156586964|NCT00069095|565233482|FG002|Primary Treatment Phase|Other Violation|1|||
156586965|NCT00069095|565233483|FG003|Primary Treatment Phase|Other Violation|1|||
156586966|NCT00069095|565233484|FG004|Primary Treatment Phase|Other Violation|0|||
156586967|NCT00069095|565233485|FG005|Primary Treatment Phase|Other Violation|1|||
156586968|NCT00069095|565233480|FG000|Primary Treatment Phase|Violation criteria|0|||
156586969|NCT00069095|565233481|FG001|Primary Treatment Phase|Violation criteria|2|||
156586970|NCT00069095|565233482|FG002|Primary Treatment Phase|Violation criteria|4|||
156586971|NCT00069095|565233483|FG003|Primary Treatment Phase|Violation criteria|3|||
156586972|NCT00069095|565233484|FG004|Primary Treatment Phase|Violation criteria|1|||
156586973|NCT00069095|565233485|FG005|Primary Treatment Phase|Violation criteria|5|||
156586974|NCT00069095|565233480|FG000|Post-study Treatment Phase|Missing reason|1|||
156586975|NCT00069095|565233481|FG001|Post-study Treatment Phase|Missing reason|3|||
156586976|NCT00069095|565233482|FG002|Post-study Treatment Phase|Missing reason|12|||
156586977|NCT00069095|565233483|FG003|Post-study Treatment Phase|Missing reason|8|||
156586978|NCT00069095|565233484|FG004|Post-study Treatment Phase|Missing reason|18|||
156586979|NCT00069095|565233485|FG005|Post-study Treatment Phase|Missing reason|17|||
156586980|NCT00069095|565233480|FG000|Post-study Treatment Phase|Adverse Event|2|||
156586981|NCT00069095|565233481|FG001|Post-study Treatment Phase|Adverse Event|3|||
156586982|NCT00069095|565233482|FG002|Post-study Treatment Phase|Adverse Event|1|||
156586983|NCT00069095|565233483|FG003|Post-study Treatment Phase|Adverse Event|0|||
156586984|NCT00069095|565233484|FG004|Post-study Treatment Phase|Adverse Event|5|||
156586985|NCT00069095|565233485|FG005|Post-study Treatment Phase|Adverse Event|1|||
156586986|NCT00069095|565233480|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
156586987|NCT00069095|565233481|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
156586988|NCT00069095|565233482|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
156586989|NCT00069095|565233483|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
156586990|NCT00069095|565233484|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
156586991|NCT00069095|565233485|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
156586992|NCT00069095|565233480|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
156586993|NCT00069095|565233481|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
156586994|NCT00069095|565233482|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
156586995|NCT00069095|565233483|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
156586996|NCT00069095|565233484|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
156586997|NCT00069095|565233485|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
156586998|NCT00069095|565233480|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
156586999|NCT00069095|565233481|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
156587000|NCT00069095|565233482|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
156587001|NCT00069095|565233483|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
156587002|NCT00069095|565233484|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
156587003|NCT00069095|565233485|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
156587004|NCT00069095|565233480|FG000|Post-study Treatment Phase|Participant had complete response|1|||
156587005|NCT00069095|565233481|FG001|Post-study Treatment Phase|Participant had complete response|1|||
156587006|NCT00069095|565233482|FG002|Post-study Treatment Phase|Participant had complete response|0|||
156587007|NCT00069095|565233483|FG003|Post-study Treatment Phase|Participant had complete response|0|||
156587008|NCT00069095|565233484|FG004|Post-study Treatment Phase|Participant had complete response|0|||
156587009|NCT00069095|565233485|FG005|Post-study Treatment Phase|Participant had complete response|0|||
156587010|NCT00069095|565233480|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
156587011|NCT00069095|565233481|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
156587012|NCT00069095|565233482|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
156587013|NCT00069095|565233483|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
156587014|NCT00069095|565233484|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
156587015|NCT00069095|565233485|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
156587016|NCT00069095|565233480|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
156587017|NCT00069095|565233481|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
156587018|NCT00069095|565233482|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
156587019|NCT00069095|565233483|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
156587020|NCT00069095|565233484|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
156587021|NCT00069095|565233485|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
156587022|NCT00069095|565233480|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
156587023|NCT00069095|565233481|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
156587024|NCT00069095|565233482|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
156587025|NCT00069095|565233483|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
156587026|NCT00069095|565233484|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
156587027|NCT00069095|565233485|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
156587028|NCT00069095|565233480|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
156587029|NCT00069095|565233481|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
156587030|NCT00069095|565233482|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
156587031|NCT00069095|565233483|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
156587032|NCT00069095|565233484|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
156587033|NCT00069095|565233485|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
156587034|NCT00069095|565233480|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
156587035|NCT00069095|565233481|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
156587036|NCT00069095|565233482|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
156587037|NCT00069095|565233483|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
156587038|NCT00069095|565233484|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
156587039|NCT00069095|565233485|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
156587040|NCT00069095|565233480|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
156587041|NCT00069095|565233481|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
156587042|NCT00069095|565233482|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
156587043|NCT00069095|565233483|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
156587044|NCT00069095|565233484|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
156587045|NCT00069095|565233485|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
156587046|NCT00069095|565233480|FG000|Post-study Treatment Phase|Surgery|0|||
156587047|NCT00069095|565233481|FG001|Post-study Treatment Phase|Surgery|0|||
156587048|NCT00069095|565233482|FG002|Post-study Treatment Phase|Surgery|0|||
156587049|NCT00069095|565233483|FG003|Post-study Treatment Phase|Surgery|1|||
156587050|NCT00069095|565233484|FG004|Post-study Treatment Phase|Surgery|1|||
156587051|NCT00069095|565233485|FG005|Post-study Treatment Phase|Surgery|0|||
156587052|NCT00069095|565233480|FG000|Post-study Treatment Phase|Death|0|||
156587053|NCT00069095|565233481|FG001|Post-study Treatment Phase|Death|0|||
156587054|NCT00069095|565233482|FG002|Post-study Treatment Phase|Death|0|||
156587055|NCT00069095|565233483|FG003|Post-study Treatment Phase|Death|0|||
156587056|NCT00069095|565233484|FG004|Post-study Treatment Phase|Death|1|||
156587057|NCT00069095|565233485|FG005|Post-study Treatment Phase|Death|0|||
156587058|NCT00069095|565233480|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
156587059|NCT00069095|565233481|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
156587060|NCT00069095|565233482|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
156587061|NCT00069095|565233483|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
156587062|NCT00069095|565233484|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
156587063|NCT00069095|565233485|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
156587064|NCT00069095|565233480|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
156587065|NCT00069095|565233481|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
156587066|NCT00069095|565233482|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
156587067|NCT00069095|565233483|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
156587068|NCT00069095|565233484|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
156587069|NCT00069095|565233485|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
156587070|NCT00069095|565233480|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
156587071|NCT00069095|565233481|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
156587072|NCT00069095|565233482|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
156587073|NCT00069095|565233483|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
156587074|NCT00069095|565233484|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
156587075|NCT00069095|565233485|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
156587076|NCT00069095|565233480|FG000|Post-study Treatment Phase|Investigator decision|0|||
156587077|NCT00069095|565233481|FG001|Post-study Treatment Phase|Investigator decision|0|||
156587078|NCT00069095|565233482|FG002|Post-study Treatment Phase|Investigator decision|0|||
156587079|NCT00069095|565233483|FG003|Post-study Treatment Phase|Investigator decision|0|||
156587080|NCT00069095|565233484|FG004|Post-study Treatment Phase|Investigator decision|0|||
156587081|NCT00069095|565233485|FG005|Post-study Treatment Phase|Investigator decision|1|||
156587082|NCT00069095|565233480|FG000|Follow-up Phase|Death|174|||
156587083|NCT00069095|565233481|FG001|Follow-up Phase|Death|206|||
156587084|NCT00069095|565233482|FG002|Follow-up Phase|Death|120|||
156587085|NCT00069095|565233483|FG003|Follow-up Phase|Death|112|||
156587086|NCT00069095|565233484|FG004|Follow-up Phase|Death|92|||
156587087|NCT00069095|565233485|FG005|Follow-up Phase|Death|101|||
156587088|NCT05610176|565233486|FG000|Overall Study|Death|6|||
156587089|NCT00850759|565233493|FG000|Overall Study|Lost to Follow-up|7|||
156587090|NCT00850759|565233494|FG001|Overall Study|Lost to Follow-up|5|||
156587091|NCT00850759|565233495|FG002|Overall Study|Lost to Follow-up|5|||
156587092|NCT00850759|565233496|FG003|Overall Study|Lost to Follow-up|3|||
156587093|NCT01727713|565233497|FG000|Overall Study|Lost to Follow-up|5|||
156587094|NCT01727713|565233497|FG000|Overall Study|Adverse Event|10|||
156587095|NCT01727713|565233497|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
156587096|NCT01727713|565233497|FG000|Overall Study|Withdrawal by Subject|13|||
156587097|NCT01727713|565233497|FG000|Overall Study|Protocol Deviation|2|||
156587098|NCT02389816|565233499|FG000|Overall Study|Randomized but Not Treated|1|||
156587099|NCT02389816|565233500|FG001|Overall Study|Randomized but Not Treated|0|||
156587100|NCT02389816|565233501|FG002|Overall Study|Randomized but Not Treated|0|||
156587101|NCT02389816|565233499|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
156587102|NCT02389816|565233500|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
156587103|NCT02389816|565233501|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
156587104|NCT02389816|565233499|FG000|Overall Study|Major Protocol Deviation|1|||
156587105|NCT02389816|565233500|FG001|Overall Study|Major Protocol Deviation|0|||
156587106|NCT02389816|565233501|FG002|Overall Study|Major Protocol Deviation|0|||
156587107|NCT02389816|565233499|FG000|Overall Study|Lost to Follow-up|1|||
156587108|NCT02389816|565233500|FG001|Overall Study|Lost to Follow-up|0|||
156587109|NCT02389816|565233501|FG002|Overall Study|Lost to Follow-up|0|||
156587110|NCT02389816|565233499|FG000|Overall Study|Withdrawal of Consent|6|||
156587111|NCT02389816|565233500|FG001|Overall Study|Withdrawal of Consent|4|||
156587112|NCT02389816|565233501|FG002|Overall Study|Withdrawal of Consent|4|||
156587113|NCT02389816|565233499|FG000|Overall Study|Lack of Efficacy|1|||
156587114|NCT02389816|565233500|FG001|Overall Study|Lack of Efficacy|0|||
156587115|NCT02389816|565233501|FG002|Overall Study|Lack of Efficacy|0|||
156587116|NCT02389816|565233499|FG000|Overall Study|Non Compliance with Study Drug|1|||
156587117|NCT02389816|565233500|FG001|Overall Study|Non Compliance with Study Drug|1|||
156587118|NCT02389816|565233501|FG002|Overall Study|Non Compliance with Study Drug|1|||
156587119|NCT02389816|565233499|FG000|Overall Study|Reason not Specified|0|||
156587120|NCT02389816|565233500|FG001|Overall Study|Reason not Specified|2|||
156587121|NCT02389816|565233501|FG002|Overall Study|Reason not Specified|0|||
156587122|NCT00578864|565233508|FG000|Overall Study|Death|1|||
156587123|NCT00578864|565233509|FG001|Overall Study|Death|0|||
156587124|NCT01253044|565233513|FG000|Overall Study|Lost to Follow-up|38|||
156587125|NCT01253044|565233514|FG001|Overall Study|Lost to Follow-up|29|||
156587126|NCT01217190|565233515|FG000|Second Dosing|Withdrawal by Subject|0|||
156587127|NCT01217190|565233516|FG001|Second Dosing|Withdrawal by Subject|2|||
156587128|NCT01594476|565233517|FG000|Overall Study|Protocol Violation|1|||
156587129|NCT01594476|565233518|FG001|Overall Study|Protocol Violation|3|||
156587130|NCT01425190|565233519|FG000|Overall Study|Full dose not consumed.|1|||
156587131|NCT01425190|565233520|FG001|Overall Study|Full dose not consumed.|0|||
156587132|NCT01425190|565233521|FG002|Overall Study|Full dose not consumed.|0|||
156587133|NCT02552355|565233522|FG000|Overall Study|Adverse Event|0|||
156587134|NCT02552355|565233523|FG001|Overall Study|Adverse Event|2|||
156587135|NCT02552355|565233524|FG002|Overall Study|Adverse Event|2|||
156587136|NCT02552355|565233525|FG003|Overall Study|Adverse Event|0|||
156587137|NCT02552355|565233522|FG000|Overall Study|Withdrawal by Subject|0|||
156587138|NCT02552355|565233523|FG001|Overall Study|Withdrawal by Subject|0|||
156587139|NCT02552355|565233524|FG002|Overall Study|Withdrawal by Subject|0|||
156587140|NCT02552355|565233525|FG003|Overall Study|Withdrawal by Subject|1|||
156587141|NCT00850460|565233528|FG000|Overall Study|Lost to Follow-up|4|||
156587142|NCT00850460|565233529|FG001|Overall Study|Lost to Follow-up|4|||
156587143|NCT03007953|565233532|FG000|Overall Study|Withdrawal by Subject|5|||
156587144|NCT03007953|565233533|FG001|Overall Study|Withdrawal by Subject|2|||
156587145|NCT03007953|565233532|FG000|Overall Study|Death|5|||
156587146|NCT03007953|565233533|FG001|Overall Study|Death|7|||
156587147|NCT03007953|565233532|FG000|Overall Study|Lost to Follow-up|3|||
156587148|NCT03007953|565233533|FG001|Overall Study|Lost to Follow-up|2|||
156587149|NCT03007953|565233532|FG000|Overall Study|Enrolled in Hospice|3|||
156587150|NCT03007953|565233533|FG001|Overall Study|Enrolled in Hospice|2|||
156587151|NCT01052012|565233534|FG000|Overall Study|Not treated|2|||
156587152|NCT01052012|565233535|FG001|Overall Study|Not treated|5|||
156587153|NCT01052012|565233536|FG002|Overall Study|Not treated|0|||
156587154|NCT01052012|565233537|FG003|Overall Study|Not treated|0|||
156587155|NCT01052012|565233538|FG004|Overall Study|Not treated|11|||
156587156|NCT01052012|565233539|FG005|Overall Study|Not treated|8|||
156587157|NCT01052012|565233534|FG000|Overall Study|Adverse Event|1|||
156587158|NCT01052012|565233535|FG001|Overall Study|Adverse Event|0|||
156587159|NCT01052012|565233536|FG002|Overall Study|Adverse Event|0|||
156587160|NCT01052012|565233537|FG003|Overall Study|Adverse Event|1|||
156587161|NCT01052012|565233538|FG004|Overall Study|Adverse Event|0|||
156587162|NCT01052012|565233539|FG005|Overall Study|Adverse Event|0|||
156587163|NCT01052012|565233534|FG000|Overall Study|Lost to Follow-up|0|||
156587164|NCT01052012|565233535|FG001|Overall Study|Lost to Follow-up|0|||
156587165|NCT01052012|565233536|FG002|Overall Study|Lost to Follow-up|0|||
156587166|NCT01052012|565233537|FG003|Overall Study|Lost to Follow-up|0|||
156587167|NCT01052012|565233538|FG004|Overall Study|Lost to Follow-up|1|||
156587168|NCT01052012|565233539|FG005|Overall Study|Lost to Follow-up|0|||
156587169|NCT01052012|565233534|FG000|Overall Study|Withdrawal by Subject|1|||
156587170|NCT01052012|565233535|FG001|Overall Study|Withdrawal by Subject|1|||
156587171|NCT01052012|565233536|FG002|Overall Study|Withdrawal by Subject|0|||
156587172|NCT01052012|565233537|FG003|Overall Study|Withdrawal by Subject|0|||
156587173|NCT01052012|565233538|FG004|Overall Study|Withdrawal by Subject|3|||
156587174|NCT01052012|565233539|FG005|Overall Study|Withdrawal by Subject|1|||
156587175|NCT01052012|565233534|FG000|Overall Study|Physician Decision|0|||
156587176|NCT01052012|565233535|FG001|Overall Study|Physician Decision|0|||
156587177|NCT01052012|565233536|FG002|Overall Study|Physician Decision|0|||
156587178|NCT01052012|565233537|FG003|Overall Study|Physician Decision|0|||
156587179|NCT01052012|565233538|FG004|Overall Study|Physician Decision|0|||
156587180|NCT01052012|565233539|FG005|Overall Study|Physician Decision|1|||
156587181|NCT01052012|565233534|FG000|Overall Study|Other|0|||
156587182|NCT01052012|565233535|FG001|Overall Study|Other|0|||
156587183|NCT01052012|565233536|FG002|Overall Study|Other|0|||
156587184|NCT01052012|565233537|FG003|Overall Study|Other|0|||
156587185|NCT01052012|565233538|FG004|Overall Study|Other|1|||
156587186|NCT01052012|565233539|FG005|Overall Study|Other|0|||
156587187|NCT02224846|565233540|FG000|Period 1 (Month 3)|Adverse Event|2|||
156587188|NCT02224846|565233541|FG001|Period 1 (Month 3)|Adverse Event|1|||
156587189|NCT02224846|565233540|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
156587190|NCT02224846|565233541|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
156587191|NCT02224846|565233540|FG000|Period 1 (Month 3)|Protocol Violation|4|||
156587192|NCT02224846|565233541|FG001|Period 1 (Month 3)|Protocol Violation|8|||
156587193|NCT02224846|565233540|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
156587194|NCT02224846|565233541|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
156587195|NCT02224846|565233540|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
156587196|NCT02224846|565233541|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
156587197|NCT02224846|565233540|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
156587198|NCT02224846|565233541|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
156587199|NCT02224846|565233540|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
156587200|NCT02224846|565233541|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
156587201|NCT02224846|565233540|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
156587202|NCT02224846|565233541|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
156587203|NCT02224846|565233540|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
156587204|NCT02224846|565233541|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
156587205|NCT02224846|565233540|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
156587206|NCT02224846|565233541|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
156587207|NCT02224846|565233540|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
156587208|NCT02224846|565233541|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
156587209|NCT02224846|565233540|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
156587210|NCT02224846|565233541|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
156587211|NCT02224846|565233540|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
156587212|NCT02224846|565233541|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
156587213|NCT02224846|565233540|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
156587214|NCT02224846|565233541|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
156587215|NCT02224846|565233540|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
156587216|NCT02224846|565233541|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
156587217|NCT02224846|565233540|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
156587218|NCT02224846|565233541|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
156587219|NCT02224846|565233540|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
156587220|NCT02224846|565233541|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
156587221|NCT03196297|565233545|FG000|Main Period|Withdrawal by Subject|4|||
156587222|NCT03196297|565233545|FG000|Extension Period|Withdrawal by Subject|1|||
156587223|NCT03196297|565233545|FG000|Extension Period|Lack of Efficacy|2|||
156587224|NCT02538666|565233546|FG000|Pre-Treatment|Disease progression|1|||
156587225|NCT02538666|565233547|FG001|Pre-Treatment|Disease progression|0|||
156587226|NCT02538666|565233548|FG002|Pre-Treatment|Disease progression|0|||
156587227|NCT02538666|565233546|FG000|Pre-Treatment|no longer meets study criteria|1|||
156587228|NCT02538666|565233547|FG001|Pre-Treatment|no longer meets study criteria|0|||
156587229|NCT02538666|565233548|FG002|Pre-Treatment|no longer meets study criteria|0|||
156587230|NCT02538666|565233546|FG000|Pre-Treatment|Withdrew Consent|0|||
156587231|NCT02538666|565233547|FG001|Pre-Treatment|Withdrew Consent|1|||
156587232|NCT02538666|565233548|FG002|Pre-Treatment|Withdrew Consent|1|||
156587233|NCT02538666|565233546|FG000|Treatment|Disease progression|270|||
156587234|NCT02538666|565233547|FG001|Treatment|Disease progression|227|||
156587235|NCT02538666|565233548|FG002|Treatment|Disease progression|165|||
156587236|NCT02538666|565233546|FG000|Treatment|Study drug toxicity|1|||
156587237|NCT02538666|565233547|FG001|Treatment|Study drug toxicity|29|||
156587238|NCT02538666|565233548|FG002|Treatment|Study drug toxicity|92|||
156587239|NCT02538666|565233546|FG000|Treatment|Death|0|||
156587240|NCT02538666|565233547|FG001|Treatment|Death|2|||
156587241|NCT02538666|565233548|FG002|Treatment|Death|3|||
156587242|NCT02538666|565233546|FG000|Treatment|Adverse event unrelated to study drug|8|||
156587243|NCT02538666|565233547|FG001|Treatment|Adverse event unrelated to study drug|10|||
156587244|NCT02538666|565233548|FG002|Treatment|Adverse event unrelated to study drug|15|||
156587245|NCT02538666|565233546|FG000|Treatment|Participant request to discontinue study treatment|3|||
156587246|NCT02538666|565233547|FG001|Treatment|Participant request to discontinue study treatment|6|||
156587247|NCT02538666|565233548|FG002|Treatment|Participant request to discontinue study treatment|11|||
156587248|NCT02538666|565233546|FG000|Treatment|Participant withdrew consent|2|||
156587249|NCT02538666|565233547|FG001|Treatment|Participant withdrew consent|5|||
156587250|NCT02538666|565233548|FG002|Treatment|Participant withdrew consent|3|||
156587251|NCT02538666|565233546|FG000|Treatment|Lost to Follow-up|0|||
156587252|NCT02538666|565233547|FG001|Treatment|Lost to Follow-up|1|||
156587253|NCT02538666|565233548|FG002|Treatment|Lost to Follow-up|1|||
156587254|NCT02538666|565233546|FG000|Treatment|Maximum clinical benefit|4|||
156587255|NCT02538666|565233547|FG001|Treatment|Maximum clinical benefit|3|||
156587256|NCT02538666|565233548|FG002|Treatment|Maximum clinical benefit|4|||
156587257|NCT02538666|565233546|FG000|Treatment|Poor/non-compliance|0|||
156587258|NCT02538666|565233547|FG001|Treatment|Poor/non-compliance|1|||
156587259|NCT02538666|565233548|FG002|Treatment|Poor/non-compliance|0|||
156587260|NCT02538666|565233546|FG000|Treatment|Participant no longer meets study criteria|0|||
156587261|NCT02538666|565233547|FG001|Treatment|Participant no longer meets study criteria|2|||
156587262|NCT02538666|565233548|FG002|Treatment|Participant no longer meets study criteria|0|||
156587263|NCT02538666|565233546|FG000|Treatment|Administrative reason by sponsor|0|||
156587264|NCT02538666|565233547|FG001|Treatment|Administrative reason by sponsor|0|||
156587265|NCT02538666|565233548|FG002|Treatment|Administrative reason by sponsor|1|||
156587266|NCT02538666|565233546|FG000|Treatment|Other reasons|8|||
156587267|NCT02538666|565233547|FG001|Treatment|Other reasons|15|||
156587268|NCT02538666|565233548|FG002|Treatment|Other reasons|5|||
156587269|NCT02538666|565233546|FG000|Treatment|Not reported|2|||
156587270|NCT02538666|565233547|FG001|Treatment|Not reported|2|||
156587271|NCT02538666|565233548|FG002|Treatment|Not reported|2|||
156587272|NCT00320385|565233553|FG000|Overall Study|Lost to Follow-up|7|||
156587273|NCT00320385|565233554|FG001|Overall Study|Lost to Follow-up|10|||
156587274|NCT00320385|565233553|FG000|Overall Study|Withdrawal by Subject|6|||
156587275|NCT00320385|565233554|FG001|Overall Study|Withdrawal by Subject|7|||
156587276|NCT00320385|565233553|FG000|Overall Study|Sponsor Terminated Study|2|||
156587277|NCT00320385|565233554|FG001|Overall Study|Sponsor Terminated Study|1|||
156587278|NCT00320385|565233553|FG000|Overall Study|Investigator Decision|0|||
156587279|NCT00320385|565233554|FG001|Overall Study|Investigator Decision|1|||
156587280|NCT00320385|565233553|FG000|Overall Study|Death|1|||
156587281|NCT00320385|565233554|FG001|Overall Study|Death|2|||
156587282|NCT00320385|565233553|FG000|Overall Study|Serious Adverse Event|1|||
156587283|NCT00320385|565233554|FG001|Overall Study|Serious Adverse Event|0|||
156587284|NCT00320385|565233553|FG000|Overall Study|Withdrew Consent|1|||
156587285|NCT00320385|565233554|FG001|Overall Study|Withdrew Consent|0|||
156587286|NCT00320385|565233553|FG000|Overall Study|Adverse Event|0|||
156587287|NCT00320385|565233554|FG001|Overall Study|Adverse Event|1|||
156587288|NCT04370028|565233555|FG000|Overall Study|Withdrawal by Subject|695|||
156587289|NCT04370028|565233555|FG000|Overall Study|Protocol Violation|9|||
156587290|NCT04370028|565233555|FG000|Overall Study|Adverse Event|3|||
156587291|NCT02582749|565233560|FG000|Overall Study|Study terminated by funder|5|||
156587292|NCT02582749|565233561|FG001|Overall Study|Study terminated by funder|10|||
156587293|NCT02582749|565233560|FG000|Overall Study|Withdrawal by Subject|0|||
156587294|NCT02582749|565233561|FG001|Overall Study|Withdrawal by Subject|1|||
156587295|NCT02213198|565233562|FG000|Baseline|No show for intake|7|||
156587296|NCT02213198|565233563|FG001|Baseline|No show for intake|9|||
156587297|NCT02213198|565233562|FG000|Baseline|Withdrawal by Subject|34|||
156587298|NCT02213198|565233563|FG001|Baseline|Withdrawal by Subject|11|||
156587299|NCT02213198|565233562|FG000|Baseline|transferred out of clinic|7|||
156587300|NCT02213198|565233563|FG001|Baseline|transferred out of clinic|9|||
156587301|NCT02213198|565233562|FG000|Baseline|Lost to Follow-up|40|||
156587302|NCT02213198|565233563|FG001|Baseline|Lost to Follow-up|21|||
156587303|NCT02213198|565233562|FG000|Baseline|incarcerated,violent|0|||
156587304|NCT02213198|565233563|FG001|Baseline|incarcerated,violent|1|||
156587305|NCT02213198|565233562|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
156587306|NCT02213198|565233563|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
156587307|NCT02213198|565233562|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
156587308|NCT02213198|565233563|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
156587309|NCT02213198|565233562|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
156587310|NCT02213198|565233563|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
156587311|NCT02213198|565233562|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
156587312|NCT02213198|565233563|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
156587313|NCT02213198|565233562|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
156587314|NCT02213198|565233563|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
156587315|NCT02213198|565233562|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
156587316|NCT02213198|565233563|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
156587317|NCT01518192|565233564|FG000|Overall Study|Lost to Follow-up|29|||
156587318|NCT01518192|565233565|FG001|Overall Study|Lost to Follow-up|26|||
156587319|NCT01518192|565233566|FG002|Overall Study|Lost to Follow-up|35|||
156587320|NCT00001262|565233567|FG000|Overall Study|Death|10|||
156587321|NCT00001262|565233568|FG001|Overall Study|Death|11|||
156587322|NCT00001262|565233569|FG002|Overall Study|Death|0|||
156634896|NCT03917654|565407820|FG005|Year 1|Withdrawal by Subject|1|||
156587323|NCT00001262|565233567|FG000|Overall Study|Withdrawal by Subject|0|||
156587324|NCT00001262|565233568|FG001|Overall Study|Withdrawal by Subject|3|||
156587325|NCT00001262|565233569|FG002|Overall Study|Withdrawal by Subject|0|||
156587326|NCT00783705|565233571|FG000|Overall Study|Adverse Event|2|||
156587327|NCT00783705|565233572|FG001|Overall Study|Adverse Event|0|||
156587328|NCT00783705|565233571|FG000|Overall Study|Withdrawal by Subject|3|||
156587329|NCT00783705|565233572|FG001|Overall Study|Withdrawal by Subject|2|||
156587330|NCT00783705|565233571|FG000|Overall Study|Lost to Follow-up|1|||
156587331|NCT00783705|565233572|FG001|Overall Study|Lost to Follow-up|3|||
156587332|NCT00601523|565233573|FG000|Overall Study|Adverse Event|42|||
156587333|NCT00601523|565233574|FG001|Overall Study|Adverse Event|14|||
156587334|NCT00601523|565233573|FG000|Overall Study|Lack of Efficacy|3|||
156587335|NCT00601523|565233574|FG001|Overall Study|Lack of Efficacy|0|||
156587336|NCT00601523|565233573|FG000|Overall Study|Protocol Violation|5|||
156587337|NCT00601523|565233574|FG001|Overall Study|Protocol Violation|1|||
156587338|NCT00601523|565233573|FG000|Overall Study|Lost to Follow-up|0|||
156587339|NCT00601523|565233574|FG001|Overall Study|Lost to Follow-up|1|||
156587340|NCT00601523|565233573|FG000|Overall Study|Withdrawal by Subject|18|||
156587341|NCT00601523|565233574|FG001|Overall Study|Withdrawal by Subject|9|||
156587342|NCT00601523|565233573|FG000|Overall Study|Other|9|||
156587343|NCT00601523|565233574|FG001|Overall Study|Other|1|||
156587344|NCT01987986|565233575|FG000|Overall Study|Lost to Follow-up|1|||
156587345|NCT01987986|565233576|FG001|Overall Study|Lost to Follow-up|0|||
156587346|NCT01987986|565233577|FG002|Overall Study|Lost to Follow-up|0|||
156587347|NCT01987986|565233578|FG003|Overall Study|Lost to Follow-up|0|||
156587348|NCT01987986|565233575|FG000|Overall Study|Adverse Event|1|||
156587349|NCT01987986|565233576|FG001|Overall Study|Adverse Event|0|||
156587350|NCT01987986|565233577|FG002|Overall Study|Adverse Event|2|||
156587351|NCT01987986|565233578|FG003|Overall Study|Adverse Event|0|||
156587352|NCT01617434|565233579|FG000|Overall Study|Adverse Event|12|||
156587353|NCT01617434|565233580|FG001|Overall Study|Adverse Event|3|||
156587354|NCT01617434|565233579|FG000|Overall Study|Protocol Violation|8|||
156587355|NCT01617434|565233580|FG001|Overall Study|Protocol Violation|7|||
156587356|NCT01617434|565233579|FG000|Overall Study|Withdrawal Criteria|12|||
156587357|NCT01617434|565233580|FG001|Overall Study|Withdrawal Criteria|37|||
156587358|NCT01617434|565233579|FG000|Overall Study|Unclassified|3|||
156587359|NCT01617434|565233580|FG001|Overall Study|Unclassified|4|||
156587360|NCT05513053|565233584|FG000|Overall Study|Lost to Follow-up|9|||
156587361|NCT05513053|565233585|FG001|Overall Study|Lost to Follow-up|11|||
156587362|NCT05513053|565233584|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156587363|NCT05513053|565233585|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156587364|NCT05513053|565233584|FG000|Overall Study|Withdrawal by Subject|2|||
156587365|NCT05513053|565233585|FG001|Overall Study|Withdrawal by Subject|9|||
156587366|NCT05513053|565233584|FG000|Overall Study|Protocol Violation|6|||
156587367|NCT05513053|565233585|FG001|Overall Study|Protocol Violation|3|||
156587368|NCT05513053|565233584|FG000|Overall Study|Adverse Event|0|||
156587369|NCT05513053|565233585|FG001|Overall Study|Adverse Event|2|||
156587370|NCT04038255|565235317|FG000|Overall Study|Lost to Follow-up|0|||
156587371|NCT04038255|565235318|FG001|Overall Study|Lost to Follow-up|9|||
156587372|NCT04038255|565235319|FG002|Overall Study|Lost to Follow-up|5|||
156587373|NCT04038255|565235317|FG000|Overall Study|Withdrawal by Subject|0|||
156587374|NCT04038255|565235318|FG001|Overall Study|Withdrawal by Subject|0|||
156587375|NCT04038255|565235319|FG002|Overall Study|Withdrawal by Subject|1|||
156587376|NCT05183867|565235320|FG000|Overall Study|Withdrawal by Subject|3|||
156587377|NCT05183867|565235321|FG001|Overall Study|Withdrawal by Subject|2|||
156587378|NCT05183867|565235322|FG002|Overall Study|Withdrawal by Subject|0|||
156587379|NCT04491877|565235325|FG000|Overall Study|Protocol Deviation|1|||
156587380|NCT04491877|565235326|FG001|Overall Study|Protocol Deviation|0|||
156587381|NCT04491877|565235327|FG002|Overall Study|Protocol Deviation|2|||
156587382|NCT04491877|565235328|FG003|Overall Study|Protocol Deviation|0|||
156587383|NCT04491877|565235329|FG004|Overall Study|Protocol Deviation|0|||
156587384|NCT04491877|565235330|FG005|Overall Study|Protocol Deviation|0|||
156587385|NCT04491877|565235331|FG006|Overall Study|Protocol Deviation|1|||
156587386|NCT04491877|565235332|FG007|Overall Study|Protocol Deviation|1|||
156587387|NCT04491877|565235333|FG008|Overall Study|Protocol Deviation|0|||
156587388|NCT04491877|565235325|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156587389|NCT04491877|565235326|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156587390|NCT04491877|565235327|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156587391|NCT04491877|565235328|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
156587392|NCT04491877|565235329|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156587393|NCT04491877|565235330|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
156587394|NCT04491877|565235331|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
156587395|NCT04491877|565235332|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
156587396|NCT04491877|565235333|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
156587397|NCT04491877|565235325|FG000|Overall Study|Lost to Follow-up|0|||
156587398|NCT04491877|565235326|FG001|Overall Study|Lost to Follow-up|2|||
156587399|NCT04491877|565235327|FG002|Overall Study|Lost to Follow-up|0|||
156587400|NCT04491877|565235328|FG003|Overall Study|Lost to Follow-up|0|||
156587401|NCT04491877|565235329|FG004|Overall Study|Lost to Follow-up|0|||
156587402|NCT04491877|565235330|FG005|Overall Study|Lost to Follow-up|0|||
156587403|NCT04491877|565235331|FG006|Overall Study|Lost to Follow-up|2|||
156587404|NCT04491877|565235332|FG007|Overall Study|Lost to Follow-up|1|||
156587405|NCT04491877|565235333|FG008|Overall Study|Lost to Follow-up|1|||
156587406|NCT02614287|565235334|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
156587407|NCT02614287|565235335|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
156587408|NCT02614287|565235334|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
156587409|NCT02614287|565235335|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
156587410|NCT02614287|565235334|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
156587411|NCT02614287|565235335|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
156587412|NCT02614287|565235334|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
156587413|NCT02614287|565235335|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
156587414|NCT02614287|565235334|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
156587415|NCT02614287|565235335|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
156587416|NCT02614287|565235334|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
156587417|NCT02614287|565235335|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
156587418|NCT02614287|565235334|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
156587419|NCT02614287|565235335|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
156587420|NCT02614287|565235334|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
156587421|NCT02614287|565235335|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
156587422|NCT00683475|565235336|FG000|Overall Study|Withdrawal by Subject|1|||
156587423|NCT00683475|565235337|FG001|Overall Study|Withdrawal by Subject|0|||
156587424|NCT00683475|565235336|FG000|Overall Study|Never Treated: Adverse Event|2|||
156587425|NCT00683475|565235337|FG001|Overall Study|Never Treated: Adverse Event|3|||
156587426|NCT00683475|565235336|FG000|Overall Study|Never Treated: Progressive Disease|1|||
156587427|NCT00683475|565235337|FG001|Overall Study|Never Treated: Progressive Disease|0|||
156587428|NCT01953328|565235338|FG000|Overall Study|Withdrawal by Subject|0|||
156587429|NCT01953328|565235339|FG001|Overall Study|Withdrawal by Subject|0|||
156587430|NCT01953328|565235340|FG002|Overall Study|Withdrawal by Subject|0|||
156587431|NCT01953328|565235341|FG003|Overall Study|Withdrawal by Subject|0|||
156587432|NCT01953328|565235342|FG004|Overall Study|Withdrawal by Subject|1|||
156587433|NCT01953328|565235343|FG005|Overall Study|Withdrawal by Subject|0|||
156587434|NCT01953328|565235344|FG006|Overall Study|Withdrawal by Subject|0|||
156587435|NCT01953328|565235345|FG007|Overall Study|Withdrawal by Subject|0|||
156587436|NCT01953328|565235338|FG000|Overall Study|Lost to Follow-up|0|||
156587437|NCT01953328|565235339|FG001|Overall Study|Lost to Follow-up|0|||
156587438|NCT01953328|565235340|FG002|Overall Study|Lost to Follow-up|0|||
156587439|NCT01953328|565235341|FG003|Overall Study|Lost to Follow-up|0|||
156587440|NCT01953328|565235342|FG004|Overall Study|Lost to Follow-up|1|||
156587441|NCT01953328|565235343|FG005|Overall Study|Lost to Follow-up|0|||
156587442|NCT01953328|565235344|FG006|Overall Study|Lost to Follow-up|0|||
156587443|NCT01953328|565235345|FG007|Overall Study|Lost to Follow-up|0|||
156587444|NCT02429258|565235352|FG000|Overall Study|Withdrawal by Subject|2|||
156587445|NCT02429258|565235353|FG001|Overall Study|Withdrawal by Subject|0|||
156587446|NCT02429258|565235352|FG000|Overall Study|Protocol Violation|0|||
156587447|NCT02429258|565235353|FG001|Overall Study|Protocol Violation|1|||
156587448|NCT03364335|565235355|FG000|Overall Study|Adverse Event|3|||
156587449|NCT03364335|565235356|FG001|Overall Study|Adverse Event|4|||
156587450|NCT03364335|565235357|FG002|Overall Study|Adverse Event|1|||
156587451|NCT03364335|565235358|FG003|Overall Study|Adverse Event|2|||
156587452|NCT03364335|565235359|FG004|Overall Study|Adverse Event|0|||
156587453|NCT03364335|565235355|FG000|Overall Study|Lost to Follow-up|7|||
156587454|NCT03364335|565235356|FG001|Overall Study|Lost to Follow-up|7|||
156587455|NCT03364335|565235357|FG002|Overall Study|Lost to Follow-up|10|||
156587456|NCT03364335|565235358|FG003|Overall Study|Lost to Follow-up|11|||
156587457|NCT03364335|565235359|FG004|Overall Study|Lost to Follow-up|11|||
156587458|NCT00492856|565235360|FG000|Induction|Adverse Event|2|||
156587459|NCT00492856|565235361|FG001|Induction|Adverse Event|0|||
156587460|NCT00492856|565235362|FG002|Induction|Adverse Event|0|||
156587461|NCT00492856|565235363|FG003|Induction|Adverse Event|0|||
156587462|NCT00492856|565235360|FG000|Induction|Withdrawal by Subject|1|||
156587463|NCT00492856|565235361|FG001|Induction|Withdrawal by Subject|0|||
156587464|NCT00492856|565235362|FG002|Induction|Withdrawal by Subject|0|||
156587465|NCT00492856|565235363|FG003|Induction|Withdrawal by Subject|0|||
156587466|NCT00492856|565235360|FG000|Induction|Death|3|||
156587467|NCT00492856|565235361|FG001|Induction|Death|0|||
156587468|NCT00492856|565235362|FG002|Induction|Death|0|||
156587469|NCT00492856|565235363|FG003|Induction|Death|0|||
156587470|NCT00492856|565235360|FG000|Consolidation|Adverse Event|6|||
156587471|NCT00492856|565235361|FG001|Consolidation|Adverse Event|0|||
156587472|NCT00492856|565235362|FG002|Consolidation|Adverse Event|0|||
156587473|NCT00492856|565235363|FG003|Consolidation|Adverse Event|0|||
156587474|NCT00492856|565235360|FG000|Consolidation|Not protocol specified|2|||
156587475|NCT00492856|565235361|FG001|Consolidation|Not protocol specified|0|||
156587476|NCT00492856|565235362|FG002|Consolidation|Not protocol specified|0|||
156587477|NCT00492856|565235363|FG003|Consolidation|Not protocol specified|0|||
156587478|NCT00492856|565235360|FG000|Consolidation|Lost to Follow-up|1|||
156587479|NCT00492856|565235361|FG001|Consolidation|Lost to Follow-up|0|||
156587480|NCT00492856|565235362|FG002|Consolidation|Lost to Follow-up|0|||
156587481|NCT00492856|565235363|FG003|Consolidation|Lost to Follow-up|0|||
156587482|NCT00492856|565235360|FG000|Post-consolidation|Adverse Event|0|||
156587483|NCT00492856|565235361|FG001|Post-consolidation|Adverse Event|4|||
156587484|NCT00492856|565235362|FG002|Post-consolidation|Adverse Event|0|||
156587485|NCT00492856|565235363|FG003|Post-consolidation|Adverse Event|1|||
156587486|NCT00492856|565235360|FG000|Post-consolidation|Withdrawal by Subject|0|||
156587487|NCT00492856|565235361|FG001|Post-consolidation|Withdrawal by Subject|4|||
156587488|NCT00492856|565235362|FG002|Post-consolidation|Withdrawal by Subject|0|||
156587489|NCT00492856|565235363|FG003|Post-consolidation|Withdrawal by Subject|0|||
156587490|NCT00492856|565235360|FG000|Post-consolidation|Death|0|||
156587491|NCT00492856|565235361|FG001|Post-consolidation|Death|1|||
156587492|NCT00492856|565235362|FG002|Post-consolidation|Death|0|||
156587493|NCT00492856|565235363|FG003|Post-consolidation|Death|0|||
156587494|NCT00492856|565235360|FG000|Post-consolidation|Not protocol specified|0|||
156587495|NCT00492856|565235361|FG001|Post-consolidation|Not protocol specified|1|||
156587496|NCT00492856|565235362|FG002|Post-consolidation|Not protocol specified|0|||
156587497|NCT00492856|565235363|FG003|Post-consolidation|Not protocol specified|0|||
156587498|NCT00492856|565235360|FG000|Post-consolidation|Lost to Follow-up|0|||
156587499|NCT00492856|565235361|FG001|Post-consolidation|Lost to Follow-up|2|||
156587500|NCT00492856|565235362|FG002|Post-consolidation|Lost to Follow-up|0|||
156587501|NCT00492856|565235363|FG003|Post-consolidation|Lost to Follow-up|0|||
156587502|NCT00492856|565235360|FG000|Post-consolidation|Observation Arm|0|||
156587503|NCT00492856|565235361|FG001|Post-consolidation|Observation Arm|0|||
156587504|NCT00492856|565235362|FG002|Post-consolidation|Observation Arm|27|||
156587505|NCT00492856|565235363|FG003|Post-consolidation|Observation Arm|0|||
156587506|NCT03987919|565235364|FG000|Overall Study|Adverse Event|1|||
156587507|NCT03987919|565235365|FG001|Overall Study|Adverse Event|4|||
156587508|NCT03987919|565235366|FG002|Overall Study|Adverse Event|1|||
156587509|NCT03987919|565235367|FG003|Overall Study|Adverse Event|3|||
156587510|NCT03987919|565235364|FG000|Overall Study|Death|4|||
156587511|NCT03987919|565235365|FG001|Overall Study|Death|4|||
156587512|NCT03987919|565235366|FG002|Overall Study|Death|4|||
156587513|NCT03987919|565235367|FG003|Overall Study|Death|1|||
156587514|NCT03987919|565235364|FG000|Overall Study|Lost to Follow-up|5|||
156587515|NCT03987919|565235365|FG001|Overall Study|Lost to Follow-up|6|||
156587516|NCT03987919|565235366|FG002|Overall Study|Lost to Follow-up|8|||
156587517|NCT03987919|565235367|FG003|Overall Study|Lost to Follow-up|12|||
156587518|NCT03987919|565235364|FG000|Overall Study|Physician Decision|0|||
156587519|NCT03987919|565235365|FG001|Overall Study|Physician Decision|2|||
156587520|NCT03987919|565235366|FG002|Overall Study|Physician Decision|0|||
156587521|NCT03987919|565235367|FG003|Overall Study|Physician Decision|4|||
156587522|NCT03987919|565235364|FG000|Overall Study|Pregnancy|1|||
156587523|NCT03987919|565235365|FG001|Overall Study|Pregnancy|0|||
156587524|NCT03987919|565235366|FG002|Overall Study|Pregnancy|1|||
156587525|NCT03987919|565235367|FG003|Overall Study|Pregnancy|1|||
156587526|NCT03987919|565235364|FG000|Overall Study|Protocol Violation|0|||
156587527|NCT03987919|565235365|FG001|Overall Study|Protocol Violation|1|||
156587528|NCT03987919|565235366|FG002|Overall Study|Protocol Violation|0|||
156587529|NCT03987919|565235367|FG003|Overall Study|Protocol Violation|0|||
156587530|NCT03987919|565235364|FG000|Overall Study|Site terminated by Sponsor|0|||
156587531|NCT03987919|565235365|FG001|Overall Study|Site terminated by Sponsor|0|||
156587532|NCT03987919|565235366|FG002|Overall Study|Site terminated by Sponsor|0|||
156587533|NCT03987919|565235367|FG003|Overall Study|Site terminated by Sponsor|1|||
156587534|NCT03987919|565235364|FG000|Overall Study|Withdrawal by Subject|7|||
156587535|NCT03987919|565235365|FG001|Overall Study|Withdrawal by Subject|7|||
156587536|NCT03987919|565235366|FG002|Overall Study|Withdrawal by Subject|8|||
156587537|NCT03987919|565235367|FG003|Overall Study|Withdrawal by Subject|4|||
156587538|NCT03987919|565235364|FG000|Overall Study|Other - as reported by the investigator|1|||
156587539|NCT03987919|565235365|FG001|Overall Study|Other - as reported by the investigator|3|||
156587540|NCT03987919|565235366|FG002|Overall Study|Other - as reported by the investigator|2|||
156587541|NCT03987919|565235367|FG003|Overall Study|Other - as reported by the investigator|0|||
156587542|NCT03725202|565235370|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
156587543|NCT03725202|565235371|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
156587544|NCT03725202|565235372|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
156587545|NCT03725202|565235373|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
156587546|NCT03725202|565235374|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
156587547|NCT03725202|565235375|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
156587548|NCT03725202|565235376|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
156587549|NCT03725202|565235377|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
156587550|NCT03725202|565235370|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
156587551|NCT03725202|565235371|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
156587552|NCT03725202|565235372|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
156587553|NCT03725202|565235373|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
156587554|NCT03725202|565235374|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
156587555|NCT03725202|565235375|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
156587556|NCT03725202|565235376|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
156587557|NCT03725202|565235377|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
156587558|NCT03725202|565235370|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
156587559|NCT03725202|565235371|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
156587560|NCT03725202|565235372|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
156587561|NCT03725202|565235373|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
156587562|NCT03725202|565235374|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
156587563|NCT03725202|565235375|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
156587564|NCT03725202|565235376|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
156587565|NCT03725202|565235377|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
156587566|NCT03725202|565235370|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
156587567|NCT03725202|565235371|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
156587568|NCT03725202|565235372|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
156587569|NCT03725202|565235373|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
156587570|NCT03725202|565235374|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
156587571|NCT03725202|565235375|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
156587572|NCT03725202|565235376|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
156587573|NCT03725202|565235377|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
156587574|NCT03725202|565235370|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
156587575|NCT03725202|565235371|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
156587576|NCT03725202|565235372|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
156587577|NCT03725202|565235373|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
156587578|NCT03725202|565235374|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
156587579|NCT03725202|565235375|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
156587580|NCT03725202|565235376|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
156587581|NCT03725202|565235377|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
156587582|NCT03725202|565235370|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
156587583|NCT03725202|565235371|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
156587584|NCT03725202|565235372|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
156587585|NCT03725202|565235373|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
156587586|NCT03725202|565235374|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
156587587|NCT03725202|565235375|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
156587588|NCT03725202|565235376|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
156587589|NCT03725202|565235377|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
156587590|NCT03725202|565235370|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
156587591|NCT03725202|565235371|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
156587592|NCT03725202|565235372|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
156587593|NCT03725202|565235373|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
156587594|NCT03725202|565235374|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
156587595|NCT03725202|565235375|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
156587596|NCT03725202|565235376|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
156587597|NCT03725202|565235377|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
156587598|NCT03725202|565235370|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
156587599|NCT03725202|565235371|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
156587600|NCT03725202|565235372|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
156587601|NCT03725202|565235373|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
156587602|NCT03725202|565235374|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
156587603|NCT03725202|565235375|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
156587604|NCT03725202|565235376|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
156587605|NCT03725202|565235377|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
156587606|NCT03725202|565235370|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
156587607|NCT03725202|565235371|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
156587608|NCT03725202|565235372|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
156587609|NCT03725202|565235373|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
156587610|NCT03725202|565235374|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
156587611|NCT03725202|565235375|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
156587612|NCT03725202|565235376|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
156587613|NCT03725202|565235377|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
156587614|NCT03725202|565235370|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
156587615|NCT03725202|565235371|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
156587616|NCT03725202|565235372|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
156587617|NCT03725202|565235373|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
156587618|NCT03725202|565235374|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
156863645|NCT00627393|566258730|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
156587619|NCT03725202|565235375|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
156587620|NCT03725202|565235376|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
156587621|NCT03725202|565235377|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
156587622|NCT03725202|565235370|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
156587623|NCT03725202|565235371|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
156587624|NCT03725202|565235372|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
156587625|NCT03725202|565235373|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
156587626|NCT03725202|565235374|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
156587627|NCT03725202|565235375|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
156587628|NCT03725202|565235376|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
156587629|NCT03725202|565235377|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
156587630|NCT03725202|565235370|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
156587631|NCT03725202|565235371|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
156587632|NCT03725202|565235372|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
156587633|NCT03725202|565235373|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
156587634|NCT03725202|565235374|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
156587635|NCT03725202|565235375|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
156587636|NCT03725202|565235376|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
156587637|NCT03725202|565235377|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
156587638|NCT01520324|565235378|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
156587639|NCT01328249|565235381|FG000|Overall Study|Adverse Event|3|||
156587640|NCT01328249|565235382|FG001|Overall Study|Adverse Event|0|||
156587641|NCT01328249|565235381|FG000|Overall Study|Disease progression|1|||
156587642|NCT01328249|565235382|FG001|Overall Study|Disease progression|0|||
156587643|NCT01328249|565235381|FG000|Overall Study|Withdrawal by Subject|1|||
156587644|NCT01328249|565235382|FG001|Overall Study|Withdrawal by Subject|1|||
156587645|NCT01328249|565235381|FG000|Overall Study|Moved before end of treatment visit|1|||
156587646|NCT01328249|565235382|FG001|Overall Study|Moved before end of treatment visit|0|||
156587647|NCT01328249|565235381|FG000|Overall Study|Subject choice|1|||
156587648|NCT01328249|565235382|FG001|Overall Study|Subject choice|1|||
156587649|NCT01328249|565235381|FG000|Overall Study|Protocol Violation|0|||
156587650|NCT01328249|565235382|FG001|Overall Study|Protocol Violation|1|||
156587651|NCT00748553|565235383|FG000|Overall Study|Adverse Event|0|||
156587652|NCT00748553|565235384|FG001|Overall Study|Adverse Event|1|||
156587653|NCT00748553|565235383|FG000|Overall Study|disease progression|2|||
156587654|NCT00748553|565235384|FG001|Overall Study|disease progression|0|||
156587655|NCT00748553|565235383|FG000|Overall Study|noncompliance|1|||
156587656|NCT00748553|565235384|FG001|Overall Study|noncompliance|0|||
156587657|NCT00948818|565235386|FG000|Overall Study|Adverse Event|10|||
156587658|NCT00948818|565235387|FG001|Overall Study|Adverse Event|32|||
156587659|NCT00948818|565235386|FG000|Overall Study|Protocol Violation|9|||
156587660|NCT00948818|565235387|FG001|Overall Study|Protocol Violation|10|||
156587661|NCT00948818|565235386|FG000|Overall Study|Withdrawal by Subject|25|||
156587662|NCT00948818|565235387|FG001|Overall Study|Withdrawal by Subject|25|||
156587663|NCT00948818|565235386|FG000|Overall Study|Lost to Follow-up|10|||
156587664|NCT00948818|565235387|FG001|Overall Study|Lost to Follow-up|17|||
156587665|NCT00948818|565235386|FG000|Overall Study|Lack of Efficacy|4|||
156587666|NCT00948818|565235387|FG001|Overall Study|Lack of Efficacy|5|||
156587667|NCT00948818|565235386|FG000|Overall Study|Other Reason|4|||
156587668|NCT00948818|565235387|FG001|Overall Study|Other Reason|5|||
156587669|NCT02330549|565235388|FG000|Overall Study|Adverse Event|1|||
156587670|NCT02330549|565235389|FG001|Overall Study|Adverse Event|0|||
156587671|NCT02330549|565235388|FG000|Overall Study|Subject withdrew consent|2|||
156587672|NCT02330549|565235389|FG001|Overall Study|Subject withdrew consent|1|||
156587673|NCT02330549|565235388|FG000|Overall Study|Failure to meet randomization criteria|1|||
156587674|NCT02330549|565235389|FG001|Overall Study|Failure to meet randomization criteria|0|||
156587675|NCT00745368|565235390|FG000|Overall Study|Unable to provide sample|3|||
156587676|NCT00495495|565235391|FG000|Overall Study|Protocol Violation|99|||
156587677|NCT00434512|565235392|FG000|Overall Study|Migrated/moved from study area|0|||
156587678|NCT00434512|565235393|FG001|Overall Study|Migrated/moved from study area|0|||
156587679|NCT00434512|565235394|FG002|Overall Study|Migrated/moved from study area|0|||
156587680|NCT00434512|565235395|FG003|Overall Study|Migrated/moved from study area|1|||
156587681|NCT00434512|565235396|FG004|Overall Study|Migrated/moved from study area|1|||
156587682|NCT00434512|565235397|FG005|Overall Study|Migrated/moved from study area|1|||
156587683|NCT00434512|565235392|FG000|Overall Study|Other|0|||
156587684|NCT00434512|565235393|FG001|Overall Study|Other|1|||
156587685|NCT00434512|565235394|FG002|Overall Study|Other|0|||
156587686|NCT00434512|565235395|FG003|Overall Study|Other|0|||
156587687|NCT00434512|565235396|FG004|Overall Study|Other|0|||
156587688|NCT00434512|565235397|FG005|Overall Study|Other|0|||
156587689|NCT00441441|565235403|FG000|Overall Study|Adverse Event|2|||
156587690|NCT00441441|565235404|FG001|Overall Study|Adverse Event|1|||
156587691|NCT00441441|565235403|FG000|Overall Study|Protocol Violation|4|||
156587692|NCT00441441|565235404|FG001|Overall Study|Protocol Violation|6|||
156587693|NCT00441441|565235403|FG000|Overall Study|Exacerbation of asthma|1|||
156587694|NCT00441441|565235404|FG001|Overall Study|Exacerbation of asthma|2|||
156587695|NCT00441441|565235403|FG000|Overall Study|Withdrawal by Subject|1|||
156587696|NCT00441441|565235404|FG001|Overall Study|Withdrawal by Subject|2|||
156587697|NCT00441441|565235403|FG000|Overall Study|Other|3|||
156587698|NCT00441441|565235404|FG001|Overall Study|Other|3|||
156587699|NCT05619172|565235408|FG000|Safety Cohort 1|Death|7|||
156587700|NCT05619172|565235409|FG001|Safety Cohort 1|Death|0|||
156587701|NCT05619172|565235408|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
156587702|NCT05619172|565235409|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
156587703|NCT05619172|565235408|FG000|Safety Cohort 2|Death|0|||
156587704|NCT05619172|565235409|FG001|Safety Cohort 2|Death|1|||
156587705|NCT05619172|565235408|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
156587706|NCT05619172|565235409|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
156587707|NCT03165721|565235410|FG000|Overall Study|Refused further treatment|3|||
156587708|NCT03165721|565235411|FG001|Overall Study|Refused further treatment|0|||
156587709|NCT03165721|565235412|FG002|Overall Study|Refused further treatment|0|||
156587710|NCT03165721|565235410|FG000|Overall Study|Physician Decision|1|||
156587711|NCT03165721|565235411|FG001|Overall Study|Physician Decision|0|||
156587712|NCT03165721|565235412|FG002|Overall Study|Physician Decision|0|||
156587713|NCT01457118|565235414|FG000|Overall Study|Adverse Event|1|||
156587714|NCT01457118|565235415|FG001|Overall Study|Adverse Event|0|||
156587715|NCT01457118|565235416|FG002|Overall Study|Adverse Event|0|||
156587716|NCT01457118|565235417|FG003|Overall Study|Adverse Event|1|||
156587717|NCT01457118|565235414|FG000|Overall Study|Clinical Progression|0|||
156587718|NCT01457118|565235415|FG001|Overall Study|Clinical Progression|1|||
156587719|NCT01457118|565235416|FG002|Overall Study|Clinical Progression|0|||
156587720|NCT01457118|565235417|FG003|Overall Study|Clinical Progression|1|||
156587721|NCT01457118|565235414|FG000|Overall Study|Physician Decision|2|||
156587722|NCT01457118|565235415|FG001|Overall Study|Physician Decision|0|||
156587723|NCT01457118|565235416|FG002|Overall Study|Physician Decision|0|||
156587724|NCT01457118|565235417|FG003|Overall Study|Physician Decision|0|||
156587725|NCT01457118|565235414|FG000|Overall Study|Progressive Disease by RECIST|12|||
156587726|NCT01457118|565235415|FG001|Overall Study|Progressive Disease by RECIST|3|||
156587727|NCT01457118|565235416|FG002|Overall Study|Progressive Disease by RECIST|1|||
156587728|NCT01457118|565235417|FG003|Overall Study|Progressive Disease by RECIST|0|||
156587729|NCT01457118|565235414|FG000|Overall Study|Withdrawal by Subject|5|||
156587730|NCT01457118|565235415|FG001|Overall Study|Withdrawal by Subject|0|||
156587731|NCT01457118|565235416|FG002|Overall Study|Withdrawal by Subject|0|||
156587732|NCT01457118|565235417|FG003|Overall Study|Withdrawal by Subject|0|||
156587733|NCT01842308|565235420|FG000|Overall Study|Withdrawal by Subject|0|||
156587734|NCT01842308|565235421|FG001|Overall Study|Withdrawal by Subject|0|||
156587735|NCT01842308|565235422|FG002|Overall Study|Withdrawal by Subject|0|||
156587736|NCT01842308|565235423|FG003|Overall Study|Withdrawal by Subject|0|||
156587737|NCT01842308|565235424|FG004|Overall Study|Withdrawal by Subject|1|||
156587738|NCT00748540|565235428|FG000|Overall Study|Physician Decision|1|||
156587739|NCT04743635|565235429|FG000|Overall Study|Lost to Follow-up|2|||
156587740|NCT04743635|565235430|FG001|Overall Study|Lost to Follow-up|0|||
156587741|NCT01954121|565235432|FG000|Overall Study|Lack of Efficacy|94|||
156587742|NCT01954121|565235433|FG001|Overall Study|Lack of Efficacy|41|||
156587743|NCT01954121|565235432|FG000|Overall Study|Protocol Violation|0|||
156587744|NCT01954121|565235433|FG001|Overall Study|Protocol Violation|2|||
156587745|NCT01954121|565235432|FG000|Overall Study|Lost to Follow-up|5|||
156587746|NCT01954121|565235433|FG001|Overall Study|Lost to Follow-up|6|||
156587747|NCT01954121|565235432|FG000|Overall Study|Withdrawal by Subject|18|||
156587748|NCT01954121|565235433|FG001|Overall Study|Withdrawal by Subject|12|||
156587749|NCT01954121|565235432|FG000|Overall Study|Pregnancy|1|||
156587750|NCT01954121|565235433|FG001|Overall Study|Pregnancy|1|||
156587751|NCT01954121|565235432|FG000|Overall Study|AE, serious fatal|1|||
156587752|NCT01954121|565235433|FG001|Overall Study|AE, serious fatal|0|||
156587753|NCT01954121|565235432|FG000|Overall Study|AE, non-serious non-fatal|5|||
156587754|NCT01954121|565235433|FG001|Overall Study|AE, non-serious non-fatal|22|||
156587755|NCT01954121|565235432|FG000|Overall Study|SAE, non-fatal|1|||
156587756|NCT01954121|565235433|FG001|Overall Study|SAE, non-fatal|4|||
156587757|NCT01954121|565235432|FG000|Overall Study|Non-compliant with study procedures|1|||
156587758|NCT01954121|565235433|FG001|Overall Study|Non-compliant with study procedures|0|||
156587759|NCT01954121|565235432|FG000|Overall Study|Non-compliant patient|1|||
156587760|NCT01954121|565235433|FG001|Overall Study|Non-compliant patient|1|||
156587761|NCT01954121|565235432|FG000|Overall Study|Subject did not follow instructions|0|||
156587762|NCT01954121|565235433|FG001|Overall Study|Subject did not follow instructions|2|||
156587763|NCT00872170|565235434|FG000|Overall Study|Adverse Event|1|||
156587764|NCT00872170|565235435|FG001|Overall Study|Adverse Event|0|||
156587765|NCT04072146|565235436|FG000|Overall Study|Adverse Event|0|||
156587766|NCT04072146|565235437|FG001|Overall Study|Adverse Event|1|||
156587767|NCT00540436|565235441|FG000|First 12-Week Treatment Period|Adverse Event|1|||
156587768|NCT00540436|565235441|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
156587769|NCT00540436|565235441|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
156587770|NCT00540436|565235441|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
156587771|NCT01064648|565235442|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
156587772|NCT01064648|565235443|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
156587773|NCT01064648|565235444|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
156587774|NCT01064648|565235445|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
156587775|NCT01064648|565235442|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
156587776|NCT01064648|565235443|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
156587777|NCT01064648|565235444|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
156587778|NCT01064648|565235445|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
156587779|NCT01064648|565235442|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
156587780|NCT01064648|565235443|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
156587781|NCT01064648|565235444|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
156587782|NCT01064648|565235445|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
156587783|NCT01064648|565235442|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
156587784|NCT01064648|565235443|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
156587785|NCT01064648|565235444|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
156587786|NCT01064648|565235445|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
156587787|NCT01064648|565235442|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
156587788|NCT01064648|565235443|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
156587789|NCT01064648|565235444|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
156587790|NCT01064648|565235445|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
156587791|NCT01064648|565235442|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
156587792|NCT01064648|565235443|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
156587793|NCT01064648|565235444|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
156587794|NCT01064648|565235445|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
156587795|NCT01064648|565235442|FG000|Phase II|Adverse Event|0|||
156587796|NCT01064648|565235443|FG001|Phase II|Adverse Event|0|||
156587797|NCT01064648|565235444|FG002|Phase II|Adverse Event|15|||
156587798|NCT01064648|565235445|FG003|Phase II|Adverse Event|8|||
156587799|NCT01064648|565235442|FG000|Phase II|Death|0|||
156587800|NCT01064648|565235443|FG001|Phase II|Death|0|||
156587801|NCT01064648|565235444|FG002|Phase II|Death|4|||
156587802|NCT01064648|565235445|FG003|Phase II|Death|5|||
156587803|NCT01064648|565235442|FG000|Phase II|Withdrawal by Subject|0|||
156587804|NCT01064648|565235443|FG001|Phase II|Withdrawal by Subject|0|||
156587805|NCT01064648|565235444|FG002|Phase II|Withdrawal by Subject|2|||
156587806|NCT01064648|565235445|FG003|Phase II|Withdrawal by Subject|5|||
156587807|NCT01064648|565235442|FG000|Phase II|Progression|0|||
156587808|NCT01064648|565235443|FG001|Phase II|Progression|0|||
156587809|NCT01064648|565235444|FG002|Phase II|Progression|21|||
156587810|NCT01064648|565235445|FG003|Phase II|Progression|27|||
156587811|NCT01064648|565235442|FG000|Phase II|Non-protocol specified|0|||
156587812|NCT01064648|565235443|FG001|Phase II|Non-protocol specified|0|||
156587813|NCT01064648|565235444|FG002|Phase II|Non-protocol specified|5|||
156587814|NCT01064648|565235445|FG003|Phase II|Non-protocol specified|3|||
156587815|NCT01064648|565235442|FG000|Phase II|Under Review|0|||
156587816|NCT01064648|565235443|FG001|Phase II|Under Review|0|||
156587817|NCT01064648|565235444|FG002|Phase II|Under Review|2|||
156587818|NCT01064648|565235445|FG003|Phase II|Under Review|0|||
156587819|NCT05281523|565235446|FG000|Overall Study|Adverse Event|1|||
156587820|NCT05281523|565235447|FG001|Overall Study|Adverse Event|1|||
156587821|NCT05281523|565235446|FG000|Overall Study|Physician Decision|1|||
156587822|NCT05281523|565235447|FG001|Overall Study|Physician Decision|1|||
156587823|NCT05281523|565235446|FG000|Overall Study|Withdrawal by Subject|5|||
156587824|NCT05281523|565235447|FG001|Overall Study|Withdrawal by Subject|15|||
156587825|NCT05281523|565235446|FG000|Overall Study|GCP violations|3|||
156587826|NCT05281523|565235447|FG001|Overall Study|GCP violations|4|||
156587827|NCT05513391|565235448|FG000|Overall Study|Adverse Event|1|||
156587828|NCT05513391|565235449|FG001|Overall Study|Adverse Event|0|||
156587829|NCT05513391|565235448|FG000|Overall Study|Protocol Deviation|0|||
156587830|NCT05513391|565235449|FG001|Overall Study|Protocol Deviation|1|||
156587831|NCT05513391|565235448|FG000|Overall Study|Withdrawal by Subject|3|||
156587832|NCT05513391|565235449|FG001|Overall Study|Withdrawal by Subject|1|||
156587833|NCT05513391|565235448|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156587834|NCT05513391|565235449|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156587835|NCT05513391|565235448|FG000|Overall Study|Lost to Follow-up|0|||
156587836|NCT05513391|565235449|FG001|Overall Study|Lost to Follow-up|2|||
156587837|NCT02429427|565235450|FG000|Overall Study|Adverse Event|220|||
156587838|NCT02429427|565235451|FG001|Overall Study|Adverse Event|92|||
156587839|NCT02429427|565235450|FG000|Overall Study|Protocol Violation|10|||
156587840|NCT02429427|565235451|FG001|Overall Study|Protocol Violation|6|||
156587841|NCT02429427|565235450|FG000|Overall Study|Lost to Follow-up|15|||
156587842|NCT02429427|565235451|FG001|Overall Study|Lost to Follow-up|6|||
156587843|NCT02429427|565235450|FG000|Overall Study|Withdrawal by Subject|64|||
156587844|NCT02429427|565235451|FG001|Overall Study|Withdrawal by Subject|34|||
156587845|NCT02429427|565235450|FG000|Overall Study|Other|62|||
156587846|NCT02429427|565235451|FG001|Overall Study|Other|41|||
156587847|NCT00719732|565235452|FG000|Overall Study|Lost to Follow-up|20|||
156587848|NCT00719732|565235452|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
156587849|NCT00719732|565235452|FG000|Overall Study|Illness not associated with device|1|||
156587850|NCT00436215|565235453|FG000|Overall Study|Refused further treatment|3|||
156587851|NCT00436215|565235453|FG000|Overall Study|Small bowel obstruction|1|||
156587852|NCT02364947|565236976|FG000|Overall Study|Withdrawal by Subject|10|||
156587853|NCT02364947|565236977|FG001|Overall Study|Withdrawal by Subject|8|||
156587854|NCT02364947|565236978|FG002|Overall Study|Withdrawal by Subject|9|||
156587855|NCT02364947|565236976|FG000|Overall Study|Adverse Event|45|||
156587856|NCT02364947|565236977|FG001|Overall Study|Adverse Event|33|||
156587857|NCT02364947|565236978|FG002|Overall Study|Adverse Event|11|||
156587858|NCT02364947|565236976|FG000|Overall Study|Protocol Violation|1|||
156587859|NCT02364947|565236977|FG001|Overall Study|Protocol Violation|1|||
156587860|NCT02364947|565236978|FG002|Overall Study|Protocol Violation|1|||
156587861|NCT02364947|565236976|FG000|Overall Study|Physician Decision|3|||
156587862|NCT02364947|565236977|FG001|Overall Study|Physician Decision|2|||
156587863|NCT02364947|565236978|FG002|Overall Study|Physician Decision|5|||
156587864|NCT02364947|565236976|FG000|Overall Study|Death|0|||
156587865|NCT02364947|565236977|FG001|Overall Study|Death|1|||
156587866|NCT02364947|565236978|FG002|Overall Study|Death|0|||
156587867|NCT00423085|565236982|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
156587868|NCT00423085|565236983|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
156587869|NCT00423085|565236984|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
156587870|NCT00423085|565236985|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
156587871|NCT00423085|565236982|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
156587872|NCT00423085|565236983|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
156587873|NCT00423085|565236984|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
156587874|NCT00423085|565236985|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156587875|NCT00423085|565236982|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
156587876|NCT00423085|565236983|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
156587877|NCT00423085|565236984|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
156587878|NCT00423085|565236985|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
156587879|NCT00423085|565236982|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
156587880|NCT00423085|565236983|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
156587881|NCT00423085|565236984|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
156587882|NCT00423085|565236985|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
156587883|NCT00423085|565236982|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
156587884|NCT00423085|565236983|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
156587885|NCT00423085|565236984|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
156587886|NCT00423085|565236985|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
156587887|NCT00423085|565236982|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
156587888|NCT00423085|565236983|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
156587889|NCT00423085|565236984|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
156587890|NCT00423085|565236985|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
156587891|NCT00423085|565236982|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
156587892|NCT00423085|565236983|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
156587893|NCT00423085|565236984|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
156587894|NCT00423085|565236985|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
156587895|NCT00423085|565236982|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
156587896|NCT00423085|565236983|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
156587897|NCT00423085|565236984|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
156587898|NCT00423085|565236985|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
156587899|NCT00423085|565236982|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
156587900|NCT00423085|565236983|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
156587901|NCT00423085|565236984|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
156587902|NCT00423085|565236985|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
156587903|NCT00423085|565236982|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
156587904|NCT00423085|565236983|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
156587905|NCT00423085|565236984|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
156587906|NCT00423085|565236985|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
156587907|NCT00423085|565236982|FG000|52-Week Open-Label Extension Phase|Death|0|||
156587908|NCT00423085|565236983|FG001|52-Week Open-Label Extension Phase|Death|0|||
156587909|NCT00423085|565236984|FG002|52-Week Open-Label Extension Phase|Death|0|||
156587910|NCT00423085|565236985|FG003|52-Week Open-Label Extension Phase|Death|2|||
156587911|NCT02702518|565236986|FG000|Overall Study|Lost to Follow-up|3|||
156587912|NCT02702518|565236987|FG001|Overall Study|Lost to Follow-up|4|||
156587913|NCT00853489|565236988|FG000|Overall Study|Lost to Follow-up|5|||
156587914|NCT00853489|565236989|FG001|Overall Study|Lost to Follow-up|2|||
156587915|NCT03331666|565236990|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
156587916|NCT03331666|565236991|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
156587917|NCT05525975|565236992|FG000|Overall Study|Surgery cancellation|4|||
156587918|NCT05525975|565236993|FG001|Overall Study|Surgery cancellation|5|||
156587919|NCT05525975|565236992|FG000|Overall Study|didn't fill prescription|1|||
156587920|NCT05525975|565236993|FG001|Overall Study|didn't fill prescription|0|||
156587921|NCT05525975|565236992|FG000|Overall Study|Withdrawal by Subject|0|||
156587922|NCT05525975|565236993|FG001|Overall Study|Withdrawal by Subject|3|||
156587923|NCT02326467|565236994|FG000|Overall Study|Withdrawal by Subject|1|||
156587924|NCT01251276|565236996|FG000|Overall Study|Protocol Violation|1|||
156587925|NCT01251276|565236997|FG001|Overall Study|Protocol Violation|0|||
156587926|NCT01251276|565236996|FG000|Overall Study|Lost to Follow-up|0|||
156587927|NCT01251276|565236997|FG001|Overall Study|Lost to Follow-up|1|||
156587928|NCT02245568|565236998|FG000|Overall Study|Study terminated by Sponsor|346|||
156587929|NCT02245568|565236998|FG000|Overall Study|Adverse Event|144|||
156587930|NCT02245568|565236998|FG000|Overall Study|Lack of Efficacy|98|||
156587931|NCT02245568|565236998|FG000|Overall Study|Withdrawal by Caregiver|85|||
156587932|NCT02245568|565236998|FG000|Overall Study|Withdrawal by Subject|77|||
156587933|NCT02245568|565236998|FG000|Overall Study|Withdrawal by Legal Representative|31|||
156587934|NCT02245568|565236998|FG000|Overall Study|Missing (Site closure)|16|||
156587935|NCT02245568|565236998|FG000|Overall Study|Physician Decision|14|||
156587936|NCT02245568|565236998|FG000|Overall Study|Non-compliance with study drug|11|||
156587937|NCT02245568|565236998|FG000|Overall Study|Death|9|||
156587938|NCT02245568|565236998|FG000|Overall Study|Blue staining|6|||
156587939|NCT02245568|565236998|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
156587940|NCT02245568|565236998|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
156587941|NCT02245568|565236998|FG000|Overall Study|Lost to Follow-up|5|||
156587942|NCT00262080|565237002|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
156587943|NCT00262080|565237003|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
156587944|NCT00262080|565237004|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
156587945|NCT00262080|565237002|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
156587946|NCT00262080|565237003|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
156587947|NCT00262080|565237004|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
156587948|NCT00262080|565237002|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
156587949|NCT00262080|565237003|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
156587950|NCT00262080|565237004|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
156587951|NCT00262080|565237002|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
156587952|NCT00262080|565237003|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
156587953|NCT00262080|565237004|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
156587954|NCT00262080|565237002|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
156587955|NCT00262080|565237003|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
156587956|NCT00262080|565237004|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
156587957|NCT00262080|565237002|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
156587958|NCT00262080|565237003|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
156587959|NCT00262080|565237004|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
156587960|NCT01051986|565237005|FG000|Overall Study|Death|1|||
156587961|NCT01051986|565237006|FG001|Overall Study|Death|0|||
156587962|NCT01051986|565237005|FG000|Overall Study|Withdrawal by Subject|2|||
156587963|NCT01051986|565237006|FG001|Overall Study|Withdrawal by Subject|1|||
156587964|NCT01051986|565237005|FG000|Overall Study|Protocol Violation|2|||
156587965|NCT01051986|565237006|FG001|Overall Study|Protocol Violation|3|||
156587966|NCT01725152|565237008|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
156587967|NCT01725152|565237009|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
156587968|NCT01725152|565237008|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
156587969|NCT01725152|565237009|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
156587970|NCT01725152|565237008|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
156587971|NCT01725152|565237009|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
156587972|NCT01725152|565237008|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
156863646|NCT00627393|566258731|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
156863647|NCT00888134|566258735|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
156587973|NCT01725152|565237009|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
156587974|NCT02044159|565237010|FG000|Overall Study|Consent declined (deferred consent)|2|||
156587975|NCT02044159|565237011|FG001|Overall Study|Consent declined (deferred consent)|4|||
156587976|NCT02044159|565237010|FG000|Overall Study|No longer eligible, drug not given|1|||
156587977|NCT02044159|565237011|FG001|Overall Study|No longer eligible, drug not given|0|||
156587978|NCT02044159|565237010|FG000|Overall Study|Nurse declined to give study drug|1|||
156587979|NCT02044159|565237011|FG001|Overall Study|Nurse declined to give study drug|0|||
156587980|NCT01111539|565237014|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
156587981|NCT01111539|565237015|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156587982|NCT01111539|565237016|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156587983|NCT01111539|565237017|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156587984|NCT01111539|565237018|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156587985|NCT01111539|565237014|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
156587986|NCT01111539|565237015|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156587987|NCT01111539|565237016|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156587988|NCT01111539|565237017|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156587989|NCT01111539|565237018|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156587990|NCT01111539|565237014|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
156587991|NCT01111539|565237015|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156587992|NCT01111539|565237016|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156587993|NCT01111539|565237017|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156587994|NCT01111539|565237018|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156587995|NCT01111539|565237014|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
156587996|NCT01111539|565237015|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
156587997|NCT01111539|565237016|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
156587998|NCT01111539|565237017|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
156587999|NCT01111539|565237018|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
156588000|NCT01111539|565237014|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
156588001|NCT01111539|565237015|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
156588002|NCT01111539|565237016|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
156588003|NCT01111539|565237017|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
156588004|NCT01111539|565237018|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
156588005|NCT01111539|565237014|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
156588006|NCT01111539|565237015|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156588007|NCT01111539|565237016|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156588008|NCT01111539|565237017|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156588009|NCT01111539|565237018|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156588010|NCT01111539|565237014|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
156588011|NCT01111539|565237015|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
156588012|NCT01111539|565237016|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
156588013|NCT01111539|565237017|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
156588014|NCT01111539|565237018|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
156588015|NCT01111539|565237014|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156588016|NCT01111539|565237015|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156588017|NCT01111539|565237016|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
156588018|NCT01111539|565237017|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156588019|NCT01111539|565237018|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
156588020|NCT01111539|565237014|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156588021|NCT01111539|565237015|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156588022|NCT01111539|565237016|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
156588023|NCT01111539|565237017|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156588024|NCT01111539|565237018|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
156588025|NCT01111539|565237014|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
156588026|NCT01111539|565237015|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
156588027|NCT01111539|565237016|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
156588028|NCT01111539|565237017|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
156588029|NCT01111539|565237018|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
156588030|NCT01111539|565237014|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
156588031|NCT01111539|565237015|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
156588032|NCT01111539|565237016|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
156588033|NCT01111539|565237017|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
156588034|NCT01111539|565237018|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
156588035|NCT01111539|565237014|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
156588036|NCT01111539|565237015|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
156588037|NCT01111539|565237016|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
156634897|NCT03917654|565407821|FG006|Year 1|Withdrawal by Subject|6|||
156863648|NCT00888134|566258735|FG000|Follow-up|being followed for long-term survival|1|||
156588038|NCT01111539|565237017|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
156588039|NCT01111539|565237018|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
156588040|NCT01111539|565237014|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
156588041|NCT01111539|565237015|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
156588042|NCT01111539|565237016|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
156588043|NCT01111539|565237017|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
156588044|NCT01111539|565237018|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
156588045|NCT01111539|565237014|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156588046|NCT01111539|565237015|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156588047|NCT01111539|565237016|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156588048|NCT01111539|565237017|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156588049|NCT01111539|565237018|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
156588050|NCT03580382|565237023|FG000|Overall Study|Early Termination of Study|0|||
156588051|NCT03580382|565237024|FG001|Overall Study|Early Termination of Study|3|||
156588052|NCT02808312|565237025|FG000|Overall Study|Enrolled but Never Treated|0|||
156588053|NCT02808312|565237026|FG001|Overall Study|Enrolled but Never Treated|0|||
156588054|NCT02808312|565237027|FG002|Overall Study|Enrolled but Never Treated|1|||
156588055|NCT02808312|565237028|FG003|Overall Study|Enrolled but Never Treated|0|||
156588056|NCT02808312|565237029|FG004|Overall Study|Enrolled but Never Treated|0|||
156588057|NCT03628417|565237030|FG000|Overall Study|Death|1|||
156588058|NCT03628417|565237031|FG001|Overall Study|Death|1|||
156588059|NCT02420223|565237032|FG000|Overall Study|Adverse Event|1|||
156588060|NCT02420223|565237033|FG001|Overall Study|Adverse Event|0|||
156588061|NCT02420223|565237032|FG000|Overall Study|Physician Decision|0|||
156588062|NCT02420223|565237033|FG001|Overall Study|Physician Decision|2|||
156588063|NCT01361009|565237034|FG000|Overall Study|Protocol Violation|116|||
156588064|NCT01826422|565237035|FG000|Overall Study|Withdrawal by Subject|1|||
156588065|NCT01826422|565237036|FG001|Overall Study|Withdrawal by Subject|3|||
156588066|NCT04009096|565237040|FG000|Overall Study|Withdrawal by Subject|0|||
156588067|NCT04009096|565237041|FG001|Overall Study|Withdrawal by Subject|7|||
156588068|NCT04009096|565237042|FG002|Overall Study|Withdrawal by Subject|0|||
156588069|NCT04009096|565237040|FG000|Overall Study|Physician Decision|0|||
156588070|NCT04009096|565237041|FG001|Overall Study|Physician Decision|1|||
156588071|NCT04009096|565237042|FG002|Overall Study|Physician Decision|0|||
156588072|NCT00450372|565237043|FG000|Overall Study|Physician Decision|1|||
156588073|NCT00769704|565237044|FG000|Overall Study|Lost to Follow-up|3|||
156588074|NCT00769704|565237045|FG001|Overall Study|Lost to Follow-up|2|||
156588075|NCT00769704|565237044|FG000|Overall Study|Death|95|||
156588076|NCT00769704|565237045|FG001|Overall Study|Death|190|||
156588077|NCT00769704|565237044|FG000|Overall Study|Withdrawal by Subject|12|||
156588078|NCT00769704|565237045|FG001|Overall Study|Withdrawal by Subject|5|||
156588079|NCT00769704|565237044|FG000|Overall Study|Other|1|||
156588080|NCT00769704|565237045|FG001|Overall Study|Other|2|||
156588081|NCT05131451|565237046|FG000|Overall Study|Protocol Violation|1|||
156588082|NCT05131451|565237047|FG001|Overall Study|Protocol Violation|0|||
156588083|NCT01856595|565237054|FG000|Overall Study|Withdrawal by Subject|0|||
156588084|NCT01856595|565237055|FG001|Overall Study|Withdrawal by Subject|1|||
156588085|NCT01856595|565237056|FG002|Overall Study|Withdrawal by Subject|0|||
156588086|NCT01856595|565237057|FG003|Overall Study|Withdrawal by Subject|0|||
156588087|NCT01856595|565237058|FG004|Overall Study|Withdrawal by Subject|0|||
156588088|NCT01856595|565237059|FG005|Overall Study|Withdrawal by Subject|0|||
156588089|NCT01856595|565237060|FG006|Overall Study|Withdrawal by Subject|1|||
156588090|NCT01856595|565237061|FG007|Overall Study|Withdrawal by Subject|0|||
156588091|NCT01856595|565237062|FG008|Overall Study|Withdrawal by Subject|0|||
156588092|NCT04426825|565237064|FG000|Overall Study|Death|17|||
156588093|NCT04426825|565237064|FG000|Overall Study|Lost to Follow-up|1|||
156588094|NCT04426825|565237064|FG000|Overall Study|Study terminated by sponsor|5|||
156588095|NCT01863849|565237072|FG000|Overall Study|Lost to Follow-up|1|||
156588096|NCT01863849|565237073|FG001|Overall Study|Lost to Follow-up|0|||
156588097|NCT01533935|565237075|FG000|Overall Study|Adverse Event|5|||
156588098|NCT01533935|565237076|FG001|Overall Study|Adverse Event|7|||
156588099|NCT01533935|565237077|FG002|Overall Study|Adverse Event|1|||
156588100|NCT01533935|565237078|FG003|Overall Study|Adverse Event|5|||
156588101|NCT01533935|565237079|FG004|Overall Study|Adverse Event|3|||
156588102|NCT01533935|565237075|FG000|Overall Study|Protocol Violation|0|||
156588103|NCT01533935|565237076|FG001|Overall Study|Protocol Violation|2|||
156588104|NCT01533935|565237077|FG002|Overall Study|Protocol Violation|0|||
156588105|NCT01533935|565237078|FG003|Overall Study|Protocol Violation|0|||
156588106|NCT01533935|565237079|FG004|Overall Study|Protocol Violation|0|||
156588107|NCT01533935|565237075|FG000|Overall Study|Lost to Follow-up|0|||
156588108|NCT01533935|565237076|FG001|Overall Study|Lost to Follow-up|0|||
156588109|NCT01533935|565237077|FG002|Overall Study|Lost to Follow-up|1|||
156588110|NCT01533935|565237078|FG003|Overall Study|Lost to Follow-up|0|||
156588111|NCT01533935|565237079|FG004|Overall Study|Lost to Follow-up|0|||
156588112|NCT01533935|565237075|FG000|Overall Study|Withdrawal by Subject|0|||
156588113|NCT01533935|565237076|FG001|Overall Study|Withdrawal by Subject|4|||
156588114|NCT01533935|565237077|FG002|Overall Study|Withdrawal by Subject|5|||
156588115|NCT01533935|565237078|FG003|Overall Study|Withdrawal by Subject|2|||
156588116|NCT01533935|565237079|FG004|Overall Study|Withdrawal by Subject|4|||
156588117|NCT01533935|565237075|FG000|Overall Study|Other reason not defined above|1|||
156588118|NCT01533935|565237076|FG001|Overall Study|Other reason not defined above|0|||
156588119|NCT01533935|565237077|FG002|Overall Study|Other reason not defined above|1|||
156588120|NCT01533935|565237078|FG003|Overall Study|Other reason not defined above|0|||
156588121|NCT01533935|565237079|FG004|Overall Study|Other reason not defined above|1|||
156588122|NCT05132569|565237080|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
156588123|NCT05132569|565237081|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
156588124|NCT05132569|565237080|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
156588125|NCT05132569|565237081|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
156588126|NCT05132569|565237080|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
156588127|NCT05132569|565237081|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
156588128|NCT01554956|565237082|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
156588129|NCT01554956|565237083|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
156588130|NCT01554956|565237084|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
156588131|NCT01554956|565237082|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
156588132|NCT01554956|565237083|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
156588133|NCT01554956|565237084|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
156588134|NCT01554956|565237082|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
156588135|NCT01554956|565237083|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
156588136|NCT01554956|565237084|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
156588137|NCT00913978|565237085|FG000|Overall Study|Surgeon choice|1|||
156588138|NCT00913978|565237086|FG001|Overall Study|Surgeon choice|3|||
156588139|NCT04716933|565237087|FG000|Overall Study|Sponsor Decision|36|||
156588140|NCT04716933|565237088|FG001|Overall Study|Sponsor Decision|33|||
156588141|NCT04716933|565237087|FG000|Overall Study|Death|65|||
156588142|NCT04716933|565237088|FG001|Overall Study|Death|67|||
156588143|NCT00532948|565237089|FG000|Overall Study|Protocol Violation|1|||
156588144|NCT00532948|565237090|FG001|Overall Study|Protocol Violation|0|||
156588145|NCT00532948|565237091|FG002|Overall Study|Protocol Violation|0|||
156588146|NCT00532948|565237089|FG000|Overall Study|Death|3|||
156588147|NCT00532948|565237090|FG001|Overall Study|Death|3|||
156588148|NCT00532948|565237091|FG002|Overall Study|Death|4|||
156588149|NCT00532948|565237089|FG000|Overall Study|Violation of selection criteria at entry|0|||
156588150|NCT00532948|565237090|FG001|Overall Study|Violation of selection criteria at entry|1|||
156588151|NCT00532948|565237091|FG002|Overall Study|Violation of selection criteria at entry|0|||
156588152|NCT00532948|565237089|FG000|Overall Study|Failure to return|0|||
156588153|NCT00532948|565237090|FG001|Overall Study|Failure to return|1|||
156588154|NCT00532948|565237091|FG002|Overall Study|Failure to return|0|||
156588155|NCT03885726|565237093|FG000|Overall Study|Staffing issues/lost interest|1|||
156588156|NCT03885726|565237093|FG000|Overall Study|Early discharge from hospital|3|||
156588157|NCT02702193|565237098|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
156588158|NCT02702193|565237099|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
156588159|NCT02702193|565237098|FG000|4 Month Follow up|Withdrawal by Subject|1|||
156588160|NCT02702193|565237099|FG001|4 Month Follow up|Withdrawal by Subject|0|||
156588161|NCT02702193|565237098|FG000|4 Month Follow up|Lost to Follow-up|17|||
156588162|NCT02702193|565237099|FG001|4 Month Follow up|Lost to Follow-up|18|||
156588163|NCT02702193|565237098|FG000|8 Month Follow up|Withdrawal by Subject|1|||
156588164|NCT02702193|565237099|FG001|8 Month Follow up|Withdrawal by Subject|0|||
156588165|NCT02702193|565237098|FG000|8 Month Follow up|Lost to Follow-up|14|||
156588166|NCT02702193|565237099|FG001|8 Month Follow up|Lost to Follow-up|18|||
156588167|NCT02702193|565237098|FG000|12 Month Follow up|Withdrawal by Subject|1|||
156588168|NCT02702193|565237099|FG001|12 Month Follow up|Withdrawal by Subject|0|||
156588169|NCT02702193|565237098|FG000|12 Month Follow up|Lost to Follow-up|16|||
156588170|NCT02702193|565237099|FG001|12 Month Follow up|Lost to Follow-up|18|||
156588171|NCT05692154|565237101|FG000|Overall Study|Adverse Event|0|||
156588172|NCT05692154|565237102|FG001|Overall Study|Adverse Event|1|||
156588173|NCT01912729|565237105|FG000|Overall Study|Withdrawal by Subject|0|||
156588174|NCT01912729|565237106|FG001|Overall Study|Withdrawal by Subject|1|||
156588175|NCT00309777|565237118|FG000|Overall Study|Adverse Event|13|||
156588176|NCT00309777|565237119|FG001|Overall Study|Adverse Event|2|||
156588177|NCT00309777|565237120|FG002|Overall Study|Adverse Event|8|||
156588178|NCT00309777|565237121|FG003|Overall Study|Adverse Event|1|||
156588179|NCT00309777|565237118|FG000|Overall Study|Protocol Violation|4|||
156588180|NCT00309777|565237119|FG001|Overall Study|Protocol Violation|1|||
156588181|NCT00309777|565237120|FG002|Overall Study|Protocol Violation|3|||
156588182|NCT00309777|565237121|FG003|Overall Study|Protocol Violation|1|||
156588183|NCT00309777|565237118|FG000|Overall Study|Withdrawal by Subject|6|||
156588184|NCT00309777|565237119|FG001|Overall Study|Withdrawal by Subject|5|||
156588185|NCT00309777|565237120|FG002|Overall Study|Withdrawal by Subject|7|||
156634898|NCT03917654|565407822|FG007|Year 1|Withdrawal by Subject|2|||
156588186|NCT00309777|565237121|FG003|Overall Study|Withdrawal by Subject|2|||
156588187|NCT00309777|565237118|FG000|Overall Study|Lost to Follow-up|0|||
156588188|NCT00309777|565237119|FG001|Overall Study|Lost to Follow-up|0|||
156588189|NCT00309777|565237120|FG002|Overall Study|Lost to Follow-up|1|||
156588190|NCT00309777|565237121|FG003|Overall Study|Lost to Follow-up|0|||
156588191|NCT00309777|565237118|FG000|Overall Study|Death|0|||
156588192|NCT00309777|565237119|FG001|Overall Study|Death|1|||
156588193|NCT00309777|565237120|FG002|Overall Study|Death|0|||
156588194|NCT00309777|565237121|FG003|Overall Study|Death|0|||
156588195|NCT01830543|565238768|FG000|Overall Study|Subject Decision|19|||
156588196|NCT01830543|565238769|FG001|Overall Study|Subject Decision|21|||
156588197|NCT01830543|565238770|FG002|Overall Study|Subject Decision|57|||
156588198|NCT01830543|565238768|FG000|Overall Study|Adverse Event|91|||
156588199|NCT01830543|565238769|FG001|Overall Study|Adverse Event|77|||
156588200|NCT01830543|565238770|FG002|Overall Study|Adverse Event|76|||
156588201|NCT01830543|565238768|FG000|Overall Study|Death|20|||
156588202|NCT01830543|565238769|FG001|Overall Study|Death|22|||
156588203|NCT01830543|565238770|FG002|Overall Study|Death|22|||
156588204|NCT01830543|565238768|FG000|Overall Study|Protocol Violation|3|||
156588205|NCT01830543|565238769|FG001|Overall Study|Protocol Violation|7|||
156588206|NCT01830543|565238770|FG002|Overall Study|Protocol Violation|7|||
156588207|NCT01830543|565238768|FG000|Overall Study|Physician Decision|11|||
156588208|NCT01830543|565238769|FG001|Overall Study|Physician Decision|5|||
156588209|NCT01830543|565238770|FG002|Overall Study|Physician Decision|12|||
156588210|NCT01830543|565238768|FG000|Overall Study|Withdrawal by consent|3|||
156588211|NCT01830543|565238769|FG001|Overall Study|Withdrawal by consent|3|||
156588212|NCT01830543|565238770|FG002|Overall Study|Withdrawal by consent|3|||
156588213|NCT01830543|565238768|FG000|Overall Study|Other|12|||
156588214|NCT01830543|565238769|FG001|Overall Study|Other|17|||
156588215|NCT01830543|565238770|FG002|Overall Study|Other|37|||
156588216|NCT04263142|565238771|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
156588217|NCT04263142|565238772|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
156588218|NCT04263142|565238773|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
156588219|NCT04263142|565238774|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
156588220|NCT04263142|565238775|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
156588221|NCT04263142|565238771|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
156588222|NCT04263142|565238772|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
156588223|NCT04263142|565238773|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
156588224|NCT04263142|565238774|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
156588225|NCT04263142|565238775|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
156588226|NCT03010423|565238779|FG000|Overall Study|Study termination|8|||
156588227|NCT00520676|565238780|FG000|Overall Study|Death|84|||
156588228|NCT00520676|565238781|FG001|Overall Study|Death|81|||
156588229|NCT00520676|565238780|FG000|Overall Study|Lost to Follow-up|6|||
156588230|NCT00520676|565238781|FG001|Overall Study|Lost to Follow-up|10|||
156588231|NCT00520676|565238780|FG000|Overall Study|Physician Decision|4|||
156588232|NCT00520676|565238781|FG001|Overall Study|Physician Decision|1|||
156588233|NCT00520676|565238780|FG000|Overall Study|Withdrawal by Subject|7|||
156588234|NCT00520676|565238781|FG001|Overall Study|Withdrawal by Subject|11|||
156588235|NCT01597557|565238786|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
156588236|NCT01597557|565238787|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
156588237|NCT00115349|565238790|FG000|Overall Study|Study closed due to low enrollment.|11|||
156588238|NCT00115349|565238791|FG001|Overall Study|Study closed due to low enrollment.|9|||
156588239|NCT04402008|565238794|FG000|Overall Study|Adverse Event|0|||
156588240|NCT04402008|565238795|FG001|Overall Study|Adverse Event|0|||
156588241|NCT04402008|565238796|FG002|Overall Study|Adverse Event|0|||
156588242|NCT04402008|565238797|FG003|Overall Study|Adverse Event|1|||
156588243|NCT04402008|565238798|FG004|Overall Study|Adverse Event|0|||
156588244|NCT04402008|565238799|FG005|Overall Study|Adverse Event|0|||
156588245|NCT04402008|565238800|FG006|Overall Study|Adverse Event|0|||
156588246|NCT04402008|565238794|FG000|Overall Study|Disease Progression|3|||
156588247|NCT04402008|565238795|FG001|Overall Study|Disease Progression|2|||
156588248|NCT04402008|565238796|FG002|Overall Study|Disease Progression|3|||
156588249|NCT04402008|565238797|FG003|Overall Study|Disease Progression|3|||
156588250|NCT04402008|565238798|FG004|Overall Study|Disease Progression|4|||
156588251|NCT04402008|565238799|FG005|Overall Study|Disease Progression|3|||
156588252|NCT04402008|565238800|FG006|Overall Study|Disease Progression|10|||
156588253|NCT04402008|565238794|FG000|Overall Study|Withdrawal by Subject|0|||
156588254|NCT04402008|565238795|FG001|Overall Study|Withdrawal by Subject|1|||
156588255|NCT04402008|565238796|FG002|Overall Study|Withdrawal by Subject|0|||
156588256|NCT04402008|565238797|FG003|Overall Study|Withdrawal by Subject|0|||
156588257|NCT04402008|565238798|FG004|Overall Study|Withdrawal by Subject|1|||
156588258|NCT04402008|565238799|FG005|Overall Study|Withdrawal by Subject|0|||
156588259|NCT04402008|565238800|FG006|Overall Study|Withdrawal by Subject|0|||
156588260|NCT04402008|565238794|FG000|Overall Study|Sponsor Decision|0|||
156588261|NCT04402008|565238795|FG001|Overall Study|Sponsor Decision|0|||
156588262|NCT04402008|565238796|FG002|Overall Study|Sponsor Decision|0|||
156588263|NCT04402008|565238797|FG003|Overall Study|Sponsor Decision|0|||
156588264|NCT04402008|565238798|FG004|Overall Study|Sponsor Decision|0|||
156588265|NCT04402008|565238799|FG005|Overall Study|Sponsor Decision|0|||
156588266|NCT04402008|565238800|FG006|Overall Study|Sponsor Decision|3|||
156588267|NCT04402008|565238794|FG000|Overall Study|Death|0|||
156588268|NCT04402008|565238795|FG001|Overall Study|Death|0|||
156588269|NCT04402008|565238796|FG002|Overall Study|Death|0|||
156588270|NCT04402008|565238797|FG003|Overall Study|Death|0|||
156588271|NCT04402008|565238798|FG004|Overall Study|Death|1|||
156588272|NCT04402008|565238799|FG005|Overall Study|Death|0|||
156588273|NCT04402008|565238800|FG006|Overall Study|Death|2|||
156588274|NCT04402008|565238794|FG000|Overall Study|Other|0|||
156588275|NCT04402008|565238795|FG001|Overall Study|Other|0|||
156588276|NCT04402008|565238796|FG002|Overall Study|Other|0|||
156588277|NCT04402008|565238797|FG003|Overall Study|Other|0|||
156588278|NCT04402008|565238798|FG004|Overall Study|Other|0|||
156588279|NCT04402008|565238799|FG005|Overall Study|Other|0|||
156588280|NCT04402008|565238800|FG006|Overall Study|Other|5|||
156588281|NCT00210158|565238804|FG000|Overall Study|Protocol Violation|0|||
156588282|NCT00210158|565238805|FG001|Overall Study|Protocol Violation|2|||
156588283|NCT03249792|565238806|FG000|Arms 1, 2, and 4|Death|1|||
156588284|NCT03249792|565238807|FG001|Arms 1, 2, and 4|Death|1|||
156588285|NCT03249792|565238808|FG002|Arms 1, 2, and 4|Death|0|||
156588286|NCT03249792|565238809|FG003|Arms 1, 2, and 4|Death|2|||
156588287|NCT03249792|565238810|FG004|Arms 1, 2, and 4|Death|3|||
156588288|NCT03249792|565238811|FG005|Arms 1, 2, and 4|Death|2|||
156588289|NCT03249792|565238812|FG006|Arms 1, 2, and 4|Death|2|||
156588290|NCT03249792|565238813|FG007|Arms 1, 2, and 4|Death|4|||
156588291|NCT03249792|565238814|FG008|Arms 1, 2, and 4|Death|2|||
156588292|NCT03249792|565238815|FG009|Arms 1, 2, and 4|Death|1|||
156588293|NCT03249792|565238816|FG010|Arms 1, 2, and 4|Death|7|||
156588294|NCT03249792|565238817|FG011|Arms 1, 2, and 4|Death|7|||
156588295|NCT03249792|565238818|FG012|Arms 1, 2, and 4|Death|12|||
156588296|NCT03249792|565238819|FG013|Arms 1, 2, and 4|Death|7|||
156588297|NCT03249792|565238820|FG014|Arms 1, 2, and 4|Death|0|||
156588298|NCT03249792|565238821|FG015|Arms 1, 2, and 4|Death|4|||
156588299|NCT03249792|565238822|FG016|Arms 1, 2, and 4|Death|4|||
156588300|NCT03249792|565238823|FG017|Arms 1, 2, and 4|Death|12|||
156588301|NCT03249792|565238824|FG018|Arms 1, 2, and 4|Death|6|||
156588302|NCT03249792|565238825|FG019|Arms 1, 2, and 4|Death|4|||
156588303|NCT03249792|565238826|FG020|Arms 1, 2, and 4|Death|2|||
156588304|NCT03249792|565238827|FG021|Arms 1, 2, and 4|Death|3|||
156588305|NCT03249792|565238828|FG022|Arms 1, 2, and 4|Death|1|||
156588306|NCT03249792|565238829|FG023|Arms 1, 2, and 4|Death|1|||
156588307|NCT03249792|565238830|FG024|Arms 1, 2, and 4|Death|4|||
156588308|NCT03249792|565238831|FG025|Arms 1, 2, and 4|Death|0|||
156588309|NCT03249792|565238832|FG026|Arms 1, 2, and 4|Death|0|||
156588310|NCT03249792|565238833|FG027|Arms 1, 2, and 4|Death|0|||
156588311|NCT03249792|565238834|FG028|Arms 1, 2, and 4|Death|0|||
156588312|NCT03249792|565238835|FG029|Arms 1, 2, and 4|Death|0|||
156588313|NCT03249792|565238836|FG030|Arms 1, 2, and 4|Death|0|||
156588314|NCT03249792|565238837|FG031|Arms 1, 2, and 4|Death|0|||
156588315|NCT03249792|565238838|FG032|Arms 1, 2, and 4|Death|0|||
156588316|NCT03249792|565238806|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588317|NCT03249792|565238807|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588318|NCT03249792|565238808|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
156588319|NCT03249792|565238809|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588320|NCT03249792|565238810|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588321|NCT03249792|565238811|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
156588322|NCT03249792|565238812|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
156588323|NCT03249792|565238813|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588324|NCT03249792|565238814|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
156588325|NCT03249792|565238815|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
156588326|NCT03249792|565238816|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
156588327|NCT03249792|565238817|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
156588328|NCT03249792|565238818|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
156588329|NCT03249792|565238819|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
156588330|NCT03249792|565238820|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588331|NCT03249792|565238821|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588332|NCT03249792|565238822|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
156588333|NCT03249792|565238823|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588334|NCT03249792|565238824|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
156588335|NCT03249792|565238825|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588336|NCT03249792|565238826|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588337|NCT03249792|565238827|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588338|NCT03249792|565238828|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
156588339|NCT03249792|565238829|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
156588340|NCT03249792|565238830|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588341|NCT03249792|565238831|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588342|NCT03249792|565238832|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588343|NCT03249792|565238833|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588344|NCT03249792|565238834|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588345|NCT03249792|565238835|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588346|NCT03249792|565238836|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588347|NCT03249792|565238837|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588348|NCT03249792|565238838|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156588349|NCT03249792|565238806|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
156588350|NCT03249792|565238807|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
156588351|NCT03249792|565238808|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
156588352|NCT03249792|565238809|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
156588353|NCT03249792|565238810|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
156588354|NCT03249792|565238811|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
156588355|NCT03249792|565238812|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
156588356|NCT03249792|565238813|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
156588357|NCT03249792|565238814|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
156588358|NCT03249792|565238815|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
156588359|NCT03249792|565238816|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
156588360|NCT03249792|565238817|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
156588361|NCT03249792|565238818|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
156588362|NCT03249792|565238819|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
156588363|NCT03249792|565238820|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
156588364|NCT03249792|565238821|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
156588365|NCT03249792|565238822|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
156588366|NCT03249792|565238823|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
156588367|NCT03249792|565238824|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
156588368|NCT03249792|565238825|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
156588369|NCT03249792|565238826|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
156588370|NCT03249792|565238827|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
156588371|NCT03249792|565238828|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
156588372|NCT03249792|565238829|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
156588373|NCT03249792|565238830|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
156588374|NCT03249792|565238831|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
156588375|NCT03249792|565238832|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
156588376|NCT03249792|565238833|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
156588377|NCT03249792|565238834|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
156588378|NCT03249792|565238835|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
156588379|NCT03249792|565238836|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
156588380|NCT03249792|565238837|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
156588381|NCT03249792|565238838|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
156588382|NCT03249792|565238806|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588383|NCT03249792|565238807|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588384|NCT03249792|565238808|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588385|NCT03249792|565238809|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588386|NCT03249792|565238810|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588387|NCT03249792|565238811|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588388|NCT03249792|565238812|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588389|NCT03249792|565238813|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588390|NCT03249792|565238814|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
156588391|NCT03249792|565238815|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588392|NCT03249792|565238816|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588393|NCT03249792|565238817|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588394|NCT03249792|565238818|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588395|NCT03249792|565238819|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588396|NCT03249792|565238820|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588397|NCT03249792|565238821|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588398|NCT03249792|565238822|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
156588399|NCT03249792|565238823|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
156588400|NCT03249792|565238824|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588401|NCT03249792|565238825|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
156588402|NCT03249792|565238826|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588403|NCT03249792|565238827|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588404|NCT03249792|565238828|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588405|NCT03249792|565238829|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588406|NCT03249792|565238830|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588407|NCT03249792|565238831|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588408|NCT03249792|565238832|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588409|NCT03249792|565238833|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588410|NCT03249792|565238834|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588411|NCT03249792|565238835|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588412|NCT03249792|565238836|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588413|NCT03249792|565238837|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588414|NCT03249792|565238838|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
156588415|NCT03249792|565238806|FG000|Switch Over Period|Withdrawal by Subject|0|||
156588416|NCT03249792|565238807|FG001|Switch Over Period|Withdrawal by Subject|0|||
156588417|NCT03249792|565238808|FG002|Switch Over Period|Withdrawal by Subject|0|||
156588418|NCT03249792|565238809|FG003|Switch Over Period|Withdrawal by Subject|0|||
156588419|NCT03249792|565238810|FG004|Switch Over Period|Withdrawal by Subject|0|||
156588420|NCT03249792|565238811|FG005|Switch Over Period|Withdrawal by Subject|0|||
156588421|NCT03249792|565238812|FG006|Switch Over Period|Withdrawal by Subject|0|||
156588422|NCT03249792|565238813|FG007|Switch Over Period|Withdrawal by Subject|0|||
156588423|NCT03249792|565238814|FG008|Switch Over Period|Withdrawal by Subject|0|||
156588424|NCT03249792|565238815|FG009|Switch Over Period|Withdrawal by Subject|0|||
156588425|NCT03249792|565238816|FG010|Switch Over Period|Withdrawal by Subject|0|||
156588426|NCT03249792|565238817|FG011|Switch Over Period|Withdrawal by Subject|0|||
156588427|NCT03249792|565238818|FG012|Switch Over Period|Withdrawal by Subject|0|||
156588428|NCT03249792|565238819|FG013|Switch Over Period|Withdrawal by Subject|0|||
156588429|NCT03249792|565238820|FG014|Switch Over Period|Withdrawal by Subject|0|||
156588430|NCT03249792|565238821|FG015|Switch Over Period|Withdrawal by Subject|0|||
156588431|NCT03249792|565238822|FG016|Switch Over Period|Withdrawal by Subject|0|||
156588432|NCT03249792|565238823|FG017|Switch Over Period|Withdrawal by Subject|0|||
156588433|NCT03249792|565238824|FG018|Switch Over Period|Withdrawal by Subject|0|||
156588434|NCT03249792|565238825|FG019|Switch Over Period|Withdrawal by Subject|0|||
156588435|NCT03249792|565238826|FG020|Switch Over Period|Withdrawal by Subject|0|||
156588436|NCT03249792|565238827|FG021|Switch Over Period|Withdrawal by Subject|0|||
156588437|NCT03249792|565238828|FG022|Switch Over Period|Withdrawal by Subject|0|||
156588438|NCT03249792|565238829|FG023|Switch Over Period|Withdrawal by Subject|0|||
156588439|NCT03249792|565238830|FG024|Switch Over Period|Withdrawal by Subject|0|||
156588440|NCT03249792|565238831|FG025|Switch Over Period|Withdrawal by Subject|0|||
156588441|NCT03249792|565238832|FG026|Switch Over Period|Withdrawal by Subject|0|||
156588442|NCT03249792|565238833|FG027|Switch Over Period|Withdrawal by Subject|0|||
156588443|NCT03249792|565238834|FG028|Switch Over Period|Withdrawal by Subject|0|||
156588444|NCT03249792|565238835|FG029|Switch Over Period|Withdrawal by Subject|0|||
156588445|NCT03249792|565238836|FG030|Switch Over Period|Withdrawal by Subject|0|||
156588446|NCT03249792|565238837|FG031|Switch Over Period|Withdrawal by Subject|1|||
156588447|NCT03249792|565238838|FG032|Switch Over Period|Withdrawal by Subject|0|||
156588448|NCT03249792|565238806|FG000|Switch Over Period|Progressive Disease|0|||
156588449|NCT03249792|565238807|FG001|Switch Over Period|Progressive Disease|0|||
156588450|NCT03249792|565238808|FG002|Switch Over Period|Progressive Disease|0|||
156588451|NCT03249792|565238809|FG003|Switch Over Period|Progressive Disease|0|||
156588452|NCT03249792|565238810|FG004|Switch Over Period|Progressive Disease|0|||
156588453|NCT03249792|565238811|FG005|Switch Over Period|Progressive Disease|0|||
156588454|NCT03249792|565238812|FG006|Switch Over Period|Progressive Disease|0|||
156588455|NCT03249792|565238813|FG007|Switch Over Period|Progressive Disease|0|||
156588456|NCT03249792|565238814|FG008|Switch Over Period|Progressive Disease|0|||
156588457|NCT03249792|565238815|FG009|Switch Over Period|Progressive Disease|0|||
156588458|NCT03249792|565238816|FG010|Switch Over Period|Progressive Disease|0|||
156588459|NCT03249792|565238817|FG011|Switch Over Period|Progressive Disease|0|||
156588460|NCT03249792|565238818|FG012|Switch Over Period|Progressive Disease|0|||
156588461|NCT03249792|565238819|FG013|Switch Over Period|Progressive Disease|0|||
156588462|NCT03249792|565238820|FG014|Switch Over Period|Progressive Disease|0|||
156588463|NCT03249792|565238821|FG015|Switch Over Period|Progressive Disease|0|||
156588464|NCT03249792|565238822|FG016|Switch Over Period|Progressive Disease|0|||
156588465|NCT03249792|565238823|FG017|Switch Over Period|Progressive Disease|0|||
156588466|NCT03249792|565238824|FG018|Switch Over Period|Progressive Disease|0|||
156588467|NCT03249792|565238825|FG019|Switch Over Period|Progressive Disease|0|||
156588468|NCT03249792|565238826|FG020|Switch Over Period|Progressive Disease|0|||
156588469|NCT03249792|565238827|FG021|Switch Over Period|Progressive Disease|0|||
156588470|NCT03249792|565238828|FG022|Switch Over Period|Progressive Disease|0|||
156588471|NCT03249792|565238829|FG023|Switch Over Period|Progressive Disease|0|||
156588472|NCT03249792|565238830|FG024|Switch Over Period|Progressive Disease|0|||
156588473|NCT03249792|565238831|FG025|Switch Over Period|Progressive Disease|0|||
156588474|NCT03249792|565238832|FG026|Switch Over Period|Progressive Disease|1|||
156588475|NCT03249792|565238833|FG027|Switch Over Period|Progressive Disease|0|||
156588476|NCT03249792|565238834|FG028|Switch Over Period|Progressive Disease|1|||
156588477|NCT03249792|565238835|FG029|Switch Over Period|Progressive Disease|2|||
156588478|NCT03249792|565238836|FG030|Switch Over Period|Progressive Disease|1|||
156588479|NCT03249792|565238837|FG031|Switch Over Period|Progressive Disease|0|||
156588480|NCT03249792|565238838|FG032|Switch Over Period|Progressive Disease|1|||
156588481|NCT03249792|565238806|FG000|Switch Over Period|Adverse Event|0|||
156588482|NCT03249792|565238807|FG001|Switch Over Period|Adverse Event|0|||
156588483|NCT03249792|565238808|FG002|Switch Over Period|Adverse Event|0|||
156588484|NCT03249792|565238809|FG003|Switch Over Period|Adverse Event|0|||
156588485|NCT03249792|565238810|FG004|Switch Over Period|Adverse Event|0|||
156588486|NCT03249792|565238811|FG005|Switch Over Period|Adverse Event|0|||
156588487|NCT03249792|565238812|FG006|Switch Over Period|Adverse Event|0|||
156588488|NCT03249792|565238813|FG007|Switch Over Period|Adverse Event|0|||
156588489|NCT03249792|565238814|FG008|Switch Over Period|Adverse Event|0|||
156588490|NCT03249792|565238815|FG009|Switch Over Period|Adverse Event|0|||
156588491|NCT03249792|565238816|FG010|Switch Over Period|Adverse Event|0|||
156588492|NCT03249792|565238817|FG011|Switch Over Period|Adverse Event|0|||
156588493|NCT03249792|565238818|FG012|Switch Over Period|Adverse Event|0|||
156588494|NCT03249792|565238819|FG013|Switch Over Period|Adverse Event|0|||
156588495|NCT03249792|565238820|FG014|Switch Over Period|Adverse Event|0|||
156588496|NCT03249792|565238821|FG015|Switch Over Period|Adverse Event|0|||
156588497|NCT03249792|565238822|FG016|Switch Over Period|Adverse Event|0|||
156588498|NCT03249792|565238823|FG017|Switch Over Period|Adverse Event|0|||
156588499|NCT03249792|565238824|FG018|Switch Over Period|Adverse Event|0|||
156588500|NCT03249792|565238825|FG019|Switch Over Period|Adverse Event|0|||
156588501|NCT03249792|565238826|FG020|Switch Over Period|Adverse Event|0|||
156588502|NCT03249792|565238827|FG021|Switch Over Period|Adverse Event|0|||
156588503|NCT03249792|565238828|FG022|Switch Over Period|Adverse Event|0|||
156588504|NCT03249792|565238829|FG023|Switch Over Period|Adverse Event|0|||
156588505|NCT03249792|565238830|FG024|Switch Over Period|Adverse Event|0|||
156588506|NCT03249792|565238831|FG025|Switch Over Period|Adverse Event|1|||
156588507|NCT03249792|565238832|FG026|Switch Over Period|Adverse Event|0|||
156588508|NCT03249792|565238833|FG027|Switch Over Period|Adverse Event|1|||
156588509|NCT03249792|565238834|FG028|Switch Over Period|Adverse Event|0|||
156588510|NCT03249792|565238835|FG029|Switch Over Period|Adverse Event|0|||
156588511|NCT03249792|565238836|FG030|Switch Over Period|Adverse Event|0|||
156588512|NCT03249792|565238837|FG031|Switch Over Period|Adverse Event|0|||
156588513|NCT03249792|565238838|FG032|Switch Over Period|Adverse Event|0|||
156588514|NCT00995345|565238841|FG000|Overall Study|Withdrawal by Subject|4|||
156588515|NCT00995345|565238842|FG001|Overall Study|Withdrawal by Subject|2|||
156588516|NCT00995345|565238843|FG002|Overall Study|Withdrawal by Subject|1|||
156588517|NCT00995345|565238844|FG003|Overall Study|Withdrawal by Subject|3|||
156588518|NCT00995345|565238845|FG004|Overall Study|Withdrawal by Subject|1|||
156588519|NCT00995345|565238841|FG000|Overall Study|Adverse Event|3|||
156588520|NCT00995345|565238842|FG001|Overall Study|Adverse Event|1|||
156588521|NCT00995345|565238843|FG002|Overall Study|Adverse Event|2|||
156588522|NCT00995345|565238844|FG003|Overall Study|Adverse Event|0|||
156588523|NCT00995345|565238845|FG004|Overall Study|Adverse Event|1|||
156588524|NCT00995345|565238841|FG000|Overall Study|Lost to Follow-up|2|||
156588525|NCT00995345|565238842|FG001|Overall Study|Lost to Follow-up|2|||
156588526|NCT00995345|565238843|FG002|Overall Study|Lost to Follow-up|2|||
156588527|NCT00995345|565238844|FG003|Overall Study|Lost to Follow-up|1|||
156588528|NCT00995345|565238845|FG004|Overall Study|Lost to Follow-up|0|||
156588529|NCT00995345|565238841|FG000|Overall Study|all other reasons combined|2|||
156588530|NCT00995345|565238842|FG001|Overall Study|all other reasons combined|2|||
156588531|NCT00995345|565238843|FG002|Overall Study|all other reasons combined|2|||
156588532|NCT00995345|565238844|FG003|Overall Study|all other reasons combined|1|||
156588533|NCT00995345|565238845|FG004|Overall Study|all other reasons combined|3|||
156588534|NCT02509598|565238847|FG000|Overall Study|Withdrawal by Subject|1|||
156588535|NCT01201798|565238848|FG000|Overall Study|Adverse Event|2|||
156588536|NCT01201798|565238849|FG001|Overall Study|Adverse Event|0|||
156588537|NCT01201798|565238848|FG000|Overall Study|Lost to Follow-up|3|||
156588538|NCT01201798|565238849|FG001|Overall Study|Lost to Follow-up|5|||
156588539|NCT01201798|565238848|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
156588540|NCT01201798|565238849|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
156588541|NCT01201798|565238848|FG000|Overall Study|Noncompliance|1|||
156588542|NCT01201798|565238849|FG001|Overall Study|Noncompliance|0|||
156588543|NCT01201798|565238848|FG000|Overall Study|Protocol Violation|1|||
156588544|NCT01201798|565238849|FG001|Overall Study|Protocol Violation|1|||
156588545|NCT01201798|565238848|FG000|Overall Study|Treatment Failure|1|||
156588546|NCT01201798|565238849|FG001|Overall Study|Treatment Failure|8|||
156588547|NCT05122650|565238857|FG000|Overall Study|Adverse Event|4|||
156588548|NCT05122650|565238858|FG001|Overall Study|Adverse Event|16|||
156588549|NCT05122650|565238859|FG002|Overall Study|Adverse Event|11|||
156588550|NCT05122650|565238860|FG003|Overall Study|Adverse Event|12|||
156588551|NCT05122650|565238857|FG000|Overall Study|Lack of Efficacy|0|||
156588552|NCT05122650|565238858|FG001|Overall Study|Lack of Efficacy|1|||
156588553|NCT05122650|565238859|FG002|Overall Study|Lack of Efficacy|1|||
156588554|NCT05122650|565238860|FG003|Overall Study|Lack of Efficacy|2|||
156588555|NCT05122650|565238857|FG000|Overall Study|Lost to Follow-up|1|||
156588556|NCT05122650|565238858|FG001|Overall Study|Lost to Follow-up|1|||
156588557|NCT05122650|565238859|FG002|Overall Study|Lost to Follow-up|3|||
156588558|NCT05122650|565238860|FG003|Overall Study|Lost to Follow-up|0|||
156588559|NCT05122650|565238857|FG000|Overall Study|Non-compliance with study intervention|0|||
156588560|NCT05122650|565238858|FG001|Overall Study|Non-compliance with study intervention|0|||
156588561|NCT05122650|565238859|FG002|Overall Study|Non-compliance with study intervention|0|||
156588562|NCT05122650|565238860|FG003|Overall Study|Non-compliance with study intervention|2|||
156588563|NCT05122650|565238857|FG000|Overall Study|Protocol Violation|0|||
156588564|NCT05122650|565238858|FG001|Overall Study|Protocol Violation|1|||
156588565|NCT05122650|565238859|FG002|Overall Study|Protocol Violation|0|||
156588566|NCT05122650|565238860|FG003|Overall Study|Protocol Violation|1|||
156588567|NCT05122650|565238857|FG000|Overall Study|Randomized by mistake|0|||
156588568|NCT05122650|565238858|FG001|Overall Study|Randomized by mistake|0|||
156588569|NCT05122650|565238859|FG002|Overall Study|Randomized by mistake|3|||
156588570|NCT05122650|565238860|FG003|Overall Study|Randomized by mistake|2|||
156588571|NCT05122650|565238857|FG000|Overall Study|Sponsor request|0|||
156588572|NCT05122650|565238858|FG001|Overall Study|Sponsor request|1|||
156588573|NCT05122650|565238859|FG002|Overall Study|Sponsor request|1|||
156588574|NCT05122650|565238860|FG003|Overall Study|Sponsor request|2|||
156588575|NCT05122650|565238857|FG000|Overall Study|Withdrawal by Subject|3|||
156588576|NCT05122650|565238858|FG001|Overall Study|Withdrawal by Subject|7|||
156588577|NCT05122650|565238859|FG002|Overall Study|Withdrawal by Subject|4|||
156588578|NCT05122650|565238860|FG003|Overall Study|Withdrawal by Subject|8|||
156588579|NCT05122650|565238857|FG000|Overall Study|Other|5|||
156588580|NCT05122650|565238858|FG001|Overall Study|Other|0|||
156588581|NCT05122650|565238859|FG002|Overall Study|Other|0|||
156588582|NCT05122650|565238860|FG003|Overall Study|Other|0|||
156588583|NCT03609359|565238863|FG000|Overall Study|Progression of primary disease (PD)|25|||
156588584|NCT03609359|565238863|FG000|Overall Study|Patient's refusal|1|||
156588585|NCT03609359|565238863|FG000|Overall Study|Physician Decision|1|||
156588586|NCT03609359|565238863|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
156588587|NCT00740779|565238865|FG000|Overall Study|Adverse Event|4|||
156588588|NCT00740779|565238866|FG001|Overall Study|Adverse Event|6|||
156588589|NCT00740779|565238867|FG002|Overall Study|Adverse Event|3|||
156588590|NCT00740779|565238865|FG000|Overall Study|Protocol Violation|1|||
156588591|NCT00740779|565238866|FG001|Overall Study|Protocol Violation|1|||
156588592|NCT00740779|565238867|FG002|Overall Study|Protocol Violation|1|||
156588593|NCT00740779|565238865|FG000|Overall Study|Lack of Efficacy|0|||
156588594|NCT00740779|565238866|FG001|Overall Study|Lack of Efficacy|0|||
156588595|NCT00740779|565238867|FG002|Overall Study|Lack of Efficacy|2|||
156588596|NCT00740779|565238865|FG000|Overall Study|Withdrawal by Subject|2|||
156588597|NCT00740779|565238866|FG001|Overall Study|Withdrawal by Subject|4|||
156588598|NCT00740779|565238867|FG002|Overall Study|Withdrawal by Subject|2|||
156588599|NCT00740779|565238865|FG000|Overall Study|Lost to Follow-up|2|||
156588600|NCT00740779|565238866|FG001|Overall Study|Lost to Follow-up|3|||
156588601|NCT00740779|565238867|FG002|Overall Study|Lost to Follow-up|5|||
156588602|NCT00988559|565238868|FG000|Overall Study|Withdrawal by Subject|1|||
156588603|NCT00988559|565238869|FG001|Overall Study|Withdrawal by Subject|1|||
156588604|NCT00988559|565238870|FG002|Overall Study|Withdrawal by Subject|0|||
156588605|NCT00988559|565238871|FG003|Overall Study|Withdrawal by Subject|1|||
156588606|NCT00988559|565238868|FG000|Overall Study|Pregnancy|0|||
156588607|NCT00988559|565238869|FG001|Overall Study|Pregnancy|1|||
156588608|NCT00988559|565238870|FG002|Overall Study|Pregnancy|1|||
156588609|NCT00988559|565238871|FG003|Overall Study|Pregnancy|0|||
156588610|NCT00988559|565238868|FG000|Overall Study|Lost to Follow-up|0|||
156588611|NCT00988559|565238869|FG001|Overall Study|Lost to Follow-up|0|||
156588612|NCT00988559|565238870|FG002|Overall Study|Lost to Follow-up|1|||
156588613|NCT00988559|565238871|FG003|Overall Study|Lost to Follow-up|0|||
156588614|NCT05372575|565238872|FG000|Overall Study|Protocol Violation|7|||
156588615|NCT05372575|565238873|FG001|Overall Study|Protocol Violation|16|||
156588616|NCT00829166|565238874|FG000|Overall Study|Death|305|||
156588617|NCT00829166|565238875|FG001|Overall Study|Death|333|||
156588618|NCT00829166|565238874|FG000|Overall Study|Lost to Follow-up|5|||
156588619|NCT00829166|565238875|FG001|Overall Study|Lost to Follow-up|4|||
156588620|NCT00829166|565238874|FG000|Overall Study|Physician's Decision|4|||
156588621|NCT00829166|565238875|FG001|Overall Study|Physician's Decision|3|||
156588622|NCT00829166|565238874|FG000|Overall Study|Subject's Decision|41|||
156588623|NCT00829166|565238875|FG001|Overall Study|Subject's Decision|55|||
156588624|NCT00829166|565238874|FG000|Overall Study|Sponsor's Decision|137|||
156588625|NCT00829166|565238875|FG001|Overall Study|Sponsor's Decision|98|||
156588626|NCT00829166|565238874|FG000|Overall Study|Reason Not Specified|3|||
156588627|NCT00829166|565238875|FG001|Overall Study|Reason Not Specified|3|||
156588628|NCT03510663|565238876|FG000|Overall Study|Withdrawal by Subject|0|||
156588629|NCT03510663|565238877|FG001|Overall Study|Withdrawal by Subject|1|||
156588630|NCT03510663|565238878|FG002|Overall Study|Withdrawal by Subject|0|||
156588631|NCT03510663|565238879|FG003|Overall Study|Withdrawal by Subject|0|||
156588632|NCT03510663|565238880|FG004|Overall Study|Withdrawal by Subject|0|||
156588633|NCT03510663|565238881|FG005|Overall Study|Withdrawal by Subject|0|||
156588634|NCT03510663|565238882|FG006|Overall Study|Withdrawal by Subject|0|||
156588635|NCT03510663|565238883|FG007|Overall Study|Withdrawal by Subject|0|||
156588636|NCT02761993|565238888|FG000|Overall Study|Adverse Event|0|||
156588637|NCT02761993|565238889|FG001|Overall Study|Adverse Event|2|||
156588638|NCT02761993|565238890|FG002|Overall Study|Adverse Event|0|||
156588639|NCT02761993|565238888|FG000|Overall Study|Lost to Follow-up|1|||
156588640|NCT02761993|565238889|FG001|Overall Study|Lost to Follow-up|3|||
156588641|NCT02761993|565238890|FG002|Overall Study|Lost to Follow-up|2|||
156588642|NCT02761993|565238888|FG000|Overall Study|Withdrawal by Subject|1|||
156588643|NCT02761993|565238889|FG001|Overall Study|Withdrawal by Subject|1|||
156588644|NCT02761993|565238890|FG002|Overall Study|Withdrawal by Subject|2|||
156588645|NCT01465178|565238891|FG000|Overall Study|Withdrawal by Subject|1|||
156588646|NCT01465178|565238892|FG001|Overall Study|Withdrawal by Subject|0|||
156588647|NCT02993224|565238895|FG000|Core Phase - Period 1|Adverse Event|4|||
156588648|NCT02993224|565238895|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
156588649|NCT02993224|565238895|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
156588650|NCT02993224|565238895|FG000|Core Phase- Period 2|Adverse Event|1|||
156588651|NCT02993224|565238895|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
156588652|NCT02993224|565238895|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
156588653|NCT02993224|565238895|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
156588654|NCT02993224|565238895|FG000|Extension Phase|Adverse Event|3|||
156588655|NCT02993224|565238895|FG000|Extension Phase|Withdrawal by Subject|3|||
156588656|NCT02993224|565238895|FG000|Extension Phase|Lost to Follow-up|2|||
156588657|NCT02993224|565238895|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
156588658|NCT03342469|565238898|FG000|Overall Study|Withdrawal by Subject|0|||
156588659|NCT03342469|565238899|FG001|Overall Study|Withdrawal by Subject|1|||
156588660|NCT03342469|565238900|FG002|Overall Study|Withdrawal by Subject|0|||
156588661|NCT03342469|565238901|FG003|Overall Study|Withdrawal by Subject|0|||
156588662|NCT02689219|565238902|FG000|Overall Study|Death|1|||
156588663|NCT02689219|565238903|FG001|Overall Study|Death|1|||
156588664|NCT02689219|565238902|FG000|Overall Study|Disease Progression|10|||
156588665|NCT02689219|565238903|FG001|Overall Study|Disease Progression|6|||
156588666|NCT01477892|565238904|FG000|Overall Study|Withdrawal by Subject|0|||
156588667|NCT01477892|565238905|FG001|Overall Study|Withdrawal by Subject|2|||
156588668|NCT05515601|565238910|FG000|Overall Study|Withdrawal by Subject|1|||
156588669|NCT05515601|565238911|FG001|Overall Study|Withdrawal by Subject|3|||
156588670|NCT05515601|565238912|FG002|Overall Study|Withdrawal by Subject|2|||
156588671|NCT05515601|565238913|FG003|Overall Study|Withdrawal by Subject|1|||
156588672|NCT05515601|565238914|FG004|Overall Study|Withdrawal by Subject|1|||
156588673|NCT05515601|565238915|FG005|Overall Study|Withdrawal by Subject|1|||
156588674|NCT05515601|565238910|FG000|Overall Study|Lost to Follow-up|0|||
156588675|NCT05515601|565238911|FG001|Overall Study|Lost to Follow-up|0|||
156588676|NCT05515601|565238912|FG002|Overall Study|Lost to Follow-up|0|||
156588677|NCT05515601|565238913|FG003|Overall Study|Lost to Follow-up|0|||
156588678|NCT05515601|565238914|FG004|Overall Study|Lost to Follow-up|1|||
156588679|NCT05515601|565238915|FG005|Overall Study|Lost to Follow-up|0|||
156588680|NCT00364845|565238916|FG000|Overall Study|Adverse Event|1|||
156588681|NCT00364845|565238917|FG001|Overall Study|Adverse Event|0|||
156588682|NCT00364845|565238916|FG000|Overall Study|Withdrawal by Subject|2|||
156588683|NCT00364845|565238917|FG001|Overall Study|Withdrawal by Subject|1|||
156588684|NCT00364845|565238916|FG000|Overall Study|Physician Decision|8|||
156588685|NCT00364845|565238917|FG001|Overall Study|Physician Decision|8|||
156588686|NCT00364845|565238916|FG000|Overall Study|Lost to Follow-up|0|||
156588687|NCT00364845|565238917|FG001|Overall Study|Lost to Follow-up|1|||
156588688|NCT00364845|565238916|FG000|Overall Study|Death|0|||
156588689|NCT00364845|565238917|FG001|Overall Study|Death|1|||
156588690|NCT02426658|565238918|FG000|Overall Study|Withdrawal by Subject|1|||
156588691|NCT02426658|565238918|FG000|Overall Study|Patient expired before treatment|2|||
156588692|NCT03255291|565238921|FG000|Overall Study|Determined to be ineligible|10|||
156588693|NCT03255291|565238922|FG001|Overall Study|Determined to be ineligible|12|||
156588694|NCT03255291|565238923|FG002|Overall Study|Determined to be ineligible|6|||
156588695|NCT03255291|565238924|FG003|Overall Study|Determined to be ineligible|6|||
156588696|NCT03255291|565238925|FG004|Overall Study|Determined to be ineligible|5|||
156588697|NCT03255291|565238926|FG005|Overall Study|Determined to be ineligible|10|||
156588698|NCT03255291|565238921|FG000|Overall Study|Baseline data collection issues|3|||
156588699|NCT03255291|565238922|FG001|Overall Study|Baseline data collection issues|0|||
156588700|NCT03255291|565238923|FG002|Overall Study|Baseline data collection issues|0|||
156588701|NCT03255291|565238924|FG003|Overall Study|Baseline data collection issues|0|||
156588702|NCT03255291|565238925|FG004|Overall Study|Baseline data collection issues|2|||
156588703|NCT03255291|565238926|FG005|Overall Study|Baseline data collection issues|0|||
156588704|NCT01423617|565238927|FG000|Overall Study|Lost to Follow-up|0|||
156588705|NCT01423617|565238928|FG001|Overall Study|Lost to Follow-up|1|||
156588706|NCT01515306|565238929|FG000|Overall Study|Adverse Event|3|||
156588707|NCT01515306|565238930|FG001|Overall Study|Adverse Event|2|||
156588708|NCT01515306|565238929|FG000|Overall Study|Progressive Disease|19|||
156588709|NCT01515306|565238930|FG001|Overall Study|Progressive Disease|9|||
156588710|NCT01515306|565238929|FG000|Overall Study|Withdrawal by Subject|1|||
156588711|NCT01515306|565238930|FG001|Overall Study|Withdrawal by Subject|2|||
156588712|NCT01515306|565238929|FG000|Overall Study|Physician Decision|1|||
156588713|NCT01515306|565238930|FG001|Overall Study|Physician Decision|1|||
156588714|NCT00634244|565238931|FG000|Overall Study|Never started treatment|0|||
156588715|NCT00634244|565238932|FG001|Overall Study|Never started treatment|1|||
156588716|NCT00634244|565238933|FG002|Overall Study|Never started treatment|0|||
156588717|NCT00634244|565238931|FG000|Overall Study|Death|1|||
156588718|NCT00634244|565238932|FG001|Overall Study|Death|6|||
156588719|NCT00634244|565238933|FG002|Overall Study|Death|0|||
156588720|NCT00634244|565238931|FG000|Overall Study|Adverse Event|0|||
156588721|NCT00634244|565238932|FG001|Overall Study|Adverse Event|2|||
156588722|NCT00634244|565238933|FG002|Overall Study|Adverse Event|0|||
156588723|NCT00634244|565238931|FG000|Overall Study|Withdrawal by Subject|0|||
156588724|NCT00634244|565238932|FG001|Overall Study|Withdrawal by Subject|1|||
156588725|NCT00634244|565238933|FG002|Overall Study|Withdrawal by Subject|0|||
156588726|NCT00634244|565238931|FG000|Overall Study|Physician Decision|0|||
156588727|NCT00634244|565238932|FG001|Overall Study|Physician Decision|1|||
156588728|NCT00634244|565238933|FG002|Overall Study|Physician Decision|0|||
156588729|NCT00634244|565238931|FG000|Overall Study|Disease progression/relapse|0|||
156588730|NCT00634244|565238932|FG001|Overall Study|Disease progression/relapse|1|||
156588731|NCT00634244|565238933|FG002|Overall Study|Disease progression/relapse|0|||
156588732|NCT00634244|565238931|FG000|Overall Study|Other complicating disease|0|||
156588733|NCT00634244|565238932|FG001|Overall Study|Other complicating disease|1|||
156588734|NCT00634244|565238933|FG002|Overall Study|Other complicating disease|0|||
156588735|NCT03591146|565238939|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
156588736|NCT03591146|565238940|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
156588737|NCT03591146|565238941|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
156588738|NCT03591146|565238942|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
156588739|NCT03591146|565238943|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
156588740|NCT03591146|565238939|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
156588741|NCT03591146|565238940|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
156588742|NCT03591146|565238941|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
156588743|NCT03591146|565238942|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
156588744|NCT03591146|565238943|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
156588745|NCT03591146|565238939|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
156588746|NCT03591146|565238940|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
156588747|NCT03591146|565238941|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
156588748|NCT03591146|565238942|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
156588749|NCT03591146|565238943|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
156588750|NCT03591146|565238939|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
156588751|NCT03591146|565238940|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
156588752|NCT03591146|565238941|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
156588753|NCT03591146|565238942|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
156588754|NCT03591146|565238943|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
156588755|NCT04737031|565238944|FG000|Overall Study|Patients who did not have a treatment visit|0|||
156588756|NCT04737031|565238945|FG001|Overall Study|Patients who did not have a treatment visit|31|||
156588757|NCT04737031|565238946|FG002|Overall Study|Patients who did not have a treatment visit|93|||
156588758|NCT04737031|565238947|FG003|Overall Study|Patients who did not have a treatment visit|227|||
156588759|NCT03453151|565238948|FG000|Overall Study|Withdrawal by Subject|1|||
156588760|NCT03453151|565238948|FG000|Overall Study|Physician Decision|3|||
156588761|NCT01204658|565238951|FG000|Primary Phase|Adverse Event|0|||
156588762|NCT01204658|565238952|FG001|Primary Phase|Adverse Event|0|||
156588763|NCT01204658|565238953|FG002|Primary Phase|Adverse Event|1|||
156588764|NCT01204658|565238954|FG003|Primary Phase|Adverse Event|0|||
156588765|NCT04594239|565238959|FG000|Overall Study|Withdrawal by Subject|3|||
156588766|NCT04594239|565238960|FG001|Overall Study|Withdrawal by Subject|4|||
156588767|NCT04594239|565238961|FG002|Overall Study|Withdrawal by Subject|2|||
156588768|NCT04594239|565238962|FG003|Overall Study|Withdrawal by Subject|4|||
156588769|NCT04594239|565238959|FG000|Overall Study|Lost to Follow-up|8|||
156588770|NCT04594239|565238960|FG001|Overall Study|Lost to Follow-up|5|||
156588771|NCT04594239|565238961|FG002|Overall Study|Lost to Follow-up|4|||
156588772|NCT04594239|565238962|FG003|Overall Study|Lost to Follow-up|6|||
156588773|NCT04594239|565238959|FG000|Overall Study|Subject relocated|0|||
156588774|NCT04594239|565238960|FG001|Overall Study|Subject relocated|0|||
156588775|NCT04594239|565238961|FG002|Overall Study|Subject relocated|0|||
156588776|NCT04594239|565238962|FG003|Overall Study|Subject relocated|1|||
156588777|NCT02678780|565238963|FG000|Overall Study|Adverse Event|11|||
156588778|NCT02678780|565238964|FG001|Overall Study|Adverse Event|14|||
156588779|NCT02678780|565238963|FG000|Overall Study|Withdrawal by Subject|2|||
156588780|NCT02678780|565238964|FG001|Overall Study|Withdrawal by Subject|1|||
156588781|NCT02678780|565238963|FG000|Overall Study|Sponsor discontinuation|7|||
156588782|NCT02678780|565238964|FG001|Overall Study|Sponsor discontinuation|4|||
156588783|NCT02678780|565238963|FG000|Overall Study|Death|1|||
156588784|NCT02678780|565238964|FG001|Overall Study|Death|1|||
156588785|NCT02678780|565238963|FG000|Overall Study|Other|6|||
156588786|NCT02678780|565238964|FG001|Overall Study|Other|8|||
156588787|NCT03050359|565240573|FG000|Overall Study|Randomized But Not Treated|2|||
156588788|NCT03050359|565240574|FG001|Overall Study|Randomized But Not Treated|0|||
156588789|NCT03050359|565240573|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
156588790|NCT03050359|565240574|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
156588791|NCT03050359|565240573|FG000|Overall Study|Significant Protocol Deviation|2|||
156588792|NCT03050359|565240574|FG001|Overall Study|Significant Protocol Deviation|3|||
156588793|NCT03050359|565240573|FG000|Overall Study|Lost to Follow-up|2|||
156588794|NCT03050359|565240574|FG001|Overall Study|Lost to Follow-up|1|||
156588795|NCT03050359|565240573|FG000|Overall Study|Voluntary Withdrawal|4|||
156588796|NCT03050359|565240574|FG001|Overall Study|Voluntary Withdrawal|6|||
156588797|NCT03050359|565240573|FG000|Overall Study|Pregnancy|1|||
156588798|NCT03050359|565240574|FG001|Overall Study|Pregnancy|0|||
156588799|NCT03050359|565240573|FG000|Overall Study|Reason Not Specified|1|||
156588800|NCT03050359|565240574|FG001|Overall Study|Reason Not Specified|0|||
156588801|NCT02020031|565240575|FG000|Overall Study|Physician Decision|1|||
156588802|NCT02020031|565240576|FG001|Overall Study|Physician Decision|1|||
156588803|NCT00755846|565240579|FG000|Overall Study|Adverse Event|0|||
156588804|NCT00755846|565240580|FG001|Overall Study|Adverse Event|0|||
156588805|NCT00755846|565240581|FG002|Overall Study|Adverse Event|0|||
156588806|NCT00755846|565240582|FG003|Overall Study|Adverse Event|1|||
156588807|NCT00755846|565240583|FG004|Overall Study|Adverse Event|3|||
156588808|NCT00755846|565240584|FG005|Overall Study|Adverse Event|2|||
156588809|NCT00755846|565240579|FG000|Overall Study|Protocol Violation|1|||
156588810|NCT00755846|565240580|FG001|Overall Study|Protocol Violation|1|||
156588811|NCT00755846|565240581|FG002|Overall Study|Protocol Violation|1|||
156588812|NCT00755846|565240582|FG003|Overall Study|Protocol Violation|1|||
156588813|NCT00755846|565240583|FG004|Overall Study|Protocol Violation|1|||
156588814|NCT00755846|565240584|FG005|Overall Study|Protocol Violation|1|||
156588815|NCT00755846|565240579|FG000|Overall Study|Lost to Follow-up|0|||
156588816|NCT00755846|565240580|FG001|Overall Study|Lost to Follow-up|2|||
156588817|NCT00755846|565240581|FG002|Overall Study|Lost to Follow-up|1|||
156588818|NCT00755846|565240582|FG003|Overall Study|Lost to Follow-up|0|||
156588819|NCT00755846|565240583|FG004|Overall Study|Lost to Follow-up|4|||
156588820|NCT00755846|565240584|FG005|Overall Study|Lost to Follow-up|2|||
156588821|NCT00755846|565240579|FG000|Overall Study|Withdrawal by Subject|2|||
156588822|NCT00755846|565240580|FG001|Overall Study|Withdrawal by Subject|3|||
156588823|NCT00755846|565240581|FG002|Overall Study|Withdrawal by Subject|5|||
156588824|NCT00755846|565240582|FG003|Overall Study|Withdrawal by Subject|2|||
156588825|NCT00755846|565240583|FG004|Overall Study|Withdrawal by Subject|0|||
156588826|NCT00755846|565240584|FG005|Overall Study|Withdrawal by Subject|1|||
156588827|NCT00755846|565240579|FG000|Overall Study|Hyperglycemic Rescue|21|||
156588828|NCT00755846|565240580|FG001|Overall Study|Hyperglycemic Rescue|7|||
156588829|NCT00755846|565240581|FG002|Overall Study|Hyperglycemic Rescue|5|||
156588830|NCT00755846|565240582|FG003|Overall Study|Hyperglycemic Rescue|8|||
156588831|NCT00755846|565240583|FG004|Overall Study|Hyperglycemic Rescue|8|||
156588832|NCT00755846|565240584|FG005|Overall Study|Hyperglycemic Rescue|7|||
156588833|NCT00755846|565240579|FG000|Overall Study|Physician Decision|1|||
156588834|NCT00755846|565240580|FG001|Overall Study|Physician Decision|3|||
156588835|NCT00755846|565240581|FG002|Overall Study|Physician Decision|0|||
156588836|NCT00755846|565240582|FG003|Overall Study|Physician Decision|1|||
156588837|NCT00755846|565240583|FG004|Overall Study|Physician Decision|0|||
156588838|NCT00755846|565240584|FG005|Overall Study|Physician Decision|1|||
156588839|NCT00755846|565240579|FG000|Overall Study|Administrative Error|0|||
156588840|NCT00755846|565240580|FG001|Overall Study|Administrative Error|1|||
156588841|NCT00755846|565240581|FG002|Overall Study|Administrative Error|0|||
156588842|NCT00755846|565240582|FG003|Overall Study|Administrative Error|0|||
156588843|NCT00755846|565240583|FG004|Overall Study|Administrative Error|0|||
156588844|NCT00755846|565240584|FG005|Overall Study|Administrative Error|0|||
156588845|NCT00755846|565240579|FG000|Overall Study|Participant Non-compliance|0|||
156588846|NCT00755846|565240580|FG001|Overall Study|Participant Non-compliance|0|||
156588847|NCT00755846|565240581|FG002|Overall Study|Participant Non-compliance|0|||
156588848|NCT00755846|565240582|FG003|Overall Study|Participant Non-compliance|0|||
156588849|NCT00755846|565240583|FG004|Overall Study|Participant Non-compliance|1|||
156588850|NCT00755846|565240584|FG005|Overall Study|Participant Non-compliance|0|||
156588851|NCT03484923|565240588|FG000|Overall Study|Adverse Event|3|||
156588852|NCT03484923|565240589|FG001|Overall Study|Adverse Event|3|||
156588853|NCT03484923|565240590|FG002|Overall Study|Adverse Event|5|||
156588854|NCT03484923|565240591|FG003|Overall Study|Adverse Event|11|||
156588855|NCT03484923|565240592|FG004|Overall Study|Adverse Event|1|||
156588856|NCT03484923|565240588|FG000|Overall Study|Death|2|||
156588857|NCT03484923|565240589|FG001|Overall Study|Death|2|||
156588858|NCT03484923|565240590|FG002|Overall Study|Death|3|||
156588859|NCT03484923|565240591|FG003|Overall Study|Death|0|||
156588860|NCT03484923|565240592|FG004|Overall Study|Death|1|||
156588861|NCT03484923|565240588|FG000|Overall Study|Physician Decision|6|||
156588862|NCT03484923|565240589|FG001|Overall Study|Physician Decision|7|||
156588863|NCT03484923|565240590|FG002|Overall Study|Physician Decision|6|||
156588864|NCT03484923|565240591|FG003|Overall Study|Physician Decision|3|||
156588865|NCT03484923|565240592|FG004|Overall Study|Physician Decision|2|||
156588866|NCT03484923|565240588|FG000|Overall Study|Progressive disease|33|||
156588867|NCT03484923|565240589|FG001|Overall Study|Progressive disease|28|||
156588868|NCT03484923|565240590|FG002|Overall Study|Progressive disease|26|||
156588869|NCT03484923|565240591|FG003|Overall Study|Progressive disease|30|||
156588870|NCT03484923|565240592|FG004|Overall Study|Progressive disease|16|||
156588871|NCT03484923|565240588|FG000|Overall Study|Subject Decision|1|||
156588872|NCT03484923|565240589|FG001|Overall Study|Subject Decision|3|||
156588873|NCT03484923|565240590|FG002|Overall Study|Subject Decision|3|||
156588874|NCT03484923|565240591|FG003|Overall Study|Subject Decision|0|||
156588875|NCT03484923|565240592|FG004|Overall Study|Subject Decision|1|||
156588876|NCT03439748|565240593|FG000|Overall Study|Withdrawal by Subject|11|||
156588877|NCT03439748|565240594|FG001|Overall Study|Withdrawal by Subject|17|||
156588878|NCT01028651|565240595|FG000|Overall Study|Death|2|||
156588879|NCT01028651|565240595|FG000|Overall Study|Adverse Event|1|||
156588880|NCT00390416|565240596|FG000|Overall Study|Withdrawal by Subject|1|||
156588881|NCT00390416|565240596|FG000|Overall Study|Not treated|3|||
156588882|NCT01592409|565240597|FG000|Overall Study|Withdrawal by Subject|0|||
156588883|NCT01592409|565240598|FG001|Overall Study|Withdrawal by Subject|1|||
156588884|NCT01728584|565240601|FG000|Overall Study|Adverse Event|1|||
156588885|NCT01728584|565240602|FG001|Overall Study|Adverse Event|0|||
156588886|NCT01728584|565240603|FG002|Overall Study|Adverse Event|0|||
156588887|NCT01728584|565240604|FG003|Overall Study|Adverse Event|0|||
156588888|NCT01728584|565240601|FG000|Overall Study|Physician Decision|4|||
156588889|NCT01728584|565240602|FG001|Overall Study|Physician Decision|0|||
156588890|NCT01728584|565240603|FG002|Overall Study|Physician Decision|1|||
156588891|NCT01728584|565240604|FG003|Overall Study|Physician Decision|0|||
156588892|NCT01728584|565240601|FG000|Overall Study|Withdrawal by Subject|1|||
156588893|NCT01728584|565240602|FG001|Overall Study|Withdrawal by Subject|0|||
156588894|NCT01728584|565240603|FG002|Overall Study|Withdrawal by Subject|0|||
156588895|NCT01728584|565240604|FG003|Overall Study|Withdrawal by Subject|0|||
156588896|NCT01728584|565240601|FG000|Overall Study|Screen failure|1|||
156588897|NCT01728584|565240602|FG001|Overall Study|Screen failure|0|||
156588898|NCT01728584|565240603|FG002|Overall Study|Screen failure|0|||
156588899|NCT01728584|565240604|FG003|Overall Study|Screen failure|0|||
156588900|NCT01728584|565240601|FG000|Overall Study|Other reason (not specified)|1|||
156588901|NCT01728584|565240602|FG001|Overall Study|Other reason (not specified)|0|||
156588902|NCT01728584|565240603|FG002|Overall Study|Other reason (not specified)|0|||
156588903|NCT01728584|565240604|FG003|Overall Study|Other reason (not specified)|1|||
156588904|NCT02935634|565240605|FG000|Randomization|Participant withdrew consent|0|||
156588905|NCT02935634|565240606|FG001|Randomization|Participant withdrew consent|1|||
156588906|NCT02935634|565240607|FG002|Randomization|Participant withdrew consent|0|||
156588907|NCT02935634|565240608|FG003|Randomization|Participant withdrew consent|0|||
156588908|NCT02935634|565240609|FG004|Randomization|Participant withdrew consent|0|||
156588909|NCT02935634|565240610|FG005|Randomization|Participant withdrew consent|0|||
156588910|NCT02935634|565240605|FG000|Randomization|Death|2|||
156588911|NCT02935634|565240606|FG001|Randomization|Death|1|||
156588912|NCT02935634|565240607|FG002|Randomization|Death|1|||
156588913|NCT02935634|565240608|FG003|Randomization|Death|0|||
156588914|NCT02935634|565240609|FG004|Randomization|Death|0|||
156588915|NCT02935634|565240610|FG005|Randomization|Death|0|||
156588916|NCT02935634|565240605|FG000|Randomization|Other reasons|0|||
156588917|NCT02935634|565240606|FG001|Randomization|Other reasons|2|||
156588918|NCT02935634|565240607|FG002|Randomization|Other reasons|2|||
156588919|NCT02935634|565240608|FG003|Randomization|Other reasons|0|||
156588920|NCT02935634|565240609|FG004|Randomization|Other reasons|0|||
156588921|NCT02935634|565240610|FG005|Randomization|Other reasons|0|||
156588922|NCT02935634|565240605|FG000|Treatment: Track 1|Disease progression|15|||
156588923|NCT02935634|565240606|FG001|Treatment: Track 1|Disease progression|17|||
156588924|NCT02935634|565240607|FG002|Treatment: Track 1|Disease progression|28|||
156588925|NCT02935634|565240608|FG003|Treatment: Track 1|Disease progression|4|||
156588926|NCT02935634|565240609|FG004|Treatment: Track 1|Disease progression|6|||
156588927|NCT02935634|565240610|FG005|Treatment: Track 1|Disease progression|2|||
156588928|NCT02935634|565240605|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
156588929|NCT02935634|565240606|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
156588930|NCT02935634|565240607|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
156588931|NCT02935634|565240608|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
156588932|NCT02935634|565240609|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
156588933|NCT02935634|565240610|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
156588934|NCT02935634|565240605|FG000|Treatment: Track 1|Lost to Follow-up|1|||
156588935|NCT02935634|565240606|FG001|Treatment: Track 1|Lost to Follow-up|0|||
156588936|NCT02935634|565240607|FG002|Treatment: Track 1|Lost to Follow-up|0|||
156588937|NCT02935634|565240608|FG003|Treatment: Track 1|Lost to Follow-up|0|||
156588938|NCT02935634|565240609|FG004|Treatment: Track 1|Lost to Follow-up|0|||
156588939|NCT02935634|565240610|FG005|Treatment: Track 1|Lost to Follow-up|0|||
156588940|NCT02935634|565240605|FG000|Treatment: Track 1|Study drug toxicity|2|||
156588941|NCT02935634|565240606|FG001|Treatment: Track 1|Study drug toxicity|1|||
156588942|NCT02935634|565240607|FG002|Treatment: Track 1|Study drug toxicity|3|||
156588943|NCT02935634|565240608|FG003|Treatment: Track 1|Study drug toxicity|0|||
156588944|NCT02935634|565240609|FG004|Treatment: Track 1|Study drug toxicity|0|||
156588945|NCT02935634|565240610|FG005|Treatment: Track 1|Study drug toxicity|1|||
156588946|NCT02935634|565240605|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
156588947|NCT02935634|565240606|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
156588948|NCT02935634|565240607|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
156588949|NCT02935634|565240608|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
156588950|NCT02935634|565240609|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
156588951|NCT02935634|565240610|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
156588952|NCT02935634|565240605|FG000|Treatment: Track 1|Participant withdrew consent|2|||
156588953|NCT02935634|565240606|FG001|Treatment: Track 1|Participant withdrew consent|0|||
156588954|NCT02935634|565240607|FG002|Treatment: Track 1|Participant withdrew consent|1|||
156588955|NCT02935634|565240608|FG003|Treatment: Track 1|Participant withdrew consent|0|||
156588956|NCT02935634|565240609|FG004|Treatment: Track 1|Participant withdrew consent|1|||
156588957|NCT02935634|565240610|FG005|Treatment: Track 1|Participant withdrew consent|0|||
156588958|NCT02935634|565240605|FG000|Treatment: Track 1|Other reasons|0|||
156588959|NCT02935634|565240606|FG001|Treatment: Track 1|Other reasons|0|||
156588960|NCT02935634|565240607|FG002|Treatment: Track 1|Other reasons|2|||
156588961|NCT02935634|565240608|FG003|Treatment: Track 1|Other reasons|0|||
156588962|NCT02935634|565240609|FG004|Treatment: Track 1|Other reasons|0|||
156588963|NCT02935634|565240610|FG005|Treatment: Track 1|Other reasons|0|||
156588964|NCT02935634|565240605|FG000|Treatment: Track 2|Disease progression|13|||
156588965|NCT02935634|565240606|FG001|Treatment: Track 2|Disease progression|26|||
156588966|NCT02935634|565240607|FG002|Treatment: Track 2|Disease progression|20|||
156588967|NCT02935634|565240608|FG003|Treatment: Track 2|Disease progression|5|||
156588968|NCT02935634|565240609|FG004|Treatment: Track 2|Disease progression|1|||
156588969|NCT02935634|565240610|FG005|Treatment: Track 2|Disease progression|4|||
156588970|NCT02935634|565240605|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
156588971|NCT02935634|565240606|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
156588972|NCT02935634|565240607|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
156588973|NCT02935634|565240608|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
156588974|NCT02935634|565240609|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
156588975|NCT02935634|565240610|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
156588976|NCT02935634|565240605|FG000|Treatment: Track 2|Study drug toxicity|7|||
156588977|NCT02935634|565240606|FG001|Treatment: Track 2|Study drug toxicity|3|||
156588978|NCT02935634|565240607|FG002|Treatment: Track 2|Study drug toxicity|0|||
156588979|NCT02935634|565240608|FG003|Treatment: Track 2|Study drug toxicity|0|||
156588980|NCT02935634|565240609|FG004|Treatment: Track 2|Study drug toxicity|0|||
156588981|NCT02935634|565240610|FG005|Treatment: Track 2|Study drug toxicity|0|||
156588982|NCT02935634|565240605|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
156588983|NCT02935634|565240606|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
156588984|NCT02935634|565240607|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
156588985|NCT02935634|565240608|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
156588986|NCT02935634|565240609|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
156588987|NCT02935634|565240610|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
156588988|NCT02935634|565240605|FG000|Treatment: Track 2|Participant withdrew consent|0|||
156588989|NCT02935634|565240606|FG001|Treatment: Track 2|Participant withdrew consent|1|||
156588990|NCT02935634|565240607|FG002|Treatment: Track 2|Participant withdrew consent|1|||
156588991|NCT02935634|565240608|FG003|Treatment: Track 2|Participant withdrew consent|0|||
156588992|NCT02935634|565240609|FG004|Treatment: Track 2|Participant withdrew consent|1|||
156588993|NCT02935634|565240610|FG005|Treatment: Track 2|Participant withdrew consent|0|||
156588994|NCT06150573|565240614|FG000|Overall Study|Did not meet study criteria|1|||
156588995|NCT06150573|565240615|FG001|Overall Study|Did not meet study criteria|0|||
156588996|NCT06150573|565240614|FG000|Overall Study|Adverse Event|1|||
156588997|NCT06150573|565240615|FG001|Overall Study|Adverse Event|0|||
156588998|NCT06150573|565240614|FG000|Overall Study|Lost to Follow-up|0|||
156588999|NCT06150573|565240615|FG001|Overall Study|Lost to Follow-up|1|||
156589000|NCT06150573|565240614|FG000|Overall Study|Protocol Violation|0|||
156589001|NCT06150573|565240615|FG001|Overall Study|Protocol Violation|1|||
156589002|NCT06150573|565240614|FG000|Overall Study|Withdrawal by Subject|2|||
156589003|NCT06150573|565240615|FG001|Overall Study|Withdrawal by Subject|0|||
156589004|NCT01327651|565240616|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
156589005|NCT01327651|565240617|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
156589006|NCT01327651|565240618|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
156589007|NCT01327651|565240619|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
156589008|NCT01327651|565240620|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
156589009|NCT01327651|565240621|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
156589010|NCT01327651|565240622|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
156589011|NCT01327651|565240623|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
156589012|NCT01327651|565240624|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
156589013|NCT01327651|565240616|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
156589014|NCT01327651|565240617|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156589015|NCT01327651|565240618|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156589016|NCT01327651|565240619|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156589017|NCT01327651|565240620|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156589018|NCT01327651|565240621|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156589019|NCT01327651|565240622|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156589020|NCT01327651|565240623|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156589021|NCT01327651|565240624|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156863649|NCT03043313|566258736|FG000|Overall Study|Withdrawal by Subject|5|||
156863650|NCT03043313|566258737|FG001|Overall Study|Withdrawal by Subject|1|||
156589022|NCT01327651|565240616|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
156589023|NCT01327651|565240617|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
156589024|NCT01327651|565240618|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
156589025|NCT01327651|565240619|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
156589026|NCT01327651|565240620|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
156589027|NCT01327651|565240621|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
156589028|NCT01327651|565240622|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
156589029|NCT01327651|565240623|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
156589030|NCT01327651|565240624|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
156589031|NCT01327651|565240616|FG000|Post Study Follow-up|Lost to Follow-up|0|||
156589032|NCT01327651|565240617|FG001|Post Study Follow-up|Lost to Follow-up|1|||
156589033|NCT01327651|565240618|FG002|Post Study Follow-up|Lost to Follow-up|1|||
156589034|NCT01327651|565240619|FG003|Post Study Follow-up|Lost to Follow-up|0|||
156589035|NCT01327651|565240620|FG004|Post Study Follow-up|Lost to Follow-up|0|||
156589036|NCT01327651|565240621|FG005|Post Study Follow-up|Lost to Follow-up|0|||
156589037|NCT01327651|565240622|FG006|Post Study Follow-up|Lost to Follow-up|4|||
156589038|NCT01327651|565240623|FG007|Post Study Follow-up|Lost to Follow-up|1|||
156589039|NCT01327651|565240624|FG008|Post Study Follow-up|Lost to Follow-up|2|||
156589040|NCT02284906|565240629|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156589041|NCT02284906|565240630|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
156589042|NCT02284906|565240631|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156589043|NCT02284906|565240629|FG000|Overall Study|Major Protocol Deviation|0|||
156589044|NCT02284906|565240630|FG001|Overall Study|Major Protocol Deviation|1|||
156589045|NCT02284906|565240631|FG002|Overall Study|Major Protocol Deviation|0|||
156589046|NCT02284906|565240629|FG000|Overall Study|Voluntary Withdrawal|2|||
156589047|NCT02284906|565240630|FG001|Overall Study|Voluntary Withdrawal|4|||
156589048|NCT02284906|565240631|FG002|Overall Study|Voluntary Withdrawal|5|||
156589049|NCT02284906|565240629|FG000|Overall Study|Study Termination|0|||
156589050|NCT02284906|565240630|FG001|Overall Study|Study Termination|11|||
156589051|NCT02284906|565240631|FG002|Overall Study|Study Termination|14|||
156589052|NCT02284906|565240629|FG000|Overall Study|Reason not Specified|1|||
156589053|NCT02284906|565240630|FG001|Overall Study|Reason not Specified|1|||
156589054|NCT02284906|565240631|FG002|Overall Study|Reason not Specified|0|||
156589055|NCT01409031|565240632|FG000|Overall Study|transferred to other hosp|1|||
156589056|NCT01409031|565240633|FG001|Overall Study|transferred to other hosp|0|||
156589057|NCT04056455|565240634|FG000|Overall Study|Adverse Event|1|||
156589058|NCT04056455|565240635|FG001|Overall Study|Adverse Event|0|||
156589059|NCT03521687|565240637|FG000|Overall Study|Adverse Event|4|||
156589060|NCT03521687|565240637|FG000|Overall Study|Physician Decision|1|||
156589061|NCT04891770|565240644|FG000|Overall Study|Withdrew consent|1|||
156589062|NCT04891770|565240645|FG001|Overall Study|Withdrew consent|3|||
156589063|NCT04891770|565240646|FG002|Overall Study|Withdrew consent|0|||
156589064|NCT04891770|565240644|FG000|Overall Study|Enrolled but never treated|0|||
156589065|NCT04891770|565240645|FG001|Overall Study|Enrolled but never treated|0|||
156589066|NCT04891770|565240646|FG002|Overall Study|Enrolled but never treated|1|||
156589067|NCT04891770|565240644|FG000|Overall Study|Investigator's discretion|0|||
156589068|NCT04891770|565240645|FG001|Overall Study|Investigator's discretion|1|||
156589069|NCT04891770|565240646|FG002|Overall Study|Investigator's discretion|0|||
156589070|NCT00830037|565240650|FG000|Overall Study|Withdrawal by Subject|2|||
156589071|NCT00830037|565240651|FG001|Overall Study|Withdrawal by Subject|3|||
156589072|NCT00830037|565240650|FG000|Overall Study|Lost to Follow-up|1|||
156589073|NCT00830037|565240651|FG001|Overall Study|Lost to Follow-up|2|||
156589074|NCT00830037|565240650|FG000|Overall Study|Active when terminated by DSMB|15|||
156589075|NCT00830037|565240651|FG001|Overall Study|Active when terminated by DSMB|14|||
156589076|NCT01952834|565240653|FG000|Overall Study|Adverse Event|1|||
156589077|NCT04285346|565240654|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
156589078|NCT04285346|565240655|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
156589079|NCT04285346|565240654|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
156589080|NCT04285346|565240655|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156589081|NCT04285346|565240654|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
156589082|NCT04285346|565240655|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156589083|NCT01975272|565240658|FG000|Overall Study|Excluded after protocol amendment|1|||
156589084|NCT01975272|565240659|FG001|Overall Study|Excluded after protocol amendment|1|||
156589085|NCT01975272|565240660|FG002|Overall Study|Excluded after protocol amendment|2|||
156589086|NCT00610935|565240661|FG000|Overall Study|Lost to Follow-up|0|||
156589087|NCT00610935|565240662|FG001|Overall Study|Lost to Follow-up|1|||
156589088|NCT00610935|565240661|FG000|Overall Study|Withdrawal by Subject|0|||
156589089|NCT00610935|565240662|FG001|Overall Study|Withdrawal by Subject|2|||
156589090|NCT00610935|565240661|FG000|Overall Study|Sponsor Discontinuation|1|||
156589091|NCT00610935|565240662|FG001|Overall Study|Sponsor Discontinuation|0|||
156589092|NCT02399813|565240673|FG000|Overall Study|Progressive Disease-Radiographic|2|||
156589093|NCT02399813|565240673|FG000|Overall Study|Death|20|||
156589094|NCT02399813|565240673|FG000|Overall Study|Withdrawal by Subject|3|||
156589095|NCT02399813|565240673|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
156589096|NCT02399813|565240673|FG000|Overall Study|Lost to Follow-up|2|||
156589097|NCT02399813|565240673|FG000|Overall Study|Other than specified|5|||
156589098|NCT03280550|565240674|FG000|Overall Study|Withdrawal by Subject|2|||
156589099|NCT03280550|565240675|FG001|Overall Study|Withdrawal by Subject|2|||
156589100|NCT03280550|565240674|FG000|Overall Study|Physician Decision|0|||
156589101|NCT03280550|565240675|FG001|Overall Study|Physician Decision|1|||
156589102|NCT03345836|565240678|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
156589103|NCT03345836|565240679|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
156634899|NCT03917654|565407823|FG008|Year 1|Withdrawal by Subject|5|||
156589104|NCT03345836|565240680|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
156589105|NCT03345836|565240681|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
156589106|NCT03345836|565240682|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
156589107|NCT03345836|565240683|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
156589108|NCT03345836|565240678|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
156589109|NCT03345836|565240679|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
156589110|NCT03345836|565240680|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
156589111|NCT03345836|565240681|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
156589112|NCT03345836|565240682|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
156589113|NCT03345836|565240683|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
156589114|NCT03345836|565240678|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
156589115|NCT03345836|565240679|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
156589116|NCT03345836|565240680|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
156589117|NCT03345836|565240681|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
156589118|NCT03345836|565240682|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
156589119|NCT03345836|565240683|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
156589120|NCT03345836|565240678|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
156589121|NCT03345836|565240679|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
156589122|NCT03345836|565240680|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
156589123|NCT03345836|565240681|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
156589124|NCT03345836|565240682|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
156589125|NCT03345836|565240683|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
156589126|NCT03345836|565240678|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
156589127|NCT03345836|565240679|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
156589128|NCT03345836|565240680|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
156589129|NCT03345836|565240681|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
156589130|NCT03345836|565240682|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
156589131|NCT03345836|565240683|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
156589132|NCT03345836|565240678|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
156589133|NCT03345836|565240679|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
156589134|NCT03345836|565240680|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
156589135|NCT03345836|565240681|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
156589136|NCT03345836|565240682|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
156589137|NCT03345836|565240683|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
156589138|NCT03345836|565240678|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
156589139|NCT03345836|565240679|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
156589140|NCT03345836|565240680|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
156589141|NCT03345836|565240681|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
156589142|NCT03345836|565240682|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
156589143|NCT03345836|565240683|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
156589144|NCT03345836|565240678|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
156589145|NCT03345836|565240679|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
156589146|NCT03345836|565240680|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
156589147|NCT03345836|565240681|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
156589148|NCT03345836|565240682|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
156589149|NCT03345836|565240683|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
156589150|NCT03345836|565240678|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
156589151|NCT03345836|565240679|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
156589152|NCT03345836|565240680|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
156589153|NCT03345836|565240681|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
156589154|NCT03345836|565240682|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
156589155|NCT03345836|565240683|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
156589156|NCT03345836|565240678|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
156589157|NCT03345836|565240679|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
156589158|NCT03345836|565240680|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
156589159|NCT03345836|565240681|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
156589160|NCT03345836|565240682|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
156589161|NCT03345836|565240683|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
156589162|NCT03345836|565240678|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
156589163|NCT03345836|565240679|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
156589164|NCT03345836|565240680|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
156589165|NCT03345836|565240681|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
156589166|NCT03345836|565240682|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
156589167|NCT03345836|565240683|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
156589168|NCT00222729|565240686|FG000|Overall Study|Adverse Event|3|||
156589169|NCT01915849|565240689|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
156589170|NCT01915849|565240690|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
156589171|NCT01915849|565240691|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
156589172|NCT01915849|565240692|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
156589173|NCT01915849|565240689|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
156589174|NCT01915849|565240690|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
156589175|NCT01915849|565240691|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
156589176|NCT01915849|565240692|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
156589177|NCT05091060|565240693|FG000|Overall Study|Lost to Follow-up|1|||
156589178|NCT02775864|565240694|FG000|Overall Study|Data ended end of 2010|1764|||
156589179|NCT02775864|565240695|FG001|Overall Study|Data ended end of 2010|2880|||
156589180|NCT02775864|565240696|FG002|Overall Study|Data ended end of 2010|1140|||
156589181|NCT02775864|565240697|FG003|Overall Study|Data ended end of 2010|1194|||
156589182|NCT02775864|565240694|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
156589183|NCT02775864|565240695|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
156589184|NCT02775864|565240696|FG002|Overall Study|Medicaid eligibility discontinued|720|||
156589185|NCT02775864|565240697|FG003|Overall Study|Medicaid eligibility discontinued|890|||
156589186|NCT01318083|565240698|FG000|Overall Study|Adverse Event|4|||
156589187|NCT01318083|565240699|FG001|Overall Study|Adverse Event|1|||
156589188|NCT01318083|565240700|FG002|Overall Study|Adverse Event|2|||
156589189|NCT01318083|565240698|FG000|Overall Study|Withdrawal by Subject|1|||
156589190|NCT01318083|565240699|FG001|Overall Study|Withdrawal by Subject|0|||
156589191|NCT01318083|565240700|FG002|Overall Study|Withdrawal by Subject|2|||
156589192|NCT01318083|565240698|FG000|Overall Study|Lack of Efficacy|0|||
156589193|NCT01318083|565240699|FG001|Overall Study|Lack of Efficacy|0|||
156589194|NCT01318083|565240700|FG002|Overall Study|Lack of Efficacy|1|||
156589195|NCT01318083|565240698|FG000|Overall Study|Treatment Complications|1|||
156589196|NCT01318083|565240699|FG001|Overall Study|Treatment Complications|0|||
156589197|NCT01318083|565240700|FG002|Overall Study|Treatment Complications|0|||
156589198|NCT01318083|565240698|FG000|Overall Study|Lack of Study Medication Compliance|0|||
156589199|NCT01318083|565240699|FG001|Overall Study|Lack of Study Medication Compliance|1|||
156589200|NCT01318083|565240700|FG002|Overall Study|Lack of Study Medication Compliance|0|||
156589201|NCT02028338|565240704|FG000|Overall Study|Withdrawal by Subject|3|||
156589202|NCT02028338|565240705|FG001|Overall Study|Withdrawal by Subject|1|||
156589203|NCT02028338|565240704|FG000|Overall Study|Unable to contact participant|1|||
156589204|NCT02028338|565240705|FG001|Overall Study|Unable to contact participant|0|||
156589205|NCT03552549|565240706|FG000|Overall Study|Disease progression|25|||
156589206|NCT03552549|565240707|FG001|Overall Study|Disease progression|17|||
156589207|NCT03552549|565240706|FG000|Overall Study|Adverse event in first 12 months|12|||
156589208|NCT03552549|565240707|FG001|Overall Study|Adverse event in first 12 months|8|||
156589209|NCT03552549|565240706|FG000|Overall Study|Withdrawal by Subject|7|||
156589210|NCT03552549|565240707|FG001|Overall Study|Withdrawal by Subject|7|||
156589211|NCT03552549|565240706|FG000|Overall Study|Unknown (no reason provided)|4|||
156589212|NCT03552549|565240707|FG001|Overall Study|Unknown (no reason provided)|2|||
156589213|NCT03552549|565240706|FG000|Overall Study|Not in participant's best interest|2|||
156589214|NCT03552549|565240707|FG001|Overall Study|Not in participant's best interest|1|||
156589215|NCT03552549|565240706|FG000|Overall Study|Did not complete study treatment|2|||
156589216|NCT03552549|565240707|FG001|Overall Study|Did not complete study treatment|3|||
156589217|NCT03552549|565240706|FG000|Overall Study|Did not meet eligibility criteria|1|||
156589218|NCT03552549|565240707|FG001|Overall Study|Did not meet eligibility criteria|0|||
156589219|NCT03552549|565240706|FG000|Overall Study|Administrative|0|||
156589220|NCT03552549|565240707|FG001|Overall Study|Administrative|14|||
156589221|NCT00256867|565240712|FG000|Overall Study|Adverse Event|0|||
156589222|NCT00256867|565240713|FG001|Overall Study|Adverse Event|1|||
156589223|NCT00256867|565240714|FG002|Overall Study|Adverse Event|1|||
156589224|NCT00256867|565240715|FG003|Overall Study|Adverse Event|1|||
156589225|NCT00256867|565240716|FG004|Overall Study|Adverse Event|2|||
156589226|NCT00256867|565240717|FG005|Overall Study|Adverse Event|2|||
156589227|NCT00256867|565240718|FG006|Overall Study|Adverse Event|1|||
156589228|NCT00256867|565240719|FG007|Overall Study|Adverse Event|4|||
156589229|NCT00256867|565240712|FG000|Overall Study|Lost to Follow-up|2|||
156589230|NCT00256867|565240713|FG001|Overall Study|Lost to Follow-up|2|||
156589231|NCT00256867|565240714|FG002|Overall Study|Lost to Follow-up|2|||
156589232|NCT00256867|565240715|FG003|Overall Study|Lost to Follow-up|3|||
156589233|NCT00256867|565240716|FG004|Overall Study|Lost to Follow-up|2|||
156589234|NCT00256867|565240717|FG005|Overall Study|Lost to Follow-up|0|||
156589235|NCT00256867|565240718|FG006|Overall Study|Lost to Follow-up|1|||
156589236|NCT00256867|565240719|FG007|Overall Study|Lost to Follow-up|2|||
156589237|NCT00256867|565240712|FG000|Overall Study|Protocol Violation|0|||
156589238|NCT00256867|565240713|FG001|Overall Study|Protocol Violation|0|||
156589239|NCT00256867|565240714|FG002|Overall Study|Protocol Violation|0|||
156589240|NCT00256867|565240715|FG003|Overall Study|Protocol Violation|1|||
156589241|NCT00256867|565240716|FG004|Overall Study|Protocol Violation|0|||
156589242|NCT00256867|565240717|FG005|Overall Study|Protocol Violation|1|||
156589243|NCT00256867|565240718|FG006|Overall Study|Protocol Violation|0|||
156589244|NCT00256867|565240719|FG007|Overall Study|Protocol Violation|1|||
156589245|NCT00256867|565240712|FG000|Overall Study|Withdrawal by Subject|0|||
156589246|NCT00256867|565240713|FG001|Overall Study|Withdrawal by Subject|0|||
156589247|NCT00256867|565240714|FG002|Overall Study|Withdrawal by Subject|1|||
156589248|NCT00256867|565240715|FG003|Overall Study|Withdrawal by Subject|1|||
156589249|NCT00256867|565240716|FG004|Overall Study|Withdrawal by Subject|2|||
156589250|NCT00256867|565240717|FG005|Overall Study|Withdrawal by Subject|2|||
156589251|NCT00256867|565240718|FG006|Overall Study|Withdrawal by Subject|3|||
156589252|NCT00256867|565240719|FG007|Overall Study|Withdrawal by Subject|2|||
156589253|NCT00256867|565240712|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156589254|NCT00256867|565240713|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
156589255|NCT00256867|565240714|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156589256|NCT00256867|565240715|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156589257|NCT00256867|565240716|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156589258|NCT00256867|565240717|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156589259|NCT00256867|565240718|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156589260|NCT00256867|565240719|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156589261|NCT00256867|565240712|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
156589262|NCT00256867|565240713|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
156589263|NCT00256867|565240714|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
156589264|NCT00256867|565240715|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
156589265|NCT00256867|565240716|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
156589266|NCT00256867|565240717|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
156589267|NCT00256867|565240718|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
156589268|NCT00256867|565240719|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
156589269|NCT00256867|565240712|FG000|Overall Study|Investigator's Decision|0|||
156589270|NCT00256867|565240713|FG001|Overall Study|Investigator's Decision|0|||
156589271|NCT00256867|565240714|FG002|Overall Study|Investigator's Decision|0|||
156589272|NCT00256867|565240715|FG003|Overall Study|Investigator's Decision|0|||
156589273|NCT00256867|565240716|FG004|Overall Study|Investigator's Decision|1|||
156589274|NCT00256867|565240717|FG005|Overall Study|Investigator's Decision|0|||
156589275|NCT00256867|565240718|FG006|Overall Study|Investigator's Decision|0|||
156589276|NCT00256867|565240719|FG007|Overall Study|Investigator's Decision|0|||
156589277|NCT00256867|565240712|FG000|Overall Study|Non-compliance with study medication|0|||
156589278|NCT00256867|565240713|FG001|Overall Study|Non-compliance with study medication|0|||
156589279|NCT00256867|565240714|FG002|Overall Study|Non-compliance with study medication|0|||
156589280|NCT00256867|565240715|FG003|Overall Study|Non-compliance with study medication|0|||
156589281|NCT00256867|565240716|FG004|Overall Study|Non-compliance with study medication|0|||
156589282|NCT00256867|565240717|FG005|Overall Study|Non-compliance with study medication|0|||
156589283|NCT00256867|565240718|FG006|Overall Study|Non-compliance with study medication|0|||
156589284|NCT00256867|565240719|FG007|Overall Study|Non-compliance with study medication|1|||
156589285|NCT00256867|565240712|FG000|Overall Study|Participant travelled Overseas|0|||
156589286|NCT00256867|565240713|FG001|Overall Study|Participant travelled Overseas|1|||
156589287|NCT00256867|565240714|FG002|Overall Study|Participant travelled Overseas|0|||
156589288|NCT00256867|565240715|FG003|Overall Study|Participant travelled Overseas|0|||
156589289|NCT00256867|565240716|FG004|Overall Study|Participant travelled Overseas|0|||
156589290|NCT00256867|565240717|FG005|Overall Study|Participant travelled Overseas|0|||
156589291|NCT00256867|565240718|FG006|Overall Study|Participant travelled Overseas|0|||
156589292|NCT00256867|565240719|FG007|Overall Study|Participant travelled Overseas|0|||
156589293|NCT00256867|565240712|FG000|Overall Study|Participant out of assessment window|0|||
156589294|NCT00256867|565240713|FG001|Overall Study|Participant out of assessment window|0|||
156589295|NCT00256867|565240714|FG002|Overall Study|Participant out of assessment window|1|||
156589296|NCT00256867|565240715|FG003|Overall Study|Participant out of assessment window|0|||
156589297|NCT00256867|565240716|FG004|Overall Study|Participant out of assessment window|0|||
156589298|NCT00256867|565240717|FG005|Overall Study|Participant out of assessment window|0|||
156589299|NCT00256867|565240718|FG006|Overall Study|Participant out of assessment window|0|||
156589300|NCT00256867|565240719|FG007|Overall Study|Participant out of assessment window|0|||
156589301|NCT00256867|565240712|FG000|Overall Study|Withdrawal by participant|0|||
156589302|NCT00256867|565240713|FG001|Overall Study|Withdrawal by participant|0|||
156589303|NCT00256867|565240714|FG002|Overall Study|Withdrawal by participant|0|||
156589304|NCT00256867|565240715|FG003|Overall Study|Withdrawal by participant|0|||
156589305|NCT00256867|565240716|FG004|Overall Study|Withdrawal by participant|0|||
156589306|NCT00256867|565240717|FG005|Overall Study|Withdrawal by participant|1|||
156589307|NCT00256867|565240718|FG006|Overall Study|Withdrawal by participant|0|||
156589308|NCT00256867|565240719|FG007|Overall Study|Withdrawal by participant|0|||
156589309|NCT01930799|565240725|FG000|Overall Study|Withdrawal by Subject|3|||
156589310|NCT01930799|565240725|FG000|Overall Study|Lost to Follow-up|5|||
156589311|NCT00875017|565240726|FG000|First Intervention|Withdrawal by Subject|1|||
156589312|NCT00875017|565240727|FG001|First Intervention|Withdrawal by Subject|0|||
156589313|NCT00875017|565240728|FG002|First Intervention|Withdrawal by Subject|1|||
156589314|NCT00875017|565240729|FG003|First Intervention|Withdrawal by Subject|0|||
156589315|NCT00875017|565240730|FG004|First Intervention|Withdrawal by Subject|0|||
156589316|NCT00875017|565240731|FG005|First Intervention|Withdrawal by Subject|0|||
156589317|NCT00875017|565240726|FG000|First Intervention|Adverse Event|0|||
156589318|NCT00875017|565240727|FG001|First Intervention|Adverse Event|0|||
156589319|NCT00875017|565240728|FG002|First Intervention|Adverse Event|0|||
156589320|NCT00875017|565240729|FG003|First Intervention|Adverse Event|1|||
156589321|NCT00875017|565240730|FG004|First Intervention|Adverse Event|0|||
156589322|NCT00875017|565240731|FG005|First Intervention|Adverse Event|0|||
156589323|NCT00875017|565240726|FG000|First Intervention|Problems collecting rectal effluent|1|||
156589324|NCT00875017|565240727|FG001|First Intervention|Problems collecting rectal effluent|0|||
156589325|NCT00875017|565240728|FG002|First Intervention|Problems collecting rectal effluent|0|||
156589326|NCT00875017|565240729|FG003|First Intervention|Problems collecting rectal effluent|0|||
156589327|NCT00875017|565240730|FG004|First Intervention|Problems collecting rectal effluent|0|||
156589328|NCT00875017|565240731|FG005|First Intervention|Problems collecting rectal effluent|0|||
156589329|NCT00875017|565240726|FG000|First Intervention|Intolerance to nasogastric tube|0|||
156589330|NCT00875017|565240727|FG001|First Intervention|Intolerance to nasogastric tube|0|||
156589331|NCT00875017|565240728|FG002|First Intervention|Intolerance to nasogastric tube|0|||
156589332|NCT00875017|565240729|FG003|First Intervention|Intolerance to nasogastric tube|0|||
156589333|NCT00875017|565240730|FG004|First Intervention|Intolerance to nasogastric tube|1|||
156589334|NCT00875017|565240731|FG005|First Intervention|Intolerance to nasogastric tube|0|||
156589335|NCT00875017|565240726|FG000|Washout|Problem collecting rectal effluent|0|||
156589336|NCT00875017|565240727|FG001|Washout|Problem collecting rectal effluent|0|||
156589337|NCT00875017|565240728|FG002|Washout|Problem collecting rectal effluent|1|||
156589338|NCT00875017|565240729|FG003|Washout|Problem collecting rectal effluent|0|||
156589339|NCT00875017|565240730|FG004|Washout|Problem collecting rectal effluent|0|||
156589340|NCT00875017|565240731|FG005|Washout|Problem collecting rectal effluent|0|||
156589341|NCT00875017|565240726|FG000|Second Intervention|Adverse Event|0|||
156589342|NCT00875017|565240727|FG001|Second Intervention|Adverse Event|0|||
156589343|NCT00875017|565240728|FG002|Second Intervention|Adverse Event|0|||
156589344|NCT00875017|565240729|FG003|Second Intervention|Adverse Event|1|||
156589345|NCT00875017|565240730|FG004|Second Intervention|Adverse Event|0|||
156589346|NCT00875017|565240731|FG005|Second Intervention|Adverse Event|0|||
156589347|NCT00875017|565240726|FG000|Washout|Problems collecting rectal effluent|0|||
156589348|NCT00875017|565240727|FG001|Washout|Problems collecting rectal effluent|1|||
156589349|NCT00875017|565240728|FG002|Washout|Problems collecting rectal effluent|0|||
156589350|NCT00875017|565240729|FG003|Washout|Problems collecting rectal effluent|0|||
156589351|NCT00875017|565240730|FG004|Washout|Problems collecting rectal effluent|0|||
156589352|NCT00875017|565240731|FG005|Washout|Problems collecting rectal effluent|0|||
156589353|NCT00875017|565240726|FG000|Third Intervention|Adverse Event|0|||
156589354|NCT00875017|565240727|FG001|Third Intervention|Adverse Event|1|||
156589355|NCT00875017|565240728|FG002|Third Intervention|Adverse Event|1|||
156589356|NCT00875017|565240729|FG003|Third Intervention|Adverse Event|0|||
156589357|NCT00875017|565240730|FG004|Third Intervention|Adverse Event|0|||
156589358|NCT00875017|565240731|FG005|Third Intervention|Adverse Event|0|||
156589359|NCT00875017|565240726|FG000|Washout|Withdrawal by Subject|0|||
156589360|NCT00875017|565240727|FG001|Washout|Withdrawal by Subject|0|||
156589361|NCT00875017|565240728|FG002|Washout|Withdrawal by Subject|0|||
156589362|NCT00875017|565240729|FG003|Washout|Withdrawal by Subject|0|||
156589363|NCT00875017|565240730|FG004|Washout|Withdrawal by Subject|1|||
156589364|NCT00875017|565240731|FG005|Washout|Withdrawal by Subject|0|||
156589365|NCT00875017|565240726|FG000|Fourth Intervention|Inability to comply with fasting|0|||
156589366|NCT00875017|565240727|FG001|Fourth Intervention|Inability to comply with fasting|0|||
156589367|NCT00875017|565240728|FG002|Fourth Intervention|Inability to comply with fasting|0|||
156589368|NCT00875017|565240729|FG003|Fourth Intervention|Inability to comply with fasting|0|||
156589369|NCT00875017|565240730|FG004|Fourth Intervention|Inability to comply with fasting|0|||
156589370|NCT00875017|565240731|FG005|Fourth Intervention|Inability to comply with fasting|1|||
156589371|NCT01921257|565240734|FG000|Overall Study|Adverse Event|1|||
156589372|NCT01921257|565240734|FG000|Overall Study|Protocol Violation|1|||
156589373|NCT01921257|565240734|FG000|Overall Study|Withdrawal by Subject|1|||
156589374|NCT04369430|565240742|FG000|Overall Study|Adverse Event|2|||
156589375|NCT04369430|565240743|FG001|Overall Study|Adverse Event|3|||
156863651|NCT03043313|566258738|FG002|Overall Study|Withdrawal by Subject|1|||
156589376|NCT04369430|565240742|FG000|Overall Study|Death|1|||
156589377|NCT04369430|565240743|FG001|Overall Study|Death|0|||
156589378|NCT04369430|565240742|FG000|Overall Study|Withdrawal by Subject|4|||
156589379|NCT04369430|565240743|FG001|Overall Study|Withdrawal by Subject|3|||
156589380|NCT04369430|565240742|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
156589381|NCT04369430|565240743|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
156589382|NCT04369430|565240742|FG000|Overall Study|Lost to Follow-up|0|||
156589383|NCT04369430|565240743|FG001|Overall Study|Lost to Follow-up|1|||
156589384|NCT00142519|565240746|FG000|Overall Study|Not Treated|7|||
156589385|NCT00142519|565240747|FG001|Overall Study|Not Treated|9|||
156589386|NCT00142519|565240746|FG000|Overall Study|Protocol Violation|1|||
156589387|NCT00142519|565240747|FG001|Overall Study|Protocol Violation|0|||
156589388|NCT00142519|565240746|FG000|Overall Study|Withdrawal by Subject|10|||
156589389|NCT00142519|565240747|FG001|Overall Study|Withdrawal by Subject|7|||
156589390|NCT01468909|565240748|FG000|Overall Study|Never Treated|2|||
156589391|NCT01468909|565240749|FG001|Overall Study|Never Treated|2|||
156589392|NCT03229759|565240753|FG000|Overall Study|Screen Failure|30|||
156589393|NCT02723604|565242721|FG000|Overall Study|ineligible|1|||
156589394|NCT02723604|565242721|FG000|Overall Study|never received treatment|1|||
156589395|NCT00111475|565242722|FG000|Overall Study|Lost to Follow-up|0|||
156589396|NCT00111475|565242723|FG001|Overall Study|Lost to Follow-up|0|||
156589397|NCT00111475|565242724|FG002|Overall Study|Lost to Follow-up|0|||
156589398|NCT00111475|565242725|FG003|Overall Study|Lost to Follow-up|0|||
156589399|NCT00111475|565242726|FG004|Overall Study|Lost to Follow-up|0|||
156589400|NCT00111475|565242727|FG005|Overall Study|Lost to Follow-up|1|||
156589401|NCT00111475|565242728|FG006|Overall Study|Lost to Follow-up|0|||
156589402|NCT00111475|565242729|FG007|Overall Study|Lost to Follow-up|0|||
156589403|NCT00111475|565242730|FG008|Overall Study|Lost to Follow-up|0|||
156589404|NCT00111475|565242731|FG009|Overall Study|Lost to Follow-up|0|||
156589405|NCT03303092|565242734|FG000|Overall Study|Adverse Event|1|||
156589406|NCT03303092|565242735|FG001|Overall Study|Adverse Event|0|||
156589407|NCT03303092|565242736|FG002|Overall Study|Adverse Event|1|||
156589408|NCT03303092|565242734|FG000|Overall Study|Protocol Violation|1|||
156589409|NCT03303092|565242735|FG001|Overall Study|Protocol Violation|5|||
156589410|NCT03303092|565242736|FG002|Overall Study|Protocol Violation|1|||
156589411|NCT03303092|565242734|FG000|Overall Study|Withdrawal by Subject|1|||
156589412|NCT03303092|565242735|FG001|Overall Study|Withdrawal by Subject|1|||
156589413|NCT03303092|565242736|FG002|Overall Study|Withdrawal by Subject|3|||
156589414|NCT01995136|565242740|FG000|Overall Study|Change in residence|1|||
156589415|NCT00833248|565242744|FG000|Overall Study|Adverse Event|3|||
156589416|NCT00833248|565242745|FG001|Overall Study|Adverse Event|0|||
156589417|NCT00833248|565242744|FG000|Overall Study|Protocol Violation|1|||
156589418|NCT00833248|565242745|FG001|Overall Study|Protocol Violation|2|||
156589419|NCT00833248|565242744|FG000|Overall Study|Withdrawal by Subject|0|||
156589420|NCT00833248|565242745|FG001|Overall Study|Withdrawal by Subject|1|||
156589421|NCT01030458|565242752|FG000|Overall Study|Lost to Follow-up|9|||
156589422|NCT01030458|565242753|FG001|Overall Study|Lost to Follow-up|10|||
156589423|NCT01030458|565242752|FG000|Overall Study|Withdrawal by Subject|2|||
156589424|NCT01030458|565242753|FG001|Overall Study|Withdrawal by Subject|3|||
156589425|NCT01030458|565242752|FG000|Overall Study|Logistical reasons|9|||
156589426|NCT01030458|565242753|FG001|Overall Study|Logistical reasons|5|||
156589427|NCT01030458|565242752|FG000|Overall Study|Moved or changed job|6|||
156589428|NCT01030458|565242753|FG001|Overall Study|Moved or changed job|13|||
156589429|NCT01030458|565242752|FG000|Overall Study|Side effect of medication|1|||
156589430|NCT01030458|565242753|FG001|Overall Study|Side effect of medication|1|||
156589431|NCT00839423|565242756|FG000|Overall Study|Adverse Event|4|||
156589432|NCT00839423|565242757|FG001|Overall Study|Adverse Event|3|||
156589433|NCT00839423|565242758|FG002|Overall Study|Adverse Event|7|||
156589434|NCT00839423|565242759|FG003|Overall Study|Adverse Event|16|||
156589435|NCT00839423|565242756|FG000|Overall Study|Lack of Efficacy|6|||
156589436|NCT00839423|565242757|FG001|Overall Study|Lack of Efficacy|6|||
156589437|NCT00839423|565242758|FG002|Overall Study|Lack of Efficacy|3|||
156589438|NCT00839423|565242759|FG003|Overall Study|Lack of Efficacy|2|||
156589439|NCT00839423|565242756|FG000|Overall Study|Non-compliance|0|||
156589440|NCT00839423|565242757|FG001|Overall Study|Non-compliance|0|||
156589441|NCT00839423|565242758|FG002|Overall Study|Non-compliance|0|||
156589442|NCT00839423|565242759|FG003|Overall Study|Non-compliance|1|||
156589443|NCT00839423|565242756|FG000|Overall Study|Protocol Violation|0|||
156589444|NCT00839423|565242757|FG001|Overall Study|Protocol Violation|1|||
156589445|NCT00839423|565242758|FG002|Overall Study|Protocol Violation|2|||
156589446|NCT00839423|565242759|FG003|Overall Study|Protocol Violation|0|||
156589447|NCT00839423|565242756|FG000|Overall Study|Withdrawal of consent|4|||
156589448|NCT00839423|565242757|FG001|Overall Study|Withdrawal of consent|0|||
156589449|NCT00839423|565242758|FG002|Overall Study|Withdrawal of consent|4|||
156589450|NCT00839423|565242759|FG003|Overall Study|Withdrawal of consent|1|||
156589451|NCT00839423|565242756|FG000|Overall Study|Lost to Follow-up|1|||
156589452|NCT00839423|565242757|FG001|Overall Study|Lost to Follow-up|0|||
156589453|NCT00839423|565242758|FG002|Overall Study|Lost to Follow-up|1|||
156589454|NCT00839423|565242759|FG003|Overall Study|Lost to Follow-up|0|||
156589455|NCT00839423|565242756|FG000|Overall Study|Administrative or other reasons|3|||
156589456|NCT00839423|565242757|FG001|Overall Study|Administrative or other reasons|0|||
156589457|NCT00839423|565242758|FG002|Overall Study|Administrative or other reasons|1|||
156589458|NCT00839423|565242759|FG003|Overall Study|Administrative or other reasons|0|||
156589459|NCT01071096|565242760|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
156589460|NCT01071096|565242761|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
156589461|NCT02585999|565242762|FG000|Overall Study|Lost to Follow-up|1|||
156589462|NCT02585999|565242762|FG000|Overall Study|Protocol Violation|1|||
156589463|NCT01332019|565242763|FG000|Overall Study|Was Not Dosed|1|||
156589464|NCT01332019|565242764|FG001|Overall Study|Was Not Dosed|0|||
156589465|NCT01332019|565242763|FG000|Overall Study|Other|16|||
156589466|NCT01332019|565242764|FG001|Overall Study|Other|18|||
156589467|NCT01332019|565242763|FG000|Overall Study|Death|2|||
156589468|NCT01332019|565242764|FG001|Overall Study|Death|1|||
156589469|NCT01332019|565242763|FG000|Overall Study|Physician Decision|4|||
156589470|NCT01332019|565242764|FG001|Overall Study|Physician Decision|3|||
156589471|NCT01332019|565242763|FG000|Overall Study|Withdrawal by Subject|73|||
156589472|NCT01332019|565242764|FG001|Overall Study|Withdrawal by Subject|71|||
156589473|NCT01332019|565242763|FG000|Overall Study|Lost to Follow-up|4|||
156589474|NCT01332019|565242764|FG001|Overall Study|Lost to Follow-up|7|||
156589475|NCT01332019|565242763|FG000|Overall Study|Adverse Event|13|||
156589476|NCT01332019|565242764|FG001|Overall Study|Adverse Event|22|||
156589477|NCT01369849|565242767|FG000|Overall Study|Ineligible prior to treatment|0|||
156589478|NCT01369849|565242768|FG001|Overall Study|Ineligible prior to treatment|0|||
156589479|NCT01369849|565242769|FG002|Overall Study|Ineligible prior to treatment|1|||
156589480|NCT01369849|565242767|FG000|Overall Study|Ineligible after receiving treatment|0|||
156589481|NCT01369849|565242768|FG001|Overall Study|Ineligible after receiving treatment|1|||
156589482|NCT01369849|565242769|FG002|Overall Study|Ineligible after receiving treatment|0|||
156589483|NCT00871377|565242770|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
156589484|NCT00871377|565242771|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
156589485|NCT00871377|565242772|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
156589486|NCT00871377|565242773|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
156589487|NCT00871377|565242774|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
156589488|NCT00871377|565242775|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
156589489|NCT00871377|565242770|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
156589490|NCT00871377|565242771|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
156589491|NCT00871377|565242772|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
156589492|NCT00871377|565242773|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
156589493|NCT00871377|565242774|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
156589494|NCT00871377|565242775|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
156589495|NCT00871377|565242770|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
156589496|NCT00871377|565242771|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589497|NCT00871377|565242772|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589498|NCT00871377|565242773|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589499|NCT00871377|565242774|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589500|NCT00871377|565242775|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589501|NCT00871377|565242770|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589502|NCT00871377|565242771|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589503|NCT00871377|565242772|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589504|NCT00871377|565242773|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589505|NCT00871377|565242774|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
156589506|NCT00871377|565242775|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
156589507|NCT00871377|565242770|FG000|Third Intervention (10 Weeks)|Death|0|||
156589508|NCT00871377|565242771|FG001|Third Intervention (10 Weeks)|Death|0|||
156589509|NCT00871377|565242772|FG002|Third Intervention (10 Weeks)|Death|0|||
156589510|NCT00871377|565242773|FG003|Third Intervention (10 Weeks)|Death|1|||
156589511|NCT00871377|565242774|FG004|Third Intervention (10 Weeks)|Death|0|||
156589512|NCT00871377|565242775|FG005|Third Intervention (10 Weeks)|Death|0|||
156589513|NCT04281030|565242776|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
156589514|NCT04281030|565242777|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
156589515|NCT04281030|565242776|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
156589516|NCT04281030|565242777|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
156589517|NCT00288860|565242780|FG000|Overall Study|Did not complete intake|4|||
156589518|NCT00288860|565242781|FG001|Overall Study|Did not complete intake|8|||
156589519|NCT00288860|565242780|FG000|Overall Study|Death|4|||
156589520|NCT00288860|565242781|FG001|Overall Study|Death|3|||
156589521|NCT00288860|565242780|FG000|Overall Study|Withdrawal by Subject|20|||
156589522|NCT00288860|565242781|FG001|Overall Study|Withdrawal by Subject|15|||
156589523|NCT00288860|565242780|FG000|Overall Study|Lost to Follow-up|74|||
156589524|NCT00288860|565242781|FG001|Overall Study|Lost to Follow-up|71|||
156589525|NCT05142332|565242782|FG000|Overall Study|Withdrawal by Subject|0|||
156589526|NCT05142332|565242783|FG001|Overall Study|Withdrawal by Subject|1|||
156589527|NCT05142332|565242784|FG002|Overall Study|Withdrawal by Subject|2|||
156589528|NCT05142332|565242785|FG003|Overall Study|Withdrawal by Subject|0|||
156589529|NCT05142332|565242786|FG004|Overall Study|Withdrawal by Subject|0|||
156589530|NCT05142332|565242787|FG005|Overall Study|Withdrawal by Subject|2|||
156589531|NCT05142332|565242788|FG006|Overall Study|Withdrawal by Subject|6|||
156589532|NCT05142332|565242782|FG000|Overall Study|Left ED|3|||
156589533|NCT05142332|565242783|FG001|Overall Study|Left ED|0|||
156589534|NCT05142332|565242784|FG002|Overall Study|Left ED|4|||
156589535|NCT05142332|565242785|FG003|Overall Study|Left ED|6|||
156589536|NCT05142332|565242786|FG004|Overall Study|Left ED|1|||
156589537|NCT05142332|565242787|FG005|Overall Study|Left ED|2|||
156589538|NCT05142332|565242788|FG006|Overall Study|Left ED|6|||
156589539|NCT05142332|565242782|FG000|Overall Study|Physician Decision|0|||
156589540|NCT05142332|565242783|FG001|Overall Study|Physician Decision|0|||
156589541|NCT05142332|565242784|FG002|Overall Study|Physician Decision|2|||
156589542|NCT05142332|565242785|FG003|Overall Study|Physician Decision|1|||
156589543|NCT05142332|565242786|FG004|Overall Study|Physician Decision|0|||
156589544|NCT05142332|565242787|FG005|Overall Study|Physician Decision|0|||
156589545|NCT05142332|565242788|FG006|Overall Study|Physician Decision|3|||
156589546|NCT05142332|565242782|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
156589547|NCT05142332|565242783|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
156589548|NCT05142332|565242784|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
156589549|NCT05142332|565242785|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
156589550|NCT05142332|565242786|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
156589551|NCT05142332|565242787|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
156589552|NCT05142332|565242788|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
156589553|NCT02116660|565242789|FG000|Overall Study|Deteriorating renal function|0|||
156589554|NCT02116660|565242790|FG001|Overall Study|Deteriorating renal function|1|||
156589555|NCT02116660|565242789|FG000|Overall Study|Adverse Event|1|||
156589556|NCT02116660|565242790|FG001|Overall Study|Adverse Event|1|||
156589557|NCT02116660|565242789|FG000|Overall Study|Withdrawal by Subject|0|||
156589558|NCT02116660|565242790|FG001|Overall Study|Withdrawal by Subject|2|||
156589559|NCT02116660|565242789|FG000|Overall Study|Organization reason|1|||
156589560|NCT02116660|565242790|FG001|Overall Study|Organization reason|0|||
156589561|NCT01718509|565242791|FG000|Overall Study|Lost to Follow-up|18|||
156589562|NCT01718509|565242792|FG001|Overall Study|Lost to Follow-up|15|||
156589563|NCT01718509|565242791|FG000|Overall Study|Withdrawal by Subject|7|||
156589564|NCT01718509|565242792|FG001|Overall Study|Withdrawal by Subject|13|||
156589565|NCT01718509|565242791|FG000|Overall Study|Adverse Event|5|||
156589566|NCT01718509|565242792|FG001|Overall Study|Adverse Event|7|||
156589567|NCT01718509|565242791|FG000|Overall Study|Other|13|||
156589568|NCT01718509|565242792|FG001|Overall Study|Other|11|||
156589569|NCT01718509|565242791|FG000|Overall Study|Protocol Violation|4|||
156589570|NCT01718509|565242792|FG001|Overall Study|Protocol Violation|2|||
156589571|NCT01718509|565242791|FG000|Overall Study|Lack of Efficacy|1|||
156589572|NCT01718509|565242792|FG001|Overall Study|Lack of Efficacy|0|||
156589573|NCT00411788|565242799|FG000|Overall Study|Protocol Violation|1|||
156589574|NCT00411788|565242799|FG000|Overall Study|Adverse Event|1|||
156589575|NCT00848549|565242800|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
156589576|NCT00848549|565242801|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
156589577|NCT00848549|565242800|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
156589578|NCT00848549|565242801|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
156589579|NCT00848549|565242800|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
156589580|NCT00848549|565242801|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
156589581|NCT00848549|565242800|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
156589582|NCT00848549|565242801|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
156589583|NCT00848549|565242800|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
156589584|NCT00848549|565242801|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
156589585|NCT00848549|565242800|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
156589586|NCT00848549|565242801|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
156589587|NCT00848549|565242800|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
156589588|NCT00848549|565242801|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
156589589|NCT00848549|565242800|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
156589590|NCT00848549|565242801|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
156589591|NCT00848549|565242800|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
156589592|NCT00848549|565242801|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
156589593|NCT00848549|565242800|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
156589594|NCT00848549|565242801|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
156589595|NCT00848549|565242800|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
156589596|NCT00848549|565242801|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
156589597|NCT00848549|565242800|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
156589598|NCT00848549|565242801|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
156589599|NCT00848549|565242800|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
156589600|NCT00848549|565242801|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
156589601|NCT00848549|565242800|FG000|E2090-E044-314 (Extension Study)|Other|5|||
156589602|NCT00848549|565242801|FG001|E2090-E044-314 (Extension Study)|Other|6|||
156589603|NCT02561299|565242802|FG000|Overall Study|Death|2|||
156589604|NCT02561299|565242803|FG001|Overall Study|Death|4|||
156589605|NCT02561299|565242802|FG000|Overall Study|Lost to Follow-up|1|||
156589606|NCT02561299|565242803|FG001|Overall Study|Lost to Follow-up|0|||
156589607|NCT02561299|565242802|FG000|Overall Study|Withdrawal by Subject|2|||
156863652|NCT03043313|566258736|FG000|Overall Study|Lost to Follow-up|1|||
156589608|NCT02561299|565242803|FG001|Overall Study|Withdrawal by Subject|2|||
156634900|NCT03917654|565407824|FG009|Year 1|Withdrawal by Subject|3|||
156589609|NCT05631548|565242804|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
156589610|NCT05631548|565242805|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
156589611|NCT01219959|565242806|FG000|Overall Study|Adverse Event|6|||
156589612|NCT01219959|565242807|FG001|Overall Study|Adverse Event|14|||
156589613|NCT01219959|565242806|FG000|Overall Study|Physician Decision|0|||
156589614|NCT01219959|565242807|FG001|Overall Study|Physician Decision|4|||
156589615|NCT01219959|565242806|FG000|Overall Study|Withdrawal by Subject|0|||
156589616|NCT01219959|565242807|FG001|Overall Study|Withdrawal by Subject|2|||
156589617|NCT01219959|565242806|FG000|Overall Study|Renal Transplantation|0|||
156589618|NCT01219959|565242807|FG001|Overall Study|Renal Transplantation|3|||
156589619|NCT01219959|565242806|FG000|Overall Study|Other|1|||
156589620|NCT01219959|565242807|FG001|Overall Study|Other|0|||
156589621|NCT00471536|565242819|FG000|Overall Study|Withdrawal by Subject|1|||
156589622|NCT01980706|565242822|FG000|Overall Study|Withdrawal by Subject|9|||
156589623|NCT01980706|565242823|FG001|Overall Study|Withdrawal by Subject|6|||
156589624|NCT01980706|565242824|FG002|Overall Study|Withdrawal by Subject|2|||
156589625|NCT01980706|565242822|FG000|Overall Study|Adverse Event|1|||
156589626|NCT01980706|565242823|FG001|Overall Study|Adverse Event|2|||
156589627|NCT01980706|565242824|FG002|Overall Study|Adverse Event|5|||
156589628|NCT01980706|565242822|FG000|Overall Study|Lost to Follow-up|3|||
156589629|NCT01980706|565242823|FG001|Overall Study|Lost to Follow-up|4|||
156589630|NCT01980706|565242824|FG002|Overall Study|Lost to Follow-up|3|||
156589631|NCT01980706|565242822|FG000|Overall Study|miscellaneous|4|||
156589632|NCT01980706|565242823|FG001|Overall Study|miscellaneous|5|||
156589633|NCT01980706|565242824|FG002|Overall Study|miscellaneous|3|||
156589634|NCT02546674|565242825|FG000|Overall Study|Adverse Event|19|||
156589635|NCT02546674|565242825|FG000|Overall Study|Death|1|||
156589636|NCT02546674|565242825|FG000|Overall Study|Lost to Follow-up|1|||
156589637|NCT02546674|565242825|FG000|Overall Study|Physician Decision|13|||
156589638|NCT02546674|565242825|FG000|Overall Study|Pregnancy|1|||
156589639|NCT02546674|565242825|FG000|Overall Study|Progressive Disease|2|||
156589640|NCT02546674|565242825|FG000|Overall Study|Protocol Deviation|2|||
156589641|NCT02546674|565242825|FG000|Overall Study|Subject/Guardian Decision|6|||
156589642|NCT02546674|565242825|FG000|Overall Study|Withdrawal of Informed Consent|3|||
156589643|NCT01094730|565242828|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
156589644|NCT01094730|565242829|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
156589645|NCT01094730|565242828|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
156589646|NCT01094730|565242829|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
156589647|NCT01094730|565242828|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
156589648|NCT01094730|565242829|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
156589649|NCT01094730|565242828|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
156589650|NCT01094730|565242829|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
156589651|NCT01094730|565242828|FG000|Period 2 (14 Days)|Protocol Violation|2|||
156589652|NCT01094730|565242829|FG001|Period 2 (14 Days)|Protocol Violation|0|||
156589653|NCT01094730|565242828|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
156589654|NCT01094730|565242829|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
156589655|NCT01094730|565242828|FG000|Period 2 (14 Days)|Adverse Event|0|||
156589656|NCT01094730|565242829|FG001|Period 2 (14 Days)|Adverse Event|1|||
156589657|NCT01094730|565242828|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
156589658|NCT01094730|565242829|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
156589659|NCT02232087|565242830|FG000|Overall Study|Withdrawal by Subject|2|||
156589660|NCT02232087|565242831|FG001|Overall Study|Withdrawal by Subject|0|||
156589661|NCT02232087|565242832|FG002|Overall Study|Withdrawal by Subject|0|||
156589662|NCT02232087|565242833|FG003|Overall Study|Withdrawal by Subject|0|||
156589663|NCT02232087|565242834|FG004|Overall Study|Withdrawal by Subject|0|||
156589664|NCT02232087|565242835|FG005|Overall Study|Withdrawal by Subject|1|||
156589665|NCT02232087|565242830|FG000|Overall Study|poor inhalation technique|0|||
156589666|NCT02232087|565242831|FG001|Overall Study|poor inhalation technique|1|||
156589667|NCT02232087|565242832|FG002|Overall Study|poor inhalation technique|0|||
156589668|NCT02232087|565242833|FG003|Overall Study|poor inhalation technique|0|||
156589669|NCT02232087|565242834|FG004|Overall Study|poor inhalation technique|0|||
156589670|NCT02232087|565242835|FG005|Overall Study|poor inhalation technique|2|||
156589671|NCT02232087|565242830|FG000|Overall Study|protocol stop criteria|0|||
156589672|NCT02232087|565242831|FG001|Overall Study|protocol stop criteria|1|||
156589673|NCT02232087|565242832|FG002|Overall Study|protocol stop criteria|0|||
156589674|NCT02232087|565242833|FG003|Overall Study|protocol stop criteria|1|||
156589675|NCT02232087|565242834|FG004|Overall Study|protocol stop criteria|0|||
156589676|NCT02232087|565242835|FG005|Overall Study|protocol stop criteria|0|||
156589677|NCT02232087|565242830|FG000|Overall Study|Adverse Event|0|||
156863653|NCT03043313|566258737|FG001|Overall Study|Lost to Follow-up|1|||
156863654|NCT03043313|566258738|FG002|Overall Study|Lost to Follow-up|0|||
156589678|NCT02232087|565242831|FG001|Overall Study|Adverse Event|0|||
156589679|NCT02232087|565242832|FG002|Overall Study|Adverse Event|0|||
156589680|NCT02232087|565242833|FG003|Overall Study|Adverse Event|0|||
156589681|NCT02232087|565242834|FG004|Overall Study|Adverse Event|1|||
156589682|NCT02232087|565242835|FG005|Overall Study|Adverse Event|0|||
156589683|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
156589684|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
156589685|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
156589686|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
156589687|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
156589688|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
156589689|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
156589690|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
156589691|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
156589692|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
156589693|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
156589694|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
156589695|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
156589696|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
156589697|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
156589698|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
156589699|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
156589700|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156589701|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
156589702|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
156589703|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
156589704|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
156589705|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
156589706|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156589707|NCT01106625|565242836|FG000|Core Period: Baseline to Week 26|Other|8|||
156589708|NCT01106625|565242837|FG001|Core Period: Baseline to Week 26|Other|7|||
156589709|NCT01106625|565242838|FG002|Core Period: Baseline to Week 26|Other|4|||
156589710|NCT01106625|565242836|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
156589711|NCT01106625|565242837|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
156589712|NCT01106625|565242838|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
156589713|NCT01106625|565242836|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
156589714|NCT01106625|565242837|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
156589715|NCT01106625|565242838|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
156589716|NCT01106625|565242836|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156589717|NCT01106625|565242837|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156589718|NCT01106625|565242838|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
156589719|NCT01106625|565242836|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156589720|NCT01106625|565242837|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156589721|NCT01106625|565242838|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156589722|NCT01106625|565242836|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
156589723|NCT01106625|565242837|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156589724|NCT01106625|565242838|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156589725|NCT01106625|565242836|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
156589726|NCT01106625|565242837|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
156589727|NCT01106625|565242838|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
156589728|NCT01106625|565242836|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
156589729|NCT01106625|565242837|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
156589730|NCT01106625|565242838|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
156589731|NCT01106625|565242836|FG000|Extension Period: Week 26 to Week 52|Other|5|||
156589732|NCT01106625|565242837|FG001|Extension Period: Week 26 to Week 52|Other|5|||
156589733|NCT01106625|565242838|FG002|Extension Period: Week 26 to Week 52|Other|4|||
156589734|NCT01864018|565242841|FG000|Overall Study|Ineligible|3|||
156589735|NCT01864018|565242842|FG001|Overall Study|Ineligible|1|||
156589736|NCT02512068|565242844|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
156589737|NCT02512068|565242845|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
156589738|NCT02512068|565242844|FG000|Overall Study|Major Protocol Deviation|1|||
156589739|NCT02512068|565242845|FG001|Overall Study|Major Protocol Deviation|0|||
156589740|NCT02512068|565242844|FG000|Overall Study|Voluntary Withdrawal|0|||
156589741|NCT02512068|565242845|FG001|Overall Study|Voluntary Withdrawal|1|||
156589742|NCT02512068|565242844|FG000|Overall Study|Lack of Efficacy|0|||
156589743|NCT02512068|565242845|FG001|Overall Study|Lack of Efficacy|1|||
156589744|NCT02512068|565242844|FG000|Overall Study|Reason Not Specified|3|||
156589745|NCT02512068|565242845|FG001|Overall Study|Reason Not Specified|5|||
156589746|NCT01401010|565242848|FG000|Overall Study|Could not interpret assay results|1|||
156589747|NCT01401010|565242849|FG001|Overall Study|Could not interpret assay results|0|||
156589748|NCT01798706|565242852|FG000|Overall Study|Adverse Event|15|||
156589749|NCT01798706|565242853|FG001|Overall Study|Adverse Event|10|||
156589750|NCT01798706|565242852|FG000|Overall Study|Lack of Efficacy|0|||
156589751|NCT01798706|565242853|FG001|Overall Study|Lack of Efficacy|2|||
156589752|NCT01798706|565242852|FG000|Overall Study|Poor compliance to protocol|1|||
156589753|NCT01798706|565242853|FG001|Overall Study|Poor compliance to protocol|0|||
156589754|NCT01798706|565242852|FG000|Overall Study|Other than specified above|5|||
156589755|NCT01798706|565242853|FG001|Overall Study|Other than specified above|9|||
156589756|NCT05896761|565242854|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
156589757|NCT05896761|565242855|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
156589758|NCT05896761|565242854|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
156589759|NCT05896761|565242855|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
156589760|NCT01511419|565242856|FG000|Dose 2|Physician Decision|1|||
156589761|NCT01511419|565242857|FG001|Dose 2|Physician Decision|0|||
156589762|NCT00937768|565242858|FG000|Overall Study|Refused Further Treatment|3|||
156589763|NCT00937768|565242859|FG001|Overall Study|Refused Further Treatment|2|||
156589764|NCT00937768|565242858|FG000|Overall Study|Disease Progression|1|||
156589765|NCT00937768|565242859|FG001|Overall Study|Disease Progression|1|||
156589766|NCT00937768|565242858|FG000|Overall Study|Alternate Treatment|0|||
156589767|NCT00937768|565242859|FG001|Overall Study|Alternate Treatment|1|||
156589768|NCT00937768|565242858|FG000|Overall Study|No Further Funding|4|||
156589769|NCT00937768|565242859|FG001|Overall Study|No Further Funding|4|||
156589770|NCT01687413|565242862|FG000|Overall Study|Withdrawal by Subject|0|||
156589771|NCT01687413|565242863|FG001|Overall Study|Withdrawal by Subject|2|||
156589772|NCT01687413|565242862|FG000|Overall Study|Not eligible|0|||
156589773|NCT01687413|565242863|FG001|Overall Study|Not eligible|2|||
156589774|NCT01687413|565242862|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
156589775|NCT01687413|565242863|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
156589776|NCT04973228|565242866|FG000|Overall Study|Adverse Event|2|||
156589777|NCT04973228|565242867|FG001|Overall Study|Adverse Event|3|||
156589778|NCT04973228|565242866|FG000|Overall Study|Lack of Efficacy|1|||
156589779|NCT04973228|565242867|FG001|Overall Study|Lack of Efficacy|3|||
156589780|NCT04973228|565242866|FG000|Overall Study|Lost to Follow-up|12|||
156589781|NCT04973228|565242867|FG001|Overall Study|Lost to Follow-up|4|||
156589782|NCT04973228|565242866|FG000|Overall Study|Withdrawal by Subject|11|||
156589783|NCT04973228|565242867|FG001|Overall Study|Withdrawal by Subject|4|||
156589784|NCT04973228|565242866|FG000|Overall Study|Did not tolerate application|1|||
156589785|NCT04973228|565242867|FG001|Overall Study|Did not tolerate application|0|||
156589786|NCT04973228|565242866|FG000|Overall Study|Wanted to early terminate and use own product|0|||
156589787|NCT04973228|565242867|FG001|Overall Study|Wanted to early terminate and use own product|1|||
156589788|NCT04973228|565242866|FG000|Overall Study|Missed visits due to new work schedule|1|||
156589789|NCT04973228|565242867|FG001|Overall Study|Missed visits due to new work schedule|0|||
156589790|NCT00091390|565242872|FG000|Overall Study|Protocol Violation|1|||
156589791|NCT00091390|565242872|FG000|Overall Study|No protocol treatment|3|||
156589792|NCT00406640|565242873|FG000|Acute Phase|Adverse Event|18|||
156589793|NCT00406640|565242874|FG001|Acute Phase|Adverse Event|13|||
156589794|NCT00406640|565242873|FG000|Acute Phase|Failed to Return|5|||
156589795|NCT00406640|565242874|FG001|Acute Phase|Failed to Return|1|||
156589796|NCT00406640|565242873|FG000|Acute Phase|Physician Decision|0|||
156589797|NCT00406640|565242874|FG001|Acute Phase|Physician Decision|1|||
156589798|NCT00406640|565242873|FG000|Acute Phase|Lost to Follow-up|7|||
156589799|NCT00406640|565242874|FG001|Acute Phase|Lost to Follow-up|4|||
156589800|NCT00406640|565242873|FG000|Acute Phase|Protocol deviation|4|||
156589801|NCT00406640|565242874|FG001|Acute Phase|Protocol deviation|10|||
156589802|NCT00406640|565242873|FG000|Acute Phase|Protocol Violation|3|||
156589803|NCT00406640|565242874|FG001|Acute Phase|Protocol Violation|2|||
156589804|NCT00406640|565242873|FG000|Acute Phase|Withdrawal by Subject|11|||
156589805|NCT00406640|565242874|FG001|Acute Phase|Withdrawal by Subject|9|||
156589806|NCT00406640|565242873|FG000|Acute Phase|Lack of Efficacy|3|||
156589807|NCT00406640|565242874|FG001|Acute Phase|Lack of Efficacy|3|||
156589808|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
156589809|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
156589810|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|Death|1|||
156589811|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|Death|0|||
156589812|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
156589813|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
156589814|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
156589815|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
156589816|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
156589817|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
156589818|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|non-compliance|7|||
156589819|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|non-compliance|5|||
156589820|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
156589821|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
156589822|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
156589823|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
156589824|NCT00406640|565242873|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
156589825|NCT00406640|565242874|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
156589826|NCT00406640|565242873|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
156589827|NCT00406640|565242874|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
156589828|NCT00406640|565242873|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
156589829|NCT00406640|565242874|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
156589830|NCT00406640|565242873|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
156589831|NCT00406640|565242874|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
156589832|NCT00406640|565242873|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
156589833|NCT00406640|565242874|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
156589834|NCT00406640|565242873|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
156589835|NCT00406640|565242874|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
156589836|NCT00406640|565242873|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
156589837|NCT00406640|565242874|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
156589838|NCT00406640|565242873|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
156589839|NCT00406640|565242874|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
156589840|NCT02669862|565245404|FG000|Overall Study|Lost to Follow-up|0|||
156589841|NCT02669862|565245405|FG001|Overall Study|Lost to Follow-up|2|||
156589842|NCT02669862|565245406|FG002|Overall Study|Lost to Follow-up|1|||
156589843|NCT02669862|565245404|FG000|Overall Study|Withdrawal by Subject|2|||
156589844|NCT02669862|565245405|FG001|Overall Study|Withdrawal by Subject|2|||
156589845|NCT02669862|565245406|FG002|Overall Study|Withdrawal by Subject|3|||
156589846|NCT02669862|565245404|FG000|Overall Study|moved|0|||
156589847|NCT02669862|565245405|FG001|Overall Study|moved|1|||
156589848|NCT02669862|565245406|FG002|Overall Study|moved|0|||
156589849|NCT02669862|565245404|FG000|Overall Study|Protocol Violation|0|||
156589850|NCT02669862|565245405|FG001|Overall Study|Protocol Violation|0|||
156589851|NCT02669862|565245406|FG002|Overall Study|Protocol Violation|1|||
156589852|NCT00311181|565245407|FG000|Overall Study|Final DFTs were not obtained|96|||
156589853|NCT02294318|565245408|FG000|Overall Study|Worsening of drinking|3|||
156589854|NCT02294318|565245409|FG001|Overall Study|Worsening of drinking|0|||
156589855|NCT02294318|565245408|FG000|Overall Study|Not exposed to intervention|0|||
156589856|NCT02294318|565245409|FG001|Overall Study|Not exposed to intervention|2|||
156589857|NCT01694420|565245413|FG000|Overall Study|Lost to Follow-up|3|||
156589858|NCT00506948|565245416|FG000|Overall Study|Death|4|||
156589859|NCT00506948|565245416|FG000|Overall Study|Adverse Event|5|||
156589860|NCT00506948|565245416|FG000|Overall Study|Physician Decision|1|||
156589861|NCT00762372|565245417|FG000|Overall Study|Adverse Event|1|||
156589862|NCT00762372|565245418|FG001|Overall Study|Adverse Event|0|||
156589863|NCT00762372|565245419|FG002|Overall Study|Adverse Event|0|||
156589864|NCT02395653|565245420|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
156589865|NCT02395653|565245420|FG000|Overall Study|Consent Withdrawn at Screening|1|||
156589866|NCT02395653|565245420|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
156589867|NCT02395653|565245420|FG000|Overall Study|Investigator Decision at Screening|1|||
156589868|NCT02395653|565245420|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
156589869|NCT02395653|565245420|FG000|Overall Study|Withdrawal by Subject|1|||
156589870|NCT02395653|565245420|FG000|Overall Study|Lost to Follow-up|1|||
156589871|NCT01194804|565245421|FG000|Overall Study|Withdrawal by Subject|1|||
156589872|NCT02670915|565245422|FG000|Overall Study|Withdrawal by Subject|0|||
156589873|NCT02670915|565245423|FG001|Overall Study|Withdrawal by Subject|1|||
156589874|NCT02670915|565245424|FG002|Overall Study|Withdrawal by Subject|4|||
156589875|NCT02670915|565245422|FG000|Overall Study|Withdrawal by parent/guardian|4|||
156589876|NCT02670915|565245423|FG001|Overall Study|Withdrawal by parent/guardian|4|||
156589877|NCT02670915|565245424|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156589878|NCT02670915|565245422|FG000|Overall Study|Unclassified|0|||
156589879|NCT02670915|565245423|FG001|Overall Study|Unclassified|3|||
156589880|NCT02670915|565245424|FG002|Overall Study|Unclassified|0|||
156589881|NCT00818207|565245425|FG000|Overall Study|Adverse Event|6|||
156589882|NCT00818207|565245426|FG001|Overall Study|Adverse Event|0|||
156589883|NCT00818207|565245425|FG000|Overall Study|Lost to Follow-up|160|||
156589884|NCT00818207|565245426|FG001|Overall Study|Lost to Follow-up|146|||
156589885|NCT00818207|565245425|FG000|Overall Study|Multiple reasons|11|||
156589886|NCT00818207|565245426|FG001|Overall Study|Multiple reasons|12|||
156589887|NCT00818207|565245425|FG000|Overall Study|Withdrawal by Subject|42|||
156589888|NCT00818207|565245426|FG001|Overall Study|Withdrawal by Subject|104|||
156589889|NCT00818207|565245425|FG000|Overall Study|Death|3|||
156589890|NCT00818207|565245426|FG001|Overall Study|Death|5|||
156589891|NCT02494778|565245427|FG000|Overall Study|Death|3|||
156589892|NCT02494778|565245427|FG000|Overall Study|Other|173|||
156589893|NCT02494778|565245427|FG000|Overall Study|Lack of Efficacy|4|||
156589894|NCT02494778|565245427|FG000|Overall Study|Adverse Event|18|||
156589895|NCT02494778|565245427|FG000|Overall Study|Withdrawal by Subject|20|||
156589896|NCT02494778|565245427|FG000|Overall Study|Lost to Follow-up|2|||
156589897|NCT02494778|565245427|FG000|Overall Study|Noncompliant with study drug admin.|1|||
156589898|NCT02616185|565245428|FG000|Overall Study|Death|0|||
156589899|NCT02616185|565245429|FG001|Overall Study|Death|0|||
156589900|NCT02616185|565245430|FG002|Overall Study|Death|0|||
156589901|NCT02616185|565245431|FG003|Overall Study|Death|1|||
156589902|NCT02616185|565245432|FG004|Overall Study|Death|2|||
156589903|NCT02616185|565245433|FG005|Overall Study|Death|0|||
156589904|NCT02616185|565245434|FG006|Overall Study|Death|0|||
156589905|NCT02616185|565245435|FG007|Overall Study|Death|2|||
156589906|NCT02616185|565245436|FG008|Overall Study|Death|1|||
156589907|NCT02616185|565245428|FG000|Overall Study|Study terminated by sponsor|0|||
156589908|NCT02616185|565245429|FG001|Overall Study|Study terminated by sponsor|0|||
156589909|NCT02616185|565245430|FG002|Overall Study|Study terminated by sponsor|1|||
156589910|NCT02616185|565245431|FG003|Overall Study|Study terminated by sponsor|0|||
156589911|NCT02616185|565245432|FG004|Overall Study|Study terminated by sponsor|0|||
156589912|NCT02616185|565245433|FG005|Overall Study|Study terminated by sponsor|0|||
156589913|NCT02616185|565245434|FG006|Overall Study|Study terminated by sponsor|5|||
156589914|NCT02616185|565245435|FG007|Overall Study|Study terminated by sponsor|2|||
156589915|NCT02616185|565245436|FG008|Overall Study|Study terminated by sponsor|0|||
156589916|NCT02616185|565245428|FG000|Overall Study|Participant refused further follow-up|1|||
156589917|NCT02616185|565245429|FG001|Overall Study|Participant refused further follow-up|1|||
156589918|NCT02616185|565245430|FG002|Overall Study|Participant refused further follow-up|2|||
156589919|NCT02616185|565245431|FG003|Overall Study|Participant refused further follow-up|3|||
156589920|NCT02616185|565245432|FG004|Overall Study|Participant refused further follow-up|4|||
156589921|NCT02616185|565245433|FG005|Overall Study|Participant refused further follow-up|0|||
156589922|NCT02616185|565245434|FG006|Overall Study|Participant refused further follow-up|3|||
156589923|NCT02616185|565245435|FG007|Overall Study|Participant refused further follow-up|4|||
156589924|NCT02616185|565245436|FG008|Overall Study|Participant refused further follow-up|3|||
156589925|NCT02616185|565245428|FG000|Overall Study|Not reported|0|||
156589926|NCT02616185|565245429|FG001|Overall Study|Not reported|0|||
156589927|NCT02616185|565245430|FG002|Overall Study|Not reported|0|||
156589928|NCT02616185|565245431|FG003|Overall Study|Not reported|1|||
156589929|NCT02616185|565245432|FG004|Overall Study|Not reported|3|||
156589930|NCT02616185|565245433|FG005|Overall Study|Not reported|1|||
156589931|NCT02616185|565245434|FG006|Overall Study|Not reported|0|||
156589932|NCT02616185|565245435|FG007|Overall Study|Not reported|5|||
156589933|NCT02616185|565245436|FG008|Overall Study|Not reported|2|||
156589934|NCT01303380|565245437|FG000|Overall Study|Lack of compliance to study procedures|1|||
156589935|NCT03621943|565245438|FG000|First Randomized Intervention|Lost to Follow-up|51|||
156589936|NCT03621943|565245439|FG001|First Randomized Intervention|Lost to Follow-up|54|||
156589937|NCT03621943|565245438|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
156589938|NCT03621943|565245439|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
156589939|NCT03621943|565245438|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
156589940|NCT03621943|565245439|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
156589941|NCT03621943|565245438|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
156589942|NCT03621943|565245439|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
156589943|NCT00967226|565245440|FG000|Overall Study|Adverse Event|0|||
156589944|NCT00967226|565245441|FG001|Overall Study|Adverse Event|5|||
156589945|NCT00967226|565245440|FG000|Overall Study|Protocol Violation|2|||
156589946|NCT00967226|565245441|FG001|Overall Study|Protocol Violation|0|||
156589947|NCT00967226|565245440|FG000|Overall Study|Physician Decision|0|||
156589948|NCT00967226|565245441|FG001|Overall Study|Physician Decision|1|||
156589949|NCT02174861|565245442|FG000|Overall Study|Decision by sponsor|8|||
156589950|NCT02174861|565245442|FG000|Overall Study|Withdrawal by Subject|124|||
156589951|NCT02174861|565245442|FG000|Overall Study|Lost to Follow-up|26|||
156589952|NCT01215734|565245443|FG000|Overall Study|Death|0|||
156589953|NCT01215734|565245444|FG001|Overall Study|Death|1|||
156589954|NCT00315705|565245445|FG000|Phase 1|Refused further treatment|1|||
156589955|NCT00315705|565245445|FG000|Phase 1|Failure to achieve response|8|||
156589956|NCT00315705|565245445|FG000|Phase 1|Disease relapse|4|||
156589957|NCT00315705|565245445|FG000|Phase 1|Scheduled for transplant|9|||
156589958|NCT00315705|565245445|FG000|Phase 1|Death|3|||
156589959|NCT00315705|565245445|FG000|Phase 2|Physician Decision|4|||
156589960|NCT00315705|565245445|FG000|Phase 2|Adverse Event|1|||
156589961|NCT00315705|565245445|FG000|Phase 2|Failure to achieve response|3|||
156589962|NCT00315705|565245445|FG000|Phase 2|Disease relapse|1|||
156589963|NCT00315705|565245445|FG000|Phase 2|Scheduled for transplant|8|||
156589964|NCT00315705|565245445|FG000|Phase 2|Other|1|||
156589965|NCT00315705|565245445|FG000|Phase 2|Death|7|||
156589966|NCT01346371|565245446|FG000|Overall Study|Lost to Follow-up|2|||
156589967|NCT01346371|565245447|FG001|Overall Study|Lost to Follow-up|0|||
156589968|NCT01716533|565245451|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
156589969|NCT01716533|565245452|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
156589970|NCT01716533|565245453|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
156589971|NCT01716533|565245454|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
156589972|NCT01716533|565245451|FG000|Overall Study|Withdrawal by Subject|0|||
156589973|NCT01716533|565245452|FG001|Overall Study|Withdrawal by Subject|0|||
156589974|NCT01716533|565245453|FG002|Overall Study|Withdrawal by Subject|0|||
156589975|NCT01716533|565245454|FG003|Overall Study|Withdrawal by Subject|5|||
156589976|NCT01716533|565245451|FG000|Overall Study|Death|0|||
156589977|NCT01716533|565245452|FG001|Overall Study|Death|0|||
156589978|NCT01716533|565245453|FG002|Overall Study|Death|0|||
156589979|NCT01716533|565245454|FG003|Overall Study|Death|2|||
156589980|NCT01716533|565245451|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
156589981|NCT01716533|565245452|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
156589982|NCT01716533|565245453|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
156589983|NCT01716533|565245454|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
156589984|NCT01670656|565245461|FG000|Overall Study|Non-compliance with study drug|0|||
156589985|NCT01670656|565245462|FG001|Overall Study|Non-compliance with study drug|0|||
156589986|NCT01670656|565245463|FG002|Overall Study|Non-compliance with study drug|3|||
156589987|NCT01670656|565245464|FG003|Overall Study|Non-compliance with study drug|0|||
156589988|NCT01670656|565245465|FG004|Overall Study|Non-compliance with study drug|1|||
156589989|NCT01670656|565245461|FG000|Overall Study|Pregnancy|0|||
156589990|NCT01670656|565245462|FG001|Overall Study|Pregnancy|0|||
156589991|NCT01670656|565245463|FG002|Overall Study|Pregnancy|0|||
156589992|NCT01670656|565245464|FG003|Overall Study|Pregnancy|0|||
156589993|NCT01670656|565245465|FG004|Overall Study|Pregnancy|1|||
156589994|NCT01670656|565245461|FG000|Overall Study|Withdrawal by Subject|1|||
156589995|NCT01670656|565245462|FG001|Overall Study|Withdrawal by Subject|1|||
156589996|NCT01670656|565245463|FG002|Overall Study|Withdrawal by Subject|0|||
156589997|NCT01670656|565245464|FG003|Overall Study|Withdrawal by Subject|0|||
156589998|NCT01670656|565245465|FG004|Overall Study|Withdrawal by Subject|0|||
156589999|NCT01670656|565245461|FG000|Overall Study|Non-compliance with protocol|0|||
156590000|NCT01670656|565245462|FG001|Overall Study|Non-compliance with protocol|3|||
156590001|NCT01670656|565245463|FG002|Overall Study|Non-compliance with protocol|1|||
156590002|NCT01670656|565245464|FG003|Overall Study|Non-compliance with protocol|1|||
156590003|NCT01670656|565245465|FG004|Overall Study|Non-compliance with protocol|2|||
156590004|NCT01670656|565245461|FG000|Overall Study|Adverse Event|2|||
156590005|NCT01670656|565245462|FG001|Overall Study|Adverse Event|2|||
156590006|NCT01670656|565245463|FG002|Overall Study|Adverse Event|2|||
156590007|NCT01670656|565245464|FG003|Overall Study|Adverse Event|3|||
156590008|NCT01670656|565245465|FG004|Overall Study|Adverse Event|3|||
156590009|NCT01670656|565245461|FG000|Overall Study|Subject withdrew consent|0|||
156590010|NCT01670656|565245462|FG001|Overall Study|Subject withdrew consent|1|||
156590011|NCT01670656|565245463|FG002|Overall Study|Subject withdrew consent|2|||
156590012|NCT01670656|565245464|FG003|Overall Study|Subject withdrew consent|1|||
156590013|NCT01670656|565245465|FG004|Overall Study|Subject withdrew consent|1|||
156590014|NCT01670656|565245461|FG000|Overall Study|Lost to Follow-up|0|||
156590015|NCT01670656|565245462|FG001|Overall Study|Lost to Follow-up|0|||
156590016|NCT01670656|565245463|FG002|Overall Study|Lost to Follow-up|0|||
156590017|NCT01670656|565245464|FG003|Overall Study|Lost to Follow-up|0|||
156590018|NCT01670656|565245465|FG004|Overall Study|Lost to Follow-up|3|||
156590019|NCT01670656|565245461|FG000|Overall Study|Subject moved|0|||
156590020|NCT01670656|565245462|FG001|Overall Study|Subject moved|0|||
156590021|NCT01670656|565245463|FG002|Overall Study|Subject moved|0|||
156590022|NCT01670656|565245464|FG003|Overall Study|Subject moved|1|||
156590023|NCT01670656|565245465|FG004|Overall Study|Subject moved|0|||
156590024|NCT00789958|565245466|FG000|Overall Study|Adverse Event|3|||
156590025|NCT00789958|565245466|FG000|Overall Study|Withdrawal by Subject|4|||
156590026|NCT00789958|565245466|FG000|Overall Study|Progression|3|||
156590027|NCT00789958|565245466|FG000|Overall Study|not protocol specified|1|||
156590028|NCT00789958|565245466|FG000|Overall Study|Not eligible/not analyzable|26|||
156590029|NCT02622724|565245467|FG000|Overall Study|Death|51|||
156590030|NCT02622724|565245468|FG001|Overall Study|Death|53|||
156590031|NCT02622724|565245467|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
156590032|NCT02622724|565245468|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
156590033|NCT02622724|565245467|FG000|Overall Study|Early termination of study|38|||
156590034|NCT02622724|565245468|FG001|Overall Study|Early termination of study|43|||
156590035|NCT00487084|565245469|FG000|Overall Study|Did not receive intervention|4|||
156590036|NCT00487084|565245470|FG001|Overall Study|Did not receive intervention|3|||
156590037|NCT00487084|565245471|FG002|Overall Study|Did not receive intervention|5|||
156590038|NCT00254293|565245472|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
156590039|NCT00254293|565245473|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
156590040|NCT00254293|565245474|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
156590041|NCT00254293|565245475|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
156590042|NCT00254293|565245476|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
156590043|NCT00254293|565245477|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
156590044|NCT00254293|565245478|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
156590045|NCT00254293|565245472|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
156590046|NCT00254293|565245473|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
156590047|NCT00254293|565245474|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
156590048|NCT00254293|565245475|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
156863655|NCT03043313|566258736|FG000|Overall Study|Death|28|||
156590049|NCT00254293|565245476|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
156590050|NCT00254293|565245477|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
156590051|NCT00254293|565245478|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
156590052|NCT00254293|565245472|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
156590053|NCT00254293|565245473|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
156590054|NCT00254293|565245474|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
156590055|NCT00254293|565245475|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
156590056|NCT00254293|565245476|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
156590057|NCT00254293|565245477|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
156590058|NCT00254293|565245478|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
156590059|NCT00254293|565245472|FG000|LTE Open Label Variable SC Dosing|Death|0|||
156590060|NCT00254293|565245473|FG001|LTE Open Label Variable SC Dosing|Death|0|||
156590061|NCT00254293|565245474|FG002|LTE Open Label Variable SC Dosing|Death|1|||
156590062|NCT00254293|565245475|FG003|LTE Open Label Variable SC Dosing|Death|0|||
156590063|NCT00254293|565245476|FG004|LTE Open Label Variable SC Dosing|Death|0|||
156590064|NCT00254293|565245477|FG005|LTE Open Label Variable SC Dosing|Death|0|||
156590065|NCT00254293|565245478|FG006|LTE Open Label Variable SC Dosing|Death|0|||
156590066|NCT00254293|565245472|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
156590067|NCT00254293|565245473|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
156590068|NCT00254293|565245474|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
156590069|NCT00254293|565245475|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
156590070|NCT00254293|565245476|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
156590071|NCT00254293|565245477|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
156590072|NCT00254293|565245478|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
156590073|NCT00254293|565245472|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
156590074|NCT00254293|565245473|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
156590075|NCT00254293|565245474|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
156590076|NCT00254293|565245475|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
156590077|NCT00254293|565245476|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
156590078|NCT00254293|565245477|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
156590079|NCT00254293|565245478|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
156590080|NCT00254293|565245472|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
156590081|NCT00254293|565245473|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
156590082|NCT00254293|565245474|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
156590083|NCT00254293|565245475|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
156590084|NCT00254293|565245476|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
156590085|NCT00254293|565245477|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
156590086|NCT00254293|565245478|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
156590087|NCT00254293|565245472|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
156590088|NCT00254293|565245473|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
156590089|NCT00254293|565245474|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
156590090|NCT00254293|565245475|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
156590091|NCT00254293|565245476|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
156590092|NCT00254293|565245477|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
156590093|NCT00254293|565245478|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
156590094|NCT00254293|565245472|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
156590095|NCT00254293|565245473|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
156590096|NCT00254293|565245474|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
156590097|NCT00254293|565245475|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
156590098|NCT00254293|565245476|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
156590099|NCT00254293|565245477|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
156590100|NCT00254293|565245478|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
156590101|NCT00254293|565245472|FG000|LTE Open Label Variable SC Dosing|Other|0|||
156590102|NCT00254293|565245473|FG001|LTE Open Label Variable SC Dosing|Other|0|||
156590103|NCT00254293|565245474|FG002|LTE Open Label Variable SC Dosing|Other|2|||
156590104|NCT00254293|565245475|FG003|LTE Open Label Variable SC Dosing|Other|0|||
156590105|NCT00254293|565245476|FG004|LTE Open Label Variable SC Dosing|Other|0|||
156590106|NCT00254293|565245477|FG005|LTE Open Label Variable SC Dosing|Other|0|||
156590107|NCT00254293|565245478|FG006|LTE Open Label Variable SC Dosing|Other|0|||
156590108|NCT00254293|565245472|FG000|LTE Open Label Fixed Dosing|Death|0|||
156590109|NCT00254293|565245473|FG001|LTE Open Label Fixed Dosing|Death|0|||
156590110|NCT00254293|565245474|FG002|LTE Open Label Fixed Dosing|Death|0|||
156590111|NCT00254293|565245475|FG003|LTE Open Label Fixed Dosing|Death|0|||
156590112|NCT00254293|565245476|FG004|LTE Open Label Fixed Dosing|Death|0|||
156590113|NCT00254293|565245477|FG005|LTE Open Label Fixed Dosing|Death|0|||
156590114|NCT00254293|565245478|FG006|LTE Open Label Fixed Dosing|Death|3|||
156590115|NCT00254293|565245472|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
156590116|NCT00254293|565245473|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
156634901|NCT03917654|565407825|FG010|Year 1|Withdrawal by Subject|1|||
156590117|NCT00254293|565245474|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
156590118|NCT00254293|565245475|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
156590119|NCT00254293|565245476|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
156590120|NCT00254293|565245477|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
156590121|NCT00254293|565245478|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
156590122|NCT00254293|565245472|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
156590123|NCT00254293|565245473|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
156590124|NCT00254293|565245474|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
156590125|NCT00254293|565245475|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
156590126|NCT00254293|565245476|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
156590127|NCT00254293|565245477|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
156590128|NCT00254293|565245478|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
156590129|NCT00254293|565245472|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156590130|NCT00254293|565245473|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156590131|NCT00254293|565245474|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156590132|NCT00254293|565245475|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156590133|NCT00254293|565245476|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156590134|NCT00254293|565245477|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156590135|NCT00254293|565245478|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
156590136|NCT00254293|565245472|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
156590137|NCT00254293|565245473|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
156590138|NCT00254293|565245474|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
156590139|NCT00254293|565245475|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
156590140|NCT00254293|565245476|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
156590141|NCT00254293|565245477|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
156590142|NCT00254293|565245478|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
156590143|NCT00254293|565245472|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
156590144|NCT00254293|565245473|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
156590145|NCT00254293|565245474|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
156590146|NCT00254293|565245475|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
156590147|NCT00254293|565245476|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
156590148|NCT00254293|565245477|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
156590149|NCT00254293|565245478|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
156590150|NCT00254293|565245472|FG000|LTE Open Label Fixed Dosing|Other|0|||
156590151|NCT00254293|565245473|FG001|LTE Open Label Fixed Dosing|Other|0|||
156590152|NCT00254293|565245474|FG002|LTE Open Label Fixed Dosing|Other|0|||
156590153|NCT00254293|565245475|FG003|LTE Open Label Fixed Dosing|Other|0|||
156590154|NCT00254293|565245476|FG004|LTE Open Label Fixed Dosing|Other|0|||
156590155|NCT00254293|565245477|FG005|LTE Open Label Fixed Dosing|Other|0|||
156590156|NCT00254293|565245478|FG006|LTE Open Label Fixed Dosing|Other|1|||
156590157|NCT01575197|565245479|FG000|Overall Study|Migration out of study area|1|||
156590158|NCT01575197|565245480|FG001|Overall Study|Migration out of study area|5|||
156590159|NCT01575197|565245481|FG002|Overall Study|Migration out of study area|4|||
156590160|NCT01575197|565245479|FG000|Overall Study|SAE|0|||
156590161|NCT01575197|565245480|FG001|Overall Study|SAE|1|||
156590162|NCT01575197|565245481|FG002|Overall Study|SAE|0|||
156590163|NCT01575197|565245479|FG000|Overall Study|Lost to Follow-up|0|||
156590164|NCT01575197|565245480|FG001|Overall Study|Lost to Follow-up|1|||
156590165|NCT01575197|565245481|FG002|Overall Study|Lost to Follow-up|0|||
156590166|NCT01575197|565245479|FG000|Overall Study|Withdrawal by Subject|0|||
156590167|NCT01575197|565245480|FG001|Overall Study|Withdrawal by Subject|1|||
156590168|NCT01575197|565245481|FG002|Overall Study|Withdrawal by Subject|1|||
156590169|NCT01575197|565245479|FG000|Overall Study|Protocol Violation|2|||
156590170|NCT01575197|565245480|FG001|Overall Study|Protocol Violation|1|||
156590171|NCT01575197|565245481|FG002|Overall Study|Protocol Violation|1|||
156590172|NCT02709083|565245482|FG000|Overall Study|Original PI left institution|7|||
156590173|NCT02681055|565245483|FG000|Weeks 5-12|Adverse Event|1|||
156590174|NCT02695524|565245484|FG000|Overall Study|Lost to Follow-up|3|||
156590175|NCT02695524|565245485|FG001|Overall Study|Lost to Follow-up|2|||
156590176|NCT02695524|565245484|FG000|Overall Study|Death|0|||
156590177|NCT02695524|565245485|FG001|Overall Study|Death|1|||
156590178|NCT04348656|565245486|FG000|Overall Study|Withdrawal by Subject|2|||
156590179|NCT04348656|565245487|FG001|Overall Study|Withdrawal by Subject|0|||
156590180|NCT04348656|565245486|FG000|Overall Study|Lost to Follow-up|11|||
156590181|NCT04348656|565245487|FG001|Overall Study|Lost to Follow-up|6|||
156590182|NCT00310388|565245488|FG000|Primary Reporting Phase|Adverse Event|101|||
156590183|NCT00310388|565245489|FG001|Primary Reporting Phase|Adverse Event|0|||
156590184|NCT00310388|565245488|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
156590185|NCT00310388|565245489|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
156590186|NCT00310388|565245488|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
156590187|NCT00310388|565245489|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
156590188|NCT00310388|565245488|FG000|Primary Reporting Phase|Protocol Violation|10|||
156634902|NCT03917654|565407826|FG011|Year 1|Withdrawal by Subject|0|||
156863656|NCT03043313|566258737|FG001|Overall Study|Death|26|||
156863657|NCT03043313|566258738|FG002|Overall Study|Death|17|||
156590189|NCT00310388|565245489|FG001|Primary Reporting Phase|Protocol Violation|0|||
156590190|NCT00310388|565245488|FG000|Primary Reporting Phase|Pregnancy|3|||
156590191|NCT00310388|565245489|FG001|Primary Reporting Phase|Pregnancy|0|||
156590192|NCT00310388|565245488|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
156590193|NCT00310388|565245489|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
156590194|NCT00310388|565245488|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
156590195|NCT00310388|565245489|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
156590196|NCT00310388|565245488|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
156590197|NCT00310388|565245489|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
156590198|NCT00310388|565245488|FG000|Primary Reporting Phase|Physician Decision|2|||
156590199|NCT00310388|565245489|FG001|Primary Reporting Phase|Physician Decision|0|||
156590200|NCT00310388|565245488|FG000|Primary Reporting Phase|Request of the sponsor|19|||
156590201|NCT00310388|565245489|FG001|Primary Reporting Phase|Request of the sponsor|0|||
156590202|NCT00310388|565245488|FG000|Primary Reporting Phase|Failed to return|8|||
156590203|NCT00310388|565245489|FG001|Primary Reporting Phase|Failed to return|0|||
156590204|NCT00310388|565245488|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
156590205|NCT00310388|565245489|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
156590206|NCT00310388|565245488|FG000|Primary Reporting Phase|Participant request|2|||
156590207|NCT00310388|565245489|FG001|Primary Reporting Phase|Participant request|0|||
156590208|NCT00310388|565245488|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
156590209|NCT00310388|565245489|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
156590210|NCT00310388|565245488|FG000|Primary Reporting Phase|Discontinuation of study|1|||
156590211|NCT00310388|565245489|FG001|Primary Reporting Phase|Discontinuation of study|0|||
156590212|NCT00310388|565245488|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
156590213|NCT00310388|565245489|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
156590214|NCT00310388|565245488|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
156590215|NCT00310388|565245489|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
156590216|NCT00310388|565245488|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
156590217|NCT00310388|565245489|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
156590218|NCT00310388|565245488|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
156590219|NCT00310388|565245489|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
156590220|NCT00310388|565245488|FG000|Primary Reporting Phase|Participant passed away|1|||
156590221|NCT00310388|565245489|FG001|Primary Reporting Phase|Participant passed away|0|||
156590222|NCT00310388|565245488|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
156590223|NCT00310388|565245489|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
156590224|NCT00310388|565245488|FG000|Primary Reporting Phase|Missing|1|||
156590225|NCT00310388|565245489|FG001|Primary Reporting Phase|Missing|0|||
156590226|NCT00310388|565245488|FG000|Primary Reporting Phase|Other|1|||
156590227|NCT00310388|565245489|FG001|Primary Reporting Phase|Other|0|||
156590228|NCT00310388|565245488|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
156590229|NCT00310388|565245489|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
156590230|NCT00310388|565245488|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
156590231|NCT00310388|565245489|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
156590232|NCT00310388|565245488|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
156590233|NCT00310388|565245489|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
156590234|NCT00310388|565245488|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
156590235|NCT00310388|565245489|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
156590236|NCT05906732|565245492|FG000|Overall Study|Withdrawal by Subject|1|||
156590237|NCT05906732|565245493|FG001|Overall Study|Withdrawal by Subject|0|||
156590238|NCT05906732|565245494|FG002|Overall Study|Withdrawal by Subject|0|||
156590239|NCT05906732|565245495|FG003|Overall Study|Withdrawal by Subject|0|||
156590240|NCT05906732|565245492|FG000|Overall Study|Physician Decision|2|||
156590241|NCT05906732|565245493|FG001|Overall Study|Physician Decision|4|||
156590242|NCT05906732|565245494|FG002|Overall Study|Physician Decision|0|||
156590243|NCT05906732|565245495|FG003|Overall Study|Physician Decision|0|||
156590244|NCT01248130|565245496|FG000|Overall Study|Protocol Violation|1|||
156590245|NCT01248130|565245497|FG001|Overall Study|Protocol Violation|0|||
156590246|NCT01248130|565245496|FG000|Overall Study|Ineligible|1|||
156590247|NCT01248130|565245497|FG001|Overall Study|Ineligible|0|||
156590248|NCT02052778|565245498|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
156590249|NCT02052778|565245499|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
156590250|NCT02052778|565245500|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
156590251|NCT02052778|565245501|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
156590252|NCT02052778|565245502|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
156590253|NCT02052778|565245503|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
156590254|NCT02052778|565245504|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590255|NCT02052778|565245505|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
156863658|NCT03043313|566258736|FG000|Overall Study|Participation terminated by sponsor|11|||
156590256|NCT02052778|565245506|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
156590257|NCT02052778|565245507|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
156590258|NCT02052778|565245508|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
156590259|NCT02052778|565245509|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
156590260|NCT02052778|565245510|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
156590261|NCT02052778|565245511|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
156590262|NCT02052778|565245512|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590263|NCT02052778|565245513|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590264|NCT02052778|565245514|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590265|NCT02052778|565245515|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590266|NCT02052778|565245516|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590267|NCT02052778|565245517|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590268|NCT02052778|565245518|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590269|NCT02052778|565245519|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590270|NCT02052778|565245520|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156590271|NCT02052778|565245498|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
156590272|NCT02052778|565245499|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
156590273|NCT02052778|565245500|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
156590274|NCT02052778|565245501|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
156590275|NCT02052778|565245502|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
156590276|NCT02052778|565245503|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
156590277|NCT02052778|565245504|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
156590278|NCT02052778|565245505|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
156590279|NCT02052778|565245506|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
156590280|NCT02052778|565245507|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590281|NCT02052778|565245508|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590282|NCT02052778|565245509|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
156590283|NCT02052778|565245510|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
156590284|NCT02052778|565245511|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
156590285|NCT02052778|565245512|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590286|NCT02052778|565245513|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590287|NCT02052778|565245514|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590288|NCT02052778|565245515|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590289|NCT02052778|565245516|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590290|NCT02052778|565245517|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590291|NCT02052778|565245518|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590292|NCT02052778|565245519|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590293|NCT02052778|565245520|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156590294|NCT02052778|565245498|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590295|NCT02052778|565245499|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590296|NCT02052778|565245500|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590297|NCT02052778|565245501|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590298|NCT02052778|565245502|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590299|NCT02052778|565245503|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590300|NCT02052778|565245504|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590301|NCT02052778|565245505|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590302|NCT02052778|565245506|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590303|NCT02052778|565245507|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590304|NCT02052778|565245508|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590305|NCT02052778|565245509|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590306|NCT02052778|565245510|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590307|NCT02052778|565245511|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
156590308|NCT02052778|565245512|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590309|NCT02052778|565245513|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590310|NCT02052778|565245514|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590311|NCT02052778|565245515|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590312|NCT02052778|565245516|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590313|NCT02052778|565245517|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590314|NCT02052778|565245518|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590315|NCT02052778|565245519|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590316|NCT02052778|565245520|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156590317|NCT02052778|565245498|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
156590318|NCT02052778|565245499|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
156590319|NCT02052778|565245500|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
156590320|NCT02052778|565245501|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
156590321|NCT02052778|565245502|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
156590322|NCT02052778|565245503|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
156590323|NCT02052778|565245504|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
156590324|NCT02052778|565245505|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
156590325|NCT02052778|565245506|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
156590326|NCT02052778|565245507|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
156590327|NCT02052778|565245508|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
156590328|NCT02052778|565245509|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
156590329|NCT02052778|565245510|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
156590330|NCT02052778|565245511|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
156590331|NCT02052778|565245512|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
156590332|NCT02052778|565245513|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
156590333|NCT02052778|565245514|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
156590334|NCT02052778|565245515|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
156590335|NCT02052778|565245516|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
156590336|NCT02052778|565245517|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
156590337|NCT02052778|565245518|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
156590338|NCT02052778|565245519|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
156590339|NCT02052778|565245520|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
156590340|NCT02052778|565245498|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590341|NCT02052778|565245499|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590342|NCT02052778|565245500|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590343|NCT02052778|565245501|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590344|NCT02052778|565245502|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590345|NCT02052778|565245503|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590346|NCT02052778|565245504|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590347|NCT02052778|565245505|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590348|NCT02052778|565245506|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
156590349|NCT02052778|565245507|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590350|NCT02052778|565245508|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590351|NCT02052778|565245509|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590352|NCT02052778|565245510|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590353|NCT02052778|565245511|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
156590354|NCT02052778|565245512|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590355|NCT02052778|565245513|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590356|NCT02052778|565245514|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590357|NCT02052778|565245515|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590358|NCT02052778|565245516|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590359|NCT02052778|565245517|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590360|NCT02052778|565245518|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590361|NCT02052778|565245519|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590362|NCT02052778|565245520|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156590363|NCT02052778|565245498|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590364|NCT02052778|565245499|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590365|NCT02052778|565245500|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590366|NCT02052778|565245501|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590367|NCT02052778|565245502|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590368|NCT02052778|565245503|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
156590369|NCT02052778|565245504|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590370|NCT02052778|565245505|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590371|NCT02052778|565245506|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590372|NCT02052778|565245507|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590373|NCT02052778|565245508|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590374|NCT02052778|565245509|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590375|NCT02052778|565245510|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
156590376|NCT02052778|565245511|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590377|NCT02052778|565245512|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590378|NCT02052778|565245513|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590379|NCT02052778|565245514|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590380|NCT02052778|565245515|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590381|NCT02052778|565245516|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590382|NCT02052778|565245517|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590383|NCT02052778|565245518|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590384|NCT02052778|565245519|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590385|NCT02052778|565245520|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156590386|NCT02052778|565245498|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590387|NCT02052778|565245499|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590388|NCT02052778|565245500|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590389|NCT02052778|565245501|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590390|NCT02052778|565245502|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590391|NCT02052778|565245503|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590392|NCT02052778|565245504|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590393|NCT02052778|565245505|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590394|NCT02052778|565245506|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590395|NCT02052778|565245507|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590396|NCT02052778|565245508|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590397|NCT02052778|565245509|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590398|NCT02052778|565245510|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590399|NCT02052778|565245511|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590400|NCT02052778|565245512|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
156590401|NCT02052778|565245513|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
156590402|NCT02052778|565245514|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
156590403|NCT02052778|565245515|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
156590404|NCT02052778|565245516|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
156590405|NCT02052778|565245517|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
156590406|NCT02052778|565245518|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
156590407|NCT02052778|565245519|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
156590408|NCT02052778|565245520|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
156590409|NCT02052778|565245498|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590410|NCT02052778|565245499|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590411|NCT02052778|565245500|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590412|NCT02052778|565245501|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590413|NCT02052778|565245502|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590414|NCT02052778|565245503|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590415|NCT02052778|565245504|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590416|NCT02052778|565245505|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590417|NCT02052778|565245506|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590418|NCT02052778|565245507|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590419|NCT02052778|565245508|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590420|NCT02052778|565245509|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590421|NCT02052778|565245510|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590422|NCT02052778|565245511|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590423|NCT02052778|565245512|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
156590424|NCT02052778|565245513|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
156590425|NCT02052778|565245514|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590426|NCT02052778|565245515|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
156590427|NCT02052778|565245516|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
156590428|NCT02052778|565245517|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
156590429|NCT02052778|565245518|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
156590430|NCT02052778|565245519|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
156590431|NCT02052778|565245520|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156590432|NCT02052778|565245498|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590433|NCT02052778|565245499|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590434|NCT02052778|565245500|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590435|NCT02052778|565245501|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590436|NCT02052778|565245502|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590437|NCT02052778|565245503|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590438|NCT02052778|565245504|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590439|NCT02052778|565245505|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590440|NCT02052778|565245506|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590441|NCT02052778|565245507|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590442|NCT02052778|565245508|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590443|NCT02052778|565245509|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590444|NCT02052778|565245510|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590445|NCT02052778|565245511|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590446|NCT02052778|565245512|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
156590447|NCT02052778|565245513|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
156590448|NCT02052778|565245514|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
156590449|NCT02052778|565245515|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590450|NCT02052778|565245516|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
156590451|NCT02052778|565245517|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
156590452|NCT02052778|565245518|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590453|NCT02052778|565245519|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590454|NCT02052778|565245520|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156590455|NCT02052778|565245498|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590456|NCT02052778|565245499|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590457|NCT02052778|565245500|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590458|NCT02052778|565245501|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590459|NCT02052778|565245502|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590460|NCT02052778|565245503|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590461|NCT02052778|565245504|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590462|NCT02052778|565245505|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590463|NCT02052778|565245506|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590464|NCT02052778|565245507|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590465|NCT02052778|565245508|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590466|NCT02052778|565245509|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590467|NCT02052778|565245510|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590468|NCT02052778|565245511|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590469|NCT02052778|565245512|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
156590470|NCT02052778|565245513|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
156590471|NCT02052778|565245514|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590472|NCT02052778|565245515|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590473|NCT02052778|565245516|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590474|NCT02052778|565245517|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590475|NCT02052778|565245518|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590476|NCT02052778|565245519|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590477|NCT02052778|565245520|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156590478|NCT02052778|565245498|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590479|NCT02052778|565245499|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590480|NCT02052778|565245500|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590481|NCT02052778|565245501|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590482|NCT02052778|565245502|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590483|NCT02052778|565245503|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590484|NCT02052778|565245504|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590485|NCT02052778|565245505|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590486|NCT02052778|565245506|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590487|NCT02052778|565245507|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590488|NCT02052778|565245508|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590489|NCT02052778|565245509|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590490|NCT02052778|565245510|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590491|NCT02052778|565245511|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590492|NCT02052778|565245512|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
156590493|NCT02052778|565245513|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
156590494|NCT02052778|565245514|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590495|NCT02052778|565245515|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590496|NCT02052778|565245516|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590497|NCT02052778|565245517|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
156590498|NCT02052778|565245518|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590499|NCT02052778|565245519|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590500|NCT02052778|565245520|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156590501|NCT02052778|565245498|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
156590502|NCT02052778|565245499|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
156590503|NCT02052778|565245500|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
156590504|NCT02052778|565245501|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
156590505|NCT02052778|565245502|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
156590506|NCT02052778|565245503|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
156590507|NCT02052778|565245504|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
156590508|NCT02052778|565245505|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
156590509|NCT02052778|565245506|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
156590510|NCT02052778|565245507|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
156590511|NCT02052778|565245508|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
156590512|NCT02052778|565245509|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
156590513|NCT02052778|565245510|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
156590514|NCT02052778|565245511|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
156590515|NCT02052778|565245512|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
156590516|NCT02052778|565245513|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
156590517|NCT02052778|565245514|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
156590518|NCT02052778|565245515|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
156590519|NCT02052778|565245516|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
156590520|NCT02052778|565245517|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
156590521|NCT02052778|565245518|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
156590522|NCT02052778|565245519|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
156590523|NCT02052778|565245520|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
156590524|NCT02052778|565245498|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590525|NCT02052778|565245499|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590526|NCT02052778|565245500|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590527|NCT02052778|565245501|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590528|NCT02052778|565245502|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590529|NCT02052778|565245503|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590530|NCT02052778|565245504|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590531|NCT02052778|565245505|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590532|NCT02052778|565245506|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590533|NCT02052778|565245507|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590534|NCT02052778|565245508|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590535|NCT02052778|565245509|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590536|NCT02052778|565245510|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590537|NCT02052778|565245511|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590538|NCT02052778|565245512|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
156590539|NCT02052778|565245513|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
156590540|NCT02052778|565245514|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
156590541|NCT02052778|565245515|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590542|NCT02052778|565245516|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
156590543|NCT02052778|565245517|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590544|NCT02052778|565245518|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590545|NCT02052778|565245519|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590546|NCT02052778|565245520|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156590547|NCT02052778|565245498|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590548|NCT02052778|565245499|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590549|NCT02052778|565245500|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590550|NCT02052778|565245501|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590551|NCT02052778|565245502|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590552|NCT02052778|565245503|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590553|NCT02052778|565245504|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590554|NCT02052778|565245505|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590555|NCT02052778|565245506|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590556|NCT02052778|565245507|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590557|NCT02052778|565245508|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590558|NCT02052778|565245509|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590559|NCT02052778|565245510|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590560|NCT02052778|565245511|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590561|NCT02052778|565245512|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590562|NCT02052778|565245513|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590563|NCT02052778|565245514|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590564|NCT02052778|565245515|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590565|NCT02052778|565245516|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590566|NCT02052778|565245517|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590567|NCT02052778|565245518|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590568|NCT02052778|565245519|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156590569|NCT02052778|565245520|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
156590570|NCT02052778|565245498|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590571|NCT02052778|565245499|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590572|NCT02052778|565245500|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590573|NCT02052778|565245501|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590574|NCT02052778|565245502|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590575|NCT02052778|565245503|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590576|NCT02052778|565245504|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590577|NCT02052778|565245505|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590578|NCT02052778|565245506|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590579|NCT02052778|565245507|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590580|NCT02052778|565245508|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590581|NCT02052778|565245509|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590582|NCT02052778|565245510|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590583|NCT02052778|565245511|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590584|NCT02052778|565245512|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590585|NCT02052778|565245513|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590586|NCT02052778|565245514|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590587|NCT02052778|565245515|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590588|NCT02052778|565245516|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590589|NCT02052778|565245517|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590590|NCT02052778|565245518|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590591|NCT02052778|565245519|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156590592|NCT02052778|565245520|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
156590593|NCT02052778|565245498|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590594|NCT02052778|565245499|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590595|NCT02052778|565245500|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590596|NCT02052778|565245501|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590597|NCT02052778|565245502|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590598|NCT02052778|565245503|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590599|NCT02052778|565245504|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590600|NCT02052778|565245505|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590601|NCT02052778|565245506|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590602|NCT02052778|565245507|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590603|NCT02052778|565245508|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590604|NCT02052778|565245509|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590605|NCT02052778|565245510|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590606|NCT02052778|565245511|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590607|NCT02052778|565245512|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590608|NCT02052778|565245513|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590609|NCT02052778|565245514|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590610|NCT02052778|565245515|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590611|NCT02052778|565245516|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590612|NCT02052778|565245517|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590613|NCT02052778|565245518|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590614|NCT02052778|565245519|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156590615|NCT02052778|565245520|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
156590616|NCT02052778|565245498|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590617|NCT02052778|565245499|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590618|NCT02052778|565245500|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590619|NCT02052778|565245501|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590620|NCT02052778|565245502|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590621|NCT02052778|565245503|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590622|NCT02052778|565245504|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590623|NCT02052778|565245505|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590624|NCT02052778|565245506|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590625|NCT02052778|565245507|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590626|NCT02052778|565245508|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590627|NCT02052778|565245509|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590628|NCT02052778|565245510|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590629|NCT02052778|565245511|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590630|NCT02052778|565245512|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590631|NCT02052778|565245513|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590632|NCT02052778|565245514|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590633|NCT02052778|565245515|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590634|NCT02052778|565245516|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590635|NCT02052778|565245517|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590636|NCT02052778|565245518|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590637|NCT02052778|565245519|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
156590638|NCT02052778|565245520|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
156590639|NCT02052778|565245498|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590640|NCT02052778|565245499|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590641|NCT02052778|565245500|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590642|NCT02052778|565245501|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590643|NCT02052778|565245502|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590644|NCT02052778|565245503|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590645|NCT02052778|565245504|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590646|NCT02052778|565245505|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590647|NCT02052778|565245506|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590648|NCT02052778|565245507|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590649|NCT02052778|565245508|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590650|NCT02052778|565245509|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590651|NCT02052778|565245510|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590652|NCT02052778|565245511|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590653|NCT02052778|565245512|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590654|NCT02052778|565245513|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590655|NCT02052778|565245514|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590656|NCT02052778|565245515|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590657|NCT02052778|565245516|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590658|NCT02052778|565245517|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590659|NCT02052778|565245518|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590660|NCT02052778|565245519|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156590661|NCT02052778|565245520|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
156590662|NCT02052778|565245498|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
156590663|NCT02052778|565245499|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
156590664|NCT02052778|565245500|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
156590665|NCT02052778|565245501|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
156590666|NCT02052778|565245502|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
156590667|NCT02052778|565245503|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
156590668|NCT02052778|565245504|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
156590669|NCT02052778|565245505|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
156590670|NCT02052778|565245506|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
156590671|NCT02052778|565245507|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
156590672|NCT02052778|565245508|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
156590673|NCT02052778|565245509|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
156590674|NCT02052778|565245510|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
156590675|NCT02052778|565245511|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
156590676|NCT02052778|565245512|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
156590677|NCT02052778|565245513|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
156590678|NCT02052778|565245514|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
156590679|NCT02052778|565245515|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
156590680|NCT02052778|565245516|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
156590681|NCT02052778|565245517|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
156590682|NCT02052778|565245518|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
156590683|NCT02052778|565245519|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
156590684|NCT02052778|565245520|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
156590685|NCT02052778|565245498|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590686|NCT02052778|565245499|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590687|NCT02052778|565245500|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590688|NCT02052778|565245501|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590689|NCT02052778|565245502|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590690|NCT02052778|565245503|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590691|NCT02052778|565245504|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590692|NCT02052778|565245505|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590693|NCT02052778|565245506|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590694|NCT02052778|565245507|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590695|NCT02052778|565245508|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590696|NCT02052778|565245509|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590697|NCT02052778|565245510|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590698|NCT02052778|565245511|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590699|NCT02052778|565245512|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590700|NCT02052778|565245513|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590701|NCT02052778|565245514|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590702|NCT02052778|565245515|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590703|NCT02052778|565245516|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590704|NCT02052778|565245517|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590705|NCT02052778|565245518|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590706|NCT02052778|565245519|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
156590707|NCT02052778|565245520|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
156590708|NCT02345252|565245529|FG000|Double-Blind Phase|Adverse Event|2|||
156590709|NCT02345252|565245530|FG001|Double-Blind Phase|Adverse Event|3|||
156590710|NCT02345252|565245529|FG000|Double-Blind Phase|Death|1|||
156590711|NCT02345252|565245530|FG001|Double-Blind Phase|Death|2|||
156590712|NCT02345252|565245529|FG000|Double-Blind Phase|Lack of Efficacy|1|||
156590713|NCT02345252|565245530|FG001|Double-Blind Phase|Lack of Efficacy|0|||
156590714|NCT02345252|565245529|FG000|Double-Blind Phase|Investigator's Discretion|4|||
156590715|NCT02345252|565245530|FG001|Double-Blind Phase|Investigator's Discretion|6|||
156590716|NCT02345252|565245529|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
156590717|NCT02345252|565245530|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
156590718|NCT02345252|565245529|FG000|Double-Blind Phase|Protocol Violation|2|||
156590719|NCT02345252|565245530|FG001|Double-Blind Phase|Protocol Violation|1|||
156590720|NCT02345252|565245529|FG000|Double-Blind Phase|Withdrew Consent|21|||
156590721|NCT02345252|565245530|FG001|Double-Blind Phase|Withdrew Consent|23|||
156590722|NCT02345252|565245529|FG000|Double-Blind Phase|Lost to Follow-up|8|||
156590723|NCT02345252|565245530|FG001|Double-Blind Phase|Lost to Follow-up|10|||
156590724|NCT02345252|565245529|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
156590725|NCT02345252|565245530|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
156590726|NCT02651194|565245537|FG000|Overall Study|Lost to Follow-up|3|||
156590727|NCT02651194|565245537|FG000|Overall Study|Other|2|||
156590728|NCT01188564|565245538|FG000|Double-blind Phase|randomized not treated|1|||
156590729|NCT01188564|565245539|FG001|Double-blind Phase|randomized not treated|0|||
156590730|NCT04171037|565245540|FG000|Overall Study|Lost to Follow-up|1|||
156590731|NCT04171037|565245541|FG001|Overall Study|Lost to Follow-up|0|||
156590732|NCT04171037|565245540|FG000|Overall Study|Physician Decision|3|||
156590733|NCT04171037|565245541|FG001|Overall Study|Physician Decision|3|||
156590734|NCT02864940|565245542|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
156590735|NCT02864940|565245543|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
156590736|NCT01958125|565245544|FG000|Overall Study|Missing diary data|2|||
156590737|NCT01958125|565245545|FG001|Overall Study|Missing diary data|6|||
156590738|NCT01958125|565245544|FG000|Overall Study|No headache attacks|0|||
156590739|NCT01958125|565245545|FG001|Overall Study|No headache attacks|2|||
156590740|NCT04096326|565245546|FG000|Overall Study|Withdrawal by Subject|0|||
156590741|NCT04096326|565245547|FG001|Overall Study|Withdrawal by Subject|0|||
156590742|NCT04096326|565245548|FG002|Overall Study|Withdrawal by Subject|0|||
156590743|NCT04096326|565245549|FG003|Overall Study|Withdrawal by Subject|0|||
156590744|NCT04096326|565245550|FG004|Overall Study|Withdrawal by Subject|0|||
156590745|NCT04096326|565245551|FG005|Overall Study|Withdrawal by Subject|0|||
156590746|NCT04096326|565245552|FG006|Overall Study|Withdrawal by Subject|1|||
156590747|NCT04096326|565245553|FG007|Overall Study|Withdrawal by Subject|0|||
156590748|NCT04096326|565245554|FG008|Overall Study|Withdrawal by Subject|0|||
156590749|NCT04096326|565245555|FG009|Overall Study|Withdrawal by Subject|0|||
156590750|NCT04096326|565245546|FG000|Overall Study|Lost to Follow-up|0|||
156590751|NCT04096326|565245547|FG001|Overall Study|Lost to Follow-up|1|||
156590752|NCT04096326|565245548|FG002|Overall Study|Lost to Follow-up|0|||
156590753|NCT04096326|565245549|FG003|Overall Study|Lost to Follow-up|0|||
156590754|NCT04096326|565245550|FG004|Overall Study|Lost to Follow-up|0|||
156590755|NCT04096326|565245551|FG005|Overall Study|Lost to Follow-up|0|||
156590756|NCT04096326|565245552|FG006|Overall Study|Lost to Follow-up|0|||
156590757|NCT04096326|565245553|FG007|Overall Study|Lost to Follow-up|0|||
156590758|NCT04096326|565245554|FG008|Overall Study|Lost to Follow-up|0|||
156590759|NCT04096326|565245555|FG009|Overall Study|Lost to Follow-up|0|||
156590760|NCT04096326|565245546|FG000|Overall Study|COVID-19-related reasons|0|||
156590761|NCT04096326|565245547|FG001|Overall Study|COVID-19-related reasons|0|||
156590762|NCT04096326|565245548|FG002|Overall Study|COVID-19-related reasons|0|||
156590763|NCT04096326|565245549|FG003|Overall Study|COVID-19-related reasons|0|||
156590764|NCT04096326|565245550|FG004|Overall Study|COVID-19-related reasons|1|||
156590765|NCT04096326|565245551|FG005|Overall Study|COVID-19-related reasons|5|||
156590766|NCT04096326|565245552|FG006|Overall Study|COVID-19-related reasons|0|||
156590767|NCT04096326|565245553|FG007|Overall Study|COVID-19-related reasons|0|||
156590768|NCT04096326|565245554|FG008|Overall Study|COVID-19-related reasons|0|||
156590769|NCT04096326|565245555|FG009|Overall Study|COVID-19-related reasons|0|||
156590770|NCT04804033|565245556|FG000|Period 1: DBT Phase|Adverse Event|1|||
156590771|NCT04804033|565245557|FG001|Period 1: DBT Phase|Adverse Event|5|||
156590772|NCT04804033|565245558|FG002|Period 1: DBT Phase|Adverse Event|3|||
156590773|NCT04804033|565245559|FG003|Period 1: DBT Phase|Adverse Event|4|||
156590774|NCT04804033|565245556|FG000|Period 1: DBT Phase|Death|1|||
156590775|NCT04804033|565245557|FG001|Period 1: DBT Phase|Death|0|||
156590776|NCT04804033|565245558|FG002|Period 1: DBT Phase|Death|0|||
156590777|NCT04804033|565245559|FG003|Period 1: DBT Phase|Death|0|||
156590778|NCT04804033|565245556|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
156590779|NCT04804033|565245557|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
156590780|NCT04804033|565245558|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
156590781|NCT04804033|565245559|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
156590782|NCT04804033|565245556|FG000|Period 1: DBT Phase|Non-compliance|1|||
156590783|NCT04804033|565245557|FG001|Period 1: DBT Phase|Non-compliance|0|||
156590784|NCT04804033|565245558|FG002|Period 1: DBT Phase|Non-compliance|1|||
156590785|NCT04804033|565245559|FG003|Period 1: DBT Phase|Non-compliance|2|||
156590786|NCT04804033|565245556|FG000|Period 1: DBT Phase|Other|0|||
156590787|NCT04804033|565245557|FG001|Period 1: DBT Phase|Other|1|||
156590788|NCT04804033|565245558|FG002|Period 1: DBT Phase|Other|0|||
156590789|NCT04804033|565245559|FG003|Period 1: DBT Phase|Other|0|||
156590790|NCT04804033|565245556|FG000|Period 1: DBT Phase|Pregnancy|2|||
156590791|NCT04804033|565245557|FG001|Period 1: DBT Phase|Pregnancy|0|||
156590792|NCT04804033|565245558|FG002|Period 1: DBT Phase|Pregnancy|0|||
156590793|NCT04804033|565245559|FG003|Period 1: DBT Phase|Pregnancy|0|||
156590794|NCT04804033|565245556|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
156590795|NCT04804033|565245557|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
156590796|NCT04804033|565245558|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
156590797|NCT04804033|565245559|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
156590798|NCT04804033|565245556|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
156590799|NCT04804033|565245557|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
156590800|NCT04804033|565245558|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
156590801|NCT04804033|565245559|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
156590802|NCT04804033|565245556|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
156590803|NCT04804033|565245557|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
156590804|NCT04804033|565245558|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
156590805|NCT04804033|565245559|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
156590806|NCT04804033|565245556|FG000|Period 2: OLE Phase|Adverse Event|3|||
156590807|NCT04804033|565245557|FG001|Period 2: OLE Phase|Adverse Event|4|||
156590808|NCT04804033|565245558|FG002|Period 2: OLE Phase|Adverse Event|2|||
156590809|NCT04804033|565245559|FG003|Period 2: OLE Phase|Adverse Event|0|||
156590810|NCT04804033|565245556|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
156590811|NCT04804033|565245557|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
156590812|NCT04804033|565245558|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
156590813|NCT04804033|565245559|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
156590814|NCT04804033|565245556|FG000|Period 2: OLE Phase|Non-compliance|2|||
156590815|NCT04804033|565245557|FG001|Period 2: OLE Phase|Non-compliance|2|||
156590816|NCT04804033|565245558|FG002|Period 2: OLE Phase|Non-compliance|0|||
156590817|NCT04804033|565245559|FG003|Period 2: OLE Phase|Non-compliance|1|||
156590818|NCT04804033|565245556|FG000|Period 2: OLE Phase|Other|0|||
156590819|NCT04804033|565245557|FG001|Period 2: OLE Phase|Other|2|||
156590820|NCT04804033|565245558|FG002|Period 2: OLE Phase|Other|0|||
156590821|NCT04804033|565245559|FG003|Period 2: OLE Phase|Other|0|||
156590822|NCT04804033|565245556|FG000|Period 2: OLE Phase|Physician Decision|1|||
156590823|NCT04804033|565245557|FG001|Period 2: OLE Phase|Physician Decision|1|||
156590824|NCT04804033|565245558|FG002|Period 2: OLE Phase|Physician Decision|0|||
156590825|NCT04804033|565245559|FG003|Period 2: OLE Phase|Physician Decision|0|||
156590826|NCT04804033|565245556|FG000|Period 2: OLE Phase|Pregnancy|0|||
156590827|NCT04804033|565245557|FG001|Period 2: OLE Phase|Pregnancy|0|||
156590828|NCT04804033|565245558|FG002|Period 2: OLE Phase|Pregnancy|2|||
156590829|NCT04804033|565245559|FG003|Period 2: OLE Phase|Pregnancy|0|||
156590830|NCT04804033|565245556|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
156590831|NCT04804033|565245557|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
156590832|NCT04804033|565245558|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
156590833|NCT04804033|565245559|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
156590834|NCT04804033|565245556|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
156590835|NCT04804033|565245557|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
156590836|NCT04804033|565245558|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
156590837|NCT04804033|565245559|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
156590838|NCT04804033|565245556|FG000|Period 2: OLE Phase|Not reported|0|||
156590839|NCT04804033|565245557|FG001|Period 2: OLE Phase|Not reported|2|||
156590840|NCT04804033|565245558|FG002|Period 2: OLE Phase|Not reported|0|||
156590841|NCT04804033|565245559|FG003|Period 2: OLE Phase|Not reported|0|||
156590842|NCT04804033|565245556|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
156590843|NCT04804033|565245557|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
156590844|NCT04804033|565245558|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
156590845|NCT04804033|565245559|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
156590846|NCT04804033|565245556|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
156590847|NCT04804033|565245557|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
156590848|NCT04804033|565245558|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
156590849|NCT04804033|565245559|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
156590850|NCT04804033|565245556|FG000|Period 3: Follow-up Phase|Other|0|||
156590851|NCT04804033|565245557|FG001|Period 3: Follow-up Phase|Other|1|||
156590852|NCT04804033|565245558|FG002|Period 3: Follow-up Phase|Other|2|||
156590853|NCT04804033|565245559|FG003|Period 3: Follow-up Phase|Other|1|||
156590854|NCT04804033|565245556|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
156590855|NCT04804033|565245557|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
156590856|NCT04804033|565245558|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
156590857|NCT04804033|565245559|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
156590858|NCT04804033|565245556|FG000|Period 3: Follow-up Phase|Not reported|18|||
156590859|NCT04804033|565245557|FG001|Period 3: Follow-up Phase|Not reported|15|||
156590860|NCT04804033|565245558|FG002|Period 3: Follow-up Phase|Not reported|1|||
156590861|NCT04804033|565245559|FG003|Period 3: Follow-up Phase|Not reported|4|||
156590862|NCT02496585|565245562|FG000|Overall Study|Death|3|||
156590863|NCT02496585|565245563|FG001|Overall Study|Death|0|||
156590864|NCT02496585|565245562|FG000|Overall Study|Lost to Follow-up|2|||
156590865|NCT02496585|565245563|FG001|Overall Study|Lost to Follow-up|0|||
156590866|NCT02496585|565245562|FG000|Overall Study|Withdrawal by Subject|1|||
156590867|NCT02496585|565245563|FG001|Overall Study|Withdrawal by Subject|2|||
156590868|NCT02496585|565245562|FG000|Overall Study|Progression of Malignancy|4|||
156590869|NCT02496585|565245563|FG001|Overall Study|Progression of Malignancy|1|||
156590870|NCT01276457|565245564|FG000|Core Study|Adverse Event|6|||
156590871|NCT01276457|565245565|FG001|Core Study|Adverse Event|3|||
156590872|NCT01276457|565245564|FG000|Core Study|Lost to Follow-up|1|||
156590873|NCT01276457|565245565|FG001|Core Study|Lost to Follow-up|2|||
156590874|NCT01276457|565245564|FG000|Core Study|Administrative problems|1|||
156590875|NCT01276457|565245565|FG001|Core Study|Administrative problems|1|||
156590876|NCT01276457|565245564|FG000|Core Study|Death|2|||
156590877|NCT01276457|565245565|FG001|Core Study|Death|2|||
156590878|NCT01276457|565245564|FG000|Core Study|Lack of Efficacy|3|||
156590879|NCT01276457|565245565|FG001|Core Study|Lack of Efficacy|12|||
156590880|NCT01276457|565245564|FG000|Extension Study|Lost to Follow-up|3|||
156590881|NCT01276457|565245565|FG001|Extension Study|Lost to Follow-up|0|||
156590882|NCT01276457|565245564|FG000|Extension Study|Death|0|||
156590883|NCT01276457|565245565|FG001|Extension Study|Death|1|||
156590884|NCT01276457|565245564|FG000|Extension Study|Lack of Efficacy|3|||
156590885|NCT01276457|565245565|FG001|Extension Study|Lack of Efficacy|1|||
156590886|NCT04360187|565245566|FG000|Double-Blind Treatment|Adverse Event|9|||
156590887|NCT04360187|565245567|FG001|Double-Blind Treatment|Adverse Event|11|||
156590888|NCT04360187|565245566|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
156590889|NCT04360187|565245567|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
156590890|NCT04360187|565245566|FG000|Double-Blind Treatment|Physician Decision|1|||
156590891|NCT04360187|565245567|FG001|Double-Blind Treatment|Physician Decision|0|||
156590892|NCT04360187|565245566|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
156590893|NCT04360187|565245567|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
156590894|NCT04360187|565245566|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
156590895|NCT04360187|565245567|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
156590896|NCT04360187|565245566|FG000|Follow-Up|Lost to Follow-up|1|||
156590897|NCT04360187|565245567|FG001|Follow-Up|Lost to Follow-up|0|||
156590898|NCT02203838|565245568|FG000|Overall Study|Lack of Efficacy|7|||
156590899|NCT02203838|565245569|FG001|Overall Study|Lack of Efficacy|0|||
156590900|NCT02203838|565245570|FG002|Overall Study|Lack of Efficacy|1|||
156590901|NCT02203838|565245571|FG003|Overall Study|Lack of Efficacy|1|||
156590902|NCT02203838|565245568|FG000|Overall Study|Adverse Event|46|||
156590903|NCT02203838|565245569|FG001|Overall Study|Adverse Event|6|||
156590904|NCT02203838|565245570|FG002|Overall Study|Adverse Event|3|||
156590905|NCT02203838|565245571|FG003|Overall Study|Adverse Event|2|||
156590906|NCT02203838|565245568|FG000|Overall Study|Lost to Follow-up|39|||
156590907|NCT02203838|565245569|FG001|Overall Study|Lost to Follow-up|3|||
156590908|NCT02203838|565245570|FG002|Overall Study|Lost to Follow-up|2|||
156590909|NCT02203838|565245571|FG003|Overall Study|Lost to Follow-up|1|||
156590910|NCT02203838|565245568|FG000|Overall Study|Protocol Violation|7|||
156590911|NCT02203838|565245569|FG001|Overall Study|Protocol Violation|3|||
156590912|NCT02203838|565245570|FG002|Overall Study|Protocol Violation|0|||
156590913|NCT02203838|565245571|FG003|Overall Study|Protocol Violation|0|||
156590914|NCT02203838|565245568|FG000|Overall Study|Withdrawal by Subject|83|||
156590915|NCT02203838|565245569|FG001|Overall Study|Withdrawal by Subject|10|||
156590916|NCT02203838|565245570|FG002|Overall Study|Withdrawal by Subject|8|||
156590917|NCT02203838|565245571|FG003|Overall Study|Withdrawal by Subject|11|||
156590918|NCT02203838|565245568|FG000|Overall Study|Physician Decision|27|||
156590919|NCT02203838|565245569|FG001|Overall Study|Physician Decision|0|||
156590920|NCT02203838|565245570|FG002|Overall Study|Physician Decision|2|||
156590921|NCT02203838|565245571|FG003|Overall Study|Physician Decision|3|||
156590922|NCT02203838|565245568|FG000|Overall Study|Other|1|||
156590923|NCT02203838|565245569|FG001|Overall Study|Other|0|||
156590924|NCT02203838|565245570|FG002|Overall Study|Other|0|||
156590925|NCT02203838|565245571|FG003|Overall Study|Other|0|||
156590926|NCT02739594|565245576|FG000|Overall Study|Undesired Event|3|||
156590927|NCT02739594|565245577|FG001|Overall Study|Undesired Event|4|||
156590928|NCT02739594|565245576|FG000|Overall Study|Violation of Eligibility Criteria|1|||
156590929|NCT02739594|565245577|FG001|Overall Study|Violation of Eligibility Criteria|2|||
156590930|NCT02739594|565245576|FG000|Overall Study|Protocol Violation|5|||
156590931|NCT02739594|565245577|FG001|Overall Study|Protocol Violation|6|||
156590932|NCT02739594|565245576|FG000|Overall Study|Death|4|||
156590933|NCT02739594|565245577|FG001|Overall Study|Death|2|||
156590934|NCT02739594|565245576|FG000|Overall Study|Renal Insufficiency|4|||
156590935|NCT02739594|565245577|FG001|Overall Study|Renal Insufficiency|6|||
156590936|NCT02739594|565245576|FG000|Overall Study|Administrative Reasons|1|||
156590937|NCT02739594|565245577|FG001|Overall Study|Administrative Reasons|3|||
156590938|NCT02739594|565245576|FG000|Overall Study|Withdrawal by Subject|1|||
156590939|NCT02739594|565245577|FG001|Overall Study|Withdrawal by Subject|1|||
156590940|NCT02739594|565245576|FG000|Overall Study|Lost to Follow-up|0|||
156590941|NCT02739594|565245577|FG001|Overall Study|Lost to Follow-up|1|||
156590942|NCT02739594|565245576|FG000|Overall Study|Elevated Serum Creatinine|0|||
156590943|NCT02739594|565245577|FG001|Overall Study|Elevated Serum Creatinine|1|||
156590944|NCT02739594|565245576|FG000|Overall Study|Other|6|||
156590945|NCT02739594|565245577|FG001|Overall Study|Other|2|||
156590946|NCT00527111|565245578|FG000|Overall Study|Adverse Event|14|||
156590947|NCT00527111|565245579|FG001|Overall Study|Adverse Event|13|||
156590948|NCT00527111|565245578|FG000|Overall Study|Death|0|||
156590949|NCT00527111|565245579|FG001|Overall Study|Death|1|||
156590950|NCT00527111|565245578|FG000|Overall Study|Investigator Request|2|||
156590951|NCT00527111|565245579|FG001|Overall Study|Investigator Request|1|||
156590952|NCT00527111|565245578|FG000|Overall Study|Patient Request|2|||
156590953|NCT00527111|565245579|FG001|Overall Study|Patient Request|5|||
156590954|NCT00527111|565245578|FG000|Overall Study|Other|2|||
156590955|NCT00527111|565245579|FG001|Overall Study|Other|2|||
156590956|NCT00952289|565245582|FG000|All Participants|Death|9|||
156590957|NCT00952289|565245583|FG001|All Participants|Death|9|||
156590958|NCT00952289|565245582|FG000|All Participants|Adverse Event|8|||
156590959|NCT00952289|565245583|FG001|All Participants|Adverse Event|8|||
156590960|NCT00952289|565245582|FG000|All Participants|Disease progression|3|||
156590961|NCT00952289|565245583|FG001|All Participants|Disease progression|12|||
156590962|NCT00952289|565245582|FG000|All Participants|Withdrawal by Subject|1|||
156590963|NCT00952289|565245583|FG001|All Participants|Withdrawal by Subject|10|||
156590964|NCT00952289|565245582|FG000|All Participants|Data lost during site relocation|0|||
156590965|NCT00952289|565245583|FG001|All Participants|Data lost during site relocation|1|||
156590966|NCT00952289|565245582|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
156590967|NCT00952289|565245583|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
156590968|NCT00952289|565245582|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
156590969|NCT00952289|565245583|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
156590970|NCT00952289|565245582|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
156590971|NCT00952289|565245583|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
156590972|NCT00952289|565245582|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
156590973|NCT00952289|565245583|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
156590974|NCT00952289|565245582|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
156590975|NCT00952289|565245583|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
156590976|NCT03259334|565245584|FG000|Overall Study|Adverse Event|3|||
156590977|NCT03259334|565245585|FG001|Overall Study|Adverse Event|8|||
156590978|NCT03259334|565245586|FG002|Overall Study|Adverse Event|5|||
156590979|NCT03259334|565245584|FG000|Overall Study|Withdrawal by Subject|4|||
156590980|NCT03259334|565245585|FG001|Overall Study|Withdrawal by Subject|2|||
156590981|NCT03259334|565245586|FG002|Overall Study|Withdrawal by Subject|4|||
156590982|NCT03259334|565245584|FG000|Overall Study|Physician Decision|1|||
156590983|NCT03259334|565245585|FG001|Overall Study|Physician Decision|0|||
156590984|NCT03259334|565245586|FG002|Overall Study|Physician Decision|0|||
156590985|NCT03259334|565245584|FG000|Overall Study|Lost to Follow-up|0|||
156590986|NCT03259334|565245585|FG001|Overall Study|Lost to Follow-up|2|||
156590987|NCT03259334|565245586|FG002|Overall Study|Lost to Follow-up|1|||
156590988|NCT03259334|565245584|FG000|Overall Study|Protocol Deviation|0|||
156590989|NCT03259334|565245585|FG001|Overall Study|Protocol Deviation|3|||
156590990|NCT03259334|565245586|FG002|Overall Study|Protocol Deviation|2|||
156590991|NCT03259334|565245584|FG000|Overall Study|Lack of Efficacy|2|||
156590992|NCT03259334|565245585|FG001|Overall Study|Lack of Efficacy|0|||
156590993|NCT03259334|565245586|FG002|Overall Study|Lack of Efficacy|1|||
156590994|NCT03259334|565245584|FG000|Overall Study|Randomized but never treated|0|||
156590995|NCT03259334|565245585|FG001|Overall Study|Randomized but never treated|2|||
156590996|NCT03259334|565245586|FG002|Overall Study|Randomized but never treated|0|||
156590997|NCT00777491|565245587|FG000|Overall Study|Protocol Violation|0|||
156590998|NCT00777491|565245588|FG001|Overall Study|Protocol Violation|2|||
156590999|NCT00777491|565245587|FG000|Overall Study|Did not receive any protocol treatment|2|||
156591000|NCT00777491|565245588|FG001|Overall Study|Did not receive any protocol treatment|0|||
156591001|NCT01689207|565245589|FG000|Overall Study|Adverse Event|0|||
156591002|NCT01689207|565245590|FG001|Overall Study|Adverse Event|1|||
156591003|NCT01689207|565245591|FG002|Overall Study|Adverse Event|0|||
156591004|NCT01689207|565245592|FG003|Overall Study|Adverse Event|0|||
156591005|NCT01689207|565245593|FG004|Overall Study|Adverse Event|2|||
156591006|NCT01689207|565245594|FG005|Overall Study|Adverse Event|1|||
156591007|NCT01689207|565245595|FG006|Overall Study|Adverse Event|0|||
156591008|NCT01689207|565245596|FG007|Overall Study|Adverse Event|0|||
156591009|NCT01689207|565245597|FG008|Overall Study|Adverse Event|1|||
156591010|NCT01689207|565245598|FG009|Overall Study|Adverse Event|0|||
156591011|NCT01689207|565245599|FG010|Overall Study|Adverse Event|0|||
156591012|NCT01912768|565245600|FG000|Overall Study|Adverse Event|2|||
156591013|NCT01912768|565245601|FG001|Overall Study|Adverse Event|0|||
156591014|NCT01912768|565245600|FG000|Overall Study|Lost to Follow-up|2|||
156591015|NCT01912768|565245601|FG001|Overall Study|Lost to Follow-up|1|||
156591016|NCT01912768|565245600|FG000|Overall Study|Withdrawal by Subject|5|||
156591017|NCT01912768|565245601|FG001|Overall Study|Withdrawal by Subject|3|||
156591018|NCT01912768|565245600|FG000|Overall Study|Randomized in error|1|||
156591019|NCT01912768|565245601|FG001|Overall Study|Randomized in error|0|||
156591020|NCT00524316|565245602|FG000|Overall Study|Withdrawal by Subject|2|||
156591021|NCT00524316|565245602|FG000|Overall Study|Adverse Event|7|||
156591022|NCT00524316|565245602|FG000|Overall Study|Disease Progression|7|||
156591023|NCT01199263|565245603|FG000|Overall Study|Ineligible|0|||
156591024|NCT01199263|565245604|FG001|Overall Study|Ineligible|2|||
156591025|NCT01199263|565245603|FG000|Overall Study|Never Treated|6|||
156591026|NCT01199263|565245604|FG001|Overall Study|Never Treated|0|||
156591027|NCT00488033|565245605|FG000|Overall Study|Withdrawal by Subject|1|||
156591028|NCT00488033|565245606|FG001|Overall Study|Withdrawal by Subject|0|||
156591029|NCT00444626|565245615|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
156591030|NCT00444626|565245615|FG000|Initial Treatment Period|Adverse Event|1|||
156591031|NCT00444626|565245615|FG000|Initial Treatment Period|Lost to Follow-up|9|||
156591032|NCT00008138|565245616|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
156591033|NCT00008138|565245616|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
156591034|NCT00008138|565245616|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
156591035|NCT00008138|565245616|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
156591036|NCT00008138|565245616|FG000|Interval Debulking|Withdrawal by Subject|2|||
156591037|NCT00008138|565245616|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
156591038|NCT00008138|565245616|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
156591039|NCT00008138|565245616|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
156591040|NCT01626352|565247370|FG000|Overall Study|Disease Progression|3|||
156591041|NCT01626352|565247370|FG000|Overall Study|Intercurrent Illness|2|||
156591042|NCT01626352|565247370|FG000|Overall Study|Death|2|||
156591043|NCT01626352|565247370|FG000|Overall Study|Withdrawal by Subject|1|||
156591044|NCT01626352|565247370|FG000|Overall Study|Non-Compliance|1|||
156591045|NCT01626352|565247370|FG000|Overall Study|Never Treated|1|||
156591046|NCT03583372|565247371|FG000|Overall Study|Withdrawal by Subject|6|||
156591047|NCT03583372|565247372|FG001|Overall Study|Withdrawal by Subject|11|||
156591048|NCT03583372|565247373|FG002|Overall Study|Withdrawal by Subject|7|||
156591049|NCT03583372|565247374|FG003|Overall Study|Withdrawal by Subject|8|||
156591050|NCT03583372|565247371|FG000|Overall Study|Lost to Follow-up|4|||
156591051|NCT03583372|565247372|FG001|Overall Study|Lost to Follow-up|6|||
156591052|NCT03583372|565247373|FG002|Overall Study|Lost to Follow-up|3|||
156591053|NCT03583372|565247374|FG003|Overall Study|Lost to Follow-up|2|||
156591054|NCT03583372|565247371|FG000|Overall Study|Adverse Event|1|||
156591055|NCT03583372|565247372|FG001|Overall Study|Adverse Event|3|||
156591056|NCT03583372|565247373|FG002|Overall Study|Adverse Event|4|||
156591057|NCT03583372|565247374|FG003|Overall Study|Adverse Event|4|||
156591058|NCT03583372|565247371|FG000|Overall Study|Physician Decision|0|||
156591059|NCT03583372|565247372|FG001|Overall Study|Physician Decision|1|||
156591060|NCT03583372|565247373|FG002|Overall Study|Physician Decision|1|||
156591061|NCT03583372|565247374|FG003|Overall Study|Physician Decision|1|||
156591062|NCT03583372|565247371|FG000|Overall Study|Lack of Efficacy|0|||
156591063|NCT03583372|565247372|FG001|Overall Study|Lack of Efficacy|1|||
156591064|NCT03583372|565247373|FG002|Overall Study|Lack of Efficacy|0|||
156591065|NCT03583372|565247374|FG003|Overall Study|Lack of Efficacy|1|||
156591066|NCT03583372|565247371|FG000|Overall Study|Death|1|||
156591067|NCT03583372|565247372|FG001|Overall Study|Death|0|||
156591068|NCT03583372|565247373|FG002|Overall Study|Death|0|||
156591069|NCT03583372|565247374|FG003|Overall Study|Death|0|||
156591070|NCT03583372|565247371|FG000|Overall Study|Protocol Violation|0|||
156591071|NCT03583372|565247372|FG001|Overall Study|Protocol Violation|1|||
156591072|NCT03583372|565247373|FG002|Overall Study|Protocol Violation|0|||
156591073|NCT03583372|565247374|FG003|Overall Study|Protocol Violation|0|||
156591074|NCT03583372|565247371|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
156591075|NCT03583372|565247372|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
156591076|NCT03583372|565247373|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
156591077|NCT03583372|565247374|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
156591078|NCT03583372|565247371|FG000|Overall Study|Did Not Receive Study Drug|0|||
156591079|NCT03583372|565247372|FG001|Overall Study|Did Not Receive Study Drug|1|||
156591080|NCT03583372|565247373|FG002|Overall Study|Did Not Receive Study Drug|0|||
156591081|NCT03583372|565247374|FG003|Overall Study|Did Not Receive Study Drug|0|||
156591082|NCT03583372|565247371|FG000|Overall Study|Captured as Other in the Database|1|||
156591083|NCT03583372|565247372|FG001|Overall Study|Captured as Other in the Database|2|||
156591084|NCT03583372|565247373|FG002|Overall Study|Captured as Other in the Database|4|||
156591085|NCT03583372|565247374|FG003|Overall Study|Captured as Other in the Database|1|||
156591086|NCT02796391|565247375|FG000|Overall Study|Lost to Follow-up|2|||
156591087|NCT02796391|565247376|FG001|Overall Study|Lost to Follow-up|2|||
156591088|NCT02796391|565247377|FG002|Overall Study|Lost to Follow-up|13|||
156591089|NCT02796391|565247378|FG003|Overall Study|Lost to Follow-up|8|||
156591090|NCT02796391|565247379|FG004|Overall Study|Lost to Follow-up|14|||
156591091|NCT02796391|565247380|FG005|Overall Study|Lost to Follow-up|13|||
156591092|NCT02796391|565247375|FG000|Overall Study|COVID|0|||
156591093|NCT02796391|565247376|FG001|Overall Study|COVID|0|||
156591094|NCT02796391|565247377|FG002|Overall Study|COVID|5|||
156591095|NCT02796391|565247378|FG003|Overall Study|COVID|5|||
156591096|NCT02796391|565247379|FG004|Overall Study|COVID|2|||
156591097|NCT02796391|565247380|FG005|Overall Study|COVID|4|||
156591098|NCT02796391|565247375|FG000|Overall Study|Participant did not like study cigarettes|0|||
156591099|NCT02796391|565247376|FG001|Overall Study|Participant did not like study cigarettes|0|||
156591100|NCT02796391|565247377|FG002|Overall Study|Participant did not like study cigarettes|3|||
156591101|NCT02796391|565247378|FG003|Overall Study|Participant did not like study cigarettes|0|||
156591102|NCT02796391|565247379|FG004|Overall Study|Participant did not like study cigarettes|0|||
156591103|NCT02796391|565247380|FG005|Overall Study|Participant did not like study cigarettes|0|||
156591104|NCT02796391|565247375|FG000|Overall Study|Withdrawal by Subject|1|||
156591105|NCT02796391|565247376|FG001|Overall Study|Withdrawal by Subject|1|||
156591106|NCT02796391|565247377|FG002|Overall Study|Withdrawal by Subject|4|||
156591107|NCT02796391|565247378|FG003|Overall Study|Withdrawal by Subject|3|||
156591108|NCT02796391|565247379|FG004|Overall Study|Withdrawal by Subject|4|||
156591109|NCT02796391|565247380|FG005|Overall Study|Withdrawal by Subject|3|||
156591110|NCT02796391|565247375|FG000|Overall Study|Adverse Event|0|||
156591111|NCT02796391|565247376|FG001|Overall Study|Adverse Event|0|||
156591112|NCT02796391|565247377|FG002|Overall Study|Adverse Event|0|||
156591113|NCT02796391|565247378|FG003|Overall Study|Adverse Event|1|||
156591114|NCT02796391|565247379|FG004|Overall Study|Adverse Event|0|||
156591115|NCT02796391|565247380|FG005|Overall Study|Adverse Event|0|||
156591116|NCT02796391|565247375|FG000|Overall Study|Protocol Violation|0|||
156591117|NCT02796391|565247376|FG001|Overall Study|Protocol Violation|0|||
156591118|NCT02796391|565247377|FG002|Overall Study|Protocol Violation|0|||
156591119|NCT02796391|565247378|FG003|Overall Study|Protocol Violation|1|||
156591120|NCT02796391|565247379|FG004|Overall Study|Protocol Violation|0|||
156591121|NCT02796391|565247380|FG005|Overall Study|Protocol Violation|0|||
156591122|NCT00377611|565247385|FG000|Overall Study|Adverse Event|2|||
156591123|NCT00377611|565247386|FG001|Overall Study|Adverse Event|9|||
156591124|NCT00377611|565247385|FG000|Overall Study|Protocol Violation|2|||
156591125|NCT00377611|565247386|FG001|Overall Study|Protocol Violation|0|||
156591126|NCT00377611|565247385|FG000|Overall Study|Withdrawal by Subject|0|||
156591127|NCT00377611|565247386|FG001|Overall Study|Withdrawal by Subject|5|||
156591128|NCT00377611|565247385|FG000|Overall Study|Lost to Follow-up|18|||
156591129|NCT00377611|565247386|FG001|Overall Study|Lost to Follow-up|16|||
156591130|NCT00377611|565247385|FG000|Overall Study|Other|0|||
156591131|NCT00377611|565247386|FG001|Overall Study|Other|3|||
156591132|NCT00798655|565247392|FG000|Overall Study|Did not receive at least one dose of pan|2|||
156591133|NCT03446651|565247393|FG000|Overall Study|Lost to Follow-up|4|||
156591134|NCT03446651|565247394|FG001|Overall Study|Lost to Follow-up|0|||
156591135|NCT03446651|565247393|FG000|Overall Study|Open Label Participants|5|||
156591136|NCT03446651|565247394|FG001|Overall Study|Open Label Participants|0|||
156591137|NCT00343291|565247395|FG000|Overall Study|Adverse Event|13|||
156591138|NCT00343291|565247396|FG001|Overall Study|Adverse Event|13|||
156591139|NCT00343291|565247395|FG000|Overall Study|Death|3|||
156591140|NCT00343291|565247396|FG001|Overall Study|Death|2|||
156591141|NCT00343291|565247395|FG000|Overall Study|Progressive disease|33|||
156591142|NCT00343291|565247396|FG001|Overall Study|Progressive disease|34|||
156591143|NCT00343291|565247395|FG000|Overall Study|Withdrawal by Subject|0|||
156591144|NCT00343291|565247396|FG001|Overall Study|Withdrawal by Subject|2|||
156591145|NCT00343291|565247395|FG000|Overall Study|Other|8|||
156591146|NCT00343291|565247396|FG001|Overall Study|Other|5|||
156591147|NCT03712345|565247399|FG000|Overall Study|Failure to meet randomization criteria|0|||
156591148|NCT03712345|565247400|FG001|Overall Study|Failure to meet randomization criteria|0|||
156591149|NCT03712345|565247401|FG002|Overall Study|Failure to meet randomization criteria|1|||
156591150|NCT00960934|565247402|FG000|Overall Study|Adverse Event|2|||
156591151|NCT00960934|565247403|FG001|Overall Study|Adverse Event|3|||
156591152|NCT00960934|565247404|FG002|Overall Study|Adverse Event|3|||
156591153|NCT00960934|565247405|FG003|Overall Study|Adverse Event|2|||
156591154|NCT00960934|565247406|FG004|Overall Study|Adverse Event|4|||
156591155|NCT00960934|565247407|FG005|Overall Study|Adverse Event|3|||
156591156|NCT00960934|565247402|FG000|Overall Study|Lack of Efficacy|1|||
156591157|NCT00960934|565247403|FG001|Overall Study|Lack of Efficacy|0|||
156591158|NCT00960934|565247404|FG002|Overall Study|Lack of Efficacy|0|||
156591159|NCT00960934|565247405|FG003|Overall Study|Lack of Efficacy|0|||
156591160|NCT00960934|565247406|FG004|Overall Study|Lack of Efficacy|0|||
156591161|NCT00960934|565247407|FG005|Overall Study|Lack of Efficacy|0|||
156591162|NCT00960934|565247402|FG000|Overall Study|Lost to Follow-up|0|||
156591163|NCT00960934|565247403|FG001|Overall Study|Lost to Follow-up|1|||
156591164|NCT00960934|565247404|FG002|Overall Study|Lost to Follow-up|0|||
156591165|NCT00960934|565247405|FG003|Overall Study|Lost to Follow-up|0|||
156591166|NCT00960934|565247406|FG004|Overall Study|Lost to Follow-up|0|||
156591167|NCT00960934|565247407|FG005|Overall Study|Lost to Follow-up|0|||
156591168|NCT00960934|565247402|FG000|Overall Study|Other|2|||
156591169|NCT00960934|565247403|FG001|Overall Study|Other|1|||
156591170|NCT00960934|565247404|FG002|Overall Study|Other|5|||
156591171|NCT00960934|565247405|FG003|Overall Study|Other|4|||
156591172|NCT00960934|565247406|FG004|Overall Study|Other|2|||
156591173|NCT00960934|565247407|FG005|Overall Study|Other|2|||
156591174|NCT00960934|565247402|FG000|Overall Study|Physician Decision|0|||
156591175|NCT00960934|565247403|FG001|Overall Study|Physician Decision|1|||
156591176|NCT00960934|565247404|FG002|Overall Study|Physician Decision|0|||
156591177|NCT00960934|565247405|FG003|Overall Study|Physician Decision|0|||
156591178|NCT00960934|565247406|FG004|Overall Study|Physician Decision|0|||
156591179|NCT00960934|565247407|FG005|Overall Study|Physician Decision|0|||
156591180|NCT00960934|565247402|FG000|Overall Study|Progressive Disease|1|||
156591181|NCT00960934|565247403|FG001|Overall Study|Progressive Disease|1|||
156591182|NCT00960934|565247404|FG002|Overall Study|Progressive Disease|0|||
156591183|NCT00960934|565247405|FG003|Overall Study|Progressive Disease|0|||
156591184|NCT00960934|565247406|FG004|Overall Study|Progressive Disease|1|||
156591185|NCT00960934|565247407|FG005|Overall Study|Progressive Disease|1|||
156591186|NCT00960934|565247402|FG000|Overall Study|Protocol Violation|3|||
156591187|NCT00960934|565247403|FG001|Overall Study|Protocol Violation|4|||
156591188|NCT00960934|565247404|FG002|Overall Study|Protocol Violation|0|||
156591189|NCT00960934|565247405|FG003|Overall Study|Protocol Violation|3|||
156591190|NCT00960934|565247406|FG004|Overall Study|Protocol Violation|3|||
156591191|NCT00960934|565247407|FG005|Overall Study|Protocol Violation|2|||
156591192|NCT00960934|565247402|FG000|Overall Study|Withdrawal by Subject|5|||
156591193|NCT00960934|565247403|FG001|Overall Study|Withdrawal by Subject|6|||
156591194|NCT00960934|565247404|FG002|Overall Study|Withdrawal by Subject|4|||
156591195|NCT00960934|565247405|FG003|Overall Study|Withdrawal by Subject|5|||
156591196|NCT00960934|565247406|FG004|Overall Study|Withdrawal by Subject|5|||
156591197|NCT00960934|565247407|FG005|Overall Study|Withdrawal by Subject|7|||
156591198|NCT00960934|565247402|FG000|Overall Study|Study Terminated by Sponsor|50|||
156591199|NCT00960934|565247403|FG001|Overall Study|Study Terminated by Sponsor|46|||
156591200|NCT00960934|565247404|FG002|Overall Study|Study Terminated by Sponsor|52|||
156591201|NCT00960934|565247405|FG003|Overall Study|Study Terminated by Sponsor|50|||
156591202|NCT00960934|565247406|FG004|Overall Study|Study Terminated by Sponsor|49|||
156591203|NCT00960934|565247407|FG005|Overall Study|Study Terminated by Sponsor|49|||
156591204|NCT00756886|565247413|FG000|Overall Study|Lost to Follow-up|1|||
156591205|NCT00756886|565247414|FG001|Overall Study|Lost to Follow-up|0|||
156591206|NCT00756886|565247413|FG000|Overall Study|Adverse Event|0|||
156591207|NCT00756886|565247414|FG001|Overall Study|Adverse Event|3|||
156591208|NCT00756886|565247413|FG000|Overall Study|Lack of Efficacy|1|||
156591209|NCT00756886|565247414|FG001|Overall Study|Lack of Efficacy|0|||
156591210|NCT00756886|565247413|FG000|Overall Study|Ineligible|9|||
156591211|NCT00756886|565247414|FG001|Overall Study|Ineligible|4|||
156591212|NCT01395368|565247417|FG000|Overall Study|Physician Decision|14|||
156591213|NCT01395368|565247417|FG000|Overall Study|Withdrawal by Subject|2|||
156591214|NCT02179515|565247420|FG000|Overall Study|switched to alternative treatment|0|||
156591215|NCT02179515|565247421|FG001|Overall Study|switched to alternative treatment|1|||
156591216|NCT02179515|565247422|FG002|Overall Study|switched to alternative treatment|1|||
156591217|NCT02179515|565247420|FG000|Overall Study|Death|0|||
156591218|NCT02179515|565247421|FG001|Overall Study|Death|1|||
156591219|NCT02179515|565247422|FG002|Overall Study|Death|1|||
156591220|NCT02179515|565247420|FG000|Overall Study|refused further treatment|0|||
156591221|NCT02179515|565247421|FG001|Overall Study|refused further treatment|3|||
156591222|NCT02179515|565247422|FG002|Overall Study|refused further treatment|4|||
156591223|NCT02179515|565247420|FG000|Overall Study|Disease progression on study|2|||
156591224|NCT02179515|565247421|FG001|Overall Study|Disease progression on study|11|||
156591225|NCT02179515|565247422|FG002|Overall Study|Disease progression on study|8|||
156591226|NCT00782418|565247427|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
156591227|NCT00782418|565247428|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
156591228|NCT00782418|565247429|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
156591229|NCT00782418|565247430|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
156591230|NCT00782418|565247431|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
156591231|NCT00782418|565247432|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
156591232|NCT00782418|565247433|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
156591233|NCT00782418|565247427|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
156591234|NCT00782418|565247428|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
156591235|NCT00782418|565247429|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
156591236|NCT00782418|565247430|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
156591237|NCT00782418|565247431|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
156591238|NCT00782418|565247432|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
156591239|NCT00782418|565247433|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
156591240|NCT00882999|565247434|FG000|Overall Study|Adverse Event|0|||
156591241|NCT00882999|565247435|FG001|Overall Study|Adverse Event|0|||
156591242|NCT00882999|565247436|FG002|Overall Study|Adverse Event|0|||
156591243|NCT00882999|565247437|FG003|Overall Study|Adverse Event|0|||
156591244|NCT00882999|565247438|FG004|Overall Study|Adverse Event|1|||
156591245|NCT00882999|565247439|FG005|Overall Study|Adverse Event|0|||
156591246|NCT00882999|565247440|FG006|Overall Study|Adverse Event|0|||
156591247|NCT00882999|565247434|FG000|Overall Study|Death|0|||
156591248|NCT00882999|565247435|FG001|Overall Study|Death|1|||
156591249|NCT00882999|565247436|FG002|Overall Study|Death|0|||
156591250|NCT00882999|565247437|FG003|Overall Study|Death|0|||
156591251|NCT00882999|565247438|FG004|Overall Study|Death|0|||
156591252|NCT00882999|565247439|FG005|Overall Study|Death|0|||
156591253|NCT00882999|565247440|FG006|Overall Study|Death|0|||
156591254|NCT00882999|565247434|FG000|Overall Study|Withdrawal by Subject|7|||
156591255|NCT00882999|565247435|FG001|Overall Study|Withdrawal by Subject|6|||
156591256|NCT00882999|565247436|FG002|Overall Study|Withdrawal by Subject|3|||
156591257|NCT00882999|565247437|FG003|Overall Study|Withdrawal by Subject|3|||
156591258|NCT00882999|565247438|FG004|Overall Study|Withdrawal by Subject|6|||
156591259|NCT00882999|565247439|FG005|Overall Study|Withdrawal by Subject|5|||
156591260|NCT00882999|565247440|FG006|Overall Study|Withdrawal by Subject|5|||
156591261|NCT00882999|565247434|FG000|Overall Study|Lost to Follow-up|0|||
156591262|NCT00882999|565247435|FG001|Overall Study|Lost to Follow-up|1|||
156591263|NCT00882999|565247436|FG002|Overall Study|Lost to Follow-up|1|||
156591264|NCT00882999|565247437|FG003|Overall Study|Lost to Follow-up|2|||
156591265|NCT00882999|565247438|FG004|Overall Study|Lost to Follow-up|1|||
156591266|NCT00882999|565247439|FG005|Overall Study|Lost to Follow-up|1|||
156591267|NCT00882999|565247440|FG006|Overall Study|Lost to Follow-up|2|||
156591268|NCT00882999|565247434|FG000|Overall Study|Physician Decision|1|||
156591269|NCT00882999|565247435|FG001|Overall Study|Physician Decision|0|||
156591270|NCT00882999|565247436|FG002|Overall Study|Physician Decision|0|||
156591271|NCT00882999|565247437|FG003|Overall Study|Physician Decision|0|||
156591272|NCT00882999|565247438|FG004|Overall Study|Physician Decision|0|||
156591273|NCT00882999|565247439|FG005|Overall Study|Physician Decision|1|||
156591274|NCT00882999|565247440|FG006|Overall Study|Physician Decision|1|||
156591275|NCT01757405|565247443|FG000|Overall Study|Lost to Follow-up|1|||
156591276|NCT01757405|565247444|FG001|Overall Study|Lost to Follow-up|1|||
156591277|NCT01757405|565247443|FG000|Overall Study|Withdrawal by Subject|0|||
156591278|NCT01757405|565247444|FG001|Overall Study|Withdrawal by Subject|1|||
156591279|NCT00082758|565247446|FG000|Overall Study|Adverse Event|0|||
156591280|NCT00082758|565247447|FG001|Overall Study|Adverse Event|2|||
156591281|NCT00082758|565247448|FG002|Overall Study|Adverse Event|0|||
156591282|NCT00082758|565247446|FG000|Overall Study|Lack of Efficacy|12|||
156591283|NCT00082758|565247447|FG001|Overall Study|Lack of Efficacy|13|||
156591284|NCT00082758|565247448|FG002|Overall Study|Lack of Efficacy|0|||
156591285|NCT00082758|565247446|FG000|Overall Study|Physician Decision|0|||
156591286|NCT00082758|565247447|FG001|Overall Study|Physician Decision|1|||
156591287|NCT00082758|565247448|FG002|Overall Study|Physician Decision|0|||
156591288|NCT00082758|565247446|FG000|Overall Study|Withdrawal by Subject|3|||
156591289|NCT00082758|565247447|FG001|Overall Study|Withdrawal by Subject|0|||
156591290|NCT00082758|565247448|FG002|Overall Study|Withdrawal by Subject|0|||
156591291|NCT00082758|565247446|FG000|Overall Study|Protocol Violation|0|||
156591292|NCT00082758|565247447|FG001|Overall Study|Protocol Violation|1|||
156591293|NCT00082758|565247448|FG002|Overall Study|Protocol Violation|0|||
156591294|NCT00238303|565247449|FG000|Overall Study|Withdrawal by Subject|11|||
156591295|NCT00238303|565247450|FG001|Overall Study|Withdrawal by Subject|1|||
156591296|NCT00238303|565247451|FG002|Overall Study|Withdrawal by Subject|2|||
156591297|NCT00238303|565247449|FG000|Overall Study|Death|1|||
156591298|NCT00238303|565247450|FG001|Overall Study|Death|0|||
156591299|NCT00238303|565247451|FG002|Overall Study|Death|1|||
156591300|NCT00238303|565247449|FG000|Overall Study|Other Medical Problems|2|||
156591301|NCT00238303|565247450|FG001|Overall Study|Other Medical Problems|0|||
156591302|NCT00238303|565247451|FG002|Overall Study|Other Medical Problems|2|||
156591303|NCT00238303|565247449|FG000|Overall Study|Poor tolerance of study treatment|1|||
156591304|NCT00238303|565247450|FG001|Overall Study|Poor tolerance of study treatment|0|||
156591305|NCT00238303|565247451|FG002|Overall Study|Poor tolerance of study treatment|1|||
156591306|NCT00238303|565247449|FG000|Overall Study|Adverse Event|0|||
156591307|NCT00238303|565247450|FG001|Overall Study|Adverse Event|1|||
156591308|NCT00238303|565247451|FG002|Overall Study|Adverse Event|3|||
156591309|NCT00937560|565247453|FG000|Initial Treatment|Death|6|||
156591310|NCT00937560|565247453|FG000|Initial Treatment|Withdraw consent|3|||
156591311|NCT00937560|565247453|FG000|Initial Treatment|Adverse Event|1|||
156591312|NCT00937560|565247453|FG000|Initial Treatment|Lost to Follow-up|1|||
156591313|NCT00937560|565247453|FG000|Initial Treatment|No end of study page|10|||
156591314|NCT00937560|565247453|FG000|Maintenance Treatment|Death|12|||
156591315|NCT00937560|565247453|FG000|Maintenance Treatment|Withdraw consent|5|||
156591316|NCT00937560|565247453|FG000|Maintenance Treatment|According to protocol|1|||
156591317|NCT01994226|565247456|FG000|Overall Study|Protocol Violation|13|||
156591318|NCT01994226|565247457|FG001|Overall Study|Protocol Violation|10|||
156591319|NCT01994226|565247456|FG000|Overall Study|Early Cessation of treatment|6|||
156591320|NCT01994226|565247457|FG001|Overall Study|Early Cessation of treatment|11|||
156591321|NCT00501046|565247458|FG000|Overall Study|Adverse Event|21|||
156591322|NCT00501046|565247459|FG001|Overall Study|Adverse Event|25|||
156591323|NCT00501046|565247458|FG000|Overall Study|Death|23|||
156591324|NCT00501046|565247459|FG001|Overall Study|Death|30|||
156591325|NCT00501046|565247458|FG000|Overall Study|Lost to Follow-up|14|||
156591326|NCT00501046|565247459|FG001|Overall Study|Lost to Follow-up|13|||
156591327|NCT00501046|565247458|FG000|Overall Study|Physician Decision|7|||
156591328|NCT00501046|565247459|FG001|Overall Study|Physician Decision|2|||
156591329|NCT00501046|565247458|FG000|Overall Study|Pregnancy|0|||
156591330|NCT00501046|565247459|FG001|Overall Study|Pregnancy|3|||
156591331|NCT00501046|565247458|FG000|Overall Study|Protocol Violation|2|||
156591332|NCT00501046|565247459|FG001|Overall Study|Protocol Violation|1|||
156591333|NCT00501046|565247458|FG000|Overall Study|Withdrawal by Subject|84|||
156591334|NCT00501046|565247459|FG001|Overall Study|Withdrawal by Subject|83|||
156591335|NCT00501046|565247458|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
156591336|NCT00501046|565247459|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
156591337|NCT02488551|565247463|FG000|Overall Study|Lost to Follow-up|4|||
156591338|NCT02488551|565247464|FG001|Overall Study|Lost to Follow-up|7|||
156591339|NCT02488551|565247465|FG002|Overall Study|Lost to Follow-up|0|||
156591340|NCT02488551|565247466|FG003|Overall Study|Lost to Follow-up|0|||
156591341|NCT02488551|565247463|FG000|Overall Study|Military Deployment|1|||
156591342|NCT02488551|565247464|FG001|Overall Study|Military Deployment|1|||
156591343|NCT02488551|565247465|FG002|Overall Study|Military Deployment|0|||
156591344|NCT02488551|565247466|FG003|Overall Study|Military Deployment|0|||
156591345|NCT01934894|565247467|FG000|Overall Study|Adverse Event|1|||
156591346|NCT01934894|565247468|FG001|Overall Study|Adverse Event|2|||
156591347|NCT01934894|565247467|FG000|Overall Study|Death|2|||
156591348|NCT01934894|565247468|FG001|Overall Study|Death|0|||
156591349|NCT01934894|565247467|FG000|Overall Study|Withdrawal by Subject|0|||
156591350|NCT01934894|565247468|FG001|Overall Study|Withdrawal by Subject|1|||
156591351|NCT01934894|565247467|FG000|Overall Study|Progressive Disease|3|||
156591352|NCT01934894|565247468|FG001|Overall Study|Progressive Disease|2|||
156591353|NCT01954251|565247473|FG000|Overall Study|Adverse Event|5|||
156591354|NCT01954251|565247474|FG001|Overall Study|Adverse Event|7|||
156591355|NCT01954251|565247473|FG000|Overall Study|Lost to Follow-up|6|||
156591356|NCT01954251|565247474|FG001|Overall Study|Lost to Follow-up|6|||
156591357|NCT01954251|565247473|FG000|Overall Study|Withdrawal by Subject|2|||
156591358|NCT01954251|565247474|FG001|Overall Study|Withdrawal by Subject|6|||
156591359|NCT02175771|565247475|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
156591360|NCT02175771|565247476|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156591361|NCT02175771|565247477|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156591362|NCT02175771|565247478|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156591363|NCT02175771|565247479|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156591364|NCT02175771|565247480|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156591365|NCT02175771|565247481|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156591366|NCT02175771|565247482|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156591367|NCT02175771|565247483|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156591368|NCT02175771|565247475|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
156591369|NCT02175771|565247476|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156591370|NCT02175771|565247477|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156591371|NCT02175771|565247478|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156591372|NCT02175771|565247479|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156591373|NCT02175771|565247480|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156591374|NCT02175771|565247481|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156591375|NCT02175771|565247482|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156591376|NCT02175771|565247483|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156591377|NCT02175771|565247475|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
156591378|NCT02175771|565247476|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156591379|NCT02175771|565247477|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156591380|NCT02175771|565247478|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156591381|NCT02175771|565247479|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156591382|NCT02175771|565247480|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156591383|NCT02175771|565247481|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156591384|NCT02175771|565247482|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156591385|NCT02175771|565247483|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156591386|NCT02175771|565247475|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
156591387|NCT02175771|565247476|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
156591388|NCT02175771|565247477|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
156591389|NCT02175771|565247478|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
156591390|NCT02175771|565247479|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
156591391|NCT02175771|565247480|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
156591392|NCT02175771|565247481|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
156591393|NCT02175771|565247482|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
156591394|NCT02175771|565247483|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
156591395|NCT02175771|565247475|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
156591396|NCT02175771|565247476|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156591397|NCT02175771|565247477|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156591398|NCT02175771|565247478|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156591399|NCT02175771|565247479|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156591400|NCT02175771|565247480|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156591401|NCT02175771|565247481|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156591402|NCT02175771|565247482|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156591403|NCT02175771|565247483|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156591404|NCT02175771|565247475|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
156591405|NCT02175771|565247476|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156591406|NCT02175771|565247477|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156591407|NCT02175771|565247478|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156591408|NCT02175771|565247479|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156591409|NCT02175771|565247480|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156591410|NCT02175771|565247481|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156591411|NCT02175771|565247482|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156591412|NCT02175771|565247483|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156591413|NCT02175771|565247475|FG000|Run-In Period (Pre-assignment)|Other|8|||
156591414|NCT02175771|565247476|FG001|Run-In Period (Pre-assignment)|Other|0|||
156591415|NCT02175771|565247477|FG002|Run-In Period (Pre-assignment)|Other|0|||
156591416|NCT02175771|565247478|FG003|Run-In Period (Pre-assignment)|Other|0|||
156591417|NCT02175771|565247479|FG004|Run-In Period (Pre-assignment)|Other|0|||
156591418|NCT02175771|565247480|FG005|Run-In Period (Pre-assignment)|Other|0|||
156591419|NCT02175771|565247481|FG006|Run-In Period (Pre-assignment)|Other|0|||
156591420|NCT02175771|565247482|FG007|Run-In Period (Pre-assignment)|Other|0|||
156591421|NCT02175771|565247483|FG008|Run-In Period (Pre-assignment)|Other|0|||
156591422|NCT02175771|565247475|FG000|Treatment Period|Adverse Event|0|||
156591423|NCT02175771|565247476|FG001|Treatment Period|Adverse Event|2|||
156591424|NCT02175771|565247477|FG002|Treatment Period|Adverse Event|1|||
156591425|NCT02175771|565247478|FG003|Treatment Period|Adverse Event|1|||
156591426|NCT02175771|565247479|FG004|Treatment Period|Adverse Event|1|||
156591427|NCT02175771|565247480|FG005|Treatment Period|Adverse Event|3|||
156591428|NCT02175771|565247481|FG006|Treatment Period|Adverse Event|2|||
156591429|NCT02175771|565247482|FG007|Treatment Period|Adverse Event|0|||
156591430|NCT02175771|565247483|FG008|Treatment Period|Adverse Event|1|||
156591431|NCT02175771|565247475|FG000|Treatment Period|Withdrawal by Subject|0|||
156591432|NCT02175771|565247476|FG001|Treatment Period|Withdrawal by Subject|9|||
156591433|NCT02175771|565247477|FG002|Treatment Period|Withdrawal by Subject|3|||
156591434|NCT02175771|565247478|FG003|Treatment Period|Withdrawal by Subject|6|||
156591435|NCT02175771|565247479|FG004|Treatment Period|Withdrawal by Subject|2|||
156591436|NCT02175771|565247480|FG005|Treatment Period|Withdrawal by Subject|4|||
156591437|NCT02175771|565247481|FG006|Treatment Period|Withdrawal by Subject|2|||
156591438|NCT02175771|565247482|FG007|Treatment Period|Withdrawal by Subject|9|||
156591439|NCT02175771|565247483|FG008|Treatment Period|Withdrawal by Subject|2|||
156591440|NCT02175771|565247475|FG000|Treatment Period|Noncompliance|0|||
156591441|NCT02175771|565247476|FG001|Treatment Period|Noncompliance|1|||
156591442|NCT02175771|565247477|FG002|Treatment Period|Noncompliance|2|||
156591443|NCT02175771|565247478|FG003|Treatment Period|Noncompliance|0|||
156591444|NCT02175771|565247479|FG004|Treatment Period|Noncompliance|0|||
156591445|NCT02175771|565247480|FG005|Treatment Period|Noncompliance|0|||
156591446|NCT02175771|565247481|FG006|Treatment Period|Noncompliance|0|||
156591447|NCT02175771|565247482|FG007|Treatment Period|Noncompliance|0|||
156591448|NCT02175771|565247483|FG008|Treatment Period|Noncompliance|1|||
156591449|NCT02175771|565247475|FG000|Treatment Period|Protocol Violation|0|||
156591450|NCT02175771|565247476|FG001|Treatment Period|Protocol Violation|0|||
156591451|NCT02175771|565247477|FG002|Treatment Period|Protocol Violation|0|||
156591452|NCT02175771|565247478|FG003|Treatment Period|Protocol Violation|0|||
156591453|NCT02175771|565247479|FG004|Treatment Period|Protocol Violation|0|||
156591454|NCT02175771|565247480|FG005|Treatment Period|Protocol Violation|0|||
156591455|NCT02175771|565247481|FG006|Treatment Period|Protocol Violation|0|||
156591456|NCT02175771|565247482|FG007|Treatment Period|Protocol Violation|1|||
156591457|NCT02175771|565247483|FG008|Treatment Period|Protocol Violation|0|||
156591458|NCT02175771|565247475|FG000|Treatment Period|Disease progression|0|||
156591459|NCT02175771|565247476|FG001|Treatment Period|Disease progression|0|||
156591460|NCT02175771|565247477|FG002|Treatment Period|Disease progression|0|||
156591461|NCT02175771|565247478|FG003|Treatment Period|Disease progression|0|||
156591462|NCT02175771|565247479|FG004|Treatment Period|Disease progression|0|||
156591463|NCT02175771|565247480|FG005|Treatment Period|Disease progression|0|||
156591464|NCT02175771|565247481|FG006|Treatment Period|Disease progression|0|||
156591465|NCT02175771|565247482|FG007|Treatment Period|Disease progression|2|||
156591466|NCT02175771|565247483|FG008|Treatment Period|Disease progression|0|||
156591467|NCT02175771|565247475|FG000|Treatment Period|Lost to Follow-up|0|||
156591468|NCT02175771|565247476|FG001|Treatment Period|Lost to Follow-up|3|||
156591469|NCT02175771|565247477|FG002|Treatment Period|Lost to Follow-up|1|||
156863659|NCT03043313|566258737|FG001|Overall Study|Participation terminated by sponsor|13|||
156591470|NCT02175771|565247478|FG003|Treatment Period|Lost to Follow-up|3|||
156591471|NCT02175771|565247479|FG004|Treatment Period|Lost to Follow-up|1|||
156591472|NCT02175771|565247480|FG005|Treatment Period|Lost to Follow-up|2|||
156591473|NCT02175771|565247481|FG006|Treatment Period|Lost to Follow-up|1|||
156591474|NCT02175771|565247482|FG007|Treatment Period|Lost to Follow-up|2|||
156591475|NCT02175771|565247483|FG008|Treatment Period|Lost to Follow-up|2|||
156591476|NCT02175771|565247475|FG000|Treatment Period|Lack of Efficacy|0|||
156591477|NCT02175771|565247476|FG001|Treatment Period|Lack of Efficacy|0|||
156591478|NCT02175771|565247477|FG002|Treatment Period|Lack of Efficacy|0|||
156591479|NCT02175771|565247478|FG003|Treatment Period|Lack of Efficacy|0|||
156591480|NCT02175771|565247479|FG004|Treatment Period|Lack of Efficacy|0|||
156591481|NCT02175771|565247480|FG005|Treatment Period|Lack of Efficacy|1|||
156591482|NCT02175771|565247481|FG006|Treatment Period|Lack of Efficacy|0|||
156591483|NCT02175771|565247482|FG007|Treatment Period|Lack of Efficacy|1|||
156591484|NCT02175771|565247483|FG008|Treatment Period|Lack of Efficacy|0|||
156591485|NCT02175771|565247475|FG000|Treatment Period|Other|0|||
156591486|NCT02175771|565247476|FG001|Treatment Period|Other|1|||
156591487|NCT02175771|565247477|FG002|Treatment Period|Other|0|||
156591488|NCT02175771|565247478|FG003|Treatment Period|Other|3|||
156591489|NCT02175771|565247479|FG004|Treatment Period|Other|1|||
156591490|NCT02175771|565247480|FG005|Treatment Period|Other|0|||
156591491|NCT02175771|565247481|FG006|Treatment Period|Other|0|||
156591492|NCT02175771|565247482|FG007|Treatment Period|Other|2|||
156591493|NCT02175771|565247483|FG008|Treatment Period|Other|0|||
156591494|NCT03364673|565247484|FG000|Overall Study|Withdrawal by Subject|2|||
156591495|NCT03364673|565247484|FG000|Overall Study|Injury unrelated to study|3|||
156591496|NCT02208024|565247485|FG000|Overall Study|Withdrawal by Subject|1|||
156591497|NCT00779324|565247486|FG000|Overall Study|Lost to Follow-up|2|||
156591498|NCT00779324|565247487|FG001|Overall Study|Lost to Follow-up|1|||
156591499|NCT00779324|565247486|FG000|Overall Study|Withdrawal by Subject|4|||
156591500|NCT00779324|565247487|FG001|Overall Study|Withdrawal by Subject|2|||
156591501|NCT00779324|565247486|FG000|Overall Study|Missed visit|1|||
156591502|NCT00779324|565247487|FG001|Overall Study|Missed visit|1|||
156591503|NCT02207556|565247488|FG000|Overall Study|Physician Decision|1|||
156591504|NCT02207556|565247489|FG001|Overall Study|Physician Decision|0|||
156591505|NCT02207556|565247488|FG000|Overall Study|Withdrawal by Subject|1|||
156591506|NCT02207556|565247489|FG001|Overall Study|Withdrawal by Subject|0|||
156591507|NCT02207556|565247488|FG000|Overall Study|Death|0|||
156591508|NCT02207556|565247489|FG001|Overall Study|Death|5|||
156591509|NCT03558555|565247490|FG000|Overall Study|Lost to Follow-up|2|||
156591510|NCT03558555|565247491|FG001|Overall Study|Lost to Follow-up|1|||
156591511|NCT00496873|565247501|FG000|Overall Study|Ineligible|2|||
156591512|NCT00496873|565247501|FG000|Overall Study|Death|2|||
156591513|NCT00496873|565247501|FG000|Overall Study|Withdrawal by Subject|3|||
156591514|NCT01842620|565247502|FG000|Period 1|Withdrawal by Subject|1|||
156591515|NCT01842620|565247503|FG001|Period 1|Withdrawal by Subject|0|||
156591516|NCT02402218|565247506|FG000|Overall Study|Did not pickup study medication|12|||
156591517|NCT02402218|565247507|FG001|Overall Study|Did not pickup study medication|9|||
156591518|NCT02402218|565247508|FG002|Overall Study|Did not pickup study medication|13|||
156591519|NCT02402218|565247506|FG000|Overall Study|Lack of Efficacy|0|||
156591520|NCT02402218|565247507|FG001|Overall Study|Lack of Efficacy|1|||
156591521|NCT02402218|565247508|FG002|Overall Study|Lack of Efficacy|1|||
156591522|NCT02402218|565247506|FG000|Overall Study|Death|1|||
156591523|NCT02402218|565247507|FG001|Overall Study|Death|0|||
156591524|NCT02402218|565247508|FG002|Overall Study|Death|0|||
156591525|NCT02402218|565247506|FG000|Overall Study|Reinfection|0|||
156591526|NCT02402218|565247507|FG001|Overall Study|Reinfection|0|||
156591527|NCT02402218|565247508|FG002|Overall Study|Reinfection|1|||
156591528|NCT02402218|565247506|FG000|Overall Study|Adverse Event|0|||
156591529|NCT02402218|565247507|FG001|Overall Study|Adverse Event|2|||
156591530|NCT02402218|565247508|FG002|Overall Study|Adverse Event|1|||
156591531|NCT02402218|565247506|FG000|Overall Study|Withdrawal by Subject|1|||
156591532|NCT02402218|565247507|FG001|Overall Study|Withdrawal by Subject|1|||
156591533|NCT02402218|565247508|FG002|Overall Study|Withdrawal by Subject|1|||
156591534|NCT03827473|565247509|FG000|Overall Study|Withdrawal by Subject|1|||
156591535|NCT03827473|565247510|FG001|Overall Study|Withdrawal by Subject|0|||
156591536|NCT04436822|565247511|FG000|Overall Study|Physician Decision|2|||
156591537|NCT04436822|565247512|FG001|Overall Study|Physician Decision|0|||
156591538|NCT04436822|565247511|FG000|Overall Study|Sponsor request|1|||
156591539|NCT04436822|565247512|FG001|Overall Study|Sponsor request|0|||
156591540|NCT04436822|565247511|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156591541|NCT04436822|565247512|FG001|Overall Study|Withdrawal by parent/guardian|3|||
156591542|NCT04436822|565247511|FG000|Overall Study|Unsuccessful procedure|0|||
156591543|NCT04436822|565247512|FG001|Overall Study|Unsuccessful procedure|1|||
156591544|NCT04436822|565247511|FG000|Overall Study|Withdrawal due to Covid-19|8|||
156591545|NCT04436822|565247512|FG001|Overall Study|Withdrawal due to Covid-19|1|||
156591546|NCT04436822|565247511|FG000|Overall Study|Withdrawal by Subject|1|||
156591547|NCT04436822|565247512|FG001|Overall Study|Withdrawal by Subject|0|||
156591548|NCT04436822|565247511|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
156591549|NCT04436822|565247512|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
156591550|NCT03807739|565247513|FG000|Overall Study|Adverse Event|1|||
156591551|NCT03807739|565247514|FG001|Overall Study|Adverse Event|0|||
156591552|NCT03807739|565247515|FG002|Overall Study|Adverse Event|0|||
156591553|NCT03807739|565247516|FG003|Overall Study|Adverse Event|0|||
156591554|NCT03807739|565247513|FG000|Overall Study|Withdrawal by Subject|1|||
156591555|NCT03807739|565247514|FG001|Overall Study|Withdrawal by Subject|0|||
156591556|NCT03807739|565247515|FG002|Overall Study|Withdrawal by Subject|0|||
156591557|NCT03807739|565247516|FG003|Overall Study|Withdrawal by Subject|0|||
156591558|NCT02371759|565247517|FG000|Overall Study|Protocol Violation|3|||
156591559|NCT02371759|565247518|FG001|Overall Study|Protocol Violation|1|||
156591560|NCT02371759|565247519|FG002|Overall Study|Protocol Violation|1|||
156591561|NCT02371759|565247520|FG003|Overall Study|Protocol Violation|0|||
156591562|NCT02371759|565247521|FG004|Overall Study|Protocol Violation|3|||
156591563|NCT02371759|565247522|FG005|Overall Study|Protocol Violation|1|||
156591564|NCT02371759|565247523|FG006|Overall Study|Protocol Violation|0|||
156591565|NCT02371759|565247524|FG007|Overall Study|Protocol Violation|3|||
156591566|NCT02371759|565247517|FG000|Overall Study|Withdrawal by Subject|0|||
156591567|NCT02371759|565247518|FG001|Overall Study|Withdrawal by Subject|0|||
156591568|NCT02371759|565247519|FG002|Overall Study|Withdrawal by Subject|0|||
156591569|NCT02371759|565247520|FG003|Overall Study|Withdrawal by Subject|0|||
156591570|NCT02371759|565247521|FG004|Overall Study|Withdrawal by Subject|0|||
156591571|NCT02371759|565247522|FG005|Overall Study|Withdrawal by Subject|0|||
156591572|NCT02371759|565247523|FG006|Overall Study|Withdrawal by Subject|0|||
156591573|NCT02371759|565247524|FG007|Overall Study|Withdrawal by Subject|1|||
156591574|NCT03375112|565247525|FG000|Overall Study|Withdrawal by Subject|3|||
156591575|NCT03375112|565247526|FG001|Overall Study|Withdrawal by Subject|0|||
156591576|NCT03599141|565247529|FG000|Overall Study|Lost to Follow-up|3|||
156591577|NCT03599141|565247530|FG001|Overall Study|Lost to Follow-up|1|||
156591578|NCT00303108|565247534|FG000|Overall Study|Adverse Event|5|||
156591579|NCT00303108|565247535|FG001|Overall Study|Adverse Event|6|||
156591580|NCT00303108|565247536|FG002|Overall Study|Adverse Event|7|||
156591581|NCT00303108|565247534|FG000|Overall Study|Patient Request|4|||
156591582|NCT00303108|565247535|FG001|Overall Study|Patient Request|2|||
156591583|NCT00303108|565247536|FG002|Overall Study|Patient Request|8|||
156591584|NCT00303108|565247534|FG000|Overall Study|Failed Entry|1|||
156591585|NCT00303108|565247535|FG001|Overall Study|Failed Entry|0|||
156591586|NCT00303108|565247536|FG002|Overall Study|Failed Entry|1|||
156591587|NCT00303108|565247534|FG000|Overall Study|ineligible|2|||
156591588|NCT00303108|565247535|FG001|Overall Study|ineligible|1|||
156591589|NCT00303108|565247536|FG002|Overall Study|ineligible|0|||
156591590|NCT00894413|565247539|FG000|Overall Study|Physician Decision|0|||
156591591|NCT00894413|565247540|FG001|Overall Study|Physician Decision|2|||
156591592|NCT00894413|565247539|FG000|Overall Study|Adverse Event|0|||
156591593|NCT00894413|565247540|FG001|Overall Study|Adverse Event|2|||
156591594|NCT00894413|565247539|FG000|Overall Study|Withdrawal by Subject|0|||
156591595|NCT00894413|565247540|FG001|Overall Study|Withdrawal by Subject|4|||
156591596|NCT02435277|565247541|FG000|Overall Study|Adverse Event|1|||
156591597|NCT02435277|565247542|FG001|Overall Study|Adverse Event|1|||
156591598|NCT02435277|565247543|FG002|Overall Study|Adverse Event|0|||
156591599|NCT02435277|565247544|FG003|Overall Study|Adverse Event|0|||
156591600|NCT02435277|565247541|FG000|Overall Study|Withdrawal by Subject|1|||
156591601|NCT02435277|565247542|FG001|Overall Study|Withdrawal by Subject|0|||
156591602|NCT02435277|565247543|FG002|Overall Study|Withdrawal by Subject|0|||
156591603|NCT02435277|565247544|FG003|Overall Study|Withdrawal by Subject|0|||
156591604|NCT02635737|565247545|FG000|Overall Study|Protocol Violation|1|||
156591605|NCT00786032|565248999|FG000|Overall Study|Death|4|||
156591606|NCT00786032|565248999|FG000|Overall Study|Withdrawal by Subject|14|||
156591607|NCT00786032|565248999|FG000|Overall Study|Did not complete in the timeframe|6|||
156591608|NCT02457182|565249000|FG000|Overall Study|Lost to Follow-up|1|||
156591609|NCT02457182|565249001|FG001|Overall Study|Lost to Follow-up|0|||
156591610|NCT00165841|565249004|FG000|Overall Study|Adverse Event|2|||
156591611|NCT00165841|565249005|FG001|Overall Study|Adverse Event|3|||
156591612|NCT00165841|565249004|FG000|Overall Study|Lack of Efficacy|6|||
156591613|NCT00165841|565249005|FG001|Overall Study|Lack of Efficacy|33|||
156591614|NCT00165841|565249004|FG000|Overall Study|Lost to Follow-up|4|||
156591615|NCT00165841|565249005|FG001|Overall Study|Lost to Follow-up|4|||
156591616|NCT00165841|565249004|FG000|Overall Study|Withdrawal by Subject|7|||
156591617|NCT00165841|565249005|FG001|Overall Study|Withdrawal by Subject|8|||
156591618|NCT00165841|565249004|FG000|Overall Study|Physician Decision|1|||
156591619|NCT00165841|565249005|FG001|Overall Study|Physician Decision|0|||
156591620|NCT00165841|565249004|FG000|Overall Study|Protocol Violation|6|||
156591621|NCT00165841|565249005|FG001|Overall Study|Protocol Violation|8|||
156591622|NCT00165841|565249004|FG000|Overall Study|Other|3|||
156591623|NCT00165841|565249005|FG001|Overall Study|Other|5|||
156591624|NCT00165841|565249004|FG000|Overall Study|Medication Noncompliance|1|||
156591625|NCT00165841|565249005|FG001|Overall Study|Medication Noncompliance|1|||
156591626|NCT01000727|565249008|FG000|Overall Study|Lost to Follow-up|41|||
156591627|NCT01000727|565249009|FG001|Overall Study|Lost to Follow-up|43|||
156591628|NCT01000727|565249008|FG000|Overall Study|Withdrawal by Subject|111|||
156591629|NCT01000727|565249009|FG001|Overall Study|Withdrawal by Subject|109|||
156591630|NCT01000727|565249008|FG000|Overall Study|Study closed/terminated|23|||
156591631|NCT01000727|565249009|FG001|Overall Study|Study closed/terminated|24|||
156591632|NCT03196193|565249010|FG000|Overall Study|Adverse Event|1|||
156591633|NCT03196193|565249011|FG001|Overall Study|Adverse Event|0|||
156591634|NCT03196193|565249010|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
156591635|NCT03196193|565249011|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
156591636|NCT01026389|565249015|FG000|Overall Study|Withdrawal by Subject|1|||
156591637|NCT01026389|565249016|FG001|Overall Study|Withdrawal by Subject|3|||
156591638|NCT01026389|565249015|FG000|Overall Study|change of treatment, patient moved|4|||
156591639|NCT01026389|565249016|FG001|Overall Study|change of treatment, patient moved|2|||
156591640|NCT01697267|565249017|FG000|Overall Study|Death|3|||
156591641|NCT01697267|565249018|FG001|Overall Study|Death|1|||
156591642|NCT01697267|565249017|FG000|Overall Study|Withdrawal by Subject|5|||
156591643|NCT01697267|565249018|FG001|Overall Study|Withdrawal by Subject|5|||
156591644|NCT01697267|565249017|FG000|Overall Study|Adverse Event|2|||
156591645|NCT01697267|565249018|FG001|Overall Study|Adverse Event|1|||
156591646|NCT01697267|565249017|FG000|Overall Study|Lost to Follow-up|2|||
156591647|NCT01697267|565249018|FG001|Overall Study|Lost to Follow-up|4|||
156591648|NCT01697267|565249017|FG000|Overall Study|Physician Decision|2|||
156591649|NCT01697267|565249018|FG001|Overall Study|Physician Decision|4|||
156591650|NCT03544268|565249019|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
156591651|NCT03544268|565249020|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
156591652|NCT04410198|565249021|FG000|Overall Study|Death|10|||
156591653|NCT04410198|565249021|FG000|Overall Study|Withdrawal by Subject|7|||
156591654|NCT04410198|565249021|FG000|Overall Study|Transferred/Relocation|4|||
156591655|NCT04410198|565249021|FG000|Overall Study|Kidney Transplant|9|||
156591656|NCT04410198|565249021|FG000|Overall Study|Adverse Event|4|||
156591657|NCT04410198|565249021|FG000|Overall Study|Physician Decision|2|||
156591658|NCT04410198|565249021|FG000|Overall Study|Other than specified|1|||
156591659|NCT02006667|565249022|FG000|Overall Study|Adverse Event|3|||
156591660|NCT02006667|565249022|FG000|Overall Study|Death|2|||
156591661|NCT02006667|565249022|FG000|Overall Study|Withdrawal by Subject|1|||
156591662|NCT04831515|565249025|FG000|First Intervention|Adverse Event|0|||
156591663|NCT04831515|565249026|FG001|First Intervention|Adverse Event|1|||
156591664|NCT02338492|565249036|FG000|Overall Study|Death|32|||
156591665|NCT02338492|565249036|FG000|Overall Study|Adverse Event|3|||
156591666|NCT02338492|565249036|FG000|Overall Study|Lost to Follow-up|4|||
156591667|NCT02338492|565249036|FG000|Overall Study|Reason not captured above|6|||
156591668|NCT00174785|565249037|FG000|Overall Study|Adverse Event|293|||
156591669|NCT00174785|565249038|FG001|Overall Study|Adverse Event|191|||
156591670|NCT00174785|565249037|FG000|Overall Study|Protocol Violation|14|||
156591671|NCT00174785|565249038|FG001|Overall Study|Protocol Violation|14|||
156591672|NCT00174785|565249037|FG000|Overall Study|Withdrawal by Subject|173|||
156591673|NCT00174785|565249038|FG001|Overall Study|Withdrawal by Subject|175|||
156591674|NCT00174785|565249037|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
156591675|NCT00174785|565249038|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
156591676|NCT00174785|565249037|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
156591677|NCT00174785|565249038|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
156591678|NCT00174785|565249037|FG000|Overall Study|Other prohibited medication|5|||
156591679|NCT00174785|565249038|FG001|Overall Study|Other prohibited medication|3|||
156591680|NCT00174785|565249037|FG000|Overall Study|Family request|6|||
156591681|NCT00174785|565249038|FG001|Overall Study|Family request|8|||
156591682|NCT00174785|565249037|FG000|Overall Study|Not pre-specified/Not coded|56|||
156591683|NCT00174785|565249038|FG001|Overall Study|Not pre-specified/Not coded|70|||
156591684|NCT00120289|565249039|FG000|Overall Study|Death|96|||
156591685|NCT00120289|565249040|FG001|Overall Study|Death|82|||
156591686|NCT00120289|565249039|FG000|Overall Study|Lost to Follow-up|11|||
156591687|NCT00120289|565249040|FG001|Overall Study|Lost to Follow-up|14|||
156591688|NCT00120289|565249039|FG000|Overall Study|Withdrawal by Subject|14|||
156591689|NCT00120289|565249040|FG001|Overall Study|Withdrawal by Subject|13|||
156591690|NCT00194025|565249042|FG000|Overall Study|Adverse Event|1|||
156591691|NCT00194025|565249042|FG000|Overall Study|non-adherence with study medication|4|||
156591692|NCT00543569|565249043|FG000|Overall Study|Death|2|||
156591693|NCT00543569|565249044|FG001|Overall Study|Death|2|||
156591694|NCT00543569|565249045|FG002|Overall Study|Death|3|||
156591695|NCT00543569|565249046|FG003|Overall Study|Death|1|||
156591696|NCT00543569|565249043|FG000|Overall Study|Lost to Follow-up|0|||
156591697|NCT00543569|565249044|FG001|Overall Study|Lost to Follow-up|0|||
156591698|NCT00543569|565249045|FG002|Overall Study|Lost to Follow-up|1|||
156591699|NCT00543569|565249046|FG003|Overall Study|Lost to Follow-up|1|||
156591700|NCT00543569|565249043|FG000|Overall Study|Miscellaneous Reasons|7|||
156591701|NCT00543569|565249044|FG001|Overall Study|Miscellaneous Reasons|3|||
156591702|NCT00543569|565249045|FG002|Overall Study|Miscellaneous Reasons|11|||
156591703|NCT00543569|565249046|FG003|Overall Study|Miscellaneous Reasons|4|||
156591704|NCT00543569|565249043|FG000|Overall Study|Randomized but never received study drug|3|||
156591705|NCT00543569|565249044|FG001|Overall Study|Randomized but never received study drug|3|||
156863660|NCT03043313|566258738|FG002|Overall Study|Participation terminated by sponsor|13|||
156591706|NCT00543569|565249045|FG002|Overall Study|Randomized but never received study drug|5|||
156591707|NCT00543569|565249046|FG003|Overall Study|Randomized but never received study drug|3|||
156591708|NCT00862849|565249047|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
156591709|NCT00862849|565249048|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
156591710|NCT00862849|565249049|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
156591711|NCT00862849|565249050|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
156591712|NCT00862849|565249051|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
156591713|NCT00862849|565249052|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
156591714|NCT00862849|565249047|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
156591715|NCT00862849|565249048|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
156591716|NCT00862849|565249049|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
156591717|NCT00862849|565249050|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
156591718|NCT00862849|565249051|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
156591719|NCT00862849|565249052|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
156591720|NCT00511342|565249061|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
156591721|NCT00511342|565249062|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
156591722|NCT00511342|565249061|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
156591723|NCT00511342|565249062|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
156591724|NCT00511342|565249061|FG000|Overall Study|Pregnancy|0|||
156591725|NCT00511342|565249062|FG001|Overall Study|Pregnancy|1|||
156591726|NCT00511342|565249061|FG000|Overall Study|Pregnancy wish|0|||
156591727|NCT00511342|565249062|FG001|Overall Study|Pregnancy wish|1|||
156591728|NCT00511342|565249061|FG000|Overall Study|Lost to Follow-up|1|||
156591729|NCT00511342|565249062|FG001|Overall Study|Lost to Follow-up|5|||
156591730|NCT00511342|565249061|FG000|Overall Study|Other Reason|2|||
156591731|NCT00511342|565249062|FG001|Overall Study|Other Reason|2|||
156591732|NCT02432040|565249063|FG000|Overall Study|Lack of Efficacy|3|||
156591733|NCT02432040|565249064|FG001|Overall Study|Lack of Efficacy|0|||
156591734|NCT02432040|565249063|FG000|Overall Study|Lost to Follow-up|4|||
156591735|NCT02432040|565249064|FG001|Overall Study|Lost to Follow-up|5|||
156591736|NCT02432040|565249063|FG000|Overall Study|Physician Decision|1|||
156591737|NCT02432040|565249064|FG001|Overall Study|Physician Decision|1|||
156591738|NCT01100307|565249065|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
156591739|NCT01100307|565249066|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
156591740|NCT01100307|565249065|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
156591741|NCT01100307|565249066|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
156591742|NCT01100307|565249065|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
156591743|NCT01100307|565249066|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
156591744|NCT01100307|565249065|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
156591745|NCT01100307|565249066|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
156591746|NCT01100307|565249065|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
156591747|NCT01100307|565249066|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
156591748|NCT01100307|565249065|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
156591749|NCT01100307|565249066|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
156591750|NCT00997321|565249067|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
156591751|NCT00997321|565249068|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
156591752|NCT00608530|565249073|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
156591753|NCT00608530|565249074|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
156591754|NCT00608530|565249075|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
156591755|NCT00608530|565249076|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
156591756|NCT00608530|565249073|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
156591757|NCT00608530|565249074|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
156591758|NCT00608530|565249075|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
156591759|NCT00608530|565249076|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
156591760|NCT00608530|565249073|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
156591761|NCT00608530|565249074|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
156591762|NCT00608530|565249075|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
156591763|NCT00608530|565249076|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
156591764|NCT00608530|565249073|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
156591765|NCT00608530|565249074|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
156591766|NCT00608530|565249075|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
156591767|NCT00608530|565249076|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
156591768|NCT00608530|565249073|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
156591769|NCT00608530|565249074|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
156591770|NCT00608530|565249075|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
156591771|NCT00608530|565249076|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
156591772|NCT00608530|565249073|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
156591773|NCT00608530|565249074|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
156591774|NCT00608530|565249075|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
156591775|NCT00608530|565249076|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
156591776|NCT00077610|565249077|FG000|Overall Study|Adverse Event|9|||
156591777|NCT00077610|565249078|FG001|Overall Study|Adverse Event|7|||
156591778|NCT00077610|565249079|FG002|Overall Study|Adverse Event|1|||
156591779|NCT00077610|565249077|FG000|Overall Study|Lost to Follow-up|0|||
156591780|NCT00077610|565249078|FG001|Overall Study|Lost to Follow-up|1|||
156591781|NCT00077610|565249079|FG002|Overall Study|Lost to Follow-up|2|||
156591782|NCT00077610|565249077|FG000|Overall Study|Withdrawal by Subject|4|||
156591783|NCT00077610|565249078|FG001|Overall Study|Withdrawal by Subject|10|||
156591784|NCT00077610|565249079|FG002|Overall Study|Withdrawal by Subject|6|||
156591785|NCT00077610|565249077|FG000|Overall Study|Death|17|||
156591786|NCT00077610|565249078|FG001|Overall Study|Death|13|||
156591787|NCT00077610|565249079|FG002|Overall Study|Death|13|||
156591788|NCT00077610|565249077|FG000|Overall Study|Renal transplant|12|||
156591789|NCT00077610|565249078|FG001|Overall Study|Renal transplant|15|||
156591790|NCT00077610|565249079|FG002|Overall Study|Renal transplant|11|||
156591791|NCT00077610|565249077|FG000|Overall Study|Withdrew from dialysis care|5|||
156591792|NCT00077610|565249078|FG001|Overall Study|Withdrew from dialysis care|0|||
156591793|NCT00077610|565249079|FG002|Overall Study|Withdrew from dialysis care|3|||
156591794|NCT00077610|565249077|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156591795|NCT00077610|565249078|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156591796|NCT00077610|565249079|FG002|Overall Study|Insufficient Therapeutic Response|0|||
156591797|NCT00077610|565249077|FG000|Overall Study|Multiple blood transfusions|0|||
156591798|NCT00077610|565249078|FG001|Overall Study|Multiple blood transfusions|0|||
156591799|NCT00077610|565249079|FG002|Overall Study|Multiple blood transfusions|1|||
156591800|NCT00077610|565249077|FG000|Overall Study|Principal Investigator's decision|1|||
156591801|NCT00077610|565249078|FG001|Overall Study|Principal Investigator's decision|0|||
156591802|NCT00077610|565249079|FG002|Overall Study|Principal Investigator's decision|1|||
156591803|NCT00077610|565249077|FG000|Overall Study|Worsening of health condition|1|||
156591804|NCT00077610|565249078|FG001|Overall Study|Worsening of health condition|1|||
156591805|NCT00077610|565249079|FG002|Overall Study|Worsening of health condition|0|||
156591806|NCT00077610|565249077|FG000|Overall Study|Given Epogen in hospital|1|||
156591807|NCT00077610|565249078|FG001|Overall Study|Given Epogen in hospital|0|||
156591808|NCT00077610|565249079|FG002|Overall Study|Given Epogen in hospital|0|||
156591809|NCT00077610|565249077|FG000|Overall Study|Transferred to other unit|0|||
156591810|NCT00077610|565249078|FG001|Overall Study|Transferred to other unit|0|||
156591811|NCT00077610|565249079|FG002|Overall Study|Transferred to other unit|1|||
156591812|NCT00077610|565249077|FG000|Overall Study|Transferred to nursing home|0|||
156591813|NCT00077610|565249078|FG001|Overall Study|Transferred to nursing home|0|||
156591814|NCT00077610|565249079|FG002|Overall Study|Transferred to nursing home|1|||
156591815|NCT00077610|565249077|FG000|Overall Study|Transfer to satellite unit|1|||
156591816|NCT00077610|565249078|FG001|Overall Study|Transfer to satellite unit|0|||
156591817|NCT00077610|565249079|FG002|Overall Study|Transfer to satellite unit|0|||
156591818|NCT00077610|565249077|FG000|Overall Study|Transfer to other center for surgery|1|||
156591819|NCT00077610|565249078|FG001|Overall Study|Transfer to other center for surgery|0|||
156591820|NCT00077610|565249079|FG002|Overall Study|Transfer to other center for surgery|0|||
156591821|NCT00077610|565249077|FG000|Overall Study|Change in dialysis modality|1|||
156591822|NCT00077610|565249078|FG001|Overall Study|Change in dialysis modality|0|||
156591823|NCT00077610|565249079|FG002|Overall Study|Change in dialysis modality|0|||
156591824|NCT00077610|565249077|FG000|Overall Study|Relocation|0|||
156591825|NCT00077610|565249078|FG001|Overall Study|Relocation|8|||
156591826|NCT00077610|565249079|FG002|Overall Study|Relocation|5|||
156591827|NCT00077610|565249077|FG000|Overall Study|Financial issues|0|||
156591828|NCT00077610|565249078|FG001|Overall Study|Financial issues|1|||
156591829|NCT00077610|565249079|FG002|Overall Study|Financial issues|0|||
156591830|NCT00077610|565249077|FG000|Overall Study|Sponsors decision to withdraw|0|||
156591831|NCT00077610|565249078|FG001|Overall Study|Sponsors decision to withdraw|0|||
156591832|NCT00077610|565249079|FG002|Overall Study|Sponsors decision to withdraw|1|||
156591833|NCT01357915|565249081|FG000|Overall Study|Lost to Follow-up|3|||
156591834|NCT01357915|565249082|FG001|Overall Study|Lost to Follow-up|0|||
156591835|NCT00305253|565249083|FG000|Overall Study|Withdrawal by Subject|0|||
156591836|NCT00305253|565249084|FG001|Overall Study|Withdrawal by Subject|1|||
156591837|NCT01153763|565249087|FG000|Overall Study|Study Closed|16|||
156591838|NCT01153763|565249087|FG000|Overall Study|Lost to Follow-up|1|||
156591839|NCT01153763|565249087|FG000|Overall Study|Physician Decision|2|||
156591840|NCT01153763|565249087|FG000|Overall Study|Withdrawal by Subject|2|||
156591841|NCT02841787|565249090|FG000|Overall Study|Lost to Follow-up|1|||
156591842|NCT02841787|565249091|FG001|Overall Study|Lost to Follow-up|0|||
156591843|NCT02841787|565249092|FG002|Overall Study|Lost to Follow-up|0|||
156591844|NCT02841787|565249090|FG000|Overall Study|Symptoms dropped below threshold|1|||
156591845|NCT02841787|565249091|FG001|Overall Study|Symptoms dropped below threshold|0|||
156591846|NCT02841787|565249092|FG002|Overall Study|Symptoms dropped below threshold|0|||
156591847|NCT02841787|565249090|FG000|Overall Study|Withdrawal by Subject|1|||
156591848|NCT02841787|565249091|FG001|Overall Study|Withdrawal by Subject|4|||
156591849|NCT02841787|565249092|FG002|Overall Study|Withdrawal by Subject|0|||
156591850|NCT01474746|565249093|FG000|Overall Study|Lost to Follow-up|1|||
156591851|NCT01474746|565249094|FG001|Overall Study|Lost to Follow-up|1|||
156591852|NCT01474746|565249093|FG000|Overall Study|Withdrawal by Subject|2|||
156591853|NCT01474746|565249094|FG001|Overall Study|Withdrawal by Subject|1|||
156591854|NCT01766336|565249098|FG000|Overall Study|Adverse Event|11|||
156591855|NCT01766336|565249099|FG001|Overall Study|Adverse Event|8|||
156591856|NCT01766336|565249098|FG000|Overall Study|Death|4|||
156591857|NCT01766336|565249099|FG001|Overall Study|Death|3|||
156591858|NCT01766336|565249098|FG000|Overall Study|Lost to Follow-up|1|||
156591859|NCT01766336|565249099|FG001|Overall Study|Lost to Follow-up|3|||
156591860|NCT01766336|565249098|FG000|Overall Study|Physician Decision|4|||
156591861|NCT01766336|565249099|FG001|Overall Study|Physician Decision|2|||
156591862|NCT01766336|565249098|FG000|Overall Study|Protocol Violation|0|||
156591863|NCT01766336|565249099|FG001|Overall Study|Protocol Violation|1|||
156591864|NCT01766336|565249098|FG000|Overall Study|Sponsor Decision|52|||
156591865|NCT01766336|565249099|FG001|Overall Study|Sponsor Decision|43|||
156591866|NCT01766336|565249098|FG000|Overall Study|Withdrawal by Subject|18|||
156591867|NCT01766336|565249099|FG001|Overall Study|Withdrawal by Subject|15|||
156591868|NCT03029650|565249100|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
156591869|NCT03029650|565249101|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
156591870|NCT03029650|565249100|FG000|Washout (1 Week)|Physician Decision|0|||
156591871|NCT03029650|565249101|FG001|Washout (1 Week)|Physician Decision|1|||
156591872|NCT04544709|565249102|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
156591873|NCT03135028|565249103|FG000|Overall Study|Death|6|||
156591874|NCT03135028|565249103|FG000|Overall Study|Study Terminated by Sponsor|2|||
156591875|NCT03135028|565249103|FG000|Overall Study|Withdrew Consent|1|||
156591876|NCT02065869|565249104|FG000|Overall Study|Death|7|||
156591877|NCT02065869|565249104|FG000|Overall Study|Disease relapse|16|||
156591878|NCT02065869|565249104|FG000|Overall Study|Lost to Follow-up|4|||
156591879|NCT02065869|565249104|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
156591880|NCT02065869|565249104|FG000|Overall Study|Withdrawal by Subject|1|||
156591881|NCT01814800|565249105|FG000|Overall Study|Adverse Event|2|||
156591882|NCT01814800|565249105|FG000|Overall Study|Pregnancy|1|||
156591883|NCT01814800|565249105|FG000|Overall Study|Sponsor decision|1|||
156591884|NCT01814800|565249105|FG000|Overall Study|Subject relocation|1|||
156591885|NCT03136185|565249106|FG000|Overall Study|Adverse Event|0|||
156591886|NCT03136185|565249107|FG001|Overall Study|Adverse Event|1|||
156591887|NCT03136185|565249108|FG002|Overall Study|Adverse Event|3|||
156591888|NCT03136185|565249109|FG003|Overall Study|Adverse Event|1|||
156591889|NCT03136185|565249110|FG004|Overall Study|Adverse Event|2|||
156591890|NCT03136185|565249111|FG005|Overall Study|Adverse Event|2|||
156591891|NCT03136185|565249112|FG006|Overall Study|Adverse Event|5|||
156591892|NCT03136185|565249113|FG007|Overall Study|Adverse Event|1|||
156591893|NCT03136185|565249114|FG008|Overall Study|Adverse Event|1|||
156591894|NCT03136185|565249106|FG000|Overall Study|Death|0|||
156591895|NCT03136185|565249107|FG001|Overall Study|Death|0|||
156591896|NCT03136185|565249108|FG002|Overall Study|Death|0|||
156591897|NCT03136185|565249109|FG003|Overall Study|Death|1|||
156591898|NCT03136185|565249110|FG004|Overall Study|Death|1|||
156591899|NCT03136185|565249111|FG005|Overall Study|Death|0|||
156591900|NCT03136185|565249112|FG006|Overall Study|Death|1|||
156591901|NCT03136185|565249113|FG007|Overall Study|Death|0|||
156591902|NCT03136185|565249114|FG008|Overall Study|Death|0|||
156591903|NCT03136185|565249106|FG000|Overall Study|Physician Decision|3|||
156591904|NCT03136185|565249107|FG001|Overall Study|Physician Decision|1|||
156591905|NCT03136185|565249108|FG002|Overall Study|Physician Decision|1|||
156591906|NCT03136185|565249109|FG003|Overall Study|Physician Decision|2|||
156591907|NCT03136185|565249110|FG004|Overall Study|Physician Decision|1|||
156591908|NCT03136185|565249111|FG005|Overall Study|Physician Decision|2|||
156591909|NCT03136185|565249112|FG006|Overall Study|Physician Decision|1|||
156591910|NCT03136185|565249113|FG007|Overall Study|Physician Decision|0|||
156591911|NCT03136185|565249114|FG008|Overall Study|Physician Decision|1|||
156591912|NCT03136185|565249106|FG000|Overall Study|Protocol Defined Disease Progression|0|||
156591913|NCT03136185|565249107|FG001|Overall Study|Protocol Defined Disease Progression|0|||
156591914|NCT03136185|565249108|FG002|Overall Study|Protocol Defined Disease Progression|1|||
156591915|NCT03136185|565249109|FG003|Overall Study|Protocol Defined Disease Progression|0|||
156591916|NCT03136185|565249110|FG004|Overall Study|Protocol Defined Disease Progression|0|||
156591917|NCT03136185|565249111|FG005|Overall Study|Protocol Defined Disease Progression|1|||
156591918|NCT03136185|565249112|FG006|Overall Study|Protocol Defined Disease Progression|0|||
156591919|NCT03136185|565249113|FG007|Overall Study|Protocol Defined Disease Progression|1|||
156591920|NCT03136185|565249114|FG008|Overall Study|Protocol Defined Disease Progression|1|||
156591921|NCT03136185|565249106|FG000|Overall Study|Withdrawal by Subject|1|||
156591922|NCT03136185|565249107|FG001|Overall Study|Withdrawal by Subject|0|||
156591923|NCT03136185|565249108|FG002|Overall Study|Withdrawal by Subject|1|||
156591924|NCT03136185|565249109|FG003|Overall Study|Withdrawal by Subject|1|||
156591925|NCT03136185|565249110|FG004|Overall Study|Withdrawal by Subject|1|||
156591926|NCT03136185|565249111|FG005|Overall Study|Withdrawal by Subject|1|||
156591927|NCT03136185|565249112|FG006|Overall Study|Withdrawal by Subject|2|||
156863661|NCT00795535|566258739|FG000|Overall Study|incomplete data and technical problems|20|||
156591928|NCT03136185|565249113|FG007|Overall Study|Withdrawal by Subject|3|||
156591929|NCT03136185|565249114|FG008|Overall Study|Withdrawal by Subject|3|||
156591930|NCT03136185|565249106|FG000|Overall Study|Not Reported|4|||
156591931|NCT03136185|565249107|FG001|Overall Study|Not Reported|1|||
156591932|NCT03136185|565249108|FG002|Overall Study|Not Reported|0|||
156591933|NCT03136185|565249109|FG003|Overall Study|Not Reported|1|||
156591934|NCT03136185|565249110|FG004|Overall Study|Not Reported|0|||
156591935|NCT03136185|565249111|FG005|Overall Study|Not Reported|2|||
156591936|NCT03136185|565249112|FG006|Overall Study|Not Reported|1|||
156591937|NCT03136185|565249113|FG007|Overall Study|Not Reported|1|||
156591938|NCT03136185|565249114|FG008|Overall Study|Not Reported|0|||
156591939|NCT05118386|565249117|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
156591940|NCT05118386|565249118|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
156591941|NCT05118386|565249119|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
156591942|NCT05118386|565249120|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
156591943|NCT05118386|565249121|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
156591944|NCT05118386|565249122|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
156591945|NCT05118386|565249117|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
156591946|NCT05118386|565249118|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
156591947|NCT05118386|565249119|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
156591948|NCT05118386|565249120|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
156591949|NCT05118386|565249121|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
156591950|NCT05118386|565249122|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
156591951|NCT02427477|565249125|FG000|Period 1|Adverse Event|1|||
156591952|NCT02427477|565249126|FG001|Period 1|Adverse Event|0|||
156591953|NCT01067508|565249127|FG000|Overall Study|Physician Decision|0|||
156591954|NCT01067508|565249128|FG001|Overall Study|Physician Decision|1|||
156591955|NCT01067508|565249127|FG000|Overall Study|Withdrawal by Subject|0|||
156591956|NCT01067508|565249128|FG001|Overall Study|Withdrawal by Subject|1|||
156591957|NCT00632463|565249133|FG000|Overall Study|Adverse Event|0|||
156591958|NCT00632463|565249134|FG001|Overall Study|Adverse Event|1|||
156591959|NCT00632463|565249135|FG002|Overall Study|Adverse Event|0|||
156591960|NCT02065622|565249136|FG000|Induction Study|Adverse Event|13|||
156591961|NCT02065622|565249137|FG001|Induction Study|Adverse Event|19|||
156591962|NCT02065622|565249138|FG002|Induction Study|Adverse Event|0|||
156591963|NCT02065622|565249139|FG003|Induction Study|Adverse Event|0|||
156591964|NCT02065622|565249140|FG004|Induction Study|Adverse Event|0|||
156591965|NCT02065622|565249136|FG000|Induction Study|Withdrawal by Subject|3|||
156591966|NCT02065622|565249137|FG001|Induction Study|Withdrawal by Subject|5|||
156591967|NCT02065622|565249138|FG002|Induction Study|Withdrawal by Subject|0|||
156591968|NCT02065622|565249139|FG003|Induction Study|Withdrawal by Subject|0|||
156591969|NCT02065622|565249140|FG004|Induction Study|Withdrawal by Subject|0|||
156591970|NCT02065622|565249136|FG000|Induction Study|Lost to Follow-up|1|||
156591971|NCT02065622|565249137|FG001|Induction Study|Lost to Follow-up|0|||
156591972|NCT02065622|565249138|FG002|Induction Study|Lost to Follow-up|0|||
156591973|NCT02065622|565249139|FG003|Induction Study|Lost to Follow-up|0|||
156591974|NCT02065622|565249140|FG004|Induction Study|Lost to Follow-up|0|||
156591975|NCT02065622|565249136|FG000|Induction Study|Lack of Efficacy|22|||
156591976|NCT02065622|565249137|FG001|Induction Study|Lack of Efficacy|27|||
156591977|NCT02065622|565249138|FG002|Induction Study|Lack of Efficacy|0|||
156591978|NCT02065622|565249139|FG003|Induction Study|Lack of Efficacy|0|||
156591979|NCT02065622|565249140|FG004|Induction Study|Lack of Efficacy|0|||
156591980|NCT02065622|565249136|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
156591981|NCT02065622|565249137|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
156591982|NCT02065622|565249138|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
156591983|NCT02065622|565249139|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
156591984|NCT02065622|565249140|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
156591985|NCT02065622|565249136|FG000|Induction Study|Subject Noncompliance|1|||
156591986|NCT02065622|565249137|FG001|Induction Study|Subject Noncompliance|1|||
156591987|NCT02065622|565249138|FG002|Induction Study|Subject Noncompliance|0|||
156591988|NCT02065622|565249139|FG003|Induction Study|Subject Noncompliance|0|||
156591989|NCT02065622|565249140|FG004|Induction Study|Subject Noncompliance|0|||
156591990|NCT02065622|565249136|FG000|Induction Study|Other, Not Specified|3|||
156591991|NCT02065622|565249137|FG001|Induction Study|Other, Not Specified|2|||
156591992|NCT02065622|565249138|FG002|Induction Study|Other, Not Specified|0|||
156591993|NCT02065622|565249139|FG003|Induction Study|Other, Not Specified|0|||
156591994|NCT02065622|565249140|FG004|Induction Study|Other, Not Specified|0|||
156591995|NCT02065622|565249136|FG000|Maintenance Study|Adverse Event|0|||
156591996|NCT02065622|565249137|FG001|Maintenance Study|Adverse Event|0|||
156591997|NCT02065622|565249138|FG002|Maintenance Study|Adverse Event|25|||
156591998|NCT02065622|565249139|FG003|Maintenance Study|Adverse Event|22|||
156591999|NCT02065622|565249140|FG004|Maintenance Study|Adverse Event|11|||
156592000|NCT02065622|565249136|FG000|Maintenance Study|Withdrawal by Subject|0|||
156592001|NCT02065622|565249137|FG001|Maintenance Study|Withdrawal by Subject|0|||
156592002|NCT02065622|565249138|FG002|Maintenance Study|Withdrawal by Subject|11|||
156592003|NCT02065622|565249139|FG003|Maintenance Study|Withdrawal by Subject|5|||
156592004|NCT02065622|565249140|FG004|Maintenance Study|Withdrawal by Subject|7|||
156592005|NCT02065622|565249136|FG000|Maintenance Study|Lost to Follow-up|0|||
156592006|NCT02065622|565249137|FG001|Maintenance Study|Lost to Follow-up|0|||
156592007|NCT02065622|565249138|FG002|Maintenance Study|Lost to Follow-up|4|||
156592008|NCT02065622|565249139|FG003|Maintenance Study|Lost to Follow-up|1|||
156592009|NCT02065622|565249140|FG004|Maintenance Study|Lost to Follow-up|1|||
156592010|NCT02065622|565249136|FG000|Maintenance Study|Lack of Efficacy|0|||
156592011|NCT02065622|565249137|FG001|Maintenance Study|Lack of Efficacy|0|||
156592012|NCT02065622|565249138|FG002|Maintenance Study|Lack of Efficacy|70|||
156592013|NCT02065622|565249139|FG003|Maintenance Study|Lack of Efficacy|55|||
156592014|NCT02065622|565249140|FG004|Maintenance Study|Lack of Efficacy|19|||
156592015|NCT02065622|565249136|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
156592016|NCT02065622|565249137|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
156592017|NCT02065622|565249138|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
156592018|NCT02065622|565249139|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
156592019|NCT02065622|565249140|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
156592020|NCT02065622|565249136|FG000|Maintenance Study|Subject Non-Compliance|0|||
156592021|NCT02065622|565249137|FG001|Maintenance Study|Subject Non-Compliance|0|||
156592022|NCT02065622|565249138|FG002|Maintenance Study|Subject Non-Compliance|1|||
156592023|NCT02065622|565249139|FG003|Maintenance Study|Subject Non-Compliance|3|||
156592024|NCT02065622|565249140|FG004|Maintenance Study|Subject Non-Compliance|2|||
156592025|NCT02065622|565249136|FG000|Maintenance Study|Other, Not Specified|0|||
156592026|NCT02065622|565249137|FG001|Maintenance Study|Other, Not Specified|0|||
156592027|NCT02065622|565249138|FG002|Maintenance Study|Other, Not Specified|6|||
156592028|NCT02065622|565249139|FG003|Maintenance Study|Other, Not Specified|14|||
156592029|NCT02065622|565249140|FG004|Maintenance Study|Other, Not Specified|2|||
156592030|NCT02065622|565249136|FG000|Maintenance Study|Unknown Reason|0|||
156592031|NCT02065622|565249137|FG001|Maintenance Study|Unknown Reason|0|||
156592032|NCT02065622|565249138|FG002|Maintenance Study|Unknown Reason|0|||
156592033|NCT02065622|565249139|FG003|Maintenance Study|Unknown Reason|1|||
156592034|NCT02065622|565249140|FG004|Maintenance Study|Unknown Reason|0|||
156592035|NCT02349789|565250569|FG000|Overall Study|Withdrawal by Subject|2|||
156592036|NCT02922634|565250570|FG000|Overall Study|Withdrawal by Subject|5|||
156592037|NCT02922634|565250570|FG000|Overall Study|Did not have their surgery|5|||
156592038|NCT00352755|565250571|FG000|Overall Study|Physician Decision|1|||
156592039|NCT00352755|565250571|FG000|Overall Study|Adverse Event|1|||
156592040|NCT02397694|565250574|FG000|Double-Blinded Phase|Adverse Event|1|||
156592041|NCT02397694|565250575|FG001|Double-Blinded Phase|Adverse Event|0|||
156592042|NCT02397694|565250574|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
156592043|NCT02397694|565250575|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
156592044|NCT02397694|565250574|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
156592045|NCT02397694|565250575|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
156592046|NCT02397694|565250574|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
156592047|NCT02397694|565250575|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
156592048|NCT02397694|565250574|FG000|Open Label Extension Phase|Protocol Violation|1|||
156592049|NCT02397694|565250575|FG001|Open Label Extension Phase|Protocol Violation|0|||
156592050|NCT02397694|565250574|FG000|Open Label Extension Phase|Withdrew Consent|3|||
156592051|NCT02397694|565250575|FG001|Open Label Extension Phase|Withdrew Consent|1|||
156592052|NCT02397694|565250574|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
156592053|NCT02397694|565250575|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
156592054|NCT01116687|565250576|FG000|Overall Study|Withdrawal by Subject|4|||
156592055|NCT00424528|565250577|FG000|Overall Study|Adverse Event|2|||
156592056|NCT00424528|565250578|FG001|Overall Study|Adverse Event|1|||
156592057|NCT00424528|565250579|FG002|Overall Study|Adverse Event|2|||
156592058|NCT00424528|565250577|FG000|Overall Study|Protocol Violation|1|||
156592059|NCT00424528|565250578|FG001|Overall Study|Protocol Violation|1|||
156592060|NCT00424528|565250579|FG002|Overall Study|Protocol Violation|0|||
156592061|NCT00424528|565250577|FG000|Overall Study|Lost to Follow-up|0|||
156592062|NCT00424528|565250578|FG001|Overall Study|Lost to Follow-up|1|||
156592063|NCT00424528|565250579|FG002|Overall Study|Lost to Follow-up|0|||
156592064|NCT00424528|565250577|FG000|Overall Study|noncompliance with study requirements|2|||
156592065|NCT00424528|565250578|FG001|Overall Study|noncompliance with study requirements|1|||
156592066|NCT00424528|565250579|FG002|Overall Study|noncompliance with study requirements|2|||
156592067|NCT02115113|565250580|FG000|Participants in Run-in Period|Death|0|||
156592068|NCT02115113|565250581|FG001|Participants in Run-in Period|Death|0|||
156592069|NCT02115113|565250582|FG002|Participants in Run-in Period|Death|1|||
156592070|NCT02115113|565250580|FG000|Participants in Run-in Period|Administrative problems|0|||
156592071|NCT02115113|565250581|FG001|Participants in Run-in Period|Administrative problems|0|||
156592072|NCT02115113|565250582|FG002|Participants in Run-in Period|Administrative problems|1|||
156592073|NCT02115113|565250580|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
156592074|NCT02115113|565250581|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
156592075|NCT02115113|565250582|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
156592076|NCT02115113|565250580|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
156592077|NCT02115113|565250581|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
156592078|NCT02115113|565250582|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
156592079|NCT02115113|565250580|FG000|Participants Randomized|Lost to Follow-up|1|||
156592080|NCT02115113|565250581|FG001|Participants Randomized|Lost to Follow-up|0|||
156592081|NCT02115113|565250582|FG002|Participants Randomized|Lost to Follow-up|0|||
156592082|NCT02115113|565250580|FG000|Participants Randomized|Death|1|||
156592083|NCT02115113|565250581|FG001|Participants Randomized|Death|0|||
156592084|NCT02115113|565250582|FG002|Participants Randomized|Death|0|||
156592085|NCT01009983|565250584|FG000|Overall Study|necessary scans not completed|1|||
156592086|NCT00296725|565250587|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
156592087|NCT00296725|565250587|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
156592088|NCT00296725|565250587|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
156592089|NCT03137121|565250597|FG000|Overall Study|Withdrawal by Subject|0|||
156592090|NCT03137121|565250598|FG001|Overall Study|Withdrawal by Subject|1|||
156592091|NCT00280150|565250602|FG000|Overall Study|Adverse Event|0|||
156592092|NCT00280150|565250603|FG001|Overall Study|Adverse Event|1|||
156592093|NCT00280150|565250604|FG002|Overall Study|Adverse Event|2|||
156592094|NCT00280150|565250605|FG003|Overall Study|Adverse Event|3|||
156592095|NCT00280150|565250602|FG000|Overall Study|Lack of Efficacy|0|||
156592096|NCT00280150|565250603|FG001|Overall Study|Lack of Efficacy|0|||
156592097|NCT00280150|565250604|FG002|Overall Study|Lack of Efficacy|0|||
156592098|NCT00280150|565250605|FG003|Overall Study|Lack of Efficacy|3|||
156592099|NCT00280150|565250602|FG000|Overall Study|Physician Decision|0|||
156592100|NCT00280150|565250603|FG001|Overall Study|Physician Decision|0|||
156592101|NCT00280150|565250604|FG002|Overall Study|Physician Decision|0|||
156592102|NCT00280150|565250605|FG003|Overall Study|Physician Decision|1|||
156592103|NCT00280150|565250602|FG000|Overall Study|Protocol Violation|0|||
156592104|NCT00280150|565250603|FG001|Overall Study|Protocol Violation|0|||
156592105|NCT00280150|565250604|FG002|Overall Study|Protocol Violation|0|||
156592106|NCT00280150|565250605|FG003|Overall Study|Protocol Violation|1|||
156592107|NCT00280150|565250602|FG000|Overall Study|Withdrawal by Subject|0|||
156592108|NCT00280150|565250603|FG001|Overall Study|Withdrawal by Subject|0|||
156592109|NCT00280150|565250604|FG002|Overall Study|Withdrawal by Subject|0|||
156592110|NCT00280150|565250605|FG003|Overall Study|Withdrawal by Subject|1|||
156592111|NCT00280150|565250602|FG000|Overall Study|Did not get consolidation therapy|3|||
156592112|NCT00280150|565250603|FG001|Overall Study|Did not get consolidation therapy|0|||
156592113|NCT00280150|565250604|FG002|Overall Study|Did not get consolidation therapy|3|||
156592114|NCT00280150|565250605|FG003|Overall Study|Did not get consolidation therapy|0|||
156592115|NCT00280150|565250602|FG000|Overall Study|Declining Performance Status|0|||
156592116|NCT00280150|565250603|FG001|Overall Study|Declining Performance Status|0|||
156592117|NCT00280150|565250604|FG002|Overall Study|Declining Performance Status|0|||
156592118|NCT00280150|565250605|FG003|Overall Study|Declining Performance Status|1|||
156592119|NCT02939937|565250612|FG000|Overall Study|Adverse Event|5|||
156592120|NCT02939937|565250613|FG001|Overall Study|Adverse Event|0|||
156592121|NCT02939937|565250612|FG000|Overall Study|Lost to Follow-up|1|||
156592122|NCT02939937|565250613|FG001|Overall Study|Lost to Follow-up|3|||
156592123|NCT00568958|565250615|FG000|Allocation|Withdrawal by Subject|7|||
156592124|NCT00568958|565250616|FG001|Allocation|Withdrawal by Subject|3|||
156592125|NCT00568958|565250615|FG000|Allocation|Physician Decision|2|||
156592126|NCT00568958|565250616|FG001|Allocation|Physician Decision|0|||
156592127|NCT00568958|565250615|FG000|Follow-Up|Withdrawal by Subject|6|||
156592128|NCT00568958|565250616|FG001|Follow-Up|Withdrawal by Subject|6|||
156592129|NCT00568958|565250615|FG000|Follow-Up|Physician Decision|1|||
156592130|NCT00568958|565250616|FG001|Follow-Up|Physician Decision|1|||
156592131|NCT00568958|565250615|FG000|Follow-Up|Family Emergency|1|||
156592132|NCT00568958|565250616|FG001|Follow-Up|Family Emergency|0|||
156592133|NCT00568958|565250615|FG000|Follow-Up|Adverse Event|1|||
156592134|NCT00568958|565250616|FG001|Follow-Up|Adverse Event|0|||
156592135|NCT05254613|565250628|FG000|Overall Study|Lost to Follow-up|0|||
156592136|NCT05254613|565250629|FG001|Overall Study|Lost to Follow-up|0|||
156592137|NCT05254613|565250630|FG002|Overall Study|Lost to Follow-up|1|||
156592138|NCT02387372|565250631|FG000|Overall Study|Not Treated|1|||
156592139|NCT02387372|565250632|FG001|Overall Study|Not Treated|0|||
156592140|NCT01911845|565250634|FG000|Overall Study|Adverse Event|2|||
156592141|NCT01911845|565250634|FG000|Overall Study|Lost to Follow-up|1|||
156592142|NCT01911845|565250634|FG000|Overall Study|Other (not specified)|3|||
156592143|NCT01576016|565250635|FG000|Lead Safety|Death|132|||
156592144|NCT01576016|565250636|FG001|Lead Safety|Death|0|||
156592145|NCT01576016|565250635|FG000|Lead Safety|Withdrawal by Subject|81|||
156592146|NCT01576016|565250636|FG001|Lead Safety|Withdrawal by Subject|0|||
156592147|NCT01576016|565250635|FG000|Lead Safety|System Explanted without Replacement|24|||
156592148|NCT01576016|565250636|FG001|Lead Safety|System Explanted without Replacement|0|||
156592149|NCT01576016|565250635|FG000|Lead Safety|Physician Decision|14|||
156592150|NCT01576016|565250636|FG001|Lead Safety|Physician Decision|0|||
156592151|NCT01576016|565250635|FG000|Lead Safety|Lost to Follow-up|13|||
156592152|NCT01576016|565250636|FG001|Lead Safety|Lost to Follow-up|0|||
156592153|NCT01576016|565250635|FG000|Lead Safety|Unsuccessful implant|2|||
156592154|NCT01576016|565250636|FG001|Lead Safety|Unsuccessful implant|0|||
156592155|NCT01576016|565250635|FG000|Lead Safety|Sponsor request|1|||
156592156|NCT01576016|565250636|FG001|Lead Safety|Sponsor request|0|||
156592157|NCT01576016|565250635|FG000|Lead Safety|Device replaced with CRT-D|1|||
156592158|NCT01576016|565250636|FG001|Lead Safety|Device replaced with CRT-D|0|||
156592159|NCT01576016|565250635|FG000|Lead Safety|Patient on Palliative Care|1|||
156592160|NCT01576016|565250636|FG001|Lead Safety|Patient on Palliative Care|0|||
156592161|NCT01576016|565250635|FG000|Lead Safety|Patient noncompliance|1|||
156592162|NCT01576016|565250636|FG001|Lead Safety|Patient noncompliance|0|||
156592163|NCT01576016|565250635|FG000|Lead Safety|Too far from study site|1|||
156592164|NCT01576016|565250636|FG001|Lead Safety|Too far from study site|0|||
156592165|NCT01576016|565250635|FG000|Lead Safety|System deactivated|1|||
156592166|NCT01576016|565250636|FG001|Lead Safety|System deactivated|0|||
156592167|NCT01576016|565250635|FG000|Lead Safety|Patient no longer followed by study PI|1|||
156592168|NCT01576016|565250636|FG001|Lead Safety|Patient no longer followed by study PI|0|||
156592169|NCT01576016|565250635|FG000|MRI Safety|Withdrawal by Subject|0|||
156592170|NCT01576016|565250636|FG001|MRI Safety|Withdrawal by Subject|10|||
156592171|NCT01576016|565250635|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
156592172|NCT01576016|565250636|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
156592173|NCT01576016|565250635|FG000|MRI Safety|Has not yet completed MRI scan|0|||
156592174|NCT01576016|565250636|FG001|MRI Safety|Has not yet completed MRI scan|56|||
156592175|NCT01576016|565250635|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
156592176|NCT01576016|565250636|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
156592177|NCT01774344|565250637|FG000|Overall Study|Withdrawal by Subject|3|||
156592178|NCT01774344|565250638|FG001|Overall Study|Withdrawal by Subject|10|||
156592179|NCT01774344|565250637|FG000|Overall Study|Protocol Violation|0|||
156592180|NCT01774344|565250638|FG001|Overall Study|Protocol Violation|1|||
156592181|NCT01774344|565250637|FG000|Overall Study|Lost to Follow-up|4|||
156592182|NCT01774344|565250638|FG001|Overall Study|Lost to Follow-up|10|||
156592183|NCT01774344|565250637|FG000|Overall Study|End of survival follow-up not available|2|||
156592184|NCT01774344|565250638|FG001|Overall Study|End of survival follow-up not available|2|||
156592185|NCT01774344|565250637|FG000|Overall Study|Data collection finished|4|||
156592186|NCT01774344|565250638|FG001|Overall Study|Data collection finished|14|||
156592187|NCT01774344|565250637|FG000|Overall Study|Other|0|||
156592188|NCT01774344|565250638|FG001|Overall Study|Other|1|||
156592189|NCT01774344|565250637|FG000|Overall Study|Did not enter Survival Follow up|49|||
156592190|NCT01774344|565250638|FG001|Overall Study|Did not enter Survival Follow up|83|||
156592191|NCT00436566|565250651|FG000|Overall Study|Withdrawal by Subject|2|||
156592192|NCT00436566|565250651|FG000|Overall Study|Protocol Violation|1|||
156592193|NCT04507867|565250652|FG000|Overall Study|Death|7|||
156592194|NCT04507867|565250653|FG001|Overall Study|Death|1|||
156592195|NCT01860534|565250656|FG000|ROP #1|Needed treatment for ROP|0|||
156592196|NCT01860534|565250657|FG001|ROP #1|Needed treatment for ROP|1|||
156592197|NCT01860534|565250656|FG000|ROP #2|discharged prior to ROP #2|1|||
156592198|NCT01860534|565250657|FG001|ROP #2|discharged prior to ROP #2|0|||
156592199|NCT00617409|565250663|FG000|Overall Study|Withdrawal by Subject|4|||
156592200|NCT00617409|565250664|FG001|Overall Study|Withdrawal by Subject|1|||
156592201|NCT00617409|565250665|FG002|Overall Study|Withdrawal by Subject|2|||
156592202|NCT00617409|565250663|FG000|Overall Study|Adverse Event|0|||
156592203|NCT00617409|565250664|FG001|Overall Study|Adverse Event|2|||
156592204|NCT00617409|565250665|FG002|Overall Study|Adverse Event|3|||
156592205|NCT00617409|565250663|FG000|Overall Study|Disease Progression|8|||
156592206|NCT00617409|565250664|FG001|Overall Study|Disease Progression|8|||
156592207|NCT00617409|565250665|FG002|Overall Study|Disease Progression|18|||
156592208|NCT00617409|565250663|FG000|Overall Study|Death|3|||
156592209|NCT00617409|565250664|FG001|Overall Study|Death|5|||
156592210|NCT00617409|565250665|FG002|Overall Study|Death|4|||
156592211|NCT00617409|565250663|FG000|Overall Study|Alternative Therapy|1|||
156592212|NCT00617409|565250664|FG001|Overall Study|Alternative Therapy|2|||
156592213|NCT00617409|565250665|FG002|Overall Study|Alternative Therapy|0|||
156592214|NCT02124707|565250666|FG000|Overall Study|Adverse Event|5|||
156592215|NCT02124707|565250666|FG000|Overall Study|Physician Decision|1|||
156592216|NCT02124707|565250666|FG000|Overall Study|Death|1|||
156592217|NCT03198754|565250675|FG000|Overall Study|Withdrawal by Subject|5|||
156592218|NCT03198754|565250676|FG001|Overall Study|Withdrawal by Subject|4|||
156592219|NCT03198754|565250675|FG000|Overall Study|Lost to Follow-up|4|||
156592220|NCT03198754|565250676|FG001|Overall Study|Lost to Follow-up|3|||
156592221|NCT03198754|565250675|FG000|Overall Study|Ineligible|2|||
156592222|NCT03198754|565250676|FG001|Overall Study|Ineligible|1|||
156592223|NCT03247413|565250682|FG000|Overall Study|Lost to Follow-up|28|||
156592224|NCT00668200|565250683|FG000|Overall Study|Withdrawal by Subject|2|||
156592225|NCT00668200|565250683|FG000|Overall Study|Lost to Follow-up|1|||
156592226|NCT01496430|565250687|FG000|Overall Study|Adverse Event|0|||
156592227|NCT01496430|565250688|FG001|Overall Study|Adverse Event|0|||
156592228|NCT01496430|565250689|FG002|Overall Study|Adverse Event|1|||
156592229|NCT01496430|565250687|FG000|Overall Study|Major Protocol Deviation|0|||
156592230|NCT01496430|565250688|FG001|Overall Study|Major Protocol Deviation|0|||
156592231|NCT01496430|565250689|FG002|Overall Study|Major Protocol Deviation|1|||
156592232|NCT01496430|565250687|FG000|Overall Study|Lost to Follow-up|2|||
156592233|NCT01496430|565250688|FG001|Overall Study|Lost to Follow-up|3|||
156592234|NCT01496430|565250689|FG002|Overall Study|Lost to Follow-up|1|||
156592235|NCT01496430|565250687|FG000|Overall Study|Voluntary Withdrawal|2|||
156592236|NCT01496430|565250688|FG001|Overall Study|Voluntary Withdrawal|1|||
156592237|NCT01496430|565250689|FG002|Overall Study|Voluntary Withdrawal|6|||
156592238|NCT01496430|565250687|FG000|Overall Study|Principal Investigator Discretion|0|||
156592239|NCT01496430|565250688|FG001|Overall Study|Principal Investigator Discretion|1|||
156592240|NCT01496430|565250689|FG002|Overall Study|Principal Investigator Discretion|1|||
156592241|NCT01496430|565250687|FG000|Overall Study|Other|2|||
156592242|NCT01496430|565250688|FG001|Overall Study|Other|0|||
156592243|NCT01496430|565250689|FG002|Overall Study|Other|0|||
156592244|NCT02196038|565250692|FG000|Overall Study|Death|16|||
156592245|NCT02196038|565250693|FG001|Overall Study|Death|21|||
156592246|NCT02196038|565250692|FG000|Overall Study|Withdrawal by Subject|0|||
156592247|NCT02196038|565250693|FG001|Overall Study|Withdrawal by Subject|1|||
156592248|NCT02196038|565250692|FG000|Overall Study|Lost to Follow-up|1|||
156592249|NCT02196038|565250693|FG001|Overall Study|Lost to Follow-up|0|||
156592250|NCT01151579|565250705|FG000|Overall Study|Physician Decision|3|||
156592251|NCT01151579|565250706|FG001|Overall Study|Physician Decision|1|||
156592252|NCT01151579|565250705|FG000|Overall Study|Withdrawal by Subject|3|||
156592253|NCT01151579|565250706|FG001|Overall Study|Withdrawal by Subject|2|||
156592254|NCT01151579|565250705|FG000|Overall Study|Not meet inclusion criteria|6|||
156592255|NCT01151579|565250706|FG001|Overall Study|Not meet inclusion criteria|4|||
156592256|NCT00369668|565250715|FG000|Overall Study|Lack of Efficacy|4|||
156592257|NCT00369668|565250716|FG001|Overall Study|Lack of Efficacy|5|||
156592258|NCT00369668|565250717|FG002|Overall Study|Lack of Efficacy|7|||
156592259|NCT03855137|565250718|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
156592260|NCT03855137|565250719|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
156592261|NCT03855137|565250720|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
156592262|NCT03855137|565250718|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
156592263|NCT03855137|565250719|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
156592264|NCT03855137|565250720|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
156592265|NCT03855137|565250718|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
156592266|NCT03855137|565250719|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
156592267|NCT03855137|565250720|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
156592268|NCT03855137|565250718|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
156592269|NCT03855137|565250719|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
156592270|NCT03855137|565250720|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
156592271|NCT03855137|565250718|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
156592272|NCT03855137|565250719|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
156592273|NCT03855137|565250720|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
156592274|NCT03855137|565250718|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
156592275|NCT03855137|565250719|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
156592276|NCT03855137|565250720|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
156592277|NCT03855137|565250718|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
156592278|NCT03855137|565250719|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
156592279|NCT03855137|565250720|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
156592280|NCT03855137|565250718|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
156592281|NCT03855137|565250719|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
156592282|NCT03855137|565250720|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
156592283|NCT03855137|565250718|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
156592284|NCT03855137|565250719|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
156592285|NCT03855137|565250720|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
156592286|NCT03855137|565250718|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
156592287|NCT03855137|565250719|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
156592288|NCT03855137|565250720|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
156592289|NCT03213626|565250721|FG000|Overall Study|Adverse Event|1|||
156592290|NCT03213626|565250721|FG000|Overall Study|Progressive Disease|6|||
156592291|NCT01005732|565250722|FG000|Overall Study|Lost to Follow-up|10|||
156592292|NCT01005732|565250722|FG000|Overall Study|Death|1|||
156592293|NCT01552928|565250723|FG000|Period 3|Adverse Event|0|||
156592294|NCT01552928|565250724|FG001|Period 3|Adverse Event|0|||
156592295|NCT01552928|565250725|FG002|Period 3|Adverse Event|1|||
156592296|NCT01552928|565250726|FG003|Period 3|Adverse Event|0|||
156592297|NCT00488618|565250730|FG000|Overall Study|Adverse Event|13|||
156592298|NCT00488618|565250731|FG001|Overall Study|Adverse Event|17|||
156592299|NCT00488618|565250730|FG000|Overall Study|Insufficient Therapeutic Response|18|||
156592300|NCT00488618|565250731|FG001|Overall Study|Insufficient Therapeutic Response|11|||
156592301|NCT00488618|565250730|FG000|Overall Study|Protocol Violation|0|||
156592302|NCT00488618|565250731|FG001|Overall Study|Protocol Violation|2|||
156592303|NCT00488618|565250730|FG000|Overall Study|Withdrawal of Consent|15|||
156863662|NCT00374140|566258742|FG000|Overall Study|Lost to Follow-up|1|||
156592304|NCT00488618|565250731|FG001|Overall Study|Withdrawal of Consent|13|||
156592305|NCT00488618|565250730|FG000|Overall Study|Lost to Follow-up|1|||
156592306|NCT00488618|565250731|FG001|Overall Study|Lost to Follow-up|0|||
156592307|NCT00992446|565250732|FG000|Overall Study|Disease Progression|1|||
156592308|NCT00992446|565250732|FG000|Overall Study|Withdrawal by Subject|2|||
156592309|NCT00992446|565250732|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
156592310|NCT02625324|565252883|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
156592311|NCT02625324|565252883|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
156592312|NCT02625324|565252883|FG000|6-Month Follow-up Subject Accountability|Death|5|||
156592313|NCT02625324|565252883|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
156592314|NCT02625324|565252883|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
156592315|NCT02625324|565252883|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
156592316|NCT02625324|565252883|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
156592317|NCT02625324|565252883|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
156592318|NCT02625324|565252883|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
156592319|NCT02625324|565252883|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
156592320|NCT02625324|565252883|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
156592321|NCT02625324|565252883|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
156592322|NCT02625324|565252883|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
156592323|NCT02625324|565252883|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
156592324|NCT02625324|565252883|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
156592325|NCT02625324|565252883|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
156592326|NCT02625324|565252883|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
156592327|NCT00789191|565252884|FG000|Overall Study|Adverse Event|2|||
156592328|NCT00789191|565252885|FG001|Overall Study|Adverse Event|4|||
156592329|NCT00789191|565252884|FG000|Overall Study|Lack of Efficacy|0|||
156592330|NCT00789191|565252885|FG001|Overall Study|Lack of Efficacy|5|||
156592331|NCT00789191|565252884|FG000|Overall Study|Protocol Violation|5|||
156592332|NCT00789191|565252885|FG001|Overall Study|Protocol Violation|3|||
156592333|NCT00789191|565252884|FG000|Overall Study|Withdrawal Criteria|2|||
156592334|NCT00789191|565252885|FG001|Overall Study|Withdrawal Criteria|4|||
156592335|NCT00789191|565252884|FG000|Overall Study|Unclassified|5|||
156592336|NCT00789191|565252885|FG001|Overall Study|Unclassified|3|||
156592337|NCT03497429|565252887|FG000|Overall Study|Progressive disease|3|||
156592338|NCT03497429|565252888|FG001|Overall Study|Progressive disease|4|||
156592339|NCT03497429|565252887|FG000|Overall Study|Adverse Event|0|||
156592340|NCT03497429|565252888|FG001|Overall Study|Adverse Event|2|||
156592341|NCT00605722|565252892|FG000|Overall Study|Adverse Event|6|||
156592342|NCT00605722|565252892|FG000|Overall Study|Insufficient therapeutic response|44|||
156592343|NCT00605722|565252892|FG000|Overall Study|Failure to return|1|||
156592344|NCT00356863|565252895|FG000|Overall Study|Death|16|||
156592345|NCT00356863|565252896|FG001|Overall Study|Death|32|||
156592346|NCT00356863|565252895|FG000|Overall Study|Lost to Follow-up|76|||
156592347|NCT00356863|565252896|FG001|Overall Study|Lost to Follow-up|43|||
156592348|NCT00836277|565252897|FG000|Overall Study|Not evaluable for response|6|||
156592349|NCT02871401|565252899|FG000|Overall Study|Adverse Event|1|||
156592350|NCT02871401|565252900|FG001|Overall Study|Adverse Event|0|||
156592351|NCT03162055|565252901|FG000|Overall Study|Adverse Event|6|||
156592352|NCT03162055|565252902|FG001|Overall Study|Adverse Event|5|||
156592353|NCT03162055|565252901|FG000|Overall Study|Death|3|||
156592354|NCT03162055|565252902|FG001|Overall Study|Death|3|||
156592355|NCT03162055|565252901|FG000|Overall Study|Lost to Follow-up|0|||
156592356|NCT03162055|565252902|FG001|Overall Study|Lost to Follow-up|1|||
156592357|NCT03162055|565252901|FG000|Overall Study|Study-specific withdrawal criteria|22|||
156592358|NCT03162055|565252902|FG001|Overall Study|Study-specific withdrawal criteria|14|||
156592359|NCT03162055|565252901|FG000|Overall Study|Withdrawal by Subject|17|||
156592360|NCT03162055|565252902|FG001|Overall Study|Withdrawal by Subject|2|||
156592361|NCT03162055|565252901|FG000|Overall Study|Did not receive treatment|2|||
156592362|NCT03162055|565252902|FG001|Overall Study|Did not receive treatment|0|||
156592363|NCT03162055|565252901|FG000|Overall Study|Incorrect randomization|4|||
156592364|NCT03162055|565252902|FG001|Overall Study|Incorrect randomization|3|||
156592365|NCT03162055|565252901|FG000|Overall Study|Other|8|||
156592366|NCT03162055|565252902|FG001|Overall Study|Other|15|||
156592367|NCT04031404|565252903|FG000|Baseline|Lost to Follow-up|0|||
156592368|NCT04031404|565252904|FG001|Baseline|Lost to Follow-up|1|||
156592369|NCT04031404|565252903|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
156592370|NCT04031404|565252904|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
156592371|NCT04031404|565252903|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
156592372|NCT04031404|565252904|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
156592373|NCT04031404|565252903|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
156592374|NCT04031404|565252904|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
156592375|NCT04031404|565252903|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
156592376|NCT04031404|565252904|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
156592377|NCT01993615|565252908|FG000|Overall Study|Death|1|||
156592378|NCT01993615|565252909|FG001|Overall Study|Death|0|||
156592379|NCT02282982|565252915|FG000|Overall Study|Lost to Follow-up|15|||
156592380|NCT02282982|565252915|FG000|Overall Study|Withdrew consent|2|||
156592381|NCT02282982|565252915|FG000|Overall Study|Death|4|||
156592382|NCT02282982|565252915|FG000|Overall Study|Lack of product|156|||
156592383|NCT02282982|565252915|FG000|Overall Study|Palivizumab is ended|11|||
156592384|NCT02282982|565252915|FG000|Overall Study|Other, not specified|18|||
156592385|NCT01354353|565252916|FG000|Overall Study|Adverse Event|1|||
156592386|NCT01354353|565252917|FG001|Overall Study|Adverse Event|0|||
156592387|NCT01354353|565252918|FG002|Overall Study|Adverse Event|0|||
156592388|NCT01354353|565252919|FG003|Overall Study|Adverse Event|4|||
156592389|NCT01354353|565252920|FG004|Overall Study|Adverse Event|0|||
156592390|NCT01354353|565252921|FG005|Overall Study|Adverse Event|5|||
156592391|NCT01354353|565252916|FG000|Overall Study|Entry Criteria Not Met|0|||
156592392|NCT01354353|565252917|FG001|Overall Study|Entry Criteria Not Met|0|||
156592393|NCT01354353|565252918|FG002|Overall Study|Entry Criteria Not Met|0|||
156592394|NCT01354353|565252919|FG003|Overall Study|Entry Criteria Not Met|1|||
156592395|NCT01354353|565252920|FG004|Overall Study|Entry Criteria Not Met|1|||
156592396|NCT01354353|565252921|FG005|Overall Study|Entry Criteria Not Met|0|||
156592397|NCT01354353|565252916|FG000|Overall Study|Physician Decision|0|||
156592398|NCT01354353|565252917|FG001|Overall Study|Physician Decision|1|||
156592399|NCT01354353|565252918|FG002|Overall Study|Physician Decision|1|||
156592400|NCT01354353|565252919|FG003|Overall Study|Physician Decision|0|||
156592401|NCT01354353|565252920|FG004|Overall Study|Physician Decision|0|||
156592402|NCT01354353|565252921|FG005|Overall Study|Physician Decision|0|||
156592403|NCT01354353|565252916|FG000|Overall Study|Withdrawal by Subject|2|||
156592404|NCT01354353|565252917|FG001|Overall Study|Withdrawal by Subject|0|||
156592405|NCT01354353|565252918|FG002|Overall Study|Withdrawal by Subject|1|||
156592406|NCT01354353|565252919|FG003|Overall Study|Withdrawal by Subject|0|||
156592407|NCT01354353|565252920|FG004|Overall Study|Withdrawal by Subject|0|||
156592408|NCT01354353|565252921|FG005|Overall Study|Withdrawal by Subject|1|||
156592409|NCT00502320|565252922|FG000|Overall Study|Lost to Follow-up|1|||
156592410|NCT00502320|565252923|FG001|Overall Study|Lost to Follow-up|1|||
156592411|NCT00502320|565252922|FG000|Overall Study|Withdrew Consent|1|||
156592412|NCT00502320|565252923|FG001|Overall Study|Withdrew Consent|0|||
156592413|NCT00502320|565252922|FG000|Overall Study|No longer met criteria|1|||
156592414|NCT00502320|565252923|FG001|Overall Study|No longer met criteria|0|||
156592415|NCT00502320|565252922|FG000|Overall Study|Screen Failure|0|||
156592416|NCT00502320|565252923|FG001|Overall Study|Screen Failure|1|||
156592417|NCT00502320|565252922|FG000|Overall Study|Adverse Event|3|||
156592418|NCT00502320|565252923|FG001|Overall Study|Adverse Event|5|||
156592419|NCT01098461|565252931|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
156592420|NCT01098461|565252932|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
156592421|NCT01098461|565252933|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
156592422|NCT01098461|565252934|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
156592423|NCT01098461|565252931|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
156592424|NCT01098461|565252932|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
156592425|NCT01098461|565252933|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
156592426|NCT01098461|565252934|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
156592427|NCT01098461|565252931|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
156592428|NCT01098461|565252932|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
156592429|NCT01098461|565252933|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
156592430|NCT01098461|565252934|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
156592431|NCT01098461|565252931|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
156592432|NCT01098461|565252932|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
156592433|NCT01098461|565252933|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
156592434|NCT01098461|565252934|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
156592435|NCT01098461|565252931|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
156592436|NCT01098461|565252932|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
156592437|NCT01098461|565252933|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
156592438|NCT01098461|565252934|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
156592439|NCT01098461|565252931|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
156592440|NCT01098461|565252932|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
156592441|NCT01098461|565252933|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
156592442|NCT01098461|565252934|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
156592443|NCT01098461|565252931|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
156592444|NCT01098461|565252932|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
156592445|NCT01098461|565252933|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
156592446|NCT01098461|565252934|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
156592447|NCT02662985|565252935|FG000|Treatment Period 1|Adverse Event|0|||
156592448|NCT02662985|565252936|FG001|Treatment Period 1|Adverse Event|2|||
156592449|NCT02662985|565252935|FG000|Treatment Period 1|Protocol Violation|0|||
156863663|NCT00374140|566258742|FG000|Overall Study|Protocol Violation|1|||
156592450|NCT02662985|565252936|FG001|Treatment Period 1|Protocol Violation|1|||
156592451|NCT02662985|565252935|FG000|Treatment Period 1|Physician Decision|1|||
156592452|NCT02662985|565252936|FG001|Treatment Period 1|Physician Decision|0|||
156592453|NCT02662985|565252935|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156592454|NCT02662985|565252936|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156592455|NCT02662985|565252935|FG000|Treatment Period 2|Lack of Efficacy|0|||
156592456|NCT02662985|565252936|FG001|Treatment Period 2|Lack of Efficacy|1|||
156592457|NCT02662985|565252935|FG000|Treatment Period 2|Lost to Follow-up|1|||
156592458|NCT02662985|565252936|FG001|Treatment Period 2|Lost to Follow-up|0|||
156592459|NCT02662985|565252935|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
156592460|NCT02662985|565252936|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
156592461|NCT02662985|565252935|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
156592462|NCT02662985|565252936|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
156592463|NCT02662985|565252935|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
156592464|NCT02662985|565252936|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
156592465|NCT02662985|565252935|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
156592466|NCT02662985|565252936|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
156592467|NCT02662985|565252935|FG000|Treatment Period 3 (Extension Period)|Death|0|||
156592468|NCT02662985|565252936|FG001|Treatment Period 3 (Extension Period)|Death|1|||
156592469|NCT05373706|565252941|FG000|Overall Study|Lost to Follow-up|2|||
156592470|NCT05373706|565252942|FG001|Overall Study|Lost to Follow-up|2|||
156592471|NCT01486784|565252943|FG000|Overall Study|Withdrawal by Subject|0|||
156592472|NCT01486784|565252944|FG001|Overall Study|Withdrawal by Subject|0|||
156592473|NCT01486784|565252945|FG002|Overall Study|Withdrawal by Subject|1|||
156592474|NCT01486784|565252946|FG003|Overall Study|Withdrawal by Subject|0|||
156592475|NCT01486784|565252947|FG004|Overall Study|Withdrawal by Subject|1|||
156592476|NCT01486784|565252948|FG005|Overall Study|Withdrawal by Subject|2|||
156592477|NCT01486784|565252943|FG000|Overall Study|Subject did not meet entry criteria|0|||
156592478|NCT01486784|565252944|FG001|Overall Study|Subject did not meet entry criteria|0|||
156592479|NCT01486784|565252945|FG002|Overall Study|Subject did not meet entry criteria|0|||
156592480|NCT01486784|565252946|FG003|Overall Study|Subject did not meet entry criteria|0|||
156592481|NCT01486784|565252947|FG004|Overall Study|Subject did not meet entry criteria|1|||
156592482|NCT01486784|565252948|FG005|Overall Study|Subject did not meet entry criteria|0|||
156592483|NCT01486784|565252943|FG000|Overall Study|Death|0|||
156592484|NCT01486784|565252944|FG001|Overall Study|Death|0|||
156592485|NCT01486784|565252945|FG002|Overall Study|Death|0|||
156592486|NCT01486784|565252946|FG003|Overall Study|Death|0|||
156592487|NCT01486784|565252947|FG004|Overall Study|Death|0|||
156592488|NCT01486784|565252948|FG005|Overall Study|Death|1|||
156592489|NCT03491553|565252949|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
156592490|NCT03491553|565252950|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
156592491|NCT03491553|565252951|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
156592492|NCT03491553|565252952|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
156592493|NCT03491553|565252953|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
156592494|NCT03491553|565252954|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
156592495|NCT03491553|565252949|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
156592496|NCT03491553|565252950|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
156592497|NCT03491553|565252951|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
156592498|NCT03491553|565252952|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
156592499|NCT03491553|565252953|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
156592500|NCT03491553|565252954|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
156592501|NCT03633227|565252955|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
156592502|NCT03633227|565252956|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
156592503|NCT03633227|565252955|FG000|Double Blind (DB), up to Week 48|Death|2|||
156592504|NCT03633227|565252956|FG001|Double Blind (DB), up to Week 48|Death|1|||
156592505|NCT03633227|565252955|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
156592506|NCT03633227|565252956|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
156592507|NCT03633227|565252955|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
156592508|NCT03633227|565252956|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
156592509|NCT03633227|565252955|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
156592510|NCT03633227|565252956|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
156592511|NCT03633227|565252955|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
156592512|NCT03633227|565252956|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
156592513|NCT03633227|565252955|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
156592514|NCT03633227|565252956|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
156592515|NCT03633227|565252955|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
156592516|NCT03633227|565252956|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
156592517|NCT03633227|565252955|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
156592518|NCT03633227|565252956|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
156592519|NCT03633227|565252955|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
156592520|NCT03633227|565252956|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
156592521|NCT03633227|565252955|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
156592522|NCT03633227|565252956|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
156592523|NCT03633227|565252955|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
156592524|NCT03633227|565252956|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
156592525|NCT01479374|565252963|FG000|Overall Study|Adverse Event|2|||
156592526|NCT01479374|565252964|FG001|Overall Study|Adverse Event|1|||
156592527|NCT01479374|565252965|FG002|Overall Study|Adverse Event|0|||
156592528|NCT01479374|565252963|FG000|Overall Study|Lost to Follow-up|1|||
156592529|NCT01479374|565252964|FG001|Overall Study|Lost to Follow-up|2|||
156592530|NCT01479374|565252965|FG002|Overall Study|Lost to Follow-up|0|||
156592531|NCT01479374|565252963|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
156592532|NCT01479374|565252964|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
156592533|NCT01479374|565252965|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
156592534|NCT01479374|565252963|FG000|Overall Study|Other|0|||
156592535|NCT01479374|565252964|FG001|Overall Study|Other|4|||
156592536|NCT01479374|565252965|FG002|Overall Study|Other|5|||
156592537|NCT01606761|565252967|FG000|Prior to Week 24|Lost to Follow-up|0|||
156592538|NCT01606761|565252968|FG001|Prior to Week 24|Lost to Follow-up|3|||
156592539|NCT01606761|565252969|FG002|Prior to Week 24|Lost to Follow-up|2|||
156592540|NCT01606761|565252970|FG003|Prior to Week 24|Lost to Follow-up|0|||
156592541|NCT01606761|565252971|FG004|Prior to Week 24|Lost to Follow-up|0|||
156592542|NCT01606761|565252967|FG000|Prior to Week 24|Withdrawal by Subject|12|||
156592543|NCT01606761|565252968|FG001|Prior to Week 24|Withdrawal by Subject|10|||
156592544|NCT01606761|565252969|FG002|Prior to Week 24|Withdrawal by Subject|9|||
156592545|NCT01606761|565252970|FG003|Prior to Week 24|Withdrawal by Subject|0|||
156592546|NCT01606761|565252971|FG004|Prior to Week 24|Withdrawal by Subject|0|||
156592547|NCT01606761|565252967|FG000|Prior to Week 24|Adverse Event|11|||
156592548|NCT01606761|565252968|FG001|Prior to Week 24|Adverse Event|18|||
156592549|NCT01606761|565252969|FG002|Prior to Week 24|Adverse Event|22|||
156592550|NCT01606761|565252970|FG003|Prior to Week 24|Adverse Event|0|||
156592551|NCT01606761|565252971|FG004|Prior to Week 24|Adverse Event|0|||
156592552|NCT01606761|565252967|FG000|Prior to Week 24|Lack of Efficacy|15|||
156592553|NCT01606761|565252968|FG001|Prior to Week 24|Lack of Efficacy|14|||
156592554|NCT01606761|565252969|FG002|Prior to Week 24|Lack of Efficacy|8|||
156592555|NCT01606761|565252970|FG003|Prior to Week 24|Lack of Efficacy|0|||
156592556|NCT01606761|565252971|FG004|Prior to Week 24|Lack of Efficacy|0|||
156592557|NCT01606761|565252967|FG000|Prior to Week 24|Physician Decision|0|||
156592558|NCT01606761|565252968|FG001|Prior to Week 24|Physician Decision|3|||
156592559|NCT01606761|565252969|FG002|Prior to Week 24|Physician Decision|1|||
156592560|NCT01606761|565252970|FG003|Prior to Week 24|Physician Decision|0|||
156592561|NCT01606761|565252971|FG004|Prior to Week 24|Physician Decision|0|||
156592562|NCT01606761|565252967|FG000|Prior to Week 24|Other|4|||
156592563|NCT01606761|565252968|FG001|Prior to Week 24|Other|7|||
156592564|NCT01606761|565252969|FG002|Prior to Week 24|Other|5|||
156592565|NCT01606761|565252970|FG003|Prior to Week 24|Other|0|||
156592566|NCT01606761|565252971|FG004|Prior to Week 24|Other|0|||
156592567|NCT01606761|565252967|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
156592568|NCT01606761|565252968|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
156592569|NCT01606761|565252969|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
156592570|NCT01606761|565252970|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
156592571|NCT01606761|565252971|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
156592572|NCT01606761|565252967|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
156592573|NCT01606761|565252968|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
156592574|NCT01606761|565252969|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
156592575|NCT01606761|565252970|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
156592576|NCT01606761|565252971|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
156592577|NCT01606761|565252967|FG000|Week 24 to Week 52|Adverse Event|0|||
156592578|NCT01606761|565252968|FG001|Week 24 to Week 52|Adverse Event|11|||
156592579|NCT01606761|565252969|FG002|Week 24 to Week 52|Adverse Event|14|||
156592580|NCT01606761|565252970|FG003|Week 24 to Week 52|Adverse Event|3|||
156592581|NCT01606761|565252971|FG004|Week 24 to Week 52|Adverse Event|15|||
156592582|NCT01606761|565252967|FG000|Week 24 to Week 52|Death|0|||
156592583|NCT01606761|565252968|FG001|Week 24 to Week 52|Death|0|||
156592584|NCT01606761|565252969|FG002|Week 24 to Week 52|Death|2|||
156592585|NCT01606761|565252970|FG003|Week 24 to Week 52|Death|1|||
156592586|NCT01606761|565252971|FG004|Week 24 to Week 52|Death|0|||
156592587|NCT01606761|565252967|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
156592588|NCT01606761|565252968|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
156592589|NCT01606761|565252969|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
156592590|NCT01606761|565252970|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
156592591|NCT01606761|565252971|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
156592592|NCT01606761|565252967|FG000|Week 24 to Week 52|Physician Decision|0|||
156592593|NCT01606761|565252968|FG001|Week 24 to Week 52|Physician Decision|1|||
156592594|NCT01606761|565252969|FG002|Week 24 to Week 52|Physician Decision|1|||
156592595|NCT01606761|565252970|FG003|Week 24 to Week 52|Physician Decision|0|||
156592596|NCT01606761|565252971|FG004|Week 24 to Week 52|Physician Decision|0|||
156863664|NCT02651675|566258743|FG000|Overall Study|Death|0|||
156592597|NCT01606761|565252967|FG000|Week 24 to Week 52|Other|0|||
156592598|NCT01606761|565252968|FG001|Week 24 to Week 52|Other|1|||
156592599|NCT01606761|565252969|FG002|Week 24 to Week 52|Other|5|||
156592600|NCT01606761|565252970|FG003|Week 24 to Week 52|Other|2|||
156592601|NCT01606761|565252971|FG004|Week 24 to Week 52|Other|2|||
156592602|NCT01606761|565252967|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
156592603|NCT01606761|565252968|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
156592604|NCT01606761|565252969|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
156592605|NCT01606761|565252970|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
156592606|NCT01606761|565252971|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
156592607|NCT01606761|565252967|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
156592608|NCT01606761|565252968|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
156592609|NCT01606761|565252969|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
156592610|NCT01606761|565252970|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
156592611|NCT01606761|565252971|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
156592612|NCT01606761|565252967|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
156592613|NCT01606761|565252968|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
156592614|NCT01606761|565252969|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
156592615|NCT01606761|565252970|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
156592616|NCT01606761|565252971|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
156592617|NCT01606761|565252967|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
156592618|NCT01606761|565252968|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
156592619|NCT01606761|565252969|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
156592620|NCT01606761|565252970|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
156592621|NCT01606761|565252971|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
156592622|NCT05086289|565252972|FG000|Overall Study|Adverse Event|4|||
156592623|NCT05086289|565252973|FG001|Overall Study|Adverse Event|2|||
156592624|NCT05086289|565252972|FG000|Overall Study|Lost to Follow-up|2|||
156592625|NCT05086289|565252973|FG001|Overall Study|Lost to Follow-up|0|||
156592626|NCT05086289|565252972|FG000|Overall Study|Non-compliance with study drug|2|||
156592627|NCT05086289|565252973|FG001|Overall Study|Non-compliance with study drug|1|||
156592628|NCT05086289|565252972|FG000|Overall Study|Physician Decision|2|||
156592629|NCT05086289|565252973|FG001|Overall Study|Physician Decision|0|||
156592630|NCT05086289|565252972|FG000|Overall Study|Withdrawal by Subject|5|||
156592631|NCT05086289|565252973|FG001|Overall Study|Withdrawal by Subject|2|||
156592632|NCT01996748|565252979|FG000|Overall Study|Personal reason|1|||
156592633|NCT01996748|565252980|FG001|Overall Study|Personal reason|0|||
156592634|NCT01996748|565252979|FG000|Overall Study|Physician Decision|2|||
156592635|NCT01996748|565252980|FG001|Overall Study|Physician Decision|0|||
156592636|NCT01996748|565252979|FG000|Overall Study|Adverse Event|1|||
156592637|NCT01996748|565252980|FG001|Overall Study|Adverse Event|4|||
156592638|NCT01996748|565252979|FG000|Overall Study|Withdrawal by Subject|0|||
156592639|NCT01996748|565252980|FG001|Overall Study|Withdrawal by Subject|1|||
156592640|NCT01996748|565252979|FG000|Overall Study|Lost to Follow-up|4|||
156592641|NCT01996748|565252980|FG001|Overall Study|Lost to Follow-up|1|||
156592642|NCT03628508|565252981|FG000|Overall Study|Lost to Follow-up|1|||
156592643|NCT00515008|565252982|FG000|Overall Study|Lost to Follow-up|1|||
156592644|NCT00515008|565252983|FG001|Overall Study|Lost to Follow-up|0|||
156592645|NCT00515008|565252982|FG000|Overall Study|Declined|0|||
156592646|NCT00515008|565252983|FG001|Overall Study|Declined|3|||
156592647|NCT00515008|565252982|FG000|Overall Study|Left the Boston Area|1|||
156592648|NCT00515008|565252983|FG001|Overall Study|Left the Boston Area|1|||
156592649|NCT00515008|565252982|FG000|Overall Study|Scheduling conflict|1|||
156592650|NCT00515008|565252983|FG001|Overall Study|Scheduling conflict|0|||
156592651|NCT03238235|565252984|FG000|Overall Study|Adverse Event|2|||
156592652|NCT03238235|565252985|FG001|Overall Study|Adverse Event|0|||
156592653|NCT03238235|565252984|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
156592654|NCT03238235|565252985|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
156592655|NCT00243230|565252990|FG000|Double-Blind Period|Adverse Event|0|||
156592656|NCT00243230|565252991|FG001|Double-Blind Period|Adverse Event|2|||
156592657|NCT00243230|565252992|FG002|Double-Blind Period|Adverse Event|2|||
156592658|NCT00243230|565252993|FG003|Double-Blind Period|Adverse Event|0|||
156592659|NCT00243230|565252990|FG000|Double-Blind Period|Withdrawal by Subject|1|||
156592660|NCT00243230|565252991|FG001|Double-Blind Period|Withdrawal by Subject|0|||
156592661|NCT00243230|565252992|FG002|Double-Blind Period|Withdrawal by Subject|0|||
156592662|NCT00243230|565252993|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156592663|NCT00243230|565252990|FG000|Double-Blind Period|Protocol Violation|0|||
156592664|NCT00243230|565252991|FG001|Double-Blind Period|Protocol Violation|0|||
156592665|NCT00243230|565252992|FG002|Double-Blind Period|Protocol Violation|1|||
156592666|NCT00243230|565252993|FG003|Double-Blind Period|Protocol Violation|0|||
156592667|NCT00243230|565252990|FG000|Double-Blind Period|Randomized but Not Treated|0|||
156592668|NCT00243230|565252991|FG001|Double-Blind Period|Randomized but Not Treated|0|||
156592669|NCT00243230|565252992|FG002|Double-Blind Period|Randomized but Not Treated|2|||
156592670|NCT00243230|565252993|FG003|Double-Blind Period|Randomized but Not Treated|0|||
156592671|NCT00243230|565252990|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
156592672|NCT00243230|565252991|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
156592673|NCT00243230|565252992|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
156592674|NCT00243230|565252993|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
156592675|NCT00243230|565252990|FG000|Open Label Period|Adverse Event|0|||
156592676|NCT00243230|565252991|FG001|Open Label Period|Adverse Event|0|||
156592677|NCT00243230|565252992|FG002|Open Label Period|Adverse Event|0|||
156592678|NCT00243230|565252993|FG003|Open Label Period|Adverse Event|2|||
156592679|NCT00243230|565252990|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
156592680|NCT00243230|565252991|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
156592681|NCT00243230|565252992|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
156592682|NCT00243230|565252993|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
156592683|NCT00243230|565252990|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
156592684|NCT00243230|565252991|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
156592685|NCT00243230|565252992|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
156592686|NCT00243230|565252993|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
156592687|NCT00243230|565252990|FG000|Open Label Period|Lost to Follow-up|0|||
156592688|NCT00243230|565252991|FG001|Open Label Period|Lost to Follow-up|0|||
156592689|NCT00243230|565252992|FG002|Open Label Period|Lost to Follow-up|0|||
156592690|NCT00243230|565252993|FG003|Open Label Period|Lost to Follow-up|2|||
156592691|NCT00243230|565252990|FG000|Open Label Period|Withdrawal by Subject|0|||
156592692|NCT00243230|565252991|FG001|Open Label Period|Withdrawal by Subject|0|||
156592693|NCT00243230|565252992|FG002|Open Label Period|Withdrawal by Subject|0|||
156592694|NCT00243230|565252993|FG003|Open Label Period|Withdrawal by Subject|2|||
156592695|NCT00243230|565252990|FG000|Open Label Period|Protocol Violation|0|||
156592696|NCT00243230|565252991|FG001|Open Label Period|Protocol Violation|0|||
156592697|NCT00243230|565252992|FG002|Open Label Period|Protocol Violation|0|||
156592698|NCT00243230|565252993|FG003|Open Label Period|Protocol Violation|2|||
156592699|NCT00243230|565252990|FG000|Open Label Period|Administrative Reason|0|||
156592700|NCT00243230|565252991|FG001|Open Label Period|Administrative Reason|0|||
156592701|NCT00243230|565252992|FG002|Open Label Period|Administrative Reason|0|||
156592702|NCT00243230|565252993|FG003|Open Label Period|Administrative Reason|63|||
156592703|NCT03011840|565252995|FG000|Overall Study|Not received PIL in post PIL phase|0|||
156592704|NCT03011840|565252996|FG001|Overall Study|Not received PIL in post PIL phase|21|||
156592705|NCT03201198|565253002|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
156592706|NCT03201198|565253003|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
156592707|NCT03201198|565253002|FG000|Overall Study|Withdrawal by Subject|2|||
156592708|NCT03201198|565253003|FG001|Overall Study|Withdrawal by Subject|3|||
156592709|NCT00471445|565253004|FG000|Overall Study|Withdrawal by Subject|1|||
156592710|NCT00471445|565253005|FG001|Overall Study|Withdrawal by Subject|1|||
156592711|NCT00471445|565253004|FG000|Overall Study|Ineligible|1|||
156592712|NCT00471445|565253005|FG001|Overall Study|Ineligible|0|||
156592713|NCT00471445|565253004|FG000|Overall Study|Protocol Violation|0|||
156592714|NCT00471445|565253005|FG001|Overall Study|Protocol Violation|1|||
156592715|NCT04715230|565253011|FG000|Overall Study|Withdrawal by Subject|1|||
156592716|NCT04715230|565253012|FG001|Overall Study|Withdrawal by Subject|0|||
156592717|NCT04715230|565253013|FG002|Overall Study|Withdrawal by Subject|0|||
156592718|NCT04715230|565253011|FG000|Overall Study|Lost to Follow-up|0|||
156592719|NCT04715230|565253012|FG001|Overall Study|Lost to Follow-up|5|||
156592720|NCT04715230|565253013|FG002|Overall Study|Lost to Follow-up|1|||
156592721|NCT02596711|565253020|FG000|Overall Study|Lost to Follow-up|1|||
156592722|NCT02596711|565253021|FG001|Overall Study|Lost to Follow-up|2|||
156592723|NCT02596711|565253022|FG002|Overall Study|Lost to Follow-up|3|||
156592724|NCT00586924|565253023|FG000|Overall Study|Adverse event/serious adverse event|0|||
156592725|NCT00586924|565253024|FG001|Overall Study|Adverse event/serious adverse event|0|||
156592726|NCT00586924|565253025|FG002|Overall Study|Adverse event/serious adverse event|0|||
156592727|NCT00586924|565253026|FG003|Overall Study|Adverse event/serious adverse event|1|||
156592728|NCT00586924|565253027|FG004|Overall Study|Adverse event/serious adverse event|0|||
156592729|NCT00586924|565253028|FG005|Overall Study|Adverse event/serious adverse event|2|||
156592730|NCT00586924|565253023|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
156592731|NCT00586924|565253024|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
156592732|NCT00586924|565253025|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
156592733|NCT00586924|565253026|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
156592734|NCT00586924|565253027|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
156592735|NCT00586924|565253028|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
156592736|NCT00586924|565253023|FG000|Overall Study|Disease progression|0|||
156592737|NCT00586924|565253024|FG001|Overall Study|Disease progression|0|||
156592738|NCT00586924|565253025|FG002|Overall Study|Disease progression|0|||
156592739|NCT00586924|565253026|FG003|Overall Study|Disease progression|1|||
156592740|NCT00586924|565253027|FG004|Overall Study|Disease progression|1|||
156592741|NCT00586924|565253028|FG005|Overall Study|Disease progression|0|||
156592742|NCT00586924|565253023|FG000|Overall Study|Development of neutralizing antibodies|2|||
156592743|NCT00586924|565253024|FG001|Overall Study|Development of neutralizing antibodies|2|||
156592744|NCT00586924|565253025|FG002|Overall Study|Development of neutralizing antibodies|2|||
156592745|NCT00586924|565253026|FG003|Overall Study|Development of neutralizing antibodies|0|||
156592746|NCT00586924|565253027|FG004|Overall Study|Development of neutralizing antibodies|0|||
156592747|NCT00586924|565253028|FG005|Overall Study|Development of neutralizing antibodies|22|||
156592748|NCT00586924|565253023|FG000|Overall Study|Complete response|0|||
156592749|NCT00586924|565253024|FG001|Overall Study|Complete response|1|||
156592750|NCT00586924|565253025|FG002|Overall Study|Complete response|0|||
156592751|NCT00586924|565253026|FG003|Overall Study|Complete response|0|||
156592752|NCT00586924|565253027|FG004|Overall Study|Complete response|2|||
156592753|NCT00586924|565253028|FG005|Overall Study|Complete response|2|||
156592754|NCT00586924|565253023|FG000|Overall Study|Other|1|||
156592755|NCT00586924|565253024|FG001|Overall Study|Other|0|||
156592756|NCT00586924|565253025|FG002|Overall Study|Other|1|||
156592757|NCT00586924|565253026|FG003|Overall Study|Other|1|||
156592758|NCT00586924|565253027|FG004|Overall Study|Other|1|||
156592759|NCT00586924|565253028|FG005|Overall Study|Other|6|||
156592760|NCT01767194|565253030|FG000|Overall Study|Adverse Event|1|||
156592761|NCT01767194|565253031|FG001|Overall Study|Adverse Event|1|||
156592762|NCT01767194|565253030|FG000|Overall Study|Death|0|||
156592763|NCT01767194|565253031|FG001|Overall Study|Death|1|||
156592764|NCT01767194|565253030|FG000|Overall Study|Lack of Efficacy|12|||
156592765|NCT01767194|565253031|FG001|Overall Study|Lack of Efficacy|11|||
156592766|NCT01767194|565253030|FG000|Overall Study|Physician Decision|2|||
156592767|NCT01767194|565253031|FG001|Overall Study|Physician Decision|23|||
156592768|NCT01767194|565253030|FG000|Overall Study|Withdrawal by Subject|0|||
156592769|NCT01767194|565253031|FG001|Overall Study|Withdrawal by Subject|1|||
156592770|NCT01767194|565253030|FG000|Overall Study|Ineligible|1|||
156592771|NCT01767194|565253031|FG001|Overall Study|Ineligible|1|||
156592772|NCT01767194|565253030|FG000|Overall Study|Refusal by patient/parent|2|||
156592773|NCT01767194|565253031|FG001|Overall Study|Refusal by patient/parent|4|||
156592774|NCT01767194|565253030|FG000|Overall Study|Criteria not met on time for next cycle|0|||
156592775|NCT01767194|565253031|FG001|Overall Study|Criteria not met on time for next cycle|1|||
156592776|NCT02112994|565253032|FG000|Overall Study|Progressive Disease|0|||
156592777|NCT02112994|565253033|FG001|Overall Study|Progressive Disease|0|||
156592778|NCT02112994|565253034|FG002|Overall Study|Progressive Disease|1|||
156592779|NCT02112994|565253032|FG000|Overall Study|Pregnancy|0|||
156592780|NCT02112994|565253033|FG001|Overall Study|Pregnancy|1|||
156592781|NCT02112994|565253034|FG002|Overall Study|Pregnancy|1|||
156592782|NCT02112994|565253032|FG000|Overall Study|Liver Transplant|0|||
156592783|NCT02112994|565253033|FG001|Overall Study|Liver Transplant|1|||
156592784|NCT02112994|565253034|FG002|Overall Study|Liver Transplant|0|||
156592785|NCT02112994|565253032|FG000|Overall Study|Withdrawal by Subject|0|||
156592786|NCT02112994|565253033|FG001|Overall Study|Withdrawal by Subject|0|||
156592787|NCT02112994|565253034|FG002|Overall Study|Withdrawal by Subject|1|||
156592788|NCT01683071|565253038|FG000|Part 1|Lack of Efficacy|1|||
156592789|NCT01683071|565253039|FG001|Part 1|Lack of Efficacy|0|||
156592790|NCT01683071|565253040|FG002|Part 1|Lack of Efficacy|0|||
156592791|NCT01683071|565253041|FG003|Part 1|Lack of Efficacy|3|||
156592792|NCT01683071|565253042|FG004|Part 1|Lack of Efficacy|0|||
156592793|NCT01683071|565253043|FG005|Part 1|Lack of Efficacy|0|||
156592794|NCT01683071|565253038|FG000|Part 1|Withdrawal by Subject|1|||
156592795|NCT01683071|565253039|FG001|Part 1|Withdrawal by Subject|2|||
156592796|NCT01683071|565253040|FG002|Part 1|Withdrawal by Subject|2|||
156592797|NCT01683071|565253041|FG003|Part 1|Withdrawal by Subject|1|||
156592798|NCT01683071|565253042|FG004|Part 1|Withdrawal by Subject|0|||
156592799|NCT01683071|565253043|FG005|Part 1|Withdrawal by Subject|0|||
156592800|NCT01683071|565253038|FG000|Part 1|Surgery Cancelled|1|||
156592801|NCT01683071|565253039|FG001|Part 1|Surgery Cancelled|0|||
156592802|NCT01683071|565253040|FG002|Part 1|Surgery Cancelled|0|||
156592803|NCT01683071|565253041|FG003|Part 1|Surgery Cancelled|0|||
156592804|NCT01683071|565253042|FG004|Part 1|Surgery Cancelled|0|||
156863665|NCT02651675|566258744|FG001|Overall Study|Death|0|||
156592805|NCT01683071|565253043|FG005|Part 1|Surgery Cancelled|0|||
156592806|NCT01683071|565253038|FG000|Part 1|Did not receive study drug|1|||
156592807|NCT01683071|565253039|FG001|Part 1|Did not receive study drug|0|||
156592808|NCT01683071|565253040|FG002|Part 1|Did not receive study drug|0|||
156592809|NCT01683071|565253041|FG003|Part 1|Did not receive study drug|1|||
156592810|NCT01683071|565253042|FG004|Part 1|Did not receive study drug|0|||
156592811|NCT01683071|565253043|FG005|Part 1|Did not receive study drug|0|||
156592812|NCT01683071|565253038|FG000|Part 1|Early termination; met exclusion criteria|0|||
156592813|NCT01683071|565253039|FG001|Part 1|Early termination; met exclusion criteria|2|||
156592814|NCT01683071|565253040|FG002|Part 1|Early termination; met exclusion criteria|1|||
156863666|NCT02651675|566258745|FG002|Overall Study|Death|1|||
156592815|NCT01683071|565253041|FG003|Part 1|Early termination; met exclusion criteria|0|||
156592816|NCT01683071|565253042|FG004|Part 1|Early termination; met exclusion criteria|0|||
156863667|NCT02246530|566258746|FG000|Overall Study|Lost to Follow-up|4|||
156592817|NCT01683071|565253043|FG005|Part 1|Early termination; met exclusion criteria|0|||
156592818|NCT01683071|565253038|FG000|Part 2|Lack of Efficacy|0|||
156592819|NCT01683071|565253039|FG001|Part 2|Lack of Efficacy|0|||
156592820|NCT01683071|565253040|FG002|Part 2|Lack of Efficacy|0|||
156592821|NCT01683071|565253041|FG003|Part 2|Lack of Efficacy|0|||
156592822|NCT01683071|565253042|FG004|Part 2|Lack of Efficacy|3|||
156592823|NCT01683071|565253043|FG005|Part 2|Lack of Efficacy|4|||
156592824|NCT01683071|565253038|FG000|Part 2|Lost to Follow-up|0|||
156592825|NCT01683071|565253039|FG001|Part 2|Lost to Follow-up|0|||
156592826|NCT01683071|565253040|FG002|Part 2|Lost to Follow-up|0|||
156592827|NCT01683071|565253041|FG003|Part 2|Lost to Follow-up|0|||
156592828|NCT01683071|565253042|FG004|Part 2|Lost to Follow-up|2|||
156592829|NCT01683071|565253043|FG005|Part 2|Lost to Follow-up|0|||
156592830|NCT01683071|565253038|FG000|Part 2|Withdrawal by Subject|0|||
156592831|NCT01683071|565253039|FG001|Part 2|Withdrawal by Subject|0|||
156592832|NCT01683071|565253040|FG002|Part 2|Withdrawal by Subject|0|||
156592833|NCT01683071|565253041|FG003|Part 2|Withdrawal by Subject|0|||
156592834|NCT01683071|565253042|FG004|Part 2|Withdrawal by Subject|3|||
156592835|NCT01683071|565253043|FG005|Part 2|Withdrawal by Subject|3|||
156592836|NCT01683071|565253038|FG000|Part 2|Surgery cancelled|0|||
156592837|NCT01683071|565253039|FG001|Part 2|Surgery cancelled|0|||
156592838|NCT01683071|565253040|FG002|Part 2|Surgery cancelled|0|||
156592839|NCT01683071|565253041|FG003|Part 2|Surgery cancelled|0|||
156592840|NCT01683071|565253042|FG004|Part 2|Surgery cancelled|4|||
156592841|NCT01683071|565253043|FG005|Part 2|Surgery cancelled|2|||
156592842|NCT01683071|565253038|FG000|Part 2|Did not receive study drug|0|||
156592843|NCT01683071|565253039|FG001|Part 2|Did not receive study drug|0|||
156592844|NCT01683071|565253040|FG002|Part 2|Did not receive study drug|0|||
156592845|NCT01683071|565253041|FG003|Part 2|Did not receive study drug|0|||
156592846|NCT01683071|565253042|FG004|Part 2|Did not receive study drug|2|||
156592847|NCT01683071|565253043|FG005|Part 2|Did not receive study drug|1|||
156592848|NCT01683071|565253038|FG000|Part 2|Met exclusion criterion|0|||
156592849|NCT01683071|565253039|FG001|Part 2|Met exclusion criterion|0|||
156592850|NCT01683071|565253040|FG002|Part 2|Met exclusion criterion|0|||
156592851|NCT01683071|565253041|FG003|Part 2|Met exclusion criterion|0|||
156592852|NCT01683071|565253042|FG004|Part 2|Met exclusion criterion|1|||
156592853|NCT01683071|565253043|FG005|Part 2|Met exclusion criterion|1|||
156592854|NCT01683071|565253038|FG000|Part 2|Protocol deviation|0|||
156592855|NCT01683071|565253039|FG001|Part 2|Protocol deviation|0|||
156592856|NCT01683071|565253040|FG002|Part 2|Protocol deviation|0|||
156592857|NCT01683071|565253041|FG003|Part 2|Protocol deviation|0|||
156592858|NCT01683071|565253042|FG004|Part 2|Protocol deviation|1|||
156592859|NCT01683071|565253043|FG005|Part 2|Protocol deviation|2|||
156592860|NCT01683071|565253038|FG000|Part 2|Withdrawal by investigator decision|0|||
156592861|NCT01683071|565253039|FG001|Part 2|Withdrawal by investigator decision|0|||
156592862|NCT01683071|565253040|FG002|Part 2|Withdrawal by investigator decision|0|||
156592863|NCT01683071|565253041|FG003|Part 2|Withdrawal by investigator decision|0|||
156592864|NCT01683071|565253042|FG004|Part 2|Withdrawal by investigator decision|1|||
156592865|NCT01683071|565253043|FG005|Part 2|Withdrawal by investigator decision|2|||
156592866|NCT02198651|565255093|FG000|Lead-in Period|Withdrew consent|13|||
156592867|NCT02198651|565255094|FG001|Lead-in Period|Withdrew consent|0|||
156592868|NCT02198651|565255095|FG002|Lead-in Period|Withdrew consent|0|||
156592869|NCT02198651|565255096|FG003|Lead-in Period|Withdrew consent|0|||
156592870|NCT02198651|565255097|FG004|Lead-in Period|Withdrew consent|0|||
156592871|NCT02198651|565255093|FG000|Lead-in Period|Adverse Event|2|||
156592872|NCT02198651|565255094|FG001|Lead-in Period|Adverse Event|0|||
156592873|NCT02198651|565255095|FG002|Lead-in Period|Adverse Event|0|||
156592874|NCT02198651|565255096|FG003|Lead-in Period|Adverse Event|0|||
156592875|NCT02198651|565255097|FG004|Lead-in Period|Adverse Event|0|||
156592876|NCT02198651|565255093|FG000|Lead-in Period|Other, not specified|22|||
156592877|NCT02198651|565255094|FG001|Lead-in Period|Other, not specified|0|||
156592878|NCT02198651|565255095|FG002|Lead-in Period|Other, not specified|0|||
156592879|NCT02198651|565255096|FG003|Lead-in Period|Other, not specified|0|||
156592880|NCT02198651|565255097|FG004|Lead-in Period|Other, not specified|0|||
156592881|NCT02198651|565255093|FG000|Double-blind Period|Withdrew consent|0|||
156592882|NCT02198651|565255094|FG001|Double-blind Period|Withdrew consent|4|||
156592883|NCT02198651|565255095|FG002|Double-blind Period|Withdrew consent|0|||
156592884|NCT02198651|565255096|FG003|Double-blind Period|Withdrew consent|0|||
156592885|NCT02198651|565255097|FG004|Double-blind Period|Withdrew consent|0|||
156592886|NCT02198651|565255093|FG000|Double-blind Period|Adverse Event|0|||
156592887|NCT02198651|565255094|FG001|Double-blind Period|Adverse Event|1|||
156592888|NCT02198651|565255095|FG002|Double-blind Period|Adverse Event|0|||
156592889|NCT02198651|565255096|FG003|Double-blind Period|Adverse Event|0|||
156592890|NCT02198651|565255097|FG004|Double-blind Period|Adverse Event|0|||
156592891|NCT02198651|565255093|FG000|Double-blind Period|Other, not specified|0|||
156592892|NCT02198651|565255094|FG001|Double-blind Period|Other, not specified|4|||
156592893|NCT02198651|565255095|FG002|Double-blind Period|Other, not specified|1|||
156592894|NCT02198651|565255096|FG003|Double-blind Period|Other, not specified|0|||
156592895|NCT02198651|565255097|FG004|Double-blind Period|Other, not specified|0|||
156592896|NCT02198651|565255093|FG000|Open-label Rescue Period|Withdrew consent|0|||
156592897|NCT02198651|565255094|FG001|Open-label Rescue Period|Withdrew consent|0|||
156592898|NCT02198651|565255095|FG002|Open-label Rescue Period|Withdrew consent|0|||
156592899|NCT02198651|565255096|FG003|Open-label Rescue Period|Withdrew consent|2|||
156592900|NCT02198651|565255097|FG004|Open-label Rescue Period|Withdrew consent|0|||
156592901|NCT02198651|565255093|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
156592902|NCT02198651|565255094|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
156592903|NCT02198651|565255095|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
156592904|NCT02198651|565255096|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
156592905|NCT02198651|565255097|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
156592906|NCT00333619|565255107|FG000|Overall Study|Death|12|||
156592907|NCT00333619|565255108|FG001|Overall Study|Death|6|||
156592908|NCT00333619|565255107|FG000|Overall Study|Withdrawal by Subject|6|||
156592909|NCT00333619|565255108|FG001|Overall Study|Withdrawal by Subject|1|||
156592910|NCT00333619|565255107|FG000|Overall Study|Lost to Follow-up|3|||
156592911|NCT00333619|565255108|FG001|Overall Study|Lost to Follow-up|3|||
156592912|NCT01120379|565255117|FG000|One Year Timepoint|Withdrawal by Subject|41|||
156592913|NCT01120379|565255117|FG000|One Year Timepoint|Lost to Follow-up|115|||
156592914|NCT01120379|565255117|FG000|One Year Timepoint|Death|108|||
156592915|NCT01120379|565255117|FG000|One Year Timepoint|Physician Decision|9|||
156592916|NCT01120379|565255117|FG000|One Year Timepoint|Any other reason for early termination|5|||
156592917|NCT01120379|565255117|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
156592918|NCT01120379|565255117|FG000|Two Year Timepoint|Lost to Follow-up|87|||
156592919|NCT01120379|565255117|FG000|Two Year Timepoint|Death|123|||
156592920|NCT01120379|565255117|FG000|Two Year Timepoint|Physician Decision|12|||
156592921|NCT01120379|565255117|FG000|Two Year Timepoint|Any other reason for early termination|4|||
156592922|NCT01120379|565255117|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
156592923|NCT01120379|565255117|FG000|Three Year Timepoint|Lost to Follow-up|43|||
156592924|NCT01120379|565255117|FG000|Three Year Timepoint|Death|120|||
156592925|NCT01120379|565255117|FG000|Three Year Timepoint|Physician Decision|9|||
156592926|NCT01120379|565255117|FG000|Three Year Timepoint|Any other reason for early termination|17|||
156592927|NCT01120379|565255117|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
156592928|NCT01120379|565255117|FG000|Four Year Timepoint|Lost to Follow-up|10|||
156592929|NCT01120379|565255117|FG000|Four Year Timepoint|Death|131|||
156592930|NCT01120379|565255117|FG000|Four Year Timepoint|Physician Decision|5|||
156592931|NCT01120379|565255117|FG000|Four Year Timepoint|Any other reason for early termination|217|||
156592932|NCT00831441|565255121|FG000|Randomized|Death|82|||
156592933|NCT00831441|565255122|FG001|Randomized|Death|81|||
156592934|NCT00831441|565255121|FG000|Randomized|Adverse Event|248|||
156592935|NCT00831441|565255122|FG001|Randomized|Adverse Event|321|||
156592936|NCT00831441|565255121|FG000|Randomized|Emergency procedure|2|||
156592937|NCT00831441|565255122|FG001|Randomized|Emergency procedure|2|||
156592938|NCT00831441|565255121|FG000|Randomized|Elective procedure|26|||
156592939|NCT00831441|565255122|FG001|Randomized|Elective procedure|25|||
156592940|NCT00831441|565255121|FG000|Randomized|Physician Decision|26|||
156592941|NCT00831441|565255122|FG001|Randomized|Physician Decision|35|||
156592942|NCT00831441|565255121|FG000|Randomized|No longer met criteria|13|||
156592943|NCT00831441|565255122|FG001|Randomized|No longer met criteria|19|||
156592944|NCT00831441|565255121|FG000|Randomized|Withdrawal by Subject|178|||
156592945|NCT00831441|565255122|FG001|Randomized|Withdrawal by Subject|212|||
156592946|NCT00831441|565255121|FG000|Randomized|Lost to Follow-up|26|||
156592947|NCT00831441|565255122|FG001|Randomized|Lost to Follow-up|35|||
156592948|NCT00831441|565255121|FG000|Randomized|Administrative reason by sponsor|2780|||
156592949|NCT00831441|565255122|FG001|Randomized|Administrative reason by sponsor|2671|||
156592950|NCT00831441|565255121|FG000|Randomized|poor/non-compliance|30|||
156592951|NCT00831441|565255122|FG001|Randomized|poor/non-compliance|38|||
156592952|NCT00831441|565255121|FG000|Randomized|non-specified|276|||
156592953|NCT00831441|565255122|FG001|Randomized|non-specified|266|||
156592954|NCT00831441|565255121|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
156592955|NCT00831441|565255122|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
156592956|NCT00831441|565255121|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
156592957|NCT00831441|565255122|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
156592958|NCT00831441|565255121|FG000|Follow Up (30 Days)|Death|63|||
156592959|NCT00831441|565255122|FG001|Follow Up (30 Days)|Death|86|||
156592960|NCT00831441|565255121|FG000|Follow Up (30 Days)|non-specified|16|||
156592961|NCT00831441|565255122|FG001|Follow Up (30 Days)|non-specified|26|||
156592962|NCT00831441|565255121|FG000|Follow Up (30 Days)|missing end of study status|0|||
156592963|NCT00831441|565255122|FG001|Follow Up (30 Days)|missing end of study status|1|||
156592964|NCT05674344|565255123|FG000|Overall Study|Screen Fail|21|||
156592965|NCT05674344|565255123|FG000|Overall Study|Incomplete study procedures|3|||
156592966|NCT00111917|565255124|FG000|Overall Study|Withdrawal by Subject|1|||
156592967|NCT00111917|565255125|FG001|Overall Study|Withdrawal by Subject|1|||
156592968|NCT01640925|565255126|FG000|Overall Study|Withdrawal by Subject|1|||
156592969|NCT01640925|565255127|FG001|Overall Study|Withdrawal by Subject|0|||
156592970|NCT01640925|565255126|FG000|Overall Study|Previously enrolled in this trial|13|||
156592971|NCT01640925|565255127|FG001|Overall Study|Previously enrolled in this trial|11|||
156592972|NCT02156492|565255128|FG000|Period 1|No Reason Given|0|||
156592973|NCT02156492|565255129|FG001|Period 1|No Reason Given|1|||
156592974|NCT02156492|565255130|FG002|Period 1|No Reason Given|0|||
156592975|NCT02156492|565255128|FG000|Period 3|Adverse Event|0|||
156592976|NCT02156492|565255129|FG001|Period 3|Adverse Event|1|||
156592977|NCT02156492|565255130|FG002|Period 3|Adverse Event|0|||
156592978|NCT00485589|565255139|FG000|Overall Study|Death|2|||
156592979|NCT00485589|565255140|FG001|Overall Study|Death|2|||
156592980|NCT00485589|565255141|FG002|Overall Study|Death|0|||
156592981|NCT00485589|565255139|FG000|Overall Study|Failure to return|6|||
156592982|NCT00485589|565255140|FG001|Overall Study|Failure to return|5|||
156592983|NCT00485589|565255141|FG002|Overall Study|Failure to return|1|||
156592984|NCT00485589|565255139|FG000|Overall Study|Protocol Violation|1|||
156592985|NCT00485589|565255140|FG001|Overall Study|Protocol Violation|0|||
156592986|NCT00485589|565255141|FG002|Overall Study|Protocol Violation|0|||
156592987|NCT00485589|565255139|FG000|Overall Study|Violation of selection criteria at entry|0|||
156592988|NCT00485589|565255140|FG001|Overall Study|Violation of selection criteria at entry|3|||
156592989|NCT00485589|565255141|FG002|Overall Study|Violation of selection criteria at entry|1|||
156592990|NCT00485589|565255139|FG000|Overall Study|Administrative/Other|1|||
156592991|NCT00485589|565255140|FG001|Overall Study|Administrative/Other|2|||
156592992|NCT00485589|565255141|FG002|Overall Study|Administrative/Other|1|||
156592993|NCT00485589|565255139|FG000|Overall Study|Insufficient therapeutic response|10|||
156592994|NCT00485589|565255140|FG001|Overall Study|Insufficient therapeutic response|3|||
156592995|NCT00485589|565255141|FG002|Overall Study|Insufficient therapeutic response|1|||
156592996|NCT00485589|565255139|FG000|Overall Study|Refused treatment/did not cooperate|1|||
156592997|NCT00485589|565255140|FG001|Overall Study|Refused treatment/did not cooperate|0|||
156592998|NCT00485589|565255141|FG002|Overall Study|Refused treatment/did not cooperate|2|||
156592999|NCT00485589|565255139|FG000|Overall Study|Withdrawal by Subject|3|||
156593000|NCT00485589|565255140|FG001|Overall Study|Withdrawal by Subject|2|||
156593001|NCT00485589|565255141|FG002|Overall Study|Withdrawal by Subject|2|||
156593002|NCT00485589|565255139|FG000|Overall Study|Adverse Event|3|||
156593003|NCT00485589|565255140|FG001|Overall Study|Adverse Event|3|||
156593004|NCT00485589|565255141|FG002|Overall Study|Adverse Event|10|||
156593005|NCT02924688|565255144|FG000|Overall Study|Adverse Event|9|||
156593006|NCT02924688|565255145|FG001|Overall Study|Adverse Event|3|||
156593007|NCT02924688|565255146|FG002|Overall Study|Adverse Event|2|||
156593008|NCT02924688|565255147|FG003|Overall Study|Adverse Event|2|||
156593009|NCT02924688|565255148|FG004|Overall Study|Adverse Event|3|||
156593010|NCT02924688|565255149|FG005|Overall Study|Adverse Event|2|||
156593011|NCT02924688|565255144|FG000|Overall Study|Lack of Efficacy|2|||
156593012|NCT02924688|565255145|FG001|Overall Study|Lack of Efficacy|3|||
156593013|NCT02924688|565255146|FG002|Overall Study|Lack of Efficacy|4|||
156593014|NCT02924688|565255147|FG003|Overall Study|Lack of Efficacy|2|||
156593015|NCT02924688|565255148|FG004|Overall Study|Lack of Efficacy|1|||
156593016|NCT02924688|565255149|FG005|Overall Study|Lack of Efficacy|1|||
156593017|NCT02924688|565255144|FG000|Overall Study|Protocol Violation|3|||
156593018|NCT02924688|565255145|FG001|Overall Study|Protocol Violation|7|||
156593019|NCT02924688|565255146|FG002|Overall Study|Protocol Violation|5|||
156593020|NCT02924688|565255147|FG003|Overall Study|Protocol Violation|6|||
156593021|NCT02924688|565255148|FG004|Overall Study|Protocol Violation|2|||
156593022|NCT02924688|565255149|FG005|Overall Study|Protocol Violation|2|||
156593023|NCT02924688|565255144|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
156593024|NCT02924688|565255145|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
156593025|NCT02924688|565255146|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
156593026|NCT02924688|565255147|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
156593027|NCT02924688|565255148|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
156593028|NCT02924688|565255149|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
156593029|NCT02924688|565255144|FG000|Overall Study|Lost to Follow-up|2|||
156593030|NCT02924688|565255145|FG001|Overall Study|Lost to Follow-up|4|||
156593031|NCT02924688|565255146|FG002|Overall Study|Lost to Follow-up|2|||
156593032|NCT02924688|565255147|FG003|Overall Study|Lost to Follow-up|4|||
156593033|NCT02924688|565255148|FG004|Overall Study|Lost to Follow-up|2|||
156593034|NCT02924688|565255149|FG005|Overall Study|Lost to Follow-up|4|||
156593035|NCT02924688|565255144|FG000|Overall Study|Physician Decision|2|||
156593036|NCT02924688|565255145|FG001|Overall Study|Physician Decision|1|||
156593037|NCT02924688|565255146|FG002|Overall Study|Physician Decision|0|||
156593038|NCT02924688|565255147|FG003|Overall Study|Physician Decision|1|||
156593039|NCT02924688|565255148|FG004|Overall Study|Physician Decision|1|||
156593040|NCT02924688|565255149|FG005|Overall Study|Physician Decision|1|||
156593041|NCT02924688|565255144|FG000|Overall Study|Withdrawal by Subject|14|||
156593042|NCT02924688|565255145|FG001|Overall Study|Withdrawal by Subject|13|||
156593043|NCT02924688|565255146|FG002|Overall Study|Withdrawal by Subject|9|||
156593044|NCT02924688|565255147|FG003|Overall Study|Withdrawal by Subject|12|||
156593045|NCT02924688|565255148|FG004|Overall Study|Withdrawal by Subject|13|||
156593046|NCT02924688|565255149|FG005|Overall Study|Withdrawal by Subject|14|||
156593047|NCT01944969|565255152|FG000|Overall Study|Adverse Event|1|||
156593048|NCT01944969|565255152|FG000|Overall Study|Lack of Efficacy|1|||
156593049|NCT01944969|565255152|FG000|Overall Study|Non-compliance with IMP|1|||
156593050|NCT01944969|565255152|FG000|Overall Study|Administrative or other reasons|23|||
156593051|NCT03072719|565255153|FG000|Overall Study|Adverse Event|1|||
156593052|NCT03072719|565255154|FG001|Overall Study|Adverse Event|1|||
156593053|NCT01104584|565255157|FG000|Overall Study|Study drug never administered|21|||
156593054|NCT01104584|565255157|FG000|Overall Study|Study prematurely discontinued|2|||
156593055|NCT02370498|565255158|FG000|Overall Study|Adverse Event|10|||
156593056|NCT02370498|565255159|FG001|Overall Study|Adverse Event|8|||
156593057|NCT02370498|565255158|FG000|Overall Study|Death|263|||
156593058|NCT02370498|565255159|FG001|Overall Study|Death|265|||
156593059|NCT02370498|565255158|FG000|Overall Study|Protocol Violation|1|||
156593060|NCT02370498|565255159|FG001|Overall Study|Protocol Violation|2|||
156593061|NCT02370498|565255158|FG000|Overall Study|Withdrawal by Subject|7|||
156593062|NCT02370498|565255159|FG001|Overall Study|Withdrawal by Subject|12|||
156593063|NCT02370498|565255158|FG000|Overall Study|Sponsor's decision|15|||
156593064|NCT02370498|565255159|FG001|Overall Study|Sponsor's decision|9|||
156593065|NCT04017442|565255160|FG000|Overall Study|Withdrawal by Subject|0|||
156593066|NCT04017442|565255161|FG001|Overall Study|Withdrawal by Subject|3|||
156593067|NCT04017442|565255160|FG000|Overall Study|Lost to Follow-up|21|||
156593068|NCT04017442|565255161|FG001|Overall Study|Lost to Follow-up|19|||
156593069|NCT02586233|565255165|FG000|Overall Study|Randomized but did not receive treatment|0|||
156593070|NCT02586233|565255166|FG001|Overall Study|Randomized but did not receive treatment|1|||
156593071|NCT02586233|565255167|FG002|Overall Study|Randomized but did not receive treatment|0|||
156593072|NCT02586233|565255168|FG003|Overall Study|Randomized but did not receive treatment|0|||
156593073|NCT02586233|565255169|FG004|Overall Study|Randomized but did not receive treatment|0|||
156593074|NCT02586233|565255170|FG005|Overall Study|Randomized but did not receive treatment|2|||
156593075|NCT02586233|565255171|FG006|Overall Study|Randomized but did not receive treatment|2|||
156593076|NCT02586233|565255165|FG000|Overall Study|Death|0|||
156593077|NCT02586233|565255166|FG001|Overall Study|Death|1|||
156593078|NCT02586233|565255167|FG002|Overall Study|Death|0|||
156593079|NCT02586233|565255168|FG003|Overall Study|Death|0|||
156593080|NCT02586233|565255169|FG004|Overall Study|Death|2|||
156593081|NCT02586233|565255170|FG005|Overall Study|Death|0|||
156593082|NCT02586233|565255171|FG006|Overall Study|Death|0|||
156593083|NCT03225716|565255172|FG000|Overall Study|Withdrawal by Subject|2|||
156593084|NCT03225716|565255173|FG001|Overall Study|Withdrawal by Subject|2|||
156593085|NCT03225716|565255174|FG002|Overall Study|Withdrawal by Subject|0|||
156593086|NCT03225716|565255172|FG000|Overall Study|Lack of Efficacy|1|||
156593087|NCT03225716|565255173|FG001|Overall Study|Lack of Efficacy|0|||
156593088|NCT03225716|565255174|FG002|Overall Study|Lack of Efficacy|0|||
156593089|NCT03225716|565255172|FG000|Overall Study|Adverse Event|2|||
156593090|NCT03225716|565255173|FG001|Overall Study|Adverse Event|0|||
156593091|NCT03225716|565255174|FG002|Overall Study|Adverse Event|1|||
156593092|NCT03225716|565255172|FG000|Overall Study|Study early termination by Sponsor|0|||
156593093|NCT03225716|565255173|FG001|Overall Study|Study early termination by Sponsor|0|||
156593094|NCT03225716|565255174|FG002|Overall Study|Study early termination by Sponsor|2|||
156593095|NCT00848250|565255175|FG000|Overall Study|surgery was completed without cardiopulm|0|||
156593096|NCT00848250|565255176|FG001|Overall Study|surgery was completed without cardiopulm|1|||
156593097|NCT01205451|565255184|FG000|Overall Study|Lost to Follow-up|1|||
156593098|NCT01205451|565255185|FG001|Overall Study|Lost to Follow-up|1|||
156593099|NCT01205451|565255184|FG000|Overall Study|Withdrawal by Subject|5|||
156593100|NCT01205451|565255185|FG001|Overall Study|Withdrawal by Subject|9|||
156593101|NCT03421964|565255193|FG000|Overall Study|Lost to Follow-up|11|||
156593102|NCT03421964|565255194|FG001|Overall Study|Lost to Follow-up|21|||
156593103|NCT03421964|565255193|FG000|Overall Study|Withdrawal by Subject|9|||
156593104|NCT03421964|565255194|FG001|Overall Study|Withdrawal by Subject|3|||
156593105|NCT03421964|565255193|FG000|Overall Study|Incarcerated|1|||
156593106|NCT03421964|565255194|FG001|Overall Study|Incarcerated|0|||
156593107|NCT03421964|565255193|FG000|Overall Study|Inpt Treatment Facility|1|||
156593108|NCT03421964|565255194|FG001|Overall Study|Inpt Treatment Facility|1|||
156593109|NCT03421964|565255193|FG000|Overall Study|Virtual Platform Issues|1|||
156593110|NCT03421964|565255194|FG001|Overall Study|Virtual Platform Issues|1|||
156593111|NCT02938585|565255195|FG000|Overall Study|Withdrawal by parent or guardian|0|||
156593112|NCT02938585|565255196|FG001|Overall Study|Withdrawal by parent or guardian|1|||
156593113|NCT02938585|565255197|FG002|Overall Study|Withdrawal by parent or guardian|0|||
156593114|NCT02938585|565255198|FG003|Overall Study|Withdrawal by parent or guardian|0|||
156593115|NCT02938585|565255195|FG000|Overall Study|Withdrawal by Subject|0|||
156593116|NCT02938585|565255196|FG001|Overall Study|Withdrawal by Subject|0|||
156593117|NCT02938585|565255197|FG002|Overall Study|Withdrawal by Subject|0|||
156593118|NCT02938585|565255198|FG003|Overall Study|Withdrawal by Subject|5|||
156593119|NCT02106455|565255206|FG000|Overall Study|Case Report Form Uncollected|6|||
156593120|NCT02106455|565255206|FG000|Overall Study|Protocol Deviation|2|||
156593121|NCT00213980|565255207|FG000|Overall Study|Withdrawal by Subject|3|||
156593122|NCT00213980|565255208|FG001|Overall Study|Withdrawal by Subject|1|||
156593123|NCT00213980|565255207|FG000|Overall Study|Adverse Event|1|||
156593124|NCT00213980|565255208|FG001|Overall Study|Adverse Event|1|||
156593125|NCT00213980|565255207|FG000|Overall Study|Disease progression|0|||
156593126|NCT00213980|565255208|FG001|Overall Study|Disease progression|2|||
156593127|NCT00213980|565255207|FG000|Overall Study|Developed ovarian cancer|1|||
156593128|NCT00213980|565255208|FG001|Overall Study|Developed ovarian cancer|0|||
156593129|NCT00213980|565255207|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
156593130|NCT00213980|565255208|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
156593131|NCT03607838|565255209|FG000|Overall Study|Lack of Efficacy|14|||
156593132|NCT03607838|565255210|FG001|Overall Study|Lack of Efficacy|20|||
156593133|NCT03607838|565255209|FG000|Overall Study|Withdrawal by Subject|13|||
156593134|NCT03607838|565255210|FG001|Overall Study|Withdrawal by Subject|8|||
156593135|NCT03607838|565255209|FG000|Overall Study|Lost to Follow-up|6|||
156593136|NCT03607838|565255210|FG001|Overall Study|Lost to Follow-up|11|||
156593137|NCT03607838|565255209|FG000|Overall Study|Adverse Event|2|||
156593138|NCT03607838|565255210|FG001|Overall Study|Adverse Event|2|||
156593139|NCT03607838|565255209|FG000|Overall Study|Physician Decision|2|||
156593140|NCT03607838|565255210|FG001|Overall Study|Physician Decision|0|||
156593141|NCT03607838|565255209|FG000|Overall Study|Failure to meet randomization criteria|1|||
156593142|NCT03607838|565255210|FG001|Overall Study|Failure to meet randomization criteria|2|||
156593143|NCT03607838|565255209|FG000|Overall Study|Pregnancy|1|||
156593144|NCT03607838|565255210|FG001|Overall Study|Pregnancy|0|||
156593145|NCT03607838|565255209|FG000|Overall Study|Protocol Violation|1|||
156593146|NCT03607838|565255210|FG001|Overall Study|Protocol Violation|0|||
156593147|NCT03607838|565255209|FG000|Overall Study|Due to work|1|||
156593148|NCT03607838|565255210|FG001|Overall Study|Due to work|0|||
156593149|NCT03607838|565255209|FG000|Overall Study|Litigation|0|||
156593150|NCT03607838|565255210|FG001|Overall Study|Litigation|1|||
156593151|NCT03607838|565255209|FG000|Overall Study|Temperature excursion for study drug|0|||
156593152|NCT03607838|565255210|FG001|Overall Study|Temperature excursion for study drug|1|||
156593153|NCT03607838|565255209|FG000|Overall Study|Change of mind|0|||
156593154|NCT03607838|565255210|FG001|Overall Study|Change of mind|1|||
156593155|NCT02411201|565255211|FG000|Overall Study|Adverse Event|2|||
156593156|NCT02411201|565255211|FG000|Overall Study|Withdrawal by Subject|2|||
156593157|NCT02411201|565255211|FG000|Overall Study|Age group completed|2|||
156593158|NCT01260467|565255212|FG000|Overall Study|Withdrawal by Subject|2|||
156593159|NCT00798694|565255213|FG000|Overall Study|Lost to Follow-up|1|||
156593160|NCT00798694|565255214|FG001|Overall Study|Lost to Follow-up|1|||
156593161|NCT00798694|565255213|FG000|Overall Study|Physician Decision|1|||
156593162|NCT00798694|565255214|FG001|Overall Study|Physician Decision|0|||
156593163|NCT03364608|565255218|FG000|Overall Study|Withdrawal by Subject|4|||
156593164|NCT03364608|565255218|FG000|Overall Study|Protocol Violation|2|||
156593165|NCT03364608|565255218|FG000|Overall Study|Lost to Follow-up|2|||
156593166|NCT03888391|565255221|FG000|Overall Study|Lost to Follow-up|15|||
156593167|NCT02504268|565255224|FG000|Overall Study|Adverse Event|18|||
156593168|NCT02504268|565255225|FG001|Overall Study|Adverse Event|8|||
156593169|NCT02504268|565255226|FG002|Overall Study|Adverse Event|14|||
156593170|NCT02504268|565255227|FG003|Overall Study|Adverse Event|0|||
156593171|NCT02504268|565255228|FG004|Overall Study|Adverse Event|0|||
156593172|NCT02504268|565255229|FG005|Overall Study|Adverse Event|0|||
156593173|NCT02504268|565255230|FG006|Overall Study|Adverse Event|0|||
156593174|NCT02504268|565255231|FG007|Overall Study|Adverse Event|0|||
156593175|NCT02504268|565255232|FG008|Overall Study|Adverse Event|0|||
156593176|NCT02504268|565255224|FG000|Overall Study|Withdrawal of Consent|11|||
156593177|NCT02504268|565255225|FG001|Overall Study|Withdrawal of Consent|10|||
156593178|NCT02504268|565255226|FG002|Overall Study|Withdrawal of Consent|3|||
156593179|NCT02504268|565255227|FG003|Overall Study|Withdrawal of Consent|0|||
156593180|NCT02504268|565255228|FG004|Overall Study|Withdrawal of Consent|0|||
156593181|NCT02504268|565255229|FG005|Overall Study|Withdrawal of Consent|0|||
156593182|NCT02504268|565255230|FG006|Overall Study|Withdrawal of Consent|0|||
156593183|NCT02504268|565255231|FG007|Overall Study|Withdrawal of Consent|0|||
156593184|NCT02504268|565255232|FG008|Overall Study|Withdrawal of Consent|0|||
156593185|NCT02504268|565255224|FG000|Overall Study|Pregnancy|2|||
156593186|NCT02504268|565255225|FG001|Overall Study|Pregnancy|0|||
156593187|NCT02504268|565255226|FG002|Overall Study|Pregnancy|0|||
156593188|NCT02504268|565255227|FG003|Overall Study|Pregnancy|0|||
156593189|NCT02504268|565255228|FG004|Overall Study|Pregnancy|0|||
156593190|NCT02504268|565255229|FG005|Overall Study|Pregnancy|0|||
156593191|NCT02504268|565255230|FG006|Overall Study|Pregnancy|0|||
156593192|NCT02504268|565255231|FG007|Overall Study|Pregnancy|0|||
156593193|NCT02504268|565255232|FG008|Overall Study|Pregnancy|0|||
156593194|NCT02504268|565255224|FG000|Overall Study|Lost to Follow-up|3|||
156593195|NCT02504268|565255225|FG001|Overall Study|Lost to Follow-up|6|||
156593196|NCT02504268|565255226|FG002|Overall Study|Lost to Follow-up|4|||
156593197|NCT02504268|565255227|FG003|Overall Study|Lost to Follow-up|0|||
156593198|NCT02504268|565255228|FG004|Overall Study|Lost to Follow-up|0|||
156593199|NCT02504268|565255229|FG005|Overall Study|Lost to Follow-up|0|||
156593200|NCT02504268|565255230|FG006|Overall Study|Lost to Follow-up|0|||
156593201|NCT02504268|565255231|FG007|Overall Study|Lost to Follow-up|0|||
156593202|NCT02504268|565255232|FG008|Overall Study|Lost to Follow-up|0|||
156593203|NCT02504268|565255224|FG000|Overall Study|Death|1|||
156863668|NCT02246530|566258747|FG001|Overall Study|Lost to Follow-up|0|||
156593204|NCT02504268|565255225|FG001|Overall Study|Death|1|||
156593205|NCT02504268|565255226|FG002|Overall Study|Death|0|||
156593206|NCT02504268|565255227|FG003|Overall Study|Death|0|||
156593207|NCT02504268|565255228|FG004|Overall Study|Death|0|||
156593208|NCT02504268|565255229|FG005|Overall Study|Death|0|||
156593209|NCT02504268|565255230|FG006|Overall Study|Death|0|||
156593210|NCT02504268|565255231|FG007|Overall Study|Death|0|||
156593211|NCT02504268|565255232|FG008|Overall Study|Death|0|||
156593212|NCT02504268|565255224|FG000|Overall Study|Subject Request to Discontinue|11|||
156593213|NCT02504268|565255225|FG001|Overall Study|Subject Request to Discontinue|3|||
156593214|NCT02504268|565255226|FG002|Overall Study|Subject Request to Discontinue|6|||
156593215|NCT02504268|565255227|FG003|Overall Study|Subject Request to Discontinue|0|||
156593216|NCT02504268|565255228|FG004|Overall Study|Subject Request to Discontinue|0|||
156593217|NCT02504268|565255229|FG005|Overall Study|Subject Request to Discontinue|0|||
156593218|NCT02504268|565255230|FG006|Overall Study|Subject Request to Discontinue|0|||
156593219|NCT02504268|565255231|FG007|Overall Study|Subject Request to Discontinue|0|||
156593220|NCT02504268|565255232|FG008|Overall Study|Subject Request to Discontinue|0|||
156593221|NCT02504268|565255224|FG000|Overall Study|No Longer Meets Study Criteria|2|||
156593222|NCT02504268|565255225|FG001|Overall Study|No Longer Meets Study Criteria|3|||
156593223|NCT02504268|565255226|FG002|Overall Study|No Longer Meets Study Criteria|0|||
156593224|NCT02504268|565255227|FG003|Overall Study|No Longer Meets Study Criteria|0|||
156593225|NCT02504268|565255228|FG004|Overall Study|No Longer Meets Study Criteria|0|||
156593226|NCT02504268|565255229|FG005|Overall Study|No Longer Meets Study Criteria|0|||
156593227|NCT02504268|565255230|FG006|Overall Study|No Longer Meets Study Criteria|0|||
156593228|NCT02504268|565255231|FG007|Overall Study|No Longer Meets Study Criteria|0|||
156593229|NCT02504268|565255232|FG008|Overall Study|No Longer Meets Study Criteria|0|||
156593230|NCT02504268|565255224|FG000|Overall Study|Lack of Efficacy|11|||
156593231|NCT02504268|565255225|FG001|Overall Study|Lack of Efficacy|35|||
156593232|NCT02504268|565255226|FG002|Overall Study|Lack of Efficacy|9|||
156593233|NCT02504268|565255227|FG003|Overall Study|Lack of Efficacy|0|||
156593234|NCT02504268|565255228|FG004|Overall Study|Lack of Efficacy|0|||
156593235|NCT02504268|565255229|FG005|Overall Study|Lack of Efficacy|0|||
156593236|NCT02504268|565255230|FG006|Overall Study|Lack of Efficacy|0|||
156593237|NCT02504268|565255231|FG007|Overall Study|Lack of Efficacy|0|||
156593238|NCT02504268|565255232|FG008|Overall Study|Lack of Efficacy|0|||
156593239|NCT02504268|565255224|FG000|Overall Study|Poor/Non-Compliance|3|||
156593240|NCT02504268|565255225|FG001|Overall Study|Poor/Non-Compliance|2|||
156593241|NCT02504268|565255226|FG002|Overall Study|Poor/Non-Compliance|3|||
156593242|NCT02504268|565255227|FG003|Overall Study|Poor/Non-Compliance|0|||
156593243|NCT02504268|565255228|FG004|Overall Study|Poor/Non-Compliance|0|||
156593244|NCT02504268|565255229|FG005|Overall Study|Poor/Non-Compliance|0|||
156593245|NCT02504268|565255230|FG006|Overall Study|Poor/Non-Compliance|0|||
156593246|NCT02504268|565255231|FG007|Overall Study|Poor/Non-Compliance|0|||
156593247|NCT02504268|565255232|FG008|Overall Study|Poor/Non-Compliance|0|||
156593248|NCT02504268|565255224|FG000|Overall Study|Not Disclosed|1|||
156593249|NCT02504268|565255225|FG001|Overall Study|Not Disclosed|0|||
156593250|NCT02504268|565255226|FG002|Overall Study|Not Disclosed|2|||
156593251|NCT02504268|565255227|FG003|Overall Study|Not Disclosed|0|||
156593252|NCT02504268|565255228|FG004|Overall Study|Not Disclosed|0|||
156593253|NCT02504268|565255229|FG005|Overall Study|Not Disclosed|0|||
156593254|NCT02504268|565255230|FG006|Overall Study|Not Disclosed|0|||
156593255|NCT02504268|565255231|FG007|Overall Study|Not Disclosed|0|||
156593256|NCT02504268|565255232|FG008|Overall Study|Not Disclosed|0|||
156593257|NCT03025217|565255233|FG000|Overall Study|Pregnancy|1|||
156593258|NCT03025217|565255233|FG000|Overall Study|Lost to Follow-up|1|||
156593259|NCT03025217|565255233|FG000|Overall Study|Not eligible, poor English|2|||
156593260|NCT03654755|565255239|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
156593261|NCT03654755|565255240|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
156593262|NCT03654755|565255241|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
156593263|NCT03654755|565255239|FG000|Overall Study|Withdrawal by Subject|2|||
156593264|NCT03654755|565255240|FG001|Overall Study|Withdrawal by Subject|4|||
156593265|NCT03654755|565255241|FG002|Overall Study|Withdrawal by Subject|8|||
156593266|NCT03654755|565255239|FG000|Overall Study|Lost to Follow-up|1|||
156593267|NCT03654755|565255240|FG001|Overall Study|Lost to Follow-up|3|||
156593268|NCT03654755|565255241|FG002|Overall Study|Lost to Follow-up|7|||
156593269|NCT03654755|565255239|FG000|Overall Study|Physician Decision|0|||
156593270|NCT03654755|565255240|FG001|Overall Study|Physician Decision|1|||
156593271|NCT03654755|565255241|FG002|Overall Study|Physician Decision|0|||
156593272|NCT03654755|565255239|FG000|Overall Study|Adverse Event|0|||
156593273|NCT03654755|565255240|FG001|Overall Study|Adverse Event|0|||
156593274|NCT03654755|565255241|FG002|Overall Study|Adverse Event|4|||
156593275|NCT03654755|565255239|FG000|Overall Study|Lack of Efficacy|0|||
156593276|NCT03654755|565255240|FG001|Overall Study|Lack of Efficacy|0|||
156593277|NCT03654755|565255241|FG002|Overall Study|Lack of Efficacy|1|||
156593278|NCT00992784|565255243|FG000|Overall Study|Adverse Event|2|||
156593279|NCT00992784|565255244|FG001|Overall Study|Adverse Event|1|||
156593280|NCT00992784|565255245|FG002|Overall Study|Adverse Event|0|||
156593281|NCT00992784|565255243|FG000|Overall Study|Withdrawal by Subject|1|||
156593282|NCT00992784|565255244|FG001|Overall Study|Withdrawal by Subject|1|||
156593283|NCT00992784|565255245|FG002|Overall Study|Withdrawal by Subject|1|||
156593284|NCT00781599|565255246|FG000|Overall Study|Lost to Follow-up|7|||
156593285|NCT00781599|565255247|FG001|Overall Study|Lost to Follow-up|4|||
156593286|NCT01088438|565255248|FG000|Overall Study|Withdrawal by Subject|11|||
156593287|NCT01088438|565255249|FG001|Overall Study|Withdrawal by Subject|6|||
156593288|NCT01088438|565255248|FG000|Overall Study|Lost to Follow-up|18|||
156593289|NCT01088438|565255249|FG001|Overall Study|Lost to Follow-up|30|||
156593290|NCT01363713|565255250|FG000|Overall Study|Adverse Event|1|||
156593291|NCT01363713|565255250|FG000|Overall Study|Protocol Violation|3|||
156593292|NCT01363713|565255250|FG000|Overall Study|Withdrawal by Subject|2|||
156593293|NCT01199055|565255251|FG000|Overall Study|Death|0|||
156593294|NCT01199055|565255252|FG001|Overall Study|Death|1|||
156593295|NCT01199055|565255253|FG002|Overall Study|Death|0|||
156593296|NCT01199055|565255251|FG000|Overall Study|Physician Decision|0|||
156593297|NCT01199055|565255252|FG001|Overall Study|Physician Decision|1|||
156593298|NCT01199055|565255253|FG002|Overall Study|Physician Decision|1|||
156593299|NCT01199055|565255251|FG000|Overall Study|Progressive disease|2|||
156593300|NCT01199055|565255252|FG001|Overall Study|Progressive disease|1|||
156593301|NCT01199055|565255253|FG002|Overall Study|Progressive disease|2|||
156593302|NCT01199055|565255251|FG000|Overall Study|Withdrawal by Subject|0|||
156593303|NCT01199055|565255252|FG001|Overall Study|Withdrawal by Subject|0|||
156593304|NCT01199055|565255253|FG002|Overall Study|Withdrawal by Subject|1|||
156593305|NCT00642746|565255258|FG000|Overall Study|Patient unevaluable|1|||
156593306|NCT00642746|565255259|FG001|Overall Study|Patient unevaluable|0|||
156593307|NCT00424294|565255260|FG000|Overall Study|Adverse Event|4|||
156593308|NCT00424294|565255261|FG001|Overall Study|Adverse Event|10|||
156593309|NCT00424294|565255260|FG000|Overall Study|Lack of Efficacy|2|||
156593310|NCT00424294|565255261|FG001|Overall Study|Lack of Efficacy|1|||
156593311|NCT00424294|565255260|FG000|Overall Study|Withdrawal by Subject|1|||
156593312|NCT00424294|565255261|FG001|Overall Study|Withdrawal by Subject|2|||
156593313|NCT00424294|565255260|FG000|Overall Study|Other|0|||
156593314|NCT00424294|565255261|FG001|Overall Study|Other|2|||
156593315|NCT00424294|565255260|FG000|Overall Study|Randomized but not Treated|1|||
156593316|NCT00424294|565255261|FG001|Overall Study|Randomized but not Treated|0|||
156593317|NCT02108951|565255264|FG000|Overall Study|Lost to Follow-up|1|||
156593318|NCT02108951|565255264|FG000|Overall Study|Patient's/guardian's decision|1|||
156593319|NCT02108951|565255264|FG000|Overall Study|Study Terminated by Sponsor|14|||
156593320|NCT03337152|565255265|FG000|Overall Study|Physician Decision|1|||
156593321|NCT03337152|565255266|FG001|Overall Study|Physician Decision|0|||
156593322|NCT03337152|565255265|FG000|Overall Study|Lost to Follow-up|1|||
156593323|NCT03337152|565255266|FG001|Overall Study|Lost to Follow-up|3|||
156593324|NCT03337152|565255265|FG000|Overall Study|Adverse Event|3|||
156593325|NCT03337152|565255266|FG001|Overall Study|Adverse Event|1|||
156593326|NCT03337152|565255265|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
156593327|NCT03337152|565255266|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
156593328|NCT00718666|565255267|FG000|Booster Phase Year 5|No active participation request|0|||
156593329|NCT00718666|565255268|FG001|Booster Phase Year 5|No active participation request|0|||
156593330|NCT00718666|565255269|FG002|Booster Phase Year 5|No active participation request|1|||
156593331|NCT00718666|565255267|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
156593332|NCT00718666|565255268|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
156593333|NCT00718666|565255269|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
156593334|NCT00718666|565255267|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
156593335|NCT00718666|565255268|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
156593336|NCT00718666|565255269|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
156593337|NCT00718666|565255267|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
156593338|NCT00718666|565255268|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
156593339|NCT00718666|565255269|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
156593340|NCT00421343|565255270|FG000|Overall Study|Death|1|||
156593341|NCT00421343|565255270|FG000|Overall Study|Withdrawal by Subject|2|||
156593342|NCT00421343|565255270|FG000|Overall Study|Lost to Follow-up|3|||
156593343|NCT00678587|565255271|FG000|Overall Study|Adverse Event|3|||
156593344|NCT00678587|565255272|FG001|Overall Study|Adverse Event|3|||
156593345|NCT00678587|565255271|FG000|Overall Study|Lack of Efficacy|1|||
156593346|NCT00678587|565255272|FG001|Overall Study|Lack of Efficacy|0|||
156593347|NCT00678587|565255271|FG000|Overall Study|Protocol Violation|2|||
156593348|NCT00678587|565255272|FG001|Overall Study|Protocol Violation|1|||
156593349|NCT00678587|565255271|FG000|Overall Study|Study Closed/Terminated|1|||
156593350|NCT00678587|565255272|FG001|Overall Study|Study Closed/Terminated|0|||
156593351|NCT00678587|565255271|FG000|Overall Study|Lost to Follow-up|3|||
156593352|NCT00678587|565255272|FG001|Overall Study|Lost to Follow-up|5|||
156593353|NCT00678587|565255271|FG000|Overall Study|Investigator Discretion|2|||
156593354|NCT00678587|565255272|FG001|Overall Study|Investigator Discretion|6|||
156593355|NCT00678587|565255271|FG000|Overall Study|Withdrew Consent|8|||
156593356|NCT00678587|565255272|FG001|Overall Study|Withdrew Consent|3|||
156593357|NCT03806179|565255273|FG000|Overall Study|Progressive disease|0|||
156593358|NCT03806179|565255274|FG001|Overall Study|Progressive disease|2|||
156593359|NCT04032171|565256504|FG000|Overall Study|Study Termination|1|||
156593360|NCT04032171|565256505|FG001|Overall Study|Study Termination|0|||
156593361|NCT00289185|565256506|FG000|Overall Study|Withdrawal by Subject|4|||
156593362|NCT00289185|565256507|FG001|Overall Study|Withdrawal by Subject|8|||
156593363|NCT00289185|565256506|FG000|Overall Study|Lost to Follow-up|23|||
156593364|NCT00289185|565256507|FG001|Overall Study|Lost to Follow-up|17|||
156593365|NCT00289185|565256506|FG000|Overall Study|Death|1|||
156593366|NCT00289185|565256507|FG001|Overall Study|Death|1|||
156593367|NCT01124448|565256510|FG000|Overall Study|Lost to Follow-up|0|||
156593368|NCT01124448|565256511|FG001|Overall Study|Lost to Follow-up|3|||
156593369|NCT01124448|565256510|FG000|Overall Study|Protocol Violation|2|||
156593370|NCT01124448|565256511|FG001|Overall Study|Protocol Violation|0|||
156593371|NCT03471767|565256512|FG000|Overall Study|Withdrawal by Subject|3|||
156593372|NCT03471767|565256513|FG001|Overall Study|Withdrawal by Subject|1|||
156593373|NCT03471767|565256512|FG000|Overall Study|Adverse Event|1|||
156593374|NCT03471767|565256513|FG001|Overall Study|Adverse Event|0|||
156593375|NCT03471767|565256512|FG000|Overall Study|Lost to Follow-up|1|||
156593376|NCT03471767|565256513|FG001|Overall Study|Lost to Follow-up|0|||
156593377|NCT03471767|565256512|FG000|Overall Study|PI Withdrawal|1|||
156593378|NCT03471767|565256513|FG001|Overall Study|PI Withdrawal|3|||
156593379|NCT01952730|565256514|FG000|Overall Study|FDA shut down core lab used by study|1|||
156593380|NCT00976950|565256517|FG000|Overall Study|Adverse Event|3|||
156593381|NCT00976950|565256517|FG000|Overall Study|Events with no relationship to Aptivus|3|||
156593382|NCT01514188|565256520|FG000|Overall Study|Adverse Event|3|||
156593383|NCT01514188|565256521|FG001|Overall Study|Adverse Event|5|||
156593384|NCT01514188|565256520|FG000|Overall Study|Withdrawal by Subject|2|||
156593385|NCT01514188|565256521|FG001|Overall Study|Withdrawal by Subject|4|||
156593386|NCT01514188|565256520|FG000|Overall Study|Protocol Violation|2|||
156593387|NCT01514188|565256521|FG001|Overall Study|Protocol Violation|4|||
156593388|NCT01514188|565256520|FG000|Overall Study|Physician Decision|0|||
156593389|NCT01514188|565256521|FG001|Overall Study|Physician Decision|2|||
156593390|NCT01514188|565256520|FG000|Overall Study|Disease Progression|13|||
156593391|NCT01514188|565256521|FG001|Overall Study|Disease Progression|14|||
156593392|NCT01514188|565256520|FG000|Overall Study|Death|1|||
156593393|NCT01514188|565256521|FG001|Overall Study|Death|3|||
156593394|NCT01514188|565256520|FG000|Overall Study|Other|2|||
156593395|NCT01514188|565256521|FG001|Overall Study|Other|1|||
156593396|NCT01019486|565256522|FG000|Overall Study|Withdrawal by Subject|1|||
156593397|NCT01019486|565256523|FG001|Overall Study|Withdrawal by Subject|1|||
156593398|NCT01019486|565256524|FG002|Overall Study|Withdrawal by Subject|1|||
156593399|NCT02932332|565256525|FG000|Overall Study|Withdrawal by Subject|1|||
156593400|NCT02932332|565256526|FG001|Overall Study|Withdrawal by Subject|1|||
156593401|NCT02932332|565256527|FG002|Overall Study|Withdrawal by Subject|0|||
156593402|NCT02932332|565256528|FG003|Overall Study|Withdrawal by Subject|1|||
156593403|NCT02932332|565256525|FG000|Overall Study|Chest pain|0|||
156593404|NCT02932332|565256526|FG001|Overall Study|Chest pain|0|||
156593405|NCT02932332|565256527|FG002|Overall Study|Chest pain|0|||
156593406|NCT02932332|565256528|FG003|Overall Study|Chest pain|1|||
156593407|NCT02932332|565256525|FG000|Overall Study|Not Dyspneic cough|1|||
156593408|NCT02932332|565256526|FG001|Overall Study|Not Dyspneic cough|2|||
156593409|NCT02932332|565256527|FG002|Overall Study|Not Dyspneic cough|1|||
156593410|NCT02932332|565256528|FG003|Overall Study|Not Dyspneic cough|0|||
156593411|NCT03442829|565256530|FG000|Overall Study|Scheduling clash|3|||
156593412|NCT03442829|565256531|FG001|Overall Study|Scheduling clash|1|||
156593413|NCT03442829|565256530|FG000|Overall Study|Illness unrelated to study|1|||
156593414|NCT03442829|565256531|FG001|Overall Study|Illness unrelated to study|1|||
156593415|NCT02493426|565256532|FG000|Overall Study|Withdrawal by Subject|0|||
156593416|NCT02493426|565256533|FG001|Overall Study|Withdrawal by Subject|1|||
156593417|NCT01069523|565256534|FG000|Overall Study|Withdrawal by Subject|4|||
156593418|NCT01069523|565256535|FG001|Overall Study|Withdrawal by Subject|7|||
156593419|NCT01875367|565256538|FG000|Overall Study|Not complete at least 2 questionaries|4|||
156593420|NCT01875367|565256539|FG001|Overall Study|Not complete at least 2 questionaries|2|||
156593421|NCT01875367|565256538|FG000|Overall Study|Not receive study treatment|1|||
156593422|NCT01875367|565256539|FG001|Overall Study|Not receive study treatment|0|||
156593423|NCT02605447|565256542|FG000|Overall Study|Death|66|||
156593424|NCT02605447|565256542|FG000|Overall Study|Physician Decision|1|||
156593425|NCT02605447|565256542|FG000|Overall Study|Lost to Follow-up|24|||
156593426|NCT02605447|565256542|FG000|Overall Study|Withdrawal by Subject|10|||
156593427|NCT02605447|565256542|FG000|Overall Study|Not disclosed|1|||
156593428|NCT02237157|565256543|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
156593429|NCT02237157|565256544|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
156593430|NCT02237157|565256545|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
156593431|NCT02237157|565256546|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
156593432|NCT02237157|565256543|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
156863669|NCT01506596|566258748|FG000|Overall Study|ineligible pathology|1|||
156593433|NCT02237157|565256544|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
156593434|NCT02237157|565256545|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
156593435|NCT02237157|565256546|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
156593436|NCT04533815|565256551|FG000|Overall Study|Adverse Event|2|||
156593437|NCT04533815|565256551|FG000|Overall Study|Site withdrew|5|||
156593438|NCT02045212|565256552|FG000|Overall Study|Adverse Event|0|||
156593439|NCT02045212|565256553|FG001|Overall Study|Adverse Event|1|||
156593440|NCT02045212|565256552|FG000|Overall Study|Withdrawal by Subject|1|||
156593441|NCT02045212|565256553|FG001|Overall Study|Withdrawal by Subject|0|||
156593442|NCT02045212|565256552|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
156593443|NCT02045212|565256553|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
156593444|NCT00488592|565256554|FG000|Overall Study|Withdrawal by Subject|1|||
156593445|NCT00488592|565256554|FG000|Overall Study|Disease progression|1|||
156593446|NCT00488592|565256554|FG000|Overall Study|Enrolled but not treated|1|||
156593447|NCT00441103|565256555|FG000|Overall Study|Adverse Event|2|||
156593448|NCT00441103|565256556|FG001|Overall Study|Adverse Event|1|||
156593449|NCT00441103|565256555|FG000|Overall Study|Death|1|||
156593450|NCT00441103|565256556|FG001|Overall Study|Death|0|||
156593451|NCT00441103|565256555|FG000|Overall Study|Disease Progression|2|||
156593452|NCT00441103|565256556|FG001|Overall Study|Disease Progression|0|||
156593453|NCT00441103|565256555|FG000|Overall Study|Lost to Follow-up|1|||
156593454|NCT00441103|565256556|FG001|Overall Study|Lost to Follow-up|0|||
156593455|NCT00441103|565256555|FG000|Overall Study|Protocol Violation|1|||
156593456|NCT00441103|565256556|FG001|Overall Study|Protocol Violation|0|||
156593457|NCT00441103|565256555|FG000|Overall Study|Participant unable to use Rebiject II|1|||
156593458|NCT00441103|565256556|FG001|Overall Study|Participant unable to use Rebiject II|0|||
156593459|NCT00441103|565256555|FG000|Overall Study|Participant refused MRI|1|||
156593460|NCT00441103|565256556|FG001|Overall Study|Participant refused MRI|0|||
156593461|NCT00441103|565256555|FG000|Overall Study|Inclusion criteria absent|1|||
156593462|NCT00441103|565256556|FG001|Overall Study|Inclusion criteria absent|0|||
156593463|NCT00441103|565256555|FG000|Overall Study|Non-compliant|0|||
156593464|NCT00441103|565256556|FG001|Overall Study|Non-compliant|1|||
156593465|NCT00441103|565256555|FG000|Overall Study|Participant decided to withdraw|1|||
156593466|NCT00441103|565256556|FG001|Overall Study|Participant decided to withdraw|0|||
156593467|NCT00441103|565256555|FG000|Overall Study|Participant's reason|0|||
156593468|NCT00441103|565256556|FG001|Overall Study|Participant's reason|1|||
156593469|NCT00441103|565256555|FG000|Overall Study|Participant decided to stop|0|||
156593470|NCT00441103|565256556|FG001|Overall Study|Participant decided to stop|1|||
156593471|NCT05836818|565256557|FG000|Overall Study|Physician Decision|1|||
156593472|NCT05836818|565256558|FG001|Overall Study|Physician Decision|1|||
156593473|NCT05836818|565256559|FG002|Overall Study|Physician Decision|0|||
156593474|NCT05836818|565256557|FG000|Overall Study|Withdrawal by Subject|0|||
156593475|NCT05836818|565256558|FG001|Overall Study|Withdrawal by Subject|0|||
156593476|NCT05836818|565256559|FG002|Overall Study|Withdrawal by Subject|1|||
156593477|NCT05836818|565256557|FG000|Overall Study|Later found to be previously vaccinated|0|||
156593478|NCT05836818|565256558|FG001|Overall Study|Later found to be previously vaccinated|1|||
156593479|NCT05836818|565256559|FG002|Overall Study|Later found to be previously vaccinated|3|||
156593480|NCT05836818|565256557|FG000|Overall Study|Pregnancy|0|||
156593481|NCT05836818|565256558|FG001|Overall Study|Pregnancy|1|||
156593482|NCT05836818|565256559|FG002|Overall Study|Pregnancy|0|||
156593483|NCT05836818|565256557|FG000|Overall Study|Allergic to vaccines|0|||
156593484|NCT05836818|565256558|FG001|Overall Study|Allergic to vaccines|1|||
156593485|NCT05836818|565256559|FG002|Overall Study|Allergic to vaccines|0|||
156593486|NCT03738566|565256560|FG000|Initial Study Phase|Withdrawal by Subject|1|||
156593487|NCT03738566|565256561|FG001|Initial Study Phase|Withdrawal by Subject|1|||
156593488|NCT03738566|565256562|FG002|Initial Study Phase|Withdrawal by Subject|2|||
156593489|NCT03738566|565256563|FG003|Initial Study Phase|Withdrawal by Subject|0|||
156593490|NCT03738566|565256560|FG000|Initial Study Phase|Death|0|||
156593491|NCT03738566|565256561|FG001|Initial Study Phase|Death|1|||
156593492|NCT03738566|565256562|FG002|Initial Study Phase|Death|0|||
156593493|NCT03738566|565256563|FG003|Initial Study Phase|Death|0|||
156593494|NCT03738566|565256560|FG000|Initial Study Phase|Treatment failure|5|||
156593495|NCT03738566|565256561|FG001|Initial Study Phase|Treatment failure|0|||
156593496|NCT03738566|565256562|FG002|Initial Study Phase|Treatment failure|0|||
156593497|NCT03738566|565256563|FG003|Initial Study Phase|Treatment failure|0|||
156593498|NCT03738566|565256560|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
156593499|NCT03738566|565256561|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
156593500|NCT03738566|565256562|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
156593501|NCT03738566|565256563|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
156593502|NCT03126539|565256567|FG000|Overall Study|Lost to Follow-up|1|||
156593503|NCT03126539|565256568|FG001|Overall Study|Lost to Follow-up|1|||
156593504|NCT03126539|565256569|FG002|Overall Study|Lost to Follow-up|1|||
156593505|NCT03126539|565256570|FG003|Overall Study|Lost to Follow-up|0|||
156593506|NCT03126539|565256571|FG004|Overall Study|Lost to Follow-up|0|||
156593507|NCT01627067|565256572|FG000|Overall Study|Screen Failure|1|||
156593508|NCT00926796|565256573|FG000|Overall Study|Did not receive randomized treatment|4|||
156593509|NCT00926796|565256574|FG001|Overall Study|Did not receive randomized treatment|7|||
156593510|NCT00926796|565256573|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
156593511|NCT00926796|565256574|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
156593512|NCT00926796|565256573|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
156593513|NCT00926796|565256574|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
156593514|NCT00926796|565256573|FG000|Overall Study|Adverse Event|7|||
156593515|NCT00926796|565256574|FG001|Overall Study|Adverse Event|14|||
156593516|NCT00926796|565256573|FG000|Overall Study|Lost to Follow-up|22|||
156593517|NCT00926796|565256574|FG001|Overall Study|Lost to Follow-up|13|||
156593518|NCT00926796|565256573|FG000|Overall Study|Protocol Violation|15|||
156593519|NCT00926796|565256574|FG001|Overall Study|Protocol Violation|11|||
156593520|NCT00926796|565256573|FG000|Overall Study|Withdrawal by Subject|1|||
156593521|NCT00926796|565256574|FG001|Overall Study|Withdrawal by Subject|0|||
156593522|NCT01072539|565256580|FG000|Overall Study|Treated prior to the Site Initiation|1|||
156593523|NCT01072539|565256580|FG000|Overall Study|Protocol Violation|2|||
156593524|NCT00946530|565256581|FG000|Overall Study|Withdrawal by Subject|0|||
156593525|NCT00946530|565256582|FG001|Overall Study|Withdrawal by Subject|3|||
156593526|NCT00946530|565256583|FG002|Overall Study|Withdrawal by Subject|0|||
156593527|NCT00946530|565256584|FG003|Overall Study|Withdrawal by Subject|3|||
156593528|NCT00946530|565256581|FG000|Overall Study|Physician Decision|1|||
156593529|NCT00946530|565256582|FG001|Overall Study|Physician Decision|1|||
156593530|NCT00946530|565256583|FG002|Overall Study|Physician Decision|1|||
156593531|NCT00946530|565256584|FG003|Overall Study|Physician Decision|1|||
156593532|NCT00115804|565256585|FG000|Overall Study|Adverse Event|2|||
156593533|NCT00621855|565256586|FG000|Overall Study|Adverse Event|32|||
156593534|NCT00621855|565256587|FG001|Overall Study|Adverse Event|31|||
156593535|NCT00621855|565256588|FG002|Overall Study|Adverse Event|48|||
156593536|NCT00621855|565256589|FG003|Overall Study|Adverse Event|34|||
156593537|NCT00621855|565256590|FG004|Overall Study|Adverse Event|31|||
156593538|NCT00621855|565256586|FG000|Overall Study|Lost to Follow-up|0|||
156593539|NCT00621855|565256587|FG001|Overall Study|Lost to Follow-up|1|||
156593540|NCT00621855|565256588|FG002|Overall Study|Lost to Follow-up|3|||
156593541|NCT00621855|565256589|FG003|Overall Study|Lost to Follow-up|4|||
156593542|NCT00621855|565256590|FG004|Overall Study|Lost to Follow-up|1|||
156593543|NCT00621855|565256586|FG000|Overall Study|Protocol Violation|16|||
156593544|NCT00621855|565256587|FG001|Overall Study|Protocol Violation|8|||
156593545|NCT00621855|565256588|FG002|Overall Study|Protocol Violation|6|||
156593546|NCT00621855|565256589|FG003|Overall Study|Protocol Violation|7|||
156593547|NCT00621855|565256590|FG004|Overall Study|Protocol Violation|8|||
156593548|NCT00621855|565256586|FG000|Overall Study|Withdrawal by Subject|16|||
156593549|NCT00621855|565256587|FG001|Overall Study|Withdrawal by Subject|11|||
156593550|NCT00621855|565256588|FG002|Overall Study|Withdrawal by Subject|13|||
156593551|NCT00621855|565256589|FG003|Overall Study|Withdrawal by Subject|13|||
156593552|NCT00621855|565256590|FG004|Overall Study|Withdrawal by Subject|9|||
156593553|NCT00621855|565256586|FG000|Overall Study|Other|9|||
156593554|NCT00621855|565256587|FG001|Overall Study|Other|7|||
156593555|NCT00621855|565256588|FG002|Overall Study|Other|6|||
156593556|NCT00621855|565256589|FG003|Overall Study|Other|5|||
156593557|NCT00621855|565256590|FG004|Overall Study|Other|4|||
156593558|NCT00621855|565256586|FG000|Overall Study|Patients did not receive study drug|3|||
156593559|NCT00621855|565256587|FG001|Overall Study|Patients did not receive study drug|3|||
156593560|NCT00621855|565256588|FG002|Overall Study|Patients did not receive study drug|5|||
156593561|NCT00621855|565256589|FG003|Overall Study|Patients did not receive study drug|4|||
156593562|NCT00621855|565256590|FG004|Overall Study|Patients did not receive study drug|2|||
156593563|NCT04387136|565256591|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
156593564|NCT04387136|565256592|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
156593565|NCT01029886|565256595|FG000|Overall Study|Adverse Event|12|||
156593566|NCT01029886|565256596|FG001|Overall Study|Adverse Event|25|||
156593567|NCT01029886|565256595|FG000|Overall Study|Lost to Follow-up|1|||
156593568|NCT01029886|565256596|FG001|Overall Study|Lost to Follow-up|0|||
156593569|NCT01029886|565256595|FG000|Overall Study|Physician Decision|2|||
156593570|NCT01029886|565256596|FG001|Overall Study|Physician Decision|6|||
156593571|NCT01029886|565256595|FG000|Overall Study|Protocol Violation|17|||
156593572|NCT01029886|565256596|FG001|Overall Study|Protocol Violation|5|||
156593573|NCT01029886|565256595|FG000|Overall Study|Withdrawal by Subject|8|||
156593574|NCT01029886|565256596|FG001|Overall Study|Withdrawal by Subject|18|||
156593575|NCT01029886|565256595|FG000|Overall Study|Entry Criteria Not Met|13|||
156593576|NCT01029886|565256596|FG001|Overall Study|Entry Criteria Not Met|5|||
156593577|NCT01029886|565256595|FG000|Overall Study|Sponsor Decision|1|||
156593578|NCT01029886|565256596|FG001|Overall Study|Sponsor Decision|0|||
156593579|NCT01029886|565256595|FG000|Overall Study|Loss Glucose Control|7|||
156593580|NCT01029886|565256596|FG001|Overall Study|Loss Glucose Control|1|||
156593581|NCT03294681|565256597|FG000|Overall Study|Withdrawal by Subject|1|||
156593582|NCT03089216|565256600|FG000|Overall Study|Adverse Event|0|||
156593583|NCT03089216|565256601|FG001|Overall Study|Adverse Event|0|||
156593584|NCT03089216|565256602|FG002|Overall Study|Adverse Event|0|||
156593585|NCT03089216|565256603|FG003|Overall Study|Adverse Event|1|||
156593586|NCT00417976|565256604|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
156593587|NCT00417976|565256604|FG000|Overall Study|Treatment -related toxicity|2|||
156593588|NCT04501679|565256605|FG000|Overall Study|Pregnancy|0|||
156593589|NCT04501679|565256606|FG001|Overall Study|Pregnancy|1|||
156593590|NCT04501679|565256605|FG000|Overall Study|Adverse Event|4|||
156593591|NCT04501679|565256606|FG001|Overall Study|Adverse Event|2|||
156593592|NCT04501679|565256605|FG000|Overall Study|Withdrawal by Subject|2|||
156593593|NCT04501679|565256606|FG001|Overall Study|Withdrawal by Subject|0|||
156593594|NCT04501679|565256605|FG000|Overall Study|Physician Decision|1|||
156593595|NCT04501679|565256606|FG001|Overall Study|Physician Decision|0|||
156593596|NCT04501679|565256605|FG000|Overall Study|Lost to Follow-up|2|||
156593597|NCT04501679|565256606|FG001|Overall Study|Lost to Follow-up|0|||
156593598|NCT02121756|565256609|FG000|Overall Study|Adverse Event|3|||
156593599|NCT02121756|565256610|FG001|Overall Study|Adverse Event|0|||
156593600|NCT02121756|565256609|FG000|Overall Study|Protocol Violation|1|||
156593601|NCT02121756|565256610|FG001|Overall Study|Protocol Violation|1|||
156593602|NCT02121756|565256609|FG000|Overall Study|Physician Decision|2|||
156593603|NCT02121756|565256610|FG001|Overall Study|Physician Decision|1|||
156593604|NCT00751114|565256611|FG000|Overall Study|Adverse Event|2|||
156593605|NCT00751114|565256612|FG001|Overall Study|Adverse Event|4|||
156593606|NCT00751114|565256611|FG000|Overall Study|Protocol Violation|8|||
156593607|NCT00751114|565256612|FG001|Overall Study|Protocol Violation|9|||
156593608|NCT00751114|565256611|FG000|Overall Study|Withdrawal by Subject|9|||
156593609|NCT00751114|565256612|FG001|Overall Study|Withdrawal by Subject|4|||
156593610|NCT00751114|565256611|FG000|Overall Study|Lost to Follow-up|4|||
156593611|NCT00751114|565256612|FG001|Overall Study|Lost to Follow-up|7|||
156593612|NCT00751114|565256611|FG000|Overall Study|Lack of Efficacy|0|||
156593613|NCT00751114|565256612|FG001|Overall Study|Lack of Efficacy|7|||
156593614|NCT00751114|565256611|FG000|Overall Study|Not Treated|13|||
156593615|NCT00751114|565256612|FG001|Overall Study|Not Treated|1|||
156593616|NCT00751114|565256611|FG000|Overall Study|Out of country for 2 months|1|||
156593617|NCT00751114|565256612|FG001|Overall Study|Out of country for 2 months|0|||
156593618|NCT00751114|565256611|FG000|Overall Study|Move to another city|1|||
156593619|NCT00751114|565256612|FG001|Overall Study|Move to another city|0|||
156593620|NCT02358369|565256613|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
156593621|NCT02358369|565256614|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
156593622|NCT02358369|565256615|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
156593623|NCT02358369|565256616|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
156593624|NCT02358369|565256617|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
156593625|NCT02358369|565256613|FG000|Treatment Period A/B|Adverse Event|0|||
156593626|NCT02358369|565256614|FG001|Treatment Period A/B|Adverse Event|0|||
156593627|NCT02358369|565256615|FG002|Treatment Period A/B|Adverse Event|1|||
156593628|NCT02358369|565256616|FG003|Treatment Period A/B|Adverse Event|2|||
156593629|NCT02358369|565256617|FG004|Treatment Period A/B|Adverse Event|0|||
156593630|NCT02358369|565256613|FG000|Treatment Period A/B|Death|0|||
156593631|NCT02358369|565256614|FG001|Treatment Period A/B|Death|0|||
156593632|NCT02358369|565256615|FG002|Treatment Period A/B|Death|1|||
156593633|NCT02358369|565256616|FG003|Treatment Period A/B|Death|0|||
156593634|NCT02358369|565256617|FG004|Treatment Period A/B|Death|0|||
156593635|NCT02358369|565256613|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
156593636|NCT02358369|565256614|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
156593637|NCT02358369|565256615|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
156593638|NCT02358369|565256616|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
156593639|NCT02358369|565256617|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
156593640|NCT02358369|565256613|FG000|Treatment Period C|Adverse Event|0|||
156593641|NCT02358369|565256614|FG001|Treatment Period C|Adverse Event|0|||
156593642|NCT02358369|565256615|FG002|Treatment Period C|Adverse Event|0|||
156593643|NCT02358369|565256616|FG003|Treatment Period C|Adverse Event|0|||
156593644|NCT02358369|565256617|FG004|Treatment Period C|Adverse Event|7|||
156593645|NCT03095521|565256618|FG000|Overall Study|Withdrawal by Subject|0|||
156593646|NCT03095521|565256619|FG001|Overall Study|Withdrawal by Subject|1|||
156593647|NCT03095521|565256618|FG000|Overall Study|Lost to Follow-up|0|||
156593648|NCT03095521|565256619|FG001|Overall Study|Lost to Follow-up|1|||
156593649|NCT01536119|565256622|FG000|Overall Study|Lost to Follow-up|17|||
156593650|NCT01536119|565256623|FG001|Overall Study|Lost to Follow-up|14|||
156593651|NCT04191577|565256624|FG000|Overall Study|Withdrawal by Subject|2|||
156593652|NCT04191577|565256625|FG001|Overall Study|Withdrawal by Subject|2|||
156593653|NCT04191577|565256626|FG002|Overall Study|Withdrawal by Subject|1|||
156593654|NCT04191577|565256624|FG000|Overall Study|Physician Decision|1|||
156593655|NCT04191577|565256625|FG001|Overall Study|Physician Decision|1|||
156593656|NCT04191577|565256626|FG002|Overall Study|Physician Decision|0|||
156593657|NCT04191577|565256624|FG000|Overall Study|Adverse Event|0|||
156593658|NCT04191577|565256625|FG001|Overall Study|Adverse Event|0|||
156593659|NCT04191577|565256626|FG002|Overall Study|Adverse Event|1|||
156593660|NCT04191577|565256624|FG000|Overall Study|Death|0|||
156593661|NCT04191577|565256625|FG001|Overall Study|Death|0|||
156593662|NCT04191577|565256626|FG002|Overall Study|Death|1|||
156593663|NCT00430521|565256629|FG000|Overall Study|Adverse Event|0|||
156593664|NCT00430521|565256630|FG001|Overall Study|Adverse Event|0|||
156593665|NCT00430521|565256631|FG002|Overall Study|Adverse Event|0|||
156593666|NCT00430521|565256632|FG003|Overall Study|Adverse Event|0|||
156593667|NCT00430521|565256633|FG004|Overall Study|Adverse Event|0|||
156593668|NCT00430521|565256634|FG005|Overall Study|Adverse Event|2|||
156593669|NCT00430521|565256635|FG006|Overall Study|Adverse Event|1|||
156593670|NCT00430521|565256636|FG007|Overall Study|Adverse Event|0|||
156593671|NCT00430521|565256629|FG000|Overall Study|Lost to Follow-up|7|||
156593672|NCT00430521|565256630|FG001|Overall Study|Lost to Follow-up|8|||
156593673|NCT00430521|565256631|FG002|Overall Study|Lost to Follow-up|3|||
156593674|NCT00430521|565256632|FG003|Overall Study|Lost to Follow-up|5|||
156593675|NCT00430521|565256633|FG004|Overall Study|Lost to Follow-up|5|||
156593676|NCT00430521|565256634|FG005|Overall Study|Lost to Follow-up|2|||
156593677|NCT00430521|565256635|FG006|Overall Study|Lost to Follow-up|8|||
156593678|NCT00430521|565256636|FG007|Overall Study|Lost to Follow-up|10|||
156593679|NCT00430521|565256629|FG000|Overall Study|Pregnancy|0|||
156593680|NCT00430521|565256630|FG001|Overall Study|Pregnancy|0|||
156593681|NCT00430521|565256631|FG002|Overall Study|Pregnancy|0|||
156593682|NCT00430521|565256632|FG003|Overall Study|Pregnancy|0|||
156593683|NCT00430521|565256633|FG004|Overall Study|Pregnancy|0|||
156593684|NCT00430521|565256634|FG005|Overall Study|Pregnancy|0|||
156593685|NCT00430521|565256635|FG006|Overall Study|Pregnancy|1|||
156593686|NCT00430521|565256636|FG007|Overall Study|Pregnancy|0|||
156593687|NCT00430521|565256629|FG000|Overall Study|Vaccine Expired|0|||
156593688|NCT00430521|565256630|FG001|Overall Study|Vaccine Expired|0|||
156593689|NCT00430521|565256631|FG002|Overall Study|Vaccine Expired|0|||
156593690|NCT00430521|565256632|FG003|Overall Study|Vaccine Expired|0|||
156593691|NCT00430521|565256633|FG004|Overall Study|Vaccine Expired|0|||
156593692|NCT00430521|565256634|FG005|Overall Study|Vaccine Expired|1|||
156593693|NCT00430521|565256635|FG006|Overall Study|Vaccine Expired|0|||
156593694|NCT00430521|565256636|FG007|Overall Study|Vaccine Expired|0|||
156593695|NCT00430521|565256629|FG000|Overall Study|Protocol Violation|1|||
156593696|NCT00430521|565256630|FG001|Overall Study|Protocol Violation|0|||
156593697|NCT00430521|565256631|FG002|Overall Study|Protocol Violation|0|||
156593698|NCT00430521|565256632|FG003|Overall Study|Protocol Violation|0|||
156593699|NCT00430521|565256633|FG004|Overall Study|Protocol Violation|0|||
156593700|NCT00430521|565256634|FG005|Overall Study|Protocol Violation|0|||
156593701|NCT00430521|565256635|FG006|Overall Study|Protocol Violation|0|||
156593702|NCT00430521|565256636|FG007|Overall Study|Protocol Violation|0|||
156593703|NCT00430521|565256629|FG000|Overall Study|Withdrawal by Subject|3|||
156593704|NCT00430521|565256630|FG001|Overall Study|Withdrawal by Subject|1|||
156593705|NCT00430521|565256631|FG002|Overall Study|Withdrawal by Subject|0|||
156593706|NCT00430521|565256632|FG003|Overall Study|Withdrawal by Subject|3|||
156593707|NCT00430521|565256633|FG004|Overall Study|Withdrawal by Subject|0|||
156593708|NCT00430521|565256634|FG005|Overall Study|Withdrawal by Subject|0|||
156593709|NCT00430521|565256635|FG006|Overall Study|Withdrawal by Subject|0|||
156593710|NCT00430521|565256636|FG007|Overall Study|Withdrawal by Subject|2|||
156593711|NCT01274338|565258068|FG000|Overall Study|Lack of Efficacy|72|||
156593712|NCT01274338|565258069|FG001|Overall Study|Lack of Efficacy|108|||
156593713|NCT01274338|565258070|FG002|Overall Study|Lack of Efficacy|116|||
156593714|NCT01274338|565258071|FG003|Overall Study|Lack of Efficacy|0|||
156593715|NCT01274338|565258072|FG004|Overall Study|Lack of Efficacy|0|||
156593716|NCT01274338|565258073|FG005|Overall Study|Lack of Efficacy|0|||
156593717|NCT01274338|565258068|FG000|Overall Study|Adverse Event|272|||
156593718|NCT01274338|565258069|FG001|Overall Study|Adverse Event|105|||
156593719|NCT01274338|565258070|FG002|Overall Study|Adverse Event|180|||
156593720|NCT01274338|565258071|FG003|Overall Study|Adverse Event|1|||
156593721|NCT01274338|565258072|FG004|Overall Study|Adverse Event|0|||
156593722|NCT01274338|565258073|FG005|Overall Study|Adverse Event|0|||
156593723|NCT01274338|565258068|FG000|Overall Study|Death|8|||
156593724|NCT01274338|565258069|FG001|Overall Study|Death|1|||
156593725|NCT01274338|565258070|FG002|Overall Study|Death|0|||
156593726|NCT01274338|565258071|FG003|Overall Study|Death|0|||
156593727|NCT01274338|565258072|FG004|Overall Study|Death|0|||
156593728|NCT01274338|565258073|FG005|Overall Study|Death|0|||
156593729|NCT01274338|565258068|FG000|Overall Study|Withdrawal by Subject|27|||
156593730|NCT01274338|565258069|FG001|Overall Study|Withdrawal by Subject|99|||
156593731|NCT01274338|565258070|FG002|Overall Study|Withdrawal by Subject|17|||
156593732|NCT01274338|565258071|FG003|Overall Study|Withdrawal by Subject|0|||
156593733|NCT01274338|565258072|FG004|Overall Study|Withdrawal by Subject|0|||
156593734|NCT01274338|565258073|FG005|Overall Study|Withdrawal by Subject|0|||
156593735|NCT01274338|565258068|FG000|Overall Study|Did not start treatment|8|||
156593736|NCT01274338|565258069|FG001|Overall Study|Did not start treatment|116|||
156593737|NCT01274338|565258070|FG002|Overall Study|Did not start treatment|7|||
156593738|NCT01274338|565258071|FG003|Overall Study|Did not start treatment|0|||
156593739|NCT01274338|565258072|FG004|Overall Study|Did not start treatment|0|||
156593740|NCT01274338|565258073|FG005|Overall Study|Did not start treatment|0|||
156593741|NCT01274338|565258068|FG000|Overall Study|Alternative therapy|0|||
156593742|NCT01274338|565258069|FG001|Overall Study|Alternative therapy|1|||
156593743|NCT01274338|565258070|FG002|Overall Study|Alternative therapy|0|||
156593744|NCT01274338|565258071|FG003|Overall Study|Alternative therapy|0|||
156593745|NCT01274338|565258072|FG004|Overall Study|Alternative therapy|0|||
156593746|NCT01274338|565258073|FG005|Overall Study|Alternative therapy|0|||
156593747|NCT01274338|565258068|FG000|Overall Study|Other complicating diseases|0|||
156593748|NCT01274338|565258069|FG001|Overall Study|Other complicating diseases|3|||
156593749|NCT01274338|565258070|FG002|Overall Study|Other complicating diseases|1|||
156593750|NCT01274338|565258071|FG003|Overall Study|Other complicating diseases|0|||
156593751|NCT01274338|565258072|FG004|Overall Study|Other complicating diseases|0|||
156593752|NCT01274338|565258073|FG005|Overall Study|Other complicating diseases|0|||
156593753|NCT01274338|565258068|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
156593754|NCT01274338|565258069|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
156593755|NCT01274338|565258070|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
156593756|NCT01274338|565258071|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
156593757|NCT01274338|565258072|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
156593758|NCT01274338|565258073|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
156593759|NCT01274338|565258068|FG000|Overall Study|Pregnancy|0|||
156593760|NCT01274338|565258069|FG001|Overall Study|Pregnancy|0|||
156593761|NCT01274338|565258070|FG002|Overall Study|Pregnancy|1|||
156593762|NCT01274338|565258071|FG003|Overall Study|Pregnancy|0|||
156593763|NCT01274338|565258072|FG004|Overall Study|Pregnancy|0|||
156593764|NCT01274338|565258073|FG005|Overall Study|Pregnancy|0|||
156593765|NCT01274338|565258068|FG000|Overall Study|Reason not reported|12|||
156593766|NCT01274338|565258069|FG001|Overall Study|Reason not reported|21|||
156593767|NCT01274338|565258070|FG002|Overall Study|Reason not reported|3|||
156593768|NCT01274338|565258071|FG003|Overall Study|Reason not reported|0|||
156593769|NCT01274338|565258072|FG004|Overall Study|Reason not reported|1|||
156593770|NCT01274338|565258073|FG005|Overall Study|Reason not reported|0|||
156593771|NCT01927744|565258074|FG000|Overall Study|Death|2|||
156593772|NCT01927744|565258075|FG001|Overall Study|Death|9|||
156593773|NCT00369967|565258076|FG000|Overall Study|Lost to Follow-up|23|||
156593774|NCT00369967|565258077|FG001|Overall Study|Lost to Follow-up|12|||
156593775|NCT03073213|565258078|FG000|Multiple Dose Period|Protocol Violation|0|||
156593776|NCT03073213|565258079|FG001|Multiple Dose Period|Protocol Violation|0|||
156593777|NCT03073213|565258080|FG002|Multiple Dose Period|Protocol Violation|1|||
156593778|NCT02064205|565258081|FG000|Overall Study|Withdrawal by Subject|1|||
156593779|NCT01708941|565258083|FG000|Overall Study|Adverse Event|4|||
156593780|NCT01708941|565258084|FG001|Overall Study|Adverse Event|6|||
156593781|NCT01708941|565258085|FG002|Overall Study|Adverse Event|1|||
156593782|NCT01708941|565258086|FG003|Overall Study|Adverse Event|0|||
156593783|NCT01708941|565258083|FG000|Overall Study|Death|1|||
156593784|NCT01708941|565258084|FG001|Overall Study|Death|1|||
156593785|NCT01708941|565258085|FG002|Overall Study|Death|2|||
156593786|NCT01708941|565258086|FG003|Overall Study|Death|14|||
156593787|NCT01708941|565258083|FG000|Overall Study|Withdrawal by Subject|1|||
156593788|NCT01708941|565258084|FG001|Overall Study|Withdrawal by Subject|0|||
156593789|NCT01708941|565258085|FG002|Overall Study|Withdrawal by Subject|3|||
156593790|NCT01708941|565258086|FG003|Overall Study|Withdrawal by Subject|4|||
156593791|NCT01708941|565258083|FG000|Overall Study|Disease progression|9|||
156593792|NCT01708941|565258084|FG001|Overall Study|Disease progression|10|||
156593793|NCT01708941|565258085|FG002|Overall Study|Disease progression|8|||
156593794|NCT01708941|565258086|FG003|Overall Study|Disease progression|0|||
156593795|NCT01708941|565258083|FG000|Overall Study|Alternative therapy|0|||
156593796|NCT01708941|565258084|FG001|Overall Study|Alternative therapy|0|||
156593797|NCT01708941|565258085|FG002|Overall Study|Alternative therapy|2|||
156593798|NCT01708941|565258086|FG003|Overall Study|Alternative therapy|0|||
156593799|NCT01708941|565258083|FG000|Overall Study|Ineligible and never started treatment|1|||
156593800|NCT01708941|565258084|FG001|Overall Study|Ineligible and never started treatment|0|||
156593801|NCT01708941|565258085|FG002|Overall Study|Ineligible and never started treatment|1|||
156593802|NCT01708941|565258086|FG003|Overall Study|Ineligible and never started treatment|0|||
156593803|NCT01708941|565258083|FG000|Overall Study|Never started treatment|2|||
156593804|NCT01708941|565258084|FG001|Overall Study|Never started treatment|1|||
156593805|NCT01708941|565258085|FG002|Overall Study|Never started treatment|0|||
156593806|NCT01708941|565258086|FG003|Overall Study|Never started treatment|0|||
156593807|NCT01708941|565258083|FG000|Overall Study|Ineligible|0|||
156593808|NCT01708941|565258084|FG001|Overall Study|Ineligible|0|||
156593809|NCT01708941|565258085|FG002|Overall Study|Ineligible|2|||
156593810|NCT01708941|565258086|FG003|Overall Study|Ineligible|0|||
156593811|NCT02226146|565258087|FG000|Overall Study|Received rescue therapy|1|||
156593812|NCT02226146|565258087|FG000|Overall Study|Withdrawal by Subject|2|||
156593813|NCT05464836|565258088|FG000|Overall Study|Progression of Disease|1|||
156593814|NCT05464836|565258088|FG000|Overall Study|Physician Decision|1|||
156593815|NCT01522976|565258089|FG000|Overall Study|Ineligible|4|||
156593816|NCT01522976|565258090|FG001|Overall Study|Ineligible|0|||
156593817|NCT01522976|565258091|FG002|Overall Study|Ineligible|1|||
156593818|NCT01522976|565258089|FG000|Overall Study|Death|7|||
156593819|NCT01522976|565258090|FG001|Overall Study|Death|6|||
156593820|NCT01522976|565258091|FG002|Overall Study|Death|2|||
156593821|NCT01522976|565258089|FG000|Overall Study|Still on treatment|9|||
156593822|NCT01522976|565258090|FG001|Overall Study|Still on treatment|9|||
156593823|NCT01522976|565258091|FG002|Overall Study|Still on treatment|6|||
156593824|NCT01522976|565258089|FG000|Overall Study|Disease progression|28|||
156593825|NCT01522976|565258090|FG001|Overall Study|Disease progression|30|||
156593826|NCT01522976|565258091|FG002|Overall Study|Disease progression|25|||
156593827|NCT01522976|565258089|FG000|Overall Study|Adverse Event|17|||
156593828|NCT01522976|565258090|FG001|Overall Study|Adverse Event|7|||
156593829|NCT01522976|565258091|FG002|Overall Study|Adverse Event|18|||
156593830|NCT01522976|565258089|FG000|Overall Study|Refusal unrelated to adverse event|10|||
156593831|NCT01522976|565258090|FG001|Overall Study|Refusal unrelated to adverse event|13|||
156593832|NCT01522976|565258091|FG002|Overall Study|Refusal unrelated to adverse event|14|||
156593833|NCT01522976|565258089|FG000|Overall Study|Not protocol specified|22|||
156593834|NCT01522976|565258090|FG001|Overall Study|Not protocol specified|27|||
156593835|NCT01522976|565258091|FG002|Overall Study|Not protocol specified|27|||
156593836|NCT02883049|565258092|FG000|Induction|Adverse Event|52|||
156593837|NCT02883049|565258093|FG001|Induction|Adverse Event|2|||
156593838|NCT02883049|565258094|FG002|Induction|Adverse Event|0|||
156593839|NCT02883049|565258095|FG003|Induction|Adverse Event|0|||
156593840|NCT02883049|565258096|FG004|Induction|Adverse Event|0|||
156593841|NCT02883049|565258097|FG005|Induction|Adverse Event|0|||
156593842|NCT02883049|565258098|FG006|Induction|Adverse Event|0|||
156593843|NCT02883049|565258099|FG007|Induction|Adverse Event|0|||
156593844|NCT02883049|565258100|FG008|Induction|Adverse Event|0|||
156593845|NCT02883049|565258101|FG009|Induction|Adverse Event|0|||
156593846|NCT02883049|565258102|FG010|Induction|Adverse Event|0|||
156593847|NCT02883049|565258103|FG011|Induction|Adverse Event|0|||
156593848|NCT02883049|565258104|FG012|Induction|Adverse Event|0|||
156593849|NCT02883049|565258105|FG013|Induction|Adverse Event|0|||
156593850|NCT02883049|565258106|FG014|Induction|Adverse Event|0|||
156593851|NCT02883049|565258107|FG015|Induction|Adverse Event|0|||
156593852|NCT02883049|565258092|FG000|Induction|Death|76|||
156593853|NCT02883049|565258093|FG001|Induction|Death|8|||
156593854|NCT02883049|565258094|FG002|Induction|Death|0|||
156593855|NCT02883049|565258095|FG003|Induction|Death|0|||
156593856|NCT02883049|565258096|FG004|Induction|Death|0|||
156593857|NCT02883049|565258097|FG005|Induction|Death|0|||
156593858|NCT02883049|565258098|FG006|Induction|Death|0|||
156593859|NCT02883049|565258099|FG007|Induction|Death|0|||
156593860|NCT02883049|565258100|FG008|Induction|Death|0|||
156593861|NCT02883049|565258101|FG009|Induction|Death|0|||
156593862|NCT02883049|565258102|FG010|Induction|Death|0|||
156593863|NCT02883049|565258103|FG011|Induction|Death|0|||
156593864|NCT02883049|565258104|FG012|Induction|Death|0|||
156593865|NCT02883049|565258105|FG013|Induction|Death|0|||
156593866|NCT02883049|565258106|FG014|Induction|Death|0|||
156593867|NCT02883049|565258107|FG015|Induction|Death|0|||
156593868|NCT02883049|565258092|FG000|Induction|Lost to Follow-up|2|||
156593869|NCT02883049|565258093|FG001|Induction|Lost to Follow-up|0|||
156593870|NCT02883049|565258094|FG002|Induction|Lost to Follow-up|0|||
156593871|NCT02883049|565258095|FG003|Induction|Lost to Follow-up|0|||
156593872|NCT02883049|565258096|FG004|Induction|Lost to Follow-up|0|||
156593873|NCT02883049|565258097|FG005|Induction|Lost to Follow-up|0|||
156593874|NCT02883049|565258098|FG006|Induction|Lost to Follow-up|0|||
156593875|NCT02883049|565258099|FG007|Induction|Lost to Follow-up|0|||
156593876|NCT02883049|565258100|FG008|Induction|Lost to Follow-up|0|||
156593877|NCT02883049|565258101|FG009|Induction|Lost to Follow-up|0|||
156593878|NCT02883049|565258102|FG010|Induction|Lost to Follow-up|0|||
156593879|NCT02883049|565258103|FG011|Induction|Lost to Follow-up|0|||
156593880|NCT02883049|565258104|FG012|Induction|Lost to Follow-up|0|||
156593881|NCT02883049|565258105|FG013|Induction|Lost to Follow-up|0|||
156593882|NCT02883049|565258106|FG014|Induction|Lost to Follow-up|0|||
156593883|NCT02883049|565258107|FG015|Induction|Lost to Follow-up|0|||
156593884|NCT02883049|565258092|FG000|Induction|Physician Decision|1407|||
156593885|NCT02883049|565258093|FG001|Induction|Physician Decision|8|||
156593886|NCT02883049|565258094|FG002|Induction|Physician Decision|0|||
156593887|NCT02883049|565258095|FG003|Induction|Physician Decision|0|||
156593888|NCT02883049|565258096|FG004|Induction|Physician Decision|0|||
156593889|NCT02883049|565258097|FG005|Induction|Physician Decision|0|||
156593890|NCT02883049|565258098|FG006|Induction|Physician Decision|0|||
156593891|NCT02883049|565258099|FG007|Induction|Physician Decision|0|||
156593892|NCT02883049|565258100|FG008|Induction|Physician Decision|0|||
156593893|NCT02883049|565258101|FG009|Induction|Physician Decision|0|||
156593894|NCT02883049|565258102|FG010|Induction|Physician Decision|0|||
156593895|NCT02883049|565258103|FG011|Induction|Physician Decision|0|||
156593896|NCT02883049|565258104|FG012|Induction|Physician Decision|0|||
156593897|NCT02883049|565258105|FG013|Induction|Physician Decision|0|||
156593898|NCT02883049|565258106|FG014|Induction|Physician Decision|0|||
156593899|NCT02883049|565258107|FG015|Induction|Physician Decision|0|||
156593900|NCT02883049|565258092|FG000|Induction|Protocol Violation|6|||
156593901|NCT02883049|565258093|FG001|Induction|Protocol Violation|0|||
156593902|NCT02883049|565258094|FG002|Induction|Protocol Violation|0|||
156593903|NCT02883049|565258095|FG003|Induction|Protocol Violation|0|||
156593904|NCT02883049|565258096|FG004|Induction|Protocol Violation|0|||
156593905|NCT02883049|565258097|FG005|Induction|Protocol Violation|0|||
156593906|NCT02883049|565258098|FG006|Induction|Protocol Violation|0|||
156593907|NCT02883049|565258099|FG007|Induction|Protocol Violation|0|||
156593908|NCT02883049|565258100|FG008|Induction|Protocol Violation|0|||
156593909|NCT02883049|565258101|FG009|Induction|Protocol Violation|0|||
156593910|NCT02883049|565258102|FG010|Induction|Protocol Violation|0|||
156593911|NCT02883049|565258103|FG011|Induction|Protocol Violation|0|||
156593912|NCT02883049|565258104|FG012|Induction|Protocol Violation|0|||
156593913|NCT02883049|565258105|FG013|Induction|Protocol Violation|0|||
156593914|NCT02883049|565258106|FG014|Induction|Protocol Violation|0|||
156593915|NCT02883049|565258107|FG015|Induction|Protocol Violation|0|||
156593916|NCT02883049|565258092|FG000|Induction|Withdrawal by Subject|6|||
156593917|NCT02883049|565258093|FG001|Induction|Withdrawal by Subject|0|||
156593918|NCT02883049|565258094|FG002|Induction|Withdrawal by Subject|0|||
156593919|NCT02883049|565258095|FG003|Induction|Withdrawal by Subject|0|||
156593920|NCT02883049|565258096|FG004|Induction|Withdrawal by Subject|0|||
156593921|NCT02883049|565258097|FG005|Induction|Withdrawal by Subject|0|||
156593922|NCT02883049|565258098|FG006|Induction|Withdrawal by Subject|0|||
156593923|NCT02883049|565258099|FG007|Induction|Withdrawal by Subject|0|||
156593924|NCT02883049|565258100|FG008|Induction|Withdrawal by Subject|0|||
156593925|NCT02883049|565258101|FG009|Induction|Withdrawal by Subject|0|||
156593926|NCT02883049|565258102|FG010|Induction|Withdrawal by Subject|0|||
156593927|NCT02883049|565258103|FG011|Induction|Withdrawal by Subject|0|||
156593928|NCT02883049|565258104|FG012|Induction|Withdrawal by Subject|0|||
156593929|NCT02883049|565258105|FG013|Induction|Withdrawal by Subject|0|||
156593930|NCT02883049|565258106|FG014|Induction|Withdrawal by Subject|0|||
156593931|NCT02883049|565258107|FG015|Induction|Withdrawal by Subject|0|||
156593932|NCT02883049|565258092|FG000|Induction|Ineligible|35|||
156593933|NCT02883049|565258093|FG001|Induction|Ineligible|1|||
156593934|NCT02883049|565258094|FG002|Induction|Ineligible|0|||
156593935|NCT02883049|565258095|FG003|Induction|Ineligible|0|||
156593936|NCT02883049|565258096|FG004|Induction|Ineligible|0|||
156593937|NCT02883049|565258097|FG005|Induction|Ineligible|0|||
156593938|NCT02883049|565258098|FG006|Induction|Ineligible|0|||
156593939|NCT02883049|565258099|FG007|Induction|Ineligible|0|||
156593940|NCT02883049|565258100|FG008|Induction|Ineligible|0|||
156593941|NCT02883049|565258101|FG009|Induction|Ineligible|0|||
156593942|NCT02883049|565258102|FG010|Induction|Ineligible|0|||
156593943|NCT02883049|565258103|FG011|Induction|Ineligible|0|||
156593944|NCT02883049|565258104|FG012|Induction|Ineligible|0|||
156593945|NCT02883049|565258105|FG013|Induction|Ineligible|0|||
156593946|NCT02883049|565258106|FG014|Induction|Ineligible|0|||
156593947|NCT02883049|565258107|FG015|Induction|Ineligible|0|||
156593948|NCT02883049|565258092|FG000|Induction|Refusal of further protocol therapy|466|||
156593949|NCT02883049|565258093|FG001|Induction|Refusal of further protocol therapy|2|||
156593950|NCT02883049|565258094|FG002|Induction|Refusal of further protocol therapy|0|||
156593951|NCT02883049|565258095|FG003|Induction|Refusal of further protocol therapy|0|||
156593952|NCT02883049|565258096|FG004|Induction|Refusal of further protocol therapy|0|||
156593953|NCT02883049|565258097|FG005|Induction|Refusal of further protocol therapy|0|||
156593954|NCT02883049|565258098|FG006|Induction|Refusal of further protocol therapy|0|||
156593955|NCT02883049|565258099|FG007|Induction|Refusal of further protocol therapy|0|||
156593956|NCT02883049|565258100|FG008|Induction|Refusal of further protocol therapy|0|||
156593957|NCT02883049|565258101|FG009|Induction|Refusal of further protocol therapy|0|||
156593958|NCT02883049|565258102|FG010|Induction|Refusal of further protocol therapy|0|||
156593959|NCT02883049|565258103|FG011|Induction|Refusal of further protocol therapy|0|||
156593960|NCT02883049|565258104|FG012|Induction|Refusal of further protocol therapy|0|||
156593961|NCT02883049|565258105|FG013|Induction|Refusal of further protocol therapy|0|||
156593962|NCT02883049|565258106|FG014|Induction|Refusal of further protocol therapy|0|||
156593963|NCT02883049|565258107|FG015|Induction|Refusal of further protocol therapy|0|||
156593964|NCT02883049|565258092|FG000|Induction|Identified as Ph+ patients|279|||
156593965|NCT02883049|565258093|FG001|Induction|Identified as Ph+ patients|1|||
156593966|NCT02883049|565258094|FG002|Induction|Identified as Ph+ patients|0|||
156593967|NCT02883049|565258095|FG003|Induction|Identified as Ph+ patients|0|||
156593968|NCT02883049|565258096|FG004|Induction|Identified as Ph+ patients|0|||
156593969|NCT02883049|565258097|FG005|Induction|Identified as Ph+ patients|0|||
156593970|NCT02883049|565258098|FG006|Induction|Identified as Ph+ patients|0|||
156593971|NCT02883049|565258099|FG007|Induction|Identified as Ph+ patients|0|||
156593972|NCT02883049|565258100|FG008|Induction|Identified as Ph+ patients|0|||
156593973|NCT02883049|565258101|FG009|Induction|Identified as Ph+ patients|0|||
156593974|NCT02883049|565258102|FG010|Induction|Identified as Ph+ patients|0|||
156593975|NCT02883049|565258103|FG011|Induction|Identified as Ph+ patients|0|||
156593976|NCT02883049|565258104|FG012|Induction|Identified as Ph+ patients|0|||
156593977|NCT02883049|565258105|FG013|Induction|Identified as Ph+ patients|0|||
156593978|NCT02883049|565258106|FG014|Induction|Identified as Ph+ patients|0|||
156593979|NCT02883049|565258107|FG015|Induction|Identified as Ph+ patients|0|||
156593980|NCT02883049|565258092|FG000|Induction|M3 Marrow at Day29|8|||
156593981|NCT02883049|565258093|FG001|Induction|M3 Marrow at Day29|1|||
156593982|NCT02883049|565258094|FG002|Induction|M3 Marrow at Day29|0|||
156593983|NCT02883049|565258095|FG003|Induction|M3 Marrow at Day29|0|||
156593984|NCT02883049|565258096|FG004|Induction|M3 Marrow at Day29|0|||
156593985|NCT02883049|565258097|FG005|Induction|M3 Marrow at Day29|0|||
156593986|NCT02883049|565258098|FG006|Induction|M3 Marrow at Day29|0|||
156593987|NCT02883049|565258099|FG007|Induction|M3 Marrow at Day29|0|||
156593988|NCT02883049|565258100|FG008|Induction|M3 Marrow at Day29|0|||
156593989|NCT02883049|565258101|FG009|Induction|M3 Marrow at Day29|0|||
156593990|NCT02883049|565258102|FG010|Induction|M3 Marrow at Day29|0|||
156593991|NCT02883049|565258103|FG011|Induction|M3 Marrow at Day29|0|||
156593992|NCT02883049|565258104|FG012|Induction|M3 Marrow at Day29|0|||
156593993|NCT02883049|565258105|FG013|Induction|M3 Marrow at Day29|0|||
156593994|NCT02883049|565258106|FG014|Induction|M3 Marrow at Day29|0|||
156593995|NCT02883049|565258107|FG015|Induction|M3 Marrow at Day29|0|||
156593996|NCT02883049|565258092|FG000|Induction|Inevaluable|33|||
156593997|NCT02883049|565258093|FG001|Induction|Inevaluable|1|||
156593998|NCT02883049|565258094|FG002|Induction|Inevaluable|0|||
156593999|NCT02883049|565258095|FG003|Induction|Inevaluable|0|||
156594000|NCT02883049|565258096|FG004|Induction|Inevaluable|0|||
156594001|NCT02883049|565258097|FG005|Induction|Inevaluable|0|||
156594002|NCT02883049|565258098|FG006|Induction|Inevaluable|0|||
156594003|NCT02883049|565258099|FG007|Induction|Inevaluable|0|||
156594004|NCT02883049|565258100|FG008|Induction|Inevaluable|0|||
156594005|NCT02883049|565258101|FG009|Induction|Inevaluable|0|||
156594006|NCT02883049|565258102|FG010|Induction|Inevaluable|0|||
156594007|NCT02883049|565258103|FG011|Induction|Inevaluable|0|||
156594008|NCT02883049|565258104|FG012|Induction|Inevaluable|0|||
156594009|NCT02883049|565258105|FG013|Induction|Inevaluable|0|||
156594010|NCT02883049|565258106|FG014|Induction|Inevaluable|0|||
156594011|NCT02883049|565258107|FG015|Induction|Inevaluable|0|||
156594012|NCT02883049|565258092|FG000|Induction|Identified as VHR at end of Induction|244|||
156594013|NCT02883049|565258093|FG001|Induction|Identified as VHR at end of Induction|0|||
156594014|NCT02883049|565258094|FG002|Induction|Identified as VHR at end of Induction|0|||
156594015|NCT02883049|565258095|FG003|Induction|Identified as VHR at end of Induction|0|||
156594016|NCT02883049|565258096|FG004|Induction|Identified as VHR at end of Induction|0|||
156594017|NCT02883049|565258097|FG005|Induction|Identified as VHR at end of Induction|0|||
156594018|NCT02883049|565258098|FG006|Induction|Identified as VHR at end of Induction|0|||
156594019|NCT02883049|565258099|FG007|Induction|Identified as VHR at end of Induction|0|||
156594020|NCT02883049|565258100|FG008|Induction|Identified as VHR at end of Induction|0|||
156594021|NCT02883049|565258101|FG009|Induction|Identified as VHR at end of Induction|0|||
156594022|NCT02883049|565258102|FG010|Induction|Identified as VHR at end of Induction|0|||
156594023|NCT02883049|565258103|FG011|Induction|Identified as VHR at end of Induction|0|||
156594024|NCT02883049|565258104|FG012|Induction|Identified as VHR at end of Induction|0|||
156594025|NCT02883049|565258105|FG013|Induction|Identified as VHR at end of Induction|0|||
156594026|NCT02883049|565258106|FG014|Induction|Identified as VHR at end of Induction|0|||
156594027|NCT02883049|565258107|FG015|Induction|Identified as VHR at end of Induction|0|||
156594028|NCT02883049|565258092|FG000|Induction|Moved to another non-COG institution|3|||
156594029|NCT02883049|565258093|FG001|Induction|Moved to another non-COG institution|0|||
156594030|NCT02883049|565258094|FG002|Induction|Moved to another non-COG institution|0|||
156594031|NCT02883049|565258095|FG003|Induction|Moved to another non-COG institution|0|||
156594032|NCT02883049|565258096|FG004|Induction|Moved to another non-COG institution|0|||
156594033|NCT02883049|565258097|FG005|Induction|Moved to another non-COG institution|0|||
156594034|NCT02883049|565258098|FG006|Induction|Moved to another non-COG institution|0|||
156594035|NCT02883049|565258099|FG007|Induction|Moved to another non-COG institution|0|||
156594036|NCT02883049|565258100|FG008|Induction|Moved to another non-COG institution|0|||
156594037|NCT02883049|565258101|FG009|Induction|Moved to another non-COG institution|0|||
156594038|NCT02883049|565258102|FG010|Induction|Moved to another non-COG institution|0|||
156594039|NCT02883049|565258103|FG011|Induction|Moved to another non-COG institution|0|||
156594040|NCT02883049|565258104|FG012|Induction|Moved to another non-COG institution|0|||
156594041|NCT02883049|565258105|FG013|Induction|Moved to another non-COG institution|0|||
156594042|NCT02883049|565258106|FG014|Induction|Moved to another non-COG institution|0|||
156594043|NCT02883049|565258107|FG015|Induction|Moved to another non-COG institution|0|||
156594044|NCT02883049|565258092|FG000|Induction|Randomization closed|41|||
156594045|NCT02883049|565258093|FG001|Induction|Randomization closed|0|||
156594046|NCT02883049|565258094|FG002|Induction|Randomization closed|0|||
156594047|NCT02883049|565258095|FG003|Induction|Randomization closed|0|||
156594048|NCT02883049|565258096|FG004|Induction|Randomization closed|0|||
156594049|NCT02883049|565258097|FG005|Induction|Randomization closed|0|||
156594050|NCT02883049|565258098|FG006|Induction|Randomization closed|0|||
156594051|NCT02883049|565258099|FG007|Induction|Randomization closed|0|||
156594052|NCT02883049|565258100|FG008|Induction|Randomization closed|0|||
156594053|NCT02883049|565258101|FG009|Induction|Randomization closed|0|||
156594054|NCT02883049|565258102|FG010|Induction|Randomization closed|0|||
156594055|NCT02883049|565258103|FG011|Induction|Randomization closed|0|||
156594056|NCT02883049|565258104|FG012|Induction|Randomization closed|0|||
156594057|NCT02883049|565258105|FG013|Induction|Randomization closed|0|||
156594058|NCT02883049|565258106|FG014|Induction|Randomization closed|0|||
156594059|NCT02883049|565258107|FG015|Induction|Randomization closed|0|||
156594060|NCT02883049|565258092|FG000|Induction|MRD negative|36|||
156594061|NCT02883049|565258093|FG001|Induction|MRD negative|0|||
156594062|NCT02883049|565258094|FG002|Induction|MRD negative|0|||
156594063|NCT02883049|565258095|FG003|Induction|MRD negative|0|||
156594064|NCT02883049|565258096|FG004|Induction|MRD negative|0|||
156594065|NCT02883049|565258097|FG005|Induction|MRD negative|0|||
156594066|NCT02883049|565258098|FG006|Induction|MRD negative|0|||
156594067|NCT02883049|565258099|FG007|Induction|MRD negative|0|||
156863670|NCT04366349|566258750|FG000|Overall Study|Withdrawal by Subject|1|||
156594068|NCT02883049|565258100|FG008|Induction|MRD negative|0|||
156594069|NCT02883049|565258101|FG009|Induction|MRD negative|0|||
156594070|NCT02883049|565258102|FG010|Induction|MRD negative|0|||
156594071|NCT02883049|565258103|FG011|Induction|MRD negative|0|||
156594072|NCT02883049|565258104|FG012|Induction|MRD negative|0|||
156594073|NCT02883049|565258105|FG013|Induction|MRD negative|0|||
156594074|NCT02883049|565258106|FG014|Induction|MRD negative|0|||
156594075|NCT02883049|565258107|FG015|Induction|MRD negative|0|||
156594076|NCT02883049|565258092|FG000|Induction|Identified as HR patients|165|||
156594077|NCT02883049|565258093|FG001|Induction|Identified as HR patients|0|||
156594078|NCT02883049|565258094|FG002|Induction|Identified as HR patients|0|||
156594079|NCT02883049|565258095|FG003|Induction|Identified as HR patients|0|||
156594080|NCT02883049|565258096|FG004|Induction|Identified as HR patients|0|||
156594081|NCT02883049|565258097|FG005|Induction|Identified as HR patients|0|||
156594082|NCT02883049|565258098|FG006|Induction|Identified as HR patients|0|||
156594083|NCT02883049|565258099|FG007|Induction|Identified as HR patients|0|||
156594084|NCT02883049|565258100|FG008|Induction|Identified as HR patients|0|||
156594085|NCT02883049|565258101|FG009|Induction|Identified as HR patients|0|||
156594086|NCT02883049|565258102|FG010|Induction|Identified as HR patients|0|||
156594087|NCT02883049|565258103|FG011|Induction|Identified as HR patients|0|||
156594088|NCT02883049|565258104|FG012|Induction|Identified as HR patients|0|||
156594089|NCT02883049|565258105|FG013|Induction|Identified as HR patients|0|||
156594090|NCT02883049|565258106|FG014|Induction|Identified as HR patients|0|||
156594091|NCT02883049|565258107|FG015|Induction|Identified as HR patients|0|||
156594092|NCT02883049|565258092|FG000|Induction|Developed SMN|0|||
156594093|NCT02883049|565258093|FG001|Induction|Developed SMN|1|||
156594094|NCT02883049|565258094|FG002|Induction|Developed SMN|0|||
156594095|NCT02883049|565258095|FG003|Induction|Developed SMN|0|||
156594096|NCT02883049|565258096|FG004|Induction|Developed SMN|0|||
156594097|NCT02883049|565258097|FG005|Induction|Developed SMN|0|||
156594098|NCT02883049|565258098|FG006|Induction|Developed SMN|0|||
156594099|NCT02883049|565258099|FG007|Induction|Developed SMN|0|||
156594100|NCT02883049|565258100|FG008|Induction|Developed SMN|0|||
156594101|NCT02883049|565258101|FG009|Induction|Developed SMN|0|||
156594102|NCT02883049|565258102|FG010|Induction|Developed SMN|0|||
156594103|NCT02883049|565258103|FG011|Induction|Developed SMN|0|||
156594104|NCT02883049|565258104|FG012|Induction|Developed SMN|0|||
156594105|NCT02883049|565258105|FG013|Induction|Developed SMN|0|||
156594106|NCT02883049|565258106|FG014|Induction|Developed SMN|0|||
156594107|NCT02883049|565258107|FG015|Induction|Developed SMN|0|||
156594108|NCT02883049|565258092|FG000|Induction|Enrolled onto another COG study|72|||
156594109|NCT02883049|565258093|FG001|Induction|Enrolled onto another COG study|0|||
156594110|NCT02883049|565258094|FG002|Induction|Enrolled onto another COG study|0|||
156594111|NCT02883049|565258095|FG003|Induction|Enrolled onto another COG study|0|||
156594112|NCT02883049|565258096|FG004|Induction|Enrolled onto another COG study|0|||
156594113|NCT02883049|565258097|FG005|Induction|Enrolled onto another COG study|0|||
156594114|NCT02883049|565258098|FG006|Induction|Enrolled onto another COG study|0|||
156594115|NCT02883049|565258099|FG007|Induction|Enrolled onto another COG study|0|||
156594116|NCT02883049|565258100|FG008|Induction|Enrolled onto another COG study|0|||
156594117|NCT02883049|565258101|FG009|Induction|Enrolled onto another COG study|0|||
156594118|NCT02883049|565258102|FG010|Induction|Enrolled onto another COG study|0|||
156594119|NCT02883049|565258103|FG011|Induction|Enrolled onto another COG study|0|||
156594120|NCT02883049|565258104|FG012|Induction|Enrolled onto another COG study|0|||
156594121|NCT02883049|565258105|FG013|Induction|Enrolled onto another COG study|0|||
156594122|NCT02883049|565258106|FG014|Induction|Enrolled onto another COG study|0|||
156594123|NCT02883049|565258107|FG015|Induction|Enrolled onto another COG study|0|||
156594124|NCT02883049|565258092|FG000|Induction|Incomplete induction data|17|||
156594125|NCT02883049|565258093|FG001|Induction|Incomplete induction data|0|||
156594126|NCT02883049|565258094|FG002|Induction|Incomplete induction data|0|||
156594127|NCT02883049|565258095|FG003|Induction|Incomplete induction data|0|||
156594128|NCT02883049|565258096|FG004|Induction|Incomplete induction data|0|||
156594129|NCT02883049|565258097|FG005|Induction|Incomplete induction data|0|||
156594130|NCT02883049|565258098|FG006|Induction|Incomplete induction data|0|||
156594131|NCT02883049|565258099|FG007|Induction|Incomplete induction data|0|||
156594132|NCT02883049|565258100|FG008|Induction|Incomplete induction data|0|||
156594133|NCT02883049|565258101|FG009|Induction|Incomplete induction data|0|||
156594134|NCT02883049|565258102|FG010|Induction|Incomplete induction data|0|||
156594135|NCT02883049|565258103|FG011|Induction|Incomplete induction data|0|||
156594136|NCT02883049|565258104|FG012|Induction|Incomplete induction data|0|||
156594137|NCT02883049|565258105|FG013|Induction|Incomplete induction data|0|||
156594138|NCT02883049|565258106|FG014|Induction|Incomplete induction data|0|||
156594139|NCT02883049|565258107|FG015|Induction|Incomplete induction data|0|||
156594140|NCT02883049|565258092|FG000|Post Induction|Adverse Event|0|||
156594141|NCT02883049|565258093|FG001|Post Induction|Adverse Event|0|||
156594142|NCT02883049|565258094|FG002|Post Induction|Adverse Event|0|||
156594143|NCT02883049|565258095|FG003|Post Induction|Adverse Event|7|||
156594144|NCT02883049|565258096|FG004|Post Induction|Adverse Event|8|||
156594145|NCT02883049|565258097|FG005|Post Induction|Adverse Event|3|||
156594146|NCT02883049|565258098|FG006|Post Induction|Adverse Event|4|||
156594147|NCT02883049|565258099|FG007|Post Induction|Adverse Event|5|||
156594148|NCT02883049|565258100|FG008|Post Induction|Adverse Event|6|||
156594149|NCT02883049|565258101|FG009|Post Induction|Adverse Event|7|||
156594150|NCT02883049|565258102|FG010|Post Induction|Adverse Event|2|||
156594151|NCT02883049|565258103|FG011|Post Induction|Adverse Event|2|||
156594152|NCT02883049|565258104|FG012|Post Induction|Adverse Event|0|||
156594153|NCT02883049|565258105|FG013|Post Induction|Adverse Event|0|||
156594154|NCT02883049|565258106|FG014|Post Induction|Adverse Event|5|||
156594155|NCT02883049|565258107|FG015|Post Induction|Adverse Event|2|||
156594156|NCT02883049|565258092|FG000|Post Induction|Death|0|||
156594157|NCT02883049|565258093|FG001|Post Induction|Death|0|||
156594158|NCT02883049|565258094|FG002|Post Induction|Death|0|||
156594159|NCT02883049|565258095|FG003|Post Induction|Death|9|||
156594160|NCT02883049|565258096|FG004|Post Induction|Death|9|||
156594161|NCT02883049|565258097|FG005|Post Induction|Death|0|||
156594162|NCT02883049|565258098|FG006|Post Induction|Death|1|||
156594163|NCT02883049|565258099|FG007|Post Induction|Death|6|||
156594164|NCT02883049|565258100|FG008|Post Induction|Death|5|||
156594165|NCT02883049|565258101|FG009|Post Induction|Death|3|||
156594166|NCT02883049|565258102|FG010|Post Induction|Death|1|||
156594167|NCT02883049|565258103|FG011|Post Induction|Death|0|||
156594168|NCT02883049|565258104|FG012|Post Induction|Death|1|||
156594169|NCT02883049|565258105|FG013|Post Induction|Death|1|||
156594170|NCT02883049|565258106|FG014|Post Induction|Death|10|||
156594171|NCT02883049|565258107|FG015|Post Induction|Death|2|||
156594172|NCT02883049|565258092|FG000|Post Induction|Lost to Follow-up|0|||
156594173|NCT02883049|565258093|FG001|Post Induction|Lost to Follow-up|0|||
156594174|NCT02883049|565258094|FG002|Post Induction|Lost to Follow-up|0|||
156594175|NCT02883049|565258095|FG003|Post Induction|Lost to Follow-up|0|||
156594176|NCT02883049|565258096|FG004|Post Induction|Lost to Follow-up|1|||
156594177|NCT02883049|565258097|FG005|Post Induction|Lost to Follow-up|1|||
156594178|NCT02883049|565258098|FG006|Post Induction|Lost to Follow-up|0|||
156594179|NCT02883049|565258099|FG007|Post Induction|Lost to Follow-up|0|||
156594180|NCT02883049|565258100|FG008|Post Induction|Lost to Follow-up|3|||
156594181|NCT02883049|565258101|FG009|Post Induction|Lost to Follow-up|0|||
156594182|NCT02883049|565258102|FG010|Post Induction|Lost to Follow-up|1|||
156594183|NCT02883049|565258103|FG011|Post Induction|Lost to Follow-up|0|||
156594184|NCT02883049|565258104|FG012|Post Induction|Lost to Follow-up|0|||
156594185|NCT02883049|565258105|FG013|Post Induction|Lost to Follow-up|0|||
156594186|NCT02883049|565258106|FG014|Post Induction|Lost to Follow-up|0|||
156594187|NCT02883049|565258107|FG015|Post Induction|Lost to Follow-up|0|||
156594188|NCT02883049|565258092|FG000|Post Induction|Physician Decision|0|||
156594189|NCT02883049|565258093|FG001|Post Induction|Physician Decision|0|||
156594190|NCT02883049|565258094|FG002|Post Induction|Physician Decision|0|||
156594191|NCT02883049|565258095|FG003|Post Induction|Physician Decision|27|||
156594192|NCT02883049|565258096|FG004|Post Induction|Physician Decision|27|||
156594193|NCT02883049|565258097|FG005|Post Induction|Physician Decision|23|||
156594194|NCT02883049|565258098|FG006|Post Induction|Physician Decision|30|||
156594195|NCT02883049|565258099|FG007|Post Induction|Physician Decision|56|||
156594196|NCT02883049|565258100|FG008|Post Induction|Physician Decision|85|||
156594197|NCT02883049|565258101|FG009|Post Induction|Physician Decision|12|||
156594198|NCT02883049|565258102|FG010|Post Induction|Physician Decision|5|||
156594199|NCT02883049|565258103|FG011|Post Induction|Physician Decision|14|||
156594200|NCT02883049|565258104|FG012|Post Induction|Physician Decision|1|||
156594201|NCT02883049|565258105|FG013|Post Induction|Physician Decision|11|||
156594202|NCT02883049|565258106|FG014|Post Induction|Physician Decision|19|||
156594203|NCT02883049|565258107|FG015|Post Induction|Physician Decision|5|||
156594204|NCT02883049|565258092|FG000|Post Induction|Protocol Violation|0|||
156594205|NCT02883049|565258093|FG001|Post Induction|Protocol Violation|0|||
156594206|NCT02883049|565258094|FG002|Post Induction|Protocol Violation|0|||
156594207|NCT02883049|565258095|FG003|Post Induction|Protocol Violation|0|||
156594208|NCT02883049|565258096|FG004|Post Induction|Protocol Violation|0|||
156594209|NCT02883049|565258097|FG005|Post Induction|Protocol Violation|0|||
156594210|NCT02883049|565258098|FG006|Post Induction|Protocol Violation|0|||
156594211|NCT02883049|565258099|FG007|Post Induction|Protocol Violation|1|||
156594212|NCT02883049|565258100|FG008|Post Induction|Protocol Violation|0|||
156594213|NCT02883049|565258101|FG009|Post Induction|Protocol Violation|0|||
156594214|NCT02883049|565258102|FG010|Post Induction|Protocol Violation|0|||
156594215|NCT02883049|565258103|FG011|Post Induction|Protocol Violation|0|||
156594216|NCT02883049|565258104|FG012|Post Induction|Protocol Violation|0|||
156594217|NCT02883049|565258105|FG013|Post Induction|Protocol Violation|0|||
156594218|NCT02883049|565258106|FG014|Post Induction|Protocol Violation|0|||
156594219|NCT02883049|565258107|FG015|Post Induction|Protocol Violation|0|||
156594220|NCT02883049|565258092|FG000|Post Induction|Withdrawal by Subject|0|||
156594221|NCT02883049|565258093|FG001|Post Induction|Withdrawal by Subject|0|||
156594222|NCT02883049|565258094|FG002|Post Induction|Withdrawal by Subject|0|||
156594223|NCT02883049|565258095|FG003|Post Induction|Withdrawal by Subject|5|||
156594224|NCT02883049|565258096|FG004|Post Induction|Withdrawal by Subject|2|||
156594225|NCT02883049|565258097|FG005|Post Induction|Withdrawal by Subject|1|||
156594226|NCT02883049|565258098|FG006|Post Induction|Withdrawal by Subject|0|||
156594227|NCT02883049|565258099|FG007|Post Induction|Withdrawal by Subject|0|||
156594228|NCT02883049|565258100|FG008|Post Induction|Withdrawal by Subject|2|||
156594229|NCT02883049|565258101|FG009|Post Induction|Withdrawal by Subject|0|||
156594230|NCT02883049|565258102|FG010|Post Induction|Withdrawal by Subject|1|||
156594231|NCT02883049|565258103|FG011|Post Induction|Withdrawal by Subject|1|||
156634903|NCT03917654|565407815|FG000|Year 1|Travel|0|||
156594232|NCT02883049|565258104|FG012|Post Induction|Withdrawal by Subject|0|||
156594233|NCT02883049|565258105|FG013|Post Induction|Withdrawal by Subject|0|||
156594234|NCT02883049|565258106|FG014|Post Induction|Withdrawal by Subject|1|||
156594235|NCT02883049|565258107|FG015|Post Induction|Withdrawal by Subject|0|||
156594236|NCT02883049|565258092|FG000|Post Induction|Ineligible|0|||
156594237|NCT02883049|565258093|FG001|Post Induction|Ineligible|0|||
156594238|NCT02883049|565258094|FG002|Post Induction|Ineligible|2|||
156594239|NCT02883049|565258095|FG003|Post Induction|Ineligible|0|||
156594240|NCT02883049|565258096|FG004|Post Induction|Ineligible|0|||
156594241|NCT02883049|565258097|FG005|Post Induction|Ineligible|0|||
156594242|NCT02883049|565258098|FG006|Post Induction|Ineligible|1|||
156594243|NCT02883049|565258099|FG007|Post Induction|Ineligible|0|||
156594244|NCT02883049|565258100|FG008|Post Induction|Ineligible|0|||
156594245|NCT02883049|565258101|FG009|Post Induction|Ineligible|0|||
156594246|NCT02883049|565258102|FG010|Post Induction|Ineligible|1|||
156594247|NCT02883049|565258103|FG011|Post Induction|Ineligible|0|||
156594248|NCT02883049|565258104|FG012|Post Induction|Ineligible|0|||
156594249|NCT02883049|565258105|FG013|Post Induction|Ineligible|0|||
156594250|NCT02883049|565258106|FG014|Post Induction|Ineligible|0|||
156594251|NCT02883049|565258107|FG015|Post Induction|Ineligible|1|||
156594252|NCT02883049|565258092|FG000|Post Induction|Refusal of further protocol therapy|0|||
156594253|NCT02883049|565258093|FG001|Post Induction|Refusal of further protocol therapy|0|||
156594254|NCT02883049|565258094|FG002|Post Induction|Refusal of further protocol therapy|0|||
156594255|NCT02883049|565258095|FG003|Post Induction|Refusal of further protocol therapy|11|||
156594256|NCT02883049|565258096|FG004|Post Induction|Refusal of further protocol therapy|15|||
156594257|NCT02883049|565258097|FG005|Post Induction|Refusal of further protocol therapy|9|||
156594258|NCT02883049|565258098|FG006|Post Induction|Refusal of further protocol therapy|13|||
156594259|NCT02883049|565258099|FG007|Post Induction|Refusal of further protocol therapy|5|||
156594260|NCT02883049|565258100|FG008|Post Induction|Refusal of further protocol therapy|21|||
156594261|NCT02883049|565258101|FG009|Post Induction|Refusal of further protocol therapy|7|||
156594262|NCT02883049|565258102|FG010|Post Induction|Refusal of further protocol therapy|0|||
156594263|NCT02883049|565258103|FG011|Post Induction|Refusal of further protocol therapy|7|||
156594264|NCT02883049|565258104|FG012|Post Induction|Refusal of further protocol therapy|3|||
156594265|NCT02883049|565258105|FG013|Post Induction|Refusal of further protocol therapy|0|||
156594266|NCT02883049|565258106|FG014|Post Induction|Refusal of further protocol therapy|4|||
156594267|NCT02883049|565258107|FG015|Post Induction|Refusal of further protocol therapy|1|||
156594268|NCT02883049|565258092|FG000|Post Induction|Inevaluable|0|||
156594269|NCT02883049|565258093|FG001|Post Induction|Inevaluable|0|||
156594270|NCT02883049|565258094|FG002|Post Induction|Inevaluable|0|||
156594271|NCT02883049|565258095|FG003|Post Induction|Inevaluable|1|||
156594272|NCT02883049|565258096|FG004|Post Induction|Inevaluable|1|||
156594273|NCT02883049|565258097|FG005|Post Induction|Inevaluable|2|||
156594274|NCT02883049|565258098|FG006|Post Induction|Inevaluable|7|||
156594275|NCT02883049|565258099|FG007|Post Induction|Inevaluable|6|||
156594276|NCT02883049|565258100|FG008|Post Induction|Inevaluable|4|||
156594277|NCT02883049|565258101|FG009|Post Induction|Inevaluable|4|||
156594278|NCT02883049|565258102|FG010|Post Induction|Inevaluable|1|||
156594279|NCT02883049|565258103|FG011|Post Induction|Inevaluable|1|||
156594280|NCT02883049|565258104|FG012|Post Induction|Inevaluable|2|||
156594281|NCT02883049|565258105|FG013|Post Induction|Inevaluable|0|||
156594282|NCT02883049|565258106|FG014|Post Induction|Inevaluable|0|||
156594283|NCT02883049|565258107|FG015|Post Induction|Inevaluable|1|||
156594284|NCT02883049|565258092|FG000|Post Induction|Moved to another non-COG institution|0|||
156594285|NCT02883049|565258093|FG001|Post Induction|Moved to another non-COG institution|0|||
156594286|NCT02883049|565258094|FG002|Post Induction|Moved to another non-COG institution|0|||
156594287|NCT02883049|565258095|FG003|Post Induction|Moved to another non-COG institution|0|||
156594288|NCT02883049|565258096|FG004|Post Induction|Moved to another non-COG institution|0|||
156594289|NCT02883049|565258097|FG005|Post Induction|Moved to another non-COG institution|0|||
156594290|NCT02883049|565258098|FG006|Post Induction|Moved to another non-COG institution|0|||
156594291|NCT02883049|565258099|FG007|Post Induction|Moved to another non-COG institution|2|||
156594292|NCT02883049|565258100|FG008|Post Induction|Moved to another non-COG institution|2|||
156594293|NCT02883049|565258101|FG009|Post Induction|Moved to another non-COG institution|0|||
156594294|NCT02883049|565258102|FG010|Post Induction|Moved to another non-COG institution|0|||
156594295|NCT02883049|565258103|FG011|Post Induction|Moved to another non-COG institution|1|||
156594296|NCT02883049|565258104|FG012|Post Induction|Moved to another non-COG institution|0|||
156594297|NCT02883049|565258105|FG013|Post Induction|Moved to another non-COG institution|0|||
156594298|NCT02883049|565258106|FG014|Post Induction|Moved to another non-COG institution|0|||
156594299|NCT02883049|565258107|FG015|Post Induction|Moved to another non-COG institution|0|||
156594300|NCT02883049|565258092|FG000|Post Induction|Randomization closed|0|||
156594301|NCT02883049|565258093|FG001|Post Induction|Randomization closed|0|||
156594302|NCT02883049|565258094|FG002|Post Induction|Randomization closed|0|||
156594303|NCT02883049|565258095|FG003|Post Induction|Randomization closed|0|||
156594304|NCT02883049|565258096|FG004|Post Induction|Randomization closed|0|||
156594305|NCT02883049|565258097|FG005|Post Induction|Randomization closed|0|||
156594306|NCT02883049|565258098|FG006|Post Induction|Randomization closed|0|||
156594307|NCT02883049|565258099|FG007|Post Induction|Randomization closed|20|||
156594308|NCT02883049|565258100|FG008|Post Induction|Randomization closed|0|||
156594309|NCT02883049|565258101|FG009|Post Induction|Randomization closed|0|||
156594310|NCT02883049|565258102|FG010|Post Induction|Randomization closed|0|||
156594311|NCT02883049|565258103|FG011|Post Induction|Randomization closed|0|||
156594312|NCT02883049|565258104|FG012|Post Induction|Randomization closed|0|||
156594313|NCT02883049|565258105|FG013|Post Induction|Randomization closed|0|||
156594314|NCT02883049|565258106|FG014|Post Induction|Randomization closed|0|||
156594315|NCT02883049|565258107|FG015|Post Induction|Randomization closed|0|||
156594316|NCT02883049|565258092|FG000|Post Induction|MRD negative|0|||
156594317|NCT02883049|565258093|FG001|Post Induction|MRD negative|0|||
156594318|NCT02883049|565258094|FG002|Post Induction|MRD negative|0|||
156594319|NCT02883049|565258095|FG003|Post Induction|MRD negative|0|||
156594320|NCT02883049|565258096|FG004|Post Induction|MRD negative|0|||
156594321|NCT02883049|565258097|FG005|Post Induction|MRD negative|0|||
156594322|NCT02883049|565258098|FG006|Post Induction|MRD negative|0|||
156594323|NCT02883049|565258099|FG007|Post Induction|MRD negative|11|||
156594324|NCT02883049|565258100|FG008|Post Induction|MRD negative|0|||
156594325|NCT02883049|565258101|FG009|Post Induction|MRD negative|0|||
156594326|NCT02883049|565258102|FG010|Post Induction|MRD negative|0|||
156594327|NCT02883049|565258103|FG011|Post Induction|MRD negative|0|||
156594328|NCT02883049|565258104|FG012|Post Induction|MRD negative|0|||
156594329|NCT02883049|565258105|FG013|Post Induction|MRD negative|0|||
156594330|NCT02883049|565258106|FG014|Post Induction|MRD negative|0|||
156594331|NCT02883049|565258107|FG015|Post Induction|MRD negative|0|||
156594332|NCT02883049|565258092|FG000|Post Induction|Developed SMN|0|||
156594333|NCT02883049|565258093|FG001|Post Induction|Developed SMN|0|||
156594334|NCT02883049|565258094|FG002|Post Induction|Developed SMN|0|||
156594335|NCT02883049|565258095|FG003|Post Induction|Developed SMN|0|||
156594336|NCT02883049|565258096|FG004|Post Induction|Developed SMN|1|||
156594337|NCT02883049|565258097|FG005|Post Induction|Developed SMN|0|||
156594338|NCT02883049|565258098|FG006|Post Induction|Developed SMN|1|||
156594339|NCT02883049|565258099|FG007|Post Induction|Developed SMN|0|||
156594340|NCT02883049|565258100|FG008|Post Induction|Developed SMN|0|||
156594341|NCT02883049|565258101|FG009|Post Induction|Developed SMN|0|||
156594342|NCT02883049|565258102|FG010|Post Induction|Developed SMN|1|||
156594343|NCT02883049|565258103|FG011|Post Induction|Developed SMN|1|||
156594344|NCT02883049|565258104|FG012|Post Induction|Developed SMN|0|||
156594345|NCT02883049|565258105|FG013|Post Induction|Developed SMN|0|||
156594346|NCT02883049|565258106|FG014|Post Induction|Developed SMN|1|||
156594347|NCT02883049|565258107|FG015|Post Induction|Developed SMN|0|||
156594348|NCT02883049|565258092|FG000|Post Induction|Enrolled onto another COG study|0|||
156594349|NCT02883049|565258093|FG001|Post Induction|Enrolled onto another COG study|0|||
156594350|NCT02883049|565258094|FG002|Post Induction|Enrolled onto another COG study|0|||
156594351|NCT02883049|565258095|FG003|Post Induction|Enrolled onto another COG study|1|||
156594352|NCT02883049|565258096|FG004|Post Induction|Enrolled onto another COG study|1|||
156594353|NCT02883049|565258097|FG005|Post Induction|Enrolled onto another COG study|0|||
156594354|NCT02883049|565258098|FG006|Post Induction|Enrolled onto another COG study|0|||
156594355|NCT02883049|565258099|FG007|Post Induction|Enrolled onto another COG study|4|||
156594356|NCT02883049|565258100|FG008|Post Induction|Enrolled onto another COG study|0|||
156594357|NCT02883049|565258101|FG009|Post Induction|Enrolled onto another COG study|0|||
156594358|NCT02883049|565258102|FG010|Post Induction|Enrolled onto another COG study|0|||
156594359|NCT02883049|565258103|FG011|Post Induction|Enrolled onto another COG study|2|||
156594360|NCT02883049|565258104|FG012|Post Induction|Enrolled onto another COG study|0|||
156594361|NCT02883049|565258105|FG013|Post Induction|Enrolled onto another COG study|1|||
156594362|NCT02883049|565258106|FG014|Post Induction|Enrolled onto another COG study|0|||
156594363|NCT02883049|565258107|FG015|Post Induction|Enrolled onto another COG study|0|||
156594364|NCT02883049|565258092|FG000|Post Induction|Recurrent leukemia|0|||
156594365|NCT02883049|565258093|FG001|Post Induction|Recurrent leukemia|0|||
156594366|NCT02883049|565258094|FG002|Post Induction|Recurrent leukemia|0|||
156594367|NCT02883049|565258095|FG003|Post Induction|Recurrent leukemia|17|||
156594368|NCT02883049|565258096|FG004|Post Induction|Recurrent leukemia|12|||
156594369|NCT02883049|565258097|FG005|Post Induction|Recurrent leukemia|4|||
156594370|NCT02883049|565258098|FG006|Post Induction|Recurrent leukemia|1|||
156594371|NCT02883049|565258099|FG007|Post Induction|Recurrent leukemia|13|||
156594372|NCT02883049|565258100|FG008|Post Induction|Recurrent leukemia|27|||
156594373|NCT02883049|565258101|FG009|Post Induction|Recurrent leukemia|5|||
156594374|NCT02883049|565258102|FG010|Post Induction|Recurrent leukemia|3|||
156594375|NCT02883049|565258103|FG011|Post Induction|Recurrent leukemia|12|||
156594376|NCT02883049|565258104|FG012|Post Induction|Recurrent leukemia|1|||
156594377|NCT02883049|565258105|FG013|Post Induction|Recurrent leukemia|1|||
156594378|NCT02883049|565258106|FG014|Post Induction|Recurrent leukemia|9|||
156594379|NCT02883049|565258107|FG015|Post Induction|Recurrent leukemia|3|||
156594380|NCT02883049|565258092|FG000|Post Induction|Induction Failure|0|||
156594381|NCT02883049|565258093|FG001|Post Induction|Induction Failure|0|||
156594382|NCT02883049|565258094|FG002|Post Induction|Induction Failure|0|||
156594383|NCT02883049|565258095|FG003|Post Induction|Induction Failure|0|||
156594384|NCT02883049|565258096|FG004|Post Induction|Induction Failure|0|||
156594385|NCT02883049|565258097|FG005|Post Induction|Induction Failure|0|||
156594386|NCT02883049|565258098|FG006|Post Induction|Induction Failure|0|||
156594387|NCT02883049|565258099|FG007|Post Induction|Induction Failure|2|||
156594388|NCT02883049|565258100|FG008|Post Induction|Induction Failure|2|||
156594389|NCT02883049|565258101|FG009|Post Induction|Induction Failure|0|||
156594390|NCT02883049|565258102|FG010|Post Induction|Induction Failure|0|||
156594391|NCT02883049|565258103|FG011|Post Induction|Induction Failure|0|||
156594392|NCT02883049|565258104|FG012|Post Induction|Induction Failure|0|||
156594393|NCT02883049|565258105|FG013|Post Induction|Induction Failure|2|||
156594394|NCT02883049|565258106|FG014|Post Induction|Induction Failure|0|||
156594395|NCT02883049|565258107|FG015|Post Induction|Induction Failure|0|||
156594396|NCT00229203|565258108|FG000|Overall Study|Progressive disease|18|||
156594397|NCT00229203|565258109|FG001|Overall Study|Progressive disease|9|||
156594398|NCT00229203|565258108|FG000|Overall Study|Toxicity|6|||
156594399|NCT00229203|565258109|FG001|Overall Study|Toxicity|1|||
156594400|NCT00229203|565258108|FG000|Overall Study|Death|4|||
156594401|NCT00229203|565258109|FG001|Overall Study|Death|2|||
156594402|NCT00229203|565258108|FG000|Overall Study|Other|3|||
156594403|NCT00229203|565258109|FG001|Overall Study|Other|3|||
156594404|NCT00229203|565258108|FG000|Overall Study|Withdrawal by Subject|1|||
156594405|NCT00229203|565258109|FG001|Overall Study|Withdrawal by Subject|4|||
156594406|NCT03457103|565258110|FG000|Overall Study|illness/hospitalization|4|||
156594407|NCT03457103|565258111|FG001|Overall Study|illness/hospitalization|2|||
156594408|NCT03457103|565258110|FG000|Overall Study|Lost to Follow-up|2|||
156594409|NCT03457103|565258111|FG001|Overall Study|Lost to Follow-up|1|||
156594410|NCT03457103|565258110|FG000|Overall Study|Withdrawal by Subject|1|||
156594411|NCT03457103|565258111|FG001|Overall Study|Withdrawal by Subject|2|||
156594412|NCT03457103|565258110|FG000|Overall Study|financial/ insurance issues|1|||
156594413|NCT03457103|565258111|FG001|Overall Study|financial/ insurance issues|1|||
156594414|NCT03004469|565258114|FG000|Overall Study|Adverse Event|6|||
156594415|NCT03004469|565258115|FG001|Overall Study|Adverse Event|4|||
156594416|NCT03004469|565258116|FG002|Overall Study|Adverse Event|6|||
156594417|NCT03004469|565258114|FG000|Overall Study|Lack of Efficacy|1|||
156594418|NCT03004469|565258115|FG001|Overall Study|Lack of Efficacy|0|||
156594419|NCT03004469|565258116|FG002|Overall Study|Lack of Efficacy|1|||
156594420|NCT03004469|565258114|FG000|Overall Study|Lost to Follow-up|23|||
156594421|NCT03004469|565258115|FG001|Overall Study|Lost to Follow-up|14|||
156594422|NCT03004469|565258116|FG002|Overall Study|Lost to Follow-up|6|||
156594423|NCT03004469|565258114|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156594424|NCT03004469|565258115|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156594425|NCT03004469|565258116|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156594426|NCT03004469|565258114|FG000|Overall Study|Protocol Violation|0|||
156594427|NCT03004469|565258115|FG001|Overall Study|Protocol Violation|0|||
156594428|NCT03004469|565258116|FG002|Overall Study|Protocol Violation|1|||
156594429|NCT03004469|565258114|FG000|Overall Study|Withdrawal by Subject|29|||
156594430|NCT03004469|565258115|FG001|Overall Study|Withdrawal by Subject|27|||
156594431|NCT03004469|565258116|FG002|Overall Study|Withdrawal by Subject|10|||
156594432|NCT03004469|565258114|FG000|Overall Study|Other unspecified reason|0|||
156594433|NCT03004469|565258115|FG001|Overall Study|Other unspecified reason|4|||
156594434|NCT03004469|565258116|FG002|Overall Study|Other unspecified reason|1|||
156594435|NCT01163253|565258117|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
156594436|NCT01163253|565258118|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
156594437|NCT01163253|565258117|FG000|Overall Study|Study Terminated by Sponsor|978|||
156594438|NCT01163253|565258118|FG001|Overall Study|Study Terminated by Sponsor|349|||
156594439|NCT01163253|565258117|FG000|Overall Study|Protocol Violation|43|||
156594440|NCT01163253|565258118|FG001|Overall Study|Protocol Violation|12|||
156594441|NCT01163253|565258117|FG000|Overall Study|Withdrawal by Subject|199|||
156594442|NCT01163253|565258118|FG001|Overall Study|Withdrawal by Subject|50|||
156594443|NCT01163253|565258117|FG000|Overall Study|Medication Error|1|||
156594444|NCT01163253|565258118|FG001|Overall Study|Medication Error|0|||
156594445|NCT01163253|565258117|FG000|Overall Study|Lost to Follow-up|125|||
156594446|NCT01163253|565258118|FG001|Overall Study|Lost to Follow-up|23|||
156594447|NCT01163253|565258117|FG000|Overall Study|Insufficient Clinical Response|423|||
156594448|NCT01163253|565258118|FG001|Overall Study|Insufficient Clinical Response|29|||
156594449|NCT01163253|565258117|FG000|Overall Study|Adverse Event|300|||
156594450|NCT01163253|565258118|FG001|Overall Study|Adverse Event|78|||
156594451|NCT01163253|565258117|FG000|Overall Study|Death|17|||
156594452|NCT01163253|565258118|FG001|Overall Study|Death|5|||
156594453|NCT01163253|565258117|FG000|Overall Study|Ongoing|13|||
156594454|NCT01163253|565258118|FG001|Overall Study|Ongoing|4|||
156594455|NCT01163253|565258117|FG000|Overall Study|Other Unspecified|170|||
156594456|NCT01163253|565258118|FG001|Overall Study|Other Unspecified|34|||
156594457|NCT01397552|565258119|FG000|Overall Study|Adverse Event|1|||
156594458|NCT01397552|565258120|FG001|Overall Study|Adverse Event|0|||
156594459|NCT01397552|565258119|FG000|Overall Study|Withdrawal by Subject|2|||
156594460|NCT01397552|565258120|FG001|Overall Study|Withdrawal by Subject|1|||
156594461|NCT00423735|565258121|FG000|Overall Study|Ineligible / No protocol treatment|8|||
156594462|NCT00423735|565258122|FG001|Overall Study|Ineligible / No protocol treatment|6|||
156594463|NCT00423735|565258123|FG002|Overall Study|Ineligible / No protocol treatment|0|||
156594464|NCT00579501|565258129|FG000|Overall Study|Death|1|||
156594465|NCT00579501|565258129|FG000|Overall Study|End of neoadjuvant therapy|25|||
156594466|NCT00579501|565258129|FG000|Overall Study|toxicity|1|||
156594467|NCT00579501|565258129|FG000|Overall Study|Secondary lesion|1|||
156594468|NCT00579501|565258129|FG000|Overall Study|Radiation therapy before surgery|1|||
156594469|NCT00190983|565258130|FG000|Overall Study|Inevaluable (never treated)|2|||
156594470|NCT01089582|565258131|FG000|Overall Study|Death|2|||
156594471|NCT01089582|565258131|FG000|Overall Study|Adverse Event|15|||
156594472|NCT01089582|565258131|FG000|Overall Study|Lost to Follow-up|8|||
156594473|NCT01089582|565258131|FG000|Overall Study|Other|4|||
156594474|NCT01089582|565258131|FG000|Overall Study|Withdrawal by Subject|1|||
156594475|NCT02287402|565258132|FG000|Treatment Period|Adverse Event|17|||
156594476|NCT02287402|565258132|FG000|Treatment Period|Voluntary Withdrawal|10|||
156594477|NCT02287402|565258132|FG000|Follow-up|Lost to Follow-up|1|||
156594478|NCT02287402|565258132|FG000|Follow-up|Voluntary Withdrawal|2|||
156594479|NCT04069156|565258133|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
156594480|NCT04069156|565258134|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
156594481|NCT04069156|565258133|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
156594482|NCT04069156|565258134|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
156594483|NCT04069156|565258133|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
156594484|NCT04069156|565258134|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
156594485|NCT04069156|565258133|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
156594486|NCT04069156|565258134|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
156594487|NCT04247815|565258135|FG000|Overall Study|Adverse Event|1|||
156594488|NCT04247815|565258136|FG001|Overall Study|Adverse Event|0|||
156594489|NCT04247815|565258135|FG000|Overall Study|Withdrawal by Subject|1|||
156594490|NCT04247815|565258136|FG001|Overall Study|Withdrawal by Subject|0|||
156594491|NCT04247815|565258135|FG000|Overall Study|Protocol Violation|0|||
156594492|NCT04247815|565258136|FG001|Overall Study|Protocol Violation|1|||
156594493|NCT02394808|565258137|FG000|Period 1|Unsatisfactory lens fitting|0|||
156594494|NCT02394808|565258138|FG001|Period 1|Unsatisfactory lens fitting|1|||
156594495|NCT02394808|565258137|FG000|Period 2|Lost to Follow-up|1|||
156594496|NCT02394808|565258138|FG001|Period 2|Lost to Follow-up|0|||
156594497|NCT05025787|565258139|FG000|Overall Study|Lack of Efficacy|0|||
156594498|NCT05025787|565258140|FG001|Overall Study|Lack of Efficacy|1|||
156594499|NCT05025787|565258139|FG000|Overall Study|Adverse Event|2|||
156594500|NCT05025787|565258140|FG001|Overall Study|Adverse Event|4|||
156594501|NCT05025787|565258139|FG000|Overall Study|Non compliance|0|||
156594502|NCT05025787|565258140|FG001|Overall Study|Non compliance|1|||
156594503|NCT05025787|565258139|FG000|Overall Study|Protocol Violation|3|||
156594504|NCT05025787|565258140|FG001|Overall Study|Protocol Violation|1|||
156594505|NCT05025787|565258139|FG000|Overall Study|Stopping criteria met|1|||
156594506|NCT05025787|565258140|FG001|Overall Study|Stopping criteria met|1|||
156594507|NCT05025787|565258139|FG000|Overall Study|Withdrawal by Subject|3|||
156594508|NCT05025787|565258140|FG001|Overall Study|Withdrawal by Subject|1|||
156594509|NCT02951988|565258141|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
156594510|NCT02951988|565258142|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
156594511|NCT02951988|565258143|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
156594512|NCT02951988|565258144|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
156594513|NCT02951988|565258141|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
156594514|NCT02951988|565258142|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
156594515|NCT02951988|565258143|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
156594516|NCT02951988|565258144|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
156594517|NCT02951988|565258141|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
156594518|NCT02951988|565258142|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
156594519|NCT02951988|565258143|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
156594520|NCT02951988|565258144|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
156594521|NCT02951988|565258141|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
156594522|NCT02951988|565258142|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
156594523|NCT02951988|565258143|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
156594524|NCT02951988|565258144|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
156594525|NCT02951988|565258141|FG000|Open-Label Treatment Period|Protocol Violation|22|||
156594526|NCT02951988|565258142|FG001|Open-Label Treatment Period|Protocol Violation|0|||
156594527|NCT02951988|565258143|FG002|Open-Label Treatment Period|Protocol Violation|0|||
156594528|NCT02951988|565258144|FG003|Open-Label Treatment Period|Protocol Violation|0|||
156594529|NCT02951988|565258141|FG000|Open-Label Treatment Period|Pregnancy|2|||
156594530|NCT02951988|565258142|FG001|Open-Label Treatment Period|Pregnancy|0|||
156594531|NCT02951988|565258143|FG002|Open-Label Treatment Period|Pregnancy|0|||
156594532|NCT02951988|565258144|FG003|Open-Label Treatment Period|Pregnancy|0|||
156594533|NCT02951988|565258141|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
156594534|NCT02951988|565258142|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
156594535|NCT02951988|565258143|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
156594536|NCT02951988|565258144|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
156594537|NCT02951988|565258141|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
156594538|NCT02951988|565258142|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
156594539|NCT02951988|565258143|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
156594540|NCT02951988|565258144|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
156594541|NCT02951988|565258141|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
156594542|NCT02951988|565258142|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
156594543|NCT02951988|565258143|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
156594544|NCT02951988|565258144|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
156594545|NCT02951988|565258141|FG000|Open-Label Treatment Period|Adverse Event|45|||
156594546|NCT02951988|565258142|FG001|Open-Label Treatment Period|Adverse Event|0|||
156594547|NCT02951988|565258143|FG002|Open-Label Treatment Period|Adverse Event|0|||
156594548|NCT02951988|565258144|FG003|Open-Label Treatment Period|Adverse Event|0|||
156594549|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
156594550|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
156594551|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
156594552|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
156594553|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
156594554|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
156594555|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
156594556|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
156594557|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
156594558|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
156594559|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
156594560|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
156594561|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156594562|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
156594563|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
156594564|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
156594565|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Pregnancy|0|||
156594566|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Pregnancy|1|||
156594567|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Pregnancy|1|||
156594568|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Pregnancy|0|||
156594569|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156594570|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
156594571|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
156594572|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
156594573|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156594574|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
156594575|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
156594576|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
156594577|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156594578|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Adverse Event|8|||
156594579|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Adverse Event|3|||
156594580|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Adverse Event|6|||
156594581|NCT02951988|565258141|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
156594582|NCT02951988|565258142|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
156594583|NCT02951988|565258143|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
156594584|NCT02951988|565258144|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
156594585|NCT00516269|565258145|FG000|Overall Study|Adverse Event|2|||
156594586|NCT00516269|565258146|FG001|Overall Study|Adverse Event|1|||
156594587|NCT00516269|565258145|FG000|Overall Study|Lost to Follow-up|0|||
156594588|NCT00516269|565258146|FG001|Overall Study|Lost to Follow-up|1|||
156594589|NCT00516269|565258145|FG000|Overall Study|Protocol Violation|0|||
156594590|NCT00516269|565258146|FG001|Overall Study|Protocol Violation|1|||
156594591|NCT04570657|565258148|FG000|Overall Study|Adverse Event|0|||
156594592|NCT04570657|565258149|FG001|Overall Study|Adverse Event|0|||
156594593|NCT04570657|565258150|FG002|Overall Study|Adverse Event|1|||
156594594|NCT04570657|565258148|FG000|Overall Study|Lost to Follow-up|0|||
156594595|NCT04570657|565258149|FG001|Overall Study|Lost to Follow-up|0|||
156594596|NCT04570657|565258150|FG002|Overall Study|Lost to Follow-up|1|||
156594597|NCT04570657|565258148|FG000|Overall Study|Physician Decision|0|||
156594598|NCT04570657|565258149|FG001|Overall Study|Physician Decision|1|||
156594599|NCT04570657|565258150|FG002|Overall Study|Physician Decision|0|||
156594600|NCT04570657|565258148|FG000|Overall Study|Withdrawal by Subject|1|||
156594601|NCT04570657|565258149|FG001|Overall Study|Withdrawal by Subject|2|||
156594602|NCT04570657|565258150|FG002|Overall Study|Withdrawal by Subject|2|||
156594603|NCT01079962|565258151|FG000|Overall Study|Adverse Event|2|||
156594604|NCT01079962|565258152|FG001|Overall Study|Adverse Event|2|||
156594605|NCT01079962|565258151|FG000|Overall Study|Withdrawal by Subject|5|||
156594606|NCT01079962|565258152|FG001|Overall Study|Withdrawal by Subject|7|||
156594607|NCT01079962|565258151|FG000|Overall Study|Protocol Violation|2|||
156594608|NCT01079962|565258152|FG001|Overall Study|Protocol Violation|2|||
156594609|NCT01079962|565258151|FG000|Overall Study|No blood pressure (BP) control|3|||
156594610|NCT01079962|565258152|FG001|Overall Study|No blood pressure (BP) control|0|||
156594611|NCT01079962|565258151|FG000|Overall Study|Inclusion/exclusion criteria|1|||
156594612|NCT01079962|565258152|FG001|Overall Study|Inclusion/exclusion criteria|3|||
156594613|NCT01079962|565258151|FG000|Overall Study|Participant not returning for next visit|1|||
156594614|NCT01079962|565258152|FG001|Overall Study|Participant not returning for next visit|0|||
156594615|NCT01079962|565258151|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
156594616|NCT01079962|565258152|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
156594617|NCT01331239|565258153|FG000|Part II: Core Study|Adverse Event|0|||
156594618|NCT01331239|565258154|FG001|Part II: Core Study|Adverse Event|3|||
156594619|NCT01331239|565258155|FG002|Part II: Core Study|Adverse Event|0|||
156594620|NCT01331239|565258153|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
156594621|NCT01331239|565258154|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
156594622|NCT01331239|565258155|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
156594623|NCT01331239|565258153|FG000|Part II: Core Study|Withdrawal by Subject|0|||
156594624|NCT01331239|565258154|FG001|Part II: Core Study|Withdrawal by Subject|2|||
156594625|NCT01331239|565258155|FG002|Part II: Core Study|Withdrawal by Subject|0|||
156594626|NCT01331239|565258153|FG000|Part II: Core Study|Administrative problems|0|||
156594627|NCT01331239|565258154|FG001|Part II: Core Study|Administrative problems|1|||
156594628|NCT01331239|565258155|FG002|Part II: Core Study|Administrative problems|0|||
156594629|NCT01008995|565258156|FG000|Controlled Period|Adverse Event|1|||
156594630|NCT01008995|565258157|FG001|Controlled Period|Adverse Event|2|||
156594631|NCT01008995|565258158|FG002|Controlled Period|Adverse Event|0|||
156594632|NCT01008995|565258159|FG003|Controlled Period|Adverse Event|0|||
156594633|NCT01008995|565258156|FG000|Controlled Period|Other|2|||
156594634|NCT01008995|565258157|FG001|Controlled Period|Other|1|||
156594635|NCT01008995|565258158|FG002|Controlled Period|Other|0|||
156594636|NCT01008995|565258159|FG003|Controlled Period|Other|0|||
156594637|NCT01008995|565258156|FG000|After Controlled Period|Adverse Event|0|||
156594638|NCT01008995|565258157|FG001|After Controlled Period|Adverse Event|0|||
156594639|NCT01008995|565258158|FG002|After Controlled Period|Adverse Event|1|||
156594640|NCT01008995|565258159|FG003|After Controlled Period|Adverse Event|1|||
156594641|NCT01008995|565258156|FG000|After Controlled Period|Other|0|||
156594642|NCT01008995|565258157|FG001|After Controlled Period|Other|0|||
156594643|NCT01008995|565258158|FG002|After Controlled Period|Other|1|||
156594644|NCT01008995|565258159|FG003|After Controlled Period|Other|0|||
156594645|NCT04167306|565258160|FG000|Overall Study|Lost to Follow-up|2|||
156594646|NCT04167306|565258161|FG001|Overall Study|Lost to Follow-up|2|||
156594647|NCT04167306|565258162|FG002|Overall Study|Lost to Follow-up|5|||
156594648|NCT04167306|565258163|FG003|Overall Study|Lost to Follow-up|5|||
156594649|NCT04167306|565258160|FG000|Overall Study|Adverse Event|13|||
156594650|NCT04167306|565258161|FG001|Overall Study|Adverse Event|14|||
156594651|NCT04167306|565258162|FG002|Overall Study|Adverse Event|5|||
156594652|NCT04167306|565258163|FG003|Overall Study|Adverse Event|4|||
156594653|NCT04167306|565258160|FG000|Overall Study|Withdrawal by Subject|4|||
156594654|NCT04167306|565258161|FG001|Overall Study|Withdrawal by Subject|6|||
156594655|NCT04167306|565258162|FG002|Overall Study|Withdrawal by Subject|8|||
156594656|NCT04167306|565258163|FG003|Overall Study|Withdrawal by Subject|3|||
156594657|NCT04167306|565258160|FG000|Overall Study|covid|1|||
156594658|NCT04167306|565258161|FG001|Overall Study|covid|1|||
156594659|NCT04167306|565258162|FG002|Overall Study|covid|2|||
156594660|NCT04167306|565258163|FG003|Overall Study|covid|1|||
156594661|NCT04167306|565258160|FG000|Overall Study|concomitant medication|0|||
156594662|NCT04167306|565258161|FG001|Overall Study|concomitant medication|0|||
156594663|NCT04167306|565258162|FG002|Overall Study|concomitant medication|0|||
156594664|NCT04167306|565258163|FG003|Overall Study|concomitant medication|1|||
156594665|NCT04167306|565258160|FG000|Overall Study|Alcohol treatment|0|||
156594666|NCT04167306|565258161|FG001|Overall Study|Alcohol treatment|4|||
156594667|NCT04167306|565258162|FG002|Overall Study|Alcohol treatment|3|||
156594668|NCT04167306|565258163|FG003|Overall Study|Alcohol treatment|2|||
156594669|NCT04167306|565258160|FG000|Overall Study|non-compliance|0|||
156594670|NCT04167306|565258161|FG001|Overall Study|non-compliance|0|||
156594671|NCT04167306|565258162|FG002|Overall Study|non-compliance|1|||
156594672|NCT04167306|565258163|FG003|Overall Study|non-compliance|0|||
156594673|NCT04167306|565258160|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
156594674|NCT04167306|565258161|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
156594675|NCT04167306|565258162|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
156594676|NCT04167306|565258163|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
156594677|NCT03731364|565258166|FG000|Overall Study|Adverse Event|0|||
156594678|NCT03731364|565258167|FG001|Overall Study|Adverse Event|0|||
156594679|NCT03731364|565258168|FG002|Overall Study|Adverse Event|1|||
156594680|NCT03731364|565258169|FG003|Overall Study|Adverse Event|2|||
156594681|NCT03731364|565258170|FG004|Overall Study|Adverse Event|1|||
156594682|NCT01934192|565258173|FG000|Overall Study|Protocol Violation|0|||
156594683|NCT01934192|565258174|FG001|Overall Study|Protocol Violation|0|||
156594684|NCT01934192|565258175|FG002|Overall Study|Protocol Violation|0|||
156594685|NCT01934192|565258176|FG003|Overall Study|Protocol Violation|1|||
156594686|NCT01934192|565258173|FG000|Overall Study|Other: reached stopping criteria|6|||
156594687|NCT01934192|565258174|FG001|Overall Study|Other: reached stopping criteria|5|||
156594688|NCT01934192|565258175|FG002|Overall Study|Other: reached stopping criteria|1|||
156594689|NCT01934192|565258176|FG003|Overall Study|Other: reached stopping criteria|0|||
156594690|NCT01934192|565258173|FG000|Overall Study|Physician Decision|3|||
156594691|NCT01934192|565258174|FG001|Overall Study|Physician Decision|2|||
156594692|NCT01934192|565258175|FG002|Overall Study|Physician Decision|0|||
156594693|NCT01934192|565258176|FG003|Overall Study|Physician Decision|0|||
156594694|NCT01189435|565258177|FG000|Overall Study|Withdrawal by Subject|1|||
156594695|NCT01189435|565258177|FG000|Overall Study|Physician Decision|1|||
156594696|NCT00403559|565258178|FG000|Overall Study|Adverse Event|0|||
156594697|NCT00403559|565258179|FG001|Overall Study|Adverse Event|1|||
156594698|NCT00403559|565258178|FG000|Overall Study|Lost to Follow-up|3|||
156594699|NCT00403559|565258179|FG001|Overall Study|Lost to Follow-up|3|||
156594700|NCT00403559|565258178|FG000|Overall Study|Withdrawal by Subject|1|||
156594701|NCT00403559|565258179|FG001|Overall Study|Withdrawal by Subject|0|||
156594702|NCT00547378|565258180|FG000|Randomized Cohort|Withdrawal by Subject|7|||
156594703|NCT00547378|565258181|FG001|Randomized Cohort|Withdrawal by Subject|5|||
156594704|NCT00547378|565258182|FG002|Randomized Cohort|Withdrawal by Subject|0|||
156594705|NCT00547378|565258180|FG000|Randomized Cohort|Death|0|||
156594706|NCT00547378|565258181|FG001|Randomized Cohort|Death|1|||
156594707|NCT00547378|565258182|FG002|Randomized Cohort|Death|0|||
156594708|NCT00547378|565258180|FG000|Randomized Cohort|Lost to Follow-up|1|||
156594709|NCT00547378|565258181|FG001|Randomized Cohort|Lost to Follow-up|0|||
156594710|NCT00547378|565258182|FG002|Randomized Cohort|Lost to Follow-up|0|||
156594711|NCT00547378|565258180|FG000|Randomized Cohort|Adverse Event|1|||
156594712|NCT00547378|565258181|FG001|Randomized Cohort|Adverse Event|0|||
156594713|NCT00547378|565258182|FG002|Randomized Cohort|Adverse Event|0|||
156594714|NCT00547378|565258180|FG000|Randomized Cohort|Other reasons|2|||
156594715|NCT00547378|565258181|FG001|Randomized Cohort|Other reasons|0|||
156594716|NCT00547378|565258182|FG002|Randomized Cohort|Other reasons|0|||
156594717|NCT00547378|565258180|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
156594718|NCT00547378|565258181|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
156594719|NCT00547378|565258182|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
156594720|NCT00547378|565258180|FG000|All Implanted Cohort|Adverse Event|4|||
156594721|NCT00547378|565258181|FG001|All Implanted Cohort|Adverse Event|10|||
156594722|NCT00547378|565258182|FG002|All Implanted Cohort|Adverse Event|17|||
156594723|NCT00547378|565258180|FG000|All Implanted Cohort|Lost to Follow-up|0|||
156594724|NCT00547378|565258181|FG001|All Implanted Cohort|Lost to Follow-up|1|||
156594725|NCT00547378|565258182|FG002|All Implanted Cohort|Lost to Follow-up|14|||
156594726|NCT00547378|565258180|FG000|All Implanted Cohort|Death|3|||
156594727|NCT00547378|565258181|FG001|All Implanted Cohort|Death|1|||
156594728|NCT00547378|565258182|FG002|All Implanted Cohort|Death|4|||
156594729|NCT00547378|565258180|FG000|All Implanted Cohort|Physician Decision|0|||
156594730|NCT00547378|565258181|FG001|All Implanted Cohort|Physician Decision|2|||
156594731|NCT00547378|565258182|FG002|All Implanted Cohort|Physician Decision|6|||
156594732|NCT00547378|565258180|FG000|All Implanted Cohort|Site closure|2|||
156594733|NCT00547378|565258181|FG001|All Implanted Cohort|Site closure|0|||
156594734|NCT00547378|565258182|FG002|All Implanted Cohort|Site closure|1|||
156594735|NCT00547378|565258180|FG000|All Implanted Cohort|Other reasons|1|||
156594736|NCT00547378|565258181|FG001|All Implanted Cohort|Other reasons|0|||
156594737|NCT00547378|565258182|FG002|All Implanted Cohort|Other reasons|1|||
156594738|NCT04105244|565258183|FG000|Overall Study|Withdrawal by Subject|10|||
156594739|NCT04105244|565258184|FG001|Overall Study|Withdrawal by Subject|12|||
156594740|NCT04105244|565258183|FG000|Overall Study|Lost to Follow-up|20|||
156594741|NCT04105244|565258184|FG001|Overall Study|Lost to Follow-up|15|||
156594742|NCT04105244|565258183|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
156594743|NCT04105244|565258184|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
156594744|NCT04105244|565258183|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
156594745|NCT04105244|565258184|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
156594746|NCT02768194|565258185|FG000|Period 1|Adverse Event|0|||
156594747|NCT02768194|565258186|FG001|Period 1|Adverse Event|0|||
156594748|NCT02768194|565258187|FG002|Period 1|Adverse Event|0|||
156594749|NCT02768194|565258188|FG003|Period 1|Adverse Event|1|||
156594750|NCT02768194|565258189|FG004|Period 1|Adverse Event|0|||
156594751|NCT02768194|565258190|FG005|Period 1|Adverse Event|0|||
156594752|NCT02768194|565258185|FG000|Period 2|Other (Reason not specified)|1|||
156594753|NCT02768194|565258186|FG001|Period 2|Other (Reason not specified)|0|||
156594754|NCT02768194|565258187|FG002|Period 2|Other (Reason not specified)|0|||
156594755|NCT02768194|565258188|FG003|Period 2|Other (Reason not specified)|0|||
156594756|NCT02768194|565258189|FG004|Period 2|Other (Reason not specified)|0|||
156594757|NCT02768194|565258190|FG005|Period 2|Other (Reason not specified)|0|||
156594758|NCT02768194|565258185|FG000|Period 3|Other (Reason not specified)|0|||
156594759|NCT02768194|565258186|FG001|Period 3|Other (Reason not specified)|1|||
156594760|NCT02768194|565258187|FG002|Period 3|Other (Reason not specified)|0|||
156594761|NCT02768194|565258188|FG003|Period 3|Other (Reason not specified)|0|||
156594762|NCT02768194|565258189|FG004|Period 3|Other (Reason not specified)|0|||
156594763|NCT02768194|565258190|FG005|Period 3|Other (Reason not specified)|0|||
156594764|NCT04863014|565258191|FG000|Overall Study|Lost to Follow-up|3|||
156594765|NCT04863014|565258192|FG001|Overall Study|Lost to Follow-up|2|||
156594766|NCT04863014|565258191|FG000|Overall Study|Subject Decision|0|||
156594767|NCT04863014|565258192|FG001|Overall Study|Subject Decision|4|||
156594768|NCT01982773|565258193|FG000|Overall Study|Withdrawal by Subject|1|||
156594769|NCT01982773|565258194|FG001|Overall Study|Withdrawal by Subject|3|||
156594770|NCT01982773|565258193|FG000|Overall Study|Lost to Follow-up|7|||
156594771|NCT01982773|565258194|FG001|Overall Study|Lost to Follow-up|1|||
156594772|NCT00448916|565258195|FG000|Overall Study|Adverse Event|2|||
156594773|NCT00448916|565258196|FG001|Overall Study|Adverse Event|2|||
156594774|NCT00448916|565258197|FG002|Overall Study|Adverse Event|3|||
156594775|NCT00448916|565258198|FG003|Overall Study|Adverse Event|2|||
156594776|NCT00448916|565258195|FG000|Overall Study|Lack of Efficacy|1|||
156594777|NCT00448916|565258196|FG001|Overall Study|Lack of Efficacy|0|||
156594778|NCT00448916|565258197|FG002|Overall Study|Lack of Efficacy|2|||
156594779|NCT00448916|565258198|FG003|Overall Study|Lack of Efficacy|1|||
156594780|NCT00448916|565258195|FG000|Overall Study|Withdrawal by Subject|3|||
156594781|NCT00448916|565258196|FG001|Overall Study|Withdrawal by Subject|3|||
156594782|NCT00448916|565258197|FG002|Overall Study|Withdrawal by Subject|1|||
156594783|NCT00448916|565258198|FG003|Overall Study|Withdrawal by Subject|1|||
156594784|NCT00448916|565258195|FG000|Overall Study|Other|1|||
156594785|NCT00448916|565258196|FG001|Overall Study|Other|0|||
156594786|NCT00448916|565258197|FG002|Overall Study|Other|0|||
156594787|NCT00448916|565258198|FG003|Overall Study|Other|0|||
156594788|NCT00448916|565258195|FG000|Overall Study|Lost to Follow-up|0|||
156594789|NCT00448916|565258196|FG001|Overall Study|Lost to Follow-up|1|||
156594790|NCT00448916|565258197|FG002|Overall Study|Lost to Follow-up|0|||
156594791|NCT00448916|565258198|FG003|Overall Study|Lost to Follow-up|1|||
156594792|NCT00448916|565258195|FG000|Overall Study|Protocol Violation|0|||
156594793|NCT00448916|565258196|FG001|Overall Study|Protocol Violation|0|||
156594794|NCT00448916|565258197|FG002|Overall Study|Protocol Violation|0|||
156594795|NCT00448916|565258198|FG003|Overall Study|Protocol Violation|1|||
156594796|NCT03655717|565258199|FG000|Overall Study|Withdrawal by Subject|4|||
156594797|NCT03655717|565258200|FG001|Overall Study|Withdrawal by Subject|8|||
156594798|NCT03655717|565258201|FG002|Overall Study|Withdrawal by Subject|1|||
156594799|NCT03655717|565258202|FG003|Overall Study|Withdrawal by Subject|0|||
156594800|NCT03655717|565258203|FG004|Overall Study|Withdrawal by Subject|0|||
156594801|NCT03655717|565258204|FG005|Overall Study|Withdrawal by Subject|1|||
156594802|NCT03655717|565258205|FG006|Overall Study|Withdrawal by Subject|3|||
156594803|NCT03655717|565258206|FG007|Overall Study|Withdrawal by Subject|1|||
156594804|NCT03655717|565258207|FG008|Overall Study|Withdrawal by Subject|2|||
156594805|NCT03655717|565258208|FG009|Overall Study|Withdrawal by Subject|0|||
156594806|NCT03655717|565258209|FG010|Overall Study|Withdrawal by Subject|0|||
156594807|NCT03655717|565258210|FG011|Overall Study|Withdrawal by Subject|1|||
156594808|NCT03655717|565258211|FG012|Overall Study|Withdrawal by Subject|0|||
156594809|NCT03655717|565258212|FG013|Overall Study|Withdrawal by Subject|3|||
156594810|NCT03655717|565258213|FG014|Overall Study|Withdrawal by Subject|0|||
156594811|NCT03655717|565258214|FG015|Overall Study|Withdrawal by Subject|1|||
156594812|NCT03655717|565258215|FG016|Overall Study|Withdrawal by Subject|0|||
156594813|NCT03655717|565258216|FG017|Overall Study|Withdrawal by Subject|0|||
156594814|NCT03655717|565258217|FG018|Overall Study|Withdrawal by Subject|1|||
156594815|NCT03655717|565258218|FG019|Overall Study|Withdrawal by Subject|0|||
156594816|NCT03655717|565258219|FG020|Overall Study|Withdrawal by Subject|0|||
156594817|NCT03655717|565258220|FG021|Overall Study|Withdrawal by Subject|1|||
156594818|NCT03655717|565258221|FG022|Overall Study|Withdrawal by Subject|2|||
156594819|NCT03655717|565258222|FG023|Overall Study|Withdrawal by Subject|1|||
156594820|NCT03655717|565258223|FG024|Overall Study|Withdrawal by Subject|1|||
156594821|NCT03655717|565258224|FG025|Overall Study|Withdrawal by Subject|0|||
156594822|NCT03655717|565258199|FG000|Overall Study|Physician Decision|3|||
156594823|NCT03655717|565258200|FG001|Overall Study|Physician Decision|3|||
156594824|NCT03655717|565258201|FG002|Overall Study|Physician Decision|0|||
156594825|NCT03655717|565258202|FG003|Overall Study|Physician Decision|0|||
156594826|NCT03655717|565258203|FG004|Overall Study|Physician Decision|0|||
156594827|NCT03655717|565258204|FG005|Overall Study|Physician Decision|0|||
156594828|NCT03655717|565258205|FG006|Overall Study|Physician Decision|0|||
156594829|NCT03655717|565258206|FG007|Overall Study|Physician Decision|0|||
156594830|NCT03655717|565258207|FG008|Overall Study|Physician Decision|0|||
156594831|NCT03655717|565258208|FG009|Overall Study|Physician Decision|1|||
156594832|NCT03655717|565258209|FG010|Overall Study|Physician Decision|0|||
156594833|NCT03655717|565258210|FG011|Overall Study|Physician Decision|0|||
156594834|NCT03655717|565258211|FG012|Overall Study|Physician Decision|0|||
156594835|NCT03655717|565258212|FG013|Overall Study|Physician Decision|0|||
156594836|NCT03655717|565258213|FG014|Overall Study|Physician Decision|0|||
156594837|NCT03655717|565258214|FG015|Overall Study|Physician Decision|0|||
156594838|NCT03655717|565258215|FG016|Overall Study|Physician Decision|0|||
156594839|NCT03655717|565258216|FG017|Overall Study|Physician Decision|0|||
156594840|NCT03655717|565258217|FG018|Overall Study|Physician Decision|0|||
156594841|NCT03655717|565258218|FG019|Overall Study|Physician Decision|1|||
156594842|NCT03655717|565258219|FG020|Overall Study|Physician Decision|0|||
156594843|NCT03655717|565258220|FG021|Overall Study|Physician Decision|0|||
156594844|NCT03655717|565258221|FG022|Overall Study|Physician Decision|0|||
156594845|NCT03655717|565258222|FG023|Overall Study|Physician Decision|1|||
156594846|NCT03655717|565258223|FG024|Overall Study|Physician Decision|0|||
156594847|NCT03655717|565258224|FG025|Overall Study|Physician Decision|0|||
156594848|NCT03655717|565258199|FG000|Overall Study|Lost to Follow-up|3|||
156594849|NCT03655717|565258200|FG001|Overall Study|Lost to Follow-up|1|||
156594850|NCT03655717|565258201|FG002|Overall Study|Lost to Follow-up|0|||
156594851|NCT03655717|565258202|FG003|Overall Study|Lost to Follow-up|1|||
156594852|NCT03655717|565258203|FG004|Overall Study|Lost to Follow-up|0|||
156594853|NCT03655717|565258204|FG005|Overall Study|Lost to Follow-up|1|||
156594854|NCT03655717|565258205|FG006|Overall Study|Lost to Follow-up|0|||
156594855|NCT03655717|565258206|FG007|Overall Study|Lost to Follow-up|0|||
156594856|NCT03655717|565258207|FG008|Overall Study|Lost to Follow-up|0|||
156594857|NCT03655717|565258208|FG009|Overall Study|Lost to Follow-up|0|||
156594858|NCT03655717|565258209|FG010|Overall Study|Lost to Follow-up|0|||
156594859|NCT03655717|565258210|FG011|Overall Study|Lost to Follow-up|1|||
156594860|NCT03655717|565258211|FG012|Overall Study|Lost to Follow-up|0|||
156594861|NCT03655717|565258212|FG013|Overall Study|Lost to Follow-up|0|||
156594862|NCT03655717|565258213|FG014|Overall Study|Lost to Follow-up|0|||
156594863|NCT03655717|565258214|FG015|Overall Study|Lost to Follow-up|0|||
156594864|NCT03655717|565258215|FG016|Overall Study|Lost to Follow-up|0|||
156594865|NCT03655717|565258216|FG017|Overall Study|Lost to Follow-up|0|||
156594866|NCT03655717|565258217|FG018|Overall Study|Lost to Follow-up|0|||
156594867|NCT03655717|565258218|FG019|Overall Study|Lost to Follow-up|0|||
156594868|NCT03655717|565258219|FG020|Overall Study|Lost to Follow-up|0|||
156594869|NCT03655717|565258220|FG021|Overall Study|Lost to Follow-up|0|||
156594870|NCT03655717|565258221|FG022|Overall Study|Lost to Follow-up|0|||
156594871|NCT03655717|565258222|FG023|Overall Study|Lost to Follow-up|0|||
156594872|NCT03655717|565258223|FG024|Overall Study|Lost to Follow-up|0|||
156594873|NCT03655717|565258224|FG025|Overall Study|Lost to Follow-up|0|||
156594874|NCT01185249|565258225|FG000|Overall Study|Patients discharged or change in status|42|||
156594875|NCT02365584|565258226|FG000|Overall Study|Adverse Event|2|||
156594876|NCT02365584|565258227|FG001|Overall Study|Adverse Event|2|||
156594877|NCT02365584|565258226|FG000|Overall Study|Withdrawal by Subject|1|||
156594878|NCT02365584|565258227|FG001|Overall Study|Withdrawal by Subject|0|||
156594879|NCT02365584|565258226|FG000|Overall Study|Disease Progression|9|||
156594880|NCT02365584|565258227|FG001|Overall Study|Disease Progression|12|||
156594881|NCT01973452|565258228|FG000|Overall Study|Lack of Efficacy|0|||
156594882|NCT01973452|565258229|FG001|Overall Study|Lack of Efficacy|1|||
156594883|NCT01973452|565258228|FG000|Overall Study|Lost to Follow-up|1|||
156594884|NCT01973452|565258229|FG001|Overall Study|Lost to Follow-up|0|||
156594885|NCT01973452|565258228|FG000|Overall Study|Withdrawal by Subject|10|||
156594886|NCT01973452|565258229|FG001|Overall Study|Withdrawal by Subject|9|||
156594887|NCT01973452|565258228|FG000|Overall Study|Ineligible|1|||
156594888|NCT01973452|565258229|FG001|Overall Study|Ineligible|1|||
156594889|NCT01973452|565258228|FG000|Overall Study|Surgery canceled by participant|5|||
156594890|NCT01973452|565258229|FG001|Overall Study|Surgery canceled by participant|3|||
156594891|NCT03521193|565258231|FG000|Overall Study|Withdrawal by Subject|8|||
156594892|NCT03521193|565258232|FG001|Overall Study|Withdrawal by Subject|0|||
156594893|NCT03521193|565258231|FG000|Overall Study|non compliant to ASA treatment|8|||
156594894|NCT03521193|565258232|FG001|Overall Study|non compliant to ASA treatment|0|||
156594895|NCT03675737|565258233|FG000|Overall Study|Death|593|||
156594896|NCT03675737|565258234|FG001|Overall Study|Death|660|||
156594897|NCT03675737|565258233|FG000|Overall Study|Lost to Follow-up|1|||
156594898|NCT03675737|565258234|FG001|Overall Study|Lost to Follow-up|5|||
156594899|NCT03675737|565258233|FG000|Overall Study|Physician Decision|1|||
156594900|NCT03675737|565258234|FG001|Overall Study|Physician Decision|0|||
156594901|NCT03675737|565258233|FG000|Overall Study|Withdrawal by Subject|14|||
156594902|NCT03675737|565258234|FG001|Overall Study|Withdrawal by Subject|12|||
156594903|NCT03675737|565258233|FG000|Overall Study|Ongoing in Study|181|||
156594904|NCT03675737|565258234|FG001|Overall Study|Ongoing in Study|112|||
156594905|NCT00209170|565259954|FG000|Overall Study|Adverse Event|0|||
156594906|NCT00209170|565259955|FG001|Overall Study|Adverse Event|1|||
156594907|NCT00209170|565259954|FG000|Overall Study|Withdrawal by Subject|2|||
156594908|NCT00209170|565259955|FG001|Overall Study|Withdrawal by Subject|1|||
156594909|NCT00209170|565259954|FG000|Overall Study|Lack of Efficacy|0|||
156594910|NCT00209170|565259955|FG001|Overall Study|Lack of Efficacy|1|||
156594911|NCT02108600|565259956|FG000|Overall Study|Withdrawal by Subject|2|||
156594912|NCT02108600|565259957|FG001|Overall Study|Withdrawal by Subject|0|||
156594913|NCT02108600|565259956|FG000|Overall Study|Lost to Follow-up|1|||
156594914|NCT02108600|565259957|FG001|Overall Study|Lost to Follow-up|1|||
156594915|NCT03150095|565259958|FG000|Overall Study|Death|0|||
156594916|NCT03150095|565259959|FG001|Overall Study|Death|1|||
156594917|NCT03150095|565259958|FG000|Overall Study|Lost to Follow-up|1|||
156594918|NCT03150095|565259959|FG001|Overall Study|Lost to Follow-up|1|||
156594919|NCT03150095|565259958|FG000|Overall Study|Withdrawal by Subject|4|||
156594920|NCT03150095|565259959|FG001|Overall Study|Withdrawal by Subject|0|||
156594921|NCT03150095|565259958|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
156594922|NCT03150095|565259959|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
156594923|NCT01295580|565259960|FG000|Overall Study|Protocol Violation|4|||
156594924|NCT01295580|565259961|FG001|Overall Study|Protocol Violation|2|||
156594925|NCT01295580|565259960|FG000|Overall Study|Withdrawal by Subject|1|||
156594926|NCT01295580|565259961|FG001|Overall Study|Withdrawal by Subject|4|||
156594927|NCT01295580|565259960|FG000|Overall Study|Adverse Event|2|||
156594928|NCT01295580|565259961|FG001|Overall Study|Adverse Event|1|||
156594929|NCT01295580|565259960|FG000|Overall Study|Lost to Follow-up|1|||
156594930|NCT01295580|565259961|FG001|Overall Study|Lost to Follow-up|0|||
156594931|NCT01295580|565259960|FG000|Overall Study|Lack of Efficacy|1|||
156594932|NCT01295580|565259961|FG001|Overall Study|Lack of Efficacy|0|||
156594933|NCT01295580|565259960|FG000|Overall Study|Other: inconvenience|1|||
156594934|NCT01295580|565259961|FG001|Overall Study|Other: inconvenience|0|||
156594935|NCT01295580|565259960|FG000|Overall Study|Other: family objection|0|||
156594936|NCT01295580|565259961|FG001|Overall Study|Other: family objection|1|||
156594937|NCT00089479|565259972|FG000|Overall Study|Death|108|||
156594938|NCT00089479|565259973|FG001|Overall Study|Death|75|||
156594939|NCT00089479|565259972|FG000|Overall Study|Withdrawal by Subject|86|||
156594940|NCT00089479|565259973|FG001|Overall Study|Withdrawal by Subject|107|||
156594941|NCT00089479|565259972|FG000|Overall Study|Lost to Follow-up|137|||
156594942|NCT00089479|565259973|FG001|Overall Study|Lost to Follow-up|107|||
156594943|NCT03943953|565259974|FG000|Trial of ITG 1|Lost to Follow-up|19|||
156594944|NCT03943953|565259975|FG001|Trial of ITG 1|Lost to Follow-up|1|||
156594945|NCT03943953|565259974|FG000|Trial of ITG 2|Lost to Follow-up|8|||
156594946|NCT03943953|565259975|FG001|Trial of ITG 2|Lost to Follow-up|0|||
156594947|NCT03943953|565259974|FG000|Trial of ITG 3|Lost to Follow-up|2|||
156594948|NCT03943953|565259975|FG001|Trial of ITG 3|Lost to Follow-up|0|||
156594949|NCT03943953|565259974|FG000|Trial of ITG 4|Lost to Follow-up|2|||
156594950|NCT03943953|565259975|FG001|Trial of ITG 4|Lost to Follow-up|0|||
156594951|NCT01742078|565259978|FG000|Overall Study|Withdrawal by Subject|0|||
156594952|NCT01742078|565259979|FG001|Overall Study|Withdrawal by Subject|0|||
156594953|NCT01742078|565259980|FG002|Overall Study|Withdrawal by Subject|0|||
156594954|NCT01742078|565259981|FG003|Overall Study|Withdrawal by Subject|1|||
156594955|NCT01742078|565259982|FG004|Overall Study|Withdrawal by Subject|0|||
156594956|NCT01742078|565259983|FG005|Overall Study|Withdrawal by Subject|0|||
156594957|NCT01742078|565259984|FG006|Overall Study|Withdrawal by Subject|0|||
156594958|NCT01742078|565259985|FG007|Overall Study|Withdrawal by Subject|0|||
156594959|NCT01742078|565259986|FG008|Overall Study|Withdrawal by Subject|0|||
156594960|NCT05600309|565259989|FG000|Overall Study|Death|41|||
156594961|NCT05600309|565259990|FG001|Overall Study|Death|38|||
156594962|NCT05600309|565259989|FG000|Overall Study|Sponsor Decision|9|||
156594963|NCT05600309|565259990|FG001|Overall Study|Sponsor Decision|6|||
156594964|NCT05822830|565259991|FG000|Overall Study|Adverse Event|6|||
156594965|NCT05822830|565259992|FG001|Overall Study|Adverse Event|6|||
156594966|NCT05822830|565259991|FG000|Overall Study|Assigned Treatment by Mistake|5|||
156594967|NCT05822830|565259992|FG001|Overall Study|Assigned Treatment by Mistake|3|||
156594968|NCT05822830|565259991|FG000|Overall Study|Lost to Follow-up|16|||
156594969|NCT05822830|565259992|FG001|Overall Study|Lost to Follow-up|18|||
156594970|NCT05822830|565259991|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156594971|NCT05822830|565259992|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156594972|NCT05822830|565259991|FG000|Overall Study|Participant was Out of the Country|0|||
156594973|NCT05822830|565259992|FG001|Overall Study|Participant was Out of the Country|1|||
156594974|NCT05822830|565259991|FG000|Overall Study|Pregnancy|1|||
156594975|NCT05822830|565259992|FG001|Overall Study|Pregnancy|2|||
156594976|NCT05822830|565259991|FG000|Overall Study|Withdrawal by Subject|27|||
156594977|NCT05822830|565259992|FG001|Overall Study|Withdrawal by Subject|26|||
156594978|NCT03368664|565259999|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
156594979|NCT03368664|565259999|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
156594980|NCT03368664|565259999|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
156594981|NCT03368664|565259999|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
156594982|NCT01025817|565260001|FG000|Completed Study Medication|Adverse Event|66|||
156594983|NCT01025817|565260002|FG001|Completed Study Medication|Adverse Event|39|||
156594984|NCT01025817|565260001|FG000|Completed Study Medication|Protocol Deviation|9|||
156594985|NCT01025817|565260002|FG001|Completed Study Medication|Protocol Deviation|8|||
156594986|NCT01025817|565260001|FG000|Completed Study Medication|Withdrawal by Subject|8|||
156594987|NCT01025817|565260002|FG001|Completed Study Medication|Withdrawal by Subject|9|||
156594988|NCT01025817|565260001|FG000|Completed Study Medication|Administrative problems|7|||
156594989|NCT01025817|565260002|FG001|Completed Study Medication|Administrative problems|5|||
156594990|NCT01025817|565260001|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
156594991|NCT01025817|565260002|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
156594992|NCT01025817|565260001|FG000|Completed Study Medication|Abnormal test procedure|4|||
156594993|NCT01025817|565260002|FG001|Completed Study Medication|Abnormal test procedure|0|||
156594994|NCT01025817|565260001|FG000|Completed Study Medication|Graft loss|2|||
156594995|NCT01025817|565260002|FG001|Completed Study Medication|Graft loss|5|||
156594996|NCT01025817|565260001|FG000|Completed Study Medication|Death|2|||
156594997|NCT01025817|565260002|FG001|Completed Study Medication|Death|2|||
156594998|NCT01025817|565260001|FG000|Completed Study Medication|Abnormal lab values|0|||
156594999|NCT01025817|565260002|FG001|Completed Study Medication|Abnormal lab values|2|||
156595000|NCT01025817|565260001|FG000|Completed Study Medication|Subject no longer required study drug|0|||
156595001|NCT01025817|565260002|FG001|Completed Study Medication|Subject no longer required study drug|1|||
156595002|NCT01025817|565260001|FG000|Completed Study Medication|Lost to Follow-up|0|||
156595003|NCT01025817|565260002|FG001|Completed Study Medication|Lost to Follow-up|1|||
156595004|NCT01025817|565260001|FG000|Completed Study|Withdrawal by Subject|8|||
156595005|NCT01025817|565260002|FG001|Completed Study|Withdrawal by Subject|16|||
156595006|NCT01025817|565260001|FG000|Completed Study|Death|6|||
156595007|NCT01025817|565260002|FG001|Completed Study|Death|5|||
156595008|NCT01025817|565260001|FG000|Completed Study|Missing|2|||
156595009|NCT01025817|565260002|FG001|Completed Study|Missing|0|||
156595010|NCT01025817|565260001|FG000|Completed Study|Lost to Follow-up|0|||
156595011|NCT01025817|565260002|FG001|Completed Study|Lost to Follow-up|1|||
156595012|NCT00807846|565260005|FG000|Overall Study|Adverse Event|5|||
156595013|NCT00807846|565260006|FG001|Overall Study|Adverse Event|0|||
156595014|NCT00807846|565260005|FG000|Overall Study|Lack of Efficacy|2|||
156595015|NCT00807846|565260006|FG001|Overall Study|Lack of Efficacy|0|||
156595016|NCT00807846|565260005|FG000|Overall Study|Protocol Violation|2|||
156595017|NCT00807846|565260006|FG001|Overall Study|Protocol Violation|1|||
156595018|NCT00807846|565260005|FG000|Overall Study|Withdrawal by Subject|2|||
156595019|NCT00807846|565260006|FG001|Overall Study|Withdrawal by Subject|1|||
156595020|NCT00807846|565260005|FG000|Overall Study|Other|1|||
156595021|NCT00807846|565260006|FG001|Overall Study|Other|2|||
156595022|NCT01081873|565260007|FG000|Overall Study|Death|86|||
156595023|NCT01081873|565260007|FG000|Overall Study|Withdrawal by Subject|10|||
156595024|NCT01081873|565260007|FG000|Overall Study|Lost to Follow-up|142|||
156595025|NCT01081873|565260007|FG000|Overall Study|Progression of prostate cancer|13|||
156595026|NCT01081873|565260007|FG000|Overall Study|Other|47|||
156595027|NCT02491073|565260009|FG000|Overall Study|screen failure|1|||
156595028|NCT02491073|565260010|FG001|Overall Study|screen failure|0|||
156595029|NCT01165021|565260011|FG000|Overall Study|Death|1|||
156595030|NCT03977727|565260012|FG000|Second Treatment|Lost to Follow-up|0|||
156595031|NCT03977727|565260013|FG001|Second Treatment|Lost to Follow-up|3|||
156595032|NCT01419665|565260014|FG000|Combination Treatment|Adverse Event|7|||
156595033|NCT01419665|565260015|FG001|Combination Treatment|Adverse Event|10|||
156595034|NCT01419665|565260014|FG000|Combination Treatment|Physician Decision|5|||
156595035|NCT01419665|565260015|FG001|Combination Treatment|Physician Decision|8|||
156595036|NCT01419665|565260014|FG000|Combination Treatment|Protocol Violation|6|||
156595037|NCT01419665|565260015|FG001|Combination Treatment|Protocol Violation|2|||
156595038|NCT01419665|565260014|FG000|Combination Treatment|disease progression|10|||
156595039|NCT01419665|565260015|FG001|Combination Treatment|disease progression|9|||
156595040|NCT01419665|565260014|FG000|Combination Treatment|Death|5|||
156595041|NCT01419665|565260015|FG001|Combination Treatment|Death|7|||
156595042|NCT01419665|565260014|FG000|Combination Treatment|administrative problems|0|||
156595043|NCT01419665|565260015|FG001|Combination Treatment|administrative problems|1|||
156595044|NCT01419665|565260014|FG000|Combination Treatment|Withdrawal by Subject|5|||
156595045|NCT01419665|565260015|FG001|Combination Treatment|Withdrawal by Subject|4|||
156595046|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
156595047|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
156595048|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
156595049|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
156863671|NCT04366349|566258751|FG001|Overall Study|Withdrawal by Subject|0|||
156863672|NCT04366349|566258752|FG002|Overall Study|Withdrawal by Subject|0|||
156595050|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
156595051|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
156595052|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
156863673|NCT04366349|566258753|FG003|Overall Study|Withdrawal by Subject|0|||
156595053|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
156595054|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
156595055|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
156595056|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
156595057|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
156595058|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|Death|1|||
156595059|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|Death|2|||
156595060|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
156595061|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
156595062|NCT01419665|565260014|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
156595063|NCT01419665|565260015|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
156595064|NCT01419665|565260014|FG000|Open Label Phase|Death|1|||
156595065|NCT01419665|565260015|FG001|Open Label Phase|Death|0|||
156595066|NCT01419665|565260014|FG000|Open Label Phase|disease progression|0|||
156595067|NCT01419665|565260015|FG001|Open Label Phase|disease progression|1|||
156595068|NCT02683525|565260017|FG000|Overall Study|Lost to Follow-up|1|||
156595069|NCT02683525|565260017|FG000|Overall Study|Physician Decision|1|||
156595070|NCT02683525|565260017|FG000|Overall Study|Disease Progression|6|||
156595071|NCT03352414|565260021|FG000|Overall Study|Ineligible by operative criteria|12|||
156595072|NCT03352414|565260022|FG001|Overall Study|Ineligible by operative criteria|10|||
156595073|NCT01341652|565260023|FG000|Overall Study|Incorrect Random Assignment|0|||
156595074|NCT01341652|565260024|FG001|Overall Study|Incorrect Random Assignment|1|||
156595075|NCT01341652|565260023|FG000|Overall Study|ineligible; presence metastatic disease|0|||
156595076|NCT01341652|565260024|FG001|Overall Study|ineligible; presence metastatic disease|1|||
156595077|NCT02998554|565260028|FG000|Overall Study|Adverse Event|8|||
156595078|NCT02998554|565260029|FG001|Overall Study|Adverse Event|3|||
156595079|NCT02998554|565260028|FG000|Overall Study|Protocol deviation|1|||
156595080|NCT02998554|565260029|FG001|Overall Study|Protocol deviation|0|||
156595081|NCT02998554|565260028|FG000|Overall Study|Withdrawal by Subject|2|||
156595082|NCT02998554|565260029|FG001|Overall Study|Withdrawal by Subject|6|||
156595083|NCT02998554|565260028|FG000|Overall Study|Lost to Follow-up|0|||
156595084|NCT02998554|565260029|FG001|Overall Study|Lost to Follow-up|1|||
156595085|NCT02998554|565260028|FG000|Overall Study|Lack of Efficacy|0|||
156595086|NCT02998554|565260029|FG001|Overall Study|Lack of Efficacy|1|||
156595087|NCT02953782|565260030|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
156595088|NCT02953782|565260031|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
156595089|NCT02953782|565260032|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
156595090|NCT02953782|565260033|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
156595091|NCT02953782|565260034|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
156595092|NCT02953782|565260035|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
156595093|NCT02953782|565260036|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
156595094|NCT02953782|565260037|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
156595095|NCT02953782|565260030|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
156595096|NCT02953782|565260031|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
156595097|NCT02953782|565260032|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
156595098|NCT02953782|565260033|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
156595099|NCT02953782|565260034|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
156595100|NCT02953782|565260035|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
156595101|NCT02953782|565260036|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
156595102|NCT02953782|565260037|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
156595103|NCT02953782|565260030|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
156595104|NCT02953782|565260031|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
156595105|NCT02953782|565260032|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
156595106|NCT02953782|565260033|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
156595107|NCT02953782|565260034|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
156595108|NCT02953782|565260035|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
156595109|NCT02953782|565260036|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
156595110|NCT02953782|565260037|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
156595111|NCT02953782|565260030|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
156595112|NCT02953782|565260031|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
156595113|NCT02953782|565260032|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
156595114|NCT02953782|565260033|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
156595115|NCT02953782|565260034|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
156595116|NCT02953782|565260035|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
156595117|NCT02953782|565260036|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
156595118|NCT02953782|565260037|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
156595119|NCT02953782|565260030|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
156595120|NCT02953782|565260031|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
156595121|NCT02953782|565260032|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
156595122|NCT02953782|565260033|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
156595123|NCT02953782|565260034|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
156595124|NCT02953782|565260035|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
156595125|NCT02953782|565260036|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
156595126|NCT02953782|565260037|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
156595127|NCT02953782|565260030|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
156595128|NCT02953782|565260031|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
156595129|NCT02953782|565260032|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
156595130|NCT02953782|565260033|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
156595131|NCT02953782|565260034|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
156595132|NCT02953782|565260035|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
156595133|NCT02953782|565260036|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
156595134|NCT02953782|565260037|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
156595135|NCT02953782|565260030|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
156595136|NCT02953782|565260031|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
156595137|NCT02953782|565260032|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
156595138|NCT02953782|565260033|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
156595139|NCT02953782|565260034|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
156595140|NCT02953782|565260035|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
156595141|NCT02953782|565260036|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
156595142|NCT02953782|565260037|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
156595143|NCT02953782|565260030|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
156595144|NCT02953782|565260031|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
156595145|NCT02953782|565260032|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
156595146|NCT02953782|565260033|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
156595147|NCT02953782|565260034|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
156595148|NCT02953782|565260035|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
156595149|NCT02953782|565260036|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
156595150|NCT02953782|565260037|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
156595151|NCT01737840|565260038|FG000|Overall Study|Diagnosed with an other pathology|2|||
156595152|NCT01737840|565260039|FG001|Overall Study|Diagnosed with an other pathology|2|||
156595153|NCT03105700|565260042|FG000|Overall Study|screen fail|3|||
156595154|NCT03105700|565260042|FG000|Overall Study|Lost to Follow-up|4|||
156595155|NCT01449682|565260043|FG000|Overall Study|Death|0|||
156595156|NCT01449682|565260044|FG001|Overall Study|Death|1|||
156595157|NCT01449682|565260043|FG000|Overall Study|Adverse Event|1|||
156595158|NCT01449682|565260044|FG001|Overall Study|Adverse Event|0|||
156595159|NCT02720016|565260049|FG000|Overall Study|Separation of couple|6|||
156595160|NCT02720016|565260050|FG001|Overall Study|Separation of couple|8|||
156595161|NCT02720016|565260051|FG002|Overall Study|Separation of couple|2|||
156595162|NCT02720016|565260049|FG000|Overall Study|Withdrawal by Subject|6|||
156595163|NCT02720016|565260050|FG001|Overall Study|Withdrawal by Subject|6|||
156595164|NCT02720016|565260051|FG002|Overall Study|Withdrawal by Subject|4|||
156595165|NCT02720016|565260049|FG000|Overall Study|Scheduling issues|2|||
156595166|NCT02720016|565260050|FG001|Overall Study|Scheduling issues|4|||
156595167|NCT02720016|565260051|FG002|Overall Study|Scheduling issues|7|||
156595168|NCT02720016|565260049|FG000|Overall Study|Childcare|2|||
156595169|NCT02720016|565260050|FG001|Overall Study|Childcare|0|||
156595170|NCT02720016|565260051|FG002|Overall Study|Childcare|2|||
156595171|NCT02720016|565260049|FG000|Overall Study|Withdrawal by PI|2|||
156595172|NCT02720016|565260050|FG001|Overall Study|Withdrawal by PI|2|||
156595173|NCT02720016|565260051|FG002|Overall Study|Withdrawal by PI|0|||
156595174|NCT02720016|565260049|FG000|Overall Study|Moved away|2|||
156595175|NCT02720016|565260050|FG001|Overall Study|Moved away|0|||
156595176|NCT02720016|565260051|FG002|Overall Study|Moved away|0|||
156595177|NCT02720016|565260049|FG000|Overall Study|Not Primary Health Concern|0|||
156595178|NCT02720016|565260050|FG001|Overall Study|Not Primary Health Concern|0|||
156595179|NCT02720016|565260051|FG002|Overall Study|Not Primary Health Concern|2|||
156595180|NCT02720016|565260049|FG000|Overall Study|Transportation issues|0|||
156595181|NCT02720016|565260050|FG001|Overall Study|Transportation issues|0|||
156595182|NCT02720016|565260051|FG002|Overall Study|Transportation issues|1|||
156595183|NCT02720016|565260049|FG000|Overall Study|Other|0|||
156595184|NCT02720016|565260050|FG001|Overall Study|Other|0|||
156595185|NCT02720016|565260051|FG002|Overall Study|Other|2|||
156595186|NCT05319080|565260053|FG000|Overall Study|Withdrawal by Subject|2|||
156595187|NCT05319080|565260053|FG000|Overall Study|Physician Decision|4|||
156595188|NCT00406783|565260056|FG000|Overall Study|Adverse Event|4|||
156595189|NCT00406783|565260057|FG001|Overall Study|Adverse Event|4|||
156595190|NCT00406783|565260056|FG000|Overall Study|Treatment Failure|2|||
156595191|NCT00406783|565260057|FG001|Overall Study|Treatment Failure|3|||
156595192|NCT00406783|565260056|FG000|Overall Study|Lost to Follow-up|3|||
156595193|NCT00406783|565260057|FG001|Overall Study|Lost to Follow-up|0|||
156595194|NCT00406783|565260056|FG000|Overall Study|Withdrawal by Subject|1|||
156595195|NCT00406783|565260057|FG001|Overall Study|Withdrawal by Subject|4|||
156595196|NCT00406783|565260056|FG000|Overall Study|Protocol Violation|4|||
156595197|NCT00406783|565260057|FG001|Overall Study|Protocol Violation|4|||
156595198|NCT00064350|565260058|FG000|Induction Treatment|Disease Progression|5|||
156595199|NCT00064350|565260059|FG001|Induction Treatment|Disease Progression|1|||
156595200|NCT00064350|565260060|FG002|Induction Treatment|Disease Progression|110|||
156595201|NCT00064350|565260058|FG000|Induction Treatment|Adverse Event|0|||
156595202|NCT00064350|565260059|FG001|Induction Treatment|Adverse Event|2|||
156595203|NCT00064350|565260060|FG002|Induction Treatment|Adverse Event|49|||
156595204|NCT00064350|565260058|FG000|Induction Treatment|Death|0|||
156595205|NCT00064350|565260059|FG001|Induction Treatment|Death|0|||
156595206|NCT00064350|565260060|FG002|Induction Treatment|Death|9|||
156595207|NCT00064350|565260058|FG000|Induction Treatment|Withdrawal by Subject|0|||
156595208|NCT00064350|565260059|FG001|Induction Treatment|Withdrawal by Subject|0|||
156595209|NCT00064350|565260060|FG002|Induction Treatment|Withdrawal by Subject|21|||
156595210|NCT00064350|565260058|FG000|Induction Treatment|Ineligible or never started treatment|3|||
156595211|NCT00064350|565260059|FG001|Induction Treatment|Ineligible or never started treatment|6|||
156595212|NCT00064350|565260060|FG002|Induction Treatment|Ineligible or never started treatment|34|||
156595213|NCT00064350|565260058|FG000|Induction Treatment|Other|0|||
156595214|NCT00064350|565260059|FG001|Induction Treatment|Other|0|||
156595215|NCT00064350|565260060|FG002|Induction Treatment|Other|13|||
156595216|NCT00064350|565260058|FG000|Randomization|Adverse Event|8|||
156595217|NCT00064350|565260059|FG001|Randomization|Adverse Event|3|||
156595218|NCT00064350|565260060|FG002|Randomization|Adverse Event|0|||
156595219|NCT00064350|565260058|FG000|Randomization|Death|3|||
156595220|NCT00064350|565260059|FG001|Randomization|Death|0|||
156595221|NCT00064350|565260060|FG002|Randomization|Death|0|||
156595222|NCT00064350|565260058|FG000|Randomization|Withdrawal by Subject|1|||
156595223|NCT00064350|565260059|FG001|Randomization|Withdrawal by Subject|0|||
156595224|NCT00064350|565260060|FG002|Randomization|Withdrawal by Subject|0|||
156595225|NCT00064350|565260058|FG000|Randomization|Ineligible or never started treatment|9|||
156595226|NCT00064350|565260059|FG001|Randomization|Ineligible or never started treatment|15|||
156595227|NCT00064350|565260060|FG002|Randomization|Ineligible or never started treatment|0|||
156595228|NCT00064350|565260058|FG000|Randomization|Other|5|||
156595229|NCT00064350|565260059|FG001|Randomization|Other|0|||
156595230|NCT00064350|565260060|FG002|Randomization|Other|0|||
156595231|NCT00064350|565260058|FG000|Cross-Over|Adverse Event|0|||
156595232|NCT00064350|565260059|FG001|Cross-Over|Adverse Event|1|||
156595233|NCT00064350|565260060|FG002|Cross-Over|Adverse Event|0|||
156595234|NCT00064350|565260058|FG000|Cross-Over|Death|1|||
156595235|NCT00064350|565260059|FG001|Cross-Over|Death|3|||
156595236|NCT00064350|565260060|FG002|Cross-Over|Death|0|||
156595237|NCT00064350|565260058|FG000|Cross-Over|Withdrawal by Subject|2|||
156595238|NCT00064350|565260059|FG001|Cross-Over|Withdrawal by Subject|2|||
156595239|NCT00064350|565260060|FG002|Cross-Over|Withdrawal by Subject|0|||
156595240|NCT00064350|565260058|FG000|Cross-Over|Ineligible or never started treatment|3|||
156595241|NCT00064350|565260059|FG001|Cross-Over|Ineligible or never started treatment|6|||
156595242|NCT00064350|565260060|FG002|Cross-Over|Ineligible or never started treatment|0|||
156595243|NCT00064350|565260058|FG000|Cross-Over|Other|0|||
156595244|NCT00064350|565260059|FG001|Cross-Over|Other|2|||
156595245|NCT00064350|565260060|FG002|Cross-Over|Other|0|||
156595246|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
156595247|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
156595248|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
156595249|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
156595250|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
156595251|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
156595252|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
156595253|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
156595254|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
156595255|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
156595256|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
156595257|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
156595258|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
156595259|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
156595260|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
156595261|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
156595262|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Missing|3|||
156595263|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Missing|1|||
156595264|NCT00838916|565260061|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
156595265|NCT00838916|565260062|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
156595266|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
156595267|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
156595268|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
156595269|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
156595270|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
156595271|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
156595272|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
156595273|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
156595274|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
156595275|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
156595276|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
156595277|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
156595278|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
156595279|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
156595280|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
156595281|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
156595282|NCT00838916|565260061|FG000|Follow-up Period (8 Weeks)|Missing|3|||
156595283|NCT00838916|565260062|FG001|Follow-up Period (8 Weeks)|Missing|0|||
156595284|NCT01927419|565260063|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156595285|NCT01927419|565260064|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
156595286|NCT01927419|565260063|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
156595287|NCT01927419|565260064|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
156595288|NCT01927419|565260063|FG000|Treatment Period|Disease progression|17|||
156595289|NCT01927419|565260064|FG001|Treatment Period|Disease progression|20|||
156595290|NCT01927419|565260063|FG000|Treatment Period|Study drug toxicity|48|||
156595291|NCT01927419|565260064|FG001|Treatment Period|Study drug toxicity|10|||
156595292|NCT01927419|565260063|FG000|Treatment Period|Death|0|||
156595293|NCT01927419|565260064|FG001|Treatment Period|Death|1|||
156595294|NCT01927419|565260063|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
156595295|NCT01927419|565260064|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
156595296|NCT01927419|565260063|FG000|Treatment Period|Participant request to discontinue|12|||
156595297|NCT01927419|565260064|FG001|Treatment Period|Participant request to discontinue|4|||
156595298|NCT01927419|565260063|FG000|Treatment Period|Withdrawal by Subject|1|||
156595299|NCT01927419|565260064|FG001|Treatment Period|Withdrawal by Subject|1|||
156595300|NCT01927419|565260063|FG000|Treatment Period|Maximum Clinical Benefit|6|||
156595301|NCT01927419|565260064|FG001|Treatment Period|Maximum Clinical Benefit|2|||
156595302|NCT01927419|565260063|FG000|Treatment Period|Other reasons|3|||
156595303|NCT01927419|565260064|FG001|Treatment Period|Other reasons|4|||
156595304|NCT01927419|565260063|FG000|Treatment Period|Not Reported|1|||
156595305|NCT01927419|565260064|FG001|Treatment Period|Not Reported|1|||
156595306|NCT03488251|565260065|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
156595307|NCT03488251|565260066|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
156595308|NCT03488251|565260067|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
156595309|NCT03488251|565260068|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
156595310|NCT03488251|565260065|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
156595311|NCT03488251|565260066|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
156595312|NCT03488251|565260067|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
156595313|NCT03488251|565260068|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
156595314|NCT03488251|565260065|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
156595315|NCT03488251|565260066|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
156595316|NCT03488251|565260067|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
156595317|NCT03488251|565260068|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
156595318|NCT03488251|565260065|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
156595319|NCT03488251|565260066|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
156595320|NCT03488251|565260067|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
156595321|NCT03488251|565260068|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
156595322|NCT03488251|565260065|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
156595323|NCT03488251|565260066|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
156595324|NCT03488251|565260067|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
156595325|NCT03488251|565260068|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
156595326|NCT00115765|565260071|FG000|Overall Study|Withdrawal by Subject|22|||
156595327|NCT00115765|565260072|FG001|Overall Study|Withdrawal by Subject|53|||
156595328|NCT00115765|565260073|FG002|Overall Study|Withdrawal by Subject|76|||
156595329|NCT00115765|565260074|FG003|Overall Study|Withdrawal by Subject|15|||
156595330|NCT00115765|565260071|FG000|Overall Study|Physician Decision|4|||
156595331|NCT00115765|565260072|FG001|Overall Study|Physician Decision|15|||
156595332|NCT00115765|565260073|FG002|Overall Study|Physician Decision|18|||
156595333|NCT00115765|565260074|FG003|Overall Study|Physician Decision|13|||
156595334|NCT00115765|565260071|FG000|Overall Study|Lost to Follow-up|3|||
156595335|NCT00115765|565260072|FG001|Overall Study|Lost to Follow-up|20|||
156595336|NCT00115765|565260073|FG002|Overall Study|Lost to Follow-up|18|||
156595337|NCT00115765|565260074|FG003|Overall Study|Lost to Follow-up|1|||
156595338|NCT00115765|565260071|FG000|Overall Study|Other|6|||
156595339|NCT00115765|565260072|FG001|Overall Study|Other|12|||
156595340|NCT00115765|565260073|FG002|Overall Study|Other|9|||
156595341|NCT00115765|565260074|FG003|Overall Study|Other|2|||
156595342|NCT03600714|565260075|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
156595343|NCT01935336|565260078|FG000|Overall Study|Adverse Event|1|||
156595344|NCT01935336|565260079|FG001|Overall Study|Adverse Event|0|||
156595345|NCT01935336|565260080|FG002|Overall Study|Adverse Event|0|||
156595346|NCT01935336|565260081|FG003|Overall Study|Adverse Event|0|||
156595347|NCT01935336|565260078|FG000|Overall Study|Progressive disease|5|||
156595348|NCT01935336|565260079|FG001|Overall Study|Progressive disease|3|||
156595349|NCT01935336|565260080|FG002|Overall Study|Progressive disease|47|||
156595350|NCT01935336|565260081|FG003|Overall Study|Progressive disease|66|||
156595351|NCT00592553|565260082|FG000|Overall Study|Protocol Noncompliance|1|||
156595352|NCT00592553|565260083|FG001|Overall Study|Protocol Noncompliance|0|||
156595353|NCT00592553|565260084|FG002|Overall Study|Protocol Noncompliance|0|||
156595354|NCT01810042|565260087|FG000|Overall Study|Lost to Follow-up|10|||
156595355|NCT03707158|565260088|FG000|Midtreatment|Lost to Follow-up|16|||
156595356|NCT03707158|565260089|FG001|Midtreatment|Lost to Follow-up|7|||
156595357|NCT03707158|565260088|FG000|Midtreatment|Withdrawal by Subject|28|||
156595358|NCT03707158|565260089|FG001|Midtreatment|Withdrawal by Subject|19|||
156595359|NCT03707158|565260088|FG000|Posttreatment|Lost to Follow-up|0|||
156595360|NCT03707158|565260089|FG001|Posttreatment|Lost to Follow-up|5|||
156595361|NCT03707158|565260088|FG000|Follow-up|Lost to Follow-up|19|||
156595362|NCT03707158|565260089|FG001|Follow-up|Lost to Follow-up|18|||
156595363|NCT03707158|565260088|FG000|Follow-up|Withdrawal by Subject|13|||
156595364|NCT03707158|565260089|FG001|Follow-up|Withdrawal by Subject|6|||
156595365|NCT01454401|565260093|FG000|Overall Study|Death|1|||
156595366|NCT01454401|565260093|FG000|Overall Study|hospitalised|1|||
156595367|NCT01454401|565260093|FG000|Overall Study|osteomyelitis|2|||
156595368|NCT01454401|565260093|FG000|Overall Study|non-adherence|1|||
156595369|NCT01968187|565260094|FG000|Overall Study|Adverse Event|0|||
156595370|NCT01968187|565260095|FG001|Overall Study|Adverse Event|1|||
156595371|NCT01968187|565260094|FG000|Overall Study|Randomized but not treated|1|||
156595372|NCT01968187|565260095|FG001|Overall Study|Randomized but not treated|0|||
156595373|NCT01877382|565260096|FG000|Dose Escalation|Progressive disease|2|||
156595374|NCT01877382|565260097|FG001|Dose Escalation|Progressive disease|0|||
156595375|NCT01877382|565260098|FG002|Dose Escalation|Progressive disease|1|||
156595376|NCT01877382|565260099|FG003|Dose Escalation|Progressive disease|6|||
156595377|NCT01877382|565260100|FG004|Dose Escalation|Progressive disease|1|||
156595378|NCT01877382|565260101|FG005|Dose Escalation|Progressive disease|0|||
156595379|NCT01877382|565260102|FG006|Dose Escalation|Progressive disease|3|||
156595380|NCT01877382|565260103|FG007|Dose Escalation|Progressive disease|10|||
156595381|NCT01877382|565260104|FG008|Dose Escalation|Progressive disease|4|||
156595382|NCT01877382|565260105|FG009|Dose Escalation|Progressive disease|2|||
156595383|NCT01877382|565260106|FG010|Dose Escalation|Progressive disease|3|||
156595384|NCT01877382|565260107|FG011|Dose Escalation|Progressive disease|3|||
156595385|NCT01877382|565260108|FG012|Dose Escalation|Progressive disease|13|||
156595386|NCT01877382|565260109|FG013|Dose Escalation|Progressive disease|1|||
156595387|NCT01877382|565260110|FG014|Dose Escalation|Progressive disease|0|||
156595388|NCT01877382|565260096|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
156595389|NCT01877382|565260097|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595390|NCT01877382|565260098|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595391|NCT01877382|565260099|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
156595392|NCT01877382|565260100|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595393|NCT01877382|565260101|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595394|NCT01877382|565260102|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
156595395|NCT01877382|565260103|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595396|NCT01877382|565260104|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595397|NCT01877382|565260105|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595398|NCT01877382|565260106|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595399|NCT01877382|565260107|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595400|NCT01877382|565260108|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595401|NCT01877382|565260109|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595402|NCT01877382|565260110|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595403|NCT01877382|565260096|FG000|Dose Escalation|Clinical progression|0|||
156595404|NCT01877382|565260097|FG001|Dose Escalation|Clinical progression|1|||
156595405|NCT01877382|565260098|FG002|Dose Escalation|Clinical progression|0|||
156595406|NCT01877382|565260099|FG003|Dose Escalation|Clinical progression|2|||
156863674|NCT04366349|566258754|FG004|Overall Study|Withdrawal by Subject|0|||
156595407|NCT01877382|565260100|FG004|Dose Escalation|Clinical progression|0|||
156595408|NCT01877382|565260101|FG005|Dose Escalation|Clinical progression|0|||
156595409|NCT01877382|565260102|FG006|Dose Escalation|Clinical progression|1|||
156595410|NCT01877382|565260103|FG007|Dose Escalation|Clinical progression|0|||
156595411|NCT01877382|565260104|FG008|Dose Escalation|Clinical progression|0|||
156595412|NCT01877382|565260105|FG009|Dose Escalation|Clinical progression|1|||
156595413|NCT01877382|565260106|FG010|Dose Escalation|Clinical progression|0|||
156595414|NCT01877382|565260107|FG011|Dose Escalation|Clinical progression|0|||
156595415|NCT01877382|565260108|FG012|Dose Escalation|Clinical progression|2|||
156595416|NCT01877382|565260109|FG013|Dose Escalation|Clinical progression|1|||
156595417|NCT01877382|565260110|FG014|Dose Escalation|Clinical progression|0|||
156595418|NCT01877382|565260096|FG000|Dose Escalation|Adverse Event|0|||
156595419|NCT01877382|565260097|FG001|Dose Escalation|Adverse Event|0|||
156595420|NCT01877382|565260098|FG002|Dose Escalation|Adverse Event|0|||
156595421|NCT01877382|565260099|FG003|Dose Escalation|Adverse Event|4|||
156595422|NCT01877382|565260100|FG004|Dose Escalation|Adverse Event|1|||
156595423|NCT01877382|565260101|FG005|Dose Escalation|Adverse Event|2|||
156595424|NCT01877382|565260102|FG006|Dose Escalation|Adverse Event|1|||
156595425|NCT01877382|565260103|FG007|Dose Escalation|Adverse Event|2|||
156595426|NCT01877382|565260104|FG008|Dose Escalation|Adverse Event|0|||
156595427|NCT01877382|565260105|FG009|Dose Escalation|Adverse Event|0|||
156595428|NCT01877382|565260106|FG010|Dose Escalation|Adverse Event|0|||
156595429|NCT01877382|565260107|FG011|Dose Escalation|Adverse Event|0|||
156595430|NCT01877382|565260108|FG012|Dose Escalation|Adverse Event|1|||
156595431|NCT01877382|565260109|FG013|Dose Escalation|Adverse Event|0|||
156595432|NCT01877382|565260110|FG014|Dose Escalation|Adverse Event|0|||
156595433|NCT01877382|565260096|FG000|Dose Escalation|Withdrawal by Subject|0|||
156595434|NCT01877382|565260097|FG001|Dose Escalation|Withdrawal by Subject|0|||
156595435|NCT01877382|565260098|FG002|Dose Escalation|Withdrawal by Subject|0|||
156595436|NCT01877382|565260099|FG003|Dose Escalation|Withdrawal by Subject|0|||
156595437|NCT01877382|565260100|FG004|Dose Escalation|Withdrawal by Subject|0|||
156595438|NCT01877382|565260101|FG005|Dose Escalation|Withdrawal by Subject|3|||
156595439|NCT01877382|565260102|FG006|Dose Escalation|Withdrawal by Subject|2|||
156595440|NCT01877382|565260103|FG007|Dose Escalation|Withdrawal by Subject|1|||
156595441|NCT01877382|565260104|FG008|Dose Escalation|Withdrawal by Subject|1|||
156595442|NCT01877382|565260105|FG009|Dose Escalation|Withdrawal by Subject|0|||
156595443|NCT01877382|565260106|FG010|Dose Escalation|Withdrawal by Subject|0|||
156595444|NCT01877382|565260107|FG011|Dose Escalation|Withdrawal by Subject|0|||
156595445|NCT01877382|565260108|FG012|Dose Escalation|Withdrawal by Subject|0|||
156595446|NCT01877382|565260109|FG013|Dose Escalation|Withdrawal by Subject|0|||
156595447|NCT01877382|565260110|FG014|Dose Escalation|Withdrawal by Subject|0|||
156595448|NCT01877382|565260096|FG000|Dose Escalation|Protocol Violation|0|||
156595449|NCT01877382|565260097|FG001|Dose Escalation|Protocol Violation|0|||
156595450|NCT01877382|565260098|FG002|Dose Escalation|Protocol Violation|0|||
156595451|NCT01877382|565260099|FG003|Dose Escalation|Protocol Violation|0|||
156595452|NCT01877382|565260100|FG004|Dose Escalation|Protocol Violation|0|||
156595453|NCT01877382|565260101|FG005|Dose Escalation|Protocol Violation|0|||
156595454|NCT01877382|565260102|FG006|Dose Escalation|Protocol Violation|1|||
156595455|NCT01877382|565260103|FG007|Dose Escalation|Protocol Violation|0|||
156595456|NCT01877382|565260104|FG008|Dose Escalation|Protocol Violation|0|||
156595457|NCT01877382|565260105|FG009|Dose Escalation|Protocol Violation|0|||
156595458|NCT01877382|565260106|FG010|Dose Escalation|Protocol Violation|0|||
156595459|NCT01877382|565260107|FG011|Dose Escalation|Protocol Violation|0|||
156595460|NCT01877382|565260108|FG012|Dose Escalation|Protocol Violation|0|||
156595461|NCT01877382|565260109|FG013|Dose Escalation|Protocol Violation|0|||
156595462|NCT01877382|565260110|FG014|Dose Escalation|Protocol Violation|0|||
156595463|NCT01877382|565260096|FG000|Dose Escalation|Study terminated by sponsor|0|||
156595464|NCT01877382|565260097|FG001|Dose Escalation|Study terminated by sponsor|0|||
156595465|NCT01877382|565260098|FG002|Dose Escalation|Study terminated by sponsor|0|||
156595466|NCT01877382|565260099|FG003|Dose Escalation|Study terminated by sponsor|0|||
156595467|NCT01877382|565260100|FG004|Dose Escalation|Study terminated by sponsor|0|||
156595468|NCT01877382|565260101|FG005|Dose Escalation|Study terminated by sponsor|0|||
156595469|NCT01877382|565260102|FG006|Dose Escalation|Study terminated by sponsor|0|||
156595470|NCT01877382|565260103|FG007|Dose Escalation|Study terminated by sponsor|1|||
156595471|NCT01877382|565260104|FG008|Dose Escalation|Study terminated by sponsor|1|||
156595472|NCT01877382|565260105|FG009|Dose Escalation|Study terminated by sponsor|0|||
156595473|NCT01877382|565260106|FG010|Dose Escalation|Study terminated by sponsor|0|||
156595474|NCT01877382|565260107|FG011|Dose Escalation|Study terminated by sponsor|0|||
156595475|NCT01877382|565260108|FG012|Dose Escalation|Study terminated by sponsor|3|||
156595476|NCT01877382|565260109|FG013|Dose Escalation|Study terminated by sponsor|0|||
156595477|NCT01877382|565260110|FG014|Dose Escalation|Study terminated by sponsor|0|||
156595478|NCT01877382|565260096|FG000|Dose Escalation|Death|0|||
156595479|NCT01877382|565260097|FG001|Dose Escalation|Death|0|||
156595480|NCT01877382|565260098|FG002|Dose Escalation|Death|0|||
156595481|NCT01877382|565260099|FG003|Dose Escalation|Death|0|||
156595482|NCT01877382|565260100|FG004|Dose Escalation|Death|0|||
156595483|NCT01877382|565260101|FG005|Dose Escalation|Death|0|||
156595484|NCT01877382|565260102|FG006|Dose Escalation|Death|0|||
156595485|NCT01877382|565260103|FG007|Dose Escalation|Death|1|||
156595486|NCT01877382|565260104|FG008|Dose Escalation|Death|0|||
156595487|NCT01877382|565260105|FG009|Dose Escalation|Death|0|||
156595488|NCT01877382|565260106|FG010|Dose Escalation|Death|0|||
156595489|NCT01877382|565260107|FG011|Dose Escalation|Death|0|||
156595490|NCT01877382|565260108|FG012|Dose Escalation|Death|1|||
156595491|NCT01877382|565260109|FG013|Dose Escalation|Death|1|||
156595492|NCT01877382|565260110|FG014|Dose Escalation|Death|0|||
156595493|NCT01877382|565260096|FG000|Dose Expansion|Progressive disease|0|||
156595494|NCT01877382|565260097|FG001|Dose Expansion|Progressive disease|0|||
156595495|NCT01877382|565260098|FG002|Dose Expansion|Progressive disease|0|||
156595496|NCT01877382|565260099|FG003|Dose Expansion|Progressive disease|0|||
156595497|NCT01877382|565260100|FG004|Dose Expansion|Progressive disease|0|||
156595498|NCT01877382|565260101|FG005|Dose Expansion|Progressive disease|0|||
156595499|NCT01877382|565260102|FG006|Dose Expansion|Progressive disease|0|||
156595500|NCT01877382|565260103|FG007|Dose Expansion|Progressive disease|0|||
156595501|NCT01877382|565260104|FG008|Dose Expansion|Progressive disease|0|||
156595502|NCT01877382|565260105|FG009|Dose Expansion|Progressive disease|0|||
156595503|NCT01877382|565260106|FG010|Dose Expansion|Progressive disease|0|||
156595504|NCT01877382|565260107|FG011|Dose Expansion|Progressive disease|0|||
156595505|NCT01877382|565260108|FG012|Dose Expansion|Progressive disease|0|||
156595506|NCT01877382|565260109|FG013|Dose Expansion|Progressive disease|0|||
156595507|NCT01877382|565260110|FG014|Dose Expansion|Progressive disease|11|||
156595508|NCT01877382|565260096|FG000|Dose Expansion|Clinical progression|0|||
156595509|NCT01877382|565260097|FG001|Dose Expansion|Clinical progression|0|||
156595510|NCT01877382|565260098|FG002|Dose Expansion|Clinical progression|0|||
156595511|NCT01877382|565260099|FG003|Dose Expansion|Clinical progression|0|||
156595512|NCT01877382|565260100|FG004|Dose Expansion|Clinical progression|0|||
156595513|NCT01877382|565260101|FG005|Dose Expansion|Clinical progression|0|||
156595514|NCT01877382|565260102|FG006|Dose Expansion|Clinical progression|0|||
156595515|NCT01877382|565260103|FG007|Dose Expansion|Clinical progression|0|||
156595516|NCT01877382|565260104|FG008|Dose Expansion|Clinical progression|0|||
156595517|NCT01877382|565260105|FG009|Dose Expansion|Clinical progression|0|||
156595518|NCT01877382|565260106|FG010|Dose Expansion|Clinical progression|0|||
156595519|NCT01877382|565260107|FG011|Dose Expansion|Clinical progression|0|||
156595520|NCT01877382|565260108|FG012|Dose Expansion|Clinical progression|0|||
156595521|NCT01877382|565260109|FG013|Dose Expansion|Clinical progression|0|||
156595522|NCT01877382|565260110|FG014|Dose Expansion|Clinical progression|6|||
156595523|NCT01877382|565260096|FG000|Dose Expansion|Adverse Event|0|||
156595524|NCT01877382|565260097|FG001|Dose Expansion|Adverse Event|0|||
156595525|NCT01877382|565260098|FG002|Dose Expansion|Adverse Event|0|||
156595526|NCT01877382|565260099|FG003|Dose Expansion|Adverse Event|0|||
156595527|NCT01877382|565260100|FG004|Dose Expansion|Adverse Event|0|||
156595528|NCT01877382|565260101|FG005|Dose Expansion|Adverse Event|0|||
156595529|NCT01877382|565260102|FG006|Dose Expansion|Adverse Event|0|||
156595530|NCT01877382|565260103|FG007|Dose Expansion|Adverse Event|0|||
156595531|NCT01877382|565260104|FG008|Dose Expansion|Adverse Event|0|||
156595532|NCT01877382|565260105|FG009|Dose Expansion|Adverse Event|0|||
156595533|NCT01877382|565260106|FG010|Dose Expansion|Adverse Event|0|||
156595534|NCT01877382|565260107|FG011|Dose Expansion|Adverse Event|0|||
156595535|NCT01877382|565260108|FG012|Dose Expansion|Adverse Event|0|||
156595536|NCT01877382|565260109|FG013|Dose Expansion|Adverse Event|0|||
156595537|NCT01877382|565260110|FG014|Dose Expansion|Adverse Event|1|||
156595538|NCT01877382|565260096|FG000|Dose Expansion|Death|0|||
156595539|NCT01877382|565260097|FG001|Dose Expansion|Death|0|||
156595540|NCT01877382|565260098|FG002|Dose Expansion|Death|0|||
156595541|NCT01877382|565260099|FG003|Dose Expansion|Death|0|||
156595542|NCT01877382|565260100|FG004|Dose Expansion|Death|0|||
156595543|NCT01877382|565260101|FG005|Dose Expansion|Death|0|||
156595544|NCT01877382|565260102|FG006|Dose Expansion|Death|0|||
156595545|NCT01877382|565260103|FG007|Dose Expansion|Death|0|||
156595546|NCT01877382|565260104|FG008|Dose Expansion|Death|0|||
156595547|NCT01877382|565260105|FG009|Dose Expansion|Death|0|||
156595548|NCT01877382|565260106|FG010|Dose Expansion|Death|0|||
156595549|NCT01877382|565260107|FG011|Dose Expansion|Death|0|||
156595550|NCT01877382|565260108|FG012|Dose Expansion|Death|0|||
156595551|NCT01877382|565260109|FG013|Dose Expansion|Death|0|||
156595552|NCT01877382|565260110|FG014|Dose Expansion|Death|1|||
156595553|NCT01877382|565260096|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595554|NCT01877382|565260097|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595555|NCT01877382|565260098|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595556|NCT01877382|565260099|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595557|NCT01877382|565260100|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595558|NCT01877382|565260101|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595559|NCT01877382|565260102|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595560|NCT01877382|565260103|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156634904|NCT03917654|565407816|FG001|Year 1|Travel|1|||
156595561|NCT01877382|565260104|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595562|NCT01877382|565260105|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595563|NCT01877382|565260106|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595564|NCT01877382|565260107|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595565|NCT01877382|565260108|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595566|NCT01877382|565260109|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156595567|NCT01877382|565260110|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
156595568|NCT05108805|565260115|FG000|Overall Study|T-cell expansion was not successful.|5|||
156595569|NCT00479557|565260116|FG000|Overall Study|Death|0|||
156595570|NCT00479557|565260117|FG001|Overall Study|Death|0|||
156595571|NCT00479557|565260118|FG002|Overall Study|Death|0|||
156595572|NCT00479557|565260119|FG003|Overall Study|Death|0|||
156595573|NCT00479557|565260120|FG004|Overall Study|Death|0|||
156595574|NCT00479557|565260121|FG005|Overall Study|Death|1|||
156595575|NCT00479557|565260122|FG006|Overall Study|Death|0|||
156595576|NCT00479557|565260116|FG000|Overall Study|Lack of Efficacy|1|||
156595577|NCT00479557|565260117|FG001|Overall Study|Lack of Efficacy|0|||
156595578|NCT00479557|565260118|FG002|Overall Study|Lack of Efficacy|0|||
156595579|NCT00479557|565260119|FG003|Overall Study|Lack of Efficacy|0|||
156595580|NCT00479557|565260120|FG004|Overall Study|Lack of Efficacy|0|||
156595581|NCT00479557|565260121|FG005|Overall Study|Lack of Efficacy|0|||
156595582|NCT00479557|565260122|FG006|Overall Study|Lack of Efficacy|0|||
156595583|NCT00479557|565260116|FG000|Overall Study|Lost to Follow-up|0|||
156595584|NCT00479557|565260117|FG001|Overall Study|Lost to Follow-up|2|||
156595585|NCT00479557|565260118|FG002|Overall Study|Lost to Follow-up|0|||
156595586|NCT00479557|565260119|FG003|Overall Study|Lost to Follow-up|2|||
156595587|NCT00479557|565260120|FG004|Overall Study|Lost to Follow-up|0|||
156595588|NCT00479557|565260121|FG005|Overall Study|Lost to Follow-up|0|||
156595589|NCT00479557|565260122|FG006|Overall Study|Lost to Follow-up|0|||
156595590|NCT00479557|565260116|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
156595591|NCT00479557|565260117|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156595592|NCT00479557|565260118|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
156595593|NCT00479557|565260119|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
156595594|NCT00479557|565260120|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156595595|NCT00479557|565260121|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
156595596|NCT00479557|565260122|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156595597|NCT00479557|565260116|FG000|Overall Study|AE not related to Study Drug|1|||
156595598|NCT00479557|565260117|FG001|Overall Study|AE not related to Study Drug|3|||
156595599|NCT00479557|565260118|FG002|Overall Study|AE not related to Study Drug|0|||
156595600|NCT00479557|565260119|FG003|Overall Study|AE not related to Study Drug|0|||
156595601|NCT00479557|565260120|FG004|Overall Study|AE not related to Study Drug|2|||
156595602|NCT00479557|565260121|FG005|Overall Study|AE not related to Study Drug|2|||
156595603|NCT00479557|565260122|FG006|Overall Study|AE not related to Study Drug|1|||
156595604|NCT00479557|565260116|FG000|Overall Study|Caregiver Request|2|||
156595605|NCT00479557|565260117|FG001|Overall Study|Caregiver Request|2|||
156595606|NCT00479557|565260118|FG002|Overall Study|Caregiver Request|2|||
156595607|NCT00479557|565260119|FG003|Overall Study|Caregiver Request|0|||
156595608|NCT00479557|565260120|FG004|Overall Study|Caregiver Request|1|||
156595609|NCT00479557|565260121|FG005|Overall Study|Caregiver Request|2|||
156595610|NCT00479557|565260122|FG006|Overall Study|Caregiver Request|0|||
156595611|NCT00479557|565260116|FG000|Overall Study|Investigator Request|0|||
156595612|NCT00479557|565260117|FG001|Overall Study|Investigator Request|0|||
156595613|NCT00479557|565260118|FG002|Overall Study|Investigator Request|1|||
156595614|NCT00479557|565260119|FG003|Overall Study|Investigator Request|0|||
156595615|NCT00479557|565260120|FG004|Overall Study|Investigator Request|0|||
156595616|NCT00479557|565260121|FG005|Overall Study|Investigator Request|0|||
156595617|NCT00479557|565260122|FG006|Overall Study|Investigator Request|0|||
156595618|NCT00479557|565260116|FG000|Overall Study|Subject Request|3|||
156595619|NCT00479557|565260117|FG001|Overall Study|Subject Request|0|||
156595620|NCT00479557|565260118|FG002|Overall Study|Subject Request|1|||
156595621|NCT00479557|565260119|FG003|Overall Study|Subject Request|1|||
156595622|NCT00479557|565260120|FG004|Overall Study|Subject Request|1|||
156595623|NCT00479557|565260121|FG005|Overall Study|Subject Request|4|||
156595624|NCT00479557|565260122|FG006|Overall Study|Subject Request|1|||
156595625|NCT00479557|565260116|FG000|Overall Study|Other|2|||
156595626|NCT00479557|565260117|FG001|Overall Study|Other|3|||
156595627|NCT00479557|565260118|FG002|Overall Study|Other|1|||
156595628|NCT00479557|565260119|FG003|Overall Study|Other|0|||
156595629|NCT00479557|565260120|FG004|Overall Study|Other|0|||
156595630|NCT00479557|565260121|FG005|Overall Study|Other|3|||
156595631|NCT00479557|565260122|FG006|Overall Study|Other|0|||
156595632|NCT01511107|565260125|FG000|Overall Study|Ineligible|3|||
156595633|NCT01511107|565260126|FG001|Overall Study|Ineligible|2|||
156595634|NCT01511107|565260125|FG000|Overall Study|Lost to Follow-up|10|||
156595635|NCT01511107|565260126|FG001|Overall Study|Lost to Follow-up|19|||
156634905|NCT03917654|565407817|FG002|Year 1|Travel|1|||
156595636|NCT01511107|565260125|FG000|Overall Study|Withdrawal by Subject|9|||
156595637|NCT01511107|565260126|FG001|Overall Study|Withdrawal by Subject|20|||
156595638|NCT03422133|565260127|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
156595639|NCT03422133|565260128|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
156595640|NCT05195359|565262120|FG000|Overall Study|Lost to Follow-up|124|||
156595641|NCT05195359|565262121|FG001|Overall Study|Lost to Follow-up|34|||
156595642|NCT01146951|565262122|FG000|Overall Study|Adverse Event|4|||
156595643|NCT01146951|565262123|FG001|Overall Study|Adverse Event|1|||
156595644|NCT01747811|565262128|FG000|Overall Study|Lack of Efficacy|2|||
156595645|NCT01747811|565262129|FG001|Overall Study|Lack of Efficacy|4|||
156595646|NCT01617655|565262130|FG000|Overall Study|Adverse Event|2|||
156595647|NCT01617655|565262131|FG001|Overall Study|Adverse Event|3|||
156595648|NCT01617655|565262130|FG000|Overall Study|Poor compliance to protocol|1|||
156595649|NCT01617655|565262131|FG001|Overall Study|Poor compliance to protocol|4|||
156595650|NCT01617655|565262130|FG000|Overall Study|Participants moved|0|||
156595651|NCT01617655|565262131|FG001|Overall Study|Participants moved|4|||
156595652|NCT01617655|565262130|FG000|Overall Study|Consent withdrawn by participant|1|||
156595653|NCT01617655|565262131|FG001|Overall Study|Consent withdrawn by participant|1|||
156595654|NCT01617655|565262130|FG000|Overall Study|Last visit outside protocol visit window|1|||
156595655|NCT01617655|565262131|FG001|Overall Study|Last visit outside protocol visit window|10|||
156595656|NCT01617655|565262130|FG000|Overall Study|Site closure|3|||
156595657|NCT01617655|565262131|FG001|Overall Study|Site closure|5|||
156595658|NCT01617655|565262130|FG000|Overall Study|Other than specified above|1|||
156595659|NCT01617655|565262131|FG001|Overall Study|Other than specified above|2|||
156595660|NCT01175213|565262134|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
156595661|NCT01175213|565262135|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
156595662|NCT01175213|565262134|FG000|IGSC, 10%/rHuPH20|Death|1|||
156595663|NCT01175213|565262135|FG001|IGSC, 10%/rHuPH20|Death|0|||
156595664|NCT01175213|565262134|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
156595665|NCT01175213|565262135|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
156595666|NCT01175213|565262134|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
156595667|NCT01175213|565262135|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
156595668|NCT01175213|565262134|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
156595669|NCT01175213|565262135|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
156595670|NCT01175213|565262134|FG000|Safety Follow-up|Adverse Event|1|||
156595671|NCT01175213|565262135|FG001|Safety Follow-up|Adverse Event|0|||
156595672|NCT02680587|565262139|FG000|Overall Study|Withdrawal by Subject|1|||
156595673|NCT02680587|565262140|FG001|Overall Study|Withdrawal by Subject|0|||
156595674|NCT00259740|565262142|FG000|Overall Study|Physician Decision|1|||
156595675|NCT00259740|565262143|FG001|Overall Study|Physician Decision|1|||
156595676|NCT00259740|565262142|FG000|Overall Study|Adverse Event|0|||
156595677|NCT00259740|565262143|FG001|Overall Study|Adverse Event|2|||
156595678|NCT00259740|565262142|FG000|Overall Study|Withdrawal by Subject|2|||
156595679|NCT00259740|565262143|FG001|Overall Study|Withdrawal by Subject|6|||
156595680|NCT00259740|565262142|FG000|Overall Study|Death|1|||
156595681|NCT00259740|565262143|FG001|Overall Study|Death|1|||
156595682|NCT00259740|565262142|FG000|Overall Study|Disease progression|19|||
156595683|NCT00259740|565262143|FG001|Overall Study|Disease progression|36|||
156595684|NCT00259740|565262142|FG000|Overall Study|Ongoing|17|||
156595685|NCT00259740|565262143|FG001|Overall Study|Ongoing|3|||
156595686|NCT00259740|565262142|FG000|Overall Study|Other|3|||
156595687|NCT00259740|565262143|FG001|Overall Study|Other|0|||
156595688|NCT00259740|565262142|FG000|Overall Study|Requirement for alternative therapy|0|||
156595689|NCT00259740|565262143|FG001|Overall Study|Requirement for alternative therapy|4|||
156595690|NCT02492997|565262144|FG000|Overall Study|Withdrawal by Subject|1|||
156595691|NCT02492997|565262145|FG001|Overall Study|Withdrawal by Subject|0|||
156595692|NCT02492997|565262144|FG000|Overall Study|Gained Weight|1|||
156595693|NCT02492997|565262145|FG001|Overall Study|Gained Weight|0|||
156595694|NCT02492997|565262144|FG000|Overall Study|Lost to Follow-up|0|||
156595695|NCT02492997|565262145|FG001|Overall Study|Lost to Follow-up|1|||
156595696|NCT01844830|565262150|FG000|Overall Study|Withdrawal by Subject|1|||
156595697|NCT01844830|565262151|FG001|Overall Study|Withdrawal by Subject|0|||
156595698|NCT04735393|565262157|FG000|Overall Study|Lost to Follow-up|46|||
156595699|NCT04735393|565262158|FG001|Overall Study|Lost to Follow-up|24|||
156595700|NCT04735393|565262157|FG000|Overall Study|Physician Decision|2|||
156595701|NCT04735393|565262158|FG001|Overall Study|Physician Decision|1|||
156595702|NCT04735393|565262157|FG000|Overall Study|Not Detailed|1|||
156595703|NCT04735393|565262158|FG001|Overall Study|Not Detailed|2|||
156595704|NCT04735393|565262157|FG000|Overall Study|Withdrawal by Subject|71|||
156595705|NCT04735393|565262158|FG001|Overall Study|Withdrawal by Subject|28|||
156595706|NCT04735393|565262157|FG000|Overall Study|Adverse Event|56|||
156595707|NCT04735393|565262158|FG001|Overall Study|Adverse Event|7|||
156595708|NCT04735393|565262157|FG000|Overall Study|Protocol Violation|6|||
156595709|NCT04735393|565262158|FG001|Overall Study|Protocol Violation|1|||
156595710|NCT04735393|565262157|FG000|Overall Study|Trial terminated by Sponsor|49|||
156595711|NCT04735393|565262158|FG001|Overall Study|Trial terminated by Sponsor|29|||
156595712|NCT02130427|565262159|FG000|Overall Study|Imaging results not interpretable|30|||
156595713|NCT05441592|565262166|FG000|Overall Study|Lost to Follow-up|1|||
156595714|NCT05441592|565262167|FG001|Overall Study|Lost to Follow-up|5|||
156595715|NCT01021852|565262168|FG000|Treatment Period 1|Adverse Event|3|||
156595716|NCT01021852|565262169|FG001|Treatment Period 1|Adverse Event|1|||
156595717|NCT01021852|565262170|FG002|Treatment Period 1|Adverse Event|1|||
156595718|NCT01021852|565262171|FG003|Treatment Period 1|Adverse Event|0|||
156595719|NCT01021852|565262172|FG004|Treatment Period 1|Adverse Event|2|||
156595720|NCT01021852|565262173|FG005|Treatment Period 1|Adverse Event|2|||
156595721|NCT01021852|565262174|FG006|Treatment Period 1|Adverse Event|0|||
156595722|NCT01021852|565262175|FG007|Treatment Period 1|Adverse Event|0|||
156595723|NCT01021852|565262168|FG000|Treatment Period 1|Pregnancy|0|||
156595724|NCT01021852|565262169|FG001|Treatment Period 1|Pregnancy|0|||
156595725|NCT01021852|565262170|FG002|Treatment Period 1|Pregnancy|1|||
156595726|NCT01021852|565262171|FG003|Treatment Period 1|Pregnancy|0|||
156595727|NCT01021852|565262172|FG004|Treatment Period 1|Pregnancy|0|||
156595728|NCT01021852|565262173|FG005|Treatment Period 1|Pregnancy|0|||
156595729|NCT01021852|565262174|FG006|Treatment Period 1|Pregnancy|0|||
156595730|NCT01021852|565262175|FG007|Treatment Period 1|Pregnancy|0|||
156595731|NCT01021852|565262168|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156595732|NCT01021852|565262169|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156595733|NCT01021852|565262170|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156595734|NCT01021852|565262171|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156595735|NCT01021852|565262172|FG004|Treatment Period 1|Withdrawal by Subject|1|||
156595736|NCT01021852|565262173|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156595737|NCT01021852|565262174|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156595738|NCT01021852|565262175|FG007|Treatment Period 1|Withdrawal by Subject|1|||
156595739|NCT01021852|565262168|FG000|Treatment Period 1|Not Treated|0|||
156595740|NCT01021852|565262169|FG001|Treatment Period 1|Not Treated|0|||
156595741|NCT01021852|565262170|FG002|Treatment Period 1|Not Treated|0|||
156595742|NCT01021852|565262171|FG003|Treatment Period 1|Not Treated|2|||
156595743|NCT01021852|565262172|FG004|Treatment Period 1|Not Treated|0|||
156595744|NCT01021852|565262173|FG005|Treatment Period 1|Not Treated|0|||
156595745|NCT01021852|565262174|FG006|Treatment Period 1|Not Treated|0|||
156595746|NCT01021852|565262175|FG007|Treatment Period 1|Not Treated|0|||
156595747|NCT01021852|565262168|FG000|Washout Period-Placebo|Adverse Event|0|||
156595748|NCT01021852|565262169|FG001|Washout Period-Placebo|Adverse Event|0|||
156595749|NCT01021852|565262170|FG002|Washout Period-Placebo|Adverse Event|0|||
156595750|NCT01021852|565262171|FG003|Washout Period-Placebo|Adverse Event|1|||
156595751|NCT01021852|565262172|FG004|Washout Period-Placebo|Adverse Event|0|||
156595752|NCT01021852|565262173|FG005|Washout Period-Placebo|Adverse Event|1|||
156595753|NCT01021852|565262174|FG006|Washout Period-Placebo|Adverse Event|0|||
156595754|NCT01021852|565262175|FG007|Washout Period-Placebo|Adverse Event|0|||
156595755|NCT01021852|565262168|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
156595756|NCT01021852|565262169|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
156595757|NCT01021852|565262170|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
156595758|NCT01021852|565262171|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
156595759|NCT01021852|565262172|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
156595760|NCT01021852|565262173|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
156595761|NCT01021852|565262174|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
156595762|NCT01021852|565262175|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
156595763|NCT01021852|565262168|FG000|Washout Period-Placebo|Protocol Violation|0|||
156595764|NCT01021852|565262169|FG001|Washout Period-Placebo|Protocol Violation|0|||
156595765|NCT01021852|565262170|FG002|Washout Period-Placebo|Protocol Violation|0|||
156595766|NCT01021852|565262171|FG003|Washout Period-Placebo|Protocol Violation|0|||
156595767|NCT01021852|565262172|FG004|Washout Period-Placebo|Protocol Violation|0|||
156595768|NCT01021852|565262173|FG005|Washout Period-Placebo|Protocol Violation|0|||
156595769|NCT01021852|565262174|FG006|Washout Period-Placebo|Protocol Violation|1|||
156595770|NCT01021852|565262175|FG007|Washout Period-Placebo|Protocol Violation|0|||
156595771|NCT01021852|565262168|FG000|Washout Period-No Drug|Adverse Event|1|||
156595772|NCT01021852|565262169|FG001|Washout Period-No Drug|Adverse Event|0|||
156595773|NCT01021852|565262170|FG002|Washout Period-No Drug|Adverse Event|0|||
156595774|NCT01021852|565262171|FG003|Washout Period-No Drug|Adverse Event|0|||
156595775|NCT01021852|565262172|FG004|Washout Period-No Drug|Adverse Event|0|||
156595776|NCT01021852|565262173|FG005|Washout Period-No Drug|Adverse Event|1|||
156595777|NCT01021852|565262174|FG006|Washout Period-No Drug|Adverse Event|0|||
156595778|NCT01021852|565262175|FG007|Washout Period-No Drug|Adverse Event|0|||
156595779|NCT01021852|565262168|FG000|Treatment Period 2|Adverse Event|0|||
156595780|NCT01021852|565262169|FG001|Treatment Period 2|Adverse Event|1|||
156595781|NCT01021852|565262170|FG002|Treatment Period 2|Adverse Event|0|||
156595782|NCT01021852|565262171|FG003|Treatment Period 2|Adverse Event|0|||
156595783|NCT01021852|565262172|FG004|Treatment Period 2|Adverse Event|1|||
156595784|NCT01021852|565262173|FG005|Treatment Period 2|Adverse Event|0|||
156595785|NCT01021852|565262174|FG006|Treatment Period 2|Adverse Event|1|||
156595786|NCT01021852|565262175|FG007|Treatment Period 2|Adverse Event|0|||
156595787|NCT01021852|565262168|FG000|Treatment Period 2|Lack of Efficacy|0|||
156595788|NCT01021852|565262169|FG001|Treatment Period 2|Lack of Efficacy|0|||
156595789|NCT01021852|565262170|FG002|Treatment Period 2|Lack of Efficacy|0|||
156595790|NCT01021852|565262171|FG003|Treatment Period 2|Lack of Efficacy|0|||
156595791|NCT01021852|565262172|FG004|Treatment Period 2|Lack of Efficacy|0|||
156595792|NCT01021852|565262173|FG005|Treatment Period 2|Lack of Efficacy|1|||
156595793|NCT01021852|565262174|FG006|Treatment Period 2|Lack of Efficacy|0|||
156595794|NCT01021852|565262175|FG007|Treatment Period 2|Lack of Efficacy|0|||
156595795|NCT01021852|565262168|FG000|Treatment Period 2|Physician Decision|0|||
156595796|NCT01021852|565262169|FG001|Treatment Period 2|Physician Decision|0|||
156595797|NCT01021852|565262170|FG002|Treatment Period 2|Physician Decision|1|||
156595798|NCT01021852|565262171|FG003|Treatment Period 2|Physician Decision|0|||
156595799|NCT01021852|565262172|FG004|Treatment Period 2|Physician Decision|0|||
156595800|NCT01021852|565262173|FG005|Treatment Period 2|Physician Decision|0|||
156595801|NCT01021852|565262174|FG006|Treatment Period 2|Physician Decision|0|||
156595802|NCT01021852|565262175|FG007|Treatment Period 2|Physician Decision|0|||
156595803|NCT01021852|565262168|FG000|Treatment Period 2|Protocol Violation|0|||
156595804|NCT01021852|565262169|FG001|Treatment Period 2|Protocol Violation|0|||
156595805|NCT01021852|565262170|FG002|Treatment Period 2|Protocol Violation|0|||
156595806|NCT01021852|565262171|FG003|Treatment Period 2|Protocol Violation|0|||
156595807|NCT01021852|565262172|FG004|Treatment Period 2|Protocol Violation|1|||
156595808|NCT01021852|565262173|FG005|Treatment Period 2|Protocol Violation|0|||
156595809|NCT01021852|565262174|FG006|Treatment Period 2|Protocol Violation|1|||
156595810|NCT01021852|565262175|FG007|Treatment Period 2|Protocol Violation|0|||
156595811|NCT01021852|565262168|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156595812|NCT01021852|565262169|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156595813|NCT01021852|565262170|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156595814|NCT01021852|565262171|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156595815|NCT01021852|565262172|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156595816|NCT01021852|565262173|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156595817|NCT01021852|565262174|FG006|Treatment Period 2|Withdrawal by Subject|1|||
156595818|NCT01021852|565262175|FG007|Treatment Period 2|Withdrawal by Subject|2|||
156595819|NCT01371981|565262176|FG000|Overall Study|Adverse Event|12|||
156595820|NCT01371981|565262177|FG001|Overall Study|Adverse Event|17|||
156595821|NCT01371981|565262178|FG002|Overall Study|Adverse Event|0|||
156595822|NCT01371981|565262179|FG003|Overall Study|Adverse Event|4|||
156595823|NCT01371981|565262180|FG004|Overall Study|Adverse Event|1|||
156595824|NCT01371981|565262181|FG005|Overall Study|Adverse Event|0|||
156595825|NCT01371981|565262176|FG000|Overall Study|Death|22|||
156595826|NCT01371981|565262177|FG001|Overall Study|Death|16|||
156595827|NCT01371981|565262178|FG002|Overall Study|Death|0|||
156595828|NCT01371981|565262179|FG003|Overall Study|Death|0|||
156595829|NCT01371981|565262180|FG004|Overall Study|Death|2|||
156595830|NCT01371981|565262181|FG005|Overall Study|Death|2|||
156595831|NCT01371981|565262176|FG000|Overall Study|Lack of Efficacy|69|||
156595832|NCT01371981|565262177|FG001|Overall Study|Lack of Efficacy|61|||
156595833|NCT01371981|565262178|FG002|Overall Study|Lack of Efficacy|4|||
156595834|NCT01371981|565262179|FG003|Overall Study|Lack of Efficacy|8|||
156595835|NCT01371981|565262180|FG004|Overall Study|Lack of Efficacy|5|||
156595836|NCT01371981|565262181|FG005|Overall Study|Lack of Efficacy|0|||
156595837|NCT01371981|565262176|FG000|Overall Study|Physician Decision|48|||
156595838|NCT01371981|565262177|FG001|Overall Study|Physician Decision|63|||
156595839|NCT01371981|565262178|FG002|Overall Study|Physician Decision|1|||
156595840|NCT01371981|565262179|FG003|Overall Study|Physician Decision|7|||
156595841|NCT01371981|565262180|FG004|Overall Study|Physician Decision|14|||
156595842|NCT01371981|565262181|FG005|Overall Study|Physician Decision|3|||
156595843|NCT01371981|565262176|FG000|Overall Study|Withdrawal by Subject|12|||
156595844|NCT01371981|565262177|FG001|Overall Study|Withdrawal by Subject|19|||
156595845|NCT01371981|565262178|FG002|Overall Study|Withdrawal by Subject|1|||
156595846|NCT01371981|565262179|FG003|Overall Study|Withdrawal by Subject|2|||
156595847|NCT01371981|565262180|FG004|Overall Study|Withdrawal by Subject|10|||
156595848|NCT01371981|565262181|FG005|Overall Study|Withdrawal by Subject|3|||
156595849|NCT01371981|565262176|FG000|Overall Study|Ineligible|19|||
156595850|NCT01371981|565262177|FG001|Overall Study|Ineligible|13|||
156595851|NCT01371981|565262178|FG002|Overall Study|Ineligible|0|||
156595852|NCT01371981|565262179|FG003|Overall Study|Ineligible|0|||
156595853|NCT01371981|565262180|FG004|Overall Study|Ineligible|0|||
156595854|NCT01371981|565262181|FG005|Overall Study|Ineligible|4|||
156595855|NCT01371981|565262176|FG000|Overall Study|Did not start treatment|2|||
156595856|NCT01371981|565262177|FG001|Overall Study|Did not start treatment|3|||
156595857|NCT01371981|565262178|FG002|Overall Study|Did not start treatment|0|||
156595858|NCT01371981|565262179|FG003|Overall Study|Did not start treatment|0|||
156595859|NCT01371981|565262180|FG004|Overall Study|Did not start treatment|0|||
156595860|NCT01371981|565262181|FG005|Overall Study|Did not start treatment|2|||
156595861|NCT01655823|565262182|FG000|Overall Study|Lost to Follow-up|0|||
156595862|NCT01655823|565262183|FG001|Overall Study|Lost to Follow-up|1|||
156595863|NCT01655823|565262184|FG002|Overall Study|Lost to Follow-up|0|||
156595864|NCT01655823|565262185|FG003|Overall Study|Lost to Follow-up|0|||
156595865|NCT01655823|565262186|FG004|Overall Study|Lost to Follow-up|1|||
156595866|NCT01655823|565262182|FG000|Overall Study|Withdrawal by Subject|0|||
156595867|NCT01655823|565262183|FG001|Overall Study|Withdrawal by Subject|1|||
156595868|NCT01655823|565262184|FG002|Overall Study|Withdrawal by Subject|0|||
156595869|NCT01655823|565262185|FG003|Overall Study|Withdrawal by Subject|1|||
156595870|NCT01655823|565262186|FG004|Overall Study|Withdrawal by Subject|0|||
156595871|NCT00603980|565262187|FG000|Study Qualification|Protocol Violation|3|||
156595872|NCT00603980|565262187|FG000|Study Qualification|Inconsistent data reporting|13|||
156595873|NCT00603980|565262187|FG000|Main Study|14th subject completed trial|1|||
156595874|NCT01029002|565262188|FG000|Overall Study|Lost to Follow-up|2|||
156595875|NCT01029002|565262189|FG001|Overall Study|Lost to Follow-up|4|||
156595876|NCT02632110|565262194|FG000|Overall Study|Withdrawal by Subject|1|||
156595877|NCT02632110|565262195|FG001|Overall Study|Withdrawal by Subject|1|||
156595878|NCT02632110|565262196|FG002|Overall Study|Withdrawal by Subject|0|||
156595879|NCT02632110|565262197|FG003|Overall Study|Withdrawal by Subject|0|||
156595880|NCT02632110|565262198|FG004|Overall Study|Withdrawal by Subject|1|||
156595881|NCT02632110|565262199|FG005|Overall Study|Withdrawal by Subject|1|||
156595882|NCT02632110|565262200|FG006|Overall Study|Withdrawal by Subject|3|||
156595883|NCT02632110|565262201|FG007|Overall Study|Withdrawal by Subject|3|||
156595884|NCT02632110|565262202|FG008|Overall Study|Withdrawal by Subject|1|||
156595885|NCT02632110|565262203|FG009|Overall Study|Withdrawal by Subject|1|||
156595886|NCT02618928|565262206|FG000|Overall Study|Failure to Return|28|||
156595887|NCT02618928|565262206|FG000|Overall Study|Insufficient Virological Response|1|||
156595888|NCT02618928|565262206|FG000|Overall Study|Withdrawal by Subject|2|||
156595889|NCT02618928|565262206|FG000|Overall Study|Death|3|||
156595890|NCT02618928|565262206|FG000|Overall Study|Other|11|||
156595891|NCT02618928|565262206|FG000|Overall Study|Missing|6|||
156595892|NCT02618928|565262206|FG000|Overall Study|Treatment Never Started|7|||
156595893|NCT01096849|565262207|FG000|Overall Study|Consent Withdrawn|1|||
156595894|NCT01096849|565262208|FG001|Overall Study|Consent Withdrawn|4|||
156595895|NCT01096849|565262209|FG002|Overall Study|Consent Withdrawn|2|||
156595896|NCT01096849|565262207|FG000|Overall Study|Lack of Efficacy|0|||
156595897|NCT01096849|565262208|FG001|Overall Study|Lack of Efficacy|2|||
156595898|NCT01096849|565262209|FG002|Overall Study|Lack of Efficacy|0|||
156595899|NCT01096849|565262207|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
156595900|NCT01096849|565262208|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
156595901|NCT01096849|565262209|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
156595902|NCT01096849|565262207|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
156595903|NCT01096849|565262208|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
156595904|NCT01096849|565262209|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
156595905|NCT01096849|565262207|FG000|Overall Study|Administrative Reasons|0|||
156595906|NCT01096849|565262208|FG001|Overall Study|Administrative Reasons|1|||
156595907|NCT01096849|565262209|FG002|Overall Study|Administrative Reasons|2|||
156595908|NCT01096849|565262207|FG000|Overall Study|Lost to Follow-up|1|||
156595909|NCT01096849|565262208|FG001|Overall Study|Lost to Follow-up|3|||
156595910|NCT01096849|565262209|FG002|Overall Study|Lost to Follow-up|1|||
156595911|NCT02357849|565262215|FG000|Overall Study|Withdrawal by Subject|2|||
156595912|NCT02357849|565262216|FG001|Overall Study|Withdrawal by Subject|3|||
156595913|NCT01822691|565262218|FG000|Overall Study|Withdrawal by Subject|2|||
156595914|NCT01778127|565262221|FG000|Overall Study|Lost to Follow-up|5|||
156595915|NCT01778127|565262222|FG001|Overall Study|Lost to Follow-up|1|||
156595916|NCT01778127|565262223|FG002|Overall Study|Lost to Follow-up|2|||
156595917|NCT01778127|565262221|FG000|Overall Study|Withdrawal by Subject|3|||
156595918|NCT01778127|565262222|FG001|Overall Study|Withdrawal by Subject|1|||
156595919|NCT01778127|565262223|FG002|Overall Study|Withdrawal by Subject|4|||
156595920|NCT01348425|565262224|FG000|Overall Study|Imaging was not taken.|1|||
156595921|NCT01348425|565262225|FG001|Overall Study|Imaging was not taken.|1|||
156595922|NCT00995670|565262231|FG000|Overall Study|Failed arterial cannulation|1|||
156595923|NCT00995670|565262232|FG001|Overall Study|Failed arterial cannulation|0|||
156595924|NCT00995670|565262233|FG002|Overall Study|Failed arterial cannulation|3|||
156595925|NCT00675103|565262234|FG000|Overall Study|Lack of Efficacy|2|||
156595926|NCT00675103|565262234|FG000|Overall Study|Adverse Event|1|||
156595927|NCT01208038|565262235|FG000|Overall Study|Withdrawal by Subject|1|||
156595928|NCT02773238|565262236|FG000|Overall Study|Lack of Efficacy|4|||
156595929|NCT03260205|565262241|FG000|Overall Study|Adverse Event|2|||
156595930|NCT03260205|565262242|FG001|Overall Study|Adverse Event|0|||
156595931|NCT03260205|565262243|FG002|Overall Study|Adverse Event|2|||
156595932|NCT03260205|565262244|FG003|Overall Study|Adverse Event|2|||
156595933|NCT03260205|565262245|FG004|Overall Study|Adverse Event|4|||
156595934|NCT03260205|565262241|FG000|Overall Study|Lost to Follow-up|2|||
156595935|NCT03260205|565262242|FG001|Overall Study|Lost to Follow-up|2|||
156595936|NCT03260205|565262243|FG002|Overall Study|Lost to Follow-up|1|||
156595937|NCT03260205|565262244|FG003|Overall Study|Lost to Follow-up|1|||
156595938|NCT03260205|565262245|FG004|Overall Study|Lost to Follow-up|5|||
156595939|NCT03260205|565262241|FG000|Overall Study|Protocol Violation|0|||
156595940|NCT03260205|565262242|FG001|Overall Study|Protocol Violation|0|||
156595941|NCT03260205|565262243|FG002|Overall Study|Protocol Violation|2|||
156595942|NCT03260205|565262244|FG003|Overall Study|Protocol Violation|0|||
156595943|NCT03260205|565262245|FG004|Overall Study|Protocol Violation|1|||
156595944|NCT03260205|565262241|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
156595945|NCT03260205|565262242|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
156595946|NCT03260205|565262243|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
156595947|NCT03260205|565262244|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
156595948|NCT03260205|565262245|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
156595949|NCT03260205|565262241|FG000|Overall Study|Other: Unspecified|0|||
156595950|NCT03260205|565262242|FG001|Overall Study|Other: Unspecified|0|||
156595951|NCT03260205|565262243|FG002|Overall Study|Other: Unspecified|3|||
156595952|NCT03260205|565262244|FG003|Overall Study|Other: Unspecified|1|||
156595953|NCT03260205|565262245|FG004|Overall Study|Other: Unspecified|1|||
156595954|NCT03260205|565262241|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
156595955|NCT03260205|565262242|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
156595956|NCT03260205|565262243|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
156595957|NCT03260205|565262244|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
156595958|NCT03260205|565262245|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
156595959|NCT03423979|565262246|FG000|Overall Study|Death|5|||
156595960|NCT03423979|565262246|FG000|Overall Study|Adverse Event|4|||
156595961|NCT03423979|565262246|FG000|Overall Study|Withdrawal by Subject|3|||
156595962|NCT03423979|565262246|FG000|Overall Study|Lost to Follow-up|16|||
156595963|NCT00808249|565262247|FG000|Overall Study|Adverse Event|4|||
156595964|NCT00808249|565262248|FG001|Overall Study|Adverse Event|7|||
156595965|NCT00808249|565262249|FG002|Overall Study|Adverse Event|10|||
156595966|NCT00808249|565262250|FG003|Overall Study|Adverse Event|6|||
156595967|NCT00808249|565262247|FG000|Overall Study|Lost to Follow-up|2|||
156595968|NCT00808249|565262248|FG001|Overall Study|Lost to Follow-up|3|||
156595969|NCT00808249|565262249|FG002|Overall Study|Lost to Follow-up|3|||
156595970|NCT00808249|565262250|FG003|Overall Study|Lost to Follow-up|5|||
156595971|NCT00808249|565262247|FG000|Overall Study|Withdrawal by Subject|4|||
156595972|NCT00808249|565262248|FG001|Overall Study|Withdrawal by Subject|0|||
156595973|NCT00808249|565262249|FG002|Overall Study|Withdrawal by Subject|2|||
156595974|NCT00808249|565262250|FG003|Overall Study|Withdrawal by Subject|4|||
156595975|NCT00808249|565262247|FG000|Overall Study|Protocol Violation|3|||
156595976|NCT00808249|565262248|FG001|Overall Study|Protocol Violation|3|||
156595977|NCT00808249|565262249|FG002|Overall Study|Protocol Violation|3|||
156595978|NCT00808249|565262250|FG003|Overall Study|Protocol Violation|0|||
156595979|NCT00808249|565262247|FG000|Overall Study|Lack of Efficacy|1|||
156595980|NCT00808249|565262248|FG001|Overall Study|Lack of Efficacy|1|||
156595981|NCT00808249|565262249|FG002|Overall Study|Lack of Efficacy|0|||
156595982|NCT00808249|565262250|FG003|Overall Study|Lack of Efficacy|0|||
156595983|NCT00808249|565262247|FG000|Overall Study|study specific discontinuation criteria|1|||
156595984|NCT00808249|565262248|FG001|Overall Study|study specific discontinuation criteria|0|||
156595985|NCT00808249|565262249|FG002|Overall Study|study specific discontinuation criteria|1|||
156595986|NCT00808249|565262250|FG003|Overall Study|study specific discontinuation criteria|0|||
156595987|NCT00808249|565262247|FG000|Overall Study|All other reasons|2|||
156595988|NCT00808249|565262248|FG001|Overall Study|All other reasons|1|||
156595989|NCT00808249|565262249|FG002|Overall Study|All other reasons|3|||
156595990|NCT00808249|565262250|FG003|Overall Study|All other reasons|1|||
156595991|NCT03829332|565262251|FG000|Overall Study|Death|225|||
156595992|NCT03829332|565262252|FG001|Overall Study|Death|230|||
156595993|NCT03829332|565262251|FG000|Overall Study|Lost to Follow-up|1|||
156595994|NCT03829332|565262252|FG001|Overall Study|Lost to Follow-up|3|||
156595995|NCT03829332|565262251|FG000|Overall Study|Physician Decision|1|||
156595996|NCT03829332|565262252|FG001|Overall Study|Physician Decision|0|||
156595997|NCT03829332|565262251|FG000|Overall Study|Sponsor Decision|71|||
156595998|NCT03829332|565262252|FG001|Overall Study|Sponsor Decision|72|||
156595999|NCT03829332|565262251|FG000|Overall Study|Withdrawal by Subject|11|||
156596000|NCT03829332|565262252|FG001|Overall Study|Withdrawal by Subject|9|||
156596001|NCT04095286|565262253|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596002|NCT04095286|565262254|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
156596003|NCT04095286|565262255|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596004|NCT04095286|565262256|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596005|NCT04095286|565262257|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596006|NCT04095286|565262258|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596007|NCT04095286|565262253|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
156596008|NCT04095286|565262254|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
156596009|NCT04095286|565262255|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
156596010|NCT04095286|565262256|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
156596011|NCT04095286|565262257|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
156596012|NCT04095286|565262258|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
156596013|NCT04095286|565262253|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
156596014|NCT04095286|565262254|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
156596015|NCT04095286|565262255|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
156596016|NCT04095286|565262256|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
156596017|NCT04095286|565262257|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
156596018|NCT04095286|565262258|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
156596019|NCT04095286|565262253|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596020|NCT04095286|565262254|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596021|NCT04095286|565262255|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
156596022|NCT04095286|565262256|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596023|NCT04095286|565262257|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596024|NCT04095286|565262258|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
156596025|NCT04095286|565262253|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
156596026|NCT04095286|565262254|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
156596027|NCT04095286|565262255|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
156596028|NCT04095286|565262256|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
156596029|NCT04095286|565262257|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
156596030|NCT04095286|565262258|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
156596031|NCT02509494|565262259|FG000|Overall Study|Lost to Follow-up|8|||
156596032|NCT02509494|565262260|FG001|Overall Study|Lost to Follow-up|47|||
156596033|NCT02509494|565262261|FG002|Overall Study|Lost to Follow-up|19|||
156596034|NCT02509494|565262262|FG003|Overall Study|Lost to Follow-up|6|||
156596035|NCT02509494|565262263|FG004|Overall Study|Lost to Follow-up|3|||
156596036|NCT02509494|565262264|FG005|Overall Study|Lost to Follow-up|3|||
156596037|NCT02509494|565262265|FG006|Overall Study|Lost to Follow-up|1|||
156596038|NCT02509494|565262266|FG007|Overall Study|Lost to Follow-up|3|||
156596039|NCT02509494|565262267|FG008|Overall Study|Lost to Follow-up|1|||
156596040|NCT02509494|565262259|FG000|Overall Study|Physician Decision|2|||
156596041|NCT02509494|565262260|FG001|Overall Study|Physician Decision|1|||
156596042|NCT02509494|565262261|FG002|Overall Study|Physician Decision|0|||
156596043|NCT02509494|565262262|FG003|Overall Study|Physician Decision|0|||
156596044|NCT02509494|565262263|FG004|Overall Study|Physician Decision|0|||
156596045|NCT02509494|565262264|FG005|Overall Study|Physician Decision|0|||
156596046|NCT02509494|565262265|FG006|Overall Study|Physician Decision|0|||
156596047|NCT02509494|565262266|FG007|Overall Study|Physician Decision|0|||
156596048|NCT02509494|565262267|FG008|Overall Study|Physician Decision|0|||
156596049|NCT02509494|565262259|FG000|Overall Study|Withdrawal by Subject|4|||
156596050|NCT02509494|565262260|FG001|Overall Study|Withdrawal by Subject|17|||
156596051|NCT02509494|565262261|FG002|Overall Study|Withdrawal by Subject|7|||
156596052|NCT02509494|565262262|FG003|Overall Study|Withdrawal by Subject|5|||
156596053|NCT02509494|565262263|FG004|Overall Study|Withdrawal by Subject|0|||
156596054|NCT02509494|565262264|FG005|Overall Study|Withdrawal by Subject|6|||
156596055|NCT02509494|565262265|FG006|Overall Study|Withdrawal by Subject|1|||
156596056|NCT02509494|565262266|FG007|Overall Study|Withdrawal by Subject|2|||
156596057|NCT02509494|565262267|FG008|Overall Study|Withdrawal by Subject|1|||
156596058|NCT02509494|565262259|FG000|Overall Study|Death|0|||
156596059|NCT02509494|565262260|FG001|Overall Study|Death|1|||
156596060|NCT02509494|565262261|FG002|Overall Study|Death|0|||
156596061|NCT02509494|565262262|FG003|Overall Study|Death|0|||
156596062|NCT02509494|565262263|FG004|Overall Study|Death|1|||
156596063|NCT02509494|565262264|FG005|Overall Study|Death|0|||
156596064|NCT02509494|565262265|FG006|Overall Study|Death|0|||
156596065|NCT02509494|565262266|FG007|Overall Study|Death|1|||
156596066|NCT02509494|565262267|FG008|Overall Study|Death|0|||
156596067|NCT02509494|565262259|FG000|Overall Study|Other|0|||
156596068|NCT02509494|565262260|FG001|Overall Study|Other|4|||
156596069|NCT02509494|565262261|FG002|Overall Study|Other|5|||
156596070|NCT02509494|565262262|FG003|Overall Study|Other|0|||
156596071|NCT02509494|565262263|FG004|Overall Study|Other|0|||
156596072|NCT02509494|565262264|FG005|Overall Study|Other|0|||
156596073|NCT02509494|565262265|FG006|Overall Study|Other|0|||
156596074|NCT02509494|565262266|FG007|Overall Study|Other|0|||
156596075|NCT02509494|565262267|FG008|Overall Study|Other|0|||
156596076|NCT02509494|565262259|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156596077|NCT02509494|565262260|FG001|Overall Study|Non-Compliance With Study Drug|11|||
156596078|NCT02509494|565262261|FG002|Overall Study|Non-Compliance With Study Drug|7|||
156596079|NCT02509494|565262262|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156596080|NCT02509494|565262263|FG004|Overall Study|Non-Compliance With Study Drug|1|||
156596081|NCT02509494|565262264|FG005|Overall Study|Non-Compliance With Study Drug|2|||
156596082|NCT02509494|565262265|FG006|Overall Study|Non-Compliance With Study Drug|1|||
156596083|NCT02509494|565262266|FG007|Overall Study|Non-Compliance With Study Drug|1|||
156596084|NCT02509494|565262267|FG008|Overall Study|Non-Compliance With Study Drug|0|||
156596085|NCT05371912|565262268|FG000|Overall Study|Lost to Follow-up|3|||
156596086|NCT05371912|565262269|FG001|Overall Study|Lost to Follow-up|2|||
156596087|NCT04752189|565262270|FG000|Overall Study|Withdrawal by Subject|0|||
156596088|NCT04752189|565262271|FG001|Overall Study|Withdrawal by Subject|150|||
156596089|NCT04752189|565262270|FG000|Overall Study|Lost to Follow-up|261|||
156596090|NCT04752189|565262271|FG001|Overall Study|Lost to Follow-up|126|||
156863675|NCT04366349|566258755|FG005|Overall Study|Withdrawal by Subject|0|||
156596091|NCT00975195|565262272|FG000|Overall Study|Adverse Event|108|||
156596092|NCT00975195|565262273|FG001|Overall Study|Adverse Event|101|||
156596093|NCT00975195|565262272|FG000|Overall Study|Lack of Efficacy|6|||
156596094|NCT00975195|565262273|FG001|Overall Study|Lack of Efficacy|6|||
156596095|NCT00975195|565262272|FG000|Overall Study|Protocol Violation|27|||
156596096|NCT00975195|565262273|FG001|Overall Study|Protocol Violation|23|||
156596097|NCT00975195|565262272|FG000|Overall Study|Lost to Follow-up|9|||
156596098|NCT00975195|565262273|FG001|Overall Study|Lost to Follow-up|7|||
156596099|NCT00975195|565262272|FG000|Overall Study|Withdrawal by Subject|48|||
156596100|NCT00975195|565262273|FG001|Overall Study|Withdrawal by Subject|61|||
156596101|NCT00975195|565262272|FG000|Overall Study|Other reason not defined above|29|||
156596102|NCT00975195|565262273|FG001|Overall Study|Other reason not defined above|33|||
156596103|NCT00975195|565262272|FG000|Overall Study|Not treated|1|||
156596104|NCT00975195|565262273|FG001|Overall Study|Not treated|2|||
156596105|NCT02598661|565262278|FG000|Overall Study|Death|27|||
156596106|NCT02598661|565262279|FG001|Overall Study|Death|34|||
156596107|NCT02598661|565262280|FG002|Overall Study|Death|14|||
156596108|NCT02598661|565262281|FG003|Overall Study|Death|1|||
156596109|NCT02598661|565262282|FG004|Overall Study|Death|0|||
156596110|NCT02598661|565262278|FG000|Overall Study|Lost to Follow-up|2|||
156596111|NCT02598661|565262279|FG001|Overall Study|Lost to Follow-up|3|||
156596112|NCT02598661|565262280|FG002|Overall Study|Lost to Follow-up|2|||
156596113|NCT02598661|565262281|FG003|Overall Study|Lost to Follow-up|0|||
156596114|NCT02598661|565262282|FG004|Overall Study|Lost to Follow-up|0|||
156596115|NCT02598661|565262278|FG000|Overall Study|Withdrawal by Subject|13|||
156596116|NCT02598661|565262279|FG001|Overall Study|Withdrawal by Subject|24|||
156596117|NCT02598661|565262280|FG002|Overall Study|Withdrawal by Subject|14|||
156596118|NCT02598661|565262281|FG003|Overall Study|Withdrawal by Subject|1|||
156596119|NCT02598661|565262282|FG004|Overall Study|Withdrawal by Subject|1|||
156596120|NCT02598661|565262278|FG000|Overall Study|Adverse Event|0|||
156596121|NCT02598661|565262279|FG001|Overall Study|Adverse Event|0|||
156596122|NCT02598661|565262280|FG002|Overall Study|Adverse Event|1|||
156596123|NCT02598661|565262281|FG003|Overall Study|Adverse Event|0|||
156596124|NCT02598661|565262282|FG004|Overall Study|Adverse Event|0|||
156596125|NCT02598661|565262278|FG000|Overall Study|Randomized, Never Treated|0|||
156596126|NCT02598661|565262279|FG001|Overall Study|Randomized, Never Treated|0|||
156596127|NCT02598661|565262280|FG002|Overall Study|Randomized, Never Treated|0|||
156596128|NCT02598661|565262281|FG003|Overall Study|Randomized, Never Treated|0|||
156596129|NCT02598661|565262282|FG004|Overall Study|Randomized, Never Treated|1|||
156596130|NCT03003403|565262283|FG000|Overall Study|Ineligible|8|||
156596131|NCT03003403|565262284|FG001|Overall Study|Ineligible|7|||
156596132|NCT03003403|565262283|FG000|Overall Study|Withdrawal by Subject|3|||
156596133|NCT03003403|565262284|FG001|Overall Study|Withdrawal by Subject|1|||
156596134|NCT04092816|565264072|FG000|Overall Study|Lost to Follow-up|1|||
156596135|NCT04092816|565264073|FG001|Overall Study|Lost to Follow-up|2|||
156596136|NCT02475850|565264078|FG000|Overall Study|Death|155|||
156596137|NCT02475850|565264079|FG001|Overall Study|Death|141|||
156596138|NCT02475850|565264078|FG000|Overall Study|Lost to Follow-up|217|||
156596139|NCT02475850|565264079|FG001|Overall Study|Lost to Follow-up|188|||
156596140|NCT02475850|565264078|FG000|Overall Study|Withdrawal by Subject|221|||
156596141|NCT02475850|565264079|FG001|Overall Study|Withdrawal by Subject|155|||
156596142|NCT03057951|565264085|FG000|Overall Study|Adverse Event|553|||
156596143|NCT03057951|565264086|FG001|Overall Study|Adverse Event|575|||
156596144|NCT03057951|565264085|FG000|Overall Study|Protocol Violation|30|||
156596145|NCT03057951|565264086|FG001|Overall Study|Protocol Violation|24|||
156596146|NCT03057951|565264085|FG000|Overall Study|Lost to Follow-up|6|||
156596147|NCT03057951|565264086|FG001|Overall Study|Lost to Follow-up|16|||
156596148|NCT03057951|565264085|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
156596149|NCT03057951|565264086|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
156596150|NCT03057951|565264085|FG000|Overall Study|Study drug stopped, reason missing|6|||
156596151|NCT03057951|565264086|FG001|Overall Study|Study drug stopped, reason missing|1|||
156596152|NCT03057951|565264085|FG000|Overall Study|Medical advice|6|||
156596153|NCT03057951|565264086|FG001|Overall Study|Medical advice|2|||
156596154|NCT03057951|565264085|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
156596155|NCT03057951|565264086|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
156596156|NCT03057951|565264085|FG000|Overall Study|Investigator decision|2|||
156596157|NCT03057951|565264086|FG001|Overall Study|Investigator decision|0|||
156596158|NCT03057951|565264085|FG000|Overall Study|Patient decision|5|||
156596159|NCT03057951|565264086|FG001|Overall Study|Patient decision|2|||
156596160|NCT03057951|565264085|FG000|Overall Study|Not attending study visits|3|||
156596161|NCT03057951|565264086|FG001|Overall Study|Not attending study visits|0|||
156596162|NCT03057951|565264085|FG000|Overall Study|Patient moved away|3|||
156596163|NCT03057951|565264086|FG001|Overall Study|Patient moved away|4|||
156596164|NCT03057951|565264085|FG000|Overall Study|Other reason than stated above|23|||
156596165|NCT03057951|565264086|FG001|Overall Study|Other reason than stated above|29|||
156596166|NCT03057951|565264085|FG000|Overall Study|Not treated|2|||
156596167|NCT03057951|565264086|FG001|Overall Study|Not treated|1|||
156596168|NCT02700919|565264087|FG000|Overall Study|Physician Decision|1|||
156596169|NCT02700919|565264088|FG001|Overall Study|Physician Decision|0|||
156596170|NCT02700919|565264089|FG002|Overall Study|Physician Decision|0|||
156596171|NCT02700919|565264087|FG000|Overall Study|Protocol Violation|1|||
156596172|NCT02700919|565264088|FG001|Overall Study|Protocol Violation|0|||
156596173|NCT02700919|565264089|FG002|Overall Study|Protocol Violation|0|||
156596174|NCT02700919|565264087|FG000|Overall Study|Adverse Event|1|||
156596175|NCT02700919|565264088|FG001|Overall Study|Adverse Event|3|||
156596176|NCT02700919|565264089|FG002|Overall Study|Adverse Event|1|||
156596177|NCT02700919|565264087|FG000|Overall Study|Withdrawal by Subject|5|||
156596178|NCT02700919|565264088|FG001|Overall Study|Withdrawal by Subject|8|||
156596179|NCT02700919|565264089|FG002|Overall Study|Withdrawal by Subject|2|||
156596180|NCT02700919|565264087|FG000|Overall Study|Lost to Follow-up|2|||
156596181|NCT02700919|565264088|FG001|Overall Study|Lost to Follow-up|0|||
156596182|NCT02700919|565264089|FG002|Overall Study|Lost to Follow-up|0|||
156596183|NCT02700919|565264087|FG000|Overall Study|Other|2|||
156596184|NCT02700919|565264088|FG001|Overall Study|Other|1|||
156596185|NCT02700919|565264089|FG002|Overall Study|Other|1|||
156596186|NCT03569449|565264092|FG000|Overall Study|Lost to Follow-up|0|||
156596187|NCT03569449|565264093|FG001|Overall Study|Lost to Follow-up|1|||
156596188|NCT03569449|565264094|FG002|Overall Study|Lost to Follow-up|0|||
156596189|NCT03569449|565264095|FG003|Overall Study|Lost to Follow-up|2|||
156596190|NCT03569449|565264096|FG004|Overall Study|Lost to Follow-up|0|||
156596191|NCT03569449|565264097|FG005|Overall Study|Lost to Follow-up|0|||
156596192|NCT03569449|565264098|FG006|Overall Study|Lost to Follow-up|0|||
156596193|NCT03569449|565264099|FG007|Overall Study|Lost to Follow-up|0|||
156596194|NCT03569449|565264100|FG008|Overall Study|Lost to Follow-up|0|||
156596195|NCT03569449|565264101|FG009|Overall Study|Lost to Follow-up|0|||
156596196|NCT03569449|565264102|FG010|Overall Study|Lost to Follow-up|0|||
156596197|NCT03569449|565264103|FG011|Overall Study|Lost to Follow-up|0|||
156596198|NCT03569449|565264104|FG012|Overall Study|Lost to Follow-up|0|||
156596199|NCT03569449|565264105|FG013|Overall Study|Lost to Follow-up|0|||
156596200|NCT03569449|565264106|FG014|Overall Study|Lost to Follow-up|1|||
156596201|NCT03569449|565264107|FG015|Overall Study|Lost to Follow-up|0|||
156596202|NCT03569449|565264092|FG000|Overall Study|Withdrawal by Subject|0|||
156596203|NCT03569449|565264093|FG001|Overall Study|Withdrawal by Subject|1|||
156596204|NCT03569449|565264094|FG002|Overall Study|Withdrawal by Subject|0|||
156596205|NCT03569449|565264095|FG003|Overall Study|Withdrawal by Subject|0|||
156596206|NCT03569449|565264096|FG004|Overall Study|Withdrawal by Subject|1|||
156596207|NCT03569449|565264097|FG005|Overall Study|Withdrawal by Subject|0|||
156596208|NCT03569449|565264098|FG006|Overall Study|Withdrawal by Subject|0|||
156596209|NCT03569449|565264099|FG007|Overall Study|Withdrawal by Subject|0|||
156596210|NCT03569449|565264100|FG008|Overall Study|Withdrawal by Subject|0|||
156596211|NCT03569449|565264101|FG009|Overall Study|Withdrawal by Subject|0|||
156596212|NCT03569449|565264102|FG010|Overall Study|Withdrawal by Subject|0|||
156596213|NCT03569449|565264103|FG011|Overall Study|Withdrawal by Subject|0|||
156596214|NCT03569449|565264104|FG012|Overall Study|Withdrawal by Subject|0|||
156596215|NCT03569449|565264105|FG013|Overall Study|Withdrawal by Subject|0|||
156596216|NCT03569449|565264106|FG014|Overall Study|Withdrawal by Subject|0|||
156596217|NCT03569449|565264107|FG015|Overall Study|Withdrawal by Subject|0|||
156596218|NCT04124692|565264108|FG000|Overall Study|Medical reason|0|||
156596219|NCT04124692|565264109|FG001|Overall Study|Medical reason|1|||
156596220|NCT04124692|565264108|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
156596221|NCT04124692|565264109|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
156596222|NCT04124692|565264108|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
156596223|NCT04124692|565264109|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
156596224|NCT04124692|565264108|FG000|Overall Study|Lost to Follow-up|2|||
156596225|NCT04124692|565264109|FG001|Overall Study|Lost to Follow-up|4|||
156596226|NCT04124692|565264108|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
156596227|NCT04124692|565264109|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
156596228|NCT05279898|565264121|FG000|Overall Study|Withdrawal by Subject|1|||
156596229|NCT05279898|565264122|FG001|Overall Study|Withdrawal by Subject|0|||
156596230|NCT05279898|565264121|FG000|Overall Study|Physician Decision|1|||
156596231|NCT05279898|565264122|FG001|Overall Study|Physician Decision|1|||
156596232|NCT05136170|565264123|FG000|Overall Study|Withdrawal by Subject|2|||
156596233|NCT05136170|565264124|FG001|Overall Study|Withdrawal by Subject|2|||
156596234|NCT05136170|565264123|FG000|Overall Study|Can no longer make office visits|1|||
156596235|NCT05136170|565264124|FG001|Overall Study|Can no longer make office visits|0|||
156596236|NCT04393038|565264125|FG000|Overall Study|Adverse Event|11|||
156596237|NCT04393038|565264126|FG001|Overall Study|Adverse Event|2|||
156596238|NCT04393038|565264125|FG000|Overall Study|Protocol Violation|1|||
156596239|NCT04393038|565264126|FG001|Overall Study|Protocol Violation|0|||
156596240|NCT04393038|565264125|FG000|Overall Study|Death|6|||
156596241|NCT04393038|565264126|FG001|Overall Study|Death|4|||
156596242|NCT04393038|565264125|FG000|Overall Study|Withdrawal by Subject|24|||
156596243|NCT04393038|565264126|FG001|Overall Study|Withdrawal by Subject|8|||
156596244|NCT04393038|565264125|FG000|Overall Study|Lost to Follow-up|5|||
156596245|NCT04393038|565264126|FG001|Overall Study|Lost to Follow-up|4|||
156596246|NCT04393038|565264125|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
156596247|NCT04393038|565264126|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
156596248|NCT04393038|565264125|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
156596249|NCT04393038|565264126|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
156596250|NCT05168813|565264127|FG000|Part A (Open-label)|Lost to Follow-up|21|||
156596251|NCT05168813|565264128|FG001|Part A (Open-label)|Lost to Follow-up|39|||
156596252|NCT05168813|565264129|FG002|Part A (Open-label)|Lost to Follow-up|8|||
156596253|NCT05168813|565264130|FG003|Part A (Open-label)|Lost to Follow-up|26|||
156596254|NCT05168813|565264131|FG004|Part A (Open-label)|Lost to Follow-up|0|||
156596255|NCT05168813|565264132|FG005|Part A (Open-label)|Lost to Follow-up|0|||
156596256|NCT05168813|565264127|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
156596257|NCT05168813|565264128|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
156596258|NCT05168813|565264129|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
156596259|NCT05168813|565264130|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
156596260|NCT05168813|565264131|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
156596261|NCT05168813|565264132|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
156596262|NCT05168813|565264127|FG000|Part A (Open-label)|Death|23|||
156596263|NCT05168813|565264128|FG001|Part A (Open-label)|Death|28|||
156596264|NCT05168813|565264129|FG002|Part A (Open-label)|Death|1|||
156596265|NCT05168813|565264130|FG003|Part A (Open-label)|Death|9|||
156596266|NCT05168813|565264131|FG004|Part A (Open-label)|Death|0|||
156596267|NCT05168813|565264132|FG005|Part A (Open-label)|Death|0|||
156596268|NCT05168813|565264127|FG000|Part A (Open-label)|Physician Decision|0|||
156596269|NCT05168813|565264128|FG001|Part A (Open-label)|Physician Decision|1|||
156596270|NCT05168813|565264129|FG002|Part A (Open-label)|Physician Decision|0|||
156596271|NCT05168813|565264130|FG003|Part A (Open-label)|Physician Decision|2|||
156596272|NCT05168813|565264131|FG004|Part A (Open-label)|Physician Decision|0|||
156596273|NCT05168813|565264132|FG005|Part A (Open-label)|Physician Decision|0|||
156596274|NCT05168813|565264127|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
156596275|NCT05168813|565264128|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
156596276|NCT05168813|565264129|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
156596277|NCT05168813|565264130|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
156596278|NCT05168813|565264131|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
156596279|NCT05168813|565264132|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
156596280|NCT05168813|565264127|FG000|Part A (Open-label)|Protocol Violation|0|||
156596281|NCT05168813|565264128|FG001|Part A (Open-label)|Protocol Violation|1|||
156596282|NCT05168813|565264129|FG002|Part A (Open-label)|Protocol Violation|0|||
156596283|NCT05168813|565264130|FG003|Part A (Open-label)|Protocol Violation|0|||
156596284|NCT05168813|565264131|FG004|Part A (Open-label)|Protocol Violation|0|||
156596285|NCT05168813|565264132|FG005|Part A (Open-label)|Protocol Violation|0|||
156596286|NCT05168813|565264127|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
156596287|NCT05168813|565264128|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
156596288|NCT05168813|565264129|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
156596289|NCT05168813|565264130|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
156596290|NCT05168813|565264131|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
156596291|NCT05168813|565264132|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
156596292|NCT05168813|565264127|FG000|Part A (Open-label)|Other|0|||
156596293|NCT05168813|565264128|FG001|Part A (Open-label)|Other|1|||
156596294|NCT05168813|565264129|FG002|Part A (Open-label)|Other|0|||
156596295|NCT05168813|565264130|FG003|Part A (Open-label)|Other|0|||
156596296|NCT05168813|565264131|FG004|Part A (Open-label)|Other|0|||
156596297|NCT05168813|565264132|FG005|Part A (Open-label)|Other|0|||
156596298|NCT05168813|565264127|FG000|Part B (Blinded)|Lost to Follow-up|0|||
156596299|NCT05168813|565264128|FG001|Part B (Blinded)|Lost to Follow-up|0|||
156596300|NCT05168813|565264129|FG002|Part B (Blinded)|Lost to Follow-up|0|||
156596301|NCT05168813|565264130|FG003|Part B (Blinded)|Lost to Follow-up|0|||
156596302|NCT05168813|565264131|FG004|Part B (Blinded)|Lost to Follow-up|219|||
156596303|NCT05168813|565264132|FG005|Part B (Blinded)|Lost to Follow-up|88|||
156596304|NCT05168813|565264127|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
156596305|NCT05168813|565264128|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
156596306|NCT05168813|565264129|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
156596307|NCT05168813|565264130|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
156596308|NCT05168813|565264131|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
156596309|NCT05168813|565264132|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
156596310|NCT05168813|565264127|FG000|Part B (Blinded)|Death|0|||
156596311|NCT05168813|565264128|FG001|Part B (Blinded)|Death|0|||
156596312|NCT05168813|565264129|FG002|Part B (Blinded)|Death|0|||
156596313|NCT05168813|565264130|FG003|Part B (Blinded)|Death|0|||
156596314|NCT05168813|565264131|FG004|Part B (Blinded)|Death|63|||
156596315|NCT05168813|565264132|FG005|Part B (Blinded)|Death|19|||
156596316|NCT05168813|565264127|FG000|Part B (Blinded)|Physician Decision|0|||
156596317|NCT05168813|565264128|FG001|Part B (Blinded)|Physician Decision|0|||
156596318|NCT05168813|565264129|FG002|Part B (Blinded)|Physician Decision|0|||
156596319|NCT05168813|565264130|FG003|Part B (Blinded)|Physician Decision|0|||
156596320|NCT05168813|565264131|FG004|Part B (Blinded)|Physician Decision|6|||
156596321|NCT05168813|565264132|FG005|Part B (Blinded)|Physician Decision|1|||
156863676|NCT05194124|566258760|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156596322|NCT05168813|565264127|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
156596323|NCT05168813|565264128|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
156596324|NCT05168813|565264129|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
156596325|NCT05168813|565264130|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
156596326|NCT05168813|565264131|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
156596327|NCT05168813|565264132|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
156596328|NCT05168813|565264127|FG000|Part B (Blinded)|Pregnancy|0|||
156596329|NCT05168813|565264128|FG001|Part B (Blinded)|Pregnancy|0|||
156596330|NCT05168813|565264129|FG002|Part B (Blinded)|Pregnancy|0|||
156596331|NCT05168813|565264130|FG003|Part B (Blinded)|Pregnancy|0|||
156596332|NCT05168813|565264131|FG004|Part B (Blinded)|Pregnancy|1|||
156596333|NCT05168813|565264132|FG005|Part B (Blinded)|Pregnancy|0|||
156596334|NCT05168813|565264127|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
156596335|NCT05168813|565264128|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
156596336|NCT05168813|565264129|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
156596337|NCT05168813|565264130|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
156596338|NCT05168813|565264131|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
156596339|NCT05168813|565264132|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
156596340|NCT05168813|565264127|FG000|Part B (Blinded)|Other|0|||
156596341|NCT05168813|565264128|FG001|Part B (Blinded)|Other|0|||
156596342|NCT05168813|565264129|FG002|Part B (Blinded)|Other|0|||
156596343|NCT05168813|565264130|FG003|Part B (Blinded)|Other|0|||
156596344|NCT05168813|565264131|FG004|Part B (Blinded)|Other|41|||
156596345|NCT05168813|565264132|FG005|Part B (Blinded)|Other|27|||
156596346|NCT01754922|565264134|FG000|Overall Study|Adverse Event|0|||
156596347|NCT01754922|565264135|FG001|Overall Study|Adverse Event|1|||
156596348|NCT01207388|565264136|FG000|Overall Study|Death|67|||
156596349|NCT01207388|565264136|FG000|Overall Study|Withdrawal by Subject|1|||
156596350|NCT04580394|565264141|FG000|First Intervention|Incorrectly Randomized|1|||
156596351|NCT04580394|565264141|FG000|First Intervention|Physician Decision|1|||
156596352|NCT04580394|565264141|FG000|First Intervention|Lost to Follow-up|1|||
156596353|NCT04580394|565264141|FG000|Washout (One Week)|Withdrawal by Subject|1|||
156596354|NCT04580394|565264141|FG000|Washout (One Week)|Adverse Event|1|||
156596355|NCT04580394|565264141|FG000|Washout (One Week)|Withdrawal by Subject|2|||
156596356|NCT04580394|565264141|FG000|Third Intervention|Adverse Event|1|||
156596357|NCT04580394|565264141|FG000|Third Intervention|Withdrawal by Subject|1|||
156596358|NCT04580394|565264141|FG000|Washout (One Week)|Withdrawal by Subject|2|||
156596359|NCT04397718|565264144|FG000|Overall Study|Death|7|||
156596360|NCT04397718|565264145|FG001|Overall Study|Death|11|||
156596361|NCT04397718|565264144|FG000|Overall Study|Lost to Follow-up|0|||
156596362|NCT04397718|565264145|FG001|Overall Study|Lost to Follow-up|4|||
156596363|NCT06087328|565264146|FG000|28-Day Treatment|Lost to Follow-up|7|||
156596364|NCT06087328|565264147|FG001|28-Day Treatment|Lost to Follow-up|3|||
156596365|NCT06087328|565264148|FG002|28-Day Treatment|Lost to Follow-up|4|||
156596366|NCT06087328|565264146|FG000|1-month Follow-up|Lost to Follow-up|0|||
156596367|NCT06087328|565264147|FG001|1-month Follow-up|Lost to Follow-up|1|||
156596368|NCT06087328|565264148|FG002|1-month Follow-up|Lost to Follow-up|1|||
156596369|NCT03201965|565264149|FG000|Overall Study|Death|5|||
156596370|NCT03201965|565264150|FG001|Overall Study|Death|65|||
156596371|NCT03201965|565264151|FG002|Overall Study|Death|47|||
156596372|NCT03201965|565264149|FG000|Overall Study|Lost to Follow-up|0|||
156596373|NCT03201965|565264150|FG001|Overall Study|Lost to Follow-up|6|||
156596374|NCT03201965|565264151|FG002|Overall Study|Lost to Follow-up|0|||
156596375|NCT03201965|565264149|FG000|Overall Study|Withdrawal by Subject|3|||
156596376|NCT03201965|565264150|FG001|Overall Study|Withdrawal by Subject|23|||
156596377|NCT03201965|565264151|FG002|Overall Study|Withdrawal by Subject|8|||
156596378|NCT03201965|565264149|FG000|Overall Study|Sponsor's Decision|20|||
156596379|NCT03201965|565264150|FG001|Overall Study|Sponsor's Decision|99|||
156596380|NCT03201965|565264151|FG002|Overall Study|Sponsor's Decision|140|||
156596381|NCT03589326|565264152|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
156596382|NCT03589326|565264153|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
156596383|NCT03589326|565264152|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
156596384|NCT03589326|565264153|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
156596385|NCT03589326|565264152|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
156596386|NCT03589326|565264153|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
156596387|NCT03589326|565264152|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
156596388|NCT03589326|565264153|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
156596389|NCT03589326|565264152|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
156596390|NCT03589326|565264153|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
156596391|NCT00118482|565264160|FG000|Overall Study|Lost to Follow-up|7|||
156596392|NCT00118482|565264161|FG001|Overall Study|Lost to Follow-up|7|||
156596393|NCT00118482|565264160|FG000|Overall Study|Withdrawal by Subject|23|||
156596394|NCT00118482|565264161|FG001|Overall Study|Withdrawal by Subject|22|||
156596395|NCT04146467|565264164|FG000|Overall Study|Adverse Event|0|||
156596396|NCT04146467|565264165|FG001|Overall Study|Adverse Event|1|||
156596397|NCT04146467|565264164|FG000|Overall Study|Lost to Follow-up|0|||
156596398|NCT04146467|565264165|FG001|Overall Study|Lost to Follow-up|2|||
156596399|NCT02128763|565264167|FG000|Overall Study|Death|1|||
156596400|NCT02128763|565264168|FG001|Overall Study|Death|0|||
156596401|NCT02128763|565264167|FG000|Overall Study|Lost to Follow-up|19|||
156596402|NCT02128763|565264168|FG001|Overall Study|Lost to Follow-up|16|||
156596403|NCT01253421|565264169|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
156596404|NCT01253421|565264170|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
156596405|NCT01253421|565264171|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
156596406|NCT01253421|565264172|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
156596407|NCT01253421|565264173|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
156596408|NCT01253421|565264169|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
156596409|NCT01253421|565264170|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
156596410|NCT01253421|565264171|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
156596411|NCT01253421|565264172|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
156596412|NCT01253421|565264173|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
156596413|NCT01253421|565264169|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
156596414|NCT01253421|565264170|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
156596415|NCT01253421|565264171|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
156596416|NCT01253421|565264172|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
156596417|NCT01253421|565264173|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
156596418|NCT01253421|565264169|FG000|Assessment and Scheduling|Physician Decision|1|||
156596419|NCT01253421|565264170|FG001|Assessment and Scheduling|Physician Decision|0|||
156596420|NCT01253421|565264171|FG002|Assessment and Scheduling|Physician Decision|0|||
156596421|NCT01253421|565264172|FG003|Assessment and Scheduling|Physician Decision|0|||
156596422|NCT01253421|565264173|FG004|Assessment and Scheduling|Physician Decision|0|||
156596423|NCT01253421|565264169|FG000|Drug+Scanning Visit|Physician Decision|0|||
156596424|NCT01253421|565264170|FG001|Drug+Scanning Visit|Physician Decision|0|||
156596425|NCT01253421|565264171|FG002|Drug+Scanning Visit|Physician Decision|0|||
156596426|NCT01253421|565264172|FG003|Drug+Scanning Visit|Physician Decision|0|||
156596427|NCT01253421|565264173|FG004|Drug+Scanning Visit|Physician Decision|1|||
156596428|NCT01608724|565264175|FG000|Overall Study|Withdrawal by Subject|131|||
156596429|NCT01608724|565264175|FG000|Overall Study|Lost to Follow-up|41|||
156596430|NCT01608724|565264175|FG000|Overall Study|Study-specific discontinuation criteria|32|||
156596431|NCT01608724|565264175|FG000|Overall Study|Adverse Event|29|||
156596432|NCT01608724|565264175|FG000|Overall Study|Protocol Violation|6|||
156596433|NCT01608724|565264175|FG000|Overall Study|bood sugar too high, etc.|3|||
156596434|NCT01608724|565264175|FG000|Overall Study|Safety reasons|1|||
156596435|NCT04633473|565264176|FG000|Overall Study|Withdrawal by Subject|6|||
156596436|NCT00099359|565264177|FG000|Overall Study|Death|11|||
156596437|NCT00099359|565264178|FG001|Overall Study|Death|15|||
156596438|NCT00099359|565264179|FG002|Overall Study|Death|17|||
156596439|NCT00099359|565264177|FG000|Overall Study|Withdrawal by Subject|19|||
156596440|NCT00099359|565264178|FG001|Overall Study|Withdrawal by Subject|19|||
156596441|NCT00099359|565264179|FG002|Overall Study|Withdrawal by Subject|23|||
156596442|NCT00099359|565264177|FG000|Overall Study|Lost to Follow-up|15|||
156596443|NCT00099359|565264178|FG001|Overall Study|Lost to Follow-up|24|||
156596444|NCT00099359|565264179|FG002|Overall Study|Lost to Follow-up|24|||
156596445|NCT00099359|565264177|FG000|Overall Study|moved out of area|9|||
156596446|NCT00099359|565264178|FG001|Overall Study|moved out of area|7|||
156596447|NCT00099359|565264179|FG002|Overall Study|moved out of area|4|||
156596448|NCT00717366|565264180|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
156596449|NCT00717366|565264181|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
156596450|NCT00717366|565264180|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
156596451|NCT00717366|565264181|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
156596452|NCT00717366|565264180|FG000|Core Study Period (20 Weeks)|Death|0|||
156596453|NCT00717366|565264181|FG001|Core Study Period (20 Weeks)|Death|1|||
156596454|NCT00717366|565264180|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
156596455|NCT00717366|565264181|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
156596456|NCT00717366|565264180|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
156596457|NCT00717366|565264181|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
156596458|NCT00717366|565264180|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
156596459|NCT00717366|565264181|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
156596460|NCT00717366|565264180|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
156596461|NCT00717366|565264181|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
156596462|NCT01553916|565264182|FG000|Overall Study|Withdrawal by Subject|2|||
156596463|NCT01553916|565264182|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
156596464|NCT02104804|565264185|FG000|Overall Study|Did not take study medication|0|||
156596465|NCT02104804|565264186|FG001|Overall Study|Did not take study medication|1|||
156596466|NCT02104804|565264185|FG000|Overall Study|Study specific discontinuation criteria|6|||
156596467|NCT02104804|565264186|FG001|Overall Study|Study specific discontinuation criteria|1|||
156596468|NCT02104804|565264185|FG000|Overall Study|Other listed|2|||
156596469|NCT02104804|565264186|FG001|Overall Study|Other listed|1|||
156596470|NCT02104804|565264185|FG000|Overall Study|Protocol Violation|0|||
156596471|NCT02104804|565264186|FG001|Overall Study|Protocol Violation|1|||
156596472|NCT02104804|565264185|FG000|Overall Study|Adverse Event|4|||
156596473|NCT02104804|565264186|FG001|Overall Study|Adverse Event|3|||
156596474|NCT02104804|565264185|FG000|Overall Study|Withdrawal by Subject|4|||
156596475|NCT02104804|565264186|FG001|Overall Study|Withdrawal by Subject|12|||
156596476|NCT01968954|565264189|FG000|Overall Study|Adverse Event|6|||
156596477|NCT01968954|565264190|FG001|Overall Study|Adverse Event|3|||
156596478|NCT01968954|565264189|FG000|Overall Study|Death|1|||
156596479|NCT01968954|565264190|FG001|Overall Study|Death|2|||
156596480|NCT01968954|565264189|FG000|Overall Study|Lost to Follow-up|6|||
156596481|NCT01968954|565264190|FG001|Overall Study|Lost to Follow-up|4|||
156596482|NCT01968954|565264189|FG000|Overall Study|Withdrawal by Subject|20|||
156596483|NCT01968954|565264190|FG001|Overall Study|Withdrawal by Subject|23|||
156596484|NCT01968954|565264189|FG000|Overall Study|Other|7|||
156596485|NCT01968954|565264190|FG001|Overall Study|Other|8|||
156596486|NCT01968954|565264189|FG000|Overall Study|Protocol Violation|0|||
156596487|NCT01968954|565264190|FG001|Overall Study|Protocol Violation|1|||
156596488|NCT01968954|565264189|FG000|Overall Study|Did not met inclusion criteria|0|||
156596489|NCT01968954|565264190|FG001|Overall Study|Did not met inclusion criteria|2|||
156596490|NCT00645567|565264194|FG000|Overall Study|Adverse Event|1|||
156596491|NCT03259490|565264195|FG000|Period 1|Withdrawal by Subject|0|||
156596492|NCT03259490|565264196|FG001|Period 1|Withdrawal by Subject|1|||
156596493|NCT03259490|565264195|FG000|Period 2|Protocol Violation|1|||
156596494|NCT03259490|565264196|FG001|Period 2|Protocol Violation|0|||
156596495|NCT00255086|565264197|FG000|Overall Study|Adverse Event|1|||
156596496|NCT00255086|565264198|FG001|Overall Study|Adverse Event|1|||
156596497|NCT00255086|565264197|FG000|Overall Study|Protocol Violation|1|||
156596498|NCT00255086|565264198|FG001|Overall Study|Protocol Violation|1|||
156596499|NCT00434122|565264199|FG000|Overall Study|Non-compliance with protocol|0|||
156596500|NCT00434122|565264200|FG001|Overall Study|Non-compliance with protocol|1|||
156596501|NCT00434122|565264199|FG000|Overall Study|loss of subject contact|1|||
156596502|NCT00434122|565264200|FG001|Overall Study|loss of subject contact|1|||
156596503|NCT00434122|565264199|FG000|Overall Study|Personal reasons|1|||
156596504|NCT00434122|565264200|FG001|Overall Study|Personal reasons|1|||
156596505|NCT00434122|565264199|FG000|Overall Study|Large follicle size|2|||
156596506|NCT00434122|565264200|FG001|Overall Study|Large follicle size|2|||
156596507|NCT00434122|565264199|FG000|Overall Study|Low follicular response.|1|||
156596508|NCT00434122|565264200|FG001|Overall Study|Low follicular response.|2|||
156596509|NCT00434122|565264199|FG000|Overall Study|Travelling of subject.|1|||
156596510|NCT00434122|565264200|FG001|Overall Study|Travelling of subject.|0|||
156596511|NCT01963208|565264202|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
156596512|NCT01963208|565264203|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
156596513|NCT01963208|565264204|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
156596514|NCT01963208|565264205|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
156596515|NCT01963208|565264206|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
156596516|NCT01963208|565264207|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
156596517|NCT01963208|565264202|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
156596518|NCT01963208|565264203|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
156596519|NCT01963208|565264204|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
156596520|NCT01963208|565264205|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
156596521|NCT01963208|565264206|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
156596522|NCT01963208|565264207|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
156596523|NCT01963208|565264202|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
156596524|NCT01963208|565264203|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
156596525|NCT01963208|565264204|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
156596526|NCT01963208|565264205|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
156596527|NCT01963208|565264206|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
156596528|NCT01963208|565264207|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
156596529|NCT01963208|565264202|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
156596530|NCT01963208|565264203|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
156596531|NCT01963208|565264204|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
156596532|NCT01963208|565264205|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
156596533|NCT01963208|565264206|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
156596534|NCT01963208|565264207|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
156596535|NCT01963208|565264202|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
156596536|NCT01963208|565264203|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
156596537|NCT01963208|565264204|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
156596538|NCT01963208|565264205|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
156596539|NCT01963208|565264206|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
156596540|NCT01963208|565264207|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
156596541|NCT01963208|565264202|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
156596542|NCT01963208|565264203|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
156596543|NCT01963208|565264204|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
156596544|NCT01963208|565264205|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
156596545|NCT01963208|565264206|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
156596546|NCT01963208|565264207|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
156596547|NCT01963208|565264202|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
156596548|NCT01963208|565264203|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
156596549|NCT01963208|565264204|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
156596550|NCT01963208|565264205|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
156596551|NCT01963208|565264206|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
156596552|NCT01963208|565264207|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
156596553|NCT01963208|565264202|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
156596554|NCT01963208|565264203|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
156596555|NCT01963208|565264204|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
156596556|NCT01963208|565264205|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
156596557|NCT01963208|565264206|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
156596558|NCT01963208|565264207|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
156596559|NCT01963208|565264202|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
156596560|NCT01963208|565264203|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
156596561|NCT01963208|565264204|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
156596562|NCT01963208|565264205|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
156596563|NCT01963208|565264206|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
156596564|NCT01963208|565264207|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
156596565|NCT01963208|565264202|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
156596566|NCT01963208|565264203|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
156596567|NCT01963208|565264204|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
156596568|NCT01963208|565264205|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
156596569|NCT01963208|565264206|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
156596570|NCT01963208|565264207|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
156596571|NCT01963208|565264202|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
156596572|NCT01963208|565264203|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
156596573|NCT01963208|565264204|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
156596574|NCT01963208|565264205|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
156596575|NCT01963208|565264206|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
156596576|NCT01963208|565264207|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
156596577|NCT01963208|565264202|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
156596578|NCT01963208|565264203|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
156596579|NCT01963208|565264204|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
156596580|NCT01963208|565264205|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
156596581|NCT01963208|565264206|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
156596582|NCT01963208|565264207|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
156596583|NCT01963208|565264202|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
156596584|NCT01963208|565264203|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
156596585|NCT01963208|565264204|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
156596586|NCT01963208|565264205|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
156596587|NCT01963208|565264206|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
156596588|NCT01963208|565264207|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
156596589|NCT01963208|565264202|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
156596590|NCT01963208|565264203|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
156596591|NCT01963208|565264204|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
156596592|NCT01963208|565264205|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
156596593|NCT01963208|565264206|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
156596594|NCT01963208|565264207|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
156596595|NCT00438399|565264208|FG000|Overall Study|Lost to Follow-up|2|||
156596596|NCT00438399|565264209|FG001|Overall Study|Lost to Follow-up|2|||
156596597|NCT00438399|565264210|FG002|Overall Study|Lost to Follow-up|1|||
156596598|NCT00438399|565264211|FG003|Overall Study|Lost to Follow-up|1|||
156596599|NCT00438399|565264212|FG004|Overall Study|Lost to Follow-up|1|||
156596600|NCT00438399|565264213|FG005|Overall Study|Lost to Follow-up|1|||
156596601|NCT00438399|565264208|FG000|Overall Study|Adverse Event|0|||
156596602|NCT00438399|565264209|FG001|Overall Study|Adverse Event|0|||
156596603|NCT00438399|565264210|FG002|Overall Study|Adverse Event|1|||
156596604|NCT00438399|565264211|FG003|Overall Study|Adverse Event|1|||
156596605|NCT00438399|565264212|FG004|Overall Study|Adverse Event|0|||
156596606|NCT00438399|565264213|FG005|Overall Study|Adverse Event|1|||
156596607|NCT00438399|565264208|FG000|Overall Study|Withdrawal by Subject|5|||
156596608|NCT00438399|565264209|FG001|Overall Study|Withdrawal by Subject|6|||
156596609|NCT00438399|565264210|FG002|Overall Study|Withdrawal by Subject|3|||
156596610|NCT00438399|565264211|FG003|Overall Study|Withdrawal by Subject|2|||
156596611|NCT00438399|565264212|FG004|Overall Study|Withdrawal by Subject|2|||
156596612|NCT00438399|565264213|FG005|Overall Study|Withdrawal by Subject|2|||
156596613|NCT00438399|565264208|FG000|Overall Study|Protocol Violation|0|||
156596614|NCT00438399|565264209|FG001|Overall Study|Protocol Violation|0|||
156596615|NCT00438399|565264210|FG002|Overall Study|Protocol Violation|1|||
156596616|NCT00438399|565264211|FG003|Overall Study|Protocol Violation|0|||
156596617|NCT00438399|565264212|FG004|Overall Study|Protocol Violation|0|||
156596618|NCT00438399|565264213|FG005|Overall Study|Protocol Violation|1|||
156596619|NCT00438399|565264208|FG000|Overall Study|Subje stopped study|0|||
156596620|NCT00438399|565264209|FG001|Overall Study|Subje stopped study|0|||
156596621|NCT00438399|565264210|FG002|Overall Study|Subje stopped study|1|||
156596622|NCT00438399|565264211|FG003|Overall Study|Subje stopped study|0|||
156596623|NCT00438399|565264212|FG004|Overall Study|Subje stopped study|0|||
156596624|NCT00438399|565264213|FG005|Overall Study|Subje stopped study|0|||
156596625|NCT00438399|565264208|FG000|Overall Study|Pregnancy|0|||
156596626|NCT00438399|565264209|FG001|Overall Study|Pregnancy|0|||
156596627|NCT00438399|565264210|FG002|Overall Study|Pregnancy|0|||
156596628|NCT00438399|565264211|FG003|Overall Study|Pregnancy|0|||
156596629|NCT00438399|565264212|FG004|Overall Study|Pregnancy|0|||
156596630|NCT00438399|565264213|FG005|Overall Study|Pregnancy|1|||
156596631|NCT00438399|565264208|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
156596632|NCT00438399|565264209|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
156596633|NCT00438399|565264210|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
156596634|NCT00438399|565264211|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
156596635|NCT00438399|565264212|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
156596636|NCT00438399|565264213|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
156596637|NCT01364233|565264214|FG000|Overall Study|Lost to Follow-up|1|||
156596638|NCT00819585|565264219|FG000|Core Study|Adverse Event|2|||
156596639|NCT00819585|565264220|FG001|Core Study|Adverse Event|1|||
156596640|NCT00819585|565264221|FG002|Core Study|Adverse Event|1|||
156596641|NCT00819585|565264222|FG003|Core Study|Adverse Event|4|||
156596642|NCT00819585|565264223|FG004|Core Study|Adverse Event|1|||
156596643|NCT00819585|565264224|FG005|Core Study|Adverse Event|0|||
156596644|NCT00819585|565264225|FG006|Core Study|Adverse Event|2|||
156596645|NCT00819585|565264226|FG007|Core Study|Adverse Event|0|||
156596646|NCT00819585|565264227|FG008|Core Study|Adverse Event|0|||
156596647|NCT00819585|565264228|FG009|Core Study|Adverse Event|0|||
156596648|NCT00819585|565264229|FG010|Core Study|Adverse Event|0|||
156596649|NCT00819585|565264219|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
156596650|NCT00819585|565264220|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
156596651|NCT00819585|565264221|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
156596652|NCT00819585|565264222|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
156596653|NCT00819585|565264223|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
156596654|NCT00819585|565264224|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
156596655|NCT00819585|565264225|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
156596656|NCT00819585|565264226|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
156596657|NCT00819585|565264227|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
156596658|NCT00819585|565264228|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
156596659|NCT00819585|565264229|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
156596660|NCT00819585|565264219|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596661|NCT00819585|565264220|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
156596662|NCT00819585|565264221|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596663|NCT00819585|565264222|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596664|NCT00819585|565264223|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596665|NCT00819585|565264224|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596666|NCT00819585|565264225|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
156596667|NCT00819585|565264226|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596668|NCT00819585|565264227|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596669|NCT00819585|565264228|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596670|NCT00819585|565264229|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
156596671|NCT00819585|565264219|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
156596672|NCT00819585|565264220|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
156596673|NCT00819585|565264221|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
156596674|NCT00819585|565264222|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
156596675|NCT00819585|565264223|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
156596676|NCT00819585|565264224|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
156596677|NCT00819585|565264225|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
156596678|NCT00819585|565264226|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
156596679|NCT00819585|565264227|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
156596680|NCT00819585|565264228|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
156596681|NCT00819585|565264229|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
156596682|NCT00819585|565264219|FG000|Core Study|Subject Withdrew Consent|0|||
156596683|NCT00819585|565264220|FG001|Core Study|Subject Withdrew Consent|3|||
156596684|NCT00819585|565264221|FG002|Core Study|Subject Withdrew Consent|2|||
156596685|NCT00819585|565264222|FG003|Core Study|Subject Withdrew Consent|1|||
156596686|NCT00819585|565264223|FG004|Core Study|Subject Withdrew Consent|0|||
156596687|NCT00819585|565264224|FG005|Core Study|Subject Withdrew Consent|0|||
156596688|NCT00819585|565264225|FG006|Core Study|Subject Withdrew Consent|3|||
156596689|NCT00819585|565264226|FG007|Core Study|Subject Withdrew Consent|0|||
156596690|NCT00819585|565264227|FG008|Core Study|Subject Withdrew Consent|0|||
156596691|NCT00819585|565264228|FG009|Core Study|Subject Withdrew Consent|0|||
156596692|NCT00819585|565264229|FG010|Core Study|Subject Withdrew Consent|0|||
156596693|NCT00819585|565264219|FG000|Core Study|Lost to Follow-up|2|||
156596694|NCT00819585|565264220|FG001|Core Study|Lost to Follow-up|1|||
156596695|NCT00819585|565264221|FG002|Core Study|Lost to Follow-up|2|||
156596696|NCT00819585|565264222|FG003|Core Study|Lost to Follow-up|0|||
156596697|NCT00819585|565264223|FG004|Core Study|Lost to Follow-up|1|||
156596698|NCT00819585|565264224|FG005|Core Study|Lost to Follow-up|1|||
156596699|NCT00819585|565264225|FG006|Core Study|Lost to Follow-up|1|||
156596700|NCT00819585|565264226|FG007|Core Study|Lost to Follow-up|0|||
156596701|NCT00819585|565264227|FG008|Core Study|Lost to Follow-up|0|||
156596702|NCT00819585|565264228|FG009|Core Study|Lost to Follow-up|0|||
156596703|NCT00819585|565264229|FG010|Core Study|Lost to Follow-up|0|||
156596704|NCT00819585|565264219|FG000|Core Study|Administrative Problems|0|||
156596705|NCT00819585|565264220|FG001|Core Study|Administrative Problems|0|||
156596706|NCT00819585|565264221|FG002|Core Study|Administrative Problems|0|||
156596707|NCT00819585|565264222|FG003|Core Study|Administrative Problems|0|||
156596708|NCT00819585|565264223|FG004|Core Study|Administrative Problems|0|||
156596709|NCT00819585|565264224|FG005|Core Study|Administrative Problems|0|||
156596710|NCT00819585|565264225|FG006|Core Study|Administrative Problems|2|||
156596711|NCT00819585|565264226|FG007|Core Study|Administrative Problems|0|||
156596712|NCT00819585|565264227|FG008|Core Study|Administrative Problems|0|||
156596713|NCT00819585|565264228|FG009|Core Study|Administrative Problems|0|||
156596714|NCT00819585|565264229|FG010|Core Study|Administrative Problems|0|||
156596715|NCT00819585|565264219|FG000|Core Study|Death|0|||
156596716|NCT00819585|565264220|FG001|Core Study|Death|0|||
156596717|NCT00819585|565264221|FG002|Core Study|Death|0|||
156596718|NCT00819585|565264222|FG003|Core Study|Death|0|||
156596719|NCT00819585|565264223|FG004|Core Study|Death|0|||
156596720|NCT00819585|565264224|FG005|Core Study|Death|0|||
156596721|NCT00819585|565264225|FG006|Core Study|Death|1|||
156596722|NCT00819585|565264226|FG007|Core Study|Death|0|||
156596723|NCT00819585|565264227|FG008|Core Study|Death|0|||
156596724|NCT00819585|565264228|FG009|Core Study|Death|0|||
156596725|NCT00819585|565264229|FG010|Core Study|Death|0|||
156596726|NCT00819585|565264219|FG000|Core Study|Protocol Violation|0|||
156596727|NCT00819585|565264220|FG001|Core Study|Protocol Violation|0|||
156596728|NCT00819585|565264221|FG002|Core Study|Protocol Violation|1|||
156596729|NCT00819585|565264222|FG003|Core Study|Protocol Violation|0|||
156596730|NCT00819585|565264223|FG004|Core Study|Protocol Violation|0|||
156596731|NCT00819585|565264224|FG005|Core Study|Protocol Violation|1|||
156596732|NCT00819585|565264225|FG006|Core Study|Protocol Violation|3|||
156596733|NCT00819585|565264226|FG007|Core Study|Protocol Violation|0|||
156596734|NCT00819585|565264227|FG008|Core Study|Protocol Violation|0|||
156596735|NCT00819585|565264228|FG009|Core Study|Protocol Violation|0|||
156596736|NCT00819585|565264229|FG010|Core Study|Protocol Violation|0|||
156596737|NCT00819585|565264219|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
156596738|NCT00819585|565264220|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
156596739|NCT00819585|565264221|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
156596740|NCT00819585|565264222|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
156596741|NCT00819585|565264223|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
156596742|NCT00819585|565264224|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
156596743|NCT00819585|565264225|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
156596744|NCT00819585|565264226|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
156596745|NCT00819585|565264227|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
156596746|NCT00819585|565264228|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
156596747|NCT00819585|565264229|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
156596748|NCT00819585|565264219|FG000|Extension Study|Subject Withdrew Consent|0|||
156596749|NCT00819585|565264220|FG001|Extension Study|Subject Withdrew Consent|0|||
156596750|NCT00819585|565264221|FG002|Extension Study|Subject Withdrew Consent|0|||
156596751|NCT00819585|565264222|FG003|Extension Study|Subject Withdrew Consent|0|||
156596752|NCT00819585|565264223|FG004|Extension Study|Subject Withdrew Consent|0|||
156596753|NCT00819585|565264224|FG005|Extension Study|Subject Withdrew Consent|0|||
156596754|NCT00819585|565264225|FG006|Extension Study|Subject Withdrew Consent|0|||
156596755|NCT00819585|565264226|FG007|Extension Study|Subject Withdrew Consent|0|||
156596756|NCT00819585|565264227|FG008|Extension Study|Subject Withdrew Consent|3|||
156596757|NCT00819585|565264228|FG009|Extension Study|Subject Withdrew Consent|0|||
156596758|NCT00819585|565264229|FG010|Extension Study|Subject Withdrew Consent|1|||
156596759|NCT00819585|565264219|FG000|Extension Study|Lost to Follow-up|0|||
156596760|NCT00819585|565264220|FG001|Extension Study|Lost to Follow-up|0|||
156596761|NCT00819585|565264221|FG002|Extension Study|Lost to Follow-up|0|||
156596762|NCT00819585|565264222|FG003|Extension Study|Lost to Follow-up|0|||
156596763|NCT00819585|565264223|FG004|Extension Study|Lost to Follow-up|0|||
156596764|NCT00819585|565264224|FG005|Extension Study|Lost to Follow-up|0|||
156596765|NCT00819585|565264225|FG006|Extension Study|Lost to Follow-up|0|||
156596766|NCT00819585|565264226|FG007|Extension Study|Lost to Follow-up|0|||
156596767|NCT00819585|565264227|FG008|Extension Study|Lost to Follow-up|2|||
156596768|NCT00819585|565264228|FG009|Extension Study|Lost to Follow-up|1|||
156596769|NCT00819585|565264229|FG010|Extension Study|Lost to Follow-up|1|||
156596770|NCT00819585|565264219|FG000|Extension Study|Death|0|||
156596771|NCT00819585|565264220|FG001|Extension Study|Death|0|||
156596772|NCT00819585|565264221|FG002|Extension Study|Death|0|||
156596773|NCT00819585|565264222|FG003|Extension Study|Death|0|||
156596774|NCT00819585|565264223|FG004|Extension Study|Death|0|||
156596775|NCT00819585|565264224|FG005|Extension Study|Death|0|||
156596776|NCT00819585|565264225|FG006|Extension Study|Death|0|||
156596777|NCT00819585|565264226|FG007|Extension Study|Death|0|||
156596778|NCT00819585|565264227|FG008|Extension Study|Death|2|||
156596779|NCT00819585|565264228|FG009|Extension Study|Death|0|||
156596780|NCT00819585|565264229|FG010|Extension Study|Death|0|||
156596781|NCT00349752|565264230|FG000|Overall Study|Adverse Event|8|||
156596782|NCT00349752|565264231|FG001|Overall Study|Adverse Event|12|||
156596783|NCT00349752|565264230|FG000|Overall Study|Lack of Efficacy|37|||
156596784|NCT00349752|565264231|FG001|Overall Study|Lack of Efficacy|42|||
156596785|NCT00349752|565264230|FG000|Overall Study|Lost to Follow-up|4|||
156596786|NCT00349752|565264231|FG001|Overall Study|Lost to Follow-up|2|||
156596787|NCT00349752|565264230|FG000|Overall Study|Personal reasons|6|||
156596788|NCT00349752|565264231|FG001|Overall Study|Personal reasons|5|||
156596789|NCT00349752|565264230|FG000|Overall Study|Other: Required exclusionary medication|0|||
156596790|NCT00349752|565264231|FG001|Overall Study|Other: Required exclusionary medication|1|||
156596791|NCT00349752|565264230|FG000|Overall Study|Other: Non compliance|0|||
156596792|NCT00349752|565264231|FG001|Overall Study|Other: Non compliance|1|||
156596793|NCT00349752|565264230|FG000|Overall Study|Other: Patient stopped steroids|0|||
156596794|NCT00349752|565264231|FG001|Overall Study|Other: Patient stopped steroids|1|||
156596795|NCT00349752|565264230|FG000|Overall Study|Other: Patient's steroid use|1|||
156596796|NCT00349752|565264231|FG001|Overall Study|Other: Patient's steroid use|0|||
156596797|NCT00349752|565264230|FG000|Overall Study|Other: Ineligible|1|||
156596798|NCT00349752|565264231|FG001|Overall Study|Other: Ineligible|0|||
156596799|NCT00349752|565264230|FG000|Overall Study|Other: Inadvertently unblinded|1|||
156596800|NCT00349752|565264231|FG001|Overall Study|Other: Inadvertently unblinded|0|||
156596801|NCT00349752|565264230|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
156596802|NCT00349752|565264231|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
156596803|NCT03334396|565264232|FG000|Overall Study|Adverse Event|1|||
156596804|NCT03334396|565264233|FG001|Overall Study|Adverse Event|0|||
156596805|NCT03334396|565264234|FG002|Overall Study|Adverse Event|1|||
156596806|NCT03334396|565264235|FG003|Overall Study|Adverse Event|0|||
156596807|NCT03334396|565264236|FG004|Overall Study|Adverse Event|0|||
156596808|NCT03334396|565264237|FG005|Overall Study|Adverse Event|0|||
156596809|NCT03334396|565264238|FG006|Overall Study|Adverse Event|0|||
156596810|NCT03334396|565264239|FG007|Overall Study|Adverse Event|0|||
156596811|NCT03334396|565264232|FG000|Overall Study|Lack of Efficacy|10|||
156596812|NCT03334396|565264233|FG001|Overall Study|Lack of Efficacy|4|||
156596813|NCT03334396|565264234|FG002|Overall Study|Lack of Efficacy|1|||
156596814|NCT03334396|565264235|FG003|Overall Study|Lack of Efficacy|3|||
156596815|NCT03334396|565264236|FG004|Overall Study|Lack of Efficacy|1|||
156596816|NCT03334396|565264237|FG005|Overall Study|Lack of Efficacy|0|||
156596817|NCT03334396|565264238|FG006|Overall Study|Lack of Efficacy|0|||
156596818|NCT03334396|565264239|FG007|Overall Study|Lack of Efficacy|1|||
156596819|NCT03334396|565264232|FG000|Overall Study|Lost to Follow-up|0|||
156596820|NCT03334396|565264233|FG001|Overall Study|Lost to Follow-up|0|||
156596821|NCT03334396|565264234|FG002|Overall Study|Lost to Follow-up|1|||
156596822|NCT03334396|565264235|FG003|Overall Study|Lost to Follow-up|0|||
156596823|NCT03334396|565264236|FG004|Overall Study|Lost to Follow-up|0|||
156596824|NCT03334396|565264237|FG005|Overall Study|Lost to Follow-up|0|||
156596825|NCT03334396|565264238|FG006|Overall Study|Lost to Follow-up|1|||
156596826|NCT03334396|565264239|FG007|Overall Study|Lost to Follow-up|0|||
156596827|NCT03334396|565264232|FG000|Overall Study|Physician Decision|1|||
156596828|NCT03334396|565264233|FG001|Overall Study|Physician Decision|0|||
156596829|NCT03334396|565264234|FG002|Overall Study|Physician Decision|0|||
156596830|NCT03334396|565264235|FG003|Overall Study|Physician Decision|0|||
156596831|NCT03334396|565264236|FG004|Overall Study|Physician Decision|0|||
156596832|NCT03334396|565264237|FG005|Overall Study|Physician Decision|0|||
156596833|NCT03334396|565264238|FG006|Overall Study|Physician Decision|0|||
156596834|NCT03334396|565264239|FG007|Overall Study|Physician Decision|0|||
156596835|NCT03334396|565264232|FG000|Overall Study|Withdrawal by Subject|10|||
156596836|NCT03334396|565264233|FG001|Overall Study|Withdrawal by Subject|5|||
156596837|NCT03334396|565264234|FG002|Overall Study|Withdrawal by Subject|7|||
156596838|NCT03334396|565264235|FG003|Overall Study|Withdrawal by Subject|2|||
156596839|NCT03334396|565264236|FG004|Overall Study|Withdrawal by Subject|2|||
156596840|NCT03334396|565264237|FG005|Overall Study|Withdrawal by Subject|1|||
156596841|NCT03334396|565264238|FG006|Overall Study|Withdrawal by Subject|2|||
156596842|NCT03334396|565264239|FG007|Overall Study|Withdrawal by Subject|0|||
156596843|NCT03334396|565264232|FG000|Overall Study|Pregnancy|0|||
156596844|NCT03334396|565264233|FG001|Overall Study|Pregnancy|1|||
156596845|NCT03334396|565264234|FG002|Overall Study|Pregnancy|0|||
156596846|NCT03334396|565264235|FG003|Overall Study|Pregnancy|0|||
156596847|NCT03334396|565264236|FG004|Overall Study|Pregnancy|0|||
156596848|NCT03334396|565264237|FG005|Overall Study|Pregnancy|0|||
156596849|NCT03334396|565264238|FG006|Overall Study|Pregnancy|0|||
156596850|NCT03334396|565264239|FG007|Overall Study|Pregnancy|0|||
156596851|NCT03334396|565264232|FG000|Overall Study|Ineligible|0|||
156596852|NCT03334396|565264233|FG001|Overall Study|Ineligible|1|||
156596853|NCT03334396|565264234|FG002|Overall Study|Ineligible|0|||
156596854|NCT03334396|565264235|FG003|Overall Study|Ineligible|0|||
156596855|NCT03334396|565264236|FG004|Overall Study|Ineligible|0|||
156596856|NCT03334396|565264237|FG005|Overall Study|Ineligible|0|||
156596857|NCT03334396|565264238|FG006|Overall Study|Ineligible|0|||
156596858|NCT03334396|565264239|FG007|Overall Study|Ineligible|0|||
156596859|NCT03334396|565264232|FG000|Overall Study|Started New Job|1|||
156596860|NCT03334396|565264233|FG001|Overall Study|Started New Job|0|||
156596861|NCT03334396|565264234|FG002|Overall Study|Started New Job|0|||
156596862|NCT03334396|565264235|FG003|Overall Study|Started New Job|0|||
156596863|NCT03334396|565264236|FG004|Overall Study|Started New Job|0|||
156596864|NCT03334396|565264237|FG005|Overall Study|Started New Job|0|||
156596865|NCT03334396|565264238|FG006|Overall Study|Started New Job|0|||
156596866|NCT03334396|565264239|FG007|Overall Study|Started New Job|0|||
156596867|NCT05084053|565266543|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
156596868|NCT05084053|565266544|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
156596869|NCT05084053|565266545|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
156596870|NCT05084053|565266546|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
156596871|NCT05084053|565266543|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
156596872|NCT05084053|565266544|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
156596873|NCT05084053|565266545|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
156596874|NCT05084053|565266546|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
156596875|NCT05084053|565266543|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
156596876|NCT05084053|565266544|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
156596877|NCT05084053|565266545|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
156596878|NCT05084053|565266546|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
156596879|NCT02180724|565266547|FG000|Overall Study|Death|26|||
156596880|NCT02180724|565266548|FG001|Overall Study|Death|1|||
156596881|NCT02180724|565266547|FG000|Overall Study|Lost to Follow-up|3|||
156596882|NCT02180724|565266548|FG001|Overall Study|Lost to Follow-up|1|||
156596883|NCT02180724|565266547|FG000|Overall Study|Withdrawal by Subject|4|||
156596884|NCT02180724|565266548|FG001|Overall Study|Withdrawal by Subject|2|||
156596885|NCT02180724|565266547|FG000|Overall Study|PI Decision|5|||
156596886|NCT02180724|565266548|FG001|Overall Study|PI Decision|2|||
156596887|NCT02180724|565266547|FG000|Overall Study|Study terminated by sponsor|54|||
156596888|NCT02180724|565266548|FG001|Overall Study|Study terminated by sponsor|8|||
156596889|NCT01255306|565266549|FG000|Overall Study|Physician Decision|1|||
156596890|NCT01255306|565266550|FG001|Overall Study|Physician Decision|1|||
156596891|NCT01677624|565266551|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
156596892|NCT03363919|565266555|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
156596893|NCT03363919|565266556|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
156596894|NCT03363919|565266555|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
156596895|NCT03363919|565266556|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
156596896|NCT01975246|565266557|FG000|Overall Study|Adverse Event|2|||
156596897|NCT01975246|565266558|FG001|Overall Study|Adverse Event|1|||
156596898|NCT01975246|565266557|FG000|Overall Study|Lack of Efficacy|1|||
156596899|NCT01975246|565266558|FG001|Overall Study|Lack of Efficacy|0|||
156596900|NCT01975246|565266557|FG000|Overall Study|Protocol Violation|1|||
156596901|NCT01975246|565266558|FG001|Overall Study|Protocol Violation|0|||
156596902|NCT01975246|565266557|FG000|Overall Study|Other than stated|0|||
156596903|NCT01975246|565266558|FG001|Overall Study|Other than stated|1|||
156596904|NCT01646398|565266559|FG000|Overall Study|Withdrawal by Subject|1|||
156596905|NCT01646398|565266560|FG001|Overall Study|Withdrawal by Subject|0|||
156596906|NCT01263093|565266561|FG000|Washout|Physician Decision|1|||
156596907|NCT01263093|565266562|FG001|Washout|Physician Decision|0|||
156596908|NCT01263093|565266561|FG000|Period 2|Adverse Event|1|||
156596909|NCT01263093|565266562|FG001|Period 2|Adverse Event|0|||
156596910|NCT00571519|565266563|FG000|Overall Study|Subject withdrew consent|0|||
156596911|NCT00571519|565266564|FG001|Overall Study|Subject withdrew consent|1|||
156596912|NCT00571519|565266565|FG002|Overall Study|Subject withdrew consent|0|||
156596913|NCT00571519|565266566|FG003|Overall Study|Subject withdrew consent|2|||
156596914|NCT00571519|565266567|FG004|Overall Study|Subject withdrew consent|1|||
156596915|NCT00571519|565266568|FG005|Overall Study|Subject withdrew consent|1|||
156596916|NCT00571519|565266569|FG006|Overall Study|Subject withdrew consent|2|||
156596917|NCT00571519|565266563|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
156596918|NCT00571519|565266564|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
156596919|NCT00571519|565266565|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
156596920|NCT00571519|565266566|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
156596921|NCT00571519|565266567|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
156596922|NCT00571519|565266568|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
156596923|NCT00571519|565266569|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
156596924|NCT00571519|565266563|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
156596925|NCT00571519|565266564|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
156596926|NCT00571519|565266565|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
156596927|NCT00571519|565266566|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
156596928|NCT00571519|565266567|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
156596929|NCT00571519|565266568|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
156596930|NCT00571519|565266569|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
156596931|NCT00571519|565266563|FG000|Overall Study|Termination of study by Sponsor|2|||
156596932|NCT00571519|565266564|FG001|Overall Study|Termination of study by Sponsor|7|||
156596933|NCT00571519|565266565|FG002|Overall Study|Termination of study by Sponsor|10|||
156596934|NCT00571519|565266566|FG003|Overall Study|Termination of study by Sponsor|24|||
156596935|NCT00571519|565266567|FG004|Overall Study|Termination of study by Sponsor|8|||
156596936|NCT00571519|565266568|FG005|Overall Study|Termination of study by Sponsor|9|||
156596937|NCT00571519|565266569|FG006|Overall Study|Termination of study by Sponsor|22|||
156596938|NCT00571519|565266563|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
156596939|NCT00571519|565266564|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
156596940|NCT00571519|565266565|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
156596941|NCT00571519|565266566|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
156596942|NCT00571519|565266567|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
156596943|NCT00571519|565266568|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
156596944|NCT00571519|565266569|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
156596945|NCT05458011|565266570|FG000|DB Period (12 Weeks)|Adverse Event|2|||
156596946|NCT05458011|565266571|FG001|DB Period (12 Weeks)|Adverse Event|1|||
156596947|NCT05458011|565266572|FG002|DB Period (12 Weeks)|Adverse Event|1|||
156596948|NCT05458011|565266570|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
156596949|NCT05458011|565266571|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
156596950|NCT05458011|565266572|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
156596951|NCT05458011|565266570|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
156596952|NCT05458011|565266571|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
156596953|NCT05458011|565266572|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
156596954|NCT05458011|565266570|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
156596955|NCT05458011|565266571|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
156596956|NCT05458011|565266572|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
156596957|NCT05458011|565266570|FG000|OL Period (12 Weeks)|Adverse Event|1|||
156596958|NCT05458011|565266571|FG001|OL Period (12 Weeks)|Adverse Event|2|||
156596959|NCT05458011|565266572|FG002|OL Period (12 Weeks)|Adverse Event|1|||
156596960|NCT05458011|565266570|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
156596961|NCT05458011|565266571|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
156596962|NCT05458011|565266572|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
156596963|NCT00574119|565266573|FG000|Overall Study|Adverse Event|1|||
156596964|NCT00574119|565266573|FG000|Overall Study|Protocol Violation|1|||
156596965|NCT00574119|565266573|FG000|Overall Study|Withdrawal by Subject|1|||
156596966|NCT00574119|565266573|FG000|Overall Study|Physician Decision|1|||
156596967|NCT02690207|565266577|FG000|Overall Study|Lost to Follow-up|48|||
156596968|NCT02690207|565266577|FG000|Overall Study|Withdrawal by Subject|46|||
156596969|NCT02690207|565266577|FG000|Overall Study|Protocol Violation|2|||
156596970|NCT02690207|565266577|FG000|Overall Study|Serious adverse event|110|||
156596971|NCT02690207|565266577|FG000|Overall Study|Non-serious Adverse Event|18|||
156596972|NCT02690207|565266577|FG000|Overall Study|Migrated/moved from study area|5|||
156596973|NCT02690207|565266577|FG000|Overall Study|Suspected HZ Episode|1|||
156596974|NCT02690207|565266577|FG000|Overall Study|Other reasons for withdrawal|23|||
156596975|NCT04656418|565266578|FG000|Overall Study|Withdrawal by Subject|1|||
156596976|NCT04656418|565266579|FG001|Overall Study|Withdrawal by Subject|3|||
156596977|NCT02586077|565266580|FG000|Overall Study|Withdrawal by Subject|1|||
156596978|NCT02586077|565266580|FG000|Overall Study|Physician Decision|4|||
156596979|NCT02586077|565266580|FG000|Overall Study|Lost to Follow-up|3|||
156596980|NCT03287245|565266581|FG000|Overall Study|Study terminated by sponsor|3|||
156596981|NCT03287245|565266582|FG001|Overall Study|Study terminated by sponsor|0|||
156596982|NCT03287245|565266583|FG002|Overall Study|Study terminated by sponsor|3|||
156596983|NCT03287245|565266584|FG003|Overall Study|Study terminated by sponsor|1|||
156596984|NCT03287245|565266581|FG000|Overall Study|Adverse Event|1|||
156596985|NCT03287245|565266582|FG001|Overall Study|Adverse Event|0|||
156596986|NCT03287245|565266583|FG002|Overall Study|Adverse Event|0|||
156596987|NCT03287245|565266584|FG003|Overall Study|Adverse Event|0|||
156596988|NCT03287245|565266581|FG000|Overall Study|Withdrawal by Subject|8|||
156596989|NCT03287245|565266582|FG001|Overall Study|Withdrawal by Subject|3|||
156596990|NCT03287245|565266583|FG002|Overall Study|Withdrawal by Subject|3|||
156596991|NCT03287245|565266584|FG003|Overall Study|Withdrawal by Subject|0|||
156596992|NCT03287245|565266581|FG000|Overall Study|Physician Decision|3|||
156596993|NCT03287245|565266582|FG001|Overall Study|Physician Decision|2|||
156596994|NCT03287245|565266583|FG002|Overall Study|Physician Decision|0|||
156596995|NCT03287245|565266584|FG003|Overall Study|Physician Decision|0|||
156596996|NCT02701192|565266585|FG000|Overall Study|Protocol Violation|2|||
156596997|NCT02701192|565266585|FG000|Overall Study|Lost to Follow-up|4|||
156596998|NCT02862548|565266586|FG000|Randomized Phase (Up to Week 48)|Death|0|||
156596999|NCT02862548|565266587|FG001|Randomized Phase (Up to Week 48)|Death|1|||
156597000|NCT02862548|565266586|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
156597001|NCT02862548|565266587|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
156597002|NCT02862548|565266586|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
156597003|NCT02862548|565266587|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
156597004|NCT02862548|565266586|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
156597005|NCT02862548|565266587|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
156597006|NCT00880763|565266588|FG000|Extension Period (Part 2)|Adverse Event|0|||
156597007|NCT00880763|565266589|FG001|Extension Period (Part 2)|Adverse Event|0|||
156597008|NCT00880763|565266590|FG002|Extension Period (Part 2)|Adverse Event|1|||
156597009|NCT00880763|565266591|FG003|Extension Period (Part 2)|Adverse Event|1|||
156597010|NCT00880763|565266588|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
156597011|NCT00880763|565266589|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
156597012|NCT00880763|565266590|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
156597013|NCT00880763|565266591|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
156597014|NCT00880763|565266588|FG000|Extension Period (Part 2)|Physician Decision|0|||
156597015|NCT00880763|565266589|FG001|Extension Period (Part 2)|Physician Decision|1|||
156597016|NCT00880763|565266590|FG002|Extension Period (Part 2)|Physician Decision|1|||
156597017|NCT00880763|565266591|FG003|Extension Period (Part 2)|Physician Decision|0|||
156597018|NCT00880763|565266588|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
156597019|NCT00880763|565266589|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
156597020|NCT00880763|565266590|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
156597021|NCT00880763|565266591|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
156597022|NCT03434418|565266592|FG000|Overall Study|Disease Progression|11|||
156597023|NCT03434418|565266592|FG000|Overall Study|Adverse Event|2|||
156597024|NCT03434418|565266592|FG000|Overall Study|Physician Decision|1|||
156597025|NCT03434418|565266592|FG000|Overall Study|Decline in Performance Status (PS)|1|||
156597026|NCT01293006|565266595|FG000|Period 2|Lost to Follow-up|1|||
156597027|NCT01293006|565266596|FG001|Period 2|Lost to Follow-up|0|||
156597028|NCT01293006|565266597|FG002|Period 2|Lost to Follow-up|0|||
156597029|NCT01293006|565266598|FG003|Period 2|Lost to Follow-up|0|||
156597030|NCT02254551|565266599|FG000|Dose Escalation|Physician Decision|1|||
156597031|NCT02254551|565266599|FG000|Dose Escalation|Dose-limiting toxicity|2|||
156597032|NCT00205699|565266602|FG000|Overall Study|Lost to Follow-up|1|||
156597033|NCT00205699|565266603|FG001|Overall Study|Lost to Follow-up|3|||
156597034|NCT00205699|565266604|FG002|Overall Study|Lost to Follow-up|5|||
156597035|NCT00205699|565266602|FG000|Overall Study|Adverse Event|1|||
156597036|NCT00205699|565266603|FG001|Overall Study|Adverse Event|0|||
156597037|NCT00205699|565266604|FG002|Overall Study|Adverse Event|0|||
156597038|NCT00205699|565266602|FG000|Overall Study|Withdrawal by Subject|1|||
156597039|NCT00205699|565266603|FG001|Overall Study|Withdrawal by Subject|2|||
156597040|NCT00205699|565266604|FG002|Overall Study|Withdrawal by Subject|1|||
156597041|NCT00205699|565266602|FG000|Overall Study|Lack of Efficacy|0|||
156597042|NCT00205699|565266603|FG001|Overall Study|Lack of Efficacy|1|||
156597043|NCT00205699|565266604|FG002|Overall Study|Lack of Efficacy|0|||
156597044|NCT01885078|565266605|FG000|Treatment Period|Adverse Event|52|||
156597045|NCT01885078|565266606|FG001|Treatment Period|Adverse Event|136|||
156597046|NCT01885078|565266607|FG002|Treatment Period|Adverse Event|30|||
156597047|NCT01885078|565266608|FG003|Treatment Period|Adverse Event|73|||
156597048|NCT01885078|565266609|FG004|Treatment Period|Adverse Event|17|||
156597049|NCT01885078|565266610|FG005|Treatment Period|Adverse Event|72|||
156597050|NCT01885078|565266611|FG006|Treatment Period|Adverse Event|24|||
156597051|NCT01885078|565266612|FG007|Treatment Period|Adverse Event|5|||
156597052|NCT01885078|565266613|FG008|Treatment Period|Adverse Event|0|||
156597053|NCT01885078|565266614|FG009|Treatment Period|Adverse Event|0|||
156597054|NCT01885078|565266605|FG000|Treatment Period|Death|13|||
156597055|NCT01885078|565266606|FG001|Treatment Period|Death|33|||
156597056|NCT01885078|565266607|FG002|Treatment Period|Death|5|||
156597057|NCT01885078|565266608|FG003|Treatment Period|Death|9|||
156597058|NCT01885078|565266609|FG004|Treatment Period|Death|2|||
156597059|NCT01885078|565266610|FG005|Treatment Period|Death|10|||
156597060|NCT01885078|565266611|FG006|Treatment Period|Death|3|||
156597061|NCT01885078|565266612|FG007|Treatment Period|Death|2|||
156597062|NCT01885078|565266613|FG008|Treatment Period|Death|0|||
156597063|NCT01885078|565266614|FG009|Treatment Period|Death|0|||
156597064|NCT01885078|565266605|FG000|Treatment Period|Lack of Efficacy|12|||
156597065|NCT01885078|565266606|FG001|Treatment Period|Lack of Efficacy|33|||
156597066|NCT01885078|565266607|FG002|Treatment Period|Lack of Efficacy|10|||
156597067|NCT01885078|565266608|FG003|Treatment Period|Lack of Efficacy|23|||
156597068|NCT01885078|565266609|FG004|Treatment Period|Lack of Efficacy|24|||
156597069|NCT01885078|565266610|FG005|Treatment Period|Lack of Efficacy|58|||
156597070|NCT01885078|565266611|FG006|Treatment Period|Lack of Efficacy|9|||
156597071|NCT01885078|565266612|FG007|Treatment Period|Lack of Efficacy|5|||
156597072|NCT01885078|565266613|FG008|Treatment Period|Lack of Efficacy|0|||
156597073|NCT01885078|565266614|FG009|Treatment Period|Lack of Efficacy|0|||
156597074|NCT01885078|565266605|FG000|Treatment Period|Lost to Follow-up|16|||
156597075|NCT01885078|565266606|FG001|Treatment Period|Lost to Follow-up|19|||
156597076|NCT01885078|565266607|FG002|Treatment Period|Lost to Follow-up|7|||
156597077|NCT01885078|565266608|FG003|Treatment Period|Lost to Follow-up|9|||
156597078|NCT01885078|565266609|FG004|Treatment Period|Lost to Follow-up|2|||
156597079|NCT01885078|565266610|FG005|Treatment Period|Lost to Follow-up|8|||
156597080|NCT01885078|565266611|FG006|Treatment Period|Lost to Follow-up|2|||
156597081|NCT01885078|565266612|FG007|Treatment Period|Lost to Follow-up|0|||
156597082|NCT01885078|565266613|FG008|Treatment Period|Lost to Follow-up|0|||
156597083|NCT01885078|565266614|FG009|Treatment Period|Lost to Follow-up|0|||
156597084|NCT01885078|565266605|FG000|Treatment Period|Physician Decision|19|||
156597085|NCT01885078|565266606|FG001|Treatment Period|Physician Decision|21|||
156597086|NCT01885078|565266607|FG002|Treatment Period|Physician Decision|5|||
156597087|NCT01885078|565266608|FG003|Treatment Period|Physician Decision|12|||
156597088|NCT01885078|565266609|FG004|Treatment Period|Physician Decision|9|||
156597089|NCT01885078|565266610|FG005|Treatment Period|Physician Decision|24|||
156597090|NCT01885078|565266611|FG006|Treatment Period|Physician Decision|4|||
156597091|NCT01885078|565266612|FG007|Treatment Period|Physician Decision|3|||
156597092|NCT01885078|565266613|FG008|Treatment Period|Physician Decision|0|||
156597093|NCT01885078|565266614|FG009|Treatment Period|Physician Decision|0|||
156597094|NCT01885078|565266605|FG000|Treatment Period|Protocol Violation|3|||
156597095|NCT01885078|565266606|FG001|Treatment Period|Protocol Violation|5|||
156597096|NCT01885078|565266607|FG002|Treatment Period|Protocol Violation|0|||
156597097|NCT01885078|565266608|FG003|Treatment Period|Protocol Violation|3|||
156597098|NCT01885078|565266609|FG004|Treatment Period|Protocol Violation|1|||
156597099|NCT01885078|565266610|FG005|Treatment Period|Protocol Violation|6|||
156597100|NCT01885078|565266611|FG006|Treatment Period|Protocol Violation|0|||
156597101|NCT01885078|565266612|FG007|Treatment Period|Protocol Violation|0|||
156597102|NCT01885078|565266613|FG008|Treatment Period|Protocol Violation|0|||
156597103|NCT01885078|565266614|FG009|Treatment Period|Protocol Violation|0|||
156597104|NCT01885078|565266605|FG000|Treatment Period|Sponsor Decision|245|||
156597105|NCT01885078|565266606|FG001|Treatment Period|Sponsor Decision|648|||
156597106|NCT01885078|565266607|FG002|Treatment Period|Sponsor Decision|49|||
156597107|NCT01885078|565266608|FG003|Treatment Period|Sponsor Decision|90|||
156597108|NCT01885078|565266609|FG004|Treatment Period|Sponsor Decision|20|||
156597109|NCT01885078|565266610|FG005|Treatment Period|Sponsor Decision|38|||
156597110|NCT01885078|565266611|FG006|Treatment Period|Sponsor Decision|162|||
156597111|NCT01885078|565266612|FG007|Treatment Period|Sponsor Decision|3|||
156597112|NCT01885078|565266613|FG008|Treatment Period|Sponsor Decision|0|||
156597113|NCT01885078|565266614|FG009|Treatment Period|Sponsor Decision|0|||
156597114|NCT01885078|565266605|FG000|Treatment Period|Withdrawal by Subject|72|||
156597115|NCT01885078|565266606|FG001|Treatment Period|Withdrawal by Subject|132|||
156597116|NCT01885078|565266607|FG002|Treatment Period|Withdrawal by Subject|25|||
156597117|NCT01885078|565266608|FG003|Treatment Period|Withdrawal by Subject|63|||
156597118|NCT01885078|565266609|FG004|Treatment Period|Withdrawal by Subject|15|||
156597119|NCT01885078|565266610|FG005|Treatment Period|Withdrawal by Subject|34|||
156597120|NCT01885078|565266611|FG006|Treatment Period|Withdrawal by Subject|17|||
156597121|NCT01885078|565266612|FG007|Treatment Period|Withdrawal by Subject|10|||
156597122|NCT01885078|565266613|FG008|Treatment Period|Withdrawal by Subject|0|||
156597123|NCT01885078|565266614|FG009|Treatment Period|Withdrawal by Subject|0|||
156597124|NCT01885078|565266605|FG000|Treatment Period|Other|0|||
156597125|NCT01885078|565266606|FG001|Treatment Period|Other|0|||
156597126|NCT01885078|565266607|FG002|Treatment Period|Other|0|||
156597127|NCT01885078|565266608|FG003|Treatment Period|Other|1|||
156597128|NCT01885078|565266609|FG004|Treatment Period|Other|0|||
156597129|NCT01885078|565266610|FG005|Treatment Period|Other|0|||
156597130|NCT01885078|565266611|FG006|Treatment Period|Other|0|||
156597131|NCT01885078|565266612|FG007|Treatment Period|Other|0|||
156597132|NCT01885078|565266613|FG008|Treatment Period|Other|0|||
156597133|NCT01885078|565266614|FG009|Treatment Period|Other|0|||
156597134|NCT01885078|565266605|FG000|Step-down Period|Sponsor Decision|0|||
156597135|NCT01885078|565266606|FG001|Step-down Period|Sponsor Decision|0|||
156597136|NCT01885078|565266607|FG002|Step-down Period|Sponsor Decision|0|||
156597137|NCT01885078|565266608|FG003|Step-down Period|Sponsor Decision|0|||
156597138|NCT01885078|565266609|FG004|Step-down Period|Sponsor Decision|0|||
156597139|NCT01885078|565266610|FG005|Step-down Period|Sponsor Decision|0|||
156597140|NCT01885078|565266611|FG006|Step-down Period|Sponsor Decision|0|||
156597141|NCT01885078|565266612|FG007|Step-down Period|Sponsor Decision|0|||
156597142|NCT01885078|565266613|FG008|Step-down Period|Sponsor Decision|1|||
156597143|NCT01885078|565266614|FG009|Step-down Period|Sponsor Decision|1|||
156597144|NCT01885078|565266605|FG000|Step-down Period|Adverse Event|0|||
156597145|NCT01885078|565266606|FG001|Step-down Period|Adverse Event|0|||
156597146|NCT01885078|565266607|FG002|Step-down Period|Adverse Event|0|||
156597147|NCT01885078|565266608|FG003|Step-down Period|Adverse Event|0|||
156597148|NCT01885078|565266609|FG004|Step-down Period|Adverse Event|0|||
156597149|NCT01885078|565266610|FG005|Step-down Period|Adverse Event|0|||
156597150|NCT01885078|565266611|FG006|Step-down Period|Adverse Event|0|||
156597151|NCT01885078|565266612|FG007|Step-down Period|Adverse Event|0|||
156597152|NCT01885078|565266613|FG008|Step-down Period|Adverse Event|29|||
156597153|NCT01885078|565266614|FG009|Step-down Period|Adverse Event|38|||
156597154|NCT01885078|565266605|FG000|Step-down Period|Withdrawal by Subject|0|||
156597155|NCT01885078|565266606|FG001|Step-down Period|Withdrawal by Subject|0|||
156597156|NCT01885078|565266607|FG002|Step-down Period|Withdrawal by Subject|0|||
156597157|NCT01885078|565266608|FG003|Step-down Period|Withdrawal by Subject|0|||
156597158|NCT01885078|565266609|FG004|Step-down Period|Withdrawal by Subject|0|||
156597159|NCT01885078|565266610|FG005|Step-down Period|Withdrawal by Subject|0|||
156597160|NCT01885078|565266611|FG006|Step-down Period|Withdrawal by Subject|0|||
156597161|NCT01885078|565266612|FG007|Step-down Period|Withdrawal by Subject|0|||
156597162|NCT01885078|565266613|FG008|Step-down Period|Withdrawal by Subject|25|||
156597163|NCT01885078|565266614|FG009|Step-down Period|Withdrawal by Subject|15|||
156597164|NCT01885078|565266605|FG000|Step-down Period|Physician Decision|0|||
156597165|NCT01885078|565266606|FG001|Step-down Period|Physician Decision|0|||
156597166|NCT01885078|565266607|FG002|Step-down Period|Physician Decision|0|||
156597167|NCT01885078|565266608|FG003|Step-down Period|Physician Decision|0|||
156597168|NCT01885078|565266609|FG004|Step-down Period|Physician Decision|0|||
156597169|NCT01885078|565266610|FG005|Step-down Period|Physician Decision|0|||
156597170|NCT01885078|565266611|FG006|Step-down Period|Physician Decision|0|||
156597171|NCT01885078|565266612|FG007|Step-down Period|Physician Decision|0|||
156597172|NCT01885078|565266613|FG008|Step-down Period|Physician Decision|7|||
156597173|NCT01885078|565266614|FG009|Step-down Period|Physician Decision|2|||
156597174|NCT01885078|565266605|FG000|Step-down Period|Death|0|||
156597175|NCT01885078|565266606|FG001|Step-down Period|Death|0|||
156597176|NCT01885078|565266607|FG002|Step-down Period|Death|0|||
156597177|NCT01885078|565266608|FG003|Step-down Period|Death|0|||
156597178|NCT01885078|565266609|FG004|Step-down Period|Death|0|||
156597179|NCT01885078|565266610|FG005|Step-down Period|Death|0|||
156597180|NCT01885078|565266611|FG006|Step-down Period|Death|0|||
156597181|NCT01885078|565266612|FG007|Step-down Period|Death|0|||
156597182|NCT01885078|565266613|FG008|Step-down Period|Death|4|||
156597183|NCT01885078|565266614|FG009|Step-down Period|Death|3|||
156597184|NCT01885078|565266605|FG000|Step-down Period|Lost to Follow-up|0|||
156597185|NCT01885078|565266606|FG001|Step-down Period|Lost to Follow-up|0|||
156597186|NCT01885078|565266607|FG002|Step-down Period|Lost to Follow-up|0|||
156597187|NCT01885078|565266608|FG003|Step-down Period|Lost to Follow-up|0|||
156597188|NCT01885078|565266609|FG004|Step-down Period|Lost to Follow-up|0|||
156597189|NCT01885078|565266610|FG005|Step-down Period|Lost to Follow-up|0|||
156597190|NCT01885078|565266611|FG006|Step-down Period|Lost to Follow-up|0|||
156597191|NCT01885078|565266612|FG007|Step-down Period|Lost to Follow-up|0|||
156597192|NCT01885078|565266613|FG008|Step-down Period|Lost to Follow-up|1|||
156597193|NCT01885078|565266614|FG009|Step-down Period|Lost to Follow-up|1|||
156597194|NCT01885078|565266605|FG000|Step-down Period|Lack of Efficacy|0|||
156597195|NCT01885078|565266606|FG001|Step-down Period|Lack of Efficacy|0|||
156597196|NCT01885078|565266607|FG002|Step-down Period|Lack of Efficacy|0|||
156597197|NCT01885078|565266608|FG003|Step-down Period|Lack of Efficacy|0|||
156597198|NCT01885078|565266609|FG004|Step-down Period|Lack of Efficacy|0|||
156597199|NCT01885078|565266610|FG005|Step-down Period|Lack of Efficacy|0|||
156597200|NCT01885078|565266611|FG006|Step-down Period|Lack of Efficacy|0|||
156597201|NCT01885078|565266612|FG007|Step-down Period|Lack of Efficacy|0|||
156597202|NCT01885078|565266613|FG008|Step-down Period|Lack of Efficacy|1|||
156597203|NCT01885078|565266614|FG009|Step-down Period|Lack of Efficacy|0|||
156597204|NCT01885078|565266605|FG000|Step-down Period|Protocol Violation|0|||
156597205|NCT01885078|565266606|FG001|Step-down Period|Protocol Violation|0|||
156597206|NCT01885078|565266607|FG002|Step-down Period|Protocol Violation|0|||
156597207|NCT01885078|565266608|FG003|Step-down Period|Protocol Violation|0|||
156597208|NCT01885078|565266609|FG004|Step-down Period|Protocol Violation|0|||
156597209|NCT01885078|565266610|FG005|Step-down Period|Protocol Violation|0|||
156597210|NCT01885078|565266611|FG006|Step-down Period|Protocol Violation|0|||
156597211|NCT01885078|565266612|FG007|Step-down Period|Protocol Violation|0|||
156597212|NCT01885078|565266613|FG008|Step-down Period|Protocol Violation|1|||
156597213|NCT01885078|565266614|FG009|Step-down Period|Protocol Violation|1|||
156597214|NCT00571688|565266618|FG000|Overall Study|Lost to Follow-up|3|||
156597215|NCT00571688|565266619|FG001|Overall Study|Lost to Follow-up|6|||
156597216|NCT00571688|565266618|FG000|Overall Study|subject did not tolerate Consta|1|||
156597217|NCT00571688|565266619|FG001|Overall Study|subject did not tolerate Consta|0|||
156597218|NCT00571688|565266618|FG000|Overall Study|subject moved out of the area|1|||
156597219|NCT00571688|565266619|FG001|Overall Study|subject moved out of the area|0|||
156597220|NCT01194869|565266620|FG000|Overall Study|Disease Progression|2|||
156597221|NCT01194869|565266620|FG000|Overall Study|Toxicity|2|||
156597222|NCT01048853|565266621|FG000|Overall Study|Death|1|||
156597223|NCT01048853|565266622|FG001|Overall Study|Death|0|||
156597224|NCT01048853|565266623|FG002|Overall Study|Death|0|||
156597225|NCT01048853|565266621|FG000|Overall Study|Lost to Follow-up|1|||
156597226|NCT01048853|565266622|FG001|Overall Study|Lost to Follow-up|4|||
156597227|NCT01048853|565266623|FG002|Overall Study|Lost to Follow-up|0|||
156597228|NCT06964165|565266627|FG000|Overall Study|Death|4|||
156597229|NCT06964165|565266628|FG001|Overall Study|Death|4|||
156597230|NCT06964165|565266627|FG000|Overall Study|Physician Decision|1|||
156597231|NCT06964165|565266628|FG001|Overall Study|Physician Decision|1|||
156597232|NCT06964165|565266627|FG000|Overall Study|Withdrawal by Subject|0|||
156597233|NCT06964165|565266628|FG001|Overall Study|Withdrawal by Subject|2|||
156597234|NCT06964165|565266627|FG000|Overall Study|Study terminated by sponsor|12|||
156597235|NCT06964165|565266628|FG001|Overall Study|Study terminated by sponsor|10|||
156597236|NCT06964165|565266627|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
156597237|NCT06964165|565266628|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
156597238|NCT06964165|565266627|FG000|Overall Study|Participant removed due to non-compliance|0|||
156597239|NCT06964165|565266628|FG001|Overall Study|Participant removed due to non-compliance|1|||
156597240|NCT03224104|565266634|FG000|Overall Study|Lack of Efficacy|2|||
156597241|NCT03224104|565266635|FG001|Overall Study|Lack of Efficacy|6|||
156597242|NCT03224104|565266636|FG002|Overall Study|Lack of Efficacy|3|||
156597243|NCT03224104|565266637|FG003|Overall Study|Lack of Efficacy|4|||
156597244|NCT03224104|565266638|FG004|Overall Study|Lack of Efficacy|42|||
156597245|NCT03224104|565266634|FG000|Overall Study|Withdrawal by Subject|0|||
156597246|NCT03224104|565266635|FG001|Overall Study|Withdrawal by Subject|2|||
156597247|NCT03224104|565266636|FG002|Overall Study|Withdrawal by Subject|0|||
156597248|NCT03224104|565266637|FG003|Overall Study|Withdrawal by Subject|1|||
156597249|NCT03224104|565266638|FG004|Overall Study|Withdrawal by Subject|3|||
156597250|NCT03224104|565266634|FG000|Overall Study|Death|0|||
156597251|NCT03224104|565266635|FG001|Overall Study|Death|1|||
156597252|NCT03224104|565266636|FG002|Overall Study|Death|0|||
156597253|NCT03224104|565266637|FG003|Overall Study|Death|0|||
156597254|NCT03224104|565266638|FG004|Overall Study|Death|0|||
156597255|NCT03224104|565266634|FG000|Overall Study|Adverse Event|1|||
156597256|NCT03224104|565266635|FG001|Overall Study|Adverse Event|0|||
156597257|NCT03224104|565266636|FG002|Overall Study|Adverse Event|0|||
156597258|NCT03224104|565266637|FG003|Overall Study|Adverse Event|1|||
156597259|NCT03224104|565266638|FG004|Overall Study|Adverse Event|3|||
156597260|NCT03224104|565266634|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
156597261|NCT03224104|565266635|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
156597262|NCT03224104|565266636|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
156597263|NCT03224104|565266637|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
156597264|NCT03224104|565266638|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
156597265|NCT03224104|565266634|FG000|Overall Study|Treatment ongoing|0|||
156597266|NCT03224104|565266635|FG001|Overall Study|Treatment ongoing|0|||
156597267|NCT03224104|565266636|FG002|Overall Study|Treatment ongoing|0|||
156597268|NCT03224104|565266637|FG003|Overall Study|Treatment ongoing|0|||
156597269|NCT03224104|565266638|FG004|Overall Study|Treatment ongoing|1|||
156597270|NCT01153893|565266648|FG000|Overall Study|Adverse Event|1|||
156597271|NCT01153893|565266649|FG001|Overall Study|Adverse Event|0|||
156597272|NCT04799405|565266650|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
156597273|NCT05294211|565266654|FG000|Overall Study|Withdrawal by Subject|3|||
156597274|NCT05294211|565266654|FG000|Overall Study|Physician Decision|2|||
156597275|NCT05294211|565266654|FG000|Overall Study|Progressed to active labor|1|||
156597276|NCT05294211|565266654|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
156597277|NCT05294211|565266654|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
156597278|NCT01842607|565266656|FG000|Overall Study|Adverse Event|11|||
156597279|NCT01842607|565266656|FG000|Overall Study|Lack of Efficacy|19|||
156597280|NCT01842607|565266656|FG000|Overall Study|Protocol Violation|8|||
156597281|NCT01842607|565266656|FG000|Overall Study|Protocol defined stopping criteria|2|||
156597282|NCT01842607|565266656|FG000|Overall Study|Lost to Follow-up|3|||
156597283|NCT01842607|565266656|FG000|Overall Study|Physician Decision|9|||
156597284|NCT01842607|565266656|FG000|Overall Study|Withdrawal by Subject|14|||
156597285|NCT00012012|565266659|FG000|Overall Study|Protocol Violation|1|||
156597286|NCT00012012|565266660|FG001|Overall Study|Protocol Violation|1|||
156597287|NCT00012012|565266659|FG000|Overall Study|Withdrawal by Subject|0|||
156597288|NCT00012012|565266660|FG001|Overall Study|Withdrawal by Subject|2|||
156597289|NCT02159469|565266661|FG000|Overall Study|Missing Completion status|1|||
156597290|NCT02159469|565266661|FG000|Overall Study|Adverse Event|5|||
156597291|NCT02159469|565266661|FG000|Overall Study|Non-compliance|2|||
156597292|NCT02159469|565266661|FG000|Overall Study|Withdrawal by Subject|9|||
156597293|NCT02159469|565266661|FG000|Overall Study|Lost to Follow-up|1|||
156597294|NCT02159469|565266661|FG000|Overall Study|Sponsor's request|2|||
156597295|NCT02159469|565266661|FG000|Overall Study|Met Stopping Criteria|3|||
156597296|NCT02159469|565266661|FG000|Overall Study|Other|1|||
156597297|NCT02159469|565266661|FG000|Overall Study|Multiple|29|||
156597298|NCT02034474|565266662|FG000|Overall Study|Adverse Event|3|||
156597299|NCT02034474|565266663|FG001|Overall Study|Adverse Event|2|||
156597300|NCT02034474|565266662|FG000|Overall Study|Withdrawal by Subject|1|||
156597301|NCT02034474|565266663|FG001|Overall Study|Withdrawal by Subject|2|||
156597302|NCT03629041|565266669|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
156863677|NCT05194124|566258761|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156597303|NCT03629041|565266670|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
156597304|NCT03629041|565266671|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
156597305|NCT03629041|565266672|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
156597306|NCT01391819|565266673|FG000|Overall Study|Withdrawal by Subject|56|||
156597307|NCT01391819|565266673|FG000|Overall Study|Migrated/moved from study area|82|||
156597308|NCT01391819|565266673|FG000|Overall Study|Lost to Follow-up|252|||
156597309|NCT01391819|565266673|FG000|Overall Study|Death|3|||
156597310|NCT01391819|565266673|FG000|Overall Study|Other|9|||
156597311|NCT03730194|565266675|FG000|First Stage Treatment|Withdrawal by Subject|1|||
156597312|NCT03730194|565266676|FG001|First Stage Treatment|Withdrawal by Subject|1|||
156597313|NCT03730194|565266677|FG002|First Stage Treatment|Withdrawal by Subject|0|||
156597314|NCT03730194|565266678|FG003|First Stage Treatment|Withdrawal by Subject|0|||
156597315|NCT03730194|565266679|FG004|First Stage Treatment|Withdrawal by Subject|0|||
156597316|NCT03730194|565266680|FG005|First Stage Treatment|Withdrawal by Subject|0|||
156597317|NCT03730194|565266675|FG000|First Stage Treatment|Protocol Violation|3|||
156597318|NCT03730194|565266676|FG001|First Stage Treatment|Protocol Violation|3|||
156597319|NCT03730194|565266677|FG002|First Stage Treatment|Protocol Violation|0|||
156597320|NCT03730194|565266678|FG003|First Stage Treatment|Protocol Violation|0|||
156597321|NCT03730194|565266679|FG004|First Stage Treatment|Protocol Violation|0|||
156597322|NCT03730194|565266680|FG005|First Stage Treatment|Protocol Violation|0|||
156597323|NCT03814590|565266685|FG000|Overall Study|Adverse Event|0|||
156597324|NCT03814590|565266686|FG001|Overall Study|Adverse Event|0|||
156597325|NCT03814590|565266687|FG002|Overall Study|Adverse Event|0|||
156597326|NCT03814590|565266688|FG003|Overall Study|Adverse Event|0|||
156597327|NCT03814590|565266689|FG004|Overall Study|Adverse Event|0|||
156597328|NCT03814590|565266690|FG005|Overall Study|Adverse Event|1|||
156597329|NCT03814590|565266691|FG006|Overall Study|Adverse Event|1|||
156597330|NCT03814590|565266692|FG007|Overall Study|Adverse Event|1|||
156597331|NCT03814590|565266693|FG008|Overall Study|Adverse Event|0|||
156597332|NCT03814590|565266694|FG009|Overall Study|Adverse Event|0|||
156597333|NCT03814590|565266695|FG010|Overall Study|Adverse Event|1|||
156597334|NCT03814590|565266696|FG011|Overall Study|Adverse Event|0|||
156597335|NCT03814590|565266697|FG012|Overall Study|Adverse Event|3|||
156597336|NCT03814590|565266698|FG013|Overall Study|Adverse Event|0|||
156597337|NCT03814590|565266685|FG000|Overall Study|Lost to Follow-up|0|||
156597338|NCT03814590|565266686|FG001|Overall Study|Lost to Follow-up|2|||
156597339|NCT03814590|565266687|FG002|Overall Study|Lost to Follow-up|1|||
156597340|NCT03814590|565266688|FG003|Overall Study|Lost to Follow-up|0|||
156597341|NCT03814590|565266689|FG004|Overall Study|Lost to Follow-up|1|||
156597342|NCT03814590|565266690|FG005|Overall Study|Lost to Follow-up|1|||
156597343|NCT03814590|565266691|FG006|Overall Study|Lost to Follow-up|1|||
156597344|NCT03814590|565266692|FG007|Overall Study|Lost to Follow-up|1|||
156597345|NCT03814590|565266693|FG008|Overall Study|Lost to Follow-up|0|||
156597346|NCT03814590|565266694|FG009|Overall Study|Lost to Follow-up|0|||
156597347|NCT03814590|565266695|FG010|Overall Study|Lost to Follow-up|1|||
156597348|NCT03814590|565266696|FG011|Overall Study|Lost to Follow-up|0|||
156597349|NCT03814590|565266697|FG012|Overall Study|Lost to Follow-up|0|||
156597350|NCT03814590|565266698|FG013|Overall Study|Lost to Follow-up|1|||
156597351|NCT03814590|565266685|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597352|NCT03814590|565266686|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597353|NCT03814590|565266687|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597354|NCT03814590|565266688|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597355|NCT03814590|565266689|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597356|NCT03814590|565266690|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597357|NCT03814590|565266691|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597358|NCT03814590|565266692|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597359|NCT03814590|565266693|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597360|NCT03814590|565266694|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
156597361|NCT03814590|565266695|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597362|NCT03814590|565266696|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597363|NCT03814590|565266697|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597364|NCT03814590|565266698|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156597365|NCT03814590|565266685|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
156597366|NCT03814590|565266686|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
156597367|NCT03814590|565266687|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
156597368|NCT03814590|565266688|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
156597369|NCT03814590|565266689|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
156597370|NCT03814590|565266690|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
156597371|NCT03814590|565266691|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
156597372|NCT03814590|565266692|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
156597373|NCT03814590|565266693|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
156597374|NCT03814590|565266694|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
156597375|NCT03814590|565266695|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
156597376|NCT03814590|565266696|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
156597377|NCT03814590|565266697|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
156597378|NCT03814590|565266698|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
156597379|NCT03814590|565266685|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597380|NCT03814590|565266686|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597381|NCT03814590|565266687|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597382|NCT03814590|565266688|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597383|NCT03814590|565266689|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597384|NCT03814590|565266690|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597385|NCT03814590|565266691|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597386|NCT03814590|565266692|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156597387|NCT03814590|565266693|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597388|NCT03814590|565266694|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156597389|NCT03814590|565266695|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597390|NCT03814590|565266696|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597391|NCT03814590|565266697|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597392|NCT03814590|565266698|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156597393|NCT03814590|565266685|FG000|Overall Study|UNKNOWN REASON|0|||
156597394|NCT03814590|565266686|FG001|Overall Study|UNKNOWN REASON|0|||
156597395|NCT03814590|565266687|FG002|Overall Study|UNKNOWN REASON|0|||
156597396|NCT03814590|565266688|FG003|Overall Study|UNKNOWN REASON|0|||
156597397|NCT03814590|565266689|FG004|Overall Study|UNKNOWN REASON|0|||
156597398|NCT03814590|565266690|FG005|Overall Study|UNKNOWN REASON|0|||
156597399|NCT03814590|565266691|FG006|Overall Study|UNKNOWN REASON|0|||
156597400|NCT03814590|565266692|FG007|Overall Study|UNKNOWN REASON|1|||
156597401|NCT03814590|565266693|FG008|Overall Study|UNKNOWN REASON|0|||
156597402|NCT03814590|565266694|FG009|Overall Study|UNKNOWN REASON|0|||
156597403|NCT03814590|565266695|FG010|Overall Study|UNKNOWN REASON|0|||
156597404|NCT03814590|565266696|FG011|Overall Study|UNKNOWN REASON|0|||
156597405|NCT03814590|565266697|FG012|Overall Study|UNKNOWN REASON|0|||
156597406|NCT03814590|565266698|FG013|Overall Study|UNKNOWN REASON|0|||
156597407|NCT01244191|565266699|FG000|Overall Study|Progressive disease|295|||
156597408|NCT01244191|565266700|FG001|Overall Study|Progressive disease|350|||
156597409|NCT01244191|565266699|FG000|Overall Study|Clinical disease progression|54|||
156597410|NCT01244191|565266700|FG001|Overall Study|Clinical disease progression|36|||
156597411|NCT01244191|565266699|FG000|Overall Study|Adverse Event|65|||
156597412|NCT01244191|565266700|FG001|Overall Study|Adverse Event|48|||
156597413|NCT01244191|565266699|FG000|Overall Study|Death|22|||
156597414|NCT01244191|565266700|FG001|Overall Study|Death|29|||
156597415|NCT01244191|565266699|FG000|Overall Study|Lost to Follow-up|0|||
156597416|NCT01244191|565266700|FG001|Overall Study|Lost to Follow-up|2|||
156597417|NCT01244191|565266699|FG000|Overall Study|Protocol Violation|1|||
156597418|NCT01244191|565266700|FG001|Overall Study|Protocol Violation|2|||
156597419|NCT01244191|565266699|FG000|Overall Study|Withdrawal by Subject|31|||
156597420|NCT01244191|565266700|FG001|Overall Study|Withdrawal by Subject|23|||
156597421|NCT01244191|565266699|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
156597422|NCT01244191|565266700|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
156597423|NCT01752842|565266701|FG000|Overall Study|Adverse Event|3|||
156597424|NCT01752842|565266702|FG001|Overall Study|Adverse Event|0|||
156597425|NCT01752842|565266701|FG000|Overall Study|Withdrawal by Subject|0|||
156597426|NCT01752842|565266702|FG001|Overall Study|Withdrawal by Subject|2|||
156597427|NCT02164513|565266703|FG000|Overall Study|Adverse Event|162|||
156597428|NCT02164513|565266704|FG001|Overall Study|Adverse Event|180|||
156597429|NCT02164513|565266705|FG002|Overall Study|Adverse Event|111|||
156597430|NCT02164513|565266703|FG000|Overall Study|Other: Study Closed or terminated|5|||
156597431|NCT02164513|565266704|FG001|Overall Study|Other: Study Closed or terminated|2|||
156597432|NCT02164513|565266705|FG002|Overall Study|Other: Study Closed or terminated|4|||
156597433|NCT02164513|565266703|FG000|Overall Study|Lost to Follow-up|30|||
156597434|NCT02164513|565266704|FG001|Overall Study|Lost to Follow-up|36|||
156597435|NCT02164513|565266705|FG002|Overall Study|Lost to Follow-up|22|||
156597436|NCT02164513|565266703|FG000|Overall Study|Physician Decision|47|||
156597437|NCT02164513|565266704|FG001|Overall Study|Physician Decision|57|||
156597438|NCT02164513|565266705|FG002|Overall Study|Physician Decision|28|||
156597439|NCT02164513|565266703|FG000|Overall Study|Withdrawal by Subject|192|||
156597440|NCT02164513|565266704|FG001|Overall Study|Withdrawal by Subject|261|||
156597441|NCT02164513|565266705|FG002|Overall Study|Withdrawal by Subject|130|||
156597442|NCT02164513|565266703|FG000|Overall Study|Other: Reason not provided by site|1|||
156597443|NCT02164513|565266704|FG001|Overall Study|Other: Reason not provided by site|0|||
156597444|NCT02164513|565266705|FG002|Overall Study|Other: Reason not provided by site|0|||
156597445|NCT05584202|565266707|FG000|Overall Study|Withdrawal of Consent|3|||
156597446|NCT05584202|565266708|FG001|Overall Study|Withdrawal of Consent|2|||
156597447|NCT05584202|565266707|FG000|Overall Study|Lost to Follow-up|2|||
156597448|NCT05584202|565266708|FG001|Overall Study|Lost to Follow-up|1|||
156597449|NCT05584202|565266707|FG000|Overall Study|Death|0|||
156597450|NCT05584202|565266708|FG001|Overall Study|Death|1|||
156597451|NCT05301322|565266709|FG000|Overall Study|Adverse Event|7|||
156597452|NCT05301322|565266710|FG001|Overall Study|Adverse Event|3|||
156597453|NCT05301322|565266709|FG000|Overall Study|Death|0|||
156597454|NCT05301322|565266710|FG001|Overall Study|Death|1|||
156597455|NCT05301322|565266709|FG000|Overall Study|Lost to Follow-up|2|||
156597456|NCT05301322|565266710|FG001|Overall Study|Lost to Follow-up|1|||
156597457|NCT05301322|565266709|FG000|Overall Study|Protocol Violation|3|||
156597458|NCT05301322|565266710|FG001|Overall Study|Protocol Violation|1|||
156597459|NCT05301322|565266709|FG000|Overall Study|Withdrawal by Subject|3|||
156597460|NCT05301322|565266710|FG001|Overall Study|Withdrawal by Subject|0|||
156597461|NCT05301322|565266709|FG000|Overall Study|Other|4|||
156597462|NCT05301322|565266710|FG001|Overall Study|Other|0|||
156597463|NCT04971785|565266711|FG000|Overall Study|Withdrew Consent|5|||
156597464|NCT04971785|565266712|FG001|Overall Study|Withdrew Consent|5|||
156597465|NCT04971785|565266713|FG002|Overall Study|Withdrew Consent|17|||
156597466|NCT04971785|565266714|FG003|Overall Study|Withdrew Consent|7|||
156597467|NCT04971785|565266711|FG000|Overall Study|Adverse Event|7|||
156597468|NCT04971785|565266712|FG001|Overall Study|Adverse Event|8|||
156597469|NCT04971785|565266713|FG002|Overall Study|Adverse Event|6|||
156597470|NCT04971785|565266714|FG003|Overall Study|Adverse Event|3|||
156597471|NCT04971785|565266711|FG000|Overall Study|Lost to Follow-up|2|||
156597472|NCT04971785|565266712|FG001|Overall Study|Lost to Follow-up|1|||
156597473|NCT04971785|565266713|FG002|Overall Study|Lost to Follow-up|6|||
156597474|NCT04971785|565266714|FG003|Overall Study|Lost to Follow-up|7|||
156597475|NCT04971785|565266711|FG000|Overall Study|Protocol Violation|3|||
156597476|NCT04971785|565266712|FG001|Overall Study|Protocol Violation|1|||
156597477|NCT04971785|565266713|FG002|Overall Study|Protocol Violation|1|||
156597478|NCT04971785|565266714|FG003|Overall Study|Protocol Violation|2|||
156597479|NCT04971785|565266711|FG000|Overall Study|Investigator's Discretion|3|||
156597480|NCT04971785|565266712|FG001|Overall Study|Investigator's Discretion|1|||
156597481|NCT04971785|565266713|FG002|Overall Study|Investigator's Discretion|1|||
156597482|NCT04971785|565266714|FG003|Overall Study|Investigator's Discretion|0|||
156597483|NCT04971785|565266711|FG000|Overall Study|Randomized but Never Treated|1|||
156597484|NCT04971785|565266712|FG001|Overall Study|Randomized but Never Treated|2|||
156597485|NCT04971785|565266713|FG002|Overall Study|Randomized but Never Treated|0|||
156597486|NCT04971785|565266714|FG003|Overall Study|Randomized but Never Treated|1|||
156597487|NCT04971785|565266711|FG000|Overall Study|Death|0|||
156597488|NCT04971785|565266712|FG001|Overall Study|Death|1|||
156597489|NCT04971785|565266713|FG002|Overall Study|Death|1|||
156597490|NCT04971785|565266714|FG003|Overall Study|Death|0|||
156597491|NCT04971785|565266711|FG000|Overall Study|Site Terminated by Sponsor|1|||
156597492|NCT04971785|565266712|FG001|Overall Study|Site Terminated by Sponsor|1|||
156597493|NCT04971785|565266713|FG002|Overall Study|Site Terminated by Sponsor|0|||
156597494|NCT04971785|565266714|FG003|Overall Study|Site Terminated by Sponsor|0|||
156597495|NCT01179347|565268781|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
156597496|NCT01179347|565268782|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
156597497|NCT01179347|565268781|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
156597498|NCT01179347|565268782|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
156597499|NCT01179347|565268781|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
156597500|NCT01179347|565268782|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
156597501|NCT01179347|565268781|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
156597502|NCT01179347|565268782|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
156597503|NCT01179347|565268781|FG000|Double-blind Period (12 Weeks)|Other|2|||
156597504|NCT01179347|565268782|FG001|Double-blind Period (12 Weeks)|Other|4|||
156597505|NCT01179347|565268781|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
156597506|NCT01179347|565268782|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
156597507|NCT01179347|565268781|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
156597508|NCT01179347|565268782|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
156597509|NCT01179347|565268781|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
156597510|NCT01179347|565268782|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
156597511|NCT01179347|565268781|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
156597512|NCT01179347|565268782|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
156597513|NCT01179347|565268781|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
156597514|NCT01179347|565268782|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
156597515|NCT01179347|565268781|FG000|Open-label Period (12 Weeks)|Other|7|||
156597516|NCT01179347|565268782|FG001|Open-label Period (12 Weeks)|Other|4|||
156597517|NCT01283997|565268783|FG000|Overall Study|Physician Decision|8|||
156597518|NCT01283997|565268784|FG001|Overall Study|Physician Decision|10|||
156597519|NCT01283997|565268783|FG000|Overall Study|Withdrawal by Subject|3|||
156597520|NCT01283997|565268784|FG001|Overall Study|Withdrawal by Subject|2|||
156597521|NCT01283997|565268783|FG000|Overall Study|Physically unable to continue|0|||
156597522|NCT01283997|565268784|FG001|Overall Study|Physically unable to continue|1|||
156597523|NCT01283997|565268783|FG000|Overall Study|Progressive disease|1|||
156597524|NCT01283997|565268784|FG001|Overall Study|Progressive disease|0|||
156597525|NCT01283997|565268783|FG000|Overall Study|Other|4|||
156597526|NCT01283997|565268784|FG001|Overall Study|Other|4|||
156597527|NCT02109744|565268785|FG000|Overall Study|Death|1|||
156597528|NCT02109744|565268786|FG001|Overall Study|Death|1|||
156597529|NCT02109744|565268785|FG000|Overall Study|no marrow exam|1|||
156597530|NCT02109744|565268786|FG001|Overall Study|no marrow exam|0|||
156597531|NCT04095442|565268790|FG000|Overall Study|Lost to Follow-up|0|||
156597532|NCT04095442|565268791|FG001|Overall Study|Lost to Follow-up|1|||
156597533|NCT04095442|565268790|FG000|Overall Study|Screen failure|1|||
156597534|NCT04095442|565268791|FG001|Overall Study|Screen failure|0|||
156597535|NCT01337167|565268792|FG000|Infant Series|Adverse Event|1|||
156597536|NCT01337167|565268793|FG001|Infant Series|Adverse Event|1|||
156597537|NCT01337167|565268792|FG000|Infant Series|Death|1|||
156597538|NCT01337167|565268793|FG001|Infant Series|Death|1|||
156597539|NCT01337167|565268792|FG000|Infant Series|Lost to Follow-up|13|||
156597540|NCT01337167|565268793|FG001|Infant Series|Lost to Follow-up|7|||
156597541|NCT01337167|565268792|FG000|Infant Series|Non-compliance with study drug|2|||
156597542|NCT01337167|565268793|FG001|Infant Series|Non-compliance with study drug|1|||
156597543|NCT01337167|565268792|FG000|Infant Series|Physician Decision|3|||
156597544|NCT01337167|565268793|FG001|Infant Series|Physician Decision|1|||
156597545|NCT01337167|565268792|FG000|Infant Series|Protocol Violation|22|||
156597546|NCT01337167|565268793|FG001|Infant Series|Protocol Violation|9|||
156597547|NCT01337167|565268792|FG000|Infant Series|Withdrawal by Subject|15|||
156597548|NCT01337167|565268793|FG001|Infant Series|Withdrawal by Subject|4|||
156597549|NCT01337167|565268792|FG000|Infant Series|Randomized but not vaccinated|5|||
156597550|NCT01337167|565268793|FG001|Infant Series|Randomized but not vaccinated|3|||
156597551|NCT01337167|565268792|FG000|Interim Period|Lost to Follow-up|51|||
156597552|NCT01337167|565268793|FG001|Interim Period|Lost to Follow-up|23|||
156597553|NCT01337167|565268792|FG000|Interim Period|Non-compliance with study drug|1|||
156597554|NCT01337167|565268793|FG001|Interim Period|Non-compliance with study drug|0|||
156597555|NCT01337167|565268792|FG000|Interim Period|Physician Decision|6|||
156597556|NCT01337167|565268793|FG001|Interim Period|Physician Decision|3|||
156597557|NCT01337167|565268792|FG000|Interim Period|Protocol Violation|5|||
156597558|NCT01337167|565268793|FG001|Interim Period|Protocol Violation|3|||
156597559|NCT01337167|565268792|FG000|Interim Period|Withdrawal by Subject|18|||
156597560|NCT01337167|565268793|FG001|Interim Period|Withdrawal by Subject|10|||
156597561|NCT01337167|565268792|FG000|Interim Period|Other protocol criterion not met|0|||
156597562|NCT01337167|565268793|FG001|Interim Period|Other protocol criterion not met|1|||
156597563|NCT01337167|565268792|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
156597564|NCT01337167|565268793|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
156597565|NCT01337167|565268792|FG000|Toddler Vaccinations|Protocol Violation|0|||
156597566|NCT01337167|565268793|FG001|Toddler Vaccinations|Protocol Violation|1|||
156597567|NCT01337167|565268792|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
156597568|NCT01337167|565268793|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
156597569|NCT03833817|565268798|FG000|Overall Study|Withdrawal by Subject|3|||
156597570|NCT03833817|565268799|FG001|Overall Study|Withdrawal by Subject|3|||
156597571|NCT03833817|565268798|FG000|Overall Study|Lost to Follow-up|3|||
156597572|NCT03833817|565268799|FG001|Overall Study|Lost to Follow-up|3|||
156597573|NCT00884221|565268800|FG000|Overall Study|Withdrawal by Subject|0|||
156597574|NCT00884221|565268801|FG001|Overall Study|Withdrawal by Subject|3|||
156597575|NCT00884221|565268800|FG000|Overall Study|Adverse Event|6|||
156597576|NCT00884221|565268801|FG001|Overall Study|Adverse Event|3|||
156597577|NCT00884221|565268800|FG000|Overall Study|Protocol Violation|16|||
156597578|NCT00884221|565268801|FG001|Overall Study|Protocol Violation|13|||
156597579|NCT00884221|565268800|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
156597580|NCT00884221|565268801|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
156597581|NCT02126670|565268804|FG000|Overall Study|Withdrawal by Subject|1|||
156597582|NCT02126670|565268805|FG001|Overall Study|Withdrawal by Subject|0|||
156597583|NCT02126670|565268806|FG002|Overall Study|Withdrawal by Subject|0|||
156597584|NCT02126670|565268807|FG003|Overall Study|Withdrawal by Subject|1|||
156597585|NCT00255034|565268812|FG000|Overall Study|Withdrawal by Subject|15|||
156597586|NCT00255034|565268813|FG001|Overall Study|Withdrawal by Subject|38|||
156597587|NCT00424346|565268814|FG000|Core Study|Adverse Event|5|||
156597588|NCT00424346|565268815|FG001|Core Study|Adverse Event|3|||
156597589|NCT00424346|565268816|FG002|Core Study|Adverse Event|1|||
156597590|NCT00424346|565268817|FG003|Core Study|Adverse Event|1|||
156597591|NCT00424346|565268814|FG000|Core Study|Abnormal Laboratory Values|0|||
156597592|NCT00424346|565268815|FG001|Core Study|Abnormal Laboratory Values|1|||
156597593|NCT00424346|565268816|FG002|Core Study|Abnormal Laboratory Values|0|||
156597594|NCT00424346|565268817|FG003|Core Study|Abnormal Laboratory Values|0|||
156597595|NCT00424346|565268814|FG000|Core Study|Lack of Efficacy|1|||
156597596|NCT00424346|565268815|FG001|Core Study|Lack of Efficacy|3|||
156597597|NCT00424346|565268816|FG002|Core Study|Lack of Efficacy|0|||
156597598|NCT00424346|565268817|FG003|Core Study|Lack of Efficacy|4|||
156597599|NCT00424346|565268814|FG000|Core Study|Withdrawal by Subject|1|||
156597600|NCT00424346|565268815|FG001|Core Study|Withdrawal by Subject|0|||
156597601|NCT00424346|565268816|FG002|Core Study|Withdrawal by Subject|0|||
156597602|NCT00424346|565268817|FG003|Core Study|Withdrawal by Subject|2|||
156597603|NCT00424346|565268814|FG000|Core Study|Lost to Follow-up|1|||
156597604|NCT00424346|565268815|FG001|Core Study|Lost to Follow-up|1|||
156597605|NCT00424346|565268816|FG002|Core Study|Lost to Follow-up|0|||
156597606|NCT00424346|565268817|FG003|Core Study|Lost to Follow-up|0|||
156597607|NCT00424346|565268814|FG000|Core Study|Administrative Problems|1|||
156597608|NCT00424346|565268815|FG001|Core Study|Administrative Problems|0|||
156597609|NCT00424346|565268816|FG002|Core Study|Administrative Problems|1|||
156597610|NCT00424346|565268817|FG003|Core Study|Administrative Problems|0|||
156597611|NCT00424346|565268814|FG000|Core Study|Protocol Violation|0|||
156597612|NCT00424346|565268815|FG001|Core Study|Protocol Violation|0|||
156597613|NCT00424346|565268816|FG002|Core Study|Protocol Violation|2|||
156597614|NCT00424346|565268817|FG003|Core Study|Protocol Violation|0|||
156597615|NCT00424346|565268814|FG000|Extension Phase|Adverse Event|0|||
156597616|NCT00424346|565268815|FG001|Extension Phase|Adverse Event|9|||
156597617|NCT00424346|565268816|FG002|Extension Phase|Adverse Event|5|||
156597618|NCT00424346|565268817|FG003|Extension Phase|Adverse Event|4|||
156597619|NCT00424346|565268814|FG000|Extension Phase|Lack of Efficacy|0|||
156597620|NCT00424346|565268815|FG001|Extension Phase|Lack of Efficacy|16|||
156597621|NCT00424346|565268816|FG002|Extension Phase|Lack of Efficacy|14|||
156597622|NCT00424346|565268817|FG003|Extension Phase|Lack of Efficacy|11|||
156597623|NCT00424346|565268814|FG000|Extension Phase|Withdrawal by Subject|0|||
156597624|NCT00424346|565268815|FG001|Extension Phase|Withdrawal by Subject|5|||
156597625|NCT00424346|565268816|FG002|Extension Phase|Withdrawal by Subject|3|||
156597626|NCT00424346|565268817|FG003|Extension Phase|Withdrawal by Subject|4|||
156597627|NCT00424346|565268814|FG000|Extension Phase|Lost to Follow-up|0|||
156597628|NCT00424346|565268815|FG001|Extension Phase|Lost to Follow-up|2|||
156597629|NCT00424346|565268816|FG002|Extension Phase|Lost to Follow-up|0|||
156597630|NCT00424346|565268817|FG003|Extension Phase|Lost to Follow-up|0|||
156597631|NCT00424346|565268814|FG000|Extension Phase|Administrative Problems|0|||
156597632|NCT00424346|565268815|FG001|Extension Phase|Administrative Problems|69|||
156597633|NCT00424346|565268816|FG002|Extension Phase|Administrative Problems|32|||
156597634|NCT00424346|565268817|FG003|Extension Phase|Administrative Problems|35|||
156597635|NCT00424346|565268814|FG000|Extension Phase|Death|0|||
156597636|NCT00424346|565268815|FG001|Extension Phase|Death|0|||
156597637|NCT00424346|565268816|FG002|Extension Phase|Death|0|||
156597638|NCT00424346|565268817|FG003|Extension Phase|Death|1|||
156597639|NCT00424346|565268814|FG000|Extension Phase|Protocol Violation|0|||
156597640|NCT00424346|565268815|FG001|Extension Phase|Protocol Violation|1|||
156597641|NCT00424346|565268816|FG002|Extension Phase|Protocol Violation|1|||
156597642|NCT00424346|565268817|FG003|Extension Phase|Protocol Violation|0|||
156597643|NCT01827319|565268818|FG000|Overall Study|Lost to Follow-up|3|||
156597644|NCT03947255|565268820|FG000|Overall Study|Study Closure by Sponsor|2|||
156597645|NCT03947255|565268821|FG001|Overall Study|Study Closure by Sponsor|2|||
156597646|NCT03947255|565268820|FG000|Overall Study|Withdrawal by Subject|2|||
156597647|NCT03947255|565268821|FG001|Overall Study|Withdrawal by Subject|2|||
156597648|NCT03947255|565268820|FG000|Overall Study|Lost to Follow-up|2|||
156597649|NCT03947255|565268821|FG001|Overall Study|Lost to Follow-up|0|||
156597650|NCT03947255|565268820|FG000|Overall Study|Death|0|||
156597651|NCT03947255|565268821|FG001|Overall Study|Death|2|||
156597652|NCT02499575|565268822|FG000|Overall Study|Protocol Violation|0|||
156597653|NCT02499575|565268823|FG001|Overall Study|Protocol Violation|1|||
156597654|NCT01245764|565268828|FG000|Study Phase A|Other|3|||
156597655|NCT01245764|565268829|FG001|Study Phase A|Other|2|||
156597656|NCT01245764|565268830|FG002|Study Phase A|Other|3|||
156597657|NCT01245764|565268831|FG003|Study Phase A|Other|1|||
156597658|NCT01245764|565268828|FG000|Study Phase A|Protocol Violation|6|||
156597659|NCT01245764|565268829|FG001|Study Phase A|Protocol Violation|3|||
156597660|NCT01245764|565268830|FG002|Study Phase A|Protocol Violation|2|||
156597661|NCT01245764|565268831|FG003|Study Phase A|Protocol Violation|2|||
156597662|NCT01245764|565268828|FG000|Study Phase A|Lost to Follow-up|0|||
156597663|NCT01245764|565268829|FG001|Study Phase A|Lost to Follow-up|0|||
156597664|NCT01245764|565268830|FG002|Study Phase A|Lost to Follow-up|5|||
156597665|NCT01245764|565268831|FG003|Study Phase A|Lost to Follow-up|0|||
156597666|NCT00003476|565268832|FG000|Overall Study|Not evaluable|1|||
156597667|NCT02667457|565268835|FG000|Overall Study|Withdrawal by Subject|1|||
156597668|NCT02667457|565268836|FG001|Overall Study|Withdrawal by Subject|0|||
156597669|NCT02667457|565268835|FG000|Overall Study|Other Reason|0|||
156597670|NCT02667457|565268836|FG001|Overall Study|Other Reason|2|||
156597671|NCT03097614|565268837|FG000|Overall Study|Adverse Event|3|||
156597672|NCT00696436|565268839|FG000|Overall Study|Adverse Event|7|||
156597673|NCT00696436|565268840|FG001|Overall Study|Adverse Event|9|||
156597674|NCT00696436|565268841|FG002|Overall Study|Adverse Event|8|||
156597675|NCT00696436|565268842|FG003|Overall Study|Adverse Event|6|||
156597676|NCT00696436|565268843|FG004|Overall Study|Adverse Event|4|||
156597677|NCT00696436|565268839|FG000|Overall Study|Protocol Violation|3|||
156597678|NCT00696436|565268840|FG001|Overall Study|Protocol Violation|2|||
156597679|NCT00696436|565268841|FG002|Overall Study|Protocol Violation|2|||
156597680|NCT00696436|565268842|FG003|Overall Study|Protocol Violation|0|||
156597681|NCT00696436|565268843|FG004|Overall Study|Protocol Violation|1|||
156597682|NCT00696436|565268839|FG000|Overall Study|Lost to Follow-up|1|||
156597683|NCT00696436|565268840|FG001|Overall Study|Lost to Follow-up|6|||
156597684|NCT00696436|565268841|FG002|Overall Study|Lost to Follow-up|2|||
156597685|NCT00696436|565268842|FG003|Overall Study|Lost to Follow-up|4|||
156597686|NCT00696436|565268843|FG004|Overall Study|Lost to Follow-up|3|||
156597687|NCT00696436|565268839|FG000|Overall Study|Withdrawal by Subject|4|||
156597688|NCT00696436|565268840|FG001|Overall Study|Withdrawal by Subject|11|||
156597689|NCT00696436|565268841|FG002|Overall Study|Withdrawal by Subject|5|||
156597690|NCT00696436|565268842|FG003|Overall Study|Withdrawal by Subject|7|||
156597691|NCT00696436|565268843|FG004|Overall Study|Withdrawal by Subject|1|||
156597692|NCT00696436|565268839|FG000|Overall Study|Lack of Efficacy|3|||
156597693|NCT00696436|565268840|FG001|Overall Study|Lack of Efficacy|1|||
156597694|NCT00696436|565268841|FG002|Overall Study|Lack of Efficacy|5|||
156597695|NCT00696436|565268842|FG003|Overall Study|Lack of Efficacy|2|||
156597696|NCT00696436|565268843|FG004|Overall Study|Lack of Efficacy|4|||
156597697|NCT00696436|565268839|FG000|Overall Study|Participant Unavailability|2|||
156597698|NCT00696436|565268840|FG001|Overall Study|Participant Unavailability|0|||
156597699|NCT00696436|565268841|FG002|Overall Study|Participant Unavailability|2|||
156597700|NCT00696436|565268842|FG003|Overall Study|Participant Unavailability|1|||
156597701|NCT00696436|565268843|FG004|Overall Study|Participant Unavailability|0|||
156597702|NCT00696436|565268839|FG000|Overall Study|Administrative Error|2|||
156597703|NCT00696436|565268840|FG001|Overall Study|Administrative Error|0|||
156597704|NCT00696436|565268841|FG002|Overall Study|Administrative Error|2|||
156597705|NCT00696436|565268842|FG003|Overall Study|Administrative Error|0|||
156597706|NCT00696436|565268843|FG004|Overall Study|Administrative Error|0|||
156597707|NCT00696436|565268839|FG000|Overall Study|Participant Non-compliance|0|||
156597708|NCT00696436|565268840|FG001|Overall Study|Participant Non-compliance|0|||
156597709|NCT00696436|565268841|FG002|Overall Study|Participant Non-compliance|1|||
156597710|NCT00696436|565268842|FG003|Overall Study|Participant Non-compliance|2|||
156597711|NCT00696436|565268843|FG004|Overall Study|Participant Non-compliance|0|||
156597712|NCT00696436|565268839|FG000|Overall Study|Administrative Decision|1|||
156597713|NCT00696436|565268840|FG001|Overall Study|Administrative Decision|0|||
156597714|NCT00696436|565268841|FG002|Overall Study|Administrative Decision|0|||
156597715|NCT00696436|565268842|FG003|Overall Study|Administrative Decision|0|||
156597716|NCT00696436|565268843|FG004|Overall Study|Administrative Decision|0|||
156597717|NCT00696436|565268839|FG000|Overall Study|Missing|0|||
156597718|NCT00696436|565268840|FG001|Overall Study|Missing|1|||
156597719|NCT00696436|565268841|FG002|Overall Study|Missing|1|||
156597720|NCT00696436|565268842|FG003|Overall Study|Missing|0|||
156597721|NCT00696436|565268843|FG004|Overall Study|Missing|0|||
156597722|NCT03039738|565268848|FG000|Overall Study|Incomplete data sets|54|||
156597723|NCT03039738|565268849|FG001|Overall Study|Incomplete data sets|0|||
156597724|NCT00912340|565268850|FG000|Overall Study|Adverse Event|2|||
156597725|NCT00912340|565268851|FG001|Overall Study|Adverse Event|4|||
156597726|NCT00912340|565268852|FG002|Overall Study|Adverse Event|0|||
156597727|NCT00912340|565268850|FG000|Overall Study|Protocol revised to remove arm|0|||
156597728|NCT00912340|565268851|FG001|Overall Study|Protocol revised to remove arm|0|||
156597729|NCT00912340|565268852|FG002|Overall Study|Protocol revised to remove arm|4|||
156597730|NCT01517412|565268855|FG000|Overall Study|Adverse Event|10|||
156597731|NCT01517412|565268856|FG001|Overall Study|Adverse Event|11|||
156597732|NCT01517412|565268855|FG000|Overall Study|Lack of Efficacy|10|||
156597733|NCT01517412|565268856|FG001|Overall Study|Lack of Efficacy|5|||
156597734|NCT01517412|565268855|FG000|Overall Study|Poor compliance to protocol|8|||
156597735|NCT01517412|565268856|FG001|Overall Study|Poor compliance to protocol|3|||
156597736|NCT01517412|565268855|FG000|Overall Study|Other than specified above|8|||
156597737|NCT01517412|565268856|FG001|Overall Study|Other than specified above|5|||
156597738|NCT01253187|565268859|FG000|Period 2|Withdrawal by Subject|0|||
156597739|NCT01253187|565268860|FG001|Period 2|Withdrawal by Subject|0|||
156597740|NCT01253187|565268861|FG002|Period 2|Withdrawal by Subject|0|||
156597741|NCT01253187|565268862|FG003|Period 2|Withdrawal by Subject|0|||
156597742|NCT01253187|565268863|FG004|Period 2|Withdrawal by Subject|1|||
156597743|NCT01253187|565268864|FG005|Period 2|Withdrawal by Subject|0|||
156597744|NCT01253187|565268859|FG000|Period 3|Pregnancy|1|||
156597745|NCT01253187|565268860|FG001|Period 3|Pregnancy|0|||
156597746|NCT01253187|565268861|FG002|Period 3|Pregnancy|0|||
156597747|NCT01253187|565268862|FG003|Period 3|Pregnancy|0|||
156597748|NCT01253187|565268863|FG004|Period 3|Pregnancy|0|||
156597749|NCT01253187|565268864|FG005|Period 3|Pregnancy|0|||
156597750|NCT01253187|565268859|FG000|Period 3|difficulty with blood sampling|0|||
156597751|NCT01253187|565268860|FG001|Period 3|difficulty with blood sampling|1|||
156597752|NCT01253187|565268861|FG002|Period 3|difficulty with blood sampling|0|||
156597753|NCT01253187|565268862|FG003|Period 3|difficulty with blood sampling|0|||
156597754|NCT01253187|565268863|FG004|Period 3|difficulty with blood sampling|0|||
156863678|NCT05194124|566258762|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156597755|NCT01253187|565268864|FG005|Period 3|difficulty with blood sampling|0|||
156597756|NCT01253187|565268859|FG000|Period 3|non-compliance|0|||
156597757|NCT01253187|565268860|FG001|Period 3|non-compliance|0|||
156597758|NCT01253187|565268861|FG002|Period 3|non-compliance|0|||
156597759|NCT01253187|565268862|FG003|Period 3|non-compliance|0|||
156597760|NCT01253187|565268863|FG004|Period 3|non-compliance|1|||
156597761|NCT01253187|565268864|FG005|Period 3|non-compliance|0|||
156597762|NCT01494987|565268866|FG000|Overall Study|Adverse Event|6|||
156597763|NCT01494987|565268867|FG001|Overall Study|Adverse Event|5|||
156597764|NCT01494987|565268866|FG000|Overall Study|Hyperglycemia|6|||
156597765|NCT01494987|565268867|FG001|Overall Study|Hyperglycemia|4|||
156597766|NCT01494987|565268866|FG000|Overall Study|Investigator's Discretion|1|||
156597767|NCT01494987|565268867|FG001|Overall Study|Investigator's Discretion|2|||
156597768|NCT01494987|565268866|FG000|Overall Study|Lost to Follow-up|1|||
156597769|NCT01494987|565268867|FG001|Overall Study|Lost to Follow-up|1|||
156597770|NCT01494987|565268866|FG000|Overall Study|Protocol Violation|3|||
156597771|NCT01494987|565268867|FG001|Overall Study|Protocol Violation|3|||
156597772|NCT01494987|565268866|FG000|Overall Study|Subject Non-Compliance|9|||
156597773|NCT01494987|565268867|FG001|Overall Study|Subject Non-Compliance|10|||
156597774|NCT01494987|565268866|FG000|Overall Study|Subject Withdrew Consent|2|||
156597775|NCT01494987|565268867|FG001|Overall Study|Subject Withdrew Consent|3|||
156597776|NCT01895452|565268871|FG000|Overall Study|Adverse Event|1|||
156597777|NCT01895452|565268872|FG001|Overall Study|Adverse Event|4|||
156597778|NCT01895452|565268871|FG000|Overall Study|Lost to Follow-up|1|||
156597779|NCT01895452|565268872|FG001|Overall Study|Lost to Follow-up|5|||
156597780|NCT01895452|565268871|FG000|Overall Study|Pregnancy|0|||
156597781|NCT01895452|565268872|FG001|Overall Study|Pregnancy|1|||
156597782|NCT01895452|565268871|FG000|Overall Study|Withdrawal by Subject|2|||
156597783|NCT01895452|565268872|FG001|Overall Study|Withdrawal by Subject|14|||
156597784|NCT01895452|565268871|FG000|Overall Study|Underlying disease|0|||
156597785|NCT01895452|565268872|FG001|Overall Study|Underlying disease|3|||
156597786|NCT01895452|565268871|FG000|Overall Study|Noncompliance with study drug|0|||
156597787|NCT01895452|565268872|FG001|Overall Study|Noncompliance with study drug|1|||
156597788|NCT01653158|565268873|FG000|Overall Study|Death|0|||
156597789|NCT01653158|565268874|FG001|Overall Study|Death|0|||
156597790|NCT01653158|565268875|FG002|Overall Study|Death|0|||
156597791|NCT01653158|565268876|FG003|Overall Study|Death|1|||
156597792|NCT01653158|565268877|FG004|Overall Study|Death|0|||
156597793|NCT01653158|565268878|FG005|Overall Study|Death|0|||
156597794|NCT01653158|565268879|FG006|Overall Study|Death|0|||
156597795|NCT01653158|565268880|FG007|Overall Study|Death|2|||
156597796|NCT01653158|565268873|FG000|Overall Study|Adverse Event|0|||
156597797|NCT01653158|565268874|FG001|Overall Study|Adverse Event|0|||
156597798|NCT01653158|565268875|FG002|Overall Study|Adverse Event|0|||
156597799|NCT01653158|565268876|FG003|Overall Study|Adverse Event|1|||
156597800|NCT01653158|565268877|FG004|Overall Study|Adverse Event|0|||
156597801|NCT01653158|565268878|FG005|Overall Study|Adverse Event|0|||
156597802|NCT01653158|565268879|FG006|Overall Study|Adverse Event|0|||
156597803|NCT01653158|565268880|FG007|Overall Study|Adverse Event|3|||
156597804|NCT01653158|565268873|FG000|Overall Study|Other|0|||
156597805|NCT01653158|565268874|FG001|Overall Study|Other|0|||
156597806|NCT01653158|565268875|FG002|Overall Study|Other|0|||
156597807|NCT01653158|565268876|FG003|Overall Study|Other|0|||
156597808|NCT01653158|565268877|FG004|Overall Study|Other|0|||
156597809|NCT01653158|565268878|FG005|Overall Study|Other|0|||
156597810|NCT01653158|565268879|FG006|Overall Study|Other|0|||
156597811|NCT01653158|565268880|FG007|Overall Study|Other|1|||
156597812|NCT01653158|565268873|FG000|Overall Study|Progressive disease|0|||
156597813|NCT01653158|565268874|FG001|Overall Study|Progressive disease|0|||
156597814|NCT01653158|565268875|FG002|Overall Study|Progressive disease|0|||
156597815|NCT01653158|565268876|FG003|Overall Study|Progressive disease|0|||
156597816|NCT01653158|565268877|FG004|Overall Study|Progressive disease|1|||
156597817|NCT01653158|565268878|FG005|Overall Study|Progressive disease|1|||
156597818|NCT01653158|565268879|FG006|Overall Study|Progressive disease|2|||
156597819|NCT01653158|565268880|FG007|Overall Study|Progressive disease|9|||
156597820|NCT01653158|565268873|FG000|Overall Study|Withdrawal by Subject|1|||
156597821|NCT01653158|565268874|FG001|Overall Study|Withdrawal by Subject|0|||
156597822|NCT01653158|565268875|FG002|Overall Study|Withdrawal by Subject|0|||
156597823|NCT01653158|565268876|FG003|Overall Study|Withdrawal by Subject|0|||
156597824|NCT01653158|565268877|FG004|Overall Study|Withdrawal by Subject|0|||
156597825|NCT01653158|565268878|FG005|Overall Study|Withdrawal by Subject|0|||
156597826|NCT01653158|565268879|FG006|Overall Study|Withdrawal by Subject|0|||
156597827|NCT01653158|565268880|FG007|Overall Study|Withdrawal by Subject|0|||
156597828|NCT04999969|565268881|FG000|Overall Study|Death|76|||
156597829|NCT04999969|565268881|FG000|Overall Study|Progressive Disease|1|||
156597830|NCT04999969|565268881|FG000|Overall Study|Withdrawal by Subject|8|||
156597831|NCT04321252|565268883|FG000|Overall Study|Withdrawal by Subject|0|||
156597832|NCT04321252|565268884|FG001|Overall Study|Withdrawal by Subject|0|||
156597833|NCT04321252|565268885|FG002|Overall Study|Withdrawal by Subject|0|||
156597834|NCT04321252|565268886|FG003|Overall Study|Withdrawal by Subject|0|||
156597835|NCT04321252|565268887|FG004|Overall Study|Withdrawal by Subject|0|||
156597836|NCT04321252|565268888|FG005|Overall Study|Withdrawal by Subject|1|||
156597837|NCT04321252|565268889|FG006|Overall Study|Withdrawal by Subject|0|||
156597838|NCT04321252|565268890|FG007|Overall Study|Withdrawal by Subject|0|||
156597839|NCT04321252|565268891|FG008|Overall Study|Withdrawal by Subject|0|||
156597840|NCT06245044|565268892|FG000|No MI help|Technical issues|18|||
156597841|NCT01658579|565268896|FG000|Treatment Period A|Other|0|||
156597842|NCT01658579|565268897|FG001|Treatment Period A|Other|0|||
156597843|NCT01658579|565268898|FG002|Treatment Period A|Other|1|||
156597844|NCT01658579|565268899|FG003|Treatment Period A|Other|1|||
156597845|NCT01658579|565268896|FG000|Treatment Period A|Adverse Event|1|||
156597846|NCT01658579|565268897|FG001|Treatment Period A|Adverse Event|0|||
156597847|NCT01658579|565268898|FG002|Treatment Period A|Adverse Event|0|||
156597848|NCT01658579|565268899|FG003|Treatment Period A|Adverse Event|0|||
156597849|NCT01658579|565268896|FG000|Treatment Period B|Other|0|||
156597850|NCT01658579|565268897|FG001|Treatment Period B|Other|0|||
156597851|NCT01658579|565268898|FG002|Treatment Period B|Other|0|||
156597852|NCT01658579|565268899|FG003|Treatment Period B|Other|1|||
156597853|NCT05590767|565268900|FG000|Overall Study|Protocol Violation|1|||
156597854|NCT05590767|565268900|FG000|Overall Study|surgery canceled|1|||
156597855|NCT05590767|565268900|FG000|Overall Study|interscalene brachial block not performed|1|||
156597856|NCT01464788|565268901|FG000|Overall Study|Lost to Follow-up|0|||
156597857|NCT01464788|565268902|FG001|Overall Study|Lost to Follow-up|1|||
156597858|NCT01464788|565268903|FG002|Overall Study|Lost to Follow-up|0|||
156597859|NCT01464788|565268901|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
156597860|NCT01464788|565268902|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
156597861|NCT01464788|565268903|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
156597862|NCT01577160|565268905|FG000|Overall Study|Adverse Event|9|||
156597863|NCT01577160|565268905|FG000|Overall Study|Lack of Efficacy|15|||
156597864|NCT01577160|565268905|FG000|Overall Study|Lost to Follow-up|40|||
156597865|NCT01577160|565268905|FG000|Overall Study|Withdrawal by Subject|18|||
156597866|NCT01577160|565268905|FG000|Overall Study|Subject Uncooperative|7|||
156597867|NCT01577160|565268905|FG000|Overall Study|Other|9|||
156597868|NCT01551758|565268906|FG000|Overall Study|Adverse Event|29|||
156597869|NCT01551758|565268907|FG001|Overall Study|Adverse Event|43|||
156597870|NCT01551758|565268906|FG000|Overall Study|Lack of Efficacy|0|||
156597871|NCT01551758|565268907|FG001|Overall Study|Lack of Efficacy|1|||
156597872|NCT01551758|565268906|FG000|Overall Study|Protocol Violation|5|||
156597873|NCT01551758|565268907|FG001|Overall Study|Protocol Violation|6|||
156597874|NCT01551758|565268906|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
156597875|NCT01551758|565268907|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
156597876|NCT01551758|565268906|FG000|Overall Study|Lost to Follow-up|29|||
156597877|NCT01551758|565268907|FG001|Overall Study|Lost to Follow-up|25|||
156597878|NCT01551758|565268906|FG000|Overall Study|Physician Decision|9|||
156597879|NCT01551758|565268907|FG001|Overall Study|Physician Decision|3|||
156597880|NCT01551758|565268906|FG000|Overall Study|Withdrawal by Subject|14|||
156597881|NCT01551758|565268907|FG001|Overall Study|Withdrawal by Subject|17|||
156597882|NCT01586156|565268909|FG000|Overall Study|Pregnancy|0|||
156597883|NCT01586156|565268910|FG001|Overall Study|Pregnancy|1|||
156597884|NCT01586156|565268911|FG002|Overall Study|Pregnancy|0|||
156597885|NCT00363246|565268912|FG000|Overall Study|Death|40|||
156597886|NCT00363246|565268912|FG000|Overall Study|Withdrawal by Subject|19|||
156597887|NCT00363246|565268912|FG000|Overall Study|Lost to Follow-up|14|||
156597888|NCT00363246|565268912|FG000|Overall Study|Bad health|6|||
156597889|NCT00363246|565268912|FG000|Overall Study|Stopped using wheelchair|11|||
156597890|NCT00363246|565268912|FG000|Overall Study|Subject expressed security concerns|2|||
156597891|NCT00363246|565268912|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
156597892|NCT00264849|565268913|FG000|Overall Study|Adverse Event|7|||
156597893|NCT00264849|565268914|FG001|Overall Study|Adverse Event|2|||
156597894|NCT00264849|565268913|FG000|Overall Study|Withdrawal by Subject|7|||
156597895|NCT00264849|565268914|FG001|Overall Study|Withdrawal by Subject|11|||
156597896|NCT00264849|565268913|FG000|Overall Study|Protocol Violation|5|||
156597897|NCT00264849|565268914|FG001|Overall Study|Protocol Violation|3|||
156597898|NCT00264849|565268913|FG000|Overall Study|Lack of Efficacy|1|||
156597899|NCT00264849|565268914|FG001|Overall Study|Lack of Efficacy|6|||
156597900|NCT00264849|565268913|FG000|Overall Study|Lost to Follow-up|0|||
156597901|NCT00264849|565268914|FG001|Overall Study|Lost to Follow-up|2|||
156597902|NCT00264849|565268913|FG000|Overall Study|Death|0|||
156597903|NCT00264849|565268914|FG001|Overall Study|Death|1|||
156597904|NCT00264849|565268913|FG000|Overall Study|Administrative Problems|2|||
156597905|NCT00264849|565268914|FG001|Overall Study|Administrative Problems|0|||
156597906|NCT04465396|565268917|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
156597907|NCT04465396|565268918|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
156597908|NCT04465396|565268919|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
156597909|NCT04465396|565268920|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
156597910|NCT01766817|565268921|FG000|Overall Study|Drug-related adverse event|1|||
156597911|NCT01766817|565268922|FG001|Overall Study|Drug-related adverse event|2|||
156597912|NCT01766817|565268923|FG002|Overall Study|Drug-related adverse event|1|||
156597913|NCT01766817|565268921|FG000|Overall Study|Drug-unrelated adverse event|3|||
156597914|NCT01766817|565268922|FG001|Overall Study|Drug-unrelated adverse event|3|||
156597915|NCT01766817|565268923|FG002|Overall Study|Drug-unrelated adverse event|3|||
156597916|NCT01766817|565268921|FG000|Overall Study|Death|1|||
156597917|NCT01766817|565268922|FG001|Overall Study|Death|1|||
156597918|NCT01766817|565268923|FG002|Overall Study|Death|0|||
156597919|NCT01766817|565268921|FG000|Overall Study|Unable to take study drug|0|||
156597920|NCT01766817|565268922|FG001|Overall Study|Unable to take study drug|1|||
156597921|NCT01766817|565268923|FG002|Overall Study|Unable to take study drug|0|||
156597922|NCT01766817|565268921|FG000|Overall Study|Withdrawal by Subject|2|||
156597923|NCT01766817|565268922|FG001|Overall Study|Withdrawal by Subject|0|||
156597924|NCT01766817|565268923|FG002|Overall Study|Withdrawal by Subject|3|||
156597925|NCT01766817|565268921|FG000|Overall Study|Subject non-compliance|0|||
156597926|NCT01766817|565268922|FG001|Overall Study|Subject non-compliance|1|||
156597927|NCT01766817|565268923|FG002|Overall Study|Subject non-compliance|2|||
156597928|NCT01766817|565268921|FG000|Overall Study|Physician Decision|3|||
156597929|NCT01766817|565268922|FG001|Overall Study|Physician Decision|3|||
156597930|NCT01766817|565268923|FG002|Overall Study|Physician Decision|4|||
156597931|NCT01766817|565268921|FG000|Overall Study|Other|1|||
156597932|NCT01766817|565268922|FG001|Overall Study|Other|0|||
156597933|NCT01766817|565268923|FG002|Overall Study|Other|0|||
156597934|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
156597935|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
156597936|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
156597937|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
156597938|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
156597939|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
156597940|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
156597941|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
156597942|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
156597943|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
156597944|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
156597945|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
156597946|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
156597947|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
156597948|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
156597949|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
156597950|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
156597951|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
156597952|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
156597953|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
156597954|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
156597955|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
156597956|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
156597957|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
156597958|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
156597959|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
156597960|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
156597961|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
156597962|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
156597963|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
156597964|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
156597965|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
156597966|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
156597967|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
156597968|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
156597969|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
156597970|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
156597971|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
156597972|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
156597973|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
156597974|NCT00383721|565268927|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
156597975|NCT00383721|565268928|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
156597976|NCT00383721|565268929|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
156597977|NCT00383721|565268930|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
156597978|NCT00383721|565268931|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
156597979|NCT00383721|565268927|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
156597980|NCT00383721|565268928|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
156597981|NCT00383721|565268929|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
156597982|NCT00383721|565268930|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
156597983|NCT00383721|565268931|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
156597984|NCT00383721|565268927|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
156597985|NCT00383721|565268928|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
156597986|NCT00383721|565268929|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
156597987|NCT00383721|565268930|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156597988|NCT00383721|565268931|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
156597989|NCT00383721|565268927|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
156597990|NCT00383721|565268928|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
156597991|NCT00383721|565268929|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
156597992|NCT00383721|565268930|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
156597993|NCT00383721|565268931|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
156597994|NCT00383721|565268927|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
156597995|NCT00383721|565268928|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
156597996|NCT00383721|565268929|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
156597997|NCT00383721|565268930|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
156597998|NCT00383721|565268931|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
156597999|NCT00383721|565268927|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
156598000|NCT00383721|565268928|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
156598001|NCT00383721|565268929|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
156598002|NCT00383721|565268930|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
156598003|NCT00383721|565268931|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
156598004|NCT00383721|565268927|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
156598005|NCT00383721|565268928|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
156598006|NCT00383721|565268929|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
156598007|NCT00383721|565268930|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
156598008|NCT00383721|565268931|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
156598009|NCT00383721|565268927|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
156598010|NCT00383721|565268928|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
156598011|NCT00383721|565268929|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
156598012|NCT00383721|565268930|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
156598013|NCT00383721|565268931|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
156598014|NCT00383721|565268927|FG000|26-Week Treatment Safety Extension|Administrative|1|||
156598015|NCT00383721|565268928|FG001|26-Week Treatment Safety Extension|Administrative|2|||
156598016|NCT00383721|565268929|FG002|26-Week Treatment Safety Extension|Administrative|3|||
156598017|NCT00383721|565268930|FG003|26-Week Treatment Safety Extension|Administrative|1|||
156598018|NCT00383721|565268931|FG004|26-Week Treatment Safety Extension|Administrative|0|||
156598019|NCT03519516|565268932|FG000|Overall Study|Adverse Event|0|||
156598020|NCT03519516|565268933|FG001|Overall Study|Adverse Event|1|||
156598021|NCT05757427|565268937|FG000|Overall Study|Adverse Event|1|||
156598022|NCT05757427|565268937|FG000|Overall Study|Device deficiency|1|||
156598023|NCT05757427|565268937|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
156598024|NCT05757427|565268937|FG000|Overall Study|MWBI scan of only 1 breast|3|||
156598025|NCT05757427|565268937|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
156598026|NCT00781963|565270505|FG000|Overall Study|Death|3|||
156598027|NCT00781963|565270506|FG001|Overall Study|Death|0|||
156598028|NCT00781963|565270505|FG000|Overall Study|Lost to Follow-up|2|||
156598029|NCT00781963|565270506|FG001|Overall Study|Lost to Follow-up|1|||
156598030|NCT00781963|565270505|FG000|Overall Study|Withdrawal by Subject|3|||
156598031|NCT00781963|565270506|FG001|Overall Study|Withdrawal by Subject|1|||
156598032|NCT00781963|565270505|FG000|Overall Study|Refused follow-up|9|||
156598033|NCT00781963|565270506|FG001|Overall Study|Refused follow-up|0|||
156598034|NCT03297216|565270507|FG000|Overall Study|Death|0|||
156598035|NCT03297216|565270508|FG001|Overall Study|Death|1|||
156598036|NCT03297216|565270507|FG000|Overall Study|Miscarriage|0|||
156598037|NCT03297216|565270508|FG001|Overall Study|Miscarriage|2|||
156598038|NCT03297216|565270507|FG000|Overall Study|Lost to Follow-up|3|||
156598039|NCT03297216|565270508|FG001|Overall Study|Lost to Follow-up|2|||
156598040|NCT00436982|565270514|FG000|Overall Study|Withdrawal by Subject|3|||
156598041|NCT00436982|565270515|FG001|Overall Study|Withdrawal by Subject|1|||
156598042|NCT00436982|565270514|FG000|Overall Study|Did not receive allocated intervention|0|||
156598043|NCT00436982|565270515|FG001|Overall Study|Did not receive allocated intervention|1|||
156598044|NCT00436982|565270514|FG000|Overall Study|no RSA data|1|||
156598045|NCT00436982|565270515|FG001|Overall Study|no RSA data|2|||
156598046|NCT00953225|565270516|FG000|Overall Study|Withdrawal by Subject|2|||
156598047|NCT00953225|565270517|FG001|Overall Study|Withdrawal by Subject|0|||
156598048|NCT04058158|565270521|FG000|Period 1|Death|1|||
156598049|NCT04058158|565270522|FG001|Period 1|Death|0|||
156598050|NCT04058158|565270521|FG000|Period 1|Adverse Event|1|||
156598051|NCT04058158|565270522|FG001|Period 1|Adverse Event|1|||
156598052|NCT04058158|565270521|FG000|Period 1|Pregnancy|0|||
156598053|NCT04058158|565270522|FG001|Period 1|Pregnancy|1|||
156598054|NCT01634113|565270523|FG000|Overall Study|Not treated|0|||
156598055|NCT01634113|565270524|FG001|Overall Study|Not treated|0|||
156598056|NCT01634113|565270525|FG002|Overall Study|Not treated|1|||
156598057|NCT00520299|565270528|FG000|Overall Study|Withdrawal by Subject|0|||
156598058|NCT00520299|565270529|FG001|Overall Study|Withdrawal by Subject|0|||
156598059|NCT00520299|565270530|FG002|Overall Study|Withdrawal by Subject|2|||
156598060|NCT00520299|565270528|FG000|Overall Study|Progressive disease|0|||
156598061|NCT00520299|565270529|FG001|Overall Study|Progressive disease|3|||
156598062|NCT00520299|565270530|FG002|Overall Study|Progressive disease|4|||
156598063|NCT01352845|565270531|FG000|Overall Study|Lost to Follow-up|313|||
156598064|NCT01352845|565270532|FG001|Overall Study|Lost to Follow-up|92|||
156598065|NCT01352845|565270531|FG000|Overall Study|No Longer Willing to Participate|205|||
156598066|NCT01352845|565270532|FG001|Overall Study|No Longer Willing to Participate|58|||
156598067|NCT01352845|565270531|FG000|Overall Study|Withdrawal by Subject|48|||
156598068|NCT01352845|565270532|FG001|Overall Study|Withdrawal by Subject|16|||
156598069|NCT01352845|565270531|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
156598070|NCT01352845|565270532|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
156598071|NCT01352845|565270531|FG000|Overall Study|Pregnancy|27|||
156598072|NCT01352845|565270532|FG001|Overall Study|Pregnancy|7|||
156598073|NCT01352845|565270531|FG000|Overall Study|Adverse Event|22|||
156598074|NCT01352845|565270532|FG001|Overall Study|Adverse Event|6|||
156598075|NCT01352845|565270531|FG000|Overall Study|Other|17|||
156598076|NCT01352845|565270532|FG001|Overall Study|Other|7|||
156598077|NCT01352845|565270531|FG000|Overall Study|Protocol Violation|12|||
156598078|NCT01352845|565270532|FG001|Overall Study|Protocol Violation|6|||
156598079|NCT01352845|565270531|FG000|Overall Study|Death|3|||
156598080|NCT01352845|565270532|FG001|Overall Study|Death|0|||
156598081|NCT02062463|565270533|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
156598082|NCT02062463|565270534|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
156598083|NCT02062463|565270535|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
156598084|NCT02062463|565270536|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
156598085|NCT02062463|565270533|FG000|Stage 2|Adverse Event|0|||
156598086|NCT02062463|565270534|FG001|Stage 2|Adverse Event|0|||
156598087|NCT02062463|565270535|FG002|Stage 2|Adverse Event|12|||
156598088|NCT02062463|565270536|FG003|Stage 2|Adverse Event|20|||
156598089|NCT02062463|565270533|FG000|Stage 2|Lack of Efficacy|0|||
156598090|NCT02062463|565270534|FG001|Stage 2|Lack of Efficacy|0|||
156598091|NCT02062463|565270535|FG002|Stage 2|Lack of Efficacy|3|||
156598092|NCT02062463|565270536|FG003|Stage 2|Lack of Efficacy|4|||
156598093|NCT02062463|565270533|FG000|Stage 2|Lost to Follow-up|0|||
156598094|NCT02062463|565270534|FG001|Stage 2|Lost to Follow-up|0|||
156598095|NCT02062463|565270535|FG002|Stage 2|Lost to Follow-up|20|||
156598096|NCT02062463|565270536|FG003|Stage 2|Lost to Follow-up|20|||
156598097|NCT02062463|565270533|FG000|Stage 2|Non-Compliance|0|||
156598098|NCT02062463|565270534|FG001|Stage 2|Non-Compliance|0|||
156598099|NCT02062463|565270535|FG002|Stage 2|Non-Compliance|0|||
156598100|NCT02062463|565270536|FG003|Stage 2|Non-Compliance|1|||
156598101|NCT02062463|565270533|FG000|Stage 2|Other than specified|0|||
156598102|NCT02062463|565270534|FG001|Stage 2|Other than specified|0|||
156598103|NCT02062463|565270535|FG002|Stage 2|Other than specified|3|||
156598104|NCT02062463|565270536|FG003|Stage 2|Other than specified|1|||
156598105|NCT02062463|565270533|FG000|Stage 2|Withdrawal by Subject|0|||
156598106|NCT02062463|565270534|FG001|Stage 2|Withdrawal by Subject|0|||
156598107|NCT02062463|565270535|FG002|Stage 2|Withdrawal by Subject|15|||
156598108|NCT02062463|565270536|FG003|Stage 2|Withdrawal by Subject|10|||
156598109|NCT01956240|565270545|FG000|Overall Study|Lost to Follow-up|6|||
156598110|NCT01956240|565270546|FG001|Overall Study|Lost to Follow-up|20|||
156598111|NCT01956240|565270545|FG000|Overall Study|Adverse Event|17|||
156598112|NCT01956240|565270546|FG001|Overall Study|Adverse Event|4|||
156598113|NCT00600028|565270549|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
156598114|NCT00600028|565270550|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
156598115|NCT00600028|565270549|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
156598116|NCT00600028|565270550|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
156598117|NCT00600028|565270549|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
156598118|NCT00600028|565270550|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
156598119|NCT01830816|565270554|FG000|Overall Study|Progressive Disease|12|||
156598120|NCT01830816|565270555|FG001|Overall Study|Progressive Disease|7|||
156598121|NCT01830816|565270556|FG002|Overall Study|Progressive Disease|7|||
156598122|NCT01830816|565270554|FG000|Overall Study|Adverse Event|3|||
156863679|NCT05194124|566258763|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
156598123|NCT01830816|565270555|FG001|Overall Study|Adverse Event|4|||
156598124|NCT01830816|565270556|FG002|Overall Study|Adverse Event|0|||
156598125|NCT01830816|565270554|FG000|Overall Study|Study Terminated by Sponsor|1|||
156598126|NCT01830816|565270555|FG001|Overall Study|Study Terminated by Sponsor|1|||
156598127|NCT01830816|565270556|FG002|Overall Study|Study Terminated by Sponsor|0|||
156598128|NCT01830816|565270554|FG000|Overall Study|Withdrawal by Subject|1|||
156598129|NCT01830816|565270555|FG001|Overall Study|Withdrawal by Subject|1|||
156598130|NCT01830816|565270556|FG002|Overall Study|Withdrawal by Subject|0|||
156598131|NCT01830816|565270554|FG000|Overall Study|Lost to Follow-up|0|||
156598132|NCT01830816|565270555|FG001|Overall Study|Lost to Follow-up|1|||
156598133|NCT01830816|565270556|FG002|Overall Study|Lost to Follow-up|0|||
156598134|NCT01830816|565270554|FG000|Overall Study|Symptomatic Deterioration|1|||
156598135|NCT01830816|565270555|FG001|Overall Study|Symptomatic Deterioration|0|||
156598136|NCT01830816|565270556|FG002|Overall Study|Symptomatic Deterioration|0|||
156598137|NCT01830816|565270554|FG000|Overall Study|Reason not Specified|2|||
156598138|NCT01830816|565270555|FG001|Overall Study|Reason not Specified|0|||
156598139|NCT01830816|565270556|FG002|Overall Study|Reason not Specified|0|||
156598140|NCT03172481|565270557|FG000|Double-blind|Withdrawal by Subject|1|||
156598141|NCT03172481|565270558|FG001|Double-blind|Withdrawal by Subject|0|||
156598142|NCT02716194|565270559|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
156598143|NCT02716194|565270560|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
156598144|NCT02716194|565270561|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
156598145|NCT00363051|565270565|FG000|Overall Study|Adminstrative problems|1|||
156598146|NCT00363051|565270566|FG001|Overall Study|Adminstrative problems|1|||
156598147|NCT00363051|565270565|FG000|Overall Study|Adverse Event|21|||
156598148|NCT00363051|565270566|FG001|Overall Study|Adverse Event|12|||
156598149|NCT00363051|565270565|FG000|Overall Study|New Cancer Therapy|2|||
156598150|NCT00363051|565270566|FG001|Overall Study|New Cancer Therapy|1|||
156598151|NCT00363051|565270565|FG000|Overall Study|Withdrawal by Subject|11|||
156598152|NCT00363051|565270566|FG001|Overall Study|Withdrawal by Subject|3|||
156598153|NCT00363051|565270565|FG000|Overall Study|Lost to Follow-up|0|||
156598154|NCT00363051|565270566|FG001|Overall Study|Lost to Follow-up|1|||
156598155|NCT00363051|565270565|FG000|Overall Study|Protocol Violation|0|||
156598156|NCT00363051|565270566|FG001|Overall Study|Protocol Violation|2|||
156598157|NCT00363051|565270565|FG000|Overall Study|Death|3|||
156598158|NCT00363051|565270566|FG001|Overall Study|Death|2|||
156598159|NCT02759562|565270567|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
156598160|NCT02759562|565270568|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
156598161|NCT02759562|565270567|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
156598162|NCT02759562|565270568|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
156598163|NCT02293993|565270569|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
156598164|NCT02293993|565270570|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
156598165|NCT02293993|565270571|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
156598166|NCT02293993|565270572|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
156598167|NCT02293993|565270569|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
156598168|NCT02293993|565270570|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
156598169|NCT02293993|565270571|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
156598170|NCT02293993|565270572|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
156598171|NCT02293993|565270569|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
156598172|NCT02293993|565270570|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
156598173|NCT02293993|565270571|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
156598174|NCT02293993|565270572|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
156598175|NCT02293993|565270569|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
156598176|NCT02293993|565270570|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
156598177|NCT02293993|565270571|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
156598178|NCT02293993|565270572|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
156598179|NCT02293993|565270569|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
156598180|NCT02293993|565270570|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
156598181|NCT02293993|565270571|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
156598182|NCT02293993|565270572|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
156598183|NCT03587584|565270573|FG000|Overall Study|SOC deviations|4|||
156598184|NCT03587584|565270574|FG001|Overall Study|SOC deviations|6|||
156598185|NCT03587584|565270573|FG000|Overall Study|Incomplete data|0|||
156598186|NCT03587584|565270574|FG001|Overall Study|Incomplete data|3|||
156598187|NCT00830115|565270575|FG000|Overall Study|Adverse Event|2|||
156598188|NCT00830115|565270575|FG000|Overall Study|Improvement/recovery|1|||
156598189|NCT01107405|565270587|FG000|Overall Study|Adverse Event|1|||
156598190|NCT01107405|565270588|FG001|Overall Study|Adverse Event|1|||
156598191|NCT01107405|565270589|FG002|Overall Study|Adverse Event|0|||
156598192|NCT01107405|565270590|FG003|Overall Study|Adverse Event|0|||
156598193|NCT01107405|565270591|FG004|Overall Study|Adverse Event|2|||
156598194|NCT01107405|565270587|FG000|Overall Study|Withdrawal by Subject|1|||
156598195|NCT01107405|565270588|FG001|Overall Study|Withdrawal by Subject|0|||
156598196|NCT01107405|565270589|FG002|Overall Study|Withdrawal by Subject|1|||
156598197|NCT01107405|565270590|FG003|Overall Study|Withdrawal by Subject|2|||
156598198|NCT01107405|565270591|FG004|Overall Study|Withdrawal by Subject|1|||
156598199|NCT01107405|565270587|FG000|Overall Study|Protocol Violation|0|||
156598200|NCT01107405|565270588|FG001|Overall Study|Protocol Violation|0|||
156598201|NCT01107405|565270589|FG002|Overall Study|Protocol Violation|1|||
156598202|NCT01107405|565270590|FG003|Overall Study|Protocol Violation|1|||
156598203|NCT01107405|565270591|FG004|Overall Study|Protocol Violation|0|||
156598204|NCT02310906|565270605|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
156598205|NCT02310906|565270606|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
156598206|NCT02310906|565270607|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
156598207|NCT02310906|565270608|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
156598208|NCT02310906|565270605|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
156598209|NCT02310906|565270606|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
156598210|NCT02310906|565270607|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
156598211|NCT02310906|565270608|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
156598212|NCT02310906|565270605|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
156598213|NCT02310906|565270606|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
156598214|NCT02310906|565270607|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
156598215|NCT02310906|565270608|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
156598216|NCT02310906|565270605|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
156598217|NCT02310906|565270606|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
156598218|NCT02310906|565270607|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
156598219|NCT02310906|565270608|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
156598220|NCT00433446|565270609|FG000|Overall Study|Adverse Event|4|||
156598221|NCT00433446|565270609|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156598222|NCT00433446|565270609|FG000|Overall Study|Progression|44|||
156598223|NCT00433446|565270609|FG000|Overall Study|Other - Not Protocol specified|3|||
156598224|NCT00433446|565270609|FG000|Overall Study|Ineligible|9|||
156598225|NCT01188538|565270610|FG000|Overall Study|Lost to Follow-up|0|||
156598226|NCT01188538|565270611|FG001|Overall Study|Lost to Follow-up|1|||
156598227|NCT02899377|565270615|FG000|Overall Study|Adverse Event|1|||
156598228|NCT02899377|565270616|FG001|Overall Study|Adverse Event|0|||
156598229|NCT01231607|565270617|FG000|Overall Study|Adverse Event|0|||
156598230|NCT01231607|565270618|FG001|Overall Study|Adverse Event|8|||
156598231|NCT01231607|565270619|FG002|Overall Study|Adverse Event|4|||
156598232|NCT01231607|565270620|FG003|Overall Study|Adverse Event|4|||
156598233|NCT01231607|565270621|FG004|Overall Study|Adverse Event|5|||
156598234|NCT01231607|565270617|FG000|Overall Study|Lost to Follow-up|13|||
156598235|NCT01231607|565270618|FG001|Overall Study|Lost to Follow-up|11|||
156598236|NCT01231607|565270619|FG002|Overall Study|Lost to Follow-up|10|||
156598237|NCT01231607|565270620|FG003|Overall Study|Lost to Follow-up|10|||
156598238|NCT01231607|565270621|FG004|Overall Study|Lost to Follow-up|4|||
156598239|NCT01231607|565270617|FG000|Overall Study|Physician Decision|4|||
156598240|NCT01231607|565270618|FG001|Overall Study|Physician Decision|4|||
156598241|NCT01231607|565270619|FG002|Overall Study|Physician Decision|3|||
156598242|NCT01231607|565270620|FG003|Overall Study|Physician Decision|5|||
156598243|NCT01231607|565270621|FG004|Overall Study|Physician Decision|4|||
156598244|NCT01231607|565270617|FG000|Overall Study|Protocol Violation|3|||
156598245|NCT01231607|565270618|FG001|Overall Study|Protocol Violation|2|||
156598246|NCT01231607|565270619|FG002|Overall Study|Protocol Violation|0|||
156598247|NCT01231607|565270620|FG003|Overall Study|Protocol Violation|2|||
156598248|NCT01231607|565270621|FG004|Overall Study|Protocol Violation|2|||
156598249|NCT01231607|565270617|FG000|Overall Study|Withdrawal by Subject|9|||
156598250|NCT01231607|565270618|FG001|Overall Study|Withdrawal by Subject|9|||
156598251|NCT01231607|565270619|FG002|Overall Study|Withdrawal by Subject|14|||
156598252|NCT01231607|565270620|FG003|Overall Study|Withdrawal by Subject|17|||
156598253|NCT01231607|565270621|FG004|Overall Study|Withdrawal by Subject|9|||
156598254|NCT01170702|565270625|FG000|Overall Study|Exclusion criteria met after consent|1|||
156598255|NCT01170702|565270626|FG001|Overall Study|Exclusion criteria met after consent|2|||
156598256|NCT01170702|565270627|FG002|Overall Study|Exclusion criteria met after consent|0|||
156598257|NCT01170702|565270628|FG003|Overall Study|Exclusion criteria met after consent|2|||
156598258|NCT01677507|565270629|FG000|Initial Assignment|Adverse Event|0|||
156598259|NCT01677507|565270630|FG001|Initial Assignment|Adverse Event|1|||
156598260|NCT01677507|565270629|FG000|Initial Assignment|Protocol Violation|0|||
156598261|NCT01677507|565270630|FG001|Initial Assignment|Protocol Violation|1|||
156598262|NCT01677507|565270629|FG000|Second Assigment|Withdrawal by Subject|2|||
156598263|NCT01677507|565270630|FG001|Second Assigment|Withdrawal by Subject|2|||
156598264|NCT01677507|565270629|FG000|Second Assigment|Adverse Event|1|||
156598265|NCT01677507|565270630|FG001|Second Assigment|Adverse Event|3|||
156598266|NCT03779334|565270631|FG000|Overall Study|Withdrawal by Subject|3|||
156598267|NCT03779334|565270632|FG001|Overall Study|Withdrawal by Subject|0|||
156598268|NCT03779334|565270633|FG002|Overall Study|Withdrawal by Subject|0|||
156598269|NCT03779334|565270631|FG000|Overall Study|Ongoing in Study|5|||
156598270|NCT03779334|565270632|FG001|Overall Study|Ongoing in Study|13|||
156598271|NCT03779334|565270633|FG002|Overall Study|Ongoing in Study|5|||
156598272|NCT00085917|565270634|FG000|Overall Study|Adverse Event|4|||
156598273|NCT00085917|565270635|FG001|Overall Study|Adverse Event|3|||
156598274|NCT01103778|565270638|FG000|Overall Study|Lost to Follow-up|1|||
156598275|NCT01103778|565270638|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
156598276|NCT01103778|565270638|FG000|Overall Study|Screen failure|1|||
156598277|NCT03670641|565270643|FG000|Overall Study|Lost to Follow-up|3|||
156598278|NCT00125190|565270649|FG000|Overall Study|Subject/Parent Decision|7|||
156598279|NCT00125190|565270649|FG000|Overall Study|Non-compliance|2|||
156598280|NCT00125190|565270649|FG000|Overall Study|Adverse Event|1|||
156598281|NCT00125190|565270649|FG000|Overall Study|Other|1|||
156598282|NCT00125190|565270649|FG000|Overall Study|Lost to Follow-up|4|||
156598283|NCT00916370|565270650|FG000|Overall Study|Death|3|||
156598284|NCT00916370|565270651|FG001|Overall Study|Death|1|||
156598285|NCT00916370|565270650|FG000|Overall Study|Withdrawal by Subject|2|||
156598286|NCT00916370|565270651|FG001|Overall Study|Withdrawal by Subject|0|||
156598287|NCT00916370|565270650|FG000|Overall Study|Physician Decision|0|||
156598288|NCT00916370|565270651|FG001|Overall Study|Physician Decision|1|||
156598289|NCT00414960|565270652|FG000|Overall Study|Adverse Event|4|||
156598290|NCT00414960|565270653|FG001|Overall Study|Adverse Event|0|||
156598291|NCT00414960|565270652|FG000|Overall Study|Withdrawal by Subject|3|||
156598292|NCT00414960|565270653|FG001|Overall Study|Withdrawal by Subject|0|||
156598293|NCT00414960|565270652|FG000|Overall Study|Physician Decision|0|||
156598294|NCT00414960|565270653|FG001|Overall Study|Physician Decision|1|||
156598295|NCT03722784|565270656|FG000|Overall Study|Withdrawal by Subject|1|||
156598296|NCT03722784|565270657|FG001|Overall Study|Withdrawal by Subject|0|||
156598297|NCT03722784|565270656|FG000|Overall Study|Physician Decision|1|||
156598298|NCT03722784|565270657|FG001|Overall Study|Physician Decision|1|||
156598299|NCT03722784|565270656|FG000|Overall Study|Protocol Violation|0|||
156598300|NCT03722784|565270657|FG001|Overall Study|Protocol Violation|1|||
156598301|NCT00738374|565270658|FG000|Induction Treatment Phase|Adverse Event|14|||
156598302|NCT00738374|565270659|FG001|Induction Treatment Phase|Adverse Event|0|||
156598303|NCT00738374|565270660|FG002|Induction Treatment Phase|Adverse Event|0|||
156598304|NCT00738374|565270661|FG003|Induction Treatment Phase|Adverse Event|0|||
156598305|NCT00738374|565270658|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
156598306|NCT00738374|565270659|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
156598307|NCT00738374|565270660|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
156598308|NCT00738374|565270661|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
156598309|NCT00738374|565270658|FG000|Induction Treatment Phase|Physician Decision|2|||
156598310|NCT00738374|565270659|FG001|Induction Treatment Phase|Physician Decision|0|||
156598311|NCT00738374|565270660|FG002|Induction Treatment Phase|Physician Decision|0|||
156598312|NCT00738374|565270661|FG003|Induction Treatment Phase|Physician Decision|0|||
156598313|NCT00738374|565270658|FG000|Induction Treatment Phase|Protocol Violation|2|||
156598314|NCT00738374|565270659|FG001|Induction Treatment Phase|Protocol Violation|0|||
156598315|NCT00738374|565270660|FG002|Induction Treatment Phase|Protocol Violation|0|||
156598316|NCT00738374|565270661|FG003|Induction Treatment Phase|Protocol Violation|0|||
156598317|NCT00738374|565270658|FG000|Induction Treatment Phase|Non-compliance|1|||
156598318|NCT00738374|565270659|FG001|Induction Treatment Phase|Non-compliance|0|||
156598319|NCT00738374|565270660|FG002|Induction Treatment Phase|Non-compliance|0|||
156598320|NCT00738374|565270661|FG003|Induction Treatment Phase|Non-compliance|0|||
156598321|NCT00738374|565270658|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
156598322|NCT00738374|565270659|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
156598323|NCT00738374|565270660|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
156598324|NCT00738374|565270661|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
156598325|NCT00738374|565270658|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
156598326|NCT00738374|565270659|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
156598327|NCT00738374|565270660|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
156598328|NCT00738374|565270661|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
156598329|NCT00738374|565270658|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
156598330|NCT00738374|565270659|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
156598331|NCT00738374|565270660|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
156598332|NCT00738374|565270661|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
156598333|NCT00738374|565270658|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
156598334|NCT00738374|565270659|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
156598335|NCT00738374|565270660|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
156598336|NCT00738374|565270661|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
156598337|NCT00738374|565270658|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
156598338|NCT00738374|565270659|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
156598339|NCT00738374|565270660|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
156598340|NCT00738374|565270661|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
156598341|NCT00738374|565270658|FG000|Maintenance Treatment/Observation Phase|Other|0|||
156598342|NCT00738374|565270659|FG001|Maintenance Treatment/Observation Phase|Other|1|||
156598343|NCT00738374|565270660|FG002|Maintenance Treatment/Observation Phase|Other|0|||
156598344|NCT00738374|565270661|FG003|Maintenance Treatment/Observation Phase|Other|0|||
156598345|NCT00603733|565272056|FG000|Active Phase ITT|Adverse Event|8|||
156598346|NCT00603733|565272057|FG001|Active Phase ITT|Adverse Event|7|||
156598347|NCT00603733|565272056|FG000|Active Phase ITT|Withdrawal by Subject|0|||
156598348|NCT00603733|565272057|FG001|Active Phase ITT|Withdrawal by Subject|3|||
156598349|NCT00603733|565272056|FG000|Active Phase ITT|Lost to Follow-up|0|||
156598350|NCT00603733|565272057|FG001|Active Phase ITT|Lost to Follow-up|1|||
156598351|NCT00603733|565272056|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
156598352|NCT00603733|565272057|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
156598353|NCT00603733|565272056|FG000|Active Phase ITT|Lack of Efficacy|1|||
156598354|NCT00603733|565272057|FG001|Active Phase ITT|Lack of Efficacy|2|||
156598355|NCT00603733|565272056|FG000|Active Phase ITT|Subject moved, site closed|1|||
156598356|NCT00603733|565272057|FG001|Active Phase ITT|Subject moved, site closed|1|||
156598357|NCT00603733|565272056|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
156598358|NCT00603733|565272057|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
156598359|NCT00603733|565272056|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
156598360|NCT00603733|565272057|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
156598361|NCT00603733|565272056|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
156598362|NCT00603733|565272057|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
156598363|NCT00603733|565272056|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
156598364|NCT00603733|565272057|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
156598365|NCT00603733|565272056|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
156598366|NCT00603733|565272057|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
156598367|NCT00603733|565272056|FG000|Maintenance Phase ITT|Adverse Event|3|||
156598368|NCT00603733|565272057|FG001|Maintenance Phase ITT|Adverse Event|6|||
156598369|NCT00603733|565272056|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
156598370|NCT00603733|565272057|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
156598371|NCT00603733|565272056|FG000|Maintenance Phase ITT|Protocol Violation|1|||
156598372|NCT00603733|565272057|FG001|Maintenance Phase ITT|Protocol Violation|1|||
156598373|NCT00603733|565272056|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
156598374|NCT00603733|565272057|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
156598375|NCT00603733|565272056|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
156598376|NCT00603733|565272057|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
156598377|NCT00603733|565272056|FG000|Maintenance Phase ITT|Physician Decision|0|||
156598378|NCT00603733|565272057|FG001|Maintenance Phase ITT|Physician Decision|1|||
156598379|NCT00603733|565272056|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
156598380|NCT00603733|565272057|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
156598381|NCT02215616|565272061|FG000|Overall Study|Sponsor requested to stop study drug|0|||
156598382|NCT02215616|565272062|FG001|Overall Study|Sponsor requested to stop study drug|0|||
156598383|NCT02215616|565272063|FG002|Overall Study|Sponsor requested to stop study drug|1|||
156598384|NCT02215616|565272064|FG003|Overall Study|Sponsor requested to stop study drug|4|||
156598385|NCT02215616|565272061|FG000|Overall Study|Death|1|||
156598386|NCT02215616|565272062|FG001|Overall Study|Death|0|||
156598387|NCT02215616|565272063|FG002|Overall Study|Death|0|||
156598388|NCT02215616|565272064|FG003|Overall Study|Death|0|||
156598389|NCT02215616|565272061|FG000|Overall Study|Adverse Event|7|||
156598390|NCT02215616|565272062|FG001|Overall Study|Adverse Event|4|||
156598391|NCT02215616|565272063|FG002|Overall Study|Adverse Event|9|||
156598392|NCT02215616|565272064|FG003|Overall Study|Adverse Event|2|||
156598393|NCT02215616|565272061|FG000|Overall Study|Withdrawal by Subject|1|||
156598394|NCT02215616|565272062|FG001|Overall Study|Withdrawal by Subject|8|||
156598395|NCT02215616|565272063|FG002|Overall Study|Withdrawal by Subject|2|||
156598396|NCT02215616|565272064|FG003|Overall Study|Withdrawal by Subject|5|||
156598397|NCT02215616|565272061|FG000|Overall Study|Non-compliance|0|||
156598398|NCT02215616|565272062|FG001|Overall Study|Non-compliance|2|||
156598399|NCT02215616|565272063|FG002|Overall Study|Non-compliance|1|||
156598400|NCT02215616|565272064|FG003|Overall Study|Non-compliance|0|||
156598401|NCT02215616|565272061|FG000|Overall Study|Protocol Violation|0|||
156598402|NCT02215616|565272062|FG001|Overall Study|Protocol Violation|2|||
156598403|NCT02215616|565272063|FG002|Overall Study|Protocol Violation|0|||
156598404|NCT02215616|565272064|FG003|Overall Study|Protocol Violation|0|||
156598405|NCT02215616|565272061|FG000|Overall Study|Lost to Follow-up|1|||
156598406|NCT02215616|565272062|FG001|Overall Study|Lost to Follow-up|1|||
156598407|NCT02215616|565272063|FG002|Overall Study|Lost to Follow-up|0|||
156598408|NCT02215616|565272064|FG003|Overall Study|Lost to Follow-up|1|||
156598409|NCT02215616|565272061|FG000|Overall Study|Other than specified|1|||
156598410|NCT02215616|565272062|FG001|Overall Study|Other than specified|0|||
156598411|NCT02215616|565272063|FG002|Overall Study|Other than specified|1|||
156598412|NCT02215616|565272064|FG003|Overall Study|Other than specified|1|||
156598413|NCT01957709|565272065|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
156598414|NCT01061736|565272067|FG000|Overall Study|Dose regimen not selected|0|||
156598415|NCT01061736|565272068|FG001|Overall Study|Dose regimen not selected|0|||
156598416|NCT01061736|565272069|FG002|Overall Study|Dose regimen not selected|0|||
156598417|NCT01061736|565272070|FG003|Overall Study|Dose regimen not selected|0|||
156598418|NCT01061736|565272071|FG004|Overall Study|Dose regimen not selected|0|||
156598419|NCT01061736|565272072|FG005|Overall Study|Dose regimen not selected|0|||
156598420|NCT01061736|565272073|FG006|Overall Study|Dose regimen not selected|79|||
156598421|NCT01061736|565272074|FG007|Overall Study|Dose regimen not selected|0|||
156598422|NCT01061736|565272075|FG008|Overall Study|Dose regimen not selected|0|||
156598423|NCT01061736|565272076|FG009|Overall Study|Dose regimen not selected|0|||
156598424|NCT01061736|565272067|FG000|Overall Study|Adverse Event|13|||
156598425|NCT01061736|565272068|FG001|Overall Study|Adverse Event|1|||
156598426|NCT01061736|565272069|FG002|Overall Study|Adverse Event|3|||
156598427|NCT01061736|565272070|FG003|Overall Study|Adverse Event|2|||
156598428|NCT01061736|565272071|FG004|Overall Study|Adverse Event|4|||
156598429|NCT01061736|565272072|FG005|Overall Study|Adverse Event|1|||
156598430|NCT01061736|565272073|FG006|Overall Study|Adverse Event|4|||
156598431|NCT01061736|565272074|FG007|Overall Study|Adverse Event|63|||
156598432|NCT01061736|565272075|FG008|Overall Study|Adverse Event|67|||
156598433|NCT01061736|565272076|FG009|Overall Study|Adverse Event|34|||
156598434|NCT01061736|565272067|FG000|Overall Study|Lack of Efficacy|0|||
156598435|NCT01061736|565272068|FG001|Overall Study|Lack of Efficacy|2|||
156598436|NCT01061736|565272069|FG002|Overall Study|Lack of Efficacy|1|||
156598437|NCT01061736|565272070|FG003|Overall Study|Lack of Efficacy|1|||
156598438|NCT01061736|565272071|FG004|Overall Study|Lack of Efficacy|1|||
156598439|NCT01061736|565272072|FG005|Overall Study|Lack of Efficacy|2|||
156598440|NCT01061736|565272073|FG006|Overall Study|Lack of Efficacy|1|||
156598441|NCT01061736|565272074|FG007|Overall Study|Lack of Efficacy|9|||
156598442|NCT01061736|565272075|FG008|Overall Study|Lack of Efficacy|9|||
156598443|NCT01061736|565272076|FG009|Overall Study|Lack of Efficacy|10|||
156598444|NCT01061736|565272067|FG000|Overall Study|Poor compliance to protocol|0|||
156598445|NCT01061736|565272068|FG001|Overall Study|Poor compliance to protocol|0|||
156598446|NCT01061736|565272069|FG002|Overall Study|Poor compliance to protocol|0|||
156598447|NCT01061736|565272070|FG003|Overall Study|Poor compliance to protocol|0|||
156598448|NCT01061736|565272071|FG004|Overall Study|Poor compliance to protocol|0|||
156598449|NCT01061736|565272072|FG005|Overall Study|Poor compliance to protocol|0|||
156598450|NCT01061736|565272073|FG006|Overall Study|Poor compliance to protocol|0|||
156598451|NCT01061736|565272074|FG007|Overall Study|Poor compliance to protocol|2|||
156598452|NCT01061736|565272075|FG008|Overall Study|Poor compliance to protocol|5|||
156598453|NCT01061736|565272076|FG009|Overall Study|Poor compliance to protocol|9|||
156598454|NCT01061736|565272067|FG000|Overall Study|Not treated|0|||
156598455|NCT01061736|565272068|FG001|Overall Study|Not treated|0|||
156598456|NCT01061736|565272069|FG002|Overall Study|Not treated|0|||
156598457|NCT01061736|565272070|FG003|Overall Study|Not treated|0|||
156598458|NCT01061736|565272071|FG004|Overall Study|Not treated|1|||
156598459|NCT01061736|565272072|FG005|Overall Study|Not treated|0|||
156598460|NCT01061736|565272073|FG006|Overall Study|Not treated|0|||
156598461|NCT01061736|565272074|FG007|Overall Study|Not treated|2|||
156598462|NCT01061736|565272075|FG008|Overall Study|Not treated|1|||
156598463|NCT01061736|565272076|FG009|Overall Study|Not treated|0|||
156598464|NCT01061736|565272067|FG000|Overall Study|Other than specified above|0|||
156598465|NCT01061736|565272068|FG001|Overall Study|Other than specified above|1|||
156598466|NCT01061736|565272069|FG002|Overall Study|Other than specified above|2|||
156598467|NCT01061736|565272070|FG003|Overall Study|Other than specified above|0|||
156598468|NCT01061736|565272071|FG004|Overall Study|Other than specified above|1|||
156598469|NCT01061736|565272072|FG005|Overall Study|Other than specified above|0|||
156598470|NCT01061736|565272073|FG006|Overall Study|Other than specified above|0|||
156598471|NCT01061736|565272074|FG007|Overall Study|Other than specified above|18|||
156598472|NCT01061736|565272075|FG008|Overall Study|Other than specified above|15|||
156598473|NCT01061736|565272076|FG009|Overall Study|Other than specified above|21|||
156598474|NCT01925612|565272077|FG000|Overall Study|Progressive Disease|1|||
156598475|NCT01925612|565272078|FG001|Overall Study|Progressive Disease|1|||
156598476|NCT01925612|565272079|FG002|Overall Study|Progressive Disease|1|||
156598477|NCT01925612|565272080|FG003|Overall Study|Progressive Disease|0|||
156598478|NCT01925612|565272081|FG004|Overall Study|Progressive Disease|0|||
156598479|NCT01925612|565272077|FG000|Overall Study|Adverse Event|3|||
156598480|NCT01925612|565272078|FG001|Overall Study|Adverse Event|3|||
156598481|NCT01925612|565272079|FG002|Overall Study|Adverse Event|0|||
156598482|NCT01925612|565272080|FG003|Overall Study|Adverse Event|1|||
156598483|NCT01925612|565272081|FG004|Overall Study|Adverse Event|2|||
156598484|NCT01093755|565272083|FG000|Overall Study|Withdrawal by Subject|3|||
156598485|NCT01093755|565272084|FG001|Overall Study|Withdrawal by Subject|4|||
156598486|NCT03115112|565272085|FG000|Overall Study|Adverse Event|5|||
156598487|NCT03115112|565272086|FG001|Overall Study|Adverse Event|1|||
156598488|NCT03115112|565272085|FG000|Overall Study|Withdrawal by Subject|4|||
156598489|NCT03115112|565272086|FG001|Overall Study|Withdrawal by Subject|2|||
156598490|NCT03115112|565272085|FG000|Overall Study|Lost to Follow-up|0|||
156598491|NCT03115112|565272086|FG001|Overall Study|Lost to Follow-up|1|||
156598492|NCT03115112|565272085|FG000|Overall Study|Death|1|||
156598493|NCT03115112|565272086|FG001|Overall Study|Death|0|||
156598494|NCT03115112|565272085|FG000|Overall Study|Pregnancy|1|||
156598495|NCT03115112|565272086|FG001|Overall Study|Pregnancy|0|||
156598496|NCT03115112|565272085|FG000|Overall Study|Site closure|1|||
156598497|NCT03115112|565272086|FG001|Overall Study|Site closure|1|||
156598498|NCT01610076|565272087|FG000|Overall Study|Technical issue with video|0|||
156598499|NCT01610076|565272088|FG001|Overall Study|Technical issue with video|1|||
156598500|NCT01610076|565272087|FG000|Overall Study|Lost to Follow-up|3|||
156598501|NCT01610076|565272088|FG001|Overall Study|Lost to Follow-up|4|||
156598502|NCT00980343|565272093|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
156598503|NCT00980343|565272094|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
156598504|NCT00469209|565272095|FG000|Overall Study|Adverse Event|1|||
156598505|NCT00469209|565272096|FG001|Overall Study|Adverse Event|0|||
156598506|NCT00469209|565272097|FG002|Overall Study|Adverse Event|1|||
156598507|NCT01082367|565272106|FG000|Double-blind Period|Administrative problems|0|||
156598508|NCT01082367|565272107|FG001|Double-blind Period|Administrative problems|1|||
156598509|NCT01082367|565272106|FG000|Double-blind Period|Lack of Efficacy|5|||
156598510|NCT01082367|565272107|FG001|Double-blind Period|Lack of Efficacy|11|||
156598511|NCT01082367|565272106|FG000|Double-blind Period|Adverse Event|0|||
156598512|NCT01082367|565272107|FG001|Double-blind Period|Adverse Event|1|||
156598513|NCT01082367|565272106|FG000|Follow-up (F-U) Period|Administrative problems|1|||
156598514|NCT01082367|565272107|FG001|Follow-up (F-U) Period|Administrative problems|0|||
156598515|NCT01082367|565272106|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
156598516|NCT01082367|565272107|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
156598517|NCT01082367|565272106|FG000|Follow-up (F-U) Period|Adverse Event|0|||
156598518|NCT01082367|565272107|FG001|Follow-up (F-U) Period|Adverse Event|1|||
156598519|NCT00098020|565272110|FG000|Overall Study|Adverse Event|2|||
156598520|NCT00098020|565272110|FG000|Overall Study|Lost to Follow-up|1|||
156598521|NCT00098020|565272110|FG000|Overall Study|elevated liver enzymes|1|||
156598522|NCT00098020|565272110|FG000|Overall Study|Low urine PCR|1|||
156598523|NCT00098020|565272110|FG000|Overall Study|Low epidermal growth factor receptor|1|||
156598524|NCT01453998|565272111|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
156598525|NCT01453998|565272112|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
156598526|NCT01453998|565272113|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
156598527|NCT01840228|565272123|FG000|Overall Study|Lost to Follow-up|1|||
156598528|NCT01840228|565272124|FG001|Overall Study|Lost to Follow-up|1|||
156598529|NCT03495453|565272127|FG000|Overall Study|Withdrawal by Subject|0|||
156598530|NCT03495453|565272128|FG001|Overall Study|Withdrawal by Subject|1|||
156598531|NCT00712933|565272129|FG000|Overall Study|Adverse Event|69|||
156598532|NCT00712933|565272129|FG000|Overall Study|Lack of Efficacy|6|||
156598533|NCT00712933|565272129|FG000|Overall Study|Lost to Follow-up|22|||
156598534|NCT00712933|565272129|FG000|Overall Study|Non-compliance with study drug|13|||
156598535|NCT00712933|565272129|FG000|Overall Study|Other Pregnancy|37|||
156598536|NCT00712933|565272129|FG000|Overall Study|Sponsor decision|14|||
156598537|NCT00712933|565272129|FG000|Overall Study|Withdrew consent|4|||
156598538|NCT00712933|565272129|FG000|Overall Study|Hip replacement surgery|1|||
156598539|NCT00712933|565272129|FG000|Overall Study|Involved in Clinical research|3|||
156598540|NCT00712933|565272129|FG000|Overall Study|Participant hospitalized|1|||
156598541|NCT00712933|565272129|FG000|Overall Study|Participant travelled overseas|2|||
156598542|NCT00712933|565272129|FG000|Overall Study|Death of patient|1|||
156598543|NCT00712933|565272129|FG000|Overall Study|Other Physician decision|1|||
156598544|NCT00712933|565272129|FG000|Overall Study|Not committed to contraception|1|||
156598545|NCT00712933|565272129|FG000|Overall Study|Participant received medication|1|||
156598546|NCT00712933|565272129|FG000|Overall Study|Physician Decision|36|||
156598547|NCT00712933|565272129|FG000|Overall Study|Protocol Violation|4|||
156598548|NCT00712933|565272129|FG000|Overall Study|Withdrawal by Subject|151|||
156598549|NCT02022033|565272133|FG000|Overall Study|Physician Decision|1|||
156598550|NCT01429077|565272134|FG000|Overall Study|Lost to Follow-up|0|||
156598551|NCT01429077|565272135|FG001|Overall Study|Lost to Follow-up|3|||
156598552|NCT01360762|565272138|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
156598553|NCT01360762|565272138|FG000|Main Study Period (12-month Treatment)|Death|5|||
156598554|NCT01360762|565272138|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
156598555|NCT01360762|565272138|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
156598556|NCT01360762|565272138|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
156598557|NCT01360762|565272138|FG000|Whole Study Period|Lost to Follow-up|10|||
156598558|NCT01360762|565272138|FG000|Whole Study Period|Death|7|||
156598559|NCT01360762|565272138|FG000|Whole Study Period|Patient relapsed|18|||
156598560|NCT01360762|565272138|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
156863680|NCT05194124|566258764|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863681|NCT05194124|566258765|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
156598561|NCT03084718|565272139|FG000|Overall Study|Withdrawal by Subject|4|||
156598562|NCT03084718|565272140|FG001|Overall Study|Withdrawal by Subject|3|||
156598563|NCT03084718|565272141|FG002|Overall Study|Withdrawal by Subject|4|||
156598564|NCT03084718|565272142|FG003|Overall Study|Withdrawal by Subject|0|||
156598565|NCT03084718|565272143|FG004|Overall Study|Withdrawal by Subject|0|||
156598566|NCT03084718|565272139|FG000|Overall Study|Physician Decision|1|||
156598567|NCT03084718|565272140|FG001|Overall Study|Physician Decision|0|||
156598568|NCT03084718|565272141|FG002|Overall Study|Physician Decision|0|||
156598569|NCT03084718|565272142|FG003|Overall Study|Physician Decision|0|||
156598570|NCT03084718|565272143|FG004|Overall Study|Physician Decision|0|||
156598571|NCT03084718|565272139|FG000|Overall Study|Adverse Event|3|||
156598572|NCT03084718|565272140|FG001|Overall Study|Adverse Event|5|||
156598573|NCT03084718|565272141|FG002|Overall Study|Adverse Event|5|||
156598574|NCT03084718|565272142|FG003|Overall Study|Adverse Event|8|||
156598575|NCT03084718|565272143|FG004|Overall Study|Adverse Event|2|||
156598576|NCT03084718|565272139|FG000|Overall Study|Lack of Efficacy|2|||
156598577|NCT03084718|565272140|FG001|Overall Study|Lack of Efficacy|0|||
156598578|NCT03084718|565272141|FG002|Overall Study|Lack of Efficacy|1|||
156598579|NCT03084718|565272142|FG003|Overall Study|Lack of Efficacy|4|||
156598580|NCT03084718|565272143|FG004|Overall Study|Lack of Efficacy|0|||
156598581|NCT03084718|565272139|FG000|Overall Study|Lost to Follow-up|0|||
156598582|NCT03084718|565272140|FG001|Overall Study|Lost to Follow-up|1|||
156598583|NCT03084718|565272141|FG002|Overall Study|Lost to Follow-up|0|||
156598584|NCT03084718|565272142|FG003|Overall Study|Lost to Follow-up|0|||
156598585|NCT03084718|565272143|FG004|Overall Study|Lost to Follow-up|2|||
156598586|NCT03084718|565272139|FG000|Overall Study|Protocol Violation|0|||
156598587|NCT03084718|565272140|FG001|Overall Study|Protocol Violation|0|||
156598588|NCT03084718|565272141|FG002|Overall Study|Protocol Violation|1|||
156598589|NCT03084718|565272142|FG003|Overall Study|Protocol Violation|0|||
156598590|NCT03084718|565272143|FG004|Overall Study|Protocol Violation|0|||
156598591|NCT03084718|565272139|FG000|Overall Study|Death|0|||
156598592|NCT03084718|565272140|FG001|Overall Study|Death|1|||
156598593|NCT03084718|565272141|FG002|Overall Study|Death|0|||
156598594|NCT03084718|565272142|FG003|Overall Study|Death|0|||
156598595|NCT03084718|565272143|FG004|Overall Study|Death|0|||
156598596|NCT03084718|565272139|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
156598597|NCT03084718|565272140|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
156598598|NCT03084718|565272141|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
156598599|NCT03084718|565272142|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
156598600|NCT03084718|565272143|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
156598601|NCT02806947|565272144|FG000|Overall Study|Withdrawal by Subject|5|||
156598602|NCT02806947|565272145|FG001|Overall Study|Withdrawal by Subject|1|||
156598603|NCT04929613|565272146|FG000|Overall Study|Withdrawal by Subject|12|||
156598604|NCT00865189|565272147|FG000|Overall Study|Other|1|||
156598605|NCT00865189|565272148|FG001|Overall Study|Other|2|||
156598606|NCT00865189|565272147|FG000|Overall Study|Death|4|||
156598607|NCT00865189|565272148|FG001|Overall Study|Death|11|||
156598608|NCT00865189|565272147|FG000|Overall Study|Lost to Follow-up|6|||
156598609|NCT00865189|565272148|FG001|Overall Study|Lost to Follow-up|6|||
156598610|NCT00865189|565272147|FG000|Overall Study|Withdrawal by Subject|1|||
156598611|NCT00865189|565272148|FG001|Overall Study|Withdrawal by Subject|0|||
156598612|NCT00634114|565272151|FG000|Overall Study|Adverse Event|6|||
156598613|NCT00634114|565272152|FG001|Overall Study|Adverse Event|8|||
156598614|NCT00634114|565272153|FG002|Overall Study|Adverse Event|3|||
156598615|NCT00634114|565272151|FG000|Overall Study|Withdrawal by Subject|9|||
156598616|NCT00634114|565272152|FG001|Overall Study|Withdrawal by Subject|6|||
156598617|NCT00634114|565272153|FG002|Overall Study|Withdrawal by Subject|11|||
156598618|NCT00634114|565272151|FG000|Overall Study|Lost to Follow-up|0|||
156598619|NCT00634114|565272152|FG001|Overall Study|Lost to Follow-up|0|||
156598620|NCT00634114|565272153|FG002|Overall Study|Lost to Follow-up|1|||
156598621|NCT00634114|565272151|FG000|Overall Study|Protocol Violation|3|||
156598622|NCT00634114|565272152|FG001|Overall Study|Protocol Violation|3|||
156598623|NCT00634114|565272153|FG002|Overall Study|Protocol Violation|1|||
156598624|NCT00634114|565272151|FG000|Overall Study|Pregnancy|1|||
156598625|NCT00634114|565272152|FG001|Overall Study|Pregnancy|0|||
156598626|NCT00634114|565272153|FG002|Overall Study|Pregnancy|0|||
156598627|NCT00634114|565272151|FG000|Overall Study|Incorrect enrolment|0|||
156598628|NCT00634114|565272152|FG001|Overall Study|Incorrect enrolment|1|||
156598629|NCT00634114|565272153|FG002|Overall Study|Incorrect enrolment|0|||
156598630|NCT00634114|565272151|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
156598631|NCT00634114|565272152|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
156598632|NCT00634114|565272153|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
156598633|NCT00634114|565272151|FG000|Overall Study|Difficult to continue|3|||
156598634|NCT00634114|565272152|FG001|Overall Study|Difficult to continue|1|||
156598635|NCT00634114|565272153|FG002|Overall Study|Difficult to continue|1|||
156598636|NCT00634114|565272151|FG000|Overall Study|Other reason|1|||
156598637|NCT00634114|565272152|FG001|Overall Study|Other reason|1|||
156598638|NCT00634114|565272153|FG002|Overall Study|Other reason|1|||
156598639|NCT01599754|565272154|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
156598640|NCT01599754|565272155|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
156598641|NCT01599754|565272154|FG000|Overall Study|Participant noncompliance|4|||
156598642|NCT01599754|565272155|FG001|Overall Study|Participant noncompliance|4|||
156598643|NCT01599754|565272154|FG000|Overall Study|Lost to Follow-up|13|||
156598644|NCT01599754|565272155|FG001|Overall Study|Lost to Follow-up|6|||
156598645|NCT01599754|565272154|FG000|Overall Study|Death|31|||
156598646|NCT01599754|565272155|FG001|Overall Study|Death|33|||
156598647|NCT01599754|565272154|FG000|Overall Study|Adverse Event|3|||
156598648|NCT01599754|565272155|FG001|Overall Study|Adverse Event|2|||
156598649|NCT01599754|565272154|FG000|Overall Study|Investigator decision|1|||
156598650|NCT01599754|565272155|FG001|Overall Study|Investigator decision|3|||
156598651|NCT01599754|565272154|FG000|Overall Study|Withdrawal by Subject|24|||
156598652|NCT01599754|565272155|FG001|Overall Study|Withdrawal by Subject|25|||
156598653|NCT01599754|565272154|FG000|Overall Study|Study terminated by sponsor|282|||
156598654|NCT01599754|565272155|FG001|Overall Study|Study terminated by sponsor|285|||
156598655|NCT02921919|565272156|FG000|Overall Study|Other|5|||
156598656|NCT02921919|565272157|FG001|Overall Study|Other|6|||
156598657|NCT02921919|565272156|FG000|Overall Study|Lost to Follow-up|0|||
156598658|NCT02921919|565272157|FG001|Overall Study|Lost to Follow-up|1|||
156598659|NCT02921919|565272156|FG000|Overall Study|Withdrawal by Subject|5|||
156598660|NCT02921919|565272157|FG001|Overall Study|Withdrawal by Subject|1|||
156598661|NCT02921919|565272156|FG000|Overall Study|Disease Progression|47|||
156598662|NCT02921919|565272157|FG001|Overall Study|Disease Progression|38|||
156598663|NCT02921919|565272156|FG000|Overall Study|Physician Decision|3|||
156598664|NCT02921919|565272157|FG001|Overall Study|Physician Decision|2|||
156598665|NCT02921919|565272156|FG000|Overall Study|Adverse Event|6|||
156598666|NCT02921919|565272157|FG001|Overall Study|Adverse Event|4|||
156598667|NCT03550131|565272159|FG000|Overall Study|Lost to Follow-up|16|||
156598668|NCT03550131|565272160|FG001|Overall Study|Lost to Follow-up|24|||
156598669|NCT03550131|565272159|FG000|Overall Study|Withdrawal by Subject|36|||
156598670|NCT03550131|565272160|FG001|Overall Study|Withdrawal by Subject|28|||
156598671|NCT03550131|565272159|FG000|Overall Study|Illness of dyad member|10|||
156598672|NCT03550131|565272160|FG001|Overall Study|Illness of dyad member|2|||
156598673|NCT03550131|565272159|FG000|Overall Study|Death of person with dementia|4|||
156598674|NCT03550131|565272160|FG001|Overall Study|Death of person with dementia|8|||
156598675|NCT01318512|565272161|FG000|Maintenance Period (6 Months)|Death|2|||
156598676|NCT01318512|565272161|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
156598677|NCT02756650|565272164|FG000|Overall Study|Physician Decision|1|||
156598678|NCT02756650|565272164|FG000|Overall Study|Adverse Event|1|||
156598679|NCT04348591|565272169|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
156598680|NCT04348591|565272170|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
156598681|NCT04348591|565272169|FG000|Imaging Session (120 Min)|Physician Decision|0|||
156598682|NCT04348591|565272170|FG001|Imaging Session (120 Min)|Physician Decision|1|||
156598683|NCT04348591|565272169|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
156598684|NCT04348591|565272170|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
156598685|NCT00910429|565272174|FG000|Overall Study|Death|18|||
156598686|NCT00910429|565272175|FG001|Overall Study|Death|12|||
156598687|NCT00910429|565272174|FG000|Overall Study|Withdrawal by Subject|3|||
156598688|NCT00910429|565272175|FG001|Overall Study|Withdrawal by Subject|2|||
156598689|NCT00910429|565272174|FG000|Overall Study|Protocol Violation|1|||
156598690|NCT00910429|565272175|FG001|Overall Study|Protocol Violation|0|||
156598691|NCT00910429|565272174|FG000|Overall Study|Lost to Follow-up|2|||
156598692|NCT00910429|565272175|FG001|Overall Study|Lost to Follow-up|1|||
156598693|NCT00910429|565272174|FG000|Overall Study|Adverse Event|10|||
156598694|NCT00910429|565272175|FG001|Overall Study|Adverse Event|5|||
156598695|NCT00910429|565272174|FG000|Overall Study|Drug non-compliance|1|||
156598696|NCT00910429|565272175|FG001|Overall Study|Drug non-compliance|0|||
156598697|NCT00910429|565272174|FG000|Overall Study|Lack of Efficacy|4|||
156598698|NCT00910429|565272175|FG001|Overall Study|Lack of Efficacy|1|||
156598699|NCT01317615|565272176|FG000|Overall Study|Disease progression|25|||
156598700|NCT01317615|565272176|FG000|Overall Study|New cancer therapy|5|||
156598701|NCT01317615|565272176|FG000|Overall Study|Death|6|||
156598702|NCT01317615|565272176|FG000|Overall Study|Withdrawal by Subject|5|||
156598703|NCT01317615|565272176|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156598704|NCT01317615|565272176|FG000|Overall Study|Adverse Event|7|||
156598705|NCT02648724|565272180|FG000|Overall Study|Withdrawal by Subject|0|||
156598706|NCT02648724|565272181|FG001|Overall Study|Withdrawal by Subject|1|||
156598707|NCT02648724|565272182|FG002|Overall Study|Withdrawal by Subject|1|||
156598708|NCT02648724|565272183|FG003|Overall Study|Withdrawal by Subject|0|||
156598709|NCT02648724|565272184|FG004|Overall Study|Withdrawal by Subject|1|||
156598710|NCT02648724|565272185|FG005|Overall Study|Withdrawal by Subject|0|||
156598711|NCT02648724|565272186|FG006|Overall Study|Withdrawal by Subject|0|||
156598712|NCT02648724|565272180|FG000|Overall Study|Progressive disease|2|||
156598713|NCT02648724|565272181|FG001|Overall Study|Progressive disease|2|||
156598714|NCT02648724|565272182|FG002|Overall Study|Progressive disease|2|||
156598715|NCT02648724|565272183|FG003|Overall Study|Progressive disease|3|||
156598716|NCT02648724|565272184|FG004|Overall Study|Progressive disease|22|||
156598717|NCT02648724|565272185|FG005|Overall Study|Progressive disease|7|||
156598718|NCT02648724|565272186|FG006|Overall Study|Progressive disease|8|||
156598719|NCT02648724|565272180|FG000|Overall Study|Other reason (unknown)|1|||
156598720|NCT02648724|565272181|FG001|Overall Study|Other reason (unknown)|0|||
156598721|NCT02648724|565272182|FG002|Overall Study|Other reason (unknown)|0|||
156598722|NCT02648724|565272183|FG003|Overall Study|Other reason (unknown)|0|||
156598723|NCT02648724|565272184|FG004|Overall Study|Other reason (unknown)|0|||
156598724|NCT02648724|565272185|FG005|Overall Study|Other reason (unknown)|0|||
156598725|NCT02648724|565272186|FG006|Overall Study|Other reason (unknown)|0|||
156598726|NCT02648724|565272180|FG000|Overall Study|Protocol Violation|0|||
156598727|NCT02648724|565272181|FG001|Overall Study|Protocol Violation|0|||
156598728|NCT02648724|565272182|FG002|Overall Study|Protocol Violation|0|||
156598729|NCT02648724|565272183|FG003|Overall Study|Protocol Violation|0|||
156598730|NCT02648724|565272184|FG004|Overall Study|Protocol Violation|1|||
156598731|NCT02648724|565272185|FG005|Overall Study|Protocol Violation|0|||
156598732|NCT02648724|565272186|FG006|Overall Study|Protocol Violation|0|||
156598733|NCT02648724|565272180|FG000|Overall Study|Death|0|||
156598734|NCT02648724|565272181|FG001|Overall Study|Death|0|||
156598735|NCT02648724|565272182|FG002|Overall Study|Death|0|||
156598736|NCT02648724|565272183|FG003|Overall Study|Death|0|||
156598737|NCT02648724|565272184|FG004|Overall Study|Death|0|||
156598738|NCT02648724|565272185|FG005|Overall Study|Death|0|||
156598739|NCT02648724|565272186|FG006|Overall Study|Death|3|||
156598740|NCT02648724|565272180|FG000|Overall Study|Physician Decision|0|||
156598741|NCT02648724|565272181|FG001|Overall Study|Physician Decision|0|||
156598742|NCT02648724|565272182|FG002|Overall Study|Physician Decision|0|||
156598743|NCT02648724|565272183|FG003|Overall Study|Physician Decision|0|||
156598744|NCT02648724|565272184|FG004|Overall Study|Physician Decision|1|||
156598745|NCT02648724|565272185|FG005|Overall Study|Physician Decision|0|||
156598746|NCT02648724|565272186|FG006|Overall Study|Physician Decision|1|||
156598747|NCT02648724|565272180|FG000|Overall Study|Transferred to named patient program|0|||
156598748|NCT02648724|565272181|FG001|Overall Study|Transferred to named patient program|0|||
156598749|NCT02648724|565272182|FG002|Overall Study|Transferred to named patient program|0|||
156598750|NCT02648724|565272183|FG003|Overall Study|Transferred to named patient program|0|||
156598751|NCT02648724|565272184|FG004|Overall Study|Transferred to named patient program|0|||
156598752|NCT02648724|565272185|FG005|Overall Study|Transferred to named patient program|1|||
156598753|NCT02648724|565272186|FG006|Overall Study|Transferred to named patient program|0|||
156598754|NCT00302718|565272187|FG000|Overall Study|Participant left the hospital|1|||
156598755|NCT00302718|565272188|FG001|Overall Study|Participant left the hospital|0|||
156598756|NCT00302718|565272189|FG002|Overall Study|Participant left the hospital|0|||
156598757|NCT00302718|565272190|FG003|Overall Study|Participant left the hospital|1|||
156598758|NCT00302718|565272187|FG000|Overall Study|Withdrawal by Subject|0|||
156598759|NCT00302718|565272188|FG001|Overall Study|Withdrawal by Subject|1|||
156598760|NCT00302718|565272189|FG002|Overall Study|Withdrawal by Subject|0|||
156598761|NCT00302718|565272190|FG003|Overall Study|Withdrawal by Subject|0|||
156598762|NCT00302718|565272187|FG000|Overall Study|Participant left primary care setting|0|||
156598763|NCT00302718|565272188|FG001|Overall Study|Participant left primary care setting|0|||
156598764|NCT00302718|565272189|FG002|Overall Study|Participant left primary care setting|2|||
156598765|NCT00302718|565272190|FG003|Overall Study|Participant left primary care setting|1|||
156598766|NCT00632541|565272191|FG000|Overall Study|Adverse Event|7|||
156598767|NCT03250377|565273711|FG000|Overall Study|Adverse Event|2|||
156598768|NCT03250377|565273712|FG001|Overall Study|Adverse Event|4|||
156598769|NCT03250377|565273713|FG002|Overall Study|Adverse Event|0|||
156598770|NCT03250377|565273714|FG003|Overall Study|Adverse Event|4|||
156598771|NCT03250377|565273711|FG000|Overall Study|Lack of Efficacy|5|||
156598772|NCT03250377|565273712|FG001|Overall Study|Lack of Efficacy|14|||
156598773|NCT03250377|565273713|FG002|Overall Study|Lack of Efficacy|1|||
156598774|NCT03250377|565273714|FG003|Overall Study|Lack of Efficacy|3|||
156598775|NCT03250377|565273711|FG000|Overall Study|Protocol Violation|0|||
156598776|NCT03250377|565273712|FG001|Overall Study|Protocol Violation|2|||
156598777|NCT03250377|565273713|FG002|Overall Study|Protocol Violation|0|||
156598778|NCT03250377|565273714|FG003|Overall Study|Protocol Violation|1|||
156598779|NCT03250377|565273711|FG000|Overall Study|Lost to Follow-up|0|||
156598780|NCT03250377|565273712|FG001|Overall Study|Lost to Follow-up|1|||
156598781|NCT03250377|565273713|FG002|Overall Study|Lost to Follow-up|0|||
156598782|NCT03250377|565273714|FG003|Overall Study|Lost to Follow-up|0|||
156598783|NCT03250377|565273711|FG000|Overall Study|Withdrawal by Subject|7|||
156598784|NCT03250377|565273712|FG001|Overall Study|Withdrawal by Subject|7|||
156598785|NCT03250377|565273713|FG002|Overall Study|Withdrawal by Subject|0|||
156598786|NCT03250377|565273714|FG003|Overall Study|Withdrawal by Subject|4|||
156598787|NCT03250377|565273711|FG000|Overall Study|Investigator's Judgment|1|||
156598788|NCT03250377|565273712|FG001|Overall Study|Investigator's Judgment|0|||
156598789|NCT03250377|565273713|FG002|Overall Study|Investigator's Judgment|0|||
156598790|NCT03250377|565273714|FG003|Overall Study|Investigator's Judgment|0|||
156598791|NCT03250377|565273711|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
156598792|NCT03250377|565273712|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
156598793|NCT03250377|565273713|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
156598794|NCT03250377|565273714|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
156598795|NCT03250377|565273711|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
156598796|NCT03250377|565273712|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
156598797|NCT03250377|565273713|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
156598798|NCT03250377|565273714|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
156598799|NCT03250377|565273711|FG000|Overall Study|Epilepsy Surgery|0|||
156598800|NCT03250377|565273712|FG001|Overall Study|Epilepsy Surgery|1|||
156598801|NCT03250377|565273713|FG002|Overall Study|Epilepsy Surgery|2|||
156598802|NCT03250377|565273714|FG003|Overall Study|Epilepsy Surgery|0|||
156598803|NCT03250377|565273711|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
156598804|NCT03250377|565273712|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
156598805|NCT03250377|565273713|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
156598806|NCT03250377|565273714|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
156598807|NCT03250377|565273711|FG000|Overall Study|Request From The Sponsor|0|||
156598808|NCT03250377|565273712|FG001|Overall Study|Request From The Sponsor|1|||
156598809|NCT03250377|565273713|FG002|Overall Study|Request From The Sponsor|0|||
156598810|NCT03250377|565273714|FG003|Overall Study|Request From The Sponsor|0|||
156598811|NCT03250377|565273711|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
156598812|NCT03250377|565273712|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
156598813|NCT03250377|565273713|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
156598814|NCT03250377|565273714|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
156598815|NCT03250377|565273711|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
156598816|NCT03250377|565273712|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
156598817|NCT03250377|565273713|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
156598818|NCT03250377|565273714|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
156598819|NCT03250377|565273711|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
156598820|NCT03250377|565273712|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
156598821|NCT03250377|565273713|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
156598822|NCT03250377|565273714|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
156598823|NCT03250377|565273711|FG000|Overall Study|Pregnancy Event|0|||
156598824|NCT03250377|565273712|FG001|Overall Study|Pregnancy Event|1|||
156598825|NCT03250377|565273713|FG002|Overall Study|Pregnancy Event|0|||
156598826|NCT03250377|565273714|FG003|Overall Study|Pregnancy Event|0|||
156598827|NCT03250377|565273711|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
156598828|NCT03250377|565273712|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
156598829|NCT03250377|565273713|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
156598830|NCT03250377|565273714|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
156598831|NCT03250377|565273711|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
156598832|NCT03250377|565273712|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
156598833|NCT03250377|565273713|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
156598834|NCT03250377|565273714|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
156598835|NCT03250377|565273711|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
156598836|NCT03250377|565273712|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
156598837|NCT03250377|565273713|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
156598838|NCT03250377|565273714|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
156598839|NCT03250377|565273711|FG000|Overall Study|Patient requested to change hospital|0|||
156598840|NCT03250377|565273712|FG001|Overall Study|Patient requested to change hospital|0|||
156598841|NCT03250377|565273713|FG002|Overall Study|Patient requested to change hospital|0|||
156598842|NCT03250377|565273714|FG003|Overall Study|Patient requested to change hospital|1|||
156598843|NCT03250377|565273711|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
156598844|NCT03250377|565273712|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
156598845|NCT03250377|565273713|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
156598846|NCT03250377|565273714|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
156598847|NCT02168803|565273715|FG000|Overall Study|Lost to Follow-up|1|||
156598848|NCT02168803|565273716|FG001|Overall Study|Lost to Follow-up|0|||
156598849|NCT02168803|565273717|FG002|Overall Study|Lost to Follow-up|1|||
156598850|NCT02168803|565273715|FG000|Overall Study|Withdrawal by Subject|1|||
156598851|NCT02168803|565273716|FG001|Overall Study|Withdrawal by Subject|1|||
156598852|NCT02168803|565273717|FG002|Overall Study|Withdrawal by Subject|2|||
156598853|NCT02168803|565273715|FG000|Overall Study|Physician Decision|0|||
156598854|NCT02168803|565273716|FG001|Overall Study|Physician Decision|1|||
156598855|NCT02168803|565273717|FG002|Overall Study|Physician Decision|0|||
156598856|NCT02168803|565273715|FG000|Overall Study|Adverse Event|0|||
156598857|NCT02168803|565273716|FG001|Overall Study|Adverse Event|1|||
156598858|NCT02168803|565273717|FG002|Overall Study|Adverse Event|1|||
156598859|NCT02168803|565273715|FG000|Overall Study|Death|0|||
156598860|NCT02168803|565273716|FG001|Overall Study|Death|0|||
156598861|NCT02168803|565273717|FG002|Overall Study|Death|1|||
156598862|NCT02168803|565273715|FG000|Overall Study|Sponsor Decision|0|||
156598863|NCT02168803|565273716|FG001|Overall Study|Sponsor Decision|0|||
156598864|NCT02168803|565273717|FG002|Overall Study|Sponsor Decision|1|||
156598865|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
156598866|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
156598867|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
156598868|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
156598869|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
156598870|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
156598871|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
156598872|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
156598873|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
156598874|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
156598875|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
156598876|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
156598877|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
156598878|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
156598879|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
156598880|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156598881|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156598882|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156598883|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
156598884|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
156598885|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
156598886|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
156598887|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
156598888|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
156598889|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
156598890|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
156598891|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
156598892|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
156598893|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
156598894|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
156598895|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
156598896|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
156598897|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
156598898|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
156598899|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
156598900|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
156598901|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
156598902|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
156598903|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
156598904|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
156598905|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
156598906|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
156598907|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
156598908|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
156598909|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
156598910|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
156598911|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
156598912|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
156598913|NCT03444870|565273718|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
156598914|NCT03444870|565273719|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
156598915|NCT03444870|565273720|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
156598916|NCT03444870|565273721|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
156598917|NCT03444870|565273722|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
156598918|NCT03444870|565273723|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
156598919|NCT03444870|565273718|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156598920|NCT03444870|565273719|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156598921|NCT03444870|565273720|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156598922|NCT03444870|565273721|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156598923|NCT03444870|565273722|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
156598924|NCT03444870|565273723|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
156598925|NCT03444870|565273718|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
156598926|NCT03444870|565273719|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
156598927|NCT03444870|565273720|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
156598928|NCT03444870|565273721|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
156598929|NCT03444870|565273722|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
156598930|NCT03444870|565273723|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
156598931|NCT03444870|565273718|FG000|Open-Label Extension (OLE) Period|Death|0|||
156598932|NCT03444870|565273719|FG001|Open-Label Extension (OLE) Period|Death|0|||
156598933|NCT03444870|565273720|FG002|Open-Label Extension (OLE) Period|Death|0|||
156598934|NCT03444870|565273721|FG003|Open-Label Extension (OLE) Period|Death|0|||
156598935|NCT03444870|565273722|FG004|Open-Label Extension (OLE) Period|Death|1|||
156598936|NCT03444870|565273723|FG005|Open-Label Extension (OLE) Period|Death|0|||
156598937|NCT02034552|565273724|FG000|Overall Study|Never treated|3|||
156598938|NCT02034552|565273725|FG001|Overall Study|Never treated|2|||
156598939|NCT02034552|565273726|FG002|Overall Study|Never treated|0|||
156598940|NCT02034552|565273724|FG000|Overall Study|Radiological progression|3|||
156598941|NCT02034552|565273725|FG001|Overall Study|Radiological progression|5|||
156598942|NCT02034552|565273726|FG002|Overall Study|Radiological progression|4|||
156598943|NCT02034552|565273724|FG000|Overall Study|AE not assoc. with disease progression|1|||
156598944|NCT02034552|565273725|FG001|Overall Study|AE not assoc. with disease progression|4|||
156598945|NCT02034552|565273726|FG002|Overall Study|AE not assoc. with disease progression|2|||
156598946|NCT02034552|565273724|FG000|Overall Study|AE associated with disease progression|0|||
156598947|NCT02034552|565273725|FG001|Overall Study|AE associated with disease progression|1|||
156598948|NCT02034552|565273726|FG002|Overall Study|AE associated with disease progression|0|||
156598949|NCT02034552|565273724|FG000|Overall Study|Withdrawal by Subject|2|||
156598950|NCT02034552|565273725|FG001|Overall Study|Withdrawal by Subject|1|||
156598951|NCT02034552|565273726|FG002|Overall Study|Withdrawal by Subject|1|||
156598952|NCT02034552|565273724|FG000|Overall Study|Non-compliance with study drug|0|||
156598953|NCT02034552|565273725|FG001|Overall Study|Non-compliance with study drug|0|||
156598954|NCT02034552|565273726|FG002|Overall Study|Non-compliance with study drug|1|||
156598955|NCT02034552|565273724|FG000|Overall Study|Clinical progression|5|||
156598956|NCT02034552|565273725|FG001|Overall Study|Clinical progression|7|||
156598957|NCT02034552|565273726|FG002|Overall Study|Clinical progression|9|||
156598958|NCT04116073|565273731|FG000|Overall Study|Withdrawal by Subject|2|||
156598959|NCT04116073|565273731|FG000|Overall Study|failed to maintained eligibility|1|||
156598960|NCT01413542|565273735|FG000|Overall Study|Physician Decision|1|||
156598961|NCT01413542|565273736|FG001|Overall Study|Physician Decision|0|||
156598962|NCT01413542|565273737|FG002|Overall Study|Physician Decision|3|||
156598963|NCT01413542|565273738|FG003|Overall Study|Physician Decision|0|||
156598964|NCT01413542|565273735|FG000|Overall Study|Adverse Event|0|||
156598965|NCT01413542|565273736|FG001|Overall Study|Adverse Event|0|||
156598966|NCT01413542|565273737|FG002|Overall Study|Adverse Event|0|||
156598967|NCT01413542|565273738|FG003|Overall Study|Adverse Event|1|||
156598968|NCT01879319|565273741|FG000|Overall Study|Withdrawal by Subject|1|||
156598969|NCT01879319|565273742|FG001|Overall Study|Withdrawal by Subject|0|||
156598970|NCT01879319|565273741|FG000|Overall Study|Lost to Follow-up|1|||
156598971|NCT01879319|565273742|FG001|Overall Study|Lost to Follow-up|5|||
156598972|NCT00084929|565273746|FG000|Overall Study|ineligible - medical contraindication|1|||
156598973|NCT00084929|565273746|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
156598974|NCT00084929|565273746|FG000|Overall Study|Ineligible - Medical history|6|||
156598975|NCT00084929|565273746|FG000|Overall Study|Withdrawal by Subject|10|||
156598976|NCT00084929|565273746|FG000|Overall Study|Missing/incomplete CTC exam|9|||
156598977|NCT00084929|565273746|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
156598978|NCT00664209|565273747|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
156598979|NCT00664209|565273747|FG000|Study Treatment Period|Physician Decision|4|||
156598980|NCT00664209|565273747|FG000|Study Treatment Period|Withdrawal by Subject|2|||
156598981|NCT02767856|565273758|FG000|Overall Study|Lost to Follow-up|9|||
156598982|NCT02767856|565273759|FG001|Overall Study|Lost to Follow-up|1|||
156598983|NCT02767856|565273758|FG000|Overall Study|Withdrawal by Subject|2|||
156598984|NCT02767856|565273759|FG001|Overall Study|Withdrawal by Subject|1|||
156598985|NCT00091026|565273762|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
156598986|NCT00091026|565273763|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
156598987|NCT00091026|565273762|FG000|Overall Study|Patient withdrew and never received trea|0|||
156598988|NCT00091026|565273763|FG001|Overall Study|Patient withdrew and never received trea|2|||
156598989|NCT00091026|565273762|FG000|Overall Study|Unknown-never received treatment|0|||
156598990|NCT00091026|565273763|FG001|Overall Study|Unknown-never received treatment|1|||
156598991|NCT00843843|565273766|FG000|Overall Study|Physician Decision|1|||
156598992|NCT00843843|565273767|FG001|Overall Study|Physician Decision|1|||
156598993|NCT00843843|565273766|FG000|Overall Study|Protocol Violation|1|||
156598994|NCT00843843|565273767|FG001|Overall Study|Protocol Violation|1|||
156598995|NCT00418379|565273768|FG000|Year 1|Adverse Event|9|||
156598996|NCT00418379|565273769|FG001|Year 1|Adverse Event|15|||
156598997|NCT00418379|565273770|FG002|Year 1|Adverse Event|3|||
156598998|NCT00418379|565273768|FG000|Year 1|Withdrawal by Subject|7|||
156598999|NCT00418379|565273769|FG001|Year 1|Withdrawal by Subject|8|||
156599000|NCT00418379|565273770|FG002|Year 1|Withdrawal by Subject|5|||
156599001|NCT00418379|565273768|FG000|Year 1|Any other reason not above-mentioned|2|||
156599002|NCT00418379|565273769|FG001|Year 1|Any other reason not above-mentioned|5|||
156599003|NCT00418379|565273770|FG002|Year 1|Any other reason not above-mentioned|7|||
156599004|NCT00418379|565273768|FG000|Year 2|Adverse Event|5|||
156599005|NCT00418379|565273769|FG001|Year 2|Adverse Event|2|||
156599006|NCT00418379|565273770|FG002|Year 2|Adverse Event|1|||
156599007|NCT00418379|565273768|FG000|Year 2|Withdrawal by Subject|1|||
156599008|NCT00418379|565273769|FG001|Year 2|Withdrawal by Subject|1|||
156599009|NCT00418379|565273770|FG002|Year 2|Withdrawal by Subject|3|||
156599010|NCT00418379|565273768|FG000|Year 2|Any other reason not above-mentioned|2|||
156599011|NCT00418379|565273769|FG001|Year 2|Any other reason not above-mentioned|1|||
156599012|NCT00418379|565273770|FG002|Year 2|Any other reason not above-mentioned|6|||
156599013|NCT00418379|565273768|FG000|Year 3|Withdrawal by Subject|1|||
156599014|NCT00418379|565273769|FG001|Year 3|Withdrawal by Subject|1|||
156599015|NCT00418379|565273770|FG002|Year 3|Withdrawal by Subject|2|||
156599016|NCT00418379|565273768|FG000|Year 3|Any other reason not above-mentioned|2|||
156599017|NCT00418379|565273769|FG001|Year 3|Any other reason not above-mentioned|1|||
156599018|NCT00418379|565273770|FG002|Year 3|Any other reason not above-mentioned|1|||
156599019|NCT00418379|565273768|FG000|Year 4|Adverse Event|0|||
156599020|NCT00418379|565273769|FG001|Year 4|Adverse Event|1|||
156599021|NCT00418379|565273770|FG002|Year 4|Adverse Event|0|||
156599022|NCT00418379|565273768|FG000|Year 4|Withdrawal by Subject|2|||
156599023|NCT00418379|565273769|FG001|Year 4|Withdrawal by Subject|3|||
156599024|NCT00418379|565273770|FG002|Year 4|Withdrawal by Subject|2|||
156599025|NCT00418379|565273768|FG000|Year 4|Any other reason not above-mentioned|1|||
156599026|NCT00418379|565273769|FG001|Year 4|Any other reason not above-mentioned|1|||
156599027|NCT00418379|565273770|FG002|Year 4|Any other reason not above-mentioned|0|||
156599028|NCT00418379|565273768|FG000|Year 5|Adverse Event|0|||
156599029|NCT00418379|565273769|FG001|Year 5|Adverse Event|1|||
156599030|NCT00418379|565273770|FG002|Year 5|Adverse Event|0|||
156599031|NCT00418379|565273768|FG000|Year 5|Any other reason not above-mentioned|2|||
156599032|NCT00418379|565273769|FG001|Year 5|Any other reason not above-mentioned|4|||
156599033|NCT00418379|565273770|FG002|Year 5|Any other reason not above-mentioned|3|||
156599034|NCT00065442|565273771|FG000|Overall Study|Lost to Follow-up|1|||
156599035|NCT00065442|565273772|FG001|Overall Study|Lost to Follow-up|1|||
156599036|NCT00065442|565273771|FG000|Overall Study|Death|121|||
156599037|NCT00065442|565273772|FG001|Overall Study|Death|210|||
156599038|NCT00065442|565273771|FG000|Overall Study|Withdrawal by Subject|3|||
156599039|NCT00065442|565273772|FG001|Overall Study|Withdrawal by Subject|9|||
156599040|NCT01594333|565273773|FG000|Overall Study|Death|96|||
156599041|NCT01594333|565273774|FG001|Overall Study|Death|83|||
156599042|NCT01594333|565273773|FG000|Overall Study|Lost to Follow-up|5|||
156599043|NCT01594333|565273774|FG001|Overall Study|Lost to Follow-up|5|||
156599044|NCT01594333|565273773|FG000|Overall Study|Withdrawal by Subject|60|||
156599045|NCT01594333|565273774|FG001|Overall Study|Withdrawal by Subject|63|||
156599046|NCT01797965|565273775|FG000|Overall Study|Adverse Event|104|||
156599047|NCT01797965|565273776|FG001|Overall Study|Adverse Event|129|||
156599048|NCT01797965|565273777|FG002|Overall Study|Adverse Event|4|||
156599049|NCT01797965|565273778|FG003|Overall Study|Adverse Event|21|||
156599050|NCT01797965|565273775|FG000|Overall Study|Lost to Follow-up|9|||
156599051|NCT01797965|565273776|FG001|Overall Study|Lost to Follow-up|8|||
156599052|NCT01797965|565273777|FG002|Overall Study|Lost to Follow-up|1|||
156599053|NCT01797965|565273778|FG003|Overall Study|Lost to Follow-up|2|||
156599054|NCT01797965|565273775|FG000|Overall Study|Consent withdrawn|130|||
156599055|NCT01797965|565273776|FG001|Overall Study|Consent withdrawn|117|||
156599056|NCT01797965|565273777|FG002|Overall Study|Consent withdrawn|3|||
156599057|NCT01797965|565273778|FG003|Overall Study|Consent withdrawn|35|||
156599058|NCT01797965|565273775|FG000|Overall Study|Investigator decision|21|||
156599059|NCT01797965|565273776|FG001|Overall Study|Investigator decision|15|||
156599060|NCT01797965|565273777|FG002|Overall Study|Investigator decision|0|||
156599061|NCT01797965|565273778|FG003|Overall Study|Investigator decision|0|||
156599062|NCT01797965|565273775|FG000|Overall Study|Death|2|||
156599063|NCT01797965|565273776|FG001|Overall Study|Death|4|||
156599064|NCT01797965|565273777|FG002|Overall Study|Death|0|||
156599065|NCT01797965|565273778|FG003|Overall Study|Death|0|||
156599066|NCT01797965|565273775|FG000|Overall Study|Disease progression, defined by protocol|3|||
156599067|NCT01797965|565273776|FG001|Overall Study|Disease progression, defined by protocol|1|||
156599068|NCT01797965|565273777|FG002|Overall Study|Disease progression, defined by protocol|0|||
156599069|NCT01797965|565273778|FG003|Overall Study|Disease progression, defined by protocol|0|||
156599070|NCT01797965|565273775|FG000|Overall Study|Reason Not Specified|280|||
156599071|NCT01797965|565273776|FG001|Overall Study|Reason Not Specified|295|||
156599072|NCT01797965|565273777|FG002|Overall Study|Reason Not Specified|0|||
156599073|NCT01797965|565273778|FG003|Overall Study|Reason Not Specified|15|||
156599074|NCT01764256|565273779|FG000|Received All Vaccinations|Adverse Event|1|||
156599075|NCT01764256|565273780|FG001|Received All Vaccinations|Adverse Event|1|||
156599076|NCT01764256|565273781|FG002|Received All Vaccinations|Adverse Event|0|||
156599077|NCT01764256|565273782|FG003|Received All Vaccinations|Adverse Event|0|||
156599078|NCT01764256|565273779|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
156599079|NCT01764256|565273780|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
156599080|NCT01764256|565273781|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
156599081|NCT01764256|565273782|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
156599082|NCT01764256|565273779|FG000|Received All Vaccinations|Lost to Follow-up|1|||
156599083|NCT01764256|565273780|FG001|Received All Vaccinations|Lost to Follow-up|0|||
156599084|NCT01764256|565273781|FG002|Received All Vaccinations|Lost to Follow-up|0|||
156599085|NCT01764256|565273782|FG003|Received All Vaccinations|Lost to Follow-up|0|||
156599086|NCT01764256|565273779|FG000|Completed Study|Lost to Follow-up|0|||
156599087|NCT01764256|565273780|FG001|Completed Study|Lost to Follow-up|0|||
156599088|NCT01764256|565273781|FG002|Completed Study|Lost to Follow-up|0|||
156599089|NCT01764256|565273782|FG003|Completed Study|Lost to Follow-up|1|||
156599090|NCT00304915|565273783|FG000|Overall Study|Lost to Follow-up|11|||
156599091|NCT00304915|565273784|FG001|Overall Study|Lost to Follow-up|11|||
156599092|NCT00304915|565273783|FG000|Overall Study|Death|4|||
156599093|NCT00304915|565273784|FG001|Overall Study|Death|5|||
156599094|NCT00304915|565273783|FG000|Overall Study|Withdrawal by Subject|3|||
156599095|NCT00304915|565273784|FG001|Overall Study|Withdrawal by Subject|0|||
156599096|NCT00565058|565273785|FG000|Overall Study|Adverse Event|1|||
156599097|NCT00565058|565273786|FG001|Overall Study|Adverse Event|0|||
156599098|NCT02029638|565273787|FG000|Overall Study|Death|0|||
156599099|NCT02029638|565273788|FG001|Overall Study|Death|0|||
156599100|NCT02029638|565273789|FG002|Overall Study|Death|1|||
156599101|NCT02029638|565273787|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
156599102|NCT02029638|565273788|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
156599103|NCT02029638|565273789|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
156599104|NCT05489081|565273791|FG000|Overall Study|student left classroom|0|||
156599105|NCT05489081|565273792|FG001|Overall Study|student left classroom|1|||
156599106|NCT05489081|565273791|FG000|Overall Study|teacher left school|0|||
156599107|NCT05489081|565273792|FG001|Overall Study|teacher left school|2|||
156599108|NCT00973921|565273795|FG000|Overall Study|IVUS results were not available|9|||
156599109|NCT02670330|565273806|FG000|Overall Study|Protocol Deviation|1|||
156599110|NCT02670330|565273807|FG001|Overall Study|Protocol Deviation|0|||
156599111|NCT02670330|565273806|FG000|Overall Study|Study Terminated By Sponsor|36|||
156599112|NCT02670330|565273807|FG001|Overall Study|Study Terminated By Sponsor|43|||
156599113|NCT02670330|565273806|FG000|Overall Study|Adverse Event|1|||
156599114|NCT02670330|565273807|FG001|Overall Study|Adverse Event|3|||
156599115|NCT02670330|565273806|FG000|Overall Study|Withdrawal by Subject|34|||
156599116|NCT02670330|565273807|FG001|Overall Study|Withdrawal by Subject|29|||
156599117|NCT02670330|565273806|FG000|Overall Study|Lost to Follow-up|3|||
156599118|NCT02670330|565273807|FG001|Overall Study|Lost to Follow-up|2|||
156599119|NCT04404010|565273808|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
156599120|NCT04404010|565273809|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
156599121|NCT02120157|565273810|FG000|Overall Study|Death|8|||
156599122|NCT01354431|565273814|FG000|Pre-Treatment Period|Not reported|1|||
156599123|NCT01354431|565273815|FG001|Pre-Treatment Period|Not reported|0|||
156599124|NCT01354431|565273816|FG002|Pre-Treatment Period|Not reported|0|||
156599125|NCT01354431|565273814|FG000|Treatment Period|Disease Progression|50|||
156599126|NCT01354431|565273815|FG001|Treatment Period|Disease Progression|40|||
156599127|NCT01354431|565273816|FG002|Treatment Period|Disease Progression|44|||
156599128|NCT01354431|565273814|FG000|Treatment Period|Study Drug Toxicity|5|||
156599129|NCT01354431|565273815|FG001|Treatment Period|Study Drug Toxicity|8|||
156599130|NCT01354431|565273816|FG002|Treatment Period|Study Drug Toxicity|4|||
156599131|NCT01354431|565273814|FG000|Treatment Period|Death|0|||
156599132|NCT01354431|565273815|FG001|Treatment Period|Death|1|||
156599133|NCT01354431|565273816|FG002|Treatment Period|Death|0|||
156599134|NCT01354431|565273814|FG000|Treatment Period|AE unrelated to study drug|1|||
156599135|NCT01354431|565273815|FG001|Treatment Period|AE unrelated to study drug|2|||
156599136|NCT01354431|565273816|FG002|Treatment Period|AE unrelated to study drug|5|||
156599137|NCT01354431|565273814|FG000|Treatment Period|Participant request to discontinue|2|||
156599138|NCT01354431|565273815|FG001|Treatment Period|Participant request to discontinue|2|||
156599139|NCT01354431|565273816|FG002|Treatment Period|Participant request to discontinue|1|||
156599140|NCT01354431|565273814|FG000|Treatment Period|Participant withdrew consent|0|||
156599141|NCT01354431|565273815|FG001|Treatment Period|Participant withdrew consent|1|||
156599142|NCT01354431|565273816|FG002|Treatment Period|Participant withdrew consent|0|||
156599143|NCT01354431|565273814|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
156599144|NCT01354431|565273815|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
156599145|NCT01354431|565273816|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
156599146|NCT03176277|565273817|FG000|Part A Dose Escalation Study|Adverse Event|1|||
156599147|NCT03176277|565273818|FG001|Part A Dose Escalation Study|Adverse Event|0|||
156599148|NCT03176277|565273819|FG002|Part A Dose Escalation Study|Adverse Event|1|||
156599149|NCT03176277|565273820|FG003|Part A Dose Escalation Study|Adverse Event|0|||
156599150|NCT03176277|565273817|FG000|Part A Dose Escalation Study|Physician Decision|1|||
156599151|NCT03176277|565273818|FG001|Part A Dose Escalation Study|Physician Decision|1|||
156599152|NCT03176277|565273819|FG002|Part A Dose Escalation Study|Physician Decision|2|||
156599153|NCT03176277|565273820|FG003|Part A Dose Escalation Study|Physician Decision|0|||
156599154|NCT03176277|565273817|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
156599155|NCT03176277|565273818|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
156599156|NCT03176277|565273819|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
156599157|NCT03176277|565273820|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
156599158|NCT03176277|565273817|FG000|Part A Dose Escalation Study|Progressive disease|3|||
156599159|NCT03176277|565273818|FG001|Part A Dose Escalation Study|Progressive disease|1|||
156599160|NCT03176277|565273819|FG002|Part A Dose Escalation Study|Progressive disease|3|||
156599161|NCT03176277|565273820|FG003|Part A Dose Escalation Study|Progressive disease|0|||
156599162|NCT02802878|565273821|FG000|Overall Study|Withdrawal by Subject|3|||
156599163|NCT02802878|565273822|FG001|Overall Study|Withdrawal by Subject|3|||
156599164|NCT02802878|565273821|FG000|Overall Study|Protocol Violation|1|||
156599165|NCT02802878|565273822|FG001|Overall Study|Protocol Violation|0|||
156599166|NCT00702052|565273823|FG000|Overall Study|Adverse Event|23|||
156599167|NCT00702052|565273823|FG000|Overall Study|Disease Progression|30|||
156599168|NCT00702052|565273823|FG000|Overall Study|Withdrawal by Subject|5|||
156599169|NCT00101192|565273824|FG000|Overall Study|Ineligible|6|||
156599170|NCT00101192|565273824|FG000|Overall Study|Inevaluable|1|||
156599171|NCT03691610|565273825|FG000|Overall Study|Adverse Event|0|||
156599172|NCT03691610|565273826|FG001|Overall Study|Adverse Event|1|||
156599173|NCT03691610|565273827|FG002|Overall Study|Adverse Event|0|||
156599174|NCT03691610|565273828|FG003|Overall Study|Adverse Event|0|||
156599175|NCT03691610|565273825|FG000|Overall Study|Protocol Deviation|15|||
156599176|NCT03691610|565273826|FG001|Overall Study|Protocol Deviation|8|||
156599177|NCT03691610|565273827|FG002|Overall Study|Protocol Deviation|1|||
156599178|NCT03691610|565273828|FG003|Overall Study|Protocol Deviation|2|||
156599179|NCT03691610|565273825|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
156599180|NCT03691610|565273826|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
156599181|NCT03691610|565273827|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
156599182|NCT03691610|565273828|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
156599183|NCT03691610|565273825|FG000|Overall Study|Lost to Follow-up|20|||
156599184|NCT03691610|565273826|FG001|Overall Study|Lost to Follow-up|11|||
156599185|NCT03691610|565273827|FG002|Overall Study|Lost to Follow-up|5|||
156599186|NCT03691610|565273828|FG003|Overall Study|Lost to Follow-up|2|||
156599187|NCT00242580|565273829|FG000|Overall Study|Adverse Event|3|||
156599188|NCT00242580|565273830|FG001|Overall Study|Adverse Event|0|||
156599189|NCT00242580|565273831|FG002|Overall Study|Adverse Event|2|||
156599190|NCT00242580|565273829|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156599191|NCT00242580|565273830|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
156599192|NCT00242580|565273831|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
156599193|NCT00242580|565273829|FG000|Overall Study|Protocol Violation|0|||
156599194|NCT00242580|565273830|FG001|Overall Study|Protocol Violation|0|||
156599195|NCT00242580|565273831|FG002|Overall Study|Protocol Violation|1|||
156599196|NCT00242580|565273829|FG000|Overall Study|Subject withdrew consent|2|||
156599197|NCT00242580|565273830|FG001|Overall Study|Subject withdrew consent|2|||
156599198|NCT00242580|565273831|FG002|Overall Study|Subject withdrew consent|5|||
156599199|NCT00242580|565273829|FG000|Overall Study|Lost to Follow-up|0|||
156599200|NCT00242580|565273830|FG001|Overall Study|Lost to Follow-up|3|||
156599201|NCT00242580|565273831|FG002|Overall Study|Lost to Follow-up|0|||
156599202|NCT00242580|565273829|FG000|Overall Study|Death|1|||
156599203|NCT00242580|565273830|FG001|Overall Study|Death|2|||
156599204|NCT00242580|565273831|FG002|Overall Study|Death|1|||
156599205|NCT01232894|565273832|FG000|Overall Study|Lost to Follow-up|0|||
156599206|NCT01232894|565273833|FG001|Overall Study|Lost to Follow-up|1|||
156599207|NCT01232894|565273832|FG000|Overall Study|Death|1|||
156599208|NCT01232894|565273833|FG001|Overall Study|Death|0|||
156599209|NCT01232894|565273832|FG000|Overall Study|Protocol Violation|1|||
156599210|NCT01232894|565273833|FG001|Overall Study|Protocol Violation|1|||
156599211|NCT01232894|565273832|FG000|Overall Study|Withdrawal by Subject|8|||
156599212|NCT01232894|565273833|FG001|Overall Study|Withdrawal by Subject|5|||
156599213|NCT01232894|565273832|FG000|Overall Study|Physician Decision|2|||
156599214|NCT01232894|565273833|FG001|Overall Study|Physician Decision|1|||
156599215|NCT03970395|565273836|FG000|Overall Study|Withdrawal by Subject|3|||
156599216|NCT03970395|565273837|FG001|Overall Study|Withdrawal by Subject|4|||
156599217|NCT03970395|565273836|FG000|Overall Study|Lost to Follow-up|4|||
156599218|NCT03970395|565273837|FG001|Overall Study|Lost to Follow-up|8|||
156599219|NCT00929734|565273838|FG000|Overall Study|Lost to Follow-up|2|||
156599220|NCT00929734|565273839|FG001|Overall Study|Lost to Follow-up|1|||
156599221|NCT00929734|565273838|FG000|Overall Study|Withdrawal by Subject|0|||
156599222|NCT00929734|565273839|FG001|Overall Study|Withdrawal by Subject|2|||
156599223|NCT00980980|565273840|FG000|Overall Study|Withdrawal by Hospital|0|||
156599224|NCT00980980|565273841|FG001|Overall Study|Withdrawal by Hospital|1|||
156599225|NCT00980980|565273842|FG002|Overall Study|Withdrawal by Hospital|0|||
156599226|NCT03666858|565273843|FG000|Cohort 1|Adverse Event|1|||
156599227|NCT03666858|565273844|FG001|Cohort 1|Adverse Event|0|||
156599228|NCT03666858|565273843|FG000|Cohort 2|Adverse Event|0|||
156599229|NCT03666858|565273844|FG001|Cohort 2|Adverse Event|1|||
156599230|NCT00121992|565273845|FG000|Overall Study|Treatment not received|2|||
156599231|NCT00121992|565273846|FG001|Overall Study|Treatment not received|11|||
156599232|NCT03282357|565273847|FG000|Overall Study|Lost to Follow-up|3|||
156863682|NCT05194124|566258766|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156599233|NCT03282357|565273847|FG000|Overall Study|Withdrawal by Subject|4|||
156599234|NCT03282357|565273847|FG000|Overall Study|Adverse Event|1|||
156599235|NCT03282357|565273847|FG000|Overall Study|Other|9|||
156599236|NCT00622869|565273848|FG000|Overall Study|Subject Withdrew Consent|13|||
156599237|NCT00622869|565273849|FG001|Overall Study|Subject Withdrew Consent|17|||
156599238|NCT00622869|565273850|FG002|Overall Study|Subject Withdrew Consent|11|||
156599239|NCT00622869|565273848|FG000|Overall Study|Administrative Problems|11|||
156599240|NCT00622869|565273849|FG001|Overall Study|Administrative Problems|17|||
156599241|NCT00622869|565273850|FG002|Overall Study|Administrative Problems|13|||
156599242|NCT00622869|565273848|FG000|Overall Study|Death|12|||
156599243|NCT00622869|565273849|FG001|Overall Study|Death|15|||
156599244|NCT00622869|565273850|FG002|Overall Study|Death|10|||
156599245|NCT00622869|565273848|FG000|Overall Study|Lost to Follow-up|2|||
156599246|NCT00622869|565273849|FG001|Overall Study|Lost to Follow-up|4|||
156599247|NCT00622869|565273850|FG002|Overall Study|Lost to Follow-up|2|||
156599248|NCT00622869|565273848|FG000|Overall Study|Graft Loss|5|||
156599249|NCT00622869|565273849|FG001|Overall Study|Graft Loss|3|||
156599250|NCT00622869|565273850|FG002|Overall Study|Graft Loss|2|||
156599251|NCT00622869|565273848|FG000|Overall Study|Missing|0|||
156599252|NCT00622869|565273849|FG001|Overall Study|Missing|1|||
156599253|NCT00622869|565273850|FG002|Overall Study|Missing|1|||
156599254|NCT02927873|565273851|FG000|Overall Study|Lost to Follow-up|0|||
156599255|NCT02927873|565273852|FG001|Overall Study|Lost to Follow-up|1|||
156599256|NCT02927873|565273853|FG002|Overall Study|Lost to Follow-up|0|||
156599257|NCT02927873|565273854|FG003|Overall Study|Lost to Follow-up|0|||
156599258|NCT02927873|565273855|FG004|Overall Study|Lost to Follow-up|0|||
156599259|NCT02927873|565273856|FG005|Overall Study|Lost to Follow-up|0|||
156599260|NCT02927873|565273851|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156599261|NCT02927873|565273852|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
156599262|NCT02927873|565273853|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156599263|NCT02927873|565273854|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156599264|NCT02927873|565273855|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156599265|NCT02927873|565273856|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156599266|NCT02927873|565273851|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156599267|NCT02927873|565273852|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156599268|NCT02927873|565273853|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156599269|NCT02927873|565273854|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156599270|NCT02927873|565273855|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156599271|NCT02927873|565273856|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156599272|NCT02927873|565273851|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
156599273|NCT02927873|565273852|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
156599274|NCT02927873|565273853|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
156599275|NCT02927873|565273854|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
156599276|NCT02927873|565273855|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
156599277|NCT02927873|565273856|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
156599278|NCT02927873|565273851|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
156599279|NCT02927873|565273852|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
156599280|NCT02927873|565273853|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
156599281|NCT02927873|565273854|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
156599282|NCT02927873|565273855|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
156599283|NCT02927873|565273856|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
156599284|NCT02927873|565273851|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
156599285|NCT02927873|565273852|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
156599286|NCT02927873|565273853|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
156599287|NCT02927873|565273854|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
156599288|NCT02927873|565273855|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
156599289|NCT02927873|565273856|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
156599290|NCT01518244|565273857|FG000|Overall Study|Adverse Event|3|||
156599291|NCT00870818|565273858|FG000|Overall Study|Lost to Follow-up|3|||
156599292|NCT00870818|565273859|FG001|Overall Study|Lost to Follow-up|2|||
156599293|NCT00870818|565273860|FG002|Overall Study|Lost to Follow-up|1|||
156599294|NCT00870818|565273861|FG003|Overall Study|Lost to Follow-up|0|||
156599295|NCT00870818|565273862|FG004|Overall Study|Lost to Follow-up|0|||
156599296|NCT00870818|565273858|FG000|Overall Study|Withdrawal by Subject|0|||
156599297|NCT00870818|565273859|FG001|Overall Study|Withdrawal by Subject|0|||
156599298|NCT00870818|565273860|FG002|Overall Study|Withdrawal by Subject|1|||
156599299|NCT00870818|565273861|FG003|Overall Study|Withdrawal by Subject|2|||
156599300|NCT00870818|565273862|FG004|Overall Study|Withdrawal by Subject|0|||
156599301|NCT00870818|565273858|FG000|Overall Study|Terminated by sponsor|29|||
156599302|NCT00870818|565273859|FG001|Overall Study|Terminated by sponsor|70|||
156599303|NCT00870818|565273860|FG002|Overall Study|Terminated by sponsor|36|||
156599304|NCT00870818|565273861|FG003|Overall Study|Terminated by sponsor|36|||
156599305|NCT00870818|565273862|FG004|Overall Study|Terminated by sponsor|38|||
156599306|NCT00870818|565273858|FG000|Overall Study|Other|0|||
156599307|NCT00870818|565273859|FG001|Overall Study|Other|1|||
156599308|NCT00870818|565273860|FG002|Overall Study|Other|0|||
156599309|NCT00870818|565273861|FG003|Overall Study|Other|0|||
156599310|NCT00870818|565273862|FG004|Overall Study|Other|0|||
156599311|NCT04900038|565273863|FG000|Overall Study|Adverse Event|1|||
156599312|NCT04900038|565273864|FG001|Overall Study|Adverse Event|0|||
156599313|NCT04900038|565273865|FG002|Overall Study|Adverse Event|1|||
156599314|NCT04900038|565273866|FG003|Overall Study|Adverse Event|1|||
156599315|NCT04900038|565273863|FG000|Overall Study|Withdrawal by Subject|0|||
156599316|NCT04900038|565273864|FG001|Overall Study|Withdrawal by Subject|1|||
156599317|NCT04900038|565273865|FG002|Overall Study|Withdrawal by Subject|0|||
156599318|NCT04900038|565273866|FG003|Overall Study|Withdrawal by Subject|0|||
156599319|NCT04900038|565273863|FG000|Overall Study|Study terminated by sponsor|18|||
156599320|NCT04900038|565273864|FG001|Overall Study|Study terminated by sponsor|15|||
156599321|NCT04900038|565273865|FG002|Overall Study|Study terminated by sponsor|17|||
156599322|NCT04900038|565273866|FG003|Overall Study|Study terminated by sponsor|14|||
156599323|NCT04900038|565273863|FG000|Overall Study|Protocol Deviation|1|||
156599324|NCT04900038|565273864|FG001|Overall Study|Protocol Deviation|1|||
156599325|NCT04900038|565273865|FG002|Overall Study|Protocol Deviation|0|||
156599326|NCT04900038|565273866|FG003|Overall Study|Protocol Deviation|0|||
156599327|NCT04900038|565273863|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
156599328|NCT04900038|565273864|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
156599329|NCT04900038|565273865|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
156599330|NCT04900038|565273866|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
156599331|NCT04900038|565273863|FG000|Overall Study|Lost to Follow-up|0|||
156599332|NCT04900038|565273864|FG001|Overall Study|Lost to Follow-up|0|||
156599333|NCT04900038|565273865|FG002|Overall Study|Lost to Follow-up|0|||
156599334|NCT04900038|565273866|FG003|Overall Study|Lost to Follow-up|1|||
156599335|NCT03245723|565273873|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
156599336|NCT03245723|565273874|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
156599337|NCT03245723|565273873|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
156599338|NCT03245723|565273874|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
156599339|NCT03245723|565273873|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
156599340|NCT03245723|565273874|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
156599341|NCT03245723|565273873|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
156599342|NCT03245723|565273874|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
156599343|NCT06025396|565275673|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
156599344|NCT06025396|565275674|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
156599345|NCT06025396|565275675|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
156599346|NCT06025396|565275676|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
156599347|NCT06025396|565275677|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
156599348|NCT06025396|565275673|FG000|Overall Study|Withdrawal by Subject|0|||
156599349|NCT06025396|565275674|FG001|Overall Study|Withdrawal by Subject|1|||
156599350|NCT06025396|565275675|FG002|Overall Study|Withdrawal by Subject|1|||
156599351|NCT06025396|565275676|FG003|Overall Study|Withdrawal by Subject|0|||
156599352|NCT06025396|565275677|FG004|Overall Study|Withdrawal by Subject|0|||
156599353|NCT01512108|565275678|FG000|Overall Study|Adverse Event|9|||
156599354|NCT01512108|565275679|FG001|Overall Study|Adverse Event|4|||
156599355|NCT01512108|565275678|FG000|Overall Study|Protocol Violation|1|||
156599356|NCT01512108|565275679|FG001|Overall Study|Protocol Violation|2|||
156599357|NCT01512108|565275678|FG000|Overall Study|Withdrawal Criteria|1|||
156599358|NCT01512108|565275679|FG001|Overall Study|Withdrawal Criteria|0|||
156599359|NCT01512108|565275678|FG000|Overall Study|Unclassified|11|||
156599360|NCT01512108|565275679|FG001|Overall Study|Unclassified|3|||
156599361|NCT06422377|565275680|FG000|Overall Study|Study Terminated by Sponsor|1|||
156599362|NCT02017899|565275681|FG000|Overall Study|Withdrawal by Subject|0|||
156599363|NCT02017899|565275682|FG001|Overall Study|Withdrawal by Subject|0|||
156599364|NCT02017899|565275683|FG002|Overall Study|Withdrawal by Subject|0|||
156599365|NCT02017899|565275684|FG003|Overall Study|Withdrawal by Subject|1|||
156599366|NCT02017899|565275685|FG004|Overall Study|Withdrawal by Subject|1|||
156599367|NCT02017899|565275686|FG005|Overall Study|Withdrawal by Subject|0|||
156599368|NCT02420795|565275688|FG000|Overall Study|Withdrawal by Subject|1|||
156599369|NCT02420795|565275689|FG001|Overall Study|Withdrawal by Subject|0|||
156599370|NCT02420795|565275690|FG002|Overall Study|Withdrawal by Subject|0|||
156599371|NCT02420795|565275688|FG000|Overall Study|Adverse Event|1|||
156599372|NCT02420795|565275689|FG001|Overall Study|Adverse Event|0|||
156599373|NCT02420795|565275690|FG002|Overall Study|Adverse Event|0|||
156599374|NCT02420795|565275688|FG000|Overall Study|Progressive disease|2|||
156599375|NCT02420795|565275689|FG001|Overall Study|Progressive disease|2|||
156599376|NCT02420795|565275690|FG002|Overall Study|Progressive disease|4|||
156599377|NCT02420795|565275688|FG000|Overall Study|Death|0|||
156599378|NCT02420795|565275689|FG001|Overall Study|Death|0|||
156599379|NCT02420795|565275690|FG002|Overall Study|Death|1|||
156599380|NCT00971425|565275691|FG000|Overall Study|Adverse Event|1|||
156599381|NCT00971425|565275692|FG001|Overall Study|Adverse Event|1|||
156599382|NCT00971425|565275691|FG000|Overall Study|Withdrawal by Subject|0|||
156599383|NCT00971425|565275692|FG001|Overall Study|Withdrawal by Subject|1|||
156599384|NCT02528253|565275695|FG000|Overall Study|Adverse Event|3|||
156599385|NCT02528253|565275696|FG001|Overall Study|Adverse Event|4|||
156599386|NCT02528253|565275697|FG002|Overall Study|Adverse Event|4|||
156599387|NCT02528253|565275698|FG003|Overall Study|Adverse Event|8|||
156599388|NCT02528253|565275699|FG004|Overall Study|Adverse Event|18|||
156599389|NCT02528253|565275695|FG000|Overall Study|Death|2|||
156599390|NCT02528253|565275696|FG001|Overall Study|Death|2|||
156599391|NCT02528253|565275697|FG002|Overall Study|Death|1|||
156599392|NCT02528253|565275698|FG003|Overall Study|Death|0|||
156599393|NCT02528253|565275699|FG004|Overall Study|Death|1|||
156599394|NCT02528253|565275695|FG000|Overall Study|Insufficient clinical response|7|||
156599395|NCT02528253|565275696|FG001|Overall Study|Insufficient clinical response|10|||
156599396|NCT02528253|565275697|FG002|Overall Study|Insufficient clinical response|13|||
156599397|NCT02528253|565275698|FG003|Overall Study|Insufficient clinical response|12|||
156599398|NCT02528253|565275699|FG004|Overall Study|Insufficient clinical response|16|||
156599399|NCT02528253|565275695|FG000|Overall Study|Lost to Follow-up|16|||
156599400|NCT02528253|565275696|FG001|Overall Study|Lost to Follow-up|9|||
156599401|NCT02528253|565275697|FG002|Overall Study|Lost to Follow-up|31|||
156599402|NCT02528253|565275698|FG003|Overall Study|Lost to Follow-up|16|||
156599403|NCT02528253|565275699|FG004|Overall Study|Lost to Follow-up|34|||
156599404|NCT02528253|565275695|FG000|Overall Study|Other|21|||
156599405|NCT02528253|565275696|FG001|Overall Study|Other|22|||
156599406|NCT02528253|565275697|FG002|Overall Study|Other|58|||
156599407|NCT02528253|565275698|FG003|Overall Study|Other|52|||
156599408|NCT02528253|565275699|FG004|Overall Study|Other|76|||
156599409|NCT02528253|565275695|FG000|Overall Study|Withdrawal by Subject|25|||
156599410|NCT02528253|565275696|FG001|Overall Study|Withdrawal by Subject|20|||
156599411|NCT02528253|565275697|FG002|Overall Study|Withdrawal by Subject|29|||
156599412|NCT02528253|565275698|FG003|Overall Study|Withdrawal by Subject|48|||
156599413|NCT02528253|565275699|FG004|Overall Study|Withdrawal by Subject|73|||
156599414|NCT02528253|565275695|FG000|Overall Study|Protocol Violation|1|||
156599415|NCT02528253|565275696|FG001|Overall Study|Protocol Violation|2|||
156599416|NCT02528253|565275697|FG002|Overall Study|Protocol Violation|4|||
156599417|NCT02528253|565275698|FG003|Overall Study|Protocol Violation|0|||
156599418|NCT02528253|565275699|FG004|Overall Study|Protocol Violation|4|||
156599419|NCT02528253|565275695|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
156599420|NCT02528253|565275696|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
156599421|NCT02528253|565275697|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
156599422|NCT02528253|565275698|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
156599423|NCT02528253|565275699|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
156599424|NCT00505752|565275700|FG000|Overall Study|Adverse Event|1|||
156599425|NCT00505752|565275701|FG001|Overall Study|Adverse Event|0|||
156599426|NCT00505752|565275702|FG002|Overall Study|Adverse Event|1|||
156599427|NCT00505752|565275703|FG003|Overall Study|Adverse Event|0|||
156599428|NCT00505752|565275700|FG000|Overall Study|Lost to Follow-up|1|||
156599429|NCT00505752|565275701|FG001|Overall Study|Lost to Follow-up|0|||
156599430|NCT00505752|565275702|FG002|Overall Study|Lost to Follow-up|0|||
156599431|NCT00505752|565275703|FG003|Overall Study|Lost to Follow-up|0|||
156599432|NCT00505752|565275700|FG000|Overall Study|Lack of ovarian response|1|||
156599433|NCT00505752|565275701|FG001|Overall Study|Lack of ovarian response|3|||
156599434|NCT00505752|565275702|FG002|Overall Study|Lack of ovarian response|0|||
156599435|NCT00505752|565275703|FG003|Overall Study|Lack of ovarian response|0|||
156599436|NCT00505752|565275700|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
156599437|NCT00505752|565275701|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
156599438|NCT00505752|565275702|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
156599439|NCT00505752|565275703|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
156599440|NCT00505752|565275700|FG000|Overall Study|No oocytes retrieved|0|||
156599441|NCT00505752|565275701|FG001|Overall Study|No oocytes retrieved|2|||
156599442|NCT00505752|565275702|FG002|Overall Study|No oocytes retrieved|0|||
156599443|NCT00505752|565275703|FG003|Overall Study|No oocytes retrieved|1|||
156599444|NCT00505752|565275700|FG000|Overall Study|No Fertilization|1|||
156599445|NCT00505752|565275701|FG001|Overall Study|No Fertilization|1|||
156599446|NCT00505752|565275702|FG002|Overall Study|No Fertilization|2|||
156599447|NCT00505752|565275703|FG003|Overall Study|No Fertilization|1|||
156599448|NCT00505752|565275700|FG000|Overall Study|All embryos/blastocysts discarded|0|||
156599449|NCT00505752|565275701|FG001|Overall Study|All embryos/blastocysts discarded|0|||
156599450|NCT00505752|565275702|FG002|Overall Study|All embryos/blastocysts discarded|1|||
156599451|NCT00505752|565275703|FG003|Overall Study|All embryos/blastocysts discarded|1|||
156599452|NCT00505752|565275700|FG000|Overall Study|Other|1|||
156599453|NCT00505752|565275701|FG001|Overall Study|Other|2|||
156599454|NCT00505752|565275702|FG002|Overall Study|Other|1|||
156599455|NCT00505752|565275703|FG003|Overall Study|Other|2|||
156599456|NCT01624506|565275704|FG000|Overall Study|Lost to Follow-up|29|||
156599457|NCT01624506|565275705|FG001|Overall Study|Lost to Follow-up|15|||
156599458|NCT01624506|565275704|FG000|Overall Study|Withdrawal by Subject|9|||
156599459|NCT01624506|565275705|FG001|Overall Study|Withdrawal by Subject|2|||
156599460|NCT01624506|565275704|FG000|Overall Study|Death|1|||
156599461|NCT01624506|565275705|FG001|Overall Study|Death|0|||
156599462|NCT01624506|565275704|FG000|Overall Study|LINX explants|23|||
156599463|NCT01624506|565275705|FG001|Overall Study|LINX explants|0|||
156599464|NCT01624506|565275704|FG000|Overall Study|Adverse Event|3|||
156599465|NCT01624506|565275705|FG001|Overall Study|Adverse Event|0|||
156599466|NCT01149343|565275706|FG000|Overall Study|Withdrawal by Subject|1|||
156599467|NCT01149343|565275707|FG001|Overall Study|Withdrawal by Subject|1|||
156599468|NCT01149343|565275708|FG002|Overall Study|Withdrawal by Subject|1|||
156599469|NCT01149343|565275709|FG003|Overall Study|Withdrawal by Subject|5|||
156599470|NCT01149343|565275706|FG000|Overall Study|Death|10|||
156599471|NCT01149343|565275707|FG001|Overall Study|Death|13|||
156599472|NCT01149343|565275708|FG002|Overall Study|Death|18|||
156599473|NCT01149343|565275709|FG003|Overall Study|Death|18|||
156599474|NCT01149343|565275706|FG000|Overall Study|Lost to Follow-up|1|||
156599475|NCT01149343|565275707|FG001|Overall Study|Lost to Follow-up|0|||
156599476|NCT01149343|565275708|FG002|Overall Study|Lost to Follow-up|0|||
156599477|NCT01149343|565275709|FG003|Overall Study|Lost to Follow-up|1|||
156599478|NCT01149343|565275706|FG000|Overall Study|Other|8|||
156599479|NCT01149343|565275707|FG001|Overall Study|Other|10|||
156599480|NCT01149343|565275708|FG002|Overall Study|Other|2|||
156599481|NCT01149343|565275709|FG003|Overall Study|Other|14|||
156599482|NCT01149343|565275706|FG000|Overall Study|Sponsor study termination|0|||
156599483|NCT01149343|565275707|FG001|Overall Study|Sponsor study termination|0|||
156599484|NCT01149343|565275708|FG002|Overall Study|Sponsor study termination|0|||
156599485|NCT01149343|565275709|FG003|Overall Study|Sponsor study termination|2|||
156599486|NCT01149343|565275706|FG000|Overall Study|Recurrence / Progressive disease|0|||
156599487|NCT01149343|565275707|FG001|Overall Study|Recurrence / Progressive disease|0|||
156599488|NCT01149343|565275708|FG002|Overall Study|Recurrence / Progressive disease|1|||
156599489|NCT01149343|565275709|FG003|Overall Study|Recurrence / Progressive disease|0|||
156599490|NCT00132314|565275718|FG000|Overall Study|Lost to Follow-up|70|||
156599491|NCT00132314|565275719|FG001|Overall Study|Lost to Follow-up|62|||
156599492|NCT00132314|565275718|FG000|Overall Study|Lacked SSN|1|||
156599493|NCT00132314|565275719|FG001|Overall Study|Lacked SSN|3|||
156599494|NCT00132314|565275718|FG000|Overall Study|Refused intervention at baseline|2|||
156599495|NCT00132314|565275719|FG001|Overall Study|Refused intervention at baseline|7|||
156599496|NCT03472040|565275733|FG000|Overall Study|Physician Decision|0|||
156599497|NCT03472040|565275734|FG001|Overall Study|Physician Decision|3|||
156599498|NCT03472040|565275733|FG000|Overall Study|Withdrawal by Subject|10|||
156599499|NCT03472040|565275734|FG001|Overall Study|Withdrawal by Subject|23|||
156599500|NCT03472040|565275733|FG000|Overall Study|Perceived Lack of Efficacy|29|||
156599501|NCT03472040|565275734|FG001|Overall Study|Perceived Lack of Efficacy|30|||
156599502|NCT03472040|565275733|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
156599503|NCT03472040|565275734|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
156599504|NCT03472040|565275733|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
156599505|NCT03472040|565275734|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
156599506|NCT03472040|565275733|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
156599507|NCT03472040|565275734|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
156599508|NCT03472040|565275733|FG000|Overall Study|Subject Non-compliance|2|||
156599509|NCT03472040|565275734|FG001|Overall Study|Subject Non-compliance|5|||
156599510|NCT03472040|565275733|FG000|Overall Study|Discontinuation due to Rash|0|||
156599511|NCT03472040|565275734|FG001|Overall Study|Discontinuation due to Rash|1|||
156599512|NCT03472040|565275733|FG000|Overall Study|Subsequent Ineligibility|0|||
156599513|NCT03472040|565275734|FG001|Overall Study|Subsequent Ineligibility|2|||
156599514|NCT03472040|565275733|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
156599515|NCT03472040|565275734|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
156599516|NCT02769832|565275735|FG000|Overall Study|Death|30|||
156599517|NCT00225147|565275737|FG000|Open-label Phase|Lost to Follow-up|0|||
156599518|NCT00225147|565275738|FG001|Open-label Phase|Lost to Follow-up|0|||
156599519|NCT00225147|565275739|FG002|Open-label Phase|Lost to Follow-up|0|||
156599520|NCT00225147|565275740|FG003|Open-label Phase|Lost to Follow-up|4|||
156599521|NCT00225147|565275737|FG000|Open-label Phase|Withdrawal by Subject|0|||
156599522|NCT00225147|565275738|FG001|Open-label Phase|Withdrawal by Subject|0|||
156599523|NCT00225147|565275739|FG002|Open-label Phase|Withdrawal by Subject|0|||
156599524|NCT00225147|565275740|FG003|Open-label Phase|Withdrawal by Subject|6|||
156599525|NCT04019795|565275741|FG000|Overall Study|Withdrawal by Subject|1|||
156599526|NCT04019795|565275742|FG001|Overall Study|Withdrawal by Subject|2|||
156599527|NCT04019795|565275743|FG002|Overall Study|Withdrawal by Subject|2|||
156599528|NCT04019795|565275744|FG003|Overall Study|Withdrawal by Subject|1|||
156599529|NCT04019795|565275741|FG000|Overall Study|Lost to Follow-up|0|||
156599530|NCT04019795|565275742|FG001|Overall Study|Lost to Follow-up|1|||
156599531|NCT04019795|565275743|FG002|Overall Study|Lost to Follow-up|1|||
156599532|NCT04019795|565275744|FG003|Overall Study|Lost to Follow-up|2|||
156599533|NCT04019795|565275741|FG000|Overall Study|Treatment non-compliance|3|||
156599534|NCT04019795|565275742|FG001|Overall Study|Treatment non-compliance|1|||
156599535|NCT04019795|565275743|FG002|Overall Study|Treatment non-compliance|2|||
156599536|NCT04019795|565275744|FG003|Overall Study|Treatment non-compliance|0|||
156599537|NCT04019795|565275741|FG000|Overall Study|Physician Decision|0|||
156599538|NCT04019795|565275742|FG001|Overall Study|Physician Decision|0|||
156599539|NCT04019795|565275743|FG002|Overall Study|Physician Decision|1|||
156599540|NCT04019795|565275744|FG003|Overall Study|Physician Decision|0|||
156599541|NCT04019795|565275741|FG000|Overall Study|Adverse Event|1|||
156599542|NCT04019795|565275742|FG001|Overall Study|Adverse Event|0|||
156599543|NCT04019795|565275743|FG002|Overall Study|Adverse Event|0|||
156599544|NCT04019795|565275744|FG003|Overall Study|Adverse Event|0|||
156599545|NCT03625141|565275745|FG000|Overall Study|Adverse Event|0|||
156599546|NCT03625141|565275746|FG001|Overall Study|Adverse Event|2|||
156599547|NCT03625141|565275745|FG000|Overall Study|Study Terminated By Sponsor|1|||
156599548|NCT03625141|565275746|FG001|Overall Study|Study Terminated By Sponsor|13|||
156599549|NCT03625141|565275745|FG000|Overall Study|Withdrawal by Subject|3|||
156599550|NCT03625141|565275746|FG001|Overall Study|Withdrawal by Subject|0|||
156599551|NCT03625141|565275745|FG000|Overall Study|Withdrawal Of Consent|0|||
156599552|NCT03625141|565275746|FG001|Overall Study|Withdrawal Of Consent|1|||
156599553|NCT03625141|565275745|FG000|Overall Study|Death|11|||
156599554|NCT03625141|565275746|FG001|Overall Study|Death|47|||
156599555|NCT03625141|565275745|FG000|Overall Study|Progressive Disease|0|||
156599556|NCT03625141|565275746|FG001|Overall Study|Progressive Disease|2|||
156599557|NCT01114373|565275747|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
156599558|NCT01114373|565275748|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
156599559|NCT01114373|565275747|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
156599560|NCT01114373|565275748|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
156599561|NCT01114373|565275747|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
156599562|NCT01114373|565275748|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
156599563|NCT01114373|565275747|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
156599564|NCT01114373|565275748|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
156599565|NCT03819218|565275749|FG000|Overall Study|Protocol Violation|1|||
156599566|NCT02501902|565275750|FG000|Overall Study|Subject Refused Further Follow-up|0|||
156599567|NCT02501902|565275751|FG001|Overall Study|Subject Refused Further Follow-up|0|||
156599568|NCT02501902|565275752|FG002|Overall Study|Subject Refused Further Follow-up|0|||
156599569|NCT02501902|565275753|FG003|Overall Study|Subject Refused Further Follow-up|0|||
156599570|NCT02501902|565275754|FG004|Overall Study|Subject Refused Further Follow-up|0|||
156599571|NCT02501902|565275755|FG005|Overall Study|Subject Refused Further Follow-up|0|||
156599572|NCT02501902|565275756|FG006|Overall Study|Subject Refused Further Follow-up|0|||
156599573|NCT02501902|565275757|FG007|Overall Study|Subject Refused Further Follow-up|1|||
156599574|NCT02501902|565275750|FG000|Overall Study|Study Terminated by Sponsor|0|||
156599575|NCT02501902|565275751|FG001|Overall Study|Study Terminated by Sponsor|3|||
156599576|NCT02501902|565275752|FG002|Overall Study|Study Terminated by Sponsor|0|||
156599577|NCT02501902|565275753|FG003|Overall Study|Study Terminated by Sponsor|1|||
156599578|NCT02501902|565275754|FG004|Overall Study|Study Terminated by Sponsor|1|||
156599579|NCT02501902|565275755|FG005|Overall Study|Study Terminated by Sponsor|0|||
156599580|NCT02501902|565275756|FG006|Overall Study|Study Terminated by Sponsor|2|||
156599581|NCT02501902|565275757|FG007|Overall Study|Study Terminated by Sponsor|4|||
156599582|NCT02501902|565275750|FG000|Overall Study|Death|3|||
156599583|NCT02501902|565275751|FG001|Overall Study|Death|4|||
156599584|NCT02501902|565275752|FG002|Overall Study|Death|4|||
156599585|NCT02501902|565275753|FG003|Overall Study|Death|10|||
156599586|NCT02501902|565275754|FG004|Overall Study|Death|10|||
156599587|NCT02501902|565275755|FG005|Overall Study|Death|11|||
156599588|NCT02501902|565275756|FG006|Overall Study|Death|7|||
156599589|NCT02501902|565275757|FG007|Overall Study|Death|15|||
156599590|NCT02267278|565275758|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
156599591|NCT02267278|565275758|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
156599592|NCT02267278|565275758|FG000|Overall Study|Developed new cancer diagnoses|2|||
156599593|NCT02267278|565275758|FG000|Overall Study|prescribed prohibited medication|1|||
156599594|NCT02513771|565275759|FG000|Overall Study|Lost to Follow-up|1|||
156599595|NCT02513771|565275760|FG001|Overall Study|Lost to Follow-up|1|||
156599596|NCT02513771|565275759|FG000|Overall Study|Not being able to get to clinic|1|||
156599597|NCT02513771|565275760|FG001|Overall Study|Not being able to get to clinic|0|||
156599598|NCT00650091|565275764|FG000|Amended Study Design|Withdrawal by Subject|12|||
156599599|NCT00650091|565275765|FG001|Amended Study Design|Withdrawal by Subject|11|||
156599600|NCT00650091|565275766|FG002|Amended Study Design|Withdrawal by Subject|0|||
156599601|NCT00650091|565275764|FG000|Amended Study Design|Physician Decision|5|||
156599602|NCT00650091|565275765|FG001|Amended Study Design|Physician Decision|0|||
156599603|NCT00650091|565275766|FG002|Amended Study Design|Physician Decision|0|||
156599604|NCT00650091|565275764|FG000|Amended Study Design|Adverse Event|1|||
156599605|NCT00650091|565275765|FG001|Amended Study Design|Adverse Event|4|||
156599606|NCT00650091|565275766|FG002|Amended Study Design|Adverse Event|0|||
156599607|NCT00650091|565275764|FG000|Amended Study Design|Lung transplantation|4|||
156599608|NCT00650091|565275765|FG001|Amended Study Design|Lung transplantation|2|||
156599609|NCT00650091|565275766|FG002|Amended Study Design|Lung transplantation|0|||
156599610|NCT00650091|565275764|FG000|Amended Study Design|Other|1|||
156599611|NCT00650091|565275765|FG001|Amended Study Design|Other|3|||
156599612|NCT00650091|565275766|FG002|Amended Study Design|Other|0|||
156599613|NCT04295356|565275773|FG000|Overall Study|Physician Decision|1|||
156599614|NCT04295356|565275774|FG001|Overall Study|Physician Decision|0|||
156599615|NCT04295356|565275773|FG000|Overall Study|Lost to Follow-up|0|||
156599616|NCT04295356|565275774|FG001|Overall Study|Lost to Follow-up|3|||
156599617|NCT04295356|565275773|FG000|Overall Study|Protocol Violation|0|||
156599618|NCT04295356|565275774|FG001|Overall Study|Protocol Violation|1|||
156599619|NCT01280266|565275775|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
156599620|NCT01280266|565275776|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
156599621|NCT01280266|565275775|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
156599622|NCT01280266|565275776|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
156599623|NCT03067129|565275787|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
156599624|NCT03067129|565275788|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
156599625|NCT03067129|565275789|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
156599626|NCT03067129|565275790|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
156599627|NCT03067129|565275787|FG000|Overall Study|Withdrawal by Subject|0|||
156599628|NCT03067129|565275788|FG001|Overall Study|Withdrawal by Subject|0|||
156599629|NCT03067129|565275789|FG002|Overall Study|Withdrawal by Subject|1|||
156599630|NCT03067129|565275790|FG003|Overall Study|Withdrawal by Subject|2|||
156599631|NCT03067129|565275787|FG000|Overall Study|Lost to Follow-up|5|||
156599632|NCT03067129|565275788|FG001|Overall Study|Lost to Follow-up|5|||
156599633|NCT03067129|565275789|FG002|Overall Study|Lost to Follow-up|4|||
156599634|NCT03067129|565275790|FG003|Overall Study|Lost to Follow-up|3|||
156599635|NCT03372603|565275791|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
156599636|NCT03372603|565275792|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
156599637|NCT03372603|565275791|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
156599638|NCT03372603|565275792|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
156599639|NCT00712322|565275801|FG000|Overall Study|Protocol deviation|0|||
156599640|NCT00712322|565275802|FG001|Overall Study|Protocol deviation|1|||
156599641|NCT00712322|565275803|FG002|Overall Study|Protocol deviation|0|||
156599642|NCT00400712|565275806|FG000|Overall Study|Death|1|||
156599643|NCT00400712|565275807|FG001|Overall Study|Death|0|||
156599644|NCT00400712|565275806|FG000|Overall Study|Withdrawal by Subject|11|||
156599645|NCT00400712|565275807|FG001|Overall Study|Withdrawal by Subject|12|||
156599646|NCT00400712|565275806|FG000|Overall Study|Physician Decision|5|||
156599647|NCT00400712|565275807|FG001|Overall Study|Physician Decision|4|||
156599648|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
156599649|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
156599650|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
156599651|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
156599652|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
156599653|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
156599654|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Death|1|||
156599655|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Death|3|||
156599656|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
156599657|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
156599658|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
156599659|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
156599660|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
156599661|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
156599662|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
156599663|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
156599664|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
156599665|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
156599666|NCT02553317|565275813|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
156599667|NCT02553317|565275814|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
156599668|NCT00536978|565275818|FG000|Overall Study|Not eligible for Adback Infusion|22|||
156599669|NCT03076190|565275819|FG000|Overall Study|Lost to Follow-up|9|||
156599670|NCT03076190|565275820|FG001|Overall Study|Lost to Follow-up|34|||
156599671|NCT03076190|565275819|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
156599672|NCT03076190|565275820|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
156599673|NCT00077376|565275829|FG000|Overall Study|Adverse Event|8|||
156599674|NCT00077376|565275829|FG000|Overall Study|Withdrawal by Subject|2|||
156599675|NCT00077376|565275829|FG000|Overall Study|Death|1|||
156599676|NCT00077376|565275829|FG000|Overall Study|Physician Decision|1|||
156599677|NCT00077376|565275829|FG000|Overall Study|Alternative therapy|5|||
156599678|NCT00077376|565275829|FG000|Overall Study|Complicating disease|1|||
156599679|NCT00077376|565275829|FG000|Overall Study|Still on treatment|1|||
156599680|NCT00077376|565275829|FG000|Overall Study|Symptomatic deterioration|1|||
156599681|NCT00077376|565275829|FG000|Overall Study|Surgery|1|||
156599682|NCT00077376|565275829|FG000|Overall Study|Insurance ran out|1|||
156599683|NCT03784027|565275830|FG000|Period 1|Withdrawal by Subject|0|||
156599684|NCT03784027|565275831|FG001|Period 1|Withdrawal by Subject|1|||
156599685|NCT05691829|565277167|FG000|Overall Study|Physician Decision|2|||
156599686|NCT05691829|565277167|FG000|Overall Study|Eligibility criteria not met|3|||
156599687|NCT02843178|565277170|FG000|Overall Study|Lost to Follow-up|8|||
156599688|NCT02843178|565277171|FG001|Overall Study|Lost to Follow-up|8|||
156599689|NCT02843178|565277172|FG002|Overall Study|Lost to Follow-up|6|||
156599690|NCT02843178|565277173|FG003|Overall Study|Lost to Follow-up|3|||
156599691|NCT02843178|565277170|FG000|Overall Study|Withdrawal by Subject|0|||
156599692|NCT02843178|565277171|FG001|Overall Study|Withdrawal by Subject|0|||
156599693|NCT02843178|565277172|FG002|Overall Study|Withdrawal by Subject|1|||
156599694|NCT02843178|565277173|FG003|Overall Study|Withdrawal by Subject|1|||
156599695|NCT00646113|565277174|FG000|Overall Study|Lost to Follow-up|5|||
156599696|NCT00646113|565277174|FG000|Overall Study|Adverse Event|3|||
156599697|NCT03927911|565277183|FG000|Overall Study|problems with eDiary|0|||
156599698|NCT03927911|565277184|FG001|Overall Study|problems with eDiary|1|||
156599699|NCT03927911|565277185|FG002|Overall Study|problems with eDiary|0|||
156599700|NCT03927911|565277186|FG003|Overall Study|problems with eDiary|1|||
156599701|NCT03927911|565277187|FG004|Overall Study|problems with eDiary|0|||
156599702|NCT03927911|565277188|FG005|Overall Study|problems with eDiary|4|||
156599703|NCT03927911|565277183|FG000|Overall Study|Adverse Event|0|||
156599704|NCT03927911|565277184|FG001|Overall Study|Adverse Event|0|||
156599705|NCT03927911|565277185|FG002|Overall Study|Adverse Event|0|||
156599706|NCT03927911|565277186|FG003|Overall Study|Adverse Event|0|||
156599707|NCT03927911|565277187|FG004|Overall Study|Adverse Event|0|||
156599708|NCT03927911|565277188|FG005|Overall Study|Adverse Event|1|||
156599709|NCT03927911|565277183|FG000|Overall Study|not treated -study terminated by sponsor|0|||
156599710|NCT03927911|565277184|FG001|Overall Study|not treated -study terminated by sponsor|1|||
156599711|NCT03927911|565277185|FG002|Overall Study|not treated -study terminated by sponsor|0|||
156599712|NCT03927911|565277186|FG003|Overall Study|not treated -study terminated by sponsor|0|||
156599713|NCT03927911|565277187|FG004|Overall Study|not treated -study terminated by sponsor|0|||
156599714|NCT03927911|565277188|FG005|Overall Study|not treated -study terminated by sponsor|0|||
156599715|NCT03927911|565277183|FG000|Overall Study|Surgery cancelled|0|||
156599716|NCT03927911|565277184|FG001|Overall Study|Surgery cancelled|0|||
156599717|NCT03927911|565277185|FG002|Overall Study|Surgery cancelled|0|||
156599718|NCT03927911|565277186|FG003|Overall Study|Surgery cancelled|1|||
156599719|NCT03927911|565277187|FG004|Overall Study|Surgery cancelled|0|||
156599720|NCT03927911|565277188|FG005|Overall Study|Surgery cancelled|1|||
156599721|NCT03927911|565277183|FG000|Overall Study|Protocol Violation|0|||
156599722|NCT03927911|565277184|FG001|Overall Study|Protocol Violation|0|||
156599723|NCT03927911|565277185|FG002|Overall Study|Protocol Violation|0|||
156599724|NCT03927911|565277186|FG003|Overall Study|Protocol Violation|0|||
156599725|NCT03927911|565277187|FG004|Overall Study|Protocol Violation|0|||
156599726|NCT03927911|565277188|FG005|Overall Study|Protocol Violation|1|||
156599727|NCT02658968|565277189|FG000|Received Rituximab|Adverse Event|0|||
156599728|NCT02658968|565277190|FG001|Received Rituximab|Adverse Event|0|||
156599729|NCT02658968|565277191|FG002|Received Rituximab|Adverse Event|0|||
156599730|NCT02658968|565277192|FG003|Received Rituximab|Adverse Event|0|||
156599731|NCT02658968|565277193|FG004|Received Rituximab|Adverse Event|1|||
156599732|NCT02658968|565277189|FG000|Received Rituximab|Progressive disease|0|||
156599733|NCT02658968|565277190|FG001|Received Rituximab|Progressive disease|0|||
156599734|NCT02658968|565277191|FG002|Received Rituximab|Progressive disease|0|||
156599735|NCT02658968|565277192|FG003|Received Rituximab|Progressive disease|0|||
156599736|NCT02658968|565277193|FG004|Received Rituximab|Progressive disease|1|||
156599737|NCT02658968|565277189|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
156599738|NCT02658968|565277190|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
156599739|NCT02658968|565277191|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
156599740|NCT02658968|565277192|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
156599741|NCT02658968|565277193|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
156599742|NCT02658968|565277189|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
156599743|NCT02658968|565277190|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
156599744|NCT02658968|565277191|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
156599745|NCT02658968|565277192|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
156599746|NCT02658968|565277193|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
156599747|NCT02658968|565277189|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
156599748|NCT02658968|565277190|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
156599749|NCT02658968|565277191|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
156599750|NCT02658968|565277192|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
156599751|NCT02658968|565277193|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
156599752|NCT02658968|565277189|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
156599753|NCT02658968|565277190|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
156599754|NCT02658968|565277191|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
156599755|NCT02658968|565277192|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
156599756|NCT02658968|565277193|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
156599757|NCT02658968|565277189|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
156599758|NCT02658968|565277190|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
156634906|NCT03917654|565407818|FG003|Year 1|Travel|0|||
156599759|NCT02658968|565277191|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
156599760|NCT02658968|565277192|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
156599761|NCT02658968|565277193|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
156599762|NCT00949910|565277196|FG000|Overall Study|Progressive Disease|3750|||
156599763|NCT00949910|565277196|FG000|Overall Study|Symptomatic Deterioration|1088|||
156599764|NCT00949910|565277196|FG000|Overall Study|Lost to Follow-up|100|||
156599765|NCT00949910|565277196|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
156599766|NCT00949910|565277196|FG000|Overall Study|Participant Refusal|390|||
156599767|NCT00949910|565277196|FG000|Overall Study|Death Due to Malignant Disease|456|||
156599768|NCT00949910|565277196|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
156599769|NCT00949910|565277196|FG000|Overall Study|Death Due to Adverse Event|115|||
156599770|NCT00949910|565277196|FG000|Overall Study|Death Due to Toxicity|3|||
156599771|NCT00949910|565277196|FG000|Overall Study|Death from Unknown Cause|5|||
156599772|NCT00949910|565277196|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
156599773|NCT00949910|565277196|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
156599774|NCT00949910|565277196|FG000|Overall Study|Switched to Commercial Treatment|4|||
156599775|NCT00949910|565277196|FG000|Overall Study|Violation of Eligibility|23|||
156599776|NCT00949910|565277196|FG000|Overall Study|Logistical Reasons|13|||
156599777|NCT00949910|565277196|FG000|Overall Study|Non-Compliance|10|||
156599778|NCT00949910|565277196|FG000|Overall Study|Prolonged Dosing Interruption|4|||
156599779|NCT00949910|565277196|FG000|Overall Study|Adverse Event|83|||
156599780|NCT00949910|565277196|FG000|Overall Study|Serious Adverse Event|6|||
156599781|NCT00949910|565277196|FG000|Overall Study|Physician/Participant Decision|7|||
156599782|NCT00949910|565277196|FG000|Overall Study|Other|4|||
156599783|NCT00949910|565277196|FG000|Overall Study|No Data|9|||
156599784|NCT03287869|565277197|FG000|Overall Study|Adverse Event|14|||
156599785|NCT03287869|565277198|FG001|Overall Study|Adverse Event|12|||
156599786|NCT03287869|565277197|FG000|Overall Study|Lack of Efficacy|1|||
156599787|NCT03287869|565277198|FG001|Overall Study|Lack of Efficacy|0|||
156599788|NCT03287869|565277197|FG000|Overall Study|Lost to Follow-up|13|||
156599789|NCT03287869|565277198|FG001|Overall Study|Lost to Follow-up|19|||
156599790|NCT03287869|565277197|FG000|Overall Study|Non-Compliance With Study Drug|5|||
156599791|NCT03287869|565277198|FG001|Overall Study|Non-Compliance With Study Drug|9|||
156599792|NCT03287869|565277197|FG000|Overall Study|Progressive Disease|1|||
156599793|NCT03287869|565277198|FG001|Overall Study|Progressive Disease|0|||
156599794|NCT03287869|565277197|FG000|Overall Study|Protocol Deviation|2|||
156599795|NCT03287869|565277198|FG001|Overall Study|Protocol Deviation|1|||
156599796|NCT03287869|565277197|FG000|Overall Study|Withdrawal by Subject|36|||
156599797|NCT03287869|565277198|FG001|Overall Study|Withdrawal by Subject|43|||
156599798|NCT03287869|565277197|FG000|Overall Study|Early Closure of the Site|0|||
156599799|NCT03287869|565277198|FG001|Overall Study|Early Closure of the Site|1|||
156599800|NCT03287869|565277197|FG000|Overall Study|Physician Decision|5|||
156599801|NCT03287869|565277198|FG001|Overall Study|Physician Decision|5|||
156599802|NCT03287869|565277197|FG000|Overall Study|Reason not Specified|6|||
156599803|NCT03287869|565277198|FG001|Overall Study|Reason not Specified|3|||
156599804|NCT02591238|565277200|FG000|Overall Study|Pregnancy|1|||
156599805|NCT02591238|565277201|FG001|Overall Study|Pregnancy|0|||
156599806|NCT02591238|565277202|FG002|Overall Study|Pregnancy|0|||
156599807|NCT02591238|565277203|FG003|Overall Study|Pregnancy|0|||
156599808|NCT02591238|565277200|FG000|Overall Study|Withdrawal by Subject|0|||
156599809|NCT02591238|565277201|FG001|Overall Study|Withdrawal by Subject|0|||
156599810|NCT02591238|565277202|FG002|Overall Study|Withdrawal by Subject|0|||
156599811|NCT02591238|565277203|FG003|Overall Study|Withdrawal by Subject|1|||
156599812|NCT02591238|565277200|FG000|Overall Study|influenza|0|||
156599813|NCT02591238|565277201|FG001|Overall Study|influenza|0|||
156599814|NCT02591238|565277202|FG002|Overall Study|influenza|0|||
156599815|NCT02591238|565277203|FG003|Overall Study|influenza|1|||
156599816|NCT02591238|565277200|FG000|Overall Study|personal circumstances|0|||
156599817|NCT02591238|565277201|FG001|Overall Study|personal circumstances|0|||
156599818|NCT02591238|565277202|FG002|Overall Study|personal circumstances|0|||
156599819|NCT02591238|565277203|FG003|Overall Study|personal circumstances|1|||
156599820|NCT02591238|565277200|FG000|Overall Study|personal circumstances|0|||
156599821|NCT02591238|565277201|FG001|Overall Study|personal circumstances|1|||
156599822|NCT02591238|565277202|FG002|Overall Study|personal circumstances|0|||
156599823|NCT02591238|565277203|FG003|Overall Study|personal circumstances|0|||
156599824|NCT00640146|565277204|FG000|Overall Study|Adverse Event|2|||
156599825|NCT00640146|565277205|FG001|Overall Study|Adverse Event|0|||
156599826|NCT00640146|565277204|FG000|Overall Study|Lost to Follow-up|0|||
156599827|NCT00640146|565277205|FG001|Overall Study|Lost to Follow-up|1|||
156599828|NCT00640146|565277204|FG000|Overall Study|Lack of Efficacy|0|||
156599829|NCT00640146|565277205|FG001|Overall Study|Lack of Efficacy|1|||
156599830|NCT00640146|565277204|FG000|Overall Study|Withdrawal by Subject|1|||
156599831|NCT00640146|565277205|FG001|Overall Study|Withdrawal by Subject|1|||
156599832|NCT00640146|565277204|FG000|Overall Study|Randomized but not treated|1|||
156599833|NCT00640146|565277205|FG001|Overall Study|Randomized but not treated|3|||
156599834|NCT02455388|565277206|FG000|Overall Study|Protocol Violation|1|||
156599835|NCT02455388|565277207|FG001|Overall Study|Protocol Violation|0|||
156599836|NCT02455388|565277208|FG002|Overall Study|Protocol Violation|4|||
156599837|NCT02455388|565277206|FG000|Overall Study|Withdrawal by Subject|0|||
156599838|NCT02455388|565277207|FG001|Overall Study|Withdrawal by Subject|0|||
156599839|NCT02455388|565277208|FG002|Overall Study|Withdrawal by Subject|7|||
156599840|NCT00324740|565277209|FG000|Overall Study|Withdrawal by Subject|1|||
156599841|NCT00324740|565277210|FG001|Overall Study|Withdrawal by Subject|0|||
156599842|NCT00324740|565277211|FG002|Overall Study|Withdrawal by Subject|1|||
156599843|NCT02197897|565277214|FG000|Overall Study|not eligible|1|||
156599844|NCT01204697|565277215|FG000|Overall Study|Death|26|||
156599845|NCT01204697|565277216|FG001|Overall Study|Death|27|||
156599846|NCT01204697|565277215|FG000|Overall Study|Lost to Follow-up|3|||
156599847|NCT01204697|565277216|FG001|Overall Study|Lost to Follow-up|4|||
156599848|NCT01204697|565277215|FG000|Overall Study|Withdrawal by Subject|2|||
156599849|NCT01204697|565277216|FG001|Overall Study|Withdrawal by Subject|4|||
156599850|NCT01204697|565277215|FG000|Overall Study|Randomized, but not treated|0|||
156599851|NCT01204697|565277216|FG001|Overall Study|Randomized, but not treated|1|||
156599852|NCT03939637|565277221|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
156599853|NCT03939637|565277222|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
156599854|NCT03939637|565277221|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
156599855|NCT03939637|565277222|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
156599856|NCT04268004|565277223|FG000|Overall Study|Excluded from analyses|0|||
156599857|NCT04268004|565277224|FG001|Overall Study|Excluded from analyses|1|||
156599858|NCT04724733|565277227|FG000|Overall Study|Lost to Follow-up|1|||
156599859|NCT04724733|565277228|FG001|Overall Study|Lost to Follow-up|1|||
156599860|NCT04724733|565277229|FG002|Overall Study|Lost to Follow-up|1|||
156599861|NCT03341923|565277230|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
156599862|NCT03341923|565277231|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
156599863|NCT03986190|565277232|FG000|Overall Study|Withdrawal by Subject|12|||
156599864|NCT03986190|565277233|FG001|Overall Study|Withdrawal by Subject|0|||
156599865|NCT04511819|565277234|FG000|Overall Study|Non-compliance with study drug|5|||
156599866|NCT04511819|565277235|FG001|Overall Study|Non-compliance with study drug|1|||
156599867|NCT04511819|565277234|FG000|Overall Study|Withdrawal by Subject|0|||
156599868|NCT04511819|565277235|FG001|Overall Study|Withdrawal by Subject|3|||
156599869|NCT04511819|565277234|FG000|Overall Study|Adverse Event|0|||
156599870|NCT04511819|565277235|FG001|Overall Study|Adverse Event|1|||
156599871|NCT04511819|565277234|FG000|Overall Study|Protocol deviation|1|||
156599872|NCT04511819|565277235|FG001|Overall Study|Protocol deviation|0|||
156599873|NCT00844649|565277236|FG000|Overall Study|Progressive Disease|196|||
156599874|NCT00844649|565277237|FG001|Overall Study|Progressive Disease|245|||
156599875|NCT00844649|565277236|FG000|Overall Study|Adverse Event|128|||
156599876|NCT00844649|565277237|FG001|Overall Study|Adverse Event|73|||
156599877|NCT00844649|565277236|FG000|Overall Study|Physician Decision|25|||
156599878|NCT00844649|565277237|FG001|Overall Study|Physician Decision|18|||
156599879|NCT00844649|565277236|FG000|Overall Study|Protocol Violation|10|||
156599880|NCT00844649|565277237|FG001|Overall Study|Protocol Violation|6|||
156599881|NCT00844649|565277236|FG000|Overall Study|Withdrawal by Subject|28|||
156599882|NCT00844649|565277237|FG001|Overall Study|Withdrawal by Subject|39|||
156599883|NCT00844649|565277236|FG000|Overall Study|Other|7|||
156599884|NCT00844649|565277237|FG001|Overall Study|Other|10|||
156599885|NCT00844649|565277236|FG000|Overall Study|Withdrew prior to starting treatment|11|||
156599886|NCT00844649|565277237|FG001|Overall Study|Withdrew prior to starting treatment|27|||
156599887|NCT00168064|565277238|FG000|Overall Study|Adverse Event|26|||
156599888|NCT00168064|565277239|FG001|Overall Study|Adverse Event|22|||
156599889|NCT00168064|565277238|FG000|Overall Study|Withdrawal by Subject|3|||
156599890|NCT00168064|565277239|FG001|Overall Study|Withdrawal by Subject|4|||
156599891|NCT00168064|565277238|FG000|Overall Study|Lack of Efficacy|4|||
156599892|NCT00168064|565277239|FG001|Overall Study|Lack of Efficacy|4|||
156599893|NCT00168064|565277238|FG000|Overall Study|Lost to Follow-up|4|||
156599894|NCT00168064|565277239|FG001|Overall Study|Lost to Follow-up|3|||
156599895|NCT00168064|565277238|FG000|Overall Study|Non-compliance|2|||
156599896|NCT00168064|565277239|FG001|Overall Study|Non-compliance|3|||
156599897|NCT00168064|565277238|FG000|Overall Study|Concurrent Illness|4|||
156599898|NCT00168064|565277239|FG001|Overall Study|Concurrent Illness|3|||
156599899|NCT00168064|565277238|FG000|Overall Study|Subject's Best interest|2|||
156599900|NCT00168064|565277239|FG001|Overall Study|Subject's Best interest|2|||
156599901|NCT00168064|565277238|FG000|Overall Study|Various|4|||
156863683|NCT05194124|566258767|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156599902|NCT00168064|565277239|FG001|Overall Study|Various|3|||
156599903|NCT00589979|565277241|FG000|Run-In Period|Adverse Event|5|||
156599904|NCT00589979|565277242|FG001|Run-In Period|Adverse Event|0|||
156863684|NCT05194124|566258768|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156599905|NCT00589979|565277243|FG002|Run-In Period|Adverse Event|0|||
156599906|NCT00589979|565277241|FG000|Run-In Period|Protocol Violation|3|||
156599907|NCT00589979|565277242|FG001|Run-In Period|Protocol Violation|0|||
156599908|NCT00589979|565277243|FG002|Run-In Period|Protocol Violation|0|||
156599909|NCT00589979|565277241|FG000|Run-In Period|Did not qualify for randomization|54|||
156599910|NCT00589979|565277242|FG001|Run-In Period|Did not qualify for randomization|0|||
156599911|NCT00589979|565277243|FG002|Run-In Period|Did not qualify for randomization|0|||
156599912|NCT00589979|565277241|FG000|Run-In Period|Withdrawal by Subject|10|||
156599913|NCT00589979|565277242|FG001|Run-In Period|Withdrawal by Subject|0|||
156599914|NCT00589979|565277243|FG002|Run-In Period|Withdrawal by Subject|0|||
156599915|NCT00589979|565277241|FG000|Run-In Period|Informed Consent Withdrawn|4|||
156599916|NCT00589979|565277242|FG001|Run-In Period|Informed Consent Withdrawn|0|||
156599917|NCT00589979|565277243|FG002|Run-In Period|Informed Consent Withdrawn|0|||
156599918|NCT00589979|565277241|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
156599919|NCT00589979|565277242|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
156599920|NCT00589979|565277243|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
156599921|NCT00589979|565277241|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
156599922|NCT00589979|565277242|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
156599923|NCT00589979|565277243|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
156599924|NCT00589979|565277241|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
156599925|NCT00589979|565277242|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
156599926|NCT00589979|565277243|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
156599927|NCT00589979|565277241|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
156599928|NCT00589979|565277242|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
156599929|NCT00589979|565277243|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
156599930|NCT00589979|565277241|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
156599931|NCT00589979|565277242|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
156599932|NCT00589979|565277243|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
156599933|NCT00589979|565277241|FG000|Double-Blind Treatment Period 2|Other|0|||
156599934|NCT00589979|565277242|FG001|Double-Blind Treatment Period 2|Other|0|||
156599935|NCT00589979|565277243|FG002|Double-Blind Treatment Period 2|Other|1|||
156599936|NCT00589979|565277241|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
156599937|NCT00589979|565277242|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
156599938|NCT00589979|565277243|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
156599939|NCT00589979|565277241|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
156599940|NCT00589979|565277242|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
156599941|NCT00589979|565277243|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
156599942|NCT01153841|565277244|FG000|Overall Study|Adverse Event|1|||
156599943|NCT01153841|565277245|FG001|Overall Study|Adverse Event|0|||
156599944|NCT01153841|565277244|FG000|Overall Study|Withdrawal by Subject|1|||
156599945|NCT01153841|565277245|FG001|Overall Study|Withdrawal by Subject|0|||
156599946|NCT01153841|565277244|FG000|Overall Study|Protocol Violation|2|||
156599947|NCT01153841|565277245|FG001|Overall Study|Protocol Violation|0|||
156599948|NCT01153841|565277244|FG000|Overall Study|Lost to Follow-up|2|||
156599949|NCT01153841|565277245|FG001|Overall Study|Lost to Follow-up|0|||
156599950|NCT00830804|565277249|FG000|Overall Study|Lost to Follow-up|4|||
156599951|NCT00830804|565277249|FG000|Overall Study|Death|1|||
156599952|NCT00830804|565277249|FG000|Overall Study|Unable to get to clinic|7|||
156599953|NCT00830804|565277249|FG000|Overall Study|Consent withdrawn|2|||
156599954|NCT00830804|565277249|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
156599955|NCT03428997|565277255|FG000|Overall Study|Sponsor decision.|1|||
156599956|NCT03428997|565277255|FG000|Overall Study|Withdrawal by Subject|3|||
156599957|NCT03428997|565277255|FG000|Overall Study|Lost to Follow-up|4|||
156599958|NCT00510068|565277259|FG000|Double-blind Period|Disease progression|98|||
156599959|NCT00510068|565277260|FG001|Double-blind Period|Disease progression|169|||
156599960|NCT00510068|565277259|FG000|Double-blind Period|Final primary analysis|52|||
156599961|NCT00510068|565277260|FG001|Double-blind Period|Final primary analysis|18|||
156599962|NCT00510068|565277259|FG000|Double-blind Period|Adverse Event|37|||
156599963|NCT00510068|565277260|FG001|Double-blind Period|Adverse Event|7|||
156599964|NCT00510068|565277259|FG000|Double-blind Period|Withdrawal by Subject|8|||
156599965|NCT00510068|565277260|FG001|Double-blind Period|Withdrawal by Subject|6|||
156599966|NCT00510068|565277259|FG000|Double-blind Period|Death|4|||
156599967|NCT00510068|565277260|FG001|Double-blind Period|Death|3|||
156599968|NCT00510068|565277259|FG000|Double-blind Period|Abnormal test result (s)|1|||
156599969|NCT00510068|565277260|FG001|Double-blind Period|Abnormal test result (s)|0|||
156599970|NCT00510068|565277259|FG000|Double-blind Period|Lost to Follow-up|1|||
156599971|NCT00510068|565277260|FG001|Double-blind Period|Lost to Follow-up|0|||
156599972|NCT00510068|565277259|FG000|Double-blind Period|Protocol Violation|6|||
156599973|NCT00510068|565277260|FG001|Double-blind Period|Protocol Violation|0|||
156599974|NCT00510068|565277259|FG000|Open-label Period|Disease Progression|124|||
156599975|NCT00510068|565277260|FG001|Open-label Period|Disease Progression|0|||
156599976|NCT00510068|565277259|FG000|Open-label Period|Adverse Event|46|||
156599977|NCT00510068|565277260|FG001|Open-label Period|Adverse Event|0|||
156599978|NCT00510068|565277259|FG000|Open-label Period|Withdrawal by Subject|21|||
156599979|NCT00510068|565277260|FG001|Open-label Period|Withdrawal by Subject|0|||
156599980|NCT00510068|565277259|FG000|Open-label Period|Administrative problems|17|||
156599981|NCT00510068|565277260|FG001|Open-label Period|Administrative problems|0|||
156599982|NCT00510068|565277259|FG000|Open-label Period|Death|7|||
156599983|NCT00510068|565277260|FG001|Open-label Period|Death|0|||
156599984|NCT00510068|565277259|FG000|Open-label Period|New cancer therapy|7|||
156599985|NCT00510068|565277260|FG001|Open-label Period|New cancer therapy|0|||
156599986|NCT00510068|565277259|FG000|Open-label Period|Protocol Violation|2|||
156599987|NCT00510068|565277260|FG001|Open-label Period|Protocol Violation|0|||
156599988|NCT00510068|565277259|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
156599989|NCT00510068|565277260|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
156599990|NCT01397448|565277261|FG000|Overall Study|Adverse Event|4|||
156599991|NCT01397448|565277262|FG001|Overall Study|Adverse Event|4|||
156599992|NCT01397448|565277263|FG002|Overall Study|Adverse Event|6|||
156599993|NCT01397448|565277261|FG000|Overall Study|Withdrawal by Subject|4|||
156599994|NCT01397448|565277262|FG001|Overall Study|Withdrawal by Subject|4|||
156599995|NCT01397448|565277263|FG002|Overall Study|Withdrawal by Subject|3|||
156599996|NCT01397448|565277261|FG000|Overall Study|Lack of Efficacy|2|||
156599997|NCT01397448|565277262|FG001|Overall Study|Lack of Efficacy|0|||
156599998|NCT01397448|565277263|FG002|Overall Study|Lack of Efficacy|5|||
156599999|NCT01397448|565277261|FG000|Overall Study|Other|8|||
156600000|NCT01397448|565277262|FG001|Overall Study|Other|7|||
156600001|NCT01397448|565277263|FG002|Overall Study|Other|4|||
156600002|NCT02180217|565277265|FG000|Overall Study|Adverse Event|3|||
156600003|NCT02180217|565277266|FG001|Overall Study|Adverse Event|2|||
156600004|NCT02180217|565277267|FG002|Overall Study|Adverse Event|22|||
156600005|NCT02180217|565277265|FG000|Overall Study|Death|1|||
156600006|NCT02180217|565277266|FG001|Overall Study|Death|1|||
156600007|NCT02180217|565277267|FG002|Overall Study|Death|0|||
156600008|NCT02180217|565277265|FG000|Overall Study|Withdrawal by Subject|1|||
156600009|NCT02180217|565277266|FG001|Overall Study|Withdrawal by Subject|1|||
156600010|NCT02180217|565277267|FG002|Overall Study|Withdrawal by Subject|4|||
156600011|NCT02180217|565277265|FG000|Overall Study|Subject/Guardian decision|5|||
156600012|NCT02180217|565277266|FG001|Overall Study|Subject/Guardian decision|3|||
156600013|NCT02180217|565277267|FG002|Overall Study|Subject/Guardian decision|6|||
156600014|NCT02180217|565277265|FG000|Overall Study|Physician Decision|1|||
156600015|NCT02180217|565277266|FG001|Overall Study|Physician Decision|1|||
156600016|NCT02180217|565277267|FG002|Overall Study|Physician Decision|6|||
156600017|NCT02180217|565277265|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156600018|NCT02180217|565277266|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156600019|NCT02180217|565277267|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156600020|NCT00776555|565277268|FG000|Overall Study|Study terminated|3|||
156600021|NCT00776555|565277269|FG001|Overall Study|Study terminated|0|||
156600022|NCT03483116|565277273|FG000|Overall Study|Adverse Event|0|||
156600023|NCT03483116|565277274|FG001|Overall Study|Adverse Event|1|||
156600024|NCT03483116|565277275|FG002|Overall Study|Adverse Event|0|||
156600025|NCT03483116|565277276|FG003|Overall Study|Adverse Event|1|||
156600026|NCT03483116|565277273|FG000|Overall Study|Protocol Violation|1|||
156600027|NCT03483116|565277274|FG001|Overall Study|Protocol Violation|0|||
156600028|NCT03483116|565277275|FG002|Overall Study|Protocol Violation|0|||
156600029|NCT03483116|565277276|FG003|Overall Study|Protocol Violation|7|||
156600030|NCT03483116|565277273|FG000|Overall Study|Lost to Follow-up|9|||
156600031|NCT03483116|565277274|FG001|Overall Study|Lost to Follow-up|4|||
156600032|NCT03483116|565277275|FG002|Overall Study|Lost to Follow-up|9|||
156600033|NCT03483116|565277276|FG003|Overall Study|Lost to Follow-up|5|||
156600034|NCT03483116|565277273|FG000|Overall Study|Death|1|||
156600035|NCT03483116|565277274|FG001|Overall Study|Death|0|||
156600036|NCT03483116|565277275|FG002|Overall Study|Death|2|||
156600037|NCT03483116|565277276|FG003|Overall Study|Death|1|||
156600038|NCT03483116|565277273|FG000|Overall Study|Withdrawal by Subject|14|||
156600039|NCT03483116|565277274|FG001|Overall Study|Withdrawal by Subject|16|||
156600040|NCT03483116|565277275|FG002|Overall Study|Withdrawal by Subject|14|||
156600041|NCT03483116|565277276|FG003|Overall Study|Withdrawal by Subject|16|||
156600042|NCT03483116|565277273|FG000|Overall Study|Unknown other reason|3|||
156600043|NCT03483116|565277274|FG001|Overall Study|Unknown other reason|2|||
156600044|NCT03483116|565277275|FG002|Overall Study|Unknown other reason|1|||
156600045|NCT03483116|565277276|FG003|Overall Study|Unknown other reason|1|||
156600046|NCT01181102|565277277|FG000|Overall Study|Adverse Event|28|||
156600047|NCT01181102|565277278|FG001|Overall Study|Adverse Event|26|||
156600048|NCT01181102|565277277|FG000|Overall Study|Lack of Efficacy|3|||
156600049|NCT01181102|565277278|FG001|Overall Study|Lack of Efficacy|1|||
156600050|NCT01181102|565277277|FG000|Overall Study|Lost to Follow-up|2|||
156600051|NCT01181102|565277278|FG001|Overall Study|Lost to Follow-up|0|||
156600052|NCT01181102|565277277|FG000|Overall Study|Physician Decision|3|||
156600053|NCT01181102|565277278|FG001|Overall Study|Physician Decision|1|||
156600054|NCT01181102|565277277|FG000|Overall Study|Protocol Violation|5|||
156600055|NCT01181102|565277278|FG001|Overall Study|Protocol Violation|6|||
156600056|NCT01181102|565277277|FG000|Overall Study|Withdrawal by Subject|10|||
156600057|NCT01181102|565277278|FG001|Overall Study|Withdrawal by Subject|12|||
156600058|NCT00239837|565277279|FG000|Overall Study|Lost to Follow-up|3|||
156600059|NCT00239837|565277280|FG001|Overall Study|Lost to Follow-up|7|||
156600060|NCT01838590|565277281|FG000|Overall Study|Lack of Efficacy|12|||
156600061|NCT01838590|565277282|FG001|Overall Study|Lack of Efficacy|4|||
156600062|NCT01838590|565277281|FG000|Overall Study|Lost to Follow-up|0|||
156600063|NCT01838590|565277282|FG001|Overall Study|Lost to Follow-up|1|||
156600064|NCT04685499|565277283|FG000|Overall Study|Study Terminated Early|1|||
156600065|NCT00393913|565277287|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
156600066|NCT00393913|565277287|FG000|Initial Assessment|Withdrawal by Subject|16|||
156600067|NCT00393913|565277287|FG000|CPAP|Withdrawal by Subject|3|||
156600068|NCT00393913|565277287|FG000|CPAP|Physician Decision|1|||
156600069|NCT00393913|565277287|FG000|CPAP|TEchnical problem with CPAP|3|||
156600070|NCT00178464|565277288|FG000|Overall Study|Withdrawal by Subject|1|||
156600071|NCT00178464|565277288|FG000|Overall Study|Physician Decision|1|||
156600072|NCT02260648|565277289|FG000|Overall Study|Adverse Event|3|||
156600073|NCT02260648|565277290|FG001|Overall Study|Adverse Event|0|||
156600074|NCT02260648|565277291|FG002|Overall Study|Adverse Event|1|||
156600075|NCT02260648|565277289|FG000|Overall Study|Withdrawal by Subject|1|||
156600076|NCT02260648|565277290|FG001|Overall Study|Withdrawal by Subject|1|||
156600077|NCT02260648|565277291|FG002|Overall Study|Withdrawal by Subject|0|||
156600078|NCT02260648|565277289|FG000|Overall Study|Protocol Violation|1|||
156600079|NCT02260648|565277290|FG001|Overall Study|Protocol Violation|0|||
156600080|NCT02260648|565277291|FG002|Overall Study|Protocol Violation|0|||
156600081|NCT02260648|565277289|FG000|Overall Study|Discontinue Due to Study Termination|13|||
156600082|NCT02260648|565277290|FG001|Overall Study|Discontinue Due to Study Termination|12|||
156600083|NCT02260648|565277291|FG002|Overall Study|Discontinue Due to Study Termination|7|||
156600084|NCT04093258|565277292|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
156600085|NCT04093258|565277293|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
156600086|NCT00594204|565277294|FG000|Overall Study|Adverse Event|15|||
156600087|NCT00594204|565277295|FG001|Overall Study|Adverse Event|3|||
156600088|NCT00594204|565277294|FG000|Overall Study|Lost to Follow-up|9|||
156600089|NCT00594204|565277295|FG001|Overall Study|Lost to Follow-up|5|||
156600090|NCT00594204|565277294|FG000|Overall Study|Withdrawal by Subject|23|||
156600091|NCT00594204|565277295|FG001|Overall Study|Withdrawal by Subject|29|||
156600092|NCT00594204|565277294|FG000|Overall Study|Other|4|||
156600093|NCT00594204|565277295|FG001|Overall Study|Other|3|||
156600094|NCT00594204|565277294|FG000|Overall Study|Lack of Efficacy|3|||
156600095|NCT00594204|565277295|FG001|Overall Study|Lack of Efficacy|4|||
156600096|NCT00594204|565277294|FG000|Overall Study|Randomized but not treated|4|||
156600097|NCT00594204|565277295|FG001|Overall Study|Randomized but not treated|1|||
156600098|NCT00567541|565277296|FG000|Overall Study|Adverse Event|0|||
156600099|NCT00567541|565277297|FG001|Overall Study|Adverse Event|1|||
156600100|NCT01529385|565277298|FG000|Overall Study|Lost to Follow-up|2|||
156600101|NCT01529385|565277299|FG001|Overall Study|Lost to Follow-up|1|||
156600102|NCT00805545|565277300|FG000|Overall Study|Protocol Violation|3|||
156600103|NCT00805545|565277301|FG001|Overall Study|Protocol Violation|2|||
156600104|NCT00805545|565277300|FG000|Overall Study|Protocol Violation|3|||
156600105|NCT00805545|565277301|FG001|Overall Study|Protocol Violation|1|||
156600106|NCT01401465|565277302|FG000|Treatment Period 1|Adverse Event|4|||
156600107|NCT01401465|565277303|FG001|Treatment Period 1|Adverse Event|1|||
156600108|NCT01401465|565277302|FG000|Treatment Period 1|Pregnancy|0|||
156600109|NCT01401465|565277303|FG001|Treatment Period 1|Pregnancy|1|||
156600110|NCT01401465|565277302|FG000|Treatment Period 1|Protocol Violation|5|||
156600111|NCT01401465|565277303|FG001|Treatment Period 1|Protocol Violation|0|||
156600112|NCT01401465|565277302|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156600113|NCT01401465|565277303|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156600114|NCT01401465|565277302|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
156600115|NCT01401465|565277303|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
156600116|NCT01401465|565277302|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
156600117|NCT01401465|565277303|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
156600118|NCT01401465|565277302|FG000|Treatment Period 1|Scheduling Difficulties|1|||
156600119|NCT01401465|565277303|FG001|Treatment Period 1|Scheduling Difficulties|1|||
156600120|NCT01401465|565277302|FG000|Treatment Period 2|Lost to Follow-up|0|||
156600121|NCT01401465|565277303|FG001|Treatment Period 2|Lost to Follow-up|1|||
156600122|NCT01401465|565277302|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156600123|NCT01401465|565277303|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156600124|NCT01115738|565277304|FG000|Overall Study|Death|1|||
156600125|NCT01115738|565277305|FG001|Overall Study|Death|0|||
156600126|NCT01115738|565277306|FG002|Overall Study|Death|0|||
156600127|NCT01115738|565277304|FG000|Overall Study|Lost to Follow-up|0|||
156600128|NCT01115738|565277305|FG001|Overall Study|Lost to Follow-up|0|||
156600129|NCT01115738|565277306|FG002|Overall Study|Lost to Follow-up|1|||
156600130|NCT01115738|565277304|FG000|Overall Study|Physician Decision|18|||
156600131|NCT01115738|565277305|FG001|Overall Study|Physician Decision|15|||
156600132|NCT01115738|565277306|FG002|Overall Study|Physician Decision|17|||
156600133|NCT01115738|565277304|FG000|Overall Study|Withdrawal by Subject|6|||
156600134|NCT01115738|565277305|FG001|Overall Study|Withdrawal by Subject|6|||
156600135|NCT01115738|565277306|FG002|Overall Study|Withdrawal by Subject|9|||
156600136|NCT02379390|565277309|FG000|Overall Study|Adverse Event|1|||
156600137|NCT02379390|565277310|FG001|Overall Study|Adverse Event|1|||
156600138|NCT02379390|565277309|FG000|Overall Study|Investigator's decision|1|||
156600139|NCT02379390|565277310|FG001|Overall Study|Investigator's decision|0|||
156600140|NCT02379390|565277309|FG000|Overall Study|Study Termination|0|||
156600141|NCT02379390|565277310|FG001|Overall Study|Study Termination|1|||
156600142|NCT00772382|565277313|FG000|Overall Study|Adverse Event|19|||
156600143|NCT00772382|565277313|FG000|Overall Study|Death|6|||
156600144|NCT00772382|565277313|FG000|Overall Study|Lack of Efficacy|4|||
156600145|NCT00772382|565277313|FG000|Overall Study|Physician Decision|5|||
156600146|NCT00772382|565277313|FG000|Overall Study|Protocol Violation|1|||
156600147|NCT00772382|565277313|FG000|Overall Study|Withdrawal by Subject|10|||
156600148|NCT00772382|565277313|FG000|Overall Study|Other Reasons|10|||
156600149|NCT02721251|565277315|FG000|Overall Study|Withdrawal by Subject|8|||
156600150|NCT02721251|565277316|FG001|Overall Study|Withdrawal by Subject|7|||
156600151|NCT02721251|565277317|FG002|Overall Study|Withdrawal by Subject|9|||
156600152|NCT02721251|565277315|FG000|Overall Study|poor adherence|2|||
156600153|NCT02721251|565277316|FG001|Overall Study|poor adherence|2|||
156600154|NCT02721251|565277317|FG002|Overall Study|poor adherence|2|||
156600155|NCT02921763|565277320|FG000|Overall Study|Adverse Event|4|||
156600156|NCT02921763|565277320|FG000|Overall Study|Lost to Follow-up|4|||
156600157|NCT02921763|565277320|FG000|Overall Study|Lack of Efficacy|3|||
156600158|NCT02921763|565277320|FG000|Overall Study|Protocol Violation|2|||
156600159|NCT02921763|565277320|FG000|Overall Study|Withdrawal by Subject|2|||
156600160|NCT02921763|565277320|FG000|Overall Study|Physician Decision|1|||
156600161|NCT02921763|565277320|FG000|Overall Study|No data obtained|2|||
156600162|NCT01740388|565277321|FG000|Overall Study|Withdrawal by Subject|1|||
156600163|NCT01740388|565277322|FG001|Overall Study|Withdrawal by Subject|2|||
156600164|NCT01740388|565277321|FG000|Overall Study|Lost to Follow-up|2|||
156600165|NCT01740388|565277322|FG001|Overall Study|Lost to Follow-up|0|||
156600166|NCT01740388|565277321|FG000|Overall Study|Physician Decision|2|||
156600167|NCT01740388|565277322|FG001|Overall Study|Physician Decision|6|||
156600168|NCT01740388|565277321|FG000|Overall Study|Subjects missing data, completed|41|||
156600169|NCT01740388|565277322|FG001|Overall Study|Subjects missing data, completed|36|||
156600170|NCT00453180|565279428|FG000|Overall Study|Lost to Follow-up|2|||
156600171|NCT00453180|565279429|FG001|Overall Study|Lost to Follow-up|1|||
156600172|NCT00453180|565279428|FG000|Overall Study|Adverse Event|1|||
156600173|NCT00453180|565279429|FG001|Overall Study|Adverse Event|2|||
156600174|NCT00804843|565279430|FG000|Overall Study|Protocol Violation|1|||
156600175|NCT00804843|565279431|FG001|Overall Study|Protocol Violation|0|||
156600176|NCT00804843|565279430|FG000|Overall Study|Adverse Event|8|||
156600177|NCT00804843|565279431|FG001|Overall Study|Adverse Event|5|||
156600178|NCT00804843|565279430|FG000|Overall Study|Withdrawal by Subject|1|||
156600179|NCT00804843|565279431|FG001|Overall Study|Withdrawal by Subject|2|||
156600180|NCT03326869|565279437|FG000|Overall Study|Study data has been lost to natural disa|1|||
156600181|NCT03326869|565279438|FG001|Overall Study|Study data has been lost to natural disa|1|||
156600182|NCT01002742|565279441|FG000|Overall Study|Determined to be ineligible|0|||
156600183|NCT01002742|565279442|FG001|Overall Study|Determined to be ineligible|1|||
156600184|NCT00562640|565279443|FG000|Overall Study|Death|0|||
156600185|NCT00562640|565279444|FG001|Overall Study|Death|1|||
156600186|NCT00562640|565279445|FG002|Overall Study|Death|1|||
156600187|NCT00562640|565279446|FG003|Overall Study|Death|0|||
156600188|NCT01297309|565279447|FG000|Overall Study|Eligibility failure|2|||
156600189|NCT01297309|565279447|FG000|Overall Study|Screen failure|2|||
156600190|NCT01297309|565279447|FG000|Overall Study|Withdrawal by Subject|5|||
156600191|NCT01297309|565279447|FG000|Overall Study|Adverse Event|1|||
156600192|NCT01297309|565279447|FG000|Overall Study|Investigator Decision|2|||
156600193|NCT01297309|565279447|FG000|Overall Study|Death|1|||
156600194|NCT01297309|565279447|FG000|Overall Study|Participant not entering extensionperiod|1|||
156600195|NCT02670928|565279448|FG000|Overall Study|Adverse Event|3|||
156600196|NCT02670928|565279449|FG001|Overall Study|Adverse Event|1|||
156600197|NCT02670928|565279448|FG000|Overall Study|Withdrawal by Subject|4|||
156600198|NCT02670928|565279449|FG001|Overall Study|Withdrawal by Subject|0|||
156600199|NCT02670928|565279448|FG000|Overall Study|Lost to Follow-up|1|||
156600200|NCT02670928|565279449|FG001|Overall Study|Lost to Follow-up|0|||
156600201|NCT02670928|565279448|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
156600202|NCT02670928|565279449|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
156600203|NCT02678312|565279450|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
156600204|NCT02678312|565279451|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
156600205|NCT02678312|565279452|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
156600206|NCT02678312|565279453|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
156600207|NCT02678312|565279454|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
156600208|NCT02678312|565279450|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
156600209|NCT02678312|565279451|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
156600210|NCT02678312|565279452|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
156600211|NCT02678312|565279453|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
156600212|NCT02678312|565279454|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
156600213|NCT02678312|565279450|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
156600214|NCT02678312|565279451|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
156600215|NCT02678312|565279452|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
156600216|NCT02678312|565279453|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
156600217|NCT02678312|565279454|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
156600218|NCT02678312|565279450|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
156600219|NCT02678312|565279451|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
156600220|NCT02678312|565279452|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
156600221|NCT02678312|565279453|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
156600222|NCT02678312|565279454|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
156600223|NCT02678312|565279450|FG000|Part 2 Double Blind Epoch|Death|0|||
156600224|NCT02678312|565279451|FG001|Part 2 Double Blind Epoch|Death|0|||
156600225|NCT02678312|565279452|FG002|Part 2 Double Blind Epoch|Death|0|||
156600226|NCT02678312|565279453|FG003|Part 2 Double Blind Epoch|Death|8|||
156600227|NCT02678312|565279454|FG004|Part 2 Double Blind Epoch|Death|12|||
156600228|NCT02678312|565279450|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
156600229|NCT02678312|565279451|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
156600230|NCT02678312|565279452|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
156600231|NCT02678312|565279453|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
156600232|NCT02678312|565279454|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
156600233|NCT02678312|565279450|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
156600234|NCT02678312|565279451|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
156600235|NCT02678312|565279452|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
156600236|NCT02678312|565279453|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
156600237|NCT02678312|565279454|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
156600238|NCT02678312|565279450|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
156600239|NCT02678312|565279451|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
156600240|NCT02678312|565279452|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
156600241|NCT02678312|565279453|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
156600242|NCT02678312|565279454|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
156600243|NCT00656084|565279455|FG000|Overall Study|Adverse Event|4|||
156600244|NCT00656084|565279455|FG000|Overall Study|Withdrawal by Subject|1|||
156600245|NCT00656084|565279455|FG000|Overall Study|Patient Request|1|||
156600246|NCT00656084|565279455|FG000|Overall Study|Investigator Request|1|||
156600247|NCT00525785|565279462|FG000|Overall Study|Withdrawal by Subject|1|||
156600248|NCT00525785|565279462|FG000|Overall Study|Lack of Efficacy|1|||
156600249|NCT00525785|565279462|FG000|Overall Study|Physician Decision|1|||
156600250|NCT04847141|565279463|FG000|Overall Study|Adverse Event|1|||
156600251|NCT04847141|565279464|FG001|Overall Study|Adverse Event|0|||
156600252|NCT04847141|565279465|FG002|Overall Study|Adverse Event|1|||
156600253|NCT04847141|565279463|FG000|Overall Study|Withdrawal by Subject|2|||
156600254|NCT04847141|565279464|FG001|Overall Study|Withdrawal by Subject|4|||
156600255|NCT04847141|565279465|FG002|Overall Study|Withdrawal by Subject|3|||
156600256|NCT04847141|565279463|FG000|Overall Study|Lost to Follow-up|7|||
156600257|NCT04847141|565279464|FG001|Overall Study|Lost to Follow-up|5|||
156600258|NCT04847141|565279465|FG002|Overall Study|Lost to Follow-up|7|||
156600259|NCT04847141|565279463|FG000|Overall Study|Reason not Specified|0|||
156600260|NCT04847141|565279464|FG001|Overall Study|Reason not Specified|1|||
156600261|NCT04847141|565279465|FG002|Overall Study|Reason not Specified|0|||
156600262|NCT01357980|565279469|FG000|Overall Study|Lack of Efficacy|0|||
156600263|NCT01357980|565279470|FG001|Overall Study|Lack of Efficacy|1|||
156600264|NCT01357980|565279471|FG002|Overall Study|Lack of Efficacy|0|||
156600265|NCT01357980|565279472|FG003|Overall Study|Lack of Efficacy|0|||
156600266|NCT01357980|565279469|FG000|Overall Study|Consent withdrawn|0|||
156600267|NCT01357980|565279470|FG001|Overall Study|Consent withdrawn|0|||
156600268|NCT01357980|565279471|FG002|Overall Study|Consent withdrawn|1|||
156600269|NCT01357980|565279472|FG003|Overall Study|Consent withdrawn|0|||
156600270|NCT00094835|565279476|FG000|Overall Study|Physician Decision|1|||
156600271|NCT00094835|565279477|FG001|Overall Study|Physician Decision|0|||
156600272|NCT00094835|565279478|FG002|Overall Study|Physician Decision|0|||
156600273|NCT00094835|565279479|FG003|Overall Study|Physician Decision|0|||
156600274|NCT00094835|565279480|FG004|Overall Study|Physician Decision|0|||
156600275|NCT00094835|565279481|FG005|Overall Study|Physician Decision|1|||
156600276|NCT00094835|565279482|FG006|Overall Study|Physician Decision|0|||
156600277|NCT00094835|565279476|FG000|Overall Study|Withdrawal by Subject|0|||
156600278|NCT00094835|565279477|FG001|Overall Study|Withdrawal by Subject|0|||
156600279|NCT00094835|565279478|FG002|Overall Study|Withdrawal by Subject|0|||
156600280|NCT00094835|565279479|FG003|Overall Study|Withdrawal by Subject|0|||
156600281|NCT00094835|565279480|FG004|Overall Study|Withdrawal by Subject|0|||
156600282|NCT00094835|565279481|FG005|Overall Study|Withdrawal by Subject|0|||
156600283|NCT00094835|565279482|FG006|Overall Study|Withdrawal by Subject|1|||
156600284|NCT00094835|565279476|FG000|Overall Study|Lost to Follow-up|0|||
156600285|NCT00094835|565279477|FG001|Overall Study|Lost to Follow-up|0|||
156600286|NCT00094835|565279478|FG002|Overall Study|Lost to Follow-up|0|||
156600287|NCT00094835|565279479|FG003|Overall Study|Lost to Follow-up|0|||
156600288|NCT00094835|565279480|FG004|Overall Study|Lost to Follow-up|1|||
156600289|NCT00094835|565279481|FG005|Overall Study|Lost to Follow-up|0|||
156600290|NCT00094835|565279482|FG006|Overall Study|Lost to Follow-up|0|||
156600291|NCT00094835|565279476|FG000|Overall Study|Death|1|||
156600292|NCT00094835|565279477|FG001|Overall Study|Death|0|||
156600293|NCT00094835|565279478|FG002|Overall Study|Death|0|||
156600294|NCT00094835|565279479|FG003|Overall Study|Death|0|||
156600295|NCT00094835|565279480|FG004|Overall Study|Death|1|||
156600296|NCT00094835|565279481|FG005|Overall Study|Death|0|||
156600297|NCT00094835|565279482|FG006|Overall Study|Death|0|||
156600298|NCT00094835|565279476|FG000|Overall Study|Non-compliance|1|||
156600299|NCT00094835|565279477|FG001|Overall Study|Non-compliance|2|||
156600300|NCT00094835|565279478|FG002|Overall Study|Non-compliance|2|||
156600301|NCT00094835|565279479|FG003|Overall Study|Non-compliance|0|||
156600302|NCT00094835|565279480|FG004|Overall Study|Non-compliance|2|||
156600303|NCT00094835|565279481|FG005|Overall Study|Non-compliance|2|||
156600304|NCT00094835|565279482|FG006|Overall Study|Non-compliance|1|||
156600305|NCT00094835|565279476|FG000|Overall Study|Other|1|||
156600306|NCT00094835|565279477|FG001|Overall Study|Other|1|||
156600307|NCT00094835|565279478|FG002|Overall Study|Other|1|||
156600308|NCT00094835|565279479|FG003|Overall Study|Other|1|||
156600309|NCT00094835|565279480|FG004|Overall Study|Other|0|||
156600310|NCT00094835|565279481|FG005|Overall Study|Other|0|||
156600311|NCT00094835|565279482|FG006|Overall Study|Other|0|||
156600312|NCT00387348|565279483|FG000|Overall Study|Death|1|||
156600313|NCT00387348|565279484|FG001|Overall Study|Death|1|||
156600314|NCT00387348|565279485|FG002|Overall Study|Death|0|||
156600315|NCT00387348|565279483|FG000|Overall Study|Physician Decision|1|||
156600316|NCT00387348|565279484|FG001|Overall Study|Physician Decision|0|||
156600317|NCT00387348|565279485|FG002|Overall Study|Physician Decision|1|||
156600318|NCT00387348|565279483|FG000|Overall Study|Withdrawal by Subject|0|||
156600319|NCT00387348|565279484|FG001|Overall Study|Withdrawal by Subject|2|||
156600320|NCT00387348|565279485|FG002|Overall Study|Withdrawal by Subject|2|||
156600321|NCT00387348|565279483|FG000|Overall Study|Adverse Event|1|||
156600322|NCT00387348|565279484|FG001|Overall Study|Adverse Event|0|||
156600323|NCT00387348|565279485|FG002|Overall Study|Adverse Event|1|||
156600324|NCT00868166|565279500|FG000|Overall Study|Death|58|||
156600325|NCT00868166|565279501|FG001|Overall Study|Death|65|||
156600326|NCT00868166|565279500|FG000|Overall Study|Withdrawal by Subject|33|||
156600327|NCT00868166|565279501|FG001|Overall Study|Withdrawal by Subject|25|||
156600328|NCT00868166|565279500|FG000|Overall Study|Protocol Violation|1|||
156600329|NCT00868166|565279501|FG001|Overall Study|Protocol Violation|0|||
156600330|NCT00868166|565279500|FG000|Overall Study|Lost to Follow-up|1|||
156600331|NCT00868166|565279501|FG001|Overall Study|Lost to Follow-up|3|||
156600332|NCT00868166|565279500|FG000|Overall Study|Adverse Event|9|||
156600333|NCT00868166|565279501|FG001|Overall Study|Adverse Event|10|||
156600334|NCT00868166|565279500|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
156600335|NCT00868166|565279501|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
156600336|NCT00868166|565279500|FG000|Overall Study|Non-compliance with IMP|1|||
156600337|NCT00868166|565279501|FG001|Overall Study|Non-compliance with IMP|1|||
156600338|NCT00171314|565279509|FG000|Overall Study|Adverse Event|44|||
156600339|NCT00171314|565279510|FG001|Overall Study|Adverse Event|41|||
156600340|NCT00171314|565279509|FG000|Overall Study|Lack of Efficacy|19|||
156600341|NCT00171314|565279510|FG001|Overall Study|Lack of Efficacy|14|||
156600342|NCT00171314|565279509|FG000|Overall Study|Withdrawal by Subject|9|||
156600343|NCT00171314|565279510|FG001|Overall Study|Withdrawal by Subject|6|||
156600344|NCT00171314|565279509|FG000|Overall Study|Abnormal Test Procedure Results|9|||
156600345|NCT00171314|565279510|FG001|Overall Study|Abnormal Test Procedure Results|3|||
156600346|NCT00171314|565279509|FG000|Overall Study|Protocol Violation|3|||
156600347|NCT00171314|565279510|FG001|Overall Study|Protocol Violation|7|||
156600348|NCT00171314|565279509|FG000|Overall Study|Administrative Problems|4|||
156600349|NCT00171314|565279510|FG001|Overall Study|Administrative Problems|3|||
156600350|NCT00171314|565279509|FG000|Overall Study|Lost to Follow-up|1|||
156600351|NCT00171314|565279510|FG001|Overall Study|Lost to Follow-up|3|||
156600352|NCT00171314|565279509|FG000|Overall Study|Death|2|||
156600353|NCT00171314|565279510|FG001|Overall Study|Death|1|||
156600354|NCT01309841|565279515|FG000|Overall Study|Other|0|||
156600355|NCT01309841|565279516|FG001|Overall Study|Other|1|||
156600356|NCT01309841|565279517|FG002|Overall Study|Other|1|||
156600357|NCT01309841|565279515|FG000|Overall Study|Lost to Follow-up|7|||
156600358|NCT01309841|565279516|FG001|Overall Study|Lost to Follow-up|6|||
156600359|NCT01309841|565279517|FG002|Overall Study|Lost to Follow-up|4|||
156600360|NCT01309841|565279515|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
156600361|NCT01309841|565279516|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
156600362|NCT01309841|565279517|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
156600363|NCT01309841|565279515|FG000|Overall Study|Lack of Efficacy|0|||
156600364|NCT01309841|565279516|FG001|Overall Study|Lack of Efficacy|0|||
156600365|NCT01309841|565279517|FG002|Overall Study|Lack of Efficacy|2|||
156600366|NCT01309841|565279515|FG000|Overall Study|Adverse Event|9|||
156600367|NCT01309841|565279516|FG001|Overall Study|Adverse Event|22|||
156600368|NCT01309841|565279517|FG002|Overall Study|Adverse Event|11|||
156600369|NCT01309841|565279515|FG000|Overall Study|Death|1|||
156600370|NCT01309841|565279516|FG001|Overall Study|Death|0|||
156600371|NCT01309841|565279517|FG002|Overall Study|Death|0|||
156600372|NCT01309841|565279515|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156600373|NCT01309841|565279516|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156600374|NCT01309841|565279517|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
156600375|NCT01309841|565279515|FG000|Overall Study|Withdrawal by Subject|17|||
156600376|NCT01309841|565279516|FG001|Overall Study|Withdrawal by Subject|6|||
156600377|NCT01309841|565279517|FG002|Overall Study|Withdrawal by Subject|13|||
156600378|NCT01309841|565279515|FG000|Overall Study|Did Not Receive Treatment|2|||
156600379|NCT01309841|565279516|FG001|Overall Study|Did Not Receive Treatment|0|||
156600380|NCT01309841|565279517|FG002|Overall Study|Did Not Receive Treatment|1|||
156600381|NCT01309841|565279515|FG000|Overall Study|Severe non-compliance with protocol|0|||
156600382|NCT01309841|565279516|FG001|Overall Study|Severe non-compliance with protocol|5|||
156600383|NCT01309841|565279517|FG002|Overall Study|Severe non-compliance with protocol|2|||
156600384|NCT01996904|565279518|FG000|Overall Study|Lost to Follow-up|38|||
156600385|NCT01996904|565279519|FG001|Overall Study|Lost to Follow-up|27|||
156600386|NCT04664855|565279520|FG000|Overall Study|Withdrawal by Subject|0|||
156600387|NCT04664855|565279521|FG001|Overall Study|Withdrawal by Subject|2|||
156600388|NCT01441115|565279522|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
156600389|NCT02475395|565279530|FG000|Overall Study|Protocol Violation|30|||
156600390|NCT02475395|565279531|FG001|Overall Study|Protocol Violation|3|||
156600391|NCT01086150|565279532|FG000|Overall Study|Withdrawal by Subject|0|||
156600392|NCT01086150|565279533|FG001|Overall Study|Withdrawal by Subject|4|||
156600393|NCT01086150|565279534|FG002|Overall Study|Withdrawal by Subject|1|||
156600394|NCT01086150|565279532|FG000|Overall Study|Lost to Follow-up|0|||
156600395|NCT01086150|565279533|FG001|Overall Study|Lost to Follow-up|1|||
156600396|NCT01086150|565279534|FG002|Overall Study|Lost to Follow-up|0|||
156600397|NCT01086150|565279532|FG000|Overall Study|Screen Failure|0|||
156600398|NCT01086150|565279533|FG001|Overall Study|Screen Failure|1|||
156600399|NCT01086150|565279534|FG002|Overall Study|Screen Failure|0|||
156600400|NCT01681576|565279535|FG000|Period 1|Adverse Event|1|||
156600401|NCT01681576|565279536|FG001|Period 1|Adverse Event|0|||
156600402|NCT01681576|565279535|FG000|Period 1|Protocol Deviation|1|||
156600403|NCT01681576|565279536|FG001|Period 1|Protocol Deviation|0|||
156600404|NCT01681576|565279535|FG000|Period 2|subject/guardian decision|3|||
156600405|NCT01681576|565279536|FG001|Period 2|subject/guardian decision|1|||
156600406|NCT01681576|565279535|FG000|Period 2|Non-compliance with study treatment|1|||
156600407|NCT01681576|565279536|FG001|Period 2|Non-compliance with study treatment|0|||
156600408|NCT03543358|565279538|FG000|Overall Study|Death|1|||
156600409|NCT03543358|565279539|FG001|Overall Study|Death|0|||
156600410|NCT03543358|565279538|FG000|Overall Study|Disease Progression|1|||
156600411|NCT03543358|565279539|FG001|Overall Study|Disease Progression|0|||
156600412|NCT03543358|565279538|FG000|Overall Study|Parent Study Closure|1|||
156600413|NCT03543358|565279539|FG001|Overall Study|Parent Study Closure|0|||
156600414|NCT01890512|565279540|FG000|Overall Study|Physician Decision|1|||
156600415|NCT01890512|565279540|FG000|Overall Study|Withdrawal by Subject|1|||
156600416|NCT01890512|565279540|FG000|Overall Study|Protocol Violation|1|||
156600417|NCT00986427|565279541|FG000|Overall Study|Lost to Follow-up|2|||
156600418|NCT00986427|565279542|FG001|Overall Study|Lost to Follow-up|0|||
156600419|NCT00986427|565279541|FG000|Overall Study|Lack of Efficacy|1|||
156600420|NCT00986427|565279542|FG001|Overall Study|Lack of Efficacy|0|||
156600421|NCT00986427|565279541|FG000|Overall Study|Withdrawal by Subject|1|||
156600422|NCT00986427|565279542|FG001|Overall Study|Withdrawal by Subject|0|||
156600423|NCT00575094|565279543|FG000|Overall Study|Adverse Event|2|||
156600424|NCT00575094|565279543|FG000|Overall Study|Withdrawal by Subject|1|||
156600425|NCT04142216|565279545|FG000|Overall Study|Hospitalization|0|||
156600426|NCT04142216|565279546|FG001|Overall Study|Hospitalization|2|||
156600427|NCT04142216|565279545|FG000|Overall Study|Death|3|||
156600428|NCT04142216|565279546|FG001|Overall Study|Death|1|||
156600429|NCT04142216|565279545|FG000|Overall Study|Referral to another hemodialysis unit|3|||
156600430|NCT04142216|565279546|FG001|Overall Study|Referral to another hemodialysis unit|2|||
156600431|NCT04142216|565279545|FG000|Overall Study|Use of clove|0|||
156600432|NCT04142216|565279546|FG001|Overall Study|Use of clove|1|||
156600433|NCT00862121|565279549|FG000|Overall Study|Adverse Event|1|||
156600434|NCT00862121|565279550|FG001|Overall Study|Adverse Event|2|||
156600435|NCT00862121|565279549|FG000|Overall Study|Lack of Efficacy|0|||
156600436|NCT00862121|565279550|FG001|Overall Study|Lack of Efficacy|3|||
156600437|NCT00862121|565279549|FG000|Overall Study|Protocol Violation|0|||
156600438|NCT00862121|565279550|FG001|Overall Study|Protocol Violation|1|||
156600439|NCT00862121|565279549|FG000|Overall Study|Exclusion criterion violation|0|||
156600440|NCT00862121|565279550|FG001|Overall Study|Exclusion criterion violation|1|||
156600441|NCT00862121|565279549|FG000|Overall Study|Incorrect randomisation|0|||
156600442|NCT00862121|565279550|FG001|Overall Study|Incorrect randomisation|1|||
156600443|NCT01582971|565279551|FG000|Overall Study|Death|2|||
156600444|NCT01582971|565279552|FG001|Overall Study|Death|1|||
156600445|NCT01582971|565279551|FG000|Overall Study|Lost to Follow-up|18|||
156600446|NCT01582971|565279552|FG001|Overall Study|Lost to Follow-up|21|||
156600447|NCT01582971|565279551|FG000|Overall Study|Withdrawal by Subject|4|||
156600448|NCT01582971|565279552|FG001|Overall Study|Withdrawal by Subject|2|||
156600449|NCT01582971|565279551|FG000|Overall Study|Other|15|||
156600450|NCT01582971|565279552|FG001|Overall Study|Other|13|||
156600451|NCT02007954|565279553|FG000|Overall Study|Received liver transplant|3|||
156600452|NCT02007954|565279553|FG000|Overall Study|Switch in treatment modality|2|||
156600453|NCT02007954|565279553|FG000|Overall Study|Disease progression and unrelated AE|1|||
156600454|NCT02007954|565279553|FG000|Overall Study|Death|1|||
156600455|NCT01641991|565279556|FG000|Overall Study|Physician Decision|0|||
156600456|NCT01641991|565279557|FG001|Overall Study|Physician Decision|1|||
156600457|NCT01641991|565279558|FG002|Overall Study|Physician Decision|7|||
156600458|NCT01641991|565279559|FG003|Overall Study|Physician Decision|5|||
156600459|NCT01641991|565279556|FG000|Overall Study|Withdrawal by Subject|4|||
156600460|NCT01641991|565279557|FG001|Overall Study|Withdrawal by Subject|2|||
156600461|NCT01641991|565279558|FG002|Overall Study|Withdrawal by Subject|1|||
156600462|NCT01641991|565279559|FG003|Overall Study|Withdrawal by Subject|5|||
156600463|NCT01641991|565279556|FG000|Overall Study|Adverse Event|2|||
156600464|NCT01641991|565279557|FG001|Overall Study|Adverse Event|1|||
156600465|NCT01641991|565279558|FG002|Overall Study|Adverse Event|2|||
156600466|NCT01641991|565279559|FG003|Overall Study|Adverse Event|1|||
156600467|NCT01641991|565279556|FG000|Overall Study|Lost to Follow-up|0|||
156600468|NCT01641991|565279557|FG001|Overall Study|Lost to Follow-up|2|||
156600469|NCT01641991|565279558|FG002|Overall Study|Lost to Follow-up|3|||
156600470|NCT01641991|565279559|FG003|Overall Study|Lost to Follow-up|1|||
156600471|NCT01641991|565279556|FG000|Overall Study|Protocol Violation|1|||
156600472|NCT01641991|565279557|FG001|Overall Study|Protocol Violation|1|||
156600473|NCT01641991|565279558|FG002|Overall Study|Protocol Violation|3|||
156600474|NCT01641991|565279559|FG003|Overall Study|Protocol Violation|0|||
156600475|NCT01641991|565279556|FG000|Overall Study|Pregnancy|0|||
156600476|NCT01641991|565279557|FG001|Overall Study|Pregnancy|0|||
156600477|NCT01641991|565279558|FG002|Overall Study|Pregnancy|1|||
156600478|NCT01641991|565279559|FG003|Overall Study|Pregnancy|0|||
156600479|NCT01641991|565279556|FG000|Overall Study|no longer eligible|2|||
156600480|NCT01641991|565279557|FG001|Overall Study|no longer eligible|1|||
156600481|NCT01641991|565279558|FG002|Overall Study|no longer eligible|0|||
156600482|NCT01641991|565279559|FG003|Overall Study|no longer eligible|4|||
156600483|NCT01054976|565279560|FG000|Overall Study|Adverse Event|16|||
156600484|NCT01054976|565279560|FG000|Overall Study|Uncooperative participations to study|7|||
156600485|NCT01054976|565279560|FG000|Overall Study|Withdrawal by Subject|4|||
156600486|NCT01054976|565279560|FG000|Overall Study|Other|8|||
156600487|NCT01763866|565279563|FG000|Overall Study|Withdrawal by Subject|2|||
156600488|NCT01763866|565279564|FG001|Overall Study|Withdrawal by Subject|1|||
156600489|NCT01763866|565279565|FG002|Overall Study|Withdrawal by Subject|4|||
156600490|NCT01763866|565279566|FG003|Overall Study|Withdrawal by Subject|0|||
156600491|NCT01763866|565279567|FG004|Overall Study|Withdrawal by Subject|0|||
156600492|NCT01763866|565279568|FG005|Overall Study|Withdrawal by Subject|3|||
156600493|NCT01763866|565279569|FG006|Overall Study|Withdrawal by Subject|4|||
156600494|NCT01763866|565279570|FG007|Overall Study|Withdrawal by Subject|0|||
156600495|NCT01763866|565279571|FG008|Overall Study|Withdrawal by Subject|1|||
156600496|NCT01763866|565279572|FG009|Overall Study|Withdrawal by Subject|1|||
156600497|NCT01763866|565279573|FG010|Overall Study|Withdrawal by Subject|2|||
156600498|NCT01763866|565279574|FG011|Overall Study|Withdrawal by Subject|2|||
156600499|NCT01763866|565279575|FG012|Overall Study|Withdrawal by Subject|2|||
156600500|NCT01763866|565279576|FG013|Overall Study|Withdrawal by Subject|0|||
156600501|NCT01763866|565279577|FG014|Overall Study|Withdrawal by Subject|6|||
156600502|NCT01763866|565279578|FG015|Overall Study|Withdrawal by Subject|3|||
156600503|NCT01763866|565279579|FG016|Overall Study|Withdrawal by Subject|0|||
156600504|NCT01763866|565279580|FG017|Overall Study|Withdrawal by Subject|1|||
156600505|NCT01763866|565279581|FG018|Overall Study|Withdrawal by Subject|1|||
156600506|NCT01763866|565279582|FG019|Overall Study|Withdrawal by Subject|1|||
156600507|NCT01763866|565279583|FG020|Overall Study|Withdrawal by Subject|2|||
156600508|NCT01763866|565279584|FG021|Overall Study|Withdrawal by Subject|1|||
156600509|NCT01763866|565279585|FG022|Overall Study|Withdrawal by Subject|2|||
156600510|NCT01763866|565279586|FG023|Overall Study|Withdrawal by Subject|1|||
156600511|NCT01763866|565279563|FG000|Overall Study|Decision by sponsor|0|||
156600512|NCT01763866|565279564|FG001|Overall Study|Decision by sponsor|0|||
156600513|NCT01763866|565279565|FG002|Overall Study|Decision by sponsor|1|||
156600514|NCT01763866|565279566|FG003|Overall Study|Decision by sponsor|0|||
156600515|NCT01763866|565279567|FG004|Overall Study|Decision by sponsor|2|||
156600516|NCT01763866|565279568|FG005|Overall Study|Decision by sponsor|0|||
156600517|NCT01763866|565279569|FG006|Overall Study|Decision by sponsor|2|||
156600518|NCT01763866|565279570|FG007|Overall Study|Decision by sponsor|0|||
156600519|NCT01763866|565279571|FG008|Overall Study|Decision by sponsor|2|||
156600520|NCT01763866|565279572|FG009|Overall Study|Decision by sponsor|0|||
156600521|NCT01763866|565279573|FG010|Overall Study|Decision by sponsor|6|||
156600522|NCT01763866|565279574|FG011|Overall Study|Decision by sponsor|0|||
156600523|NCT01763866|565279575|FG012|Overall Study|Decision by sponsor|1|||
156600524|NCT01763866|565279576|FG013|Overall Study|Decision by sponsor|0|||
156600525|NCT01763866|565279577|FG014|Overall Study|Decision by sponsor|5|||
156600526|NCT01763866|565279578|FG015|Overall Study|Decision by sponsor|0|||
156600527|NCT01763866|565279579|FG016|Overall Study|Decision by sponsor|0|||
156600528|NCT01763866|565279580|FG017|Overall Study|Decision by sponsor|0|||
156600529|NCT01763866|565279581|FG018|Overall Study|Decision by sponsor|4|||
156600530|NCT01763866|565279582|FG019|Overall Study|Decision by sponsor|0|||
156600531|NCT01763866|565279583|FG020|Overall Study|Decision by sponsor|2|||
156600532|NCT01763866|565279584|FG021|Overall Study|Decision by sponsor|0|||
156600533|NCT01763866|565279585|FG022|Overall Study|Decision by sponsor|1|||
156600534|NCT01763866|565279586|FG023|Overall Study|Decision by sponsor|0|||
156600535|NCT01763866|565279563|FG000|Overall Study|Lost to Follow-up|0|||
156600536|NCT01763866|565279564|FG001|Overall Study|Lost to Follow-up|0|||
156600537|NCT01763866|565279565|FG002|Overall Study|Lost to Follow-up|0|||
156600538|NCT01763866|565279566|FG003|Overall Study|Lost to Follow-up|0|||
156600539|NCT01763866|565279567|FG004|Overall Study|Lost to Follow-up|0|||
156600540|NCT01763866|565279568|FG005|Overall Study|Lost to Follow-up|0|||
156600541|NCT01763866|565279569|FG006|Overall Study|Lost to Follow-up|1|||
156600542|NCT01763866|565279570|FG007|Overall Study|Lost to Follow-up|0|||
156600543|NCT01763866|565279571|FG008|Overall Study|Lost to Follow-up|0|||
156600544|NCT01763866|565279572|FG009|Overall Study|Lost to Follow-up|0|||
156600545|NCT01763866|565279573|FG010|Overall Study|Lost to Follow-up|0|||
156600546|NCT01763866|565279574|FG011|Overall Study|Lost to Follow-up|0|||
156600547|NCT01763866|565279575|FG012|Overall Study|Lost to Follow-up|1|||
156600548|NCT01763866|565279576|FG013|Overall Study|Lost to Follow-up|0|||
156600549|NCT01763866|565279577|FG014|Overall Study|Lost to Follow-up|1|||
156600550|NCT01763866|565279578|FG015|Overall Study|Lost to Follow-up|0|||
156600551|NCT01763866|565279579|FG016|Overall Study|Lost to Follow-up|0|||
156600552|NCT01763866|565279580|FG017|Overall Study|Lost to Follow-up|0|||
156600553|NCT01763866|565279581|FG018|Overall Study|Lost to Follow-up|1|||
156600554|NCT01763866|565279582|FG019|Overall Study|Lost to Follow-up|1|||
156600555|NCT01763866|565279583|FG020|Overall Study|Lost to Follow-up|0|||
156600556|NCT01763866|565279584|FG021|Overall Study|Lost to Follow-up|0|||
156600557|NCT01763866|565279585|FG022|Overall Study|Lost to Follow-up|0|||
156600558|NCT01763866|565279586|FG023|Overall Study|Lost to Follow-up|1|||
156600559|NCT01763866|565279563|FG000|Overall Study|Death|0|||
156600560|NCT01763866|565279564|FG001|Overall Study|Death|0|||
156600561|NCT01763866|565279565|FG002|Overall Study|Death|0|||
156600562|NCT01763866|565279566|FG003|Overall Study|Death|0|||
156600563|NCT01763866|565279567|FG004|Overall Study|Death|0|||
156600564|NCT01763866|565279568|FG005|Overall Study|Death|0|||
156600565|NCT01763866|565279569|FG006|Overall Study|Death|0|||
156600566|NCT01763866|565279570|FG007|Overall Study|Death|0|||
156600567|NCT01763866|565279571|FG008|Overall Study|Death|0|||
156600568|NCT01763866|565279572|FG009|Overall Study|Death|0|||
156600569|NCT01763866|565279573|FG010|Overall Study|Death|0|||
156600570|NCT01763866|565279574|FG011|Overall Study|Death|0|||
156600571|NCT01763866|565279575|FG012|Overall Study|Death|0|||
156600572|NCT01763866|565279576|FG013|Overall Study|Death|0|||
156600573|NCT01763866|565279577|FG014|Overall Study|Death|0|||
156600574|NCT01763866|565279578|FG015|Overall Study|Death|0|||
156600575|NCT01763866|565279579|FG016|Overall Study|Death|1|||
156600576|NCT01763866|565279580|FG017|Overall Study|Death|0|||
156600577|NCT01763866|565279581|FG018|Overall Study|Death|0|||
156600578|NCT01763866|565279582|FG019|Overall Study|Death|0|||
156600579|NCT01763866|565279583|FG020|Overall Study|Death|0|||
156600580|NCT01763866|565279584|FG021|Overall Study|Death|0|||
156600581|NCT01763866|565279585|FG022|Overall Study|Death|0|||
156600582|NCT01763866|565279586|FG023|Overall Study|Death|0|||
156600583|NCT01164865|565279596|FG000|Overall Study|Lost to Follow-up|2|||
156600584|NCT01164865|565279597|FG001|Overall Study|Lost to Follow-up|1|||
156600585|NCT00475540|565279598|FG000|36 Months|Lost to Follow-up|4|||
156600586|NCT00475540|565279599|FG001|36 Months|Lost to Follow-up|4|||
156600587|NCT00475540|565279598|FG000|36 Months|Death|1|||
156600588|NCT00475540|565279599|FG001|36 Months|Death|2|||
156600589|NCT00475540|565279598|FG000|36 Months|Censored due to reoperation|3|||
156600590|NCT00475540|565279599|FG001|36 Months|Censored due to reoperation|0|||
156600591|NCT00377429|565279600|FG000|Overall Study|Withdrawal by Subject|5|||
156600592|NCT00377429|565279600|FG000|Overall Study|Adverse Event|8|||
156600593|NCT00377429|565279600|FG000|Overall Study|Physician Decision|1|||
156600594|NCT00377429|565279600|FG000|Overall Study|Patient non-compliance|1|||
156600595|NCT02394795|565279603|FG000|Overall Study|Adverse Event|92|||
156600596|NCT02394795|565279604|FG001|Overall Study|Adverse Event|70|||
156600597|NCT02394795|565279603|FG000|Overall Study|Lost to Follow-up|0|||
156600598|NCT02394795|565279604|FG001|Overall Study|Lost to Follow-up|1|||
156600599|NCT02394795|565279603|FG000|Overall Study|Withdrawal by Subject|17|||
156600600|NCT02394795|565279604|FG001|Overall Study|Withdrawal by Subject|26|||
156600601|NCT02394795|565279603|FG000|Overall Study|Lack of Efficacy|181|||
156600602|NCT02394795|565279604|FG001|Overall Study|Lack of Efficacy|211|||
156600603|NCT02394795|565279603|FG000|Overall Study|Death|4|||
156600604|NCT02394795|565279604|FG001|Overall Study|Death|5|||
156600605|NCT02394795|565279603|FG000|Overall Study|Physician Decision|109|||
156600606|NCT02394795|565279604|FG001|Overall Study|Physician Decision|93|||
156600607|NCT02939599|565279606|FG000|Overall Study|Adverse Event|1|||
156600608|NCT02939599|565279607|FG001|Overall Study|Adverse Event|0|||
156600609|NCT02939599|565279606|FG000|Overall Study|Study Terminated By Sponsor|2|||
156600610|NCT02939599|565279607|FG001|Overall Study|Study Terminated By Sponsor|2|||
156600611|NCT01669811|565279608|FG000|Overall Study|Investigator decision|0|||
156600612|NCT01669811|565279609|FG001|Overall Study|Investigator decision|1|||
156600613|NCT01669811|565279608|FG000|Overall Study|Withdrawal by Subject|1|||
156600614|NCT01669811|565279609|FG001|Overall Study|Withdrawal by Subject|2|||
156600615|NCT01669811|565279608|FG000|Overall Study|Adverse Event|2|||
156600616|NCT01669811|565279609|FG001|Overall Study|Adverse Event|6|||
156600617|NCT01669811|565279608|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156600618|NCT01669811|565279609|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
156600619|NCT03288493|565279610|FG000|Overall Study|Withdrawal by Subject|4|||
156600620|NCT03288493|565279611|FG001|Overall Study|Withdrawal by Subject|0|||
156600621|NCT03288493|565279612|FG002|Overall Study|Withdrawal by Subject|0|||
156600622|NCT03288493|565279613|FG003|Overall Study|Withdrawal by Subject|0|||
156600623|NCT03288493|565279614|FG004|Overall Study|Withdrawal by Subject|0|||
156600624|NCT03288493|565279615|FG005|Overall Study|Withdrawal by Subject|2|||
156600625|NCT03288493|565279616|FG006|Overall Study|Withdrawal by Subject|0|||
156600626|NCT03288493|565279610|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
156600627|NCT03288493|565279611|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
156600628|NCT03288493|565279612|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
156600629|NCT03288493|565279613|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
156600630|NCT03288493|565279614|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
156600631|NCT03288493|565279615|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
156600632|NCT03288493|565279616|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
156600633|NCT03288493|565279610|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
156600634|NCT03288493|565279611|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
156600635|NCT03288493|565279612|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
156600636|NCT03288493|565279613|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
156600637|NCT03288493|565279614|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
156600638|NCT03288493|565279615|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
156600639|NCT03288493|565279616|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
156600640|NCT03288493|565279610|FG000|Overall Study|Death|2|||
156600641|NCT03288493|565279611|FG001|Overall Study|Death|0|||
156600642|NCT03288493|565279612|FG002|Overall Study|Death|0|||
156600643|NCT03288493|565279613|FG003|Overall Study|Death|0|||
156600644|NCT03288493|565279614|FG004|Overall Study|Death|0|||
156600645|NCT03288493|565279615|FG005|Overall Study|Death|0|||
156600646|NCT03288493|565279616|FG006|Overall Study|Death|0|||
156600647|NCT03288493|565279610|FG000|Overall Study|other reason not listed above|2|||
156600648|NCT03288493|565279611|FG001|Overall Study|other reason not listed above|0|||
156600649|NCT03288493|565279612|FG002|Overall Study|other reason not listed above|0|||
156600650|NCT03288493|565279613|FG003|Overall Study|other reason not listed above|0|||
156600651|NCT03288493|565279614|FG004|Overall Study|other reason not listed above|0|||
156600652|NCT03288493|565279615|FG005|Overall Study|other reason not listed above|0|||
156600653|NCT03288493|565279616|FG006|Overall Study|other reason not listed above|0|||
156600654|NCT01871896|565279617|FG000|Overall Study|Lost to Follow-up|1|||
156600655|NCT04507776|565281050|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
156600656|NCT03628599|565281051|FG000|Overall Study|Adverse Event|0|||
156600657|NCT03628599|565281052|FG001|Overall Study|Adverse Event|1|||
156600658|NCT01136746|565281053|FG000|Overall Study|Lost to Follow-up|0|||
156600659|NCT01136746|565281054|FG001|Overall Study|Lost to Follow-up|2|||
156600660|NCT01136746|565281053|FG000|Overall Study|Protocol Violation|2|||
156600661|NCT01136746|565281054|FG001|Overall Study|Protocol Violation|1|||
156600662|NCT01136746|565281053|FG000|Overall Study|Death|1|||
156600663|NCT01136746|565281054|FG001|Overall Study|Death|0|||
156600664|NCT00092677|565281055|FG000|Overall Study|Lost to Follow-up|0|||
156600665|NCT00092677|565281056|FG001|Overall Study|Lost to Follow-up|2|||
156600666|NCT00092677|565281055|FG000|Overall Study|Adminstrative|5|||
156600667|NCT00092677|565281056|FG001|Overall Study|Adminstrative|9|||
156600668|NCT04624672|565281057|FG000|Overall Study|Early Study Closure|2|||
156600669|NCT04624672|565281058|FG001|Overall Study|Early Study Closure|1|||
156600670|NCT00010803|565281069|FG000|Overall Study|Withdrawal by Subject|97|||
156600671|NCT00010803|565281070|FG001|Overall Study|Withdrawal by Subject|98|||
156600672|NCT05905601|565281071|FG000|Overall Study|Lost to Follow-up|1|||
156600673|NCT05905601|565281072|FG001|Overall Study|Lost to Follow-up|3|||
156600674|NCT03024255|565281073|FG000|Overall Study|Adverse Event|1|||
156600675|NCT03024255|565281074|FG001|Overall Study|Adverse Event|4|||
156600676|NCT03024255|565281075|FG002|Overall Study|Adverse Event|8|||
156600677|NCT03024255|565281076|FG003|Overall Study|Adverse Event|0|||
156600678|NCT03024255|565281073|FG000|Overall Study|Withdrawal by Subject|3|||
156600679|NCT03024255|565281074|FG001|Overall Study|Withdrawal by Subject|1|||
156600680|NCT03024255|565281075|FG002|Overall Study|Withdrawal by Subject|0|||
156600681|NCT03024255|565281076|FG003|Overall Study|Withdrawal by Subject|3|||
156600682|NCT03024255|565281073|FG000|Overall Study|Protocol Violation|0|||
156600683|NCT03024255|565281074|FG001|Overall Study|Protocol Violation|0|||
156600684|NCT03024255|565281075|FG002|Overall Study|Protocol Violation|2|||
156600685|NCT03024255|565281076|FG003|Overall Study|Protocol Violation|0|||
156600686|NCT03024255|565281073|FG000|Overall Study|Lost to Follow-up|1|||
156600687|NCT03024255|565281074|FG001|Overall Study|Lost to Follow-up|2|||
156600688|NCT03024255|565281075|FG002|Overall Study|Lost to Follow-up|1|||
156600689|NCT03024255|565281076|FG003|Overall Study|Lost to Follow-up|1|||
156600690|NCT03024255|565281073|FG000|Overall Study|Lack of Efficacy|1|||
156600691|NCT03024255|565281074|FG001|Overall Study|Lack of Efficacy|0|||
156600692|NCT03024255|565281075|FG002|Overall Study|Lack of Efficacy|0|||
156600693|NCT03024255|565281076|FG003|Overall Study|Lack of Efficacy|0|||
156600694|NCT03024255|565281073|FG000|Overall Study|Protocol Noncompliance|1|||
156600695|NCT03024255|565281074|FG001|Overall Study|Protocol Noncompliance|1|||
156600696|NCT03024255|565281075|FG002|Overall Study|Protocol Noncompliance|0|||
156600697|NCT03024255|565281076|FG003|Overall Study|Protocol Noncompliance|1|||
156600698|NCT01415908|565281077|FG000|Overall Study|Withdrawal by Subject|1|||
156600699|NCT01415908|565281078|FG001|Overall Study|Withdrawal by Subject|0|||
156600700|NCT02685995|565281081|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
156600701|NCT02685995|565281082|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
156600702|NCT01188096|565281084|FG000|Overall Study|progression of disease|4|||
156600703|NCT01188096|565281084|FG000|Overall Study|Withdrawal by Subject|2|||
156600704|NCT02384395|565281085|FG000|Overall Study|Physician Decision|4|||
156600705|NCT02384395|565281085|FG000|Overall Study|Withdrawal by Subject|3|||
156600706|NCT02384395|565281085|FG000|Overall Study|Lost to Follow-up|3|||
156600707|NCT01779648|565281086|FG000|Overall Study|Protocol Violation|1|||
156600708|NCT01779648|565281087|FG001|Overall Study|Protocol Violation|0|||
156600709|NCT01797445|565281088|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
156600710|NCT01797445|565281089|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
156600711|NCT01797445|565281088|FG000|Double-Blind Phase|Adverse Event|3|||
156600712|NCT01797445|565281089|FG001|Double-Blind Phase|Adverse Event|0|||
156600713|NCT01797445|565281088|FG000|Double-Blind Phase|Death|5|||
156600714|NCT01797445|565281089|FG001|Double-Blind Phase|Death|4|||
156600715|NCT01797445|565281088|FG000|Double-Blind Phase|Pregnancy|0|||
156600716|NCT01797445|565281089|FG001|Double-Blind Phase|Pregnancy|1|||
156600717|NCT01797445|565281088|FG000|Double-Blind Phase|Lack of Efficacy|1|||
156600718|NCT01797445|565281089|FG001|Double-Blind Phase|Lack of Efficacy|2|||
156600719|NCT01797445|565281088|FG000|Double-Blind Phase|Investigator's Discretion|15|||
156600720|NCT01797445|565281089|FG001|Double-Blind Phase|Investigator's Discretion|17|||
156600721|NCT01797445|565281088|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
156600722|NCT01797445|565281089|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
156600723|NCT01797445|565281088|FG000|Double-Blind Phase|Protocol Violation|0|||
156600724|NCT01797445|565281089|FG001|Double-Blind Phase|Protocol Violation|1|||
156600725|NCT01797445|565281088|FG000|Double-Blind Phase|Withdrew Consent|20|||
156600726|NCT01797445|565281089|FG001|Double-Blind Phase|Withdrew Consent|35|||
156600727|NCT01797445|565281088|FG000|Double-Blind Phase|Lost to Follow-up|34|||
156600728|NCT01797445|565281089|FG001|Double-Blind Phase|Lost to Follow-up|26|||
156600729|NCT01797445|565281088|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
156600730|NCT01797445|565281089|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
156600731|NCT00688545|565281090|FG000|Overall Study|Lost to Follow-up|1|||
156600732|NCT00688545|565281091|FG001|Overall Study|Lost to Follow-up|4|||
156600733|NCT00688545|565281090|FG000|Overall Study|Insurance/cost of drug|0|||
156600734|NCT00688545|565281091|FG001|Overall Study|Insurance/cost of drug|1|||
156600735|NCT00688545|565281090|FG000|Overall Study|Withdrawal by Subject|2|||
156600736|NCT00688545|565281091|FG001|Overall Study|Withdrawal by Subject|3|||
156600737|NCT00688545|565281090|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
156600738|NCT00688545|565281091|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
156600739|NCT01878097|565281094|FG000|Baseline|Surveys not fully completed|2497|||
156600740|NCT01878097|565281095|FG001|Baseline|Surveys not fully completed|1800|||
156600741|NCT01878097|565281094|FG000|Implementation Year 1|Surveys not fully completed|3202|||
156600742|NCT01878097|565281095|FG001|Implementation Year 1|Surveys not fully completed|2549|||
156600743|NCT01878097|565281094|FG000|Implementation Year 2|Surveys not fully completed|3281|||
156600744|NCT01878097|565281095|FG001|Implementation Year 2|Surveys not fully completed|2841|||
156600745|NCT01878097|565281094|FG000|Implementation Year 3|Surveys not fully completed|3494|||
156600746|NCT01878097|565281095|FG001|Implementation Year 3|Surveys not fully completed|2980|||
156600747|NCT01878097|565281094|FG000|Implementation Year 4|Surveys not fully completed|3604|||
156600748|NCT01878097|565281095|FG001|Implementation Year 4|Surveys not fully completed|3007|||
156600749|NCT01595438|565281096|FG000|Overall Study|Lost to Follow-up|20|||
156600750|NCT01595438|565281097|FG001|Overall Study|Lost to Follow-up|20|||
156600751|NCT01595438|565281096|FG000|Overall Study|Withdrawal by Subject|12|||
156600752|NCT01595438|565281097|FG001|Overall Study|Withdrawal by Subject|12|||
156600753|NCT01595438|565281096|FG000|Overall Study|Other Eligibility criteria|11|||
156600754|NCT01595438|565281097|FG001|Overall Study|Other Eligibility criteria|9|||
156863685|NCT05194124|566258769|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156600755|NCT00985738|565281099|FG000|Overall Study|Study closed prematurely|8|||
156600756|NCT00985738|565281100|FG001|Overall Study|Study closed prematurely|8|||
156600757|NCT02119026|565281105|FG000|1st-line Treatment|Adverse Event|9|||
156600758|NCT02119026|565281106|FG001|1st-line Treatment|Adverse Event|14|||
156600759|NCT02119026|565281105|FG000|1st-line Treatment|Physician Decision|3|||
156600760|NCT02119026|565281106|FG001|1st-line Treatment|Physician Decision|8|||
156600761|NCT02119026|565281105|FG000|1st-line Treatment|Withdrawal by Subject|4|||
156600762|NCT02119026|565281106|FG001|1st-line Treatment|Withdrawal by Subject|10|||
156600763|NCT02119026|565281105|FG000|1st-line Treatment|Patient condition or compliance|6|||
156600764|NCT02119026|565281106|FG001|1st-line Treatment|Patient condition or compliance|4|||
156600765|NCT02119026|565281105|FG000|1st-line Treatment|Surgery of metastases|2|||
156600766|NCT02119026|565281106|FG001|1st-line Treatment|Surgery of metastases|1|||
156600767|NCT02119026|565281105|FG000|1st-line Treatment|Death|2|||
156600768|NCT02119026|565281106|FG001|1st-line Treatment|Death|1|||
156600769|NCT02119026|565281105|FG000|2nd-line Treatment|Lost to Follow-up|2|||
156600770|NCT02119026|565281106|FG001|2nd-line Treatment|Lost to Follow-up|0|||
156600771|NCT02119026|565281105|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
156600772|NCT02119026|565281106|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
156600773|NCT02119026|565281105|FG000|2nd-line Treatment|Adverse Event|4|||
156600774|NCT02119026|565281106|FG001|2nd-line Treatment|Adverse Event|1|||
156600775|NCT03783442|565281110|FG000|Overall Study|Death|252|||
156600776|NCT03783442|565281111|FG001|Overall Study|Death|268|||
156600777|NCT03783442|565281110|FG000|Overall Study|Withdrawal by Subject|19|||
156600778|NCT03783442|565281111|FG001|Overall Study|Withdrawal by Subject|21|||
156600779|NCT03783442|565281110|FG000|Overall Study|Lost to Follow-up|7|||
156600780|NCT03783442|565281111|FG001|Overall Study|Lost to Follow-up|6|||
156600781|NCT03783442|565281110|FG000|Overall Study|Sponsor Ended Study|48|||
156600782|NCT03783442|565281111|FG001|Overall Study|Sponsor Ended Study|28|||
156600783|NCT00973622|565281114|FG000|Overall Study|did not attend MRI|14|||
156600784|NCT00973622|565281115|FG001|Overall Study|did not attend MRI|3|||
156600785|NCT00973622|565281114|FG000|Overall Study|did not pass MRI screen|6|||
156600786|NCT00973622|565281115|FG001|Overall Study|did not pass MRI screen|0|||
156600787|NCT00973622|565281114|FG000|Overall Study|did not complete rTMS sessions|11|||
156600788|NCT00973622|565281115|FG001|Overall Study|did not complete rTMS sessions|2|||
156600789|NCT00493467|565281116|FG000|Overall Study|Death|1|||
156600790|NCT03074149|565281121|FG000|Overall Study|Reason unknown|22|||
156600791|NCT03074149|565281122|FG001|Overall Study|Reason unknown|35|||
156600792|NCT03074149|565281121|FG000|Overall Study|Death|10|||
156600793|NCT03074149|565281122|FG001|Overall Study|Death|45|||
156600794|NCT02855450|565281123|FG000|Overall Study|Adverse Event|1|||
156600795|NCT02855450|565281124|FG001|Overall Study|Adverse Event|0|||
156600796|NCT02855450|565281123|FG000|Overall Study|Lost to Follow-up|4|||
156600797|NCT02855450|565281124|FG001|Overall Study|Lost to Follow-up|0|||
156600798|NCT00225212|565281125|FG000|Overall Study|Disease progression|2|||
156600799|NCT00225212|565281125|FG000|Overall Study|Death|1|||
156600800|NCT00225212|565281125|FG000|Overall Study|Adverse Event|2|||
156600801|NCT00225212|565281125|FG000|Overall Study|Intercurrent illness|1|||
156600802|NCT01335698|565281128|FG000|Treatment Stage 1|Lack of Efficacy|3|||
156600803|NCT01335698|565281129|FG001|Treatment Stage 1|Lack of Efficacy|1|||
156600804|NCT01335698|565281130|FG002|Treatment Stage 1|Lack of Efficacy|3|||
156600805|NCT01335698|565281131|FG003|Treatment Stage 1|Lack of Efficacy|3|||
156600806|NCT01335698|565281132|FG004|Treatment Stage 1|Lack of Efficacy|1|||
156600807|NCT01335698|565281128|FG000|Treatment Stage 1|Adverse Event|1|||
156600808|NCT01335698|565281129|FG001|Treatment Stage 1|Adverse Event|2|||
156600809|NCT01335698|565281130|FG002|Treatment Stage 1|Adverse Event|2|||
156600810|NCT01335698|565281131|FG003|Treatment Stage 1|Adverse Event|1|||
156600811|NCT01335698|565281132|FG004|Treatment Stage 1|Adverse Event|1|||
156600812|NCT01335698|565281128|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
156600813|NCT01335698|565281129|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
156600814|NCT01335698|565281130|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
156600815|NCT01335698|565281131|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
156600816|NCT01335698|565281132|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
156600817|NCT01335698|565281128|FG000|Treatment Stage 1|Lost to Follow-up|1|||
156600818|NCT01335698|565281129|FG001|Treatment Stage 1|Lost to Follow-up|1|||
156600819|NCT01335698|565281130|FG002|Treatment Stage 1|Lost to Follow-up|0|||
156600820|NCT01335698|565281131|FG003|Treatment Stage 1|Lost to Follow-up|0|||
156600821|NCT01335698|565281132|FG004|Treatment Stage 1|Lost to Follow-up|0|||
156600822|NCT01335698|565281128|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
156600823|NCT01335698|565281129|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
156600824|NCT01335698|565281130|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
156600825|NCT01335698|565281131|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
156600826|NCT01335698|565281132|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
156600827|NCT01335698|565281128|FG000|Treatment Stage 1|No longer meets study criteria|1|||
156600828|NCT01335698|565281129|FG001|Treatment Stage 1|No longer meets study criteria|1|||
156600829|NCT01335698|565281130|FG002|Treatment Stage 1|No longer meets study criteria|0|||
156600830|NCT01335698|565281131|FG003|Treatment Stage 1|No longer meets study criteria|1|||
156600831|NCT01335698|565281132|FG004|Treatment Stage 1|No longer meets study criteria|0|||
156600832|NCT01335698|565281128|FG000|Treatment Stage 1|Other|1|||
156600833|NCT01335698|565281129|FG001|Treatment Stage 1|Other|0|||
156600834|NCT01335698|565281130|FG002|Treatment Stage 1|Other|0|||
156600835|NCT01335698|565281131|FG003|Treatment Stage 1|Other|1|||
156600836|NCT01335698|565281132|FG004|Treatment Stage 1|Other|0|||
156600837|NCT01335698|565281128|FG000|Treatment Stage 2|Lack of Efficacy|2|||
156600838|NCT01335698|565281129|FG001|Treatment Stage 2|Lack of Efficacy|1|||
156600839|NCT01335698|565281130|FG002|Treatment Stage 2|Lack of Efficacy|3|||
156600840|NCT01335698|565281131|FG003|Treatment Stage 2|Lack of Efficacy|1|||
156600841|NCT01335698|565281132|FG004|Treatment Stage 2|Lack of Efficacy|0|||
156600842|NCT01335698|565281128|FG000|Treatment Stage 2|Adverse Event|2|||
156600843|NCT01335698|565281129|FG001|Treatment Stage 2|Adverse Event|0|||
156600844|NCT01335698|565281130|FG002|Treatment Stage 2|Adverse Event|0|||
156600845|NCT01335698|565281131|FG003|Treatment Stage 2|Adverse Event|3|||
156600846|NCT01335698|565281132|FG004|Treatment Stage 2|Adverse Event|0|||
156600847|NCT01335698|565281128|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
156600848|NCT01335698|565281129|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
156600849|NCT01335698|565281130|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
156600850|NCT01335698|565281131|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
156600851|NCT01335698|565281132|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
156600852|NCT01335698|565281128|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
156600853|NCT01335698|565281129|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
156600854|NCT01335698|565281130|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
156600855|NCT01335698|565281131|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
156600856|NCT01335698|565281132|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
156600857|NCT01335698|565281128|FG000|Treatment Stage 2|Lost to Follow-up|1|||
156600858|NCT01335698|565281129|FG001|Treatment Stage 2|Lost to Follow-up|0|||
156600859|NCT01335698|565281130|FG002|Treatment Stage 2|Lost to Follow-up|0|||
156600860|NCT01335698|565281131|FG003|Treatment Stage 2|Lost to Follow-up|0|||
156600861|NCT01335698|565281132|FG004|Treatment Stage 2|Lost to Follow-up|0|||
156600862|NCT01335698|565281128|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
156600863|NCT01335698|565281129|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
156600864|NCT01335698|565281130|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
156600865|NCT01335698|565281131|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
156600866|NCT01335698|565281132|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
156600867|NCT01335698|565281128|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
156600868|NCT01335698|565281129|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
156600869|NCT01335698|565281130|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
156600870|NCT01335698|565281131|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
156600871|NCT01335698|565281132|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
156600872|NCT01335698|565281128|FG000|Treatment Stage 2|Switched to another formulation|1|||
156600873|NCT01335698|565281129|FG001|Treatment Stage 2|Switched to another formulation|1|||
156600874|NCT01335698|565281130|FG002|Treatment Stage 2|Switched to another formulation|0|||
156600875|NCT01335698|565281131|FG003|Treatment Stage 2|Switched to another formulation|0|||
156600876|NCT01335698|565281132|FG004|Treatment Stage 2|Switched to another formulation|0|||
156600877|NCT01170221|565281133|FG000|Overall Study|Lost to Follow-up|22|||
156600878|NCT01170221|565281134|FG001|Overall Study|Lost to Follow-up|21|||
156600879|NCT01170221|565281133|FG000|Overall Study|Withdrawal by Subject|9|||
156600880|NCT01170221|565281134|FG001|Overall Study|Withdrawal by Subject|7|||
156600881|NCT01170221|565281133|FG000|Overall Study|Subject completed only screening and LFU|1|||
156600882|NCT01170221|565281134|FG001|Overall Study|Subject completed only screening and LFU|0|||
156600883|NCT01170221|565281133|FG000|Overall Study|Randomized but not treated|1|||
156600884|NCT01170221|565281134|FG001|Overall Study|Randomized but not treated|0|||
156600885|NCT00764946|565281135|FG000|Overall Study|Lack of Efficacy|1|||
156600886|NCT00764946|565281136|FG001|Overall Study|Lack of Efficacy|0|||
156600887|NCT00764946|565281137|FG002|Overall Study|Lack of Efficacy|0|||
156600888|NCT00764946|565281135|FG000|Overall Study|Lost to Follow-up|3|||
156600889|NCT00764946|565281136|FG001|Overall Study|Lost to Follow-up|4|||
156600890|NCT00764946|565281137|FG002|Overall Study|Lost to Follow-up|0|||
156600891|NCT00764946|565281135|FG000|Overall Study|Physician Decision|2|||
156600892|NCT00764946|565281136|FG001|Overall Study|Physician Decision|4|||
156600893|NCT00764946|565281137|FG002|Overall Study|Physician Decision|0|||
156600894|NCT00764946|565281135|FG000|Overall Study|Adverse Event|3|||
156600895|NCT00764946|565281136|FG001|Overall Study|Adverse Event|2|||
156600896|NCT00764946|565281137|FG002|Overall Study|Adverse Event|1|||
156600897|NCT00764946|565281135|FG000|Overall Study|Withdrawal by Subject|3|||
156600898|NCT00764946|565281136|FG001|Overall Study|Withdrawal by Subject|6|||
156600899|NCT00764946|565281137|FG002|Overall Study|Withdrawal by Subject|2|||
156600900|NCT00764946|565281135|FG000|Overall Study|Never Treated|1|||
156600901|NCT00764946|565281136|FG001|Overall Study|Never Treated|1|||
156600902|NCT00764946|565281137|FG002|Overall Study|Never Treated|1|||
156600903|NCT01162304|565281138|FG000|Overall Study|Beck scale to high|11|||
156600904|NCT00585923|565281140|FG000|Overall Study|Physician decided not to continue|31|||
156600905|NCT00585923|565281141|FG001|Overall Study|Physician decided not to continue|33|||
156600906|NCT00878215|565281142|FG000|Overall Study|Determined to be ineligible|0|||
156600907|NCT00878215|565281143|FG001|Overall Study|Determined to be ineligible|10|||
156600908|NCT00878215|565281144|FG002|Overall Study|Determined to be ineligible|0|||
156600909|NCT00878215|565281145|FG003|Overall Study|Determined to be ineligible|0|||
156600910|NCT02815293|565281146|FG000|Overall Study|Study termination by sponsor|10|||
156600911|NCT02815293|565281147|FG001|Overall Study|Study termination by sponsor|7|||
156600912|NCT02815293|565281148|FG002|Overall Study|Study termination by sponsor|0|||
156600913|NCT02815293|565281146|FG000|Overall Study|Participants not randomized|0|||
156600914|NCT02815293|565281147|FG001|Overall Study|Participants not randomized|0|||
156600915|NCT02815293|565281148|FG002|Overall Study|Participants not randomized|18|||
156600916|NCT02815293|565281146|FG000|Overall Study|Adverse Event|0|||
156600917|NCT02815293|565281147|FG001|Overall Study|Adverse Event|1|||
156600918|NCT02815293|565281148|FG002|Overall Study|Adverse Event|0|||
156600919|NCT01167582|565281151|FG000|Overall Study|Lost to Follow-up|0|||
156600920|NCT01167582|565281152|FG001|Overall Study|Lost to Follow-up|1|||
156600921|NCT03956225|565281155|FG000|Overall Study|Lack of Efficacy|1|||
156600922|NCT03956225|565281156|FG001|Overall Study|Lack of Efficacy|1|||
156600923|NCT03956225|565281155|FG000|Overall Study|Lost to Follow-up|0|||
156600924|NCT03956225|565281156|FG001|Overall Study|Lost to Follow-up|1|||
156600925|NCT03956225|565281155|FG000|Overall Study|Withdrawal by Subject|2|||
156600926|NCT03956225|565281156|FG001|Overall Study|Withdrawal by Subject|1|||
156600927|NCT03956225|565281155|FG000|Overall Study|Other Reasons|2|||
156600928|NCT03956225|565281156|FG001|Overall Study|Other Reasons|1|||
156600929|NCT02157506|565281161|FG000|Overall Study|Adverse Event|0|||
156600930|NCT02157506|565281162|FG001|Overall Study|Adverse Event|1|||
156600931|NCT02157506|565281163|FG002|Overall Study|Adverse Event|0|||
156600932|NCT02157506|565281164|FG003|Overall Study|Adverse Event|0|||
156600933|NCT02157506|565281165|FG004|Overall Study|Adverse Event|0|||
156600934|NCT02157506|565281161|FG000|Overall Study|Lost to Follow-up|0|||
156600935|NCT02157506|565281162|FG001|Overall Study|Lost to Follow-up|0|||
156600936|NCT02157506|565281163|FG002|Overall Study|Lost to Follow-up|1|||
156600937|NCT02157506|565281164|FG003|Overall Study|Lost to Follow-up|0|||
156600938|NCT02157506|565281165|FG004|Overall Study|Lost to Follow-up|0|||
156600939|NCT03448224|565281169|FG000|Overall Study|Provided same answer to every question|1|||
156600940|NCT03448224|565281170|FG001|Overall Study|Provided same answer to every question|0|||
156600941|NCT03103906|565281171|FG000|Overall Study|Adverse Event|2|||
156600942|NCT03103906|565281172|FG001|Overall Study|Adverse Event|3|||
156600943|NCT03103906|565281171|FG000|Overall Study|Other|2|||
156600944|NCT03103906|565281172|FG001|Overall Study|Other|0|||
156600945|NCT00764478|565281173|FG000|Overall Study|Adverse Event|1|||
156600946|NCT00764478|565281174|FG001|Overall Study|Adverse Event|1|||
156600947|NCT00764478|565281175|FG002|Overall Study|Adverse Event|1|||
156600948|NCT00764478|565281173|FG000|Overall Study|Withdrawal by Subject|7|||
156600949|NCT00764478|565281174|FG001|Overall Study|Withdrawal by Subject|12|||
156600950|NCT00764478|565281175|FG002|Overall Study|Withdrawal by Subject|1|||
156600951|NCT00764478|565281173|FG000|Overall Study|Lost to Follow-up|7|||
156600952|NCT00764478|565281174|FG001|Overall Study|Lost to Follow-up|8|||
156600953|NCT00764478|565281175|FG002|Overall Study|Lost to Follow-up|5|||
156600954|NCT00764478|565281173|FG000|Overall Study|Protocol Violation|0|||
156600955|NCT00764478|565281174|FG001|Overall Study|Protocol Violation|1|||
156600956|NCT00764478|565281175|FG002|Overall Study|Protocol Violation|1|||
156600957|NCT00643604|565281178|FG000|Overall Study|Death|1|||
156600958|NCT02702011|565281179|FG000|Overall Study|Withdrawal by Subject|0|||
156600959|NCT02702011|565281180|FG001|Overall Study|Withdrawal by Subject|1|||
156600960|NCT02702011|565281181|FG002|Overall Study|Withdrawal by Subject|0|||
156600961|NCT02702011|565281182|FG003|Overall Study|Withdrawal by Subject|0|||
156600962|NCT03498287|565281186|FG000|Overall Study|Withdrawal by Subject|3|||
156600963|NCT03498287|565281187|FG001|Overall Study|Withdrawal by Subject|0|||
156600964|NCT03498287|565281186|FG000|Overall Study|Protocol Violation|0|||
156600965|NCT03498287|565281187|FG001|Overall Study|Protocol Violation|4|||
156600966|NCT03498287|565281186|FG000|Overall Study|Adverse Event|0|||
156600967|NCT03498287|565281187|FG001|Overall Study|Adverse Event|1|||
156600968|NCT01195363|565281190|FG000|Overall Study|Lost to Follow-up|7|||
156600969|NCT01195363|565281191|FG001|Overall Study|Lost to Follow-up|4|||
156600970|NCT01195363|565281190|FG000|Overall Study|Adverse Event|3|||
156600971|NCT01195363|565281191|FG001|Overall Study|Adverse Event|1|||
156600972|NCT01195363|565281190|FG000|Overall Study|Lack of Efficacy|0|||
156600973|NCT01195363|565281191|FG001|Overall Study|Lack of Efficacy|4|||
156600974|NCT01195363|565281190|FG000|Overall Study|incarceration|1|||
156600975|NCT01195363|565281191|FG001|Overall Study|incarceration|0|||
156600976|NCT05263921|565283091|FG000|Overall Study|Other: family emergency.|0|||
156600977|NCT05263921|565283092|FG001|Overall Study|Other: family emergency.|0|||
156600978|NCT05263921|565283093|FG002|Overall Study|Other: family emergency.|1|||
156600979|NCT05263921|565283094|FG003|Overall Study|Other: family emergency.|0|||
156600980|NCT00340834|565283098|FG000|Core Phase of Study|Adverse Event|26|||
156600981|NCT00340834|565283099|FG001|Core Phase of Study|Adverse Event|9|||
156600982|NCT00340834|565283100|FG002|Core Phase of Study|Adverse Event|9|||
156600983|NCT00340834|565283101|FG003|Core Phase of Study|Adverse Event|0|||
156600984|NCT00340834|565283102|FG004|Core Phase of Study|Adverse Event|0|||
156600985|NCT00340834|565283098|FG000|Core Phase of Study|Withdrawal by Subject|11|||
156600986|NCT00340834|565283099|FG001|Core Phase of Study|Withdrawal by Subject|9|||
156600987|NCT00340834|565283100|FG002|Core Phase of Study|Withdrawal by Subject|16|||
156600988|NCT00340834|565283101|FG003|Core Phase of Study|Withdrawal by Subject|0|||
156600989|NCT00340834|565283102|FG004|Core Phase of Study|Withdrawal by Subject|0|||
156600990|NCT00340834|565283098|FG000|Core Phase of Study|Administrative Problems|6|||
156600991|NCT00340834|565283099|FG001|Core Phase of Study|Administrative Problems|2|||
156600992|NCT00340834|565283100|FG002|Core Phase of Study|Administrative Problems|7|||
156600993|NCT00340834|565283101|FG003|Core Phase of Study|Administrative Problems|0|||
156600994|NCT00340834|565283102|FG004|Core Phase of Study|Administrative Problems|0|||
156600995|NCT00340834|565283098|FG000|Core Phase of Study|Lack of Efficacy|3|||
156600996|NCT00340834|565283099|FG001|Core Phase of Study|Lack of Efficacy|3|||
156600997|NCT00340834|565283100|FG002|Core Phase of Study|Lack of Efficacy|7|||
156600998|NCT00340834|565283101|FG003|Core Phase of Study|Lack of Efficacy|0|||
156600999|NCT00340834|565283102|FG004|Core Phase of Study|Lack of Efficacy|0|||
156601000|NCT00340834|565283098|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
156601001|NCT00340834|565283099|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
156601002|NCT00340834|565283100|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
156601003|NCT00340834|565283101|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
156601004|NCT00340834|565283102|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
156601005|NCT00340834|565283098|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
156601006|NCT00340834|565283099|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
156601007|NCT00340834|565283100|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
156601008|NCT00340834|565283101|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
156601009|NCT00340834|565283102|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
156601010|NCT00340834|565283098|FG000|Core Phase of Study|Lost to Follow-up|1|||
156601011|NCT00340834|565283099|FG001|Core Phase of Study|Lost to Follow-up|1|||
156601012|NCT00340834|565283100|FG002|Core Phase of Study|Lost to Follow-up|4|||
156601013|NCT00340834|565283101|FG003|Core Phase of Study|Lost to Follow-up|0|||
156601014|NCT00340834|565283102|FG004|Core Phase of Study|Lost to Follow-up|0|||
156601015|NCT00340834|565283098|FG000|Core Phase of Study|Death|2|||
156601016|NCT00340834|565283099|FG001|Core Phase of Study|Death|0|||
156601017|NCT00340834|565283100|FG002|Core Phase of Study|Death|0|||
156601018|NCT00340834|565283101|FG003|Core Phase of Study|Death|0|||
156601019|NCT00340834|565283102|FG004|Core Phase of Study|Death|0|||
156601020|NCT00340834|565283098|FG000|Core Phase of Study|Protocol Violation|0|||
156601021|NCT00340834|565283099|FG001|Core Phase of Study|Protocol Violation|0|||
156601022|NCT00340834|565283100|FG002|Core Phase of Study|Protocol Violation|2|||
156601023|NCT00340834|565283101|FG003|Core Phase of Study|Protocol Violation|0|||
156601024|NCT00340834|565283102|FG004|Core Phase of Study|Protocol Violation|0|||
156601025|NCT00340834|565283098|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
156601026|NCT00340834|565283099|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
156601027|NCT00340834|565283100|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
156601028|NCT00340834|565283101|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
156601029|NCT00340834|565283102|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
156601030|NCT00340834|565283098|FG000|Extension Phase of Study|Subject withdrew consent|26|||
156601031|NCT00340834|565283099|FG001|Extension Phase of Study|Subject withdrew consent|31|||
156601032|NCT00340834|565283100|FG002|Extension Phase of Study|Subject withdrew consent|0|||
156601033|NCT00340834|565283101|FG003|Extension Phase of Study|Subject withdrew consent|12|||
156601034|NCT00340834|565283102|FG004|Extension Phase of Study|Subject withdrew consent|15|||
156601035|NCT00340834|565283098|FG000|Extension Phase of Study|Adverse Event|21|||
156601036|NCT00340834|565283099|FG001|Extension Phase of Study|Adverse Event|22|||
156601037|NCT00340834|565283100|FG002|Extension Phase of Study|Adverse Event|0|||
156601038|NCT00340834|565283101|FG003|Extension Phase of Study|Adverse Event|19|||
156601039|NCT00340834|565283102|FG004|Extension Phase of Study|Adverse Event|7|||
156601040|NCT00340834|565283098|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
156863686|NCT05194124|566258760|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156601041|NCT00340834|565283099|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
156601042|NCT00340834|565283100|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
156601043|NCT00340834|565283101|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
156601044|NCT00340834|565283102|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
156601045|NCT00340834|565283098|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
156601046|NCT00340834|565283099|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
156601047|NCT00340834|565283100|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
156601048|NCT00340834|565283101|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
156601049|NCT00340834|565283102|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
156601050|NCT00340834|565283098|FG000|Extension Phase of Study|Lost to Follow-up|1|||
156601051|NCT00340834|565283099|FG001|Extension Phase of Study|Lost to Follow-up|1|||
156601052|NCT00340834|565283100|FG002|Extension Phase of Study|Lost to Follow-up|0|||
156601053|NCT00340834|565283101|FG003|Extension Phase of Study|Lost to Follow-up|2|||
156601054|NCT00340834|565283102|FG004|Extension Phase of Study|Lost to Follow-up|3|||
156601055|NCT00340834|565283098|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
156863687|NCT05194124|566258761|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156601056|NCT00340834|565283099|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
156601057|NCT00340834|565283100|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
156601058|NCT00340834|565283101|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
156601059|NCT00340834|565283102|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
156601060|NCT00340834|565283098|FG000|Extension Phase of Study|Administrative problems|3|||
156601061|NCT00340834|565283099|FG001|Extension Phase of Study|Administrative problems|0|||
156601062|NCT00340834|565283100|FG002|Extension Phase of Study|Administrative problems|0|||
156601063|NCT00340834|565283101|FG003|Extension Phase of Study|Administrative problems|1|||
156601064|NCT00340834|565283102|FG004|Extension Phase of Study|Administrative problems|1|||
156601065|NCT00340834|565283098|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
156601066|NCT00340834|565283099|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
156601067|NCT00340834|565283100|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
156601068|NCT00340834|565283101|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
156601069|NCT00340834|565283102|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
156601070|NCT00340834|565283098|FG000|Extension Phase of Study|Protocol Violation|3|||
156601071|NCT00340834|565283099|FG001|Extension Phase of Study|Protocol Violation|0|||
156601072|NCT00340834|565283100|FG002|Extension Phase of Study|Protocol Violation|0|||
156601073|NCT00340834|565283101|FG003|Extension Phase of Study|Protocol Violation|0|||
156601074|NCT00340834|565283102|FG004|Extension Phase of Study|Protocol Violation|0|||
156601075|NCT00340834|565283098|FG000|Extension Phase of Study|Death|0|||
156601076|NCT00340834|565283099|FG001|Extension Phase of Study|Death|0|||
156601077|NCT00340834|565283100|FG002|Extension Phase of Study|Death|0|||
156601078|NCT00340834|565283101|FG003|Extension Phase of Study|Death|0|||
156601079|NCT00340834|565283102|FG004|Extension Phase of Study|Death|1|||
156601080|NCT00291499|565283103|FG000|Overall Study|Adverse Event|3|||
156601081|NCT00291499|565283104|FG001|Overall Study|Adverse Event|8|||
156601082|NCT00291499|565283103|FG000|Overall Study|Change to other therapy|2|||
156601083|NCT00291499|565283104|FG001|Overall Study|Change to other therapy|1|||
156601084|NCT00291499|565283103|FG000|Overall Study|Intercurrent illness|1|||
156601085|NCT00291499|565283104|FG001|Overall Study|Intercurrent illness|0|||
156601086|NCT00291499|565283103|FG000|Overall Study|Protocol Violation|2|||
156601087|NCT00291499|565283104|FG001|Overall Study|Protocol Violation|2|||
156601088|NCT00291499|565283103|FG000|Overall Study|Other reasons|1|||
156601089|NCT00291499|565283104|FG001|Overall Study|Other reasons|4|||
156601090|NCT02786836|565283105|FG000|Overall Study|Death|1|||
156601091|NCT02786836|565283105|FG000|Overall Study|Lack of Efficacy|2|||
156601092|NCT02786836|565283105|FG000|Overall Study|Protocol Violation|3|||
156601093|NCT02786836|565283105|FG000|Overall Study|Withdrawal by Subject|3|||
156601094|NCT02786836|565283105|FG000|Overall Study|Liver Transplantation|2|||
156601095|NCT02786836|565283105|FG000|Overall Study|Device or Pharmacy Issues|3|||
156601096|NCT01143714|565283106|FG000|Overall Study|Adverse Event|4|||
156601097|NCT01143714|565283107|FG001|Overall Study|Adverse Event|2|||
156601098|NCT01143714|565283106|FG000|Overall Study|Withdrawal by Subject|1|||
156601099|NCT01143714|565283107|FG001|Overall Study|Withdrawal by Subject|0|||
156601100|NCT01143714|565283106|FG000|Overall Study|Subject non-compliance|0|||
156601101|NCT01143714|565283107|FG001|Overall Study|Subject non-compliance|1|||
156601102|NCT01143714|565283106|FG000|Overall Study|wound closed = deemed healed|1|||
156601103|NCT01143714|565283107|FG001|Overall Study|wound closed = deemed healed|0|||
156601104|NCT01143714|565283106|FG000|Overall Study|wound size increased|1|||
156601105|NCT01143714|565283107|FG001|Overall Study|wound size increased|0|||
156601106|NCT02016898|565283117|FG000|Overall Study|Death|1|||
156601107|NCT02016898|565283118|FG001|Overall Study|Death|1|||
156601108|NCT02016898|565283117|FG000|Overall Study|Lost to Follow-up|4|||
156601109|NCT02016898|565283118|FG001|Overall Study|Lost to Follow-up|4|||
156601110|NCT01381718|565283119|FG000|Overall Study|Withdrawal by Subject|2|||
156601111|NCT01381718|565283120|FG001|Overall Study|Withdrawal by Subject|5|||
156601112|NCT01381718|565283119|FG000|Overall Study|Lost to Follow-up|3|||
156601113|NCT01381718|565283120|FG001|Overall Study|Lost to Follow-up|5|||
156601114|NCT01381718|565283119|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
156601115|NCT01381718|565283120|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
156601116|NCT01306032|565283125|FG000|First Intervention|Adverse Event|1|||
156601117|NCT01306032|565283126|FG001|First Intervention|Adverse Event|0|||
156601118|NCT01306032|565283127|FG002|First Intervention|Adverse Event|1|||
156601119|NCT01306032|565283128|FG003|First Intervention|Adverse Event|0|||
156601120|NCT01306032|565283129|FG004|First Intervention|Adverse Event|0|||
156601121|NCT01306032|565283130|FG005|First Intervention|Adverse Event|1|||
156601122|NCT01306032|565283125|FG000|First Intervention|Withdrawal by Subject|0|||
156601123|NCT01306032|565283126|FG001|First Intervention|Withdrawal by Subject|2|||
156601124|NCT01306032|565283127|FG002|First Intervention|Withdrawal by Subject|0|||
156601125|NCT01306032|565283128|FG003|First Intervention|Withdrawal by Subject|1|||
156601126|NCT01306032|565283129|FG004|First Intervention|Withdrawal by Subject|0|||
156601127|NCT01306032|565283130|FG005|First Intervention|Withdrawal by Subject|0|||
156601128|NCT01306032|565283125|FG000|First Intervention|Death|0|||
156601129|NCT01306032|565283126|FG001|First Intervention|Death|0|||
156601130|NCT01306032|565283127|FG002|First Intervention|Death|1|||
156601131|NCT01306032|565283128|FG003|First Intervention|Death|0|||
156601132|NCT01306032|565283129|FG004|First Intervention|Death|0|||
156601133|NCT01306032|565283130|FG005|First Intervention|Death|0|||
156601134|NCT01306032|565283125|FG000|First Intervention|Ineligible|0|||
156601135|NCT01306032|565283126|FG001|First Intervention|Ineligible|0|||
156601136|NCT01306032|565283127|FG002|First Intervention|Ineligible|0|||
156601137|NCT01306032|565283128|FG003|First Intervention|Ineligible|0|||
156601138|NCT01306032|565283129|FG004|First Intervention|Ineligible|0|||
156601139|NCT01306032|565283130|FG005|First Intervention|Ineligible|1|||
156601140|NCT01306032|565283125|FG000|First Intervention|Progressive disease|0|||
156601141|NCT01306032|565283126|FG001|First Intervention|Progressive disease|0|||
156601142|NCT01306032|565283127|FG002|First Intervention|Progressive disease|0|||
156601143|NCT01306032|565283128|FG003|First Intervention|Progressive disease|0|||
156601144|NCT01306032|565283129|FG004|First Intervention|Progressive disease|2|||
156601145|NCT01306032|565283130|FG005|First Intervention|Progressive disease|0|||
156601146|NCT01306032|565283125|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
156601147|NCT01306032|565283126|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
156601148|NCT01306032|565283127|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
156601149|NCT01306032|565283128|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
156601150|NCT01306032|565283129|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
156601151|NCT01306032|565283130|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
156601152|NCT01306032|565283125|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
156601153|NCT01306032|565283126|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
156601154|NCT01306032|565283127|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
156601155|NCT01306032|565283128|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
156601156|NCT01306032|565283129|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
156601157|NCT01306032|565283130|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
156601158|NCT00992186|565283131|FG000|Overall Study|Withdrawal by Subject|2|||
156601159|NCT00992186|565283131|FG000|Overall Study|Protocol Violation|1|||
156601160|NCT00992186|565283131|FG000|Overall Study|Physician Decision|1|||
156601161|NCT00992186|565283131|FG000|Overall Study|Adverse Event|9|||
156601162|NCT00992186|565283131|FG000|Overall Study|Progressive Disease|30|||
156601163|NCT00992186|565283131|FG000|Overall Study|Refusal To Receive Study Agent|3|||
156601164|NCT00555568|565283135|FG000|Overall Study|Lost to Follow-up|26|||
156601165|NCT00555568|565283136|FG001|Overall Study|Lost to Follow-up|16|||
156601166|NCT00555568|565283137|FG002|Overall Study|Lost to Follow-up|16|||
156601167|NCT01588353|565283138|FG000|Step2|Withdrawal by Subject|0|||
156601168|NCT01588353|565283139|FG001|Step2|Withdrawal by Subject|1|||
156601169|NCT01588353|565283140|FG002|Step2|Withdrawal by Subject|0|||
156601170|NCT01588353|565283138|FG000|Step3|Adverse Event|0|||
156601171|NCT01588353|565283139|FG001|Step3|Adverse Event|0|||
156601172|NCT01588353|565283140|FG002|Step3|Adverse Event|2|||
156601173|NCT01409993|565283141|FG000|Overall Study|Adverse Event|4|||
156601174|NCT01409993|565283142|FG001|Overall Study|Adverse Event|4|||
156601175|NCT01409993|565283143|FG002|Overall Study|Adverse Event|3|||
156601176|NCT01409993|565283144|FG003|Overall Study|Adverse Event|1|||
156601177|NCT01409993|565283141|FG000|Overall Study|Withdrawal by Subject|0|||
156601178|NCT01409993|565283142|FG001|Overall Study|Withdrawal by Subject|0|||
156601179|NCT01409993|565283143|FG002|Overall Study|Withdrawal by Subject|0|||
156601180|NCT01409993|565283144|FG003|Overall Study|Withdrawal by Subject|4|||
156601181|NCT01409993|565283141|FG000|Overall Study|Lost to Follow-up|0|||
156601182|NCT01409993|565283142|FG001|Overall Study|Lost to Follow-up|1|||
156601183|NCT01409993|565283143|FG002|Overall Study|Lost to Follow-up|0|||
156601184|NCT01409993|565283144|FG003|Overall Study|Lost to Follow-up|0|||
156863688|NCT05194124|566258762|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156601185|NCT02677220|565283145|FG000|Overall Study|Adverse Event|1|||
156601186|NCT00830960|565283146|FG000|Overall Study|Death|5|||
156601187|NCT00830960|565283147|FG001|Overall Study|Death|4|||
156601188|NCT00830960|565283148|FG002|Overall Study|Death|3|||
156601189|NCT00830960|565283149|FG003|Overall Study|Death|2|||
156601190|NCT00830960|565283150|FG004|Overall Study|Death|6|||
156601191|NCT00830960|565283151|FG005|Overall Study|Death|1|||
156601192|NCT00830960|565283146|FG000|Overall Study|Lost to Follow-up|1|||
156601193|NCT00830960|565283147|FG001|Overall Study|Lost to Follow-up|1|||
156601194|NCT00830960|565283148|FG002|Overall Study|Lost to Follow-up|1|||
156601195|NCT00830960|565283149|FG003|Overall Study|Lost to Follow-up|0|||
156601196|NCT00830960|565283150|FG004|Overall Study|Lost to Follow-up|0|||
156601197|NCT00830960|565283151|FG005|Overall Study|Lost to Follow-up|1|||
156601198|NCT00830960|565283146|FG000|Overall Study|Withdrawal by Subject|19|||
156601199|NCT00830960|565283147|FG001|Overall Study|Withdrawal by Subject|19|||
156601200|NCT00830960|565283148|FG002|Overall Study|Withdrawal by Subject|18|||
156601201|NCT00830960|565283149|FG003|Overall Study|Withdrawal by Subject|23|||
156601202|NCT00830960|565283150|FG004|Overall Study|Withdrawal by Subject|16|||
156601203|NCT00830960|565283151|FG005|Overall Study|Withdrawal by Subject|21|||
156601204|NCT00830960|565283146|FG000|Overall Study|Sponsor Decision|1|||
156601205|NCT00830960|565283147|FG001|Overall Study|Sponsor Decision|2|||
156601206|NCT00830960|565283148|FG002|Overall Study|Sponsor Decision|3|||
156601207|NCT00830960|565283149|FG003|Overall Study|Sponsor Decision|4|||
156601208|NCT00830960|565283150|FG004|Overall Study|Sponsor Decision|5|||
156601209|NCT00830960|565283151|FG005|Overall Study|Sponsor Decision|7|||
156601210|NCT00830960|565283146|FG000|Overall Study|No study drug received|7|||
156601211|NCT00830960|565283147|FG001|Overall Study|No study drug received|2|||
156601212|NCT00830960|565283148|FG002|Overall Study|No study drug received|4|||
156601213|NCT00830960|565283149|FG003|Overall Study|No study drug received|3|||
156601214|NCT00830960|565283150|FG004|Overall Study|No study drug received|5|||
156601215|NCT00830960|565283151|FG005|Overall Study|No study drug received|7|||
156601216|NCT01803711|565283159|FG000|Overall Study|Adverse Event|1|||
156601217|NCT01803711|565283160|FG001|Overall Study|Adverse Event|1|||
156601218|NCT01376245|565283161|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
156601219|NCT01376245|565283162|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
156601220|NCT01376245|565283163|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
156601221|NCT01376245|565283164|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
156601222|NCT01376245|565283165|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
156601223|NCT01376245|565283161|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
156601224|NCT01376245|565283162|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
156601225|NCT01376245|565283163|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
156601226|NCT01376245|565283164|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
156601227|NCT01376245|565283165|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
156601228|NCT01376245|565283161|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
156601229|NCT01376245|565283162|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
156601230|NCT01376245|565283163|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
156601231|NCT01376245|565283164|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
156601232|NCT01376245|565283165|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
156601233|NCT01376245|565283161|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
156601234|NCT01376245|565283162|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
156601235|NCT01376245|565283163|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
156601236|NCT01376245|565283164|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
156601237|NCT01376245|565283165|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
156601238|NCT01376245|565283161|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
156601239|NCT01376245|565283162|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
156601240|NCT01376245|565283163|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
156601241|NCT01376245|565283164|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
156601242|NCT01376245|565283165|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
156601243|NCT01376245|565283161|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
156601244|NCT01376245|565283162|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
156601245|NCT01376245|565283163|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
156601246|NCT01376245|565283164|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
156601247|NCT01376245|565283165|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
156601248|NCT01376245|565283161|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
156601249|NCT01376245|565283162|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
156601250|NCT01376245|565283163|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
156601251|NCT01376245|565283164|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
156601252|NCT01376245|565283165|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
156601253|NCT01376245|565283161|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
156601254|NCT01376245|565283162|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
156601255|NCT01376245|565283163|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
156601256|NCT01376245|565283164|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
156601257|NCT01376245|565283165|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
156601258|NCT01376245|565283161|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
156601259|NCT01376245|565283162|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
156601260|NCT01376245|565283163|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
156601261|NCT01376245|565283164|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
156601262|NCT01376245|565283165|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
156601263|NCT01376245|565283161|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156601264|NCT01376245|565283162|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
156601265|NCT01376245|565283163|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156601266|NCT01376245|565283164|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
156601267|NCT01376245|565283165|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
156601268|NCT01376245|565283161|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
156601269|NCT01376245|565283162|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
156601270|NCT01376245|565283163|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
156601271|NCT01376245|565283164|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
156601272|NCT01376245|565283165|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
156601273|NCT01376245|565283161|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156601274|NCT01376245|565283162|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
156601275|NCT01376245|565283163|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
156601276|NCT01376245|565283164|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
156601277|NCT01376245|565283165|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
156601278|NCT05159362|565283166|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
156601279|NCT05159362|565283167|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
156601280|NCT05159362|565283168|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
156601281|NCT00050960|565283169|FG000|Overall Study|Progressive Disease|137|||
156601282|NCT00050960|565283170|FG001|Overall Study|Progressive Disease|93|||
156601283|NCT00050960|565283169|FG000|Overall Study|Stable Disease|19|||
156601284|NCT00050960|565283170|FG001|Overall Study|Stable Disease|48|||
156601285|NCT00050960|565283169|FG000|Overall Study|Partial Response|14|||
156601286|NCT00050960|565283170|FG001|Overall Study|Partial Response|19|||
156601287|NCT00050960|565283169|FG000|Overall Study|Complete Response|0|||
156601288|NCT00050960|565283170|FG001|Overall Study|Complete Response|2|||
156601289|NCT00050960|565283169|FG000|Overall Study|Adverse Event|62|||
156601290|NCT00050960|565283170|FG001|Overall Study|Adverse Event|61|||
156601291|NCT00050960|565283169|FG000|Overall Study|Lost to Follow-up|0|||
156601292|NCT00050960|565283170|FG001|Overall Study|Lost to Follow-up|1|||
156601293|NCT00050960|565283169|FG000|Overall Study|Withdrawal by Subject|23|||
156601294|NCT00050960|565283170|FG001|Overall Study|Withdrawal by Subject|18|||
156601295|NCT00050960|565283169|FG000|Overall Study|Administrative|31|||
156601296|NCT00050960|565283170|FG001|Overall Study|Administrative|46|||
156601297|NCT00050960|565283169|FG000|Overall Study|Non-compliance|3|||
156601298|NCT00050960|565283170|FG001|Overall Study|Non-compliance|1|||
156601299|NCT00050960|565283169|FG000|Overall Study|Death|13|||
156601300|NCT00050960|565283170|FG001|Overall Study|Death|15|||
156601301|NCT01315847|565283174|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
156601302|NCT01315847|565283175|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
156601303|NCT01315847|565283174|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
156601304|NCT01315847|565283175|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
156601305|NCT02940626|565283176|FG000|Overall Study|Death|40|||
156601306|NCT02940626|565283177|FG001|Overall Study|Death|32|||
156601307|NCT02940626|565283176|FG000|Overall Study|Lost to Follow-up|5|||
156601308|NCT02940626|565283177|FG001|Overall Study|Lost to Follow-up|2|||
156601309|NCT02940626|565283176|FG000|Overall Study|Withdrawal by Subject|1|||
156601310|NCT02940626|565283177|FG001|Overall Study|Withdrawal by Subject|0|||
156601311|NCT02940626|565283176|FG000|Overall Study|Transfer to Hospice Care|1|||
156601312|NCT02940626|565283177|FG001|Overall Study|Transfer to Hospice Care|0|||
156601313|NCT02940626|565283176|FG000|Overall Study|Prohibited Concomitant Medication|0|||
156601314|NCT02940626|565283177|FG001|Overall Study|Prohibited Concomitant Medication|1|||
156601315|NCT01324622|565283178|FG000|Overall Study|Lost to Follow-up|7|||
156601316|NCT01324622|565283179|FG001|Overall Study|Lost to Follow-up|7|||
156601317|NCT01324622|565283178|FG000|Overall Study|Death|1|||
156601318|NCT01324622|565283179|FG001|Overall Study|Death|0|||
156601319|NCT01324622|565283178|FG000|Overall Study|Lack of Efficacy|1|||
156601320|NCT01324622|565283179|FG001|Overall Study|Lack of Efficacy|0|||
156601321|NCT05127421|565283180|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
156601322|NCT05127421|565283181|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
156601323|NCT05127421|565283182|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
156601324|NCT05127421|565283183|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
156601325|NCT05127421|565283180|FG000|4-Week Double-Blind Period|Physician Decision|1|||
156601326|NCT05127421|565283181|FG001|4-Week Double-Blind Period|Physician Decision|0|||
156601327|NCT05127421|565283182|FG002|4-Week Double-Blind Period|Physician Decision|0|||
156601328|NCT05127421|565283183|FG003|4-Week Double-Blind Period|Physician Decision|0|||
156601329|NCT05127421|565283180|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
156601330|NCT05127421|565283181|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
156601331|NCT05127421|565283182|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
156601332|NCT05127421|565283183|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
156601333|NCT05127421|565283180|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
156601334|NCT05127421|565283181|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
156601335|NCT05127421|565283182|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
156601336|NCT05127421|565283183|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
156601337|NCT05127421|565283180|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
156601338|NCT05127421|565283181|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
156601339|NCT05127421|565283182|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
156601340|NCT05127421|565283183|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
156601341|NCT05127421|565283180|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
156601342|NCT05127421|565283181|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
156601343|NCT05127421|565283182|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
156601344|NCT05127421|565283183|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
156601345|NCT05127421|565283180|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
156601346|NCT05127421|565283181|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
156601347|NCT05127421|565283182|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
156601348|NCT05127421|565283183|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
156601349|NCT05127421|565283180|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
156601350|NCT05127421|565283181|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
156601351|NCT05127421|565283182|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
156601352|NCT05127421|565283183|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
156601353|NCT00618449|565283184|FG000|Overall Study|Lost to Follow-up|98|||
156601354|NCT00618449|565283185|FG001|Overall Study|Lost to Follow-up|110|||
156601355|NCT02219087|565283186|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
156601356|NCT02219087|565283187|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
156601357|NCT00138424|565283188|FG000|Overall Study|Physician Decision|0|||
156601358|NCT00138424|565283189|FG001|Overall Study|Physician Decision|1|||
156601359|NCT00138424|565283190|FG002|Overall Study|Physician Decision|0|||
156601360|NCT00138424|565283191|FG003|Overall Study|Physician Decision|0|||
156601361|NCT04311177|565283192|FG000|Overall Study|Adverse Event|3|||
156601362|NCT04311177|565283193|FG001|Overall Study|Adverse Event|1|||
156601363|NCT04311177|565283192|FG000|Overall Study|Physician Decision|4|||
156601364|NCT04311177|565283193|FG001|Overall Study|Physician Decision|3|||
156601365|NCT04311177|565283192|FG000|Overall Study|Withdrawal by Subject|1|||
156601366|NCT04311177|565283193|FG001|Overall Study|Withdrawal by Subject|0|||
156601367|NCT00574496|565283202|FG000|Overall Study|Withdrawal by Subject|1|||
156601368|NCT00413062|565283203|FG000|Overall Study|Adverse event/serious adverse event|289|||
156601369|NCT00413062|565283204|FG001|Overall Study|Adverse event/serious adverse event|56|||
156601370|NCT00413062|565283203|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
156601371|NCT00413062|565283204|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
156601372|NCT00413062|565283203|FG000|Overall Study|Withdrawal of informed consent|111|||
156601373|NCT00413062|565283204|FG001|Overall Study|Withdrawal of informed consent|36|||
156601374|NCT00413062|565283203|FG000|Overall Study|Pregnancy|15|||
156601375|NCT00413062|565283204|FG001|Overall Study|Pregnancy|5|||
156601376|NCT00413062|565283203|FG000|Overall Study|Pregnancy wish|17|||
156601377|NCT00413062|565283204|FG001|Overall Study|Pregnancy wish|6|||
156601378|NCT00413062|565283203|FG000|Overall Study|Lost to Follow-up|175|||
156601379|NCT00413062|565283204|FG001|Overall Study|Lost to Follow-up|73|||
156601380|NCT00413062|565283203|FG000|Overall Study|Other reason|70|||
156601381|NCT00413062|565283204|FG001|Overall Study|Other reason|34|||
156601382|NCT02176291|565283205|FG000|Overall Study|Death|1|||
156601383|NCT02176291|565283206|FG001|Overall Study|Death|0|||
156601384|NCT02176291|565283205|FG000|Overall Study|non compliance with protocol|2|||
156601385|NCT02176291|565283206|FG001|Overall Study|non compliance with protocol|0|||
156601386|NCT02176291|565283205|FG000|Overall Study|Withdrawal by Subject|2|||
156601387|NCT02176291|565283206|FG001|Overall Study|Withdrawal by Subject|0|||
156601388|NCT01969799|565283207|FG000|Overall Study|Adverse Event|0|||
156601389|NCT01969799|565283208|FG001|Overall Study|Adverse Event|1|||
156601390|NCT01969799|565283207|FG000|Overall Study|Death|16|||
156601391|NCT01969799|565283208|FG001|Overall Study|Death|11|||
156601392|NCT01969799|565283207|FG000|Overall Study|Lost to Follow-up|0|||
156601393|NCT01969799|565283208|FG001|Overall Study|Lost to Follow-up|2|||
156601394|NCT01969799|565283207|FG000|Overall Study|Physician Decision|1|||
156601395|NCT01969799|565283208|FG001|Overall Study|Physician Decision|0|||
156601396|NCT00006604|565283209|FG000|Overall Study|Met study objective - no further FU|1|||
156601397|NCT00006604|565283210|FG001|Overall Study|Met study objective - no further FU|0|||
156601398|NCT00006604|565283211|FG002|Overall Study|Met study objective - no further FU|0|||
156601399|NCT00006604|565283212|FG003|Overall Study|Met study objective - no further FU|0|||
156601400|NCT00006604|565283213|FG004|Overall Study|Met study objective - no further FU|0|||
156601401|NCT00006604|565283214|FG005|Overall Study|Met study objective - no further FU|0|||
156601402|NCT00006604|565283215|FG006|Overall Study|Met study objective - no further FU|0|||
156601403|NCT00006604|565283216|FG007|Overall Study|Met study objective - no further FU|0|||
156601404|NCT00006604|565283217|FG008|Overall Study|Met study objective - no further FU|0|||
156601405|NCT00006604|565283218|FG009|Overall Study|Met study objective - no further FU|0|||
156601406|NCT00006604|565283219|FG010|Overall Study|Met study objective - no further FU|0|||
156601407|NCT00006604|565283220|FG011|Overall Study|Met study objective - no further FU|0|||
156601408|NCT00006604|565283221|FG012|Overall Study|Met study objective - no further FU|0|||
156601409|NCT00006604|565283222|FG013|Overall Study|Met study objective - no further FU|0|||
156601410|NCT00006604|565283223|FG014|Overall Study|Met study objective - no further FU|1|||
156601411|NCT00006604|565283224|FG015|Overall Study|Met study objective - no further FU|1|||
156601412|NCT00006604|565283225|FG016|Overall Study|Met study objective - no further FU|0|||
156601413|NCT00006604|565283209|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
156601414|NCT00006604|565283210|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
156601415|NCT00006604|565283211|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
156601416|NCT00006604|565283212|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
156601417|NCT00006604|565283213|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
156601418|NCT00006604|565283214|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
156601419|NCT00006604|565283215|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
156601420|NCT00006604|565283216|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
156601421|NCT00006604|565283217|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
156601422|NCT00006604|565283218|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
156601423|NCT00006604|565283219|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
156601424|NCT00006604|565283220|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
156601425|NCT00006604|565283221|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
156601426|NCT00006604|565283222|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
156601427|NCT00006604|565283223|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
156601428|NCT00006604|565283224|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
156601429|NCT00006604|565283225|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
156601430|NCT00006604|565283209|FG000|Overall Study|Death|0|||
156601431|NCT00006604|565283210|FG001|Overall Study|Death|0|||
156601432|NCT00006604|565283211|FG002|Overall Study|Death|0|||
156601433|NCT00006604|565283212|FG003|Overall Study|Death|0|||
156601434|NCT00006604|565283213|FG004|Overall Study|Death|0|||
156601435|NCT00006604|565283214|FG005|Overall Study|Death|0|||
156601436|NCT00006604|565283215|FG006|Overall Study|Death|0|||
156601437|NCT00006604|565283216|FG007|Overall Study|Death|0|||
156601438|NCT00006604|565283217|FG008|Overall Study|Death|0|||
156601439|NCT00006604|565283218|FG009|Overall Study|Death|1|||
156601440|NCT00006604|565283219|FG010|Overall Study|Death|1|||
156601441|NCT00006604|565283220|FG011|Overall Study|Death|1|||
156601442|NCT00006604|565283221|FG012|Overall Study|Death|0|||
156601443|NCT00006604|565283222|FG013|Overall Study|Death|0|||
156601444|NCT00006604|565283223|FG014|Overall Study|Death|0|||
156601445|NCT00006604|565283224|FG015|Overall Study|Death|0|||
156601446|NCT00006604|565283225|FG016|Overall Study|Death|0|||
156601447|NCT00006604|565283209|FG000|Overall Study|Severe debilitation, unable to continue|0|||
156601448|NCT00006604|565283210|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156601449|NCT00006604|565283211|FG002|Overall Study|Severe debilitation, unable to continue|0|||
156601450|NCT00006604|565283212|FG003|Overall Study|Severe debilitation, unable to continue|0|||
156601451|NCT00006604|565283213|FG004|Overall Study|Severe debilitation, unable to continue|0|||
156601452|NCT00006604|565283214|FG005|Overall Study|Severe debilitation, unable to continue|0|||
156601453|NCT00006604|565283215|FG006|Overall Study|Severe debilitation, unable to continue|3|||
156601454|NCT00006604|565283216|FG007|Overall Study|Severe debilitation, unable to continue|0|||
156601455|NCT00006604|565283217|FG008|Overall Study|Severe debilitation, unable to continue|0|||
156601456|NCT00006604|565283218|FG009|Overall Study|Severe debilitation, unable to continue|5|||
156601457|NCT00006604|565283219|FG010|Overall Study|Severe debilitation, unable to continue|0|||
156601458|NCT00006604|565283220|FG011|Overall Study|Severe debilitation, unable to continue|2|||
156601459|NCT00006604|565283221|FG012|Overall Study|Severe debilitation, unable to continue|1|||
156601460|NCT00006604|565283222|FG013|Overall Study|Severe debilitation, unable to continue|0|||
156601461|NCT00006604|565283223|FG014|Overall Study|Severe debilitation, unable to continue|2|||
156601462|NCT00006604|565283224|FG015|Overall Study|Severe debilitation, unable to continue|0|||
156601463|NCT00006604|565283225|FG016|Overall Study|Severe debilitation, unable to continue|0|||
156601464|NCT00006604|565283209|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
156601465|NCT00006604|565283210|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
156601466|NCT00006604|565283211|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
156601467|NCT00006604|565283212|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
156601468|NCT00006604|565283213|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
156601469|NCT00006604|565283214|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
156601470|NCT00006604|565283215|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
156601471|NCT00006604|565283216|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
156601472|NCT00006604|565283217|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
156601473|NCT00006604|565283218|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
156601474|NCT00006604|565283219|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
156601475|NCT00006604|565283220|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
156601476|NCT00006604|565283221|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
156601477|NCT00006604|565283222|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
156601478|NCT00006604|565283223|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
156601479|NCT00006604|565283224|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
156601480|NCT00006604|565283225|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
156601481|NCT00006604|565283209|FG000|Overall Study|Site closing|0|||
156601482|NCT00006604|565283210|FG001|Overall Study|Site closing|0|||
156601483|NCT00006604|565283211|FG002|Overall Study|Site closing|1|||
156601484|NCT00006604|565283212|FG003|Overall Study|Site closing|1|||
156601485|NCT00006604|565283213|FG004|Overall Study|Site closing|0|||
156601486|NCT00006604|565283214|FG005|Overall Study|Site closing|0|||
156601487|NCT00006604|565283215|FG006|Overall Study|Site closing|0|||
156601488|NCT00006604|565283216|FG007|Overall Study|Site closing|1|||
156601489|NCT00006604|565283217|FG008|Overall Study|Site closing|0|||
156601490|NCT00006604|565283218|FG009|Overall Study|Site closing|0|||
156601491|NCT00006604|565283219|FG010|Overall Study|Site closing|0|||
156601492|NCT00006604|565283220|FG011|Overall Study|Site closing|1|||
156601493|NCT00006604|565283221|FG012|Overall Study|Site closing|1|||
156601494|NCT00006604|565283222|FG013|Overall Study|Site closing|1|||
156601495|NCT00006604|565283223|FG014|Overall Study|Site closing|0|||
156601496|NCT00006604|565283224|FG015|Overall Study|Site closing|0|||
156601497|NCT00006604|565283225|FG016|Overall Study|Site closing|1|||
156601498|NCT00006604|565283209|FG000|Overall Study|Withdrawal by Subject|1|||
156601499|NCT00006604|565283210|FG001|Overall Study|Withdrawal by Subject|0|||
156601500|NCT00006604|565283211|FG002|Overall Study|Withdrawal by Subject|2|||
156601501|NCT00006604|565283212|FG003|Overall Study|Withdrawal by Subject|0|||
156601502|NCT00006604|565283213|FG004|Overall Study|Withdrawal by Subject|1|||
156601503|NCT00006604|565283214|FG005|Overall Study|Withdrawal by Subject|2|||
156601504|NCT00006604|565283215|FG006|Overall Study|Withdrawal by Subject|2|||
156601505|NCT00006604|565283216|FG007|Overall Study|Withdrawal by Subject|0|||
156601506|NCT00006604|565283217|FG008|Overall Study|Withdrawal by Subject|1|||
156601507|NCT00006604|565283218|FG009|Overall Study|Withdrawal by Subject|3|||
156601508|NCT00006604|565283219|FG010|Overall Study|Withdrawal by Subject|2|||
156601509|NCT00006604|565283220|FG011|Overall Study|Withdrawal by Subject|0|||
156601510|NCT00006604|565283221|FG012|Overall Study|Withdrawal by Subject|1|||
156601511|NCT00006604|565283222|FG013|Overall Study|Withdrawal by Subject|2|||
156601512|NCT00006604|565283223|FG014|Overall Study|Withdrawal by Subject|1|||
156601513|NCT00006604|565283224|FG015|Overall Study|Withdrawal by Subject|0|||
156601514|NCT00006604|565283225|FG016|Overall Study|Withdrawal by Subject|1|||
156601515|NCT00006604|565283209|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
156601516|NCT00006604|565283210|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
156601517|NCT00006604|565283211|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
156601518|NCT00006604|565283212|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
156601519|NCT00006604|565283213|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
156601520|NCT00006604|565283214|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
156601521|NCT00006604|565283215|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
156601522|NCT00006604|565283216|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
156601523|NCT00006604|565283217|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
156601524|NCT00006604|565283218|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
156601525|NCT00006604|565283219|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
156601526|NCT00006604|565283220|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
156601527|NCT00006604|565283221|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
156601528|NCT00006604|565283222|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
156601529|NCT00006604|565283223|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
156601530|NCT00006604|565283224|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
156601531|NCT00006604|565283225|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
156601532|NCT00006604|565283209|FG000|Overall Study|Lost to Follow-up|0|||
156601533|NCT00006604|565283210|FG001|Overall Study|Lost to Follow-up|0|||
156601534|NCT00006604|565283211|FG002|Overall Study|Lost to Follow-up|0|||
156601535|NCT00006604|565283212|FG003|Overall Study|Lost to Follow-up|0|||
156601536|NCT00006604|565283213|FG004|Overall Study|Lost to Follow-up|0|||
156601537|NCT00006604|565283214|FG005|Overall Study|Lost to Follow-up|0|||
156601538|NCT00006604|565283215|FG006|Overall Study|Lost to Follow-up|0|||
156601539|NCT00006604|565283216|FG007|Overall Study|Lost to Follow-up|1|||
156601540|NCT00006604|565283217|FG008|Overall Study|Lost to Follow-up|0|||
156601541|NCT00006604|565283218|FG009|Overall Study|Lost to Follow-up|2|||
156601542|NCT00006604|565283219|FG010|Overall Study|Lost to Follow-up|0|||
156601543|NCT00006604|565283220|FG011|Overall Study|Lost to Follow-up|0|||
156601544|NCT00006604|565283221|FG012|Overall Study|Lost to Follow-up|0|||
156601545|NCT00006604|565283222|FG013|Overall Study|Lost to Follow-up|0|||
156601546|NCT00006604|565283223|FG014|Overall Study|Lost to Follow-up|0|||
156601547|NCT00006604|565283224|FG015|Overall Study|Lost to Follow-up|1|||
156601548|NCT00006604|565283225|FG016|Overall Study|Lost to Follow-up|3|||
156601549|NCT00006604|565283209|FG000|Overall Study|Other Reason|0|||
156601550|NCT00006604|565283210|FG001|Overall Study|Other Reason|0|||
156601551|NCT00006604|565283211|FG002|Overall Study|Other Reason|0|||
156601552|NCT00006604|565283212|FG003|Overall Study|Other Reason|0|||
156601553|NCT00006604|565283213|FG004|Overall Study|Other Reason|0|||
156601554|NCT00006604|565283214|FG005|Overall Study|Other Reason|1|||
156601555|NCT00006604|565283215|FG006|Overall Study|Other Reason|0|||
156601556|NCT00006604|565283216|FG007|Overall Study|Other Reason|0|||
156601557|NCT00006604|565283217|FG008|Overall Study|Other Reason|0|||
156601558|NCT00006604|565283218|FG009|Overall Study|Other Reason|1|||
156601559|NCT00006604|565283219|FG010|Overall Study|Other Reason|0|||
156601560|NCT00006604|565283220|FG011|Overall Study|Other Reason|0|||
156601561|NCT00006604|565283221|FG012|Overall Study|Other Reason|0|||
156601562|NCT00006604|565283222|FG013|Overall Study|Other Reason|0|||
156601563|NCT00006604|565283223|FG014|Overall Study|Other Reason|0|||
156601564|NCT00006604|565283224|FG015|Overall Study|Other Reason|0|||
156601565|NCT00006604|565283225|FG016|Overall Study|Other Reason|0|||
156601566|NCT02431468|565283226|FG000|Overall Study|Adverse Event|2|||
156601567|NCT02431468|565283227|FG001|Overall Study|Adverse Event|4|||
156601568|NCT02431468|565283228|FG002|Overall Study|Adverse Event|5|||
156601569|NCT02431468|565283226|FG000|Overall Study|Withdrawal by Subject|4|||
156601570|NCT02431468|565283227|FG001|Overall Study|Withdrawal by Subject|12|||
156601571|NCT02431468|565283228|FG002|Overall Study|Withdrawal by Subject|2|||
156601572|NCT02431468|565283226|FG000|Overall Study|noncompliance, investigator termination,|2|||
156601573|NCT02431468|565283227|FG001|Overall Study|noncompliance, investigator termination,|2|||
156601574|NCT02431468|565283228|FG002|Overall Study|noncompliance, investigator termination,|2|||
156601575|NCT01361919|565283229|FG000|Overall Study|technical issues|10|||
156601576|NCT01361919|565283230|FG001|Overall Study|technical issues|12|||
156601577|NCT01361919|565283231|FG002|Overall Study|technical issues|10|||
156601578|NCT01056341|565283232|FG000|Overall Study|Treatment Intolerance|0|||
156601579|NCT01056341|565283233|FG001|Overall Study|Treatment Intolerance|2|||
156601580|NCT01056341|565283234|FG002|Overall Study|Treatment Intolerance|0|||
156601581|NCT01056341|565283235|FG003|Overall Study|Treatment Intolerance|2|||
156601582|NCT01056341|565283236|FG004|Overall Study|Treatment Intolerance|0|||
156601583|NCT01056341|565283232|FG000|Overall Study|Lack of Efficacy|32|||
156601584|NCT01056341|565283233|FG001|Overall Study|Lack of Efficacy|30|||
156601585|NCT01056341|565283234|FG002|Overall Study|Lack of Efficacy|7|||
156601586|NCT01056341|565283235|FG003|Overall Study|Lack of Efficacy|25|||
156601587|NCT01056341|565283236|FG004|Overall Study|Lack of Efficacy|9|||
156601588|NCT01056341|565283232|FG000|Overall Study|Other reasons|4|||
156601589|NCT01056341|565283233|FG001|Overall Study|Other reasons|4|||
156601590|NCT01056341|565283234|FG002|Overall Study|Other reasons|8|||
156601591|NCT01056341|565283235|FG003|Overall Study|Other reasons|9|||
156601592|NCT01056341|565283236|FG004|Overall Study|Other reasons|5|||
156601593|NCT03454412|565283237|FG000|Baseline Assesment|Physician Decision|12|||
156601594|NCT02227108|565283238|FG000|Overall Study|Did not receive treatment|2|||
156601595|NCT02227108|565283238|FG000|Overall Study|Other|3|||
156601596|NCT02227108|565283238|FG000|Overall Study|Progressive disease|17|||
156601597|NCT02227108|565283238|FG000|Overall Study|Initiation of alternative therapy|2|||
156601598|NCT02227108|565283238|FG000|Overall Study|Investigator discretion|1|||
156601599|NCT02227108|565283238|FG000|Overall Study|Adverse Event|6|||
156601600|NCT02486952|565283239|FG000|Overall Study|Not Started Induction Therapy|3|||
156601601|NCT02486952|565283239|FG000|Overall Study|Adverse Event|1|||
156601602|NCT02486952|565283239|FG000|Overall Study|Death|15|||
156601603|NCT02486952|565283239|FG000|Overall Study|Lack of Efficacy|3|||
156601604|NCT02486952|565283239|FG000|Overall Study|Lost to Follow-up|26|||
156601605|NCT02486952|565283239|FG000|Overall Study|Other|2|||
156601606|NCT01928485|565283240|FG000|Overall Study|Physician Decision|0|||
156601607|NCT01928485|565283241|FG001|Overall Study|Physician Decision|1|||
156601608|NCT04111107|565283242|FG000|Overall Study|Withdrawal by Subject|6|||
156601609|NCT04111107|565283242|FG000|Overall Study|Declining Health|5|||
156601610|NCT03589885|565283243|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
156601611|NCT03589885|565283244|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
156601612|NCT03589885|565283245|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
156601613|NCT03589885|565283246|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
156601614|NCT03589885|565283247|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
156601615|NCT03589885|565283243|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
156601616|NCT03589885|565283244|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
156601617|NCT03589885|565283245|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
156601618|NCT03589885|565283246|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
156601619|NCT03589885|565283247|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
156601620|NCT03589885|565283243|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
156601621|NCT03589885|565283244|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
156601622|NCT03589885|565283245|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
156601623|NCT03589885|565283246|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
156601624|NCT03589885|565283247|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
156601625|NCT03589885|565283243|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
156601626|NCT03589885|565283244|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
156601627|NCT03589885|565283245|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
156601628|NCT03589885|565283246|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
156601629|NCT03589885|565283247|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
156601630|NCT03589885|565283243|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
156601631|NCT03589885|565283244|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
156601632|NCT03589885|565283245|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
156601633|NCT03589885|565283246|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
156601634|NCT03589885|565283247|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
156601635|NCT03589885|565283243|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
156601636|NCT03589885|565283244|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
156601637|NCT03589885|565283245|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
156601638|NCT03589885|565283246|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
156634907|NCT03917654|565407819|FG004|Year 1|Travel|4|||
156601639|NCT03589885|565283247|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
156601640|NCT03589885|565283243|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
156601641|NCT03589885|565283244|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
156601642|NCT03589885|565283245|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
156601643|NCT03589885|565283246|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
156601644|NCT03589885|565283247|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
156601645|NCT03589885|565283243|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
156601646|NCT03589885|565283244|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
156601647|NCT03589885|565283245|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
156601648|NCT03589885|565283246|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
156601649|NCT03589885|565283247|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
156601650|NCT01714817|565283248|FG000|Year 1 Period|Lack of Efficacy|11|||
156601651|NCT01714817|565283249|FG001|Year 1 Period|Lack of Efficacy|9|||
156601652|NCT01714817|565283248|FG000|Year 1 Period|Adverse Event|20|||
156601653|NCT01714817|565283249|FG001|Year 1 Period|Adverse Event|17|||
156601654|NCT01714817|565283248|FG000|Year 1 Period|Withdrawal by Subject|6|||
156601655|NCT01714817|565283249|FG001|Year 1 Period|Withdrawal by Subject|7|||
156601656|NCT01714817|565283248|FG000|Year 1 Period|Death|1|||
156601657|NCT01714817|565283249|FG001|Year 1 Period|Death|1|||
156601658|NCT01714817|565283248|FG000|Year 1 Period|Lost to Follow-up|0|||
156601659|NCT01714817|565283249|FG001|Year 1 Period|Lost to Follow-up|2|||
156601660|NCT01714817|565283248|FG000|Year 1 Period|Poor / non-compliance|0|||
156601661|NCT01714817|565283249|FG001|Year 1 Period|Poor / non-compliance|1|||
156601662|NCT01714817|565283248|FG000|Year 1 Period|Pregnancy|2|||
156601663|NCT01714817|565283249|FG001|Year 1 Period|Pregnancy|0|||
156601664|NCT01714817|565283248|FG000|Year 1 Period|Participant no longer meets criteria|6|||
156601665|NCT01714817|565283249|FG001|Year 1 Period|Participant no longer meets criteria|2|||
156601666|NCT01714817|565283248|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
156601667|NCT01714817|565283249|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
156601668|NCT01714817|565283248|FG000|Year 1 Period|Change in Concomitant Medication|0|||
156601669|NCT01714817|565283249|FG001|Year 1 Period|Change in Concomitant Medication|1|||
156601670|NCT01714817|565283248|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
156601671|NCT01714817|565283249|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
156601672|NCT01714817|565283248|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
156601673|NCT01714817|565283249|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
156601674|NCT01714817|565283248|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
156601675|NCT01714817|565283249|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
156601676|NCT01714817|565283248|FG000|Year 2 Period|Lack of Efficacy|4|||
156601677|NCT01714817|565283249|FG001|Year 2 Period|Lack of Efficacy|12|||
156601678|NCT01714817|565283248|FG000|Year 2 Period|Adverse Event|7|||
156601679|NCT01714817|565283249|FG001|Year 2 Period|Adverse Event|6|||
156601680|NCT01714817|565283248|FG000|Year 2 Period|Participant request to stop treatment|4|||
156601681|NCT01714817|565283249|FG001|Year 2 Period|Participant request to stop treatment|4|||
156601682|NCT01714817|565283248|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
156601683|NCT01714817|565283249|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
156601684|NCT01714817|565283248|FG000|Year 2 Period|Participant withdrew consent|1|||
156601685|NCT01714817|565283249|FG001|Year 2 Period|Participant withdrew consent|5|||
156601686|NCT01714817|565283248|FG000|Year 2 Period|Participant no longer meets criteria|1|||
156601687|NCT01714817|565283249|FG001|Year 2 Period|Participant no longer meets criteria|4|||
156601688|NCT01714817|565283248|FG000|Year 2 Period|Lost to Follow-up|2|||
156601689|NCT01714817|565283249|FG001|Year 2 Period|Lost to Follow-up|0|||
156601690|NCT01714817|565283248|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
156601691|NCT01714817|565283249|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
156601692|NCT01714817|565283248|FG000|Year 2 Period|Pregnancy|1|||
156601693|NCT01714817|565283249|FG001|Year 2 Period|Pregnancy|1|||
156601694|NCT01714817|565283248|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
156601695|NCT01714817|565283249|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
156601696|NCT01714817|565283248|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
156601697|NCT01714817|565283249|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
156601698|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
156601699|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
156601700|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
156601701|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
156601702|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
156601703|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
156601704|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
156601705|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
156601706|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
156601707|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
156601708|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
156601709|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
156601710|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
156601711|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
156601712|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
156601713|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
156601714|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
156601715|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
156601716|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
156601717|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
156601718|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
156601719|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
156601720|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
156601721|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
156601722|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
156601723|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
156601724|NCT01714817|565283248|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
156601725|NCT01714817|565283249|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
156601726|NCT01374217|565283250|FG000|Overall Study|Lack of Efficacy|13|||
156601727|NCT04169061|565283253|FG000|Overall Study|Adverse Event|2|||
156601728|NCT04169061|565283253|FG000|Overall Study|Death|1|||
156601729|NCT04169061|565283253|FG000|Overall Study|Withdrawal by Subject|1|||
156601730|NCT04169061|565283253|FG000|Overall Study|Protocol Violation|1|||
156601731|NCT02555657|565283254|FG000|Overall Study|Death|274|||
156601732|NCT02555657|565283255|FG001|Overall Study|Death|262|||
156601733|NCT02555657|565283254|FG000|Overall Study|Physician Decision|0|||
156601734|NCT02555657|565283255|FG001|Overall Study|Physician Decision|1|||
156601735|NCT02555657|565283254|FG000|Overall Study|Sponsor Decision|27|||
156601736|NCT02555657|565283255|FG001|Overall Study|Sponsor Decision|15|||
156601737|NCT02555657|565283254|FG000|Overall Study|Withdrawal by Subject|11|||
156601738|NCT02555657|565283255|FG001|Overall Study|Withdrawal by Subject|32|||
156601739|NCT02807363|565283256|FG000|Dosing Period|Adverse Event|0|||
156601740|NCT02807363|565283257|FG001|Dosing Period|Adverse Event|1|||
156601741|NCT02807363|565283258|FG002|Dosing Period|Adverse Event|0|||
156601742|NCT02807363|565283259|FG003|Dosing Period|Adverse Event|0|||
156601743|NCT02188719|565283261|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
156601744|NCT02188719|565283262|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
156601745|NCT02188719|565283263|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
156601746|NCT02188719|565283264|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
156601747|NCT00192036|565283267|FG000|Overall Study|Protocol Violation|3|||
156601748|NCT00192036|565283267|FG000|Overall Study|Adverse Event|6|||
156601749|NCT00192036|565283267|FG000|Overall Study|Patient/Physician Perception|1|||
156601750|NCT00192036|565283267|FG000|Overall Study|Objective Tumor Progression|4|||
156601751|NCT00192036|565283267|FG000|Overall Study|Clinical Disease Progression|1|||
156601752|NCT00192036|565283267|FG000|Overall Study|Death|1|||
156601753|NCT00192036|565283267|FG000|Overall Study|Unknown or Not Specified|5|||
156601754|NCT03371732|565283268|FG000|Overall Study|Withdrawal by Subject|9|||
156601755|NCT03371732|565283269|FG001|Overall Study|Withdrawal by Subject|3|||
156601756|NCT03371732|565283268|FG000|Overall Study|Refusal to continue|3|||
156601757|NCT03371732|565283269|FG001|Overall Study|Refusal to continue|4|||
156601758|NCT02133742|565283271|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
156601759|NCT02133742|565283271|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
156601760|NCT02133742|565283271|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
156601761|NCT02133742|565283271|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
156601762|NCT02133742|565283271|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
156601763|NCT03479216|565283272|FG000|Overall Study|Withdrawal by Subject|3|||
156601764|NCT03479216|565283273|FG001|Overall Study|Withdrawal by Subject|2|||
156601765|NCT03479216|565283272|FG000|Overall Study|Physician Decision|2|||
156601766|NCT03479216|565283273|FG001|Overall Study|Physician Decision|3|||
156601767|NCT03337139|565283280|FG000|Phase I|Withdrawal by Subject|10|||
156601768|NCT03337139|565283281|FG001|Phase I|Withdrawal by Subject|0|||
156601769|NCT01561560|565283288|FG000|First Two Weeks of Wear|Time/job conflict|0|||
156601770|NCT01561560|565283289|FG001|First Two Weeks of Wear|Time/job conflict|1|||
156601771|NCT01561560|565283288|FG000|First Two Weeks of Wear|Adverse Event|0|||
156601772|NCT01561560|565283289|FG001|First Two Weeks of Wear|Adverse Event|1|||
156601773|NCT01561560|565283288|FG000|Second Two Weeks of Wear|Adverse Event|0|||
156601774|NCT01561560|565283289|FG001|Second Two Weeks of Wear|Adverse Event|1|||
156601775|NCT03862131|565283290|FG000|Overall Study|Lost to Follow-up|1|||
156601776|NCT03862131|565283291|FG001|Overall Study|Lost to Follow-up|0|||
156601777|NCT03862131|565283292|FG002|Overall Study|Lost to Follow-up|1|||
156601778|NCT03862131|565283290|FG000|Overall Study|Determined to be ineligible|0|||
156601779|NCT03862131|565283291|FG001|Overall Study|Determined to be ineligible|0|||
156601780|NCT03862131|565283292|FG002|Overall Study|Determined to be ineligible|5|||
156601781|NCT03862131|565283290|FG000|Overall Study|Death|4|||
156601782|NCT03862131|565283291|FG001|Overall Study|Death|4|||
156601783|NCT03862131|565283292|FG002|Overall Study|Death|0|||
156601784|NCT03862131|565283290|FG000|Overall Study|Withdrawal by Subject|5|||
156601785|NCT03862131|565283291|FG001|Overall Study|Withdrawal by Subject|3|||
156601786|NCT03862131|565283292|FG002|Overall Study|Withdrawal by Subject|0|||
156601787|NCT03862131|565283290|FG000|Overall Study|Physician Decision|0|||
156601788|NCT03862131|565283291|FG001|Overall Study|Physician Decision|1|||
156601789|NCT03862131|565283292|FG002|Overall Study|Physician Decision|0|||
156601790|NCT00093470|565284973|FG000|Overall Study|Disease progression|39|||
156601791|NCT00093470|565284974|FG001|Overall Study|Disease progression|0|||
156601792|NCT00093470|565284973|FG000|Overall Study|Adverse Event|15|||
156601793|NCT00093470|565284974|FG001|Overall Study|Adverse Event|0|||
156601794|NCT00093470|565284973|FG000|Overall Study|Death|2|||
156601795|NCT00093470|565284974|FG001|Overall Study|Death|0|||
156601796|NCT00093470|565284973|FG000|Overall Study|Withdrawal by Subject|8|||
156601797|NCT00093470|565284974|FG001|Overall Study|Withdrawal by Subject|0|||
156601798|NCT00093470|565284973|FG000|Overall Study|Alternative therapy|2|||
156601799|NCT00093470|565284974|FG001|Overall Study|Alternative therapy|0|||
156601800|NCT00093470|565284973|FG000|Overall Study|Other complicating disease|3|||
156601801|NCT00093470|565284974|FG001|Overall Study|Other complicating disease|0|||
156601802|NCT00093470|565284973|FG000|Overall Study|Physician Decision|2|||
156601803|NCT00093470|565284974|FG001|Overall Study|Physician Decision|0|||
156601804|NCT00093470|565284973|FG000|Overall Study|Never started treatment|1|||
156601805|NCT00093470|565284974|FG001|Overall Study|Never started treatment|0|||
156601806|NCT00093470|565284973|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
156601807|NCT00093470|565284974|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
156601808|NCT02514772|565284980|FG000|Overall Study|Adverse Event|1|||
156601809|NCT02514772|565284981|FG001|Overall Study|Adverse Event|0|||
156601810|NCT02514772|565284980|FG000|Overall Study|Death|0|||
156601811|NCT02514772|565284981|FG001|Overall Study|Death|1|||
156601812|NCT02514772|565284980|FG000|Overall Study|Withdrawal by Subject|2|||
156601813|NCT02514772|565284981|FG001|Overall Study|Withdrawal by Subject|1|||
156601814|NCT00877006|565284982|FG000|Treatment Period|Death|2|||
156601815|NCT00877006|565284983|FG001|Treatment Period|Death|1|||
156601816|NCT00877006|565284982|FG000|Treatment Period|Adverse Event|10|||
156601817|NCT00877006|565284983|FG001|Treatment Period|Adverse Event|3|||
156601818|NCT00877006|565284982|FG000|Treatment Period|Withdrawal by Subject|2|||
156601819|NCT00877006|565284983|FG001|Treatment Period|Withdrawal by Subject|3|||
156601820|NCT00877006|565284982|FG000|Treatment Period|Protocol Violation|1|||
156601821|NCT00877006|565284983|FG001|Treatment Period|Protocol Violation|0|||
156601822|NCT00877006|565284982|FG000|Treatment Period|Lost to Follow-up|0|||
156601823|NCT00877006|565284983|FG001|Treatment Period|Lost to Follow-up|1|||
156601824|NCT00877006|565284982|FG000|Treatment Period|Disease Progression|1|||
156601825|NCT00877006|565284983|FG001|Treatment Period|Disease Progression|2|||
156601826|NCT00877006|565284982|FG000|Treatment Period|Started New Treatment Regimen|2|||
156601827|NCT00877006|565284983|FG001|Treatment Period|Started New Treatment Regimen|5|||
156601828|NCT00877006|565284982|FG000|Treatment Period|Other|4|||
156601829|NCT00877006|565284983|FG001|Treatment Period|Other|4|||
156601830|NCT00877006|565284982|FG000|Treatment Period|Randomized but Not Treated|3|||
156601831|NCT00877006|565284983|FG001|Treatment Period|Randomized but Not Treated|8|||
156601832|NCT00877006|565284982|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
156601833|NCT00877006|565284983|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
156601834|NCT00877006|565284982|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
156601835|NCT00877006|565284983|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
156601836|NCT00877006|565284982|FG000|Long-Term Follow-up Period|Death|26|||
156601837|NCT00877006|565284983|FG001|Long-Term Follow-up Period|Death|18|||
156601838|NCT00877006|565284982|FG000|Long-Term Follow-up Period|Other|7|||
156601839|NCT00877006|565284983|FG001|Long-Term Follow-up Period|Other|9|||
156601840|NCT04671342|565284984|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
156601841|NCT04671342|565284984|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
156601842|NCT04671342|565284984|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
156601843|NCT04671342|565284984|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
156601844|NCT04671342|565284984|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
156601845|NCT04671342|565284984|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
156601846|NCT03583606|565284985|FG000|Overall Study|Lost to Follow-up|0|||
156601847|NCT03583606|565284986|FG001|Overall Study|Lost to Follow-up|1|||
156601848|NCT03583606|565284987|FG002|Overall Study|Lost to Follow-up|0|||
156601849|NCT03583606|565284985|FG000|Overall Study|Ineligible at baseline|1|||
156601850|NCT03583606|565284986|FG001|Overall Study|Ineligible at baseline|0|||
156601851|NCT03583606|565284987|FG002|Overall Study|Ineligible at baseline|0|||
156601852|NCT00817206|565284988|FG000|Overall Study|Adverse Event|10|||
156601853|NCT00817206|565284989|FG001|Overall Study|Adverse Event|3|||
156601854|NCT00817206|565284988|FG000|Overall Study|Protocol Violation|0|||
156601855|NCT00817206|565284989|FG001|Overall Study|Protocol Violation|2|||
156601856|NCT00817206|565284988|FG000|Overall Study|Lost to Follow-up|0|||
156601857|NCT00817206|565284989|FG001|Overall Study|Lost to Follow-up|1|||
156601858|NCT00817206|565284988|FG000|Overall Study|Death|2|||
156601859|NCT00817206|565284989|FG001|Overall Study|Death|0|||
156601860|NCT00817206|565284988|FG000|Overall Study|Withdrawal by Subject|7|||
156601861|NCT00817206|565284989|FG001|Overall Study|Withdrawal by Subject|3|||
156601862|NCT00817206|565284988|FG000|Overall Study|Physician Decision|2|||
156601863|NCT00817206|565284989|FG001|Overall Study|Physician Decision|0|||
156601864|NCT00126581|565284990|FG000|Overall Study|Adverse Event|3|||
156601865|NCT00126581|565284991|FG001|Overall Study|Adverse Event|7|||
156601866|NCT00126581|565284990|FG000|Overall Study|Death|3|||
156601867|NCT00126581|565284991|FG001|Overall Study|Death|2|||
156601868|NCT00126581|565284990|FG000|Overall Study|Withdrawal by Subject|1|||
156601869|NCT00126581|565284991|FG001|Overall Study|Withdrawal by Subject|4|||
156601870|NCT00126581|565284990|FG000|Overall Study|Alternative therapy|3|||
156601871|NCT00126581|565284991|FG001|Overall Study|Alternative therapy|3|||
156601872|NCT00126581|565284990|FG000|Overall Study|Other illness/MD discretion|3|||
156601873|NCT00126581|565284991|FG001|Overall Study|Other illness/MD discretion|4|||
156601874|NCT00793182|565284992|FG000|Overall Study|Adverse Event|0|||
156601875|NCT00793182|565284993|FG001|Overall Study|Adverse Event|1|||
156601876|NCT03728140|565284994|FG000|Overall Study|Abnormal embryo transfer operation|10|||
156601877|NCT03728140|565284995|FG001|Overall Study|Abnormal embryo transfer operation|7|||
156601878|NCT00851253|565284996|FG000|Overall Study|Disease Progression|1|||
156601879|NCT00851253|565284997|FG001|Overall Study|Disease Progression|0|||
156601880|NCT03892707|565285007|FG000|Overall Study|Screen failure|6|||
156601881|NCT03892707|565285008|FG001|Overall Study|Screen failure|0|||
156601882|NCT03892707|565285007|FG000|Overall Study|Pain resolution|0|||
156601883|NCT03892707|565285008|FG001|Overall Study|Pain resolution|4|||
156601884|NCT03892707|565285007|FG000|Overall Study|Withdrawal by Subject|0|||
156601885|NCT03892707|565285008|FG001|Overall Study|Withdrawal by Subject|1|||
156601886|NCT03892707|565285007|FG000|Overall Study|Other (long business trip)|0|||
156601887|NCT03892707|565285008|FG001|Overall Study|Other (long business trip)|1|||
156601888|NCT04190186|565285010|FG000|Overall Study|ILR is no longer functioning|0|||
156601889|NCT04190186|565285011|FG001|Overall Study|ILR is no longer functioning|1|||
156601890|NCT04190186|565285010|FG000|Overall Study|Lost to Follow-up|0|||
156601891|NCT04190186|565285011|FG001|Overall Study|Lost to Follow-up|1|||
156601892|NCT04190186|565285010|FG000|Overall Study|Withdrawal by Subject|2|||
156601893|NCT04190186|565285011|FG001|Overall Study|Withdrawal by Subject|0|||
156601894|NCT04190186|565285010|FG000|Overall Study|Subject choice to explant|1|||
156601895|NCT04190186|565285011|FG001|Overall Study|Subject choice to explant|0|||
156601896|NCT04190186|565285010|FG000|Overall Study|Physician Decision|0|||
156601897|NCT04190186|565285011|FG001|Overall Study|Physician Decision|1|||
156601898|NCT04190186|565285010|FG000|Overall Study|Study was stopped|4|||
156601899|NCT04190186|565285011|FG001|Overall Study|Study was stopped|5|||
156601900|NCT01457924|565285012|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
156601901|NCT01457924|565285013|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
156601902|NCT01457924|565285014|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
156601903|NCT01457924|565285015|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
156601904|NCT01457924|565285016|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
156601905|NCT01457924|565285012|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
156601906|NCT01457924|565285013|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
156601907|NCT01457924|565285014|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
156601908|NCT01457924|565285015|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
156601909|NCT01457924|565285016|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
156601910|NCT01457924|565285012|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
156601911|NCT01457924|565285013|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
156601912|NCT01457924|565285014|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
156601913|NCT01457924|565285015|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
156601914|NCT01457924|565285016|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
156601915|NCT01457924|565285012|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
156601916|NCT01457924|565285013|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
156601917|NCT01457924|565285014|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
156601918|NCT01457924|565285015|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
156601919|NCT01457924|565285016|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
156601920|NCT01457924|565285012|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
156601921|NCT01457924|565285013|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
156601922|NCT01457924|565285014|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
156601923|NCT01457924|565285015|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
156601924|NCT01457924|565285016|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
156601925|NCT01457924|565285012|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
156601926|NCT01457924|565285013|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
156601927|NCT01457924|565285014|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
156601928|NCT01457924|565285015|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
156601929|NCT01457924|565285016|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
156601930|NCT01457924|565285012|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
156601931|NCT01457924|565285013|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
156601932|NCT01457924|565285014|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
156601933|NCT01457924|565285015|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
156601934|NCT01457924|565285016|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
156601935|NCT01457924|565285012|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
156601936|NCT01457924|565285013|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
156601937|NCT01457924|565285014|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
156601938|NCT01457924|565285015|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
156601939|NCT01457924|565285016|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
156601940|NCT01457924|565285012|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
156601941|NCT01457924|565285013|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
156601942|NCT01457924|565285014|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
156601943|NCT01457924|565285015|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
156601944|NCT01457924|565285016|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
156601945|NCT01457924|565285012|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
156601946|NCT01457924|565285013|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
156601947|NCT01457924|565285014|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
156601948|NCT01457924|565285015|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
156601949|NCT01457924|565285016|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
156601950|NCT01457924|565285012|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
156601951|NCT01457924|565285013|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
156601952|NCT01457924|565285014|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
156601953|NCT01457924|565285015|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
156601954|NCT01457924|565285016|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
156601955|NCT01457924|565285012|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
156601956|NCT01457924|565285013|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
156601957|NCT01457924|565285014|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
156601958|NCT01457924|565285015|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
156601959|NCT01457924|565285016|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
156601960|NCT01457924|565285012|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
156601961|NCT01457924|565285013|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
156601962|NCT01457924|565285014|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
156601963|NCT01457924|565285015|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
156601964|NCT01457924|565285016|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
156601965|NCT03017846|565285017|FG000|Overall Study|Lost to Follow-up|3|||
156601966|NCT03017846|565285017|FG000|Overall Study|Adverse Event|2|||
156601967|NCT02505542|565285018|FG000|Part A: Open-Label Period|Adverse Event|31|||
156601968|NCT02505542|565285019|FG001|Part A: Open-Label Period|Adverse Event|0|||
156601969|NCT02505542|565285020|FG002|Part A: Open-Label Period|Adverse Event|0|||
156601970|NCT02505542|565285021|FG003|Part A: Open-Label Period|Adverse Event|0|||
156601971|NCT02505542|565285018|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
156601972|NCT02505542|565285019|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
156601973|NCT02505542|565285020|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
156601974|NCT02505542|565285021|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
156601975|NCT02505542|565285018|FG000|Part A: Open-Label Period|Protocol Violation|1|||
156601976|NCT02505542|565285019|FG001|Part A: Open-Label Period|Protocol Violation|0|||
156601977|NCT02505542|565285020|FG002|Part A: Open-Label Period|Protocol Violation|0|||
156601978|NCT02505542|565285021|FG003|Part A: Open-Label Period|Protocol Violation|0|||
156601979|NCT02505542|565285018|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
156601980|NCT02505542|565285019|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
156601981|NCT02505542|565285020|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
156601982|NCT02505542|565285021|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
156601983|NCT02505542|565285018|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
156601984|NCT02505542|565285019|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
156601985|NCT02505542|565285020|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
156601986|NCT02505542|565285021|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
156601987|NCT02505542|565285018|FG000|Part A: Open-Label Period|New medical history available|1|||
156601988|NCT02505542|565285019|FG001|Part A: Open-Label Period|New medical history available|0|||
156601989|NCT02505542|565285020|FG002|Part A: Open-Label Period|New medical history available|0|||
156601990|NCT02505542|565285021|FG003|Part A: Open-Label Period|New medical history available|0|||
156601991|NCT02505542|565285018|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
156601992|NCT02505542|565285019|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
156601993|NCT02505542|565285020|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
156601994|NCT02505542|565285021|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
156601995|NCT02505542|565285018|FG000|Part A: Open-Label Period|Pregnancy|2|||
156601996|NCT02505542|565285019|FG001|Part A: Open-Label Period|Pregnancy|0|||
156601997|NCT02505542|565285020|FG002|Part A: Open-Label Period|Pregnancy|0|||
156601998|NCT02505542|565285021|FG003|Part A: Open-Label Period|Pregnancy|0|||
156601999|NCT02505542|565285018|FG000|Part A: Open-Label Period|Sponsor directive|1|||
156602000|NCT02505542|565285019|FG001|Part A: Open-Label Period|Sponsor directive|0|||
156602001|NCT02505542|565285020|FG002|Part A: Open-Label Period|Sponsor directive|0|||
156602002|NCT02505542|565285021|FG003|Part A: Open-Label Period|Sponsor directive|0|||
156602003|NCT02505542|565285018|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
156602004|NCT02505542|565285019|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
156602005|NCT02505542|565285020|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
156602006|NCT02505542|565285021|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
156602007|NCT02505542|565285018|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
156602008|NCT02505542|565285019|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
156602009|NCT02505542|565285020|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
156602010|NCT02505542|565285021|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
156602011|NCT02505542|565285018|FG000|Part A: Open-Label Period|Non-compliance|1|||
156602012|NCT02505542|565285019|FG001|Part A: Open-Label Period|Non-compliance|0|||
156602013|NCT02505542|565285020|FG002|Part A: Open-Label Period|Non-compliance|0|||
156602014|NCT02505542|565285021|FG003|Part A: Open-Label Period|Non-compliance|0|||
156602015|NCT02505542|565285018|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
156602016|NCT02505542|565285019|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
156602017|NCT02505542|565285020|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
156602018|NCT02505542|565285021|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
156602019|NCT02505542|565285018|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
156602020|NCT02505542|565285019|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
156602021|NCT02505542|565285020|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
156602022|NCT02505542|565285021|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
156602023|NCT02505542|565285018|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
156602024|NCT02505542|565285019|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
156602025|NCT02505542|565285020|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
156602026|NCT02505542|565285021|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
156602027|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Adverse Event|0|||
156602028|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Adverse Event|0|||
156602029|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Adverse Event|1|||
156602030|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Adverse Event|3|||
156602031|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
156602032|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
156602033|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
156602034|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
156602035|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
156602036|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
156602037|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
156602038|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
156602039|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
156602040|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
156602041|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
156602042|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
156602043|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
156602044|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
156602045|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
156602046|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
156602047|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
156602048|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
156602049|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
156602050|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
156602051|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
156602052|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
156602053|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
156602054|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
156602055|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Miscalculation|0|||
156602056|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Miscalculation|1|||
156602057|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Miscalculation|0|||
156602058|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Miscalculation|0|||
156602059|NCT02505542|565285018|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
156602060|NCT02505542|565285019|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
156602061|NCT02505542|565285020|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
156602062|NCT02505542|565285021|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
156602063|NCT02759861|565285022|FG000|Overall Study|Death|1|||
156602064|NCT02151682|565285023|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
156602065|NCT02151682|565285024|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
156602066|NCT02151682|565285025|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
156602067|NCT02151682|565285026|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
156602068|NCT02151682|565285027|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
156602069|NCT02151682|565285028|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
156602070|NCT02151682|565285023|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
156602071|NCT02151682|565285024|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
156602072|NCT02151682|565285025|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
156602073|NCT02151682|565285026|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
156602074|NCT02151682|565285027|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
156602075|NCT02151682|565285028|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
156602076|NCT02151682|565285023|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
156602077|NCT02151682|565285024|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
156602078|NCT02151682|565285025|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
156602079|NCT02151682|565285026|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
156602080|NCT02151682|565285027|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
156602081|NCT02151682|565285028|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
156602082|NCT02151682|565285023|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
156602083|NCT02151682|565285024|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
156602084|NCT02151682|565285025|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
156602085|NCT02151682|565285026|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
156602086|NCT02151682|565285027|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
156602087|NCT02151682|565285028|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
156602088|NCT02151682|565285023|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
156602089|NCT02151682|565285024|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
156602090|NCT02151682|565285025|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
156602091|NCT02151682|565285026|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
156602092|NCT02151682|565285027|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
156602093|NCT02151682|565285028|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
156602094|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
156602095|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
156602096|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
156602097|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
156602098|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
156602099|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
156602100|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
156602101|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
156602102|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
156602103|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
156602104|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
156602105|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
156602106|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
156602107|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
156602108|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
156602109|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
156602110|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
156602111|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
156602112|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
156602113|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
156602114|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
156602115|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
156602116|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
156602117|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
156602118|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
156602119|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
156602120|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
156602121|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
156602122|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
156602123|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
156602124|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
156602125|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
156602126|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
156602127|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
156602128|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
156602129|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
156602130|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
156602131|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
156863689|NCT05194124|566258763|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156602132|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
156602133|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
156602134|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
156602135|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
156602136|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
156602137|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
156602138|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
156602139|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
156602140|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
156602141|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
156602142|NCT02151682|565285023|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
156602143|NCT02151682|565285024|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
156602144|NCT02151682|565285025|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
156602145|NCT02151682|565285026|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
156602146|NCT02151682|565285027|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
156602147|NCT02151682|565285028|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
156602148|NCT02151682|565285023|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
156602149|NCT02151682|565285024|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
156602150|NCT02151682|565285025|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
156602151|NCT02151682|565285026|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
156602152|NCT02151682|565285027|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
156602153|NCT02151682|565285028|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
156602154|NCT02151682|565285023|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
156602155|NCT02151682|565285024|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
156602156|NCT02151682|565285025|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
156602157|NCT02151682|565285026|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
156602158|NCT02151682|565285027|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
156602159|NCT02151682|565285028|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
156602160|NCT02151682|565285023|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
156602161|NCT02151682|565285024|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
156602162|NCT02151682|565285025|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
156602163|NCT02151682|565285026|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
156602164|NCT02151682|565285027|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
156602165|NCT02151682|565285028|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
156602166|NCT02151682|565285023|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
156602167|NCT02151682|565285024|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
156602168|NCT02151682|565285025|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
156602169|NCT02151682|565285026|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
156602170|NCT02151682|565285027|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
156602171|NCT02151682|565285028|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
156602172|NCT00618995|565285029|FG000|Period 1|Adverse Event|0|||
156602173|NCT00618995|565285030|FG001|Period 1|Adverse Event|0|||
156602174|NCT00618995|565285031|FG002|Period 1|Adverse Event|1|||
156602175|NCT00618995|565285032|FG003|Period 1|Adverse Event|0|||
156602176|NCT00618995|565285029|FG000|Period 1|Protocol Violation|0|||
156602177|NCT00618995|565285030|FG001|Period 1|Protocol Violation|1|||
156602178|NCT00618995|565285031|FG002|Period 1|Protocol Violation|1|||
156602179|NCT00618995|565285032|FG003|Period 1|Protocol Violation|0|||
156602180|NCT00618995|565285029|FG000|Period 2|Protocol Violation|0|||
156602181|NCT00618995|565285030|FG001|Period 2|Protocol Violation|0|||
156602182|NCT00618995|565285031|FG002|Period 2|Protocol Violation|1|||
156602183|NCT00618995|565285032|FG003|Period 2|Protocol Violation|0|||
156602184|NCT00618995|565285029|FG000|Period 4|Adverse Event|1|||
156602185|NCT00618995|565285030|FG001|Period 4|Adverse Event|0|||
156602186|NCT00618995|565285031|FG002|Period 4|Adverse Event|0|||
156602187|NCT00618995|565285032|FG003|Period 4|Adverse Event|0|||
156602188|NCT01213264|565285033|FG000|Overall Study|Adverse Event|1|||
156602189|NCT01213264|565285034|FG001|Overall Study|Adverse Event|0|||
156602190|NCT01213264|565285035|FG002|Overall Study|Adverse Event|0|||
156602191|NCT01213264|565285033|FG000|Overall Study|Lost to Follow-up|1|||
156602192|NCT01213264|565285034|FG001|Overall Study|Lost to Follow-up|2|||
156602193|NCT01213264|565285035|FG002|Overall Study|Lost to Follow-up|6|||
156602194|NCT01438307|565285036|FG000|Overall Study|Death|1|||
156602195|NCT01438307|565285037|FG001|Overall Study|Death|1|||
156602196|NCT06000501|565285038|FG000|Overall Study|Screen failure|3|||
156602197|NCT06000501|565285038|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
156602198|NCT06000501|565285038|FG000|Overall Study|Physician Decision|4|||
156602199|NCT06000501|565285038|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
156602200|NCT06000501|565285038|FG000|Overall Study|Scheduling issues|2|||
156602201|NCT02378883|565285039|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
156602202|NCT02378883|565285039|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
156602203|NCT02378883|565285039|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
156602204|NCT02378883|565285039|FG000|30 Day Follow-Up|Physician Decision|2|||
156602205|NCT02378883|565285039|FG000|30 Day Follow-Up|Missed Visit|2|||
156602206|NCT02378883|565285039|FG000|30 Day Follow-Up|Death|1|||
156602207|NCT02378883|565285039|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
156602208|NCT02378883|565285039|FG000|12 Months Follow-Up|Death|2|||
156602209|NCT00318565|565285040|FG000|Overall Study|Excluded per protocol|24|||
156602210|NCT01504971|565285044|FG000|Overall Study|Physician Decision|13|||
156602211|NCT00050622|565285045|FG000|Overall Study|Adverse Event|1|||
156602212|NCT00936117|565285048|FG000|Overall Study|Adverse Event|7|||
156602213|NCT00936117|565285048|FG000|Overall Study|Unable to continue oral medication|3|||
156602214|NCT04581863|565285049|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
156602215|NCT04581863|565285050|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
156602216|NCT01357889|565285053|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
156602217|NCT01357889|565285054|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
156602218|NCT01357889|565285053|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
156602219|NCT01357889|565285054|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
156602220|NCT01357889|565285053|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
156602221|NCT01357889|565285054|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
156602222|NCT01357889|565285053|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
156602223|NCT01357889|565285054|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
156602224|NCT01357889|565285053|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
156602225|NCT01357889|565285054|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
156602226|NCT01357889|565285053|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
156602227|NCT01357889|565285054|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
156602228|NCT01357889|565285053|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
156602229|NCT01357889|565285054|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
156602230|NCT01357889|565285053|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
156602231|NCT01357889|565285054|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
156602232|NCT01357889|565285053|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
156602233|NCT01357889|565285054|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
156602234|NCT01357889|565285053|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
156602235|NCT01357889|565285054|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
156602236|NCT01357889|565285053|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
156602237|NCT01357889|565285054|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
156602238|NCT01357889|565285053|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
156602239|NCT01357889|565285054|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
156602240|NCT01357889|565285053|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
156602241|NCT01357889|565285054|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
156602242|NCT02693691|565285055|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
156602243|NCT02693691|565285055|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
156602244|NCT02693691|565285055|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
156602245|NCT02693691|565285055|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
156602246|NCT02693691|565285055|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
156602247|NCT02693691|565285055|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
156602248|NCT02693691|565285055|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
156602249|NCT00039741|565285060|FG000|Overall Study|Death|0|||
156602250|NCT00039741|565285061|FG001|Overall Study|Death|1|||
156602251|NCT00039741|565285062|FG002|Overall Study|Death|0|||
156602252|NCT00039741|565285063|FG003|Overall Study|Death|0|||
156602253|NCT00039741|565285060|FG000|Overall Study|Lost to Follow-up|3|||
156602254|NCT00039741|565285061|FG001|Overall Study|Lost to Follow-up|1|||
156602255|NCT00039741|565285062|FG002|Overall Study|Lost to Follow-up|5|||
156602256|NCT00039741|565285063|FG003|Overall Study|Lost to Follow-up|2|||
156602257|NCT00039741|565285060|FG000|Overall Study|Confounding medical condition|1|||
156602258|NCT00039741|565285061|FG001|Overall Study|Confounding medical condition|0|||
156602259|NCT00039741|565285062|FG002|Overall Study|Confounding medical condition|0|||
156602260|NCT00039741|565285063|FG003|Overall Study|Confounding medical condition|0|||
156602261|NCT00039741|565285060|FG000|Overall Study|Not able to get to clinic|5|||
156602262|NCT00039741|565285061|FG001|Overall Study|Not able to get to clinic|2|||
156602263|NCT00039741|565285062|FG002|Overall Study|Not able to get to clinic|0|||
156602264|NCT00039741|565285063|FG003|Overall Study|Not able to get to clinic|3|||
156602265|NCT00039741|565285060|FG000|Overall Study|Moved|3|||
156602266|NCT00039741|565285061|FG001|Overall Study|Moved|2|||
156602267|NCT00039741|565285062|FG002|Overall Study|Moved|3|||
156602268|NCT00039741|565285063|FG003|Overall Study|Moved|6|||
156602269|NCT00039741|565285060|FG000|Overall Study|Non-compliance with protocol|1|||
156602270|NCT00039741|565285061|FG001|Overall Study|Non-compliance with protocol|0|||
156602271|NCT00039741|565285062|FG002|Overall Study|Non-compliance with protocol|1|||
156602272|NCT00039741|565285063|FG003|Overall Study|Non-compliance with protocol|0|||
156602273|NCT00039741|565285060|FG000|Overall Study|Withdrew consent|0|||
156602274|NCT00039741|565285061|FG001|Overall Study|Withdrew consent|5|||
156602275|NCT00039741|565285062|FG002|Overall Study|Withdrew consent|0|||
156602276|NCT00039741|565285063|FG003|Overall Study|Withdrew consent|1|||
156602277|NCT00039741|565285060|FG000|Overall Study|Missed final visit|2|||
156602278|NCT00039741|565285061|FG001|Overall Study|Missed final visit|1|||
156602279|NCT00039741|565285062|FG002|Overall Study|Missed final visit|2|||
156602280|NCT00039741|565285063|FG003|Overall Study|Missed final visit|2|||
156602281|NCT00946881|565285064|FG000|First Treatment|Withdrawal by Subject|1|||
156602282|NCT00946881|565285064|FG000|First Treatment|Patient relocated to another state|1|||
156602283|NCT00946881|565285064|FG000|Retreatment|Withdrawal by Subject|1|||
156602284|NCT00293423|565285065|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
156602285|NCT00293423|565285066|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
156602286|NCT00293423|565285065|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
156602287|NCT00293423|565285066|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
156602288|NCT00293423|565285065|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
156602289|NCT00293423|565285066|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
156602290|NCT00293423|565285065|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
156602291|NCT00293423|565285066|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
156602292|NCT00293423|565285065|FG000|Surgical Resection|processing error during surgical resection|1|||
156602293|NCT00293423|565285066|FG001|Surgical Resection|processing error during surgical resection|0|||
156602294|NCT00293423|565285065|FG000|Surgical Resection|Withdrawal by Subject|4|||
156602295|NCT00293423|565285066|FG001|Surgical Resection|Withdrawal by Subject|0|||
156602296|NCT00293423|565285065|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
156602297|NCT00293423|565285066|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
156602298|NCT01182337|565285069|FG000|Overall Study|Withdrawal by Subject|3|||
156602299|NCT01182337|565285070|FG001|Overall Study|Withdrawal by Subject|1|||
156602300|NCT01182337|565285069|FG000|Overall Study|Lost to Follow-up|0|||
156602301|NCT01182337|565285070|FG001|Overall Study|Lost to Follow-up|1|||
156602302|NCT01578785|565285076|FG000|Overall Study|Withdrawal by Subject|0|||
156602303|NCT01578785|565285077|FG001|Overall Study|Withdrawal by Subject|1|||
156602304|NCT01578785|565285076|FG000|Overall Study|Study terminated by sponsor|59|||
156602305|NCT01578785|565285077|FG001|Overall Study|Study terminated by sponsor|118|||
156602306|NCT00966693|565285078|FG000|Overall Study|Adverse Event|0|||
156602307|NCT00966693|565285079|FG001|Overall Study|Adverse Event|0|||
156602308|NCT00966693|565285080|FG002|Overall Study|Adverse Event|1|||
156602309|NCT00966693|565285081|FG003|Overall Study|Adverse Event|2|||
156602310|NCT00966693|565285078|FG000|Overall Study|Death|0|||
156602311|NCT00966693|565285079|FG001|Overall Study|Death|0|||
156602312|NCT00966693|565285080|FG002|Overall Study|Death|1|||
156602313|NCT00966693|565285081|FG003|Overall Study|Death|0|||
156602314|NCT00966693|565285078|FG000|Overall Study|Withdrawal by Subject|1|||
156602315|NCT00966693|565285079|FG001|Overall Study|Withdrawal by Subject|0|||
156602316|NCT00966693|565285080|FG002|Overall Study|Withdrawal by Subject|0|||
156602317|NCT00966693|565285081|FG003|Overall Study|Withdrawal by Subject|5|||
156602318|NCT00966693|565285078|FG000|Overall Study|Disease Progression|0|||
156602319|NCT00966693|565285079|FG001|Overall Study|Disease Progression|0|||
156602320|NCT00966693|565285080|FG002|Overall Study|Disease Progression|1|||
156602321|NCT00966693|565285081|FG003|Overall Study|Disease Progression|16|||
156602322|NCT00599027|565285082|FG000|Overall Study|Withdrawal by Subject|1|||
156602323|NCT00599027|565285083|FG001|Overall Study|Withdrawal by Subject|1|||
156602324|NCT00599027|565285082|FG000|Overall Study|Adverse Event|0|||
156602325|NCT00599027|565285083|FG001|Overall Study|Adverse Event|1|||
156602326|NCT00599027|565285082|FG000|Overall Study|Treatment Failure|0|||
156602327|NCT00599027|565285083|FG001|Overall Study|Treatment Failure|1|||
156602328|NCT02581982|565285084|FG000|Overall Study|Lack of Efficacy|12|||
156602329|NCT02581982|565285084|FG000|Overall Study|Adverse Event|3|||
156602330|NCT02581982|565285084|FG000|Overall Study|Physician Decision|1|||
156602331|NCT00405821|565285085|FG000|Overall Study|Death|5|||
156602332|NCT00405821|565285086|FG001|Overall Study|Death|7|||
156602333|NCT00405821|565285085|FG000|Overall Study|Lost to Follow-up|7|||
156602334|NCT00405821|565285086|FG001|Overall Study|Lost to Follow-up|7|||
156602335|NCT00405821|565285085|FG000|Overall Study|Protocol Violation|1|||
156602336|NCT00405821|565285086|FG001|Overall Study|Protocol Violation|0|||
156602337|NCT00405821|565285085|FG000|Overall Study|initiated ART|9|||
156602338|NCT00405821|565285086|FG001|Overall Study|initiated ART|8|||
156602339|NCT00476996|565285094|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
156602340|NCT00476996|565285095|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
156602341|NCT00476996|565285096|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
156602342|NCT00476996|565285097|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
156602343|NCT00476996|565285094|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
156602344|NCT00476996|565285095|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
156602345|NCT00476996|565285096|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
156602346|NCT00476996|565285097|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
156634908|NCT03917654|565407820|FG005|Year 1|Travel|4|||
156602347|NCT00476996|565285094|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
156602348|NCT00476996|565285095|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
156602349|NCT00476996|565285096|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
156602350|NCT00476996|565285097|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
156602351|NCT00476996|565285094|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
156602352|NCT00476996|565285095|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
156602353|NCT00476996|565285096|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
156602354|NCT00476996|565285097|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
156602355|NCT00476996|565285094|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
156602356|NCT00476996|565285095|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
156602357|NCT00476996|565285096|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
156602358|NCT00476996|565285097|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
156602359|NCT00476996|565285094|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
156602360|NCT00476996|565285095|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
156602361|NCT00476996|565285096|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
156602362|NCT00476996|565285097|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
156602363|NCT00476996|565285094|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
156602364|NCT00476996|565285095|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
156602365|NCT00476996|565285096|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
156602366|NCT00476996|565285097|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
156602367|NCT00476996|565285094|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
156602368|NCT00476996|565285095|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
156602369|NCT00476996|565285096|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
156602370|NCT00476996|565285097|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
156602371|NCT00476996|565285094|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
156602372|NCT00476996|565285095|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
156602373|NCT00476996|565285096|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
156602374|NCT00476996|565285097|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
156602375|NCT00476996|565285094|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
156602376|NCT00476996|565285095|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
156602377|NCT00476996|565285096|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
156602378|NCT00476996|565285097|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
156602379|NCT00476996|565285094|FG000|OLE Phase (From Week 48)|Death|0|||
156602380|NCT00476996|565285095|FG001|OLE Phase (From Week 48)|Death|0|||
156602381|NCT00476996|565285096|FG002|OLE Phase (From Week 48)|Death|0|||
156602382|NCT00476996|565285097|FG003|OLE Phase (From Week 48)|Death|7|||
156602383|NCT00476996|565285094|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
156602384|NCT00476996|565285095|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
156602385|NCT00476996|565285096|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
156602386|NCT00476996|565285097|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
156602387|NCT00476996|565285094|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
156602388|NCT00476996|565285095|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
156602389|NCT00476996|565285096|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
156602390|NCT00476996|565285097|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
156602391|NCT00476996|565285094|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
156602392|NCT00476996|565285095|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
156602393|NCT00476996|565285096|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
156602394|NCT00476996|565285097|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
156602395|NCT00476996|565285094|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
156602396|NCT00476996|565285095|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
156602397|NCT00476996|565285096|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
156602398|NCT00476996|565285097|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
156602399|NCT02031432|565285126|FG000|Overall Study|Protocol Violation|1|||
156602400|NCT02031432|565285126|FG000|Overall Study|Lack of Efficacy|5|||
156602401|NCT02031432|565285126|FG000|Overall Study|Cancer Progression|2|||
156602402|NCT02031432|565285126|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
156602403|NCT02031432|565285126|FG000|Overall Study|Adverse Event|8|||
156602404|NCT02031432|565285126|FG000|Overall Study|Withdrawal by Subject|5|||
156602405|NCT02031432|565285126|FG000|Overall Study|Lost to Follow-up|1|||
156602406|NCT02031432|565285126|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
156602407|NCT02031432|565285126|FG000|Overall Study|Death|10|||
156602408|NCT02148211|565285127|FG000|Overall Study|Lost to Follow-up|352|||
156602409|NCT01617187|565285128|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
156602410|NCT01617187|565285129|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
156602411|NCT01617187|565285130|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
156602412|NCT01617187|565285131|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
156602413|NCT01617187|565285128|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
156602414|NCT01617187|565285129|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
156602415|NCT01617187|565285130|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
156602416|NCT01617187|565285131|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
156602417|NCT01617187|565285128|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
156602418|NCT01617187|565285129|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
156602419|NCT01617187|565285130|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
156602420|NCT01617187|565285131|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
156602421|NCT01617187|565285128|FG000|Treatment Through Study Completion|Adverse Event|1|||
156602422|NCT01617187|565285129|FG001|Treatment Through Study Completion|Adverse Event|1|||
156602423|NCT01617187|565285130|FG002|Treatment Through Study Completion|Adverse Event|0|||
156602424|NCT01617187|565285131|FG003|Treatment Through Study Completion|Adverse Event|1|||
156602425|NCT01617187|565285128|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
156602426|NCT01617187|565285129|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
156602427|NCT01617187|565285130|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
156602428|NCT01617187|565285131|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
156602429|NCT01617187|565285128|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
156602430|NCT01617187|565285129|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
156602431|NCT01617187|565285130|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
156602432|NCT01617187|565285131|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
156602433|NCT01617187|565285128|FG000|Treatment Through Study Completion|Protocol Violation|1|||
156602434|NCT01617187|565285129|FG001|Treatment Through Study Completion|Protocol Violation|0|||
156602435|NCT01617187|565285130|FG002|Treatment Through Study Completion|Protocol Violation|0|||
156602436|NCT01617187|565285131|FG003|Treatment Through Study Completion|Protocol Violation|1|||
156602437|NCT05406440|565287173|FG000|Overall Study|Lost to Follow-up|0|||
156602438|NCT05406440|565287174|FG001|Overall Study|Lost to Follow-up|0|||
156602439|NCT05406440|565287175|FG002|Overall Study|Lost to Follow-up|0|||
156602440|NCT05406440|565287176|FG003|Overall Study|Lost to Follow-up|0|||
156602441|NCT05406440|565287177|FG004|Overall Study|Lost to Follow-up|2|||
156602442|NCT05406440|565287178|FG005|Overall Study|Lost to Follow-up|0|||
156602443|NCT05406440|565287179|FG006|Overall Study|Lost to Follow-up|0|||
156602444|NCT05406440|565287173|FG000|Overall Study|Physician Decision|0|||
156602445|NCT05406440|565287174|FG001|Overall Study|Physician Decision|0|||
156602446|NCT05406440|565287175|FG002|Overall Study|Physician Decision|0|||
156602447|NCT05406440|565287176|FG003|Overall Study|Physician Decision|0|||
156602448|NCT05406440|565287177|FG004|Overall Study|Physician Decision|1|||
156602449|NCT05406440|565287178|FG005|Overall Study|Physician Decision|0|||
156602450|NCT05406440|565287179|FG006|Overall Study|Physician Decision|0|||
156602451|NCT05406440|565287173|FG000|Overall Study|Withdrawal by Subject|0|||
156602452|NCT05406440|565287174|FG001|Overall Study|Withdrawal by Subject|0|||
156602453|NCT05406440|565287175|FG002|Overall Study|Withdrawal by Subject|0|||
156602454|NCT05406440|565287176|FG003|Overall Study|Withdrawal by Subject|0|||
156602455|NCT05406440|565287177|FG004|Overall Study|Withdrawal by Subject|0|||
156602456|NCT05406440|565287178|FG005|Overall Study|Withdrawal by Subject|2|||
156602457|NCT05406440|565287179|FG006|Overall Study|Withdrawal by Subject|0|||
156602458|NCT01412151|565287180|FG000|Week 0 - 306 - Treatment Period|Death|1|||
156602459|NCT01412151|565287180|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
156602460|NCT01412151|565287180|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
156602461|NCT01412151|565287180|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
156602462|NCT03127852|565287181|FG000|Overall Study|Withdrawal by Subject|4|||
156602463|NCT03127852|565287182|FG001|Overall Study|Withdrawal by Subject|1|||
156602464|NCT03127852|565287181|FG000|Overall Study|Death|1|||
156602465|NCT03127852|565287182|FG001|Overall Study|Death|1|||
156602466|NCT01824693|565287183|FG000|Overall Study|Death|0|||
156602467|NCT01824693|565287184|FG001|Overall Study|Death|1|||
156602468|NCT01824693|565287185|FG002|Overall Study|Death|0|||
156602469|NCT01824693|565287183|FG000|Overall Study|Physician Decision|1|||
156602470|NCT01824693|565287184|FG001|Overall Study|Physician Decision|1|||
156602471|NCT01824693|565287185|FG002|Overall Study|Physician Decision|1|||
156602472|NCT01824693|565287183|FG000|Overall Study|Withdrawal by Subject|0|||
156602473|NCT01824693|565287184|FG001|Overall Study|Withdrawal by Subject|0|||
156602474|NCT01824693|565287185|FG002|Overall Study|Withdrawal by Subject|1|||
156602475|NCT01824693|565287183|FG000|Overall Study|Progressive Disease|0|||
156602476|NCT01824693|565287184|FG001|Overall Study|Progressive Disease|5|||
156602477|NCT01824693|565287185|FG002|Overall Study|Progressive Disease|0|||
156602478|NCT01824693|565287183|FG000|Overall Study|Ineligible|0|||
156602479|NCT01824693|565287184|FG001|Overall Study|Ineligible|0|||
156602480|NCT01824693|565287185|FG002|Overall Study|Ineligible|3|||
156602481|NCT01824693|565287183|FG000|Overall Study|No Transplant Planned|0|||
156602482|NCT01824693|565287184|FG001|Overall Study|No Transplant Planned|0|||
156602483|NCT01824693|565287185|FG002|Overall Study|No Transplant Planned|10|||
156602484|NCT02150213|565287186|FG000|Overall Study|Lost to Follow-up|1|||
156602485|NCT02150213|565287186|FG000|Overall Study|Withdrawal by Subject|1|||
156602486|NCT01175590|565287187|FG000|Overall Study|Lost to Follow-up|1|||
156602487|NCT01175590|565287188|FG001|Overall Study|Lost to Follow-up|0|||
156602488|NCT01175590|565287187|FG000|Overall Study|Withdrawal by Subject|0|||
156602489|NCT01175590|565287188|FG001|Overall Study|Withdrawal by Subject|2|||
156602490|NCT01175590|565287187|FG000|Overall Study|Adverse Event|4|||
156602491|NCT01175590|565287188|FG001|Overall Study|Adverse Event|0|||
156602492|NCT01175590|565287187|FG000|Overall Study|Physician Decision|1|||
156602493|NCT01175590|565287188|FG001|Overall Study|Physician Decision|4|||
156602494|NCT01175590|565287187|FG000|Overall Study|Lack of Efficacy|1|||
156602495|NCT01175590|565287188|FG001|Overall Study|Lack of Efficacy|1|||
156602496|NCT01175590|565287187|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
156602497|NCT01175590|565287188|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
156602498|NCT01175590|565287187|FG000|Overall Study|Treated not as randomized|3|||
156602499|NCT01175590|565287188|FG001|Overall Study|Treated not as randomized|2|||
156602500|NCT01175590|565287187|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
156602501|NCT01175590|565287188|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
156602502|NCT01175590|565287187|FG000|Overall Study|Protocol Violation|0|||
156602503|NCT01175590|565287188|FG001|Overall Study|Protocol Violation|1|||
156602504|NCT02966353|565287189|FG000|Overall Study|Withdrawal by Subject|7|||
156602505|NCT02966353|565287189|FG000|Overall Study|Adverse Event|4|||
156602506|NCT02966353|565287189|FG000|Overall Study|Death|4|||
156602507|NCT02966353|565287189|FG000|Overall Study|Physician Decision|3|||
156602508|NCT02966353|565287189|FG000|Overall Study|Progressive disease|2|||
156602509|NCT02966353|565287189|FG000|Overall Study|Protocol deviation|2|||
156602510|NCT01090102|565287190|FG000|First 12 Weeks|Withdrawal by Subject|1|||
156602511|NCT01090102|565287191|FG001|First 12 Weeks|Withdrawal by Subject|1|||
156602512|NCT01090102|565287190|FG000|First 12 Weeks|Adverse Event|2|||
156602513|NCT01090102|565287191|FG001|First 12 Weeks|Adverse Event|0|||
156602514|NCT01090102|565287190|FG000|First 12 Weeks|Death|1|||
156602515|NCT01090102|565287191|FG001|First 12 Weeks|Death|1|||
156602516|NCT01090102|565287190|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
156602517|NCT01090102|565287191|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
156602518|NCT03518034|565287192|FG000|Overall Study|Not Treated|5|||
156602519|NCT03518034|565287193|FG001|Overall Study|Not Treated|1|||
156602520|NCT03518034|565287192|FG000|Overall Study|Withdrawal by Subject|309|||
156602521|NCT03518034|565287193|FG001|Overall Study|Withdrawal by Subject|351|||
156602522|NCT03518034|565287192|FG000|Overall Study|Lost to Follow-up|446|||
156602523|NCT03518034|565287193|FG001|Overall Study|Lost to Follow-up|458|||
156602524|NCT03518034|565287192|FG000|Overall Study|Adverse Event|138|||
156602525|NCT03518034|565287193|FG001|Overall Study|Adverse Event|130|||
156602526|NCT03518034|565287192|FG000|Overall Study|Lack of Efficacy|11|||
156602527|NCT03518034|565287193|FG001|Overall Study|Lack of Efficacy|23|||
156602528|NCT03518034|565287192|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
156602529|NCT03518034|565287193|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
156602530|NCT03518034|565287192|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
156602531|NCT03518034|565287193|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
156602532|NCT03518034|565287192|FG000|Overall Study|Other, Not Specified|84|||
156602533|NCT03518034|565287193|FG001|Overall Study|Other, Not Specified|53|||
156602534|NCT03518034|565287192|FG000|Overall Study|Reason Missing|2|||
156602535|NCT03518034|565287193|FG001|Overall Study|Reason Missing|3|||
156602536|NCT01019252|565287194|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
156602537|NCT01019252|565287195|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
156602538|NCT01019252|565287194|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
156602539|NCT01019252|565287195|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
156602540|NCT01019252|565287194|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
156602541|NCT01019252|565287195|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
156602542|NCT01019252|565287194|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
156602543|NCT01019252|565287195|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
156602544|NCT02273037|565287197|FG000|Overall Study|Lost to Follow-up|1|||
156602545|NCT02273037|565287198|FG001|Overall Study|Lost to Follow-up|0|||
156602546|NCT02273037|565287197|FG000|Overall Study|Delivered before monitoring initiated|1|||
156602547|NCT02273037|565287198|FG001|Overall Study|Delivered before monitoring initiated|3|||
156602548|NCT02273037|565287197|FG000|Overall Study|Breech delivery|2|||
156602549|NCT02273037|565287198|FG001|Overall Study|Breech delivery|3|||
156602550|NCT02273037|565287197|FG000|Overall Study|Multiple delivery|2|||
156602551|NCT02273037|565287198|FG001|Overall Study|Multiple delivery|2|||
156602552|NCT02273037|565287197|FG000|Overall Study|Other complication|2|||
156602553|NCT02273037|565287198|FG001|Overall Study|Other complication|0|||
156602554|NCT02062398|565287199|FG000|Overall Study|Implant removal|1|||
156602555|NCT00415519|565287200|FG000|Overall Study|Adverse Event|1|||
156602556|NCT00415519|565287201|FG001|Overall Study|Adverse Event|0|||
156602557|NCT00415519|565287200|FG000|Overall Study|Withdrawal by Subject|2|||
156602558|NCT00415519|565287201|FG001|Overall Study|Withdrawal by Subject|0|||
156602559|NCT00415519|565287200|FG000|Overall Study|Patient's convenience|1|||
156602560|NCT00415519|565287201|FG001|Overall Study|Patient's convenience|0|||
156602561|NCT03351478|565287202|FG000|Overall Study|At the subject's own request|11|||
156602562|NCT03351478|565287203|FG001|Overall Study|At the subject's own request|12|||
156602563|NCT03351478|565287204|FG002|Overall Study|At the subject's own request|5|||
156602564|NCT03351478|565287202|FG000|Overall Study|Adverse Event|1|||
156602565|NCT03351478|565287203|FG001|Overall Study|Adverse Event|2|||
156602566|NCT03351478|565287204|FG002|Overall Study|Adverse Event|1|||
156602567|NCT03351478|565287202|FG000|Overall Study|Poor compliance to protocol|1|||
156602568|NCT03351478|565287203|FG001|Overall Study|Poor compliance to protocol|0|||
156602569|NCT03351478|565287204|FG002|Overall Study|Poor compliance to protocol|0|||
156602570|NCT03351478|565287202|FG000|Overall Study|Reason not Specified|1|||
156602571|NCT03351478|565287203|FG001|Overall Study|Reason not Specified|3|||
156602572|NCT03351478|565287204|FG002|Overall Study|Reason not Specified|0|||
156602573|NCT03351478|565287202|FG000|Overall Study|Lost to Follow-up|0|||
156602574|NCT03351478|565287203|FG001|Overall Study|Lost to Follow-up|0|||
156602575|NCT03351478|565287204|FG002|Overall Study|Lost to Follow-up|1|||
156602576|NCT03485222|565287205|FG000|Overall Study|Death|0|||
156602577|NCT03485222|565287206|FG001|Overall Study|Death|1|||
156602578|NCT03485222|565287205|FG000|Overall Study|Lost to Follow-up|2|||
156602579|NCT03485222|565287206|FG001|Overall Study|Lost to Follow-up|1|||
156602580|NCT03657810|565287209|FG000|Overall Study|Adverse Event|0|||
156602581|NCT03657810|565287210|FG001|Overall Study|Adverse Event|1|||
156602582|NCT03657810|565287211|FG002|Overall Study|Adverse Event|0|||
156602583|NCT03657810|565287209|FG000|Overall Study|Lack of Efficacy|4|||
156602584|NCT03657810|565287210|FG001|Overall Study|Lack of Efficacy|1|||
156602585|NCT03657810|565287211|FG002|Overall Study|Lack of Efficacy|3|||
156602586|NCT03657810|565287209|FG000|Overall Study|Protocol Violation|1|||
156602587|NCT03657810|565287210|FG001|Overall Study|Protocol Violation|0|||
156602588|NCT03657810|565287211|FG002|Overall Study|Protocol Violation|0|||
156602589|NCT03657810|565287209|FG000|Overall Study|Lost to Follow-up|0|||
156602590|NCT03657810|565287210|FG001|Overall Study|Lost to Follow-up|1|||
156602591|NCT03657810|565287211|FG002|Overall Study|Lost to Follow-up|0|||
156602592|NCT03657810|565287209|FG000|Overall Study|Not provided|0|||
156602593|NCT03657810|565287210|FG001|Overall Study|Not provided|1|||
156602594|NCT03657810|565287211|FG002|Overall Study|Not provided|0|||
156602595|NCT03911869|565287212|FG000|Safety Lead-in Phase|Death|7|||
156602596|NCT03911869|565287213|FG001|Safety Lead-in Phase|Death|0|||
156602597|NCT03911869|565287214|FG002|Safety Lead-in Phase|Death|0|||
156602598|NCT03911869|565287212|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
156602599|NCT03911869|565287213|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
156602600|NCT03911869|565287214|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
156602601|NCT03911869|565287212|FG000|Safety Lead-in Phase|Other|1|||
156602602|NCT03911869|565287213|FG001|Safety Lead-in Phase|Other|0|||
156602603|NCT03911869|565287214|FG002|Safety Lead-in Phase|Other|0|||
156602604|NCT03911869|565287212|FG000|Phase 2|Death|0|||
156602605|NCT03911869|565287213|FG001|Phase 2|Death|3|||
156602606|NCT03911869|565287214|FG002|Phase 2|Death|0|||
156602607|NCT01527110|565287216|FG000|Overall Study|Adverse Event|1|||
156602608|NCT02007252|565287217|FG000|Overall Study|Administrative problems|3|||
156602609|NCT02007252|565287218|FG001|Overall Study|Administrative problems|7|||
156602610|NCT02007252|565287217|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156602611|NCT02007252|565287218|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156602612|NCT02007252|565287217|FG000|Overall Study|Adverse Event|7|||
156602613|NCT02007252|565287218|FG001|Overall Study|Adverse Event|4|||
156602614|NCT00608881|565287219|FG000|Overall Study|Death|22|||
156602615|NCT00608881|565287220|FG001|Overall Study|Death|13|||
156602616|NCT00608881|565287219|FG000|Overall Study|Adverse Event|5|||
156602617|NCT00608881|565287220|FG001|Overall Study|Adverse Event|3|||
156602618|NCT00608881|565287219|FG000|Overall Study|Lost to Follow-up|28|||
156602619|NCT00608881|565287220|FG001|Overall Study|Lost to Follow-up|14|||
156602620|NCT00608881|565287219|FG000|Overall Study|Withdrawal by Subject|18|||
156602621|NCT00608881|565287220|FG001|Overall Study|Withdrawal by Subject|29|||
156602622|NCT00608881|565287219|FG000|Overall Study|Physician Decision|5|||
156602623|NCT00608881|565287220|FG001|Overall Study|Physician Decision|5|||
156602624|NCT00608881|565287219|FG000|Overall Study|Institutionalized|1|||
156602625|NCT00608881|565287220|FG001|Overall Study|Institutionalized|2|||
156602626|NCT00367341|565287222|FG000|Overall Study|Physician Decision|1|||
156602627|NCT00367341|565287223|FG001|Overall Study|Physician Decision|0|||
156602628|NCT00367341|565287222|FG000|Overall Study|Protocol Violation|1|||
156602629|NCT00367341|565287223|FG001|Overall Study|Protocol Violation|0|||
156602630|NCT03325556|565287224|FG000|Open-label Period|Lack of Response in OL period|70|||
156602631|NCT03325556|565287225|FG001|Open-label Period|Lack of Response in OL period|0|||
156602632|NCT03325556|565287226|FG002|Open-label Period|Lack of Response in OL period|0|||
156602633|NCT03325556|565287224|FG000|Open-label Period|Adverse Event|27|||
156602634|NCT03325556|565287225|FG001|Open-label Period|Adverse Event|0|||
156602635|NCT03325556|565287226|FG002|Open-label Period|Adverse Event|0|||
156602636|NCT03325556|565287224|FG000|Open-label Period|Death|1|||
156602637|NCT03325556|565287225|FG001|Open-label Period|Death|0|||
156602638|NCT03325556|565287226|FG002|Open-label Period|Death|0|||
156602639|NCT03325556|565287224|FG000|Open-label Period|Lost to Follow-up|1|||
156602640|NCT03325556|565287225|FG001|Open-label Period|Lost to Follow-up|0|||
156602641|NCT03325556|565287226|FG002|Open-label Period|Lost to Follow-up|0|||
156602642|NCT03325556|565287224|FG000|Open-label Period|Non-compliance with study drug|5|||
156602643|NCT03325556|565287225|FG001|Open-label Period|Non-compliance with study drug|0|||
156634909|NCT03917654|565407821|FG006|Year 1|Travel|10|||
156602644|NCT03325556|565287226|FG002|Open-label Period|Non-compliance with study drug|0|||
156602645|NCT03325556|565287224|FG000|Open-label Period|Use of prohibited medication|1|||
156602646|NCT03325556|565287225|FG001|Open-label Period|Use of prohibited medication|0|||
156602647|NCT03325556|565287226|FG002|Open-label Period|Use of prohibited medication|0|||
156602648|NCT03325556|565287224|FG000|Open-label Period|Protocol Violation|4|||
156602649|NCT03325556|565287225|FG001|Open-label Period|Protocol Violation|0|||
156602650|NCT03325556|565287226|FG002|Open-label Period|Protocol Violation|0|||
156602651|NCT03325556|565287224|FG000|Open-label Period|Withdrawal by Subject|17|||
156602652|NCT03325556|565287225|FG001|Open-label Period|Withdrawal by Subject|0|||
156602653|NCT03325556|565287226|FG002|Open-label Period|Withdrawal by Subject|0|||
156602654|NCT03325556|565287224|FG000|Open-label Period|Not otherwise specified|8|||
156602655|NCT03325556|565287225|FG001|Open-label Period|Not otherwise specified|0|||
156602656|NCT03325556|565287226|FG002|Open-label Period|Not otherwise specified|0|||
156602657|NCT03325556|565287224|FG000|Open-label Period|Administrative discont. at study termination|41|||
156602658|NCT03325556|565287225|FG001|Open-label Period|Administrative discont. at study termination|0|||
156602659|NCT03325556|565287226|FG002|Open-label Period|Administrative discont. at study termination|0|||
156602660|NCT03325556|565287224|FG000|Double-blind Period|Relapse|0|||
156602661|NCT03325556|565287225|FG001|Double-blind Period|Relapse|15|||
156602662|NCT03325556|565287226|FG002|Double-blind Period|Relapse|34|||
156602663|NCT03325556|565287224|FG000|Double-blind Period|Adverse Event|0|||
156602664|NCT03325556|565287225|FG001|Double-blind Period|Adverse Event|3|||
156602665|NCT03325556|565287226|FG002|Double-blind Period|Adverse Event|1|||
156602666|NCT03325556|565287224|FG000|Double-blind Period|Noncompliance with study drug|0|||
156602667|NCT03325556|565287225|FG001|Double-blind Period|Noncompliance with study drug|0|||
156602668|NCT03325556|565287226|FG002|Double-blind Period|Noncompliance with study drug|1|||
156602669|NCT03325556|565287224|FG000|Double-blind Period|Use of prohibited medication|0|||
156602670|NCT03325556|565287225|FG001|Double-blind Period|Use of prohibited medication|1|||
156602671|NCT03325556|565287226|FG002|Double-blind Period|Use of prohibited medication|0|||
156602672|NCT03325556|565287224|FG000|Double-blind Period|Physician Decision|0|||
156602673|NCT03325556|565287225|FG001|Double-blind Period|Physician Decision|0|||
156602674|NCT03325556|565287226|FG002|Double-blind Period|Physician Decision|1|||
156602675|NCT03325556|565287224|FG000|Double-blind Period|Withdrawal by Subject|0|||
156602676|NCT03325556|565287225|FG001|Double-blind Period|Withdrawal by Subject|6|||
156602677|NCT03325556|565287226|FG002|Double-blind Period|Withdrawal by Subject|4|||
156602678|NCT03325556|565287224|FG000|Double-blind Period|Not otherwise specified|0|||
156602679|NCT03325556|565287225|FG001|Double-blind Period|Not otherwise specified|1|||
156602680|NCT03325556|565287226|FG002|Double-blind Period|Not otherwise specified|5|||
156602681|NCT03325556|565287224|FG000|Double-blind Period|Administrative discont. at study termination|0|||
156602682|NCT03325556|565287225|FG001|Double-blind Period|Administrative discont. at study termination|35|||
156602683|NCT03325556|565287226|FG002|Double-blind Period|Administrative discont. at study termination|31|||
156602684|NCT01705587|565287227|FG000|Overall Study|Withdrawal by Subject|0|||
156602685|NCT01705587|565287228|FG001|Overall Study|Withdrawal by Subject|1|||
156602686|NCT02227849|565287229|FG000|Overall Study|Adverse Event|4|||
156602687|NCT02227849|565287229|FG000|Overall Study|Physician Decision|1|||
156602688|NCT02227849|565287229|FG000|Overall Study|Withdrawal by Subject|3|||
156602689|NCT01373918|565287232|FG000|Overall Study|Physician Decision|0|||
156602690|NCT01373918|565287233|FG001|Overall Study|Physician Decision|1|||
156602691|NCT00510484|565287234|FG000|Wash-out Period|Adverse Event|0|||
156602692|NCT00510484|565287235|FG001|Wash-out Period|Adverse Event|1|||
156602693|NCT01590212|565287236|FG000|Overall Study|Withdrawal by Subject|2|||
156602694|NCT01590212|565287237|FG001|Overall Study|Withdrawal by Subject|2|||
156602695|NCT01590212|565287238|FG002|Overall Study|Withdrawal by Subject|2|||
156602696|NCT01590212|565287236|FG000|Overall Study|Lost to Follow-up|1|||
156602697|NCT01590212|565287237|FG001|Overall Study|Lost to Follow-up|2|||
156602698|NCT01590212|565287238|FG002|Overall Study|Lost to Follow-up|3|||
156602699|NCT00762268|565287239|FG000|Overall Study|Withdrawal by Subject|3|||
156602700|NCT00762268|565287240|FG001|Overall Study|Withdrawal by Subject|3|||
156602701|NCT03004976|565287241|FG000|Overall Study|Lost to Follow-up|7|||
156602702|NCT03004976|565287242|FG001|Overall Study|Lost to Follow-up|5|||
156602703|NCT03004976|565287241|FG000|Overall Study|Physician Decision|1|||
156602704|NCT03004976|565287242|FG001|Overall Study|Physician Decision|0|||
156602705|NCT03004976|565287241|FG000|Overall Study|Withdrawal by Subject|1|||
156602706|NCT03004976|565287242|FG001|Overall Study|Withdrawal by Subject|0|||
156602707|NCT03004976|565287241|FG000|Overall Study|Death|4|||
156602708|NCT03004976|565287242|FG001|Overall Study|Death|1|||
156602709|NCT02533401|565287243|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
156602710|NCT02533401|565287243|FG000|Overall Study|Death|5|||
156602711|NCT02533401|565287243|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
156602712|NCT02533401|565287243|FG000|Overall Study|Lost to Follow-up|1|||
156602713|NCT02533401|565287243|FG000|Overall Study|Violation of Selection Criteria|1|||
156602714|NCT01106391|565287246|FG000|Overall Study|Death|12|||
156602715|NCT01106391|565287246|FG000|Overall Study|Withdrawal by Subject|7|||
156602716|NCT01387074|565287247|FG000|Overall Study|Lost to Follow-up|7|||
156602717|NCT01387074|565287247|FG000|Overall Study|Lack of Efficacy|1|||
156602718|NCT00150345|565287248|FG000|Overall Study|Death|5|||
156602719|NCT00150345|565287249|FG001|Overall Study|Death|2|||
156602720|NCT00150345|565287248|FG000|Overall Study|Adverse Event|8|||
156602721|NCT00150345|565287249|FG001|Overall Study|Adverse Event|6|||
156602722|NCT00150345|565287248|FG000|Overall Study|Lack of Efficacy|5|||
156602723|NCT00150345|565287249|FG001|Overall Study|Lack of Efficacy|4|||
156602724|NCT00150345|565287248|FG000|Overall Study|Withdrawal by Subject|3|||
156602725|NCT00150345|565287249|FG001|Overall Study|Withdrawal by Subject|4|||
156602726|NCT00150345|565287248|FG000|Overall Study|Laboratory abnormality|1|||
156602727|NCT00150345|565287249|FG001|Overall Study|Laboratory abnormality|2|||
156602728|NCT00150345|565287248|FG000|Overall Study|Other|12|||
156602729|NCT00150345|565287249|FG001|Overall Study|Other|14|||
156602730|NCT01392742|565287250|FG000|Overall Study|Premature study termination|42|||
156602731|NCT01392742|565287250|FG000|Overall Study|Failure to return|35|||
156602732|NCT01392742|565287250|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
156602733|NCT01392742|565287250|FG000|Overall Study|Lost to Follow-up|34|||
156602734|NCT01392742|565287250|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
156602735|NCT01392742|565287250|FG000|Overall Study|ITR and Protocol deviation|1|||
156602736|NCT01392742|565287250|FG000|Overall Study|Adverse event/intercurrent illness|17|||
156602737|NCT01392742|565287250|FG000|Overall Study|Protocol Violation|14|||
156602738|NCT01392742|565287250|FG000|Overall Study|Other|3|||
156602739|NCT01392742|565287250|FG000|Overall Study|Missing information|13|||
156602740|NCT01998958|565287251|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602741|NCT01998958|565287252|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
156602742|NCT01998958|565287253|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602743|NCT01998958|565287254|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602744|NCT01998958|565287255|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602745|NCT01998958|565287256|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602746|NCT01998958|565287257|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602747|NCT01998958|565287258|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602748|NCT01998958|565287259|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602749|NCT01998958|565287260|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602750|NCT01998958|565287261|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602751|NCT01998958|565287262|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602752|NCT01998958|565287263|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602753|NCT01998958|565287264|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602754|NCT01998958|565287265|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602755|NCT01998958|565287266|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602756|NCT01998958|565287267|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602757|NCT01998958|565287268|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602758|NCT01998958|565287269|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602759|NCT01998958|565287270|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602760|NCT01998958|565287271|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602761|NCT01998958|565287272|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602762|NCT01998958|565287273|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602763|NCT01998958|565287274|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602764|NCT01998958|565287275|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602765|NCT01998958|565287276|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602766|NCT01998958|565287277|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602767|NCT01998958|565287278|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602768|NCT01998958|565287279|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602769|NCT01998958|565287280|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602770|NCT01998958|565287281|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602771|NCT01998958|565287282|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156602772|NCT01998958|565287251|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602773|NCT01998958|565287252|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
156602774|NCT01998958|565287253|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602775|NCT01998958|565287254|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602776|NCT01998958|565287255|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602777|NCT01998958|565287256|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602778|NCT01998958|565287257|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602779|NCT01998958|565287258|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602780|NCT01998958|565287259|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602781|NCT01998958|565287260|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602782|NCT01998958|565287261|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602783|NCT01998958|565287262|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602784|NCT01998958|565287263|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602785|NCT01998958|565287264|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602786|NCT01998958|565287265|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602787|NCT01998958|565287266|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602788|NCT01998958|565287267|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602789|NCT01998958|565287268|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602790|NCT01998958|565287269|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602791|NCT01998958|565287270|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602792|NCT01998958|565287271|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602793|NCT01998958|565287272|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602794|NCT01998958|565287273|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602795|NCT01998958|565287274|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602796|NCT01998958|565287275|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602797|NCT01998958|565287276|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602798|NCT01998958|565287277|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602799|NCT01998958|565287278|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602800|NCT01998958|565287279|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602801|NCT01998958|565287280|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602802|NCT01998958|565287281|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602803|NCT01998958|565287282|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
156602804|NCT01998958|565287251|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
156602805|NCT01998958|565287252|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
156602806|NCT01998958|565287253|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
156602807|NCT01998958|565287254|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
156602808|NCT01998958|565287255|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
156602809|NCT01998958|565287256|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
156602810|NCT01998958|565287257|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
156602811|NCT01998958|565287258|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
156602812|NCT01998958|565287259|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
156602813|NCT01998958|565287260|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
156602814|NCT01998958|565287261|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
156602815|NCT01998958|565287262|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
156602816|NCT01998958|565287263|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
156602817|NCT01998958|565287264|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
156602818|NCT01998958|565287265|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
156602819|NCT01998958|565287266|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
156602820|NCT01998958|565287267|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
156602821|NCT01998958|565287268|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
156602822|NCT01998958|565287269|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
156602823|NCT01998958|565287270|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
156602824|NCT01998958|565287271|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
156602825|NCT01998958|565287272|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
156602826|NCT01998958|565287273|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
156602827|NCT01998958|565287274|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
156602828|NCT01998958|565287275|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
156602829|NCT01998958|565287276|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
156602830|NCT01998958|565287277|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
156602831|NCT01998958|565287278|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
156602832|NCT01998958|565287279|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
156602833|NCT01998958|565287280|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
156602834|NCT01998958|565287281|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
156602835|NCT01998958|565287282|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
156602836|NCT01998958|565287251|FG000|Period 1 (Panel A and B)|Other|1|||
156602837|NCT01998958|565287252|FG001|Period 1 (Panel A and B)|Other|0|||
156602838|NCT01998958|565287253|FG002|Period 1 (Panel A and B)|Other|0|||
156602839|NCT01998958|565287254|FG003|Period 1 (Panel A and B)|Other|0|||
156602840|NCT01998958|565287255|FG004|Period 1 (Panel A and B)|Other|0|||
156602841|NCT01998958|565287256|FG005|Period 1 (Panel A and B)|Other|0|||
156602842|NCT01998958|565287257|FG006|Period 1 (Panel A and B)|Other|0|||
156602843|NCT01998958|565287258|FG007|Period 1 (Panel A and B)|Other|0|||
156602844|NCT01998958|565287259|FG008|Period 1 (Panel A and B)|Other|0|||
156602845|NCT01998958|565287260|FG009|Period 1 (Panel A and B)|Other|0|||
156602846|NCT01998958|565287261|FG010|Period 1 (Panel A and B)|Other|0|||
156602847|NCT01998958|565287262|FG011|Period 1 (Panel A and B)|Other|0|||
156602848|NCT01998958|565287263|FG012|Period 1 (Panel A and B)|Other|0|||
156602849|NCT01998958|565287264|FG013|Period 1 (Panel A and B)|Other|0|||
156602850|NCT01998958|565287265|FG014|Period 1 (Panel A and B)|Other|0|||
156602851|NCT01998958|565287266|FG015|Period 1 (Panel A and B)|Other|0|||
156602852|NCT01998958|565287267|FG016|Period 1 (Panel A and B)|Other|0|||
156602853|NCT01998958|565287268|FG017|Period 1 (Panel A and B)|Other|0|||
156602854|NCT01998958|565287269|FG018|Period 1 (Panel A and B)|Other|0|||
156602855|NCT01998958|565287270|FG019|Period 1 (Panel A and B)|Other|0|||
156602856|NCT01998958|565287271|FG020|Period 1 (Panel A and B)|Other|0|||
156602857|NCT01998958|565287272|FG021|Period 1 (Panel A and B)|Other|0|||
156602858|NCT01998958|565287273|FG022|Period 1 (Panel A and B)|Other|0|||
156602859|NCT01998958|565287274|FG023|Period 1 (Panel A and B)|Other|0|||
156602860|NCT01998958|565287275|FG024|Period 1 (Panel A and B)|Other|0|||
156602861|NCT01998958|565287276|FG025|Period 1 (Panel A and B)|Other|0|||
156602862|NCT01998958|565287277|FG026|Period 1 (Panel A and B)|Other|0|||
156602863|NCT01998958|565287278|FG027|Period 1 (Panel A and B)|Other|0|||
156602864|NCT01998958|565287279|FG028|Period 1 (Panel A and B)|Other|0|||
156602865|NCT01998958|565287280|FG029|Period 1 (Panel A and B)|Other|0|||
156602866|NCT01998958|565287281|FG030|Period 1 (Panel A and B)|Other|0|||
156602867|NCT01998958|565287282|FG031|Period 1 (Panel A and B)|Other|0|||
156602868|NCT01998958|565287251|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
156602869|NCT01998958|565287252|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
156602870|NCT01998958|565287253|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
156602871|NCT01998958|565287254|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
156602872|NCT01998958|565287255|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
156602873|NCT01998958|565287256|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
156602874|NCT01998958|565287257|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
156602875|NCT01998958|565287258|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
156602876|NCT01998958|565287259|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
156602877|NCT01998958|565287260|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
156602878|NCT01998958|565287261|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
156602879|NCT01998958|565287262|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
156602880|NCT01998958|565287263|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
156602881|NCT01998958|565287264|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
156602882|NCT01998958|565287265|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
156602883|NCT01998958|565287266|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
156602884|NCT01998958|565287267|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
156602885|NCT01998958|565287268|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
156602886|NCT01998958|565287269|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
156602887|NCT01998958|565287270|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
156602888|NCT01998958|565287271|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
156602889|NCT01998958|565287272|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
156602890|NCT01998958|565287273|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
156602891|NCT01998958|565287274|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
156602892|NCT01998958|565287275|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
156602893|NCT01998958|565287276|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
156602894|NCT01998958|565287277|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
156602895|NCT01998958|565287278|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
156602896|NCT01998958|565287279|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
156602897|NCT01998958|565287280|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
156602898|NCT01998958|565287281|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
156602899|NCT01998958|565287282|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
156602900|NCT01998958|565287251|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602901|NCT01998958|565287252|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602902|NCT01998958|565287253|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602903|NCT01998958|565287254|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602904|NCT01998958|565287255|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602905|NCT01998958|565287256|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602906|NCT01998958|565287257|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602907|NCT01998958|565287258|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602908|NCT01998958|565287259|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602909|NCT01998958|565287260|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602910|NCT01998958|565287261|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602911|NCT01998958|565287262|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602912|NCT01998958|565287263|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602913|NCT01998958|565287264|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602914|NCT01998958|565287265|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
156602915|NCT01998958|565287266|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602916|NCT01998958|565287267|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602917|NCT01998958|565287268|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602918|NCT01998958|565287269|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
156602919|NCT01998958|565287270|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602920|NCT01998958|565287271|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602921|NCT01998958|565287272|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602922|NCT01998958|565287273|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602923|NCT01998958|565287274|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602924|NCT01998958|565287275|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602925|NCT01998958|565287276|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602926|NCT01998958|565287277|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602927|NCT01998958|565287278|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602928|NCT01998958|565287279|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602929|NCT01998958|565287280|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602930|NCT01998958|565287281|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602931|NCT01998958|565287282|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156602932|NCT01998958|565287251|FG000|Open Label Phase (Optional)|Adverse Event|0|||
156602933|NCT01998958|565287252|FG001|Open Label Phase (Optional)|Adverse Event|0|||
156602934|NCT01998958|565287253|FG002|Open Label Phase (Optional)|Adverse Event|0|||
156602935|NCT01998958|565287254|FG003|Open Label Phase (Optional)|Adverse Event|0|||
156602936|NCT01998958|565287255|FG004|Open Label Phase (Optional)|Adverse Event|0|||
156602937|NCT01998958|565287256|FG005|Open Label Phase (Optional)|Adverse Event|0|||
156602938|NCT01998958|565287257|FG006|Open Label Phase (Optional)|Adverse Event|0|||
156602939|NCT01998958|565287258|FG007|Open Label Phase (Optional)|Adverse Event|0|||
156602940|NCT01998958|565287259|FG008|Open Label Phase (Optional)|Adverse Event|0|||
156602941|NCT01998958|565287260|FG009|Open Label Phase (Optional)|Adverse Event|0|||
156602942|NCT01998958|565287261|FG010|Open Label Phase (Optional)|Adverse Event|0|||
156863690|NCT05194124|566258764|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156602943|NCT01998958|565287262|FG011|Open Label Phase (Optional)|Adverse Event|0|||
156602944|NCT01998958|565287263|FG012|Open Label Phase (Optional)|Adverse Event|0|||
156602945|NCT01998958|565287264|FG013|Open Label Phase (Optional)|Adverse Event|0|||
156602946|NCT01998958|565287265|FG014|Open Label Phase (Optional)|Adverse Event|0|||
156602947|NCT01998958|565287266|FG015|Open Label Phase (Optional)|Adverse Event|0|||
156602948|NCT01998958|565287267|FG016|Open Label Phase (Optional)|Adverse Event|0|||
156602949|NCT01998958|565287268|FG017|Open Label Phase (Optional)|Adverse Event|0|||
156602950|NCT01998958|565287269|FG018|Open Label Phase (Optional)|Adverse Event|0|||
156602951|NCT01998958|565287270|FG019|Open Label Phase (Optional)|Adverse Event|0|||
156602952|NCT01998958|565287271|FG020|Open Label Phase (Optional)|Adverse Event|0|||
156602953|NCT01998958|565287272|FG021|Open Label Phase (Optional)|Adverse Event|0|||
156602954|NCT01998958|565287273|FG022|Open Label Phase (Optional)|Adverse Event|0|||
156602955|NCT01998958|565287274|FG023|Open Label Phase (Optional)|Adverse Event|1|||
156602956|NCT01998958|565287275|FG024|Open Label Phase (Optional)|Adverse Event|0|||
156602957|NCT01998958|565287276|FG025|Open Label Phase (Optional)|Adverse Event|0|||
156602958|NCT01998958|565287277|FG026|Open Label Phase (Optional)|Adverse Event|0|||
156602959|NCT01998958|565287278|FG027|Open Label Phase (Optional)|Adverse Event|0|||
156602960|NCT01998958|565287279|FG028|Open Label Phase (Optional)|Adverse Event|0|||
156602961|NCT01998958|565287280|FG029|Open Label Phase (Optional)|Adverse Event|0|||
156602962|NCT01998958|565287281|FG030|Open Label Phase (Optional)|Adverse Event|0|||
156602963|NCT01998958|565287282|FG031|Open Label Phase (Optional)|Adverse Event|0|||
156602964|NCT01998958|565287251|FG000|Open Label Phase (Optional)|Other|0|||
156602965|NCT01998958|565287252|FG001|Open Label Phase (Optional)|Other|0|||
156602966|NCT01998958|565287253|FG002|Open Label Phase (Optional)|Other|0|||
156602967|NCT01998958|565287254|FG003|Open Label Phase (Optional)|Other|0|||
156602968|NCT01998958|565287255|FG004|Open Label Phase (Optional)|Other|0|||
156602969|NCT01998958|565287256|FG005|Open Label Phase (Optional)|Other|0|||
156602970|NCT01998958|565287257|FG006|Open Label Phase (Optional)|Other|0|||
156602971|NCT01998958|565287258|FG007|Open Label Phase (Optional)|Other|0|||
156602972|NCT01998958|565287259|FG008|Open Label Phase (Optional)|Other|0|||
156602973|NCT01998958|565287260|FG009|Open Label Phase (Optional)|Other|0|||
156602974|NCT01998958|565287261|FG010|Open Label Phase (Optional)|Other|0|||
156602975|NCT01998958|565287262|FG011|Open Label Phase (Optional)|Other|0|||
156602976|NCT01998958|565287263|FG012|Open Label Phase (Optional)|Other|0|||
156602977|NCT01998958|565287264|FG013|Open Label Phase (Optional)|Other|0|||
156602978|NCT01998958|565287265|FG014|Open Label Phase (Optional)|Other|0|||
156602979|NCT01998958|565287266|FG015|Open Label Phase (Optional)|Other|0|||
156602980|NCT01998958|565287267|FG016|Open Label Phase (Optional)|Other|0|||
156602981|NCT01998958|565287268|FG017|Open Label Phase (Optional)|Other|0|||
156602982|NCT01998958|565287269|FG018|Open Label Phase (Optional)|Other|0|||
156602983|NCT01998958|565287270|FG019|Open Label Phase (Optional)|Other|0|||
156602984|NCT01998958|565287271|FG020|Open Label Phase (Optional)|Other|0|||
156602985|NCT01998958|565287272|FG021|Open Label Phase (Optional)|Other|0|||
156602986|NCT01998958|565287273|FG022|Open Label Phase (Optional)|Other|5|||
156602987|NCT01998958|565287274|FG023|Open Label Phase (Optional)|Other|1|||
156602988|NCT01998958|565287275|FG024|Open Label Phase (Optional)|Other|0|||
156602989|NCT01998958|565287276|FG025|Open Label Phase (Optional)|Other|0|||
156602990|NCT01998958|565287277|FG026|Open Label Phase (Optional)|Other|0|||
156602991|NCT01998958|565287278|FG027|Open Label Phase (Optional)|Other|0|||
156602992|NCT01998958|565287279|FG028|Open Label Phase (Optional)|Other|0|||
156602993|NCT01998958|565287280|FG029|Open Label Phase (Optional)|Other|0|||
156602994|NCT01998958|565287281|FG030|Open Label Phase (Optional)|Other|0|||
156602995|NCT01998958|565287282|FG031|Open Label Phase (Optional)|Other|0|||
156602996|NCT01998958|565287251|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
156602997|NCT01998958|565287252|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
156602998|NCT01998958|565287253|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
156602999|NCT01998958|565287254|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603000|NCT01998958|565287255|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603001|NCT01998958|565287256|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603002|NCT01998958|565287257|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603003|NCT01998958|565287258|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603004|NCT01998958|565287259|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603005|NCT01998958|565287260|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603006|NCT01998958|565287261|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603007|NCT01998958|565287262|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603008|NCT01998958|565287263|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603009|NCT01998958|565287264|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603010|NCT01998958|565287265|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603011|NCT01998958|565287266|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603012|NCT01998958|565287267|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603013|NCT01998958|565287268|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603014|NCT01998958|565287269|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603015|NCT01998958|565287270|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603016|NCT01998958|565287271|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603017|NCT01998958|565287272|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603018|NCT01998958|565287273|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
156603019|NCT01998958|565287274|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603020|NCT01998958|565287275|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603021|NCT01998958|565287276|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603022|NCT01998958|565287277|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603023|NCT01998958|565287278|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603024|NCT01998958|565287279|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603025|NCT01998958|565287280|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603026|NCT01998958|565287281|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603027|NCT01998958|565287282|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
156603028|NCT01998958|565287251|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603029|NCT01998958|565287252|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603030|NCT01998958|565287253|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603031|NCT01998958|565287254|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603032|NCT01998958|565287255|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603033|NCT01998958|565287256|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603034|NCT01998958|565287257|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603035|NCT01998958|565287258|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603036|NCT01998958|565287259|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603037|NCT01998958|565287260|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603038|NCT01998958|565287261|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603039|NCT01998958|565287262|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603040|NCT01998958|565287263|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603041|NCT01998958|565287264|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603042|NCT01998958|565287265|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603043|NCT01998958|565287266|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603044|NCT01998958|565287267|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603045|NCT01998958|565287268|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603046|NCT01998958|565287269|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603047|NCT01998958|565287270|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603048|NCT01998958|565287271|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603049|NCT01998958|565287272|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
156603050|NCT01998958|565287273|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
156603051|NCT01998958|565287274|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603052|NCT01998958|565287275|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603053|NCT01998958|565287276|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603054|NCT01998958|565287277|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603055|NCT01998958|565287278|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603056|NCT01998958|565287279|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603057|NCT01998958|565287280|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603058|NCT01998958|565287281|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603059|NCT01998958|565287282|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
156603060|NCT01998958|565287251|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603061|NCT01998958|565287252|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603062|NCT01998958|565287253|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603063|NCT01998958|565287254|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603064|NCT01998958|565287255|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603065|NCT01998958|565287256|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603066|NCT01998958|565287257|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603067|NCT01998958|565287258|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603068|NCT01998958|565287259|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603069|NCT01998958|565287260|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603070|NCT01998958|565287261|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603071|NCT01998958|565287262|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603072|NCT01998958|565287263|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603073|NCT01998958|565287264|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603074|NCT01998958|565287265|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603075|NCT01998958|565287266|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603076|NCT01998958|565287267|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603077|NCT01998958|565287268|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603078|NCT01998958|565287269|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603079|NCT01998958|565287270|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603080|NCT01998958|565287271|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603081|NCT01998958|565287272|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
156603082|NCT01998958|565287273|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
156603083|NCT01998958|565287274|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
156603084|NCT01998958|565287275|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603085|NCT01998958|565287276|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603086|NCT01998958|565287277|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603087|NCT01998958|565287278|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603088|NCT01998958|565287279|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603089|NCT01998958|565287280|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603090|NCT01998958|565287281|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603091|NCT01998958|565287282|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156603092|NCT01532570|565287285|FG000|Overall Study|Lack of Efficacy|1|||
156603093|NCT01532570|565287286|FG001|Overall Study|Lack of Efficacy|0|||
156603094|NCT01532570|565287287|FG002|Overall Study|Lack of Efficacy|0|||
156603095|NCT01532570|565287288|FG003|Overall Study|Lack of Efficacy|0|||
156603096|NCT01532570|565287285|FG000|Overall Study|Withdrawal by Subject|0|||
156603097|NCT01532570|565287286|FG001|Overall Study|Withdrawal by Subject|1|||
156603098|NCT01532570|565287287|FG002|Overall Study|Withdrawal by Subject|0|||
156603099|NCT01532570|565287288|FG003|Overall Study|Withdrawal by Subject|0|||
156603100|NCT05224076|565287295|FG000|Overall Study|Lost to Follow-up|24|||
156603101|NCT01807949|565287296|FG000|Overall Study|Adverse Event|1|||
156603102|NCT01807949|565287297|FG001|Overall Study|Adverse Event|2|||
156603103|NCT01807949|565287298|FG002|Overall Study|Adverse Event|2|||
156603104|NCT01807949|565287296|FG000|Overall Study|Withdrawal by Subject|1|||
156603105|NCT01807949|565287297|FG001|Overall Study|Withdrawal by Subject|2|||
156603106|NCT01807949|565287298|FG002|Overall Study|Withdrawal by Subject|2|||
156603107|NCT01807949|565287296|FG000|Overall Study|Non-Compliance|0|||
156603108|NCT01807949|565287297|FG001|Overall Study|Non-Compliance|0|||
156603109|NCT01807949|565287298|FG002|Overall Study|Non-Compliance|1|||
156603110|NCT01807949|565287296|FG000|Overall Study|Undefined|0|||
156603111|NCT01807949|565287297|FG001|Overall Study|Undefined|1|||
156603112|NCT01807949|565287298|FG002|Overall Study|Undefined|2|||
156603113|NCT01807949|565287296|FG000|Overall Study|Randomized But Not Treated|0|||
156603114|NCT01807949|565287297|FG001|Overall Study|Randomized But Not Treated|2|||
156603115|NCT01807949|565287298|FG002|Overall Study|Randomized But Not Treated|2|||
156603116|NCT00881361|565287299|FG000|Overall Study|Terminated prior to surgery|27|||
156603117|NCT00881361|565287300|FG001|Overall Study|Terminated prior to surgery|7|||
156603118|NCT00881361|565287301|FG002|Overall Study|Terminated prior to surgery|0|||
156603119|NCT00881361|565287299|FG000|Overall Study|Ineligible|17|||
156603120|NCT00881361|565287300|FG001|Overall Study|Ineligible|2|||
156603121|NCT00881361|565287301|FG002|Overall Study|Ineligible|2|||
156603122|NCT02141217|565287302|FG000|Overall Study|Adverse Event|1|||
156603123|NCT02141217|565287303|FG001|Overall Study|Adverse Event|2|||
156603124|NCT02141217|565287302|FG000|Overall Study|Protocol Violation|1|||
156603125|NCT02141217|565287303|FG001|Overall Study|Protocol Violation|4|||
156603126|NCT02141217|565287302|FG000|Overall Study|Withdrawal by Subject|6|||
156603127|NCT02141217|565287303|FG001|Overall Study|Withdrawal by Subject|0|||
156603128|NCT02141217|565287302|FG000|Overall Study|Lost to Follow-up|1|||
156603129|NCT02141217|565287303|FG001|Overall Study|Lost to Follow-up|1|||
156603130|NCT02141217|565287302|FG000|Overall Study|Physician Decision|1|||
156603131|NCT02141217|565287303|FG001|Overall Study|Physician Decision|0|||
156603132|NCT02141217|565287302|FG000|Overall Study|Surgical Intervention|1|||
156603133|NCT02141217|565287303|FG001|Overall Study|Surgical Intervention|1|||
156603134|NCT00448760|565287304|FG000|Overall Study|Death|3|||
156603135|NCT04603391|565287305|FG000|First Intervention (4 Days)|Adverse Event|1|||
156603136|NCT04603391|565287306|FG001|First Intervention (4 Days)|Adverse Event|0|||
156603137|NCT04603391|565287305|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
156603138|NCT04603391|565287306|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
156603139|NCT00067470|565287309|FG000|Overall Study|Withdrawal by Subject|0|||
156603140|NCT00067470|565287310|FG001|Overall Study|Withdrawal by Subject|1|||
156603141|NCT01342952|565287311|FG000|Overall Study|Adverse Event|0|||
156603142|NCT01342952|565287312|FG001|Overall Study|Adverse Event|5|||
156603143|NCT01342952|565287313|FG002|Overall Study|Adverse Event|1|||
156603144|NCT01342952|565287314|FG003|Overall Study|Adverse Event|0|||
156603145|NCT01342952|565287311|FG000|Overall Study|Lost to Follow-up|0|||
156603146|NCT01342952|565287312|FG001|Overall Study|Lost to Follow-up|2|||
156603147|NCT01342952|565287313|FG002|Overall Study|Lost to Follow-up|0|||
156603148|NCT01342952|565287314|FG003|Overall Study|Lost to Follow-up|0|||
156603149|NCT01342952|565287311|FG000|Overall Study|Withdrawal by Subject|1|||
156603150|NCT01342952|565287312|FG001|Overall Study|Withdrawal by Subject|1|||
156603151|NCT01342952|565287313|FG002|Overall Study|Withdrawal by Subject|0|||
156603152|NCT01342952|565287314|FG003|Overall Study|Withdrawal by Subject|0|||
156603153|NCT01342952|565287311|FG000|Overall Study|Physician Decision|3|||
156603154|NCT01342952|565287312|FG001|Overall Study|Physician Decision|3|||
156603155|NCT01342952|565287313|FG002|Overall Study|Physician Decision|1|||
156603156|NCT01342952|565287314|FG003|Overall Study|Physician Decision|0|||
156603157|NCT00416312|565287316|FG000|Overall Study|tumors not visible on imaging|2|||
156603158|NCT02727660|565287318|FG000|Overall Study|Lack of Efficacy|40|||
156603159|NCT02727660|565287319|FG001|Overall Study|Lack of Efficacy|40|||
156603160|NCT02727660|565287320|FG002|Overall Study|Lack of Efficacy|70|||
156603161|NCT02727660|565287318|FG000|Overall Study|Adverse Event|28|||
156603162|NCT02727660|565287319|FG001|Overall Study|Adverse Event|21|||
156603163|NCT02727660|565287320|FG002|Overall Study|Adverse Event|32|||
156603164|NCT02727660|565287318|FG000|Overall Study|Withdrawal by Subject|26|||
156603165|NCT02727660|565287319|FG001|Overall Study|Withdrawal by Subject|25|||
156603166|NCT02727660|565287320|FG002|Overall Study|Withdrawal by Subject|30|||
156603167|NCT02727660|565287318|FG000|Overall Study|Physician Decision|3|||
156603168|NCT02727660|565287319|FG001|Overall Study|Physician Decision|8|||
156603169|NCT02727660|565287320|FG002|Overall Study|Physician Decision|14|||
156603170|NCT02727660|565287318|FG000|Overall Study|Lost to Follow-up|5|||
156603171|NCT02727660|565287319|FG001|Overall Study|Lost to Follow-up|9|||
156603172|NCT02727660|565287320|FG002|Overall Study|Lost to Follow-up|8|||
156603173|NCT02727660|565287318|FG000|Overall Study|Protocol Violation|7|||
156603174|NCT02727660|565287319|FG001|Overall Study|Protocol Violation|5|||
156603175|NCT02727660|565287320|FG002|Overall Study|Protocol Violation|5|||
156603176|NCT02727660|565287318|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
156603177|NCT02727660|565287319|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
156603178|NCT02727660|565287320|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
156603179|NCT02727660|565287318|FG000|Overall Study|Administrative Reasons|2|||
156603180|NCT02727660|565287319|FG001|Overall Study|Administrative Reasons|3|||
156603181|NCT02727660|565287320|FG002|Overall Study|Administrative Reasons|4|||
156603182|NCT01192204|565287322|FG000|Overall Study|could not keep recall appointments|1|||
156603183|NCT01192204|565287323|FG001|Overall Study|could not keep recall appointments|0|||
156603184|NCT03699631|565287326|FG000|Overall Study|Adverse Event|3|||
156603185|NCT00964158|565287327|FG000|Overall Study|Lost to Follow-up|0|||
156603186|NCT00964158|565287328|FG001|Overall Study|Lost to Follow-up|1|||
156603187|NCT00964158|565287329|FG002|Overall Study|Lost to Follow-up|2|||
156603188|NCT00964158|565287327|FG000|Overall Study|Withdrawal by Subject|0|||
156603189|NCT00964158|565287328|FG001|Overall Study|Withdrawal by Subject|0|||
156603190|NCT00964158|565287329|FG002|Overall Study|Withdrawal by Subject|6|||
156603191|NCT00507416|565287330|FG000|Overall Study|Adverse Event|58|||
156603192|NCT00507416|565287331|FG001|Overall Study|Adverse Event|67|||
156603193|NCT00507416|565287332|FG002|Overall Study|Adverse Event|65|||
156603194|NCT00507416|565287330|FG000|Overall Study|Protocol Violation|1|||
156603195|NCT00507416|565287331|FG001|Overall Study|Protocol Violation|2|||
156603196|NCT00507416|565287332|FG002|Overall Study|Protocol Violation|0|||
156603197|NCT00507416|565287330|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
156603198|NCT00507416|565287331|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
156603199|NCT00507416|565287332|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
156603200|NCT00507416|565287330|FG000|Overall Study|Progressive Disease|20|||
156603201|NCT00507416|565287331|FG001|Overall Study|Progressive Disease|10|||
156603202|NCT00507416|565287332|FG002|Overall Study|Progressive Disease|13|||
156603203|NCT00507416|565287330|FG000|Overall Study|Patient declined further treatment|18|||
156603204|NCT00507416|565287331|FG001|Overall Study|Patient declined further treatment|14|||
156603205|NCT00507416|565287332|FG002|Overall Study|Patient declined further treatment|11|||
156603206|NCT00507416|565287330|FG000|Overall Study|Other|11|||
156603207|NCT00507416|565287331|FG001|Overall Study|Other|16|||
156603208|NCT00507416|565287332|FG002|Overall Study|Other|13|||
156603209|NCT00507416|565287330|FG000|Overall Study|Did not Receive Study Treatment|3|||
156603210|NCT00507416|565287331|FG001|Overall Study|Did not Receive Study Treatment|9|||
156603211|NCT00507416|565287332|FG002|Overall Study|Did not Receive Study Treatment|4|||
156603212|NCT03101514|565287333|FG000|Overall Study|Withdrawal by Subject|4|||
156603213|NCT03101514|565287333|FG000|Overall Study|Protocol Violation|2|||
156603214|NCT03101514|565287333|FG000|Overall Study|patient's information was incomplete|1|||
156603215|NCT03571256|565287334|FG000|Overall Study|Adverse Event|3|||
156603216|NCT03571256|565287335|FG001|Overall Study|Adverse Event|0|||
156603217|NCT03571256|565287336|FG002|Overall Study|Adverse Event|1|||
156603218|NCT03571256|565287334|FG000|Overall Study|Withdrawal by Subject|3|||
156603219|NCT03571256|565287335|FG001|Overall Study|Withdrawal by Subject|1|||
156603220|NCT03571256|565287336|FG002|Overall Study|Withdrawal by Subject|1|||
156603221|NCT03571256|565287334|FG000|Overall Study|Other than specified|0|||
156603222|NCT03571256|565287335|FG001|Overall Study|Other than specified|1|||
156603223|NCT03571256|565287336|FG002|Overall Study|Other than specified|1|||
156603224|NCT03571256|565287334|FG000|Overall Study|Protocol Violation|0|||
156603225|NCT03571256|565287335|FG001|Overall Study|Protocol Violation|1|||
156603226|NCT03571256|565287336|FG002|Overall Study|Protocol Violation|1|||
156603227|NCT02270684|565287337|FG000|Overall Study|Lost to Follow-up|0|||
156603228|NCT02270684|565287338|FG001|Overall Study|Lost to Follow-up|3|||
156603229|NCT02270684|565287337|FG000|Overall Study|Study terminated|1|||
156603230|NCT02270684|565287338|FG001|Overall Study|Study terminated|0|||
156603231|NCT02247401|565287341|FG000|Overall Study|Adverse Event|1|||
156603232|NCT02247401|565287342|FG001|Overall Study|Adverse Event|0|||
156603233|NCT02247401|565287343|FG002|Overall Study|Adverse Event|0|||
156603234|NCT02247401|565287341|FG000|Overall Study|Withdrawal by Subject|4|||
156603235|NCT02247401|565287342|FG001|Overall Study|Withdrawal by Subject|1|||
156603236|NCT02247401|565287343|FG002|Overall Study|Withdrawal by Subject|1|||
156603237|NCT02247401|565287341|FG000|Overall Study|Lost to Follow-up|1|||
156603238|NCT02247401|565287342|FG001|Overall Study|Lost to Follow-up|1|||
156603239|NCT02247401|565287343|FG002|Overall Study|Lost to Follow-up|1|||
156603240|NCT03695393|565287347|FG000|Overall Study|Death|3|||
156603241|NCT03695393|565287348|FG001|Overall Study|Death|1|||
156603242|NCT03695393|565287347|FG000|Overall Study|Lost to Follow-up|0|||
156603243|NCT03695393|565287348|FG001|Overall Study|Lost to Follow-up|1|||
156603244|NCT04585451|565287349|FG000|Overall Study|Withdrawal by Subject|26|||
156603245|NCT04585451|565287350|FG001|Overall Study|Withdrawal by Subject|0|||
156603246|NCT01769469|565287353|FG000|Overall Study|Consent Withdrawn|5|||
156603247|NCT01769469|565287353|FG000|Overall Study|Moved Out Of Area|3|||
156603248|NCT01769469|565287353|FG000|Overall Study|Lost to Follow-up|17|||
156603249|NCT01769469|565287353|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
156603250|NCT01769469|565287353|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
156603251|NCT01265420|565287354|FG000|Overall Study|Lost to Follow-up|1|||
156603252|NCT02554253|565287355|FG000|Overall Study|ineligible after enrollment|1|||
156603253|NCT02554253|565287356|FG001|Overall Study|ineligible after enrollment|0|||
156603254|NCT02554253|565287355|FG000|Overall Study|converted to transcatheter procedure|0|||
156603255|NCT02554253|565287356|FG001|Overall Study|converted to transcatheter procedure|1|||
156603256|NCT02554253|565287355|FG000|Overall Study|received both drugs|0|||
156603257|NCT02554253|565287356|FG001|Overall Study|received both drugs|1|||
156603258|NCT01736254|565287358|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
156603259|NCT01736254|565287358|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
156603260|NCT02559206|565287359|FG000|Overall Study|Adverse Event|0|||
156603261|NCT02559206|565287360|FG001|Overall Study|Adverse Event|4|||
156603262|NCT02559206|565287361|FG002|Overall Study|Adverse Event|1|||
156603263|NCT02559206|565287362|FG003|Overall Study|Adverse Event|5|||
156603264|NCT02559206|565287363|FG004|Overall Study|Adverse Event|3|||
156603265|NCT02559206|565287364|FG005|Overall Study|Adverse Event|0|||
156603266|NCT02559206|565287365|FG006|Overall Study|Adverse Event|1|||
156603267|NCT02559206|565287366|FG007|Overall Study|Adverse Event|0|||
156603268|NCT02559206|565287359|FG000|Overall Study|Protocol Violation|1|||
156603269|NCT02559206|565287360|FG001|Overall Study|Protocol Violation|0|||
156603270|NCT02559206|565287361|FG002|Overall Study|Protocol Violation|1|||
156603271|NCT02559206|565287362|FG003|Overall Study|Protocol Violation|0|||
156603272|NCT02559206|565287363|FG004|Overall Study|Protocol Violation|0|||
156603273|NCT02559206|565287364|FG005|Overall Study|Protocol Violation|2|||
156603274|NCT02559206|565287365|FG006|Overall Study|Protocol Violation|0|||
156603275|NCT02559206|565287366|FG007|Overall Study|Protocol Violation|0|||
156603276|NCT02559206|565287359|FG000|Overall Study|Withdrawal by Subject|3|||
156603277|NCT02559206|565287360|FG001|Overall Study|Withdrawal by Subject|3|||
156603278|NCT02559206|565287361|FG002|Overall Study|Withdrawal by Subject|1|||
156603279|NCT02559206|565287362|FG003|Overall Study|Withdrawal by Subject|3|||
156603280|NCT02559206|565287363|FG004|Overall Study|Withdrawal by Subject|5|||
156603281|NCT02559206|565287364|FG005|Overall Study|Withdrawal by Subject|4|||
156603282|NCT02559206|565287365|FG006|Overall Study|Withdrawal by Subject|1|||
156603283|NCT02559206|565287366|FG007|Overall Study|Withdrawal by Subject|2|||
156603284|NCT02559206|565287359|FG000|Overall Study|Lost to Follow-up|3|||
156603285|NCT02559206|565287360|FG001|Overall Study|Lost to Follow-up|5|||
156603286|NCT02559206|565287361|FG002|Overall Study|Lost to Follow-up|3|||
156603287|NCT02559206|565287362|FG003|Overall Study|Lost to Follow-up|3|||
156603288|NCT02559206|565287363|FG004|Overall Study|Lost to Follow-up|2|||
156603289|NCT02559206|565287364|FG005|Overall Study|Lost to Follow-up|5|||
156603290|NCT02559206|565287365|FG006|Overall Study|Lost to Follow-up|1|||
156603291|NCT02559206|565287366|FG007|Overall Study|Lost to Follow-up|4|||
156603292|NCT02559206|565287359|FG000|Overall Study|Lack of Efficacy|1|||
156603293|NCT02559206|565287360|FG001|Overall Study|Lack of Efficacy|0|||
156603294|NCT02559206|565287361|FG002|Overall Study|Lack of Efficacy|3|||
156603295|NCT02559206|565287362|FG003|Overall Study|Lack of Efficacy|2|||
156603296|NCT02559206|565287363|FG004|Overall Study|Lack of Efficacy|2|||
156603297|NCT02559206|565287364|FG005|Overall Study|Lack of Efficacy|3|||
156603298|NCT02559206|565287365|FG006|Overall Study|Lack of Efficacy|3|||
156603299|NCT02559206|565287366|FG007|Overall Study|Lack of Efficacy|3|||
156603300|NCT02559206|565287359|FG000|Overall Study|Other Not Specified|0|||
156603301|NCT02559206|565287360|FG001|Overall Study|Other Not Specified|0|||
156603302|NCT02559206|565287361|FG002|Overall Study|Other Not Specified|0|||
156603303|NCT02559206|565287362|FG003|Overall Study|Other Not Specified|1|||
156603304|NCT02559206|565287363|FG004|Overall Study|Other Not Specified|0|||
156603305|NCT02559206|565287364|FG005|Overall Study|Other Not Specified|0|||
156603306|NCT02559206|565287365|FG006|Overall Study|Other Not Specified|0|||
156603307|NCT02559206|565287366|FG007|Overall Study|Other Not Specified|0|||
156603308|NCT01375647|565289329|FG000|Overall Study|Lost to Follow-up|3|||
156603309|NCT01375647|565289330|FG001|Overall Study|Lost to Follow-up|3|||
156603310|NCT01375647|565289331|FG002|Overall Study|Lost to Follow-up|7|||
156603311|NCT01375647|565289332|FG003|Overall Study|Lost to Follow-up|10|||
156603312|NCT01375647|565289329|FG000|Overall Study|Death|1|||
156603313|NCT01375647|565289330|FG001|Overall Study|Death|2|||
156603314|NCT01375647|565289331|FG002|Overall Study|Death|1|||
156603315|NCT01375647|565289332|FG003|Overall Study|Death|0|||
156603316|NCT01375647|565289329|FG000|Overall Study|Withdrawal by Subject|17|||
156603317|NCT01375647|565289330|FG001|Overall Study|Withdrawal by Subject|20|||
156603318|NCT01375647|565289331|FG002|Overall Study|Withdrawal by Subject|26|||
156603319|NCT01375647|565289332|FG003|Overall Study|Withdrawal by Subject|14|||
156603320|NCT01375647|565289329|FG000|Overall Study|Physician Decision|1|||
156603321|NCT01375647|565289330|FG001|Overall Study|Physician Decision|0|||
156603322|NCT01375647|565289331|FG002|Overall Study|Physician Decision|0|||
156603323|NCT01375647|565289332|FG003|Overall Study|Physician Decision|0|||
156603324|NCT01770145|565289333|FG000|Baseline|Adverse Event|20|||
156603325|NCT01770145|565289333|FG000|Baseline|Withdrawal by Subject|1|||
156603326|NCT01770145|565289333|FG000|Baseline|Lost to Follow-up|1|||
156603327|NCT01770145|565289333|FG000|Baseline|Unable to define optimal dose|4|||
156603328|NCT01770145|565289333|FG000|Treatment|Adverse Event|3|||
156603329|NCT01770145|565289333|FG000|Treatment|Withdrawal by Subject|1|||
156603330|NCT01102140|565289334|FG000|Overall Study|Lost to Follow-up|1|||
156603331|NCT01102140|565289335|FG001|Overall Study|Lost to Follow-up|0|||
156603332|NCT01102140|565289334|FG000|Overall Study|Investigator terminated study|2|||
156603333|NCT01102140|565289335|FG001|Overall Study|Investigator terminated study|2|||
156603334|NCT03788967|565289338|FG000|Overall Study|Lost to Follow-up|14|||
156603335|NCT03788967|565289339|FG001|Overall Study|Lost to Follow-up|10|||
156603336|NCT03788967|565289338|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
156603337|NCT03788967|565289339|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
156603338|NCT03788967|565289338|FG000|Overall Study|Participant Withdrawal of Consent|13|||
156603339|NCT03788967|565289339|FG001|Overall Study|Participant Withdrawal of Consent|5|||
156603340|NCT03788967|565289338|FG000|Overall Study|Adverse Event|1|||
156603341|NCT03788967|565289339|FG001|Overall Study|Adverse Event|1|||
156603342|NCT03788967|565289338|FG000|Overall Study|COVID-19|1|||
156603343|NCT03788967|565289339|FG001|Overall Study|COVID-19|2|||
156603344|NCT04268303|565289340|FG000|Overall Study|Lost to Follow-up|1|||
156603345|NCT04268303|565289341|FG001|Overall Study|Lost to Follow-up|1|||
156603346|NCT04268303|565289342|FG002|Overall Study|Lost to Follow-up|2|||
156603347|NCT04268303|565289340|FG000|Overall Study|Withdrawal by Subject|0|||
156603348|NCT04268303|565289341|FG001|Overall Study|Withdrawal by Subject|1|||
156603349|NCT04268303|565289342|FG002|Overall Study|Withdrawal by Subject|1|||
156603350|NCT04268303|565289340|FG000|Overall Study|Adverse Event|2|||
156603351|NCT04268303|565289341|FG001|Overall Study|Adverse Event|0|||
156603352|NCT04268303|565289342|FG002|Overall Study|Adverse Event|0|||
156603353|NCT00355134|565289343|FG000|Core Phase|Withdrawal by Subject|35|||
156603354|NCT00355134|565289344|FG001|Core Phase|Withdrawal by Subject|24|||
156603355|NCT00355134|565289345|FG002|Core Phase|Withdrawal by Subject|35|||
156603356|NCT00355134|565289346|FG003|Core Phase|Withdrawal by Subject|0|||
156603357|NCT00355134|565289347|FG004|Core Phase|Withdrawal by Subject|0|||
156603358|NCT00355134|565289343|FG000|Core Phase|Adverse Event|28|||
156603359|NCT00355134|565289344|FG001|Core Phase|Adverse Event|22|||
156603360|NCT00355134|565289345|FG002|Core Phase|Adverse Event|16|||
156603361|NCT00355134|565289346|FG003|Core Phase|Adverse Event|0|||
156603362|NCT00355134|565289347|FG004|Core Phase|Adverse Event|0|||
156603363|NCT00355134|565289343|FG000|Core Phase|Lost to Follow-up|17|||
156603364|NCT00355134|565289344|FG001|Core Phase|Lost to Follow-up|13|||
156603365|NCT00355134|565289345|FG002|Core Phase|Lost to Follow-up|21|||
156603366|NCT00355134|565289346|FG003|Core Phase|Lost to Follow-up|0|||
156603367|NCT00355134|565289347|FG004|Core Phase|Lost to Follow-up|0|||
156603368|NCT00355134|565289343|FG000|Core Phase|Abnormal laboratory value(s)|19|||
156603369|NCT00355134|565289344|FG001|Core Phase|Abnormal laboratory value(s)|14|||
156603370|NCT00355134|565289345|FG002|Core Phase|Abnormal laboratory value(s)|2|||
156603371|NCT00355134|565289346|FG003|Core Phase|Abnormal laboratory value(s)|0|||
156603372|NCT00355134|565289347|FG004|Core Phase|Abnormal laboratory value(s)|0|||
156603373|NCT00355134|565289343|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
156603374|NCT00355134|565289344|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
156603375|NCT00355134|565289345|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
156603376|NCT00355134|565289346|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
156603377|NCT00355134|565289347|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
156603378|NCT00355134|565289343|FG000|Core Phase|Administrative problems|5|||
156603379|NCT00355134|565289344|FG001|Core Phase|Administrative problems|3|||
156603380|NCT00355134|565289345|FG002|Core Phase|Administrative problems|5|||
156603381|NCT00355134|565289346|FG003|Core Phase|Administrative problems|0|||
156603382|NCT00355134|565289347|FG004|Core Phase|Administrative problems|0|||
156603383|NCT00355134|565289343|FG000|Core Phase|Protocol Violation|3|||
156603384|NCT00355134|565289344|FG001|Core Phase|Protocol Violation|2|||
156603385|NCT00355134|565289345|FG002|Core Phase|Protocol Violation|2|||
156603386|NCT00355134|565289346|FG003|Core Phase|Protocol Violation|0|||
156603387|NCT00355134|565289347|FG004|Core Phase|Protocol Violation|0|||
156603388|NCT00355134|565289343|FG000|Core Phase|Abnormal test procedure result(s)|1|||
156603389|NCT00355134|565289344|FG001|Core Phase|Abnormal test procedure result(s)|2|||
156603390|NCT00355134|565289345|FG002|Core Phase|Abnormal test procedure result(s)|1|||
156603391|NCT00355134|565289346|FG003|Core Phase|Abnormal test procedure result(s)|0|||
156603392|NCT00355134|565289347|FG004|Core Phase|Abnormal test procedure result(s)|0|||
156603393|NCT00355134|565289343|FG000|Core Phase|Condition no longer requires study drug|1|||
156603394|NCT00355134|565289344|FG001|Core Phase|Condition no longer requires study drug|0|||
156603395|NCT00355134|565289345|FG002|Core Phase|Condition no longer requires study drug|1|||
156603396|NCT00355134|565289346|FG003|Core Phase|Condition no longer requires study drug|0|||
156603397|NCT00355134|565289347|FG004|Core Phase|Condition no longer requires study drug|0|||
156603398|NCT00355134|565289343|FG000|Extension Phase|Withdrawal by Subject|7|||
156603399|NCT00355134|565289344|FG001|Extension Phase|Withdrawal by Subject|11|||
156603400|NCT00355134|565289345|FG002|Extension Phase|Withdrawal by Subject|0|||
156603401|NCT00355134|565289346|FG003|Extension Phase|Withdrawal by Subject|7|||
156603402|NCT00355134|565289347|FG004|Extension Phase|Withdrawal by Subject|5|||
156603403|NCT00355134|565289343|FG000|Extension Phase|Adverse Event|13|||
156603404|NCT00355134|565289344|FG001|Extension Phase|Adverse Event|9|||
156603405|NCT00355134|565289345|FG002|Extension Phase|Adverse Event|0|||
156603406|NCT00355134|565289346|FG003|Extension Phase|Adverse Event|3|||
156603407|NCT00355134|565289347|FG004|Extension Phase|Adverse Event|5|||
156603408|NCT00355134|565289343|FG000|Extension Phase|Lost to Follow-up|2|||
156603409|NCT00355134|565289344|FG001|Extension Phase|Lost to Follow-up|6|||
156603410|NCT00355134|565289345|FG002|Extension Phase|Lost to Follow-up|0|||
156603411|NCT00355134|565289346|FG003|Extension Phase|Lost to Follow-up|2|||
156603412|NCT00355134|565289347|FG004|Extension Phase|Lost to Follow-up|4|||
156603413|NCT00355134|565289343|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
156603414|NCT00355134|565289344|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
156603415|NCT00355134|565289345|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
156603416|NCT00355134|565289346|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
156603417|NCT00355134|565289347|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
156603418|NCT00355134|565289343|FG000|Extension Phase|Administrative problems|2|||
156603419|NCT00355134|565289344|FG001|Extension Phase|Administrative problems|4|||
156603420|NCT00355134|565289345|FG002|Extension Phase|Administrative problems|0|||
156603421|NCT00355134|565289346|FG003|Extension Phase|Administrative problems|1|||
156603422|NCT00355134|565289347|FG004|Extension Phase|Administrative problems|1|||
156603423|NCT00355134|565289343|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
156603424|NCT00355134|565289344|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
156603425|NCT00355134|565289345|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
156603426|NCT00355134|565289346|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
156603427|NCT00355134|565289347|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
156603428|NCT00355134|565289343|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
156603429|NCT00355134|565289344|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
156603430|NCT00355134|565289345|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
156603431|NCT00355134|565289346|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
156603432|NCT00355134|565289347|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
156603433|NCT00355134|565289343|FG000|Extension Phase|Protocol Violation|0|||
156603434|NCT00355134|565289344|FG001|Extension Phase|Protocol Violation|0|||
156603435|NCT00355134|565289345|FG002|Extension Phase|Protocol Violation|0|||
156603436|NCT00355134|565289346|FG003|Extension Phase|Protocol Violation|1|||
156603437|NCT00355134|565289347|FG004|Extension Phase|Protocol Violation|0|||
156603438|NCT03621189|565289360|FG000|Overall Study|Withdrawal by Subject|0|||
156603439|NCT03621189|565289361|FG001|Overall Study|Withdrawal by Subject|3|||
156603440|NCT03621189|565289360|FG000|Overall Study|Physician Decision|0|||
156603441|NCT03621189|565289361|FG001|Overall Study|Physician Decision|2|||
156603442|NCT03488238|565289362|FG000|Overall Study|Equipment malfunction|1|||
156603443|NCT03488238|565289362|FG000|Overall Study|Adverse Event|1|||
156603444|NCT01316939|565289365|FG000|Overall Study|Study closed/terminated|26|||
156603445|NCT01316939|565289366|FG001|Overall Study|Study closed/terminated|25|||
156603446|NCT01316939|565289367|FG002|Overall Study|Study closed/terminated|23|||
156603447|NCT01316939|565289365|FG000|Overall Study|Lack of Efficacy|24|||
156603448|NCT01316939|565289366|FG001|Overall Study|Lack of Efficacy|25|||
156603449|NCT01316939|565289367|FG002|Overall Study|Lack of Efficacy|25|||
156603450|NCT01316939|565289365|FG000|Overall Study|Adverse Event|9|||
156603451|NCT01316939|565289366|FG001|Overall Study|Adverse Event|12|||
156603452|NCT01316939|565289367|FG002|Overall Study|Adverse Event|11|||
156603453|NCT01316939|565289365|FG000|Overall Study|Withdrawal by Subject|1|||
156603454|NCT01316939|565289366|FG001|Overall Study|Withdrawal by Subject|3|||
156603455|NCT01316939|565289367|FG002|Overall Study|Withdrawal by Subject|6|||
156603456|NCT01316939|565289365|FG000|Overall Study|Physician Decision|2|||
156603457|NCT01316939|565289366|FG001|Overall Study|Physician Decision|2|||
156603458|NCT01316939|565289367|FG002|Overall Study|Physician Decision|1|||
156603459|NCT01316939|565289365|FG000|Overall Study|Lost to Follow-up|0|||
156603460|NCT01316939|565289366|FG001|Overall Study|Lost to Follow-up|0|||
156603461|NCT01316939|565289367|FG002|Overall Study|Lost to Follow-up|2|||
156603462|NCT01316939|565289365|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
156603463|NCT01316939|565289366|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
156603464|NCT01316939|565289367|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
156603465|NCT01316939|565289365|FG000|Overall Study|Protocol Violation|0|||
156603466|NCT01316939|565289366|FG001|Overall Study|Protocol Violation|1|||
156603467|NCT01316939|565289367|FG002|Overall Study|Protocol Violation|0|||
156603468|NCT01432457|565289368|FG000|Overall Study|Adverse Event|7|||
156603469|NCT01432457|565289369|FG001|Overall Study|Adverse Event|10|||
156603470|NCT01432457|565289370|FG002|Overall Study|Adverse Event|16|||
156603471|NCT01432457|565289368|FG000|Overall Study|Lack of Efficacy|2|||
156603472|NCT01432457|565289369|FG001|Overall Study|Lack of Efficacy|1|||
156603473|NCT01432457|565289370|FG002|Overall Study|Lack of Efficacy|1|||
156603474|NCT01432457|565289368|FG000|Overall Study|Lost to Follow-up|11|||
156603475|NCT01432457|565289369|FG001|Overall Study|Lost to Follow-up|15|||
156603476|NCT01432457|565289370|FG002|Overall Study|Lost to Follow-up|20|||
156603477|NCT01432457|565289368|FG000|Overall Study|Protocol Violation|3|||
156603478|NCT01432457|565289369|FG001|Overall Study|Protocol Violation|2|||
156603479|NCT01432457|565289370|FG002|Overall Study|Protocol Violation|6|||
156603480|NCT01432457|565289368|FG000|Overall Study|Withdrawal by Subject|6|||
156603481|NCT01432457|565289369|FG001|Overall Study|Withdrawal by Subject|11|||
156603482|NCT01432457|565289370|FG002|Overall Study|Withdrawal by Subject|9|||
156603483|NCT01432457|565289368|FG000|Overall Study|Reasons not defined|2|||
156603484|NCT01432457|565289369|FG001|Overall Study|Reasons not defined|3|||
156603485|NCT01432457|565289370|FG002|Overall Study|Reasons not defined|4|||
156603486|NCT01432457|565289368|FG000|Overall Study|Did not take study drug|6|||
156603487|NCT01432457|565289369|FG001|Overall Study|Did not take study drug|6|||
156603488|NCT01432457|565289370|FG002|Overall Study|Did not take study drug|3|||
156603489|NCT04134728|565289371|FG000|Overall Study|Adverse Event|3|||
156603490|NCT04134728|565289372|FG001|Overall Study|Adverse Event|2|||
156603491|NCT04134728|565289373|FG002|Overall Study|Adverse Event|9|||
156603492|NCT04134728|565289374|FG003|Overall Study|Adverse Event|0|||
156603493|NCT04134728|565289375|FG004|Overall Study|Adverse Event|0|||
156603494|NCT04134728|565289376|FG005|Overall Study|Adverse Event|0|||
156603495|NCT04134728|565289371|FG000|Overall Study|Lack of Efficacy|3|||
156603496|NCT04134728|565289372|FG001|Overall Study|Lack of Efficacy|3|||
156603497|NCT04134728|565289373|FG002|Overall Study|Lack of Efficacy|1|||
156603498|NCT04134728|565289374|FG003|Overall Study|Lack of Efficacy|2|||
156603499|NCT04134728|565289375|FG004|Overall Study|Lack of Efficacy|0|||
156603500|NCT04134728|565289376|FG005|Overall Study|Lack of Efficacy|0|||
156603501|NCT04134728|565289371|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156603502|NCT04134728|565289372|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156603503|NCT04134728|565289373|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
156603504|NCT04134728|565289374|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156603505|NCT04134728|565289375|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156603506|NCT04134728|565289376|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156603507|NCT04134728|565289371|FG000|Overall Study|Protocol Deviation|0|||
156603508|NCT04134728|565289372|FG001|Overall Study|Protocol Deviation|0|||
156603509|NCT04134728|565289373|FG002|Overall Study|Protocol Deviation|1|||
156603510|NCT04134728|565289374|FG003|Overall Study|Protocol Deviation|0|||
156603511|NCT04134728|565289375|FG004|Overall Study|Protocol Deviation|0|||
156603512|NCT04134728|565289376|FG005|Overall Study|Protocol Deviation|0|||
156603513|NCT04134728|565289371|FG000|Overall Study|Informed Consent Withdrawn|3|||
156603514|NCT04134728|565289372|FG001|Overall Study|Informed Consent Withdrawn|6|||
156603515|NCT04134728|565289373|FG002|Overall Study|Informed Consent Withdrawn|8|||
156603516|NCT04134728|565289374|FG003|Overall Study|Informed Consent Withdrawn|1|||
156603517|NCT04134728|565289375|FG004|Overall Study|Informed Consent Withdrawn|1|||
156603518|NCT04134728|565289376|FG005|Overall Study|Informed Consent Withdrawn|0|||
156603519|NCT04134728|565289371|FG000|Overall Study|Physician Decision|2|||
156603520|NCT04134728|565289372|FG001|Overall Study|Physician Decision|0|||
156603521|NCT04134728|565289373|FG002|Overall Study|Physician Decision|0|||
156603522|NCT04134728|565289374|FG003|Overall Study|Physician Decision|0|||
156603523|NCT04134728|565289375|FG004|Overall Study|Physician Decision|0|||
156603524|NCT04134728|565289376|FG005|Overall Study|Physician Decision|0|||
156603525|NCT04134728|565289371|FG000|Overall Study|Lost to Follow-up|1|||
156603526|NCT04134728|565289372|FG001|Overall Study|Lost to Follow-up|2|||
156603527|NCT04134728|565289373|FG002|Overall Study|Lost to Follow-up|1|||
156603528|NCT04134728|565289374|FG003|Overall Study|Lost to Follow-up|0|||
156603529|NCT04134728|565289375|FG004|Overall Study|Lost to Follow-up|0|||
156603530|NCT04134728|565289376|FG005|Overall Study|Lost to Follow-up|1|||
156603531|NCT04134728|565289371|FG000|Overall Study|Investigator Site Closed|0|||
156603532|NCT04134728|565289372|FG001|Overall Study|Investigator Site Closed|1|||
156603533|NCT04134728|565289373|FG002|Overall Study|Investigator Site Closed|1|||
156603534|NCT04134728|565289374|FG003|Overall Study|Investigator Site Closed|0|||
156603535|NCT04134728|565289375|FG004|Overall Study|Investigator Site Closed|0|||
156603536|NCT04134728|565289376|FG005|Overall Study|Investigator Site Closed|0|||
156603537|NCT03382262|565289377|FG000|Overall Study|Physician Decision|0|||
156603538|NCT03382262|565289378|FG001|Overall Study|Physician Decision|0|||
156603539|NCT03382262|565289379|FG002|Overall Study|Physician Decision|1|||
156603540|NCT03382262|565289380|FG003|Overall Study|Physician Decision|0|||
156603541|NCT03382262|565289377|FG000|Overall Study|Withdrawal by Subject|0|||
156603542|NCT03382262|565289378|FG001|Overall Study|Withdrawal by Subject|0|||
156603543|NCT03382262|565289379|FG002|Overall Study|Withdrawal by Subject|0|||
156603544|NCT03382262|565289380|FG003|Overall Study|Withdrawal by Subject|1|||
156603545|NCT00233324|565289381|FG000|Main Study|Death|68|||
156603546|NCT00233324|565289382|FG001|Main Study|Death|60|||
156603547|NCT00233324|565289383|FG002|Main Study|Death|62|||
156603548|NCT00233324|565289384|FG003|Main Study|Death|47|||
156603549|NCT00233324|565289381|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
156603550|NCT00233324|565289382|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
156603551|NCT00233324|565289383|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
156603552|NCT00233324|565289384|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
156603553|NCT00233324|565289381|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
156603554|NCT00233324|565289382|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
156603555|NCT00233324|565289383|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
156603556|NCT00233324|565289384|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
156603557|NCT00801892|565289385|FG000|Main Study Period|Withdrawal by Subject|0|||
156603558|NCT00801892|565289386|FG001|Main Study Period|Withdrawal by Subject|1|||
156603559|NCT00801892|565289385|FG000|Sham Crossover Period|Lost to Follow-up|0|||
156603560|NCT00801892|565289386|FG001|Sham Crossover Period|Lost to Follow-up|2|||
156603561|NCT01711541|565289387|FG000|Overall Study|Cancel prior to treatment|0|||
156603562|NCT01711541|565289388|FG001|Overall Study|Cancel prior to treatment|0|||
156603563|NCT01711541|565289389|FG002|Overall Study|Cancel prior to treatment|0|||
156603564|NCT01711541|565289390|FG003|Overall Study|Cancel prior to treatment|1|||
156603565|NCT01711541|565289391|FG004|Overall Study|Cancel prior to treatment|0|||
156603566|NCT01711541|565289387|FG000|Overall Study|Ineligible|0|||
156603567|NCT01711541|565289388|FG001|Overall Study|Ineligible|1|||
156603568|NCT01711541|565289389|FG002|Overall Study|Ineligible|0|||
156603569|NCT01711541|565289390|FG003|Overall Study|Ineligible|0|||
156603570|NCT01711541|565289391|FG004|Overall Study|Ineligible|0|||
156603571|NCT00438464|565289392|FG000|Overall Study|Terminated Early|14|||
156603572|NCT00438464|565289393|FG001|Overall Study|Terminated Early|5|||
156603573|NCT00438464|565289392|FG000|Overall Study|Incomplete data submission|0|||
156603574|NCT00438464|565289393|FG001|Overall Study|Incomplete data submission|2|||
156603575|NCT00728936|565289394|FG000|Overall Study|Withdrawal by Subject|0|||
156603576|NCT00728936|565289395|FG001|Overall Study|Withdrawal by Subject|0|||
156603577|NCT00728936|565289396|FG002|Overall Study|Withdrawal by Subject|0|||
156603578|NCT00728936|565289397|FG003|Overall Study|Withdrawal by Subject|0|||
156603579|NCT00728936|565289398|FG004|Overall Study|Withdrawal by Subject|0|||
156603580|NCT00728936|565289399|FG005|Overall Study|Withdrawal by Subject|1|||
156603581|NCT00728936|565289400|FG006|Overall Study|Withdrawal by Subject|0|||
156603582|NCT03943446|565289401|FG000|Overall Study|Lost to Follow-up|0|||
156603583|NCT03943446|565289402|FG001|Overall Study|Lost to Follow-up|0|||
156603584|NCT03943446|565289403|FG002|Overall Study|Lost to Follow-up|1|||
156603585|NCT03943446|565289401|FG000|Overall Study|Withdrawal by Subject|1|||
156603586|NCT03943446|565289402|FG001|Overall Study|Withdrawal by Subject|1|||
156603587|NCT03943446|565289403|FG002|Overall Study|Withdrawal by Subject|2|||
156603588|NCT03943446|565289401|FG000|Overall Study|Study Terminated by Sponsor|1|||
156603589|NCT03943446|565289402|FG001|Overall Study|Study Terminated by Sponsor|2|||
156603590|NCT03943446|565289403|FG002|Overall Study|Study Terminated by Sponsor|1|||
156603591|NCT03943446|565289401|FG000|Overall Study|Reason not Specified|5|||
156603592|NCT03943446|565289402|FG001|Overall Study|Reason not Specified|1|||
156603593|NCT03943446|565289403|FG002|Overall Study|Reason not Specified|3|||
156603594|NCT01281189|565289415|FG000|Overall Study|Adverse Event|7|||
156603595|NCT01281189|565289416|FG001|Overall Study|Adverse Event|9|||
156603596|NCT01281189|565289415|FG000|Overall Study|Lost to Follow-up|6|||
156603597|NCT01281189|565289416|FG001|Overall Study|Lost to Follow-up|4|||
156603598|NCT01281189|565289415|FG000|Overall Study|Withdrawal by Subject|21|||
156603599|NCT01281189|565289416|FG001|Overall Study|Withdrawal by Subject|24|||
156603600|NCT01281189|565289415|FG000|Overall Study|Physician Decision|2|||
156603601|NCT01281189|565289416|FG001|Overall Study|Physician Decision|3|||
156603602|NCT01281189|565289415|FG000|Overall Study|Death|103|||
156603603|NCT01281189|565289416|FG001|Overall Study|Death|91|||
156603604|NCT01281189|565289415|FG000|Overall Study|Other|8|||
156603605|NCT01281189|565289416|FG001|Overall Study|Other|12|||
156603606|NCT05355818|565289417|FG000|Overall Study|Adverse Event|1|||
156603607|NCT05355818|565289418|FG001|Overall Study|Adverse Event|1|||
156603608|NCT05355818|565289417|FG000|Overall Study|Lack of Efficacy|2|||
156603609|NCT05355818|565289418|FG001|Overall Study|Lack of Efficacy|1|||
156603610|NCT05355818|565289417|FG000|Overall Study|Lost to Follow-up|0|||
156603611|NCT05355818|565289418|FG001|Overall Study|Lost to Follow-up|1|||
156603612|NCT01601704|565289420|FG000|Overall Study|Randomized but not dispensed study med|1|||
156603613|NCT01601704|565289421|FG001|Overall Study|Randomized but not dispensed study med|4|||
156603614|NCT04897594|565289424|FG000|Overall Study|Lost to Follow-up|0|||
156603615|NCT04897594|565289425|FG001|Overall Study|Lost to Follow-up|1|||
156603616|NCT04897594|565289426|FG002|Overall Study|Lost to Follow-up|1|||
156603617|NCT04897594|565289424|FG000|Overall Study|Sponsor Decision|0|||
156603618|NCT04897594|565289425|FG001|Overall Study|Sponsor Decision|0|||
156603619|NCT04897594|565289426|FG002|Overall Study|Sponsor Decision|1|||
156603620|NCT04897594|565289424|FG000|Overall Study|Withdrawal by Subject|1|||
156603621|NCT04897594|565289425|FG001|Overall Study|Withdrawal by Subject|0|||
156603622|NCT04897594|565289426|FG002|Overall Study|Withdrawal by Subject|1|||
156603623|NCT00511108|565289427|FG000|Overall Study|Adverse Event|2|||
156603624|NCT00511108|565289428|FG001|Overall Study|Adverse Event|0|||
156603625|NCT00511108|565289429|FG002|Overall Study|Adverse Event|1|||
156603626|NCT00511108|565289430|FG003|Overall Study|Adverse Event|2|||
156603627|NCT00511108|565289427|FG000|Overall Study|Lost to Follow-up|0|||
156603628|NCT00511108|565289428|FG001|Overall Study|Lost to Follow-up|2|||
156603629|NCT00511108|565289429|FG002|Overall Study|Lost to Follow-up|1|||
156603630|NCT00511108|565289430|FG003|Overall Study|Lost to Follow-up|0|||
156603631|NCT00511108|565289427|FG000|Overall Study|Physician Decision|0|||
156603632|NCT00511108|565289428|FG001|Overall Study|Physician Decision|0|||
156603633|NCT00511108|565289429|FG002|Overall Study|Physician Decision|0|||
156603634|NCT00511108|565289430|FG003|Overall Study|Physician Decision|1|||
156603635|NCT00511108|565289427|FG000|Overall Study|Withdrawal by Subject|4|||
156603636|NCT00511108|565289428|FG001|Overall Study|Withdrawal by Subject|0|||
156603637|NCT00511108|565289429|FG002|Overall Study|Withdrawal by Subject|3|||
156603638|NCT00511108|565289430|FG003|Overall Study|Withdrawal by Subject|2|||
156603639|NCT02147691|565289431|FG000|Overall Study|Withdrawal by Subject|2|||
156603640|NCT02147691|565289432|FG001|Overall Study|Withdrawal by Subject|0|||
156603641|NCT02147691|565289431|FG000|Overall Study|Adverse Event|2|||
156603642|NCT02147691|565289432|FG001|Overall Study|Adverse Event|0|||
156603643|NCT02147691|565289431|FG000|Overall Study|Lost to Follow-up|0|||
156603644|NCT02147691|565289432|FG001|Overall Study|Lost to Follow-up|1|||
156603645|NCT02432703|565289435|FG000|Overall Study|Adverse Event|1|||
156603646|NCT02432703|565289436|FG001|Overall Study|Adverse Event|4|||
156603647|NCT02432703|565289435|FG000|Overall Study|Lack of Efficacy|1|||
156603648|NCT02432703|565289436|FG001|Overall Study|Lack of Efficacy|0|||
156603649|NCT02432703|565289435|FG000|Overall Study|Lost to Follow-up|5|||
156603650|NCT02432703|565289436|FG001|Overall Study|Lost to Follow-up|3|||
156603651|NCT02432703|565289435|FG000|Overall Study|Withdrawal by Subject|9|||
156603652|NCT02432703|565289436|FG001|Overall Study|Withdrawal by Subject|6|||
156603653|NCT02432703|565289435|FG000|Overall Study|Other|6|||
156603654|NCT02432703|565289436|FG001|Overall Study|Other|5|||
156603655|NCT04325906|565289440|FG000|Overall Study|Withdrawal by Subject|2|||
156603656|NCT04325906|565289441|FG001|Overall Study|Withdrawal by Subject|0|||
156603657|NCT01628393|565289446|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
156603658|NCT01628393|565289447|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
156603659|NCT01628393|565289448|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
156603660|NCT01628393|565289449|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
156603661|NCT01628393|565289450|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
156603662|NCT01628393|565289446|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
156603663|NCT01628393|565289447|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
156603664|NCT01628393|565289448|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
156603665|NCT01628393|565289449|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
156603666|NCT01628393|565289450|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
156603667|NCT01628393|565289446|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
156603668|NCT01628393|565289447|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
156603669|NCT01628393|565289448|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
156603670|NCT01628393|565289449|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
156603671|NCT01628393|565289450|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
156603672|NCT01628393|565289446|FG000|Blinded Active Extension Period|Adverse Event|0|||
156603673|NCT01628393|565289447|FG001|Blinded Active Extension Period|Adverse Event|1|||
156603674|NCT01628393|565289448|FG002|Blinded Active Extension Period|Adverse Event|0|||
156603675|NCT01628393|565289449|FG003|Blinded Active Extension Period|Adverse Event|2|||
156603676|NCT01628393|565289450|FG004|Blinded Active Extension Period|Adverse Event|2|||
156603677|NCT01628393|565289446|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
156603678|NCT01628393|565289447|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
156603679|NCT01628393|565289448|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
156603680|NCT01628393|565289449|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
156603681|NCT01628393|565289450|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
156603682|NCT01628393|565289446|FG000|Blinded Active Extension Period|Physician Decision|0|||
156603683|NCT01628393|565289447|FG001|Blinded Active Extension Period|Physician Decision|3|||
156603684|NCT01628393|565289448|FG002|Blinded Active Extension Period|Physician Decision|0|||
156603685|NCT01628393|565289449|FG003|Blinded Active Extension Period|Physician Decision|1|||
156603686|NCT01628393|565289450|FG004|Blinded Active Extension Period|Physician Decision|0|||
156603687|NCT01628393|565289446|FG000|Blinded Active Extension Period|Protocol Violation|0|||
156603688|NCT01628393|565289447|FG001|Blinded Active Extension Period|Protocol Violation|0|||
156603689|NCT01628393|565289448|FG002|Blinded Active Extension Period|Protocol Violation|2|||
156603690|NCT01628393|565289449|FG003|Blinded Active Extension Period|Protocol Violation|1|||
156603691|NCT01628393|565289450|FG004|Blinded Active Extension Period|Protocol Violation|0|||
156603692|NCT01628393|565289446|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
156603693|NCT01628393|565289447|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
156603694|NCT01628393|565289448|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
156603695|NCT01628393|565289449|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
156603696|NCT01628393|565289450|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
156603697|NCT01665768|565289451|FG000|Overall Study|Adverse Event|3|||
156603698|NCT01665768|565289451|FG000|Overall Study|Lack of Efficacy|19|||
156603699|NCT01665768|565289451|FG000|Overall Study|Withdrawal by Subject|1|||
156603700|NCT01329341|565289452|FG000|Overall Study|Withdrawal by Subject|44|||
156603701|NCT00561340|565289453|FG000|Overall Study|refused to drink pediasure|6|||
156603702|NCT00561340|565289454|FG001|Overall Study|refused to drink pediasure|0|||
156603703|NCT02988219|565289460|FG000|Overall Study|Lack of Efficacy|1|||
156603704|NCT02988219|565289461|FG001|Overall Study|Lack of Efficacy|1|||
156603705|NCT02988219|565289460|FG000|Overall Study|Withdrawal by Subject|0|||
156603706|NCT02988219|565289461|FG001|Overall Study|Withdrawal by Subject|2|||
156603707|NCT01522443|565289465|FG000|Overall Study|No longer receiving clinical benefit|36|||
156603708|NCT01522443|565289466|FG001|Overall Study|No longer receiving clinical benefit|28|||
156603709|NCT01522443|565289465|FG000|Overall Study|Adverse Event|10|||
156603710|NCT01522443|565289466|FG001|Overall Study|Adverse Event|15|||
156603711|NCT01522443|565289465|FG000|Overall Study|Withdrawal by Subject|5|||
156603712|NCT01522443|565289466|FG001|Overall Study|Withdrawal by Subject|8|||
156603713|NCT01522443|565289465|FG000|Overall Study|No study treatment given|1|||
156603714|NCT01522443|565289466|FG001|Overall Study|No study treatment given|1|||
156603715|NCT01522443|565289465|FG000|Overall Study|Other|1|||
156603716|NCT01522443|565289466|FG001|Overall Study|Other|3|||
156603717|NCT03260894|565289467|FG000|Overall Study|Death|6|||
156603718|NCT03260894|565289468|FG001|Overall Study|Death|8|||
156603719|NCT03260894|565289467|FG000|Overall Study|Withdrawal by Subject|4|||
156603720|NCT03260894|565289468|FG001|Overall Study|Withdrawal by Subject|11|||
156603721|NCT03260894|565289467|FG000|Overall Study|On-going at clinical cut off date|36|||
156603722|NCT03260894|565289468|FG001|Overall Study|On-going at clinical cut off date|31|||
156603723|NCT00290589|565289470|FG000|Overall Study|Lost to Follow-up|2|||
156603724|NCT00290589|565289471|FG001|Overall Study|Lost to Follow-up|2|||
156603725|NCT05014542|565289472|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
156603726|NCT05014542|565289473|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
156603727|NCT05014542|565289472|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
156603728|NCT05014542|565289473|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
156603729|NCT05014542|565289472|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
156603730|NCT05014542|565289473|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
156603731|NCT05014542|565289472|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
156603732|NCT05014542|565289473|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
156603733|NCT00691093|565289474|FG000|Overall Study|Adverse Event|1|||
156603734|NCT00691093|565289474|FG000|Overall Study|Lost to Follow-up|1|||
156603735|NCT00691093|565289474|FG000|Overall Study|Lack of Efficacy|1|||
156603736|NCT00691093|565289474|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
156603737|NCT01700985|565289476|FG000|Overall Study|Incarcerated|0|||
156603738|NCT01700985|565289477|FG001|Overall Study|Incarcerated|1|||
156603739|NCT00965146|565289478|FG000|Overall Study|Death|7|||
156603740|NCT00965146|565289478|FG000|Overall Study|Lost to Follow-up|22|||
156603741|NCT00965146|565289478|FG000|Overall Study|Withdrawal by Subject|17|||
156603742|NCT00965146|565289478|FG000|Overall Study|Unable to return|1|||
156603743|NCT00965146|565289478|FG000|Overall Study|Unwilling to return|11|||
156603744|NCT00965146|565289478|FG000|Overall Study|Intercurrent illness|1|||
156603745|NCT00965146|565289478|FG000|Overall Study|Revision / Removal of Study Implant|6|||
156603746|NCT00965146|565289478|FG000|Overall Study|Overall Study Termination|145|||
156603747|NCT01148693|565289479|FG000|Overall Study|Attempts for cannulation were failed|13|||
156603748|NCT01148693|565289480|FG001|Overall Study|Attempts for cannulation were failed|10|||
156603749|NCT01135017|565289481|FG000|Overall Study|Adverse Event|3|||
156603750|NCT01135017|565289482|FG001|Overall Study|Adverse Event|8|||
156603751|NCT01135017|565289481|FG000|Overall Study|Other than above|3|||
156603752|NCT01135017|565289482|FG001|Overall Study|Other than above|4|||
156603753|NCT02146248|565289483|FG000|Overall Study|Withdrawal by Subject|2|||
156603754|NCT00425100|565289484|FG000|Overall Study|Adverse Event|36|||
156603755|NCT00425100|565289484|FG000|Overall Study|Lack of Efficacy|4|||
156603756|NCT00425100|565289484|FG000|Overall Study|Lost to Follow-up|2|||
156603757|NCT00425100|565289484|FG000|Overall Study|Protocol Violation|4|||
156603758|NCT00425100|565289484|FG000|Overall Study|Withdrawal by Subject|7|||
156603759|NCT01767519|565289486|FG000|Overall Study|Other Reasons|4|||
156603760|NCT01767519|565289487|FG001|Overall Study|Other Reasons|4|||
156603761|NCT01767519|565289488|FG002|Overall Study|Other Reasons|2|||
156603762|NCT01767519|565289486|FG000|Overall Study|Protocol Violation|0|||
156603763|NCT01767519|565289487|FG001|Overall Study|Protocol Violation|3|||
156603764|NCT01767519|565289488|FG002|Overall Study|Protocol Violation|0|||
156603765|NCT01767519|565289486|FG000|Overall Study|Personal Reasons|1|||
156603766|NCT01767519|565289487|FG001|Overall Study|Personal Reasons|0|||
156603767|NCT01767519|565289488|FG002|Overall Study|Personal Reasons|0|||
156603768|NCT01767519|565289486|FG000|Overall Study|Lost to Follow-up|3|||
156603769|NCT01767519|565289487|FG001|Overall Study|Lost to Follow-up|1|||
156603770|NCT01767519|565289488|FG002|Overall Study|Lost to Follow-up|2|||
156603771|NCT01767519|565289486|FG000|Overall Study|Lack of Efficacy|1|||
156603772|NCT01767519|565289487|FG001|Overall Study|Lack of Efficacy|0|||
156603773|NCT01767519|565289488|FG002|Overall Study|Lack of Efficacy|0|||
156603774|NCT01767519|565289486|FG000|Overall Study|Adverse Event|5|||
156603775|NCT01767519|565289487|FG001|Overall Study|Adverse Event|5|||
156603776|NCT01767519|565289488|FG002|Overall Study|Adverse Event|1|||
156603777|NCT01181778|565289493|FG000|Overall Study|Physician Decision|48|||
156603778|NCT04021706|565291336|FG000|Overall Study|Adverse Event|2|||
156603779|NCT04021706|565291337|FG001|Overall Study|Adverse Event|0|||
156603780|NCT04021706|565291336|FG000|Overall Study|Withdrawal by Subject|1|||
156603781|NCT04021706|565291337|FG001|Overall Study|Withdrawal by Subject|2|||
156603782|NCT04021706|565291336|FG000|Overall Study|Physician Decision|1|||
156603783|NCT04021706|565291337|FG001|Overall Study|Physician Decision|0|||
156603784|NCT02332798|565291340|FG000|Overall Study|Unwilling to Participate in Study|0|||
156603785|NCT02332798|565291341|FG001|Overall Study|Unwilling to Participate in Study|1|||
156603786|NCT02332798|565291342|FG002|Overall Study|Unwilling to Participate in Study|1|||
156603787|NCT02332798|565291340|FG000|Overall Study|Positive Urine Drug Test|0|||
156603788|NCT02332798|565291341|FG001|Overall Study|Positive Urine Drug Test|1|||
156603789|NCT02332798|565291342|FG002|Overall Study|Positive Urine Drug Test|0|||
156603790|NCT02332798|565291340|FG000|Overall Study|Abnormal Laboratory Findings|1|||
156603791|NCT02332798|565291341|FG001|Overall Study|Abnormal Laboratory Findings|0|||
156603792|NCT02332798|565291342|FG002|Overall Study|Abnormal Laboratory Findings|0|||
156603793|NCT00595868|565291343|FG000|Overall Study|Lost to Follow-up|45|||
156603794|NCT00595868|565291344|FG001|Overall Study|Lost to Follow-up|50|||
156603795|NCT02688153|565291345|FG000|Overall Study|Death|7|||
156603796|NCT02688153|565291346|FG001|Overall Study|Death|5|||
156603797|NCT02688153|565291345|FG000|Overall Study|Withdrawal by Subject|4|||
156603798|NCT02688153|565291346|FG001|Overall Study|Withdrawal by Subject|2|||
156603799|NCT02688153|565291345|FG000|Overall Study|Valve Explant|1|||
156603800|NCT02688153|565291346|FG001|Overall Study|Valve Explant|0|||
156603801|NCT02688153|565291345|FG000|Overall Study|Conversion to Commercial Valve|3|||
156603802|NCT02688153|565291346|FG001|Overall Study|Conversion to Commercial Valve|0|||
156603803|NCT00107172|565291347|FG000|Overall Study|Withdrawal by Subject|1|||
156603804|NCT00107172|565291348|FG001|Overall Study|Withdrawal by Subject|0|||
156603805|NCT00107172|565291347|FG000|Overall Study|Death|0|||
156603806|NCT00107172|565291348|FG001|Overall Study|Death|2|||
156603807|NCT00107172|565291347|FG000|Overall Study|Other Reason|4|||
156603808|NCT00107172|565291348|FG001|Overall Study|Other Reason|3|||
156603809|NCT00859573|565291352|FG000|Overall Study|Withdrawal by Subject|4|||
156603810|NCT00859573|565291353|FG001|Overall Study|Withdrawal by Subject|1|||
156603811|NCT00859573|565291352|FG000|Overall Study|Physician Decision|1|||
156603812|NCT00859573|565291353|FG001|Overall Study|Physician Decision|1|||
156603813|NCT01135394|565291354|FG000|Screening|Lost to Follow-up|2|||
156603814|NCT01135394|565291354|FG000|Screening|Withdrawal by Subject|10|||
156603815|NCT01135394|565291354|FG000|Screening|Screening failure|16|||
156603816|NCT01135394|565291354|FG000|Screening|Physician Decision|5|||
156603817|NCT01135394|565291354|FG000|Baseline Assessment|Withdrawal by Subject|9|||
156603818|NCT01135394|565291354|FG000|Baseline Assessment|Physician Decision|3|||
156603819|NCT01135394|565291354|FG000|Baseline Assessment|Lost to Follow-up|2|||
156603820|NCT01135394|565291354|FG000|Baseline Assessment|Adverse Event|1|||
156603821|NCT01135394|565291354|FG000|Study Treatment|Withdrawal by Subject|1|||
156603822|NCT01135394|565291354|FG000|Study Treatment|Physician Decision|1|||
156603823|NCT01135394|565291354|FG000|Study Treatment|Adverse Event|2|||
156603824|NCT01742091|565291357|FG000|Overall Study|Adverse Event|0|||
156603825|NCT01742091|565291358|FG001|Overall Study|Adverse Event|0|||
156603826|NCT01742091|565291359|FG002|Overall Study|Adverse Event|0|||
156603827|NCT01742091|565291360|FG003|Overall Study|Adverse Event|0|||
156603828|NCT01742091|565291361|FG004|Overall Study|Adverse Event|1|||
156603829|NCT01742091|565291362|FG005|Overall Study|Adverse Event|0|||
156603830|NCT01742091|565291357|FG000|Overall Study|Physician Decision|0|||
156603831|NCT01742091|565291358|FG001|Overall Study|Physician Decision|0|||
156603832|NCT01742091|565291359|FG002|Overall Study|Physician Decision|0|||
156603833|NCT01742091|565291360|FG003|Overall Study|Physician Decision|0|||
156603834|NCT01742091|565291361|FG004|Overall Study|Physician Decision|0|||
156603835|NCT01742091|565291362|FG005|Overall Study|Physician Decision|1|||
156603836|NCT01742091|565291357|FG000|Overall Study|Withdrawal by Subject|0|||
156603837|NCT01742091|565291358|FG001|Overall Study|Withdrawal by Subject|0|||
156603838|NCT01742091|565291359|FG002|Overall Study|Withdrawal by Subject|0|||
156603839|NCT01742091|565291360|FG003|Overall Study|Withdrawal by Subject|1|||
156603840|NCT01742091|565291361|FG004|Overall Study|Withdrawal by Subject|0|||
156603841|NCT01742091|565291362|FG005|Overall Study|Withdrawal by Subject|0|||
156603842|NCT01742091|565291357|FG000|Overall Study|Lost to Follow-up|0|||
156603843|NCT01742091|565291358|FG001|Overall Study|Lost to Follow-up|0|||
156603844|NCT01742091|565291359|FG002|Overall Study|Lost to Follow-up|0|||
156603845|NCT01742091|565291360|FG003|Overall Study|Lost to Follow-up|0|||
156603846|NCT01742091|565291361|FG004|Overall Study|Lost to Follow-up|0|||
156603847|NCT01742091|565291362|FG005|Overall Study|Lost to Follow-up|1|||
156603848|NCT03750240|565291364|FG000|Overall Study|Technical Difficulties|2|||
156603849|NCT00439725|565291365|FG000|Treatment Period|Withdrawal by Subject|22|||
156603850|NCT00439725|565291366|FG001|Treatment Period|Withdrawal by Subject|19|||
156603851|NCT00439725|565291365|FG000|Treatment Period|Study terminated by sponsor|156|||
156603852|NCT00439725|565291366|FG001|Treatment Period|Study terminated by sponsor|148|||
156603853|NCT00439725|565291365|FG000|Treatment Period|Site closed by investigator|1|||
156603854|NCT00439725|565291366|FG001|Treatment Period|Site closed by investigator|2|||
156603855|NCT00439725|565291365|FG000|Treatment Period|Adverse Event|39|||
156603856|NCT00439725|565291366|FG001|Treatment Period|Adverse Event|18|||
156603857|NCT00439725|565291365|FG000|Treatment Period|Physician Decision|1|||
156603858|NCT00439725|565291366|FG001|Treatment Period|Physician Decision|1|||
156603859|NCT00439725|565291365|FG000|Treatment Period|Protocol Violation|2|||
156603860|NCT00439725|565291366|FG001|Treatment Period|Protocol Violation|1|||
156603861|NCT00439725|565291365|FG000|Treatment Period|Clinical endpoint reached|6|||
156603862|NCT00439725|565291366|FG001|Treatment Period|Clinical endpoint reached|50|||
156603863|NCT00439725|565291365|FG000|Treatment Period|Technical problems|1|||
156603864|NCT00439725|565291366|FG001|Treatment Period|Technical problems|0|||
156603865|NCT00439725|565291365|FG000|Treatment Period|Lost to Follow-up|1|||
156603866|NCT00439725|565291366|FG001|Treatment Period|Lost to Follow-up|1|||
156603867|NCT00439725|565291365|FG000|Treatment Period|Participant convenience|1|||
156603868|NCT00439725|565291366|FG001|Treatment Period|Participant convenience|0|||
156603869|NCT00439725|565291365|FG000|Treatment Period|Protocol driven decision point|1|||
156603870|NCT00439725|565291366|FG001|Treatment Period|Protocol driven decision point|1|||
156603871|NCT00439725|565291365|FG000|Treatment Period|Death|1|||
156603872|NCT00439725|565291366|FG001|Treatment Period|Death|1|||
156603873|NCT00439725|565291365|FG000|Treatment Period|Participant did not receive treatment|4|||
156603874|NCT00439725|565291366|FG001|Treatment Period|Participant did not receive treatment|4|||
156603875|NCT00439725|565291365|FG000|Observational Period|Withdrawal by Subject|2|||
156603876|NCT00439725|565291366|FG001|Observational Period|Withdrawal by Subject|2|||
156603877|NCT00439725|565291365|FG000|Observational Period|Lost to Follow-up|0|||
156603878|NCT00439725|565291366|FG001|Observational Period|Lost to Follow-up|1|||
156603879|NCT00439725|565291365|FG000|Observational Period|Death|0|||
156603880|NCT00439725|565291366|FG001|Observational Period|Death|2|||
156603881|NCT00439725|565291365|FG000|Observational Period|Study termination by sponsor|1|||
156603882|NCT00439725|565291366|FG001|Observational Period|Study termination by sponsor|1|||
156603883|NCT00439725|565291365|FG000|Observational Period|Clinical endpoint reached|3|||
156603884|NCT00439725|565291366|FG001|Observational Period|Clinical endpoint reached|1|||
156603885|NCT00439725|565291365|FG000|Observational Period|Technical problems|1|||
156603886|NCT00439725|565291366|FG001|Observational Period|Technical problems|0|||
156603887|NCT00439725|565291365|FG000|Observational Period|Participant convenience|1|||
156603888|NCT00439725|565291366|FG001|Observational Period|Participant convenience|0|||
156603889|NCT02848313|565291367|FG000|Overall Study|Adverse Event|1|||
156603890|NCT02848313|565291368|FG001|Overall Study|Adverse Event|2|||
156603891|NCT02848313|565291367|FG000|Overall Study|Lack of Efficacy|0|||
156603892|NCT02848313|565291368|FG001|Overall Study|Lack of Efficacy|1|||
156603893|NCT02848313|565291367|FG000|Overall Study|Withdrawal by Subject|1|||
156603894|NCT02848313|565291368|FG001|Overall Study|Withdrawal by Subject|1|||
156603895|NCT02848313|565291367|FG000|Overall Study|Lost to follow up|1|||
156603896|NCT02848313|565291368|FG001|Overall Study|Lost to follow up|0|||
156603897|NCT03510910|565291369|FG000|Overall Study|Incomplete Survey|2|||
156603898|NCT03510910|565291370|FG001|Overall Study|Incomplete Survey|3|||
156603899|NCT01673490|565291371|FG000|Overall Study|Lost to Follow-up|1|||
156603900|NCT01673490|565291371|FG000|Overall Study|Adverse Event|3|||
156603901|NCT01673490|565291371|FG000|Overall Study|Withdrawal by Subject|3|||
156603902|NCT00379236|565291372|FG000|Double-blind|Adverse Event|11|||
156603903|NCT00379236|565291373|FG001|Double-blind|Adverse Event|6|||
156603904|NCT00379236|565291374|FG002|Double-blind|Adverse Event|0|||
156603905|NCT00379236|565291372|FG000|Double-blind|Protocol Violation|3|||
156603906|NCT00379236|565291373|FG001|Double-blind|Protocol Violation|3|||
156603907|NCT00379236|565291374|FG002|Double-blind|Protocol Violation|0|||
156603908|NCT00379236|565291372|FG000|Double-blind|Withdrawal by Subject|12|||
156863691|NCT05194124|566258765|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863692|NCT05194124|566258766|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863693|NCT05194124|566258767|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863694|NCT05194124|566258768|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863695|NCT05194124|566258769|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
156863696|NCT03642873|566258772|FG000|Third Intervention (1 Day)|Screen failure|0|||
156863697|NCT03642873|566258773|FG001|Third Intervention (1 Day)|Screen failure|0|||
156863698|NCT03642873|566258774|FG002|Third Intervention (1 Day)|Screen failure|0|||
156863699|NCT03642873|566258775|FG003|Third Intervention (1 Day)|Screen failure|0|||
156863700|NCT03642873|566258776|FG004|Third Intervention (1 Day)|Screen failure|1|||
156863701|NCT03642873|566258777|FG005|Third Intervention (1 Day)|Screen failure|0|||
156863702|NCT03694353|566258785|FG000|Overall Study|Withdrawal by Subject|1|||
156863703|NCT03694353|566258785|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
156863704|NCT03804528|566258786|FG000|Overall Study|Time Commitment|18|||
156863705|NCT03804528|566258786|FG000|Overall Study|Health Reasons|5|||
156603909|NCT00379236|565291373|FG001|Double-blind|Withdrawal by Subject|13|||
156603910|NCT00379236|565291374|FG002|Double-blind|Withdrawal by Subject|0|||
156603911|NCT00379236|565291372|FG000|Double-blind|Lost to Follow-up|4|||
156603912|NCT00379236|565291373|FG001|Double-blind|Lost to Follow-up|3|||
156603913|NCT00379236|565291374|FG002|Double-blind|Lost to Follow-up|0|||
156863706|NCT05138653|566258789|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
156863707|NCT05138653|566258790|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156603914|NCT00379236|565291372|FG000|Double-blind|Use of exclusionary medication|1|||
156603915|NCT00379236|565291373|FG001|Double-blind|Use of exclusionary medication|2|||
156603916|NCT00379236|565291374|FG002|Double-blind|Use of exclusionary medication|0|||
156603917|NCT00379236|565291372|FG000|Double-blind|Other|3|||
156603918|NCT00379236|565291373|FG001|Double-blind|Other|7|||
156603919|NCT00379236|565291374|FG002|Double-blind|Other|0|||
156603920|NCT00379236|565291372|FG000|Double-blind|Data could not be retrieved|2|||
156603921|NCT00379236|565291373|FG001|Double-blind|Data could not be retrieved|2|||
156603922|NCT00379236|565291374|FG002|Double-blind|Data could not be retrieved|0|||
156603923|NCT00379236|565291372|FG000|Open-label Extension|Adverse Event|0|||
156603924|NCT00379236|565291373|FG001|Open-label Extension|Adverse Event|0|||
156603925|NCT00379236|565291374|FG002|Open-label Extension|Adverse Event|13|||
156603926|NCT00379236|565291372|FG000|Open-label Extension|Protocol Violation|0|||
156603927|NCT00379236|565291373|FG001|Open-label Extension|Protocol Violation|0|||
156603928|NCT00379236|565291374|FG002|Open-label Extension|Protocol Violation|7|||
156603929|NCT00379236|565291372|FG000|Open-label Extension|Withdrawal by Subject|0|||
156603930|NCT00379236|565291373|FG001|Open-label Extension|Withdrawal by Subject|0|||
156603931|NCT00379236|565291374|FG002|Open-label Extension|Withdrawal by Subject|13|||
156603932|NCT00379236|565291372|FG000|Open-label Extension|Lost to Follow-up|0|||
156603933|NCT00379236|565291373|FG001|Open-label Extension|Lost to Follow-up|0|||
156603934|NCT00379236|565291374|FG002|Open-label Extension|Lost to Follow-up|12|||
156603935|NCT00379236|565291372|FG000|Open-label Extension|Use of exclusionary medication|0|||
156603936|NCT00379236|565291373|FG001|Open-label Extension|Use of exclusionary medication|0|||
156603937|NCT00379236|565291374|FG002|Open-label Extension|Use of exclusionary medication|3|||
156603938|NCT00379236|565291372|FG000|Open-label Extension|Other|0|||
156603939|NCT00379236|565291373|FG001|Open-label Extension|Other|0|||
156603940|NCT00379236|565291374|FG002|Open-label Extension|Other|7|||
156603941|NCT04914819|565291380|FG000|Overall Study|Pregnancy|3|||
156603942|NCT04914819|565291381|FG001|Overall Study|Pregnancy|1|||
156603943|NCT04914819|565291380|FG000|Overall Study|Discontinued study|4|||
156603944|NCT04914819|565291381|FG001|Overall Study|Discontinued study|1|||
156603945|NCT04914819|565291380|FG000|Overall Study|Lost to Follow-up|7|||
156603946|NCT04914819|565291381|FG001|Overall Study|Lost to Follow-up|0|||
156603947|NCT02715804|565291382|FG000|Overall Study|Death|222|||
156603948|NCT02715804|565291383|FG001|Overall Study|Death|106|||
156603949|NCT02715804|565291382|FG000|Overall Study|Withdrawal by Subject|5|||
156603950|NCT02715804|565291383|FG001|Overall Study|Withdrawal by Subject|4|||
156603951|NCT02715804|565291382|FG000|Overall Study|Other than specified|2|||
156603952|NCT02715804|565291383|FG001|Overall Study|Other than specified|3|||
156603953|NCT01625611|565291386|FG000|Overall Study|No adlib drinks Lab 1|3|||
156603954|NCT01625611|565291387|FG001|Overall Study|No adlib drinks Lab 1|0|||
156603955|NCT01625611|565291386|FG000|Overall Study|Technical issues with PET|1|||
156603956|NCT01625611|565291387|FG001|Overall Study|Technical issues with PET|0|||
156603957|NCT01625611|565291386|FG000|Overall Study|Unable to complete study procedures|1|||
156603958|NCT01625611|565291387|FG001|Overall Study|Unable to complete study procedures|0|||
156603959|NCT01625611|565291386|FG000|Overall Study|Withdrawal by Subject|3|||
156603960|NCT01625611|565291387|FG001|Overall Study|Withdrawal by Subject|0|||
156603961|NCT00948194|565291388|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
156603962|NCT00948194|565291389|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
156603963|NCT02905825|565291398|FG000|Overall Study|Protocol Violation|11|||
156603964|NCT02905825|565291398|FG000|Overall Study|Device Malfunction|1|||
156603965|NCT01709708|565291399|FG000|Overall Study|Protocol Violation|1|||
156603966|NCT01709708|565291400|FG001|Overall Study|Protocol Violation|2|||
156603967|NCT00527072|565291401|FG000|Overall Study|Adverse Event|13|||
156603968|NCT00527072|565291401|FG000|Overall Study|Lack of Efficacy|11|||
156603969|NCT00527072|565291401|FG000|Overall Study|Lost to Follow-up|3|||
156603970|NCT00527072|565291401|FG000|Overall Study|Protocol Violation|2|||
156603971|NCT00527072|565291401|FG000|Overall Study|Withdrawal by Subject|7|||
156603972|NCT02657434|565291402|FG000|Overall Study|Study Terminated By Sponsor|64|||
156603973|NCT02657434|565291403|FG001|Overall Study|Study Terminated By Sponsor|82|||
156603974|NCT02657434|565291402|FG000|Overall Study|Death|189|||
156603975|NCT02657434|565291403|FG001|Overall Study|Death|190|||
156603976|NCT02657434|565291402|FG000|Overall Study|Lost to Follow-up|2|||
156603977|NCT02657434|565291403|FG001|Overall Study|Lost to Follow-up|2|||
156603978|NCT02657434|565291402|FG000|Overall Study|Randomization by Error|2|||
156603979|NCT02657434|565291403|FG001|Overall Study|Randomization by Error|0|||
156603980|NCT02657434|565291402|FG000|Overall Study|Withdrawal by Subject|28|||
156603981|NCT02657434|565291403|FG001|Overall Study|Withdrawal by Subject|17|||
156603982|NCT02657434|565291402|FG000|Overall Study|Protocol Violation|1|||
156603983|NCT02657434|565291403|FG001|Overall Study|Protocol Violation|0|||
156603984|NCT02657434|565291402|FG000|Overall Study|Physician Decision|0|||
156603985|NCT02657434|565291403|FG001|Overall Study|Physician Decision|1|||
156603986|NCT02137837|565291411|FG000|Overall Study|Adverse Event|0|||
156603987|NCT02137837|565291412|FG001|Overall Study|Adverse Event|2|||
156603988|NCT02137837|565291413|FG002|Overall Study|Adverse Event|1|||
156603989|NCT02137837|565291411|FG000|Overall Study|Refusal unrelated to adverse event|2|||
156603990|NCT02137837|565291412|FG001|Overall Study|Refusal unrelated to adverse event|2|||
156634910|NCT03917654|565407822|FG007|Year 1|Travel|8|||
156603991|NCT02137837|565291413|FG002|Overall Study|Refusal unrelated to adverse event|1|||
156603992|NCT02137837|565291411|FG000|Overall Study|Progression/relapse|9|||
156603993|NCT02137837|565291412|FG001|Overall Study|Progression/relapse|7|||
156603994|NCT02137837|565291413|FG002|Overall Study|Progression/relapse|7|||
156603995|NCT02137837|565291411|FG000|Overall Study|Not protocol specified|2|||
156603996|NCT02137837|565291412|FG001|Overall Study|Not protocol specified|1|||
156603997|NCT02137837|565291413|FG002|Overall Study|Not protocol specified|3|||
156603998|NCT01181141|565291414|FG000|Overall Study|Adverse Event|2|||
156603999|NCT01181141|565291415|FG001|Overall Study|Adverse Event|1|||
156604000|NCT01181141|565291414|FG000|Overall Study|Lack of Efficacy|1|||
156604001|NCT01181141|565291415|FG001|Overall Study|Lack of Efficacy|0|||
156604002|NCT01181141|565291414|FG000|Overall Study|Lost to Follow-up|1|||
156604003|NCT01181141|565291415|FG001|Overall Study|Lost to Follow-up|1|||
156604004|NCT01181141|565291414|FG000|Overall Study|Physician Decision|2|||
156604005|NCT01181141|565291415|FG001|Overall Study|Physician Decision|0|||
156604006|NCT01181141|565291414|FG000|Overall Study|Protocol Violation|3|||
156604007|NCT01181141|565291415|FG001|Overall Study|Protocol Violation|1|||
156604008|NCT01181141|565291414|FG000|Overall Study|Withdrawal by Subject|3|||
156604009|NCT01181141|565291415|FG001|Overall Study|Withdrawal by Subject|1|||
156604010|NCT00118911|565291416|FG000|Overall Study|Withdrawal by Subject|2|||
156604011|NCT00118911|565291417|FG001|Overall Study|Withdrawal by Subject|5|||
156604012|NCT03496662|565291419|FG000|Overall Study|Adverse Event|0|||
156604013|NCT03496662|565291420|FG001|Overall Study|Adverse Event|0|||
156604014|NCT03496662|565291421|FG002|Overall Study|Adverse Event|4|||
156604015|NCT03496662|565291419|FG000|Overall Study|Withdrawal by Subject|1|||
156604016|NCT03496662|565291420|FG001|Overall Study|Withdrawal by Subject|0|||
156604017|NCT03496662|565291421|FG002|Overall Study|Withdrawal by Subject|2|||
156604018|NCT03496662|565291419|FG000|Overall Study|Death|0|||
156604019|NCT03496662|565291420|FG001|Overall Study|Death|0|||
156604020|NCT03496662|565291421|FG002|Overall Study|Death|2|||
156604021|NCT03496662|565291419|FG000|Overall Study|Noncompliance|0|||
156604022|NCT03496662|565291420|FG001|Overall Study|Noncompliance|0|||
156604023|NCT03496662|565291421|FG002|Overall Study|Noncompliance|1|||
156604024|NCT01467661|565291422|FG000|Overall Study|Adverse Event|16|||
156604025|NCT01467661|565291422|FG000|Overall Study|Withdrawal by Subject|1|||
156604026|NCT01467661|565291422|FG000|Overall Study|Lack of Efficacy|3|||
156604027|NCT01467661|565291422|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
156604028|NCT03814005|565291425|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
156604029|NCT03814005|565291426|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
156604030|NCT03814005|565291427|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
156604031|NCT03814005|565291425|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
156604032|NCT03814005|565291426|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
156604033|NCT03814005|565291427|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
156604034|NCT03814005|565291425|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
156604035|NCT03814005|565291426|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
156604036|NCT03814005|565291427|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
156604037|NCT03814005|565291425|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
156604038|NCT03814005|565291426|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
156604039|NCT03814005|565291427|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
156604040|NCT03814005|565291425|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
156604041|NCT03814005|565291426|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
156604042|NCT03814005|565291427|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
156604043|NCT03814005|565291425|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
156604044|NCT03814005|565291426|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
156604045|NCT03814005|565291427|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
156604046|NCT03395223|565291428|FG000|Overall Study|Lost to Follow-up|3|||
156604047|NCT03395223|565291428|FG000|Overall Study|Other|1|||
156604048|NCT00810810|565291429|FG000|Overall Study|Withdrawal by Subject|0|||
156604049|NCT00810810|565291430|FG001|Overall Study|Withdrawal by Subject|8|||
156604050|NCT00810810|565291431|FG002|Overall Study|Withdrawal by Subject|10|||
156604051|NCT00810810|565291432|FG003|Overall Study|Withdrawal by Subject|8|||
156604052|NCT00810810|565291429|FG000|Overall Study|Physician Decision|0|||
156604053|NCT00810810|565291430|FG001|Overall Study|Physician Decision|3|||
156604054|NCT00810810|565291431|FG002|Overall Study|Physician Decision|1|||
156604055|NCT00810810|565291432|FG003|Overall Study|Physician Decision|5|||
156604056|NCT01896856|565291433|FG000|Overall Study|Transportation issues / Non-compliance|0|||
156604057|NCT01896856|565291434|FG001|Overall Study|Transportation issues / Non-compliance|0|||
156604058|NCT01896856|565291435|FG002|Overall Study|Transportation issues / Non-compliance|1|||
156604059|NCT01896856|565291436|FG003|Overall Study|Transportation issues / Non-compliance|0|||
156604060|NCT01896856|565291437|FG004|Overall Study|Transportation issues / Non-compliance|0|||
156604061|NCT01896856|565291438|FG005|Overall Study|Transportation issues / Non-compliance|0|||
156604062|NCT01156532|565291439|FG000|Overall Study|Family Reasons|1|||
156604063|NCT01156532|565291439|FG000|Overall Study|Lost to Follow-up|1|||
156604064|NCT02563925|565291442|FG000|Overall Study|Withdrawal by Subject|2|||
156604065|NCT00282867|565291446|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
156604066|NCT00282867|565291447|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
156604067|NCT00282867|565291448|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
156604068|NCT05067452|565291449|FG000|Overall Study|Lost to Follow-up|0|||
156604069|NCT05067452|565291450|FG001|Overall Study|Lost to Follow-up|4|||
156604070|NCT01074658|565291451|FG000|Overall Study|No implant attempted|19|||
156604071|NCT00426556|565291452|FG000|Phase I - Core Phase|Disease Progression|0|||
156604072|NCT00426556|565291453|FG001|Phase I - Core Phase|Disease Progression|6|||
156604073|NCT00426556|565291454|FG002|Phase I - Core Phase|Disease Progression|2|||
156604074|NCT00426556|565291455|FG003|Phase I - Core Phase|Disease Progression|0|||
156604075|NCT00426556|565291452|FG000|Phase I - Core Phase|Adverse Event|1|||
156604076|NCT00426556|565291453|FG001|Phase I - Core Phase|Adverse Event|3|||
156604077|NCT00426556|565291454|FG002|Phase I - Core Phase|Adverse Event|1|||
156604078|NCT00426556|565291455|FG003|Phase I - Core Phase|Adverse Event|0|||
156604079|NCT00426556|565291452|FG000|Phase I - Core Phase|Death|0|||
156604080|NCT00426556|565291453|FG001|Phase I - Core Phase|Death|1|||
156604081|NCT00426556|565291454|FG002|Phase I - Core Phase|Death|0|||
156604082|NCT00426556|565291455|FG003|Phase I - Core Phase|Death|0|||
156604083|NCT00426556|565291452|FG000|Phase I - Extension Phase|Adverse Event|0|||
156604084|NCT00426556|565291453|FG001|Phase I - Extension Phase|Adverse Event|1|||
156604085|NCT00426556|565291454|FG002|Phase I - Extension Phase|Adverse Event|1|||
156604086|NCT00426556|565291455|FG003|Phase I - Extension Phase|Adverse Event|0|||
156604087|NCT00426556|565291452|FG000|Phase I - Extension Phase|Disease Progression|5|||
156604088|NCT00426556|565291453|FG001|Phase I - Extension Phase|Disease Progression|5|||
156604089|NCT00426556|565291454|FG002|Phase I - Extension Phase|Disease Progression|6|||
156604090|NCT00426556|565291455|FG003|Phase I - Extension Phase|Disease Progression|0|||
156604091|NCT00426556|565291452|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
156604092|NCT00426556|565291453|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
156604093|NCT00426556|565291454|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
156604094|NCT00426556|565291455|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
156604095|NCT00426556|565291452|FG000|Phase II - Core Phase|Disease Progression|0|||
156604096|NCT00426556|565291453|FG001|Phase II - Core Phase|Disease Progression|0|||
156604097|NCT00426556|565291454|FG002|Phase II - Core Phase|Disease Progression|0|||
156604098|NCT00426556|565291455|FG003|Phase II - Core Phase|Disease Progression|16|||
156604099|NCT00426556|565291452|FG000|Phase II - Core Phase|Adverse Event|0|||
156604100|NCT00426556|565291453|FG001|Phase II - Core Phase|Adverse Event|0|||
156604101|NCT00426556|565291454|FG002|Phase II - Core Phase|Adverse Event|0|||
156604102|NCT00426556|565291455|FG003|Phase II - Core Phase|Adverse Event|8|||
156604103|NCT00426556|565291452|FG000|Phase II - Extension Phase|Disease Progression|0|||
156604104|NCT00426556|565291453|FG001|Phase II - Extension Phase|Disease Progression|0|||
156604105|NCT00426556|565291454|FG002|Phase II - Extension Phase|Disease Progression|0|||
156604106|NCT00426556|565291455|FG003|Phase II - Extension Phase|Disease Progression|21|||
156604107|NCT00426556|565291452|FG000|Phase II - Extension Phase|Adverse Event|0|||
156604108|NCT00426556|565291453|FG001|Phase II - Extension Phase|Adverse Event|0|||
156604109|NCT00426556|565291454|FG002|Phase II - Extension Phase|Adverse Event|0|||
156604110|NCT00426556|565291455|FG003|Phase II - Extension Phase|Adverse Event|2|||
156604111|NCT00432562|565291461|FG000|Overall Study|Death|3|||
156604112|NCT00432562|565291462|FG001|Overall Study|Death|0|||
156604113|NCT03970824|565291463|FG000|Overall Study|Withdrawal by Subject|1|||
156604114|NCT03970824|565291464|FG001|Overall Study|Withdrawal by Subject|1|||
156604115|NCT03970824|565291465|FG002|Overall Study|Withdrawal by Subject|3|||
156604116|NCT03970824|565291463|FG000|Overall Study|Lost to Follow-up|0|||
156604117|NCT03970824|565291464|FG001|Overall Study|Lost to Follow-up|2|||
156604118|NCT03970824|565291465|FG002|Overall Study|Lost to Follow-up|1|||
156604119|NCT03970824|565291463|FG000|Overall Study|Adverse Event|1|||
156604120|NCT03970824|565291464|FG001|Overall Study|Adverse Event|0|||
156604121|NCT03970824|565291465|FG002|Overall Study|Adverse Event|0|||
156604122|NCT00493974|565291470|FG000|Overall Study|Death|1|||
156604123|NCT00493974|565291471|FG001|Overall Study|Death|2|||
156604124|NCT00493974|565291470|FG000|Overall Study|Withdrawal by Subject|8|||
156604125|NCT00493974|565291471|FG001|Overall Study|Withdrawal by Subject|6|||
156604126|NCT00493974|565291470|FG000|Overall Study|Lost to Follow-up|4|||
156604127|NCT00493974|565291471|FG001|Overall Study|Lost to Follow-up|6|||
156604128|NCT00862654|565291472|FG000|Overall Study|Lack of Efficacy|1|||
156604129|NCT00862654|565291473|FG001|Overall Study|Lack of Efficacy|0|||
156604130|NCT00862654|565291474|FG002|Overall Study|Lack of Efficacy|1|||
156604131|NCT00862654|565291475|FG003|Overall Study|Lack of Efficacy|0|||
156604132|NCT00862654|565291472|FG000|Overall Study|Lost to Follow-up|1|||
156604133|NCT00862654|565291473|FG001|Overall Study|Lost to Follow-up|2|||
156604134|NCT00862654|565291474|FG002|Overall Study|Lost to Follow-up|1|||
156604135|NCT00862654|565291475|FG003|Overall Study|Lost to Follow-up|3|||
156604136|NCT00862654|565291472|FG000|Overall Study|Adverse Event|0|||
156604137|NCT00862654|565291473|FG001|Overall Study|Adverse Event|1|||
156604138|NCT00862654|565291474|FG002|Overall Study|Adverse Event|1|||
156604139|NCT00862654|565291475|FG003|Overall Study|Adverse Event|0|||
156604140|NCT00862654|565291472|FG000|Overall Study|Pregnancy|1|||
156604141|NCT00862654|565291473|FG001|Overall Study|Pregnancy|1|||
156604142|NCT00862654|565291474|FG002|Overall Study|Pregnancy|0|||
156604143|NCT00862654|565291475|FG003|Overall Study|Pregnancy|0|||
156604144|NCT00862654|565291472|FG000|Overall Study|Withdrawal by Subject|2|||
156604145|NCT00862654|565291473|FG001|Overall Study|Withdrawal by Subject|2|||
156604146|NCT00862654|565291474|FG002|Overall Study|Withdrawal by Subject|2|||
156604147|NCT00862654|565291475|FG003|Overall Study|Withdrawal by Subject|3|||
156604148|NCT00862654|565291472|FG000|Overall Study|Subject mistake|0|||
156604149|NCT00862654|565291473|FG001|Overall Study|Subject mistake|1|||
156604150|NCT00862654|565291474|FG002|Overall Study|Subject mistake|0|||
156604151|NCT00862654|565291475|FG003|Overall Study|Subject mistake|0|||
156604152|NCT00862654|565291472|FG000|Overall Study|Familly constraint|0|||
156604153|NCT00862654|565291473|FG001|Overall Study|Familly constraint|1|||
156604154|NCT00862654|565291474|FG002|Overall Study|Familly constraint|0|||
156604155|NCT00862654|565291475|FG003|Overall Study|Familly constraint|0|||
156604156|NCT00862654|565291472|FG000|Overall Study|Never used study drugs|1|||
156604157|NCT00862654|565291473|FG001|Overall Study|Never used study drugs|0|||
156604158|NCT00862654|565291474|FG002|Overall Study|Never used study drugs|0|||
156604159|NCT00862654|565291475|FG003|Overall Study|Never used study drugs|0|||
156604160|NCT00862654|565291472|FG000|Overall Study|Included after end of inclusions|0|||
156604161|NCT00862654|565291473|FG001|Overall Study|Included after end of inclusions|0|||
156604162|NCT00862654|565291474|FG002|Overall Study|Included after end of inclusions|1|||
156604163|NCT00862654|565291475|FG003|Overall Study|Included after end of inclusions|0|||
156604164|NCT03219567|565291476|FG000|Overall Study|Withdrawal by Subject|0|||
156604165|NCT03219567|565291477|FG001|Overall Study|Withdrawal by Subject|1|||
156604166|NCT02713789|565291481|FG000|Overall Study|Lost to Follow-up|0|||
156604167|NCT02713789|565291482|FG001|Overall Study|Lost to Follow-up|1|||
156604168|NCT02713789|565291483|FG002|Overall Study|Lost to Follow-up|1|||
156604169|NCT02726113|565291484|FG000|Total Enrollment|Physician Decision|0|||
156604170|NCT02726113|565291485|FG001|Total Enrollment|Physician Decision|1|||
156604171|NCT02726113|565291484|FG000|Total Enrollment|Protocol Violation|1|||
156604172|NCT02726113|565291485|FG001|Total Enrollment|Protocol Violation|0|||
156604173|NCT02726113|565291484|FG000|Total Enrollment|Withdrawal by Subject|2|||
156604174|NCT02726113|565291485|FG001|Total Enrollment|Withdrawal by Subject|1|||
156604175|NCT02726113|565291484|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
156604176|NCT02726113|565291485|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
156604177|NCT02726113|565291484|FG000|Genomic Analysis|Protocol Violation|1|||
156604178|NCT02726113|565291485|FG001|Genomic Analysis|Protocol Violation|0|||
156604179|NCT02726113|565291484|FG000|Genomic Analysis|Withdrawal by Subject|2|||
156604180|NCT02726113|565291485|FG001|Genomic Analysis|Withdrawal by Subject|1|||
156604181|NCT02726113|565291484|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
156604182|NCT02726113|565291485|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
156604183|NCT03549117|565291486|FG000|Overall Study|Withdrawal by Subject|1|||
156604184|NCT03549117|565291487|FG001|Overall Study|Withdrawal by Subject|0|||
156604185|NCT03148756|565291491|FG000|Overall Study|Study Terminated|0|||
156604186|NCT03148756|565291492|FG001|Overall Study|Study Terminated|1|||
156604187|NCT00637377|565291498|FG000|Overall Study|Adverse Event|2|||
156604188|NCT00637377|565291499|FG001|Overall Study|Adverse Event|6|||
156604189|NCT00637377|565291500|FG002|Overall Study|Adverse Event|8|||
156604190|NCT00637377|565291501|FG003|Overall Study|Adverse Event|9|||
156604191|NCT00637377|565291498|FG000|Overall Study|Death|1|||
156604192|NCT00637377|565291499|FG001|Overall Study|Death|3|||
156604193|NCT00637377|565291500|FG002|Overall Study|Death|2|||
156604194|NCT00637377|565291501|FG003|Overall Study|Death|1|||
156604195|NCT00637377|565291498|FG000|Overall Study|Lack of Efficacy|0|||
156604196|NCT00637377|565291499|FG001|Overall Study|Lack of Efficacy|0|||
156604197|NCT00637377|565291500|FG002|Overall Study|Lack of Efficacy|1|||
156604198|NCT00637377|565291501|FG003|Overall Study|Lack of Efficacy|1|||
156604199|NCT00637377|565291498|FG000|Overall Study|Lost to Follow-up|4|||
156604200|NCT00637377|565291499|FG001|Overall Study|Lost to Follow-up|1|||
156604201|NCT00637377|565291500|FG002|Overall Study|Lost to Follow-up|2|||
156604202|NCT00637377|565291501|FG003|Overall Study|Lost to Follow-up|2|||
156604203|NCT00637377|565291498|FG000|Overall Study|Protocol Violation|2|||
156604204|NCT00637377|565291499|FG001|Overall Study|Protocol Violation|1|||
156604205|NCT00637377|565291500|FG002|Overall Study|Protocol Violation|1|||
156604206|NCT00637377|565291501|FG003|Overall Study|Protocol Violation|0|||
156604207|NCT00637377|565291498|FG000|Overall Study|Withdrawal by Subject|11|||
156604208|NCT00637377|565291499|FG001|Overall Study|Withdrawal by Subject|15|||
156604209|NCT00637377|565291500|FG002|Overall Study|Withdrawal by Subject|13|||
156604210|NCT00637377|565291501|FG003|Overall Study|Withdrawal by Subject|11|||
156604211|NCT00637377|565291498|FG000|Overall Study|Other (no further information available)|7|||
156604212|NCT00637377|565291499|FG001|Overall Study|Other (no further information available)|6|||
156604213|NCT00637377|565291500|FG002|Overall Study|Other (no further information available)|10|||
156604214|NCT00637377|565291501|FG003|Overall Study|Other (no further information available)|5|||
156604215|NCT01293084|565291503|FG000|Overall Study|Physician Decision|3|||
156604216|NCT01293084|565291503|FG000|Overall Study|Withdrawal by Subject|2|||
156604217|NCT04186663|565291504|FG000|Overall Study|Lost to Follow-up|1|||
156604218|NCT04186663|565291504|FG000|Overall Study|Unable to complete blood draw|3|||
156604219|NCT00719862|565291509|FG000|Overall Study|Adverse Event|1|||
156604220|NCT00719862|565291510|FG001|Overall Study|Adverse Event|2|||
156604221|NCT00719862|565291509|FG000|Overall Study|Lack of Efficacy|3|||
156604222|NCT00719862|565291510|FG001|Overall Study|Lack of Efficacy|0|||
156604223|NCT00719862|565291509|FG000|Overall Study|Non-Compliance|1|||
156604224|NCT00719862|565291510|FG001|Overall Study|Non-Compliance|0|||
156604225|NCT00719862|565291509|FG000|Overall Study|Withdrawal by Subject|1|||
156604226|NCT00719862|565291510|FG001|Overall Study|Withdrawal by Subject|0|||
156604227|NCT00719862|565291509|FG000|Overall Study|Lost to Follow-up|0|||
156604228|NCT00719862|565291510|FG001|Overall Study|Lost to Follow-up|1|||
156604229|NCT00719862|565291509|FG000|Overall Study|Other|2|||
156604230|NCT00719862|565291510|FG001|Overall Study|Other|3|||
156604231|NCT04432376|565293478|FG000|Double-blind Treatment Period|Adverse Event|2|||
156604232|NCT04432376|565293479|FG001|Double-blind Treatment Period|Adverse Event|6|||
156604233|NCT04432376|565293480|FG002|Double-blind Treatment Period|Adverse Event|0|||
156604234|NCT04432376|565293478|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
156604235|NCT04432376|565293479|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
156604236|NCT04432376|565293480|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
156604237|NCT04432376|565293478|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
156604238|NCT04432376|565293479|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
156604239|NCT04432376|565293480|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156604240|NCT04432376|565293478|FG000|Double-blind Treatment Period|Protocol Violation|0|||
156604241|NCT04432376|565293479|FG001|Double-blind Treatment Period|Protocol Violation|1|||
156604242|NCT04432376|565293480|FG002|Double-blind Treatment Period|Protocol Violation|0|||
156604243|NCT04432376|565293478|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
156604244|NCT04432376|565293479|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
156604245|NCT04432376|565293480|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
156604246|NCT00462488|565293481|FG000|Overall Study|Protocol Violation|1|||
156604247|NCT00462488|565293482|FG001|Overall Study|Protocol Violation|0|||
156604248|NCT00462488|565293481|FG000|Overall Study|Lack of Efficacy|19|||
156604249|NCT00462488|565293482|FG001|Overall Study|Lack of Efficacy|17|||
156604250|NCT02088541|565293485|FG000|Overall Study|Adverse Event|3|||
156604251|NCT02088541|565293486|FG001|Overall Study|Adverse Event|0|||
156604252|NCT02088541|565293487|FG002|Overall Study|Adverse Event|3|||
156604253|NCT02088541|565293488|FG003|Overall Study|Adverse Event|3|||
156604254|NCT02088541|565293489|FG004|Overall Study|Adverse Event|0|||
156604255|NCT02088541|565293485|FG000|Overall Study|Death|51|||
156604256|NCT02088541|565293486|FG001|Overall Study|Death|21|||
156604257|NCT02088541|565293487|FG002|Overall Study|Death|85|||
156604258|NCT02088541|565293488|FG003|Overall Study|Death|28|||
156604259|NCT02088541|565293489|FG004|Overall Study|Death|38|||
156604260|NCT02088541|565293485|FG000|Overall Study|Lost to Follow-up|2|||
156604261|NCT02088541|565293486|FG001|Overall Study|Lost to Follow-up|0|||
156604262|NCT02088541|565293487|FG002|Overall Study|Lost to Follow-up|1|||
156604263|NCT02088541|565293488|FG003|Overall Study|Lost to Follow-up|0|||
156604264|NCT02088541|565293489|FG004|Overall Study|Lost to Follow-up|0|||
156604265|NCT02088541|565293485|FG000|Overall Study|Physician Decision|2|||
156604266|NCT02088541|565293486|FG001|Overall Study|Physician Decision|1|||
156604267|NCT02088541|565293487|FG002|Overall Study|Physician Decision|2|||
156604268|NCT02088541|565293488|FG003|Overall Study|Physician Decision|0|||
156604269|NCT02088541|565293489|FG004|Overall Study|Physician Decision|2|||
156604270|NCT02088541|565293485|FG000|Overall Study|Disease progression|7|||
156604271|NCT02088541|565293486|FG001|Overall Study|Disease progression|1|||
156604272|NCT02088541|565293487|FG002|Overall Study|Disease progression|2|||
156604273|NCT02088541|565293488|FG003|Overall Study|Disease progression|3|||
156604274|NCT02088541|565293489|FG004|Overall Study|Disease progression|1|||
156604275|NCT02088541|565293485|FG000|Overall Study|Study terminated by sponsor|1|||
156604276|NCT02088541|565293486|FG001|Overall Study|Study terminated by sponsor|1|||
156604277|NCT02088541|565293487|FG002|Overall Study|Study terminated by sponsor|12|||
156604278|NCT02088541|565293488|FG003|Overall Study|Study terminated by sponsor|2|||
156604279|NCT02088541|565293489|FG004|Overall Study|Study terminated by sponsor|6|||
156604280|NCT02088541|565293485|FG000|Overall Study|Withdrawal by Subject|3|||
156604281|NCT02088541|565293486|FG001|Overall Study|Withdrawal by Subject|2|||
156604282|NCT02088541|565293487|FG002|Overall Study|Withdrawal by Subject|9|||
156604283|NCT02088541|565293488|FG003|Overall Study|Withdrawal by Subject|7|||
156604284|NCT02088541|565293489|FG004|Overall Study|Withdrawal by Subject|10|||
156604285|NCT02088541|565293485|FG000|Overall Study|Other|2|||
156604286|NCT02088541|565293486|FG001|Overall Study|Other|1|||
156604287|NCT02088541|565293487|FG002|Overall Study|Other|3|||
156604288|NCT02088541|565293488|FG003|Overall Study|Other|1|||
156604289|NCT02088541|565293489|FG004|Overall Study|Other|1|||
156604290|NCT05742841|565293490|FG000|Overall Study|Withdrawal by Subject|1|||
156604291|NCT05742841|565293490|FG000|Overall Study|Lost to Follow-up|1|||
156604292|NCT03706040|565293491|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
156604293|NCT03706040|565293492|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
156604294|NCT03706040|565293493|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
156604295|NCT03706040|565293494|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
156604296|NCT03706040|565293495|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
156604297|NCT03706040|565293496|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
156604298|NCT03706040|565293497|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
156604299|NCT03706040|565293491|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
156604300|NCT03706040|565293492|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
156604301|NCT03706040|565293493|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
156604302|NCT03706040|565293494|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
156604303|NCT03706040|565293495|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
156604304|NCT03706040|565293496|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
156604305|NCT03706040|565293497|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
156604306|NCT03706040|565293491|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
156604307|NCT03706040|565293492|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
156604308|NCT03706040|565293493|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
156604309|NCT03706040|565293494|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
156604310|NCT03706040|565293495|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
156604311|NCT03706040|565293496|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
156604312|NCT03706040|565293497|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
156604313|NCT03706040|565293491|FG000|Period A (Week 0 to Week 16)|Other|2|||
156604314|NCT03706040|565293492|FG001|Period A (Week 0 to Week 16)|Other|0|||
156604315|NCT03706040|565293493|FG002|Period A (Week 0 to Week 16)|Other|2|||
156604316|NCT03706040|565293494|FG003|Period A (Week 0 to Week 16)|Other|0|||
156604317|NCT03706040|565293495|FG004|Period A (Week 0 to Week 16)|Other|0|||
156604318|NCT03706040|565293496|FG005|Period A (Week 0 to Week 16)|Other|0|||
156604319|NCT03706040|565293497|FG006|Period A (Week 0 to Week 16)|Other|0|||
156604320|NCT03706040|565293491|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
156604321|NCT03706040|565293492|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
156604322|NCT03706040|565293493|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
156604323|NCT03706040|565293494|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
156604324|NCT03706040|565293495|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
156604325|NCT03706040|565293496|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
156604326|NCT03706040|565293497|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
156604327|NCT03706040|565293491|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
156604328|NCT03706040|565293492|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
156604329|NCT03706040|565293493|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
156604330|NCT03706040|565293494|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
156604331|NCT03706040|565293495|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
156604332|NCT03706040|565293496|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
156604333|NCT03706040|565293497|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
156604334|NCT03706040|565293491|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156604335|NCT03706040|565293492|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156604336|NCT03706040|565293493|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156604337|NCT03706040|565293494|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156604338|NCT03706040|565293495|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156604339|NCT03706040|565293496|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
156604340|NCT03706040|565293497|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
156604341|NCT03706040|565293491|FG000|Period B (Week 16 to Week 52)|Other|0|||
156604342|NCT03706040|565293492|FG001|Period B (Week 16 to Week 52)|Other|0|||
156604343|NCT03706040|565293493|FG002|Period B (Week 16 to Week 52)|Other|0|||
156604344|NCT03706040|565293494|FG003|Period B (Week 16 to Week 52)|Other|4|||
156604345|NCT03706040|565293495|FG004|Period B (Week 16 to Week 52)|Other|5|||
156604346|NCT03706040|565293496|FG005|Period B (Week 16 to Week 52)|Other|23|||
156604347|NCT03706040|565293497|FG006|Period B (Week 16 to Week 52)|Other|17|||
156604348|NCT00927758|565293498|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
156604349|NCT00927758|565293499|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
156604350|NCT00927758|565293500|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
156604351|NCT00927758|565293501|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
156604352|NCT00927758|565293502|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
156604353|NCT00927758|565293503|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
156604354|NCT00927758|565293498|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
156604355|NCT00927758|565293499|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
156604356|NCT00927758|565293500|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
156604357|NCT00927758|565293501|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
156604358|NCT00927758|565293502|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
156604359|NCT00927758|565293503|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
156604360|NCT02940860|565293506|FG000|Overall Study|Non-serious AE|1|||
156604361|NCT02940860|565293507|FG001|Overall Study|Non-serious AE|2|||
156604362|NCT02940860|565293506|FG000|Overall Study|Serious AE|7|||
156604363|NCT02940860|565293507|FG001|Overall Study|Serious AE|3|||
156604364|NCT02940860|565293506|FG000|Overall Study|Withdrawal by Subject|19|||
156604365|NCT02940860|565293507|FG001|Overall Study|Withdrawal by Subject|9|||
156604366|NCT02940860|565293506|FG000|Overall Study|Lost to Follow-up|13|||
156604367|NCT02940860|565293507|FG001|Overall Study|Lost to Follow-up|7|||
156604368|NCT02940860|565293506|FG000|Overall Study|Physician Decision|5|||
156604369|NCT02940860|565293507|FG001|Overall Study|Physician Decision|3|||
156604370|NCT02940860|565293506|FG000|Overall Study|Sponsor Decision|0|||
156604371|NCT02940860|565293507|FG001|Overall Study|Sponsor Decision|1|||
156604372|NCT02940860|565293506|FG000|Overall Study|Protocol Violation|0|||
156604373|NCT02940860|565293507|FG001|Overall Study|Protocol Violation|2|||
156604374|NCT02940860|565293506|FG000|Overall Study|Death|3|||
156604375|NCT02940860|565293507|FG001|Overall Study|Death|2|||
156604376|NCT02940860|565293506|FG000|Overall Study|Moved, poor venous access, transport|6|||
156604377|NCT02940860|565293507|FG001|Overall Study|Moved, poor venous access, transport|4|||
156604378|NCT02940860|565293506|FG000|Overall Study|Not treated|2|||
156604379|NCT02940860|565293507|FG001|Overall Study|Not treated|2|||
156604380|NCT02431793|565293509|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
156604381|NCT02431793|565293510|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
156604382|NCT02431793|565293511|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
156604383|NCT02431793|565293509|FG000|Overall Study|Withdrawal by Subject|7|||
156604384|NCT02431793|565293510|FG001|Overall Study|Withdrawal by Subject|5|||
156604385|NCT02431793|565293511|FG002|Overall Study|Withdrawal by Subject|5|||
156604386|NCT02431793|565293509|FG000|Overall Study|Lost to Follow-up|101|||
156604387|NCT02431793|565293510|FG001|Overall Study|Lost to Follow-up|122|||
156604388|NCT02431793|565293511|FG002|Overall Study|Lost to Follow-up|104|||
156604389|NCT01563107|565293516|FG000|Overall Study|Physician Decision|0|||
156604390|NCT01563107|565293517|FG001|Overall Study|Physician Decision|1|||
156604391|NCT01563107|565293518|FG002|Overall Study|Physician Decision|1|||
156604392|NCT01563107|565293519|FG003|Overall Study|Physician Decision|3|||
156604393|NCT01563107|565293516|FG000|Overall Study|Withdrawal by Subject|1|||
156604394|NCT01563107|565293517|FG001|Overall Study|Withdrawal by Subject|2|||
156604395|NCT01563107|565293518|FG002|Overall Study|Withdrawal by Subject|1|||
156604396|NCT01563107|565293519|FG003|Overall Study|Withdrawal by Subject|2|||
156604397|NCT02707601|565293520|FG000|Overall Study|Death|0|||
156604398|NCT02707601|565293521|FG001|Overall Study|Death|1|||
156604399|NCT02707601|565293520|FG000|Overall Study|Lack of Efficacy|0|||
156604400|NCT02707601|565293521|FG001|Overall Study|Lack of Efficacy|1|||
156604401|NCT02707601|565293520|FG000|Overall Study|Investigator's Discretion|1|||
156604402|NCT02707601|565293521|FG001|Overall Study|Investigator's Discretion|0|||
156604403|NCT02707601|565293520|FG000|Overall Study|Withdrew Consent|0|||
156604404|NCT02707601|565293521|FG001|Overall Study|Withdrew Consent|1|||
156604405|NCT02707601|565293520|FG000|Overall Study|Lost to Follow-up|1|||
156604406|NCT02707601|565293521|FG001|Overall Study|Lost to Follow-up|1|||
156604407|NCT02707601|565293520|FG000|Overall Study|Participants Randomized but Not Treated|2|||
156604408|NCT02707601|565293521|FG001|Overall Study|Participants Randomized but Not Treated|0|||
156604409|NCT00063986|565293523|FG000|Overall Study|Withdrawal by Subject|1|||
156604410|NCT00063986|565293523|FG000|Overall Study|Ineligible|1|||
156604411|NCT00063986|565293523|FG000|Overall Study|Intra-operatively ineligible|4|||
156604412|NCT00247273|565293524|FG000|Overall Study|Adverse Event|85|||
156604413|NCT00247273|565293525|FG001|Overall Study|Adverse Event|80|||
156604414|NCT00247273|565293524|FG000|Overall Study|Physician Decision|6|||
156604415|NCT00247273|565293525|FG001|Overall Study|Physician Decision|3|||
156604416|NCT00247273|565293524|FG000|Overall Study|Lost to Follow-up|7|||
156604417|NCT00247273|565293525|FG001|Overall Study|Lost to Follow-up|7|||
156604418|NCT00247273|565293524|FG000|Overall Study|Withdrawal by Subject|46|||
156604419|NCT00247273|565293525|FG001|Overall Study|Withdrawal by Subject|47|||
156604420|NCT00247273|565293524|FG000|Overall Study|Did not take any study drug|2|||
156604421|NCT00247273|565293525|FG001|Overall Study|Did not take any study drug|0|||
156604422|NCT00270998|565293526|FG000|3 Month Follow-up|Adverse Event|1|||
156604423|NCT00270998|565293527|FG001|3 Month Follow-up|Adverse Event|0|||
156604424|NCT00270998|565293528|FG002|3 Month Follow-up|Adverse Event|0|||
156604425|NCT00270998|565293526|FG000|3 Month Follow-up|Lack of Efficacy|1|||
156604426|NCT00270998|565293527|FG001|3 Month Follow-up|Lack of Efficacy|2|||
156604427|NCT00270998|565293528|FG002|3 Month Follow-up|Lack of Efficacy|1|||
156604428|NCT00270998|565293526|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
156604429|NCT00270998|565293527|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
156604430|NCT00270998|565293528|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
156604431|NCT00270998|565293526|FG000|3 Month Follow-up|Pessary did not fit|12|||
156604432|NCT00270998|565293527|FG001|3 Month Follow-up|Pessary did not fit|0|||
156604433|NCT00270998|565293528|FG002|3 Month Follow-up|Pessary did not fit|0|||
156604434|NCT00270998|565293526|FG000|3 Month Follow-up|Personal/family health|1|||
156604435|NCT00270998|565293527|FG001|3 Month Follow-up|Personal/family health|1|||
156604436|NCT00270998|565293528|FG002|3 Month Follow-up|Personal/family health|0|||
156604437|NCT00270998|565293526|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
156604438|NCT00270998|565293527|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
156604439|NCT00270998|565293528|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
156604440|NCT00270998|565293526|FG000|12 Month Follow-up|Lack of Efficacy|5|||
156604441|NCT00270998|565293527|FG001|12 Month Follow-up|Lack of Efficacy|4|||
156604442|NCT00270998|565293528|FG002|12 Month Follow-up|Lack of Efficacy|3|||
156604443|NCT00270998|565293526|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
156604444|NCT00270998|565293527|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
156604445|NCT00270998|565293528|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
156604446|NCT00270998|565293526|FG000|12 Month Follow-up|Pessary did not fit|1|||
156604447|NCT00270998|565293527|FG001|12 Month Follow-up|Pessary did not fit|0|||
156604448|NCT00270998|565293528|FG002|12 Month Follow-up|Pessary did not fit|0|||
156604449|NCT00270998|565293526|FG000|12 Month Follow-up|Personal/family health|0|||
156604450|NCT00270998|565293527|FG001|12 Month Follow-up|Personal/family health|5|||
156604451|NCT00270998|565293528|FG002|12 Month Follow-up|Personal/family health|1|||
156604452|NCT00270998|565293526|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
156604453|NCT00270998|565293527|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
156604454|NCT00270998|565293528|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
156604455|NCT04075396|565293531|FG000|Overall Study|Death|11|||
156604456|NCT04075396|565293532|FG001|Overall Study|Death|9|||
156604457|NCT04075396|565293531|FG000|Overall Study|Withdrawal by Subject|1|||
156604458|NCT04075396|565293532|FG001|Overall Study|Withdrawal by Subject|2|||
156604459|NCT04075396|565293531|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
156604460|NCT04075396|565293532|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
156604461|NCT04075396|565293531|FG000|Overall Study|Enrolled but not-treated|0|||
156604462|NCT04075396|565293532|FG001|Overall Study|Enrolled but not-treated|1|||
156604463|NCT00105560|565293540|FG000|Overall Study|Lost to Follow-up|1|||
156604464|NCT01248364|565293541|FG000|Overall Study|Adverse Event|0|||
156604465|NCT01248364|565293542|FG001|Overall Study|Adverse Event|1|||
156604466|NCT01248364|565293543|FG002|Overall Study|Adverse Event|0|||
156604467|NCT01248364|565293544|FG003|Overall Study|Adverse Event|0|||
156604468|NCT02559713|565293547|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
156604469|NCT01021813|565293548|FG000|DB Treatment Phase|Adverse Event|60|||
156604470|NCT01021813|565293549|FG001|DB Treatment Phase|Adverse Event|22|||
156604471|NCT01021813|565293550|FG002|DB Treatment Phase|Adverse Event|0|||
156604472|NCT01021813|565293551|FG003|DB Treatment Phase|Adverse Event|0|||
156604473|NCT01021813|565293552|FG004|DB Treatment Phase|Adverse Event|0|||
156604474|NCT01021813|565293548|FG000|DB Treatment Phase|Lack of Efficacy|44|||
156604475|NCT01021813|565293549|FG001|DB Treatment Phase|Lack of Efficacy|28|||
156604476|NCT01021813|565293550|FG002|DB Treatment Phase|Lack of Efficacy|0|||
156604477|NCT01021813|565293551|FG003|DB Treatment Phase|Lack of Efficacy|0|||
156604478|NCT01021813|565293552|FG004|DB Treatment Phase|Lack of Efficacy|0|||
156604479|NCT01021813|565293548|FG000|DB Treatment Phase|Lost to Follow-up|14|||
156604480|NCT01021813|565293549|FG001|DB Treatment Phase|Lost to Follow-up|12|||
156604481|NCT01021813|565293550|FG002|DB Treatment Phase|Lost to Follow-up|0|||
156604482|NCT01021813|565293551|FG003|DB Treatment Phase|Lost to Follow-up|0|||
156604483|NCT01021813|565293552|FG004|DB Treatment Phase|Lost to Follow-up|0|||
156604484|NCT01021813|565293548|FG000|DB Treatment Phase|Physician Decision|17|||
156604485|NCT01021813|565293549|FG001|DB Treatment Phase|Physician Decision|8|||
156604486|NCT01021813|565293550|FG002|DB Treatment Phase|Physician Decision|0|||
156604487|NCT01021813|565293551|FG003|DB Treatment Phase|Physician Decision|0|||
156604488|NCT01021813|565293552|FG004|DB Treatment Phase|Physician Decision|0|||
156604489|NCT01021813|565293548|FG000|DB Treatment Phase|Pregnancy|1|||
156604490|NCT01021813|565293549|FG001|DB Treatment Phase|Pregnancy|0|||
156604491|NCT01021813|565293550|FG002|DB Treatment Phase|Pregnancy|0|||
156604492|NCT01021813|565293551|FG003|DB Treatment Phase|Pregnancy|0|||
156604493|NCT01021813|565293552|FG004|DB Treatment Phase|Pregnancy|0|||
156604494|NCT01021813|565293548|FG000|DB Treatment Phase|Protocol Violation|4|||
156604495|NCT01021813|565293549|FG001|DB Treatment Phase|Protocol Violation|3|||
156604496|NCT01021813|565293550|FG002|DB Treatment Phase|Protocol Violation|0|||
156604497|NCT01021813|565293551|FG003|DB Treatment Phase|Protocol Violation|0|||
156604498|NCT01021813|565293552|FG004|DB Treatment Phase|Protocol Violation|0|||
156604499|NCT01021813|565293548|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
156604500|NCT01021813|565293549|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
156604501|NCT01021813|565293550|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
156604502|NCT01021813|565293551|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
156604503|NCT01021813|565293552|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
156604504|NCT01021813|565293548|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
156604505|NCT01021813|565293549|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
156604506|NCT01021813|565293550|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
156604507|NCT01021813|565293551|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
156604508|NCT01021813|565293552|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
156604509|NCT01021813|565293548|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
156604510|NCT01021813|565293549|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
156604511|NCT01021813|565293550|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
156604512|NCT01021813|565293551|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
156604513|NCT01021813|565293552|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
156604514|NCT01021813|565293548|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
156604515|NCT01021813|565293549|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
156604516|NCT01021813|565293550|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
156604517|NCT01021813|565293551|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
156604518|NCT01021813|565293552|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
156604519|NCT01021813|565293548|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
156604520|NCT01021813|565293549|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
156604521|NCT01021813|565293550|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
156604522|NCT01021813|565293551|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
156604523|NCT01021813|565293552|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
156604524|NCT01021813|565293548|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
156604525|NCT01021813|565293549|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
156604526|NCT01021813|565293550|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
156604527|NCT01021813|565293551|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
156604528|NCT01021813|565293552|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
156604529|NCT01117012|565293556|FG000|Overall Study|Adverse Event|0|||
156604530|NCT01117012|565293557|FG001|Overall Study|Adverse Event|1|||
156604531|NCT01117012|565293556|FG000|Overall Study|Death|1|||
156604532|NCT01117012|565293557|FG001|Overall Study|Death|1|||
156604533|NCT01117012|565293556|FG000|Overall Study|Withdrawal by Subject|3|||
156604534|NCT01117012|565293557|FG001|Overall Study|Withdrawal by Subject|0|||
156604535|NCT01117012|565293556|FG000|Overall Study|Undefined|4|||
156604536|NCT01117012|565293557|FG001|Overall Study|Undefined|3|||
156604537|NCT00673894|565293561|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
156604538|NCT00673894|565293562|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
156604539|NCT00673894|565293561|FG000|First Intervention 4 Weeks|Adverse Event|1|||
156604540|NCT00673894|565293562|FG001|First Intervention 4 Weeks|Adverse Event|0|||
156604541|NCT00326417|565293563|FG000|Overall Study|Withdrawal by Subject|0|||
156604542|NCT00326417|565293564|FG001|Overall Study|Withdrawal by Subject|0|||
156604543|NCT00326417|565293565|FG002|Overall Study|Withdrawal by Subject|1|||
156604544|NCT00326417|565293566|FG003|Overall Study|Withdrawal by Subject|0|||
156604545|NCT00326417|565293563|FG000|Overall Study|Arm Closed|7|||
156604546|NCT00326417|565293564|FG001|Overall Study|Arm Closed|0|||
156604547|NCT00326417|565293565|FG002|Overall Study|Arm Closed|0|||
156604548|NCT00326417|565293566|FG003|Overall Study|Arm Closed|3|||
156604549|NCT00326417|565293563|FG000|Overall Study|Death|7|||
156604550|NCT00326417|565293564|FG001|Overall Study|Death|0|||
156604551|NCT00326417|565293565|FG002|Overall Study|Death|0|||
156604552|NCT00326417|565293566|FG003|Overall Study|Death|0|||
156604553|NCT00844285|565293567|FG000|Overall Study|Other|0|||
156604554|NCT00844285|565293568|FG001|Overall Study|Other|1|||
156604555|NCT00844285|565293569|FG002|Overall Study|Other|0|||
156604556|NCT00844285|565293567|FG000|Overall Study|Other than specified|95|||
156604557|NCT00844285|565293568|FG001|Overall Study|Other than specified|129|||
156604558|NCT00844285|565293569|FG002|Overall Study|Other than specified|12|||
156604559|NCT00844285|565293567|FG000|Overall Study|Site closure|256|||
156604560|NCT00844285|565293568|FG001|Overall Study|Site closure|450|||
156604561|NCT00844285|565293569|FG002|Overall Study|Site closure|50|||
156604562|NCT00844285|565293567|FG000|Overall Study|Follow-up < 8 years|16|||
156604563|NCT00844285|565293568|FG001|Overall Study|Follow-up < 8 years|23|||
156604564|NCT00844285|565293569|FG002|Overall Study|Follow-up < 8 years|4|||
156604565|NCT00844285|565293567|FG000|Overall Study|Protocol Violation|26|||
156604566|NCT00844285|565293568|FG001|Overall Study|Protocol Violation|28|||
156604567|NCT00844285|565293569|FG002|Overall Study|Protocol Violation|54|||
156604568|NCT00844285|565293567|FG000|Overall Study|Death|22|||
156604569|NCT00844285|565293568|FG001|Overall Study|Death|21|||
156604570|NCT00844285|565293569|FG002|Overall Study|Death|8|||
156604571|NCT00844285|565293567|FG000|Overall Study|Withdrew Consent|344|||
156604572|NCT00844285|565293568|FG001|Overall Study|Withdrew Consent|466|||
156604573|NCT00844285|565293569|FG002|Overall Study|Withdrew Consent|70|||
156604574|NCT00844285|565293567|FG000|Overall Study|Lost to Follow-up|330|||
156604575|NCT00844285|565293568|FG001|Overall Study|Lost to Follow-up|486|||
156604576|NCT00844285|565293569|FG002|Overall Study|Lost to Follow-up|74|||
156604577|NCT04682353|565293572|FG000|Overall Study|Lost to Follow-up|0|||
156604578|NCT04682353|565293573|FG001|Overall Study|Lost to Follow-up|1|||
156604579|NCT04682353|565293574|FG002|Overall Study|Lost to Follow-up|0|||
156604580|NCT04682353|565293575|FG003|Overall Study|Lost to Follow-up|1|||
156604581|NCT04682353|565293572|FG000|Overall Study|Personal reasons|0|||
156604582|NCT04682353|565293573|FG001|Overall Study|Personal reasons|1|||
156604583|NCT04682353|565293574|FG002|Overall Study|Personal reasons|0|||
156604584|NCT04682353|565293575|FG003|Overall Study|Personal reasons|0|||
156604585|NCT00555906|565293576|FG000|Phase 1|Objective Progression or Relapse|3|||
156604586|NCT00555906|565293577|FG001|Phase 1|Objective Progression or Relapse|5|||
156604587|NCT00555906|565293578|FG002|Phase 1|Objective Progression or Relapse|3|||
156604588|NCT00555906|565293579|FG003|Phase 1|Objective Progression or Relapse|1|||
156604589|NCT00555906|565293580|FG004|Phase 1|Objective Progression or Relapse|0|||
156604590|NCT00555906|565293576|FG000|Phase 1|Global Deterioration of Health Status|0|||
156604591|NCT00555906|565293577|FG001|Phase 1|Global Deterioration of Health Status|1|||
156604592|NCT00555906|565293578|FG002|Phase 1|Global Deterioration of Health Status|1|||
156604593|NCT00555906|565293579|FG003|Phase 1|Global Deterioration of Health Status|1|||
156634911|NCT03917654|565407823|FG008|Year 1|Travel|2|||
156604594|NCT00555906|565293580|FG004|Phase 1|Global Deterioration of Health Status|0|||
156604595|NCT00555906|565293576|FG000|Phase 1|Adverse Event|0|||
156604596|NCT00555906|565293577|FG001|Phase 1|Adverse Event|0|||
156604597|NCT00555906|565293578|FG002|Phase 1|Adverse Event|3|||
156604598|NCT00555906|565293579|FG003|Phase 1|Adverse Event|2|||
156604599|NCT00555906|565293580|FG004|Phase 1|Adverse Event|0|||
156604600|NCT00555906|565293576|FG000|Phase 1|Withdrawal by Subject|0|||
156604601|NCT00555906|565293577|FG001|Phase 1|Withdrawal by Subject|0|||
156604602|NCT00555906|565293578|FG002|Phase 1|Withdrawal by Subject|0|||
156604603|NCT00555906|565293579|FG003|Phase 1|Withdrawal by Subject|1|||
156604604|NCT00555906|565293580|FG004|Phase 1|Withdrawal by Subject|0|||
156604605|NCT00555906|565293576|FG000|Phase 2|Adverse Event|0|||
156604606|NCT00555906|565293577|FG001|Phase 2|Adverse Event|0|||
156604607|NCT00555906|565293578|FG002|Phase 2|Adverse Event|0|||
156604608|NCT00555906|565293579|FG003|Phase 2|Adverse Event|0|||
156604609|NCT00555906|565293580|FG004|Phase 2|Adverse Event|4|||
156604610|NCT00555906|565293576|FG000|Phase 2|Global Deterioration of Health Status|0|||
156604611|NCT00555906|565293577|FG001|Phase 2|Global Deterioration of Health Status|0|||
156604612|NCT00555906|565293578|FG002|Phase 2|Global Deterioration of Health Status|0|||
156604613|NCT00555906|565293579|FG003|Phase 2|Global Deterioration of Health Status|0|||
156604614|NCT00555906|565293580|FG004|Phase 2|Global Deterioration of Health Status|2|||
156604615|NCT00555906|565293576|FG000|Phase 2|Objective Progression or Relapse|0|||
156604616|NCT00555906|565293577|FG001|Phase 2|Objective Progression or Relapse|0|||
156604617|NCT00555906|565293578|FG002|Phase 2|Objective Progression or Relapse|0|||
156604618|NCT00555906|565293579|FG003|Phase 2|Objective Progression or Relapse|0|||
156604619|NCT00555906|565293580|FG004|Phase 2|Objective Progression or Relapse|16|||
156604620|NCT00555906|565293576|FG000|Phase 2|Withdrawal by Subject|0|||
156604621|NCT00555906|565293577|FG001|Phase 2|Withdrawal by Subject|0|||
156604622|NCT00555906|565293578|FG002|Phase 2|Withdrawal by Subject|0|||
156604623|NCT00555906|565293579|FG003|Phase 2|Withdrawal by Subject|0|||
156604624|NCT00555906|565293580|FG004|Phase 2|Withdrawal by Subject|2|||
156604625|NCT00555906|565293576|FG000|Phase 2|Other|0|||
156604626|NCT00555906|565293577|FG001|Phase 2|Other|0|||
156604627|NCT00555906|565293578|FG002|Phase 2|Other|0|||
156604628|NCT00555906|565293579|FG003|Phase 2|Other|0|||
156604629|NCT00555906|565293580|FG004|Phase 2|Other|6|||
156604630|NCT00555906|565293576|FG000|Phase 2|Randomized but not Treated|0|||
156604631|NCT00555906|565293577|FG001|Phase 2|Randomized but not Treated|0|||
156604632|NCT00555906|565293578|FG002|Phase 2|Randomized but not Treated|0|||
156604633|NCT00555906|565293579|FG003|Phase 2|Randomized but not Treated|0|||
156604634|NCT00555906|565293580|FG004|Phase 2|Randomized but not Treated|2|||
156604635|NCT01586806|565293581|FG000|Overall Study|Protocol Violation|0|||
156604636|NCT01586806|565293582|FG001|Overall Study|Protocol Violation|1|||
156604637|NCT01586806|565293583|FG002|Overall Study|Protocol Violation|0|||
156604638|NCT01586806|565293581|FG000|Overall Study|Withdrawal by Subject|1|||
156604639|NCT01586806|565293582|FG001|Overall Study|Withdrawal by Subject|0|||
156604640|NCT01586806|565293583|FG002|Overall Study|Withdrawal by Subject|0|||
156604641|NCT01586806|565293581|FG000|Overall Study|Lost to Follow-up|2|||
156604642|NCT01586806|565293582|FG001|Overall Study|Lost to Follow-up|3|||
156604643|NCT01586806|565293583|FG002|Overall Study|Lost to Follow-up|2|||
156604644|NCT01185704|565293584|FG000|Overall Study|Randomized but not treated|3|||
156604645|NCT01185704|565293585|FG001|Overall Study|Randomized but not treated|3|||
156604646|NCT01185704|565293584|FG000|Overall Study|Lack of ovarian response|5|||
156604647|NCT01185704|565293585|FG001|Overall Study|Lack of ovarian response|1|||
156604648|NCT01185704|565293584|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
156604649|NCT01185704|565293585|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
156604650|NCT01185704|565293584|FG000|Overall Study|Ectopic pregnancy|0|||
156604651|NCT01185704|565293585|FG001|Overall Study|Ectopic pregnancy|1|||
156604652|NCT01313208|565293586|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
156604653|NCT01313208|565293587|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
156604654|NCT01313208|565293586|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
156604655|NCT01313208|565293587|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
156604656|NCT01313208|565293586|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
156604657|NCT01313208|565293587|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
156604658|NCT01313208|565293586|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
156604659|NCT01313208|565293587|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
156604660|NCT01313208|565293586|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
156604661|NCT01313208|565293587|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
156604662|NCT01313208|565293586|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
156604663|NCT01313208|565293587|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
156604664|NCT01313208|565293586|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
156604665|NCT01313208|565293587|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
156604666|NCT01313208|565293586|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
156604667|NCT01313208|565293587|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
156604668|NCT01313208|565293586|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
156604669|NCT01313208|565293587|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
156604670|NCT00187889|565293588|FG000|Overall Study|Withdrawal by Subject|6|||
156604671|NCT00187889|565293589|FG001|Overall Study|Withdrawal by Subject|4|||
156604672|NCT01998880|565293594|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
156604673|NCT01998880|565293595|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
156604674|NCT01998880|565293594|FG000|Overall Study|Disease Progression|1|||
156604675|NCT01998880|565293595|FG001|Overall Study|Disease Progression|8|||
156604676|NCT01998880|565293594|FG000|Overall Study|Withdrew Consent|2|||
156604677|NCT01998880|565293595|FG001|Overall Study|Withdrew Consent|1|||
156604678|NCT01998880|565293594|FG000|Overall Study|Death|3|||
156604679|NCT01998880|565293595|FG001|Overall Study|Death|6|||
156604680|NCT01998880|565293594|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156604681|NCT01998880|565293595|FG001|Overall Study|Insufficient Therapeutic Response|5|||
156604682|NCT01998880|565293594|FG000|Overall Study|Administrative/Other|1|||
156604683|NCT01998880|565293595|FG001|Overall Study|Administrative/Other|1|||
156604684|NCT01998880|565293594|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
156604685|NCT01998880|565293595|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
156604686|NCT01998880|565293594|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
156604687|NCT01998880|565293595|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156604688|NCT01998880|565293594|FG000|Overall Study|Did Not Receive Treatment|3|||
156604689|NCT01998880|565293595|FG001|Overall Study|Did Not Receive Treatment|2|||
156604690|NCT02248857|565293596|FG000|3 Month|Withdrawal by Subject|9|||
156604691|NCT02248857|565293597|FG001|3 Month|Withdrawal by Subject|3|||
156604692|NCT02248857|565293598|FG002|3 Month|Withdrawal by Subject|4|||
156604693|NCT02248857|565293596|FG000|3 Month|Unable to reach for 3 month|35|||
156604694|NCT02248857|565293597|FG001|3 Month|Unable to reach for 3 month|29|||
156604695|NCT02248857|565293598|FG002|3 Month|Unable to reach for 3 month|26|||
156604696|NCT02248857|565293596|FG000|3 Month|Partially completed, unable to finish|2|||
156604697|NCT02248857|565293597|FG001|3 Month|Partially completed, unable to finish|2|||
156604698|NCT02248857|565293598|FG002|3 Month|Partially completed, unable to finish|1|||
156863708|NCT05138653|566258791|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863709|NCT05138653|566258792|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863710|NCT05138653|566258793|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863711|NCT05138653|566258794|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863712|NCT05138653|566258795|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863713|NCT05138653|566258796|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863714|NCT05138653|566258797|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863715|NCT05138653|566258798|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863716|NCT05138653|566258799|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863717|NCT05138653|566258800|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863718|NCT05138653|566258801|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863719|NCT05138653|566258802|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863720|NCT05138653|566258803|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863721|NCT05138653|566258804|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863722|NCT05138653|566258789|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863723|NCT05138653|566258790|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
156863724|NCT05138653|566258791|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863725|NCT05138653|566258792|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863726|NCT05138653|566258793|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863727|NCT05138653|566258794|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863728|NCT05138653|566258795|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863729|NCT05138653|566258796|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863730|NCT05138653|566258797|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
156863731|NCT05138653|566258798|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863732|NCT05138653|566258799|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863733|NCT05138653|566258800|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863734|NCT05138653|566258801|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863735|NCT05138653|566258802|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863736|NCT05138653|566258803|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863737|NCT05138653|566258804|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863738|NCT05138653|566258789|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863739|NCT05138653|566258790|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
156863740|NCT05138653|566258791|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863741|NCT05138653|566258792|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863742|NCT05138653|566258793|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
156863743|NCT05138653|566258794|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863744|NCT05138653|566258795|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863745|NCT05138653|566258796|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156604699|NCT02248857|565293596|FG000|6 Month|Lost to Follow-up|27|||
156604700|NCT02248857|565293597|FG001|6 Month|Lost to Follow-up|26|||
156604701|NCT02248857|565293598|FG002|6 Month|Lost to Follow-up|15|||
156604702|NCT02248857|565293596|FG000|6 Month|Partially completed, unable to finish|0|||
156604703|NCT02248857|565293597|FG001|6 Month|Partially completed, unable to finish|1|||
156604704|NCT02248857|565293598|FG002|6 Month|Partially completed, unable to finish|0|||
156604705|NCT02248857|565293596|FG000|6 Month|Withdrawal by Subject|0|||
156604706|NCT02248857|565293597|FG001|6 Month|Withdrawal by Subject|2|||
156604707|NCT02248857|565293598|FG002|6 Month|Withdrawal by Subject|2|||
156604708|NCT02248857|565293596|FG000|6 Month|Death|1|||
156604709|NCT02248857|565293597|FG001|6 Month|Death|0|||
156604710|NCT02248857|565293598|FG002|6 Month|Death|0|||
156604711|NCT02671461|565293599|FG000|Treatment|Adverse Event|0|||
156604712|NCT02671461|565293600|FG001|Treatment|Adverse Event|0|||
156604713|NCT02671461|565293601|FG002|Treatment|Adverse Event|1|||
156604714|NCT02671461|565293599|FG000|Treatment|Administrative Reason by Sponsor|1|||
156604715|NCT02671461|565293600|FG001|Treatment|Administrative Reason by Sponsor|3|||
156604716|NCT02671461|565293601|FG002|Treatment|Administrative Reason by Sponsor|4|||
156604717|NCT02671461|565293599|FG000|Treatment|Randomized, not treated|1|||
156604718|NCT02671461|565293600|FG001|Treatment|Randomized, not treated|0|||
156604719|NCT02671461|565293601|FG002|Treatment|Randomized, not treated|0|||
156604720|NCT02671461|565293599|FG000|Follow-up|Withdrawal by Subject|1|||
156604721|NCT02671461|565293600|FG001|Follow-up|Withdrawal by Subject|0|||
156604722|NCT02671461|565293601|FG002|Follow-up|Withdrawal by Subject|0|||
156604723|NCT02671461|565293599|FG000|Follow-up|Lost to Follow-up|0|||
156604724|NCT02671461|565293600|FG001|Follow-up|Lost to Follow-up|0|||
156604725|NCT02671461|565293601|FG002|Follow-up|Lost to Follow-up|1|||
156604726|NCT02671461|565293599|FG000|Follow-up|Administrative Reason by Sponsor|0|||
156604727|NCT02671461|565293600|FG001|Follow-up|Administrative Reason by Sponsor|1|||
156604728|NCT02671461|565293601|FG002|Follow-up|Administrative Reason by Sponsor|0|||
156604729|NCT01412060|565293602|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
156604730|NCT01412060|565293603|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
156604731|NCT01412060|565293604|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
156604732|NCT01412060|565293602|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
156604733|NCT01412060|565293603|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
156604734|NCT01412060|565293604|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
156604735|NCT01412060|565293602|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
156604736|NCT01412060|565293603|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
156604737|NCT01412060|565293604|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
156604738|NCT01412060|565293602|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
156604739|NCT01412060|565293603|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
156604740|NCT01412060|565293604|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
156604741|NCT01412060|565293602|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
156604742|NCT01412060|565293603|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
156604743|NCT01412060|565293604|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
156604744|NCT01412060|565293602|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
156604745|NCT01412060|565293603|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
156604746|NCT01412060|565293604|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
156604747|NCT01412060|565293602|FG000|Period Between RIP and SP|Adverse Event|4|||
156604748|NCT01412060|565293603|FG001|Period Between RIP and SP|Adverse Event|0|||
156604749|NCT01412060|565293604|FG002|Period Between RIP and SP|Adverse Event|0|||
156604750|NCT01412060|565293602|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
156604751|NCT01412060|565293603|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
156604752|NCT01412060|565293604|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
156604753|NCT01412060|565293602|FG000|Period Between RIP and SP|Protocol Violation|2|||
156604754|NCT01412060|565293603|FG001|Period Between RIP and SP|Protocol Violation|0|||
156604755|NCT01412060|565293604|FG002|Period Between RIP and SP|Protocol Violation|0|||
156604756|NCT01412060|565293602|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
156604757|NCT01412060|565293603|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
156604758|NCT01412060|565293604|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
156604759|NCT01412060|565293602|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
156604760|NCT01412060|565293603|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
156604761|NCT01412060|565293604|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
156604762|NCT01412060|565293602|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
156604763|NCT01412060|565293603|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
156604764|NCT01412060|565293604|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
156604765|NCT01412060|565293602|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
156604766|NCT01412060|565293603|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
156604767|NCT01412060|565293604|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
156604768|NCT01412060|565293602|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
156604769|NCT01412060|565293603|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
156634912|NCT03917654|565407824|FG009|Year 1|Travel|5|||
156604770|NCT01412060|565293604|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
156604771|NCT01412060|565293602|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
156604772|NCT01412060|565293603|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
156604773|NCT01412060|565293604|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
156604774|NCT01412060|565293602|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
156604775|NCT01412060|565293603|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
156604776|NCT01412060|565293604|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
156604777|NCT01412060|565293602|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
156604778|NCT01412060|565293603|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
156604779|NCT01412060|565293604|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
156604780|NCT01412060|565293602|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
156604781|NCT01412060|565293603|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
156604782|NCT01412060|565293604|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
156604783|NCT01412060|565293602|FG000|Period Between SP and DBP|Protocol Violation|2|||
156604784|NCT01412060|565293603|FG001|Period Between SP and DBP|Protocol Violation|0|||
156604785|NCT01412060|565293604|FG002|Period Between SP and DBP|Protocol Violation|0|||
156604786|NCT01412060|565293602|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
156604787|NCT01412060|565293603|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
156604788|NCT01412060|565293604|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
156604789|NCT01412060|565293602|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
156604790|NCT01412060|565293603|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
156604791|NCT01412060|565293604|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
156604792|NCT01412060|565293602|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
156604793|NCT01412060|565293603|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
156604794|NCT01412060|565293604|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
156604795|NCT01412060|565293602|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
156604796|NCT01412060|565293603|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
156604797|NCT01412060|565293604|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
156604798|NCT01412060|565293602|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
156604799|NCT01412060|565293603|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
156604800|NCT01412060|565293604|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
156604801|NCT01412060|565293602|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
156604802|NCT01412060|565293603|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
156604803|NCT01412060|565293604|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
156604804|NCT01412060|565293602|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
156604805|NCT01412060|565293603|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
156604806|NCT01412060|565293604|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
156604807|NCT01412060|565293602|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
156604808|NCT01412060|565293603|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
156604809|NCT01412060|565293604|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
156604810|NCT01412060|565293602|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
156604811|NCT01412060|565293603|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
156604812|NCT01412060|565293604|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
156604813|NCT01412060|565293602|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
156604814|NCT01412060|565293603|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
156604815|NCT01412060|565293604|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
156604816|NCT00004732|565293605|FG000|Overall Study|Withdrawal by Subject|36|||
156604817|NCT00004732|565293606|FG001|Overall Study|Withdrawal by Subject|64|||
156604818|NCT00004732|565293605|FG000|Overall Study|Lost to Follow-up|33|||
156604819|NCT00004732|565293606|FG001|Overall Study|Lost to Follow-up|47|||
156604820|NCT01688635|565293610|FG000|Washout 1|Withdrawal by Subject|1|||
156604821|NCT01688635|565293611|FG001|Washout 1|Withdrawal by Subject|0|||
156604822|NCT01688635|565293610|FG000|Washout 1|Adverse Event|0|||
156604823|NCT01688635|565293611|FG001|Washout 1|Adverse Event|1|||
156604824|NCT01688635|565293610|FG000|Washout 1|Physician Decision|0|||
156604825|NCT01688635|565293611|FG001|Washout 1|Physician Decision|1|||
156604826|NCT01688635|565293610|FG000|Washout 2|Physician Decision|1|||
156604827|NCT01688635|565293611|FG001|Washout 2|Physician Decision|0|||
156604828|NCT01688635|565293610|FG000|Washout 2|Withdrawal by Subject|1|||
156604829|NCT01688635|565293611|FG001|Washout 2|Withdrawal by Subject|0|||
156604830|NCT01688635|565293610|FG000|Washout 2|Sponsor Decision|1|||
156604831|NCT01688635|565293611|FG001|Washout 2|Sponsor Decision|2|||
156604832|NCT01688635|565293610|FG000|Washout 3|Withdrawal by Subject|1|||
156604833|NCT01688635|565293611|FG001|Washout 3|Withdrawal by Subject|0|||
156604834|NCT02674685|565293612|FG000|Overall Study|Withdrawal by Subject|4|||
156604835|NCT02661464|565293615|FG000|Overall Study|Lost to Follow-up|28|||
156604836|NCT02661464|565293616|FG001|Overall Study|Lost to Follow-up|0|||
156604837|NCT02661464|565293617|FG002|Overall Study|Lost to Follow-up|0|||
156604838|NCT02661464|565293618|FG003|Overall Study|Lost to Follow-up|0|||
156863746|NCT05138653|566258797|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156604839|NCT02661464|565293615|FG000|Overall Study|Withdrawal by Subject|3|||
156604840|NCT02661464|565293616|FG001|Overall Study|Withdrawal by Subject|1|||
156604841|NCT02661464|565293617|FG002|Overall Study|Withdrawal by Subject|0|||
156604842|NCT02661464|565293618|FG003|Overall Study|Withdrawal by Subject|0|||
156604843|NCT02661464|565293615|FG000|Overall Study|Participants terminated prematurely|288|||
156604844|NCT02661464|565293616|FG001|Overall Study|Participants terminated prematurely|52|||
156604845|NCT02661464|565293617|FG002|Overall Study|Participants terminated prematurely|1|||
156604846|NCT02661464|565293618|FG003|Overall Study|Participants terminated prematurely|1|||
156604847|NCT02661464|565293615|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
156604848|NCT02661464|565293616|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
156604849|NCT02661464|565293617|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
156604850|NCT02661464|565293618|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
156604851|NCT05567393|565293620|FG000|Overall Study|Voluntary Withdrawal|0|||
156604852|NCT05567393|565293621|FG001|Overall Study|Voluntary Withdrawal|0|||
156604853|NCT05567393|565293622|FG002|Overall Study|Voluntary Withdrawal|0|||
156604854|NCT05567393|565293623|FG003|Overall Study|Voluntary Withdrawal|0|||
156604855|NCT05567393|565293624|FG004|Overall Study|Voluntary Withdrawal|0|||
156604856|NCT05567393|565293625|FG005|Overall Study|Voluntary Withdrawal|0|||
156604857|NCT05567393|565293626|FG006|Overall Study|Voluntary Withdrawal|0|||
156604858|NCT05567393|565293627|FG007|Overall Study|Voluntary Withdrawal|0|||
156604859|NCT05567393|565293628|FG008|Overall Study|Voluntary Withdrawal|0|||
156604860|NCT05567393|565293629|FG009|Overall Study|Voluntary Withdrawal|0|||
156604861|NCT05567393|565293630|FG010|Overall Study|Voluntary Withdrawal|0|||
156604862|NCT05567393|565293631|FG011|Overall Study|Voluntary Withdrawal|0|||
156604863|NCT05567393|565293632|FG012|Overall Study|Voluntary Withdrawal|0|||
156604864|NCT05567393|565293633|FG013|Overall Study|Voluntary Withdrawal|1|||
156604865|NCT05567393|565293634|FG014|Overall Study|Voluntary Withdrawal|0|||
156604866|NCT05567393|565293635|FG015|Overall Study|Voluntary Withdrawal|0|||
156604867|NCT05567393|565293636|FG016|Overall Study|Voluntary Withdrawal|0|||
156604868|NCT05567393|565293637|FG017|Overall Study|Voluntary Withdrawal|0|||
156604869|NCT02177175|565293642|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
156604870|NCT02177175|565293643|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
156604871|NCT01924299|565293644|FG000|Period 2|Withdrawal by Subject|1|||
156604872|NCT01924299|565293645|FG001|Period 2|Withdrawal by Subject|0|||
156604873|NCT01924299|565293644|FG000|Period 2|Adverse Event|0|||
156604874|NCT01924299|565293645|FG001|Period 2|Adverse Event|1|||
156604875|NCT04199793|565293646|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
156604876|NCT04199793|565293647|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
156604877|NCT04199793|565293646|FG000|Overall Study|Withdrawal by Subject|1|||
156604878|NCT04199793|565293647|FG001|Overall Study|Withdrawal by Subject|1|||
156604879|NCT03820726|565293648|FG000|Overall Study|Other than listed|23|||
156604880|NCT03820726|565293648|FG000|Overall Study|Withdrawal by Subject|37|||
156604881|NCT03820726|565293648|FG000|Overall Study|Lost to Follow-up|3|||
156604882|NCT03820726|565293648|FG000|Overall Study|Protocol deviation|1|||
156604883|NCT03820726|565293648|FG000|Overall Study|Adverse Event|146|||
156604884|NCT03820726|565293648|FG000|Overall Study|Not treated|1|||
156604885|NCT00141037|565293653|FG000|Overall Study|Physician Decision|1|||
156604886|NCT00141037|565293654|FG001|Overall Study|Physician Decision|2|||
156604887|NCT00141037|565293653|FG000|Overall Study|Lost to Follow-up|3|||
156604888|NCT00141037|565293654|FG001|Overall Study|Lost to Follow-up|1|||
156604889|NCT00141037|565293653|FG000|Overall Study|Protocol Violation|0|||
156604890|NCT00141037|565293654|FG001|Overall Study|Protocol Violation|2|||
156604891|NCT00141037|565293653|FG000|Overall Study|Withdrawal by Subject|2|||
156604892|NCT00141037|565293654|FG001|Overall Study|Withdrawal by Subject|1|||
156604893|NCT00141037|565293653|FG000|Overall Study|Other|0|||
156604894|NCT00141037|565293654|FG001|Overall Study|Other|1|||
156604895|NCT00141037|565293653|FG000|Overall Study|Moved from area|1|||
156604896|NCT00141037|565293654|FG001|Overall Study|Moved from area|7|||
156604897|NCT00141037|565293653|FG000|Overall Study|Graft Failure|3|||
156604898|NCT00141037|565293654|FG001|Overall Study|Graft Failure|4|||
156604899|NCT00888615|565293655|FG000|Overall Study|No treatment|2|||
156604900|NCT00861380|565293656|FG000|Overall Study|Withdrawal Information not recorded|8427|||
156604901|NCT00861380|565293657|FG001|Overall Study|Withdrawal Information not recorded|9112|||
156604902|NCT00861380|565293658|FG002|Overall Study|Withdrawal Information not recorded|8872|||
156604903|NCT00861380|565293659|FG003|Overall Study|Withdrawal Information not recorded|3689|||
156604904|NCT00861380|565293660|FG004|Overall Study|Withdrawal Information not recorded|1812|||
156604905|NCT00861380|565293661|FG005|Overall Study|Withdrawal Information not recorded|6249|||
156604906|NCT00861380|565293662|FG006|Overall Study|Withdrawal Information not recorded|3020|||
156604907|NCT00628758|565293663|FG000|Overall Study|Adverse Event|2|||
156604908|NCT00628758|565293664|FG001|Overall Study|Adverse Event|3|||
156604909|NCT00628758|565293663|FG000|Overall Study|Withdrawal by Subject|6|||
156604910|NCT00628758|565293664|FG001|Overall Study|Withdrawal by Subject|3|||
156604911|NCT00628758|565293663|FG000|Overall Study|Death|1|||
156604912|NCT00628758|565293664|FG001|Overall Study|Death|0|||
156604913|NCT00628758|565293663|FG000|Overall Study|Protocol Violation|5|||
156604914|NCT00628758|565293664|FG001|Overall Study|Protocol Violation|1|||
156604915|NCT00628758|565293663|FG000|Overall Study|Lost to Follow-up|25|||
156604916|NCT00628758|565293664|FG001|Overall Study|Lost to Follow-up|31|||
156604917|NCT00628758|565293663|FG000|Overall Study|Pregnancy|2|||
156604918|NCT00628758|565293664|FG001|Overall Study|Pregnancy|2|||
156604919|NCT00628758|565293663|FG000|Overall Study|Investigator Moved|3|||
156604920|NCT00628758|565293664|FG001|Overall Study|Investigator Moved|0|||
156604921|NCT00628758|565293663|FG000|Overall Study|Treatment Failure|0|||
156604922|NCT00628758|565293664|FG001|Overall Study|Treatment Failure|2|||
156604923|NCT01184846|565293665|FG000|Overall Study|Adverse Event|2|||
156604924|NCT01184846|565293665|FG000|Overall Study|Insufficient response|1|||
156604925|NCT03984812|565295741|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604926|NCT03984812|565295742|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604927|NCT03984812|565295743|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
156604928|NCT03984812|565295744|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604929|NCT03984812|565295745|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604930|NCT03984812|565295746|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604931|NCT03984812|565295747|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604932|NCT03984812|565295748|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604933|NCT03984812|565295749|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604934|NCT03984812|565295750|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604935|NCT03984812|565295751|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
156604936|NCT02971007|565295752|FG000|Overall Study|Adverse Event|1|||
156604937|NCT02971007|565295753|FG001|Overall Study|Adverse Event|0|||
156604938|NCT02971007|565295754|FG002|Overall Study|Adverse Event|0|||
156604939|NCT02971007|565295752|FG000|Overall Study|Lost to Follow-up|0|||
156604940|NCT02971007|565295753|FG001|Overall Study|Lost to Follow-up|1|||
156604941|NCT02971007|565295754|FG002|Overall Study|Lost to Follow-up|1|||
156604942|NCT02971007|565295752|FG000|Overall Study|Withdrawal by Subject|0|||
156604943|NCT02971007|565295753|FG001|Overall Study|Withdrawal by Subject|1|||
156604944|NCT02971007|565295754|FG002|Overall Study|Withdrawal by Subject|0|||
156604945|NCT02971007|565295752|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
156604946|NCT02971007|565295753|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
156604947|NCT02971007|565295754|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
156604948|NCT02971007|565295752|FG000|Overall Study|Patient discontinued study drug|0|||
156604949|NCT02971007|565295753|FG001|Overall Study|Patient discontinued study drug|1|||
156604950|NCT02971007|565295754|FG002|Overall Study|Patient discontinued study drug|0|||
156604951|NCT02580240|565295758|FG000|Overall Study|Physician Decision|2|||
156604952|NCT02580240|565295759|FG001|Overall Study|Physician Decision|0|||
156604953|NCT00607919|565295760|FG000|Acute Phase|Adverse Event|9|||
156604954|NCT00607919|565295761|FG001|Acute Phase|Adverse Event|2|||
156604955|NCT00607919|565295760|FG000|Acute Phase|Entry Criteria Not Met|1|||
156604956|NCT00607919|565295761|FG001|Acute Phase|Entry Criteria Not Met|1|||
156604957|NCT00607919|565295760|FG000|Acute Phase|Lack of Efficacy|1|||
156604958|NCT00607919|565295761|FG001|Acute Phase|Lack of Efficacy|2|||
156604959|NCT00607919|565295760|FG000|Acute Phase|Lost to Follow-up|9|||
156604960|NCT00607919|565295761|FG001|Acute Phase|Lost to Follow-up|3|||
156604961|NCT00607919|565295760|FG000|Acute Phase|Parent/Caregiver Decision|6|||
156604962|NCT00607919|565295761|FG001|Acute Phase|Parent/Caregiver Decision|4|||
156604963|NCT00607919|565295760|FG000|Acute Phase|Protocol Violation|5|||
156604964|NCT00607919|565295761|FG001|Acute Phase|Protocol Violation|1|||
156604965|NCT00607919|565295760|FG000|Acute Phase|Withdrawal by Subject|3|||
156604966|NCT00607919|565295761|FG001|Acute Phase|Withdrawal by Subject|3|||
156604967|NCT00607919|565295760|FG000|Open-Label Phase|Adverse Event|1|||
156604968|NCT00607919|565295761|FG001|Open-Label Phase|Adverse Event|5|||
156604969|NCT00607919|565295760|FG000|Open-Label Phase|Lost to Follow-up|4|||
156604970|NCT00607919|565295761|FG001|Open-Label Phase|Lost to Follow-up|1|||
156604971|NCT00607919|565295760|FG000|Open-Label Phase|Protocol Violation|2|||
156604972|NCT00607919|565295761|FG001|Open-Label Phase|Protocol Violation|2|||
156604973|NCT00607919|565295760|FG000|Open-Label Phase|Withdrawal by Subject|2|||
156604974|NCT00607919|565295761|FG001|Open-Label Phase|Withdrawal by Subject|2|||
156604975|NCT00607919|565295760|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
156604976|NCT00607919|565295761|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
156604977|NCT02001688|565295762|FG000|Overall Study|Withdrawal by Subject|0|||
156604978|NCT02001688|565295763|FG001|Overall Study|Withdrawal by Subject|0|||
156604979|NCT02001688|565295764|FG002|Overall Study|Withdrawal by Subject|1|||
156604980|NCT02001688|565295762|FG000|Overall Study|Adverse Event|0|||
156604981|NCT02001688|565295763|FG001|Overall Study|Adverse Event|1|||
156604982|NCT02001688|565295764|FG002|Overall Study|Adverse Event|0|||
156604983|NCT03051217|565295766|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
156863747|NCT05138653|566258798|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156604984|NCT03051217|565295767|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156604985|NCT03051217|565295768|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
156604986|NCT03051217|565295769|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156604987|NCT03051217|565295770|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156604988|NCT03051217|565295771|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156604989|NCT03051217|565295772|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156604990|NCT03051217|565295766|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
156604991|NCT03051217|565295767|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
156604992|NCT03051217|565295768|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
156604993|NCT03051217|565295769|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
156604994|NCT03051217|565295770|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
156604995|NCT03051217|565295771|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
156604996|NCT03051217|565295772|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
156604997|NCT03051217|565295766|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
156604998|NCT03051217|565295767|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
156604999|NCT03051217|565295768|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
156605000|NCT03051217|565295769|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156605001|NCT03051217|565295770|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156605002|NCT03051217|565295771|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156605003|NCT03051217|565295772|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156605004|NCT03051217|565295766|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
156605005|NCT03051217|565295767|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
156605006|NCT03051217|565295768|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
156605007|NCT03051217|565295769|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
156605008|NCT03051217|565295770|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
156605009|NCT03051217|565295771|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
156605010|NCT03051217|565295772|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
156605011|NCT03051217|565295766|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
156605012|NCT03051217|565295767|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
156605013|NCT03051217|565295768|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
156605014|NCT03051217|565295769|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
156605015|NCT03051217|565295770|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
156605016|NCT03051217|565295771|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
156605017|NCT03051217|565295772|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
156605018|NCT03051217|565295766|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
156605019|NCT03051217|565295767|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
156605020|NCT03051217|565295768|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
156605021|NCT03051217|565295769|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
156605022|NCT03051217|565295770|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
156605023|NCT03051217|565295771|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
156605024|NCT03051217|565295772|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
156605025|NCT03051217|565295766|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
156605026|NCT03051217|565295767|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
156605027|NCT03051217|565295768|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
156605028|NCT03051217|565295769|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
156605029|NCT03051217|565295770|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
156605030|NCT03051217|565295771|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
156605031|NCT03051217|565295772|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
156605032|NCT03051217|565295766|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
156605033|NCT03051217|565295767|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
156605034|NCT03051217|565295768|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
156605035|NCT03051217|565295769|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
156605036|NCT03051217|565295770|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
156605037|NCT03051217|565295771|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
156605038|NCT03051217|565295772|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
156605039|NCT01675141|565295773|FG000|Overall Study|Lenalidomide outside NIH|3|||
156605040|NCT01675141|565295773|FG000|Overall Study|Withdrawal by Subject|3|||
156605041|NCT01675141|565295773|FG000|Overall Study|Physician Decision|4|||
156605042|NCT01675141|565295773|FG000|Overall Study|No treatment, per protocol|1|||
156605043|NCT00105183|565295778|FG000|Overall Study|Death|19|||
156605044|NCT00105183|565295779|FG001|Overall Study|Death|13|||
156605045|NCT00105183|565295780|FG002|Overall Study|Death|15|||
156605046|NCT00105183|565295778|FG000|Overall Study|Withdrawal by Subject|1|||
156605047|NCT00105183|565295779|FG001|Overall Study|Withdrawal by Subject|1|||
156605048|NCT00105183|565295780|FG002|Overall Study|Withdrawal by Subject|4|||
156605049|NCT00105183|565295778|FG000|Overall Study|Physician Decision|1|||
156605050|NCT00105183|565295779|FG001|Overall Study|Physician Decision|2|||
156605051|NCT00105183|565295780|FG002|Overall Study|Physician Decision|3|||
156605052|NCT00105183|565295778|FG000|Overall Study|Lost to Follow-up|0|||
156605053|NCT00105183|565295779|FG001|Overall Study|Lost to Follow-up|1|||
156605054|NCT00105183|565295780|FG002|Overall Study|Lost to Follow-up|1|||
156605055|NCT00105183|565295778|FG000|Overall Study|Other reason|1|||
156605056|NCT00105183|565295779|FG001|Overall Study|Other reason|2|||
156605057|NCT00105183|565295780|FG002|Overall Study|Other reason|0|||
156605058|NCT00615914|565295784|FG000|Overall Study|Adverse Event|274|||
156605059|NCT00615914|565295784|FG000|Overall Study|Death|20|||
156605060|NCT00615914|565295784|FG000|Overall Study|Lack of Efficacy|59|||
156605061|NCT00615914|565295784|FG000|Overall Study|Lost to Follow-up|187|||
156605062|NCT00615914|565295784|FG000|Overall Study|Withdrawal by Subject|16|||
156605063|NCT00615914|565295784|FG000|Overall Study|Physician Decision|4|||
156605064|NCT00615914|565295784|FG000|Overall Study|No data was collected.|65|||
156605065|NCT00615914|565295784|FG000|Overall Study|No treatment|2|||
156605066|NCT00615914|565295784|FG000|Overall Study|Irregularly enrolled patients|10|||
156605067|NCT03673956|565295785|FG000|Overall Study|Lost to Follow-up|1|||
156605068|NCT03673956|565295786|FG001|Overall Study|Lost to Follow-up|0|||
156605069|NCT03673956|565295787|FG002|Overall Study|Lost to Follow-up|0|||
156605070|NCT03673956|565295788|FG003|Overall Study|Lost to Follow-up|0|||
156605071|NCT03673956|565295785|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
156605072|NCT03673956|565295786|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
156605073|NCT03673956|565295787|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
156605074|NCT03673956|565295788|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
156605075|NCT01855945|565295793|FG000|Overall Study|Adverse Event|0|||
156605076|NCT01855945|565295794|FG001|Overall Study|Adverse Event|0|||
156605077|NCT01855945|565295795|FG002|Overall Study|Adverse Event|0|||
156605078|NCT01855945|565295796|FG003|Overall Study|Adverse Event|0|||
156605079|NCT01855945|565295797|FG004|Overall Study|Adverse Event|0|||
156863748|NCT05138653|566258799|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863749|NCT05138653|566258800|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863750|NCT05138653|566258801|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863751|NCT05138653|566258802|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863752|NCT05138653|566258803|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863753|NCT05138653|566258804|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863754|NCT05138653|566258789|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863755|NCT05138653|566258790|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863756|NCT05138653|566258791|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863757|NCT05138653|566258792|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863758|NCT05138653|566258793|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863759|NCT05138653|566258794|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863760|NCT05138653|566258795|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
156863761|NCT05138653|566258796|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863762|NCT05138653|566258797|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863763|NCT05138653|566258798|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863764|NCT05138653|566258799|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863765|NCT05138653|566258800|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863766|NCT05138653|566258801|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863767|NCT05138653|566258802|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863768|NCT05138653|566258803|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863769|NCT05138653|566258804|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863770|NCT05138653|566258789|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863771|NCT05138653|566258790|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863772|NCT05138653|566258791|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863773|NCT05138653|566258792|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863774|NCT05138653|566258793|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863775|NCT05138653|566258794|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863776|NCT05138653|566258795|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863777|NCT05138653|566258796|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863778|NCT05138653|566258797|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863779|NCT05138653|566258798|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863780|NCT05138653|566258799|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
156863781|NCT05138653|566258800|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863782|NCT05138653|566258801|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
156863783|NCT05138653|566258802|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863784|NCT05138653|566258803|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
156863785|NCT05138653|566258804|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863786|NCT05138653|566258789|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156605080|NCT01855945|565295798|FG005|Overall Study|Adverse Event|0|||
156605081|NCT01855945|565295799|FG006|Overall Study|Adverse Event|1|||
156605082|NCT01855945|565295800|FG007|Overall Study|Adverse Event|0|||
156605083|NCT01855945|565295801|FG008|Overall Study|Adverse Event|0|||
156605084|NCT01855945|565295802|FG009|Overall Study|Adverse Event|0|||
156605085|NCT01855945|565295803|FG010|Overall Study|Adverse Event|0|||
156605086|NCT01855945|565295804|FG011|Overall Study|Adverse Event|0|||
156605087|NCT01855945|565295793|FG000|Overall Study|Death|0|||
156605088|NCT01855945|565295794|FG001|Overall Study|Death|0|||
156605089|NCT01855945|565295795|FG002|Overall Study|Death|0|||
156605090|NCT01855945|565295796|FG003|Overall Study|Death|0|||
156605091|NCT01855945|565295797|FG004|Overall Study|Death|0|||
156605092|NCT01855945|565295798|FG005|Overall Study|Death|0|||
156605093|NCT01855945|565295799|FG006|Overall Study|Death|2|||
156605094|NCT01855945|565295800|FG007|Overall Study|Death|0|||
156605095|NCT01855945|565295801|FG008|Overall Study|Death|0|||
156605096|NCT01855945|565295802|FG009|Overall Study|Death|0|||
156605097|NCT01855945|565295803|FG010|Overall Study|Death|0|||
156605098|NCT01855945|565295804|FG011|Overall Study|Death|0|||
156605099|NCT01855945|565295793|FG000|Overall Study|Lost to Follow-up|11|||
156605100|NCT01855945|565295794|FG001|Overall Study|Lost to Follow-up|10|||
156605101|NCT01855945|565295795|FG002|Overall Study|Lost to Follow-up|7|||
156605102|NCT01855945|565295796|FG003|Overall Study|Lost to Follow-up|3|||
156605103|NCT01855945|565295797|FG004|Overall Study|Lost to Follow-up|0|||
156605104|NCT01855945|565295798|FG005|Overall Study|Lost to Follow-up|3|||
156605105|NCT01855945|565295799|FG006|Overall Study|Lost to Follow-up|4|||
156605106|NCT01855945|565295800|FG007|Overall Study|Lost to Follow-up|7|||
156605107|NCT01855945|565295801|FG008|Overall Study|Lost to Follow-up|2|||
156605108|NCT01855945|565295802|FG009|Overall Study|Lost to Follow-up|0|||
156605109|NCT01855945|565295803|FG010|Overall Study|Lost to Follow-up|0|||
156605110|NCT01855945|565295804|FG011|Overall Study|Lost to Follow-up|2|||
156605111|NCT01855945|565295793|FG000|Overall Study|Other - Unclassified|1|||
156605112|NCT01855945|565295794|FG001|Overall Study|Other - Unclassified|1|||
156605113|NCT01855945|565295795|FG002|Overall Study|Other - Unclassified|1|||
156605114|NCT01855945|565295796|FG003|Overall Study|Other - Unclassified|0|||
156605115|NCT01855945|565295797|FG004|Overall Study|Other - Unclassified|0|||
156605116|NCT01855945|565295798|FG005|Overall Study|Other - Unclassified|0|||
156605117|NCT01855945|565295799|FG006|Overall Study|Other - Unclassified|2|||
156605118|NCT01855945|565295800|FG007|Overall Study|Other - Unclassified|1|||
156605119|NCT01855945|565295801|FG008|Overall Study|Other - Unclassified|0|||
156605120|NCT01855945|565295802|FG009|Overall Study|Other - Unclassified|0|||
156605121|NCT01855945|565295803|FG010|Overall Study|Other - Unclassified|1|||
156605122|NCT01855945|565295804|FG011|Overall Study|Other - Unclassified|0|||
156605123|NCT01855945|565295793|FG000|Overall Study|Withdrawal by Subject|4|||
156605124|NCT01855945|565295794|FG001|Overall Study|Withdrawal by Subject|0|||
156605125|NCT01855945|565295795|FG002|Overall Study|Withdrawal by Subject|4|||
156605126|NCT01855945|565295796|FG003|Overall Study|Withdrawal by Subject|1|||
156605127|NCT01855945|565295797|FG004|Overall Study|Withdrawal by Subject|1|||
156605128|NCT01855945|565295798|FG005|Overall Study|Withdrawal by Subject|0|||
156605129|NCT01855945|565295799|FG006|Overall Study|Withdrawal by Subject|1|||
156605130|NCT01855945|565295800|FG007|Overall Study|Withdrawal by Subject|0|||
156605131|NCT01855945|565295801|FG008|Overall Study|Withdrawal by Subject|0|||
156605132|NCT01855945|565295802|FG009|Overall Study|Withdrawal by Subject|2|||
156605133|NCT01855945|565295803|FG010|Overall Study|Withdrawal by Subject|4|||
156605134|NCT01855945|565295804|FG011|Overall Study|Withdrawal by Subject|1|||
156605135|NCT02156804|565295805|FG000|Overall Study|Withdrawal by Subject|1|||
156605136|NCT03228394|565295806|FG000|Overall Study|Lost to Follow-up|0|||
156605137|NCT03228394|565295807|FG001|Overall Study|Lost to Follow-up|0|||
156605138|NCT03228394|565295808|FG002|Overall Study|Lost to Follow-up|1|||
156605139|NCT03228394|565295809|FG003|Overall Study|Lost to Follow-up|1|||
156605140|NCT03228394|565295810|FG004|Overall Study|Lost to Follow-up|0|||
156605141|NCT03228394|565295811|FG005|Overall Study|Lost to Follow-up|0|||
156605142|NCT03228394|565295812|FG006|Overall Study|Lost to Follow-up|2|||
156605143|NCT03228394|565295813|FG007|Overall Study|Lost to Follow-up|0|||
156605144|NCT03228394|565295806|FG000|Overall Study|Withdrawal by Subject|0|||
156605145|NCT03228394|565295807|FG001|Overall Study|Withdrawal by Subject|0|||
156605146|NCT03228394|565295808|FG002|Overall Study|Withdrawal by Subject|1|||
156605147|NCT03228394|565295809|FG003|Overall Study|Withdrawal by Subject|0|||
156605148|NCT03228394|565295810|FG004|Overall Study|Withdrawal by Subject|0|||
156605149|NCT03228394|565295811|FG005|Overall Study|Withdrawal by Subject|0|||
156605150|NCT03228394|565295812|FG006|Overall Study|Withdrawal by Subject|1|||
156605151|NCT03228394|565295813|FG007|Overall Study|Withdrawal by Subject|3|||
156605152|NCT03228394|565295806|FG000|Overall Study|Protocol Violation|0|||
156605153|NCT03228394|565295807|FG001|Overall Study|Protocol Violation|0|||
156605154|NCT03228394|565295808|FG002|Overall Study|Protocol Violation|0|||
156605155|NCT03228394|565295809|FG003|Overall Study|Protocol Violation|1|||
156605156|NCT03228394|565295810|FG004|Overall Study|Protocol Violation|0|||
156605157|NCT03228394|565295811|FG005|Overall Study|Protocol Violation|0|||
156605158|NCT03228394|565295812|FG006|Overall Study|Protocol Violation|0|||
156605159|NCT03228394|565295813|FG007|Overall Study|Protocol Violation|0|||
156863787|NCT05138653|566258790|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156605160|NCT03228394|565295806|FG000|Overall Study|Physician Decision|0|||
156605161|NCT03228394|565295807|FG001|Overall Study|Physician Decision|0|||
156605162|NCT03228394|565295808|FG002|Overall Study|Physician Decision|0|||
156605163|NCT03228394|565295809|FG003|Overall Study|Physician Decision|0|||
156605164|NCT03228394|565295810|FG004|Overall Study|Physician Decision|0|||
156605165|NCT03228394|565295811|FG005|Overall Study|Physician Decision|0|||
156605166|NCT03228394|565295812|FG006|Overall Study|Physician Decision|1|||
156605167|NCT03228394|565295813|FG007|Overall Study|Physician Decision|0|||
156605168|NCT03228394|565295806|FG000|Overall Study|Noncompliance|0|||
156605169|NCT03228394|565295807|FG001|Overall Study|Noncompliance|0|||
156605170|NCT03228394|565295808|FG002|Overall Study|Noncompliance|0|||
156605171|NCT03228394|565295809|FG003|Overall Study|Noncompliance|0|||
156605172|NCT03228394|565295810|FG004|Overall Study|Noncompliance|0|||
156605173|NCT03228394|565295811|FG005|Overall Study|Noncompliance|0|||
156605174|NCT03228394|565295812|FG006|Overall Study|Noncompliance|1|||
156605175|NCT03228394|565295813|FG007|Overall Study|Noncompliance|0|||
156605176|NCT02443805|565295816|FG000|Overall Study|Adverse Event|100|||
156605177|NCT02443805|565295817|FG001|Overall Study|Adverse Event|18|||
156605178|NCT02443805|565295816|FG000|Overall Study|Withdrawal by Subject|73|||
156605179|NCT02443805|565295817|FG001|Overall Study|Withdrawal by Subject|74|||
156605180|NCT02443805|565295816|FG000|Overall Study|Lost to Follow-up|19|||
156605181|NCT02443805|565295817|FG001|Overall Study|Lost to Follow-up|14|||
156605182|NCT02443805|565295816|FG000|Overall Study|Pregnancy|6|||
156605183|NCT02443805|565295817|FG001|Overall Study|Pregnancy|5|||
156605184|NCT02443805|565295816|FG000|Overall Study|Protocol Violation|2|||
156605185|NCT02443805|565295817|FG001|Overall Study|Protocol Violation|4|||
156605186|NCT02443805|565295816|FG000|Overall Study|Lack of Efficacy|1|||
156605187|NCT02443805|565295817|FG001|Overall Study|Lack of Efficacy|1|||
156605188|NCT02443805|565295816|FG000|Overall Study|Non-compliance with study drug|6|||
156605189|NCT02443805|565295817|FG001|Overall Study|Non-compliance with study drug|4|||
156605190|NCT02443805|565295816|FG000|Overall Study|Withdrawal by parent/guardian|3|||
156605191|NCT02443805|565295817|FG001|Overall Study|Withdrawal by parent/guardian|5|||
156605192|NCT02443805|565295816|FG000|Overall Study|Any other reason not above-mentioned|3|||
156605193|NCT02443805|565295817|FG001|Overall Study|Any other reason not above-mentioned|2|||
156605194|NCT00961116|565295818|FG000|Washout Period of 7 Days|Adverse Event|1|||
156605195|NCT00961116|565295819|FG001|Washout Period of 7 Days|Adverse Event|1|||
156605196|NCT00961116|565295818|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
156605197|NCT00961116|565295819|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156605198|NCT00961116|565295818|FG000|Washout Period of 7 Days|Protocol Violation|0|||
156605199|NCT00961116|565295819|FG001|Washout Period of 7 Days|Protocol Violation|1|||
156605200|NCT00968708|565295820|FG000|Overall Study|Adverse Event|169|||
156605201|NCT00968708|565295821|FG001|Overall Study|Adverse Event|150|||
156605202|NCT00968708|565295820|FG000|Overall Study|Major Protocol Deviation|0|||
156605203|NCT00968708|565295821|FG001|Overall Study|Major Protocol Deviation|1|||
156605204|NCT00968708|565295820|FG000|Overall Study|Lost to Follow-up|19|||
156605205|NCT00968708|565295821|FG001|Overall Study|Lost to Follow-up|11|||
156605206|NCT00968708|565295820|FG000|Overall Study|Voluntary Withdrawal|104|||
156605207|NCT00968708|565295821|FG001|Overall Study|Voluntary Withdrawal|101|||
156605208|NCT00968708|565295820|FG000|Overall Study|Investigator Discretion|0|||
156605209|NCT00968708|565295821|FG001|Overall Study|Investigator Discretion|1|||
156605210|NCT00968708|565295820|FG000|Overall Study|Other|26|||
156605211|NCT00968708|565295821|FG001|Overall Study|Other|34|||
156605212|NCT02708966|565295822|FG000|Overall Study|Lost to Follow-up|2|||
156605213|NCT02708966|565295823|FG001|Overall Study|Lost to Follow-up|2|||
156605214|NCT00389441|565295826|FG000|Overall Study|Adverse Event|7|||
156605215|NCT00389441|565295826|FG000|Overall Study|Death|4|||
156605216|NCT00389441|565295826|FG000|Overall Study|Lost to Follow-up|2|||
156605217|NCT00389441|565295826|FG000|Overall Study|Withdrawal by Subject|4|||
156605218|NCT00389441|565295826|FG000|Overall Study|Physician Decision|1|||
156605219|NCT00389441|565295826|FG000|Overall Study|Protocol Violation|1|||
156605220|NCT00389441|565295826|FG000|Overall Study|Global deterioration of health status|4|||
156605221|NCT00389441|565295826|FG000|Overall Study|Objective progression or relapse|26|||
156605222|NCT00389441|565295826|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
156605223|NCT00389441|565295826|FG000|Overall Study|Clinical progression|1|||
156605224|NCT02260388|565295827|FG000|Overall Study|Lost to Follow-up|2|||
156605225|NCT02260388|565295828|FG001|Overall Study|Lost to Follow-up|8|||
156605226|NCT02260388|565295829|FG002|Overall Study|Lost to Follow-up|3|||
156605227|NCT02260388|565295830|FG003|Overall Study|Lost to Follow-up|4|||
156605228|NCT01981109|565295831|FG000|Overall Study|Death|36|||
156605229|NCT01981109|565295831|FG000|Overall Study|Withdrawal by Subject|40|||
156605230|NCT01981109|565295831|FG000|Overall Study|Lost to Follow-up|9|||
156605231|NCT01981109|565295831|FG000|Overall Study|No Discontinuation Documentation|37|||
156605232|NCT01981109|565295831|FG000|Overall Study|Study Termination|100|||
156605233|NCT01981109|565295831|FG000|Overall Study|No data available|2|||
156605234|NCT03407170|565295832|FG000|Overall Study|Adverse Event|1|||
156605235|NCT00305604|565295835|FG000|Overall Study|Adverse Event|6|||
156605236|NCT00305604|565295836|FG001|Overall Study|Adverse Event|3|||
156605237|NCT00305604|565295835|FG000|Overall Study|Lack of Efficacy|11|||
156605238|NCT00305604|565295836|FG001|Overall Study|Lack of Efficacy|18|||
156605239|NCT00305604|565295835|FG000|Overall Study|Lost to Follow-up|0|||
156605240|NCT00305604|565295836|FG001|Overall Study|Lost to Follow-up|4|||
156605241|NCT00305604|565295835|FG000|Overall Study|Protocol Violation|2|||
156605242|NCT00305604|565295836|FG001|Overall Study|Protocol Violation|1|||
156605243|NCT00305604|565295835|FG000|Overall Study|Withdrawal by Subject|12|||
156605244|NCT00305604|565295836|FG001|Overall Study|Withdrawal by Subject|21|||
156605245|NCT00305604|565295835|FG000|Overall Study|Patient moved|1|||
156605246|NCT00305604|565295836|FG001|Overall Study|Patient moved|0|||
156605247|NCT00636441|565295837|FG000|Overall Study|Adverse Event|0|||
156605248|NCT00636441|565295838|FG001|Overall Study|Adverse Event|1|||
156605249|NCT00636441|565295839|FG002|Overall Study|Adverse Event|1|||
156605250|NCT00636441|565295840|FG003|Overall Study|Adverse Event|0|||
156605251|NCT00636441|565295841|FG004|Overall Study|Adverse Event|0|||
156605252|NCT00636441|565295842|FG005|Overall Study|Adverse Event|1|||
156605253|NCT00636441|565295843|FG006|Overall Study|Adverse Event|0|||
156605254|NCT00636441|565295837|FG000|Overall Study|Late, ineligible|0|||
156605255|NCT00636441|565295838|FG001|Overall Study|Late, ineligible|0|||
156605256|NCT00636441|565295839|FG002|Overall Study|Late, ineligible|0|||
156605257|NCT00636441|565295840|FG003|Overall Study|Late, ineligible|0|||
156605258|NCT00636441|565295841|FG004|Overall Study|Late, ineligible|0|||
156605259|NCT00636441|565295842|FG005|Overall Study|Late, ineligible|0|||
156605260|NCT00636441|565295843|FG006|Overall Study|Late, ineligible|1|||
156605261|NCT00636441|565295837|FG000|Overall Study|Screen Failure|0|||
156605262|NCT00636441|565295838|FG001|Overall Study|Screen Failure|0|||
156605263|NCT00636441|565295839|FG002|Overall Study|Screen Failure|0|||
156605264|NCT00636441|565295840|FG003|Overall Study|Screen Failure|0|||
156605265|NCT00636441|565295841|FG004|Overall Study|Screen Failure|0|||
156605266|NCT00636441|565295842|FG005|Overall Study|Screen Failure|0|||
156605267|NCT00636441|565295843|FG006|Overall Study|Screen Failure|17|||
156863788|NCT05138653|566258791|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863789|NCT05138653|566258792|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863790|NCT05138653|566258793|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863791|NCT05138653|566258794|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863792|NCT05138653|566258795|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863793|NCT05138653|566258796|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863794|NCT05138653|566258797|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863795|NCT05138653|566258798|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863796|NCT05138653|566258799|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863797|NCT05138653|566258800|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863798|NCT05138653|566258801|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863799|NCT05138653|566258802|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863800|NCT05138653|566258803|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863801|NCT05138653|566258804|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
156863802|NCT05138653|566258789|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863803|NCT05138653|566258790|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863804|NCT05138653|566258791|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863805|NCT05138653|566258792|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863806|NCT05138653|566258793|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863807|NCT05138653|566258794|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863808|NCT05138653|566258795|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863809|NCT05138653|566258796|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863810|NCT05138653|566258797|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863811|NCT05138653|566258798|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863812|NCT05138653|566258799|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863813|NCT05138653|566258800|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863814|NCT05138653|566258801|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863815|NCT05138653|566258802|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
156863816|NCT05138653|566258803|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863817|NCT05138653|566258804|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863818|NCT04607005|566258805|FG000|Overall Study|Adverse Event|0|||
156863819|NCT04607005|566258806|FG001|Overall Study|Adverse Event|1|||
156863820|NCT04607005|566258805|FG000|Overall Study|Lack of Efficacy|1|||
156863821|NCT04607005|566258806|FG001|Overall Study|Lack of Efficacy|6|||
156863822|NCT04607005|566258805|FG000|Overall Study|Withdrawal by Subject|4|||
156863823|NCT04607005|566258806|FG001|Overall Study|Withdrawal by Subject|9|||
156863824|NCT04607005|566258805|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
156863825|NCT04607005|566258806|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
156863826|NCT02331134|566258807|FG000|Overall Study|Withdrawal by Subject|1|||
156605268|NCT02849626|565295846|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
156605269|NCT02849626|565295847|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
156605270|NCT02849626|565295848|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
156605271|NCT02849626|565295849|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
156605272|NCT02849626|565295846|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
156605273|NCT02849626|565295847|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
156605274|NCT02849626|565295848|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
156605275|NCT02849626|565295849|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
156605276|NCT02849626|565295846|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
156605277|NCT02849626|565295847|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
156605278|NCT02849626|565295848|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
156605279|NCT02849626|565295849|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
156605280|NCT02849626|565295846|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
156605281|NCT02849626|565295847|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
156605282|NCT02849626|565295848|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
156605283|NCT02849626|565295849|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
156605284|NCT02849626|565295846|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
156605285|NCT02849626|565295847|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
156605286|NCT02849626|565295848|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
156605287|NCT02849626|565295849|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
156605288|NCT02849626|565295846|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
156605289|NCT02849626|565295847|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
156605290|NCT02849626|565295848|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
156605291|NCT02849626|565295849|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
156605292|NCT02849626|565295846|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
156605293|NCT02849626|565295847|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
156605294|NCT02849626|565295848|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
156605295|NCT02849626|565295849|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
156605296|NCT02849626|565295846|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
156605297|NCT02849626|565295847|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
156605298|NCT02849626|565295848|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
156605299|NCT02849626|565295849|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
156605300|NCT02849626|565295846|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
156605301|NCT02849626|565295847|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
156605302|NCT02849626|565295848|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
156605303|NCT02849626|565295849|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
156605304|NCT02849626|565295846|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
156605305|NCT02849626|565295847|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
156605306|NCT02849626|565295848|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
156605307|NCT02849626|565295849|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
156605308|NCT02849626|565295846|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
156605309|NCT02849626|565295847|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
156605310|NCT02849626|565295848|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
156605311|NCT02849626|565295849|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
156605312|NCT04176445|565295850|FG000|Overall Study|Adverse Event|0|||
156605313|NCT04176445|565295851|FG001|Overall Study|Adverse Event|1|||
156605314|NCT04176445|565295850|FG000|Overall Study|change plans weaning after first intervention|0|||
156605315|NCT04176445|565295851|FG001|Overall Study|change plans weaning after first intervention|1|||
156605316|NCT04046341|565295852|FG000|Overall Study|Lost to Follow-up|2|||
156605317|NCT04046341|565295852|FG000|Overall Study|Withdrawal by Subject|1|||
156605318|NCT04377672|565295853|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
156605319|NCT02447458|565295854|FG000|Overall Study|Other|0|||
156605320|NCT02447458|565295855|FG001|Overall Study|Other|0|||
156605321|NCT02447458|565295856|FG002|Overall Study|Other|1|||
156605322|NCT02447458|565295857|FG003|Overall Study|Other|0|||
156605323|NCT02447458|565295858|FG004|Overall Study|Other|0|||
156605324|NCT02447458|565295859|FG005|Overall Study|Other|0|||
156605325|NCT00435994|565295860|FG000|Overall Study|Lost to Follow-up|7|||
156605326|NCT00435994|565295861|FG001|Overall Study|Lost to Follow-up|0|||
156605327|NCT00435994|565295862|FG002|Overall Study|Lost to Follow-up|0|||
156605328|NCT03505749|565295863|FG000|Overall Study|Lost to Follow-up|7|||
156605329|NCT03505749|565295864|FG001|Overall Study|Lost to Follow-up|11|||
156605330|NCT03505749|565295863|FG000|Overall Study|Withdrawal by Subject|6|||
156605331|NCT03505749|565295864|FG001|Overall Study|Withdrawal by Subject|0|||
156605332|NCT03505749|565295863|FG000|Overall Study|Discharged from treatment|3|||
156605333|NCT03505749|565295864|FG001|Overall Study|Discharged from treatment|6|||
156605334|NCT01151540|565295865|FG000|Overall Study|Other|2|||
156605335|NCT01151540|565295865|FG000|Overall Study|Adverse event, non-fatal|4|||
156605336|NCT01151540|565295865|FG000|Overall Study|Withdrawal by Subject|7|||
156605337|NCT03846219|565295867|FG000|Overall Study|Withdrawal by Subject|3|||
156863827|NCT04825574|566258808|FG000|Overall Study|Commercial treatment became available|1|||
156863828|NCT04825574|566258808|FG000|Overall Study|Disease progression|1|||
156605338|NCT03846219|565295868|FG001|Overall Study|Withdrawal by Subject|2|||
156605339|NCT03846219|565295869|FG002|Overall Study|Withdrawal by Subject|2|||
156605340|NCT03846219|565295867|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
156634913|NCT03917654|565407825|FG010|Year 1|Travel|3|||
156605341|NCT03846219|565295868|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
156605342|NCT03846219|565295869|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
156605343|NCT03846219|565295867|FG000|Overall Study|Physician Decision|0|||
156605344|NCT03846219|565295868|FG001|Overall Study|Physician Decision|0|||
156605345|NCT03846219|565295869|FG002|Overall Study|Physician Decision|2|||
156605346|NCT05109702|565295870|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
156605347|NCT05109702|565295871|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
156605348|NCT05109702|565295872|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
156605349|NCT05109702|565295870|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
156605350|NCT05109702|565295871|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
156605351|NCT05109702|565295872|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
156605352|NCT05109702|565295870|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
156605353|NCT05109702|565295871|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
156605354|NCT05109702|565295872|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
156605355|NCT05109702|565295870|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
156605356|NCT05109702|565295871|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
156605357|NCT05109702|565295872|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
156605358|NCT05109702|565295870|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
156605359|NCT05109702|565295871|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
156605360|NCT05109702|565295872|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
156605361|NCT02322411|565295875|FG000|Overall Study|Lost to Follow-up|4|||
156605362|NCT02322411|565295876|FG001|Overall Study|Lost to Follow-up|7|||
156605363|NCT02322411|565295875|FG000|Overall Study|Withdrawal by Subject|1|||
156605364|NCT02322411|565295876|FG001|Overall Study|Withdrawal by Subject|0|||
156605365|NCT01392378|565295877|FG000|Infant Series|Adverse Event|0|||
156605366|NCT01392378|565295878|FG001|Infant Series|Adverse Event|0|||
156605367|NCT01392378|565295879|FG002|Infant Series|Adverse Event|0|||
156605368|NCT01392378|565295880|FG003|Infant Series|Adverse Event|1|||
156605369|NCT01392378|565295881|FG004|Infant Series|Adverse Event|0|||
156605370|NCT01392378|565295877|FG000|Infant Series|Lost to Follow-up|0|||
156605371|NCT01392378|565295878|FG001|Infant Series|Lost to Follow-up|0|||
156605372|NCT01392378|565295879|FG002|Infant Series|Lost to Follow-up|0|||
156605373|NCT01392378|565295880|FG003|Infant Series|Lost to Follow-up|1|||
156605374|NCT01392378|565295881|FG004|Infant Series|Lost to Follow-up|0|||
156605375|NCT01392378|565295877|FG000|Infant Series|Protocol Violation|0|||
156605376|NCT01392378|565295878|FG001|Infant Series|Protocol Violation|1|||
156605377|NCT01392378|565295879|FG002|Infant Series|Protocol Violation|0|||
156605378|NCT01392378|565295880|FG003|Infant Series|Protocol Violation|0|||
156605379|NCT01392378|565295881|FG004|Infant Series|Protocol Violation|0|||
156605380|NCT01392378|565295877|FG000|Infant Series|Withdrawal by Parent|4|||
156605381|NCT01392378|565295878|FG001|Infant Series|Withdrawal by Parent|1|||
156605382|NCT01392378|565295879|FG002|Infant Series|Withdrawal by Parent|0|||
156605383|NCT01392378|565295880|FG003|Infant Series|Withdrawal by Parent|0|||
156605384|NCT01392378|565295881|FG004|Infant Series|Withdrawal by Parent|0|||
156605385|NCT01392378|565295877|FG000|After Infant Series|Lost to Follow-up|0|||
156605386|NCT01392378|565295878|FG001|After Infant Series|Lost to Follow-up|0|||
156605387|NCT01392378|565295879|FG002|After Infant Series|Lost to Follow-up|1|||
156605388|NCT01392378|565295880|FG003|After Infant Series|Lost to Follow-up|0|||
156605389|NCT01392378|565295881|FG004|After Infant Series|Lost to Follow-up|0|||
156605390|NCT01392378|565295877|FG000|After Infant Series|Withdrawal by Parent|0|||
156605391|NCT01392378|565295878|FG001|After Infant Series|Withdrawal by Parent|1|||
156605392|NCT01392378|565295879|FG002|After Infant Series|Withdrawal by Parent|1|||
156605393|NCT01392378|565295880|FG003|After Infant Series|Withdrawal by Parent|0|||
156605394|NCT01392378|565295881|FG004|After Infant Series|Withdrawal by Parent|1|||
156605395|NCT01392378|565295877|FG000|Toddler Dose|Lost to Follow-up|0|||
156605396|NCT01392378|565295878|FG001|Toddler Dose|Lost to Follow-up|0|||
156605397|NCT01392378|565295879|FG002|Toddler Dose|Lost to Follow-up|0|||
156605398|NCT01392378|565295880|FG003|Toddler Dose|Lost to Follow-up|1|||
156605399|NCT01392378|565295881|FG004|Toddler Dose|Lost to Follow-up|0|||
156605400|NCT01392378|565295877|FG000|Toddler Dose|Withdrawal by Parent|0|||
156605401|NCT01392378|565295878|FG001|Toddler Dose|Withdrawal by Parent|1|||
156605402|NCT01392378|565295879|FG002|Toddler Dose|Withdrawal by Parent|0|||
156605403|NCT01392378|565295880|FG003|Toddler Dose|Withdrawal by Parent|1|||
156605404|NCT01392378|565295881|FG004|Toddler Dose|Withdrawal by Parent|1|||
156605405|NCT02261883|565295882|FG000|Overall Study|Death|3|||
156605406|NCT02261883|565295883|FG001|Overall Study|Death|2|||
156605407|NCT02261883|565295882|FG000|Overall Study|Physician Decision|1|||
156605408|NCT02261883|565295883|FG001|Overall Study|Physician Decision|0|||
156605409|NCT02261883|565295882|FG000|Overall Study|Protocol Violation|1|||
156605410|NCT02261883|565295883|FG001|Overall Study|Protocol Violation|0|||
156605411|NCT02261883|565295882|FG000|Overall Study|Withdrawal by Subject|0|||
156605412|NCT02261883|565295883|FG001|Overall Study|Withdrawal by Subject|1|||
156605413|NCT02261883|565295882|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
156605414|NCT02261883|565295883|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
156605415|NCT00903370|565295885|FG000|Overall Study|Death|13|||
156605416|NCT00903370|565295886|FG001|Overall Study|Death|10|||
156634914|NCT03917654|565407826|FG011|Year 1|Travel|3|||
156605417|NCT00903370|565295885|FG000|Overall Study|Withdrawal by Subject|9|||
156605418|NCT00903370|565295886|FG001|Overall Study|Withdrawal by Subject|6|||
156605419|NCT00903370|565295885|FG000|Overall Study|Lost to Follow-up|6|||
156605420|NCT00903370|565295886|FG001|Overall Study|Lost to Follow-up|8|||
156605421|NCT00345540|565295889|FG000|Overall Study|Withdrawal by Subject|1|||
156605422|NCT01938001|565295890|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
156605423|NCT01938001|565295891|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
156605424|NCT01938001|565295890|FG000|Pre-Treatment|Death|1|||
156605425|NCT01938001|565295891|FG001|Pre-Treatment|Death|0|||
156605426|NCT01938001|565295890|FG000|Treatment|Death|2|||
156605427|NCT01938001|565295891|FG001|Treatment|Death|0|||
156605428|NCT01938001|565295890|FG000|Treatment|Adverse Event|14|||
156605429|NCT01938001|565295891|FG001|Treatment|Adverse Event|8|||
156605430|NCT01938001|565295890|FG000|Treatment|Progressive Disease|21|||
156605431|NCT01938001|565295891|FG001|Treatment|Progressive Disease|54|||
156605432|NCT01938001|565295890|FG000|Treatment|Withdrawal by Subject|13|||
156605433|NCT01938001|565295891|FG001|Treatment|Withdrawal by Subject|7|||
156605434|NCT01938001|565295890|FG000|Treatment|Other reasons|2|||
156605435|NCT01938001|565295891|FG001|Treatment|Other reasons|1|||
156605436|NCT02983799|565295899|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
156605437|NCT02983799|565295900|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
156605438|NCT02983799|565295901|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
156605439|NCT02983799|565295902|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
156605440|NCT02983799|565295903|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
156605441|NCT02983799|565295899|FG000|Overall Study|Death|20|||
156605442|NCT02983799|565295900|FG001|Overall Study|Death|5|||
156605443|NCT02983799|565295901|FG002|Overall Study|Death|23|||
156605444|NCT02983799|565295902|FG003|Overall Study|Death|47|||
156605445|NCT02983799|565295903|FG004|Overall Study|Death|7|||
156605446|NCT02983799|565295899|FG000|Overall Study|Withdrawal by Subject|1|||
156605447|NCT02983799|565295900|FG001|Overall Study|Withdrawal by Subject|0|||
156605448|NCT02983799|565295901|FG002|Overall Study|Withdrawal by Subject|3|||
156605449|NCT02983799|565295902|FG003|Overall Study|Withdrawal by Subject|4|||
156605450|NCT02983799|565295903|FG004|Overall Study|Withdrawal by Subject|1|||
156605451|NCT02983799|565295899|FG000|Overall Study|Protocol Violation|0|||
156605452|NCT02983799|565295900|FG001|Overall Study|Protocol Violation|1|||
156605453|NCT02983799|565295901|FG002|Overall Study|Protocol Violation|0|||
156605454|NCT02983799|565295902|FG003|Overall Study|Protocol Violation|0|||
156605455|NCT02983799|565295903|FG004|Overall Study|Protocol Violation|1|||
156605456|NCT02983799|565295899|FG000|Overall Study|Lost to Follow-up|1|||
156605457|NCT02983799|565295900|FG001|Overall Study|Lost to Follow-up|0|||
156605458|NCT02983799|565295901|FG002|Overall Study|Lost to Follow-up|1|||
156605459|NCT02983799|565295902|FG003|Overall Study|Lost to Follow-up|0|||
156605460|NCT02983799|565295903|FG004|Overall Study|Lost to Follow-up|0|||
156605461|NCT02293902|565295917|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
156605462|NCT02293902|565295918|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
156605463|NCT02293902|565295919|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
156605464|NCT02293902|565295920|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
156605465|NCT02293902|565295921|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
156605466|NCT02293902|565295917|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
156605467|NCT02293902|565295918|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
156605468|NCT02293902|565295919|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
156605469|NCT02293902|565295920|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
156605470|NCT02293902|565295921|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
156605471|NCT02293902|565295917|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
156605472|NCT02293902|565295918|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
156605473|NCT02293902|565295919|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
156605474|NCT02293902|565295920|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
156605475|NCT02293902|565295921|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
156605476|NCT02293902|565295917|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
156605477|NCT02293902|565295918|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
156605478|NCT02293902|565295919|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
156605479|NCT02293902|565295920|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
156605480|NCT02293902|565295921|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
156605481|NCT02293902|565295917|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
156605482|NCT02293902|565295918|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
156605483|NCT02293902|565295919|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
156605484|NCT02293902|565295920|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
156605485|NCT02293902|565295921|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
156605486|NCT03366844|565297741|FG000|Overall Study|Physician Decision|1|||
156605487|NCT03366844|565297741|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
156605488|NCT02687711|565297744|FG000|Overall Study|Adverse Event|89|||
156605489|NCT02687711|565297744|FG000|Overall Study|Lack of Efficacy|70|||
156605490|NCT02687711|565297744|FG000|Overall Study|Lost to Follow-up|20|||
156605491|NCT02687711|565297744|FG000|Overall Study|Consent withdrawn|15|||
156605492|NCT02687711|565297744|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
156605493|NCT02687711|565297744|FG000|Overall Study|Too expensive|4|||
156605494|NCT02687711|565297744|FG000|Overall Study|Participant moved abroad|1|||
156605495|NCT02687711|565297744|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
156605496|NCT02687711|565297744|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
156605497|NCT02687711|565297744|FG000|Overall Study|Disliked taste|1|||
156605498|NCT02687711|565297744|FG000|Overall Study|Low mood|1|||
156605499|NCT02687711|565297744|FG000|Overall Study|Side effects|1|||
156605500|NCT02687711|565297744|FG000|Overall Study|Change of Hospital|1|||
156605501|NCT02687711|565297744|FG000|Overall Study|Liver Encephalopathy|1|||
156605502|NCT02687711|565297744|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
156605503|NCT02687711|565297744|FG000|Overall Study|Withdrawn due to intake interruption|1|||
156605504|NCT02687711|565297744|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
156605505|NCT02687711|565297744|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
156605506|NCT02687711|565297744|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
156605507|NCT03077243|565297745|FG000|Overall Study|Death|1|||
156605508|NCT03077243|565297746|FG001|Overall Study|Death|2|||
156605509|NCT03077243|565297747|FG002|Overall Study|Death|0|||
156605510|NCT03077243|565297748|FG003|Overall Study|Death|0|||
156605511|NCT03077243|565297745|FG000|Overall Study|Withdrawal by Subject|1|||
156605512|NCT03077243|565297746|FG001|Overall Study|Withdrawal by Subject|3|||
156605513|NCT03077243|565297747|FG002|Overall Study|Withdrawal by Subject|0|||
156605514|NCT03077243|565297748|FG003|Overall Study|Withdrawal by Subject|0|||
156605515|NCT03077243|565297745|FG000|Overall Study|Physician Decision|1|||
156605516|NCT03077243|565297746|FG001|Overall Study|Physician Decision|0|||
156605517|NCT03077243|565297747|FG002|Overall Study|Physician Decision|0|||
156605518|NCT03077243|565297748|FG003|Overall Study|Physician Decision|0|||
156605519|NCT03077243|565297745|FG000|Overall Study|Research at two study sites terminated early|0|||
156605520|NCT03077243|565297746|FG001|Overall Study|Research at two study sites terminated early|0|||
156605521|NCT03077243|565297747|FG002|Overall Study|Research at two study sites terminated early|0|||
156605522|NCT03077243|565297748|FG003|Overall Study|Research at two study sites terminated early|69|||
156605523|NCT01544478|565297750|FG000|Overall Study|Adverse Event|1|||
156605524|NCT01544478|565297750|FG000|Overall Study|Death|1|||
156605525|NCT01544478|565297750|FG000|Overall Study|Lost to Follow-up|48|||
156605526|NCT01544478|565297750|FG000|Overall Study|Physician Decision|15|||
156605527|NCT01544478|565297750|FG000|Overall Study|Pregnancy|1|||
156605528|NCT01544478|565297750|FG000|Overall Study|Withdrawal by Subject|52|||
156605529|NCT00212758|565297753|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
156605530|NCT00212758|565297754|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
156605531|NCT00212758|565297753|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
156605532|NCT00212758|565297754|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
156605533|NCT02574481|565297755|FG000|Overall Study|Withdrawal by Subject|29|||
156605534|NCT02574481|565297756|FG001|Overall Study|Withdrawal by Subject|15|||
156605535|NCT02574481|565297757|FG002|Overall Study|Withdrawal by Subject|4|||
156605536|NCT02574481|565297758|FG003|Overall Study|Withdrawal by Subject|1|||
156605537|NCT02574481|565297755|FG000|Overall Study|Adverse Event|5|||
156605538|NCT02574481|565297756|FG001|Overall Study|Adverse Event|1|||
156605539|NCT02574481|565297757|FG002|Overall Study|Adverse Event|1|||
156605540|NCT02574481|565297758|FG003|Overall Study|Adverse Event|0|||
156605541|NCT02574481|565297755|FG000|Overall Study|Visit Missed|15|||
156605542|NCT02574481|565297756|FG001|Overall Study|Visit Missed|7|||
156605543|NCT02574481|565297757|FG002|Overall Study|Visit Missed|5|||
156605544|NCT02574481|565297758|FG003|Overall Study|Visit Missed|0|||
156605545|NCT02574481|565297755|FG000|Overall Study|Other|7|||
156605546|NCT02574481|565297756|FG001|Overall Study|Other|2|||
156605547|NCT02574481|565297757|FG002|Overall Study|Other|0|||
156605548|NCT02574481|565297758|FG003|Overall Study|Other|0|||
156605549|NCT02574481|565297755|FG000|Overall Study|Death|48|||
156605550|NCT02574481|565297756|FG001|Overall Study|Death|26|||
156605551|NCT02574481|565297757|FG002|Overall Study|Death|12|||
156605552|NCT02574481|565297758|FG003|Overall Study|Death|4|||
156605553|NCT02574481|565297755|FG000|Overall Study|Physician Decision|5|||
156605554|NCT02574481|565297756|FG001|Overall Study|Physician Decision|2|||
156605555|NCT02574481|565297757|FG002|Overall Study|Physician Decision|0|||
156605556|NCT02574481|565297758|FG003|Overall Study|Physician Decision|0|||
156605557|NCT02574481|565297755|FG000|Overall Study|Lost to Follow-up|5|||
156605558|NCT02574481|565297756|FG001|Overall Study|Lost to Follow-up|1|||
156605559|NCT02574481|565297757|FG002|Overall Study|Lost to Follow-up|3|||
156605560|NCT02574481|565297758|FG003|Overall Study|Lost to Follow-up|0|||
156605561|NCT01105936|565297759|FG000|Period 1|Adverse Event|0|||
156605562|NCT01105936|565297760|FG001|Period 1|Adverse Event|0|||
156605563|NCT01105936|565297761|FG002|Period 1|Adverse Event|0|||
156605564|NCT01105936|565297762|FG003|Period 1|Adverse Event|1|||
156605565|NCT01105936|565297759|FG000|Period 2|Adverse Event|1|||
156605566|NCT01105936|565297760|FG001|Period 2|Adverse Event|0|||
156605567|NCT01105936|565297761|FG002|Period 2|Adverse Event|0|||
156605568|NCT01105936|565297762|FG003|Period 2|Adverse Event|0|||
156605569|NCT01105936|565297759|FG000|Period 3|Protocol Violation|0|||
156605570|NCT01105936|565297760|FG001|Period 3|Protocol Violation|2|||
156605571|NCT01105936|565297761|FG002|Period 3|Protocol Violation|0|||
156605572|NCT01105936|565297762|FG003|Period 3|Protocol Violation|0|||
156605573|NCT03170258|565297767|FG000|Overall Study|Physician Decision|4|||
156605574|NCT03170258|565297768|FG001|Overall Study|Physician Decision|0|||
156605575|NCT03170258|565297767|FG000|Overall Study|Equipment issues|1|||
156605576|NCT03170258|565297768|FG001|Overall Study|Equipment issues|0|||
156605577|NCT03170258|565297767|FG000|Overall Study|Medication|1|||
156605578|NCT03170258|565297768|FG001|Overall Study|Medication|0|||
156605579|NCT03170258|565297767|FG000|Overall Study|Sleep issues|1|||
156605580|NCT03170258|565297768|FG001|Overall Study|Sleep issues|0|||
156605581|NCT03276572|565297771|FG000|Overall Study|In follow-up|0|||
156605582|NCT03276572|565297772|FG001|Overall Study|In follow-up|0|||
156605583|NCT03276572|565297773|FG002|Overall Study|In follow-up|0|||
156605584|NCT03276572|565297774|FG003|Overall Study|In follow-up|0|||
156605585|NCT03276572|565297775|FG004|Overall Study|In follow-up|0|||
156605586|NCT03276572|565297776|FG005|Overall Study|In follow-up|1|||
156605587|NCT03276572|565297777|FG006|Overall Study|In follow-up|1|||
156605588|NCT03276572|565297771|FG000|Overall Study|Lost to Follow-up|0|||
156605589|NCT03276572|565297772|FG001|Overall Study|Lost to Follow-up|0|||
156605590|NCT03276572|565297773|FG002|Overall Study|Lost to Follow-up|0|||
156605591|NCT03276572|565297774|FG003|Overall Study|Lost to Follow-up|0|||
156605592|NCT03276572|565297775|FG004|Overall Study|Lost to Follow-up|0|||
156605593|NCT03276572|565297776|FG005|Overall Study|Lost to Follow-up|0|||
156605594|NCT03276572|565297777|FG006|Overall Study|Lost to Follow-up|1|||
156605595|NCT02954952|565297792|FG000|Overall Study|Withdrawal by Subject|1|||
156605596|NCT02954952|565297793|FG001|Overall Study|Withdrawal by Subject|0|||
156605597|NCT02954952|565297794|FG002|Overall Study|Withdrawal by Subject|0|||
156605598|NCT02954952|565297792|FG000|Overall Study|No data collected|0|||
156605599|NCT02954952|565297793|FG001|Overall Study|No data collected|1|||
156605600|NCT02954952|565297794|FG002|Overall Study|No data collected|0|||
156605601|NCT02911519|565297795|FG000|Overall Study|Lost to Follow-up|2|||
156605602|NCT02911519|565297796|FG001|Overall Study|Lost to Follow-up|2|||
156605603|NCT02911519|565297795|FG000|Overall Study|Death|0|||
156605604|NCT02911519|565297796|FG001|Overall Study|Death|2|||
156605605|NCT00724815|565297799|FG000|Overall Study|Randomized, not treated|31|||
156605606|NCT00724815|565297800|FG001|Overall Study|Randomized, not treated|30|||
156605607|NCT00724815|565297799|FG000|Overall Study|Adverse Event|5|||
156605608|NCT00724815|565297800|FG001|Overall Study|Adverse Event|3|||
156605609|NCT00724815|565297799|FG000|Overall Study|Lost to Follow-up|4|||
156605610|NCT00724815|565297800|FG001|Overall Study|Lost to Follow-up|1|||
156605611|NCT00724815|565297799|FG000|Overall Study|Other Various|3|||
156605612|NCT00724815|565297800|FG001|Overall Study|Other Various|5|||
156605613|NCT00810043|565297801|FG000|Overall Study|Withdrawal by Subject|1|||
156605614|NCT00810043|565297802|FG001|Overall Study|Withdrawal by Subject|0|||
156605615|NCT00810043|565297803|FG002|Overall Study|Withdrawal by Subject|2|||
156605616|NCT00810043|565297801|FG000|Overall Study|Lost to Follow-up|1|||
156605617|NCT00810043|565297802|FG001|Overall Study|Lost to Follow-up|0|||
156605618|NCT00810043|565297803|FG002|Overall Study|Lost to Follow-up|0|||
156605619|NCT00810043|565297801|FG000|Overall Study|Physician Decision|0|||
156605620|NCT00810043|565297802|FG001|Overall Study|Physician Decision|0|||
156605621|NCT00810043|565297803|FG002|Overall Study|Physician Decision|2|||
156605622|NCT00810043|565297801|FG000|Overall Study|Death|2|||
156605623|NCT00810043|565297802|FG001|Overall Study|Death|0|||
156605624|NCT00810043|565297803|FG002|Overall Study|Death|0|||
156605625|NCT00810043|565297801|FG000|Overall Study|Unrelated medical problem|0|||
156605626|NCT00810043|565297802|FG001|Overall Study|Unrelated medical problem|1|||
156605627|NCT00810043|565297803|FG002|Overall Study|Unrelated medical problem|0|||
156605628|NCT00810043|565297801|FG000|Overall Study|Non-medical problem|0|||
156605629|NCT00810043|565297802|FG001|Overall Study|Non-medical problem|0|||
156605630|NCT00810043|565297803|FG002|Overall Study|Non-medical problem|1|||
156605631|NCT00810043|565297801|FG000|Overall Study|No longer met enrollment criteria|0|||
156605632|NCT00810043|565297802|FG001|Overall Study|No longer met enrollment criteria|0|||
156605633|NCT00810043|565297803|FG002|Overall Study|No longer met enrollment criteria|3|||
156605634|NCT00445341|565297807|FG000|Overall Study|refused further treatment|1|||
156605635|NCT00445341|565297807|FG000|Overall Study|taken off treatment too early|1|||
156605636|NCT00641706|565297810|FG000|Overall Study|Adverse Event|2|||
156605637|NCT00641706|565297811|FG001|Overall Study|Adverse Event|1|||
156605638|NCT00641706|565297810|FG000|Overall Study|Withdrawal by Subject|6|||
156605639|NCT00641706|565297811|FG001|Overall Study|Withdrawal by Subject|1|||
156605640|NCT00641706|565297810|FG000|Overall Study|Clinical Decline|1|||
156605641|NCT00641706|565297811|FG001|Overall Study|Clinical Decline|0|||
156605642|NCT00641706|565297810|FG000|Overall Study|Lead Investigator Decision|0|||
156605643|NCT00641706|565297811|FG001|Overall Study|Lead Investigator Decision|1|||
156605644|NCT00109772|565297812|FG000|Double-blind Treatment|Adverse Event|14|||
156605645|NCT00109772|565297813|FG001|Double-blind Treatment|Adverse Event|5|||
156605646|NCT00109772|565297812|FG000|Double-blind Treatment|Lack of Efficacy|1|||
156605647|NCT00109772|565297813|FG001|Double-blind Treatment|Lack of Efficacy|0|||
156605648|NCT00109772|565297812|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
156605649|NCT00109772|565297813|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
156605650|NCT00109772|565297812|FG000|Double-blind Treatment|Lost to Follow-up|2|||
156605651|NCT00109772|565297813|FG001|Double-blind Treatment|Lost to Follow-up|3|||
156605652|NCT00109772|565297812|FG000|Double-blind Treatment|Protocol Violation|0|||
156605653|NCT00109772|565297813|FG001|Double-blind Treatment|Protocol Violation|1|||
156605654|NCT00109772|565297812|FG000|Double-blind Treatment|Other|0|||
156605655|NCT00109772|565297813|FG001|Double-blind Treatment|Other|4|||
156605656|NCT00109772|565297812|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
156605657|NCT00109772|565297813|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
156605658|NCT00109772|565297812|FG000|Open-label Extension|Adverse Event|10|||
156605659|NCT00109772|565297813|FG001|Open-label Extension|Adverse Event|19|||
156605660|NCT00109772|565297812|FG000|Open-label Extension|Lack of Efficacy|19|||
156605661|NCT00109772|565297813|FG001|Open-label Extension|Lack of Efficacy|11|||
156605662|NCT00109772|565297812|FG000|Open-label Extension|Withdrawal by Subject|9|||
156605663|NCT00109772|565297813|FG001|Open-label Extension|Withdrawal by Subject|6|||
156605664|NCT00109772|565297812|FG000|Open-label Extension|Lost to Follow-up|1|||
156605665|NCT00109772|565297813|FG001|Open-label Extension|Lost to Follow-up|0|||
156605666|NCT00109772|565297812|FG000|Open-label Extension|Death|0|||
156605667|NCT00109772|565297813|FG001|Open-label Extension|Death|1|||
156605668|NCT00109772|565297812|FG000|Open-label Extension|Protocol Violation|2|||
156605669|NCT00109772|565297813|FG001|Open-label Extension|Protocol Violation|2|||
156605670|NCT00109772|565297812|FG000|Open-label Extension|Other|4|||
156605671|NCT00109772|565297813|FG001|Open-label Extension|Other|10|||
156605672|NCT01989754|565297814|FG000|Overall Study|Withdrawal by Subject|10|||
156605673|NCT01989754|565297815|FG001|Overall Study|Withdrawal by Subject|14|||
156605674|NCT01989754|565297814|FG000|Overall Study|Lost to Follow-up|28|||
156605675|NCT01989754|565297815|FG001|Overall Study|Lost to Follow-up|20|||
156605676|NCT01989754|565297814|FG000|Overall Study|Closed Site|1|||
156605677|NCT01989754|565297815|FG001|Overall Study|Closed Site|1|||
156605678|NCT01359046|565297816|FG000|Overall Study|Did not receive allocated intervention|6|||
156605679|NCT01359046|565297817|FG001|Overall Study|Did not receive allocated intervention|6|||
156605680|NCT01359046|565297816|FG000|Overall Study|Physician Decision|1|||
156605681|NCT01359046|565297817|FG001|Overall Study|Physician Decision|11|||
156605682|NCT01369225|565297820|FG000|Overall Study|Withdrawal by Subject|1|||
156605683|NCT01369225|565297821|FG001|Overall Study|Withdrawal by Subject|0|||
156605684|NCT01369225|565297822|FG002|Overall Study|Withdrawal by Subject|2|||
156605685|NCT01369225|565297823|FG003|Overall Study|Withdrawal by Subject|1|||
156605686|NCT01369225|565297824|FG004|Overall Study|Withdrawal by Subject|0|||
156605687|NCT01369225|565297825|FG005|Overall Study|Withdrawal by Subject|0|||
156605688|NCT01369225|565297820|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
156605689|NCT01369225|565297821|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
156605690|NCT01369225|565297822|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
156605691|NCT01369225|565297823|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
156605692|NCT01369225|565297824|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
156605693|NCT01369225|565297825|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
156605694|NCT01369225|565297820|FG000|Overall Study|Other|1|||
156605695|NCT01369225|565297821|FG001|Overall Study|Other|0|||
156605696|NCT01369225|565297822|FG002|Overall Study|Other|0|||
156605697|NCT01369225|565297823|FG003|Overall Study|Other|0|||
156605698|NCT01369225|565297824|FG004|Overall Study|Other|1|||
156605699|NCT01369225|565297825|FG005|Overall Study|Other|0|||
156605700|NCT01369225|565297820|FG000|Overall Study|Adverse Event|0|||
156605701|NCT01369225|565297821|FG001|Overall Study|Adverse Event|0|||
156605702|NCT01369225|565297822|FG002|Overall Study|Adverse Event|0|||
156605703|NCT01369225|565297823|FG003|Overall Study|Adverse Event|1|||
156605704|NCT01369225|565297824|FG004|Overall Study|Adverse Event|1|||
156605705|NCT01369225|565297825|FG005|Overall Study|Adverse Event|0|||
156605706|NCT00792701|565297826|FG000|Overall Study|Adverse Event|0|||
156605707|NCT00792701|565297827|FG001|Overall Study|Adverse Event|22|||
156605708|NCT00792701|565297826|FG000|Overall Study|Ineligible|1|||
156605709|NCT00792701|565297827|FG001|Overall Study|Ineligible|3|||
156605710|NCT00792701|565297826|FG000|Overall Study|Withdrawal by Subject|1|||
156605711|NCT00792701|565297827|FG001|Overall Study|Withdrawal by Subject|19|||
156605712|NCT00792701|565297826|FG000|Overall Study|Not protocol specified|17|||
156605713|NCT00792701|565297827|FG001|Overall Study|Not protocol specified|0|||
156605714|NCT05507580|565297828|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156605715|NCT05507580|565297829|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
156605716|NCT05507580|565297830|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
156605717|NCT05507580|565297831|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
156605718|NCT05507580|565297832|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
156605719|NCT05507580|565297833|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
156605720|NCT05507580|565297828|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
156605721|NCT05507580|565297829|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156605722|NCT05507580|565297830|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156605723|NCT05507580|565297831|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156605724|NCT05507580|565297832|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156605725|NCT05507580|565297833|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156605726|NCT05507580|565297828|FG000|Double-Blind Treatment Period|Other, not specified|5|||
156605727|NCT05507580|565297829|FG001|Double-Blind Treatment Period|Other, not specified|4|||
156605728|NCT05507580|565297830|FG002|Double-Blind Treatment Period|Other, not specified|0|||
156605729|NCT05507580|565297831|FG003|Double-Blind Treatment Period|Other, not specified|0|||
156605730|NCT05507580|565297832|FG004|Double-Blind Treatment Period|Other, not specified|0|||
156605731|NCT05507580|565297833|FG005|Double-Blind Treatment Period|Other, not specified|0|||
156605732|NCT05507580|565297828|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
156605733|NCT05507580|565297829|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
156605734|NCT05507580|565297830|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
156605735|NCT05507580|565297831|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
156605736|NCT05507580|565297832|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
156605737|NCT05507580|565297833|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
156605738|NCT05507580|565297828|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
156605739|NCT05507580|565297829|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
156605740|NCT05507580|565297830|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
156605741|NCT05507580|565297831|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
156605742|NCT05507580|565297832|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
156605743|NCT05507580|565297833|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
156605744|NCT05507580|565297828|FG000|Single-Blind Treatment Period|Other, not specified|0|||
156605745|NCT05507580|565297829|FG001|Single-Blind Treatment Period|Other, not specified|0|||
156605746|NCT05507580|565297830|FG002|Single-Blind Treatment Period|Other, not specified|2|||
156605747|NCT05507580|565297831|FG003|Single-Blind Treatment Period|Other, not specified|7|||
156605748|NCT05507580|565297832|FG004|Single-Blind Treatment Period|Other, not specified|3|||
156605749|NCT05507580|565297833|FG005|Single-Blind Treatment Period|Other, not specified|5|||
156605750|NCT03037307|565297834|FG000|Period 1|Did Not Meet Study Criteria|0|||
156605751|NCT03037307|565297835|FG001|Period 1|Did Not Meet Study Criteria|0|||
156605752|NCT03037307|565297836|FG002|Period 1|Did Not Meet Study Criteria|0|||
156605753|NCT03037307|565297837|FG003|Period 1|Did Not Meet Study Criteria|1|||
156605754|NCT03037307|565297838|FG004|Period 1|Did Not Meet Study Criteria|0|||
156605755|NCT03037307|565297839|FG005|Period 1|Did Not Meet Study Criteria|0|||
156605756|NCT00802867|565297840|FG000|Overall Study|Lost to Follow-up|6|||
156605757|NCT00802867|565297840|FG000|Overall Study|Protocol Violation|6|||
156605758|NCT00802867|565297840|FG000|Overall Study|Withdrawal by Subject|1|||
156605759|NCT03000686|565297847|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
156605760|NCT03000686|565297848|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
156605761|NCT03000686|565297849|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
156605762|NCT03000686|565297850|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
156605763|NCT02920450|565297851|FG000|Overall Study|Death|1|||
156605764|NCT02920450|565297852|FG001|Overall Study|Death|0|||
156605765|NCT02920450|565297853|FG002|Overall Study|Death|0|||
156605766|NCT02920450|565297854|FG003|Overall Study|Death|0|||
156605767|NCT02920450|565297851|FG000|Overall Study|Withdrawal by Subject|1|||
156605768|NCT02920450|565297852|FG001|Overall Study|Withdrawal by Subject|0|||
156605769|NCT02920450|565297853|FG002|Overall Study|Withdrawal by Subject|0|||
156605770|NCT02920450|565297854|FG003|Overall Study|Withdrawal by Subject|0|||
156605771|NCT00770224|565297861|FG000|Step 1: Induction|Adverse Event|3|||
156605772|NCT00770224|565297862|FG001|Step 1: Induction|Adverse Event|0|||
156605773|NCT00770224|565297861|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
156605774|NCT00770224|565297862|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
156605775|NCT00770224|565297861|FG000|Step 1: Induction|Other reason not protocol specified|2|||
156605776|NCT00770224|565297862|FG001|Step 1: Induction|Other reason not protocol specified|0|||
156605777|NCT00770224|565297861|FG000|Step 1: Induction|Ineligible|2|||
156605778|NCT00770224|565297862|FG001|Step 1: Induction|Ineligible|0|||
156605779|NCT00770224|565297861|FG000|Step 1: Induction|No protocol treatment given|1|||
156605780|NCT00770224|565297862|FG001|Step 1: Induction|No protocol treatment given|0|||
156605781|NCT00770224|565297861|FG000|Step 2: Maintenance|Adverse Event|0|||
156605782|NCT00770224|565297862|FG001|Step 2: Maintenance|Adverse Event|10|||
156605783|NCT00770224|565297861|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
156605784|NCT00770224|565297862|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
156605785|NCT00770224|565297861|FG000|Step 2: Maintenance|Progression/relapse|0|||
156605786|NCT00770224|565297862|FG001|Step 2: Maintenance|Progression/relapse|1|||
156605787|NCT00770224|565297861|FG000|Step 2: Maintenance|Death|0|||
156605788|NCT00770224|565297862|FG001|Step 2: Maintenance|Death|2|||
156605789|NCT00770224|565297861|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
156605790|NCT00770224|565297862|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
156605791|NCT00770224|565297861|FG000|Step 2: Maintenance|Ineligible|0|||
156605792|NCT00770224|565297862|FG001|Step 2: Maintenance|Ineligible|2|||
156863829|NCT04272242|566258809|FG000|Overall Study|Withdrawal by Subject|3|||
156605793|NCT04737759|565297863|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
156605794|NCT04737759|565297864|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
156605795|NCT04737759|565297863|FG000|Overall Study|Death|2|||
156605796|NCT04737759|565297864|FG001|Overall Study|Death|0|||
156605797|NCT04737759|565297863|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
156605798|NCT04737759|565297864|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
156605799|NCT04737759|565297863|FG000|Overall Study|Lost to Follow-up|4|||
156605800|NCT04737759|565297864|FG001|Overall Study|Lost to Follow-up|12|||
156605801|NCT01484561|565297865|FG000|Overall Study|Lack of Efficacy|3|||
156605802|NCT01484561|565297866|FG001|Overall Study|Lack of Efficacy|1|||
156605803|NCT01484561|565297865|FG000|Overall Study|Lost to Follow-up|1|||
156605804|NCT01484561|565297866|FG001|Overall Study|Lost to Follow-up|0|||
156605805|NCT01484561|565297865|FG000|Overall Study|Withdrawal by Subject|3|||
156605806|NCT01484561|565297866|FG001|Overall Study|Withdrawal by Subject|0|||
156605807|NCT01484561|565297865|FG000|Overall Study|Other|1|||
156605808|NCT01484561|565297866|FG001|Overall Study|Other|1|||
156605809|NCT01484561|565297865|FG000|Overall Study|Adverse Event|1|||
156605810|NCT01484561|565297866|FG001|Overall Study|Adverse Event|4|||
156605811|NCT01112982|565297867|FG000|Overall Study|Withdrawal by Subject|1|||
156605812|NCT01112982|565297867|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
156605813|NCT03371251|565297868|FG000|Overall Study|Withdrawal by Subject|1|||
156605814|NCT03371251|565297869|FG001|Overall Study|Withdrawal by Subject|0|||
156605815|NCT03371251|565297870|FG002|Overall Study|Withdrawal by Subject|1|||
156605816|NCT03371251|565297871|FG003|Overall Study|Withdrawal by Subject|0|||
156605817|NCT03371251|565297872|FG004|Overall Study|Withdrawal by Subject|2|||
156605818|NCT03371251|565297873|FG005|Overall Study|Withdrawal by Subject|2|||
156605819|NCT03371251|565297868|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
156605820|NCT03371251|565297869|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
156605821|NCT03371251|565297870|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
156605822|NCT03371251|565297871|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
156605823|NCT03371251|565297872|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
156605824|NCT03371251|565297873|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
156605825|NCT03371251|565297868|FG000|Overall Study|Adverse Event|0|||
156605826|NCT03371251|565297869|FG001|Overall Study|Adverse Event|0|||
156605827|NCT03371251|565297870|FG002|Overall Study|Adverse Event|0|||
156605828|NCT03371251|565297871|FG003|Overall Study|Adverse Event|0|||
156605829|NCT03371251|565297872|FG004|Overall Study|Adverse Event|1|||
156605830|NCT03371251|565297873|FG005|Overall Study|Adverse Event|0|||
156605831|NCT03371251|565297868|FG000|Overall Study|Decision by Sponsor|0|||
156605832|NCT03371251|565297869|FG001|Overall Study|Decision by Sponsor|0|||
156605833|NCT03371251|565297870|FG002|Overall Study|Decision by Sponsor|0|||
156605834|NCT03371251|565297871|FG003|Overall Study|Decision by Sponsor|0|||
156605835|NCT03371251|565297872|FG004|Overall Study|Decision by Sponsor|2|||
156605836|NCT03371251|565297873|FG005|Overall Study|Decision by Sponsor|0|||
156605837|NCT00294684|565297874|FG000|Overall Study|Lost to Follow-up|5|||
156605838|NCT00294684|565297875|FG001|Overall Study|Lost to Follow-up|8|||
156605839|NCT05425719|565297876|FG000|Overall Study|Lost to Follow-up|4|||
156605840|NCT05425719|565297877|FG001|Overall Study|Lost to Follow-up|0|||
156605841|NCT05425719|565297876|FG000|Overall Study|Withdrew consent|1|||
156605842|NCT05425719|565297877|FG001|Overall Study|Withdrew consent|1|||
156605843|NCT01033487|565297880|FG000|Fourth Intervention Period|Adverse Event|0|||
156605844|NCT01033487|565297881|FG001|Fourth Intervention Period|Adverse Event|0|||
156605845|NCT01033487|565297882|FG002|Fourth Intervention Period|Adverse Event|0|||
156605846|NCT01033487|565297883|FG003|Fourth Intervention Period|Adverse Event|0|||
156605847|NCT01033487|565297884|FG004|Fourth Intervention Period|Adverse Event|0|||
156605848|NCT01033487|565297885|FG005|Fourth Intervention Period|Adverse Event|0|||
156605849|NCT01033487|565297886|FG006|Fourth Intervention Period|Adverse Event|0|||
156605850|NCT01033487|565297887|FG007|Fourth Intervention Period|Adverse Event|0|||
156605851|NCT01033487|565297888|FG008|Fourth Intervention Period|Adverse Event|1|||
156605852|NCT01033487|565297889|FG009|Fourth Intervention Period|Adverse Event|0|||
156605853|NCT02193828|565297890|FG000|Overall Study|Withdrawal by Subject|0|||
156605854|NCT02193828|565297891|FG001|Overall Study|Withdrawal by Subject|0|||
156605855|NCT02193828|565297892|FG002|Overall Study|Withdrawal by Subject|1|||
156605856|NCT02193828|565297893|FG003|Overall Study|Withdrawal by Subject|1|||
156605857|NCT00889681|565297894|FG000|Overall Study|Not meeting qualification Criteria|2|||
156605858|NCT00889681|565297894|FG000|Overall Study|Insurance disapproval|1|||
156605859|NCT01957787|565297895|FG000|Overall Study|Death|18|||
156605860|NCT01957787|565297895|FG000|Overall Study|Lost to Follow-up|3|||
156605861|NCT01957787|565297895|FG000|Overall Study|Withdrawal by Subject|3|||
156605862|NCT01957787|565297895|FG000|Overall Study|Entered Hospice or Similar Program|2|||
156605863|NCT01957787|565297895|FG000|Overall Study|Index Tumor(s) Resected|2|||
156605864|NCT01957787|565297895|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
156605865|NCT01957787|565297895|FG000|Overall Study|Local therapy, not cryoablation|6|||
156605866|NCT03954444|565297896|FG000|Overall Study|Withdrawal by Subject|5|||
156605867|NCT03954444|565297897|FG001|Overall Study|Withdrawal by Subject|5|||
156605868|NCT03954444|565297898|FG002|Overall Study|Withdrawal by Subject|5|||
156605869|NCT03954444|565297896|FG000|Overall Study|Adverse Event|1|||
156605870|NCT03954444|565297897|FG001|Overall Study|Adverse Event|3|||
156605871|NCT03954444|565297898|FG002|Overall Study|Adverse Event|2|||
156605872|NCT03954444|565297896|FG000|Overall Study|Protocol Violation|0|||
156605873|NCT03954444|565297897|FG001|Overall Study|Protocol Violation|3|||
156605874|NCT03954444|565297898|FG002|Overall Study|Protocol Violation|5|||
156605875|NCT03954444|565297896|FG000|Overall Study|Use of prohibited therapy|1|||
156605876|NCT03954444|565297897|FG001|Overall Study|Use of prohibited therapy|1|||
156605877|NCT03954444|565297898|FG002|Overall Study|Use of prohibited therapy|2|||
156605878|NCT03954444|565297896|FG000|Overall Study|Lost to Follow-up|1|||
156605879|NCT03954444|565297897|FG001|Overall Study|Lost to Follow-up|0|||
156605880|NCT03954444|565297898|FG002|Overall Study|Lost to Follow-up|1|||
156605881|NCT03954444|565297896|FG000|Overall Study|Non-compliant with study drug application|2|||
156605882|NCT03954444|565297897|FG001|Overall Study|Non-compliant with study drug application|2|||
156605883|NCT03954444|565297898|FG002|Overall Study|Non-compliant with study drug application|0|||
156605884|NCT03954444|565297896|FG000|Overall Study|Administrative reasons|0|||
156605885|NCT03954444|565297897|FG001|Overall Study|Administrative reasons|0|||
156605886|NCT03954444|565297898|FG002|Overall Study|Administrative reasons|1|||
156605887|NCT03954444|565297896|FG000|Overall Study|Miscellaneous|3|||
156605888|NCT03954444|565297897|FG001|Overall Study|Miscellaneous|2|||
156605889|NCT03954444|565297898|FG002|Overall Study|Miscellaneous|1|||
156605890|NCT03094832|565297905|FG000|Overall Study|Lost to Follow-up|0|||
156605891|NCT03094832|565297906|FG001|Overall Study|Lost to Follow-up|0|||
156605892|NCT03094832|565297907|FG002|Overall Study|Lost to Follow-up|0|||
156605893|NCT03094832|565297908|FG003|Overall Study|Lost to Follow-up|1|||
156605894|NCT03094832|565297909|FG004|Overall Study|Lost to Follow-up|1|||
156605895|NCT03094832|565297905|FG000|Overall Study|Death|1|||
156605896|NCT03094832|565297906|FG001|Overall Study|Death|0|||
156605897|NCT03094832|565297907|FG002|Overall Study|Death|0|||
156605898|NCT03094832|565297908|FG003|Overall Study|Death|0|||
156605899|NCT03094832|565297909|FG004|Overall Study|Death|0|||
156605900|NCT03094832|565297905|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156605901|NCT03094832|565297906|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156605902|NCT03094832|565297907|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156605903|NCT03094832|565297908|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156605904|NCT03094832|565297909|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156605905|NCT03094832|565297905|FG000|Overall Study|Other|13|||
156605906|NCT03094832|565297906|FG001|Overall Study|Other|20|||
156605907|NCT03094832|565297907|FG002|Overall Study|Other|1|||
156605908|NCT03094832|565297908|FG003|Overall Study|Other|7|||
156605909|NCT03094832|565297909|FG004|Overall Study|Other|1|||
156605910|NCT00788697|565297912|FG000|Overall Study|No study drug administered|12|||
156605911|NCT00788697|565297912|FG000|Overall Study|Training Patients|74|||
156605912|NCT00788697|565297912|FG000|Overall Study|no truth standard procedure available|5|||
156605913|NCT00788697|565297912|FG000|Overall Study|Technically inadequate truth standard|1|||
156605914|NCT00788697|565297912|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
156605915|NCT00367432|565297913|FG000|First Period (16 Weeks)|Adverse Event|6|||
156605916|NCT00367432|565297914|FG001|First Period (16 Weeks)|Adverse Event|0|||
156605917|NCT00367432|565297913|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
156605918|NCT00367432|565297914|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
156605919|NCT00367432|565297913|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
156605920|NCT00367432|565297914|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
156605921|NCT00367432|565297913|FG000|First Period (16 Weeks)|Other Reason|2|||
156605922|NCT00367432|565297914|FG001|First Period (16 Weeks)|Other Reason|0|||
156605923|NCT00367432|565297913|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
156605924|NCT00367432|565297914|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
156605925|NCT00367432|565297913|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
156605926|NCT00367432|565297914|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
156605927|NCT00367432|565297913|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
156605928|NCT00367432|565297914|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
156605929|NCT00367432|565297913|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
156605930|NCT00367432|565297914|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
156605931|NCT00367432|565297913|FG000|Second Period (up to 54 Months)|Other Reason|6|||
156605932|NCT00367432|565297914|FG001|Second Period (up to 54 Months)|Other Reason|2|||
156605933|NCT00014911|565297915|FG000|Overall Study|Adverse Event|1|||
156605934|NCT00014911|565297915|FG000|Overall Study|Lost to Follow-up|1|||
156605935|NCT00014911|565297915|FG000|Overall Study|Withdrawal by Subject|6|||
156605936|NCT00014911|565297915|FG000|Overall Study|Unknown Reasons|2|||
156605937|NCT00014911|565297915|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
156605938|NCT04179786|565297916|FG000|Overall Study|Withdrawal by Subject|8|||
156605939|NCT03310580|565297917|FG000|Overall Study|Adverse Event|0|||
156605940|NCT03310580|565297918|FG001|Overall Study|Adverse Event|1|||
156605941|NCT03310580|565297919|FG002|Overall Study|Adverse Event|0|||
156605942|NCT03205982|565297921|FG000|Overall Study|Lost to Follow-up|20|||
156605943|NCT03205982|565297922|FG001|Overall Study|Lost to Follow-up|19|||
156605944|NCT03205982|565297921|FG000|Overall Study|Withdrawal by Subject|4|||
156605945|NCT03205982|565297922|FG001|Overall Study|Withdrawal by Subject|3|||
156605946|NCT03205982|565297921|FG000|Overall Study|Withdrawal by PI|0|||
156605947|NCT03205982|565297922|FG001|Overall Study|Withdrawal by PI|1|||
156605948|NCT01626989|565297930|FG000|Screening Period|Screen Failure|15|||
156605949|NCT01626989|565297931|FG001|Screening Period|Screen Failure|0|||
156605950|NCT01626989|565297932|FG002|Screening Period|Screen Failure|0|||
156605951|NCT01626989|565297930|FG000|Screening Period|Withdrawal by Subject|2|||
156605952|NCT01626989|565297931|FG001|Screening Period|Withdrawal by Subject|0|||
156605953|NCT01626989|565297932|FG002|Screening Period|Withdrawal by Subject|0|||
156605954|NCT02947022|565297933|FG000|Overall Study|Study Stopped|1|||
156605955|NCT02038790|565299611|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
156605956|NCT02038790|565299612|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
156605957|NCT02431702|565299613|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
156605958|NCT02431702|565299614|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
156605959|NCT02431702|565299615|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
156605960|NCT02431702|565299616|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
156605961|NCT02431702|565299617|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
156605962|NCT02431702|565299618|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
156605963|NCT02431702|565299619|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
156605964|NCT02431702|565299613|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
156605965|NCT02431702|565299614|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
156605966|NCT02431702|565299615|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
156605967|NCT02431702|565299616|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
156605968|NCT02431702|565299617|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
156605969|NCT02431702|565299618|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
156605970|NCT02431702|565299619|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
156605971|NCT02431702|565299613|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
156605972|NCT02431702|565299614|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
156605973|NCT02431702|565299615|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
156605974|NCT02431702|565299616|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
156605975|NCT02431702|565299617|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
156605976|NCT02431702|565299618|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
156605977|NCT02431702|565299619|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
156605978|NCT02431702|565299613|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
156605979|NCT02431702|565299614|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
156605980|NCT02431702|565299615|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
156605981|NCT02431702|565299616|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
156605982|NCT02431702|565299617|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
156605983|NCT02431702|565299618|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
156605984|NCT02431702|565299619|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
156605985|NCT02431702|565299613|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
156605986|NCT02431702|565299614|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
156605987|NCT02431702|565299615|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
156605988|NCT02431702|565299616|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
156605989|NCT02431702|565299617|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
156605990|NCT02431702|565299618|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
156605991|NCT02431702|565299619|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
156605992|NCT02431702|565299613|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
156605993|NCT02431702|565299614|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
156605994|NCT02431702|565299615|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
156605995|NCT02431702|565299616|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
156605996|NCT02431702|565299617|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
156605997|NCT02431702|565299618|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
156605998|NCT02431702|565299619|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
156605999|NCT02431702|565299613|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
156606000|NCT02431702|565299614|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
156606001|NCT02431702|565299615|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
156606002|NCT02431702|565299616|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
156606003|NCT02431702|565299617|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
156606004|NCT02431702|565299618|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
156606005|NCT02431702|565299619|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
156606006|NCT02431702|565299613|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
156606007|NCT02431702|565299614|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
156606008|NCT02431702|565299615|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
156863830|NCT04272242|566258809|FG000|Overall Study|Lost to Follow-up|1|||
156606009|NCT02431702|565299616|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
156606010|NCT02431702|565299617|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
156606011|NCT02431702|565299618|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
156606012|NCT02431702|565299619|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
156606013|NCT02431702|565299613|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
156606014|NCT02431702|565299614|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
156606015|NCT02431702|565299615|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
156606016|NCT02431702|565299616|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
156606017|NCT02431702|565299617|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
156606018|NCT02431702|565299618|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
156606019|NCT02431702|565299619|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
156606020|NCT02431702|565299613|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
156606021|NCT02431702|565299614|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
156606022|NCT02431702|565299615|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
156606023|NCT02431702|565299616|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
156606024|NCT02431702|565299617|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
156606025|NCT02431702|565299618|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
156606026|NCT02431702|565299619|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
156606027|NCT02431702|565299613|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
156606028|NCT02431702|565299614|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
156606029|NCT02431702|565299615|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
156606030|NCT02431702|565299616|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
156606031|NCT02431702|565299617|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
156606032|NCT02431702|565299618|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
156606033|NCT02431702|565299619|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
156606034|NCT02431702|565299613|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
156606035|NCT02431702|565299614|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
156606036|NCT02431702|565299615|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
156606037|NCT02431702|565299616|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
156606038|NCT02431702|565299617|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
156606039|NCT02431702|565299618|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
156606040|NCT02431702|565299619|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
156606041|NCT02431702|565299613|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
156606042|NCT02431702|565299614|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
156606043|NCT02431702|565299615|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
156606044|NCT02431702|565299616|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
156606045|NCT02431702|565299617|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
156606046|NCT02431702|565299618|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
156606047|NCT02431702|565299619|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
156606048|NCT02431702|565299613|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
156606049|NCT02431702|565299614|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
156606050|NCT02431702|565299615|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
156606051|NCT02431702|565299616|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
156606052|NCT02431702|565299617|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
156606053|NCT02431702|565299618|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
156606054|NCT02431702|565299619|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
156606055|NCT02431702|565299613|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
156606056|NCT02431702|565299614|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
156606057|NCT02431702|565299615|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
156606058|NCT02431702|565299616|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
156606059|NCT02431702|565299617|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
156606060|NCT02431702|565299618|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
156606061|NCT02431702|565299619|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
156606062|NCT03907969|565299620|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
156606063|NCT03907969|565299621|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
156606064|NCT03907969|565299622|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
156606065|NCT03907969|565299623|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
156606066|NCT03907969|565299624|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
156606067|NCT03907969|565299625|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
156606068|NCT03907969|565299626|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
156606069|NCT03907969|565299627|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
156606070|NCT03907969|565299628|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
156606071|NCT03907969|565299629|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
156635003|NCT03917654|565407819|FG004|Year 2|Married|0|||
156863831|NCT04272242|566258809|FG000|Overall Study|Adverse Event|1|||
156863832|NCT03204188|566258811|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
156606072|NCT03907969|565299630|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
156606073|NCT03907969|565299620|FG000|Monotherapy Part A|Progressive Disease|0|||
156606074|NCT03907969|565299621|FG001|Monotherapy Part A|Progressive Disease|1|||
156606075|NCT03907969|565299622|FG002|Monotherapy Part A|Progressive Disease|0|||
156606076|NCT03907969|565299623|FG003|Monotherapy Part A|Progressive Disease|0|||
156606077|NCT03907969|565299624|FG004|Monotherapy Part A|Progressive Disease|0|||
156606078|NCT03907969|565299625|FG005|Monotherapy Part A|Progressive Disease|1|||
156606079|NCT03907969|565299626|FG006|Monotherapy Part A|Progressive Disease|2|||
156606080|NCT03907969|565299627|FG007|Monotherapy Part A|Progressive Disease|0|||
156606081|NCT03907969|565299628|FG008|Monotherapy Part A|Progressive Disease|0|||
156606082|NCT03907969|565299629|FG009|Monotherapy Part A|Progressive Disease|0|||
156606083|NCT03907969|565299630|FG010|Monotherapy Part A|Progressive Disease|0|||
156606084|NCT03907969|565299620|FG000|Monotherapy Part A|Death|0|||
156606085|NCT03907969|565299621|FG001|Monotherapy Part A|Death|0|||
156606086|NCT03907969|565299622|FG002|Monotherapy Part A|Death|1|||
156606087|NCT03907969|565299623|FG003|Monotherapy Part A|Death|1|||
156606088|NCT03907969|565299624|FG004|Monotherapy Part A|Death|0|||
156606089|NCT03907969|565299625|FG005|Monotherapy Part A|Death|1|||
156606090|NCT03907969|565299626|FG006|Monotherapy Part A|Death|0|||
156606091|NCT03907969|565299627|FG007|Monotherapy Part A|Death|0|||
156606092|NCT03907969|565299628|FG008|Monotherapy Part A|Death|0|||
156606093|NCT03907969|565299629|FG009|Monotherapy Part A|Death|0|||
156606094|NCT03907969|565299630|FG010|Monotherapy Part A|Death|0|||
156606095|NCT03907969|565299620|FG000|Combination Therapy Part A|Adverse Event|0|||
156606096|NCT03907969|565299621|FG001|Combination Therapy Part A|Adverse Event|0|||
156606097|NCT03907969|565299622|FG002|Combination Therapy Part A|Adverse Event|0|||
156606098|NCT03907969|565299623|FG003|Combination Therapy Part A|Adverse Event|0|||
156606099|NCT03907969|565299624|FG004|Combination Therapy Part A|Adverse Event|0|||
156606100|NCT03907969|565299625|FG005|Combination Therapy Part A|Adverse Event|0|||
156606101|NCT03907969|565299626|FG006|Combination Therapy Part A|Adverse Event|0|||
156606102|NCT03907969|565299627|FG007|Combination Therapy Part A|Adverse Event|0|||
156606103|NCT03907969|565299628|FG008|Combination Therapy Part A|Adverse Event|0|||
156606104|NCT03907969|565299629|FG009|Combination Therapy Part A|Adverse Event|1|||
156606105|NCT03907969|565299630|FG010|Combination Therapy Part A|Adverse Event|1|||
156606106|NCT03907969|565299620|FG000|Combination Therapy Part A|Progressive disease|0|||
156606107|NCT03907969|565299621|FG001|Combination Therapy Part A|Progressive disease|0|||
156606108|NCT03907969|565299622|FG002|Combination Therapy Part A|Progressive disease|0|||
156606109|NCT03907969|565299623|FG003|Combination Therapy Part A|Progressive disease|0|||
156606110|NCT03907969|565299624|FG004|Combination Therapy Part A|Progressive disease|0|||
156606111|NCT03907969|565299625|FG005|Combination Therapy Part A|Progressive disease|0|||
156606112|NCT03907969|565299626|FG006|Combination Therapy Part A|Progressive disease|0|||
156606113|NCT03907969|565299627|FG007|Combination Therapy Part A|Progressive disease|1|||
156606114|NCT03907969|565299628|FG008|Combination Therapy Part A|Progressive disease|0|||
156606115|NCT03907969|565299629|FG009|Combination Therapy Part A|Progressive disease|2|||
156606116|NCT03907969|565299630|FG010|Combination Therapy Part A|Progressive disease|3|||
156606117|NCT03907969|565299620|FG000|Combination Therapy Part A|Death|0|||
156606118|NCT03907969|565299621|FG001|Combination Therapy Part A|Death|0|||
156606119|NCT03907969|565299622|FG002|Combination Therapy Part A|Death|0|||
156606120|NCT03907969|565299623|FG003|Combination Therapy Part A|Death|0|||
156606121|NCT03907969|565299624|FG004|Combination Therapy Part A|Death|0|||
156606122|NCT03907969|565299625|FG005|Combination Therapy Part A|Death|0|||
156606123|NCT03907969|565299626|FG006|Combination Therapy Part A|Death|0|||
156606124|NCT03907969|565299627|FG007|Combination Therapy Part A|Death|0|||
156606125|NCT03907969|565299628|FG008|Combination Therapy Part A|Death|1|||
156606126|NCT03907969|565299629|FG009|Combination Therapy Part A|Death|0|||
156606127|NCT03907969|565299630|FG010|Combination Therapy Part A|Death|1|||
156606128|NCT03907969|565299620|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
156606129|NCT03907969|565299621|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
156606130|NCT03907969|565299622|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
156606131|NCT03907969|565299623|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
156606132|NCT03907969|565299624|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
156606133|NCT03907969|565299625|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
156606134|NCT03907969|565299626|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
156606135|NCT03907969|565299627|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
156606136|NCT03907969|565299628|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
156606137|NCT03907969|565299629|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
156606138|NCT03907969|565299630|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
156606139|NCT03907969|565299620|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
156606140|NCT03907969|565299621|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
156606141|NCT03907969|565299622|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
156606142|NCT03907969|565299623|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
156606143|NCT03907969|565299624|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
156606144|NCT03907969|565299625|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
156606145|NCT03907969|565299626|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
156606146|NCT03907969|565299627|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
156606147|NCT03907969|565299628|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
156606148|NCT03907969|565299629|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
156606149|NCT03907969|565299630|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
156606150|NCT03907969|565299620|FG000|Combination Therapy Part A|Physician Decision|0|||
156606151|NCT03907969|565299621|FG001|Combination Therapy Part A|Physician Decision|0|||
156606152|NCT03907969|565299622|FG002|Combination Therapy Part A|Physician Decision|0|||
156606153|NCT03907969|565299623|FG003|Combination Therapy Part A|Physician Decision|0|||
156606154|NCT03907969|565299624|FG004|Combination Therapy Part A|Physician Decision|0|||
156606155|NCT03907969|565299625|FG005|Combination Therapy Part A|Physician Decision|0|||
156606156|NCT03907969|565299626|FG006|Combination Therapy Part A|Physician Decision|0|||
156606157|NCT03907969|565299627|FG007|Combination Therapy Part A|Physician Decision|1|||
156606158|NCT03907969|565299628|FG008|Combination Therapy Part A|Physician Decision|0|||
156606159|NCT03907969|565299629|FG009|Combination Therapy Part A|Physician Decision|0|||
156606160|NCT03907969|565299630|FG010|Combination Therapy Part A|Physician Decision|1|||
156606161|NCT04209530|565299632|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
156606162|NCT04209530|565299633|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
156606163|NCT04209530|565299632|FG000|Overall Study|Withdrawal by Subject|0|||
156606164|NCT04209530|565299633|FG001|Overall Study|Withdrawal by Subject|1|||
156606165|NCT01510028|565299634|FG000|Overall Study|Lack of Efficacy|1|||
156606166|NCT01510028|565299635|FG001|Overall Study|Lack of Efficacy|0|||
156606167|NCT01510028|565299636|FG002|Overall Study|Lack of Efficacy|0|||
156606168|NCT01510028|565299637|FG003|Overall Study|Lack of Efficacy|0|||
156606169|NCT00633893|565299638|FG000|Overall Study|Death|1|||
156606170|NCT00633893|565299639|FG001|Overall Study|Death|3|||
156606171|NCT00633893|565299640|FG002|Overall Study|Death|9|||
156606172|NCT00633893|565299638|FG000|Overall Study|Adverse Event|65|||
156606173|NCT00633893|565299639|FG001|Overall Study|Adverse Event|58|||
156606174|NCT00633893|565299640|FG002|Overall Study|Adverse Event|126|||
156606175|NCT00633893|565299638|FG000|Overall Study|Withdrawal by Subject|7|||
156606176|NCT00633893|565299639|FG001|Overall Study|Withdrawal by Subject|12|||
156606177|NCT00633893|565299640|FG002|Overall Study|Withdrawal by Subject|6|||
156606178|NCT00633893|565299638|FG000|Overall Study|Lost to Follow-up|2|||
156606179|NCT00633893|565299639|FG001|Overall Study|Lost to Follow-up|4|||
156606180|NCT00633893|565299640|FG002|Overall Study|Lost to Follow-up|8|||
156606181|NCT00633893|565299638|FG000|Overall Study|Poor/non-compliance|5|||
156606182|NCT00633893|565299639|FG001|Overall Study|Poor/non-compliance|12|||
156606183|NCT00633893|565299640|FG002|Overall Study|Poor/non-compliance|3|||
156606184|NCT00633893|565299638|FG000|Overall Study|Pregnancy|2|||
156606185|NCT00633893|565299639|FG001|Overall Study|Pregnancy|1|||
156606186|NCT00633893|565299640|FG002|Overall Study|Pregnancy|1|||
156606187|NCT00633893|565299638|FG000|Overall Study|Not meet/no longer meets criteria|4|||
156606188|NCT00633893|565299639|FG001|Overall Study|Not meet/no longer meets criteria|6|||
156606189|NCT00633893|565299640|FG002|Overall Study|Not meet/no longer meets criteria|4|||
156606190|NCT00633893|565299638|FG000|Overall Study|Other|28|||
156606191|NCT00633893|565299639|FG001|Overall Study|Other|33|||
156606192|NCT00633893|565299640|FG002|Overall Study|Other|31|||
156606193|NCT02741310|565299641|FG000|Overall Study|Sponsor Decision|2|||
156606194|NCT02741310|565299642|FG001|Overall Study|Sponsor Decision|2|||
156606195|NCT01784211|565299647|FG000|Part A (Days 1-15)|Adverse Event|1|||
156606196|NCT01784211|565299648|FG001|Part A (Days 1-15)|Adverse Event|1|||
156606197|NCT01784211|565299649|FG002|Part A (Days 1-15)|Adverse Event|0|||
156606198|NCT01784211|565299650|FG003|Part A (Days 1-15)|Adverse Event|0|||
156606199|NCT01784211|565299651|FG004|Part A (Days 1-15)|Adverse Event|0|||
156606200|NCT01784211|565299652|FG005|Part A (Days 1-15)|Adverse Event|0|||
156606201|NCT01784211|565299647|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
156606202|NCT01784211|565299648|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
156606203|NCT01784211|565299649|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
156606204|NCT01784211|565299650|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
156606205|NCT01784211|565299651|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
156606206|NCT01784211|565299652|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
156606207|NCT02044822|565299655|FG000|Overall Study|Study Terminated by Sponsor|77|||
156606208|NCT02044822|565299655|FG000|Overall Study|Investigator's Discretion|10|||
156606209|NCT02044822|565299655|FG000|Overall Study|Withdrew Consent|3|||
156606210|NCT02044822|565299655|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
156863833|NCT03204188|566258811|FG000|Immunotherapy Phase (1 Year)|Death|1|||
156863834|NCT03204188|566258811|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
156863835|NCT03204188|566258811|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
156606211|NCT02044822|565299655|FG000|Overall Study|Lost to Follow-up|1|||
156606212|NCT02025530|565299658|FG000|Overall Study|No longer met elligibility criteria|5|||
156606213|NCT02025530|565299659|FG001|Overall Study|No longer met elligibility criteria|1|||
156606214|NCT03551626|565299660|FG000|Overall Study|Adverse Event|88|||
156606215|NCT03551626|565299660|FG000|Overall Study|Disease relapse|18|||
156606216|NCT03551626|565299660|FG000|Overall Study|Withdrawal of informed consent|6|||
156606217|NCT03551626|565299660|FG000|Overall Study|Patient decision|5|||
156606218|NCT03551626|565299660|FG000|Overall Study|Physician Decision|4|||
156606219|NCT03551626|565299660|FG000|Overall Study|Lost to Follow-up|3|||
156606220|NCT03551626|565299660|FG000|Overall Study|Pregnancy|1|||
156606221|NCT03551626|565299660|FG000|Overall Study|Protocol deviation|1|||
156606222|NCT03551626|565299660|FG000|Overall Study|Technical problems|1|||
156606223|NCT00653328|565299661|FG000|Overall Study|Withdrawal by Subject|1|||
156606224|NCT00653328|565299661|FG000|Overall Study|Adverse Event|2|||
156606225|NCT00653328|565299661|FG000|Overall Study|Disease progression|10|||
156606226|NCT00653328|565299661|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
156606227|NCT01237223|565299668|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
156606228|NCT01237223|565299669|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
156606229|NCT01237223|565299670|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
156606230|NCT01237223|565299671|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
156606231|NCT01237223|565299672|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
156606232|NCT01237223|565299673|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
156606233|NCT01237223|565299668|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
156606234|NCT01237223|565299669|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
156606235|NCT01237223|565299670|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
156606236|NCT01237223|565299671|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
156606237|NCT01237223|565299672|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
156606238|NCT01237223|565299673|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
156606239|NCT01237223|565299668|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
156606240|NCT01237223|565299669|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
156606241|NCT01237223|565299670|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
156606242|NCT01237223|565299671|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
156606243|NCT01237223|565299672|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
156606244|NCT01237223|565299673|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
156606245|NCT01237223|565299668|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
156606246|NCT01237223|565299669|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
156606247|NCT01237223|565299670|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
156606248|NCT01237223|565299671|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
156606249|NCT01237223|565299672|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
156606250|NCT01237223|565299673|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
156606251|NCT01237223|565299668|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
156606252|NCT01237223|565299669|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
156606253|NCT01237223|565299670|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
156606254|NCT01237223|565299671|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
156606255|NCT01237223|565299672|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
156606256|NCT01237223|565299673|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
156606257|NCT01237223|565299668|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
156606258|NCT01237223|565299669|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
156606259|NCT01237223|565299670|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
156606260|NCT01237223|565299671|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
156606261|NCT01237223|565299672|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
156606262|NCT01237223|565299673|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
156606263|NCT01237223|565299668|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
156606264|NCT01237223|565299669|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
156606265|NCT01237223|565299670|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
156606266|NCT01237223|565299671|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
156606267|NCT01237223|565299672|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
156606268|NCT01237223|565299673|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
156606269|NCT01237223|565299668|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
156606270|NCT01237223|565299669|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
156606271|NCT01237223|565299670|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
156606272|NCT01237223|565299671|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
156606273|NCT01237223|565299672|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
156606274|NCT01237223|565299673|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
156606275|NCT01237223|565299668|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
156606276|NCT01237223|565299669|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
156606277|NCT01237223|565299670|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
156606278|NCT01237223|565299671|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
156606279|NCT01237223|565299672|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
156606280|NCT01237223|565299673|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
156606281|NCT01237223|565299668|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
156606282|NCT01237223|565299669|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
156606283|NCT01237223|565299670|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
156606284|NCT01237223|565299671|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
156606285|NCT01237223|565299672|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
156606286|NCT01237223|565299673|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
156606287|NCT01017549|565299676|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
156606288|NCT01017549|565299676|FG000|One-year Follow-up|Lost to Follow-up|2|||
156606289|NCT01017549|565299676|FG000|One-year Follow-up|Withdrawal by Subject|5|||
156606290|NCT01017549|565299676|FG000|5 Year Follow-up|Lost to Follow-up|9|||
156606291|NCT01017549|565299676|FG000|5 Year Follow-up|Mastectomy|3|||
156606292|NCT00443846|565299678|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
156606293|NCT00443846|565299679|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
156606294|NCT00443846|565299678|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
156606295|NCT00443846|565299679|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
156606296|NCT00443846|565299678|FG000|Overall Study|Adverse Event|0|||
156606297|NCT00443846|565299679|FG001|Overall Study|Adverse Event|1|||
156606298|NCT00443846|565299678|FG000|Overall Study|Personal reason|8|||
156606299|NCT00443846|565299679|FG001|Overall Study|Personal reason|3|||
156606300|NCT00443846|565299678|FG000|Overall Study|Lost to Follow-up|1|||
156606301|NCT00443846|565299679|FG001|Overall Study|Lost to Follow-up|2|||
156606302|NCT00391807|565299688|FG000|Overall Study|Did not receive study medication|23|||
156606303|NCT00391807|565299688|FG000|Overall Study|Adverse Event|177|||
156606304|NCT00391807|565299688|FG000|Overall Study|Pregnancy|25|||
156606305|NCT00391807|565299688|FG000|Overall Study|Lost to Follow-up|227|||
156606306|NCT00391807|565299688|FG000|Overall Study|Withdrawal by Subject|147|||
156606307|NCT00391807|565299688|FG000|Overall Study|Protocol Violation|20|||
156606308|NCT00391807|565299688|FG000|Overall Study|Various|96|||
156606309|NCT05441540|565299691|FG000|Overall Study|Withdrawal by Subject|2|||
156606310|NCT00813917|565299692|FG000|Overall Study|Adverse Event|0|||
156606311|NCT00813917|565299693|FG001|Overall Study|Adverse Event|1|||
156606312|NCT00813917|565299692|FG000|Overall Study|Withdrawal by Subject|3|||
156606313|NCT00813917|565299693|FG001|Overall Study|Withdrawal by Subject|4|||
156606314|NCT00813917|565299692|FG000|Overall Study|Lost to Follow-up|3|||
156606315|NCT00813917|565299693|FG001|Overall Study|Lost to Follow-up|1|||
156606316|NCT04539262|565299696|FG000|Overall Study|Adverse Event|0|||
156606317|NCT04539262|565299697|FG001|Overall Study|Adverse Event|0|||
156606318|NCT04539262|565299698|FG002|Overall Study|Adverse Event|1|||
156606319|NCT04539262|565299699|FG003|Overall Study|Adverse Event|0|||
156606320|NCT04539262|565299700|FG004|Overall Study|Adverse Event|0|||
156606321|NCT04539262|565299701|FG005|Overall Study|Adverse Event|0|||
156606322|NCT04539262|565299702|FG006|Overall Study|Adverse Event|0|||
156606323|NCT04539262|565299703|FG007|Overall Study|Adverse Event|0|||
156606324|NCT04539262|565299696|FG000|Overall Study|Withdrew Consent|0|||
156606325|NCT04539262|565299697|FG001|Overall Study|Withdrew Consent|0|||
156606326|NCT04539262|565299698|FG002|Overall Study|Withdrew Consent|0|||
156606327|NCT04539262|565299699|FG003|Overall Study|Withdrew Consent|1|||
156606328|NCT04539262|565299700|FG004|Overall Study|Withdrew Consent|0|||
156606329|NCT04539262|565299701|FG005|Overall Study|Withdrew Consent|0|||
156606330|NCT04539262|565299702|FG006|Overall Study|Withdrew Consent|0|||
156606331|NCT04539262|565299703|FG007|Overall Study|Withdrew Consent|0|||
156606332|NCT04539262|565299696|FG000|Overall Study|Randomized, Not treated|0|||
156606333|NCT04539262|565299697|FG001|Overall Study|Randomized, Not treated|1|||
156606334|NCT04539262|565299698|FG002|Overall Study|Randomized, Not treated|0|||
156606335|NCT04539262|565299699|FG003|Overall Study|Randomized, Not treated|0|||
156606336|NCT04539262|565299700|FG004|Overall Study|Randomized, Not treated|0|||
156606337|NCT04539262|565299701|FG005|Overall Study|Randomized, Not treated|0|||
156606338|NCT04539262|565299702|FG006|Overall Study|Randomized, Not treated|1|||
156606339|NCT04539262|565299703|FG007|Overall Study|Randomized, Not treated|0|||
156606340|NCT03862495|565299708|FG000|Overall Study|Lost to Follow-up|37|||
156606341|NCT03862495|565299709|FG001|Overall Study|Lost to Follow-up|35|||
156606342|NCT04397796|565299710|FG000|Overall Study|Death|3|||
156606343|NCT04397796|565299711|FG001|Overall Study|Death|1|||
156606344|NCT03363165|565299712|FG000|3-month Follow-up|Death|0|||
156606345|NCT03363165|565299713|FG001|3-month Follow-up|Death|1|||
156606346|NCT03363165|565299712|FG000|6-month Follow-up|Death|0|||
156606347|NCT03363165|565299713|FG001|6-month Follow-up|Death|1|||
156606348|NCT03363165|565299712|FG000|6-month Follow-up|Withdrawal by Subject|1|||
156606349|NCT03363165|565299713|FG001|6-month Follow-up|Withdrawal by Subject|1|||
156606350|NCT03363165|565299712|FG000|12-month Follow-up|Death|1|||
156606351|NCT03363165|565299713|FG001|12-month Follow-up|Death|1|||
156606352|NCT03363165|565299712|FG000|12-month Follow-up|Withdrawal by Subject|1|||
156606353|NCT03363165|565299713|FG001|12-month Follow-up|Withdrawal by Subject|1|||
156606354|NCT00126672|565299714|FG000|Overall Study|Adverse Event|4|||
156606355|NCT00126672|565299714|FG000|Overall Study|Lost to Follow-up|4|||
156606356|NCT01001234|565299715|FG000|Overall Study|Withdrawal by Subject|2|||
156606357|NCT01001234|565299716|FG001|Overall Study|Withdrawal by Subject|0|||
156606358|NCT01001234|565299717|FG002|Overall Study|Withdrawal by Subject|3|||
156606359|NCT01001234|565299718|FG003|Overall Study|Withdrawal by Subject|0|||
156606360|NCT01001234|565299719|FG004|Overall Study|Withdrawal by Subject|0|||
156606361|NCT01001234|565299715|FG000|Overall Study|Protocol Violation|34|||
156606362|NCT01001234|565299716|FG001|Overall Study|Protocol Violation|3|||
156606363|NCT01001234|565299717|FG002|Overall Study|Protocol Violation|19|||
156606364|NCT01001234|565299718|FG003|Overall Study|Protocol Violation|18|||
156606365|NCT01001234|565299719|FG004|Overall Study|Protocol Violation|0|||
156606366|NCT01001234|565299715|FG000|Overall Study|Lost to Follow-up|0|||
156606367|NCT01001234|565299716|FG001|Overall Study|Lost to Follow-up|0|||
156606368|NCT01001234|565299717|FG002|Overall Study|Lost to Follow-up|1|||
156606369|NCT01001234|565299718|FG003|Overall Study|Lost to Follow-up|2|||
156606370|NCT01001234|565299719|FG004|Overall Study|Lost to Follow-up|0|||
156606371|NCT01001234|565299715|FG000|Overall Study|Physician Decision|1|||
156606372|NCT01001234|565299716|FG001|Overall Study|Physician Decision|0|||
156606373|NCT01001234|565299717|FG002|Overall Study|Physician Decision|0|||
156606374|NCT01001234|565299718|FG003|Overall Study|Physician Decision|0|||
156606375|NCT01001234|565299719|FG004|Overall Study|Physician Decision|0|||
156606376|NCT01001234|565299715|FG000|Overall Study|Not Treated: Adverse Event|1|||
156606377|NCT01001234|565299716|FG001|Overall Study|Not Treated: Adverse Event|0|||
156606378|NCT01001234|565299717|FG002|Overall Study|Not Treated: Adverse Event|0|||
156606379|NCT01001234|565299718|FG003|Overall Study|Not Treated: Adverse Event|0|||
156606380|NCT01001234|565299719|FG004|Overall Study|Not Treated: Adverse Event|0|||
156606381|NCT01001234|565299715|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
156606382|NCT01001234|565299716|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
156606383|NCT01001234|565299717|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
156606384|NCT01001234|565299718|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
156606385|NCT01001234|565299719|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
156606386|NCT01001234|565299715|FG000|Overall Study|Not Treated: Protocol Violation|3|||
156606387|NCT01001234|565299716|FG001|Overall Study|Not Treated: Protocol Violation|0|||
156606388|NCT01001234|565299717|FG002|Overall Study|Not Treated: Protocol Violation|0|||
156606389|NCT01001234|565299718|FG003|Overall Study|Not Treated: Protocol Violation|0|||
156606390|NCT01001234|565299719|FG004|Overall Study|Not Treated: Protocol Violation|0|||
156606391|NCT01001234|565299715|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
156606392|NCT01001234|565299716|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
156606393|NCT01001234|565299717|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
156606394|NCT01001234|565299718|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
156606395|NCT01001234|565299719|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
156606396|NCT01001234|565299715|FG000|Overall Study|Not Treated: Pregnancy|3|||
156606397|NCT01001234|565299716|FG001|Overall Study|Not Treated: Pregnancy|0|||
156606398|NCT01001234|565299717|FG002|Overall Study|Not Treated: Pregnancy|0|||
156606399|NCT01001234|565299718|FG003|Overall Study|Not Treated: Pregnancy|0|||
156606400|NCT01001234|565299719|FG004|Overall Study|Not Treated: Pregnancy|0|||
156606401|NCT01001234|565299715|FG000|Overall Study|Not Treated: Physician Decision|37|||
156606402|NCT01001234|565299716|FG001|Overall Study|Not Treated: Physician Decision|4|||
156606403|NCT01001234|565299717|FG002|Overall Study|Not Treated: Physician Decision|0|||
156606404|NCT01001234|565299718|FG003|Overall Study|Not Treated: Physician Decision|0|||
156606405|NCT01001234|565299719|FG004|Overall Study|Not Treated: Physician Decision|0|||
156606406|NCT01001234|565299715|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
156606407|NCT01001234|565299716|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
156606408|NCT01001234|565299717|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
156606409|NCT01001234|565299718|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
156606410|NCT01001234|565299719|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
156606411|NCT01851863|565299721|FG000|Overall Study|Did not receive study medication|2|||
156606412|NCT01851863|565299722|FG001|Overall Study|Did not receive study medication|5|||
156606413|NCT01851863|565299723|FG002|Overall Study|Did not receive study medication|3|||
156606414|NCT01851863|565299724|FG003|Overall Study|Did not receive study medication|0|||
156606415|NCT01851863|565299721|FG000|Overall Study|Lost to Follow-up|3|||
156606416|NCT01851863|565299722|FG001|Overall Study|Lost to Follow-up|4|||
156606417|NCT01851863|565299723|FG002|Overall Study|Lost to Follow-up|2|||
156606418|NCT01851863|565299724|FG003|Overall Study|Lost to Follow-up|3|||
156606419|NCT00753623|565299725|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
156606420|NCT00753623|565299726|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
156606421|NCT00753623|565299725|FG000|Phase I (14 Days)|Physician Decision|1|||
156606422|NCT00753623|565299726|FG001|Phase I (14 Days)|Physician Decision|2|||
156606423|NCT00753623|565299725|FG000|Phase I (14 Days)|Adverse Event|0|||
156606424|NCT00753623|565299726|FG001|Phase I (14 Days)|Adverse Event|1|||
156606425|NCT00753623|565299725|FG000|Washout (7 Days)|Physician Decision|1|||
156606426|NCT00753623|565299726|FG001|Washout (7 Days)|Physician Decision|0|||
156606427|NCT00753623|565299725|FG000|Phase II (14 Days)|Physician Decision|0|||
156606428|NCT00753623|565299726|FG001|Phase II (14 Days)|Physician Decision|1|||
156606429|NCT03332303|565299727|FG000|Overall Study|Participant did not dose|1|||
156606430|NCT03332303|565299728|FG001|Overall Study|Participant did not dose|2|||
156606431|NCT03332303|565299729|FG002|Overall Study|Participant did not dose|0|||
156606432|NCT03332303|565299727|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
156606433|NCT03332303|565299728|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
156606434|NCT03332303|565299729|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
156606435|NCT03332303|565299727|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
156606436|NCT03332303|565299728|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
156606437|NCT03332303|565299729|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
156606438|NCT03332303|565299727|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
156606439|NCT03332303|565299728|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
156606440|NCT03332303|565299729|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
156606441|NCT03332303|565299727|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
156606442|NCT03332303|565299728|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
156606443|NCT03332303|565299729|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
156606444|NCT03332303|565299727|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
156606445|NCT03332303|565299728|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
156606446|NCT03332303|565299729|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
156606447|NCT03332303|565299727|FG000|Overall Study|Participant had a significant protocol deviation|0|||
156606448|NCT03332303|565299728|FG001|Overall Study|Participant had a significant protocol deviation|1|||
156606449|NCT03332303|565299729|FG002|Overall Study|Participant had a significant protocol deviation|0|||
156606450|NCT00996593|565299730|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
156606451|NCT00996593|565299730|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
156606452|NCT00996593|565299730|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
156606453|NCT00996593|565299730|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
156606454|NCT00996593|565299730|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
156606455|NCT00996593|565299730|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
156606456|NCT00996593|565299730|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
156606457|NCT00996593|565299730|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
156606458|NCT00996593|565299730|FG000|Long-Term Follow-Up|Site Closed|1|||
156606459|NCT00871572|565299731|FG000|Overall Study|Adverse Event|0|||
156606460|NCT00871572|565299732|FG001|Overall Study|Adverse Event|2|||
156606461|NCT00871572|565299733|FG002|Overall Study|Adverse Event|0|||
156606462|NCT00871572|565299734|FG003|Overall Study|Adverse Event|3|||
156606463|NCT00871572|565299731|FG000|Overall Study|Investigator Decision|0|||
156606464|NCT00871572|565299732|FG001|Overall Study|Investigator Decision|1|||
156606465|NCT00871572|565299733|FG002|Overall Study|Investigator Decision|0|||
156606466|NCT00871572|565299734|FG003|Overall Study|Investigator Decision|1|||
156606467|NCT00871572|565299731|FG000|Overall Study|Lost to Follow-up|0|||
156606468|NCT00871572|565299732|FG001|Overall Study|Lost to Follow-up|1|||
156606469|NCT00871572|565299733|FG002|Overall Study|Lost to Follow-up|0|||
156606470|NCT00871572|565299734|FG003|Overall Study|Lost to Follow-up|1|||
156606471|NCT00871572|565299731|FG000|Overall Study|Protocol Violation|0|||
156606472|NCT00871572|565299732|FG001|Overall Study|Protocol Violation|0|||
156606473|NCT00871572|565299733|FG002|Overall Study|Protocol Violation|1|||
156606474|NCT00871572|565299734|FG003|Overall Study|Protocol Violation|1|||
156606475|NCT00871572|565299731|FG000|Overall Study|Sponsor Decision|1|||
156606476|NCT00871572|565299732|FG001|Overall Study|Sponsor Decision|0|||
156606477|NCT00871572|565299733|FG002|Overall Study|Sponsor Decision|0|||
156606478|NCT00871572|565299734|FG003|Overall Study|Sponsor Decision|0|||
156606479|NCT00871572|565299731|FG000|Overall Study|Withdrawal by Subject|1|||
156606480|NCT00871572|565299732|FG001|Overall Study|Withdrawal by Subject|2|||
156606481|NCT00871572|565299733|FG002|Overall Study|Withdrawal by Subject|3|||
156606482|NCT00871572|565299734|FG003|Overall Study|Withdrawal by Subject|1|||
156606483|NCT00405652|565299739|FG000|Overall Study|Adverse Event|4|||
156606484|NCT00418717|565299742|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
156606485|NCT00418717|565299742|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
156606486|NCT00994162|565299745|FG000|Overall Study|Withdrawal by Subject|1|||
156606487|NCT00994162|565299745|FG000|Overall Study|Lost to Follow-up|2|||
156606488|NCT00994162|565299745|FG000|Overall Study|Product Complaint|1|||
156606489|NCT00994162|565299745|FG000|Overall Study|Poor Compliance|5|||
156606490|NCT00994162|565299745|FG000|Overall Study|Lack of Response|3|||
156606491|NCT00994162|565299745|FG000|Overall Study|Discharged from Hospital|4|||
156606492|NCT00994162|565299745|FG000|Overall Study|Death|2|||
156606493|NCT00994162|565299745|FG000|Overall Study|Care Transferred to Another Physician|2|||
156606494|NCT00994162|565299745|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
156606495|NCT00994162|565299745|FG000|Overall Study|Physician Decision|2|||
156606496|NCT00994162|565299745|FG000|Overall Study|Surrounding Wound Erythematous|1|||
156606497|NCT00994162|565299745|FG000|Overall Study|Machine Losing Vaccum|1|||
156606498|NCT00994162|565299745|FG000|Overall Study|Patient Lived Too Far Away|1|||
156606499|NCT00994162|565299745|FG000|Overall Study|Above Knee Amputation|1|||
156606500|NCT00994162|565299745|FG000|Overall Study|Reason Not Reported By Site|1|||
156606501|NCT02762708|565299748|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
156606502|NCT02762708|565299749|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
156606503|NCT02762708|565299750|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
156606504|NCT02762708|565299751|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
156606505|NCT01468701|565299752|FG000|Overall Study|Not eligible|91|||
156606506|NCT01468701|565299753|FG001|Overall Study|Not eligible|140|||
156606507|NCT01468701|565299754|FG002|Overall Study|Not eligible|29|||
156606508|NCT01468701|565299755|FG003|Overall Study|Not eligible|12|||
156606509|NCT01468701|565299756|FG004|Overall Study|Not eligible|22|||
156606510|NCT01468701|565299757|FG005|Overall Study|Not eligible|2|||
156606511|NCT01468701|565299758|FG006|Overall Study|Not eligible|39|||
156606512|NCT01468701|565299759|FG007|Overall Study|Not eligible|1|||
156606513|NCT01468701|565299760|FG008|Overall Study|Not eligible|40|||
156606514|NCT01468701|565299761|FG009|Overall Study|Not eligible|126|||
156606515|NCT01468701|565299762|FG010|Overall Study|Not eligible|39|||
156606516|NCT01468701|565299763|FG011|Overall Study|Not eligible|33|||
156606517|NCT01468701|565299764|FG012|Overall Study|Not eligible|1|||
156606518|NCT01468701|565299765|FG013|Overall Study|Not eligible|19|||
156606519|NCT01468701|565299766|FG014|Overall Study|Not eligible|1|||
156606520|NCT01468701|565299767|FG015|Overall Study|Not eligible|32|||
156606521|NCT01468701|565299768|FG016|Overall Study|Not eligible|0|||
156606522|NCT01468701|565299752|FG000|Overall Study|Lost to Follow-up|306|||
156606523|NCT01468701|565299753|FG001|Overall Study|Lost to Follow-up|0|||
156606524|NCT01468701|565299754|FG002|Overall Study|Lost to Follow-up|0|||
156606525|NCT01468701|565299755|FG003|Overall Study|Lost to Follow-up|0|||
156606526|NCT01468701|565299756|FG004|Overall Study|Lost to Follow-up|0|||
156606527|NCT01468701|565299757|FG005|Overall Study|Lost to Follow-up|0|||
156606528|NCT01468701|565299758|FG006|Overall Study|Lost to Follow-up|0|||
156606529|NCT01468701|565299759|FG007|Overall Study|Lost to Follow-up|0|||
156606530|NCT01468701|565299760|FG008|Overall Study|Lost to Follow-up|215|||
156606531|NCT01468701|565299761|FG009|Overall Study|Lost to Follow-up|309|||
156606532|NCT01468701|565299762|FG010|Overall Study|Lost to Follow-up|224|||
156606533|NCT01468701|565299763|FG011|Overall Study|Lost to Follow-up|212|||
156606534|NCT01468701|565299764|FG012|Overall Study|Lost to Follow-up|11|||
156606535|NCT01468701|565299765|FG013|Overall Study|Lost to Follow-up|164|||
156606536|NCT01468701|565299766|FG014|Overall Study|Lost to Follow-up|17|||
156606537|NCT01468701|565299767|FG015|Overall Study|Lost to Follow-up|127|||
156606538|NCT01468701|565299768|FG016|Overall Study|Lost to Follow-up|1|||
156606539|NCT01468701|565299752|FG000|Overall Study|Withdrawal by Subject|165|||
156606540|NCT01468701|565299753|FG001|Overall Study|Withdrawal by Subject|0|||
156606541|NCT01468701|565299754|FG002|Overall Study|Withdrawal by Subject|0|||
156606542|NCT01468701|565299755|FG003|Overall Study|Withdrawal by Subject|0|||
156606543|NCT01468701|565299756|FG004|Overall Study|Withdrawal by Subject|0|||
156606544|NCT01468701|565299757|FG005|Overall Study|Withdrawal by Subject|0|||
156606545|NCT01468701|565299758|FG006|Overall Study|Withdrawal by Subject|0|||
156606546|NCT01468701|565299759|FG007|Overall Study|Withdrawal by Subject|0|||
156606547|NCT01468701|565299760|FG008|Overall Study|Withdrawal by Subject|83|||
156606548|NCT01468701|565299761|FG009|Overall Study|Withdrawal by Subject|88|||
156606549|NCT01468701|565299762|FG010|Overall Study|Withdrawal by Subject|100|||
156606550|NCT01468701|565299763|FG011|Overall Study|Withdrawal by Subject|114|||
156606551|NCT01468701|565299764|FG012|Overall Study|Withdrawal by Subject|9|||
156606552|NCT01468701|565299765|FG013|Overall Study|Withdrawal by Subject|47|||
156606553|NCT01468701|565299766|FG014|Overall Study|Withdrawal by Subject|6|||
156606554|NCT01468701|565299767|FG015|Overall Study|Withdrawal by Subject|31|||
156606555|NCT01468701|565299768|FG016|Overall Study|Withdrawal by Subject|0|||
156606556|NCT01468701|565299752|FG000|Overall Study|Other reasons than listed|437|||
156606557|NCT01468701|565299753|FG001|Overall Study|Other reasons than listed|0|||
156606558|NCT01468701|565299754|FG002|Overall Study|Other reasons than listed|0|||
156606559|NCT01468701|565299755|FG003|Overall Study|Other reasons than listed|0|||
156606560|NCT01468701|565299756|FG004|Overall Study|Other reasons than listed|0|||
156606561|NCT01468701|565299757|FG005|Overall Study|Other reasons than listed|0|||
156606562|NCT01468701|565299758|FG006|Overall Study|Other reasons than listed|0|||
156606563|NCT01468701|565299759|FG007|Overall Study|Other reasons than listed|0|||
156606564|NCT01468701|565299760|FG008|Overall Study|Other reasons than listed|318|||
156606565|NCT01468701|565299761|FG009|Overall Study|Other reasons than listed|658|||
156606566|NCT01468701|565299762|FG010|Overall Study|Other reasons than listed|433|||
156606567|NCT01468701|565299763|FG011|Overall Study|Other reasons than listed|504|||
156606568|NCT01468701|565299764|FG012|Overall Study|Other reasons than listed|28|||
156606569|NCT01468701|565299765|FG013|Overall Study|Other reasons than listed|239|||
156606570|NCT01468701|565299766|FG014|Overall Study|Other reasons than listed|39|||
156606571|NCT01468701|565299767|FG015|Overall Study|Other reasons than listed|172|||
156606572|NCT01468701|565299768|FG016|Overall Study|Other reasons than listed|0|||
156606573|NCT01468701|565299752|FG000|Overall Study|No end of study case report form|0|||
156606574|NCT01468701|565299753|FG001|Overall Study|No end of study case report form|0|||
156606575|NCT01468701|565299754|FG002|Overall Study|No end of study case report form|0|||
156606576|NCT01468701|565299755|FG003|Overall Study|No end of study case report form|0|||
156606577|NCT01468701|565299756|FG004|Overall Study|No end of study case report form|0|||
156606578|NCT01468701|565299757|FG005|Overall Study|No end of study case report form|0|||
156606579|NCT01468701|565299758|FG006|Overall Study|No end of study case report form|0|||
156606580|NCT01468701|565299759|FG007|Overall Study|No end of study case report form|0|||
156606581|NCT01468701|565299760|FG008|Overall Study|No end of study case report form|4|||
156606582|NCT01468701|565299761|FG009|Overall Study|No end of study case report form|1|||
156606583|NCT01468701|565299762|FG010|Overall Study|No end of study case report form|2|||
156606584|NCT01468701|565299763|FG011|Overall Study|No end of study case report form|3|||
156606585|NCT01468701|565299764|FG012|Overall Study|No end of study case report form|0|||
156606586|NCT01468701|565299765|FG013|Overall Study|No end of study case report form|1|||
156606587|NCT01468701|565299766|FG014|Overall Study|No end of study case report form|0|||
156606588|NCT01468701|565299767|FG015|Overall Study|No end of study case report form|0|||
156606589|NCT01468701|565299768|FG016|Overall Study|No end of study case report form|0|||
156606590|NCT01468701|565299752|FG000|Overall Study|Not being followed up|0|||
156606591|NCT01468701|565299753|FG001|Overall Study|Not being followed up|4963|||
156606592|NCT01468701|565299754|FG002|Overall Study|Not being followed up|1755|||
156606593|NCT01468701|565299755|FG003|Overall Study|Not being followed up|703|||
156606594|NCT01468701|565299756|FG004|Overall Study|Not being followed up|1714|||
156606595|NCT01468701|565299757|FG005|Overall Study|Not being followed up|126|||
156606596|NCT01468701|565299758|FG006|Overall Study|Not being followed up|1170|||
156606597|NCT01468701|565299759|FG007|Overall Study|Not being followed up|4|||
156606598|NCT01468701|565299760|FG008|Overall Study|Not being followed up|0|||
156606599|NCT01468701|565299761|FG009|Overall Study|Not being followed up|0|||
156606600|NCT01468701|565299762|FG010|Overall Study|Not being followed up|0|||
156606601|NCT01468701|565299763|FG011|Overall Study|Not being followed up|0|||
156606602|NCT01468701|565299764|FG012|Overall Study|Not being followed up|0|||
156606603|NCT01468701|565299765|FG013|Overall Study|Not being followed up|0|||
156606604|NCT01468701|565299766|FG014|Overall Study|Not being followed up|0|||
156606605|NCT01468701|565299767|FG015|Overall Study|Not being followed up|0|||
156606606|NCT01468701|565299768|FG016|Overall Study|Not being followed up|0|||
156606607|NCT00631540|565299769|FG000|Overall Study|Withdrawal by Subject|5|||
156606608|NCT00631540|565299769|FG000|Overall Study|Death|4|||
156606609|NCT00631540|565299769|FG000|Overall Study|Lost to Follow-up|2|||
156606610|NCT00631540|565299769|FG000|Overall Study|Core Lab Data Unavailable|3|||
156606611|NCT00795509|565299770|FG000|Overall Study|Protocol Violation|31|||
156606612|NCT00970268|565299771|FG000|Overall Study|Withdrawal by Subject|12|||
156606613|NCT00970268|565299772|FG001|Overall Study|Withdrawal by Subject|19|||
156606614|NCT00970268|565299771|FG000|Overall Study|Adverse Event|15|||
156606615|NCT00970268|565299772|FG001|Overall Study|Adverse Event|12|||
156606616|NCT00970268|565299771|FG000|Overall Study|Lack of Efficacy|3|||
156606617|NCT00970268|565299772|FG001|Overall Study|Lack of Efficacy|6|||
156606618|NCT00970268|565299771|FG000|Overall Study|Protocol Violation|4|||
156606619|NCT00970268|565299772|FG001|Overall Study|Protocol Violation|7|||
156606620|NCT00970268|565299771|FG000|Overall Study|Other Reason|3|||
156606621|NCT00970268|565299772|FG001|Overall Study|Other Reason|1|||
156606622|NCT00970268|565299771|FG000|Overall Study|COPD Exacerbation|4|||
156606623|NCT00970268|565299772|FG001|Overall Study|COPD Exacerbation|2|||
156606624|NCT00970268|565299771|FG000|Overall Study|Lost to Follow-up|1|||
156606625|NCT00970268|565299772|FG001|Overall Study|Lost to Follow-up|2|||
156606626|NCT00970268|565299771|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
156606627|NCT00970268|565299772|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
156606628|NCT01079195|565299773|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
156606629|NCT01079195|565299773|FG000|Overall Study|No Documentation Available|437|||
156606630|NCT01079195|565299773|FG000|Overall Study|Adverse Event|157|||
156606631|NCT01079195|565299773|FG000|Overall Study|Reason Unknown|39|||
156606632|NCT01079195|565299773|FG000|Overall Study|Withdrawal by Subject|18|||
156606633|NCT01079195|565299773|FG000|Overall Study|Financial Reasons|15|||
156606634|NCT01079195|565299773|FG000|Overall Study|Lack of Effectiveness|12|||
156606635|NCT01079195|565299773|FG000|Overall Study|Physician Decision|4|||
156606636|NCT01079195|565299773|FG000|Overall Study|Improved Status of Participant|4|||
156606637|NCT01079195|565299773|FG000|Overall Study|No Follow-up Documentation Available|4|||
156606638|NCT01079195|565299773|FG000|Overall Study|Non-compliance|2|||
156606639|NCT01999946|565299777|FG000|Overall Study|Participant not released from jail|2|||
156606640|NCT01999946|565299778|FG001|Overall Study|Participant not released from jail|2|||
156606641|NCT01999946|565299779|FG002|Overall Study|Participant not released from jail|0|||
156606642|NCT01999946|565299777|FG000|Overall Study|Not included in primary outcome analysis|0|||
156606643|NCT01999946|565299778|FG001|Overall Study|Not included in primary outcome analysis|0|||
156606644|NCT01999946|565299779|FG002|Overall Study|Not included in primary outcome analysis|79|||
156606645|NCT03906136|565301266|FG000|Overall Study|Adverse Event|1|||
156606646|NCT03906136|565301267|FG001|Overall Study|Adverse Event|0|||
156606647|NCT03906136|565301266|FG000|Overall Study|Lost to Follow-up|7|||
156606648|NCT03906136|565301267|FG001|Overall Study|Lost to Follow-up|4|||
156606649|NCT03906136|565301266|FG000|Overall Study|Physician Decision|1|||
156606650|NCT03906136|565301267|FG001|Overall Study|Physician Decision|0|||
156606651|NCT03906136|565301266|FG000|Overall Study|Withdrawal by Subject|3|||
156606652|NCT03906136|565301267|FG001|Overall Study|Withdrawal by Subject|7|||
156606653|NCT02371980|565301277|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
156606654|NCT02371980|565301278|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
156606655|NCT02371980|565301279|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
156606656|NCT02371980|565301280|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
156606657|NCT02371980|565301281|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
156606658|NCT02371980|565301277|FG000|Open-label Period|Significant Protocol Deviation|19|||
156606659|NCT02371980|565301278|FG001|Open-label Period|Significant Protocol Deviation|0|||
156606660|NCT02371980|565301279|FG002|Open-label Period|Significant Protocol Deviation|0|||
156606661|NCT02371980|565301280|FG003|Open-label Period|Significant Protocol Deviation|0|||
156606662|NCT02371980|565301281|FG004|Open-label Period|Significant Protocol Deviation|0|||
156606663|NCT02371980|565301277|FG000|Open-label Period|Noncompliance with Study Drug|10|||
156606664|NCT02371980|565301278|FG001|Open-label Period|Noncompliance with Study Drug|0|||
156606665|NCT02371980|565301279|FG002|Open-label Period|Noncompliance with Study Drug|0|||
156606666|NCT02371980|565301280|FG003|Open-label Period|Noncompliance with Study Drug|0|||
156606667|NCT02371980|565301281|FG004|Open-label Period|Noncompliance with Study Drug|0|||
156606668|NCT02371980|565301277|FG000|Open-label Period|Lost to Follow-up|55|||
156606669|NCT02371980|565301278|FG001|Open-label Period|Lost to Follow-up|0|||
156606670|NCT02371980|565301279|FG002|Open-label Period|Lost to Follow-up|0|||
156606671|NCT02371980|565301280|FG003|Open-label Period|Lost to Follow-up|0|||
156606672|NCT02371980|565301281|FG004|Open-label Period|Lost to Follow-up|0|||
156606673|NCT02371980|565301277|FG000|Open-label Period|Voluntary Withdrawal|91|||
156606674|NCT02371980|565301278|FG001|Open-label Period|Voluntary Withdrawal|0|||
156606675|NCT02371980|565301279|FG002|Open-label Period|Voluntary Withdrawal|0|||
156606676|NCT02371980|565301280|FG003|Open-label Period|Voluntary Withdrawal|0|||
156606677|NCT02371980|565301281|FG004|Open-label Period|Voluntary Withdrawal|0|||
156606678|NCT02371980|565301277|FG000|Open-label Period|Pregnancy|1|||
156606679|NCT02371980|565301278|FG001|Open-label Period|Pregnancy|0|||
156606680|NCT02371980|565301279|FG002|Open-label Period|Pregnancy|0|||
156606681|NCT02371980|565301280|FG003|Open-label Period|Pregnancy|0|||
156606682|NCT02371980|565301281|FG004|Open-label Period|Pregnancy|0|||
156606683|NCT02371980|565301277|FG000|Open-label Period|Lack of Efficacy|116|||
156606684|NCT02371980|565301278|FG001|Open-label Period|Lack of Efficacy|0|||
156606685|NCT02371980|565301279|FG002|Open-label Period|Lack of Efficacy|0|||
156606686|NCT02371980|565301280|FG003|Open-label Period|Lack of Efficacy|0|||
156606687|NCT02371980|565301281|FG004|Open-label Period|Lack of Efficacy|0|||
156606688|NCT02371980|565301277|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
156606689|NCT02371980|565301278|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
156606690|NCT02371980|565301279|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
156606691|NCT02371980|565301280|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
156606692|NCT02371980|565301281|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
156606693|NCT02371980|565301277|FG000|Open-label Period|Reason not Specified|9|||
156606694|NCT02371980|565301278|FG001|Open-label Period|Reason not Specified|0|||
156606695|NCT02371980|565301279|FG002|Open-label Period|Reason not Specified|0|||
156606696|NCT02371980|565301280|FG003|Open-label Period|Reason not Specified|0|||
156606697|NCT02371980|565301281|FG004|Open-label Period|Reason not Specified|0|||
156606698|NCT02371980|565301277|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
156606699|NCT02371980|565301278|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
156606700|NCT02371980|565301279|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
156606701|NCT02371980|565301280|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
156606702|NCT02371980|565301281|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
156606703|NCT02371980|565301277|FG000|Double-blind Period|Significant Protocol Deviation|0|||
156606704|NCT02371980|565301278|FG001|Double-blind Period|Significant Protocol Deviation|2|||
156606705|NCT02371980|565301279|FG002|Double-blind Period|Significant Protocol Deviation|7|||
156606706|NCT02371980|565301280|FG003|Double-blind Period|Significant Protocol Deviation|3|||
156606707|NCT02371980|565301281|FG004|Double-blind Period|Significant Protocol Deviation|3|||
156606708|NCT02371980|565301277|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
156606709|NCT02371980|565301278|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
156606710|NCT02371980|565301279|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
156606711|NCT02371980|565301280|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
156606712|NCT02371980|565301281|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
156606713|NCT02371980|565301277|FG000|Double-blind Period|Lost to Follow-up|0|||
156606714|NCT02371980|565301278|FG001|Double-blind Period|Lost to Follow-up|8|||
156606715|NCT02371980|565301279|FG002|Double-blind Period|Lost to Follow-up|8|||
156606716|NCT02371980|565301280|FG003|Double-blind Period|Lost to Follow-up|6|||
156606717|NCT02371980|565301281|FG004|Double-blind Period|Lost to Follow-up|5|||
156606718|NCT02371980|565301277|FG000|Double-blind Period|Voluntary Withdrawal|0|||
156606719|NCT02371980|565301278|FG001|Double-blind Period|Voluntary Withdrawal|12|||
156606720|NCT02371980|565301279|FG002|Double-blind Period|Voluntary Withdrawal|8|||
156606721|NCT02371980|565301280|FG003|Double-blind Period|Voluntary Withdrawal|9|||
156606722|NCT02371980|565301281|FG004|Double-blind Period|Voluntary Withdrawal|11|||
156606723|NCT02371980|565301277|FG000|Double-blind Period|Relapse|0|||
156606724|NCT02371980|565301278|FG001|Double-blind Period|Relapse|50|||
156606725|NCT02371980|565301279|FG002|Double-blind Period|Relapse|25|||
156606726|NCT02371980|565301280|FG003|Double-blind Period|Relapse|25|||
156606727|NCT02371980|565301281|FG004|Double-blind Period|Relapse|26|||
156606728|NCT02371980|565301277|FG000|Double-blind Period|Reason not Specified|0|||
156606729|NCT02371980|565301278|FG001|Double-blind Period|Reason not Specified|3|||
156606730|NCT02371980|565301279|FG002|Double-blind Period|Reason not Specified|3|||
156606731|NCT02371980|565301280|FG003|Double-blind Period|Reason not Specified|2|||
156606732|NCT02371980|565301281|FG004|Double-blind Period|Reason not Specified|1|||
156606733|NCT02371980|565301277|FG000|Double-blind Period|Missing|0|||
156606734|NCT02371980|565301278|FG001|Double-blind Period|Missing|1|||
156606735|NCT02371980|565301279|FG002|Double-blind Period|Missing|0|||
156606736|NCT02371980|565301280|FG003|Double-blind Period|Missing|0|||
156606737|NCT02371980|565301281|FG004|Double-blind Period|Missing|0|||
156606738|NCT01280812|565301283|FG000|Overall Study|Withdrawal by Subject|2|||
156606739|NCT01280812|565301284|FG001|Overall Study|Withdrawal by Subject|1|||
156606740|NCT01280812|565301285|FG002|Overall Study|Withdrawal by Subject|0|||
156606741|NCT01280812|565301283|FG000|Overall Study|Lost to Follow-up|1|||
156606742|NCT01280812|565301284|FG001|Overall Study|Lost to Follow-up|1|||
156606743|NCT01280812|565301285|FG002|Overall Study|Lost to Follow-up|1|||
156606744|NCT00959894|565301291|FG000|Overall Study|Lost to Follow-up|10|||
156606745|NCT00959894|565301291|FG000|Overall Study|Adverse Event|3|||
156606746|NCT00959894|565301291|FG000|Overall Study|Withdrawal by Subject|1|||
156606747|NCT00959894|565301291|FG000|Overall Study|Need for contraindicated medication|1|||
156606748|NCT00959894|565301291|FG000|Overall Study|Subject moved out of town|1|||
156606749|NCT00922974|565301292|FG000|Phase II Component|Protocol Violation|2|||
156606750|NCT00922974|565301293|FG001|Phase II Component|Protocol Violation|0|||
156606751|NCT00922974|565301292|FG000|Phase II Component|Not evaluable for treatment review|5|||
156606752|NCT00922974|565301293|FG001|Phase II Component|Not evaluable for treatment review|0|||
156606753|NCT00922974|565301292|FG000|Phase III Component|Protocol Violation|8|||
156606754|NCT00922974|565301293|FG001|Phase III Component|Protocol Violation|6|||
156606755|NCT03682055|565301294|FG000|Overall Study|Lack of Efficacy|1|||
156606756|NCT03682055|565301295|FG001|Overall Study|Lack of Efficacy|2|||
156606757|NCT03682055|565301296|FG002|Overall Study|Lack of Efficacy|1|||
156606758|NCT03682055|565301297|FG003|Overall Study|Lack of Efficacy|2|||
156606759|NCT03682055|565301298|FG004|Overall Study|Lack of Efficacy|1|||
156606760|NCT03682055|565301299|FG005|Overall Study|Lack of Efficacy|3|||
156606761|NCT03682055|565301294|FG000|Overall Study|Withdrawal by Subject|0|||
156606762|NCT03682055|565301295|FG001|Overall Study|Withdrawal by Subject|0|||
156606763|NCT03682055|565301296|FG002|Overall Study|Withdrawal by Subject|0|||
156606764|NCT03682055|565301297|FG003|Overall Study|Withdrawal by Subject|0|||
156606765|NCT03682055|565301298|FG004|Overall Study|Withdrawal by Subject|0|||
156606766|NCT03682055|565301299|FG005|Overall Study|Withdrawal by Subject|1|||
156606767|NCT03682055|565301294|FG000|Overall Study|Termination of Study by Sponsor|0|||
156606768|NCT03682055|565301295|FG001|Overall Study|Termination of Study by Sponsor|0|||
156606769|NCT03682055|565301296|FG002|Overall Study|Termination of Study by Sponsor|0|||
156606770|NCT03682055|565301297|FG003|Overall Study|Termination of Study by Sponsor|0|||
156606771|NCT03682055|565301298|FG004|Overall Study|Termination of Study by Sponsor|0|||
156606772|NCT03682055|565301299|FG005|Overall Study|Termination of Study by Sponsor|3|||
156606773|NCT00191386|565301300|FG000|Overall Study|Adverse Event|16|||
156606774|NCT00191386|565301300|FG000|Overall Study|Lost to Follow-up|1|||
156606775|NCT00191386|565301300|FG000|Overall Study|Entry Criteria Exclusion|3|||
156606776|NCT00191386|565301300|FG000|Overall Study|Protocol Violation|18|||
156606777|NCT00191386|565301300|FG000|Overall Study|Withdrawal by Subject|96|||
156606778|NCT00191386|565301300|FG000|Overall Study|Physician Decision|11|||
156606779|NCT00191386|565301300|FG000|Overall Study|Lack of Efficacy|15|||
156606780|NCT01826448|565301302|FG000|Overall Study|Adverse Event|1|||
156606781|NCT01826448|565301303|FG001|Overall Study|Adverse Event|3|||
156606782|NCT01826448|565301302|FG000|Overall Study|Disease progression|2|||
156606783|NCT01826448|565301303|FG001|Overall Study|Disease progression|4|||
156606784|NCT01826448|565301302|FG000|Overall Study|Withdrawal by Subject|1|||
156606785|NCT01826448|565301303|FG001|Overall Study|Withdrawal by Subject|0|||
156606786|NCT01826448|565301302|FG000|Overall Study|Physician Decision|0|||
156606787|NCT01826448|565301303|FG001|Overall Study|Physician Decision|1|||
156606788|NCT01826448|565301302|FG000|Overall Study|2 active cancers|0|||
156606789|NCT01826448|565301303|FG001|Overall Study|2 active cancers|1|||
156606790|NCT04038385|565301304|FG000|Overall Study|Completed baseline assessment only|7|||
156606791|NCT04038385|565301305|FG001|Overall Study|Completed baseline assessment only|4|||
156606792|NCT04038385|565301304|FG000|Overall Study|Moved out of area|4|||
156606793|NCT04038385|565301305|FG001|Overall Study|Moved out of area|2|||
156606794|NCT04038385|565301304|FG000|Overall Study|Discontinued study involvement|6|||
156606795|NCT04038385|565301305|FG001|Overall Study|Discontinued study involvement|1|||
156606796|NCT00402285|565301309|FG000|Overall Study|insufficient RNA quality|7|||
156606797|NCT00402285|565301310|FG001|Overall Study|insufficient RNA quality|6|||
156606798|NCT00402285|565301311|FG002|Overall Study|insufficient RNA quality|2|||
156606799|NCT00784459|565301312|FG000|Overall Study|Adverse Event|0|||
156606800|NCT00784459|565301313|FG001|Overall Study|Adverse Event|2|||
156606801|NCT02009930|565301314|FG000|Overall Study|withdrawn|5|||
156606802|NCT00666536|565301317|FG000|Overall Study|Adverse Event|9|||
156606803|NCT00666536|565301318|FG001|Overall Study|Adverse Event|19|||
156606804|NCT00666536|565301317|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156606805|NCT00666536|565301318|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156606806|NCT00666536|565301317|FG000|Overall Study|Protocol deviation(s)|8|||
156606807|NCT00666536|565301318|FG001|Overall Study|Protocol deviation(s)|6|||
156606808|NCT00666536|565301317|FG000|Overall Study|Withdrawal by Subject|10|||
156606809|NCT00666536|565301318|FG001|Overall Study|Withdrawal by Subject|9|||
156606810|NCT00666536|565301317|FG000|Overall Study|Lost to Follow-up|4|||
156606811|NCT00666536|565301318|FG001|Overall Study|Lost to Follow-up|3|||
156606812|NCT02853123|565301322|FG000|Treatment Period 1|Adverse Event|0|||
156606813|NCT02853123|565301323|FG001|Treatment Period 1|Adverse Event|3|||
156606814|NCT02853123|565301322|FG000|Washout Period|Worsening of COPD|0|||
156606815|NCT02853123|565301323|FG001|Washout Period|Worsening of COPD|3|||
156606816|NCT02853123|565301322|FG000|Washout Period|Adverse Event|1|||
156606817|NCT02853123|565301323|FG001|Washout Period|Adverse Event|0|||
156606818|NCT02471586|565301329|FG000|Overall Study|Lost to Follow-up|3|||
156606819|NCT02471586|565301330|FG001|Overall Study|Lost to Follow-up|8|||
156606820|NCT02471586|565301331|FG002|Overall Study|Lost to Follow-up|4|||
156606821|NCT02471586|565301329|FG000|Overall Study|Death|2|||
156606822|NCT02471586|565301330|FG001|Overall Study|Death|2|||
156606823|NCT02471586|565301331|FG002|Overall Study|Death|0|||
156606824|NCT01419015|565301336|FG000|Overall Study|Death|2|||
156606825|NCT04839393|565301337|FG000|Overall Study|Adverse Event|0|||
156606826|NCT04839393|565301338|FG001|Overall Study|Adverse Event|0|||
156606827|NCT04839393|565301339|FG002|Overall Study|Adverse Event|2|||
156606828|NCT04839393|565301337|FG000|Overall Study|Withdrawal by participant|0|||
156606829|NCT04839393|565301338|FG001|Overall Study|Withdrawal by participant|0|||
156606830|NCT04839393|565301339|FG002|Overall Study|Withdrawal by participant|1|||
156606831|NCT05091918|565301342|FG000|Overall Study|Adverse Event|1|||
156606832|NCT05091918|565301342|FG000|Overall Study|Withdrawal by Subject|81|||
156606833|NCT01100658|565301343|FG000|Overall Study|Withdrawal by Subject|1|||
156606834|NCT00239356|565301344|FG000|Overall Study|Lack of Efficacy|1|||
156606835|NCT00239356|565301345|FG001|Overall Study|Lack of Efficacy|0|||
156606836|NCT00239356|565301344|FG000|Overall Study|Adverse Event|6|||
156606837|NCT00239356|565301345|FG001|Overall Study|Adverse Event|0|||
156606838|NCT00239356|565301344|FG000|Overall Study|Withdrawal by Subject|15|||
156606839|NCT00239356|565301345|FG001|Overall Study|Withdrawal by Subject|6|||
156606840|NCT00239356|565301344|FG000|Overall Study|Lost to Follow-up|3|||
156606841|NCT00239356|565301345|FG001|Overall Study|Lost to Follow-up|0|||
156606842|NCT00239356|565301344|FG000|Overall Study|poor/non-compliance|2|||
156606843|NCT00239356|565301345|FG001|Overall Study|poor/non-compliance|0|||
156606844|NCT00239356|565301344|FG000|Overall Study|Pregnancy|1|||
156606845|NCT00239356|565301345|FG001|Overall Study|Pregnancy|0|||
156606846|NCT00239356|565301344|FG000|Overall Study|Administrative reason|0|||
156606847|NCT00239356|565301345|FG001|Overall Study|Administrative reason|1|||
156606848|NCT00239356|565301344|FG000|Overall Study|Drug available on market|11|||
156606849|NCT00239356|565301345|FG001|Overall Study|Drug available on market|2|||
156606850|NCT01001572|565301346|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
156606851|NCT01001572|565301347|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
156606852|NCT01001572|565301348|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
156606853|NCT01001572|565301346|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
156606854|NCT01001572|565301347|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
156606855|NCT01001572|565301348|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
156606856|NCT01001572|565301346|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
156606857|NCT01001572|565301347|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
156606858|NCT01001572|565301348|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
156606859|NCT01001572|565301346|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
156606860|NCT01001572|565301347|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
156606861|NCT01001572|565301348|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
156606862|NCT01001572|565301346|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
156606863|NCT01001572|565301347|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
156606864|NCT01001572|565301348|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
156606865|NCT01001572|565301346|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
156606866|NCT01001572|565301347|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
156606867|NCT01001572|565301348|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
156606868|NCT01001572|565301346|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
156606869|NCT01001572|565301347|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
156606870|NCT01001572|565301348|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
156606871|NCT01001572|565301346|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
156606872|NCT01001572|565301347|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
156606873|NCT01001572|565301348|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
156606874|NCT01001572|565301346|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156606875|NCT01001572|565301347|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
156606876|NCT01001572|565301348|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
156606877|NCT01001572|565301346|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156606878|NCT01001572|565301347|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
156606879|NCT01001572|565301348|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
156606880|NCT01001572|565301346|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
156606881|NCT01001572|565301347|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
156606882|NCT01001572|565301348|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
156606883|NCT01001572|565301346|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
156606884|NCT01001572|565301347|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
156606885|NCT01001572|565301348|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
156606886|NCT01001572|565301346|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
156606887|NCT01001572|565301347|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
156606888|NCT01001572|565301348|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
156606889|NCT01001572|565301346|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156606890|NCT01001572|565301347|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156606891|NCT01001572|565301348|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156606892|NCT01094808|565301349|FG000|Overall Study|Withdrawal by Subject|1|||
156606893|NCT01094808|565301350|FG001|Overall Study|Withdrawal by Subject|1|||
156606894|NCT01094808|565301351|FG002|Overall Study|Withdrawal by Subject|0|||
156606895|NCT00369278|565301352|FG000|Overall Study|Adverse Event|14|||
156606896|NCT00369278|565301353|FG001|Overall Study|Adverse Event|11|||
156606897|NCT00369278|565301352|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156606898|NCT00369278|565301353|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
156606899|NCT00369278|565301352|FG000|Overall Study|Protocol Violation|2|||
156606900|NCT00369278|565301353|FG001|Overall Study|Protocol Violation|1|||
156606901|NCT00369278|565301352|FG000|Overall Study|Withdrawal by Subject|2|||
156606902|NCT00369278|565301353|FG001|Overall Study|Withdrawal by Subject|2|||
156606903|NCT00369278|565301352|FG000|Overall Study|Lost to Follow-up|1|||
156606904|NCT00369278|565301353|FG001|Overall Study|Lost to Follow-up|0|||
156606905|NCT00369278|565301352|FG000|Overall Study|Graft loss|1|||
156606906|NCT00369278|565301353|FG001|Overall Study|Graft loss|2|||
156606907|NCT02980692|565301360|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
156606908|NCT02980692|565301361|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
156606909|NCT02980692|565301362|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
156606910|NCT02980692|565301363|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
156606911|NCT02980692|565301364|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
156606912|NCT02980692|565301360|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
156606913|NCT02980692|565301361|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
156606914|NCT02980692|565301362|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
156606915|NCT02980692|565301363|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
156606916|NCT02980692|565301364|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
156606917|NCT02980692|565301360|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
156606918|NCT02980692|565301361|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
156606919|NCT02980692|565301362|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
156606920|NCT02980692|565301363|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
156606921|NCT02980692|565301364|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
156606922|NCT02980692|565301360|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
156606923|NCT02980692|565301361|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
156606924|NCT02980692|565301362|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
156606925|NCT02980692|565301363|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
156606926|NCT02980692|565301364|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
156606927|NCT02980692|565301360|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
156606928|NCT02980692|565301361|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
156606929|NCT02980692|565301362|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
156606930|NCT02980692|565301363|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
156606931|NCT02980692|565301364|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
156606932|NCT02980692|565301360|FG000|Double Blind Placebo Controlled Period|Other|1|||
156606933|NCT02980692|565301361|FG001|Double Blind Placebo Controlled Period|Other|0|||
156606934|NCT02980692|565301362|FG002|Double Blind Placebo Controlled Period|Other|0|||
156606935|NCT02980692|565301363|FG003|Double Blind Placebo Controlled Period|Other|0|||
156606936|NCT02980692|565301364|FG004|Double Blind Placebo Controlled Period|Other|1|||
156606937|NCT02980692|565301360|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
156606938|NCT02980692|565301361|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
156606939|NCT02980692|565301362|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
156606940|NCT02980692|565301363|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
156606941|NCT02980692|565301364|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
156606942|NCT02980692|565301360|FG000|Double-blind Follow-up Period|Adverse Event|0|||
156606943|NCT02980692|565301361|FG001|Double-blind Follow-up Period|Adverse Event|0|||
156606944|NCT02980692|565301362|FG002|Double-blind Follow-up Period|Adverse Event|0|||
156606945|NCT02980692|565301363|FG003|Double-blind Follow-up Period|Adverse Event|1|||
156606946|NCT02980692|565301364|FG004|Double-blind Follow-up Period|Adverse Event|1|||
156606947|NCT02980692|565301360|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
156606948|NCT02980692|565301361|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
156606949|NCT02980692|565301362|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
156606950|NCT02980692|565301363|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
156606951|NCT02980692|565301364|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
156606952|NCT02980692|565301360|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
156606953|NCT02980692|565301361|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
156606954|NCT02980692|565301362|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
156606955|NCT02980692|565301363|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
156606956|NCT02980692|565301364|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
156606957|NCT02980692|565301360|FG000|Double-blind Follow-up Period|Pregnancy|0|||
156606958|NCT02980692|565301361|FG001|Double-blind Follow-up Period|Pregnancy|0|||
156606959|NCT02980692|565301362|FG002|Double-blind Follow-up Period|Pregnancy|1|||
156606960|NCT02980692|565301363|FG003|Double-blind Follow-up Period|Pregnancy|1|||
156606961|NCT02980692|565301364|FG004|Double-blind Follow-up Period|Pregnancy|0|||
156606962|NCT02980692|565301360|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
156606963|NCT02980692|565301361|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
156606964|NCT02980692|565301362|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
156606965|NCT02980692|565301363|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
156606966|NCT02980692|565301364|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
156606967|NCT02980692|565301360|FG000|Double-blind Follow-up Period|Other|0|||
156606968|NCT02980692|565301361|FG001|Double-blind Follow-up Period|Other|0|||
156606969|NCT02980692|565301362|FG002|Double-blind Follow-up Period|Other|1|||
156606970|NCT02980692|565301363|FG003|Double-blind Follow-up Period|Other|1|||
156606971|NCT02980692|565301364|FG004|Double-blind Follow-up Period|Other|3|||
156606972|NCT04702984|565301374|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
156606973|NCT03725293|565301375|FG000|Overall Study|Physician Decision|9|||
156606974|NCT03725293|565301376|FG001|Overall Study|Physician Decision|6|||
156606975|NCT03725293|565301375|FG000|Overall Study|alternative vascular access needs|1|||
156606976|NCT03725293|565301376|FG001|Overall Study|alternative vascular access needs|2|||
156606977|NCT03725293|565301375|FG000|Overall Study|venous anatomy screen failures|2|||
156606978|NCT03725293|565301376|FG001|Overall Study|venous anatomy screen failures|1|||
156606979|NCT02143141|565301377|FG000|Overall Study|pain scores at 24 hours not collected|1|||
156606980|NCT02143141|565301378|FG001|Overall Study|pain scores at 24 hours not collected|0|||
156606981|NCT00064077|565301379|FG000|Overall Study|Improper prior treatment|1|||
156606982|NCT00064077|565301380|FG001|Overall Study|Improper prior treatment|0|||
156606983|NCT00064077|565301381|FG002|Overall Study|Improper prior treatment|0|||
156606984|NCT00064077|565301382|FG003|Overall Study|Improper prior treatment|0|||
156606985|NCT00064077|565301379|FG000|Overall Study|Poor risk|2|||
156606986|NCT00064077|565301380|FG001|Overall Study|Poor risk|0|||
156606987|NCT00064077|565301381|FG002|Overall Study|Poor risk|1|||
156606988|NCT00064077|565301382|FG003|Overall Study|Poor risk|1|||
156606989|NCT00064077|565301379|FG000|Overall Study|Pathology|10|||
156606990|NCT00064077|565301380|FG001|Overall Study|Pathology|7|||
156606991|NCT00064077|565301381|FG002|Overall Study|Pathology|3|||
156606992|NCT00064077|565301382|FG003|Overall Study|Pathology|4|||
156606993|NCT00064077|565301379|FG000|Overall Study|No surgery|0|||
156606994|NCT00064077|565301380|FG001|Overall Study|No surgery|0|||
156606995|NCT00064077|565301381|FG002|Overall Study|No surgery|1|||
156606996|NCT00064077|565301382|FG003|Overall Study|No surgery|0|||
156606997|NCT00064077|565301379|FG000|Overall Study|No tumor|0|||
156606998|NCT00064077|565301380|FG001|Overall Study|No tumor|0|||
156606999|NCT00064077|565301381|FG002|Overall Study|No tumor|1|||
156607000|NCT00064077|565301382|FG003|Overall Study|No tumor|0|||
156607001|NCT00064077|565301379|FG000|Overall Study|Other reasons|2|||
156607002|NCT00064077|565301380|FG001|Overall Study|Other reasons|2|||
156607003|NCT00064077|565301381|FG002|Overall Study|Other reasons|1|||
156607004|NCT00064077|565301382|FG003|Overall Study|Other reasons|2|||
156607005|NCT01057862|565301383|FG000|Overall Study|Withdrawal by Subject|1|||
156607006|NCT01057862|565301384|FG001|Overall Study|Withdrawal by Subject|2|||
156607007|NCT02255760|565301385|FG000|Overall Study|Lost to Follow-up|0|||
156607008|NCT02255760|565301386|FG001|Overall Study|Lost to Follow-up|1|||
156607009|NCT02255760|565301387|FG002|Overall Study|Lost to Follow-up|0|||
156607010|NCT02255760|565301388|FG003|Overall Study|Lost to Follow-up|0|||
156607011|NCT02255760|565301389|FG004|Overall Study|Lost to Follow-up|0|||
156607012|NCT00618813|565301390|FG000|Overall Study|Lack of Efficacy|1|||
156607013|NCT00618813|565301390|FG000|Overall Study|Physician Decision|2|||
156607014|NCT00618813|565301390|FG000|Overall Study|Withdrawal by Subject|1|||
156607015|NCT00003838|565301391|FG000|Overall Study|Death|0|||
156607016|NCT00003838|565301392|FG001|Overall Study|Death|12|||
156607017|NCT00003838|565301393|FG002|Overall Study|Death|7|||
156607018|NCT00003838|565301391|FG000|Overall Study|Lost to Follow-up|0|||
156607019|NCT00003838|565301392|FG001|Overall Study|Lost to Follow-up|1|||
156607020|NCT00003838|565301393|FG002|Overall Study|Lost to Follow-up|1|||
156607021|NCT00003838|565301391|FG000|Overall Study|Disease Progression|0|||
156607022|NCT00003838|565301392|FG001|Overall Study|Disease Progression|12|||
156607023|NCT00003838|565301393|FG002|Overall Study|Disease Progression|0|||
156607024|NCT01809197|565301394|FG000|Overall Study|Lost to Follow-up|4|||
156607025|NCT01809197|565301395|FG001|Overall Study|Lost to Follow-up|2|||
156607026|NCT01809197|565301394|FG000|Overall Study|Adverse Event|2|||
156607027|NCT01809197|565301395|FG001|Overall Study|Adverse Event|3|||
156607028|NCT01809197|565301394|FG000|Overall Study|Failed slit lamp exam|1|||
156607029|NCT01809197|565301395|FG001|Overall Study|Failed slit lamp exam|0|||
156607030|NCT01809197|565301394|FG000|Overall Study|Non-Compliance|1|||
156607031|NCT01809197|565301395|FG001|Overall Study|Non-Compliance|1|||
156607032|NCT01809197|565301394|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
156607033|NCT01809197|565301395|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
156607034|NCT01809197|565301394|FG000|Overall Study|Withdrawal by Subject|1|||
156607035|NCT01809197|565301395|FG001|Overall Study|Withdrawal by Subject|1|||
156607036|NCT01809197|565301394|FG000|Overall Study|Product not available|0|||
156607037|NCT01809197|565301395|FG001|Overall Study|Product not available|1|||
156607038|NCT00425113|565301396|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
156607039|NCT00425113|565301397|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
156607040|NCT00425113|565301396|FG000|Overall Study|diagnosis of abdominal TB|0|||
156607041|NCT00425113|565301397|FG001|Overall Study|diagnosis of abdominal TB|1|||
156607042|NCT00425113|565301396|FG000|Overall Study|missing study drug more than 14 days|0|||
156607043|NCT00425113|565301397|FG001|Overall Study|missing study drug more than 14 days|1|||
156607044|NCT00425113|565301396|FG000|Overall Study|Withdrawal by Subject|1|||
156607045|NCT00425113|565301397|FG001|Overall Study|Withdrawal by Subject|0|||
156607046|NCT00268463|565301398|FG000|Overall Study|study terminated due to low accrual|10|||
156607047|NCT00268463|565301399|FG001|Overall Study|study terminated due to low accrual|12|||
156607048|NCT03495817|565301400|FG000|26 Week Open Label|Adverse Event|3|||
156607049|NCT03495817|565301400|FG000|26 Week Open Label|Withdrawal by Subject|4|||
156607050|NCT03495817|565301400|FG000|26 Week Open Label|Lost to Follow-up|1|||
156607051|NCT03495817|565301400|FG000|26 Week Extension|Lost to Follow-up|2|||
156607052|NCT01686958|565301401|FG000|Overall Study|Withdrawal by Subject|1|||
156607053|NCT02224638|565301411|FG000|Overall Study|Adverse Event|1|||
156607054|NCT02224638|565301412|FG001|Overall Study|Adverse Event|1|||
156607055|NCT01406652|565301413|FG000|Overall Study|Lost-to-follow-up|3|||
156607056|NCT01406652|565301414|FG001|Overall Study|Lost-to-follow-up|4|||
156607057|NCT01406652|565301413|FG000|Overall Study|Withdrawal by Subject|2|||
156607058|NCT01406652|565301414|FG001|Overall Study|Withdrawal by Subject|2|||
156607059|NCT01406652|565301413|FG000|Overall Study|Insufficient follow-up|5|||
156607060|NCT01406652|565301414|FG001|Overall Study|Insufficient follow-up|4|||
156607061|NCT01406652|565301413|FG000|Overall Study|Infection not sure|10|||
156607062|NCT01406652|565301414|FG001|Overall Study|Infection not sure|10|||
156607063|NCT00587301|565301421|FG000|Overall Study|Screen Failure|9|||
156607064|NCT00587301|565301421|FG000|Overall Study|Lost to Follow-up|22|||
156607065|NCT00587301|565301421|FG000|Overall Study|Withdrawal by Subject|7|||
156607066|NCT00587301|565301421|FG000|Overall Study|Protocol Violation|7|||
156607067|NCT01400139|565301422|FG000|HYD Core Study|Adverse Event|210|||
156607068|NCT01400139|565301422|FG000|HYD Core Study|Lack of Efficacy|59|||
156607069|NCT01400139|565301422|FG000|HYD Core Study|Withdrawal by Subject|114|||
156607070|NCT01400139|565301422|FG000|HYD Core Study|Lost to Follow-up|39|||
156607071|NCT01400139|565301422|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
156607072|NCT01400139|565301422|FG000|HYD Core Study|Administrative|56|||
156607073|NCT01400139|565301422|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
156607074|NCT01400139|565301422|FG000|HYD Extension Period|Adverse Event|8|||
156607075|NCT01400139|565301422|FG000|HYD Extension Period|Withdrawal by Subject|5|||
156607076|NCT01400139|565301422|FG000|HYD Extension Period|Administrative|10|||
156607077|NCT00719953|565301427|FG000|Overall Study|Adverse Event|4|||
156607078|NCT03175562|565301428|FG000|Overall Study|Adverse Event|1|||
156607079|NCT03175562|565301428|FG000|Overall Study|Lost to Follow-up|3|||
156607080|NCT03175562|565301428|FG000|Overall Study|Withdrawal by Subject|7|||
156607081|NCT03175562|565301428|FG000|Overall Study|Other (Not Specified)|5|||
156607082|NCT01230749|565301430|FG000|Overall Study|Adverse Event|0|||
156607083|NCT01230749|565301431|FG001|Overall Study|Adverse Event|0|||
156607084|NCT01230749|565301432|FG002|Overall Study|Adverse Event|0|||
156607085|NCT01230749|565301433|FG003|Overall Study|Adverse Event|1|||
156607086|NCT01230749|565301430|FG000|Overall Study|Physician Decision|0|||
156607087|NCT01230749|565301431|FG001|Overall Study|Physician Decision|0|||
156607088|NCT01230749|565301432|FG002|Overall Study|Physician Decision|1|||
156607089|NCT01230749|565301433|FG003|Overall Study|Physician Decision|0|||
156607090|NCT01230749|565301430|FG000|Overall Study|Withdrawal by Subject|0|||
156607091|NCT01230749|565301431|FG001|Overall Study|Withdrawal by Subject|1|||
156607092|NCT01230749|565301432|FG002|Overall Study|Withdrawal by Subject|0|||
156607093|NCT01230749|565301433|FG003|Overall Study|Withdrawal by Subject|0|||
156607094|NCT01230749|565301430|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
156607095|NCT01230749|565301431|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
156607096|NCT01230749|565301432|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
156607097|NCT01230749|565301433|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
156607098|NCT03417505|565303154|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
156607099|NCT03417505|565303155|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
156607100|NCT03235726|565303160|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607101|NCT03235726|565303161|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607102|NCT03235726|565303162|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607103|NCT03235726|565303163|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607104|NCT03235726|565303164|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
156607105|NCT03235726|565303165|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607106|NCT03235726|565303166|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607107|NCT03235726|565303167|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607108|NCT03235726|565303168|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607109|NCT03235726|565303169|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
156607110|NCT03235726|565303160|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607111|NCT03235726|565303161|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607112|NCT03235726|565303162|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607113|NCT03235726|565303163|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607114|NCT03235726|565303164|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
156607115|NCT03235726|565303165|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607116|NCT03235726|565303166|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607117|NCT03235726|565303167|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607118|NCT03235726|565303168|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607119|NCT03235726|565303169|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
156607120|NCT00879437|565303170|FG000|Overall Study|Protocol Violation|0|||
156607121|NCT00879437|565303171|FG001|Overall Study|Protocol Violation|1|||
156607122|NCT00879437|565303170|FG000|Overall Study|Death|1|||
156607123|NCT00879437|565303171|FG001|Overall Study|Death|0|||
156607124|NCT04685538|565303172|FG000|Overall Study|Adverse Event|0|||
156607125|NCT04685538|565303173|FG001|Overall Study|Adverse Event|1|||
156607126|NCT04685538|565303172|FG000|Overall Study|Lost to Follow-up|0|||
156607127|NCT04685538|565303173|FG001|Overall Study|Lost to Follow-up|2|||
156607128|NCT00291187|565303174|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
156607129|NCT00291187|565303175|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
156607130|NCT00291187|565303176|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
156607131|NCT00291187|565303177|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
156607132|NCT01040845|565303178|FG000|Overall Study|Withdrawal by Subject|1|||
156607133|NCT01040845|565303179|FG001|Overall Study|Withdrawal by Subject|1|||
156607134|NCT01040845|565303178|FG000|Overall Study|Physician Decision|1|||
156607135|NCT01040845|565303179|FG001|Overall Study|Physician Decision|0|||
156607136|NCT04362813|565303180|FG000|Overall Study|Death|12|||
156607137|NCT04362813|565303181|FG001|Overall Study|Death|16|||
156607138|NCT04362813|565303180|FG000|Overall Study|Withdrawal by Subject|3|||
156607139|NCT04362813|565303181|FG001|Overall Study|Withdrawal by Subject|1|||
156607140|NCT04362813|565303180|FG000|Overall Study|Protocol Violation|0|||
156607141|NCT04362813|565303181|FG001|Overall Study|Protocol Violation|3|||
156607142|NCT04362813|565303180|FG000|Overall Study|Lost to Follow-up|1|||
156607143|NCT04362813|565303181|FG001|Overall Study|Lost to Follow-up|1|||
156607144|NCT04362813|565303180|FG000|Overall Study|Enrolled but did not receive treatment|2|||
156607145|NCT04362813|565303181|FG001|Overall Study|Enrolled but did not receive treatment|4|||
156607146|NCT01732107|565303186|FG000|Overall Study|Adverse Event|2|||
156607147|NCT01732107|565303186|FG000|Overall Study|Disease Progression|8|||
156607148|NCT01732107|565303186|FG000|Overall Study|Physician Decision|1|||
156607149|NCT01732107|565303186|FG000|Overall Study|Withdrawal by Subject|2|||
156607150|NCT04445688|565303187|FG000|Washout (One Week)|Adverse Event|2|||
156607151|NCT04445688|565303187|FG000|Washout (One Week)|Withdrawal by Subject|1|||
156607152|NCT02023268|565303188|FG000|Overall Study|Lack of Efficacy|0|||
156607153|NCT02023268|565303189|FG001|Overall Study|Lack of Efficacy|1|||
156607154|NCT02023268|565303188|FG000|Overall Study|Adverse Event|0|||
156607155|NCT02023268|565303189|FG001|Overall Study|Adverse Event|2|||
156607156|NCT02023268|565303188|FG000|Overall Study|Withdrawal by Subject|0|||
156607157|NCT02023268|565303189|FG001|Overall Study|Withdrawal by Subject|1|||
156607158|NCT00615459|565303191|FG000|Period I|Adverse Event|2|||
156607159|NCT00615459|565303192|FG001|Period I|Adverse Event|0|||
156607160|NCT00615459|565303193|FG002|Period I|Adverse Event|1|||
156607161|NCT00615459|565303194|FG003|Period I|Adverse Event|0|||
156607162|NCT00615459|565303191|FG000|Period I|Subject withdrew consent|1|||
156607163|NCT00615459|565303192|FG001|Period I|Subject withdrew consent|0|||
156607164|NCT00615459|565303193|FG002|Period I|Subject withdrew consent|0|||
156607165|NCT00615459|565303194|FG003|Period I|Subject withdrew consent|1|||
156607166|NCT00615459|565303191|FG000|Period I|Abnormal test procedure results|1|||
156607167|NCT00615459|565303192|FG001|Period I|Abnormal test procedure results|1|||
156607168|NCT00615459|565303193|FG002|Period I|Abnormal test procedure results|1|||
156607169|NCT00615459|565303194|FG003|Period I|Abnormal test procedure results|0|||
156607170|NCT00615459|565303191|FG000|Period II|Adverse Event|1|||
156607171|NCT00615459|565303192|FG001|Period II|Adverse Event|0|||
156607172|NCT00615459|565303193|FG002|Period II|Adverse Event|0|||
156607173|NCT00615459|565303194|FG003|Period II|Adverse Event|0|||
156607174|NCT00615459|565303191|FG000|Period II|Lost to Follow-up|0|||
156607175|NCT00615459|565303192|FG001|Period II|Lost to Follow-up|0|||
156607176|NCT00615459|565303193|FG002|Period II|Lost to Follow-up|0|||
156607177|NCT00615459|565303194|FG003|Period II|Lost to Follow-up|1|||
156607178|NCT00615459|565303191|FG000|Period III|Adverse Event|0|||
156607179|NCT00615459|565303192|FG001|Period III|Adverse Event|1|||
156607180|NCT00615459|565303193|FG002|Period III|Adverse Event|0|||
156607181|NCT00615459|565303194|FG003|Period III|Adverse Event|0|||
156607182|NCT00615459|565303191|FG000|Period III|Administrative problems|0|||
156607183|NCT00615459|565303192|FG001|Period III|Administrative problems|1|||
156607184|NCT00615459|565303193|FG002|Period III|Administrative problems|1|||
156607185|NCT00615459|565303194|FG003|Period III|Administrative problems|0|||
156607186|NCT00615459|565303191|FG000|Period III|Unsatisfactory therapeutic effect|0|||
156607187|NCT00615459|565303192|FG001|Period III|Unsatisfactory therapeutic effect|1|||
156607188|NCT00615459|565303193|FG002|Period III|Unsatisfactory therapeutic effect|0|||
156607189|NCT00615459|565303194|FG003|Period III|Unsatisfactory therapeutic effect|0|||
156607190|NCT00918346|565303206|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
156607191|NCT00918346|565303207|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
156607192|NCT02076334|565303208|FG000|Overall Study|Protocol Violation|1|||
156607193|NCT02076334|565303209|FG001|Overall Study|Protocol Violation|0|||
156607194|NCT02076334|565303210|FG002|Overall Study|Protocol Violation|0|||
156607195|NCT02076334|565303211|FG003|Overall Study|Protocol Violation|0|||
156607196|NCT02076334|565303208|FG000|Overall Study|Lost to Follow-up|0|||
156607197|NCT02076334|565303209|FG001|Overall Study|Lost to Follow-up|1|||
156607198|NCT02076334|565303210|FG002|Overall Study|Lost to Follow-up|1|||
156607199|NCT02076334|565303211|FG003|Overall Study|Lost to Follow-up|0|||
156607200|NCT02076334|565303208|FG000|Overall Study|muscle soreness|0|||
156607201|NCT02076334|565303209|FG001|Overall Study|muscle soreness|0|||
156607202|NCT02076334|565303210|FG002|Overall Study|muscle soreness|0|||
156607203|NCT02076334|565303211|FG003|Overall Study|muscle soreness|1|||
156607204|NCT02475629|565303212|FG000|Overall Study|Adverse Event|1|||
156607205|NCT02475629|565303212|FG000|Overall Study|Death|4|||
156607206|NCT02475629|565303212|FG000|Overall Study|Physician Decision|1|||
156607207|NCT02475629|565303212|FG000|Overall Study|Withdrawal by Subject|1|||
156607208|NCT02475629|565303212|FG000|Overall Study|Lost to Follow-up|1|||
156607209|NCT02475629|565303212|FG000|Overall Study|Subject non-compliance|1|||
156607210|NCT03379376|565303213|FG000|Overall Study|Lost to Follow-up|2|||
156607211|NCT03379376|565303213|FG000|Overall Study|Did not wish to complete follow up|1|||
156607212|NCT03379376|565303213|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
156607213|NCT03379376|565303213|FG000|Overall Study|Death|1|||
156607214|NCT01611298|565303214|FG000|Overall Study|Relapsed|2|||
156607215|NCT03238352|565303215|FG000|Overall Study|Lost to Follow-up|0|||
156607216|NCT03238352|565303216|FG001|Overall Study|Lost to Follow-up|2|||
156607217|NCT03238352|565303217|FG002|Overall Study|Lost to Follow-up|1|||
156607218|NCT03238352|565303215|FG000|Overall Study|Withdrawal by Subject|0|||
156607219|NCT03238352|565303216|FG001|Overall Study|Withdrawal by Subject|1|||
156607220|NCT03238352|565303217|FG002|Overall Study|Withdrawal by Subject|0|||
156607221|NCT01963780|565303218|FG000|Overall Study|Death|7|||
156607222|NCT04153929|565303219|FG000|Overall Study|Other than listed|2|||
156607223|NCT04153929|565303220|FG001|Overall Study|Other than listed|2|||
156607224|NCT04153929|565303221|FG002|Overall Study|Other than listed|0|||
156607225|NCT04153929|565303222|FG003|Overall Study|Other than listed|1|||
156607226|NCT04153929|565303223|FG004|Overall Study|Other than listed|0|||
156607227|NCT04153929|565303224|FG005|Overall Study|Other than listed|2|||
156607228|NCT04153929|565303225|FG006|Overall Study|Other than listed|2|||
156607229|NCT04153929|565303226|FG007|Overall Study|Other than listed|1|||
156607230|NCT04153929|565303219|FG000|Overall Study|Lost to Follow-up|2|||
156607231|NCT04153929|565303220|FG001|Overall Study|Lost to Follow-up|1|||
156607232|NCT04153929|565303221|FG002|Overall Study|Lost to Follow-up|0|||
156607233|NCT04153929|565303222|FG003|Overall Study|Lost to Follow-up|1|||
156607234|NCT04153929|565303223|FG004|Overall Study|Lost to Follow-up|1|||
156607235|NCT04153929|565303224|FG005|Overall Study|Lost to Follow-up|0|||
156607236|NCT04153929|565303225|FG006|Overall Study|Lost to Follow-up|0|||
156607237|NCT04153929|565303226|FG007|Overall Study|Lost to Follow-up|0|||
156607238|NCT04153929|565303219|FG000|Overall Study|Withdrawal by Subject|3|||
156607239|NCT04153929|565303220|FG001|Overall Study|Withdrawal by Subject|1|||
156607240|NCT04153929|565303221|FG002|Overall Study|Withdrawal by Subject|0|||
156607241|NCT04153929|565303222|FG003|Overall Study|Withdrawal by Subject|3|||
156607242|NCT04153929|565303223|FG004|Overall Study|Withdrawal by Subject|1|||
156607243|NCT04153929|565303224|FG005|Overall Study|Withdrawal by Subject|0|||
156607244|NCT04153929|565303225|FG006|Overall Study|Withdrawal by Subject|1|||
156607245|NCT04153929|565303226|FG007|Overall Study|Withdrawal by Subject|0|||
156607246|NCT04153929|565303219|FG000|Overall Study|Protocol Violation|0|||
156607247|NCT04153929|565303220|FG001|Overall Study|Protocol Violation|0|||
156607248|NCT04153929|565303221|FG002|Overall Study|Protocol Violation|0|||
156607249|NCT04153929|565303222|FG003|Overall Study|Protocol Violation|0|||
156607250|NCT04153929|565303223|FG004|Overall Study|Protocol Violation|0|||
156607251|NCT04153929|565303224|FG005|Overall Study|Protocol Violation|0|||
156607252|NCT04153929|565303225|FG006|Overall Study|Protocol Violation|1|||
156607253|NCT04153929|565303226|FG007|Overall Study|Protocol Violation|2|||
156607254|NCT04153929|565303219|FG000|Overall Study|Adverse Event|3|||
156607255|NCT04153929|565303220|FG001|Overall Study|Adverse Event|5|||
156607256|NCT04153929|565303221|FG002|Overall Study|Adverse Event|5|||
156607257|NCT04153929|565303222|FG003|Overall Study|Adverse Event|11|||
156607258|NCT04153929|565303223|FG004|Overall Study|Adverse Event|15|||
156607259|NCT04153929|565303224|FG005|Overall Study|Adverse Event|4|||
156607260|NCT04153929|565303225|FG006|Overall Study|Adverse Event|8|||
156607261|NCT04153929|565303226|FG007|Overall Study|Adverse Event|2|||
156607262|NCT04153929|565303219|FG000|Overall Study|Not treated|1|||
156607263|NCT04153929|565303220|FG001|Overall Study|Not treated|0|||
156607264|NCT04153929|565303221|FG002|Overall Study|Not treated|0|||
156607265|NCT04153929|565303222|FG003|Overall Study|Not treated|0|||
156607266|NCT04153929|565303223|FG004|Overall Study|Not treated|0|||
156607267|NCT04153929|565303224|FG005|Overall Study|Not treated|0|||
156607268|NCT04153929|565303225|FG006|Overall Study|Not treated|1|||
156607269|NCT04153929|565303226|FG007|Overall Study|Not treated|0|||
156607270|NCT04083794|565303227|FG000|Overall Study|Lost to Follow-up|9|||
156607271|NCT03383614|565303228|FG000|Overall Study|Withdrawal by Subject|0|||
156607272|NCT03383614|565303229|FG001|Overall Study|Withdrawal by Subject|1|||
156607273|NCT03383614|565303230|FG002|Overall Study|Withdrawal by Subject|0|||
156607274|NCT03383614|565303231|FG003|Overall Study|Withdrawal by Subject|0|||
156607275|NCT01654523|565303233|FG000|Overall Study|Withdrawal by Subject|1|||
156607276|NCT04294095|565303234|FG000|Overall Study|Adverse Event|1|||
156607277|NCT04294095|565303235|FG001|Overall Study|Adverse Event|0|||
156607278|NCT02999100|565303236|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
156607279|NCT02999100|565303237|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
156607280|NCT02999100|565303238|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
156607281|NCT02999100|565303239|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
156607282|NCT02999100|565303240|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
156607283|NCT02999100|565303241|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
156607284|NCT02999100|565303236|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
156607285|NCT02999100|565303237|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
156607286|NCT02999100|565303238|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
156607287|NCT02999100|565303239|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
156607288|NCT02999100|565303240|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
156607289|NCT02999100|565303241|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
156607290|NCT02999100|565303236|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
156607291|NCT02999100|565303237|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
156607292|NCT02999100|565303238|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
156607293|NCT02999100|565303239|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
156607294|NCT02999100|565303240|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
156607295|NCT02999100|565303241|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
156607296|NCT03595384|565303242|FG000|Overall Study|Other time commitments|8|||
156607297|NCT03595384|565303242|FG000|Overall Study|Changes to session time|7|||
156607298|NCT03595384|565303242|FG000|Overall Study|Relocation out of country|1|||
156607299|NCT03803202|565303243|FG000|Overall Study|Other|0|||
156607300|NCT03803202|565303244|FG001|Overall Study|Other|1|||
156607301|NCT03803202|565303245|FG002|Overall Study|Other|0|||
156607302|NCT03803202|565303246|FG003|Overall Study|Other|0|||
156607303|NCT03803202|565303247|FG004|Overall Study|Other|0|||
156607304|NCT03803202|565303248|FG005|Overall Study|Other|0|||
156607305|NCT03803202|565303249|FG006|Overall Study|Other|0|||
156607306|NCT03803202|565303250|FG007|Overall Study|Other|0|||
156607307|NCT03803202|565303251|FG008|Overall Study|Other|0|||
156607308|NCT03803202|565303243|FG000|Overall Study|Death|0|||
156607309|NCT03803202|565303244|FG001|Overall Study|Death|0|||
156607310|NCT03803202|565303245|FG002|Overall Study|Death|0|||
156607311|NCT03803202|565303246|FG003|Overall Study|Death|0|||
156607312|NCT03803202|565303247|FG004|Overall Study|Death|0|||
156607313|NCT03803202|565303248|FG005|Overall Study|Death|1|||
156607314|NCT03803202|565303249|FG006|Overall Study|Death|0|||
156607315|NCT03803202|565303250|FG007|Overall Study|Death|0|||
156607316|NCT03803202|565303251|FG008|Overall Study|Death|0|||
156607317|NCT03803202|565303243|FG000|Overall Study|Withdrawal by Subject|0|||
156607318|NCT03803202|565303244|FG001|Overall Study|Withdrawal by Subject|0|||
156607319|NCT03803202|565303245|FG002|Overall Study|Withdrawal by Subject|1|||
156607320|NCT03803202|565303246|FG003|Overall Study|Withdrawal by Subject|0|||
156607321|NCT03803202|565303247|FG004|Overall Study|Withdrawal by Subject|0|||
156607322|NCT03803202|565303248|FG005|Overall Study|Withdrawal by Subject|0|||
156607323|NCT03803202|565303249|FG006|Overall Study|Withdrawal by Subject|0|||
156607324|NCT03803202|565303250|FG007|Overall Study|Withdrawal by Subject|1|||
156607325|NCT03803202|565303251|FG008|Overall Study|Withdrawal by Subject|0|||
156607326|NCT03803202|565303243|FG000|Overall Study|Lost to Follow-up|0|||
156607327|NCT03803202|565303244|FG001|Overall Study|Lost to Follow-up|0|||
156607328|NCT03803202|565303245|FG002|Overall Study|Lost to Follow-up|0|||
156607329|NCT03803202|565303246|FG003|Overall Study|Lost to Follow-up|1|||
156607330|NCT03803202|565303247|FG004|Overall Study|Lost to Follow-up|1|||
156607331|NCT03803202|565303248|FG005|Overall Study|Lost to Follow-up|0|||
156607332|NCT03803202|565303249|FG006|Overall Study|Lost to Follow-up|1|||
156607333|NCT03803202|565303250|FG007|Overall Study|Lost to Follow-up|0|||
156607334|NCT03803202|565303251|FG008|Overall Study|Lost to Follow-up|0|||
156607335|NCT00293241|565303252|FG000|Overall Study|Lost to Follow-up|9|||
156607336|NCT00293241|565303253|FG001|Overall Study|Lost to Follow-up|16|||
156607337|NCT00293241|565303252|FG000|Overall Study|Physician Decision|23|||
156607338|NCT00293241|565303253|FG001|Overall Study|Physician Decision|17|||
156607339|NCT00293241|565303252|FG000|Overall Study|Withdrawal by Subject|4|||
156607340|NCT00293241|565303253|FG001|Overall Study|Withdrawal by Subject|8|||
156607341|NCT01125293|565303254|FG000|Overall Study|Disease Progression|1|||
156607342|NCT01125293|565303255|FG001|Overall Study|Disease Progression|3|||
156607343|NCT01125293|565303256|FG002|Overall Study|Disease Progression|4|||
156607344|NCT01125293|565303257|FG003|Overall Study|Disease Progression|3|||
156607345|NCT01125293|565303258|FG004|Overall Study|Disease Progression|5|||
156607346|NCT01125293|565303259|FG005|Overall Study|Disease Progression|12|||
156607347|NCT01125293|565303254|FG000|Overall Study|Adverse Event|1|||
156607348|NCT01125293|565303255|FG001|Overall Study|Adverse Event|0|||
156607349|NCT01125293|565303256|FG002|Overall Study|Adverse Event|0|||
156607350|NCT01125293|565303257|FG003|Overall Study|Adverse Event|0|||
156607351|NCT01125293|565303258|FG004|Overall Study|Adverse Event|2|||
156607352|NCT01125293|565303259|FG005|Overall Study|Adverse Event|8|||
156607353|NCT01125293|565303254|FG000|Overall Study|Symptomatic Deterioration|1|||
156607354|NCT01125293|565303255|FG001|Overall Study|Symptomatic Deterioration|0|||
156607355|NCT01125293|565303256|FG002|Overall Study|Symptomatic Deterioration|0|||
156607356|NCT01125293|565303257|FG003|Overall Study|Symptomatic Deterioration|0|||
156607357|NCT01125293|565303258|FG004|Overall Study|Symptomatic Deterioration|0|||
156607358|NCT01125293|565303259|FG005|Overall Study|Symptomatic Deterioration|0|||
156607359|NCT01125293|565303254|FG000|Overall Study|Death|0|||
156607360|NCT01125293|565303255|FG001|Overall Study|Death|0|||
156607361|NCT01125293|565303256|FG002|Overall Study|Death|0|||
156607362|NCT01125293|565303257|FG003|Overall Study|Death|0|||
156607363|NCT01125293|565303258|FG004|Overall Study|Death|1|||
156607364|NCT01125293|565303259|FG005|Overall Study|Death|0|||
156607365|NCT01125293|565303254|FG000|Overall Study|Withdrawal by Subject|0|||
156607366|NCT01125293|565303255|FG001|Overall Study|Withdrawal by Subject|0|||
156607367|NCT01125293|565303256|FG002|Overall Study|Withdrawal by Subject|0|||
156607368|NCT01125293|565303257|FG003|Overall Study|Withdrawal by Subject|0|||
156607369|NCT01125293|565303258|FG004|Overall Study|Withdrawal by Subject|2|||
156607370|NCT01125293|565303259|FG005|Overall Study|Withdrawal by Subject|1|||
156607371|NCT01125293|565303254|FG000|Overall Study|Physician Decision|0|||
156607372|NCT01125293|565303255|FG001|Overall Study|Physician Decision|0|||
156607373|NCT01125293|565303256|FG002|Overall Study|Physician Decision|0|||
156607374|NCT01125293|565303257|FG003|Overall Study|Physician Decision|0|||
156607375|NCT01125293|565303258|FG004|Overall Study|Physician Decision|0|||
156607376|NCT01125293|565303259|FG005|Overall Study|Physician Decision|2|||
156607377|NCT01270958|565303262|FG000|Overall Study|Lost to Follow-up|2|||
156607378|NCT01270958|565303262|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
156607379|NCT00260429|565303265|FG000|Overall Study|failure to follow appointments|1|||
156607380|NCT00260429|565303266|FG001|Overall Study|failure to follow appointments|0|||
156607381|NCT00260429|565303265|FG000|Overall Study|scheduled hand surgery|1|||
156607382|NCT00260429|565303266|FG001|Overall Study|scheduled hand surgery|0|||
156607383|NCT00659126|565303267|FG000|Overall Study|Adverse Event|2|||
156607384|NCT00659126|565303268|FG001|Overall Study|Adverse Event|2|||
156607385|NCT00659126|565303267|FG000|Overall Study|Screen failure|1|||
156607386|NCT00659126|565303268|FG001|Overall Study|Screen failure|1|||
156607387|NCT00659126|565303267|FG000|Overall Study|Technical problems with MRI|0|||
156607388|NCT00659126|565303268|FG001|Overall Study|Technical problems with MRI|1|||
156607389|NCT01142193|565303272|FG000|Overall Study|Adverse Event|12|||
156607390|NCT01142193|565303273|FG001|Overall Study|Adverse Event|4|||
156607391|NCT01142193|565303272|FG000|Overall Study|Lack of Efficacy|2|||
156607392|NCT01142193|565303273|FG001|Overall Study|Lack of Efficacy|1|||
156607393|NCT01142193|565303272|FG000|Overall Study|Physician Decision|1|||
156607394|NCT01142193|565303273|FG001|Overall Study|Physician Decision|1|||
156607395|NCT01142193|565303272|FG000|Overall Study|Withdrawal by Subject|4|||
156607396|NCT01142193|565303273|FG001|Overall Study|Withdrawal by Subject|3|||
156607397|NCT01142193|565303272|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
156607398|NCT01142193|565303273|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
156607399|NCT01142193|565303272|FG000|Overall Study|Other|1|||
156607400|NCT01142193|565303273|FG001|Overall Study|Other|2|||
156607401|NCT03136367|565303288|FG000|T1 Consultation|discontinued mistakenly included|2|||
156607402|NCT03136367|565303289|FG001|T1 Consultation|discontinued mistakenly included|6|||
156607403|NCT03136367|565303290|FG002|T1 Consultation|discontinued mistakenly included|1|||
156607404|NCT03136367|565303288|FG000|T1 Consultation|Discontinued other|0|||
156607405|NCT03136367|565303289|FG001|T1 Consultation|Discontinued other|1|||
156607406|NCT03136367|565303290|FG002|T1 Consultation|Discontinued other|0|||
156607407|NCT03136367|565303288|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
156607408|NCT03136367|565303289|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
156607409|NCT03136367|565303290|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
156607410|NCT03136367|565303288|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
156607411|NCT03136367|565303289|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
156607412|NCT03136367|565303290|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
156607413|NCT03136367|565303288|FG000|T2 Post-consultation|Discontinued other|0|||
156607414|NCT03136367|565303289|FG001|T2 Post-consultation|Discontinued other|2|||
156607415|NCT03136367|565303290|FG002|T2 Post-consultation|Discontinued other|6|||
156607416|NCT03136367|565303288|FG000|T2 Post-consultation|Discontinued transferred care|0|||
156607417|NCT03136367|565303289|FG001|T2 Post-consultation|Discontinued transferred care|0|||
156607418|NCT03136367|565303290|FG002|T2 Post-consultation|Discontinued transferred care|3|||
156607419|NCT03136367|565303288|FG000|T2 Post-consultation|Discontinued lost contact|0|||
156607420|NCT03136367|565303289|FG001|T2 Post-consultation|Discontinued lost contact|1|||
156607421|NCT03136367|565303290|FG002|T2 Post-consultation|Discontinued lost contact|0|||
156607422|NCT03136367|565303288|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
156607423|NCT03136367|565303289|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
156607424|NCT03136367|565303290|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
156607425|NCT03136367|565303288|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
156607426|NCT03136367|565303289|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
156607427|NCT03136367|565303290|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
156607428|NCT03136367|565303288|FG000|T3 1 Week After Surgery|other discontinued|2|||
156607429|NCT03136367|565303289|FG001|T3 1 Week After Surgery|other discontinued|4|||
156607430|NCT03136367|565303290|FG002|T3 1 Week After Surgery|other discontinued|3|||
156607431|NCT03136367|565303288|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
156607432|NCT03136367|565303289|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
156607433|NCT03136367|565303290|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
156607434|NCT03136367|565303288|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
156607435|NCT03136367|565303289|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
156607436|NCT03136367|565303290|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
156607437|NCT03136367|565303288|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
156607438|NCT03136367|565303289|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
156607439|NCT03136367|565303290|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
156607440|NCT03136367|565303288|FG000|T4 12 Weeks After Surgery|Death|0|||
156607441|NCT03136367|565303289|FG001|T4 12 Weeks After Surgery|Death|1|||
156607442|NCT03136367|565303290|FG002|T4 12 Weeks After Surgery|Death|3|||
156607443|NCT03136367|565303288|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
156607444|NCT03136367|565303289|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
156607445|NCT03136367|565303290|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
156607446|NCT03136367|565303288|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
156607447|NCT03136367|565303289|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
156607448|NCT03136367|565303290|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
156607449|NCT03136367|565303288|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
156607450|NCT03136367|565303289|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
156607451|NCT03136367|565303290|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
156607452|NCT03136367|565303288|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
156607453|NCT03136367|565303289|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
156607454|NCT03136367|565303290|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
156607455|NCT03136367|565303288|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
156607456|NCT03136367|565303289|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
156607457|NCT03136367|565303290|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
156607458|NCT03136367|565303288|FG000|T5 1 Year After Surgery|Death|0|||
156607459|NCT03136367|565303289|FG001|T5 1 Year After Surgery|Death|0|||
156607460|NCT03136367|565303290|FG002|T5 1 Year After Surgery|Death|1|||
156607461|NCT03136367|565303288|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
156607462|NCT03136367|565303289|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
156607463|NCT03136367|565303290|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
156607464|NCT03136367|565303288|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
156607465|NCT03136367|565303289|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
156607466|NCT03136367|565303290|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
156607467|NCT03136367|565303288|FG000|T5 1 Year After Surgery|study ended before due|31|||
156607468|NCT03136367|565303289|FG001|T5 1 Year After Surgery|study ended before due|103|||
156607469|NCT03136367|565303290|FG002|T5 1 Year After Surgery|study ended before due|110|||
156607470|NCT03136367|565303288|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
156607471|NCT03136367|565303289|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
156607472|NCT03136367|565303290|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
156607473|NCT02146833|565303294|FG000|Overall Study|Death|10|||
156607474|NCT02146833|565303294|FG000|Overall Study|No longer consented to study treatment|1|||
156607475|NCT03726333|565303295|FG000|Overall Study|Progressive Disease|0|||
156607476|NCT03726333|565303296|FG001|Overall Study|Progressive Disease|0|||
156607477|NCT03726333|565303297|FG002|Overall Study|Progressive Disease|1|||
156607478|NCT03726333|565303298|FG003|Overall Study|Progressive Disease|0|||
156607479|NCT03726333|565303299|FG004|Overall Study|Progressive Disease|0|||
156607480|NCT00446641|565305491|FG000|Overall Study|Withdrawal by Subject|8|||
156607481|NCT00446641|565305492|FG001|Overall Study|Withdrawal by Subject|3|||
156607482|NCT00446641|565305491|FG000|Overall Study|poor compliance|8|||
156607483|NCT00446641|565305492|FG001|Overall Study|poor compliance|6|||
156607484|NCT00446641|565305491|FG000|Overall Study|Lost to Follow-up|1|||
156607485|NCT00446641|565305492|FG001|Overall Study|Lost to Follow-up|1|||
156607486|NCT00405275|565305499|FG000|Overall Study|Death|1|||
156607487|NCT00405275|565305500|FG001|Overall Study|Death|0|||
156607488|NCT00405275|565305499|FG000|Overall Study|Lost to Follow-up|5|||
156607489|NCT00405275|565305500|FG001|Overall Study|Lost to Follow-up|1|||
156607490|NCT00405275|565305499|FG000|Overall Study|Withdrawal by Subject|7|||
156607491|NCT00405275|565305500|FG001|Overall Study|Withdrawal by Subject|9|||
156607492|NCT00405275|565305499|FG000|Overall Study|Unwilling to continue|10|||
156607493|NCT00405275|565305500|FG001|Overall Study|Unwilling to continue|9|||
156607494|NCT00088595|565305501|FG000|Overall Study|Adverse Event|11|||
156607495|NCT00088595|565305501|FG000|Overall Study|Withdrawal by Subject|8|||
156607496|NCT00088595|565305501|FG000|Overall Study|Ongoing (After Core)|7|||
156607497|NCT00088595|565305501|FG000|Overall Study|New Cancer Therapy|2|||
156607498|NCT01308853|565305512|FG000|Overall Study|Adverse Event|1|||
156607499|NCT01308853|565305512|FG000|Overall Study|Lost to Follow-up|2|||
156607500|NCT01308853|565305512|FG000|Overall Study|Insertion of permanent implants|1|||
156607501|NCT01376388|565305517|FG000|Overall Study|Adverse Event|13|||
156607502|NCT01376388|565305517|FG000|Overall Study|Lack of Efficacy|2|||
156607503|NCT01376388|565305517|FG000|Overall Study|Withdrawal by Subject|3|||
156607504|NCT02959970|565305525|FG000|Overall Study|Adverse Event|1|||
156607505|NCT02959970|565305526|FG001|Overall Study|Adverse Event|0|||
156607506|NCT02959970|565305525|FG000|Overall Study|Withdrawal by Subject|0|||
156607507|NCT02959970|565305526|FG001|Overall Study|Withdrawal by Subject|2|||
156607508|NCT02959970|565305525|FG000|Overall Study|Lost to Follow-up|1|||
156607509|NCT02959970|565305526|FG001|Overall Study|Lost to Follow-up|5|||
156607510|NCT01473355|565305531|FG000|Overall Study|Protocol Violation|2|||
156607511|NCT01473355|565305531|FG000|Overall Study|Adverse Event|2|||
156607512|NCT01473355|565305531|FG000|Overall Study|Lost to Follow-up|2|||
156607513|NCT02017704|565305533|FG000|Overall Study|Withdrawal by Subject|2|||
156607514|NCT02017704|565305534|FG001|Overall Study|Withdrawal by Subject|0|||
156607515|NCT00928512|565305535|FG000|Overall Study|Adverse Event|4|||
156607516|NCT00928512|565305536|FG001|Overall Study|Adverse Event|3|||
156607517|NCT00928512|565305537|FG002|Overall Study|Adverse Event|2|||
156607518|NCT00928512|565305538|FG003|Overall Study|Adverse Event|8|||
156607519|NCT00928512|565305539|FG004|Overall Study|Adverse Event|6|||
156607520|NCT00928512|565305535|FG000|Overall Study|Lack of Efficacy|2|||
156607521|NCT00928512|565305536|FG001|Overall Study|Lack of Efficacy|0|||
156607522|NCT00928512|565305537|FG002|Overall Study|Lack of Efficacy|4|||
156607523|NCT00928512|565305538|FG003|Overall Study|Lack of Efficacy|7|||
156607524|NCT00928512|565305539|FG004|Overall Study|Lack of Efficacy|3|||
156607525|NCT00928512|565305535|FG000|Overall Study|Protocol Violation|0|||
156607526|NCT00928512|565305536|FG001|Overall Study|Protocol Violation|1|||
156607527|NCT00928512|565305537|FG002|Overall Study|Protocol Violation|0|||
156607528|NCT00928512|565305538|FG003|Overall Study|Protocol Violation|1|||
156607529|NCT00928512|565305539|FG004|Overall Study|Protocol Violation|3|||
156607530|NCT00928512|565305535|FG000|Overall Study|Withdrawal by Subject|3|||
156607531|NCT00928512|565305536|FG001|Overall Study|Withdrawal by Subject|0|||
156607532|NCT00928512|565305537|FG002|Overall Study|Withdrawal by Subject|3|||
156607533|NCT00928512|565305538|FG003|Overall Study|Withdrawal by Subject|4|||
156607534|NCT00928512|565305539|FG004|Overall Study|Withdrawal by Subject|0|||
156607535|NCT00928512|565305535|FG000|Overall Study|Lost to Follow-up|1|||
156607536|NCT00928512|565305536|FG001|Overall Study|Lost to Follow-up|1|||
156607537|NCT00928512|565305537|FG002|Overall Study|Lost to Follow-up|2|||
156607538|NCT00928512|565305538|FG003|Overall Study|Lost to Follow-up|1|||
156607539|NCT00928512|565305539|FG004|Overall Study|Lost to Follow-up|3|||
156607540|NCT00928512|565305535|FG000|Overall Study|Administrative Problems|0|||
156607541|NCT00928512|565305536|FG001|Overall Study|Administrative Problems|1|||
156607542|NCT00928512|565305537|FG002|Overall Study|Administrative Problems|0|||
156607543|NCT00928512|565305538|FG003|Overall Study|Administrative Problems|0|||
156607544|NCT00928512|565305539|FG004|Overall Study|Administrative Problems|0|||
156607545|NCT01749800|565305542|FG000|Overall Study|not meeting inclusion criteria|3|||
156607546|NCT01749800|565305543|FG001|Overall Study|not meeting inclusion criteria|0|||
156607547|NCT01749800|565305544|FG002|Overall Study|not meeting inclusion criteria|0|||
156607548|NCT01749800|565305542|FG000|Overall Study|Withdrawal by Subject|0|||
156607549|NCT01749800|565305543|FG001|Overall Study|Withdrawal by Subject|1|||
156607550|NCT01749800|565305544|FG002|Overall Study|Withdrawal by Subject|0|||
156607551|NCT01296698|565305545|FG000|Overall Study|Adverse Event|1|||
156607552|NCT01296698|565305546|FG001|Overall Study|Adverse Event|0|||
156607553|NCT01296698|565305545|FG000|Overall Study|Death|1|||
156607554|NCT01296698|565305546|FG001|Overall Study|Death|0|||
156607555|NCT01296698|565305545|FG000|Overall Study|Lost to Follow-up|19|||
156607556|NCT01296698|565305546|FG001|Overall Study|Lost to Follow-up|1|||
156607557|NCT01296698|565305545|FG000|Overall Study|Withdrawal by Subject|12|||
156607558|NCT01296698|565305546|FG001|Overall Study|Withdrawal by Subject|0|||
156607559|NCT01296698|565305545|FG000|Overall Study|Difficulty Contacting Subject|2|||
156607560|NCT01296698|565305546|FG001|Overall Study|Difficulty Contacting Subject|0|||
156607561|NCT01296698|565305545|FG000|Overall Study|Study Terminated by Sponsor|209|||
156607562|NCT01296698|565305546|FG001|Overall Study|Study Terminated by Sponsor|12|||
156607563|NCT01975675|565305553|FG000|Overall Study|Death|0|||
156607564|NCT01975675|565305554|FG001|Overall Study|Death|1|||
156607565|NCT01975675|565305555|FG002|Overall Study|Death|0|||
156607566|NCT01975675|565305556|FG003|Overall Study|Death|0|||
156607567|NCT00224003|565305557|FG000|Overall Study|Adverse Event|1|||
156607568|NCT00224003|565305557|FG000|Overall Study|Protocol Violation|2|||
156607569|NCT00224003|565305557|FG000|Overall Study|Withdrawal by Subject|1|||
156607570|NCT00224003|565305557|FG000|Overall Study|unk|3|||
156607571|NCT03639987|565305558|FG000|Overall Study|Study terminated by sponsor|26|||
156607572|NCT03639987|565305559|FG001|Overall Study|Study terminated by sponsor|25|||
156607573|NCT03639987|565305558|FG000|Overall Study|Lost to Follow-up|0|||
156607574|NCT03639987|565305559|FG001|Overall Study|Lost to Follow-up|1|||
156607575|NCT03549429|565305560|FG000|Overall Study|Protocol Violation|5|||
156607576|NCT03549429|565305561|FG001|Overall Study|Protocol Violation|3|||
156607577|NCT00729326|565305568|FG000|Overall Study|Lost to Follow-up|2|||
156607578|NCT00729326|565305569|FG001|Overall Study|Lost to Follow-up|0|||
156607579|NCT00729326|565305568|FG000|Overall Study|Physician Decision|0|||
156607580|NCT00729326|565305569|FG001|Overall Study|Physician Decision|1|||
156607581|NCT00729326|565305568|FG000|Overall Study|Protocol Violation|3|||
156607582|NCT00729326|565305569|FG001|Overall Study|Protocol Violation|2|||
156607583|NCT00729326|565305568|FG000|Overall Study|Subject Decision|4|||
156607584|NCT00729326|565305569|FG001|Overall Study|Subject Decision|4|||
156607585|NCT00729326|565305568|FG000|Overall Study|Sponsor Decision|1|||
156607586|NCT00729326|565305569|FG001|Overall Study|Sponsor Decision|2|||
156607587|NCT01235728|565305573|FG000|Overall Study|Protocol Violation|0|||
156607588|NCT01235728|565305574|FG001|Overall Study|Protocol Violation|0|||
156607589|NCT01235728|565305575|FG002|Overall Study|Protocol Violation|0|||
156607590|NCT01235728|565305576|FG003|Overall Study|Protocol Violation|1|||
156607591|NCT01235728|565305577|FG004|Overall Study|Protocol Violation|0|||
156607592|NCT01235728|565305578|FG005|Overall Study|Protocol Violation|0|||
156607593|NCT01235728|565305579|FG006|Overall Study|Protocol Violation|0|||
156607594|NCT01235728|565305580|FG007|Overall Study|Protocol Violation|0|||
156607595|NCT01000025|565305581|FG000|Overall Study|Adverse Event|43|||
156607596|NCT01000025|565305582|FG001|Overall Study|Adverse Event|2|||
156607597|NCT01000025|565305581|FG000|Overall Study|Withdrawal by Subject|13|||
156607598|NCT01000025|565305582|FG001|Overall Study|Withdrawal by Subject|8|||
156607599|NCT01000025|565305581|FG000|Overall Study|Death|23|||
156607600|NCT01000025|565305582|FG001|Overall Study|Death|13|||
156607601|NCT01000025|565305581|FG000|Overall Study|Lack of Efficacy|363|||
156607602|NCT01000025|565305582|FG001|Overall Study|Lack of Efficacy|208|||
156607603|NCT01000025|565305581|FG000|Overall Study|Intercurrent Illness|26|||
156607604|NCT01000025|565305582|FG001|Overall Study|Intercurrent Illness|7|||
156607605|NCT04423757|565305583|FG000|Overall Study|Adverse Event|2|||
156607606|NCT04423757|565305584|FG001|Overall Study|Adverse Event|0|||
156607607|NCT04423757|565305583|FG000|Overall Study|Not treated|1|||
156607608|NCT04423757|565305584|FG001|Overall Study|Not treated|1|||
156607609|NCT02738580|565305585|FG000|Overall Study|Adverse Event|1|||
156607610|NCT02738580|565305586|FG001|Overall Study|Adverse Event|0|||
156607611|NCT02738580|565305585|FG000|Overall Study|Lack of Efficacy|3|||
156607612|NCT02738580|565305586|FG001|Overall Study|Lack of Efficacy|2|||
156607613|NCT02738580|565305585|FG000|Overall Study|Withdrawal by Subject|0|||
156607614|NCT02738580|565305586|FG001|Overall Study|Withdrawal by Subject|1|||
156607615|NCT02738580|565305585|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
156635004|NCT03917654|565407820|FG005|Year 2|Married|0|||
156607616|NCT02738580|565305586|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
156607617|NCT04354155|565305587|FG000|Overall Study|Withdrawal by Subject|1|||
156607618|NCT04354155|565305587|FG000|Overall Study|Did not meet criteria for study intervention|1|||
156607619|NCT03199638|565305592|FG000|Overall Study|inability to drink glutamine during regularly|0|||
156607620|NCT03199638|565305593|FG001|Overall Study|inability to drink glutamine during regularly|2|||
156607621|NCT01575899|565305594|FG000|Overall Study|Lost to Follow-up|3|||
156607622|NCT01575899|565305595|FG001|Overall Study|Lost to Follow-up|4|||
156607623|NCT01575899|565305596|FG002|Overall Study|Lost to Follow-up|2|||
156607624|NCT01575899|565305594|FG000|Overall Study|Protocol Violation|2|||
156607625|NCT01575899|565305595|FG001|Overall Study|Protocol Violation|1|||
156607626|NCT01575899|565305596|FG002|Overall Study|Protocol Violation|0|||
156607627|NCT03097029|565305597|FG000|Overall Study|Withdrawal by Subject|1|||
156607628|NCT02807844|565305598|FG000|Overall Study|Physician Decision|0|||
156607629|NCT02807844|565305599|FG001|Overall Study|Physician Decision|0|||
156607630|NCT02807844|565305600|FG002|Overall Study|Physician Decision|0|||
156607631|NCT02807844|565305601|FG003|Overall Study|Physician Decision|0|||
156607632|NCT02807844|565305602|FG004|Overall Study|Physician Decision|0|||
156607633|NCT02807844|565305603|FG005|Overall Study|Physician Decision|0|||
156607634|NCT02807844|565305604|FG006|Overall Study|Physician Decision|3|||
156607635|NCT02807844|565305605|FG007|Overall Study|Physician Decision|0|||
156607636|NCT02807844|565305606|FG008|Overall Study|Physician Decision|1|||
156607637|NCT02807844|565305607|FG009|Overall Study|Physician Decision|2|||
156607638|NCT02807844|565305598|FG000|Overall Study|Death|0|||
156607639|NCT02807844|565305599|FG001|Overall Study|Death|0|||
156607640|NCT02807844|565305600|FG002|Overall Study|Death|2|||
156607641|NCT02807844|565305601|FG003|Overall Study|Death|4|||
156607642|NCT02807844|565305602|FG004|Overall Study|Death|1|||
156607643|NCT02807844|565305603|FG005|Overall Study|Death|2|||
156607644|NCT02807844|565305604|FG006|Overall Study|Death|1|||
156607645|NCT02807844|565305605|FG007|Overall Study|Death|2|||
156607646|NCT02807844|565305606|FG008|Overall Study|Death|0|||
156607647|NCT02807844|565305607|FG009|Overall Study|Death|1|||
156607648|NCT02807844|565305598|FG000|Overall Study|Withdrawal by Subject|0|||
156607649|NCT02807844|565305599|FG001|Overall Study|Withdrawal by Subject|0|||
156607650|NCT02807844|565305600|FG002|Overall Study|Withdrawal by Subject|2|||
156607651|NCT02807844|565305601|FG003|Overall Study|Withdrawal by Subject|1|||
156607652|NCT02807844|565305602|FG004|Overall Study|Withdrawal by Subject|1|||
156607653|NCT02807844|565305603|FG005|Overall Study|Withdrawal by Subject|0|||
156607654|NCT02807844|565305604|FG006|Overall Study|Withdrawal by Subject|1|||
156607655|NCT02807844|565305605|FG007|Overall Study|Withdrawal by Subject|0|||
156607656|NCT02807844|565305606|FG008|Overall Study|Withdrawal by Subject|0|||
156607657|NCT02807844|565305607|FG009|Overall Study|Withdrawal by Subject|0|||
156607658|NCT02807844|565305598|FG000|Overall Study|Progressive disease|5|||
156607659|NCT02807844|565305599|FG001|Overall Study|Progressive disease|12|||
156607660|NCT02807844|565305600|FG002|Overall Study|Progressive disease|8|||
156607661|NCT02807844|565305601|FG003|Overall Study|Progressive disease|8|||
156607662|NCT02807844|565305602|FG004|Overall Study|Progressive disease|3|||
156607663|NCT02807844|565305603|FG005|Overall Study|Progressive disease|8|||
156607664|NCT02807844|565305604|FG006|Overall Study|Progressive disease|14|||
156607665|NCT02807844|565305605|FG007|Overall Study|Progressive disease|17|||
156607666|NCT02807844|565305606|FG008|Overall Study|Progressive disease|19|||
156607667|NCT02807844|565305607|FG009|Overall Study|Progressive disease|15|||
156607668|NCT02807844|565305598|FG000|Overall Study|Adverse Event|1|||
156607669|NCT02807844|565305599|FG001|Overall Study|Adverse Event|0|||
156607670|NCT02807844|565305600|FG002|Overall Study|Adverse Event|0|||
156607671|NCT02807844|565305601|FG003|Overall Study|Adverse Event|0|||
156607672|NCT02807844|565305602|FG004|Overall Study|Adverse Event|1|||
156607673|NCT02807844|565305603|FG005|Overall Study|Adverse Event|1|||
156607674|NCT02807844|565305604|FG006|Overall Study|Adverse Event|1|||
156607675|NCT02807844|565305605|FG007|Overall Study|Adverse Event|1|||
156607676|NCT02807844|565305606|FG008|Overall Study|Adverse Event|1|||
156607677|NCT02807844|565305607|FG009|Overall Study|Adverse Event|2|||
156607678|NCT00709124|565305608|FG000|Overall Study|Death|3|||
156607679|NCT00709124|565305609|FG001|Overall Study|Death|1|||
156607680|NCT00709124|565305608|FG000|Overall Study|encephalopathy; can't do assessment|1|||
156607681|NCT00709124|565305609|FG001|Overall Study|encephalopathy; can't do assessment|0|||
156607682|NCT00373490|565305610|FG000|Overall Study|Adverse Event|0|||
156607683|NCT00373490|565305611|FG001|Overall Study|Adverse Event|1|||
156607684|NCT00373490|565305610|FG000|Overall Study|Lack of Efficacy|9|||
156607685|NCT00373490|565305611|FG001|Overall Study|Lack of Efficacy|4|||
156607686|NCT00373490|565305610|FG000|Overall Study|Withdrawal by Subject|0|||
156607687|NCT00373490|565305611|FG001|Overall Study|Withdrawal by Subject|1|||
156607688|NCT00108953|565305618|FG000|Follow-up|Death|18|||
156607689|NCT00108953|565305619|FG001|Follow-up|Death|26|||
156607690|NCT00108953|565305618|FG000|Follow-up|Lost to Follow-up|1|||
156607691|NCT00108953|565305619|FG001|Follow-up|Lost to Follow-up|1|||
156607692|NCT00108953|565305618|FG000|Follow-up|Study terminated by sponsor|10|||
156607693|NCT00108953|565305619|FG001|Follow-up|Study terminated by sponsor|6|||
156607694|NCT00753688|565305620|FG000|Overall Study|Death|102|||
156607695|NCT00753688|565305621|FG001|Overall Study|Death|203|||
156607696|NCT00753688|565305620|FG000|Overall Study|Missing|4|||
156607697|NCT00753688|565305621|FG001|Overall Study|Missing|9|||
156607698|NCT00753688|565305620|FG000|Overall Study|Participant Withdrew Consent|2|||
156607699|NCT00753688|565305621|FG001|Overall Study|Participant Withdrew Consent|2|||
156607700|NCT00753688|565305620|FG000|Overall Study|Ongoing - in Follow-up|15|||
156607701|NCT00753688|565305621|FG001|Overall Study|Ongoing - in Follow-up|31|||
156607702|NCT00753688|565305620|FG000|Overall Study|Adverse Event|0|||
156607703|NCT00753688|565305621|FG001|Overall Study|Adverse Event|1|||
156607704|NCT02228564|565305622|FG000|Overall Study|Withdrawal by Subject|10|||
156607705|NCT02228564|565305622|FG000|Overall Study|Death|11|||
156607706|NCT02228564|565305622|FG000|Overall Study|Physician Decision|5|||
156607707|NCT02228564|565305622|FG000|Overall Study|Lost to Follow-up|17|||
156607708|NCT02228564|565305622|FG000|Overall Study|Other|6|||
156607709|NCT02633046|565305628|FG000|Overall Study|Adverse Event|8|||
156607710|NCT02633046|565305628|FG000|Overall Study|Physician Decision|7|||
156607711|NCT02633046|565305628|FG000|Overall Study|Withdrawal by Subject|8|||
156607712|NCT02633046|565305628|FG000|Overall Study|Increased proteinuria|2|||
156607713|NCT02633046|565305628|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
156607714|NCT02633046|565305628|FG000|Overall Study|Mutual decision patient and physician|1|||
156607715|NCT02142504|565305629|FG000|Overall Study|Protocol Violation|2|||
156607716|NCT02142504|565305630|FG001|Overall Study|Protocol Violation|1|||
156607717|NCT02142504|565305631|FG002|Overall Study|Protocol Violation|2|||
156607718|NCT02142504|565305629|FG000|Overall Study|Adverse Event|2|||
156607719|NCT02142504|565305630|FG001|Overall Study|Adverse Event|3|||
156607720|NCT02142504|565305631|FG002|Overall Study|Adverse Event|4|||
156607721|NCT02142504|565305629|FG000|Overall Study|Lost to Follow-up|12|||
156607722|NCT02142504|565305630|FG001|Overall Study|Lost to Follow-up|19|||
156607723|NCT02142504|565305631|FG002|Overall Study|Lost to Follow-up|17|||
156607724|NCT02142504|565305629|FG000|Overall Study|Withdrawal by Subject|7|||
156607725|NCT02142504|565305630|FG001|Overall Study|Withdrawal by Subject|9|||
156607726|NCT02142504|565305631|FG002|Overall Study|Withdrawal by Subject|11|||
156607727|NCT02142504|565305629|FG000|Overall Study|Pregnancy|4|||
156607728|NCT02142504|565305630|FG001|Overall Study|Pregnancy|4|||
156607729|NCT02142504|565305631|FG002|Overall Study|Pregnancy|2|||
156607730|NCT02142504|565305629|FG000|Overall Study|Physician Decision|0|||
156607731|NCT02142504|565305630|FG001|Overall Study|Physician Decision|1|||
156607732|NCT02142504|565305631|FG002|Overall Study|Physician Decision|3|||
156607733|NCT02142504|565305629|FG000|Overall Study|Reason Not Specified|4|||
156607734|NCT02142504|565305630|FG001|Overall Study|Reason Not Specified|5|||
156607735|NCT02142504|565305631|FG002|Overall Study|Reason Not Specified|4|||
156607736|NCT01998399|565305638|FG000|Overall Study|Lost to Follow-up|1|||
156607737|NCT01998399|565305639|FG001|Overall Study|Lost to Follow-up|3|||
156607738|NCT01998399|565305638|FG000|Overall Study|Death|4|||
156607739|NCT01998399|565305639|FG001|Overall Study|Death|2|||
156607740|NCT01998399|565305638|FG000|Overall Study|Study stopped before dosing completed|3|||
156607741|NCT01998399|565305639|FG001|Overall Study|Study stopped before dosing completed|3|||
156607742|NCT01998399|565305638|FG000|Overall Study|Withdrawal by Subject|0|||
156607743|NCT01998399|565305639|FG001|Overall Study|Withdrawal by Subject|1|||
156607744|NCT00617591|565305640|FG000|Overall Study|Withdrew consent during Induction|4|||
156607745|NCT00617591|565305640|FG000|Overall Study|Withdrew consent during Maintenance|6|||
156607746|NCT04114539|565305642|FG000|Overall Study|Adverse Event|14|||
156607747|NCT04114539|565305642|FG000|Overall Study|Lost to Follow-up|2|||
156607748|NCT04114539|565305642|FG000|Overall Study|Non-compliance with Protocol|2|||
156607749|NCT04114539|565305642|FG000|Overall Study|Non-compliance with Study Drug|1|||
156607750|NCT04114539|565305642|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
156607751|NCT04114539|565305642|FG000|Overall Study|Withdrew consent|10|||
156607752|NCT04114539|565305642|FG000|Overall Study|Others not specified|5|||
156607753|NCT04114539|565305642|FG000|Overall Study|Investigator Decision|2|||
156607754|NCT01455415|565305643|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
156607755|NCT01455415|565305644|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
156607756|NCT01455415|565305643|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
156607757|NCT01455415|565305644|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
156607758|NCT01455415|565305643|FG000|Period 1|Drug Error not Associated to AE|0|||
156607759|NCT01455415|565305644|FG001|Period 1|Drug Error not Associated to AE|1|||
156607760|NCT01455415|565305643|FG000|Period 1|AE Not Related to Study Drug|2|||
156607761|NCT01455415|565305644|FG001|Period 1|AE Not Related to Study Drug|6|||
156607762|NCT01455415|565305643|FG000|Period 1|Withdrawal by Subject|4|||
156607763|NCT01455415|565305644|FG001|Period 1|Withdrawal by Subject|5|||
156607764|NCT01455415|565305643|FG000|Period 1|Unspecified Reason|1|||
156607765|NCT01455415|565305644|FG001|Period 1|Unspecified Reason|1|||
156607766|NCT01455415|565305643|FG000|Period 1|Protocol Violation|0|||
156607767|NCT01455415|565305644|FG001|Period 1|Protocol Violation|2|||
156607768|NCT01455415|565305643|FG000|Washout|AE Related to Study Drug|2|||
156607769|NCT01455415|565305644|FG001|Washout|AE Related to Study Drug|0|||
156607770|NCT01455415|565305643|FG000|Washout|Lost to Follow-up|1|||
156607771|NCT01455415|565305644|FG001|Washout|Lost to Follow-up|0|||
156607772|NCT01455415|565305643|FG000|Washout|Drug Error not Associated to AE|2|||
156635005|NCT03917654|565407821|FG006|Year 2|Married|1|||
156607773|NCT01455415|565305644|FG001|Washout|Drug Error not Associated to AE|1|||
156607774|NCT01455415|565305643|FG000|Washout|AE Not Related to Study Drug|2|||
156607775|NCT01455415|565305644|FG001|Washout|AE Not Related to Study Drug|3|||
156607776|NCT01455415|565305643|FG000|Washout|Unspecified Reason|1|||
156607777|NCT01455415|565305644|FG001|Washout|Unspecified Reason|2|||
156607778|NCT01455415|565305643|FG000|Washout|Protocol Violation|0|||
156607779|NCT01455415|565305644|FG001|Washout|Protocol Violation|1|||
156607780|NCT01455415|565305643|FG000|Period 2|AE Related to Study Drug|1|||
156607781|NCT01455415|565305644|FG001|Period 2|AE Related to Study Drug|2|||
156607782|NCT01455415|565305643|FG000|Period 2|Lost to Follow-up|2|||
156607783|NCT01455415|565305644|FG001|Period 2|Lost to Follow-up|1|||
156607784|NCT01455415|565305643|FG000|Period 2|AE Not Related to Study Drug|2|||
156607785|NCT01455415|565305644|FG001|Period 2|AE Not Related to Study Drug|1|||
156607786|NCT01455415|565305643|FG000|Period 2|Lack of Efficacy|2|||
156607787|NCT01455415|565305644|FG001|Period 2|Lack of Efficacy|0|||
156607788|NCT01455415|565305643|FG000|Period 2|Withdrawal by Subject|2|||
156607789|NCT01455415|565305644|FG001|Period 2|Withdrawal by Subject|3|||
156607790|NCT01455415|565305643|FG000|Period 2|Unspecified Reason|2|||
156607791|NCT01455415|565305644|FG001|Period 2|Unspecified Reason|3|||
156607792|NCT01455415|565305643|FG000|Period 2|Protocol Violation|2|||
156607793|NCT01455415|565305644|FG001|Period 2|Protocol Violation|0|||
156607794|NCT01455415|565305643|FG000|Follow-up|AE Related to Study Drug|0|||
156607795|NCT01455415|565305644|FG001|Follow-up|AE Related to Study Drug|1|||
156607796|NCT01455415|565305643|FG000|Follow-up|Lack of Efficacy|0|||
156607797|NCT01455415|565305644|FG001|Follow-up|Lack of Efficacy|1|||
156607798|NCT01455415|565305643|FG000|Follow-up|Withdrawal by Subject|2|||
156607799|NCT01455415|565305644|FG001|Follow-up|Withdrawal by Subject|0|||
156607800|NCT01455415|565305643|FG000|Follow-up|Unspecified Reason|1|||
156607801|NCT01455415|565305644|FG001|Follow-up|Unspecified Reason|0|||
156607802|NCT00719537|565305645|FG000|Overall Study|Withdrawal by Subject|1|||
156607803|NCT00719537|565305646|FG001|Overall Study|Withdrawal by Subject|0|||
156607804|NCT00719537|565305645|FG000|Overall Study|Lost to Follow-up|0|||
156607805|NCT00719537|565305646|FG001|Overall Study|Lost to Follow-up|1|||
156607806|NCT02460978|565305647|FG000|Overall Study|Adverse Event|17|||
156607807|NCT02460978|565305648|FG001|Overall Study|Adverse Event|11|||
156607808|NCT02460978|565305649|FG002|Overall Study|Adverse Event|11|||
156607809|NCT02460978|565305647|FG000|Overall Study|Withdrawal by Subject|5|||
156607810|NCT02460978|565305648|FG001|Overall Study|Withdrawal by Subject|5|||
156607811|NCT02460978|565305649|FG002|Overall Study|Withdrawal by Subject|14|||
156607812|NCT02460978|565305647|FG000|Overall Study|Lost to Follow-up|2|||
156607813|NCT02460978|565305648|FG001|Overall Study|Lost to Follow-up|3|||
156607814|NCT02460978|565305649|FG002|Overall Study|Lost to Follow-up|1|||
156607815|NCT02460978|565305647|FG000|Overall Study|Protocol Violation|1|||
156607816|NCT02460978|565305648|FG001|Overall Study|Protocol Violation|1|||
156607817|NCT02460978|565305649|FG002|Overall Study|Protocol Violation|1|||
156607818|NCT02460978|565305647|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
156607819|NCT02460978|565305648|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
156607820|NCT02460978|565305649|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
156607821|NCT02460978|565305647|FG000|Overall Study|Pregnancy|0|||
156607822|NCT02460978|565305648|FG001|Overall Study|Pregnancy|0|||
156607823|NCT02460978|565305649|FG002|Overall Study|Pregnancy|2|||
156607824|NCT00588523|565305655|FG000|Overall Study|Not treated|3|||
156607825|NCT01459068|565305658|FG000|Overall Study|Withdrawal by Subject|8|||
156607826|NCT01459068|565305659|FG001|Overall Study|Withdrawal by Subject|18|||
156607827|NCT01459068|565305658|FG000|Overall Study|Lost to Follow-up|31|||
156607828|NCT01459068|565305659|FG001|Overall Study|Lost to Follow-up|15|||
156607829|NCT01459068|565305658|FG000|Overall Study|Death|0|||
156607830|NCT01459068|565305659|FG001|Overall Study|Death|1|||
156607831|NCT02023112|565305662|FG000|Overall Study|Withdrawal by Subject|2|||
156607832|NCT02023112|565305663|FG001|Overall Study|Withdrawal by Subject|1|||
156607833|NCT01425749|565305664|FG000|Overall Study|progression of melanoma|0|||
156607834|NCT01425749|565305665|FG001|Overall Study|progression of melanoma|1|||
156607835|NCT02910219|565305666|FG000|Overall Study|Withdrawal by Subject|1|||
156607836|NCT02910219|565305667|FG001|Overall Study|Withdrawal by Subject|1|||
156607837|NCT02096042|565305668|FG000|Overall Study|Disease Progression|1|||
156607838|NCT02096042|565305669|FG001|Overall Study|Disease Progression|0|||
156607839|NCT02096042|565305670|FG002|Overall Study|Disease Progression|0|||
156607840|NCT00701441|565305674|FG000|Overall Study|failure in cpap compliance|0|||
156607841|NCT00701441|565305675|FG001|Overall Study|failure in cpap compliance|4|||
156607842|NCT01225172|565305680|FG000|Overall Study|Subject decision to stop|1|||
156607843|NCT01225172|565305681|FG001|Overall Study|Subject decision to stop|0|||
156607844|NCT01225172|565305680|FG000|Overall Study|Subject request to discontinue treatment|3|||
156607845|NCT01225172|565305681|FG001|Overall Study|Subject request to discontinue treatment|1|||
156607846|NCT01225172|565305680|FG000|Overall Study|Subject no longer meets study criteria|1|||
156607847|NCT01225172|565305681|FG001|Overall Study|Subject no longer meets study criteria|0|||
156607848|NCT01225172|565305680|FG000|Overall Study|Withdrawal by Subject|1|||
156607849|NCT01225172|565305681|FG001|Overall Study|Withdrawal by Subject|0|||
156607850|NCT01068717|565305682|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
156607851|NCT01068717|565305683|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
156607852|NCT01068717|565305684|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
156607853|NCT01068717|565305685|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
156607854|NCT01822223|565305686|FG000|Overall Study|Death|0|||
156607855|NCT01822223|565305687|FG001|Overall Study|Death|1|||
156607856|NCT02679781|565305690|FG000|Overall Study|Lost to Follow-up|1|||
156607857|NCT02679781|565305691|FG001|Overall Study|Lost to Follow-up|2|||
156607858|NCT02679781|565305690|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
156607859|NCT02679781|565305691|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
156607860|NCT04209400|565305692|FG000|Overall Study|Withdrawal by Subject|0|||
156607861|NCT04209400|565305693|FG001|Overall Study|Withdrawal by Subject|1|||
156607862|NCT03700736|565305698|FG000|Overall Study|Pregnancy|1|||
156607863|NCT03700736|565305699|FG001|Overall Study|Pregnancy|1|||
156607864|NCT03700736|565305698|FG000|Overall Study|Withdrawal by Subject|2|||
156607865|NCT03700736|565305699|FG001|Overall Study|Withdrawal by Subject|6|||
156607866|NCT01696396|565307770|FG000|Overall Study|Withdrawal by Subject|19|||
156607867|NCT01696396|565307771|FG001|Overall Study|Withdrawal by Subject|5|||
156607868|NCT01696396|565307772|FG002|Overall Study|Withdrawal by Subject|19|||
156607869|NCT01696396|565307773|FG003|Overall Study|Withdrawal by Subject|11|||
156607870|NCT01696396|565307770|FG000|Overall Study|Decision by Sponsor|3|||
156607871|NCT01696396|565307771|FG001|Overall Study|Decision by Sponsor|1|||
156607872|NCT01696396|565307772|FG002|Overall Study|Decision by Sponsor|2|||
156607873|NCT01696396|565307773|FG003|Overall Study|Decision by Sponsor|2|||
156607874|NCT01696396|565307770|FG000|Overall Study|Lost to Follow-up|9|||
156607875|NCT01696396|565307771|FG001|Overall Study|Lost to Follow-up|1|||
156607876|NCT01696396|565307772|FG002|Overall Study|Lost to Follow-up|4|||
156607877|NCT01696396|565307773|FG003|Overall Study|Lost to Follow-up|1|||
156607878|NCT01696396|565307770|FG000|Overall Study|Death|0|||
156607879|NCT01696396|565307771|FG001|Overall Study|Death|0|||
156607880|NCT01696396|565307772|FG002|Overall Study|Death|1|||
156607881|NCT01696396|565307773|FG003|Overall Study|Death|0|||
156607882|NCT00880100|565307778|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
156607883|NCT00880100|565307778|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
156607884|NCT00880100|565307778|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
156607885|NCT03424044|565307779|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
156607886|NCT03424044|565307780|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
156607887|NCT03424044|565307781|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
156607888|NCT03424044|565307782|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
156607889|NCT03424044|565307783|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
156607890|NCT03424044|565307784|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
156607891|NCT03424044|565307785|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
156607892|NCT03424044|565307786|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
156607893|NCT03424044|565307787|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
156607894|NCT03424044|565307779|FG000|First Intervention (76 Hours)|Adverse Event|0|||
156607895|NCT03424044|565307780|FG001|First Intervention (76 Hours)|Adverse Event|0|||
156607896|NCT03424044|565307781|FG002|First Intervention (76 Hours)|Adverse Event|0|||
156607897|NCT03424044|565307782|FG003|First Intervention (76 Hours)|Adverse Event|0|||
156607898|NCT03424044|565307783|FG004|First Intervention (76 Hours)|Adverse Event|1|||
156607899|NCT03424044|565307784|FG005|First Intervention (76 Hours)|Adverse Event|0|||
156607900|NCT03424044|565307785|FG006|First Intervention (76 Hours)|Adverse Event|0|||
156607901|NCT03424044|565307786|FG007|First Intervention (76 Hours)|Adverse Event|0|||
156607902|NCT03424044|565307787|FG008|First Intervention (76 Hours)|Adverse Event|0|||
156607903|NCT03424044|565307779|FG000|First Intervention (76 Hours)|device issues|0|||
156607904|NCT03424044|565307780|FG001|First Intervention (76 Hours)|device issues|0|||
156607905|NCT03424044|565307781|FG002|First Intervention (76 Hours)|device issues|0|||
156607906|NCT03424044|565307782|FG003|First Intervention (76 Hours)|device issues|0|||
156607907|NCT03424044|565307783|FG004|First Intervention (76 Hours)|device issues|0|||
156607908|NCT03424044|565307784|FG005|First Intervention (76 Hours)|device issues|0|||
156607909|NCT03424044|565307785|FG006|First Intervention (76 Hours)|device issues|1|||
156607910|NCT03424044|565307786|FG007|First Intervention (76 Hours)|device issues|1|||
156607911|NCT03424044|565307787|FG008|First Intervention (76 Hours)|device issues|1|||
156607912|NCT03424044|565307779|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
156607913|NCT03424044|565307780|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
156607914|NCT03424044|565307781|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
156607915|NCT03424044|565307782|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
156607916|NCT03424044|565307783|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
156607917|NCT03424044|565307784|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
156635006|NCT03917654|565407822|FG007|Year 2|Married|1|||
156607918|NCT03424044|565307785|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
156607919|NCT03424044|565307786|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
156607920|NCT03424044|565307787|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
156607921|NCT03424044|565307779|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
156607922|NCT03424044|565307780|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
156607923|NCT03424044|565307781|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
156607924|NCT03424044|565307782|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
156607925|NCT03424044|565307783|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
156607926|NCT03424044|565307784|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
156607927|NCT03424044|565307785|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
156607928|NCT03424044|565307786|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
156607929|NCT03424044|565307787|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
156607930|NCT04402385|565307791|FG000|Overall Study|Withdrawal by Subject|4|||
156607931|NCT04402385|565307792|FG001|Overall Study|Withdrawal by Subject|4|||
156607932|NCT04402385|565307791|FG000|Overall Study|Lost to Follow-up|1|||
156607933|NCT04402385|565307792|FG001|Overall Study|Lost to Follow-up|1|||
156607934|NCT04402385|565307791|FG000|Overall Study|Physician Decision|0|||
156607935|NCT04402385|565307792|FG001|Overall Study|Physician Decision|1|||
156607936|NCT00731666|565307793|FG000|Overall Study|Adverse Event|2|||
156607937|NCT00731666|565307793|FG000|Overall Study|Lost to Follow-up|8|||
156607938|NCT00731666|565307793|FG000|Overall Study|Withdrawal by Subject|2|||
156607939|NCT00106249|565307794|FG000|Overall Study|Lost to Follow-up|3|||
156607940|NCT00106249|565307795|FG001|Overall Study|Lost to Follow-up|2|||
156607941|NCT00114218|565307810|FG000|Overall Study|Wrong Cell Type|2|||
156607942|NCT00114218|565307810|FG000|Overall Study|Wrong Primary|1|||
156607943|NCT00114218|565307810|FG000|Overall Study|Never Treated|1|||
156607944|NCT01505114|565307811|FG000|Overall Study|Withdrawal by Subject|5|||
156607945|NCT01505114|565307812|FG001|Overall Study|Withdrawal by Subject|4|||
156607946|NCT01505114|565307813|FG002|Overall Study|Withdrawal by Subject|4|||
156607947|NCT01505114|565307814|FG003|Overall Study|Withdrawal by Subject|7|||
156607948|NCT01505114|565307811|FG000|Overall Study|Death|1|||
156607949|NCT01505114|565307812|FG001|Overall Study|Death|0|||
156607950|NCT01505114|565307813|FG002|Overall Study|Death|0|||
156607951|NCT01505114|565307814|FG003|Overall Study|Death|1|||
156607952|NCT01505114|565307811|FG000|Overall Study|unable to adhere to visit schedule|3|||
156607953|NCT01505114|565307812|FG001|Overall Study|unable to adhere to visit schedule|2|||
156607954|NCT01505114|565307813|FG002|Overall Study|unable to adhere to visit schedule|3|||
156607955|NCT01505114|565307814|FG003|Overall Study|unable to adhere to visit schedule|3|||
156607956|NCT01505114|565307811|FG000|Overall Study|Lost to Follow-up|11|||
156607957|NCT01505114|565307812|FG001|Overall Study|Lost to Follow-up|5|||
156607958|NCT01505114|565307813|FG002|Overall Study|Lost to Follow-up|8|||
156607959|NCT01505114|565307814|FG003|Overall Study|Lost to Follow-up|7|||
156607960|NCT01505114|565307811|FG000|Overall Study|relocated|4|||
156607961|NCT01505114|565307812|FG001|Overall Study|relocated|2|||
156607962|NCT01505114|565307813|FG002|Overall Study|relocated|2|||
156607963|NCT01505114|565307814|FG003|Overall Study|relocated|3|||
156607964|NCT01505114|565307811|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
156607965|NCT01505114|565307812|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
156607966|NCT01505114|565307813|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
156607967|NCT01505114|565307814|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
156607968|NCT01505114|565307811|FG000|Overall Study|staff safety concerns|0|||
156607969|NCT01505114|565307812|FG001|Overall Study|staff safety concerns|0|||
156607970|NCT01505114|565307813|FG002|Overall Study|staff safety concerns|0|||
156607971|NCT01505114|565307814|FG003|Overall Study|staff safety concerns|1|||
156607972|NCT01505114|565307811|FG000|Overall Study|investigator decision|1|||
156607973|NCT01505114|565307812|FG001|Overall Study|investigator decision|0|||
156607974|NCT01505114|565307813|FG002|Overall Study|investigator decision|1|||
156607975|NCT01505114|565307814|FG003|Overall Study|investigator decision|0|||
156607976|NCT01421069|565307816|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
156607977|NCT01421069|565307816|FG000|Parent Study|Failed to return|3|||
156607978|NCT01421069|565307816|FG000|Parent Study|Withdrawal by Subject|1|||
156607979|NCT01421069|565307816|FG000|Parent Study|Lost to Follow-up|2|||
156607980|NCT01421069|565307816|FG000|Parent Study|Lack of Efficacy|1|||
156607981|NCT01421069|565307816|FG000|Overall Period for Extension Study|Other|2|||
156607982|NCT01421069|565307816|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
156607983|NCT01421069|565307816|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
156607984|NCT01421069|565307816|FG000|Overall Period for Extension Study|Pregnancy|1|||
156607985|NCT01421069|565307816|FG000|Overall Period for Extension Study|Adverse Event|1|||
156607986|NCT01421069|565307816|FG000|Overall Period for Extension Study|Protocol Violation|1|||
156607987|NCT01421069|565307816|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
156607988|NCT01421069|565307816|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
156607989|NCT01421069|565307816|FG000|Active Treatment Period|Other|1|||
156607990|NCT01421069|565307816|FG000|Active Treatment Period|No longer willing to participate in study|8|||
156635007|NCT03917654|565407823|FG008|Year 2|Married|0|||
156607991|NCT01421069|565307816|FG000|Active Treatment Period|Insufficient clinical response|1|||
156607992|NCT01421069|565307816|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
156607993|NCT01421069|565307816|FG000|Active Treatment Period|Pregnancy|1|||
156607994|NCT01421069|565307816|FG000|Active Treatment Period|Adverse Event|1|||
156607995|NCT01421069|565307816|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
156607996|NCT01421069|565307816|FG000|Active Treatment Period|Enrolled in observational period|29|||
156607997|NCT01421069|565307816|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
156607998|NCT01421069|565307816|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
156607999|NCT01421069|565307816|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
156608000|NCT01421069|565307816|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
156608001|NCT01421069|565307816|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
156608002|NCT01421069|565307816|FG000|2b. Retreatment Period|Protocol Violation|1|||
156608003|NCT01421069|565307816|FG000|Observational Period|Other|1|||
156608004|NCT01421069|565307816|FG000|Observational Period|No longer willing to participate in study|4|||
156608005|NCT01421069|565307816|FG000|Observational Period|Lost to Follow-up|3|||
156608006|NCT01641081|565307817|FG000|Period 1|Sponsor request (potential unblinding)|0|||
156608007|NCT01641081|565307818|FG001|Period 1|Sponsor request (potential unblinding)|0|||
156608008|NCT01641081|565307819|FG002|Period 1|Sponsor request (potential unblinding)|0|||
156608009|NCT01641081|565307820|FG003|Period 1|Sponsor request (potential unblinding)|0|||
156608010|NCT01641081|565307821|FG004|Period 1|Sponsor request (potential unblinding)|0|||
156608011|NCT01641081|565307822|FG005|Period 1|Sponsor request (potential unblinding)|0|||
156608012|NCT01641081|565307823|FG006|Period 1|Sponsor request (potential unblinding)|1|||
156608013|NCT01641081|565307824|FG007|Period 1|Sponsor request (potential unblinding)|0|||
156608014|NCT01641081|565307825|FG008|Period 1|Sponsor request (potential unblinding)|0|||
156608015|NCT01641081|565307826|FG009|Period 1|Sponsor request (potential unblinding)|0|||
156608016|NCT01641081|565307817|FG000|Period 1|Protocol Violation|0|||
156608017|NCT01641081|565307818|FG001|Period 1|Protocol Violation|0|||
156608018|NCT01641081|565307819|FG002|Period 1|Protocol Violation|0|||
156608019|NCT01641081|565307820|FG003|Period 1|Protocol Violation|0|||
156608020|NCT01641081|565307821|FG004|Period 1|Protocol Violation|1|||
156608021|NCT01641081|565307822|FG005|Period 1|Protocol Violation|0|||
156608022|NCT01641081|565307823|FG006|Period 1|Protocol Violation|0|||
156608023|NCT01641081|565307824|FG007|Period 1|Protocol Violation|1|||
156608024|NCT01641081|565307825|FG008|Period 1|Protocol Violation|0|||
156608025|NCT01641081|565307826|FG009|Period 1|Protocol Violation|0|||
156608026|NCT01641081|565307817|FG000|Period 1|Adverse Event|1|||
156608027|NCT01641081|565307818|FG001|Period 1|Adverse Event|0|||
156608028|NCT01641081|565307819|FG002|Period 1|Adverse Event|0|||
156608029|NCT01641081|565307820|FG003|Period 1|Adverse Event|0|||
156608030|NCT01641081|565307821|FG004|Period 1|Adverse Event|0|||
156608031|NCT01641081|565307822|FG005|Period 1|Adverse Event|0|||
156608032|NCT01641081|565307823|FG006|Period 1|Adverse Event|0|||
156608033|NCT01641081|565307824|FG007|Period 1|Adverse Event|2|||
156608034|NCT01641081|565307825|FG008|Period 1|Adverse Event|0|||
156608035|NCT01641081|565307826|FG009|Period 1|Adverse Event|0|||
156608036|NCT01641081|565307817|FG000|Period 2|Adverse Event|0|||
156608037|NCT01641081|565307818|FG001|Period 2|Adverse Event|0|||
156608038|NCT01641081|565307819|FG002|Period 2|Adverse Event|0|||
156608039|NCT01641081|565307820|FG003|Period 2|Adverse Event|0|||
156608040|NCT01641081|565307821|FG004|Period 2|Adverse Event|0|||
156608041|NCT01641081|565307822|FG005|Period 2|Adverse Event|1|||
156608042|NCT01641081|565307823|FG006|Period 2|Adverse Event|0|||
156608043|NCT01641081|565307824|FG007|Period 2|Adverse Event|0|||
156608044|NCT01641081|565307825|FG008|Period 2|Adverse Event|0|||
156608045|NCT01641081|565307826|FG009|Period 2|Adverse Event|0|||
156608046|NCT01641081|565307817|FG000|Period 2|Withdrawal by Subject|0|||
156608047|NCT01641081|565307818|FG001|Period 2|Withdrawal by Subject|0|||
156608048|NCT01641081|565307819|FG002|Period 2|Withdrawal by Subject|0|||
156608049|NCT01641081|565307820|FG003|Period 2|Withdrawal by Subject|1|||
156608050|NCT01641081|565307821|FG004|Period 2|Withdrawal by Subject|0|||
156608051|NCT01641081|565307822|FG005|Period 2|Withdrawal by Subject|0|||
156608052|NCT01641081|565307823|FG006|Period 2|Withdrawal by Subject|2|||
156608053|NCT01641081|565307824|FG007|Period 2|Withdrawal by Subject|0|||
156608054|NCT01641081|565307825|FG008|Period 2|Withdrawal by Subject|0|||
156608055|NCT01641081|565307826|FG009|Period 2|Withdrawal by Subject|0|||
156608056|NCT01641081|565307817|FG000|Period 2|Protocol Violation|1|||
156608057|NCT01641081|565307818|FG001|Period 2|Protocol Violation|0|||
156608058|NCT01641081|565307819|FG002|Period 2|Protocol Violation|0|||
156608059|NCT01641081|565307820|FG003|Period 2|Protocol Violation|0|||
156608060|NCT01641081|565307821|FG004|Period 2|Protocol Violation|0|||
156608061|NCT01641081|565307822|FG005|Period 2|Protocol Violation|0|||
156608062|NCT01641081|565307823|FG006|Period 2|Protocol Violation|0|||
156608063|NCT01641081|565307824|FG007|Period 2|Protocol Violation|0|||
156608064|NCT01641081|565307825|FG008|Period 2|Protocol Violation|0|||
156608065|NCT01641081|565307826|FG009|Period 2|Protocol Violation|0|||
156608066|NCT01641081|565307817|FG000|Period 3|Adverse Event|0|||
156608067|NCT01641081|565307818|FG001|Period 3|Adverse Event|0|||
156608068|NCT01641081|565307819|FG002|Period 3|Adverse Event|1|||
156608069|NCT01641081|565307820|FG003|Period 3|Adverse Event|0|||
156608070|NCT01641081|565307821|FG004|Period 3|Adverse Event|0|||
156608071|NCT01641081|565307822|FG005|Period 3|Adverse Event|0|||
156608072|NCT01641081|565307823|FG006|Period 3|Adverse Event|0|||
156608073|NCT01641081|565307824|FG007|Period 3|Adverse Event|0|||
156608074|NCT01641081|565307825|FG008|Period 3|Adverse Event|0|||
156608075|NCT01641081|565307826|FG009|Period 3|Adverse Event|0|||
156608076|NCT01641081|565307817|FG000|Period 3|Withdrawal by Subject|0|||
156608077|NCT01641081|565307818|FG001|Period 3|Withdrawal by Subject|0|||
156608078|NCT01641081|565307819|FG002|Period 3|Withdrawal by Subject|0|||
156608079|NCT01641081|565307820|FG003|Period 3|Withdrawal by Subject|0|||
156608080|NCT01641081|565307821|FG004|Period 3|Withdrawal by Subject|0|||
156608081|NCT01641081|565307822|FG005|Period 3|Withdrawal by Subject|0|||
156608082|NCT01641081|565307823|FG006|Period 3|Withdrawal by Subject|0|||
156608083|NCT01641081|565307824|FG007|Period 3|Withdrawal by Subject|0|||
156608084|NCT01641081|565307825|FG008|Period 3|Withdrawal by Subject|1|||
156608085|NCT01641081|565307826|FG009|Period 3|Withdrawal by Subject|0|||
156608086|NCT01641081|565307817|FG000|Period 4|Adverse Event|0|||
156608087|NCT01641081|565307818|FG001|Period 4|Adverse Event|1|||
156608088|NCT01641081|565307819|FG002|Period 4|Adverse Event|0|||
156608089|NCT01641081|565307820|FG003|Period 4|Adverse Event|1|||
156608090|NCT01641081|565307821|FG004|Period 4|Adverse Event|0|||
156608091|NCT01641081|565307822|FG005|Period 4|Adverse Event|0|||
156608092|NCT01641081|565307823|FG006|Period 4|Adverse Event|0|||
156608093|NCT01641081|565307824|FG007|Period 4|Adverse Event|0|||
156608094|NCT01641081|565307825|FG008|Period 4|Adverse Event|0|||
156608095|NCT01641081|565307826|FG009|Period 4|Adverse Event|0|||
156608096|NCT01641081|565307817|FG000|Period 5|Adverse Event|0|||
156608097|NCT01641081|565307818|FG001|Period 5|Adverse Event|0|||
156608098|NCT01641081|565307819|FG002|Period 5|Adverse Event|2|||
156608099|NCT01641081|565307820|FG003|Period 5|Adverse Event|0|||
156608100|NCT01641081|565307821|FG004|Period 5|Adverse Event|0|||
156608101|NCT01641081|565307822|FG005|Period 5|Adverse Event|0|||
156608102|NCT01641081|565307823|FG006|Period 5|Adverse Event|0|||
156608103|NCT01641081|565307824|FG007|Period 5|Adverse Event|0|||
156608104|NCT01641081|565307825|FG008|Period 5|Adverse Event|0|||
156608105|NCT01641081|565307826|FG009|Period 5|Adverse Event|0|||
156608106|NCT01095666|565307830|FG000|Overall Study|Lack of Efficacy|0|||
156608107|NCT01095666|565307831|FG001|Overall Study|Lack of Efficacy|0|||
156608108|NCT01095666|565307832|FG002|Overall Study|Lack of Efficacy|1|||
156608109|NCT01095666|565307830|FG000|Overall Study|Adverse Event|2|||
156608110|NCT01095666|565307831|FG001|Overall Study|Adverse Event|1|||
156608111|NCT01095666|565307832|FG002|Overall Study|Adverse Event|3|||
156608112|NCT01095666|565307830|FG000|Overall Study|Lost to Follow-up|2|||
156608113|NCT01095666|565307831|FG001|Overall Study|Lost to Follow-up|2|||
156608114|NCT01095666|565307832|FG002|Overall Study|Lost to Follow-up|0|||
156608115|NCT01095666|565307830|FG000|Overall Study|Withdrawal by Subject|6|||
156608116|NCT01095666|565307831|FG001|Overall Study|Withdrawal by Subject|6|||
156608117|NCT01095666|565307832|FG002|Overall Study|Withdrawal by Subject|1|||
156608118|NCT01095666|565307830|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
156608119|NCT01095666|565307831|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
156608120|NCT01095666|565307832|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
156608121|NCT01202760|565307835|FG000|Overall Study|Entry Criteria Not Met|0|||
156608122|NCT01202760|565307836|FG001|Overall Study|Entry Criteria Not Met|3|||
156608123|NCT01202760|565307837|FG002|Overall Study|Entry Criteria Not Met|1|||
156608124|NCT01202760|565307835|FG000|Overall Study|Adverse Event|11|||
156608125|NCT01202760|565307836|FG001|Overall Study|Adverse Event|9|||
156608126|NCT01202760|565307837|FG002|Overall Study|Adverse Event|10|||
156608127|NCT01202760|565307835|FG000|Overall Study|Death|2|||
156608128|NCT01202760|565307836|FG001|Overall Study|Death|1|||
156608129|NCT01202760|565307837|FG002|Overall Study|Death|0|||
156608130|NCT01202760|565307835|FG000|Overall Study|Lack of Efficacy|6|||
156608131|NCT01202760|565307836|FG001|Overall Study|Lack of Efficacy|8|||
156608132|NCT01202760|565307837|FG002|Overall Study|Lack of Efficacy|7|||
156608133|NCT01202760|565307835|FG000|Overall Study|Lost to Follow-up|0|||
156608134|NCT01202760|565307836|FG001|Overall Study|Lost to Follow-up|2|||
156608135|NCT01202760|565307837|FG002|Overall Study|Lost to Follow-up|1|||
156608136|NCT01202760|565307835|FG000|Overall Study|Parent / Caregiver Decision|0|||
156608137|NCT01202760|565307836|FG001|Overall Study|Parent / Caregiver Decision|1|||
156608138|NCT01202760|565307837|FG002|Overall Study|Parent / Caregiver Decision|0|||
156608139|NCT01202760|565307835|FG000|Overall Study|Withdrawal by Subject|17|||
156608140|NCT01202760|565307836|FG001|Overall Study|Withdrawal by Subject|18|||
156608141|NCT01202760|565307837|FG002|Overall Study|Withdrawal by Subject|14|||
156608142|NCT01202760|565307835|FG000|Overall Study|Physician Decision|0|||
156608143|NCT01202760|565307836|FG001|Overall Study|Physician Decision|1|||
156608144|NCT01202760|565307837|FG002|Overall Study|Physician Decision|0|||
156608145|NCT01202760|565307835|FG000|Overall Study|Protocol Violation|7|||
156608146|NCT01202760|565307836|FG001|Overall Study|Protocol Violation|5|||
156608147|NCT01202760|565307837|FG002|Overall Study|Protocol Violation|2|||
156608148|NCT01202760|565307835|FG000|Overall Study|Sponsor Decision|4|||
156608149|NCT01202760|565307836|FG001|Overall Study|Sponsor Decision|4|||
156608150|NCT01202760|565307837|FG002|Overall Study|Sponsor Decision|0|||
156608151|NCT02810951|565307838|FG000|Overall Study|Adverse Event|1|||
156608152|NCT01250756|565307839|FG000|Infant Series|Withdrawal by Subject|4|||
156608153|NCT01250756|565307840|FG001|Infant Series|Withdrawal by Subject|5|||
156608154|NCT01250756|565307839|FG000|Infant Series|Randomized, Not Vaccinated|2|||
156608155|NCT01250756|565307840|FG001|Infant Series|Randomized, Not Vaccinated|2|||
156608156|NCT01250756|565307839|FG000|Infant Series|Other|22|||
156608157|NCT01250756|565307840|FG001|Infant Series|Other|0|||
156608158|NCT01250756|565307839|FG000|After Infant Series|Adverse Event|5|||
156608159|NCT01250756|565307840|FG001|After Infant Series|Adverse Event|2|||
156608160|NCT01250756|565307839|FG000|After Infant Series|Withdrawal by Subject|4|||
156608161|NCT01250756|565307840|FG001|After Infant Series|Withdrawal by Subject|1|||
156608162|NCT01250756|565307839|FG000|After Infant Series|Other|2|||
156608163|NCT01250756|565307840|FG001|After Infant Series|Other|1|||
156608164|NCT01250756|565307839|FG000|Toddler Dose|Adverse Event|0|||
156608165|NCT01250756|565307840|FG001|Toddler Dose|Adverse Event|1|||
156608166|NCT01250756|565307839|FG000|After Toddler Dose|Adverse Event|0|||
156608167|NCT01250756|565307840|FG001|After Toddler Dose|Adverse Event|1|||
156608168|NCT02925312|565307844|FG000|Overall Study|Lost to Follow-up|25|||
156608169|NCT02925312|565307845|FG001|Overall Study|Lost to Follow-up|0|||
156608170|NCT02925312|565307844|FG000|Overall Study|Adverse Event|2|||
156608171|NCT02925312|565307845|FG001|Overall Study|Adverse Event|0|||
156608172|NCT00376246|565307846|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
156608173|NCT00376246|565307847|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
156608174|NCT00376246|565307846|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156608175|NCT00376246|565307847|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
156608176|NCT00376246|565307846|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
156608177|NCT00376246|565307847|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156608178|NCT00166517|565307852|FG000|Overall Study|Lost to Follow-up|1|||
156608179|NCT00166517|565307853|FG001|Overall Study|Lost to Follow-up|0|||
156608180|NCT00166517|565307852|FG000|Overall Study|Protocol Violation|4|||
156608181|NCT00166517|565307853|FG001|Overall Study|Protocol Violation|1|||
156608182|NCT00166517|565307852|FG000|Overall Study|Withdrawal by Subject|0|||
156608183|NCT00166517|565307853|FG001|Overall Study|Withdrawal by Subject|1|||
156608184|NCT03094611|565307857|FG000|Overall Study|Lack of Efficacy|1|||
156608185|NCT03094611|565307857|FG000|Overall Study|Stem Cell Transplant|1|||
156608186|NCT04285853|565307858|FG000|Overall Study|Withdrawal by Subject|1|||
156608187|NCT04285853|565307859|FG001|Overall Study|Withdrawal by Subject|0|||
156608188|NCT04285853|565307858|FG000|Overall Study|Lost to Follow-up|9|||
156608189|NCT04285853|565307859|FG001|Overall Study|Lost to Follow-up|5|||
156608190|NCT02758613|565307861|FG000|Treatment|Physician and Sponsor Decision|1|||
156608191|NCT02758613|565307862|FG001|Treatment|Physician and Sponsor Decision|0|||
156608192|NCT02758613|565307863|FG002|Treatment|Physician and Sponsor Decision|0|||
156608193|NCT02758613|565307864|FG003|Treatment|Physician and Sponsor Decision|0|||
156608194|NCT02758613|565307861|FG000|Treatment|Withdrawal by Subject|1|||
156608195|NCT02758613|565307862|FG001|Treatment|Withdrawal by Subject|0|||
156608196|NCT02758613|565307863|FG002|Treatment|Withdrawal by Subject|1|||
156608197|NCT02758613|565307864|FG003|Treatment|Withdrawal by Subject|0|||
156608198|NCT01496274|565307865|FG000|Overall Study|Protocol Violation|0|||
156608199|NCT01496274|565307866|FG001|Overall Study|Protocol Violation|1|||
156608200|NCT01496274|565307865|FG000|Overall Study|Adverse Event|1|||
156608201|NCT01496274|565307866|FG001|Overall Study|Adverse Event|1|||
156608202|NCT01496274|565307865|FG000|Overall Study|Withdrawal by Subject|2|||
156608203|NCT01496274|565307866|FG001|Overall Study|Withdrawal by Subject|0|||
156608204|NCT01496274|565307865|FG000|Overall Study|Lost to Follow-up|0|||
156608205|NCT01496274|565307866|FG001|Overall Study|Lost to Follow-up|3|||
156608206|NCT00351819|565307869|FG000|Overall Study|Lost to Follow-up|4|||
156608207|NCT00351819|565307870|FG001|Overall Study|Lost to Follow-up|4|||
156608208|NCT00351819|565307869|FG000|Overall Study|Withdrawal by Subject|0|||
156608209|NCT00351819|565307870|FG001|Overall Study|Withdrawal by Subject|4|||
156608210|NCT00351819|565307869|FG000|Overall Study|Elevated PSA|1|||
156608211|NCT00351819|565307870|FG001|Overall Study|Elevated PSA|1|||
156608212|NCT00351819|565307869|FG000|Overall Study|Traumatic ankle fracture|1|||
156608213|NCT00351819|565307870|FG001|Overall Study|Traumatic ankle fracture|0|||
156608214|NCT00351819|565307869|FG000|Overall Study|Unprofessional behavior|1|||
156608215|NCT00351819|565307870|FG001|Overall Study|Unprofessional behavior|0|||
156608216|NCT00351819|565307869|FG000|Overall Study|Non-compliance|0|||
156608217|NCT00351819|565307870|FG001|Overall Study|Non-compliance|1|||
156608218|NCT00351819|565307869|FG000|Overall Study|Incarcerated|0|||
156608219|NCT00351819|565307870|FG001|Overall Study|Incarcerated|1|||
156608220|NCT00351819|565307869|FG000|Overall Study|Enrolled in another trial|0|||
156608221|NCT00351819|565307870|FG001|Overall Study|Enrolled in another trial|1|||
156608222|NCT00249795|565307871|FG000|Overall Study|Not treated|16|||
156608223|NCT00249795|565307872|FG001|Overall Study|Not treated|14|||
156608224|NCT00249795|565307871|FG000|Overall Study|Symptomatic hypotension|127|||
156608225|NCT00249795|565307872|FG001|Overall Study|Symptomatic hypotension|64|||
156608226|NCT00249795|565307871|FG000|Overall Study|Other Serious Adverse Event|84|||
156608227|NCT00249795|565307872|FG001|Overall Study|Other Serious Adverse Event|93|||
156608228|NCT00249795|565307871|FG000|Overall Study|Qualifying condition not present|26|||
156608229|NCT00249795|565307872|FG001|Overall Study|Qualifying condition not present|29|||
156608230|NCT00249795|565307871|FG000|Overall Study|Withdrawal by Subject|678|||
156608231|NCT00249795|565307872|FG001|Overall Study|Withdrawal by Subject|742|||
156608232|NCT00249795|565307871|FG000|Overall Study|Thromboembolic / outcome event|39|||
156608233|NCT00249795|565307872|FG001|Overall Study|Thromboembolic / outcome event|45|||
156608234|NCT00249795|565307871|FG000|Overall Study|Oral anticoagulant required|2|||
156608235|NCT00249795|565307872|FG001|Overall Study|Oral anticoagulant required|0|||
156608236|NCT00249795|565307871|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
156608237|NCT00249795|565307872|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
156608238|NCT00249795|565307871|FG000|Overall Study|Non-compliance|71|||
156608239|NCT00249795|565307872|FG001|Overall Study|Non-compliance|69|||
156608240|NCT00249795|565307871|FG000|Overall Study|Study drug intolerance|3|||
156608241|NCT00249795|565307872|FG001|Overall Study|Study drug intolerance|3|||
156608242|NCT00249795|565307871|FG000|Overall Study|Other adverse events (non-serious)|188|||
156608243|NCT00249795|565307872|FG001|Overall Study|Other adverse events (non-serious)|159|||
156608244|NCT00249795|565307871|FG000|Overall Study|Physician withdrew consent|71|||
156608245|NCT00249795|565307872|FG001|Overall Study|Physician withdrew consent|63|||
156608246|NCT00249795|565307871|FG000|Overall Study|Surgery / procedure|4|||
156608247|NCT00249795|565307872|FG001|Overall Study|Surgery / procedure|5|||
156608248|NCT00249795|565307871|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
156608249|NCT00249795|565307872|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
156608250|NCT00249795|565307871|FG000|Overall Study|Lightheadedness / dizziness|15|||
156608251|NCT00249795|565307872|FG001|Overall Study|Lightheadedness / dizziness|11|||
156608252|NCT00249795|565307871|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
156608253|NCT00249795|565307872|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
156608254|NCT00249795|565307871|FG000|Overall Study|Other contraindicated medication|1|||
156608255|NCT00249795|565307872|FG001|Overall Study|Other contraindicated medication|1|||
156608256|NCT00249795|565307871|FG000|Overall Study|Event related to cardiac condition|17|||
156608257|NCT00249795|565307872|FG001|Overall Study|Event related to cardiac condition|16|||
156608258|NCT00249795|565307871|FG000|Overall Study|Patient not wish to continue after May08|4|||
156608259|NCT00249795|565307872|FG001|Overall Study|Patient not wish to continue after May08|6|||
156608260|NCT00249795|565307871|FG000|Overall Study|Site not agree to continue after May08|1|||
156608261|NCT00249795|565307872|FG001|Overall Study|Site not agree to continue after May08|1|||
156608262|NCT00249795|565307871|FG000|Overall Study|Lost to Follow-up|0|||
156608263|NCT00249795|565307872|FG001|Overall Study|Lost to Follow-up|2|||
156608264|NCT00249795|565307871|FG000|Overall Study|Missing|0|||
156608265|NCT00249795|565307872|FG001|Overall Study|Missing|1|||
156608266|NCT00196196|565307874|FG000|Overall Study|Withdrawal by Subject|2|||
156608267|NCT00196196|565307874|FG000|Overall Study|Did not have required condition (hydroce|5|||
156608268|NCT01015820|565307877|FG000|Overall Study|Suboptimal measurements|1|||
156608269|NCT01015820|565307878|FG001|Overall Study|Suboptimal measurements|0|||
156608270|NCT03034057|565307879|FG000|Overall Study|Withdrawal by Subject|10|||
156608271|NCT03034057|565307879|FG000|Overall Study|Protocol Violation|1|||
156608272|NCT03034057|565307879|FG000|Overall Study|Not defined|2|||
156608273|NCT03034057|565307879|FG000|Overall Study|Lost to Follow-up|19|||
156608274|NCT03034057|565307879|FG000|Overall Study|Adverse Event|22|||
156608275|NCT03034057|565307879|FG000|Overall Study|Medication error without associated AE|1|||
156608276|NCT03339401|565307880|FG000|Overall Study|Death|2|||
156608277|NCT03339401|565307881|FG001|Overall Study|Death|1|||
156608278|NCT03339401|565307880|FG000|Overall Study|Withdrawal by Subject|2|||
156608279|NCT03339401|565307881|FG001|Overall Study|Withdrawal by Subject|0|||
156608280|NCT03339401|565307880|FG000|Overall Study|Study terminated|4|||
156608281|NCT03339401|565307881|FG001|Overall Study|Study terminated|3|||
156608282|NCT03339401|565307880|FG000|Overall Study|Investigator Decision|1|||
156608283|NCT03339401|565307881|FG001|Overall Study|Investigator Decision|0|||
156608284|NCT00718523|565307882|FG000|Overall Study|Withdrawal by Subject|5|||
156608285|NCT00718523|565307883|FG001|Overall Study|Withdrawal by Subject|7|||
156608286|NCT00718523|565307882|FG000|Overall Study|Death|13|||
156608287|NCT00718523|565307883|FG001|Overall Study|Death|17|||
156608288|NCT01313078|565307884|FG000|Overall Study|Death|1|||
156608289|NCT01313078|565307884|FG000|Overall Study|Discontinued study drug|1|||
156608290|NCT01313078|565307884|FG000|Overall Study|Withdrawal by Subject|1|||
156608291|NCT00910728|565307885|FG000|Overall Study|Lack of Efficacy|2|||
156608292|NCT00910728|565307886|FG001|Overall Study|Lack of Efficacy|3|||
156608293|NCT00910728|565307887|FG002|Overall Study|Lack of Efficacy|1|||
156608294|NCT00910728|565307888|FG003|Overall Study|Lack of Efficacy|2|||
156608295|NCT00910728|565307889|FG004|Overall Study|Lack of Efficacy|1|||
156608296|NCT00910728|565307890|FG005|Overall Study|Lack of Efficacy|0|||
156608297|NCT00910728|565307891|FG006|Overall Study|Lack of Efficacy|2|||
156608298|NCT00910728|565307892|FG007|Overall Study|Lack of Efficacy|2|||
156608299|NCT00910728|565307893|FG008|Overall Study|Lack of Efficacy|2|||
156608300|NCT00910728|565307885|FG000|Overall Study|Withdrawal by Subject|0|||
156608301|NCT00910728|565307886|FG001|Overall Study|Withdrawal by Subject|0|||
156608302|NCT00910728|565307887|FG002|Overall Study|Withdrawal by Subject|0|||
156608303|NCT00910728|565307888|FG003|Overall Study|Withdrawal by Subject|0|||
156608304|NCT00910728|565307889|FG004|Overall Study|Withdrawal by Subject|3|||
156608305|NCT00910728|565307890|FG005|Overall Study|Withdrawal by Subject|1|||
156608306|NCT00910728|565307891|FG006|Overall Study|Withdrawal by Subject|2|||
156608307|NCT00910728|565307892|FG007|Overall Study|Withdrawal by Subject|0|||
156608308|NCT00910728|565307893|FG008|Overall Study|Withdrawal by Subject|0|||
156608309|NCT00910728|565307885|FG000|Overall Study|(not specified)|2|||
156608310|NCT00910728|565307886|FG001|Overall Study|(not specified)|0|||
156608311|NCT00910728|565307887|FG002|Overall Study|(not specified)|1|||
156608312|NCT00910728|565307888|FG003|Overall Study|(not specified)|0|||
156608313|NCT00910728|565307889|FG004|Overall Study|(not specified)|1|||
156608314|NCT00910728|565307890|FG005|Overall Study|(not specified)|0|||
156608315|NCT00910728|565307891|FG006|Overall Study|(not specified)|0|||
156608316|NCT00910728|565307892|FG007|Overall Study|(not specified)|0|||
156608317|NCT00910728|565307893|FG008|Overall Study|(not specified)|0|||
156608318|NCT00910728|565307885|FG000|Overall Study|Adverse Event|2|||
156608319|NCT00910728|565307886|FG001|Overall Study|Adverse Event|0|||
156608320|NCT00910728|565307887|FG002|Overall Study|Adverse Event|1|||
156608321|NCT00910728|565307888|FG003|Overall Study|Adverse Event|1|||
156608322|NCT00910728|565307889|FG004|Overall Study|Adverse Event|0|||
156608323|NCT00910728|565307890|FG005|Overall Study|Adverse Event|0|||
156608324|NCT00910728|565307891|FG006|Overall Study|Adverse Event|2|||
156608325|NCT00910728|565307892|FG007|Overall Study|Adverse Event|1|||
156608326|NCT00910728|565307893|FG008|Overall Study|Adverse Event|1|||
156608327|NCT03404518|565307894|FG000|Overall Study|Lost to Follow-up|28|||
156608328|NCT03404518|565307895|FG001|Overall Study|Lost to Follow-up|30|||
156608329|NCT03404518|565307894|FG000|Overall Study|Protocol Violation|13|||
156608330|NCT03404518|565307895|FG001|Overall Study|Protocol Violation|6|||
156608331|NCT05041062|565307896|FG000|Overall Study|Adverse Event|2|||
156608332|NCT03693404|565307900|FG000|Overall Study|Withdrawal by Subject|1|||
156608333|NCT03693404|565307901|FG001|Overall Study|Withdrawal by Subject|0|||
156608334|NCT03693404|565307900|FG000|Overall Study|Lost to Follow-up|0|||
156608335|NCT03693404|565307901|FG001|Overall Study|Lost to Follow-up|5|||
156608336|NCT03693404|565307900|FG000|Overall Study|Excluded from Analysis|0|||
156608337|NCT03693404|565307901|FG001|Overall Study|Excluded from Analysis|1|||
156608338|NCT01176240|565307902|FG000|Study 306A|Lack of Efficacy|2|||
156608339|NCT01176240|565307903|FG001|Study 306A|Lack of Efficacy|1|||
156608340|NCT01176240|565307902|FG000|Study 306A|Protocol Violation|0|||
156608341|NCT01176240|565307903|FG001|Study 306A|Protocol Violation|1|||
156608342|NCT01176240|565307902|FG000|Study 306A|Withdrawal by Subject|0|||
156608343|NCT01176240|565307903|FG001|Study 306A|Withdrawal by Subject|1|||
156608344|NCT01176240|565307902|FG000|Study 306A|Stop due to diverse problems|1|||
156608345|NCT01176240|565307903|FG001|Study 306A|Stop due to diverse problems|0|||
156608346|NCT01176240|565307902|FG000|Study 306B|Lack of Efficacy|5|||
156608347|NCT01176240|565307903|FG001|Study 306B|Lack of Efficacy|3|||
156608348|NCT01176240|565307902|FG000|Study 306B|Adverse Event|10|||
156608349|NCT01176240|565307903|FG001|Study 306B|Adverse Event|5|||
156608350|NCT01176240|565307902|FG000|Study 306B|Protocol Violation|2|||
156608351|NCT01176240|565307903|FG001|Study 306B|Protocol Violation|3|||
156608352|NCT01176240|565307902|FG000|Study 306B|Withdrawal by Subject|4|||
156608353|NCT01176240|565307903|FG001|Study 306B|Withdrawal by Subject|1|||
156608354|NCT01176240|565307902|FG000|Study 306B|Physician Decision|2|||
156608355|NCT01176240|565307903|FG001|Study 306B|Physician Decision|1|||
156608356|NCT01176240|565307902|FG000|Study 306B|Supine Hypertension|1|||
156608357|NCT01176240|565307903|FG001|Study 306B|Supine Hypertension|2|||
156608358|NCT01176240|565307902|FG000|Study 306B|Lost to Follow-up|0|||
156608359|NCT01176240|565307903|FG001|Study 306B|Lost to Follow-up|1|||
156608360|NCT01176240|565307902|FG000|Study 306B|withdrew prior to dosing|2|||
156608361|NCT01176240|565307903|FG001|Study 306B|withdrew prior to dosing|1|||
156608362|NCT05200455|565307904|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
156608363|NCT00807014|565307907|FG000|Overall Study|Participant Considered Disease Cured|13|||
156608364|NCT00807014|565307908|FG001|Overall Study|Participant Considered Disease Cured|2|||
156608365|NCT00807014|565307907|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
156608366|NCT00807014|565307908|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
156608367|NCT00807014|565307907|FG000|Overall Study|Protocol Violation|2|||
156608368|NCT00807014|565307908|FG001|Overall Study|Protocol Violation|8|||
156608369|NCT00807014|565307907|FG000|Overall Study|Adverse Event|0|||
156608370|NCT00807014|565307908|FG001|Overall Study|Adverse Event|2|||
156608371|NCT00807014|565307907|FG000|Overall Study|Lost to Follow-up|9|||
156608372|NCT00807014|565307908|FG001|Overall Study|Lost to Follow-up|7|||
156608373|NCT00807014|565307907|FG000|Overall Study|Recovery|1|||
156608374|NCT00807014|565307908|FG001|Overall Study|Recovery|0|||
156608375|NCT00807014|565307907|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
156608376|NCT00807014|565307908|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
156608377|NCT00651313|565307909|FG000|Overall Study|Adverse Event|0|||
156608378|NCT00651313|565307910|FG001|Overall Study|Adverse Event|1|||
156608379|NCT00651313|565307909|FG000|Overall Study|Withdrawal by Subject|3|||
156608380|NCT00651313|565307910|FG001|Overall Study|Withdrawal by Subject|1|||
156608381|NCT00651313|565307909|FG000|Overall Study|Lost to Follow-up|1|||
156608382|NCT00651313|565307910|FG001|Overall Study|Lost to Follow-up|1|||
156608383|NCT00651313|565307909|FG000|Overall Study|Adminstrative Discontinuation|2|||
156608384|NCT00651313|565307910|FG001|Overall Study|Adminstrative Discontinuation|3|||
156608385|NCT00892957|565307912|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
156608386|NCT00892957|565307913|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
156608387|NCT00892957|565307912|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
156608388|NCT00892957|565307913|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
156608389|NCT03307629|565307919|FG000|Overall Study|Withdrawal by Subject|0|||
156608390|NCT03307629|565307920|FG001|Overall Study|Withdrawal by Subject|0|||
156608391|NCT03307629|565307921|FG002|Overall Study|Withdrawal by Subject|0|||
156608392|NCT03307629|565307922|FG003|Overall Study|Withdrawal by Subject|2|||
156608393|NCT03307629|565307919|FG000|Overall Study|Disease Progression|0|||
156608394|NCT03307629|565307920|FG001|Overall Study|Disease Progression|0|||
156608395|NCT03307629|565307921|FG002|Overall Study|Disease Progression|0|||
156608396|NCT03307629|565307922|FG003|Overall Study|Disease Progression|3|||
156608397|NCT03307629|565307919|FG000|Overall Study|Death|0|||
156608398|NCT03307629|565307920|FG001|Overall Study|Death|3|||
156608399|NCT03307629|565307921|FG002|Overall Study|Death|0|||
156608400|NCT03307629|565307922|FG003|Overall Study|Death|1|||
156608401|NCT02853032|565307927|FG000|Overall Study|Adverse Event|4|||
156608402|NCT02853032|565307928|FG001|Overall Study|Adverse Event|0|||
156608403|NCT02853032|565307927|FG000|Overall Study|Withdrawal by Subject|3|||
156608404|NCT02853032|565307928|FG001|Overall Study|Withdrawal by Subject|1|||
156608405|NCT02853032|565307927|FG000|Overall Study|Requested to withdraw from all treatment|2|||
156608406|NCT02853032|565307928|FG001|Overall Study|Requested to withdraw from all treatment|2|||
156608407|NCT04876599|565307929|FG000|Overall Study|Missed|2|||
156608408|NCT04876599|565307930|FG001|Overall Study|Missed|0|||
156608409|NCT04876599|565307929|FG000|Overall Study|Declined|2|||
156608410|NCT04876599|565307930|FG001|Overall Study|Declined|3|||
156608411|NCT00676208|565307937|FG000|Overall Study|Lost to Follow-up|0|||
156608412|NCT00676208|565307938|FG001|Overall Study|Lost to Follow-up|2|||
156608413|NCT00676208|565307937|FG000|Overall Study|Incomplete data|2|||
156608414|NCT00676208|565307938|FG001|Overall Study|Incomplete data|4|||
156608415|NCT00669032|565307939|FG000|Overall Study|Lost to Follow-up|6|||
156608416|NCT00669032|565307940|FG001|Overall Study|Lost to Follow-up|5|||
156608417|NCT00669032|565307939|FG000|Overall Study|Lack of Efficacy|8|||
156608418|NCT00669032|565307940|FG001|Overall Study|Lack of Efficacy|19|||
156608419|NCT00669032|565307939|FG000|Overall Study|Withdrawal by Subject|12|||
156608420|NCT00669032|565307940|FG001|Overall Study|Withdrawal by Subject|13|||
156608421|NCT00669032|565307939|FG000|Overall Study|Adverse Event|12|||
156608422|NCT00669032|565307940|FG001|Overall Study|Adverse Event|16|||
156608423|NCT00669032|565307939|FG000|Overall Study|Physician Decision|1|||
156608424|NCT00669032|565307940|FG001|Overall Study|Physician Decision|1|||
156608425|NCT00669032|565307939|FG000|Overall Study|No fulfilment of the selection criteria|5|||
156608426|NCT00669032|565307940|FG001|Overall Study|No fulfilment of the selection criteria|5|||
156608427|NCT01607073|565307943|FG000|Overall Study|Adverse Event|1|||
156608428|NCT00642018|565307944|FG000|Overall Study|Adverse Event|11|||
156608429|NCT00642018|565307945|FG001|Overall Study|Adverse Event|36|||
156608430|NCT00642018|565307944|FG000|Overall Study|Withdrawal by Subject|4|||
156608431|NCT00642018|565307945|FG001|Overall Study|Withdrawal by Subject|10|||
156608432|NCT00642018|565307944|FG000|Overall Study|Progressive Disease|13|||
156608433|NCT00642018|565307945|FG001|Overall Study|Progressive Disease|18|||
156608434|NCT00642018|565307944|FG000|Overall Study|Physician Decision|0|||
156608435|NCT00642018|565307945|FG001|Overall Study|Physician Decision|10|||
156608436|NCT00642018|565307944|FG000|Overall Study|Protocol Violation|0|||
156608437|NCT00642018|565307945|FG001|Overall Study|Protocol Violation|1|||
156608438|NCT00642018|565307944|FG000|Overall Study|Death|0|||
156608439|NCT00642018|565307945|FG001|Overall Study|Death|3|||
156608440|NCT00642018|565307944|FG000|Overall Study|Entry Criteria Not Met|0|||
156608441|NCT00642018|565307945|FG001|Overall Study|Entry Criteria Not Met|1|||
156608442|NCT01410799|565307946|FG000|Overall Study|PI decision|13|||
156608443|NCT04126031|565307948|FG000|Part A|Withdrawal by Subject|0|||
156608444|NCT04126031|565307949|FG001|Part A|Withdrawal by Subject|0|||
156608445|NCT04126031|565307950|FG002|Part A|Withdrawal by Subject|1|||
156608446|NCT04126031|565307951|FG003|Part A|Withdrawal by Subject|0|||
156608447|NCT04126031|565307952|FG004|Part A|Withdrawal by Subject|0|||
156608448|NCT04126031|565307953|FG005|Part A|Withdrawal by Subject|0|||
156608449|NCT04126031|565307948|FG000|Part A|Other|1|||
156608450|NCT04126031|565307949|FG001|Part A|Other|0|||
156608451|NCT04126031|565307950|FG002|Part A|Other|0|||
156608452|NCT04126031|565307951|FG003|Part A|Other|0|||
156608453|NCT04126031|565307952|FG004|Part A|Other|0|||
156608454|NCT04126031|565307953|FG005|Part A|Other|0|||
156608455|NCT04126031|565307948|FG000|Part B|Adverse Event|0|||
156608456|NCT04126031|565307949|FG001|Part B|Adverse Event|0|||
156608457|NCT04126031|565307950|FG002|Part B|Adverse Event|0|||
156608458|NCT04126031|565307951|FG003|Part B|Adverse Event|0|||
156608459|NCT04126031|565307952|FG004|Part B|Adverse Event|0|||
156608460|NCT04126031|565307953|FG005|Part B|Adverse Event|2|||
156608461|NCT04126031|565307948|FG000|Part B|Pre-existing hypertransaminasemia|0|||
156608462|NCT04126031|565307949|FG001|Part B|Pre-existing hypertransaminasemia|0|||
156608463|NCT04126031|565307950|FG002|Part B|Pre-existing hypertransaminasemia|0|||
156608464|NCT04126031|565307951|FG003|Part B|Pre-existing hypertransaminasemia|0|||
156608465|NCT04126031|565307952|FG004|Part B|Pre-existing hypertransaminasemia|1|||
156608466|NCT04126031|565307953|FG005|Part B|Pre-existing hypertransaminasemia|0|||
156608467|NCT00617656|565307954|FG000|Overall Study|Inclusion error|4|||
156608468|NCT00617656|565307955|FG001|Overall Study|Inclusion error|4|||
156608469|NCT00617656|565307956|FG002|Overall Study|Inclusion error|0|||
156608470|NCT00617656|565307957|FG003|Overall Study|Inclusion error|0|||
156608471|NCT00617656|565307954|FG000|Overall Study|Missing data|44|||
156608472|NCT00617656|565307955|FG001|Overall Study|Missing data|30|||
156608473|NCT00617656|565307956|FG002|Overall Study|Missing data|13|||
156608474|NCT00617656|565307957|FG003|Overall Study|Missing data|6|||
156608475|NCT00617656|565307954|FG000|Overall Study|Withdrawal by Subject|0|||
156608476|NCT00617656|565307955|FG001|Overall Study|Withdrawal by Subject|2|||
156608477|NCT00617656|565307956|FG002|Overall Study|Withdrawal by Subject|0|||
156608478|NCT00617656|565307957|FG003|Overall Study|Withdrawal by Subject|0|||
156608479|NCT00131664|565307958|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
156608480|NCT00131664|565307959|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
156608481|NCT00131664|565307960|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
156608482|NCT00131664|565307961|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
156608483|NCT00131664|565307962|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
156608484|NCT00131664|565307963|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
156608485|NCT00131664|565307958|FG000|First Period (First 6 Months)|Death|0|||
156608486|NCT00131664|565307959|FG001|First Period (First 6 Months)|Death|1|||
156608487|NCT00131664|565307960|FG002|First Period (First 6 Months)|Death|0|||
156608488|NCT00131664|565307961|FG003|First Period (First 6 Months)|Death|0|||
156608489|NCT00131664|565307962|FG004|First Period (First 6 Months)|Death|0|||
156608490|NCT00131664|565307963|FG005|First Period (First 6 Months)|Death|0|||
156608491|NCT00131664|565307958|FG000|First Period (First 6 Months)|Protocol Violation|2|||
156608492|NCT00131664|565307959|FG001|First Period (First 6 Months)|Protocol Violation|2|||
156608493|NCT00131664|565307960|FG002|First Period (First 6 Months)|Protocol Violation|1|||
156608494|NCT00131664|565307961|FG003|First Period (First 6 Months)|Protocol Violation|0|||
156608495|NCT00131664|565307962|FG004|First Period (First 6 Months)|Protocol Violation|0|||
156608496|NCT00131664|565307963|FG005|First Period (First 6 Months)|Protocol Violation|0|||
156608497|NCT00131664|565307958|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
156608498|NCT00131664|565307959|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
156608499|NCT00131664|565307960|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
156608500|NCT00131664|565307961|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
156608501|NCT00131664|565307962|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
156608502|NCT00131664|565307963|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
156608503|NCT00131664|565307958|FG000|First Period (First 6 Months)|Adverse Event|9|||
156608504|NCT00131664|565307959|FG001|First Period (First 6 Months)|Adverse Event|4|||
156608505|NCT00131664|565307960|FG002|First Period (First 6 Months)|Adverse Event|5|||
156608506|NCT00131664|565307961|FG003|First Period (First 6 Months)|Adverse Event|0|||
156608507|NCT00131664|565307962|FG004|First Period (First 6 Months)|Adverse Event|0|||
156608508|NCT00131664|565307963|FG005|First Period (First 6 Months)|Adverse Event|0|||
156608509|NCT00131664|565307958|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
156608510|NCT00131664|565307959|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
156608511|NCT00131664|565307960|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
156608512|NCT00131664|565307961|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
156608513|NCT00131664|565307962|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
156608514|NCT00131664|565307963|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
156608515|NCT00131664|565307958|FG000|First Period (First 6 Months)|Administrative reasons|2|||
156608516|NCT00131664|565307959|FG001|First Period (First 6 Months)|Administrative reasons|0|||
156608517|NCT00131664|565307960|FG002|First Period (First 6 Months)|Administrative reasons|5|||
156608518|NCT00131664|565307961|FG003|First Period (First 6 Months)|Administrative reasons|0|||
156608519|NCT00131664|565307962|FG004|First Period (First 6 Months)|Administrative reasons|0|||
156608520|NCT00131664|565307963|FG005|First Period (First 6 Months)|Administrative reasons|0|||
156608521|NCT00131664|565307958|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
156608522|NCT00131664|565307959|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
156608523|NCT00131664|565307960|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
156608524|NCT00131664|565307961|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
156608525|NCT00131664|565307962|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
156608526|NCT00131664|565307963|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
156608527|NCT00131664|565307958|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
156608528|NCT00131664|565307959|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
156608529|NCT00131664|565307960|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
156608530|NCT00131664|565307961|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
156608531|NCT00131664|565307962|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
156608532|NCT00131664|565307963|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
156608533|NCT00131664|565307958|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
156608534|NCT00131664|565307959|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
156608535|NCT00131664|565307960|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
156608536|NCT00131664|565307961|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
156608537|NCT00131664|565307962|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
156608538|NCT00131664|565307963|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
156608539|NCT00131664|565307958|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
156608540|NCT00131664|565307959|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
156608541|NCT00131664|565307960|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
156608542|NCT00131664|565307961|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
156608543|NCT00131664|565307962|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
156608544|NCT00131664|565307963|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
156608545|NCT00131664|565307958|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
156608546|NCT00131664|565307959|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
156608547|NCT00131664|565307960|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
156608548|NCT00131664|565307961|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
156608549|NCT00131664|565307962|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
156608550|NCT00131664|565307963|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
156608551|NCT00131664|565307958|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
156608552|NCT00131664|565307959|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
156608553|NCT00131664|565307960|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
156608554|NCT00131664|565307961|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
156608555|NCT00131664|565307962|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
156608556|NCT00131664|565307963|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
156608557|NCT01946412|565307964|FG000|Overall Study|Adverse Event|1|||
156608558|NCT01946412|565307964|FG000|Overall Study|Non-Compliance|1|||
156608559|NCT01946412|565307964|FG000|Overall Study|Continued with commercial Kalydeco|2|||
156608560|NCT01946412|565307964|FG000|Overall Study|Difficulty in swallowing|1|||
156634716|NCT03426995|565407780|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634717|NCT03426995|565407762|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634718|NCT03426995|565407763|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634719|NCT03426995|565407764|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634720|NCT03426995|565407765|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634721|NCT03426995|565407766|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634722|NCT03426995|565407767|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
156634723|NCT03426995|565407768|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634724|NCT03426995|565407769|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634725|NCT03426995|565407770|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634726|NCT03426995|565407771|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634727|NCT03426995|565407772|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634728|NCT03426995|565407773|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634729|NCT03426995|565407774|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634730|NCT03426995|565407775|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634731|NCT03426995|565407776|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634732|NCT03426995|565407777|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634733|NCT03426995|565407778|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634734|NCT03426995|565407779|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634735|NCT03426995|565407780|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
156634736|NCT03426995|565407762|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634737|NCT03426995|565407763|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634738|NCT03426995|565407764|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634739|NCT03426995|565407765|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634740|NCT03426995|565407766|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
156634741|NCT03426995|565407767|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
156634742|NCT03426995|565407768|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634743|NCT03426995|565407769|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634744|NCT03426995|565407770|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634745|NCT03426995|565407771|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634746|NCT03426995|565407772|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634747|NCT03426995|565407773|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156608561|NCT01594749|565309851|FG000|Overall Study|Adverse Event|2|||
156608562|NCT01594749|565309852|FG001|Overall Study|Adverse Event|1|||
156608563|NCT01594749|565309851|FG000|Overall Study|Withdrawal by Subject|2|||
156608564|NCT01594749|565309852|FG001|Overall Study|Withdrawal by Subject|2|||
156608565|NCT01594749|565309851|FG000|Overall Study|Protocol Violation|2|||
156608566|NCT01594749|565309852|FG001|Overall Study|Protocol Violation|0|||
156608567|NCT01594749|565309851|FG000|Overall Study|Physician Decision|1|||
156608568|NCT01594749|565309852|FG001|Overall Study|Physician Decision|1|||
156608569|NCT01594749|565309851|FG000|Overall Study|Non-compliance with Protocol|0|||
156608570|NCT01594749|565309852|FG001|Overall Study|Non-compliance with Protocol|1|||
156608571|NCT01594749|565309851|FG000|Overall Study|Lost to Follow-up|1|||
156608572|NCT01594749|565309852|FG001|Overall Study|Lost to Follow-up|0|||
156608573|NCT01594749|565309851|FG000|Overall Study|Death|9|||
156608574|NCT01594749|565309852|FG001|Overall Study|Death|3|||
156608575|NCT01594749|565309851|FG000|Overall Study|Not Treated|4|||
156608576|NCT01594749|565309852|FG001|Overall Study|Not Treated|10|||
156608577|NCT01594749|565309851|FG000|Overall Study|Lost Source Documentation|1|||
156608578|NCT01594749|565309852|FG001|Overall Study|Lost Source Documentation|0|||
156608579|NCT00323310|565309853|FG000|Overall Study|Withdrawal by Subject|1|||
156608580|NCT00323310|565309853|FG000|Overall Study|a parent refused blood draw|1|||
156608581|NCT00323310|565309853|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
156608582|NCT03565991|565309854|FG000|Overall Study|Other|11|||
156608583|NCT03565991|565309855|FG001|Overall Study|Other|0|||
156608584|NCT03565991|565309854|FG000|Overall Study|Global deterioration of health status|14|||
156608585|NCT03565991|565309855|FG001|Overall Study|Global deterioration of health status|4|||
156608586|NCT03565991|565309854|FG000|Overall Study|Withdrawal by Subject|2|||
156608587|NCT03565991|565309855|FG001|Overall Study|Withdrawal by Subject|6|||
156608588|NCT03565991|565309854|FG000|Overall Study|Progressive disease|121|||
156608589|NCT03565991|565309855|FG001|Overall Study|Progressive disease|29|||
156608590|NCT03565991|565309854|FG000|Overall Study|Death|3|||
156608591|NCT03565991|565309855|FG001|Overall Study|Death|0|||
156608592|NCT03565991|565309854|FG000|Overall Study|Adverse Event|7|||
156608593|NCT03565991|565309855|FG001|Overall Study|Adverse Event|2|||
156608594|NCT02944513|565309856|FG000|Overall Study|Withdrawal by Subject|4|||
156608595|NCT02944513|565309857|FG001|Overall Study|Withdrawal by Subject|1|||
156608596|NCT00937326|565309859|FG000|Overall Study|Adverse Event|0|||
156608597|NCT00937326|565309860|FG001|Overall Study|Adverse Event|3|||
156608598|NCT00937326|565309861|FG002|Overall Study|Adverse Event|1|||
156608599|NCT00937326|565309862|FG003|Overall Study|Adverse Event|1|||
156608600|NCT00937326|565309863|FG004|Overall Study|Adverse Event|2|||
156608601|NCT00937326|565309859|FG000|Overall Study|Death|0|||
156608602|NCT00937326|565309860|FG001|Overall Study|Death|0|||
156608603|NCT00937326|565309861|FG002|Overall Study|Death|1|||
156608604|NCT00937326|565309862|FG003|Overall Study|Death|0|||
156608605|NCT00937326|565309863|FG004|Overall Study|Death|0|||
156608606|NCT00937326|565309859|FG000|Overall Study|Withdrawal by Subject|3|||
156608607|NCT00937326|565309860|FG001|Overall Study|Withdrawal by Subject|4|||
156608608|NCT00937326|565309861|FG002|Overall Study|Withdrawal by Subject|1|||
156608609|NCT00937326|565309862|FG003|Overall Study|Withdrawal by Subject|4|||
156608610|NCT00937326|565309863|FG004|Overall Study|Withdrawal by Subject|3|||
156608611|NCT00937326|565309859|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
156608612|NCT00937326|565309860|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
156608613|NCT00937326|565309861|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
156608614|NCT00937326|565309862|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
156608615|NCT00937326|565309863|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
156608616|NCT00790218|565309864|FG000|Overall Study|Death|1|||
156608617|NCT00790218|565309865|FG001|Overall Study|Death|0|||
156608618|NCT00790218|565309866|FG002|Overall Study|Death|0|||
156608619|NCT00086385|565309867|FG000|Overall Study|Death|2|||
156608620|NCT00086385|565309868|FG001|Overall Study|Death|2|||
156608621|NCT00086385|565309869|FG002|Overall Study|Death|1|||
156608622|NCT00086385|565309870|FG003|Overall Study|Death|1|||
156608623|NCT00693420|565309874|FG000|Overall Study|Adverse Event|4|||
156608624|NCT00693420|565309875|FG001|Overall Study|Adverse Event|4|||
156608625|NCT00693420|565309874|FG000|Overall Study|Lost to Follow-up|0|||
156608626|NCT00693420|565309875|FG001|Overall Study|Lost to Follow-up|3|||
156608627|NCT00693420|565309874|FG000|Overall Study|Withdrawal by Subject|1|||
156608628|NCT00693420|565309875|FG001|Overall Study|Withdrawal by Subject|0|||
156608629|NCT00693420|565309874|FG000|Overall Study|Protocol Violation|0|||
156608630|NCT00693420|565309875|FG001|Overall Study|Protocol Violation|2|||
156608631|NCT00693420|565309874|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
156608632|NCT00693420|565309875|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
156608633|NCT00693420|565309874|FG000|Overall Study|Personal Reasons|1|||
156608634|NCT00693420|565309875|FG001|Overall Study|Personal Reasons|4|||
156608635|NCT03250624|565309877|FG000|Overall Study|Lack of Efficacy|1|||
156608636|NCT03250624|565309878|FG001|Overall Study|Lack of Efficacy|4|||
156608637|NCT03250624|565309877|FG000|Overall Study|Adverse Event|0|||
156608638|NCT03250624|565309878|FG001|Overall Study|Adverse Event|1|||
156608639|NCT03250624|565309877|FG000|Overall Study|Other|1|||
156608640|NCT03250624|565309878|FG001|Overall Study|Other|2|||
156608641|NCT00948428|565309881|FG000|Overall Study|Withdrawal by Subject|6|||
156608642|NCT00948428|565309882|FG001|Overall Study|Withdrawal by Subject|12|||
156608643|NCT00948428|565309883|FG002|Overall Study|Withdrawal by Subject|7|||
156608644|NCT00948428|565309881|FG000|Overall Study|Adverse Event|6|||
156608645|NCT00948428|565309882|FG001|Overall Study|Adverse Event|3|||
156608646|NCT00948428|565309883|FG002|Overall Study|Adverse Event|0|||
156608647|NCT00948428|565309881|FG000|Overall Study|Lost to Follow-up|2|||
156608648|NCT00948428|565309882|FG001|Overall Study|Lost to Follow-up|1|||
156608649|NCT00948428|565309883|FG002|Overall Study|Lost to Follow-up|1|||
156608650|NCT00948428|565309881|FG000|Overall Study|Death|2|||
156608651|NCT00948428|565309882|FG001|Overall Study|Death|0|||
156608652|NCT00948428|565309883|FG002|Overall Study|Death|0|||
156608653|NCT00948428|565309881|FG000|Overall Study|Intercurrent Illness|1|||
156608654|NCT00948428|565309882|FG001|Overall Study|Intercurrent Illness|0|||
156608655|NCT00948428|565309883|FG002|Overall Study|Intercurrent Illness|0|||
156608656|NCT00948428|565309881|FG000|Overall Study|Non-compliance|1|||
156608657|NCT00948428|565309882|FG001|Overall Study|Non-compliance|2|||
156608658|NCT00948428|565309883|FG002|Overall Study|Non-compliance|0|||
156608659|NCT00509028|565309884|FG000|Overall Study|Adverse Event|2|||
156608660|NCT00509028|565309885|FG001|Overall Study|Adverse Event|0|||
156608661|NCT00509028|565309884|FG000|Overall Study|Withdrawal by Subject|4|||
156608662|NCT00509028|565309885|FG001|Overall Study|Withdrawal by Subject|3|||
156608663|NCT00509028|565309884|FG000|Overall Study|Lost to Follow-up|0|||
156608664|NCT00509028|565309885|FG001|Overall Study|Lost to Follow-up|1|||
156608665|NCT00509028|565309884|FG000|Overall Study|Protocol Violation|4|||
156608666|NCT00509028|565309885|FG001|Overall Study|Protocol Violation|2|||
156608667|NCT00509028|565309884|FG000|Overall Study|Non-compliance|2|||
156608668|NCT00509028|565309885|FG001|Overall Study|Non-compliance|1|||
156608669|NCT05516134|565309894|FG000|Overall Study|Lost to Follow-up|1|||
156608670|NCT05516134|565309895|FG001|Overall Study|Lost to Follow-up|0|||
156608671|NCT05516134|565309896|FG002|Overall Study|Lost to Follow-up|0|||
156608672|NCT01843205|565309905|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
156608673|NCT01843205|565309906|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
156608674|NCT00606177|565309907|FG000|Overall Study|Adverse Event|9|||
156608675|NCT00606177|565309908|FG001|Overall Study|Adverse Event|5|||
156608676|NCT00606177|565309907|FG000|Overall Study|Lack of Efficacy|3|||
156608677|NCT00606177|565309908|FG001|Overall Study|Lack of Efficacy|7|||
156608678|NCT00606177|565309907|FG000|Overall Study|Physician Decision|1|||
156608679|NCT00606177|565309908|FG001|Overall Study|Physician Decision|0|||
156608680|NCT00606177|565309907|FG000|Overall Study|Protocol Violation|1|||
156608681|NCT00606177|565309908|FG001|Overall Study|Protocol Violation|4|||
156608682|NCT00606177|565309907|FG000|Overall Study|Withdrawal by Subject|5|||
156608683|NCT00606177|565309908|FG001|Overall Study|Withdrawal by Subject|6|||
156608684|NCT00606177|565309907|FG000|Overall Study|Progression to depressive phase|6|||
156608685|NCT00606177|565309908|FG001|Overall Study|Progression to depressive phase|1|||
156608686|NCT00606177|565309907|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
156608687|NCT00606177|565309908|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
156608688|NCT00606177|565309907|FG000|Overall Study|Change of residence or other commitments|1|||
156608689|NCT00606177|565309908|FG001|Overall Study|Change of residence or other commitments|1|||
156608690|NCT00136357|565309909|FG000|Overall Study|Withdrawal by Subject|3|||
156608691|NCT00136357|565309910|FG001|Overall Study|Withdrawal by Subject|2|||
156608692|NCT01355497|565309911|FG000|Overall Study|Death|19|||
156608693|NCT01355497|565309912|FG001|Overall Study|Death|18|||
156608694|NCT01355497|565309911|FG000|Overall Study|Lost to Follow-up|3|||
156608695|NCT01355497|565309912|FG001|Overall Study|Lost to Follow-up|0|||
156608696|NCT01355497|565309911|FG000|Overall Study|Protocol Violation|0|||
156608697|NCT01355497|565309912|FG001|Overall Study|Protocol Violation|1|||
156608698|NCT01355497|565309911|FG000|Overall Study|other-not provided|9|||
156608699|NCT01355497|565309912|FG001|Overall Study|other-not provided|4|||
156608700|NCT01355497|565309911|FG000|Overall Study|Withdrawal by Subject|12|||
156608701|NCT01355497|565309912|FG001|Overall Study|Withdrawal by Subject|20|||
156608702|NCT01355497|565309911|FG000|Overall Study|noncompliance|1|||
156608703|NCT01355497|565309912|FG001|Overall Study|noncompliance|2|||
156608704|NCT01355497|565309911|FG000|Overall Study|progressive disease|11|||
156608705|NCT01355497|565309912|FG001|Overall Study|progressive disease|8|||
156608706|NCT01355497|565309911|FG000|Overall Study|Adverse Event|11|||
156608707|NCT01355497|565309912|FG001|Overall Study|Adverse Event|10|||
156608708|NCT01518309|565309917|FG000|Overall Study|Adverse Event|6|||
156608709|NCT01518309|565309917|FG000|Overall Study|Death|6|||
156608710|NCT01518309|565309917|FG000|Overall Study|Lack of Efficacy|7|||
156608711|NCT01518309|565309917|FG000|Overall Study|Withdrawal by Subject|6|||
156608712|NCT01518309|565309917|FG000|Overall Study|Physician Decision|3|||
156608713|NCT01518309|565309917|FG000|Overall Study|Sponsor Decision|2|||
156608714|NCT01518309|565309917|FG000|Overall Study|Not in Predefined Categories|9|||
156608715|NCT02603172|565309919|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
156608716|NCT02603172|565309920|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
156608717|NCT02603172|565309921|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
156608718|NCT02603172|565309922|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
156608719|NCT02603172|565309923|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
156608720|NCT02603172|565309924|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
156608721|NCT02603172|565309925|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
156608722|NCT02603172|565309926|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
156608723|NCT00863317|565309927|FG000|Overall Study|Lost to Follow-up|8|||
156608724|NCT00863317|565309928|FG001|Overall Study|Lost to Follow-up|9|||
156608725|NCT00038142|565309931|FG000|Overall Study|Ineligible|1|||
156608726|NCT00038142|565309932|FG001|Overall Study|Ineligible|0|||
156608727|NCT00038142|565309931|FG000|Overall Study|Progressive Disease|11|||
156608728|NCT00038142|565309932|FG001|Overall Study|Progressive Disease|7|||
156608729|NCT00038142|565309931|FG000|Overall Study|Death|1|||
156608730|NCT00038142|565309932|FG001|Overall Study|Death|0|||
156608731|NCT00038142|565309931|FG000|Overall Study|Adverse Event|1|||
156608732|NCT00038142|565309932|FG001|Overall Study|Adverse Event|0|||
156608733|NCT00038142|565309931|FG000|Overall Study|Unknown Reason|8|||
156608734|NCT00038142|565309932|FG001|Overall Study|Unknown Reason|0|||
156608735|NCT00441727|565309933|FG000|Overall Study|Protocol Violation|19|||
156608736|NCT00441727|565309934|FG001|Overall Study|Protocol Violation|28|||
156608737|NCT00441727|565309935|FG002|Overall Study|Protocol Violation|32|||
156608738|NCT00441727|565309933|FG000|Overall Study|Adverse Event|26|||
156608739|NCT00441727|565309934|FG001|Overall Study|Adverse Event|33|||
156608740|NCT00441727|565309935|FG002|Overall Study|Adverse Event|28|||
156608741|NCT00441727|565309933|FG000|Overall Study|Lack of Efficacy|7|||
156608742|NCT00441727|565309934|FG001|Overall Study|Lack of Efficacy|8|||
156608743|NCT00441727|565309935|FG002|Overall Study|Lack of Efficacy|48|||
156608744|NCT00441727|565309933|FG000|Overall Study|Withdrawal by Subject|40|||
156608745|NCT00441727|565309934|FG001|Overall Study|Withdrawal by Subject|34|||
156608746|NCT00441727|565309935|FG002|Overall Study|Withdrawal by Subject|47|||
156608747|NCT00441727|565309933|FG000|Overall Study|Lost to Follow-up|5|||
156608748|NCT00441727|565309934|FG001|Overall Study|Lost to Follow-up|6|||
156608749|NCT00441727|565309935|FG002|Overall Study|Lost to Follow-up|5|||
156608750|NCT00441727|565309933|FG000|Overall Study|Safety Reasons|3|||
156608751|NCT00441727|565309934|FG001|Overall Study|Safety Reasons|1|||
156608752|NCT00441727|565309935|FG002|Overall Study|Safety Reasons|3|||
156608753|NCT00441727|565309933|FG000|Overall Study|Various reason specified|6|||
156608754|NCT00441727|565309934|FG001|Overall Study|Various reason specified|8|||
156608755|NCT00441727|565309935|FG002|Overall Study|Various reason specified|5|||
156608756|NCT02133001|565309940|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
156608757|NCT02133001|565309941|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
156608758|NCT02133001|565309940|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
156608759|NCT02133001|565309941|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
156608760|NCT02133001|565309940|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
156608761|NCT02133001|565309941|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
156608762|NCT02133001|565309940|FG000|Double Blind (Day 1-25)|Other|2|||
156608763|NCT02133001|565309941|FG001|Double Blind (Day 1-25)|Other|2|||
156608764|NCT02133001|565309940|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
156608765|NCT02133001|565309941|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
156608766|NCT02133001|565309940|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
156608767|NCT02133001|565309941|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
156608768|NCT02133001|565309940|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
156608769|NCT02133001|565309941|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
156608770|NCT02133001|565309940|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
156608771|NCT02133001|565309941|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
156608772|NCT04211961|565309942|FG000|Overall Study|Death|0|||
156608773|NCT04211961|565309943|FG001|Overall Study|Death|1|||
156608774|NCT04211961|565309942|FG000|Overall Study|Lost to Follow-up|0|||
156608775|NCT04211961|565309943|FG001|Overall Study|Lost to Follow-up|1|||
156608776|NCT04211961|565309942|FG000|Overall Study|Withdrawal by Subject|0|||
156608777|NCT04211961|565309943|FG001|Overall Study|Withdrawal by Subject|1|||
156608778|NCT03933215|565309946|FG000|Overall Study|Other|6|||
156608779|NCT03933215|565309946|FG000|Overall Study|Sponsor decision|5|||
156608780|NCT03933215|565309946|FG000|Overall Study|Protocol Violation|5|||
156608781|NCT03933215|565309946|FG000|Overall Study|Withdrawal by Subject|6|||
156608782|NCT03933215|565309946|FG000|Overall Study|Lost to Follow-up|6|||
156608783|NCT03933215|565309946|FG000|Overall Study|Enrolled but not treated|38|||
156608784|NCT05784129|565309949|FG000|Overall Study|Study terminated by sponsor|2|||
156608785|NCT05784129|565309950|FG001|Overall Study|Study terminated by sponsor|2|||
156608786|NCT00407550|565309951|FG000|Overall Study|Adverse Event|0|||
156608787|NCT00407550|565309952|FG001|Overall Study|Adverse Event|1|||
156608788|NCT00407550|565309951|FG000|Overall Study|Withdrawal by Subject|0|||
156608789|NCT00407550|565309952|FG001|Overall Study|Withdrawal by Subject|2|||
156608790|NCT00407550|565309951|FG000|Overall Study|Death|1|||
156608791|NCT00407550|565309952|FG001|Overall Study|Death|0|||
156608792|NCT00407550|565309951|FG000|Overall Study|Insurance or Other medical condition|2|||
156608793|NCT00407550|565309952|FG001|Overall Study|Insurance or Other medical condition|1|||
156608794|NCT01444898|565309953|FG000|Overall Study|Withdrawal by Subject|1|||
156608795|NCT01831804|565309958|FG000|Overall Study|Adverse Event|0|||
156608796|NCT01831804|565309959|FG001|Overall Study|Adverse Event|0|||
156608797|NCT01831804|565309960|FG002|Overall Study|Adverse Event|0|||
156608798|NCT01831804|565309961|FG003|Overall Study|Adverse Event|0|||
156608799|NCT01831804|565309962|FG004|Overall Study|Adverse Event|0|||
156608800|NCT01831804|565309963|FG005|Overall Study|Adverse Event|0|||
156608801|NCT01831804|565309964|FG006|Overall Study|Adverse Event|1|||
156608802|NCT01831804|565309965|FG007|Overall Study|Adverse Event|0|||
156608803|NCT01831804|565309966|FG008|Overall Study|Adverse Event|1|||
156608804|NCT01831804|565309958|FG000|Overall Study|Protocol Violation|0|||
156608805|NCT01831804|565309959|FG001|Overall Study|Protocol Violation|0|||
156608806|NCT01831804|565309960|FG002|Overall Study|Protocol Violation|2|||
156608807|NCT01831804|565309961|FG003|Overall Study|Protocol Violation|0|||
156608808|NCT01831804|565309962|FG004|Overall Study|Protocol Violation|0|||
156608809|NCT01831804|565309963|FG005|Overall Study|Protocol Violation|0|||
156608810|NCT01831804|565309964|FG006|Overall Study|Protocol Violation|0|||
156608811|NCT01831804|565309965|FG007|Overall Study|Protocol Violation|0|||
156608812|NCT01831804|565309966|FG008|Overall Study|Protocol Violation|0|||
156608813|NCT01831804|565309958|FG000|Overall Study|Protocol defined stopping criteria|1|||
156608814|NCT01831804|565309959|FG001|Overall Study|Protocol defined stopping criteria|1|||
156608815|NCT01831804|565309960|FG002|Overall Study|Protocol defined stopping criteria|3|||
156608816|NCT01831804|565309961|FG003|Overall Study|Protocol defined stopping criteria|0|||
156608817|NCT01831804|565309962|FG004|Overall Study|Protocol defined stopping criteria|1|||
156608818|NCT01831804|565309963|FG005|Overall Study|Protocol defined stopping criteria|0|||
156608819|NCT01831804|565309964|FG006|Overall Study|Protocol defined stopping criteria|0|||
156608820|NCT01831804|565309965|FG007|Overall Study|Protocol defined stopping criteria|0|||
156608821|NCT01831804|565309966|FG008|Overall Study|Protocol defined stopping criteria|0|||
156608822|NCT01831804|565309958|FG000|Overall Study|Lost to Follow-up|0|||
156608823|NCT01831804|565309959|FG001|Overall Study|Lost to Follow-up|0|||
156608824|NCT01831804|565309960|FG002|Overall Study|Lost to Follow-up|1|||
156608825|NCT01831804|565309961|FG003|Overall Study|Lost to Follow-up|0|||
156608826|NCT01831804|565309962|FG004|Overall Study|Lost to Follow-up|0|||
156608827|NCT01831804|565309963|FG005|Overall Study|Lost to Follow-up|0|||
156608828|NCT01831804|565309964|FG006|Overall Study|Lost to Follow-up|0|||
156608829|NCT01831804|565309965|FG007|Overall Study|Lost to Follow-up|0|||
156608830|NCT01831804|565309966|FG008|Overall Study|Lost to Follow-up|1|||
156608831|NCT01831804|565309958|FG000|Overall Study|Investigator discretion|0|||
156608832|NCT01831804|565309959|FG001|Overall Study|Investigator discretion|0|||
156608833|NCT01831804|565309960|FG002|Overall Study|Investigator discretion|0|||
156608834|NCT01831804|565309961|FG003|Overall Study|Investigator discretion|0|||
156608835|NCT01831804|565309962|FG004|Overall Study|Investigator discretion|1|||
156608836|NCT01831804|565309963|FG005|Overall Study|Investigator discretion|0|||
156608837|NCT01831804|565309964|FG006|Overall Study|Investigator discretion|0|||
156608838|NCT01831804|565309965|FG007|Overall Study|Investigator discretion|1|||
156608839|NCT01831804|565309966|FG008|Overall Study|Investigator discretion|0|||
156608840|NCT01831804|565309958|FG000|Overall Study|Withdrew Consent|0|||
156608841|NCT01831804|565309959|FG001|Overall Study|Withdrew Consent|1|||
156608842|NCT01831804|565309960|FG002|Overall Study|Withdrew Consent|0|||
156608843|NCT01831804|565309961|FG003|Overall Study|Withdrew Consent|0|||
156608844|NCT01831804|565309962|FG004|Overall Study|Withdrew Consent|0|||
156608845|NCT01831804|565309963|FG005|Overall Study|Withdrew Consent|0|||
156608846|NCT01831804|565309964|FG006|Overall Study|Withdrew Consent|0|||
156608847|NCT01831804|565309965|FG007|Overall Study|Withdrew Consent|2|||
156608848|NCT01831804|565309966|FG008|Overall Study|Withdrew Consent|0|||
156608849|NCT01819506|565309967|FG000|Overall Study|Physician Decision|5|||
156608850|NCT01819506|565309968|FG001|Overall Study|Physician Decision|2|||
156608851|NCT01819506|565309967|FG000|Overall Study|Withdrawal by Subject|3|||
156608852|NCT01819506|565309968|FG001|Overall Study|Withdrawal by Subject|3|||
156608853|NCT03168555|565309970|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
156608854|NCT03168555|565309970|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
156608855|NCT03168555|565309970|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
156608856|NCT03168555|565309970|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
156608857|NCT01235507|565309971|FG000|Overall Study|Adverse Event|1|||
156608858|NCT01235507|565309971|FG000|Overall Study|Withdrawal by Subject|1|||
156608859|NCT01587274|565309974|FG000|Overall Study|Lost to Follow-up|4|||
156608860|NCT01587274|565309975|FG001|Overall Study|Lost to Follow-up|5|||
156608861|NCT01587274|565309976|FG002|Overall Study|Lost to Follow-up|3|||
156608862|NCT01042938|565309979|FG000|Overall Study|Withdrawal by Subject|1|||
156608863|NCT01042938|565309980|FG001|Overall Study|Withdrawal by Subject|1|||
156608864|NCT01042938|565309979|FG000|Overall Study|Protocol Violation|1|||
156608865|NCT01042938|565309980|FG001|Overall Study|Protocol Violation|1|||
156608866|NCT01042938|565309979|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
156608867|NCT01042938|565309980|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
156608868|NCT03136484|565309981|FG000|Overall Study|Withdrawal by Subject|19|||
156608869|NCT03136484|565309982|FG001|Overall Study|Withdrawal by Subject|14|||
156608870|NCT03136484|565309981|FG000|Overall Study|Lost to Follow-up|7|||
156608871|NCT03136484|565309982|FG001|Overall Study|Lost to Follow-up|8|||
156608872|NCT03136484|565309981|FG000|Overall Study|Death|1|||
156608873|NCT03136484|565309982|FG001|Overall Study|Death|0|||
156608874|NCT01449955|565309987|FG000|Overall Study|Withdrawal by Subject|1|||
156608875|NCT01449955|565309988|FG001|Overall Study|Withdrawal by Subject|2|||
156608876|NCT04018612|565309991|FG000|Overall Study|Withdrawal by Subject|1|||
156608877|NCT04018612|565309992|FG001|Overall Study|Withdrawal by Subject|0|||
156608878|NCT04018612|565309993|FG002|Overall Study|Withdrawal by Subject|1|||
156608879|NCT00361218|565309994|FG000|Overall Study|Lost to Follow-up|11|||
156608880|NCT00361218|565309994|FG000|Overall Study|Personal Reasons|7|||
156608881|NCT00361218|565309994|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
156608882|NCT02566109|565309995|FG000|Overall Study|Withdrawal by Subject|1|||
156608883|NCT01041404|565309998|FG000|Overall Study|Adverse Event|45|||
156608884|NCT01041404|565309999|FG001|Overall Study|Adverse Event|35|||
156608885|NCT01041404|565309998|FG000|Overall Study|Lack of Efficacy|200|||
156608886|NCT01041404|565309999|FG001|Overall Study|Lack of Efficacy|210|||
156608887|NCT01041404|565309998|FG000|Overall Study|Violation of Selection Criteria|0|||
156608888|NCT01041404|565309999|FG001|Overall Study|Violation of Selection Criteria|1|||
156608889|NCT01041404|565309998|FG000|Overall Study|Protocol Violation|4|||
156608890|NCT01041404|565309999|FG001|Overall Study|Protocol Violation|0|||
156608891|NCT01041404|565309998|FG000|Overall Study|Withdrawal by Subject|29|||
156608892|NCT01041404|565309999|FG001|Overall Study|Withdrawal by Subject|23|||
156608893|NCT01041404|565309998|FG000|Overall Study|Failure to Return|1|||
156608894|NCT01041404|565309999|FG001|Overall Study|Failure to Return|2|||
156608895|NCT01041404|565309998|FG000|Overall Study|Other|11|||
156608896|NCT01041404|565309999|FG001|Overall Study|Other|23|||
156608897|NCT00318370|565310002|FG000|Period 1|Lack of Efficacy|5|||
156608898|NCT00318370|565310003|FG001|Period 1|Lack of Efficacy|0|||
156608899|NCT00318370|565310004|FG002|Period 1|Lack of Efficacy|0|||
156608900|NCT00318370|565310002|FG000|Period 1|Physician Decision|1|||
156608901|NCT00318370|565310003|FG001|Period 1|Physician Decision|0|||
156608902|NCT00318370|565310004|FG002|Period 1|Physician Decision|0|||
156608903|NCT00318370|565310002|FG000|Period 1|Withdrawal by Subject|1|||
156608904|NCT00318370|565310003|FG001|Period 1|Withdrawal by Subject|0|||
156608905|NCT00318370|565310004|FG002|Period 1|Withdrawal by Subject|0|||
156608906|NCT00318370|565310002|FG000|Period 2|Adverse Event|0|||
156608907|NCT00318370|565310003|FG001|Period 2|Adverse Event|3|||
156608908|NCT00318370|565310004|FG002|Period 2|Adverse Event|0|||
156608909|NCT00318370|565310002|FG000|Period 2|Lack of Efficacy|0|||
156608910|NCT00318370|565310003|FG001|Period 2|Lack of Efficacy|5|||
156608911|NCT00318370|565310004|FG002|Period 2|Lack of Efficacy|0|||
156608912|NCT00318370|565310002|FG000|Period 2|Physician Decision|0|||
156608913|NCT00318370|565310003|FG001|Period 2|Physician Decision|1|||
156608914|NCT00318370|565310004|FG002|Period 2|Physician Decision|0|||
156608915|NCT00318370|565310002|FG000|Period 2|Withdrawal by Subject|0|||
156608916|NCT00318370|565310003|FG001|Period 2|Withdrawal by Subject|1|||
156608917|NCT00318370|565310004|FG002|Period 2|Withdrawal by Subject|0|||
156608918|NCT00318370|565310002|FG000|Period 2|Other|0|||
156608919|NCT00318370|565310003|FG001|Period 2|Other|1|||
156608920|NCT00318370|565310004|FG002|Period 2|Other|0|||
156608921|NCT00318370|565310002|FG000|Period 3|Adverse Event|0|||
156608922|NCT00318370|565310003|FG001|Period 3|Adverse Event|0|||
156608923|NCT00318370|565310004|FG002|Period 3|Adverse Event|1|||
156608924|NCT00318370|565310002|FG000|Period 3|Lack of Efficacy|0|||
156608925|NCT00318370|565310003|FG001|Period 3|Lack of Efficacy|0|||
156608926|NCT00318370|565310004|FG002|Period 3|Lack of Efficacy|24|||
156608927|NCT00318370|565310002|FG000|Period 3|Death|0|||
156608928|NCT00318370|565310003|FG001|Period 3|Death|0|||
156608929|NCT00318370|565310004|FG002|Period 3|Death|1|||
156608930|NCT00318370|565310002|FG000|Period 3|Physician Decision|0|||
156608931|NCT00318370|565310003|FG001|Period 3|Physician Decision|0|||
156608932|NCT00318370|565310004|FG002|Period 3|Physician Decision|1|||
156608933|NCT00318370|565310002|FG000|Period 3|Withdrawal by Subject|0|||
156608934|NCT00318370|565310003|FG001|Period 3|Withdrawal by Subject|0|||
156608935|NCT00318370|565310004|FG002|Period 3|Withdrawal by Subject|3|||
156608936|NCT00318370|565310002|FG000|Period 3|Other|0|||
156608937|NCT00318370|565310003|FG001|Period 3|Other|0|||
156608938|NCT00318370|565310004|FG002|Period 3|Other|3|||
156608939|NCT01731990|565312098|FG000|Overall Study|Adverse Event|1|||
156608940|NCT01731990|565312099|FG001|Overall Study|Adverse Event|5|||
156608941|NCT01731990|565312098|FG000|Overall Study|Withdrawal by Subject|1|||
156608942|NCT01731990|565312099|FG001|Overall Study|Withdrawal by Subject|1|||
156608943|NCT01731990|565312098|FG000|Overall Study|Protocol deviation|1|||
156608944|NCT01731990|565312099|FG001|Overall Study|Protocol deviation|2|||
156608945|NCT01731990|565312098|FG000|Overall Study|Death|1|||
156608946|NCT01731990|565312099|FG001|Overall Study|Death|0|||
156608947|NCT01183104|565312102|FG000|Overall Study|Adverse Event|8|||
156608948|NCT01183104|565312103|FG001|Overall Study|Adverse Event|6|||
156608949|NCT01183104|565312102|FG000|Overall Study|Death|0|||
156608950|NCT01183104|565312103|FG001|Overall Study|Death|1|||
156608951|NCT01183104|565312102|FG000|Overall Study|Lost to Follow-up|14|||
156608952|NCT01183104|565312103|FG001|Overall Study|Lost to Follow-up|7|||
156608953|NCT01183104|565312102|FG000|Overall Study|Physician Decision|5|||
156608954|NCT01183104|565312103|FG001|Overall Study|Physician Decision|8|||
156608955|NCT01183104|565312102|FG000|Overall Study|Withdrawal by Subject|6|||
156608956|NCT01183104|565312103|FG001|Overall Study|Withdrawal by Subject|11|||
156608957|NCT01183104|565312102|FG000|Overall Study|Nonparticipation in Extension Study|39|||
156608958|NCT01183104|565312103|FG001|Overall Study|Nonparticipation in Extension Study|50|||
156608959|NCT01183104|565312102|FG000|Overall Study|Did not receive study drug|5|||
156608960|NCT01183104|565312103|FG001|Overall Study|Did not receive study drug|9|||
156608961|NCT01957215|565312108|FG000|Overall Study|Adverse Event|2|||
156608962|NCT01957215|565312109|FG001|Overall Study|Adverse Event|2|||
156608963|NCT01957215|565312108|FG000|Overall Study|Lost to Follow-up|3|||
156608964|NCT01957215|565312109|FG001|Overall Study|Lost to Follow-up|3|||
156608965|NCT01957215|565312108|FG000|Overall Study|Protocol Violation|1|||
156608966|NCT01957215|565312109|FG001|Overall Study|Protocol Violation|2|||
156608967|NCT01957215|565312108|FG000|Overall Study|Withdrawal by Subject|7|||
156608968|NCT01957215|565312109|FG001|Overall Study|Withdrawal by Subject|5|||
156608969|NCT03597503|565312113|FG000|Overall Study|Withdrawal by Subject|0|||
156608970|NCT03597503|565312114|FG001|Overall Study|Withdrawal by Subject|2|||
156608971|NCT03597503|565312113|FG000|Overall Study|Lost to Follow-up|1|||
156608972|NCT03597503|565312114|FG001|Overall Study|Lost to Follow-up|2|||
156608973|NCT03597503|565312113|FG000|Overall Study|Protocol Violation|1|||
156608974|NCT03597503|565312114|FG001|Overall Study|Protocol Violation|0|||
156608975|NCT02578992|565312117|FG000|Overall Study|equipment not available or malfunction|3|||
156608976|NCT02578992|565312118|FG001|Overall Study|equipment not available or malfunction|3|||
156608977|NCT00420342|565312119|FG000|Overall Study|Lost to Follow-up|1|||
156608978|NCT00420342|565312120|FG001|Overall Study|Lost to Follow-up|0|||
156608979|NCT00420342|565312121|FG002|Overall Study|Lost to Follow-up|1|||
156608980|NCT00420342|565312119|FG000|Overall Study|Withdrawal by Subject|0|||
156608981|NCT00420342|565312120|FG001|Overall Study|Withdrawal by Subject|2|||
156608982|NCT00420342|565312121|FG002|Overall Study|Withdrawal by Subject|0|||
156608983|NCT00839436|565312126|FG000|Overall Study|Developed exclusionary condition|1|||
156608984|NCT00839436|565312127|FG001|Overall Study|Developed exclusionary condition|0|||
156608985|NCT00839436|565312128|FG002|Overall Study|Developed exclusionary condition|0|||
156608986|NCT00839436|565312126|FG000|Overall Study|Withdrawal by Subject|0|||
156608987|NCT00839436|565312127|FG001|Overall Study|Withdrawal by Subject|1|||
156608988|NCT00839436|565312128|FG002|Overall Study|Withdrawal by Subject|0|||
156608989|NCT00839436|565312126|FG000|Overall Study|Study drug no longer available|0|||
156608990|NCT00839436|565312127|FG001|Overall Study|Study drug no longer available|0|||
156608991|NCT00839436|565312128|FG002|Overall Study|Study drug no longer available|1|||
156608992|NCT01440972|565312129|FG000|Overall Study|Withdrawal by Subject|3|||
156608993|NCT01440972|565312130|FG001|Overall Study|Withdrawal by Subject|2|||
156608994|NCT04072575|565312131|FG000|Overall Study|Physician Decision|1|||
156608995|NCT04072575|565312131|FG000|Overall Study|Adverse Event|7|||
156608996|NCT04072575|565312131|FG000|Overall Study|Withdrawal by Subject|14|||
156608997|NCT04072575|565312131|FG000|Overall Study|Other|2|||
156608998|NCT02580591|565312132|FG000|Overall Study|Adverse Event|0|||
156608999|NCT02580591|565312133|FG001|Overall Study|Adverse Event|1|||
156609000|NCT02580591|565312134|FG002|Overall Study|Adverse Event|2|||
156609001|NCT02580591|565312135|FG003|Overall Study|Adverse Event|5|||
156609002|NCT02580591|565312132|FG000|Overall Study|Protocol Violation|3|||
156609003|NCT02580591|565312133|FG001|Overall Study|Protocol Violation|2|||
156609004|NCT02580591|565312134|FG002|Overall Study|Protocol Violation|1|||
156609005|NCT02580591|565312135|FG003|Overall Study|Protocol Violation|1|||
156609006|NCT02580591|565312132|FG000|Overall Study|Lost to Follow-up|5|||
156609007|NCT02580591|565312133|FG001|Overall Study|Lost to Follow-up|3|||
156609008|NCT02580591|565312134|FG002|Overall Study|Lost to Follow-up|3|||
156609009|NCT02580591|565312135|FG003|Overall Study|Lost to Follow-up|1|||
156609010|NCT02580591|565312132|FG000|Overall Study|Withdrawal by Subject|6|||
156609011|NCT02580591|565312133|FG001|Overall Study|Withdrawal by Subject|1|||
156609012|NCT02580591|565312134|FG002|Overall Study|Withdrawal by Subject|2|||
156609013|NCT02580591|565312135|FG003|Overall Study|Withdrawal by Subject|3|||
156609014|NCT02580591|565312132|FG000|Overall Study|Not treated|1|||
156609015|NCT02580591|565312133|FG001|Overall Study|Not treated|1|||
156609016|NCT02580591|565312134|FG002|Overall Study|Not treated|0|||
156609017|NCT02580591|565312135|FG003|Overall Study|Not treated|0|||
156609018|NCT02580591|565312132|FG000|Overall Study|Other than specified|3|||
156609019|NCT02580591|565312133|FG001|Overall Study|Other than specified|2|||
156609020|NCT02580591|565312134|FG002|Overall Study|Other than specified|5|||
156609021|NCT02580591|565312135|FG003|Overall Study|Other than specified|2|||
156609022|NCT01599806|565312138|FG000|Overall Study|Lost to Follow-up|20|||
156609023|NCT01599806|565312139|FG001|Overall Study|Lost to Follow-up|20|||
156609024|NCT01599806|565312138|FG000|Overall Study|Withdrawal by Subject|12|||
156609025|NCT01599806|565312139|FG001|Overall Study|Withdrawal by Subject|12|||
156609026|NCT01599806|565312138|FG000|Overall Study|Other Eligibility criteria|11|||
156609027|NCT01599806|565312139|FG001|Overall Study|Other Eligibility criteria|9|||
156609028|NCT03006926|565312140|FG000|Overall Study|Adverse Event|0|||
156609029|NCT03006926|565312141|FG001|Overall Study|Adverse Event|27|||
156609030|NCT03006926|565312140|FG000|Overall Study|Withdrawal by Subject|0|||
156609031|NCT03006926|565312141|FG001|Overall Study|Withdrawal by Subject|1|||
156609032|NCT03006926|565312140|FG000|Overall Study|Radiological Disease Progression|0|||
156609033|NCT03006926|565312141|FG001|Overall Study|Radiological Disease Progression|52|||
156609034|NCT03006926|565312140|FG000|Overall Study|Clinical Disease Progression|0|||
156609035|NCT03006926|565312141|FG001|Overall Study|Clinical Disease Progression|10|||
156609036|NCT03006926|565312140|FG000|Overall Study|Other|0|||
156609037|NCT03006926|565312141|FG001|Overall Study|Other|8|||
156609038|NCT01838213|565312142|FG000|Overall Study|Ineligible|166|||
156609039|NCT01838213|565312143|FG001|Overall Study|Ineligible|191|||
156609040|NCT04882072|565312148|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
156609041|NCT04882072|565312149|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
156609042|NCT04882072|565312148|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
156609043|NCT04882072|565312149|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
156609044|NCT04882072|565312148|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
156609045|NCT04882072|565312149|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
156609046|NCT02918318|565312150|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
156609047|NCT02918318|565312151|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
156609048|NCT02918318|565312152|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
156609049|NCT02918318|565312153|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
156609050|NCT02918318|565312154|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
156609051|NCT02918318|565312150|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
156609052|NCT02918318|565312151|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
156609053|NCT02918318|565312152|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
156609054|NCT02918318|565312153|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
156609055|NCT02918318|565312154|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
156609056|NCT02918318|565312150|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
156609057|NCT02918318|565312151|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
156609058|NCT02918318|565312152|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
156609059|NCT02918318|565312153|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
156609060|NCT02918318|565312154|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
156609061|NCT02918318|565312150|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
156609062|NCT02918318|565312151|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
156609063|NCT02918318|565312152|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
156609064|NCT02918318|565312153|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
156609065|NCT02918318|565312154|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
156609066|NCT02918318|565312150|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
156609067|NCT02918318|565312151|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
156609068|NCT02918318|565312152|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
156609069|NCT02918318|565312153|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
156609070|NCT02918318|565312154|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
156609071|NCT02918318|565312150|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
156609072|NCT02918318|565312151|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
156609073|NCT02918318|565312152|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
156609074|NCT02918318|565312153|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
156609075|NCT02918318|565312154|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
156609076|NCT02918318|565312150|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
156609077|NCT02918318|565312151|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
156609078|NCT02918318|565312152|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
156609079|NCT02918318|565312153|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
156609080|NCT02918318|565312154|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
156609081|NCT02918318|565312150|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
156609082|NCT02918318|565312151|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
156609083|NCT02918318|565312152|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
156609084|NCT02918318|565312153|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
156609085|NCT02918318|565312154|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
156609086|NCT02918318|565312150|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
156609087|NCT02918318|565312151|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
156609088|NCT02918318|565312152|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
156609089|NCT02918318|565312153|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
156609090|NCT02918318|565312154|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
156609091|NCT02918318|565312150|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
156609092|NCT02918318|565312151|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
156609093|NCT02918318|565312152|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
156609094|NCT02918318|565312153|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
156609095|NCT02918318|565312154|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
156609096|NCT02918318|565312150|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
156609097|NCT02918318|565312151|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
156609098|NCT02918318|565312152|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
156609099|NCT02918318|565312153|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
156609100|NCT02918318|565312154|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
156609101|NCT02918318|565312150|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
156609102|NCT02918318|565312151|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
156609103|NCT02918318|565312152|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
156609104|NCT02918318|565312153|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
156609105|NCT02918318|565312154|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
156609106|NCT00990249|565312155|FG000|Overall Study|Disease Progression|8|||
156609107|NCT00990249|565312155|FG000|Overall Study|Non-Compliance|1|||
156609108|NCT00990249|565312155|FG000|Overall Study|Death|2|||
156609109|NCT00990249|565312155|FG000|Overall Study|Not treated|2|||
156609110|NCT01548417|565312156|FG000|Overall Study|Withdrawal by Subject|0|||
156609111|NCT01548417|565312157|FG001|Overall Study|Withdrawal by Subject|2|||
156609112|NCT04583969|565312158|FG000|Overall Study|Death|31|||
156609113|NCT04583969|565312159|FG001|Overall Study|Death|38|||
156609114|NCT04583969|565312158|FG000|Overall Study|Lost to Follow-up|16|||
156609115|NCT04583969|565312159|FG001|Overall Study|Lost to Follow-up|13|||
156609116|NCT04583969|565312158|FG000|Overall Study|Protocol Violation|1|||
156609117|NCT04583969|565312159|FG001|Overall Study|Protocol Violation|0|||
156609118|NCT04583969|565312158|FG000|Overall Study|Withdrawal by Subject|3|||
156609119|NCT04583969|565312159|FG001|Overall Study|Withdrawal by Subject|3|||
156609120|NCT04583969|565312158|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
156609121|NCT04583969|565312159|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
156609122|NCT04583969|565312158|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
156609123|NCT04583969|565312159|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
156609124|NCT04583969|565312158|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
156609125|NCT04583969|565312159|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
156609126|NCT04583969|565312158|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
156609127|NCT04583969|565312159|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
156609128|NCT04583969|565312158|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
156609129|NCT04583969|565312159|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
156609130|NCT02873208|565312160|FG000|Overall Study|Withdrawal by Subject|36|||
156609131|NCT02873208|565312160|FG000|Overall Study|Lost to Follow-up|22|||
156609132|NCT02873208|565312160|FG000|Overall Study|Adverse Event|15|||
156609133|NCT02873208|565312160|FG000|Overall Study|Non-compliance with study drug|12|||
156609134|NCT02873208|565312160|FG000|Overall Study|Protocol Violation|8|||
156609135|NCT02873208|565312160|FG000|Overall Study|Pregnancy|2|||
156609136|NCT02873208|565312160|FG000|Overall Study|Incarceration|1|||
156609137|NCT02873208|565312160|FG000|Overall Study|Lack of Efficacy|1|||
156609138|NCT02873208|565312160|FG000|Overall Study|Physician Decision|1|||
156609139|NCT00415584|565312161|FG000|Overall Study|Withdrawal by Subject|1|||
156609140|NCT01061567|565312162|FG000|Overall Study|Adverse Event|32|||
156609141|NCT01061567|565312162|FG000|Overall Study|Death|2|||
156609142|NCT01061567|565312162|FG000|Overall Study|Lack of Efficacy|3|||
156609143|NCT01061567|565312162|FG000|Overall Study|Lost to Follow-up|24|||
156609144|NCT01061567|565312162|FG000|Overall Study|Protocol Violation|1|||
156609145|NCT01061567|565312162|FG000|Overall Study|Withdrawal by Subject|11|||
156609146|NCT01061567|565312162|FG000|Overall Study|Other reason than stated above|3|||
156609147|NCT00563368|565312163|FG000|Overall Study|Lost to Follow-up|14|||
156609148|NCT00563368|565312164|FG001|Overall Study|Lost to Follow-up|14|||
156609149|NCT00563368|565312165|FG002|Overall Study|Lost to Follow-up|12|||
156609150|NCT00563368|565312166|FG003|Overall Study|Lost to Follow-up|6|||
156609151|NCT00563368|565312167|FG004|Overall Study|Lost to Follow-up|9|||
156609152|NCT00563368|565312168|FG005|Overall Study|Lost to Follow-up|8|||
156609153|NCT00563368|565312169|FG006|Overall Study|Lost to Follow-up|9|||
156609154|NCT00563368|565312163|FG000|Overall Study|Adverse Event|3|||
156609155|NCT00563368|565312164|FG001|Overall Study|Adverse Event|4|||
156609156|NCT00563368|565312165|FG002|Overall Study|Adverse Event|5|||
156609157|NCT00563368|565312166|FG003|Overall Study|Adverse Event|9|||
156609158|NCT00563368|565312167|FG004|Overall Study|Adverse Event|6|||
156609159|NCT00563368|565312168|FG005|Overall Study|Adverse Event|10|||
156609160|NCT00563368|565312169|FG006|Overall Study|Adverse Event|17|||
156609161|NCT00563368|565312163|FG000|Overall Study|Withdrawal by Subject|11|||
156609162|NCT00563368|565312164|FG001|Overall Study|Withdrawal by Subject|6|||
156609163|NCT00563368|565312165|FG002|Overall Study|Withdrawal by Subject|5|||
156609164|NCT00563368|565312166|FG003|Overall Study|Withdrawal by Subject|7|||
156609165|NCT00563368|565312167|FG004|Overall Study|Withdrawal by Subject|8|||
156609166|NCT00563368|565312168|FG005|Overall Study|Withdrawal by Subject|5|||
156609167|NCT00563368|565312169|FG006|Overall Study|Withdrawal by Subject|4|||
156609168|NCT00563368|565312163|FG000|Overall Study|protocol non-compliance|1|||
156609169|NCT00563368|565312164|FG001|Overall Study|protocol non-compliance|1|||
156609170|NCT00563368|565312165|FG002|Overall Study|protocol non-compliance|2|||
156609171|NCT00563368|565312166|FG003|Overall Study|protocol non-compliance|1|||
156609172|NCT00563368|565312167|FG004|Overall Study|protocol non-compliance|0|||
156609173|NCT00563368|565312168|FG005|Overall Study|protocol non-compliance|1|||
156609174|NCT00563368|565312169|FG006|Overall Study|protocol non-compliance|3|||
156609175|NCT00563368|565312163|FG000|Overall Study|Pregnancy|1|||
156609176|NCT00563368|565312164|FG001|Overall Study|Pregnancy|0|||
156609177|NCT00563368|565312165|FG002|Overall Study|Pregnancy|1|||
156609178|NCT00563368|565312166|FG003|Overall Study|Pregnancy|2|||
156609179|NCT00563368|565312167|FG004|Overall Study|Pregnancy|1|||
156609180|NCT00563368|565312168|FG005|Overall Study|Pregnancy|2|||
156609181|NCT00563368|565312169|FG006|Overall Study|Pregnancy|0|||
156609182|NCT00563368|565312163|FG000|Overall Study|requirement for restricted medication|0|||
156609183|NCT00563368|565312164|FG001|Overall Study|requirement for restricted medication|0|||
156609184|NCT00563368|565312165|FG002|Overall Study|requirement for restricted medication|2|||
156609185|NCT00563368|565312166|FG003|Overall Study|requirement for restricted medication|0|||
156609186|NCT00563368|565312167|FG004|Overall Study|requirement for restricted medication|0|||
156609187|NCT00563368|565312168|FG005|Overall Study|requirement for restricted medication|0|||
156609188|NCT00563368|565312169|FG006|Overall Study|requirement for restricted medication|0|||
156609189|NCT00563368|565312163|FG000|Overall Study|Other|5|||
156609190|NCT00563368|565312164|FG001|Overall Study|Other|5|||
156609191|NCT00563368|565312165|FG002|Overall Study|Other|3|||
156609192|NCT00563368|565312166|FG003|Overall Study|Other|4|||
156609193|NCT00563368|565312167|FG004|Overall Study|Other|4|||
156609194|NCT00563368|565312168|FG005|Overall Study|Other|4|||
156609195|NCT00563368|565312169|FG006|Overall Study|Other|0|||
156609196|NCT02640755|565312170|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
156609197|NCT02640755|565312171|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
156609198|NCT02640755|565312170|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
156609199|NCT02640755|565312171|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
156609200|NCT02640755|565312170|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
156609201|NCT02640755|565312171|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
156609202|NCT01192100|565312178|FG000|Overall Study|Withdrawal by Subject|0|||
156609203|NCT01192100|565312179|FG001|Overall Study|Withdrawal by Subject|0|||
156609204|NCT01192100|565312180|FG002|Overall Study|Withdrawal by Subject|0|||
156609205|NCT01192100|565312181|FG003|Overall Study|Withdrawal by Subject|0|||
156609206|NCT01192100|565312182|FG004|Overall Study|Withdrawal by Subject|1|||
156609207|NCT01192100|565312183|FG005|Overall Study|Withdrawal by Subject|0|||
156609208|NCT01192100|565312178|FG000|Overall Study|Protocol Violation|0|||
156609209|NCT01192100|565312179|FG001|Overall Study|Protocol Violation|0|||
156609210|NCT01192100|565312180|FG002|Overall Study|Protocol Violation|0|||
156609211|NCT01192100|565312181|FG003|Overall Study|Protocol Violation|1|||
156609212|NCT01192100|565312182|FG004|Overall Study|Protocol Violation|0|||
156609213|NCT01192100|565312183|FG005|Overall Study|Protocol Violation|0|||
156609214|NCT02057068|565312184|FG000|Overall Study|Withdrawal by Subject|2|||
156609215|NCT02057068|565312185|FG001|Overall Study|Withdrawal by Subject|2|||
156609216|NCT02057068|565312184|FG000|Overall Study|Caregiver (CG) Health|0|||
156609217|NCT02057068|565312185|FG001|Overall Study|Caregiver (CG) Health|2|||
156609218|NCT02057068|565312184|FG000|Overall Study|Carepartner (CP) Health|4|||
156609219|NCT02057068|565312185|FG001|Overall Study|Carepartner (CP) Health|2|||
156609220|NCT02057068|565312184|FG000|Overall Study|Lost to Follow-up|2|||
156609221|NCT02057068|565312185|FG001|Overall Study|Lost to Follow-up|2|||
156609222|NCT00841672|565312187|FG000|Overall Study|Adverse Event|7|||
156609223|NCT00841672|565312188|FG001|Overall Study|Adverse Event|16|||
156609224|NCT00841672|565312187|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156609225|NCT00841672|565312188|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156609226|NCT00841672|565312187|FG000|Overall Study|Subject withdrew consent|2|||
156609227|NCT00841672|565312188|FG001|Overall Study|Subject withdrew consent|4|||
156609228|NCT00841672|565312187|FG000|Overall Study|Lost to Follow-up|1|||
156609229|NCT00841672|565312188|FG001|Overall Study|Lost to Follow-up|1|||
156609230|NCT00841672|565312187|FG000|Overall Study|Administrative problems|9|||
156609231|NCT00841672|565312188|FG001|Overall Study|Administrative problems|9|||
156609232|NCT00841672|565312187|FG000|Overall Study|Misrandomized|1|||
156609233|NCT00841672|565312188|FG001|Overall Study|Misrandomized|0|||
156609234|NCT00841672|565312187|FG000|Overall Study|Protocol Deviation|0|||
156609235|NCT00841672|565312188|FG001|Overall Study|Protocol Deviation|1|||
156609236|NCT00842361|565312191|FG000|Overall Study|Protocol Violation|1|||
156609237|NCT00842361|565312192|FG001|Overall Study|Protocol Violation|0|||
156609238|NCT00842361|565312191|FG000|Overall Study|Unclassified|0|||
156609239|NCT00842361|565312192|FG001|Overall Study|Unclassified|2|||
156609240|NCT02186561|565312193|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
156609241|NCT02186561|565312193|FG000|Enrollment|Enrollment Cap Reached|5|||
156609242|NCT02186561|565312193|FG000|Enrollment|Insurance Denial|2|||
156609243|NCT02186561|565312193|FG000|Enrollment|Withdrawal by Subject|2|||
156609244|NCT02186561|565312193|FG000|Enrollment|Investigator Withdrew Consent|1|||
156609245|NCT02186561|565312193|FG000|30-Day Post Index Procedure Visit|Death|1|||
156609246|NCT02186561|565312193|FG000|1- Year Post Index Procedure Visit|Death|1|||
156609247|NCT02186561|565312193|FG000|1- Year Post Index Procedure Visit|Missed|1|||
156609248|NCT01072448|565312196|FG000|Overall Study|Adverse Event|9|||
156609249|NCT01072448|565312197|FG001|Overall Study|Adverse Event|10|||
156609250|NCT01072448|565312196|FG000|Overall Study|Subject withdrew consent|4|||
156609251|NCT01072448|565312197|FG001|Overall Study|Subject withdrew consent|9|||
156609252|NCT01072448|565312196|FG000|Overall Study|Protocol deviation|3|||
156609253|NCT01072448|565312197|FG001|Overall Study|Protocol deviation|4|||
156609254|NCT01072448|565312196|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156609255|NCT01072448|565312197|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156609256|NCT01072448|565312196|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156609257|NCT01072448|565312197|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156609258|NCT01072448|565312196|FG000|Overall Study|Lost to Follow-up|1|||
156609259|NCT01072448|565312197|FG001|Overall Study|Lost to Follow-up|1|||
156609260|NCT01072448|565312196|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156609261|NCT01072448|565312197|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156609262|NCT01072448|565312196|FG000|Overall Study|Death|0|||
156609263|NCT01072448|565312197|FG001|Overall Study|Death|2|||
156609264|NCT01814826|565312200|FG000|Overall Study|Other|3|||
156609265|NCT01814826|565312201|FG001|Overall Study|Other|5|||
156609266|NCT01814826|565312202|FG002|Overall Study|Other|0|||
156609267|NCT01814826|565312200|FG000|Overall Study|Death|29|||
156609268|NCT01814826|565312201|FG001|Overall Study|Death|24|||
156609269|NCT01814826|565312202|FG002|Overall Study|Death|3|||
156609270|NCT02917629|565312203|FG000|Overall Study|Withdrawal by Subject|0|||
156609271|NCT02917629|565312204|FG001|Overall Study|Withdrawal by Subject|1|||
156609272|NCT03271307|565312205|FG000|Overall Study|Lost to Follow-up|0|||
156609273|NCT03271307|565312206|FG001|Overall Study|Lost to Follow-up|0|||
156609274|NCT03271307|565312207|FG002|Overall Study|Lost to Follow-up|0|||
156609275|NCT03271307|565312208|FG003|Overall Study|Lost to Follow-up|28|||
156609276|NCT03271307|565312209|FG004|Overall Study|Lost to Follow-up|91|||
156609277|NCT01203787|565312210|FG000|Overall Study|Death|12|||
156609278|NCT01203787|565312211|FG001|Overall Study|Death|10|||
156609279|NCT01203787|565312210|FG000|Overall Study|Withdrawal by Subject|6|||
156609280|NCT01203787|565312211|FG001|Overall Study|Withdrawal by Subject|2|||
156609281|NCT01203787|565312210|FG000|Overall Study|Lost to Follow-up|2|||
156609282|NCT01203787|565312211|FG001|Overall Study|Lost to Follow-up|0|||
156609283|NCT01203787|565312210|FG000|Overall Study|Adverse Event|11|||
156609284|NCT01203787|565312211|FG001|Overall Study|Adverse Event|15|||
156609285|NCT01601470|565312212|FG000|Period 2 - LCZ696|Physician Decision|1|||
156609286|NCT03032510|565312213|FG000|Overall Study|Adverse Event|5|||
156609287|NCT03032510|565312214|FG001|Overall Study|Adverse Event|2|||
156609288|NCT03032510|565312213|FG000|Overall Study|Lost to Follow-up|8|||
156609289|NCT03032510|565312214|FG001|Overall Study|Lost to Follow-up|7|||
156609290|NCT03032510|565312213|FG000|Overall Study|Withdrawal by Subject|8|||
156609291|NCT03032510|565312214|FG001|Overall Study|Withdrawal by Subject|7|||
156609292|NCT03032510|565312213|FG000|Overall Study|Subject noncompliance|4|||
156609293|NCT03032510|565312214|FG001|Overall Study|Subject noncompliance|2|||
156609294|NCT03032510|565312213|FG000|Overall Study|Physician Decision|2|||
156609295|NCT03032510|565312214|FG001|Overall Study|Physician Decision|0|||
156609296|NCT00856986|565312215|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
156609297|NCT00856986|565312216|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
156609298|NCT00856986|565312217|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
156609299|NCT00856986|565312218|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
156609300|NCT00856986|565312219|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
156609301|NCT00856986|565312215|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
156609302|NCT00856986|565312216|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
156609303|NCT00856986|565312217|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
156609304|NCT00856986|565312218|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
156609305|NCT00856986|565312219|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
156609306|NCT00856986|565312215|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
156609307|NCT00856986|565312216|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
156609308|NCT00856986|565312217|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
156609309|NCT00856986|565312218|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
156609310|NCT00856986|565312219|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
156609311|NCT00856986|565312215|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
156609312|NCT00856986|565312216|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
156609313|NCT00856986|565312217|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
156609314|NCT00856986|565312218|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
156609315|NCT00856986|565312219|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
156609316|NCT00856986|565312215|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
156609317|NCT00856986|565312216|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
156609318|NCT00856986|565312217|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
156609319|NCT00856986|565312218|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
156609320|NCT00856986|565312219|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
156609321|NCT00856986|565312215|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
156609322|NCT00856986|565312216|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
156609323|NCT00856986|565312217|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
156609324|NCT00856986|565312218|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
156609325|NCT00856986|565312219|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
156609326|NCT00856986|565312215|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
156609327|NCT00856986|565312216|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
156609328|NCT00856986|565312217|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
156609329|NCT00856986|565312218|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
156609330|NCT00856986|565312219|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
156609331|NCT00856986|565312215|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
156609332|NCT00856986|565312216|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
156609333|NCT00856986|565312217|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
156609334|NCT00856986|565312218|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
156609335|NCT00856986|565312219|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
156609336|NCT00856986|565312215|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
156609337|NCT00856986|565312216|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
156609338|NCT00856986|565312217|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
156609339|NCT00856986|565312218|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
156609340|NCT00856986|565312219|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
156609341|NCT00856986|565312215|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
156609342|NCT00856986|565312216|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
156609343|NCT00856986|565312217|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
156609344|NCT00856986|565312218|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
156609345|NCT00856986|565312219|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
156609346|NCT00856986|565312215|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
156609347|NCT00856986|565312216|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
156609348|NCT00856986|565312217|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
156609349|NCT00856986|565312218|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
156609350|NCT00856986|565312219|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
156609351|NCT00856986|565312215|FG000|Main Period, Weeks 0-26|Unclassified|7|||
156609352|NCT00856986|565312216|FG001|Main Period, Weeks 0-26|Unclassified|6|||
156609353|NCT00856986|565312217|FG002|Main Period, Weeks 0-26|Unclassified|7|||
156609354|NCT00856986|565312218|FG003|Main Period, Weeks 0-26|Unclassified|0|||
156609355|NCT00856986|565312219|FG004|Main Period, Weeks 0-26|Unclassified|0|||
156609356|NCT00856986|565312215|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
156609357|NCT00856986|565312216|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
156609358|NCT00856986|565312217|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
156609359|NCT00856986|565312218|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
156609360|NCT00856986|565312219|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
156609361|NCT00856986|565312215|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
156609362|NCT00856986|565312216|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
156609363|NCT00856986|565312217|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
156609364|NCT00856986|565312218|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
156609365|NCT00856986|565312219|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
156609366|NCT00856986|565312215|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
156609367|NCT00856986|565312216|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
156609368|NCT00856986|565312217|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
156609369|NCT00856986|565312218|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
156609370|NCT00856986|565312219|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
156609371|NCT00856986|565312215|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
156609372|NCT00856986|565312216|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
156609373|NCT00856986|565312217|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
156609374|NCT00856986|565312218|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
156609375|NCT00856986|565312219|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
156609376|NCT00856986|565312215|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
156609377|NCT00856986|565312216|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
156609378|NCT00856986|565312217|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
156609379|NCT00856986|565312218|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
156609380|NCT00856986|565312219|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
156609381|NCT00856986|565312215|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
156609382|NCT00856986|565312216|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
156609383|NCT00856986|565312217|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
156609384|NCT00856986|565312218|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
156609385|NCT00856986|565312219|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
156609386|NCT04968353|565312224|FG000|Overall Study|Non-compliance|1|||
156609387|NCT04968353|565312225|FG001|Overall Study|Non-compliance|0|||
156609388|NCT04968353|565312226|FG002|Overall Study|Non-compliance|2|||
156609389|NCT04968353|565312227|FG003|Overall Study|Non-compliance|0|||
156609390|NCT01750840|565312228|FG000|Overall Study|Lost to Follow-up|4|||
156609391|NCT01570309|565312229|FG000|Overall Study|Withdrawal by Subject|3|||
156609392|NCT01570309|565312230|FG001|Overall Study|Withdrawal by Subject|3|||
156609393|NCT01602549|565312231|FG000|Overall Study|Protocol Violation|0|||
156609394|NCT01602549|565312232|FG001|Overall Study|Protocol Violation|1|||
156609395|NCT01602549|565312231|FG000|Overall Study|Withdrawal by Subject|1|||
156609396|NCT01602549|565312232|FG001|Overall Study|Withdrawal by Subject|0|||
156609397|NCT01576406|565312233|FG000|Overall Study|Lost to Follow-up|1|||
156609398|NCT01576406|565312234|FG001|Overall Study|Lost to Follow-up|2|||
156609399|NCT01576406|565312235|FG002|Overall Study|Lost to Follow-up|0|||
156609400|NCT01576406|565312236|FG003|Overall Study|Lost to Follow-up|0|||
156609401|NCT01576406|565312237|FG004|Overall Study|Lost to Follow-up|0|||
156609402|NCT01576406|565312238|FG005|Overall Study|Lost to Follow-up|0|||
156609403|NCT01576406|565312233|FG000|Overall Study|Death|3|||
156609404|NCT01576406|565312234|FG001|Overall Study|Death|4|||
156609405|NCT01576406|565312235|FG002|Overall Study|Death|8|||
156609406|NCT01576406|565312236|FG003|Overall Study|Death|5|||
156609407|NCT01576406|565312237|FG004|Overall Study|Death|7|||
156609408|NCT01576406|565312238|FG005|Overall Study|Death|9|||
156609409|NCT01576406|565312233|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
156609410|NCT01576406|565312234|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
156609411|NCT01576406|565312235|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
156609412|NCT01576406|565312236|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
156609413|NCT01576406|565312237|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
156609414|NCT01576406|565312238|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
156609415|NCT01576406|565312233|FG000|Overall Study|Withdrawal the consent|2|||
156609416|NCT01576406|565312234|FG001|Overall Study|Withdrawal the consent|2|||
156609417|NCT01576406|565312235|FG002|Overall Study|Withdrawal the consent|5|||
156609418|NCT01576406|565312236|FG003|Overall Study|Withdrawal the consent|1|||
156609419|NCT01576406|565312237|FG004|Overall Study|Withdrawal the consent|1|||
156609420|NCT01576406|565312238|FG005|Overall Study|Withdrawal the consent|3|||
156609421|NCT01576406|565312233|FG000|Overall Study|Other|0|||
156609422|NCT01576406|565312234|FG001|Overall Study|Other|0|||
156609423|NCT01576406|565312235|FG002|Overall Study|Other|2|||
156609424|NCT01576406|565312236|FG003|Overall Study|Other|2|||
156609425|NCT01576406|565312237|FG004|Overall Study|Other|0|||
156609426|NCT01576406|565312238|FG005|Overall Study|Other|0|||
156609427|NCT02091921|565312239|FG000|Overall Study|Adverse Event|3|||
156609428|NCT02483078|565312240|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
156609429|NCT02483078|565312241|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
156609430|NCT02483078|565312240|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
156609431|NCT02483078|565312241|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
156609432|NCT02483078|565312240|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
156609433|NCT02483078|565312241|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
156609434|NCT02483078|565312240|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
156609435|NCT02483078|565312241|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
156609436|NCT02483078|565312240|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
156609437|NCT02483078|565312241|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
156609438|NCT02483078|565312240|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
156609439|NCT02483078|565312241|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
156609440|NCT03627494|565312244|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
156609441|NCT03627494|565312245|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609442|NCT03627494|565312246|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
156609443|NCT03627494|565312247|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609444|NCT03627494|565312248|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609445|NCT03627494|565312249|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609446|NCT03627494|565312250|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609447|NCT03627494|565312251|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609448|NCT03627494|565312252|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609449|NCT03627494|565312253|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609450|NCT03627494|565312254|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609451|NCT03627494|565312255|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
156609452|NCT03627494|565312244|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609453|NCT03627494|565312245|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609454|NCT03627494|565312246|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609455|NCT03627494|565312247|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609456|NCT03627494|565312248|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609457|NCT03627494|565312249|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609458|NCT03627494|565312250|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609459|NCT03627494|565312251|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609460|NCT03627494|565312252|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
156609461|NCT03627494|565312253|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609462|NCT03627494|565312254|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609463|NCT03627494|565312255|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
156609464|NCT03627494|565312244|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609465|NCT03627494|565312245|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609466|NCT03627494|565312246|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609467|NCT03627494|565312247|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609468|NCT03627494|565312248|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609469|NCT03627494|565312249|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609470|NCT03627494|565312250|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609471|NCT03627494|565312251|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609472|NCT03627494|565312252|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609473|NCT03627494|565312253|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
156609474|NCT03627494|565312254|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
156609475|NCT03627494|565312255|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
156609476|NCT00608894|565313935|FG000|Overall Study|Withdrawal by Subject|0|||
156609477|NCT00608894|565313936|FG001|Overall Study|Withdrawal by Subject|2|||
156609478|NCT02828644|565313938|FG000|Overall Study|Lost to Follow-up|23|||
156609479|NCT02828644|565313939|FG001|Overall Study|Lost to Follow-up|22|||
156609480|NCT02408484|565313940|FG000|Overall Study|Withdrawal by Subject|3|||
156609481|NCT02408484|565313940|FG000|Overall Study|Not treated during study period|1|||
156609482|NCT02436915|565313941|FG000|Overall Study|Withdrawal by Subject|0|||
156609483|NCT02436915|565313942|FG001|Overall Study|Withdrawal by Subject|1|||
156609484|NCT01117181|565313944|FG000|Overall Study|Lost to Follow-up|1|||
156609485|NCT01117181|565313945|FG001|Overall Study|Lost to Follow-up|0|||
156609486|NCT01117181|565313944|FG000|Overall Study|Withdrawal by Subject|0|||
156609487|NCT01117181|565313945|FG001|Overall Study|Withdrawal by Subject|2|||
156609488|NCT01495689|565313952|FG000|Overall Study|Death|0|||
156609489|NCT01495689|565313953|FG001|Overall Study|Death|1|||
156609490|NCT01495689|565313952|FG000|Overall Study|Withdrawal by Subject|3|||
156609491|NCT01495689|565313953|FG001|Overall Study|Withdrawal by Subject|0|||
156609492|NCT01495689|565313952|FG000|Overall Study|Lost to Follow-up|7|||
156609493|NCT01495689|565313953|FG001|Overall Study|Lost to Follow-up|6|||
156609494|NCT03805971|565313954|FG000|Overall Study|Withdrawal by Subject|1|||
156609495|NCT03805971|565313954|FG000|Overall Study|Protocol Violation|2|||
156609496|NCT00254163|565313957|FG000|Overall Study|Adverse Event|29|||
156609497|NCT00254163|565313958|FG001|Overall Study|Adverse Event|26|||
156609498|NCT00254163|565313957|FG000|Overall Study|Patient request/withdrew consent|6|||
156609499|NCT00254163|565313958|FG001|Overall Study|Patient request/withdrew consent|4|||
156609500|NCT00254163|565313957|FG000|Overall Study|Investigator request|1|||
156609501|NCT00254163|565313958|FG001|Overall Study|Investigator request|3|||
156609502|NCT00254163|565313957|FG000|Overall Study|Failed entry|1|||
156609503|NCT00254163|565313958|FG001|Overall Study|Failed entry|3|||
156609504|NCT00254163|565313957|FG000|Overall Study|Progressive disease|0|||
156609505|NCT00254163|565313958|FG001|Overall Study|Progressive disease|1|||
156609506|NCT00254163|565313957|FG000|Overall Study|Death|0|||
156609507|NCT00254163|565313958|FG001|Overall Study|Death|1|||
156609508|NCT00254163|565313957|FG000|Overall Study|Other|8|||
156609509|NCT00254163|565313958|FG001|Overall Study|Other|8|||
156609510|NCT01119963|565313959|FG000|Overall Study|Lost to Follow-up|1|||
156609511|NCT01119963|565313960|FG001|Overall Study|Lost to Follow-up|1|||
156609512|NCT00524043|565313962|FG000|Overall Study|Lack of Efficacy|15|||
156609513|NCT00524043|565313963|FG001|Overall Study|Lack of Efficacy|13|||
156609514|NCT00524043|565313964|FG002|Overall Study|Lack of Efficacy|14|||
156609515|NCT00524043|565313962|FG000|Overall Study|Withdrawal by Subject|5|||
156609516|NCT00524043|565313963|FG001|Overall Study|Withdrawal by Subject|7|||
156609517|NCT00524043|565313964|FG002|Overall Study|Withdrawal by Subject|7|||
156609518|NCT00524043|565313962|FG000|Overall Study|Adverse Event|5|||
156609519|NCT00524043|565313963|FG001|Overall Study|Adverse Event|2|||
156609520|NCT00524043|565313964|FG002|Overall Study|Adverse Event|7|||
156609521|NCT00524043|565313962|FG000|Overall Study|Lost to Follow-up|3|||
156609522|NCT00524043|565313963|FG001|Overall Study|Lost to Follow-up|5|||
156609523|NCT00524043|565313964|FG002|Overall Study|Lost to Follow-up|3|||
156609524|NCT00524043|565313962|FG000|Overall Study|Various (eg, incarceration)|2|||
156609525|NCT00524043|565313963|FG001|Overall Study|Various (eg, incarceration)|1|||
156609526|NCT00524043|565313964|FG002|Overall Study|Various (eg, incarceration)|0|||
156609527|NCT00517413|565313969|FG000|Overall Study|Adverse Event|7|||
156609528|NCT00517413|565313969|FG000|Overall Study|Death|13|||
156609529|NCT00517413|565313969|FG000|Overall Study|Protocol Violation|15|||
156609530|NCT00517413|565313969|FG000|Overall Study|Withdrawal by Subject|2|||
156609531|NCT00517413|565313969|FG000|Overall Study|Failure to return|1|||
156609532|NCT00517413|565313969|FG000|Overall Study|Other-Reasons|23|||
156609533|NCT03938636|565313970|FG000|Overall Study|Protocol Violation|0|||
156609534|NCT03938636|565313971|FG001|Overall Study|Protocol Violation|1|||
156609535|NCT03938636|565313972|FG002|Overall Study|Protocol Violation|1|||
156609536|NCT03938636|565313970|FG000|Overall Study|Subject withdrew due to death in family|0|||
156609537|NCT03938636|565313971|FG001|Overall Study|Subject withdrew due to death in family|1|||
156609538|NCT03938636|565313972|FG002|Overall Study|Subject withdrew due to death in family|0|||
156609539|NCT03938636|565313970|FG000|Overall Study|Missed visit|0|||
156609540|NCT03938636|565313971|FG001|Overall Study|Missed visit|1|||
156609541|NCT03938636|565313972|FG002|Overall Study|Missed visit|0|||
156609542|NCT03938636|565313970|FG000|Overall Study|Adverse Event|0|||
156609543|NCT03938636|565313971|FG001|Overall Study|Adverse Event|0|||
156609544|NCT03938636|565313972|FG002|Overall Study|Adverse Event|1|||
156609545|NCT03938636|565313970|FG000|Overall Study|Lost to Follow-up|0|||
156609546|NCT03938636|565313971|FG001|Overall Study|Lost to Follow-up|0|||
156609547|NCT03938636|565313972|FG002|Overall Study|Lost to Follow-up|1|||
156609548|NCT02579863|565313973|FG000|Overall Study|Final Disposition Unknown|2|||
156609549|NCT02579863|565313974|FG001|Overall Study|Final Disposition Unknown|1|||
156609550|NCT02579863|565313973|FG000|Overall Study|Adverse Event|18|||
156609551|NCT02579863|565313974|FG001|Overall Study|Adverse Event|11|||
156609552|NCT02579863|565313973|FG000|Overall Study|Death|31|||
156609553|NCT02579863|565313974|FG001|Overall Study|Death|29|||
156609554|NCT02579863|565313973|FG000|Overall Study|Lost to Follow-up|2|||
156609555|NCT02579863|565313974|FG001|Overall Study|Lost to Follow-up|1|||
156609556|NCT02579863|565313973|FG000|Overall Study|Physician Decision|1|||
156609557|NCT02579863|565313974|FG001|Overall Study|Physician Decision|2|||
156609558|NCT02579863|565313973|FG000|Overall Study|Screen Failure|0|||
156609559|NCT02579863|565313974|FG001|Overall Study|Screen Failure|2|||
156609560|NCT02579863|565313973|FG000|Overall Study|Study Terminated at Selected Sites|82|||
156609561|NCT02579863|565313974|FG001|Overall Study|Study Terminated at Selected Sites|88|||
156609562|NCT02579863|565313973|FG000|Overall Study|Withdrawal by Subject|20|||
156609563|NCT02579863|565313974|FG001|Overall Study|Withdrawal by Subject|20|||
156609564|NCT00809614|565313979|FG000|Overall Study|Lack of Efficacy|2|||
156609565|NCT00809614|565313980|FG001|Overall Study|Lack of Efficacy|3|||
156609566|NCT00809614|565313979|FG000|Overall Study|Withdrawal by Subject|1|||
156609567|NCT00809614|565313980|FG001|Overall Study|Withdrawal by Subject|1|||
156609568|NCT01224106|565313981|FG000|Double-Blind Treatment Phase|Death|3|||
156609569|NCT01224106|565313982|FG001|Double-Blind Treatment Phase|Death|0|||
156609570|NCT01224106|565313983|FG002|Double-Blind Treatment Phase|Death|0|||
156609571|NCT01224106|565313984|FG003|Double-Blind Treatment Phase|Death|0|||
156609572|NCT01224106|565313985|FG004|Double-Blind Treatment Phase|Death|0|||
156609573|NCT01224106|565313981|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
156609574|NCT01224106|565313982|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
156609575|NCT01224106|565313983|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
156609576|NCT01224106|565313984|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
156609577|NCT01224106|565313985|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
156609578|NCT01224106|565313981|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156609579|NCT01224106|565313982|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
156609580|NCT01224106|565313983|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
156609581|NCT01224106|565313984|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
156609582|NCT01224106|565313985|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
156609583|NCT01224106|565313981|FG000|Double-Blind Treatment Phase|Other|0|||
156609584|NCT01224106|565313982|FG001|Double-Blind Treatment Phase|Other|0|||
156609585|NCT01224106|565313983|FG002|Double-Blind Treatment Phase|Other|1|||
156609586|NCT01224106|565313984|FG003|Double-Blind Treatment Phase|Other|0|||
156609587|NCT01224106|565313985|FG004|Double-Blind Treatment Phase|Other|0|||
156609588|NCT01224106|565313981|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
156609589|NCT01224106|565313982|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
156609590|NCT01224106|565313983|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
156609591|NCT01224106|565313984|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
156609592|NCT01224106|565313985|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
156609593|NCT01224106|565313981|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
156609594|NCT01224106|565313982|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
156609595|NCT01224106|565313983|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
156609596|NCT01224106|565313984|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
156609597|NCT01224106|565313985|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
156609598|NCT01224106|565313981|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156609599|NCT01224106|565313982|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156609600|NCT01224106|565313983|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156609601|NCT01224106|565313984|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156609602|NCT01224106|565313985|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156609603|NCT01224106|565313981|FG000|Open-Label Extension (OLE) Phase|Death|0|||
156609604|NCT01224106|565313982|FG001|Open-Label Extension (OLE) Phase|Death|0|||
156609605|NCT01224106|565313983|FG002|Open-Label Extension (OLE) Phase|Death|0|||
156609606|NCT01224106|565313984|FG003|Open-Label Extension (OLE) Phase|Death|1|||
156609607|NCT01224106|565313985|FG004|Open-Label Extension (OLE) Phase|Death|3|||
156609608|NCT01224106|565313981|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
156609609|NCT01224106|565313982|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
156609610|NCT01224106|565313983|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
156609611|NCT01224106|565313984|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
156609612|NCT01224106|565313985|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
156609613|NCT01224106|565313981|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
156609614|NCT01224106|565313982|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
156609615|NCT01224106|565313983|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
156609616|NCT01224106|565313984|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
156609617|NCT01224106|565313985|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
156609618|NCT01224106|565313981|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
156609619|NCT01224106|565313982|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
156609620|NCT01224106|565313983|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
156609621|NCT01224106|565313984|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
156609622|NCT01224106|565313985|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
156609623|NCT01224106|565313981|FG000|Open-Label Extension (OLE) Phase|Other|0|||
156609624|NCT01224106|565313982|FG001|Open-Label Extension (OLE) Phase|Other|0|||
156609625|NCT01224106|565313983|FG002|Open-Label Extension (OLE) Phase|Other|0|||
156609626|NCT01224106|565313984|FG003|Open-Label Extension (OLE) Phase|Other|5|||
156609627|NCT01224106|565313985|FG004|Open-Label Extension (OLE) Phase|Other|3|||
156609628|NCT00364832|565313986|FG000|Core Period|Early Withdrawals|2|||
156609629|NCT00364832|565313987|FG001|Core Period|Early Withdrawals|2|||
156609630|NCT00364832|565313988|FG002|Core Period|Early Withdrawals|1|||
156609631|NCT00364832|565313989|FG003|Core Period|Early Withdrawals|1|||
156609632|NCT00364832|565313990|FG004|Core Period|Early Withdrawals|0|||
156609633|NCT00364832|565313991|FG005|Core Period|Early Withdrawals|0|||
156609634|NCT00364832|565313992|FG006|Core Period|Early Withdrawals|4|||
156609635|NCT00364832|565313993|FG007|Core Period|Early Withdrawals|1|||
156609636|NCT00364832|565313994|FG008|Core Period|Early Withdrawals|0|||
156609637|NCT00364832|565313995|FG009|Core Period|Early Withdrawals|0|||
156609638|NCT00364832|565313996|FG010|Core Period|Early Withdrawals|0|||
156609639|NCT00364832|565313997|FG011|Core Period|Early Withdrawals|0|||
156609640|NCT00364832|565313986|FG000|Extension Year 1|Early Withdrawals|0|||
156609641|NCT00364832|565313987|FG001|Extension Year 1|Early Withdrawals|0|||
156609642|NCT00364832|565313988|FG002|Extension Year 1|Early Withdrawals|0|||
156609643|NCT00364832|565313989|FG003|Extension Year 1|Early Withdrawals|0|||
156609644|NCT00364832|565313990|FG004|Extension Year 1|Early Withdrawals|0|||
156609645|NCT00364832|565313991|FG005|Extension Year 1|Early Withdrawals|0|||
156609646|NCT00364832|565313992|FG006|Extension Year 1|Early Withdrawals|0|||
156609647|NCT00364832|565313993|FG007|Extension Year 1|Early Withdrawals|0|||
156609648|NCT00364832|565313994|FG008|Extension Year 1|Early Withdrawals|0|||
156609649|NCT00364832|565313995|FG009|Extension Year 1|Early Withdrawals|4|||
156609650|NCT00364832|565313996|FG010|Extension Year 1|Early Withdrawals|2|||
156609651|NCT00364832|565313997|FG011|Extension Year 1|Early Withdrawals|10|||
156609652|NCT00364832|565313986|FG000|Extension Year 2|Early Withdrawals|0|||
156609653|NCT00364832|565313987|FG001|Extension Year 2|Early Withdrawals|0|||
156609654|NCT00364832|565313988|FG002|Extension Year 2|Early Withdrawals|0|||
156609655|NCT00364832|565313989|FG003|Extension Year 2|Early Withdrawals|0|||
156609656|NCT00364832|565313990|FG004|Extension Year 2|Early Withdrawals|0|||
156609657|NCT00364832|565313991|FG005|Extension Year 2|Early Withdrawals|0|||
156609658|NCT00364832|565313992|FG006|Extension Year 2|Early Withdrawals|0|||
156609659|NCT00364832|565313993|FG007|Extension Year 2|Early Withdrawals|0|||
156609660|NCT00364832|565313994|FG008|Extension Year 2|Early Withdrawals|0|||
156609661|NCT00364832|565313995|FG009|Extension Year 2|Early Withdrawals|5|||
156609662|NCT00364832|565313996|FG010|Extension Year 2|Early Withdrawals|5|||
156609663|NCT00364832|565313997|FG011|Extension Year 2|Early Withdrawals|3|||
156609664|NCT03210220|565313998|FG000|Overall Study|Physician Decision|1|||
156609665|NCT03210220|565313999|FG001|Overall Study|Physician Decision|0|||
156609666|NCT00865046|565314005|FG000|Overall Study|Lost to Follow-up|1|||
156609667|NCT00865046|565314006|FG001|Overall Study|Lost to Follow-up|4|||
156609668|NCT00865046|565314007|FG002|Overall Study|Lost to Follow-up|0|||
156609669|NCT00865046|565314005|FG000|Overall Study|Death|0|||
156609670|NCT00865046|565314006|FG001|Overall Study|Death|1|||
156609671|NCT00865046|565314007|FG002|Overall Study|Death|1|||
156609672|NCT00865046|565314005|FG000|Overall Study|Withdrawal by Subject|5|||
156609673|NCT00865046|565314006|FG001|Overall Study|Withdrawal by Subject|0|||
156609674|NCT00865046|565314007|FG002|Overall Study|Withdrawal by Subject|0|||
156609675|NCT01098032|565314013|FG000|Overall Study|Withdrawal by Subject|1|||
156609676|NCT01098032|565314014|FG001|Overall Study|Withdrawal by Subject|1|||
156609677|NCT02959190|565314015|FG000|Open Label|Adverse Event|5|||
156609678|NCT02959190|565314016|FG001|Open Label|Adverse Event|7|||
156609679|NCT02959190|565314017|FG002|Open Label|Adverse Event|3|||
156609680|NCT02959190|565314018|FG003|Open Label|Adverse Event|4|||
156609681|NCT02959190|565314015|FG000|Open Label|Pregnancy|0|||
156609682|NCT02959190|565314016|FG001|Open Label|Pregnancy|1|||
156609683|NCT02959190|565314017|FG002|Open Label|Pregnancy|0|||
156609684|NCT02959190|565314018|FG003|Open Label|Pregnancy|0|||
156609685|NCT02959190|565314015|FG000|Open Label|Withdrawal by Subject|2|||
156609686|NCT02959190|565314016|FG001|Open Label|Withdrawal by Subject|8|||
156609687|NCT02959190|565314017|FG002|Open Label|Withdrawal by Subject|0|||
156609688|NCT02959190|565314018|FG003|Open Label|Withdrawal by Subject|0|||
156609689|NCT02959190|565314015|FG000|Open Label|Physician Decision|0|||
156609690|NCT02959190|565314016|FG001|Open Label|Physician Decision|0|||
156609691|NCT02959190|565314017|FG002|Open Label|Physician Decision|1|||
156609692|NCT02959190|565314018|FG003|Open Label|Physician Decision|0|||
156609693|NCT02959190|565314015|FG000|Open Label|Protocol Violation|0|||
156609694|NCT02959190|565314016|FG001|Open Label|Protocol Violation|0|||
156609695|NCT02959190|565314017|FG002|Open Label|Protocol Violation|0|||
156609696|NCT02959190|565314018|FG003|Open Label|Protocol Violation|2|||
156609697|NCT02959190|565314015|FG000|Post Treatment Follow Up|Adverse Event|1|||
156609698|NCT02959190|565314016|FG001|Post Treatment Follow Up|Adverse Event|1|||
156609699|NCT02959190|565314017|FG002|Post Treatment Follow Up|Adverse Event|0|||
156609700|NCT02959190|565314018|FG003|Post Treatment Follow Up|Adverse Event|0|||
156609701|NCT02959190|565314015|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
156609702|NCT02959190|565314016|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
156609703|NCT02959190|565314017|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
156609704|NCT02959190|565314018|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
156609705|NCT02709109|565314029|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
156609706|NCT02709109|565314030|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
156609707|NCT02709109|565314031|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
156609708|NCT02709109|565314032|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
156609709|NCT02709109|565314029|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
156609710|NCT02709109|565314030|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
156609711|NCT02709109|565314031|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
156609712|NCT02709109|565314032|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
156609713|NCT02709109|565314029|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
156609714|NCT02709109|565314030|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
156609715|NCT02709109|565314031|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
156609716|NCT02709109|565314032|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
156609717|NCT02709109|565314029|FG000|Washout Period (28 Days)|Other|2|||
156609718|NCT02709109|565314030|FG001|Washout Period (28 Days)|Other|2|||
156609719|NCT02709109|565314031|FG002|Washout Period (28 Days)|Other|3|||
156609720|NCT02709109|565314032|FG003|Washout Period (28 Days)|Other|0|||
156609721|NCT02709109|565314029|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
156609722|NCT02709109|565314030|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
156609723|NCT02709109|565314031|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
156609724|NCT02709109|565314032|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
156609725|NCT02709109|565314029|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
156609726|NCT02709109|565314030|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
156609727|NCT02709109|565314031|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
156609728|NCT02709109|565314032|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
156609729|NCT02709109|565314029|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
156609730|NCT02709109|565314030|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
156609731|NCT02709109|565314031|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
156609732|NCT02709109|565314032|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
156609733|NCT02709109|565314029|FG000|Treatment Period 2 (28 Days)|Other|0|||
156609734|NCT02709109|565314030|FG001|Treatment Period 2 (28 Days)|Other|0|||
156609735|NCT02709109|565314031|FG002|Treatment Period 2 (28 Days)|Other|1|||
156609736|NCT02709109|565314032|FG003|Treatment Period 2 (28 Days)|Other|0|||
156609737|NCT00741260|565314033|FG000|Overall Study|Disease Progression|3|||
156609738|NCT00741260|565314034|FG001|Overall Study|Disease Progression|5|||
156609739|NCT00741260|565314035|FG002|Overall Study|Disease Progression|3|||
156609740|NCT00741260|565314036|FG003|Overall Study|Disease Progression|3|||
156609741|NCT00741260|565314037|FG004|Overall Study|Disease Progression|5|||
156609742|NCT00741260|565314038|FG005|Overall Study|Disease Progression|37|||
156609743|NCT00741260|565314039|FG006|Overall Study|Disease Progression|4|||
156609744|NCT00741260|565314033|FG000|Overall Study|Death|0|||
156609745|NCT00741260|565314034|FG001|Overall Study|Death|1|||
156609746|NCT00741260|565314035|FG002|Overall Study|Death|0|||
156609747|NCT00741260|565314036|FG003|Overall Study|Death|1|||
156609748|NCT00741260|565314037|FG004|Overall Study|Death|2|||
156609749|NCT00741260|565314038|FG005|Overall Study|Death|2|||
156609750|NCT00741260|565314039|FG006|Overall Study|Death|1|||
156609751|NCT00741260|565314033|FG000|Overall Study|Withdrawal by Subject|0|||
156609752|NCT00741260|565314034|FG001|Overall Study|Withdrawal by Subject|0|||
156609753|NCT00741260|565314035|FG002|Overall Study|Withdrawal by Subject|0|||
156609754|NCT00741260|565314036|FG003|Overall Study|Withdrawal by Subject|0|||
156609755|NCT00741260|565314037|FG004|Overall Study|Withdrawal by Subject|1|||
156609756|NCT00741260|565314038|FG005|Overall Study|Withdrawal by Subject|3|||
156609757|NCT00741260|565314039|FG006|Overall Study|Withdrawal by Subject|1|||
156609758|NCT00741260|565314033|FG000|Overall Study|Physician Decision|1|||
156609759|NCT00741260|565314034|FG001|Overall Study|Physician Decision|1|||
156609760|NCT00741260|565314035|FG002|Overall Study|Physician Decision|0|||
156609761|NCT00741260|565314036|FG003|Overall Study|Physician Decision|0|||
156609762|NCT00741260|565314037|FG004|Overall Study|Physician Decision|0|||
156609763|NCT00741260|565314038|FG005|Overall Study|Physician Decision|0|||
156609764|NCT00741260|565314039|FG006|Overall Study|Physician Decision|0|||
156609765|NCT00741260|565314033|FG000|Overall Study|Other|2|||
156609766|NCT00741260|565314034|FG001|Overall Study|Other|1|||
156609767|NCT00741260|565314035|FG002|Overall Study|Other|1|||
156609768|NCT00741260|565314036|FG003|Overall Study|Other|2|||
156609769|NCT00741260|565314037|FG004|Overall Study|Other|1|||
156609770|NCT00741260|565314038|FG005|Overall Study|Other|3|||
156609771|NCT00741260|565314039|FG006|Overall Study|Other|1|||
156609772|NCT02565615|565314040|FG000|Overall Study|Death|0|||
156609773|NCT02565615|565314041|FG001|Overall Study|Death|1|||
156609774|NCT02565615|565314042|FG002|Overall Study|Death|0|||
156609775|NCT02565615|565314043|FG003|Overall Study|Death|0|||
156609776|NCT02565615|565314044|FG004|Overall Study|Death|4|||
156609777|NCT02565615|565314040|FG000|Overall Study|Not willing to participate in study|2|||
156609778|NCT02565615|565314041|FG001|Overall Study|Not willing to participate in study|21|||
156609779|NCT02565615|565314042|FG002|Overall Study|Not willing to participate in study|0|||
156609780|NCT02565615|565314043|FG003|Overall Study|Not willing to participate in study|1|||
156609781|NCT02565615|565314044|FG004|Overall Study|Not willing to participate in study|169|||
156609782|NCT02565615|565314040|FG000|Overall Study|Lost to Follow-up|0|||
156609783|NCT02565615|565314041|FG001|Overall Study|Lost to Follow-up|4|||
156609784|NCT02565615|565314042|FG002|Overall Study|Lost to Follow-up|0|||
156609785|NCT02565615|565314043|FG003|Overall Study|Lost to Follow-up|1|||
156609786|NCT02565615|565314044|FG004|Overall Study|Lost to Follow-up|765|||
156609787|NCT02565615|565314040|FG000|Overall Study|Not meeting eligibility criteria|0|||
156609788|NCT02565615|565314041|FG001|Overall Study|Not meeting eligibility criteria|7|||
156609789|NCT02565615|565314042|FG002|Overall Study|Not meeting eligibility criteria|0|||
156609790|NCT02565615|565314043|FG003|Overall Study|Not meeting eligibility criteria|0|||
156609791|NCT02565615|565314044|FG004|Overall Study|Not meeting eligibility criteria|25|||
156609792|NCT02565615|565314040|FG000|Overall Study|Reason not defined|0|||
156609793|NCT02565615|565314041|FG001|Overall Study|Reason not defined|2|||
156609794|NCT02565615|565314042|FG002|Overall Study|Reason not defined|0|||
156609795|NCT02565615|565314043|FG003|Overall Study|Reason not defined|1|||
156609796|NCT02565615|565314044|FG004|Overall Study|Reason not defined|62|||
156609797|NCT02565615|565314040|FG000|Overall Study|Adverse Event|1|||
156609798|NCT02565615|565314041|FG001|Overall Study|Adverse Event|1|||
156609799|NCT02565615|565314042|FG002|Overall Study|Adverse Event|0|||
156609800|NCT02565615|565314043|FG003|Overall Study|Adverse Event|0|||
156609801|NCT02565615|565314044|FG004|Overall Study|Adverse Event|9|||
156609802|NCT02565615|565314040|FG000|Overall Study|Untreated|0|||
156609803|NCT02565615|565314041|FG001|Overall Study|Untreated|0|||
156609804|NCT02565615|565314042|FG002|Overall Study|Untreated|0|||
156609805|NCT02565615|565314043|FG003|Overall Study|Untreated|0|||
156609806|NCT02565615|565314044|FG004|Overall Study|Untreated|567|||
156609807|NCT01928082|565314049|FG000|Overall Study|Study terminated.|1|||
156609808|NCT05563714|565314051|FG000|Overall Study|Death|2|||
156609809|NCT05563714|565314052|FG001|Overall Study|Death|2|||
156609810|NCT05563714|565314053|FG002|Overall Study|Death|0|||
156609811|NCT05563714|565314054|FG003|Overall Study|Death|0|||
156609812|NCT05563714|565314051|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
156609813|NCT05563714|565314052|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
156609814|NCT05563714|565314053|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
156609815|NCT05563714|565314054|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
156609816|NCT05563714|565314051|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
156609817|NCT05563714|565314052|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
156609818|NCT05563714|565314053|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
156609819|NCT05563714|565314054|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
156609820|NCT05563714|565314051|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
156609821|NCT05563714|565314052|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
156609822|NCT05563714|565314053|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
156609823|NCT05563714|565314054|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
156609824|NCT05563714|565314051|FG000|Overall Study|Lost to Follow-up|22|||
156609825|NCT05563714|565314052|FG001|Overall Study|Lost to Follow-up|19|||
156609826|NCT05563714|565314053|FG002|Overall Study|Lost to Follow-up|0|||
156609827|NCT05563714|565314054|FG003|Overall Study|Lost to Follow-up|0|||
156609828|NCT01815580|565314057|FG000|Overall Study|Lost to Follow-up|4|||
156609829|NCT01815580|565314058|FG001|Overall Study|Lost to Follow-up|7|||
156609830|NCT01815580|565314057|FG000|Overall Study|Withdrawal by Subject|3|||
156609831|NCT01815580|565314058|FG001|Overall Study|Withdrawal by Subject|4|||
156609832|NCT01815580|565314057|FG000|Overall Study|Excluded from analysis|5|||
156609833|NCT01815580|565314058|FG001|Overall Study|Excluded from analysis|4|||
156609834|NCT02120352|565314064|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
156609835|NCT02120352|565314065|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
156609836|NCT02120352|565314066|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
156609837|NCT02120352|565314067|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
156609838|NCT02120352|565314068|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
156609839|NCT02120352|565314069|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
156609840|NCT02120352|565314070|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
156609841|NCT02120352|565314064|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
156609842|NCT02120352|565314065|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
156609843|NCT02120352|565314066|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
156609844|NCT02120352|565314067|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
156609845|NCT02120352|565314068|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
156609846|NCT02120352|565314069|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
156609847|NCT02120352|565314070|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
156609848|NCT02120352|565314064|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
156609849|NCT02120352|565314065|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
156609850|NCT02120352|565314066|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
156609851|NCT02120352|565314067|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
156609852|NCT02120352|565314068|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
156609853|NCT02120352|565314069|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
156609854|NCT02120352|565314070|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
156609855|NCT02120352|565314064|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
156609856|NCT02120352|565314065|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
156609857|NCT02120352|565314066|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
156609858|NCT02120352|565314067|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
156609859|NCT02120352|565314068|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
156609860|NCT02120352|565314069|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
156609861|NCT02120352|565314070|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
156609862|NCT02120352|565314064|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
156609863|NCT02120352|565314065|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
156609864|NCT02120352|565314066|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
156609865|NCT02120352|565314067|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
156609866|NCT02120352|565314068|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
156609867|NCT02120352|565314069|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
156609868|NCT02120352|565314070|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
156609869|NCT02120352|565314064|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
156609870|NCT02120352|565314065|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
156609871|NCT02120352|565314066|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
156609872|NCT02120352|565314067|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
156609873|NCT02120352|565314068|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
156609874|NCT02120352|565314069|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
156609875|NCT02120352|565314070|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
156609876|NCT02120352|565314064|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
156609877|NCT02120352|565314065|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
156609878|NCT02120352|565314066|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
156609879|NCT02120352|565314067|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
156609880|NCT02120352|565314068|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
156609881|NCT02120352|565314069|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
156609882|NCT02120352|565314070|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
156609883|NCT02120352|565314064|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
156609884|NCT02120352|565314065|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
156609885|NCT02120352|565314066|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
156609886|NCT02120352|565314067|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
156609887|NCT02120352|565314068|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
156609888|NCT02120352|565314069|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
156609889|NCT02120352|565314070|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
156609890|NCT02120352|565314064|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
156609891|NCT02120352|565314065|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
156609892|NCT02120352|565314066|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
156609893|NCT02120352|565314067|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
156609894|NCT02120352|565314068|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
156609895|NCT02120352|565314069|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
156609896|NCT02120352|565314070|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
156609897|NCT02120352|565314064|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
156609898|NCT02120352|565314065|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
156609899|NCT02120352|565314066|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
156609900|NCT02120352|565314067|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
156609901|NCT02120352|565314068|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
156609902|NCT02120352|565314069|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
156609903|NCT02120352|565314070|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
156609904|NCT02120352|565314064|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
156609905|NCT02120352|565314065|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
156609906|NCT02120352|565314066|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
156609907|NCT02120352|565314067|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
156609908|NCT02120352|565314068|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
156609909|NCT02120352|565314069|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
156609910|NCT02120352|565314070|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
156609911|NCT02120352|565314064|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
156609912|NCT02120352|565314065|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
156609913|NCT02120352|565314066|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
156609914|NCT02120352|565314067|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
156609915|NCT02120352|565314068|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
156609916|NCT02120352|565314069|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
156609917|NCT02120352|565314070|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
156609918|NCT02120352|565314064|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
156609919|NCT02120352|565314065|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
156609920|NCT02120352|565314066|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
156609921|NCT02120352|565314067|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
156609922|NCT02120352|565314068|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
156609923|NCT02120352|565314069|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
156609924|NCT02120352|565314070|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
156609925|NCT02120352|565314064|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
156609926|NCT02120352|565314065|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
156609927|NCT02120352|565314066|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
156609928|NCT02120352|565314067|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
156609929|NCT02120352|565314068|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
156609930|NCT02120352|565314069|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
156609931|NCT02120352|565314070|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
156609932|NCT02120352|565314064|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
156609933|NCT02120352|565314065|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
156609934|NCT02120352|565314066|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
156609935|NCT02120352|565314067|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
156609936|NCT02120352|565314068|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
156609937|NCT02120352|565314069|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
156609938|NCT02120352|565314070|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
156609939|NCT02120352|565314064|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
156609940|NCT02120352|565314065|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
156609941|NCT02120352|565314066|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
156609942|NCT02120352|565314067|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
156609943|NCT02120352|565314068|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
156609944|NCT02120352|565314069|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
156609945|NCT02120352|565314070|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
156609946|NCT02120352|565314064|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
156609947|NCT02120352|565314065|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
156609948|NCT02120352|565314066|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
156609949|NCT02120352|565314067|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
156609950|NCT02120352|565314068|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
156609951|NCT02120352|565314069|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
156609952|NCT02120352|565314070|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
156609953|NCT02120352|565314064|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
156609954|NCT02120352|565314065|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
156609955|NCT02120352|565314066|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
156609956|NCT02120352|565314067|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
156609957|NCT02120352|565314068|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
156609958|NCT02120352|565314069|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
156609959|NCT02120352|565314070|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
156609960|NCT02120352|565314064|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
156609961|NCT02120352|565314065|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
156609962|NCT02120352|565314066|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
156609963|NCT02120352|565314067|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
156609964|NCT02120352|565314068|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
156609965|NCT02120352|565314069|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
156609966|NCT02120352|565314070|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
156609967|NCT02120352|565314064|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
156609968|NCT02120352|565314065|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
156609969|NCT02120352|565314066|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
156609970|NCT02120352|565314067|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
156609971|NCT02120352|565314068|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
156609972|NCT02120352|565314069|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
156609973|NCT02120352|565314070|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
156609974|NCT02120352|565314064|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
156609975|NCT02120352|565314065|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
156609976|NCT02120352|565314066|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
156609977|NCT02120352|565314067|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
156609978|NCT02120352|565314068|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
156609979|NCT02120352|565314069|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
156609980|NCT02120352|565314070|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
156609981|NCT02120352|565314064|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
156609982|NCT02120352|565314065|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
156609983|NCT02120352|565314066|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
156609984|NCT02120352|565314067|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
156609985|NCT02120352|565314068|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
156609986|NCT02120352|565314069|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
156609987|NCT02120352|565314070|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
156609988|NCT03997760|565314074|FG000|Overall Study|Protocol Deviation|0|||
156609989|NCT03997760|565314075|FG001|Overall Study|Protocol Deviation|1|||
156609990|NCT03997760|565314076|FG002|Overall Study|Protocol Deviation|0|||
156609991|NCT03997760|565314077|FG003|Overall Study|Protocol Deviation|0|||
156609992|NCT00431496|565314078|FG000|Overall Study|Adverse Event|3|||
156609993|NCT00431496|565314078|FG000|Overall Study|Lost to Follow-up|1|||
156609994|NCT00431496|565314078|FG000|Overall Study|Withdrawal by Subject|2|||
156609995|NCT00431496|565314078|FG000|Overall Study|Protocol-specified criteria|5|||
156609996|NCT02343952|565314079|FG000|Study Treatment|Disease Progression|23|||
156609997|NCT02343952|565314079|FG000|Study Treatment|Death|3|||
156609998|NCT02343952|565314079|FG000|Study Treatment|Adverse Event|19|||
156609999|NCT02343952|565314079|FG000|Study Treatment|Withdrawal by Subject|7|||
156610000|NCT02343952|565314079|FG000|Study Treatment|other complicating Diseases|1|||
156610001|NCT02343952|565314079|FG000|Follow up|Withdrawal by Subject|3|||
156610002|NCT02343952|565314079|FG000|Follow up|Death|33|||
156610003|NCT02343952|565314079|FG000|Follow up|Patient does not meet eligibility for study.|1|||
156610004|NCT02343952|565314079|FG000|Follow up|Research department closed by the practice.|5|||
156610005|NCT02343952|565314079|FG000|Follow up|Patient went home to Russia|1|||
156610006|NCT02343952|565314079|FG000|Follow up|Disease Progression|1|||
156610007|NCT02343952|565314079|FG000|Follow up|study terminated|1|||
156610008|NCT02671760|565314081|FG000|Overall Study|Lost to Follow-up|0|||
156610009|NCT02671760|565314082|FG001|Overall Study|Lost to Follow-up|1|||
156610010|NCT02671760|565314083|FG002|Overall Study|Lost to Follow-up|0|||
156610011|NCT02999191|565314084|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
156610012|NCT02999191|565314085|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
156610013|NCT02999191|565314086|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
156610014|NCT02079519|565314092|FG000|Overall Study|Disease Progression|9|||
156610015|NCT02079519|565314092|FG000|Overall Study|Adverse Event|1|||
156610016|NCT01802515|565314093|FG000|Overall Study|Withdrawal by Subject|3|||
156610017|NCT01802515|565314094|FG001|Overall Study|Withdrawal by Subject|0|||
156610018|NCT01802515|565314095|FG002|Overall Study|Withdrawal by Subject|0|||
156610019|NCT01906476|565314098|FG000|Overall Study|Lost to Follow-up|17|||
156610020|NCT01906476|565314099|FG001|Overall Study|Lost to Follow-up|16|||
156610021|NCT01993667|565314101|FG000|Overall Study|Insufficient data to analyze|16|||
156610022|NCT01993667|565314102|FG001|Overall Study|Insufficient data to analyze|16|||
156610023|NCT01993667|565314101|FG000|Overall Study|Insufficient altitude reached|3|||
156610024|NCT01993667|565314102|FG001|Overall Study|Insufficient altitude reached|1|||
156610025|NCT01993667|565314101|FG000|Overall Study|Lost to Follow-up|2|||
156610026|NCT01993667|565314102|FG001|Overall Study|Lost to Follow-up|2|||
156610027|NCT01931150|565314103|FG000|Overall Study|Withdrawal by Subject|1|||
156610028|NCT01931150|565314104|FG001|Overall Study|Withdrawal by Subject|2|||
156610029|NCT00845845|565314107|FG000|Overall Study|Lost to Follow-up|0|||
156610030|NCT00845845|565314108|FG001|Overall Study|Lost to Follow-up|4|||
156610031|NCT01685203|565314109|FG000|Overall Study|Lost to Follow-up|3|||
156610032|NCT01685203|565314110|FG001|Overall Study|Lost to Follow-up|3|||
156610033|NCT01685203|565314111|FG002|Overall Study|Lost to Follow-up|0|||
156610034|NCT01685203|565314112|FG003|Overall Study|Lost to Follow-up|1|||
156610035|NCT01685203|565314113|FG004|Overall Study|Lost to Follow-up|0|||
156610036|NCT01685203|565314114|FG005|Overall Study|Lost to Follow-up|0|||
156610037|NCT01685203|565314115|FG006|Overall Study|Lost to Follow-up|0|||
156610038|NCT01685203|565314109|FG000|Overall Study|Adverse Event|0|||
156610039|NCT01685203|565314110|FG001|Overall Study|Adverse Event|0|||
156610040|NCT01685203|565314111|FG002|Overall Study|Adverse Event|0|||
156610041|NCT01685203|565314112|FG003|Overall Study|Adverse Event|0|||
156610042|NCT01685203|565314113|FG004|Overall Study|Adverse Event|0|||
156610043|NCT01685203|565314114|FG005|Overall Study|Adverse Event|2|||
156610044|NCT01685203|565314115|FG006|Overall Study|Adverse Event|0|||
156610045|NCT01685203|565314109|FG000|Overall Study|Adverse event and withdrew consent|1|||
156610046|NCT01685203|565314110|FG001|Overall Study|Adverse event and withdrew consent|0|||
156610047|NCT01685203|565314111|FG002|Overall Study|Adverse event and withdrew consent|0|||
156610048|NCT01685203|565314112|FG003|Overall Study|Adverse event and withdrew consent|0|||
156610049|NCT01685203|565314113|FG004|Overall Study|Adverse event and withdrew consent|0|||
156610050|NCT01685203|565314114|FG005|Overall Study|Adverse event and withdrew consent|0|||
156610051|NCT01685203|565314115|FG006|Overall Study|Adverse event and withdrew consent|0|||
156610052|NCT01685203|565314109|FG000|Overall Study|Patient's decision|0|||
156610053|NCT01685203|565314110|FG001|Overall Study|Patient's decision|0|||
156610054|NCT01685203|565314111|FG002|Overall Study|Patient's decision|0|||
156610055|NCT01685203|565314112|FG003|Overall Study|Patient's decision|0|||
156610056|NCT01685203|565314113|FG004|Overall Study|Patient's decision|0|||
156610057|NCT01685203|565314114|FG005|Overall Study|Patient's decision|1|||
156610058|NCT01685203|565314115|FG006|Overall Study|Patient's decision|0|||
156610059|NCT02896192|565314116|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
156610060|NCT02896192|565314116|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
156610061|NCT02896192|565314116|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
156610062|NCT00479167|565314120|FG000|Overall Study|Withdrawal by Subject|1|||
156610063|NCT03619837|565314121|FG000|Screening|received organs from HCV-negative donors|47|||
156610064|NCT03619837|565314121|FG000|Screening|died on the wait-list|2|||
156610065|NCT03619837|565314121|FG000|Screening|remained on the wait list|40|||
156610066|NCT03619837|565314121|FG000|Screening|didn't meet eligibility criteria|3|||
156610067|NCT03619837|565314121|FG000|Screening|withdrew consent|2|||
156610068|NCT03619837|565314121|FG000|Screening|never listed for HCV-viremic donor|1|||
156610069|NCT03619837|565314121|FG000|Screening|developed exclusion criteria|2|||
156610070|NCT03619837|565314121|FG000|Screening|excluded by the investigator due to non-compliance|1|||
156610071|NCT04095793|565314122|FG000|Overall Study|Adverse Event|3|||
156610072|NCT04095793|565314122|FG000|Overall Study|Study Terminated by Sponsor|103|||
156610073|NCT04095793|565314122|FG000|Overall Study|Withdrawal by Subject|4|||
156610074|NCT01432756|565316032|FG000|Overall Study|Lost to Follow-up|1|||
156610075|NCT01432756|565316033|FG001|Overall Study|Lost to Follow-up|0|||
156610076|NCT01432756|565316034|FG002|Overall Study|Lost to Follow-up|2|||
156610077|NCT01432756|565316035|FG003|Overall Study|Lost to Follow-up|1|||
156610078|NCT02712008|565316036|FG000|Baseline (Day 1) up to Week 12|Death|3|||
156610079|NCT02712008|565316037|FG001|Baseline (Day 1) up to Week 12|Death|0|||
156610080|NCT02712008|565316038|FG002|Baseline (Day 1) up to Week 12|Death|0|||
156610081|NCT02712008|565316039|FG003|Baseline (Day 1) up to Week 12|Death|0|||
156610082|NCT02712008|565316040|FG004|Baseline (Day 1) up to Week 12|Death|0|||
156610083|NCT02712008|565316041|FG005|Baseline (Day 1) up to Week 12|Death|0|||
156610084|NCT02712008|565316042|FG006|Baseline (Day 1) up to Week 12|Death|0|||
156610085|NCT02712008|565316043|FG007|Baseline (Day 1) up to Week 12|Death|0|||
156610086|NCT02712008|565316036|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156610087|NCT02712008|565316037|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
156610088|NCT02712008|565316038|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
156610089|NCT02712008|565316039|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156610090|NCT02712008|565316040|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156610091|NCT02712008|565316041|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156610092|NCT02712008|565316042|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156610093|NCT02712008|565316043|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156610094|NCT02712008|565316036|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
156610095|NCT02712008|565316037|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156610096|NCT02712008|565316038|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
156610097|NCT02712008|565316039|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156610098|NCT02712008|565316040|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156610099|NCT02712008|565316041|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156610100|NCT02712008|565316042|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156610101|NCT02712008|565316043|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156610102|NCT02712008|565316036|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
156610103|NCT02712008|565316037|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
156610104|NCT02712008|565316038|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
156610105|NCT02712008|565316039|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
156610106|NCT02712008|565316040|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
156610107|NCT02712008|565316041|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
156610108|NCT02712008|565316042|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
156610109|NCT02712008|565316043|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
156610110|NCT02712008|565316036|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
156610111|NCT02712008|565316037|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
156610112|NCT02712008|565316038|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
156610113|NCT02712008|565316039|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
156610114|NCT02712008|565316040|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
156610115|NCT02712008|565316041|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
156610116|NCT02712008|565316042|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
156610117|NCT02712008|565316043|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
156610118|NCT02712008|565316036|FG000|From Week 12 up to Week 36|Adverse Event|0|||
156610119|NCT02712008|565316037|FG001|From Week 12 up to Week 36|Adverse Event|0|||
156610120|NCT02712008|565316038|FG002|From Week 12 up to Week 36|Adverse Event|0|||
156610121|NCT02712008|565316039|FG003|From Week 12 up to Week 36|Adverse Event|0|||
156610122|NCT02712008|565316040|FG004|From Week 12 up to Week 36|Adverse Event|1|||
156610123|NCT02712008|565316041|FG005|From Week 12 up to Week 36|Adverse Event|0|||
156610124|NCT02712008|565316042|FG006|From Week 12 up to Week 36|Adverse Event|0|||
156610125|NCT02712008|565316043|FG007|From Week 12 up to Week 36|Adverse Event|2|||
156610126|NCT02712008|565316036|FG000|From Week 12 up to Week 36|Death|1|||
156610127|NCT02712008|565316037|FG001|From Week 12 up to Week 36|Death|0|||
156610128|NCT02712008|565316038|FG002|From Week 12 up to Week 36|Death|0|||
156610129|NCT02712008|565316039|FG003|From Week 12 up to Week 36|Death|0|||
156610130|NCT02712008|565316040|FG004|From Week 12 up to Week 36|Death|0|||
156610131|NCT02712008|565316041|FG005|From Week 12 up to Week 36|Death|0|||
156610132|NCT02712008|565316042|FG006|From Week 12 up to Week 36|Death|1|||
156610133|NCT02712008|565316043|FG007|From Week 12 up to Week 36|Death|0|||
156610134|NCT02712008|565316036|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
156610135|NCT02712008|565316037|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
156610136|NCT02712008|565316038|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
156610137|NCT02712008|565316039|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
156610138|NCT02712008|565316040|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
156610139|NCT02712008|565316041|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
156610140|NCT02712008|565316042|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
156610141|NCT02712008|565316043|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
156610142|NCT02712008|565316036|FG000|From Week 12 up to Week 36|Physician Decision|0|||
156610143|NCT02712008|565316037|FG001|From Week 12 up to Week 36|Physician Decision|0|||
156610144|NCT02712008|565316038|FG002|From Week 12 up to Week 36|Physician Decision|0|||
156610145|NCT02712008|565316039|FG003|From Week 12 up to Week 36|Physician Decision|1|||
156610146|NCT02712008|565316040|FG004|From Week 12 up to Week 36|Physician Decision|1|||
156610147|NCT02712008|565316041|FG005|From Week 12 up to Week 36|Physician Decision|0|||
156610148|NCT02712008|565316042|FG006|From Week 12 up to Week 36|Physician Decision|0|||
156610149|NCT02712008|565316043|FG007|From Week 12 up to Week 36|Physician Decision|0|||
156610150|NCT02712008|565316036|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
156610151|NCT02712008|565316037|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
156610152|NCT02712008|565316038|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
156610153|NCT02712008|565316039|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
156610154|NCT02712008|565316040|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
156610155|NCT02712008|565316041|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
156610156|NCT02712008|565316042|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
156610157|NCT02712008|565316043|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
156610158|NCT01131078|565316044|FG000|Overall Study|Adverse Event|22|||
156610159|NCT01131078|565316045|FG001|Overall Study|Adverse Event|12|||
156610160|NCT01131078|565316046|FG002|Overall Study|Adverse Event|17|||
156610161|NCT01131078|565316044|FG000|Overall Study|Progressive Disease|58|||
156610162|NCT01131078|565316045|FG001|Overall Study|Progressive Disease|77|||
156610163|NCT01131078|565316046|FG002|Overall Study|Progressive Disease|71|||
156610164|NCT01131078|565316044|FG000|Overall Study|Protocol Violation|1|||
156610165|NCT01131078|565316045|FG001|Overall Study|Protocol Violation|0|||
156610166|NCT01131078|565316046|FG002|Overall Study|Protocol Violation|0|||
156610167|NCT01131078|565316044|FG000|Overall Study|Lost to Follow-up|1|||
156610168|NCT01131078|565316045|FG001|Overall Study|Lost to Follow-up|1|||
156610169|NCT01131078|565316046|FG002|Overall Study|Lost to Follow-up|1|||
156610170|NCT01131078|565316044|FG000|Overall Study|Withdrawal by Subject|2|||
156610171|NCT01131078|565316045|FG001|Overall Study|Withdrawal by Subject|4|||
156610172|NCT01131078|565316046|FG002|Overall Study|Withdrawal by Subject|3|||
156610173|NCT01131078|565316044|FG000|Overall Study|Non-compliance|3|||
156610174|NCT01131078|565316045|FG001|Overall Study|Non-compliance|0|||
156610175|NCT01131078|565316046|FG002|Overall Study|Non-compliance|0|||
156610176|NCT01131078|565316044|FG000|Overall Study|Physician Decision|10|||
156610177|NCT01131078|565316045|FG001|Overall Study|Physician Decision|6|||
156610178|NCT01131078|565316046|FG002|Overall Study|Physician Decision|8|||
156610179|NCT01131078|565316044|FG000|Overall Study|Death|4|||
156610180|NCT01131078|565316045|FG001|Overall Study|Death|0|||
156610181|NCT01131078|565316046|FG002|Overall Study|Death|2|||
156610182|NCT01131078|565316044|FG000|Overall Study|Other|0|||
156610183|NCT01131078|565316045|FG001|Overall Study|Other|1|||
156610184|NCT01131078|565316046|FG002|Overall Study|Other|0|||
156610185|NCT01199198|565316047|FG000|Overall Study|Adverse Event|3|||
156610186|NCT01199198|565316048|FG001|Overall Study|Adverse Event|0|||
156610187|NCT01199198|565316047|FG000|Overall Study|Lost to Follow-up|1|||
156610188|NCT01199198|565316048|FG001|Overall Study|Lost to Follow-up|5|||
156610189|NCT01199198|565316047|FG000|Overall Study|Withdrawal by Subject|1|||
156610190|NCT01199198|565316048|FG001|Overall Study|Withdrawal by Subject|2|||
156610191|NCT01199198|565316047|FG000|Overall Study|ICU Transfer|1|||
156610192|NCT01199198|565316048|FG001|Overall Study|ICU Transfer|2|||
156610193|NCT01199198|565316047|FG000|Overall Study|Hospice-care transfer|1|||
156610194|NCT01199198|565316048|FG001|Overall Study|Hospice-care transfer|2|||
156610195|NCT02177786|565316050|FG000|Overall Study|Withdrew Consent|2|||
156610196|NCT02177786|565316051|FG001|Overall Study|Withdrew Consent|6|||
156610197|NCT02177786|565316052|FG002|Overall Study|Withdrew Consent|9|||
156610198|NCT02177786|565316053|FG003|Overall Study|Withdrew Consent|5|||
156610199|NCT02177786|565316050|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
156610200|NCT02177786|565316051|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
156610201|NCT02177786|565316052|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
156610202|NCT02177786|565316053|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
156610203|NCT02177786|565316050|FG000|Overall Study|Adverse Event|1|||
156610204|NCT02177786|565316051|FG001|Overall Study|Adverse Event|1|||
156610205|NCT02177786|565316052|FG002|Overall Study|Adverse Event|2|||
156610206|NCT02177786|565316053|FG003|Overall Study|Adverse Event|3|||
156610207|NCT02177786|565316050|FG000|Overall Study|Death|1|||
156610208|NCT02177786|565316051|FG001|Overall Study|Death|1|||
156610209|NCT02177786|565316052|FG002|Overall Study|Death|1|||
156610210|NCT02177786|565316053|FG003|Overall Study|Death|1|||
156610211|NCT02177786|565316050|FG000|Overall Study|Lost to Follow-up|0|||
156610212|NCT02177786|565316051|FG001|Overall Study|Lost to Follow-up|0|||
156610213|NCT02177786|565316052|FG002|Overall Study|Lost to Follow-up|2|||
156610214|NCT02177786|565316053|FG003|Overall Study|Lost to Follow-up|2|||
156610215|NCT02177786|565316050|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156610216|NCT02177786|565316051|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156610217|NCT02177786|565316052|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156610218|NCT02177786|565316053|FG003|Overall Study|Non-Compliance with Study Drug|1|||
156610219|NCT02177786|565316050|FG000|Overall Study|Protocol Violation|0|||
156610220|NCT02177786|565316051|FG001|Overall Study|Protocol Violation|0|||
156610221|NCT02177786|565316052|FG002|Overall Study|Protocol Violation|2|||
156610222|NCT02177786|565316053|FG003|Overall Study|Protocol Violation|0|||
156610223|NCT02177786|565316050|FG000|Overall Study|Progressive Disease|0|||
156610224|NCT02177786|565316051|FG001|Overall Study|Progressive Disease|1|||
156610225|NCT02177786|565316052|FG002|Overall Study|Progressive Disease|0|||
156610226|NCT02177786|565316053|FG003|Overall Study|Progressive Disease|0|||
156610227|NCT02177786|565316050|FG000|Overall Study|Missing study completion status|0|||
156610228|NCT02177786|565316051|FG001|Overall Study|Missing study completion status|1|||
156610229|NCT02177786|565316052|FG002|Overall Study|Missing study completion status|0|||
156610230|NCT02177786|565316053|FG003|Overall Study|Missing study completion status|0|||
156610231|NCT01305941|565316054|FG000|Overall Study|Adverse Event|6|||
156610232|NCT01305941|565316054|FG000|Overall Study|Clinical decline|2|||
156610233|NCT01305941|565316054|FG000|Overall Study|Withdrawal by Subject|1|||
156610234|NCT01305941|565316054|FG000|Overall Study|Death|1|||
156610235|NCT02043509|565316055|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
156610236|NCT02043509|565316056|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
156610237|NCT02043509|565316055|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
156610238|NCT02043509|565316056|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
156610239|NCT02043509|565316055|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
156610240|NCT02043509|565316056|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
156610241|NCT02043509|565316055|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
156610242|NCT02043509|565316056|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
156610243|NCT00608244|565316062|FG000|Overall Study|Adverse Event|1|||
156610244|NCT00608244|565316062|FG000|Overall Study|Low trough levels|1|||
156610245|NCT00430027|565316063|FG000|Overall Study|Study terminated|8|||
156610246|NCT01977040|565316068|FG000|Overall Study|Vasa previa not confirmed|2|||
156610247|NCT00688623|565316071|FG000|Overall Study|Adverse Event|22|||
156610248|NCT00688623|565316071|FG000|Overall Study|abnormal lab value|1|||
156610249|NCT00688623|565316071|FG000|Overall Study|Withdrawal by Subject|4|||
156610250|NCT00688623|565316071|FG000|Overall Study|Death|3|||
156610251|NCT00688623|565316071|FG000|Overall Study|disease progression|23|||
156610252|NCT00688623|565316071|FG000|Overall Study|Protocol Violation|2|||
156610253|NCT02443155|565316072|FG000|Overall Study|Adverse Event|3|||
156610254|NCT02443155|565316073|FG001|Overall Study|Adverse Event|4|||
156610255|NCT02443155|565316074|FG002|Overall Study|Adverse Event|1|||
156610256|NCT02443155|565316075|FG003|Overall Study|Adverse Event|2|||
156610257|NCT02443155|565316072|FG000|Overall Study|Unclassified|0|||
156610258|NCT02443155|565316073|FG001|Overall Study|Unclassified|0|||
156610259|NCT02443155|565316074|FG002|Overall Study|Unclassified|2|||
156610260|NCT02443155|565316075|FG003|Overall Study|Unclassified|1|||
156610261|NCT02443155|565316072|FG000|Overall Study|Withdrawal by Subject|4|||
156610262|NCT02443155|565316073|FG001|Overall Study|Withdrawal by Subject|7|||
156610263|NCT02443155|565316074|FG002|Overall Study|Withdrawal by Subject|3|||
156610264|NCT02443155|565316075|FG003|Overall Study|Withdrawal by Subject|9|||
156610265|NCT02443155|565316072|FG000|Overall Study|Pregnancy|3|||
156610266|NCT02443155|565316073|FG001|Overall Study|Pregnancy|1|||
156610267|NCT02443155|565316074|FG002|Overall Study|Pregnancy|1|||
156610268|NCT02443155|565316075|FG003|Overall Study|Pregnancy|2|||
156610269|NCT02443155|565316072|FG000|Overall Study|Lost to Follow-up|1|||
156610270|NCT02443155|565316073|FG001|Overall Study|Lost to Follow-up|2|||
156610271|NCT02443155|565316074|FG002|Overall Study|Lost to Follow-up|0|||
156610272|NCT02443155|565316075|FG003|Overall Study|Lost to Follow-up|1|||
156610273|NCT02443155|565316072|FG000|Overall Study|Protocol Violation|1|||
156610274|NCT02443155|565316073|FG001|Overall Study|Protocol Violation|0|||
156610275|NCT02443155|565316074|FG002|Overall Study|Protocol Violation|1|||
156610276|NCT02443155|565316075|FG003|Overall Study|Protocol Violation|1|||
156610277|NCT02443155|565316072|FG000|Overall Study|Death|0|||
156610278|NCT02443155|565316073|FG001|Overall Study|Death|0|||
156610279|NCT02443155|565316074|FG002|Overall Study|Death|1|||
156610280|NCT02443155|565316075|FG003|Overall Study|Death|0|||
156610281|NCT02000219|565316076|FG000|14-Week Study Period|Physician Decision|1|||
156610282|NCT02000219|565316076|FG000|14-Week Study Period|Adverse Event|1|||
156610283|NCT02000219|565316076|FG000|14-Week Study Period|Underwent transplantation|1|||
156610284|NCT02000219|565316076|FG000|Continuation Period|Withdrawal by Subject|1|||
156610285|NCT02000219|565316076|FG000|Continuation Period|Had liver transplant|2|||
156610286|NCT02000219|565316076|FG000|Continuation Period|Non-compliance with study drug|2|||
156610287|NCT02667236|565316077|FG000|Overall Study|Adverse Event|1|||
156610288|NCT02667236|565316078|FG001|Overall Study|Adverse Event|1|||
156610289|NCT02667236|565316077|FG000|Overall Study|Withdrawal by Subject|2|||
156610290|NCT02667236|565316078|FG001|Overall Study|Withdrawal by Subject|0|||
156610291|NCT00634751|565316083|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
156610292|NCT00634751|565316084|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
156610293|NCT00634751|565316085|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
156610294|NCT00634751|565316086|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
156610295|NCT00634751|565316083|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
156610296|NCT00634751|565316084|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
156610297|NCT00634751|565316085|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
156610298|NCT00634751|565316086|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
156610299|NCT00634751|565316083|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
156610300|NCT00634751|565316084|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
156610301|NCT00634751|565316085|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
156610302|NCT00634751|565316086|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
156610303|NCT02809118|565316089|FG000|Overall Study|Withdrawal by Subject|0|||
156610304|NCT02809118|565316090|FG001|Overall Study|Withdrawal by Subject|1|||
156610305|NCT02809118|565316091|FG002|Overall Study|Withdrawal by Subject|1|||
156610306|NCT01235338|565316092|FG000|Overall Study|Adverse Event|3|||
156610307|NCT01235338|565316093|FG001|Overall Study|Adverse Event|2|||
156610308|NCT01235338|565316092|FG000|Overall Study|Protocol Violation|1|||
156610309|NCT01235338|565316093|FG001|Overall Study|Protocol Violation|1|||
156610310|NCT01235338|565316092|FG000|Overall Study|Withdrawal by Subject|5|||
156610311|NCT01235338|565316093|FG001|Overall Study|Withdrawal by Subject|0|||
156610312|NCT01235338|565316092|FG000|Overall Study|Exclusion criteria violations|1|||
156610313|NCT01235338|565316093|FG001|Overall Study|Exclusion criteria violations|1|||
156610314|NCT01235338|565316092|FG000|Overall Study|Positive drug screen|0|||
156610315|NCT01235338|565316093|FG001|Overall Study|Positive drug screen|1|||
156610316|NCT01235338|565316092|FG000|Overall Study|Prohibited meds|1|||
156610317|NCT01235338|565316093|FG001|Overall Study|Prohibited meds|0|||
156610318|NCT02996110|565316095|FG000|Pre-Treatment|Other Reasons|0|||
156610319|NCT02996110|565316096|FG001|Pre-Treatment|Other Reasons|1|||
156610320|NCT02996110|565316097|FG002|Pre-Treatment|Other Reasons|0|||
156610321|NCT02996110|565316098|FG003|Pre-Treatment|Other Reasons|0|||
156610322|NCT02996110|565316099|FG004|Pre-Treatment|Other Reasons|1|||
156610323|NCT02996110|565316095|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
156610324|NCT02996110|565316096|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
156610325|NCT02996110|565316097|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
156610326|NCT02996110|565316098|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
156610327|NCT02996110|565316099|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
156610328|NCT02996110|565316095|FG000|Track 1|Disease Progression|15|||
156610329|NCT02996110|565316096|FG001|Track 1|Disease Progression|17|||
156610330|NCT02996110|565316097|FG002|Track 1|Disease Progression|0|||
156610331|NCT02996110|565316098|FG003|Track 1|Disease Progression|0|||
156610332|NCT02996110|565316099|FG004|Track 1|Disease Progression|0|||
156610333|NCT02996110|565316095|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
156610334|NCT02996110|565316096|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
156610335|NCT02996110|565316097|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
156610336|NCT02996110|565316098|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
156610337|NCT02996110|565316099|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
156610338|NCT02996110|565316095|FG000|Track 1|Study Drug Toxicity|5|||
156610339|NCT02996110|565316096|FG001|Track 1|Study Drug Toxicity|3|||
156610340|NCT02996110|565316097|FG002|Track 1|Study Drug Toxicity|0|||
156610341|NCT02996110|565316098|FG003|Track 1|Study Drug Toxicity|0|||
156610342|NCT02996110|565316099|FG004|Track 1|Study Drug Toxicity|0|||
156610343|NCT02996110|565316095|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
156610344|NCT02996110|565316096|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
156610345|NCT02996110|565316097|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
156610346|NCT02996110|565316098|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
156610347|NCT02996110|565316099|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
156610348|NCT02996110|565316095|FG000|Track 1|Administrative Reason by Sponsor|0|||
156610349|NCT02996110|565316096|FG001|Track 1|Administrative Reason by Sponsor|1|||
156610350|NCT02996110|565316097|FG002|Track 1|Administrative Reason by Sponsor|0|||
156610351|NCT02996110|565316098|FG003|Track 1|Administrative Reason by Sponsor|0|||
156610352|NCT02996110|565316099|FG004|Track 1|Administrative Reason by Sponsor|0|||
156610353|NCT02996110|565316095|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
156610354|NCT02996110|565316096|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
156610355|NCT02996110|565316097|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
156610356|NCT02996110|565316098|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
156610357|NCT02996110|565316099|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
156610358|NCT02996110|565316095|FG000|Track 2|Disease Progression|33|||
156610359|NCT02996110|565316096|FG001|Track 2|Disease Progression|26|||
156610360|NCT02996110|565316097|FG002|Track 2|Disease Progression|19|||
156610361|NCT02996110|565316098|FG003|Track 2|Disease Progression|16|||
156610362|NCT02996110|565316099|FG004|Track 2|Disease Progression|15|||
156610363|NCT02996110|565316095|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
156610364|NCT02996110|565316096|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
156610365|NCT02996110|565316097|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
156610366|NCT02996110|565316098|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
156610367|NCT02996110|565316099|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
156610368|NCT02996110|565316095|FG000|Track 2|Death|0|||
156610369|NCT02996110|565316096|FG001|Track 2|Death|0|||
156610370|NCT02996110|565316097|FG002|Track 2|Death|1|||
156610371|NCT02996110|565316098|FG003|Track 2|Death|0|||
156610372|NCT02996110|565316099|FG004|Track 2|Death|1|||
156610373|NCT02996110|565316095|FG000|Track 2|Study Drug Toxicity|4|||
156610374|NCT02996110|565316096|FG001|Track 2|Study Drug Toxicity|1|||
156610375|NCT02996110|565316097|FG002|Track 2|Study Drug Toxicity|4|||
156610376|NCT02996110|565316098|FG003|Track 2|Study Drug Toxicity|1|||
156610377|NCT02996110|565316099|FG004|Track 2|Study Drug Toxicity|0|||
156610378|NCT02996110|565316095|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
156610379|NCT02996110|565316096|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
156610380|NCT02996110|565316097|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
156610381|NCT02996110|565316098|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
156610382|NCT02996110|565316099|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
156610383|NCT02996110|565316095|FG000|Track 2|Participant Withdrew Consent|1|||
156610384|NCT02996110|565316096|FG001|Track 2|Participant Withdrew Consent|2|||
156610385|NCT02996110|565316097|FG002|Track 2|Participant Withdrew Consent|3|||
156610386|NCT02996110|565316098|FG003|Track 2|Participant Withdrew Consent|1|||
156610387|NCT02996110|565316099|FG004|Track 2|Participant Withdrew Consent|1|||
156610388|NCT02996110|565316095|FG000|Track 2|Other Reasons|0|||
156610389|NCT02996110|565316096|FG001|Track 2|Other Reasons|0|||
156610390|NCT02996110|565316097|FG002|Track 2|Other Reasons|1|||
156610391|NCT02996110|565316098|FG003|Track 2|Other Reasons|0|||
156610392|NCT02996110|565316099|FG004|Track 2|Other Reasons|1|||
156610393|NCT00216086|565316100|FG000|Overall Study|Protocol Violation|1|||
156610394|NCT00216086|565316100|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
156610395|NCT00216086|565316100|FG000|Overall Study|Social Reasons|2|||
156610396|NCT01080625|565316101|FG000|Overall Study|Physician Decision|0|||
156610397|NCT01080625|565316102|FG001|Overall Study|Physician Decision|2|||
156610398|NCT01080625|565316103|FG002|Overall Study|Physician Decision|1|||
156610399|NCT00446797|565316104|FG000|Overall Study|Lack of Efficacy|0|||
156610400|NCT00446797|565316105|FG001|Overall Study|Lack of Efficacy|2|||
156610401|NCT00446797|565316104|FG000|Overall Study|Lost to Follow-up|5|||
156610402|NCT00446797|565316105|FG001|Overall Study|Lost to Follow-up|3|||
156610403|NCT00446797|565316104|FG000|Overall Study|Withdrawal by Subject|2|||
156610404|NCT00446797|565316105|FG001|Overall Study|Withdrawal by Subject|2|||
156610405|NCT00446797|565316104|FG000|Overall Study|Protocol Violation|1|||
156610406|NCT00446797|565316105|FG001|Overall Study|Protocol Violation|3|||
156610407|NCT00446797|565316104|FG000|Overall Study|subject entered at another site|0|||
156610408|NCT00446797|565316105|FG001|Overall Study|subject entered at another site|1|||
156610409|NCT00446797|565316104|FG000|Overall Study|did not meet entrance criteria|0|||
156610410|NCT00446797|565316105|FG001|Overall Study|did not meet entrance criteria|1|||
156610411|NCT02728206|565316111|FG000|Overall Study|Death|1|||
156610412|NCT01929018|565316124|FG000|Overall Study|Lost to Follow-up|1|||
156610413|NCT01929018|565316125|FG001|Overall Study|Lost to Follow-up|0|||
156610414|NCT01929018|565316124|FG000|Overall Study|Hospitalization|0|||
156610415|NCT01929018|565316125|FG001|Overall Study|Hospitalization|1|||
156610416|NCT01366534|565316126|FG000|Overall Study|Lost to Follow-up|1|||
156610417|NCT01366534|565316127|FG001|Overall Study|Lost to Follow-up|0|||
156610418|NCT01366534|565316128|FG002|Overall Study|Lost to Follow-up|0|||
156610419|NCT01366534|565316126|FG000|Overall Study|Migrated|1|||
156610420|NCT01366534|565316127|FG001|Overall Study|Migrated|1|||
156610421|NCT01366534|565316128|FG002|Overall Study|Migrated|0|||
156610422|NCT01366534|565316126|FG000|Overall Study|Declined challenged|0|||
156610423|NCT01366534|565316127|FG001|Overall Study|Declined challenged|1|||
156610424|NCT01366534|565316128|FG002|Overall Study|Declined challenged|0|||
156610425|NCT00282568|565316131|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
156610426|NCT00282568|565316131|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
156610427|NCT00282568|565316131|FG000|Extended Treatment Period|Adverse Event|17|||
156610428|NCT00282568|565316131|FG000|Extended Treatment Period|Non-compliance|4|||
156610429|NCT00282568|565316131|FG000|Extended Treatment Period|Physician Decision|1|||
156610430|NCT00282568|565316131|FG000|Extended Treatment Period|Lost to Follow-up|2|||
156610431|NCT01266070|565316132|FG000|Overall Study|Adverse Event|3|||
156610432|NCT01266070|565316132|FG000|Overall Study|Protocol Violation|1|||
156610433|NCT02417064|565316133|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
156610434|NCT02417064|565316134|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
156610435|NCT02417064|565316135|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
156610436|NCT02417064|565316133|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
156610437|NCT02417064|565316134|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
156610438|NCT02417064|565316135|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
156610439|NCT02417064|565316133|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
156610440|NCT02417064|565316134|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
156610441|NCT02417064|565316135|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
156610442|NCT02417064|565316133|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
156610443|NCT02417064|565316134|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
156610444|NCT02417064|565316135|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
156610445|NCT02417064|565316133|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
156610446|NCT02417064|565316134|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
156610447|NCT02417064|565316135|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
156610448|NCT02417064|565316133|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
156610449|NCT02417064|565316134|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
156610450|NCT02417064|565316135|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
156610451|NCT02417064|565316133|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
156610452|NCT02417064|565316134|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
156610453|NCT02417064|565316135|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
156610454|NCT02417064|565316133|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
156610455|NCT02417064|565316134|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
156610456|NCT02417064|565316135|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
156610457|NCT02417064|565316133|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
156610458|NCT02417064|565316134|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
156610459|NCT02417064|565316135|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
156610460|NCT02417064|565316133|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
156610461|NCT02417064|565316134|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
156610462|NCT02417064|565316135|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
156610463|NCT02417064|565316133|FG000|Follow-up Phase (24 Weeks)|Other|2|||
156610464|NCT02417064|565316134|FG001|Follow-up Phase (24 Weeks)|Other|2|||
156610465|NCT02417064|565316135|FG002|Follow-up Phase (24 Weeks)|Other|3|||
156610466|NCT03185819|565316136|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
156610467|NCT03185819|565316137|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
156610468|NCT03185819|565316138|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
156610469|NCT03185819|565316139|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
156610470|NCT03185819|565316136|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
156610471|NCT03185819|565316137|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
156610472|NCT03185819|565316138|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
156610473|NCT03185819|565316139|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
156610474|NCT03185819|565316136|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
156610475|NCT03185819|565316137|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
156610476|NCT03185819|565316138|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
156610477|NCT03185819|565316139|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
156610478|NCT03185819|565316136|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
156610479|NCT03185819|565316137|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
156610480|NCT03185819|565316138|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
156610481|NCT03185819|565316139|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
156610482|NCT03185819|565316136|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
156610483|NCT03185819|565316137|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
156610484|NCT03185819|565316138|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
156610485|NCT03185819|565316139|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
156610486|NCT03185819|565316136|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
156610487|NCT03185819|565316137|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
156610488|NCT03185819|565316138|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
156610489|NCT03185819|565316139|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
156610490|NCT03185819|565316136|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
156610491|NCT03185819|565316137|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
156610492|NCT03185819|565316138|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
156610493|NCT03185819|565316139|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
156610494|NCT03185819|565316136|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
156610495|NCT03185819|565316137|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
156610496|NCT03185819|565316138|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
156610497|NCT03185819|565316139|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
156610498|NCT03185819|565316136|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
156610499|NCT03185819|565316137|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
156610500|NCT03185819|565316138|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
156610501|NCT03185819|565316139|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
156610502|NCT03185819|565316136|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
156610503|NCT03185819|565316137|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
156610504|NCT03185819|565316138|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
156610505|NCT03185819|565316139|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
156610506|NCT03185819|565316136|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
156610507|NCT03185819|565316137|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
156610508|NCT03185819|565316138|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
156610509|NCT03185819|565316139|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
156610510|NCT03185819|565316136|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
156610511|NCT03185819|565316137|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
156610512|NCT03185819|565316138|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
156610513|NCT03185819|565316139|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
156610514|NCT03185819|565316136|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
156610515|NCT03185819|565316137|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
156610516|NCT03185819|565316138|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
156610517|NCT03185819|565316139|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
156610518|NCT02939976|565316140|FG000|Overall Study|Lost to Follow-up|7|||
156610519|NCT02939976|565316141|FG001|Overall Study|Lost to Follow-up|1|||
156610520|NCT02939976|565316142|FG002|Overall Study|Lost to Follow-up|1|||
156610521|NCT02939976|565316143|FG003|Overall Study|Lost to Follow-up|2|||
156610522|NCT02939976|565316140|FG000|Overall Study|Withdrawal by Subject|4|||
156610523|NCT02939976|565316141|FG001|Overall Study|Withdrawal by Subject|0|||
156610524|NCT02939976|565316142|FG002|Overall Study|Withdrawal by Subject|2|||
156610525|NCT02939976|565316143|FG003|Overall Study|Withdrawal by Subject|4|||
156610526|NCT02939976|565316140|FG000|Overall Study|Due to early study closure|4|||
156610527|NCT02939976|565316141|FG001|Overall Study|Due to early study closure|3|||
156610528|NCT02939976|565316142|FG002|Overall Study|Due to early study closure|2|||
156610529|NCT02939976|565316143|FG003|Overall Study|Due to early study closure|3|||
156610530|NCT04080752|565316144|FG000|Overall Study|Adverse Event|2|||
156610531|NCT04080752|565316145|FG001|Overall Study|Adverse Event|3|||
156610532|NCT04080752|565316144|FG000|Overall Study|Lack of Efficacy|1|||
156610533|NCT04080752|565316145|FG001|Overall Study|Lack of Efficacy|0|||
156610534|NCT04080752|565316144|FG000|Overall Study|Lost to Follow-up|1|||
156610535|NCT04080752|565316145|FG001|Overall Study|Lost to Follow-up|0|||
156610536|NCT04080752|565316144|FG000|Overall Study|Pregnancy|0|||
156610537|NCT04080752|565316145|FG001|Overall Study|Pregnancy|1|||
156610538|NCT04080752|565316144|FG000|Overall Study|Withdrawal by Subject|7|||
156610539|NCT04080752|565316145|FG001|Overall Study|Withdrawal by Subject|0|||
156610540|NCT04080752|565316144|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156610541|NCT04080752|565316145|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156610542|NCT04080752|565316144|FG000|Overall Study|Other|2|||
156610543|NCT04080752|565316145|FG001|Overall Study|Other|1|||
156610544|NCT01585168|565316146|FG000|Overall Study|Lost to Follow-up|3|||
156610545|NCT01585168|565316147|FG001|Overall Study|Lost to Follow-up|1|||
156610546|NCT01585168|565316148|FG002|Overall Study|Lost to Follow-up|1|||
156610547|NCT01585168|565316149|FG003|Overall Study|Lost to Follow-up|1|||
156610548|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
156610549|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
156610550|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
156610551|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
156610552|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
156610553|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
156610554|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
156610555|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
156610556|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
156610557|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
156610558|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
156610559|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
156610560|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
156610561|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
156610562|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
156610563|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
156610564|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
156610565|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
156610566|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
156610567|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
156610568|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
156610569|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
156610570|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
156610571|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
156610572|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Other|0|||
156610573|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Other|1|||
156610574|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Other|0|||
156610575|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Other|0|||
156610576|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
156610577|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
156610578|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
156610579|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
156610580|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
156610581|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
156610582|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
156610583|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
156610584|NCT01194414|565316150|FG000|24 Weeks Double Blind Period|Death|0|||
156610585|NCT01194414|565316151|FG001|24 Weeks Double Blind Period|Death|1|||
156610586|NCT01194414|565316152|FG002|24 Weeks Double Blind Period|Death|0|||
156610587|NCT01194414|565316153|FG003|24 Weeks Double Blind Period|Death|0|||
156610588|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
156610589|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
156610590|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
156610591|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
156610592|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
156610593|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
156610594|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
156610595|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
156610596|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
156610597|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
156610598|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
156610599|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
156610600|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
156610601|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
156610602|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
156610603|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
156610604|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
156610605|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
156610606|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
156610607|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
156610608|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
156610609|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
156610610|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
156610611|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
156610612|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Other|2|||
156610613|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Other|1|||
156610614|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Other|0|||
156610615|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Other|0|||
156610616|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
156610617|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
156610618|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
156610619|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
156610620|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
156610621|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
156610622|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
156610623|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
156610624|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
156610625|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
156610626|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
156610627|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
156610628|NCT01194414|565316150|FG000|72 Weeks Open Label Extension|Death|1|||
156610629|NCT01194414|565316151|FG001|72 Weeks Open Label Extension|Death|2|||
156610630|NCT01194414|565316152|FG002|72 Weeks Open Label Extension|Death|0|||
156610631|NCT01194414|565316153|FG003|72 Weeks Open Label Extension|Death|2|||
156610632|NCT01782885|565316154|FG000|Overall Study|Lost to Follow-up|4|||
156610633|NCT01782885|565316155|FG001|Overall Study|Lost to Follow-up|6|||
156610634|NCT03447821|565316157|FG000|Overall Study|Withdrawal by Subject|1|||
156610635|NCT03447821|565316158|FG001|Overall Study|Withdrawal by Subject|1|||
156610636|NCT03447821|565316159|FG002|Overall Study|Withdrawal by Subject|0|||
156610637|NCT03447821|565316157|FG000|Overall Study|Lost to Follow-up|0|||
156610638|NCT03447821|565316158|FG001|Overall Study|Lost to Follow-up|0|||
156610639|NCT03447821|565316159|FG002|Overall Study|Lost to Follow-up|1|||
156610640|NCT02977507|565316160|FG000|Overall Study|Protocol Deviation|1|||
156610641|NCT02977507|565316161|FG001|Overall Study|Protocol Deviation|0|||
156610642|NCT02977507|565316160|FG000|Overall Study|Lost to Follow-up|1|||
156610643|NCT02977507|565316161|FG001|Overall Study|Lost to Follow-up|0|||
156610644|NCT00654420|565316162|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
156610645|NCT00654420|565316163|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
156610646|NCT00654420|565316164|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
156610647|NCT00654420|565316165|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
156610648|NCT00654420|565316162|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
156610649|NCT00654420|565316163|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
156610650|NCT00654420|565316164|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
156610651|NCT00654420|565316165|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
156610652|NCT00654420|565316162|FG000|Phase II|Adverse Event|0|||
156610653|NCT00654420|565316163|FG001|Phase II|Adverse Event|0|||
156610654|NCT00654420|565316164|FG002|Phase II|Adverse Event|3|||
156610655|NCT00654420|565316165|FG003|Phase II|Adverse Event|3|||
156610656|NCT00654420|565316162|FG000|Phase II|Lost to Follow-up|0|||
156610657|NCT00654420|565316163|FG001|Phase II|Lost to Follow-up|0|||
156610658|NCT00654420|565316164|FG002|Phase II|Lost to Follow-up|0|||
156610659|NCT00654420|565316165|FG003|Phase II|Lost to Follow-up|1|||
156610660|NCT00654420|565316162|FG000|Phase II|Physician Decision|0|||
156610661|NCT00654420|565316163|FG001|Phase II|Physician Decision|0|||
156610662|NCT00654420|565316164|FG002|Phase II|Physician Decision|0|||
156610663|NCT00654420|565316165|FG003|Phase II|Physician Decision|4|||
156610664|NCT00654420|565316162|FG000|Phase II|Progressive Disease|0|||
156610665|NCT00654420|565316163|FG001|Phase II|Progressive Disease|0|||
156610666|NCT00654420|565316164|FG002|Phase II|Progressive Disease|29|||
156610667|NCT00654420|565316165|FG003|Phase II|Progressive Disease|29|||
156610668|NCT00654420|565316162|FG000|Phase II|Withdrawal by Subject|0|||
156610669|NCT00654420|565316163|FG001|Phase II|Withdrawal by Subject|0|||
156610670|NCT00654420|565316164|FG002|Phase II|Withdrawal by Subject|4|||
156610671|NCT00654420|565316165|FG003|Phase II|Withdrawal by Subject|1|||
156610672|NCT00654420|565316162|FG000|Phase II|Missing Disposition Record|0|||
156610673|NCT00654420|565316163|FG001|Phase II|Missing Disposition Record|0|||
156610674|NCT00654420|565316164|FG002|Phase II|Missing Disposition Record|1|||
156610675|NCT00654420|565316165|FG003|Phase II|Missing Disposition Record|0|||
156610676|NCT00610207|565316170|FG000|Overall Study|Lost to Follow-up|3|||
156610677|NCT01594411|565316182|FG000|Overall Study|Lost to Follow-up|2|||
156610678|NCT00422669|565316183|FG000|Overall Study|The study was terminated early.|98|||
156610679|NCT00422669|565316184|FG001|Overall Study|The study was terminated early.|100|||
156610680|NCT00422669|565316185|FG002|Overall Study|The study was terminated early.|7|||
156610681|NCT02650895|565316186|FG000|Overall Study|Withdrawal by Subject|0|||
156610682|NCT02650895|565316187|FG001|Overall Study|Withdrawal by Subject|1|||
156610683|NCT02650895|565316188|FG002|Overall Study|Withdrawal by Subject|0|||
156610684|NCT02650895|565316189|FG003|Overall Study|Withdrawal by Subject|0|||
156610685|NCT02650895|565316190|FG004|Overall Study|Withdrawal by Subject|0|||
156610686|NCT02650895|565316191|FG005|Overall Study|Withdrawal by Subject|0|||
156610687|NCT00400946|565318435|FG000|Overall Study|Ineligible|0|||
156610688|NCT00400946|565318436|FG001|Overall Study|Ineligible|0|||
156610689|NCT00400946|565318437|FG002|Overall Study|Ineligible|0|||
156610690|NCT00400946|565318438|FG003|Overall Study|Ineligible|5|||
156610691|NCT00400946|565318439|FG004|Overall Study|Ineligible|1|||
156610692|NCT00400946|565318435|FG000|Overall Study|Induction Failure|0|||
156610693|NCT00400946|565318436|FG001|Overall Study|Induction Failure|0|||
156610694|NCT00400946|565318437|FG002|Overall Study|Induction Failure|0|||
156610695|NCT00400946|565318438|FG003|Overall Study|Induction Failure|11|||
156610696|NCT00400946|565318439|FG004|Overall Study|Induction Failure|8|||
156610697|NCT00400946|565318435|FG000|Overall Study|Induction Death|0|||
156610698|NCT00400946|565318436|FG001|Overall Study|Induction Death|0|||
156610699|NCT00400946|565318437|FG002|Overall Study|Induction Death|0|||
156610700|NCT00400946|565318438|FG003|Overall Study|Induction Death|13|||
156610701|NCT00400946|565318439|FG004|Overall Study|Induction Death|3|||
156610702|NCT00400946|565318435|FG000|Overall Study|Lost to Follow-up|1|||
156610703|NCT00400946|565318436|FG001|Overall Study|Lost to Follow-up|1|||
156610704|NCT00400946|565318437|FG002|Overall Study|Lost to Follow-up|0|||
156610705|NCT00400946|565318438|FG003|Overall Study|Lost to Follow-up|0|||
156610706|NCT00400946|565318439|FG004|Overall Study|Lost to Follow-up|1|||
156610707|NCT00400946|565318435|FG000|Overall Study|Remission Death|1|||
156610708|NCT00400946|565318436|FG001|Overall Study|Remission Death|1|||
156610709|NCT00400946|565318437|FG002|Overall Study|Remission Death|0|||
156610710|NCT00400946|565318438|FG003|Overall Study|Remission Death|0|||
156610711|NCT00400946|565318439|FG004|Overall Study|Remission Death|1|||
156610712|NCT00400946|565318435|FG000|Overall Study|Relapse|9|||
156610713|NCT00400946|565318436|FG001|Overall Study|Relapse|2|||
156610714|NCT00400946|565318437|FG002|Overall Study|Relapse|1|||
156610715|NCT00400946|565318438|FG003|Overall Study|Relapse|1|||
156610716|NCT00400946|565318439|FG004|Overall Study|Relapse|5|||
156610717|NCT00400946|565318435|FG000|Overall Study|Transplant in CR1|0|||
156610718|NCT00400946|565318436|FG001|Overall Study|Transplant in CR1|0|||
156610719|NCT00400946|565318437|FG002|Overall Study|Transplant in CR1|0|||
156610720|NCT00400946|565318438|FG003|Overall Study|Transplant in CR1|10|||
156610721|NCT00400946|565318439|FG004|Overall Study|Transplant in CR1|1|||
156610722|NCT00400946|565318435|FG000|Overall Study|Withdrawal by Subject|2|||
156610723|NCT00400946|565318436|FG001|Overall Study|Withdrawal by Subject|5|||
156610724|NCT00400946|565318437|FG002|Overall Study|Withdrawal by Subject|1|||
156610725|NCT00400946|565318438|FG003|Overall Study|Withdrawal by Subject|5|||
156610726|NCT00400946|565318439|FG004|Overall Study|Withdrawal by Subject|8|||
156610727|NCT00400946|565318435|FG000|Overall Study|Clinical|1|||
156610728|NCT00400946|565318436|FG001|Overall Study|Clinical|2|||
156610729|NCT00400946|565318437|FG002|Overall Study|Clinical|0|||
156610730|NCT00400946|565318438|FG003|Overall Study|Clinical|2|||
156610731|NCT00400946|565318439|FG004|Overall Study|Clinical|9|||
156610732|NCT00400946|565318435|FG000|Overall Study|Other|0|||
156610733|NCT00400946|565318436|FG001|Overall Study|Other|0|||
156610734|NCT00400946|565318437|FG002|Overall Study|Other|0|||
156610735|NCT00400946|565318438|FG003|Overall Study|Other|0|||
156610736|NCT00400946|565318439|FG004|Overall Study|Other|1|||
156610737|NCT01004159|565318440|FG000|Overall Study|Adverse Event|2|||
156610738|NCT01004159|565318440|FG000|Overall Study|Disease Progression|18|||
156610739|NCT04483544|565318442|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
156610740|NCT04483544|565318442|FG000|Post-Treatment|Admitted to hospice|2|||
156610741|NCT04483544|565318442|FG000|Post-Treatment|Study terminated|3|||
156610742|NCT04315298|565318447|FG000|Overall Study|Withdrawal by Subject|0|||
156610743|NCT04315298|565318448|FG001|Overall Study|Withdrawal by Subject|0|||
156610744|NCT04315298|565318449|FG002|Overall Study|Withdrawal by Subject|0|||
156610745|NCT04315298|565318450|FG003|Overall Study|Withdrawal by Subject|2|||
156610746|NCT04315298|565318451|FG004|Overall Study|Withdrawal by Subject|2|||
156610747|NCT04315298|565318452|FG005|Overall Study|Withdrawal by Subject|2|||
156610748|NCT04315298|565318453|FG006|Overall Study|Withdrawal by Subject|0|||
156610749|NCT04315298|565318454|FG007|Overall Study|Withdrawal by Subject|1|||
156610750|NCT04315298|565318455|FG008|Overall Study|Withdrawal by Subject|1|||
156610751|NCT04315298|565318456|FG009|Overall Study|Withdrawal by Subject|1|||
156610752|NCT04315298|565318457|FG010|Overall Study|Withdrawal by Subject|0|||
156610753|NCT04315298|565318458|FG011|Overall Study|Withdrawal by Subject|0|||
156610754|NCT04315298|565318459|FG012|Overall Study|Withdrawal by Subject|0|||
156610755|NCT04315298|565318460|FG013|Overall Study|Withdrawal by Subject|0|||
156610756|NCT04315298|565318461|FG014|Overall Study|Withdrawal by Subject|0|||
156610757|NCT04315298|565318462|FG015|Overall Study|Withdrawal by Subject|0|||
156610758|NCT04315298|565318463|FG016|Overall Study|Withdrawal by Subject|0|||
156610759|NCT04315298|565318464|FG017|Overall Study|Withdrawal by Subject|0|||
156610760|NCT04315298|565318465|FG018|Overall Study|Withdrawal by Subject|0|||
156610761|NCT04315298|565318447|FG000|Overall Study|Physician Decision|0|||
156610762|NCT04315298|565318448|FG001|Overall Study|Physician Decision|0|||
156610763|NCT04315298|565318449|FG002|Overall Study|Physician Decision|0|||
156610764|NCT04315298|565318450|FG003|Overall Study|Physician Decision|0|||
156610765|NCT04315298|565318451|FG004|Overall Study|Physician Decision|1|||
156610766|NCT04315298|565318452|FG005|Overall Study|Physician Decision|0|||
156610767|NCT04315298|565318453|FG006|Overall Study|Physician Decision|0|||
156610768|NCT04315298|565318454|FG007|Overall Study|Physician Decision|0|||
156610769|NCT04315298|565318455|FG008|Overall Study|Physician Decision|0|||
156610770|NCT04315298|565318456|FG009|Overall Study|Physician Decision|0|||
156610771|NCT04315298|565318457|FG010|Overall Study|Physician Decision|0|||
156610772|NCT04315298|565318458|FG011|Overall Study|Physician Decision|0|||
156610773|NCT04315298|565318459|FG012|Overall Study|Physician Decision|0|||
156610774|NCT04315298|565318460|FG013|Overall Study|Physician Decision|0|||
156610775|NCT04315298|565318461|FG014|Overall Study|Physician Decision|0|||
156610776|NCT04315298|565318462|FG015|Overall Study|Physician Decision|0|||
156610777|NCT04315298|565318463|FG016|Overall Study|Physician Decision|0|||
156610778|NCT04315298|565318464|FG017|Overall Study|Physician Decision|0|||
156610779|NCT04315298|565318465|FG018|Overall Study|Physician Decision|0|||
156610780|NCT04315298|565318447|FG000|Overall Study|Lost to Follow-up|5|||
156610781|NCT04315298|565318448|FG001|Overall Study|Lost to Follow-up|10|||
156610782|NCT04315298|565318449|FG002|Overall Study|Lost to Follow-up|6|||
156610783|NCT04315298|565318450|FG003|Overall Study|Lost to Follow-up|8|||
156610784|NCT04315298|565318451|FG004|Overall Study|Lost to Follow-up|12|||
156610785|NCT04315298|565318452|FG005|Overall Study|Lost to Follow-up|13|||
156610786|NCT04315298|565318453|FG006|Overall Study|Lost to Follow-up|9|||
156610787|NCT04315298|565318454|FG007|Overall Study|Lost to Follow-up|16|||
156610788|NCT04315298|565318455|FG008|Overall Study|Lost to Follow-up|14|||
156610789|NCT04315298|565318456|FG009|Overall Study|Lost to Follow-up|0|||
156610790|NCT04315298|565318457|FG010|Overall Study|Lost to Follow-up|2|||
156610791|NCT04315298|565318458|FG011|Overall Study|Lost to Follow-up|1|||
156610792|NCT04315298|565318459|FG012|Overall Study|Lost to Follow-up|0|||
156610793|NCT04315298|565318460|FG013|Overall Study|Lost to Follow-up|0|||
156610794|NCT04315298|565318461|FG014|Overall Study|Lost to Follow-up|0|||
156610795|NCT04315298|565318462|FG015|Overall Study|Lost to Follow-up|2|||
156610796|NCT04315298|565318463|FG016|Overall Study|Lost to Follow-up|0|||
156610797|NCT04315298|565318464|FG017|Overall Study|Lost to Follow-up|0|||
156610798|NCT04315298|565318465|FG018|Overall Study|Lost to Follow-up|0|||
156610799|NCT04315298|565318447|FG000|Overall Study|Death|24|||
156610800|NCT04315298|565318448|FG001|Overall Study|Death|60|||
156610801|NCT04315298|565318449|FG002|Overall Study|Death|49|||
156610802|NCT04315298|565318450|FG003|Overall Study|Death|59|||
156610803|NCT04315298|565318451|FG004|Overall Study|Death|70|||
156610804|NCT04315298|565318452|FG005|Overall Study|Death|114|||
156610805|NCT04315298|565318453|FG006|Overall Study|Death|9|||
156610806|NCT04315298|565318454|FG007|Overall Study|Death|12|||
156610807|NCT04315298|565318455|FG008|Overall Study|Death|21|||
156610808|NCT04315298|565318456|FG009|Overall Study|Death|16|||
156610809|NCT04315298|565318457|FG010|Overall Study|Death|40|||
156610810|NCT04315298|565318458|FG011|Overall Study|Death|40|||
156610811|NCT04315298|565318459|FG012|Overall Study|Death|3|||
156610812|NCT04315298|565318460|FG013|Overall Study|Death|4|||
156610813|NCT04315298|565318461|FG014|Overall Study|Death|6|||
156610814|NCT04315298|565318462|FG015|Overall Study|Death|4|||
156610815|NCT04315298|565318463|FG016|Overall Study|Death|3|||
156610816|NCT04315298|565318464|FG017|Overall Study|Death|1|||
156610817|NCT04315298|565318465|FG018|Overall Study|Death|0|||
156610818|NCT00736385|565318466|FG000|Overall Study|Withdrawal by Subject|2|||
156610819|NCT00736385|565318467|FG001|Overall Study|Withdrawal by Subject|2|||
156610820|NCT00736385|565318466|FG000|Overall Study|Adverse Event|0|||
156610821|NCT00736385|565318467|FG001|Overall Study|Adverse Event|1|||
156610822|NCT00098865|565318468|FG000|Overall Study|Progressive Disease|6|||
156610823|NCT00098865|565318468|FG000|Overall Study|Adverse Event|2|||
156610824|NCT00098865|565318468|FG000|Overall Study|Alternative Therapy|1|||
156610825|NCT03267511|565318469|FG000|Overall Study|Lost to Follow-up|0|||
156610826|NCT03267511|565318470|FG001|Overall Study|Lost to Follow-up|0|||
156610827|NCT03267511|565318471|FG002|Overall Study|Lost to Follow-up|0|||
156610828|NCT03267511|565318472|FG003|Overall Study|Lost to Follow-up|1|||
156610829|NCT00364351|565318473|FG000|Overall Study|Adverse Event|90|||
156610830|NCT00364351|565318474|FG001|Overall Study|Adverse Event|44|||
156610831|NCT00364351|565318473|FG000|Overall Study|Condition under investigation worsened|469|||
156610832|NCT00364351|565318474|FG001|Overall Study|Condition under investigation worsened|497|||
156610833|NCT00364351|565318473|FG000|Overall Study|Prohibited concomitant medication|0|||
156610834|NCT00364351|565318474|FG001|Overall Study|Prohibited concomitant medication|2|||
156610835|NCT00364351|565318473|FG000|Overall Study|Lost to Follow-up|1|||
156610836|NCT00364351|565318474|FG001|Overall Study|Lost to Follow-up|1|||
156610837|NCT00364351|565318473|FG000|Overall Study|Withdrawal by Subject|30|||
156610838|NCT00364351|565318474|FG001|Overall Study|Withdrawal by Subject|29|||
156610839|NCT00364351|565318473|FG000|Overall Study|Incorrect enrollment|1|||
156610840|NCT00364351|565318474|FG001|Overall Study|Incorrect enrollment|1|||
156610841|NCT00364351|565318473|FG000|Overall Study|Sponsor decision|1|||
156610842|NCT00364351|565318474|FG001|Overall Study|Sponsor decision|0|||
156610843|NCT00364351|565318473|FG000|Overall Study|Poor treatment compliance|0|||
156610844|NCT00364351|565318474|FG001|Overall Study|Poor treatment compliance|3|||
156610845|NCT00364351|565318473|FG000|Overall Study|Investigator error|0|||
156610846|NCT00364351|565318474|FG001|Overall Study|Investigator error|2|||
156610847|NCT00364351|565318473|FG000|Overall Study|Patient could not travel to site|0|||
156610848|NCT00364351|565318474|FG001|Overall Study|Patient could not travel to site|1|||
156610849|NCT00364351|565318473|FG000|Overall Study|Randomised treatment not started|0|||
156610850|NCT00364351|565318474|FG001|Overall Study|Randomised treatment not started|3|||
156610851|NCT01685060|565318475|FG000|Overall Study|Rollover patients|16|||
156610852|NCT01685060|565318475|FG000|Overall Study|Adverse Event|12|||
156610853|NCT01685060|565318475|FG000|Overall Study|Progressive disease|69|||
156610854|NCT01685060|565318475|FG000|Overall Study|Physician Decision|14|||
156610855|NCT01685060|565318475|FG000|Overall Study|Subject/guardian decision|20|||
156610856|NCT01685060|565318475|FG000|Overall Study|Lost to Follow-up|1|||
156610857|NCT01685060|565318475|FG000|Overall Study|Death|8|||
156610858|NCT01572844|565318476|FG000|Overall Study|Physician Decision|1|||
156610859|NCT01572844|565318477|FG001|Overall Study|Physician Decision|1|||
156610860|NCT03654560|565318484|FG000|Overall Study|Death|3|||
156610861|NCT03654560|565318485|FG001|Overall Study|Death|1|||
156610862|NCT03654560|565318484|FG000|Overall Study|Lost to Follow-up|1|||
156610863|NCT03654560|565318485|FG001|Overall Study|Lost to Follow-up|0|||
156610864|NCT00209092|565318486|FG000|Overall Study|Progression of disease|7|||
156610865|NCT00209092|565318487|FG001|Overall Study|Progression of disease|1|||
156610866|NCT00209092|565318486|FG000|Overall Study|Adverse Event|0|||
156610867|NCT00209092|565318487|FG001|Overall Study|Adverse Event|1|||
156610868|NCT00209092|565318486|FG000|Overall Study|Withdrawal by Subject|1|||
156610869|NCT00209092|565318487|FG001|Overall Study|Withdrawal by Subject|0|||
156610870|NCT05283499|565318488|FG000|Overall Study|Did not receive intervention|1|||
156610871|NCT05283499|565318489|FG001|Overall Study|Did not receive intervention|2|||
156610872|NCT06048809|565318496|FG000|Overall Study|Adverse Event|2|||
156610873|NCT06048809|565318497|FG001|Overall Study|Adverse Event|0|||
156610874|NCT06048809|565318496|FG000|Overall Study|Withdrawal by Subject|1|||
156610875|NCT06048809|565318497|FG001|Overall Study|Withdrawal by Subject|1|||
156610876|NCT03135262|565318504|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
156610877|NCT03135262|565318505|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
156610878|NCT03135262|565318506|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
156610879|NCT03135262|565318507|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
156610880|NCT03135262|565318508|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
156610881|NCT03135262|565318504|FG000|Overall Study|Progression of disease|0|||
156610882|NCT03135262|565318505|FG001|Overall Study|Progression of disease|0|||
156610883|NCT03135262|565318506|FG002|Overall Study|Progression of disease|0|||
156610884|NCT03135262|565318507|FG003|Overall Study|Progression of disease|1|||
156610885|NCT03135262|565318508|FG004|Overall Study|Progression of disease|0|||
156610886|NCT03135262|565318504|FG000|Overall Study|Death|6|||
156610887|NCT03135262|565318505|FG001|Overall Study|Death|2|||
156610888|NCT03135262|565318506|FG002|Overall Study|Death|2|||
156610889|NCT03135262|565318507|FG003|Overall Study|Death|2|||
156610890|NCT03135262|565318508|FG004|Overall Study|Death|0|||
156610891|NCT03135262|565318504|FG000|Overall Study|Withdrawal by Subject|0|||
156610892|NCT03135262|565318505|FG001|Overall Study|Withdrawal by Subject|0|||
156610893|NCT03135262|565318506|FG002|Overall Study|Withdrawal by Subject|1|||
156610894|NCT03135262|565318507|FG003|Overall Study|Withdrawal by Subject|0|||
156610895|NCT03135262|565318508|FG004|Overall Study|Withdrawal by Subject|1|||
156610896|NCT03135262|565318504|FG000|Overall Study|Study terminated by sponsor|2|||
156610897|NCT03135262|565318505|FG001|Overall Study|Study terminated by sponsor|4|||
156610898|NCT03135262|565318506|FG002|Overall Study|Study terminated by sponsor|4|||
156610899|NCT03135262|565318507|FG003|Overall Study|Study terminated by sponsor|3|||
156610900|NCT03135262|565318508|FG004|Overall Study|Study terminated by sponsor|0|||
156610901|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
156610902|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
156610903|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
156610904|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
156610905|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
156610906|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
156610907|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
156610908|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
156610909|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
156610910|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
156610911|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
156610912|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
156610913|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
156610914|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
156610915|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
156610916|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
156610917|NCT01291511|565318509|FG000|Cross-Titration and Stabilization Phase|Death|1|||
156610918|NCT01291511|565318510|FG001|Cross-Titration and Stabilization Phase|Death|0|||
156610919|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
156610920|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
156610921|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
156610922|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
156610923|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
156610924|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
156610925|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
156610926|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
156610927|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
156610928|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
156610929|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
156610930|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
156610931|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
156610932|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
156610933|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
156610934|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
156610935|NCT01291511|565318509|FG000|Double-blind Relapse Prevention Phase|Death|1|||
156610936|NCT01291511|565318510|FG001|Double-blind Relapse Prevention Phase|Death|0|||
156610937|NCT01047436|565318512|FG000|Overall Study|Protocol Violation|1|||
156610938|NCT01047436|565318513|FG001|Overall Study|Protocol Violation|0|||
156610939|NCT01408732|565318516|FG000|Overall Study|Withdrawal by Subject|2|||
156610940|NCT01408732|565318517|FG001|Overall Study|Withdrawal by Subject|2|||
156610941|NCT00424099|565318518|FG000|Overall Study|Adverse Event|0|||
156610942|NCT00424099|565318519|FG001|Overall Study|Adverse Event|1|||
156610943|NCT00424099|565318520|FG002|Overall Study|Adverse Event|1|||
156610944|NCT00424099|565318521|FG003|Overall Study|Adverse Event|0|||
156610945|NCT00424099|565318518|FG000|Overall Study|Death|0|||
156610946|NCT00424099|565318519|FG001|Overall Study|Death|1|||
156610947|NCT00424099|565318520|FG002|Overall Study|Death|0|||
156610948|NCT00424099|565318521|FG003|Overall Study|Death|0|||
156610949|NCT00424099|565318518|FG000|Overall Study|Illness|2|||
156610950|NCT00424099|565318519|FG001|Overall Study|Illness|0|||
156610951|NCT00424099|565318520|FG002|Overall Study|Illness|1|||
156610952|NCT00424099|565318521|FG003|Overall Study|Illness|4|||
156610953|NCT00424099|565318518|FG000|Overall Study|Lost to Follow-up|0|||
156610954|NCT00424099|565318519|FG001|Overall Study|Lost to Follow-up|0|||
156610955|NCT00424099|565318520|FG002|Overall Study|Lost to Follow-up|3|||
156610956|NCT00424099|565318521|FG003|Overall Study|Lost to Follow-up|0|||
156610957|NCT00424099|565318518|FG000|Overall Study|Hospitalized|1|||
156610958|NCT00424099|565318519|FG001|Overall Study|Hospitalized|2|||
156610959|NCT00424099|565318520|FG002|Overall Study|Hospitalized|1|||
156610960|NCT00424099|565318521|FG003|Overall Study|Hospitalized|3|||
156610961|NCT00424099|565318518|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
156610962|NCT00424099|565318519|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
156610963|NCT00424099|565318520|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
156610964|NCT00424099|565318521|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
156610965|NCT00424099|565318518|FG000|Overall Study|Withdrawal by Subject|1|||
156610966|NCT00424099|565318519|FG001|Overall Study|Withdrawal by Subject|9|||
156610967|NCT00424099|565318520|FG002|Overall Study|Withdrawal by Subject|4|||
156610968|NCT00424099|565318521|FG003|Overall Study|Withdrawal by Subject|6|||
156610969|NCT00424099|565318518|FG000|Overall Study|Physician Decision|0|||
156610970|NCT00424099|565318519|FG001|Overall Study|Physician Decision|0|||
156610971|NCT00424099|565318520|FG002|Overall Study|Physician Decision|1|||
156610972|NCT00424099|565318521|FG003|Overall Study|Physician Decision|0|||
156610973|NCT00424099|565318518|FG000|Overall Study|Missing|0|||
156610974|NCT00424099|565318519|FG001|Overall Study|Missing|0|||
156610975|NCT00424099|565318520|FG002|Overall Study|Missing|1|||
156610976|NCT00424099|565318521|FG003|Overall Study|Missing|0|||
156610977|NCT00764322|565318522|FG000|Overall Study|Withdrawal by Subject|11|||
156610978|NCT00764322|565318522|FG000|Overall Study|No CYP2D6 genotyping|9|||
156610979|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
156610980|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
156610981|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
156610982|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
156610983|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
156610984|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
156610985|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
156610986|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
156610987|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
156610988|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
156610989|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
156610990|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
156610991|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
156610992|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
156610993|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
156610994|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
156610995|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
156610996|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
156610997|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
156610998|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
156610999|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
156611000|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
156611001|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
156611002|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
156611003|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
156611004|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
156611005|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
156611006|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
156611007|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
156611008|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
156611009|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
156611010|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
156611011|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
156611012|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
156611013|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
156611014|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
156611015|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
156611016|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
156611017|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
156611018|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
156611019|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
156611020|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
156611021|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
156611022|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
156611023|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
156611024|NCT03689972|565318523|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
156611025|NCT03689972|565318524|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
156611026|NCT03689972|565318525|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
156611027|NCT03689972|565318526|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
156611028|NCT03689972|565318527|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
156611029|NCT03689972|565318523|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
156611030|NCT03689972|565318524|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
156611031|NCT03689972|565318525|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
156611032|NCT03689972|565318526|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
156611033|NCT03689972|565318527|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
156611034|NCT03689972|565318523|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
156611035|NCT03689972|565318524|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
156611036|NCT03689972|565318525|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
156611037|NCT03689972|565318526|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
156611038|NCT03689972|565318527|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
156611039|NCT03689972|565318523|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
156611040|NCT03689972|565318524|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
156611041|NCT03689972|565318525|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
156611042|NCT03689972|565318526|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
156611043|NCT03689972|565318527|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
156611044|NCT03689972|565318523|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
156611045|NCT03689972|565318524|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
156611046|NCT03689972|565318525|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
156611047|NCT03689972|565318526|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
156611048|NCT03689972|565318527|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
156611049|NCT03689972|565318523|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
156611050|NCT03689972|565318524|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
156611051|NCT03689972|565318525|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
156611052|NCT03689972|565318526|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
156611053|NCT03689972|565318527|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
156611054|NCT03689972|565318523|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
156611055|NCT03689972|565318524|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
156611056|NCT03689972|565318525|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
156611057|NCT03689972|565318526|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
156611058|NCT03689972|565318527|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
156611059|NCT03689972|565318523|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
156611060|NCT03689972|565318524|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
156611061|NCT03689972|565318525|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
156611062|NCT03689972|565318526|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
156611063|NCT03689972|565318527|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
156611064|NCT03689972|565318523|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
156611065|NCT03689972|565318524|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
156611066|NCT03689972|565318525|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
156611067|NCT03689972|565318526|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
156611068|NCT03689972|565318527|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
156611069|NCT03689972|565318523|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
156611070|NCT03689972|565318524|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
156611071|NCT03689972|565318525|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
156611072|NCT03689972|565318526|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
156611073|NCT03689972|565318527|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
156611074|NCT01131130|565318529|FG000|Period 1 - Baseline|Pregnancy|1|||
156611075|NCT01131130|565318529|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
156611076|NCT02437162|565318530|FG000|Overall Study|Protocol Violation|0|||
156611077|NCT02437162|565318531|FG001|Overall Study|Protocol Violation|1|||
156611078|NCT02437162|565318532|FG002|Overall Study|Protocol Violation|0|||
156611079|NCT02437162|565318530|FG000|Overall Study|Randomized but not treated|0|||
156611080|NCT02437162|565318531|FG001|Overall Study|Randomized but not treated|0|||
156611081|NCT02437162|565318532|FG002|Overall Study|Randomized but not treated|1|||
156611082|NCT02437162|565318530|FG000|Overall Study|Study discontinued by Sponsor|93|||
156611083|NCT02437162|565318531|FG001|Overall Study|Study discontinued by Sponsor|98|||
156611084|NCT02437162|565318532|FG002|Overall Study|Study discontinued by Sponsor|97|||
156611085|NCT02437162|565318530|FG000|Overall Study|Withdrawal by Subject|13|||
156611086|NCT02437162|565318531|FG001|Overall Study|Withdrawal by Subject|7|||
156611087|NCT02437162|565318532|FG002|Overall Study|Withdrawal by Subject|9|||
156611088|NCT02437162|565318530|FG000|Overall Study|Adverse Event|0|||
156611089|NCT02437162|565318531|FG001|Overall Study|Adverse Event|1|||
156611090|NCT02437162|565318532|FG002|Overall Study|Adverse Event|0|||
156611091|NCT02437162|565318530|FG000|Overall Study|Lost to Follow-up|1|||
156611092|NCT02437162|565318531|FG001|Overall Study|Lost to Follow-up|0|||
156611093|NCT02437162|565318532|FG002|Overall Study|Lost to Follow-up|1|||
156611094|NCT02437162|565318530|FG000|Overall Study|Death|0|||
156611095|NCT02437162|565318531|FG001|Overall Study|Death|1|||
156611096|NCT02437162|565318532|FG002|Overall Study|Death|0|||
156611097|NCT02437162|565318530|FG000|Overall Study|Other|0|||
156611098|NCT02437162|565318531|FG001|Overall Study|Other|0|||
156611099|NCT02437162|565318532|FG002|Overall Study|Other|1|||
156611100|NCT03981744|565318533|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
156611101|NCT03981744|565318534|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
156611102|NCT03981744|565318535|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
156611103|NCT03981744|565318536|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
156611104|NCT03981744|565318533|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
156611105|NCT03981744|565318534|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
156611106|NCT03981744|565318535|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
156611107|NCT03981744|565318536|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
156611108|NCT03981744|565318533|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
156611109|NCT03981744|565318534|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
156611110|NCT03981744|565318535|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
156611111|NCT03981744|565318536|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
156611112|NCT03321526|565318537|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
156611113|NCT03321526|565318538|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
156611114|NCT03321526|565318537|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
156611115|NCT03321526|565318538|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
156611116|NCT03321526|565318537|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
156611117|NCT03321526|565318538|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
156611118|NCT03321526|565318537|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
156611119|NCT03321526|565318538|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
156611120|NCT03321526|565318537|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
156611121|NCT03321526|565318538|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
156611122|NCT03321526|565318537|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
156611123|NCT03321526|565318538|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
156611124|NCT03321526|565318537|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
156611125|NCT03321526|565318538|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
156611126|NCT03321526|565318537|FG000|Follow-up Phase (2 Weeks)|Other|24|||
156611127|NCT03321526|565318538|FG001|Follow-up Phase (2 Weeks)|Other|24|||
156611128|NCT03097133|565318539|FG000|Overall Study|Lost to Follow-up|3|||
156611129|NCT03097133|565318540|FG001|Overall Study|Lost to Follow-up|2|||
156611130|NCT03097133|565318539|FG000|Overall Study|Withdrawal by Subject|2|||
156611131|NCT03097133|565318540|FG001|Overall Study|Withdrawal by Subject|5|||
156611132|NCT03097133|565318539|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
156611133|NCT03097133|565318540|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
156611134|NCT03097133|565318539|FG000|Overall Study|Other|3|||
156611135|NCT03097133|565318540|FG001|Overall Study|Other|2|||
156611136|NCT03097133|565318539|FG000|Overall Study|Adverse Event|1|||
156611137|NCT03097133|565318540|FG001|Overall Study|Adverse Event|0|||
156611138|NCT01989572|565318543|FG000|Overall Study|Lack of Efficacy|35|||
156611139|NCT01989572|565318544|FG001|Overall Study|Lack of Efficacy|48|||
156611140|NCT01989572|565318545|FG002|Overall Study|Lack of Efficacy|48|||
156611141|NCT01989572|565318546|FG003|Overall Study|Lack of Efficacy|43|||
156611142|NCT01989572|565318547|FG004|Overall Study|Lack of Efficacy|71|||
156611143|NCT01989572|565318548|FG005|Overall Study|Lack of Efficacy|79|||
156611144|NCT01989572|565318543|FG000|Overall Study|Adverse Event|2|||
156611145|NCT01989572|565318544|FG001|Overall Study|Adverse Event|1|||
156611146|NCT01989572|565318545|FG002|Overall Study|Adverse Event|3|||
156611147|NCT01989572|565318546|FG003|Overall Study|Adverse Event|0|||
156611148|NCT01989572|565318547|FG004|Overall Study|Adverse Event|3|||
156611149|NCT01989572|565318548|FG005|Overall Study|Adverse Event|0|||
156611150|NCT01989572|565318543|FG000|Overall Study|Death|0|||
156611151|NCT01989572|565318544|FG001|Overall Study|Death|0|||
156611152|NCT01989572|565318545|FG002|Overall Study|Death|0|||
156611153|NCT01989572|565318546|FG003|Overall Study|Death|0|||
156611154|NCT01989572|565318547|FG004|Overall Study|Death|1|||
156611155|NCT01989572|565318548|FG005|Overall Study|Death|0|||
156611156|NCT01989572|565318543|FG000|Overall Study|Withdrawal by Subject|4|||
156611157|NCT01989572|565318544|FG001|Overall Study|Withdrawal by Subject|1|||
156611158|NCT01989572|565318545|FG002|Overall Study|Withdrawal by Subject|5|||
156611159|NCT01989572|565318546|FG003|Overall Study|Withdrawal by Subject|1|||
156611160|NCT01989572|565318547|FG004|Overall Study|Withdrawal by Subject|12|||
156611161|NCT01989572|565318548|FG005|Overall Study|Withdrawal by Subject|4|||
156611162|NCT01989572|565318543|FG000|Overall Study|complicating disease|1|||
156611163|NCT01989572|565318544|FG001|Overall Study|complicating disease|1|||
156611164|NCT01989572|565318545|FG002|Overall Study|complicating disease|2|||
156611165|NCT01989572|565318546|FG003|Overall Study|complicating disease|0|||
156611166|NCT01989572|565318547|FG004|Overall Study|complicating disease|1|||
156611167|NCT01989572|565318548|FG005|Overall Study|complicating disease|0|||
156611168|NCT01989572|565318543|FG000|Overall Study|error|2|||
156611169|NCT01989572|565318544|FG001|Overall Study|error|1|||
156611170|NCT01989572|565318545|FG002|Overall Study|error|1|||
156611171|NCT01989572|565318546|FG003|Overall Study|error|1|||
156611172|NCT01989572|565318547|FG004|Overall Study|error|1|||
156611173|NCT01989572|565318548|FG005|Overall Study|error|1|||
156611174|NCT01989572|565318543|FG000|Overall Study|maximum dose reached|0|||
156611175|NCT01989572|565318544|FG001|Overall Study|maximum dose reached|1|||
156611176|NCT01989572|565318545|FG002|Overall Study|maximum dose reached|0|||
156611177|NCT01989572|565318546|FG003|Overall Study|maximum dose reached|0|||
156611178|NCT01989572|565318547|FG004|Overall Study|maximum dose reached|1|||
156611179|NCT01989572|565318548|FG005|Overall Study|maximum dose reached|0|||
156611180|NCT01989572|565318543|FG000|Overall Study|unknown/not specify|3|||
156611181|NCT01989572|565318544|FG001|Overall Study|unknown/not specify|4|||
156611182|NCT01989572|565318545|FG002|Overall Study|unknown/not specify|1|||
156611183|NCT01989572|565318546|FG003|Overall Study|unknown/not specify|3|||
156611184|NCT01989572|565318547|FG004|Overall Study|unknown/not specify|3|||
156611185|NCT01989572|565318548|FG005|Overall Study|unknown/not specify|5|||
156611186|NCT01989572|565318543|FG000|Overall Study|not start protocol therapy|5|||
156611187|NCT01989572|565318544|FG001|Overall Study|not start protocol therapy|1|||
156611188|NCT01989572|565318545|FG002|Overall Study|not start protocol therapy|2|||
156611189|NCT01989572|565318546|FG003|Overall Study|not start protocol therapy|3|||
156611190|NCT01989572|565318547|FG004|Overall Study|not start protocol therapy|4|||
156611191|NCT01989572|565318548|FG005|Overall Study|not start protocol therapy|18|||
156611192|NCT01989572|565318543|FG000|Overall Study|alternative therapy|3|||
156611193|NCT01989572|565318544|FG001|Overall Study|alternative therapy|0|||
156611194|NCT01989572|565318545|FG002|Overall Study|alternative therapy|0|||
156611195|NCT01989572|565318546|FG003|Overall Study|alternative therapy|0|||
156611196|NCT01989572|565318547|FG004|Overall Study|alternative therapy|1|||
156611197|NCT01989572|565318548|FG005|Overall Study|alternative therapy|3|||
156611198|NCT00732641|565318553|FG000|Overall Study|Relapse or Progressive Disease|65|||
156611199|NCT00732641|565318554|FG001|Overall Study|Relapse or Progressive Disease|101|||
156611200|NCT00732641|565318553|FG000|Overall Study|Serious Adverse Events|12|||
156611201|NCT00732641|565318554|FG001|Overall Study|Serious Adverse Events|3|||
156611202|NCT00732641|565318553|FG000|Overall Study|Physician Decision|6|||
156611203|NCT00732641|565318554|FG001|Overall Study|Physician Decision|0|||
156611204|NCT00732641|565318553|FG000|Overall Study|Withdrawal by Subject|4|||
156611205|NCT00732641|565318554|FG001|Overall Study|Withdrawal by Subject|2|||
156611206|NCT00732641|565318553|FG000|Overall Study|Unable to Complete|1|||
156611207|NCT00732641|565318554|FG001|Overall Study|Unable to Complete|1|||
156611208|NCT00732641|565318553|FG000|Overall Study|Other|18|||
156611209|NCT00732641|565318554|FG001|Overall Study|Other|5|||
156611210|NCT00732238|565318555|FG000|Overall Study|Bacteremia|4|||
156611211|NCT00732238|565318556|FG001|Overall Study|Bacteremia|1|||
156611212|NCT00732238|565318555|FG000|Overall Study|Asymptomatic bacteriuria|1|||
156611213|NCT00732238|565318556|FG001|Overall Study|Asymptomatic bacteriuria|0|||
156611214|NCT02280096|565318557|FG000|Overall Study|Pregnancy|1|||
156611215|NCT02280096|565318558|FG001|Overall Study|Pregnancy|0|||
156611216|NCT02280096|565318557|FG000|Overall Study|Functional neurological disorder|1|||
156611217|NCT02280096|565318558|FG001|Overall Study|Functional neurological disorder|0|||
156611218|NCT02280096|565318557|FG000|Overall Study|Lack of attachment|0|||
156611219|NCT02280096|565318558|FG001|Overall Study|Lack of attachment|1|||
156611220|NCT00246376|565318561|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
156611221|NCT00246376|565318562|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
156611222|NCT00246376|565318563|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
156611223|NCT00246376|565318564|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
156611224|NCT00246376|565318565|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
156611225|NCT00246376|565318561|FG000|Overall Study|Adverse Event|2|||
156611226|NCT00246376|565318562|FG001|Overall Study|Adverse Event|3|||
156611227|NCT00246376|565318563|FG002|Overall Study|Adverse Event|1|||
156611228|NCT00246376|565318564|FG003|Overall Study|Adverse Event|3|||
156611229|NCT00246376|565318565|FG004|Overall Study|Adverse Event|1|||
156611230|NCT00246376|565318561|FG000|Overall Study|Lost to Follow-up|2|||
156611231|NCT00246376|565318562|FG001|Overall Study|Lost to Follow-up|11|||
156611232|NCT00246376|565318563|FG002|Overall Study|Lost to Follow-up|11|||
156611233|NCT00246376|565318564|FG003|Overall Study|Lost to Follow-up|16|||
156611234|NCT00246376|565318565|FG004|Overall Study|Lost to Follow-up|13|||
156611235|NCT03434041|565318570|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
156611236|NCT03434041|565318571|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
156611237|NCT03434041|565318570|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
156611238|NCT03434041|565318571|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
156611239|NCT03434041|565318570|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
156611240|NCT03434041|565318571|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
156611241|NCT03434041|565318570|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
156611242|NCT03434041|565318571|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
156611243|NCT03434041|565318570|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
156611244|NCT03434041|565318571|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
156611245|NCT03434041|565318570|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
156611246|NCT03434041|565318571|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
156611247|NCT03434041|565318570|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
156611248|NCT03434041|565318571|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
156611249|NCT03434041|565318570|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
156611250|NCT03434041|565318571|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
156611251|NCT03434041|565318570|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
156611252|NCT03434041|565318571|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
156611253|NCT03434041|565318570|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
156611254|NCT03434041|565318571|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
156611255|NCT03434041|565318570|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
156611256|NCT03434041|565318571|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
156611257|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
156611258|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
156611259|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
156611260|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
156611261|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
156611262|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
156611263|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
156611264|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
156611265|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
156611266|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
156611267|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
156611268|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
156611269|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
156611270|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
156611271|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
156611272|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
156611273|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
156611274|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
156611275|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
156611276|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
156611277|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
156611278|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
156611279|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
156611280|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
156611281|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
156611282|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
156611283|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
156611284|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
156611285|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
156611286|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
156611287|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
156611288|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
156611289|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
156611290|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
156611291|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
156611292|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
156611293|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
156611294|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
156611295|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
156611296|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
156611297|NCT03605836|565318572|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
156611298|NCT03605836|565318573|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
156611299|NCT03605836|565318574|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
156611300|NCT03605836|565318575|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
156611301|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
156611302|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
156611303|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
156611304|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
156611305|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
156611306|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
156611307|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
156611308|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
156611309|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
156611310|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
156611311|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
156611312|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
156611313|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
156611314|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
156611315|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
156611316|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
156611317|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
156611318|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
156611319|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
156611320|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
156611321|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
156611322|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
156611323|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
156611324|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
156611325|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
156611326|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
156611327|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
156611328|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
156611329|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
156611330|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
156611331|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
156611332|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
156611333|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
156611334|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
156611335|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
156611336|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
156611337|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
156611338|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
156611339|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
156611340|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
156611341|NCT03605836|565318572|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
156611342|NCT03605836|565318573|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
156611343|NCT03605836|565318574|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
156611344|NCT03605836|565318575|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
156611345|NCT00329784|565318577|FG000|Overall Study|Lost to Follow-up|0|||
156611346|NCT00329784|565318578|FG001|Overall Study|Lost to Follow-up|1|||
156611347|NCT00329784|565318579|FG002|Overall Study|Lost to Follow-up|0|||
156611348|NCT00329784|565318580|FG003|Overall Study|Lost to Follow-up|0|||
156611349|NCT00329784|565318577|FG000|Overall Study|Withdrawal by Subject|4|||
156611350|NCT00329784|565318578|FG001|Overall Study|Withdrawal by Subject|2|||
156611351|NCT00329784|565318579|FG002|Overall Study|Withdrawal by Subject|0|||
156611352|NCT00329784|565318580|FG003|Overall Study|Withdrawal by Subject|0|||
156611353|NCT00329784|565318577|FG000|Overall Study|Other|1|||
156611354|NCT00329784|565318578|FG001|Overall Study|Other|2|||
156611355|NCT00329784|565318579|FG002|Overall Study|Other|0|||
156611356|NCT00329784|565318580|FG003|Overall Study|Other|0|||
156611357|NCT03236506|565318583|FG000|Overall Study|Death|1|||
156611358|NCT03236506|565318584|FG001|Overall Study|Death|1|||
156611359|NCT03236506|565318585|FG002|Overall Study|Death|1|||
156611360|NCT03236506|565318583|FG000|Overall Study|Withdrawal by Subject|3|||
156611361|NCT03236506|565318584|FG001|Overall Study|Withdrawal by Subject|3|||
156611362|NCT03236506|565318585|FG002|Overall Study|Withdrawal by Subject|4|||
156611363|NCT03236506|565318583|FG000|Overall Study|Did not initiate treatment|2|||
156611364|NCT03236506|565318584|FG001|Overall Study|Did not initiate treatment|1|||
156611365|NCT03236506|565318585|FG002|Overall Study|Did not initiate treatment|2|||
156611366|NCT01451398|565318590|FG000|Overall Study|Adverse Event|7|||
156611367|NCT01451398|565318591|FG001|Overall Study|Adverse Event|9|||
156611368|NCT01451398|565318590|FG000|Overall Study|Protocol Violation|1|||
156611369|NCT01451398|565318591|FG001|Overall Study|Protocol Violation|2|||
156611370|NCT01451398|565318590|FG000|Overall Study|Physician Decision|1|||
156611371|NCT01451398|565318591|FG001|Overall Study|Physician Decision|1|||
156611372|NCT01451398|565318590|FG000|Overall Study|Withdrawal by Subject|10|||
156611373|NCT01451398|565318591|FG001|Overall Study|Withdrawal by Subject|14|||
156611374|NCT01451398|565318590|FG000|Overall Study|Lost to Follow-up|6|||
156611375|NCT01451398|565318591|FG001|Overall Study|Lost to Follow-up|4|||
156611376|NCT01451398|565318590|FG000|Overall Study|Non-compliance with study drug|1|||
156611377|NCT01451398|565318591|FG001|Overall Study|Non-compliance with study drug|3|||
156611378|NCT01451398|565318590|FG000|Overall Study|Non-compliance with protocol|1|||
156611379|NCT01451398|565318591|FG001|Overall Study|Non-compliance with protocol|1|||
156611380|NCT01451398|565318590|FG000|Overall Study|Moved out of country|0|||
156611381|NCT01451398|565318591|FG001|Overall Study|Moved out of country|1|||
156611382|NCT01451398|565318590|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
156611383|NCT01451398|565318591|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
156611384|NCT01451398|565318590|FG000|Overall Study|Lack of Efficacy|0|||
156611385|NCT01451398|565318591|FG001|Overall Study|Lack of Efficacy|1|||
156611386|NCT02427100|565318593|FG000|Overall Study|Lost to Follow-up|0|||
156611387|NCT02427100|565318594|FG001|Overall Study|Lost to Follow-up|2|||
156611388|NCT01610206|565318597|FG000|Overall Study|Adverse Event|10|||
156611389|NCT01610206|565318598|FG001|Overall Study|Adverse Event|30|||
156611390|NCT00924729|565318599|FG000|Overall Study|insufficient volume for analysis|1|||
156611391|NCT00924729|565318600|FG001|Overall Study|insufficient volume for analysis|0|||
156611392|NCT00924729|565318599|FG000|Overall Study|Protocol Violation|1|||
156611393|NCT00924729|565318600|FG001|Overall Study|Protocol Violation|0|||
156611394|NCT01929707|565318601|FG000|Intervention Period 1|Lost to Follow-up|0|||
156611395|NCT01929707|565318602|FG001|Intervention Period 1|Lost to Follow-up|0|||
156611396|NCT01929707|565318603|FG002|Intervention Period 1|Lost to Follow-up|0|||
156611397|NCT01929707|565318604|FG003|Intervention Period 1|Lost to Follow-up|1|||
156611398|NCT01929707|565318605|FG004|Intervention Period 1|Lost to Follow-up|0|||
156611399|NCT01929707|565318606|FG005|Intervention Period 1|Lost to Follow-up|0|||
156611400|NCT01929707|565318607|FG006|Intervention Period 1|Lost to Follow-up|0|||
156611401|NCT01929707|565318608|FG007|Intervention Period 1|Lost to Follow-up|0|||
156611402|NCT01929707|565318601|FG000|Intervention Period 1|Withdrawal by Subject|0|||
156611403|NCT01929707|565318602|FG001|Intervention Period 1|Withdrawal by Subject|0|||
156611404|NCT01929707|565318603|FG002|Intervention Period 1|Withdrawal by Subject|0|||
156611405|NCT01929707|565318604|FG003|Intervention Period 1|Withdrawal by Subject|2|||
156611406|NCT01929707|565318605|FG004|Intervention Period 1|Withdrawal by Subject|0|||
156611407|NCT01929707|565318606|FG005|Intervention Period 1|Withdrawal by Subject|0|||
156611408|NCT01929707|565318607|FG006|Intervention Period 1|Withdrawal by Subject|0|||
156611409|NCT01929707|565318608|FG007|Intervention Period 1|Withdrawal by Subject|0|||
156611410|NCT01929707|565318601|FG000|Intervention Period 2|Withdrawal by Subject|0|||
156611411|NCT01929707|565318602|FG001|Intervention Period 2|Withdrawal by Subject|0|||
156611412|NCT01929707|565318603|FG002|Intervention Period 2|Withdrawal by Subject|0|||
156611413|NCT01929707|565318604|FG003|Intervention Period 2|Withdrawal by Subject|0|||
156611414|NCT01929707|565318605|FG004|Intervention Period 2|Withdrawal by Subject|0|||
156611415|NCT01929707|565318606|FG005|Intervention Period 2|Withdrawal by Subject|2|||
156611416|NCT01929707|565318607|FG006|Intervention Period 2|Withdrawal by Subject|0|||
156611417|NCT01929707|565318608|FG007|Intervention Period 2|Withdrawal by Subject|0|||
156611418|NCT00023712|565318609|FG000|Overall Study|Not platinum sensitive|1|||
156611419|NCT00023712|565318610|FG001|Overall Study|Not platinum sensitive|0|||
156611420|NCT00023712|565318609|FG000|Overall Study|Never treated|1|||
156611421|NCT00023712|565318610|FG001|Overall Study|Never treated|1|||
156611422|NCT00437203|565318611|FG000|Overall Study|Death|0|||
156611423|NCT00437203|565318612|FG001|Overall Study|Death|0|||
156611424|NCT00437203|565318613|FG002|Overall Study|Death|1|||
156611425|NCT00437203|565318614|FG003|Overall Study|Death|0|||
156611426|NCT00437203|565318615|FG004|Overall Study|Death|0|||
156611427|NCT00437203|565318616|FG005|Overall Study|Death|0|||
156611428|NCT00437203|565318617|FG006|Overall Study|Death|0|||
156611429|NCT00437203|565318618|FG007|Overall Study|Death|1|||
156611430|NCT00437203|565318619|FG008|Overall Study|Death|0|||
156611431|NCT00437203|565318620|FG009|Overall Study|Death|1|||
156611432|NCT00437203|565318611|FG000|Overall Study|Adverse Event|1|||
156611433|NCT00437203|565318612|FG001|Overall Study|Adverse Event|1|||
156611434|NCT00437203|565318613|FG002|Overall Study|Adverse Event|0|||
156611435|NCT00437203|565318614|FG003|Overall Study|Adverse Event|0|||
156611436|NCT00437203|565318615|FG004|Overall Study|Adverse Event|0|||
156611437|NCT00437203|565318616|FG005|Overall Study|Adverse Event|0|||
156611438|NCT00437203|565318617|FG006|Overall Study|Adverse Event|0|||
156611439|NCT00437203|565318618|FG007|Overall Study|Adverse Event|1|||
156611440|NCT00437203|565318619|FG008|Overall Study|Adverse Event|0|||
156611441|NCT00437203|565318620|FG009|Overall Study|Adverse Event|1|||
156611442|NCT00437203|565318611|FG000|Overall Study|Study terminated by sponsor|0|||
156611443|NCT00437203|565318612|FG001|Overall Study|Study terminated by sponsor|0|||
156611444|NCT00437203|565318613|FG002|Overall Study|Study terminated by sponsor|0|||
156611445|NCT00437203|565318614|FG003|Overall Study|Study terminated by sponsor|0|||
156611446|NCT00437203|565318615|FG004|Overall Study|Study terminated by sponsor|0|||
156611447|NCT00437203|565318616|FG005|Overall Study|Study terminated by sponsor|0|||
156611448|NCT00437203|565318617|FG006|Overall Study|Study terminated by sponsor|0|||
156611449|NCT00437203|565318618|FG007|Overall Study|Study terminated by sponsor|0|||
156611450|NCT00437203|565318619|FG008|Overall Study|Study terminated by sponsor|1|||
156611451|NCT00437203|565318620|FG009|Overall Study|Study terminated by sponsor|0|||
156611452|NCT00437203|565318611|FG000|Overall Study|Objective progression or relapse|5|||
156611453|NCT00437203|565318612|FG001|Overall Study|Objective progression or relapse|6|||
156611454|NCT00437203|565318613|FG002|Overall Study|Objective progression or relapse|2|||
156611455|NCT00437203|565318614|FG003|Overall Study|Objective progression or relapse|3|||
156611456|NCT00437203|565318615|FG004|Overall Study|Objective progression or relapse|3|||
156611457|NCT00437203|565318616|FG005|Overall Study|Objective progression or relapse|3|||
156611458|NCT00437203|565318617|FG006|Overall Study|Objective progression or relapse|6|||
156611459|NCT00437203|565318618|FG007|Overall Study|Objective progression or relapse|1|||
156611460|NCT00437203|565318619|FG008|Overall Study|Objective progression or relapse|2|||
156611461|NCT00437203|565318620|FG009|Overall Study|Objective progression or relapse|2|||
156611462|NCT00437203|565318611|FG000|Overall Study|Other|0|||
156611463|NCT00437203|565318612|FG001|Overall Study|Other|1|||
156611464|NCT00437203|565318613|FG002|Overall Study|Other|0|||
156611465|NCT00437203|565318614|FG003|Overall Study|Other|0|||
156611466|NCT00437203|565318615|FG004|Overall Study|Other|0|||
156611467|NCT00437203|565318616|FG005|Overall Study|Other|0|||
156611468|NCT00437203|565318617|FG006|Overall Study|Other|1|||
156611469|NCT00437203|565318618|FG007|Overall Study|Other|0|||
156611470|NCT00437203|565318619|FG008|Overall Study|Other|0|||
156611471|NCT00437203|565318620|FG009|Overall Study|Other|0|||
156611472|NCT01915095|565318627|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
156611473|NCT01915095|565318628|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
156611474|NCT01915095|565318629|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
156611475|NCT01915095|565318630|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
156611476|NCT01915095|565318631|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
156611477|NCT02067533|565318632|FG000|Overall Study|Lost to Follow-up|4|||
156611478|NCT02067533|565318633|FG001|Overall Study|Lost to Follow-up|2|||
156611479|NCT00565812|565318634|FG000|Overall Study|Death|2|||
156611480|NCT00565812|565318635|FG001|Overall Study|Death|1|||
156611481|NCT00565812|565318636|FG002|Overall Study|Death|3|||
156611482|NCT00565812|565318634|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
156611483|NCT00565812|565318635|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
156611484|NCT00565812|565318636|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
156611485|NCT00565812|565318634|FG000|Overall Study|Lost to Follow-up|10|||
156611486|NCT00565812|565318635|FG001|Overall Study|Lost to Follow-up|8|||
156611487|NCT00565812|565318636|FG002|Overall Study|Lost to Follow-up|8|||
156611488|NCT00565812|565318634|FG000|Overall Study|Withdrawal by Subject|58|||
156611489|NCT00565812|565318635|FG001|Overall Study|Withdrawal by Subject|47|||
156611490|NCT00565812|565318636|FG002|Overall Study|Withdrawal by Subject|48|||
156611491|NCT00565812|565318634|FG000|Overall Study|Work Schedule|5|||
156611492|NCT00565812|565318635|FG001|Overall Study|Work Schedule|3|||
156611493|NCT00565812|565318636|FG002|Overall Study|Work Schedule|1|||
156611494|NCT00565812|565318634|FG000|Overall Study|Protocol Violation|2|||
156611495|NCT00565812|565318635|FG001|Overall Study|Protocol Violation|6|||
156611496|NCT00565812|565318636|FG002|Overall Study|Protocol Violation|4|||
156611497|NCT00565812|565318634|FG000|Overall Study|Adverse Event|41|||
156611498|NCT00565812|565318635|FG001|Overall Study|Adverse Event|54|||
156611499|NCT00565812|565318636|FG002|Overall Study|Adverse Event|40|||
156611500|NCT00565812|565318634|FG000|Overall Study|Jury Duty|1|||
156611501|NCT00565812|565318635|FG001|Overall Study|Jury Duty|0|||
156611502|NCT00565812|565318636|FG002|Overall Study|Jury Duty|0|||
156611503|NCT00565812|565318634|FG000|Overall Study|Relocated Out of Area|5|||
156611504|NCT00565812|565318635|FG001|Overall Study|Relocated Out of Area|8|||
156611505|NCT00565812|565318636|FG002|Overall Study|Relocated Out of Area|9|||
156611506|NCT00565812|565318634|FG000|Overall Study|Sponsor Decision|1|||
156611507|NCT00565812|565318635|FG001|Overall Study|Sponsor Decision|5|||
156611508|NCT00565812|565318636|FG002|Overall Study|Sponsor Decision|1|||
156611509|NCT00565812|565318634|FG000|Overall Study|Domestic Reasons|7|||
156611510|NCT00565812|565318635|FG001|Overall Study|Domestic Reasons|1|||
156611511|NCT00565812|565318636|FG002|Overall Study|Domestic Reasons|3|||
156611512|NCT00565812|565318634|FG000|Overall Study|Research Site Closure|6|||
156611513|NCT00565812|565318635|FG001|Overall Study|Research Site Closure|1|||
156611514|NCT00565812|565318636|FG002|Overall Study|Research Site Closure|8|||
156611515|NCT00565812|565318634|FG000|Overall Study|Surgical Intervention|0|||
156611516|NCT00565812|565318635|FG001|Overall Study|Surgical Intervention|1|||
156611517|NCT00565812|565318636|FG002|Overall Study|Surgical Intervention|2|||
156611518|NCT00565812|565318634|FG000|Overall Study|Low Compliance|1|||
156611519|NCT00565812|565318635|FG001|Overall Study|Low Compliance|0|||
156611520|NCT00565812|565318636|FG002|Overall Study|Low Compliance|1|||
156611521|NCT00565812|565318634|FG000|Overall Study|Follow-up Visit Not Completed|2|||
156611522|NCT00565812|565318635|FG001|Overall Study|Follow-up Visit Not Completed|0|||
156611523|NCT00565812|565318636|FG002|Overall Study|Follow-up Visit Not Completed|1|||
156611524|NCT00565812|565318634|FG000|Overall Study|Physician Decision|2|||
156611525|NCT00565812|565318635|FG001|Overall Study|Physician Decision|0|||
156611526|NCT00565812|565318636|FG002|Overall Study|Physician Decision|0|||
156611527|NCT00383708|565318637|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
156611528|NCT00383708|565318637|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
156611529|NCT00383708|565318637|FG000|Run-in Period|Protocol Violation|4|||
156611530|NCT00383708|565318637|FG000|Run-in Period|Adverse Event|2|||
156611531|NCT00383708|565318637|FG000|Run-in Period|Claustrophobia|1|||
156611532|NCT00383708|565318637|FG000|Co-administration Period|Adverse Event|5|||
156611533|NCT01997281|565318641|FG000|Overall Study|Withdrawal by Subject|1|||
156611534|NCT01997281|565318642|FG001|Overall Study|Withdrawal by Subject|0|||
156611535|NCT02384993|565318643|FG000|Overall Study|Adverse Event|0|||
156611536|NCT02384993|565318644|FG001|Overall Study|Adverse Event|1|||
156611537|NCT00643448|565318650|FG000|Overall Study|Lack of Efficacy|2|||
156611538|NCT00643448|565318651|FG001|Overall Study|Lack of Efficacy|0|||
156611539|NCT00643448|565318652|FG002|Overall Study|Lack of Efficacy|4|||
156611540|NCT00643448|565318650|FG000|Overall Study|Adverse Event|2|||
156611541|NCT00643448|565318651|FG001|Overall Study|Adverse Event|2|||
156611542|NCT00643448|565318652|FG002|Overall Study|Adverse Event|2|||
156611543|NCT00643448|565318650|FG000|Overall Study|QTcF>550 ms|0|||
156611544|NCT00643448|565318651|FG001|Overall Study|QTcF>550 ms|3|||
156611545|NCT00643448|565318652|FG002|Overall Study|QTcF>550 ms|0|||
156611546|NCT00981682|565318653|FG000|Overall Study|Adverse Event|48|||
156611547|NCT00981682|565318653|FG000|Overall Study|Withdrawal by Subject|52|||
156611548|NCT00981682|565318653|FG000|Overall Study|Lost to Follow-up|14|||
156611549|NCT00981682|565318653|FG000|Overall Study|Lack of Efficacy|13|||
156611550|NCT00981682|565318653|FG000|Overall Study|Protocol Violation|6|||
156611551|NCT00981682|565318653|FG000|Overall Study|administrative|9|||
156611552|NCT03695471|565320404|FG000|Overall Study|Cancellation|1|||
156611553|NCT02859558|565320405|FG000|Step 1|Not Eligible|0|||
156611554|NCT02859558|565320406|FG001|Step 1|Not Eligible|0|||
156611555|NCT02859558|565320407|FG002|Step 1|Not Eligible|0|||
156611556|NCT02859558|565320408|FG003|Step 1|Not Eligible|0|||
156611557|NCT02859558|565320409|FG004|Step 1|Not Eligible|3|||
156611558|NCT02859558|565320405|FG000|Step 1|Lost to Follow-up|1|||
156611559|NCT02859558|565320406|FG001|Step 1|Lost to Follow-up|3|||
156611560|NCT02859558|565320407|FG002|Step 1|Lost to Follow-up|3|||
156611561|NCT02859558|565320408|FG003|Step 1|Lost to Follow-up|0|||
156611562|NCT02859558|565320409|FG004|Step 1|Lost to Follow-up|0|||
156611563|NCT02859558|565320405|FG000|Step 1|Did Not Return to Clinic|2|||
156611564|NCT02859558|565320406|FG001|Step 1|Did Not Return to Clinic|3|||
156611565|NCT02859558|565320407|FG002|Step 1|Did Not Return to Clinic|4|||
156611566|NCT02859558|565320408|FG003|Step 1|Did Not Return to Clinic|0|||
156611567|NCT02859558|565320409|FG004|Step 1|Did Not Return to Clinic|0|||
156611568|NCT02859558|565320405|FG000|Step 1|Moved|0|||
156611569|NCT02859558|565320406|FG001|Step 1|Moved|1|||
156611570|NCT02859558|565320407|FG002|Step 1|Moved|1|||
156611571|NCT02859558|565320408|FG003|Step 1|Moved|0|||
156611572|NCT02859558|565320409|FG004|Step 1|Moved|0|||
156611573|NCT02859558|565320405|FG000|Step 1|Withdrawal By Participant|1|||
156611574|NCT02859558|565320406|FG001|Step 1|Withdrawal By Participant|2|||
156611575|NCT02859558|565320407|FG002|Step 1|Withdrawal By Participant|1|||
156611576|NCT02859558|565320408|FG003|Step 1|Withdrawal By Participant|0|||
156611577|NCT02859558|565320409|FG004|Step 1|Withdrawal By Participant|0|||
156611578|NCT02859558|565320405|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
156611579|NCT02859558|565320406|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
156611580|NCT02859558|565320407|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
156611581|NCT02859558|565320408|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
156611582|NCT02859558|565320409|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
156611583|NCT02859558|565320405|FG000|Step 1|Incarceration|0|||
156611584|NCT02859558|565320406|FG001|Step 1|Incarceration|1|||
156611585|NCT02859558|565320407|FG002|Step 1|Incarceration|0|||
156611586|NCT02859558|565320408|FG003|Step 1|Incarceration|0|||
156611587|NCT02859558|565320409|FG004|Step 1|Incarceration|0|||
156611588|NCT02859558|565320405|FG000|Step 1|Non-Adherence to Study Drug|2|||
156611589|NCT02859558|565320406|FG001|Step 1|Non-Adherence to Study Drug|0|||
156611590|NCT02859558|565320407|FG002|Step 1|Non-Adherence to Study Drug|1|||
156611591|NCT02859558|565320408|FG003|Step 1|Non-Adherence to Study Drug|0|||
156611592|NCT02859558|565320409|FG004|Step 1|Non-Adherence to Study Drug|0|||
156611593|NCT02859558|565320405|FG000|Step 1|Non-Adherence to Study Requirements|3|||
156611594|NCT02859558|565320406|FG001|Step 1|Non-Adherence to Study Requirements|1|||
156611595|NCT02859558|565320407|FG002|Step 1|Non-Adherence to Study Requirements|0|||
156611596|NCT02859558|565320408|FG003|Step 1|Non-Adherence to Study Requirements|0|||
156611597|NCT02859558|565320409|FG004|Step 1|Non-Adherence to Study Requirements|0|||
156611598|NCT02859558|565320405|FG000|Step 1|Virologic Failure|2|||
156611599|NCT02859558|565320406|FG001|Step 1|Virologic Failure|1|||
156611600|NCT02859558|565320407|FG002|Step 1|Virologic Failure|1|||
156611601|NCT02859558|565320408|FG003|Step 1|Virologic Failure|0|||
156611602|NCT02859558|565320409|FG004|Step 1|Virologic Failure|0|||
156611603|NCT02859558|565320405|FG000|Step 2|Lost to Follow-up|3|||
156611604|NCT02859558|565320406|FG001|Step 2|Lost to Follow-up|3|||
156611605|NCT02859558|565320407|FG002|Step 2|Lost to Follow-up|1|||
156611606|NCT02859558|565320408|FG003|Step 2|Lost to Follow-up|0|||
156611607|NCT02859558|565320409|FG004|Step 2|Lost to Follow-up|0|||
156611608|NCT02859558|565320405|FG000|Step 2|Withdrawal by Subject|0|||
156611609|NCT02859558|565320406|FG001|Step 2|Withdrawal by Subject|1|||
156611610|NCT02859558|565320407|FG002|Step 2|Withdrawal by Subject|1|||
156611611|NCT02859558|565320408|FG003|Step 2|Withdrawal by Subject|0|||
156611612|NCT02859558|565320409|FG004|Step 2|Withdrawal by Subject|0|||
156611613|NCT02859558|565320405|FG000|Step 2|Unexpected Closure of Site|0|||
156611614|NCT02859558|565320406|FG001|Step 2|Unexpected Closure of Site|1|||
156611615|NCT02859558|565320407|FG002|Step 2|Unexpected Closure of Site|1|||
156611616|NCT02859558|565320408|FG003|Step 2|Unexpected Closure of Site|0|||
156611617|NCT02859558|565320409|FG004|Step 2|Unexpected Closure of Site|0|||
156611618|NCT02859558|565320405|FG000|Step 2|Death|1|||
156611619|NCT02859558|565320406|FG001|Step 2|Death|0|||
156611620|NCT02859558|565320407|FG002|Step 2|Death|0|||
156611621|NCT02859558|565320408|FG003|Step 2|Death|0|||
156611622|NCT02859558|565320409|FG004|Step 2|Death|0|||
156611623|NCT02859558|565320405|FG000|Step 2|Incarceration|0|||
156611624|NCT02859558|565320406|FG001|Step 2|Incarceration|0|||
156611625|NCT02859558|565320407|FG002|Step 2|Incarceration|1|||
156611626|NCT02859558|565320408|FG003|Step 2|Incarceration|0|||
156611627|NCT02859558|565320409|FG004|Step 2|Incarceration|0|||
156611628|NCT04507360|565320410|FG000|Week 1|Lost to Follow-up|0|||
156611629|NCT04507360|565320411|FG001|Week 1|Lost to Follow-up|0|||
156611630|NCT04507360|565320412|FG002|Week 1|Lost to Follow-up|0|||
156611631|NCT04507360|565320413|FG003|Week 1|Lost to Follow-up|0|||
156611632|NCT04507360|565320414|FG004|Week 1|Lost to Follow-up|0|||
156611633|NCT04507360|565320415|FG005|Week 1|Lost to Follow-up|0|||
156611634|NCT04507360|565320416|FG006|Week 1|Lost to Follow-up|0|||
156611635|NCT04507360|565320417|FG007|Week 1|Lost to Follow-up|0|||
156611636|NCT04507360|565320418|FG008|Week 1|Lost to Follow-up|72|||
156611637|NCT04507360|565320419|FG009|Week 1|Lost to Follow-up|22|||
156611638|NCT04507360|565320420|FG010|Week 1|Lost to Follow-up|10|||
156611639|NCT04507360|565320410|FG000|Week 2|Lost to Follow-up|0|||
156611640|NCT04507360|565320411|FG001|Week 2|Lost to Follow-up|0|||
156611641|NCT04507360|565320412|FG002|Week 2|Lost to Follow-up|0|||
156611642|NCT04507360|565320413|FG003|Week 2|Lost to Follow-up|0|||
156611643|NCT04507360|565320414|FG004|Week 2|Lost to Follow-up|0|||
156611644|NCT04507360|565320415|FG005|Week 2|Lost to Follow-up|0|||
156611645|NCT04507360|565320416|FG006|Week 2|Lost to Follow-up|0|||
156611646|NCT04507360|565320417|FG007|Week 2|Lost to Follow-up|0|||
156611647|NCT04507360|565320418|FG008|Week 2|Lost to Follow-up|121|||
156611648|NCT04507360|565320419|FG009|Week 2|Lost to Follow-up|85|||
156611649|NCT04507360|565320420|FG010|Week 2|Lost to Follow-up|82|||
156611650|NCT04507360|565320410|FG000|Week 3|Lost to Follow-up|0|||
156611651|NCT04507360|565320411|FG001|Week 3|Lost to Follow-up|0|||
156611652|NCT04507360|565320412|FG002|Week 3|Lost to Follow-up|0|||
156611653|NCT04507360|565320413|FG003|Week 3|Lost to Follow-up|0|||
156611654|NCT04507360|565320414|FG004|Week 3|Lost to Follow-up|0|||
156611655|NCT04507360|565320415|FG005|Week 3|Lost to Follow-up|0|||
156611656|NCT04507360|565320416|FG006|Week 3|Lost to Follow-up|0|||
156611657|NCT04507360|565320417|FG007|Week 3|Lost to Follow-up|0|||
156611658|NCT04507360|565320418|FG008|Week 3|Lost to Follow-up|123|||
156611659|NCT04507360|565320419|FG009|Week 3|Lost to Follow-up|92|||
156611660|NCT04507360|565320420|FG010|Week 3|Lost to Follow-up|84|||
156611661|NCT04507360|565320410|FG000|Week 4|Lost to Follow-up|0|||
156611662|NCT04507360|565320411|FG001|Week 4|Lost to Follow-up|0|||
156611663|NCT04507360|565320412|FG002|Week 4|Lost to Follow-up|0|||
156611664|NCT04507360|565320413|FG003|Week 4|Lost to Follow-up|0|||
156611665|NCT04507360|565320414|FG004|Week 4|Lost to Follow-up|0|||
156611666|NCT04507360|565320415|FG005|Week 4|Lost to Follow-up|0|||
156611667|NCT04507360|565320416|FG006|Week 4|Lost to Follow-up|0|||
156611668|NCT04507360|565320417|FG007|Week 4|Lost to Follow-up|0|||
156611669|NCT04507360|565320418|FG008|Week 4|Lost to Follow-up|131|||
156611670|NCT04507360|565320419|FG009|Week 4|Lost to Follow-up|115|||
156611671|NCT04507360|565320420|FG010|Week 4|Lost to Follow-up|102|||
156611672|NCT04507360|565320410|FG000|Week 5|Lost to Follow-up|0|||
156611673|NCT04507360|565320411|FG001|Week 5|Lost to Follow-up|0|||
156611674|NCT04507360|565320412|FG002|Week 5|Lost to Follow-up|0|||
156611675|NCT04507360|565320413|FG003|Week 5|Lost to Follow-up|0|||
156611676|NCT04507360|565320414|FG004|Week 5|Lost to Follow-up|0|||
156611677|NCT04507360|565320415|FG005|Week 5|Lost to Follow-up|0|||
156611678|NCT04507360|565320416|FG006|Week 5|Lost to Follow-up|0|||
156611679|NCT04507360|565320417|FG007|Week 5|Lost to Follow-up|0|||
156611680|NCT04507360|565320418|FG008|Week 5|Lost to Follow-up|103|||
156611681|NCT04507360|565320419|FG009|Week 5|Lost to Follow-up|135|||
156611682|NCT04507360|565320420|FG010|Week 5|Lost to Follow-up|143|||
156611683|NCT04507360|565320410|FG000|Week 8|Lost to Follow-up|0|||
156611684|NCT04507360|565320411|FG001|Week 8|Lost to Follow-up|0|||
156611685|NCT04507360|565320412|FG002|Week 8|Lost to Follow-up|0|||
156611686|NCT04507360|565320413|FG003|Week 8|Lost to Follow-up|0|||
156611687|NCT04507360|565320414|FG004|Week 8|Lost to Follow-up|0|||
156611688|NCT04507360|565320415|FG005|Week 8|Lost to Follow-up|0|||
156611689|NCT04507360|565320416|FG006|Week 8|Lost to Follow-up|0|||
156611690|NCT04507360|565320417|FG007|Week 8|Lost to Follow-up|0|||
156611691|NCT04507360|565320418|FG008|Week 8|Lost to Follow-up|139|||
156611692|NCT04507360|565320419|FG009|Week 8|Lost to Follow-up|145|||
156611693|NCT04507360|565320420|FG010|Week 8|Lost to Follow-up|152|||
156611694|NCT03050307|565320424|FG000|Overall Study|Adverse Event|4|||
156611695|NCT03050307|565320425|FG001|Overall Study|Adverse Event|2|||
156611696|NCT03050307|565320424|FG000|Overall Study|Significant Protocol Deviation|0|||
156611697|NCT03050307|565320425|FG001|Overall Study|Significant Protocol Deviation|1|||
156611698|NCT03050307|565320424|FG000|Overall Study|Lost to Follow-up|0|||
156611699|NCT03050307|565320425|FG001|Overall Study|Lost to Follow-up|1|||
156611700|NCT03050307|565320424|FG000|Overall Study|Voluntary Withdrawal|3|||
156611701|NCT03050307|565320425|FG001|Overall Study|Voluntary Withdrawal|4|||
156611702|NCT03050307|565320424|FG000|Overall Study|Reason not Specified|1|||
156611703|NCT03050307|565320425|FG001|Overall Study|Reason not Specified|1|||
156611704|NCT00653068|565320426|FG000|Overall Study|Death|9|||
156611705|NCT00653068|565320426|FG000|Overall Study|Lack of Efficacy|34|||
156611706|NCT00653068|565320426|FG000|Overall Study|Physician Decision|4|||
156611707|NCT00653068|565320426|FG000|Overall Study|Withdrawal by Subject|1|||
156611708|NCT00653068|565320426|FG000|Overall Study|Ineligible|2|||
156611709|NCT03950440|565320427|FG000|Overall Study|Death|8|||
156611710|NCT03950440|565320428|FG001|Overall Study|Death|2|||
156611711|NCT03950440|565320429|FG002|Overall Study|Death|1|||
156611712|NCT00439309|565320430|FG000|Follow-Up|Death|1|||
156611713|NCT00439309|565320431|FG001|Follow-Up|Death|0|||
156611714|NCT00439309|565320430|FG000|Follow-Up|Lost to Follow-up|2|||
156611715|NCT00439309|565320431|FG001|Follow-Up|Lost to Follow-up|0|||
156611716|NCT00439309|565320430|FG000|Follow-Up|Withdrawal by Subject|0|||
156611717|NCT00439309|565320431|FG001|Follow-Up|Withdrawal by Subject|1|||
156611718|NCT00439309|565320430|FG000|Follow-Up|Late response by subject|0|||
156611719|NCT00439309|565320431|FG001|Follow-Up|Late response by subject|1|||
156611720|NCT02892734|565320432|FG000|Treatment on Study|Progressive Disease|2|||
156611721|NCT02892734|565320432|FG000|Follow up for 2 Years|Death|2|||
156611722|NCT02892734|565320432|FG000|Follow up for 2 Years|Study closed early|1|||
156611723|NCT00464620|565320433|FG000|Overall Study|Physician Decision|1|||
156611724|NCT00464620|565320434|FG001|Overall Study|Physician Decision|0|||
156611725|NCT00464620|565320435|FG002|Overall Study|Physician Decision|0|||
156611726|NCT00464620|565320433|FG000|Overall Study|Withdrawal by Subject|1|||
156611727|NCT00464620|565320434|FG001|Overall Study|Withdrawal by Subject|0|||
156611728|NCT00464620|565320435|FG002|Overall Study|Withdrawal by Subject|3|||
156611729|NCT00464620|565320433|FG000|Overall Study|Ineligible sarcoma subtype|0|||
156611730|NCT00464620|565320434|FG001|Overall Study|Ineligible sarcoma subtype|2|||
156611731|NCT00464620|565320435|FG002|Overall Study|Ineligible sarcoma subtype|2|||
156611732|NCT00464620|565320433|FG000|Overall Study|Use of prohibited concomitant medication|0|||
156611733|NCT00464620|565320434|FG001|Overall Study|Use of prohibited concomitant medication|0|||
156611734|NCT00464620|565320435|FG002|Overall Study|Use of prohibited concomitant medication|2|||
156611735|NCT02204410|565320436|FG000|Overall Study|Lost to Follow-up|5|||
156611736|NCT02204410|565320436|FG000|Overall Study|Physician Decision|2|||
156611737|NCT02204410|565320436|FG000|Overall Study|Protocol Violation|1|||
156611738|NCT02204410|565320436|FG000|Overall Study|Withdrawal by Subject|3|||
156611739|NCT02158728|565320450|FG000|Overall Study|no procedure according to CIP done|3|||
156611740|NCT02158728|565320450|FG000|Overall Study|no qualified dataset|24|||
156611741|NCT01536418|565320464|FG000|Overall Study|Protocol Violation|2|||
156611742|NCT01536418|565320465|FG001|Overall Study|Protocol Violation|3|||
156611743|NCT01536418|565320464|FG000|Overall Study|Physician Decision|1|||
156611744|NCT01536418|565320465|FG001|Overall Study|Physician Decision|3|||
156611745|NCT01536418|565320464|FG000|Overall Study|Study closed/terminated|41|||
156611746|NCT01536418|565320465|FG001|Overall Study|Study closed/terminated|37|||
156611747|NCT01536418|565320464|FG000|Overall Study|Lack of Efficacy|10|||
156611748|NCT01536418|565320465|FG001|Overall Study|Lack of Efficacy|16|||
156611749|NCT01536418|565320464|FG000|Overall Study|Adverse Event|9|||
156611750|NCT01536418|565320465|FG001|Overall Study|Adverse Event|4|||
156611751|NCT01536418|565320464|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
156611752|NCT01536418|565320465|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
156611753|NCT01536418|565320464|FG000|Overall Study|Withdrawal by Subject|5|||
156611754|NCT01536418|565320465|FG001|Overall Study|Withdrawal by Subject|3|||
156611755|NCT02658149|565320470|FG000|Overall Study|Physician Decision|1|||
156611756|NCT02658149|565320471|FG001|Overall Study|Physician Decision|0|||
156611757|NCT00711412|565320472|FG000|Induction Treatment|Death|2|||
156611758|NCT00711412|565320472|FG000|Induction Treatment|Adverse Event|1|||
156611759|NCT00711412|565320472|FG000|Induction Treatment|Other|1|||
156611760|NCT00711412|565320472|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
156611761|NCT00711412|565320472|FG000|Evaluated for Combination Treatment|Death|1|||
156611762|NCT00711412|565320472|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
156611763|NCT00711412|565320472|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
156611764|NCT00711412|565320472|FG000|Combination Treatment|Progressive Disease|1|||
156611765|NCT00711412|565320472|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
156611766|NCT00711412|565320472|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
156611767|NCT00711412|565320472|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
156611768|NCT00711412|565320472|FG000|Evaluation for Response and Surgery|Death|1|||
156611769|NCT00711412|565320472|FG000|Survival Follow up Until Death|Other|12|||
156611770|NCT02234050|565320474|FG000|Overall Study|Lack of Efficacy|38|||
156611771|NCT02234050|565320475|FG001|Overall Study|Lack of Efficacy|22|||
156611772|NCT02234050|565320474|FG000|Overall Study|Adverse Event|13|||
156611773|NCT02234050|565320475|FG001|Overall Study|Adverse Event|1|||
156611774|NCT02234050|565320474|FG000|Overall Study|Withdrawal by Subject|4|||
156611775|NCT02234050|565320475|FG001|Overall Study|Withdrawal by Subject|2|||
156611776|NCT02234050|565320474|FG000|Overall Study|Sponsor's decision|6|||
156611777|NCT02234050|565320475|FG001|Overall Study|Sponsor's decision|0|||
156611778|NCT01680991|565320477|FG000|Overall Study|Adverse Event|1|||
156611779|NCT01680991|565320478|FG001|Overall Study|Adverse Event|0|||
156611780|NCT01680991|565320479|FG002|Overall Study|Adverse Event|0|||
156611781|NCT01680991|565320477|FG000|Overall Study|Death|1|||
156611782|NCT01680991|565320478|FG001|Overall Study|Death|0|||
156611783|NCT01680991|565320479|FG002|Overall Study|Death|1|||
156611784|NCT01680991|565320477|FG000|Overall Study|Protocol Violation|0|||
156611785|NCT01680991|565320478|FG001|Overall Study|Protocol Violation|1|||
156611786|NCT01680991|565320479|FG002|Overall Study|Protocol Violation|0|||
156611787|NCT01680991|565320477|FG000|Overall Study|Withdrawal by Subject|5|||
156611788|NCT01680991|565320478|FG001|Overall Study|Withdrawal by Subject|1|||
156611789|NCT01680991|565320479|FG002|Overall Study|Withdrawal by Subject|0|||
156611790|NCT01680991|565320477|FG000|Overall Study|Progressive disease (PD)|0|||
156611791|NCT01680991|565320478|FG001|Overall Study|Progressive disease (PD)|10|||
156611792|NCT01680991|565320479|FG002|Overall Study|Progressive disease (PD)|0|||
156611793|NCT01680991|565320477|FG000|Overall Study|Physician Decision|0|||
156611794|NCT01680991|565320478|FG001|Overall Study|Physician Decision|7|||
156611795|NCT01680991|565320479|FG002|Overall Study|Physician Decision|2|||
156611796|NCT01680991|565320477|FG000|Overall Study|Bad physical condition|0|||
156611797|NCT01680991|565320478|FG001|Overall Study|Bad physical condition|0|||
156611798|NCT01680991|565320479|FG002|Overall Study|Bad physical condition|1|||
156611799|NCT01680991|565320477|FG000|Overall Study|PD confirmed in other hospital|1|||
156611800|NCT01680991|565320478|FG001|Overall Study|PD confirmed in other hospital|0|||
156611801|NCT01680991|565320479|FG002|Overall Study|PD confirmed in other hospital|0|||
156611802|NCT04097028|565320480|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
156611803|NCT04097028|565320480|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
156611804|NCT04097028|565320480|FG000|Overall Study|Disease Progression prior to Surgery|2|||
156611805|NCT04097028|565320480|FG000|Overall Study|Adverse Event prior to Surgery|1|||
156611806|NCT02473289|565320481|FG000|Overall Study|Adverse Event|2|||
156611807|NCT02473289|565320482|FG001|Overall Study|Adverse Event|3|||
156611808|NCT02473289|565320481|FG000|Overall Study|Lost to Follow-up|1|||
156611809|NCT02473289|565320482|FG001|Overall Study|Lost to Follow-up|1|||
156611810|NCT02473289|565320481|FG000|Overall Study|Protocol Violation|0|||
156611811|NCT02473289|565320482|FG001|Overall Study|Protocol Violation|1|||
156611812|NCT02473289|565320481|FG000|Overall Study|Withdrawal of consent|6|||
156611813|NCT02473289|565320482|FG001|Overall Study|Withdrawal of consent|7|||
156611814|NCT02473289|565320481|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
156611815|NCT02473289|565320482|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
156611816|NCT02473289|565320481|FG000|Overall Study|Other|2|||
156611817|NCT02473289|565320482|FG001|Overall Study|Other|0|||
156611818|NCT02244619|565320483|FG000|Overall Study|Did not receive study intervention|8|||
156611819|NCT02244619|565320484|FG001|Overall Study|Did not receive study intervention|21|||
156611820|NCT01156363|565320485|FG000|Overall Study|Adverse Event|6|||
156611821|NCT01156363|565320485|FG000|Overall Study|Insufficient Therapeutic Response|5|||
156611822|NCT01156363|565320485|FG000|Overall Study|Failure to Return|1|||
156611823|NCT01156363|565320485|FG000|Overall Study|Refused Treatment|4|||
156611824|NCT01156363|565320485|FG000|Overall Study|Other|6|||
156611825|NCT03285490|565320487|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
156611826|NCT03285490|565320488|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
156611827|NCT03285490|565320487|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
156611828|NCT03285490|565320488|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
156611829|NCT03745989|565320489|FG000|Overall Study|Death|3|||
156611830|NCT03745989|565320490|FG001|Overall Study|Death|7|||
156611831|NCT03745989|565320491|FG002|Overall Study|Death|4|||
156611832|NCT03745989|565320489|FG000|Overall Study|Lost to Follow-up|0|||
156611833|NCT03745989|565320490|FG001|Overall Study|Lost to Follow-up|2|||
156611834|NCT03745989|565320491|FG002|Overall Study|Lost to Follow-up|0|||
156611835|NCT03745989|565320489|FG000|Overall Study|Sponsor Decision|0|||
156611836|NCT03745989|565320490|FG001|Overall Study|Sponsor Decision|2|||
156611837|NCT03745989|565320491|FG002|Overall Study|Sponsor Decision|8|||
156611838|NCT03745989|565320489|FG000|Overall Study|Withdrawal by Subject|0|||
156611839|NCT03745989|565320490|FG001|Overall Study|Withdrawal by Subject|1|||
156611840|NCT03745989|565320491|FG002|Overall Study|Withdrawal by Subject|3|||
156611841|NCT00068822|565320492|FG000|First Randomized Intervention|Lost to Follow-up|1|||
156611842|NCT00068822|565320493|FG001|First Randomized Intervention|Lost to Follow-up|2|||
156611843|NCT00735072|565320499|FG000|Overall Study|interrupted study med during ARV change|1|||
156611844|NCT00735072|565320500|FG001|Overall Study|interrupted study med during ARV change|0|||
156611845|NCT00735072|565320499|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
156611846|NCT00735072|565320500|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
156611847|NCT00911144|565320501|FG000|Overall Study|Withdrawal by Subject|16|||
156611848|NCT00911144|565320502|FG001|Overall Study|Withdrawal by Subject|5|||
156611849|NCT00047008|565320504|FG000|Overall Study|Withdrawn consent|2|||
156611850|NCT00047008|565320505|FG001|Overall Study|Withdrawn consent|3|||
156611851|NCT00047008|565320504|FG000|Overall Study|Ineligible|9|||
156611852|NCT00047008|565320505|FG001|Overall Study|Ineligible|8|||
156611853|NCT00429572|565320506|FG000|Overall Study|Disease progression|1|||
156611854|NCT02773368|565320507|FG000|Overall Study|Lost to Follow-up|4|||
156611855|NCT02773368|565320508|FG001|Overall Study|Lost to Follow-up|1|||
156611856|NCT02773368|565320507|FG000|Overall Study|Withdrawal by Subject|5|||
156611857|NCT02773368|565320508|FG001|Overall Study|Withdrawal by Subject|1|||
156611858|NCT02773368|565320507|FG000|Overall Study|Unclassified|1|||
156611859|NCT02773368|565320508|FG001|Overall Study|Unclassified|1|||
156611860|NCT02773368|565320507|FG000|Overall Study|Missing|0|||
156611861|NCT02773368|565320508|FG001|Overall Study|Missing|1|||
156611862|NCT02635867|565320511|FG000|Overall Study|Lost to Follow-up|4|||
156611863|NCT02635867|565320512|FG001|Overall Study|Lost to Follow-up|3|||
156611864|NCT02635867|565320513|FG002|Overall Study|Lost to Follow-up|3|||
156611865|NCT02635867|565320514|FG003|Overall Study|Lost to Follow-up|4|||
156611866|NCT02635867|565320515|FG004|Overall Study|Lost to Follow-up|1|||
156611867|NCT02565576|565320518|FG000|Overall Study|abnormal lab value|2|||
156611868|NCT02565576|565320519|FG001|Overall Study|abnormal lab value|0|||
156611869|NCT02565576|565320518|FG000|Overall Study|subject / guardian decision|1|||
156611870|NCT02565576|565320519|FG001|Overall Study|subject / guardian decision|3|||
156611871|NCT02565576|565320518|FG000|Overall Study|Lost to Follow-up|1|||
156611872|NCT02565576|565320519|FG001|Overall Study|Lost to Follow-up|0|||
156611873|NCT02565576|565320518|FG000|Overall Study|Death|0|||
156611874|NCT02565576|565320519|FG001|Overall Study|Death|2|||
156611875|NCT02565576|565320518|FG000|Overall Study|Adverse Event|1|||
156611876|NCT02565576|565320519|FG001|Overall Study|Adverse Event|0|||
156611877|NCT00939341|565320520|FG000|Overall Study|Adverse Event|15|||
156611878|NCT00939341|565320520|FG000|Overall Study|Pregnancy|1|||
156611879|NCT00939341|565320520|FG000|Overall Study|Lost to Follow-up|23|||
156611880|NCT00939341|565320520|FG000|Overall Study|Withdrawal by Subject|13|||
156611881|NCT00939341|565320520|FG000|Overall Study|Protocol Violation|6|||
156611882|NCT00939341|565320520|FG000|Overall Study|Incorrect enrolment|8|||
156611883|NCT00796003|565320522|FG000|Overall Study|Disease Progression|2|||
156611884|NCT00796003|565320523|FG001|Overall Study|Disease Progression|13|||
156611885|NCT00796003|565320522|FG000|Overall Study|Adverse Event|1|||
156611886|NCT00796003|565320523|FG001|Overall Study|Adverse Event|7|||
156611887|NCT00796003|565320522|FG000|Overall Study|Specified organ function not met|0|||
156611888|NCT00796003|565320523|FG001|Overall Study|Specified organ function not met|1|||
156611889|NCT00796003|565320522|FG000|Overall Study|Physician Decision|0|||
156611890|NCT00796003|565320523|FG001|Overall Study|Physician Decision|4|||
156611891|NCT00796003|565320522|FG000|Overall Study|Withdrawal by Subject|0|||
156611892|NCT00796003|565320523|FG001|Overall Study|Withdrawal by Subject|1|||
156611893|NCT00796003|565320522|FG000|Overall Study|Other|0|||
156611894|NCT00796003|565320523|FG001|Overall Study|Other|1|||
156611895|NCT00796003|565320522|FG000|Overall Study|Participants Not treated|0|||
156611896|NCT00796003|565320523|FG001|Overall Study|Participants Not treated|2|||
156611897|NCT04338321|565320528|FG000|Overall Study|Adverse Event|4|||
156611898|NCT04338321|565320529|FG001|Overall Study|Adverse Event|10|||
156611899|NCT04338321|565320528|FG000|Overall Study|Death|1|||
156611900|NCT04338321|565320529|FG001|Overall Study|Death|1|||
156611901|NCT04338321|565320528|FG000|Overall Study|Lost to Follow-up|4|||
156611902|NCT04338321|565320529|FG001|Overall Study|Lost to Follow-up|9|||
156611903|NCT04338321|565320528|FG000|Overall Study|Withdrawal by Subject|45|||
156611904|NCT04338321|565320529|FG001|Overall Study|Withdrawal by Subject|69|||
156611905|NCT04338321|565320528|FG000|Overall Study|Physician Decision|5|||
156611906|NCT04338321|565320529|FG001|Overall Study|Physician Decision|9|||
156611907|NCT04338321|565320528|FG000|Overall Study|Other|3|||
156611908|NCT04338321|565320529|FG001|Overall Study|Other|10|||
156611909|NCT02910089|565320530|FG000|Overall Study|Lost insurance eligibility|22|||
156611910|NCT02910089|565320531|FG001|Overall Study|Lost insurance eligibility|16|||
156611911|NCT00633360|565320534|FG000|Overall Study|Lost to Follow-up|1|||
156611912|NCT00633360|565320535|FG001|Overall Study|Lost to Follow-up|1|||
156611913|NCT00633360|565320534|FG000|Overall Study|Adverse Event|3|||
156611914|NCT00633360|565320535|FG001|Overall Study|Adverse Event|1|||
156611915|NCT00633360|565320534|FG000|Overall Study|Protocol Violation|0|||
156611916|NCT00633360|565320535|FG001|Overall Study|Protocol Violation|1|||
156611917|NCT00621244|565320538|FG000|Overall Study|Withdrawal by Subject|7|||
156611918|NCT00621244|565320539|FG001|Overall Study|Withdrawal by Subject|3|||
156611919|NCT00621244|565320540|FG002|Overall Study|Withdrawal by Subject|3|||
156611920|NCT00621244|565320541|FG003|Overall Study|Withdrawal by Subject|3|||
156611921|NCT00621244|565320538|FG000|Overall Study|Disease progression|44|||
156611922|NCT00621244|565320539|FG001|Overall Study|Disease progression|20|||
156611923|NCT00621244|565320540|FG002|Overall Study|Disease progression|20|||
156611924|NCT00621244|565320541|FG003|Overall Study|Disease progression|15|||
156611925|NCT00621244|565320538|FG000|Overall Study|Death|3|||
156611926|NCT00621244|565320539|FG001|Overall Study|Death|3|||
156611927|NCT00621244|565320540|FG002|Overall Study|Death|1|||
156611928|NCT00621244|565320541|FG003|Overall Study|Death|1|||
156611929|NCT00621244|565320538|FG000|Overall Study|Adverse Event|27|||
156611930|NCT00621244|565320539|FG001|Overall Study|Adverse Event|7|||
156611931|NCT00621244|565320540|FG002|Overall Study|Adverse Event|9|||
156611932|NCT00621244|565320541|FG003|Overall Study|Adverse Event|2|||
156611933|NCT00621244|565320538|FG000|Overall Study|Administrative problems|5|||
156611934|NCT00621244|565320539|FG001|Overall Study|Administrative problems|1|||
156611935|NCT00621244|565320540|FG002|Overall Study|Administrative problems|0|||
156611936|NCT00621244|565320541|FG003|Overall Study|Administrative problems|2|||
156611937|NCT01690988|565320542|FG000|Overall Study|Withdrawal by Subject|2|||
156611938|NCT01690988|565320543|FG001|Overall Study|Withdrawal by Subject|2|||
156611939|NCT01690988|565320544|FG002|Overall Study|Withdrawal by Subject|3|||
156611940|NCT01690988|565320542|FG000|Overall Study|Physician Decision|0|||
156611941|NCT01690988|565320543|FG001|Overall Study|Physician Decision|0|||
156611942|NCT01690988|565320544|FG002|Overall Study|Physician Decision|1|||
156611943|NCT01690988|565320542|FG000|Overall Study|Operation Cancelled|1|||
156611944|NCT01690988|565320543|FG001|Overall Study|Operation Cancelled|1|||
156611945|NCT01690988|565320544|FG002|Overall Study|Operation Cancelled|0|||
156611946|NCT01690988|565320542|FG000|Overall Study|Determined ineligible|1|||
156611947|NCT01690988|565320543|FG001|Overall Study|Determined ineligible|0|||
156611948|NCT01690988|565320544|FG002|Overall Study|Determined ineligible|0|||
156611949|NCT01690988|565320542|FG000|Overall Study|Death|1|||
156611950|NCT01690988|565320543|FG001|Overall Study|Death|1|||
156611951|NCT01690988|565320544|FG002|Overall Study|Death|1|||
156611952|NCT01690988|565320542|FG000|Overall Study|Sedated|1|||
156611953|NCT01690988|565320543|FG001|Overall Study|Sedated|1|||
156611954|NCT01690988|565320544|FG002|Overall Study|Sedated|2|||
156611955|NCT00312728|565320545|FG000|Overall Study|Progressive disease|53|||
156611956|NCT00312728|565320545|FG000|Overall Study|Adverse Event|32|||
156611957|NCT00312728|565320545|FG000|Overall Study|Withdrawal by Subject|10|||
156611958|NCT00312728|565320545|FG000|Overall Study|Required non-protocol cancer treatment|2|||
156611959|NCT00312728|565320545|FG000|Overall Study|Protocol Violation|2|||
156611960|NCT00312728|565320545|FG000|Overall Study|Other|10|||
156611961|NCT00312728|565320545|FG000|Overall Study|Other|1|||
156611962|NCT03696576|565320546|FG000|Overall Study|Soreness of throat after therapy|1|||
156611963|NCT03696576|565320547|FG001|Overall Study|Soreness of throat after therapy|1|||
156611964|NCT03696576|565320546|FG000|Overall Study|Lost to Follow-up|2|||
156611965|NCT03696576|565320547|FG001|Overall Study|Lost to Follow-up|4|||
156611966|NCT00560794|565320549|FG000|Overall Study|Adverse Event|2|||
156611967|NCT00560794|565320549|FG000|Overall Study|Patient was not Compliant|1|||
156611968|NCT00560794|565320549|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
156611969|NCT00560794|565320549|FG000|Overall Study|Hematological Relapse|1|||
156611970|NCT00560794|565320549|FG000|Overall Study|Received Bone Marrow Transplant|6|||
156611971|NCT04857892|565320550|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
156611972|NCT04857892|565320551|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
156611973|NCT04857892|565320552|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
156611974|NCT04857892|565320553|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
156611975|NCT04857892|565320554|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
156611976|NCT04857892|565320550|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
156611977|NCT04857892|565320551|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
156611978|NCT04857892|565320552|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
156611979|NCT04857892|565320553|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
156611980|NCT04857892|565320554|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
156611981|NCT04857892|565320550|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
156635008|NCT03917654|565407824|FG009|Year 2|Married|0|||
156611982|NCT04857892|565320551|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
156611983|NCT04857892|565320552|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
156611984|NCT04857892|565320553|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
156611985|NCT04857892|565320554|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
156611986|NCT00368472|565320559|FG000|Overall Study|Adverse Event|22|||
156611987|NCT00368472|565320559|FG000|Overall Study|Medication non-compliance|4|||
156611988|NCT00368472|565320559|FG000|Overall Study|Protocol Violation|2|||
156611989|NCT00368472|565320559|FG000|Overall Study|Request of Investigator or Sponsor|3|||
156611990|NCT00368472|565320559|FG000|Overall Study|Withdrawal by Subject|40|||
156611991|NCT00368472|565320559|FG000|Overall Study|Diary non-compliance|1|||
156611992|NCT00368472|565320559|FG000|Overall Study|Other|32|||
156611993|NCT00368472|565320559|FG000|Overall Study|Missing Final Disposition Date|1|||
156611994|NCT01627782|565320560|FG000|Overall Study|Adverse Event|1|||
156611995|NCT01627782|565320561|FG001|Overall Study|Adverse Event|2|||
156611996|NCT01627782|565320562|FG002|Overall Study|Adverse Event|0|||
156611997|NCT01627782|565320563|FG003|Overall Study|Adverse Event|1|||
156611998|NCT01627782|565320560|FG000|Overall Study|Lack of Efficacy|11|||
156611999|NCT01627782|565320561|FG001|Overall Study|Lack of Efficacy|1|||
156612000|NCT01627782|565320562|FG002|Overall Study|Lack of Efficacy|15|||
156612001|NCT01627782|565320563|FG003|Overall Study|Lack of Efficacy|2|||
156612002|NCT01627782|565320560|FG000|Overall Study|Protocol Violation|1|||
156612003|NCT01627782|565320561|FG001|Overall Study|Protocol Violation|0|||
156612004|NCT01627782|565320562|FG002|Overall Study|Protocol Violation|0|||
156612005|NCT01627782|565320563|FG003|Overall Study|Protocol Violation|0|||
156612006|NCT01627782|565320560|FG000|Overall Study|Withdrawal by Subject|2|||
156612007|NCT01627782|565320561|FG001|Overall Study|Withdrawal by Subject|1|||
156612008|NCT01627782|565320562|FG002|Overall Study|Withdrawal by Subject|0|||
156612009|NCT01627782|565320563|FG003|Overall Study|Withdrawal by Subject|0|||
156612010|NCT01627782|565320560|FG000|Overall Study|Other|0|||
156612011|NCT01627782|565320561|FG001|Overall Study|Other|2|||
156612012|NCT01627782|565320562|FG002|Overall Study|Other|0|||
156612013|NCT01627782|565320563|FG003|Overall Study|Other|3|||
156612014|NCT01627782|565320560|FG000|Overall Study|Randomized But Not Treated|1|||
156612015|NCT01627782|565320561|FG001|Overall Study|Randomized But Not Treated|0|||
156612016|NCT01627782|565320562|FG002|Overall Study|Randomized But Not Treated|0|||
156612017|NCT01627782|565320563|FG003|Overall Study|Randomized But Not Treated|0|||
156612018|NCT01998906|565322452|FG000|Overall Study|Participants ongoing in follow-up|77|||
156612019|NCT01998906|565322453|FG001|Overall Study|Participants ongoing in follow-up|60|||
156612020|NCT01998906|565322454|FG002|Overall Study|Participants ongoing in follow-up|58|||
156612021|NCT01998906|565322452|FG000|Overall Study|Death|21|||
156612022|NCT01998906|565322453|FG001|Overall Study|Death|30|||
156612023|NCT01998906|565322454|FG002|Overall Study|Death|17|||
156612024|NCT01998906|565322452|FG000|Overall Study|Lack of Efficacy|10|||
156612025|NCT01998906|565322453|FG001|Overall Study|Lack of Efficacy|9|||
156612026|NCT01998906|565322454|FG002|Overall Study|Lack of Efficacy|8|||
156612027|NCT01998906|565322452|FG000|Overall Study|Failure to return|0|||
156612028|NCT01998906|565322453|FG001|Overall Study|Failure to return|2|||
156612029|NCT01998906|565322454|FG002|Overall Study|Failure to return|4|||
156612030|NCT01998906|565322452|FG000|Overall Study|Violation of Selection Criteria|0|||
156612031|NCT01998906|565322453|FG001|Overall Study|Violation of Selection Criteria|0|||
156612032|NCT01998906|565322454|FG002|Overall Study|Violation of Selection Criteria|1|||
156612033|NCT01998906|565322452|FG000|Overall Study|Withdrawal by Subject|1|||
156612034|NCT01998906|565322453|FG001|Overall Study|Withdrawal by Subject|4|||
156612035|NCT01998906|565322454|FG002|Overall Study|Withdrawal by Subject|3|||
156612036|NCT01998906|565322452|FG000|Overall Study|Administrative/Other|2|||
156612037|NCT01998906|565322453|FG001|Overall Study|Administrative/Other|1|||
156612038|NCT01998906|565322454|FG002|Overall Study|Administrative/Other|3|||
156612039|NCT01998906|565322452|FG000|Overall Study|Other|3|||
156612040|NCT01998906|565322453|FG001|Overall Study|Other|8|||
156612041|NCT01998906|565322454|FG002|Overall Study|Other|4|||
156612042|NCT06073054|565322466|FG000|Overall Study|Withdrawal by Subject|2|||
156612043|NCT03345342|565322467|FG000|Open-Label Phase|Adverse Event|30|||
156612044|NCT03345342|565322468|FG001|Open-Label Phase|Adverse Event|0|||
156612045|NCT03345342|565322469|FG002|Open-Label Phase|Adverse Event|0|||
156612046|NCT03345342|565322470|FG003|Open-Label Phase|Adverse Event|0|||
156612047|NCT03345342|565322471|FG004|Open-Label Phase|Adverse Event|0|||
156612048|NCT03345342|565322467|FG000|Open-Label Phase|Death|1|||
156612049|NCT03345342|565322468|FG001|Open-Label Phase|Death|0|||
156612050|NCT03345342|565322469|FG002|Open-Label Phase|Death|0|||
156612051|NCT03345342|565322470|FG003|Open-Label Phase|Death|0|||
156612052|NCT03345342|565322471|FG004|Open-Label Phase|Death|0|||
156612053|NCT03345342|565322467|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
156612054|NCT03345342|565322468|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
156612055|NCT03345342|565322469|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
156612056|NCT03345342|565322470|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
156612057|NCT03345342|565322471|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
156612058|NCT03345342|565322467|FG000|Open-Label Phase|Lack of Efficacy|6|||
156612059|NCT03345342|565322468|FG001|Open-Label Phase|Lack of Efficacy|0|||
156612060|NCT03345342|565322469|FG002|Open-Label Phase|Lack of Efficacy|0|||
156612061|NCT03345342|565322470|FG003|Open-Label Phase|Lack of Efficacy|0|||
156612062|NCT03345342|565322471|FG004|Open-Label Phase|Lack of Efficacy|0|||
156612063|NCT03345342|565322467|FG000|Open-Label Phase|Lost to Follow-up|9|||
156612064|NCT03345342|565322468|FG001|Open-Label Phase|Lost to Follow-up|0|||
156612065|NCT03345342|565322469|FG002|Open-Label Phase|Lost to Follow-up|0|||
156612066|NCT03345342|565322470|FG003|Open-Label Phase|Lost to Follow-up|0|||
156612067|NCT03345342|565322471|FG004|Open-Label Phase|Lost to Follow-up|0|||
156612068|NCT03345342|565322467|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
156612069|NCT03345342|565322468|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
156612070|NCT03345342|565322469|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
156612071|NCT03345342|565322470|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
156612072|NCT03345342|565322471|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
156612073|NCT03345342|565322467|FG000|Open-Label Phase|Physician Decision|4|||
156612074|NCT03345342|565322468|FG001|Open-Label Phase|Physician Decision|0|||
156612075|NCT03345342|565322469|FG002|Open-Label Phase|Physician Decision|0|||
156612076|NCT03345342|565322470|FG003|Open-Label Phase|Physician Decision|0|||
156612077|NCT03345342|565322471|FG004|Open-Label Phase|Physician Decision|0|||
156612078|NCT03345342|565322467|FG000|Open-Label Phase|Protocol Violation|8|||
156612079|NCT03345342|565322468|FG001|Open-Label Phase|Protocol Violation|0|||
156612080|NCT03345342|565322469|FG002|Open-Label Phase|Protocol Violation|0|||
156612081|NCT03345342|565322470|FG003|Open-Label Phase|Protocol Violation|0|||
156612082|NCT03345342|565322471|FG004|Open-Label Phase|Protocol Violation|0|||
156612083|NCT03345342|565322467|FG000|Open-Label Phase|Withdrawal by Subject|57|||
156612084|NCT03345342|565322468|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156612085|NCT03345342|565322469|FG002|Open-Label Phase|Withdrawal by Subject|0|||
156612086|NCT03345342|565322470|FG003|Open-Label Phase|Withdrawal by Subject|0|||
156612087|NCT03345342|565322471|FG004|Open-Label Phase|Withdrawal by Subject|0|||
156612088|NCT03345342|565322467|FG000|Open-Label Phase|Other|15|||
156612089|NCT03345342|565322468|FG001|Open-Label Phase|Other|0|||
156612090|NCT03345342|565322469|FG002|Open-Label Phase|Other|0|||
156612091|NCT03345342|565322470|FG003|Open-Label Phase|Other|0|||
156612092|NCT03345342|565322471|FG004|Open-Label Phase|Other|0|||
156612093|NCT03345342|565322467|FG000|Double-Blind Phase|Adverse Event|0|||
156612094|NCT03345342|565322468|FG001|Double-Blind Phase|Adverse Event|1|||
156612095|NCT03345342|565322469|FG002|Double-Blind Phase|Adverse Event|6|||
156612096|NCT03345342|565322470|FG003|Double-Blind Phase|Adverse Event|0|||
156612097|NCT03345342|565322471|FG004|Double-Blind Phase|Adverse Event|0|||
156612098|NCT03345342|565322467|FG000|Double-Blind Phase|Death|0|||
156612099|NCT03345342|565322468|FG001|Double-Blind Phase|Death|2|||
156612100|NCT03345342|565322469|FG002|Double-Blind Phase|Death|1|||
156612101|NCT03345342|565322470|FG003|Double-Blind Phase|Death|0|||
156612102|NCT03345342|565322471|FG004|Double-Blind Phase|Death|0|||
156612103|NCT03345342|565322467|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
156612104|NCT03345342|565322468|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
156612105|NCT03345342|565322469|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
156612106|NCT03345342|565322470|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
156612107|NCT03345342|565322471|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
156612108|NCT03345342|565322467|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156612109|NCT03345342|565322468|FG001|Double-Blind Phase|Lost to Follow-up|1|||
156612110|NCT03345342|565322469|FG002|Double-Blind Phase|Lost to Follow-up|7|||
156612111|NCT03345342|565322470|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156612112|NCT03345342|565322471|FG004|Double-Blind Phase|Lost to Follow-up|0|||
156612113|NCT03345342|565322467|FG000|Double-Blind Phase|Physician Decision|0|||
156612114|NCT03345342|565322468|FG001|Double-Blind Phase|Physician Decision|1|||
156612115|NCT03345342|565322469|FG002|Double-Blind Phase|Physician Decision|4|||
156612116|NCT03345342|565322470|FG003|Double-Blind Phase|Physician Decision|0|||
156612117|NCT03345342|565322471|FG004|Double-Blind Phase|Physician Decision|0|||
156612118|NCT03345342|565322467|FG000|Double-Blind Phase|Protocol Violation|0|||
156612119|NCT03345342|565322468|FG001|Double-Blind Phase|Protocol Violation|0|||
156612120|NCT03345342|565322469|FG002|Double-Blind Phase|Protocol Violation|1|||
156612121|NCT03345342|565322470|FG003|Double-Blind Phase|Protocol Violation|0|||
156612122|NCT03345342|565322471|FG004|Double-Blind Phase|Protocol Violation|0|||
156612123|NCT03345342|565322467|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156612124|NCT03345342|565322468|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
156612125|NCT03345342|565322469|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
156612126|NCT03345342|565322470|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156612127|NCT03345342|565322471|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156612128|NCT03345342|565322467|FG000|Double-Blind Phase|Other|0|||
156612129|NCT03345342|565322468|FG001|Double-Blind Phase|Other|1|||
156612130|NCT03345342|565322469|FG002|Double-Blind Phase|Other|3|||
156612131|NCT03345342|565322470|FG003|Double-Blind Phase|Other|0|||
156612132|NCT03345342|565322471|FG004|Double-Blind Phase|Other|0|||
156612133|NCT03345342|565322467|FG000|Follow-Up Phase|Adverse Event|0|||
156612134|NCT03345342|565322468|FG001|Follow-Up Phase|Adverse Event|0|||
156612135|NCT03345342|565322469|FG002|Follow-Up Phase|Adverse Event|0|||
156612136|NCT03345342|565322470|FG003|Follow-Up Phase|Adverse Event|0|||
156612137|NCT03345342|565322471|FG004|Follow-Up Phase|Adverse Event|4|||
156612138|NCT03345342|565322467|FG000|Follow-Up Phase|Lost to Follow-up|0|||
156612139|NCT03345342|565322468|FG001|Follow-Up Phase|Lost to Follow-up|0|||
156612140|NCT03345342|565322469|FG002|Follow-Up Phase|Lost to Follow-up|0|||
156612141|NCT03345342|565322470|FG003|Follow-Up Phase|Lost to Follow-up|0|||
156612142|NCT03345342|565322471|FG004|Follow-Up Phase|Lost to Follow-up|6|||
156612143|NCT03345342|565322467|FG000|Follow-Up Phase|Physician Decision|0|||
156612144|NCT03345342|565322468|FG001|Follow-Up Phase|Physician Decision|0|||
156612145|NCT03345342|565322469|FG002|Follow-Up Phase|Physician Decision|0|||
156612146|NCT03345342|565322470|FG003|Follow-Up Phase|Physician Decision|0|||
156612147|NCT03345342|565322471|FG004|Follow-Up Phase|Physician Decision|5|||
156612148|NCT03345342|565322467|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
156612149|NCT03345342|565322468|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
156612150|NCT03345342|565322469|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
156612151|NCT03345342|565322470|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
156612152|NCT03345342|565322471|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
156612153|NCT03345342|565322467|FG000|Follow-Up Phase|Other|0|||
156612154|NCT03345342|565322468|FG001|Follow-Up Phase|Other|0|||
156612155|NCT03345342|565322469|FG002|Follow-Up Phase|Other|0|||
156612156|NCT03345342|565322470|FG003|Follow-Up Phase|Other|3|||
156612157|NCT03345342|565322471|FG004|Follow-Up Phase|Other|1|||
156612158|NCT02418585|565322472|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
156612159|NCT02418585|565322473|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
156612160|NCT02418585|565322472|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
156612161|NCT02418585|565322473|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
156612162|NCT02418585|565322472|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
156612163|NCT02418585|565322473|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
156612164|NCT02418585|565322472|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
156612165|NCT02418585|565322473|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
156612166|NCT02418585|565322472|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
156612167|NCT02418585|565322473|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
156612168|NCT02418585|565322472|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
156612169|NCT02418585|565322473|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
156612170|NCT02418585|565322472|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
156612171|NCT02418585|565322473|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
156612172|NCT02418585|565322472|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
156612173|NCT02418585|565322473|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
156612174|NCT02418585|565322472|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
156612175|NCT02418585|565322473|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
156612176|NCT02418585|565322472|FG000|Follow-up Phase (24 Weeks)|Other|3|||
156612177|NCT02418585|565322473|FG001|Follow-up Phase (24 Weeks)|Other|2|||
156612178|NCT04159701|565322474|FG000|Period 1: Treatment Period|Pregnancy|1|||
156612179|NCT04159701|565322475|FG001|Period 1: Treatment Period|Pregnancy|0|||
156612180|NCT04159701|565322474|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
156612181|NCT04159701|565322475|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
156612182|NCT04159701|565322474|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
156612183|NCT04159701|565322475|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
156612184|NCT04159701|565322474|FG000|Washout Period|site terminated by sponsor|0|||
156612185|NCT04159701|565322475|FG001|Washout Period|site terminated by sponsor|1|||
156612186|NCT04159701|565322474|FG000|Washout Period|study terminated by sponsor|10|||
156612187|NCT04159701|565322475|FG001|Washout Period|study terminated by sponsor|3|||
156612188|NCT04159701|565322474|FG000|Washout Period|Withdrawal by Subject|1|||
156612189|NCT04159701|565322475|FG001|Washout Period|Withdrawal by Subject|0|||
156612190|NCT04159701|565322474|FG000|Washout Period|Inadvertent Enrollment|1|||
156612191|NCT04159701|565322475|FG001|Washout Period|Inadvertent Enrollment|0|||
156612192|NCT04159701|565322474|FG000|Washout Period|Miscellaneous|1|||
156612193|NCT04159701|565322475|FG001|Washout Period|Miscellaneous|0|||
156612194|NCT04159701|565322474|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
156612195|NCT04159701|565322475|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
156612196|NCT04159701|565322474|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
156612197|NCT04159701|565322475|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
156612198|NCT04159701|565322474|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
156612199|NCT04159701|565322475|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
156612200|NCT04159701|565322474|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
156612201|NCT04159701|565322475|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
156612202|NCT04159701|565322474|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
156612203|NCT04159701|565322475|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
156612204|NCT01849562|565322479|FG000|Overall Study|Lost to Follow-up|1|||
156612205|NCT01849562|565322480|FG001|Overall Study|Lost to Follow-up|0|||
156612206|NCT01849562|565322481|FG002|Overall Study|Lost to Follow-up|0|||
156612207|NCT01849562|565322479|FG000|Overall Study|Non-compliance with Study Drug|1|||
156612208|NCT01849562|565322480|FG001|Overall Study|Non-compliance with Study Drug|0|||
156612209|NCT01849562|565322481|FG002|Overall Study|Non-compliance with Study Drug|0|||
156612210|NCT00481988|565322484|FG000|Overall Study|Withdrawal by Subject|1|||
156612211|NCT00481988|565322485|FG001|Overall Study|Withdrawal by Subject|1|||
156612212|NCT04599972|565322492|FG000|Overall Study|Withdrawal by Subject|6|||
156612213|NCT04599972|565322493|FG001|Overall Study|Withdrawal by Subject|1|||
156612214|NCT04599972|565322492|FG000|Overall Study|Adverse Event|1|||
156612215|NCT04599972|565322493|FG001|Overall Study|Adverse Event|1|||
156612216|NCT04599972|565322492|FG000|Overall Study|Lost to Follow-up|1|||
156612217|NCT04599972|565322493|FG001|Overall Study|Lost to Follow-up|6|||
156612218|NCT04599972|565322492|FG000|Overall Study|Protocol Violation|1|||
156612219|NCT04599972|565322493|FG001|Overall Study|Protocol Violation|0|||
156612220|NCT04599972|565322492|FG000|Overall Study|Other reason|1|||
156612221|NCT04599972|565322493|FG001|Overall Study|Other reason|0|||
156612222|NCT00638690|565322496|FG000|Overall Study|Death|655|||
156612223|NCT00638690|565322497|FG001|Overall Study|Death|335|||
156612224|NCT00638690|565322496|FG000|Overall Study|Withdrawal by Subject|22|||
156612225|NCT00638690|565322497|FG001|Overall Study|Withdrawal by Subject|5|||
156612226|NCT00638690|565322496|FG000|Overall Study|Lost to Follow-up|4|||
156612227|NCT00638690|565322497|FG001|Overall Study|Lost to Follow-up|2|||
156612228|NCT01347073|565322500|FG000|Overall Study|Adverse Event|1|||
156612229|NCT01347073|565322500|FG000|Overall Study|Liver Transplant|1|||
156612230|NCT01975376|565322512|FG000|Overall Study|Adverse Event|5|||
156612231|NCT01975376|565322513|FG001|Overall Study|Adverse Event|5|||
156612232|NCT01975376|565322512|FG000|Overall Study|Death|65|||
156612233|NCT01975376|565322513|FG001|Overall Study|Death|72|||
156612234|NCT01975376|565322512|FG000|Overall Study|Lost to Follow-up|70|||
156612235|NCT01975376|565322513|FG001|Overall Study|Lost to Follow-up|66|||
156612236|NCT01975376|565322512|FG000|Overall Study|Withdrew consent|68|||
156612237|NCT01975376|565322513|FG001|Overall Study|Withdrew consent|62|||
156612238|NCT01975376|565322512|FG000|Overall Study|Other|2|||
156612239|NCT01975376|565322513|FG001|Overall Study|Other|4|||
156612240|NCT01975376|565322512|FG000|Overall Study|Randomized, Not Treated|16|||
156612241|NCT01975376|565322513|FG001|Overall Study|Randomized, Not Treated|8|||
156612242|NCT01819194|565322519|FG000|Overall Study|Loss of study articles|2|||
156612243|NCT00045630|565322520|FG000|Overall Study|Adverse Event|1|||
156612244|NCT00045630|565322520|FG000|Overall Study|Refusal unrelated to adverse event|1|||
156612245|NCT00045630|565322520|FG000|Overall Study|Progression/relapse|1|||
156612246|NCT00045630|565322520|FG000|Overall Study|Death|1|||
156612247|NCT00045630|565322520|FG000|Overall Study|Ineligible|2|||
156612248|NCT04449276|565322521|FG000|Overall Study|Adverse Event|1|||
156612249|NCT04449276|565322522|FG001|Overall Study|Adverse Event|2|||
156612250|NCT04449276|565322523|FG002|Overall Study|Adverse Event|0|||
156612251|NCT04449276|565322524|FG003|Overall Study|Adverse Event|0|||
156612252|NCT04449276|565322525|FG004|Overall Study|Adverse Event|2|||
156612253|NCT04449276|565322526|FG005|Overall Study|Adverse Event|0|||
156612254|NCT04449276|565322527|FG006|Overall Study|Adverse Event|0|||
156612255|NCT04449276|565322528|FG007|Overall Study|Adverse Event|1|||
156612256|NCT04449276|565322521|FG000|Overall Study|Withdrawal by Subject|2|||
156612257|NCT04449276|565322522|FG001|Overall Study|Withdrawal by Subject|0|||
156612258|NCT04449276|565322523|FG002|Overall Study|Withdrawal by Subject|0|||
156612259|NCT04449276|565322524|FG003|Overall Study|Withdrawal by Subject|1|||
156612260|NCT04449276|565322525|FG004|Overall Study|Withdrawal by Subject|0|||
156612261|NCT04449276|565322526|FG005|Overall Study|Withdrawal by Subject|0|||
156612262|NCT04449276|565322527|FG006|Overall Study|Withdrawal by Subject|0|||
156612263|NCT04449276|565322528|FG007|Overall Study|Withdrawal by Subject|0|||
156612264|NCT04449276|565322521|FG000|Overall Study|Other|0|||
156612265|NCT04449276|565322522|FG001|Overall Study|Other|2|||
156612266|NCT04449276|565322523|FG002|Overall Study|Other|3|||
156612267|NCT04449276|565322524|FG003|Overall Study|Other|2|||
156612268|NCT04449276|565322525|FG004|Overall Study|Other|0|||
156612269|NCT04449276|565322526|FG005|Overall Study|Other|0|||
156612270|NCT04449276|565322527|FG006|Overall Study|Other|0|||
156612271|NCT04449276|565322528|FG007|Overall Study|Other|1|||
156612272|NCT01614795|565322529|FG000|Overall Study|Adverse Event|0|||
156612273|NCT01614795|565322530|FG001|Overall Study|Adverse Event|0|||
156612274|NCT01614795|565322531|FG002|Overall Study|Adverse Event|1|||
156612275|NCT01614795|565322532|FG003|Overall Study|Adverse Event|1|||
156612276|NCT01614795|565322529|FG000|Overall Study|Lack of Efficacy|10|||
156612277|NCT01614795|565322530|FG001|Overall Study|Lack of Efficacy|10|||
156612278|NCT01614795|565322531|FG002|Overall Study|Lack of Efficacy|9|||
156612279|NCT01614795|565322532|FG003|Overall Study|Lack of Efficacy|8|||
156612280|NCT01614795|565322529|FG000|Overall Study|Physician Decision|1|||
156612281|NCT01614795|565322530|FG001|Overall Study|Physician Decision|0|||
156612282|NCT01614795|565322531|FG002|Overall Study|Physician Decision|1|||
156612283|NCT01614795|565322532|FG003|Overall Study|Physician Decision|1|||
156612284|NCT01614795|565322529|FG000|Overall Study|Withdrawal by Subject|0|||
156612285|NCT01614795|565322530|FG001|Overall Study|Withdrawal by Subject|1|||
156612286|NCT01614795|565322531|FG002|Overall Study|Withdrawal by Subject|0|||
156612287|NCT01614795|565322532|FG003|Overall Study|Withdrawal by Subject|2|||
156612288|NCT01614795|565322529|FG000|Overall Study|Ineligible|0|||
156612289|NCT01614795|565322530|FG001|Overall Study|Ineligible|1|||
156612290|NCT01614795|565322531|FG002|Overall Study|Ineligible|0|||
156612291|NCT01614795|565322532|FG003|Overall Study|Ineligible|0|||
156612292|NCT00701103|565322534|FG000|Overall Study|Adverse Event|0|||
156612293|NCT00701103|565322535|FG001|Overall Study|Adverse Event|0|||
156612294|NCT00701103|565322536|FG002|Overall Study|Adverse Event|1|||
156612295|NCT00701103|565322537|FG003|Overall Study|Adverse Event|1|||
156612296|NCT00701103|565322538|FG004|Overall Study|Adverse Event|0|||
156612297|NCT00701103|565322539|FG005|Overall Study|Adverse Event|1|||
156612298|NCT00701103|565322540|FG006|Overall Study|Adverse Event|1|||
156612299|NCT00701103|565322541|FG007|Overall Study|Adverse Event|0|||
156612300|NCT00701103|565322542|FG008|Overall Study|Adverse Event|0|||
156612301|NCT00701103|565322543|FG009|Overall Study|Adverse Event|2|||
156612302|NCT00701103|565322544|FG010|Overall Study|Adverse Event|0|||
156612303|NCT00701103|565322534|FG000|Overall Study|Progressive Disease|5|||
156612304|NCT00701103|565322535|FG001|Overall Study|Progressive Disease|2|||
156612305|NCT00701103|565322536|FG002|Overall Study|Progressive Disease|6|||
156612306|NCT00701103|565322537|FG003|Overall Study|Progressive Disease|5|||
156612307|NCT00701103|565322538|FG004|Overall Study|Progressive Disease|6|||
156612308|NCT00701103|565322539|FG005|Overall Study|Progressive Disease|5|||
156612309|NCT00701103|565322540|FG006|Overall Study|Progressive Disease|7|||
156612310|NCT00701103|565322541|FG007|Overall Study|Progressive Disease|7|||
156612311|NCT00701103|565322542|FG008|Overall Study|Progressive Disease|8|||
156612312|NCT00701103|565322543|FG009|Overall Study|Progressive Disease|8|||
156612313|NCT00701103|565322544|FG010|Overall Study|Progressive Disease|11|||
156612314|NCT00701103|565322534|FG000|Overall Study|Withdrawal by Subject|0|||
156612315|NCT00701103|565322535|FG001|Overall Study|Withdrawal by Subject|1|||
156612316|NCT00701103|565322536|FG002|Overall Study|Withdrawal by Subject|1|||
156612317|NCT00701103|565322537|FG003|Overall Study|Withdrawal by Subject|0|||
156612318|NCT00701103|565322538|FG004|Overall Study|Withdrawal by Subject|0|||
156612319|NCT00701103|565322539|FG005|Overall Study|Withdrawal by Subject|0|||
156612320|NCT00701103|565322540|FG006|Overall Study|Withdrawal by Subject|0|||
156612321|NCT00701103|565322541|FG007|Overall Study|Withdrawal by Subject|0|||
156612322|NCT00701103|565322542|FG008|Overall Study|Withdrawal by Subject|0|||
156612323|NCT00701103|565322543|FG009|Overall Study|Withdrawal by Subject|0|||
156612324|NCT00701103|565322544|FG010|Overall Study|Withdrawal by Subject|0|||
156612325|NCT00701103|565322534|FG000|Overall Study|Other|0|||
156612326|NCT00701103|565322535|FG001|Overall Study|Other|0|||
156612327|NCT00701103|565322536|FG002|Overall Study|Other|0|||
156612328|NCT00701103|565322537|FG003|Overall Study|Other|0|||
156612329|NCT00701103|565322538|FG004|Overall Study|Other|0|||
156612330|NCT00701103|565322539|FG005|Overall Study|Other|0|||
156612331|NCT00701103|565322540|FG006|Overall Study|Other|0|||
156612332|NCT00701103|565322541|FG007|Overall Study|Other|0|||
156612333|NCT00701103|565322542|FG008|Overall Study|Other|1|||
156612334|NCT00701103|565322543|FG009|Overall Study|Other|1|||
156612335|NCT00701103|565322544|FG010|Overall Study|Other|0|||
156612336|NCT00179517|565322545|FG000|Overall Study|Withdrawal by Subject|2|||
156612337|NCT00179517|565322546|FG001|Overall Study|Withdrawal by Subject|1|||
156612338|NCT01448707|565322552|FG000|Overall Study|Adverse Event|3|||
156612339|NCT01448707|565322553|FG001|Overall Study|Adverse Event|1|||
156612340|NCT01448707|565322552|FG000|Overall Study|Lost to Follow-up|2|||
156612341|NCT01448707|565322553|FG001|Overall Study|Lost to Follow-up|6|||
156612342|NCT01448707|565322552|FG000|Overall Study|Withdrawal by Subject|6|||
156612343|NCT01448707|565322553|FG001|Overall Study|Withdrawal by Subject|7|||
156612344|NCT01448707|565322552|FG000|Overall Study|Other|7|||
156612345|NCT01448707|565322553|FG001|Overall Study|Other|4|||
156612346|NCT02033850|565322559|FG000|Overall Study|Death|1|||
156612347|NCT02033850|565322560|FG001|Overall Study|Death|0|||
156612348|NCT02033850|565322559|FG000|Overall Study|unrelated medical reason|1|||
156612349|NCT02033850|565322560|FG001|Overall Study|unrelated medical reason|1|||
156612350|NCT02820038|565322564|FG000|Overall Study|Lost to Follow-up|7|||
156612351|NCT02820038|565322565|FG001|Overall Study|Lost to Follow-up|11|||
156612352|NCT02820038|565322566|FG002|Overall Study|Lost to Follow-up|2|||
156612353|NCT02820038|565322567|FG003|Overall Study|Lost to Follow-up|9|||
156612354|NCT02820038|565322564|FG000|Overall Study|Withdrawal by Subject|3|||
156612355|NCT02820038|565322565|FG001|Overall Study|Withdrawal by Subject|14|||
156612356|NCT02820038|565322566|FG002|Overall Study|Withdrawal by Subject|3|||
156612357|NCT02820038|565322567|FG003|Overall Study|Withdrawal by Subject|13|||
156612358|NCT03215667|565322568|FG000|Overall Study|Physician Decision|4|||
156612359|NCT00614991|565322569|FG000|Overall Study|Adverse Event|3|||
156612360|NCT00614991|565322570|FG001|Overall Study|Adverse Event|3|||
156612361|NCT00614991|565322571|FG002|Overall Study|Adverse Event|0|||
156612362|NCT00614991|565322572|FG003|Overall Study|Adverse Event|0|||
156612363|NCT00614991|565322573|FG004|Overall Study|Adverse Event|1|||
156612364|NCT00614991|565322574|FG005|Overall Study|Adverse Event|0|||
156612365|NCT01922739|565322580|FG000|Titration/Adjustment Period|Adverse Event|3|||
156612366|NCT01922739|565322580|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
156612367|NCT01922739|565322580|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
156612368|NCT01922739|565322580|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
156612369|NCT01922739|565322580|FG000|Open-label Treatment Period|Adverse Event|6|||
156612370|NCT01922739|565322580|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
156612371|NCT01922739|565322580|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
156612372|NCT01922739|565322580|FG000|Open-label Treatment Period|Protocol Violation|5|||
156612373|NCT01922739|565322580|FG000|Open-label Treatment Period|Pregnancy|1|||
156612374|NCT01922739|565322580|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
156612375|NCT01922739|565322580|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
156612376|NCT01922739|565322580|FG000|Open-label Treatment Period|Physician Decision|1|||
156612377|NCT01922739|565322580|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
156612378|NCT00044213|565322581|FG000|Overall Study|Withdrawal by Subject|50|||
156612379|NCT00044213|565322582|FG001|Overall Study|Withdrawal by Subject|65|||
156612380|NCT00044213|565322583|FG002|Overall Study|Withdrawal by Subject|91|||
156612381|NCT00044213|565322584|FG003|Overall Study|Withdrawal by Subject|83|||
156612382|NCT00044213|565322581|FG000|Overall Study|Death|42|||
156612383|NCT00044213|565322582|FG001|Overall Study|Death|42|||
156612384|NCT00044213|565322583|FG002|Overall Study|Death|42|||
156612385|NCT00044213|565322584|FG003|Overall Study|Death|49|||
156612386|NCT00044213|565322581|FG000|Overall Study|Lost to Follow-up|8|||
156612387|NCT00044213|565322582|FG001|Overall Study|Lost to Follow-up|5|||
156612388|NCT00044213|565322583|FG002|Overall Study|Lost to Follow-up|5|||
156612389|NCT00044213|565322584|FG003|Overall Study|Lost to Follow-up|4|||
156612390|NCT00422240|565322585|FG000|Overall Study|Lack of Efficacy|1|||
156612391|NCT00422240|565322586|FG001|Overall Study|Lack of Efficacy|2|||
156612392|NCT00422240|565322587|FG002|Overall Study|Lack of Efficacy|0|||
156612393|NCT00422240|565322588|FG003|Overall Study|Lack of Efficacy|1|||
156612394|NCT00422240|565322585|FG000|Overall Study|Adverse Event|11|||
156612395|NCT00422240|565322586|FG001|Overall Study|Adverse Event|4|||
156612396|NCT00422240|565322587|FG002|Overall Study|Adverse Event|5|||
156612397|NCT00422240|565322588|FG003|Overall Study|Adverse Event|2|||
156612398|NCT00422240|565322585|FG000|Overall Study|Subject request|21|||
156612399|NCT00422240|565322586|FG001|Overall Study|Subject request|17|||
156612400|NCT00422240|565322587|FG002|Overall Study|Subject request|18|||
156612401|NCT00422240|565322588|FG003|Overall Study|Subject request|30|||
156612402|NCT00422240|565322585|FG000|Overall Study|Protocol Violation|0|||
156612403|NCT00422240|565322586|FG001|Overall Study|Protocol Violation|1|||
156612404|NCT00422240|565322587|FG002|Overall Study|Protocol Violation|0|||
156612405|NCT00422240|565322588|FG003|Overall Study|Protocol Violation|1|||
156612406|NCT00422240|565322585|FG000|Overall Study|Lost to Follow-up|31|||
156612407|NCT00422240|565322586|FG001|Overall Study|Lost to Follow-up|32|||
156612408|NCT00422240|565322587|FG002|Overall Study|Lost to Follow-up|19|||
156612409|NCT00422240|565322588|FG003|Overall Study|Lost to Follow-up|34|||
156612410|NCT00422240|565322585|FG000|Overall Study|Other|1|||
156612411|NCT00422240|565322586|FG001|Overall Study|Other|0|||
156612412|NCT00422240|565322587|FG002|Overall Study|Other|0|||
156612413|NCT00422240|565322588|FG003|Overall Study|Other|1|||
156612414|NCT00422240|565322585|FG000|Overall Study|Pregnancy|3|||
156612415|NCT00422240|565322586|FG001|Overall Study|Pregnancy|1|||
156612416|NCT00422240|565322587|FG002|Overall Study|Pregnancy|1|||
156612417|NCT00422240|565322588|FG003|Overall Study|Pregnancy|2|||
156612418|NCT01927068|565322592|FG000|Overall Study|Death|37|||
156612419|NCT01927068|565322593|FG001|Overall Study|Death|3|||
156612420|NCT01927068|565322592|FG000|Overall Study|Withdrawal by Subject|50|||
156612421|NCT01927068|565322593|FG001|Overall Study|Withdrawal by Subject|3|||
156612422|NCT01927068|565322592|FG000|Overall Study|Lost to Follow-up|10|||
156612423|NCT01927068|565322593|FG001|Overall Study|Lost to Follow-up|2|||
156612424|NCT01927068|565322592|FG000|Overall Study|Physician Decision|9|||
156612425|NCT01927068|565322593|FG001|Overall Study|Physician Decision|0|||
156612426|NCT01927068|565322592|FG000|Overall Study|Missed last follow-up visit|2|||
156612427|NCT01927068|565322593|FG001|Overall Study|Missed last follow-up visit|0|||
156612428|NCT00880607|565322594|FG000|Overall Study|Physician Decision|2|||
156612429|NCT00880607|565322595|FG001|Overall Study|Physician Decision|2|||
156612430|NCT00880607|565322594|FG000|Overall Study|Protocol Violation|2|||
156612431|NCT00880607|565322595|FG001|Overall Study|Protocol Violation|1|||
156612432|NCT00880607|565322594|FG000|Overall Study|surgery did not extend past L1 level|3|||
156612433|NCT00880607|565322595|FG001|Overall Study|surgery did not extend past L1 level|0|||
156612434|NCT05104749|565322596|FG000|Overall Study|Lost to Follow-up|2|||
156612435|NCT05104749|565322597|FG001|Overall Study|Lost to Follow-up|3|||
156612436|NCT02963766|565322598|FG000|Double-Blind Period|Adverse Event|1|||
156612437|NCT02963766|565322599|FG001|Double-Blind Period|Adverse Event|0|||
156612438|NCT02963766|565322600|FG002|Double-Blind Period|Adverse Event|1|||
156612439|NCT02963766|565322598|FG000|Double-Blind Period|Physician Decision|1|||
156612440|NCT02963766|565322599|FG001|Double-Blind Period|Physician Decision|0|||
156612441|NCT02963766|565322600|FG002|Double-Blind Period|Physician Decision|0|||
156612442|NCT02963766|565322598|FG000|Double-Blind Period|Withdrawal by Subject|1|||
156612443|NCT02963766|565322599|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156612444|NCT02963766|565322600|FG002|Double-Blind Period|Withdrawal by Subject|0|||
156612445|NCT02963766|565322598|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
156612446|NCT02963766|565322599|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
156612447|NCT02963766|565322600|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
156612448|NCT02963766|565322598|FG000|Double-Blind Period|Protocol Violation|1|||
156612449|NCT02963766|565322599|FG001|Double-Blind Period|Protocol Violation|0|||
156612450|NCT02963766|565322600|FG002|Double-Blind Period|Protocol Violation|0|||
156612451|NCT02963766|565322598|FG000|Double-Blind Period|Lost to Follow-up|0|||
156612452|NCT02963766|565322599|FG001|Double-Blind Period|Lost to Follow-up|1|||
156612453|NCT02963766|565322600|FG002|Double-Blind Period|Lost to Follow-up|0|||
156612454|NCT02963766|565322598|FG000|Open Label Extension (OLE)|Physician Decision|1|||
156612455|NCT02963766|565322599|FG001|Open Label Extension (OLE)|Physician Decision|2|||
156612456|NCT02963766|565322600|FG002|Open Label Extension (OLE)|Physician Decision|2|||
156612457|NCT02963766|565322598|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
156612458|NCT02963766|565322599|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
156612459|NCT02963766|565322600|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
156612460|NCT02224274|565322603|FG000|Overall Study|Death|1|||
156612461|NCT02224274|565322604|FG001|Overall Study|Death|0|||
156612462|NCT00887068|565322605|FG000|Overall Study|Withdrawal by Subject|2|||
156612463|NCT00887068|565322606|FG001|Overall Study|Withdrawal by Subject|0|||
156612464|NCT00887068|565322605|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
156612465|NCT00887068|565322606|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
156612466|NCT00499460|565322607|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
156612467|NCT00499460|565322608|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
156612468|NCT00499460|565322607|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
156612469|NCT00499460|565322608|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
156612470|NCT00499460|565322607|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
156612471|NCT00499460|565322608|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
156612472|NCT03073200|565322610|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156612473|NCT03073200|565322611|FG001|Double Blind Treatment Period|Protocol Violation|0|||
156612474|NCT03073200|565322612|FG002|Double Blind Treatment Period|Protocol Violation|0|||
156612475|NCT03073200|565322613|FG003|Double Blind Treatment Period|Protocol Violation|0|||
156612476|NCT03073200|565322614|FG004|Double Blind Treatment Period|Protocol Violation|0|||
156612477|NCT03073200|565322615|FG005|Double Blind Treatment Period|Protocol Violation|0|||
156612478|NCT03073200|565322616|FG006|Double Blind Treatment Period|Protocol Violation|0|||
156612479|NCT03073200|565322617|FG007|Double Blind Treatment Period|Protocol Violation|0|||
156612480|NCT03073200|565322618|FG008|Double Blind Treatment Period|Protocol Violation|0|||
156612481|NCT03073200|565322619|FG009|Double Blind Treatment Period|Protocol Violation|0|||
156612482|NCT03073200|565322620|FG010|Double Blind Treatment Period|Protocol Violation|0|||
156612483|NCT03073200|565322621|FG011|Double Blind Treatment Period|Protocol Violation|0|||
156612484|NCT03073200|565322622|FG012|Double Blind Treatment Period|Protocol Violation|0|||
156612485|NCT03073200|565322623|FG013|Double Blind Treatment Period|Protocol Violation|0|||
156612486|NCT03073200|565322624|FG014|Double Blind Treatment Period|Protocol Violation|0|||
156612487|NCT03073200|565322610|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612488|NCT03073200|565322611|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
156612489|NCT03073200|565322612|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612490|NCT03073200|565322613|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612491|NCT03073200|565322614|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612492|NCT03073200|565322615|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612493|NCT03073200|565322616|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612494|NCT03073200|565322617|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612495|NCT03073200|565322618|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612496|NCT03073200|565322619|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612497|NCT03073200|565322620|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612498|NCT03073200|565322621|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612499|NCT03073200|565322622|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612500|NCT03073200|565322623|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612501|NCT03073200|565322624|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
156612502|NCT03073200|565322610|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
156612503|NCT03073200|565322611|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612504|NCT03073200|565322612|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612505|NCT03073200|565322613|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612506|NCT03073200|565322614|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612507|NCT03073200|565322615|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612508|NCT03073200|565322616|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612509|NCT03073200|565322617|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612510|NCT03073200|565322618|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612511|NCT03073200|565322619|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612512|NCT03073200|565322620|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612513|NCT03073200|565322621|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612514|NCT03073200|565322622|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612515|NCT03073200|565322623|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612516|NCT03073200|565322624|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
156612517|NCT03073200|565322610|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612518|NCT03073200|565322611|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612519|NCT03073200|565322612|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612520|NCT03073200|565322613|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
156612521|NCT03073200|565322614|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
156612522|NCT03073200|565322615|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612523|NCT03073200|565322616|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612524|NCT03073200|565322617|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612525|NCT03073200|565322618|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612526|NCT03073200|565322619|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612527|NCT03073200|565322620|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612528|NCT03073200|565322621|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612529|NCT03073200|565322622|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612530|NCT03073200|565322623|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612531|NCT03073200|565322624|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
156612532|NCT03073200|565322610|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
156612533|NCT03073200|565322611|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
156612534|NCT03073200|565322612|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
156612535|NCT03073200|565322613|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
156612536|NCT03073200|565322614|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
156612537|NCT03073200|565322615|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
156612538|NCT03073200|565322616|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
156612539|NCT03073200|565322617|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
156612540|NCT03073200|565322618|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
156612541|NCT03073200|565322619|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
156612542|NCT03073200|565322620|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
156612543|NCT03073200|565322621|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
156612544|NCT03073200|565322622|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
156612545|NCT03073200|565322623|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
156612546|NCT03073200|565322624|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
156612547|NCT03073200|565322610|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612548|NCT03073200|565322611|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612549|NCT03073200|565322612|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612550|NCT03073200|565322613|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612551|NCT03073200|565322614|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
156612552|NCT03073200|565322615|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612553|NCT03073200|565322616|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612554|NCT03073200|565322617|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612555|NCT03073200|565322618|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612556|NCT03073200|565322619|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612557|NCT03073200|565322620|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612558|NCT03073200|565322621|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612559|NCT03073200|565322622|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612560|NCT03073200|565322623|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612561|NCT03073200|565322624|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
156612562|NCT03073200|565322610|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612563|NCT03073200|565322611|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612564|NCT03073200|565322612|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612565|NCT03073200|565322613|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
156612566|NCT03073200|565322614|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
156612567|NCT03073200|565322615|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612568|NCT03073200|565322616|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612569|NCT03073200|565322617|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612570|NCT03073200|565322618|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612571|NCT03073200|565322619|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612572|NCT03073200|565322620|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612573|NCT03073200|565322621|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612574|NCT03073200|565322622|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612575|NCT03073200|565322623|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612576|NCT03073200|565322624|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
156612577|NCT03073200|565322610|FG000|Extension Period|Lost to Follow-up|0|||
156612578|NCT03073200|565322611|FG001|Extension Period|Lost to Follow-up|0|||
156612579|NCT03073200|565322612|FG002|Extension Period|Lost to Follow-up|0|||
156612580|NCT03073200|565322613|FG003|Extension Period|Lost to Follow-up|0|||
156612581|NCT03073200|565322614|FG004|Extension Period|Lost to Follow-up|0|||
156612582|NCT03073200|565322615|FG005|Extension Period|Lost to Follow-up|0|||
156612583|NCT03073200|565322616|FG006|Extension Period|Lost to Follow-up|1|||
156612584|NCT03073200|565322617|FG007|Extension Period|Lost to Follow-up|1|||
156612585|NCT03073200|565322618|FG008|Extension Period|Lost to Follow-up|0|||
156612586|NCT03073200|565322619|FG009|Extension Period|Lost to Follow-up|0|||
156612587|NCT03073200|565322620|FG010|Extension Period|Lost to Follow-up|0|||
156612588|NCT03073200|565322621|FG011|Extension Period|Lost to Follow-up|0|||
156612589|NCT03073200|565322622|FG012|Extension Period|Lost to Follow-up|0|||
156612590|NCT03073200|565322623|FG013|Extension Period|Lost to Follow-up|0|||
156612591|NCT03073200|565322624|FG014|Extension Period|Lost to Follow-up|0|||
156612592|NCT03073200|565322610|FG000|Extension Period|Sponsor Decision|0|||
156612593|NCT03073200|565322611|FG001|Extension Period|Sponsor Decision|0|||
156612594|NCT03073200|565322612|FG002|Extension Period|Sponsor Decision|0|||
156612595|NCT03073200|565322613|FG003|Extension Period|Sponsor Decision|0|||
156612596|NCT03073200|565322614|FG004|Extension Period|Sponsor Decision|0|||
156612597|NCT03073200|565322615|FG005|Extension Period|Sponsor Decision|0|||
156612598|NCT03073200|565322616|FG006|Extension Period|Sponsor Decision|0|||
156612599|NCT03073200|565322617|FG007|Extension Period|Sponsor Decision|0|||
156612600|NCT03073200|565322618|FG008|Extension Period|Sponsor Decision|1|||
156612601|NCT03073200|565322619|FG009|Extension Period|Sponsor Decision|0|||
156612602|NCT03073200|565322620|FG010|Extension Period|Sponsor Decision|0|||
156612603|NCT03073200|565322621|FG011|Extension Period|Sponsor Decision|0|||
156612604|NCT03073200|565322622|FG012|Extension Period|Sponsor Decision|0|||
156612605|NCT03073200|565322623|FG013|Extension Period|Sponsor Decision|0|||
156612606|NCT03073200|565322624|FG014|Extension Period|Sponsor Decision|0|||
156612607|NCT03073200|565322610|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
156612608|NCT03073200|565322611|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
156612609|NCT03073200|565322612|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
156612610|NCT03073200|565322613|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
156612611|NCT03073200|565322614|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
156612612|NCT03073200|565322615|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
156612613|NCT03073200|565322616|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
156612614|NCT03073200|565322617|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
156612615|NCT03073200|565322618|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
156612616|NCT03073200|565322619|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
156612617|NCT03073200|565322620|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
156612618|NCT03073200|565322621|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
156612619|NCT03073200|565322622|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
156612620|NCT03073200|565322623|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
156612621|NCT03073200|565322624|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
156612622|NCT03073200|565322610|FG000|Extension Period|Withdrawal by Subject|0|||
156612623|NCT03073200|565322611|FG001|Extension Period|Withdrawal by Subject|0|||
156612624|NCT03073200|565322612|FG002|Extension Period|Withdrawal by Subject|0|||
156612625|NCT03073200|565322613|FG003|Extension Period|Withdrawal by Subject|0|||
156612626|NCT03073200|565322614|FG004|Extension Period|Withdrawal by Subject|0|||
156612627|NCT03073200|565322615|FG005|Extension Period|Withdrawal by Subject|0|||
156612628|NCT03073200|565322616|FG006|Extension Period|Withdrawal by Subject|1|||
156612629|NCT03073200|565322617|FG007|Extension Period|Withdrawal by Subject|2|||
156612630|NCT03073200|565322618|FG008|Extension Period|Withdrawal by Subject|0|||
156612631|NCT03073200|565322619|FG009|Extension Period|Withdrawal by Subject|0|||
156612632|NCT03073200|565322620|FG010|Extension Period|Withdrawal by Subject|0|||
156612633|NCT03073200|565322621|FG011|Extension Period|Withdrawal by Subject|0|||
156612634|NCT03073200|565322622|FG012|Extension Period|Withdrawal by Subject|0|||
156612635|NCT03073200|565322623|FG013|Extension Period|Withdrawal by Subject|0|||
156612636|NCT03073200|565322624|FG014|Extension Period|Withdrawal by Subject|0|||
156612637|NCT03073200|565322610|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612638|NCT03073200|565322611|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612639|NCT03073200|565322612|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612640|NCT03073200|565322613|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612641|NCT03073200|565322614|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612642|NCT03073200|565322615|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612643|NCT03073200|565322616|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612644|NCT03073200|565322617|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612645|NCT03073200|565322618|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612646|NCT03073200|565322619|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612647|NCT03073200|565322620|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612648|NCT03073200|565322621|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
156612649|NCT03073200|565322622|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612650|NCT03073200|565322623|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612651|NCT03073200|565322624|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
156612652|NCT03073200|565322610|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612653|NCT03073200|565322611|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612654|NCT03073200|565322612|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612655|NCT03073200|565322613|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612656|NCT03073200|565322614|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612657|NCT03073200|565322615|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612658|NCT03073200|565322616|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612659|NCT03073200|565322617|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612660|NCT03073200|565322618|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612661|NCT03073200|565322619|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612662|NCT03073200|565322620|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612663|NCT03073200|565322621|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
156612664|NCT03073200|565322622|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612665|NCT03073200|565322623|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612666|NCT03073200|565322624|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
156612667|NCT03073200|565322610|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612668|NCT03073200|565322611|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612669|NCT03073200|565322612|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612670|NCT03073200|565322613|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612671|NCT03073200|565322614|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612672|NCT03073200|565322615|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612673|NCT03073200|565322616|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612674|NCT03073200|565322617|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612675|NCT03073200|565322618|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612676|NCT03073200|565322619|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612677|NCT03073200|565322620|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
156612678|NCT03073200|565322621|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
156612679|NCT03073200|565322622|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612680|NCT03073200|565322623|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612681|NCT03073200|565322624|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156612682|NCT03073200|565322610|FG000|Randomized Withdrawal Period|Adverse Event|0|||
156612683|NCT03073200|565322611|FG001|Randomized Withdrawal Period|Adverse Event|0|||
156612684|NCT03073200|565322612|FG002|Randomized Withdrawal Period|Adverse Event|0|||
156612685|NCT03073200|565322613|FG003|Randomized Withdrawal Period|Adverse Event|0|||
156612686|NCT03073200|565322614|FG004|Randomized Withdrawal Period|Adverse Event|0|||
156612687|NCT03073200|565322615|FG005|Randomized Withdrawal Period|Adverse Event|0|||
156612688|NCT03073200|565322616|FG006|Randomized Withdrawal Period|Adverse Event|0|||
156612689|NCT03073200|565322617|FG007|Randomized Withdrawal Period|Adverse Event|0|||
156612690|NCT03073200|565322618|FG008|Randomized Withdrawal Period|Adverse Event|0|||
156612691|NCT03073200|565322619|FG009|Randomized Withdrawal Period|Adverse Event|0|||
156612692|NCT03073200|565322620|FG010|Randomized Withdrawal Period|Adverse Event|1|||
156612693|NCT03073200|565322621|FG011|Randomized Withdrawal Period|Adverse Event|0|||
156612694|NCT03073200|565322622|FG012|Randomized Withdrawal Period|Adverse Event|0|||
156612695|NCT03073200|565322623|FG013|Randomized Withdrawal Period|Adverse Event|0|||
156612696|NCT03073200|565322624|FG014|Randomized Withdrawal Period|Adverse Event|0|||
156612697|NCT03073200|565322610|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612698|NCT03073200|565322611|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612699|NCT03073200|565322612|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612700|NCT03073200|565322613|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612701|NCT03073200|565322614|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612702|NCT03073200|565322615|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612703|NCT03073200|565322616|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612704|NCT03073200|565322617|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612705|NCT03073200|565322618|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612706|NCT03073200|565322619|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612707|NCT03073200|565322620|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612708|NCT03073200|565322621|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612709|NCT03073200|565322622|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612710|NCT03073200|565322623|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
156612711|NCT03073200|565322624|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
156612712|NCT03073200|565322610|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612713|NCT03073200|565322611|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612714|NCT03073200|565322612|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612715|NCT03073200|565322613|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612716|NCT03073200|565322614|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612717|NCT03073200|565322615|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612718|NCT03073200|565322616|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612719|NCT03073200|565322617|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156635009|NCT03917654|565407825|FG010|Year 2|Married|0|||
156612720|NCT03073200|565322618|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612721|NCT03073200|565322619|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612722|NCT03073200|565322620|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612723|NCT03073200|565322621|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612724|NCT03073200|565322622|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612725|NCT03073200|565322623|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
156612726|NCT03073200|565322624|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156612727|NCT03073200|565322610|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612728|NCT03073200|565322611|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612729|NCT03073200|565322612|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612730|NCT03073200|565322613|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612731|NCT03073200|565322614|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612732|NCT03073200|565322615|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612733|NCT03073200|565322616|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612734|NCT03073200|565322617|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612735|NCT03073200|565322618|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612736|NCT03073200|565322619|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612737|NCT03073200|565322620|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612738|NCT03073200|565322621|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612739|NCT03073200|565322622|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612740|NCT03073200|565322623|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
156612741|NCT03073200|565322624|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
156612742|NCT03073200|565322610|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612743|NCT03073200|565322611|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612744|NCT03073200|565322612|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612745|NCT03073200|565322613|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612746|NCT03073200|565322614|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612747|NCT03073200|565322615|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612748|NCT03073200|565322616|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612749|NCT03073200|565322617|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612750|NCT03073200|565322618|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612751|NCT03073200|565322619|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612752|NCT03073200|565322620|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612753|NCT03073200|565322621|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612754|NCT03073200|565322622|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612755|NCT03073200|565322623|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
156612756|NCT03073200|565322624|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
156612757|NCT03073200|565322610|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612758|NCT03073200|565322611|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612759|NCT03073200|565322612|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612760|NCT03073200|565322613|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612761|NCT03073200|565322614|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612762|NCT03073200|565322615|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612763|NCT03073200|565322616|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612764|NCT03073200|565322617|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612765|NCT03073200|565322618|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612766|NCT03073200|565322619|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612767|NCT03073200|565322620|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612768|NCT03073200|565322621|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612769|NCT03073200|565322622|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612770|NCT03073200|565322623|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
156612771|NCT03073200|565322624|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
156612772|NCT03073200|565322610|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612773|NCT03073200|565322611|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612774|NCT03073200|565322612|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612775|NCT03073200|565322613|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612776|NCT03073200|565322614|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612777|NCT03073200|565322615|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612778|NCT03073200|565322616|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612779|NCT03073200|565322617|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612780|NCT03073200|565322618|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612781|NCT03073200|565322619|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612782|NCT03073200|565322620|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612783|NCT03073200|565322621|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612784|NCT03073200|565322622|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612785|NCT03073200|565322623|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
156612786|NCT03073200|565322624|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
156612787|NCT03073200|565322610|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612788|NCT03073200|565322611|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612789|NCT03073200|565322612|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612790|NCT03073200|565322613|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612791|NCT03073200|565322614|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612792|NCT03073200|565322615|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612793|NCT03073200|565322616|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612794|NCT03073200|565322617|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612795|NCT03073200|565322618|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612796|NCT03073200|565322619|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612797|NCT03073200|565322620|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612798|NCT03073200|565322621|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612799|NCT03073200|565322622|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612800|NCT03073200|565322623|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
156612801|NCT03073200|565322624|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156612802|NCT03073200|565322610|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612803|NCT03073200|565322611|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612804|NCT03073200|565322612|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612805|NCT03073200|565322613|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612806|NCT03073200|565322614|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612807|NCT03073200|565322615|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612808|NCT03073200|565322616|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612809|NCT03073200|565322617|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612810|NCT03073200|565322618|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612811|NCT03073200|565322619|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612812|NCT03073200|565322620|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612813|NCT03073200|565322621|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612814|NCT03073200|565322622|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612815|NCT03073200|565322623|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
156612816|NCT03073200|565322624|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
156612817|NCT00901394|565322625|FG000|Overall Study|Physician Decision|1|||
156612818|NCT00901394|565322626|FG001|Overall Study|Physician Decision|1|||
156612819|NCT00901394|565322627|FG002|Overall Study|Physician Decision|2|||
156612820|NCT01474889|565322628|FG000|Overall Study|Physician Decision|1|||
156612821|NCT01474889|565322629|FG001|Overall Study|Physician Decision|0|||
156612822|NCT01474889|565322630|FG002|Overall Study|Physician Decision|0|||
156612823|NCT01474889|565322628|FG000|Overall Study|Did not meet inclusion|1|||
156612824|NCT01474889|565322629|FG001|Overall Study|Did not meet inclusion|0|||
156612825|NCT01474889|565322630|FG002|Overall Study|Did not meet inclusion|0|||
156612826|NCT01474889|565322628|FG000|Overall Study|Withdrawal by Subject|0|||
156612827|NCT01474889|565322629|FG001|Overall Study|Withdrawal by Subject|1|||
156612828|NCT01474889|565322630|FG002|Overall Study|Withdrawal by Subject|0|||
156612829|NCT02290340|565322633|FG000|Overall Study|Lost to Follow-up|0|||
156612830|NCT02290340|565322634|FG001|Overall Study|Lost to Follow-up|0|||
156612831|NCT02290340|565322635|FG002|Overall Study|Lost to Follow-up|0|||
156612832|NCT02290340|565322636|FG003|Overall Study|Lost to Follow-up|1|||
156612833|NCT02290340|565322633|FG000|Overall Study|Withdrawal by Subject|1|||
156612834|NCT02290340|565322634|FG001|Overall Study|Withdrawal by Subject|0|||
156612835|NCT02290340|565322635|FG002|Overall Study|Withdrawal by Subject|0|||
156612836|NCT02290340|565322636|FG003|Overall Study|Withdrawal by Subject|0|||
156612837|NCT02290340|565322633|FG000|Overall Study|Other|1|||
156612838|NCT02290340|565322634|FG001|Overall Study|Other|0|||
156612839|NCT02290340|565322635|FG002|Overall Study|Other|0|||
156612840|NCT02290340|565322636|FG003|Overall Study|Other|1|||
156612841|NCT04964557|565322639|FG000|Overall Study|Withdrawal by Subject|3|||
156612842|NCT04964557|565322640|FG001|Overall Study|Withdrawal by Subject|2|||
156612843|NCT04964557|565322639|FG000|Overall Study|Lost to Follow-up|1|||
156612844|NCT04964557|565322640|FG001|Overall Study|Lost to Follow-up|2|||
156612845|NCT04964557|565322639|FG000|Overall Study|Physician Decision|2|||
156612846|NCT04964557|565322640|FG001|Overall Study|Physician Decision|0|||
156612847|NCT04964557|565322639|FG000|Overall Study|Death|3|||
156612848|NCT04964557|565322640|FG001|Overall Study|Death|0|||
156612849|NCT04964557|565322639|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
156612850|NCT04964557|565322640|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
156612851|NCT03209362|565322642|FG000|Overall Study|Adverse Event|0|||
156612852|NCT03209362|565322643|FG001|Overall Study|Adverse Event|1|||
156612853|NCT03209362|565322642|FG000|Overall Study|Lost to Follow-up|0|||
156612854|NCT03209362|565322643|FG001|Overall Study|Lost to Follow-up|1|||
156612855|NCT03209362|565322642|FG000|Overall Study|Withdrawal by Subject|2|||
156612856|NCT03209362|565322643|FG001|Overall Study|Withdrawal by Subject|0|||
156612857|NCT03209362|565322642|FG000|Overall Study|Other|0|||
156612858|NCT03209362|565322643|FG001|Overall Study|Other|1|||
156612859|NCT00251589|565322644|FG000|Overall Study|Adverse Event|5|||
156612860|NCT00251589|565322645|FG001|Overall Study|Adverse Event|1|||
156612861|NCT00251589|565322646|FG002|Overall Study|Adverse Event|2|||
156612862|NCT00251589|565322647|FG003|Overall Study|Adverse Event|1|||
156612863|NCT00251589|565322644|FG000|Overall Study|Withdrawal by Subject|1|||
156612864|NCT00251589|565322645|FG001|Overall Study|Withdrawal by Subject|1|||
156612865|NCT00251589|565322646|FG002|Overall Study|Withdrawal by Subject|0|||
156612866|NCT00251589|565322647|FG003|Overall Study|Withdrawal by Subject|0|||
156612867|NCT00251589|565322644|FG000|Overall Study|Discontinued due to progressive disease|9|||
156612868|NCT00251589|565322645|FG001|Overall Study|Discontinued due to progressive disease|1|||
156612869|NCT00251589|565322646|FG002|Overall Study|Discontinued due to progressive disease|0|||
156612870|NCT00251589|565322647|FG003|Overall Study|Discontinued due to progressive disease|1|||
156612871|NCT04888507|565325344|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
156612872|NCT00636155|565325345|FG000|Overall Study|Adverse Event|8|||
156612873|NCT00636155|565325345|FG000|Overall Study|Lack of Efficacy|1|||
156612874|NCT00636155|565325345|FG000|Overall Study|Withdrawal by Subject|3|||
156612875|NCT00636155|565325345|FG000|Overall Study|Stem cell transplant|1|||
156612876|NCT00636155|565325345|FG000|Overall Study|Physician Decision|5|||
156612877|NCT00766142|565325346|FG000|Overall Study|Protocol Violation|4|||
156612878|NCT00777257|565325352|FG000|Overall Study|Adverse Event|3|||
156612879|NCT00777257|565325353|FG001|Overall Study|Adverse Event|1|||
156612880|NCT00777257|565325354|FG002|Overall Study|Adverse Event|0|||
156612881|NCT00777257|565325352|FG000|Overall Study|Lost to Follow-up|3|||
156612882|NCT00777257|565325353|FG001|Overall Study|Lost to Follow-up|3|||
156612883|NCT00777257|565325354|FG002|Overall Study|Lost to Follow-up|2|||
156612884|NCT00777257|565325352|FG000|Overall Study|Protocol Violation|2|||
156612885|NCT00777257|565325353|FG001|Overall Study|Protocol Violation|2|||
156612886|NCT00777257|565325354|FG002|Overall Study|Protocol Violation|2|||
156612887|NCT00777257|565325352|FG000|Overall Study|Withdrawal by Subject|3|||
156612888|NCT00777257|565325353|FG001|Overall Study|Withdrawal by Subject|6|||
156612889|NCT00777257|565325354|FG002|Overall Study|Withdrawal by Subject|5|||
156612890|NCT01431521|565325355|FG000|Overall Study|Withdrawal by Subject|0|||
156612891|NCT01431521|565325356|FG001|Overall Study|Withdrawal by Subject|0|||
156612892|NCT01431521|565325357|FG002|Overall Study|Withdrawal by Subject|1|||
156612893|NCT01431521|565325358|FG003|Overall Study|Withdrawal by Subject|0|||
156612894|NCT02000622|565325359|FG000|Overall Study|Withdrawal by Subject|5|||
156612895|NCT02000622|565325360|FG001|Overall Study|Withdrawal by Subject|7|||
156612896|NCT02000622|565325359|FG000|Overall Study|Lost to Follow-up|4|||
156612897|NCT02000622|565325360|FG001|Overall Study|Lost to Follow-up|0|||
156612898|NCT02000622|565325359|FG000|Overall Study|Death|159|||
156612899|NCT02000622|565325360|FG001|Overall Study|Death|73|||
156612900|NCT02000622|565325359|FG000|Overall Study|Withdrawn due to site closure|1|||
156612901|NCT02000622|565325360|FG001|Overall Study|Withdrawn due to site closure|0|||
156612902|NCT01405027|565325361|FG000|Overall Study|Withdrawn consent|3|||
156612903|NCT01405027|565325362|FG001|Overall Study|Withdrawn consent|0|||
156612904|NCT01405027|565325361|FG000|Overall Study|Lost to Follow-up|16|||
156612905|NCT01405027|565325362|FG001|Overall Study|Lost to Follow-up|24|||
156612906|NCT01405027|565325361|FG000|Overall Study|Investigator judgement|0|||
156612907|NCT01405027|565325362|FG001|Overall Study|Investigator judgement|2|||
156612908|NCT01405027|565325361|FG000|Overall Study|Death|1|||
156612909|NCT01405027|565325362|FG001|Overall Study|Death|0|||
156612910|NCT01405027|565325361|FG000|Overall Study|Other or Unknown|12|||
156612911|NCT01405027|565325362|FG001|Overall Study|Other or Unknown|25|||
156612912|NCT01938391|565325366|FG000|6 Month Follow up|Withdrawal by Subject|1|||
156612913|NCT01938391|565325366|FG000|12 Month Follow up|Physician Decision|1|||
156612914|NCT01938391|565325366|FG000|12 Month Follow up|Withdrawal by Subject|1|||
156612915|NCT01077193|565325367|FG000|Overall Study|Lost to Follow-up|1|||
156612916|NCT01077193|565325367|FG000|Overall Study|Withdrawal by Subject|2|||
156612917|NCT01077193|565325367|FG000|Overall Study|Lack of Efficacy|1|||
156612918|NCT01077193|565325367|FG000|Overall Study|Study Terminated by Sponsor|40|||
156612919|NCT04924114|565325371|FG000|Overall Study|Withdrawal by Subject|0|||
156612920|NCT04924114|565325372|FG001|Overall Study|Withdrawal by Subject|2|||
156612921|NCT04924114|565325373|FG002|Overall Study|Withdrawal by Subject|2|||
156612922|NCT04924114|565325374|FG003|Overall Study|Withdrawal by Subject|0|||
156612923|NCT04924114|565325375|FG004|Overall Study|Withdrawal by Subject|2|||
156612924|NCT04960202|565325376|FG000|Overall Study|Other|5|||
156612925|NCT04960202|565325377|FG001|Overall Study|Other|0|||
156612926|NCT04960202|565325376|FG000|Overall Study|Withdrawal by Subject|37|||
156612927|NCT04960202|565325377|FG001|Overall Study|Withdrawal by Subject|43|||
156612928|NCT04960202|565325376|FG000|Overall Study|Lost to Follow-up|20|||
156612929|NCT04960202|565325377|FG001|Overall Study|Lost to Follow-up|16|||
156612930|NCT04960202|565325376|FG000|Overall Study|Death|0|||
156612931|NCT04960202|565325377|FG001|Overall Study|Death|15|||
156612932|NCT03671148|565325378|FG000|Overall Study|Adverse Event|3|||
156612933|NCT03671148|565325379|FG001|Overall Study|Adverse Event|2|||
156612934|NCT03671148|565325378|FG000|Overall Study|Withdrawal by Subject|8|||
156612935|NCT03671148|565325379|FG001|Overall Study|Withdrawal by Subject|2|||
156612936|NCT03671148|565325378|FG000|Overall Study|Lost to Follow-up|1|||
156612937|NCT03671148|565325379|FG001|Overall Study|Lost to Follow-up|2|||
156612938|NCT03671148|565325378|FG000|Overall Study|Lack of Efficacy|7|||
156612939|NCT03671148|565325379|FG001|Overall Study|Lack of Efficacy|2|||
156612940|NCT03671148|565325378|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
156612941|NCT03671148|565325379|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
156612942|NCT03671148|565325378|FG000|Overall Study|Other|1|||
156612943|NCT03671148|565325379|FG001|Overall Study|Other|0|||
156612944|NCT03671148|565325378|FG000|Overall Study|Incomplete Randomization Visit|1|||
156612945|NCT03671148|565325379|FG001|Overall Study|Incomplete Randomization Visit|0|||
156612946|NCT00673816|565325382|FG000|Overall Study|Adverse Event|1|||
156612947|NCT00673816|565325382|FG000|Overall Study|Withdrawal by Subject|1|||
156612948|NCT01804842|565325383|FG000|Overall Study|Adverse Event|1|||
156612949|NCT01804842|565325384|FG001|Overall Study|Adverse Event|1|||
156612950|NCT01804842|565325385|FG002|Overall Study|Adverse Event|0|||
156612951|NCT01804842|565325383|FG000|Overall Study|Lost to Follow-up|1|||
156612952|NCT01804842|565325384|FG001|Overall Study|Lost to Follow-up|0|||
156612953|NCT01804842|565325385|FG002|Overall Study|Lost to Follow-up|0|||
156612954|NCT01804842|565325383|FG000|Overall Study|Non-Compliance|1|||
156612955|NCT01804842|565325384|FG001|Overall Study|Non-Compliance|1|||
156612956|NCT01804842|565325385|FG002|Overall Study|Non-Compliance|0|||
156612957|NCT01804842|565325383|FG000|Overall Study|Personal Reason|0|||
156612958|NCT01804842|565325384|FG001|Overall Study|Personal Reason|0|||
156612959|NCT01804842|565325385|FG002|Overall Study|Personal Reason|1|||
156612960|NCT03774875|565325387|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
156612961|NCT03774875|565325388|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
156612962|NCT03774875|565325387|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
156612963|NCT03774875|565325388|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
156612964|NCT03774875|565325387|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
156612965|NCT03774875|565325388|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
156612966|NCT03774875|565325387|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
156612967|NCT03774875|565325388|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
156612968|NCT03774875|565325387|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
156612969|NCT03774875|565325388|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
156612970|NCT03774875|565325387|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
156612971|NCT03774875|565325388|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
156612972|NCT03774875|565325387|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
156612973|NCT03774875|565325388|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
156612974|NCT03774875|565325387|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
156612975|NCT03774875|565325388|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
156612976|NCT03774875|565325387|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
156612977|NCT03774875|565325388|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
156612978|NCT03774875|565325387|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
156612979|NCT03774875|565325388|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
156612980|NCT03774875|565325387|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
156612981|NCT03774875|565325388|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
156612982|NCT03774875|565325387|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
156612983|NCT03774875|565325388|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
156612984|NCT03774875|565325387|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
156612985|NCT03774875|565325388|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
156612986|NCT02498392|565325389|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
156612987|NCT02498392|565325390|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
156612988|NCT02498392|565325389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
156612989|NCT02498392|565325390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
156612990|NCT02498392|565325389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
156612991|NCT02498392|565325390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
156612992|NCT02498392|565325389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
156612993|NCT02498392|565325390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
156612994|NCT02498392|565325389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
156612995|NCT02498392|565325390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
156612996|NCT02498392|565325389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
156612997|NCT02498392|565325390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
156612998|NCT02352090|565325391|FG000|Overall Study|general malaise|1|||
156612999|NCT02352090|565325392|FG001|Overall Study|general malaise|0|||
156613000|NCT02352090|565325393|FG002|Overall Study|general malaise|0|||
156613001|NCT02352090|565325391|FG000|Overall Study|non-specified mild side-effects|0|||
156613002|NCT02352090|565325392|FG001|Overall Study|non-specified mild side-effects|0|||
156613003|NCT02352090|565325393|FG002|Overall Study|non-specified mild side-effects|2|||
156613004|NCT03687827|565325394|FG000|Treatment Period 1|Death|0|||
156613005|NCT03687827|565325395|FG001|Treatment Period 1|Death|1|||
156613006|NCT03687827|565325394|FG000|Treatment Period 1|Lost to Follow-up|2|||
156613007|NCT03687827|565325395|FG001|Treatment Period 1|Lost to Follow-up|2|||
156613008|NCT03687827|565325394|FG000|Treatment Period 1|Physician Decision|5|||
156613009|NCT03687827|565325395|FG001|Treatment Period 1|Physician Decision|2|||
156613010|NCT03687827|565325394|FG000|Treatment Period 1|Withdrawal by Subject|7|||
156613011|NCT03687827|565325395|FG001|Treatment Period 1|Withdrawal by Subject|3|||
156613012|NCT03687827|565325394|FG000|Treatment Period 2|Physician Decision|4|||
156613013|NCT03687827|565325395|FG001|Treatment Period 2|Physician Decision|1|||
156613014|NCT03687827|565325394|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156613015|NCT03687827|565325395|FG001|Treatment Period 2|Withdrawal by Subject|2|||
156613016|NCT00413777|565325399|FG000|Fixed-dose Period|Lost to Follow-up|1|||
156613017|NCT00413777|565325400|FG001|Fixed-dose Period|Lost to Follow-up|1|||
156613018|NCT00413777|565325399|FG000|Fixed-dose Period|Adverse Event|2|||
156613019|NCT00413777|565325400|FG001|Fixed-dose Period|Adverse Event|1|||
156613020|NCT00413777|565325399|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
156613021|NCT00413777|565325400|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
156613022|NCT00413777|565325399|FG000|Fixed-dose Period|Withdrew Consent|0|||
156613023|NCT00413777|565325400|FG001|Fixed-dose Period|Withdrew Consent|1|||
156613024|NCT01678313|565325403|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
156613025|NCT01678313|565325404|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
156613026|NCT01678313|565325403|FG000|Completed the 3-month Therapy|Physician Decision|3|||
156613027|NCT01678313|565325404|FG001|Completed the 3-month Therapy|Physician Decision|4|||
156613028|NCT01678313|565325403|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
156613029|NCT01678313|565325404|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
156613030|NCT01678313|565325403|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
156613031|NCT01678313|565325404|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
156613032|NCT00981292|565325405|FG000|Day 1|Protocol Violation|1|||
156613033|NCT00981292|565325406|FG001|Day 1|Protocol Violation|0|||
156613034|NCT00981292|565325407|FG002|Day 1|Protocol Violation|0|||
156613035|NCT00981292|565325408|FG003|Day 1|Protocol Violation|0|||
156613036|NCT00981292|565325409|FG004|Day 1|Protocol Violation|0|||
156613037|NCT00981292|565325410|FG005|Day 1|Protocol Violation|2|||
156613038|NCT00981292|565325405|FG000|Day 2|Protocol Violation|2|||
156613039|NCT00981292|565325406|FG001|Day 2|Protocol Violation|0|||
156613040|NCT00981292|565325407|FG002|Day 2|Protocol Violation|0|||
156613041|NCT00981292|565325408|FG003|Day 2|Protocol Violation|0|||
156613042|NCT00981292|565325409|FG004|Day 2|Protocol Violation|0|||
156613043|NCT00981292|565325410|FG005|Day 2|Protocol Violation|0|||
156613044|NCT00981292|565325405|FG000|Day 3|Protocol Violation|0|||
156613045|NCT00981292|565325406|FG001|Day 3|Protocol Violation|0|||
156613046|NCT00981292|565325407|FG002|Day 3|Protocol Violation|0|||
156613047|NCT00981292|565325408|FG003|Day 3|Protocol Violation|0|||
156613048|NCT00981292|565325409|FG004|Day 3|Protocol Violation|0|||
156613049|NCT00981292|565325410|FG005|Day 3|Protocol Violation|1|||
156613050|NCT03377452|565325411|FG000|Overall Study|Refused assessment|0|||
156613051|NCT03377452|565325412|FG001|Overall Study|Refused assessment|2|||
156613052|NCT03377452|565325411|FG000|Overall Study|Lost to Follow-up|5|||
156613053|NCT03377452|565325412|FG001|Overall Study|Lost to Follow-up|4|||
156613054|NCT05179057|565325413|FG000|Overall Study|Adverse Event|3|||
156613055|NCT05179057|565325414|FG001|Overall Study|Adverse Event|2|||
156613056|NCT05179057|565325413|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
156613057|NCT05179057|565325414|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
156613058|NCT05179057|565325413|FG000|Overall Study|Study terminated|13|||
156613059|NCT05179057|565325414|FG001|Overall Study|Study terminated|7|||
156613060|NCT05179057|565325413|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
156613061|NCT05179057|565325414|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
156613062|NCT05179057|565325413|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
156613063|NCT05179057|565325414|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
156613064|NCT02782104|565325417|FG000|Overall Study|Other|215|||
156613065|NCT02782104|565325417|FG000|Overall Study|Induction Day 28 Non Responder|9|||
156613066|NCT02782104|565325417|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156613067|NCT02782104|565325417|FG000|Overall Study|Death|8|||
156613068|NCT02782104|565325417|FG000|Overall Study|Pregnancy|6|||
156613069|NCT02782104|565325417|FG000|Overall Study|Withdrawal by Subject|63|||
156613070|NCT02782104|565325417|FG000|Overall Study|Protocol Violation|7|||
156613071|NCT02782104|565325417|FG000|Overall Study|Lack of Efficacy|61|||
156613072|NCT02782104|565325417|FG000|Overall Study|Lost to Follow-up|23|||
156613073|NCT02782104|565325417|FG000|Overall Study|Adverse Event|74|||
156613074|NCT03464136|565325418|FG000|Overall Study|Lost to Follow-up|5|||
156613075|NCT03464136|565325419|FG001|Overall Study|Lost to Follow-up|8|||
156613076|NCT03464136|565325418|FG000|Overall Study|Withdrawal by Subject|16|||
156613077|NCT03464136|565325419|FG001|Overall Study|Withdrawal by Subject|13|||
156613078|NCT03464136|565325418|FG000|Overall Study|Death|1|||
156613079|NCT03464136|565325419|FG001|Overall Study|Death|0|||
156613080|NCT03464136|565325418|FG000|Overall Study|Other|8|||
156613081|NCT03464136|565325419|FG001|Overall Study|Other|4|||
156613082|NCT02438787|565325420|FG000|Overall Study|Adverse Event|1|||
156613083|NCT02438787|565325421|FG001|Overall Study|Adverse Event|0|||
156613084|NCT02438787|565325422|FG002|Overall Study|Adverse Event|2|||
156613085|NCT02438787|565325420|FG000|Overall Study|Lack of Efficacy|1|||
156613086|NCT02438787|565325421|FG001|Overall Study|Lack of Efficacy|2|||
156613087|NCT02438787|565325422|FG002|Overall Study|Lack of Efficacy|0|||
156613088|NCT02438787|565325420|FG000|Overall Study|Lost to Follow-up|0|||
156613089|NCT02438787|565325421|FG001|Overall Study|Lost to Follow-up|1|||
156613090|NCT02438787|565325422|FG002|Overall Study|Lost to Follow-up|0|||
156613091|NCT02438787|565325420|FG000|Overall Study|Protocol Violation|0|||
156613092|NCT02438787|565325421|FG001|Overall Study|Protocol Violation|0|||
156613093|NCT02438787|565325422|FG002|Overall Study|Protocol Violation|1|||
156613094|NCT02438787|565325420|FG000|Overall Study|Withdrawal by Subject|15|||
156613095|NCT02438787|565325421|FG001|Overall Study|Withdrawal by Subject|7|||
156613096|NCT02438787|565325422|FG002|Overall Study|Withdrawal by Subject|10|||
156613097|NCT02438787|565325420|FG000|Overall Study|Study discontinued by sponsor|64|||
156613098|NCT02438787|565325421|FG001|Overall Study|Study discontinued by sponsor|72|||
156613099|NCT02438787|565325422|FG002|Overall Study|Study discontinued by sponsor|69|||
156613100|NCT02438787|565325420|FG000|Overall Study|Other|0|||
156613101|NCT02438787|565325421|FG001|Overall Study|Other|1|||
156613102|NCT02438787|565325422|FG002|Overall Study|Other|0|||
156613103|NCT02438787|565325420|FG000|Overall Study|Site terminated by sponsor|0|||
156613104|NCT02438787|565325421|FG001|Overall Study|Site terminated by sponsor|0|||
156613105|NCT02438787|565325422|FG002|Overall Study|Site terminated by sponsor|1|||
156613106|NCT03412565|565325423|FG000|Overall Study|Lost to Follow-up|0|||
156613107|NCT03412565|565325424|FG001|Overall Study|Lost to Follow-up|0|||
156613108|NCT03412565|565325425|FG002|Overall Study|Lost to Follow-up|1|||
156613109|NCT03412565|565325426|FG003|Overall Study|Lost to Follow-up|0|||
156613110|NCT03412565|565325423|FG000|Overall Study|Physician Decision|0|||
156613111|NCT03412565|565325424|FG001|Overall Study|Physician Decision|0|||
156613112|NCT03412565|565325425|FG002|Overall Study|Physician Decision|0|||
156613113|NCT03412565|565325426|FG003|Overall Study|Physician Decision|1|||
156613114|NCT03412565|565325423|FG000|Overall Study|Withdrawal by Subject|0|||
156613115|NCT03412565|565325424|FG001|Overall Study|Withdrawal by Subject|4|||
156613116|NCT03412565|565325425|FG002|Overall Study|Withdrawal by Subject|5|||
156613117|NCT03412565|565325426|FG003|Overall Study|Withdrawal by Subject|5|||
156613118|NCT03412565|565325423|FG000|Overall Study|Death|1|||
156613119|NCT03412565|565325424|FG001|Overall Study|Death|3|||
156613120|NCT03412565|565325425|FG002|Overall Study|Death|4|||
156613121|NCT03412565|565325426|FG003|Overall Study|Death|5|||
156613122|NCT03412565|565325423|FG000|Overall Study|Data collection ended|0|||
156613123|NCT03412565|565325424|FG001|Overall Study|Data collection ended|41|||
156613124|NCT03412565|565325425|FG002|Overall Study|Data collection ended|41|||
156613125|NCT03412565|565325426|FG003|Overall Study|Data collection ended|40|||
156613126|NCT03375203|565325427|FG000|Overall Study|Protocol Violation|0|||
156613127|NCT03375203|565325428|FG001|Overall Study|Protocol Violation|0|||
156613128|NCT03375203|565325429|FG002|Overall Study|Protocol Violation|1|||
156613129|NCT03375203|565325430|FG003|Overall Study|Protocol Violation|0|||
156613130|NCT03375203|565325431|FG004|Overall Study|Protocol Violation|0|||
156613131|NCT03375203|565325427|FG000|Overall Study|Adverse Event|2|||
156613132|NCT03375203|565325428|FG001|Overall Study|Adverse Event|3|||
156613133|NCT03375203|565325429|FG002|Overall Study|Adverse Event|0|||
156613134|NCT03375203|565325430|FG003|Overall Study|Adverse Event|2|||
156613135|NCT03375203|565325431|FG004|Overall Study|Adverse Event|2|||
156613136|NCT03375203|565325427|FG000|Overall Study|Withdrawal by Subject|3|||
156613137|NCT03375203|565325428|FG001|Overall Study|Withdrawal by Subject|0|||
156613138|NCT03375203|565325429|FG002|Overall Study|Withdrawal by Subject|1|||
156613139|NCT03375203|565325430|FG003|Overall Study|Withdrawal by Subject|0|||
156613140|NCT03375203|565325431|FG004|Overall Study|Withdrawal by Subject|2|||
156613141|NCT03375203|565325427|FG000|Overall Study|Non-compliance with study drug|1|||
156613142|NCT03375203|565325428|FG001|Overall Study|Non-compliance with study drug|0|||
156613143|NCT03375203|565325429|FG002|Overall Study|Non-compliance with study drug|0|||
156613144|NCT03375203|565325430|FG003|Overall Study|Non-compliance with study drug|0|||
156613145|NCT03375203|565325431|FG004|Overall Study|Non-compliance with study drug|0|||
156613146|NCT03375203|565325427|FG000|Overall Study|Randomized, not treated.|0|||
156613147|NCT03375203|565325428|FG001|Overall Study|Randomized, not treated.|1|||
156613148|NCT03375203|565325429|FG002|Overall Study|Randomized, not treated.|0|||
156613149|NCT03375203|565325430|FG003|Overall Study|Randomized, not treated.|0|||
156613150|NCT03375203|565325431|FG004|Overall Study|Randomized, not treated.|0|||
156613151|NCT03107793|565325432|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
156613152|NCT03107793|565325433|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
156635010|NCT03917654|565407826|FG011|Year 2|Married|0|||
156613153|NCT03107793|565325434|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
156613154|NCT03107793|565325435|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
156613155|NCT03107793|565325436|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
156613156|NCT03107793|565325432|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
156613157|NCT03107793|565325433|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
156613158|NCT03107793|565325434|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
156613159|NCT03107793|565325435|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
156613160|NCT03107793|565325436|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
156613161|NCT03107793|565325432|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
156613162|NCT03107793|565325433|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
156613163|NCT03107793|565325434|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
156613164|NCT03107793|565325435|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
156613165|NCT03107793|565325436|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
156613166|NCT03107793|565325432|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
156613167|NCT03107793|565325433|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156613168|NCT03107793|565325434|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156613169|NCT03107793|565325435|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156613170|NCT03107793|565325436|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156613171|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156613172|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
156613173|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
156613174|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156613175|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156613176|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156613177|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
156613178|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
156613179|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156613180|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156613181|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
156613182|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
156613183|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
156613184|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
156613185|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
156613186|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156613187|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
156613188|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
156613189|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156613190|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156613191|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
156613192|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
156613193|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
156613194|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
156613195|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
156613196|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
156613197|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
156613198|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
156613199|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
156613200|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
156613201|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156613202|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
156613203|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156613204|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156613205|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156613206|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
156613207|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
156613208|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
156613209|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
156613210|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
156613211|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
156613212|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
156613213|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
156613214|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
156613215|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
156613216|NCT03107793|565325432|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
156613217|NCT03107793|565325433|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
156613218|NCT03107793|565325434|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
156613219|NCT03107793|565325435|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
156613220|NCT03107793|565325436|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
156613221|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
156613222|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
156613223|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
156613224|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
156613225|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
156613226|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
156613227|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
156613228|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
156613229|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
156613230|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
156613231|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
156613232|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
156613233|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
156613234|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
156613235|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
156613236|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Death|0|||
156613237|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Death|0|||
156613238|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Death|0|||
156613239|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Death|0|||
156613240|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Death|1|||
156613241|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
156613242|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
156613243|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
156613244|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
156613245|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
156613246|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
156613247|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
156613248|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
156613249|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
156613250|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
156613251|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
156613252|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
156613253|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
156613254|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
156613255|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
156613256|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
156613257|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
156613258|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
156613259|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
156613260|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
156613261|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
156613262|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
156613263|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
156613264|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
156613265|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
156613266|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Other|0|||
156613267|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Other|0|||
156613268|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Other|0|||
156613269|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Other|1|||
156613270|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Other|3|||
156613271|NCT03107793|565325432|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
156613272|NCT03107793|565325433|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
156613273|NCT03107793|565325434|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
156613274|NCT03107793|565325435|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
156613275|NCT03107793|565325436|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
156613276|NCT03277105|565325437|FG000|Overall Study|Death|129|||
156613277|NCT03277105|565325438|FG001|Overall Study|Death|124|||
156613278|NCT03277105|565325437|FG000|Overall Study|Lost to Follow-up|2|||
156613279|NCT03277105|565325438|FG001|Overall Study|Lost to Follow-up|4|||
156613280|NCT03277105|565325437|FG000|Overall Study|Withdrawal by Subject|10|||
156613281|NCT03277105|565325438|FG001|Overall Study|Withdrawal by Subject|10|||
156613282|NCT03277105|565325437|FG000|Overall Study|Other|118|||
156613283|NCT03277105|565325438|FG001|Overall Study|Other|125|||
156613284|NCT05180721|565325442|FG000|Overall Study|Lost to Follow-up|4|||
156613285|NCT01872897|565325450|FG000|Overall Study|Withdrawal by Subject|1|||
156613286|NCT01872897|565325451|FG001|Overall Study|Withdrawal by Subject|0|||
156613287|NCT02040857|565325452|FG000|Overall Study|Adverse Event|14|||
156613288|NCT02040857|565325452|FG000|Overall Study|Physician Decision|5|||
156613289|NCT02040857|565325452|FG000|Overall Study|Withdrawal by Subject|31|||
156613290|NCT02040857|565325452|FG000|Overall Study|patient non-compliance|3|||
156613291|NCT02040857|565325452|FG000|Overall Study|Lost to Follow-up|2|||
156613292|NCT02040857|565325452|FG000|Overall Study|recurrence|4|||
156613293|NCT02040857|565325452|FG000|Overall Study|ineligible|1|||
156613294|NCT03146403|565325458|FG000|Overall Study|Withdrawal by Subject|0|||
156613295|NCT03146403|565325459|FG001|Overall Study|Withdrawal by Subject|3|||
156613296|NCT03146403|565325458|FG000|Overall Study|Lost to Follow-up|2|||
156613297|NCT03146403|565325459|FG001|Overall Study|Lost to Follow-up|0|||
156613298|NCT01024920|565325460|FG000|Overall Study|Progressive disease|47|||
156613299|NCT01024920|565325461|FG001|Overall Study|Progressive disease|25|||
156613300|NCT01024920|565325460|FG000|Overall Study|Adverse Event|8|||
156613301|NCT01024920|565325461|FG001|Overall Study|Adverse Event|4|||
156613302|NCT01024920|565325460|FG000|Overall Study|Lost to Follow-up|0|||
156613303|NCT01024920|565325461|FG001|Overall Study|Lost to Follow-up|1|||
156613304|NCT01024920|565325460|FG000|Overall Study|Patient refusal to continue|4|||
156613305|NCT01024920|565325461|FG001|Overall Study|Patient refusal to continue|0|||
156613306|NCT01024920|565325460|FG000|Overall Study|Other than listed|5|||
156613307|NCT01024920|565325461|FG001|Overall Study|Other than listed|1|||
156613308|NCT01024920|565325460|FG000|Overall Study|Not treated|3|||
156613309|NCT01024920|565325461|FG001|Overall Study|Not treated|0|||
156613310|NCT01024920|565325460|FG000|Overall Study|Protocol Violation|0|||
156613311|NCT01024920|565325461|FG001|Overall Study|Protocol Violation|1|||
156613312|NCT02182999|565325463|FG000|Overall Study|Adverse Event|4|||
156613313|NCT02182999|565325464|FG001|Overall Study|Adverse Event|3|||
156613314|NCT02182999|565325463|FG000|Overall Study|Physician Decision|1|||
156613315|NCT02182999|565325464|FG001|Overall Study|Physician Decision|0|||
156613316|NCT02348840|565325470|FG000|Overall Study|Withdrawal by Subject|2|||
156613317|NCT02348840|565325471|FG001|Overall Study|Withdrawal by Subject|1|||
156613318|NCT02348840|565325472|FG002|Overall Study|Withdrawal by Subject|0|||
156613319|NCT02348840|565325473|FG003|Overall Study|Withdrawal by Subject|0|||
156613320|NCT00373880|565325474|FG000|Overall Study|Physician Decision|3|||
156613321|NCT00373880|565325474|FG000|Overall Study|Arrested|1|||
156613322|NCT00373880|565325474|FG000|Overall Study|Protocol Violation|14|||
156613323|NCT02865928|565325482|FG000|Overall Study|Withdrawal by Subject|1|||
156613324|NCT02865928|565325483|FG001|Overall Study|Withdrawal by Subject|0|||
156613325|NCT02865928|565325482|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
156613326|NCT02865928|565325483|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
156613327|NCT02865928|565325482|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
156613328|NCT02865928|565325483|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
156613329|NCT03152110|565325484|FG000|Overall Study|Withdrawal by Subject|3|||
156613330|NCT00552344|565325489|FG000|Overall Study|Lack of Efficacy|55|||
156613331|NCT00552344|565325489|FG000|Overall Study|Loss of efficacy|75|||
156613332|NCT00552344|565325489|FG000|Overall Study|Lost to Follow-up|8|||
156613333|NCT00552344|565325489|FG000|Overall Study|Withdrawal by Subject|48|||
156613334|NCT00552344|565325489|FG000|Overall Study|SAE, non-fatal|6|||
156613335|NCT00552344|565325489|FG000|Overall Study|AE, non-serious non-fatal|38|||
156613336|NCT00552344|565325489|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
156613337|NCT00552344|565325489|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
156613338|NCT00552344|565325489|FG000|Overall Study|Other Reason|22|||
156613339|NCT01634100|565325490|FG000|Overall Study|Withdrawal by Subject|1|||
156613340|NCT01634100|565325491|FG001|Overall Study|Withdrawal by Subject|0|||
156613341|NCT01634100|565325492|FG002|Overall Study|Withdrawal by Subject|1|||
156613342|NCT01634100|565325493|FG003|Overall Study|Withdrawal by Subject|0|||
156613343|NCT01634100|565325494|FG004|Overall Study|Withdrawal by Subject|0|||
156613344|NCT01634100|565325495|FG005|Overall Study|Withdrawal by Subject|0|||
156613345|NCT00471276|565325496|FG000|Overall Study|Death|2|||
156613346|NCT00471276|565325496|FG000|Overall Study|Adverse Event|16|||
156613347|NCT00471276|565325496|FG000|Overall Study|Protocol Violation|1|||
156613348|NCT00471276|565325496|FG000|Overall Study|Objective progression or relapse|54|||
156613349|NCT00471276|565325496|FG000|Overall Study|Global deterioration of health status|1|||
156613350|NCT00471276|565325496|FG000|Overall Study|Other|3|||
156613351|NCT00471276|565325496|FG000|Overall Study|Refused treatment|6|||
156613352|NCT00338806|565325497|FG000|Acute Phase|Withdrawal by Subject|0|||
156613353|NCT00338806|565325498|FG001|Acute Phase|Withdrawal by Subject|1|||
156613354|NCT00338806|565325497|FG000|Follow-up|Lost to Follow-up|1|||
156613355|NCT00338806|565325498|FG001|Follow-up|Lost to Follow-up|3|||
156613356|NCT00744991|565325501|FG000|Overall Study|Progressive Disease|11|||
156613357|NCT00744991|565325501|FG000|Overall Study|Withdrawal by Subject|8|||
156613358|NCT00744991|565325501|FG000|Overall Study|Physician Decision|3|||
156613359|NCT00744991|565325501|FG000|Overall Study|Adverse Event|2|||
156613360|NCT00744991|565325501|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
156613361|NCT01662986|565325504|FG000|Overall Study|Adverse Event|5|||
156613362|NCT01662986|565325505|FG001|Overall Study|Adverse Event|4|||
156613363|NCT01662986|565325504|FG000|Overall Study|Protocol Violation|2|||
156613364|NCT01662986|565325505|FG001|Overall Study|Protocol Violation|3|||
156613365|NCT01662986|565325504|FG000|Overall Study|Lost to Follow-up|5|||
156613366|NCT01662986|565325505|FG001|Overall Study|Lost to Follow-up|4|||
156613367|NCT01662986|565325504|FG000|Overall Study|Withdrawal by Subject|2|||
156613368|NCT01662986|565325505|FG001|Overall Study|Withdrawal by Subject|2|||
156613369|NCT01662986|565325504|FG000|Overall Study|Not Treated|1|||
156613370|NCT01662986|565325505|FG001|Overall Study|Not Treated|0|||
156613371|NCT01662986|565325504|FG000|Overall Study|Other than stated above|3|||
156613372|NCT01662986|565325505|FG001|Overall Study|Other than stated above|0|||
156613373|NCT01624467|565325506|FG000|Overall Study|Withdrawal by Subject|2|||
156613374|NCT01624467|565325506|FG000|Overall Study|Lost to Follow-up|1|||
156613375|NCT01624467|565325506|FG000|Overall Study|Adverse Event|7|||
156613376|NCT01624467|565325506|FG000|Overall Study|Progressive Disease|19|||
156613377|NCT01624467|565325506|FG000|Overall Study|Per Sponsor Requirement|1|||
156613378|NCT01624467|565325506|FG000|Overall Study|Subject Withdrew from Treatment|1|||
156613379|NCT03964493|565325507|FG000|Overall Study|Withdrawal by Subject|4|||
156613380|NCT03964493|565325508|FG001|Overall Study|Withdrawal by Subject|1|||
156613381|NCT03964493|565325507|FG000|Overall Study|Lost to Follow-up|13|||
156613382|NCT03964493|565325508|FG001|Overall Study|Lost to Follow-up|4|||
156613383|NCT02493868|565325517|FG000|Induction Phase: DE Participants|Adverse Event|22|||
156613384|NCT02493868|565325518|FG001|Induction Phase: DE Participants|Adverse Event|0|||
156613385|NCT02493868|565325517|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
156613386|NCT02493868|565325518|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
156613387|NCT02493868|565325517|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
156613388|NCT02493868|565325518|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
156613389|NCT02493868|565325517|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
156613390|NCT02493868|565325518|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
156613391|NCT02493868|565325517|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
156613392|NCT02493868|565325518|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
156613393|NCT02493868|565325517|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
156613394|NCT02493868|565325518|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
156613395|NCT02493868|565325517|FG000|Induction Phase: DE Participants|Other|8|||
156613396|NCT02493868|565325518|FG001|Induction Phase: DE Participants|Other|0|||
156613397|NCT02493868|565325517|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
156613398|NCT02493868|565325518|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
156613399|NCT02493868|565325517|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
156613400|NCT02493868|565325518|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
156613401|NCT02493868|565325517|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
156613402|NCT02493868|565325518|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
156613403|NCT02493868|565325517|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
156613404|NCT02493868|565325518|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
156613405|NCT02493868|565325517|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
156613406|NCT02493868|565325518|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
156613407|NCT02493868|565325517|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
156613408|NCT02493868|565325518|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
156613409|NCT02493868|565325517|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
156613410|NCT02493868|565325518|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
156613411|NCT02493868|565325517|FG000|Optimization Phase: DE+TE Participants|Other|10|||
156613412|NCT02493868|565325518|FG001|Optimization Phase: DE+TE Participants|Other|2|||
156613413|NCT02493868|565325517|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
156613414|NCT02493868|565325518|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
156613415|NCT02493868|565325517|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
156613416|NCT02493868|565325518|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
156613417|NCT02493868|565325517|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
156613418|NCT02493868|565325518|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
156613419|NCT02493868|565325517|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
156613420|NCT02493868|565325518|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
156613421|NCT02493868|565325517|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
156613422|NCT02493868|565325518|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
156613423|NCT02493868|565325517|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
156613424|NCT02493868|565325518|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
156613425|NCT02493868|565325517|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
156613426|NCT02493868|565325518|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
156613427|NCT02493868|565325517|FG000|Follow-up Phase|Lost to Follow-up|1|||
156613428|NCT02493868|565325518|FG001|Follow-up Phase|Lost to Follow-up|0|||
156613429|NCT02493868|565325517|FG000|Follow-up Phase|Withdrawal by Subject|3|||
156613430|NCT02493868|565325518|FG001|Follow-up Phase|Withdrawal by Subject|0|||
156613431|NCT02493868|565325517|FG000|Follow-up Phase|Investigator Decision|5|||
156613432|NCT02493868|565325518|FG001|Follow-up Phase|Investigator Decision|1|||
156613433|NCT02493868|565325517|FG000|Follow-up Phase|Other|2|||
156613434|NCT02493868|565325518|FG001|Follow-up Phase|Other|1|||
156613435|NCT02407236|565325519|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
156613436|NCT02407236|565325520|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
156613437|NCT02407236|565325521|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
156613438|NCT02407236|565325522|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
156613439|NCT02407236|565325523|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
156613440|NCT02407236|565325524|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
156613441|NCT02407236|565325525|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
156613442|NCT02407236|565325526|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
156613443|NCT02407236|565325527|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
156613444|NCT02407236|565325528|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
156613445|NCT02407236|565325529|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
156613446|NCT02407236|565325530|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
156613447|NCT02407236|565325531|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
156613448|NCT02407236|565325519|FG000|Induction Study (8 Weeks)|Death|0|||
156613449|NCT02407236|565325520|FG001|Induction Study (8 Weeks)|Death|0|||
156613450|NCT02407236|565325521|FG002|Induction Study (8 Weeks)|Death|1|||
156613451|NCT02407236|565325522|FG003|Induction Study (8 Weeks)|Death|0|||
156613452|NCT02407236|565325523|FG004|Induction Study (8 Weeks)|Death|0|||
156613453|NCT02407236|565325524|FG005|Induction Study (8 Weeks)|Death|0|||
156613454|NCT02407236|565325525|FG006|Induction Study (8 Weeks)|Death|0|||
156613455|NCT02407236|565325526|FG007|Induction Study (8 Weeks)|Death|0|||
156613456|NCT02407236|565325527|FG008|Induction Study (8 Weeks)|Death|0|||
156613457|NCT02407236|565325528|FG009|Induction Study (8 Weeks)|Death|0|||
156613458|NCT02407236|565325529|FG010|Induction Study (8 Weeks)|Death|0|||
156613459|NCT02407236|565325530|FG011|Induction Study (8 Weeks)|Death|0|||
156613460|NCT02407236|565325531|FG012|Induction Study (8 Weeks)|Death|0|||
156613461|NCT02407236|565325519|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
156613462|NCT02407236|565325520|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
156613463|NCT02407236|565325521|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
156613464|NCT02407236|565325522|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613465|NCT02407236|565325523|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613466|NCT02407236|565325524|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613467|NCT02407236|565325525|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613468|NCT02407236|565325526|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613469|NCT02407236|565325527|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613470|NCT02407236|565325528|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613471|NCT02407236|565325529|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613472|NCT02407236|565325530|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613473|NCT02407236|565325531|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
156613474|NCT02407236|565325519|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613475|NCT02407236|565325520|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613476|NCT02407236|565325521|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
156613477|NCT02407236|565325522|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613478|NCT02407236|565325523|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613479|NCT02407236|565325524|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613480|NCT02407236|565325525|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613481|NCT02407236|565325526|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613482|NCT02407236|565325527|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613483|NCT02407236|565325528|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613484|NCT02407236|565325529|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613485|NCT02407236|565325530|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613486|NCT02407236|565325531|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
156613487|NCT02407236|565325519|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
156613488|NCT02407236|565325520|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
156613489|NCT02407236|565325521|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
156613490|NCT02407236|565325522|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
156613491|NCT02407236|565325523|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
156613492|NCT02407236|565325524|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
156613493|NCT02407236|565325525|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
156613494|NCT02407236|565325526|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
156613495|NCT02407236|565325527|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
156613496|NCT02407236|565325528|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
156613497|NCT02407236|565325529|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
156613498|NCT02407236|565325530|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
156613499|NCT02407236|565325531|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
156613500|NCT02407236|565325519|FG000|Induction Study (8 Weeks)|Other|2|||
156613501|NCT02407236|565325520|FG001|Induction Study (8 Weeks)|Other|1|||
156613502|NCT02407236|565325521|FG002|Induction Study (8 Weeks)|Other|5|||
156613503|NCT02407236|565325522|FG003|Induction Study (8 Weeks)|Other|0|||
156613504|NCT02407236|565325523|FG004|Induction Study (8 Weeks)|Other|0|||
156613505|NCT02407236|565325524|FG005|Induction Study (8 Weeks)|Other|0|||
156613506|NCT02407236|565325525|FG006|Induction Study (8 Weeks)|Other|0|||
156613507|NCT02407236|565325526|FG007|Induction Study (8 Weeks)|Other|0|||
156613508|NCT02407236|565325527|FG008|Induction Study (8 Weeks)|Other|0|||
156613509|NCT02407236|565325528|FG009|Induction Study (8 Weeks)|Other|0|||
156613510|NCT02407236|565325529|FG010|Induction Study (8 Weeks)|Other|0|||
156613511|NCT02407236|565325530|FG011|Induction Study (8 Weeks)|Other|0|||
156613512|NCT02407236|565325531|FG012|Induction Study (8 Weeks)|Other|0|||
156613513|NCT02407236|565325519|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
156613514|NCT02407236|565325520|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
156613515|NCT02407236|565325521|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
156613516|NCT02407236|565325522|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
156613517|NCT02407236|565325523|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
156613518|NCT02407236|565325524|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
156613519|NCT02407236|565325525|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
156613520|NCT02407236|565325526|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
156613521|NCT02407236|565325527|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
156613522|NCT02407236|565325528|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
156613523|NCT02407236|565325529|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
156613524|NCT02407236|565325530|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
156613525|NCT02407236|565325531|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
156613526|NCT02407236|565325519|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
156613527|NCT02407236|565325520|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
156613528|NCT02407236|565325521|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
156613529|NCT02407236|565325522|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
156613530|NCT02407236|565325523|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
156613531|NCT02407236|565325524|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
156613532|NCT02407236|565325525|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
156613533|NCT02407236|565325526|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
156613534|NCT02407236|565325527|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
156613535|NCT02407236|565325528|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
156613536|NCT02407236|565325529|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
156613537|NCT02407236|565325530|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
156613538|NCT02407236|565325531|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
156613539|NCT02407236|565325519|FG000|Maintenance Study (44 Weeks)|Other|0|||
156613540|NCT02407236|565325520|FG001|Maintenance Study (44 Weeks)|Other|0|||
156613541|NCT02407236|565325521|FG002|Maintenance Study (44 Weeks)|Other|0|||
156613542|NCT02407236|565325522|FG003|Maintenance Study (44 Weeks)|Other|5|||
156613543|NCT02407236|565325523|FG004|Maintenance Study (44 Weeks)|Other|7|||
156613544|NCT02407236|565325524|FG005|Maintenance Study (44 Weeks)|Other|8|||
156613545|NCT02407236|565325525|FG006|Maintenance Study (44 Weeks)|Other|4|||
156613546|NCT02407236|565325526|FG007|Maintenance Study (44 Weeks)|Other|6|||
156613547|NCT02407236|565325527|FG008|Maintenance Study (44 Weeks)|Other|0|||
156613548|NCT02407236|565325528|FG009|Maintenance Study (44 Weeks)|Other|0|||
156613549|NCT02407236|565325529|FG010|Maintenance Study (44 Weeks)|Other|0|||
156613550|NCT02407236|565325530|FG011|Maintenance Study (44 Weeks)|Other|0|||
156613551|NCT02407236|565325531|FG012|Maintenance Study (44 Weeks)|Other|0|||
156613552|NCT02407236|565325519|FG000|Maintenance Study (44 Weeks)|Death|0|||
156613553|NCT02407236|565325520|FG001|Maintenance Study (44 Weeks)|Death|0|||
156613554|NCT02407236|565325521|FG002|Maintenance Study (44 Weeks)|Death|0|||
156613555|NCT02407236|565325522|FG003|Maintenance Study (44 Weeks)|Death|0|||
156613556|NCT02407236|565325523|FG004|Maintenance Study (44 Weeks)|Death|0|||
156613557|NCT02407236|565325524|FG005|Maintenance Study (44 Weeks)|Death|0|||
156613558|NCT02407236|565325525|FG006|Maintenance Study (44 Weeks)|Death|0|||
156613559|NCT02407236|565325526|FG007|Maintenance Study (44 Weeks)|Death|1|||
156613560|NCT02407236|565325527|FG008|Maintenance Study (44 Weeks)|Death|0|||
156613561|NCT02407236|565325528|FG009|Maintenance Study (44 Weeks)|Death|0|||
156613562|NCT02407236|565325529|FG010|Maintenance Study (44 Weeks)|Death|0|||
156613563|NCT02407236|565325530|FG011|Maintenance Study (44 Weeks)|Death|0|||
156613564|NCT02407236|565325531|FG012|Maintenance Study (44 Weeks)|Death|0|||
156613565|NCT02407236|565325519|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
156613566|NCT02407236|565325520|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
156613567|NCT02407236|565325521|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
156613568|NCT02407236|565325522|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
156613569|NCT02407236|565325523|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
156613570|NCT02407236|565325524|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
156613571|NCT02407236|565325525|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
156613572|NCT02407236|565325526|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
156613573|NCT02407236|565325527|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
156613574|NCT02407236|565325528|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
156613575|NCT02407236|565325529|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
156613576|NCT02407236|565325530|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
156613577|NCT02407236|565325531|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
156613578|NCT02407236|565325519|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613579|NCT02407236|565325520|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613580|NCT02407236|565325521|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613581|NCT02407236|565325522|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613582|NCT02407236|565325523|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613583|NCT02407236|565325524|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613584|NCT02407236|565325525|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613585|NCT02407236|565325526|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613586|NCT02407236|565325527|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613587|NCT02407236|565325528|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613588|NCT02407236|565325529|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
156613589|NCT02407236|565325530|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613590|NCT02407236|565325531|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
156613591|NCT02407236|565325519|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
156613592|NCT02407236|565325520|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
156613593|NCT02407236|565325521|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
156613594|NCT02407236|565325522|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
156613595|NCT02407236|565325523|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
156613596|NCT02407236|565325524|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
156613597|NCT02407236|565325525|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
156613598|NCT02407236|565325526|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
156613599|NCT02407236|565325527|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
156613600|NCT02407236|565325528|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
156613601|NCT02407236|565325529|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
156613602|NCT02407236|565325530|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
156613603|NCT02407236|565325531|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
156613604|NCT02407236|565325519|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
156613605|NCT02407236|565325520|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
156613606|NCT02407236|565325521|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
156613607|NCT02407236|565325522|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
156613608|NCT02407236|565325523|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
156613609|NCT02407236|565325524|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
156613610|NCT02407236|565325525|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
156613611|NCT02407236|565325526|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
156613612|NCT02407236|565325527|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
156613613|NCT02407236|565325528|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
156613614|NCT02407236|565325529|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
156613615|NCT02407236|565325530|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
156613616|NCT02407236|565325531|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
156613617|NCT02177812|565325537|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
156613618|NCT02177812|565325538|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
156613619|NCT02177812|565325539|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
156613620|NCT02177812|565325540|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
156613621|NCT02177812|565325541|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
156613622|NCT02177812|565325542|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
156613623|NCT02177812|565325543|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
156613624|NCT02177812|565325544|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
156613625|NCT02177812|565325545|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
156613626|NCT02177812|565325537|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
156613627|NCT02177812|565325538|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
156613628|NCT02177812|565325539|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
156613629|NCT02177812|565325540|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
156613630|NCT02177812|565325541|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
156613631|NCT02177812|565325542|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
156613632|NCT02177812|565325543|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
156613633|NCT02177812|565325544|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
156613634|NCT02177812|565325545|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
156613635|NCT02177812|565325537|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
156613636|NCT02177812|565325538|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
156613637|NCT02177812|565325539|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
156613638|NCT02177812|565325540|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
156613639|NCT02177812|565325541|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
156613640|NCT02177812|565325542|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
156613641|NCT02177812|565325543|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
156613642|NCT02177812|565325544|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
156613643|NCT02177812|565325545|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
156613644|NCT00089999|565325546|FG000|Overall Study|Adverse Event|4|||
156613645|NCT00089999|565325547|FG001|Overall Study|Adverse Event|7|||
156613646|NCT00089999|565325546|FG000|Overall Study|Withdrawal by Subject|0|||
156613647|NCT00089999|565325547|FG001|Overall Study|Withdrawal by Subject|4|||
156613648|NCT00089999|565325546|FG000|Overall Study|Lost to Follow-up|2|||
156613649|NCT00089999|565325547|FG001|Overall Study|Lost to Follow-up|1|||
156613650|NCT00089999|565325546|FG000|Overall Study|Radiological Progression of Cancer|52|||
156613651|NCT00089999|565325547|FG001|Overall Study|Radiological Progression of Cancer|44|||
156613652|NCT00089999|565325546|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
156613653|NCT00089999|565325547|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
156613654|NCT00089999|565325546|FG000|Overall Study|Death|3|||
156613655|NCT00089999|565325547|FG001|Overall Study|Death|3|||
156613656|NCT00089999|565325546|FG000|Overall Study|Poor General Condition|1|||
156613657|NCT00089999|565325547|FG001|Overall Study|Poor General Condition|0|||
156613658|NCT00089999|565325546|FG000|Overall Study|Clinical Progression|1|||
156613659|NCT00089999|565325547|FG001|Overall Study|Clinical Progression|2|||
156613660|NCT00089999|565325546|FG000|Overall Study|Physician Decision|2|||
156613661|NCT00089999|565325547|FG001|Overall Study|Physician Decision|2|||
156613662|NCT00089999|565325546|FG000|Overall Study|Patient Underwent Surgery|2|||
156613663|NCT00089999|565325547|FG001|Overall Study|Patient Underwent Surgery|0|||
156613664|NCT00089999|565325546|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
156613665|NCT00089999|565325547|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
156613666|NCT03039569|565325548|FG000|Overall Study|Lost to Follow-up|5|||
156613667|NCT03039569|565325549|FG001|Overall Study|Lost to Follow-up|4|||
156613668|NCT01167153|565325550|FG000|Overall Study|Non-effective therapy|1|||
156613669|NCT01167153|565325551|FG001|Overall Study|Non-effective therapy|4|||
156613670|NCT01167153|565325550|FG000|Overall Study|AE including clinical laboratory AE|2|||
156613671|NCT01167153|565325551|FG001|Overall Study|AE including clinical laboratory AE|8|||
156613672|NCT01167153|565325550|FG000|Overall Study|Hypotension|1|||
156613673|NCT01167153|565325551|FG001|Overall Study|Hypotension|0|||
156613674|NCT01167153|565325550|FG000|Overall Study|Lost to Follow-up|7|||
156613675|NCT01167153|565325551|FG001|Overall Study|Lost to Follow-up|9|||
156613676|NCT01167153|565325550|FG000|Overall Study|Non-compliance to concomitant medication|0|||
156613677|NCT01167153|565325551|FG001|Overall Study|Non-compliance to concomitant medication|2|||
156613678|NCT01167153|565325550|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
156613679|NCT01167153|565325551|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
156613680|NCT01167153|565325550|FG000|Overall Study|Withdrawal consent|1|||
156613681|NCT01167153|565325551|FG001|Overall Study|Withdrawal consent|1|||
156613682|NCT01167153|565325550|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
156613683|NCT01167153|565325551|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
156613684|NCT05643170|565326763|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
156613685|NCT05643170|565326763|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
156613686|NCT02358863|565326768|FG000|Overall Study|Physician Decision|3|||
156613687|NCT02632344|565326781|FG000|Overall Study|Adverse Event|3|||
156613688|NCT02632344|565326781|FG000|Overall Study|Lack of Efficacy|3|||
156613689|NCT02632344|565326781|FG000|Overall Study|Withdrawal by Subject|2|||
156613690|NCT05426460|565326786|FG000|Overall Study|Protocol Violation|1|||
156613691|NCT05426460|565326787|FG001|Overall Study|Protocol Violation|1|||
156613692|NCT05426460|565326788|FG002|Overall Study|Protocol Violation|1|||
156613693|NCT05426460|565326789|FG003|Overall Study|Protocol Violation|0|||
156613694|NCT02973997|565326793|FG000|Overall Study|Withdrawal by Subject|4|||
156613695|NCT02973997|565326794|FG001|Overall Study|Withdrawal by Subject|0|||
156613696|NCT02973997|565326793|FG000|Overall Study|Adverse Event|4|||
156613697|NCT02973997|565326794|FG001|Overall Study|Adverse Event|1|||
156613698|NCT02973997|565326793|FG000|Overall Study|Disease Progression|11|||
156613699|NCT02973997|565326794|FG001|Overall Study|Disease Progression|20|||
156613700|NCT02973997|565326793|FG000|Overall Study|Alternative Therapy|3|||
156613701|NCT02973997|565326794|FG001|Overall Study|Alternative Therapy|0|||
156613702|NCT02973997|565326793|FG000|Overall Study|Other complicating disease|0|||
156613703|NCT02973997|565326794|FG001|Overall Study|Other complicating disease|1|||
156613704|NCT02973997|565326793|FG000|Overall Study|Death|0|||
156613705|NCT02973997|565326794|FG001|Overall Study|Death|1|||
156613706|NCT00444951|565326795|FG000|Overall Study|Lost to Follow-up|1|||
156613707|NCT00444951|565326796|FG001|Overall Study|Lost to Follow-up|1|||
156613708|NCT00444951|565326797|FG002|Overall Study|Lost to Follow-up|0|||
156613709|NCT00444951|565326795|FG000|Overall Study|Withdrawal by Subject|4|||
156613710|NCT00444951|565326796|FG001|Overall Study|Withdrawal by Subject|5|||
156613711|NCT00444951|565326797|FG002|Overall Study|Withdrawal by Subject|3|||
156613712|NCT00366444|565326799|FG000|Overall Study|Withdrawal by Subject|1|||
156613713|NCT00366444|565326800|FG001|Overall Study|Withdrawal by Subject|1|||
156613714|NCT00366444|565326799|FG000|Overall Study|Lack of Efficacy|0|||
156613715|NCT00366444|565326800|FG001|Overall Study|Lack of Efficacy|1|||
156613716|NCT04984876|565326801|FG000|Overall Study|Subject decision|2|||
156613717|NCT04984876|565326802|FG001|Overall Study|Subject decision|10|||
156613718|NCT04984876|565326803|FG002|Overall Study|Subject decision|3|||
156613719|NCT04984876|565326804|FG003|Overall Study|Subject decision|3|||
156613720|NCT04984876|565326805|FG004|Overall Study|Subject decision|3|||
156613721|NCT04984876|565326806|FG005|Overall Study|Subject decision|0|||
156613722|NCT04984876|565326801|FG000|Overall Study|Guardian decision|0|||
156613723|NCT04984876|565326802|FG001|Overall Study|Guardian decision|1|||
156613724|NCT04984876|565326803|FG002|Overall Study|Guardian decision|0|||
156613725|NCT04984876|565326804|FG003|Overall Study|Guardian decision|2|||
156613726|NCT04984876|565326805|FG004|Overall Study|Guardian decision|0|||
156613727|NCT04984876|565326806|FG005|Overall Study|Guardian decision|1|||
156613728|NCT04984876|565326801|FG000|Overall Study|Lost to Follow-up|0|||
156613729|NCT04984876|565326802|FG001|Overall Study|Lost to Follow-up|0|||
156613730|NCT04984876|565326803|FG002|Overall Study|Lost to Follow-up|1|||
156613731|NCT04984876|565326804|FG003|Overall Study|Lost to Follow-up|1|||
156613732|NCT04984876|565326805|FG004|Overall Study|Lost to Follow-up|0|||
156613733|NCT04984876|565326806|FG005|Overall Study|Lost to Follow-up|0|||
156613734|NCT04984876|565326801|FG000|Overall Study|Physician Decision|1|||
156613735|NCT04984876|565326802|FG001|Overall Study|Physician Decision|0|||
156613736|NCT04984876|565326803|FG002|Overall Study|Physician Decision|0|||
156613737|NCT04984876|565326804|FG003|Overall Study|Physician Decision|1|||
156613738|NCT04984876|565326805|FG004|Overall Study|Physician Decision|0|||
156613739|NCT04984876|565326806|FG005|Overall Study|Physician Decision|0|||
156613740|NCT04984876|565326801|FG000|Overall Study|Adverse Event|0|||
156613741|NCT04984876|565326802|FG001|Overall Study|Adverse Event|0|||
156613742|NCT04984876|565326803|FG002|Overall Study|Adverse Event|1|||
156613743|NCT04984876|565326804|FG003|Overall Study|Adverse Event|0|||
156613744|NCT04984876|565326805|FG004|Overall Study|Adverse Event|0|||
156613745|NCT04984876|565326806|FG005|Overall Study|Adverse Event|0|||
156613746|NCT01462045|565326809|FG000|Overall Study|Family matter|0|||
156613747|NCT01462045|565326810|FG001|Overall Study|Family matter|1|||
156613748|NCT01462045|565326811|FG002|Overall Study|Family matter|0|||
156613749|NCT03558828|565326812|FG000|Overall Study|Lost to Follow-up|4|||
156613750|NCT03558828|565326813|FG001|Overall Study|Lost to Follow-up|3|||
156613751|NCT03558828|565326814|FG002|Overall Study|Lost to Follow-up|3|||
156613752|NCT03558828|565326815|FG003|Overall Study|Lost to Follow-up|5|||
156613753|NCT03558828|565326816|FG004|Overall Study|Lost to Follow-up|2|||
156613754|NCT03558828|565326817|FG005|Overall Study|Lost to Follow-up|3|||
156613755|NCT03558828|565326812|FG000|Overall Study|dropped before the intervention|1|||
156613756|NCT03558828|565326813|FG001|Overall Study|dropped before the intervention|1|||
156613757|NCT03558828|565326814|FG002|Overall Study|dropped before the intervention|0|||
156613758|NCT03558828|565326815|FG003|Overall Study|dropped before the intervention|0|||
156613759|NCT03558828|565326816|FG004|Overall Study|dropped before the intervention|0|||
156613760|NCT03558828|565326817|FG005|Overall Study|dropped before the intervention|0|||
156613761|NCT02252588|565326818|FG000|Overall Study|Withdrawal by Subject|4|||
156613762|NCT02252588|565326819|FG001|Overall Study|Withdrawal by Subject|0|||
156613763|NCT00693693|565326833|FG000|Overall Study|Lost to Follow-up|1|||
156613764|NCT00693693|565326834|FG001|Overall Study|Lost to Follow-up|1|||
156613765|NCT00693693|565326835|FG002|Overall Study|Lost to Follow-up|2|||
156613766|NCT00285649|565326836|FG000|Overall Study|Lost to Follow-up|6|||
156613767|NCT00285649|565326837|FG001|Overall Study|Lost to Follow-up|4|||
156613768|NCT00285649|565326838|FG002|Overall Study|Lost to Follow-up|4|||
156613769|NCT00285649|565326836|FG000|Overall Study|Withdrawal by Subject|3|||
156613770|NCT00285649|565326837|FG001|Overall Study|Withdrawal by Subject|2|||
156613771|NCT00285649|565326838|FG002|Overall Study|Withdrawal by Subject|2|||
156613772|NCT02972593|565326839|FG000|Overall Study|Lost to Follow-up|19|||
156613773|NCT02972593|565326840|FG001|Overall Study|Lost to Follow-up|15|||
156613774|NCT02972593|565326839|FG000|Overall Study|Protocol Violation|1|||
156613775|NCT02972593|565326840|FG001|Overall Study|Protocol Violation|0|||
156613776|NCT01855425|565326845|FG000|Overall Study|Physician Decision|20|||
156613777|NCT01025232|565326855|FG000|Overall Study|Study drug no longer available|3|||
156613778|NCT01025232|565326856|FG001|Overall Study|Study drug no longer available|6|||
156613779|NCT03748420|565326857|FG000|Overall Study|No 12 month medication adherence data available|0|||
156613780|NCT03748420|565326858|FG001|Overall Study|No 12 month medication adherence data available|1|||
156613781|NCT03748420|565326857|FG000|Overall Study|Death|24|||
156613782|NCT03748420|565326858|FG001|Overall Study|Death|28|||
156613783|NCT03748420|565326857|FG000|Overall Study|Lost to Follow-up|231|||
156613784|NCT03748420|565326858|FG001|Overall Study|Lost to Follow-up|230|||
156613785|NCT02203916|565326860|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156613786|NCT02203916|565326861|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
156613787|NCT02203916|565326862|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
156613788|NCT02203916|565326860|FG000|Overall Study|Major Protocol Deviation|1|||
156613789|NCT02203916|565326861|FG001|Overall Study|Major Protocol Deviation|1|||
156613790|NCT02203916|565326862|FG002|Overall Study|Major Protocol Deviation|0|||
156613791|NCT02203916|565326860|FG000|Overall Study|Lost to Follow-up|0|||
156613792|NCT02203916|565326861|FG001|Overall Study|Lost to Follow-up|1|||
156613793|NCT02203916|565326862|FG002|Overall Study|Lost to Follow-up|0|||
156613794|NCT02203916|565326860|FG000|Overall Study|Voluntary Withdrawal|3|||
156613795|NCT02203916|565326861|FG001|Overall Study|Voluntary Withdrawal|3|||
156613796|NCT02203916|565326862|FG002|Overall Study|Voluntary Withdrawal|8|||
156613797|NCT02203916|565326860|FG000|Overall Study|Lack of Efficacy|3|||
156613798|NCT02203916|565326861|FG001|Overall Study|Lack of Efficacy|0|||
156613799|NCT02203916|565326862|FG002|Overall Study|Lack of Efficacy|0|||
156613800|NCT02203916|565326860|FG000|Overall Study|Reason Not Specified|0|||
156613801|NCT02203916|565326861|FG001|Overall Study|Reason Not Specified|2|||
156613802|NCT02203916|565326862|FG002|Overall Study|Reason Not Specified|1|||
156613803|NCT00414973|565326863|FG000|Overall Study|Withdrawal by Subject|14|||
156613804|NCT00414973|565326864|FG001|Overall Study|Withdrawal by Subject|4|||
156613805|NCT00414973|565326865|FG002|Overall Study|Withdrawal by Subject|1|||
156613806|NCT00414973|565326866|FG003|Overall Study|Withdrawal by Subject|0|||
156613807|NCT00414973|565326863|FG000|Overall Study|Adverse Event|10|||
156613808|NCT00414973|565326864|FG001|Overall Study|Adverse Event|0|||
156613809|NCT00414973|565326865|FG002|Overall Study|Adverse Event|1|||
156613810|NCT00414973|565326866|FG003|Overall Study|Adverse Event|0|||
156613811|NCT00414973|565326863|FG000|Overall Study|Protocol Violation|3|||
156613812|NCT00414973|565326864|FG001|Overall Study|Protocol Violation|4|||
156613813|NCT00414973|565326865|FG002|Overall Study|Protocol Violation|0|||
156613814|NCT00414973|565326866|FG003|Overall Study|Protocol Violation|0|||
156613815|NCT00414973|565326863|FG000|Overall Study|Lost to Follow-up|0|||
156613816|NCT00414973|565326864|FG001|Overall Study|Lost to Follow-up|2|||
156613817|NCT00414973|565326865|FG002|Overall Study|Lost to Follow-up|0|||
156613818|NCT00414973|565326866|FG003|Overall Study|Lost to Follow-up|0|||
156613819|NCT00414973|565326863|FG000|Overall Study|Sponsor Decision|1|||
156613820|NCT00414973|565326864|FG001|Overall Study|Sponsor Decision|0|||
156613821|NCT00414973|565326865|FG002|Overall Study|Sponsor Decision|0|||
156613822|NCT00414973|565326866|FG003|Overall Study|Sponsor Decision|0|||
156613823|NCT00414973|565326863|FG000|Overall Study|Death|0|||
156613824|NCT00414973|565326864|FG001|Overall Study|Death|0|||
156613825|NCT00414973|565326865|FG002|Overall Study|Death|1|||
156613826|NCT00414973|565326866|FG003|Overall Study|Death|0|||
156613827|NCT01466062|565326867|FG000|Overall Study|Adverse Event|1|||
156613828|NCT01466062|565326867|FG000|Overall Study|Withdrawal by Subject|1|||
156613829|NCT01925014|565326868|FG000|Overall Study|Inappropriate enrollment|4|||
156613830|NCT01925014|565326869|FG001|Overall Study|Inappropriate enrollment|6|||
156613831|NCT01925014|565326868|FG000|Overall Study|Withdrawal by Subject|5|||
156613832|NCT01925014|565326869|FG001|Overall Study|Withdrawal by Subject|13|||
156613833|NCT01196091|565326873|FG000|Overall Study|Adverse Event|22|||
156613834|NCT01196091|565326874|FG001|Overall Study|Adverse Event|27|||
156613835|NCT01196091|565326875|FG002|Overall Study|Adverse Event|26|||
156613836|NCT01196091|565326873|FG000|Overall Study|Death|3|||
156613837|NCT01196091|565326874|FG001|Overall Study|Death|2|||
156613838|NCT01196091|565326875|FG002|Overall Study|Death|2|||
156613839|NCT01196091|565326873|FG000|Overall Study|Entry Criteria Not Met|11|||
156613840|NCT01196091|565326874|FG001|Overall Study|Entry Criteria Not Met|11|||
156613841|NCT01196091|565326875|FG002|Overall Study|Entry Criteria Not Met|10|||
156613842|NCT01196091|565326873|FG000|Overall Study|Lack of Efficacy|15|||
156613843|NCT01196091|565326874|FG001|Overall Study|Lack of Efficacy|12|||
156613844|NCT01196091|565326875|FG002|Overall Study|Lack of Efficacy|17|||
156613845|NCT01196091|565326873|FG000|Overall Study|Lost to Follow-up|5|||
156613846|NCT01196091|565326874|FG001|Overall Study|Lost to Follow-up|5|||
156613847|NCT01196091|565326875|FG002|Overall Study|Lost to Follow-up|6|||
156613848|NCT01196091|565326873|FG000|Overall Study|Parent/Caregiver Decision|0|||
156613849|NCT01196091|565326874|FG001|Overall Study|Parent/Caregiver Decision|0|||
156613850|NCT01196091|565326875|FG002|Overall Study|Parent/Caregiver Decision|1|||
156613851|NCT01196091|565326873|FG000|Overall Study|Withdrawal by Subject|16|||
156613852|NCT01196091|565326874|FG001|Overall Study|Withdrawal by Subject|19|||
156613853|NCT01196091|565326875|FG002|Overall Study|Withdrawal by Subject|22|||
156613854|NCT01196091|565326873|FG000|Overall Study|Physician Decision|3|||
156613855|NCT01196091|565326874|FG001|Overall Study|Physician Decision|3|||
156613856|NCT01196091|565326875|FG002|Overall Study|Physician Decision|4|||
156613857|NCT01196091|565326873|FG000|Overall Study|Protocol Violation|1|||
156613858|NCT01196091|565326874|FG001|Overall Study|Protocol Violation|3|||
156613859|NCT01196091|565326875|FG002|Overall Study|Protocol Violation|3|||
156613860|NCT01196091|565326873|FG000|Overall Study|Sponsor Decision|6|||
156613861|NCT01196091|565326874|FG001|Overall Study|Sponsor Decision|5|||
156613862|NCT01196091|565326875|FG002|Overall Study|Sponsor Decision|4|||
156613863|NCT01196091|565326873|FG000|Overall Study|Excluded Site|5|||
156613864|NCT01196091|565326874|FG001|Overall Study|Excluded Site|11|||
156613865|NCT01196091|565326875|FG002|Overall Study|Excluded Site|8|||
156613866|NCT01196091|565326873|FG000|Overall Study|Randomized, No Study Drug Received|1|||
156613867|NCT01196091|565326874|FG001|Overall Study|Randomized, No Study Drug Received|0|||
156613868|NCT01196091|565326875|FG002|Overall Study|Randomized, No Study Drug Received|1|||
156613869|NCT03077711|565326876|FG000|Overall Study|Lost to Follow-up|2|||
156613870|NCT03077711|565326877|FG001|Overall Study|Lost to Follow-up|2|||
156613871|NCT03077711|565326876|FG000|Overall Study|noncompliant taking medication|2|||
156613872|NCT03077711|565326877|FG001|Overall Study|noncompliant taking medication|0|||
156613873|NCT01437267|565326878|FG000|Overall Study|Withdrawal by Subject|0|||
156613874|NCT01437267|565326879|FG001|Overall Study|Withdrawal by Subject|0|||
156613875|NCT01437267|565326880|FG002|Overall Study|Withdrawal by Subject|0|||
156613876|NCT01437267|565326881|FG003|Overall Study|Withdrawal by Subject|1|||
156613877|NCT01437267|565326882|FG004|Overall Study|Withdrawal by Subject|0|||
156613878|NCT01437267|565326883|FG005|Overall Study|Withdrawal by Subject|0|||
156613879|NCT01437267|565326878|FG000|Overall Study|Protocol Violation|0|||
156613880|NCT01437267|565326879|FG001|Overall Study|Protocol Violation|1|||
156613881|NCT01437267|565326880|FG002|Overall Study|Protocol Violation|0|||
156613882|NCT01437267|565326881|FG003|Overall Study|Protocol Violation|0|||
156613883|NCT01437267|565326882|FG004|Overall Study|Protocol Violation|0|||
156613884|NCT01437267|565326883|FG005|Overall Study|Protocol Violation|0|||
156613885|NCT03934203|565326884|FG000|Overall Study|Adverse Event|0|||
156613886|NCT03934203|565326885|FG001|Overall Study|Adverse Event|0|||
156613887|NCT03934203|565326886|FG002|Overall Study|Adverse Event|1|||
156613888|NCT03934203|565326887|FG003|Overall Study|Adverse Event|0|||
156613889|NCT03934203|565326888|FG004|Overall Study|Adverse Event|1|||
156613890|NCT03934203|565326889|FG005|Overall Study|Adverse Event|0|||
156613891|NCT03934203|565326890|FG006|Overall Study|Adverse Event|2|||
156613892|NCT03934203|565326891|FG007|Overall Study|Adverse Event|0|||
156613893|NCT03934203|565326892|FG008|Overall Study|Adverse Event|0|||
156613894|NCT03934203|565326893|FG009|Overall Study|Adverse Event|0|||
156613895|NCT03934203|565326894|FG010|Overall Study|Adverse Event|0|||
156613896|NCT03934203|565326895|FG011|Overall Study|Adverse Event|0|||
156613897|NCT03934203|565326896|FG012|Overall Study|Adverse Event|0|||
156613898|NCT03934203|565326897|FG013|Overall Study|Adverse Event|1|||
156613899|NCT03934203|565326898|FG014|Overall Study|Adverse Event|0|||
156613900|NCT00333970|565326899|FG000|Overall Study|Withdrawal by Subject|13|||
156613901|NCT00333970|565326900|FG001|Overall Study|Withdrawal by Subject|7|||
156613902|NCT00441480|565326901|FG000|Overall Study|Protocol Violation|1|||
156613903|NCT00441480|565326902|FG001|Overall Study|Protocol Violation|1|||
156613904|NCT00441480|565326901|FG000|Overall Study|Withdrawal by Subject|2|||
156613905|NCT00441480|565326902|FG001|Overall Study|Withdrawal by Subject|3|||
156613906|NCT00899678|565326903|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
156613907|NCT00899678|565326904|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
156613908|NCT00899678|565326905|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
156613909|NCT00899678|565326903|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
156613910|NCT00899678|565326904|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
156613911|NCT00899678|565326905|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
156613912|NCT00899678|565326903|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
156613913|NCT00899678|565326904|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
156613914|NCT00899678|565326905|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
156613915|NCT00899678|565326903|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
156613916|NCT00899678|565326904|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
156613917|NCT00899678|565326905|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
156613918|NCT00899678|565326903|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
156613919|NCT00899678|565326904|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
156613920|NCT00899678|565326905|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
156613921|NCT00899678|565326903|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
156613922|NCT00899678|565326904|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
156613923|NCT00899678|565326905|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
156613924|NCT00899678|565326903|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
156613925|NCT00899678|565326904|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
156613926|NCT00899678|565326905|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
156613927|NCT00899678|565326903|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
156613928|NCT00899678|565326904|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
156613929|NCT00899678|565326905|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
156613930|NCT00899678|565326903|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
156613931|NCT00899678|565326904|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
156613932|NCT00899678|565326905|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
156613933|NCT02092324|565326906|FG000|Overall Study|Adverse Event|1|||
156613934|NCT02092324|565326906|FG000|Overall Study|Lack of Efficacy|6|||
156613935|NCT02092324|565326906|FG000|Overall Study|Proceed to Transplant|3|||
156613936|NCT02092324|565326906|FG000|Overall Study|Physician Decision|7|||
156613937|NCT02092324|565326906|FG000|Overall Study|Misdiagnosis|2|||
156613938|NCT00398138|565326909|FG000|Overall Study|Adverse Event|2|||
156613939|NCT02569398|565326910|FG000|Overall Study|Adverse Event|0|||
156613940|NCT02569398|565326911|FG001|Overall Study|Adverse Event|1|||
156613941|NCT02569398|565326912|FG002|Overall Study|Adverse Event|6|||
156613942|NCT02569398|565326910|FG000|Overall Study|Withdrawal by Subject|43|||
156613943|NCT02569398|565326911|FG001|Overall Study|Withdrawal by Subject|43|||
156613944|NCT02569398|565326912|FG002|Overall Study|Withdrawal by Subject|30|||
156613945|NCT02569398|565326910|FG000|Overall Study|Study terminated by sponsor|130|||
156613946|NCT02569398|565326911|FG001|Overall Study|Study terminated by sponsor|131|||
156613947|NCT02569398|565326912|FG002|Overall Study|Study terminated by sponsor|134|||
156613948|NCT02569398|565326910|FG000|Overall Study|Other|12|||
156613949|NCT02569398|565326911|FG001|Overall Study|Other|14|||
156613950|NCT02569398|565326912|FG002|Overall Study|Other|13|||
156613951|NCT03039192|565326913|FG000|Overall Study|Lost to Follow-up|4|||
156613952|NCT03039192|565326914|FG001|Overall Study|Lost to Follow-up|4|||
156613953|NCT03039192|565326913|FG000|Overall Study|Adverse event, serious fatal|0|||
156613954|NCT03039192|565326914|FG001|Overall Study|Adverse event, serious fatal|1|||
156613955|NCT03039192|565326913|FG000|Overall Study|Adverse event, non-fatal|0|||
156613956|NCT03039192|565326914|FG001|Overall Study|Adverse event, non-fatal|2|||
156613957|NCT03039192|565326913|FG000|Overall Study|Withdrawal by Subject|6|||
156613958|NCT03039192|565326914|FG001|Overall Study|Withdrawal by Subject|9|||
156613959|NCT03039192|565326913|FG000|Overall Study|Discontinued from treatment phase|19|||
156613960|NCT03039192|565326914|FG001|Overall Study|Discontinued from treatment phase|12|||
156613961|NCT03039192|565326913|FG000|Overall Study|Other|3|||
156613962|NCT03039192|565326914|FG001|Overall Study|Other|2|||
156613963|NCT03287830|565328974|FG000|Overall Study|Withdrawal by Subject|1|||
156613964|NCT03287830|565328975|FG001|Overall Study|Withdrawal by Subject|1|||
156613965|NCT03287830|565328974|FG000|Overall Study|not meeting inclusion criteria|5|||
156613966|NCT03287830|565328975|FG001|Overall Study|not meeting inclusion criteria|12|||
156613967|NCT02155712|565328978|FG000|Overall Study|Death|12|||
156613968|NCT02155712|565328979|FG001|Overall Study|Death|0|||
156613969|NCT02155712|565328978|FG000|Overall Study|Lost to Follow-up|37|||
156613970|NCT02155712|565328979|FG001|Overall Study|Lost to Follow-up|22|||
156613971|NCT02155712|565328978|FG000|Overall Study|Revision of device|4|||
156613972|NCT02155712|565328979|FG001|Overall Study|Revision of device|3|||
156613973|NCT02155712|565328978|FG000|Overall Study|Withdrawal by Subject|39|||
156613974|NCT02155712|565328979|FG001|Overall Study|Withdrawal by Subject|21|||
156613975|NCT02155712|565328978|FG000|Overall Study|Site termination|77|||
156613976|NCT02155712|565328979|FG001|Overall Study|Site termination|19|||
156613977|NCT02155712|565328978|FG000|Overall Study|Sponsor terminated study early|150|||
156613978|NCT02155712|565328979|FG001|Overall Study|Sponsor terminated study early|0|||
156613979|NCT02155712|565328978|FG000|Overall Study|Missed final 5-year protocol visit|0|||
156613980|NCT02155712|565328979|FG001|Overall Study|Missed final 5-year protocol visit|32|||
156613981|NCT02155712|565328978|FG000|Overall Study|Censored because surgery cancelled|6|||
156613982|NCT02155712|565328979|FG001|Overall Study|Censored because surgery cancelled|10|||
156613983|NCT02155712|565328978|FG000|Overall Study|Censored because study device was not implanted|61|||
156613984|NCT02155712|565328979|FG001|Overall Study|Censored because study device was not implanted|66|||
156613985|NCT02155712|565328978|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
156613986|NCT02155712|565328979|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
156613987|NCT00976963|565328980|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
156613988|NCT00976963|565328981|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
156613989|NCT00976963|565328980|FG000|Overall Study|administrative error|1|||
156613990|NCT00976963|565328981|FG001|Overall Study|administrative error|0|||
156613991|NCT00976963|565328980|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
156613992|NCT00976963|565328981|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
156613993|NCT00608842|565328982|FG000|Overall Study|Participant's Request|0|||
156613994|NCT00608842|565328983|FG001|Overall Study|Participant's Request|1|||
156613995|NCT00608842|565328984|FG002|Overall Study|Participant's Request|2|||
156613996|NCT00608842|565328985|FG003|Overall Study|Participant's Request|1|||
156613997|NCT00608842|565328982|FG000|Overall Study|Lost to Follow-up|1|||
156613998|NCT00608842|565328983|FG001|Overall Study|Lost to Follow-up|0|||
156613999|NCT00608842|565328984|FG002|Overall Study|Lost to Follow-up|0|||
156614000|NCT00608842|565328985|FG003|Overall Study|Lost to Follow-up|0|||
156614001|NCT01688999|565328988|FG000|Overall Study|Withdrawal by Subject|5|||
156614002|NCT01688999|565328989|FG001|Overall Study|Withdrawal by Subject|1|||
156614003|NCT01688999|565328990|FG002|Overall Study|Withdrawal by Subject|1|||
156614004|NCT01688999|565328988|FG000|Overall Study|Adverse Event|2|||
156614005|NCT01688999|565328989|FG001|Overall Study|Adverse Event|0|||
156614006|NCT01688999|565328990|FG002|Overall Study|Adverse Event|2|||
156614007|NCT01688999|565328988|FG000|Overall Study|Ineligible/Not treated|1|||
156614008|NCT01688999|565328989|FG001|Overall Study|Ineligible/Not treated|0|||
156614009|NCT01688999|565328990|FG002|Overall Study|Ineligible/Not treated|0|||
156614010|NCT02768103|565328991|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
156614011|NCT03039790|565329008|FG000|Overall Study|Lost to Follow-up|2|||
156614012|NCT03039790|565329009|FG001|Overall Study|Lost to Follow-up|0|||
156614013|NCT03039790|565329010|FG002|Overall Study|Lost to Follow-up|1|||
156614014|NCT03039790|565329011|FG003|Overall Study|Lost to Follow-up|1|||
156614015|NCT03039790|565329012|FG004|Overall Study|Lost to Follow-up|0|||
156614016|NCT03039790|565329013|FG005|Overall Study|Lost to Follow-up|1|||
156614017|NCT03039790|565329014|FG006|Overall Study|Lost to Follow-up|1|||
156614018|NCT03039790|565329015|FG007|Overall Study|Lost to Follow-up|1|||
156614019|NCT03039790|565329016|FG008|Overall Study|Lost to Follow-up|0|||
156614020|NCT03039790|565329017|FG009|Overall Study|Lost to Follow-up|1|||
156614021|NCT03039790|565329018|FG010|Overall Study|Lost to Follow-up|1|||
156614022|NCT03039790|565329019|FG011|Overall Study|Lost to Follow-up|0|||
156614023|NCT03039790|565329020|FG012|Overall Study|Lost to Follow-up|1|||
156614024|NCT03039790|565329021|FG013|Overall Study|Lost to Follow-up|0|||
156614025|NCT03039790|565329022|FG014|Overall Study|Lost to Follow-up|3|||
156614026|NCT03039790|565329023|FG015|Overall Study|Lost to Follow-up|1|||
156614027|NCT03039790|565329024|FG016|Overall Study|Lost to Follow-up|2|||
156614028|NCT03039790|565329025|FG017|Overall Study|Lost to Follow-up|2|||
156614029|NCT03039790|565329026|FG018|Overall Study|Lost to Follow-up|1|||
156614030|NCT03039790|565329027|FG019|Overall Study|Lost to Follow-up|3|||
156614031|NCT03039790|565329008|FG000|Overall Study|Withdrawal of Consent|1|||
156614032|NCT03039790|565329009|FG001|Overall Study|Withdrawal of Consent|0|||
156614033|NCT03039790|565329010|FG002|Overall Study|Withdrawal of Consent|0|||
156614034|NCT03039790|565329011|FG003|Overall Study|Withdrawal of Consent|1|||
156614035|NCT03039790|565329012|FG004|Overall Study|Withdrawal of Consent|0|||
156614036|NCT03039790|565329013|FG005|Overall Study|Withdrawal of Consent|0|||
156614037|NCT03039790|565329014|FG006|Overall Study|Withdrawal of Consent|0|||
156614038|NCT03039790|565329015|FG007|Overall Study|Withdrawal of Consent|0|||
156614039|NCT03039790|565329016|FG008|Overall Study|Withdrawal of Consent|0|||
156614040|NCT03039790|565329017|FG009|Overall Study|Withdrawal of Consent|1|||
156614041|NCT03039790|565329018|FG010|Overall Study|Withdrawal of Consent|0|||
156614042|NCT03039790|565329019|FG011|Overall Study|Withdrawal of Consent|0|||
156614043|NCT03039790|565329020|FG012|Overall Study|Withdrawal of Consent|2|||
156614044|NCT03039790|565329021|FG013|Overall Study|Withdrawal of Consent|0|||
156614045|NCT03039790|565329022|FG014|Overall Study|Withdrawal of Consent|1|||
156614046|NCT03039790|565329023|FG015|Overall Study|Withdrawal of Consent|5|||
156614047|NCT03039790|565329024|FG016|Overall Study|Withdrawal of Consent|3|||
156614048|NCT03039790|565329025|FG017|Overall Study|Withdrawal of Consent|0|||
156614049|NCT03039790|565329026|FG018|Overall Study|Withdrawal of Consent|2|||
156614050|NCT03039790|565329027|FG019|Overall Study|Withdrawal of Consent|5|||
156614051|NCT03039790|565329008|FG000|Overall Study|Death|0|||
156614052|NCT03039790|565329009|FG001|Overall Study|Death|0|||
156614053|NCT03039790|565329010|FG002|Overall Study|Death|0|||
156614054|NCT03039790|565329011|FG003|Overall Study|Death|0|||
156614055|NCT03039790|565329012|FG004|Overall Study|Death|0|||
156614056|NCT03039790|565329013|FG005|Overall Study|Death|0|||
156614057|NCT03039790|565329014|FG006|Overall Study|Death|0|||
156614058|NCT03039790|565329015|FG007|Overall Study|Death|0|||
156614059|NCT03039790|565329016|FG008|Overall Study|Death|0|||
156614060|NCT03039790|565329017|FG009|Overall Study|Death|0|||
156614061|NCT03039790|565329018|FG010|Overall Study|Death|0|||
156614062|NCT03039790|565329019|FG011|Overall Study|Death|0|||
156614063|NCT03039790|565329020|FG012|Overall Study|Death|0|||
156614064|NCT03039790|565329021|FG013|Overall Study|Death|0|||
156614065|NCT03039790|565329022|FG014|Overall Study|Death|0|||
156614066|NCT03039790|565329023|FG015|Overall Study|Death|1|||
156614067|NCT03039790|565329024|FG016|Overall Study|Death|3|||
156614068|NCT03039790|565329025|FG017|Overall Study|Death|0|||
156614069|NCT03039790|565329026|FG018|Overall Study|Death|2|||
156614070|NCT03039790|565329027|FG019|Overall Study|Death|0|||
156614071|NCT03039790|565329008|FG000|Overall Study|Reason, not Specified|1|||
156614072|NCT03039790|565329009|FG001|Overall Study|Reason, not Specified|0|||
156614073|NCT03039790|565329010|FG002|Overall Study|Reason, not Specified|0|||
156614074|NCT03039790|565329011|FG003|Overall Study|Reason, not Specified|0|||
156614075|NCT03039790|565329012|FG004|Overall Study|Reason, not Specified|0|||
156614076|NCT03039790|565329013|FG005|Overall Study|Reason, not Specified|0|||
156614077|NCT03039790|565329014|FG006|Overall Study|Reason, not Specified|0|||
156614078|NCT03039790|565329015|FG007|Overall Study|Reason, not Specified|0|||
156614079|NCT03039790|565329016|FG008|Overall Study|Reason, not Specified|0|||
156614080|NCT03039790|565329017|FG009|Overall Study|Reason, not Specified|0|||
156614081|NCT03039790|565329018|FG010|Overall Study|Reason, not Specified|0|||
156614082|NCT03039790|565329019|FG011|Overall Study|Reason, not Specified|0|||
156614083|NCT03039790|565329020|FG012|Overall Study|Reason, not Specified|0|||
156614084|NCT03039790|565329021|FG013|Overall Study|Reason, not Specified|0|||
156614085|NCT03039790|565329022|FG014|Overall Study|Reason, not Specified|0|||
156614086|NCT03039790|565329023|FG015|Overall Study|Reason, not Specified|0|||
156614087|NCT03039790|565329024|FG016|Overall Study|Reason, not Specified|2|||
156614088|NCT03039790|565329025|FG017|Overall Study|Reason, not Specified|0|||
156614089|NCT03039790|565329026|FG018|Overall Study|Reason, not Specified|1|||
156614090|NCT03039790|565329027|FG019|Overall Study|Reason, not Specified|0|||
156614091|NCT00498368|565329030|FG000|Overall Study|Withdrawal by Subject|3|||
156614092|NCT00498368|565329031|FG001|Overall Study|Withdrawal by Subject|2|||
156614093|NCT02266004|565329032|FG000|Overall Study|unrelated adverse event|1|||
156614094|NCT02266004|565329032|FG000|Overall Study|Physician Decision|1|||
156614095|NCT00537771|565329036|FG000|Overall Study|Withdrawal by Subject|6|||
156614096|NCT00537771|565329037|FG001|Overall Study|Withdrawal by Subject|23|||
156614097|NCT00537771|565329036|FG000|Overall Study|Adverse Event|8|||
156614098|NCT00537771|565329037|FG001|Overall Study|Adverse Event|15|||
156614099|NCT00537771|565329036|FG000|Overall Study|Lost to Follow-up|9|||
156614100|NCT00537771|565329037|FG001|Overall Study|Lost to Follow-up|15|||
156614101|NCT00537771|565329036|FG000|Overall Study|Protocol Violation|2|||
156614102|NCT00537771|565329037|FG001|Overall Study|Protocol Violation|6|||
156614103|NCT00537771|565329036|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
156614104|NCT00537771|565329037|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
156614105|NCT02736929|565329038|FG000|Main Study|Lost to Follow-up|7|||
156614106|NCT02736929|565329039|FG001|Main Study|Lost to Follow-up|1|||
156614107|NCT02736929|565329040|FG002|Main Study|Lost to Follow-up|0|||
156614108|NCT02736929|565329038|FG000|Main Study|Withdrawal by Subject|1|||
156614109|NCT02736929|565329039|FG001|Main Study|Withdrawal by Subject|1|||
156614110|NCT02736929|565329040|FG002|Main Study|Withdrawal by Subject|0|||
156614111|NCT02736929|565329038|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
156614112|NCT02736929|565329039|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
156614113|NCT02736929|565329040|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
156614114|NCT02465489|565329043|FG000|Overall Study|Adverse Event|5|||
156614115|NCT02148952|565329046|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
156614116|NCT02148952|565329047|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
156614117|NCT02148952|565329046|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
156614118|NCT02148952|565329047|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
156614119|NCT02148952|565329046|FG000|Follow-Up|Lost to Follow-up|219|||
156614120|NCT02148952|565329047|FG001|Follow-Up|Lost to Follow-up|231|||
156614121|NCT02148952|565329046|FG000|Follow-Up|Withdrawal by Subject|46|||
156614122|NCT02148952|565329047|FG001|Follow-Up|Withdrawal by Subject|48|||
156614123|NCT01600105|565329048|FG000|Total Participants|Withdrawal by Subject|1|||
156614124|NCT01600105|565329049|FG001|Total Participants|Withdrawal by Subject|0|||
156614125|NCT01600105|565329048|FG000|Total Participants|No images in PACS|10|||
156614126|NCT01600105|565329049|FG001|Total Participants|No images in PACS|0|||
156614127|NCT01600105|565329048|FG000|Total Participants|Insufficient image quality|30|||
156614128|NCT01600105|565329049|FG001|Total Participants|Insufficient image quality|10|||
156614129|NCT01600105|565329048|FG000|Sub Study I|Insufficient image quality|0|||
156614130|NCT01600105|565329049|FG001|Sub Study I|Insufficient image quality|10|||
156614131|NCT01600105|565329048|FG000|Sub Study II|Withdrawal by Subject|1|||
156614132|NCT01600105|565329049|FG001|Sub Study II|Withdrawal by Subject|0|||
156614133|NCT01600105|565329048|FG000|Sub Study II|No images in PACS|1|||
156614134|NCT01600105|565329049|FG001|Sub Study II|No images in PACS|0|||
156614135|NCT01600105|565329048|FG000|Sub Study II|Insufficient image quality|3|||
156614136|NCT01600105|565329049|FG001|Sub Study II|Insufficient image quality|0|||
156614137|NCT01600105|565329048|FG000|Sub Study III|Insufficient image quality|5|||
156614138|NCT01600105|565329049|FG001|Sub Study III|Insufficient image quality|0|||
156614139|NCT01600105|565329048|FG000|Sub Study V|Poor Image Quality|2|||
156614140|NCT01600105|565329049|FG001|Sub Study V|Poor Image Quality|0|||
156614141|NCT01263444|565329050|FG000|Overall Study|Adverse Event|8|||
156614142|NCT01263444|565329050|FG000|Overall Study|Withdrawal by Subject|1|||
156614143|NCT01263444|565329050|FG000|Overall Study|Protocol Violation|1|||
156614144|NCT01764022|565329051|FG000|Overall Study|Death|3|||
156614145|NCT01764022|565329052|FG001|Overall Study|Death|5|||
156614146|NCT01764022|565329051|FG000|Overall Study|Withdrawal by Subject|2|||
156614147|NCT01764022|565329052|FG001|Overall Study|Withdrawal by Subject|6|||
156614148|NCT01764022|565329051|FG000|Overall Study|Lack of Efficacy|0|||
156614149|NCT01764022|565329052|FG001|Overall Study|Lack of Efficacy|1|||
156614150|NCT01764022|565329051|FG000|Overall Study|Physician Decision|0|||
156614151|NCT01764022|565329052|FG001|Overall Study|Physician Decision|2|||
156614152|NCT01764022|565329051|FG000|Overall Study|Lost to Follow-up|2|||
156614153|NCT01764022|565329052|FG001|Overall Study|Lost to Follow-up|0|||
156614154|NCT01764022|565329051|FG000|Overall Study|Protocol Violation|1|||
156614155|NCT01764022|565329052|FG001|Overall Study|Protocol Violation|0|||
156614156|NCT01899768|565329053|FG000|Part A|Adverse Event|2|||
156614157|NCT01899768|565329053|FG000|Part A|Withdrawal by Subject|1|||
156614158|NCT01899768|565329053|FG000|Part B|Adverse Event|1|||
156614159|NCT01899768|565329053|FG000|Part B|Withdrawal by Subject|1|||
156614160|NCT04043416|565329054|FG000|Washout|Change in health condition|0|||
156614161|NCT04043416|565329055|FG001|Washout|Change in health condition|1|||
156614162|NCT01487863|565329059|FG000|Overall Study|Death|19|||
156614163|NCT01487863|565329060|FG001|Overall Study|Death|19|||
156614164|NCT04247828|565329061|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
156614165|NCT02324049|565329065|FG000|Part C|Study terminated|11|||
156614166|NCT02159365|565329066|FG000|Overall Study|Disease Progression|23|||
156614167|NCT02159365|565329066|FG000|Overall Study|Other reasons|11|||
156614168|NCT02159365|565329066|FG000|Overall Study|Administrative reason by Sponsor|9|||
156614169|NCT02159365|565329066|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
156614170|NCT02159365|565329066|FG000|Overall Study|Study drug toxicity|7|||
156614171|NCT02159365|565329066|FG000|Overall Study|Maximum clinical benefit|3|||
156614172|NCT02159365|565329066|FG000|Overall Study|Subject request to discontinue treatment|3|||
156614173|NCT02159365|565329066|FG000|Overall Study|Subject withdrew consent|3|||
156614174|NCT02159365|565329066|FG000|Overall Study|Death|1|||
156614175|NCT02159365|565329066|FG000|Overall Study|Lost to Follow-up|1|||
156614176|NCT03198728|565329067|FG000|Overall Study|Adverse Event|10|||
156614177|NCT03198728|565329068|FG001|Overall Study|Adverse Event|5|||
156614178|NCT03198728|565329067|FG000|Overall Study|Lost to Follow-up|21|||
156614179|NCT03198728|565329068|FG001|Overall Study|Lost to Follow-up|7|||
156614180|NCT03198728|565329067|FG000|Overall Study|Physician Decision|7|||
156614181|NCT03198728|565329068|FG001|Overall Study|Physician Decision|2|||
156614182|NCT03198728|565329067|FG000|Overall Study|Withdrawal by Subject|14|||
156614183|NCT03198728|565329068|FG001|Overall Study|Withdrawal by Subject|10|||
156614184|NCT04051944|565329069|FG000|Overall Study|Study ending|1|||
156614185|NCT04051944|565329070|FG001|Overall Study|Study ending|1|||
156614186|NCT04051944|565329069|FG000|Overall Study|Early study termination by participant|1|||
156614187|NCT04051944|565329070|FG001|Overall Study|Early study termination by participant|0|||
156614188|NCT04051944|565329069|FG000|Overall Study|Withdrawal by Subject|2|||
156614189|NCT04051944|565329070|FG001|Overall Study|Withdrawal by Subject|2|||
156614190|NCT04051944|565329069|FG000|Overall Study|Lack of Efficacy|3|||
156614191|NCT04051944|565329070|FG001|Overall Study|Lack of Efficacy|0|||
156614192|NCT04051944|565329069|FG000|Overall Study|Adverse event, non- fatal|1|||
156614193|NCT04051944|565329070|FG001|Overall Study|Adverse event, non- fatal|1|||
156614194|NCT03083470|565329071|FG000|Overall Study|Lost to Follow-up|0|||
156614195|NCT03083470|565329072|FG001|Overall Study|Lost to Follow-up|0|||
156614196|NCT03083470|565329073|FG002|Overall Study|Lost to Follow-up|0|||
156614197|NCT03083470|565329074|FG003|Overall Study|Lost to Follow-up|0|||
156614198|NCT03083470|565329075|FG004|Overall Study|Lost to Follow-up|1|||
156614199|NCT03083470|565329071|FG000|Overall Study|Withdrawal by Subject|0|||
156614200|NCT03083470|565329072|FG001|Overall Study|Withdrawal by Subject|0|||
156614201|NCT03083470|565329073|FG002|Overall Study|Withdrawal by Subject|0|||
156614202|NCT03083470|565329074|FG003|Overall Study|Withdrawal by Subject|0|||
156614203|NCT03083470|565329075|FG004|Overall Study|Withdrawal by Subject|1|||
156614204|NCT01512693|565329076|FG000|Overall Study|Withdrawal by Subject|0|||
156614205|NCT01512693|565329077|FG001|Overall Study|Withdrawal by Subject|1|||
156614206|NCT01526928|565329078|FG000|Overall Study|Progressive Disease|35|||
156614207|NCT01526928|565329079|FG001|Overall Study|Progressive Disease|17|||
156614208|NCT01526928|565329080|FG002|Overall Study|Progressive Disease|150|||
156614209|NCT01526928|565329081|FG003|Overall Study|Progressive Disease|182|||
156614210|NCT01526928|565329082|FG004|Overall Study|Progressive Disease|76|||
156614211|NCT01526928|565329083|FG005|Overall Study|Progressive Disease|4|||
156614212|NCT01526928|565329078|FG000|Overall Study|Adverse Event|2|||
156614213|NCT01526928|565329079|FG001|Overall Study|Adverse Event|1|||
156614214|NCT01526928|565329080|FG002|Overall Study|Adverse Event|29|||
156614215|NCT01526928|565329081|FG003|Overall Study|Adverse Event|40|||
156614216|NCT01526928|565329082|FG004|Overall Study|Adverse Event|13|||
156614217|NCT01526928|565329083|FG005|Overall Study|Adverse Event|2|||
156614218|NCT01526928|565329078|FG000|Overall Study|Death|0|||
156614219|NCT01526928|565329079|FG001|Overall Study|Death|0|||
156614220|NCT01526928|565329080|FG002|Overall Study|Death|3|||
156614221|NCT01526928|565329081|FG003|Overall Study|Death|0|||
156614222|NCT01526928|565329082|FG004|Overall Study|Death|0|||
156614223|NCT01526928|565329083|FG005|Overall Study|Death|0|||
156614224|NCT01526928|565329078|FG000|Overall Study|Withdrawal by Subject|1|||
156614225|NCT01526928|565329079|FG001|Overall Study|Withdrawal by Subject|0|||
156614226|NCT01526928|565329080|FG002|Overall Study|Withdrawal by Subject|13|||
156614227|NCT01526928|565329081|FG003|Overall Study|Withdrawal by Subject|11|||
156614228|NCT01526928|565329082|FG004|Overall Study|Withdrawal by Subject|3|||
156614229|NCT01526928|565329083|FG005|Overall Study|Withdrawal by Subject|0|||
156614230|NCT01526928|565329078|FG000|Overall Study|Physician Decision|0|||
156614231|NCT01526928|565329079|FG001|Overall Study|Physician Decision|0|||
156614232|NCT01526928|565329080|FG002|Overall Study|Physician Decision|2|||
156614233|NCT01526928|565329081|FG003|Overall Study|Physician Decision|5|||
156614234|NCT01526928|565329082|FG004|Overall Study|Physician Decision|0|||
156614235|NCT01526928|565329083|FG005|Overall Study|Physician Decision|0|||
156614236|NCT01526928|565329078|FG000|Overall Study|Other Reason|0|||
156614237|NCT01526928|565329079|FG001|Overall Study|Other Reason|1|||
156614238|NCT01526928|565329080|FG002|Overall Study|Other Reason|11|||
156614239|NCT01526928|565329081|FG003|Overall Study|Other Reason|4|||
156614240|NCT01526928|565329082|FG004|Overall Study|Other Reason|1|||
156614241|NCT01526928|565329083|FG005|Overall Study|Other Reason|0|||
156614242|NCT01526928|565329078|FG000|Overall Study|Lost to Follow-up|0|||
156614243|NCT01526928|565329079|FG001|Overall Study|Lost to Follow-up|0|||
156614244|NCT01526928|565329080|FG002|Overall Study|Lost to Follow-up|0|||
156614245|NCT01526928|565329081|FG003|Overall Study|Lost to Follow-up|1|||
156614246|NCT01526928|565329082|FG004|Overall Study|Lost to Follow-up|0|||
156614247|NCT01526928|565329083|FG005|Overall Study|Lost to Follow-up|0|||
156614248|NCT01526928|565329078|FG000|Overall Study|Protocol Deviation|0|||
156614249|NCT01526928|565329079|FG001|Overall Study|Protocol Deviation|0|||
156614250|NCT01526928|565329080|FG002|Overall Study|Protocol Deviation|0|||
156614251|NCT01526928|565329081|FG003|Overall Study|Protocol Deviation|2|||
156614252|NCT01526928|565329082|FG004|Overall Study|Protocol Deviation|0|||
156614253|NCT01526928|565329083|FG005|Overall Study|Protocol Deviation|0|||
156614254|NCT01526928|565329078|FG000|Overall Study|Missing|0|||
156614255|NCT01526928|565329079|FG001|Overall Study|Missing|0|||
156614256|NCT01526928|565329080|FG002|Overall Study|Missing|1|||
156614257|NCT01526928|565329081|FG003|Overall Study|Missing|0|||
156614258|NCT01526928|565329082|FG004|Overall Study|Missing|2|||
156614259|NCT01526928|565329083|FG005|Overall Study|Missing|0|||
156614260|NCT00736450|565329090|FG000|Overall Study|Not ABC gene eligible|19|||
156614261|NCT00736450|565329090|FG000|Overall Study|Withdrawal by Subject|5|||
156614262|NCT00736450|565329090|FG000|Overall Study|Physician Decision|1|||
156614263|NCT00981747|565329107|FG000|Losartan|Withdrawal by Subject|1|||
156614264|NCT00981747|565329107|FG000|Losartan|Death|1|||
156614265|NCT00981747|565329107|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
156614266|NCT02829775|565329115|FG000|Overall Study|Death|1|||
156614267|NCT02829775|565329115|FG000|Overall Study|Withdrawal by Subject|3|||
156614268|NCT02829775|565329115|FG000|Overall Study|Disease remission|1|||
156614269|NCT00033371|565329116|FG000|Overall Study|Adverse Event|1|||
156614270|NCT00033371|565329117|FG001|Overall Study|Adverse Event|5|||
156614271|NCT00033371|565329116|FG000|Overall Study|Lost to Follow-up|2|||
156614272|NCT00033371|565329117|FG001|Overall Study|Lost to Follow-up|1|||
156614273|NCT00033371|565329116|FG000|Overall Study|Withdrawal by Subject|3|||
156614274|NCT00033371|565329117|FG001|Overall Study|Withdrawal by Subject|3|||
156614275|NCT00033371|565329116|FG000|Overall Study|Disease Progression|0|||
156614276|NCT00033371|565329117|FG001|Overall Study|Disease Progression|1|||
156614277|NCT02699125|565329120|FG000|Placebo|Lost to Follow-up|2|||
156614278|NCT02699125|565329121|FG001|Placebo|Lost to Follow-up|0|||
156614279|NCT02699125|565329120|FG000|Placebo|Protocol Violation|1|||
156614280|NCT02699125|565329121|FG001|Placebo|Protocol Violation|0|||
156614281|NCT02699125|565329120|FG000|Placebo|Withdrawal by Subject|0|||
156614282|NCT02699125|565329121|FG001|Placebo|Withdrawal by Subject|4|||
156614283|NCT02699125|565329120|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
156614284|NCT02699125|565329121|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
156614285|NCT01390038|565329124|FG000|Overall Study|Death|1|||
156614286|NCT01390038|565329124|FG000|Overall Study|Lost to Follow-up|1|||
156614287|NCT01390038|565329124|FG000|Overall Study|Withdrawal by Subject|4|||
156614288|NCT01390038|565329124|FG000|Overall Study|Simpliciti System Removal|2|||
156614289|NCT03799627|565329129|FG000|Overall Study|Adverse Event|1|||
156614290|NCT03799627|565329130|FG001|Overall Study|Adverse Event|2|||
156614291|NCT03799627|565329131|FG002|Overall Study|Adverse Event|0|||
156614292|NCT03799627|565329132|FG003|Overall Study|Adverse Event|0|||
156614293|NCT03799627|565329133|FG004|Overall Study|Adverse Event|2|||
156614294|NCT03799627|565329134|FG005|Overall Study|Adverse Event|5|||
156614295|NCT03799627|565329135|FG006|Overall Study|Adverse Event|0|||
156614296|NCT03799627|565329136|FG007|Overall Study|Adverse Event|2|||
156614297|NCT03799627|565329137|FG008|Overall Study|Adverse Event|0|||
156614298|NCT03799627|565329129|FG000|Overall Study|Physician Decision|2|||
156614299|NCT03799627|565329130|FG001|Overall Study|Physician Decision|2|||
156614300|NCT03799627|565329131|FG002|Overall Study|Physician Decision|0|||
156614301|NCT03799627|565329132|FG003|Overall Study|Physician Decision|0|||
156614302|NCT03799627|565329133|FG004|Overall Study|Physician Decision|2|||
156614303|NCT03799627|565329134|FG005|Overall Study|Physician Decision|2|||
156614304|NCT03799627|565329135|FG006|Overall Study|Physician Decision|0|||
156614305|NCT03799627|565329136|FG007|Overall Study|Physician Decision|0|||
156614306|NCT03799627|565329137|FG008|Overall Study|Physician Decision|0|||
156614307|NCT03799627|565329129|FG000|Overall Study|Withdrawal by Subject|1|||
156614308|NCT03799627|565329130|FG001|Overall Study|Withdrawal by Subject|1|||
156614309|NCT03799627|565329131|FG002|Overall Study|Withdrawal by Subject|0|||
156614310|NCT03799627|565329132|FG003|Overall Study|Withdrawal by Subject|2|||
156614311|NCT03799627|565329133|FG004|Overall Study|Withdrawal by Subject|0|||
156614312|NCT03799627|565329134|FG005|Overall Study|Withdrawal by Subject|3|||
156614313|NCT03799627|565329135|FG006|Overall Study|Withdrawal by Subject|0|||
156614314|NCT03799627|565329136|FG007|Overall Study|Withdrawal by Subject|0|||
156614315|NCT03799627|565329137|FG008|Overall Study|Withdrawal by Subject|0|||
156614316|NCT03799627|565329129|FG000|Overall Study|Lack of Efficacy|0|||
156614317|NCT03799627|565329130|FG001|Overall Study|Lack of Efficacy|0|||
156614318|NCT03799627|565329131|FG002|Overall Study|Lack of Efficacy|0|||
156614319|NCT03799627|565329132|FG003|Overall Study|Lack of Efficacy|1|||
156614320|NCT03799627|565329133|FG004|Overall Study|Lack of Efficacy|0|||
156614321|NCT03799627|565329134|FG005|Overall Study|Lack of Efficacy|0|||
156614322|NCT03799627|565329135|FG006|Overall Study|Lack of Efficacy|0|||
156614323|NCT03799627|565329136|FG007|Overall Study|Lack of Efficacy|0|||
156614324|NCT03799627|565329137|FG008|Overall Study|Lack of Efficacy|0|||
156614325|NCT03799627|565329129|FG000|Overall Study|Lost to Follow-up|0|||
156614326|NCT03799627|565329130|FG001|Overall Study|Lost to Follow-up|0|||
156614327|NCT03799627|565329131|FG002|Overall Study|Lost to Follow-up|0|||
156614328|NCT03799627|565329132|FG003|Overall Study|Lost to Follow-up|0|||
156614329|NCT03799627|565329133|FG004|Overall Study|Lost to Follow-up|0|||
156614330|NCT03799627|565329134|FG005|Overall Study|Lost to Follow-up|0|||
156614331|NCT03799627|565329135|FG006|Overall Study|Lost to Follow-up|1|||
156614332|NCT03799627|565329136|FG007|Overall Study|Lost to Follow-up|0|||
156614333|NCT03799627|565329137|FG008|Overall Study|Lost to Follow-up|1|||
156614334|NCT03799627|565329129|FG000|Overall Study|Death|0|||
156614335|NCT03799627|565329130|FG001|Overall Study|Death|0|||
156614336|NCT03799627|565329131|FG002|Overall Study|Death|0|||
156614337|NCT03799627|565329132|FG003|Overall Study|Death|1|||
156614338|NCT03799627|565329133|FG004|Overall Study|Death|0|||
156614339|NCT03799627|565329134|FG005|Overall Study|Death|0|||
156614340|NCT03799627|565329135|FG006|Overall Study|Death|0|||
156614341|NCT03799627|565329136|FG007|Overall Study|Death|0|||
156614342|NCT03799627|565329137|FG008|Overall Study|Death|0|||
156614343|NCT03799627|565329129|FG000|Overall Study|Study Drug Put on Hold|1|||
156614344|NCT03799627|565329130|FG001|Overall Study|Study Drug Put on Hold|0|||
156614345|NCT03799627|565329131|FG002|Overall Study|Study Drug Put on Hold|0|||
156614346|NCT03799627|565329132|FG003|Overall Study|Study Drug Put on Hold|0|||
156614347|NCT03799627|565329133|FG004|Overall Study|Study Drug Put on Hold|0|||
156614348|NCT03799627|565329134|FG005|Overall Study|Study Drug Put on Hold|0|||
156614349|NCT03799627|565329135|FG006|Overall Study|Study Drug Put on Hold|0|||
156614350|NCT03799627|565329136|FG007|Overall Study|Study Drug Put on Hold|0|||
156614351|NCT03799627|565329137|FG008|Overall Study|Study Drug Put on Hold|0|||
156614352|NCT03799627|565329129|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
156614353|NCT03799627|565329130|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
156614354|NCT03799627|565329131|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
156614355|NCT03799627|565329132|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
156614356|NCT03799627|565329133|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
156614357|NCT03799627|565329134|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
156614358|NCT03799627|565329135|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
156614359|NCT03799627|565329136|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
156614360|NCT03799627|565329137|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
156614361|NCT03799627|565329129|FG000|Overall Study|Kidney Transplantation|1|||
156614362|NCT03799627|565329130|FG001|Overall Study|Kidney Transplantation|0|||
156614363|NCT03799627|565329131|FG002|Overall Study|Kidney Transplantation|0|||
156614364|NCT03799627|565329132|FG003|Overall Study|Kidney Transplantation|1|||
156614365|NCT03799627|565329133|FG004|Overall Study|Kidney Transplantation|1|||
156614366|NCT03799627|565329134|FG005|Overall Study|Kidney Transplantation|0|||
156614367|NCT03799627|565329135|FG006|Overall Study|Kidney Transplantation|0|||
156614368|NCT03799627|565329136|FG007|Overall Study|Kidney Transplantation|0|||
156614369|NCT03799627|565329137|FG008|Overall Study|Kidney Transplantation|0|||
156614370|NCT03799627|565329129|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
156614371|NCT03799627|565329130|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
156614372|NCT03799627|565329131|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
156614373|NCT03799627|565329132|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
156614374|NCT03799627|565329133|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
156614375|NCT03799627|565329134|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
156614376|NCT03799627|565329135|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
156614377|NCT03799627|565329136|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
156614378|NCT03799627|565329137|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
156614379|NCT03799627|565329129|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
156614380|NCT03799627|565329130|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
156614381|NCT03799627|565329131|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
156614382|NCT03799627|565329132|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
156614383|NCT03799627|565329133|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
156614384|NCT03799627|565329134|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
156614385|NCT03799627|565329135|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
156614386|NCT03799627|565329136|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
156614387|NCT03799627|565329137|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
156614388|NCT03799627|565329129|FG000|Overall Study|Met Exclusion Criteria|0|||
156614389|NCT03799627|565329130|FG001|Overall Study|Met Exclusion Criteria|0|||
156614390|NCT03799627|565329131|FG002|Overall Study|Met Exclusion Criteria|0|||
156614391|NCT03799627|565329132|FG003|Overall Study|Met Exclusion Criteria|1|||
156614392|NCT03799627|565329133|FG004|Overall Study|Met Exclusion Criteria|0|||
156614393|NCT03799627|565329134|FG005|Overall Study|Met Exclusion Criteria|0|||
156614394|NCT03799627|565329135|FG006|Overall Study|Met Exclusion Criteria|0|||
156614395|NCT03799627|565329136|FG007|Overall Study|Met Exclusion Criteria|0|||
156614396|NCT03799627|565329137|FG008|Overall Study|Met Exclusion Criteria|0|||
156614397|NCT03799627|565329129|FG000|Overall Study|Investigational Product Noncompliance|0|||
156614398|NCT03799627|565329130|FG001|Overall Study|Investigational Product Noncompliance|0|||
156614399|NCT03799627|565329131|FG002|Overall Study|Investigational Product Noncompliance|0|||
156614400|NCT03799627|565329132|FG003|Overall Study|Investigational Product Noncompliance|1|||
156614401|NCT03799627|565329133|FG004|Overall Study|Investigational Product Noncompliance|0|||
156614402|NCT03799627|565329134|FG005|Overall Study|Investigational Product Noncompliance|0|||
156614403|NCT03799627|565329135|FG006|Overall Study|Investigational Product Noncompliance|0|||
156614404|NCT03799627|565329136|FG007|Overall Study|Investigational Product Noncompliance|0|||
156614405|NCT03799627|565329137|FG008|Overall Study|Investigational Product Noncompliance|0|||
156614406|NCT03799627|565329129|FG000|Overall Study|Participant Relocation|0|||
156614407|NCT03799627|565329130|FG001|Overall Study|Participant Relocation|0|||
156614408|NCT03799627|565329131|FG002|Overall Study|Participant Relocation|0|||
156614409|NCT03799627|565329132|FG003|Overall Study|Participant Relocation|1|||
156614410|NCT03799627|565329133|FG004|Overall Study|Participant Relocation|0|||
156614411|NCT03799627|565329134|FG005|Overall Study|Participant Relocation|1|||
156614412|NCT03799627|565329135|FG006|Overall Study|Participant Relocation|0|||
156614413|NCT03799627|565329136|FG007|Overall Study|Participant Relocation|0|||
156614414|NCT03799627|565329137|FG008|Overall Study|Participant Relocation|0|||
156614415|NCT03799627|565329129|FG000|Overall Study|Eurofin Issue|0|||
156614416|NCT03799627|565329130|FG001|Overall Study|Eurofin Issue|0|||
156614417|NCT03799627|565329131|FG002|Overall Study|Eurofin Issue|0|||
156614418|NCT03799627|565329132|FG003|Overall Study|Eurofin Issue|0|||
156614419|NCT03799627|565329133|FG004|Overall Study|Eurofin Issue|1|||
156614420|NCT03799627|565329134|FG005|Overall Study|Eurofin Issue|0|||
156614421|NCT03799627|565329135|FG006|Overall Study|Eurofin Issue|0|||
156614422|NCT03799627|565329136|FG007|Overall Study|Eurofin Issue|0|||
156614423|NCT03799627|565329137|FG008|Overall Study|Eurofin Issue|0|||
156614424|NCT03799627|565329129|FG000|Overall Study|Noncompliance with Site Instructions|0|||
156614425|NCT03799627|565329130|FG001|Overall Study|Noncompliance with Site Instructions|0|||
156614426|NCT03799627|565329131|FG002|Overall Study|Noncompliance with Site Instructions|0|||
156614427|NCT03799627|565329132|FG003|Overall Study|Noncompliance with Site Instructions|0|||
156614428|NCT03799627|565329133|FG004|Overall Study|Noncompliance with Site Instructions|1|||
156614429|NCT03799627|565329134|FG005|Overall Study|Noncompliance with Site Instructions|0|||
156614430|NCT03799627|565329135|FG006|Overall Study|Noncompliance with Site Instructions|0|||
156614431|NCT03799627|565329136|FG007|Overall Study|Noncompliance with Site Instructions|0|||
156614432|NCT03799627|565329137|FG008|Overall Study|Noncompliance with Site Instructions|0|||
156614433|NCT03799627|565329129|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
156614434|NCT03799627|565329130|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
156614435|NCT03799627|565329131|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
156614436|NCT03799627|565329132|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
156614437|NCT03799627|565329133|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
156614438|NCT03799627|565329134|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
156614439|NCT03799627|565329135|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
156614440|NCT03799627|565329136|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
156614441|NCT03799627|565329137|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
156614442|NCT03799627|565329129|FG000|Overall Study|Changes In Hemoglobin Values|1|||
156614443|NCT03799627|565329130|FG001|Overall Study|Changes In Hemoglobin Values|2|||
156614444|NCT03799627|565329131|FG002|Overall Study|Changes In Hemoglobin Values|1|||
156614445|NCT03799627|565329132|FG003|Overall Study|Changes In Hemoglobin Values|0|||
156614446|NCT03799627|565329133|FG004|Overall Study|Changes In Hemoglobin Values|0|||
156614447|NCT03799627|565329134|FG005|Overall Study|Changes In Hemoglobin Values|2|||
156614448|NCT03799627|565329135|FG006|Overall Study|Changes In Hemoglobin Values|1|||
156614449|NCT03799627|565329136|FG007|Overall Study|Changes In Hemoglobin Values|0|||
156614450|NCT03799627|565329137|FG008|Overall Study|Changes In Hemoglobin Values|1|||
156614451|NCT03418376|565329150|FG000|Overall Study|Musculoskeletal injury|1|||
156614452|NCT03418376|565329151|FG001|Overall Study|Musculoskeletal injury|2|||
156614453|NCT03418376|565329152|FG002|Overall Study|Musculoskeletal injury|1|||
156614454|NCT03418376|565329153|FG003|Overall Study|Musculoskeletal injury|0|||
156614455|NCT03418376|565329150|FG000|Overall Study|Personal reasons|0|||
156614456|NCT03418376|565329151|FG001|Overall Study|Personal reasons|2|||
156614457|NCT03418376|565329152|FG002|Overall Study|Personal reasons|2|||
156614458|NCT03418376|565329153|FG003|Overall Study|Personal reasons|1|||
156614459|NCT03418376|565329150|FG000|Overall Study|Exacerbation|0|||
156614460|NCT03418376|565329151|FG001|Overall Study|Exacerbation|1|||
156614461|NCT03418376|565329152|FG002|Overall Study|Exacerbation|0|||
156614462|NCT03418376|565329153|FG003|Overall Study|Exacerbation|0|||
156614463|NCT00814307|565329154|FG000|Overall Study|Randomized but not treated|1|||
156614464|NCT00814307|565329155|FG001|Overall Study|Randomized but not treated|0|||
156614465|NCT00814307|565329156|FG002|Overall Study|Randomized but not treated|0|||
156614466|NCT00814307|565329157|FG003|Overall Study|Randomized but not treated|0|||
156614467|NCT00814307|565329154|FG000|Overall Study|Adverse Event|3|||
156614468|NCT00814307|565329155|FG001|Overall Study|Adverse Event|9|||
156614469|NCT00814307|565329156|FG002|Overall Study|Adverse Event|3|||
156614470|NCT00814307|565329157|FG003|Overall Study|Adverse Event|2|||
156614471|NCT00814307|565329154|FG000|Overall Study|Lack of Efficacy|1|||
156614472|NCT00814307|565329155|FG001|Overall Study|Lack of Efficacy|1|||
156614473|NCT00814307|565329156|FG002|Overall Study|Lack of Efficacy|3|||
156614474|NCT00814307|565329157|FG003|Overall Study|Lack of Efficacy|4|||
156614475|NCT00814307|565329154|FG000|Overall Study|Other|1|||
156614476|NCT00814307|565329155|FG001|Overall Study|Other|2|||
156614477|NCT00814307|565329156|FG002|Overall Study|Other|0|||
156614478|NCT00814307|565329157|FG003|Overall Study|Other|1|||
156614479|NCT00814307|565329154|FG000|Overall Study|Protocol Violation|2|||
156614480|NCT00814307|565329155|FG001|Overall Study|Protocol Violation|8|||
156614481|NCT00814307|565329156|FG002|Overall Study|Protocol Violation|1|||
156614482|NCT00814307|565329157|FG003|Overall Study|Protocol Violation|1|||
156614483|NCT00814307|565329154|FG000|Overall Study|Withdrawal by Subject|4|||
156614484|NCT00814307|565329155|FG001|Overall Study|Withdrawal by Subject|6|||
156614485|NCT00814307|565329156|FG002|Overall Study|Withdrawal by Subject|0|||
156614486|NCT00814307|565329157|FG003|Overall Study|Withdrawal by Subject|2|||
156614487|NCT00814307|565329154|FG000|Overall Study|Death|0|||
156614488|NCT00814307|565329155|FG001|Overall Study|Death|1|||
156614489|NCT00814307|565329156|FG002|Overall Study|Death|0|||
156614490|NCT00814307|565329157|FG003|Overall Study|Death|0|||
156614491|NCT00149890|565329161|FG000|Overall Study|Adverse Event|1|||
156614492|NCT00149890|565329162|FG001|Overall Study|Adverse Event|8|||
156614493|NCT00149890|565329161|FG000|Overall Study|Lack of Efficacy|8|||
156614494|NCT00149890|565329162|FG001|Overall Study|Lack of Efficacy|9|||
156614495|NCT00149890|565329161|FG000|Overall Study|Protocol Violation|1|||
156614496|NCT00149890|565329162|FG001|Overall Study|Protocol Violation|0|||
156614497|NCT00149890|565329161|FG000|Overall Study|Lost to Follow-up|1|||
156614498|NCT00149890|565329162|FG001|Overall Study|Lost to Follow-up|0|||
156614499|NCT00149890|565329161|FG000|Overall Study|Graft Loss|2|||
156614500|NCT00149890|565329162|FG001|Overall Study|Graft Loss|1|||
156614501|NCT04757376|565329163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
156614502|NCT04757376|565329164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
156614503|NCT04757376|565329165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
156614504|NCT04757376|565329166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
156614505|NCT04757376|565329167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
156614506|NCT04757376|565329163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
156614507|NCT04757376|565329164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
156614508|NCT04757376|565329165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
156614509|NCT04757376|565329166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
156614510|NCT04757376|565329167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
156614511|NCT04757376|565329163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
156614512|NCT04757376|565329164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
156614513|NCT04757376|565329165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
156614514|NCT04757376|565329166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
156614515|NCT04757376|565329167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
156614516|NCT04757376|565329163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
156614517|NCT04757376|565329164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
156614518|NCT04757376|565329165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
156614519|NCT04757376|565329166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
156614520|NCT04757376|565329167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
156614521|NCT04757376|565329163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
156614522|NCT04757376|565329164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
156614523|NCT04757376|565329165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
156614524|NCT04757376|565329166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
156614525|NCT04757376|565329167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
156614526|NCT04757376|565329163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
156614527|NCT04757376|565329164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
156614528|NCT04757376|565329165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
156614529|NCT04757376|565329166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
156614530|NCT04757376|565329167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
156614531|NCT04757376|565329163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
156614532|NCT04757376|565329164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
156614533|NCT04757376|565329165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
156614534|NCT04757376|565329166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
156614535|NCT04757376|565329167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
156614536|NCT04757376|565329163|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
156614537|NCT04757376|565329164|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
156614538|NCT04757376|565329165|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
156614539|NCT04757376|565329166|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
156614540|NCT04757376|565329167|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
156614541|NCT01307046|565329168|FG000|Overall Study|Adverse Event|3|||
156614542|NCT01307046|565329169|FG001|Overall Study|Adverse Event|3|||
156614543|NCT01307046|565329168|FG000|Overall Study|Lack of Efficacy|0|||
156614544|NCT01307046|565329169|FG001|Overall Study|Lack of Efficacy|2|||
156614545|NCT01307046|565329168|FG000|Overall Study|Physician Decision|2|||
156614546|NCT01307046|565329169|FG001|Overall Study|Physician Decision|0|||
156614547|NCT01307046|565329168|FG000|Overall Study|Withdrawal by Subject|1|||
156614548|NCT01307046|565329169|FG001|Overall Study|Withdrawal by Subject|1|||
156614549|NCT01307046|565329168|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
156614550|NCT01307046|565329169|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
156614551|NCT01307046|565329168|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
156614552|NCT01307046|565329169|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
156614553|NCT03898323|565329170|FG000|Overall Study|Physician Decision|1|||
156614554|NCT03954704|565329174|FG000|Overall Study|Death|1|||
156614555|NCT03954704|565329175|FG001|Overall Study|Death|1|||
156614556|NCT03954704|565329176|FG002|Overall Study|Death|1|||
156614557|NCT03954704|565329177|FG003|Overall Study|Death|3|||
156614558|NCT03954704|565329178|FG004|Overall Study|Death|2|||
156614559|NCT03954704|565329179|FG005|Overall Study|Death|2|||
156614560|NCT03954704|565329180|FG006|Overall Study|Death|0|||
156614561|NCT03954704|565329174|FG000|Overall Study|Withdrew Consent|0|||
156614562|NCT03954704|565329175|FG001|Overall Study|Withdrew Consent|0|||
156614563|NCT03954704|565329176|FG002|Overall Study|Withdrew Consent|1|||
156614564|NCT03954704|565329177|FG003|Overall Study|Withdrew Consent|0|||
156614565|NCT03954704|565329178|FG004|Overall Study|Withdrew Consent|0|||
156614566|NCT03954704|565329179|FG005|Overall Study|Withdrew Consent|1|||
156614567|NCT03954704|565329180|FG006|Overall Study|Withdrew Consent|0|||
156614568|NCT03954704|565329174|FG000|Overall Study|Lost to Follow-up|0|||
156614569|NCT03954704|565329175|FG001|Overall Study|Lost to Follow-up|0|||
156614570|NCT03954704|565329176|FG002|Overall Study|Lost to Follow-up|0|||
156614571|NCT03954704|565329177|FG003|Overall Study|Lost to Follow-up|0|||
156614572|NCT03954704|565329178|FG004|Overall Study|Lost to Follow-up|0|||
156614573|NCT03954704|565329179|FG005|Overall Study|Lost to Follow-up|0|||
156614574|NCT03954704|565329180|FG006|Overall Study|Lost to Follow-up|1|||
156614575|NCT03954704|565329174|FG000|Overall Study|Study Terminated by Sponsor|0|||
156614576|NCT03954704|565329175|FG001|Overall Study|Study Terminated by Sponsor|0|||
156614577|NCT03954704|565329176|FG002|Overall Study|Study Terminated by Sponsor|1|||
156614578|NCT03954704|565329177|FG003|Overall Study|Study Terminated by Sponsor|0|||
156614579|NCT03954704|565329178|FG004|Overall Study|Study Terminated by Sponsor|1|||
156614580|NCT03954704|565329179|FG005|Overall Study|Study Terminated by Sponsor|4|||
156614581|NCT03954704|565329180|FG006|Overall Study|Study Terminated by Sponsor|2|||
156614582|NCT03954704|565329174|FG000|Overall Study|Enrolled but not Treated|0|||
156614583|NCT03954704|565329175|FG001|Overall Study|Enrolled but not Treated|0|||
156614584|NCT03954704|565329176|FG002|Overall Study|Enrolled but not Treated|0|||
156614585|NCT03954704|565329177|FG003|Overall Study|Enrolled but not Treated|0|||
156614586|NCT03954704|565329178|FG004|Overall Study|Enrolled but not Treated|0|||
156614587|NCT03954704|565329179|FG005|Overall Study|Enrolled but not Treated|1|||
156614588|NCT03954704|565329180|FG006|Overall Study|Enrolled but not Treated|0|||
156614589|NCT02571972|565329185|FG000|Overall Study|Protocol Violation|2|||
156614590|NCT02571972|565329185|FG000|Overall Study|Withdrawal by Subject|2|||
156614591|NCT03559192|565329188|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
156614592|NCT03559192|565329189|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
156614593|NCT03559192|565329190|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
156614594|NCT03559192|565329188|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
156614595|NCT03559192|565329189|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
156614596|NCT03559192|565329190|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
156614597|NCT03559192|565329188|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
156614598|NCT03559192|565329189|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
156614599|NCT03559192|565329190|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
156614600|NCT03559192|565329188|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
156614601|NCT03559192|565329189|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
156614602|NCT03559192|565329190|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
156614603|NCT03559192|565329188|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
156614604|NCT03559192|565329189|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
156614605|NCT03559192|565329190|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
156614606|NCT03559192|565329188|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
156614607|NCT03559192|565329189|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
156614608|NCT03559192|565329190|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
156614609|NCT03559192|565329188|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
156614610|NCT03559192|565329189|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
156614611|NCT03559192|565329190|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
156614612|NCT03559192|565329188|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
156614613|NCT03559192|565329189|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
156614614|NCT03559192|565329190|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
156614615|NCT03559192|565329188|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
156614616|NCT03559192|565329189|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
156614617|NCT03559192|565329190|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
156614618|NCT03277794|565329193|FG000|Overall Study|Lost to Follow-up|2|||
156614619|NCT03277794|565329194|FG001|Overall Study|Lost to Follow-up|4|||
156614620|NCT03277794|565329193|FG000|Overall Study|Withdrew due to high acuity|1|||
156614621|NCT03277794|565329194|FG001|Overall Study|Withdrew due to high acuity|0|||
156614622|NCT05166603|565329198|FG000|Overall Study|Withdrawal by Subject|68|||
156614623|NCT05166603|565329199|FG001|Overall Study|Withdrawal by Subject|0|||
156614624|NCT02710422|565331080|FG000|Overall Study|Termination of study|9|||
156614625|NCT02710422|565331081|FG001|Overall Study|Termination of study|9|||
156614626|NCT01370499|565331082|FG000|Overall Study|Adverse Event|38|||
156614627|NCT01370499|565331083|FG001|Overall Study|Adverse Event|12|||
156614628|NCT01370499|565331082|FG000|Overall Study|Lack of Efficacy|4|||
156614629|NCT01370499|565331083|FG001|Overall Study|Lack of Efficacy|2|||
156614630|NCT01370499|565331082|FG000|Overall Study|Lost to Follow-up|2|||
156614631|NCT01370499|565331083|FG001|Overall Study|Lost to Follow-up|1|||
156614632|NCT01370499|565331082|FG000|Overall Study|Physician Decision|3|||
156614633|NCT01370499|565331083|FG001|Overall Study|Physician Decision|3|||
156614634|NCT01370499|565331082|FG000|Overall Study|Protocol Violation|5|||
156614635|NCT01370499|565331083|FG001|Overall Study|Protocol Violation|4|||
156614636|NCT01370499|565331082|FG000|Overall Study|Withdrawal by Subject|18|||
156614637|NCT01370499|565331083|FG001|Overall Study|Withdrawal by Subject|7|||
156614638|NCT01370499|565331082|FG000|Overall Study|Sponsor Decision|41|||
156614639|NCT01370499|565331083|FG001|Overall Study|Sponsor Decision|15|||
156614640|NCT00887822|565331084|FG000|Overall Study|Insufficient therapeutic response|53|||
156614641|NCT00887822|565331085|FG001|Overall Study|Insufficient therapeutic response|55|||
156614642|NCT00887822|565331084|FG000|Overall Study|Adverse Event|14|||
156614643|NCT00887822|565331085|FG001|Overall Study|Adverse Event|17|||
156614644|NCT00887822|565331084|FG000|Overall Study|Failure to return|11|||
156614645|NCT00887822|565331085|FG001|Overall Study|Failure to return|11|||
156614646|NCT00887822|565331084|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
156614647|NCT00887822|565331085|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
156614648|NCT00887822|565331084|FG000|Overall Study|Administrative/Other than specified|5|||
156614649|NCT00887822|565331085|FG001|Overall Study|Administrative/Other than specified|4|||
156614650|NCT00887822|565331084|FG000|Overall Study|Death|2|||
156614651|NCT00887822|565331085|FG001|Overall Study|Death|3|||
156614652|NCT00887822|565331084|FG000|Overall Study|Protocol Violation|0|||
156614653|NCT00887822|565331085|FG001|Overall Study|Protocol Violation|1|||
156614654|NCT00887822|565331084|FG000|Overall Study|Randomized but not treated|0|||
156614655|NCT00887822|565331085|FG001|Overall Study|Randomized but not treated|1|||
156614656|NCT02045979|565331089|FG000|Overall Study|Informed Consent Withdrawn|2|||
156614657|NCT02045979|565331090|FG001|Overall Study|Informed Consent Withdrawn|0|||
156614658|NCT02045979|565331091|FG002|Overall Study|Informed Consent Withdrawn|1|||
156614659|NCT02045979|565331089|FG000|Overall Study|not specified above|0|||
156614660|NCT02045979|565331090|FG001|Overall Study|not specified above|1|||
156614661|NCT02045979|565331091|FG002|Overall Study|not specified above|0|||
156614662|NCT00378534|565331097|FG000|Overall Study|Participants did not receive transplant|3|||
156614663|NCT00378534|565331098|FG001|Overall Study|Participants did not receive transplant|0|||
156614664|NCT00425945|565331102|FG000|Overall Study|Concern about Supplement|2|||
156614665|NCT00425945|565331103|FG001|Overall Study|Concern about Supplement|0|||
156614666|NCT00425945|565331102|FG000|Overall Study|Inconvenience|0|||
156614667|NCT00425945|565331103|FG001|Overall Study|Inconvenience|2|||
156614668|NCT00425945|565331102|FG000|Overall Study|Lost to Follow-up|0|||
156614669|NCT00425945|565331103|FG001|Overall Study|Lost to Follow-up|2|||
156614670|NCT00425945|565331102|FG000|Overall Study|Began hypertension medication|1|||
156614671|NCT00425945|565331103|FG001|Overall Study|Began hypertension medication|0|||
156614672|NCT00425945|565331102|FG000|Overall Study|Began cancer treatments|1|||
156614673|NCT00425945|565331103|FG001|Overall Study|Began cancer treatments|0|||
156614674|NCT00425945|565331102|FG000|Overall Study|Moved from area|0|||
156614675|NCT00425945|565331103|FG001|Overall Study|Moved from area|1|||
156614676|NCT03878160|565331107|FG000|Overall Study|Lost to Follow-up|1|||
156614677|NCT03878160|565331108|FG001|Overall Study|Lost to Follow-up|1|||
156614678|NCT03878160|565331109|FG002|Overall Study|Lost to Follow-up|1|||
156614679|NCT03878160|565331107|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
156614680|NCT03878160|565331108|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
156614681|NCT03878160|565331109|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
156614682|NCT05618808|565331111|FG000|Overall Study|Withdrawal by Subject|3|||
156614683|NCT05618808|565331112|FG001|Overall Study|Withdrawal by Subject|1|||
156614684|NCT05618808|565331113|FG002|Overall Study|Withdrawal by Subject|3|||
156614685|NCT02365506|565331114|FG000|Overall Study|Investigator's Discretion|0|||
156614686|NCT02365506|565331115|FG001|Overall Study|Investigator's Discretion|0|||
156614687|NCT02365506|565331116|FG002|Overall Study|Investigator's Discretion|1|||
156614688|NCT04288089|565331119|FG000|Overall Study|Ongoing Treatment|2|||
156614689|NCT04288089|565331120|FG001|Overall Study|Ongoing Treatment|1|||
156614690|NCT04288089|565331121|FG002|Overall Study|Ongoing Treatment|1|||
156614691|NCT04288089|565331122|FG003|Overall Study|Ongoing Treatment|4|||
156614692|NCT00592072|565331123|FG000|Wash Out Period|Lost to Follow-up|1|||
156614693|NCT00592072|565331124|FG001|Wash Out Period|Lost to Follow-up|1|||
156614694|NCT04007367|565331126|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
156614695|NCT04007367|565331127|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
156614696|NCT04007367|565331128|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
156614697|NCT04007367|565331126|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
156614698|NCT04007367|565331127|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
156614699|NCT04007367|565331128|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
156614700|NCT04007367|565331126|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
156614701|NCT04007367|565331127|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
156614702|NCT04007367|565331128|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
156614703|NCT04007367|565331126|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
156614704|NCT04007367|565331127|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
156614705|NCT04007367|565331128|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
156614706|NCT04007367|565331126|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
156614707|NCT04007367|565331127|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
156614708|NCT04007367|565331128|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
156614709|NCT02010567|565331129|FG000|Overall Study|Adverse Event|0|||
156614710|NCT02010567|565331130|FG001|Overall Study|Adverse Event|0|||
156614711|NCT02010567|565331131|FG002|Overall Study|Adverse Event|1|||
156614712|NCT02010567|565331132|FG003|Overall Study|Adverse Event|0|||
156614713|NCT02010567|565331133|FG004|Overall Study|Adverse Event|1|||
156614714|NCT00118040|565331135|FG000|Overall Study|Adverse Event|0|||
156614715|NCT00118040|565331136|FG001|Overall Study|Adverse Event|1|||
156614716|NCT00118040|565331137|FG002|Overall Study|Adverse Event|0|||
156614717|NCT00118040|565331135|FG000|Overall Study|Withdrawal by Subject|0|||
156614718|NCT00118040|565331136|FG001|Overall Study|Withdrawal by Subject|0|||
156614719|NCT00118040|565331137|FG002|Overall Study|Withdrawal by Subject|2|||
156614720|NCT00118040|565331135|FG000|Overall Study|Medical Contraindication|0|||
156614721|NCT00118040|565331136|FG001|Overall Study|Medical Contraindication|0|||
156614722|NCT00118040|565331137|FG002|Overall Study|Medical Contraindication|1|||
156614723|NCT00118040|565331135|FG000|Overall Study|Non-Compliant Participant|1|||
156614724|NCT00118040|565331136|FG001|Overall Study|Non-Compliant Participant|1|||
156614725|NCT00118040|565331137|FG002|Overall Study|Non-Compliant Participant|2|||
156614726|NCT00118040|565331135|FG000|Overall Study|Other|0|||
156614727|NCT00118040|565331136|FG001|Overall Study|Other|0|||
156614728|NCT00118040|565331137|FG002|Overall Study|Other|1|||
156614729|NCT04476108|565331138|FG000|Overall Study|Adverse Event|4|||
156614730|NCT04476108|565331139|FG001|Overall Study|Adverse Event|1|||
156614731|NCT04476108|565331138|FG000|Overall Study|Lost to Follow-up|1|||
156614732|NCT04476108|565331139|FG001|Overall Study|Lost to Follow-up|0|||
156614733|NCT04476108|565331138|FG000|Overall Study|Inadvertent Enrollment|1|||
156614734|NCT04476108|565331139|FG001|Overall Study|Inadvertent Enrollment|0|||
156614735|NCT04476108|565331138|FG000|Overall Study|Protocol Violation|1|||
156614736|NCT04476108|565331139|FG001|Overall Study|Protocol Violation|1|||
156614737|NCT04476108|565331138|FG000|Overall Study|Withdrawal by Subject|1|||
156614738|NCT04476108|565331139|FG001|Overall Study|Withdrawal by Subject|1|||
156614739|NCT00850135|565331140|FG000|Overall Study|Physician Decision|1|||
156614740|NCT02253992|565331141|FG000|Overall Study|Study drug toxicity|1|||
156614741|NCT02253992|565331142|FG001|Overall Study|Study drug toxicity|0|||
156614742|NCT02253992|565331143|FG002|Overall Study|Study drug toxicity|10|||
156614743|NCT02253992|565331141|FG000|Overall Study|Disease progression|4|||
156614744|NCT02253992|565331142|FG001|Overall Study|Disease progression|3|||
156614745|NCT02253992|565331143|FG002|Overall Study|Disease progression|98|||
156614746|NCT02253992|565331141|FG000|Overall Study|Withdrawal by Subject|0|||
156614747|NCT02253992|565331142|FG001|Overall Study|Withdrawal by Subject|0|||
156614748|NCT02253992|565331143|FG002|Overall Study|Withdrawal by Subject|3|||
156614749|NCT02253992|565331141|FG000|Overall Study|Adverse Event|0|||
156614750|NCT02253992|565331142|FG001|Overall Study|Adverse Event|0|||
156614751|NCT02253992|565331143|FG002|Overall Study|Adverse Event|8|||
156614752|NCT02253992|565331141|FG000|Overall Study|Death|0|||
156614753|NCT02253992|565331142|FG001|Overall Study|Death|0|||
156614754|NCT02253992|565331143|FG002|Overall Study|Death|1|||
156614755|NCT02253992|565331141|FG000|Overall Study|Subject discontinued study drug|1|||
156614756|NCT02253992|565331142|FG001|Overall Study|Subject discontinued study drug|0|||
156614757|NCT02253992|565331143|FG002|Overall Study|Subject discontinued study drug|1|||
156614758|NCT02253992|565331141|FG000|Overall Study|Completed treatment as per protocol|0|||
156614759|NCT02253992|565331142|FG001|Overall Study|Completed treatment as per protocol|1|||
156614760|NCT02253992|565331143|FG002|Overall Study|Completed treatment as per protocol|22|||
156614761|NCT02253992|565331141|FG000|Overall Study|Other|0|||
156614762|NCT02253992|565331142|FG001|Overall Study|Other|0|||
156614763|NCT02253992|565331143|FG002|Overall Study|Other|1|||
156614764|NCT00623766|565331149|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
156614765|NCT00623766|565331150|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
156614766|NCT00623766|565331149|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
156614767|NCT00623766|565331150|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
156614768|NCT00623766|565331149|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
156614769|NCT00623766|565331150|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
156635094|NCT03917654|565407826|FG011|Year 2|Adverse Event|0|||
156614770|NCT00623766|565331149|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
156614771|NCT00623766|565331150|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
156614772|NCT00623766|565331149|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
156614773|NCT00623766|565331150|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
156614774|NCT00893763|565331152|FG000|Overall Study|extubated|110|||
156614775|NCT00893763|565331153|FG001|Overall Study|extubated|110|||
156614776|NCT00796549|565331154|FG000|Overall Study|Adverse Event|11|||
156614777|NCT00796549|565331154|FG000|Overall Study|not entered|149|||
156614778|NCT00796549|565331154|FG000|Overall Study|Other|2|||
156614779|NCT00796549|565331154|FG000|Overall Study|Progressive disease|56|||
156614780|NCT03523715|565331156|FG000|Overall Study|Lost to Follow-up|11|||
156614781|NCT03523715|565331157|FG001|Overall Study|Lost to Follow-up|14|||
156614782|NCT03523715|565331156|FG000|Overall Study|Did not meet inclusion criteria|1|||
156614783|NCT03523715|565331157|FG001|Overall Study|Did not meet inclusion criteria|0|||
156614784|NCT03523715|565331156|FG000|Overall Study|Internally inconsistent reporting|0|||
156614785|NCT03523715|565331157|FG001|Overall Study|Internally inconsistent reporting|2|||
156614786|NCT00606229|565331158|FG000|Overall Study|Adverse Event|11|||
156614787|NCT00606229|565331158|FG000|Overall Study|Lack of Efficacy|1|||
156614788|NCT00606229|565331158|FG000|Overall Study|Withdrawal by Subject|4|||
156614789|NCT00606229|565331158|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
156614790|NCT00606229|565331158|FG000|Overall Study|change of residence or other commitments|2|||
156614791|NCT02139280|565331159|FG000|Overall Study|No longer eligible|2|||
156614792|NCT02139280|565331160|FG001|Overall Study|No longer eligible|0|||
156614793|NCT04157751|565331161|FG000|Overall Study|Withdrawal by Subject|12|||
156614794|NCT04157751|565331162|FG001|Overall Study|Withdrawal by Subject|17|||
156614795|NCT04157751|565331161|FG000|Overall Study|Lost to Follow-up|6|||
156614796|NCT04157751|565331162|FG001|Overall Study|Lost to Follow-up|2|||
156614797|NCT04157751|565331161|FG000|Overall Study|Adverse Event|34|||
156614798|NCT04157751|565331162|FG001|Overall Study|Adverse Event|23|||
156614799|NCT04157751|565331161|FG000|Overall Study|Not treated|1|||
156614800|NCT04157751|565331162|FG001|Overall Study|Not treated|5|||
156614801|NCT04157751|565331161|FG000|Overall Study|Other reason not stated above|10|||
156614802|NCT04157751|565331162|FG001|Overall Study|Other reason not stated above|10|||
156614803|NCT04731922|565331163|FG000|Overall Study|Adverse Event|0|||
156614804|NCT04731922|565331164|FG001|Overall Study|Adverse Event|0|||
156614805|NCT04731922|565331165|FG002|Overall Study|Adverse Event|0|||
156614806|NCT04731922|565331166|FG003|Overall Study|Adverse Event|0|||
156614807|NCT04731922|565331167|FG004|Overall Study|Adverse Event|0|||
156614808|NCT04731922|565331168|FG005|Overall Study|Adverse Event|0|||
156614809|NCT04731922|565331169|FG006|Overall Study|Adverse Event|0|||
156614810|NCT04731922|565331170|FG007|Overall Study|Adverse Event|0|||
156614811|NCT04731922|565331171|FG008|Overall Study|Adverse Event|0|||
156614812|NCT04731922|565331172|FG009|Overall Study|Adverse Event|0|||
156614813|NCT04731922|565331173|FG010|Overall Study|Adverse Event|1|||
156614814|NCT04731922|565331174|FG011|Overall Study|Adverse Event|0|||
156614815|NCT04731922|565331175|FG012|Overall Study|Adverse Event|0|||
156614816|NCT04731922|565331176|FG013|Overall Study|Adverse Event|0|||
156614817|NCT04731922|565331177|FG014|Overall Study|Adverse Event|0|||
156614818|NCT04731922|565331178|FG015|Overall Study|Adverse Event|0|||
156614819|NCT04731922|565331179|FG016|Overall Study|Adverse Event|0|||
156614820|NCT04731922|565331163|FG000|Overall Study|Lost to Follow-up|0|||
156614821|NCT04731922|565331164|FG001|Overall Study|Lost to Follow-up|0|||
156614822|NCT04731922|565331165|FG002|Overall Study|Lost to Follow-up|0|||
156614823|NCT04731922|565331166|FG003|Overall Study|Lost to Follow-up|1|||
156614824|NCT04731922|565331167|FG004|Overall Study|Lost to Follow-up|0|||
156614825|NCT04731922|565331168|FG005|Overall Study|Lost to Follow-up|1|||
156614826|NCT04731922|565331169|FG006|Overall Study|Lost to Follow-up|0|||
156614827|NCT04731922|565331170|FG007|Overall Study|Lost to Follow-up|0|||
156614828|NCT04731922|565331171|FG008|Overall Study|Lost to Follow-up|0|||
156614829|NCT04731922|565331172|FG009|Overall Study|Lost to Follow-up|0|||
156614830|NCT04731922|565331173|FG010|Overall Study|Lost to Follow-up|0|||
156614831|NCT04731922|565331174|FG011|Overall Study|Lost to Follow-up|0|||
156614832|NCT04731922|565331175|FG012|Overall Study|Lost to Follow-up|0|||
156614833|NCT04731922|565331176|FG013|Overall Study|Lost to Follow-up|0|||
156614834|NCT04731922|565331177|FG014|Overall Study|Lost to Follow-up|0|||
156614835|NCT04731922|565331178|FG015|Overall Study|Lost to Follow-up|0|||
156614836|NCT04731922|565331179|FG016|Overall Study|Lost to Follow-up|0|||
156614837|NCT04731922|565331163|FG000|Overall Study|Withdrawal by Subject|1|||
156614838|NCT04731922|565331164|FG001|Overall Study|Withdrawal by Subject|0|||
156614839|NCT04731922|565331165|FG002|Overall Study|Withdrawal by Subject|0|||
156614840|NCT04731922|565331166|FG003|Overall Study|Withdrawal by Subject|0|||
156614841|NCT04731922|565331167|FG004|Overall Study|Withdrawal by Subject|1|||
156614842|NCT04731922|565331168|FG005|Overall Study|Withdrawal by Subject|0|||
156614843|NCT04731922|565331169|FG006|Overall Study|Withdrawal by Subject|1|||
156614844|NCT04731922|565331170|FG007|Overall Study|Withdrawal by Subject|0|||
156614845|NCT04731922|565331171|FG008|Overall Study|Withdrawal by Subject|0|||
156614846|NCT04731922|565331172|FG009|Overall Study|Withdrawal by Subject|0|||
156614847|NCT04731922|565331173|FG010|Overall Study|Withdrawal by Subject|0|||
156614848|NCT04731922|565331174|FG011|Overall Study|Withdrawal by Subject|0|||
156614849|NCT04731922|565331175|FG012|Overall Study|Withdrawal by Subject|0|||
156614850|NCT04731922|565331176|FG013|Overall Study|Withdrawal by Subject|1|||
156614851|NCT04731922|565331177|FG014|Overall Study|Withdrawal by Subject|0|||
156614852|NCT04731922|565331178|FG015|Overall Study|Withdrawal by Subject|0|||
156614853|NCT04731922|565331179|FG016|Overall Study|Withdrawal by Subject|0|||
156614854|NCT04731922|565331163|FG000|Overall Study|Other|0|||
156614855|NCT04731922|565331164|FG001|Overall Study|Other|0|||
156614856|NCT04731922|565331165|FG002|Overall Study|Other|0|||
156614857|NCT04731922|565331166|FG003|Overall Study|Other|0|||
156614858|NCT04731922|565331167|FG004|Overall Study|Other|0|||
156614859|NCT04731922|565331168|FG005|Overall Study|Other|0|||
156614860|NCT04731922|565331169|FG006|Overall Study|Other|1|||
156614861|NCT04731922|565331170|FG007|Overall Study|Other|0|||
156614862|NCT04731922|565331171|FG008|Overall Study|Other|0|||
156614863|NCT04731922|565331172|FG009|Overall Study|Other|0|||
156614864|NCT04731922|565331173|FG010|Overall Study|Other|0|||
156614865|NCT04731922|565331174|FG011|Overall Study|Other|0|||
156614866|NCT04731922|565331175|FG012|Overall Study|Other|0|||
156614867|NCT04731922|565331176|FG013|Overall Study|Other|0|||
156614868|NCT04731922|565331177|FG014|Overall Study|Other|0|||
156614869|NCT04731922|565331178|FG015|Overall Study|Other|0|||
156614870|NCT04731922|565331179|FG016|Overall Study|Other|0|||
156614871|NCT00422903|565331182|FG000|Overall Study|Disease Progression|3|||
156614872|NCT00422903|565331183|FG001|Overall Study|Disease Progression|1|||
156614873|NCT00422903|565331182|FG000|Overall Study|Adverse Event|0|||
156614874|NCT00422903|565331183|FG001|Overall Study|Adverse Event|2|||
156614875|NCT00422903|565331182|FG000|Overall Study|Informed Consent Withdrawn|1|||
156614876|NCT00422903|565331183|FG001|Overall Study|Informed Consent Withdrawn|2|||
156614877|NCT01302691|565331188|FG000|Overall Study|Adverse Event|2|||
156614878|NCT01302691|565331189|FG001|Overall Study|Adverse Event|0|||
156614879|NCT01302691|565331188|FG000|Overall Study|Death|0|||
156614880|NCT01302691|565331189|FG001|Overall Study|Death|1|||
156614881|NCT01302691|565331188|FG000|Overall Study|Lost to Follow-up|1|||
156614882|NCT01302691|565331189|FG001|Overall Study|Lost to Follow-up|0|||
156614883|NCT01302691|565331188|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
156614884|NCT01302691|565331189|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
156614885|NCT01302691|565331188|FG000|Overall Study|Physician Decision|0|||
156614886|NCT01302691|565331189|FG001|Overall Study|Physician Decision|1|||
156614887|NCT01302691|565331188|FG000|Overall Study|Protocol Violation|1|||
156614888|NCT01302691|565331189|FG001|Overall Study|Protocol Violation|0|||
156614889|NCT03446612|565331190|FG000|Overall Study|Protocol defined stopping criteria|0|||
156614890|NCT03446612|565331191|FG001|Overall Study|Protocol defined stopping criteria|1|||
156614891|NCT01810380|565331197|FG000|Overall Study|Randomised not treated|2|||
156614892|NCT01810380|565331198|FG001|Overall Study|Randomised not treated|1|||
156614893|NCT01810380|565331199|FG002|Overall Study|Randomised not treated|1|||
156614894|NCT01810380|565331197|FG000|Overall Study|Adverse Event|11|||
156614895|NCT01810380|565331198|FG001|Overall Study|Adverse Event|14|||
156614896|NCT01810380|565331199|FG002|Overall Study|Adverse Event|4|||
156614897|NCT01810380|565331197|FG000|Overall Study|Lack of Efficacy|24|||
156614898|NCT01810380|565331198|FG001|Overall Study|Lack of Efficacy|10|||
156614899|NCT01810380|565331199|FG002|Overall Study|Lack of Efficacy|11|||
156614900|NCT01810380|565331197|FG000|Overall Study|Protocol Violation|1|||
156614901|NCT01810380|565331198|FG001|Overall Study|Protocol Violation|0|||
156614902|NCT01810380|565331199|FG002|Overall Study|Protocol Violation|1|||
156614903|NCT01810380|565331197|FG000|Overall Study|Withdrawal by Subject|6|||
156614904|NCT01810380|565331198|FG001|Overall Study|Withdrawal by Subject|0|||
156614905|NCT01810380|565331199|FG002|Overall Study|Withdrawal by Subject|6|||
156614906|NCT01810380|565331197|FG000|Overall Study|Administrative or other reasons|11|||
156614907|NCT01810380|565331198|FG001|Overall Study|Administrative or other reasons|13|||
156614908|NCT01810380|565331199|FG002|Overall Study|Administrative or other reasons|9|||
156614909|NCT03148795|565331209|FG000|Overall Study|Progressive Disease|1|||
156614910|NCT00441012|565331210|FG000|Overall Study|Adverse Event|0|||
156614911|NCT00441012|565331211|FG001|Overall Study|Adverse Event|1|||
156614912|NCT00441012|565331210|FG000|Overall Study|Lost to Follow-up|3|||
156614913|NCT00441012|565331211|FG001|Overall Study|Lost to Follow-up|3|||
156614914|NCT00441012|565331210|FG000|Overall Study|Protocol Violation|10|||
156614915|NCT00441012|565331211|FG001|Overall Study|Protocol Violation|9|||
156614916|NCT00441012|565331210|FG000|Overall Study|Withdrawal by Subject|4|||
156614917|NCT00441012|565331211|FG001|Overall Study|Withdrawal by Subject|0|||
156614918|NCT00441012|565331210|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
156614919|NCT00441012|565331211|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
156614920|NCT04489940|565331212|FG000|Overall Study|Other|2|||
156614921|NCT04489940|565331212|FG000|Overall Study|Withdrawal by Subject|2|||
156614922|NCT04489940|565331212|FG000|Overall Study|Death|5|||
156614923|NCT04489940|565331212|FG000|Overall Study|Lost to Follow-up|1|||
156614924|NCT04498468|565331213|FG000|Overall Study|Lost to Follow-up|3|||
156614925|NCT02725268|565331214|FG000|Overall Study|Death|58|||
156614926|NCT02725268|565331215|FG001|Overall Study|Death|59|||
156614927|NCT02725268|565331216|FG002|Overall Study|Death|30|||
156614928|NCT02725268|565331217|FG003|Overall Study|Death|16|||
156614929|NCT02725268|565331214|FG000|Overall Study|Lost to Follow-up|4|||
156614930|NCT02725268|565331215|FG001|Overall Study|Lost to Follow-up|3|||
156614931|NCT02725268|565331216|FG002|Overall Study|Lost to Follow-up|0|||
156614932|NCT02725268|565331217|FG003|Overall Study|Lost to Follow-up|1|||
156614933|NCT02725268|565331214|FG000|Overall Study|Site Terminated by Sponsor|0|||
156614934|NCT02725268|565331215|FG001|Overall Study|Site Terminated by Sponsor|1|||
156614935|NCT02725268|565331216|FG002|Overall Study|Site Terminated by Sponsor|0|||
156614936|NCT02725268|565331217|FG003|Overall Study|Site Terminated by Sponsor|0|||
156614937|NCT02725268|565331214|FG000|Overall Study|Withdrawal by Subject|8|||
156614938|NCT02725268|565331215|FG001|Overall Study|Withdrawal by Subject|6|||
156614939|NCT02725268|565331216|FG002|Overall Study|Withdrawal by Subject|8|||
156614940|NCT02725268|565331217|FG003|Overall Study|Withdrawal by Subject|1|||
156614941|NCT02725268|565331214|FG000|Overall Study|Reason not Specified|2|||
156614942|NCT02725268|565331215|FG001|Overall Study|Reason not Specified|1|||
156614943|NCT02725268|565331216|FG002|Overall Study|Reason not Specified|0|||
156614944|NCT02725268|565331217|FG003|Overall Study|Reason not Specified|0|||
156614945|NCT00262314|565331223|FG000|Overall Study|Changing physicians|38|||
156614946|NCT00262314|565331223|FG000|Overall Study|Death|12|||
156614947|NCT00262314|565331223|FG000|Overall Study|Patient's decision|92|||
156614948|NCT00262314|565331223|FG000|Overall Study|Other|95|||
156614949|NCT00262314|565331223|FG000|Overall Study|Lost to Follow-up|70|||
156614950|NCT00262314|565331223|FG000|Overall Study|Administrative withdrawal|30|||
156614951|NCT00117572|565331228|FG000|Overall Study|Site withdrew before starting treatment|2|||
156614952|NCT00117572|565331229|FG001|Overall Study|Site withdrew before starting treatment|3|||
156614953|NCT00117572|565331228|FG000|Overall Study|Withdrawal by Subject|3|||
156614954|NCT00117572|565331229|FG001|Overall Study|Withdrawal by Subject|3|||
156614955|NCT00117572|565331228|FG000|Overall Study|Protocol Violation|1|||
156614956|NCT00117572|565331229|FG001|Overall Study|Protocol Violation|0|||
156614957|NCT04973085|565331230|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
156614958|NCT04973085|565331231|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
156614959|NCT00654368|565331234|FG000|Overall Study|Ineligibility determined|6|||
156614960|NCT00654368|565331235|FG001|Overall Study|Ineligibility determined|0|||
156614961|NCT00654368|565331236|FG002|Overall Study|Ineligibility determined|0|||
156614962|NCT00654368|565331234|FG000|Overall Study|Protocol deviation|3|||
156614963|NCT00654368|565331235|FG001|Overall Study|Protocol deviation|2|||
156614964|NCT00654368|565331236|FG002|Overall Study|Protocol deviation|1|||
156614965|NCT00654368|565331234|FG000|Overall Study|Non-compliance|2|||
156614966|NCT00654368|565331235|FG001|Overall Study|Non-compliance|1|||
156614967|NCT00654368|565331236|FG002|Overall Study|Non-compliance|2|||
156614968|NCT00654368|565331234|FG000|Overall Study|Withdrawal by Subject|5|||
156614969|NCT00654368|565331235|FG001|Overall Study|Withdrawal by Subject|2|||
156614970|NCT00654368|565331236|FG002|Overall Study|Withdrawal by Subject|2|||
156614971|NCT00654368|565331234|FG000|Overall Study|Disease progression|21|||
156614972|NCT00654368|565331235|FG001|Overall Study|Disease progression|31|||
156614973|NCT00654368|565331236|FG002|Overall Study|Disease progression|13|||
156614974|NCT00654368|565331234|FG000|Overall Study|Requirement for alternative therapy|1|||
156614975|NCT00654368|565331235|FG001|Overall Study|Requirement for alternative therapy|1|||
156614976|NCT00654368|565331236|FG002|Overall Study|Requirement for alternative therapy|1|||
156614977|NCT00654368|565331234|FG000|Overall Study|Physician Decision|0|||
156614978|NCT00654368|565331235|FG001|Overall Study|Physician Decision|0|||
156614979|NCT00654368|565331236|FG002|Overall Study|Physician Decision|2|||
156614980|NCT00654368|565331234|FG000|Overall Study|Death|1|||
156614981|NCT00654368|565331235|FG001|Overall Study|Death|0|||
156614982|NCT00654368|565331236|FG002|Overall Study|Death|0|||
156614983|NCT00654368|565331234|FG000|Overall Study|Pregnancy|0|||
156614984|NCT00654368|565331235|FG001|Overall Study|Pregnancy|0|||
156614985|NCT00654368|565331236|FG002|Overall Study|Pregnancy|2|||
156614986|NCT00654368|565331234|FG000|Overall Study|Other|0|||
156614987|NCT00654368|565331235|FG001|Overall Study|Other|2|||
156614988|NCT00654368|565331236|FG002|Overall Study|Other|3|||
156614989|NCT00654368|565331234|FG000|Overall Study|Adverse Event|14|||
156614990|NCT00654368|565331235|FG001|Overall Study|Adverse Event|9|||
156614991|NCT00654368|565331236|FG002|Overall Study|Adverse Event|6|||
156614992|NCT01387594|565331238|FG000|Overall Study|Withdrawal by Subject|0|||
156614993|NCT01387594|565331239|FG001|Overall Study|Withdrawal by Subject|2|||
156614994|NCT01387594|565331238|FG000|Overall Study|Lost to Follow-up|0|||
156614995|NCT01387594|565331239|FG001|Overall Study|Lost to Follow-up|1|||
156614996|NCT02254304|565331246|FG000|Overall Study|Adverse Event|2|||
156614997|NCT02254304|565331247|FG001|Overall Study|Adverse Event|1|||
156614998|NCT02254304|565331246|FG000|Overall Study|Lost to Follow-up|2|||
156614999|NCT02254304|565331247|FG001|Overall Study|Lost to Follow-up|2|||
156615000|NCT02254304|565331246|FG000|Overall Study|Protocol Violation|1|||
156615001|NCT02254304|565331247|FG001|Overall Study|Protocol Violation|0|||
156615002|NCT02254304|565331246|FG000|Overall Study|Withdrawal by Subject|3|||
156615003|NCT02254304|565331247|FG001|Overall Study|Withdrawal by Subject|0|||
156615004|NCT02254304|565331246|FG000|Overall Study|Injection site pain and Injection fear|1|||
156615005|NCT02254304|565331247|FG001|Overall Study|Injection site pain and Injection fear|0|||
156615006|NCT02254304|565331246|FG000|Overall Study|Personal causes|4|||
156615007|NCT02254304|565331247|FG001|Overall Study|Personal causes|1|||
156615008|NCT02254304|565331246|FG000|Overall Study|Personal decision|1|||
156615009|NCT02254304|565331247|FG001|Overall Study|Personal decision|0|||
156615010|NCT01592773|565333865|FG000|Overall Study|Study Terminated by Sponsor|582|||
156615011|NCT01592773|565333865|FG000|Overall Study|Withdrawal by Subject|35|||
156615012|NCT01592773|565333865|FG000|Overall Study|Lost to Follow-up|19|||
156615013|NCT01592773|565333865|FG000|Overall Study|Adverse Event|17|||
156615014|NCT01592773|565333865|FG000|Overall Study|Lack of Efficacy|9|||
156615015|NCT01592773|565333865|FG000|Overall Study|Protocol Violation|2|||
156615016|NCT01592773|565333865|FG000|Overall Study|Inclusion/exclusion not meet|1|||
156615017|NCT01592773|565333865|FG000|Overall Study|Other Reason|1|||
156615018|NCT04418427|565333866|FG000|Overall Study|Death|0|||
156615019|NCT04418427|565333867|FG001|Overall Study|Death|1|||
156615020|NCT04418427|565333868|FG002|Overall Study|Death|0|||
156615021|NCT04418427|565333866|FG000|Overall Study|Lost to Follow-up|0|||
156615022|NCT04418427|565333867|FG001|Overall Study|Lost to Follow-up|2|||
156615023|NCT04418427|565333868|FG002|Overall Study|Lost to Follow-up|2|||
156615024|NCT04418427|565333866|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
156615025|NCT04418427|565333867|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
156615026|NCT04418427|565333868|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
156615027|NCT04418427|565333866|FG000|Overall Study|Pre-existing medical condition|0|||
156615028|NCT04418427|565333867|FG001|Overall Study|Pre-existing medical condition|1|||
156615029|NCT04418427|565333868|FG002|Overall Study|Pre-existing medical condition|0|||
156615030|NCT00121485|565333869|FG000|Overall Study|Not implanted|1|||
156615031|NCT00121485|565333870|FG001|Overall Study|Not implanted|5|||
156615032|NCT00121485|565333869|FG000|Overall Study|Crossover|0|||
156615033|NCT00121485|565333870|FG001|Overall Study|Crossover|2|||
156615034|NCT01673373|565333873|FG000|Overall Study|Death|2|||
156615035|NCT02200510|565333879|FG000|Overall Study|Death|1|||
156615036|NCT02200510|565333880|FG001|Overall Study|Death|1|||
156615037|NCT02200510|565333879|FG000|Overall Study|Protocol Violation|0|||
156615038|NCT02200510|565333880|FG001|Overall Study|Protocol Violation|1|||
156615039|NCT02200510|565333879|FG000|Overall Study|Lost to Follow-up|7|||
156615040|NCT02200510|565333880|FG001|Overall Study|Lost to Follow-up|1|||
156615041|NCT02200510|565333879|FG000|Overall Study|potential COI - joined study team|1|||
156615042|NCT02200510|565333880|FG001|Overall Study|potential COI - joined study team|0|||
156615043|NCT04969900|565333881|FG000|Overall Study|Physician Decision|1|||
156615044|NCT04969900|565333882|FG001|Overall Study|Physician Decision|1|||
156615045|NCT04969900|565333881|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
156615046|NCT04969900|565333882|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
156615047|NCT03261037|565333883|FG000|Overall Study|Withdrawal by Subject|2|||
156615048|NCT03261037|565333884|FG001|Overall Study|Withdrawal by Subject|13|||
156615049|NCT03261037|565333885|FG002|Overall Study|Withdrawal by Subject|0|||
156615050|NCT03261037|565333886|FG003|Overall Study|Withdrawal by Subject|18|||
156615051|NCT03261037|565333883|FG000|Overall Study|Non-compliance with study procedures|0|||
156615052|NCT03261037|565333884|FG001|Overall Study|Non-compliance with study procedures|2|||
156615053|NCT03261037|565333885|FG002|Overall Study|Non-compliance with study procedures|0|||
156615054|NCT03261037|565333886|FG003|Overall Study|Non-compliance with study procedures|6|||
156615055|NCT03261037|565333883|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
156615056|NCT03261037|565333884|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
156615057|NCT03261037|565333885|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
156615058|NCT03261037|565333886|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
156615059|NCT03261037|565333883|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
156615060|NCT03261037|565333884|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
156615061|NCT03261037|565333885|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
156615062|NCT03261037|565333886|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
156615063|NCT03261037|565333883|FG000|Overall Study|Diagnosed but protocol deviation|1|||
156615064|NCT03261037|565333884|FG001|Overall Study|Diagnosed but protocol deviation|0|||
156615065|NCT03261037|565333885|FG002|Overall Study|Diagnosed but protocol deviation|0|||
156615066|NCT03261037|565333886|FG003|Overall Study|Diagnosed but protocol deviation|0|||
156615067|NCT03261037|565333883|FG000|Overall Study|Participant did not want to continue the study|0|||
156615068|NCT03261037|565333884|FG001|Overall Study|Participant did not want to continue the study|1|||
156615069|NCT03261037|565333885|FG002|Overall Study|Participant did not want to continue the study|0|||
156615070|NCT03261037|565333886|FG003|Overall Study|Participant did not want to continue the study|0|||
156615071|NCT03261037|565333883|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
156615072|NCT03261037|565333884|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
156615073|NCT03261037|565333885|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
156615074|NCT03261037|565333886|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
156615075|NCT03261037|565333883|FG000|Overall Study|Participant presented clinical improvement|0|||
156615076|NCT03261037|565333884|FG001|Overall Study|Participant presented clinical improvement|2|||
156615077|NCT03261037|565333885|FG002|Overall Study|Participant presented clinical improvement|0|||
156615078|NCT03261037|565333886|FG003|Overall Study|Participant presented clinical improvement|0|||
156615079|NCT03261037|565333883|FG000|Overall Study|Technical difficulties|0|||
156615080|NCT03261037|565333884|FG001|Overall Study|Technical difficulties|0|||
156615081|NCT03261037|565333885|FG002|Overall Study|Technical difficulties|0|||
156615082|NCT03261037|565333886|FG003|Overall Study|Technical difficulties|1|||
156615083|NCT03261037|565333883|FG000|Overall Study|Equipment failed to work|0|||
156615084|NCT03261037|565333884|FG001|Overall Study|Equipment failed to work|0|||
156615085|NCT03261037|565333885|FG002|Overall Study|Equipment failed to work|0|||
156615086|NCT03261037|565333886|FG003|Overall Study|Equipment failed to work|1|||
156615087|NCT03261037|565333883|FG000|Overall Study|End of study for participant and no follow up|0|||
156615088|NCT03261037|565333884|FG001|Overall Study|End of study for participant and no follow up|0|||
156615089|NCT03261037|565333885|FG002|Overall Study|End of study for participant and no follow up|0|||
156615090|NCT03261037|565333886|FG003|Overall Study|End of study for participant and no follow up|1|||
156615091|NCT03261037|565333883|FG000|Overall Study|Participant was too weak to continue in study|1|||
156615092|NCT03261037|565333884|FG001|Overall Study|Participant was too weak to continue in study|0|||
156615093|NCT03261037|565333885|FG002|Overall Study|Participant was too weak to continue in study|0|||
156615094|NCT03261037|565333886|FG003|Overall Study|Participant was too weak to continue in study|0|||
156615095|NCT02881151|565333889|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
156615096|NCT00589602|565333894|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
156615097|NCT04284787|565333895|FG000|Overall Study|Disease Progression|9|||
156615098|NCT04284787|565333896|FG001|Overall Study|Disease Progression|12|||
156615099|NCT04284787|565333895|FG000|Overall Study|Physician Decision|12|||
156615100|NCT04284787|565333896|FG001|Overall Study|Physician Decision|7|||
156615101|NCT04284787|565333895|FG000|Overall Study|Transplant|5|||
156615102|NCT04284787|565333896|FG001|Overall Study|Transplant|4|||
156615103|NCT04284787|565333895|FG000|Overall Study|Death|1|||
156615104|NCT04284787|565333896|FG001|Overall Study|Death|2|||
156615105|NCT04284787|565333895|FG000|Overall Study|Adverse Event|0|||
156615106|NCT04284787|565333896|FG001|Overall Study|Adverse Event|4|||
156615107|NCT04284787|565333895|FG000|Overall Study|Non-adherence|2|||
156615108|NCT04284787|565333896|FG001|Overall Study|Non-adherence|0|||
156615109|NCT04284787|565333895|FG000|Overall Study|Lack of Efficacy|2|||
156615110|NCT04284787|565333896|FG001|Overall Study|Lack of Efficacy|0|||
156615111|NCT01874353|565333897|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
156615112|NCT01874353|565333898|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
156615113|NCT01874353|565333899|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
156615114|NCT01874353|565333900|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
156615115|NCT01874353|565333897|FG000|Overall Study|Lost to Follow-up|2|||
156615116|NCT01874353|565333898|FG001|Overall Study|Lost to Follow-up|2|||
156615117|NCT01874353|565333899|FG002|Overall Study|Lost to Follow-up|2|||
156615118|NCT01874353|565333900|FG003|Overall Study|Lost to Follow-up|0|||
156615119|NCT01874353|565333897|FG000|Overall Study|Death|110|||
156615120|NCT01874353|565333898|FG001|Overall Study|Death|60|||
156615121|NCT01874353|565333899|FG002|Overall Study|Death|13|||
156615122|NCT01874353|565333900|FG003|Overall Study|Death|7|||
156615123|NCT01874353|565333897|FG000|Overall Study|Withdrawal by Subject|13|||
156615124|NCT01874353|565333898|FG001|Overall Study|Withdrawal by Subject|11|||
156615125|NCT01874353|565333899|FG002|Overall Study|Withdrawal by Subject|0|||
156615126|NCT01874353|565333900|FG003|Overall Study|Withdrawal by Subject|0|||
156615127|NCT03887052|565333901|FG000|Overall Study|Adverse Event|2|||
156615128|NCT03887052|565333901|FG000|Overall Study|Physician Decision|2|||
156615129|NCT03887052|565333901|FG000|Overall Study|Withdrawal by Subject|3|||
156615130|NCT03887052|565333901|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
156615131|NCT03887052|565333901|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
156615132|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
156615133|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
156615134|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|Death|1|||
156615135|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|Death|1|||
156615136|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
156615137|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
156615138|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
156615139|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
156615140|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
156615141|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
156615142|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
156615143|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
156615144|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
156615145|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
156635095|NCT05012943|565407827|FG000|Overall Study|Adverse Event|2|||
156615146|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
156615147|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
156615148|NCT03728881|565333902|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
156615149|NCT03728881|565333903|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
156615150|NCT03728881|565333902|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
156615151|NCT03728881|565333903|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
156615152|NCT03728881|565333902|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
156615153|NCT03728881|565333903|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
156615154|NCT04517253|565333906|FG000|Primary Treatment Period|Adverse Event|1|||
156615155|NCT04517253|565333907|FG001|Primary Treatment Period|Adverse Event|0|||
156615156|NCT04517253|565333908|FG002|Primary Treatment Period|Adverse Event|0|||
156615157|NCT04517253|565333906|FG000|Primary Treatment Period|Death|0|||
156615158|NCT04517253|565333907|FG001|Primary Treatment Period|Death|1|||
156615159|NCT04517253|565333908|FG002|Primary Treatment Period|Death|0|||
156615160|NCT04517253|565333906|FG000|Maintenance Period|Withdrawal by Subject|1|||
156615161|NCT04517253|565333907|FG001|Maintenance Period|Withdrawal by Subject|0|||
156615162|NCT04517253|565333908|FG002|Maintenance Period|Withdrawal by Subject|0|||
156615163|NCT04517253|565333906|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
156615164|NCT04517253|565333907|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
156615165|NCT04517253|565333908|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
156615166|NCT06048367|565333909|FG000|Overall Study|Withdrawal by Subject|0|||
156615167|NCT06048367|565333910|FG001|Overall Study|Withdrawal by Subject|1|||
156615168|NCT06048367|565333911|FG002|Overall Study|Withdrawal by Subject|0|||
156615169|NCT06048367|565333912|FG003|Overall Study|Withdrawal by Subject|0|||
156615170|NCT06048367|565333913|FG004|Overall Study|Withdrawal by Subject|0|||
156615171|NCT06048367|565333909|FG000|Overall Study|Withdrawal by Subject|0|||
156615172|NCT06048367|565333910|FG001|Overall Study|Withdrawal by Subject|0|||
156615173|NCT06048367|565333911|FG002|Overall Study|Withdrawal by Subject|1|||
156615174|NCT06048367|565333912|FG003|Overall Study|Withdrawal by Subject|0|||
156615175|NCT06048367|565333913|FG004|Overall Study|Withdrawal by Subject|0|||
156615176|NCT06048367|565333909|FG000|Overall Study|Withdrawal by Subject|0|||
156615177|NCT06048367|565333910|FG001|Overall Study|Withdrawal by Subject|0|||
156615178|NCT06048367|565333911|FG002|Overall Study|Withdrawal by Subject|0|||
156615179|NCT06048367|565333912|FG003|Overall Study|Withdrawal by Subject|1|||
156615180|NCT06048367|565333913|FG004|Overall Study|Withdrawal by Subject|0|||
156615181|NCT06048367|565333909|FG000|Overall Study|Withdrawal by Subject|0|||
156615182|NCT06048367|565333910|FG001|Overall Study|Withdrawal by Subject|0|||
156615183|NCT06048367|565333911|FG002|Overall Study|Withdrawal by Subject|0|||
156615184|NCT06048367|565333912|FG003|Overall Study|Withdrawal by Subject|1|||
156615185|NCT06048367|565333913|FG004|Overall Study|Withdrawal by Subject|0|||
156615186|NCT04088331|565333914|FG000|Overall Study|Lost to Follow-up|3|||
156615187|NCT04088331|565333914|FG000|Overall Study|Withdrawal by Subject|7|||
156615188|NCT04088331|565333914|FG000|Overall Study|Adverse Event|4|||
156615189|NCT05505734|565333915|FG000|Overall Study|Withdrawal by Subject|51|||
156615190|NCT05505734|565333916|FG001|Overall Study|Withdrawal by Subject|64|||
156615191|NCT05505734|565333915|FG000|Overall Study|Adverse Event|6|||
156615192|NCT05505734|565333916|FG001|Overall Study|Adverse Event|20|||
156615193|NCT05505734|565333915|FG000|Overall Study|Protocol Violation|8|||
156615194|NCT05505734|565333916|FG001|Overall Study|Protocol Violation|15|||
156615195|NCT05505734|565333915|FG000|Overall Study|Lack of therapeutic response|0|||
156615196|NCT05505734|565333916|FG001|Overall Study|Lack of therapeutic response|1|||
156615197|NCT05505734|565333915|FG000|Overall Study|Lost to Follow-up|247|||
156615198|NCT05505734|565333916|FG001|Overall Study|Lost to Follow-up|237|||
156615199|NCT05505734|565333915|FG000|Overall Study|Physician Decision|22|||
156615200|NCT05505734|565333916|FG001|Overall Study|Physician Decision|13|||
156615201|NCT05505734|565333915|FG000|Overall Study|Death|2|||
156615202|NCT05505734|565333916|FG001|Overall Study|Death|1|||
156615203|NCT05505734|565333915|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156615204|NCT05505734|565333916|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156615205|NCT05505734|565333915|FG000|Overall Study|Pregnancy|1|||
156615206|NCT05505734|565333916|FG001|Overall Study|Pregnancy|0|||
156615207|NCT05505734|565333915|FG000|Overall Study|Other|17|||
156615208|NCT05505734|565333916|FG001|Overall Study|Other|13|||
156615209|NCT03598140|565333917|FG000|Overall Study|enrolled but didn't start|1|||
156615210|NCT03598140|565333918|FG001|Overall Study|enrolled but didn't start|0|||
156615211|NCT02060903|565333922|FG000|Overall Study|Lost to Follow-up|4|||
156615212|NCT02060903|565333923|FG001|Overall Study|Lost to Follow-up|0|||
156615213|NCT02060903|565333922|FG000|Overall Study|Withdrawal by Subject|0|||
156615214|NCT02060903|565333923|FG001|Overall Study|Withdrawal by Subject|7|||
156615215|NCT01266876|565333924|FG000|Overall Study|Adverse Event|0|||
156615216|NCT01266876|565333925|FG001|Overall Study|Adverse Event|0|||
156615217|NCT01266876|565333926|FG002|Overall Study|Adverse Event|0|||
156615218|NCT01266876|565333927|FG003|Overall Study|Adverse Event|1|||
156615219|NCT01266876|565333928|FG004|Overall Study|Adverse Event|0|||
156615220|NCT05016037|565333930|FG000|Overall Study|Lost to Follow-up|2|||
156615221|NCT03575351|565333931|FG000|Overall Study|Adverse Event|1|||
156615222|NCT03575351|565333932|FG001|Overall Study|Adverse Event|0|||
156615223|NCT03575351|565333931|FG000|Overall Study|Death|2|||
156615224|NCT03575351|565333932|FG001|Overall Study|Death|2|||
156615225|NCT03575351|565333931|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
156615226|NCT03575351|565333932|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
156615227|NCT03575351|565333931|FG000|Overall Study|Lack of Efficacy|28|||
156615228|NCT03575351|565333932|FG001|Overall Study|Lack of Efficacy|0|||
156615229|NCT03575351|565333931|FG000|Overall Study|Withdrawal by Subject|1|||
156615230|NCT03575351|565333932|FG001|Overall Study|Withdrawal by Subject|1|||
156615231|NCT03575351|565333931|FG000|Overall Study|Physician Decision|3|||
156615232|NCT03575351|565333932|FG001|Overall Study|Physician Decision|0|||
156615233|NCT03575351|565333931|FG000|Overall Study|Disease relapse|15|||
156615234|NCT03575351|565333932|FG001|Overall Study|Disease relapse|6|||
156615235|NCT03575351|565333931|FG000|Overall Study|Study drug manufacturing failure|0|||
156615236|NCT03575351|565333932|FG001|Overall Study|Study drug manufacturing failure|1|||
156615237|NCT03575351|565333931|FG000|Overall Study|other reasons|5|||
156615238|NCT03575351|565333932|FG001|Overall Study|other reasons|0|||
156615239|NCT03715205|565333933|FG000|Overall Study|Death|13|||
156615240|NCT03715205|565333933|FG000|Overall Study|Lost to Follow-up|2|||
156615241|NCT03715205|565333933|FG000|Overall Study|Physician Decision|93|||
156615242|NCT03715205|565333933|FG000|Overall Study|Withdrawal by Subject|26|||
156615243|NCT02623699|565333934|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615244|NCT02623699|565333935|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
156615245|NCT02623699|565333936|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615246|NCT02623699|565333937|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615247|NCT02623699|565333938|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615248|NCT02623699|565333939|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615249|NCT02623699|565333940|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615250|NCT02623699|565333941|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615251|NCT02623699|565333942|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615252|NCT02623699|565333943|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615253|NCT02623699|565333944|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615254|NCT02623699|565333945|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
156615255|NCT02623699|565333934|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615256|NCT02623699|565333935|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615257|NCT02623699|565333936|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615258|NCT02623699|565333937|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615259|NCT02623699|565333938|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615260|NCT02623699|565333939|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615261|NCT02623699|565333940|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
156615262|NCT02623699|565333941|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615263|NCT02623699|565333942|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615264|NCT02623699|565333943|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615265|NCT02623699|565333944|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615266|NCT02623699|565333945|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
156615267|NCT02623699|565333934|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615268|NCT02623699|565333935|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615269|NCT02623699|565333936|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615270|NCT02623699|565333937|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615271|NCT02623699|565333938|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615272|NCT02623699|565333939|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
156615273|NCT02623699|565333940|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615274|NCT02623699|565333941|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615275|NCT02623699|565333942|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615276|NCT02623699|565333943|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615277|NCT02623699|565333944|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615278|NCT02623699|565333945|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
156615279|NCT02623699|565333934|FG000|Part B (Up to 289 Days)|Death|0|||
156615280|NCT02623699|565333935|FG001|Part B (Up to 289 Days)|Death|0|||
156615281|NCT02623699|565333936|FG002|Part B (Up to 289 Days)|Death|0|||
156615282|NCT02623699|565333937|FG003|Part B (Up to 289 Days)|Death|0|||
156615283|NCT02623699|565333938|FG004|Part B (Up to 289 Days)|Death|0|||
156615284|NCT02623699|565333939|FG005|Part B (Up to 289 Days)|Death|1|||
156615285|NCT02623699|565333940|FG006|Part B (Up to 289 Days)|Death|1|||
156615286|NCT02623699|565333941|FG007|Part B (Up to 289 Days)|Death|0|||
156615287|NCT02623699|565333942|FG008|Part B (Up to 289 Days)|Death|1|||
156615288|NCT02623699|565333943|FG009|Part B (Up to 289 Days)|Death|0|||
156615289|NCT02623699|565333944|FG010|Part B (Up to 289 Days)|Death|0|||
156615290|NCT02623699|565333945|FG011|Part B (Up to 289 Days)|Death|0|||
156615291|NCT02623699|565333934|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
156615292|NCT02623699|565333935|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
156615293|NCT02623699|565333936|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
156615294|NCT02623699|565333937|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
156615295|NCT02623699|565333938|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
156615296|NCT02623699|565333939|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
156615297|NCT02623699|565333940|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
156615298|NCT02623699|565333941|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
156615299|NCT02623699|565333942|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
156615300|NCT02623699|565333943|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
156615301|NCT02623699|565333944|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
156615302|NCT02623699|565333945|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
156615303|NCT02623699|565333934|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615304|NCT02623699|565333935|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615305|NCT02623699|565333936|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615306|NCT02623699|565333937|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615307|NCT02623699|565333938|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615308|NCT02623699|565333939|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615309|NCT02623699|565333940|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615310|NCT02623699|565333941|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615311|NCT02623699|565333942|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615312|NCT02623699|565333943|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
156615313|NCT02623699|565333944|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
156615314|NCT02623699|565333945|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
156615315|NCT02623699|565333934|FG000|Part C (Up to 236 Days)|Death|0|||
156615316|NCT02623699|565333935|FG001|Part C (Up to 236 Days)|Death|0|||
156615317|NCT02623699|565333936|FG002|Part C (Up to 236 Days)|Death|0|||
156615318|NCT02623699|565333937|FG003|Part C (Up to 236 Days)|Death|0|||
156615319|NCT02623699|565333938|FG004|Part C (Up to 236 Days)|Death|0|||
156615320|NCT02623699|565333939|FG005|Part C (Up to 236 Days)|Death|0|||
156615321|NCT02623699|565333940|FG006|Part C (Up to 236 Days)|Death|0|||
156615322|NCT02623699|565333941|FG007|Part C (Up to 236 Days)|Death|0|||
156615323|NCT02623699|565333942|FG008|Part C (Up to 236 Days)|Death|0|||
156615324|NCT02623699|565333943|FG009|Part C (Up to 236 Days)|Death|0|||
156615325|NCT02623699|565333944|FG010|Part C (Up to 236 Days)|Death|0|||
156615326|NCT02623699|565333945|FG011|Part C (Up to 236 Days)|Death|1|||
156615327|NCT02623699|565333934|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
156615328|NCT02623699|565333935|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
156615329|NCT02623699|565333936|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
156615330|NCT02623699|565333937|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
156615331|NCT02623699|565333938|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
156615332|NCT02623699|565333939|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
156615333|NCT02623699|565333940|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
156615334|NCT02623699|565333941|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
156615335|NCT02623699|565333942|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
156615336|NCT02623699|565333943|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
156615337|NCT02623699|565333944|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
156615338|NCT02623699|565333945|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
156615339|NCT00557323|565333946|FG000|Overall Study|Death|3|||
156615340|NCT00557323|565333946|FG000|Overall Study|Withdrawal by Subject|2|||
156615341|NCT00557323|565333946|FG000|Overall Study|Administrative change|2|||
156615342|NCT03369704|565333947|FG000|Treatment Epoch|technical problems|1|||
156615343|NCT03369704|565333948|FG001|Treatment Epoch|technical problems|0|||
156615344|NCT03369704|565333947|FG000|Treatment Epoch|Protocol Violation|1|||
156615345|NCT03369704|565333948|FG001|Treatment Epoch|Protocol Violation|0|||
156615346|NCT03369704|565333947|FG000|Treatment Epoch|Lost to Follow-up|0|||
156615347|NCT03369704|565333948|FG001|Treatment Epoch|Lost to Follow-up|1|||
156615348|NCT03369704|565333947|FG000|Treatment Epoch|Lack of Efficacy|0|||
156615349|NCT03369704|565333948|FG001|Treatment Epoch|Lack of Efficacy|2|||
156615350|NCT03369704|565333947|FG000|Treatment Epoch|Adverse Event|2|||
156615351|NCT03369704|565333948|FG001|Treatment Epoch|Adverse Event|0|||
156615352|NCT03369704|565333947|FG000|Follow-up Epoch|Lost to Follow-up|1|||
156615353|NCT03369704|565333948|FG001|Follow-up Epoch|Lost to Follow-up|0|||
156615354|NCT05333289|565333950|FG000|Overall Study|Other|1|||
156615355|NCT05333289|565333951|FG001|Overall Study|Other|0|||
156615356|NCT05333289|565333952|FG002|Overall Study|Other|0|||
156615357|NCT05333289|565333953|FG003|Overall Study|Other|1|||
156615358|NCT05333289|565333954|FG004|Overall Study|Other|1|||
156615359|NCT05333289|565333955|FG005|Overall Study|Other|2|||
156615360|NCT05333289|565333956|FG006|Overall Study|Other|2|||
156615361|NCT05333289|565333957|FG007|Overall Study|Other|0|||
156615362|NCT05333289|565333950|FG000|Overall Study|Withdrawal by Subject|1|||
156615363|NCT05333289|565333951|FG001|Overall Study|Withdrawal by Subject|2|||
156615364|NCT05333289|565333952|FG002|Overall Study|Withdrawal by Subject|2|||
156615365|NCT05333289|565333953|FG003|Overall Study|Withdrawal by Subject|1|||
156615366|NCT05333289|565333954|FG004|Overall Study|Withdrawal by Subject|1|||
156615367|NCT05333289|565333955|FG005|Overall Study|Withdrawal by Subject|2|||
156615368|NCT05333289|565333956|FG006|Overall Study|Withdrawal by Subject|1|||
156615369|NCT05333289|565333957|FG007|Overall Study|Withdrawal by Subject|3|||
156615370|NCT05333289|565333950|FG000|Overall Study|Protocol Violation|1|||
156615371|NCT05333289|565333951|FG001|Overall Study|Protocol Violation|0|||
156615372|NCT05333289|565333952|FG002|Overall Study|Protocol Violation|0|||
156615373|NCT05333289|565333953|FG003|Overall Study|Protocol Violation|0|||
156615374|NCT05333289|565333954|FG004|Overall Study|Protocol Violation|0|||
156615375|NCT05333289|565333955|FG005|Overall Study|Protocol Violation|0|||
156615376|NCT05333289|565333956|FG006|Overall Study|Protocol Violation|0|||
156615377|NCT05333289|565333957|FG007|Overall Study|Protocol Violation|0|||
156615378|NCT05333289|565333950|FG000|Overall Study|Physician Decision|0|||
156615379|NCT05333289|565333951|FG001|Overall Study|Physician Decision|0|||
156615380|NCT05333289|565333952|FG002|Overall Study|Physician Decision|1|||
156615381|NCT05333289|565333953|FG003|Overall Study|Physician Decision|0|||
156615382|NCT05333289|565333954|FG004|Overall Study|Physician Decision|0|||
156615383|NCT05333289|565333955|FG005|Overall Study|Physician Decision|2|||
156615384|NCT05333289|565333956|FG006|Overall Study|Physician Decision|0|||
156615385|NCT05333289|565333957|FG007|Overall Study|Physician Decision|0|||
156615386|NCT05333289|565333950|FG000|Overall Study|Lost to Follow-up|6|||
156615387|NCT05333289|565333951|FG001|Overall Study|Lost to Follow-up|0|||
156615388|NCT05333289|565333952|FG002|Overall Study|Lost to Follow-up|1|||
156615389|NCT05333289|565333953|FG003|Overall Study|Lost to Follow-up|6|||
156615390|NCT05333289|565333954|FG004|Overall Study|Lost to Follow-up|3|||
156615391|NCT05333289|565333955|FG005|Overall Study|Lost to Follow-up|3|||
156615392|NCT05333289|565333956|FG006|Overall Study|Lost to Follow-up|2|||
156615393|NCT05333289|565333957|FG007|Overall Study|Lost to Follow-up|1|||
156615394|NCT05333289|565333950|FG000|Overall Study|Death|1|||
156615395|NCT05333289|565333951|FG001|Overall Study|Death|0|||
156615396|NCT05333289|565333952|FG002|Overall Study|Death|0|||
156615397|NCT05333289|565333953|FG003|Overall Study|Death|0|||
156615398|NCT05333289|565333954|FG004|Overall Study|Death|0|||
156615399|NCT05333289|565333955|FG005|Overall Study|Death|0|||
156615400|NCT05333289|565333956|FG006|Overall Study|Death|0|||
156615401|NCT05333289|565333957|FG007|Overall Study|Death|0|||
156615402|NCT00372489|565333959|FG000|Overall Study|Adverse Event|18|||
156615403|NCT00372489|565333959|FG000|Overall Study|Lack of Efficacy|1|||
156615404|NCT00372489|565333959|FG000|Overall Study|Lost to Follow-up|3|||
156615405|NCT00372489|565333959|FG000|Overall Study|Physician Decision|3|||
156615406|NCT00372489|565333959|FG000|Overall Study|Withdrawal by Subject|5|||
156615407|NCT00372489|565333959|FG000|Overall Study|Patient Relocation|2|||
156615408|NCT00372489|565333959|FG000|Overall Study|Renal transplant|6|||
156615409|NCT00372489|565333959|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
156615410|NCT03733249|565333960|FG000|Overall Study|Death|7|||
156615411|NCT03733249|565333960|FG000|Overall Study|Disease relapse|16|||
156615412|NCT03733249|565333960|FG000|Overall Study|Lost to Follow-up|4|||
156615413|NCT03733249|565333960|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
156615414|NCT03733249|565333960|FG000|Overall Study|Withdrawal by Subject|1|||
156615415|NCT00772889|565333962|FG000|Overall Study|Adverse Event|7|||
156615416|NCT00772889|565333963|FG001|Overall Study|Adverse Event|4|||
156615417|NCT00772889|565333964|FG002|Overall Study|Adverse Event|0|||
156615418|NCT00772889|565333962|FG000|Overall Study|Withdrawal by Subject|9|||
156615419|NCT00772889|565333963|FG001|Overall Study|Withdrawal by Subject|8|||
156615420|NCT00772889|565333964|FG002|Overall Study|Withdrawal by Subject|9|||
156615421|NCT00772889|565333962|FG000|Overall Study|Lost to Follow-up|6|||
156615422|NCT00772889|565333963|FG001|Overall Study|Lost to Follow-up|6|||
156615423|NCT00772889|565333964|FG002|Overall Study|Lost to Follow-up|7|||
156615424|NCT03323086|565333965|FG000|Overall Study|Lost to Follow-up|3|||
156615425|NCT03323086|565333966|FG001|Overall Study|Lost to Follow-up|2|||
156615426|NCT00355615|565333967|FG000|Randomized Double Blind Period|Adverse Event|1|||
156615427|NCT00355615|565333968|FG001|Randomized Double Blind Period|Adverse Event|0|||
156615428|NCT00355615|565333969|FG002|Randomized Double Blind Period|Adverse Event|0|||
156615429|NCT00355615|565333970|FG003|Randomized Double Blind Period|Adverse Event|0|||
156615430|NCT00355615|565333971|FG004|Randomized Double Blind Period|Adverse Event|0|||
156615431|NCT00355615|565333967|FG000|Randomized Double Blind Period|Protocol Violation|0|||
156615432|NCT00355615|565333968|FG001|Randomized Double Blind Period|Protocol Violation|0|||
156615433|NCT00355615|565333969|FG002|Randomized Double Blind Period|Protocol Violation|1|||
156615434|NCT00355615|565333970|FG003|Randomized Double Blind Period|Protocol Violation|1|||
156615435|NCT00355615|565333971|FG004|Randomized Double Blind Period|Protocol Violation|0|||
156615436|NCT00355615|565333967|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
156615437|NCT00355615|565333968|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
156615438|NCT00355615|565333969|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
156615439|NCT00355615|565333970|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
156615440|NCT00355615|565333971|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
156615441|NCT00355615|565333967|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
156615442|NCT00355615|565333968|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
156615443|NCT00355615|565333969|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
156615444|NCT00355615|565333970|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
156615445|NCT00355615|565333971|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
156615446|NCT00355615|565333967|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
156615447|NCT00355615|565333968|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
156615448|NCT00355615|565333969|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
156615449|NCT00355615|565333970|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
156615450|NCT00355615|565333971|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
156615451|NCT00355615|565333967|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
156615452|NCT00355615|565333968|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
156615453|NCT00355615|565333969|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
156615454|NCT00355615|565333970|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
156615455|NCT00355615|565333971|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
156615456|NCT04259346|565333974|FG000|Overall Study|Lost to Follow-up|1|||
156615457|NCT04259346|565333975|FG001|Overall Study|Lost to Follow-up|3|||
156615458|NCT04259346|565333974|FG000|Overall Study|Protocol Violation|1|||
156615459|NCT04259346|565333975|FG001|Overall Study|Protocol Violation|0|||
156615460|NCT04259346|565333974|FG000|Overall Study|Withdrawal by Subject|1|||
156615461|NCT04259346|565333975|FG001|Overall Study|Withdrawal by Subject|0|||
156615462|NCT04259346|565333974|FG000|Overall Study|Adverse Event|1|||
156615463|NCT04259346|565333975|FG001|Overall Study|Adverse Event|1|||
156615464|NCT00085644|565333983|FG000|Double-Blind Period|Adverse Event|5|||
156615465|NCT00085644|565333984|FG001|Double-Blind Period|Adverse Event|2|||
156615466|NCT00085644|565333985|FG002|Double-Blind Period|Adverse Event|0|||
156615467|NCT00085644|565333983|FG000|Double-Blind Period|Withdrawal by Subject|3|||
156615468|NCT00085644|565333984|FG001|Double-Blind Period|Withdrawal by Subject|0|||
156615469|NCT00085644|565333985|FG002|Double-Blind Period|Withdrawal by Subject|0|||
156615470|NCT00085644|565333983|FG000|Double-Blind Period|Lost to Follow-up|2|||
156615471|NCT00085644|565333984|FG001|Double-Blind Period|Lost to Follow-up|1|||
156615472|NCT00085644|565333985|FG002|Double-Blind Period|Lost to Follow-up|0|||
156615473|NCT00085644|565333983|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
156615474|NCT00085644|565333984|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
156615475|NCT00085644|565333985|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
156615476|NCT00085644|565333983|FG000|Double-Blind Period|Contemplating pregnancy|1|||
156615477|NCT00085644|565333984|FG001|Double-Blind Period|Contemplating pregnancy|0|||
156615478|NCT00085644|565333985|FG002|Double-Blind Period|Contemplating pregnancy|0|||
156615479|NCT00085644|565333983|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
156615480|NCT00085644|565333984|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
156615481|NCT00085644|565333985|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
156615482|NCT00085644|565333983|FG000|Open-Label Period|Adverse Event|0|||
156615483|NCT00085644|565333984|FG001|Open-Label Period|Adverse Event|0|||
156615484|NCT00085644|565333985|FG002|Open-Label Period|Adverse Event|38|||
156615485|NCT00085644|565333983|FG000|Open-Label Period|Withdrawal by Subject|0|||
156615486|NCT00085644|565333984|FG001|Open-Label Period|Withdrawal by Subject|0|||
156615487|NCT00085644|565333985|FG002|Open-Label Period|Withdrawal by Subject|29|||
156615488|NCT00085644|565333983|FG000|Open-Label Period|Lost to Follow-up|0|||
156615489|NCT00085644|565333984|FG001|Open-Label Period|Lost to Follow-up|0|||
156615490|NCT00085644|565333985|FG002|Open-Label Period|Lost to Follow-up|13|||
156615491|NCT00085644|565333983|FG000|Open-Label Period|Lack of Efficacy|0|||
156615492|NCT00085644|565333984|FG001|Open-Label Period|Lack of Efficacy|0|||
156615493|NCT00085644|565333985|FG002|Open-Label Period|Lack of Efficacy|15|||
156615494|NCT00085644|565333983|FG000|Open-Label Period|Pregnancy|0|||
156615495|NCT00085644|565333984|FG001|Open-Label Period|Pregnancy|0|||
156615496|NCT00085644|565333985|FG002|Open-Label Period|Pregnancy|3|||
156615497|NCT00085644|565333983|FG000|Open-Label Period|Contemplating pregnancy|0|||
156615498|NCT00085644|565333984|FG001|Open-Label Period|Contemplating pregnancy|0|||
156615499|NCT00085644|565333985|FG002|Open-Label Period|Contemplating pregnancy|3|||
156615500|NCT00085644|565333983|FG000|Open-Label Period|Protocol Violation|0|||
156615501|NCT00085644|565333984|FG001|Open-Label Period|Protocol Violation|0|||
156615502|NCT00085644|565333985|FG002|Open-Label Period|Protocol Violation|4|||
156615503|NCT00085644|565333983|FG000|Open-Label Period|Personal reason|0|||
156615504|NCT00085644|565333984|FG001|Open-Label Period|Personal reason|0|||
156615505|NCT00085644|565333985|FG002|Open-Label Period|Personal reason|4|||
156615506|NCT03330106|565333986|FG000|Part A|Withdrawal by Subject|1|||
156615507|NCT03330106|565333987|FG001|Part A|Withdrawal by Subject|1|||
156615508|NCT03330106|565333988|FG002|Part A|Withdrawal by Subject|0|||
156615509|NCT03330106|565333989|FG003|Part A|Withdrawal by Subject|0|||
156615510|NCT03330106|565333986|FG000|Part A|Death|2|||
156615511|NCT03330106|565333987|FG001|Part A|Death|1|||
156615512|NCT03330106|565333988|FG002|Part A|Death|0|||
156615513|NCT03330106|565333989|FG003|Part A|Death|0|||
156615514|NCT03330106|565333986|FG000|Part A|Adverse Event|0|||
156615515|NCT03330106|565333987|FG001|Part A|Adverse Event|1|||
156615516|NCT03330106|565333988|FG002|Part A|Adverse Event|0|||
156615517|NCT03330106|565333989|FG003|Part A|Adverse Event|0|||
156615518|NCT03330106|565333986|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
156615519|NCT03330106|565333987|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
156615520|NCT03330106|565333988|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
156615521|NCT03330106|565333989|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
156615522|NCT03330106|565333986|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
156615523|NCT03330106|565333987|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
156615524|NCT03330106|565333988|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
156615525|NCT03330106|565333989|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
156615526|NCT03330106|565333986|FG000|Part A|Progressive Disease|0|||
156615527|NCT03330106|565333987|FG001|Part A|Progressive Disease|1|||
156615528|NCT03330106|565333988|FG002|Part A|Progressive Disease|0|||
156615529|NCT03330106|565333989|FG003|Part A|Progressive Disease|0|||
156615530|NCT03330106|565333986|FG000|Part B|Lost to Follow-up|0|||
156615531|NCT03330106|565333987|FG001|Part B|Lost to Follow-up|0|||
156615532|NCT03330106|565333988|FG002|Part B|Lost to Follow-up|0|||
156615533|NCT03330106|565333989|FG003|Part B|Lost to Follow-up|1|||
156615534|NCT03330106|565333986|FG000|Part B|Withdrawal by Subject|0|||
156615535|NCT03330106|565333987|FG001|Part B|Withdrawal by Subject|0|||
156615536|NCT03330106|565333988|FG002|Part B|Withdrawal by Subject|4|||
156615537|NCT03330106|565333989|FG003|Part B|Withdrawal by Subject|0|||
156615538|NCT03330106|565333986|FG000|Part B|Death|0|||
156615539|NCT03330106|565333987|FG001|Part B|Death|0|||
156615540|NCT03330106|565333988|FG002|Part B|Death|2|||
156615541|NCT03330106|565333989|FG003|Part B|Death|0|||
156615542|NCT03330106|565333986|FG000|Part B|Clinical Progression|0|||
156615543|NCT03330106|565333987|FG001|Part B|Clinical Progression|0|||
156615544|NCT03330106|565333988|FG002|Part B|Clinical Progression|1|||
156615545|NCT03330106|565333989|FG003|Part B|Clinical Progression|1|||
156615546|NCT03330106|565333986|FG000|Part B|Symptomatic Deterioration|0|||
156615547|NCT03330106|565333987|FG001|Part B|Symptomatic Deterioration|0|||
156615548|NCT03330106|565333988|FG002|Part B|Symptomatic Deterioration|0|||
156615549|NCT03330106|565333989|FG003|Part B|Symptomatic Deterioration|1|||
156615550|NCT03330106|565333986|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
156615551|NCT03330106|565333987|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
156615552|NCT03330106|565333988|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
156615553|NCT03330106|565333989|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
156615554|NCT03330106|565333986|FG000|Part B|Progressive Disease|0|||
156615555|NCT03330106|565333987|FG001|Part B|Progressive Disease|0|||
156615556|NCT03330106|565333988|FG002|Part B|Progressive Disease|11|||
156615557|NCT03330106|565333989|FG003|Part B|Progressive Disease|4|||
156615558|NCT00486889|565333991|FG000|Overall Study|Death|3|||
156615559|NCT00486889|565333991|FG000|Overall Study|Non-compliant|2|||
156615560|NCT00486889|565333991|FG000|Overall Study|Withdrawal by Subject|6|||
156615561|NCT01738594|565333993|FG000|Registration and Treatment Start|Adverse Event|0|||
156615562|NCT01738594|565333994|FG001|Registration and Treatment Start|Adverse Event|1|||
156615563|NCT01738594|565333995|FG002|Registration and Treatment Start|Adverse Event|0|||
156615564|NCT01738594|565333996|FG003|Registration and Treatment Start|Adverse Event|0|||
156615565|NCT01738594|565333997|FG004|Registration and Treatment Start|Adverse Event|0|||
156615566|NCT01738594|565333998|FG005|Registration and Treatment Start|Adverse Event|0|||
156615567|NCT01738594|565333999|FG006|Registration and Treatment Start|Adverse Event|0|||
156615568|NCT01738594|565334000|FG007|Registration and Treatment Start|Adverse Event|0|||
156615569|NCT01738594|565333993|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
156615570|NCT01738594|565333994|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
156615571|NCT01738594|565333995|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
156615572|NCT01738594|565333996|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
156615573|NCT01738594|565333997|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
156615574|NCT01738594|565333998|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
156615575|NCT01738594|565333999|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
156615576|NCT01738594|565334000|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
156615577|NCT01738594|565333993|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
156615578|NCT01738594|565333994|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
156615579|NCT01738594|565333995|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
156615580|NCT01738594|565333996|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
156615581|NCT01738594|565333997|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
156615582|NCT01738594|565333998|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
156615583|NCT01738594|565333999|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
156615584|NCT01738594|565334000|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
156615585|NCT01738594|565333993|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
156615586|NCT01738594|565333994|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
156615587|NCT01738594|565333995|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
156615588|NCT01738594|565333996|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
156615589|NCT01738594|565333997|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
156615590|NCT01738594|565333998|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
156615591|NCT01738594|565333999|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
156615592|NCT01738594|565334000|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
156615593|NCT01738594|565333993|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
156615594|NCT01738594|565333994|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
156615595|NCT01738594|565333995|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
156635096|NCT05012943|565407828|FG001|Overall Study|Adverse Event|1|||
156615596|NCT01738594|565333996|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
156615597|NCT01738594|565333997|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
156615598|NCT01738594|565333998|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
156615599|NCT01738594|565333999|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
156615600|NCT01738594|565334000|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
156615601|NCT01738594|565333993|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
156615602|NCT01738594|565333994|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
156615603|NCT01738594|565333995|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
156615604|NCT01738594|565333996|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
156615605|NCT01738594|565333997|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
156615606|NCT01738594|565333998|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
156615607|NCT01738594|565333999|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
156615608|NCT01738594|565334000|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
156615609|NCT01738594|565333993|FG000|Follow up for 1 Year|Death|0|||
156615610|NCT01738594|565333994|FG001|Follow up for 1 Year|Death|0|||
156615611|NCT01738594|565333995|FG002|Follow up for 1 Year|Death|0|||
156615612|NCT01738594|565333996|FG003|Follow up for 1 Year|Death|0|||
156615613|NCT01738594|565333997|FG004|Follow up for 1 Year|Death|0|||
156615614|NCT01738594|565333998|FG005|Follow up for 1 Year|Death|1|||
156615615|NCT01738594|565333999|FG006|Follow up for 1 Year|Death|0|||
156615616|NCT01738594|565334000|FG007|Follow up for 1 Year|Death|0|||
156615617|NCT01738594|565333993|FG000|Follow up for 1 Year|Other|0|||
156615618|NCT01738594|565333994|FG001|Follow up for 1 Year|Other|0|||
156615619|NCT01738594|565333995|FG002|Follow up for 1 Year|Other|0|||
156615620|NCT01738594|565333996|FG003|Follow up for 1 Year|Other|0|||
156615621|NCT01738594|565333997|FG004|Follow up for 1 Year|Other|0|||
156615622|NCT01738594|565333998|FG005|Follow up for 1 Year|Other|2|||
156615623|NCT01738594|565333999|FG006|Follow up for 1 Year|Other|0|||
156615624|NCT01738594|565334000|FG007|Follow up for 1 Year|Other|0|||
156615625|NCT04430036|565334003|FG000|Safety Run in Phase|Progression of disease|2|||
156615626|NCT00942422|565334004|FG000|Overall Study|Withdrawal by Subject|1|||
156615627|NCT00942422|565334004|FG000|Overall Study|Death|1|||
156615628|NCT00942422|565334004|FG000|Overall Study|Progressive diease|1|||
156615629|NCT01039428|565334008|FG000|Overall Study|Protocol Violation|1|||
156615630|NCT01039428|565334009|FG001|Overall Study|Protocol Violation|0|||
156615631|NCT01039428|565334008|FG000|Overall Study|Withdrawal by Subject|1|||
156615632|NCT01039428|565334009|FG001|Overall Study|Withdrawal by Subject|0|||
156615633|NCT01313039|565334010|FG000|Overall Study|Physician Decision|1|||
156615634|NCT01313039|565334010|FG000|Overall Study|Adverse Event|1|||
156615635|NCT00090766|565334011|FG000|Overall Study|Nephrectomy Planned|0|||
156615636|NCT00090766|565334012|FG001|Overall Study|Nephrectomy Planned|0|||
156615637|NCT00090766|565334013|FG002|Overall Study|Nephrectomy Planned|1|||
156615638|NCT00090766|565334011|FG000|Overall Study|Death|1|||
156615639|NCT00090766|565334012|FG001|Overall Study|Death|0|||
156615640|NCT00090766|565334013|FG002|Overall Study|Death|0|||
156615641|NCT00090766|565334011|FG000|Overall Study|Admin|0|||
156615642|NCT00090766|565334012|FG001|Overall Study|Admin|2|||
156615643|NCT00090766|565334013|FG002|Overall Study|Admin|0|||
156615644|NCT00090766|565334011|FG000|Overall Study|Lost to Follow-up|2|||
156615645|NCT00090766|565334012|FG001|Overall Study|Lost to Follow-up|0|||
156615646|NCT00090766|565334013|FG002|Overall Study|Lost to Follow-up|2|||
156615647|NCT00804986|565334014|FG000|Overall Study|Adverse Event|0|||
156615648|NCT00804986|565334015|FG001|Overall Study|Adverse Event|1|||
156615649|NCT00804986|565334016|FG002|Overall Study|Adverse Event|2|||
156615650|NCT00804986|565334017|FG003|Overall Study|Adverse Event|1|||
156615651|NCT00804986|565334018|FG004|Overall Study|Adverse Event|3|||
156615652|NCT00804986|565334019|FG005|Overall Study|Adverse Event|0|||
156615653|NCT00804986|565334014|FG000|Overall Study|Lack of Efficacy|0|||
156615654|NCT00804986|565334015|FG001|Overall Study|Lack of Efficacy|0|||
156615655|NCT00804986|565334016|FG002|Overall Study|Lack of Efficacy|0|||
156615656|NCT00804986|565334017|FG003|Overall Study|Lack of Efficacy|1|||
156615657|NCT00804986|565334018|FG004|Overall Study|Lack of Efficacy|0|||
156615658|NCT00804986|565334019|FG005|Overall Study|Lack of Efficacy|3|||
156615659|NCT00804986|565334014|FG000|Overall Study|Lost to Follow-up|0|||
156615660|NCT00804986|565334015|FG001|Overall Study|Lost to Follow-up|0|||
156615661|NCT00804986|565334016|FG002|Overall Study|Lost to Follow-up|0|||
156615662|NCT00804986|565334017|FG003|Overall Study|Lost to Follow-up|1|||
156615663|NCT00804986|565334018|FG004|Overall Study|Lost to Follow-up|1|||
156615664|NCT00804986|565334019|FG005|Overall Study|Lost to Follow-up|3|||
156615665|NCT00804986|565334014|FG000|Overall Study|Protocol Violation|0|||
156615666|NCT00804986|565334015|FG001|Overall Study|Protocol Violation|1|||
156615667|NCT00804986|565334016|FG002|Overall Study|Protocol Violation|0|||
156615668|NCT00804986|565334017|FG003|Overall Study|Protocol Violation|1|||
156615669|NCT00804986|565334018|FG004|Overall Study|Protocol Violation|0|||
156615670|NCT00804986|565334019|FG005|Overall Study|Protocol Violation|0|||
156615671|NCT00804986|565334014|FG000|Overall Study|Withdrawal by Subject|0|||
156615672|NCT00804986|565334015|FG001|Overall Study|Withdrawal by Subject|3|||
156615673|NCT00804986|565334016|FG002|Overall Study|Withdrawal by Subject|0|||
156615674|NCT00804986|565334017|FG003|Overall Study|Withdrawal by Subject|3|||
156615675|NCT00804986|565334018|FG004|Overall Study|Withdrawal by Subject|5|||
156615676|NCT00804986|565334019|FG005|Overall Study|Withdrawal by Subject|3|||
156615677|NCT00804986|565334014|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
156615678|NCT00804986|565334015|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
156615679|NCT00804986|565334016|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
156615680|NCT00804986|565334017|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
156615681|NCT00804986|565334018|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
156615682|NCT00804986|565334019|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
156615683|NCT00804986|565334014|FG000|Overall Study|Sponsor Decision|0|||
156615684|NCT00804986|565334015|FG001|Overall Study|Sponsor Decision|1|||
156615685|NCT00804986|565334016|FG002|Overall Study|Sponsor Decision|0|||
156615686|NCT00804986|565334017|FG003|Overall Study|Sponsor Decision|0|||
156615687|NCT00804986|565334018|FG004|Overall Study|Sponsor Decision|0|||
156615688|NCT00804986|565334019|FG005|Overall Study|Sponsor Decision|0|||
156615689|NCT00804986|565334014|FG000|Overall Study|Physician Decision|1|||
156615690|NCT00804986|565334015|FG001|Overall Study|Physician Decision|0|||
156615691|NCT00804986|565334016|FG002|Overall Study|Physician Decision|0|||
156615692|NCT00804986|565334017|FG003|Overall Study|Physician Decision|0|||
156615693|NCT00804986|565334018|FG004|Overall Study|Physician Decision|0|||
156615694|NCT00804986|565334019|FG005|Overall Study|Physician Decision|0|||
156615695|NCT02774291|565334020|FG000|Overall Study|Lost to Follow-up|1|||
156615696|NCT00397891|565334027|FG000|Overall Study|Withdrawal by Subject|1|||
156615697|NCT00397891|565334028|FG001|Overall Study|Withdrawal by Subject|0|||
156615698|NCT00397891|565334029|FG002|Overall Study|Withdrawal by Subject|0|||
156615699|NCT00397891|565334030|FG003|Overall Study|Withdrawal by Subject|0|||
156615700|NCT00397891|565334031|FG004|Overall Study|Withdrawal by Subject|1|||
156615701|NCT00412113|565334032|FG000|Overall Study|Adverse Event|11|||
156615702|NCT00412113|565334033|FG001|Overall Study|Adverse Event|15|||
156615703|NCT00412113|565334032|FG000|Overall Study|did not receive treatment|1|||
156615704|NCT00412113|565334033|FG001|Overall Study|did not receive treatment|0|||
156615705|NCT00796224|565334036|FG000|Overall Study|Adverse Event|1|||
156615706|NCT00796224|565334037|FG001|Overall Study|Adverse Event|0|||
156615707|NCT00796224|565334036|FG000|Overall Study|Protocol Violation|0|||
156615708|NCT00796224|565334037|FG001|Overall Study|Protocol Violation|1|||
156615709|NCT02116361|565334038|FG000|Overall Study|Pregnancy|0|||
156615710|NCT02116361|565334039|FG001|Overall Study|Pregnancy|0|||
156615711|NCT02116361|565334040|FG002|Overall Study|Pregnancy|0|||
156615712|NCT02116361|565334041|FG003|Overall Study|Pregnancy|1|||
156615713|NCT02116361|565334038|FG000|Overall Study|Protocol Violation|1|||
156615714|NCT02116361|565334039|FG001|Overall Study|Protocol Violation|0|||
156615715|NCT02116361|565334040|FG002|Overall Study|Protocol Violation|0|||
156615716|NCT02116361|565334041|FG003|Overall Study|Protocol Violation|2|||
156615717|NCT02116361|565334038|FG000|Overall Study|Physician Decision|2|||
156615718|NCT02116361|565334039|FG001|Overall Study|Physician Decision|3|||
156615719|NCT02116361|565334040|FG002|Overall Study|Physician Decision|0|||
156615720|NCT02116361|565334041|FG003|Overall Study|Physician Decision|0|||
156615721|NCT02116361|565334038|FG000|Overall Study|Adverse Event|1|||
156615722|NCT02116361|565334039|FG001|Overall Study|Adverse Event|0|||
156615723|NCT02116361|565334040|FG002|Overall Study|Adverse Event|0|||
156615724|NCT02116361|565334041|FG003|Overall Study|Adverse Event|3|||
156615725|NCT02116361|565334038|FG000|Overall Study|Other Reasons|3|||
156615726|NCT02116361|565334039|FG001|Overall Study|Other Reasons|3|||
156615727|NCT02116361|565334040|FG002|Overall Study|Other Reasons|3|||
156615728|NCT02116361|565334041|FG003|Overall Study|Other Reasons|3|||
156615729|NCT02116361|565334038|FG000|Overall Study|Lack of Efficacy|5|||
156615730|NCT02116361|565334039|FG001|Overall Study|Lack of Efficacy|7|||
156615731|NCT02116361|565334040|FG002|Overall Study|Lack of Efficacy|4|||
156615732|NCT02116361|565334041|FG003|Overall Study|Lack of Efficacy|3|||
156615733|NCT02116361|565334038|FG000|Overall Study|Lost to Follow-up|4|||
156615734|NCT02116361|565334039|FG001|Overall Study|Lost to Follow-up|5|||
156615735|NCT02116361|565334040|FG002|Overall Study|Lost to Follow-up|7|||
156615736|NCT02116361|565334041|FG003|Overall Study|Lost to Follow-up|5|||
156615737|NCT02116361|565334038|FG000|Overall Study|Personal Reasons|6|||
156615738|NCT02116361|565334039|FG001|Overall Study|Personal Reasons|6|||
156615739|NCT02116361|565334040|FG002|Overall Study|Personal Reasons|4|||
156615740|NCT02116361|565334041|FG003|Overall Study|Personal Reasons|9|||
156615741|NCT02116361|565334038|FG000|Overall Study|Investigator Decision - Relapse|9|||
156615742|NCT02116361|565334039|FG001|Overall Study|Investigator Decision - Relapse|7|||
156615743|NCT02116361|565334040|FG002|Overall Study|Investigator Decision - Relapse|8|||
156615744|NCT02116361|565334041|FG003|Overall Study|Investigator Decision - Relapse|5|||
156615745|NCT03227224|565334044|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
156615746|NCT03227224|565334045|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
156615747|NCT03227224|565334046|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
156615748|NCT03227224|565334047|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
156615749|NCT03227224|565334044|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
156615750|NCT03227224|565334045|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
156615751|NCT03227224|565334046|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
156615752|NCT03227224|565334047|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
156615753|NCT03227224|565334044|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
156615754|NCT03227224|565334045|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
156615755|NCT03227224|565334046|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
156615756|NCT03227224|565334047|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
156615757|NCT03227224|565334044|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
156615758|NCT03227224|565334045|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156615759|NCT03227224|565334046|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156615760|NCT03227224|565334047|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156615761|NCT03227224|565334044|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
156615762|NCT03227224|565334045|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
156615763|NCT03227224|565334046|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
156615764|NCT03227224|565334047|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
156615765|NCT03227224|565334044|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
156615766|NCT03227224|565334045|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
156615767|NCT03227224|565334046|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
156615768|NCT03227224|565334047|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
156615769|NCT03227224|565334044|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
156615770|NCT03227224|565334045|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
156615771|NCT03227224|565334046|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
156615772|NCT03227224|565334047|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
156615773|NCT03227224|565334044|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
156615774|NCT03227224|565334045|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
156615775|NCT03227224|565334046|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
156615776|NCT03227224|565334047|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
156615777|NCT03227224|565334044|FG000|Follow-up Phase (2 Weeks)|Other|4|||
156615778|NCT03227224|565334045|FG001|Follow-up Phase (2 Weeks)|Other|4|||
156615779|NCT03227224|565334046|FG002|Follow-up Phase (2 Weeks)|Other|6|||
156615780|NCT03227224|565334047|FG003|Follow-up Phase (2 Weeks)|Other|3|||
156615781|NCT04195750|565334048|FG000|Overall Study|Death|245|||
156615782|NCT04195750|565334049|FG001|Overall Study|Death|253|||
156615783|NCT04195750|565334050|FG002|Overall Study|Death|5|||
156615784|NCT04195750|565334048|FG000|Overall Study|Physician Decision|0|||
156615785|NCT04195750|565334049|FG001|Overall Study|Physician Decision|1|||
156615786|NCT04195750|565334050|FG002|Overall Study|Physician Decision|0|||
156615787|NCT04195750|565334048|FG000|Overall Study|Withdrawal by Subject|9|||
156615788|NCT04195750|565334049|FG001|Overall Study|Withdrawal by Subject|8|||
156615789|NCT04195750|565334050|FG002|Overall Study|Withdrawal by Subject|0|||
156615790|NCT04195750|565334048|FG000|Overall Study|Ongoing|120|||
156615791|NCT04195750|565334049|FG001|Overall Study|Ongoing|110|||
156615792|NCT04195750|565334050|FG002|Overall Study|Ongoing|4|||
156615793|NCT02406027|565334051|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
156615794|NCT02406027|565334052|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
156615795|NCT02406027|565334053|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
156615796|NCT02406027|565334054|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
156615797|NCT02406027|565334055|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
156615798|NCT02406027|565334056|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
156615799|NCT02406027|565334057|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
156615800|NCT02406027|565334051|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
156615801|NCT02406027|565334052|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
156615802|NCT02406027|565334053|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
156615803|NCT02406027|565334054|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
156615804|NCT02406027|565334055|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
156615805|NCT02406027|565334056|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
156615806|NCT02406027|565334057|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
156615807|NCT02406027|565334051|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
156615808|NCT02406027|565334052|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
156615809|NCT02406027|565334053|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
156615810|NCT02406027|565334054|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
156615811|NCT02406027|565334055|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
156615812|NCT02406027|565334056|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
156615813|NCT02406027|565334057|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
156615814|NCT02406027|565334051|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
156615815|NCT02406027|565334052|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
156615816|NCT02406027|565334053|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
156615817|NCT02406027|565334054|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
156615818|NCT02406027|565334055|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
156615819|NCT02406027|565334056|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
156615820|NCT02406027|565334057|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
156615821|NCT02406027|565334051|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
156615822|NCT02406027|565334052|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
156615823|NCT02406027|565334053|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
156615824|NCT02406027|565334054|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
156615825|NCT02406027|565334055|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
156615826|NCT02406027|565334056|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
156615827|NCT02406027|565334057|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
156615828|NCT02406027|565334051|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
156615829|NCT02406027|565334052|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
156615830|NCT02406027|565334053|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
156615831|NCT02406027|565334054|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
156615832|NCT02406027|565334055|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
156615833|NCT02406027|565334056|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
156615834|NCT02406027|565334057|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
156615835|NCT02406027|565334051|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
156615836|NCT02406027|565334052|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
156615837|NCT02406027|565334053|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
156615838|NCT02406027|565334054|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
156615839|NCT02406027|565334055|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
156615840|NCT02406027|565334056|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
156615841|NCT02406027|565334057|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
156615842|NCT02406027|565334051|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
156615843|NCT02406027|565334052|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
156615844|NCT02406027|565334053|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
156615845|NCT02406027|565334054|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
156615846|NCT02406027|565334055|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
156615847|NCT02406027|565334056|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
156615848|NCT02406027|565334057|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
156615849|NCT02406027|565334051|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
156615850|NCT02406027|565334052|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
156615851|NCT02406027|565334053|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
156615852|NCT02406027|565334054|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
156615853|NCT02406027|565334055|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
156615854|NCT02406027|565334056|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
156615855|NCT02406027|565334057|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
156615856|NCT02406027|565334051|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
156615857|NCT02406027|565334052|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
156615858|NCT02406027|565334053|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
156615859|NCT02406027|565334054|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
156615860|NCT02406027|565334055|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
156615861|NCT02406027|565334056|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
156615862|NCT02406027|565334057|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
156615863|NCT03782376|565334058|FG000|Overall Study|Lost to Follow-up|2|||
156615864|NCT03782376|565334059|FG001|Overall Study|Lost to Follow-up|2|||
156615865|NCT03782376|565334058|FG000|Overall Study|Withdrawal by Subject|7|||
156615866|NCT03782376|565334059|FG001|Overall Study|Withdrawal by Subject|11|||
156615867|NCT03782376|565334058|FG000|Overall Study|Death|1|||
156615868|NCT03782376|565334059|FG001|Overall Study|Death|0|||
156615869|NCT03782376|565334058|FG000|Overall Study|Other|16|||
156615870|NCT03782376|565334059|FG001|Overall Study|Other|17|||
156615871|NCT02659098|565334060|FG000|Overall Study|Withdrawal by Subject|7|||
156615872|NCT04363944|565334061|FG000|Overall Study|Withdrawal by Subject|2|||
156615873|NCT04363944|565334062|FG001|Overall Study|Withdrawal by Subject|0|||
156615874|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
156615875|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
156615876|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Death|0|||
156615877|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Death|4|||
156615878|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
156615879|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
156615880|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
156615881|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
156615882|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
156615883|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
156615884|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
156615885|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
156615886|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
156615887|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
156615888|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Other|4|||
156615889|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Other|3|||
156615890|NCT03517722|565334063|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
156615891|NCT03517722|565334064|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
156615892|NCT03517722|565334063|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
156615893|NCT03517722|565334064|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
156615894|NCT03517722|565334063|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
156615895|NCT03517722|565334064|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
156615896|NCT03517722|565334063|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
156615897|NCT03517722|565334064|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
156615898|NCT03517722|565334063|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
156615899|NCT03517722|565334064|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
156615900|NCT03573804|565334065|FG000|Overall Study|claustrophobia or MRI table problems|10|||
156615901|NCT00952419|565334066|FG000|Overall Study|Adverse Event|2|||
156615902|NCT00952419|565334067|FG001|Overall Study|Adverse Event|0|||
156615903|NCT00952419|565334068|FG002|Overall Study|Adverse Event|0|||
156615904|NCT00952419|565334066|FG000|Overall Study|Protocol Violation|3|||
156615905|NCT00952419|565334067|FG001|Overall Study|Protocol Violation|7|||
156615906|NCT00952419|565334068|FG002|Overall Study|Protocol Violation|0|||
156615907|NCT00952419|565334066|FG000|Overall Study|Withdrawal by Subject|1|||
156615908|NCT00952419|565334067|FG001|Overall Study|Withdrawal by Subject|3|||
156615909|NCT00952419|565334068|FG002|Overall Study|Withdrawal by Subject|0|||
156615910|NCT01654224|565335336|FG000|Overall Study|Lost to Follow-up|2|||
156615911|NCT01654224|565335337|FG001|Overall Study|Lost to Follow-up|2|||
156615912|NCT01654224|565335336|FG000|Overall Study|Did not receive allocation|1|||
156615913|NCT01654224|565335337|FG001|Overall Study|Did not receive allocation|8|||
156615914|NCT01654224|565335336|FG000|Overall Study|Insufficient blood sample|3|||
156615915|NCT01654224|565335337|FG001|Overall Study|Insufficient blood sample|2|||
156615916|NCT03763942|565335338|FG000|Overall Study|Lost to Follow-up|114|||
156615917|NCT03763942|565335339|FG001|Overall Study|Lost to Follow-up|54|||
156615918|NCT03763942|565335338|FG000|Overall Study|Protocol Violation|1|||
156615919|NCT03763942|565335339|FG001|Overall Study|Protocol Violation|0|||
156615920|NCT03763942|565335338|FG000|Overall Study|Withdrawal by Subject|2|||
156615921|NCT03763942|565335339|FG001|Overall Study|Withdrawal by Subject|0|||
156615922|NCT03763942|565335338|FG000|Overall Study|Other|2|||
156615923|NCT03763942|565335339|FG001|Overall Study|Other|3|||
156615924|NCT00166504|565335340|FG000|Overall Study|Adverse Event|3|||
156615925|NCT00166504|565335341|FG001|Overall Study|Adverse Event|3|||
156615926|NCT00166504|565335340|FG000|Overall Study|Lost to Follow-up|1|||
156615927|NCT00166504|565335341|FG001|Overall Study|Lost to Follow-up|1|||
156615928|NCT00166504|565335340|FG000|Overall Study|Withdrawal by Subject|1|||
156615929|NCT00166504|565335341|FG001|Overall Study|Withdrawal by Subject|0|||
156615930|NCT04423718|565335344|FG000|Main Study|Adverse Event|9|||
156615931|NCT04423718|565335345|FG001|Main Study|Adverse Event|5|||
156615932|NCT04423718|565335346|FG002|Main Study|Adverse Event|8|||
156615933|NCT04423718|565335344|FG000|Main Study|Physician Decision|3|||
156615934|NCT04423718|565335345|FG001|Main Study|Physician Decision|3|||
156615935|NCT04423718|565335346|FG002|Main Study|Physician Decision|2|||
156615936|NCT04423718|565335344|FG000|Main Study|Protocol Violation|0|||
156615937|NCT04423718|565335345|FG001|Main Study|Protocol Violation|0|||
156615938|NCT04423718|565335346|FG002|Main Study|Protocol Violation|1|||
156615939|NCT04423718|565335344|FG000|Main Study|Lost to Follow-up|3|||
156615940|NCT04423718|565335345|FG001|Main Study|Lost to Follow-up|3|||
156615941|NCT04423718|565335346|FG002|Main Study|Lost to Follow-up|4|||
156615942|NCT04423718|565335344|FG000|Main Study|Lack of Efficacy|2|||
156615943|NCT04423718|565335345|FG001|Main Study|Lack of Efficacy|1|||
156615944|NCT04423718|565335346|FG002|Main Study|Lack of Efficacy|0|||
156615945|NCT04423718|565335344|FG000|Main Study|Withdrawal by Subject|14|||
156615946|NCT04423718|565335345|FG001|Main Study|Withdrawal by Subject|20|||
156615947|NCT04423718|565335346|FG002|Main Study|Withdrawal by Subject|20|||
156615948|NCT04423718|565335344|FG000|Main Study|Death|10|||
156615949|NCT04423718|565335345|FG001|Main Study|Death|7|||
156615950|NCT04423718|565335346|FG002|Main Study|Death|7|||
156615951|NCT04423718|565335344|FG000|Main Study|COVID-19 pandemic|2|||
156615952|NCT04423718|565335345|FG001|Main Study|COVID-19 pandemic|2|||
156615953|NCT04423718|565335346|FG002|Main Study|COVID-19 pandemic|2|||
156615954|NCT04423718|565335344|FG000|Main Study|Other|7|||
156615955|NCT04423718|565335345|FG001|Main Study|Other|3|||
156615956|NCT04423718|565335346|FG002|Main Study|Other|2|||
156615957|NCT04423718|565335344|FG000|Extension Phase|Other|1|||
156615958|NCT04423718|565335345|FG001|Extension Phase|Other|0|||
156615959|NCT04423718|565335346|FG002|Extension Phase|Other|0|||
156615960|NCT04423718|565335344|FG000|Extension Phase|Logistical problems|0|||
156615961|NCT04423718|565335345|FG001|Extension Phase|Logistical problems|1|||
156615962|NCT04423718|565335346|FG002|Extension Phase|Logistical problems|1|||
156615963|NCT04423718|565335344|FG000|Extension Phase|Physician Decision|1|||
156615964|NCT04423718|565335345|FG001|Extension Phase|Physician Decision|0|||
156615965|NCT04423718|565335346|FG002|Extension Phase|Physician Decision|1|||
156615966|NCT04423718|565335344|FG000|Extension Phase|Lack of Efficacy|2|||
156615967|NCT04423718|565335345|FG001|Extension Phase|Lack of Efficacy|0|||
156615968|NCT04423718|565335346|FG002|Extension Phase|Lack of Efficacy|1|||
156615969|NCT04423718|565335344|FG000|Extension Phase|Lost to Follow-up|0|||
156615970|NCT04423718|565335345|FG001|Extension Phase|Lost to Follow-up|2|||
156615971|NCT04423718|565335346|FG002|Extension Phase|Lost to Follow-up|3|||
156615972|NCT04423718|565335344|FG000|Extension Phase|Adverse Event|2|||
156615973|NCT04423718|565335345|FG001|Extension Phase|Adverse Event|3|||
156615974|NCT04423718|565335346|FG002|Extension Phase|Adverse Event|1|||
156615975|NCT04423718|565335344|FG000|Extension Phase|Death|4|||
156615976|NCT04423718|565335345|FG001|Extension Phase|Death|7|||
156615977|NCT04423718|565335346|FG002|Extension Phase|Death|2|||
156615978|NCT04423718|565335344|FG000|Extension Phase|Withdrawal by Subject|11|||
156615979|NCT04423718|565335345|FG001|Extension Phase|Withdrawal by Subject|11|||
156615980|NCT04423718|565335346|FG002|Extension Phase|Withdrawal by Subject|7|||
156615981|NCT05298774|565335349|FG000|Overall Study|Physician Decision|3|||
156615982|NCT05298774|565335349|FG000|Overall Study|Withdrawal by Subject|2|||
156615983|NCT05298774|565335349|FG000|Overall Study|Lost to Follow-up|3|||
156615984|NCT05298774|565335349|FG000|Overall Study|Screen failure|1|||
156615985|NCT04992507|565335350|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
156615986|NCT04992507|565335351|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
156615987|NCT04992507|565335350|FG000|Overall Study|Death|0|||
156615988|NCT04992507|565335351|FG001|Overall Study|Death|1|||
156615989|NCT04651777|565335352|FG000|Overall Study|Adverse Event|1|||
156615990|NCT04651777|565335352|FG000|Overall Study|Withdrawal by Subject|2|||
156615991|NCT03070119|565335353|FG000|Overall Study|Adverse Event|0|||
156615992|NCT03070119|565335354|FG001|Overall Study|Adverse Event|0|||
156615993|NCT03070119|565335355|FG002|Overall Study|Adverse Event|1|||
156615994|NCT03070119|565335353|FG000|Overall Study|Lost to Follow-up|0|||
156615995|NCT03070119|565335354|FG001|Overall Study|Lost to Follow-up|1|||
156615996|NCT03070119|565335355|FG002|Overall Study|Lost to Follow-up|0|||
156615997|NCT03070119|565335353|FG000|Overall Study|Consent Withdrawn|6|||
156615998|NCT03070119|565335354|FG001|Overall Study|Consent Withdrawn|5|||
156615999|NCT03070119|565335355|FG002|Overall Study|Consent Withdrawn|3|||
156616000|NCT03070119|565335353|FG000|Overall Study|Investigator Decision|0|||
156616001|NCT03070119|565335354|FG001|Overall Study|Investigator Decision|0|||
156616002|NCT03070119|565335355|FG002|Overall Study|Investigator Decision|1|||
156616003|NCT03070119|565335353|FG000|Overall Study|Death|7|||
156616004|NCT03070119|565335354|FG001|Overall Study|Death|14|||
156616005|NCT03070119|565335355|FG002|Overall Study|Death|5|||
156616006|NCT03070119|565335353|FG000|Overall Study|Disease Progression|5|||
156616007|NCT03070119|565335354|FG001|Overall Study|Disease Progression|7|||
156616008|NCT03070119|565335355|FG002|Overall Study|Disease Progression|7|||
156616009|NCT03070119|565335353|FG000|Overall Study|Reason not Specified|2|||
156616010|NCT03070119|565335354|FG001|Overall Study|Reason not Specified|2|||
156616011|NCT03070119|565335355|FG002|Overall Study|Reason not Specified|1|||
156616012|NCT01023516|565335356|FG000|Overall Study|Voluntary discontinuation|7|||
156616013|NCT01023516|565335357|FG001|Overall Study|Voluntary discontinuation|5|||
156616014|NCT01023516|565335356|FG000|Overall Study|Adverse Event|9|||
156616015|NCT01023516|565335357|FG001|Overall Study|Adverse Event|6|||
156616016|NCT01023516|565335356|FG000|Overall Study|Safety reason|0|||
156616017|NCT01023516|565335357|FG001|Overall Study|Safety reason|3|||
156616018|NCT01023516|565335356|FG000|Overall Study|Study-specific criteria|4|||
156616019|NCT01023516|565335357|FG001|Overall Study|Study-specific criteria|2|||
156616020|NCT01023516|565335356|FG000|Overall Study|Incorrect enrolment|4|||
156616021|NCT01023516|565335357|FG001|Overall Study|Incorrect enrolment|2|||
156616022|NCT01058395|565335358|FG000|Overall Study|Death|2|||
156616023|NCT01058395|565335359|FG001|Overall Study|Death|1|||
156616024|NCT01058395|565335358|FG000|Overall Study|Lost to Follow-up|1|||
156616025|NCT01058395|565335359|FG001|Overall Study|Lost to Follow-up|0|||
156616026|NCT01996865|565335360|FG000|Induction Period|Protocol Violation|1|||
156616027|NCT01996865|565335361|FG001|Induction Period|Protocol Violation|0|||
156616028|NCT01996865|565335362|FG002|Induction Period|Protocol Violation|0|||
156616029|NCT01996865|565335360|FG000|Induction Period|Progressive Disease|4|||
156616030|NCT01996865|565335361|FG001|Induction Period|Progressive Disease|0|||
156616031|NCT01996865|565335362|FG002|Induction Period|Progressive Disease|0|||
156616032|NCT01996865|565335360|FG000|Induction Period|Lost to Follow-up|10|||
156616033|NCT01996865|565335361|FG001|Induction Period|Lost to Follow-up|0|||
156616034|NCT01996865|565335362|FG002|Induction Period|Lost to Follow-up|0|||
156616035|NCT01996865|565335360|FG000|Induction Period|Other Reasons|13|||
156616036|NCT01996865|565335361|FG001|Induction Period|Other Reasons|0|||
156616037|NCT01996865|565335362|FG002|Induction Period|Other Reasons|0|||
156616038|NCT01996865|565335360|FG000|Induction Period|Adverse Event|20|||
156616039|NCT01996865|565335361|FG001|Induction Period|Adverse Event|0|||
156616040|NCT01996865|565335362|FG002|Induction Period|Adverse Event|0|||
156616041|NCT01996865|565335360|FG000|Induction Period|Withdrawal by Subject|60|||
156616042|NCT01996865|565335361|FG001|Induction Period|Withdrawal by Subject|0|||
156616043|NCT01996865|565335362|FG002|Induction Period|Withdrawal by Subject|0|||
156616044|NCT01996865|565335360|FG000|Induction Period|Death|111|||
156616045|NCT01996865|565335361|FG001|Induction Period|Death|0|||
156616046|NCT01996865|565335362|FG002|Induction Period|Death|0|||
156616047|NCT01996865|565335360|FG000|Maintenance Period|Protocol Violation|0|||
156616048|NCT01996865|565335361|FG001|Maintenance Period|Protocol Violation|1|||
156616049|NCT01996865|565335362|FG002|Maintenance Period|Protocol Violation|1|||
156616050|NCT01996865|565335360|FG000|Maintenance Period|Other reasons|0|||
156616051|NCT01996865|565335361|FG001|Maintenance Period|Other reasons|8|||
156616052|NCT01996865|565335362|FG002|Maintenance Period|Other reasons|5|||
156616053|NCT01996865|565335360|FG000|Maintenance Period|Progressive Disease|0|||
156616054|NCT01996865|565335361|FG001|Maintenance Period|Progressive Disease|6|||
156616055|NCT01996865|565335362|FG002|Maintenance Period|Progressive Disease|23|||
156616056|NCT01996865|565335360|FG000|Maintenance Period|Withdrawal by Subject|0|||
156616057|NCT01996865|565335361|FG001|Maintenance Period|Withdrawal by Subject|18|||
156616058|NCT01996865|565335362|FG002|Maintenance Period|Withdrawal by Subject|4|||
156616059|NCT01996865|565335360|FG000|Maintenance Period|Adverse Event|0|||
156616060|NCT01996865|565335361|FG001|Maintenance Period|Adverse Event|7|||
156616061|NCT01996865|565335362|FG002|Maintenance Period|Adverse Event|7|||
156616062|NCT01996865|565335360|FG000|Maintenance Period|Death|0|||
156616063|NCT01996865|565335361|FG001|Maintenance Period|Death|15|||
156616064|NCT01996865|565335362|FG002|Maintenance Period|Death|3|||
156616065|NCT01996865|565335360|FG000|Maintenance Period|Lost to Follow-up|0|||
156616066|NCT01996865|565335361|FG001|Maintenance Period|Lost to Follow-up|2|||
156616067|NCT01996865|565335362|FG002|Maintenance Period|Lost to Follow-up|0|||
156616068|NCT00515099|565335363|FG000|Overall Study|Lost to Follow-up|0|||
156616069|NCT00515099|565335364|FG001|Overall Study|Lost to Follow-up|4|||
156616070|NCT00515099|565335363|FG000|Overall Study|Withdrawal by Subject|2|||
156616071|NCT00515099|565335364|FG001|Overall Study|Withdrawal by Subject|0|||
156616072|NCT00515099|565335363|FG000|Overall Study|IRB Recommendation|1|||
156616073|NCT00515099|565335364|FG001|Overall Study|IRB Recommendation|0|||
156616074|NCT00376675|565335367|FG000|Overall Study|Withdrawal by Subject|9|||
156616075|NCT00376675|565335368|FG001|Overall Study|Withdrawal by Subject|2|||
156616076|NCT00376675|565335367|FG000|Overall Study|Adverse Event|10|||
156616077|NCT00376675|565335368|FG001|Overall Study|Adverse Event|5|||
156616078|NCT00376675|565335367|FG000|Overall Study|Other Reason|1|||
156616079|NCT00376675|565335368|FG001|Overall Study|Other Reason|7|||
156616080|NCT01332851|565335371|FG000|Overall Study|Withdrawal by Subject|4|||
156616081|NCT01332851|565335372|FG001|Overall Study|Withdrawal by Subject|2|||
156616082|NCT01332851|565335371|FG000|Overall Study|Lost to Follow-up|7|||
156616083|NCT01332851|565335372|FG001|Overall Study|Lost to Follow-up|11|||
156616084|NCT05559203|565335373|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
156616085|NCT01947894|565335374|FG000|Overall Study|Other|3|||
156616086|NCT01947894|565335375|FG001|Overall Study|Other|4|||
156616087|NCT01947894|565335376|FG002|Overall Study|Other|3|||
156616088|NCT01947894|565335374|FG000|Overall Study|Withdrawal by Subject|12|||
156616089|NCT01947894|565335375|FG001|Overall Study|Withdrawal by Subject|4|||
156616090|NCT01947894|565335376|FG002|Overall Study|Withdrawal by Subject|1|||
156616091|NCT01947894|565335374|FG000|Overall Study|Death|12|||
156616092|NCT01947894|565335375|FG001|Overall Study|Death|1|||
156616093|NCT01947894|565335376|FG002|Overall Study|Death|0|||
156616094|NCT01947894|565335374|FG000|Overall Study|Physician Decision|2|||
156616095|NCT01947894|565335375|FG001|Overall Study|Physician Decision|0|||
156616096|NCT01947894|565335376|FG002|Overall Study|Physician Decision|0|||
156616097|NCT01947894|565335374|FG000|Overall Study|Adverse Event|5|||
156616098|NCT01947894|565335375|FG001|Overall Study|Adverse Event|1|||
156616099|NCT01947894|565335376|FG002|Overall Study|Adverse Event|0|||
156616100|NCT01947894|565335374|FG000|Overall Study|Switched to other growth hormone brand|53|||
156616101|NCT01947894|565335375|FG001|Overall Study|Switched to other growth hormone brand|8|||
156616102|NCT01947894|565335376|FG002|Overall Study|Switched to other growth hormone brand|23|||
156616103|NCT03796195|565335377|FG000|Overall Study|Study closed early|1|||
156616104|NCT04445051|565335378|FG000|Overall Study|Adverse Event|0|||
156616105|NCT04445051|565335379|FG001|Overall Study|Adverse Event|0|||
156616106|NCT04445051|565335380|FG002|Overall Study|Adverse Event|1|||
156616107|NCT04445051|565335381|FG003|Overall Study|Adverse Event|0|||
156616108|NCT04445051|565335382|FG004|Overall Study|Adverse Event|0|||
156616109|NCT04445051|565335383|FG005|Overall Study|Adverse Event|0|||
156616110|NCT02392468|565335384|FG000|Overall Study|Adverse Event|0|||
156616111|NCT02392468|565335385|FG001|Overall Study|Adverse Event|1|||
156616112|NCT02392468|565335386|FG002|Overall Study|Adverse Event|0|||
156616113|NCT02392468|565335387|FG003|Overall Study|Adverse Event|0|||
156616114|NCT02392468|565335388|FG004|Overall Study|Adverse Event|0|||
156616115|NCT02392468|565335389|FG005|Overall Study|Adverse Event|1|||
156616116|NCT03630016|565335390|FG000|Overall Study|Poor Sensor Placement|1|||
156616117|NCT05083949|565335391|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
156616118|NCT05083949|565335392|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
156616119|NCT05083949|565335391|FG000|Period 1|Adverse Event|1|||
156616120|NCT05083949|565335392|FG001|Period 1|Adverse Event|1|||
156616121|NCT05083949|565335391|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
156616122|NCT05083949|565335392|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
156616123|NCT05083949|565335391|FG000|Period 2|Adverse Event|0|||
156616124|NCT05083949|565335392|FG001|Period 2|Adverse Event|2|||
156616125|NCT01678560|565335395|FG000|Overall Study|Physician Decision|4|||
156616126|NCT01678560|565335396|FG001|Overall Study|Physician Decision|4|||
156616127|NCT01678560|565335395|FG000|Overall Study|Death|0|||
156616128|NCT01678560|565335396|FG001|Overall Study|Death|1|||
156616129|NCT01678560|565335395|FG000|Overall Study|Withdrawal by Subject|0|||
156616130|NCT01678560|565335396|FG001|Overall Study|Withdrawal by Subject|1|||
156616131|NCT02201472|565335397|FG000|Overall Study|Lack of Efficacy|2|||
156616132|NCT01300767|565335398|FG000|Overall Study|Discomfort|2|||
156616133|NCT01300767|565335398|FG000|Overall Study|Biomicroscopy|1|||
156616134|NCT01300767|565335398|FG000|Overall Study|Unacceptable fit|1|||
156616135|NCT01188811|565335403|FG000|Overall Study|Withdrawal by Subject|0|||
156616136|NCT01188811|565335404|FG001|Overall Study|Withdrawal by Subject|2|||
156616137|NCT01188811|565335403|FG000|Overall Study|Adverse Event|6|||
156616138|NCT01188811|565335404|FG001|Overall Study|Adverse Event|0|||
156616139|NCT01602744|565335405|FG000|Overall Study|Death|17|||
156616140|NCT01602744|565335406|FG001|Overall Study|Death|15|||
156616141|NCT01602744|565335405|FG000|Overall Study|Lost to Follow-up|13|||
156616142|NCT01602744|565335406|FG001|Overall Study|Lost to Follow-up|8|||
156616143|NCT01316380|565335409|FG000|Overall Study|Adverse Event|0|||
156616144|NCT01316380|565335410|FG001|Overall Study|Adverse Event|2|||
156616145|NCT01316380|565335411|FG002|Overall Study|Adverse Event|1|||
156616146|NCT01316380|565335409|FG000|Overall Study|Protocol Violation|0|||
156616147|NCT01316380|565335410|FG001|Overall Study|Protocol Violation|0|||
156616148|NCT01316380|565335411|FG002|Overall Study|Protocol Violation|1|||
156616149|NCT01316380|565335409|FG000|Overall Study|Withdrawal by Subject|1|||
156616150|NCT01316380|565335410|FG001|Overall Study|Withdrawal by Subject|2|||
156616151|NCT01316380|565335411|FG002|Overall Study|Withdrawal by Subject|0|||
156616152|NCT01316380|565335409|FG000|Overall Study|Other|0|||
156616153|NCT01316380|565335410|FG001|Overall Study|Other|1|||
156616154|NCT01316380|565335411|FG002|Overall Study|Other|1|||
156616155|NCT01316380|565335409|FG000|Overall Study|Not treated|1|||
156616156|NCT01316380|565335410|FG001|Overall Study|Not treated|0|||
156616157|NCT01316380|565335411|FG002|Overall Study|Not treated|0|||
156616158|NCT00471315|565335413|FG000|Overall Study|Adverse Event|7|||
156616159|NCT00471315|565335413|FG000|Overall Study|Withdrawal by Subject|1|||
156616160|NCT00609167|565335417|FG000|Overall Study|Withdrawal by Subject|1|||
156616161|NCT00609167|565335418|FG001|Overall Study|Withdrawal by Subject|0|||
156616162|NCT00609167|565335417|FG000|Overall Study|Lack of Efficacy|1|||
156616163|NCT00609167|565335418|FG001|Overall Study|Lack of Efficacy|0|||
156616164|NCT00609167|565335417|FG000|Overall Study|Adverse Event|5|||
156616165|NCT00609167|565335418|FG001|Overall Study|Adverse Event|1|||
156616166|NCT00609167|565335417|FG000|Overall Study|Disease Progression|1|||
156616167|NCT00609167|565335418|FG001|Overall Study|Disease Progression|0|||
156616168|NCT00609167|565335417|FG000|Overall Study|Stem Cell Transplant|0|||
156616169|NCT00609167|565335418|FG001|Overall Study|Stem Cell Transplant|6|||
156616170|NCT00712270|565335419|FG000|Overall Study|Withdrawal by Subject|11|||
156616171|NCT00712270|565335419|FG000|Overall Study|Screen Failure|3|||
156616172|NCT02574520|565335420|FG000|Overall Study|Not dosed|2|||
156616173|NCT02574520|565335421|FG001|Overall Study|Not dosed|0|||
156616174|NCT02574520|565335422|FG002|Overall Study|Not dosed|5|||
156616175|NCT02574520|565335423|FG003|Overall Study|Not dosed|4|||
156616176|NCT02574520|565335420|FG000|Overall Study|Adverse Event|0|||
156616177|NCT02574520|565335421|FG001|Overall Study|Adverse Event|0|||
156616178|NCT02574520|565335422|FG002|Overall Study|Adverse Event|0|||
156616179|NCT02574520|565335423|FG003|Overall Study|Adverse Event|1|||
156616180|NCT02574520|565335420|FG000|Overall Study|Withdrawal by Subject|0|||
156616181|NCT02574520|565335421|FG001|Overall Study|Withdrawal by Subject|0|||
156616182|NCT02574520|565335422|FG002|Overall Study|Withdrawal by Subject|0|||
156616183|NCT02574520|565335423|FG003|Overall Study|Withdrawal by Subject|1|||
156616184|NCT02574520|565335420|FG000|Overall Study|Other|0|||
156616185|NCT02574520|565335421|FG001|Overall Study|Other|0|||
156616186|NCT02574520|565335422|FG002|Overall Study|Other|0|||
156616187|NCT02574520|565335423|FG003|Overall Study|Other|2|||
156616188|NCT01365091|565335426|FG000|Period 1|Adverse Event|1|||
156616189|NCT01365091|565335427|FG001|Period 1|Adverse Event|0|||
156616190|NCT01365091|565335428|FG002|Period 1|Adverse Event|2|||
156616191|NCT01365091|565335429|FG003|Period 1|Adverse Event|3|||
156616192|NCT01365091|565335426|FG000|Period 1|Positive test result for drugs of abuse|1|||
156616193|NCT01365091|565335427|FG001|Period 1|Positive test result for drugs of abuse|0|||
156616194|NCT01365091|565335428|FG002|Period 1|Positive test result for drugs of abuse|0|||
156616195|NCT01365091|565335429|FG003|Period 1|Positive test result for drugs of abuse|0|||
156616196|NCT01365091|565335426|FG000|Period 1|No longer met study criteria|0|||
156616197|NCT01365091|565335427|FG001|Period 1|No longer met study criteria|1|||
156616198|NCT01365091|565335428|FG002|Period 1|No longer met study criteria|0|||
156616199|NCT01365091|565335429|FG003|Period 1|No longer met study criteria|0|||
156616200|NCT01365091|565335426|FG000|Period 1|Withdrawal by Subject|0|||
156616201|NCT01365091|565335427|FG001|Period 1|Withdrawal by Subject|1|||
156616202|NCT01365091|565335428|FG002|Period 1|Withdrawal by Subject|0|||
156616203|NCT01365091|565335429|FG003|Period 1|Withdrawal by Subject|0|||
156616204|NCT01365091|565335426|FG000|Period 1|Personal reasons|0|||
156616205|NCT01365091|565335427|FG001|Period 1|Personal reasons|0|||
156616206|NCT01365091|565335428|FG002|Period 1|Personal reasons|1|||
156616207|NCT01365091|565335429|FG003|Period 1|Personal reasons|0|||
156616208|NCT01365091|565335426|FG000|Period 2|Withdrawal by Subject|1|||
156616209|NCT01365091|565335427|FG001|Period 2|Withdrawal by Subject|0|||
156616210|NCT01365091|565335428|FG002|Period 2|Withdrawal by Subject|0|||
156616211|NCT01365091|565335429|FG003|Period 2|Withdrawal by Subject|0|||
156616212|NCT01365091|565335426|FG000|Period 2|Adverse Event|0|||
156616213|NCT01365091|565335427|FG001|Period 2|Adverse Event|0|||
156616214|NCT01365091|565335428|FG002|Period 2|Adverse Event|1|||
156616215|NCT01365091|565335429|FG003|Period 2|Adverse Event|0|||
156616216|NCT03935594|565335440|FG000|Overall Study|Physician Decision|3|||
156616217|NCT01435122|565335441|FG000|Overall Study|Early withdrawal due to toxicity|8|||
156616218|NCT04412668|565335442|FG000|Overall Study|Death - multiple comorbidities|2|||
156616219|NCT04412668|565335443|FG001|Overall Study|Death - multiple comorbidities|0|||
156616220|NCT04412668|565335444|FG002|Overall Study|Death - multiple comorbidities|0|||
156616221|NCT04412668|565335442|FG000|Overall Study|Withdrawal by Subject|3|||
156616222|NCT04412668|565335443|FG001|Overall Study|Withdrawal by Subject|0|||
156616223|NCT04412668|565335444|FG002|Overall Study|Withdrawal by Subject|0|||
156616224|NCT04412668|565335442|FG000|Overall Study|Other than Specified|2|||
156616225|NCT04412668|565335443|FG001|Overall Study|Other than Specified|0|||
156616226|NCT04412668|565335444|FG002|Overall Study|Other than Specified|0|||
156616227|NCT03864627|565335446|FG000|Overall Study|Adverse Event|0|||
156616228|NCT03864627|565335447|FG001|Overall Study|Adverse Event|1|||
156616229|NCT03864627|565335446|FG000|Overall Study|Lack of Efficacy|0|||
156616230|NCT03864627|565335447|FG001|Overall Study|Lack of Efficacy|1|||
156616231|NCT03864627|565335446|FG000|Overall Study|Lost to Follow-up|0|||
156616232|NCT03864627|565335447|FG001|Overall Study|Lost to Follow-up|1|||
156616233|NCT03864627|565335446|FG000|Overall Study|Withdrawal by Subject|4|||
156616234|NCT03864627|565335447|FG001|Overall Study|Withdrawal by Subject|8|||
156616235|NCT03864627|565335446|FG000|Overall Study|Study terminated by sponsor|0|||
156616236|NCT03864627|565335447|FG001|Overall Study|Study terminated by sponsor|1|||
156616237|NCT01388491|565335448|FG000|Overall Study|Adverse Event|10|||
156616238|NCT01388491|565335449|FG001|Overall Study|Adverse Event|9|||
156616239|NCT01388491|565335448|FG000|Overall Study|Sponsor Request|9|||
156616240|NCT01388491|565335449|FG001|Overall Study|Sponsor Request|7|||
156616241|NCT01388491|565335448|FG000|Overall Study|Withdrawal by Subject|6|||
156616242|NCT01388491|565335449|FG001|Overall Study|Withdrawal by Subject|10|||
156616243|NCT01388491|565335448|FG000|Overall Study|Lost to Follow-up|4|||
156616244|NCT01388491|565335449|FG001|Overall Study|Lost to Follow-up|3|||
156616245|NCT01388491|565335448|FG000|Overall Study|Protocol Violation|2|||
156616246|NCT01388491|565335449|FG001|Overall Study|Protocol Violation|0|||
156616247|NCT01388491|565335448|FG000|Overall Study|Noncompliance|2|||
156616248|NCT01388491|565335449|FG001|Overall Study|Noncompliance|0|||
156616249|NCT01388491|565335448|FG000|Overall Study|Pregnancy|1|||
156616250|NCT01388491|565335449|FG001|Overall Study|Pregnancy|0|||
156616251|NCT04035473|565335451|FG000|Screening/Baseline|Death|0|||
156616252|NCT04035473|565335452|FG001|Screening/Baseline|Death|1|||
156616253|NCT04035473|565335451|FG000|Screening/Baseline|Adverse Event|0|||
156616254|NCT04035473|565335452|FG001|Screening/Baseline|Adverse Event|1|||
156616255|NCT04035473|565335451|FG000|Follow-up Period|Adverse Event|2|||
156616256|NCT04035473|565335452|FG001|Follow-up Period|Adverse Event|0|||
156616257|NCT00112840|565335453|FG000|Overall Study|Physician Decision|1|||
156616258|NCT00112840|565335454|FG001|Overall Study|Physician Decision|0|||
156616259|NCT00112840|565335455|FG002|Overall Study|Physician Decision|0|||
156616260|NCT00112840|565335453|FG000|Overall Study|Withdrawal by Subject|1|||
156616261|NCT00112840|565335454|FG001|Overall Study|Withdrawal by Subject|0|||
156616262|NCT00112840|565335455|FG002|Overall Study|Withdrawal by Subject|1|||
156616263|NCT00112840|565335453|FG000|Overall Study|Protocol Violation|0|||
156616264|NCT00112840|565335454|FG001|Overall Study|Protocol Violation|0|||
156616265|NCT00112840|565335455|FG002|Overall Study|Protocol Violation|5|||
156616266|NCT02875366|565335456|FG000|Overall Study|Adverse Event|0|||
156616267|NCT02875366|565335457|FG001|Overall Study|Adverse Event|2|||
156616268|NCT02875366|565335456|FG000|Overall Study|Noncompliance|0|||
156616269|NCT02875366|565335457|FG001|Overall Study|Noncompliance|1|||
156616270|NCT01201967|565335458|FG000|Overall Study|Lost to Follow-up|6|||
156616271|NCT01201967|565335459|FG001|Overall Study|Lost to Follow-up|5|||
156616272|NCT02497287|565335460|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
156616273|NCT02497287|565335460|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
156616274|NCT02497287|565335460|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
156616275|NCT02497287|565335460|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
156616276|NCT02497287|565335460|FG000|Induction Phase (4 Weeks)|Other|13|||
156616277|NCT02497287|565335460|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
156616278|NCT02497287|565335460|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
156616279|NCT02497287|565335460|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
156616280|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
156616281|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
156616282|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
156616283|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
156616284|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
156616285|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
156616286|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
156616287|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
156616288|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
156616289|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
156616290|NCT02497287|565335460|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
156616291|NCT02497287|565335460|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
156616292|NCT02497287|565335460|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
156616293|NCT02497287|565335460|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
156616294|NCT02497287|565335460|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
156616295|NCT02497287|565335460|FG000|Follow-up Phase (4 Week)|Other|1|||
156616296|NCT00740116|565337289|FG000|Overall Study|Withdrawal by Subject|1|||
156616297|NCT00740116|565337290|FG001|Overall Study|Withdrawal by Subject|1|||
156616298|NCT00740116|565337289|FG000|Overall Study|Protocol Violation|1|||
156616299|NCT00740116|565337290|FG001|Overall Study|Protocol Violation|4|||
156616300|NCT04076579|565337293|FG000|Overall Study|Adverse Event|2|||
156616301|NCT04076579|565337294|FG001|Overall Study|Adverse Event|0|||
156616302|NCT04076579|565337293|FG000|Overall Study|discontinued due to toxicity|1|||
156616303|NCT04076579|565337294|FG001|Overall Study|discontinued due to toxicity|0|||
156616304|NCT04076579|565337293|FG000|Overall Study|Physician Decision|1|||
156616305|NCT04076579|565337294|FG001|Overall Study|Physician Decision|0|||
156616306|NCT04076579|565337293|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
156616307|NCT04076579|565337294|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
156616308|NCT04076579|565337293|FG000|Overall Study|Noncompliance|0|||
156616309|NCT04076579|565337294|FG001|Overall Study|Noncompliance|1|||
156616310|NCT04076579|565337293|FG000|Overall Study|Withdrawal by Subject|0|||
156616311|NCT04076579|565337294|FG001|Overall Study|Withdrawal by Subject|2|||
156616312|NCT01997892|565337297|FG000|Overall Study|Physician Decision|2|||
156616313|NCT01997892|565337297|FG000|Overall Study|Lost to Follow-up|6|||
156616314|NCT01997892|565337297|FG000|Overall Study|Death|14|||
156616315|NCT01997892|565337297|FG000|Overall Study|Renal transplant|8|||
156616316|NCT01997892|565337297|FG000|Overall Study|Other|3|||
156616317|NCT01997892|565337297|FG000|Overall Study|Study completion data not recorded|35|||
156616318|NCT02531633|565337298|FG000|Part A (52 Weeks)|Sponsor request|24|||
156616319|NCT02531633|565337299|FG001|Part A (52 Weeks)|Sponsor request|24|||
156616320|NCT02531633|565337300|FG002|Part A (52 Weeks)|Sponsor request|18|||
156616321|NCT02531633|565337301|FG003|Part A (52 Weeks)|Sponsor request|18|||
156616322|NCT02531633|565337302|FG004|Part A (52 Weeks)|Sponsor request|19|||
156616323|NCT02531633|565337303|FG005|Part A (52 Weeks)|Sponsor request|0|||
156616324|NCT02531633|565337304|FG006|Part A (52 Weeks)|Sponsor request|0|||
156616325|NCT02531633|565337305|FG007|Part A (52 Weeks)|Sponsor request|0|||
156616326|NCT02531633|565337306|FG008|Part A (52 Weeks)|Sponsor request|0|||
156616327|NCT02531633|565337307|FG009|Part A (52 Weeks)|Sponsor request|0|||
156616328|NCT02531633|565337298|FG000|Part A (52 Weeks)|Protocol Violation|1|||
156616329|NCT02531633|565337299|FG001|Part A (52 Weeks)|Protocol Violation|0|||
156616330|NCT02531633|565337300|FG002|Part A (52 Weeks)|Protocol Violation|0|||
156616331|NCT02531633|565337301|FG003|Part A (52 Weeks)|Protocol Violation|0|||
156616332|NCT02531633|565337302|FG004|Part A (52 Weeks)|Protocol Violation|0|||
156616333|NCT02531633|565337303|FG005|Part A (52 Weeks)|Protocol Violation|0|||
156616334|NCT02531633|565337304|FG006|Part A (52 Weeks)|Protocol Violation|0|||
156616335|NCT02531633|565337305|FG007|Part A (52 Weeks)|Protocol Violation|0|||
156616336|NCT02531633|565337306|FG008|Part A (52 Weeks)|Protocol Violation|0|||
156616337|NCT02531633|565337307|FG009|Part A (52 Weeks)|Protocol Violation|0|||
156616338|NCT02531633|565337298|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
156616339|NCT02531633|565337299|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
156616340|NCT02531633|565337300|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
156616341|NCT02531633|565337301|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
156616342|NCT02531633|565337302|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
156616343|NCT02531633|565337303|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
156616344|NCT02531633|565337304|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
156616345|NCT02531633|565337305|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
156616346|NCT02531633|565337306|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
156616347|NCT02531633|565337307|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
156616348|NCT02531633|565337298|FG000|Part A (52 Weeks)|Physician Decision|1|||
156616349|NCT02531633|565337299|FG001|Part A (52 Weeks)|Physician Decision|4|||
156616350|NCT02531633|565337300|FG002|Part A (52 Weeks)|Physician Decision|3|||
156616351|NCT02531633|565337301|FG003|Part A (52 Weeks)|Physician Decision|1|||
156616352|NCT02531633|565337302|FG004|Part A (52 Weeks)|Physician Decision|0|||
156616353|NCT02531633|565337303|FG005|Part A (52 Weeks)|Physician Decision|0|||
156616354|NCT02531633|565337304|FG006|Part A (52 Weeks)|Physician Decision|0|||
156616355|NCT02531633|565337305|FG007|Part A (52 Weeks)|Physician Decision|0|||
156616356|NCT02531633|565337306|FG008|Part A (52 Weeks)|Physician Decision|0|||
156616357|NCT02531633|565337307|FG009|Part A (52 Weeks)|Physician Decision|0|||
156616358|NCT02531633|565337298|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
156616359|NCT02531633|565337299|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
156616360|NCT02531633|565337300|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
156616361|NCT02531633|565337301|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
156616362|NCT02531633|565337302|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
156616363|NCT02531633|565337303|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
156616364|NCT02531633|565337304|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
156616365|NCT02531633|565337305|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
156616366|NCT02531633|565337306|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
156616367|NCT02531633|565337307|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
156616368|NCT02531633|565337298|FG000|Part A (52 Weeks)|Other|2|||
156616369|NCT02531633|565337299|FG001|Part A (52 Weeks)|Other|0|||
156616370|NCT02531633|565337300|FG002|Part A (52 Weeks)|Other|0|||
156616371|NCT02531633|565337301|FG003|Part A (52 Weeks)|Other|0|||
156616372|NCT02531633|565337302|FG004|Part A (52 Weeks)|Other|0|||
156616373|NCT02531633|565337303|FG005|Part A (52 Weeks)|Other|0|||
156616374|NCT02531633|565337304|FG006|Part A (52 Weeks)|Other|0|||
156616375|NCT02531633|565337305|FG007|Part A (52 Weeks)|Other|0|||
156616376|NCT02531633|565337306|FG008|Part A (52 Weeks)|Other|0|||
156616377|NCT02531633|565337307|FG009|Part A (52 Weeks)|Other|0|||
156616378|NCT02531633|565337298|FG000|Part B (104 Weeks)|Sponsor request|0|||
156616379|NCT02531633|565337299|FG001|Part B (104 Weeks)|Sponsor request|0|||
156616380|NCT02531633|565337300|FG002|Part B (104 Weeks)|Sponsor request|0|||
156616381|NCT02531633|565337301|FG003|Part B (104 Weeks)|Sponsor request|0|||
156616382|NCT02531633|565337302|FG004|Part B (104 Weeks)|Sponsor request|0|||
156616383|NCT02531633|565337303|FG005|Part B (104 Weeks)|Sponsor request|8|||
156616384|NCT02531633|565337304|FG006|Part B (104 Weeks)|Sponsor request|5|||
156616385|NCT02531633|565337305|FG007|Part B (104 Weeks)|Sponsor request|3|||
156616386|NCT02531633|565337306|FG008|Part B (104 Weeks)|Sponsor request|5|||
156616387|NCT02531633|565337307|FG009|Part B (104 Weeks)|Sponsor request|4|||
156616388|NCT02531633|565337298|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
156616389|NCT02531633|565337299|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
156616390|NCT02531633|565337300|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
156616391|NCT02531633|565337301|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
156616392|NCT02531633|565337302|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
156616393|NCT02531633|565337303|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
156616394|NCT02531633|565337304|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
156616395|NCT02531633|565337305|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
156616396|NCT02531633|565337306|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
156616397|NCT02531633|565337307|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
156616398|NCT04097925|565337308|FG000|Overall Study|Withdrawal by Subject|1|||
156616399|NCT00186121|565337312|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
156616400|NCT00186121|565337312|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
156616401|NCT00186121|565337312|FG000|Overall Study|Not eligible (no treatment)|1|||
156616402|NCT03650387|565337313|FG000|Overall Study|Withdrawal by Subject|13|||
156616403|NCT03650387|565337313|FG000|Overall Study|Lost to Follow-up|12|||
156616404|NCT03650387|565337313|FG000|Overall Study|Adverse Event (Not related)|1|||
156616405|NCT03650387|565337313|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
156616406|NCT00417248|565337314|FG000|Overall Study|Study Terminated|6|||
156616407|NCT00417248|565337314|FG000|Overall Study|Death|1|||
156616408|NCT00417248|565337314|FG000|Overall Study|Lack of Efficacy|1|||
156616409|NCT01569568|565337315|FG000|Overall Study|Physician Decision|0|||
156616410|NCT01569568|565337316|FG001|Overall Study|Physician Decision|2|||
156616411|NCT05815758|565337317|FG000|Overall Study|Adverse Event|6|||
156616412|NCT05815758|565337318|FG001|Overall Study|Adverse Event|2|||
156616413|NCT05815758|565337317|FG000|Overall Study|Lost to Follow-up|14|||
156616414|NCT05815758|565337318|FG001|Overall Study|Lost to Follow-up|1|||
156616415|NCT05815758|565337317|FG000|Overall Study|Withdrawal by Subject|6|||
156616416|NCT05815758|565337318|FG001|Overall Study|Withdrawal by Subject|6|||
156616417|NCT05815758|565337317|FG000|Overall Study|Protocol Violation|1|||
156616418|NCT05815758|565337318|FG001|Overall Study|Protocol Violation|1|||
156616419|NCT05815758|565337317|FG000|Overall Study|Discontinued|4|||
156616420|NCT05815758|565337318|FG001|Overall Study|Discontinued|4|||
156616421|NCT03661983|565337319|FG000|Open Label Stabilization Phase|Adverse Event|5|||
156616422|NCT03661983|565337320|FG001|Open Label Stabilization Phase|Adverse Event|0|||
156616423|NCT03661983|565337321|FG002|Open Label Stabilization Phase|Adverse Event|0|||
156616424|NCT03661983|565337322|FG003|Open Label Stabilization Phase|Adverse Event|0|||
156616425|NCT03661983|565337319|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
156616426|NCT03661983|565337320|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
156616427|NCT03661983|565337321|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
156616428|NCT03661983|565337322|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
156616429|NCT03661983|565337319|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
156616430|NCT03661983|565337320|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
156616431|NCT03661983|565337321|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
156616432|NCT03661983|565337322|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
156616433|NCT03661983|565337319|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
156616434|NCT03661983|565337320|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
156616435|NCT03661983|565337321|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
156616436|NCT03661983|565337322|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
156616437|NCT03661983|565337319|FG000|Double-blind Randomized Phase|Adverse Event|0|||
156616438|NCT03661983|565337320|FG001|Double-blind Randomized Phase|Adverse Event|1|||
156616439|NCT03661983|565337321|FG002|Double-blind Randomized Phase|Adverse Event|0|||
156616440|NCT03661983|565337322|FG003|Double-blind Randomized Phase|Adverse Event|0|||
156616441|NCT03661983|565337319|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
156616442|NCT03661983|565337320|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
156616443|NCT03661983|565337321|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
156616444|NCT03661983|565337322|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
156616445|NCT03661983|565337319|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
156616446|NCT03661983|565337320|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
156616447|NCT03661983|565337321|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
156616448|NCT03661983|565337322|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
156616449|NCT03661983|565337319|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
156616450|NCT03661983|565337320|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
156616451|NCT03661983|565337321|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
156616452|NCT03661983|565337322|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
156616453|NCT02903966|565337323|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
156616454|NCT02903966|565337324|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
156616455|NCT02903966|565337323|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
156616456|NCT02903966|565337324|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
156616457|NCT02903966|565337323|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
156616458|NCT02903966|565337324|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
156616459|NCT00934791|565337325|FG000|Overall Study|Withdrawal by Subject|1|||
156616460|NCT00934791|565337326|FG001|Overall Study|Withdrawal by Subject|0|||
156616461|NCT01320033|565337328|FG000|Overall Study|Lack of Efficacy|0|||
156616462|NCT01320033|565337329|FG001|Overall Study|Lack of Efficacy|0|||
156616463|NCT01320033|565337330|FG002|Overall Study|Lack of Efficacy|1|||
156616464|NCT01320033|565337328|FG000|Overall Study|Adverse Event|9|||
156616465|NCT01320033|565337329|FG001|Overall Study|Adverse Event|7|||
156616466|NCT01320033|565337330|FG002|Overall Study|Adverse Event|8|||
156616467|NCT01320033|565337328|FG000|Overall Study|Withdrawal by Subject|22|||
156616468|NCT01320033|565337329|FG001|Overall Study|Withdrawal by Subject|23|||
156616469|NCT01320033|565337330|FG002|Overall Study|Withdrawal by Subject|23|||
156616470|NCT01320033|565337328|FG000|Overall Study|Protocol Violation|3|||
156616471|NCT01320033|565337329|FG001|Overall Study|Protocol Violation|5|||
156616472|NCT01320033|565337330|FG002|Overall Study|Protocol Violation|3|||
156616473|NCT01320033|565337328|FG000|Overall Study|Lost to Follow-up|22|||
156616474|NCT01320033|565337329|FG001|Overall Study|Lost to Follow-up|26|||
156616475|NCT01320033|565337330|FG002|Overall Study|Lost to Follow-up|17|||
156616476|NCT01320033|565337328|FG000|Overall Study|Other|2|||
156616477|NCT01320033|565337329|FG001|Overall Study|Other|3|||
156616478|NCT01320033|565337330|FG002|Overall Study|Other|1|||
156616479|NCT02425891|565337331|FG000|Overall Study|Death|333|||
156616480|NCT02425891|565337332|FG001|Overall Study|Death|314|||
156616481|NCT02425891|565337331|FG000|Overall Study|Lost to Follow-up|4|||
156616482|NCT02425891|565337332|FG001|Overall Study|Lost to Follow-up|6|||
156616483|NCT02425891|565337331|FG000|Overall Study|Non-Compliance|1|||
156616484|NCT02425891|565337332|FG001|Overall Study|Non-Compliance|1|||
156616485|NCT02425891|565337331|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
156616486|NCT02425891|565337332|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
156616487|NCT02425891|565337331|FG000|Overall Study|Physician Decision|0|||
156616488|NCT02425891|565337332|FG001|Overall Study|Physician Decision|1|||
156616489|NCT02425891|565337331|FG000|Overall Study|Protocol Violation|1|||
156616490|NCT02425891|565337332|FG001|Overall Study|Protocol Violation|1|||
156616491|NCT02425891|565337331|FG000|Overall Study|Study Terminated By Sponsor|85|||
156616492|NCT02425891|565337332|FG001|Overall Study|Study Terminated By Sponsor|95|||
156616493|NCT02425891|565337331|FG000|Overall Study|Withdrawal by Subject|27|||
156616494|NCT02425891|565337332|FG001|Overall Study|Withdrawal by Subject|32|||
156616495|NCT00963469|565337333|FG000|Overall Study|Adverse Event|15|||
156616496|NCT00963469|565337334|FG001|Overall Study|Adverse Event|11|||
156616497|NCT00963469|565337335|FG002|Overall Study|Adverse Event|1|||
156616498|NCT00963469|565337333|FG000|Overall Study|Lack of Efficacy|10|||
156616499|NCT00963469|565337334|FG001|Overall Study|Lack of Efficacy|7|||
156616500|NCT00963469|565337335|FG002|Overall Study|Lack of Efficacy|2|||
156616501|NCT00963469|565337333|FG000|Overall Study|Lost to Follow-up|1|||
156616502|NCT00963469|565337334|FG001|Overall Study|Lost to Follow-up|1|||
156616503|NCT00963469|565337335|FG002|Overall Study|Lost to Follow-up|0|||
156616504|NCT00963469|565337333|FG000|Overall Study|Protocol Violation|5|||
156616505|NCT00963469|565337334|FG001|Overall Study|Protocol Violation|5|||
156616506|NCT00963469|565337335|FG002|Overall Study|Protocol Violation|3|||
156616507|NCT00963469|565337333|FG000|Overall Study|Withdrawal by Subject|4|||
156616508|NCT00963469|565337334|FG001|Overall Study|Withdrawal by Subject|1|||
156616509|NCT00963469|565337335|FG002|Overall Study|Withdrawal by Subject|1|||
156616510|NCT00963469|565337333|FG000|Overall Study|Pre-randomization Adverse Event|1|||
156616511|NCT00963469|565337334|FG001|Overall Study|Pre-randomization Adverse Event|2|||
156616512|NCT00963469|565337335|FG002|Overall Study|Pre-randomization Adverse Event|0|||
156616513|NCT00963469|565337333|FG000|Overall Study|Moved|1|||
156616514|NCT00963469|565337334|FG001|Overall Study|Moved|0|||
156616515|NCT00963469|565337335|FG002|Overall Study|Moved|0|||
156616516|NCT00963469|565337333|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
156616517|NCT00963469|565337334|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
156616518|NCT00963469|565337335|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
156616519|NCT04124952|565337338|FG000|Overall Study|Lost to Follow-up|1|||
156616520|NCT02974621|565337345|FG000|Overall Study|Didn't receive study treatment|1|||
156616521|NCT02974621|565337346|FG001|Overall Study|Didn't receive study treatment|10|||
156616522|NCT05304611|565337348|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616523|NCT05304611|565337349|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616524|NCT05304611|565337350|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616525|NCT05304611|565337351|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616526|NCT05304611|565337352|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616527|NCT05304611|565337353|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616528|NCT05304611|565337354|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
156616529|NCT05304611|565337355|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616530|NCT05304611|565337356|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
156616531|NCT05304611|565337357|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616532|NCT05304611|565337358|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616533|NCT05304611|565337359|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
156616534|NCT05304611|565337348|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
156616535|NCT05304611|565337349|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
156616536|NCT05304611|565337350|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
156616537|NCT05304611|565337351|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
156616538|NCT05304611|565337352|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
156616539|NCT05304611|565337353|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
156616540|NCT05304611|565337354|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
156616541|NCT05304611|565337355|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
156616542|NCT05304611|565337356|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
156616543|NCT05304611|565337357|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
156616544|NCT05304611|565337358|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
156616545|NCT05304611|565337359|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
156616546|NCT05304611|565337348|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
156616547|NCT05304611|565337349|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
156616548|NCT05304611|565337350|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
156616549|NCT05304611|565337351|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
156616550|NCT05304611|565337352|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
156616551|NCT05304611|565337353|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
156616552|NCT05304611|565337354|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
156616553|NCT05304611|565337355|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
156616554|NCT05304611|565337356|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
156616555|NCT05304611|565337357|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
156616556|NCT05304611|565337358|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
156616557|NCT05304611|565337359|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
156616558|NCT00963820|565337360|FG000|Dose Escalation Phase|Progressive Disease|3|||
156616559|NCT00963820|565337361|FG001|Dose Escalation Phase|Progressive Disease|3|||
156616560|NCT00963820|565337362|FG002|Dose Escalation Phase|Progressive Disease|3|||
156616561|NCT00963820|565337363|FG003|Dose Escalation Phase|Progressive Disease|3|||
156616562|NCT00963820|565337364|FG004|Dose Escalation Phase|Progressive Disease|4|||
156616563|NCT00963820|565337365|FG005|Dose Escalation Phase|Progressive Disease|3|||
156616564|NCT00963820|565337366|FG006|Dose Escalation Phase|Progressive Disease|3|||
156616565|NCT00963820|565337367|FG007|Dose Escalation Phase|Progressive Disease|2|||
156616566|NCT00963820|565337368|FG008|Dose Escalation Phase|Progressive Disease|0|||
156616567|NCT00963820|565337369|FG009|Dose Escalation Phase|Progressive Disease|0|||
156616568|NCT00963820|565337370|FG010|Dose Escalation Phase|Progressive Disease|0|||
156616569|NCT00963820|565337371|FG011|Dose Escalation Phase|Progressive Disease|0|||
156616570|NCT00963820|565337360|FG000|Dose Escalation Phase|Adverse Event|0|||
156616571|NCT00963820|565337361|FG001|Dose Escalation Phase|Adverse Event|0|||
156616572|NCT00963820|565337362|FG002|Dose Escalation Phase|Adverse Event|0|||
156616573|NCT00963820|565337363|FG003|Dose Escalation Phase|Adverse Event|0|||
156616574|NCT00963820|565337364|FG004|Dose Escalation Phase|Adverse Event|0|||
156616575|NCT00963820|565337365|FG005|Dose Escalation Phase|Adverse Event|0|||
156616576|NCT00963820|565337366|FG006|Dose Escalation Phase|Adverse Event|3|||
156616577|NCT00963820|565337367|FG007|Dose Escalation Phase|Adverse Event|1|||
156616578|NCT00963820|565337368|FG008|Dose Escalation Phase|Adverse Event|0|||
156616579|NCT00963820|565337369|FG009|Dose Escalation Phase|Adverse Event|0|||
156616580|NCT00963820|565337370|FG010|Dose Escalation Phase|Adverse Event|0|||
156616581|NCT00963820|565337371|FG011|Dose Escalation Phase|Adverse Event|0|||
156616582|NCT00963820|565337360|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
156616583|NCT00963820|565337361|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
156616584|NCT00963820|565337362|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
156616585|NCT00963820|565337363|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156616586|NCT00963820|565337364|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
156616587|NCT00963820|565337365|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
156616588|NCT00963820|565337366|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
156616589|NCT00963820|565337367|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
156616590|NCT00963820|565337368|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
156616591|NCT00963820|565337369|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
156616592|NCT00963820|565337370|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
156616593|NCT00963820|565337371|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
156616594|NCT00963820|565337360|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616595|NCT00963820|565337361|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616596|NCT00963820|565337362|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616597|NCT00963820|565337363|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616598|NCT00963820|565337364|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616599|NCT00963820|565337365|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616600|NCT00963820|565337366|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
156616601|NCT00963820|565337367|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616602|NCT00963820|565337368|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616603|NCT00963820|565337369|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616604|NCT00963820|565337370|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616605|NCT00963820|565337371|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
156616606|NCT00963820|565337360|FG000|Expansion Phase|Progressive Disease|0|||
156616607|NCT00963820|565337361|FG001|Expansion Phase|Progressive Disease|0|||
156616608|NCT00963820|565337362|FG002|Expansion Phase|Progressive Disease|0|||
156616609|NCT00963820|565337363|FG003|Expansion Phase|Progressive Disease|0|||
156616610|NCT00963820|565337364|FG004|Expansion Phase|Progressive Disease|0|||
156616611|NCT00963820|565337365|FG005|Expansion Phase|Progressive Disease|0|||
156616612|NCT00963820|565337366|FG006|Expansion Phase|Progressive Disease|0|||
156616613|NCT00963820|565337367|FG007|Expansion Phase|Progressive Disease|0|||
156616614|NCT00963820|565337368|FG008|Expansion Phase|Progressive Disease|8|||
156616615|NCT00963820|565337369|FG009|Expansion Phase|Progressive Disease|6|||
156616616|NCT00963820|565337370|FG010|Expansion Phase|Progressive Disease|4|||
156616617|NCT00963820|565337371|FG011|Expansion Phase|Progressive Disease|2|||
156616618|NCT00963820|565337360|FG000|Expansion Phase|Adverse Event|0|||
156616619|NCT00963820|565337361|FG001|Expansion Phase|Adverse Event|0|||
156616620|NCT00963820|565337362|FG002|Expansion Phase|Adverse Event|0|||
156616621|NCT00963820|565337363|FG003|Expansion Phase|Adverse Event|0|||
156616622|NCT00963820|565337364|FG004|Expansion Phase|Adverse Event|0|||
156616623|NCT00963820|565337365|FG005|Expansion Phase|Adverse Event|0|||
156616624|NCT00963820|565337366|FG006|Expansion Phase|Adverse Event|0|||
156616625|NCT00963820|565337367|FG007|Expansion Phase|Adverse Event|0|||
156616626|NCT00963820|565337368|FG008|Expansion Phase|Adverse Event|1|||
156616627|NCT00963820|565337369|FG009|Expansion Phase|Adverse Event|3|||
156616628|NCT00963820|565337370|FG010|Expansion Phase|Adverse Event|0|||
156616629|NCT00963820|565337371|FG011|Expansion Phase|Adverse Event|0|||
156616630|NCT00963820|565337360|FG000|Expansion Phase|Withdrawal by Subject|0|||
156616631|NCT00963820|565337361|FG001|Expansion Phase|Withdrawal by Subject|0|||
156616632|NCT00963820|565337362|FG002|Expansion Phase|Withdrawal by Subject|0|||
156616633|NCT00963820|565337363|FG003|Expansion Phase|Withdrawal by Subject|0|||
156616634|NCT00963820|565337364|FG004|Expansion Phase|Withdrawal by Subject|0|||
156616635|NCT00963820|565337365|FG005|Expansion Phase|Withdrawal by Subject|0|||
156616636|NCT00963820|565337366|FG006|Expansion Phase|Withdrawal by Subject|0|||
156616637|NCT00963820|565337367|FG007|Expansion Phase|Withdrawal by Subject|0|||
156616638|NCT00963820|565337368|FG008|Expansion Phase|Withdrawal by Subject|1|||
156616639|NCT00963820|565337369|FG009|Expansion Phase|Withdrawal by Subject|0|||
156616640|NCT00963820|565337370|FG010|Expansion Phase|Withdrawal by Subject|1|||
156616641|NCT00963820|565337371|FG011|Expansion Phase|Withdrawal by Subject|1|||
156616642|NCT00963820|565337360|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616643|NCT00963820|565337361|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616644|NCT00963820|565337362|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616645|NCT00963820|565337363|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616646|NCT00963820|565337364|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156635097|NCT05012943|565407829|FG002|Overall Study|Adverse Event|0|||
156616647|NCT00963820|565337365|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616648|NCT00963820|565337366|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616649|NCT00963820|565337367|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616650|NCT00963820|565337368|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616651|NCT00963820|565337369|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616652|NCT00963820|565337370|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
156616653|NCT00963820|565337371|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
156616654|NCT02354690|565337372|FG000|Overall Study|Physician Decision|1|||
156616655|NCT04556175|565337376|FG000|Overall Study|Study terminated due to COVID-19|8|||
156616656|NCT04556175|565337377|FG001|Overall Study|Study terminated due to COVID-19|8|||
156616657|NCT05549505|565337379|FG000|Overall Study|Lost to Follow-up|2|||
156616658|NCT05549505|565337380|FG001|Overall Study|Lost to Follow-up|0|||
156616659|NCT05549505|565337379|FG000|Overall Study|Withdrawal by Subject|3|||
156616660|NCT05549505|565337380|FG001|Overall Study|Withdrawal by Subject|3|||
156616661|NCT05549505|565337379|FG000|Overall Study|Other: Miscellaneous|3|||
156616662|NCT05549505|565337380|FG001|Overall Study|Other: Miscellaneous|6|||
156616663|NCT02756845|565337383|FG000|Overall Study|Death|12|||
156616664|NCT02756845|565337384|FG001|Overall Study|Death|2|||
156616665|NCT02756845|565337383|FG000|Overall Study|Withdrawal by Subject|1|||
156616666|NCT02756845|565337384|FG001|Overall Study|Withdrawal by Subject|0|||
156616667|NCT03342404|565337385|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
156616668|NCT03342404|565337386|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
156616669|NCT03342404|565337385|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
156616670|NCT03342404|565337386|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
156616671|NCT03342404|565337385|FG000|Blinded Treatment Phase|Adverse Event|5|||
156616672|NCT03342404|565337386|FG001|Blinded Treatment Phase|Adverse Event|4|||
156616673|NCT03342404|565337385|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
156616674|NCT03342404|565337386|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
156616675|NCT03342404|565337385|FG000|Blinded Treatment Phase|Other reasons|1|||
156616676|NCT03342404|565337386|FG001|Blinded Treatment Phase|Other reasons|0|||
156616677|NCT03342404|565337385|FG000|Blinded Treatment Phase|Physician Decision|1|||
156616678|NCT03342404|565337386|FG001|Blinded Treatment Phase|Physician Decision|0|||
156616679|NCT03342404|565337385|FG000|Blinded Treatment Phase|Death|1|||
156616680|NCT03342404|565337386|FG001|Blinded Treatment Phase|Death|0|||
156616681|NCT03342404|565337385|FG000|Open-Label Phase|Lost to Follow-up|0|||
156616682|NCT03342404|565337386|FG001|Open-Label Phase|Lost to Follow-up|1|||
156616683|NCT03342404|565337385|FG000|Open-Label Phase|Other reasons|0|||
156616684|NCT03342404|565337386|FG001|Open-Label Phase|Other reasons|1|||
156616685|NCT03342404|565337385|FG000|Open-Label Phase|Adverse Event|0|||
156616686|NCT03342404|565337386|FG001|Open-Label Phase|Adverse Event|3|||
156616687|NCT03342404|565337385|FG000|Open-Label Phase|Withdrawal by Subject|0|||
156616688|NCT03342404|565337386|FG001|Open-Label Phase|Withdrawal by Subject|6|||
156616689|NCT02750501|565337387|FG000|Overall Study|Adverse Event|4|||
156616690|NCT02750501|565337387|FG000|Overall Study|Physician Decision|1|||
156616691|NCT02750501|565337387|FG000|Overall Study|Protocol Violation|1|||
156616692|NCT02750501|565337387|FG000|Overall Study|G-tube came out|1|||
156616693|NCT02750501|565337387|FG000|Overall Study|Non-compliant use of PERT|1|||
156616694|NCT00403390|565337388|FG000|Overall Study|Withdrawal by Subject|1|||
156616695|NCT00403390|565337389|FG001|Overall Study|Withdrawal by Subject|0|||
156616696|NCT00403390|565337388|FG000|Overall Study|samples lost|1|||
156616697|NCT00403390|565337389|FG001|Overall Study|samples lost|0|||
156616698|NCT00403390|565337388|FG000|Overall Study|non-compliant|1|||
156616699|NCT00403390|565337389|FG001|Overall Study|non-compliant|0|||
156616700|NCT01878175|565337390|FG000|Overall Study|Developed contraindicated health problem|2|||
156616701|NCT01796106|565337391|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
156616702|NCT01796106|565337392|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
156616703|NCT04107935|565337393|FG000|Overall Study|Death|1|||
156616704|NCT04107935|565337394|FG001|Overall Study|Death|0|||
156616705|NCT01842334|565337395|FG000|Overall Study|Withdrawal by Subject|3|||
156616706|NCT01842334|565337396|FG001|Overall Study|Withdrawal by Subject|3|||
156616707|NCT01842334|565337395|FG000|Overall Study|Moved away mid-study|0|||
156616708|NCT01842334|565337396|FG001|Overall Study|Moved away mid-study|1|||
156616709|NCT01249157|565337398|FG000|Overall Study|Withdrawal by Subject|1|||
156616710|NCT02470429|565337401|FG000|Overall Study|Adverse Event|1|||
156616711|NCT02470429|565337402|FG001|Overall Study|Adverse Event|0|||
156616712|NCT02470429|565337401|FG000|Overall Study|Withdrawal by Subject|1|||
156616713|NCT02470429|565337402|FG001|Overall Study|Withdrawal by Subject|0|||
156616714|NCT00959699|565337405|FG000|Treatment Period|Adverse Event|3|||
156616715|NCT00959699|565337406|FG001|Treatment Period|Adverse Event|13|||
156616716|NCT00959699|565337405|FG000|Treatment Period|Lack of Efficacy|15|||
156616717|NCT00959699|565337406|FG001|Treatment Period|Lack of Efficacy|6|||
156616718|NCT00959699|565337405|FG000|Treatment Period|Lost to Follow-up|0|||
156616719|NCT00959699|565337406|FG001|Treatment Period|Lost to Follow-up|1|||
156616720|NCT00959699|565337405|FG000|Treatment Period|Withdrawal by Subject|1|||
156616721|NCT00959699|565337406|FG001|Treatment Period|Withdrawal by Subject|3|||
156616722|NCT00959699|565337405|FG000|Treatment Period|Non-Compliance with Protocol|0|||
156616723|NCT00959699|565337406|FG001|Treatment Period|Non-Compliance with Protocol|1|||
156616724|NCT00959699|565337405|FG000|Treatment Period|Did not receive treatment|0|||
156616725|NCT00959699|565337406|FG001|Treatment Period|Did not receive treatment|1|||
156616726|NCT00959699|565337405|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
156616727|NCT00959699|565337406|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
156616728|NCT00959699|565337405|FG000|Follow-up Period|Lost to Follow-up|3|||
156616729|NCT00959699|565337406|FG001|Follow-up Period|Lost to Follow-up|2|||
156616730|NCT00959699|565337405|FG000|Follow-up Period|Withdrawal by Subject|3|||
156616731|NCT00959699|565337406|FG001|Follow-up Period|Withdrawal by Subject|4|||
156616732|NCT04228445|565337407|FG000|Overall Study|Lost to Follow-up|1|||
156616733|NCT04228445|565337408|FG001|Overall Study|Lost to Follow-up|1|||
156616734|NCT04228445|565337407|FG000|Overall Study|Physician Decision|1|||
156616735|NCT04228445|565337408|FG001|Overall Study|Physician Decision|2|||
156616736|NCT04228445|565337407|FG000|Overall Study|Withdrawal by Subject|0|||
156616737|NCT04228445|565337408|FG001|Overall Study|Withdrawal by Subject|1|||
156616738|NCT04228445|565337407|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
156616739|NCT04228445|565337408|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
156616740|NCT00606294|565337411|FG000|Overall Study|Withdrawal by Subject|36|||
156616741|NCT00606294|565337412|FG001|Overall Study|Withdrawal by Subject|0|||
156616742|NCT03924427|565337413|FG000|Overall Study|Adverse Event|4|||
156616743|NCT03924427|565337413|FG000|Overall Study|Lack of Efficacy|1|||
156616744|NCT03924427|565337413|FG000|Overall Study|Withdrawal by Subject|1|||
156616745|NCT01976624|565337418|FG000|Overall Study|Participants contraindicated|2|||
156616746|NCT01976624|565337418|FG000|Overall Study|Participants age less than 19 years|12|||
156616747|NCT05307523|565337419|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
156616748|NCT05307523|565337420|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
156616749|NCT05307523|565337419|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
156616750|NCT05307523|565337420|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
156616751|NCT05116683|565337421|FG000|Overall Study|Physician Decision|4|||
156616752|NCT00683774|565337423|FG000|Overall Study|Withdrawal by Subject|0|||
156616753|NCT00683774|565337424|FG001|Overall Study|Withdrawal by Subject|1|||
156616754|NCT00683774|565337423|FG000|Overall Study|Physician Decision|3|||
156616755|NCT00683774|565337424|FG001|Overall Study|Physician Decision|0|||
156616756|NCT03595176|565337425|FG000|Overall Study|Death|0|||
156616757|NCT03595176|565337426|FG001|Overall Study|Death|2|||
156616758|NCT03595176|565337425|FG000|Overall Study|Lost to Follow-up|0|||
156616759|NCT03595176|565337426|FG001|Overall Study|Lost to Follow-up|1|||
156616760|NCT02735044|565337428|FG000|Overall Study|Adverse Event|3|||
156616761|NCT02735044|565337429|FG001|Overall Study|Adverse Event|3|||
156616762|NCT02735044|565337428|FG000|Overall Study|Lack of Efficacy|1|||
156616763|NCT02735044|565337429|FG001|Overall Study|Lack of Efficacy|0|||
156616764|NCT02735044|565337428|FG000|Overall Study|Poor compliance to protocol|7|||
156616765|NCT02735044|565337429|FG001|Overall Study|Poor compliance to protocol|7|||
156616766|NCT02735044|565337428|FG000|Overall Study|Randomized and not treated|0|||
156616767|NCT02735044|565337429|FG001|Overall Study|Randomized and not treated|2|||
156616768|NCT02735044|565337428|FG000|Overall Study|Other, not specified above|5|||
156616769|NCT02735044|565337429|FG001|Overall Study|Other, not specified above|11|||
156616770|NCT01682759|565337431|FG000|Overall Study|Death|2|||
156616771|NCT01682759|565337432|FG001|Overall Study|Death|1|||
156616772|NCT01682759|565337431|FG000|Overall Study|Lost to Follow-up|10|||
156616773|NCT01682759|565337432|FG001|Overall Study|Lost to Follow-up|13|||
156616774|NCT01682759|565337431|FG000|Overall Study|Physician Decision|1|||
156616775|NCT01682759|565337432|FG001|Overall Study|Physician Decision|1|||
156616776|NCT01682759|565337431|FG000|Overall Study|Withdrawal by Subject|56|||
156616777|NCT01682759|565337432|FG001|Overall Study|Withdrawal by Subject|55|||
156616778|NCT01226472|565337435|FG000|Overall Study|Progressive Disease|1|||
156616779|NCT03128307|565337438|FG000|Overall Study|Lost to Follow-up|29|||
156616780|NCT03128307|565337438|FG000|Overall Study|Withdrawal by Subject|5|||
156616781|NCT02499172|565339057|FG000|Overall Study|Financial reason|0|||
156616782|NCT02499172|565339058|FG001|Overall Study|Financial reason|0|||
156616783|NCT02499172|565339059|FG002|Overall Study|Financial reason|523|||
156616784|NCT02499172|565339060|FG003|Overall Study|Financial reason|436|||
156616785|NCT02499172|565339057|FG000|Overall Study|Lost to Follow-up|65|||
156616786|NCT02499172|565339058|FG001|Overall Study|Lost to Follow-up|64|||
156616787|NCT02499172|565339059|FG002|Overall Study|Lost to Follow-up|0|||
156616788|NCT02499172|565339060|FG003|Overall Study|Lost to Follow-up|0|||
156616789|NCT01293123|565339061|FG000|Overall Study|Lost to Follow-up|0|||
156616790|NCT01293123|565339062|FG001|Overall Study|Lost to Follow-up|1|||
156616791|NCT02608099|565339086|FG000|Overall Study|Ablation procedure not initiated|3|||
156616792|NCT02608099|565339087|FG001|Overall Study|Ablation procedure not initiated|2|||
156616793|NCT01952041|565339088|FG000|Overall Study|Lost to Follow-up|9|||
156616794|NCT01952041|565339089|FG001|Overall Study|Lost to Follow-up|16|||
156616795|NCT01952041|565339088|FG000|Overall Study|Withdrawal by Subject|7|||
156616796|NCT01952041|565339089|FG001|Overall Study|Withdrawal by Subject|5|||
156616797|NCT01952041|565339088|FG000|Overall Study|Death|1|||
156616798|NCT01952041|565339089|FG001|Overall Study|Death|0|||
156616799|NCT01736176|565339090|FG000|Overall Study|Adverse Event|3|||
156616800|NCT01736176|565339090|FG000|Overall Study|Withdrawal by Subject|4|||
156616801|NCT01736176|565339090|FG000|Overall Study|Lack of Efficacy|3|||
156616802|NCT01736176|565339090|FG000|Overall Study|Unable to Complete PEG Placement|1|||
156616803|NCT02145429|565339091|FG000|Overall Study|Death|4|||
156616804|NCT02145429|565339092|FG001|Overall Study|Death|5|||
156616805|NCT02145429|565339091|FG000|Overall Study|Lost to Follow-up|4|||
156616806|NCT02145429|565339092|FG001|Overall Study|Lost to Follow-up|3|||
156616807|NCT02145429|565339091|FG000|Overall Study|Withdrawal by Subject|8|||
156616808|NCT02145429|565339092|FG001|Overall Study|Withdrawal by Subject|3|||
156616809|NCT02943577|565339093|FG000|Overall Study|Protocol Violation|0|||
156616810|NCT02943577|565339094|FG001|Overall Study|Protocol Violation|1|||
156616811|NCT02943577|565339093|FG000|Overall Study|Adverse Event|3|||
156616812|NCT02943577|565339094|FG001|Overall Study|Adverse Event|2|||
156616813|NCT02943577|565339093|FG000|Overall Study|Lost to Follow-up|0|||
156616814|NCT02943577|565339094|FG001|Overall Study|Lost to Follow-up|1|||
156616815|NCT02943577|565339093|FG000|Overall Study|Withdrawal by Subject|1|||
156616816|NCT02943577|565339094|FG001|Overall Study|Withdrawal by Subject|1|||
156616817|NCT02943577|565339093|FG000|Overall Study|Pregnancy|1|||
156616818|NCT02943577|565339094|FG001|Overall Study|Pregnancy|0|||
156616819|NCT01944462|565339101|FG000|PPPP Educational Program|Lost to Follow-up|60|||
156616820|NCT00808028|565339102|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
156616821|NCT00808028|565339103|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
156616822|NCT00808028|565339104|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
156616823|NCT00808028|565339105|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
156616824|NCT00808028|565339102|FG000|Stage 1 (6 Months)|Other|1|||
156616825|NCT00808028|565339103|FG001|Stage 1 (6 Months)|Other|0|||
156616826|NCT00808028|565339104|FG002|Stage 1 (6 Months)|Other|2|||
156616827|NCT00808028|565339105|FG003|Stage 1 (6 Months)|Other|4|||
156616828|NCT00808028|565339102|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
156616829|NCT00808028|565339103|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
156616830|NCT00808028|565339104|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
156616831|NCT00808028|565339105|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
156616832|NCT00808028|565339102|FG000|Stage 1 (6 Months)|Adverse Event|0|||
156616833|NCT00808028|565339103|FG001|Stage 1 (6 Months)|Adverse Event|0|||
156616834|NCT00808028|565339104|FG002|Stage 1 (6 Months)|Adverse Event|1|||
156616835|NCT00808028|565339105|FG003|Stage 1 (6 Months)|Adverse Event|2|||
156616836|NCT00808028|565339102|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
156616837|NCT00808028|565339103|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
156616838|NCT00808028|565339104|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
156616839|NCT00808028|565339105|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
156616840|NCT00808028|565339102|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
156616841|NCT00808028|565339103|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
156616842|NCT00808028|565339104|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
156616843|NCT00808028|565339105|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
156616844|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
156616845|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
156616846|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
156616847|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
156616848|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
156616849|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
156616850|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
156616851|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
156616852|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
156616853|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
156616854|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
156616855|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
156616856|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
156616857|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
156616858|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
156616859|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
156616860|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
156616861|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
156616862|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
156616863|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
156616864|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
156616865|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
156616866|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
156616867|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
156616868|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
156616869|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
156616870|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
156616871|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
156616872|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
156616873|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
156616874|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
156616875|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
156616876|NCT00808028|565339102|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
156616877|NCT00808028|565339103|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
156616878|NCT00808028|565339104|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
156616879|NCT00808028|565339105|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
156616880|NCT01222767|565339106|FG000|Overall Study|Progressive disease|13|||
156616881|NCT01222767|565339106|FG000|Overall Study|Adverse Event|2|||
156616882|NCT01222767|565339106|FG000|Overall Study|Surgical resection|1|||
156616883|NCT01222767|565339106|FG000|Overall Study|Never treated|1|||
156616884|NCT00081263|565339111|FG000|Overall Study|clerical error|1|||
156616885|NCT00081263|565339112|FG001|Overall Study|clerical error|0|||
156616886|NCT00081263|565339111|FG000|Overall Study|wrong cell type|7|||
156616887|NCT00081263|565339112|FG001|Overall Study|wrong cell type|5|||
156616888|NCT00081263|565339111|FG000|Overall Study|improper pre-protocol therapy|0|||
156616889|NCT00081263|565339112|FG001|Overall Study|improper pre-protocol therapy|1|||
156616890|NCT00081263|565339111|FG000|Overall Study|Inadequate pathology|0|||
156616891|NCT00081263|565339112|FG001|Overall Study|Inadequate pathology|1|||
156616892|NCT00081263|565339111|FG000|Overall Study|Never treated|4|||
156616893|NCT00081263|565339112|FG001|Overall Study|Never treated|5|||
156616894|NCT00081263|565339111|FG000|Overall Study|Inadequate data|5|||
156616895|NCT00081263|565339112|FG001|Overall Study|Inadequate data|10|||
156616896|NCT01852591|565339113|FG000|Overall Study|Withdrawal by Subject|2|||
156616897|NCT01852591|565339113|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
156616898|NCT01267955|565339120|FG000|Stage 1 (6 Months)|Death|3|||
156616899|NCT01267955|565339120|FG000|Stage 2 (6 Months)|Death|5|||
156616900|NCT01267955|565339120|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
156616901|NCT00729560|565339121|FG000|Overall Study|Withdrawal by Subject|3|||
156616902|NCT03233308|565339122|FG000|Overall Study|Adverse Event|1|||
156616903|NCT03233308|565339122|FG000|Overall Study|Protocol Violation|1|||
156616904|NCT03662789|565339123|FG000|Overall Study|Lost to Follow-up|1|||
156616905|NCT03662789|565339124|FG001|Overall Study|Lost to Follow-up|2|||
156616906|NCT03662789|565339123|FG000|Overall Study|Could not perform treadmill test|4|||
156616907|NCT03662789|565339124|FG001|Overall Study|Could not perform treadmill test|4|||
156616908|NCT03662789|565339123|FG000|Overall Study|Death|0|||
156616909|NCT03662789|565339124|FG001|Overall Study|Death|1|||
156616910|NCT02136134|565339125|FG000|Overall Study|Death|170|||
156616911|NCT02136134|565339126|FG001|Overall Study|Death|148|||
156616912|NCT02136134|565339125|FG000|Overall Study|Withdrawal by Subject|19|||
156616913|NCT02136134|565339126|FG001|Overall Study|Withdrawal by Subject|10|||
156616914|NCT02136134|565339125|FG000|Overall Study|Lost to Follow-up|3|||
156616915|NCT02136134|565339126|FG001|Overall Study|Lost to Follow-up|3|||
156616916|NCT02136134|565339125|FG000|Overall Study|Uspecified|55|||
156616917|NCT02136134|565339126|FG001|Overall Study|Uspecified|90|||
156616918|NCT00732472|565339127|FG000|Overall Study|Adverse Event|0|||
156616919|NCT00732472|565339128|FG001|Overall Study|Adverse Event|1|||
156616920|NCT00732472|565339129|FG002|Overall Study|Adverse Event|1|||
156616921|NCT00732472|565339130|FG003|Overall Study|Adverse Event|1|||
156616922|NCT00732472|565339127|FG000|Overall Study|Protocol Violation|0|||
156616923|NCT00732472|565339128|FG001|Overall Study|Protocol Violation|0|||
156616924|NCT00732472|565339129|FG002|Overall Study|Protocol Violation|0|||
156616925|NCT00732472|565339130|FG003|Overall Study|Protocol Violation|1|||
156616926|NCT00732472|565339127|FG000|Overall Study|Withdrawal by Subject|0|||
156616927|NCT00732472|565339128|FG001|Overall Study|Withdrawal by Subject|2|||
156616928|NCT00732472|565339129|FG002|Overall Study|Withdrawal by Subject|0|||
156616929|NCT00732472|565339130|FG003|Overall Study|Withdrawal by Subject|1|||
156616930|NCT02559115|565339132|FG000|Overall Study|Withdrawal by Subject|3|||
156616931|NCT01426009|565339143|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
156616932|NCT01426009|565339143|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
156616933|NCT01426009|565339143|FG000|Washout 1|Withdrawal by Subject|1|||
156616934|NCT01426009|565339143|FG000|Washout 1|Personal Reasons|1|||
156616935|NCT01426009|565339143|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
156616936|NCT01426009|565339143|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
156616937|NCT01426009|565339143|FG000|Washout 2|electrive surgery|1|||
156616938|NCT01426009|565339143|FG000|Washout 3|personal reasons|1|||
156616939|NCT01426009|565339143|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
156616940|NCT01426009|565339143|FG000|Washout 4|Lost to Follow-up|1|||
156616941|NCT02005211|565339154|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
156616942|NCT02005211|565339155|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
156616943|NCT02005211|565339156|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
156616944|NCT02005211|565339157|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
156616945|NCT02005211|565339158|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
156635559|NCT00602667|565409962|FG002|Overall Study|Still on Therapy|2|||
156616946|NCT02005211|565339159|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
156616947|NCT02005211|565339160|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
156616948|NCT00397631|565339162|FG000|Overall Study|Adverse Event|5|||
156616949|NCT00397631|565339163|FG001|Overall Study|Adverse Event|6|||
156616950|NCT00397631|565339162|FG000|Overall Study|Lack of Efficacy|7|||
156616951|NCT00397631|565339163|FG001|Overall Study|Lack of Efficacy|10|||
156616952|NCT00397631|565339162|FG000|Overall Study|Lost to Follow-up|8|||
156616953|NCT00397631|565339163|FG001|Overall Study|Lost to Follow-up|9|||
156616954|NCT00397631|565339162|FG000|Overall Study|Physician Decision|2|||
156616955|NCT00397631|565339163|FG001|Overall Study|Physician Decision|0|||
156616956|NCT00397631|565339162|FG000|Overall Study|Protocol Violation|0|||
156616957|NCT00397631|565339163|FG001|Overall Study|Protocol Violation|1|||
156616958|NCT00397631|565339162|FG000|Overall Study|Withdrawal by Subject|7|||
156616959|NCT00397631|565339163|FG001|Overall Study|Withdrawal by Subject|14|||
156616960|NCT00397631|565339162|FG000|Overall Study|protocol discontinuation criteria|1|||
156616961|NCT00397631|565339163|FG001|Overall Study|protocol discontinuation criteria|4|||
156616962|NCT02202161|565339164|FG000|Overall Study|Adverse Event|1|||
156616963|NCT02202161|565339165|FG001|Overall Study|Adverse Event|1|||
156616964|NCT02202161|565339166|FG002|Overall Study|Adverse Event|0|||
156616965|NCT02202161|565339167|FG003|Overall Study|Adverse Event|0|||
156616966|NCT02202161|565339168|FG004|Overall Study|Adverse Event|0|||
156616967|NCT02202161|565339169|FG005|Overall Study|Adverse Event|1|||
156616968|NCT02202161|565339170|FG006|Overall Study|Adverse Event|0|||
156616969|NCT02202161|565339171|FG007|Overall Study|Adverse Event|0|||
156616970|NCT02202161|565339164|FG000|Overall Study|Did not meet continuation criteria|0|||
156616971|NCT02202161|565339165|FG001|Overall Study|Did not meet continuation criteria|0|||
156616972|NCT02202161|565339166|FG002|Overall Study|Did not meet continuation criteria|0|||
156616973|NCT02202161|565339167|FG003|Overall Study|Did not meet continuation criteria|0|||
156616974|NCT02202161|565339168|FG004|Overall Study|Did not meet continuation criteria|0|||
156616975|NCT02202161|565339169|FG005|Overall Study|Did not meet continuation criteria|0|||
156616976|NCT02202161|565339170|FG006|Overall Study|Did not meet continuation criteria|0|||
156616977|NCT02202161|565339171|FG007|Overall Study|Did not meet continuation criteria|3|||
156616978|NCT02202161|565339164|FG000|Overall Study|Physician Decision|0|||
156616979|NCT02202161|565339165|FG001|Overall Study|Physician Decision|0|||
156616980|NCT02202161|565339166|FG002|Overall Study|Physician Decision|0|||
156616981|NCT02202161|565339167|FG003|Overall Study|Physician Decision|0|||
156616982|NCT02202161|565339168|FG004|Overall Study|Physician Decision|0|||
156616983|NCT02202161|565339169|FG005|Overall Study|Physician Decision|0|||
156616984|NCT02202161|565339170|FG006|Overall Study|Physician Decision|0|||
156616985|NCT02202161|565339171|FG007|Overall Study|Physician Decision|3|||
156616986|NCT02202161|565339164|FG000|Overall Study|Withdrawal by Subject|0|||
156616987|NCT02202161|565339165|FG001|Overall Study|Withdrawal by Subject|0|||
156616988|NCT02202161|565339166|FG002|Overall Study|Withdrawal by Subject|0|||
156616989|NCT02202161|565339167|FG003|Overall Study|Withdrawal by Subject|0|||
156616990|NCT02202161|565339168|FG004|Overall Study|Withdrawal by Subject|1|||
156616991|NCT02202161|565339169|FG005|Overall Study|Withdrawal by Subject|0|||
156616992|NCT02202161|565339170|FG006|Overall Study|Withdrawal by Subject|0|||
156616993|NCT02202161|565339171|FG007|Overall Study|Withdrawal by Subject|0|||
156616994|NCT03797144|565339174|FG000|Enrollment|Protocol Violation|4|||
156616995|NCT03797144|565339175|FG001|Enrollment|Protocol Violation|1|||
156616996|NCT03797144|565339174|FG000|Surgery|Protocol Violation|1|||
156616997|NCT03797144|565339175|FG001|Surgery|Protocol Violation|0|||
156616998|NCT03797144|565339174|FG000|3 Month|Early termination cut-off date|2|||
156616999|NCT03797144|565339175|FG001|3 Month|Early termination cut-off date|0|||
156617000|NCT03797144|565339174|FG000|12 Month|Early termination cut-off date|8|||
156617001|NCT03797144|565339175|FG001|12 Month|Early termination cut-off date|9|||
156617002|NCT03797144|565339174|FG000|24 Month|Early termination cut-off date|1|||
156617003|NCT03797144|565339175|FG001|24 Month|Early termination cut-off date|1|||
156617004|NCT03299166|565339179|FG000|Overall Study|Adverse Event|9|||
156617005|NCT03299166|565339180|FG001|Overall Study|Adverse Event|4|||
156617006|NCT03299166|565339179|FG000|Overall Study|Withdrawal by Subject|6|||
156617007|NCT03299166|565339180|FG001|Overall Study|Withdrawal by Subject|5|||
156617008|NCT03299166|565339179|FG000|Overall Study|Physician Decision|1|||
156617009|NCT03299166|565339180|FG001|Overall Study|Physician Decision|1|||
156617010|NCT03299166|565339179|FG000|Overall Study|Sponsor Decision|3|||
156617011|NCT03299166|565339180|FG001|Overall Study|Sponsor Decision|0|||
156617012|NCT03299166|565339179|FG000|Overall Study|Lost to Follow-up|2|||
156617013|NCT03299166|565339180|FG001|Overall Study|Lost to Follow-up|4|||
156617014|NCT03299166|565339179|FG000|Overall Study|Randomization Error|0|||
156617015|NCT03299166|565339180|FG001|Overall Study|Randomization Error|1|||
156617016|NCT03299166|565339179|FG000|Overall Study|Subject unable to return due to COVID|1|||
156617017|NCT03299166|565339180|FG001|Overall Study|Subject unable to return due to COVID|0|||
156617018|NCT03299166|565339179|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
156617019|NCT03299166|565339180|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
156617020|NCT00423592|565339182|FG000|Overall Study|Adverse Event (through Week 12)|2|||
156617021|NCT00423592|565339182|FG000|Overall Study|Adverse Event (post Week 12)|5|||
156617022|NCT00062647|565339183|FG000|Overall Study|Death|2|||
156617023|NCT00062647|565339184|FG001|Overall Study|Death|2|||
156617024|NCT00062647|565339183|FG000|Overall Study|Adverse Event|1|||
156617025|NCT00062647|565339184|FG001|Overall Study|Adverse Event|1|||
156617026|NCT00062647|565339183|FG000|Overall Study|Withdrawal by Subject|2|||
156617027|NCT00062647|565339184|FG001|Overall Study|Withdrawal by Subject|1|||
156617028|NCT00062647|565339183|FG000|Overall Study|Protocol Violation|1|||
156617029|NCT00062647|565339184|FG001|Overall Study|Protocol Violation|0|||
156617030|NCT00062647|565339183|FG000|Overall Study|Lost to Follow-up|1|||
156617031|NCT00062647|565339184|FG001|Overall Study|Lost to Follow-up|2|||
156617032|NCT00062647|565339183|FG000|Overall Study|Failed continuation criteria|4|||
156617033|NCT00062647|565339184|FG001|Overall Study|Failed continuation criteria|2|||
156617034|NCT00062647|565339183|FG000|Overall Study|Other|4|||
156617035|NCT00062647|565339184|FG001|Overall Study|Other|4|||
156617036|NCT00062647|565339183|FG000|Overall Study|Never received study treatment|1|||
156617037|NCT00062647|565339184|FG001|Overall Study|Never received study treatment|1|||
156617038|NCT00002981|565339185|FG000|Overall Study|Inevaluable|6|||
156617039|NCT00255008|565339188|FG000|Overall Study|Adverse Event|1|||
156617040|NCT00255008|565339189|FG001|Overall Study|Adverse Event|1|||
156617041|NCT00255008|565339190|FG002|Overall Study|Adverse Event|2|||
156617042|NCT00255008|565339191|FG003|Overall Study|Adverse Event|0|||
156617043|NCT00255008|565339188|FG000|Overall Study|Lost to Follow-up|1|||
156617044|NCT00255008|565339189|FG001|Overall Study|Lost to Follow-up|0|||
156617045|NCT00255008|565339190|FG002|Overall Study|Lost to Follow-up|1|||
156617046|NCT00255008|565339191|FG003|Overall Study|Lost to Follow-up|2|||
156617047|NCT00255008|565339188|FG000|Overall Study|Did not meet viral reduction criteria|4|||
156617048|NCT00255008|565339189|FG001|Overall Study|Did not meet viral reduction criteria|5|||
156617049|NCT00255008|565339190|FG002|Overall Study|Did not meet viral reduction criteria|0|||
156617050|NCT00255008|565339191|FG003|Overall Study|Did not meet viral reduction criteria|1|||
156617051|NCT00255008|565339188|FG000|Overall Study|Withdrew consent|0|||
156617052|NCT00255008|565339189|FG001|Overall Study|Withdrew consent|0|||
156617053|NCT00255008|565339190|FG002|Overall Study|Withdrew consent|2|||
156617054|NCT00255008|565339191|FG003|Overall Study|Withdrew consent|0|||
156617055|NCT00255008|565339188|FG000|Overall Study|Sponsor request|18|||
156617056|NCT00255008|565339189|FG001|Overall Study|Sponsor request|3|||
156617057|NCT00255008|565339190|FG002|Overall Study|Sponsor request|8|||
156617058|NCT00255008|565339191|FG003|Overall Study|Sponsor request|17|||
156617059|NCT00255008|565339188|FG000|Overall Study|Adverse lab experience|1|||
156617060|NCT00255008|565339189|FG001|Overall Study|Adverse lab experience|0|||
156617061|NCT00255008|565339190|FG002|Overall Study|Adverse lab experience|0|||
156617062|NCT00255008|565339191|FG003|Overall Study|Adverse lab experience|0|||
156617063|NCT00255008|565339188|FG000|Overall Study|Other|7|||
156617064|NCT00255008|565339189|FG001|Overall Study|Other|0|||
156617065|NCT00255008|565339190|FG002|Overall Study|Other|3|||
156617066|NCT00255008|565339191|FG003|Overall Study|Other|2|||
156617067|NCT00322387|565339195|FG000|Treatment Period|Adverse Event|0|||
156617068|NCT00322387|565339196|FG001|Treatment Period|Adverse Event|1|||
156617069|NCT00322387|565339195|FG000|Follow-up Period|Final assessment not done|1|||
156617070|NCT00322387|565339196|FG001|Follow-up Period|Final assessment not done|3|||
156617071|NCT00322387|565339195|FG000|Follow-up Period|Death|1|||
156617072|NCT00322387|565339196|FG001|Follow-up Period|Death|0|||
156617073|NCT00707486|565339197|FG000|Overall Study|Withdrawal by Subject|1|||
156617074|NCT02299206|565339200|FG000|Overall Study|Lost to Follow-up|1|||
156617075|NCT02299206|565339200|FG000|Overall Study|Withdrawal by Subject|1|||
156617076|NCT00691054|565339201|FG000|Overall Study|Withdrawal by Subject|1|||
156617077|NCT01855919|565340950|FG000|Overall Study|Adverse Event|16|||
156617078|NCT01855919|565340951|FG001|Overall Study|Adverse Event|8|||
156617079|NCT01855919|565340950|FG000|Overall Study|Lack of Efficacy|1|||
156617080|NCT01855919|565340951|FG001|Overall Study|Lack of Efficacy|3|||
156617081|NCT01855919|565340950|FG000|Overall Study|Withdrawal by Subject|4|||
156617082|NCT01855919|565340951|FG001|Overall Study|Withdrawal by Subject|10|||
156617083|NCT01855919|565340950|FG000|Overall Study|Entry Criteria Not Met|1|||
156617084|NCT01855919|565340951|FG001|Overall Study|Entry Criteria Not Met|1|||
156617085|NCT01855919|565340950|FG000|Overall Study|Protocol Violation|1|||
156617086|NCT01855919|565340951|FG001|Overall Study|Protocol Violation|4|||
156617087|NCT03455530|565340954|FG000|Overall Study|Withdrawal by Subject|9|||
156617088|NCT03455530|565340955|FG001|Overall Study|Withdrawal by Subject|1|||
156617089|NCT03455530|565340956|FG002|Overall Study|Withdrawal by Subject|3|||
156617090|NCT03455530|565340957|FG003|Overall Study|Withdrawal by Subject|3|||
156617091|NCT02972658|565340962|FG000|Overall Study|Adverse Event|0|||
156617092|NCT02972658|565340963|FG001|Overall Study|Adverse Event|3|||
156617093|NCT02972658|565340964|FG002|Overall Study|Adverse Event|0|||
156617094|NCT02972658|565340965|FG003|Overall Study|Adverse Event|2|||
156617095|NCT02972658|565340962|FG000|Overall Study|Other-determined by Investigator|1|||
156617096|NCT02972658|565340963|FG001|Overall Study|Other-determined by Investigator|1|||
156617097|NCT02972658|565340964|FG002|Overall Study|Other-determined by Investigator|0|||
156617098|NCT02972658|565340965|FG003|Overall Study|Other-determined by Investigator|0|||
156617099|NCT02972658|565340962|FG000|Overall Study|Death|0|||
156617100|NCT02972658|565340963|FG001|Overall Study|Death|0|||
156617101|NCT02972658|565340964|FG002|Overall Study|Death|0|||
156617102|NCT02972658|565340965|FG003|Overall Study|Death|1|||
156617103|NCT02972658|565340962|FG000|Overall Study|Lost to Follow-up|0|||
156617104|NCT02972658|565340963|FG001|Overall Study|Lost to Follow-up|1|||
156617105|NCT02972658|565340964|FG002|Overall Study|Lost to Follow-up|1|||
156617106|NCT02972658|565340965|FG003|Overall Study|Lost to Follow-up|2|||
156617107|NCT02972658|565340962|FG000|Overall Study|Progressive Disease|0|||
156617108|NCT02972658|565340963|FG001|Overall Study|Progressive Disease|1|||
156617109|NCT02972658|565340964|FG002|Overall Study|Progressive Disease|0|||
156617110|NCT02972658|565340965|FG003|Overall Study|Progressive Disease|1|||
156617111|NCT02972658|565340962|FG000|Overall Study|Withdrawal by Subject|4|||
156617112|NCT02972658|565340963|FG001|Overall Study|Withdrawal by Subject|4|||
156617113|NCT02972658|565340964|FG002|Overall Study|Withdrawal by Subject|1|||
156617114|NCT02972658|565340965|FG003|Overall Study|Withdrawal by Subject|6|||
156617115|NCT02972658|565340962|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
156617116|NCT02972658|565340963|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
156617117|NCT02972658|565340964|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
156617118|NCT02972658|565340965|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
156617119|NCT02972658|565340962|FG000|Overall Study|Sponsor Decision|70|||
156617120|NCT02972658|565340963|FG001|Overall Study|Sponsor Decision|127|||
156617121|NCT02972658|565340964|FG002|Overall Study|Sponsor Decision|72|||
156617122|NCT02972658|565340965|FG003|Overall Study|Sponsor Decision|119|||
156617123|NCT03958149|565340970|FG000|Overall Study|Withdrawal by Subject|0|||
156617124|NCT03958149|565340971|FG001|Overall Study|Withdrawal by Subject|1|||
156617125|NCT02785588|565340972|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
156617126|NCT02785588|565340972|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
156617127|NCT03037489|565340973|FG000|Overall Study|Adverse Event|4|||
156617128|NCT03037489|565340974|FG001|Overall Study|Adverse Event|0|||
156617129|NCT03037489|565340973|FG000|Overall Study|Withdrawal by Subject|3|||
156617130|NCT03037489|565340974|FG001|Overall Study|Withdrawal by Subject|0|||
156617131|NCT00621764|565340976|FG000|Overall Study|Protocol Violation|0|||
156617132|NCT00621764|565340977|FG001|Overall Study|Protocol Violation|0|||
156617133|NCT00621764|565340978|FG002|Overall Study|Protocol Violation|0|||
156617134|NCT00621764|565340979|FG003|Overall Study|Protocol Violation|1|||
156617135|NCT00724243|565340984|FG000|Overall Study|Lack of Efficacy|10|||
156617136|NCT00724243|565340984|FG000|Overall Study|Adverse Event|5|||
156617137|NCT03031327|565340985|FG000|Overall Study|Withdrawal by Subject|0|||
156617138|NCT03031327|565340986|FG001|Overall Study|Withdrawal by Subject|1|||
156617139|NCT03031327|565340987|FG002|Overall Study|Withdrawal by Subject|1|||
156617140|NCT00669240|565340988|FG000|Overall Study|Lack of Efficacy|33|||
156617141|NCT00669240|565340988|FG000|Overall Study|Withdrawal by Subject|42|||
156617142|NCT00669240|565340988|FG000|Overall Study|Lost to Follow-up|34|||
156617143|NCT00669240|565340988|FG000|Overall Study|Adverse Event|21|||
156617144|NCT00669240|565340988|FG000|Overall Study|Other|19|||
156617145|NCT00669240|565340988|FG000|Overall Study|Enrolled but not treated|15|||
156617146|NCT00669240|565340988|FG000|Overall Study|Enrolled but no dosing record|1|||
156617147|NCT00686699|565340989|FG000|Treatment Period 1|Adverse Event|0|||
156617148|NCT00686699|565340990|FG001|Treatment Period 1|Adverse Event|2|||
156617149|NCT01888965|565340991|FG000|Overall Study|Adverse Event|5|||
156617150|NCT01888965|565340991|FG000|Overall Study|Lack of Efficacy|4|||
156617151|NCT00908895|565340992|FG000|Overall Study|Lost to Follow-up|1|||
156617152|NCT00908895|565340993|FG001|Overall Study|Lost to Follow-up|3|||
156617153|NCT00908895|565340992|FG000|Overall Study|algodystrophy|2|||
156617154|NCT00908895|565340993|FG001|Overall Study|algodystrophy|2|||
156617155|NCT00908895|565340992|FG000|Overall Study|Adverse Event|1|||
156617156|NCT00908895|565340993|FG001|Overall Study|Adverse Event|1|||
156617157|NCT03793010|565340994|FG000|Overall Study|Withdrawal by Subject|5|||
156617158|NCT03793010|565340995|FG001|Overall Study|Withdrawal by Subject|7|||
156617159|NCT03793010|565340994|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
156617160|NCT03793010|565340995|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
156617161|NCT03793010|565340994|FG000|Overall Study|Lost to Follow-up|1|||
156617162|NCT03793010|565340995|FG001|Overall Study|Lost to Follow-up|2|||
156617163|NCT03793010|565340994|FG000|Overall Study|Patient couldn't sit still for injection|1|||
156617164|NCT03793010|565340995|FG001|Overall Study|Patient couldn't sit still for injection|0|||
156617165|NCT03793010|565340994|FG000|Overall Study|Withdrew to pursue other treatment|1|||
156617166|NCT03793010|565340995|FG001|Overall Study|Withdrew to pursue other treatment|0|||
156617167|NCT03793010|565340994|FG000|Overall Study|Did not meet eligibility criteria|1|||
156617168|NCT03793010|565340995|FG001|Overall Study|Did not meet eligibility criteria|0|||
156617169|NCT00364611|565340998|FG000|Overall Study|Did not receive study medication|0|||
156617170|NCT00364611|565340999|FG001|Overall Study|Did not receive study medication|1|||
156617171|NCT00364611|565340998|FG000|Overall Study|Adverse Event|7|||
156617172|NCT00364611|565340999|FG001|Overall Study|Adverse Event|4|||
156617173|NCT00364611|565340998|FG000|Overall Study|Participant's Request|3|||
156617174|NCT00364611|565340999|FG001|Overall Study|Participant's Request|4|||
156617175|NCT00364611|565340998|FG000|Overall Study|Disease Progression|38|||
156617176|NCT00364611|565340999|FG001|Overall Study|Disease Progression|8|||
156617177|NCT00364611|565340998|FG000|Overall Study|Investigator decision|2|||
156617178|NCT00364611|565340999|FG001|Overall Study|Investigator decision|2|||
156617179|NCT00364611|565340998|FG000|Overall Study|Found Ineligible|1|||
156617180|NCT00364611|565340999|FG001|Overall Study|Found Ineligible|0|||
156617181|NCT00364611|565340998|FG000|Overall Study|Presumed CR on Study|0|||
156617182|NCT00364611|565340999|FG001|Overall Study|Presumed CR on Study|1|||
156617183|NCT00364611|565340998|FG000|Overall Study|Receiving Liver Ablation|0|||
156617184|NCT00364611|565340999|FG001|Overall Study|Receiving Liver Ablation|1|||
156617185|NCT02059174|565341015|FG000|Period 1|Withdrawal by Subject|0|||
156617186|NCT02059174|565341016|FG001|Period 1|Withdrawal by Subject|2|||
156617187|NCT02059174|565341015|FG000|Period 2|Withdrawal by Subject|0|||
156617188|NCT02059174|565341016|FG001|Period 2|Withdrawal by Subject|2|||
156617189|NCT02059174|565341015|FG000|Period 2|Protocol Violation|1|||
156617190|NCT02059174|565341016|FG001|Period 2|Protocol Violation|0|||
156617191|NCT02059174|565341015|FG000|Period 3|Physician Decision|1|||
156617192|NCT02059174|565341016|FG001|Period 3|Physician Decision|0|||
156617193|NCT00087594|565341021|FG000|Overall Study|Adverse Event|2|||
156617194|NCT00087594|565341022|FG001|Overall Study|Adverse Event|3|||
156617195|NCT00087594|565341021|FG000|Overall Study|Lost to Follow-up|0|||
156617196|NCT00087594|565341022|FG001|Overall Study|Lost to Follow-up|2|||
156617197|NCT00087594|565341021|FG000|Overall Study|Withdrawal by Subject|4|||
156617198|NCT00087594|565341022|FG001|Overall Study|Withdrawal by Subject|2|||
156617199|NCT00087594|565341021|FG000|Overall Study|Lack of Efficacy|2|||
156617200|NCT00087594|565341022|FG001|Overall Study|Lack of Efficacy|5|||
156617201|NCT00768040|565341023|FG000|Overall Study|Adverse Event|3|||
156617202|NCT00768040|565341024|FG001|Overall Study|Adverse Event|2|||
156617203|NCT00768040|565341023|FG000|Overall Study|Abnormal laboratory value|1|||
156617204|NCT00768040|565341024|FG001|Overall Study|Abnormal laboratory value|1|||
156617205|NCT02274311|565341031|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
156617206|NCT00508001|565341032|FG000|Overall Study|Adverse Event|2|||
156617207|NCT00508001|565341033|FG001|Overall Study|Adverse Event|0|||
156617208|NCT00508001|565341034|FG002|Overall Study|Adverse Event|4|||
156617209|NCT00508001|565341032|FG000|Overall Study|condition under investigation worsened|13|||
156617210|NCT00508001|565341033|FG001|Overall Study|condition under investigation worsened|7|||
156617211|NCT00508001|565341034|FG002|Overall Study|condition under investigation worsened|1|||
156617212|NCT00508001|565341032|FG000|Overall Study|Death|0|||
156617213|NCT00508001|565341033|FG001|Overall Study|Death|1|||
156617214|NCT00508001|565341034|FG002|Overall Study|Death|1|||
156617215|NCT00508001|565341032|FG000|Overall Study|Withdrawal by Subject|4|||
156617216|NCT00508001|565341033|FG001|Overall Study|Withdrawal by Subject|4|||
156617217|NCT00508001|565341034|FG002|Overall Study|Withdrawal by Subject|1|||
156617218|NCT04437511|565341035|FG000|Overall Study|Adverse Event|50|||
156617219|NCT04437511|565341036|FG001|Overall Study|Adverse Event|21|||
156617220|NCT04437511|565341035|FG000|Overall Study|Death|15|||
156617221|NCT04437511|565341036|FG001|Overall Study|Death|10|||
156617222|NCT04437511|565341035|FG000|Overall Study|Lost to Follow-up|11|||
156617223|NCT04437511|565341036|FG001|Overall Study|Lost to Follow-up|11|||
156617224|NCT04437511|565341035|FG000|Overall Study|Physician Decision|19|||
156617225|NCT04437511|565341036|FG001|Overall Study|Physician Decision|10|||
156617226|NCT04437511|565341035|FG000|Overall Study|Progressive Disease|4|||
156617227|NCT04437511|565341036|FG001|Overall Study|Progressive Disease|7|||
156617228|NCT04437511|565341035|FG000|Overall Study|Withdrawal by Subject|111|||
156617229|NCT04437511|565341036|FG001|Overall Study|Withdrawal by Subject|94|||
156617230|NCT04437511|565341035|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
156617231|NCT04437511|565341036|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
156617232|NCT04437511|565341035|FG000|Overall Study|Continuing Study|7|||
156617233|NCT04437511|565341036|FG001|Overall Study|Continuing Study|5|||
156617234|NCT03093350|565341041|FG000|Overall Study|Death|1|||
156617235|NCT03093350|565341041|FG000|Overall Study|Signed consent, never began treartment|1|||
156617236|NCT01263470|565341045|FG000|Overall Study|Adverse Event|2|||
156617237|NCT01263470|565341046|FG001|Overall Study|Adverse Event|2|||
156617238|NCT01263470|565341047|FG002|Overall Study|Adverse Event|1|||
156617239|NCT01263470|565341048|FG003|Overall Study|Adverse Event|1|||
156617240|NCT01263470|565341049|FG004|Overall Study|Adverse Event|2|||
156617241|NCT01263470|565341050|FG005|Overall Study|Adverse Event|2|||
156617242|NCT01263470|565341045|FG000|Overall Study|Protocol Violation|0|||
156617243|NCT01263470|565341046|FG001|Overall Study|Protocol Violation|1|||
156617244|NCT01263470|565341047|FG002|Overall Study|Protocol Violation|0|||
156617245|NCT01263470|565341048|FG003|Overall Study|Protocol Violation|0|||
156617246|NCT01263470|565341049|FG004|Overall Study|Protocol Violation|0|||
156617247|NCT01263470|565341050|FG005|Overall Study|Protocol Violation|1|||
156617248|NCT01263470|565341045|FG000|Overall Study|Withdrawal by Subject|0|||
156617249|NCT01263470|565341046|FG001|Overall Study|Withdrawal by Subject|1|||
156617250|NCT01263470|565341047|FG002|Overall Study|Withdrawal by Subject|1|||
156617251|NCT01263470|565341048|FG003|Overall Study|Withdrawal by Subject|2|||
156617252|NCT01263470|565341049|FG004|Overall Study|Withdrawal by Subject|0|||
156617253|NCT01263470|565341050|FG005|Overall Study|Withdrawal by Subject|2|||
156617254|NCT01263470|565341045|FG000|Overall Study|Lack of Efficacy|0|||
156617255|NCT01263470|565341046|FG001|Overall Study|Lack of Efficacy|0|||
156617256|NCT01263470|565341047|FG002|Overall Study|Lack of Efficacy|2|||
156617257|NCT01263470|565341048|FG003|Overall Study|Lack of Efficacy|0|||
156617258|NCT01263470|565341049|FG004|Overall Study|Lack of Efficacy|0|||
156617259|NCT01263470|565341050|FG005|Overall Study|Lack of Efficacy|0|||
156617260|NCT01263470|565341045|FG000|Overall Study|Participant Unavailability|0|||
156617261|NCT01263470|565341046|FG001|Overall Study|Participant Unavailability|1|||
156617262|NCT01263470|565341047|FG002|Overall Study|Participant Unavailability|0|||
156617263|NCT01263470|565341048|FG003|Overall Study|Participant Unavailability|0|||
156617264|NCT01263470|565341049|FG004|Overall Study|Participant Unavailability|0|||
156617265|NCT01263470|565341050|FG005|Overall Study|Participant Unavailability|0|||
156617266|NCT01263470|565341045|FG000|Overall Study|Study Drug Non-compliance|0|||
156617267|NCT01263470|565341046|FG001|Overall Study|Study Drug Non-compliance|0|||
156617268|NCT01263470|565341047|FG002|Overall Study|Study Drug Non-compliance|0|||
156617269|NCT01263470|565341048|FG003|Overall Study|Study Drug Non-compliance|0|||
156617270|NCT01263470|565341049|FG004|Overall Study|Study Drug Non-compliance|1|||
156617271|NCT01263470|565341050|FG005|Overall Study|Study Drug Non-compliance|0|||
156617272|NCT00610714|565341051|FG000|Overall Study|Adverse Event|3|||
156617273|NCT00610714|565341052|FG001|Overall Study|Adverse Event|1|||
156617274|NCT00610714|565341051|FG000|Overall Study|Death|12|||
156617275|NCT00610714|565341052|FG001|Overall Study|Death|18|||
156617276|NCT00610714|565341051|FG000|Overall Study|Withdrawal by Subject|9|||
156617277|NCT00610714|565341052|FG001|Overall Study|Withdrawal by Subject|3|||
156617278|NCT00610714|565341051|FG000|Overall Study|Study completion at 120 PFS events|2|||
156617279|NCT00610714|565341052|FG001|Overall Study|Study completion at 120 PFS events|2|||
156617280|NCT01327573|565341053|FG000|Overall Study|Physician Decision|3|||
156617281|NCT01327573|565341054|FG001|Overall Study|Physician Decision|1|||
156617282|NCT01108263|565341055|FG000|Overall Study|Adverse Event|0|||
156617283|NCT01108263|565341056|FG001|Overall Study|Adverse Event|1|||
156617284|NCT00638989|565341057|FG000|Overall Study|Lost to Follow-up|0|||
156617285|NCT00638989|565341058|FG001|Overall Study|Lost to Follow-up|0|||
156617286|NCT00638989|565341059|FG002|Overall Study|Lost to Follow-up|1|||
156617287|NCT05245071|565341060|FG000|Overall Study|Progressive disease|18|||
156617288|NCT05245071|565341060|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
156617289|NCT05245071|565341060|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
156617290|NCT01602822|565341061|FG000|Overall Study|Adverse Event|11|||
156617291|NCT00853112|565341065|FG000|Overall Study|Randomized but not treated|0|||
156617292|NCT00853112|565341066|FG001|Overall Study|Randomized but not treated|1|||
156617293|NCT00853112|565341067|FG002|Overall Study|Randomized but not treated|0|||
156617294|NCT00853112|565341068|FG003|Overall Study|Randomized but not treated|2|||
156617295|NCT00853112|565341069|FG004|Overall Study|Randomized but not treated|0|||
156617296|NCT00853112|565341070|FG005|Overall Study|Randomized but not treated|0|||
156617297|NCT00853112|565341071|FG006|Overall Study|Randomized but not treated|1|||
156617298|NCT01553591|565341072|FG000|Overall Study|Voluntarily withdrew|94|||
156617299|NCT01553591|565341073|FG001|Overall Study|Voluntarily withdrew|79|||
156617300|NCT01553591|565341074|FG002|Overall Study|Voluntarily withdrew|96|||
156617301|NCT01553591|565341072|FG000|Overall Study|Adverse Event|36|||
156617302|NCT01553591|565341073|FG001|Overall Study|Adverse Event|45|||
156617303|NCT01553591|565341074|FG002|Overall Study|Adverse Event|16|||
156617304|NCT01553591|565341072|FG000|Overall Study|Lost to Follow-up|25|||
156617305|NCT01553591|565341073|FG001|Overall Study|Lost to Follow-up|23|||
156617306|NCT01553591|565341074|FG002|Overall Study|Lost to Follow-up|16|||
156617307|NCT01553591|565341072|FG000|Overall Study|Physician decision: other|11|||
156617308|NCT01553591|565341073|FG001|Overall Study|Physician decision: other|14|||
156617309|NCT01553591|565341074|FG002|Overall Study|Physician decision: other|16|||
156617310|NCT01553591|565341072|FG000|Overall Study|Physician decision: lack of efficacy|2|||
156617311|NCT01553591|565341073|FG001|Overall Study|Physician decision: lack of efficacy|3|||
156617312|NCT01553591|565341074|FG002|Overall Study|Physician decision: lack of efficacy|7|||
156617313|NCT01553591|565341072|FG000|Overall Study|Protocol Violation|3|||
156617314|NCT01553591|565341073|FG001|Overall Study|Protocol Violation|4|||
156617315|NCT01553591|565341074|FG002|Overall Study|Protocol Violation|4|||
156617316|NCT01553591|565341072|FG000|Overall Study|Sponsor decision|1|||
156617317|NCT01553591|565341073|FG001|Overall Study|Sponsor decision|0|||
156617318|NCT01553591|565341074|FG002|Overall Study|Sponsor decision|3|||
156617319|NCT01553591|565341072|FG000|Overall Study|Randomized and never dispensed drug|0|||
156617320|NCT01553591|565341073|FG001|Overall Study|Randomized and never dispensed drug|1|||
156617321|NCT01553591|565341074|FG002|Overall Study|Randomized and never dispensed drug|0|||
156617322|NCT02477800|565341075|FG000|Placebo-Controlled Period|Adverse Event|16|||
156617323|NCT02477800|565341076|FG001|Placebo-Controlled Period|Adverse Event|25|||
156617324|NCT02477800|565341077|FG002|Placebo-Controlled Period|Adverse Event|28|||
156617325|NCT02477800|565341078|FG003|Placebo-Controlled Period|Adverse Event|0|||
156617326|NCT02477800|565341079|FG004|Placebo-Controlled Period|Adverse Event|0|||
156617327|NCT02477800|565341080|FG005|Placebo-Controlled Period|Adverse Event|0|||
156617328|NCT02477800|565341081|FG006|Placebo-Controlled Period|Adverse Event|0|||
156617329|NCT02477800|565341075|FG000|Placebo-Controlled Period|Change of Treatment|1|||
156617330|NCT02477800|565341076|FG001|Placebo-Controlled Period|Change of Treatment|2|||
156617331|NCT02477800|565341077|FG002|Placebo-Controlled Period|Change of Treatment|1|||
156617332|NCT02477800|565341078|FG003|Placebo-Controlled Period|Change of Treatment|0|||
156617333|NCT02477800|565341079|FG004|Placebo-Controlled Period|Change of Treatment|0|||
156617334|NCT02477800|565341080|FG005|Placebo-Controlled Period|Change of Treatment|0|||
156617335|NCT02477800|565341081|FG006|Placebo-Controlled Period|Change of Treatment|0|||
156617336|NCT02477800|565341075|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
156617337|NCT02477800|565341076|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
156617338|NCT02477800|565341077|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
156617339|NCT02477800|565341078|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
156617340|NCT02477800|565341079|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
156617341|NCT02477800|565341080|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
156617342|NCT02477800|565341081|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
156617343|NCT02477800|565341075|FG000|Placebo-Controlled Period|Death|0|||
156617344|NCT02477800|565341076|FG001|Placebo-Controlled Period|Death|3|||
156617345|NCT02477800|565341077|FG002|Placebo-Controlled Period|Death|2|||
156617346|NCT02477800|565341078|FG003|Placebo-Controlled Period|Death|0|||
156617347|NCT02477800|565341079|FG004|Placebo-Controlled Period|Death|0|||
156617348|NCT02477800|565341080|FG005|Placebo-Controlled Period|Death|0|||
156617349|NCT02477800|565341081|FG006|Placebo-Controlled Period|Death|0|||
156617350|NCT02477800|565341075|FG000|Placebo-Controlled Period|Disease Progression|1|||
156617351|NCT02477800|565341076|FG001|Placebo-Controlled Period|Disease Progression|0|||
156617352|NCT02477800|565341077|FG002|Placebo-Controlled Period|Disease Progression|1|||
156617353|NCT02477800|565341078|FG003|Placebo-Controlled Period|Disease Progression|0|||
156617354|NCT02477800|565341079|FG004|Placebo-Controlled Period|Disease Progression|0|||
156617355|NCT02477800|565341080|FG005|Placebo-Controlled Period|Disease Progression|0|||
156617356|NCT02477800|565341081|FG006|Placebo-Controlled Period|Disease Progression|0|||
156617357|NCT02477800|565341075|FG000|Placebo-Controlled Period|Investigator Decision|3|||
156617358|NCT02477800|565341076|FG001|Placebo-Controlled Period|Investigator Decision|2|||
156617359|NCT02477800|565341077|FG002|Placebo-Controlled Period|Investigator Decision|1|||
156617360|NCT02477800|565341078|FG003|Placebo-Controlled Period|Investigator Decision|0|||
156617361|NCT02477800|565341079|FG004|Placebo-Controlled Period|Investigator Decision|0|||
156617362|NCT02477800|565341080|FG005|Placebo-Controlled Period|Investigator Decision|0|||
156617363|NCT02477800|565341081|FG006|Placebo-Controlled Period|Investigator Decision|0|||
156617364|NCT02477800|565341075|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
156617365|NCT02477800|565341076|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
156617366|NCT02477800|565341077|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
156617367|NCT02477800|565341078|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
156617368|NCT02477800|565341079|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
156617369|NCT02477800|565341080|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
156617370|NCT02477800|565341081|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
156617371|NCT02477800|565341075|FG000|Placebo-Controlled Period|Relocation|2|||
156617372|NCT02477800|565341076|FG001|Placebo-Controlled Period|Relocation|0|||
156617373|NCT02477800|565341077|FG002|Placebo-Controlled Period|Relocation|0|||
156617374|NCT02477800|565341078|FG003|Placebo-Controlled Period|Relocation|0|||
156617375|NCT02477800|565341079|FG004|Placebo-Controlled Period|Relocation|0|||
156617376|NCT02477800|565341080|FG005|Placebo-Controlled Period|Relocation|0|||
156617377|NCT02477800|565341081|FG006|Placebo-Controlled Period|Relocation|0|||
156617378|NCT02477800|565341075|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
156617379|NCT02477800|565341076|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
156617380|NCT02477800|565341077|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
156617381|NCT02477800|565341078|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
156617382|NCT02477800|565341079|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
156617383|NCT02477800|565341080|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
156617384|NCT02477800|565341081|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
156617385|NCT02477800|565341075|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
156617386|NCT02477800|565341076|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
156617387|NCT02477800|565341077|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
156617388|NCT02477800|565341078|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
156617389|NCT02477800|565341079|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
156617390|NCT02477800|565341080|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
156617391|NCT02477800|565341081|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
156617392|NCT02477800|565341075|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
156617393|NCT02477800|565341076|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
156617394|NCT02477800|565341077|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
156617395|NCT02477800|565341078|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
156617396|NCT02477800|565341079|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
156617397|NCT02477800|565341080|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
156617398|NCT02477800|565341081|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
156617399|NCT02477800|565341075|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
156617400|NCT02477800|565341076|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
156617401|NCT02477800|565341077|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
156617402|NCT02477800|565341078|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156617403|NCT02477800|565341079|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156617404|NCT02477800|565341080|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156617405|NCT02477800|565341081|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156617406|NCT02477800|565341075|FG000|Placebo-Controlled Period|Reason not Specified|161|||
156617407|NCT02477800|565341076|FG001|Placebo-Controlled Period|Reason not Specified|161|||
156617408|NCT02477800|565341077|FG002|Placebo-Controlled Period|Reason not Specified|189|||
156617409|NCT02477800|565341078|FG003|Placebo-Controlled Period|Reason not Specified|0|||
156617410|NCT02477800|565341079|FG004|Placebo-Controlled Period|Reason not Specified|0|||
156617411|NCT02477800|565341080|FG005|Placebo-Controlled Period|Reason not Specified|0|||
156617412|NCT02477800|565341081|FG006|Placebo-Controlled Period|Reason not Specified|0|||
156617413|NCT02477800|565341075|FG000|Long Term Extension Period|Adverse Event|0|||
156617414|NCT02477800|565341076|FG001|Long Term Extension Period|Adverse Event|0|||
156617415|NCT02477800|565341077|FG002|Long Term Extension Period|Adverse Event|0|||
156617416|NCT02477800|565341078|FG003|Long Term Extension Period|Adverse Event|6|||
156617417|NCT02477800|565341079|FG004|Long Term Extension Period|Adverse Event|2|||
156617418|NCT02477800|565341080|FG005|Long Term Extension Period|Adverse Event|4|||
156617419|NCT02477800|565341081|FG006|Long Term Extension Period|Adverse Event|3|||
156617420|NCT02477800|565341075|FG000|Long Term Extension Period|Death|0|||
156617421|NCT02477800|565341076|FG001|Long Term Extension Period|Death|0|||
156617422|NCT02477800|565341077|FG002|Long Term Extension Period|Death|0|||
156617423|NCT02477800|565341078|FG003|Long Term Extension Period|Death|1|||
156617424|NCT02477800|565341079|FG004|Long Term Extension Period|Death|1|||
156617425|NCT02477800|565341080|FG005|Long Term Extension Period|Death|1|||
156617426|NCT02477800|565341081|FG006|Long Term Extension Period|Death|2|||
156617427|NCT02477800|565341075|FG000|Long Term Extension Period|Consent Withdrawn|0|||
156617428|NCT02477800|565341076|FG001|Long Term Extension Period|Consent Withdrawn|0|||
156617429|NCT02477800|565341077|FG002|Long Term Extension Period|Consent Withdrawn|0|||
156617430|NCT02477800|565341078|FG003|Long Term Extension Period|Consent Withdrawn|10|||
156617431|NCT02477800|565341079|FG004|Long Term Extension Period|Consent Withdrawn|4|||
156617432|NCT02477800|565341080|FG005|Long Term Extension Period|Consent Withdrawn|13|||
156617433|NCT02477800|565341081|FG006|Long Term Extension Period|Consent Withdrawn|16|||
156617434|NCT02477800|565341075|FG000|Long Term Extension Period|Disease Progression|0|||
156617435|NCT02477800|565341076|FG001|Long Term Extension Period|Disease Progression|0|||
156617436|NCT02477800|565341077|FG002|Long Term Extension Period|Disease Progression|0|||
156617437|NCT02477800|565341078|FG003|Long Term Extension Period|Disease Progression|3|||
156617438|NCT02477800|565341079|FG004|Long Term Extension Period|Disease Progression|1|||
156617439|NCT02477800|565341080|FG005|Long Term Extension Period|Disease Progression|1|||
156617440|NCT02477800|565341081|FG006|Long Term Extension Period|Disease Progression|0|||
156617441|NCT02477800|565341075|FG000|Long Term Extension Period|Investigator Decision|0|||
156617442|NCT02477800|565341076|FG001|Long Term Extension Period|Investigator Decision|0|||
156617443|NCT02477800|565341077|FG002|Long Term Extension Period|Investigator Decision|0|||
156617444|NCT02477800|565341078|FG003|Long Term Extension Period|Investigator Decision|0|||
156617445|NCT02477800|565341079|FG004|Long Term Extension Period|Investigator Decision|0|||
156617446|NCT02477800|565341080|FG005|Long Term Extension Period|Investigator Decision|0|||
156617447|NCT02477800|565341081|FG006|Long Term Extension Period|Investigator Decision|2|||
156617448|NCT02477800|565341075|FG000|Long Term Extension Period|Lost to Follow-up|0|||
156617449|NCT02477800|565341076|FG001|Long Term Extension Period|Lost to Follow-up|0|||
156617450|NCT02477800|565341077|FG002|Long Term Extension Period|Lost to Follow-up|0|||
156617451|NCT02477800|565341078|FG003|Long Term Extension Period|Lost to Follow-up|0|||
156617452|NCT02477800|565341079|FG004|Long Term Extension Period|Lost to Follow-up|1|||
156617453|NCT02477800|565341080|FG005|Long Term Extension Period|Lost to Follow-up|3|||
156617454|NCT02477800|565341081|FG006|Long Term Extension Period|Lost to Follow-up|0|||
156617455|NCT02477800|565341075|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
156617456|NCT02477800|565341076|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
156617457|NCT02477800|565341077|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
156617458|NCT02477800|565341078|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
156617459|NCT02477800|565341079|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
156617460|NCT02477800|565341080|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
156617461|NCT02477800|565341081|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
156617462|NCT02477800|565341075|FG000|Long Term Extension Period|Study Visit Burden|0|||
156617463|NCT02477800|565341076|FG001|Long Term Extension Period|Study Visit Burden|0|||
156617464|NCT02477800|565341077|FG002|Long Term Extension Period|Study Visit Burden|0|||
156617465|NCT02477800|565341078|FG003|Long Term Extension Period|Study Visit Burden|3|||
156617466|NCT02477800|565341079|FG004|Long Term Extension Period|Study Visit Burden|0|||
156635560|NCT00602667|565409960|FG000|Overall Study|Death|0|||
156617467|NCT02477800|565341080|FG005|Long Term Extension Period|Study Visit Burden|2|||
156617468|NCT02477800|565341081|FG006|Long Term Extension Period|Study Visit Burden|2|||
156617469|NCT02477800|565341075|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
156617470|NCT02477800|565341076|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
156617471|NCT02477800|565341077|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
156617472|NCT02477800|565341078|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
156617473|NCT02477800|565341079|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
156617474|NCT02477800|565341080|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
156617475|NCT02477800|565341081|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
156617476|NCT02477800|565341075|FG000|Long Term Extension Period|Reason not Specified|0|||
156617477|NCT02477800|565341076|FG001|Long Term Extension Period|Reason not Specified|0|||
156617478|NCT02477800|565341077|FG002|Long Term Extension Period|Reason not Specified|0|||
156617479|NCT02477800|565341078|FG003|Long Term Extension Period|Reason not Specified|126|||
156617480|NCT02477800|565341079|FG004|Long Term Extension Period|Reason not Specified|140|||
156617481|NCT02477800|565341080|FG005|Long Term Extension Period|Reason not Specified|270|||
156617482|NCT02477800|565341081|FG006|Long Term Extension Period|Reason not Specified|224|||
156617483|NCT02871791|565341082|FG000|Phase 1b|Death|0|||
156617484|NCT02871791|565341083|FG001|Phase 1b|Death|1|||
156617485|NCT02871791|565341082|FG000|Phase 1b|progressive disease|6|||
156617486|NCT02871791|565341083|FG001|Phase 1b|progressive disease|2|||
156617487|NCT02871791|565341082|FG000|Phase 2|Death|1|||
156617488|NCT02871791|565341083|FG001|Phase 2|Death|0|||
156617489|NCT02871791|565341082|FG000|Phase 2|Lost to Follow-up|2|||
156617490|NCT02871791|565341083|FG001|Phase 2|Lost to Follow-up|0|||
156617491|NCT03685643|565341088|FG000|Overall Study|Lost to Follow-up|14|||
156617492|NCT03685643|565341089|FG001|Overall Study|Lost to Follow-up|22|||
156617493|NCT01833806|565341090|FG000|Overall Study|Alternative treatment|2|||
156617494|NCT01833806|565341090|FG000|Overall Study|Death|5|||
156617495|NCT01833806|565341090|FG000|Overall Study|Physician Decision|1|||
156617496|NCT01833806|565341090|FG000|Overall Study|Lost to Follow-up|1|||
156617497|NCT01885104|565341105|FG000|Overall Study|Withdrawal of Consent|1|||
156617498|NCT01885104|565341106|FG001|Overall Study|Withdrawal of Consent|0|||
156617499|NCT01885104|565341105|FG000|Overall Study|Lost to Follow-up|0|||
156617500|NCT01885104|565341106|FG001|Overall Study|Lost to Follow-up|1|||
156617501|NCT01885104|565341105|FG000|Overall Study|Physician Decision|1|||
156617502|NCT01885104|565341106|FG001|Overall Study|Physician Decision|0|||
156617503|NCT00126425|565341107|FG000|Overall Study|Withdrawal by Subject|17|||
156617504|NCT00126425|565341108|FG001|Overall Study|Withdrawal by Subject|1|||
156617505|NCT00126425|565341107|FG000|Overall Study|Lost to Follow-up|8|||
156617506|NCT00126425|565341108|FG001|Overall Study|Lost to Follow-up|4|||
156617507|NCT00126425|565341107|FG000|Overall Study|Protocol Violation|9|||
156617508|NCT00126425|565341108|FG001|Overall Study|Protocol Violation|6|||
156617509|NCT00126425|565341107|FG000|Overall Study|Adverse Event|1|||
156617510|NCT00126425|565341108|FG001|Overall Study|Adverse Event|0|||
156617511|NCT00126425|565341107|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
156617512|NCT00126425|565341108|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
156617513|NCT00126425|565341107|FG000|Overall Study|Other|5|||
156617514|NCT00126425|565341108|FG001|Overall Study|Other|0|||
156617515|NCT01894776|565341109|FG000|Overall Study|Withdrawal by Subject|1|||
156617516|NCT02415595|565341110|FG000|Overall Study|Administrative reason by sponsor|39|||
156617517|NCT02415595|565341111|FG001|Overall Study|Administrative reason by sponsor|40|||
156617518|NCT02415595|565341112|FG002|Overall Study|Administrative reason by sponsor|41|||
156617519|NCT02415595|565341113|FG003|Overall Study|Administrative reason by sponsor|39|||
156617520|NCT02415595|565341110|FG000|Overall Study|Adverse Event|1|||
156617521|NCT02415595|565341111|FG001|Overall Study|Adverse Event|3|||
156617522|NCT02415595|565341112|FG002|Overall Study|Adverse Event|5|||
156617523|NCT02415595|565341113|FG003|Overall Study|Adverse Event|10|||
156617524|NCT02415595|565341110|FG000|Overall Study|Lack of Efficacy|4|||
156617525|NCT02415595|565341111|FG001|Overall Study|Lack of Efficacy|4|||
156617526|NCT02415595|565341112|FG002|Overall Study|Lack of Efficacy|0|||
156617527|NCT02415595|565341113|FG003|Overall Study|Lack of Efficacy|0|||
156617528|NCT02415595|565341110|FG000|Overall Study|Lost to Follow-up|1|||
156617529|NCT02415595|565341111|FG001|Overall Study|Lost to Follow-up|3|||
156617530|NCT02415595|565341112|FG002|Overall Study|Lost to Follow-up|1|||
156617531|NCT02415595|565341113|FG003|Overall Study|Lost to Follow-up|1|||
156617532|NCT02415595|565341110|FG000|Overall Study|Poor/Non-compliance|1|||
156617533|NCT02415595|565341111|FG001|Overall Study|Poor/Non-compliance|0|||
156617534|NCT02415595|565341112|FG002|Overall Study|Poor/Non-compliance|1|||
156617535|NCT02415595|565341113|FG003|Overall Study|Poor/Non-compliance|0|||
156617536|NCT02415595|565341110|FG000|Overall Study|Reached stopping criteria|0|||
156617537|NCT02415595|565341111|FG001|Overall Study|Reached stopping criteria|1|||
156617538|NCT02415595|565341112|FG002|Overall Study|Reached stopping criteria|1|||
156617539|NCT02415595|565341113|FG003|Overall Study|Reached stopping criteria|0|||
156617540|NCT02415595|565341110|FG000|Overall Study|Withdrawal by Subject|4|||
156617541|NCT02415595|565341111|FG001|Overall Study|Withdrawal by Subject|0|||
156617542|NCT02415595|565341112|FG002|Overall Study|Withdrawal by Subject|1|||
156617543|NCT02415595|565341113|FG003|Overall Study|Withdrawal by Subject|3|||
156617544|NCT02415595|565341110|FG000|Overall Study|Other|0|||
156617545|NCT02415595|565341111|FG001|Overall Study|Other|1|||
156617546|NCT02415595|565341112|FG002|Overall Study|Other|1|||
156617547|NCT02415595|565341113|FG003|Overall Study|Other|0|||
156617548|NCT02614261|565341114|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
156617549|NCT02614261|565341115|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
156617550|NCT02614261|565341116|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
156617551|NCT02614261|565341117|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
156617552|NCT02614261|565341114|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
156617553|NCT02614261|565341115|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156617554|NCT02614261|565341116|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156617555|NCT02614261|565341117|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156617556|NCT02614261|565341114|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
156617557|NCT02614261|565341115|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
156617558|NCT02614261|565341116|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156617559|NCT02614261|565341117|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156617560|NCT02614261|565341114|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
156617561|NCT02614261|565341115|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
156617562|NCT02614261|565341116|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
156617563|NCT02614261|565341117|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
156617564|NCT02614261|565341114|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
156617565|NCT02614261|565341115|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
156617566|NCT02614261|565341116|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
156617567|NCT02614261|565341117|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
156617568|NCT02614261|565341114|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
156617569|NCT02614261|565341115|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
156617570|NCT02614261|565341116|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
156617571|NCT02614261|565341117|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
156617572|NCT02614261|565341114|FG000|Double-Blind Treatment Phase|Screen failure|0|||
156617573|NCT02614261|565341115|FG001|Double-Blind Treatment Phase|Screen failure|1|||
156617574|NCT02614261|565341116|FG002|Double-Blind Treatment Phase|Screen failure|2|||
156617575|NCT02614261|565341117|FG003|Double-Blind Treatment Phase|Screen failure|0|||
156617576|NCT02614261|565341114|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
156617577|NCT02614261|565341115|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
156617578|NCT02614261|565341116|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
156617579|NCT02614261|565341117|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156617580|NCT02614261|565341114|FG000|Open-Label Extension Phase|Adverse Event|23|||
156617581|NCT02614261|565341115|FG001|Open-Label Extension Phase|Adverse Event|12|||
156617582|NCT02614261|565341116|FG002|Open-Label Extension Phase|Adverse Event|11|||
156617583|NCT02614261|565341117|FG003|Open-Label Extension Phase|Adverse Event|0|||
156617584|NCT02614261|565341114|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
156617585|NCT02614261|565341115|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
156617586|NCT02614261|565341116|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
156617587|NCT02614261|565341117|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
156617588|NCT02614261|565341114|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
156617589|NCT02614261|565341115|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
156617590|NCT02614261|565341116|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
156617591|NCT02614261|565341117|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
156617592|NCT02614261|565341114|FG000|Open-Label Extension Phase|Physician Decision|2|||
156617593|NCT02614261|565341115|FG001|Open-Label Extension Phase|Physician Decision|0|||
156617594|NCT02614261|565341116|FG002|Open-Label Extension Phase|Physician Decision|0|||
156617595|NCT02614261|565341117|FG003|Open-Label Extension Phase|Physician Decision|0|||
156617596|NCT02614261|565341114|FG000|Open-Label Extension Phase|Pregnancy|1|||
156617597|NCT02614261|565341115|FG001|Open-Label Extension Phase|Pregnancy|2|||
156617598|NCT02614261|565341116|FG002|Open-Label Extension Phase|Pregnancy|1|||
156617599|NCT02614261|565341117|FG003|Open-Label Extension Phase|Pregnancy|0|||
156617600|NCT02614261|565341114|FG000|Open-Label Extension Phase|Protocol Violation|3|||
156617601|NCT02614261|565341115|FG001|Open-Label Extension Phase|Protocol Violation|4|||
156617602|NCT02614261|565341116|FG002|Open-Label Extension Phase|Protocol Violation|1|||
156617603|NCT02614261|565341117|FG003|Open-Label Extension Phase|Protocol Violation|0|||
156617604|NCT02614261|565341114|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
156617605|NCT02614261|565341115|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
156617606|NCT02614261|565341116|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
156617607|NCT02614261|565341117|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
156617608|NCT02614261|565341114|FG000|Follow-up Phase|Adverse Event|2|||
156617609|NCT02614261|565341115|FG001|Follow-up Phase|Adverse Event|0|||
156617610|NCT02614261|565341116|FG002|Follow-up Phase|Adverse Event|1|||
156617611|NCT02614261|565341117|FG003|Follow-up Phase|Adverse Event|0|||
156617612|NCT02614261|565341114|FG000|Follow-up Phase|Lost to Follow-up|12|||
156617613|NCT02614261|565341115|FG001|Follow-up Phase|Lost to Follow-up|5|||
156617614|NCT02614261|565341116|FG002|Follow-up Phase|Lost to Follow-up|2|||
156617615|NCT02614261|565341117|FG003|Follow-up Phase|Lost to Follow-up|0|||
156617616|NCT02614261|565341114|FG000|Follow-up Phase|Physician Decision|5|||
156617617|NCT02614261|565341115|FG001|Follow-up Phase|Physician Decision|1|||
156617618|NCT02614261|565341116|FG002|Follow-up Phase|Physician Decision|0|||
156617619|NCT02614261|565341117|FG003|Follow-up Phase|Physician Decision|0|||
156617620|NCT02614261|565341114|FG000|Follow-up Phase|Pregnancy|0|||
156617621|NCT02614261|565341115|FG001|Follow-up Phase|Pregnancy|1|||
156617622|NCT02614261|565341116|FG002|Follow-up Phase|Pregnancy|0|||
156617623|NCT02614261|565341117|FG003|Follow-up Phase|Pregnancy|0|||
156617624|NCT02614261|565341114|FG000|Follow-up Phase|Protocol Violation|1|||
156617625|NCT02614261|565341115|FG001|Follow-up Phase|Protocol Violation|0|||
156617626|NCT02614261|565341116|FG002|Follow-up Phase|Protocol Violation|0|||
156617627|NCT02614261|565341117|FG003|Follow-up Phase|Protocol Violation|0|||
156617628|NCT02614261|565341114|FG000|Follow-up Phase|Withdrawal by Subject|12|||
156617629|NCT02614261|565341115|FG001|Follow-up Phase|Withdrawal by Subject|4|||
156617630|NCT02614261|565341116|FG002|Follow-up Phase|Withdrawal by Subject|11|||
156617631|NCT02614261|565341117|FG003|Follow-up Phase|Withdrawal by Subject|0|||
156617632|NCT02614261|565341114|FG000|Israel Addendum|Withdrawal by Subject|0|||
156617633|NCT02614261|565341115|FG001|Israel Addendum|Withdrawal by Subject|0|||
156617634|NCT02614261|565341116|FG002|Israel Addendum|Withdrawal by Subject|0|||
156617635|NCT02614261|565341117|FG003|Israel Addendum|Withdrawal by Subject|4|||
156617636|NCT04350372|565341120|FG000|Overall Study|Death|1|||
156617637|NCT03512275|565341122|FG000|Overall Study|Withdrawal by Subject|1|||
156617638|NCT03512275|565341123|FG001|Overall Study|Withdrawal by Subject|3|||
156617639|NCT03512275|565341122|FG000|Overall Study|Physician Decision|0|||
156617640|NCT03512275|565341123|FG001|Overall Study|Physician Decision|1|||
156617641|NCT03512275|565341122|FG000|Overall Study|Lost to Follow-up|0|||
156617642|NCT03512275|565341123|FG001|Overall Study|Lost to Follow-up|3|||
156617643|NCT03512275|565341122|FG000|Overall Study|Other|1|||
156617644|NCT03512275|565341123|FG001|Overall Study|Other|0|||
156617645|NCT00113555|565341124|FG000|Overall Study|Baseline Failure|59|||
156617646|NCT00113555|565341124|FG000|Overall Study|Permanently Explanted|7|||
156617647|NCT00113555|565341124|FG000|Overall Study|Death|1|||
156617648|NCT00113555|565341124|FG000|Overall Study|Missed Followup|4|||
156617649|NCT00113555|565341124|FG000|Overall Study|Lost to Follow-up|8|||
156617650|NCT04474366|565341125|FG000|Overall Study|Lost to Follow-up|2|||
156617651|NCT04474366|565341126|FG001|Overall Study|Lost to Follow-up|5|||
156617652|NCT01700140|565341127|FG000|Overall Study|Use of rescue drugs|3|||
156617653|NCT01700140|565341128|FG001|Overall Study|Use of rescue drugs|3|||
156617654|NCT01700140|565341129|FG002|Overall Study|Use of rescue drugs|1|||
156617655|NCT01700140|565341127|FG000|Overall Study|Discontinuation of radiotherapy|1|||
156617656|NCT01700140|565341128|FG001|Overall Study|Discontinuation of radiotherapy|0|||
156617657|NCT01700140|565341129|FG002|Overall Study|Discontinuation of radiotherapy|0|||
156617658|NCT01700140|565341127|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
156617659|NCT01700140|565341128|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
156617660|NCT01700140|565341129|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
156617661|NCT01700140|565341127|FG000|Overall Study|Aggravation of symptoms|1|||
156617662|NCT01700140|565341128|FG001|Overall Study|Aggravation of symptoms|0|||
156617663|NCT01700140|565341129|FG002|Overall Study|Aggravation of symptoms|0|||
156617664|NCT01700140|565341127|FG000|Overall Study|Adverse Event|0|||
156617665|NCT01700140|565341128|FG001|Overall Study|Adverse Event|1|||
156617666|NCT01700140|565341129|FG002|Overall Study|Adverse Event|0|||
156617667|NCT01700140|565341127|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
156617668|NCT01700140|565341128|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
156617669|NCT01700140|565341129|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
156617670|NCT00102804|565341130|FG000|Overall Study|Progressive Disease (PD)|307|||
156617671|NCT00102804|565341131|FG001|Overall Study|Progressive Disease (PD)|196|||
156617672|NCT00102804|565341130|FG000|Overall Study|Withdrawal by Subject|46|||
156617673|NCT00102804|565341131|FG001|Overall Study|Withdrawal by Subject|7|||
156617674|NCT00102804|565341130|FG000|Overall Study|Adverse Event|37|||
156617675|NCT00102804|565341131|FG001|Overall Study|Adverse Event|3|||
156617676|NCT00102804|565341130|FG000|Overall Study|Physician Decision|24|||
156617677|NCT00102804|565341131|FG001|Overall Study|Physician Decision|6|||
156617678|NCT00102804|565341130|FG000|Overall Study|Death|5|||
156617679|NCT00102804|565341131|FG001|Overall Study|Death|6|||
156617680|NCT00102804|565341130|FG000|Overall Study|Enrollment Criteria Not Met|6|||
156617681|NCT00102804|565341131|FG001|Overall Study|Enrollment Criteria Not Met|0|||
156617682|NCT00102804|565341130|FG000|Overall Study|Lost to Follow-up|4|||
156617683|NCT00102804|565341131|FG001|Overall Study|Lost to Follow-up|1|||
156617684|NCT00102804|565341130|FG000|Overall Study|Protocol Violation|2|||
156617685|NCT00102804|565341131|FG001|Overall Study|Protocol Violation|1|||
156617686|NCT00102804|565341130|FG000|Overall Study|Satisfactory Response|2|||
156617687|NCT00102804|565341131|FG001|Overall Study|Satisfactory Response|0|||
156617688|NCT00102804|565341130|FG000|Overall Study|Sponsor Decision|1|||
156617689|NCT00102804|565341131|FG001|Overall Study|Sponsor Decision|0|||
156617690|NCT00102804|565341130|FG000|Overall Study|Alive, Receiving Treatment|7|||
156617691|NCT00102804|565341131|FG001|Overall Study|Alive, Receiving Treatment|2|||
156617692|NCT03858686|565341132|FG000|Period 1|Adverse Event|1|||
156617693|NCT03858686|565341133|FG001|Period 1|Adverse Event|1|||
156617694|NCT03858686|565341132|FG000|Period 1|Lack of compliance|0|||
156617695|NCT03858686|565341133|FG001|Period 1|Lack of compliance|1|||
156617696|NCT03858686|565341132|FG000|Period 1|Adverse Event|0|||
156617697|NCT03858686|565341133|FG001|Period 1|Adverse Event|1|||
156617698|NCT03858686|565341132|FG000|Period 2|Adverse Event|0|||
156617699|NCT03858686|565341133|FG001|Period 2|Adverse Event|1|||
156617700|NCT02094612|565342759|FG000|Overall Study|Lost to Follow-up|47|||
156617701|NCT02094612|565342760|FG001|Overall Study|Lost to Follow-up|47|||
156617702|NCT02094612|565342759|FG000|Overall Study|Never started ADHD medication|32|||
156617703|NCT02094612|565342760|FG001|Overall Study|Never started ADHD medication|23|||
156617704|NCT04167514|565342761|FG000|Overall Study|Adverse event, not serious|0|||
156617705|NCT04167514|565342762|FG001|Overall Study|Adverse event, not serious|1|||
156617706|NCT04167514|565342761|FG000|Overall Study|Lost to Follow-up|1|||
156617707|NCT04167514|565342762|FG001|Overall Study|Lost to Follow-up|0|||
156617708|NCT04167514|565342761|FG000|Overall Study|Participant Decision|2|||
156617709|NCT04167514|565342762|FG001|Overall Study|Participant Decision|4|||
156617710|NCT04167514|565342761|FG000|Overall Study|Physician Decision|3|||
156617711|NCT04167514|565342762|FG001|Overall Study|Physician Decision|2|||
156617712|NCT04167514|565342761|FG000|Overall Study|Death|14|||
156617713|NCT04167514|565342762|FG001|Overall Study|Death|18|||
156617714|NCT04167514|565342761|FG000|Overall Study|Enrolled but treatment not administered|2|||
156617715|NCT04167514|565342762|FG001|Overall Study|Enrolled but treatment not administered|0|||
156617716|NCT04167514|565342761|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
156617717|NCT04167514|565342762|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
156617718|NCT04167514|565342761|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
156617719|NCT04167514|565342762|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
156617720|NCT00290355|565342763|FG000|Overall Study|Serious adverse event|7|||
156617721|NCT00290355|565342764|FG001|Overall Study|Serious adverse event|4|||
156617722|NCT00290355|565342763|FG000|Overall Study|Study product reactogenicity|1|||
156617723|NCT00290355|565342764|FG001|Overall Study|Study product reactogenicity|0|||
156617724|NCT00290355|565342763|FG000|Overall Study|Protocol Violation|1|||
156617725|NCT00290355|565342764|FG001|Overall Study|Protocol Violation|0|||
156617726|NCT00290355|565342763|FG000|Overall Study|Withdrawal by Subject|2|||
156617727|NCT00290355|565342764|FG001|Overall Study|Withdrawal by Subject|0|||
156617728|NCT00290355|565342763|FG000|Overall Study|Migrated / moved from the study area|1|||
156617729|NCT00290355|565342764|FG001|Overall Study|Migrated / moved from the study area|0|||
156617730|NCT00290355|565342763|FG000|Overall Study|Lost to Follow-up|3|||
156617731|NCT00290355|565342764|FG001|Overall Study|Lost to Follow-up|1|||
156617732|NCT00290355|565342763|FG000|Overall Study|Other|2|||
156617733|NCT00290355|565342764|FG001|Overall Study|Other|0|||
156617734|NCT03345849|565342765|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
156617735|NCT03345849|565342766|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
156617736|NCT03345849|565342767|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
156617737|NCT03345849|565342768|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
156617738|NCT03345849|565342765|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
156617739|NCT03345849|565342766|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
156617740|NCT03345849|565342767|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
156617741|NCT03345849|565342768|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
156617742|NCT03345849|565342765|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
156617743|NCT03345849|565342766|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
156617744|NCT03345849|565342767|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
156617745|NCT03345849|565342768|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
156617746|NCT03345849|565342765|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
156617747|NCT03345849|565342766|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
156617748|NCT03345849|565342767|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
156617749|NCT03345849|565342768|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
156617750|NCT03345849|565342765|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
156617751|NCT03345849|565342766|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
156617752|NCT03345849|565342767|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
156617753|NCT03345849|565342768|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
156617754|NCT03345849|565342765|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
156617755|NCT03345849|565342766|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
156617756|NCT03345849|565342767|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
156617757|NCT03345849|565342768|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
156617758|NCT03345849|565342765|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
156617759|NCT03345849|565342766|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
156617760|NCT03345849|565342767|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
156617761|NCT03345849|565342768|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
156617762|NCT03345849|565342765|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
156617763|NCT03345849|565342766|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
156617764|NCT03345849|565342767|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
156617765|NCT03345849|565342768|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
156617766|NCT03345849|565342765|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
156617767|NCT03345849|565342766|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
156617768|NCT03345849|565342767|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
156617769|NCT03345849|565342768|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
156617770|NCT03345849|565342765|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
156617771|NCT03345849|565342766|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
156617772|NCT03345849|565342767|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
156617773|NCT03345849|565342768|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
156617774|NCT03345849|565342765|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
156617775|NCT03345849|565342766|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
156617776|NCT03345849|565342767|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
156617777|NCT03345849|565342768|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
156617778|NCT03991936|565342769|FG000|Overall Study|Lost to Follow-up|1|||
156617779|NCT03991936|565342770|FG001|Overall Study|Lost to Follow-up|1|||
156617780|NCT03991936|565342771|FG002|Overall Study|Lost to Follow-up|1|||
156617781|NCT03991936|565342772|FG003|Overall Study|Lost to Follow-up|1|||
156617782|NCT03991936|565342773|FG004|Overall Study|Lost to Follow-up|1|||
156617783|NCT00939055|565342774|FG000|Overall Study|Discontinuation prior to procedure|4|||
156617784|NCT00939055|565342775|FG001|Overall Study|Discontinuation prior to procedure|0|||
156617785|NCT00584987|565342776|FG000|Overall Study|Protocol Violation|1|||
156617786|NCT00584987|565342777|FG001|Overall Study|Protocol Violation|1|||
156617787|NCT00584987|565342778|FG002|Overall Study|Protocol Violation|1|||
156617788|NCT00584987|565342779|FG003|Overall Study|Protocol Violation|0|||
156617789|NCT00584987|565342776|FG000|Overall Study|Adverse Event|0|||
156617790|NCT00584987|565342777|FG001|Overall Study|Adverse Event|0|||
156617791|NCT00584987|565342778|FG002|Overall Study|Adverse Event|0|||
156617792|NCT00584987|565342779|FG003|Overall Study|Adverse Event|1|||
156617793|NCT02773849|565342786|FG000|Overall Study|Lost to Follow-up|11|||
156617794|NCT02773849|565342786|FG000|Overall Study|Death|26|||
156617795|NCT02773849|565342786|FG000|Overall Study|Withdrawal by Subject|5|||
156617796|NCT02773849|565342786|FG000|Overall Study|Withdrawal of Consent|9|||
156617797|NCT02773849|565342786|FG000|Overall Study|Other: not due to lack of tolerability|11|||
156617798|NCT00723489|565342787|FG000|Overall Study|Physician Decision|0|||
156617799|NCT00723489|565342788|FG001|Overall Study|Physician Decision|1|||
156617800|NCT00723489|565342789|FG002|Overall Study|Physician Decision|0|||
156617801|NCT00723489|565342790|FG003|Overall Study|Physician Decision|0|||
156617802|NCT00723489|565342787|FG000|Overall Study|Pregnancy|0|||
156617803|NCT00723489|565342788|FG001|Overall Study|Pregnancy|0|||
156617804|NCT00723489|565342789|FG002|Overall Study|Pregnancy|0|||
156617805|NCT00723489|565342790|FG003|Overall Study|Pregnancy|1|||
156617806|NCT00723489|565342787|FG000|Overall Study|Withdrawal by Subject|0|||
156617807|NCT00723489|565342788|FG001|Overall Study|Withdrawal by Subject|0|||
156617808|NCT00723489|565342789|FG002|Overall Study|Withdrawal by Subject|0|||
156617809|NCT00723489|565342790|FG003|Overall Study|Withdrawal by Subject|1|||
156617810|NCT00723489|565342787|FG000|Overall Study|Seropositive at baseline|1|||
156617811|NCT00723489|565342788|FG001|Overall Study|Seropositive at baseline|0|||
156617812|NCT00723489|565342789|FG002|Overall Study|Seropositive at baseline|0|||
156617813|NCT00723489|565342790|FG003|Overall Study|Seropositive at baseline|0|||
156617814|NCT00723489|565342787|FG000|Overall Study|Prohibited Medication|0|||
156617815|NCT00723489|565342788|FG001|Overall Study|Prohibited Medication|0|||
156617816|NCT00723489|565342789|FG002|Overall Study|Prohibited Medication|0|||
156617817|NCT00723489|565342790|FG003|Overall Study|Prohibited Medication|1|||
156617818|NCT00723489|565342787|FG000|Overall Study|Samples Collected Out of Window|0|||
156617819|NCT00723489|565342788|FG001|Overall Study|Samples Collected Out of Window|3|||
156617820|NCT00723489|565342789|FG002|Overall Study|Samples Collected Out of Window|0|||
156617821|NCT00723489|565342790|FG003|Overall Study|Samples Collected Out of Window|0|||
156617822|NCT01599585|565342797|FG000|Overall Study|Withdrawal by Subject|16|||
156617823|NCT01599585|565342798|FG001|Overall Study|Withdrawal by Subject|9|||
156617824|NCT01599585|565342797|FG000|Overall Study|Lost to Follow-up|3|||
156617825|NCT01599585|565342798|FG001|Overall Study|Lost to Follow-up|5|||
156617826|NCT01599585|565342797|FG000|Overall Study|randomized did not start treatment|3|||
156617827|NCT01599585|565342798|FG001|Overall Study|randomized did not start treatment|3|||
156617828|NCT03657576|565342799|FG000|Overall Study|Death|0|||
156617829|NCT03657576|565342800|FG001|Overall Study|Death|1|||
156617830|NCT03657576|565342801|FG002|Overall Study|Death|1|||
156617831|NCT03657576|565342802|FG003|Overall Study|Death|0|||
156617832|NCT03657576|565342803|FG004|Overall Study|Death|0|||
156617833|NCT03657576|565342804|FG005|Overall Study|Death|0|||
156617834|NCT03657576|565342799|FG000|Overall Study|Withdrawal by Subject|0|||
156617835|NCT03657576|565342800|FG001|Overall Study|Withdrawal by Subject|0|||
156617836|NCT03657576|565342801|FG002|Overall Study|Withdrawal by Subject|0|||
156617837|NCT03657576|565342802|FG003|Overall Study|Withdrawal by Subject|1|||
156617838|NCT03657576|565342803|FG004|Overall Study|Withdrawal by Subject|0|||
156617839|NCT03657576|565342804|FG005|Overall Study|Withdrawal by Subject|0|||
156617840|NCT03657576|565342799|FG000|Overall Study|Screen Fail|0|||
156617841|NCT03657576|565342800|FG001|Overall Study|Screen Fail|0|||
156617842|NCT03657576|565342801|FG002|Overall Study|Screen Fail|0|||
156617843|NCT03657576|565342802|FG003|Overall Study|Screen Fail|0|||
156617844|NCT03657576|565342803|FG004|Overall Study|Screen Fail|0|||
156617845|NCT03657576|565342804|FG005|Overall Study|Screen Fail|5|||
156617846|NCT03657576|565342799|FG000|Overall Study|Disease Progression|1|||
156617847|NCT03657576|565342800|FG001|Overall Study|Disease Progression|1|||
156617848|NCT03657576|565342801|FG002|Overall Study|Disease Progression|0|||
156617849|NCT03657576|565342802|FG003|Overall Study|Disease Progression|5|||
156617850|NCT03657576|565342803|FG004|Overall Study|Disease Progression|0|||
156617851|NCT03657576|565342804|FG005|Overall Study|Disease Progression|0|||
156617852|NCT03657576|565342799|FG000|Overall Study|Insurance Coverage|0|||
156617853|NCT03657576|565342800|FG001|Overall Study|Insurance Coverage|0|||
156617854|NCT03657576|565342801|FG002|Overall Study|Insurance Coverage|0|||
156617855|NCT03657576|565342802|FG003|Overall Study|Insurance Coverage|1|||
156617856|NCT03657576|565342803|FG004|Overall Study|Insurance Coverage|0|||
156617857|NCT03657576|565342804|FG005|Overall Study|Insurance Coverage|0|||
156617858|NCT00777036|565342805|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
156617859|NCT00777036|565342806|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
156617860|NCT00777036|565342807|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
156617861|NCT00777036|565342808|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
156617862|NCT00777036|565342805|FG000|On Treatment|Administrative Reason By Sponsor|1|||
156617863|NCT00777036|565342806|FG001|On Treatment|Administrative Reason By Sponsor|0|||
156617864|NCT00777036|565342807|FG002|On Treatment|Administrative Reason By Sponsor|9|||
156617865|NCT00777036|565342808|FG003|On Treatment|Administrative Reason By Sponsor|0|||
156617866|NCT00777036|565342805|FG000|On Treatment|Failure to Meet Study Criteria|0|||
156617867|NCT00777036|565342806|FG001|On Treatment|Failure to Meet Study Criteria|1|||
156617868|NCT00777036|565342807|FG002|On Treatment|Failure to Meet Study Criteria|4|||
156617869|NCT00777036|565342808|FG003|On Treatment|Failure to Meet Study Criteria|0|||
156617870|NCT00777036|565342805|FG000|On Treatment|Pregnancy|1|||
156617871|NCT00777036|565342806|FG001|On Treatment|Pregnancy|0|||
156617872|NCT00777036|565342807|FG002|On Treatment|Pregnancy|1|||
156617873|NCT00777036|565342808|FG003|On Treatment|Pregnancy|0|||
156617874|NCT00777036|565342805|FG000|On Treatment|Non-compliance with Study Drug|1|||
156617875|NCT00777036|565342806|FG001|On Treatment|Non-compliance with Study Drug|0|||
156617876|NCT00777036|565342807|FG002|On Treatment|Non-compliance with Study Drug|1|||
156617877|NCT00777036|565342808|FG003|On Treatment|Non-compliance with Study Drug|0|||
156617878|NCT00777036|565342805|FG000|On Treatment|Maximum Clinical Benefit|2|||
156617879|NCT00777036|565342806|FG001|On Treatment|Maximum Clinical Benefit|0|||
156617880|NCT00777036|565342807|FG002|On Treatment|Maximum Clinical Benefit|5|||
156617881|NCT00777036|565342808|FG003|On Treatment|Maximum Clinical Benefit|0|||
156617882|NCT00777036|565342805|FG000|On Treatment|Withdrawal by Subject|0|||
156617883|NCT00777036|565342806|FG001|On Treatment|Withdrawal by Subject|2|||
156617884|NCT00777036|565342807|FG002|On Treatment|Withdrawal by Subject|2|||
156617885|NCT00777036|565342808|FG003|On Treatment|Withdrawal by Subject|0|||
156617886|NCT00777036|565342805|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
156617887|NCT00777036|565342806|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
156617888|NCT00777036|565342807|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
156617889|NCT00777036|565342808|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
156617890|NCT00777036|565342805|FG000|On Treatment|Death|0|||
156617891|NCT00777036|565342806|FG001|On Treatment|Death|2|||
156617892|NCT00777036|565342807|FG002|On Treatment|Death|0|||
156617893|NCT00777036|565342808|FG003|On Treatment|Death|0|||
156617894|NCT00777036|565342805|FG000|On Treatment|Study Drug Toxicity|1|||
156617895|NCT00777036|565342806|FG001|On Treatment|Study Drug Toxicity|0|||
156617896|NCT00777036|565342807|FG002|On Treatment|Study Drug Toxicity|4|||
156617897|NCT00777036|565342808|FG003|On Treatment|Study Drug Toxicity|0|||
156617898|NCT00777036|565342805|FG000|On Treatment|Progressive Disease|6|||
156617899|NCT00777036|565342806|FG001|On Treatment|Progressive Disease|4|||
156617900|NCT00777036|565342807|FG002|On Treatment|Progressive Disease|7|||
156617901|NCT00777036|565342808|FG003|On Treatment|Progressive Disease|0|||
156617902|NCT00777036|565342805|FG000|On Treatment|Not Reported|0|||
156617903|NCT00777036|565342806|FG001|On Treatment|Not Reported|0|||
156617904|NCT00777036|565342807|FG002|On Treatment|Not Reported|2|||
156617905|NCT00777036|565342808|FG003|On Treatment|Not Reported|0|||
156617906|NCT00777036|565342805|FG000|On Treatment|Site Closed|0|||
156617907|NCT00777036|565342806|FG001|On Treatment|Site Closed|1|||
156617908|NCT00777036|565342807|FG002|On Treatment|Site Closed|1|||
156617909|NCT00777036|565342808|FG003|On Treatment|Site Closed|0|||
156617910|NCT00777036|565342805|FG000|Follow-Up|Withdrawal by Subject|0|||
156617911|NCT00777036|565342806|FG001|Follow-Up|Withdrawal by Subject|0|||
156617912|NCT00777036|565342807|FG002|Follow-Up|Withdrawal by Subject|5|||
156617913|NCT00777036|565342808|FG003|Follow-Up|Withdrawal by Subject|0|||
156617914|NCT00777036|565342805|FG000|Follow-Up|Death|1|||
156617915|NCT00777036|565342806|FG001|Follow-Up|Death|9|||
156617916|NCT00777036|565342807|FG002|Follow-Up|Death|0|||
156617917|NCT00777036|565342808|FG003|Follow-Up|Death|0|||
156617918|NCT00777036|565342805|FG000|Follow-Up|Lost to Follow-up|3|||
156617919|NCT00777036|565342806|FG001|Follow-Up|Lost to Follow-up|0|||
156617920|NCT00777036|565342807|FG002|Follow-Up|Lost to Follow-up|0|||
156617921|NCT00777036|565342808|FG003|Follow-Up|Lost to Follow-up|0|||
156617922|NCT00777036|565342805|FG000|Follow-Up|Reason Not Specified|4|||
156617923|NCT00777036|565342806|FG001|Follow-Up|Reason Not Specified|0|||
156617924|NCT00777036|565342807|FG002|Follow-Up|Reason Not Specified|13|||
156617925|NCT00777036|565342808|FG003|Follow-Up|Reason Not Specified|0|||
156617926|NCT00777036|565342805|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
156617927|NCT00777036|565342806|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
156617928|NCT00777036|565342807|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
156617929|NCT00777036|565342808|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
156617930|NCT05564039|565342811|FG000|Overall Study|Adverse Event|1|||
156617931|NCT05564039|565342812|FG001|Overall Study|Adverse Event|0|||
156617932|NCT05564039|565342811|FG000|Overall Study|Death|1|||
156617933|NCT05564039|565342812|FG001|Overall Study|Death|1|||
156617934|NCT05564039|565342811|FG000|Overall Study|Lost to Follow-up|3|||
156617935|NCT05564039|565342812|FG001|Overall Study|Lost to Follow-up|2|||
156617936|NCT05564039|565342811|FG000|Overall Study|Withdrawal by Subject|2|||
156617937|NCT05564039|565342812|FG001|Overall Study|Withdrawal by Subject|0|||
156617938|NCT05564039|565342811|FG000|Overall Study|Inadvertent enrollment|3|||
156617939|NCT05564039|565342812|FG001|Overall Study|Inadvertent enrollment|6|||
156617940|NCT01685372|565342813|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
156617941|NCT01685372|565342814|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
156617942|NCT00829010|565342817|FG000|Overall Study|Adverse Event|1|||
156617943|NCT00829010|565342818|FG001|Overall Study|Adverse Event|0|||
156617944|NCT00829010|565342819|FG002|Overall Study|Adverse Event|0|||
156617945|NCT00829010|565342820|FG003|Overall Study|Adverse Event|0|||
156617946|NCT00829010|565342821|FG004|Overall Study|Adverse Event|0|||
156617947|NCT00829010|565342817|FG000|Overall Study|Withdrawal by Subject|0|||
156617948|NCT00829010|565342818|FG001|Overall Study|Withdrawal by Subject|1|||
156617949|NCT00829010|565342819|FG002|Overall Study|Withdrawal by Subject|1|||
156617950|NCT00829010|565342820|FG003|Overall Study|Withdrawal by Subject|0|||
156617951|NCT00829010|565342821|FG004|Overall Study|Withdrawal by Subject|2|||
156617952|NCT00829010|565342817|FG000|Overall Study|Lost to Follow-up|1|||
156617953|NCT00829010|565342818|FG001|Overall Study|Lost to Follow-up|0|||
156617954|NCT00829010|565342819|FG002|Overall Study|Lost to Follow-up|2|||
156617955|NCT00829010|565342820|FG003|Overall Study|Lost to Follow-up|0|||
156617956|NCT00829010|565342821|FG004|Overall Study|Lost to Follow-up|0|||
156617957|NCT00829010|565342817|FG000|Overall Study|Fatality|5|||
156617958|NCT00829010|565342818|FG001|Overall Study|Fatality|4|||
156617959|NCT00829010|565342819|FG002|Overall Study|Fatality|0|||
156617960|NCT00829010|565342820|FG003|Overall Study|Fatality|3|||
156617961|NCT00829010|565342821|FG004|Overall Study|Fatality|0|||
156617962|NCT00829010|565342817|FG000|Overall Study|Migrated/Moved from study area|3|||
156617963|NCT00829010|565342818|FG001|Overall Study|Migrated/Moved from study area|4|||
156617964|NCT00829010|565342819|FG002|Overall Study|Migrated/Moved from study area|0|||
156617965|NCT00829010|565342820|FG003|Overall Study|Migrated/Moved from study area|5|||
156617966|NCT00829010|565342821|FG004|Overall Study|Migrated/Moved from study area|0|||
156617967|NCT01029691|565342822|FG000|Continued APAP to Delivery|Death|0|||
156617968|NCT01029691|565342823|FG001|Continued APAP to Delivery|Death|0|||
156617969|NCT01029691|565342824|FG002|Continued APAP to Delivery|Death|1|||
156617970|NCT00137267|565342825|FG000|Overall Study|Lost to Follow-up|15|||
156617971|NCT00137267|565342826|FG001|Overall Study|Lost to Follow-up|21|||
156617972|NCT00528840|565342829|FG000|Overall Study|Lost to Follow-up|10|||
156617973|NCT00528840|565342829|FG000|Overall Study|Adverse Event|1|||
156617974|NCT00528840|565342829|FG000|Overall Study|Withdrawal by Subject|17|||
156617975|NCT00528840|565342829|FG000|Overall Study|Death|2|||
156617976|NCT00528840|565342829|FG000|Overall Study|Administrative Reasons|1|||
156617977|NCT00528840|565342829|FG000|Overall Study|Other|2|||
156617978|NCT01603628|565342830|FG000|Overall Study|Personal Reasons|1|||
156617979|NCT01603628|565342831|FG001|Overall Study|Personal Reasons|1|||
156617980|NCT01603628|565342832|FG002|Overall Study|Personal Reasons|2|||
156617981|NCT01603628|565342830|FG000|Overall Study|Protocol Violation|1|||
156617982|NCT01603628|565342831|FG001|Overall Study|Protocol Violation|1|||
156617983|NCT01603628|565342832|FG002|Overall Study|Protocol Violation|0|||
156617984|NCT01603628|565342830|FG000|Overall Study|Lost to Follow-up|0|||
156617985|NCT01603628|565342831|FG001|Overall Study|Lost to Follow-up|1|||
156617986|NCT01603628|565342832|FG002|Overall Study|Lost to Follow-up|0|||
156617987|NCT01603628|565342830|FG000|Overall Study|Other Miscellaneous Reason|1|||
156617988|NCT01603628|565342831|FG001|Overall Study|Other Miscellaneous Reason|0|||
156617989|NCT01603628|565342832|FG002|Overall Study|Other Miscellaneous Reason|0|||
156617990|NCT01969565|565342833|FG000|Overall Study|Withdrawal by Subject|1|||
156617991|NCT00832091|565342834|FG000|Overall Study|Adverse Event|1|||
156617992|NCT00832091|565342835|FG001|Overall Study|Adverse Event|1|||
156617993|NCT00832091|565342834|FG000|Overall Study|Protocol Violation|1|||
156617994|NCT00832091|565342835|FG001|Overall Study|Protocol Violation|0|||
156617995|NCT00832091|565342834|FG000|Overall Study|Withdrawal by Subject|2|||
156617996|NCT00832091|565342835|FG001|Overall Study|Withdrawal by Subject|1|||
156617997|NCT00832091|565342834|FG000|Overall Study|Prohibited Medication|1|||
156617998|NCT00832091|565342835|FG001|Overall Study|Prohibited Medication|0|||
156617999|NCT00952588|565342836|FG000|Overall Study|Death|28|||
156618000|NCT00952588|565342837|FG001|Overall Study|Death|13|||
156618001|NCT00952588|565342836|FG000|Overall Study|Withdrawal by Subject|2|||
156618002|NCT00952588|565342837|FG001|Overall Study|Withdrawal by Subject|5|||
156618003|NCT00952588|565342836|FG000|Overall Study|Adverse Event|2|||
156618004|NCT00952588|565342837|FG001|Overall Study|Adverse Event|3|||
156618005|NCT00952588|565342836|FG000|Overall Study|Lost to Follow-up|2|||
156618006|NCT00952588|565342837|FG001|Overall Study|Lost to Follow-up|0|||
156618007|NCT00952588|565342836|FG000|Overall Study|Physician Decision|0|||
156618008|NCT00952588|565342837|FG001|Overall Study|Physician Decision|1|||
156618009|NCT00952588|565342836|FG000|Overall Study|Lack of Efficacy|2|||
156618010|NCT00952588|565342837|FG001|Overall Study|Lack of Efficacy|2|||
156618011|NCT00886587|565342838|FG000|Overall Study|Adverse Event|2|||
156618012|NCT00886587|565342839|FG001|Overall Study|Adverse Event|1|||
156618013|NCT00886587|565342838|FG000|Overall Study|Protocol Violation|2|||
156618014|NCT00886587|565342839|FG001|Overall Study|Protocol Violation|0|||
156618015|NCT00886587|565342838|FG000|Overall Study|Withdrawal by Subject|0|||
156618016|NCT00886587|565342839|FG001|Overall Study|Withdrawal by Subject|1|||
156618017|NCT00696774|565342843|FG000|Period II|Adverse Event|0|||
156618018|NCT00696774|565342844|FG001|Period II|Adverse Event|0|||
156618019|NCT00696774|565342845|FG002|Period II|Adverse Event|15|||
156618020|NCT00696774|565342843|FG000|Period II|Lost to Follow-up|0|||
156618021|NCT00696774|565342844|FG001|Period II|Lost to Follow-up|0|||
156618022|NCT00696774|565342845|FG002|Period II|Lost to Follow-up|4|||
156618023|NCT00696774|565342843|FG000|Period II|Protocol Violation|0|||
156618024|NCT00696774|565342844|FG001|Period II|Protocol Violation|0|||
156618025|NCT00696774|565342845|FG002|Period II|Protocol Violation|11|||
156618026|NCT00696774|565342843|FG000|Period II|Withdrawal by Subject|0|||
156618027|NCT00696774|565342844|FG001|Period II|Withdrawal by Subject|0|||
156618028|NCT00696774|565342845|FG002|Period II|Withdrawal by Subject|4|||
156618029|NCT00696774|565342843|FG000|Period II|Sponsor Decision|0|||
156618030|NCT00696774|565342844|FG001|Period II|Sponsor Decision|0|||
156618031|NCT00696774|565342845|FG002|Period II|Sponsor Decision|0|||
156618032|NCT00696774|565342843|FG000|Period II|Lack of Efficacy|0|||
156618033|NCT00696774|565342844|FG001|Period II|Lack of Efficacy|0|||
156618034|NCT00696774|565342845|FG002|Period II|Lack of Efficacy|2|||
156618035|NCT00696774|565342843|FG000|Period III|Adverse Event|1|||
156618036|NCT00696774|565342844|FG001|Period III|Adverse Event|1|||
156618037|NCT00696774|565342845|FG002|Period III|Adverse Event|0|||
156618038|NCT00696774|565342843|FG000|Period III|Lost to Follow-up|2|||
156618039|NCT00696774|565342844|FG001|Period III|Lost to Follow-up|1|||
156618040|NCT00696774|565342845|FG002|Period III|Lost to Follow-up|0|||
156618041|NCT00696774|565342843|FG000|Period III|Protocol Violation|1|||
156618042|NCT00696774|565342844|FG001|Period III|Protocol Violation|1|||
156618043|NCT00696774|565342845|FG002|Period III|Protocol Violation|0|||
156618044|NCT00696774|565342843|FG000|Period III|Withdrawal by Subject|1|||
156618045|NCT00696774|565342844|FG001|Period III|Withdrawal by Subject|2|||
156618046|NCT00696774|565342845|FG002|Period III|Withdrawal by Subject|0|||
156618047|NCT00696774|565342843|FG000|Period III|Sponsor Decision|2|||
156618048|NCT00696774|565342844|FG001|Period III|Sponsor Decision|0|||
156618049|NCT00696774|565342845|FG002|Period III|Sponsor Decision|0|||
156618050|NCT00696774|565342843|FG000|Period III|Lack of Efficacy|0|||
156618051|NCT00696774|565342844|FG001|Period III|Lack of Efficacy|2|||
156618052|NCT00696774|565342845|FG002|Period III|Lack of Efficacy|0|||
156618053|NCT02943668|565342852|FG000|Overall Study|Disease Progression|1|||
156618054|NCT00572728|565342859|FG000|Overall Study|Withdrawal by Subject|10|||
156618055|NCT00572728|565342859|FG000|Overall Study|Ineligible|3|||
156618056|NCT00572728|565342859|FG000|Overall Study|Enrolled under Amendment 4|5|||
156618057|NCT00572728|565342859|FG000|Overall Study|Offstudy due to complicating disease|1|||
156618058|NCT00572728|565342859|FG000|Overall Study|FLT1 not completed|4|||
156618059|NCT00572728|565342859|FG000|Overall Study|First Chemotherapy not initiated|2|||
156618060|NCT00572728|565342859|FG000|Overall Study|FLT2 not completed|5|||
156618061|NCT00572728|565342859|FG000|Overall Study|Second chemotherapy not initiated|1|||
156618062|NCT00572728|565342859|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
156618063|NCT00572728|565342859|FG000|Overall Study|Pathology missing|1|||
156618064|NCT03457636|565342864|FG000|Overall Study|Lost to Follow-up|2|||
156618065|NCT01828567|565342867|FG000|Overall Study|Lost to Follow-up|27|||
156618066|NCT01828567|565342868|FG001|Overall Study|Lost to Follow-up|9|||
156618067|NCT01828567|565342867|FG000|Overall Study|Excluded - did not meet criteria|4|||
156618068|NCT01828567|565342868|FG001|Overall Study|Excluded - did not meet criteria|1|||
156618069|NCT02332876|565342873|FG000|Overall Study|Lost to Follow-up|1|||
156618070|NCT02332876|565342874|FG001|Overall Study|Lost to Follow-up|1|||
156618071|NCT03325010|565342875|FG000|Overall Study|Adverse Event|3|||
156618072|NCT03325010|565342876|FG001|Overall Study|Adverse Event|8|||
156618073|NCT03325010|565342875|FG000|Overall Study|Protocol Violation|1|||
156618074|NCT03325010|565342876|FG001|Overall Study|Protocol Violation|8|||
156618075|NCT03325010|565342875|FG000|Overall Study|Withdrawal by Subject|1|||
156618076|NCT03325010|565342876|FG001|Overall Study|Withdrawal by Subject|3|||
156618077|NCT03325010|565342875|FG000|Overall Study|Lost to Follow-up|1|||
156618078|NCT03325010|565342876|FG001|Overall Study|Lost to Follow-up|0|||
156618079|NCT03325010|565342875|FG000|Overall Study|Physician Decision|1|||
156618080|NCT03325010|565342876|FG001|Overall Study|Physician Decision|1|||
156618081|NCT03325010|565342875|FG000|Overall Study|Lack of Efficacy|2|||
156618082|NCT03325010|565342876|FG001|Overall Study|Lack of Efficacy|0|||
156618083|NCT04063865|565342881|FG000|Overall Study|Physician Decision|1|||
156618084|NCT04063865|565342882|FG001|Overall Study|Physician Decision|3|||
156618085|NCT04063865|565342881|FG000|Overall Study|Study Closed Prior to Completion|4|||
156618086|NCT04063865|565342882|FG001|Overall Study|Study Closed Prior to Completion|4|||
156618087|NCT04063865|565342881|FG000|Overall Study|Withdrawal by Subject|1|||
156618088|NCT04063865|565342882|FG001|Overall Study|Withdrawal by Subject|1|||
156618089|NCT00320190|565342883|FG000|First 12 Months|Completed but did not enter extension|5|||
156618090|NCT00320190|565342884|FG001|First 12 Months|Completed but did not enter extension|3|||
156618091|NCT00320190|565342883|FG000|First 12 Months|Sponsor terminated study|2|||
156618092|NCT00320190|565342884|FG001|First 12 Months|Sponsor terminated study|2|||
156618093|NCT00320190|565342883|FG000|First 12 Months|Lost to Follow-up|0|||
156618094|NCT00320190|565342884|FG001|First 12 Months|Lost to Follow-up|1|||
156618095|NCT00320190|565342883|FG000|First 12 Months|Enrollment failure|0|||
156618096|NCT00320190|565342884|FG001|First 12 Months|Enrollment failure|1|||
156618097|NCT00320190|565342883|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
156618098|NCT00320190|565342884|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
156618099|NCT00320190|565342883|FG000|First 12 Months|Investigator request|0|||
156618100|NCT00320190|565342884|FG001|First 12 Months|Investigator request|1|||
156618101|NCT00320190|565342883|FG000|First 12 Months|Study drug toxicity|0|||
156618102|NCT00320190|565342884|FG001|First 12 Months|Study drug toxicity|1|||
156618103|NCT00320190|565342883|FG000|First 12 Months|Withdrawal by Subject|0|||
156618104|NCT00320190|565342884|FG001|First 12 Months|Withdrawal by Subject|1|||
156618105|NCT00320190|565342883|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
156618106|NCT00320190|565342884|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
156618107|NCT00320190|565342883|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
156618108|NCT00320190|565342884|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
156618109|NCT00320190|565342883|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
156618110|NCT00320190|565342884|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
156618111|NCT01060124|565342885|FG000|Overall Study|Other|16|||
156618112|NCT01060124|565342885|FG000|Overall Study|Adverse Event|14|||
156618113|NCT01060124|565342885|FG000|Overall Study|Withdrawal by Subject|7|||
156618114|NCT00518336|565342891|FG000|Year 7|Lost to Follow-up|2|||
156618115|NCT00518336|565342892|FG001|Year 7|Lost to Follow-up|0|||
156618116|NCT00518336|565342891|FG000|Year 7|Could not attend in time|0|||
156618117|NCT00518336|565342892|FG001|Year 7|Could not attend in time|3|||
156618118|NCT00518336|565342891|FG000|Year 8|Lost to Follow-up|1|||
156618119|NCT00518336|565342892|FG001|Year 8|Lost to Follow-up|1|||
156618120|NCT00518336|565342891|FG000|Year 8|Could not attend in time|0|||
156618121|NCT00518336|565342892|FG001|Year 8|Could not attend in time|1|||
156618122|NCT00518336|565342891|FG000|Year 9|Migrated/moved from study area|1|||
156618123|NCT00518336|565342892|FG001|Year 9|Migrated/moved from study area|1|||
156618124|NCT00518336|565342891|FG000|Year 9|Lost to Follow-up|3|||
156618125|NCT00518336|565342892|FG001|Year 9|Lost to Follow-up|0|||
156618126|NCT00518336|565342891|FG000|Year 9|Personal reasons|1|||
156618127|NCT00518336|565342892|FG001|Year 9|Personal reasons|0|||
156618128|NCT02141854|565342893|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
156618129|NCT02141854|565342894|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156618130|NCT02141854|565342895|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156618131|NCT02141854|565342896|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156618132|NCT02141854|565342897|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156618133|NCT02141854|565342898|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156618134|NCT02141854|565342893|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
156618135|NCT02141854|565342894|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156618136|NCT02141854|565342895|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156618137|NCT02141854|565342896|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156618138|NCT02141854|565342897|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156618139|NCT02141854|565342898|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156618140|NCT02141854|565342893|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
156618141|NCT02141854|565342894|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156618142|NCT02141854|565342895|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156618143|NCT02141854|565342896|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156618144|NCT02141854|565342897|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156618145|NCT02141854|565342898|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156618146|NCT02141854|565342893|FG000|Run-In Period (Pre-assignment)|Other|14|||
156618147|NCT02141854|565342894|FG001|Run-In Period (Pre-assignment)|Other|0|||
156618148|NCT02141854|565342895|FG002|Run-In Period (Pre-assignment)|Other|0|||
156618149|NCT02141854|565342896|FG003|Run-In Period (Pre-assignment)|Other|0|||
156618150|NCT02141854|565342897|FG004|Run-In Period (Pre-assignment)|Other|0|||
156618151|NCT02141854|565342898|FG005|Run-In Period (Pre-assignment)|Other|0|||
156618152|NCT02141854|565342893|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
156618153|NCT02141854|565342894|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
156618154|NCT02141854|565342895|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
156618155|NCT02141854|565342896|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
156618156|NCT02141854|565342897|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
156618157|NCT02141854|565342898|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
156618158|NCT02141854|565342893|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
156618159|NCT02141854|565342894|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156618160|NCT02141854|565342895|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156618161|NCT02141854|565342896|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156618162|NCT02141854|565342897|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156618163|NCT02141854|565342898|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156618164|NCT02141854|565342893|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
156618165|NCT02141854|565342894|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156618166|NCT02141854|565342895|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156618167|NCT02141854|565342896|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156618168|NCT02141854|565342897|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156618169|NCT02141854|565342898|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156618170|NCT02141854|565342893|FG000|Treatment Period|Protocol Violation|0|||
156618171|NCT02141854|565342894|FG001|Treatment Period|Protocol Violation|1|||
156618172|NCT02141854|565342895|FG002|Treatment Period|Protocol Violation|0|||
156618173|NCT02141854|565342896|FG003|Treatment Period|Protocol Violation|2|||
156618174|NCT02141854|565342897|FG004|Treatment Period|Protocol Violation|2|||
156618175|NCT02141854|565342898|FG005|Treatment Period|Protocol Violation|1|||
156618176|NCT02141854|565342893|FG000|Treatment Period|Noncompliance|0|||
156618177|NCT02141854|565342894|FG001|Treatment Period|Noncompliance|0|||
156618178|NCT02141854|565342895|FG002|Treatment Period|Noncompliance|0|||
156618179|NCT02141854|565342896|FG003|Treatment Period|Noncompliance|1|||
156618180|NCT02141854|565342897|FG004|Treatment Period|Noncompliance|0|||
156618181|NCT02141854|565342898|FG005|Treatment Period|Noncompliance|0|||
156618182|NCT02141854|565342893|FG000|Treatment Period|Lack of Efficacy|0|||
156618183|NCT02141854|565342894|FG001|Treatment Period|Lack of Efficacy|0|||
156618184|NCT02141854|565342895|FG002|Treatment Period|Lack of Efficacy|0|||
156618185|NCT02141854|565342896|FG003|Treatment Period|Lack of Efficacy|1|||
156618186|NCT02141854|565342897|FG004|Treatment Period|Lack of Efficacy|1|||
156618187|NCT02141854|565342898|FG005|Treatment Period|Lack of Efficacy|7|||
156618188|NCT02141854|565342893|FG000|Treatment Period|Pregnancy|0|||
156618189|NCT02141854|565342894|FG001|Treatment Period|Pregnancy|1|||
156618190|NCT02141854|565342895|FG002|Treatment Period|Pregnancy|0|||
156618191|NCT02141854|565342896|FG003|Treatment Period|Pregnancy|0|||
156618192|NCT02141854|565342897|FG004|Treatment Period|Pregnancy|0|||
156618193|NCT02141854|565342898|FG005|Treatment Period|Pregnancy|0|||
156618194|NCT02141854|565342893|FG000|Treatment Period|Other|0|||
156618195|NCT02141854|565342894|FG001|Treatment Period|Other|1|||
156618196|NCT02141854|565342895|FG002|Treatment Period|Other|2|||
156618197|NCT02141854|565342896|FG003|Treatment Period|Other|0|||
156618198|NCT02141854|565342897|FG004|Treatment Period|Other|1|||
156618199|NCT02141854|565342898|FG005|Treatment Period|Other|2|||
156618200|NCT02141854|565342893|FG000|Treatment Period|Adverse Event|0|||
156618201|NCT02141854|565342894|FG001|Treatment Period|Adverse Event|2|||
156618202|NCT02141854|565342895|FG002|Treatment Period|Adverse Event|2|||
156618203|NCT02141854|565342896|FG003|Treatment Period|Adverse Event|0|||
156618204|NCT02141854|565342897|FG004|Treatment Period|Adverse Event|2|||
156618205|NCT02141854|565342898|FG005|Treatment Period|Adverse Event|2|||
156618206|NCT02141854|565342893|FG000|Treatment Period|Withdrawal by Subject|0|||
156618207|NCT02141854|565342894|FG001|Treatment Period|Withdrawal by Subject|2|||
156618208|NCT02141854|565342895|FG002|Treatment Period|Withdrawal by Subject|3|||
156618209|NCT02141854|565342896|FG003|Treatment Period|Withdrawal by Subject|3|||
156618210|NCT02141854|565342897|FG004|Treatment Period|Withdrawal by Subject|4|||
156618211|NCT02141854|565342898|FG005|Treatment Period|Withdrawal by Subject|7|||
156618212|NCT02141854|565342893|FG000|Treatment Period|Disease progression|0|||
156618213|NCT02141854|565342894|FG001|Treatment Period|Disease progression|2|||
156618214|NCT02141854|565342895|FG002|Treatment Period|Disease progression|1|||
156618215|NCT02141854|565342896|FG003|Treatment Period|Disease progression|3|||
156618216|NCT02141854|565342897|FG004|Treatment Period|Disease progression|0|||
156618217|NCT02141854|565342898|FG005|Treatment Period|Disease progression|18|||
156618218|NCT02141854|565342893|FG000|Treatment Period|Lost to Follow-up|0|||
156618219|NCT02141854|565342894|FG001|Treatment Period|Lost to Follow-up|1|||
156618220|NCT02141854|565342895|FG002|Treatment Period|Lost to Follow-up|1|||
156618221|NCT02141854|565342896|FG003|Treatment Period|Lost to Follow-up|1|||
156618222|NCT02141854|565342897|FG004|Treatment Period|Lost to Follow-up|0|||
156618223|NCT02141854|565342898|FG005|Treatment Period|Lost to Follow-up|1|||
156618224|NCT01190020|565342899|FG000|Overall Study|Adverse Event|2|||
156618225|NCT01190020|565342900|FG001|Overall Study|Adverse Event|0|||
156618226|NCT01190020|565342899|FG000|Overall Study|Lost to Follow-up|2|||
156618227|NCT01190020|565342900|FG001|Overall Study|Lost to Follow-up|0|||
156618228|NCT01190020|565342899|FG000|Overall Study|Withdrawal by Subject|3|||
156618229|NCT01190020|565342900|FG001|Overall Study|Withdrawal by Subject|0|||
156618230|NCT03074318|565342901|FG000|Overall Study|Adverse Event|0|||
156618231|NCT03074318|565342902|FG001|Overall Study|Adverse Event|1|||
156618232|NCT03074318|565342903|FG002|Overall Study|Adverse Event|1|||
156618233|NCT03074318|565342904|FG003|Overall Study|Adverse Event|1|||
156618234|NCT03074318|565342901|FG000|Overall Study|Death|1|||
156618235|NCT03074318|565342902|FG001|Overall Study|Death|0|||
156618236|NCT03074318|565342903|FG002|Overall Study|Death|0|||
156618237|NCT03074318|565342904|FG003|Overall Study|Death|0|||
156618238|NCT03074318|565342901|FG000|Overall Study|Withdrawal by Subject|1|||
156618239|NCT03074318|565342902|FG001|Overall Study|Withdrawal by Subject|2|||
156618240|NCT03074318|565342903|FG002|Overall Study|Withdrawal by Subject|2|||
156618241|NCT03074318|565342904|FG003|Overall Study|Withdrawal by Subject|4|||
156618242|NCT03074318|565342901|FG000|Overall Study|Trial Closure|2|||
156618243|NCT03074318|565342902|FG001|Overall Study|Trial Closure|2|||
156618244|NCT03074318|565342903|FG002|Overall Study|Trial Closure|3|||
156618245|NCT03074318|565342904|FG003|Overall Study|Trial Closure|11|||
156618246|NCT03399786|565342905|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156618247|NCT03399786|565342906|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156618248|NCT03399786|565342907|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156618249|NCT03399786|565342908|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156618250|NCT03399786|565342905|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
156618251|NCT03399786|565342906|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
156618252|NCT03399786|565342907|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
156618253|NCT03399786|565342908|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
156618254|NCT03399786|565342905|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
156618255|NCT03399786|565342906|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
156618256|NCT03399786|565342907|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
156618257|NCT03399786|565342908|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
156618258|NCT03053180|565344581|FG000|Overall Study|Failure to Return|1|||
156618259|NCT01465958|565344586|FG000|Run-in Phase|Protocol Violation|1|||
156618260|NCT01465958|565344587|FG001|Run-in Phase|Protocol Violation|0|||
156618261|NCT01465958|565344586|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
156618262|NCT01465958|565344587|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
156618263|NCT04397757|565344590|FG000|Overall Study|Death|3|||
156618264|NCT04397757|565344591|FG001|Overall Study|Death|11|||
156618265|NCT04397757|565344590|FG000|Overall Study|Withdrawal by Subject|2|||
156618266|NCT04397757|565344591|FG001|Overall Study|Withdrawal by Subject|0|||
156618267|NCT04397757|565344590|FG000|Overall Study|Lost to Follow-up|4|||
156618268|NCT04397757|565344591|FG001|Overall Study|Lost to Follow-up|3|||
156618269|NCT04564027|565344594|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
156618270|NCT04564027|565344595|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
156618271|NCT04564027|565344596|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
156618272|NCT04564027|565344597|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
156618273|NCT05492877|565344600|FG000|Overall Study|Adverse Event|11|||
156618274|NCT05492877|565344601|FG001|Overall Study|Adverse Event|7|||
156618275|NCT05492877|565344600|FG000|Overall Study|Death|1|||
156618276|NCT05492877|565344601|FG001|Overall Study|Death|0|||
156618277|NCT05492877|565344600|FG000|Overall Study|Lost to Follow-up|1|||
156618278|NCT05492877|565344601|FG001|Overall Study|Lost to Follow-up|1|||
156618279|NCT05492877|565344600|FG000|Overall Study|Physician Decision|1|||
156618280|NCT05492877|565344601|FG001|Overall Study|Physician Decision|2|||
156618281|NCT05492877|565344600|FG000|Overall Study|Protocol Violation|1|||
156618282|NCT05492877|565344601|FG001|Overall Study|Protocol Violation|1|||
156618283|NCT05492877|565344600|FG000|Overall Study|Withdrawal by Subject|3|||
156618284|NCT05492877|565344601|FG001|Overall Study|Withdrawal by Subject|7|||
156618285|NCT05492877|565344600|FG000|Overall Study|Reason not specified|6|||
156618286|NCT05492877|565344601|FG001|Overall Study|Reason not specified|4|||
156618287|NCT00129376|565344602|FG000|Overall Study|Adverse Event|1|||
156618288|NCT00129376|565344602|FG000|Overall Study|Lack of Efficacy|1|||
156618289|NCT02561273|565344610|FG000|Overall Study|Protocol Violation|1|||
156618290|NCT02561273|565344611|FG001|Overall Study|Protocol Violation|0|||
156618291|NCT04554394|565344623|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
156618292|NCT04554394|565344624|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
156618293|NCT04554394|565344623|FG000|Overall Study|Withdrawal by Subject|2|||
156618294|NCT04554394|565344624|FG001|Overall Study|Withdrawal by Subject|2|||
156618295|NCT04554394|565344623|FG000|Overall Study|Lost to Follow-up|2|||
156618296|NCT04554394|565344624|FG001|Overall Study|Lost to Follow-up|2|||
156618297|NCT04554394|565344623|FG000|Overall Study|Physician Decision|1|||
156618298|NCT04554394|565344624|FG001|Overall Study|Physician Decision|1|||
156618299|NCT01766401|565344625|FG000|Overall Study|Adverse Event|7|||
156618300|NCT01766401|565344626|FG001|Overall Study|Adverse Event|22|||
156618301|NCT01766401|565344625|FG000|Overall Study|Lack of Efficacy|1|||
156618302|NCT01766401|565344626|FG001|Overall Study|Lack of Efficacy|2|||
156618303|NCT01766401|565344625|FG000|Overall Study|Protocol Violation|3|||
156618304|NCT01766401|565344626|FG001|Overall Study|Protocol Violation|8|||
156618305|NCT01766401|565344625|FG000|Overall Study|Withdrawal by Subject|15|||
156618306|NCT01766401|565344626|FG001|Overall Study|Withdrawal by Subject|12|||
156618307|NCT01766401|565344625|FG000|Overall Study|Lost to Follow-up|10|||
156618308|NCT01766401|565344626|FG001|Overall Study|Lost to Follow-up|11|||
156618309|NCT01766401|565344625|FG000|Overall Study|Pregnancy|1|||
156618310|NCT01766401|565344626|FG001|Overall Study|Pregnancy|1|||
156618311|NCT01108068|565344627|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
156618312|NCT01108068|565344628|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
156618313|NCT00398086|565344629|FG000|Overall Study|Unacceptable Toxicity|2|||
156618314|NCT00398086|565344630|FG001|Overall Study|Unacceptable Toxicity|8|||
156618315|NCT00398086|565344631|FG002|Overall Study|Unacceptable Toxicity|2|||
156618316|NCT00398086|565344629|FG000|Overall Study|Adverse Event|1|||
156618317|NCT00398086|565344630|FG001|Overall Study|Adverse Event|4|||
156618318|NCT00398086|565344631|FG002|Overall Study|Adverse Event|0|||
156618319|NCT00398086|565344629|FG000|Overall Study|Physician Decision|1|||
156618320|NCT00398086|565344630|FG001|Overall Study|Physician Decision|4|||
156618321|NCT00398086|565344631|FG002|Overall Study|Physician Decision|0|||
156618322|NCT00398086|565344629|FG000|Overall Study|Withdrawal by Subject|5|||
156618323|NCT00398086|565344630|FG001|Overall Study|Withdrawal by Subject|7|||
156618324|NCT00398086|565344631|FG002|Overall Study|Withdrawal by Subject|0|||
156618325|NCT01021553|565344632|FG000|Overall Study|Adverse Event|1|||
156618326|NCT01021553|565344633|FG001|Overall Study|Adverse Event|0|||
156618327|NCT01021553|565344634|FG002|Overall Study|Adverse Event|0|||
156618328|NCT01021553|565344632|FG000|Overall Study|Lack of Efficacy|2|||
156618329|NCT01021553|565344633|FG001|Overall Study|Lack of Efficacy|2|||
156618330|NCT01021553|565344634|FG002|Overall Study|Lack of Efficacy|0|||
156618331|NCT01021553|565344632|FG000|Overall Study|Protocol Violation|0|||
156618332|NCT01021553|565344633|FG001|Overall Study|Protocol Violation|2|||
156618333|NCT01021553|565344634|FG002|Overall Study|Protocol Violation|2|||
156618334|NCT01021553|565344632|FG000|Overall Study|Lost to Follow-up|0|||
156618335|NCT01021553|565344633|FG001|Overall Study|Lost to Follow-up|0|||
156618336|NCT01021553|565344634|FG002|Overall Study|Lost to Follow-up|1|||
156618337|NCT01021553|565344632|FG000|Overall Study|Withdrawal by Subject|1|||
156618338|NCT01021553|565344633|FG001|Overall Study|Withdrawal by Subject|1|||
156618339|NCT01021553|565344634|FG002|Overall Study|Withdrawal by Subject|0|||
156618340|NCT01950364|565344635|FG000|Overall Study|Adverse Event|3|||
156618341|NCT01950364|565344636|FG001|Overall Study|Adverse Event|0|||
156618342|NCT01950364|565344635|FG000|Overall Study|Stem Cell Transplant|2|||
156618343|NCT01950364|565344636|FG001|Overall Study|Stem Cell Transplant|6|||
156618344|NCT01950364|565344635|FG000|Overall Study|Disease Progression|5|||
156618345|NCT01950364|565344636|FG001|Overall Study|Disease Progression|2|||
156618346|NCT01950364|565344635|FG000|Overall Study|Withdrawal by Subject|0|||
156618347|NCT01950364|565344636|FG001|Overall Study|Withdrawal by Subject|1|||
156618348|NCT01950364|565344635|FG000|Overall Study|Protocol Violation|0|||
156618349|NCT01950364|565344636|FG001|Overall Study|Protocol Violation|1|||
156618350|NCT00033293|565344637|FG000|Overall Study|Death|0|||
156618351|NCT00033293|565344638|FG001|Overall Study|Death|1|||
156618352|NCT00033293|565344637|FG000|Overall Study|Lack of Efficacy|5|||
156618353|NCT00033293|565344638|FG001|Overall Study|Lack of Efficacy|8|||
156618354|NCT00033293|565344637|FG000|Overall Study|Lost to Follow-up|0|||
156618355|NCT00033293|565344638|FG001|Overall Study|Lost to Follow-up|1|||
156618356|NCT00033293|565344637|FG000|Overall Study|Physician Decision|3|||
156618357|NCT00033293|565344638|FG001|Overall Study|Physician Decision|1|||
156618358|NCT00033293|565344637|FG000|Overall Study|Withdrawal by Subject|1|||
156618359|NCT00033293|565344638|FG001|Overall Study|Withdrawal by Subject|0|||
156618360|NCT00033293|565344637|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
156618361|NCT00033293|565344638|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
156618362|NCT00033293|565344637|FG000|Overall Study|Treatment refused|0|||
156618363|NCT00033293|565344638|FG001|Overall Study|Treatment refused|6|||
156618364|NCT00935701|565344639|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
156618365|NCT02087241|565344640|FG000|Overall Study|Death|2|||
156618366|NCT02087241|565344641|FG001|Overall Study|Death|1|||
156618367|NCT02087241|565344642|FG002|Overall Study|Death|1|||
156618368|NCT02087241|565344643|FG003|Overall Study|Death|1|||
156618369|NCT02087241|565344640|FG000|Overall Study|Withdrawal by Subject|1|||
156618370|NCT02087241|565344641|FG001|Overall Study|Withdrawal by Subject|0|||
156618371|NCT02087241|565344642|FG002|Overall Study|Withdrawal by Subject|0|||
156618372|NCT02087241|565344643|FG003|Overall Study|Withdrawal by Subject|1|||
156618373|NCT02087241|565344640|FG000|Overall Study|Progressive Disease|0|||
156618374|NCT02087241|565344641|FG001|Overall Study|Progressive Disease|0|||
156618375|NCT02087241|565344642|FG002|Overall Study|Progressive Disease|0|||
156618376|NCT02087241|565344643|FG003|Overall Study|Progressive Disease|1|||
156618377|NCT02087241|565344640|FG000|Overall Study|Study Terminated by Sponsor|0|||
156618378|NCT02087241|565344641|FG001|Overall Study|Study Terminated by Sponsor|2|||
156618379|NCT02087241|565344642|FG002|Overall Study|Study Terminated by Sponsor|0|||
156618380|NCT02087241|565344643|FG003|Overall Study|Study Terminated by Sponsor|4|||
156618381|NCT01955005|565344644|FG000|Overall Study|Withdrawal by Subject|3|||
156618382|NCT01955005|565344645|FG001|Overall Study|Withdrawal by Subject|5|||
156618383|NCT00836953|565344646|FG000|Overall Study|Withdrawal by Subject|1|||
156618384|NCT00836953|565344646|FG000|Overall Study|Lost to Follow-up|1|||
156618385|NCT01200758|565344647|FG000|Stage I|Death|0|||
156618386|NCT01200758|565344648|FG001|Stage I|Death|1|||
156618387|NCT01200758|565344649|FG002|Stage I|Death|0|||
156618388|NCT01200758|565344650|FG003|Stage I|Death|0|||
156618389|NCT01200758|565344647|FG000|Stage I|Physician Decision|1|||
156618390|NCT01200758|565344648|FG001|Stage I|Physician Decision|1|||
156618391|NCT01200758|565344649|FG002|Stage I|Physician Decision|0|||
156618392|NCT01200758|565344650|FG003|Stage I|Physician Decision|0|||
156618393|NCT01200758|565344647|FG000|Stage I|Lack of Efficacy|2|||
156618394|NCT01200758|565344648|FG001|Stage I|Lack of Efficacy|1|||
156618395|NCT01200758|565344649|FG002|Stage I|Lack of Efficacy|0|||
156618396|NCT01200758|565344650|FG003|Stage I|Lack of Efficacy|0|||
156618397|NCT01200758|565344647|FG000|Stage I|Adverse Event|5|||
156618398|NCT01200758|565344648|FG001|Stage I|Adverse Event|5|||
156618399|NCT01200758|565344649|FG002|Stage I|Adverse Event|0|||
156618400|NCT01200758|565344650|FG003|Stage I|Adverse Event|0|||
156618401|NCT01200758|565344647|FG000|Stage I|Withdrawal by Subject|1|||
156618402|NCT01200758|565344648|FG001|Stage I|Withdrawal by Subject|2|||
156618403|NCT01200758|565344649|FG002|Stage I|Withdrawal by Subject|0|||
156618404|NCT01200758|565344650|FG003|Stage I|Withdrawal by Subject|0|||
156618405|NCT01200758|565344647|FG000|Stage I|Disease Progression|9|||
156618406|NCT01200758|565344648|FG001|Stage I|Disease Progression|7|||
156618407|NCT01200758|565344649|FG002|Stage I|Disease Progression|0|||
156618408|NCT01200758|565344650|FG003|Stage I|Disease Progression|0|||
156618409|NCT01200758|565344647|FG000|Stage 2|Disease Progression|0|||
156618410|NCT01200758|565344648|FG001|Stage 2|Disease Progression|0|||
156618411|NCT01200758|565344649|FG002|Stage 2|Disease Progression|16|||
156618412|NCT01200758|565344650|FG003|Stage 2|Disease Progression|21|||
156618413|NCT01200758|565344647|FG000|Stage 2|Lack of Efficacy|0|||
156618414|NCT01200758|565344648|FG001|Stage 2|Lack of Efficacy|0|||
156618415|NCT01200758|565344649|FG002|Stage 2|Lack of Efficacy|4|||
156618416|NCT01200758|565344650|FG003|Stage 2|Lack of Efficacy|2|||
156618417|NCT01200758|565344647|FG000|Stage 2|Physician Decision|0|||
156618418|NCT01200758|565344648|FG001|Stage 2|Physician Decision|0|||
156618419|NCT01200758|565344649|FG002|Stage 2|Physician Decision|5|||
156618420|NCT01200758|565344650|FG003|Stage 2|Physician Decision|7|||
156618421|NCT01200758|565344647|FG000|Stage 2|Adverse Event|0|||
156618422|NCT01200758|565344648|FG001|Stage 2|Adverse Event|0|||
156618423|NCT01200758|565344649|FG002|Stage 2|Adverse Event|5|||
156618424|NCT01200758|565344650|FG003|Stage 2|Adverse Event|9|||
156618425|NCT01200758|565344647|FG000|Stage 2|Withdrawal by Subject|0|||
156618426|NCT01200758|565344648|FG001|Stage 2|Withdrawal by Subject|0|||
156618427|NCT01200758|565344649|FG002|Stage 2|Withdrawal by Subject|4|||
156618428|NCT01200758|565344650|FG003|Stage 2|Withdrawal by Subject|1|||
156618429|NCT01200758|565344647|FG000|Stage 2|Lost to Follow-up|0|||
156618430|NCT01200758|565344648|FG001|Stage 2|Lost to Follow-up|0|||
156618431|NCT01200758|565344649|FG002|Stage 2|Lost to Follow-up|3|||
156618432|NCT01200758|565344650|FG003|Stage 2|Lost to Follow-up|1|||
156618433|NCT01200758|565344647|FG000|Stage 2|Protocol Violation|0|||
156618434|NCT01200758|565344648|FG001|Stage 2|Protocol Violation|0|||
156618435|NCT01200758|565344649|FG002|Stage 2|Protocol Violation|1|||
156618436|NCT01200758|565344650|FG003|Stage 2|Protocol Violation|4|||
156618437|NCT01200758|565344647|FG000|Stage 2|Death|0|||
156618438|NCT01200758|565344648|FG001|Stage 2|Death|0|||
156618439|NCT01200758|565344649|FG002|Stage 2|Death|3|||
156618440|NCT01200758|565344650|FG003|Stage 2|Death|5|||
156618441|NCT02201251|565344651|FG000|Overall Study|Adverse Event|1|||
156618442|NCT02201251|565344652|FG001|Overall Study|Adverse Event|1|||
156618443|NCT02201251|565344651|FG000|Overall Study|Protocol Violation|1|||
156618444|NCT02201251|565344652|FG001|Overall Study|Protocol Violation|0|||
156618445|NCT02201251|565344651|FG000|Overall Study|Noncompliance with Study Drug|0|||
156618446|NCT02201251|565344652|FG001|Overall Study|Noncompliance with Study Drug|1|||
156618447|NCT02201251|565344651|FG000|Overall Study|Withdrawal by Subject|2|||
156618448|NCT02201251|565344652|FG001|Overall Study|Withdrawal by Subject|1|||
156618449|NCT02711553|565344655|FG000|Overall Study|Withdrawal by Subject|2|||
156618450|NCT02711553|565344656|FG001|Overall Study|Withdrawal by Subject|1|||
156618451|NCT02711553|565344657|FG002|Overall Study|Withdrawal by Subject|1|||
156618452|NCT02711553|565344658|FG003|Overall Study|Withdrawal by Subject|0|||
156618453|NCT02711553|565344655|FG000|Overall Study|Lost to Follow-up|3|||
156618454|NCT02711553|565344656|FG001|Overall Study|Lost to Follow-up|3|||
156618455|NCT02711553|565344657|FG002|Overall Study|Lost to Follow-up|6|||
156618456|NCT02711553|565344658|FG003|Overall Study|Lost to Follow-up|3|||
156635561|NCT00602667|565409961|FG001|Overall Study|Death|1|||
156618457|NCT02711553|565344655|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
156618458|NCT02711553|565344656|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
156618459|NCT02711553|565344657|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
156618460|NCT02711553|565344658|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
156618461|NCT04048876|565344661|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
156618462|NCT04048876|565344662|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
156618463|NCT04048876|565344663|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
156618464|NCT04048876|565344664|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
156618465|NCT04048876|565344661|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
156618466|NCT04048876|565344662|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
156618467|NCT04048876|565344663|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
156618468|NCT04048876|565344664|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
156618469|NCT04048876|565344661|FG000|Placebo Controlled Phase|Adverse Event|0|||
156618470|NCT04048876|565344662|FG001|Placebo Controlled Phase|Adverse Event|1|||
156618471|NCT04048876|565344663|FG002|Placebo Controlled Phase|Adverse Event|0|||
156618472|NCT04048876|565344664|FG003|Placebo Controlled Phase|Adverse Event|0|||
156618473|NCT04048876|565344661|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
156618474|NCT04048876|565344662|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
156618475|NCT04048876|565344663|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
156618476|NCT04048876|565344664|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
156618477|NCT01197794|565344667|FG000|Overall Study|Adverse Event|3|||
156618478|NCT01197794|565344668|FG001|Overall Study|Adverse Event|2|||
156618479|NCT01197794|565344669|FG002|Overall Study|Adverse Event|4|||
156618480|NCT01197794|565344670|FG003|Overall Study|Adverse Event|4|||
156618481|NCT01197794|565344671|FG004|Overall Study|Adverse Event|4|||
156618482|NCT01197794|565344672|FG005|Overall Study|Adverse Event|2|||
156618483|NCT01197794|565344673|FG006|Overall Study|Adverse Event|3|||
156618484|NCT01197794|565344667|FG000|Overall Study|Protocol Violation|0|||
156618485|NCT01197794|565344668|FG001|Overall Study|Protocol Violation|0|||
156618486|NCT01197794|565344669|FG002|Overall Study|Protocol Violation|0|||
156618487|NCT01197794|565344670|FG003|Overall Study|Protocol Violation|0|||
156618488|NCT01197794|565344671|FG004|Overall Study|Protocol Violation|2|||
156618489|NCT01197794|565344672|FG005|Overall Study|Protocol Violation|0|||
156618490|NCT01197794|565344673|FG006|Overall Study|Protocol Violation|1|||
156618491|NCT01197794|565344667|FG000|Overall Study|Development of study withdrawal criteria|3|||
156618492|NCT01197794|565344668|FG001|Overall Study|Development of study withdrawal criteria|0|||
156618493|NCT01197794|565344669|FG002|Overall Study|Development of study withdrawal criteria|0|||
156618494|NCT01197794|565344670|FG003|Overall Study|Development of study withdrawal criteria|1|||
156618495|NCT01197794|565344671|FG004|Overall Study|Development of study withdrawal criteria|0|||
156618496|NCT01197794|565344672|FG005|Overall Study|Development of study withdrawal criteria|0|||
156618497|NCT01197794|565344673|FG006|Overall Study|Development of study withdrawal criteria|1|||
156618498|NCT01197794|565344667|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
156618499|NCT01197794|565344668|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
156618500|NCT01197794|565344669|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
156618501|NCT01197794|565344670|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
156618502|NCT01197794|565344671|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
156618503|NCT01197794|565344672|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
156618504|NCT01197794|565344673|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
156618505|NCT01197794|565344667|FG000|Overall Study|Withdrawal by Subject|3|||
156618506|NCT01197794|565344668|FG001|Overall Study|Withdrawal by Subject|3|||
156618507|NCT01197794|565344669|FG002|Overall Study|Withdrawal by Subject|4|||
156618508|NCT01197794|565344670|FG003|Overall Study|Withdrawal by Subject|1|||
156618509|NCT01197794|565344671|FG004|Overall Study|Withdrawal by Subject|1|||
156618510|NCT01197794|565344672|FG005|Overall Study|Withdrawal by Subject|5|||
156618511|NCT01197794|565344673|FG006|Overall Study|Withdrawal by Subject|6|||
156618512|NCT01197794|565344667|FG000|Overall Study|Lost to Follow-up|1|||
156618513|NCT01197794|565344668|FG001|Overall Study|Lost to Follow-up|1|||
156618514|NCT01197794|565344669|FG002|Overall Study|Lost to Follow-up|0|||
156618515|NCT01197794|565344670|FG003|Overall Study|Lost to Follow-up|1|||
156618516|NCT01197794|565344671|FG004|Overall Study|Lost to Follow-up|0|||
156618517|NCT01197794|565344672|FG005|Overall Study|Lost to Follow-up|1|||
156618518|NCT01197794|565344673|FG006|Overall Study|Lost to Follow-up|0|||
156618519|NCT01197794|565344667|FG000|Overall Study|Other|1|||
156618520|NCT01197794|565344668|FG001|Overall Study|Other|1|||
156618521|NCT01197794|565344669|FG002|Overall Study|Other|3|||
156618522|NCT01197794|565344670|FG003|Overall Study|Other|0|||
156618523|NCT01197794|565344671|FG004|Overall Study|Other|2|||
156618524|NCT01197794|565344672|FG005|Overall Study|Other|2|||
156618525|NCT01197794|565344673|FG006|Overall Study|Other|4|||
156618526|NCT04055844|565344674|FG000|Overall Study|Adverse Event|12|||
156618527|NCT04055844|565344674|FG000|Overall Study|Poor Performance|1|||
156618528|NCT04055844|565344674|FG000|Overall Study|Death|1|||
156618529|NCT02724111|565344681|FG000|Overall Study|Protocol Violation|2|||
156618530|NCT02724111|565344682|FG001|Overall Study|Protocol Violation|5|||
156618531|NCT02996500|565344683|FG000|Overall Study|Adverse Event|1|||
156618532|NCT02996500|565344684|FG001|Overall Study|Adverse Event|1|||
156618533|NCT02996500|565344685|FG002|Overall Study|Adverse Event|4|||
156618534|NCT02996500|565344686|FG003|Overall Study|Adverse Event|3|||
156618535|NCT02996500|565344687|FG004|Overall Study|Adverse Event|1|||
156618536|NCT02996500|565344688|FG005|Overall Study|Adverse Event|2|||
156618537|NCT02996500|565344683|FG000|Overall Study|Lack of Efficacy|0|||
156618538|NCT02996500|565344684|FG001|Overall Study|Lack of Efficacy|0|||
156618539|NCT02996500|565344685|FG002|Overall Study|Lack of Efficacy|0|||
156618540|NCT02996500|565344686|FG003|Overall Study|Lack of Efficacy|0|||
156618541|NCT02996500|565344687|FG004|Overall Study|Lack of Efficacy|2|||
156618542|NCT02996500|565344688|FG005|Overall Study|Lack of Efficacy|0|||
156618543|NCT02996500|565344683|FG000|Overall Study|Lost to Follow-up|1|||
156618544|NCT02996500|565344684|FG001|Overall Study|Lost to Follow-up|0|||
156618545|NCT02996500|565344685|FG002|Overall Study|Lost to Follow-up|0|||
156618546|NCT02996500|565344686|FG003|Overall Study|Lost to Follow-up|0|||
156618547|NCT02996500|565344687|FG004|Overall Study|Lost to Follow-up|0|||
156618548|NCT02996500|565344688|FG005|Overall Study|Lost to Follow-up|1|||
156618549|NCT02996500|565344683|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156618550|NCT02996500|565344684|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156618551|NCT02996500|565344685|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
156618552|NCT02996500|565344686|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156618553|NCT02996500|565344687|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
156618554|NCT02996500|565344688|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156618555|NCT02996500|565344683|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156618556|NCT02996500|565344684|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156618557|NCT02996500|565344685|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156618558|NCT02996500|565344686|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156618559|NCT02996500|565344687|FG004|Overall Study|Non-Compliance With Study Drug|0|||
156618560|NCT02996500|565344688|FG005|Overall Study|Non-Compliance With Study Drug|1|||
156618561|NCT02996500|565344683|FG000|Overall Study|Progressive Disease|1|||
156618562|NCT02996500|565344684|FG001|Overall Study|Progressive Disease|0|||
156618563|NCT02996500|565344685|FG002|Overall Study|Progressive Disease|0|||
156618564|NCT02996500|565344686|FG003|Overall Study|Progressive Disease|0|||
156618565|NCT02996500|565344687|FG004|Overall Study|Progressive Disease|0|||
156618566|NCT02996500|565344688|FG005|Overall Study|Progressive Disease|0|||
156618567|NCT02996500|565344683|FG000|Overall Study|Other|2|||
156618568|NCT02996500|565344684|FG001|Overall Study|Other|0|||
156618569|NCT02996500|565344685|FG002|Overall Study|Other|2|||
156618570|NCT02996500|565344686|FG003|Overall Study|Other|0|||
156618571|NCT02996500|565344687|FG004|Overall Study|Other|0|||
156618572|NCT02996500|565344688|FG005|Overall Study|Other|0|||
156618573|NCT02996500|565344683|FG000|Overall Study|Protocol Violation|0|||
156618574|NCT02996500|565344684|FG001|Overall Study|Protocol Violation|0|||
156618575|NCT02996500|565344685|FG002|Overall Study|Protocol Violation|0|||
156618576|NCT02996500|565344686|FG003|Overall Study|Protocol Violation|1|||
156618577|NCT02996500|565344687|FG004|Overall Study|Protocol Violation|0|||
156618578|NCT02996500|565344688|FG005|Overall Study|Protocol Violation|0|||
156618579|NCT02996500|565344683|FG000|Overall Study|Withdrawal by Subject|3|||
156618580|NCT02996500|565344684|FG001|Overall Study|Withdrawal by Subject|0|||
156618581|NCT02996500|565344685|FG002|Overall Study|Withdrawal by Subject|3|||
156618582|NCT02996500|565344686|FG003|Overall Study|Withdrawal by Subject|0|||
156618583|NCT02996500|565344687|FG004|Overall Study|Withdrawal by Subject|2|||
156618584|NCT02996500|565344688|FG005|Overall Study|Withdrawal by Subject|0|||
156618585|NCT03258762|565344695|FG000|Overall Study|Lost to Follow-up|0|||
156618586|NCT03258762|565344696|FG001|Overall Study|Lost to Follow-up|1|||
156618587|NCT01868594|565344697|FG000|Overall Study|Do not meet inclusion criteria|4|||
156618588|NCT01868594|565344698|FG001|Overall Study|Do not meet inclusion criteria|3|||
156618589|NCT00656799|565344703|FG000|Overall Study|Death|2|||
156618590|NCT02422186|565344704|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
156618591|NCT02422186|565344705|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
156618592|NCT02422186|565344704|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
156618593|NCT02422186|565344705|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
156618594|NCT02422186|565344704|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
156618595|NCT02422186|565344705|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
156618596|NCT02422186|565344704|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
156618597|NCT02422186|565344705|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
156618598|NCT02422186|565344704|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
156618599|NCT02422186|565344705|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
156618600|NCT02422186|565344704|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
156618601|NCT02422186|565344705|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
156618602|NCT02422186|565344704|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
156618603|NCT02422186|565344705|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
156618604|NCT02422186|565344704|FG000|Follow-up Phase (2 Weeks)|Other|3|||
156618605|NCT02422186|565344705|FG001|Follow-up Phase (2 Weeks)|Other|0|||
156618606|NCT00211536|565347391|FG000|Overall Study|Withdrawal by Subject|2|||
156618607|NCT00211536|565347392|FG001|Overall Study|Withdrawal by Subject|2|||
156618608|NCT00211536|565347391|FG000|Overall Study|Physician Decision|0|||
156618609|NCT00211536|565347392|FG001|Overall Study|Physician Decision|5|||
156618610|NCT00211536|565347391|FG000|Overall Study|Adverse Event|2|||
156618611|NCT00211536|565347392|FG001|Overall Study|Adverse Event|0|||
156618612|NCT02583399|565347393|FG000|Overall Study|Able to be discharged|3|||
156618613|NCT02583399|565347393|FG000|Overall Study|Wanted to use a restricted medication|3|||
156618614|NCT01004861|565347394|FG000|Overall Study|Disease progression|3|||
156618615|NCT01004861|565347395|FG001|Overall Study|Disease progression|4|||
156618616|NCT01004861|565347396|FG002|Overall Study|Disease progression|5|||
156618617|NCT01004861|565347397|FG003|Overall Study|Disease progression|4|||
156618618|NCT01004861|565347398|FG004|Overall Study|Disease progression|4|||
156618619|NCT01004861|565347399|FG005|Overall Study|Disease progression|4|||
156618620|NCT01004861|565347400|FG006|Overall Study|Disease progression|5|||
156618621|NCT01004861|565347401|FG007|Overall Study|Disease progression|1|||
156618622|NCT01004861|565347402|FG008|Overall Study|Disease progression|4|||
156618623|NCT01004861|565347403|FG009|Overall Study|Disease progression|7|||
156618624|NCT01004861|565347404|FG010|Overall Study|Disease progression|6|||
156618625|NCT01004861|565347405|FG011|Overall Study|Disease progression|3|||
156618626|NCT01004861|565347406|FG012|Overall Study|Disease progression|8|||
156618627|NCT01004861|565347394|FG000|Overall Study|Physician Decision|0|||
156618628|NCT01004861|565347395|FG001|Overall Study|Physician Decision|2|||
156618629|NCT01004861|565347396|FG002|Overall Study|Physician Decision|1|||
156618630|NCT01004861|565347397|FG003|Overall Study|Physician Decision|1|||
156618631|NCT01004861|565347398|FG004|Overall Study|Physician Decision|1|||
156618632|NCT01004861|565347399|FG005|Overall Study|Physician Decision|0|||
156618633|NCT01004861|565347400|FG006|Overall Study|Physician Decision|0|||
156618634|NCT01004861|565347401|FG007|Overall Study|Physician Decision|1|||
156618635|NCT01004861|565347402|FG008|Overall Study|Physician Decision|0|||
156618636|NCT01004861|565347403|FG009|Overall Study|Physician Decision|0|||
156618637|NCT01004861|565347404|FG010|Overall Study|Physician Decision|0|||
156618638|NCT01004861|565347405|FG011|Overall Study|Physician Decision|0|||
156618639|NCT01004861|565347406|FG012|Overall Study|Physician Decision|3|||
156618640|NCT01004861|565347394|FG000|Overall Study|Adverse Event|0|||
156618641|NCT01004861|565347395|FG001|Overall Study|Adverse Event|0|||
156618642|NCT01004861|565347396|FG002|Overall Study|Adverse Event|0|||
156618643|NCT01004861|565347397|FG003|Overall Study|Adverse Event|1|||
156618644|NCT01004861|565347398|FG004|Overall Study|Adverse Event|0|||
156618645|NCT01004861|565347399|FG005|Overall Study|Adverse Event|2|||
156618646|NCT01004861|565347400|FG006|Overall Study|Adverse Event|1|||
156618647|NCT01004861|565347401|FG007|Overall Study|Adverse Event|1|||
156618648|NCT01004861|565347402|FG008|Overall Study|Adverse Event|13|||
156618649|NCT01004861|565347403|FG009|Overall Study|Adverse Event|1|||
156618650|NCT01004861|565347404|FG010|Overall Study|Adverse Event|1|||
156618651|NCT01004861|565347405|FG011|Overall Study|Adverse Event|0|||
156618652|NCT01004861|565347406|FG012|Overall Study|Adverse Event|2|||
156618653|NCT01004861|565347394|FG000|Overall Study|Protocol Violation|0|||
156618654|NCT01004861|565347395|FG001|Overall Study|Protocol Violation|0|||
156618655|NCT01004861|565347396|FG002|Overall Study|Protocol Violation|0|||
156618656|NCT01004861|565347397|FG003|Overall Study|Protocol Violation|0|||
156618657|NCT01004861|565347398|FG004|Overall Study|Protocol Violation|1|||
156618658|NCT01004861|565347399|FG005|Overall Study|Protocol Violation|0|||
156618659|NCT01004861|565347400|FG006|Overall Study|Protocol Violation|0|||
156618660|NCT01004861|565347401|FG007|Overall Study|Protocol Violation|0|||
156618661|NCT01004861|565347402|FG008|Overall Study|Protocol Violation|0|||
156618662|NCT01004861|565347403|FG009|Overall Study|Protocol Violation|0|||
156618663|NCT01004861|565347404|FG010|Overall Study|Protocol Violation|0|||
156618664|NCT01004861|565347405|FG011|Overall Study|Protocol Violation|0|||
156618665|NCT01004861|565347406|FG012|Overall Study|Protocol Violation|0|||
156618666|NCT01004861|565347394|FG000|Overall Study|Lost to Follow-up|0|||
156618667|NCT01004861|565347395|FG001|Overall Study|Lost to Follow-up|0|||
156618668|NCT01004861|565347396|FG002|Overall Study|Lost to Follow-up|0|||
156618669|NCT01004861|565347397|FG003|Overall Study|Lost to Follow-up|0|||
156618670|NCT01004861|565347398|FG004|Overall Study|Lost to Follow-up|0|||
156618671|NCT01004861|565347399|FG005|Overall Study|Lost to Follow-up|0|||
156618672|NCT01004861|565347400|FG006|Overall Study|Lost to Follow-up|0|||
156618673|NCT01004861|565347401|FG007|Overall Study|Lost to Follow-up|1|||
156618674|NCT01004861|565347402|FG008|Overall Study|Lost to Follow-up|3|||
156618675|NCT01004861|565347403|FG009|Overall Study|Lost to Follow-up|0|||
156618676|NCT01004861|565347404|FG010|Overall Study|Lost to Follow-up|0|||
156618677|NCT01004861|565347405|FG011|Overall Study|Lost to Follow-up|1|||
156618678|NCT01004861|565347406|FG012|Overall Study|Lost to Follow-up|0|||
156618679|NCT01004861|565347394|FG000|Overall Study|Non-compliance|0|||
156618680|NCT01004861|565347395|FG001|Overall Study|Non-compliance|0|||
156618681|NCT01004861|565347396|FG002|Overall Study|Non-compliance|0|||
156618682|NCT01004861|565347397|FG003|Overall Study|Non-compliance|0|||
156618683|NCT01004861|565347398|FG004|Overall Study|Non-compliance|0|||
156618684|NCT01004861|565347399|FG005|Overall Study|Non-compliance|0|||
156618685|NCT01004861|565347400|FG006|Overall Study|Non-compliance|0|||
156618686|NCT01004861|565347401|FG007|Overall Study|Non-compliance|0|||
156618687|NCT01004861|565347402|FG008|Overall Study|Non-compliance|5|||
156618688|NCT01004861|565347403|FG009|Overall Study|Non-compliance|0|||
156618689|NCT01004861|565347404|FG010|Overall Study|Non-compliance|0|||
156618690|NCT01004861|565347405|FG011|Overall Study|Non-compliance|0|||
156618691|NCT01004861|565347406|FG012|Overall Study|Non-compliance|1|||
156618692|NCT01004861|565347394|FG000|Overall Study|Other|0|||
156618693|NCT01004861|565347395|FG001|Overall Study|Other|0|||
156618694|NCT01004861|565347396|FG002|Overall Study|Other|0|||
156618695|NCT01004861|565347397|FG003|Overall Study|Other|0|||
156618696|NCT01004861|565347398|FG004|Overall Study|Other|0|||
156618697|NCT01004861|565347399|FG005|Overall Study|Other|0|||
156618698|NCT01004861|565347400|FG006|Overall Study|Other|0|||
156618699|NCT01004861|565347401|FG007|Overall Study|Other|0|||
156618700|NCT01004861|565347402|FG008|Overall Study|Other|0|||
156618701|NCT01004861|565347403|FG009|Overall Study|Other|2|||
156618702|NCT01004861|565347404|FG010|Overall Study|Other|1|||
156618703|NCT01004861|565347405|FG011|Overall Study|Other|2|||
156618704|NCT01004861|565347406|FG012|Overall Study|Other|3|||
156618705|NCT01004861|565347394|FG000|Overall Study|Patient decision|0|||
156618706|NCT01004861|565347395|FG001|Overall Study|Patient decision|0|||
156618707|NCT01004861|565347396|FG002|Overall Study|Patient decision|0|||
156618708|NCT01004861|565347397|FG003|Overall Study|Patient decision|0|||
156618709|NCT01004861|565347398|FG004|Overall Study|Patient decision|1|||
156618710|NCT01004861|565347399|FG005|Overall Study|Patient decision|0|||
156618711|NCT01004861|565347400|FG006|Overall Study|Patient decision|1|||
156618712|NCT01004861|565347401|FG007|Overall Study|Patient decision|0|||
156618713|NCT01004861|565347402|FG008|Overall Study|Patient decision|7|||
156618714|NCT01004861|565347403|FG009|Overall Study|Patient decision|1|||
156618715|NCT01004861|565347404|FG010|Overall Study|Patient decision|1|||
156618716|NCT01004861|565347405|FG011|Overall Study|Patient decision|2|||
156618717|NCT01004861|565347406|FG012|Overall Study|Patient decision|3|||
156618718|NCT01004861|565347394|FG000|Overall Study|Transitioned to Phase 4 study|0|||
156618719|NCT01004861|565347395|FG001|Overall Study|Transitioned to Phase 4 study|0|||
156618720|NCT01004861|565347396|FG002|Overall Study|Transitioned to Phase 4 study|0|||
156618721|NCT01004861|565347397|FG003|Overall Study|Transitioned to Phase 4 study|0|||
156618722|NCT01004861|565347398|FG004|Overall Study|Transitioned to Phase 4 study|0|||
156618723|NCT01004861|565347399|FG005|Overall Study|Transitioned to Phase 4 study|0|||
156618724|NCT01004861|565347400|FG006|Overall Study|Transitioned to Phase 4 study|0|||
156618725|NCT01004861|565347401|FG007|Overall Study|Transitioned to Phase 4 study|0|||
156618726|NCT01004861|565347402|FG008|Overall Study|Transitioned to Phase 4 study|2|||
156618727|NCT01004861|565347403|FG009|Overall Study|Transitioned to Phase 4 study|0|||
156618728|NCT01004861|565347404|FG010|Overall Study|Transitioned to Phase 4 study|0|||
156618729|NCT01004861|565347405|FG011|Overall Study|Transitioned to Phase 4 study|0|||
156618730|NCT01004861|565347406|FG012|Overall Study|Transitioned to Phase 4 study|0|||
156618731|NCT01004861|565347394|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618732|NCT01004861|565347395|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618733|NCT01004861|565347396|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618734|NCT01004861|565347397|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618735|NCT01004861|565347398|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618736|NCT01004861|565347399|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618737|NCT01004861|565347400|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618738|NCT01004861|565347401|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618739|NCT01004861|565347402|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
156618740|NCT01004861|565347403|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618741|NCT01004861|565347404|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618742|NCT01004861|565347405|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618743|NCT01004861|565347406|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
156618744|NCT01004861|565347394|FG000|Overall Study|Patient withdrew|0|||
156618745|NCT01004861|565347395|FG001|Overall Study|Patient withdrew|0|||
156618746|NCT01004861|565347396|FG002|Overall Study|Patient withdrew|0|||
156618747|NCT01004861|565347397|FG003|Overall Study|Patient withdrew|0|||
156618748|NCT01004861|565347398|FG004|Overall Study|Patient withdrew|0|||
156618749|NCT01004861|565347399|FG005|Overall Study|Patient withdrew|0|||
156618750|NCT01004861|565347400|FG006|Overall Study|Patient withdrew|0|||
156618751|NCT01004861|565347401|FG007|Overall Study|Patient withdrew|0|||
156618752|NCT01004861|565347402|FG008|Overall Study|Patient withdrew|1|||
156618753|NCT01004861|565347403|FG009|Overall Study|Patient withdrew|0|||
156618754|NCT01004861|565347404|FG010|Overall Study|Patient withdrew|0|||
156618755|NCT01004861|565347405|FG011|Overall Study|Patient withdrew|0|||
156618756|NCT01004861|565347406|FG012|Overall Study|Patient withdrew|0|||
156618757|NCT01004861|565347394|FG000|Overall Study|Surgical resection|0|||
156618758|NCT01004861|565347395|FG001|Overall Study|Surgical resection|0|||
156618759|NCT01004861|565347396|FG002|Overall Study|Surgical resection|0|||
156618760|NCT01004861|565347397|FG003|Overall Study|Surgical resection|0|||
156618761|NCT01004861|565347398|FG004|Overall Study|Surgical resection|0|||
156618762|NCT01004861|565347399|FG005|Overall Study|Surgical resection|0|||
156618763|NCT01004861|565347400|FG006|Overall Study|Surgical resection|0|||
156618764|NCT01004861|565347401|FG007|Overall Study|Surgical resection|0|||
156618765|NCT01004861|565347402|FG008|Overall Study|Surgical resection|1|||
156618766|NCT01004861|565347403|FG009|Overall Study|Surgical resection|0|||
156618767|NCT01004861|565347404|FG010|Overall Study|Surgical resection|0|||
156618768|NCT01004861|565347405|FG011|Overall Study|Surgical resection|0|||
156618769|NCT01004861|565347406|FG012|Overall Study|Surgical resection|0|||
156618770|NCT01004861|565347394|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618771|NCT01004861|565347395|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618772|NCT01004861|565347396|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618773|NCT01004861|565347397|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618774|NCT01004861|565347398|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618775|NCT01004861|565347399|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618776|NCT01004861|565347400|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618777|NCT01004861|565347401|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618778|NCT01004861|565347402|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
156618779|NCT01004861|565347403|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618780|NCT01004861|565347404|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618781|NCT01004861|565347405|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618782|NCT01004861|565347406|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
156618783|NCT01004861|565347394|FG000|Overall Study|Study termination by Sponsor|0|||
156618784|NCT01004861|565347395|FG001|Overall Study|Study termination by Sponsor|0|||
156618785|NCT01004861|565347396|FG002|Overall Study|Study termination by Sponsor|0|||
156618786|NCT01004861|565347397|FG003|Overall Study|Study termination by Sponsor|0|||
156618787|NCT01004861|565347398|FG004|Overall Study|Study termination by Sponsor|0|||
156618788|NCT01004861|565347399|FG005|Overall Study|Study termination by Sponsor|0|||
156618789|NCT01004861|565347400|FG006|Overall Study|Study termination by Sponsor|0|||
156618790|NCT01004861|565347401|FG007|Overall Study|Study termination by Sponsor|0|||
156618791|NCT01004861|565347402|FG008|Overall Study|Study termination by Sponsor|1|||
156618792|NCT01004861|565347403|FG009|Overall Study|Study termination by Sponsor|0|||
156618793|NCT01004861|565347404|FG010|Overall Study|Study termination by Sponsor|0|||
156618794|NCT01004861|565347405|FG011|Overall Study|Study termination by Sponsor|0|||
156618795|NCT01004861|565347406|FG012|Overall Study|Study termination by Sponsor|0|||
156618796|NCT04610827|565347408|FG000|Overall Study|Withdrawal by Subject|1|||
156618797|NCT04610827|565347409|FG001|Overall Study|Withdrawal by Subject|1|||
156618798|NCT04610827|565347410|FG002|Overall Study|Withdrawal by Subject|0|||
156618799|NCT01693562|565347411|FG000|Escalation Phase|Withdrawal by Subject|0|||
156618800|NCT01693562|565347412|FG001|Escalation Phase|Withdrawal by Subject|1|||
156618801|NCT01693562|565347413|FG002|Escalation Phase|Withdrawal by Subject|0|||
156618802|NCT01693562|565347414|FG003|Escalation Phase|Withdrawal by Subject|0|||
156618803|NCT01693562|565347415|FG004|Escalation Phase|Withdrawal by Subject|0|||
156618804|NCT01693562|565347416|FG005|Escalation Phase|Withdrawal by Subject|2|||
156618805|NCT01693562|565347417|FG006|Escalation Phase|Withdrawal by Subject|0|||
156618806|NCT01693562|565347418|FG007|Escalation Phase|Withdrawal by Subject|0|||
156618807|NCT01693562|565347419|FG008|Escalation Phase|Withdrawal by Subject|0|||
156618808|NCT01693562|565347420|FG009|Escalation Phase|Withdrawal by Subject|0|||
156618809|NCT01693562|565347421|FG010|Escalation Phase|Withdrawal by Subject|0|||
156618810|NCT01693562|565347422|FG011|Escalation Phase|Withdrawal by Subject|0|||
156618811|NCT01693562|565347423|FG012|Escalation Phase|Withdrawal by Subject|0|||
156618812|NCT01693562|565347424|FG013|Escalation Phase|Withdrawal by Subject|0|||
156618813|NCT01693562|565347425|FG014|Escalation Phase|Withdrawal by Subject|0|||
156618814|NCT01693562|565347426|FG015|Escalation Phase|Withdrawal by Subject|0|||
156618815|NCT01693562|565347427|FG016|Escalation Phase|Withdrawal by Subject|0|||
156618816|NCT01693562|565347428|FG017|Escalation Phase|Withdrawal by Subject|0|||
156618817|NCT01693562|565347429|FG018|Escalation Phase|Withdrawal by Subject|0|||
156618818|NCT01693562|565347430|FG019|Escalation Phase|Withdrawal by Subject|0|||
156618819|NCT01693562|565347431|FG020|Escalation Phase|Withdrawal by Subject|0|||
156618820|NCT01693562|565347432|FG021|Escalation Phase|Withdrawal by Subject|0|||
156618821|NCT01693562|565347433|FG022|Escalation Phase|Withdrawal by Subject|0|||
156618822|NCT01693562|565347411|FG000|Escalation Phase|Death|4|||
156618823|NCT01693562|565347412|FG001|Escalation Phase|Death|2|||
156618824|NCT01693562|565347413|FG002|Escalation Phase|Death|0|||
156618825|NCT01693562|565347414|FG003|Escalation Phase|Death|3|||
156618826|NCT01693562|565347415|FG004|Escalation Phase|Death|6|||
156618827|NCT01693562|565347416|FG005|Escalation Phase|Death|4|||
156618828|NCT01693562|565347417|FG006|Escalation Phase|Death|0|||
156618829|NCT01693562|565347418|FG007|Escalation Phase|Death|0|||
156618830|NCT01693562|565347419|FG008|Escalation Phase|Death|0|||
156618831|NCT01693562|565347420|FG009|Escalation Phase|Death|0|||
156618832|NCT01693562|565347421|FG010|Escalation Phase|Death|0|||
156618833|NCT01693562|565347422|FG011|Escalation Phase|Death|0|||
156618834|NCT01693562|565347423|FG012|Escalation Phase|Death|0|||
156618835|NCT01693562|565347424|FG013|Escalation Phase|Death|0|||
156618836|NCT01693562|565347425|FG014|Escalation Phase|Death|0|||
156618837|NCT01693562|565347426|FG015|Escalation Phase|Death|0|||
156618838|NCT01693562|565347427|FG016|Escalation Phase|Death|0|||
156618839|NCT01693562|565347428|FG017|Escalation Phase|Death|0|||
156618840|NCT01693562|565347429|FG018|Escalation Phase|Death|0|||
156618841|NCT01693562|565347430|FG019|Escalation Phase|Death|0|||
156618842|NCT01693562|565347431|FG020|Escalation Phase|Death|0|||
156618843|NCT01693562|565347432|FG021|Escalation Phase|Death|0|||
156618844|NCT01693562|565347433|FG022|Escalation Phase|Death|0|||
156618845|NCT01693562|565347411|FG000|Escalation Phase|Lost to Follow-up|0|||
156618846|NCT01693562|565347412|FG001|Escalation Phase|Lost to Follow-up|1|||
156618847|NCT01693562|565347413|FG002|Escalation Phase|Lost to Follow-up|1|||
156618848|NCT01693562|565347414|FG003|Escalation Phase|Lost to Follow-up|0|||
156618849|NCT01693562|565347415|FG004|Escalation Phase|Lost to Follow-up|0|||
156618850|NCT01693562|565347416|FG005|Escalation Phase|Lost to Follow-up|0|||
156618851|NCT01693562|565347417|FG006|Escalation Phase|Lost to Follow-up|0|||
156618852|NCT01693562|565347418|FG007|Escalation Phase|Lost to Follow-up|0|||
156618853|NCT01693562|565347419|FG008|Escalation Phase|Lost to Follow-up|0|||
156618854|NCT01693562|565347420|FG009|Escalation Phase|Lost to Follow-up|0|||
156618855|NCT01693562|565347421|FG010|Escalation Phase|Lost to Follow-up|0|||
156618856|NCT01693562|565347422|FG011|Escalation Phase|Lost to Follow-up|0|||
156618857|NCT01693562|565347423|FG012|Escalation Phase|Lost to Follow-up|0|||
156618858|NCT01693562|565347424|FG013|Escalation Phase|Lost to Follow-up|0|||
156618859|NCT01693562|565347425|FG014|Escalation Phase|Lost to Follow-up|0|||
156618860|NCT01693562|565347426|FG015|Escalation Phase|Lost to Follow-up|0|||
156618861|NCT01693562|565347427|FG016|Escalation Phase|Lost to Follow-up|0|||
156618862|NCT01693562|565347428|FG017|Escalation Phase|Lost to Follow-up|0|||
156618863|NCT01693562|565347429|FG018|Escalation Phase|Lost to Follow-up|0|||
156618864|NCT01693562|565347430|FG019|Escalation Phase|Lost to Follow-up|0|||
156618865|NCT01693562|565347431|FG020|Escalation Phase|Lost to Follow-up|0|||
156618866|NCT01693562|565347432|FG021|Escalation Phase|Lost to Follow-up|0|||
156618867|NCT01693562|565347433|FG022|Escalation Phase|Lost to Follow-up|0|||
156618868|NCT01693562|565347411|FG000|Escalation Phase|Other|0|||
156618869|NCT01693562|565347412|FG001|Escalation Phase|Other|0|||
156618870|NCT01693562|565347413|FG002|Escalation Phase|Other|2|||
156618871|NCT01693562|565347414|FG003|Escalation Phase|Other|0|||
156618872|NCT01693562|565347415|FG004|Escalation Phase|Other|0|||
156618873|NCT01693562|565347416|FG005|Escalation Phase|Other|1|||
156618874|NCT01693562|565347417|FG006|Escalation Phase|Other|0|||
156618875|NCT01693562|565347418|FG007|Escalation Phase|Other|0|||
156618876|NCT01693562|565347419|FG008|Escalation Phase|Other|0|||
156618877|NCT01693562|565347420|FG009|Escalation Phase|Other|0|||
156618878|NCT01693562|565347421|FG010|Escalation Phase|Other|0|||
156618879|NCT01693562|565347422|FG011|Escalation Phase|Other|0|||
156618880|NCT01693562|565347423|FG012|Escalation Phase|Other|0|||
156618881|NCT01693562|565347424|FG013|Escalation Phase|Other|0|||
156618882|NCT01693562|565347425|FG014|Escalation Phase|Other|0|||
156618883|NCT01693562|565347426|FG015|Escalation Phase|Other|0|||
156618884|NCT01693562|565347427|FG016|Escalation Phase|Other|0|||
156618885|NCT01693562|565347428|FG017|Escalation Phase|Other|0|||
156618886|NCT01693562|565347429|FG018|Escalation Phase|Other|0|||
156618887|NCT01693562|565347430|FG019|Escalation Phase|Other|0|||
156618888|NCT01693562|565347431|FG020|Escalation Phase|Other|0|||
156618889|NCT01693562|565347432|FG021|Escalation Phase|Other|0|||
156618890|NCT01693562|565347433|FG022|Escalation Phase|Other|0|||
156618891|NCT01693562|565347411|FG000|Exploration Phase|Withdrawal by Subject|0|||
156618892|NCT01693562|565347412|FG001|Exploration Phase|Withdrawal by Subject|0|||
156618893|NCT01693562|565347413|FG002|Exploration Phase|Withdrawal by Subject|0|||
156618894|NCT01693562|565347414|FG003|Exploration Phase|Withdrawal by Subject|0|||
156618895|NCT01693562|565347415|FG004|Exploration Phase|Withdrawal by Subject|0|||
156618896|NCT01693562|565347416|FG005|Exploration Phase|Withdrawal by Subject|0|||
156618897|NCT01693562|565347417|FG006|Exploration Phase|Withdrawal by Subject|2|||
156618898|NCT01693562|565347418|FG007|Exploration Phase|Withdrawal by Subject|0|||
156618899|NCT01693562|565347419|FG008|Exploration Phase|Withdrawal by Subject|0|||
156618900|NCT01693562|565347420|FG009|Exploration Phase|Withdrawal by Subject|0|||
156618901|NCT01693562|565347421|FG010|Exploration Phase|Withdrawal by Subject|0|||
156618902|NCT01693562|565347422|FG011|Exploration Phase|Withdrawal by Subject|0|||
156618903|NCT01693562|565347423|FG012|Exploration Phase|Withdrawal by Subject|0|||
156618904|NCT01693562|565347424|FG013|Exploration Phase|Withdrawal by Subject|0|||
156618905|NCT01693562|565347425|FG014|Exploration Phase|Withdrawal by Subject|0|||
156618906|NCT01693562|565347426|FG015|Exploration Phase|Withdrawal by Subject|0|||
156618907|NCT01693562|565347427|FG016|Exploration Phase|Withdrawal by Subject|0|||
156618908|NCT01693562|565347428|FG017|Exploration Phase|Withdrawal by Subject|0|||
156618909|NCT01693562|565347429|FG018|Exploration Phase|Withdrawal by Subject|0|||
156618910|NCT01693562|565347430|FG019|Exploration Phase|Withdrawal by Subject|0|||
156635562|NCT00602667|565409962|FG002|Overall Study|Death|1|||
156618911|NCT01693562|565347431|FG020|Exploration Phase|Withdrawal by Subject|0|||
156618912|NCT01693562|565347432|FG021|Exploration Phase|Withdrawal by Subject|0|||
156618913|NCT01693562|565347433|FG022|Exploration Phase|Withdrawal by Subject|0|||
156618914|NCT01693562|565347411|FG000|Exploration Phase|Death|0|||
156618915|NCT01693562|565347412|FG001|Exploration Phase|Death|0|||
156618916|NCT01693562|565347413|FG002|Exploration Phase|Death|0|||
156618917|NCT01693562|565347414|FG003|Exploration Phase|Death|0|||
156618918|NCT01693562|565347415|FG004|Exploration Phase|Death|0|||
156618919|NCT01693562|565347416|FG005|Exploration Phase|Death|0|||
156618920|NCT01693562|565347417|FG006|Exploration Phase|Death|17|||
156618921|NCT01693562|565347418|FG007|Exploration Phase|Death|0|||
156618922|NCT01693562|565347419|FG008|Exploration Phase|Death|0|||
156618923|NCT01693562|565347420|FG009|Exploration Phase|Death|0|||
156618924|NCT01693562|565347421|FG010|Exploration Phase|Death|0|||
156618925|NCT01693562|565347422|FG011|Exploration Phase|Death|0|||
156618926|NCT01693562|565347423|FG012|Exploration Phase|Death|0|||
156618927|NCT01693562|565347424|FG013|Exploration Phase|Death|0|||
156618928|NCT01693562|565347425|FG014|Exploration Phase|Death|0|||
156618929|NCT01693562|565347426|FG015|Exploration Phase|Death|0|||
156618930|NCT01693562|565347427|FG016|Exploration Phase|Death|0|||
156618931|NCT01693562|565347428|FG017|Exploration Phase|Death|0|||
156618932|NCT01693562|565347429|FG018|Exploration Phase|Death|0|||
156618933|NCT01693562|565347430|FG019|Exploration Phase|Death|0|||
156618934|NCT01693562|565347431|FG020|Exploration Phase|Death|0|||
156618935|NCT01693562|565347432|FG021|Exploration Phase|Death|0|||
156618936|NCT01693562|565347433|FG022|Exploration Phase|Death|0|||
156618937|NCT01693562|565347411|FG000|Exploration Phase|Other|0|||
156618938|NCT01693562|565347412|FG001|Exploration Phase|Other|0|||
156618939|NCT01693562|565347413|FG002|Exploration Phase|Other|0|||
156618940|NCT01693562|565347414|FG003|Exploration Phase|Other|0|||
156618941|NCT01693562|565347415|FG004|Exploration Phase|Other|0|||
156618942|NCT01693562|565347416|FG005|Exploration Phase|Other|0|||
156618943|NCT01693562|565347417|FG006|Exploration Phase|Other|2|||
156618944|NCT01693562|565347418|FG007|Exploration Phase|Other|0|||
156618945|NCT01693562|565347419|FG008|Exploration Phase|Other|0|||
156618946|NCT01693562|565347420|FG009|Exploration Phase|Other|0|||
156618947|NCT01693562|565347421|FG010|Exploration Phase|Other|0|||
156618948|NCT01693562|565347422|FG011|Exploration Phase|Other|0|||
156618949|NCT01693562|565347423|FG012|Exploration Phase|Other|0|||
156618950|NCT01693562|565347424|FG013|Exploration Phase|Other|0|||
156618951|NCT01693562|565347425|FG014|Exploration Phase|Other|0|||
156618952|NCT01693562|565347426|FG015|Exploration Phase|Other|0|||
156618953|NCT01693562|565347427|FG016|Exploration Phase|Other|0|||
156618954|NCT01693562|565347428|FG017|Exploration Phase|Other|0|||
156618955|NCT01693562|565347429|FG018|Exploration Phase|Other|0|||
156618956|NCT01693562|565347430|FG019|Exploration Phase|Other|0|||
156618957|NCT01693562|565347431|FG020|Exploration Phase|Other|0|||
156618958|NCT01693562|565347432|FG021|Exploration Phase|Other|0|||
156618959|NCT01693562|565347433|FG022|Exploration Phase|Other|0|||
156618960|NCT01693562|565347411|FG000|Expansion Phase|Withdrawal by Subject|0|||
156618961|NCT01693562|565347412|FG001|Expansion Phase|Withdrawal by Subject|0|||
156618962|NCT01693562|565347413|FG002|Expansion Phase|Withdrawal by Subject|0|||
156618963|NCT01693562|565347414|FG003|Expansion Phase|Withdrawal by Subject|0|||
156618964|NCT01693562|565347415|FG004|Expansion Phase|Withdrawal by Subject|0|||
156618965|NCT01693562|565347416|FG005|Expansion Phase|Withdrawal by Subject|0|||
156618966|NCT01693562|565347417|FG006|Expansion Phase|Withdrawal by Subject|0|||
156618967|NCT01693562|565347418|FG007|Expansion Phase|Withdrawal by Subject|16|||
156618968|NCT01693562|565347419|FG008|Expansion Phase|Withdrawal by Subject|2|||
156618969|NCT01693562|565347420|FG009|Expansion Phase|Withdrawal by Subject|54|||
156618970|NCT01693562|565347421|FG010|Expansion Phase|Withdrawal by Subject|2|||
156618971|NCT01693562|565347422|FG011|Expansion Phase|Withdrawal by Subject|2|||
156618972|NCT01693562|565347423|FG012|Expansion Phase|Withdrawal by Subject|3|||
156618973|NCT01693562|565347424|FG013|Expansion Phase|Withdrawal by Subject|5|||
156618974|NCT01693562|565347425|FG014|Expansion Phase|Withdrawal by Subject|16|||
156618975|NCT01693562|565347426|FG015|Expansion Phase|Withdrawal by Subject|7|||
156618976|NCT01693562|565347427|FG016|Expansion Phase|Withdrawal by Subject|40|||
156618977|NCT01693562|565347428|FG017|Expansion Phase|Withdrawal by Subject|4|||
156618978|NCT01693562|565347429|FG018|Expansion Phase|Withdrawal by Subject|8|||
156618979|NCT01693562|565347430|FG019|Expansion Phase|Withdrawal by Subject|3|||
156618980|NCT01693562|565347431|FG020|Expansion Phase|Withdrawal by Subject|1|||
156618981|NCT01693562|565347432|FG021|Expansion Phase|Withdrawal by Subject|8|||
156618982|NCT01693562|565347433|FG022|Expansion Phase|Withdrawal by Subject|1|||
156618983|NCT01693562|565347411|FG000|Expansion Phase|Death|0|||
156618984|NCT01693562|565347412|FG001|Expansion Phase|Death|0|||
156618985|NCT01693562|565347413|FG002|Expansion Phase|Death|0|||
156618986|NCT01693562|565347414|FG003|Expansion Phase|Death|0|||
156618987|NCT01693562|565347415|FG004|Expansion Phase|Death|0|||
156618988|NCT01693562|565347416|FG005|Expansion Phase|Death|0|||
156618989|NCT01693562|565347417|FG006|Expansion Phase|Death|0|||
156618990|NCT01693562|565347418|FG007|Expansion Phase|Death|42|||
156618991|NCT01693562|565347419|FG008|Expansion Phase|Death|17|||
156618992|NCT01693562|565347420|FG009|Expansion Phase|Death|208|||
156618993|NCT01693562|565347421|FG010|Expansion Phase|Death|30|||
156618994|NCT01693562|565347422|FG011|Expansion Phase|Death|8|||
156618995|NCT01693562|565347423|FG012|Expansion Phase|Death|19|||
156618996|NCT01693562|565347424|FG013|Expansion Phase|Death|42|||
156618997|NCT01693562|565347425|FG014|Expansion Phase|Death|23|||
156618998|NCT01693562|565347426|FG015|Expansion Phase|Death|23|||
156618999|NCT01693562|565347427|FG016|Expansion Phase|Death|128|||
156619000|NCT01693562|565347428|FG017|Expansion Phase|Death|16|||
156619001|NCT01693562|565347429|FG018|Expansion Phase|Death|36|||
156619002|NCT01693562|565347430|FG019|Expansion Phase|Death|16|||
156619003|NCT01693562|565347431|FG020|Expansion Phase|Death|17|||
156619004|NCT01693562|565347432|FG021|Expansion Phase|Death|35|||
156619005|NCT01693562|565347433|FG022|Expansion Phase|Death|7|||
156619006|NCT01693562|565347411|FG000|Expansion Phase|Lost to Follow-up|0|||
156619007|NCT01693562|565347412|FG001|Expansion Phase|Lost to Follow-up|0|||
156619008|NCT01693562|565347413|FG002|Expansion Phase|Lost to Follow-up|0|||
156619009|NCT01693562|565347414|FG003|Expansion Phase|Lost to Follow-up|0|||
156619010|NCT01693562|565347415|FG004|Expansion Phase|Lost to Follow-up|0|||
156619011|NCT01693562|565347416|FG005|Expansion Phase|Lost to Follow-up|0|||
156619012|NCT01693562|565347417|FG006|Expansion Phase|Lost to Follow-up|0|||
156619013|NCT01693562|565347418|FG007|Expansion Phase|Lost to Follow-up|1|||
156619014|NCT01693562|565347419|FG008|Expansion Phase|Lost to Follow-up|2|||
156619015|NCT01693562|565347420|FG009|Expansion Phase|Lost to Follow-up|10|||
156619016|NCT01693562|565347421|FG010|Expansion Phase|Lost to Follow-up|4|||
156619017|NCT01693562|565347422|FG011|Expansion Phase|Lost to Follow-up|4|||
156619018|NCT01693562|565347423|FG012|Expansion Phase|Lost to Follow-up|1|||
156619019|NCT01693562|565347424|FG013|Expansion Phase|Lost to Follow-up|3|||
156619020|NCT01693562|565347425|FG014|Expansion Phase|Lost to Follow-up|0|||
156619021|NCT01693562|565347426|FG015|Expansion Phase|Lost to Follow-up|1|||
156619022|NCT01693562|565347427|FG016|Expansion Phase|Lost to Follow-up|1|||
156619023|NCT01693562|565347428|FG017|Expansion Phase|Lost to Follow-up|0|||
156619024|NCT01693562|565347429|FG018|Expansion Phase|Lost to Follow-up|2|||
156619025|NCT01693562|565347430|FG019|Expansion Phase|Lost to Follow-up|1|||
156619026|NCT01693562|565347431|FG020|Expansion Phase|Lost to Follow-up|2|||
156619027|NCT01693562|565347432|FG021|Expansion Phase|Lost to Follow-up|2|||
156619028|NCT01693562|565347433|FG022|Expansion Phase|Lost to Follow-up|1|||
156619029|NCT01693562|565347411|FG000|Expansion Phase|Other|0|||
156619030|NCT01693562|565347412|FG001|Expansion Phase|Other|0|||
156619031|NCT01693562|565347413|FG002|Expansion Phase|Other|0|||
156619032|NCT01693562|565347414|FG003|Expansion Phase|Other|0|||
156619033|NCT01693562|565347415|FG004|Expansion Phase|Other|0|||
156619034|NCT01693562|565347416|FG005|Expansion Phase|Other|0|||
156619035|NCT01693562|565347417|FG006|Expansion Phase|Other|0|||
156619036|NCT01693562|565347418|FG007|Expansion Phase|Other|3|||
156619037|NCT01693562|565347419|FG008|Expansion Phase|Other|1|||
156619038|NCT01693562|565347420|FG009|Expansion Phase|Other|28|||
156619039|NCT01693562|565347421|FG010|Expansion Phase|Other|4|||
156619040|NCT01693562|565347422|FG011|Expansion Phase|Other|7|||
156619041|NCT01693562|565347423|FG012|Expansion Phase|Other|0|||
156619042|NCT01693562|565347424|FG013|Expansion Phase|Other|1|||
156619043|NCT01693562|565347425|FG014|Expansion Phase|Other|1|||
156619044|NCT01693562|565347426|FG015|Expansion Phase|Other|0|||
156619045|NCT01693562|565347427|FG016|Expansion Phase|Other|28|||
156619046|NCT01693562|565347428|FG017|Expansion Phase|Other|0|||
156619047|NCT01693562|565347429|FG018|Expansion Phase|Other|1|||
156619048|NCT01693562|565347430|FG019|Expansion Phase|Other|0|||
156619049|NCT01693562|565347431|FG020|Expansion Phase|Other|1|||
156619050|NCT01693562|565347432|FG021|Expansion Phase|Other|17|||
156619051|NCT01693562|565347433|FG022|Expansion Phase|Other|1|||
156619052|NCT02759939|565347434|FG000|Overall Study|Missing data on first outcome assessed|11|||
156619053|NCT02759939|565347435|FG001|Overall Study|Missing data on first outcome assessed|2|||
156619054|NCT02759939|565347436|FG002|Overall Study|Missing data on first outcome assessed|5|||
156619055|NCT02759939|565347437|FG003|Overall Study|Missing data on first outcome assessed|2|||
156619056|NCT02759939|565347434|FG000|Overall Study|Ineligible for T2 and T3|310|||
156619057|NCT02759939|565347435|FG001|Overall Study|Ineligible for T2 and T3|179|||
156619058|NCT02759939|565347436|FG002|Overall Study|Ineligible for T2 and T3|366|||
156619059|NCT02759939|565347437|FG003|Overall Study|Ineligible for T2 and T3|391|||
156619060|NCT02759939|565347434|FG000|Overall Study|Lost to Follow-up|735|||
156619061|NCT02759939|565347435|FG001|Overall Study|Lost to Follow-up|791|||
156619062|NCT02759939|565347436|FG002|Overall Study|Lost to Follow-up|783|||
156619063|NCT02759939|565347437|FG003|Overall Study|Lost to Follow-up|650|||
156619064|NCT04735432|565347438|FG000|Overall Study|Other - due to personal reason|1|||
156619065|NCT04735432|565347439|FG001|Overall Study|Other - due to personal reason|0|||
156619066|NCT04735432|565347438|FG000|Overall Study|Adverse Event|2|||
156619067|NCT04735432|565347439|FG001|Overall Study|Adverse Event|0|||
156619068|NCT02306148|565347440|FG000|Overall Study|Adverse Event|12|||
156619069|NCT02306148|565347441|FG001|Overall Study|Adverse Event|6|||
156619070|NCT02306148|565347440|FG000|Overall Study|Lost to Follow-up|1|||
156619071|NCT02306148|565347441|FG001|Overall Study|Lost to Follow-up|4|||
156619072|NCT04657003|565347448|FG000|Overall Study|Adverse Event|5|||
156619073|NCT04657003|565347449|FG001|Overall Study|Adverse Event|1|||
156619074|NCT04657003|565347450|FG002|Overall Study|Adverse Event|5|||
156619075|NCT04657003|565347448|FG000|Overall Study|Death|0|||
156619076|NCT04657003|565347449|FG001|Overall Study|Death|2|||
156619077|NCT04657003|565347450|FG002|Overall Study|Death|0|||
156619078|NCT04657003|565347448|FG000|Overall Study|Lost to Follow-up|8|||
156619079|NCT04657003|565347449|FG001|Overall Study|Lost to Follow-up|4|||
156619080|NCT04657003|565347450|FG002|Overall Study|Lost to Follow-up|10|||
156619081|NCT04657003|565347448|FG000|Overall Study|Other - As Reported by Investigator|3|||
156619082|NCT04657003|565347449|FG001|Overall Study|Other - As Reported by Investigator|2|||
156619083|NCT04657003|565347450|FG002|Overall Study|Other - As Reported by Investigator|2|||
156619084|NCT04657003|565347448|FG000|Overall Study|Pregnancy|2|||
156619085|NCT04657003|565347449|FG001|Overall Study|Pregnancy|0|||
156619086|NCT04657003|565347450|FG002|Overall Study|Pregnancy|2|||
156619087|NCT04657003|565347448|FG000|Overall Study|Withdrawal by Subject|16|||
156619088|NCT04657003|565347449|FG001|Overall Study|Withdrawal by Subject|7|||
156619089|NCT04657003|565347450|FG002|Overall Study|Withdrawal by Subject|10|||
156619090|NCT01823991|565347453|FG000|Overall Study|Withdrawal by Subject|8|||
156619091|NCT01823991|565347454|FG001|Overall Study|Withdrawal by Subject|5|||
156619092|NCT05158244|565347455|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
156619093|NCT05158244|565347456|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
156619094|NCT05158244|565347457|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
156619095|NCT05158244|565347458|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
156619096|NCT05158244|565347459|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
156619097|NCT05158244|565347455|FG000|Overall Study|Withdrawal by Subject|0|||
156619098|NCT05158244|565347456|FG001|Overall Study|Withdrawal by Subject|0|||
156619099|NCT05158244|565347457|FG002|Overall Study|Withdrawal by Subject|1|||
156619100|NCT05158244|565347458|FG003|Overall Study|Withdrawal by Subject|0|||
156619101|NCT05158244|565347459|FG004|Overall Study|Withdrawal by Subject|0|||
156619102|NCT02408016|565347461|FG000|Overall Study|Death|6|||
156619103|NCT02408016|565347462|FG001|Overall Study|Death|1|||
156619104|NCT02408016|565347463|FG002|Overall Study|Death|0|||
156619105|NCT02408016|565347461|FG000|Overall Study|Physician Decision|0|||
156619106|NCT02408016|565347462|FG001|Overall Study|Physician Decision|2|||
156619107|NCT02408016|565347463|FG002|Overall Study|Physician Decision|0|||
156619108|NCT00805194|565347464|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
156619109|NCT00805194|565347465|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
156619110|NCT00805194|565347464|FG000|Overall Study|Worsening or AE of underlying disease|64|||
156619111|NCT00805194|565347465|FG001|Overall Study|Worsening or AE of underlying disease|70|||
156619112|NCT00805194|565347464|FG000|Overall Study|Other AE|84|||
156619113|NCT00805194|565347465|FG001|Overall Study|Other AE|73|||
156619114|NCT00805194|565347464|FG000|Overall Study|Protocol Violation|9|||
156619115|NCT00805194|565347465|FG001|Overall Study|Protocol Violation|9|||
156619116|NCT00805194|565347464|FG000|Overall Study|Lost to Follow-up|5|||
156619117|NCT00805194|565347465|FG001|Overall Study|Lost to Follow-up|5|||
156619118|NCT00805194|565347464|FG000|Overall Study|Withdrawal by Subject|60|||
156619119|NCT00805194|565347465|FG001|Overall Study|Withdrawal by Subject|42|||
156619120|NCT00805194|565347464|FG000|Overall Study|Not treated|3|||
156619121|NCT00805194|565347465|FG001|Overall Study|Not treated|4|||
156619122|NCT00805194|565347464|FG000|Overall Study|Reasons other than stated above|20|||
156619123|NCT00805194|565347465|FG001|Overall Study|Reasons other than stated above|16|||
156619124|NCT02185040|565347469|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
156619125|NCT02185040|565347470|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
156619126|NCT02185040|565347471|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
156619127|NCT02185040|565347472|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
156619128|NCT02185040|565347473|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
156619129|NCT02185040|565347474|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
156619130|NCT02185040|565347475|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
156619131|NCT02185040|565347469|FG000|Part 1 Treatment Phase|Adverse Event|1|||
156619132|NCT02185040|565347470|FG001|Part 1 Treatment Phase|Adverse Event|0|||
156619133|NCT02185040|565347471|FG002|Part 1 Treatment Phase|Adverse Event|0|||
156619134|NCT02185040|565347472|FG003|Part 1 Treatment Phase|Adverse Event|2|||
156619135|NCT02185040|565347473|FG004|Part 1 Treatment Phase|Adverse Event|3|||
156619136|NCT02185040|565347474|FG005|Part 1 Treatment Phase|Adverse Event|0|||
156619137|NCT02185040|565347475|FG006|Part 1 Treatment Phase|Adverse Event|0|||
156619138|NCT02185040|565347469|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
156619139|NCT02185040|565347470|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
156619140|NCT02185040|565347471|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
156619141|NCT02185040|565347472|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
156619142|NCT02185040|565347473|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
156619143|NCT02185040|565347474|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
156619144|NCT02185040|565347475|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
156619145|NCT02185040|565347469|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
156619146|NCT02185040|565347470|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
156619147|NCT02185040|565347471|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
156619148|NCT02185040|565347472|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
156619149|NCT02185040|565347473|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
156619150|NCT02185040|565347474|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
156619151|NCT02185040|565347475|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
156619152|NCT02185040|565347469|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
156619153|NCT02185040|565347470|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
156619154|NCT02185040|565347471|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
156619155|NCT02185040|565347472|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
156619156|NCT02185040|565347473|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
156619157|NCT02185040|565347474|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
156619158|NCT02185040|565347475|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
156619159|NCT02185040|565347469|FG000|Active Treatment Extension Phase|Adverse Event|0|||
156619160|NCT02185040|565347470|FG001|Active Treatment Extension Phase|Adverse Event|0|||
156619161|NCT02185040|565347471|FG002|Active Treatment Extension Phase|Adverse Event|0|||
156619162|NCT02185040|565347472|FG003|Active Treatment Extension Phase|Adverse Event|0|||
156619163|NCT02185040|565347473|FG004|Active Treatment Extension Phase|Adverse Event|0|||
156619164|NCT02185040|565347474|FG005|Active Treatment Extension Phase|Adverse Event|1|||
156619165|NCT02185040|565347475|FG006|Active Treatment Extension Phase|Adverse Event|4|||
156619166|NCT02185040|565347469|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
156619167|NCT02185040|565347470|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
156619168|NCT02185040|565347471|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
156619169|NCT02185040|565347472|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
156619170|NCT02185040|565347473|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
156619171|NCT02185040|565347474|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
156619172|NCT02185040|565347475|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
156619173|NCT02185040|565347469|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
156619174|NCT02185040|565347470|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
156619175|NCT02185040|565347471|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
156619176|NCT02185040|565347472|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
156619177|NCT02185040|565347473|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
156619178|NCT02185040|565347474|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
156619179|NCT02185040|565347475|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
156619180|NCT02646891|565347480|FG000|Overall Study|Adverse Event|0|||
156619181|NCT02646891|565347481|FG001|Overall Study|Adverse Event|1|||
156619182|NCT02646891|565347482|FG002|Overall Study|Adverse Event|0|||
156619183|NCT02646891|565347483|FG003|Overall Study|Adverse Event|0|||
156619184|NCT02646891|565347484|FG004|Overall Study|Adverse Event|0|||
156619185|NCT02646891|565347485|FG005|Overall Study|Adverse Event|0|||
156619186|NCT02646891|565347486|FG006|Overall Study|Adverse Event|0|||
156619187|NCT02646891|565347487|FG007|Overall Study|Adverse Event|0|||
156619188|NCT02646891|565347488|FG008|Overall Study|Adverse Event|0|||
156619189|NCT02646891|565347489|FG009|Overall Study|Adverse Event|0|||
156619190|NCT02646891|565347480|FG000|Overall Study|Lost to Follow-up|0|||
156619191|NCT02646891|565347481|FG001|Overall Study|Lost to Follow-up|0|||
156619192|NCT02646891|565347482|FG002|Overall Study|Lost to Follow-up|0|||
156619193|NCT02646891|565347483|FG003|Overall Study|Lost to Follow-up|0|||
156619194|NCT02646891|565347484|FG004|Overall Study|Lost to Follow-up|0|||
156619195|NCT02646891|565347485|FG005|Overall Study|Lost to Follow-up|0|||
156619196|NCT02646891|565347486|FG006|Overall Study|Lost to Follow-up|2|||
156619197|NCT02646891|565347487|FG007|Overall Study|Lost to Follow-up|2|||
156619198|NCT02646891|565347488|FG008|Overall Study|Lost to Follow-up|2|||
156619199|NCT02646891|565347489|FG009|Overall Study|Lost to Follow-up|2|||
156619200|NCT02646891|565347480|FG000|Overall Study|Protocol Violation|0|||
156619201|NCT02646891|565347481|FG001|Overall Study|Protocol Violation|0|||
156619202|NCT02646891|565347482|FG002|Overall Study|Protocol Violation|0|||
156619203|NCT02646891|565347483|FG003|Overall Study|Protocol Violation|0|||
156619204|NCT02646891|565347484|FG004|Overall Study|Protocol Violation|0|||
156619205|NCT02646891|565347485|FG005|Overall Study|Protocol Violation|0|||
156619206|NCT02646891|565347486|FG006|Overall Study|Protocol Violation|1|||
156619207|NCT02646891|565347487|FG007|Overall Study|Protocol Violation|1|||
156619208|NCT02646891|565347488|FG008|Overall Study|Protocol Violation|0|||
156619209|NCT02646891|565347489|FG009|Overall Study|Protocol Violation|0|||
156619210|NCT02646891|565347480|FG000|Overall Study|Withdrawal by Subject|2|||
156619211|NCT02646891|565347481|FG001|Overall Study|Withdrawal by Subject|0|||
156619212|NCT02646891|565347482|FG002|Overall Study|Withdrawal by Subject|1|||
156619213|NCT02646891|565347483|FG003|Overall Study|Withdrawal by Subject|0|||
156619214|NCT02646891|565347484|FG004|Overall Study|Withdrawal by Subject|0|||
156619215|NCT02646891|565347485|FG005|Overall Study|Withdrawal by Subject|0|||
156619216|NCT02646891|565347486|FG006|Overall Study|Withdrawal by Subject|5|||
156619217|NCT02646891|565347487|FG007|Overall Study|Withdrawal by Subject|9|||
156619218|NCT02646891|565347488|FG008|Overall Study|Withdrawal by Subject|7|||
156619219|NCT02646891|565347489|FG009|Overall Study|Withdrawal by Subject|3|||
156619220|NCT02646891|565347480|FG000|Overall Study|Death|0|||
156619221|NCT02646891|565347481|FG001|Overall Study|Death|0|||
156619222|NCT02646891|565347482|FG002|Overall Study|Death|0|||
156619223|NCT02646891|565347483|FG003|Overall Study|Death|0|||
156619224|NCT02646891|565347484|FG004|Overall Study|Death|0|||
156619225|NCT02646891|565347485|FG005|Overall Study|Death|0|||
156619226|NCT02646891|565347486|FG006|Overall Study|Death|1|||
156619227|NCT02646891|565347487|FG007|Overall Study|Death|1|||
156619228|NCT02646891|565347488|FG008|Overall Study|Death|1|||
156619229|NCT02646891|565347489|FG009|Overall Study|Death|0|||
156619230|NCT01542632|565347490|FG000|Overall Study|Withdrawal of Consent|0|||
156619231|NCT01542632|565347491|FG001|Overall Study|Withdrawal of Consent|0|||
156619232|NCT01542632|565347492|FG002|Overall Study|Withdrawal of Consent|0|||
156619233|NCT01542632|565347493|FG003|Overall Study|Withdrawal of Consent|2|||
156619234|NCT01542632|565347494|FG004|Overall Study|Withdrawal of Consent|3|||
156619235|NCT01542632|565347495|FG005|Overall Study|Withdrawal of Consent|0|||
156619236|NCT01542632|565347490|FG000|Overall Study|Adverse Event|0|||
156619237|NCT01542632|565347491|FG001|Overall Study|Adverse Event|0|||
156619238|NCT01542632|565347492|FG002|Overall Study|Adverse Event|1|||
156619239|NCT01542632|565347493|FG003|Overall Study|Adverse Event|0|||
156619240|NCT01542632|565347494|FG004|Overall Study|Adverse Event|0|||
156619241|NCT01542632|565347495|FG005|Overall Study|Adverse Event|0|||
156619242|NCT01542632|565347490|FG000|Overall Study|Lost to Follow-up|0|||
156619243|NCT01542632|565347491|FG001|Overall Study|Lost to Follow-up|1|||
156619244|NCT01542632|565347492|FG002|Overall Study|Lost to Follow-up|0|||
156619245|NCT01542632|565347493|FG003|Overall Study|Lost to Follow-up|0|||
156619246|NCT01542632|565347494|FG004|Overall Study|Lost to Follow-up|0|||
156619247|NCT01542632|565347495|FG005|Overall Study|Lost to Follow-up|0|||
156619248|NCT01542632|565347490|FG000|Overall Study|Sponsor/Investigator Decision|0|||
156619249|NCT01542632|565347491|FG001|Overall Study|Sponsor/Investigator Decision|0|||
156619250|NCT01542632|565347492|FG002|Overall Study|Sponsor/Investigator Decision|0|||
156619251|NCT01542632|565347493|FG003|Overall Study|Sponsor/Investigator Decision|0|||
156619252|NCT01542632|565347494|FG004|Overall Study|Sponsor/Investigator Decision|1|||
156619253|NCT01542632|565347495|FG005|Overall Study|Sponsor/Investigator Decision|0|||
156619254|NCT00033514|565347496|FG000|Overall Study|Lost to Follow-up|1|||
156619255|NCT00033514|565347497|FG001|Overall Study|Lost to Follow-up|1|||
156619256|NCT00033514|565347496|FG000|Overall Study|Withdrawal by Subject|0|||
156619257|NCT00033514|565347497|FG001|Overall Study|Withdrawal by Subject|3|||
156619258|NCT03225833|565347498|FG000|Overall Study|Adverse Event|0|||
156619259|NCT03225833|565347499|FG001|Overall Study|Adverse Event|1|||
156619260|NCT03225833|565347500|FG002|Overall Study|Adverse Event|2|||
156619261|NCT03225833|565347501|FG003|Overall Study|Adverse Event|0|||
156619262|NCT03225833|565347502|FG004|Overall Study|Adverse Event|0|||
156619263|NCT03225833|565347503|FG005|Overall Study|Adverse Event|2|||
156619264|NCT03225833|565347498|FG000|Overall Study|Withdrawal by Subject|1|||
156619265|NCT03225833|565347499|FG001|Overall Study|Withdrawal by Subject|0|||
156619266|NCT03225833|565347500|FG002|Overall Study|Withdrawal by Subject|0|||
156619267|NCT03225833|565347501|FG003|Overall Study|Withdrawal by Subject|0|||
156619268|NCT03225833|565347502|FG004|Overall Study|Withdrawal by Subject|1|||
156619269|NCT03225833|565347503|FG005|Overall Study|Withdrawal by Subject|0|||
156619270|NCT03225833|565347498|FG000|Overall Study|Termination of Study by Sponsor|4|||
156619271|NCT03225833|565347499|FG001|Overall Study|Termination of Study by Sponsor|0|||
156619272|NCT03225833|565347500|FG002|Overall Study|Termination of Study by Sponsor|0|||
156619273|NCT03225833|565347501|FG003|Overall Study|Termination of Study by Sponsor|0|||
156619274|NCT03225833|565347502|FG004|Overall Study|Termination of Study by Sponsor|0|||
156619275|NCT03225833|565347503|FG005|Overall Study|Termination of Study by Sponsor|7|||
156619276|NCT03225833|565347498|FG000|Overall Study|Sponsor Decision|0|||
156619277|NCT03225833|565347499|FG001|Overall Study|Sponsor Decision|0|||
156619278|NCT03225833|565347500|FG002|Overall Study|Sponsor Decision|0|||
156619279|NCT03225833|565347501|FG003|Overall Study|Sponsor Decision|0|||
156619280|NCT03225833|565347502|FG004|Overall Study|Sponsor Decision|0|||
156619281|NCT03225833|565347503|FG005|Overall Study|Sponsor Decision|1|||
156619282|NCT05827978|565347515|FG000|Overall Study|Adverse Event|1|||
156619283|NCT05827978|565347516|FG001|Overall Study|Adverse Event|0|||
156619284|NCT05827978|565347517|FG002|Overall Study|Adverse Event|0|||
156619285|NCT05827978|565347518|FG003|Overall Study|Adverse Event|1|||
156619286|NCT05827978|565347519|FG004|Overall Study|Adverse Event|0|||
156619287|NCT05827978|565347520|FG005|Overall Study|Adverse Event|0|||
156619288|NCT05827978|565347515|FG000|Overall Study|Death|1|||
156619289|NCT05827978|565347516|FG001|Overall Study|Death|5|||
156619290|NCT05827978|565347517|FG002|Overall Study|Death|2|||
156619291|NCT05827978|565347518|FG003|Overall Study|Death|3|||
156619292|NCT05827978|565347519|FG004|Overall Study|Death|1|||
156619293|NCT05827978|565347520|FG005|Overall Study|Death|3|||
156619294|NCT05827978|565347515|FG000|Overall Study|Lost to Follow-up|57|||
156619295|NCT05827978|565347516|FG001|Overall Study|Lost to Follow-up|88|||
156619296|NCT05827978|565347517|FG002|Overall Study|Lost to Follow-up|54|||
156619297|NCT05827978|565347518|FG003|Overall Study|Lost to Follow-up|47|||
156619298|NCT05827978|565347519|FG004|Overall Study|Lost to Follow-up|25|||
156619299|NCT05827978|565347520|FG005|Overall Study|Lost to Follow-up|10|||
156619300|NCT05827978|565347515|FG000|Overall Study|Noncompliance with Study Procedures|0|||
156619301|NCT05827978|565347516|FG001|Overall Study|Noncompliance with Study Procedures|1|||
156619302|NCT05827978|565347517|FG002|Overall Study|Noncompliance with Study Procedures|1|||
156619303|NCT05827978|565347518|FG003|Overall Study|Noncompliance with Study Procedures|1|||
156619304|NCT05827978|565347519|FG004|Overall Study|Noncompliance with Study Procedures|1|||
156619305|NCT05827978|565347520|FG005|Overall Study|Noncompliance with Study Procedures|0|||
156619306|NCT05827978|565347515|FG000|Overall Study|Physician Decision|2|||
156619307|NCT05827978|565347516|FG001|Overall Study|Physician Decision|0|||
156619308|NCT05827978|565347517|FG002|Overall Study|Physician Decision|1|||
156619309|NCT05827978|565347518|FG003|Overall Study|Physician Decision|2|||
156619310|NCT05827978|565347519|FG004|Overall Study|Physician Decision|1|||
156619311|NCT05827978|565347520|FG005|Overall Study|Physician Decision|1|||
156619312|NCT05827978|565347515|FG000|Overall Study|Protocol Violation|5|||
156619313|NCT05827978|565347516|FG001|Overall Study|Protocol Violation|2|||
156619314|NCT05827978|565347517|FG002|Overall Study|Protocol Violation|0|||
156619315|NCT05827978|565347518|FG003|Overall Study|Protocol Violation|0|||
156619316|NCT05827978|565347519|FG004|Overall Study|Protocol Violation|0|||
156619317|NCT05827978|565347520|FG005|Overall Study|Protocol Violation|0|||
156619318|NCT05827978|565347515|FG000|Overall Study|Withdrawal by Subject|17|||
156619319|NCT05827978|565347516|FG001|Overall Study|Withdrawal by Subject|16|||
156619320|NCT05827978|565347517|FG002|Overall Study|Withdrawal by Subject|10|||
156619321|NCT05827978|565347518|FG003|Overall Study|Withdrawal by Subject|12|||
156619322|NCT05827978|565347519|FG004|Overall Study|Withdrawal by Subject|10|||
156619323|NCT05827978|565347520|FG005|Overall Study|Withdrawal by Subject|9|||
156619324|NCT05827978|565347515|FG000|Overall Study|Other Than Specified|0|||
156619325|NCT05827978|565347516|FG001|Overall Study|Other Than Specified|0|||
156619326|NCT05827978|565347517|FG002|Overall Study|Other Than Specified|1|||
156619327|NCT05827978|565347518|FG003|Overall Study|Other Than Specified|0|||
156619328|NCT05827978|565347519|FG004|Overall Study|Other Than Specified|2|||
156619329|NCT05827978|565347520|FG005|Overall Study|Other Than Specified|0|||
156619330|NCT04566445|565347521|FG000|Overall Study|Death|4|||
156619331|NCT04566445|565347522|FG001|Overall Study|Death|1|||
156619332|NCT04566445|565347523|FG002|Overall Study|Death|1|||
156619333|NCT04566445|565347521|FG000|Overall Study|Lost to Follow-up|3|||
156619334|NCT04566445|565347522|FG001|Overall Study|Lost to Follow-up|1|||
156619335|NCT04566445|565347523|FG002|Overall Study|Lost to Follow-up|1|||
156619336|NCT04566445|565347521|FG000|Overall Study|Study terminated by sponsor|11|||
156619337|NCT04566445|565347522|FG001|Overall Study|Study terminated by sponsor|17|||
156619338|NCT04566445|565347523|FG002|Overall Study|Study terminated by sponsor|32|||
156619339|NCT04566445|565347521|FG000|Overall Study|Withdrawal by Subject|12|||
156619340|NCT04566445|565347522|FG001|Overall Study|Withdrawal by Subject|14|||
156619341|NCT04566445|565347523|FG002|Overall Study|Withdrawal by Subject|13|||
156619342|NCT04566445|565347521|FG000|Overall Study|Randomized but not treated due to AE|2|||
156619343|NCT04566445|565347522|FG001|Overall Study|Randomized but not treated due to AE|1|||
156619344|NCT04566445|565347523|FG002|Overall Study|Randomized but not treated due to AE|0|||
156619345|NCT04566445|565347521|FG000|Overall Study|Adverse Event|1|||
156619346|NCT04566445|565347522|FG001|Overall Study|Adverse Event|1|||
156619347|NCT04566445|565347523|FG002|Overall Study|Adverse Event|0|||
156619348|NCT04785144|565347524|FG000|Overall Study|Withdrawal by Subject|4|||
156619349|NCT04785144|565347525|FG001|Overall Study|Withdrawal by Subject|1|||
156619350|NCT04785144|565347526|FG002|Overall Study|Withdrawal by Subject|0|||
156619351|NCT04785144|565347527|FG003|Overall Study|Withdrawal by Subject|0|||
156619352|NCT04785144|565347528|FG004|Overall Study|Withdrawal by Subject|0|||
156619353|NCT04785144|565347529|FG005|Overall Study|Withdrawal by Subject|2|||
156619354|NCT04785144|565347530|FG006|Overall Study|Withdrawal by Subject|2|||
156619355|NCT04785144|565347531|FG007|Overall Study|Withdrawal by Subject|0|||
156619356|NCT04785144|565347532|FG008|Overall Study|Withdrawal by Subject|1|||
156619357|NCT04785144|565347533|FG009|Overall Study|Withdrawal by Subject|0|||
156619358|NCT04785144|565347524|FG000|Overall Study|Lost to Follow-up|1|||
156619359|NCT04785144|565347525|FG001|Overall Study|Lost to Follow-up|0|||
156619360|NCT04785144|565347526|FG002|Overall Study|Lost to Follow-up|0|||
156619361|NCT04785144|565347527|FG003|Overall Study|Lost to Follow-up|0|||
156619362|NCT04785144|565347528|FG004|Overall Study|Lost to Follow-up|1|||
156619363|NCT04785144|565347529|FG005|Overall Study|Lost to Follow-up|2|||
156619364|NCT04785144|565347530|FG006|Overall Study|Lost to Follow-up|1|||
156619365|NCT04785144|565347531|FG007|Overall Study|Lost to Follow-up|2|||
156619366|NCT04785144|565347532|FG008|Overall Study|Lost to Follow-up|4|||
156619367|NCT04785144|565347533|FG009|Overall Study|Lost to Follow-up|1|||
156619368|NCT04785144|565347524|FG000|Overall Study|Protocol Violation|0|||
156619369|NCT04785144|565347525|FG001|Overall Study|Protocol Violation|0|||
156619370|NCT04785144|565347526|FG002|Overall Study|Protocol Violation|0|||
156619371|NCT04785144|565347527|FG003|Overall Study|Protocol Violation|0|||
156619372|NCT04785144|565347528|FG004|Overall Study|Protocol Violation|0|||
156619373|NCT04785144|565347529|FG005|Overall Study|Protocol Violation|0|||
156619374|NCT04785144|565347530|FG006|Overall Study|Protocol Violation|1|||
156619375|NCT04785144|565347531|FG007|Overall Study|Protocol Violation|0|||
156619376|NCT04785144|565347532|FG008|Overall Study|Protocol Violation|0|||
156619377|NCT04785144|565347533|FG009|Overall Study|Protocol Violation|0|||
156619378|NCT04785144|565347524|FG000|Overall Study|Physician Decision|0|||
156619379|NCT04785144|565347525|FG001|Overall Study|Physician Decision|0|||
156619380|NCT04785144|565347526|FG002|Overall Study|Physician Decision|0|||
156619381|NCT04785144|565347527|FG003|Overall Study|Physician Decision|0|||
156619382|NCT04785144|565347528|FG004|Overall Study|Physician Decision|0|||
156619383|NCT04785144|565347529|FG005|Overall Study|Physician Decision|0|||
156619384|NCT04785144|565347530|FG006|Overall Study|Physician Decision|0|||
156619385|NCT04785144|565347531|FG007|Overall Study|Physician Decision|0|||
156619386|NCT04785144|565347532|FG008|Overall Study|Physician Decision|0|||
156619387|NCT04785144|565347533|FG009|Overall Study|Physician Decision|1|||
156619388|NCT04785144|565347524|FG000|Overall Study|Unable to continue due to work schedule|0|||
156619389|NCT04785144|565347525|FG001|Overall Study|Unable to continue due to work schedule|0|||
156619390|NCT04785144|565347526|FG002|Overall Study|Unable to continue due to work schedule|0|||
156619391|NCT04785144|565347527|FG003|Overall Study|Unable to continue due to work schedule|0|||
156619392|NCT04785144|565347528|FG004|Overall Study|Unable to continue due to work schedule|0|||
156619393|NCT04785144|565347529|FG005|Overall Study|Unable to continue due to work schedule|0|||
156619394|NCT04785144|565347530|FG006|Overall Study|Unable to continue due to work schedule|0|||
156619395|NCT04785144|565347531|FG007|Overall Study|Unable to continue due to work schedule|0|||
156619396|NCT04785144|565347532|FG008|Overall Study|Unable to continue due to work schedule|0|||
156619397|NCT04785144|565347533|FG009|Overall Study|Unable to continue due to work schedule|1|||
156619398|NCT00712712|565347536|FG000|Overall Study|Protocol Violation|11|||
156619399|NCT00712712|565347536|FG000|Overall Study|Radiofrequency not done|3|||
156619400|NCT00712712|565347536|FG000|Overall Study|Death|8|||
156619401|NCT00712712|565347536|FG000|Overall Study|Withdrawal by Subject|1|||
156619402|NCT02061540|565347542|FG000|Overall Study|Adverse Event|2|||
156619403|NCT02061540|565347542|FG000|Overall Study|Withdrawal by Subject|2|||
156619404|NCT04005755|565347545|FG000|Overall Study|Adverse Event|6|||
156619405|NCT04005755|565347545|FG000|Overall Study|Physician Decision|3|||
156619406|NCT04005755|565347545|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
156619407|NCT04005755|565347545|FG000|Overall Study|Withdrawal by Subject|3|||
156619408|NCT04005755|565347545|FG000|Overall Study|Lost to Follow-up|1|||
156619409|NCT02289833|565347546|FG000|Overall Study|Study discontinuation|0|||
156619410|NCT02289833|565347547|FG001|Overall Study|Study discontinuation|1|||
156619411|NCT02289833|565347546|FG000|Overall Study|Lost to Follow-up|4|||
156619412|NCT02289833|565347547|FG001|Overall Study|Lost to Follow-up|0|||
156619413|NCT02289833|565347546|FG000|Overall Study|Death|23|||
156619414|NCT02289833|565347547|FG001|Overall Study|Death|16|||
156619415|NCT02723019|565347554|FG000|Overall Study|Death|17|||
156619416|NCT02723019|565347555|FG001|Overall Study|Death|13|||
156619417|NCT02723019|565347554|FG000|Overall Study|Withdrawal by Subject|11|||
156619418|NCT02723019|565347555|FG001|Overall Study|Withdrawal by Subject|7|||
156619419|NCT02723019|565347554|FG000|Overall Study|Lost to Follow-up|57|||
156619420|NCT02723019|565347555|FG001|Overall Study|Lost to Follow-up|70|||
156619421|NCT00611767|565347557|FG000|Overall Study|Withdrawal by Subject|4|||
156619422|NCT00611767|565347558|FG001|Overall Study|Withdrawal by Subject|1|||
156619423|NCT00611767|565347557|FG000|Overall Study|Thiopental not available|3|||
156619424|NCT00611767|565347558|FG001|Overall Study|Thiopental not available|0|||
156619425|NCT00611767|565347557|FG000|Overall Study|didn't like the medication|1|||
156619426|NCT00611767|565347558|FG001|Overall Study|didn't like the medication|1|||
156619427|NCT00611767|565347557|FG000|Overall Study|Physician Decision|1|||
156619428|NCT00611767|565347558|FG001|Overall Study|Physician Decision|0|||
156619429|NCT01947127|565347561|FG000|Overall Study|Protocol Violation|18|||
156619430|NCT01947127|565347562|FG001|Overall Study|Protocol Violation|38|||
156619431|NCT01947127|565347561|FG000|Overall Study|Withdrawal by Subject|1|||
156619432|NCT01947127|565347562|FG001|Overall Study|Withdrawal by Subject|1|||
156619433|NCT01947127|565347561|FG000|Overall Study|Data loss|4|||
156619434|NCT01947127|565347562|FG001|Overall Study|Data loss|4|||
156619435|NCT01756833|565347563|FG000|Overall Study|Withdrawal by Subject|4|||
156619436|NCT01756833|565347564|FG001|Overall Study|Withdrawal by Subject|3|||
156619437|NCT00808132|565347565|FG000|Overall Study|Adverse Event|34|||
156619438|NCT00808132|565347566|FG001|Overall Study|Adverse Event|33|||
156619439|NCT00808132|565347567|FG002|Overall Study|Adverse Event|16|||
156619440|NCT00808132|565347568|FG003|Overall Study|Adverse Event|31|||
156619441|NCT00808132|565347569|FG004|Overall Study|Adverse Event|33|||
156619442|NCT00808132|565347565|FG000|Overall Study|Death|0|||
156619443|NCT00808132|565347566|FG001|Overall Study|Death|0|||
156619444|NCT00808132|565347567|FG002|Overall Study|Death|0|||
156619445|NCT00808132|565347568|FG003|Overall Study|Death|0|||
156619446|NCT00808132|565347569|FG004|Overall Study|Death|1|||
156619447|NCT00808132|565347565|FG000|Overall Study|Physician Decision|0|||
156619448|NCT00808132|565347566|FG001|Overall Study|Physician Decision|1|||
156619449|NCT00808132|565347567|FG002|Overall Study|Physician Decision|0|||
156619450|NCT00808132|565347568|FG003|Overall Study|Physician Decision|0|||
156619451|NCT00808132|565347569|FG004|Overall Study|Physician Decision|0|||
156619452|NCT00808132|565347565|FG000|Overall Study|Lost to Follow-up|8|||
156619453|NCT00808132|565347566|FG001|Overall Study|Lost to Follow-up|10|||
156619454|NCT00808132|565347567|FG002|Overall Study|Lost to Follow-up|11|||
156619455|NCT00808132|565347568|FG003|Overall Study|Lost to Follow-up|8|||
156619456|NCT00808132|565347569|FG004|Overall Study|Lost to Follow-up|9|||
156619457|NCT00808132|565347565|FG000|Overall Study|Protocol Violation|8|||
156619458|NCT00808132|565347566|FG001|Overall Study|Protocol Violation|9|||
156619459|NCT00808132|565347567|FG002|Overall Study|Protocol Violation|4|||
156619460|NCT00808132|565347568|FG003|Overall Study|Protocol Violation|9|||
156619461|NCT00808132|565347569|FG004|Overall Study|Protocol Violation|5|||
156619462|NCT00808132|565347565|FG000|Overall Study|Withdrawal by Subject|27|||
156619463|NCT00808132|565347566|FG001|Overall Study|Withdrawal by Subject|18|||
156619464|NCT00808132|565347567|FG002|Overall Study|Withdrawal by Subject|2|||
156619465|NCT00808132|565347568|FG003|Overall Study|Withdrawal by Subject|7|||
156619466|NCT00808132|565347569|FG004|Overall Study|Withdrawal by Subject|16|||
156619467|NCT00808132|565347565|FG000|Overall Study|Other|6|||
156619468|NCT00808132|565347566|FG001|Overall Study|Other|4|||
156619469|NCT00808132|565347567|FG002|Overall Study|Other|6|||
156619470|NCT00808132|565347568|FG003|Overall Study|Other|2|||
156619471|NCT00808132|565347569|FG004|Overall Study|Other|15|||
156619472|NCT00808132|565347565|FG000|Overall Study|Randomized, but not treated|10|||
156619473|NCT00808132|565347566|FG001|Overall Study|Randomized, but not treated|7|||
156619474|NCT00808132|565347567|FG002|Overall Study|Randomized, but not treated|9|||
156619475|NCT00808132|565347568|FG003|Overall Study|Randomized, but not treated|8|||
156619476|NCT00808132|565347569|FG004|Overall Study|Randomized, but not treated|9|||
156619477|NCT00808132|565347565|FG000|Overall Study|Unsatisfactory response|5|||
156619478|NCT00808132|565347566|FG001|Overall Study|Unsatisfactory response|6|||
156619479|NCT00808132|565347567|FG002|Overall Study|Unsatisfactory response|6|||
156619480|NCT00808132|565347568|FG003|Overall Study|Unsatisfactory response|4|||
156619481|NCT00808132|565347569|FG004|Overall Study|Unsatisfactory response|12|||
156619482|NCT02795182|565347570|FG000|Overall Study|Death|5|||
156619483|NCT02795182|565347571|FG001|Overall Study|Death|4|||
156619484|NCT02795182|565347572|FG002|Overall Study|Death|4|||
156619485|NCT02795182|565347573|FG003|Overall Study|Death|18|||
156619486|NCT02795182|565347570|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
156619487|NCT02795182|565347571|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
156619488|NCT02795182|565347572|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
156619489|NCT02795182|565347573|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
156619490|NCT02795182|565347570|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
156619491|NCT02795182|565347571|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
156619492|NCT02795182|565347572|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
156619493|NCT02795182|565347573|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
156619494|NCT02795182|565347570|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
156619495|NCT02795182|565347571|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
156619496|NCT02795182|565347572|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
156619497|NCT02795182|565347573|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
156619498|NCT02795182|565347570|FG000|Overall Study|Withdrawal by Subject|4|||
156619499|NCT02795182|565347571|FG001|Overall Study|Withdrawal by Subject|0|||
156619500|NCT02795182|565347572|FG002|Overall Study|Withdrawal by Subject|0|||
156619501|NCT02795182|565347573|FG003|Overall Study|Withdrawal by Subject|3|||
156619502|NCT02795182|565347570|FG000|Overall Study|Lost to Follow-up|0|||
156619503|NCT02795182|565347571|FG001|Overall Study|Lost to Follow-up|0|||
156619504|NCT02795182|565347572|FG002|Overall Study|Lost to Follow-up|1|||
156619505|NCT02795182|565347573|FG003|Overall Study|Lost to Follow-up|1|||
156619506|NCT02795182|565347570|FG000|Overall Study|Roll Over to Long Term Extension|3|||
156619507|NCT02795182|565347571|FG001|Overall Study|Roll Over to Long Term Extension|3|||
156619508|NCT02795182|565347572|FG002|Overall Study|Roll Over to Long Term Extension|2|||
156619509|NCT02795182|565347573|FG003|Overall Study|Roll Over to Long Term Extension|5|||
156619510|NCT02795182|565347570|FG000|Overall Study|Progressive Disease|0|||
156619511|NCT02795182|565347571|FG001|Overall Study|Progressive Disease|1|||
156619512|NCT02795182|565347572|FG002|Overall Study|Progressive Disease|0|||
156619513|NCT02795182|565347573|FG003|Overall Study|Progressive Disease|4|||
156619514|NCT02795182|565347570|FG000|Overall Study|Physician Decision|0|||
156619515|NCT02795182|565347571|FG001|Overall Study|Physician Decision|0|||
156619516|NCT02795182|565347572|FG002|Overall Study|Physician Decision|0|||
156619517|NCT02795182|565347573|FG003|Overall Study|Physician Decision|1|||
156619518|NCT02187224|565347574|FG000|Overall Study|Did not show up for test day|1|||
156619519|NCT02187224|565347575|FG001|Overall Study|Did not show up for test day|0|||
156619520|NCT01347840|565347578|FG000|Overall Study|Withdrawal by Subject|1|||
156619521|NCT01010776|565347579|FG000|Main Phase|Withdrawal by Subject|14|||
156619522|NCT01010776|565347579|FG000|Main Phase|Lack of Efficacy|8|||
156619523|NCT01010776|565347579|FG000|Main Phase|Adverse Event|7|||
156619524|NCT01010776|565347579|FG000|Main Phase|Lost to Follow-up|6|||
156619525|NCT01010776|565347579|FG000|Main Phase|Non-compliance to study medication|5|||
156619526|NCT01010776|565347579|FG000|Main Phase|Selection failure|2|||
156619527|NCT01010776|565347579|FG000|Main Phase|Inform consent withdrawal|1|||
156619528|NCT01010776|565347579|FG000|Main Phase|Other|1|||
156619529|NCT01010776|565347579|FG000|Main Phase|Did not received study medication|5|||
156619530|NCT01010776|565347579|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
156619531|NCT01010776|565347579|FG000|Extension Phase|Other|3|||
156619532|NCT02573012|565347586|FG000|Overall Study|Adverse Event|5|||
156619533|NCT02573012|565347587|FG001|Overall Study|Adverse Event|5|||
156619534|NCT02573012|565347586|FG000|Overall Study|Lack of Efficacy|5|||
156619535|NCT02573012|565347587|FG001|Overall Study|Lack of Efficacy|4|||
156619536|NCT02573012|565347586|FG000|Overall Study|Non-compliance|1|||
156619537|NCT02573012|565347587|FG001|Overall Study|Non-compliance|2|||
156619538|NCT02573012|565347586|FG000|Overall Study|Withdrawal by Subject|2|||
156619539|NCT02573012|565347587|FG001|Overall Study|Withdrawal by Subject|2|||
156619540|NCT02573012|565347586|FG000|Overall Study|Study Ended per Protocol|1|||
156619541|NCT02573012|565347587|FG001|Overall Study|Study Ended per Protocol|0|||
156619542|NCT02573012|565347586|FG000|Overall Study|Physician Decision|1|||
156619543|NCT02573012|565347587|FG001|Overall Study|Physician Decision|2|||
156619544|NCT03231228|565347589|FG000|Overall Study|Lost to Follow-up|2|||
156619545|NCT03231228|565347590|FG001|Overall Study|Lost to Follow-up|0|||
156619546|NCT03231228|565347589|FG000|Overall Study|Physician Decision|1|||
156619547|NCT03231228|565347590|FG001|Overall Study|Physician Decision|0|||
156619548|NCT02382276|565347591|FG000|Overall Study|Withdrawal by Subject|4|||
156619549|NCT02382276|565347592|FG001|Overall Study|Withdrawal by Subject|8|||
156619550|NCT02382276|565347593|FG002|Overall Study|Withdrawal by Subject|5|||
156619551|NCT02382276|565347591|FG000|Overall Study|Adverse Event|7|||
156619552|NCT02382276|565347592|FG001|Overall Study|Adverse Event|2|||
156619553|NCT02382276|565347593|FG002|Overall Study|Adverse Event|32|||
156619554|NCT02382276|565347591|FG000|Overall Study|Physician Decision|0|||
156619555|NCT02382276|565347592|FG001|Overall Study|Physician Decision|0|||
156619556|NCT02382276|565347593|FG002|Overall Study|Physician Decision|2|||
156619557|NCT01222416|565347594|FG000|Overall Study|ineligible;metastasis|3|||
156619558|NCT01222416|565347595|FG001|Overall Study|ineligible;metastasis|0|||
156619559|NCT01222416|565347594|FG000|Overall Study|Adverse Event|4|||
156619560|NCT01222416|565347595|FG001|Overall Study|Adverse Event|0|||
156619561|NCT01222416|565347594|FG000|Overall Study|Withdrawal by Subject|5|||
156619562|NCT01222416|565347595|FG001|Overall Study|Withdrawal by Subject|0|||
156619563|NCT01222416|565347594|FG000|Overall Study|scheduling|6|||
156619564|NCT01222416|565347595|FG001|Overall Study|scheduling|0|||
156619565|NCT01222416|565347594|FG000|Overall Study|missed view/scan|1|||
156619566|NCT01222416|565347595|FG001|Overall Study|missed view/scan|0|||
156619567|NCT01222416|565347594|FG000|Overall Study|Death|1|||
156619568|NCT01222416|565347595|FG001|Overall Study|Death|0|||
156619569|NCT00281528|565347598|FG000|Overall Study|Progressive Disease|28|||
156619570|NCT00281528|565347599|FG001|Overall Study|Progressive Disease|18|||
156619571|NCT00281528|565347600|FG002|Overall Study|Progressive Disease|27|||
156619572|NCT00281528|565347598|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
156619573|NCT00281528|565347599|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
156619574|NCT00281528|565347600|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
156619575|NCT00281528|565347598|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
156619576|NCT00281528|565347599|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
156619577|NCT00281528|565347600|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
156619578|NCT00281528|565347598|FG000|Overall Study|Physician Decision|11|||
156619579|NCT00281528|565347599|FG001|Overall Study|Physician Decision|4|||
156619580|NCT00281528|565347600|FG002|Overall Study|Physician Decision|5|||
156619581|NCT00281528|565347598|FG000|Overall Study|Protocol Violation|1|||
156619582|NCT00281528|565347599|FG001|Overall Study|Protocol Violation|0|||
156619583|NCT00281528|565347600|FG002|Overall Study|Protocol Violation|1|||
156619584|NCT00281528|565347598|FG000|Overall Study|Withdrawal by Subject|5|||
156619585|NCT00281528|565347599|FG001|Overall Study|Withdrawal by Subject|5|||
156619586|NCT00281528|565347600|FG002|Overall Study|Withdrawal by Subject|7|||
156619587|NCT00281528|565347598|FG000|Overall Study|Other|6|||
156619588|NCT00281528|565347599|FG001|Overall Study|Other|3|||
156619589|NCT00281528|565347600|FG002|Overall Study|Other|5|||
156619590|NCT03049852|565347610|FG000|Overall Study|Lost to Follow-up|0|||
156619591|NCT03049852|565347611|FG001|Overall Study|Lost to Follow-up|1|||
156619592|NCT03049852|565347612|FG002|Overall Study|Lost to Follow-up|0|||
156619593|NCT02709889|565347613|FG000|Overall Study|Withdrawal by Subject|11|||
156619594|NCT02709889|565347614|FG001|Overall Study|Withdrawal by Subject|10|||
156619595|NCT02709889|565347615|FG002|Overall Study|Withdrawal by Subject|2|||
156619596|NCT02709889|565347616|FG003|Overall Study|Withdrawal by Subject|12|||
156619597|NCT02709889|565347613|FG000|Overall Study|Death|25|||
156619598|NCT02709889|565347614|FG001|Overall Study|Death|38|||
156619599|NCT02709889|565347615|FG002|Overall Study|Death|4|||
156619600|NCT02709889|565347616|FG003|Overall Study|Death|44|||
156619601|NCT02709889|565347613|FG000|Overall Study|Physician Decision|1|||
156619602|NCT02709889|565347614|FG001|Overall Study|Physician Decision|2|||
156619603|NCT02709889|565347615|FG002|Overall Study|Physician Decision|3|||
156619604|NCT02709889|565347616|FG003|Overall Study|Physician Decision|5|||
156619605|NCT02709889|565347613|FG000|Overall Study|Lost to Follow-up|2|||
156619606|NCT02709889|565347614|FG001|Overall Study|Lost to Follow-up|0|||
156619607|NCT02709889|565347615|FG002|Overall Study|Lost to Follow-up|0|||
156619608|NCT02709889|565347616|FG003|Overall Study|Lost to Follow-up|4|||
156619609|NCT02709889|565347613|FG000|Overall Study|Study Terminated by Sponsor|4|||
156619610|NCT02709889|565347614|FG001|Overall Study|Study Terminated by Sponsor|6|||
156619611|NCT02709889|565347615|FG002|Overall Study|Study Terminated by Sponsor|2|||
156619612|NCT02709889|565347616|FG003|Overall Study|Study Terminated by Sponsor|17|||
156619613|NCT02709889|565347613|FG000|Overall Study|Other, Not Specified|0|||
156619614|NCT02709889|565347614|FG001|Overall Study|Other, Not Specified|1|||
156619615|NCT02709889|565347615|FG002|Overall Study|Other, Not Specified|1|||
156619616|NCT02709889|565347616|FG003|Overall Study|Other, Not Specified|6|||
156619617|NCT00925522|565347621|FG000|Overall Study|study closed -- business decision|20|||
156619618|NCT02545049|565347626|FG000|Overall Study|Withdrawal by Subject|1|||
156619619|NCT02545049|565347627|FG001|Overall Study|Withdrawal by Subject|7|||
156619620|NCT02545049|565347626|FG000|Overall Study|Lost to Follow-up|4|||
156619621|NCT02545049|565347627|FG001|Overall Study|Lost to Follow-up|6|||
156619622|NCT02545049|565347626|FG000|Overall Study|GCP violations|37|||
156619623|NCT02545049|565347627|FG001|Overall Study|GCP violations|48|||
156619624|NCT05281094|565347629|FG000|Overall Study|Adverse Event|1|||
156619625|NCT05281094|565347630|FG001|Overall Study|Adverse Event|0|||
156619626|NCT05281094|565347629|FG000|Overall Study|Lost to Follow-up|29|||
156619627|NCT05281094|565347630|FG001|Overall Study|Lost to Follow-up|22|||
156619628|NCT05281094|565347629|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
156619629|NCT05281094|565347630|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
156619630|NCT05281094|565347629|FG000|Overall Study|Death|1|||
156619631|NCT05281094|565347630|FG001|Overall Study|Death|2|||
156619632|NCT05281094|565347629|FG000|Overall Study|Not pre-specified reason|8|||
156619633|NCT05281094|565347630|FG001|Overall Study|Not pre-specified reason|5|||
156619634|NCT04191096|565347631|FG000|Overall Study|Death|102|||
156619635|NCT04191096|565347632|FG001|Overall Study|Death|89|||
156619636|NCT04191096|565347631|FG000|Overall Study|Lost to Follow-up|1|||
156619637|NCT04191096|565347632|FG001|Overall Study|Lost to Follow-up|1|||
156619638|NCT04191096|565347631|FG000|Overall Study|Withdrawal by Subject|5|||
156619639|NCT04191096|565347632|FG001|Overall Study|Withdrawal by Subject|5|||
156619640|NCT04191096|565347631|FG000|Overall Study|Participants Ongoing|518|||
156619641|NCT04191096|565347632|FG001|Overall Study|Participants Ongoing|530|||
156619642|NCT04223778|565347633|FG000|Overall Study|Death|1|||
156619643|NCT04223778|565347634|FG001|Overall Study|Death|1|||
156619644|NCT04223778|565347633|FG000|Overall Study|Lost to Follow-up|4|||
156619645|NCT04223778|565347634|FG001|Overall Study|Lost to Follow-up|5|||
156619646|NCT04223778|565347633|FG000|Overall Study|Physician Decision|10|||
156619647|NCT04223778|565347634|FG001|Overall Study|Physician Decision|6|||
156619648|NCT04223778|565347633|FG000|Overall Study|Withdrawal by Subject|35|||
156619649|NCT04223778|565347634|FG001|Overall Study|Withdrawal by Subject|17|||
156619650|NCT04223778|565347633|FG000|Overall Study|Not Reported|7|||
156619651|NCT04223778|565347634|FG001|Overall Study|Not Reported|8|||
156619652|NCT00027027|565349421|FG000|Overall Study|Adverse Event|0|||
156619653|NCT00027027|565349422|FG001|Overall Study|Adverse Event|0|||
156619654|NCT00027027|565349423|FG002|Overall Study|Adverse Event|1|||
156619655|NCT00027027|565349424|FG003|Overall Study|Adverse Event|0|||
156619656|NCT00027027|565349425|FG004|Overall Study|Adverse Event|1|||
156619657|NCT00027027|565349421|FG000|Overall Study|Admitted for Signs of PD|0|||
156619658|NCT00027027|565349422|FG001|Overall Study|Admitted for Signs of PD|0|||
156619659|NCT00027027|565349423|FG002|Overall Study|Admitted for Signs of PD|0|||
156619660|NCT00027027|565349424|FG003|Overall Study|Admitted for Signs of PD|0|||
156619661|NCT00027027|565349425|FG004|Overall Study|Admitted for Signs of PD|1|||
156619662|NCT00027027|565349421|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
156619663|NCT00027027|565349422|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
156619664|NCT00027027|565349423|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
156619665|NCT00027027|565349424|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
156619666|NCT00027027|565349425|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
156619667|NCT00027027|565349421|FG000|Overall Study|PD Requiring Surgery|0|||
156619668|NCT00027027|565349422|FG001|Overall Study|PD Requiring Surgery|0|||
156619669|NCT00027027|565349423|FG002|Overall Study|PD Requiring Surgery|1|||
156619670|NCT00027027|565349424|FG003|Overall Study|PD Requiring Surgery|0|||
156619671|NCT00027027|565349425|FG004|Overall Study|PD Requiring Surgery|0|||
156619672|NCT00027027|565349421|FG000|Overall Study|Physician Decision Due To PD|2|||
156619673|NCT00027027|565349422|FG001|Overall Study|Physician Decision Due To PD|3|||
156619674|NCT00027027|565349423|FG002|Overall Study|Physician Decision Due To PD|2|||
156619675|NCT00027027|565349424|FG003|Overall Study|Physician Decision Due To PD|3|||
156619676|NCT00027027|565349425|FG004|Overall Study|Physician Decision Due To PD|5|||
156619677|NCT00027027|565349421|FG000|Overall Study|Withdrawal by Subject|0|||
156619678|NCT00027027|565349422|FG001|Overall Study|Withdrawal by Subject|0|||
156619679|NCT00027027|565349423|FG002|Overall Study|Withdrawal by Subject|0|||
156619680|NCT00027027|565349424|FG003|Overall Study|Withdrawal by Subject|0|||
156619681|NCT00027027|565349425|FG004|Overall Study|Withdrawal by Subject|1|||
156619682|NCT02442765|565349429|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
156619683|NCT02442765|565349430|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
156619684|NCT02442765|565349431|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
156619685|NCT02442765|565349432|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
156619686|NCT02442765|565349433|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
156619687|NCT02442765|565349434|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
156619688|NCT02442765|565349435|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
156619689|NCT02442765|565349436|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
156619690|NCT02442765|565349429|FG000|Stage 2- (Days 43 to 85)|Death|0|||
156619691|NCT02442765|565349430|FG001|Stage 2- (Days 43 to 85)|Death|0|||
156619692|NCT02442765|565349431|FG002|Stage 2- (Days 43 to 85)|Death|0|||
156619693|NCT02442765|565349432|FG003|Stage 2- (Days 43 to 85)|Death|1|||
156619694|NCT02442765|565349433|FG004|Stage 2- (Days 43 to 85)|Death|1|||
156619695|NCT02442765|565349434|FG005|Stage 2- (Days 43 to 85)|Death|0|||
156619696|NCT02442765|565349435|FG006|Stage 2- (Days 43 to 85)|Death|2|||
156619697|NCT02442765|565349436|FG007|Stage 2- (Days 43 to 85)|Death|0|||
156619698|NCT02442765|565349429|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
156619699|NCT02442765|565349430|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
156619700|NCT02442765|565349431|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
156619701|NCT02442765|565349432|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
156619702|NCT02442765|565349433|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
156619703|NCT02442765|565349434|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
156619704|NCT02442765|565349435|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
156619705|NCT02442765|565349436|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
156619706|NCT02442765|565349429|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
156619707|NCT02442765|565349430|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
156619708|NCT02442765|565349431|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
156619709|NCT02442765|565349432|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
156619710|NCT02442765|565349433|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
156619711|NCT02442765|565349434|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
156619712|NCT02442765|565349435|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
156619713|NCT02442765|565349436|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
156619714|NCT02442765|565349429|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
156619715|NCT02442765|565349430|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
156619716|NCT02442765|565349431|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
156619717|NCT02442765|565349432|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
156619718|NCT02442765|565349433|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
156619719|NCT02442765|565349434|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
156619720|NCT02442765|565349435|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
156619721|NCT02442765|565349436|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
156619722|NCT02442765|565349429|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
156619723|NCT02442765|565349430|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
156619724|NCT02442765|565349431|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
156619725|NCT02442765|565349432|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
156619726|NCT02442765|565349433|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
156619727|NCT02442765|565349434|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
156619728|NCT02442765|565349435|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
156619729|NCT02442765|565349436|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
156619730|NCT02442765|565349429|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
156619731|NCT02442765|565349430|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
156619732|NCT02442765|565349431|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
156619733|NCT02442765|565349432|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
156619734|NCT02442765|565349433|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
156619735|NCT02442765|565349434|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
156619736|NCT02442765|565349435|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
156619737|NCT02442765|565349436|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
156619738|NCT02442765|565349429|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
156619739|NCT02442765|565349430|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
156619740|NCT02442765|565349431|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
156619741|NCT02442765|565349432|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
156619742|NCT02442765|565349433|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
156619743|NCT02442765|565349434|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
156619744|NCT02442765|565349435|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
156619745|NCT02442765|565349436|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
156619746|NCT00003389|565349437|FG000|Overall Study|Disease progression|6|||
156619747|NCT00003389|565349438|FG001|Overall Study|Disease progression|1|||
156619748|NCT00003389|565349437|FG000|Overall Study|Adverse Event|13|||
156619749|NCT00003389|565349438|FG001|Overall Study|Adverse Event|2|||
156619750|NCT00003389|565349437|FG000|Overall Study|Death|0|||
156619751|NCT00003389|565349438|FG001|Overall Study|Death|3|||
156619752|NCT00003389|565349437|FG000|Overall Study|Withdrawal by Subject|12|||
156619753|NCT00003389|565349438|FG001|Overall Study|Withdrawal by Subject|5|||
156619754|NCT00003389|565349437|FG000|Overall Study|Alternative therapy|2|||
156619755|NCT00003389|565349438|FG001|Overall Study|Alternative therapy|1|||
156619756|NCT00003389|565349437|FG000|Overall Study|Complicating disease|1|||
156619757|NCT00003389|565349438|FG001|Overall Study|Complicating disease|0|||
156619758|NCT00003389|565349437|FG000|Overall Study|Off-treatment reason missing|31|||
156619759|NCT00003389|565349438|FG001|Overall Study|Off-treatment reason missing|21|||
156619760|NCT00003389|565349437|FG000|Overall Study|Ineligible|33|||
156619761|NCT00003389|565349438|FG001|Overall Study|Ineligible|27|||
156619762|NCT05466240|565349440|FG000|Overall Study|Adverse Event|1|||
156619763|NCT05466240|565349441|FG001|Overall Study|Adverse Event|0|||
156619764|NCT05466240|565349440|FG000|Overall Study|Withdrawal by Subject|1|||
156619765|NCT05466240|565349441|FG001|Overall Study|Withdrawal by Subject|0|||
156619766|NCT03347279|565349442|FG000|Overall Study|Withdrawal by Subject|8|||
156619767|NCT03347279|565349443|FG001|Overall Study|Withdrawal by Subject|15|||
156619768|NCT03347279|565349442|FG000|Overall Study|Death|0|||
156619769|NCT03347279|565349443|FG001|Overall Study|Death|2|||
156619770|NCT03347279|565349442|FG000|Overall Study|Lost to Follow-up|5|||
156619771|NCT03347279|565349443|FG001|Overall Study|Lost to Follow-up|2|||
156619772|NCT03347279|565349442|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
156619773|NCT03347279|565349443|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
156619774|NCT03818399|565349444|FG000|Overall Study|Lost to Follow-up|11|||
156619775|NCT03818399|565349444|FG000|Overall Study|Withdrawal by Subject|1|||
156619776|NCT03818399|565349444|FG000|Overall Study|Protocol Violation|2|||
156619777|NCT00718887|565349445|FG000|Overall Study|Withdrawal by Subject|3|||
156619778|NCT00718887|565349446|FG001|Overall Study|Withdrawal by Subject|2|||
156619779|NCT00718887|565349445|FG000|Overall Study|Not identified|2|||
156619780|NCT00718887|565349446|FG001|Overall Study|Not identified|7|||
156619781|NCT00775138|565349449|FG000|Overall Study|Withdrawal by Subject|0|||
156619782|NCT00775138|565349450|FG001|Overall Study|Withdrawal by Subject|0|||
156619783|NCT00775138|565349451|FG002|Overall Study|Withdrawal by Subject|2|||
156619784|NCT00775138|565349452|FG003|Overall Study|Withdrawal by Subject|2|||
156619785|NCT00775138|565349449|FG000|Overall Study|Adverse Event|0|||
156619786|NCT00775138|565349450|FG001|Overall Study|Adverse Event|0|||
156619787|NCT00775138|565349451|FG002|Overall Study|Adverse Event|1|||
156619788|NCT00775138|565349452|FG003|Overall Study|Adverse Event|0|||
156619789|NCT03557801|565349453|FG000|Overall Study|Protocol Violation|1|||
156619790|NCT03557801|565349454|FG001|Overall Study|Protocol Violation|0|||
156619791|NCT03557801|565349455|FG002|Overall Study|Protocol Violation|0|||
156619792|NCT03557801|565349453|FG000|Overall Study|Withdrawal by Subject|1|||
156619793|NCT03557801|565349454|FG001|Overall Study|Withdrawal by Subject|0|||
156619794|NCT03557801|565349455|FG002|Overall Study|Withdrawal by Subject|3|||
156619795|NCT03557801|565349453|FG000|Overall Study|Lost to Follow-up|0|||
156619796|NCT03557801|565349454|FG001|Overall Study|Lost to Follow-up|1|||
156619797|NCT03557801|565349455|FG002|Overall Study|Lost to Follow-up|0|||
156619798|NCT00535236|565349456|FG000|Overall Study|Adverse Event|1|||
156619799|NCT00535236|565349457|FG001|Overall Study|Adverse Event|0|||
156619800|NCT00535236|565349458|FG002|Overall Study|Adverse Event|9|||
156619801|NCT00535236|565349459|FG003|Overall Study|Adverse Event|3|||
156619802|NCT00535236|565349460|FG004|Overall Study|Adverse Event|3|||
156619803|NCT00535236|565349461|FG005|Overall Study|Adverse Event|0|||
156619804|NCT00535236|565349462|FG006|Overall Study|Adverse Event|5|||
156619805|NCT00535236|565349463|FG007|Overall Study|Adverse Event|1|||
156619806|NCT00535236|565349464|FG008|Overall Study|Adverse Event|2|||
156619807|NCT00535236|565349465|FG009|Overall Study|Adverse Event|1|||
156619808|NCT00535236|565349456|FG000|Overall Study|Lost to Follow-up|1|||
156619809|NCT00535236|565349457|FG001|Overall Study|Lost to Follow-up|2|||
156619810|NCT00535236|565349458|FG002|Overall Study|Lost to Follow-up|0|||
156619811|NCT00535236|565349459|FG003|Overall Study|Lost to Follow-up|0|||
156619812|NCT00535236|565349460|FG004|Overall Study|Lost to Follow-up|2|||
156619813|NCT00535236|565349461|FG005|Overall Study|Lost to Follow-up|0|||
156619814|NCT00535236|565349462|FG006|Overall Study|Lost to Follow-up|0|||
156619815|NCT00535236|565349463|FG007|Overall Study|Lost to Follow-up|0|||
156619816|NCT00535236|565349464|FG008|Overall Study|Lost to Follow-up|6|||
156619817|NCT00535236|565349465|FG009|Overall Study|Lost to Follow-up|1|||
156619818|NCT00535236|565349456|FG000|Overall Study|Physician Decision|0|||
156619819|NCT00535236|565349457|FG001|Overall Study|Physician Decision|0|||
156619820|NCT00535236|565349458|FG002|Overall Study|Physician Decision|0|||
156619821|NCT00535236|565349459|FG003|Overall Study|Physician Decision|0|||
156619822|NCT00535236|565349460|FG004|Overall Study|Physician Decision|1|||
156619823|NCT00535236|565349461|FG005|Overall Study|Physician Decision|0|||
156619824|NCT00535236|565349462|FG006|Overall Study|Physician Decision|1|||
156619825|NCT00535236|565349463|FG007|Overall Study|Physician Decision|0|||
156619826|NCT00535236|565349464|FG008|Overall Study|Physician Decision|0|||
156619827|NCT00535236|565349465|FG009|Overall Study|Physician Decision|0|||
156619828|NCT00535236|565349456|FG000|Overall Study|Protocol Violation|2|||
156619829|NCT00535236|565349457|FG001|Overall Study|Protocol Violation|0|||
156619830|NCT00535236|565349458|FG002|Overall Study|Protocol Violation|1|||
156619831|NCT00535236|565349459|FG003|Overall Study|Protocol Violation|0|||
156619832|NCT00535236|565349460|FG004|Overall Study|Protocol Violation|0|||
156619833|NCT00535236|565349461|FG005|Overall Study|Protocol Violation|0|||
156619834|NCT00535236|565349462|FG006|Overall Study|Protocol Violation|0|||
156619835|NCT00535236|565349463|FG007|Overall Study|Protocol Violation|0|||
156619836|NCT00535236|565349464|FG008|Overall Study|Protocol Violation|1|||
156619837|NCT00535236|565349465|FG009|Overall Study|Protocol Violation|0|||
156619838|NCT00535236|565349456|FG000|Overall Study|Withdrawal by Subject|3|||
156619839|NCT00535236|565349457|FG001|Overall Study|Withdrawal by Subject|0|||
156619840|NCT00535236|565349458|FG002|Overall Study|Withdrawal by Subject|2|||
156619841|NCT00535236|565349459|FG003|Overall Study|Withdrawal by Subject|1|||
156619842|NCT00535236|565349460|FG004|Overall Study|Withdrawal by Subject|6|||
156619843|NCT00535236|565349461|FG005|Overall Study|Withdrawal by Subject|1|||
156619844|NCT00535236|565349462|FG006|Overall Study|Withdrawal by Subject|5|||
156619845|NCT00535236|565349463|FG007|Overall Study|Withdrawal by Subject|0|||
156619846|NCT00535236|565349464|FG008|Overall Study|Withdrawal by Subject|4|||
156619847|NCT00535236|565349465|FG009|Overall Study|Withdrawal by Subject|2|||
156619848|NCT00141297|565349467|FG000|Overall Study|Adverse Event|0|||
156619849|NCT00141297|565349468|FG001|Overall Study|Adverse Event|0|||
156619850|NCT00141297|565349469|FG002|Overall Study|Adverse Event|1|||
156619851|NCT00141297|565349470|FG003|Overall Study|Adverse Event|0|||
156619852|NCT00141297|565349471|FG004|Overall Study|Adverse Event|1|||
156619853|NCT00141297|565349472|FG005|Overall Study|Adverse Event|1|||
156619854|NCT00141297|565349473|FG006|Overall Study|Adverse Event|0|||
156619855|NCT00141297|565349474|FG007|Overall Study|Adverse Event|1|||
156619856|NCT00141297|565349475|FG008|Overall Study|Adverse Event|1|||
156619857|NCT00141297|565349476|FG009|Overall Study|Adverse Event|0|||
156619858|NCT00141297|565349467|FG000|Overall Study|Death|1|||
156619859|NCT00141297|565349468|FG001|Overall Study|Death|0|||
156619860|NCT00141297|565349469|FG002|Overall Study|Death|0|||
156619861|NCT00141297|565349470|FG003|Overall Study|Death|0|||
156619862|NCT00141297|565349471|FG004|Overall Study|Death|0|||
156619863|NCT00141297|565349472|FG005|Overall Study|Death|0|||
156619864|NCT00141297|565349473|FG006|Overall Study|Death|0|||
156619865|NCT00141297|565349474|FG007|Overall Study|Death|0|||
156619866|NCT00141297|565349475|FG008|Overall Study|Death|1|||
156619867|NCT00141297|565349476|FG009|Overall Study|Death|0|||
156619868|NCT00141297|565349467|FG000|Overall Study|Withdrawal by Subject|0|||
156619869|NCT00141297|565349468|FG001|Overall Study|Withdrawal by Subject|0|||
156619870|NCT00141297|565349469|FG002|Overall Study|Withdrawal by Subject|0|||
156619871|NCT00141297|565349470|FG003|Overall Study|Withdrawal by Subject|0|||
156619872|NCT00141297|565349471|FG004|Overall Study|Withdrawal by Subject|0|||
156619873|NCT00141297|565349472|FG005|Overall Study|Withdrawal by Subject|0|||
156619874|NCT00141297|565349473|FG006|Overall Study|Withdrawal by Subject|0|||
156619875|NCT00141297|565349474|FG007|Overall Study|Withdrawal by Subject|0|||
156619876|NCT00141297|565349475|FG008|Overall Study|Withdrawal by Subject|1|||
156619877|NCT00141297|565349476|FG009|Overall Study|Withdrawal by Subject|0|||
156619878|NCT00141297|565349467|FG000|Overall Study|Other|0|||
156619879|NCT00141297|565349468|FG001|Overall Study|Other|0|||
156619880|NCT00141297|565349469|FG002|Overall Study|Other|0|||
156619881|NCT00141297|565349470|FG003|Overall Study|Other|1|||
156619882|NCT00141297|565349471|FG004|Overall Study|Other|5|||
156619883|NCT00141297|565349472|FG005|Overall Study|Other|0|||
156619884|NCT00141297|565349473|FG006|Overall Study|Other|0|||
156619885|NCT00141297|565349474|FG007|Overall Study|Other|0|||
156619886|NCT00141297|565349475|FG008|Overall Study|Other|2|||
156619887|NCT00141297|565349476|FG009|Overall Study|Other|0|||
156619888|NCT00141297|565349467|FG000|Overall Study|Progressive Disease|2|||
156619889|NCT00141297|565349468|FG001|Overall Study|Progressive Disease|3|||
156619890|NCT00141297|565349469|FG002|Overall Study|Progressive Disease|6|||
156619891|NCT00141297|565349470|FG003|Overall Study|Progressive Disease|2|||
156619892|NCT00141297|565349471|FG004|Overall Study|Progressive Disease|15|||
156619893|NCT00141297|565349472|FG005|Overall Study|Progressive Disease|2|||
156619894|NCT00141297|565349473|FG006|Overall Study|Progressive Disease|3|||
156619895|NCT00141297|565349474|FG007|Overall Study|Progressive Disease|3|||
156619896|NCT00141297|565349475|FG008|Overall Study|Progressive Disease|15|||
156619897|NCT00141297|565349476|FG009|Overall Study|Progressive Disease|6|||
156619898|NCT00141297|565349467|FG000|Overall Study|Transitioned|0|||
156619899|NCT00141297|565349468|FG001|Overall Study|Transitioned|0|||
156619900|NCT00141297|565349469|FG002|Overall Study|Transitioned|0|||
156619901|NCT00141297|565349470|FG003|Overall Study|Transitioned|0|||
156619902|NCT00141297|565349471|FG004|Overall Study|Transitioned|1|||
156619903|NCT00141297|565349472|FG005|Overall Study|Transitioned|0|||
156619904|NCT00141297|565349473|FG006|Overall Study|Transitioned|0|||
156619905|NCT00141297|565349474|FG007|Overall Study|Transitioned|0|||
156619906|NCT00141297|565349475|FG008|Overall Study|Transitioned|0|||
156619907|NCT00141297|565349476|FG009|Overall Study|Transitioned|0|||
156619908|NCT02987205|565349477|FG000|Overall Study|Adverse Event|1|||
156619909|NCT02987205|565349477|FG000|Overall Study|Withdrawal by Subject|3|||
156619910|NCT03558503|565349478|FG000|Overall Study|Adverse Event|1|||
156619911|NCT03558503|565349478|FG000|Overall Study|Death|1|||
156619912|NCT03558503|565349478|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
156619913|NCT00958191|565349481|FG000|Overall Study|Death|4|||
156619914|NCT00958191|565349481|FG000|Overall Study|Lost to Follow-up|5|||
156619915|NCT00958191|565349481|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
156619916|NCT00958191|565349481|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
156619917|NCT00958191|565349481|FG000|Overall Study|Revision of study device|4|||
156619918|NCT00958191|565349481|FG000|Overall Study|Site termination|11|||
156619919|NCT00958191|565349481|FG000|Overall Study|No 5 yr x-rays|56|||
156619920|NCT01642004|565349482|FG000|Randomization|Adverse Event unrelated to study drug|1|||
156619921|NCT01642004|565349483|FG001|Randomization|Adverse Event unrelated to study drug|0|||
156619922|NCT01642004|565349482|FG000|Randomization|Participant withdrew consent|1|||
156619923|NCT01642004|565349483|FG001|Randomization|Participant withdrew consent|6|||
156619924|NCT01642004|565349482|FG000|Randomization|No longer meets study criteria|2|||
156619925|NCT01642004|565349483|FG001|Randomization|No longer meets study criteria|2|||
156619926|NCT01642004|565349482|FG000|Treatment|Disease progression|95|||
156619927|NCT01642004|565349483|FG001|Treatment|Disease progression|79|||
156619928|NCT01642004|565349482|FG000|Treatment|Study drug toxicity|10|||
156619929|NCT01642004|565349483|FG001|Treatment|Study drug toxicity|13|||
156619930|NCT01642004|565349482|FG000|Treatment|Death|1|||
156619931|NCT01642004|565349483|FG001|Treatment|Death|1|||
156619932|NCT01642004|565349482|FG000|Treatment|Adverse event unrelated to study drug|9|||
156619933|NCT01642004|565349483|FG001|Treatment|Adverse event unrelated to study drug|13|||
156619934|NCT01642004|565349482|FG000|Treatment|Maximum clinical benefit|1|||
156619935|NCT01642004|565349483|FG001|Treatment|Maximum clinical benefit|9|||
156619936|NCT01642004|565349482|FG000|Treatment|Poor/non-compliance|1|||
156619937|NCT01642004|565349483|FG001|Treatment|Poor/non-compliance|0|||
156619938|NCT01642004|565349482|FG000|Treatment|No longer meets study criteria|1|||
156619939|NCT01642004|565349483|FG001|Treatment|No longer meets study criteria|2|||
156619940|NCT01642004|565349482|FG000|Treatment|Other reasons|2|||
156619941|NCT01642004|565349483|FG001|Treatment|Other reasons|0|||
156619942|NCT01642004|565349482|FG000|Treatment|Not reported|0|||
156619943|NCT01642004|565349483|FG001|Treatment|Not reported|3|||
156619944|NCT01642004|565349482|FG000|Treatment|Participant request to discontinue study treatment|6|||
156619945|NCT01642004|565349483|FG001|Treatment|Participant request to discontinue study treatment|4|||
156619946|NCT01642004|565349482|FG000|Treatment|Participant withdrew consent|5|||
156619947|NCT01642004|565349483|FG001|Treatment|Participant withdrew consent|5|||
156619948|NCT02718625|565349484|FG000|Overall Study|Adverse Event|0|||
156619949|NCT02718625|565349485|FG001|Overall Study|Adverse Event|1|||
156619950|NCT02718625|565349484|FG000|Overall Study|Termination of Study by Sponsor|0|||
156619951|NCT02718625|565349485|FG001|Overall Study|Termination of Study by Sponsor|1|||
156619952|NCT01818765|565349486|FG000|Overall Study|Death|2|||
156619953|NCT01562327|565349487|FG000|Overall Study|Adverse Event|2|||
156619954|NCT01562327|565349487|FG000|Overall Study|Lack of Efficacy|1|||
156619955|NCT01562327|565349487|FG000|Overall Study|Participant drop-out|1|||
156619956|NCT01562327|565349487|FG000|Overall Study|Infusion not received at 6 month window|4|||
156619957|NCT00170846|565349488|FG000|Overall Study|Subject withdrew Informed Consent|5|||
156619958|NCT00170846|565349489|FG001|Overall Study|Subject withdrew Informed Consent|12|||
156619959|NCT00170846|565349490|FG002|Overall Study|Subject withdrew Informed Consent|8|||
156619960|NCT00170846|565349488|FG000|Overall Study|Lost to Follow-up|6|||
156619961|NCT00170846|565349489|FG001|Overall Study|Lost to Follow-up|3|||
156619962|NCT00170846|565349490|FG002|Overall Study|Lost to Follow-up|2|||
156619963|NCT00170846|565349488|FG000|Overall Study|Death|0|||
156619964|NCT00170846|565349489|FG001|Overall Study|Death|3|||
156619965|NCT00170846|565349490|FG002|Overall Study|Death|3|||
156619966|NCT00170846|565349488|FG000|Overall Study|Reason Missing|0|||
156619967|NCT00170846|565349489|FG001|Overall Study|Reason Missing|1|||
156619968|NCT00170846|565349490|FG002|Overall Study|Reason Missing|0|||
156619969|NCT00887913|565349495|FG000|Overall Study|Withdrawal by Subject|6|||
156619970|NCT00415623|565349502|FG000|Overall Study|Adverse Event|3|||
156619971|NCT00415623|565349503|FG001|Overall Study|Adverse Event|4|||
156619972|NCT00415623|565349502|FG000|Overall Study|Death|1|||
156619973|NCT00415623|565349503|FG001|Overall Study|Death|0|||
156619974|NCT00415623|565349502|FG000|Overall Study|Withdrawal by Subject|1|||
156619975|NCT00415623|565349503|FG001|Overall Study|Withdrawal by Subject|1|||
156619976|NCT01708915|565349505|FG000|Overall Study|Adverse Event|1|||
156619977|NCT01708915|565349506|FG001|Overall Study|Adverse Event|0|||
156619978|NCT01708915|565349507|FG002|Overall Study|Adverse Event|9|||
156619979|NCT01708915|565349508|FG003|Overall Study|Adverse Event|13|||
156619980|NCT01708915|565349505|FG000|Overall Study|Lack of Efficacy|84|||
156619981|NCT01708915|565349506|FG001|Overall Study|Lack of Efficacy|60|||
156619982|NCT01708915|565349507|FG002|Overall Study|Lack of Efficacy|35|||
156619983|NCT01708915|565349508|FG003|Overall Study|Lack of Efficacy|15|||
156619984|NCT01708915|565349505|FG000|Overall Study|Protocol Violation|0|||
156619985|NCT01708915|565349506|FG001|Overall Study|Protocol Violation|0|||
156619986|NCT01708915|565349507|FG002|Overall Study|Protocol Violation|0|||
156619987|NCT01708915|565349508|FG003|Overall Study|Protocol Violation|1|||
156619988|NCT01708915|565349505|FG000|Overall Study|Withdrawal by Subject|0|||
156619989|NCT01708915|565349506|FG001|Overall Study|Withdrawal by Subject|1|||
156619990|NCT01708915|565349507|FG002|Overall Study|Withdrawal by Subject|2|||
156619991|NCT01708915|565349508|FG003|Overall Study|Withdrawal by Subject|2|||
156619992|NCT01708915|565349505|FG000|Overall Study|Other reasons than stated above|1|||
156619993|NCT01708915|565349506|FG001|Overall Study|Other reasons than stated above|1|||
156619994|NCT01708915|565349507|FG002|Overall Study|Other reasons than stated above|0|||
156619995|NCT01708915|565349508|FG003|Overall Study|Other reasons than stated above|2|||
156619996|NCT03267576|565349509|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
156619997|NCT03267576|565349510|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
156619998|NCT03267576|565349509|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
156619999|NCT03267576|565349510|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
156620000|NCT01369069|565349511|FG000|Overall Study|Lost to Follow-up|8|||
156620001|NCT01369069|565349512|FG001|Overall Study|Lost to Follow-up|9|||
156620002|NCT01369069|565349511|FG000|Overall Study|Withdrawal by Subject|9|||
156620003|NCT01369069|565349512|FG001|Overall Study|Withdrawal by Subject|7|||
156620004|NCT00882362|565349513|FG000|Overall Study|Adverse Event|13|||
156620005|NCT00882362|565349514|FG001|Overall Study|Adverse Event|10|||
156620006|NCT00882362|565349513|FG000|Overall Study|Withdrawal by Subject|13|||
156620007|NCT00882362|565349514|FG001|Overall Study|Withdrawal by Subject|10|||
156620008|NCT00882362|565349513|FG000|Overall Study|Lack of Efficacy|3|||
156620009|NCT00882362|565349514|FG001|Overall Study|Lack of Efficacy|0|||
156620010|NCT00882362|565349513|FG000|Overall Study|Protocol Violation|7|||
156620011|NCT00882362|565349514|FG001|Overall Study|Protocol Violation|2|||
156620012|NCT00882362|565349513|FG000|Overall Study|Pregnancy|1|||
156620013|NCT00882362|565349514|FG001|Overall Study|Pregnancy|0|||
156620014|NCT00882362|565349513|FG000|Overall Study|Physician Decision|5|||
156620015|NCT00882362|565349514|FG001|Overall Study|Physician Decision|1|||
156620016|NCT00882362|565349513|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
156620017|NCT00882362|565349514|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
156620018|NCT00882362|565349513|FG000|Overall Study|change of residence or other commitments|5|||
156620019|NCT00882362|565349514|FG001|Overall Study|change of residence or other commitments|0|||
156620020|NCT01268514|565349515|FG000|Overall Study|Adverse Event|20|||
156620021|NCT01268514|565349515|FG000|Overall Study|Death|8|||
156620022|NCT01268514|565349515|FG000|Overall Study|Lost to Follow-up|5|||
156620023|NCT01268514|565349515|FG000|Overall Study|Withdrawal by Subject|3|||
156620024|NCT01268514|565349515|FG000|Overall Study|Withdrawal by Surgeon|5|||
156620025|NCT01846208|565349516|FG000|Overall Study|Withdrew prior to treatment|1|||
156620026|NCT01846208|565349517|FG001|Overall Study|Withdrew prior to treatment|1|||
156620027|NCT01846208|565349518|FG002|Overall Study|Withdrew prior to treatment|1|||
156620028|NCT01846208|565349516|FG000|Overall Study|Dosing Symptoms|1|||
156620029|NCT01846208|565349517|FG001|Overall Study|Dosing Symptoms|2|||
156620030|NCT01846208|565349518|FG002|Overall Study|Dosing Symptoms|6|||
156620031|NCT01846208|565349516|FG000|Overall Study|Withdrawal by Subject|5|||
156620032|NCT01846208|565349517|FG001|Overall Study|Withdrawal by Subject|0|||
156620033|NCT01846208|565349518|FG002|Overall Study|Withdrawal by Subject|0|||
156620034|NCT01846208|565349516|FG000|Overall Study|Non-compliance|1|||
156620035|NCT01846208|565349517|FG001|Overall Study|Non-compliance|1|||
156620036|NCT01846208|565349518|FG002|Overall Study|Non-compliance|0|||
156620037|NCT01846208|565349516|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
156620038|NCT01846208|565349517|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
156620039|NCT01846208|565349518|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
156620040|NCT01846208|565349516|FG000|Overall Study|Refused SU OFC|0|||
156620041|NCT01846208|565349517|FG001|Overall Study|Refused SU OFC|0|||
156620042|NCT01846208|565349518|FG002|Overall Study|Refused SU OFC|1|||
156620043|NCT01424306|565349519|FG000|Overall Study|Protocol Violation|0|||
156620044|NCT01424306|565349520|FG001|Overall Study|Protocol Violation|0|||
156620045|NCT01424306|565349521|FG002|Overall Study|Protocol Violation|0|||
156620046|NCT01424306|565349522|FG003|Overall Study|Protocol Violation|0|||
156620047|NCT01424306|565349523|FG004|Overall Study|Protocol Violation|1|||
156620048|NCT01424306|565349524|FG005|Overall Study|Protocol Violation|0|||
156620049|NCT01432938|565349525|FG000|First Intervention|Protocol Violation|1|||
156620050|NCT01432938|565349526|FG001|First Intervention|Protocol Violation|0|||
156620051|NCT01432938|565349525|FG000|First Intervention|Physician Decision|1|||
156620052|NCT01432938|565349526|FG001|First Intervention|Physician Decision|0|||
156620053|NCT01432938|565349525|FG000|Second Intervention|Adverse Event|1|||
156620054|NCT01432938|565349526|FG001|Second Intervention|Adverse Event|0|||
156620055|NCT01875874|565349532|FG000|Overall Study|Death|3|||
156620056|NCT01601873|565349533|FG000|Overall Study|Lost to Follow-up|2|||
156620057|NCT01601873|565349534|FG001|Overall Study|Lost to Follow-up|3|||
156620058|NCT02096471|565349537|FG000|Overall Study|Adverse Event|1|||
156620059|NCT02096471|565349537|FG000|Overall Study|Lack of Efficacy|7|||
156620060|NCT02096471|565349537|FG000|Overall Study|Withdrawal by Subject|3|||
156620061|NCT02096471|565349537|FG000|Overall Study|Non-Compliant|2|||
156620062|NCT00374127|565349538|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
156620063|NCT00374127|565349538|FG000|Overall Study|Blood could not be drawn.|2|||
156620064|NCT00374127|565349538|FG000|Overall Study|Protocol Violation|5|||
156620065|NCT00374127|565349538|FG000|Overall Study|Pregnancy|1|||
156620066|NCT03344562|565349539|FG000|Overall Study|Withdrawal by Subject|2|||
156620067|NCT03344562|565349540|FG001|Overall Study|Withdrawal by Subject|0|||
156620068|NCT02736474|565349547|FG000|Overall Study|Lost to Follow-up|0|||
156620069|NCT02736474|565349548|FG001|Overall Study|Lost to Follow-up|1|||
156620070|NCT02463331|565349549|FG000|Overall Study|Adverse Event|4|||
156620071|NCT02463331|565349550|FG001|Overall Study|Adverse Event|2|||
156620072|NCT02463331|565349549|FG000|Overall Study|Lost to Follow-up|1|||
156620073|NCT02463331|565349550|FG001|Overall Study|Lost to Follow-up|1|||
156620074|NCT02463331|565349549|FG000|Overall Study|Pregnancy|2|||
156620075|NCT02463331|565349550|FG001|Overall Study|Pregnancy|3|||
156620076|NCT02463331|565349549|FG000|Overall Study|Lack of Efficacy|6|||
156620077|NCT02463331|565349550|FG001|Overall Study|Lack of Efficacy|0|||
156620078|NCT02463331|565349549|FG000|Overall Study|Physician Decision|3|||
156620079|NCT02463331|565349550|FG001|Overall Study|Physician Decision|0|||
156620080|NCT00703781|565349553|FG000|Overall Study|Withdrawal by Subject|1|||
156620081|NCT00703781|565349554|FG001|Overall Study|Withdrawal by Subject|2|||
156620082|NCT00703781|565349553|FG000|Overall Study|Cancelled surgery|1|||
156620083|NCT00703781|565349554|FG001|Overall Study|Cancelled surgery|0|||
156620084|NCT01987609|565349561|FG000|Overall Study|Adverse Event|1|||
156620085|NCT00125268|565349562|FG000|Overall Study|Withdrawal by Subject|1|||
156620086|NCT00125268|565349563|FG001|Overall Study|Withdrawal by Subject|1|||
156620087|NCT02561572|565349564|FG000|Overall Study|Inadequate time before surgery|2|||
156620088|NCT02561572|565349565|FG001|Overall Study|Inadequate time before surgery|1|||
156620089|NCT02561572|565349564|FG000|Overall Study|Protocol Violation|0|||
156620090|NCT02561572|565349565|FG001|Overall Study|Protocol Violation|1|||
156620091|NCT02691468|565349566|FG000|Overall Study|Bronchial blocker use|2|||
156620092|NCT02691468|565349567|FG001|Overall Study|Bronchial blocker use|1|||
156620093|NCT02691468|565349566|FG000|Overall Study|Lost to Follow-up|2|||
156620094|NCT02691468|565349567|FG001|Overall Study|Lost to Follow-up|1|||
156620095|NCT02691468|565349566|FG000|Overall Study|Failure to advance FOB|2|||
156620096|NCT02691468|565349567|FG001|Overall Study|Failure to advance FOB|0|||
156620097|NCT02683668|565349570|FG000|Period 2|Withdrawal by Subject|0|||
156620098|NCT02683668|565349571|FG001|Period 2|Withdrawal by Subject|1|||
156620099|NCT02683668|565349572|FG002|Period 2|Withdrawal by Subject|0|||
156620100|NCT00631969|565349573|FG000|Overall Study|Adverse Event|3|||
156620101|NCT00631969|565349574|FG001|Overall Study|Adverse Event|1|||
156620102|NCT00631969|565349573|FG000|Overall Study|Lack of Efficacy|2|||
156620103|NCT00631969|565349574|FG001|Overall Study|Lack of Efficacy|8|||
156620104|NCT00631969|565349573|FG000|Overall Study|Lost to Follow-up|2|||
156620105|NCT00631969|565349574|FG001|Overall Study|Lost to Follow-up|1|||
156620106|NCT00631969|565349573|FG000|Overall Study|Protocol Violation|1|||
156620107|NCT00631969|565349574|FG001|Overall Study|Protocol Violation|1|||
156620108|NCT00631969|565349573|FG000|Overall Study|Consent Withdrawn|5|||
156620109|NCT00631969|565349574|FG001|Overall Study|Consent Withdrawn|7|||
156620110|NCT00631969|565349573|FG000|Overall Study|Noncompliant With Study Medication|0|||
156620111|NCT00631969|565349574|FG001|Overall Study|Noncompliant With Study Medication|1|||
156620112|NCT00631969|565349573|FG000|Overall Study|No Drug Exposure|2|||
156620113|NCT00631969|565349574|FG001|Overall Study|No Drug Exposure|2|||
156620114|NCT03893630|565349575|FG000|Overall Study|Lost to Follow-up|5|||
156620115|NCT03893630|565349576|FG001|Overall Study|Lost to Follow-up|4|||
156620116|NCT03893630|565349577|FG002|Overall Study|Lost to Follow-up|2|||
156620117|NCT03893630|565349575|FG000|Overall Study|Withdrawal by Subject|3|||
156620118|NCT03893630|565349576|FG001|Overall Study|Withdrawal by Subject|6|||
156620119|NCT03893630|565349577|FG002|Overall Study|Withdrawal by Subject|3|||
156620120|NCT03893630|565349575|FG000|Overall Study|Discontinued Intervention|0|||
156620121|NCT03893630|565349576|FG001|Overall Study|Discontinued Intervention|4|||
156620122|NCT03893630|565349577|FG002|Overall Study|Discontinued Intervention|2|||
156620123|NCT00561795|565351197|FG000|Overall Study|Adverse Event|3|||
156620124|NCT00561795|565351198|FG001|Overall Study|Adverse Event|3|||
156620125|NCT00561795|565351199|FG002|Overall Study|Adverse Event|0|||
156620126|NCT00561795|565351200|FG003|Overall Study|Adverse Event|0|||
156620127|NCT00561795|565351197|FG000|Overall Study|Study Closed/Terminated|0|||
156620128|NCT00561795|565351198|FG001|Overall Study|Study Closed/Terminated|3|||
156620129|NCT00561795|565351199|FG002|Overall Study|Study Closed/Terminated|0|||
156620130|NCT00561795|565351200|FG003|Overall Study|Study Closed/Terminated|0|||
156620131|NCT00561795|565351197|FG000|Overall Study|Physician Decision|1|||
156620132|NCT00561795|565351198|FG001|Overall Study|Physician Decision|0|||
156620133|NCT00561795|565351199|FG002|Overall Study|Physician Decision|0|||
156620134|NCT00561795|565351200|FG003|Overall Study|Physician Decision|0|||
156620135|NCT02807376|565351201|FG000|Overall Study|Intra-operative exclusion criteria|3|||
156620136|NCT02807376|565351202|FG001|Overall Study|Intra-operative exclusion criteria|0|||
156620137|NCT02807376|565351201|FG000|Overall Study|Lost to Follow-up|0|||
156620138|NCT02807376|565351202|FG001|Overall Study|Lost to Follow-up|1|||
156620139|NCT00948389|565351205|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
156620140|NCT00948389|565351206|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
156620141|NCT00948389|565351207|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
156620142|NCT00948389|565351208|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
156620143|NCT00948389|565351209|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
156620144|NCT00948389|565351205|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
156620145|NCT00948389|565351206|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
156620146|NCT00948389|565351207|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
156620147|NCT00948389|565351208|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
156620148|NCT00948389|565351209|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
156620149|NCT00948389|565351205|FG000|Overall Study|Both Progression and Toxicity|1|||
156620150|NCT00948389|565351206|FG001|Overall Study|Both Progression and Toxicity|0|||
156620151|NCT00948389|565351207|FG002|Overall Study|Both Progression and Toxicity|0|||
156620152|NCT00948389|565351208|FG003|Overall Study|Both Progression and Toxicity|0|||
156620153|NCT00948389|565351209|FG004|Overall Study|Both Progression and Toxicity|0|||
156620154|NCT01072500|565351216|FG000|Overall Study|Death|2|||
156620155|NCT01072500|565351217|FG001|Overall Study|Death|2|||
156620156|NCT01072500|565351216|FG000|Overall Study|Lost to Follow-up|5|||
156620157|NCT01072500|565351217|FG001|Overall Study|Lost to Follow-up|2|||
156620158|NCT01072500|565351216|FG000|Overall Study|Withdrawal by Subject|17|||
156620159|NCT01072500|565351217|FG001|Overall Study|Withdrawal by Subject|10|||
156620160|NCT00103207|565351218|FG000|Overall Study|Adverse Event|3|||
156620161|NCT00103207|565351218|FG000|Overall Study|Death|1|||
156620162|NCT00103207|565351218|FG000|Overall Study|Withdrawal by Subject|2|||
156620163|NCT00103207|565351218|FG000|Overall Study|Other complicating disease|1|||
156620164|NCT00103207|565351218|FG000|Overall Study|Ineligible|4|||
156620165|NCT00103207|565351218|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
156620166|NCT03798366|565351219|FG000|Overall Study|Lost to Follow-up|0|||
156620167|NCT03798366|565351220|FG001|Overall Study|Lost to Follow-up|1|||
156620168|NCT00811395|565351221|FG000|Extension Treatment|Adverse Event|1|||
156620169|NCT00811395|565351222|FG001|Extension Treatment|Adverse Event|2|||
156620170|NCT00811395|565351223|FG002|Extension Treatment|Adverse Event|2|||
156620171|NCT00811395|565351224|FG003|Extension Treatment|Adverse Event|2|||
156620172|NCT00811395|565351225|FG004|Extension Treatment|Adverse Event|0|||
156620173|NCT00811395|565351226|FG005|Extension Treatment|Adverse Event|1|||
156620174|NCT00811395|565351221|FG000|Extension Treatment|Progressive disease|1|||
156620175|NCT00811395|565351222|FG001|Extension Treatment|Progressive disease|1|||
156620176|NCT00811395|565351223|FG002|Extension Treatment|Progressive disease|0|||
156620177|NCT00811395|565351224|FG003|Extension Treatment|Progressive disease|0|||
156620178|NCT00811395|565351225|FG004|Extension Treatment|Progressive disease|0|||
156620179|NCT00811395|565351226|FG005|Extension Treatment|Progressive disease|0|||
156620180|NCT00811395|565351221|FG000|Extension Treatment|Participant did not wish to continue|0|||
156620181|NCT00811395|565351222|FG001|Extension Treatment|Participant did not wish to continue|3|||
156620182|NCT00811395|565351223|FG002|Extension Treatment|Participant did not wish to continue|0|||
156620183|NCT00811395|565351224|FG003|Extension Treatment|Participant did not wish to continue|1|||
156620184|NCT00811395|565351225|FG004|Extension Treatment|Participant did not wish to continue|0|||
156620185|NCT00811395|565351226|FG005|Extension Treatment|Participant did not wish to continue|1|||
156620186|NCT00811395|565351221|FG000|Extension Treatment|Other than above|0|||
156620187|NCT00811395|565351222|FG001|Extension Treatment|Other than above|0|||
156620188|NCT00811395|565351223|FG002|Extension Treatment|Other than above|1|||
156620189|NCT00811395|565351224|FG003|Extension Treatment|Other than above|0|||
156620190|NCT00811395|565351225|FG004|Extension Treatment|Other than above|0|||
156620191|NCT00811395|565351226|FG005|Extension Treatment|Other than above|0|||
156620192|NCT03018340|565351233|FG000|Overall Study|Adverse Event|1|||
156620193|NCT03018340|565351234|FG001|Overall Study|Adverse Event|2|||
156620194|NCT03018340|565351233|FG000|Overall Study|Withdrawal by Subject|0|||
156620195|NCT03018340|565351234|FG001|Overall Study|Withdrawal by Subject|8|||
156620196|NCT03018340|565351233|FG000|Overall Study|Lack of Efficacy|0|||
156620197|NCT03018340|565351234|FG001|Overall Study|Lack of Efficacy|1|||
156620198|NCT03018340|565351233|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
156620199|NCT03018340|565351234|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
156620200|NCT03018340|565351233|FG000|Overall Study|Lost to Follow-up|1|||
156620201|NCT03018340|565351234|FG001|Overall Study|Lost to Follow-up|7|||
156620202|NCT03018340|565351233|FG000|Overall Study|Protocol Violation|3|||
156620203|NCT03018340|565351234|FG001|Overall Study|Protocol Violation|7|||
156620204|NCT03018340|565351233|FG000|Overall Study|Not further specified|0|||
156620205|NCT03018340|565351234|FG001|Overall Study|Not further specified|1|||
156620206|NCT01836549|565351235|FG000|Overall Study|Did not receive study drug|0|||
156620207|NCT01836549|565351236|FG001|Overall Study|Did not receive study drug|0|||
156620208|NCT01836549|565351237|FG002|Overall Study|Did not receive study drug|1|||
156620209|NCT01836549|565351238|FG003|Overall Study|Did not receive study drug|0|||
156620210|NCT01836549|565351239|FG004|Overall Study|Did not receive study drug|0|||
156620211|NCT01836549|565351240|FG005|Overall Study|Did not receive study drug|0|||
156620212|NCT01836549|565351241|FG006|Overall Study|Did not receive study drug|0|||
156620213|NCT01836549|565351235|FG000|Overall Study|Patient declared ineligible|0|||
156620214|NCT01836549|565351236|FG001|Overall Study|Patient declared ineligible|0|||
156620215|NCT01836549|565351237|FG002|Overall Study|Patient declared ineligible|0|||
156620216|NCT01836549|565351238|FG003|Overall Study|Patient declared ineligible|1|||
156620217|NCT01836549|565351239|FG004|Overall Study|Patient declared ineligible|0|||
156620218|NCT01836549|565351240|FG005|Overall Study|Patient declared ineligible|0|||
156620219|NCT01836549|565351241|FG006|Overall Study|Patient declared ineligible|0|||
156620220|NCT01836549|565351235|FG000|Overall Study|Patient inevaluable to start therapy|0|||
156620221|NCT01836549|565351236|FG001|Overall Study|Patient inevaluable to start therapy|0|||
156620222|NCT01836549|565351237|FG002|Overall Study|Patient inevaluable to start therapy|0|||
156620223|NCT01836549|565351238|FG003|Overall Study|Patient inevaluable to start therapy|0|||
156620224|NCT01836549|565351239|FG004|Overall Study|Patient inevaluable to start therapy|0|||
156620225|NCT01836549|565351240|FG005|Overall Study|Patient inevaluable to start therapy|0|||
156620226|NCT01836549|565351241|FG006|Overall Study|Patient inevaluable to start therapy|1|||
156620227|NCT04652102|565351242|FG000|Overall Study|Adverse Event|14|||
156620228|NCT04652102|565351243|FG001|Overall Study|Adverse Event|13|||
156620229|NCT04652102|565351242|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
156620230|NCT04652102|565351243|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
156620231|NCT04652102|565351242|FG000|Overall Study|Physician Decision|78|||
156620232|NCT04652102|565351243|FG001|Overall Study|Physician Decision|40|||
156620233|NCT04652102|565351242|FG000|Overall Study|Study Ended by Sponsor|64|||
156620234|NCT04652102|565351243|FG001|Overall Study|Study Ended by Sponsor|17|||
156620235|NCT04652102|565351242|FG000|Overall Study|Withdrawal by Subject|4625|||
156620236|NCT04652102|565351243|FG001|Overall Study|Withdrawal by Subject|5594|||
156620237|NCT04652102|565351242|FG000|Overall Study|Lost to Follow-up|2019|||
156620238|NCT04652102|565351243|FG001|Overall Study|Lost to Follow-up|1082|||
156620239|NCT04652102|565351242|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
156620240|NCT04652102|565351243|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
156620241|NCT04652102|565351242|FG000|Overall Study|Miscellaneous|80|||
156620242|NCT04652102|565351243|FG001|Overall Study|Miscellaneous|64|||
156620243|NCT02192190|565351244|FG000|Overall Study|Adverse Event|1|||
156620244|NCT02192190|565351245|FG001|Overall Study|Adverse Event|1|||
156620245|NCT02192190|565351246|FG002|Overall Study|Adverse Event|0|||
156620246|NCT02192190|565351247|FG003|Overall Study|Adverse Event|0|||
156620247|NCT02192190|565351248|FG004|Overall Study|Adverse Event|0|||
156620248|NCT02192190|565351249|FG005|Overall Study|Adverse Event|0|||
156620249|NCT02192190|565351244|FG000|Overall Study|Lost to Follow-up|3|||
156620250|NCT02192190|565351245|FG001|Overall Study|Lost to Follow-up|3|||
156620251|NCT02192190|565351246|FG002|Overall Study|Lost to Follow-up|2|||
156620252|NCT02192190|565351247|FG003|Overall Study|Lost to Follow-up|1|||
156620253|NCT02192190|565351248|FG004|Overall Study|Lost to Follow-up|4|||
156620254|NCT02192190|565351249|FG005|Overall Study|Lost to Follow-up|3|||
156620255|NCT02192190|565351244|FG000|Overall Study|Physician Decision|2|||
156620256|NCT02192190|565351245|FG001|Overall Study|Physician Decision|0|||
156620257|NCT02192190|565351246|FG002|Overall Study|Physician Decision|0|||
156620258|NCT02192190|565351247|FG003|Overall Study|Physician Decision|0|||
156620259|NCT02192190|565351248|FG004|Overall Study|Physician Decision|0|||
156620260|NCT02192190|565351249|FG005|Overall Study|Physician Decision|0|||
156620261|NCT02192190|565351244|FG000|Overall Study|Terminated by Sponsor|43|||
156620262|NCT02192190|565351245|FG001|Overall Study|Terminated by Sponsor|23|||
156620263|NCT02192190|565351246|FG002|Overall Study|Terminated by Sponsor|20|||
156620264|NCT02192190|565351247|FG003|Overall Study|Terminated by Sponsor|23|||
156620265|NCT02192190|565351248|FG004|Overall Study|Terminated by Sponsor|21|||
156620266|NCT02192190|565351249|FG005|Overall Study|Terminated by Sponsor|23|||
156620267|NCT02192190|565351244|FG000|Overall Study|Withdrawal by Subject|4|||
156620268|NCT02192190|565351245|FG001|Overall Study|Withdrawal by Subject|1|||
156620269|NCT02192190|565351246|FG002|Overall Study|Withdrawal by Subject|2|||
156620270|NCT02192190|565351247|FG003|Overall Study|Withdrawal by Subject|1|||
156620271|NCT02192190|565351248|FG004|Overall Study|Withdrawal by Subject|5|||
156620272|NCT02192190|565351249|FG005|Overall Study|Withdrawal by Subject|3|||
156620273|NCT02192190|565351244|FG000|Overall Study|Could not Keep Visit Schedule|1|||
156620274|NCT02192190|565351245|FG001|Overall Study|Could not Keep Visit Schedule|0|||
156620275|NCT02192190|565351246|FG002|Overall Study|Could not Keep Visit Schedule|0|||
156620276|NCT02192190|565351247|FG003|Overall Study|Could not Keep Visit Schedule|0|||
156620277|NCT02192190|565351248|FG004|Overall Study|Could not Keep Visit Schedule|0|||
156620278|NCT02192190|565351249|FG005|Overall Study|Could not Keep Visit Schedule|0|||
156620279|NCT02192190|565351244|FG000|Overall Study|Positive Drug Screen|0|||
156620280|NCT02192190|565351245|FG001|Overall Study|Positive Drug Screen|0|||
156620281|NCT02192190|565351246|FG002|Overall Study|Positive Drug Screen|0|||
156620282|NCT02192190|565351247|FG003|Overall Study|Positive Drug Screen|1|||
156620283|NCT02192190|565351248|FG004|Overall Study|Positive Drug Screen|0|||
156620284|NCT02192190|565351249|FG005|Overall Study|Positive Drug Screen|0|||
156620285|NCT02192190|565351244|FG000|Overall Study|Inadequate Pain Relief|0|||
156620286|NCT02192190|565351245|FG001|Overall Study|Inadequate Pain Relief|1|||
156620287|NCT02192190|565351246|FG002|Overall Study|Inadequate Pain Relief|1|||
156620288|NCT02192190|565351247|FG003|Overall Study|Inadequate Pain Relief|0|||
156620289|NCT02192190|565351248|FG004|Overall Study|Inadequate Pain Relief|0|||
156620290|NCT02192190|565351249|FG005|Overall Study|Inadequate Pain Relief|0|||
156620291|NCT01657253|565351250|FG000|Overall Study|Lost to Follow-up|6|||
156620292|NCT01657253|565351251|FG001|Overall Study|Lost to Follow-up|5|||
156620293|NCT01657253|565351250|FG000|Overall Study|Withdrawal by Subject|11|||
156620294|NCT01657253|565351251|FG001|Overall Study|Withdrawal by Subject|12|||
156620295|NCT01657253|565351250|FG000|Overall Study|Adverse Event|0|||
156620296|NCT01657253|565351251|FG001|Overall Study|Adverse Event|1|||
156620297|NCT00381706|565351252|FG000|Overall Study|Never treated|7|||
156620298|NCT00381706|565351253|FG001|Overall Study|Never treated|2|||
156620299|NCT00381706|565351254|FG002|Overall Study|Never treated|1|||
156620300|NCT02364999|565351255|FG000|Overall Study|Death|136|||
156620301|NCT02364999|565351256|FG001|Overall Study|Death|138|||
156620302|NCT02364999|565351255|FG000|Overall Study|Lost to Follow-up|10|||
156620303|NCT02364999|565351256|FG001|Overall Study|Lost to Follow-up|15|||
156620304|NCT02364999|565351255|FG000|Overall Study|Protocol Violation|3|||
156620305|NCT02364999|565351256|FG001|Overall Study|Protocol Violation|2|||
156620306|NCT02364999|565351255|FG000|Overall Study|Withdrawal by Subject|14|||
156620307|NCT02364999|565351256|FG001|Overall Study|Withdrawal by Subject|14|||
156620308|NCT02364999|565351255|FG000|Overall Study|Other|0|||
156620309|NCT02364999|565351256|FG001|Overall Study|Other|1|||
156620310|NCT02364999|565351255|FG000|Overall Study|Randomized but did not receive treatment|2|||
156620311|NCT02364999|565351256|FG001|Overall Study|Randomized but did not receive treatment|3|||
156620312|NCT00550615|565351257|FG000|Overall Study|Withdrawal by Subject|0|||
156620313|NCT00550615|565351258|FG001|Overall Study|Withdrawal by Subject|0|||
156620314|NCT00550615|565351259|FG002|Overall Study|Withdrawal by Subject|2|||
156620315|NCT00550615|565351260|FG003|Overall Study|Withdrawal by Subject|3|||
156620316|NCT00550615|565351257|FG000|Overall Study|Not evaluable|0|||
156620317|NCT00550615|565351258|FG001|Overall Study|Not evaluable|0|||
156620318|NCT00550615|565351259|FG002|Overall Study|Not evaluable|2|||
156620319|NCT00550615|565351260|FG003|Overall Study|Not evaluable|7|||
156620320|NCT00890201|565351263|FG000|Overall Study|Protocol Violation|5|||
156620321|NCT00890201|565351264|FG001|Overall Study|Protocol Violation|56|||
156620322|NCT02181504|565351265|FG000|Overall Study|Adverse Event|1|||
156620323|NCT02181504|565351266|FG001|Overall Study|Adverse Event|1|||
156620324|NCT02181504|565351267|FG002|Overall Study|Adverse Event|1|||
156620325|NCT01469637|565351272|FG000|First Intervention|Unacceptable behavior|0|||
156620326|NCT01469637|565351273|FG001|First Intervention|Unacceptable behavior|1|||
156620327|NCT01469637|565351272|FG000|Second Intervention|Incarcerated|1|||
156620328|NCT01469637|565351273|FG001|Second Intervention|Incarcerated|0|||
156620329|NCT01371721|565351276|FG000|Overall Study|Adverse Event|5|||
156620330|NCT01371721|565351277|FG001|Overall Study|Adverse Event|4|||
156620331|NCT01371721|565351278|FG002|Overall Study|Adverse Event|5|||
156620332|NCT01371721|565351276|FG000|Overall Study|Protocol Violation|6|||
156620333|NCT01371721|565351277|FG001|Overall Study|Protocol Violation|4|||
156620334|NCT01371721|565351278|FG002|Overall Study|Protocol Violation|5|||
156620335|NCT01371721|565351276|FG000|Overall Study|Lost to Follow-up|8|||
156620336|NCT01371721|565351277|FG001|Overall Study|Lost to Follow-up|2|||
156620337|NCT01371721|565351278|FG002|Overall Study|Lost to Follow-up|6|||
156620338|NCT01371721|565351276|FG000|Overall Study|Withdrawal by Subject|5|||
156620339|NCT01371721|565351277|FG001|Overall Study|Withdrawal by Subject|7|||
156620340|NCT01371721|565351278|FG002|Overall Study|Withdrawal by Subject|11|||
156620341|NCT01371721|565351276|FG000|Overall Study|Other|2|||
156620342|NCT01371721|565351277|FG001|Overall Study|Other|3|||
156620343|NCT01371721|565351278|FG002|Overall Study|Other|0|||
156620344|NCT01371721|565351276|FG000|Overall Study|Lack of Efficacy|2|||
156620345|NCT01371721|565351277|FG001|Overall Study|Lack of Efficacy|4|||
156620346|NCT01371721|565351278|FG002|Overall Study|Lack of Efficacy|3|||
156620347|NCT01371721|565351276|FG000|Overall Study|Randomized but not treated|1|||
156620348|NCT01371721|565351277|FG001|Overall Study|Randomized but not treated|0|||
156620349|NCT01371721|565351278|FG002|Overall Study|Randomized but not treated|0|||
156620350|NCT00545584|565351279|FG000|Overall Study|Only one reason for discontinuation|62|||
156620351|NCT00545584|565351280|FG001|Overall Study|Only one reason for discontinuation|61|||
156620352|NCT00545584|565351281|FG002|Overall Study|Only one reason for discontinuation|48|||
156620353|NCT00545584|565351279|FG000|Overall Study|Two or more reasons for discontinuation|17|||
156620354|NCT00545584|565351280|FG001|Overall Study|Two or more reasons for discontinuation|19|||
156620355|NCT00545584|565351281|FG002|Overall Study|Two or more reasons for discontinuation|8|||
156620356|NCT00135694|565351287|FG000|Overall Study|Adverse Event|17|||
156620357|NCT00135694|565351288|FG001|Overall Study|Adverse Event|4|||
156620358|NCT00135694|565351289|FG002|Overall Study|Adverse Event|0|||
156620359|NCT00135694|565351287|FG000|Overall Study|Death|14|||
156620360|NCT00135694|565351288|FG001|Overall Study|Death|1|||
156620361|NCT00135694|565351289|FG002|Overall Study|Death|2|||
156620362|NCT00135694|565351287|FG000|Overall Study|Lost to Follow-up|8|||
156620363|NCT00135694|565351288|FG001|Overall Study|Lost to Follow-up|7|||
156620364|NCT00135694|565351289|FG002|Overall Study|Lost to Follow-up|1|||
156620365|NCT00135694|565351287|FG000|Overall Study|Withdrawal by Subject|41|||
156620366|NCT00135694|565351288|FG001|Overall Study|Withdrawal by Subject|7|||
156620367|NCT00135694|565351289|FG002|Overall Study|Withdrawal by Subject|4|||
156620368|NCT00135694|565351287|FG000|Overall Study|Protocol Violation|19|||
156620369|NCT00135694|565351288|FG001|Overall Study|Protocol Violation|1|||
156620370|NCT00135694|565351289|FG002|Overall Study|Protocol Violation|0|||
156620371|NCT00135694|565351287|FG000|Overall Study|Hepatitis C related reasons|39|||
156620372|NCT00135694|565351288|FG001|Overall Study|Hepatitis C related reasons|1|||
156620373|NCT00135694|565351289|FG002|Overall Study|Hepatitis C related reasons|0|||
156620374|NCT00135694|565351287|FG000|Overall Study|Ineligible for Random assignment|42|||
156620375|NCT00135694|565351288|FG001|Overall Study|Ineligible for Random assignment|0|||
156620376|NCT00135694|565351289|FG002|Overall Study|Ineligible for Random assignment|0|||
156620377|NCT02584660|565351290|FG000|Overall Study|Adverse Event|4|||
156620378|NCT02584660|565351291|FG001|Overall Study|Adverse Event|0|||
156620379|NCT02584660|565351290|FG000|Overall Study|Lost to Follow-up|3|||
156620380|NCT02584660|565351291|FG001|Overall Study|Lost to Follow-up|4|||
156620381|NCT02584660|565351290|FG000|Overall Study|Protocol Violation|0|||
156620382|NCT02584660|565351291|FG001|Overall Study|Protocol Violation|1|||
156620383|NCT02584660|565351290|FG000|Overall Study|Withdrawal by Subject|0|||
156620384|NCT02584660|565351291|FG001|Overall Study|Withdrawal by Subject|2|||
156620385|NCT02584660|565351290|FG000|Overall Study|Other|0|||
156620386|NCT02584660|565351291|FG001|Overall Study|Other|1|||
156620387|NCT00461552|565351292|FG000|Overall Study|Drug Dispensing error|0|||
156620388|NCT00461552|565351293|FG001|Overall Study|Drug Dispensing error|2|||
156620389|NCT00660816|565351294|FG000|Overall Study|Adverse Event|1|||
156620390|NCT00660816|565351295|FG001|Overall Study|Adverse Event|2|||
156620391|NCT00660816|565351294|FG000|Overall Study|Withdrawal by Subject|1|||
156620392|NCT00660816|565351295|FG001|Overall Study|Withdrawal by Subject|0|||
156620393|NCT00660816|565351294|FG000|Overall Study|Death|0|||
156620394|NCT00660816|565351295|FG001|Overall Study|Death|2|||
156620395|NCT00660816|565351294|FG000|Overall Study|Lack of Efficacy|1|||
156620396|NCT00660816|565351295|FG001|Overall Study|Lack of Efficacy|0|||
156620397|NCT00660816|565351294|FG000|Overall Study|Physician Decision|0|||
156620398|NCT00660816|565351295|FG001|Overall Study|Physician Decision|2|||
156620399|NCT00660816|565351294|FG000|Overall Study|Protocol Violation|1|||
156620400|NCT00660816|565351295|FG001|Overall Study|Protocol Violation|0|||
156620401|NCT00660816|565351294|FG000|Overall Study|Disease Progression|16|||
156620402|NCT00660816|565351295|FG001|Overall Study|Disease Progression|12|||
156620403|NCT00660816|565351294|FG000|Overall Study|Complicating Disease|0|||
156620404|NCT00660816|565351295|FG001|Overall Study|Complicating Disease|1|||
156620405|NCT00374452|565351296|FG000|Overall Study|Left clinic before intervention started|4|||
156620406|NCT00374452|565351297|FG001|Overall Study|Left clinic before intervention started|1|||
156620407|NCT00374452|565351296|FG000|Overall Study|Change in job role before intervention|0|||
156620408|NCT00374452|565351297|FG001|Overall Study|Change in job role before intervention|1|||
156620409|NCT00374452|565351296|FG000|Overall Study|Left clinic after intervention started|1|||
156620410|NCT00374452|565351297|FG001|Overall Study|Left clinic after intervention started|1|||
156620411|NCT00374452|565351296|FG000|Overall Study|Withdrawal by Subject|0|||
156620412|NCT00374452|565351297|FG001|Overall Study|Withdrawal by Subject|2|||
156620413|NCT02877134|565351298|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620414|NCT02877134|565351299|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
156620415|NCT02877134|565351300|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620416|NCT02877134|565351301|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620417|NCT02877134|565351302|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620418|NCT02877134|565351303|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
156620419|NCT02877134|565351304|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620420|NCT02877134|565351305|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620421|NCT02877134|565351306|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620422|NCT02877134|565351307|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620423|NCT02877134|565351308|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620424|NCT02877134|565351309|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
156620425|NCT02877134|565351298|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620426|NCT02877134|565351299|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
156620427|NCT02877134|565351300|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620428|NCT02877134|565351301|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
156620429|NCT02877134|565351302|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620430|NCT02877134|565351303|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620431|NCT02877134|565351304|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
156620432|NCT02877134|565351305|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620433|NCT02877134|565351306|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620434|NCT02877134|565351307|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620435|NCT02877134|565351308|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620436|NCT02877134|565351309|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
156620437|NCT02877134|565351298|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
156620438|NCT02877134|565351299|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
156620439|NCT02877134|565351300|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
156620440|NCT02877134|565351301|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
156620441|NCT02877134|565351302|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
156620442|NCT02877134|565351303|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
156620443|NCT02877134|565351304|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
156620444|NCT02877134|565351305|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
156620445|NCT02877134|565351306|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
156620446|NCT02877134|565351307|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
156620447|NCT02877134|565351308|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
156620448|NCT02877134|565351309|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
156620449|NCT02877134|565351298|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
156620450|NCT02877134|565351299|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
156620451|NCT02877134|565351300|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
156620452|NCT02877134|565351301|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
156620453|NCT02877134|565351302|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
156620454|NCT02877134|565351303|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
156620455|NCT02877134|565351304|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
156620456|NCT02877134|565351305|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
156620457|NCT02877134|565351306|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
156620458|NCT02877134|565351307|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
156620459|NCT02877134|565351308|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
156620460|NCT02877134|565351309|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
156620461|NCT02877134|565351298|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620462|NCT02877134|565351299|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620463|NCT02877134|565351300|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620464|NCT02877134|565351301|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620465|NCT02877134|565351302|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620466|NCT02877134|565351303|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620467|NCT02877134|565351304|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620468|NCT02877134|565351305|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620469|NCT02877134|565351306|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
156620470|NCT02877134|565351307|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620471|NCT02877134|565351308|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620472|NCT02877134|565351309|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
156620473|NCT02877134|565351298|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
156620474|NCT02877134|565351299|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
156620475|NCT02877134|565351300|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
156620476|NCT02877134|565351301|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
156620477|NCT02877134|565351302|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
156620478|NCT02877134|565351303|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
156620479|NCT02877134|565351304|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
156620480|NCT02877134|565351305|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
156620481|NCT02877134|565351306|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
156620482|NCT02877134|565351307|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
156620483|NCT02877134|565351308|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
156620484|NCT02877134|565351309|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
156620485|NCT02877134|565351298|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620486|NCT02877134|565351299|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620487|NCT02877134|565351300|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620488|NCT02877134|565351301|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620489|NCT02877134|565351302|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620490|NCT02877134|565351303|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620491|NCT02877134|565351304|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620492|NCT02877134|565351305|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
156620493|NCT02877134|565351306|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
156620494|NCT02877134|565351307|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
156620495|NCT02877134|565351308|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620496|NCT02877134|565351309|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
156620497|NCT02877134|565351298|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
156620498|NCT02877134|565351299|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
156620499|NCT02877134|565351300|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
156620500|NCT02877134|565351301|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
156620501|NCT02877134|565351302|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
156620502|NCT02877134|565351303|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
156620503|NCT02877134|565351304|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
156620504|NCT02877134|565351305|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
156620505|NCT02877134|565351306|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
156620506|NCT02877134|565351307|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
156620507|NCT02877134|565351308|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
156620508|NCT02877134|565351309|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
156620509|NCT00523744|565351310|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
156620510|NCT00523744|565351310|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
156620511|NCT00523744|565351310|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
156620512|NCT00523744|565351310|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
156620513|NCT00523744|565351310|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
156620514|NCT00523744|565351310|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
156620515|NCT01289028|565351311|FG000|Overall Study|Progressive Disease|49|||
156620516|NCT01289028|565351311|FG000|Overall Study|Adverse Event|14|||
156620517|NCT01289028|565351311|FG000|Overall Study|Withdrawal by Subject|6|||
156620518|NCT01289028|565351311|FG000|Overall Study|Death|4|||
156620519|NCT01289028|565351311|FG000|Overall Study|Lack of Efficacy|2|||
156620520|NCT01289028|565351311|FG000|Overall Study|No longer required|2|||
156620521|NCT01289028|565351311|FG000|Overall Study|Lost to Follow-up|2|||
156620522|NCT01289028|565351311|FG000|Overall Study|New Cancer Therapy|2|||
156620523|NCT01289028|565351311|FG000|Overall Study|Abnormal Lab Value|1|||
156620524|NCT01289028|565351311|FG000|Overall Study|Missing reason for discon|1|||
156620525|NCT01055457|565351312|FG000|Overall Study|Lost to Follow-up|0|||
156620526|NCT01055457|565351313|FG001|Overall Study|Lost to Follow-up|1|||
156620527|NCT01055457|565351314|FG002|Overall Study|Lost to Follow-up|0|||
156620528|NCT01055457|565351315|FG003|Overall Study|Lost to Follow-up|0|||
156620529|NCT01055457|565351316|FG004|Overall Study|Lost to Follow-up|0|||
156620530|NCT01055457|565351317|FG005|Overall Study|Lost to Follow-up|1|||
156620531|NCT01055457|565351318|FG006|Overall Study|Lost to Follow-up|0|||
156620532|NCT01055457|565351319|FG007|Overall Study|Lost to Follow-up|0|||
156620533|NCT01055457|565351320|FG008|Overall Study|Lost to Follow-up|0|||
156620534|NCT01055457|565351321|FG009|Overall Study|Lost to Follow-up|0|||
156620535|NCT01055457|565351312|FG000|Overall Study|Protocol Violation|0|||
156620536|NCT01055457|565351313|FG001|Overall Study|Protocol Violation|0|||
156620537|NCT01055457|565351314|FG002|Overall Study|Protocol Violation|1|||
156620538|NCT01055457|565351315|FG003|Overall Study|Protocol Violation|1|||
156620539|NCT01055457|565351316|FG004|Overall Study|Protocol Violation|1|||
156620540|NCT01055457|565351317|FG005|Overall Study|Protocol Violation|2|||
156620541|NCT01055457|565351318|FG006|Overall Study|Protocol Violation|1|||
156620542|NCT01055457|565351319|FG007|Overall Study|Protocol Violation|0|||
156620543|NCT01055457|565351320|FG008|Overall Study|Protocol Violation|0|||
156620544|NCT01055457|565351321|FG009|Overall Study|Protocol Violation|1|||
156620545|NCT01055457|565351312|FG000|Overall Study|Subject Disinterest|0|||
156620546|NCT01055457|565351313|FG001|Overall Study|Subject Disinterest|0|||
156620547|NCT01055457|565351314|FG002|Overall Study|Subject Disinterest|0|||
156620548|NCT01055457|565351315|FG003|Overall Study|Subject Disinterest|0|||
156620549|NCT01055457|565351316|FG004|Overall Study|Subject Disinterest|0|||
156620550|NCT01055457|565351317|FG005|Overall Study|Subject Disinterest|0|||
156620551|NCT01055457|565351318|FG006|Overall Study|Subject Disinterest|0|||
156620552|NCT01055457|565351319|FG007|Overall Study|Subject Disinterest|1|||
156620553|NCT01055457|565351320|FG008|Overall Study|Subject Disinterest|0|||
156620554|NCT01055457|565351321|FG009|Overall Study|Subject Disinterest|0|||
156620555|NCT01055457|565351312|FG000|Overall Study|Subject Ineligible|1|||
156620556|NCT01055457|565351313|FG001|Overall Study|Subject Ineligible|0|||
156620557|NCT01055457|565351314|FG002|Overall Study|Subject Ineligible|1|||
156620558|NCT01055457|565351315|FG003|Overall Study|Subject Ineligible|0|||
156620559|NCT01055457|565351316|FG004|Overall Study|Subject Ineligible|1|||
156620560|NCT01055457|565351317|FG005|Overall Study|Subject Ineligible|0|||
156620561|NCT01055457|565351318|FG006|Overall Study|Subject Ineligible|0|||
156620562|NCT01055457|565351319|FG007|Overall Study|Subject Ineligible|0|||
156620563|NCT01055457|565351320|FG008|Overall Study|Subject Ineligible|0|||
156620564|NCT01055457|565351321|FG009|Overall Study|Subject Ineligible|0|||
156620565|NCT01055457|565351312|FG000|Overall Study|Discomfort|0|||
156620566|NCT01055457|565351313|FG001|Overall Study|Discomfort|0|||
156620567|NCT01055457|565351314|FG002|Overall Study|Discomfort|0|||
156620568|NCT01055457|565351315|FG003|Overall Study|Discomfort|0|||
156620569|NCT01055457|565351316|FG004|Overall Study|Discomfort|1|||
156620570|NCT01055457|565351317|FG005|Overall Study|Discomfort|0|||
156620571|NCT01055457|565351318|FG006|Overall Study|Discomfort|0|||
156620572|NCT01055457|565351319|FG007|Overall Study|Discomfort|0|||
156620573|NCT01055457|565351320|FG008|Overall Study|Discomfort|0|||
156620574|NCT01055457|565351321|FG009|Overall Study|Discomfort|0|||
156620575|NCT01055457|565351312|FG000|Overall Study|Pregnancy|0|||
156620576|NCT01055457|565351313|FG001|Overall Study|Pregnancy|0|||
156620577|NCT01055457|565351314|FG002|Overall Study|Pregnancy|0|||
156620578|NCT01055457|565351315|FG003|Overall Study|Pregnancy|1|||
156620579|NCT01055457|565351316|FG004|Overall Study|Pregnancy|0|||
156620580|NCT01055457|565351317|FG005|Overall Study|Pregnancy|0|||
156620581|NCT01055457|565351318|FG006|Overall Study|Pregnancy|0|||
156620582|NCT01055457|565351319|FG007|Overall Study|Pregnancy|0|||
156620583|NCT01055457|565351320|FG008|Overall Study|Pregnancy|0|||
156620584|NCT01055457|565351321|FG009|Overall Study|Pregnancy|0|||
156620585|NCT01055457|565351312|FG000|Overall Study|Adverse Event|0|||
156620586|NCT01055457|565351313|FG001|Overall Study|Adverse Event|0|||
156620587|NCT01055457|565351314|FG002|Overall Study|Adverse Event|0|||
156620588|NCT01055457|565351315|FG003|Overall Study|Adverse Event|1|||
156620589|NCT01055457|565351316|FG004|Overall Study|Adverse Event|0|||
156620590|NCT01055457|565351317|FG005|Overall Study|Adverse Event|0|||
156620591|NCT01055457|565351318|FG006|Overall Study|Adverse Event|0|||
156620592|NCT01055457|565351319|FG007|Overall Study|Adverse Event|0|||
156620593|NCT01055457|565351320|FG008|Overall Study|Adverse Event|0|||
156620594|NCT01055457|565351321|FG009|Overall Study|Adverse Event|0|||
156620595|NCT00998985|565351328|FG000|Overall Study|Withdrawal by Subject|0|||
156620596|NCT00998985|565351329|FG001|Overall Study|Withdrawal by Subject|0|||
156620597|NCT00998985|565351330|FG002|Overall Study|Withdrawal by Subject|0|||
156620598|NCT00998985|565351331|FG003|Overall Study|Withdrawal by Subject|0|||
156620599|NCT00998985|565351332|FG004|Overall Study|Withdrawal by Subject|0|||
156620600|NCT00998985|565351333|FG005|Overall Study|Withdrawal by Subject|0|||
156620601|NCT00998985|565351334|FG006|Overall Study|Withdrawal by Subject|0|||
156620602|NCT00998985|565351335|FG007|Overall Study|Withdrawal by Subject|0|||
156620603|NCT00998985|565351336|FG008|Overall Study|Withdrawal by Subject|1|||
156620604|NCT00998985|565351337|FG009|Overall Study|Withdrawal by Subject|0|||
156620605|NCT00998985|565351338|FG010|Overall Study|Withdrawal by Subject|0|||
156620606|NCT00998985|565351339|FG011|Overall Study|Withdrawal by Subject|0|||
156620607|NCT00998985|565351340|FG012|Overall Study|Withdrawal by Subject|0|||
156620608|NCT00998985|565351341|FG013|Overall Study|Withdrawal by Subject|0|||
156620609|NCT00998985|565351328|FG000|Overall Study|Protocol Violation|0|||
156620610|NCT00998985|565351329|FG001|Overall Study|Protocol Violation|0|||
156620611|NCT00998985|565351330|FG002|Overall Study|Protocol Violation|0|||
156620612|NCT00998985|565351331|FG003|Overall Study|Protocol Violation|0|||
156620613|NCT00998985|565351332|FG004|Overall Study|Protocol Violation|0|||
156620614|NCT00998985|565351333|FG005|Overall Study|Protocol Violation|1|||
156620615|NCT00998985|565351334|FG006|Overall Study|Protocol Violation|0|||
156620616|NCT00998985|565351335|FG007|Overall Study|Protocol Violation|0|||
156620617|NCT00998985|565351336|FG008|Overall Study|Protocol Violation|0|||
156620618|NCT00998985|565351337|FG009|Overall Study|Protocol Violation|0|||
156620619|NCT00998985|565351338|FG010|Overall Study|Protocol Violation|0|||
156620620|NCT00998985|565351339|FG011|Overall Study|Protocol Violation|0|||
156620621|NCT00998985|565351340|FG012|Overall Study|Protocol Violation|0|||
156620622|NCT00998985|565351341|FG013|Overall Study|Protocol Violation|0|||
156620623|NCT01024946|565351342|FG000|Overall Study|Screen Failure|3|||
156620624|NCT01024946|565351342|FG000|Overall Study|Withdrawal by Subject|1|||
156620625|NCT01024946|565351342|FG000|Overall Study|Adverse Event|1|||
156620626|NCT03147495|565351343|FG000|Overall Study|Physician Decision|0|||
156620627|NCT03147495|565351344|FG001|Overall Study|Physician Decision|6|||
156620628|NCT02483611|565351345|FG000|Overall Study|Protocol Violation|0|||
156620629|NCT02483611|565351346|FG001|Overall Study|Protocol Violation|0|||
156620630|NCT02483611|565351347|FG002|Overall Study|Protocol Violation|1|||
156620631|NCT02608892|565351348|FG000|Overall Study|Lost to Follow-up|1|||
156620632|NCT02608892|565351349|FG001|Overall Study|Lost to Follow-up|0|||
156620633|NCT00877890|565351350|FG000|Overall Study|Adverse Event|6|||
156620634|NCT00877890|565351351|FG001|Overall Study|Adverse Event|6|||
156620635|NCT00877890|565351350|FG000|Overall Study|Lost to Follow-up|5|||
156620636|NCT00877890|565351351|FG001|Overall Study|Lost to Follow-up|5|||
156620637|NCT00877890|565351350|FG000|Overall Study|Protocol Violation|0|||
156620638|NCT00877890|565351351|FG001|Overall Study|Protocol Violation|1|||
156620639|NCT00877890|565351350|FG000|Overall Study|Withdrawal of Consent|6|||
156620640|NCT00877890|565351351|FG001|Overall Study|Withdrawal of Consent|12|||
156620641|NCT00877890|565351350|FG000|Overall Study|Investigator Decision|0|||
156620642|NCT00877890|565351351|FG001|Overall Study|Investigator Decision|2|||
156620643|NCT00877890|565351350|FG000|Overall Study|Loss of Glucose Control|3|||
156620644|NCT00877890|565351351|FG001|Overall Study|Loss of Glucose Control|4|||
156620645|NCT00984009|565351352|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
156620646|NCT02520141|565351359|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
156620647|NCT02168816|565351362|FG000|Overall Study|Lost to Follow-up|2|||
156620648|NCT02168816|565351363|FG001|Overall Study|Lost to Follow-up|2|||
156620649|NCT01225211|565351364|FG000|Overall Study|Adverse Event|0|||
156620650|NCT01225211|565351365|FG001|Overall Study|Adverse Event|0|||
156620651|NCT01225211|565351366|FG002|Overall Study|Adverse Event|1|||
156620652|NCT01225211|565351367|FG003|Overall Study|Adverse Event|0|||
156620653|NCT01225211|565351368|FG004|Overall Study|Adverse Event|0|||
156620654|NCT01225211|565351369|FG005|Overall Study|Adverse Event|0|||
156620655|NCT01225211|565351370|FG006|Overall Study|Adverse Event|0|||
156620656|NCT01225211|565351371|FG007|Overall Study|Adverse Event|0|||
156620657|NCT01225211|565351372|FG008|Overall Study|Adverse Event|0|||
156620658|NCT01225211|565351373|FG009|Overall Study|Adverse Event|1|||
156620659|NCT01225211|565351364|FG000|Overall Study|Withdrawal by Subject|0|||
156620660|NCT01225211|565351365|FG001|Overall Study|Withdrawal by Subject|0|||
156620661|NCT01225211|565351366|FG002|Overall Study|Withdrawal by Subject|0|||
156620662|NCT01225211|565351367|FG003|Overall Study|Withdrawal by Subject|0|||
156620663|NCT01225211|565351368|FG004|Overall Study|Withdrawal by Subject|0|||
156620664|NCT01225211|565351369|FG005|Overall Study|Withdrawal by Subject|0|||
156620665|NCT01225211|565351370|FG006|Overall Study|Withdrawal by Subject|1|||
156620666|NCT01225211|565351371|FG007|Overall Study|Withdrawal by Subject|0|||
156620667|NCT01225211|565351372|FG008|Overall Study|Withdrawal by Subject|1|||
156620668|NCT01225211|565351373|FG009|Overall Study|Withdrawal by Subject|3|||
156620669|NCT01225211|565351364|FG000|Overall Study|Other|0|||
156620670|NCT01225211|565351365|FG001|Overall Study|Other|0|||
156620671|NCT01225211|565351366|FG002|Overall Study|Other|0|||
156620672|NCT01225211|565351367|FG003|Overall Study|Other|0|||
156620673|NCT01225211|565351368|FG004|Overall Study|Other|0|||
156620674|NCT01225211|565351369|FG005|Overall Study|Other|0|||
156620675|NCT01225211|565351370|FG006|Overall Study|Other|0|||
156620676|NCT01225211|565351371|FG007|Overall Study|Other|0|||
156620677|NCT01225211|565351372|FG008|Overall Study|Other|0|||
156620678|NCT01225211|565351373|FG009|Overall Study|Other|1|||
156620679|NCT00537810|565351378|FG000|Overall Study|Withdrawal by Subject|4|||
156620680|NCT00537810|565351379|FG001|Overall Study|Withdrawal by Subject|11|||
156620681|NCT00537810|565351380|FG002|Overall Study|Withdrawal by Subject|4|||
156620682|NCT00537810|565351381|FG003|Overall Study|Withdrawal by Subject|3|||
156620683|NCT00537810|565351378|FG000|Overall Study|Medically withdrawn|2|||
156620684|NCT00537810|565351379|FG001|Overall Study|Medically withdrawn|2|||
156620685|NCT00537810|565351380|FG002|Overall Study|Medically withdrawn|0|||
156620686|NCT00537810|565351381|FG003|Overall Study|Medically withdrawn|1|||
156620687|NCT01066546|565351382|FG000|Overall Study|Study terminated by sponsor|5|||
156620688|NCT03452397|565351383|FG000|Overall Study|Adverse Event|1|||
156620689|NCT03452397|565351384|FG001|Overall Study|Adverse Event|0|||
156620690|NCT03452397|565351385|FG002|Overall Study|Adverse Event|0|||
156620691|NCT03452397|565351386|FG003|Overall Study|Adverse Event|0|||
156620692|NCT03452397|565351383|FG000|Overall Study|Administrative reason|0|||
156620693|NCT03452397|565351384|FG001|Overall Study|Administrative reason|0|||
156620694|NCT03452397|565351385|FG002|Overall Study|Administrative reason|1|||
156620695|NCT03452397|565351386|FG003|Overall Study|Administrative reason|1|||
156620696|NCT03452397|565351383|FG000|Overall Study|Withdrawal by Subject|0|||
156620697|NCT03452397|565351384|FG001|Overall Study|Withdrawal by Subject|0|||
156620698|NCT03452397|565351385|FG002|Overall Study|Withdrawal by Subject|1|||
156620699|NCT03452397|565351386|FG003|Overall Study|Withdrawal by Subject|0|||
156620700|NCT00410514|565351387|FG000|Overall Study|Adverse Event|2|||
156620701|NCT00410514|565351388|FG001|Overall Study|Adverse Event|2|||
156620702|NCT00410514|565351389|FG002|Overall Study|Adverse Event|2|||
156620703|NCT00410514|565351387|FG000|Overall Study|Protocol Violation|0|||
156620704|NCT00410514|565351388|FG001|Overall Study|Protocol Violation|1|||
156620705|NCT00410514|565351389|FG002|Overall Study|Protocol Violation|1|||
156620706|NCT00410514|565351387|FG000|Overall Study|Lost to Follow-up|0|||
156620707|NCT00410514|565351388|FG001|Overall Study|Lost to Follow-up|0|||
156620708|NCT00410514|565351389|FG002|Overall Study|Lost to Follow-up|2|||
156620709|NCT00410514|565351387|FG000|Overall Study|Non-compliant with study procedures|0|||
156620710|NCT00410514|565351388|FG001|Overall Study|Non-compliant with study procedures|0|||
156620711|NCT00410514|565351389|FG002|Overall Study|Non-compliant with study procedures|2|||
156620712|NCT01436357|565351390|FG000|Overall Study|Death|5|||
156620713|NCT01436357|565351391|FG001|Overall Study|Death|1|||
156620714|NCT01436357|565351390|FG000|Overall Study|Enrolled but not vaccinated|1|||
156620715|NCT01436357|565351391|FG001|Overall Study|Enrolled but not vaccinated|1|||
156620716|NCT01436357|565351390|FG000|Overall Study|Incarceration|18|||
156620717|NCT01436357|565351391|FG001|Overall Study|Incarceration|20|||
156620718|NCT01436357|565351390|FG000|Overall Study|Lost to Follow-up|67|||
156620719|NCT01436357|565351391|FG001|Overall Study|Lost to Follow-up|61|||
156620720|NCT01436357|565351390|FG000|Overall Study|Protocol Violation|1|||
156620721|NCT01436357|565351391|FG001|Overall Study|Protocol Violation|0|||
156620722|NCT01436357|565351390|FG000|Overall Study|Withdrawal by Subject|26|||
156620723|NCT01436357|565351391|FG001|Overall Study|Withdrawal by Subject|38|||
156620724|NCT01436357|565351390|FG000|Overall Study|Physician Decision|3|||
156620725|NCT01436357|565351391|FG001|Overall Study|Physician Decision|4|||
156620726|NCT01436357|565351390|FG000|Overall Study|Moved out of area|1|||
156620727|NCT01436357|565351391|FG001|Overall Study|Moved out of area|2|||
156620728|NCT01436357|565351390|FG000|Overall Study|Subject in rehab|0|||
156620729|NCT01436357|565351391|FG001|Overall Study|Subject in rehab|1|||
156620730|NCT02390167|565352476|FG000|Overall Study|Lost to Follow-up|1|||
156620731|NCT01265719|565352478|FG000|Overall Study|Does not meet entrance criteria|0|||
156620732|NCT01265719|565352479|FG001|Overall Study|Does not meet entrance criteria|3|||
156620733|NCT01265719|565352478|FG000|Overall Study|Other reasons|2|||
156620734|NCT01265719|565352479|FG001|Overall Study|Other reasons|0|||
156620735|NCT01265719|565352478|FG000|Overall Study|Withdrawal by Subject|8|||
156620736|NCT01265719|565352479|FG001|Overall Study|Withdrawal by Subject|3|||
156620737|NCT01265719|565352478|FG000|Overall Study|Lost to Follow-up|2|||
156620738|NCT01265719|565352479|FG001|Overall Study|Lost to Follow-up|7|||
156620739|NCT01265719|565352478|FG000|Overall Study|Adverse Event|2|||
156620740|NCT01265719|565352479|FG001|Overall Study|Adverse Event|0|||
156620741|NCT01451203|565352482|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
156620742|NCT01451203|565352483|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
156620743|NCT01451203|565352482|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
156620744|NCT01451203|565352483|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
156620745|NCT01451203|565352482|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
156620746|NCT01451203|565352483|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
156620747|NCT01451203|565352482|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
156620748|NCT01451203|565352483|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
156620749|NCT01451203|565352482|FG000|Double-blind Treatment Period|Adverse Event|6|||
156620750|NCT01451203|565352483|FG001|Double-blind Treatment Period|Adverse Event|9|||
156620751|NCT01451203|565352482|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
156620752|NCT01451203|565352483|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
156620753|NCT01451203|565352482|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
156620754|NCT01451203|565352483|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
156620755|NCT01451203|565352482|FG000|Double-blind Treatment Period|Investigator decision|2|||
156620756|NCT01451203|565352483|FG001|Double-blind Treatment Period|Investigator decision|0|||
156620757|NCT01451203|565352482|FG000|Post-treatment Period|Consent withdrawn|2|||
156620758|NCT01451203|565352483|FG001|Post-treatment Period|Consent withdrawn|4|||
156620759|NCT01451203|565352482|FG000|Post-treatment Period|Lack of Efficacy|12|||
156620760|NCT01451203|565352483|FG001|Post-treatment Period|Lack of Efficacy|28|||
156620761|NCT01451203|565352482|FG000|Post-treatment Period|Adverse Event|0|||
156620762|NCT01451203|565352483|FG001|Post-treatment Period|Adverse Event|1|||
156620763|NCT01451203|565352482|FG000|Post-treatment Period|Investigator decision|0|||
156620764|NCT01451203|565352483|FG001|Post-treatment Period|Investigator decision|1|||
156620765|NCT02554721|565352484|FG000|Overall Study|Adverse Event|1|||
156620766|NCT02554721|565352485|FG001|Overall Study|Adverse Event|0|||
156620767|NCT02554721|565352486|FG002|Overall Study|Adverse Event|0|||
156620768|NCT02554721|565352487|FG003|Overall Study|Adverse Event|0|||
156620769|NCT02554721|565352488|FG004|Overall Study|Adverse Event|1|||
156620770|NCT02554721|565352484|FG000|Overall Study|Noncompliance|0|||
156620771|NCT02554721|565352485|FG001|Overall Study|Noncompliance|0|||
156620772|NCT02554721|565352486|FG002|Overall Study|Noncompliance|0|||
156620773|NCT02554721|565352487|FG003|Overall Study|Noncompliance|0|||
156620774|NCT02554721|565352488|FG004|Overall Study|Noncompliance|1|||
156620775|NCT00626327|565352494|FG000|Overall Study|Withdrawal by Subject|21|||
156620776|NCT00626327|565352495|FG001|Overall Study|Withdrawal by Subject|29|||
156620777|NCT00626327|565352496|FG002|Overall Study|Withdrawal by Subject|30|||
156620778|NCT00626327|565352494|FG000|Overall Study|Adverse Event|1|||
156620779|NCT00626327|565352495|FG001|Overall Study|Adverse Event|0|||
156620780|NCT00626327|565352496|FG002|Overall Study|Adverse Event|0|||
156620781|NCT00626327|565352494|FG000|Overall Study|Lost to Follow-up|24|||
156620782|NCT00626327|565352495|FG001|Overall Study|Lost to Follow-up|21|||
156620783|NCT00626327|565352496|FG002|Overall Study|Lost to Follow-up|23|||
156620784|NCT00626327|565352494|FG000|Overall Study|Inappropriate enrollment|4|||
156620785|NCT00626327|565352495|FG001|Overall Study|Inappropriate enrollment|5|||
156620786|NCT00626327|565352496|FG002|Overall Study|Inappropriate enrollment|3|||
156620787|NCT00626327|565352494|FG000|Overall Study|Administrative Reason|2|||
156620788|NCT00626327|565352495|FG001|Overall Study|Administrative Reason|0|||
156620789|NCT00626327|565352496|FG002|Overall Study|Administrative Reason|6|||
156620790|NCT00626327|565352494|FG000|Overall Study|Protocol Violation|26|||
156620791|NCT00626327|565352495|FG001|Overall Study|Protocol Violation|4|||
156620792|NCT00626327|565352496|FG002|Overall Study|Protocol Violation|26|||
156620793|NCT00945945|565352497|FG000|Overall Study|Adverse Event|15|||
156620794|NCT00945945|565352498|FG001|Overall Study|Adverse Event|35|||
156620795|NCT00945945|565352497|FG000|Overall Study|Withdrawal by Subject|7|||
156620796|NCT00945945|565352498|FG001|Overall Study|Withdrawal by Subject|10|||
156620797|NCT00945945|565352497|FG000|Overall Study|Lost to Follow-up|4|||
156620798|NCT00945945|565352498|FG001|Overall Study|Lost to Follow-up|5|||
156620799|NCT00945945|565352497|FG000|Overall Study|Lack of Efficacy|6|||
156620800|NCT00945945|565352498|FG001|Overall Study|Lack of Efficacy|2|||
156620801|NCT00945945|565352497|FG000|Overall Study|Protocol Violation|4|||
156620802|NCT00945945|565352498|FG001|Overall Study|Protocol Violation|2|||
156620803|NCT00945945|565352497|FG000|Overall Study|Entry Criteria Not Met|0|||
156620804|NCT00945945|565352498|FG001|Overall Study|Entry Criteria Not Met|1|||
156620805|NCT04880642|565352501|FG000|Randomization|Withdrawal by Subject|2|||
156620806|NCT04880642|565352502|FG001|Randomization|Withdrawal by Subject|3|||
156620807|NCT04880642|565352501|FG000|Treatment Period|Adverse Event|0|||
156620808|NCT04880642|565352502|FG001|Treatment Period|Adverse Event|1|||
156620809|NCT04880642|565352501|FG000|Treatment Period|Death|6|||
156620810|NCT04880642|565352502|FG001|Treatment Period|Death|6|||
156620811|NCT04880642|565352501|FG000|Treatment Period|Lost to Follow-up|1|||
156620812|NCT04880642|565352502|FG001|Treatment Period|Lost to Follow-up|0|||
156620813|NCT04880642|565352501|FG000|Treatment Period|Protocol Violation|0|||
156620814|NCT04880642|565352502|FG001|Treatment Period|Protocol Violation|1|||
156620815|NCT04880642|565352501|FG000|Treatment Period|Withdrawal by Subject|5|||
156620816|NCT04880642|565352502|FG001|Treatment Period|Withdrawal by Subject|3|||
156620817|NCT04880642|565352501|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
156620818|NCT04880642|565352502|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
156620819|NCT04880642|565352501|FG000|Follow-up|Death|4|||
156620820|NCT04880642|565352502|FG001|Follow-up|Death|3|||
156620821|NCT04880642|565352501|FG000|Follow-up|Withdrawal by Subject|1|||
156620822|NCT04880642|565352502|FG001|Follow-up|Withdrawal by Subject|0|||
156620823|NCT04235959|565352504|FG000|Overall Study|Protocol Violation|0|||
156620824|NCT04235959|565352505|FG001|Overall Study|Protocol Violation|1|||
156620825|NCT04235959|565352506|FG002|Overall Study|Protocol Violation|0|||
156620826|NCT04235959|565352504|FG000|Overall Study|Adverse Event|1|||
156620827|NCT04235959|565352505|FG001|Overall Study|Adverse Event|0|||
156620828|NCT04235959|565352506|FG002|Overall Study|Adverse Event|0|||
156620829|NCT00125138|565352507|FG000|Overall Study|Adverse Event|1|||
156620830|NCT00125138|565352508|FG001|Overall Study|Adverse Event|0|||
156620831|NCT00125138|565352509|FG002|Overall Study|Adverse Event|3|||
156620832|NCT00125138|565352510|FG003|Overall Study|Adverse Event|2|||
156620833|NCT00125138|565352507|FG000|Overall Study|Withdrawal by Subject|2|||
156620834|NCT00125138|565352508|FG001|Overall Study|Withdrawal by Subject|3|||
156620835|NCT00125138|565352509|FG002|Overall Study|Withdrawal by Subject|1|||
156620836|NCT00125138|565352510|FG003|Overall Study|Withdrawal by Subject|1|||
156620837|NCT00125138|565352507|FG000|Overall Study|Lack of Efficacy|0|||
156620838|NCT00125138|565352508|FG001|Overall Study|Lack of Efficacy|0|||
156620839|NCT00125138|565352509|FG002|Overall Study|Lack of Efficacy|0|||
156620840|NCT00125138|565352510|FG003|Overall Study|Lack of Efficacy|1|||
156620841|NCT00125138|565352507|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
156620842|NCT00125138|565352508|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
156620843|NCT00125138|565352509|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
156620844|NCT00125138|565352510|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
156620845|NCT03228836|565352515|FG000|Overall Study|Adverse Event|3|||
156620846|NCT03228836|565352515|FG000|Overall Study|Withdrawal by Subject|1|||
156620847|NCT03228836|565352515|FG000|Overall Study|Death|1|||
156620848|NCT03228836|565352515|FG000|Overall Study|Physician Decision|1|||
156620849|NCT03228836|565352515|FG000|Overall Study|Disease Progression|7|||
156620850|NCT03228836|565352515|FG000|Overall Study|Other|4|||
156620851|NCT01611558|565352518|FG000|Induction Phase|Study drug toxicity|15|||
156620852|NCT01611558|565352518|FG000|Induction Phase|Disease progression|18|||
156620853|NCT01611558|565352518|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
156620854|NCT01611558|565352518|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
156620855|NCT01611558|565352518|FG000|Induction Phase|Death|1|||
156620856|NCT01611558|565352518|FG000|Maintenance Phase|Withdrawal by Subject|1|||
156620857|NCT01611558|565352518|FG000|Maintenance Phase|Elevated Uric acid|1|||
156620858|NCT04005885|565352532|FG000|First Intervention|Withdrawal by Subject|1|||
156620859|NCT04005885|565352533|FG001|First Intervention|Withdrawal by Subject|1|||
156620860|NCT04005885|565352532|FG000|Second Intervention|Withdrawal by Subject|0|||
156620861|NCT04005885|565352533|FG001|Second Intervention|Withdrawal by Subject|2|||
156620862|NCT01412333|565352534|FG000|Overall Study|Adverse Event|40|||
156620863|NCT01412333|565352535|FG001|Overall Study|Adverse Event|42|||
156620864|NCT01412333|565352534|FG000|Overall Study|Death|5|||
156620865|NCT01412333|565352535|FG001|Overall Study|Death|6|||
156620866|NCT01412333|565352534|FG000|Overall Study|Lack of Efficacy|22|||
156620867|NCT01412333|565352535|FG001|Overall Study|Lack of Efficacy|10|||
156620868|NCT01412333|565352534|FG000|Overall Study|Lost to Follow-up|15|||
156620869|NCT01412333|565352535|FG001|Overall Study|Lost to Follow-up|12|||
156620870|NCT01412333|565352534|FG000|Overall Study|Non-Compliance|3|||
156620871|NCT01412333|565352535|FG001|Overall Study|Non-Compliance|7|||
156620872|NCT01412333|565352534|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156620873|NCT01412333|565352535|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156620874|NCT01412333|565352534|FG000|Overall Study|Other|30|||
156620875|NCT01412333|565352535|FG001|Overall Study|Other|33|||
156620876|NCT01412333|565352534|FG000|Overall Study|Physician Decision|11|||
156620877|NCT01412333|565352535|FG001|Overall Study|Physician Decision|16|||
156620878|NCT01412333|565352534|FG000|Overall Study|Pregnancy|6|||
156620879|NCT01412333|565352535|FG001|Overall Study|Pregnancy|4|||
156620880|NCT01412333|565352534|FG000|Overall Study|Protocol Violation|1|||
156620881|NCT01412333|565352535|FG001|Overall Study|Protocol Violation|2|||
156620882|NCT01412333|565352534|FG000|Overall Study|Study Terminated By Sponsor|3|||
156620883|NCT01412333|565352535|FG001|Overall Study|Study Terminated By Sponsor|2|||
156620884|NCT01412333|565352534|FG000|Overall Study|Withdrawal by Subject|51|||
156620885|NCT01412333|565352535|FG001|Overall Study|Withdrawal by Subject|54|||
156620886|NCT01412333|565352534|FG000|Overall Study|Missing|1|||
156620887|NCT01412333|565352535|FG001|Overall Study|Missing|3|||
156620888|NCT00750867|565352538|FG000|Overall Study|Adverse Event|2|||
156620889|NCT00394654|565352539|FG000|Overall Study|Lost to Follow-up|1|||
156620890|NCT00394654|565352540|FG001|Overall Study|Lost to Follow-up|0|||
156620891|NCT00394654|565352539|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
156620892|NCT00394654|565352540|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
156620893|NCT00474539|565352541|FG000|Infant Series|Withdrawal by Subject|3|||
156620894|NCT00474539|565352542|FG001|Infant Series|Withdrawal by Subject|4|||
156620895|NCT00474539|565352541|FG000|Infant Series|Randomization error|5|||
156620896|NCT00474539|565352542|FG001|Infant Series|Randomization error|0|||
156620897|NCT00474539|565352541|FG000|Infant Series|Lost to Follow-up|2|||
156620898|NCT00474539|565352542|FG001|Infant Series|Lost to Follow-up|1|||
156620899|NCT00474539|565352541|FG000|Infant Series|Protocol Violation|0|||
156620900|NCT00474539|565352542|FG001|Infant Series|Protocol Violation|1|||
156620901|NCT00474539|565352541|FG000|After Infant Series|Lost to Follow-up|3|||
156620902|NCT00474539|565352542|FG001|After Infant Series|Lost to Follow-up|0|||
156620903|NCT00474539|565352541|FG000|After Infant Series|Withdrawal by Subject|1|||
156620904|NCT00474539|565352542|FG001|After Infant Series|Withdrawal by Subject|0|||
156620905|NCT00474539|565352541|FG000|Toddler Dose|Protocol Violation|1|||
156620906|NCT00474539|565352542|FG001|Toddler Dose|Protocol Violation|0|||
156620907|NCT03442595|565352543|FG000|Overall Study|Lost to Follow-up|94|||
156620908|NCT03442595|565352544|FG001|Overall Study|Lost to Follow-up|0|||
156620909|NCT00598585|565352545|FG000|Overall Study|Lost to Follow-up|1|||
156620910|NCT00598585|565352546|FG001|Overall Study|Lost to Follow-up|0|||
156620911|NCT00542425|565352548|FG000|Initial 24 Weeks|Administrative reasons|0|||
156620912|NCT00542425|565352549|FG001|Initial 24 Weeks|Administrative reasons|0|||
156620913|NCT00542425|565352550|FG002|Initial 24 Weeks|Administrative reasons|1|||
156620914|NCT00542425|565352551|FG003|Initial 24 Weeks|Administrative reasons|1|||
156620915|NCT00542425|565352552|FG004|Initial 24 Weeks|Administrative reasons|0|||
156620916|NCT00542425|565352548|FG000|Initial 24 Weeks|Adverse Event|0|||
156620917|NCT00542425|565352549|FG001|Initial 24 Weeks|Adverse Event|1|||
156620918|NCT00542425|565352550|FG002|Initial 24 Weeks|Adverse Event|1|||
156620919|NCT00542425|565352551|FG003|Initial 24 Weeks|Adverse Event|3|||
156620920|NCT00542425|565352552|FG004|Initial 24 Weeks|Adverse Event|2|||
156620921|NCT00542425|565352548|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
156620922|NCT00542425|565352549|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
156620923|NCT00542425|565352550|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
156620924|NCT00542425|565352551|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
156620925|NCT00542425|565352552|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
156620926|NCT00542425|565352548|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
156620927|NCT00542425|565352549|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
156620928|NCT00542425|565352550|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
156620929|NCT00542425|565352551|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
156620930|NCT00542425|565352552|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
156620931|NCT00542425|565352548|FG000|Initial 24 Weeks|Non-compliance|0|||
156620932|NCT00542425|565352549|FG001|Initial 24 Weeks|Non-compliance|0|||
156620933|NCT00542425|565352550|FG002|Initial 24 Weeks|Non-compliance|0|||
156620934|NCT00542425|565352551|FG003|Initial 24 Weeks|Non-compliance|1|||
156620935|NCT00542425|565352552|FG004|Initial 24 Weeks|Non-compliance|1|||
156620936|NCT00542425|565352548|FG000|Initial 24 Weeks|Protocol Violation|0|||
156620937|NCT00542425|565352549|FG001|Initial 24 Weeks|Protocol Violation|0|||
156620938|NCT00542425|565352550|FG002|Initial 24 Weeks|Protocol Violation|0|||
156620939|NCT00542425|565352551|FG003|Initial 24 Weeks|Protocol Violation|1|||
156620940|NCT00542425|565352552|FG004|Initial 24 Weeks|Protocol Violation|0|||
156620941|NCT00542425|565352548|FG000|Initial 24 Weeks|Refusal of treatment|2|||
156620942|NCT00542425|565352549|FG001|Initial 24 Weeks|Refusal of treatment|2|||
156620943|NCT00542425|565352550|FG002|Initial 24 Weeks|Refusal of treatment|1|||
156620944|NCT00542425|565352551|FG003|Initial 24 Weeks|Refusal of treatment|4|||
156620945|NCT00542425|565352552|FG004|Initial 24 Weeks|Refusal of treatment|1|||
156620946|NCT00542425|565352548|FG000|Initial 24 Weeks|Other|0|||
156620947|NCT00542425|565352549|FG001|Initial 24 Weeks|Other|2|||
156620948|NCT00542425|565352550|FG002|Initial 24 Weeks|Other|1|||
156620949|NCT00542425|565352551|FG003|Initial 24 Weeks|Other|0|||
156620950|NCT00542425|565352552|FG004|Initial 24 Weeks|Other|0|||
156620951|NCT00542425|565352548|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
156620952|NCT00542425|565352549|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
156620953|NCT00542425|565352550|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
156620954|NCT00542425|565352551|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
156620955|NCT00542425|565352552|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
156620956|NCT00542425|565352548|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
156620957|NCT00542425|565352549|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
156620958|NCT00542425|565352550|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
156620959|NCT00542425|565352551|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
156620960|NCT00542425|565352552|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
156620961|NCT00542425|565352548|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
156620962|NCT00542425|565352549|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
156620963|NCT00542425|565352550|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
156620964|NCT00542425|565352551|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
156620965|NCT00542425|565352552|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
156620966|NCT00542425|565352548|FG000|Extended 24 Weeks of Treatment|Other|1|||
156620967|NCT00542425|565352549|FG001|Extended 24 Weeks of Treatment|Other|1|||
156620968|NCT00542425|565352550|FG002|Extended 24 Weeks of Treatment|Other|0|||
156620969|NCT00542425|565352551|FG003|Extended 24 Weeks of Treatment|Other|0|||
156620970|NCT00542425|565352552|FG004|Extended 24 Weeks of Treatment|Other|1|||
156620971|NCT00472043|565352554|FG000|Overall Study|Withdrawal by Subject|1|||
156620972|NCT00472043|565352555|FG001|Overall Study|Withdrawal by Subject|0|||
156620973|NCT00472043|565352554|FG000|Overall Study|Death|1|||
156620974|NCT00472043|565352555|FG001|Overall Study|Death|0|||
156620975|NCT02590406|565352557|FG000|Overall Study|Adverse Event|1|||
156620976|NCT02590406|565352558|FG001|Overall Study|Adverse Event|0|||
156620977|NCT02590406|565352557|FG000|Overall Study|Saturometer malfunction|0|||
156620978|NCT02590406|565352558|FG001|Overall Study|Saturometer malfunction|1|||
156620979|NCT03032523|565352559|FG000|Overall Study|Withdrawal by Subject|2|||
156620980|NCT03032523|565352560|FG001|Overall Study|Withdrawal by Subject|2|||
156620981|NCT03032523|565352559|FG000|Overall Study|Physician Decision|1|||
156620982|NCT03032523|565352560|FG001|Overall Study|Physician Decision|0|||
156620983|NCT00957723|565352561|FG000|Overall Study|Death|3|||
156620984|NCT00957723|565352561|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
156620985|NCT00957723|565352561|FG000|Overall Study|Lost to Follow-up|8|||
156620986|NCT00957723|565352561|FG000|Overall Study|Withdrawal by Subject|24|||
156620987|NCT00957723|565352561|FG000|Overall Study|Investigative Site Terminated|61|||
156620988|NCT00957723|565352561|FG000|Overall Study|Intercurrent Illness|2|||
156620989|NCT00957723|565352561|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
156620990|NCT05375838|565352562|FG000|Overall Study|Other|0|||
156620991|NCT05375838|565352563|FG001|Overall Study|Other|0|||
156620992|NCT05375838|565352564|FG002|Overall Study|Other|0|||
156620993|NCT05375838|565352565|FG003|Overall Study|Other|1|||
156620994|NCT05375838|565352566|FG004|Overall Study|Other|1|||
156620995|NCT05375838|565352567|FG005|Overall Study|Other|0|||
156620996|NCT05375838|565352562|FG000|Overall Study|Withdrawal by Subject|2|||
156620997|NCT05375838|565352563|FG001|Overall Study|Withdrawal by Subject|1|||
156620998|NCT05375838|565352564|FG002|Overall Study|Withdrawal by Subject|3|||
156620999|NCT05375838|565352565|FG003|Overall Study|Withdrawal by Subject|2|||
156621000|NCT05375838|565352566|FG004|Overall Study|Withdrawal by Subject|2|||
156621001|NCT05375838|565352567|FG005|Overall Study|Withdrawal by Subject|0|||
156621002|NCT05375838|565352562|FG000|Overall Study|Protocol Violation|0|||
156621003|NCT05375838|565352563|FG001|Overall Study|Protocol Violation|0|||
156621004|NCT05375838|565352564|FG002|Overall Study|Protocol Violation|0|||
156621005|NCT05375838|565352565|FG003|Overall Study|Protocol Violation|0|||
156621006|NCT05375838|565352566|FG004|Overall Study|Protocol Violation|1|||
156621007|NCT05375838|565352567|FG005|Overall Study|Protocol Violation|0|||
156621008|NCT05375838|565352562|FG000|Overall Study|Physician Decision|0|||
156621009|NCT05375838|565352563|FG001|Overall Study|Physician Decision|1|||
156621010|NCT05375838|565352564|FG002|Overall Study|Physician Decision|0|||
156621011|NCT05375838|565352565|FG003|Overall Study|Physician Decision|0|||
156621012|NCT05375838|565352566|FG004|Overall Study|Physician Decision|0|||
156621013|NCT05375838|565352567|FG005|Overall Study|Physician Decision|1|||
156621014|NCT05375838|565352562|FG000|Overall Study|Lost to Follow-up|2|||
156621015|NCT05375838|565352563|FG001|Overall Study|Lost to Follow-up|7|||
156621016|NCT05375838|565352564|FG002|Overall Study|Lost to Follow-up|0|||
156621017|NCT05375838|565352565|FG003|Overall Study|Lost to Follow-up|4|||
156621018|NCT05375838|565352566|FG004|Overall Study|Lost to Follow-up|2|||
156621019|NCT05375838|565352567|FG005|Overall Study|Lost to Follow-up|3|||
156621020|NCT02178592|565352568|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
156621021|NCT02178592|565352569|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
156621022|NCT02178592|565352568|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
156621023|NCT02178592|565352569|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
156621024|NCT02178592|565352568|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
156621025|NCT02178592|565352569|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
156621026|NCT02178592|565352568|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
156621027|NCT02178592|565352569|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
156621028|NCT02178592|565352568|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
156621029|NCT02178592|565352569|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
156621030|NCT02178592|565352568|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
156621031|NCT02178592|565352569|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
156621032|NCT02178592|565352568|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
156621033|NCT02178592|565352569|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
156621034|NCT02178592|565352568|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
156621035|NCT02178592|565352569|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
156621036|NCT02178592|565352568|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
156621037|NCT02178592|565352569|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
156621038|NCT02178592|565352568|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
156621039|NCT02178592|565352569|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
156621040|NCT02178592|565352568|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
156621041|NCT02178592|565352569|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
156621042|NCT02178592|565352568|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
156621043|NCT02178592|565352569|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
156621044|NCT02036476|565352572|FG000|Overall Study|Withdrawal by Subject|2|||
156621045|NCT02036476|565352572|FG000|Overall Study|Progressive Disease|4|||
156621046|NCT02036476|565352572|FG000|Overall Study|Unacceptable Toxicity|2|||
156621047|NCT01984294|565352575|FG000|Overall Study|Randomized but Never Treated|0|||
156621048|NCT01984294|565352576|FG001|Overall Study|Randomized but Never Treated|0|||
156621049|NCT01984294|565352577|FG002|Overall Study|Randomized but Never Treated|1|||
156621050|NCT01984294|565352575|FG000|Overall Study|Lack of Efficacy|4|||
156621051|NCT01984294|565352576|FG001|Overall Study|Lack of Efficacy|2|||
156621052|NCT01984294|565352577|FG002|Overall Study|Lack of Efficacy|6|||
156621053|NCT01984294|565352575|FG000|Overall Study|Adverse Event|0|||
156621054|NCT01984294|565352576|FG001|Overall Study|Adverse Event|1|||
156621055|NCT01984294|565352577|FG002|Overall Study|Adverse Event|0|||
156621056|NCT02698176|565352578|FG000|Overall Study|Progressive disease|4|||
156621057|NCT02698176|565352579|FG001|Overall Study|Progressive disease|3|||
156621058|NCT02698176|565352580|FG002|Overall Study|Progressive disease|1|||
156621059|NCT02698176|565352581|FG003|Overall Study|Progressive disease|0|||
156621060|NCT02698176|565352578|FG000|Overall Study|Adverse Event|2|||
156621061|NCT02698176|565352579|FG001|Overall Study|Adverse Event|0|||
156621062|NCT02698176|565352580|FG002|Overall Study|Adverse Event|0|||
156621063|NCT02698176|565352581|FG003|Overall Study|Adverse Event|0|||
156621064|NCT02698176|565352578|FG000|Overall Study|Clinical progression|3|||
156621065|NCT02698176|565352579|FG001|Overall Study|Clinical progression|0|||
156621066|NCT02698176|565352580|FG002|Overall Study|Clinical progression|0|||
156621067|NCT02698176|565352581|FG003|Overall Study|Clinical progression|0|||
156621068|NCT02985684|565352584|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
156621069|NCT02985684|565352584|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
156621070|NCT02985684|565352584|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
156621071|NCT02449915|565352585|FG000|Overall Study|Exclusion criteria - drug use|1|||
156621072|NCT02449915|565352586|FG001|Overall Study|Exclusion criteria - drug use|0|||
156621073|NCT02449915|565352585|FG000|Overall Study|Withdrawal by Subject|0|||
156621074|NCT02449915|565352586|FG001|Overall Study|Withdrawal by Subject|2|||
156621075|NCT02449915|565352585|FG000|Overall Study|Intraoperative surgical findings|1|||
156621076|NCT02449915|565352586|FG001|Overall Study|Intraoperative surgical findings|1|||
156621077|NCT02449915|565352585|FG000|Overall Study|Abnormal preop lab|0|||
156621078|NCT02449915|565352586|FG001|Overall Study|Abnormal preop lab|1|||
156621079|NCT01021293|565352592|FG000|Overall Study|Serious Adverse Event|2|||
156621080|NCT01021293|565352593|FG001|Overall Study|Serious Adverse Event|1|||
156621081|NCT01021293|565352592|FG000|Overall Study|Adverse Event|2|||
156621082|NCT01021293|565352593|FG001|Overall Study|Adverse Event|1|||
156621083|NCT01021293|565352592|FG000|Overall Study|Withdrawal by Subject|1|||
156621084|NCT01021293|565352593|FG001|Overall Study|Withdrawal by Subject|3|||
156621085|NCT01021293|565352592|FG000|Overall Study|Migrated/moved from study area|6|||
156621086|NCT01021293|565352593|FG001|Overall Study|Migrated/moved from study area|18|||
156621087|NCT01021293|565352592|FG000|Overall Study|Lost to Follow-up|1|||
156621088|NCT01021293|565352593|FG001|Overall Study|Lost to Follow-up|1|||
156621089|NCT01084096|565354254|FG000|Overall Study|Lost to Follow-up|1501|||
156621090|NCT01084096|565354255|FG001|Overall Study|Lost to Follow-up|1833|||
156621091|NCT01084096|565354254|FG000|Overall Study|Withdrawal by Subject|3|||
156621092|NCT01084096|565354255|FG001|Overall Study|Withdrawal by Subject|0|||
156621093|NCT01084096|565354254|FG000|Overall Study|Woman had a miscarriage|21|||
156621094|NCT01084096|565354255|FG001|Overall Study|Woman had a miscarriage|17|||
156621095|NCT02033369|565354256|FG000|Overall Study|Physician Decision|1|||
156621096|NCT02033369|565354257|FG001|Overall Study|Physician Decision|2|||
156621097|NCT02033369|565354256|FG000|Overall Study|Not a good demographic match|0|||
156621098|NCT02033369|565354257|FG001|Overall Study|Not a good demographic match|2|||
156621099|NCT02033369|565354256|FG000|Overall Study|Withdrawal by Subject|1|||
156621100|NCT02033369|565354257|FG001|Overall Study|Withdrawal by Subject|1|||
156621101|NCT02033369|565354256|FG000|Overall Study|Lost to Follow-up|1|||
156621102|NCT02033369|565354257|FG001|Overall Study|Lost to Follow-up|0|||
156621103|NCT02033369|565354256|FG000|Overall Study|Protocol Violation|2|||
156621104|NCT02033369|565354257|FG001|Overall Study|Protocol Violation|0|||
156621105|NCT04335929|565354258|FG000|Overall Study|Lost to Follow-up|10|||
156621106|NCT02967562|565354259|FG000|Overall Study|Consent not obtained|1|||
156621107|NCT02967562|565354260|FG001|Overall Study|Consent not obtained|0|||
156621108|NCT02967562|565354259|FG000|Overall Study|High leak precluding analysis|1|||
156621109|NCT02967562|565354260|FG001|Overall Study|High leak precluding analysis|1|||
156621110|NCT00286156|565354261|FG000|Overall Study|Missed 12 month visit|0|||
156621111|NCT00286156|565354262|FG001|Overall Study|Missed 12 month visit|0|||
156621112|NCT00286156|565354263|FG002|Overall Study|Missed 12 month visit|1|||
156621113|NCT00286156|565354261|FG000|Overall Study|AE: pulmonary embolus|0|||
156621114|NCT00286156|565354262|FG001|Overall Study|AE: pulmonary embolus|1|||
156621115|NCT00286156|565354263|FG002|Overall Study|AE: pulmonary embolus|0|||
156621116|NCT00286156|565354261|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
156621117|NCT00286156|565354262|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
156621118|NCT00286156|565354263|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
156621119|NCT00286156|565354261|FG000|Overall Study|AE: pneumonia|1|||
156621120|NCT00286156|565354262|FG001|Overall Study|AE: pneumonia|0|||
156621121|NCT00286156|565354263|FG002|Overall Study|AE: pneumonia|0|||
156621122|NCT02870348|565354267|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
156621123|NCT01051856|565354268|FG000|Overall Study|Withdrawal by Subject|1|||
156621124|NCT01051856|565354269|FG001|Overall Study|Withdrawal by Subject|0|||
156621125|NCT00672139|565354270|FG000|Overall Study|Death|14|||
156621126|NCT00672139|565354271|FG001|Overall Study|Death|23|||
156621127|NCT00672139|565354270|FG000|Overall Study|Withdrawal by Subject|2|||
156621128|NCT00672139|565354271|FG001|Overall Study|Withdrawal by Subject|11|||
156621129|NCT00672139|565354270|FG000|Overall Study|Adverse Event|4|||
156621130|NCT00672139|565354271|FG001|Overall Study|Adverse Event|7|||
156621131|NCT00672139|565354270|FG000|Overall Study|Physician Decision|2|||
156621132|NCT00672139|565354271|FG001|Overall Study|Physician Decision|0|||
156621133|NCT00672139|565354270|FG000|Overall Study|Lack of Efficacy|4|||
156621134|NCT00672139|565354271|FG001|Overall Study|Lack of Efficacy|1|||
156621135|NCT00672139|565354270|FG000|Overall Study|Protocol Violation|1|||
156621136|NCT00672139|565354271|FG001|Overall Study|Protocol Violation|1|||
156621137|NCT00672139|565354270|FG000|Overall Study|hospice discharge, caregiver requests|3|||
156621138|NCT00672139|565354271|FG001|Overall Study|hospice discharge, caregiver requests|2|||
156621139|NCT02381795|565354272|FG000|Overall Study|Withdrawal by Subject|1|||
156621140|NCT02381795|565354272|FG000|Overall Study|Study Terminated|2|||
156621141|NCT02176226|565354273|FG000|Overall Study|Lost to Follow-up|3|||
156621142|NCT02176226|565354273|FG000|Overall Study|Withdrew prior to treatment|6|||
156621143|NCT01488994|565354278|FG000|Overall Study|Withdrawal by Subject|0|||
156621144|NCT01488994|565354279|FG001|Overall Study|Withdrawal by Subject|1|||
156621145|NCT02908841|565354280|FG000|Overall Study|Physician Decision|4|||
156621146|NCT02908841|565354281|FG001|Overall Study|Physician Decision|0|||
156621147|NCT01117428|565354284|FG000|Overall Study|Lack of Efficacy|1|||
156621148|NCT01117428|565354285|FG001|Overall Study|Lack of Efficacy|0|||
156621149|NCT01117428|565354286|FG002|Overall Study|Lack of Efficacy|0|||
156621150|NCT01117428|565354287|FG003|Overall Study|Lack of Efficacy|0|||
156621151|NCT01117428|565354288|FG004|Overall Study|Lack of Efficacy|0|||
156621152|NCT01117428|565354289|FG005|Overall Study|Lack of Efficacy|0|||
156621153|NCT01117428|565354284|FG000|Overall Study|Adverse Event|4|||
156621154|NCT01117428|565354285|FG001|Overall Study|Adverse Event|0|||
156621155|NCT01117428|565354286|FG002|Overall Study|Adverse Event|0|||
156621156|NCT01117428|565354287|FG003|Overall Study|Adverse Event|0|||
156621157|NCT01117428|565354288|FG004|Overall Study|Adverse Event|1|||
156621158|NCT01117428|565354289|FG005|Overall Study|Adverse Event|2|||
156621159|NCT01117428|565354284|FG000|Overall Study|Death|0|||
156621160|NCT01117428|565354285|FG001|Overall Study|Death|1|||
156621161|NCT01117428|565354286|FG002|Overall Study|Death|2|||
156621162|NCT01117428|565354287|FG003|Overall Study|Death|0|||
156621163|NCT01117428|565354288|FG004|Overall Study|Death|0|||
156621164|NCT01117428|565354289|FG005|Overall Study|Death|1|||
156621165|NCT01117428|565354284|FG000|Overall Study|Physician Decision|0|||
156621166|NCT01117428|565354285|FG001|Overall Study|Physician Decision|1|||
156621167|NCT01117428|565354286|FG002|Overall Study|Physician Decision|0|||
156621168|NCT01117428|565354287|FG003|Overall Study|Physician Decision|0|||
156621169|NCT01117428|565354288|FG004|Overall Study|Physician Decision|0|||
156621170|NCT01117428|565354289|FG005|Overall Study|Physician Decision|0|||
156621171|NCT01117428|565354284|FG000|Overall Study|Withdrawal by Subject|0|||
156621172|NCT01117428|565354285|FG001|Overall Study|Withdrawal by Subject|0|||
156621173|NCT01117428|565354286|FG002|Overall Study|Withdrawal by Subject|1|||
156621174|NCT01117428|565354287|FG003|Overall Study|Withdrawal by Subject|0|||
156621175|NCT01117428|565354288|FG004|Overall Study|Withdrawal by Subject|0|||
156621176|NCT01117428|565354289|FG005|Overall Study|Withdrawal by Subject|0|||
156621177|NCT01117428|565354284|FG000|Overall Study|Progressive disease|15|||
156621178|NCT01117428|565354285|FG001|Overall Study|Progressive disease|27|||
156621179|NCT01117428|565354286|FG002|Overall Study|Progressive disease|10|||
156621180|NCT01117428|565354287|FG003|Overall Study|Progressive disease|12|||
156621181|NCT01117428|565354288|FG004|Overall Study|Progressive disease|16|||
156621182|NCT01117428|565354289|FG005|Overall Study|Progressive disease|17|||
156621183|NCT02519777|565354290|FG000|Overall Study|Death|1|||
156621184|NCT02519777|565354291|FG001|Overall Study|Death|0|||
156621185|NCT02519777|565354292|FG002|Overall Study|Death|0|||
156621186|NCT02519777|565354290|FG000|Overall Study|Lost to Follow-up|0|||
156621187|NCT02519777|565354291|FG001|Overall Study|Lost to Follow-up|4|||
156621188|NCT02519777|565354292|FG002|Overall Study|Lost to Follow-up|2|||
156621189|NCT02519777|565354290|FG000|Overall Study|Withdrawal by Subject|3|||
156621190|NCT02519777|565354291|FG001|Overall Study|Withdrawal by Subject|1|||
156621191|NCT02519777|565354292|FG002|Overall Study|Withdrawal by Subject|0|||
156621192|NCT02519777|565354290|FG000|Overall Study|Severe Debilitation|1|||
156621193|NCT02519777|565354291|FG001|Overall Study|Severe Debilitation|1|||
156621194|NCT02519777|565354292|FG002|Overall Study|Severe Debilitation|1|||
156621195|NCT02519777|565354290|FG000|Overall Study|Not able to get to clinic|1|||
156621196|NCT02519777|565354291|FG001|Overall Study|Not able to get to clinic|2|||
156621197|NCT02519777|565354292|FG002|Overall Study|Not able to get to clinic|1|||
156621198|NCT01038635|565354294|FG000|Overall Study|Disease Progression|2|||
156621199|NCT01038635|565354295|FG001|Overall Study|Disease Progression|0|||
156621200|NCT01038635|565354296|FG002|Overall Study|Disease Progression|0|||
156621201|NCT01038635|565354297|FG003|Overall Study|Disease Progression|0|||
156621202|NCT01038635|565354298|FG004|Overall Study|Disease Progression|0|||
156621203|NCT01038635|565354299|FG005|Overall Study|Disease Progression|0|||
156621204|NCT01038635|565354300|FG006|Overall Study|Disease Progression|1|||
156621205|NCT01038635|565354301|FG007|Overall Study|Disease Progression|4|||
156621206|NCT01038635|565354302|FG008|Overall Study|Disease Progression|0|||
156621207|NCT01038635|565354294|FG000|Overall Study|Death|0|||
156621208|NCT01038635|565354295|FG001|Overall Study|Death|0|||
156621209|NCT01038635|565354296|FG002|Overall Study|Death|0|||
156621210|NCT01038635|565354297|FG003|Overall Study|Death|0|||
156621211|NCT01038635|565354298|FG004|Overall Study|Death|1|||
156621212|NCT01038635|565354299|FG005|Overall Study|Death|0|||
156621213|NCT01038635|565354300|FG006|Overall Study|Death|1|||
156621214|NCT01038635|565354301|FG007|Overall Study|Death|1|||
156621215|NCT01038635|565354302|FG008|Overall Study|Death|2|||
156621216|NCT01227252|565354303|FG000|Overall Study|Sponsor Decision|0|||
156621217|NCT01227252|565354304|FG001|Overall Study|Sponsor Decision|1|||
156621218|NCT01227252|565354305|FG002|Overall Study|Sponsor Decision|0|||
156621219|NCT01227252|565354306|FG003|Overall Study|Sponsor Decision|0|||
156621220|NCT01227252|565354303|FG000|Overall Study|Lost to Follow-up|0|||
156621221|NCT01227252|565354304|FG001|Overall Study|Lost to Follow-up|1|||
156621222|NCT01227252|565354305|FG002|Overall Study|Lost to Follow-up|0|||
156621223|NCT01227252|565354306|FG003|Overall Study|Lost to Follow-up|0|||
156621224|NCT01227252|565354303|FG000|Overall Study|Withdrawal by Subject|0|||
156621225|NCT01227252|565354304|FG001|Overall Study|Withdrawal by Subject|1|||
156621226|NCT01227252|565354305|FG002|Overall Study|Withdrawal by Subject|0|||
156621227|NCT01227252|565354306|FG003|Overall Study|Withdrawal by Subject|0|||
156621228|NCT01034709|565354310|FG000|Overall Study|Protocol Violation|9|||
156621229|NCT01034709|565354311|FG001|Overall Study|Protocol Violation|16|||
156621230|NCT01060150|565354312|FG000|Overall Study|Adverse Event|6|||
156621231|NCT01060150|565354312|FG000|Overall Study|Lost to Follow-up|1|||
156621232|NCT01060150|565354312|FG000|Overall Study|Protocol Violation|6|||
156621233|NCT01060150|565354312|FG000|Overall Study|Withdrawal by Subject|8|||
156621234|NCT01060150|565354312|FG000|Overall Study|Enrolled, but not treated|2|||
156621235|NCT02447952|565354315|FG000|Overall Study|Adverse Event|2|||
156621236|NCT02447952|565354315|FG000|Overall Study|Physician Decision|1|||
156621237|NCT02447952|565354315|FG000|Overall Study|Withdrawal by Subject|4|||
156621238|NCT01970540|565354316|FG000|Overall Study|Non-treatment-related AE|0|||
156621239|NCT01970540|565354317|FG001|Overall Study|Non-treatment-related AE|0|||
156621240|NCT01970540|565354318|FG002|Overall Study|Non-treatment-related AE|1|||
156621241|NCT01970540|565354316|FG000|Overall Study|Progressive disease|55|||
156621242|NCT01970540|565354317|FG001|Overall Study|Progressive disease|23|||
156621243|NCT01970540|565354318|FG002|Overall Study|Progressive disease|10|||
156621244|NCT01970540|565354316|FG000|Overall Study|Treatment delay over protocol|0|||
156621245|NCT01970540|565354317|FG001|Overall Study|Treatment delay over protocol|0|||
156621246|NCT01970540|565354318|FG002|Overall Study|Treatment delay over protocol|1|||
156621247|NCT01970540|565354316|FG000|Overall Study|Physician Decision|7|||
156621248|NCT01970540|565354317|FG001|Overall Study|Physician Decision|2|||
156621249|NCT01970540|565354318|FG002|Overall Study|Physician Decision|0|||
156621250|NCT01970540|565354316|FG000|Overall Study|Clinical progression|0|||
156621251|NCT01970540|565354317|FG001|Overall Study|Clinical progression|1|||
156621252|NCT01970540|565354318|FG002|Overall Study|Clinical progression|1|||
156621253|NCT01970540|565354316|FG000|Overall Study|End of study|2|||
156621254|NCT01970540|565354317|FG001|Overall Study|End of study|0|||
156621255|NCT01970540|565354318|FG002|Overall Study|End of study|2|||
156621256|NCT01970540|565354316|FG000|Overall Study|Adverse Event|0|||
156621257|NCT01970540|565354317|FG001|Overall Study|Adverse Event|2|||
156621258|NCT01970540|565354318|FG002|Overall Study|Adverse Event|1|||
156621259|NCT01970540|565354316|FG000|Overall Study|Treatment-related AE|4|||
156621260|NCT01970540|565354317|FG001|Overall Study|Treatment-related AE|0|||
156621261|NCT01970540|565354318|FG002|Overall Study|Treatment-related AE|2|||
156621262|NCT01970540|565354316|FG000|Overall Study|Withdrawal by Subject|4|||
156621263|NCT01970540|565354317|FG001|Overall Study|Withdrawal by Subject|0|||
156621264|NCT01970540|565354318|FG002|Overall Study|Withdrawal by Subject|1|||
156621265|NCT01970540|565354316|FG000|Overall Study|Clinical deterioration|1|||
156621266|NCT01970540|565354317|FG001|Overall Study|Clinical deterioration|0|||
156621267|NCT01970540|565354318|FG002|Overall Study|Clinical deterioration|0|||
156621268|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Adverse Event|30|||
156621269|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Adverse Event|25|||
156621270|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Adverse Event|23|||
156621271|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Adverse Event|14|||
156621272|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Death|0|||
156621273|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Death|0|||
156621274|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Death|1|||
156621275|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Death|0|||
156621276|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Physician Decision|0|||
156621277|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Physician Decision|1|||
156621278|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Physician Decision|0|||
156621279|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Physician Decision|1|||
156621280|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
156621281|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
156621282|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
156621283|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
156621284|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Other|6|||
156621285|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Other|1|||
156621286|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Other|0|||
156621287|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Other|2|||
156621288|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
156621289|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
156621290|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
156621291|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
156621292|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
156621293|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
156621294|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
156621295|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
156621296|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
156621297|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
156621298|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
156621299|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
156621300|NCT00242710|565354320|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
156621301|NCT00242710|565354321|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
156621302|NCT00242710|565354322|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
156621303|NCT00242710|565354323|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
156621304|NCT00242710|565354320|FG000|Period Between Core Study and Extension|Adverse Event|2|||
156621305|NCT00242710|565354321|FG001|Period Between Core Study and Extension|Adverse Event|3|||
156621306|NCT00242710|565354322|FG002|Period Between Core Study and Extension|Adverse Event|5|||
156621307|NCT00242710|565354323|FG003|Period Between Core Study and Extension|Adverse Event|2|||
156621308|NCT00242710|565354320|FG000|Period Between Core Study and Extension|Physician Decision|1|||
156621309|NCT00242710|565354321|FG001|Period Between Core Study and Extension|Physician Decision|1|||
156621310|NCT00242710|565354322|FG002|Period Between Core Study and Extension|Physician Decision|0|||
156621311|NCT00242710|565354323|FG003|Period Between Core Study and Extension|Physician Decision|0|||
156621312|NCT00242710|565354320|FG000|Period Between Core Study and Extension|Other|24|||
156621313|NCT00242710|565354321|FG001|Period Between Core Study and Extension|Other|24|||
156621314|NCT00242710|565354322|FG002|Period Between Core Study and Extension|Other|9|||
156621315|NCT00242710|565354323|FG003|Period Between Core Study and Extension|Other|11|||
156621316|NCT00242710|565354320|FG000|Period Between Core Study and Extension|Extension not Available|17|||
156621317|NCT00242710|565354321|FG001|Period Between Core Study and Extension|Extension not Available|21|||
156621318|NCT00242710|565354322|FG002|Period Between Core Study and Extension|Extension not Available|8|||
156621319|NCT00242710|565354323|FG003|Period Between Core Study and Extension|Extension not Available|7|||
156621320|NCT00242710|565354320|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
156621321|NCT00242710|565354321|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
156621322|NCT00242710|565354322|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
156621323|NCT00242710|565354323|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
156621324|NCT00242710|565354320|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
156621325|NCT00242710|565354321|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
156621326|NCT00242710|565354322|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
156621327|NCT00242710|565354323|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
156621328|NCT00242710|565354320|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
156621329|NCT00242710|565354321|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
156621330|NCT00242710|565354322|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
156621331|NCT00242710|565354323|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
156621332|NCT00242710|565354320|FG000|Study Extension (up to Year 2)|Death|0|||
156621333|NCT00242710|565354321|FG001|Study Extension (up to Year 2)|Death|0|||
156621334|NCT00242710|565354322|FG002|Study Extension (up to Year 2)|Death|0|||
156621335|NCT00242710|565354323|FG003|Study Extension (up to Year 2)|Death|1|||
156621336|NCT00242710|565354320|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
156621337|NCT00242710|565354321|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
156621338|NCT00242710|565354322|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
156621339|NCT00242710|565354323|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
156621340|NCT00242710|565354320|FG000|Study Extension (up to Year 2)|Other|3|||
156621341|NCT00242710|565354321|FG001|Study Extension (up to Year 2)|Other|5|||
156621342|NCT00242710|565354322|FG002|Study Extension (up to Year 2)|Other|4|||
156621343|NCT00242710|565354323|FG003|Study Extension (up to Year 2)|Other|3|||
156621344|NCT00242710|565354320|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
156621345|NCT00242710|565354321|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
156621346|NCT00242710|565354322|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
156621347|NCT00242710|565354323|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
156621348|NCT00242710|565354320|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
156621349|NCT00242710|565354321|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
156621350|NCT00242710|565354322|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
156621351|NCT00242710|565354323|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
156621352|NCT01683058|565354324|FG000|Overall Study|Lost to Follow-up|9|||
156621353|NCT01683058|565354324|FG000|Overall Study|Adverse Event|6|||
156621354|NCT01683058|565354324|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
156621355|NCT01683058|565354324|FG000|Overall Study|Withdrawal by Subject|7|||
156621356|NCT01683058|565354324|FG000|Overall Study|Lack of Efficacy|2|||
156621357|NCT01057394|565354325|FG000|Overall Study|Not eligible|0|||
156621358|NCT01057394|565354326|FG001|Overall Study|Not eligible|2|||
156621359|NCT01195636|565354327|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
156621360|NCT01195636|565354328|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
156621361|NCT01195636|565354327|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
156621362|NCT01195636|565354328|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
156621363|NCT01195636|565354327|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156621364|NCT01195636|565354328|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
156621365|NCT01195636|565354327|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
156621366|NCT01195636|565354328|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
156621367|NCT01195636|565354327|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
156621368|NCT01195636|565354328|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
156621369|NCT01195636|565354327|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
156621370|NCT01195636|565354328|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
156621371|NCT01195636|565354327|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
156621372|NCT01195636|565354328|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
156621373|NCT01195636|565354327|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
156621374|NCT01195636|565354328|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
156621375|NCT00579527|565354329|FG000|Overall Study|Death|4|||
156621376|NCT00203294|565354330|FG000|Overall Study|Withdrawal by Subject|8|||
156621377|NCT00203294|565354331|FG001|Overall Study|Withdrawal by Subject|13|||
156621378|NCT02177942|565354341|FG000|Overall Study|Adverse Event|1|||
156621379|NCT02177942|565354342|FG001|Overall Study|Adverse Event|0|||
156621380|NCT02177942|565354341|FG000|Overall Study|Lost to Follow-up|1|||
156621381|NCT02177942|565354342|FG001|Overall Study|Lost to Follow-up|1|||
156621382|NCT02177942|565354341|FG000|Overall Study|Protocol Violation|4|||
156621383|NCT02177942|565354342|FG001|Overall Study|Protocol Violation|6|||
156621384|NCT02177942|565354341|FG000|Overall Study|Withdrawal by Subject|71|||
156621385|NCT02177942|565354342|FG001|Overall Study|Withdrawal by Subject|81|||
156621386|NCT01566981|565354343|FG000|Overall Study|Lost to Follow-up|5|||
156621387|NCT01566981|565354344|FG001|Overall Study|Lost to Follow-up|8|||
156621388|NCT02405091|565354350|FG000|Overall Study|Adverse Event|16|||
156621389|NCT02405091|565354351|FG001|Overall Study|Adverse Event|10|||
156621390|NCT02405091|565354352|FG002|Overall Study|Adverse Event|0|||
156621391|NCT02405091|565354350|FG000|Overall Study|Protocol Violation|1|||
156621392|NCT02405091|565354351|FG001|Overall Study|Protocol Violation|0|||
156621393|NCT02405091|565354352|FG002|Overall Study|Protocol Violation|0|||
156621394|NCT02405091|565354350|FG000|Overall Study|Noncompliance|1|||
156621395|NCT02405091|565354351|FG001|Overall Study|Noncompliance|6|||
156621396|NCT02405091|565354352|FG002|Overall Study|Noncompliance|2|||
156621397|NCT02405091|565354350|FG000|Overall Study|Withdrawal by Subject|4|||
156621398|NCT02405091|565354351|FG001|Overall Study|Withdrawal by Subject|8|||
156621399|NCT02405091|565354352|FG002|Overall Study|Withdrawal by Subject|0|||
156621400|NCT02405091|565354350|FG000|Overall Study|Death|0|||
156621401|NCT02405091|565354351|FG001|Overall Study|Death|1|||
156621402|NCT02405091|565354352|FG002|Overall Study|Death|0|||
156621403|NCT02405091|565354350|FG000|Overall Study|Lost to Follow-up|5|||
156621404|NCT02405091|565354351|FG001|Overall Study|Lost to Follow-up|6|||
156621405|NCT02405091|565354352|FG002|Overall Study|Lost to Follow-up|0|||
156621406|NCT02405091|565354350|FG000|Overall Study|Physician Decision|2|||
156621407|NCT02405091|565354351|FG001|Overall Study|Physician Decision|2|||
156621408|NCT02405091|565354352|FG002|Overall Study|Physician Decision|0|||
156621409|NCT01948791|565354360|FG000|Overall Study|Adverse Event|12|||
156621410|NCT01948791|565354360|FG000|Overall Study|Lack of Efficacy|3|||
156621411|NCT01948791|565354360|FG000|Overall Study|Protocol Violation|2|||
156621412|NCT01948791|565354360|FG000|Overall Study|Withdrawal by Subject|5|||
156621413|NCT01948791|565354360|FG000|Overall Study|Lost to Follow-up|6|||
156621414|NCT01948791|565354360|FG000|Overall Study|Management issues|1|||
156621415|NCT01948791|565354360|FG000|Overall Study|Others|7|||
156621416|NCT01948791|565354360|FG000|Overall Study|Screening failure|35|||
156621417|NCT01234337|565354361|FG000|Overall Study|Adverse Event|58|||
156621418|NCT01234337|565354362|FG001|Overall Study|Adverse Event|21|||
156621419|NCT01234337|565354361|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
156621420|NCT01234337|565354362|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
156621421|NCT01234337|565354361|FG000|Overall Study|Investi. decision not protocol driven|5|||
156621422|NCT01234337|565354362|FG001|Overall Study|Investi. decision not protocol driven|6|||
156621423|NCT01234337|565354361|FG000|Overall Study|Non-compliant with study medication|3|||
156621424|NCT01234337|565354362|FG001|Overall Study|Non-compliant with study medication|2|||
156621425|NCT01234337|565354361|FG000|Overall Study|Randomized but not treated|6|||
156621426|NCT01234337|565354362|FG001|Overall Study|Randomized but not treated|4|||
156621427|NCT01234337|565354361|FG000|Overall Study|Lost to Follow-up|0|||
156621428|NCT01234337|565354362|FG001|Overall Study|Lost to Follow-up|1|||
156621429|NCT01234337|565354361|FG000|Overall Study|Protocol Violation|2|||
156621430|NCT01234337|565354362|FG001|Overall Study|Protocol Violation|3|||
156621431|NCT01234337|565354361|FG000|Overall Study|Withdrawal by Subject|11|||
156621432|NCT01234337|565354362|FG001|Overall Study|Withdrawal by Subject|9|||
156621433|NCT01234337|565354361|FG000|Overall Study|Death|0|||
156621434|NCT01234337|565354362|FG001|Overall Study|Death|1|||
156621435|NCT01234337|565354361|FG000|Overall Study|Switch to commercial drug|0|||
156621436|NCT01234337|565354362|FG001|Overall Study|Switch to commercial drug|1|||
156621437|NCT00247962|565354370|FG000|Overall Study|Adverse Event|15|||
156621438|NCT00247962|565354371|FG001|Overall Study|Adverse Event|12|||
156621439|NCT00247962|565354370|FG000|Overall Study|Lost to Follow-up|3|||
156621440|NCT00247962|565354371|FG001|Overall Study|Lost to Follow-up|1|||
156621441|NCT00247962|565354370|FG000|Overall Study|Physician Decision|0|||
156621442|NCT00247962|565354371|FG001|Overall Study|Physician Decision|1|||
156621443|NCT00247962|565354370|FG000|Overall Study|Protocol Violation|1|||
156621444|NCT00247962|565354371|FG001|Overall Study|Protocol Violation|1|||
156621445|NCT00247962|565354370|FG000|Overall Study|Withdrawal by Subject|3|||
156621446|NCT00247962|565354371|FG001|Overall Study|Withdrawal by Subject|2|||
156621447|NCT00247962|565354370|FG000|Overall Study|Lack of Efficacy|4|||
156621448|NCT00247962|565354371|FG001|Overall Study|Lack of Efficacy|2|||
156621449|NCT02555722|565354372|FG000|Week 2|Adverse Event|0|||
156621450|NCT02555722|565354373|FG001|Week 2|Adverse Event|1|||
156621451|NCT02555722|565354372|FG000|Week 2|Withdrawal by Subject|1|||
156621452|NCT02555722|565354373|FG001|Week 2|Withdrawal by Subject|0|||
156621453|NCT02555722|565354372|FG000|Month 1|Lens Discomfort|1|||
156621454|NCT02555722|565354373|FG001|Month 1|Lens Discomfort|0|||
156621455|NCT02555722|565354372|FG000|Month 2|Withdrawal by Subject|3|||
156621456|NCT02555722|565354373|FG001|Month 2|Withdrawal by Subject|0|||
156621457|NCT02555722|565354372|FG000|Month 2|Lost to Follow-up|1|||
156621458|NCT02555722|565354373|FG001|Month 2|Lost to Follow-up|0|||
156621459|NCT00702949|565354374|FG000|Overall Study|Refusal|3|||
156621460|NCT00702949|565354375|FG001|Overall Study|Refusal|2|||
156621461|NCT00702949|565354376|FG002|Overall Study|Refusal|2|||
156621462|NCT00702949|565354374|FG000|Overall Study|Adverse Event|1|||
156621463|NCT00702949|565354375|FG001|Overall Study|Adverse Event|6|||
156621464|NCT00702949|565354376|FG002|Overall Study|Adverse Event|3|||
156621465|NCT00702949|565354374|FG000|Overall Study|Other Medical Reason/unknown|1|||
156621466|NCT00702949|565354375|FG001|Overall Study|Other Medical Reason/unknown|1|||
156621467|NCT00702949|565354376|FG002|Overall Study|Other Medical Reason/unknown|3|||
156621468|NCT03525613|565354381|FG000|Overall Study|Adverse Event|11|||
156621469|NCT03525613|565354382|FG001|Overall Study|Adverse Event|8|||
156621470|NCT03525613|565354383|FG002|Overall Study|Adverse Event|3|||
156621471|NCT03525613|565354384|FG003|Overall Study|Adverse Event|3|||
156621472|NCT03525613|565354381|FG000|Overall Study|Lost to Follow-up|4|||
156621473|NCT03525613|565354382|FG001|Overall Study|Lost to Follow-up|5|||
156621474|NCT03525613|565354383|FG002|Overall Study|Lost to Follow-up|3|||
156621475|NCT03525613|565354384|FG003|Overall Study|Lost to Follow-up|2|||
156621476|NCT03525613|565354381|FG000|Overall Study|Physician Decision|0|||
156621477|NCT03525613|565354382|FG001|Overall Study|Physician Decision|1|||
156621478|NCT03525613|565354383|FG002|Overall Study|Physician Decision|0|||
156621479|NCT03525613|565354384|FG003|Overall Study|Physician Decision|1|||
156621480|NCT03525613|565354381|FG000|Overall Study|Consent Withdrawal|25|||
156621481|NCT03525613|565354382|FG001|Overall Study|Consent Withdrawal|16|||
156621482|NCT03525613|565354383|FG002|Overall Study|Consent Withdrawal|12|||
156621483|NCT03525613|565354384|FG003|Overall Study|Consent Withdrawal|9|||
156621484|NCT03525613|565354381|FG000|Overall Study|Death|20|||
156621485|NCT03525613|565354382|FG001|Overall Study|Death|9|||
156621486|NCT03525613|565354383|FG002|Overall Study|Death|7|||
156621487|NCT03525613|565354384|FG003|Overall Study|Death|1|||
156621488|NCT03525613|565354381|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
156621489|NCT03525613|565354382|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
156621490|NCT03525613|565354383|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
156621491|NCT03525613|565354384|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
156621492|NCT02583711|565354387|FG000|Overall Study|Withdrawal by Subject|0|||
156621493|NCT02583711|565354388|FG001|Overall Study|Withdrawal by Subject|10|||
156621494|NCT02583711|565354389|FG002|Overall Study|Withdrawal by Subject|0|||
156621495|NCT01012037|565354390|FG000|Overall Study|Adverse Event|0|||
156621496|NCT01012037|565354391|FG001|Overall Study|Adverse Event|8|||
156621497|NCT01012037|565354392|FG002|Overall Study|Adverse Event|3|||
156621498|NCT01012037|565354390|FG000|Overall Study|Protocol Violation|0|||
156621499|NCT01012037|565354391|FG001|Overall Study|Protocol Violation|3|||
156621500|NCT01012037|565354392|FG002|Overall Study|Protocol Violation|5|||
156621501|NCT01012037|565354390|FG000|Overall Study|Withdrawal by Subject|0|||
156621502|NCT01012037|565354391|FG001|Overall Study|Withdrawal by Subject|4|||
156621503|NCT01012037|565354392|FG002|Overall Study|Withdrawal by Subject|1|||
156621504|NCT01012037|565354390|FG000|Overall Study|Other reason (not specified)|1|||
156621505|NCT01012037|565354391|FG001|Overall Study|Other reason (not specified)|1|||
156621506|NCT01012037|565354392|FG002|Overall Study|Other reason (not specified)|1|||
156621507|NCT03196973|565354398|FG000|Overall Study|Adverse Event|1|||
156621508|NCT03196973|565354399|FG001|Overall Study|Adverse Event|1|||
156621509|NCT03196973|565354400|FG002|Overall Study|Adverse Event|2|||
156621510|NCT03196973|565354398|FG000|Overall Study|Lack of Efficacy|2|||
156621511|NCT03196973|565354399|FG001|Overall Study|Lack of Efficacy|6|||
156621512|NCT03196973|565354400|FG002|Overall Study|Lack of Efficacy|1|||
156621513|NCT03196973|565354398|FG000|Overall Study|Lost to Follow-up|4|||
156621514|NCT03196973|565354399|FG001|Overall Study|Lost to Follow-up|3|||
156621515|NCT03196973|565354400|FG002|Overall Study|Lost to Follow-up|2|||
156621516|NCT03196973|565354398|FG000|Overall Study|Consent withdrawn|2|||
156621517|NCT03196973|565354399|FG001|Overall Study|Consent withdrawn|1|||
156621518|NCT03196973|565354400|FG002|Overall Study|Consent withdrawn|0|||
156621519|NCT03196973|565354398|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
156621520|NCT03196973|565354399|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
156621521|NCT03196973|565354400|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
156621522|NCT01809327|565354401|FG000|Overall Study|Lost to Follow-up|5|||
156621523|NCT01809327|565354402|FG001|Overall Study|Lost to Follow-up|2|||
156621524|NCT01809327|565354403|FG002|Overall Study|Lost to Follow-up|4|||
156621525|NCT01809327|565354404|FG003|Overall Study|Lost to Follow-up|2|||
156621526|NCT01809327|565354405|FG004|Overall Study|Lost to Follow-up|3|||
156621527|NCT01809327|565354401|FG000|Overall Study|Withdrawal by Subject|6|||
156621528|NCT01809327|565354402|FG001|Overall Study|Withdrawal by Subject|4|||
156621529|NCT01809327|565354403|FG002|Overall Study|Withdrawal by Subject|4|||
156621530|NCT01809327|565354404|FG003|Overall Study|Withdrawal by Subject|2|||
156621531|NCT01809327|565354405|FG004|Overall Study|Withdrawal by Subject|5|||
156621532|NCT01809327|565354401|FG000|Overall Study|Adverse Event|4|||
156621533|NCT01809327|565354402|FG001|Overall Study|Adverse Event|3|||
156621534|NCT01809327|565354403|FG002|Overall Study|Adverse Event|7|||
156621535|NCT01809327|565354404|FG003|Overall Study|Adverse Event|4|||
156621536|NCT01809327|565354405|FG004|Overall Study|Adverse Event|8|||
156621537|NCT01809327|565354401|FG000|Overall Study|Death|1|||
156621538|NCT01809327|565354402|FG001|Overall Study|Death|0|||
156621539|NCT01809327|565354403|FG002|Overall Study|Death|0|||
156621540|NCT01809327|565354404|FG003|Overall Study|Death|0|||
156621541|NCT01809327|565354405|FG004|Overall Study|Death|0|||
156621542|NCT01809327|565354401|FG000|Overall Study|Protocol Violation|0|||
156621543|NCT01809327|565354402|FG001|Overall Study|Protocol Violation|1|||
156621544|NCT01809327|565354403|FG002|Overall Study|Protocol Violation|0|||
156621545|NCT01809327|565354404|FG003|Overall Study|Protocol Violation|0|||
156621546|NCT01809327|565354405|FG004|Overall Study|Protocol Violation|0|||
156621547|NCT01809327|565354401|FG000|Overall Study|Physician Decision|1|||
156621548|NCT01809327|565354402|FG001|Overall Study|Physician Decision|1|||
156621549|NCT01809327|565354403|FG002|Overall Study|Physician Decision|0|||
156621550|NCT01809327|565354404|FG003|Overall Study|Physician Decision|0|||
156621551|NCT01809327|565354405|FG004|Overall Study|Physician Decision|0|||
156621552|NCT01809327|565354401|FG000|Overall Study|Pregnancy|1|||
156621553|NCT01809327|565354402|FG001|Overall Study|Pregnancy|0|||
156621554|NCT01809327|565354403|FG002|Overall Study|Pregnancy|0|||
156621555|NCT01809327|565354404|FG003|Overall Study|Pregnancy|0|||
156621556|NCT01809327|565354405|FG004|Overall Study|Pregnancy|0|||
156621557|NCT01809327|565354401|FG000|Overall Study|Other|14|||
156621558|NCT01809327|565354402|FG001|Overall Study|Other|15|||
156621559|NCT01809327|565354403|FG002|Overall Study|Other|7|||
156621560|NCT01809327|565354404|FG003|Overall Study|Other|4|||
156621561|NCT01809327|565354405|FG004|Overall Study|Other|9|||
156621562|NCT01610414|565354406|FG000|Study Start - Month 13|Serious Adverse Event|65|||
156621563|NCT01610414|565354407|FG001|Study Start - Month 13|Serious Adverse Event|67|||
156621564|NCT01610414|565354406|FG000|Study Start - Month 13|Adverse Event|14|||
156621565|NCT01610414|565354407|FG001|Study Start - Month 13|Adverse Event|14|||
156621566|NCT01610414|565354406|FG000|Study Start - Month 13|Protocol Violation|3|||
156621567|NCT01610414|565354407|FG001|Study Start - Month 13|Protocol Violation|1|||
156621568|NCT01610414|565354406|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
156621569|NCT01610414|565354407|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
156621570|NCT01610414|565354406|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
156621571|NCT01610414|565354407|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
156621572|NCT01610414|565354406|FG000|Study Start - Month 13|Lost to Follow-up|4|||
156621573|NCT01610414|565354407|FG001|Study Start - Month 13|Lost to Follow-up|6|||
156621574|NCT01610414|565354406|FG000|Study Start - Month 13|Suspected HZ episode|1|||
156621575|NCT01610414|565354407|FG001|Study Start - Month 13|Suspected HZ episode|3|||
156621576|NCT01610414|565354406|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
156621577|NCT01610414|565354407|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
156621578|NCT01610414|565354406|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
156621579|NCT01610414|565354407|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
156621580|NCT01610414|565354406|FG000|Month 13 - Month 25|Adverse Event|8|||
156621581|NCT01610414|565354407|FG001|Month 13 - Month 25|Adverse Event|4|||
156621582|NCT01610414|565354406|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
156621583|NCT01610414|565354407|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
156621584|NCT01610414|565354406|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
156621585|NCT01610414|565354407|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
156621586|NCT01610414|565354406|FG000|Month 13 - Month 25|Protocol Violation|0|||
156621587|NCT01610414|565354407|FG001|Month 13 - Month 25|Protocol Violation|2|||
156621588|NCT01610414|565354406|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
156621589|NCT01610414|565354407|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
156621590|NCT01610414|565354406|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
156621591|NCT01610414|565354407|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
156621592|NCT01610414|565354406|FG000|After Month 25|Study end not reached|48|||
156621593|NCT01610414|565354407|FG001|After Month 25|Study end not reached|53|||
156621594|NCT04009824|565354408|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
156621595|NCT04009824|565354409|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
156621596|NCT04009824|565354410|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
156621597|NCT04009824|565354411|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
156621598|NCT04009824|565354412|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
156621599|NCT02975206|565354413|FG000|Overall Study|Withdrawal by Subject|14|||
156621600|NCT02975206|565354414|FG001|Overall Study|Withdrawal by Subject|11|||
156621601|NCT02975206|565354415|FG002|Overall Study|Withdrawal by Subject|11|||
156621602|NCT02975206|565354413|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
156621603|NCT02975206|565354414|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
156621604|NCT02975206|565354415|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
156621605|NCT00392210|565354419|FG000|First Voiding Trial|Physician Decision|2|||
156621606|NCT00392210|565354420|FG001|First Voiding Trial|Physician Decision|2|||
156621607|NCT02067104|565354421|FG000|Overall Study|Study termination due to low accrual|4|||
156621608|NCT02067104|565354422|FG001|Overall Study|Study termination due to low accrual|5|||
156621609|NCT02610231|565354428|FG000|Overall Study|Withdrawal by Subject|27|||
156621610|NCT02610231|565354428|FG000|Overall Study|Adverse Event|20|||
156621611|NCT02610231|565354428|FG000|Overall Study|Death|5|||
156621612|NCT02610231|565354428|FG000|Overall Study|Surgery|2|||
156621613|NCT02610231|565354428|FG000|Overall Study|Physician Decision|1|||
156621614|NCT02610231|565354428|FG000|Overall Study|Non Compliance|2|||
156621615|NCT02610231|565354428|FG000|Overall Study|Other|3|||
156621616|NCT01279954|565354431|FG000|Overall Study|Lack of Efficacy|3|||
156621617|NCT01279954|565354432|FG001|Overall Study|Lack of Efficacy|4|||
156621618|NCT02140762|565354433|FG000|Overall Study|Adverse Event|1|||
156621619|NCT02140762|565354434|FG001|Overall Study|Adverse Event|1|||
156621620|NCT02140762|565354433|FG000|Overall Study|Lost to Follow-up|9|||
156621621|NCT02140762|565354434|FG001|Overall Study|Lost to Follow-up|5|||
156621622|NCT02140762|565354433|FG000|Overall Study|Protocol Violation|1|||
156621623|NCT02140762|565354434|FG001|Overall Study|Protocol Violation|1|||
156621624|NCT02140762|565354433|FG000|Overall Study|Withdrawal by Subject|6|||
156621625|NCT02140762|565354434|FG001|Overall Study|Withdrawal by Subject|4|||
156621626|NCT02140762|565354433|FG000|Overall Study|Other|0|||
156621627|NCT02140762|565354434|FG001|Overall Study|Other|1|||
156621628|NCT01711359|565354436|FG000|Treatment Period|Withdrawal by Subject|18|||
156621629|NCT01711359|565354437|FG001|Treatment Period|Withdrawal by Subject|7|||
156621630|NCT01711359|565354438|FG002|Treatment Period|Withdrawal by Subject|13|||
156621631|NCT01711359|565354436|FG000|Treatment Period|Lack of Efficacy|13|||
156621632|NCT01711359|565354437|FG001|Treatment Period|Lack of Efficacy|2|||
156621633|NCT01711359|565354438|FG002|Treatment Period|Lack of Efficacy|2|||
156621634|NCT01711359|565354436|FG000|Treatment Period|Adverse Event|8|||
156621635|NCT01711359|565354437|FG001|Treatment Period|Adverse Event|10|||
156621636|NCT01711359|565354438|FG002|Treatment Period|Adverse Event|24|||
156621637|NCT01711359|565354436|FG000|Treatment Period|Physician Decision|4|||
156621638|NCT01711359|565354437|FG001|Treatment Period|Physician Decision|3|||
156621639|NCT01711359|565354438|FG002|Treatment Period|Physician Decision|2|||
156621640|NCT01711359|565354436|FG000|Treatment Period|Death|3|||
156621641|NCT01711359|565354437|FG001|Treatment Period|Death|0|||
156621642|NCT01711359|565354438|FG002|Treatment Period|Death|0|||
156621643|NCT01711359|565354436|FG000|Treatment Period|Entry Criteria Not Met|1|||
156621644|NCT01711359|565354437|FG001|Treatment Period|Entry Criteria Not Met|0|||
156621645|NCT01711359|565354438|FG002|Treatment Period|Entry Criteria Not Met|0|||
156621646|NCT01711359|565354436|FG000|Treatment Period|Sponsor Decision|1|||
156621647|NCT01711359|565354437|FG001|Treatment Period|Sponsor Decision|0|||
156621648|NCT01711359|565354438|FG002|Treatment Period|Sponsor Decision|0|||
156621649|NCT01711359|565354436|FG000|Treatment Period|Lost to Follow-up|1|||
156621650|NCT01711359|565354437|FG001|Treatment Period|Lost to Follow-up|1|||
156621651|NCT01711359|565354438|FG002|Treatment Period|Lost to Follow-up|1|||
156621652|NCT01711359|565354436|FG000|Treatment Period|Randomized, Not Treated|3|||
156621653|NCT01711359|565354437|FG001|Treatment Period|Randomized, Not Treated|1|||
156621654|NCT01711359|565354438|FG002|Treatment Period|Randomized, Not Treated|0|||
156621655|NCT01385098|565354441|FG000|Overall Study|Adverse Event|10|||
156621656|NCT01385098|565354441|FG000|Overall Study|Lost to Follow-up|4|||
156621657|NCT00303602|565356595|FG000|Overall Study|Adverse Event|2|||
156621658|NCT00303602|565356596|FG001|Overall Study|Adverse Event|2|||
156621659|NCT00303602|565356595|FG000|Overall Study|Withdrawal by Subject|5|||
156621660|NCT00303602|565356596|FG001|Overall Study|Withdrawal by Subject|6|||
156621661|NCT00303602|565356595|FG000|Overall Study|Lost to Follow-up|5|||
156621662|NCT00303602|565356596|FG001|Overall Study|Lost to Follow-up|2|||
156621663|NCT00303602|565356595|FG000|Overall Study|Protocol entry criteria not met|2|||
156621664|NCT00303602|565356596|FG001|Overall Study|Protocol entry criteria not met|2|||
156621665|NCT00303602|565356595|FG000|Overall Study|Physician Decision|2|||
156621666|NCT00303602|565356596|FG001|Overall Study|Physician Decision|1|||
156621667|NCT00303602|565356595|FG000|Overall Study|Noncompliance|2|||
156621668|NCT00303602|565356596|FG001|Overall Study|Noncompliance|2|||
156621669|NCT00303602|565356595|FG000|Overall Study|Protocol Violation|1|||
156621670|NCT00303602|565356596|FG001|Overall Study|Protocol Violation|0|||
156621671|NCT02551874|565356603|FG000|Overall Study|Lost to Follow-up|0|||
156621672|NCT02551874|565356604|FG001|Overall Study|Lost to Follow-up|2|||
156621673|NCT02551874|565356603|FG000|Overall Study|Pregnancy|0|||
156621674|NCT02551874|565356604|FG001|Overall Study|Pregnancy|1|||
156621675|NCT02551874|565356603|FG000|Overall Study|Reason not reported|10|||
156621676|NCT02551874|565356604|FG001|Overall Study|Reason not reported|4|||
156621677|NCT02551874|565356603|FG000|Overall Study|Did not receive randomized treatment|0|||
156621678|NCT02551874|565356604|FG001|Overall Study|Did not receive randomized treatment|7|||
156621679|NCT02551874|565356603|FG000|Overall Study|Did not enter long-term study|18|||
156621680|NCT02551874|565356604|FG001|Overall Study|Did not enter long-term study|25|||
156621681|NCT02491463|565356605|FG000|Overall Study|Withdrawal by Subject|1|||
156621682|NCT02491463|565356606|FG001|Overall Study|Withdrawal by Subject|2|||
156621683|NCT02491463|565356607|FG002|Overall Study|Withdrawal by Subject|0|||
156621684|NCT02491463|565356608|FG003|Overall Study|Withdrawal by Subject|0|||
156621685|NCT02491463|565356605|FG000|Overall Study|Migrated/moved from study area|1|||
156621686|NCT02491463|565356606|FG001|Overall Study|Migrated/moved from study area|5|||
156621687|NCT02491463|565356607|FG002|Overall Study|Migrated/moved from study area|1|||
156621688|NCT02491463|565356608|FG003|Overall Study|Migrated/moved from study area|1|||
156621689|NCT02491463|565356605|FG000|Overall Study|Lost to Follow-up|0|||
156621690|NCT02491463|565356606|FG001|Overall Study|Lost to Follow-up|3|||
156621691|NCT02491463|565356607|FG002|Overall Study|Lost to Follow-up|3|||
156621692|NCT02491463|565356608|FG003|Overall Study|Lost to Follow-up|0|||
156621693|NCT01491802|565356609|FG000|Overall Study|Adverse Event|1|||
156621694|NCT01491802|565356610|FG001|Overall Study|Adverse Event|1|||
156621695|NCT01491802|565356609|FG000|Overall Study|Withdrawal by Subject|0|||
156621696|NCT01491802|565356610|FG001|Overall Study|Withdrawal by Subject|1|||
156621697|NCT01864746|565356613|FG000|Overall Study|Disease recurrence|25|||
156621698|NCT01864746|565356614|FG001|Overall Study|Disease recurrence|40|||
156621699|NCT01864746|565356613|FG000|Overall Study|Second primary invasive nonbreast|2|||
156621700|NCT01864746|565356614|FG001|Overall Study|Second primary invasive nonbreast|3|||
156621701|NCT01864746|565356613|FG000|Overall Study|Death|2|||
156621702|NCT01864746|565356614|FG001|Overall Study|Death|1|||
156621703|NCT01864746|565356613|FG000|Overall Study|Adverse Event|33|||
156621704|NCT01864746|565356614|FG001|Overall Study|Adverse Event|5|||
156621705|NCT01864746|565356613|FG000|Overall Study|Withdrawal by Subject|56|||
156621706|NCT01864746|565356614|FG001|Overall Study|Withdrawal by Subject|41|||
156621707|NCT01864746|565356613|FG000|Overall Study|Physician Decision|5|||
156621708|NCT01864746|565356614|FG001|Overall Study|Physician Decision|6|||
156621709|NCT00663208|565356615|FG000|Treatment Period|Lost to Follow-up|0|||
156621710|NCT00663208|565356616|FG001|Treatment Period|Lost to Follow-up|1|||
156621711|NCT00663208|565356617|FG002|Treatment Period|Lost to Follow-up|0|||
156621712|NCT00663208|565356618|FG003|Treatment Period|Lost to Follow-up|0|||
156621713|NCT00663208|565356619|FG004|Treatment Period|Lost to Follow-up|0|||
156621714|NCT00663208|565356620|FG005|Treatment Period|Lost to Follow-up|0|||
156621715|NCT00663208|565356621|FG006|Treatment Period|Lost to Follow-up|0|||
156621716|NCT00663208|565356615|FG000|Follow-up Period|Lost to Follow-up|2|||
156621717|NCT00663208|565356616|FG001|Follow-up Period|Lost to Follow-up|0|||
156621718|NCT00663208|565356617|FG002|Follow-up Period|Lost to Follow-up|3|||
156621719|NCT00663208|565356618|FG003|Follow-up Period|Lost to Follow-up|2|||
156621720|NCT00663208|565356619|FG004|Follow-up Period|Lost to Follow-up|0|||
156621721|NCT00663208|565356620|FG005|Follow-up Period|Lost to Follow-up|0|||
156621722|NCT00663208|565356621|FG006|Follow-up Period|Lost to Follow-up|0|||
156621723|NCT00663208|565356615|FG000|Follow-up Period|Other reason|1|||
156621724|NCT00663208|565356616|FG001|Follow-up Period|Other reason|0|||
156621725|NCT00663208|565356617|FG002|Follow-up Period|Other reason|0|||
156621726|NCT00663208|565356618|FG003|Follow-up Period|Other reason|0|||
156621727|NCT00663208|565356619|FG004|Follow-up Period|Other reason|0|||
156621728|NCT00663208|565356620|FG005|Follow-up Period|Other reason|0|||
156621729|NCT00663208|565356621|FG006|Follow-up Period|Other reason|1|||
156621730|NCT01005966|565356622|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
156621731|NCT01005966|565356623|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
156621732|NCT01005966|565356624|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
156621733|NCT01005966|565356625|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
156621734|NCT01005966|565356626|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
156621735|NCT01005966|565356622|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
156621736|NCT01005966|565356623|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
156621737|NCT01005966|565356624|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
156621738|NCT01005966|565356625|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
156621739|NCT01005966|565356626|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
156621740|NCT01005966|565356622|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
156621741|NCT01005966|565356623|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
156621742|NCT01005966|565356624|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
156621743|NCT01005966|565356625|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
156621744|NCT01005966|565356626|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
156621745|NCT01005966|565356622|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
156621746|NCT01005966|565356623|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
156621747|NCT01005966|565356624|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
156621748|NCT01005966|565356625|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
156621749|NCT01005966|565356626|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
156621750|NCT01005966|565356622|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156621751|NCT01005966|565356623|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156621752|NCT01005966|565356624|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156621753|NCT01005966|565356625|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156621754|NCT01005966|565356626|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156621755|NCT01005966|565356622|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156621756|NCT01005966|565356623|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156621757|NCT01005966|565356624|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
156621758|NCT01005966|565356625|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156621759|NCT01005966|565356626|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156621760|NCT01005966|565356622|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
156621761|NCT01005966|565356623|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
156621762|NCT01005966|565356624|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
156621763|NCT01005966|565356625|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
156621764|NCT01005966|565356626|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
156621765|NCT01005966|565356622|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
156621766|NCT01005966|565356623|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
156621767|NCT01005966|565356624|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
156621768|NCT01005966|565356625|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
156621769|NCT01005966|565356626|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
156621770|NCT01005966|565356622|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
156621771|NCT01005966|565356623|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
156621772|NCT01005966|565356624|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
156621773|NCT01005966|565356625|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
156621774|NCT01005966|565356626|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
156621775|NCT00039377|565356627|FG000|Initial Registration|Adverse Event|2|||
156621776|NCT00039377|565356628|FG001|Initial Registration|Adverse Event|0|||
156621777|NCT00039377|565356629|FG002|Initial Registration|Adverse Event|0|||
156621778|NCT00039377|565356630|FG003|Initial Registration|Adverse Event|0|||
156621779|NCT00039377|565356627|FG000|Initial Registration|Relapsed|6|||
156621780|NCT00039377|565356628|FG001|Initial Registration|Relapsed|0|||
156621781|NCT00039377|565356629|FG002|Initial Registration|Relapsed|0|||
156621782|NCT00039377|565356630|FG003|Initial Registration|Relapsed|0|||
156621783|NCT00039377|565356627|FG000|Initial Registration|Received non-protocol therapy|11|||
156621784|NCT00039377|565356628|FG001|Initial Registration|Received non-protocol therapy|0|||
156621785|NCT00039377|565356629|FG002|Initial Registration|Received non-protocol therapy|0|||
156621786|NCT00039377|565356630|FG003|Initial Registration|Received non-protocol therapy|0|||
156621787|NCT00039377|565356627|FG000|Initial Registration|Withdrawal by Subject|3|||
156621788|NCT00039377|565356628|FG001|Initial Registration|Withdrawal by Subject|0|||
156621789|NCT00039377|565356629|FG002|Initial Registration|Withdrawal by Subject|0|||
156621790|NCT00039377|565356630|FG003|Initial Registration|Withdrawal by Subject|0|||
156621791|NCT03890731|565356631|FG000|Overall Study|Progressive disease|1|||
156621792|NCT03890731|565356631|FG000|Overall Study|Patient's decision|1|||
156621793|NCT03890731|565356631|FG000|Overall Study|Adverse Event|4|||
156621794|NCT02528643|565356632|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
156621795|NCT02528643|565356633|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
156621796|NCT02528643|565356632|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
156621797|NCT02528643|565356633|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
156621798|NCT02528643|565356632|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
156621799|NCT02528643|565356633|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
156621800|NCT02528643|565356632|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
156621801|NCT02528643|565356633|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
156621802|NCT02528643|565356632|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
156621803|NCT02528643|565356633|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
156621804|NCT02528643|565356632|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
156621805|NCT02528643|565356633|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
156621806|NCT02528643|565356632|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
156621807|NCT02528643|565356633|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
156621808|NCT04144140|565356634|FG000|Overall Study|Other|0|||
156621809|NCT04144140|565356635|FG001|Overall Study|Other|0|||
156621810|NCT04144140|565356636|FG002|Overall Study|Other|0|||
156621811|NCT04144140|565356637|FG003|Overall Study|Other|0|||
156621812|NCT04144140|565356638|FG004|Overall Study|Other|0|||
156621813|NCT04144140|565356639|FG005|Overall Study|Other|1|||
156621814|NCT04144140|565356640|FG006|Overall Study|Other|0|||
156621815|NCT01640353|565356641|FG000|Overall Study|Withdrew prior to treatment|10|||
156621816|NCT01640353|565356641|FG000|Overall Study|Withdrawn from analysis at term site|12|||
156621817|NCT01640353|565356641|FG000|Overall Study|Withdrawal by Subject|5|||
156621818|NCT01640353|565356641|FG000|Overall Study|Death|2|||
156621819|NCT01640353|565356641|FG000|Overall Study|Early site termination|3|||
156621820|NCT01640353|565356641|FG000|Overall Study|Lost to Follow-up|12|||
156621821|NCT01640353|565356641|FG000|Overall Study|Physician Decision|1|||
156621822|NCT03758612|565356642|FG000|Washout Period|Withdrawal by Subject|0|||
156621823|NCT03758612|565356643|FG001|Washout Period|Withdrawal by Subject|0|||
156621824|NCT03758612|565356644|FG002|Washout Period|Withdrawal by Subject|2|||
156621825|NCT03758612|565356645|FG003|Washout Period|Withdrawal by Subject|0|||
156621826|NCT03758612|565356646|FG004|Washout Period|Withdrawal by Subject|0|||
156621827|NCT03758612|565356647|FG005|Washout Period|Withdrawal by Subject|0|||
156621828|NCT03758612|565356648|FG006|Washout Period|Withdrawal by Subject|0|||
156621829|NCT03758612|565356649|FG007|Washout Period|Withdrawal by Subject|0|||
156621830|NCT03758612|565356650|FG008|Washout Period|Withdrawal by Subject|0|||
156621831|NCT03758612|565356651|FG009|Washout Period|Withdrawal by Subject|0|||
156621832|NCT03758612|565356652|FG010|Washout Period|Withdrawal by Subject|0|||
156621833|NCT03758612|565356653|FG011|Washout Period|Withdrawal by Subject|0|||
156621834|NCT03758612|565356642|FG000|Period 2|Protocol Violation|0|||
156621835|NCT03758612|565356643|FG001|Period 2|Protocol Violation|0|||
156621836|NCT03758612|565356644|FG002|Period 2|Protocol Violation|0|||
156621837|NCT03758612|565356645|FG003|Period 2|Protocol Violation|0|||
156621838|NCT03758612|565356646|FG004|Period 2|Protocol Violation|1|||
156621839|NCT03758612|565356647|FG005|Period 2|Protocol Violation|0|||
156621840|NCT03758612|565356648|FG006|Period 2|Protocol Violation|0|||
156621841|NCT03758612|565356649|FG007|Period 2|Protocol Violation|0|||
156621842|NCT03758612|565356650|FG008|Period 2|Protocol Violation|0|||
156621843|NCT03758612|565356651|FG009|Period 2|Protocol Violation|0|||
156621844|NCT03758612|565356652|FG010|Period 2|Protocol Violation|0|||
156621845|NCT03758612|565356653|FG011|Period 2|Protocol Violation|0|||
156621846|NCT02679222|565356655|FG000|Overall Study|No time for project|1|||
156621847|NCT04354870|565356656|FG000|Overall Study|Lost to Follow-up|32|||
156621848|NCT04354870|565356657|FG001|Overall Study|Lost to Follow-up|12|||
156621849|NCT04354870|565356656|FG000|Overall Study|Withdrawal by Subject|10|||
156621850|NCT04354870|565356657|FG001|Overall Study|Withdrawal by Subject|16|||
156621851|NCT04354870|565356656|FG000|Overall Study|Did not complete all study visits|6|||
156621852|NCT04354870|565356657|FG001|Overall Study|Did not complete all study visits|5|||
156621853|NCT04450394|565356658|FG000|Overall Study|Adverse Event|2|||
156621854|NCT04450394|565356659|FG001|Overall Study|Adverse Event|0|||
156621855|NCT04450394|565356660|FG002|Overall Study|Adverse Event|0|||
156621856|NCT04450394|565356658|FG000|Overall Study|Death|0|||
156621857|NCT04450394|565356659|FG001|Overall Study|Death|1|||
156621858|NCT04450394|565356660|FG002|Overall Study|Death|0|||
156621859|NCT04450394|565356658|FG000|Overall Study|Lost to Follow-up|0|||
156621860|NCT04450394|565356659|FG001|Overall Study|Lost to Follow-up|3|||
156621861|NCT04450394|565356660|FG002|Overall Study|Lost to Follow-up|0|||
156621862|NCT04450394|565356658|FG000|Overall Study|Physician Decision|0|||
156621863|NCT04450394|565356659|FG001|Overall Study|Physician Decision|1|||
156621864|NCT04450394|565356660|FG002|Overall Study|Physician Decision|0|||
156621865|NCT04450394|565356658|FG000|Overall Study|Protocol Violation|2|||
156621866|NCT04450394|565356659|FG001|Overall Study|Protocol Violation|0|||
156621867|NCT04450394|565356660|FG002|Overall Study|Protocol Violation|0|||
156621868|NCT04450394|565356658|FG000|Overall Study|Withdrawal by Subject|6|||
156621869|NCT04450394|565356659|FG001|Overall Study|Withdrawal by Subject|9|||
156621870|NCT04450394|565356660|FG002|Overall Study|Withdrawal by Subject|0|||
156621871|NCT01066819|565356661|FG000|Overall Study|Adverse Event|18|||
156621872|NCT01066819|565356662|FG001|Overall Study|Adverse Event|1|||
156621873|NCT01066819|565356663|FG002|Overall Study|Adverse Event|6|||
156621874|NCT01066819|565356664|FG003|Overall Study|Adverse Event|0|||
156621875|NCT01066819|565356665|FG004|Overall Study|Adverse Event|0|||
156621876|NCT01066819|565356666|FG005|Overall Study|Adverse Event|0|||
156621877|NCT01066819|565356661|FG000|Overall Study|Death|5|||
156621878|NCT01066819|565356662|FG001|Overall Study|Death|0|||
156621879|NCT01066819|565356663|FG002|Overall Study|Death|1|||
156621880|NCT01066819|565356664|FG003|Overall Study|Death|0|||
156621881|NCT01066819|565356665|FG004|Overall Study|Death|0|||
156621882|NCT01066819|565356666|FG005|Overall Study|Death|0|||
156621883|NCT01066819|565356661|FG000|Overall Study|Lack of Efficacy|22|||
156621884|NCT01066819|565356662|FG001|Overall Study|Lack of Efficacy|1|||
156621885|NCT01066819|565356663|FG002|Overall Study|Lack of Efficacy|2|||
156621886|NCT01066819|565356664|FG003|Overall Study|Lack of Efficacy|1|||
156621887|NCT01066819|565356665|FG004|Overall Study|Lack of Efficacy|0|||
156621888|NCT01066819|565356666|FG005|Overall Study|Lack of Efficacy|0|||
156621889|NCT01066819|565356661|FG000|Overall Study|Physician Decision|6|||
156621890|NCT01066819|565356662|FG001|Overall Study|Physician Decision|2|||
156621891|NCT01066819|565356663|FG002|Overall Study|Physician Decision|3|||
156621892|NCT01066819|565356664|FG003|Overall Study|Physician Decision|0|||
156621893|NCT01066819|565356665|FG004|Overall Study|Physician Decision|0|||
156621894|NCT01066819|565356666|FG005|Overall Study|Physician Decision|0|||
156621895|NCT01066819|565356661|FG000|Overall Study|Protocol Violation|12|||
156621896|NCT01066819|565356662|FG001|Overall Study|Protocol Violation|6|||
156621897|NCT01066819|565356663|FG002|Overall Study|Protocol Violation|0|||
156621898|NCT01066819|565356664|FG003|Overall Study|Protocol Violation|0|||
156621899|NCT01066819|565356665|FG004|Overall Study|Protocol Violation|0|||
156621900|NCT01066819|565356666|FG005|Overall Study|Protocol Violation|0|||
156621901|NCT01066819|565356661|FG000|Overall Study|Withdrawal by Subject|29|||
156621902|NCT01066819|565356662|FG001|Overall Study|Withdrawal by Subject|11|||
156621903|NCT01066819|565356663|FG002|Overall Study|Withdrawal by Subject|6|||
156621904|NCT01066819|565356664|FG003|Overall Study|Withdrawal by Subject|0|||
156621905|NCT01066819|565356665|FG004|Overall Study|Withdrawal by Subject|0|||
156621906|NCT01066819|565356666|FG005|Overall Study|Withdrawal by Subject|0|||
156621907|NCT01066819|565356661|FG000|Overall Study|Administrative|6|||
156621908|NCT01066819|565356662|FG001|Overall Study|Administrative|4|||
156621909|NCT01066819|565356663|FG002|Overall Study|Administrative|2|||
156621910|NCT01066819|565356664|FG003|Overall Study|Administrative|0|||
156621911|NCT01066819|565356665|FG004|Overall Study|Administrative|0|||
156621912|NCT01066819|565356666|FG005|Overall Study|Administrative|0|||
156621913|NCT01066819|565356661|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
156621914|NCT01066819|565356662|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
156621915|NCT01066819|565356663|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
156621916|NCT01066819|565356664|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
156621917|NCT01066819|565356665|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
156621918|NCT01066819|565356666|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
156621919|NCT01066819|565356661|FG000|Overall Study|Early termination|2|||
156621920|NCT01066819|565356662|FG001|Overall Study|Early termination|0|||
156621921|NCT01066819|565356663|FG002|Overall Study|Early termination|0|||
156621922|NCT01066819|565356664|FG003|Overall Study|Early termination|0|||
156621923|NCT01066819|565356665|FG004|Overall Study|Early termination|0|||
156621924|NCT01066819|565356666|FG005|Overall Study|Early termination|0|||
156621925|NCT01066819|565356661|FG000|Overall Study|Failed to return|298|||
156621926|NCT01066819|565356662|FG001|Overall Study|Failed to return|107|||
156621927|NCT01066819|565356663|FG002|Overall Study|Failed to return|68|||
156621928|NCT01066819|565356664|FG003|Overall Study|Failed to return|7|||
156621929|NCT01066819|565356665|FG004|Overall Study|Failed to return|2|||
156621930|NCT01066819|565356666|FG005|Overall Study|Failed to return|3|||
156621931|NCT01066819|565356661|FG000|Overall Study|Lab test not done|9|||
156621932|NCT01066819|565356662|FG001|Overall Study|Lab test not done|0|||
156621933|NCT01066819|565356663|FG002|Overall Study|Lab test not done|2|||
156621934|NCT01066819|565356664|FG003|Overall Study|Lab test not done|1|||
156621935|NCT01066819|565356665|FG004|Overall Study|Lab test not done|0|||
156621936|NCT01066819|565356666|FG005|Overall Study|Lab test not done|0|||
156621937|NCT01066819|565356661|FG000|Overall Study|Miscellaneous|28|||
156621938|NCT01066819|565356662|FG001|Overall Study|Miscellaneous|10|||
156621939|NCT01066819|565356663|FG002|Overall Study|Miscellaneous|18|||
156621940|NCT01066819|565356664|FG003|Overall Study|Miscellaneous|1|||
156621941|NCT01066819|565356665|FG004|Overall Study|Miscellaneous|0|||
156621942|NCT01066819|565356666|FG005|Overall Study|Miscellaneous|0|||
156621943|NCT01066819|565356661|FG000|Overall Study|Non responders|123|||
156621944|NCT01066819|565356662|FG001|Overall Study|Non responders|2|||
156621945|NCT01066819|565356663|FG002|Overall Study|Non responders|7|||
156621946|NCT01066819|565356664|FG003|Overall Study|Non responders|2|||
156621947|NCT01066819|565356665|FG004|Overall Study|Non responders|0|||
156621948|NCT01066819|565356666|FG005|Overall Study|Non responders|1|||
156621949|NCT01066819|565356661|FG000|Overall Study|Not categorised|9|||
156621950|NCT01066819|565356662|FG001|Overall Study|Not categorised|2|||
156621951|NCT01066819|565356663|FG002|Overall Study|Not categorised|6|||
156621952|NCT01066819|565356664|FG003|Overall Study|Not categorised|1|||
156621953|NCT01066819|565356665|FG004|Overall Study|Not categorised|0|||
156621954|NCT01066819|565356666|FG005|Overall Study|Not categorised|0|||
156621955|NCT01066819|565356661|FG000|Overall Study|Relapse|16|||
156621956|NCT01066819|565356662|FG001|Overall Study|Relapse|4|||
156621957|NCT01066819|565356663|FG002|Overall Study|Relapse|3|||
156621958|NCT01066819|565356664|FG003|Overall Study|Relapse|0|||
156621959|NCT01066819|565356665|FG004|Overall Study|Relapse|0|||
156621960|NCT01066819|565356666|FG005|Overall Study|Relapse|0|||
156621961|NCT01066819|565356661|FG000|Overall Study|Results not available|1|||
156621962|NCT01066819|565356662|FG001|Overall Study|Results not available|0|||
156621963|NCT01066819|565356663|FG002|Overall Study|Results not available|0|||
156621964|NCT01066819|565356664|FG003|Overall Study|Results not available|0|||
156621965|NCT01066819|565356665|FG004|Overall Study|Results not available|0|||
156621966|NCT01066819|565356666|FG005|Overall Study|Results not available|0|||
156621967|NCT01066819|565356661|FG000|Overall Study|Screen failure|1|||
156621968|NCT01066819|565356662|FG001|Overall Study|Screen failure|0|||
156621969|NCT01066819|565356663|FG002|Overall Study|Screen failure|0|||
156621970|NCT01066819|565356664|FG003|Overall Study|Screen failure|0|||
156621971|NCT01066819|565356665|FG004|Overall Study|Screen failure|0|||
156621972|NCT01066819|565356666|FG005|Overall Study|Screen failure|0|||
156621973|NCT01066819|565356661|FG000|Overall Study|Spontaneous cure|1|||
156621974|NCT01066819|565356662|FG001|Overall Study|Spontaneous cure|0|||
156621975|NCT01066819|565356663|FG002|Overall Study|Spontaneous cure|0|||
156621976|NCT01066819|565356664|FG003|Overall Study|Spontaneous cure|0|||
156621977|NCT01066819|565356665|FG004|Overall Study|Spontaneous cure|0|||
156621978|NCT01066819|565356666|FG005|Overall Study|Spontaneous cure|0|||
156621979|NCT01066819|565356661|FG000|Overall Study|Treatment never started|85|||
156621980|NCT01066819|565356662|FG001|Overall Study|Treatment never started|19|||
156621981|NCT01066819|565356663|FG002|Overall Study|Treatment never started|19|||
156621982|NCT01066819|565356664|FG003|Overall Study|Treatment never started|3|||
156621983|NCT01066819|565356665|FG004|Overall Study|Treatment never started|2|||
156621984|NCT01066819|565356666|FG005|Overall Study|Treatment never started|2|||
156621985|NCT01066819|565356661|FG000|Overall Study|Treatment stopped|12|||
156621986|NCT01066819|565356662|FG001|Overall Study|Treatment stopped|1|||
156621987|NCT01066819|565356663|FG002|Overall Study|Treatment stopped|2|||
156621988|NCT01066819|565356664|FG003|Overall Study|Treatment stopped|1|||
156621989|NCT01066819|565356665|FG004|Overall Study|Treatment stopped|0|||
156621990|NCT01066819|565356666|FG005|Overall Study|Treatment stopped|0|||
156621991|NCT01066819|565356661|FG000|Overall Study|Other|5|||
156621992|NCT01066819|565356662|FG001|Overall Study|Other|1|||
156621993|NCT01066819|565356663|FG002|Overall Study|Other|1|||
156621994|NCT01066819|565356664|FG003|Overall Study|Other|0|||
156621995|NCT01066819|565356665|FG004|Overall Study|Other|0|||
156621996|NCT01066819|565356666|FG005|Overall Study|Other|0|||
156621997|NCT00303719|565356669|FG000|Overall Study|Not evaluable, prior therapies|0|||
156621998|NCT00303719|565356670|FG001|Overall Study|Not evaluable, prior therapies|30|||
156621999|NCT00303719|565356669|FG000|Overall Study|Lost to Follow-up|0|||
156622000|NCT00303719|565356670|FG001|Overall Study|Lost to Follow-up|7|||
156622001|NCT01641952|565356671|FG000|Overall Study|Lost to Follow-up|28|||
156622002|NCT01641952|565356671|FG000|Overall Study|Adverse Event|6|||
156622003|NCT03633461|565356672|FG000|Overall Study|Lost to Follow-up|0|||
156622004|NCT03633461|565356673|FG001|Overall Study|Lost to Follow-up|1|||
156622005|NCT02516605|565356680|FG000|Overall Study|Protocol Violation|0|||
156622006|NCT02516605|565356681|FG001|Overall Study|Protocol Violation|0|||
156622007|NCT02516605|565356682|FG002|Overall Study|Protocol Violation|0|||
156622008|NCT02516605|565356683|FG003|Overall Study|Protocol Violation|0|||
156622009|NCT02516605|565356684|FG004|Overall Study|Protocol Violation|1|||
156622010|NCT02516605|565356680|FG000|Overall Study|Withdrawal by Subject|0|||
156622011|NCT02516605|565356681|FG001|Overall Study|Withdrawal by Subject|0|||
156622012|NCT02516605|565356682|FG002|Overall Study|Withdrawal by Subject|0|||
156622013|NCT02516605|565356683|FG003|Overall Study|Withdrawal by Subject|1|||
156622014|NCT02516605|565356684|FG004|Overall Study|Withdrawal by Subject|0|||
156622015|NCT02643420|565356685|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
156622016|NCT02643420|565356686|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
156622017|NCT02643420|565356685|FG000|Overall Study|Withdrawal by Subject|25|||
156622018|NCT02643420|565356686|FG001|Overall Study|Withdrawal by Subject|19|||
156622019|NCT02643420|565356685|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
156622020|NCT02643420|565356686|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
156622021|NCT02643420|565356685|FG000|Overall Study|Lost to Follow-up|6|||
156622022|NCT02643420|565356686|FG001|Overall Study|Lost to Follow-up|10|||
156622023|NCT02643420|565356685|FG000|Overall Study|Investigator Decision|2|||
156622024|NCT02643420|565356686|FG001|Overall Study|Investigator Decision|4|||
156622025|NCT02643420|565356685|FG000|Overall Study|Sponsor decision|1|||
156622026|NCT02643420|565356686|FG001|Overall Study|Sponsor decision|1|||
156622027|NCT02643420|565356685|FG000|Overall Study|Death|0|||
156622028|NCT02643420|565356686|FG001|Overall Study|Death|2|||
156622029|NCT02643420|565356685|FG000|Overall Study|Reason not Specified|8|||
156622030|NCT02643420|565356686|FG001|Overall Study|Reason not Specified|7|||
156622031|NCT01710709|565356687|FG000|Overall Study|Lost to Follow-up|29|||
156622032|NCT01710709|565356687|FG000|Overall Study|Adverse Event|48|||
156622033|NCT01710709|565356687|FG000|Overall Study|Participant met withdrawal criteria|33|||
156622034|NCT01710709|565356687|FG000|Overall Study|Participant withdrawn by investigator|2|||
156622035|NCT01710709|565356687|FG000|Overall Study|Withdrawal by Subject|53|||
156622036|NCT01710709|565356687|FG000|Overall Study|Protocol Violation|5|||
156622037|NCT01710709|565356687|FG000|Overall Study|Lack of Efficacy|3|||
156622038|NCT01716585|565356691|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
156622039|NCT01716585|565356692|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
156622040|NCT01716585|565356691|FG000|Double-blind Treatment|Adverse Event|2|||
156622041|NCT01716585|565356692|FG001|Double-blind Treatment|Adverse Event|1|||
156622042|NCT01716585|565356691|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
156622043|NCT01716585|565356692|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
156622044|NCT01716585|565356691|FG000|Double-blind Treatment|Lost to Follow-up|2|||
156622045|NCT01716585|565356692|FG001|Double-blind Treatment|Lost to Follow-up|0|||
156622046|NCT01716585|565356691|FG000|Double-blind Treatment|Subject Noncompliant|1|||
156622047|NCT01716585|565356692|FG001|Double-blind Treatment|Subject Noncompliant|0|||
156622048|NCT01716585|565356691|FG000|Double-blind Treatment|Other|1|||
156622049|NCT01716585|565356692|FG001|Double-blind Treatment|Other|0|||
156622050|NCT01716585|565356691|FG000|Open-label Treatment|Adverse Event|0|||
156622051|NCT01716585|565356692|FG001|Open-label Treatment|Adverse Event|2|||
156622052|NCT01716585|565356691|FG000|Open-label Treatment|Virologic Failure|0|||
156622053|NCT01716585|565356692|FG001|Open-label Treatment|Virologic Failure|2|||
156622054|NCT01716585|565356691|FG000|Open-label Treatment|Withdrawal by Subject|0|||
156622055|NCT01716585|565356692|FG001|Open-label Treatment|Withdrawal by Subject|3|||
156622056|NCT02275052|565356693|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156622057|NCT02275052|565356694|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156622058|NCT02275052|565356695|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156622059|NCT02275052|565356696|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156622060|NCT02275052|565356693|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
156622061|NCT02275052|565356694|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
156622062|NCT02275052|565356695|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
156622063|NCT02275052|565356696|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
156622064|NCT02275052|565356693|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
156622065|NCT02275052|565356694|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
156622066|NCT02275052|565356695|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156622067|NCT02275052|565356696|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156622068|NCT02275052|565356693|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
156622069|NCT02275052|565356694|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
156622070|NCT02275052|565356695|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
156622071|NCT02275052|565356696|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
156622072|NCT02275052|565356693|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
156622073|NCT02275052|565356694|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
156622074|NCT02275052|565356695|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
156622075|NCT02275052|565356696|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
156622076|NCT02275052|565356693|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
156622077|NCT02275052|565356694|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
156622078|NCT02275052|565356695|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
156622079|NCT02275052|565356696|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
156622080|NCT02275052|565356693|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
156622081|NCT02275052|565356694|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
156622082|NCT02275052|565356695|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
156622083|NCT02275052|565356696|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
156622084|NCT02275052|565356693|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156622085|NCT02275052|565356694|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156622086|NCT02275052|565356695|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
156622087|NCT02275052|565356696|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
156622088|NCT02275052|565356693|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156622089|NCT02275052|565356694|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156622090|NCT02275052|565356695|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156622091|NCT02275052|565356696|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
156622092|NCT02275052|565356693|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
156622093|NCT02275052|565356694|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
156622094|NCT02275052|565356695|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156622095|NCT02275052|565356696|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
156622096|NCT02275052|565356693|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156622097|NCT02275052|565356694|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156622098|NCT02275052|565356695|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156622099|NCT02275052|565356696|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
156622100|NCT05102734|565356697|FG000|Overall Study|Did not require vasopressors|1|||
156622101|NCT05102734|565356698|FG001|Overall Study|Did not require vasopressors|0|||
156622102|NCT05102734|565356697|FG000|Overall Study|Did not have functioning PA catheter|1|||
156622103|NCT05102734|565356698|FG001|Overall Study|Did not have functioning PA catheter|0|||
156622104|NCT05102734|565356697|FG000|Overall Study|Inadequate video quality|2|||
156622105|NCT05102734|565356698|FG001|Overall Study|Inadequate video quality|0|||
156622106|NCT03055806|565356704|FG000|Overall Study|Adverse Event|0|||
156622107|NCT03055806|565356705|FG001|Overall Study|Adverse Event|0|||
156622108|NCT03055806|565356706|FG002|Overall Study|Adverse Event|1|||
156622109|NCT03055806|565356707|FG003|Overall Study|Adverse Event|1|||
156622110|NCT03055806|565356704|FG000|Overall Study|Lost to Follow-up|0|||
156622111|NCT03055806|565356705|FG001|Overall Study|Lost to Follow-up|3|||
156622112|NCT03055806|565356706|FG002|Overall Study|Lost to Follow-up|6|||
156622113|NCT03055806|565356707|FG003|Overall Study|Lost to Follow-up|7|||
156622114|NCT03055806|565356704|FG000|Overall Study|Physician Decision|1|||
156622115|NCT03055806|565356705|FG001|Overall Study|Physician Decision|0|||
156622116|NCT03055806|565356706|FG002|Overall Study|Physician Decision|0|||
156622117|NCT03055806|565356707|FG003|Overall Study|Physician Decision|1|||
156622118|NCT03055806|565356704|FG000|Overall Study|Protocol Violation|1|||
156622119|NCT03055806|565356705|FG001|Overall Study|Protocol Violation|0|||
156622120|NCT03055806|565356706|FG002|Overall Study|Protocol Violation|0|||
156622121|NCT03055806|565356707|FG003|Overall Study|Protocol Violation|0|||
156622122|NCT03055806|565356704|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
156622123|NCT03055806|565356705|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
156622124|NCT03055806|565356706|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
156622125|NCT03055806|565356707|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
156622126|NCT03055806|565356704|FG000|Overall Study|Withdrawal of consent to continue study|2|||
156622127|NCT03055806|565356705|FG001|Overall Study|Withdrawal of consent to continue study|3|||
156622128|NCT03055806|565356706|FG002|Overall Study|Withdrawal of consent to continue study|4|||
156622129|NCT03055806|565356707|FG003|Overall Study|Withdrawal of consent to continue study|6|||
156622130|NCT03055806|565356704|FG000|Overall Study|Partner not willing to try intercourse|1|||
156622131|NCT03055806|565356705|FG001|Overall Study|Partner not willing to try intercourse|0|||
156622132|NCT03055806|565356706|FG002|Overall Study|Partner not willing to try intercourse|0|||
156622133|NCT03055806|565356707|FG003|Overall Study|Partner not willing to try intercourse|0|||
156622134|NCT04601194|565356708|FG000|Overall Study|Lost to Follow-up|7|||
156622135|NCT02630459|565356709|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
156622136|NCT02630459|565356710|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
156622137|NCT02630459|565356711|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
156622138|NCT02630459|565356712|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
156622139|NCT02630459|565356713|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
156622140|NCT02630459|565356714|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
156622141|NCT02630459|565356715|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
156622142|NCT02630459|565356716|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
156622143|NCT02630459|565356709|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
156622144|NCT02630459|565356710|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
156622145|NCT02630459|565356711|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
156622146|NCT02630459|565356712|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
156622147|NCT02630459|565356713|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
156622148|NCT02630459|565356714|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
156622149|NCT02630459|565356715|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
156622150|NCT02630459|565356716|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
156622151|NCT02630459|565356709|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
156622152|NCT02630459|565356710|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
156622153|NCT02630459|565356711|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
156622154|NCT02630459|565356712|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
156622155|NCT02630459|565356713|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
156622156|NCT02630459|565356714|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
156622157|NCT02630459|565356715|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
156622158|NCT02630459|565356716|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
156622159|NCT02630459|565356709|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
156622160|NCT02630459|565356710|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
156622161|NCT02630459|565356711|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
156622162|NCT02630459|565356712|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
156622163|NCT02630459|565356713|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
156622164|NCT02630459|565356714|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
156622165|NCT02630459|565356715|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
156622166|NCT02630459|565356716|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
156622167|NCT02630459|565356709|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
156622168|NCT02630459|565356710|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
156622169|NCT02630459|565356711|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
156622170|NCT02630459|565356712|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
156622171|NCT02630459|565356713|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
156622172|NCT02630459|565356714|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
156622173|NCT02630459|565356715|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
156622174|NCT02630459|565356716|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
156622175|NCT02630459|565356709|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
156622176|NCT02630459|565356710|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
156622177|NCT02630459|565356711|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
156622178|NCT02630459|565356712|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
156622179|NCT02630459|565356713|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
156622180|NCT02630459|565356714|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
156622181|NCT02630459|565356715|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
156622182|NCT02630459|565356716|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
156622183|NCT02630459|565356709|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
156622184|NCT02630459|565356710|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
156622185|NCT02630459|565356711|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
156622186|NCT02630459|565356712|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
156622187|NCT02630459|565356713|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
156622188|NCT02630459|565356714|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
156622189|NCT02630459|565356715|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
156622190|NCT02630459|565356716|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
156622191|NCT00846027|565356717|FG000|Overall Study|Death|3|||
156622192|NCT00846027|565356717|FG000|Overall Study|Disease Progression|30|||
156622193|NCT00846027|565356717|FG000|Overall Study|Toxicity|12|||
156622194|NCT00846027|565356717|FG000|Overall Study|Patient Decision|7|||
156622195|NCT00846027|565356717|FG000|Overall Study|Investigator Discretion|29|||
156622196|NCT00846027|565356717|FG000|Overall Study|Protocol Violation|2|||
156622197|NCT00846027|565356717|FG000|Overall Study|Subject Not Treated|7|||
156622198|NCT04905563|565356720|FG000|Overall Study|Withdrawal by Subject|1|||
156622199|NCT04905563|565356721|FG001|Overall Study|Withdrawal by Subject|0|||
156622200|NCT04905563|565356720|FG000|Overall Study|Standard of care orders entered by resident|1|||
156622201|NCT04905563|565356721|FG001|Overall Study|Standard of care orders entered by resident|0|||
156622202|NCT04905563|565356720|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
156622203|NCT04905563|565356721|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
156622204|NCT04905563|565356720|FG000|Overall Study|Withdrawal by Subject|0|||
156622205|NCT04905563|565356721|FG001|Overall Study|Withdrawal by Subject|1|||
156622206|NCT01797302|565356722|FG000|Overall Study|Lost to Follow-up|16|||
156622207|NCT01797302|565356723|FG001|Overall Study|Lost to Follow-up|23|||
156622208|NCT01797302|565356724|FG002|Overall Study|Lost to Follow-up|22|||
156622209|NCT01797302|565356722|FG000|Overall Study|Withdrawal by Subject|1|||
156622210|NCT01797302|565356723|FG001|Overall Study|Withdrawal by Subject|3|||
156622211|NCT01797302|565356724|FG002|Overall Study|Withdrawal by Subject|4|||
156622212|NCT00689611|565356727|FG000|Overall Study|Death|6|||
156622213|NCT00689611|565356728|FG001|Overall Study|Death|9|||
156622214|NCT00689611|565356727|FG000|Overall Study|Withdrawal by Subject|8|||
156622215|NCT00689611|565356728|FG001|Overall Study|Withdrawal by Subject|9|||
156622216|NCT00689611|565356727|FG000|Overall Study|Lost to Follow-up|27|||
156622217|NCT00689611|565356728|FG001|Overall Study|Lost to Follow-up|28|||
156622218|NCT00568399|565356730|FG000|Overall Study|Death|2|||
156622219|NCT00568399|565356730|FG000|Overall Study|Adverse Event|5|||
156622220|NCT00568399|565356730|FG000|Overall Study|Withdrawal by Subject|8|||
156622221|NCT00106626|565356731|FG000|Overall Study|Adverse Event|5|||
156622222|NCT00106626|565356732|FG001|Overall Study|Adverse Event|4|||
156622223|NCT00106626|565356733|FG002|Overall Study|Adverse Event|3|||
156622224|NCT00106626|565356734|FG003|Overall Study|Adverse Event|3|||
156622225|NCT00106626|565356731|FG000|Overall Study|Progressive Disease|4|||
156622226|NCT00106626|565356732|FG001|Overall Study|Progressive Disease|1|||
156622227|NCT00106626|565356733|FG002|Overall Study|Progressive Disease|9|||
156622228|NCT00106626|565356734|FG003|Overall Study|Progressive Disease|10|||
156622229|NCT00106626|565356731|FG000|Overall Study|Received radiation on new therapy|1|||
156622230|NCT00106626|565356732|FG001|Overall Study|Received radiation on new therapy|0|||
156622231|NCT00106626|565356733|FG002|Overall Study|Received radiation on new therapy|0|||
156622232|NCT00106626|565356734|FG003|Overall Study|Received radiation on new therapy|0|||
156622233|NCT00106626|565356731|FG000|Overall Study|> 14 day delay in therapy start|0|||
156622234|NCT00106626|565356732|FG001|Overall Study|> 14 day delay in therapy start|1|||
156622235|NCT00106626|565356733|FG002|Overall Study|> 14 day delay in therapy start|0|||
156622236|NCT00106626|565356734|FG003|Overall Study|> 14 day delay in therapy start|0|||
156622237|NCT00405756|565356735|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
156622238|NCT00405756|565356736|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
156622239|NCT00405756|565356737|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
156622240|NCT00405756|565356735|FG000|Double-blind Treatment|Adverse Event|31|||
156622241|NCT00405756|565356736|FG001|Double-blind Treatment|Adverse Event|27|||
156622242|NCT00405756|565356737|FG002|Double-blind Treatment|Adverse Event|12|||
156622243|NCT00405756|565356735|FG000|Double-blind Treatment|Disease Progression|47|||
156622244|NCT00405756|565356736|FG001|Double-blind Treatment|Disease Progression|81|||
156622245|NCT00405756|565356737|FG002|Double-blind Treatment|Disease Progression|102|||
156622246|NCT00405756|565356735|FG000|Double-blind Treatment|Lack of Efficacy|1|||
156622247|NCT00405756|565356736|FG001|Double-blind Treatment|Lack of Efficacy|4|||
156622248|NCT00405756|565356737|FG002|Double-blind Treatment|Lack of Efficacy|2|||
156622249|NCT00405756|565356735|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
156622250|NCT00405756|565356736|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
156622251|NCT00405756|565356737|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
156622252|NCT00405756|565356735|FG000|Double-blind Treatment|Lost to Follow-up|1|||
156622253|NCT00405756|565356736|FG001|Double-blind Treatment|Lost to Follow-up|0|||
156622254|NCT00405756|565356737|FG002|Double-blind Treatment|Lost to Follow-up|0|||
156622255|NCT00405756|565356735|FG000|Double-blind Treatment|Death|4|||
156622256|NCT00405756|565356736|FG001|Double-blind Treatment|Death|4|||
156622257|NCT00405756|565356737|FG002|Double-blind Treatment|Death|4|||
156622258|NCT00405756|565356735|FG000|Double-blind Treatment|Protocol Violation|1|||
156622259|NCT00405756|565356736|FG001|Double-blind Treatment|Protocol Violation|0|||
156622260|NCT00405756|565356737|FG002|Double-blind Treatment|Protocol Violation|2|||
156622261|NCT00405756|565356735|FG000|Double-blind Treatment|Other|7|||
156622262|NCT00405756|565356736|FG001|Double-blind Treatment|Other|4|||
156622263|NCT00405756|565356737|FG002|Double-blind Treatment|Other|4|||
156622264|NCT00405756|565356735|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
156622265|NCT00405756|565356736|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
156622266|NCT00405756|565356737|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
156622267|NCT00405756|565356735|FG000|Open-label Extension|Adverse Event|1|||
156622268|NCT00405756|565356736|FG001|Open-label Extension|Adverse Event|3|||
156622269|NCT00405756|565356737|FG002|Open-label Extension|Adverse Event|7|||
156622270|NCT00405756|565356735|FG000|Open-label Extension|Disease Progression|8|||
156622271|NCT00405756|565356736|FG001|Open-label Extension|Disease Progression|23|||
156622272|NCT00405756|565356737|FG002|Open-label Extension|Disease Progression|26|||
156622273|NCT00405756|565356735|FG000|Open-label Extension|Withdrawal by Subject|2|||
156622274|NCT00405756|565356736|FG001|Open-label Extension|Withdrawal by Subject|3|||
156622275|NCT00405756|565356737|FG002|Open-label Extension|Withdrawal by Subject|3|||
156622276|NCT00405756|565356735|FG000|Open-label Extension|Death|1|||
156622277|NCT00405756|565356736|FG001|Open-label Extension|Death|2|||
156622278|NCT00405756|565356737|FG002|Open-label Extension|Death|4|||
156622279|NCT00405756|565356735|FG000|Open-label Extension|Other|0|||
156622280|NCT00405756|565356736|FG001|Open-label Extension|Other|1|||
156622281|NCT00405756|565356737|FG002|Open-label Extension|Other|7|||
156622282|NCT00405756|565356735|FG000|Follow-up|Ongoing in Follow-up Period|52|||
156622283|NCT00405756|565356736|FG001|Follow-up|Ongoing in Follow-up Period|51|||
156622284|NCT00405756|565356737|FG002|Follow-up|Ongoing in Follow-up Period|60|||
156622285|NCT00405756|565356735|FG000|Follow-up|Death|21|||
156622286|NCT00405756|565356736|FG001|Follow-up|Death|31|||
156622287|NCT00405756|565356737|FG002|Follow-up|Death|24|||
156622288|NCT00405756|565356735|FG000|Follow-up|Lost to Follow-up|2|||
156622289|NCT00405756|565356736|FG001|Follow-up|Lost to Follow-up|8|||
156622290|NCT00405756|565356737|FG002|Follow-up|Lost to Follow-up|4|||
156622291|NCT03480360|565356740|FG000|Overall Study|Death|2|||
156622292|NCT02120469|565356745|FG000|Overall Study|HER-2/neu-amplified|1|||
156622293|NCT02120469|565356746|FG001|Overall Study|HER-2/neu-amplified|0|||
156622294|NCT02120469|565356747|FG002|Overall Study|HER-2/neu-amplified|1|||
156622295|NCT01040728|565356748|FG000|Overall Study|Adverse Event|4|||
156622296|NCT01040728|565356749|FG001|Overall Study|Adverse Event|8|||
156622297|NCT01040728|565356750|FG002|Overall Study|Adverse Event|0|||
156622298|NCT01040728|565356751|FG003|Overall Study|Adverse Event|4|||
156622299|NCT01040728|565356748|FG000|Overall Study|Withdrawal by Subject|0|||
156622300|NCT01040728|565356749|FG001|Overall Study|Withdrawal by Subject|1|||
156622301|NCT01040728|565356750|FG002|Overall Study|Withdrawal by Subject|1|||
156622302|NCT01040728|565356751|FG003|Overall Study|Withdrawal by Subject|0|||
156622303|NCT01040728|565356748|FG000|Overall Study|Protocol Violation|0|||
156622304|NCT01040728|565356749|FG001|Overall Study|Protocol Violation|0|||
156622305|NCT01040728|565356750|FG002|Overall Study|Protocol Violation|0|||
156622306|NCT01040728|565356751|FG003|Overall Study|Protocol Violation|1|||
156622307|NCT01040728|565356748|FG000|Overall Study|Lack of Efficacy|0|||
156622308|NCT01040728|565356749|FG001|Overall Study|Lack of Efficacy|1|||
156622309|NCT01040728|565356750|FG002|Overall Study|Lack of Efficacy|0|||
156622310|NCT01040728|565356751|FG003|Overall Study|Lack of Efficacy|1|||
156622311|NCT01040728|565356748|FG000|Overall Study|Other reasons not listed above|0|||
156622312|NCT01040728|565356749|FG001|Overall Study|Other reasons not listed above|1|||
156622313|NCT01040728|565356750|FG002|Overall Study|Other reasons not listed above|0|||
156622314|NCT01040728|565356751|FG003|Overall Study|Other reasons not listed above|0|||
156622315|NCT00590031|565356753|FG000|Overall Study|Adverse Event|3|||
156622316|NCT00590031|565356753|FG000|Overall Study|Withdrawal by Subject|1|||
156622317|NCT00590031|565356753|FG000|Overall Study|Metastatic Disease|1|||
156622318|NCT00590031|565356753|FG000|Overall Study|Admin Hold|1|||
156622319|NCT00826540|565356758|FG000|Overall Study|ineligible|3|||
156622320|NCT00826540|565356758|FG000|Overall Study|Withdrawal by Subject|1|||
156622321|NCT02802735|565356759|FG000|Overall Study|Withdrawal by Subject|0|||
156622322|NCT02802735|565356760|FG001|Overall Study|Withdrawal by Subject|1|||
156622323|NCT02802735|565356761|FG002|Overall Study|Withdrawal by Subject|0|||
156622324|NCT02802735|565356762|FG003|Overall Study|Withdrawal by Subject|0|||
156622325|NCT02802735|565356763|FG004|Overall Study|Withdrawal by Subject|0|||
156622326|NCT01166386|565356764|FG000|Overall Study|Withdrawal by Subject|3|||
156622327|NCT01166386|565356765|FG001|Overall Study|Withdrawal by Subject|5|||
156622328|NCT03922711|565356770|FG000|Overall Study|Adverse Event|3|||
156622329|NCT03922711|565356771|FG001|Overall Study|Adverse Event|2|||
156622330|NCT03922711|565356772|FG002|Overall Study|Adverse Event|2|||
156622331|NCT03922711|565356770|FG000|Overall Study|Protocol Violation|1|||
156622332|NCT03922711|565356771|FG001|Overall Study|Protocol Violation|0|||
156622333|NCT03922711|565356772|FG002|Overall Study|Protocol Violation|0|||
156622334|NCT03922711|565356770|FG000|Overall Study|Withdrawal by Subject|0|||
156622335|NCT03922711|565356771|FG001|Overall Study|Withdrawal by Subject|3|||
156622336|NCT03922711|565356772|FG002|Overall Study|Withdrawal by Subject|1|||
156622337|NCT03922711|565356770|FG000|Overall Study|Not further specified|0|||
156622338|NCT03922711|565356771|FG001|Overall Study|Not further specified|0|||
156622339|NCT03922711|565356772|FG002|Overall Study|Not further specified|1|||
156622340|NCT02390362|565356773|FG000|Overall Study|Withdrawal by Subject|0|||
156622341|NCT02390362|565356774|FG001|Overall Study|Withdrawal by Subject|1|||
156622342|NCT00554840|565356779|FG000|Overall Study|Physician Decision|0|||
156622343|NCT00554840|565356780|FG001|Overall Study|Physician Decision|1|||
156622344|NCT00795717|565356783|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
156622345|NCT00795717|565356784|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
156622346|NCT00795717|565356783|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
156622347|NCT00795717|565356784|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
156622348|NCT00795717|565356783|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
156622349|NCT00795717|565356784|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
156622350|NCT00795717|565356783|FG000|Phase II|too busy|0|||
156622351|NCT00795717|565356784|FG001|Phase II|too busy|1|||
156622352|NCT04728815|565356787|FG000|Overall Study|Lost to Follow-up|3|||
156622353|NCT04728815|565356788|FG001|Overall Study|Lost to Follow-up|0|||
156622354|NCT04728815|565356789|FG002|Overall Study|Lost to Follow-up|0|||
156622355|NCT04728815|565356790|FG003|Overall Study|Lost to Follow-up|1|||
156622356|NCT04728815|565356791|FG004|Overall Study|Lost to Follow-up|1|||
156622357|NCT04728815|565356792|FG005|Overall Study|Lost to Follow-up|0|||
156622358|NCT04728815|565356793|FG006|Overall Study|Lost to Follow-up|2|||
156622359|NCT04728815|565356794|FG007|Overall Study|Lost to Follow-up|0|||
156622360|NCT04728815|565356787|FG000|Overall Study|Physician Decision|0|||
156622361|NCT04728815|565356788|FG001|Overall Study|Physician Decision|0|||
156622362|NCT04728815|565356789|FG002|Overall Study|Physician Decision|1|||
156622363|NCT04728815|565356790|FG003|Overall Study|Physician Decision|0|||
156622364|NCT04728815|565356791|FG004|Overall Study|Physician Decision|0|||
156622365|NCT04728815|565356792|FG005|Overall Study|Physician Decision|0|||
156622366|NCT04728815|565356793|FG006|Overall Study|Physician Decision|0|||
156622367|NCT04728815|565356794|FG007|Overall Study|Physician Decision|0|||
156622368|NCT04728815|565356787|FG000|Overall Study|Treatment drop|0|||
156622369|NCT04728815|565356788|FG001|Overall Study|Treatment drop|2|||
156622370|NCT04728815|565356789|FG002|Overall Study|Treatment drop|1|||
156622371|NCT04728815|565356790|FG003|Overall Study|Treatment drop|0|||
156622372|NCT04728815|565356791|FG004|Overall Study|Treatment drop|3|||
156622373|NCT04728815|565356792|FG005|Overall Study|Treatment drop|1|||
156622374|NCT04728815|565356793|FG006|Overall Study|Treatment drop|3|||
156622375|NCT04728815|565356794|FG007|Overall Study|Treatment drop|0|||
156622376|NCT04728815|565356787|FG000|Overall Study|Study drop|0|||
156622377|NCT04728815|565356788|FG001|Overall Study|Study drop|3|||
156622378|NCT04728815|565356789|FG002|Overall Study|Study drop|3|||
156622379|NCT04728815|565356790|FG003|Overall Study|Study drop|0|||
156622380|NCT04728815|565356791|FG004|Overall Study|Study drop|0|||
156622381|NCT04728815|565356792|FG005|Overall Study|Study drop|0|||
156622382|NCT04728815|565356793|FG006|Overall Study|Study drop|7|||
156622383|NCT04728815|565356794|FG007|Overall Study|Study drop|0|||
156622384|NCT00957034|565356795|FG000|Overall Study|Adverse Event|0|||
156622385|NCT00957034|565356796|FG001|Overall Study|Adverse Event|1|||
156622386|NCT00957034|565356797|FG002|Overall Study|Adverse Event|1|||
156622387|NCT00957034|565356795|FG000|Overall Study|Sponsor Terminated Study|6|||
156622388|NCT00957034|565356796|FG001|Overall Study|Sponsor Terminated Study|1|||
156622389|NCT00957034|565356797|FG002|Overall Study|Sponsor Terminated Study|5|||
156622390|NCT00957034|565356795|FG000|Overall Study|Withdrawal by Subject|0|||
156622391|NCT00957034|565356796|FG001|Overall Study|Withdrawal by Subject|2|||
156622392|NCT00957034|565356797|FG002|Overall Study|Withdrawal by Subject|0|||
156622393|NCT05315297|565356798|FG000|Overall Study|Lost to Follow-up|6|||
156622394|NCT05315297|565356799|FG001|Overall Study|Lost to Follow-up|4|||
156622395|NCT05315297|565356798|FG000|Overall Study|Withdrawal by Subject|0|||
156622396|NCT05315297|565356799|FG001|Overall Study|Withdrawal by Subject|1|||
156622397|NCT00027846|565359323|FG000|Overall Study|Lost to Follow-up|0|||
156622398|NCT00027846|565359324|FG001|Overall Study|Lost to Follow-up|41|||
156622399|NCT00027846|565359325|FG002|Overall Study|Lost to Follow-up|9|||
156622400|NCT00027846|565359323|FG000|Overall Study|Withdrawal by Subject|0|||
156622401|NCT00027846|565359324|FG001|Overall Study|Withdrawal by Subject|14|||
156622402|NCT00027846|565359325|FG002|Overall Study|Withdrawal by Subject|7|||
156622403|NCT00027846|565359323|FG000|Overall Study|Ineligible for study|2|||
156622404|NCT00027846|565359324|FG001|Overall Study|Ineligible for study|6|||
156622405|NCT00027846|565359325|FG002|Overall Study|Ineligible for study|14|||
156622406|NCT00027846|565359323|FG000|Overall Study|Entry into another COG therapeutic study|0|||
156622407|NCT00027846|565359324|FG001|Overall Study|Entry into another COG therapeutic study|5|||
156622408|NCT00027846|565359325|FG002|Overall Study|Entry into another COG therapeutic study|2|||
156622409|NCT00027846|565359323|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
156622410|NCT00027846|565359324|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
156622411|NCT00027846|565359325|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
156622412|NCT01503229|565359326|FG000|Overall Study|Withdrew consent|1|||
156622413|NCT01354964|565359327|FG000|Overall Study|Lost to Follow-up|2|||
156622414|NCT01354964|565359328|FG001|Overall Study|Lost to Follow-up|0|||
156622415|NCT01354964|565359327|FG000|Overall Study|IV access issues|1|||
156622416|NCT01354964|565359328|FG001|Overall Study|IV access issues|1|||
156622417|NCT01354964|565359327|FG000|Overall Study|Physician Decision|1|||
156622418|NCT01354964|565359328|FG001|Overall Study|Physician Decision|0|||
156622419|NCT00711009|565359329|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
156622420|NCT00711009|565359330|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
156622421|NCT00711009|565359329|FG000|Overall Study|Withdrawal by Subject|4|||
156622422|NCT00711009|565359330|FG001|Overall Study|Withdrawal by Subject|2|||
156622423|NCT00711009|565359329|FG000|Overall Study|Lost to Follow-up|3|||
156622424|NCT00711009|565359330|FG001|Overall Study|Lost to Follow-up|9|||
156622425|NCT00711009|565359329|FG000|Overall Study|Participant Noncompliant|0|||
156622426|NCT00711009|565359330|FG001|Overall Study|Participant Noncompliant|1|||
156622427|NCT00711009|565359329|FG000|Overall Study|Virologic Failure|2|||
156622428|NCT00711009|565359330|FG001|Overall Study|Virologic Failure|1|||
156622429|NCT00711009|565359329|FG000|Overall Study|Pregnancy|1|||
156622430|NCT00711009|565359330|FG001|Overall Study|Pregnancy|0|||
156622431|NCT00711009|565359329|FG000|Overall Study|Site closing|0|||
156622432|NCT00711009|565359330|FG001|Overall Study|Site closing|1|||
156622433|NCT00711009|565359329|FG000|Overall Study|Dose adjustment|1|||
156622434|NCT00711009|565359330|FG001|Overall Study|Dose adjustment|0|||
156622435|NCT02534324|565359332|FG000|Overall Study|Protocol Violation|4|||
156622436|NCT02534324|565359333|FG001|Overall Study|Protocol Violation|1|||
156622437|NCT02534324|565359332|FG000|Overall Study|Lost to Follow-up|20|||
156622438|NCT02534324|565359333|FG001|Overall Study|Lost to Follow-up|7|||
156622439|NCT02534324|565359332|FG000|Overall Study|Adverse Event|1|||
156622440|NCT02534324|565359333|FG001|Overall Study|Adverse Event|0|||
156622441|NCT05604781|565359334|FG000|Overall Study|Lost to Follow-up|3|||
156622442|NCT05604781|565359334|FG000|Overall Study|Adverse Event|1|||
156622443|NCT01459016|565359335|FG000|Overall Study|Withdrawal by Subject|11|||
156622444|NCT01459016|565359335|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
156622445|NCT03922945|565359349|FG000|Overall Study|Adverse Event|1|||
156622446|NCT03922945|565359350|FG001|Overall Study|Adverse Event|1|||
156622447|NCT03922945|565359351|FG002|Overall Study|Adverse Event|2|||
156622448|NCT03922945|565359349|FG000|Overall Study|Lost to Follow-up|13|||
156622449|NCT03922945|565359350|FG001|Overall Study|Lost to Follow-up|9|||
156622450|NCT03922945|565359351|FG002|Overall Study|Lost to Follow-up|20|||
156622451|NCT03922945|565359349|FG000|Overall Study|Lack of Efficacy|2|||
156622452|NCT03922945|565359350|FG001|Overall Study|Lack of Efficacy|0|||
156622453|NCT03922945|565359351|FG002|Overall Study|Lack of Efficacy|1|||
156622454|NCT03922945|565359349|FG000|Overall Study|Protocol Non-Compliance|0|||
156622455|NCT03922945|565359350|FG001|Overall Study|Protocol Non-Compliance|0|||
156622456|NCT03922945|565359351|FG002|Overall Study|Protocol Non-Compliance|1|||
156622457|NCT03922945|565359349|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
156622458|NCT03922945|565359350|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
156622459|NCT03922945|565359351|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
156622460|NCT03922945|565359349|FG000|Overall Study|All Other Personal Reasons|1|||
156622461|NCT03922945|565359350|FG001|Overall Study|All Other Personal Reasons|1|||
156622462|NCT03922945|565359351|FG002|Overall Study|All Other Personal Reasons|2|||
156622463|NCT02889861|565359352|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
156622464|NCT00313716|565359353|FG000|Overall Study|Death|3|||
156622465|NCT00313716|565359354|FG001|Overall Study|Death|2|||
156622466|NCT00313716|565359355|FG002|Overall Study|Death|9|||
156622467|NCT00313716|565359356|FG003|Overall Study|Death|3|||
156622468|NCT00313716|565359357|FG004|Overall Study|Death|5|||
156622469|NCT00313716|565359358|FG005|Overall Study|Death|9|||
156622470|NCT00313716|565359353|FG000|Overall Study|Lost to Follow-up|2|||
156622471|NCT00313716|565359354|FG001|Overall Study|Lost to Follow-up|5|||
156622472|NCT00313716|565359355|FG002|Overall Study|Lost to Follow-up|2|||
156622473|NCT00313716|565359356|FG003|Overall Study|Lost to Follow-up|1|||
156622474|NCT00313716|565359357|FG004|Overall Study|Lost to Follow-up|0|||
156622475|NCT00313716|565359358|FG005|Overall Study|Lost to Follow-up|4|||
156622476|NCT00313716|565359353|FG000|Overall Study|Withdrawal by Subject|0|||
156622477|NCT00313716|565359354|FG001|Overall Study|Withdrawal by Subject|1|||
156622478|NCT00313716|565359355|FG002|Overall Study|Withdrawal by Subject|1|||
156622479|NCT00313716|565359356|FG003|Overall Study|Withdrawal by Subject|0|||
156622480|NCT00313716|565359357|FG004|Overall Study|Withdrawal by Subject|1|||
156622481|NCT00313716|565359358|FG005|Overall Study|Withdrawal by Subject|0|||
156622482|NCT04067310|565359364|FG000|Overall Study|Physician Decision|2|||
156622483|NCT04067310|565359365|FG001|Overall Study|Physician Decision|6|||
156622484|NCT04067310|565359364|FG000|Overall Study|Lost to Follow-up|0|||
156622485|NCT04067310|565359365|FG001|Overall Study|Lost to Follow-up|1|||
156622486|NCT04067310|565359364|FG000|Overall Study|Withdrawal by Subject|3|||
156622487|NCT04067310|565359365|FG001|Overall Study|Withdrawal by Subject|0|||
156622488|NCT01041027|565359366|FG000|Overall Study|Withdrawal by Subject|2|||
156622489|NCT01041027|565359366|FG000|Overall Study|Protocol Violation|1|||
156622490|NCT01041027|565359366|FG000|Overall Study|Delayed Radiation Therapy|1|||
156622491|NCT01041027|565359366|FG000|Overall Study|Adverse Event|4|||
156622492|NCT01347931|565359367|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
156622493|NCT01249404|565359368|FG000|Overall Study|Study treatment not received|0|||
156622494|NCT01249404|565359369|FG001|Overall Study|Study treatment not received|1|||
156622495|NCT01249404|565359370|FG002|Overall Study|Study treatment not received|2|||
156622496|NCT01249404|565359368|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
156622497|NCT01249404|565359369|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
156622498|NCT01249404|565359370|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
156622499|NCT01249404|565359368|FG000|Overall Study|Adverse Event|2|||
156622500|NCT01249404|565359369|FG001|Overall Study|Adverse Event|2|||
156622501|NCT01249404|565359370|FG002|Overall Study|Adverse Event|2|||
156622502|NCT01249404|565359368|FG000|Overall Study|Withdrawal by Subject|2|||
156622503|NCT01249404|565359369|FG001|Overall Study|Withdrawal by Subject|2|||
156622504|NCT01249404|565359370|FG002|Overall Study|Withdrawal by Subject|0|||
156622505|NCT01249404|565359368|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
156622506|NCT01249404|565359369|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
156622507|NCT01249404|565359370|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
156622508|NCT01249404|565359368|FG000|Overall Study|Non compliance to visit schedule|0|||
156622509|NCT01249404|565359369|FG001|Overall Study|Non compliance to visit schedule|1|||
156622510|NCT01249404|565359370|FG002|Overall Study|Non compliance to visit schedule|0|||
156622511|NCT02493712|565359371|FG000|Overall Study|Withdrawal by Subject|1|||
156622512|NCT02493712|565359372|FG001|Overall Study|Withdrawal by Subject|0|||
156622513|NCT02493712|565359373|FG002|Overall Study|Withdrawal by Subject|2|||
156622514|NCT02493712|565359371|FG000|Overall Study|Protocol Violation|0|||
156622515|NCT02493712|565359372|FG001|Overall Study|Protocol Violation|0|||
156622516|NCT02493712|565359373|FG002|Overall Study|Protocol Violation|1|||
156622517|NCT02493712|565359371|FG000|Overall Study|Lost to Follow-up|1|||
156622518|NCT02493712|565359372|FG001|Overall Study|Lost to Follow-up|0|||
156622519|NCT02493712|565359373|FG002|Overall Study|Lost to Follow-up|0|||
156622520|NCT02493712|565359371|FG000|Overall Study|Physician Decision|0|||
156622521|NCT02493712|565359372|FG001|Overall Study|Physician Decision|1|||
156622522|NCT02493712|565359373|FG002|Overall Study|Physician Decision|0|||
156622523|NCT02493712|565359371|FG000|Overall Study|Lack of Efficacy|0|||
156622524|NCT02493712|565359372|FG001|Overall Study|Lack of Efficacy|5|||
156622525|NCT02493712|565359373|FG002|Overall Study|Lack of Efficacy|3|||
156622526|NCT02058940|565359374|FG000|Overall Study|Discharged from Critical Care Unit|1|||
156622527|NCT02039687|565359375|FG000|Overall Study|Adverse Event|0|||
156622528|NCT02039687|565359376|FG001|Overall Study|Adverse Event|0|||
156622529|NCT02039687|565359377|FG002|Overall Study|Adverse Event|1|||
156622530|NCT02039687|565359378|FG003|Overall Study|Adverse Event|0|||
156622531|NCT02039687|565359375|FG000|Overall Study|Withdrawal by Subject|0|||
156622532|NCT02039687|565359376|FG001|Overall Study|Withdrawal by Subject|1|||
156622533|NCT02039687|565359377|FG002|Overall Study|Withdrawal by Subject|0|||
156622534|NCT02039687|565359378|FG003|Overall Study|Withdrawal by Subject|0|||
156622535|NCT02039687|565359375|FG000|Overall Study|treatment assignment could not be confir|0|||
156622536|NCT02039687|565359376|FG001|Overall Study|treatment assignment could not be confir|0|||
156622537|NCT02039687|565359377|FG002|Overall Study|treatment assignment could not be confir|2|||
156622538|NCT02039687|565359378|FG003|Overall Study|treatment assignment could not be confir|0|||
156622539|NCT00443534|565359381|FG000|Overall Study|Lack of Efficacy|67|||
156622540|NCT00443534|565359381|FG000|Overall Study|Adverse Event|16|||
156622541|NCT00443534|565359381|FG000|Overall Study|Death|9|||
156622542|NCT00443534|565359381|FG000|Overall Study|Withdrawal by Subject|8|||
156622543|NCT00443534|565359381|FG000|Overall Study|Study Terminated by Sponsor|12|||
156622544|NCT00443534|565359381|FG000|Overall Study|Other|10|||
156622545|NCT00443534|565359381|FG000|Overall Study|Enrolled, Not Treated|1|||
156622546|NCT03419741|565359382|FG000|Overall Study|Adverse Event|1|||
156622547|NCT03419741|565359383|FG001|Overall Study|Adverse Event|0|||
156622548|NCT03419741|565359382|FG000|Overall Study|Withdrawal by Subject|1|||
156622549|NCT03419741|565359383|FG001|Overall Study|Withdrawal by Subject|2|||
156622550|NCT02500901|565359384|FG000|Overall Study|Disease ProgressionDD|2|||
156622551|NCT01398176|565359395|FG000|Overall Study|Lost to Follow-up|1|||
156622552|NCT01398176|565359396|FG001|Overall Study|Lost to Follow-up|3|||
156622553|NCT01398176|565359395|FG000|Overall Study|Physician Decision|2|||
156622554|NCT01398176|565359396|FG001|Overall Study|Physician Decision|3|||
156622555|NCT00542321|565359397|FG000|Overall Study|Death|0|||
156622556|NCT00542321|565359398|FG001|Overall Study|Death|1|||
156622557|NCT00253747|565359403|FG000|Overall Study|Lost to Follow-up|13|||
156622558|NCT00253747|565359404|FG001|Overall Study|Lost to Follow-up|14|||
156622559|NCT00253747|565359403|FG000|Overall Study|Withdrawal by Subject|10|||
156622560|NCT00253747|565359404|FG001|Overall Study|Withdrawal by Subject|11|||
156622561|NCT00253747|565359403|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
156622562|NCT00253747|565359404|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
156622563|NCT00348686|565359405|FG000|Overall Study|Withdrawal by Subject|45|||
156622564|NCT00348686|565359405|FG000|Overall Study|Adverse Event|5|||
156622565|NCT00348686|565359405|FG000|Overall Study|Protocol Violation|6|||
156622566|NCT00348686|565359405|FG000|Overall Study|Lost to Follow-up|2|||
156622567|NCT00348686|565359405|FG000|Overall Study|Multiple Reasons|8|||
156622568|NCT01258738|565359406|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
156622569|NCT01258738|565359407|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
156622570|NCT01258738|565359406|FG000|Double-blind Period|Withdrawal by Subject|2|||
156622571|NCT01258738|565359407|FG001|Double-blind Period|Withdrawal by Subject|2|||
156622572|NCT01258738|565359406|FG000|Double-blind Period|Protocol Violation|1|||
156622573|NCT01258738|565359407|FG001|Double-blind Period|Protocol Violation|1|||
156622574|NCT01258738|565359406|FG000|Double-blind Period|Adverse Event|3|||
156622575|NCT01258738|565359407|FG001|Double-blind Period|Adverse Event|1|||
156622576|NCT01258738|565359406|FG000|Open-label Period|Did not meet inclusion criteria|0|||
156622577|NCT01258738|565359407|FG001|Open-label Period|Did not meet inclusion criteria|1|||
156622578|NCT01258738|565359406|FG000|Open-label Period|Insufficient clinical response|5|||
156622579|NCT01258738|565359407|FG001|Open-label Period|Insufficient clinical response|3|||
156622580|NCT01258738|565359406|FG000|Open-label Period|Lost to Follow-up|0|||
156622581|NCT01258738|565359407|FG001|Open-label Period|Lost to Follow-up|2|||
156622582|NCT01258738|565359406|FG000|Open-label Period|Withdrawal by Subject|5|||
156622583|NCT01258738|565359407|FG001|Open-label Period|Withdrawal by Subject|6|||
156622584|NCT01258738|565359406|FG000|Open-label Period|Protocol Violation|2|||
156622585|NCT01258738|565359407|FG001|Open-label Period|Protocol Violation|2|||
156622586|NCT01258738|565359406|FG000|Open-label Period|Adverse Event|4|||
156622587|NCT01258738|565359407|FG001|Open-label Period|Adverse Event|5|||
156622588|NCT01258738|565359406|FG000|Open-label Period|Other Reasons|0|||
156622589|NCT01258738|565359407|FG001|Open-label Period|Other Reasons|1|||
156622590|NCT01258738|565359406|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
156622591|NCT01258738|565359407|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
156622592|NCT02418000|565359408|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
156622593|NCT02418000|565359409|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
156622594|NCT02418000|565359410|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
156622595|NCT02418000|565359411|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
156622596|NCT02418000|565359412|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
156622597|NCT02418000|565359408|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
156622598|NCT02418000|565359409|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
156622599|NCT02418000|565359410|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
156622600|NCT02418000|565359411|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
156622601|NCT02418000|565359412|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
156622602|NCT02418000|565359408|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
156622603|NCT02418000|565359409|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
156622604|NCT02418000|565359410|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
156622605|NCT02418000|565359411|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
156622606|NCT02418000|565359412|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
156622607|NCT02418000|565359408|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
156622608|NCT02418000|565359409|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
156622609|NCT02418000|565359410|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
156622610|NCT02418000|565359411|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
156622611|NCT02418000|565359412|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
156622612|NCT02418000|565359408|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
156622613|NCT02418000|565359409|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
156622614|NCT02418000|565359410|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
156622615|NCT02418000|565359411|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
156622616|NCT02418000|565359412|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
156622617|NCT02418000|565359408|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622618|NCT02418000|565359409|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622619|NCT02418000|565359410|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
156622620|NCT02418000|565359411|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622621|NCT02418000|565359412|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622622|NCT02418000|565359408|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622623|NCT02418000|565359409|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622624|NCT02418000|565359410|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622625|NCT02418000|565359411|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
156622626|NCT02418000|565359412|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622627|NCT02418000|565359408|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
156622628|NCT02418000|565359409|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
156622629|NCT02418000|565359410|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
156622630|NCT02418000|565359411|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
156622631|NCT02418000|565359412|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
156622632|NCT02418000|565359408|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622633|NCT02418000|565359409|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622634|NCT02418000|565359410|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622635|NCT02418000|565359411|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
156622636|NCT02418000|565359412|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
156622637|NCT03018028|565359423|FG000|Overall Study|Withdrawal by Subject|3|||
156622638|NCT03018028|565359424|FG001|Overall Study|Withdrawal by Subject|0|||
156622639|NCT03018028|565359425|FG002|Overall Study|Withdrawal by Subject|1|||
156622640|NCT03018028|565359426|FG003|Overall Study|Withdrawal by Subject|2|||
156622641|NCT03018028|565359427|FG004|Overall Study|Withdrawal by Subject|0|||
156622642|NCT02195531|565359428|FG000|Overall Study|Withdrawal by Subject|1|||
156622643|NCT02195531|565359429|FG001|Overall Study|Withdrawal by Subject|1|||
156622644|NCT02195531|565359430|FG002|Overall Study|Withdrawal by Subject|1|||
156622645|NCT01284127|565359431|FG000|Overall Study|Adverse Event|2|||
156622646|NCT01284127|565359431|FG000|Overall Study|Withdrawal by Subject|4|||
156622647|NCT01284127|565359431|FG000|Overall Study|Physician Decision|1|||
156622648|NCT02516306|565359434|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
156622649|NCT02516306|565359435|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
156622650|NCT02607865|565359439|FG000|Overall Study|Lost to Follow-up|9|||
156622651|NCT02607865|565359440|FG001|Overall Study|Lost to Follow-up|7|||
156622652|NCT02607865|565359441|FG002|Overall Study|Lost to Follow-up|7|||
156622653|NCT02607865|565359442|FG003|Overall Study|Lost to Follow-up|5|||
156622654|NCT02607865|565359439|FG000|Overall Study|Withdrawal by Subject|18|||
156622655|NCT02607865|565359440|FG001|Overall Study|Withdrawal by Subject|18|||
156622656|NCT02607865|565359441|FG002|Overall Study|Withdrawal by Subject|17|||
156622657|NCT02607865|565359442|FG003|Overall Study|Withdrawal by Subject|8|||
156622658|NCT02607865|565359439|FG000|Overall Study|Death|5|||
156622659|NCT02607865|565359440|FG001|Overall Study|Death|4|||
156622660|NCT02607865|565359441|FG002|Overall Study|Death|1|||
156622661|NCT02607865|565359442|FG003|Overall Study|Death|3|||
156622662|NCT02607865|565359439|FG000|Overall Study|Unclassified|1|||
156622663|NCT02607865|565359440|FG001|Overall Study|Unclassified|1|||
156622664|NCT02607865|565359441|FG002|Overall Study|Unclassified|2|||
156622665|NCT02607865|565359442|FG003|Overall Study|Unclassified|0|||
156622666|NCT03227692|565359443|FG000|Overall Study|Protocol Violation|1|||
156622667|NCT03227692|565359444|FG001|Overall Study|Protocol Violation|1|||
156622668|NCT03227692|565359443|FG000|Overall Study|Lost to Follow-up|4|||
156622669|NCT03227692|565359444|FG001|Overall Study|Lost to Follow-up|2|||
156622670|NCT03227692|565359443|FG000|Overall Study|Adverse Event|0|||
156622671|NCT03227692|565359444|FG001|Overall Study|Adverse Event|2|||
156622672|NCT00256204|565359446|FG000|Overall Study|Adverse Event|10|||
156622673|NCT00256204|565359447|FG001|Overall Study|Adverse Event|14|||
156622674|NCT00256204|565359448|FG002|Overall Study|Adverse Event|16|||
156622675|NCT00256204|565359449|FG003|Overall Study|Adverse Event|14|||
156622676|NCT00256204|565359446|FG000|Overall Study|Death|0|||
156622677|NCT00256204|565359447|FG001|Overall Study|Death|1|||
156622678|NCT00256204|565359448|FG002|Overall Study|Death|0|||
156622679|NCT00256204|565359449|FG003|Overall Study|Death|0|||
156622680|NCT00256204|565359446|FG000|Overall Study|Lost to Follow-up|1|||
156622681|NCT00256204|565359447|FG001|Overall Study|Lost to Follow-up|1|||
156622682|NCT00256204|565359448|FG002|Overall Study|Lost to Follow-up|1|||
156622683|NCT00256204|565359449|FG003|Overall Study|Lost to Follow-up|2|||
156622684|NCT00256204|565359446|FG000|Overall Study|Protocol Violation|1|||
156622685|NCT00256204|565359447|FG001|Overall Study|Protocol Violation|0|||
156622686|NCT00256204|565359448|FG002|Overall Study|Protocol Violation|2|||
156622687|NCT00256204|565359449|FG003|Overall Study|Protocol Violation|1|||
156622688|NCT00256204|565359446|FG000|Overall Study|Physician Decision|0|||
156622689|NCT00256204|565359447|FG001|Overall Study|Physician Decision|0|||
156622690|NCT00256204|565359448|FG002|Overall Study|Physician Decision|1|||
156622691|NCT00256204|565359449|FG003|Overall Study|Physician Decision|2|||
156622692|NCT00256204|565359446|FG000|Overall Study|Withdrawal by Subject|17|||
156622693|NCT00256204|565359447|FG001|Overall Study|Withdrawal by Subject|6|||
156622694|NCT00256204|565359448|FG002|Overall Study|Withdrawal by Subject|7|||
156622695|NCT00256204|565359449|FG003|Overall Study|Withdrawal by Subject|5|||
156622696|NCT00256204|565359446|FG000|Overall Study|Need for additional prohibited treatment|38|||
156622697|NCT00256204|565359447|FG001|Overall Study|Need for additional prohibited treatment|28|||
156622698|NCT00256204|565359448|FG002|Overall Study|Need for additional prohibited treatment|27|||
156622699|NCT00256204|565359449|FG003|Overall Study|Need for additional prohibited treatment|25|||
156622700|NCT01351415|565359450|FG000|Overall Study|Withdrawal by Subject|15|||
156622701|NCT01351415|565359451|FG001|Overall Study|Withdrawal by Subject|17|||
156622702|NCT01351415|565359450|FG000|Overall Study|Trial termination by the Sponsor|28|||
156622703|NCT01351415|565359451|FG001|Overall Study|Trial termination by the Sponsor|19|||
156622704|NCT01351415|565359450|FG000|Overall Study|Lost to Follow-up|5|||
156622705|NCT01351415|565359451|FG001|Overall Study|Lost to Follow-up|7|||
156622706|NCT01351415|565359450|FG000|Overall Study|Death|190|||
156622707|NCT01351415|565359451|FG001|Overall Study|Death|187|||
156622708|NCT01351415|565359450|FG000|Overall Study|Physician Decision|2|||
156622709|NCT01351415|565359451|FG001|Overall Study|Physician Decision|3|||
156622710|NCT01351415|565359450|FG000|Overall Study|Reason unknown|0|||
156622711|NCT01351415|565359451|FG001|Overall Study|Reason unknown|2|||
156622712|NCT01351415|565359450|FG000|Overall Study|Never Started|5|||
156622713|NCT01351415|565359451|FG001|Overall Study|Never Started|5|||
156622714|NCT00994890|565359459|FG000|Overall Study|Adverse Event|13|||
156622715|NCT00994890|565359460|FG001|Overall Study|Adverse Event|9|||
156622716|NCT00994890|565359461|FG002|Overall Study|Adverse Event|11|||
156622717|NCT00994890|565359459|FG000|Overall Study|Lack of Efficacy|0|||
156622718|NCT00994890|565359460|FG001|Overall Study|Lack of Efficacy|0|||
156622719|NCT00994890|565359461|FG002|Overall Study|Lack of Efficacy|1|||
156622720|NCT00994890|565359459|FG000|Overall Study|Lost to Follow-up|6|||
156622721|NCT00994890|565359460|FG001|Overall Study|Lost to Follow-up|1|||
156622722|NCT00994890|565359461|FG002|Overall Study|Lost to Follow-up|3|||
156622723|NCT00994890|565359459|FG000|Overall Study|No longer willing to participate|8|||
156622724|NCT00994890|565359460|FG001|Overall Study|No longer willing to participate|5|||
156622725|NCT00994890|565359461|FG002|Overall Study|No longer willing to participate|13|||
156622726|NCT00994890|565359459|FG000|Overall Study|Protocol Violation|2|||
156622727|NCT00994890|565359460|FG001|Overall Study|Protocol Violation|4|||
156622728|NCT00994890|565359461|FG002|Overall Study|Protocol Violation|0|||
156622729|NCT00994890|565359459|FG000|Overall Study|Study terminated by sponsor|199|||
156622730|NCT00994890|565359460|FG001|Overall Study|Study terminated by sponsor|201|||
156622731|NCT00994890|565359461|FG002|Overall Study|Study terminated by sponsor|197|||
156622732|NCT00994890|565359459|FG000|Overall Study|Randomized, but not treated|1|||
156622733|NCT00994890|565359460|FG001|Overall Study|Randomized, but not treated|0|||
156622734|NCT00994890|565359461|FG002|Overall Study|Randomized, but not treated|0|||
156622735|NCT00994890|565359459|FG000|Overall Study|Other|2|||
156622736|NCT00994890|565359460|FG001|Overall Study|Other|2|||
156622737|NCT00994890|565359461|FG002|Overall Study|Other|1|||
156622738|NCT00699582|565359462|FG000|Overall Study|Adverse Event|4|||
156622739|NCT00699582|565359463|FG001|Overall Study|Adverse Event|11|||
156622740|NCT00699582|565359464|FG002|Overall Study|Adverse Event|23|||
156622741|NCT00699582|565359462|FG000|Overall Study|Withdrawal by Subject|6|||
156622742|NCT00699582|565359463|FG001|Overall Study|Withdrawal by Subject|7|||
156622743|NCT00699582|565359464|FG002|Overall Study|Withdrawal by Subject|4|||
156622744|NCT00699582|565359462|FG000|Overall Study|Lack of Efficacy|1|||
156622745|NCT00699582|565359463|FG001|Overall Study|Lack of Efficacy|0|||
156622746|NCT00699582|565359464|FG002|Overall Study|Lack of Efficacy|1|||
156622747|NCT00699582|565359462|FG000|Overall Study|Progressive Disease|1|||
156622748|NCT00699582|565359463|FG001|Overall Study|Progressive Disease|0|||
156622749|NCT00699582|565359464|FG002|Overall Study|Progressive Disease|0|||
156622750|NCT00699582|565359462|FG000|Overall Study|Administrative/Other|4|||
156622751|NCT00699582|565359463|FG001|Overall Study|Administrative/Other|3|||
156622752|NCT00699582|565359464|FG002|Overall Study|Administrative/Other|0|||
156622753|NCT00699582|565359462|FG000|Overall Study|Randomized, Not Treated|2|||
156622754|NCT00699582|565359463|FG001|Overall Study|Randomized, Not Treated|1|||
156622755|NCT00699582|565359464|FG002|Overall Study|Randomized, Not Treated|0|||
156622756|NCT03117309|565359467|FG000|Overall Study|Not meeting inclusion criteria|0|||
156622757|NCT03117309|565359468|FG001|Overall Study|Not meeting inclusion criteria|1|||
156622758|NCT00420212|565359478|FG000|Overall Study|Adverse Event|22|||
156622759|NCT00420212|565359479|FG001|Overall Study|Adverse Event|40|||
156622760|NCT00420212|565359480|FG002|Overall Study|Adverse Event|36|||
156622761|NCT00420212|565359478|FG000|Overall Study|Lost to Follow-up|9|||
156622762|NCT00420212|565359479|FG001|Overall Study|Lost to Follow-up|11|||
156622763|NCT00420212|565359480|FG002|Overall Study|Lost to Follow-up|11|||
156622764|NCT00420212|565359478|FG000|Overall Study|Withdrawal by Subject|31|||
156622765|NCT00420212|565359479|FG001|Overall Study|Withdrawal by Subject|22|||
156622766|NCT00420212|565359480|FG002|Overall Study|Withdrawal by Subject|19|||
156622767|NCT00420212|565359478|FG000|Overall Study|Physician Decision|4|||
156622768|NCT00420212|565359479|FG001|Overall Study|Physician Decision|4|||
156622769|NCT00420212|565359480|FG002|Overall Study|Physician Decision|3|||
156622770|NCT00420212|565359478|FG000|Overall Study|Protocol Violation|4|||
156622771|NCT00420212|565359479|FG001|Overall Study|Protocol Violation|4|||
156622772|NCT00420212|565359480|FG002|Overall Study|Protocol Violation|8|||
156622773|NCT00420212|565359478|FG000|Overall Study|Death|0|||
156622774|NCT00420212|565359479|FG001|Overall Study|Death|0|||
156622775|NCT00420212|565359480|FG002|Overall Study|Death|1|||
156622776|NCT00420212|565359478|FG000|Overall Study|Other-Unspecified|21|||
156622777|NCT00420212|565359479|FG001|Overall Study|Other-Unspecified|14|||
156622778|NCT00420212|565359480|FG002|Overall Study|Other-Unspecified|18|||
156622779|NCT01142791|565359492|FG000|Overall Study|Alternative Treatment|1|||
156622780|NCT01142791|565359493|FG001|Overall Study|Alternative Treatment|0|||
156622781|NCT01142791|565359492|FG000|Overall Study|Lost to Follow-up|1|||
156622782|NCT01142791|565359493|FG001|Overall Study|Lost to Follow-up|0|||
156622783|NCT01142791|565359492|FG000|Overall Study|Withdrawal by Subject|5|||
156622784|NCT01142791|565359493|FG001|Overall Study|Withdrawal by Subject|0|||
156622785|NCT01142791|565359492|FG000|Overall Study|Received only 1 sonication|0|||
156622786|NCT01142791|565359493|FG001|Overall Study|Received only 1 sonication|6|||
156622787|NCT01981096|565359500|FG000|Overall Study|Parent illness|1|||
156622788|NCT01981096|565359501|FG001|Overall Study|Parent illness|0|||
156622789|NCT01981096|565359500|FG000|Overall Study|Withdrawal by Subject|0|||
156622790|NCT01981096|565359501|FG001|Overall Study|Withdrawal by Subject|1|||
156622791|NCT01981096|565359500|FG000|Overall Study|Lost to Follow-up|2|||
156622792|NCT01981096|565359501|FG001|Overall Study|Lost to Follow-up|0|||
156622793|NCT00866606|565359502|FG000|Overall Study|Lost to Follow-up|3|||
156622794|NCT00866606|565359502|FG000|Overall Study|Adverse Event|1|||
156622795|NCT04129242|565359504|FG000|Overall Study|Physician Decision|1|||
156622796|NCT04129242|565359505|FG001|Overall Study|Physician Decision|1|||
156622797|NCT04129242|565359504|FG000|Overall Study|Protocol Violation|0|||
156622798|NCT04129242|565359505|FG001|Overall Study|Protocol Violation|1|||
156622799|NCT01899729|565359508|FG000|Overall Study|Adverse Event|1|||
156622800|NCT01899729|565359509|FG001|Overall Study|Adverse Event|0|||
156622801|NCT01899729|565359510|FG002|Overall Study|Adverse Event|0|||
156622802|NCT01899729|565359511|FG003|Overall Study|Adverse Event|0|||
156622803|NCT01899729|565359512|FG004|Overall Study|Adverse Event|1|||
156622804|NCT01899729|565359508|FG000|Overall Study|Withdrawal by Subject|1|||
156622805|NCT01899729|565359509|FG001|Overall Study|Withdrawal by Subject|2|||
156622806|NCT01899729|565359510|FG002|Overall Study|Withdrawal by Subject|0|||
156622807|NCT01899729|565359511|FG003|Overall Study|Withdrawal by Subject|0|||
156622808|NCT01899729|565359512|FG004|Overall Study|Withdrawal by Subject|0|||
156622809|NCT01899729|565359508|FG000|Overall Study|Lack of Efficacy|0|||
156622810|NCT01899729|565359509|FG001|Overall Study|Lack of Efficacy|0|||
156622811|NCT01899729|565359510|FG002|Overall Study|Lack of Efficacy|2|||
156622812|NCT01899729|565359511|FG003|Overall Study|Lack of Efficacy|0|||
156622813|NCT01899729|565359512|FG004|Overall Study|Lack of Efficacy|1|||
156622814|NCT01454531|565359513|FG000|Overall Study|Adverse Event|14|||
156622815|NCT01454531|565359513|FG000|Overall Study|Withdrawal by Subject|5|||
156622816|NCT01454531|565359513|FG000|Overall Study|Lost to Follow-up|1|||
156622817|NCT01454531|565359513|FG000|Overall Study|Physician Decision|1|||
156622818|NCT01454531|565359513|FG000|Overall Study|Delay in IMP administration|1|||
156622819|NCT01454531|565359513|FG000|Overall Study|Other|1|||
156622820|NCT01277666|565359514|FG000|Overall Study|Adverse Event|26|||
156622821|NCT01277666|565359515|FG001|Overall Study|Adverse Event|25|||
156622822|NCT01277666|565359516|FG002|Overall Study|Adverse Event|20|||
156622823|NCT01277666|565359514|FG000|Overall Study|Lack of Efficacy|8|||
156622824|NCT01277666|565359515|FG001|Overall Study|Lack of Efficacy|20|||
156622825|NCT01277666|565359516|FG002|Overall Study|Lack of Efficacy|12|||
156622826|NCT01277666|565359514|FG000|Overall Study|Protocol Violation|2|||
156622827|NCT01277666|565359515|FG001|Overall Study|Protocol Violation|3|||
156622828|NCT01277666|565359516|FG002|Overall Study|Protocol Violation|2|||
156622829|NCT01277666|565359514|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
156622830|NCT01277666|565359515|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
156622831|NCT01277666|565359516|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
156622832|NCT01277666|565359514|FG000|Overall Study|Lost to Follow-up|1|||
156622833|NCT01277666|565359515|FG001|Overall Study|Lost to Follow-up|1|||
156622834|NCT01277666|565359516|FG002|Overall Study|Lost to Follow-up|2|||
156622835|NCT01277666|565359514|FG000|Overall Study|Withdrawal by Subject|7|||
156622836|NCT01277666|565359515|FG001|Overall Study|Withdrawal by Subject|8|||
156622837|NCT01277666|565359516|FG002|Overall Study|Withdrawal by Subject|6|||
156622838|NCT01277666|565359514|FG000|Overall Study|Death|0|||
156622839|NCT01277666|565359515|FG001|Overall Study|Death|0|||
156622840|NCT01277666|565359516|FG002|Overall Study|Death|1|||
156622841|NCT01021423|565359517|FG000|Overall Study|Study terminated|4|||
156622842|NCT01021423|565359518|FG001|Overall Study|Study terminated|5|||
156622843|NCT00122317|565359519|FG000|Overall Study|Death|3|||
156622844|NCT00122317|565359519|FG000|Overall Study|Adverse Event|4|||
156622845|NCT00122317|565359519|FG000|Overall Study|Physician Decision|2|||
156622846|NCT00122317|565359519|FG000|Overall Study|patient non-compliance|1|||
156622847|NCT00122317|565359519|FG000|Overall Study|Withdrawal by Subject|1|||
156622848|NCT03756285|565359520|FG000|Overall Study|Lost to Follow-up|0|||
156622849|NCT03756285|565359521|FG001|Overall Study|Lost to Follow-up|1|||
156622850|NCT03756285|565359520|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
156622851|NCT03756285|565359521|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
156622852|NCT03756285|565359520|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
156622853|NCT03756285|565359521|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
156622854|NCT06334055|565359522|FG000|Overall Study|Adverse Event|4|||
156622855|NCT06334055|565359522|FG000|Overall Study|Disqualified|72|||
156622856|NCT02146274|565360916|FG000|Overall Study|Protocol Violation|73|||
156622857|NCT01524900|565360940|FG000|Overall Study|Lost to Follow-up|3|||
156622858|NCT01524900|565360941|FG001|Overall Study|Lost to Follow-up|12|||
156622859|NCT01524900|565360942|FG002|Overall Study|Lost to Follow-up|1|||
156622860|NCT01524900|565360943|FG003|Overall Study|Lost to Follow-up|0|||
156622861|NCT01524900|565360944|FG004|Overall Study|Lost to Follow-up|0|||
156622862|NCT01524900|565360940|FG000|Overall Study|Other reason than stated above|1|||
156622863|NCT01524900|565360941|FG001|Overall Study|Other reason than stated above|1|||
156622864|NCT01524900|565360942|FG002|Overall Study|Other reason than stated above|0|||
156622865|NCT01524900|565360943|FG003|Overall Study|Other reason than stated above|0|||
156622866|NCT01524900|565360944|FG004|Overall Study|Other reason than stated above|0|||
156622867|NCT01524900|565360940|FG000|Overall Study|No reason documented|2|||
156622868|NCT01524900|565360941|FG001|Overall Study|No reason documented|1|||
156622869|NCT01524900|565360942|FG002|Overall Study|No reason documented|0|||
156622870|NCT01524900|565360943|FG003|Overall Study|No reason documented|1|||
156622871|NCT01524900|565360944|FG004|Overall Study|No reason documented|0|||
156622872|NCT00959192|565360945|FG000|Overall Study|Adverse Event|1|||
156622873|NCT00959192|565360946|FG001|Overall Study|Adverse Event|1|||
156622874|NCT00959192|565360947|FG002|Overall Study|Adverse Event|1|||
156622875|NCT00959192|565360948|FG003|Overall Study|Adverse Event|0|||
156622876|NCT00959192|565360945|FG000|Overall Study|Investigator Request|1|||
156622877|NCT00959192|565360946|FG001|Overall Study|Investigator Request|0|||
156622878|NCT00959192|565360947|FG002|Overall Study|Investigator Request|0|||
156622879|NCT00959192|565360948|FG003|Overall Study|Investigator Request|0|||
156622880|NCT00959192|565360945|FG000|Overall Study|Caregiver Request|0|||
156622881|NCT00959192|565360946|FG001|Overall Study|Caregiver Request|0|||
156622882|NCT00959192|565360947|FG002|Overall Study|Caregiver Request|2|||
156622883|NCT00959192|565360948|FG003|Overall Study|Caregiver Request|1|||
156622884|NCT00532441|565360949|FG000|Overall Study|Death|1|||
156622885|NCT00532441|565360950|FG001|Overall Study|Death|0|||
156622886|NCT01967134|565360951|FG000|Overall Study|Lost to Follow-up|0|||
156622887|NCT01967134|565360952|FG001|Overall Study|Lost to Follow-up|1|||
156622888|NCT01967134|565360953|FG002|Overall Study|Lost to Follow-up|0|||
156622889|NCT01603615|565360954|FG000|Overall Study|Did not Receive Treatment|7|||
156622890|NCT01603615|565360954|FG000|Overall Study|Lost to Follow-up|9|||
156622891|NCT01603615|565360954|FG000|Overall Study|Personal Reasons|17|||
156622892|NCT01603615|565360954|FG000|Overall Study|Other Miscellaneous|1|||
156622893|NCT00305773|565360955|FG000|Overall Study|Death|3|||
156622894|NCT00305773|565360956|FG001|Overall Study|Death|2|||
156622895|NCT00305773|565360955|FG000|Overall Study|Adverse Event|1|||
156622896|NCT00305773|565360956|FG001|Overall Study|Adverse Event|2|||
156622897|NCT00305773|565360955|FG000|Overall Study|Alternative Treatment|4|||
156622898|NCT00305773|565360956|FG001|Overall Study|Alternative Treatment|4|||
156622899|NCT00305773|565360955|FG000|Overall Study|Physician Decision|1|||
156622900|NCT00305773|565360956|FG001|Overall Study|Physician Decision|1|||
156622901|NCT00305773|565360955|FG000|Overall Study|Withdrawal by Subject|1|||
156622902|NCT00305773|565360956|FG001|Overall Study|Withdrawal by Subject|4|||
156622903|NCT00305773|565360955|FG000|Overall Study|Disease Progression|1|||
156622904|NCT00305773|565360956|FG001|Overall Study|Disease Progression|3|||
156622905|NCT00305773|565360955|FG000|Overall Study|All other reasons|3|||
156622906|NCT00305773|565360956|FG001|Overall Study|All other reasons|2|||
156622907|NCT00303329|565360959|FG000|Overall Study|Adverse Event|7|||
156622908|NCT00303329|565360960|FG001|Overall Study|Adverse Event|14|||
156622909|NCT00303329|565360959|FG000|Overall Study|Abnormal Laboratory Values|0|||
156622910|NCT00303329|565360960|FG001|Overall Study|Abnormal Laboratory Values|1|||
156622911|NCT00303329|565360959|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
156622912|NCT00303329|565360960|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156622913|NCT00303329|565360959|FG000|Overall Study|Condition no longer requires study drug|0|||
156622914|NCT00303329|565360960|FG001|Overall Study|Condition no longer requires study drug|8|||
156622915|NCT00303329|565360959|FG000|Overall Study|Protocol Violation|3|||
156622916|NCT00303329|565360960|FG001|Overall Study|Protocol Violation|0|||
156622917|NCT00303329|565360959|FG000|Overall Study|Withdrawal by Subject|9|||
156622918|NCT00303329|565360960|FG001|Overall Study|Withdrawal by Subject|15|||
156622919|NCT00303329|565360959|FG000|Overall Study|Lost to Follow-up|0|||
156622920|NCT00303329|565360960|FG001|Overall Study|Lost to Follow-up|1|||
156622921|NCT00303329|565360959|FG000|Overall Study|Administrative problems|1|||
156622922|NCT00303329|565360960|FG001|Overall Study|Administrative problems|0|||
156622923|NCT00303329|565360959|FG000|Overall Study|Death|2|||
156622924|NCT00303329|565360960|FG001|Overall Study|Death|12|||
156622925|NCT00303329|565360959|FG000|Overall Study|Stopped at end of core|3|||
156622926|NCT00303329|565360960|FG001|Overall Study|Stopped at end of core|9|||
156622927|NCT00303329|565360959|FG000|Overall Study|Stopped at end of extension 1|1|||
156622928|NCT00303329|565360960|FG001|Overall Study|Stopped at end of extension 1|0|||
156622929|NCT03384316|565360961|FG000|Overall Study|Screen failure|0|||
156622930|NCT03384316|565360962|FG001|Overall Study|Screen failure|1|||
156622931|NCT00413231|565360963|FG000|0 to 30-day Post Treatment|Death|5|||
156622932|NCT00413231|565360963|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
156622933|NCT00413231|565360963|FG000|30-day to 365-day Post Treatment|Death|13|||
156622934|NCT00413231|565360963|FG000|365-day to 60-month Post Treatment|Death|36|||
156622935|NCT00413231|565360963|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
156622936|NCT00413231|565360963|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
156622937|NCT00413231|565360963|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
156622938|NCT02194699|565360975|FG000|Randomised|Did not receive treatment|1|||
156622939|NCT02194699|565360976|FG001|Randomised|Did not receive treatment|5|||
156622940|NCT02194699|565360975|FG000|Randomised|Without potential for 52 weeks of IP|5|||
156622941|NCT02194699|565360976|FG001|Randomised|Without potential for 52 weeks of IP|5|||
156622942|NCT02194699|565360975|FG000|Randomised|Duplicate patient|2|||
156622943|NCT02194699|565360976|FG001|Randomised|Duplicate patient|1|||
156622944|NCT02194699|565360975|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
156622945|NCT02194699|565360976|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
156622946|NCT02194699|565360975|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
156622947|NCT02194699|565360976|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
156622948|NCT02194699|565360975|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
156622949|NCT02194699|565360976|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
156622950|NCT02194699|565360975|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
156622951|NCT02194699|565360976|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
156622952|NCT02194699|565360975|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
156622953|NCT02194699|565360976|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
156622954|NCT02194699|565360975|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
156622955|NCT02194699|565360976|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
156622956|NCT02719028|565360977|FG000|Overall Study|Adverse Event|2|||
156622957|NCT02719028|565360978|FG001|Overall Study|Adverse Event|1|||
156622958|NCT02719028|565360979|FG002|Overall Study|Adverse Event|4|||
156622959|NCT02719028|565360980|FG003|Overall Study|Adverse Event|8|||
156622960|NCT02719028|565360977|FG000|Overall Study|Physician Decision|0|||
156622961|NCT02719028|565360978|FG001|Overall Study|Physician Decision|1|||
156622962|NCT02719028|565360979|FG002|Overall Study|Physician Decision|1|||
156622963|NCT02719028|565360980|FG003|Overall Study|Physician Decision|1|||
156622964|NCT02719028|565360977|FG000|Overall Study|Use of prohibited medication|0|||
156622965|NCT02719028|565360978|FG001|Overall Study|Use of prohibited medication|0|||
156622966|NCT02719028|565360979|FG002|Overall Study|Use of prohibited medication|1|||
156622967|NCT02719028|565360980|FG003|Overall Study|Use of prohibited medication|0|||
156622968|NCT02719028|565360977|FG000|Overall Study|Protocol Violation|0|||
156622969|NCT02719028|565360978|FG001|Overall Study|Protocol Violation|0|||
156622970|NCT02719028|565360979|FG002|Overall Study|Protocol Violation|0|||
156622971|NCT02719028|565360980|FG003|Overall Study|Protocol Violation|1|||
156622972|NCT01539720|565360982|FG000|Overall Study|Screen Fail|15|||
156622973|NCT01539720|565360983|FG001|Overall Study|Screen Fail|3|||
156622974|NCT01539720|565360982|FG000|Overall Study|Lost to Follow-up|14|||
156622975|NCT01539720|565360983|FG001|Overall Study|Lost to Follow-up|7|||
156622976|NCT00298766|565360984|FG000|Overall Study|Adverse Event|18|||
156622977|NCT00298766|565360984|FG000|Overall Study|Death|2|||
156622978|NCT00298766|565360984|FG000|Overall Study|Withdrawal by Subject|9|||
156622979|NCT00298766|565360984|FG000|Overall Study|Treatment ongoing|4|||
156622980|NCT00298766|565360984|FG000|Overall Study|Progression of amyloid markers|4|||
156622981|NCT00298766|565360984|FG000|Overall Study|Deterioration in KPS and organ function|1|||
156622982|NCT00298766|565360984|FG000|Overall Study|Subjects overall condition deterioration|4|||
156622983|NCT00298766|565360984|FG000|Overall Study|Other|4|||
156622984|NCT03287960|565360991|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
156622985|NCT03287960|565360991|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
156622986|NCT03812224|565360994|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
156622987|NCT03812224|565360995|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
156622988|NCT03812224|565360994|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
156622989|NCT03812224|565360995|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
156622990|NCT03812224|565360994|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
156622991|NCT03812224|565360995|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
156622992|NCT03812224|565360994|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
156622993|NCT03812224|565360995|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
156622994|NCT00656136|565360998|FG000|Overall Study|Progressive disease|177|||
156622995|NCT00656136|565360999|FG001|Overall Study|Progressive disease|322|||
156622996|NCT00656136|565360998|FG000|Overall Study|Other Adverse Event|5|||
156622997|NCT00656136|565360999|FG001|Overall Study|Other Adverse Event|51|||
156622998|NCT00656136|565360998|FG000|Overall Study|Protocol Violation|2|||
156622999|NCT00656136|565360999|FG001|Overall Study|Protocol Violation|3|||
156623000|NCT00656136|565360998|FG000|Overall Study|Patient refused to take study medication|7|||
156623001|NCT00656136|565360999|FG001|Overall Study|Patient refused to take study medication|10|||
156623002|NCT00656136|565360998|FG000|Overall Study|Unknown and others|4|||
156623003|NCT00656136|565360999|FG001|Overall Study|Unknown and others|4|||
156623004|NCT01191190|565361000|FG000|Overall Study|Withdrawal by Subject|1|||
156623005|NCT01667731|565361006|FG000|Overall Study|Enrolled but not treated|0|||
156623006|NCT01667731|565361007|FG001|Overall Study|Enrolled but not treated|0|||
156623007|NCT01667731|565361008|FG002|Overall Study|Enrolled but not treated|0|||
156623008|NCT01667731|565361009|FG003|Overall Study|Enrolled but not treated|0|||
156623009|NCT01667731|565361010|FG004|Overall Study|Enrolled but not treated|1|||
156623010|NCT01667731|565361006|FG000|Overall Study|Efficacy Failure|1|||
156623011|NCT01667731|565361007|FG001|Overall Study|Efficacy Failure|12|||
156623012|NCT01667731|565361008|FG002|Overall Study|Efficacy Failure|0|||
156623013|NCT01667731|565361009|FG003|Overall Study|Efficacy Failure|1|||
156623014|NCT01667731|565361010|FG004|Overall Study|Efficacy Failure|24|||
156623015|NCT01667731|565361006|FG000|Overall Study|Lost to Follow-up|2|||
156623016|NCT01667731|565361007|FG001|Overall Study|Lost to Follow-up|3|||
156623017|NCT01667731|565361008|FG002|Overall Study|Lost to Follow-up|1|||
156623018|NCT01667731|565361009|FG003|Overall Study|Lost to Follow-up|1|||
156623019|NCT01667731|565361010|FG004|Overall Study|Lost to Follow-up|2|||
156623020|NCT01667731|565361006|FG000|Overall Study|Subject Withdrew Consent|2|||
156623021|NCT01667731|565361007|FG001|Overall Study|Subject Withdrew Consent|0|||
156623022|NCT01667731|565361008|FG002|Overall Study|Subject Withdrew Consent|1|||
156623023|NCT01667731|565361009|FG003|Overall Study|Subject Withdrew Consent|0|||
156623024|NCT01667731|565361010|FG004|Overall Study|Subject Withdrew Consent|1|||
156623025|NCT01667731|565361006|FG000|Overall Study|Death|0|||
156623026|NCT01667731|565361007|FG001|Overall Study|Death|1|||
156623027|NCT01667731|565361008|FG002|Overall Study|Death|0|||
156623028|NCT01667731|565361009|FG003|Overall Study|Death|0|||
156623029|NCT01667731|565361010|FG004|Overall Study|Death|0|||
156623030|NCT02127970|565361014|FG000|Overall Study|Adverse Event|2|||
156623031|NCT02127970|565361015|FG001|Overall Study|Adverse Event|1|||
156623032|NCT02127970|565361014|FG000|Overall Study|Death|1|||
156623033|NCT02127970|565361015|FG001|Overall Study|Death|1|||
156623034|NCT02127970|565361014|FG000|Overall Study|Lost to Follow-up|14|||
156623035|NCT02127970|565361015|FG001|Overall Study|Lost to Follow-up|14|||
156623036|NCT02127970|565361014|FG000|Overall Study|Reason not Specified|4|||
156623037|NCT02127970|565361015|FG001|Overall Study|Reason not Specified|7|||
156623038|NCT02127970|565361014|FG000|Overall Study|Pregnancy|0|||
156623039|NCT02127970|565361015|FG001|Overall Study|Pregnancy|1|||
156623040|NCT02127970|565361014|FG000|Overall Study|Subject Withdrew Consent|5|||
156623041|NCT02127970|565361015|FG001|Overall Study|Subject Withdrew Consent|3|||
156623042|NCT01871870|565361019|FG000|Overall Study|Hardware issues|7|||
156623043|NCT01871870|565361019|FG000|Overall Study|hyperglycemia|2|||
156623044|NCT01731951|565361021|FG000|Overall Study|Documented Disease Progression|1|||
156623045|NCT01731951|565361022|FG001|Overall Study|Documented Disease Progression|0|||
156623046|NCT01731951|565361023|FG002|Overall Study|Documented Disease Progression|0|||
156623047|NCT01731951|565361024|FG003|Overall Study|Documented Disease Progression|0|||
156623048|NCT01731951|565361025|FG004|Overall Study|Documented Disease Progression|0|||
156623049|NCT01731951|565361026|FG005|Overall Study|Documented Disease Progression|0|||
156623050|NCT01731951|565361021|FG000|Overall Study|Lost to Follow-up|2|||
156623051|NCT01731951|565361022|FG001|Overall Study|Lost to Follow-up|0|||
156623052|NCT01731951|565361023|FG002|Overall Study|Lost to Follow-up|0|||
156623053|NCT01731951|565361024|FG003|Overall Study|Lost to Follow-up|1|||
156623054|NCT01731951|565361025|FG004|Overall Study|Lost to Follow-up|3|||
156623055|NCT01731951|565361026|FG005|Overall Study|Lost to Follow-up|1|||
156623056|NCT01731951|565361021|FG000|Overall Study|Withdrawal of Consent|1|||
156623057|NCT01731951|565361022|FG001|Overall Study|Withdrawal of Consent|0|||
156623058|NCT01731951|565361023|FG002|Overall Study|Withdrawal of Consent|0|||
156623059|NCT01731951|565361024|FG003|Overall Study|Withdrawal of Consent|0|||
156623060|NCT01731951|565361025|FG004|Overall Study|Withdrawal of Consent|0|||
156623061|NCT01731951|565361026|FG005|Overall Study|Withdrawal of Consent|2|||
156623062|NCT01731951|565361021|FG000|Overall Study|Death|13|||
156623063|NCT01731951|565361022|FG001|Overall Study|Death|15|||
156623064|NCT01731951|565361023|FG002|Overall Study|Death|9|||
156623065|NCT01731951|565361024|FG003|Overall Study|Death|8|||
156623066|NCT01731951|565361025|FG004|Overall Study|Death|9|||
156623067|NCT01731951|565361026|FG005|Overall Study|Death|6|||
156623068|NCT00490815|565361027|FG000|Overall Study|Adverse Event|2|||
156623069|NCT00490815|565361028|FG001|Overall Study|Adverse Event|3|||
156623070|NCT00490815|565361027|FG000|Overall Study|Withdrawal by Subject|4|||
156623071|NCT00490815|565361028|FG001|Overall Study|Withdrawal by Subject|0|||
156623072|NCT00490815|565361027|FG000|Overall Study|Lost to Follow-up|1|||
156623073|NCT00490815|565361028|FG001|Overall Study|Lost to Follow-up|3|||
156623074|NCT00490815|565361027|FG000|Overall Study|Death|1|||
156623075|NCT00490815|565361028|FG001|Overall Study|Death|3|||
156623076|NCT02242305|565361033|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
156623077|NCT02242305|565361034|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
156623078|NCT02242305|565361033|FG000|Overall Study|Adverse Event|1|||
156623079|NCT02242305|565361034|FG001|Overall Study|Adverse Event|0|||
156623080|NCT02242305|565361033|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
156623081|NCT02242305|565361034|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
156623082|NCT02242305|565361033|FG000|Overall Study|Subject withdraws inform consent|0|||
156623083|NCT02242305|565361034|FG001|Overall Study|Subject withdraws inform consent|4|||
156623084|NCT02242305|565361033|FG000|Overall Study|Lost to Follow-up|2|||
156623085|NCT02242305|565361034|FG001|Overall Study|Lost to Follow-up|0|||
156623086|NCT01756846|565361038|FG000|Overall Study|Lost to Follow-up|5|||
156623087|NCT01756846|565361039|FG001|Overall Study|Lost to Follow-up|10|||
156623088|NCT01756846|565361038|FG000|Overall Study|Withdrawal by Subject|1|||
156623089|NCT01756846|565361039|FG001|Overall Study|Withdrawal by Subject|2|||
156623090|NCT03490734|565361044|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
156623091|NCT03490734|565361045|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
156623092|NCT03490734|565361046|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
156623093|NCT03490734|565361047|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
156623094|NCT03490734|565361044|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
156623095|NCT03490734|565361045|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
156623096|NCT03490734|565361046|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
156623097|NCT03490734|565361047|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
156623098|NCT03490734|565361044|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
156623099|NCT03490734|565361045|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
156623100|NCT03490734|565361046|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
156623101|NCT03490734|565361047|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
156623102|NCT03490734|565361044|FG000|Post-intervention Scan Visit|Adverse Event|2|||
156623103|NCT03490734|565361045|FG001|Post-intervention Scan Visit|Adverse Event|0|||
156623104|NCT03490734|565361046|FG002|Post-intervention Scan Visit|Adverse Event|0|||
156623105|NCT03490734|565361047|FG003|Post-intervention Scan Visit|Adverse Event|0|||
156623106|NCT03490734|565361044|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
156623107|NCT03490734|565361045|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
156623108|NCT03490734|565361046|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
156623109|NCT03490734|565361047|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
156623110|NCT03490734|565361044|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
156623111|NCT03490734|565361045|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
156623112|NCT03490734|565361046|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
156623113|NCT03490734|565361047|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
156623114|NCT01326910|565361052|FG000|Overall Study|Withdrawal by Subject|3|||
156623115|NCT01326910|565361053|FG001|Overall Study|Withdrawal by Subject|2|||
156623116|NCT01326910|565361052|FG000|Overall Study|Protocol Violation|1|||
156623117|NCT01326910|565361053|FG001|Overall Study|Protocol Violation|1|||
156623118|NCT02274766|565361054|FG000|Overall Study|Withdrawal by Subject|3|||
156623119|NCT02274766|565361055|FG001|Overall Study|Withdrawal by Subject|6|||
156623120|NCT02274766|565361054|FG000|Overall Study|Did Not Receive Study Drug|1|||
156623121|NCT02274766|565361055|FG001|Overall Study|Did Not Receive Study Drug|1|||
156623122|NCT02274766|565361054|FG000|Overall Study|Subject Unwilling to Proceed|0|||
156623123|NCT02274766|565361055|FG001|Overall Study|Subject Unwilling to Proceed|1|||
156623124|NCT02274766|565361054|FG000|Overall Study|Adverse Event|0|||
156623125|NCT02274766|565361055|FG001|Overall Study|Adverse Event|1|||
156623126|NCT02886338|565361056|FG000|Overall Study|Withdrawal by Subject|1|||
156623127|NCT00561912|565363006|FG000|Overall Study|ineligible|1|||
156623128|NCT03938857|565363007|FG000|Overall Study|Physician Decision|1|||
156623129|NCT03938857|565363008|FG001|Overall Study|Physician Decision|0|||
156623130|NCT03938857|565363009|FG002|Overall Study|Physician Decision|0|||
156623131|NCT03938857|565363010|FG003|Overall Study|Physician Decision|0|||
156623132|NCT02988115|565363011|FG000|Overall Study|Adverse Event|6|||
156623133|NCT02988115|565363012|FG001|Overall Study|Adverse Event|1|||
156623134|NCT02988115|565363011|FG000|Overall Study|Sponsor Decision|5|||
156623135|NCT02988115|565363012|FG001|Overall Study|Sponsor Decision|2|||
156623136|NCT02988115|565363011|FG000|Overall Study|Withdrawal by Subject|1|||
156623137|NCT02988115|565363012|FG001|Overall Study|Withdrawal by Subject|1|||
156623138|NCT02988115|565363011|FG000|Overall Study|Withdrawn by Mistake|1|||
156623139|NCT02988115|565363012|FG001|Overall Study|Withdrawn by Mistake|0|||
156623140|NCT02988115|565363011|FG000|Overall Study|Lost to Follow-up|1|||
156623141|NCT02988115|565363012|FG001|Overall Study|Lost to Follow-up|0|||
156623142|NCT01977651|565363013|FG000|4 Month Treatment Period|Adverse Event|34|||
156623143|NCT01977651|565363013|FG000|4 Month Treatment Period|Death|3|||
156623144|NCT01977651|565363013|FG000|4 Month Treatment Period|Progressive Disease|43|||
156623145|NCT01977651|565363013|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
156623146|NCT01977651|565363013|FG000|4 Month Treatment Period|Physician Decision|4|||
156623147|NCT01977651|565363013|FG000|1 Year Extension Period|Adverse Event|14|||
156623148|NCT01977651|565363013|FG000|1 Year Extension Period|Death|10|||
156623149|NCT01977651|565363013|FG000|1 Year Extension Period|Lost to Follow-up|2|||
156623150|NCT01977651|565363013|FG000|1 Year Extension Period|Progressive Disease|86|||
156623151|NCT01977651|565363013|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
156623152|NCT01977651|565363013|FG000|1 Year Extension Period|Physician Decision|6|||
156623153|NCT01977651|565363013|FG000|1 Year Extension Period|Miscellaneous|1|||
156623154|NCT01977651|565363013|FG000|Post 1 Year Extension Period|Adverse Event|5|||
156623155|NCT01977651|565363013|FG000|Post 1 Year Extension Period|Death|13|||
156623156|NCT01977651|565363013|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
156623157|NCT01977651|565363013|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
156623158|NCT01977651|565363013|FG000|Post 1 Year Extension Period|Physician Decision|4|||
156623159|NCT01977651|565363013|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
156623160|NCT03287089|565363019|FG000|Overall Study|Lost to Follow-up|0|||
156623161|NCT03287089|565363020|FG001|Overall Study|Lost to Follow-up|2|||
156623162|NCT03287089|565363019|FG000|Overall Study|Physician Decision|0|||
156623163|NCT03287089|565363020|FG001|Overall Study|Physician Decision|2|||
156623164|NCT03287089|565363019|FG000|Overall Study|Withdrawal by Subject|0|||
156623165|NCT03287089|565363020|FG001|Overall Study|Withdrawal by Subject|2|||
156623166|NCT01729559|565363028|FG000|Overall Study|Protocol Violation|31|||
156623167|NCT01729559|565363029|FG001|Overall Study|Protocol Violation|28|||
156623168|NCT00104299|565363034|FG000|Overall Study|Adverse Event|3|||
156623169|NCT00104299|565363035|FG001|Overall Study|Adverse Event|1|||
156623170|NCT00104299|565363034|FG000|Overall Study|Death|2|||
156623171|NCT00104299|565363035|FG001|Overall Study|Death|2|||
156623172|NCT00104299|565363034|FG000|Overall Study|Withdrawal by Subject|2|||
156623173|NCT00104299|565363035|FG001|Overall Study|Withdrawal by Subject|6|||
156623174|NCT00104299|565363034|FG000|Overall Study|Physician Decision|1|||
156623175|NCT00104299|565363035|FG001|Overall Study|Physician Decision|1|||
156623176|NCT00104299|565363034|FG000|Overall Study|To have renal transplant|1|||
156623177|NCT00104299|565363035|FG001|Overall Study|To have renal transplant|0|||
156623178|NCT02452034|565363036|FG000|Overall Study|Adverse Event|0|||
156623179|NCT02452034|565363037|FG001|Overall Study|Adverse Event|0|||
156623180|NCT02452034|565363038|FG002|Overall Study|Adverse Event|0|||
156623181|NCT02452034|565363039|FG003|Overall Study|Adverse Event|0|||
156623182|NCT02452034|565363040|FG004|Overall Study|Adverse Event|0|||
156623183|NCT02452034|565363041|FG005|Overall Study|Adverse Event|1|||
156623184|NCT02452034|565363036|FG000|Overall Study|Death|0|||
156623185|NCT02452034|565363037|FG001|Overall Study|Death|0|||
156623186|NCT02452034|565363038|FG002|Overall Study|Death|0|||
156623187|NCT02452034|565363039|FG003|Overall Study|Death|0|||
156623188|NCT02452034|565363040|FG004|Overall Study|Death|1|||
156623189|NCT02452034|565363041|FG005|Overall Study|Death|1|||
156623190|NCT02452034|565363036|FG000|Overall Study|Physician Decision|0|||
156623191|NCT02452034|565363037|FG001|Overall Study|Physician Decision|1|||
156623192|NCT02452034|565363038|FG002|Overall Study|Physician Decision|1|||
156623193|NCT02452034|565363039|FG003|Overall Study|Physician Decision|0|||
156623194|NCT02452034|565363040|FG004|Overall Study|Physician Decision|0|||
156623195|NCT02452034|565363041|FG005|Overall Study|Physician Decision|0|||
156623196|NCT02452034|565363036|FG000|Overall Study|Protocol Violation|0|||
156623197|NCT02452034|565363037|FG001|Overall Study|Protocol Violation|0|||
156623198|NCT02452034|565363038|FG002|Overall Study|Protocol Violation|0|||
156623199|NCT02452034|565363039|FG003|Overall Study|Protocol Violation|0|||
156623200|NCT02452034|565363040|FG004|Overall Study|Protocol Violation|0|||
156623201|NCT02452034|565363041|FG005|Overall Study|Protocol Violation|1|||
156623202|NCT02452034|565363036|FG000|Overall Study|Screen Failure|1|||
156623203|NCT02452034|565363037|FG001|Overall Study|Screen Failure|0|||
156623204|NCT02452034|565363038|FG002|Overall Study|Screen Failure|0|||
156623205|NCT02452034|565363039|FG003|Overall Study|Screen Failure|1|||
156623206|NCT02452034|565363040|FG004|Overall Study|Screen Failure|0|||
156623207|NCT02452034|565363041|FG005|Overall Study|Screen Failure|0|||
156623208|NCT02452034|565363036|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
156623209|NCT02452034|565363037|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
156623210|NCT02452034|565363038|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
156623211|NCT02452034|565363039|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
156623212|NCT02452034|565363040|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
156623213|NCT02452034|565363041|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
156623214|NCT03672006|565363045|FG000|Overall Study|exclusion criteria met|0|||
156623215|NCT03672006|565363046|FG001|Overall Study|exclusion criteria met|1|||
156623216|NCT03288987|565363047|FG000|Overall Study|Protocol Violation|10|||
156623217|NCT03288987|565363048|FG001|Overall Study|Protocol Violation|4|||
156623218|NCT02764229|565363050|FG000|Overall Study|Withdrawal by Subject|15|||
156623219|NCT02764229|565363050|FG000|Overall Study|Adverse Event|9|||
156623220|NCT02764229|565363050|FG000|Overall Study|Physician Decision|5|||
156623221|NCT02764229|565363050|FG000|Overall Study|Lost to Follow-up|3|||
156623222|NCT02764229|565363050|FG000|Overall Study|Lack of Efficacy|1|||
156623223|NCT02764229|565363050|FG000|Overall Study|Study Stopped by Sponsor|69|||
156623224|NCT00672490|565363051|FG000|Overall Study|Withdrawal by Subject|8|||
156623225|NCT00672490|565363052|FG001|Overall Study|Withdrawal by Subject|8|||
156623226|NCT00672490|565363051|FG000|Overall Study|Lack of Compliance|2|||
156623227|NCT00672490|565363052|FG001|Overall Study|Lack of Compliance|7|||
156623228|NCT00672490|565363051|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
156623229|NCT00672490|565363052|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
156623230|NCT00672490|565363051|FG000|Overall Study|Adverse Event|5|||
156623231|NCT00672490|565363052|FG001|Overall Study|Adverse Event|8|||
156623232|NCT00672490|565363051|FG000|Overall Study|Violation of Concomitant Medicine|1|||
156623233|NCT00672490|565363052|FG001|Overall Study|Violation of Concomitant Medicine|0|||
156623234|NCT00672490|565363051|FG000|Overall Study|Intolerance|0|||
156623235|NCT00672490|565363052|FG001|Overall Study|Intolerance|2|||
156623236|NCT00672490|565363051|FG000|Overall Study|Lost to Follow-up|1|||
156623237|NCT00672490|565363052|FG001|Overall Study|Lost to Follow-up|5|||
156623238|NCT00672490|565363051|FG000|Overall Study|No reason was provided|6|||
156623239|NCT00672490|565363052|FG001|Overall Study|No reason was provided|2|||
156623240|NCT01904760|565363059|FG000|Overall Study|Protocol Violation|1|||
156623241|NCT01904760|565363060|FG001|Overall Study|Protocol Violation|0|||
156623242|NCT04249076|565363072|FG000|Overall Study|Adverse Event|1|||
156623243|NCT04249076|565363073|FG001|Overall Study|Adverse Event|1|||
156623244|NCT04249076|565363072|FG000|Overall Study|Protocol Violation|1|||
156623245|NCT04249076|565363073|FG001|Overall Study|Protocol Violation|2|||
156623246|NCT04249076|565363072|FG000|Overall Study|Lack of Efficacy|0|||
156623247|NCT04249076|565363073|FG001|Overall Study|Lack of Efficacy|1|||
156623248|NCT04249076|565363072|FG000|Overall Study|Withdrawal by Subject|0|||
156623249|NCT04249076|565363073|FG001|Overall Study|Withdrawal by Subject|1|||
156623250|NCT00783263|565363074|FG000|Overall Study|Adverse Event|3|||
156623251|NCT00783263|565363075|FG001|Overall Study|Adverse Event|0|||
156623252|NCT00783263|565363076|FG002|Overall Study|Adverse Event|2|||
156623253|NCT00783263|565363077|FG003|Overall Study|Adverse Event|1|||
156623254|NCT00783263|565363074|FG000|Overall Study|Lost to Follow-up|1|||
156623255|NCT00783263|565363075|FG001|Overall Study|Lost to Follow-up|1|||
156623256|NCT00783263|565363076|FG002|Overall Study|Lost to Follow-up|0|||
156623257|NCT00783263|565363077|FG003|Overall Study|Lost to Follow-up|0|||
156623258|NCT00783263|565363074|FG000|Overall Study|Withdrawal by Subject|0|||
156623259|NCT00783263|565363075|FG001|Overall Study|Withdrawal by Subject|1|||
156623260|NCT00783263|565363076|FG002|Overall Study|Withdrawal by Subject|1|||
156623261|NCT00783263|565363077|FG003|Overall Study|Withdrawal by Subject|2|||
156623262|NCT00732199|565363078|FG000|Overall Study|Withdrawal by Subject|25|||
156623263|NCT00732199|565363079|FG001|Overall Study|Withdrawal by Subject|18|||
156623264|NCT00732199|565363078|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
156623265|NCT00732199|565363079|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
156623266|NCT00265382|565363091|FG000|Overall Study|Adverse Event|21|||
156623267|NCT00265382|565363091|FG000|Overall Study|Laboratory Abnormality|1|||
156623268|NCT00265382|565363091|FG000|Overall Study|Lost to Follow-up|3|||
156623269|NCT00265382|565363091|FG000|Overall Study|Lack of Efficacy|6|||
156623270|NCT00265382|565363091|FG000|Overall Study|Miscellaneous|6|||
156623271|NCT00265382|565363091|FG000|Overall Study|Withdrawal by Subject|13|||
156623272|NCT00265382|565363091|FG000|Overall Study|Study terminated by sponsor|94|||
156623273|NCT00265382|565363091|FG000|Overall Study|Death|1|||
156623274|NCT02543801|565363092|FG000|Overall Study|Protocol Violation|1|||
156623275|NCT02543801|565363093|FG001|Overall Study|Protocol Violation|2|||
156623276|NCT02543801|565363094|FG002|Overall Study|Protocol Violation|0|||
156623277|NCT02543801|565363095|FG003|Overall Study|Protocol Violation|0|||
156623278|NCT00545740|565363096|FG000|Overall Study|Lack of Efficacy|34|||
156623279|NCT00545740|565363097|FG001|Overall Study|Lack of Efficacy|35|||
156623280|NCT00545740|565363098|FG002|Overall Study|Lack of Efficacy|47|||
156623281|NCT00545740|565363099|FG003|Overall Study|Lack of Efficacy|36|||
156623282|NCT00545740|565363096|FG000|Overall Study|Withdrawal by Subject|17|||
156623283|NCT00545740|565363097|FG001|Overall Study|Withdrawal by Subject|15|||
156623284|NCT00545740|565363098|FG002|Overall Study|Withdrawal by Subject|16|||
156623285|NCT00545740|565363099|FG003|Overall Study|Withdrawal by Subject|18|||
156623286|NCT00545740|565363096|FG000|Overall Study|Adverse Event|10|||
156623287|NCT00545740|565363097|FG001|Overall Study|Adverse Event|18|||
156623288|NCT00545740|565363098|FG002|Overall Study|Adverse Event|19|||
156623289|NCT00545740|565363099|FG003|Overall Study|Adverse Event|9|||
156623290|NCT00545740|565363096|FG000|Overall Study|Lost to Follow-up|7|||
156623291|NCT00545740|565363097|FG001|Overall Study|Lost to Follow-up|5|||
156623292|NCT00545740|565363098|FG002|Overall Study|Lost to Follow-up|5|||
156623293|NCT00545740|565363099|FG003|Overall Study|Lost to Follow-up|6|||
156623294|NCT00545740|565363096|FG000|Overall Study|Protocol Violation|1|||
156623295|NCT00545740|565363097|FG001|Overall Study|Protocol Violation|3|||
156623296|NCT00545740|565363098|FG002|Overall Study|Protocol Violation|1|||
156623297|NCT00545740|565363099|FG003|Overall Study|Protocol Violation|0|||
156623298|NCT00545740|565363096|FG000|Overall Study|Non-compliance|0|||
156623299|NCT00545740|565363097|FG001|Overall Study|Non-compliance|2|||
156623300|NCT00545740|565363098|FG002|Overall Study|Non-compliance|1|||
156623301|NCT00545740|565363099|FG003|Overall Study|Non-compliance|0|||
156623302|NCT00545740|565363096|FG000|Overall Study|Moved|2|||
156623303|NCT00545740|565363097|FG001|Overall Study|Moved|0|||
156623304|NCT00545740|565363098|FG002|Overall Study|Moved|1|||
156623305|NCT00545740|565363099|FG003|Overall Study|Moved|0|||
156623306|NCT00545740|565363096|FG000|Overall Study|Diverticulitis attack|0|||
156623307|NCT00545740|565363097|FG001|Overall Study|Diverticulitis attack|0|||
156623308|NCT00545740|565363098|FG002|Overall Study|Diverticulitis attack|1|||
156623309|NCT00545740|565363099|FG003|Overall Study|Diverticulitis attack|1|||
156623310|NCT00545740|565363096|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
156623311|NCT00545740|565363097|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
156623312|NCT00545740|565363098|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
156623313|NCT00545740|565363099|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
156623314|NCT00545740|565363096|FG000|Overall Study|Site closure|1|||
156623315|NCT00545740|565363097|FG001|Overall Study|Site closure|0|||
156623316|NCT00545740|565363098|FG002|Overall Study|Site closure|0|||
156623317|NCT00545740|565363099|FG003|Overall Study|Site closure|0|||
156623318|NCT00545740|565363096|FG000|Overall Study|Missed visit|1|||
156623319|NCT00545740|565363097|FG001|Overall Study|Missed visit|0|||
156623320|NCT00545740|565363098|FG002|Overall Study|Missed visit|0|||
156623321|NCT00545740|565363099|FG003|Overall Study|Missed visit|0|||
156623322|NCT00545740|565363096|FG000|Overall Study|Physician Decision|0|||
156623323|NCT00545740|565363097|FG001|Overall Study|Physician Decision|0|||
156623324|NCT00545740|565363098|FG002|Overall Study|Physician Decision|3|||
156623325|NCT00545740|565363099|FG003|Overall Study|Physician Decision|0|||
156623326|NCT00545740|565363096|FG000|Overall Study|Accepted only monthly telephone calls|1|||
156623327|NCT00545740|565363097|FG001|Overall Study|Accepted only monthly telephone calls|0|||
156623328|NCT00545740|565363098|FG002|Overall Study|Accepted only monthly telephone calls|0|||
156623329|NCT00545740|565363099|FG003|Overall Study|Accepted only monthly telephone calls|0|||
156623330|NCT00545740|565363096|FG000|Overall Study|Sponsor decision|0|||
156623331|NCT00545740|565363097|FG001|Overall Study|Sponsor decision|1|||
156623332|NCT00545740|565363098|FG002|Overall Study|Sponsor decision|0|||
156623333|NCT00545740|565363099|FG003|Overall Study|Sponsor decision|0|||
156623334|NCT00545740|565363096|FG000|Overall Study|Lack of time|0|||
156623335|NCT00545740|565363097|FG001|Overall Study|Lack of time|1|||
156623336|NCT00545740|565363098|FG002|Overall Study|Lack of time|0|||
156623337|NCT00545740|565363099|FG003|Overall Study|Lack of time|0|||
156623338|NCT00545740|565363096|FG000|Overall Study|Non-adherence to visits|0|||
156623339|NCT00545740|565363097|FG001|Overall Study|Non-adherence to visits|1|||
156623340|NCT00545740|565363098|FG002|Overall Study|Non-adherence to visits|0|||
156623341|NCT00545740|565363099|FG003|Overall Study|Non-adherence to visits|0|||
156623342|NCT00545740|565363096|FG000|Overall Study|Patient difficulties|0|||
156623343|NCT00545740|565363097|FG001|Overall Study|Patient difficulties|1|||
156623344|NCT00545740|565363098|FG002|Overall Study|Patient difficulties|0|||
156623345|NCT00545740|565363099|FG003|Overall Study|Patient difficulties|0|||
156623346|NCT00545740|565363096|FG000|Overall Study|Husband against study|0|||
156623347|NCT00545740|565363097|FG001|Overall Study|Husband against study|0|||
156623348|NCT00545740|565363098|FG002|Overall Study|Husband against study|1|||
156623349|NCT00545740|565363099|FG003|Overall Study|Husband against study|0|||
156623350|NCT02117024|565363100|FG000|Overall Study|Progressive Disease|26|||
156623351|NCT02117024|565363101|FG001|Overall Study|Progressive Disease|9|||
156623352|NCT02117024|565363100|FG000|Overall Study|Significant Clinical Progression|7|||
156623353|NCT02117024|565363101|FG001|Overall Study|Significant Clinical Progression|4|||
156623354|NCT02117024|565363100|FG000|Overall Study|Death|5|||
156623355|NCT02117024|565363101|FG001|Overall Study|Death|0|||
156623356|NCT02117024|565363100|FG000|Overall Study|Withdrawal by Subject|3|||
156623357|NCT02117024|565363101|FG001|Overall Study|Withdrawal by Subject|1|||
156623358|NCT02117024|565363100|FG000|Overall Study|Protocol Violation|1|||
156623359|NCT02117024|565363101|FG001|Overall Study|Protocol Violation|0|||
156623360|NCT02117024|565363100|FG000|Overall Study|Adverse Event|1|||
156623361|NCT02117024|565363101|FG001|Overall Study|Adverse Event|2|||
156623362|NCT02117024|565363100|FG000|Overall Study|Randomized in Error|1|||
156623363|NCT02117024|565363101|FG001|Overall Study|Randomized in Error|0|||
156623364|NCT02117024|565363100|FG000|Overall Study|Patient returned to primary oncologist|0|||
156623365|NCT02117024|565363101|FG001|Overall Study|Patient returned to primary oncologist|1|||
156623366|NCT02117024|565363100|FG000|Overall Study|Patient took treatment break|0|||
156623367|NCT02117024|565363101|FG001|Overall Study|Patient took treatment break|1|||
156623368|NCT02117024|565363100|FG000|Overall Study|Physician Decision|0|||
156623369|NCT02117024|565363101|FG001|Overall Study|Physician Decision|2|||
156623370|NCT00082628|565363111|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
156623371|NCT00082628|565363112|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
156623372|NCT00082628|565363113|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
156623373|NCT00082628|565363114|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
156623374|NCT00082628|565363115|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
156623375|NCT00082628|565363111|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
156623376|NCT00082628|565363112|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
156623377|NCT00082628|565363113|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
156623378|NCT00082628|565363114|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
156623379|NCT00082628|565363115|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
156623380|NCT00082628|565363111|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
156623381|NCT00082628|565363112|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
156623382|NCT00082628|565363113|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
156623383|NCT00082628|565363114|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
156623384|NCT00082628|565363115|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
156623385|NCT00082628|565363111|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
156623386|NCT00082628|565363112|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
156623387|NCT00082628|565363113|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
156623388|NCT00082628|565363114|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
156623389|NCT00082628|565363115|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
156623390|NCT00082628|565363111|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
156623391|NCT00082628|565363112|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
156623392|NCT00082628|565363113|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
156623393|NCT00082628|565363114|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
156623394|NCT00082628|565363115|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
156623395|NCT00082628|565363111|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
156623396|NCT00082628|565363112|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
156623397|NCT00082628|565363113|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
156623398|NCT00082628|565363114|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
156623399|NCT00082628|565363115|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
156623400|NCT00082628|565363111|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
156623401|NCT00082628|565363112|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
156623402|NCT00082628|565363113|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
156623403|NCT00082628|565363114|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
156623404|NCT00082628|565363115|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
156623405|NCT03481634|565363123|FG000|Overall Study|Withdrawal by Subject|16|||
156623406|NCT03481634|565363124|FG001|Overall Study|Withdrawal by Subject|19|||
156623407|NCT03481634|565363125|FG002|Overall Study|Withdrawal by Subject|14|||
156623408|NCT03481634|565363123|FG000|Overall Study|Protocol Violation|1|||
156623409|NCT03481634|565363124|FG001|Overall Study|Protocol Violation|0|||
156623410|NCT03481634|565363125|FG002|Overall Study|Protocol Violation|1|||
156623411|NCT03481634|565363123|FG000|Overall Study|Progressive disease|0|||
156623412|NCT03481634|565363124|FG001|Overall Study|Progressive disease|1|||
156623413|NCT03481634|565363125|FG002|Overall Study|Progressive disease|0|||
156623414|NCT03481634|565363123|FG000|Overall Study|Physician Decision|3|||
156623415|NCT03481634|565363124|FG001|Overall Study|Physician Decision|0|||
156623416|NCT03481634|565363125|FG002|Overall Study|Physician Decision|1|||
156623417|NCT03481634|565363123|FG000|Overall Study|Lost to Follow-up|3|||
156623418|NCT03481634|565363124|FG001|Overall Study|Lost to Follow-up|4|||
156623419|NCT03481634|565363125|FG002|Overall Study|Lost to Follow-up|4|||
156623420|NCT03481634|565363123|FG000|Overall Study|Death|4|||
156623421|NCT03481634|565363124|FG001|Overall Study|Death|8|||
156623422|NCT03481634|565363125|FG002|Overall Study|Death|7|||
156623423|NCT03481634|565363123|FG000|Overall Study|Adverse Event|6|||
156623424|NCT03481634|565363124|FG001|Overall Study|Adverse Event|3|||
156623425|NCT03481634|565363125|FG002|Overall Study|Adverse Event|7|||
156623426|NCT01849289|565363129|FG000|Overall Study|Adverse Event|3|||
156623427|NCT01849289|565363130|FG001|Overall Study|Adverse Event|3|||
156623428|NCT01849289|565363129|FG000|Overall Study|Protocol Violation|3|||
156623429|NCT01849289|565363130|FG001|Overall Study|Protocol Violation|3|||
156623430|NCT01849289|565363129|FG000|Overall Study|Withdrawal criteria|1|||
156623431|NCT01849289|565363130|FG001|Overall Study|Withdrawal criteria|0|||
156623432|NCT01849289|565363129|FG000|Overall Study|Unclassified|25|||
156623433|NCT01849289|565363130|FG001|Overall Study|Unclassified|18|||
156623434|NCT04491591|565363131|FG000|Overall Study|Accidently randomized|3|||
156623435|NCT04491591|565363132|FG001|Overall Study|Accidently randomized|1|||
156623436|NCT04491591|565363133|FG002|Overall Study|Accidently randomized|0|||
156623437|NCT04491591|565363131|FG000|Overall Study|Did not complete survey|28|||
156623438|NCT04491591|565363132|FG001|Overall Study|Did not complete survey|20|||
156623439|NCT04491591|565363133|FG002|Overall Study|Did not complete survey|3|||
156623440|NCT02692560|565363135|FG000|Overall Study|Withdrawal by Subject|0|||
156623441|NCT02692560|565363136|FG001|Overall Study|Withdrawal by Subject|6|||
156623442|NCT00715949|565363139|FG000|Overall Study|could not finish first test|4|||
156623443|NCT02394028|565363140|FG000|Induction Phase|Adverse Event|2|||
156623444|NCT02394028|565363141|FG001|Induction Phase|Adverse Event|4|||
156623445|NCT02394028|565363142|FG002|Induction Phase|Adverse Event|1|||
156623446|NCT02394028|565363143|FG003|Induction Phase|Adverse Event|2|||
156623447|NCT02394028|565363144|FG004|Induction Phase|Adverse Event|5|||
156623448|NCT02394028|565363145|FG005|Induction Phase|Adverse Event|2|||
156623449|NCT02394028|565363146|FG006|Induction Phase|Adverse Event|0|||
156623450|NCT02394028|565363147|FG007|Induction Phase|Adverse Event|0|||
156623451|NCT02394028|565363148|FG008|Induction Phase|Adverse Event|0|||
156623452|NCT02394028|565363149|FG009|Induction Phase|Adverse Event|0|||
156623453|NCT02394028|565363150|FG010|Induction Phase|Adverse Event|0|||
156623454|NCT02394028|565363140|FG000|Induction Phase|Lack of Efficacy|3|||
156623455|NCT02394028|565363141|FG001|Induction Phase|Lack of Efficacy|6|||
156623456|NCT02394028|565363142|FG002|Induction Phase|Lack of Efficacy|2|||
156623457|NCT02394028|565363143|FG003|Induction Phase|Lack of Efficacy|17|||
156623458|NCT02394028|565363144|FG004|Induction Phase|Lack of Efficacy|14|||
156623459|NCT02394028|565363145|FG005|Induction Phase|Lack of Efficacy|8|||
156623460|NCT02394028|565363146|FG006|Induction Phase|Lack of Efficacy|17|||
156623461|NCT02394028|565363147|FG007|Induction Phase|Lack of Efficacy|23|||
156623462|NCT02394028|565363148|FG008|Induction Phase|Lack of Efficacy|0|||
156623463|NCT02394028|565363149|FG009|Induction Phase|Lack of Efficacy|0|||
156623464|NCT02394028|565363150|FG010|Induction Phase|Lack of Efficacy|0|||
156623465|NCT02394028|565363140|FG000|Induction Phase|Lost to Follow-up|1|||
156623466|NCT02394028|565363141|FG001|Induction Phase|Lost to Follow-up|0|||
156623467|NCT02394028|565363142|FG002|Induction Phase|Lost to Follow-up|0|||
156623468|NCT02394028|565363143|FG003|Induction Phase|Lost to Follow-up|1|||
156623469|NCT02394028|565363144|FG004|Induction Phase|Lost to Follow-up|0|||
156623470|NCT02394028|565363145|FG005|Induction Phase|Lost to Follow-up|0|||
156623471|NCT02394028|565363146|FG006|Induction Phase|Lost to Follow-up|1|||
156623472|NCT02394028|565363147|FG007|Induction Phase|Lost to Follow-up|0|||
156623473|NCT02394028|565363148|FG008|Induction Phase|Lost to Follow-up|0|||
156623474|NCT02394028|565363149|FG009|Induction Phase|Lost to Follow-up|0|||
156623475|NCT02394028|565363150|FG010|Induction Phase|Lost to Follow-up|0|||
156623476|NCT02394028|565363140|FG000|Induction Phase|Non-compliance|0|||
156623477|NCT02394028|565363141|FG001|Induction Phase|Non-compliance|1|||
156623478|NCT02394028|565363142|FG002|Induction Phase|Non-compliance|3|||
156623479|NCT02394028|565363143|FG003|Induction Phase|Non-compliance|1|||
156623480|NCT02394028|565363144|FG004|Induction Phase|Non-compliance|3|||
156623481|NCT02394028|565363145|FG005|Induction Phase|Non-compliance|0|||
156623482|NCT02394028|565363146|FG006|Induction Phase|Non-compliance|1|||
156623483|NCT02394028|565363147|FG007|Induction Phase|Non-compliance|1|||
156623484|NCT02394028|565363148|FG008|Induction Phase|Non-compliance|0|||
156623485|NCT02394028|565363149|FG009|Induction Phase|Non-compliance|0|||
156623486|NCT02394028|565363150|FG010|Induction Phase|Non-compliance|0|||
156623487|NCT02394028|565363140|FG000|Induction Phase|Physician Decision|0|||
156623488|NCT02394028|565363141|FG001|Induction Phase|Physician Decision|0|||
156623489|NCT02394028|565363142|FG002|Induction Phase|Physician Decision|1|||
156623490|NCT02394028|565363143|FG003|Induction Phase|Physician Decision|4|||
156623491|NCT02394028|565363144|FG004|Induction Phase|Physician Decision|0|||
156623492|NCT02394028|565363145|FG005|Induction Phase|Physician Decision|2|||
156623493|NCT02394028|565363146|FG006|Induction Phase|Physician Decision|1|||
156623494|NCT02394028|565363147|FG007|Induction Phase|Physician Decision|0|||
156623495|NCT02394028|565363148|FG008|Induction Phase|Physician Decision|0|||
156623496|NCT02394028|565363149|FG009|Induction Phase|Physician Decision|0|||
156623497|NCT02394028|565363150|FG010|Induction Phase|Physician Decision|0|||
156623498|NCT02394028|565363140|FG000|Induction Phase|Protocol Violation|0|||
156623499|NCT02394028|565363141|FG001|Induction Phase|Protocol Violation|2|||
156623500|NCT02394028|565363142|FG002|Induction Phase|Protocol Violation|0|||
156623501|NCT02394028|565363143|FG003|Induction Phase|Protocol Violation|3|||
156623502|NCT02394028|565363144|FG004|Induction Phase|Protocol Violation|0|||
156623503|NCT02394028|565363145|FG005|Induction Phase|Protocol Violation|1|||
156623504|NCT02394028|565363146|FG006|Induction Phase|Protocol Violation|1|||
156623505|NCT02394028|565363147|FG007|Induction Phase|Protocol Violation|0|||
156623506|NCT02394028|565363148|FG008|Induction Phase|Protocol Violation|0|||
156623507|NCT02394028|565363149|FG009|Induction Phase|Protocol Violation|0|||
156623508|NCT02394028|565363150|FG010|Induction Phase|Protocol Violation|0|||
156623509|NCT02394028|565363140|FG000|Induction Phase|Withdrawal by Subject|1|||
156623510|NCT02394028|565363141|FG001|Induction Phase|Withdrawal by Subject|2|||
156623511|NCT02394028|565363142|FG002|Induction Phase|Withdrawal by Subject|4|||
156623512|NCT02394028|565363143|FG003|Induction Phase|Withdrawal by Subject|6|||
156623513|NCT02394028|565363144|FG004|Induction Phase|Withdrawal by Subject|7|||
156623514|NCT02394028|565363145|FG005|Induction Phase|Withdrawal by Subject|4|||
156623515|NCT02394028|565363146|FG006|Induction Phase|Withdrawal by Subject|3|||
156623516|NCT02394028|565363147|FG007|Induction Phase|Withdrawal by Subject|6|||
156623517|NCT02394028|565363148|FG008|Induction Phase|Withdrawal by Subject|0|||
156623518|NCT02394028|565363149|FG009|Induction Phase|Withdrawal by Subject|0|||
156623519|NCT02394028|565363150|FG010|Induction Phase|Withdrawal by Subject|0|||
156623520|NCT02394028|565363140|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623521|NCT02394028|565363141|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623522|NCT02394028|565363142|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623523|NCT02394028|565363143|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623524|NCT02394028|565363144|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623525|NCT02394028|565363145|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623526|NCT02394028|565363146|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
156623527|NCT02394028|565363147|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623528|NCT02394028|565363148|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623529|NCT02394028|565363149|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623530|NCT02394028|565363150|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
156623531|NCT02394028|565363140|FG000|Induction Phase|Sponsor decision|0|||
156623532|NCT02394028|565363141|FG001|Induction Phase|Sponsor decision|1|||
156623533|NCT02394028|565363142|FG002|Induction Phase|Sponsor decision|2|||
156623534|NCT02394028|565363143|FG003|Induction Phase|Sponsor decision|0|||
156623535|NCT02394028|565363144|FG004|Induction Phase|Sponsor decision|0|||
156623536|NCT02394028|565363145|FG005|Induction Phase|Sponsor decision|0|||
156623537|NCT02394028|565363146|FG006|Induction Phase|Sponsor decision|0|||
156623538|NCT02394028|565363147|FG007|Induction Phase|Sponsor decision|0|||
156623539|NCT02394028|565363148|FG008|Induction Phase|Sponsor decision|0|||
156623540|NCT02394028|565363149|FG009|Induction Phase|Sponsor decision|0|||
156623541|NCT02394028|565363150|FG010|Induction Phase|Sponsor decision|0|||
156623542|NCT02394028|565363140|FG000|Induction Phase|Technical reason|0|||
156623543|NCT02394028|565363141|FG001|Induction Phase|Technical reason|0|||
156623544|NCT02394028|565363142|FG002|Induction Phase|Technical reason|0|||
156623545|NCT02394028|565363143|FG003|Induction Phase|Technical reason|1|||
156623546|NCT02394028|565363144|FG004|Induction Phase|Technical reason|0|||
156623547|NCT02394028|565363145|FG005|Induction Phase|Technical reason|0|||
156623548|NCT02394028|565363146|FG006|Induction Phase|Technical reason|0|||
156623549|NCT02394028|565363147|FG007|Induction Phase|Technical reason|0|||
156623550|NCT02394028|565363148|FG008|Induction Phase|Technical reason|0|||
156623551|NCT02394028|565363149|FG009|Induction Phase|Technical reason|0|||
156623552|NCT02394028|565363150|FG010|Induction Phase|Technical reason|0|||
156623553|NCT02394028|565363140|FG000|Induction Phase|:ack of calculation|0|||
156623554|NCT02394028|565363141|FG001|Induction Phase|:ack of calculation|0|||
156623555|NCT02394028|565363142|FG002|Induction Phase|:ack of calculation|0|||
156623556|NCT02394028|565363143|FG003|Induction Phase|:ack of calculation|0|||
156623557|NCT02394028|565363144|FG004|Induction Phase|:ack of calculation|0|||
156623558|NCT02394028|565363145|FG005|Induction Phase|:ack of calculation|0|||
156623559|NCT02394028|565363146|FG006|Induction Phase|:ack of calculation|0|||
156623560|NCT02394028|565363147|FG007|Induction Phase|:ack of calculation|1|||
156623561|NCT02394028|565363148|FG008|Induction Phase|:ack of calculation|0|||
156623562|NCT02394028|565363149|FG009|Induction Phase|:ack of calculation|0|||
156623563|NCT02394028|565363150|FG010|Induction Phase|:ack of calculation|0|||
156623564|NCT02394028|565363140|FG000|Maintenance Phase|Protocol Violation|0|||
156623565|NCT02394028|565363141|FG001|Maintenance Phase|Protocol Violation|0|||
156623566|NCT02394028|565363142|FG002|Maintenance Phase|Protocol Violation|0|||
156623567|NCT02394028|565363143|FG003|Maintenance Phase|Protocol Violation|0|||
156623568|NCT02394028|565363144|FG004|Maintenance Phase|Protocol Violation|0|||
156623569|NCT02394028|565363145|FG005|Maintenance Phase|Protocol Violation|0|||
156623570|NCT02394028|565363146|FG006|Maintenance Phase|Protocol Violation|0|||
156623571|NCT02394028|565363147|FG007|Maintenance Phase|Protocol Violation|0|||
156623572|NCT02394028|565363148|FG008|Maintenance Phase|Protocol Violation|0|||
156623573|NCT02394028|565363149|FG009|Maintenance Phase|Protocol Violation|0|||
156623574|NCT02394028|565363150|FG010|Maintenance Phase|Protocol Violation|1|||
156623575|NCT02394028|565363140|FG000|Maintenance Phase|Physician Decision|0|||
156623576|NCT02394028|565363141|FG001|Maintenance Phase|Physician Decision|0|||
156623577|NCT02394028|565363142|FG002|Maintenance Phase|Physician Decision|0|||
156623578|NCT02394028|565363143|FG003|Maintenance Phase|Physician Decision|0|||
156623579|NCT02394028|565363144|FG004|Maintenance Phase|Physician Decision|0|||
156623580|NCT02394028|565363145|FG005|Maintenance Phase|Physician Decision|0|||
156623581|NCT02394028|565363146|FG006|Maintenance Phase|Physician Decision|0|||
156623582|NCT02394028|565363147|FG007|Maintenance Phase|Physician Decision|0|||
156623583|NCT02394028|565363148|FG008|Maintenance Phase|Physician Decision|1|||
156623584|NCT02394028|565363149|FG009|Maintenance Phase|Physician Decision|3|||
156623585|NCT02394028|565363150|FG010|Maintenance Phase|Physician Decision|2|||
156623586|NCT02394028|565363140|FG000|Maintenance Phase|Lack of Efficacy|0|||
156623587|NCT02394028|565363141|FG001|Maintenance Phase|Lack of Efficacy|0|||
156623588|NCT02394028|565363142|FG002|Maintenance Phase|Lack of Efficacy|0|||
156623589|NCT02394028|565363143|FG003|Maintenance Phase|Lack of Efficacy|0|||
156623590|NCT02394028|565363144|FG004|Maintenance Phase|Lack of Efficacy|0|||
156623591|NCT02394028|565363145|FG005|Maintenance Phase|Lack of Efficacy|0|||
156623592|NCT02394028|565363146|FG006|Maintenance Phase|Lack of Efficacy|0|||
156623593|NCT02394028|565363147|FG007|Maintenance Phase|Lack of Efficacy|0|||
156623594|NCT02394028|565363148|FG008|Maintenance Phase|Lack of Efficacy|7|||
156623595|NCT02394028|565363149|FG009|Maintenance Phase|Lack of Efficacy|25|||
156623596|NCT02394028|565363150|FG010|Maintenance Phase|Lack of Efficacy|33|||
156623597|NCT02394028|565363140|FG000|Maintenance Phase|Death|0|||
156623598|NCT02394028|565363141|FG001|Maintenance Phase|Death|0|||
156623599|NCT02394028|565363142|FG002|Maintenance Phase|Death|0|||
156623600|NCT02394028|565363143|FG003|Maintenance Phase|Death|0|||
156623601|NCT02394028|565363144|FG004|Maintenance Phase|Death|0|||
156623602|NCT02394028|565363145|FG005|Maintenance Phase|Death|0|||
156623603|NCT02394028|565363146|FG006|Maintenance Phase|Death|0|||
156623604|NCT02394028|565363147|FG007|Maintenance Phase|Death|0|||
156623605|NCT02394028|565363148|FG008|Maintenance Phase|Death|0|||
156623606|NCT02394028|565363149|FG009|Maintenance Phase|Death|0|||
156623607|NCT02394028|565363150|FG010|Maintenance Phase|Death|1|||
156623608|NCT02394028|565363140|FG000|Maintenance Phase|Adverse Event|0|||
156623609|NCT02394028|565363141|FG001|Maintenance Phase|Adverse Event|0|||
156623610|NCT02394028|565363142|FG002|Maintenance Phase|Adverse Event|0|||
156623611|NCT02394028|565363143|FG003|Maintenance Phase|Adverse Event|0|||
156623612|NCT02394028|565363144|FG004|Maintenance Phase|Adverse Event|0|||
156623613|NCT02394028|565363145|FG005|Maintenance Phase|Adverse Event|0|||
156623614|NCT02394028|565363146|FG006|Maintenance Phase|Adverse Event|0|||
156623615|NCT02394028|565363147|FG007|Maintenance Phase|Adverse Event|0|||
156623616|NCT02394028|565363148|FG008|Maintenance Phase|Adverse Event|1|||
156623617|NCT02394028|565363149|FG009|Maintenance Phase|Adverse Event|1|||
156623618|NCT02394028|565363150|FG010|Maintenance Phase|Adverse Event|3|||
156623619|NCT02394028|565363140|FG000|Maintenance Phase|Site closure|0|||
156623620|NCT02394028|565363141|FG001|Maintenance Phase|Site closure|0|||
156623621|NCT02394028|565363142|FG002|Maintenance Phase|Site closure|0|||
156623622|NCT02394028|565363143|FG003|Maintenance Phase|Site closure|0|||
156623623|NCT02394028|565363144|FG004|Maintenance Phase|Site closure|0|||
156623624|NCT02394028|565363145|FG005|Maintenance Phase|Site closure|0|||
156623625|NCT02394028|565363146|FG006|Maintenance Phase|Site closure|0|||
156623626|NCT02394028|565363147|FG007|Maintenance Phase|Site closure|0|||
156623627|NCT02394028|565363148|FG008|Maintenance Phase|Site closure|0|||
156623628|NCT02394028|565363149|FG009|Maintenance Phase|Site closure|1|||
156623629|NCT02394028|565363150|FG010|Maintenance Phase|Site closure|0|||
156623630|NCT02394028|565363140|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156623631|NCT02394028|565363141|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156623632|NCT02394028|565363142|FG002|Maintenance Phase|Withdrawal by Subject|0|||
156623633|NCT02394028|565363143|FG003|Maintenance Phase|Withdrawal by Subject|0|||
156623634|NCT02394028|565363144|FG004|Maintenance Phase|Withdrawal by Subject|0|||
156623635|NCT02394028|565363145|FG005|Maintenance Phase|Withdrawal by Subject|0|||
156623636|NCT02394028|565363146|FG006|Maintenance Phase|Withdrawal by Subject|0|||
156623637|NCT02394028|565363147|FG007|Maintenance Phase|Withdrawal by Subject|0|||
156623638|NCT02394028|565363148|FG008|Maintenance Phase|Withdrawal by Subject|3|||
156623639|NCT02394028|565363149|FG009|Maintenance Phase|Withdrawal by Subject|12|||
156623640|NCT02394028|565363150|FG010|Maintenance Phase|Withdrawal by Subject|12|||
156623641|NCT02993783|565363151|FG000|Overall Study|Reason not Specified|6|||
156623642|NCT02993783|565363152|FG001|Overall Study|Reason not Specified|9|||
156623643|NCT03480841|565363153|FG000|Overall Study|Lost to Follow-up|2|||
156623644|NCT00606021|565363154|FG000|Induction Phase|Death|73|||
156623645|NCT00606021|565363155|FG001|Induction Phase|Death|0|||
156623646|NCT00606021|565363156|FG002|Induction Phase|Death|0|||
156623647|NCT00606021|565363154|FG000|Induction Phase|Physician Decision|2|||
156623648|NCT00606021|565363155|FG001|Induction Phase|Physician Decision|0|||
156623649|NCT00606021|565363156|FG002|Induction Phase|Physician Decision|0|||
156623650|NCT00606021|565363154|FG000|Induction Phase|Withdrawal by Subject|2|||
156623651|NCT00606021|565363155|FG001|Induction Phase|Withdrawal by Subject|0|||
156623652|NCT00606021|565363156|FG002|Induction Phase|Withdrawal by Subject|0|||
156623653|NCT00606021|565363154|FG000|Induction Phase|Lost to Follow-up|10|||
156623654|NCT00606021|565363155|FG001|Induction Phase|Lost to Follow-up|0|||
156623655|NCT00606021|565363156|FG002|Induction Phase|Lost to Follow-up|0|||
156623656|NCT00606021|565363154|FG000|Maintenance Phase|Death|0|||
156623657|NCT00606021|565363155|FG001|Maintenance Phase|Death|17|||
156623658|NCT00606021|565363156|FG002|Maintenance Phase|Death|15|||
156623659|NCT00606021|565363154|FG000|Maintenance Phase|Physician Decision|0|||
156623660|NCT00606021|565363155|FG001|Maintenance Phase|Physician Decision|1|||
156623661|NCT00606021|565363156|FG002|Maintenance Phase|Physician Decision|0|||
156623662|NCT00606021|565363154|FG000|Maintenance Phase|Lost to Follow-up|0|||
156623663|NCT00606021|565363155|FG001|Maintenance Phase|Lost to Follow-up|5|||
156623664|NCT00606021|565363156|FG002|Maintenance Phase|Lost to Follow-up|2|||
156623665|NCT01362049|565363159|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
156623666|NCT01362049|565363160|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
156623667|NCT01362049|565363161|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
156623668|NCT01362049|565363162|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
156623669|NCT01362049|565363159|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
156623670|NCT01362049|565363160|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
156623671|NCT01362049|565363161|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
156623672|NCT01362049|565363162|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
156623673|NCT00806494|565363166|FG000|Overall Study|Adverse Event|29|||
156623674|NCT00806494|565363166|FG000|Overall Study|Lack of Efficacy|6|||
156623675|NCT00806494|565363166|FG000|Overall Study|Lost to Follow-up|10|||
156623676|NCT00806494|565363166|FG000|Overall Study|Other|30|||
156623677|NCT00806494|565363166|FG000|Overall Study|Withdrawal by Subject|5|||
156623678|NCT02417935|565363167|FG000|Treatment Period|Adverse Event|12|||
156623679|NCT02417935|565363168|FG001|Treatment Period|Adverse Event|10|||
156623680|NCT02417935|565363167|FG000|Treatment Period|Lost to Follow-up|1|||
156623681|NCT02417935|565363168|FG001|Treatment Period|Lost to Follow-up|0|||
156623682|NCT02417935|565363167|FG000|Treatment Period|Entry Criteria not met|0|||
156623683|NCT02417935|565363168|FG001|Treatment Period|Entry Criteria not met|1|||
156623684|NCT02417935|565363167|FG000|Treatment Period|Protocol Violation|2|||
156623685|NCT02417935|565363168|FG001|Treatment Period|Protocol Violation|1|||
156623686|NCT02417935|565363167|FG000|Treatment Period|Withdrawal by Subject|3|||
156623687|NCT02417935|565363168|FG001|Treatment Period|Withdrawal by Subject|3|||
156623688|NCT02417935|565363167|FG000|Treatment Period|Physician Decision|3|||
156623689|NCT02417935|565363168|FG001|Treatment Period|Physician Decision|1|||
156623690|NCT02504424|565363173|FG000|Overall Study|Withdrawal by Subject|2|||
156623691|NCT00426842|565363174|FG000|Overall Study|Lost to Follow-up|1|||
156623692|NCT00983827|565363175|FG000|Overall Study|Withdrawal by Subject|1|||
156623693|NCT01230827|565363176|FG000|Overall Study|Lost to Follow-up|0|||
156623694|NCT01230827|565363177|FG001|Overall Study|Lost to Follow-up|0|||
156623695|NCT01230827|565363178|FG002|Overall Study|Lost to Follow-up|1|||
156623696|NCT01230827|565363179|FG003|Overall Study|Lost to Follow-up|3|||
156623697|NCT01230827|565363176|FG000|Overall Study|Withdrawal by Subject|1|||
156623698|NCT01230827|565363177|FG001|Overall Study|Withdrawal by Subject|0|||
156623699|NCT01230827|565363178|FG002|Overall Study|Withdrawal by Subject|3|||
156623700|NCT01230827|565363179|FG003|Overall Study|Withdrawal by Subject|2|||
156623701|NCT01230827|565363176|FG000|Overall Study|Lack of Efficacy|14|||
156623702|NCT01230827|565363177|FG001|Overall Study|Lack of Efficacy|1|||
156623703|NCT01230827|565363178|FG002|Overall Study|Lack of Efficacy|2|||
156623704|NCT01230827|565363179|FG003|Overall Study|Lack of Efficacy|3|||
156623705|NCT01230827|565363176|FG000|Overall Study|Adverse Event|4|||
156623706|NCT01230827|565363177|FG001|Overall Study|Adverse Event|2|||
156623707|NCT01230827|565363178|FG002|Overall Study|Adverse Event|3|||
156623708|NCT01230827|565363179|FG003|Overall Study|Adverse Event|7|||
156623709|NCT01230827|565363176|FG000|Overall Study|Recovery|0|||
156623710|NCT01230827|565363177|FG001|Overall Study|Recovery|6|||
156623711|NCT01230827|565363178|FG002|Overall Study|Recovery|0|||
156623712|NCT01230827|565363179|FG003|Overall Study|Recovery|0|||
156623713|NCT01230827|565363176|FG000|Overall Study|Study terminated by Sponsor|0|||
156623714|NCT01230827|565363177|FG001|Overall Study|Study terminated by Sponsor|2|||
156623715|NCT01230827|565363178|FG002|Overall Study|Study terminated by Sponsor|56|||
156623716|NCT01230827|565363179|FG003|Overall Study|Study terminated by Sponsor|63|||
156623717|NCT00805142|565363181|FG000|Titration Period|Adverse Event|3|||
156623718|NCT00805142|565363182|FG001|Titration Period|Adverse Event|3|||
156623719|NCT00805142|565363181|FG000|Titration Period|Lack of Efficacy|1|||
156623720|NCT00805142|565363182|FG001|Titration Period|Lack of Efficacy|1|||
156623721|NCT00805142|565363181|FG000|Titration Period|Lost to Follow-up|0|||
156623722|NCT00805142|565363182|FG001|Titration Period|Lost to Follow-up|1|||
156623723|NCT00805142|565363181|FG000|Titration Period|Disease Progression|2|||
156623724|NCT00805142|565363182|FG001|Titration Period|Disease Progression|1|||
156623725|NCT00805142|565363181|FG000|Titration Period|Withdrawal of consent|0|||
156623726|NCT00805142|565363182|FG001|Titration Period|Withdrawal of consent|1|||
156623727|NCT00805142|565363181|FG000|Titration Period|Other|0|||
156623728|NCT00805142|565363182|FG001|Titration Period|Other|3|||
156623729|NCT00805142|565363181|FG000|Maintenance Period|Adverse Event|0|||
156623730|NCT00805142|565363182|FG001|Maintenance Period|Adverse Event|1|||
156623731|NCT00805142|565363181|FG000|Maintenance Period|Other|0|||
156623732|NCT00805142|565363182|FG001|Maintenance Period|Other|1|||
156623733|NCT00422942|565363183|FG000|Overall Study|Study terminated by Sponsor|3|||
156623734|NCT02828982|565363186|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156623735|NCT02828982|565363187|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156623736|NCT02312934|565363188|FG000|Overall Study|Lost to Follow-up|1|||
156623737|NCT02312934|565363189|FG001|Overall Study|Lost to Follow-up|0|||
156623738|NCT02312934|565363188|FG000|Overall Study|Physician Decision|1|||
156623739|NCT02312934|565363189|FG001|Overall Study|Physician Decision|0|||
156623740|NCT03395704|565363190|FG000|Overall Study|Adverse Event|2|||
156623741|NCT03395704|565363191|FG001|Overall Study|Adverse Event|1|||
156623742|NCT03395704|565363190|FG000|Overall Study|Withdrawal by Subject|2|||
156623743|NCT03395704|565363191|FG001|Overall Study|Withdrawal by Subject|1|||
156623744|NCT03395704|565363190|FG000|Overall Study|Physician Decision|0|||
156623745|NCT03395704|565363191|FG001|Overall Study|Physician Decision|1|||
156623746|NCT01156012|565363192|FG000|Overall Study|Adverse Event|3|||
156623747|NCT01156012|565363193|FG001|Overall Study|Adverse Event|1|||
156623748|NCT01156012|565363192|FG000|Overall Study|Lost to Follow-up|1|||
156623749|NCT01156012|565363193|FG001|Overall Study|Lost to Follow-up|0|||
156623750|NCT01156012|565363192|FG000|Overall Study|Withdrawal by Subject|1|||
156623751|NCT01156012|565363193|FG001|Overall Study|Withdrawal by Subject|0|||
156623752|NCT01156012|565363192|FG000|Overall Study|use of commercial drug instead of study|0|||
156623753|NCT01156012|565363193|FG001|Overall Study|use of commercial drug instead of study|1|||
156623754|NCT01156012|565363192|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
156623755|NCT01156012|565363193|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
156623756|NCT00424463|565363194|FG000|Overall Study|Adverse Event|2|||
156623757|NCT00424463|565363195|FG001|Overall Study|Adverse Event|3|||
156623758|NCT00424463|565363196|FG002|Overall Study|Adverse Event|2|||
156623759|NCT00424463|565363194|FG000|Overall Study|Physician Decision|0|||
156623760|NCT00424463|565363195|FG001|Overall Study|Physician Decision|2|||
156623761|NCT00424463|565363196|FG002|Overall Study|Physician Decision|2|||
156623762|NCT00424463|565363194|FG000|Overall Study|Withdrawal by Subject|4|||
156623763|NCT00424463|565363195|FG001|Overall Study|Withdrawal by Subject|2|||
156623764|NCT00424463|565363196|FG002|Overall Study|Withdrawal by Subject|5|||
156623765|NCT00424463|565363194|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
156623766|NCT00424463|565363195|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
156623767|NCT00424463|565363196|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
156623768|NCT00424463|565363194|FG000|Overall Study|Patient's convenience|0|||
156623769|NCT00424463|565363195|FG001|Overall Study|Patient's convenience|0|||
156623770|NCT00424463|565363196|FG002|Overall Study|Patient's convenience|1|||
156623771|NCT02927990|565365154|FG000|Overall Study|Protocol Violation|4|||
156623772|NCT02927990|565365154|FG000|Overall Study|Physician Decision|9|||
156623773|NCT02927990|565365154|FG000|Overall Study|Room switched and therefore no study device available|15|||
156623774|NCT02927990|565365154|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
156623775|NCT00960323|565365155|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
156623776|NCT00772031|565365159|FG000|Overall Study|Early termination of trial|12|||
156623777|NCT00772031|565365160|FG001|Overall Study|Early termination of trial|10|||
156623778|NCT00772031|565365159|FG000|Overall Study|Lost to Follow-up|20|||
156623779|NCT00772031|565365160|FG001|Overall Study|Lost to Follow-up|33|||
156623780|NCT01856920|565365161|FG000|Overall Study|Disease Progression On Study|3|||
156623781|NCT01856920|565365162|FG001|Overall Study|Disease Progression On Study|4|||
156623782|NCT01856920|565365161|FG000|Overall Study|Disease Progression before Treatment|1|||
156623783|NCT01856920|565365162|FG001|Overall Study|Disease Progression before Treatment|0|||
156623784|NCT01856920|565365161|FG000|Overall Study|Ineligible|0|||
156623785|NCT01856920|565365162|FG001|Overall Study|Ineligible|1|||
156623786|NCT01856920|565365161|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
156623787|NCT01856920|565365162|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
156623788|NCT01856920|565365161|FG000|Overall Study|Refused further Treatment|5|||
156623789|NCT01856920|565365162|FG001|Overall Study|Refused further Treatment|1|||
156623790|NCT01856920|565365161|FG000|Overall Study|Other Reasons|0|||
156623791|NCT01856920|565365162|FG001|Overall Study|Other Reasons|1|||
156623792|NCT01856920|565365161|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
156623793|NCT01856920|565365162|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
156623794|NCT02906644|565365163|FG000|First 2 Weeks|Withdrawal by Subject|0|||
156623795|NCT02906644|565365164|FG001|First 2 Weeks|Withdrawal by Subject|2|||
156623796|NCT02906644|565365163|FG000|First 2 Weeks|Physician Decision|1|||
156623797|NCT02906644|565365164|FG001|First 2 Weeks|Physician Decision|1|||
156623798|NCT02906644|565365163|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
156623799|NCT02906644|565365164|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
156623800|NCT02906644|565365163|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
156623801|NCT02906644|565365164|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
156623802|NCT02030067|565365166|FG000|Overall Study|Disease Progression|1|||
156623803|NCT02030067|565365167|FG001|Overall Study|Disease Progression|1|||
156623804|NCT02030067|565365168|FG002|Overall Study|Disease Progression|2|||
156623805|NCT02030067|565365169|FG003|Overall Study|Disease Progression|2|||
156623806|NCT02030067|565365170|FG004|Overall Study|Disease Progression|3|||
156623807|NCT02030067|565365171|FG005|Overall Study|Disease Progression|2|||
156623808|NCT02030067|565365172|FG006|Overall Study|Disease Progression|3|||
156623809|NCT02030067|565365173|FG007|Overall Study|Disease Progression|3|||
156623810|NCT02030067|565365174|FG008|Overall Study|Disease Progression|4|||
156623811|NCT02030067|565365175|FG009|Overall Study|Disease Progression|3|||
156623812|NCT02030067|565365176|FG010|Overall Study|Disease Progression|7|||
156623813|NCT02030067|565365177|FG011|Overall Study|Disease Progression|2|||
156623814|NCT02030067|565365178|FG012|Overall Study|Disease Progression|59|||
156623815|NCT02030067|565365166|FG000|Overall Study|Withdrawal by Subject|0|||
156623816|NCT02030067|565365167|FG001|Overall Study|Withdrawal by Subject|0|||
156623817|NCT02030067|565365168|FG002|Overall Study|Withdrawal by Subject|0|||
156623818|NCT02030067|565365169|FG003|Overall Study|Withdrawal by Subject|1|||
156623819|NCT02030067|565365170|FG004|Overall Study|Withdrawal by Subject|0|||
156623820|NCT02030067|565365171|FG005|Overall Study|Withdrawal by Subject|0|||
156623821|NCT02030067|565365172|FG006|Overall Study|Withdrawal by Subject|0|||
156623822|NCT02030067|565365173|FG007|Overall Study|Withdrawal by Subject|1|||
156623823|NCT02030067|565365174|FG008|Overall Study|Withdrawal by Subject|0|||
156623824|NCT02030067|565365175|FG009|Overall Study|Withdrawal by Subject|0|||
156623825|NCT02030067|565365176|FG010|Overall Study|Withdrawal by Subject|3|||
156623826|NCT02030067|565365177|FG011|Overall Study|Withdrawal by Subject|0|||
156623827|NCT02030067|565365178|FG012|Overall Study|Withdrawal by Subject|6|||
156623828|NCT02030067|565365166|FG000|Overall Study|Physician Decision|0|||
156623829|NCT02030067|565365167|FG001|Overall Study|Physician Decision|0|||
156623830|NCT02030067|565365168|FG002|Overall Study|Physician Decision|0|||
156623831|NCT02030067|565365169|FG003|Overall Study|Physician Decision|0|||
156623832|NCT02030067|565365170|FG004|Overall Study|Physician Decision|0|||
156623833|NCT02030067|565365171|FG005|Overall Study|Physician Decision|0|||
156623834|NCT02030067|565365172|FG006|Overall Study|Physician Decision|0|||
156623835|NCT02030067|565365173|FG007|Overall Study|Physician Decision|0|||
156623836|NCT02030067|565365174|FG008|Overall Study|Physician Decision|0|||
156623837|NCT02030067|565365175|FG009|Overall Study|Physician Decision|0|||
156623838|NCT02030067|565365176|FG010|Overall Study|Physician Decision|1|||
156623839|NCT02030067|565365177|FG011|Overall Study|Physician Decision|0|||
156623840|NCT02030067|565365178|FG012|Overall Study|Physician Decision|3|||
156623841|NCT02030067|565365166|FG000|Overall Study|other reasons|0|||
156623842|NCT02030067|565365167|FG001|Overall Study|other reasons|0|||
156623843|NCT02030067|565365168|FG002|Overall Study|other reasons|0|||
156623844|NCT02030067|565365169|FG003|Overall Study|other reasons|0|||
156623845|NCT02030067|565365170|FG004|Overall Study|other reasons|0|||
156623846|NCT02030067|565365171|FG005|Overall Study|other reasons|1|||
156623847|NCT02030067|565365172|FG006|Overall Study|other reasons|0|||
156623848|NCT02030067|565365173|FG007|Overall Study|other reasons|0|||
156623849|NCT02030067|565365174|FG008|Overall Study|other reasons|2|||
156623850|NCT02030067|565365175|FG009|Overall Study|other reasons|0|||
156623851|NCT02030067|565365176|FG010|Overall Study|other reasons|0|||
156623852|NCT02030067|565365177|FG011|Overall Study|other reasons|0|||
156623853|NCT02030067|565365178|FG012|Overall Study|other reasons|4|||
156623854|NCT02030067|565365166|FG000|Overall Study|Adverse Event|0|||
156623855|NCT02030067|565365167|FG001|Overall Study|Adverse Event|0|||
156623856|NCT02030067|565365168|FG002|Overall Study|Adverse Event|0|||
156623857|NCT02030067|565365169|FG003|Overall Study|Adverse Event|0|||
156623858|NCT02030067|565365170|FG004|Overall Study|Adverse Event|0|||
156623859|NCT02030067|565365171|FG005|Overall Study|Adverse Event|0|||
156623860|NCT02030067|565365172|FG006|Overall Study|Adverse Event|0|||
156623861|NCT02030067|565365173|FG007|Overall Study|Adverse Event|0|||
156623862|NCT02030067|565365174|FG008|Overall Study|Adverse Event|0|||
156623863|NCT02030067|565365175|FG009|Overall Study|Adverse Event|0|||
156623864|NCT02030067|565365176|FG010|Overall Study|Adverse Event|0|||
156623865|NCT02030067|565365177|FG011|Overall Study|Adverse Event|1|||
156623866|NCT02030067|565365178|FG012|Overall Study|Adverse Event|8|||
156623867|NCT00565721|565365186|FG000|Overall Study|Screen Failure|2|||
156623868|NCT00565721|565365186|FG000|Overall Study|Lost to Follow-up|6|||
156623869|NCT00565721|565365186|FG000|Overall Study|Technical Problems|1|||
156623870|NCT00565721|565365186|FG000|Overall Study|Physician Decision|2|||
156623871|NCT00565721|565365186|FG000|Overall Study|Other reasons|6|||
156623872|NCT04062240|565365187|FG000|Overall Study|equipment malfunction|1|||
156623873|NCT00352027|565365193|FG000|Overall Study|Progressive disease|3|||
156623874|NCT04118127|565365195|FG000|Overall Study|Trial terminated by sponsor|0|||
156623875|NCT04118127|565365196|FG001|Overall Study|Trial terminated by sponsor|12|||
156623876|NCT04118127|565365195|FG000|Overall Study|Adverse Event|1|||
156623877|NCT04118127|565365196|FG001|Overall Study|Adverse Event|2|||
156623878|NCT04118127|565365195|FG000|Overall Study|Physician Decision|0|||
156623879|NCT04118127|565365196|FG001|Overall Study|Physician Decision|1|||
156623880|NCT04118127|565365195|FG000|Overall Study|Withdrawal by Subject|2|||
156623881|NCT04118127|565365196|FG001|Overall Study|Withdrawal by Subject|1|||
156623882|NCT01874288|565365199|FG000|Overall Study|Withdrawal by Subject|1|||
156623883|NCT01874288|565365200|FG001|Overall Study|Withdrawal by Subject|0|||
156623884|NCT01874288|565365201|FG002|Overall Study|Withdrawal by Subject|2|||
156623885|NCT01874288|565365202|FG003|Overall Study|Withdrawal by Subject|1|||
156623886|NCT01874288|565365203|FG004|Overall Study|Withdrawal by Subject|1|||
156623887|NCT01874288|565365199|FG000|Overall Study|Physician Decision|0|||
156623888|NCT01874288|565365200|FG001|Overall Study|Physician Decision|0|||
156623889|NCT01874288|565365201|FG002|Overall Study|Physician Decision|0|||
156623890|NCT01874288|565365202|FG003|Overall Study|Physician Decision|1|||
156623891|NCT01874288|565365203|FG004|Overall Study|Physician Decision|0|||
156623892|NCT01874288|565365199|FG000|Overall Study|Progressive disease|2|||
156623893|NCT01874288|565365200|FG001|Overall Study|Progressive disease|0|||
156623894|NCT01874288|565365201|FG002|Overall Study|Progressive disease|3|||
156623895|NCT01874288|565365202|FG003|Overall Study|Progressive disease|5|||
156623896|NCT01874288|565365203|FG004|Overall Study|Progressive disease|1|||
156623897|NCT04212221|565365204|FG000|Overall Study|Remained on Treatment|0|||
156623898|NCT04212221|565365205|FG001|Overall Study|Remained on Treatment|0|||
156623899|NCT04212221|565365206|FG002|Overall Study|Remained on Treatment|0|||
156623900|NCT04212221|565365207|FG003|Overall Study|Remained on Treatment|1|||
156623901|NCT04212221|565365208|FG004|Overall Study|Remained on Treatment|0|||
156623902|NCT04212221|565365209|FG005|Overall Study|Remained on Treatment|0|||
156623903|NCT04212221|565365210|FG006|Overall Study|Remained on Treatment|3|||
156623904|NCT04212221|565365211|FG007|Overall Study|Remained on Treatment|9|||
156623905|NCT04212221|565365204|FG000|Overall Study|Adverse Event|0|||
156623906|NCT04212221|565365205|FG001|Overall Study|Adverse Event|0|||
156623907|NCT04212221|565365206|FG002|Overall Study|Adverse Event|0|||
156623908|NCT04212221|565365207|FG003|Overall Study|Adverse Event|0|||
156623909|NCT04212221|565365208|FG004|Overall Study|Adverse Event|0|||
156623910|NCT04212221|565365209|FG005|Overall Study|Adverse Event|0|||
156623911|NCT04212221|565365210|FG006|Overall Study|Adverse Event|2|||
156623912|NCT04212221|565365211|FG007|Overall Study|Adverse Event|3|||
156623913|NCT04212221|565365204|FG000|Overall Study|Death|0|||
156623914|NCT04212221|565365205|FG001|Overall Study|Death|0|||
156623915|NCT04212221|565365206|FG002|Overall Study|Death|0|||
156623916|NCT04212221|565365207|FG003|Overall Study|Death|0|||
156623917|NCT04212221|565365208|FG004|Overall Study|Death|0|||
156623918|NCT04212221|565365209|FG005|Overall Study|Death|0|||
156623919|NCT04212221|565365210|FG006|Overall Study|Death|0|||
156623920|NCT04212221|565365211|FG007|Overall Study|Death|2|||
156623921|NCT04212221|565365204|FG000|Overall Study|Disease progression according to irRECIST|1|||
156623922|NCT04212221|565365205|FG001|Overall Study|Disease progression according to irRECIST|2|||
156623923|NCT04212221|565365206|FG002|Overall Study|Disease progression according to irRECIST|3|||
156623924|NCT04212221|565365207|FG003|Overall Study|Disease progression according to irRECIST|3|||
156623925|NCT04212221|565365208|FG004|Overall Study|Disease progression according to irRECIST|2|||
156623926|NCT04212221|565365209|FG005|Overall Study|Disease progression according to irRECIST|2|||
156623927|NCT04212221|565365210|FG006|Overall Study|Disease progression according to irRECIST|21|||
156623928|NCT04212221|565365211|FG007|Overall Study|Disease progression according to irRECIST|17|||
156623929|NCT04212221|565365204|FG000|Overall Study|Global Deterioration of Health Status|0|||
156623930|NCT04212221|565365205|FG001|Overall Study|Global Deterioration of Health Status|0|||
156623931|NCT04212221|565365206|FG002|Overall Study|Global Deterioration of Health Status|0|||
156623932|NCT04212221|565365207|FG003|Overall Study|Global Deterioration of Health Status|0|||
156623933|NCT04212221|565365208|FG004|Overall Study|Global Deterioration of Health Status|0|||
156623934|NCT04212221|565365209|FG005|Overall Study|Global Deterioration of Health Status|0|||
156623935|NCT04212221|565365210|FG006|Overall Study|Global Deterioration of Health Status|0|||
156623936|NCT04212221|565365211|FG007|Overall Study|Global Deterioration of Health Status|2|||
156623937|NCT04212221|565365204|FG000|Overall Study|Investigator's Decision|0|||
156623938|NCT04212221|565365205|FG001|Overall Study|Investigator's Decision|0|||
156623939|NCT04212221|565365206|FG002|Overall Study|Investigator's Decision|0|||
156623940|NCT04212221|565365207|FG003|Overall Study|Investigator's Decision|1|||
156623941|NCT04212221|565365208|FG004|Overall Study|Investigator's Decision|0|||
156623942|NCT04212221|565365209|FG005|Overall Study|Investigator's Decision|0|||
156623943|NCT04212221|565365210|FG006|Overall Study|Investigator's Decision|3|||
156623944|NCT04212221|565365211|FG007|Overall Study|Investigator's Decision|0|||
156623945|NCT04212221|565365204|FG000|Overall Study|Participant refused to continue treatment|0|||
156623946|NCT04212221|565365205|FG001|Overall Study|Participant refused to continue treatment|1|||
156623947|NCT04212221|565365206|FG002|Overall Study|Participant refused to continue treatment|0|||
156623948|NCT04212221|565365207|FG003|Overall Study|Participant refused to continue treatment|1|||
156623949|NCT04212221|565365208|FG004|Overall Study|Participant refused to continue treatment|1|||
156623950|NCT04212221|565365209|FG005|Overall Study|Participant refused to continue treatment|2|||
156623951|NCT04212221|565365210|FG006|Overall Study|Participant refused to continue treatment|4|||
156623952|NCT04212221|565365211|FG007|Overall Study|Participant refused to continue treatment|2|||
156623953|NCT04212221|565365204|FG000|Overall Study|Protocol Violation|0|||
156623954|NCT04212221|565365205|FG001|Overall Study|Protocol Violation|0|||
156623955|NCT04212221|565365206|FG002|Overall Study|Protocol Violation|0|||
156623956|NCT04212221|565365207|FG003|Overall Study|Protocol Violation|0|||
156623957|NCT04212221|565365208|FG004|Overall Study|Protocol Violation|0|||
156623958|NCT04212221|565365209|FG005|Overall Study|Protocol Violation|0|||
156623959|NCT04212221|565365210|FG006|Overall Study|Protocol Violation|0|||
156623960|NCT04212221|565365211|FG007|Overall Study|Protocol Violation|1|||
156623961|NCT03099304|565365215|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
156623962|NCT03099304|565365216|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
156623963|NCT03099304|565365217|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
156623964|NCT03099304|565365218|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
156623965|NCT03099304|565365219|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
156623966|NCT03099304|565365220|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
156623967|NCT03099304|565365215|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
156623968|NCT03099304|565365216|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
156623969|NCT03099304|565365217|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
156623970|NCT03099304|565365218|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
156623971|NCT03099304|565365219|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
156623972|NCT03099304|565365220|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
156623973|NCT03099304|565365215|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
156623974|NCT03099304|565365216|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
156623975|NCT03099304|565365217|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
156623976|NCT03099304|565365218|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
156623977|NCT03099304|565365219|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
156623978|NCT03099304|565365220|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
156623979|NCT03099304|565365215|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
156623980|NCT03099304|565365216|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
156623981|NCT03099304|565365217|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
156623982|NCT03099304|565365218|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
156623983|NCT03099304|565365219|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
156623984|NCT03099304|565365220|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
156623985|NCT03099304|565365215|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
156623986|NCT03099304|565365216|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
156623987|NCT03099304|565365217|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
156623988|NCT03099304|565365218|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
156623989|NCT03099304|565365219|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
156623990|NCT03099304|565365220|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
156623991|NCT03099304|565365215|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
156623992|NCT03099304|565365216|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
156623993|NCT03099304|565365217|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
156623994|NCT03099304|565365218|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
156623995|NCT03099304|565365219|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
156623996|NCT03099304|565365220|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
156623997|NCT03099304|565365215|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
156623998|NCT03099304|565365216|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
156623999|NCT03099304|565365217|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
156624000|NCT03099304|565365218|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
156624001|NCT03099304|565365219|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
156624002|NCT03099304|565365220|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
156624003|NCT03099304|565365215|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
156624004|NCT03099304|565365216|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
156624005|NCT03099304|565365217|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
156624006|NCT03099304|565365218|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
156624007|NCT03099304|565365219|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
156624008|NCT03099304|565365220|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
156624009|NCT03099304|565365215|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
156624010|NCT03099304|565365216|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
156624011|NCT03099304|565365217|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
156624012|NCT03099304|565365218|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
156624013|NCT03099304|565365219|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
156624014|NCT03099304|565365220|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
156624015|NCT03099304|565365215|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
156624016|NCT03099304|565365216|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
156624017|NCT03099304|565365217|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
156624018|NCT03099304|565365218|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
156624019|NCT03099304|565365219|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
156624020|NCT03099304|565365220|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
156624021|NCT03099304|565365215|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
156624022|NCT03099304|565365216|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
156624023|NCT03099304|565365217|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
156624024|NCT03099304|565365218|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
156624025|NCT03099304|565365219|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
156624026|NCT03099304|565365220|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
156624027|NCT03099304|565365215|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
156624028|NCT03099304|565365216|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
156624029|NCT03099304|565365217|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
156624030|NCT03099304|565365218|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
156624031|NCT03099304|565365219|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
156624032|NCT03099304|565365220|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
156624033|NCT03099304|565365215|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
156624034|NCT03099304|565365216|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
156624035|NCT03099304|565365217|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
156624036|NCT03099304|565365218|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
156624037|NCT03099304|565365219|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
156624038|NCT03099304|565365220|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
156624039|NCT03099304|565365215|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
156624040|NCT03099304|565365216|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
156624041|NCT03099304|565365217|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
156624042|NCT03099304|565365218|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
156624043|NCT03099304|565365219|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
156624044|NCT03099304|565365220|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
156624045|NCT03099304|565365215|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
156624046|NCT03099304|565365216|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
156624047|NCT03099304|565365217|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
156624048|NCT03099304|565365218|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
156624049|NCT03099304|565365219|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
156624050|NCT03099304|565365220|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
156624051|NCT03099304|565365215|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
156624052|NCT03099304|565365216|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
156624053|NCT03099304|565365217|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
156624054|NCT03099304|565365218|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
156624055|NCT03099304|565365219|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
156624056|NCT03099304|565365220|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
156624057|NCT03099304|565365215|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
156624058|NCT03099304|565365216|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
156624059|NCT03099304|565365217|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
156624060|NCT03099304|565365218|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
156624061|NCT03099304|565365219|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
156624062|NCT03099304|565365220|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
156624063|NCT00636506|565365221|FG000|Overall Study|Lost to Follow-up|8|||
156624064|NCT00636506|565365221|FG000|Overall Study|Explanted|1|||
156624065|NCT00636506|565365221|FG000|Overall Study|Withdrawal by Subject|6|||
156624066|NCT00636506|565365221|FG000|Overall Study|Procedure aborted|1|||
156624067|NCT01624974|565365222|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
156624068|NCT01624974|565365223|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
156624069|NCT01624974|565365222|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
156624070|NCT01624974|565365223|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
156624071|NCT01624974|565365222|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
156624072|NCT01624974|565365223|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
156624073|NCT01624974|565365222|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
156624074|NCT01624974|565365223|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
156624075|NCT01624974|565365222|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
156624076|NCT01624974|565365223|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
156624077|NCT01624974|565365222|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
156624078|NCT01624974|565365223|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
156624079|NCT01624974|565365222|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
156624080|NCT01624974|565365223|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
156624081|NCT01624974|565365222|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
156624082|NCT01624974|565365223|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
156624083|NCT01624974|565365222|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
156624084|NCT01624974|565365223|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
156624085|NCT01624974|565365222|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
156624086|NCT01624974|565365223|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
156624087|NCT01624974|565365222|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
156624088|NCT01624974|565365223|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
156624089|NCT01624974|565365222|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
156624090|NCT01624974|565365223|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
156624091|NCT01681836|565365226|FG000|Second Intervention|Withdrawal by Subject|0|||
156624092|NCT01681836|565365227|FG001|Second Intervention|Withdrawal by Subject|1|||
156624093|NCT02142712|565365228|FG000|Overall Study|Lost to Follow-up|1|||
156624094|NCT02142712|565365229|FG001|Overall Study|Lost to Follow-up|1|||
156624095|NCT02142712|565365230|FG002|Overall Study|Lost to Follow-up|1|||
156624096|NCT02142712|565365231|FG003|Overall Study|Lost to Follow-up|0|||
156624097|NCT01058356|565365249|FG000|Overall Study|Adverse Event|5|||
156624098|NCT01058356|565365249|FG000|Overall Study|Administration of contraindicated drugs|12|||
156624099|NCT01058356|565365249|FG000|Overall Study|Withdrawal by Subject|21|||
156624100|NCT01058356|565365249|FG000|Overall Study|Lost to Follow-up|4|||
156624101|NCT02850276|565365250|FG000|Overall Study|screen failure|43|||
156624102|NCT02850276|565365250|FG000|Overall Study|Withdrawal by Subject|14|||
156624103|NCT02850276|565365250|FG000|Overall Study|Physician Decision|2|||
156624104|NCT02850276|565365250|FG000|Overall Study|Lost to Follow-up|2|||
156624105|NCT04815291|565365251|FG000|Overall Study|Lost to Follow-up|1|||
156624106|NCT04815291|565365251|FG000|Overall Study|Physician Decision|4|||
156624107|NCT04815291|565365251|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
156624108|NCT00989664|565365255|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
156624109|NCT00989664|565365255|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
156624110|NCT00989664|565365255|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
156624111|NCT00989664|565365255|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
156624112|NCT00989664|565365255|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
156624113|NCT00989664|565365255|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
156624114|NCT00989664|565365255|FG000|Long-Term Follow-Up|Death|3|||
156624115|NCT00095836|565365256|FG000|Overall Study|Lost to Follow-up|1|||
156624116|NCT00095836|565365256|FG000|Overall Study|Adverse Event|1|||
156624117|NCT00095836|565365256|FG000|Overall Study|Death|2|||
156624118|NCT00962780|565365257|FG000|Overall Study|Death|0|||
156624119|NCT00962780|565365258|FG001|Overall Study|Death|1|||
156624120|NCT00962780|565365257|FG000|Overall Study|Protocol Violation|9|||
156624121|NCT00962780|565365258|FG001|Overall Study|Protocol Violation|4|||
156624122|NCT00962780|565365257|FG000|Overall Study|Withdrawal by Subject|1|||
156624123|NCT00962780|565365258|FG001|Overall Study|Withdrawal by Subject|8|||
156624124|NCT00962780|565365257|FG000|Overall Study|Other|0|||
156624125|NCT00962780|565365258|FG001|Overall Study|Other|1|||
156624126|NCT02646332|565365266|FG000|Overall Study|Lost to Follow-up|0|||
156624127|NCT02646332|565365267|FG001|Overall Study|Lost to Follow-up|3|||
156624128|NCT02363322|565365268|FG000|Overall Study|Lost to Follow-up|1|||
156624129|NCT02363322|565365269|FG001|Overall Study|Lost to Follow-up|0|||
156624130|NCT01882439|565365270|FG000|Overall Study|Adverse event related to study drug|3|||
156624131|NCT01882439|565365271|FG001|Overall Study|Adverse event related to study drug|8|||
156624132|NCT01882439|565365272|FG002|Overall Study|Adverse event related to study drug|1|||
156624133|NCT01882439|565365273|FG003|Overall Study|Adverse event related to study drug|2|||
156624134|NCT01882439|565365270|FG000|Overall Study|Pregnancy|0|||
156624135|NCT01882439|565365271|FG001|Overall Study|Pregnancy|1|||
156624136|NCT01882439|565365272|FG002|Overall Study|Pregnancy|0|||
156624137|NCT01882439|565365273|FG003|Overall Study|Pregnancy|0|||
156624138|NCT01882439|565365270|FG000|Overall Study|Protocol Violation|2|||
156624139|NCT01882439|565365271|FG001|Overall Study|Protocol Violation|2|||
156624140|NCT01882439|565365272|FG002|Overall Study|Protocol Violation|0|||
156624141|NCT01882439|565365273|FG003|Overall Study|Protocol Violation|1|||
156624142|NCT01882439|565365270|FG000|Overall Study|No longer willing to participate|1|||
156624143|NCT01882439|565365271|FG001|Overall Study|No longer willing to participate|4|||
156624144|NCT01882439|565365272|FG002|Overall Study|No longer willing to participate|2|||
156624145|NCT01882439|565365273|FG003|Overall Study|No longer willing to participate|3|||
156624146|NCT01882439|565365270|FG000|Overall Study|Medication error with no associated AE|0|||
156624147|NCT01882439|565365271|FG001|Overall Study|Medication error with no associated AE|0|||
156624148|NCT01882439|565365272|FG002|Overall Study|Medication error with no associated AE|2|||
156624149|NCT01882439|565365273|FG003|Overall Study|Medication error with no associated AE|0|||
156624150|NCT01882439|565365270|FG000|Overall Study|Insufficient clinical response|1|||
156624151|NCT01882439|565365271|FG001|Overall Study|Insufficient clinical response|4|||
156624152|NCT01882439|565365272|FG002|Overall Study|Insufficient clinical response|4|||
156624153|NCT01882439|565365273|FG003|Overall Study|Insufficient clinical response|2|||
156624154|NCT01882439|565365270|FG000|Overall Study|Adverse event unrelated to study drug|2|||
156624155|NCT01882439|565365271|FG001|Overall Study|Adverse event unrelated to study drug|2|||
156624156|NCT01882439|565365272|FG002|Overall Study|Adverse event unrelated to study drug|1|||
156624157|NCT01882439|565365273|FG003|Overall Study|Adverse event unrelated to study drug|1|||
156624158|NCT01775995|565365276|FG000|Overall Study|Lost to Follow-up|1|||
156624159|NCT01775995|565365277|FG001|Overall Study|Lost to Follow-up|1|||
156624160|NCT01997333|565365278|FG000|Randomization and Treatment|Disease Progression|70|||
156624161|NCT01997333|565365279|FG001|Randomization and Treatment|Disease Progression|159|||
156624162|NCT01997333|565365278|FG000|Randomization and Treatment|Adverse Event|10|||
156624163|NCT01997333|565365279|FG001|Randomization and Treatment|Adverse Event|32|||
156624164|NCT01997333|565365278|FG000|Randomization and Treatment|Physician Decision|0|||
156624165|NCT01997333|565365279|FG001|Randomization and Treatment|Physician Decision|4|||
156624166|NCT01997333|565365278|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
156624167|NCT01997333|565365279|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
156624168|NCT01997333|565365278|FG000|Randomization and Treatment|Did not receive treatment|17|||
156624169|NCT01997333|565365279|FG001|Randomization and Treatment|Did not receive treatment|5|||
156624170|NCT01997333|565365278|FG000|Survival Follow up|Withdrawal by Subject|15|||
156624171|NCT01997333|565365279|FG001|Survival Follow up|Withdrawal by Subject|6|||
156624172|NCT01997333|565365278|FG000|Survival Follow up|Lost to Follow-up|0|||
156624173|NCT01997333|565365279|FG001|Survival Follow up|Lost to Follow-up|6|||
156624174|NCT01997333|565365278|FG000|Survival Follow up|Various|1|||
156624175|NCT01997333|565365279|FG001|Survival Follow up|Various|2|||
156624176|NCT00982111|565365281|FG000|Overall Study|Adverse Event|1|||
156624177|NCT00982111|565365282|FG001|Overall Study|Adverse Event|1|||
156624178|NCT00982111|565365281|FG000|Overall Study|Progressive Disease|46|||
156624179|NCT00982111|565365282|FG001|Overall Study|Progressive Disease|39|||
156624180|NCT00982111|565365281|FG000|Overall Study|Lost to Follow-up|9|||
156624181|NCT00982111|565365282|FG001|Overall Study|Lost to Follow-up|6|||
156624182|NCT00982111|565365281|FG000|Overall Study|New Anti-Cancer Therapy|5|||
156624183|NCT00982111|565365282|FG001|Overall Study|New Anti-Cancer Therapy|5|||
156624184|NCT00982111|565365281|FG000|Overall Study|Medical Decision|1|||
156624185|NCT00982111|565365282|FG001|Overall Study|Medical Decision|0|||
156624186|NCT00982111|565365281|FG000|Overall Study|Withdrawal by Subject|17|||
156624187|NCT00982111|565365282|FG001|Overall Study|Withdrawal by Subject|19|||
156624188|NCT00982111|565365281|FG000|Overall Study|Global Study End|0|||
156624189|NCT00982111|565365282|FG001|Overall Study|Global Study End|1|||
156624190|NCT00982111|565365281|FG000|Overall Study|Sponsor's Decision|0|||
156624191|NCT00982111|565365282|FG001|Overall Study|Sponsor's Decision|1|||
156624192|NCT01657903|565365284|FG000|Overall Study|Lost to Follow-up|1|||
156624193|NCT01657903|565365284|FG000|Overall Study|Withdrawal by Subject|1|||
156624194|NCT00620815|565365285|FG000|Overall Study|Adverse Event|1|||
156624195|NCT00620815|565365286|FG001|Overall Study|Adverse Event|1|||
156624196|NCT00620815|565365287|FG002|Overall Study|Adverse Event|2|||
156624197|NCT00620815|565365285|FG000|Overall Study|Withdrawal by Subject|1|||
156624198|NCT00620815|565365286|FG001|Overall Study|Withdrawal by Subject|2|||
156624199|NCT00620815|565365287|FG002|Overall Study|Withdrawal by Subject|0|||
156624200|NCT00620815|565365285|FG000|Overall Study|Lost to Follow-up|1|||
156624201|NCT00620815|565365286|FG001|Overall Study|Lost to Follow-up|6|||
156624202|NCT00620815|565365287|FG002|Overall Study|Lost to Follow-up|3|||
156624203|NCT00620815|565365285|FG000|Overall Study|Inappropriate enrolment|0|||
156624204|NCT00620815|565365286|FG001|Overall Study|Inappropriate enrolment|0|||
156624205|NCT00620815|565365287|FG002|Overall Study|Inappropriate enrolment|1|||
156624206|NCT00620815|565365285|FG000|Overall Study|Protocol Violation|1|||
156624207|NCT00620815|565365286|FG001|Overall Study|Protocol Violation|2|||
156624208|NCT00620815|565365287|FG002|Overall Study|Protocol Violation|1|||
156624209|NCT03458234|565365291|FG000|Overall Study|Withdrawal by Subject|1|||
156624210|NCT01266967|565367575|FG000|Overall Study|Death|69|||
156624211|NCT01266967|565367576|FG001|Overall Study|Death|61|||
156624212|NCT01266967|565367575|FG000|Overall Study|Study Closed/Terminated|15|||
156624213|NCT01266967|565367576|FG001|Overall Study|Study Closed/Terminated|17|||
156624214|NCT01266967|565367575|FG000|Overall Study|Lost to Follow-up|2|||
156624215|NCT01266967|565367576|FG001|Overall Study|Lost to Follow-up|1|||
156624216|NCT01266967|565367575|FG000|Overall Study|Physician Decision|0|||
156624217|NCT01266967|565367576|FG001|Overall Study|Physician Decision|1|||
156624218|NCT01266967|565367575|FG000|Overall Study|Withdrawal by Subject|3|||
156624219|NCT01266967|565367576|FG001|Overall Study|Withdrawal by Subject|3|||
156624220|NCT01519700|565367577|FG000|Overall Study|Death|1|||
156624221|NCT01519700|565367578|FG001|Overall Study|Death|0|||
156624222|NCT01519700|565367579|FG002|Overall Study|Death|0|||
156624223|NCT01519700|565367580|FG003|Overall Study|Death|0|||
156624224|NCT01519700|565367577|FG000|Overall Study|Lost to Follow-up|0|||
156624225|NCT01519700|565367578|FG001|Overall Study|Lost to Follow-up|0|||
156624226|NCT01519700|565367579|FG002|Overall Study|Lost to Follow-up|1|||
156624227|NCT01519700|565367580|FG003|Overall Study|Lost to Follow-up|1|||
156624228|NCT01519700|565367577|FG000|Overall Study|Physician Decision|1|||
156624229|NCT01519700|565367578|FG001|Overall Study|Physician Decision|1|||
156624230|NCT01519700|565367579|FG002|Overall Study|Physician Decision|3|||
156624231|NCT01519700|565367580|FG003|Overall Study|Physician Decision|0|||
156624232|NCT01519700|565367577|FG000|Overall Study|Withdrawal by Subject|5|||
156624233|NCT01519700|565367578|FG001|Overall Study|Withdrawal by Subject|3|||
156624234|NCT01519700|565367579|FG002|Overall Study|Withdrawal by Subject|3|||
156624235|NCT01519700|565367580|FG003|Overall Study|Withdrawal by Subject|2|||
156624236|NCT01519700|565367577|FG000|Overall Study|Other Reason|2|||
156624237|NCT01519700|565367578|FG001|Overall Study|Other Reason|2|||
156624238|NCT01519700|565367579|FG002|Overall Study|Other Reason|0|||
156624239|NCT01519700|565367580|FG003|Overall Study|Other Reason|4|||
156624240|NCT05111548|565367581|FG000|Overall Study|Withdrawal by Subject|2|||
156624241|NCT05111548|565367582|FG001|Overall Study|Withdrawal by Subject|1|||
156624242|NCT05111548|565367581|FG000|Overall Study|Adverse Event|1|||
156624243|NCT05111548|565367582|FG001|Overall Study|Adverse Event|0|||
156624244|NCT00386152|565367583|FG000|Overall Study|Adverse Event|6|||
156624245|NCT00386152|565367584|FG001|Overall Study|Adverse Event|5|||
156624246|NCT00386152|565367585|FG002|Overall Study|Adverse Event|4|||
156624247|NCT00386152|565367583|FG000|Overall Study|Chang from original chemo stratification|4|||
156624248|NCT00386152|565367584|FG001|Overall Study|Chang from original chemo stratification|5|||
156624249|NCT00386152|565367585|FG002|Overall Study|Chang from original chemo stratification|6|||
156624250|NCT00386152|565367583|FG000|Overall Study|Death|3|||
156624251|NCT00386152|565367584|FG001|Overall Study|Death|0|||
156624252|NCT00386152|565367585|FG002|Overall Study|Death|1|||
156624253|NCT00386152|565367583|FG000|Overall Study|Disease progression|7|||
156624254|NCT00386152|565367584|FG001|Overall Study|Disease progression|4|||
156624255|NCT00386152|565367585|FG002|Overall Study|Disease progression|5|||
156624256|NCT00386152|565367583|FG000|Overall Study|Physician Decision|13|||
156624257|NCT00386152|565367584|FG001|Overall Study|Physician Decision|10|||
156624258|NCT00386152|565367585|FG002|Overall Study|Physician Decision|4|||
156624259|NCT00386152|565367583|FG000|Overall Study|Lost to Follow-up|1|||
156624260|NCT00386152|565367584|FG001|Overall Study|Lost to Follow-up|0|||
156624261|NCT00386152|565367585|FG002|Overall Study|Lost to Follow-up|0|||
156624262|NCT00386152|565367583|FG000|Overall Study|Completed chemotherapy|4|||
156624263|NCT00386152|565367584|FG001|Overall Study|Completed chemotherapy|5|||
156624264|NCT00386152|565367585|FG002|Overall Study|Completed chemotherapy|1|||
156624265|NCT00386152|565367583|FG000|Overall Study|Protocol Violation|3|||
156624266|NCT00386152|565367584|FG001|Overall Study|Protocol Violation|5|||
156624267|NCT00386152|565367585|FG002|Overall Study|Protocol Violation|2|||
156624268|NCT00386152|565367583|FG000|Overall Study|Withdrawal by Subject|3|||
156624269|NCT00386152|565367584|FG001|Overall Study|Withdrawal by Subject|6|||
156624270|NCT00386152|565367585|FG002|Overall Study|Withdrawal by Subject|10|||
156624271|NCT01101321|565367586|FG000|Period 1|Withdrawal by Subject|1|||
156624272|NCT01101321|565367587|FG001|Period 1|Withdrawal by Subject|1|||
156624273|NCT01101321|565367586|FG000|Period 1|Adverse Event|3|||
156624274|NCT01101321|565367587|FG001|Period 1|Adverse Event|3|||
156624275|NCT02577107|565367591|FG000|Overall Study|Protocol deviation|0|||
156624276|NCT02577107|565367592|FG001|Overall Study|Protocol deviation|1|||
156624277|NCT00577382|565367593|FG000|Overall Study|Adverse Event|0|||
156624278|NCT00577382|565367594|FG001|Overall Study|Adverse Event|6|||
156624279|NCT00577382|565367593|FG000|Overall Study|Withdrawal by Subject|0|||
156624280|NCT00577382|565367594|FG001|Overall Study|Withdrawal by Subject|1|||
156624281|NCT00577382|565367593|FG000|Overall Study|Progressive Disease|17|||
156624282|NCT00577382|565367594|FG001|Overall Study|Progressive Disease|19|||
156624283|NCT00577382|565367593|FG000|Overall Study|Intercurrent Illness|1|||
156624284|NCT00577382|565367594|FG001|Overall Study|Intercurrent Illness|2|||
156624285|NCT00577382|565367593|FG000|Overall Study|Death|1|||
156624286|NCT00577382|565367594|FG001|Overall Study|Death|1|||
156624287|NCT00577382|565367593|FG000|Overall Study|Lost to Follow-up|2|||
156624288|NCT00577382|565367594|FG001|Overall Study|Lost to Follow-up|2|||
156624289|NCT01345162|565367595|FG000|Overall Study|Protocol Violation|2|||
156624290|NCT01345162|565367596|FG001|Overall Study|Protocol Violation|4|||
156624291|NCT03007472|565367598|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
156624292|NCT03007472|565367598|FG000|Overall Study|Death|2|||
156624293|NCT03007472|565367598|FG000|Overall Study|Loss to Follow Up|1|||
156624294|NCT00649220|565367605|FG000|Overall Study|Adverse Event|2|||
156624295|NCT00649220|565367605|FG000|Overall Study|Withdrawal by Subject|1|||
156624296|NCT03339999|565367606|FG000|Overall Study|Adverse Event|1|||
156624297|NCT03339999|565367607|FG001|Overall Study|Adverse Event|2|||
156624298|NCT03339999|565367608|FG002|Overall Study|Adverse Event|2|||
156624299|NCT03339999|565367609|FG003|Overall Study|Adverse Event|1|||
156624300|NCT03339999|565367606|FG000|Overall Study|Lack of Efficacy|0|||
156624301|NCT03339999|565367607|FG001|Overall Study|Lack of Efficacy|1|||
156624302|NCT03339999|565367608|FG002|Overall Study|Lack of Efficacy|0|||
156624303|NCT03339999|565367609|FG003|Overall Study|Lack of Efficacy|0|||
156624304|NCT03339999|565367606|FG000|Overall Study|Lost to Follow-up|0|||
156624305|NCT03339999|565367607|FG001|Overall Study|Lost to Follow-up|0|||
156624306|NCT03339999|565367608|FG002|Overall Study|Lost to Follow-up|0|||
156624307|NCT03339999|565367609|FG003|Overall Study|Lost to Follow-up|1|||
156624308|NCT03339999|565367606|FG000|Overall Study|Study Terminated by Sponsor|6|||
156624309|NCT03339999|565367607|FG001|Overall Study|Study Terminated by Sponsor|3|||
156624310|NCT03339999|565367608|FG002|Overall Study|Study Terminated by Sponsor|4|||
156624311|NCT03339999|565367609|FG003|Overall Study|Study Terminated by Sponsor|3|||
156624312|NCT00525499|565367610|FG000|Overall Study|Lost to Follow-up|2|||
156624313|NCT00525499|565367611|FG001|Overall Study|Lost to Follow-up|4|||
156624314|NCT00525499|565367612|FG002|Overall Study|Lost to Follow-up|1|||
156624315|NCT00525499|565367613|FG003|Overall Study|Lost to Follow-up|4|||
156624316|NCT00525499|565367610|FG000|Overall Study|Adverse Event|0|||
156624317|NCT00525499|565367611|FG001|Overall Study|Adverse Event|1|||
156624318|NCT00525499|565367612|FG002|Overall Study|Adverse Event|0|||
156624319|NCT00525499|565367613|FG003|Overall Study|Adverse Event|1|||
156624320|NCT00525499|565367610|FG000|Overall Study|Withdrawal by Subject|5|||
156624321|NCT00525499|565367611|FG001|Overall Study|Withdrawal by Subject|1|||
156624322|NCT00525499|565367612|FG002|Overall Study|Withdrawal by Subject|5|||
156624323|NCT00525499|565367613|FG003|Overall Study|Withdrawal by Subject|2|||
156624324|NCT00525499|565367610|FG000|Overall Study|Protocol Violation|0|||
156624325|NCT00525499|565367611|FG001|Overall Study|Protocol Violation|1|||
156624326|NCT00525499|565367612|FG002|Overall Study|Protocol Violation|1|||
156624327|NCT00525499|565367613|FG003|Overall Study|Protocol Violation|0|||
156624328|NCT00608426|565367614|FG000|Overall Study|Death|32|||
156624329|NCT00608426|565367615|FG001|Overall Study|Death|36|||
156624330|NCT00608426|565367614|FG000|Overall Study|Lost to Follow-up|485|||
156624331|NCT00608426|565367615|FG001|Overall Study|Lost to Follow-up|521|||
156624332|NCT00608426|565367614|FG000|Overall Study|refused, health issues, wrong address|319|||
156624333|NCT00608426|565367615|FG001|Overall Study|refused, health issues, wrong address|348|||
156624334|NCT00761891|565367616|FG000|Overall Study|Withdrawal by Subject|10|||
156624335|NCT01453439|565367620|FG000|Treatment Phase|Withdrawal by Subject|13|||
156624336|NCT01453439|565367621|FG001|Treatment Phase|Withdrawal by Subject|10|||
156624337|NCT01453439|565367620|FG000|Treatment Phase|Suicidal Ideation|2|||
156624338|NCT01453439|565367621|FG001|Treatment Phase|Suicidal Ideation|0|||
156624339|NCT01453439|565367620|FG000|Treatment Phase|Need for higher level of care|1|||
156624340|NCT01453439|565367621|FG001|Treatment Phase|Need for higher level of care|1|||
156624341|NCT01453439|565367620|FG000|Treatment Phase|Therapist conflict of interest|1|||
156624342|NCT01453439|565367621|FG001|Treatment Phase|Therapist conflict of interest|0|||
156624343|NCT01453439|565367620|FG000|Follow-up|Withdrawal by Subject|0|||
156624344|NCT01453439|565367621|FG001|Follow-up|Withdrawal by Subject|1|||
156624345|NCT01453439|565367620|FG000|Follow-up|Lost to Follow-up|5|||
156624346|NCT01453439|565367621|FG001|Follow-up|Lost to Follow-up|10|||
156624347|NCT01014442|565367622|FG000|Overall Study|Adverse Event|0|||
156624348|NCT01014442|565367623|FG001|Overall Study|Adverse Event|8|||
156624349|NCT01014442|565367622|FG000|Overall Study|Withdrawal by Subject|4|||
156624350|NCT01014442|565367623|FG001|Overall Study|Withdrawal by Subject|4|||
156624351|NCT01014442|565367622|FG000|Overall Study|Protocol Violation|2|||
156624352|NCT01014442|565367623|FG001|Overall Study|Protocol Violation|5|||
156624353|NCT01014442|565367622|FG000|Overall Study|Lack of Compliance|0|||
156624354|NCT01014442|565367623|FG001|Overall Study|Lack of Compliance|1|||
156624355|NCT01014442|565367622|FG000|Overall Study|Unspecified Reason|1|||
156624356|NCT01014442|565367623|FG001|Overall Study|Unspecified Reason|1|||
156624357|NCT02074059|565367624|FG000|Overall Study|Death|0|||
156624358|NCT02074059|565367625|FG001|Overall Study|Death|0|||
156624359|NCT02074059|565367626|FG002|Overall Study|Death|0|||
156624360|NCT02074059|565367627|FG003|Overall Study|Death|0|||
156624361|NCT02074059|565367628|FG004|Overall Study|Death|1|||
156624362|NCT02074059|565367629|FG005|Overall Study|Death|1|||
156624363|NCT02135848|565367635|FG000|Overall Study|Adverse Event|2|||
156624364|NCT02135848|565367636|FG001|Overall Study|Adverse Event|0|||
156624365|NCT02135848|565367635|FG000|Overall Study|Withdrawal by Subject|1|||
156624366|NCT02135848|565367636|FG001|Overall Study|Withdrawal by Subject|1|||
156624367|NCT03258710|565367637|FG000|Overall Study|Adverse Event|1|||
156624368|NCT03258710|565367637|FG000|Overall Study|Protocol-defined stopping criteria|1|||
156624369|NCT03258710|565367637|FG000|Overall Study|Physician Decision|1|||
156624370|NCT02813681|565367638|FG000|Overall Study|Physician Decision|5|||
156624371|NCT02813681|565367639|FG001|Overall Study|Physician Decision|5|||
156624372|NCT02813681|565367640|FG002|Overall Study|Physician Decision|0|||
156624373|NCT02813681|565367638|FG000|Overall Study|Lost to Follow-up|0|||
156624374|NCT02813681|565367639|FG001|Overall Study|Lost to Follow-up|1|||
156624375|NCT02813681|565367640|FG002|Overall Study|Lost to Follow-up|0|||
156624376|NCT03961529|565367643|FG000|Overall Study|Adverse Event|13|||
156624377|NCT03961529|565367644|FG001|Overall Study|Adverse Event|5|||
156624378|NCT03961529|565367645|FG002|Overall Study|Adverse Event|2|||
156624379|NCT03961529|565367643|FG000|Overall Study|Withdrawal by Subject|17|||
156624380|NCT03961529|565367644|FG001|Overall Study|Withdrawal by Subject|2|||
156624381|NCT03961529|565367645|FG002|Overall Study|Withdrawal by Subject|1|||
156624382|NCT03961529|565367643|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156624383|NCT03961529|565367644|FG001|Overall Study|Withdrawal by parent/guardian|7|||
156624384|NCT03961529|565367645|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156624385|NCT03961529|565367643|FG000|Overall Study|Physician Decision|2|||
156624386|NCT03961529|565367644|FG001|Overall Study|Physician Decision|1|||
156624387|NCT03961529|565367645|FG002|Overall Study|Physician Decision|1|||
156624388|NCT03961529|565367643|FG000|Overall Study|Lost to Follow-up|2|||
156624389|NCT03961529|565367644|FG001|Overall Study|Lost to Follow-up|1|||
156624390|NCT03961529|565367645|FG002|Overall Study|Lost to Follow-up|0|||
156624391|NCT03961529|565367643|FG000|Overall Study|Lack of Efficacy|2|||
156624392|NCT03961529|565367644|FG001|Overall Study|Lack of Efficacy|0|||
156624393|NCT03961529|565367645|FG002|Overall Study|Lack of Efficacy|1|||
156624394|NCT03961529|565367643|FG000|Overall Study|Other|6|||
156624395|NCT03961529|565367644|FG001|Overall Study|Other|1|||
156624396|NCT03961529|565367645|FG002|Overall Study|Other|0|||
156624397|NCT03644173|565367646|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
156624398|NCT03644173|565367646|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
156624399|NCT03644173|565367646|FG000|Participants at the 1-month Follow up|Death|2|||
156624400|NCT03644173|565367646|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
156624401|NCT01497899|565367647|FG000|Double-Blind Phase|Randomized but not Treated|1|||
156624402|NCT01497899|565367648|FG001|Double-Blind Phase|Randomized but not Treated|0|||
156624403|NCT01497899|565367649|FG002|Double-Blind Phase|Randomized but not Treated|0|||
156624404|NCT01497899|565367650|FG003|Double-Blind Phase|Randomized but not Treated|0|||
156624405|NCT01497899|565367647|FG000|Double-Blind Phase|Adverse Event|1|||
156624406|NCT01497899|565367648|FG001|Double-Blind Phase|Adverse Event|0|||
156624407|NCT01497899|565367649|FG002|Double-Blind Phase|Adverse Event|0|||
156624408|NCT01497899|565367650|FG003|Double-Blind Phase|Adverse Event|0|||
156624409|NCT01497899|565367647|FG000|Double-Blind Phase|Lack of Efficacy|0|||
156624410|NCT01497899|565367648|FG001|Double-Blind Phase|Lack of Efficacy|1|||
156624411|NCT01497899|565367649|FG002|Double-Blind Phase|Lack of Efficacy|0|||
156624412|NCT01497899|565367650|FG003|Double-Blind Phase|Lack of Efficacy|0|||
156624413|NCT01497899|565367647|FG000|Double-Blind Phase|Investigator's Discretion|1|||
156624414|NCT01497899|565367648|FG001|Double-Blind Phase|Investigator's Discretion|0|||
156624415|NCT01497899|565367649|FG002|Double-Blind Phase|Investigator's Discretion|0|||
156624416|NCT01497899|565367650|FG003|Double-Blind Phase|Investigator's Discretion|0|||
156624417|NCT01497899|565367647|FG000|Double-Blind Phase|Withdrew Consent|0|||
156624418|NCT01497899|565367648|FG001|Double-Blind Phase|Withdrew Consent|1|||
156624419|NCT01497899|565367649|FG002|Double-Blind Phase|Withdrew Consent|0|||
156624420|NCT01497899|565367650|FG003|Double-Blind Phase|Withdrew Consent|0|||
156624421|NCT01497899|565367647|FG000|Double-Blind Phase|Lost to Follow-up|3|||
156624422|NCT01497899|565367648|FG001|Double-Blind Phase|Lost to Follow-up|2|||
156624423|NCT01497899|565367649|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156624424|NCT01497899|565367650|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156624425|NCT01497899|565367647|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
156624426|NCT01497899|565367648|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
156624427|NCT01497899|565367649|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
156624428|NCT01497899|565367650|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
156624429|NCT01497899|565367647|FG000|Open-Label Extension Phase|Adverse Event|1|||
156624430|NCT01497899|565367648|FG001|Open-Label Extension Phase|Adverse Event|0|||
156624431|NCT01497899|565367649|FG002|Open-Label Extension Phase|Adverse Event|0|||
156624432|NCT01497899|565367650|FG003|Open-Label Extension Phase|Adverse Event|0|||
156624433|NCT01497899|565367647|FG000|Open-Label Extension Phase|Death|1|||
156624434|NCT01497899|565367648|FG001|Open-Label Extension Phase|Death|0|||
156624435|NCT01497899|565367649|FG002|Open-Label Extension Phase|Death|0|||
156624436|NCT01497899|565367650|FG003|Open-Label Extension Phase|Death|0|||
156624437|NCT01497899|565367647|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
156624438|NCT01497899|565367648|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
156624439|NCT01497899|565367649|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
156624440|NCT01497899|565367650|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
156624441|NCT01497899|565367647|FG000|Open-Label Extension Phase|Pregnancy|0|||
156624442|NCT01497899|565367648|FG001|Open-Label Extension Phase|Pregnancy|1|||
156624443|NCT01497899|565367649|FG002|Open-Label Extension Phase|Pregnancy|1|||
156624444|NCT01497899|565367650|FG003|Open-Label Extension Phase|Pregnancy|0|||
156624445|NCT01497899|565367647|FG000|Open-Label Extension Phase|Protocol Violation|0|||
156624446|NCT01497899|565367648|FG001|Open-Label Extension Phase|Protocol Violation|0|||
156624447|NCT01497899|565367649|FG002|Open-Label Extension Phase|Protocol Violation|1|||
156624448|NCT01497899|565367650|FG003|Open-Label Extension Phase|Protocol Violation|0|||
156624449|NCT01497899|565367647|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
156624450|NCT01497899|565367648|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
156624451|NCT01497899|565367649|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
156624452|NCT01497899|565367650|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
156624453|NCT03323385|565367651|FG000|Overall Study|Withdrawal by Subject|1|||
156624454|NCT03323385|565367652|FG001|Overall Study|Withdrawal by Subject|2|||
156624455|NCT03323385|565367651|FG000|Overall Study|Noncompliance|0|||
156624456|NCT03323385|565367652|FG001|Overall Study|Noncompliance|1|||
156624457|NCT02607735|565367653|FG000|Primary Study|Randomized but Never Treated|1|||
156624458|NCT02607735|565367654|FG001|Primary Study|Randomized but Never Treated|0|||
156624459|NCT02607735|565367655|FG002|Primary Study|Randomized but Never Treated|0|||
156624460|NCT02607735|565367653|FG000|Primary Study|Lost to Follow-up|4|||
156624461|NCT02607735|565367654|FG001|Primary Study|Lost to Follow-up|0|||
156624462|NCT02607735|565367655|FG002|Primary Study|Lost to Follow-up|0|||
156624463|NCT02607735|565367653|FG000|Primary Study|Withdrew Consent|2|||
156624464|NCT02607735|565367654|FG001|Primary Study|Withdrew Consent|0|||
156624465|NCT02607735|565367655|FG002|Primary Study|Withdrew Consent|0|||
156624466|NCT02607735|565367653|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
156624467|NCT02607735|565367654|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
156624468|NCT02607735|565367655|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
156624469|NCT02607735|565367653|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
156624470|NCT02607735|565367654|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
156624471|NCT02607735|565367655|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
156624472|NCT02269709|565367661|FG000|Time of Enrollment|Withdrawal by Subject|3|||
156624473|NCT02269709|565367661|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
156624474|NCT02269709|565367661|FG000|Six Month Follow-up|Lost to Follow-up|12|||
156624475|NCT02909504|565367662|FG000|Overall Study|Adverse Event|2|||
156624476|NCT02909504|565367662|FG000|Overall Study|Lack of Efficacy|3|||
156624477|NCT02909504|565367662|FG000|Overall Study|Withdrawal by Subject|4|||
156624478|NCT02909504|565367662|FG000|Overall Study|Pregnancy|1|||
156624479|NCT02909504|565367662|FG000|Overall Study|Subject moved|1|||
156624480|NCT02909504|565367662|FG000|Overall Study|Lost to Follow-up|1|||
156624481|NCT02055976|565367663|FG000|Overall Study|Other|0|||
156624482|NCT02055976|565367664|FG001|Overall Study|Other|0|||
156624483|NCT02055976|565367665|FG002|Overall Study|Other|1|||
156624484|NCT02055976|565367666|FG003|Overall Study|Other|0|||
156624485|NCT02055976|565367667|FG004|Overall Study|Other|0|||
156624486|NCT02055976|565367668|FG005|Overall Study|Other|0|||
156624487|NCT02055976|565367669|FG006|Overall Study|Other|0|||
156624488|NCT02055976|565367670|FG007|Overall Study|Other|0|||
156624489|NCT02055976|565367671|FG008|Overall Study|Other|0|||
156624490|NCT02055976|565367663|FG000|Overall Study|Adverse Event|0|||
156624491|NCT02055976|565367664|FG001|Overall Study|Adverse Event|0|||
156624492|NCT02055976|565367665|FG002|Overall Study|Adverse Event|0|||
156624493|NCT02055976|565367666|FG003|Overall Study|Adverse Event|0|||
156624494|NCT02055976|565367667|FG004|Overall Study|Adverse Event|0|||
156624495|NCT02055976|565367668|FG005|Overall Study|Adverse Event|1|||
156624496|NCT02055976|565367669|FG006|Overall Study|Adverse Event|1|||
156624497|NCT02055976|565367670|FG007|Overall Study|Adverse Event|0|||
156624498|NCT02055976|565367671|FG008|Overall Study|Adverse Event|0|||
156624499|NCT02055976|565367663|FG000|Overall Study|Does not meet entrance criteria|0|||
156624500|NCT02055976|565367664|FG001|Overall Study|Does not meet entrance criteria|0|||
156624501|NCT02055976|565367665|FG002|Overall Study|Does not meet entrance criteria|0|||
156624502|NCT02055976|565367666|FG003|Overall Study|Does not meet entrance criteria|0|||
156624503|NCT02055976|565367667|FG004|Overall Study|Does not meet entrance criteria|0|||
156624504|NCT02055976|565367668|FG005|Overall Study|Does not meet entrance criteria|0|||
156624505|NCT02055976|565367669|FG006|Overall Study|Does not meet entrance criteria|1|||
156624506|NCT02055976|565367670|FG007|Overall Study|Does not meet entrance criteria|0|||
156624507|NCT02055976|565367671|FG008|Overall Study|Does not meet entrance criteria|0|||
156624508|NCT02055976|565367663|FG000|Overall Study|Lost to Follow-up|0|||
156624509|NCT02055976|565367664|FG001|Overall Study|Lost to Follow-up|0|||
156624510|NCT02055976|565367665|FG002|Overall Study|Lost to Follow-up|0|||
156624511|NCT02055976|565367666|FG003|Overall Study|Lost to Follow-up|1|||
156624512|NCT02055976|565367667|FG004|Overall Study|Lost to Follow-up|0|||
156624513|NCT02055976|565367668|FG005|Overall Study|Lost to Follow-up|0|||
156624514|NCT02055976|565367669|FG006|Overall Study|Lost to Follow-up|0|||
156624515|NCT02055976|565367670|FG007|Overall Study|Lost to Follow-up|0|||
156624516|NCT02055976|565367671|FG008|Overall Study|Lost to Follow-up|0|||
156624517|NCT03769753|565367676|FG000|Overall Study|Not Treated|6|||
156624518|NCT03769753|565367676|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
156624519|NCT01070381|565367677|FG000|Period 2, 1 Week of Wear|Handling|0|||
156624520|NCT01070381|565367678|FG001|Period 2, 1 Week of Wear|Handling|1|||
156624521|NCT01070381|565367677|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
156624522|NCT01070381|565367678|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
156624523|NCT00684073|565367679|FG000|Selection|Selection/non-selection criteria|3|||
156624524|NCT00684073|565367679|FG000|Selection|Death|1|||
156624525|NCT00684073|565367679|FG000|Selection|noncompliance|1|||
156624526|NCT00684073|565367679|FG000|Selection|Lost to Follow-up|1|||
156624527|NCT00684073|565367679|FG000|Selection|request of the sponsor|1|||
156624528|NCT00684073|565367679|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
156624529|NCT01259388|565367680|FG000|Overall Study|Adverse Event|3|||
156624530|NCT01259388|565367681|FG001|Overall Study|Adverse Event|0|||
156624531|NCT01259388|565367680|FG000|Overall Study|Withdrawal by Subject|1|||
156624532|NCT01259388|565367681|FG001|Overall Study|Withdrawal by Subject|1|||
156624533|NCT01259388|565367680|FG000|Overall Study|Physician Decision|1|||
156624534|NCT01259388|565367681|FG001|Overall Study|Physician Decision|0|||
156624535|NCT01888367|565367684|FG000|Overall Study|Physician Decision|3|||
156624536|NCT01888367|565367685|FG001|Overall Study|Physician Decision|4|||
156624537|NCT01888367|565367686|FG002|Overall Study|Physician Decision|2|||
156624538|NCT01888367|565367684|FG000|Overall Study|Death|2|||
156624539|NCT01888367|565367685|FG001|Overall Study|Death|0|||
156624540|NCT01888367|565367686|FG002|Overall Study|Death|1|||
156624541|NCT01888367|565367684|FG000|Overall Study|Withdrawal by Subject|1|||
156624542|NCT01888367|565367685|FG001|Overall Study|Withdrawal by Subject|0|||
156624543|NCT01888367|565367686|FG002|Overall Study|Withdrawal by Subject|1|||
156624544|NCT01888367|565367684|FG000|Overall Study|Lost to Follow-up|1|||
156624545|NCT01888367|565367685|FG001|Overall Study|Lost to Follow-up|1|||
156624546|NCT01888367|565367686|FG002|Overall Study|Lost to Follow-up|0|||
156624547|NCT01888367|565367684|FG000|Overall Study|Protocol Violation|0|||
156624548|NCT01888367|565367685|FG001|Overall Study|Protocol Violation|0|||
156624549|NCT01888367|565367686|FG002|Overall Study|Protocol Violation|1|||
156624550|NCT01888367|565367684|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
156624551|NCT01888367|565367685|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
156624552|NCT01888367|565367686|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
156624553|NCT01854918|565367687|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
156624554|NCT01854918|565367688|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
156624555|NCT01854918|565367687|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
156624556|NCT01854918|565367688|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
156624557|NCT01854918|565367687|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
156624558|NCT01854918|565367688|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
156624559|NCT01854918|565367687|FG000|SOC-controlled Period (Year 1)|Death|5|||
156624560|NCT01854918|565367688|FG001|SOC-controlled Period (Year 1)|Death|5|||
156624561|NCT01854918|565367687|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
156624562|NCT01854918|565367688|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
156624563|NCT01854918|565367687|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
156624564|NCT01854918|565367688|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
156624565|NCT01854918|565367687|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
156624566|NCT01854918|565367688|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
156624567|NCT01854918|565367687|FG000|All-IP Period (Years 2 and 3)|Death|5|||
156624568|NCT01854918|565367688|FG001|All-IP Period (Years 2 and 3)|Death|16|||
156624569|NCT01920061|565367690|FG000|Overall Study|Death|1|||
156624570|NCT01920061|565367691|FG001|Overall Study|Death|1|||
156624571|NCT01920061|565367692|FG002|Overall Study|Death|0|||
156624572|NCT01920061|565367693|FG003|Overall Study|Death|1|||
156624573|NCT01920061|565367694|FG004|Overall Study|Death|1|||
156624574|NCT01920061|565367695|FG005|Overall Study|Death|0|||
156624575|NCT01920061|565367696|FG006|Overall Study|Death|0|||
156624576|NCT01920061|565367697|FG007|Overall Study|Death|1|||
156624577|NCT01920061|565367698|FG008|Overall Study|Death|0|||
156624578|NCT01920061|565367699|FG009|Overall Study|Death|1|||
156624579|NCT01920061|565367700|FG010|Overall Study|Death|0|||
156624580|NCT01920061|565367701|FG011|Overall Study|Death|1|||
156624581|NCT01920061|565367702|FG012|Overall Study|Death|0|||
156624582|NCT01920061|565367703|FG013|Overall Study|Death|2|||
156624583|NCT01920061|565367704|FG014|Overall Study|Death|0|||
156624584|NCT01920061|565367705|FG015|Overall Study|Death|0|||
156624585|NCT01920061|565367706|FG016|Overall Study|Death|0|||
156624586|NCT01920061|565367707|FG017|Overall Study|Death|0|||
156624587|NCT01920061|565367708|FG018|Overall Study|Death|1|||
156624588|NCT01920061|565367709|FG019|Overall Study|Death|0|||
156624589|NCT01920061|565367690|FG000|Overall Study|Lost to Follow-up|0|||
156624590|NCT01920061|565367691|FG001|Overall Study|Lost to Follow-up|2|||
156624591|NCT01920061|565367692|FG002|Overall Study|Lost to Follow-up|0|||
156624592|NCT01920061|565367693|FG003|Overall Study|Lost to Follow-up|0|||
156624593|NCT01920061|565367694|FG004|Overall Study|Lost to Follow-up|0|||
156624594|NCT01920061|565367695|FG005|Overall Study|Lost to Follow-up|0|||
156624595|NCT01920061|565367696|FG006|Overall Study|Lost to Follow-up|1|||
156624596|NCT01920061|565367697|FG007|Overall Study|Lost to Follow-up|0|||
156624597|NCT01920061|565367698|FG008|Overall Study|Lost to Follow-up|0|||
156624598|NCT01920061|565367699|FG009|Overall Study|Lost to Follow-up|0|||
156624599|NCT01920061|565367700|FG010|Overall Study|Lost to Follow-up|3|||
156624600|NCT01920061|565367701|FG011|Overall Study|Lost to Follow-up|0|||
156624601|NCT01920061|565367702|FG012|Overall Study|Lost to Follow-up|0|||
156624602|NCT01920061|565367703|FG013|Overall Study|Lost to Follow-up|0|||
156624603|NCT01920061|565367704|FG014|Overall Study|Lost to Follow-up|0|||
156624604|NCT01920061|565367705|FG015|Overall Study|Lost to Follow-up|0|||
156624605|NCT01920061|565367706|FG016|Overall Study|Lost to Follow-up|0|||
156624606|NCT01920061|565367707|FG017|Overall Study|Lost to Follow-up|1|||
156624607|NCT01920061|565367708|FG018|Overall Study|Lost to Follow-up|4|||
156624608|NCT01920061|565367709|FG019|Overall Study|Lost to Follow-up|3|||
156624609|NCT01920061|565367690|FG000|Overall Study|Other|1|||
156624610|NCT01920061|565367691|FG001|Overall Study|Other|1|||
156624611|NCT01920061|565367692|FG002|Overall Study|Other|2|||
156624612|NCT01920061|565367693|FG003|Overall Study|Other|1|||
156624613|NCT01920061|565367694|FG004|Overall Study|Other|0|||
156624614|NCT01920061|565367695|FG005|Overall Study|Other|1|||
156624615|NCT01920061|565367696|FG006|Overall Study|Other|0|||
156624616|NCT01920061|565367697|FG007|Overall Study|Other|0|||
156624617|NCT01920061|565367698|FG008|Overall Study|Other|0|||
156624618|NCT01920061|565367699|FG009|Overall Study|Other|1|||
156624619|NCT01920061|565367700|FG010|Overall Study|Other|1|||
156624620|NCT01920061|565367701|FG011|Overall Study|Other|2|||
156624621|NCT01920061|565367702|FG012|Overall Study|Other|1|||
156624622|NCT01920061|565367703|FG013|Overall Study|Other|4|||
156624623|NCT01920061|565367704|FG014|Overall Study|Other|0|||
156624624|NCT01920061|565367705|FG015|Overall Study|Other|1|||
156624625|NCT01920061|565367706|FG016|Overall Study|Other|1|||
156624626|NCT01920061|565367707|FG017|Overall Study|Other|0|||
156624627|NCT01920061|565367708|FG018|Overall Study|Other|1|||
156624628|NCT01920061|565367709|FG019|Overall Study|Other|1|||
156624629|NCT01920061|565367690|FG000|Overall Study|Participant refused further follow-up|0|||
156624630|NCT01920061|565367691|FG001|Overall Study|Participant refused further follow-up|0|||
156624631|NCT01920061|565367692|FG002|Overall Study|Participant refused further follow-up|0|||
156624632|NCT01920061|565367693|FG003|Overall Study|Participant refused further follow-up|0|||
156624633|NCT01920061|565367694|FG004|Overall Study|Participant refused further follow-up|1|||
156624634|NCT01920061|565367695|FG005|Overall Study|Participant refused further follow-up|1|||
156624635|NCT01920061|565367696|FG006|Overall Study|Participant refused further follow-up|0|||
156624636|NCT01920061|565367697|FG007|Overall Study|Participant refused further follow-up|0|||
156624637|NCT01920061|565367698|FG008|Overall Study|Participant refused further follow-up|1|||
156624638|NCT01920061|565367699|FG009|Overall Study|Participant refused further follow-up|0|||
156624639|NCT01920061|565367700|FG010|Overall Study|Participant refused further follow-up|1|||
156624640|NCT01920061|565367701|FG011|Overall Study|Participant refused further follow-up|0|||
156624641|NCT01920061|565367702|FG012|Overall Study|Participant refused further follow-up|1|||
156624642|NCT01920061|565367703|FG013|Overall Study|Participant refused further follow-up|0|||
156624643|NCT01920061|565367704|FG014|Overall Study|Participant refused further follow-up|1|||
156624644|NCT01920061|565367705|FG015|Overall Study|Participant refused further follow-up|2|||
156624645|NCT01920061|565367706|FG016|Overall Study|Participant refused further follow-up|1|||
156624646|NCT01920061|565367707|FG017|Overall Study|Participant refused further follow-up|1|||
156624647|NCT01920061|565367708|FG018|Overall Study|Participant refused further follow-up|0|||
156624648|NCT01920061|565367709|FG019|Overall Study|Participant refused further follow-up|0|||
156624649|NCT02146352|565367712|FG000|Overall Study|Death|1|||
156624650|NCT02146352|565367712|FG000|Overall Study|Patient entered hospice care|1|||
156624651|NCT02918006|565367714|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
156624652|NCT02918006|565367715|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
156624653|NCT02918006|565367716|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
156624654|NCT02918006|565367714|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
156624655|NCT02918006|565367715|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
156624656|NCT02918006|565367716|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
156624657|NCT02918006|565367714|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
156624658|NCT02918006|565367715|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
156624659|NCT02918006|565367716|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
156624660|NCT02918006|565367714|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
156624661|NCT02918006|565367715|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
156624662|NCT02918006|565367716|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
156624663|NCT02918006|565367714|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
156624664|NCT02918006|565367715|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
156624665|NCT02918006|565367716|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
156624666|NCT02918006|565367714|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
156624667|NCT02918006|565367715|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
156624668|NCT02918006|565367716|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
156624669|NCT02918006|565367714|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
156624670|NCT02918006|565367715|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
156624671|NCT02918006|565367716|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
156624672|NCT02918006|565367714|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
156624673|NCT02918006|565367715|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
156624674|NCT02918006|565367716|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
156624675|NCT02918006|565367714|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
156624676|NCT02918006|565367715|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
156624677|NCT02918006|565367716|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
156624678|NCT03091920|565367720|FG000|Overall Study|Adverse Event|0|||
156624679|NCT03091920|565367721|FG001|Overall Study|Adverse Event|1|||
156624680|NCT03091920|565367722|FG002|Overall Study|Adverse Event|0|||
156624681|NCT00453349|565367723|FG000|Randomized|Adverse Event|12|||
156624682|NCT00453349|565367724|FG001|Randomized|Adverse Event|11|||
156624683|NCT00453349|565367723|FG000|Randomized|Lack of Efficacy|2|||
156624684|NCT00453349|565367724|FG001|Randomized|Lack of Efficacy|1|||
156624685|NCT00453349|565367723|FG000|Randomized|Lost to Follow-up|7|||
156624686|NCT00453349|565367724|FG001|Randomized|Lost to Follow-up|5|||
156624687|NCT00453349|565367723|FG000|Randomized|Protocol Violation|1|||
156624688|NCT00453349|565367724|FG001|Randomized|Protocol Violation|1|||
156624689|NCT00453349|565367723|FG000|Randomized|Withdrawal by Subject|3|||
156624690|NCT00453349|565367724|FG001|Randomized|Withdrawal by Subject|5|||
156624691|NCT00453349|565367723|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
156624692|NCT00453349|565367724|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
156624693|NCT00453349|565367723|FG000|Completed Study|Adverse Event|12|||
156624694|NCT00453349|565367724|FG001|Completed Study|Adverse Event|11|||
156624695|NCT00453349|565367723|FG000|Completed Study|Lack of Efficacy|2|||
156624696|NCT00453349|565367724|FG001|Completed Study|Lack of Efficacy|1|||
156624697|NCT00453349|565367723|FG000|Completed Study|Lost to Follow-up|7|||
156624698|NCT00453349|565367724|FG001|Completed Study|Lost to Follow-up|5|||
156624699|NCT00453349|565367723|FG000|Completed Study|Protocol Violation|1|||
156624700|NCT00453349|565367724|FG001|Completed Study|Protocol Violation|1|||
156624701|NCT00453349|565367723|FG000|Completed Study|Withdrawal by Subject|3|||
156624702|NCT00453349|565367724|FG001|Completed Study|Withdrawal by Subject|5|||
156624703|NCT00453349|565367723|FG000|Completed Study|Lost to follow up after study treatment|2|||
156624704|NCT00453349|565367724|FG001|Completed Study|Lost to follow up after study treatment|11|||
156624705|NCT01513460|565367726|FG000|Overall Study|Death|0|||
156624706|NCT01513460|565367727|FG001|Overall Study|Death|0|||
156624707|NCT01513460|565367728|FG002|Overall Study|Death|1|||
156624708|NCT01513460|565367726|FG000|Overall Study|Lost to Follow-up|0|||
156624709|NCT01513460|565367727|FG001|Overall Study|Lost to Follow-up|0|||
156624710|NCT01513460|565367728|FG002|Overall Study|Lost to Follow-up|2|||
156624711|NCT01513460|565367726|FG000|Overall Study|Abnormal laboratory value|1|||
156624712|NCT01513460|565367727|FG001|Overall Study|Abnormal laboratory value|0|||
156624713|NCT01513460|565367728|FG002|Overall Study|Abnormal laboratory value|1|||
156624714|NCT01513460|565367726|FG000|Overall Study|Lack of Efficacy|1|||
156624715|NCT01513460|565367727|FG001|Overall Study|Lack of Efficacy|2|||
156624716|NCT01513460|565367728|FG002|Overall Study|Lack of Efficacy|5|||
156624717|NCT01513460|565367726|FG000|Overall Study|Protocol deviations|3|||
156624718|NCT01513460|565367727|FG001|Overall Study|Protocol deviations|4|||
156624719|NCT01513460|565367728|FG002|Overall Study|Protocol deviations|3|||
156624720|NCT01513460|565367726|FG000|Overall Study|Withdrawal by Subject|7|||
156624721|NCT01513460|565367727|FG001|Overall Study|Withdrawal by Subject|8|||
156624722|NCT01513460|565367728|FG002|Overall Study|Withdrawal by Subject|21|||
156624723|NCT01513460|565367726|FG000|Overall Study|Adverse Event|16|||
156624724|NCT01513460|565367727|FG001|Overall Study|Adverse Event|18|||
156624725|NCT01513460|565367728|FG002|Overall Study|Adverse Event|23|||
156624726|NCT01513460|565367726|FG000|Overall Study|Abnormal test procedure|1|||
156624727|NCT01513460|565367727|FG001|Overall Study|Abnormal test procedure|0|||
156624728|NCT01513460|565367728|FG002|Overall Study|Abnormal test procedure|0|||
156624729|NCT00489216|565367732|FG000|Overall Study|Adverse Event|1|||
156624730|NCT02475564|565367735|FG000|Overall Study|Withdrawal by Subject|1|||
156624731|NCT02475564|565367736|FG001|Overall Study|Withdrawal by Subject|0|||
156624732|NCT02475564|565367735|FG000|Overall Study|Lost to Follow-up|2|||
156624733|NCT02475564|565367736|FG001|Overall Study|Lost to Follow-up|1|||
156624734|NCT02475564|565367735|FG000|Overall Study|Intense Menstrual bleeding|1|||
156624735|NCT02475564|565367736|FG001|Overall Study|Intense Menstrual bleeding|0|||
156624736|NCT02705755|565367737|FG000|Part A (6 Days)|Adverse Event|1|||
156624737|NCT02705755|565367738|FG001|Part A (6 Days)|Adverse Event|0|||
156624738|NCT02705755|565367739|FG002|Part A (6 Days)|Adverse Event|0|||
156624739|NCT02705755|565367740|FG003|Part A (6 Days)|Adverse Event|0|||
156624740|NCT02705755|565367737|FG000|Part A (6 Days)|Physician Decision|3|||
156624741|NCT02705755|565367738|FG001|Part A (6 Days)|Physician Decision|0|||
156624742|NCT02705755|565367739|FG002|Part A (6 Days)|Physician Decision|0|||
156624743|NCT02705755|565367740|FG003|Part A (6 Days)|Physician Decision|0|||
156624744|NCT02705755|565367737|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
156624745|NCT02705755|565367738|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
156624746|NCT02705755|565367739|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
156624747|NCT02705755|565367740|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
156624748|NCT02705755|565367737|FG000|Part C (20 Weeks)|Physician Decision|0|||
156624749|NCT02705755|565367738|FG001|Part C (20 Weeks)|Physician Decision|0|||
156624750|NCT02705755|565367739|FG002|Part C (20 Weeks)|Physician Decision|0|||
156624751|NCT02705755|565367740|FG003|Part C (20 Weeks)|Physician Decision|2|||
156624752|NCT02705755|565367737|FG000|Part C (20 Weeks)|Adverse Event|0|||
156624753|NCT02705755|565367738|FG001|Part C (20 Weeks)|Adverse Event|0|||
156624754|NCT02705755|565367739|FG002|Part C (20 Weeks)|Adverse Event|0|||
156624755|NCT02705755|565367740|FG003|Part C (20 Weeks)|Adverse Event|6|||
156624756|NCT02705755|565367737|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
156624757|NCT02705755|565367738|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
156624758|NCT02705755|565367739|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
156624759|NCT02705755|565367740|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
156624760|NCT01906489|565367741|FG000|Overall Study|Adverse Event|10|||
156624761|NCT01906489|565367742|FG001|Overall Study|Adverse Event|3|||
156624762|NCT01906489|565367741|FG000|Overall Study|Worsening of CKD|6|||
156624763|NCT01906489|565367742|FG001|Overall Study|Worsening of CKD|4|||
156624764|NCT01906489|565367741|FG000|Overall Study|Withdrawal by Subject|5|||
156624765|NCT01906489|565367742|FG001|Overall Study|Withdrawal by Subject|0|||
156624766|NCT01906489|565367741|FG000|Overall Study|Worsening of Anemia|1|||
156624767|NCT01906489|565367742|FG001|Overall Study|Worsening of Anemia|0|||
156624768|NCT01906489|565367741|FG000|Overall Study|Protocol Violation|0|||
156624769|NCT01906489|565367742|FG001|Overall Study|Protocol Violation|1|||
156624770|NCT01906489|565367741|FG000|Overall Study|Non- Compliance|1|||
156624771|NCT01906489|565367742|FG001|Overall Study|Non- Compliance|0|||
156624772|NCT01906489|565367741|FG000|Overall Study|Sponsor Decision|1|||
156624773|NCT01906489|565367742|FG001|Overall Study|Sponsor Decision|0|||
156624774|NCT01906489|565367741|FG000|Overall Study|Lost to Follow-up|1|||
156624775|NCT01906489|565367742|FG001|Overall Study|Lost to Follow-up|1|||
156624776|NCT01906489|565367741|FG000|Overall Study|Other|1|||
156624777|NCT01906489|565367742|FG001|Overall Study|Other|0|||
156624778|NCT04823494|565369920|FG000|Overall Study|Programming software malfunction.|1|||
156624779|NCT04823494|565369921|FG001|Overall Study|Programming software malfunction.|0|||
156624780|NCT04823494|565369920|FG000|Overall Study|Withdrawal by Subject|1|||
156624781|NCT04823494|565369921|FG001|Overall Study|Withdrawal by Subject|0|||
156624782|NCT04823494|565369920|FG000|Overall Study|Devices lost|0|||
156624783|NCT04823494|565369921|FG001|Overall Study|Devices lost|1|||
156624784|NCT03691831|565369922|FG000|Overall Study|Lost to Follow-up|16|||
156624785|NCT03691831|565369923|FG001|Overall Study|Lost to Follow-up|12|||
156624786|NCT03691831|565369922|FG000|Overall Study|Withdrawal by Subject|9|||
156624787|NCT03691831|565369923|FG001|Overall Study|Withdrawal by Subject|17|||
156624788|NCT03691831|565369922|FG000|Overall Study|Investigator Decision|2|||
156624789|NCT03691831|565369923|FG001|Overall Study|Investigator Decision|2|||
156624790|NCT02198040|565369924|FG000|Overall Study|Work reasons|0|||
156624791|NCT02198040|565369925|FG001|Overall Study|Work reasons|1|||
156624792|NCT02198040|565369926|FG002|Overall Study|Work reasons|0|||
156624793|NCT02198040|565369924|FG000|Overall Study|Withdrawal by Subject|0|||
156624794|NCT02198040|565369925|FG001|Overall Study|Withdrawal by Subject|0|||
156624795|NCT02198040|565369926|FG002|Overall Study|Withdrawal by Subject|1|||
156624796|NCT04524663|565369927|FG000|Overall Study|Withdrawal by Subject|0|||
156624797|NCT04524663|565369928|FG001|Overall Study|Withdrawal by Subject|2|||
156624798|NCT00337935|565369929|FG000|Overall Study|Adverse Event|2|||
156624799|NCT00337935|565369930|FG001|Overall Study|Adverse Event|5|||
156624800|NCT00337935|565369929|FG000|Overall Study|Death|2|||
156624801|NCT00337935|565369930|FG001|Overall Study|Death|8|||
156624802|NCT00337935|565369929|FG000|Overall Study|Physician Decision|1|||
156624803|NCT00337935|565369930|FG001|Overall Study|Physician Decision|1|||
156624804|NCT00337935|565369929|FG000|Overall Study|Lost to Follow-up|0|||
156624805|NCT00337935|565369930|FG001|Overall Study|Lost to Follow-up|1|||
156624806|NCT00337935|565369929|FG000|Overall Study|Protocol Violation|4|||
156624807|NCT00337935|565369930|FG001|Overall Study|Protocol Violation|3|||
156624808|NCT00337935|565369929|FG000|Overall Study|Withdrawal by Subject|1|||
156624809|NCT00337935|565369930|FG001|Overall Study|Withdrawal by Subject|7|||
156624810|NCT00337935|565369929|FG000|Overall Study|Other|0|||
156624811|NCT00337935|565369930|FG001|Overall Study|Other|1|||
156624812|NCT00337935|565369929|FG000|Overall Study|Lack of Efficacy|0|||
156624813|NCT00337935|565369930|FG001|Overall Study|Lack of Efficacy|1|||
156624814|NCT01884675|565369931|FG000|Overall Study|Study closed/terminated|3|||
156624815|NCT01884675|565369932|FG001|Overall Study|Study closed/terminated|2|||
156624816|NCT03359811|565369933|FG000|Overall Study|Protocol Violation|2|||
156624817|NCT03359811|565369934|FG001|Overall Study|Protocol Violation|0|||
156624818|NCT01189201|565369941|FG000|Overall Study|Adverse Event|1|||
156624819|NCT01682876|565369942|FG000|Overall Study|Administrative reason|4|||
156624820|NCT01682876|565369943|FG001|Overall Study|Administrative reason|4|||
156624821|NCT01682876|565369944|FG002|Overall Study|Administrative reason|0|||
156624822|NCT01682876|565369945|FG003|Overall Study|Administrative reason|3|||
156624823|NCT01682876|565369942|FG000|Overall Study|Adverse Event|0|||
156624824|NCT01682876|565369943|FG001|Overall Study|Adverse Event|0|||
156624825|NCT01682876|565369944|FG002|Overall Study|Adverse Event|0|||
156624826|NCT01682876|565369945|FG003|Overall Study|Adverse Event|1|||
156624827|NCT01682876|565369942|FG000|Overall Study|Lost to Follow-up|11|||
156624828|NCT01682876|565369943|FG001|Overall Study|Lost to Follow-up|15|||
156624829|NCT01682876|565369944|FG002|Overall Study|Lost to Follow-up|9|||
156624830|NCT01682876|565369945|FG003|Overall Study|Lost to Follow-up|11|||
156624831|NCT01682876|565369942|FG000|Overall Study|Protocol Violation|1|||
156624832|NCT01682876|565369943|FG001|Overall Study|Protocol Violation|1|||
156624833|NCT01682876|565369944|FG002|Overall Study|Protocol Violation|1|||
156624834|NCT01682876|565369945|FG003|Overall Study|Protocol Violation|1|||
156624835|NCT01682876|565369942|FG000|Overall Study|Withdrawal by Subject|4|||
156624836|NCT01682876|565369943|FG001|Overall Study|Withdrawal by Subject|0|||
156624837|NCT01682876|565369944|FG002|Overall Study|Withdrawal by Subject|0|||
156624838|NCT01682876|565369945|FG003|Overall Study|Withdrawal by Subject|2|||
156624839|NCT01682876|565369942|FG000|Overall Study|Other|1|||
156624840|NCT01682876|565369943|FG001|Overall Study|Other|0|||
156624841|NCT01682876|565369944|FG002|Overall Study|Other|1|||
156624842|NCT01682876|565369945|FG003|Overall Study|Other|1|||
156624843|NCT01277757|565369946|FG000|Overall Study|Disease Progression|1|||
156624844|NCT01277757|565369946|FG000|Overall Study|Withdrawal by Subject|1|||
156624845|NCT00911508|565369950|FG000|Overall Study|Lost to Follow-up|27|||
156624846|NCT00911508|565369951|FG001|Overall Study|Lost to Follow-up|18|||
156624847|NCT00911508|565369950|FG000|Overall Study|Withdrawal by Subject|79|||
156624848|NCT00911508|565369951|FG001|Overall Study|Withdrawal by Subject|112|||
156624849|NCT00240331|565369954|FG000|Overall Study|Withdrawal by Subject|125|||
156624850|NCT00240331|565369955|FG001|Overall Study|Withdrawal by Subject|132|||
156624851|NCT00240331|565369954|FG000|Overall Study|Option selected by investigator|1|||
156624852|NCT00240331|565369955|FG001|Overall Study|Option selected by investigator|2|||
156624853|NCT01409382|565369956|FG000|Overall Study|Lost to Follow-up|1|||
156624854|NCT01409382|565369957|FG001|Overall Study|Lost to Follow-up|1|||
156624855|NCT01409382|565369956|FG000|Overall Study|Protocol Violation|0|||
156624856|NCT01409382|565369957|FG001|Overall Study|Protocol Violation|3|||
156624857|NCT01409382|565369956|FG000|Overall Study|Multiple pregnancy|2|||
156624858|NCT01409382|565369957|FG001|Overall Study|Multiple pregnancy|4|||
156624859|NCT01409382|565369956|FG000|Overall Study|Still pregnant when study ended|13|||
156624860|NCT01409382|565369957|FG001|Overall Study|Still pregnant when study ended|2|||
156624861|NCT01409382|565369956|FG000|Overall Study|Did not manage to get pregnant|64|||
156624862|NCT01409382|565369957|FG001|Overall Study|Did not manage to get pregnant|70|||
156624863|NCT01409382|565369956|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
156624864|NCT01409382|565369957|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
156624865|NCT01233076|565369958|FG000|Period 2, One Week|Lost to Follow-up|1|||
156624866|NCT01233076|565369959|FG001|Period 2, One Week|Lost to Follow-up|0|||
156624867|NCT04308668|565369960|FG000|Overall Study|Lost to Follow-up|32|||
156624868|NCT04308668|565369961|FG001|Overall Study|Lost to Follow-up|38|||
156624869|NCT04308668|565369960|FG000|Overall Study|Withdrawal by Subject|4|||
156624870|NCT04308668|565369961|FG001|Overall Study|Withdrawal by Subject|4|||
156624871|NCT04563845|565369962|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624872|NCT04563845|565369963|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624873|NCT04563845|565369964|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624874|NCT04563845|565369965|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624875|NCT04563845|565369966|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624876|NCT04563845|565369967|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624877|NCT04563845|565369968|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624878|NCT04563845|565369969|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
156624879|NCT04563845|565369970|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624880|NCT04563845|565369971|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624881|NCT04563845|565369972|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624882|NCT04563845|565369973|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624883|NCT04563845|565369974|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624884|NCT04563845|565369975|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
156624885|NCT04563845|565369962|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624886|NCT04563845|565369963|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624887|NCT04563845|565369964|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624888|NCT04563845|565369965|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624889|NCT04563845|565369966|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
156624890|NCT04563845|565369967|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624891|NCT04563845|565369968|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624892|NCT04563845|565369969|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624893|NCT04563845|565369970|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624894|NCT04563845|565369971|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624895|NCT04563845|565369972|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624896|NCT04563845|565369973|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624897|NCT04563845|565369974|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624898|NCT04563845|565369975|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
156624899|NCT01020812|565369976|FG000|Overall Study|Physician Decision|1|||
156624900|NCT01020812|565369976|FG000|Overall Study|Withdrawal by Subject|1|||
156624901|NCT01020812|565369976|FG000|Overall Study|Protocol Violation|1|||
156624902|NCT03380091|565369990|FG000|Overall Study|Withdrawal by Subject|2|||
156624903|NCT03380091|565369991|FG001|Overall Study|Withdrawal by Subject|1|||
156624904|NCT01980056|565369993|FG000|Overall Study|Death|1|||
156624905|NCT01980056|565369994|FG001|Overall Study|Death|1|||
156624906|NCT01980056|565369995|FG002|Overall Study|Death|0|||
156624907|NCT03802331|565369996|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
156624908|NCT03802331|565369997|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
156624909|NCT00368069|565369999|FG000|Overall Study|Adverse Event|5|||
156624910|NCT00368069|565370000|FG001|Overall Study|Adverse Event|2|||
156624911|NCT00368069|565369999|FG000|Overall Study|Lack of Efficacy|0|||
156624912|NCT00368069|565370000|FG001|Overall Study|Lack of Efficacy|1|||
156624913|NCT00368069|565369999|FG000|Overall Study|Lost to Follow-up|1|||
156624914|NCT00368069|565370000|FG001|Overall Study|Lost to Follow-up|0|||
156624915|NCT00368069|565369999|FG000|Overall Study|Protocol Violation|0|||
156624916|NCT00368069|565370000|FG001|Overall Study|Protocol Violation|2|||
156624917|NCT00368069|565369999|FG000|Overall Study|Withdrawal of Consent|2|||
156624918|NCT00368069|565370000|FG001|Overall Study|Withdrawal of Consent|1|||
156624919|NCT00368069|565369999|FG000|Overall Study|no blood sampling possible|0|||
156624920|NCT00368069|565370000|FG001|Overall Study|no blood sampling possible|1|||
156624921|NCT03432819|565370004|FG000|Overall Study|Lost to Follow-up|2|||
156624922|NCT03432819|565370005|FG001|Overall Study|Lost to Follow-up|2|||
156624923|NCT03432819|565370004|FG000|Overall Study|Withdrawal by Subject|5|||
156624924|NCT03432819|565370005|FG001|Overall Study|Withdrawal by Subject|3|||
156624925|NCT00083616|565370006|FG000|Overall Study|Disease Progression|16|||
156624926|NCT00083616|565370006|FG000|Overall Study|Lost to Follow-up|1|||
156624927|NCT00083616|565370006|FG000|Overall Study|Physician Decision|2|||
156624928|NCT00083616|565370006|FG000|Overall Study|Withdrawal by Subject|3|||
156624929|NCT00083616|565370006|FG000|Overall Study|Ineligibility determined|2|||
156624930|NCT00083616|565370006|FG000|Overall Study|Non-compliance|1|||
156624931|NCT00083616|565370006|FG000|Overall Study|Other|6|||
156624932|NCT01474993|565370007|FG000|Overall Study|Lost to Follow-up|1|||
156624933|NCT01474993|565370008|FG001|Overall Study|Lost to Follow-up|2|||
156624934|NCT01474993|565370007|FG000|Overall Study|Adverse Event|0|||
156624935|NCT01474993|565370008|FG001|Overall Study|Adverse Event|1|||
156624936|NCT00760994|565370009|FG000|Overall Study|Lost to Follow-up|4|||
156624937|NCT00760994|565370010|FG001|Overall Study|Lost to Follow-up|4|||
156624938|NCT00760994|565370011|FG002|Overall Study|Lost to Follow-up|3|||
156624939|NCT03451630|565370012|FG000|Overall Study|Death|15|||
156624940|NCT03451630|565370013|FG001|Overall Study|Death|16|||
156624941|NCT03451630|565370014|FG002|Overall Study|Death|11|||
156624942|NCT03451630|565370012|FG000|Overall Study|Lost to Follow-up|9|||
156624943|NCT03451630|565370013|FG001|Overall Study|Lost to Follow-up|0|||
156624944|NCT03451630|565370014|FG002|Overall Study|Lost to Follow-up|4|||
156624945|NCT03451630|565370012|FG000|Overall Study|Withdrawal by Subject|0|||
156624946|NCT03451630|565370013|FG001|Overall Study|Withdrawal by Subject|3|||
156624947|NCT03451630|565370014|FG002|Overall Study|Withdrawal by Subject|0|||
156624948|NCT03451630|565370012|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
156624949|NCT03451630|565370013|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
156624950|NCT03451630|565370014|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
156624951|NCT02041533|565370015|FG000|Pre-Treatment Period|Disease Progression|1|||
156624952|NCT02041533|565370016|FG001|Pre-Treatment Period|Disease Progression|1|||
156624953|NCT02041533|565370015|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
156624954|NCT02041533|565370016|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
156624955|NCT02041533|565370015|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
156624956|NCT02041533|565370016|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
156624957|NCT02041533|565370015|FG000|Treatment Period|Disease progression|189|||
156624958|NCT02041533|565370016|FG001|Treatment Period|Disease progression|146|||
156624959|NCT02041533|565370015|FG000|Treatment Period|Study drug toxicity|30|||
156624960|NCT02041533|565370016|FG001|Treatment Period|Study drug toxicity|34|||
156624961|NCT02041533|565370015|FG000|Treatment Period|Death|1|||
156624962|NCT02041533|565370016|FG001|Treatment Period|Death|0|||
156624963|NCT02041533|565370015|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
156624964|NCT02041533|565370016|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
156624965|NCT02041533|565370015|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
156624966|NCT02041533|565370016|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
156624967|NCT02041533|565370015|FG000|Treatment Period|Participant withdrew consent|2|||
156624968|NCT02041533|565370016|FG001|Treatment Period|Participant withdrew consent|2|||
156624969|NCT02041533|565370015|FG000|Treatment Period|Maximum clinical benefit|0|||
156624970|NCT02041533|565370016|FG001|Treatment Period|Maximum clinical benefit|18|||
156624971|NCT02041533|565370015|FG000|Treatment Period|Poor/Non-compliance|1|||
156624972|NCT02041533|565370016|FG001|Treatment Period|Poor/Non-compliance|0|||
156624973|NCT02041533|565370015|FG000|Treatment Period|Administrative reason by sponsor|1|||
156624974|NCT02041533|565370016|FG001|Treatment Period|Administrative reason by sponsor|0|||
156624975|NCT02041533|565370015|FG000|Treatment Period|Other reasons|9|||
156624976|NCT02041533|565370016|FG001|Treatment Period|Other reasons|2|||
156624977|NCT02041533|565370015|FG000|Treatment Period|Not Reported|0|||
156624978|NCT02041533|565370016|FG001|Treatment Period|Not Reported|1|||
156624979|NCT02500706|565370017|FG000|Overall Study|Adverse Event|0|||
156624980|NCT02500706|565370018|FG001|Overall Study|Adverse Event|0|||
156624981|NCT02500706|565370019|FG002|Overall Study|Adverse Event|1|||
156624982|NCT02500706|565370017|FG000|Overall Study|Lost to Follow-up|0|||
156624983|NCT02500706|565370018|FG001|Overall Study|Lost to Follow-up|1|||
156624984|NCT02500706|565370019|FG002|Overall Study|Lost to Follow-up|1|||
156624985|NCT02500706|565370017|FG000|Overall Study|Withdrawal by Subject|4|||
156624986|NCT02500706|565370018|FG001|Overall Study|Withdrawal by Subject|6|||
156624987|NCT02500706|565370019|FG002|Overall Study|Withdrawal by Subject|4|||
156624988|NCT02500706|565370017|FG000|Overall Study|Unclassified|0|||
156624989|NCT02500706|565370018|FG001|Overall Study|Unclassified|0|||
156624990|NCT02500706|565370019|FG002|Overall Study|Unclassified|1|||
156624991|NCT00529152|565370020|FG000|Overall Study|Adverse Event|2|||
156624992|NCT00529152|565370020|FG000|Overall Study|Withdrawal by Subject|2|||
156624993|NCT00529152|565370020|FG000|Overall Study|Lost to Follow-up|1|||
156624994|NCT01957111|565370024|FG000|Overall Study|Withdrawal by Subject|1|||
156624995|NCT01957111|565370025|FG001|Overall Study|Withdrawal by Subject|1|||
156624996|NCT03500419|565370026|FG000|Overall Study|Withdrawal by Subject|2|||
156624997|NCT03500419|565370027|FG001|Overall Study|Withdrawal by Subject|25|||
156624998|NCT01000311|565370028|FG000|Overall Study|Adverse Event|2|||
156624999|NCT01000311|565370029|FG001|Overall Study|Adverse Event|5|||
156625000|NCT01000311|565370028|FG000|Overall Study|Withdrawal by Subject|16|||
156625001|NCT01000311|565370029|FG001|Overall Study|Withdrawal by Subject|24|||
156625002|NCT01000311|565370028|FG000|Overall Study|Lost to Follow-up|15|||
156625003|NCT01000311|565370029|FG001|Overall Study|Lost to Follow-up|24|||
156625004|NCT01000311|565370028|FG000|Overall Study|Protocol Violation|1|||
156625005|NCT01000311|565370029|FG001|Overall Study|Protocol Violation|2|||
156625006|NCT01000311|565370028|FG000|Overall Study|Inappropriate enrollment|2|||
156625007|NCT01000311|565370029|FG001|Overall Study|Inappropriate enrollment|0|||
156625008|NCT01000311|565370028|FG000|Overall Study|Administrative reason|9|||
156625009|NCT01000311|565370029|FG001|Overall Study|Administrative reason|15|||
156625010|NCT01646255|565370030|FG000|Overall Study|Adverse Event|7|||
156625011|NCT01646255|565370031|FG001|Overall Study|Adverse Event|8|||
156625012|NCT01646255|565370030|FG000|Overall Study|Lack of Efficacy|2|||
156625013|NCT01646255|565370031|FG001|Overall Study|Lack of Efficacy|0|||
156625014|NCT01646255|565370030|FG000|Overall Study|Withdrawal by Subject|10|||
156625015|NCT01646255|565370031|FG001|Overall Study|Withdrawal by Subject|6|||
156625016|NCT01646255|565370030|FG000|Overall Study|Compliance is not well|1|||
156625017|NCT01646255|565370031|FG001|Overall Study|Compliance is not well|0|||
156625018|NCT01646255|565370030|FG000|Overall Study|Inclusion Criteria Deviation|1|||
156625019|NCT01646255|565370031|FG001|Overall Study|Inclusion Criteria Deviation|0|||
156625020|NCT01376908|565370032|FG000|Overall Study|Protocol Violation|1|||
156625021|NCT01376908|565370033|FG001|Overall Study|Protocol Violation|1|||
156625022|NCT01376908|565370032|FG000|Overall Study|Withdrawal by Subject|1|||
156625023|NCT01376908|565370033|FG001|Overall Study|Withdrawal by Subject|2|||
156625024|NCT00742391|565370034|FG000|Overall Study|Adverse Event|2|||
156625025|NCT00742391|565370035|FG001|Overall Study|Adverse Event|1|||
156625026|NCT00742391|565370034|FG000|Overall Study|Lost to Follow-up|1|||
156625027|NCT00742391|565370035|FG001|Overall Study|Lost to Follow-up|0|||
156625028|NCT00742391|565370034|FG000|Overall Study|Protocol Violation|1|||
156625029|NCT00742391|565370035|FG001|Overall Study|Protocol Violation|0|||
156625030|NCT01241318|565370036|FG000|Overall Study|Woman: false pregnancies|27|||
156625031|NCT01241318|565370037|FG001|Overall Study|Woman: false pregnancies|15|||
156625032|NCT01241318|565370036|FG000|Overall Study|Woman: miscarriage/abortion|46|||
156625033|NCT01241318|565370037|FG001|Overall Study|Woman: miscarriage/abortion|38|||
156625034|NCT01241318|565370036|FG000|Overall Study|Withdrawal by Subject|175|||
156625035|NCT01241318|565370037|FG001|Overall Study|Withdrawal by Subject|46|||
156625036|NCT01241318|565370036|FG000|Overall Study|Lost to Follow-up|740|||
156625037|NCT01241318|565370037|FG001|Overall Study|Lost to Follow-up|455|||
156625038|NCT01241318|565370036|FG000|Overall Study|Death|2|||
156625039|NCT01241318|565370037|FG001|Overall Study|Death|4|||
156625040|NCT01241318|565370036|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
156625041|NCT01241318|565370037|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
156625042|NCT01241318|565370036|FG000|Overall Study|Woman: Stillborn infant|129|||
156625043|NCT01241318|565370037|FG001|Overall Study|Woman: Stillborn infant|146|||
156625044|NCT02355665|565370038|FG000|Overall Study|Adverse Event|16|||
156625045|NCT02355665|565370039|FG001|Overall Study|Adverse Event|24|||
156625046|NCT02355665|565370038|FG000|Overall Study|Protocol Violation|2|||
156625047|NCT02355665|565370039|FG001|Overall Study|Protocol Violation|0|||
156625048|NCT02355665|565370038|FG000|Overall Study|Withdrawal by Subject|90|||
156625049|NCT02355665|565370039|FG001|Overall Study|Withdrawal by Subject|100|||
156625050|NCT02355665|565370038|FG000|Overall Study|Lost to Follow-up|131|||
156625051|NCT02355665|565370039|FG001|Overall Study|Lost to Follow-up|103|||
156625052|NCT02355665|565370038|FG000|Overall Study|Death|4|||
156625053|NCT02355665|565370039|FG001|Overall Study|Death|2|||
156625054|NCT02355665|565370038|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
156625055|NCT02355665|565370039|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
156625056|NCT00266695|565370042|FG000|Overall Study|Adverse Event|1|||
156625057|NCT00266695|565370042|FG000|Overall Study|Death|9|||
156625058|NCT00266695|565370042|FG000|Overall Study|Physician Decision|1|||
156625059|NCT00266695|565370042|FG000|Overall Study|Lost to Follow-up|3|||
156625060|NCT00266695|565370042|FG000|Overall Study|Withdrawal by Subject|15|||
156625061|NCT02380703|565370043|FG000|Overall Study|Withdrawal by Subject|12|||
156625062|NCT02380703|565370044|FG001|Overall Study|Withdrawal by Subject|9|||
156625063|NCT02380703|565370043|FG000|Overall Study|Lost to Follow-up|12|||
156625064|NCT02380703|565370044|FG001|Overall Study|Lost to Follow-up|12|||
156625065|NCT02380703|565370043|FG000|Overall Study|Caregiver death|1|||
156625066|NCT02380703|565370044|FG001|Overall Study|Caregiver death|0|||
156625067|NCT02380703|565370043|FG000|Overall Study|Person with dementia (PWD) death|7|||
156625068|NCT02380703|565370044|FG001|Overall Study|Person with dementia (PWD) death|8|||
156625069|NCT02380703|565370043|FG000|Overall Study|Entered Long-term Care|4|||
156625070|NCT02380703|565370044|FG001|Overall Study|Entered Long-term Care|7|||
156625071|NCT03607994|565370045|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
156625072|NCT03607994|565370046|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
156625073|NCT04490499|565370052|FG000|Overall Study|Withdrawal by Subject|2|||
156625074|NCT03125902|565370055|FG000|Overall Study|Adverse Event|0|||
156625075|NCT03125902|565370056|FG001|Overall Study|Adverse Event|1|||
156625076|NCT03125902|565370055|FG000|Overall Study|Death|119|||
156625077|NCT03125902|565370056|FG001|Overall Study|Death|229|||
156625078|NCT03125902|565370055|FG000|Overall Study|Lost to Follow-up|4|||
156625079|NCT03125902|565370056|FG001|Overall Study|Lost to Follow-up|13|||
156625080|NCT03125902|565370055|FG000|Overall Study|Other|0|||
156625081|NCT03125902|565370056|FG001|Overall Study|Other|4|||
156625082|NCT03125902|565370055|FG000|Overall Study|Physician Decision|2|||
156625083|NCT03125902|565370056|FG001|Overall Study|Physician Decision|1|||
156625084|NCT03125902|565370055|FG000|Overall Study|Progressive Disease|0|||
156625085|NCT03125902|565370056|FG001|Overall Study|Progressive Disease|3|||
156625086|NCT03125902|565370055|FG000|Overall Study|Study Terminated By Sponsor|74|||
156625087|NCT03125902|565370056|FG001|Overall Study|Study Terminated By Sponsor|143|||
156625088|NCT03125902|565370055|FG000|Overall Study|Withdrawal by Subject|21|||
156625089|NCT03125902|565370056|FG001|Overall Study|Withdrawal by Subject|37|||
156625090|NCT01843933|565370057|FG000|Overall Study|Data lost|6|||
156625091|NCT01843933|565370058|FG001|Overall Study|Data lost|4|||
156625092|NCT04411472|565370059|FG000|Overall Study|Adverse Event|5|||
156625093|NCT04411472|565370060|FG001|Overall Study|Adverse Event|10|||
156625094|NCT04411472|565370061|FG002|Overall Study|Adverse Event|1|||
156625095|NCT04411472|565370062|FG003|Overall Study|Adverse Event|0|||
156625096|NCT04411472|565370063|FG004|Overall Study|Adverse Event|0|||
156625097|NCT04411472|565370064|FG005|Overall Study|Adverse Event|0|||
156625098|NCT04411472|565370059|FG000|Overall Study|Protocol Violation|1|||
156625099|NCT04411472|565370060|FG001|Overall Study|Protocol Violation|0|||
156625100|NCT04411472|565370061|FG002|Overall Study|Protocol Violation|0|||
156625101|NCT04411472|565370062|FG003|Overall Study|Protocol Violation|0|||
156625102|NCT04411472|565370063|FG004|Overall Study|Protocol Violation|0|||
156625103|NCT04411472|565370064|FG005|Overall Study|Protocol Violation|0|||
156625104|NCT04411472|565370059|FG000|Overall Study|Withdrawal by Subject|0|||
156625105|NCT04411472|565370060|FG001|Overall Study|Withdrawal by Subject|1|||
156625106|NCT04411472|565370061|FG002|Overall Study|Withdrawal by Subject|0|||
156625107|NCT04411472|565370062|FG003|Overall Study|Withdrawal by Subject|1|||
156625108|NCT04411472|565370063|FG004|Overall Study|Withdrawal by Subject|0|||
156625109|NCT04411472|565370064|FG005|Overall Study|Withdrawal by Subject|0|||
156625110|NCT04411472|565370059|FG000|Overall Study|Physician Decision|1|||
156625111|NCT04411472|565370060|FG001|Overall Study|Physician Decision|0|||
156625112|NCT04411472|565370061|FG002|Overall Study|Physician Decision|0|||
156625113|NCT04411472|565370062|FG003|Overall Study|Physician Decision|0|||
156625114|NCT04411472|565370063|FG004|Overall Study|Physician Decision|0|||
156625115|NCT04411472|565370064|FG005|Overall Study|Physician Decision|0|||
156625116|NCT04411472|565370059|FG000|Overall Study|Study terminated by sponsor|17|||
156625117|NCT04411472|565370060|FG001|Overall Study|Study terminated by sponsor|20|||
156635563|NCT00602667|565409960|FG000|Overall Study|Family request|3|||
156625118|NCT04411472|565370061|FG002|Overall Study|Study terminated by sponsor|3|||
156625119|NCT04411472|565370062|FG003|Overall Study|Study terminated by sponsor|0|||
156625120|NCT04411472|565370063|FG004|Overall Study|Study terminated by sponsor|0|||
156625121|NCT04411472|565370064|FG005|Overall Study|Study terminated by sponsor|0|||
156625122|NCT00440232|565370067|FG000|Overall Study|Lost to Follow-up|1|||
156625123|NCT00440232|565370068|FG001|Overall Study|Lost to Follow-up|1|||
156625124|NCT00440232|565370067|FG000|Overall Study|Unable to treat within allowed time|0|||
156625125|NCT00440232|565370068|FG001|Overall Study|Unable to treat within allowed time|1|||
156625126|NCT00440232|565370067|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
156625127|NCT00440232|565370068|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
156625128|NCT00819052|565370069|FG000|Overall Study|Adverse Event|0|||
156625129|NCT00819052|565370070|FG001|Overall Study|Adverse Event|5|||
156625130|NCT00819052|565370069|FG000|Overall Study|Protocol Violation|1|||
156625131|NCT00819052|565370070|FG001|Overall Study|Protocol Violation|2|||
156625132|NCT00819052|565370069|FG000|Overall Study|Lost to Follow-up|1|||
156625133|NCT00819052|565370070|FG001|Overall Study|Lost to Follow-up|2|||
156625134|NCT00819052|565370069|FG000|Overall Study|Withdrawal by Subject|1|||
156625135|NCT00819052|565370070|FG001|Overall Study|Withdrawal by Subject|2|||
156625136|NCT00819052|565370069|FG000|Overall Study|Lack of Efficacy|1|||
156625137|NCT00819052|565370070|FG001|Overall Study|Lack of Efficacy|1|||
156625138|NCT00819052|565370069|FG000|Overall Study|Pregnancy|1|||
156625139|NCT00819052|565370070|FG001|Overall Study|Pregnancy|2|||
156625140|NCT00819052|565370069|FG000|Overall Study|Death or events leading to death|1|||
156625141|NCT00819052|565370070|FG001|Overall Study|Death or events leading to death|0|||
156625142|NCT00362297|565370071|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
156625143|NCT00362297|565370072|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
156625144|NCT00591786|565370075|FG000|Overall Study|Withdrawal of Informed Consent|0|||
156625145|NCT00591786|565370076|FG001|Overall Study|Withdrawal of Informed Consent|0|||
156625146|NCT00591786|565370077|FG002|Overall Study|Withdrawal of Informed Consent|1|||
156625147|NCT00591786|565370078|FG003|Overall Study|Withdrawal of Informed Consent|0|||
156625148|NCT00591786|565370079|FG004|Overall Study|Withdrawal of Informed Consent|0|||
156625149|NCT00591786|565370080|FG005|Overall Study|Withdrawal of Informed Consent|0|||
156625150|NCT00591786|565370081|FG006|Overall Study|Withdrawal of Informed Consent|0|||
156625151|NCT00591786|565370082|FG007|Overall Study|Withdrawal of Informed Consent|0|||
156625152|NCT00591786|565370083|FG008|Overall Study|Withdrawal of Informed Consent|0|||
156625153|NCT00591786|565370084|FG009|Overall Study|Withdrawal of Informed Consent|0|||
156625154|NCT00554229|565370085|FG000|Overall Study|Lost to Follow-up|3|||
156625155|NCT00554229|565370086|FG001|Overall Study|Lost to Follow-up|6|||
156625156|NCT00554229|565370085|FG000|Overall Study|Withdrawal by Subject|29|||
156625157|NCT00554229|565370086|FG001|Overall Study|Withdrawal by Subject|37|||
156625158|NCT00554229|565370085|FG000|Overall Study|Adverse Event|71|||
156625159|NCT00554229|565370086|FG001|Overall Study|Adverse Event|39|||
156625160|NCT00554229|565370085|FG000|Overall Study|Protocol Violation|3|||
156625161|NCT00554229|565370086|FG001|Overall Study|Protocol Violation|3|||
156625162|NCT00554229|565370085|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
156625163|NCT00554229|565370086|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
156625164|NCT00554229|565370085|FG000|Overall Study|Randomised but no treatment received|1|||
156625165|NCT00554229|565370086|FG001|Overall Study|Randomised but no treatment received|0|||
156625166|NCT04120116|565371649|FG000|Overall Study|Lost to Follow-up|0|||
156625167|NCT04120116|565371650|FG001|Overall Study|Lost to Follow-up|1|||
156625168|NCT04120116|565371651|FG002|Overall Study|Lost to Follow-up|0|||
156625169|NCT04120116|565371652|FG003|Overall Study|Lost to Follow-up|2|||
156625170|NCT04120116|565371649|FG000|Overall Study|Withdrawal by Subject|1|||
156625171|NCT04120116|565371650|FG001|Overall Study|Withdrawal by Subject|0|||
156625172|NCT04120116|565371651|FG002|Overall Study|Withdrawal by Subject|1|||
156625173|NCT04120116|565371652|FG003|Overall Study|Withdrawal by Subject|1|||
156625174|NCT04120116|565371649|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
156625175|NCT04120116|565371650|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
156625176|NCT04120116|565371651|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
156625177|NCT04120116|565371652|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
156625178|NCT00965458|565371653|FG000|Overall Study|Adverse Event|1|||
156625179|NCT00965458|565371654|FG001|Overall Study|Adverse Event|0|||
156625180|NCT00965458|565371653|FG000|Overall Study|Lost to Follow-up|1|||
156625181|NCT00965458|565371654|FG001|Overall Study|Lost to Follow-up|3|||
156625182|NCT00965458|565371653|FG000|Overall Study|Withdrawal by Subject|0|||
156625183|NCT00965458|565371654|FG001|Overall Study|Withdrawal by Subject|1|||
156625184|NCT01846039|565371657|FG000|Overall Study|Protocol Violation|1|||
156625185|NCT01846039|565371657|FG000|Overall Study|Subject Withdrew Consent|1|||
156625186|NCT02528331|565371668|FG000|Overall Study|Withdrawal by Subject|2|||
156625187|NCT03824704|565371673|FG000|Overall Study|Study Terminated by Sponsor|1|||
156625188|NCT02155660|565371681|FG000|Overall Study|Other Reason|8|||
156625189|NCT02155660|565371682|FG001|Overall Study|Other Reason|6|||
156625190|NCT02155660|565371683|FG002|Overall Study|Other Reason|10|||
156625191|NCT02155660|565371684|FG003|Overall Study|Other Reason|10|||
156625192|NCT02155660|565371681|FG000|Overall Study|Study-specific withdrawal criteria|0|||
156625193|NCT02155660|565371682|FG001|Overall Study|Study-specific withdrawal criteria|1|||
156625194|NCT02155660|565371683|FG002|Overall Study|Study-specific withdrawal criteria|1|||
156625195|NCT02155660|565371684|FG003|Overall Study|Study-specific withdrawal criteria|1|||
156625196|NCT02155660|565371681|FG000|Overall Study|Severe non-compliance|0|||
156625197|NCT02155660|565371682|FG001|Overall Study|Severe non-compliance|4|||
156625198|NCT02155660|565371683|FG002|Overall Study|Severe non-compliance|0|||
156625199|NCT02155660|565371684|FG003|Overall Study|Severe non-compliance|1|||
156625200|NCT02155660|565371681|FG000|Overall Study|Adverse Event|2|||
156625201|NCT02155660|565371682|FG001|Overall Study|Adverse Event|6|||
156625202|NCT02155660|565371683|FG002|Overall Study|Adverse Event|3|||
156625203|NCT02155660|565371684|FG003|Overall Study|Adverse Event|1|||
156625204|NCT02155660|565371681|FG000|Overall Study|Lost to Follow-up|3|||
156625205|NCT02155660|565371682|FG001|Overall Study|Lost to Follow-up|6|||
156625206|NCT02155660|565371683|FG002|Overall Study|Lost to Follow-up|5|||
156625207|NCT02155660|565371684|FG003|Overall Study|Lost to Follow-up|8|||
156625208|NCT02155660|565371681|FG000|Overall Study|Death|17|||
156625209|NCT02155660|565371682|FG001|Overall Study|Death|19|||
156625210|NCT02155660|565371683|FG002|Overall Study|Death|17|||
156625211|NCT02155660|565371684|FG003|Overall Study|Death|19|||
156625212|NCT02155660|565371681|FG000|Overall Study|Withdrawal by Subject|28|||
156625213|NCT02155660|565371682|FG001|Overall Study|Withdrawal by Subject|31|||
156625214|NCT02155660|565371683|FG002|Overall Study|Withdrawal by Subject|24|||
156625215|NCT02155660|565371684|FG003|Overall Study|Withdrawal by Subject|21|||
156625216|NCT03730987|565371685|FG000|Overall Study|Lost to Follow-up|2|||
156625217|NCT03730987|565371686|FG001|Overall Study|Lost to Follow-up|0|||
156625218|NCT03730987|565371687|FG002|Overall Study|Lost to Follow-up|2|||
156625219|NCT03730987|565371688|FG003|Overall Study|Lost to Follow-up|0|||
156625220|NCT02505945|565371689|FG000|Overall Study|Withdrawal by Subject|13|||
156625221|NCT02505945|565371690|FG001|Overall Study|Withdrawal by Subject|2|||
156625222|NCT02505945|565371689|FG000|Overall Study|Adverse Event|1|||
156625223|NCT02505945|565371690|FG001|Overall Study|Adverse Event|0|||
156625224|NCT02505945|565371689|FG000|Overall Study|Physician Decision|2|||
156625225|NCT02505945|565371690|FG001|Overall Study|Physician Decision|1|||
156625226|NCT02505945|565371689|FG000|Overall Study|Lost to Follow-up|6|||
156625227|NCT02505945|565371690|FG001|Overall Study|Lost to Follow-up|1|||
156625228|NCT00883896|565371696|FG000|Overall Study|Lost to Follow-up|0|||
156625229|NCT00883896|565371697|FG001|Overall Study|Lost to Follow-up|0|||
156625230|NCT00883896|565371698|FG002|Overall Study|Lost to Follow-up|0|||
156625231|NCT00883896|565371699|FG003|Overall Study|Lost to Follow-up|2|||
156625232|NCT00883896|565371696|FG000|Overall Study|Withdrawal by Subject|5|||
156625233|NCT00883896|565371697|FG001|Overall Study|Withdrawal by Subject|0|||
156625234|NCT00883896|565371698|FG002|Overall Study|Withdrawal by Subject|1|||
156625235|NCT00883896|565371699|FG003|Overall Study|Withdrawal by Subject|3|||
156625236|NCT00883896|565371696|FG000|Overall Study|Lack of Efficacy|0|||
156625237|NCT00883896|565371697|FG001|Overall Study|Lack of Efficacy|0|||
156625238|NCT00883896|565371698|FG002|Overall Study|Lack of Efficacy|0|||
156625239|NCT00883896|565371699|FG003|Overall Study|Lack of Efficacy|2|||
156625240|NCT00883896|565371696|FG000|Overall Study|Other|1|||
156625241|NCT00883896|565371697|FG001|Overall Study|Other|0|||
156625242|NCT00883896|565371698|FG002|Overall Study|Other|0|||
156625243|NCT00883896|565371699|FG003|Overall Study|Other|0|||
156625244|NCT02546193|565371700|FG000|Overall Study|Withdrawal by Subject|2|||
156625245|NCT02546193|565371701|FG001|Overall Study|Withdrawal by Subject|0|||
156625246|NCT02546193|565371702|FG002|Overall Study|Withdrawal by Subject|1|||
156625247|NCT02546193|565371703|FG003|Overall Study|Withdrawal by Subject|0|||
156625248|NCT02546193|565371700|FG000|Overall Study|Not eligible at time of induction|4|||
156625249|NCT02546193|565371701|FG001|Overall Study|Not eligible at time of induction|6|||
156625250|NCT02546193|565371702|FG002|Overall Study|Not eligible at time of induction|1|||
156625251|NCT02546193|565371703|FG003|Overall Study|Not eligible at time of induction|0|||
156625252|NCT01287403|565371707|FG000|1st Intervention (1 Day)|Adverse Event|1|||
156625253|NCT01098266|565371708|FG000|Overall Study|Physician Decision|1|||
156625254|NCT01098266|565371709|FG001|Overall Study|Physician Decision|0|||
156625255|NCT01098266|565371708|FG000|Overall Study|Death|3|||
156625256|NCT01098266|565371709|FG001|Overall Study|Death|2|||
156625257|NCT01098266|565371708|FG000|Overall Study|Withdrawal by Subject|3|||
156625258|NCT01098266|565371709|FG001|Overall Study|Withdrawal by Subject|5|||
156625259|NCT00438815|565371713|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
156625260|NCT00438815|565371713|FG000|Overall Study|3-month follow-up no longer required|12|||
156625261|NCT00438815|565371713|FG000|Overall Study|Noncompliance with protocol requirements|9|||
156625262|NCT00438815|565371713|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
156625263|NCT00438815|565371713|FG000|Overall Study|Lost to Follow-up|6|||
156625264|NCT00438815|565371713|FG000|Overall Study|Withdrawal by Subject|6|||
156625265|NCT00438815|565371713|FG000|Overall Study|Death|1|||
156625266|NCT01733758|565371714|FG000|Overall Study|Adverse Event|5|||
156625267|NCT01733758|565371715|FG001|Overall Study|Adverse Event|7|||
156625268|NCT01733758|565371716|FG002|Overall Study|Adverse Event|8|||
156625269|NCT01733758|565371717|FG003|Overall Study|Adverse Event|1|||
156625270|NCT01733758|565371714|FG000|Overall Study|Withdrawal by Subject|1|||
156625271|NCT01733758|565371715|FG001|Overall Study|Withdrawal by Subject|1|||
156625272|NCT01733758|565371716|FG002|Overall Study|Withdrawal by Subject|5|||
156625273|NCT01733758|565371717|FG003|Overall Study|Withdrawal by Subject|3|||
156625274|NCT01733758|565371714|FG000|Overall Study|Persistent Hyperglycemia|3|||
156625275|NCT01733758|565371715|FG001|Overall Study|Persistent Hyperglycemia|2|||
156625276|NCT01733758|565371716|FG002|Overall Study|Persistent Hyperglycemia|0|||
156625277|NCT01733758|565371717|FG003|Overall Study|Persistent Hyperglycemia|0|||
156625278|NCT01733758|565371714|FG000|Overall Study|Protocol Violation|0|||
156625279|NCT01733758|565371715|FG001|Overall Study|Protocol Violation|1|||
156625280|NCT01733758|565371716|FG002|Overall Study|Protocol Violation|2|||
156625281|NCT01733758|565371717|FG003|Overall Study|Protocol Violation|2|||
156625282|NCT01733758|565371714|FG000|Overall Study|Non-compliance|1|||
156625283|NCT01733758|565371715|FG001|Overall Study|Non-compliance|0|||
156625284|NCT01733758|565371716|FG002|Overall Study|Non-compliance|0|||
156625285|NCT01733758|565371717|FG003|Overall Study|Non-compliance|0|||
156625286|NCT01733758|565371714|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
156625287|NCT01733758|565371715|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
156625288|NCT01733758|565371716|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
156625289|NCT01733758|565371717|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
156625290|NCT01733758|565371714|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
156625291|NCT01733758|565371715|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
156625292|NCT01733758|565371716|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
156625293|NCT01733758|565371717|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
156625294|NCT02545270|565371722|FG000|Overall Study|technical difficulties|0|||
156625295|NCT02545270|565371723|FG001|Overall Study|technical difficulties|1|||
156625296|NCT02545270|565371724|FG002|Overall Study|technical difficulties|0|||
156625297|NCT02545270|565371722|FG000|Overall Study|Videos being too similar to other|0|||
156625298|NCT02545270|565371723|FG001|Overall Study|Videos being too similar to other|0|||
156625299|NCT02545270|565371724|FG002|Overall Study|Videos being too similar to other|2|||
156625300|NCT00727246|565371725|FG000|Overall Study|could not complete MRI|0|||
156625301|NCT00727246|565371726|FG001|Overall Study|could not complete MRI|1|||
156625302|NCT00727246|565371727|FG002|Overall Study|could not complete MRI|0|||
156625303|NCT00727246|565371728|FG003|Overall Study|could not complete MRI|1|||
156625304|NCT00727246|565371725|FG000|Overall Study|incidental finding|0|||
156625305|NCT00727246|565371726|FG001|Overall Study|incidental finding|0|||
156625306|NCT00727246|565371727|FG002|Overall Study|incidental finding|0|||
156625307|NCT00727246|565371728|FG003|Overall Study|incidental finding|1|||
156625308|NCT00727246|565371725|FG000|Overall Study|withdrawn|0|||
156625309|NCT00727246|565371726|FG001|Overall Study|withdrawn|0|||
156625310|NCT00727246|565371727|FG002|Overall Study|withdrawn|1|||
156625311|NCT00727246|565371728|FG003|Overall Study|withdrawn|0|||
156625312|NCT04594213|565371729|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
156625313|NCT04594213|565371730|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
156625314|NCT04594213|565371731|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
156625315|NCT04594213|565371732|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
156625316|NCT04594213|565371733|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
156625317|NCT04594213|565371734|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
156625318|NCT04594213|565371729|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
156625319|NCT04594213|565371730|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
156625320|NCT04594213|565371731|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
156625321|NCT04594213|565371732|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
156625322|NCT04594213|565371733|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
156625323|NCT04594213|565371734|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
156625324|NCT04594213|565371729|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
156625325|NCT04594213|565371730|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156625326|NCT04594213|565371731|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
156625327|NCT04594213|565371732|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156625328|NCT04594213|565371733|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156625329|NCT04594213|565371734|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156625330|NCT04594213|565371729|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156625331|NCT04594213|565371730|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156625332|NCT04594213|565371731|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156625333|NCT04594213|565371732|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156625334|NCT04594213|565371733|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
156625335|NCT04594213|565371734|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156625336|NCT04594213|565371729|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156625337|NCT04594213|565371730|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156625338|NCT04594213|565371731|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156625339|NCT04594213|565371732|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
156625340|NCT04594213|565371733|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
156625341|NCT04594213|565371734|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
156625342|NCT04594213|565371729|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156625343|NCT04594213|565371730|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156625344|NCT04594213|565371731|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156625345|NCT04594213|565371732|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156625346|NCT04594213|565371733|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156625347|NCT04594213|565371734|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
156625348|NCT04594213|565371729|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156625349|NCT04594213|565371730|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156625350|NCT04594213|565371731|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156625351|NCT04594213|565371732|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
156625352|NCT04594213|565371733|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156625353|NCT04594213|565371734|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156625354|NCT04594213|565371729|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
156625355|NCT04594213|565371730|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
156625356|NCT04594213|565371731|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
156625357|NCT04594213|565371732|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
156625358|NCT04594213|565371733|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
156625359|NCT04594213|565371734|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
156625360|NCT04594213|565371729|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156625361|NCT04594213|565371730|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156625362|NCT04594213|565371731|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156625363|NCT04594213|565371732|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
156625364|NCT04594213|565371733|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
156625365|NCT04594213|565371734|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
156625366|NCT04594213|565371729|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156625367|NCT04594213|565371730|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156625368|NCT04594213|565371731|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156625369|NCT04594213|565371732|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
156625370|NCT04594213|565371733|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
156625371|NCT04594213|565371734|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
156625372|NCT04594213|565371729|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
156625373|NCT04594213|565371730|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
156625374|NCT04594213|565371731|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
156625375|NCT04594213|565371732|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
156625376|NCT04594213|565371733|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
156625377|NCT04594213|565371734|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
156625378|NCT00661362|565371735|FG000|Overall Study|Adverse Event|5|||
156625379|NCT00661362|565371736|FG001|Overall Study|Adverse Event|4|||
156625380|NCT00661362|565371735|FG000|Overall Study|Incorrect enrollment|2|||
156625381|NCT00661362|565371736|FG001|Overall Study|Incorrect enrollment|0|||
156625382|NCT00661362|565371735|FG000|Overall Study|Study specific discontinuation criteria|4|||
156625383|NCT00661362|565371736|FG001|Overall Study|Study specific discontinuation criteria|11|||
156625384|NCT00661362|565371735|FG000|Overall Study|Withdrawal by Subject|13|||
156625385|NCT00661362|565371736|FG001|Overall Study|Withdrawal by Subject|23|||
156625386|NCT00661362|565371735|FG000|Overall Study|Lost to Follow-up|3|||
156625387|NCT00661362|565371736|FG001|Overall Study|Lost to Follow-up|1|||
156625388|NCT00661362|565371735|FG000|Overall Study|Severe non-compliance to protocol|0|||
156625389|NCT00661362|565371736|FG001|Overall Study|Severe non-compliance to protocol|1|||
156625390|NCT00661362|565371735|FG000|Overall Study|Safety reasons|1|||
156625391|NCT00661362|565371736|FG001|Overall Study|Safety reasons|0|||
156625392|NCT00661362|565371735|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
156625393|NCT00661362|565371736|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
156625394|NCT00535262|565371741|FG000|Overall Study|No funding|3|||
156625395|NCT01707667|565371742|FG000|Period 1|expulsion of colonic sensor catheter|1|||
156625396|NCT01707667|565371743|FG001|Period 1|expulsion of colonic sensor catheter|0|||
156625397|NCT01654666|565371744|FG000|Overall Study|Protocol Violation|7|||
156625398|NCT01654666|565371745|FG001|Overall Study|Protocol Violation|4|||
156625399|NCT01654666|565371746|FG002|Overall Study|Protocol Violation|8|||
156625400|NCT01654666|565371744|FG000|Overall Study|Lost to Follow-up|4|||
156625401|NCT01654666|565371745|FG001|Overall Study|Lost to Follow-up|5|||
156625402|NCT01654666|565371746|FG002|Overall Study|Lost to Follow-up|5|||
156625403|NCT01654666|565371744|FG000|Overall Study|Withdrawal by Subject|4|||
156625404|NCT01654666|565371745|FG001|Overall Study|Withdrawal by Subject|4|||
156625405|NCT01654666|565371746|FG002|Overall Study|Withdrawal by Subject|1|||
156625406|NCT01616173|565371748|FG000|Overall Study|Lost to Follow-up|0|||
156625407|NCT01616173|565371749|FG001|Overall Study|Lost to Follow-up|2|||
156625408|NCT01616173|565371750|FG002|Overall Study|Lost to Follow-up|0|||
156625409|NCT04382066|565371756|FG000|Overall Study|Adverse Event|1|||
156625410|NCT04382066|565371757|FG001|Overall Study|Adverse Event|0|||
156625411|NCT04382066|565371758|FG002|Overall Study|Adverse Event|0|||
156625412|NCT04382066|565371756|FG000|Overall Study|Death|1|||
156625413|NCT04382066|565371757|FG001|Overall Study|Death|0|||
156625414|NCT04382066|565371758|FG002|Overall Study|Death|1|||
156625415|NCT01430559|565371759|FG000|Overall Study|Adverse Event|7|||
156625416|NCT01430559|565371760|FG001|Overall Study|Adverse Event|3|||
156625417|NCT01430559|565371759|FG000|Overall Study|Entry criteria not met|1|||
156625418|NCT01430559|565371760|FG001|Overall Study|Entry criteria not met|1|||
156625419|NCT01430559|565371759|FG000|Overall Study|Lost to Follow-up|1|||
156625420|NCT01430559|565371760|FG001|Overall Study|Lost to Follow-up|0|||
156625421|NCT01430559|565371759|FG000|Overall Study|Medication error|1|||
156625422|NCT01430559|565371760|FG001|Overall Study|Medication error|0|||
156625423|NCT01430559|565371759|FG000|Overall Study|Withdrawal by Subject|3|||
156625424|NCT01430559|565371760|FG001|Overall Study|Withdrawal by Subject|2|||
156625425|NCT01430559|565371759|FG000|Overall Study|Protocol Violation|1|||
156625426|NCT01430559|565371760|FG001|Overall Study|Protocol Violation|0|||
156625427|NCT01430559|565371759|FG000|Overall Study|Other|3|||
156625428|NCT01430559|565371760|FG001|Overall Study|Other|3|||
156625429|NCT01430559|565371759|FG000|Overall Study|Randomized, Not Treated|3|||
156625430|NCT01430559|565371760|FG001|Overall Study|Randomized, Not Treated|3|||
156625431|NCT00504595|565371762|FG000|Overall Study|Lack of Efficacy|1|||
156625432|NCT00504595|565371763|FG001|Overall Study|Lack of Efficacy|0|||
156625433|NCT00504595|565371764|FG002|Overall Study|Lack of Efficacy|0|||
156625434|NCT00504595|565371765|FG003|Overall Study|Lack of Efficacy|0|||
156625435|NCT00504595|565371762|FG000|Overall Study|Other|0|||
156625436|NCT00504595|565371763|FG001|Overall Study|Other|0|||
156625437|NCT00504595|565371764|FG002|Overall Study|Other|2|||
156625438|NCT00504595|565371765|FG003|Overall Study|Other|0|||
156625439|NCT03742271|565371776|FG000|Overall Study|Unsatisfactory Visual Response|1|||
156625440|NCT03742271|565371776|FG000|Overall Study|Withdrawal by Subject|3|||
156625441|NCT03742271|565371776|FG000|Overall Study|Lost to Follow-up|4|||
156625442|NCT03742271|565371776|FG000|Overall Study|Failed Insertion & removal|3|||
156625443|NCT03742271|565371776|FG000|Overall Study|Protocol Violation|1|||
156625444|NCT01468844|565371777|FG000|Overall Study|Adverse Event|1|||
156625445|NCT01468844|565371778|FG001|Overall Study|Adverse Event|0|||
156625446|NCT01468844|565371777|FG000|Overall Study|Withdrawal by Subject|1|||
156625447|NCT01468844|565371778|FG001|Overall Study|Withdrawal by Subject|0|||
156625448|NCT02853318|565371779|FG000|Overall Study|Withdrawal by Subject|1|||
156625449|NCT05060003|565371780|FG000|Overall Study|ctDNA negative|7|||
156625450|NCT01747655|565371781|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
156625451|NCT01747655|565371782|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
156625452|NCT01747655|565371781|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
156625453|NCT01747655|565371782|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
156625454|NCT01747655|565371781|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
156625455|NCT01747655|565371782|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
156625456|NCT01373294|565371785|FG000|Overall Study|Adverse Event|1|||
156625457|NCT01373294|565371786|FG001|Overall Study|Adverse Event|0|||
156625458|NCT02728804|565371793|FG000|Overall Study|Ineligible|3|||
156625459|NCT02728804|565371793|FG000|Overall Study|Did not complete baseline questionnaire|9|||
156625460|NCT02728804|565371793|FG000|Overall Study|Death|99|||
156625461|NCT03969589|565371794|FG000|Overall Study|Lost to Follow-up|3|||
156625462|NCT03969589|565371795|FG001|Overall Study|Lost to Follow-up|2|||
156625463|NCT03969589|565371794|FG000|Overall Study|Declined Follow-Up|0|||
156625464|NCT03969589|565371795|FG001|Overall Study|Declined Follow-Up|1|||
156625465|NCT03143855|565371796|FG000|Overall Study|Withdrawal by Subject|4|||
156625466|NCT03143855|565371797|FG001|Overall Study|Withdrawal by Subject|3|||
156625467|NCT03143855|565371796|FG000|Overall Study|Protocol Violation|1|||
156625468|NCT03143855|565371797|FG001|Overall Study|Protocol Violation|0|||
156625469|NCT03143855|565371796|FG000|Overall Study|Participant experienced withdrawal|0|||
156625470|NCT03143855|565371797|FG001|Overall Study|Participant experienced withdrawal|1|||
156625471|NCT01078389|565373374|FG000|Overall Study|Adverse Event|10|||
156625472|NCT01078389|565373375|FG001|Overall Study|Adverse Event|6|||
156625473|NCT01078389|565373374|FG000|Overall Study|Major Protocol Deviation|2|||
156625474|NCT01078389|565373375|FG001|Overall Study|Major Protocol Deviation|0|||
156625475|NCT01078389|565373374|FG000|Overall Study|Lost to Follow-up|23|||
156625476|NCT01078389|565373375|FG001|Overall Study|Lost to Follow-up|23|||
156625477|NCT01078389|565373374|FG000|Overall Study|Voluntary Withdrawal|20|||
156625478|NCT01078389|565373375|FG001|Overall Study|Voluntary Withdrawal|36|||
156625479|NCT01078389|565373374|FG000|Overall Study|Other|9|||
156625480|NCT01078389|565373375|FG001|Overall Study|Other|2|||
156625481|NCT02361307|565373376|FG000|Overall Study|Unstable medical condition.|0|||
156625482|NCT02361307|565373377|FG001|Overall Study|Unstable medical condition.|1|||
156625483|NCT01858701|565373378|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
156625484|NCT01858701|565373379|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
156625485|NCT01858701|565373378|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
156625486|NCT01858701|565373379|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
156625487|NCT01858701|565373378|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
156625488|NCT01858701|565373379|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
156625489|NCT01858701|565373378|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
156625490|NCT01858701|565373379|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
156625491|NCT01674010|565373380|FG000|Open Treatment Phase 1|Adverse Event|10|||
156625492|NCT01674010|565373381|FG001|Open Treatment Phase 1|Adverse Event|0|||
156625493|NCT01674010|565373382|FG002|Open Treatment Phase 1|Adverse Event|0|||
156625494|NCT01674010|565373380|FG000|Open Treatment Phase 1|Death|1|||
156625495|NCT01674010|565373381|FG001|Open Treatment Phase 1|Death|0|||
156625496|NCT01674010|565373382|FG002|Open Treatment Phase 1|Death|0|||
156625497|NCT01674010|565373380|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
156625498|NCT01674010|565373381|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
156625499|NCT01674010|565373382|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
156625500|NCT01674010|565373380|FG000|Open Treatment Phase 1|Physician Decision|9|||
156625501|NCT01674010|565373381|FG001|Open Treatment Phase 1|Physician Decision|0|||
156625502|NCT01674010|565373382|FG002|Open Treatment Phase 1|Physician Decision|0|||
156625503|NCT01674010|565373380|FG000|Open Treatment Phase 1|Protocol Violation|7|||
156625504|NCT01674010|565373381|FG001|Open Treatment Phase 1|Protocol Violation|0|||
156625505|NCT01674010|565373382|FG002|Open Treatment Phase 1|Protocol Violation|0|||
156625506|NCT01674010|565373380|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
156625507|NCT01674010|565373381|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
156625508|NCT01674010|565373382|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
156625509|NCT01674010|565373380|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
156625510|NCT01674010|565373381|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
156625511|NCT01674010|565373382|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
156625512|NCT01674010|565373380|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
156625513|NCT01674010|565373381|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
156625514|NCT01674010|565373382|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
156625515|NCT01674010|565373380|FG000|Randomization Phase 2|Adverse Event|0|||
156625516|NCT01674010|565373381|FG001|Randomization Phase 2|Adverse Event|1|||
156625517|NCT01674010|565373382|FG002|Randomization Phase 2|Adverse Event|1|||
156625518|NCT01674010|565373380|FG000|Randomization Phase 2|Lost to Follow-up|0|||
156625519|NCT01674010|565373381|FG001|Randomization Phase 2|Lost to Follow-up|1|||
156625520|NCT01674010|565373382|FG002|Randomization Phase 2|Lost to Follow-up|2|||
156625521|NCT01674010|565373380|FG000|Randomization Phase 2|Mood episode recurrence|0|||
156625522|NCT01674010|565373381|FG001|Randomization Phase 2|Mood episode recurrence|8|||
156625523|NCT01674010|565373382|FG002|Randomization Phase 2|Mood episode recurrence|2|||
156625524|NCT01674010|565373380|FG000|Randomization Phase 2|Physician Decision|0|||
156625525|NCT01674010|565373381|FG001|Randomization Phase 2|Physician Decision|0|||
156625526|NCT01674010|565373382|FG002|Randomization Phase 2|Physician Decision|2|||
156625527|NCT01674010|565373380|FG000|Randomization Phase 2|Pregnancy|0|||
156625528|NCT01674010|565373381|FG001|Randomization Phase 2|Pregnancy|1|||
156625529|NCT01674010|565373382|FG002|Randomization Phase 2|Pregnancy|1|||
156625530|NCT01674010|565373380|FG000|Randomization Phase 2|Protocol Violation|0|||
156625531|NCT01674010|565373381|FG001|Randomization Phase 2|Protocol Violation|1|||
156625532|NCT01674010|565373382|FG002|Randomization Phase 2|Protocol Violation|1|||
156625533|NCT01674010|565373380|FG000|Randomization Phase 2|Sponsor Decision|0|||
156625534|NCT01674010|565373381|FG001|Randomization Phase 2|Sponsor Decision|42|||
156625535|NCT01674010|565373382|FG002|Randomization Phase 2|Sponsor Decision|45|||
156625536|NCT01674010|565373380|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
156625537|NCT01674010|565373381|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
156625538|NCT01674010|565373382|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
156625539|NCT01801475|565373389|FG000|Overall Study|Withdrawal by Subject|0|||
156625540|NCT01801475|565373390|FG001|Overall Study|Withdrawal by Subject|0|||
156625541|NCT01801475|565373391|FG002|Overall Study|Withdrawal by Subject|0|||
156625542|NCT01801475|565373392|FG003|Overall Study|Withdrawal by Subject|0|||
156625543|NCT01801475|565373393|FG004|Overall Study|Withdrawal by Subject|1|||
156625544|NCT00421928|565373396|FG000|Overall Study|Adverse Event|61|||
156625545|NCT00421928|565373397|FG001|Overall Study|Adverse Event|140|||
156625546|NCT00421928|565373398|FG002|Overall Study|Adverse Event|22|||
156625547|NCT00421928|565373396|FG000|Overall Study|Lost to Follow-up|5|||
156625548|NCT00421928|565373397|FG001|Overall Study|Lost to Follow-up|0|||
156625549|NCT00421928|565373398|FG002|Overall Study|Lost to Follow-up|3|||
156625550|NCT00421928|565373396|FG000|Overall Study|Withdrawal by Subject|50|||
156625551|NCT00421928|565373397|FG001|Overall Study|Withdrawal by Subject|48|||
156625552|NCT00421928|565373398|FG002|Overall Study|Withdrawal by Subject|43|||
156625553|NCT00421928|565373396|FG000|Overall Study|Lack of Efficacy|15|||
156625554|NCT00421928|565373397|FG001|Overall Study|Lack of Efficacy|7|||
156625555|NCT00421928|565373398|FG002|Overall Study|Lack of Efficacy|35|||
156625556|NCT00421928|565373396|FG000|Overall Study|Study drug non-compliant|6|||
156625557|NCT00421928|565373397|FG001|Overall Study|Study drug non-compliant|7|||
156625558|NCT00421928|565373398|FG002|Overall Study|Study drug non-compliant|4|||
156625559|NCT00421928|565373396|FG000|Overall Study|All other|26|||
156625560|NCT00421928|565373397|FG001|Overall Study|All other|21|||
156625561|NCT00421928|565373398|FG002|Overall Study|All other|27|||
156625562|NCT00421928|565373396|FG000|Overall Study|Death|0|||
156625563|NCT00421928|565373397|FG001|Overall Study|Death|1|||
156625564|NCT00421928|565373398|FG002|Overall Study|Death|0|||
156625565|NCT02946515|565373405|FG000|Overall Study|Lost to Follow-up|2|||
156625566|NCT02946515|565373406|FG001|Overall Study|Lost to Follow-up|1|||
156625567|NCT01545375|565373412|FG000|Overall Study|Adverse Event|2|||
156625568|NCT01545375|565373413|FG001|Overall Study|Adverse Event|1|||
156625569|NCT01545375|565373412|FG000|Overall Study|Lost to Follow-up|34|||
156625570|NCT01545375|565373413|FG001|Overall Study|Lost to Follow-up|31|||
156625571|NCT01545375|565373412|FG000|Overall Study|Protocol Violation|3|||
156625572|NCT01545375|565373413|FG001|Overall Study|Protocol Violation|3|||
156625573|NCT01545375|565373412|FG000|Overall Study|Withdrawal by Subject|58|||
156625574|NCT01545375|565373413|FG001|Overall Study|Withdrawal by Subject|55|||
156625575|NCT04177862|565373415|FG000|Overall Study|Protocol Violation|2|||
156625576|NCT04177862|565373416|FG001|Overall Study|Protocol Violation|7|||
156625577|NCT05637515|565373417|FG000|Overall Study|Withdrawal by Subject|17|||
156625578|NCT05637515|565373418|FG001|Overall Study|Withdrawal by Subject|17|||
156625579|NCT03233009|565373419|FG000|Overall Study|Lost to Follow-up|1|||
156625580|NCT02087085|565373421|FG000|Overall Study|Adverse Event|10|||
156625581|NCT02087085|565373422|FG001|Overall Study|Adverse Event|14|||
156625582|NCT02087085|565373421|FG000|Overall Study|Lack of Efficacy|4|||
156625583|NCT02087085|565373422|FG001|Overall Study|Lack of Efficacy|3|||
156625584|NCT02087085|565373421|FG000|Overall Study|Lost to Follow-up|6|||
156625585|NCT02087085|565373422|FG001|Overall Study|Lost to Follow-up|4|||
156625586|NCT02087085|565373421|FG000|Overall Study|Withdrawal by Subject|9|||
156625587|NCT02087085|565373422|FG001|Overall Study|Withdrawal by Subject|11|||
156625588|NCT02087085|565373421|FG000|Overall Study|Protocol Violation|1|||
156625589|NCT02087085|565373422|FG001|Overall Study|Protocol Violation|0|||
156625590|NCT02087085|565373421|FG000|Overall Study|Study Terminated by Sponsor|87|||
156625591|NCT02087085|565373422|FG001|Overall Study|Study Terminated by Sponsor|80|||
156625592|NCT02087085|565373421|FG000|Overall Study|Other Miscellaneous Reasons|3|||
156625593|NCT02087085|565373422|FG001|Overall Study|Other Miscellaneous Reasons|4|||
156625594|NCT00635804|565373423|FG000|Overall Study|Adverse Event|0|||
156625595|NCT00635804|565373424|FG001|Overall Study|Adverse Event|0|||
156625596|NCT00635804|565373425|FG002|Overall Study|Adverse Event|0|||
156625597|NCT00635804|565373426|FG003|Overall Study|Adverse Event|0|||
156625598|NCT00635804|565373427|FG004|Overall Study|Adverse Event|0|||
156625599|NCT00635804|565373428|FG005|Overall Study|Adverse Event|1|||
156625600|NCT00635804|565373429|FG006|Overall Study|Adverse Event|0|||
156625601|NCT00635804|565373430|FG007|Overall Study|Adverse Event|0|||
156625602|NCT00635804|565373423|FG000|Overall Study|Withdrawal by Subject|1|||
156625603|NCT00635804|565373424|FG001|Overall Study|Withdrawal by Subject|0|||
156625604|NCT00635804|565373425|FG002|Overall Study|Withdrawal by Subject|0|||
156625605|NCT00635804|565373426|FG003|Overall Study|Withdrawal by Subject|0|||
156625606|NCT00635804|565373427|FG004|Overall Study|Withdrawal by Subject|0|||
156625607|NCT00635804|565373428|FG005|Overall Study|Withdrawal by Subject|0|||
156625608|NCT00635804|565373429|FG006|Overall Study|Withdrawal by Subject|0|||
156625609|NCT00635804|565373430|FG007|Overall Study|Withdrawal by Subject|0|||
156625610|NCT01425268|565373438|FG000|Overall Study|Withdrawal by Subject|2|||
156625611|NCT01425268|565373439|FG001|Overall Study|Withdrawal by Subject|0|||
156625612|NCT01425268|565373438|FG000|Overall Study|Sponsor Decision|5|||
156625613|NCT01425268|565373439|FG001|Overall Study|Sponsor Decision|0|||
156625614|NCT01425268|565373438|FG000|Overall Study|Physician Decision|1|||
156625615|NCT01425268|565373439|FG001|Overall Study|Physician Decision|0|||
156625616|NCT00719706|565373440|FG000|Overall Study|Adverse Event|5|||
156625617|NCT00719706|565373441|FG001|Overall Study|Adverse Event|4|||
156625618|NCT00719706|565373440|FG000|Overall Study|Withdrawal by Subject|1|||
156625619|NCT00719706|565373441|FG001|Overall Study|Withdrawal by Subject|2|||
156625620|NCT00719706|565373440|FG000|Overall Study|Protocol Violation|3|||
156625621|NCT00719706|565373441|FG001|Overall Study|Protocol Violation|0|||
156625622|NCT02681094|565373442|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
156625623|NCT02681094|565373443|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
156625624|NCT02681094|565373444|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
156625625|NCT02681094|565373442|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
156625626|NCT02681094|565373443|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
156625627|NCT02681094|565373444|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
156625628|NCT02681094|565373442|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
156625629|NCT02681094|565373443|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
156625630|NCT02681094|565373444|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
156625631|NCT02681094|565373442|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
156625632|NCT02681094|565373443|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
156625633|NCT02681094|565373444|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
156625634|NCT02681094|565373442|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
156625635|NCT02681094|565373443|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
156625636|NCT02681094|565373444|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
156625637|NCT02681094|565373442|FG000|1 -Modified Enrolled Participants Set|Other|6|||
156625638|NCT02681094|565373443|FG001|1 -Modified Enrolled Participants Set|Other|6|||
156625639|NCT02681094|565373444|FG002|1 -Modified Enrolled Participants Set|Other|7|||
156625640|NCT02681094|565373442|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
156625641|NCT02681094|565373443|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
156625642|NCT02681094|565373444|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
156625643|NCT02681094|565373442|FG000|2 - Enrolled Participants Set|Participant decision|7|||
156625644|NCT02681094|565373443|FG001|2 - Enrolled Participants Set|Participant decision|10|||
156625645|NCT02681094|565373444|FG002|2 - Enrolled Participants Set|Participant decision|9|||
156625646|NCT02681094|565373442|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
156625647|NCT02681094|565373443|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
156625648|NCT02681094|565373444|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
156625649|NCT02681094|565373442|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
156625650|NCT02681094|565373443|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
156625651|NCT02681094|565373444|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
156625652|NCT02681094|565373442|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
156625653|NCT02681094|565373443|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
156625654|NCT02681094|565373444|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
156625655|NCT02681094|565373442|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
156625656|NCT02681094|565373443|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
156625657|NCT02681094|565373444|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
156625658|NCT02681094|565373442|FG000|2 - Enrolled Participants Set|Other|6|||
156625659|NCT02681094|565373443|FG001|2 - Enrolled Participants Set|Other|6|||
156625660|NCT02681094|565373444|FG002|2 - Enrolled Participants Set|Other|7|||
156625661|NCT02681094|565373442|FG000|2 - Enrolled Participants Set|No treatment given|0|||
156625662|NCT02681094|565373443|FG001|2 - Enrolled Participants Set|No treatment given|1|||
156625663|NCT02681094|565373444|FG002|2 - Enrolled Participants Set|No treatment given|1|||
156625664|NCT02406586|565373445|FG000|Overall Study|Lost to Follow-up|0|||
156625665|NCT02406586|565373446|FG001|Overall Study|Lost to Follow-up|4|||
156625666|NCT02406586|565373447|FG002|Overall Study|Lost to Follow-up|2|||
156625667|NCT02406586|565373445|FG000|Overall Study|Withdrawal by Subject|1|||
156625668|NCT02406586|565373446|FG001|Overall Study|Withdrawal by Subject|0|||
156625669|NCT02406586|565373447|FG002|Overall Study|Withdrawal by Subject|0|||
156625670|NCT01072175|565373448|FG000|Part A (Drug-Drug Interaction)|Death|1|||
156625671|NCT01072175|565373449|FG001|Part A (Drug-Drug Interaction)|Death|0|||
156625672|NCT01072175|565373450|FG002|Part A (Drug-Drug Interaction)|Death|0|||
156625673|NCT01072175|565373451|FG003|Part A (Drug-Drug Interaction)|Death|0|||
156625674|NCT01072175|565373452|FG004|Part A (Drug-Drug Interaction)|Death|0|||
156625675|NCT01072175|565373453|FG005|Part A (Drug-Drug Interaction)|Death|0|||
156625676|NCT01072175|565373454|FG006|Part A (Drug-Drug Interaction)|Death|0|||
156625677|NCT01072175|565373455|FG007|Part A (Drug-Drug Interaction)|Death|0|||
156625678|NCT01072175|565373456|FG008|Part A (Drug-Drug Interaction)|Death|0|||
156625679|NCT01072175|565373457|FG009|Part A (Drug-Drug Interaction)|Death|0|||
156625680|NCT01072175|565373458|FG010|Part A (Drug-Drug Interaction)|Death|0|||
156625681|NCT01072175|565373459|FG011|Part A (Drug-Drug Interaction)|Death|0|||
156625682|NCT01072175|565373460|FG012|Part A (Drug-Drug Interaction)|Death|0|||
156625683|NCT01072175|565373448|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
156625684|NCT01072175|565373449|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625685|NCT01072175|565373450|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625686|NCT01072175|565373451|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625687|NCT01072175|565373452|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625688|NCT01072175|565373453|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625689|NCT01072175|565373454|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625690|NCT01072175|565373455|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625691|NCT01072175|565373456|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625692|NCT01072175|565373457|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625693|NCT01072175|565373458|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625694|NCT01072175|565373459|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625695|NCT01072175|565373460|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
156625696|NCT01072175|565373448|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
156625697|NCT01072175|565373449|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625698|NCT01072175|565373450|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625699|NCT01072175|565373451|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625700|NCT01072175|565373452|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625701|NCT01072175|565373453|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625702|NCT01072175|565373454|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625703|NCT01072175|565373455|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625704|NCT01072175|565373456|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625705|NCT01072175|565373457|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625706|NCT01072175|565373458|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625707|NCT01072175|565373459|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625708|NCT01072175|565373460|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
156625709|NCT01072175|565373448|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
156625710|NCT01072175|565373449|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
156625711|NCT01072175|565373450|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
156625712|NCT01072175|565373451|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
156625713|NCT01072175|565373452|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
156625714|NCT01072175|565373453|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
156625715|NCT01072175|565373454|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
156625716|NCT01072175|565373455|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
156625717|NCT01072175|565373456|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
156625718|NCT01072175|565373457|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
156625719|NCT01072175|565373458|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
156625720|NCT01072175|565373459|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
156625721|NCT01072175|565373460|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
156625722|NCT01072175|565373448|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625723|NCT01072175|565373449|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625724|NCT01072175|565373450|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
156625725|NCT01072175|565373451|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625726|NCT01072175|565373452|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
156625727|NCT01072175|565373453|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625728|NCT01072175|565373454|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625729|NCT01072175|565373455|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625730|NCT01072175|565373456|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625731|NCT01072175|565373457|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625732|NCT01072175|565373458|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625733|NCT01072175|565373459|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625734|NCT01072175|565373460|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
156625735|NCT01072175|565373448|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625736|NCT01072175|565373449|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
156625737|NCT01072175|565373450|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625738|NCT01072175|565373451|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
156625739|NCT01072175|565373452|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
156625740|NCT01072175|565373453|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625741|NCT01072175|565373454|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625742|NCT01072175|565373455|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625743|NCT01072175|565373456|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625744|NCT01072175|565373457|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625745|NCT01072175|565373458|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625746|NCT01072175|565373459|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625747|NCT01072175|565373460|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
156625748|NCT01072175|565373448|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625749|NCT01072175|565373449|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625750|NCT01072175|565373450|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
156625751|NCT01072175|565373451|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
156625752|NCT01072175|565373452|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
156625753|NCT01072175|565373453|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625754|NCT01072175|565373454|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625755|NCT01072175|565373455|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625756|NCT01072175|565373456|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625757|NCT01072175|565373457|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625758|NCT01072175|565373458|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625759|NCT01072175|565373459|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625760|NCT01072175|565373460|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
156625761|NCT01072175|565373448|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625762|NCT01072175|565373449|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
156625763|NCT01072175|565373450|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625764|NCT01072175|565373451|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
156625765|NCT01072175|565373452|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
156625766|NCT01072175|565373453|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625767|NCT01072175|565373454|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625768|NCT01072175|565373455|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625769|NCT01072175|565373456|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625770|NCT01072175|565373457|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625771|NCT01072175|565373458|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625772|NCT01072175|565373459|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625773|NCT01072175|565373460|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
156625774|NCT01072175|565373448|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
156625775|NCT01072175|565373449|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
156625776|NCT01072175|565373450|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
156625777|NCT01072175|565373451|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
156625778|NCT01072175|565373452|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
156625779|NCT01072175|565373453|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
156625780|NCT01072175|565373454|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
156625781|NCT01072175|565373455|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
156625782|NCT01072175|565373456|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
156625783|NCT01072175|565373457|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
156625784|NCT01072175|565373458|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
156625785|NCT01072175|565373459|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
156625786|NCT01072175|565373460|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
156625787|NCT01072175|565373448|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625788|NCT01072175|565373449|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625789|NCT01072175|565373450|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625790|NCT01072175|565373451|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625791|NCT01072175|565373452|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625792|NCT01072175|565373453|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
156625793|NCT01072175|565373454|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
156625794|NCT01072175|565373455|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
156625795|NCT01072175|565373456|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625796|NCT01072175|565373457|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625797|NCT01072175|565373458|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625798|NCT01072175|565373459|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625799|NCT01072175|565373460|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
156625800|NCT01072175|565373448|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625801|NCT01072175|565373449|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625802|NCT01072175|565373450|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625803|NCT01072175|565373451|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625804|NCT01072175|565373452|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625805|NCT01072175|565373453|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625806|NCT01072175|565373454|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
156625807|NCT01072175|565373455|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
156625808|NCT01072175|565373456|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625809|NCT01072175|565373457|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625810|NCT01072175|565373458|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625811|NCT01072175|565373459|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625812|NCT01072175|565373460|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
156625813|NCT01072175|565373448|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625814|NCT01072175|565373449|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625815|NCT01072175|565373450|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625816|NCT01072175|565373451|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625817|NCT01072175|565373452|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625818|NCT01072175|565373453|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
156625819|NCT01072175|565373454|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
156625820|NCT01072175|565373455|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
156625821|NCT01072175|565373456|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625822|NCT01072175|565373457|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625823|NCT01072175|565373458|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625824|NCT01072175|565373459|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625825|NCT01072175|565373460|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
156625826|NCT01072175|565373448|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625827|NCT01072175|565373449|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625828|NCT01072175|565373450|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625829|NCT01072175|565373451|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625830|NCT01072175|565373452|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625831|NCT01072175|565373453|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
156625832|NCT01072175|565373454|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
156625833|NCT01072175|565373455|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625834|NCT01072175|565373456|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156635564|NCT00602667|565409961|FG001|Overall Study|Family request|25|||
156625835|NCT01072175|565373457|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625836|NCT01072175|565373458|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625837|NCT01072175|565373459|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625838|NCT01072175|565373460|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
156625839|NCT01072175|565373448|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625840|NCT01072175|565373449|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625841|NCT01072175|565373450|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625842|NCT01072175|565373451|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625843|NCT01072175|565373452|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625844|NCT01072175|565373453|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625845|NCT01072175|565373454|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625846|NCT01072175|565373455|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625847|NCT01072175|565373456|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
156625848|NCT01072175|565373457|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625849|NCT01072175|565373458|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625850|NCT01072175|565373459|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625851|NCT01072175|565373460|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
156625852|NCT01072175|565373448|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625853|NCT01072175|565373449|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625854|NCT01072175|565373450|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625855|NCT01072175|565373451|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625856|NCT01072175|565373452|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625857|NCT01072175|565373453|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625858|NCT01072175|565373454|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625859|NCT01072175|565373455|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625860|NCT01072175|565373456|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
156625861|NCT01072175|565373457|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625862|NCT01072175|565373458|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625863|NCT01072175|565373459|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625864|NCT01072175|565373460|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
156625865|NCT01072175|565373448|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625866|NCT01072175|565373449|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625867|NCT01072175|565373450|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625868|NCT01072175|565373451|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625869|NCT01072175|565373452|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625870|NCT01072175|565373453|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625871|NCT01072175|565373454|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625872|NCT01072175|565373455|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625873|NCT01072175|565373456|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
156625874|NCT01072175|565373457|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625875|NCT01072175|565373458|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625876|NCT01072175|565373459|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625877|NCT01072175|565373460|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
156625878|NCT01072175|565373448|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625879|NCT01072175|565373449|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625880|NCT01072175|565373450|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625881|NCT01072175|565373451|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625882|NCT01072175|565373452|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625883|NCT01072175|565373453|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625884|NCT01072175|565373454|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625885|NCT01072175|565373455|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625886|NCT01072175|565373456|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
156625887|NCT01072175|565373457|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625888|NCT01072175|565373458|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625889|NCT01072175|565373459|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625890|NCT01072175|565373460|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
156625891|NCT01072175|565373448|FG000|Part D (HPMC Capsules)|Death|0|||
156625892|NCT01072175|565373449|FG001|Part D (HPMC Capsules)|Death|0|||
156625893|NCT01072175|565373450|FG002|Part D (HPMC Capsules)|Death|0|||
156625894|NCT01072175|565373451|FG003|Part D (HPMC Capsules)|Death|0|||
156625895|NCT01072175|565373452|FG004|Part D (HPMC Capsules)|Death|0|||
156625896|NCT01072175|565373453|FG005|Part D (HPMC Capsules)|Death|0|||
156625897|NCT01072175|565373454|FG006|Part D (HPMC Capsules)|Death|0|||
156625898|NCT01072175|565373455|FG007|Part D (HPMC Capsules)|Death|0|||
156625899|NCT01072175|565373456|FG008|Part D (HPMC Capsules)|Death|0|||
156625900|NCT01072175|565373457|FG009|Part D (HPMC Capsules)|Death|10|||
156625901|NCT01072175|565373458|FG010|Part D (HPMC Capsules)|Death|12|||
156625902|NCT01072175|565373459|FG011|Part D (HPMC Capsules)|Death|28|||
156625903|NCT01072175|565373460|FG012|Part D (HPMC Capsules)|Death|26|||
156625904|NCT01072175|565373448|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
156625905|NCT01072175|565373449|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
156625906|NCT01072175|565373450|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
156625907|NCT01072175|565373451|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
156625908|NCT01072175|565373452|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
156625909|NCT01072175|565373453|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
156625910|NCT01072175|565373454|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
156625911|NCT01072175|565373455|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
156625912|NCT01072175|565373456|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
156625913|NCT01072175|565373457|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
156625914|NCT01072175|565373458|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
156625915|NCT01072175|565373459|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
156625916|NCT01072175|565373460|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
156625917|NCT01072175|565373448|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625918|NCT01072175|565373449|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625919|NCT01072175|565373450|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625920|NCT01072175|565373451|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625921|NCT01072175|565373452|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625922|NCT01072175|565373453|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625923|NCT01072175|565373454|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625924|NCT01072175|565373455|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625925|NCT01072175|565373456|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625926|NCT01072175|565373457|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
156625927|NCT01072175|565373458|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
156625928|NCT01072175|565373459|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
156625929|NCT01072175|565373460|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
156625930|NCT01072175|565373448|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625931|NCT01072175|565373449|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625932|NCT01072175|565373450|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625933|NCT01072175|565373451|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625934|NCT01072175|565373452|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625935|NCT01072175|565373453|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625936|NCT01072175|565373454|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625937|NCT01072175|565373455|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625938|NCT01072175|565373456|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
156625939|NCT01072175|565373457|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
156625940|NCT01072175|565373458|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
156625941|NCT01072175|565373459|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
156625942|NCT01072175|565373460|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
156625943|NCT01072175|565373448|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625944|NCT01072175|565373449|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625945|NCT01072175|565373450|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625946|NCT01072175|565373451|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625947|NCT01072175|565373452|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625948|NCT01072175|565373453|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625949|NCT01072175|565373454|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625950|NCT01072175|565373455|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625951|NCT01072175|565373456|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625952|NCT01072175|565373457|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625953|NCT01072175|565373458|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
156625954|NCT01072175|565373459|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
156625955|NCT01072175|565373460|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
156625956|NCT02839330|565373461|FG000|Overall Study|Adverse Event|0|||
156625957|NCT02839330|565373462|FG001|Overall Study|Adverse Event|1|||
156625958|NCT02839330|565373463|FG002|Overall Study|Adverse Event|2|||
156625959|NCT02839330|565373464|FG003|Overall Study|Adverse Event|2|||
156625960|NCT02839330|565373461|FG000|Overall Study|Death|4|||
156625961|NCT02839330|565373462|FG001|Overall Study|Death|6|||
156625962|NCT02839330|565373463|FG002|Overall Study|Death|1|||
156625963|NCT02839330|565373464|FG003|Overall Study|Death|1|||
156625964|NCT02839330|565373461|FG000|Overall Study|Withdrawal by Subject|27|||
156625965|NCT02839330|565373462|FG001|Overall Study|Withdrawal by Subject|19|||
156625966|NCT02839330|565373463|FG002|Overall Study|Withdrawal by Subject|11|||
156625967|NCT02839330|565373464|FG003|Overall Study|Withdrawal by Subject|13|||
156625968|NCT02839330|565373461|FG000|Overall Study|Lost to Follow-up|22|||
156625969|NCT02839330|565373462|FG001|Overall Study|Lost to Follow-up|27|||
156625970|NCT02839330|565373463|FG002|Overall Study|Lost to Follow-up|29|||
156625971|NCT02839330|565373464|FG003|Overall Study|Lost to Follow-up|25|||
156625972|NCT02839330|565373461|FG000|Overall Study|Administrative Reason|0|||
156625973|NCT02839330|565373462|FG001|Overall Study|Administrative Reason|0|||
156625974|NCT02839330|565373463|FG002|Overall Study|Administrative Reason|0|||
156625975|NCT02839330|565373464|FG003|Overall Study|Administrative Reason|1|||
156625976|NCT02839330|565373461|FG000|Overall Study|Protocol Violation|1|||
156625977|NCT02839330|565373462|FG001|Overall Study|Protocol Violation|2|||
156625978|NCT02839330|565373463|FG002|Overall Study|Protocol Violation|2|||
156625979|NCT02839330|565373464|FG003|Overall Study|Protocol Violation|3|||
156625980|NCT02839330|565373461|FG000|Overall Study|Other reason, not specified|4|||
156625981|NCT02839330|565373462|FG001|Overall Study|Other reason, not specified|3|||
156625982|NCT02839330|565373463|FG002|Overall Study|Other reason, not specified|3|||
156625983|NCT02839330|565373464|FG003|Overall Study|Other reason, not specified|6|||
156625984|NCT00682539|565373465|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
156625985|NCT00682539|565373466|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
156625986|NCT00682539|565373467|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
156625987|NCT00682539|565373465|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
156625988|NCT00682539|565373466|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
156625989|NCT00682539|565373467|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
156625990|NCT02477215|565373472|FG000|Dose Escalation Phase|Physician Decision|1|||
156625991|NCT02477215|565373473|FG001|Dose Escalation Phase|Physician Decision|2|||
156625992|NCT02477215|565373474|FG002|Dose Escalation Phase|Physician Decision|0|||
156625993|NCT02477215|565373472|FG000|Fixed Dose Phase|Physician Decision|0|||
156625994|NCT02477215|565373473|FG001|Fixed Dose Phase|Physician Decision|7|||
156625995|NCT02477215|565373474|FG002|Fixed Dose Phase|Physician Decision|0|||
156625996|NCT00508872|565373475|FG000|Overall Study|Lost to Follow-up|1|||
156625997|NCT00508872|565373475|FG000|Overall Study|Physician Decision|1|||
156625998|NCT02210559|565373476|FG000|Overall Study|Progressive Disease|3|||
156625999|NCT02210559|565373477|FG001|Overall Study|Progressive Disease|2|||
156626000|NCT02210559|565373476|FG000|Overall Study|Adverse Event|2|||
156626001|NCT02210559|565373477|FG001|Overall Study|Adverse Event|2|||
156626002|NCT02210559|565373476|FG000|Overall Study|Physician Decision|1|||
156626003|NCT02210559|565373477|FG001|Overall Study|Physician Decision|0|||
156626004|NCT02210559|565373476|FG000|Overall Study|Withdrawal by Subject|0|||
156626005|NCT02210559|565373477|FG001|Overall Study|Withdrawal by Subject|1|||
156626006|NCT02210559|565373476|FG000|Overall Study|Other than specified|0|||
156626007|NCT02210559|565373477|FG001|Overall Study|Other than specified|1|||
156626008|NCT00310440|565373478|FG000|Overall Study|Lost to Follow-up|17|||
156626009|NCT00310440|565373479|FG001|Overall Study|Lost to Follow-up|8|||
156626010|NCT00310440|565373478|FG000|Overall Study|Withdrawal by Subject|2|||
156626011|NCT00310440|565373479|FG001|Overall Study|Withdrawal by Subject|1|||
156626012|NCT00310440|565373478|FG000|Overall Study|Missed 12 Month Visit|7|||
156626013|NCT00310440|565373479|FG001|Overall Study|Missed 12 Month Visit|4|||
156626014|NCT00792467|565373480|FG000|Overall Study|progression of disease|17|||
156626015|NCT00792467|565373480|FG000|Overall Study|Adverse Event|1|||
156626016|NCT00792467|565373480|FG000|Overall Study|patient request|1|||
156626017|NCT00792467|565373480|FG000|Overall Study|Lost to Follow-up|1|||
156626018|NCT00792467|565373480|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
156626019|NCT00792467|565373480|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
156626020|NCT01220024|565373488|FG000|Overall Study|Lost to Follow-up|1|||
156626021|NCT01220024|565373489|FG001|Overall Study|Lost to Follow-up|1|||
156626022|NCT00174460|565373490|FG000|Overall Study|Withdrawal by Subject|0|||
156626023|NCT00174460|565373491|FG001|Overall Study|Withdrawal by Subject|1|||
156626024|NCT04225026|565373494|FG000|Overall Study|Withdrawal by Subject|4|||
156626025|NCT04225026|565373494|FG000|Overall Study|Adverse Event|1|||
156626026|NCT04225026|565373494|FG000|Overall Study|Other|1|||
156626027|NCT04225026|565373494|FG000|Overall Study|Death|11|||
156626028|NCT04225026|565373494|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
156626029|NCT00579059|565373497|FG000|Overall Study|Study Canceled at 1 Year|21|||
156626030|NCT00579059|565373498|FG001|Overall Study|Study Canceled at 1 Year|10|||
156626031|NCT04738123|565373501|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
156626032|NCT04738123|565373502|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
156626033|NCT04738123|565373501|FG000|Overall Study|Progressive Disease|0|||
156626034|NCT04738123|565373502|FG001|Overall Study|Progressive Disease|4|||
156626035|NCT04738123|565373501|FG000|Overall Study|Adverse Event|8|||
156626036|NCT04738123|565373502|FG001|Overall Study|Adverse Event|7|||
156626037|NCT04738123|565373501|FG000|Overall Study|Other Reasons|0|||
156626038|NCT04738123|565373502|FG001|Overall Study|Other Reasons|1|||
156626039|NCT04738123|565373501|FG000|Overall Study|Suicidal or assaultive behavior|0|||
156626040|NCT04738123|565373502|FG001|Overall Study|Suicidal or assaultive behavior|2|||
156626041|NCT04738123|565373501|FG000|Overall Study|Protocol Violation|2|||
156626042|NCT04738123|565373502|FG001|Overall Study|Protocol Violation|2|||
156626043|NCT04738123|565373501|FG000|Overall Study|Consent Withdrawn|35|||
156626044|NCT04738123|565373502|FG001|Overall Study|Consent Withdrawn|22|||
156626045|NCT00779506|565373503|FG000|Overall Study|Screening Failed|2|||
156626046|NCT00779506|565373503|FG000|Overall Study|Adverse Event|4|||
156626047|NCT00779506|565373503|FG000|Overall Study|Lack of Efficacy|11|||
156626048|NCT00779506|565373503|FG000|Overall Study|Protocol Violation|5|||
156626049|NCT00779506|565373503|FG000|Overall Study|Withdrawal by Subject|6|||
156626050|NCT00779506|565373503|FG000|Overall Study|Lost to Follow-up|1|||
156626051|NCT03982069|565373504|FG000|Overall Study|Lost to Follow-up|5|||
156626052|NCT03982069|565373505|FG001|Overall Study|Lost to Follow-up|5|||
156626053|NCT03982069|565373506|FG002|Overall Study|Lost to Follow-up|3|||
156626054|NCT03982069|565373507|FG003|Overall Study|Lost to Follow-up|5|||
156626055|NCT03982069|565373504|FG000|Overall Study|Physician Decision|0|||
156626056|NCT03982069|565373505|FG001|Overall Study|Physician Decision|1|||
156626057|NCT03982069|565373506|FG002|Overall Study|Physician Decision|0|||
156626058|NCT03982069|565373507|FG003|Overall Study|Physician Decision|0|||
156626059|NCT03982069|565373504|FG000|Overall Study|Withdrawal by Subject|2|||
156626060|NCT03982069|565373505|FG001|Overall Study|Withdrawal by Subject|1|||
156626061|NCT03982069|565373506|FG002|Overall Study|Withdrawal by Subject|5|||
156626062|NCT03982069|565373507|FG003|Overall Study|Withdrawal by Subject|2|||
156626063|NCT03982069|565373504|FG000|Overall Study|Specimen loss|3|||
156626064|NCT03982069|565373505|FG001|Overall Study|Specimen loss|3|||
156626065|NCT03982069|565373506|FG002|Overall Study|Specimen loss|1|||
156626066|NCT03982069|565373507|FG003|Overall Study|Specimen loss|1|||
156626067|NCT01218477|565373508|FG000|Overall Study|Disease progression|2|||
156626068|NCT01218477|565373509|FG001|Overall Study|Disease progression|3|||
156626069|NCT01218477|565373510|FG002|Overall Study|Disease progression|6|||
156626070|NCT01218477|565373511|FG003|Overall Study|Disease progression|2|||
156626071|NCT01218477|565373508|FG000|Overall Study|Study drug toxicity|0|||
156626072|NCT01218477|565373509|FG001|Overall Study|Study drug toxicity|2|||
156626073|NCT01218477|565373510|FG002|Overall Study|Study drug toxicity|5|||
156626074|NCT01218477|565373511|FG003|Overall Study|Study drug toxicity|0|||
156626075|NCT01218477|565373508|FG000|Overall Study|No longer meets study criteria|1|||
156626076|NCT01218477|565373509|FG001|Overall Study|No longer meets study criteria|0|||
156626077|NCT01218477|565373510|FG002|Overall Study|No longer meets study criteria|0|||
156626078|NCT01218477|565373511|FG003|Overall Study|No longer meets study criteria|0|||
156626079|NCT01218477|565373508|FG000|Overall Study|Withdrawal by Subject|0|||
156626080|NCT01218477|565373509|FG001|Overall Study|Withdrawal by Subject|0|||
156626081|NCT01218477|565373510|FG002|Overall Study|Withdrawal by Subject|1|||
156626082|NCT01218477|565373511|FG003|Overall Study|Withdrawal by Subject|0|||
156626083|NCT01218477|565373508|FG000|Overall Study|Prepared for cell transplantation|0|||
156626084|NCT01218477|565373509|FG001|Overall Study|Prepared for cell transplantation|1|||
156626085|NCT01218477|565373510|FG002|Overall Study|Prepared for cell transplantation|1|||
156626086|NCT01218477|565373511|FG003|Overall Study|Prepared for cell transplantation|0|||
156626087|NCT01218477|565373508|FG000|Overall Study|Administrative reason by sponsor|0|||
156626088|NCT01218477|565373509|FG001|Overall Study|Administrative reason by sponsor|0|||
156626089|NCT01218477|565373510|FG002|Overall Study|Administrative reason by sponsor|1|||
156626090|NCT01218477|565373511|FG003|Overall Study|Administrative reason by sponsor|0|||
156626091|NCT01218477|565373508|FG000|Overall Study|Maximum clinical benefit|0|||
156626092|NCT01218477|565373509|FG001|Overall Study|Maximum clinical benefit|2|||
156626093|NCT01218477|565373510|FG002|Overall Study|Maximum clinical benefit|0|||
156626094|NCT01218477|565373511|FG003|Overall Study|Maximum clinical benefit|0|||
156626095|NCT00787527|565373512|FG000|Overall Study|Toxicity|3|||
156626096|NCT03137433|565373515|FG000|Overall Study|Withdrawal by Subject|11|||
156626097|NCT03137433|565373516|FG001|Overall Study|Withdrawal by Subject|11|||
156626098|NCT03137433|565373515|FG000|Overall Study|Lost to Follow-up|5|||
156626099|NCT03137433|565373516|FG001|Overall Study|Lost to Follow-up|6|||
156626100|NCT03137433|565373515|FG000|Overall Study|Physician Decision|2|||
156626101|NCT03137433|565373516|FG001|Overall Study|Physician Decision|0|||
156626102|NCT03137433|565373515|FG000|Overall Study|Moved out of study area|1|||
156626103|NCT03137433|565373516|FG001|Overall Study|Moved out of study area|0|||
156626104|NCT03137433|565373515|FG000|Overall Study|Too far out of window due to COVID|0|||
156626105|NCT03137433|565373516|FG001|Overall Study|Too far out of window due to COVID|1|||
156626106|NCT00914940|565373517|FG000|D0 to D100 Post-transplant|Death|2|||
156626107|NCT00914940|565373517|FG000|D101 to 2 Years Post-transplant|Death|8|||
156626108|NCT00914940|565373517|FG000|2 Years to 5 Years Post-transplant|Death|3|||
156626109|NCT01853397|565373518|FG000|Overall Study|Withdrawal by Subject|0|||
156626110|NCT01853397|565373519|FG001|Overall Study|Withdrawal by Subject|0|||
156626111|NCT01853397|565373520|FG002|Overall Study|Withdrawal by Subject|0|||
156626112|NCT01853397|565373521|FG003|Overall Study|Withdrawal by Subject|1|||
156626113|NCT01853397|565373518|FG000|Overall Study|Subject Noncompliance|0|||
156626114|NCT01853397|565373519|FG001|Overall Study|Subject Noncompliance|0|||
156626115|NCT01853397|565373520|FG002|Overall Study|Subject Noncompliance|0|||
156626116|NCT01853397|565373521|FG003|Overall Study|Subject Noncompliance|1|||
156626117|NCT01724021|565373522|FG000|Overall Study|Adverse Event|11|||
156626118|NCT01724021|565373523|FG001|Overall Study|Adverse Event|6|||
156626119|NCT01724021|565373522|FG000|Overall Study|Death|46|||
156626120|NCT01724021|565373523|FG001|Overall Study|Death|58|||
156626121|NCT01724021|565373522|FG000|Overall Study|Participant request/ Withdrew consent|18|||
156626122|NCT01724021|565373523|FG001|Overall Study|Participant request/ Withdrew consent|14|||
156626123|NCT01724021|565373522|FG000|Overall Study|Lost to Follow-up|15|||
156626124|NCT01724021|565373523|FG001|Overall Study|Lost to Follow-up|15|||
156626125|NCT01724021|565373522|FG000|Overall Study|Reason Not Specified|36|||
156626126|NCT01724021|565373523|FG001|Overall Study|Reason Not Specified|39|||
156626127|NCT01724021|565373522|FG000|Overall Study|Missing|1|||
156626128|NCT01724021|565373523|FG001|Overall Study|Missing|1|||
156626129|NCT01005875|565373524|FG000|Overall Study|Death|3|||
156626130|NCT00606931|565373525|FG000|Overall Study|Withdrawal by Subject|3|||
156626131|NCT00286234|565373526|FG000|Overall Study|Protocol Violation|1|||
156626132|NCT00286234|565373527|FG001|Overall Study|Protocol Violation|2|||
156626133|NCT00286234|565373528|FG002|Overall Study|Protocol Violation|0|||
156626134|NCT00286234|565373529|FG003|Overall Study|Protocol Violation|1|||
156626135|NCT00286234|565373526|FG000|Overall Study|Physician Decision|1|||
156626136|NCT00286234|565373527|FG001|Overall Study|Physician Decision|0|||
156626137|NCT00286234|565373528|FG002|Overall Study|Physician Decision|0|||
156626138|NCT00286234|565373529|FG003|Overall Study|Physician Decision|1|||
156626139|NCT00286234|565373526|FG000|Overall Study|Adverse Event|0|||
156626140|NCT00286234|565373527|FG001|Overall Study|Adverse Event|0|||
156626141|NCT00286234|565373528|FG002|Overall Study|Adverse Event|0|||
156626142|NCT00286234|565373529|FG003|Overall Study|Adverse Event|1|||
156626143|NCT00286234|565373526|FG000|Overall Study|Adverse Event|0|||
156626144|NCT00286234|565373527|FG001|Overall Study|Adverse Event|0|||
156626145|NCT00286234|565373528|FG002|Overall Study|Adverse Event|0|||
156626146|NCT00286234|565373529|FG003|Overall Study|Adverse Event|1|||
156626147|NCT03512028|565373534|FG000|Overall Study|Withdrawal by Subject|2|||
156626148|NCT03512028|565373535|FG001|Overall Study|Withdrawal by Subject|0|||
156626149|NCT03512028|565373534|FG000|Overall Study|Protocol Violation|2|||
156626150|NCT03512028|565373535|FG001|Overall Study|Protocol Violation|0|||
156626151|NCT03529162|565373536|FG000|Overall Study|Lost to Follow-up|2|||
156626152|NCT03529162|565373537|FG001|Overall Study|Lost to Follow-up|2|||
156626153|NCT00517634|565373540|FG000|Second Treatment Period|Withdrawal by Subject|0|||
156626154|NCT00517634|565373541|FG001|Second Treatment Period|Withdrawal by Subject|0|||
156626155|NCT00517634|565373542|FG002|Second Treatment Period|Withdrawal by Subject|0|||
156626156|NCT00517634|565373543|FG003|Second Treatment Period|Withdrawal by Subject|0|||
156626157|NCT00517634|565373544|FG004|Second Treatment Period|Withdrawal by Subject|1|||
156626158|NCT00517634|565373545|FG005|Second Treatment Period|Withdrawal by Subject|0|||
156626159|NCT00701064|565373546|FG000|Overall Study|Protocol Violation|1|||
156626160|NCT00701064|565373547|FG001|Overall Study|Protocol Violation|1|||
156626161|NCT00701064|565373546|FG000|Overall Study|Withdrawal by Subject|1|||
156626162|NCT00701064|565373547|FG001|Overall Study|Withdrawal by Subject|1|||
156626163|NCT00701064|565373546|FG000|Overall Study|initiated other PTSD treatment|2|||
156626164|NCT00701064|565373547|FG001|Overall Study|initiated other PTSD treatment|2|||
156626165|NCT02098733|565373548|FG000|Overall Study|Data Not Available|5|||
156626166|NCT02098733|565373548|FG000|Overall Study|Lost to Follow-up|5|||
156626167|NCT00939094|565373549|FG000|Overall Study|Adverse Event|9|||
156626168|NCT00939094|565373550|FG001|Overall Study|Adverse Event|0|||
156626169|NCT00939094|565373549|FG000|Overall Study|Withdrawal by Subject|1|||
156626170|NCT00939094|565373550|FG001|Overall Study|Withdrawal by Subject|6|||
156626171|NCT00939094|565373549|FG000|Overall Study|Lost to Follow-up|1|||
156626172|NCT00939094|565373550|FG001|Overall Study|Lost to Follow-up|1|||
156626173|NCT00939094|565373549|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156626174|NCT00939094|565373550|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156626175|NCT00939094|565373549|FG000|Overall Study|Severe non-compliance to protocol|0|||
156626176|NCT00939094|565373550|FG001|Overall Study|Severe non-compliance to protocol|1|||
156626177|NCT00939094|565373549|FG000|Overall Study|Study stopped by sponsor|0|||
156626178|NCT00939094|565373550|FG001|Overall Study|Study stopped by sponsor|2|||
156626179|NCT00939094|565373549|FG000|Overall Study|Abnormal ECG findings|1|||
156626180|NCT00939094|565373550|FG001|Overall Study|Abnormal ECG findings|0|||
156626181|NCT01786707|565375614|FG000|Overall Study|Lost to Follow-up|1|||
156626182|NCT01786707|565375615|FG001|Overall Study|Lost to Follow-up|1|||
156626183|NCT00346775|565375616|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
156626184|NCT00346775|565375617|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
156626185|NCT00346775|565375616|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
156626186|NCT00346775|565375617|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
156626187|NCT00346775|565375616|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
156626188|NCT00346775|565375617|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
156626189|NCT01096017|565375620|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
156626190|NCT01096017|565375621|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
156626191|NCT02600559|565375622|FG000|Overall Study|Withdrawal by Subject|3|||
156626192|NCT02600559|565375622|FG000|Overall Study|Lost to Follow-up|20|||
156626193|NCT00594958|565375626|FG000|Overall Study|Withdrawal by Subject|1|||
156626194|NCT00594958|565375627|FG001|Overall Study|Withdrawal by Subject|0|||
156626195|NCT00594958|565375628|FG002|Overall Study|Withdrawal by Subject|1|||
156626196|NCT00594958|565375626|FG000|Overall Study|Adverse Event|4|||
156626197|NCT00594958|565375627|FG001|Overall Study|Adverse Event|1|||
156626198|NCT00594958|565375628|FG002|Overall Study|Adverse Event|2|||
156626199|NCT00594958|565375626|FG000|Overall Study|Pregnancy|0|||
156626200|NCT00594958|565375627|FG001|Overall Study|Pregnancy|2|||
156626201|NCT00594958|565375628|FG002|Overall Study|Pregnancy|0|||
156626202|NCT00594958|565375626|FG000|Overall Study|Protocol Violation|1|||
156626203|NCT00594958|565375627|FG001|Overall Study|Protocol Violation|0|||
156626204|NCT00594958|565375628|FG002|Overall Study|Protocol Violation|2|||
156626205|NCT00594958|565375626|FG000|Overall Study|Lost to Follow-up|5|||
156626206|NCT00594958|565375627|FG001|Overall Study|Lost to Follow-up|0|||
156626207|NCT00594958|565375628|FG002|Overall Study|Lost to Follow-up|3|||
156626208|NCT00594958|565375626|FG000|Overall Study|administrative|3|||
156626209|NCT00594958|565375627|FG001|Overall Study|administrative|0|||
156626210|NCT00594958|565375628|FG002|Overall Study|administrative|2|||
156626211|NCT04516291|565375629|FG000|Treatment Period (24 Weeks)|Other|1|||
156626212|NCT04516291|565375630|FG001|Treatment Period (24 Weeks)|Other|0|||
156626213|NCT04516291|565375631|FG002|Treatment Period (24 Weeks)|Other|0|||
156626214|NCT04516291|565375632|FG003|Treatment Period (24 Weeks)|Other|2|||
156626215|NCT04516291|565375633|FG004|Treatment Period (24 Weeks)|Other|2|||
156626216|NCT04516291|565375634|FG005|Treatment Period (24 Weeks)|Other|4|||
156626217|NCT04516291|565375635|FG006|Treatment Period (24 Weeks)|Other|2|||
156626218|NCT04516291|565375636|FG007|Treatment Period (24 Weeks)|Other|0|||
156626219|NCT04516291|565375629|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156626220|NCT04516291|565375630|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
156626221|NCT04516291|565375631|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
156626222|NCT04516291|565375632|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156626223|NCT04516291|565375633|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
156626224|NCT04516291|565375634|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156626225|NCT04516291|565375635|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156626226|NCT04516291|565375636|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156626227|NCT04516291|565375629|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
156626228|NCT04516291|565375630|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
156626229|NCT04516291|565375631|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
156626230|NCT04516291|565375632|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
156626231|NCT04516291|565375633|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
156626232|NCT04516291|565375634|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
156626233|NCT04516291|565375635|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
156626234|NCT04516291|565375636|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
156626235|NCT04516291|565375629|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156626236|NCT04516291|565375630|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156626237|NCT04516291|565375631|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156626238|NCT04516291|565375632|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156626239|NCT04516291|565375633|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156626240|NCT04516291|565375634|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156626241|NCT04516291|565375635|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156626242|NCT04516291|565375636|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156626243|NCT04516291|565375629|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
156626244|NCT04516291|565375630|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
156626245|NCT04516291|565375631|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
156626246|NCT04516291|565375632|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
156626247|NCT04516291|565375633|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
156626248|NCT04516291|565375634|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
156626249|NCT04516291|565375635|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
156626250|NCT04516291|565375636|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
156626251|NCT04516291|565375629|FG000|Follow-up Period (12 Weeks)|Other|0|||
156626252|NCT04516291|565375630|FG001|Follow-up Period (12 Weeks)|Other|1|||
156626253|NCT04516291|565375631|FG002|Follow-up Period (12 Weeks)|Other|0|||
156626254|NCT04516291|565375632|FG003|Follow-up Period (12 Weeks)|Other|2|||
156626255|NCT04516291|565375633|FG004|Follow-up Period (12 Weeks)|Other|0|||
156626256|NCT04516291|565375634|FG005|Follow-up Period (12 Weeks)|Other|0|||
156626257|NCT04516291|565375635|FG006|Follow-up Period (12 Weeks)|Other|0|||
156626258|NCT04516291|565375636|FG007|Follow-up Period (12 Weeks)|Other|0|||
156626259|NCT04516291|565375629|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156626260|NCT04516291|565375630|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156626261|NCT04516291|565375631|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156626262|NCT04516291|565375632|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156626263|NCT04516291|565375633|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
156626264|NCT04516291|565375634|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156626265|NCT04516291|565375635|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156626266|NCT04516291|565375636|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
156626267|NCT04516291|565375629|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
156626268|NCT04516291|565375630|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
156626269|NCT04516291|565375631|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
156626270|NCT04516291|565375632|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
156626271|NCT04516291|565375633|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
156626272|NCT04516291|565375634|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
156626273|NCT04516291|565375635|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
156626274|NCT04516291|565375636|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
156626275|NCT03039686|565375637|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
156626276|NCT03039686|565375638|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
156626277|NCT03039686|565375639|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
156626278|NCT03039686|565375637|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
156626279|NCT03039686|565375638|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
156626280|NCT03039686|565375639|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
156626281|NCT03039686|565375637|FG000|Double-blind Period|Withdrawal by Subject|2|||
156626282|NCT03039686|565375638|FG001|Double-blind Period|Withdrawal by Subject|2|||
156626283|NCT03039686|565375639|FG002|Double-blind Period|Withdrawal by Subject|1|||
156626284|NCT03039686|565375637|FG000|Double-blind Period|Death|0|||
156626285|NCT03039686|565375638|FG001|Double-blind Period|Death|0|||
156626286|NCT03039686|565375639|FG002|Double-blind Period|Death|1|||
156626287|NCT03039686|565375637|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
156626288|NCT03039686|565375638|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
156626289|NCT03039686|565375639|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
156626290|NCT03039686|565375637|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
156626291|NCT03039686|565375638|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
156626292|NCT03039686|565375639|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
156626293|NCT03039686|565375637|FG000|Open Label Period|Withdrawal by Subject|0|||
156626294|NCT03039686|565375638|FG001|Open Label Period|Withdrawal by Subject|3|||
156626295|NCT03039686|565375639|FG002|Open Label Period|Withdrawal by Subject|1|||
156626296|NCT02158949|565375640|FG000|Overall Study|Withdrawal by Subject|1|||
156626297|NCT02158949|565375641|FG001|Overall Study|Withdrawal by Subject|0|||
156626298|NCT02158949|565375640|FG000|Overall Study|Lost to Follow-up|5|||
156626299|NCT02158949|565375641|FG001|Overall Study|Lost to Follow-up|11|||
156626300|NCT01855607|565375642|FG000|Overall Study|Withdrawal by Subject|1|||
156626301|NCT01855607|565375642|FG000|Overall Study|Study was terminated|11|||
156626302|NCT02181634|565375643|FG000|Overall Study|Lack of Efficacy|33|||
156626303|NCT02181634|565375643|FG000|Overall Study|Adverse Event|17|||
156626304|NCT02181634|565375643|FG000|Overall Study|Physician Decision|8|||
156626305|NCT02181634|565375643|FG000|Overall Study|Withdrawal by Subject|5|||
156626306|NCT02181634|565375643|FG000|Overall Study|Death|2|||
156626307|NCT02181634|565375643|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
156626308|NCT02181634|565375643|FG000|Overall Study|Ineligible|1|||
156626309|NCT02181634|565375643|FG000|Overall Study|Max number of dose reduction|1|||
156626310|NCT02181634|565375643|FG000|Overall Study|Symptomatic progression|1|||
156626311|NCT02181634|565375643|FG000|Overall Study|Patient opted to proceed to surgery|1|||
156626312|NCT02392078|565375651|FG000|Overall Study|Did not have procedure|32|||
156626313|NCT02392078|565375652|FG001|Overall Study|Did not have procedure|43|||
156626314|NCT02392078|565375653|FG002|Overall Study|Did not have procedure|20|||
156626315|NCT02392078|565375654|FG003|Overall Study|Did not have procedure|1|||
156626316|NCT02079077|565375656|FG000|Overall Study|Lost to Follow-up|5|||
156626317|NCT02079077|565375657|FG001|Overall Study|Lost to Follow-up|7|||
156626318|NCT02079077|565375656|FG000|Overall Study|Became STIs Positive|1|||
156626319|NCT02079077|565375657|FG001|Overall Study|Became STIs Positive|2|||
156626320|NCT00134563|565375664|FG000|Overall Study|Not treated due to protocol violation|0|||
156626321|NCT00134563|565375665|FG001|Overall Study|Not treated due to protocol violation|1|||
156626322|NCT00134563|565375666|FG002|Overall Study|Not treated due to protocol violation|1|||
156626323|NCT00134563|565375664|FG000|Overall Study|Adverse Event|29|||
156626324|NCT00134563|565375665|FG001|Overall Study|Adverse Event|37|||
156626325|NCT00134563|565375666|FG002|Overall Study|Adverse Event|38|||
156626326|NCT00134563|565375664|FG000|Overall Study|Lack of Efficacy|24|||
156626327|NCT00134563|565375665|FG001|Overall Study|Lack of Efficacy|14|||
156626328|NCT00134563|565375666|FG002|Overall Study|Lack of Efficacy|17|||
156626329|NCT00134563|565375664|FG000|Overall Study|Protocol Violation|3|||
156626330|NCT00134563|565375665|FG001|Overall Study|Protocol Violation|2|||
156626331|NCT00134563|565375666|FG002|Overall Study|Protocol Violation|5|||
156626332|NCT00134563|565375664|FG000|Overall Study|Lost to Follow-up|4|||
156626333|NCT00134563|565375665|FG001|Overall Study|Lost to Follow-up|0|||
156626334|NCT00134563|565375666|FG002|Overall Study|Lost to Follow-up|2|||
156626335|NCT00134563|565375664|FG000|Overall Study|progressive disease|11|||
156626336|NCT00134563|565375665|FG001|Overall Study|progressive disease|4|||
156626337|NCT00134563|565375666|FG002|Overall Study|progressive disease|2|||
156626338|NCT00134563|565375664|FG000|Overall Study|did not wish to continue|33|||
156626339|NCT00134563|565375665|FG001|Overall Study|did not wish to continue|32|||
156626340|NCT00134563|565375666|FG002|Overall Study|did not wish to continue|26|||
156626341|NCT00134563|565375664|FG000|Overall Study|Reason other than above|0|||
156626342|NCT00134563|565375665|FG001|Overall Study|Reason other than above|2|||
156626343|NCT00134563|565375666|FG002|Overall Study|Reason other than above|5|||
156626344|NCT03382639|565375667|FG000|Overall Study|Adverse Event|2|||
156626345|NCT03382639|565375668|FG001|Overall Study|Adverse Event|0|||
156626346|NCT03382639|565375669|FG002|Overall Study|Adverse Event|1|||
156626347|NCT03382639|565375670|FG003|Overall Study|Adverse Event|1|||
156626348|NCT03382639|565375667|FG000|Overall Study|Lost to Follow-up|1|||
156626349|NCT03382639|565375668|FG001|Overall Study|Lost to Follow-up|0|||
156626350|NCT03382639|565375669|FG002|Overall Study|Lost to Follow-up|0|||
156626351|NCT03382639|565375670|FG003|Overall Study|Lost to Follow-up|0|||
156626352|NCT03382639|565375667|FG000|Overall Study|Withdrawal by Subject|4|||
156626353|NCT03382639|565375668|FG001|Overall Study|Withdrawal by Subject|3|||
156626354|NCT03382639|565375669|FG002|Overall Study|Withdrawal by Subject|2|||
156626355|NCT03382639|565375670|FG003|Overall Study|Withdrawal by Subject|3|||
156626356|NCT03382639|565375667|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
156626357|NCT03382639|565375668|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
156626358|NCT03382639|565375669|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
156626359|NCT03382639|565375670|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
156626360|NCT03382639|565375667|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
156626361|NCT03382639|565375668|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
156626362|NCT03382639|565375669|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
156626363|NCT03382639|565375670|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
156626364|NCT03382639|565375667|FG000|Overall Study|Other|2|||
156626365|NCT03382639|565375668|FG001|Overall Study|Other|0|||
156626366|NCT03382639|565375669|FG002|Overall Study|Other|0|||
156626367|NCT03382639|565375670|FG003|Overall Study|Other|3|||
156626368|NCT00285857|565375673|FG000|Overall Study|Withdrawal by Subject|2|||
156626369|NCT00285857|565375673|FG000|Overall Study|Inadequate initial breast cytology|1|||
156626370|NCT00285857|565375673|FG000|Overall Study|Adverse Event|1|||
156626371|NCT00917553|565375678|FG000|Overall Study|Lost to Follow-up|2|||
156626372|NCT00917553|565375679|FG001|Overall Study|Lost to Follow-up|1|||
156626373|NCT03172026|565375681|FG000|Overall Study|Withdrawal by Subject|1|||
156626374|NCT03172026|565375682|FG001|Overall Study|Withdrawal by Subject|0|||
156626375|NCT03172026|565375681|FG000|Overall Study|COVID restrictions|1|||
156626376|NCT03172026|565375682|FG001|Overall Study|COVID restrictions|0|||
156626377|NCT01177943|565375683|FG000|First Intervention|Withdrawal by Subject|2|||
156626378|NCT01177943|565375684|FG001|First Intervention|Withdrawal by Subject|0|||
156626379|NCT01303159|565375687|FG000|Overall Study|Death|16|||
156626380|NCT01303159|565375687|FG000|Overall Study|Study Termination|7|||
156626381|NCT00496782|565375693|FG000|Overall Study|Protocol Violation|1|||
156626382|NCT00496782|565375694|FG001|Overall Study|Protocol Violation|2|||
156626383|NCT01288911|565375698|FG000|Double-blind Period|Death|11|||
156626384|NCT01288911|565375699|FG001|Double-blind Period|Death|7|||
156626385|NCT01288911|565375698|FG000|Double-blind Period|Lost to Follow-up|0|||
156626386|NCT01288911|565375699|FG001|Double-blind Period|Lost to Follow-up|2|||
156626387|NCT01288911|565375698|FG000|Double-blind Period|Progressive Disease|75|||
156626388|NCT01288911|565375699|FG001|Double-blind Period|Progressive Disease|103|||
156626389|NCT01288911|565375698|FG000|Double-blind Period|Protocol Violation|1|||
156626390|NCT01288911|565375699|FG001|Double-blind Period|Protocol Violation|0|||
156626391|NCT01288911|565375698|FG000|Double-blind Period|Withdrawal by Subject|25|||
156626392|NCT01288911|565375699|FG001|Double-blind Period|Withdrawal by Subject|26|||
156626393|NCT01288911|565375698|FG000|Double-blind Period|Miscellaneous Reason|29|||
156626394|NCT01288911|565375699|FG001|Double-blind Period|Miscellaneous Reason|42|||
156626395|NCT01288911|565375698|FG000|Double-blind Period|Randomized but never received study drug|1|||
156626396|NCT01288911|565375699|FG001|Double-blind Period|Randomized but never received study drug|2|||
156626397|NCT01288911|565375698|FG000|Open-label Period (All Enzalutamide)|Death|0|||
156626398|NCT01288911|565375699|FG001|Open-label Period (All Enzalutamide)|Death|1|||
156626399|NCT01288911|565375698|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
156626400|NCT01288911|565375699|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
156626401|NCT01288911|565375698|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
156626402|NCT01288911|565375699|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
156626403|NCT01288911|565375698|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
156626404|NCT01288911|565375699|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
156626405|NCT01288911|565375698|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
156626406|NCT01288911|565375699|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
156626407|NCT01288911|565375698|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
156626408|NCT01288911|565375699|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
156626409|NCT02132312|565375700|FG000|Overall Study|Adverse Event|2|||
156626410|NCT02132312|565375701|FG001|Overall Study|Adverse Event|0|||
156626411|NCT02132312|565375700|FG000|Overall Study|Physician Decision|1|||
156626412|NCT02132312|565375701|FG001|Overall Study|Physician Decision|1|||
156626413|NCT02132312|565375700|FG000|Overall Study|Protocol Violation|0|||
156626414|NCT02132312|565375701|FG001|Overall Study|Protocol Violation|1|||
156626415|NCT02132312|565375700|FG000|Overall Study|Withdrawal by Subject|1|||
156626416|NCT02132312|565375701|FG001|Overall Study|Withdrawal by Subject|0|||
156626417|NCT02132312|565375700|FG000|Overall Study|Lost to Follow-up|2|||
156626418|NCT02132312|565375701|FG001|Overall Study|Lost to Follow-up|1|||
156626419|NCT01632345|565375702|FG000|Treatment: Part I|Adverse Event|1|||
156626420|NCT01632345|565375703|FG001|Treatment: Part I|Adverse Event|4|||
156626421|NCT01632345|565375704|FG002|Treatment: Part I|Adverse Event|2|||
156626422|NCT01632345|565375705|FG003|Treatment: Part I|Adverse Event|1|||
156626423|NCT01632345|565375706|FG004|Treatment: Part I|Adverse Event|3|||
156626424|NCT01632345|565375707|FG005|Treatment: Part I|Adverse Event|0|||
156626425|NCT01632345|565375708|FG006|Treatment: Part I|Adverse Event|0|||
156626426|NCT01632345|565375702|FG000|Treatment: Part I|Lack of Efficacy|0|||
156626427|NCT01632345|565375703|FG001|Treatment: Part I|Lack of Efficacy|1|||
156626428|NCT01632345|565375704|FG002|Treatment: Part I|Lack of Efficacy|0|||
156626429|NCT01632345|565375705|FG003|Treatment: Part I|Lack of Efficacy|1|||
156626430|NCT01632345|565375706|FG004|Treatment: Part I|Lack of Efficacy|1|||
156626431|NCT01632345|565375707|FG005|Treatment: Part I|Lack of Efficacy|0|||
156626432|NCT01632345|565375708|FG006|Treatment: Part I|Lack of Efficacy|0|||
156626433|NCT01632345|565375702|FG000|Treatment: Part I|Lost to Follow-up|3|||
156626434|NCT01632345|565375703|FG001|Treatment: Part I|Lost to Follow-up|2|||
156626435|NCT01632345|565375704|FG002|Treatment: Part I|Lost to Follow-up|1|||
156626436|NCT01632345|565375705|FG003|Treatment: Part I|Lost to Follow-up|3|||
156626437|NCT01632345|565375706|FG004|Treatment: Part I|Lost to Follow-up|4|||
156626438|NCT01632345|565375707|FG005|Treatment: Part I|Lost to Follow-up|0|||
156626439|NCT01632345|565375708|FG006|Treatment: Part I|Lost to Follow-up|0|||
156626440|NCT01632345|565375702|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
156626441|NCT01632345|565375703|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
156626442|NCT01632345|565375704|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
156626443|NCT01632345|565375705|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
156626444|NCT01632345|565375706|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
156626445|NCT01632345|565375707|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
156626446|NCT01632345|565375708|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
156626447|NCT01632345|565375702|FG000|Treatment: Part I|Physician Decision|2|||
156626448|NCT01632345|565375703|FG001|Treatment: Part I|Physician Decision|1|||
156626449|NCT01632345|565375704|FG002|Treatment: Part I|Physician Decision|0|||
156626450|NCT01632345|565375705|FG003|Treatment: Part I|Physician Decision|0|||
156626451|NCT01632345|565375706|FG004|Treatment: Part I|Physician Decision|1|||
156626452|NCT01632345|565375707|FG005|Treatment: Part I|Physician Decision|0|||
156626453|NCT01632345|565375708|FG006|Treatment: Part I|Physician Decision|0|||
156626454|NCT01632345|565375702|FG000|Treatment: Part I|Pregnancy|0|||
156626455|NCT01632345|565375703|FG001|Treatment: Part I|Pregnancy|1|||
156626456|NCT01632345|565375704|FG002|Treatment: Part I|Pregnancy|0|||
156626457|NCT01632345|565375705|FG003|Treatment: Part I|Pregnancy|0|||
156626458|NCT01632345|565375706|FG004|Treatment: Part I|Pregnancy|0|||
156626459|NCT01632345|565375707|FG005|Treatment: Part I|Pregnancy|0|||
156626460|NCT01632345|565375708|FG006|Treatment: Part I|Pregnancy|0|||
156626461|NCT01632345|565375702|FG000|Treatment: Part I|Protocol Deviation|0|||
156626462|NCT01632345|565375703|FG001|Treatment: Part I|Protocol Deviation|0|||
156626463|NCT01632345|565375704|FG002|Treatment: Part I|Protocol Deviation|1|||
156626464|NCT01632345|565375705|FG003|Treatment: Part I|Protocol Deviation|1|||
156626465|NCT01632345|565375706|FG004|Treatment: Part I|Protocol Deviation|0|||
156626466|NCT01632345|565375707|FG005|Treatment: Part I|Protocol Deviation|0|||
156626467|NCT01632345|565375708|FG006|Treatment: Part I|Protocol Deviation|0|||
156626468|NCT01632345|565375702|FG000|Treatment: Part I|Withdrawal by Subject|3|||
156626469|NCT01632345|565375703|FG001|Treatment: Part I|Withdrawal by Subject|4|||
156626470|NCT01632345|565375704|FG002|Treatment: Part I|Withdrawal by Subject|4|||
156626471|NCT01632345|565375705|FG003|Treatment: Part I|Withdrawal by Subject|1|||
156626472|NCT01632345|565375706|FG004|Treatment: Part I|Withdrawal by Subject|4|||
156626473|NCT01632345|565375707|FG005|Treatment: Part I|Withdrawal by Subject|0|||
156626474|NCT01632345|565375708|FG006|Treatment: Part I|Withdrawal by Subject|0|||
156626475|NCT01632345|565375702|FG000|Treatment: Part II|Adverse Event|0|||
156626476|NCT01632345|565375703|FG001|Treatment: Part II|Adverse Event|0|||
156626477|NCT01632345|565375704|FG002|Treatment: Part II|Adverse Event|0|||
156626478|NCT01632345|565375705|FG003|Treatment: Part II|Adverse Event|0|||
156626479|NCT01632345|565375706|FG004|Treatment: Part II|Adverse Event|0|||
156626480|NCT01632345|565375707|FG005|Treatment: Part II|Adverse Event|3|||
156626481|NCT01632345|565375708|FG006|Treatment: Part II|Adverse Event|8|||
156626482|NCT01632345|565375702|FG000|Treatment: Part II|Lost to Follow-up|0|||
156626483|NCT01632345|565375703|FG001|Treatment: Part II|Lost to Follow-up|0|||
156626484|NCT01632345|565375704|FG002|Treatment: Part II|Lost to Follow-up|0|||
156626485|NCT01632345|565375705|FG003|Treatment: Part II|Lost to Follow-up|0|||
156626486|NCT01632345|565375706|FG004|Treatment: Part II|Lost to Follow-up|0|||
156626487|NCT01632345|565375707|FG005|Treatment: Part II|Lost to Follow-up|3|||
156626488|NCT01632345|565375708|FG006|Treatment: Part II|Lost to Follow-up|1|||
156626489|NCT01632345|565375702|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
156626490|NCT01632345|565375703|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
156626491|NCT01632345|565375704|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
156626492|NCT01632345|565375705|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
156626493|NCT01632345|565375706|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
156626494|NCT01632345|565375707|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
156626495|NCT01632345|565375708|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
156626496|NCT01632345|565375702|FG000|Treatment: Part II|Withdrawal by Subject|0|||
156626497|NCT01632345|565375703|FG001|Treatment: Part II|Withdrawal by Subject|0|||
156626498|NCT01632345|565375704|FG002|Treatment: Part II|Withdrawal by Subject|0|||
156626499|NCT01632345|565375705|FG003|Treatment: Part II|Withdrawal by Subject|0|||
156626500|NCT01632345|565375706|FG004|Treatment: Part II|Withdrawal by Subject|0|||
156626501|NCT01632345|565375707|FG005|Treatment: Part II|Withdrawal by Subject|2|||
156626502|NCT01632345|565375708|FG006|Treatment: Part II|Withdrawal by Subject|2|||
156626503|NCT00089505|565375709|FG000|Overall Study|Death|4|||
156626504|NCT00089505|565375710|FG001|Overall Study|Death|1|||
156626505|NCT00089505|565375711|FG002|Overall Study|Death|5|||
156626506|NCT00089505|565375712|FG003|Overall Study|Death|8|||
156626507|NCT00089505|565375709|FG000|Overall Study|Withdrawal by Subject|3|||
156626508|NCT00089505|565375710|FG001|Overall Study|Withdrawal by Subject|0|||
156626509|NCT00089505|565375711|FG002|Overall Study|Withdrawal by Subject|6|||
156626510|NCT00089505|565375712|FG003|Overall Study|Withdrawal by Subject|6|||
156626511|NCT00089505|565375709|FG000|Overall Study|Lost to Follow-up|1|||
156626512|NCT00089505|565375710|FG001|Overall Study|Lost to Follow-up|1|||
156626513|NCT00089505|565375711|FG002|Overall Study|Lost to Follow-up|9|||
156626514|NCT00089505|565375712|FG003|Overall Study|Lost to Follow-up|7|||
156626515|NCT00089505|565375709|FG000|Overall Study|Physician Decision|1|||
156626516|NCT00089505|565375710|FG001|Overall Study|Physician Decision|0|||
156626517|NCT00089505|565375711|FG002|Overall Study|Physician Decision|0|||
156626518|NCT00089505|565375712|FG003|Overall Study|Physician Decision|0|||
156626519|NCT00089505|565375709|FG000|Overall Study|Protocol Violation|0|||
156626520|NCT00089505|565375710|FG001|Overall Study|Protocol Violation|0|||
156626521|NCT00089505|565375711|FG002|Overall Study|Protocol Violation|1|||
156626522|NCT00089505|565375712|FG003|Overall Study|Protocol Violation|0|||
156626523|NCT02431559|565375713|FG000|Overall Study|Adverse Event|0|||
156626524|NCT02431559|565375714|FG001|Overall Study|Adverse Event|1|||
156626525|NCT02431559|565375715|FG002|Overall Study|Adverse Event|0|||
156626526|NCT02431559|565375716|FG003|Overall Study|Adverse Event|4|||
156626527|NCT02431559|565375713|FG000|Overall Study|Progressive disease|2|||
156626528|NCT02431559|565375714|FG001|Overall Study|Progressive disease|1|||
156626529|NCT02431559|565375715|FG002|Overall Study|Progressive disease|4|||
156626530|NCT02431559|565375716|FG003|Overall Study|Progressive disease|22|||
156626531|NCT02431559|565375713|FG000|Overall Study|Withdrawal by Subject|0|||
156626532|NCT02431559|565375714|FG001|Overall Study|Withdrawal by Subject|1|||
156626533|NCT02431559|565375715|FG002|Overall Study|Withdrawal by Subject|0|||
156626534|NCT02431559|565375716|FG003|Overall Study|Withdrawal by Subject|4|||
156626535|NCT02431559|565375713|FG000|Overall Study|Physician Decision|0|||
156626536|NCT02431559|565375714|FG001|Overall Study|Physician Decision|0|||
156626537|NCT02431559|565375715|FG002|Overall Study|Physician Decision|0|||
156626538|NCT02431559|565375716|FG003|Overall Study|Physician Decision|1|||
156626539|NCT02543918|565375717|FG000|Overall Study|Never treated|0|||
156626540|NCT02543918|565375718|FG001|Overall Study|Never treated|1|||
156626541|NCT02543918|565375717|FG000|Overall Study|Lost to Follow-up|1|||
156626542|NCT02543918|565375718|FG001|Overall Study|Lost to Follow-up|1|||
156626543|NCT02543918|565375717|FG000|Overall Study|Withdrawal by Subject|1|||
156626544|NCT02543918|565375718|FG001|Overall Study|Withdrawal by Subject|1|||
156626545|NCT02543918|565375717|FG000|Overall Study|Adverse Event|1|||
156626546|NCT02543918|565375718|FG001|Overall Study|Adverse Event|1|||
156626547|NCT02452892|565375721|FG000|Week 1 Initial Randommization|Adverse Event|1|||
156626548|NCT02452892|565375722|FG001|Week 1 Initial Randommization|Adverse Event|0|||
156626549|NCT02452892|565375723|FG002|Week 1 Initial Randommization|Adverse Event|0|||
156626550|NCT02452892|565375724|FG003|Week 1 Initial Randommization|Adverse Event|0|||
156626551|NCT02452892|565375721|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
156626552|NCT02452892|565375722|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
156626553|NCT02452892|565375723|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
156626554|NCT02452892|565375724|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
156626555|NCT02452892|565375721|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
156626556|NCT02452892|565375722|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
156626557|NCT02452892|565375723|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
156626558|NCT02452892|565375724|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
156626559|NCT02452892|565375721|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
156626560|NCT02452892|565375722|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
156626561|NCT02452892|565375723|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
156626562|NCT02452892|565375724|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
156626563|NCT02452892|565375721|FG000|Follow-up|Withdrawal by Subject|0|||
156626564|NCT02452892|565375722|FG001|Follow-up|Withdrawal by Subject|0|||
156626565|NCT02452892|565375723|FG002|Follow-up|Withdrawal by Subject|0|||
156626566|NCT02452892|565375724|FG003|Follow-up|Withdrawal by Subject|1|||
156626567|NCT02452892|565375721|FG000|Follow-up|Subject left town on Day 42|1|||
156626568|NCT02452892|565375722|FG001|Follow-up|Subject left town on Day 42|0|||
156626569|NCT02452892|565375723|FG002|Follow-up|Subject left town on Day 42|0|||
156626570|NCT02452892|565375724|FG003|Follow-up|Subject left town on Day 42|0|||
156626571|NCT00486720|565375727|FG000|Overall Study|Adverse Event|1|||
156626572|NCT00486720|565375728|FG001|Overall Study|Adverse Event|2|||
156626573|NCT00486720|565375727|FG000|Overall Study|Lack of Efficacy|4|||
156626574|NCT00486720|565375728|FG001|Overall Study|Lack of Efficacy|6|||
156626575|NCT00486720|565375727|FG000|Overall Study|Physician Decision|1|||
156626576|NCT00486720|565375728|FG001|Overall Study|Physician Decision|2|||
156626577|NCT00486720|565375727|FG000|Overall Study|Protocol Violation|1|||
156626578|NCT00486720|565375728|FG001|Overall Study|Protocol Violation|0|||
156626579|NCT00486720|565375727|FG000|Overall Study|Withdrawal by Subject|3|||
156626580|NCT00486720|565375728|FG001|Overall Study|Withdrawal by Subject|1|||
156626581|NCT00486720|565375727|FG000|Overall Study|Progressive Disease|0|||
156626582|NCT00486720|565375728|FG001|Overall Study|Progressive Disease|1|||
156626583|NCT05047601|565375734|FG000|Overall Study|Lost to Follow-up|9|||
156626584|NCT05047601|565375735|FG001|Overall Study|Lost to Follow-up|11|||
156626585|NCT05047601|565375736|FG002|Overall Study|Lost to Follow-up|7|||
156626586|NCT05047601|565375734|FG000|Overall Study|Withdrawal by Subject|25|||
156626587|NCT05047601|565375735|FG001|Overall Study|Withdrawal by Subject|36|||
156626588|NCT05047601|565375736|FG002|Overall Study|Withdrawal by Subject|23|||
156626589|NCT05047601|565375734|FG000|Overall Study|Other|10|||
156626590|NCT05047601|565375735|FG001|Overall Study|Other|6|||
156626591|NCT05047601|565375736|FG002|Overall Study|Other|5|||
156626592|NCT00252499|565375751|FG000|Overall Study|Lost to Follow-up|1|||
156626593|NCT00252499|565375752|FG001|Overall Study|Lost to Follow-up|0|||
156626594|NCT00252499|565375753|FG002|Overall Study|Lost to Follow-up|0|||
156626595|NCT03137173|565375754|FG000|Overall Study|Withdrawal by Subject|8|||
156626596|NCT03137173|565375755|FG001|Overall Study|Withdrawal by Subject|13|||
156626597|NCT03137173|565375754|FG000|Overall Study|Death|1|||
156626598|NCT03137173|565375755|FG001|Overall Study|Death|3|||
156626599|NCT03137173|565375754|FG000|Overall Study|Physician Decision|1|||
156626600|NCT03137173|565375755|FG001|Overall Study|Physician Decision|0|||
156626601|NCT03137173|565375754|FG000|Overall Study|Lost to Follow-up|13|||
156626602|NCT03137173|565375755|FG001|Overall Study|Lost to Follow-up|18|||
156626603|NCT03137173|565375754|FG000|Overall Study|Other reasons|3|||
156626604|NCT03137173|565375755|FG001|Overall Study|Other reasons|2|||
156626605|NCT03524664|565375756|FG000|Overall Study|Withdrawal by Subject|1|||
156626606|NCT03524664|565375757|FG001|Overall Study|Withdrawal by Subject|2|||
156626607|NCT03524664|565375756|FG000|Overall Study|Lost to Follow-up|4|||
156626608|NCT03524664|565375757|FG001|Overall Study|Lost to Follow-up|13|||
156626609|NCT01482598|565375758|FG000|Overall Study|Death|7|||
156626610|NCT01482598|565375759|FG001|Overall Study|Death|10|||
156626611|NCT01482598|565375758|FG000|Overall Study|Physician Decision|0|||
156626612|NCT01482598|565375759|FG001|Overall Study|Physician Decision|3|||
156626613|NCT01482598|565375758|FG000|Overall Study|Withdrawal by Subject|4|||
156626614|NCT01482598|565375759|FG001|Overall Study|Withdrawal by Subject|5|||
156626615|NCT01482598|565375758|FG000|Overall Study|Lost to Follow-up|5|||
156626616|NCT01482598|565375759|FG001|Overall Study|Lost to Follow-up|4|||
156626617|NCT02694562|565375760|FG000|Overall Study|Death|8|||
156626618|NCT02694562|565375760|FG000|Overall Study|Protocol Violation|4|||
156626619|NCT02694562|565375760|FG000|Overall Study|Lost to Follow-up|3|||
156626620|NCT02694562|565375760|FG000|Overall Study|Screen Failure|2|||
156626621|NCT02694562|565375760|FG000|Overall Study|Physician Decision|1|||
156626622|NCT00423267|565375761|FG000|Period A|Withdrawal by Subject|0|||
156626623|NCT00423267|565375762|FG001|Period A|Withdrawal by Subject|1|||
156626624|NCT00423267|565375761|FG000|Period A|Non-compliance with protocol|1|||
156626625|NCT00423267|565375762|FG001|Period A|Non-compliance with protocol|0|||
156626626|NCT00423267|565375761|FG000|Period A|Administrative|1|||
156626627|NCT00423267|565375762|FG001|Period A|Administrative|0|||
156626628|NCT03702166|565375763|FG000|Overall Study|Lost to Follow-up|1|||
156626629|NCT03702166|565375763|FG000|Overall Study|Withdrawal by Subject|1|||
156626630|NCT01333865|565375764|FG000|Overall Study|Adverse Event|2|||
156626631|NCT01521494|565375771|FG000|Overall Study|Adverse Event|1|||
156626632|NCT01521494|565375772|FG001|Overall Study|Adverse Event|2|||
156626633|NCT01521494|565375773|FG002|Overall Study|Adverse Event|9|||
156626634|NCT01521494|565375774|FG003|Overall Study|Adverse Event|6|||
156626635|NCT01521494|565375775|FG004|Overall Study|Adverse Event|2|||
156626636|NCT01521494|565375771|FG000|Overall Study|Lack of Efficacy|0|||
156626637|NCT01521494|565375772|FG001|Overall Study|Lack of Efficacy|0|||
156626638|NCT01521494|565375773|FG002|Overall Study|Lack of Efficacy|0|||
156626639|NCT01521494|565375774|FG003|Overall Study|Lack of Efficacy|0|||
156626640|NCT01521494|565375775|FG004|Overall Study|Lack of Efficacy|2|||
156626641|NCT01521494|565375771|FG000|Overall Study|Withdrawal by Subject|1|||
156626642|NCT01521494|565375772|FG001|Overall Study|Withdrawal by Subject|1|||
156626643|NCT01521494|565375773|FG002|Overall Study|Withdrawal by Subject|0|||
156626644|NCT01521494|565375774|FG003|Overall Study|Withdrawal by Subject|2|||
156626645|NCT01521494|565375775|FG004|Overall Study|Withdrawal by Subject|0|||
156626646|NCT01521494|565375771|FG000|Overall Study|Decrease in serum phosphate|0|||
156626647|NCT01521494|565375772|FG001|Overall Study|Decrease in serum phosphate|2|||
156626648|NCT01521494|565375773|FG002|Overall Study|Decrease in serum phosphate|3|||
156626649|NCT01521494|565375774|FG003|Overall Study|Decrease in serum phosphate|12|||
156626650|NCT01521494|565375775|FG004|Overall Study|Decrease in serum phosphate|0|||
156626651|NCT01521494|565375771|FG000|Overall Study|Decrease in serum calcium|0|||
156626652|NCT01521494|565375772|FG001|Overall Study|Decrease in serum calcium|0|||
156626653|NCT01521494|565375773|FG002|Overall Study|Decrease in serum calcium|0|||
156626654|NCT01521494|565375774|FG003|Overall Study|Decrease in serum calcium|1|||
156626655|NCT01521494|565375775|FG004|Overall Study|Decrease in serum calcium|1|||
156626656|NCT01521494|565375771|FG000|Overall Study|Physician Decision|0|||
156626657|NCT01521494|565375772|FG001|Overall Study|Physician Decision|0|||
156626658|NCT01521494|565375773|FG002|Overall Study|Physician Decision|0|||
156626659|NCT01521494|565375774|FG003|Overall Study|Physician Decision|0|||
156626660|NCT01521494|565375775|FG004|Overall Study|Physician Decision|2|||
156626661|NCT00784836|565375777|FG000|Overall Study|Early Study Termination|3|||
156626662|NCT03417999|565375779|FG000|Overall Study|Withdrawal by Subject|1|||
156626663|NCT03417999|565375780|FG001|Overall Study|Withdrawal by Subject|0|||
156626664|NCT03417999|565375781|FG002|Overall Study|Withdrawal by Subject|0|||
156626665|NCT03417999|565375779|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
156626666|NCT03417999|565375780|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
156626667|NCT03417999|565375781|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
156626668|NCT03417999|565375779|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
156626669|NCT03417999|565375780|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
156626670|NCT03417999|565375781|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
156626671|NCT03417999|565375779|FG000|Overall Study|Inadequate study staff available to process samples|0|||
156626672|NCT03417999|565375780|FG001|Overall Study|Inadequate study staff available to process samples|0|||
156626673|NCT03417999|565375781|FG002|Overall Study|Inadequate study staff available to process samples|1|||
156626674|NCT02613910|565375782|FG000|Overall Study|Termination of study|1|||
156626675|NCT00695318|565375783|FG000|Overall Study|Lost to Follow-up|1|||
156626676|NCT00695318|565375784|FG001|Overall Study|Lost to Follow-up|0|||
156626677|NCT00695318|565375783|FG000|Overall Study|Withdrawal by Subject|2|||
156626678|NCT00695318|565375784|FG001|Overall Study|Withdrawal by Subject|0|||
156626679|NCT00695318|565375783|FG000|Overall Study|Death|1|||
156626680|NCT00695318|565375784|FG001|Overall Study|Death|1|||
156626681|NCT00695318|565375783|FG000|Overall Study|Study Terminated|1|||
156626682|NCT00695318|565375784|FG001|Overall Study|Study Terminated|0|||
156626683|NCT03726320|565377358|FG000|Overall Study|Lost to Follow-up|2|||
156626684|NCT03726320|565377359|FG001|Overall Study|Lost to Follow-up|4|||
156626685|NCT03726320|565377360|FG002|Overall Study|Lost to Follow-up|0|||
156626686|NCT03726320|565377358|FG000|Overall Study|Time Constraints|4|||
156626687|NCT03726320|565377359|FG001|Overall Study|Time Constraints|1|||
156626688|NCT03726320|565377360|FG002|Overall Study|Time Constraints|0|||
156626689|NCT03726320|565377358|FG000|Overall Study|Ineligible after enrollment|3|||
156626690|NCT03726320|565377359|FG001|Overall Study|Ineligible after enrollment|3|||
156626691|NCT03726320|565377360|FG002|Overall Study|Ineligible after enrollment|0|||
156626692|NCT03726320|565377358|FG000|Overall Study|Clinic / insurance issue|2|||
156626693|NCT03726320|565377359|FG001|Overall Study|Clinic / insurance issue|0|||
156626694|NCT03726320|565377360|FG002|Overall Study|Clinic / insurance issue|0|||
156626695|NCT03726320|565377358|FG000|Overall Study|Language barrier|1|||
156626696|NCT03726320|565377359|FG001|Overall Study|Language barrier|0|||
156626697|NCT03726320|565377360|FG002|Overall Study|Language barrier|0|||
156626698|NCT03726320|565377358|FG000|Overall Study|Provider left the clinic|0|||
156626699|NCT03726320|565377359|FG001|Overall Study|Provider left the clinic|0|||
156626700|NCT03726320|565377360|FG002|Overall Study|Provider left the clinic|1|||
156626701|NCT02028182|565377363|FG000|Overall Study|Protocol Violation|2|||
156626702|NCT01684930|565377366|FG000|Overall Study|Withdrawal by Subject|3|||
156626703|NCT01684930|565377367|FG001|Overall Study|Withdrawal by Subject|1|||
156626704|NCT01336647|565377369|FG000|Overall Study|Lost to Follow-up|4|||
156626705|NCT01336647|565377370|FG001|Overall Study|Lost to Follow-up|1|||
156626706|NCT01336647|565377371|FG002|Overall Study|Lost to Follow-up|3|||
156626707|NCT03808298|565377372|FG000|Overall Study|Adverse Event|3|||
156626708|NCT03808298|565377372|FG000|Overall Study|Physician Decision|1|||
156626709|NCT03808298|565377372|FG000|Overall Study|Withdrawal by Subject|1|||
156626710|NCT03808298|565377372|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
156626711|NCT01004822|565377373|FG000|Overall Study|Objective progression or relapse|3|||
156626712|NCT01004822|565377374|FG001|Overall Study|Objective progression or relapse|3|||
156626713|NCT01004822|565377375|FG002|Overall Study|Objective progression or relapse|0|||
156626714|NCT01004822|565377376|FG003|Overall Study|Objective progression or relapse|1|||
156626715|NCT01004822|565377377|FG004|Overall Study|Objective progression or relapse|2|||
156626716|NCT01004822|565377378|FG005|Overall Study|Objective progression or relapse|2|||
156626717|NCT01004822|565377379|FG006|Overall Study|Objective progression or relapse|1|||
156626718|NCT01004822|565377380|FG007|Overall Study|Objective progression or relapse|4|||
156626719|NCT01004822|565377373|FG000|Overall Study|Global deterioration of health status|0|||
156626720|NCT01004822|565377374|FG001|Overall Study|Global deterioration of health status|0|||
156626721|NCT01004822|565377375|FG002|Overall Study|Global deterioration of health status|0|||
156626722|NCT01004822|565377376|FG003|Overall Study|Global deterioration of health status|1|||
156626723|NCT01004822|565377377|FG004|Overall Study|Global deterioration of health status|0|||
156626724|NCT01004822|565377378|FG005|Overall Study|Global deterioration of health status|0|||
156626725|NCT01004822|565377379|FG006|Overall Study|Global deterioration of health status|1|||
156626726|NCT01004822|565377380|FG007|Overall Study|Global deterioration of health status|0|||
156626727|NCT01004822|565377373|FG000|Overall Study|No longer willing to continue|0|||
156626728|NCT01004822|565377374|FG001|Overall Study|No longer willing to continue|0|||
156626729|NCT01004822|565377375|FG002|Overall Study|No longer willing to continue|0|||
156626730|NCT01004822|565377376|FG003|Overall Study|No longer willing to continue|1|||
156626731|NCT01004822|565377377|FG004|Overall Study|No longer willing to continue|2|||
156626732|NCT01004822|565377378|FG005|Overall Study|No longer willing to continue|1|||
156626733|NCT01004822|565377379|FG006|Overall Study|No longer willing to continue|1|||
156626734|NCT01004822|565377380|FG007|Overall Study|No longer willing to continue|0|||
156626735|NCT01004822|565377373|FG000|Overall Study|Adverse Event|0|||
156626736|NCT01004822|565377374|FG001|Overall Study|Adverse Event|0|||
156626737|NCT01004822|565377375|FG002|Overall Study|Adverse Event|0|||
156626738|NCT01004822|565377376|FG003|Overall Study|Adverse Event|0|||
156626739|NCT01004822|565377377|FG004|Overall Study|Adverse Event|0|||
156626740|NCT01004822|565377378|FG005|Overall Study|Adverse Event|0|||
156626741|NCT01004822|565377379|FG006|Overall Study|Adverse Event|1|||
156626742|NCT01004822|565377380|FG007|Overall Study|Adverse Event|1|||
156626743|NCT01004822|565377373|FG000|Overall Study|Other|0|||
156626744|NCT01004822|565377374|FG001|Overall Study|Other|0|||
156626745|NCT01004822|565377375|FG002|Overall Study|Other|4|||
156626746|NCT01004822|565377376|FG003|Overall Study|Other|1|||
156626747|NCT01004822|565377377|FG004|Overall Study|Other|0|||
156626748|NCT01004822|565377378|FG005|Overall Study|Other|1|||
156626749|NCT01004822|565377379|FG006|Overall Study|Other|0|||
156626750|NCT01004822|565377380|FG007|Overall Study|Other|0|||
156626751|NCT03868410|565377381|FG000|Overall Study|Physician Decision|0|||
156626752|NCT03868410|565377382|FG001|Overall Study|Physician Decision|1|||
156626753|NCT02624713|565377386|FG000|Overall Study|Lost to Follow-up|14|||
156626754|NCT02624713|565377387|FG001|Overall Study|Lost to Follow-up|0|||
156626755|NCT00148109|565377388|FG000|Overall Study|Lack of Efficacy|10|||
156626756|NCT00148109|565377389|FG001|Overall Study|Lack of Efficacy|18|||
156626757|NCT00148109|565377388|FG000|Overall Study|Adverse Event|0|||
156626758|NCT00148109|565377389|FG001|Overall Study|Adverse Event|2|||
156626759|NCT00148109|565377388|FG000|Overall Study|Withdrawal by Subject|2|||
156626760|NCT00148109|565377389|FG001|Overall Study|Withdrawal by Subject|0|||
156626761|NCT00679354|565377397|FG000|Overall Study|Death|3|||
156626762|NCT00679354|565377397|FG000|Overall Study|Lack of Efficacy|22|||
156626763|NCT00679354|565377397|FG000|Overall Study|Physician Decision|4|||
156626764|NCT00679354|565377397|FG000|Overall Study|Ineligible|1|||
156626765|NCT03764813|565377398|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
156626766|NCT03764813|565377399|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
156626767|NCT03764813|565377400|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
156626768|NCT03764813|565377401|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
156626769|NCT00408408|565377402|FG000|Overall Study|No follow up data|2|||
156626770|NCT00408408|565377403|FG001|Overall Study|No follow up data|3|||
156626771|NCT00408408|565377404|FG002|Overall Study|No follow up data|0|||
156626772|NCT00408408|565377405|FG003|Overall Study|No follow up data|7|||
156626773|NCT00408408|565377406|FG004|Overall Study|No follow up data|5|||
156626774|NCT00408408|565377407|FG005|Overall Study|No follow up data|3|||
156626775|NCT02898662|565377412|FG000|Overall Study|Adverse Event|1|||
156626776|NCT02898662|565377413|FG001|Overall Study|Adverse Event|0|||
156626777|NCT02898662|565377412|FG000|Overall Study|Loss of asthma control|23|||
156626778|NCT02898662|565377413|FG001|Overall Study|Loss of asthma control|24|||
156626779|NCT02898662|565377412|FG000|Overall Study|Withdrawal by Subject|4|||
156626780|NCT02898662|565377413|FG001|Overall Study|Withdrawal by Subject|1|||
156626781|NCT02898662|565377412|FG000|Overall Study|Technical issue|0|||
156626782|NCT02898662|565377413|FG001|Overall Study|Technical issue|1|||
156626783|NCT02898662|565377412|FG000|Overall Study|Randomized in error|0|||
156626784|NCT02898662|565377413|FG001|Overall Study|Randomized in error|1|||
156626785|NCT02898662|565377412|FG000|Overall Study|Subject decision|1|||
156626786|NCT02898662|565377413|FG001|Overall Study|Subject decision|0|||
156626787|NCT02898662|565377412|FG000|Overall Study|Other|0|||
156626788|NCT02898662|565377413|FG001|Overall Study|Other|1|||
156626789|NCT00399542|565377414|FG000|Overall Study|Adverse Event|18|||
156626790|NCT00399542|565377415|FG001|Overall Study|Adverse Event|15|||
156626791|NCT00399542|565377414|FG000|Overall Study|Protocol Violation|13|||
156626792|NCT00399542|565377415|FG001|Overall Study|Protocol Violation|3|||
156626793|NCT00399542|565377414|FG000|Overall Study|Withdrawal by Subject|28|||
156626794|NCT00399542|565377415|FG001|Overall Study|Withdrawal by Subject|10|||
156626795|NCT00399542|565377414|FG000|Overall Study|Lack of Efficacy|18|||
156626796|NCT00399542|565377415|FG001|Overall Study|Lack of Efficacy|8|||
156626797|NCT00399542|565377414|FG000|Overall Study|Lost to Follow-up|6|||
156626798|NCT00399542|565377415|FG001|Overall Study|Lost to Follow-up|6|||
156626799|NCT00399542|565377414|FG000|Overall Study|Other|1|||
156626800|NCT00399542|565377415|FG001|Overall Study|Other|0|||
156626801|NCT00399542|565377414|FG000|Overall Study|Physician Decision|0|||
156626802|NCT00399542|565377415|FG001|Overall Study|Physician Decision|1|||
156626803|NCT00779142|565377416|FG000|Overall Study|Screen Failures|3|||
156626804|NCT04652245|565377417|FG000|Wash-Out Period|Adverse Event|0|||
156626805|NCT04652245|565377418|FG001|Wash-Out Period|Adverse Event|2|||
156626806|NCT04652245|565377417|FG000|Wash-Out Period|Withdrawal by Subject|0|||
156626807|NCT04652245|565377418|FG001|Wash-Out Period|Withdrawal by Subject|2|||
156626808|NCT00851721|565377425|FG000|Overall Study|planned surgery|1|||
156626809|NCT00851721|565377426|FG001|Overall Study|planned surgery|0|||
156626810|NCT00851721|565377425|FG000|Overall Study|Death|1|||
156626811|NCT00851721|565377426|FG001|Overall Study|Death|0|||
156626812|NCT00851721|565377425|FG000|Overall Study|Adverse Event|0|||
156626813|NCT00851721|565377426|FG001|Overall Study|Adverse Event|1|||
156626814|NCT02924129|565377427|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
156626815|NCT02924129|565377428|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
156626816|NCT02924129|565377427|FG000|Overall Study|Withdrawal by Subject|2|||
156626817|NCT02924129|565377428|FG001|Overall Study|Withdrawal by Subject|2|||
156626818|NCT02924129|565377427|FG000|Overall Study|Physician Decision|1|||
156626819|NCT02924129|565377428|FG001|Overall Study|Physician Decision|0|||
156626820|NCT02924129|565377427|FG000|Overall Study|Missed Visit|0|||
156626821|NCT02924129|565377428|FG001|Overall Study|Missed Visit|1|||
156626822|NCT00302731|565377433|FG000|Overall Study|Lost to Follow-up|1|||
156626823|NCT00302731|565377434|FG001|Overall Study|Lost to Follow-up|2|||
156626824|NCT00302731|565377435|FG002|Overall Study|Lost to Follow-up|0|||
156626825|NCT00302731|565377436|FG003|Overall Study|Lost to Follow-up|0|||
156626826|NCT00302731|565377433|FG000|Overall Study|Adverse Event|0|||
156626827|NCT00302731|565377434|FG001|Overall Study|Adverse Event|2|||
156626828|NCT00302731|565377435|FG002|Overall Study|Adverse Event|2|||
156626829|NCT00302731|565377436|FG003|Overall Study|Adverse Event|0|||
156626830|NCT00302731|565377433|FG000|Overall Study|Withdrawal by Subject|1|||
156626831|NCT00302731|565377434|FG001|Overall Study|Withdrawal by Subject|1|||
156626832|NCT00302731|565377435|FG002|Overall Study|Withdrawal by Subject|0|||
156626833|NCT00302731|565377436|FG003|Overall Study|Withdrawal by Subject|0|||
156626834|NCT00302731|565377433|FG000|Overall Study|Protocol Violation|1|||
156626835|NCT00302731|565377434|FG001|Overall Study|Protocol Violation|0|||
156626836|NCT00302731|565377435|FG002|Overall Study|Protocol Violation|0|||
156626837|NCT00302731|565377436|FG003|Overall Study|Protocol Violation|0|||
156626838|NCT00302731|565377433|FG000|Overall Study|cancer unrelated to study discovered|1|||
156626839|NCT00302731|565377434|FG001|Overall Study|cancer unrelated to study discovered|0|||
156626840|NCT00302731|565377435|FG002|Overall Study|cancer unrelated to study discovered|1|||
156626841|NCT00302731|565377436|FG003|Overall Study|cancer unrelated to study discovered|0|||
156626842|NCT01610752|565377437|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
156626843|NCT01610752|565377438|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
156626844|NCT01610752|565377439|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
156626845|NCT00283062|565377440|FG000|Overall Study|Did not receive any study medication|5|||
156626846|NCT00283062|565377441|FG001|Overall Study|Did not receive any study medication|4|||
156626847|NCT00283062|565377442|FG002|Overall Study|Did not receive any study medication|36|||
156626848|NCT00283062|565377443|FG003|Overall Study|Did not receive any study medication|45|||
156626849|NCT00283062|565377440|FG000|Overall Study|Adverse Event|2|||
156626850|NCT00283062|565377441|FG001|Overall Study|Adverse Event|0|||
156626851|NCT00283062|565377442|FG002|Overall Study|Adverse Event|1|||
156626852|NCT00283062|565377443|FG003|Overall Study|Adverse Event|0|||
156626853|NCT00283062|565377440|FG000|Overall Study|Lost to Follow-up|1|||
156626854|NCT00283062|565377441|FG001|Overall Study|Lost to Follow-up|0|||
156626855|NCT00283062|565377442|FG002|Overall Study|Lost to Follow-up|1|||
156626856|NCT00283062|565377443|FG003|Overall Study|Lost to Follow-up|0|||
156626857|NCT00283062|565377440|FG000|Overall Study|Progressive disease|0|||
156626858|NCT00283062|565377441|FG001|Overall Study|Progressive disease|0|||
156626859|NCT00283062|565377442|FG002|Overall Study|Progressive disease|1|||
156626860|NCT00283062|565377443|FG003|Overall Study|Progressive disease|0|||
156626861|NCT00283062|565377440|FG000|Overall Study|Participant did not wish to continue|3|||
156626862|NCT00283062|565377441|FG001|Overall Study|Participant did not wish to continue|2|||
156626863|NCT00283062|565377442|FG002|Overall Study|Participant did not wish to continue|1|||
156626864|NCT00283062|565377443|FG003|Overall Study|Participant did not wish to continue|0|||
156626865|NCT00283062|565377440|FG000|Overall Study|Undefined|0|||
156626866|NCT00283062|565377441|FG001|Overall Study|Undefined|1|||
156626867|NCT00283062|565377442|FG002|Overall Study|Undefined|1|||
156626868|NCT00283062|565377443|FG003|Overall Study|Undefined|4|||
156626869|NCT00283062|565377440|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
156626870|NCT00283062|565377441|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
156626871|NCT00283062|565377442|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
156626872|NCT00283062|565377443|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
156626873|NCT01535638|565377444|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
156626874|NCT01535638|565377445|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
156626875|NCT01535638|565377446|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
156626876|NCT01535638|565377447|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
156626877|NCT01535638|565377448|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
156626878|NCT01535638|565377449|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
156626879|NCT01535638|565377444|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
156626880|NCT01535638|565377445|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
156626881|NCT01535638|565377446|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
156626882|NCT01535638|565377447|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
156626883|NCT01535638|565377448|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
156626884|NCT01535638|565377449|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
156626885|NCT00827112|565377450|FG000|Overall Study|Adverse Event|2|||
156626886|NCT00827112|565377451|FG001|Overall Study|Adverse Event|0|||
156626887|NCT00827112|565377450|FG000|Overall Study|Lack of Efficacy|2|||
156626888|NCT00827112|565377451|FG001|Overall Study|Lack of Efficacy|0|||
156626889|NCT00827112|565377450|FG000|Overall Study|Lost to Follow-up|3|||
156626890|NCT00827112|565377451|FG001|Overall Study|Lost to Follow-up|2|||
156626891|NCT00827112|565377450|FG000|Overall Study|Pregnancy|0|||
156626892|NCT00827112|565377451|FG001|Overall Study|Pregnancy|1|||
156626893|NCT00827112|565377450|FG000|Overall Study|Protocol Violation|0|||
156626894|NCT00827112|565377451|FG001|Overall Study|Protocol Violation|2|||
156626895|NCT00827112|565377450|FG000|Overall Study|Withdrawal by Subject|2|||
156626896|NCT00827112|565377451|FG001|Overall Study|Withdrawal by Subject|1|||
156626897|NCT00827112|565377450|FG000|Overall Study|Randomized but not treated|5|||
156626898|NCT00827112|565377451|FG001|Overall Study|Randomized but not treated|3|||
156626899|NCT00827112|565377450|FG000|Overall Study|Other|1|||
156626900|NCT00827112|565377451|FG001|Overall Study|Other|3|||
156626901|NCT00689728|565377452|FG000|Double-Blind Treatment|Adverse Event|1|||
156626902|NCT00689728|565377453|FG001|Double-Blind Treatment|Adverse Event|0|||
156626903|NCT00689728|565377454|FG002|Double-Blind Treatment|Adverse Event|0|||
156626904|NCT00689728|565377452|FG000|Double-Blind Treatment|Protocol Violation|0|||
156626905|NCT00689728|565377453|FG001|Double-Blind Treatment|Protocol Violation|0|||
156626906|NCT00689728|565377454|FG002|Double-Blind Treatment|Protocol Violation|1|||
156626907|NCT00689728|565377452|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
156626908|NCT00689728|565377453|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
156626909|NCT00689728|565377454|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
156626910|NCT00689728|565377452|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
156626911|NCT00689728|565377453|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
156626912|NCT00689728|565377454|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
156626913|NCT00689728|565377452|FG000|Rescue|Adverse Event|0|||
156626914|NCT00689728|565377453|FG001|Rescue|Adverse Event|1|||
156626915|NCT00689728|565377454|FG002|Rescue|Adverse Event|0|||
156626916|NCT00689728|565377452|FG000|Rescue|Withdrawal by Subject|1|||
156626917|NCT00689728|565377453|FG001|Rescue|Withdrawal by Subject|1|||
156626918|NCT00689728|565377454|FG002|Rescue|Withdrawal by Subject|1|||
156626919|NCT00689728|565377452|FG000|Optional Follow-Up|Adverse Event|1|||
156626920|NCT00689728|565377453|FG001|Optional Follow-Up|Adverse Event|0|||
156626921|NCT00689728|565377454|FG002|Optional Follow-Up|Adverse Event|0|||
156626922|NCT00689728|565377452|FG000|Optional Follow-Up|Lack of Efficacy|0|||
156626923|NCT00689728|565377453|FG001|Optional Follow-Up|Lack of Efficacy|1|||
156626924|NCT00689728|565377454|FG002|Optional Follow-Up|Lack of Efficacy|1|||
156626925|NCT00689728|565377452|FG000|Optional Follow-Up|Lost to Follow-up|0|||
156626926|NCT00689728|565377453|FG001|Optional Follow-Up|Lost to Follow-up|1|||
156626927|NCT00689728|565377454|FG002|Optional Follow-Up|Lost to Follow-up|1|||
156626928|NCT00689728|565377452|FG000|Optional Follow-Up|Protocol Violation|0|||
156626929|NCT00689728|565377453|FG001|Optional Follow-Up|Protocol Violation|0|||
156626930|NCT00689728|565377454|FG002|Optional Follow-Up|Protocol Violation|1|||
156626931|NCT00689728|565377452|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
156626932|NCT00689728|565377453|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
156626933|NCT00689728|565377454|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
156626934|NCT00842829|565377457|FG000|Dose Titration Period|Adverse Event|11|||
156626935|NCT00842829|565377458|FG001|Dose Titration Period|Adverse Event|10|||
156626936|NCT00842829|565377459|FG002|Dose Titration Period|Adverse Event|0|||
156626937|NCT00842829|565377457|FG000|Dose Titration Period|Lack of Efficacy|4|||
156626938|NCT00842829|565377458|FG001|Dose Titration Period|Lack of Efficacy|1|||
156626939|NCT00842829|565377459|FG002|Dose Titration Period|Lack of Efficacy|0|||
156626940|NCT00842829|565377457|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
156626941|NCT00842829|565377458|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
156626942|NCT00842829|565377459|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
156626943|NCT00842829|565377457|FG000|Dose Titration Period|Withdrawal by Subject|2|||
156626944|NCT00842829|565377458|FG001|Dose Titration Period|Withdrawal by Subject|6|||
156626945|NCT00842829|565377459|FG002|Dose Titration Period|Withdrawal by Subject|0|||
156626946|NCT00842829|565377457|FG000|Dose Titration Period|Other|5|||
156626947|NCT00842829|565377458|FG001|Dose Titration Period|Other|4|||
156626948|NCT00842829|565377459|FG002|Dose Titration Period|Other|0|||
156626949|NCT00842829|565377457|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
156626950|NCT00842829|565377458|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
156626951|NCT00842829|565377459|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
156626952|NCT00842829|565377457|FG000|Dose Titration Period|Non-compliance to study drug|2|||
156626953|NCT00842829|565377458|FG001|Dose Titration Period|Non-compliance to study drug|1|||
156626954|NCT00842829|565377459|FG002|Dose Titration Period|Non-compliance to study drug|0|||
156626955|NCT00842829|565377457|FG000|Treatment Period|Adverse Event|0|||
156626956|NCT00842829|565377458|FG001|Treatment Period|Adverse Event|0|||
156626957|NCT00842829|565377459|FG002|Treatment Period|Adverse Event|15|||
156626958|NCT00842829|565377457|FG000|Treatment Period|Lack of Efficacy|0|||
156626959|NCT00842829|565377458|FG001|Treatment Period|Lack of Efficacy|0|||
156626960|NCT00842829|565377459|FG002|Treatment Period|Lack of Efficacy|6|||
156626961|NCT00842829|565377457|FG000|Treatment Period|Unstable persistent cancer pain|0|||
156626962|NCT00842829|565377458|FG001|Treatment Period|Unstable persistent cancer pain|0|||
156626963|NCT00842829|565377459|FG002|Treatment Period|Unstable persistent cancer pain|5|||
156626964|NCT00842829|565377457|FG000|Treatment Period|Withdrawal by Subject|0|||
156626965|NCT00842829|565377458|FG001|Treatment Period|Withdrawal by Subject|0|||
156626966|NCT00842829|565377459|FG002|Treatment Period|Withdrawal by Subject|11|||
156626967|NCT00842829|565377457|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
156626968|NCT00842829|565377458|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
156626969|NCT00842829|565377459|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
156626970|NCT00842829|565377457|FG000|Treatment Period|Protocol Violation|0|||
156626971|NCT00842829|565377458|FG001|Treatment Period|Protocol Violation|0|||
156626972|NCT00842829|565377459|FG002|Treatment Period|Protocol Violation|2|||
156626973|NCT00842829|565377457|FG000|Treatment Period|Other|0|||
156626974|NCT00842829|565377458|FG001|Treatment Period|Other|0|||
156626975|NCT00842829|565377459|FG002|Treatment Period|Other|18|||
156626976|NCT00842829|565377457|FG000|Treatment Period|Non-compliance to study procedures|0|||
156626977|NCT00842829|565377458|FG001|Treatment Period|Non-compliance to study procedures|0|||
156626978|NCT00842829|565377459|FG002|Treatment Period|Non-compliance to study procedures|4|||
156626979|NCT00842829|565377457|FG000|Treatment Period|Unclear completion status|0|||
156626980|NCT00842829|565377458|FG001|Treatment Period|Unclear completion status|0|||
156626981|NCT00842829|565377459|FG002|Treatment Period|Unclear completion status|1|||
156626982|NCT00842829|565377457|FG000|Continuation Period|Adverse Event|0|||
156626983|NCT00842829|565377458|FG001|Continuation Period|Adverse Event|0|||
156626984|NCT00842829|565377459|FG002|Continuation Period|Adverse Event|32|||
156626985|NCT00842829|565377457|FG000|Continuation Period|Lack of Efficacy|0|||
156626986|NCT00842829|565377458|FG001|Continuation Period|Lack of Efficacy|0|||
156626987|NCT00842829|565377459|FG002|Continuation Period|Lack of Efficacy|6|||
156626988|NCT00842829|565377457|FG000|Continuation Period|Unstable persistent cancer pain|0|||
156626989|NCT00842829|565377458|FG001|Continuation Period|Unstable persistent cancer pain|0|||
156626990|NCT00842829|565377459|FG002|Continuation Period|Unstable persistent cancer pain|3|||
156626991|NCT00842829|565377457|FG000|Continuation Period|Withdrawal by Subject|0|||
156626992|NCT00842829|565377458|FG001|Continuation Period|Withdrawal by Subject|0|||
156626993|NCT00842829|565377459|FG002|Continuation Period|Withdrawal by Subject|10|||
156626994|NCT00842829|565377457|FG000|Continuation Period|Other|0|||
156626995|NCT00842829|565377458|FG001|Continuation Period|Other|0|||
156626996|NCT00842829|565377459|FG002|Continuation Period|Other|7|||
156626997|NCT00842829|565377457|FG000|Continuation Period|Non-compliance to study procedures|0|||
156626998|NCT00842829|565377458|FG001|Continuation Period|Non-compliance to study procedures|0|||
156626999|NCT00842829|565377459|FG002|Continuation Period|Non-compliance to study procedures|2|||
156627000|NCT00842829|565377457|FG000|Continuation Period|Non-compliance to study drug|0|||
156627001|NCT00842829|565377458|FG001|Continuation Period|Non-compliance to study drug|0|||
156627002|NCT00842829|565377459|FG002|Continuation Period|Non-compliance to study drug|1|||
156627003|NCT02612194|565377469|FG000|Overall Study|Death|5|||
156627004|NCT02612194|565377470|FG001|Overall Study|Death|0|||
156627005|NCT02612194|565377471|FG002|Overall Study|Death|2|||
156627006|NCT02612194|565377469|FG000|Overall Study|Early Study Termination|1|||
156627007|NCT02612194|565377470|FG001|Overall Study|Early Study Termination|0|||
156627008|NCT02612194|565377471|FG002|Overall Study|Early Study Termination|0|||
156627009|NCT02539160|565377472|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
156627010|NCT02539160|565377473|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
156627011|NCT02539160|565377474|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
156627012|NCT02539160|565377475|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
156627013|NCT02539160|565377472|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
156627014|NCT02539160|565377473|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
156627015|NCT02539160|565377474|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
156627016|NCT02539160|565377475|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
156627017|NCT02539160|565377472|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
156627018|NCT02539160|565377473|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
156627019|NCT02539160|565377474|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
156627020|NCT02539160|565377475|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
156627021|NCT01681004|565377476|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
156627022|NCT01681004|565377477|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
156627023|NCT01681004|565377476|FG000|Study Completion|Lost to Follow-up|8|||
156627024|NCT01681004|565377477|FG001|Study Completion|Lost to Follow-up|3|||
156627025|NCT01681004|565377476|FG000|Study Completion|Physician Decision|1|||
156627026|NCT01681004|565377477|FG001|Study Completion|Physician Decision|3|||
156627027|NCT01681004|565377476|FG000|Study Completion|Site Termination|2|||
156627028|NCT01681004|565377477|FG001|Study Completion|Site Termination|1|||
156627029|NCT01681004|565377476|FG000|Study Completion|Death|1|||
156627030|NCT01681004|565377477|FG001|Study Completion|Death|1|||
156627031|NCT00372905|565377478|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
156627032|NCT00372905|565377479|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
156627033|NCT00372905|565377480|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
156627034|NCT00372905|565377481|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
156627035|NCT00372905|565377478|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
156627036|NCT00372905|565377479|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
156627037|NCT00372905|565377480|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
156627038|NCT00372905|565377481|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
156627039|NCT00372905|565377478|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
156627040|NCT00372905|565377479|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
156627041|NCT00372905|565377480|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
156627042|NCT00372905|565377481|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
156627043|NCT00372905|565377478|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
156627044|NCT00372905|565377479|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
156627045|NCT00372905|565377480|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
156627046|NCT00372905|565377481|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
156627047|NCT00372905|565377478|FG000|Follow up Until Relapse or Progression|Study closed|0|||
156627048|NCT00372905|565377479|FG001|Follow up Until Relapse or Progression|Study closed|0|||
156627049|NCT00372905|565377480|FG002|Follow up Until Relapse or Progression|Study closed|0|||
156627050|NCT00372905|565377481|FG003|Follow up Until Relapse or Progression|Study closed|3|||
156627051|NCT00372905|565377478|FG000|Follow up Until Relapse or Progression|Other|0|||
156627052|NCT00372905|565377479|FG001|Follow up Until Relapse or Progression|Other|1|||
156627053|NCT00372905|565377480|FG002|Follow up Until Relapse or Progression|Other|0|||
156627054|NCT00372905|565377481|FG003|Follow up Until Relapse or Progression|Other|0|||
156627055|NCT01728454|565377482|FG000|Stage 1 and 2|Pregnancy|1|||
156627056|NCT01728454|565377483|FG001|Stage 1 and 2|Pregnancy|0|||
156627057|NCT01728454|565377484|FG002|Stage 1 and 2|Pregnancy|0|||
156627058|NCT01728454|565377482|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
156627059|NCT01728454|565377483|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
156627060|NCT01728454|565377484|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
156627061|NCT01728454|565377482|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
156627062|NCT01728454|565377483|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
156627063|NCT01728454|565377484|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
156627064|NCT01728454|565377482|FG000|Stage 1 and 2|Lost to Follow-up|1|||
156627065|NCT01728454|565377483|FG001|Stage 1 and 2|Lost to Follow-up|1|||
156627066|NCT01728454|565377484|FG002|Stage 1 and 2|Lost to Follow-up|0|||
156627067|NCT01728454|565377482|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
156627068|NCT01728454|565377483|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
156627069|NCT01728454|565377484|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
156627070|NCT01728454|565377482|FG000|Stage 3|Reason Missing|0|||
156627071|NCT01728454|565377483|FG001|Stage 3|Reason Missing|0|||
156627072|NCT01728454|565377484|FG002|Stage 3|Reason Missing|1|||
156627073|NCT01728454|565377482|FG000|Stage 3|Subject Required Other Treatment|0|||
156627074|NCT01728454|565377483|FG001|Stage 3|Subject Required Other Treatment|1|||
156627075|NCT01728454|565377484|FG002|Stage 3|Subject Required Other Treatment|0|||
156627076|NCT01728454|565377482|FG000|Stage 3|Pregnancy|1|||
156627077|NCT01728454|565377483|FG001|Stage 3|Pregnancy|0|||
156627078|NCT01728454|565377484|FG002|Stage 3|Pregnancy|0|||
156627079|NCT01728454|565377482|FG000|Stage 3|Withdrew Consent|1|||
156627080|NCT01728454|565377483|FG001|Stage 3|Withdrew Consent|0|||
156627081|NCT01728454|565377484|FG002|Stage 3|Withdrew Consent|1|||
156627082|NCT01728454|565377482|FG000|Stage 3|Non-compliance with Protocol|0|||
156627083|NCT01728454|565377483|FG001|Stage 3|Non-compliance with Protocol|0|||
156627084|NCT01728454|565377484|FG002|Stage 3|Non-compliance with Protocol|1|||
156627085|NCT01728454|565377482|FG000|Stage 3|Lost to Follow-up|0|||
156627086|NCT01728454|565377483|FG001|Stage 3|Lost to Follow-up|3|||
156627087|NCT01728454|565377484|FG002|Stage 3|Lost to Follow-up|1|||
156627088|NCT01728454|565377482|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
156627089|NCT01728454|565377483|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
156627090|NCT01728454|565377484|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
156627091|NCT00689299|565377487|FG000|Overall Study|Adverse Event|2|||
156627092|NCT00689299|565377488|FG001|Overall Study|Adverse Event|1|||
156627093|NCT00689299|565377489|FG002|Overall Study|Adverse Event|1|||
156627094|NCT00689299|565377487|FG000|Overall Study|Lost to Follow-up|0|||
156627095|NCT00689299|565377488|FG001|Overall Study|Lost to Follow-up|1|||
156627096|NCT00689299|565377489|FG002|Overall Study|Lost to Follow-up|1|||
156627097|NCT00689299|565377487|FG000|Overall Study|Withdrawal by Subject|4|||
156627098|NCT00689299|565377488|FG001|Overall Study|Withdrawal by Subject|1|||
156627099|NCT00689299|565377489|FG002|Overall Study|Withdrawal by Subject|3|||
156627100|NCT00689299|565377487|FG000|Overall Study|Protocol Violation|1|||
156627101|NCT00689299|565377488|FG001|Overall Study|Protocol Violation|0|||
156627102|NCT00689299|565377489|FG002|Overall Study|Protocol Violation|0|||
156627103|NCT01190839|565377492|FG000|Overall Study|Adverse Event|32|||
156627104|NCT01190839|565377493|FG001|Overall Study|Adverse Event|41|||
156627105|NCT01190839|565377492|FG000|Overall Study|Protocol Violation|2|||
156627106|NCT01190839|565377493|FG001|Overall Study|Protocol Violation|2|||
156627107|NCT01190839|565377492|FG000|Overall Study|Lost to Follow-up|7|||
156627108|NCT01190839|565377493|FG001|Overall Study|Lost to Follow-up|1|||
156627109|NCT01190839|565377492|FG000|Overall Study|Death|1|||
156627110|NCT01190839|565377493|FG001|Overall Study|Death|0|||
156627111|NCT01190839|565377492|FG000|Overall Study|Trial stopped by Sponsor|71|||
156627112|NCT01190839|565377493|FG001|Overall Study|Trial stopped by Sponsor|68|||
156627113|NCT01190839|565377492|FG000|Overall Study|Undefined|35|||
156627114|NCT01190839|565377493|FG001|Overall Study|Undefined|31|||
156627115|NCT01190839|565377492|FG000|Overall Study|Randomized but not treated|2|||
156627116|NCT01190839|565377493|FG001|Overall Study|Randomized but not treated|4|||
156627117|NCT03077646|565377498|FG000|Overall Study|Lost to Follow-up|29|||
156627118|NCT03077646|565377499|FG001|Overall Study|Lost to Follow-up|30|||
156627119|NCT03077646|565377500|FG002|Overall Study|Lost to Follow-up|31|||
156627120|NCT02058966|565377501|FG000|Open-Label Methamphetamine|Adverse Event|1|||
156627121|NCT02058966|565377501|FG000|First Intervention|Withdrawal by Subject|1|||
156627122|NCT01265511|565377502|FG000|Overall Study|Lack of Efficacy|2|||
156627123|NCT01265511|565377503|FG001|Overall Study|Lack of Efficacy|1|||
156627124|NCT01265511|565377502|FG000|Overall Study|Met stopping rules|0|||
156627125|NCT01265511|565377503|FG001|Overall Study|Met stopping rules|2|||
156627126|NCT02993731|565377504|FG000|Overall Study|Study Termination|101|||
156627127|NCT02993731|565377505|FG001|Overall Study|Study Termination|105|||
156627128|NCT01362062|565377507|FG000|Overall Study|Adverse Event|1|||
156627129|NCT01362062|565377508|FG001|Overall Study|Adverse Event|0|||
156627130|NCT01362062|565377507|FG000|Overall Study|Lost to Follow-up|11|||
156627131|NCT01362062|565377508|FG001|Overall Study|Lost to Follow-up|0|||
156627132|NCT01362062|565377507|FG000|Overall Study|Withdrawal by Subject|2|||
156627133|NCT01362062|565377508|FG001|Overall Study|Withdrawal by Subject|0|||
156627134|NCT01362062|565377507|FG000|Overall Study|Non-compliant participant|2|||
156627135|NCT01362062|565377508|FG001|Overall Study|Non-compliant participant|0|||
156627136|NCT01362062|565377507|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
156627137|NCT01362062|565377508|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
156627138|NCT01362062|565377507|FG000|Overall Study|Had significant improvement|9|||
156627139|NCT01362062|565377508|FG001|Overall Study|Had significant improvement|0|||
156627140|NCT02545504|565377509|FG000|Overall Study|Death|174|||
156627141|NCT02545504|565377510|FG001|Overall Study|Death|168|||
156627142|NCT02545504|565377509|FG000|Overall Study|Unknown reason|30|||
156627143|NCT02545504|565377510|FG001|Overall Study|Unknown reason|32|||
156627144|NCT02545504|565377509|FG000|Overall Study|Withdrew consent|9|||
156627145|NCT02545504|565377510|FG001|Overall Study|Withdrew consent|11|||
156627146|NCT02545504|565377509|FG000|Overall Study|Investigator's discretion|3|||
156627147|NCT02545504|565377510|FG001|Overall Study|Investigator's discretion|1|||
156627148|NCT02545504|565377509|FG000|Overall Study|Lost to Follow-up|2|||
156627149|NCT02545504|565377510|FG001|Overall Study|Lost to Follow-up|2|||
156627150|NCT00434876|565377513|FG000|Overall Study|Lost to Follow-up|1|||
156627151|NCT00434876|565377514|FG001|Overall Study|Lost to Follow-up|1|||
156627152|NCT00758394|565377515|FG000|2nd Intervention Order|Lost to Follow-up|0|||
156627153|NCT00758394|565377516|FG001|2nd Intervention Order|Lost to Follow-up|1|||
156627154|NCT00758394|565377517|FG002|2nd Intervention Order|Lost to Follow-up|0|||
156627155|NCT00758394|565377518|FG003|2nd Intervention Order|Lost to Follow-up|0|||
156627156|NCT00758394|565377515|FG000|3rd Intervention|Lost to Follow-up|1|||
156627157|NCT00758394|565377516|FG001|3rd Intervention|Lost to Follow-up|0|||
156627158|NCT00758394|565377517|FG002|3rd Intervention|Lost to Follow-up|0|||
156627159|NCT00758394|565377518|FG003|3rd Intervention|Lost to Follow-up|1|||
156627160|NCT01002573|565379612|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
156627161|NCT01002573|565379613|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
156627162|NCT00690612|565379614|FG000|Overall Study|Adverse Event|1|||
156627163|NCT00690612|565379614|FG000|Overall Study|Withdrawal by Subject|2|||
156627164|NCT02926833|565379615|FG000|Overall Study|Death|1|||
156627165|NCT02926833|565379616|FG001|Overall Study|Death|1|||
156627166|NCT02926833|565379617|FG002|Overall Study|Death|2|||
156627167|NCT02926833|565379618|FG003|Overall Study|Death|13|||
156627168|NCT02926833|565379615|FG000|Overall Study|Lost to Follow-up|1|||
156627169|NCT02926833|565379616|FG001|Overall Study|Lost to Follow-up|2|||
156627170|NCT02926833|565379617|FG002|Overall Study|Lost to Follow-up|0|||
156627171|NCT02926833|565379618|FG003|Overall Study|Lost to Follow-up|3|||
156627172|NCT02926833|565379615|FG000|Overall Study|Full Consent Withdrawal|0|||
156627173|NCT02926833|565379616|FG001|Overall Study|Full Consent Withdrawal|0|||
156627174|NCT02926833|565379617|FG002|Overall Study|Full Consent Withdrawal|0|||
156627175|NCT02926833|565379618|FG003|Overall Study|Full Consent Withdrawal|2|||
156627176|NCT02926833|565379615|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
156627177|NCT02926833|565379616|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
156627178|NCT02926833|565379617|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
156627179|NCT02926833|565379618|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
156627180|NCT02926833|565379615|FG000|Overall Study|Investigator Decision|0|||
156627181|NCT02926833|565379616|FG001|Overall Study|Investigator Decision|1|||
156627182|NCT02926833|565379617|FG002|Overall Study|Investigator Decision|0|||
156627183|NCT02926833|565379618|FG003|Overall Study|Investigator Decision|0|||
156627184|NCT02926833|565379615|FG000|Overall Study|Adverse Event|0|||
156627185|NCT02926833|565379616|FG001|Overall Study|Adverse Event|0|||
156627186|NCT02926833|565379617|FG002|Overall Study|Adverse Event|1|||
156627187|NCT02926833|565379618|FG003|Overall Study|Adverse Event|0|||
156627188|NCT02926833|565379615|FG000|Overall Study|Partial Withdrawal of Consent|0|||
156627189|NCT02926833|565379616|FG001|Overall Study|Partial Withdrawal of Consent|0|||
156627190|NCT02926833|565379617|FG002|Overall Study|Partial Withdrawal of Consent|0|||
156627191|NCT02926833|565379618|FG003|Overall Study|Partial Withdrawal of Consent|1|||
156627192|NCT01945866|565379619|FG000|Overall Study|Eyes did not complete or were dropped|2|||
156627193|NCT01945866|565379620|FG001|Overall Study|Eyes did not complete or were dropped|0|||
156627194|NCT02930889|565379623|FG000|Overall Study|Lost to Follow-up|2|||
156627195|NCT02930889|565379623|FG000|Overall Study|Withdrawal by Subject|6|||
156627196|NCT02930889|565379623|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
156627197|NCT04398030|565379624|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
156627198|NCT04398030|565379625|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
156627199|NCT04398030|565379624|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
156627200|NCT04398030|565379625|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
156627201|NCT03159455|565379627|FG000|Overall Study|Adverse Event|0|||
156627202|NCT03159455|565379628|FG001|Overall Study|Adverse Event|0|||
156627203|NCT03159455|565379629|FG002|Overall Study|Adverse Event|0|||
156627204|NCT03159455|565379630|FG003|Overall Study|Adverse Event|0|||
156627205|NCT03159455|565379631|FG004|Overall Study|Adverse Event|0|||
156627206|NCT03159455|565379632|FG005|Overall Study|Adverse Event|1|||
156627207|NCT02713490|565379635|FG000|Overall Study|Withdrawal by Subject|2|||
156627208|NCT02713490|565379636|FG001|Overall Study|Withdrawal by Subject|1|||
156627209|NCT02713490|565379635|FG000|Overall Study|Did not receive study drug|1|||
156627210|NCT02713490|565379636|FG001|Overall Study|Did not receive study drug|0|||
156627211|NCT02713490|565379635|FG000|Overall Study|Met exclusion criteria|0|||
156627212|NCT02713490|565379636|FG001|Overall Study|Met exclusion criteria|1|||
156627213|NCT01714726|565379637|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
156627214|NCT01714726|565379638|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
156627215|NCT01714726|565379639|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
156627216|NCT01714726|565379640|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
156627217|NCT01714726|565379637|FG000|Double-Blinded Induction Period|Adverse Event|0|||
156627218|NCT01714726|565379638|FG001|Double-Blinded Induction Period|Adverse Event|1|||
156627219|NCT01714726|565379639|FG002|Double-Blinded Induction Period|Adverse Event|0|||
156627220|NCT01714726|565379640|FG003|Double-Blinded Induction Period|Adverse Event|0|||
156627221|NCT01714726|565379637|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
156627222|NCT01714726|565379638|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
156627223|NCT01714726|565379639|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
156627224|NCT01714726|565379640|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
156627225|NCT01714726|565379637|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
156627226|NCT01714726|565379638|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
156627227|NCT01714726|565379639|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
156627228|NCT01714726|565379640|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
156627229|NCT01714726|565379637|FG000|Open-Label Period|Other|0|||
156627230|NCT01714726|565379638|FG001|Open-Label Period|Other|0|||
156627231|NCT01714726|565379639|FG002|Open-Label Period|Other|1|||
156627232|NCT01714726|565379640|FG003|Open-Label Period|Other|3|||
156627233|NCT01714726|565379637|FG000|Open-Label Period|Adverse Event|0|||
156627234|NCT01714726|565379638|FG001|Open-Label Period|Adverse Event|0|||
156627235|NCT01714726|565379639|FG002|Open-Label Period|Adverse Event|1|||
156627236|NCT01714726|565379640|FG003|Open-Label Period|Adverse Event|0|||
156627237|NCT01714726|565379637|FG000|Open-Label Period|Withdrawal by Subject|0|||
156627238|NCT01714726|565379638|FG001|Open-Label Period|Withdrawal by Subject|0|||
156627239|NCT01714726|565379639|FG002|Open-Label Period|Withdrawal by Subject|9|||
156627240|NCT01714726|565379640|FG003|Open-Label Period|Withdrawal by Subject|19|||
156627241|NCT01714726|565379637|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
156627242|NCT01714726|565379638|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
156627243|NCT01714726|565379639|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
156627244|NCT01714726|565379640|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
156627245|NCT01714726|565379637|FG000|Open-Label Period|Lost to Follow-up|0|||
156627246|NCT01714726|565379638|FG001|Open-Label Period|Lost to Follow-up|0|||
156627247|NCT01714726|565379639|FG002|Open-Label Period|Lost to Follow-up|3|||
156627248|NCT01714726|565379640|FG003|Open-Label Period|Lost to Follow-up|4|||
156627249|NCT00501969|565379641|FG000|Overall Study|Major Protocol Violation|4|||
156627250|NCT00501969|565379641|FG000|Overall Study|Lack of Efficacy|29|||
156627251|NCT00501969|565379641|FG000|Overall Study|Adverse Event|76|||
156627252|NCT00501969|565379641|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
156627253|NCT00501969|565379641|FG000|Overall Study|Subject withdrew consent|51|||
156627254|NCT00501969|565379641|FG000|Overall Study|Lost to Follow-up|4|||
156627255|NCT00501969|565379641|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
156627256|NCT00501969|565379641|FG000|Overall Study|Other: Sponsors Request|10|||
156627257|NCT00501969|565379641|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
156627258|NCT00501969|565379641|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
156627259|NCT00501969|565379641|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
156627260|NCT00501969|565379641|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
156627261|NCT00501969|565379641|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
156627262|NCT00501969|565379641|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
156627263|NCT00501969|565379641|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
156627264|NCT00501969|565379641|FG000|Overall Study|Other: As Required by Local EC|2|||
156627265|NCT00501969|565379641|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
156627266|NCT00501969|565379641|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
156627267|NCT00665366|565379644|FG000|Overall Study|Lack of Efficacy|11|||
156627268|NCT00665366|565379645|FG001|Overall Study|Lack of Efficacy|10|||
156627269|NCT00665366|565379644|FG000|Overall Study|Adverse Event|25|||
156627270|NCT00665366|565379645|FG001|Overall Study|Adverse Event|23|||
156627271|NCT00665366|565379644|FG000|Overall Study|Withdrawal by Subject|11|||
156627272|NCT00665366|565379645|FG001|Overall Study|Withdrawal by Subject|14|||
156627273|NCT00665366|565379644|FG000|Overall Study|Lost to Follow-up|3|||
156627274|NCT00665366|565379645|FG001|Overall Study|Lost to Follow-up|5|||
156627275|NCT00665366|565379644|FG000|Overall Study|Poor compliance/noncompliance|3|||
156627276|NCT00665366|565379645|FG001|Overall Study|Poor compliance/noncompliance|5|||
156627277|NCT00665366|565379644|FG000|Overall Study|Pregnancy|1|||
156627278|NCT00665366|565379645|FG001|Overall Study|Pregnancy|0|||
156627279|NCT00665366|565379644|FG000|Overall Study|No longer meets study criteria|0|||
156627280|NCT00665366|565379645|FG001|Overall Study|No longer meets study criteria|1|||
156627281|NCT00665366|565379644|FG000|Overall Study|Other reasons|4|||
156627282|NCT00665366|565379645|FG001|Overall Study|Other reasons|1|||
156627283|NCT03628781|565379646|FG000|Overall Study|Lost to Follow-up|16|||
156627284|NCT03628781|565379647|FG001|Overall Study|Lost to Follow-up|8|||
156627285|NCT03628781|565379646|FG000|Overall Study|Withdrawal by Subject|16|||
156627286|NCT03628781|565379647|FG001|Overall Study|Withdrawal by Subject|1|||
156627287|NCT02687815|565379651|FG000|Overall Study|Lost to Follow-up|2|||
156627288|NCT02687815|565379652|FG001|Overall Study|Lost to Follow-up|4|||
156627289|NCT02687815|565379651|FG000|Overall Study|Withdrawal by Subject|2|||
156627290|NCT02687815|565379652|FG001|Overall Study|Withdrawal by Subject|4|||
156627291|NCT00379639|565379653|FG000|Overall Study|Disease Progression|3|||
156627292|NCT00379639|565379654|FG001|Overall Study|Disease Progression|3|||
156627293|NCT00379639|565379655|FG002|Overall Study|Disease Progression|3|||
156627294|NCT00379639|565379656|FG003|Overall Study|Disease Progression|4|||
156627295|NCT00379639|565379657|FG004|Overall Study|Disease Progression|4|||
156627296|NCT00379639|565379653|FG000|Overall Study|Physician Decision|0|||
156627297|NCT00379639|565379654|FG001|Overall Study|Physician Decision|2|||
156627298|NCT00379639|565379655|FG002|Overall Study|Physician Decision|1|||
156627299|NCT00379639|565379656|FG003|Overall Study|Physician Decision|1|||
156627300|NCT00379639|565379657|FG004|Overall Study|Physician Decision|0|||
156627301|NCT00379639|565379653|FG000|Overall Study|Symptomatic Deterioration|0|||
156627302|NCT00379639|565379654|FG001|Overall Study|Symptomatic Deterioration|0|||
156627303|NCT00379639|565379655|FG002|Overall Study|Symptomatic Deterioration|1|||
156627304|NCT00379639|565379656|FG003|Overall Study|Symptomatic Deterioration|0|||
156627305|NCT00379639|565379657|FG004|Overall Study|Symptomatic Deterioration|1|||
156627306|NCT00379639|565379653|FG000|Overall Study|Adverse Event|0|||
156627307|NCT00379639|565379654|FG001|Overall Study|Adverse Event|0|||
156627308|NCT00379639|565379655|FG002|Overall Study|Adverse Event|1|||
156627309|NCT00379639|565379656|FG003|Overall Study|Adverse Event|0|||
156627310|NCT00379639|565379657|FG004|Overall Study|Adverse Event|1|||
156627311|NCT00379639|565379653|FG000|Overall Study|Lost to Follow-up|0|||
156627312|NCT00379639|565379654|FG001|Overall Study|Lost to Follow-up|0|||
156627313|NCT00379639|565379655|FG002|Overall Study|Lost to Follow-up|0|||
156627314|NCT00379639|565379656|FG003|Overall Study|Lost to Follow-up|1|||
156627315|NCT00379639|565379657|FG004|Overall Study|Lost to Follow-up|0|||
156627316|NCT00379639|565379653|FG000|Overall Study|Other|0|||
156627317|NCT00379639|565379654|FG001|Overall Study|Other|0|||
156627318|NCT00379639|565379655|FG002|Overall Study|Other|3|||
156627319|NCT00379639|565379656|FG003|Overall Study|Other|0|||
156627320|NCT00379639|565379657|FG004|Overall Study|Other|0|||
156627321|NCT01238861|565379660|FG000|Overall Study|Lost to Follow-up|4|||
156627322|NCT01238861|565379661|FG001|Overall Study|Lost to Follow-up|2|||
156627323|NCT01238861|565379662|FG002|Overall Study|Lost to Follow-up|3|||
156627324|NCT01238861|565379663|FG003|Overall Study|Lost to Follow-up|1|||
156627325|NCT01238861|565379664|FG004|Overall Study|Lost to Follow-up|1|||
156627326|NCT01238861|565379665|FG005|Overall Study|Lost to Follow-up|2|||
156627327|NCT01238861|565379660|FG000|Overall Study|Unplanned surgery|1|||
156627328|NCT01238861|565379661|FG001|Overall Study|Unplanned surgery|0|||
156627329|NCT01238861|565379662|FG002|Overall Study|Unplanned surgery|0|||
156627330|NCT01238861|565379663|FG003|Overall Study|Unplanned surgery|0|||
156627331|NCT01238861|565379664|FG004|Overall Study|Unplanned surgery|0|||
156627332|NCT01238861|565379665|FG005|Overall Study|Unplanned surgery|0|||
156627333|NCT01238861|565379660|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
156627334|NCT01238861|565379661|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
156627335|NCT01238861|565379662|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
156627336|NCT01238861|565379663|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
156627337|NCT01238861|565379664|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
156627338|NCT01238861|565379665|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
156627339|NCT01238861|565379660|FG000|Overall Study|Incorrect enrollment/randomization|0|||
156627340|NCT01238861|565379661|FG001|Overall Study|Incorrect enrollment/randomization|0|||
156627341|NCT01238861|565379662|FG002|Overall Study|Incorrect enrollment/randomization|1|||
156627342|NCT01238861|565379663|FG003|Overall Study|Incorrect enrollment/randomization|0|||
156627343|NCT01238861|565379664|FG004|Overall Study|Incorrect enrollment/randomization|1|||
156627344|NCT01238861|565379665|FG005|Overall Study|Incorrect enrollment/randomization|0|||
156627345|NCT01238861|565379660|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
156627346|NCT01238861|565379661|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
156627347|NCT01238861|565379662|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
156627348|NCT01238861|565379663|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
156627349|NCT01238861|565379664|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
156627350|NCT01238861|565379665|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
156627351|NCT01238861|565379660|FG000|Overall Study|Subject moved out of state/area|0|||
156627352|NCT01238861|565379661|FG001|Overall Study|Subject moved out of state/area|0|||
156627353|NCT01238861|565379662|FG002|Overall Study|Subject moved out of state/area|1|||
156627354|NCT01238861|565379663|FG003|Overall Study|Subject moved out of state/area|1|||
156627355|NCT01238861|565379664|FG004|Overall Study|Subject moved out of state/area|0|||
156627356|NCT01238861|565379665|FG005|Overall Study|Subject moved out of state/area|0|||
156627357|NCT01238861|565379660|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
156627358|NCT01238861|565379661|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
156627359|NCT01238861|565379662|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
156627360|NCT01238861|565379663|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
156627361|NCT01238861|565379664|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
156627362|NCT01238861|565379665|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
156627363|NCT01238861|565379660|FG000|Overall Study|Personal problems|0|||
156627364|NCT01238861|565379661|FG001|Overall Study|Personal problems|0|||
156627365|NCT01238861|565379662|FG002|Overall Study|Personal problems|0|||
156627366|NCT01238861|565379663|FG003|Overall Study|Personal problems|1|||
156627367|NCT01238861|565379664|FG004|Overall Study|Personal problems|0|||
156627368|NCT01238861|565379665|FG005|Overall Study|Personal problems|0|||
156627369|NCT01238861|565379660|FG000|Overall Study|Unable to continue visits|0|||
156627370|NCT01238861|565379661|FG001|Overall Study|Unable to continue visits|0|||
156627371|NCT01238861|565379662|FG002|Overall Study|Unable to continue visits|0|||
156627372|NCT01238861|565379663|FG003|Overall Study|Unable to continue visits|1|||
156627373|NCT01238861|565379664|FG004|Overall Study|Unable to continue visits|0|||
156627374|NCT01238861|565379665|FG005|Overall Study|Unable to continue visits|1|||
156627375|NCT01238861|565379660|FG000|Overall Study|Serious adverse event|0|||
156627376|NCT01238861|565379661|FG001|Overall Study|Serious adverse event|0|||
156627377|NCT01238861|565379662|FG002|Overall Study|Serious adverse event|0|||
156627378|NCT01238861|565379663|FG003|Overall Study|Serious adverse event|0|||
156627379|NCT01238861|565379664|FG004|Overall Study|Serious adverse event|0|||
156627380|NCT01238861|565379665|FG005|Overall Study|Serious adverse event|1|||
156627381|NCT01238861|565379660|FG000|Overall Study|Lack of compliance|0|||
156627382|NCT01238861|565379661|FG001|Overall Study|Lack of compliance|0|||
156627383|NCT01238861|565379662|FG002|Overall Study|Lack of compliance|0|||
156627384|NCT01238861|565379663|FG003|Overall Study|Lack of compliance|0|||
156627385|NCT01238861|565379664|FG004|Overall Study|Lack of compliance|0|||
156627386|NCT01238861|565379665|FG005|Overall Study|Lack of compliance|1|||
156627387|NCT01238861|565379660|FG000|Overall Study|Adverse Event|0|||
156627388|NCT01238861|565379661|FG001|Overall Study|Adverse Event|1|||
156627389|NCT01238861|565379662|FG002|Overall Study|Adverse Event|0|||
156627390|NCT01238861|565379663|FG003|Overall Study|Adverse Event|0|||
156627391|NCT01238861|565379664|FG004|Overall Study|Adverse Event|0|||
156627392|NCT01238861|565379665|FG005|Overall Study|Adverse Event|0|||
156627393|NCT01238861|565379660|FG000|Overall Study|Withdrawal by Subject|6|||
156627394|NCT01238861|565379661|FG001|Overall Study|Withdrawal by Subject|5|||
156627395|NCT01238861|565379662|FG002|Overall Study|Withdrawal by Subject|4|||
156627396|NCT01238861|565379663|FG003|Overall Study|Withdrawal by Subject|8|||
156627397|NCT01238861|565379664|FG004|Overall Study|Withdrawal by Subject|10|||
156627398|NCT01238861|565379665|FG005|Overall Study|Withdrawal by Subject|9|||
156627399|NCT02452320|565379666|FG000|Overall Study|Adverse Event|0|||
156627400|NCT02452320|565379667|FG001|Overall Study|Adverse Event|1|||
156627401|NCT03737812|565379668|FG000|Overall Study|Withdrawal by Subject|1|||
156627402|NCT03737812|565379669|FG001|Overall Study|Withdrawal by Subject|2|||
156627403|NCT03737812|565379670|FG002|Overall Study|Withdrawal by Subject|1|||
156635565|NCT00602667|565409962|FG002|Overall Study|Family request|6|||
156627404|NCT03737812|565379668|FG000|Overall Study|Sponsor Discontinued the Study|4|||
156627405|NCT03737812|565379669|FG001|Overall Study|Sponsor Discontinued the Study|3|||
156627406|NCT03737812|565379670|FG002|Overall Study|Sponsor Discontinued the Study|2|||
156627407|NCT03737812|565379668|FG000|Overall Study|Adverse Event|0|||
156627408|NCT03737812|565379669|FG001|Overall Study|Adverse Event|1|||
156627409|NCT03737812|565379670|FG002|Overall Study|Adverse Event|0|||
156627410|NCT03737812|565379668|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
156627411|NCT03737812|565379669|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
156627412|NCT03737812|565379670|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
156627413|NCT02557308|565379671|FG000|Overall Study|Withdrawal by Subject|11|||
156627414|NCT02557308|565379672|FG001|Overall Study|Withdrawal by Subject|3|||
156627415|NCT02557308|565379673|FG002|Overall Study|Withdrawal by Subject|2|||
156627416|NCT02557308|565379674|FG003|Overall Study|Withdrawal by Subject|0|||
156627417|NCT02557308|565379675|FG004|Overall Study|Withdrawal by Subject|1|||
156627418|NCT02557308|565379676|FG005|Overall Study|Withdrawal by Subject|0|||
156627419|NCT02557308|565379677|FG006|Overall Study|Withdrawal by Subject|10|||
156627420|NCT02557308|565379678|FG007|Overall Study|Withdrawal by Subject|1|||
156627421|NCT02557308|565379671|FG000|Overall Study|Disease Progression|0|||
156627422|NCT02557308|565379672|FG001|Overall Study|Disease Progression|1|||
156627423|NCT02557308|565379673|FG002|Overall Study|Disease Progression|0|||
156627424|NCT02557308|565379674|FG003|Overall Study|Disease Progression|0|||
156627425|NCT02557308|565379675|FG004|Overall Study|Disease Progression|0|||
156627426|NCT02557308|565379676|FG005|Overall Study|Disease Progression|0|||
156627427|NCT02557308|565379677|FG006|Overall Study|Disease Progression|0|||
156627428|NCT02557308|565379678|FG007|Overall Study|Disease Progression|0|||
156627429|NCT02557308|565379671|FG000|Overall Study|Lack of Efficacy|3|||
156627430|NCT02557308|565379672|FG001|Overall Study|Lack of Efficacy|0|||
156627431|NCT02557308|565379673|FG002|Overall Study|Lack of Efficacy|0|||
156627432|NCT02557308|565379674|FG003|Overall Study|Lack of Efficacy|0|||
156627433|NCT02557308|565379675|FG004|Overall Study|Lack of Efficacy|0|||
156627434|NCT02557308|565379676|FG005|Overall Study|Lack of Efficacy|0|||
156627435|NCT02557308|565379677|FG006|Overall Study|Lack of Efficacy|1|||
156627436|NCT02557308|565379678|FG007|Overall Study|Lack of Efficacy|0|||
156627437|NCT02557308|565379671|FG000|Overall Study|Adverse Event|4|||
156627438|NCT02557308|565379672|FG001|Overall Study|Adverse Event|1|||
156627439|NCT02557308|565379673|FG002|Overall Study|Adverse Event|2|||
156627440|NCT02557308|565379674|FG003|Overall Study|Adverse Event|0|||
156627441|NCT02557308|565379675|FG004|Overall Study|Adverse Event|0|||
156627442|NCT02557308|565379676|FG005|Overall Study|Adverse Event|0|||
156627443|NCT02557308|565379677|FG006|Overall Study|Adverse Event|4|||
156627444|NCT02557308|565379678|FG007|Overall Study|Adverse Event|1|||
156627445|NCT02557308|565379671|FG000|Overall Study|Lost to Follow-up|2|||
156627446|NCT02557308|565379672|FG001|Overall Study|Lost to Follow-up|0|||
156627447|NCT02557308|565379673|FG002|Overall Study|Lost to Follow-up|1|||
156627448|NCT02557308|565379674|FG003|Overall Study|Lost to Follow-up|0|||
156627449|NCT02557308|565379675|FG004|Overall Study|Lost to Follow-up|0|||
156627450|NCT02557308|565379676|FG005|Overall Study|Lost to Follow-up|0|||
156627451|NCT02557308|565379677|FG006|Overall Study|Lost to Follow-up|2|||
156627452|NCT02557308|565379678|FG007|Overall Study|Lost to Follow-up|0|||
156627453|NCT02557308|565379671|FG000|Overall Study|Death|1|||
156627454|NCT02557308|565379672|FG001|Overall Study|Death|0|||
156627455|NCT02557308|565379673|FG002|Overall Study|Death|0|||
156627456|NCT02557308|565379674|FG003|Overall Study|Death|0|||
156627457|NCT02557308|565379675|FG004|Overall Study|Death|0|||
156627458|NCT02557308|565379676|FG005|Overall Study|Death|0|||
156627459|NCT02557308|565379677|FG006|Overall Study|Death|0|||
156627460|NCT02557308|565379678|FG007|Overall Study|Death|0|||
156627461|NCT02557308|565379671|FG000|Overall Study|Study Close|98|||
156627462|NCT02557308|565379672|FG001|Overall Study|Study Close|18|||
156627463|NCT02557308|565379673|FG002|Overall Study|Study Close|5|||
156627464|NCT02557308|565379674|FG003|Overall Study|Study Close|3|||
156627465|NCT02557308|565379675|FG004|Overall Study|Study Close|1|||
156627466|NCT02557308|565379676|FG005|Overall Study|Study Close|0|||
156627467|NCT02557308|565379677|FG006|Overall Study|Study Close|123|||
156627468|NCT02557308|565379678|FG007|Overall Study|Study Close|5|||
156627469|NCT02557308|565379671|FG000|Overall Study|Except for study close|5|||
156627470|NCT02557308|565379672|FG001|Overall Study|Except for study close|0|||
156627471|NCT02557308|565379673|FG002|Overall Study|Except for study close|0|||
156627472|NCT02557308|565379674|FG003|Overall Study|Except for study close|0|||
156627473|NCT02557308|565379675|FG004|Overall Study|Except for study close|3|||
156627474|NCT02557308|565379676|FG005|Overall Study|Except for study close|0|||
156627475|NCT02557308|565379677|FG006|Overall Study|Except for study close|6|||
156627476|NCT02557308|565379678|FG007|Overall Study|Except for study close|10|||
156627477|NCT03911401|565379679|FG000|Overall Study|Adverse Event|1|||
156627478|NCT03911401|565379680|FG001|Overall Study|Adverse Event|2|||
156627479|NCT03911401|565379681|FG002|Overall Study|Adverse Event|5|||
156627480|NCT03911401|565379679|FG000|Overall Study|Lack of Efficacy|1|||
156627481|NCT03911401|565379680|FG001|Overall Study|Lack of Efficacy|1|||
156627482|NCT03911401|565379681|FG002|Overall Study|Lack of Efficacy|8|||
156627483|NCT03911401|565379679|FG000|Overall Study|Physician Decision|0|||
156627484|NCT03911401|565379680|FG001|Overall Study|Physician Decision|0|||
156627485|NCT03911401|565379681|FG002|Overall Study|Physician Decision|1|||
156627486|NCT03911401|565379679|FG000|Overall Study|Withdrawal by Subject|1|||
156627487|NCT03911401|565379680|FG001|Overall Study|Withdrawal by Subject|2|||
156627488|NCT03911401|565379681|FG002|Overall Study|Withdrawal by Subject|0|||
156627489|NCT03911401|565379679|FG000|Overall Study|Withdrawal by parent/guardian|4|||
156627490|NCT03911401|565379680|FG001|Overall Study|Withdrawal by parent/guardian|4|||
156627491|NCT03911401|565379681|FG002|Overall Study|Withdrawal by parent/guardian|11|||
156627492|NCT06104423|565379682|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
156627493|NCT06104423|565379683|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
156627494|NCT06104423|565379684|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
156627495|NCT06104423|565379682|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
156627496|NCT06104423|565379683|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
156627497|NCT06104423|565379684|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
156627498|NCT03814499|565379690|FG000|Overall Study|Lost to Follow-up|3|||
156627499|NCT00351611|565379691|FG000|Overall Study|Adverse Event|11|||
156627500|NCT00351611|565379692|FG001|Overall Study|Adverse Event|3|||
156627501|NCT00351611|565379691|FG000|Overall Study|Death|1|||
156627502|NCT00351611|565379692|FG001|Overall Study|Death|0|||
156627503|NCT00351611|565379691|FG000|Overall Study|Lost to Follow-up|1|||
156627504|NCT00351611|565379692|FG001|Overall Study|Lost to Follow-up|0|||
156627505|NCT00351611|565379691|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
156627506|NCT00351611|565379692|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
156627507|NCT00351611|565379691|FG000|Overall Study|Other|1|||
156627508|NCT00351611|565379692|FG001|Overall Study|Other|0|||
156627509|NCT00351611|565379691|FG000|Overall Study|Protocol Violation|0|||
156627510|NCT00351611|565379692|FG001|Overall Study|Protocol Violation|2|||
156627511|NCT01589185|565379693|FG000|Overall Study|Death|1|||
156627512|NCT01589185|565379694|FG001|Overall Study|Death|2|||
156627513|NCT01589185|565379695|FG002|Overall Study|Death|2|||
156627514|NCT01589185|565379696|FG003|Overall Study|Death|0|||
156627515|NCT01589185|565379697|FG004|Overall Study|Death|1|||
156627516|NCT01589185|565379693|FG000|Overall Study|Lost to Follow-up|1|||
156627517|NCT01589185|565379694|FG001|Overall Study|Lost to Follow-up|0|||
156627518|NCT01589185|565379695|FG002|Overall Study|Lost to Follow-up|2|||
156627519|NCT01589185|565379696|FG003|Overall Study|Lost to Follow-up|3|||
156627520|NCT01589185|565379697|FG004|Overall Study|Lost to Follow-up|0|||
156627521|NCT03417245|565379698|FG000|Overall Study|Adverse Event|1|||
156627522|NCT03417245|565379699|FG001|Overall Study|Adverse Event|0|||
156627523|NCT03417245|565379698|FG000|Overall Study|Protocol Violation|1|||
156627524|NCT03417245|565379699|FG001|Overall Study|Protocol Violation|0|||
156627525|NCT03417245|565379698|FG000|Overall Study|Withdrawal by Subject|1|||
156627526|NCT03417245|565379699|FG001|Overall Study|Withdrawal by Subject|1|||
156627527|NCT02708524|565379702|FG000|Overall Study|Adverse Event|0|||
156627528|NCT02708524|565379703|FG001|Overall Study|Adverse Event|1|||
156627529|NCT02708524|565379704|FG002|Overall Study|Adverse Event|0|||
156627530|NCT02708524|565379705|FG003|Overall Study|Adverse Event|0|||
156627531|NCT02708524|565379702|FG000|Overall Study|Lens Discomfort|1|||
156627532|NCT02708524|565379703|FG001|Overall Study|Lens Discomfort|0|||
156627533|NCT02708524|565379704|FG002|Overall Study|Lens Discomfort|1|||
156627534|NCT02708524|565379705|FG003|Overall Study|Lens Discomfort|0|||
156627535|NCT02708524|565379702|FG000|Overall Study|Lost to Follow-up|1|||
156627536|NCT02708524|565379703|FG001|Overall Study|Lost to Follow-up|1|||
156627537|NCT02708524|565379704|FG002|Overall Study|Lost to Follow-up|1|||
156627538|NCT02708524|565379705|FG003|Overall Study|Lost to Follow-up|0|||
156627539|NCT02708524|565379702|FG000|Overall Study|Protocol Violation|0|||
156627540|NCT02708524|565379703|FG001|Overall Study|Protocol Violation|1|||
156627541|NCT02708524|565379704|FG002|Overall Study|Protocol Violation|0|||
156627542|NCT02708524|565379705|FG003|Overall Study|Protocol Violation|0|||
156627543|NCT02708524|565379702|FG000|Overall Study|Withdrawal by Subject|1|||
156627544|NCT02708524|565379703|FG001|Overall Study|Withdrawal by Subject|1|||
156627545|NCT02708524|565379704|FG002|Overall Study|Withdrawal by Subject|0|||
156627546|NCT02708524|565379705|FG003|Overall Study|Withdrawal by Subject|0|||
156627547|NCT02708524|565379702|FG000|Overall Study|Dispensed incorrect study lens|0|||
156627548|NCT02708524|565379703|FG001|Overall Study|Dispensed incorrect study lens|1|||
156627549|NCT02708524|565379704|FG002|Overall Study|Dispensed incorrect study lens|1|||
156627550|NCT02708524|565379705|FG003|Overall Study|Dispensed incorrect study lens|0|||
156627551|NCT02708524|565379702|FG000|Overall Study|Did not wear lens at final visit|0|||
156627552|NCT02708524|565379703|FG001|Overall Study|Did not wear lens at final visit|1|||
156627553|NCT02708524|565379704|FG002|Overall Study|Did not wear lens at final visit|0|||
156627554|NCT02708524|565379705|FG003|Overall Study|Did not wear lens at final visit|0|||
156627555|NCT02708524|565379702|FG000|Overall Study|Subject lost study lens|1|||
156627556|NCT02708524|565379703|FG001|Overall Study|Subject lost study lens|0|||
156627557|NCT02708524|565379704|FG002|Overall Study|Subject lost study lens|0|||
156627558|NCT02708524|565379705|FG003|Overall Study|Subject lost study lens|0|||
156627559|NCT03781167|565379714|FG000|Overall Study|Adverse Event|23|||
156627560|NCT03781167|565379715|FG001|Overall Study|Adverse Event|25|||
156627561|NCT03781167|565379714|FG000|Overall Study|Withdrew consent|16|||
156627562|NCT03781167|565379715|FG001|Overall Study|Withdrew consent|12|||
156627563|NCT03781167|565379714|FG000|Overall Study|Lost to Follow-up|0|||
156627564|NCT03781167|565379715|FG001|Overall Study|Lost to Follow-up|1|||
156627565|NCT03781167|565379714|FG000|Overall Study|Lack of Efficacy|4|||
156627566|NCT03781167|565379715|FG001|Overall Study|Lack of Efficacy|5|||
156627567|NCT03781167|565379714|FG000|Overall Study|Difficulty with drug delivery system|2|||
156627568|NCT03781167|565379715|FG001|Overall Study|Difficulty with drug delivery system|3|||
156627569|NCT03781167|565379714|FG000|Overall Study|Other, not specified|2|||
156627570|NCT03781167|565379715|FG001|Overall Study|Other, not specified|2|||
156627571|NCT00462501|565379716|FG000|Overall Study|Not treated|3|||
156627572|NCT00462501|565379716|FG000|Overall Study|Adverse Event|2|||
156627573|NCT01258803|565379718|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
156627574|NCT01258803|565379719|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
156627575|NCT01258803|565379720|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
156627576|NCT01258803|565379721|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
156627577|NCT01258803|565379722|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
156627578|NCT01258803|565379723|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
156627579|NCT01258803|565379718|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
156627580|NCT01258803|565379719|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
156627581|NCT01258803|565379720|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
156627582|NCT01258803|565379721|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
156627583|NCT01258803|565379722|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
156627584|NCT01258803|565379723|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
156627585|NCT01258803|565379718|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
156627586|NCT01258803|565379719|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
156627587|NCT01258803|565379720|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
156627588|NCT01258803|565379721|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
156627589|NCT01258803|565379722|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
156627590|NCT01258803|565379723|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
156627591|NCT00920582|565379724|FG000|Overall Study|Lost to Follow-up|5|||
156627592|NCT00920582|565379725|FG001|Overall Study|Lost to Follow-up|1|||
156627593|NCT00920582|565379726|FG002|Overall Study|Lost to Follow-up|2|||
156627594|NCT00920582|565379727|FG003|Overall Study|Lost to Follow-up|0|||
156627595|NCT00920582|565379724|FG000|Overall Study|Withdrawal by Subject|5|||
156627596|NCT00920582|565379725|FG001|Overall Study|Withdrawal by Subject|4|||
156627597|NCT00920582|565379726|FG002|Overall Study|Withdrawal by Subject|6|||
156627598|NCT00920582|565379727|FG003|Overall Study|Withdrawal by Subject|3|||
156627599|NCT00920582|565379724|FG000|Overall Study|Protocol Violation|1|||
156627600|NCT00920582|565379725|FG001|Overall Study|Protocol Violation|0|||
156627601|NCT00920582|565379726|FG002|Overall Study|Protocol Violation|0|||
156627602|NCT00920582|565379727|FG003|Overall Study|Protocol Violation|0|||
156627603|NCT00920582|565379724|FG000|Overall Study|Other|2|||
156627604|NCT00920582|565379725|FG001|Overall Study|Other|1|||
156627605|NCT00920582|565379726|FG002|Overall Study|Other|3|||
156627606|NCT00920582|565379727|FG003|Overall Study|Other|2|||
156627607|NCT01552408|565379732|FG000|Overall Study|Lost to Follow-up|2|||
156627608|NCT01552408|565379733|FG001|Overall Study|Lost to Follow-up|0|||
156627609|NCT01552408|565379732|FG000|Overall Study|Relocation|0|||
156627610|NCT01552408|565379733|FG001|Overall Study|Relocation|1|||
156627611|NCT01552408|565379732|FG000|Overall Study|Withdrawal by Subject|2|||
156627612|NCT01552408|565379733|FG001|Overall Study|Withdrawal by Subject|1|||
156627613|NCT05146999|565379734|FG000|Overall Study|Withdrew consent|6|||
156627614|NCT05146999|565379735|FG001|Overall Study|Withdrew consent|1|||
156627615|NCT05146999|565379734|FG000|Overall Study|Lost to Follow-up|3|||
156627616|NCT05146999|565379735|FG001|Overall Study|Lost to Follow-up|2|||
156627617|NCT05146999|565379734|FG000|Overall Study|Other|1|||
156627618|NCT05146999|565379735|FG001|Overall Study|Other|3|||
156627619|NCT04533204|565379736|FG000|Overall Study|Unable to understand training instructions|1|||
156627620|NCT04533204|565379737|FG001|Overall Study|Unable to understand training instructions|1|||
156627621|NCT04047472|565379738|FG000|Overall Study|Adverse Event|3|||
156627622|NCT04047472|565379739|FG001|Overall Study|Adverse Event|3|||
156627623|NCT04047472|565379738|FG000|Overall Study|Death|0|||
156627624|NCT04047472|565379739|FG001|Overall Study|Death|1|||
156627625|NCT04047472|565379738|FG000|Overall Study|Lost to Follow-up|1|||
156627626|NCT04047472|565379739|FG001|Overall Study|Lost to Follow-up|0|||
156627627|NCT04047472|565379738|FG000|Overall Study|Physician Decision|1|||
156627628|NCT04047472|565379739|FG001|Overall Study|Physician Decision|2|||
156627629|NCT04047472|565379738|FG000|Overall Study|Protocol Violation|1|||
156627630|NCT04047472|565379739|FG001|Overall Study|Protocol Violation|0|||
156627631|NCT04047472|565379738|FG000|Overall Study|Withdrawal by Subject|10|||
156627632|NCT04047472|565379739|FG001|Overall Study|Withdrawal by Subject|10|||
156627633|NCT01333501|565379743|FG000|Overall Study|Adverse Event|3|||
156627634|NCT01333501|565379744|FG001|Overall Study|Adverse Event|1|||
156627635|NCT01333501|565379743|FG000|Overall Study|Abnormal laboratory value|2|||
156627636|NCT01333501|565379744|FG001|Overall Study|Abnormal laboratory value|1|||
156627637|NCT01333501|565379743|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156627638|NCT01333501|565379744|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
156627639|NCT01333501|565379743|FG000|Overall Study|Withdrawn consent|3|||
156627640|NCT01333501|565379744|FG001|Overall Study|Withdrawn consent|12|||
156627641|NCT01016912|565379745|FG000|End of Treatment Period|Lack of Efficacy|0|||
156627642|NCT01016912|565379746|FG001|End of Treatment Period|Lack of Efficacy|1|||
156627643|NCT01016912|565379747|FG002|End of Treatment Period|Lack of Efficacy|0|||
156627644|NCT01016912|565379748|FG003|End of Treatment Period|Lack of Efficacy|4|||
156627645|NCT01016912|565379749|FG004|End of Treatment Period|Lack of Efficacy|4|||
156627646|NCT01016912|565379745|FG000|End of Treatment Period|Adverse Event|0|||
156627647|NCT01016912|565379746|FG001|End of Treatment Period|Adverse Event|1|||
156627648|NCT01016912|565379747|FG002|End of Treatment Period|Adverse Event|1|||
156627649|NCT01016912|565379748|FG003|End of Treatment Period|Adverse Event|0|||
156627650|NCT01016912|565379749|FG004|End of Treatment Period|Adverse Event|0|||
156627651|NCT01016912|565379745|FG000|End of Treatment Period|Completed double-blind period only|0|||
156627652|NCT01016912|565379746|FG001|End of Treatment Period|Completed double-blind period only|1|||
156627653|NCT01016912|565379747|FG002|End of Treatment Period|Completed double-blind period only|0|||
156627654|NCT01016912|565379748|FG003|End of Treatment Period|Completed double-blind period only|0|||
156627655|NCT01016912|565379749|FG004|End of Treatment Period|Completed double-blind period only|0|||
156627656|NCT01016912|565379745|FG000|Follow-up Period|Other reason|0|||
156627657|NCT01016912|565379746|FG001|Follow-up Period|Other reason|0|||
156627658|NCT01016912|565379747|FG002|Follow-up Period|Other reason|1|||
156627659|NCT01016912|565379748|FG003|Follow-up Period|Other reason|1|||
156627660|NCT01016912|565379749|FG004|Follow-up Period|Other reason|0|||
156627661|NCT04034225|565379750|FG000|Overall Study|Death|3|||
156627662|NCT04034225|565379750|FG000|Overall Study|Withdrawal by Subject|2|||
156627663|NCT04034225|565379750|FG000|Overall Study|Study termination by Sponsor|18|||
156627664|NCT04034225|565379750|FG000|Overall Study|Physician Decision|1|||
156627665|NCT04034225|565379750|FG000|Overall Study|Lack of Efficacy|1|||
156627666|NCT00955682|565379751|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
156627667|NCT00955682|565379752|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
156627668|NCT01348828|565379759|FG000|Overall Study|Death|20|||
156627669|NCT01348828|565379759|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
156627670|NCT01348828|565379759|FG000|Overall Study|Conversion|2|||
156627671|NCT01348828|565379759|FG000|Overall Study|missed visit|1|||
156627672|NCT04246996|565379760|FG000|Overall Study|Physician Decision|1|||
156627673|NCT04246996|565379761|FG001|Overall Study|Physician Decision|1|||
156627674|NCT04246996|565379760|FG000|Overall Study|Did not meet eligibility criteria|1|||
156627675|NCT04246996|565379761|FG001|Overall Study|Did not meet eligibility criteria|4|||
156627676|NCT02442284|565379764|FG000|Overall Study|Adverse Event|1|||
156627677|NCT02442284|565379764|FG000|Overall Study|Withdrew Consent|2|||
156627678|NCT02442284|565379764|FG000|Overall Study|Lost to Follow-up|3|||
156627679|NCT02442284|565379764|FG000|Overall Study|Other|1|||
156627680|NCT01365468|565379768|FG000|Overall Study|Physician Decision|1|||
156627681|NCT01365468|565379769|FG001|Overall Study|Physician Decision|0|||
156627682|NCT01365468|565379768|FG000|Overall Study|Disease progression|1|||
156627683|NCT01365468|565379769|FG001|Overall Study|Disease progression|0|||
156627684|NCT01365468|565379768|FG000|Overall Study|Lost to Follow-up|2|||
156627685|NCT01365468|565379769|FG001|Overall Study|Lost to Follow-up|0|||
156627686|NCT00877929|565379770|FG000|Overall Study|Adverse Event|11|||
156627687|NCT00877929|565379771|FG001|Overall Study|Adverse Event|20|||
156627688|NCT00877929|565379770|FG000|Overall Study|Protocol Violation|3|||
156627689|NCT00877929|565379771|FG001|Overall Study|Protocol Violation|3|||
156627690|NCT00877929|565379770|FG000|Overall Study|Lost to Follow-up|0|||
156627691|NCT00877929|565379771|FG001|Overall Study|Lost to Follow-up|1|||
156627692|NCT00877929|565379770|FG000|Overall Study|Withdrawal by Subject|4|||
156627693|NCT00877929|565379771|FG001|Overall Study|Withdrawal by Subject|4|||
156627694|NCT00877929|565379770|FG000|Overall Study|Lack of Efficacy|0|||
156627695|NCT00877929|565379771|FG001|Overall Study|Lack of Efficacy|1|||
156627696|NCT00877929|565379770|FG000|Overall Study|Other reason (not specified)|2|||
156627697|NCT00877929|565379771|FG001|Overall Study|Other reason (not specified)|6|||
156627698|NCT01140646|565379772|FG000|Overall Study|Adverse Event|4|||
156627699|NCT01140646|565379772|FG000|Overall Study|Refused Further Treatment|5|||
156627700|NCT00765726|565379776|FG000|Overall Study|Withdrawal by Subject|1|||
156627701|NCT00765726|565379776|FG000|Overall Study|Discontinuation of study by sponsor|8|||
156627702|NCT00950755|565379780|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
156627703|NCT00950755|565379780|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
156627704|NCT00950755|565379780|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
156627705|NCT00950755|565379780|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
156627706|NCT00950755|565379780|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
156627707|NCT00950755|565379780|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
156627708|NCT00950755|565379780|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
156627709|NCT00950755|565379780|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
156627710|NCT00950755|565379780|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
156627711|NCT00950755|565379780|FG000|Long-Term Follow-Up|Death|8|||
156627712|NCT00508820|565379783|FG000|Overall Study|Adverse Event|6|||
156627713|NCT00508820|565379784|FG001|Overall Study|Adverse Event|10|||
156627714|NCT00508820|565379783|FG000|Overall Study|Death|6|||
156627715|NCT00508820|565379784|FG001|Overall Study|Death|8|||
156627716|NCT00508820|565379783|FG000|Overall Study|Lost to Follow-up|1|||
156627717|NCT00508820|565379784|FG001|Overall Study|Lost to Follow-up|1|||
156627718|NCT00508820|565379783|FG000|Overall Study|Physician Decision|8|||
156627719|NCT00508820|565379784|FG001|Overall Study|Physician Decision|2|||
156627720|NCT00508820|565379783|FG000|Overall Study|Pregnancy|0|||
156627721|NCT00508820|565379784|FG001|Overall Study|Pregnancy|2|||
156627722|NCT00508820|565379783|FG000|Overall Study|Protocol Violation|2|||
156627723|NCT00508820|565379784|FG001|Overall Study|Protocol Violation|0|||
156627724|NCT00508820|565379783|FG000|Overall Study|Withdrawal by Subject|10|||
156627725|NCT00508820|565379784|FG001|Overall Study|Withdrawal by Subject|12|||
156627726|NCT00508820|565379783|FG000|Overall Study|Other|11|||
156627727|NCT00508820|565379784|FG001|Overall Study|Other|2|||
156627728|NCT00508820|565379783|FG000|Overall Study|Noncompliance|1|||
156627729|NCT00508820|565379784|FG001|Overall Study|Noncompliance|0|||
156627730|NCT00508820|565379783|FG000|Overall Study|Requirement for alternative therapy|7|||
156627731|NCT00508820|565379784|FG001|Overall Study|Requirement for alternative therapy|15|||
156627732|NCT00508820|565379783|FG000|Overall Study|Protocol-specified Criteria|3|||
156627733|NCT00508820|565379784|FG001|Overall Study|Protocol-specified Criteria|12|||
156627734|NCT03799198|565381219|FG000|Overall Study|Lost to Follow-up|4|||
156627735|NCT03799198|565381220|FG001|Overall Study|Lost to Follow-up|8|||
156627736|NCT03799198|565381219|FG000|Overall Study|Death|0|||
156627737|NCT03799198|565381220|FG001|Overall Study|Death|1|||
156627738|NCT02501642|565381222|FG000|Overall Study|Lost to Follow-up|7|||
156627739|NCT02501642|565381223|FG001|Overall Study|Lost to Follow-up|11|||
156627740|NCT00548340|565381228|FG000|Overall Study|Protocol Violation|2|||
156627741|NCT00548340|565381229|FG001|Overall Study|Protocol Violation|3|||
156627742|NCT00548340|565381230|FG002|Overall Study|Protocol Violation|3|||
156627743|NCT00548340|565381228|FG000|Overall Study|Adverse Event|2|||
156627744|NCT00548340|565381229|FG001|Overall Study|Adverse Event|2|||
156627745|NCT00548340|565381230|FG002|Overall Study|Adverse Event|2|||
156627746|NCT00548340|565381228|FG000|Overall Study|Lost to Follow-up|1|||
156627747|NCT00548340|565381229|FG001|Overall Study|Lost to Follow-up|1|||
156627748|NCT00548340|565381230|FG002|Overall Study|Lost to Follow-up|0|||
156627749|NCT00548340|565381228|FG000|Overall Study|Withdrawal by Subject|2|||
156627750|NCT00548340|565381229|FG001|Overall Study|Withdrawal by Subject|4|||
156627751|NCT00548340|565381230|FG002|Overall Study|Withdrawal by Subject|3|||
156627752|NCT00548340|565381228|FG000|Overall Study|Other|1|||
156627753|NCT00548340|565381229|FG001|Overall Study|Other|1|||
156627754|NCT00548340|565381230|FG002|Overall Study|Other|1|||
156627755|NCT01153971|565381233|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
156627756|NCT01153971|565381233|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
156627757|NCT01153971|565381233|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
156627758|NCT01153971|565381233|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
156627759|NCT01153971|565381233|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
156627760|NCT01153971|565381233|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
156627761|NCT01153971|565381233|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
156627762|NCT03410693|565381234|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
156627763|NCT03410693|565381235|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
156627764|NCT03410693|565381234|FG000|Overall Study|Disc trt: Lost to follow up|0|||
156627765|NCT03410693|565381235|FG001|Overall Study|Disc trt: Lost to follow up|1|||
156627766|NCT03410693|565381234|FG000|Overall Study|Disc trt: radiological progression|58|||
156627767|NCT03410693|565381235|FG001|Overall Study|Disc trt: radiological progression|50|||
156627768|NCT03410693|565381234|FG000|Overall Study|Disc trt: Other|1|||
156627769|NCT03410693|565381235|FG001|Overall Study|Disc trt: Other|0|||
156627770|NCT03410693|565381234|FG000|Overall Study|Study drug never administered|1|||
156627771|NCT03410693|565381235|FG001|Overall Study|Study drug never administered|6|||
156627772|NCT03410693|565381234|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
156627773|NCT03410693|565381235|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
156627774|NCT03410693|565381234|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
156627775|NCT03410693|565381235|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
156627776|NCT03410693|565381234|FG000|Overall Study|Disc trt: Physician decision|0|||
156627777|NCT03410693|565381235|FG001|Overall Study|Disc trt: Physician decision|5|||
156627778|NCT03410693|565381234|FG000|Overall Study|Disc trt: clinical progression|1|||
156627779|NCT03410693|565381235|FG001|Overall Study|Disc trt: clinical progression|5|||
156627780|NCT03410693|565381234|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
156627781|NCT03410693|565381235|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
156627782|NCT01789476|565381236|FG000|Overall Study|Lack of Efficacy|6|||
156627783|NCT01789476|565381237|FG001|Overall Study|Lack of Efficacy|2|||
156627784|NCT01789476|565381236|FG000|Overall Study|Adverse Event|1|||
156627785|NCT01789476|565381237|FG001|Overall Study|Adverse Event|0|||
156627786|NCT01789476|565381236|FG000|Overall Study|Unable to get IV access|1|||
156627787|NCT01789476|565381237|FG001|Overall Study|Unable to get IV access|0|||
156627788|NCT00953576|565381238|FG000|Overall Study|Adverse Event|0|||
156627789|NCT00953576|565381239|FG001|Overall Study|Adverse Event|1|||
156627790|NCT00953576|565381238|FG000|Overall Study|Ineligible after Consent|2|||
156627791|NCT00953576|565381239|FG001|Overall Study|Ineligible after Consent|0|||
156627792|NCT03778021|565381240|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
156627793|NCT03778021|565381241|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
156627794|NCT00679042|565381242|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
156627795|NCT00679042|565381242|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
156627796|NCT00679042|565381242|FG000|5-Year Follow Up|Death|1|||
156627797|NCT00679042|565381242|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
156627798|NCT00679042|565381242|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
156627799|NCT03053102|565381245|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
156627800|NCT03053102|565381245|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
156627801|NCT01798056|565381246|FG000|Overall Study|Serious Adverse Event|13|||
156627802|NCT01798056|565381247|FG001|Overall Study|Serious Adverse Event|12|||
156627803|NCT01798056|565381246|FG000|Overall Study|Withdrawal by Subject|12|||
156627804|NCT01798056|565381247|FG001|Overall Study|Withdrawal by Subject|9|||
156627805|NCT01798056|565381246|FG000|Overall Study|Migrated/moved from study area|1|||
156627806|NCT01798056|565381247|FG001|Overall Study|Migrated/moved from study area|1|||
156627807|NCT01798056|565381246|FG000|Overall Study|Lost to Follow-up|1|||
156627808|NCT01798056|565381247|FG001|Overall Study|Lost to Follow-up|1|||
156627809|NCT01798056|565381246|FG000|Overall Study|Other|0|||
156627810|NCT01798056|565381247|FG001|Overall Study|Other|2|||
156627811|NCT01269346|565381250|FG000|Treatment Phase|Disease progression|3|||
156627812|NCT01269346|565381250|FG000|Treatment Phase|Adverse Event|3|||
156627813|NCT01269346|565381250|FG000|Treatment Phase|Withdrawal by Subject|1|||
156627814|NCT01269346|565381250|FG000|Treatment Phase|Other|2|||
156627815|NCT01269346|565381250|FG000|Extension Phase|Adverse Event|6|||
156627816|NCT01269346|565381250|FG000|Extension Phase|Withdrawal by Subject|4|||
156627817|NCT01269346|565381250|FG000|Extension Phase|Disease progression|22|||
156627818|NCT01269346|565381250|FG000|Extension Phase|Physician decision or participant choice|9|||
156627819|NCT01269346|565381250|FG000|Extension Phase|Clinical progression|1|||
156627820|NCT01269346|565381250|FG000|Extension Phase|Started a prohibited con med|1|||
156627821|NCT03472586|565381259|FG000|Overall Study|Physician Decision|6|||
156627822|NCT03472586|565381259|FG000|Overall Study|Death|6|||
156627823|NCT03472586|565381259|FG000|Overall Study|Adverse Event|1|||
156627824|NCT01342445|565381260|FG000|Overall Study|Experienced side effects|0|||
156627825|NCT01342445|565381261|FG001|Overall Study|Experienced side effects|2|||
156627826|NCT02652793|565381264|FG000|Overall Study|Adverse Event|1|||
156627827|NCT02652793|565381264|FG000|Overall Study|Lost to Follow-up|2|||
156627828|NCT02652793|565381264|FG000|Overall Study|Withdrawal by Subject|1|||
156627829|NCT04963231|565381265|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
156627830|NCT04963231|565381266|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
156627831|NCT04963231|565381267|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
156627832|NCT04963231|565381265|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
156627833|NCT04963231|565381266|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
156627834|NCT04963231|565381267|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
156627835|NCT04963231|565381265|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
156627836|NCT04963231|565381266|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
156627837|NCT04963231|565381267|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
156627838|NCT04963231|565381265|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
156627839|NCT04963231|565381266|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
156627840|NCT04963231|565381267|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
156627841|NCT04963231|565381265|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
156627842|NCT04963231|565381266|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
156627843|NCT04963231|565381267|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
156627844|NCT04963231|565381265|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
156627845|NCT04963231|565381266|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
156627846|NCT04963231|565381267|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
156627847|NCT04963231|565381265|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
156627848|NCT04963231|565381266|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
156627849|NCT04963231|565381267|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
156627850|NCT01059175|565381270|FG000|Overall Study|Death|17|||
156627851|NCT01059175|565381271|FG001|Overall Study|Death|17|||
156627852|NCT01059175|565381270|FG000|Overall Study|Adverse Event|4|||
156627853|NCT01059175|565381271|FG001|Overall Study|Adverse Event|2|||
156627854|NCT01059175|565381270|FG000|Overall Study|Lost to Follow-up|0|||
156627855|NCT01059175|565381271|FG001|Overall Study|Lost to Follow-up|1|||
156627856|NCT02957149|565381272|FG000|Overall Study|Withdrawal by Subject|5|||
156627857|NCT06045026|565381273|FG000|Overall Study|Lost to Follow-up|60|||
156627858|NCT06045026|565381273|FG000|Overall Study|Adverse Event|12|||
156627859|NCT06045026|565381273|FG000|Overall Study|Withdrawal by Subject|3|||
156627860|NCT06045026|565381273|FG000|Overall Study|Enrollment closed|1|||
156627861|NCT04511533|565381274|FG000|Treatment|Other|2|||
156627862|NCT04511533|565381274|FG000|Treatment|Withdrawal by Subject|11|||
156627863|NCT04511533|565381274|FG000|Treatment|Death|5|||
156627864|NCT04511533|565381274|FG000|Treatment|Physician Decision|1|||
156627865|NCT04511533|565381274|FG000|Treatment|Progressive Disease|61|||
156627866|NCT04511533|565381274|FG000|Follow-Up|Other|7|||
156627867|NCT04511533|565381274|FG000|Follow-Up|Withdrawal by Subject|5|||
156627868|NCT04511533|565381274|FG000|Follow-Up|Lost to Follow-up|2|||
156627869|NCT04511533|565381274|FG000|Follow-Up|Death|4|||
156627870|NCT01928758|565381275|FG000|Overall Study|Lost to Follow-up|14|||
156627871|NCT01928758|565381276|FG001|Overall Study|Lost to Follow-up|9|||
156627872|NCT01928758|565381275|FG000|Overall Study|Withdrawal by Subject|5|||
156627873|NCT01928758|565381276|FG001|Overall Study|Withdrawal by Subject|2|||
156627874|NCT01928758|565381275|FG000|Overall Study|Adverse Event|3|||
156627875|NCT01928758|565381276|FG001|Overall Study|Adverse Event|5|||
156627876|NCT01928758|565381275|FG000|Overall Study|Protocol Violation|3|||
156627877|NCT01928758|565381276|FG001|Overall Study|Protocol Violation|4|||
156627878|NCT02718131|565381277|FG000|Overall Study|Withdrawal by Subject|1|||
156627879|NCT02718131|565381278|FG001|Overall Study|Withdrawal by Subject|0|||
156627880|NCT02718131|565381277|FG000|Overall Study|Adverse Event|1|||
156627881|NCT02718131|565381278|FG001|Overall Study|Adverse Event|0|||
156627882|NCT02718131|565381277|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
156627883|NCT02718131|565381278|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
156627884|NCT03198559|565381279|FG000|Overall Study|Adverse Event|2|||
156627885|NCT01474291|565381283|FG000|Overall Study|Not Evaluable for Efficacy|26|||
156627886|NCT01474291|565381283|FG000|Overall Study|Lack of Treatment Efficacy|88|||
156627887|NCT01474291|565381283|FG000|Overall Study|Adverse Event|53|||
156627888|NCT01474291|565381283|FG000|Overall Study|Lost to Follow-up|29|||
156627889|NCT01474291|565381283|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
156627890|NCT01474291|565381283|FG000|Overall Study|No Reason Reported|10|||
156627891|NCT01474291|565381283|FG000|Overall Study|Death|2|||
156627892|NCT03471507|565381284|FG000|Overall Study|Lost to Follow-up|1|||
156627893|NCT03471507|565381285|FG001|Overall Study|Lost to Follow-up|3|||
156627894|NCT03471507|565381284|FG000|Overall Study|Physician Decision|0|||
156627895|NCT03471507|565381285|FG001|Overall Study|Physician Decision|1|||
156627896|NCT03471507|565381284|FG000|Overall Study|Withdrawal by Subject|2|||
156627897|NCT03471507|565381285|FG001|Overall Study|Withdrawal by Subject|1|||
156627898|NCT02046993|565381289|FG000|Overall Study|Withdrawal by Subject|2|||
156627899|NCT02046993|565381290|FG001|Overall Study|Withdrawal by Subject|10|||
156627900|NCT02046993|565381289|FG000|Overall Study|Lost to Follow-up|1|||
156627901|NCT02046993|565381290|FG001|Overall Study|Lost to Follow-up|1|||
156627902|NCT00598442|565381295|FG000|Overall Study|Adverse Event|3|||
156627903|NCT00598442|565381296|FG001|Overall Study|Adverse Event|0|||
156627904|NCT00598442|565381297|FG002|Overall Study|Adverse Event|0|||
156627905|NCT00598442|565381295|FG000|Overall Study|Death|19|||
156627906|NCT00598442|565381296|FG001|Overall Study|Death|11|||
156627907|NCT00598442|565381297|FG002|Overall Study|Death|11|||
156627908|NCT00598442|565381295|FG000|Overall Study|Lost to Follow-up|4|||
156627909|NCT00598442|565381296|FG001|Overall Study|Lost to Follow-up|3|||
156627910|NCT00598442|565381297|FG002|Overall Study|Lost to Follow-up|3|||
156627911|NCT00598442|565381295|FG000|Overall Study|Physician Decision|2|||
156627912|NCT00598442|565381296|FG001|Overall Study|Physician Decision|1|||
156627913|NCT00598442|565381297|FG002|Overall Study|Physician Decision|1|||
156627914|NCT00598442|565381295|FG000|Overall Study|Withdrawal by Subject|8|||
156627915|NCT00598442|565381296|FG001|Overall Study|Withdrawal by Subject|16|||
156627916|NCT00598442|565381297|FG002|Overall Study|Withdrawal by Subject|6|||
156627917|NCT00598442|565381295|FG000|Overall Study|Noncompliance|0|||
156627918|NCT00598442|565381296|FG001|Overall Study|Noncompliance|2|||
156627919|NCT00598442|565381297|FG002|Overall Study|Noncompliance|1|||
156627920|NCT00598442|565381295|FG000|Overall Study|Relocation|1|||
156627921|NCT00598442|565381296|FG001|Overall Study|Relocation|4|||
156627922|NCT00598442|565381297|FG002|Overall Study|Relocation|0|||
156627923|NCT00598442|565381295|FG000|Overall Study|Renal transplant|0|||
156627924|NCT00598442|565381296|FG001|Overall Study|Renal transplant|0|||
156627925|NCT00598442|565381297|FG002|Overall Study|Renal transplant|1|||
156627926|NCT00598442|565381295|FG000|Overall Study|Site closed by sponsor|5|||
156627927|NCT00598442|565381296|FG001|Overall Study|Site closed by sponsor|2|||
156627928|NCT00598442|565381297|FG002|Overall Study|Site closed by sponsor|1|||
156627929|NCT00598442|565381295|FG000|Overall Study|Started dialysis|1|||
156627930|NCT00598442|565381296|FG001|Overall Study|Started dialysis|0|||
156627931|NCT00598442|565381297|FG002|Overall Study|Started dialysis|0|||
156627932|NCT01590628|565381307|FG000|Overall Study|Death|2|||
156627933|NCT01590628|565381308|FG001|Overall Study|Death|0|||
156627934|NCT00475657|565381309|FG000|Overall Study|Death|1|||
156627935|NCT00475657|565381309|FG000|Overall Study|Sponsor's Decision|3|||
156627936|NCT00761735|565381310|FG000|Overall Study|Lost to Follow-up|6|||
156627937|NCT00761735|565381310|FG000|Overall Study|Withdrawal by Subject|6|||
156627938|NCT00761735|565381310|FG000|Overall Study|Non-compliance with protocol|1|||
156627939|NCT00761735|565381310|FG000|Overall Study|Administrative|1|||
156627940|NCT00267202|565381323|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
156627941|NCT00267202|565381324|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
156627942|NCT00267202|565381323|FG000|Overall Study|Withdrawal by Subject|12|||
156627943|NCT00267202|565381324|FG001|Overall Study|Withdrawal by Subject|15|||
156627944|NCT00267202|565381323|FG000|Overall Study|Adverse Event|13|||
156627945|NCT00267202|565381324|FG001|Overall Study|Adverse Event|7|||
156627946|NCT00267202|565381323|FG000|Overall Study|Protocol Violation|2|||
156627947|NCT00267202|565381324|FG001|Overall Study|Protocol Violation|3|||
156627948|NCT00267202|565381323|FG000|Overall Study|Administrative problems|2|||
156627949|NCT00267202|565381324|FG001|Overall Study|Administrative problems|1|||
156627950|NCT00267202|565381323|FG000|Overall Study|Lost to Follow-up|3|||
156627951|NCT00267202|565381324|FG001|Overall Study|Lost to Follow-up|0|||
156627952|NCT03831282|565381325|FG000|Overall Study|Could not place sensor|1|||
156627953|NCT00334893|565381326|FG000|Overall Study|Not Treated|1|||
156627954|NCT00334893|565381327|FG001|Overall Study|Not Treated|0|||
156627955|NCT02260791|565381335|FG000|Overall Study|Lost to Follow-up|4|||
156627956|NCT02260791|565381336|FG001|Overall Study|Lost to Follow-up|4|||
156627957|NCT02260791|565381335|FG000|Overall Study|Lack of Efficacy|2|||
156627958|NCT02260791|565381336|FG001|Overall Study|Lack of Efficacy|1|||
156627959|NCT02260791|565381335|FG000|Overall Study|Adverse Event|13|||
156627960|NCT02260791|565381336|FG001|Overall Study|Adverse Event|9|||
156627961|NCT02260791|565381335|FG000|Overall Study|Death|1|||
156627962|NCT02260791|565381336|FG001|Overall Study|Death|0|||
156627963|NCT02260791|565381335|FG000|Overall Study|Withdrawal by Subject|11|||
156627964|NCT02260791|565381336|FG001|Overall Study|Withdrawal by Subject|16|||
156627965|NCT02260791|565381335|FG000|Overall Study|Screen failure|0|||
156627966|NCT02260791|565381336|FG001|Overall Study|Screen failure|1|||
156627967|NCT02260791|565381335|FG000|Overall Study|Protocol deviation|2|||
156627968|NCT02260791|565381336|FG001|Overall Study|Protocol deviation|3|||
156627969|NCT00736840|565381339|FG000|Overall Study|Lost to Follow-up|13|||
156627970|NCT01411917|565381340|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
156627971|NCT01411917|565381341|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
156627972|NCT02815670|565381342|FG000|Overall Study|Prematurely discontinued of the trial|1|||
156627973|NCT03289676|565381345|FG000|Overall Study|Withdrawal by Subject|2|||
156627974|NCT03289676|565381346|FG001|Overall Study|Withdrawal by Subject|0|||
156627975|NCT03289676|565381345|FG000|Overall Study|Protocol Violation|2|||
156627976|NCT03289676|565381346|FG001|Overall Study|Protocol Violation|0|||
156627977|NCT03289676|565381345|FG000|Overall Study|Lost to Follow-up|0|||
156627978|NCT03289676|565381346|FG001|Overall Study|Lost to Follow-up|1|||
156627979|NCT02354599|565381349|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156627980|NCT02354599|565381350|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
156627981|NCT02354599|565381351|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156627982|NCT02354599|565381352|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
156627983|NCT02354599|565381353|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
156627984|NCT02354599|565381354|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
156627985|NCT02354599|565381349|FG000|Overall Study|Withdrawal by Subject|1|||
156627986|NCT02354599|565381350|FG001|Overall Study|Withdrawal by Subject|1|||
156627987|NCT02354599|565381351|FG002|Overall Study|Withdrawal by Subject|0|||
156627988|NCT02354599|565381352|FG003|Overall Study|Withdrawal by Subject|0|||
156627989|NCT02354599|565381353|FG004|Overall Study|Withdrawal by Subject|0|||
156627990|NCT02354599|565381354|FG005|Overall Study|Withdrawal by Subject|0|||
156627991|NCT00660829|565381355|FG000|Overall Study|Adverse Event|3|||
156627992|NCT00660829|565381356|FG001|Overall Study|Adverse Event|4|||
156627993|NCT00660829|565381355|FG000|Overall Study|Lack of Efficacy|2|||
156627994|NCT00660829|565381356|FG001|Overall Study|Lack of Efficacy|3|||
156627995|NCT00660829|565381355|FG000|Overall Study|Non-Compliance|0|||
156627996|NCT00660829|565381356|FG001|Overall Study|Non-Compliance|4|||
156627997|NCT00660829|565381355|FG000|Overall Study|Withdrawal by Subject|1|||
156627998|NCT00660829|565381356|FG001|Overall Study|Withdrawal by Subject|2|||
156627999|NCT00660829|565381355|FG000|Overall Study|Lost to Follow-up|3|||
156628000|NCT00660829|565381356|FG001|Overall Study|Lost to Follow-up|2|||
156628001|NCT00660829|565381355|FG000|Overall Study|Other|9|||
156628002|NCT00660829|565381356|FG001|Overall Study|Other|4|||
156628003|NCT00280059|565381357|FG000|Efficacy Assessment Phase|Death|2|||
156628004|NCT00280059|565381358|FG001|Efficacy Assessment Phase|Death|0|||
156628005|NCT00280059|565381357|FG000|Efficacy Assessment Phase|Adverse Event|33|||
156628006|NCT00280059|565381358|FG001|Efficacy Assessment Phase|Adverse Event|31|||
156628007|NCT00280059|565381357|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
156628008|NCT00280059|565381358|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
156628009|NCT00280059|565381357|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
156628010|NCT00280059|565381358|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
156628011|NCT00280059|565381357|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
156628012|NCT00280059|565381358|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
156628013|NCT00280059|565381357|FG000|Efficacy Assessment Phase|Other|7|||
156628014|NCT00280059|565381358|FG001|Efficacy Assessment Phase|Other|8|||
156628015|NCT00280059|565381357|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
156628016|NCT00280059|565381358|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
156628017|NCT00495794|565381361|FG000|Overall Study|Pharmacist did not activate patient|522|||
156628018|NCT00495794|565381362|FG001|Overall Study|Pharmacist did not activate patient|0|||
156628019|NCT02127931|565381363|FG000|Overall Study|Glitch in Game|1|||
156628020|NCT01636076|565381364|FG000|Overall Study|Terminated by sponsor|1|||
156628021|NCT01636076|565381365|FG001|Overall Study|Terminated by sponsor|1|||
156628022|NCT01636076|565381364|FG000|Overall Study|Lack of Efficacy|0|||
156628023|NCT01636076|565381365|FG001|Overall Study|Lack of Efficacy|1|||
156628024|NCT01636076|565381364|FG000|Overall Study|Lost to Follow-up|1|||
156628025|NCT01636076|565381365|FG001|Overall Study|Lost to Follow-up|0|||
156628026|NCT01636076|565381364|FG000|Overall Study|Physician Decision|1|||
156628027|NCT01636076|565381365|FG001|Overall Study|Physician Decision|1|||
156628028|NCT01636076|565381364|FG000|Overall Study|Non-compliance with study treatment|1|||
156628029|NCT01636076|565381365|FG001|Overall Study|Non-compliance with study treatment|1|||
156628030|NCT01636076|565381364|FG000|Overall Study|Adverse Event|6|||
156628031|NCT01636076|565381365|FG001|Overall Study|Adverse Event|11|||
156628032|NCT01636076|565381364|FG000|Overall Study|Withdrawal by Subject|7|||
156628033|NCT01636076|565381365|FG001|Overall Study|Withdrawal by Subject|10|||
156628034|NCT01018680|565382945|FG000|Overall Study|Adverse Event|23|||
156628035|NCT01018680|565382946|FG001|Overall Study|Adverse Event|40|||
156628036|NCT01018680|565382945|FG000|Overall Study|Withdrawal by Subject|10|||
156628037|NCT01018680|565382946|FG001|Overall Study|Withdrawal by Subject|10|||
156628038|NCT01018680|565382945|FG000|Overall Study|Protocol Violation|5|||
156628039|NCT01018680|565382946|FG001|Overall Study|Protocol Violation|8|||
156628040|NCT01018680|565382945|FG000|Overall Study|Sponsor Decision|6|||
156628041|NCT01018680|565382946|FG001|Overall Study|Sponsor Decision|7|||
156628042|NCT01018680|565382945|FG000|Overall Study|Lack of Efficacy|8|||
156628043|NCT01018680|565382946|FG001|Overall Study|Lack of Efficacy|2|||
156628044|NCT01018680|565382945|FG000|Overall Study|Lost to Follow-up|5|||
156628045|NCT01018680|565382946|FG001|Overall Study|Lost to Follow-up|3|||
156628046|NCT01018680|565382945|FG000|Overall Study|Entry Criteria Not Met|1|||
156628047|NCT01018680|565382946|FG001|Overall Study|Entry Criteria Not Met|4|||
156628048|NCT01018680|565382945|FG000|Overall Study|Physician Decision|3|||
156628049|NCT01018680|565382946|FG001|Overall Study|Physician Decision|1|||
156628050|NCT05056311|565382947|FG000|Overall Study|Lost to Follow-up|14|||
156628051|NCT05056311|565382947|FG000|Overall Study|Withdrawal by Subject|1|||
156628052|NCT05056311|565382947|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
156628053|NCT00960869|565382948|FG000|Overall Study|Adverse Event|17|||
156628054|NCT00960869|565382949|FG001|Overall Study|Adverse Event|26|||
156628055|NCT00960869|565382948|FG000|Overall Study|Withdrawal by Subject|16|||
156628056|NCT00960869|565382949|FG001|Overall Study|Withdrawal by Subject|14|||
156628057|NCT00960869|565382948|FG000|Overall Study|Lost to Follow-up|1|||
156628058|NCT00960869|565382949|FG001|Overall Study|Lost to Follow-up|4|||
156628059|NCT00960869|565382948|FG000|Overall Study|Misc|19|||
156628060|NCT00960869|565382949|FG001|Overall Study|Misc|18|||
156628061|NCT01161173|565382953|FG000|Overall Study|Protocol Violation|13|||
156628062|NCT01161173|565382953|FG000|Overall Study|Lost to Follow-up|7|||
156628063|NCT01161173|565382953|FG000|Overall Study|Progressive Disease|82|||
156628064|NCT01161173|565382953|FG000|Overall Study|Withdrawal of Consent|5|||
156628065|NCT01161173|565382953|FG000|Overall Study|Unacceptable Toxicity|21|||
156628066|NCT01161173|565382953|FG000|Overall Study|Death|194|||
156628067|NCT01161173|565382953|FG000|Overall Study|End of Study|2|||
156628068|NCT01161173|565382953|FG000|Overall Study|Reasons Not Specified|23|||
156628069|NCT01911546|565382954|FG000|Overall Study|Lost to Follow-up|1|||
156628070|NCT01911546|565382954|FG000|Overall Study|Everolimus was discontinued|5|||
156628071|NCT01319422|565382955|FG000|Overall Study|Withdrawal by Subject|1|||
156628072|NCT01319422|565382956|FG001|Overall Study|Withdrawal by Subject|0|||
156628073|NCT01399619|565382957|FG000|Overall Study|Adverse Event|10|||
156628074|NCT01399619|565382958|FG001|Overall Study|Adverse Event|0|||
156628075|NCT01399619|565382959|FG002|Overall Study|Adverse Event|4|||
156628076|NCT01399619|565382960|FG003|Overall Study|Adverse Event|10|||
156628077|NCT01399619|565382957|FG000|Overall Study|Lack of Efficacy|9|||
156628078|NCT01399619|565382958|FG001|Overall Study|Lack of Efficacy|0|||
156628079|NCT01399619|565382959|FG002|Overall Study|Lack of Efficacy|5|||
156628080|NCT01399619|565382960|FG003|Overall Study|Lack of Efficacy|0|||
156628081|NCT01399619|565382957|FG000|Overall Study|Withdrawal by Subject|6|||
156628082|NCT01399619|565382958|FG001|Overall Study|Withdrawal by Subject|0|||
156628083|NCT01399619|565382959|FG002|Overall Study|Withdrawal by Subject|3|||
156628084|NCT01399619|565382960|FG003|Overall Study|Withdrawal by Subject|4|||
156628085|NCT01399619|565382957|FG000|Overall Study|Protocol Violation|0|||
156628086|NCT01399619|565382958|FG001|Overall Study|Protocol Violation|0|||
156628087|NCT01399619|565382959|FG002|Overall Study|Protocol Violation|0|||
156628088|NCT01399619|565382960|FG003|Overall Study|Protocol Violation|1|||
156628089|NCT01399619|565382957|FG000|Overall Study|Not treated|0|||
156628090|NCT01399619|565382958|FG001|Overall Study|Not treated|0|||
156628091|NCT01399619|565382959|FG002|Overall Study|Not treated|0|||
156628092|NCT01399619|565382960|FG003|Overall Study|Not treated|2|||
156628093|NCT02918968|565382961|FG000|1st Line AAT|Progressive disease|9|||
156628094|NCT02918968|565382962|FG001|1st Line AAT|Progressive disease|4|||
156628095|NCT02918968|565382961|FG000|1st Line AAT|Adverse Event|12|||
156628096|NCT02918968|565382962|FG001|1st Line AAT|Adverse Event|3|||
156628097|NCT02918968|565382961|FG000|1st Line AAT|Physician Decision|4|||
156628098|NCT02918968|565382962|FG001|1st Line AAT|Physician Decision|2|||
156628099|NCT02918968|565382961|FG000|1st Line AAT|Withdrawal by Subject|2|||
156628100|NCT02918968|565382962|FG001|1st Line AAT|Withdrawal by Subject|1|||
156628101|NCT02918968|565382961|FG000|1st Line AAT|Lost to Follow-up|0|||
156628102|NCT02918968|565382962|FG001|1st Line AAT|Lost to Follow-up|1|||
156628103|NCT02918968|565382961|FG000|1st Line AAT|Death|1|||
156628104|NCT02918968|565382962|FG001|1st Line AAT|Death|0|||
156628105|NCT02918968|565382961|FG000|1st Line AAT|Miscellaneous|1|||
156628106|NCT02918968|565382962|FG001|1st Line AAT|Miscellaneous|0|||
156628107|NCT02918968|565382961|FG000|2nd Line AAT|Progressive disease|21|||
156628108|NCT02918968|565382962|FG001|2nd Line AAT|Progressive disease|3|||
156628109|NCT02918968|565382961|FG000|2nd Line AAT|Adverse Event|2|||
156628110|NCT02918968|565382962|FG001|2nd Line AAT|Adverse Event|5|||
156628111|NCT02918968|565382961|FG000|2nd Line AAT|Physician Decision|0|||
156628112|NCT02918968|565382962|FG001|2nd Line AAT|Physician Decision|1|||
156628113|NCT02918968|565382961|FG000|2nd Line AAT|Withdrawal by Subject|2|||
156628114|NCT02918968|565382962|FG001|2nd Line AAT|Withdrawal by Subject|2|||
156628115|NCT02918968|565382961|FG000|2nd Line AAT|Death|0|||
156628116|NCT02918968|565382962|FG001|2nd Line AAT|Death|1|||
156628117|NCT00750061|565382963|FG000|Overall Study|Adverse Event|2|||
156628118|NCT00750061|565382964|FG001|Overall Study|Adverse Event|0|||
156628119|NCT00750061|565382963|FG000|Overall Study|Withdrawal by Subject|0|||
156628120|NCT00750061|565382964|FG001|Overall Study|Withdrawal by Subject|1|||
156628121|NCT00750061|565382963|FG000|Overall Study|Physician Decision|0|||
156628122|NCT00750061|565382964|FG001|Overall Study|Physician Decision|1|||
156628123|NCT00229931|565382967|FG000|Overall Study|Death|1|||
156628124|NCT00229931|565382968|FG001|Overall Study|Death|0|||
156628125|NCT00229931|565382967|FG000|Overall Study|Lost to Follow-up|3|||
156628126|NCT00229931|565382968|FG001|Overall Study|Lost to Follow-up|2|||
156628127|NCT02992743|565382969|FG000|Overall Study|Withdrawal by Subject|1|||
156628128|NCT02992743|565382970|FG001|Overall Study|Withdrawal by Subject|1|||
156628129|NCT02992743|565382969|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
156628130|NCT02992743|565382970|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
156628131|NCT02992743|565382969|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
156628132|NCT02992743|565382970|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
156628133|NCT02992743|565382969|FG000|Overall Study|No measurable disease|1|||
156628134|NCT02992743|565382970|FG001|Overall Study|No measurable disease|0|||
156628135|NCT02992743|565382969|FG000|Overall Study|Lost to Follow-up|0|||
156628136|NCT02992743|565382970|FG001|Overall Study|Lost to Follow-up|1|||
156628137|NCT00381680|565382971|FG000|Overall Study|Adverse Event|9|||
156628138|NCT00381680|565382972|FG001|Overall Study|Adverse Event|3|||
156628139|NCT00381680|565382971|FG000|Overall Study|Death|10|||
156628140|NCT00381680|565382972|FG001|Overall Study|Death|7|||
156628141|NCT00381680|565382971|FG000|Overall Study|Lost to Follow-up|3|||
156628142|NCT00381680|565382972|FG001|Overall Study|Lost to Follow-up|2|||
156628143|NCT00381680|565382971|FG000|Overall Study|Physician Decision|25|||
156628144|NCT00381680|565382972|FG001|Overall Study|Physician Decision|6|||
156628145|NCT00381680|565382971|FG000|Overall Study|Withdrawal by Subject|3|||
156628146|NCT00381680|565382972|FG001|Overall Study|Withdrawal by Subject|1|||
156628147|NCT00381680|565382971|FG000|Overall Study|Entry onto another COG Trial|1|||
156628148|NCT00381680|565382972|FG001|Overall Study|Entry onto another COG Trial|2|||
156628149|NCT00381680|565382971|FG000|Overall Study|Alternative Therapy|11|||
156628150|NCT00381680|565382972|FG001|Overall Study|Alternative Therapy|5|||
156628151|NCT00381680|565382971|FG000|Overall Study|Secondary Malignancy|3|||
156628152|NCT00381680|565382972|FG001|Overall Study|Secondary Malignancy|0|||
156628153|NCT00381680|565382971|FG000|Overall Study|Delay initiation|1|||
156628154|NCT00381680|565382972|FG001|Overall Study|Delay initiation|0|||
156628155|NCT00381680|565382971|FG000|Overall Study|Stem Cell Transplant|26|||
156628156|NCT00381680|565382972|FG001|Overall Study|Stem Cell Transplant|10|||
156628157|NCT00381680|565382971|FG000|Overall Study|Relapse|18|||
156628158|NCT00381680|565382972|FG001|Overall Study|Relapse|9|||
156628159|NCT00381680|565382971|FG000|Overall Study|Induction Failure|4|||
156628160|NCT00381680|565382972|FG001|Overall Study|Induction Failure|1|||
156628161|NCT00381680|565382971|FG000|Overall Study|Progression|1|||
156628162|NCT00381680|565382972|FG001|Overall Study|Progression|1|||
156628163|NCT00381680|565382971|FG000|Overall Study|Other not otherwise specified|7|||
156628164|NCT00381680|565382972|FG001|Overall Study|Other not otherwise specified|2|||
156628165|NCT00381680|565382971|FG000|Overall Study|Ineligible|3|||
156628166|NCT00381680|565382972|FG001|Overall Study|Ineligible|1|||
156628167|NCT00998166|565382973|FG000|Overall Study|Early Study Termination|8|||
156628168|NCT00450814|565382976|FG000|Overall Study|Failed to complete the initial therapy|0|||
156628169|NCT00450814|565382977|FG001|Overall Study|Failed to complete the initial therapy|0|||
156628170|NCT00450814|565382978|FG002|Overall Study|Failed to complete the initial therapy|0|||
156628171|NCT00450814|565382979|FG003|Overall Study|Failed to complete the initial therapy|1|||
156628172|NCT00450814|565382980|FG004|Overall Study|Failed to complete the initial therapy|1|||
156628173|NCT00450814|565382981|FG005|Overall Study|Failed to complete the initial therapy|1|||
156628174|NCT00450814|565382982|FG006|Overall Study|Failed to complete the initial therapy|0|||
156628175|NCT00450814|565382983|FG007|Overall Study|Failed to complete the initial therapy|0|||
156628176|NCT00450814|565382984|FG008|Overall Study|Failed to complete the initial therapy|0|||
156628177|NCT00450814|565382985|FG009|Overall Study|Failed to complete the initial therapy|0|||
156628178|NCT00450814|565382986|FG010|Overall Study|Failed to complete the initial therapy|0|||
156628179|NCT00450814|565382976|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
156628180|NCT00450814|565382977|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
156628181|NCT00450814|565382978|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
156628182|NCT00450814|565382979|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
156628183|NCT00450814|565382980|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
156628184|NCT00450814|565382981|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
156628185|NCT00450814|565382982|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
156628186|NCT00450814|565382983|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
156628187|NCT00450814|565382984|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
156628188|NCT00450814|565382985|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
156628189|NCT00450814|565382986|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
156628190|NCT03602976|565382991|FG000|Overall Study|Withdrawal by Subject|1|||
156628191|NCT04837807|565382992|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
156628192|NCT04837807|565382993|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
156628193|NCT04629534|565382994|FG000|Overall Study|Physician Decision|1|||
156628194|NCT04629534|565382995|FG001|Overall Study|Physician Decision|0|||
156628195|NCT04629534|565382994|FG000|Overall Study|Protocol Violation|0|||
156628196|NCT04629534|565382995|FG001|Overall Study|Protocol Violation|2|||
156628197|NCT03732534|565382996|FG000|Overall Study|Study terminated by Sponsor|6|||
156628198|NCT03907072|565382997|FG000|Overall Study|Study Terminated by Sponsor|2|||
156628199|NCT03907072|565382998|FG001|Overall Study|Study Terminated by Sponsor|2|||
156628200|NCT03907072|565382999|FG002|Overall Study|Study Terminated by Sponsor|2|||
156628201|NCT00612456|565383000|FG000|Overall Study|Adverse Event|1|||
156628202|NCT00612456|565383001|FG001|Overall Study|Adverse Event|0|||
156628203|NCT00612456|565383002|FG002|Overall Study|Adverse Event|0|||
156628204|NCT00612456|565383000|FG000|Overall Study|Lack of Efficacy|1|||
156628205|NCT00612456|565383001|FG001|Overall Study|Lack of Efficacy|1|||
156628206|NCT00612456|565383002|FG002|Overall Study|Lack of Efficacy|0|||
156628207|NCT00612456|565383000|FG000|Overall Study|Withdrawal by Subject|0|||
156628208|NCT00612456|565383001|FG001|Overall Study|Withdrawal by Subject|1|||
156628209|NCT00612456|565383002|FG002|Overall Study|Withdrawal by Subject|0|||
156628210|NCT00265109|565383005|FG000|Overall Study|Withdrawal by Subject|5|||
156628211|NCT00265109|565383005|FG000|Overall Study|Adverse Event|1|||
156628212|NCT02463097|565383006|FG000|Overall Study|Withdrawal by Subject|1|||
156628213|NCT00808665|565383007|FG000|Overall Study|Withdrawal by Subject|1|||
156628214|NCT00808665|565383008|FG001|Overall Study|Withdrawal by Subject|0|||
156628215|NCT00808665|565383007|FG000|Overall Study|only required minimally invasive surgery|1|||
156628216|NCT00808665|565383008|FG001|Overall Study|only required minimally invasive surgery|0|||
156628217|NCT00808665|565383007|FG000|Overall Study|surgery cancelled|1|||
156628218|NCT00808665|565383008|FG001|Overall Study|surgery cancelled|0|||
156628219|NCT00808665|565383007|FG000|Overall Study|required an additional procedure|0|||
156628220|NCT00808665|565383008|FG001|Overall Study|required an additional procedure|1|||
156628221|NCT00808665|565383007|FG000|Overall Study|Physician Decision|3|||
156628222|NCT00808665|565383008|FG001|Overall Study|Physician Decision|1|||
156628223|NCT00808665|565383007|FG000|Overall Study|Medication stopped by resident|0|||
156628224|NCT00808665|565383008|FG001|Overall Study|Medication stopped by resident|1|||
156628225|NCT03326323|565383009|FG000|Overall Study|Unable to receive ANH protocol|3|||
156628226|NCT01757821|565383012|FG000|Overall Study|Adverse Event|1|||
156628227|NCT03556202|565383017|FG000|Extension Treatment Period|Adverse Event|18|||
156628228|NCT03556202|565383018|FG001|Extension Treatment Period|Adverse Event|14|||
156628229|NCT03556202|565383019|FG002|Extension Treatment Period|Adverse Event|9|||
156628230|NCT03556202|565383017|FG000|Extension Treatment Period|Death|2|||
156628231|NCT03556202|565383018|FG001|Extension Treatment Period|Death|6|||
156628232|NCT03556202|565383019|FG002|Extension Treatment Period|Death|0|||
156628233|NCT03556202|565383017|FG000|Extension Treatment Period|Lack of Efficacy|5|||
156628234|NCT03556202|565383018|FG001|Extension Treatment Period|Lack of Efficacy|12|||
156628235|NCT03556202|565383019|FG002|Extension Treatment Period|Lack of Efficacy|18|||
156628236|NCT03556202|565383017|FG000|Extension Treatment Period|Lost to Follow-up|9|||
156628237|NCT03556202|565383018|FG001|Extension Treatment Period|Lost to Follow-up|20|||
156628238|NCT03556202|565383019|FG002|Extension Treatment Period|Lost to Follow-up|2|||
156628239|NCT03556202|565383017|FG000|Extension Treatment Period|Pregnancy|2|||
156628240|NCT03556202|565383018|FG001|Extension Treatment Period|Pregnancy|4|||
156628241|NCT03556202|565383019|FG002|Extension Treatment Period|Pregnancy|3|||
156628242|NCT03556202|565383017|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
156628243|NCT03556202|565383018|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
156628244|NCT03556202|565383019|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
156628245|NCT03556202|565383017|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
156628246|NCT03556202|565383018|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
156628247|NCT03556202|565383019|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
156628248|NCT03556202|565383017|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
156628249|NCT03556202|565383018|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
156628250|NCT03556202|565383019|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
156628251|NCT03556202|565383017|FG000|Extension Treatment Period|Physician Decision|0|||
156628252|NCT03556202|565383018|FG001|Extension Treatment Period|Physician Decision|8|||
156628253|NCT03556202|565383019|FG002|Extension Treatment Period|Physician Decision|2|||
156628254|NCT03556202|565383017|FG000|Extension Treatment Period|Protocol Violation|0|||
156628255|NCT03556202|565383018|FG001|Extension Treatment Period|Protocol Violation|1|||
156628256|NCT03556202|565383019|FG002|Extension Treatment Period|Protocol Violation|1|||
156628257|NCT03556202|565383017|FG000|Extension Treatment Period|Sponsor Decision|0|||
156628258|NCT03556202|565383018|FG001|Extension Treatment Period|Sponsor Decision|1|||
156628259|NCT03556202|565383019|FG002|Extension Treatment Period|Sponsor Decision|0|||
156628260|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
156628261|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
156628262|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
156628263|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Death|1|||
156628264|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Death|0|||
156628265|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Death|0|||
156628266|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
156628267|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
156628268|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
156628269|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
156628270|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
156628271|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
156628272|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
156628273|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
156628274|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
156628275|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
156628276|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
156628277|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
156628278|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
156628279|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
156628280|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
156628281|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
156628282|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
156628283|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
156628284|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
156628285|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
156628286|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
156628287|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
156628288|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
156628289|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
156628290|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
156628291|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
156628292|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
156628293|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
156628294|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
156628295|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
156628296|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
156628297|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
156628298|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
156628299|NCT03556202|565383017|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
156628300|NCT03556202|565383018|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
156628301|NCT03556202|565383019|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
156628302|NCT00678652|565383020|FG000|Overall Study|Protocol Violation|2|||
156628303|NCT00678652|565383021|FG001|Overall Study|Protocol Violation|0|||
156628304|NCT00678652|565383022|FG002|Overall Study|Protocol Violation|0|||
156628305|NCT00678652|565383023|FG003|Overall Study|Protocol Violation|0|||
156628306|NCT00678652|565383020|FG000|Overall Study|Pregnancy|0|||
156628307|NCT00678652|565383021|FG001|Overall Study|Pregnancy|0|||
156628308|NCT00678652|565383022|FG002|Overall Study|Pregnancy|1|||
156628309|NCT00678652|565383023|FG003|Overall Study|Pregnancy|0|||
156628310|NCT00678652|565383020|FG000|Overall Study|Relocation|1|||
156628311|NCT00678652|565383021|FG001|Overall Study|Relocation|0|||
156628312|NCT00678652|565383022|FG002|Overall Study|Relocation|0|||
156628313|NCT00678652|565383023|FG003|Overall Study|Relocation|0|||
156628314|NCT03319160|565383024|FG000|Overall Study|Data not available.|7|||
156628315|NCT03604159|565383025|FG000|Overall Study|Lost to Follow-up|6|||
156628316|NCT03604159|565383026|FG001|Overall Study|Lost to Follow-up|7|||
156628317|NCT00665002|565383027|FG000|Overall Study|Progression/relapse during treatment|11|||
156628318|NCT00665002|565383027|FG000|Overall Study|Cytogenetic resistance|1|||
156628319|NCT00383292|565383030|FG000|Overall Study|Adverse Event|4|||
156628320|NCT00383292|565383031|FG001|Overall Study|Adverse Event|1|||
156628321|NCT00383292|565383032|FG002|Overall Study|Adverse Event|2|||
156628322|NCT00383292|565383030|FG000|Overall Study|Death|3|||
156628323|NCT00383292|565383031|FG001|Overall Study|Death|3|||
156628324|NCT00383292|565383032|FG002|Overall Study|Death|3|||
156628325|NCT00383292|565383030|FG000|Overall Study|Physician Decision|4|||
156628326|NCT00383292|565383031|FG001|Overall Study|Physician Decision|0|||
156628327|NCT00383292|565383032|FG002|Overall Study|Physician Decision|1|||
156628328|NCT00383292|565383030|FG000|Overall Study|Withdrawal by Subject|3|||
156628329|NCT00383292|565383031|FG001|Overall Study|Withdrawal by Subject|2|||
156628330|NCT00383292|565383032|FG002|Overall Study|Withdrawal by Subject|2|||
156628331|NCT00383292|565383030|FG000|Overall Study|Other|1|||
156628332|NCT00383292|565383031|FG001|Overall Study|Other|0|||
156628333|NCT00383292|565383032|FG002|Overall Study|Other|0|||
156628334|NCT00697255|565383033|FG000|Stage 1a|Insufficient ovarian response|1|||
156628335|NCT00697255|565383034|FG001|Stage 1a|Insufficient ovarian response|0|||
156628336|NCT00697255|565383033|FG000|Stage 1a|Multifollicular growth|1|||
156628337|NCT00697255|565383034|FG001|Stage 1a|Multifollicular growth|0|||
156628338|NCT00697255|565383033|FG000|Stage 1a|Not growing of dominant follicle|1|||
156628339|NCT00697255|565383034|FG001|Stage 1a|Not growing of dominant follicle|0|||
156628340|NCT00697255|565383033|FG000|Stage 1b|Not growing of dominant follicle|0|||
156628341|NCT00697255|565383034|FG001|Stage 1b|Not growing of dominant follicle|1|||
156628342|NCT00697255|565383033|FG000|Stage 1b|Insufficient ovarian response|0|||
156628343|NCT00697255|565383034|FG001|Stage 1b|Insufficient ovarian response|1|||
156628344|NCT01365182|565383037|FG000|Overall Study|Withdrawal by Subject|10|||
156628345|NCT01365182|565383038|FG001|Overall Study|Withdrawal by Subject|13|||
156628346|NCT01365182|565383039|FG002|Overall Study|Withdrawal by Subject|12|||
156628347|NCT01815099|565383042|FG000|Overall Study|Lack of Efficacy|1|||
156628348|NCT01815099|565383042|FG000|Overall Study|unable to attend study visits|1|||
156628349|NCT01475214|565383043|FG000|Overall Study|Lost to Follow-up|1|||
156628350|NCT01475214|565383044|FG001|Overall Study|Lost to Follow-up|0|||
156628351|NCT01475214|565383045|FG002|Overall Study|Lost to Follow-up|1|||
156628352|NCT01475214|565383043|FG000|Overall Study|Physician Decision|2|||
156628353|NCT01475214|565383044|FG001|Overall Study|Physician Decision|0|||
156628354|NCT01475214|565383045|FG002|Overall Study|Physician Decision|0|||
156628355|NCT01475214|565383043|FG000|Overall Study|Withdrawal by Subject|2|||
156628356|NCT01475214|565383044|FG001|Overall Study|Withdrawal by Subject|4|||
156628357|NCT01475214|565383045|FG002|Overall Study|Withdrawal by Subject|1|||
156628358|NCT00643851|565383046|FG000|Overall Study|Death|0|||
156628359|NCT00643851|565383047|FG001|Overall Study|Death|1|||
156628360|NCT00643851|565383048|FG002|Overall Study|Death|0|||
156628361|NCT00643851|565383046|FG000|Overall Study|Lack of Efficacy|0|||
156628362|NCT00643851|565383047|FG001|Overall Study|Lack of Efficacy|1|||
156628363|NCT00643851|565383048|FG002|Overall Study|Lack of Efficacy|0|||
156628364|NCT00643851|565383046|FG000|Overall Study|Adverse Event|2|||
156628365|NCT00643851|565383047|FG001|Overall Study|Adverse Event|6|||
156628366|NCT00643851|565383048|FG002|Overall Study|Adverse Event|6|||
156628367|NCT00643851|565383046|FG000|Overall Study|Lost to Follow-up|4|||
156628368|NCT00643851|565383047|FG001|Overall Study|Lost to Follow-up|6|||
156628369|NCT00643851|565383048|FG002|Overall Study|Lost to Follow-up|9|||
156628370|NCT00643851|565383046|FG000|Overall Study|Withdrawal by Subject|8|||
156628371|NCT00643851|565383047|FG001|Overall Study|Withdrawal by Subject|15|||
156628372|NCT00643851|565383048|FG002|Overall Study|Withdrawal by Subject|9|||
156628373|NCT00643851|565383046|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
156628374|NCT00643851|565383047|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
156628375|NCT00643851|565383048|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
156628376|NCT04806334|565383049|FG000|Overall Study|Withdrawal by Subject|1|||
156628377|NCT01159665|565383050|FG000|Overall Study|Withdrawal by Subject|0|||
156628378|NCT01159665|565383051|FG001|Overall Study|Withdrawal by Subject|1|||
156628379|NCT01159665|565383052|FG002|Overall Study|Withdrawal by Subject|0|||
156628380|NCT01159665|565383053|FG003|Overall Study|Withdrawal by Subject|0|||
156628381|NCT01159665|565383054|FG004|Overall Study|Withdrawal by Subject|0|||
156628382|NCT01159665|565383055|FG005|Overall Study|Withdrawal by Subject|0|||
156628383|NCT01130831|565383056|FG000|Overall Study|Withdrawal by Subject|7|||
156628384|NCT01130831|565383056|FG000|Overall Study|Death|4|||
156628385|NCT01130831|565383056|FG000|Overall Study|Information was missing|3|||
156628386|NCT00951912|565383057|FG000|Overall Study|Lack of Efficacy|1|||
156628387|NCT00951912|565383058|FG001|Overall Study|Lack of Efficacy|0|||
156628388|NCT00951912|565383059|FG002|Overall Study|Lack of Efficacy|0|||
156628389|NCT00951912|565383057|FG000|Overall Study|Adverse Event|0|||
156628390|NCT00951912|565383058|FG001|Overall Study|Adverse Event|1|||
156628391|NCT00951912|565383059|FG002|Overall Study|Adverse Event|1|||
156628392|NCT00951912|565383057|FG000|Overall Study|Lost to Follow-up|2|||
156628393|NCT00951912|565383058|FG001|Overall Study|Lost to Follow-up|2|||
156628394|NCT00951912|565383059|FG002|Overall Study|Lost to Follow-up|0|||
156628395|NCT00951912|565383057|FG000|Overall Study|Physician Decision|1|||
156628396|NCT00951912|565383058|FG001|Overall Study|Physician Decision|0|||
156628397|NCT00951912|565383059|FG002|Overall Study|Physician Decision|1|||
156628398|NCT00951912|565383057|FG000|Overall Study|Withdrawal by Subject|1|||
156628399|NCT00951912|565383058|FG001|Overall Study|Withdrawal by Subject|1|||
156628400|NCT00951912|565383059|FG002|Overall Study|Withdrawal by Subject|0|||
156628401|NCT00951912|565383057|FG000|Overall Study|Other:Depression|1|||
156628402|NCT00951912|565383058|FG001|Overall Study|Other:Depression|0|||
156628403|NCT00951912|565383059|FG002|Overall Study|Other:Depression|0|||
156628404|NCT00951912|565383057|FG000|Overall Study|Other: Colon cancer|1|||
156628405|NCT00951912|565383058|FG001|Overall Study|Other: Colon cancer|0|||
156628406|NCT00951912|565383059|FG002|Overall Study|Other: Colon cancer|0|||
156628407|NCT00951912|565383057|FG000|Overall Study|Other: Stroke|0|||
156628408|NCT00951912|565383058|FG001|Overall Study|Other: Stroke|1|||
156628409|NCT00951912|565383059|FG002|Overall Study|Other: Stroke|0|||
156628410|NCT02173158|565383061|FG000|Efficacy Phase|Adverse Event|1|||
156628411|NCT01377194|565383062|FG000|Overall Study|Adverse Event|3|||
156628412|NCT01377194|565383063|FG001|Overall Study|Adverse Event|12|||
156628413|NCT01377194|565383064|FG002|Overall Study|Adverse Event|19|||
156628414|NCT01377194|565383062|FG000|Overall Study|Lack of Efficacy|3|||
156628415|NCT01377194|565383063|FG001|Overall Study|Lack of Efficacy|3|||
156628416|NCT01377194|565383064|FG002|Overall Study|Lack of Efficacy|3|||
156628417|NCT01377194|565383062|FG000|Overall Study|Protocol Violation|4|||
156628418|NCT01377194|565383063|FG001|Overall Study|Protocol Violation|10|||
156628419|NCT01377194|565383064|FG002|Overall Study|Protocol Violation|6|||
156628420|NCT01377194|565383062|FG000|Overall Study|Withdrawal by Subject|8|||
156628421|NCT01377194|565383063|FG001|Overall Study|Withdrawal by Subject|10|||
156628422|NCT01377194|565383064|FG002|Overall Study|Withdrawal by Subject|7|||
156628423|NCT01377194|565383062|FG000|Overall Study|Lost to Follow-up|14|||
156628424|NCT01377194|565383063|FG001|Overall Study|Lost to Follow-up|8|||
156628425|NCT01377194|565383064|FG002|Overall Study|Lost to Follow-up|11|||
156628426|NCT01977573|565383067|FG000|Overall Study|Adverse Event|7|||
156628427|NCT01977573|565383068|FG001|Overall Study|Adverse Event|0|||
156628428|NCT01977573|565383069|FG002|Overall Study|Adverse Event|2|||
156628429|NCT01977573|565383070|FG003|Overall Study|Adverse Event|1|||
156628430|NCT01977573|565383067|FG000|Overall Study|Lost to Follow-up|1|||
156628431|NCT01977573|565383068|FG001|Overall Study|Lost to Follow-up|0|||
156628432|NCT01977573|565383069|FG002|Overall Study|Lost to Follow-up|0|||
156628433|NCT01977573|565383070|FG003|Overall Study|Lost to Follow-up|1|||
156628434|NCT01977573|565383067|FG000|Overall Study|Physician Decision|1|||
156628435|NCT01977573|565383068|FG001|Overall Study|Physician Decision|0|||
156628436|NCT01977573|565383069|FG002|Overall Study|Physician Decision|0|||
156628437|NCT01977573|565383070|FG003|Overall Study|Physician Decision|0|||
156628438|NCT01977573|565383067|FG000|Overall Study|Protocol Violation|3|||
156628439|NCT01977573|565383068|FG001|Overall Study|Protocol Violation|1|||
156628440|NCT01977573|565383069|FG002|Overall Study|Protocol Violation|0|||
156628441|NCT01977573|565383070|FG003|Overall Study|Protocol Violation|0|||
156628442|NCT01977573|565383067|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
156628443|NCT01977573|565383068|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
156628444|NCT01977573|565383069|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
156628445|NCT01977573|565383070|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
156628446|NCT01977573|565383067|FG000|Overall Study|Withdrawal by Subject|6|||
156628447|NCT01977573|565383068|FG001|Overall Study|Withdrawal by Subject|1|||
156628448|NCT01977573|565383069|FG002|Overall Study|Withdrawal by Subject|1|||
156628449|NCT01977573|565383070|FG003|Overall Study|Withdrawal by Subject|1|||
156628450|NCT00323479|565383071|FG000|Overall Study|Adverse Event|2|||
156628451|NCT00323479|565383071|FG000|Overall Study|Withdrawal by Subject|2|||
156628452|NCT00323479|565383071|FG000|Overall Study|Protocol Violation|3|||
156628453|NCT00323479|565383071|FG000|Overall Study|house moving|1|||
156628454|NCT00967343|565383075|FG000|Overall Study|Study termination by sponsor|12|||
156628455|NCT00967343|565383075|FG000|Overall Study|Death|24|||
156628456|NCT00967343|565383075|FG000|Overall Study|Relapse|1|||
156628457|NCT00967343|565383075|FG000|Overall Study|Lost to Follow-up|1|||
156628458|NCT03044730|565383077|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
156628459|NCT03044730|565383077|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
156628460|NCT03044730|565383077|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
156628461|NCT03044730|565383077|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
156628462|NCT03044730|565383077|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
156628463|NCT03044730|565383077|FG000|Cycles 4 and Beyond|Adverse Event|1|||
156628464|NCT03044730|565383077|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
156628465|NCT03044730|565383077|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
156628466|NCT03044730|565383077|FG000|On Follow-up for 2 Years|Death|17|||
156628467|NCT00934661|565384766|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
156628468|NCT00934661|565384767|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
156628469|NCT01846442|565384769|FG000|Overall Study|Adverse Event|2|||
156628470|NCT01846442|565384770|FG001|Overall Study|Adverse Event|4|||
156628471|NCT01846442|565384771|FG002|Overall Study|Adverse Event|2|||
156628472|NCT01846442|565384772|FG003|Overall Study|Adverse Event|1|||
156628473|NCT01846442|565384769|FG000|Overall Study|Lost to Follow-up|0|||
156628474|NCT01846442|565384770|FG001|Overall Study|Lost to Follow-up|0|||
156628475|NCT01846442|565384771|FG002|Overall Study|Lost to Follow-up|1|||
156628476|NCT01846442|565384772|FG003|Overall Study|Lost to Follow-up|0|||
156628477|NCT01846442|565384769|FG000|Overall Study|Withdrawal by Subject|3|||
156628478|NCT01846442|565384770|FG001|Overall Study|Withdrawal by Subject|2|||
156628479|NCT01846442|565384771|FG002|Overall Study|Withdrawal by Subject|0|||
156628480|NCT01846442|565384772|FG003|Overall Study|Withdrawal by Subject|1|||
156628481|NCT01846442|565384769|FG000|Overall Study|Left the city/Lost medication|1|||
156628482|NCT01846442|565384770|FG001|Overall Study|Left the city/Lost medication|0|||
156628483|NCT01846442|565384771|FG002|Overall Study|Left the city/Lost medication|1|||
156628484|NCT01846442|565384772|FG003|Overall Study|Left the city/Lost medication|1|||
156628485|NCT02777554|565384779|FG000|Overall Study|Adverse Event|4|||
156628486|NCT02777554|565384780|FG001|Overall Study|Adverse Event|4|||
156628487|NCT02777554|565384781|FG002|Overall Study|Adverse Event|0|||
156628488|NCT02777554|565384782|FG003|Overall Study|Adverse Event|1|||
156628489|NCT02777554|565384783|FG004|Overall Study|Adverse Event|0|||
156628490|NCT02777554|565384784|FG005|Overall Study|Adverse Event|0|||
156628491|NCT02777554|565384779|FG000|Overall Study|Withdrawal by Subject|3|||
156628492|NCT02777554|565384780|FG001|Overall Study|Withdrawal by Subject|1|||
156628493|NCT02777554|565384781|FG002|Overall Study|Withdrawal by Subject|1|||
156628494|NCT02777554|565384782|FG003|Overall Study|Withdrawal by Subject|0|||
156628495|NCT02777554|565384783|FG004|Overall Study|Withdrawal by Subject|0|||
156628496|NCT02777554|565384784|FG005|Overall Study|Withdrawal by Subject|0|||
156628497|NCT02777554|565384779|FG000|Overall Study|Discharged early due to hurricane|22|||
156628498|NCT02777554|565384780|FG001|Overall Study|Discharged early due to hurricane|20|||
156628499|NCT02777554|565384781|FG002|Overall Study|Discharged early due to hurricane|0|||
156628500|NCT02777554|565384782|FG003|Overall Study|Discharged early due to hurricane|0|||
156628501|NCT02777554|565384783|FG004|Overall Study|Discharged early due to hurricane|0|||
156628502|NCT02777554|565384784|FG005|Overall Study|Discharged early due to hurricane|0|||
156628503|NCT02777554|565384779|FG000|Overall Study|Other - Miscellaneous|1|||
156628504|NCT02777554|565384780|FG001|Overall Study|Other - Miscellaneous|0|||
156628505|NCT02777554|565384781|FG002|Overall Study|Other - Miscellaneous|0|||
156628506|NCT02777554|565384782|FG003|Overall Study|Other - Miscellaneous|0|||
156628507|NCT02777554|565384783|FG004|Overall Study|Other - Miscellaneous|0|||
156628508|NCT02777554|565384784|FG005|Overall Study|Other - Miscellaneous|0|||
156628509|NCT01013207|565384785|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
156628510|NCT01541644|565384786|FG000|Overall Study|Withdrawal by Subject|3|||
156628511|NCT01458535|565384787|FG000|Overall Study|Other|0|||
156628512|NCT01458535|565384788|FG001|Overall Study|Other|0|||
156628513|NCT01458535|565384789|FG002|Overall Study|Other|0|||
156628514|NCT01458535|565384790|FG003|Overall Study|Other|0|||
156628515|NCT01458535|565384791|FG004|Overall Study|Other|1|||
156628516|NCT01458535|565384792|FG005|Overall Study|Other|1|||
156628517|NCT01458535|565384787|FG000|Overall Study|Withdrawal by Subject|0|||
156628518|NCT01458535|565384788|FG001|Overall Study|Withdrawal by Subject|0|||
156628519|NCT01458535|565384789|FG002|Overall Study|Withdrawal by Subject|2|||
156628520|NCT01458535|565384790|FG003|Overall Study|Withdrawal by Subject|0|||
156628521|NCT01458535|565384791|FG004|Overall Study|Withdrawal by Subject|1|||
156628522|NCT01458535|565384792|FG005|Overall Study|Withdrawal by Subject|1|||
156628523|NCT01458535|565384787|FG000|Overall Study|Lost to Follow-up|0|||
156628524|NCT01458535|565384788|FG001|Overall Study|Lost to Follow-up|2|||
156628525|NCT01458535|565384789|FG002|Overall Study|Lost to Follow-up|0|||
156628526|NCT01458535|565384790|FG003|Overall Study|Lost to Follow-up|3|||
156628527|NCT01458535|565384791|FG004|Overall Study|Lost to Follow-up|2|||
156628528|NCT01458535|565384792|FG005|Overall Study|Lost to Follow-up|2|||
156628529|NCT01458535|565384787|FG000|Overall Study|Adverse Event|0|||
156628530|NCT01458535|565384788|FG001|Overall Study|Adverse Event|0|||
156628531|NCT01458535|565384789|FG002|Overall Study|Adverse Event|0|||
156628532|NCT01458535|565384790|FG003|Overall Study|Adverse Event|1|||
156628533|NCT01458535|565384791|FG004|Overall Study|Adverse Event|0|||
156628534|NCT01458535|565384792|FG005|Overall Study|Adverse Event|0|||
156628535|NCT00151775|565384793|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
156628536|NCT00151775|565384794|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
156628537|NCT00151775|565384795|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156635566|NCT00602667|565409960|FG000|Overall Study|Excessive toxicity|1|||
156628538|NCT00151775|565384796|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628539|NCT00151775|565384797|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628540|NCT00151775|565384798|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628541|NCT00151775|565384799|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628542|NCT00151775|565384800|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628543|NCT00151775|565384801|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628544|NCT00151775|565384802|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628545|NCT00151775|565384803|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628546|NCT00151775|565384804|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
156628547|NCT00151775|565384793|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
156628548|NCT00151775|565384794|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628549|NCT00151775|565384795|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628550|NCT00151775|565384796|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628551|NCT00151775|565384797|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628552|NCT00151775|565384798|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628553|NCT00151775|565384799|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
156628554|NCT00151775|565384800|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628555|NCT00151775|565384801|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628556|NCT00151775|565384802|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628557|NCT00151775|565384803|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
156628558|NCT00151775|565384804|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
156628559|NCT00151775|565384793|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628560|NCT00151775|565384794|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
156628561|NCT00151775|565384795|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628562|NCT00151775|565384796|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628563|NCT00151775|565384797|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628564|NCT00151775|565384798|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628565|NCT00151775|565384799|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628566|NCT00151775|565384800|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628567|NCT00151775|565384801|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628568|NCT00151775|565384802|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628569|NCT00151775|565384803|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628570|NCT00151775|565384804|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
156628571|NCT00151775|565384793|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
156628572|NCT00151775|565384794|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
156628573|NCT00151775|565384795|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
156628574|NCT00151775|565384796|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
156628575|NCT00151775|565384797|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
156628576|NCT00151775|565384798|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
156628577|NCT00151775|565384799|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
156628578|NCT00151775|565384800|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
156628579|NCT00151775|565384801|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
156628580|NCT00151775|565384802|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
156628581|NCT00151775|565384803|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
156628582|NCT00151775|565384804|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
156628583|NCT00151775|565384793|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628584|NCT00151775|565384794|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628585|NCT00151775|565384795|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628586|NCT00151775|565384796|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628587|NCT00151775|565384797|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628588|NCT00151775|565384798|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
156628589|NCT00151775|565384799|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628590|NCT00151775|565384800|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628591|NCT00151775|565384801|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628592|NCT00151775|565384802|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628593|NCT00151775|565384803|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628594|NCT00151775|565384804|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
156628595|NCT00151775|565384793|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628596|NCT00151775|565384794|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628597|NCT00151775|565384795|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628598|NCT00151775|565384796|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628599|NCT00151775|565384797|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628600|NCT00151775|565384798|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
156628601|NCT00151775|565384799|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628602|NCT00151775|565384800|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628603|NCT00151775|565384801|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628604|NCT00151775|565384802|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628605|NCT00151775|565384803|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628606|NCT00151775|565384804|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
156628607|NCT00151775|565384793|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628608|NCT00151775|565384794|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628609|NCT00151775|565384795|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628610|NCT00151775|565384796|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628611|NCT00151775|565384797|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628612|NCT00151775|565384798|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628613|NCT00151775|565384799|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
156628614|NCT00151775|565384800|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628615|NCT00151775|565384801|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628616|NCT00151775|565384802|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628617|NCT00151775|565384803|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628618|NCT00151775|565384804|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
156628619|NCT00151775|565384793|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628620|NCT00151775|565384794|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628621|NCT00151775|565384795|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628622|NCT00151775|565384796|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628623|NCT00151775|565384797|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628624|NCT00151775|565384798|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
156628625|NCT00151775|565384799|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628626|NCT00151775|565384800|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628627|NCT00151775|565384801|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628628|NCT00151775|565384802|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628629|NCT00151775|565384803|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628630|NCT00151775|565384804|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
156628631|NCT00151775|565384793|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
156628632|NCT00151775|565384794|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
156628633|NCT00151775|565384795|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
156628634|NCT00151775|565384796|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
156628635|NCT00151775|565384797|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
156628636|NCT00151775|565384798|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
156628637|NCT00151775|565384799|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
156628638|NCT00151775|565384800|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
156628639|NCT00151775|565384801|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
156628640|NCT00151775|565384802|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
156628641|NCT00151775|565384803|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
156628642|NCT00151775|565384804|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
156628643|NCT00151775|565384793|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628644|NCT00151775|565384794|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628645|NCT00151775|565384795|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628646|NCT00151775|565384796|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628647|NCT00151775|565384797|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628648|NCT00151775|565384798|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628649|NCT00151775|565384799|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
156628650|NCT00151775|565384800|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628651|NCT00151775|565384801|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628652|NCT00151775|565384802|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628653|NCT00151775|565384803|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628654|NCT00151775|565384804|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156628655|NCT00151775|565384793|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628656|NCT00151775|565384794|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628657|NCT00151775|565384795|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
156628658|NCT00151775|565384796|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628659|NCT00151775|565384797|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628660|NCT00151775|565384798|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628661|NCT00151775|565384799|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628662|NCT00151775|565384800|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628663|NCT00151775|565384801|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628664|NCT00151775|565384802|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628665|NCT00151775|565384803|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628666|NCT00151775|565384804|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
156628667|NCT00151775|565384793|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628668|NCT00151775|565384794|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628669|NCT00151775|565384795|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
156628670|NCT00151775|565384796|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628671|NCT00151775|565384797|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628672|NCT00151775|565384798|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628673|NCT00151775|565384799|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628674|NCT00151775|565384800|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628675|NCT00151775|565384801|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628676|NCT00151775|565384802|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628677|NCT00151775|565384803|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628678|NCT00151775|565384804|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
156628679|NCT00151775|565384793|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628680|NCT00151775|565384794|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628681|NCT00151775|565384795|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628682|NCT00151775|565384796|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628683|NCT00151775|565384797|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628684|NCT00151775|565384798|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628685|NCT00151775|565384799|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628686|NCT00151775|565384800|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628687|NCT00151775|565384801|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628688|NCT00151775|565384802|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628689|NCT00151775|565384803|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
156628690|NCT00151775|565384804|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
156628691|NCT00151775|565384793|FG000|Period 4: Open Label|Increased blood pressure|0|||
156628692|NCT00151775|565384794|FG001|Period 4: Open Label|Increased blood pressure|0|||
156628693|NCT00151775|565384795|FG002|Period 4: Open Label|Increased blood pressure|0|||
156628694|NCT00151775|565384796|FG003|Period 4: Open Label|Increased blood pressure|0|||
156628695|NCT00151775|565384797|FG004|Period 4: Open Label|Increased blood pressure|1|||
156628696|NCT00151775|565384798|FG005|Period 4: Open Label|Increased blood pressure|0|||
156628697|NCT00151775|565384799|FG006|Period 4: Open Label|Increased blood pressure|0|||
156628698|NCT00151775|565384800|FG007|Period 4: Open Label|Increased blood pressure|0|||
156628699|NCT00151775|565384801|FG008|Period 4: Open Label|Increased blood pressure|0|||
156628700|NCT00151775|565384802|FG009|Period 4: Open Label|Increased blood pressure|1|||
156628701|NCT00151775|565384803|FG010|Period 4: Open Label|Increased blood pressure|0|||
156628702|NCT00151775|565384804|FG011|Period 4: Open Label|Increased blood pressure|0|||
156628703|NCT00151775|565384793|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
156628704|NCT00151775|565384794|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
156628705|NCT00151775|565384795|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
156628706|NCT00151775|565384796|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
156628707|NCT00151775|565384797|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
156628708|NCT00151775|565384798|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
156628709|NCT00151775|565384799|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
156628710|NCT00151775|565384800|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
156628711|NCT00151775|565384801|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
156628712|NCT00151775|565384802|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
156628713|NCT00151775|565384803|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
156628714|NCT00151775|565384804|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
156628715|NCT00151775|565384793|FG000|Period 4: Open Label|Adverse Event|0|||
156628716|NCT00151775|565384794|FG001|Period 4: Open Label|Adverse Event|0|||
156628717|NCT00151775|565384795|FG002|Period 4: Open Label|Adverse Event|0|||
156628718|NCT00151775|565384796|FG003|Period 4: Open Label|Adverse Event|0|||
156628719|NCT00151775|565384797|FG004|Period 4: Open Label|Adverse Event|1|||
156628720|NCT00151775|565384798|FG005|Period 4: Open Label|Adverse Event|0|||
156628721|NCT00151775|565384799|FG006|Period 4: Open Label|Adverse Event|0|||
156628722|NCT00151775|565384800|FG007|Period 4: Open Label|Adverse Event|0|||
156628723|NCT00151775|565384801|FG008|Period 4: Open Label|Adverse Event|0|||
156628724|NCT00151775|565384802|FG009|Period 4: Open Label|Adverse Event|2|||
156628725|NCT00151775|565384803|FG010|Period 4: Open Label|Adverse Event|0|||
156628726|NCT00151775|565384804|FG011|Period 4: Open Label|Adverse Event|0|||
156628727|NCT00151775|565384793|FG000|Period 4: Open Label|Lost to Follow-up|0|||
156628728|NCT00151775|565384794|FG001|Period 4: Open Label|Lost to Follow-up|0|||
156628729|NCT00151775|565384795|FG002|Period 4: Open Label|Lost to Follow-up|0|||
156628730|NCT00151775|565384796|FG003|Period 4: Open Label|Lost to Follow-up|0|||
156628731|NCT00151775|565384797|FG004|Period 4: Open Label|Lost to Follow-up|17|||
156628732|NCT00151775|565384798|FG005|Period 4: Open Label|Lost to Follow-up|0|||
156628733|NCT00151775|565384799|FG006|Period 4: Open Label|Lost to Follow-up|0|||
156628734|NCT00151775|565384800|FG007|Period 4: Open Label|Lost to Follow-up|0|||
156628735|NCT00151775|565384801|FG008|Period 4: Open Label|Lost to Follow-up|0|||
156628736|NCT00151775|565384802|FG009|Period 4: Open Label|Lost to Follow-up|7|||
156628737|NCT00151775|565384803|FG010|Period 4: Open Label|Lost to Follow-up|0|||
156628738|NCT00151775|565384804|FG011|Period 4: Open Label|Lost to Follow-up|0|||
156628739|NCT00151775|565384793|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
156628740|NCT00151775|565384794|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
156628741|NCT00151775|565384795|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
156628742|NCT00151775|565384796|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
156628743|NCT00151775|565384797|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
156628744|NCT00151775|565384798|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
156628745|NCT00151775|565384799|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
156628746|NCT00151775|565384800|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
156628747|NCT00151775|565384801|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
156628748|NCT00151775|565384802|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
156628749|NCT00151775|565384803|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
156628750|NCT00151775|565384804|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
156628751|NCT00151775|565384793|FG000|Period 4: Open Label|Other|0|||
156628752|NCT00151775|565384794|FG001|Period 4: Open Label|Other|0|||
156628753|NCT00151775|565384795|FG002|Period 4: Open Label|Other|0|||
156628754|NCT00151775|565384796|FG003|Period 4: Open Label|Other|0|||
156628755|NCT00151775|565384797|FG004|Period 4: Open Label|Other|1|||
156628756|NCT00151775|565384798|FG005|Period 4: Open Label|Other|0|||
156628757|NCT00151775|565384799|FG006|Period 4: Open Label|Other|0|||
156628758|NCT00151775|565384800|FG007|Period 4: Open Label|Other|0|||
156628759|NCT00151775|565384801|FG008|Period 4: Open Label|Other|0|||
156628760|NCT00151775|565384802|FG009|Period 4: Open Label|Other|3|||
156628761|NCT00151775|565384803|FG010|Period 4: Open Label|Other|0|||
156628762|NCT00151775|565384804|FG011|Period 4: Open Label|Other|0|||
156628763|NCT00151775|565384793|FG000|Period 4: Open Label|Physician Decision|0|||
156628764|NCT00151775|565384794|FG001|Period 4: Open Label|Physician Decision|0|||
156628765|NCT00151775|565384795|FG002|Period 4: Open Label|Physician Decision|0|||
156628766|NCT00151775|565384796|FG003|Period 4: Open Label|Physician Decision|0|||
156628767|NCT00151775|565384797|FG004|Period 4: Open Label|Physician Decision|0|||
156628768|NCT00151775|565384798|FG005|Period 4: Open Label|Physician Decision|0|||
156628769|NCT00151775|565384799|FG006|Period 4: Open Label|Physician Decision|0|||
156628770|NCT00151775|565384800|FG007|Period 4: Open Label|Physician Decision|0|||
156628771|NCT00151775|565384801|FG008|Period 4: Open Label|Physician Decision|0|||
156628772|NCT00151775|565384802|FG009|Period 4: Open Label|Physician Decision|2|||
156628773|NCT00151775|565384803|FG010|Period 4: Open Label|Physician Decision|0|||
156628774|NCT00151775|565384804|FG011|Period 4: Open Label|Physician Decision|0|||
156628775|NCT00151775|565384793|FG000|Period 4: Open Label|Protocol Violation|0|||
156628776|NCT00151775|565384794|FG001|Period 4: Open Label|Protocol Violation|0|||
156628777|NCT00151775|565384795|FG002|Period 4: Open Label|Protocol Violation|0|||
156628778|NCT00151775|565384796|FG003|Period 4: Open Label|Protocol Violation|0|||
156628779|NCT00151775|565384797|FG004|Period 4: Open Label|Protocol Violation|1|||
156628780|NCT00151775|565384798|FG005|Period 4: Open Label|Protocol Violation|0|||
156628781|NCT00151775|565384799|FG006|Period 4: Open Label|Protocol Violation|0|||
156628782|NCT00151775|565384800|FG007|Period 4: Open Label|Protocol Violation|0|||
156628783|NCT00151775|565384801|FG008|Period 4: Open Label|Protocol Violation|0|||
156628784|NCT00151775|565384802|FG009|Period 4: Open Label|Protocol Violation|0|||
156628785|NCT00151775|565384803|FG010|Period 4: Open Label|Protocol Violation|0|||
156628786|NCT00151775|565384804|FG011|Period 4: Open Label|Protocol Violation|0|||
156628787|NCT00247416|565384805|FG000|Overall Study|3 patients were found to be ineligible|1|||
156628788|NCT00247416|565384806|FG001|Overall Study|3 patients were found to be ineligible|2|||
156628789|NCT00474994|565384815|FG000|Overall Study|Patient Not treated|1|||
156628790|NCT00474994|565384815|FG000|Overall Study|Patient evaluable for toxicity only|3|||
156628791|NCT00474994|565384815|FG000|Overall Study|Patient found to be ineligible|1|||
156628792|NCT02660489|565384816|FG000|Overall Study|Lost to Follow-up|1|||
156628793|NCT02660489|565384817|FG001|Overall Study|Lost to Follow-up|1|||
156628794|NCT02660489|565384816|FG000|Overall Study|Adverse Event|1|||
156628795|NCT02660489|565384817|FG001|Overall Study|Adverse Event|3|||
156628796|NCT02660489|565384816|FG000|Overall Study|no rhinovirus infection|4|||
156628797|NCT02660489|565384817|FG001|Overall Study|no rhinovirus infection|4|||
156628798|NCT02322866|565384818|FG000|Overall Study|Adverse Event|6|||
156628799|NCT02322866|565384819|FG001|Overall Study|Adverse Event|11|||
156628800|NCT02322866|565384818|FG000|Overall Study|Withdrawal of Consent|16|||
156628801|NCT02322866|565384819|FG001|Overall Study|Withdrawal of Consent|25|||
156628802|NCT02322866|565384818|FG000|Overall Study|Lost to Follow-up|36|||
156628803|NCT02322866|565384819|FG001|Overall Study|Lost to Follow-up|39|||
156628804|NCT02322866|565384818|FG000|Overall Study|Protocol Violation|1|||
156628805|NCT02322866|565384819|FG001|Overall Study|Protocol Violation|0|||
156628806|NCT02322866|565384818|FG000|Overall Study|Noncompliance with Treatment|3|||
156628807|NCT02322866|565384819|FG001|Overall Study|Noncompliance with Treatment|4|||
156628808|NCT02322866|565384818|FG000|Overall Study|Lack of Efficacy|3|||
156628809|NCT02322866|565384819|FG001|Overall Study|Lack of Efficacy|1|||
156628810|NCT02322866|565384818|FG000|Overall Study|Other Miscellaneous Reasons|6|||
156628811|NCT02322866|565384819|FG001|Overall Study|Other Miscellaneous Reasons|6|||
156628812|NCT03735680|565384820|FG000|Overall Study|Withdrawal by Subject|0|||
156628813|NCT03735680|565384821|FG001|Overall Study|Withdrawal by Subject|1|||
156628814|NCT03735680|565384822|FG002|Overall Study|Withdrawal by Subject|0|||
156628815|NCT03735680|565384823|FG003|Overall Study|Withdrawal by Subject|0|||
156628816|NCT03735680|565384824|FG004|Overall Study|Withdrawal by Subject|0|||
156628817|NCT03735680|565384825|FG005|Overall Study|Withdrawal by Subject|1|||
156628818|NCT03735680|565384820|FG000|Overall Study|Patient unable or unwilling to continue|0|||
156628819|NCT03735680|565384821|FG001|Overall Study|Patient unable or unwilling to continue|0|||
156628820|NCT03735680|565384822|FG002|Overall Study|Patient unable or unwilling to continue|1|||
156628821|NCT03735680|565384823|FG003|Overall Study|Patient unable or unwilling to continue|0|||
156628822|NCT03735680|565384824|FG004|Overall Study|Patient unable or unwilling to continue|0|||
156628823|NCT03735680|565384825|FG005|Overall Study|Patient unable or unwilling to continue|0|||
156628824|NCT00761761|565384833|FG000|Overall Study|Lost to Follow-up|3|||
156628825|NCT00761761|565384834|FG001|Overall Study|Lost to Follow-up|1|||
156628826|NCT00761761|565384833|FG000|Overall Study|Withdrawal by Subject|3|||
156628827|NCT00761761|565384834|FG001|Overall Study|Withdrawal by Subject|0|||
156628828|NCT05064436|565384839|FG000|Overall Study|Other Reasons|1|||
156628829|NCT05064436|565384840|FG001|Overall Study|Other Reasons|0|||
156628830|NCT01711736|565384841|FG000|Overall Study|Lost to Follow-up|4|||
156628831|NCT01711736|565384842|FG001|Overall Study|Lost to Follow-up|1|||
156628832|NCT01711736|565384841|FG000|Overall Study|Withdrawal by Subject|6|||
156628833|NCT01711736|565384842|FG001|Overall Study|Withdrawal by Subject|6|||
156628834|NCT01711736|565384841|FG000|Overall Study|Migrated/moved from study area|2|||
156628835|NCT01711736|565384842|FG001|Overall Study|Migrated/moved from study area|1|||
156628836|NCT02706327|565384843|FG000|Overall Study|Lost to Follow-up|1|||
156628837|NCT02706327|565384844|FG001|Overall Study|Lost to Follow-up|1|||
156628838|NCT02706327|565384845|FG002|Overall Study|Lost to Follow-up|2|||
156628839|NCT05450198|565384846|FG000|Overall Study|Withdrawal by Subject|1|||
156628840|NCT05450198|565384847|FG001|Overall Study|Withdrawal by Subject|1|||
156628841|NCT05450198|565384848|FG002|Overall Study|Withdrawal by Subject|2|||
156628842|NCT05450198|565384849|FG003|Overall Study|Withdrawal by Subject|0|||
156628843|NCT05450198|565384846|FG000|Overall Study|Lost to Follow-up|1|||
156628844|NCT05450198|565384847|FG001|Overall Study|Lost to Follow-up|0|||
156628845|NCT05450198|565384848|FG002|Overall Study|Lost to Follow-up|2|||
156628846|NCT05450198|565384849|FG003|Overall Study|Lost to Follow-up|1|||
156628847|NCT01224171|565384855|FG000|Overall Study|Adverse Event|8|||
156628848|NCT01224171|565384856|FG001|Overall Study|Adverse Event|4|||
156628849|NCT01224171|565384855|FG000|Overall Study|Protocol Violation|0|||
156628850|NCT01224171|565384856|FG001|Overall Study|Protocol Violation|1|||
156628851|NCT01224171|565384855|FG000|Overall Study|Lack of Efficacy|5|||
156628852|NCT01224171|565384856|FG001|Overall Study|Lack of Efficacy|1|||
156628853|NCT01224171|565384855|FG000|Overall Study|Withdrawal of Consent|2|||
156628854|NCT01224171|565384856|FG001|Overall Study|Withdrawal of Consent|4|||
156628855|NCT01224171|565384855|FG000|Overall Study|Lost to Follow-up|0|||
156628856|NCT01224171|565384856|FG001|Overall Study|Lost to Follow-up|3|||
156628857|NCT01097057|565384857|FG000|Overall Study|Physician Decision|3|||
156628858|NCT01270139|565384858|FG000|Overall Study|Adverse Event|8|||
156628859|NCT01270139|565384859|FG001|Overall Study|Adverse Event|17|||
156628860|NCT01270139|565384860|FG002|Overall Study|Adverse Event|18|||
156628861|NCT01270139|565384858|FG000|Overall Study|Lost to Follow-up|10|||
156628862|NCT01270139|565384859|FG001|Overall Study|Lost to Follow-up|9|||
156628863|NCT01270139|565384860|FG002|Overall Study|Lost to Follow-up|2|||
156628864|NCT02213666|565384870|FG000|Overall Study|Withdrawal by Subject|1|||
156628865|NCT05602818|565384871|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
156628866|NCT05602818|565384872|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
156628867|NCT05602818|565384873|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
156628868|NCT05602818|565384874|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
156628869|NCT05602818|565384875|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
156628870|NCT05602818|565384876|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
156628871|NCT05602818|565384877|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
156628872|NCT05602818|565384878|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
156628873|NCT05602818|565384879|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
156628874|NCT05602818|565384880|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
156628875|NCT05602818|565384881|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
156628876|NCT05602818|565384882|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
156628877|NCT05602818|565384871|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
156628878|NCT05602818|565384872|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
156628879|NCT05602818|565384873|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628880|NCT05602818|565384874|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628881|NCT05602818|565384875|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628882|NCT05602818|565384876|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628883|NCT05602818|565384877|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628884|NCT05602818|565384878|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628885|NCT05602818|565384879|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628886|NCT05602818|565384880|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628887|NCT05602818|565384881|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628888|NCT05602818|565384882|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
156628889|NCT05602818|565384871|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
156628890|NCT05602818|565384872|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628891|NCT05602818|565384873|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628892|NCT05602818|565384874|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628893|NCT05602818|565384875|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628894|NCT05602818|565384876|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628895|NCT05602818|565384877|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628896|NCT05602818|565384878|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628897|NCT05602818|565384879|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628898|NCT05602818|565384880|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628899|NCT05602818|565384881|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628900|NCT05602818|565384882|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
156628901|NCT05602818|565384871|FG000|Qualification Phase (3 Days)|Other|1|||
156628902|NCT05602818|565384872|FG001|Qualification Phase (3 Days)|Other|0|||
156628903|NCT05602818|565384873|FG002|Qualification Phase (3 Days)|Other|0|||
156628904|NCT05602818|565384874|FG003|Qualification Phase (3 Days)|Other|0|||
156628905|NCT05602818|565384875|FG004|Qualification Phase (3 Days)|Other|0|||
156628906|NCT05602818|565384876|FG005|Qualification Phase (3 Days)|Other|0|||
156628907|NCT05602818|565384877|FG006|Qualification Phase (3 Days)|Other|0|||
156628908|NCT05602818|565384878|FG007|Qualification Phase (3 Days)|Other|0|||
156628909|NCT05602818|565384879|FG008|Qualification Phase (3 Days)|Other|0|||
156628910|NCT05602818|565384880|FG009|Qualification Phase (3 Days)|Other|0|||
156628911|NCT05602818|565384881|FG010|Qualification Phase (3 Days)|Other|0|||
156628912|NCT05602818|565384882|FG011|Qualification Phase (3 Days)|Other|0|||
156628913|NCT05602818|565384871|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628914|NCT05602818|565384872|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
156628915|NCT05602818|565384873|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628916|NCT05602818|565384874|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628917|NCT05602818|565384875|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628918|NCT05602818|565384876|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628919|NCT05602818|565384877|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628920|NCT05602818|565384878|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628921|NCT05602818|565384879|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628922|NCT05602818|565384880|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628923|NCT05602818|565384881|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628924|NCT05602818|565384882|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
156628925|NCT05602818|565384871|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
156628926|NCT05602818|565384872|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
156628927|NCT05602818|565384873|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
156628928|NCT05602818|565384874|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
156628929|NCT05602818|565384875|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
156628930|NCT05602818|565384876|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
156628931|NCT05602818|565384877|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
156628932|NCT05602818|565384878|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
156628933|NCT05602818|565384879|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
156628934|NCT05602818|565384880|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
156628935|NCT05602818|565384881|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
156628936|NCT05602818|565384882|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
156628937|NCT05602818|565384871|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628938|NCT05602818|565384872|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628939|NCT05602818|565384873|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628940|NCT05602818|565384874|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628941|NCT05602818|565384875|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628942|NCT05602818|565384876|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628943|NCT05602818|565384877|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628944|NCT05602818|565384878|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628945|NCT05602818|565384879|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628946|NCT05602818|565384880|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
156628947|NCT05602818|565384881|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
156628948|NCT05602818|565384882|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
156628949|NCT05602818|565384871|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
156628950|NCT05602818|565384872|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
156628951|NCT05602818|565384873|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
156628952|NCT05602818|565384874|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
156628953|NCT05602818|565384875|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
156628954|NCT05602818|565384876|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
156628955|NCT05602818|565384877|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
156628956|NCT05602818|565384878|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
156628957|NCT05602818|565384879|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
156628958|NCT05602818|565384880|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
156628959|NCT05602818|565384881|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
156628960|NCT05602818|565384882|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
156628961|NCT03099096|565384888|FG000|Overall Study|Adverse Event|1|||
156628962|NCT03099096|565384888|FG000|Overall Study|Physician Decision|1|||
156628963|NCT01374516|565384889|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
156628964|NCT01374516|565384890|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
156628965|NCT01374516|565384889|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
156628966|NCT01374516|565384890|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
156628967|NCT01374516|565384889|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
156628968|NCT01374516|565384890|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
156628969|NCT01374516|565384889|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
156628970|NCT01374516|565384890|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
156628971|NCT01374516|565384889|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
156628972|NCT01374516|565384890|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
156628973|NCT01374516|565384889|FG000|Surveillance Expansion Period|Protocol Violation|386|||
156628974|NCT01374516|565384890|FG001|Surveillance Expansion Period|Protocol Violation|217|||
156628975|NCT01374516|565384889|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
156628976|NCT01374516|565384890|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
156628977|NCT01374516|565384889|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
156628978|NCT01374516|565384890|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
156628979|NCT01374516|565384889|FG000|Surveillance Expansion Period|Serious adverse event|20|||
156628980|NCT01374516|565384890|FG001|Surveillance Expansion Period|Serious adverse event|5|||
156628981|NCT02190604|565384894|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628982|NCT02190604|565384895|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628983|NCT02190604|565384896|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628984|NCT02190604|565384897|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628985|NCT02190604|565384898|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628986|NCT02190604|565384899|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628987|NCT02190604|565384900|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628988|NCT02190604|565384901|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628989|NCT02190604|565384902|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628990|NCT02190604|565384903|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628991|NCT02190604|565384904|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628992|NCT02190604|565384905|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628993|NCT02190604|565384906|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628994|NCT02190604|565384907|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628995|NCT02190604|565384908|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
156628996|NCT02190604|565384909|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628997|NCT02190604|565384910|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628998|NCT02190604|565384911|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156628999|NCT02190604|565384912|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
156629000|NCT02190604|565384894|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629001|NCT02190604|565384895|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629002|NCT02190604|565384896|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629003|NCT02190604|565384897|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629004|NCT02190604|565384898|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629005|NCT02190604|565384899|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629006|NCT02190604|565384900|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629007|NCT02190604|565384901|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629008|NCT02190604|565384902|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629009|NCT02190604|565384903|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629010|NCT02190604|565384904|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629011|NCT02190604|565384905|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629012|NCT02190604|565384906|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629013|NCT02190604|565384907|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
156629014|NCT02190604|565384908|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629015|NCT02190604|565384909|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629016|NCT02190604|565384910|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629017|NCT02190604|565384911|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629018|NCT02190604|565384912|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
156629019|NCT02797951|565384913|FG000|Overall Study|Adverse Event|4|||
156629020|NCT02797951|565384913|FG000|Overall Study|Death|1|||
156629021|NCT02797951|565384913|FG000|Overall Study|Lack of Efficacy|19|||
156629022|NCT02797951|565384913|FG000|Overall Study|Lost to Follow-up|4|||
156629023|NCT02797951|565384913|FG000|Overall Study|Physician Decision|6|||
156629024|NCT02797951|565384913|FG000|Overall Study|Withdrawal by Subject|15|||
156629025|NCT00814502|565384914|FG000|Overall Study|Adverse Event|1|||
156629026|NCT00814502|565384915|FG001|Overall Study|Adverse Event|0|||
156629027|NCT00814502|565384914|FG000|Overall Study|Withdrawal by Subject|0|||
156629028|NCT00814502|565384915|FG001|Overall Study|Withdrawal by Subject|2|||
156629029|NCT01901393|565384916|FG000|Overall Study|Adverse Event|1|||
156629030|NCT01901393|565384917|FG001|Overall Study|Adverse Event|0|||
156629031|NCT03735849|565384918|FG000|Overall Study|Lost to Follow-up|1|||
156629032|NCT03735849|565384919|FG001|Overall Study|Lost to Follow-up|0|||
156629033|NCT03735849|565384920|FG002|Overall Study|Lost to Follow-up|0|||
156629034|NCT03735849|565384918|FG000|Overall Study|Participant unable to adhere to visit|1|||
156629035|NCT03735849|565384919|FG001|Overall Study|Participant unable to adhere to visit|0|||
156629036|NCT03735849|565384920|FG002|Overall Study|Participant unable to adhere to visit|0|||
156629037|NCT03735849|565384918|FG000|Overall Study|Not Randomized|0|||
156629038|NCT03735849|565384919|FG001|Overall Study|Not Randomized|0|||
156629039|NCT03735849|565384920|FG002|Overall Study|Not Randomized|4|||
156629040|NCT03125382|565384923|FG000|Randomization|screening failure|1|||
156629041|NCT03125382|565384924|FG001|Randomization|screening failure|4|||
156629042|NCT03125382|565384925|FG002|Randomization|screening failure|2|||
156629043|NCT03125382|565384926|FG003|Randomization|screening failure|0|||
156629044|NCT03125382|565384923|FG000|Follow-up|Death|1|||
156629045|NCT03125382|565384924|FG001|Follow-up|Death|2|||
156629046|NCT03125382|565384925|FG002|Follow-up|Death|1|||
156629047|NCT03125382|565384926|FG003|Follow-up|Death|2|||
156629048|NCT03125382|565384923|FG000|Follow-up|Lost to Follow-up|1|||
156629049|NCT03125382|565384924|FG001|Follow-up|Lost to Follow-up|4|||
156629050|NCT03125382|565384925|FG002|Follow-up|Lost to Follow-up|3|||
156629051|NCT03125382|565384926|FG003|Follow-up|Lost to Follow-up|1|||
156629052|NCT02243306|565384939|FG000|Overall Study|Adverse Event|0|||
156629053|NCT02243306|565384940|FG001|Overall Study|Adverse Event|1|||
156629054|NCT02243306|565384939|FG000|Overall Study|Other: Reached stopping criteria|0|||
156629055|NCT02243306|565384940|FG001|Overall Study|Other: Reached stopping criteria|1|||
156629056|NCT02243306|565384939|FG000|Overall Study|Physician Decision|0|||
156629057|NCT02243306|565384940|FG001|Overall Study|Physician Decision|1|||
156629058|NCT04768881|565384945|FG000|Overall Study|Completed Study Follow-up|0|||
156629059|NCT04768881|565384946|FG001|Overall Study|Completed Study Follow-up|2|||
156629060|NCT04768881|565384945|FG000|Overall Study|Death|3|||
156629061|NCT04768881|565384946|FG001|Overall Study|Death|2|||
156629062|NCT04768881|565384945|FG000|Overall Study|Study Terminated by Sponsor|2|||
156629063|NCT04768881|565384946|FG001|Overall Study|Study Terminated by Sponsor|2|||
156629064|NCT04768881|565384945|FG000|Overall Study|Withdrawal by Subject|2|||
156629065|NCT04768881|565384946|FG001|Overall Study|Withdrawal by Subject|0|||
156629066|NCT04768881|565384945|FG000|Overall Study|Other|2|||
156629067|NCT04768881|565384946|FG001|Overall Study|Other|0|||
156629068|NCT04236986|565384949|FG000|Overall Study|Withdrawal by Subject|3|||
156629069|NCT04236986|565384950|FG001|Overall Study|Withdrawal by Subject|1|||
156629070|NCT00307736|565384955|FG000|Overall Study|Adverse Event|0|||
156629071|NCT00307736|565384956|FG001|Overall Study|Adverse Event|0|||
156629072|NCT00307736|565384957|FG002|Overall Study|Adverse Event|1|||
156629073|NCT00307736|565384958|FG003|Overall Study|Adverse Event|3|||
156629074|NCT00307736|565384955|FG000|Overall Study|Withdrawal by Subject|0|||
156629075|NCT00307736|565384956|FG001|Overall Study|Withdrawal by Subject|0|||
156629076|NCT00307736|565384957|FG002|Overall Study|Withdrawal by Subject|2|||
156629077|NCT00307736|565384958|FG003|Overall Study|Withdrawal by Subject|0|||
156629078|NCT01990339|565384961|FG000|Overall Study|Data Not Available|49|||
156629079|NCT01990339|565384961|FG000|Overall Study|Voluntary Withdrawal|1402|||
156629080|NCT01990339|565384961|FG000|Overall Study|Lost to Follow-up|861|||
156629081|NCT01728194|565384962|FG000|Overall Study|Lost to Follow-up|4|||
156629082|NCT01728194|565384963|FG001|Overall Study|Lost to Follow-up|3|||
156629083|NCT01728194|565384962|FG000|Overall Study|Physician Decision|4|||
156629084|NCT01728194|565384963|FG001|Overall Study|Physician Decision|0|||
156629085|NCT01728194|565384962|FG000|Overall Study|Withdrawal by Subject|7|||
156629086|NCT01728194|565384963|FG001|Overall Study|Withdrawal by Subject|3|||
156629087|NCT01728194|565384962|FG000|Overall Study|Perceived Medication Side Effects|4|||
156629088|NCT01728194|565384963|FG001|Overall Study|Perceived Medication Side Effects|0|||
156629089|NCT01728194|565384962|FG000|Overall Study|Family Member Request|1|||
156629090|NCT01728194|565384963|FG001|Overall Study|Family Member Request|0|||
156629091|NCT02309372|565384966|FG000|Overall Study|Lost to Follow-up|3|||
156629092|NCT02309372|565384967|FG001|Overall Study|Lost to Follow-up|2|||
156629093|NCT00242658|565384968|FG000|Overall Study|Lost to Follow-up|22|||
156629094|NCT00242658|565384969|FG001|Overall Study|Lost to Follow-up|19|||
156629095|NCT04604015|565384972|FG000|Overall Study|Incomplete Data Collection|33|||
156629096|NCT01302366|565386674|FG000|Overall Study|patient choice or noncompliance|5|||
156629097|NCT00198107|565386677|FG000|Double-Blind Period|Adverse Event|1|||
156629098|NCT00198107|565386678|FG001|Double-Blind Period|Adverse Event|1|||
156629099|NCT00198107|565386679|FG002|Double-Blind Period|Adverse Event|0|||
156629100|NCT00198107|565386677|FG000|Double-Blind Period|Lack of Efficacy|2|||
156629101|NCT00198107|565386678|FG001|Double-Blind Period|Lack of Efficacy|0|||
156629102|NCT00198107|565386679|FG002|Double-Blind Period|Lack of Efficacy|0|||
156629103|NCT00198107|565386677|FG000|Double-Blind Period|Lost to Follow-up|2|||
156629104|NCT00198107|565386678|FG001|Double-Blind Period|Lost to Follow-up|1|||
156629105|NCT00198107|565386679|FG002|Double-Blind Period|Lost to Follow-up|0|||
156629106|NCT00198107|565386677|FG000|Double-Blind Period|Physician Decision|1|||
156629107|NCT00198107|565386678|FG001|Double-Blind Period|Physician Decision|0|||
156629108|NCT00198107|565386679|FG002|Double-Blind Period|Physician Decision|0|||
156629109|NCT00198107|565386677|FG000|Double-Blind Period|Withdrawal by Subject|0|||
156629110|NCT00198107|565386678|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156629111|NCT00198107|565386679|FG002|Double-Blind Period|Withdrawal by Subject|0|||
156629112|NCT00198107|565386677|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
156629113|NCT00198107|565386678|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
156629114|NCT00198107|565386679|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
156629115|NCT02513732|565386680|FG000|Overall Study|Lost to Follow-up|11|||
156629116|NCT02513732|565386680|FG000|Overall Study|Death|9|||
156629117|NCT02513732|565386680|FG000|Overall Study|Changing hospital|2|||
156629118|NCT00467051|565386681|FG000|Overall Study|Adverse Event|2|||
156629119|NCT02147132|565386684|FG000|Overall Study|Lost to Follow-up|1|||
156629120|NCT02147132|565386685|FG001|Overall Study|Lost to Follow-up|0|||
156629121|NCT02147132|565386686|FG002|Overall Study|Lost to Follow-up|0|||
156629122|NCT02147132|565386687|FG003|Overall Study|Lost to Follow-up|0|||
156629123|NCT00278473|565386694|FG000|Overall Study|drop out|4|||
156629124|NCT00278473|565386695|FG001|Overall Study|drop out|3|||
156629125|NCT04001790|565386696|FG000|Overall Study|Withdrawal by Subject|1|||
156629126|NCT04001790|565386697|FG001|Overall Study|Withdrawal by Subject|2|||
156629127|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Adverse Event|4|||
156629128|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Adverse Event|3|||
156629129|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Adverse Event|0|||
156629130|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Adverse Event|0|||
156629131|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Death|24|||
156629132|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Death|9|||
156629133|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Death|0|||
156629134|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Death|0|||
156629135|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
156629136|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
156629137|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
156629138|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
156629139|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Physician Decision|4|||
156629140|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Physician Decision|1|||
156629141|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Physician Decision|0|||
156629142|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Physician Decision|0|||
156629143|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Progressive disease|1|||
156629144|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Progressive disease|0|||
156629145|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Progressive disease|0|||
156629146|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Progressive disease|0|||
156629147|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
156629148|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
156629149|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
156629150|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
156629151|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
156629152|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
156629153|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
156629154|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
156629155|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
156629156|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
156629157|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
156629158|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
156629159|NCT04579666|565386698|FG000|RTP (Up to Week 52)|Other|2|||
156629160|NCT04579666|565386699|FG001|RTP (Up to Week 52)|Other|0|||
156629161|NCT04579666|565386700|FG002|RTP (Up to Week 52)|Other|0|||
156629162|NCT04579666|565386701|FG003|RTP (Up to Week 52)|Other|0|||
156629163|NCT04579666|565386698|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
156629164|NCT04579666|565386699|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
156629165|NCT04579666|565386700|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
156629166|NCT04579666|565386701|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
156629167|NCT04579666|565386698|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
156629168|NCT04579666|565386699|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
156629169|NCT04579666|565386700|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
156629170|NCT04579666|565386701|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
156629171|NCT04579666|565386698|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
156629172|NCT04579666|565386699|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
156629173|NCT04579666|565386700|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
156629174|NCT04579666|565386701|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
156629175|NCT04579666|565386698|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
156629176|NCT04579666|565386699|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
156629177|NCT04579666|565386700|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
156629178|NCT04579666|565386701|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
156629179|NCT04579666|565386698|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
156629180|NCT04579666|565386699|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
156629181|NCT04579666|565386700|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
156629182|NCT04579666|565386701|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
156629183|NCT03290131|565386702|FG000|Overall Study|Adverse Event|22|||
156629184|NCT03290131|565386703|FG001|Overall Study|Adverse Event|57|||
156629185|NCT03290131|565386704|FG002|Overall Study|Adverse Event|11|||
156629186|NCT03290131|565386702|FG000|Overall Study|Withdrawal by Subject|18|||
156629187|NCT03290131|565386703|FG001|Overall Study|Withdrawal by Subject|13|||
156629188|NCT03290131|565386704|FG002|Overall Study|Withdrawal by Subject|8|||
156629189|NCT03290131|565386702|FG000|Overall Study|MS Relapse|2|||
156629190|NCT03290131|565386703|FG001|Overall Study|MS Relapse|1|||
156629191|NCT03290131|565386704|FG002|Overall Study|MS Relapse|0|||
156629192|NCT03290131|565386702|FG000|Overall Study|Unknown reason|0|||
156629193|NCT03290131|565386703|FG001|Overall Study|Unknown reason|1|||
156629194|NCT03290131|565386704|FG002|Overall Study|Unknown reason|0|||
156629195|NCT00361504|565386705|FG000|Overall Study|Withdrawal by Subject|94|||
156629196|NCT00361504|565386706|FG001|Overall Study|Withdrawal by Subject|31|||
156629197|NCT00361504|565386705|FG000|Overall Study|Lost to Follow-up|40|||
156629198|NCT00361504|565386706|FG001|Overall Study|Lost to Follow-up|7|||
156629199|NCT00361504|565386705|FG000|Overall Study|Adverse Event|203|||
156629200|NCT00361504|565386706|FG001|Overall Study|Adverse Event|82|||
156629201|NCT00361504|565386705|FG000|Overall Study|Lack of Efficacy|72|||
156629202|NCT00361504|565386706|FG001|Overall Study|Lack of Efficacy|7|||
156629203|NCT00361504|565386705|FG000|Overall Study|Resolution of Pain|2|||
156629204|NCT00361504|565386706|FG001|Overall Study|Resolution of Pain|0|||
156629205|NCT00361504|565386705|FG000|Overall Study|Study medication non compliant|42|||
156629206|NCT00361504|565386706|FG001|Overall Study|Study medication non compliant|15|||
156629207|NCT00361504|565386705|FG000|Overall Study|All other|28|||
156629208|NCT00361504|565386706|FG001|Overall Study|All other|3|||
156629209|NCT04246593|565386716|FG000|Overall Study|Withdrawal by Subject|14|||
156629210|NCT04246593|565386717|FG001|Overall Study|Withdrawal by Subject|13|||
156629211|NCT04246593|565386716|FG000|Overall Study|Lost to Follow-up|124|||
156629212|NCT04246593|565386717|FG001|Overall Study|Lost to Follow-up|71|||
156629213|NCT04246593|565386716|FG000|Overall Study|Moved out of area/became ineligible|3|||
156629214|NCT04246593|565386717|FG001|Overall Study|Moved out of area/became ineligible|1|||
156629215|NCT04246593|565386716|FG000|Overall Study|Reason unknown|4|||
156629216|NCT04246593|565386717|FG001|Overall Study|Reason unknown|2|||
156629217|NCT01694849|565386726|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
156629218|NCT01694849|565386727|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
156629219|NCT01694849|565386728|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
156629220|NCT01694849|565386726|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
156629221|NCT01694849|565386727|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
156629222|NCT01694849|565386728|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
156629223|NCT01694849|565386726|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
156629224|NCT01694849|565386727|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
156629225|NCT01694849|565386728|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
156629226|NCT01694849|565386726|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
156629227|NCT01694849|565386727|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
156629228|NCT01694849|565386728|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
156629229|NCT01694849|565386726|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
156629230|NCT01694849|565386727|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
156629231|NCT01694849|565386728|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
156629232|NCT01694849|565386726|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
156629233|NCT01694849|565386727|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
156629234|NCT01694849|565386728|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
156629235|NCT01694849|565386726|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
156629236|NCT01694849|565386727|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
156629237|NCT01694849|565386728|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
156629238|NCT01694849|565386726|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
156629239|NCT01694849|565386727|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
156629240|NCT01694849|565386728|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
156629241|NCT01012765|565386729|FG000|Treatment Period 1|Adverse Event|1|||
156629242|NCT01012765|565386730|FG001|Treatment Period 1|Adverse Event|0|||
156629243|NCT01012765|565386731|FG002|Treatment Period 1|Adverse Event|1|||
156629244|NCT01012765|565386732|FG003|Treatment Period 1|Adverse Event|0|||
156629245|NCT01012765|565386733|FG004|Treatment Period 1|Adverse Event|0|||
156629246|NCT01012765|565386734|FG005|Treatment Period 1|Adverse Event|0|||
156629247|NCT01012765|565386729|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156629248|NCT01012765|565386730|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156629249|NCT01012765|565386731|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156629250|NCT01012765|565386732|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156629251|NCT01012765|565386733|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156629252|NCT01012765|565386734|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156629253|NCT01012765|565386729|FG000|Treatment Period 1|Administrative problems|0|||
156629254|NCT01012765|565386730|FG001|Treatment Period 1|Administrative problems|0|||
156629255|NCT01012765|565386731|FG002|Treatment Period 1|Administrative problems|1|||
156629256|NCT01012765|565386732|FG003|Treatment Period 1|Administrative problems|1|||
156629257|NCT01012765|565386733|FG004|Treatment Period 1|Administrative problems|1|||
156629258|NCT01012765|565386734|FG005|Treatment Period 1|Administrative problems|0|||
156629259|NCT01012765|565386729|FG000|Treatment Period 1|Protocol Violation|0|||
156629260|NCT01012765|565386730|FG001|Treatment Period 1|Protocol Violation|0|||
156629261|NCT01012765|565386731|FG002|Treatment Period 1|Protocol Violation|0|||
156629262|NCT01012765|565386732|FG003|Treatment Period 1|Protocol Violation|2|||
156629263|NCT01012765|565386733|FG004|Treatment Period 1|Protocol Violation|1|||
156629264|NCT01012765|565386734|FG005|Treatment Period 1|Protocol Violation|0|||
156629265|NCT01012765|565386729|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
156629266|NCT01012765|565386730|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
156629267|NCT01012765|565386731|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
156629268|NCT01012765|565386732|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
156629269|NCT01012765|565386733|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
156629270|NCT01012765|565386734|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
156629271|NCT01012765|565386729|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156629272|NCT01012765|565386730|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156629273|NCT01012765|565386731|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156629274|NCT01012765|565386732|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156629275|NCT01012765|565386733|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156629276|NCT01012765|565386734|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156629277|NCT01012765|565386729|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
156629278|NCT01012765|565386730|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
156629279|NCT01012765|565386731|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
156629280|NCT01012765|565386732|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
156629281|NCT01012765|565386733|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
156629282|NCT01012765|565386734|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
156629283|NCT01012765|565386729|FG000|Treatment Period 2|Adverse Event|0|||
156629284|NCT01012765|565386730|FG001|Treatment Period 2|Adverse Event|1|||
156629285|NCT01012765|565386731|FG002|Treatment Period 2|Adverse Event|1|||
156629286|NCT01012765|565386732|FG003|Treatment Period 2|Adverse Event|0|||
156629287|NCT01012765|565386733|FG004|Treatment Period 2|Adverse Event|0|||
156629288|NCT01012765|565386734|FG005|Treatment Period 2|Adverse Event|0|||
156629289|NCT01012765|565386729|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
156629290|NCT01012765|565386730|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
156629291|NCT01012765|565386731|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
156629292|NCT01012765|565386732|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
156629293|NCT01012765|565386733|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
156629294|NCT01012765|565386734|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
156629295|NCT01326312|565386735|FG000|Overall Study|Adverse Event|11|||
156629296|NCT01326312|565386736|FG001|Overall Study|Adverse Event|11|||
156629297|NCT01326312|565386737|FG002|Overall Study|Adverse Event|1|||
156629298|NCT01326312|565386735|FG000|Overall Study|Withdrawal by Subject|1|||
156629299|NCT01326312|565386736|FG001|Overall Study|Withdrawal by Subject|2|||
156629300|NCT01326312|565386737|FG002|Overall Study|Withdrawal by Subject|1|||
156629301|NCT01326312|565386735|FG000|Overall Study|Protocol Violation|0|||
156629302|NCT01326312|565386736|FG001|Overall Study|Protocol Violation|1|||
156629303|NCT01326312|565386737|FG002|Overall Study|Protocol Violation|0|||
156629304|NCT01326312|565386735|FG000|Overall Study|Lack of Efficacy|13|||
156629305|NCT01326312|565386736|FG001|Overall Study|Lack of Efficacy|7|||
156629306|NCT01326312|565386737|FG002|Overall Study|Lack of Efficacy|1|||
156629307|NCT01326312|565386735|FG000|Overall Study|Death|1|||
156629308|NCT01326312|565386736|FG001|Overall Study|Death|0|||
156629309|NCT01326312|565386737|FG002|Overall Study|Death|1|||
156629310|NCT01326312|565386735|FG000|Overall Study|progressive disease|0|||
156629311|NCT01326312|565386736|FG001|Overall Study|progressive disease|1|||
156629312|NCT01326312|565386737|FG002|Overall Study|progressive disease|1|||
156629313|NCT01326312|565386735|FG000|Overall Study|Study terminated by Sponsor|8|||
156629314|NCT01326312|565386736|FG001|Overall Study|Study terminated by Sponsor|32|||
156629315|NCT01326312|565386737|FG002|Overall Study|Study terminated by Sponsor|46|||
156629316|NCT01326312|565386735|FG000|Overall Study|Treatment arm terminated|19|||
156629317|NCT01326312|565386736|FG001|Overall Study|Treatment arm terminated|0|||
156629318|NCT01326312|565386737|FG002|Overall Study|Treatment arm terminated|0|||
156629319|NCT01326312|565386735|FG000|Overall Study|QTc > 500|0|||
156629320|NCT01326312|565386736|FG001|Overall Study|QTc > 500|1|||
156629321|NCT01326312|565386737|FG002|Overall Study|QTc > 500|0|||
156629322|NCT00499694|565386746|FG000|Overall Study|Patient never received treatment.|1|||
156629323|NCT00570492|565386749|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
156629324|NCT00570492|565386750|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
156629325|NCT00570492|565386751|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
156629326|NCT00570492|565386749|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
156629327|NCT00570492|565386750|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
156629328|NCT00570492|565386751|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
156629329|NCT00570492|565386749|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
156629330|NCT00570492|565386750|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
156629331|NCT00570492|565386751|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
156629332|NCT00570492|565386749|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
156629333|NCT00570492|565386750|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
156629334|NCT00570492|565386751|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
156629335|NCT00570492|565386749|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
156629336|NCT00570492|565386750|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
156629337|NCT00570492|565386751|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
156629338|NCT00570492|565386749|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
156629339|NCT00570492|565386750|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
156629340|NCT00570492|565386751|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
156629341|NCT00570492|565386749|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
156629342|NCT00570492|565386750|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
156629343|NCT00570492|565386751|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
156629344|NCT00570492|565386749|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156629345|NCT00570492|565386750|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
156629346|NCT00570492|565386751|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
156629347|NCT00570492|565386749|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
156629348|NCT00570492|565386750|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
156629349|NCT00570492|565386751|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
156629350|NCT00570492|565386749|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
156629351|NCT00570492|565386750|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
156629352|NCT00570492|565386751|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
156629353|NCT00570492|565386749|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
156629354|NCT00570492|565386750|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
156629355|NCT00570492|565386751|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
156629356|NCT00570492|565386749|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
156629357|NCT00570492|565386750|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
156629358|NCT00570492|565386751|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
156629359|NCT00570492|565386749|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
156629360|NCT00570492|565386750|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
156629361|NCT00570492|565386751|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
156629362|NCT00570492|565386749|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
156629363|NCT00570492|565386750|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
156629364|NCT00570492|565386751|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
156629365|NCT00976989|565386752|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
156629366|NCT00976989|565386753|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
156629367|NCT00976989|565386754|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
156629368|NCT00976989|565386752|FG000|Overall Study|Death|5|||
156629369|NCT00976989|565386753|FG001|Overall Study|Death|7|||
156629370|NCT00976989|565386754|FG002|Overall Study|Death|10|||
156629371|NCT00976989|565386752|FG000|Overall Study|Refused Treatment|4|||
156629372|NCT00976989|565386753|FG001|Overall Study|Refused Treatment|3|||
156629373|NCT00976989|565386754|FG002|Overall Study|Refused Treatment|5|||
156629374|NCT00976989|565386752|FG000|Overall Study|Failure to Return|2|||
156629375|NCT00976989|565386753|FG001|Overall Study|Failure to Return|1|||
156629376|NCT00976989|565386754|FG002|Overall Study|Failure to Return|0|||
156629377|NCT00976989|565386752|FG000|Overall Study|Recurrence of Disease|0|||
156629378|NCT00976989|565386753|FG001|Overall Study|Recurrence of Disease|1|||
156629379|NCT00976989|565386754|FG002|Overall Study|Recurrence of Disease|0|||
156629380|NCT00976989|565386752|FG000|Overall Study|Other|1|||
156629381|NCT00976989|565386753|FG001|Overall Study|Other|0|||
156629382|NCT00976989|565386754|FG002|Overall Study|Other|1|||
156629383|NCT00752206|565386756|FG000|Overall Study|Disease progression|8|||
156629384|NCT00752206|565386757|FG001|Overall Study|Disease progression|11|||
156629385|NCT00752206|565386756|FG000|Overall Study|Pregnancy|1|||
156629386|NCT00752206|565386757|FG001|Overall Study|Pregnancy|0|||
156629387|NCT01484691|565386758|FG000|Overall Study|Withdrawal by Subject|1|||
156629388|NCT01484691|565386759|FG001|Overall Study|Withdrawal by Subject|1|||
156629389|NCT01484691|565386760|FG002|Overall Study|Withdrawal by Subject|1|||
156629390|NCT01484691|565386758|FG000|Overall Study|Physician Decision|0|||
156629391|NCT01484691|565386759|FG001|Overall Study|Physician Decision|2|||
156629392|NCT01484691|565386760|FG002|Overall Study|Physician Decision|1|||
156629393|NCT05437211|565386765|FG000|Overall Study|Patient's decision|1|||
156629394|NCT05437211|565386766|FG001|Overall Study|Patient's decision|1|||
156629395|NCT01463631|565386770|FG000|Overall Study|Withdrawal by Subject|0|||
156629396|NCT01463631|565386771|FG001|Overall Study|Withdrawal by Subject|0|||
156629397|NCT01463631|565386772|FG002|Overall Study|Withdrawal by Subject|0|||
156629398|NCT01463631|565386773|FG003|Overall Study|Withdrawal by Subject|1|||
156629399|NCT01463631|565386770|FG000|Overall Study|Death|0|||
156629400|NCT01463631|565386771|FG001|Overall Study|Death|0|||
156629401|NCT01463631|565386772|FG002|Overall Study|Death|1|||
156629402|NCT01463631|565386773|FG003|Overall Study|Death|0|||
156629403|NCT01463631|565386770|FG000|Overall Study|Progressive Disease|0|||
156629404|NCT01463631|565386771|FG001|Overall Study|Progressive Disease|0|||
156629405|NCT01463631|565386772|FG002|Overall Study|Progressive Disease|0|||
156629406|NCT01463631|565386773|FG003|Overall Study|Progressive Disease|5|||
156629407|NCT02576652|565386776|FG000|Overall Study|Withdrawal by Subject|2|||
156629408|NCT02811640|565386777|FG000|Overall Study|Technology malfunction|2|||
156629409|NCT00553319|565386788|FG000|Overall Study|Lost to Follow-up|10|||
156629410|NCT00553319|565386789|FG001|Overall Study|Lost to Follow-up|9|||
156629411|NCT00553319|565386790|FG002|Overall Study|Lost to Follow-up|5|||
156629412|NCT00553319|565386788|FG000|Overall Study|wanted treatment elsewhere|2|||
156629413|NCT00553319|565386789|FG001|Overall Study|wanted treatment elsewhere|1|||
156629414|NCT00553319|565386790|FG002|Overall Study|wanted treatment elsewhere|1|||
156629415|NCT00553319|565386788|FG000|Overall Study|non-compliance|0|||
156629416|NCT00553319|565386789|FG001|Overall Study|non-compliance|0|||
156629417|NCT00553319|565386790|FG002|Overall Study|non-compliance|2|||
156629418|NCT00553319|565386788|FG000|Overall Study|incarceration|1|||
156629419|NCT00553319|565386789|FG001|Overall Study|incarceration|0|||
156629420|NCT00553319|565386790|FG002|Overall Study|incarceration|0|||
156629421|NCT00553319|565386788|FG000|Overall Study|moved|1|||
156629422|NCT00553319|565386789|FG001|Overall Study|moved|0|||
156629423|NCT00553319|565386790|FG002|Overall Study|moved|1|||
156629424|NCT04369742|565386796|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
156629425|NCT04369742|565386797|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
156629426|NCT04369742|565386796|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
156629427|NCT04369742|565386797|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
156629428|NCT03575975|565386798|FG000|Overall Study|Lost to Follow-up|1|||
156629429|NCT03575975|565386799|FG001|Overall Study|Lost to Follow-up|0|||
156629430|NCT03575975|565386800|FG002|Overall Study|Lost to Follow-up|0|||
156629431|NCT00465894|565386801|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
156629432|NCT00465894|565386802|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
156629433|NCT00465894|565386801|FG000|Treatment For 12 Weeks|Family Issues|1|||
156629434|NCT00465894|565386802|FG001|Treatment For 12 Weeks|Family Issues|1|||
156629435|NCT00465894|565386801|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
156629436|NCT00465894|565386802|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
156629437|NCT00129220|565386803|FG000|Study Period II|Adverse Event|9|||
156629438|NCT00129220|565386804|FG001|Study Period II|Adverse Event|5|||
156629439|NCT00129220|565386805|FG002|Study Period II|Adverse Event|7|||
156629440|NCT00129220|565386803|FG000|Study Period II|Lack of Efficacy|15|||
156629441|NCT00129220|565386804|FG001|Study Period II|Lack of Efficacy|1|||
156629442|NCT00129220|565386805|FG002|Study Period II|Lack of Efficacy|28|||
156629443|NCT00129220|565386803|FG000|Study Period II|Entry Criteria Not Met|2|||
156629444|NCT00129220|565386804|FG001|Study Period II|Entry Criteria Not Met|0|||
156629445|NCT00129220|565386805|FG002|Study Period II|Entry Criteria Not Met|2|||
156629446|NCT00129220|565386803|FG000|Study Period II|Protocol Violation|4|||
156629447|NCT00129220|565386804|FG001|Study Period II|Protocol Violation|2|||
156629448|NCT00129220|565386805|FG002|Study Period II|Protocol Violation|1|||
156629449|NCT00129220|565386803|FG000|Study Period II|Physician Decision|0|||
156629450|NCT00129220|565386804|FG001|Study Period II|Physician Decision|1|||
156629451|NCT00129220|565386805|FG002|Study Period II|Physician Decision|0|||
156629452|NCT00129220|565386803|FG000|Study Period II|Withdrawal by Subject|1|||
156629453|NCT00129220|565386804|FG001|Study Period II|Withdrawal by Subject|3|||
156629454|NCT00129220|565386805|FG002|Study Period II|Withdrawal by Subject|4|||
156629455|NCT00129220|565386803|FG000|Study Period II|Reason Not Specified|2|||
156629456|NCT00129220|565386804|FG001|Study Period II|Reason Not Specified|0|||
156629457|NCT00129220|565386805|FG002|Study Period II|Reason Not Specified|5|||
156629458|NCT00129220|565386803|FG000|Study Period III|Adverse Event|1|||
156629459|NCT00129220|565386804|FG001|Study Period III|Adverse Event|0|||
156629460|NCT00129220|565386805|FG002|Study Period III|Adverse Event|3|||
156629461|NCT00129220|565386803|FG000|Study Period III|Protocol Violation|1|||
156629462|NCT00129220|565386804|FG001|Study Period III|Protocol Violation|1|||
156629463|NCT00129220|565386805|FG002|Study Period III|Protocol Violation|2|||
156629464|NCT00129220|565386803|FG000|Study Period III|Withdrawal by Subject|1|||
156629465|NCT00129220|565386804|FG001|Study Period III|Withdrawal by Subject|0|||
156629466|NCT00129220|565386805|FG002|Study Period III|Withdrawal by Subject|3|||
156629467|NCT00129220|565386803|FG000|Study Period III|Sponsor Decision|1|||
156629468|NCT00129220|565386804|FG001|Study Period III|Sponsor Decision|0|||
156629469|NCT00129220|565386805|FG002|Study Period III|Sponsor Decision|0|||
156629470|NCT00129220|565386803|FG000|Study Period III|Reason Not Specified|9|||
156629471|NCT00129220|565386804|FG001|Study Period III|Reason Not Specified|0|||
156629472|NCT00129220|565386805|FG002|Study Period III|Reason Not Specified|2|||
156629473|NCT00540228|565386807|FG000|Overall Study|Adverse Event|2|||
156629474|NCT00540228|565386808|FG001|Overall Study|Adverse Event|0|||
156629475|NCT00540228|565386809|FG002|Overall Study|Adverse Event|0|||
156629476|NCT00540228|565386810|FG003|Overall Study|Adverse Event|0|||
156629477|NCT00540228|565386811|FG004|Overall Study|Adverse Event|0|||
156629478|NCT00540228|565386807|FG000|Overall Study|Lost to Follow-up|1|||
156629479|NCT00540228|565386808|FG001|Overall Study|Lost to Follow-up|1|||
156629480|NCT00540228|565386809|FG002|Overall Study|Lost to Follow-up|0|||
156629481|NCT00540228|565386810|FG003|Overall Study|Lost to Follow-up|0|||
156629482|NCT00540228|565386811|FG004|Overall Study|Lost to Follow-up|0|||
156629483|NCT01883362|565386812|FG000|Treatment|Adverse Event|1|||
156629484|NCT01883362|565386813|FG001|Treatment|Adverse Event|8|||
156629485|NCT01883362|565386812|FG000|Treatment|Withdrawal by Subject|6|||
156629486|NCT01883362|565386813|FG001|Treatment|Withdrawal by Subject|2|||
156629487|NCT01883362|565386812|FG000|Treatment|Administrative problems|4|||
156629488|NCT01883362|565386813|FG001|Treatment|Administrative problems|1|||
156629489|NCT01883362|565386812|FG000|Treatment|Relapse|4|||
156629490|NCT01883362|565386813|FG001|Treatment|Relapse|2|||
156629491|NCT01883362|565386812|FG000|Treatment|Randomized, not treated|1|||
156629492|NCT01883362|565386813|FG001|Treatment|Randomized, not treated|1|||
156629493|NCT01883362|565386812|FG000|Post Treatment Follow-up|Protocol Violation|0|||
156629494|NCT01883362|565386813|FG001|Post Treatment Follow-up|Protocol Violation|1|||
156629495|NCT01883362|565386812|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
156629496|NCT01883362|565386813|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
156629497|NCT01883362|565386812|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
156629498|NCT01883362|565386813|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
156629499|NCT01883362|565386812|FG000|Post Treatment Follow-up|Administrative problems|2|||
156629500|NCT01883362|565386813|FG001|Post Treatment Follow-up|Administrative problems|0|||
156629501|NCT01883362|565386812|FG000|Post Treatment Follow-up|Death|8|||
156629502|NCT01883362|565386813|FG001|Post Treatment Follow-up|Death|4|||
156629503|NCT01883362|565386812|FG000|Post Treatment Follow-up|Relapse|1|||
156629504|NCT01883362|565386813|FG001|Post Treatment Follow-up|Relapse|2|||
156629505|NCT01383317|565386814|FG000|Overall Study|Lost to Follow-up|2|||
156629506|NCT01383317|565386815|FG001|Overall Study|Lost to Follow-up|1|||
156629507|NCT01383317|565386814|FG000|Overall Study|Death|1|||
156629508|NCT01383317|565386815|FG001|Overall Study|Death|0|||
156629509|NCT01383317|565386814|FG000|Overall Study|Adverse Event|0|||
156629510|NCT01383317|565386815|FG001|Overall Study|Adverse Event|1|||
156629511|NCT01349816|565386818|FG000|Overall Study|Withdrawal by Subject|4|||
156629512|NCT01349816|565386818|FG000|Overall Study|Physician Decision|1|||
156629513|NCT01349816|565386818|FG000|Overall Study|Adverse Event|14|||
156629514|NCT01349816|565386818|FG000|Overall Study|Lost to Follow-up|2|||
156629515|NCT01349816|565386818|FG000|Overall Study|Protocol Violation|1|||
156629516|NCT01349816|565386818|FG000|Overall Study|Protocol-specified criteria|8|||
156629517|NCT02569996|565386819|FG000|Overall Study|Adverse Event|6|||
156629518|NCT02569996|565386819|FG000|Overall Study|Physician Decision|3|||
156629519|NCT02569996|565386819|FG000|Overall Study|Progression of the disease|18|||
156629520|NCT02569996|565386819|FG000|Overall Study|New anti-lymphoma treatment|1|||
156629521|NCT02569996|565386819|FG000|Overall Study|Non-compliance|9|||
156629522|NCT02569996|565386819|FG000|Overall Study|Withdrawal by Subject|5|||
156629523|NCT02569996|565386819|FG000|Overall Study|Lost to Follow-up|5|||
156629524|NCT02569996|565386819|FG000|Overall Study|Complete remission|7|||
156629525|NCT02569996|565386819|FG000|Overall Study|Unknown reason|1|||
156629526|NCT01207427|565386821|FG000|Double-blind Treatment Period|Adverse Event|0|||
156629527|NCT01207427|565386822|FG001|Double-blind Treatment Period|Adverse Event|1|||
156629528|NCT01207427|565386823|FG002|Double-blind Treatment Period|Adverse Event|0|||
156629529|NCT01207427|565386821|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156629530|NCT01207427|565386822|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
156629531|NCT01207427|565386823|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
156629532|NCT01207427|565386821|FG000|Double-blind Treatment Period|Protocol Violation|2|||
156629533|NCT01207427|565386822|FG001|Double-blind Treatment Period|Protocol Violation|1|||
156629534|NCT01207427|565386823|FG002|Double-blind Treatment Period|Protocol Violation|1|||
156629535|NCT01207427|565386821|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
156629536|NCT01207427|565386822|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
156629537|NCT01207427|565386823|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156629538|NCT01230489|565386824|FG000|Overall Study|Death|2|||
156629539|NCT01230489|565386824|FG000|Overall Study|Adverse Event|2|||
156629540|NCT01230489|565386824|FG000|Overall Study|Treatment modality changed|1|||
156629541|NCT02451137|565386825|FG000|Overall Study|Randomized but not treated|19|||
156629542|NCT02451137|565386826|FG001|Overall Study|Randomized but not treated|27|||
156629543|NCT02451137|565386825|FG000|Overall Study|Adverse Event|43|||
156629544|NCT02451137|565386826|FG001|Overall Study|Adverse Event|42|||
156629545|NCT02451137|565386825|FG000|Overall Study|Lack of Efficacy|4|||
156629546|NCT02451137|565386826|FG001|Overall Study|Lack of Efficacy|9|||
156629547|NCT02451137|565386825|FG000|Overall Study|Participant decision:discontinue insulin|41|||
156629548|NCT02451137|565386826|FG001|Overall Study|Participant decision:discontinue insulin|43|||
156629549|NCT02451137|565386825|FG000|Overall Study|Hypoglycemia|2|||
156629550|NCT02451137|565386826|FG001|Overall Study|Hypoglycemia|1|||
156629551|NCT02451137|565386825|FG000|Overall Study|Investigator's decision|23|||
156629552|NCT02451137|565386826|FG001|Overall Study|Investigator's decision|19|||
156629553|NCT02451137|565386825|FG000|Overall Study|Lost to Follow-up|53|||
156629554|NCT02451137|565386826|FG001|Overall Study|Lost to Follow-up|61|||
156629555|NCT02451137|565386825|FG000|Overall Study|Physician Decision|6|||
156629556|NCT02451137|565386826|FG001|Overall Study|Physician Decision|5|||
156629557|NCT02451137|565386825|FG000|Overall Study|Sponsor decision|13|||
156629558|NCT02451137|565386826|FG001|Overall Study|Sponsor decision|25|||
156629559|NCT02451137|565386825|FG000|Overall Study|Withdrawal by Subject|40|||
156629560|NCT02451137|565386826|FG001|Overall Study|Withdrawal by Subject|63|||
156629561|NCT02451137|565386825|FG000|Overall Study|Other than specified above|2|||
156629562|NCT02451137|565386826|FG001|Overall Study|Other than specified above|3|||
156629563|NCT02842736|565389210|FG000|Overall Study|Lost to Follow-up|13|||
156629564|NCT02842736|565389210|FG000|Overall Study|Intervention for menstrual bleeding|17|||
156629565|NCT02842736|565389210|FG000|Overall Study|Withdrawal by Subject|4|||
156629566|NCT02842736|565389210|FG000|Overall Study|Pregnancy|3|||
156629567|NCT02842736|565389210|FG000|Overall Study|Hysterectomy for fibroids|2|||
156629568|NCT02842736|565389210|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
156629569|NCT02842736|565389210|FG000|Overall Study|IUD: Mirena|1|||
156629570|NCT03323034|565389214|FG000|Overall Study|Lack of Efficacy|5|||
156629571|NCT03323034|565389215|FG001|Overall Study|Lack of Efficacy|5|||
156629572|NCT03323034|565389216|FG002|Overall Study|Lack of Efficacy|6|||
156629573|NCT03323034|565389217|FG003|Overall Study|Lack of Efficacy|5|||
156629574|NCT03323034|565389218|FG004|Overall Study|Lack of Efficacy|5|||
156629575|NCT03323034|565389214|FG000|Overall Study|Physician Decision|0|||
156629576|NCT03323034|565389215|FG001|Overall Study|Physician Decision|0|||
156629577|NCT03323034|565389216|FG002|Overall Study|Physician Decision|0|||
156629578|NCT03323034|565389217|FG003|Overall Study|Physician Decision|0|||
156629579|NCT03323034|565389218|FG004|Overall Study|Physician Decision|1|||
156629580|NCT03323034|565389214|FG000|Overall Study|Withdrawal by Subject|1|||
156629581|NCT03323034|565389215|FG001|Overall Study|Withdrawal by Subject|1|||
156629582|NCT03323034|565389216|FG002|Overall Study|Withdrawal by Subject|0|||
156629583|NCT03323034|565389217|FG003|Overall Study|Withdrawal by Subject|1|||
156629584|NCT03323034|565389218|FG004|Overall Study|Withdrawal by Subject|0|||
156629585|NCT02646566|565389220|FG000|Overall Study|Lost to Follow-up|5|||
156629586|NCT02646566|565389221|FG001|Overall Study|Lost to Follow-up|4|||
156629587|NCT02646566|565389222|FG002|Overall Study|Lost to Follow-up|5|||
156629588|NCT02646566|565389220|FG000|Overall Study|Treatment failure|1|||
156629589|NCT02646566|565389221|FG001|Overall Study|Treatment failure|0|||
156629590|NCT02646566|565389222|FG002|Overall Study|Treatment failure|0|||
156629591|NCT04887922|565389232|FG000|1st Randomization|Decided not to have surgery|0|||
156629592|NCT04887922|565389233|FG001|1st Randomization|Decided not to have surgery|1|||
156629593|NCT04887922|565389234|FG002|1st Randomization|Decided not to have surgery|0|||
156629594|NCT04887922|565389235|FG003|1st Randomization|Decided not to have surgery|0|||
156629595|NCT04887922|565389236|FG004|1st Randomization|Decided not to have surgery|0|||
156629596|NCT00953017|565389237|FG000|Overall Study|DId not show up for colonoscopy|4|||
156629597|NCT00953017|565389238|FG001|Overall Study|DId not show up for colonoscopy|4|||
156629598|NCT00953017|565389239|FG002|Overall Study|DId not show up for colonoscopy|5|||
156629599|NCT00953017|565389240|FG003|Overall Study|DId not show up for colonoscopy|4|||
156629600|NCT00953017|565389237|FG000|Overall Study|Incomplete data|1|||
156629601|NCT00953017|565389238|FG001|Overall Study|Incomplete data|1|||
156629602|NCT00953017|565389239|FG002|Overall Study|Incomplete data|0|||
156629603|NCT00953017|565389240|FG003|Overall Study|Incomplete data|0|||
156629604|NCT00953017|565389237|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
156629605|NCT00953017|565389238|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
156629606|NCT00953017|565389239|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
156629607|NCT00953017|565389240|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
156629608|NCT00953017|565389237|FG000|Overall Study|Brown stool prior to procedure|0|||
156629609|NCT00953017|565389238|FG001|Overall Study|Brown stool prior to procedure|0|||
156629610|NCT00953017|565389239|FG002|Overall Study|Brown stool prior to procedure|1|||
156629611|NCT00953017|565389240|FG003|Overall Study|Brown stool prior to procedure|0|||
156629612|NCT01300741|565389242|FG000|Overall Study|Lens deposits|1|||
156629613|NCT01300741|565389242|FG000|Overall Study|Lost to Follow-up|1|||
156629614|NCT01300741|565389242|FG000|Overall Study|Discomfort|1|||
156629615|NCT04854421|565389243|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
156629616|NCT04854421|565389244|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
156629617|NCT00718809|565389246|FG000|Overall Study|Disease progression|9|||
156629618|NCT00718809|565389247|FG001|Overall Study|Disease progression|7|||
156629619|NCT00718809|565389246|FG000|Overall Study|Adverse Event|1|||
156629620|NCT00718809|565389247|FG001|Overall Study|Adverse Event|1|||
156629621|NCT00718809|565389246|FG000|Overall Study|Withdrawal by Subject|0|||
156629622|NCT00718809|565389247|FG001|Overall Study|Withdrawal by Subject|1|||
156629623|NCT00718809|565389246|FG000|Overall Study|Lost to Follow-up|1|||
156629624|NCT00718809|565389247|FG001|Overall Study|Lost to Follow-up|0|||
156629625|NCT00718809|565389246|FG000|Overall Study|Noncompliance|1|||
156629626|NCT00718809|565389247|FG001|Overall Study|Noncompliance|0|||
156629627|NCT00463385|565389248|FG000|Overall Study|Other|4|||
156629628|NCT00463385|565389249|FG001|Overall Study|Other|3|||
156629629|NCT00463385|565389250|FG002|Overall Study|Other|6|||
156629630|NCT00463385|565389251|FG003|Overall Study|Other|4|||
156629631|NCT00463385|565389248|FG000|Overall Study|Adverse Event|5|||
156629632|NCT00463385|565389249|FG001|Overall Study|Adverse Event|8|||
156629633|NCT00463385|565389250|FG002|Overall Study|Adverse Event|4|||
156629634|NCT00463385|565389251|FG003|Overall Study|Adverse Event|2|||
156629635|NCT00463385|565389248|FG000|Overall Study|Lack of Efficacy|6|||
156629636|NCT00463385|565389249|FG001|Overall Study|Lack of Efficacy|6|||
156629637|NCT00463385|565389250|FG002|Overall Study|Lack of Efficacy|7|||
156629638|NCT00463385|565389251|FG003|Overall Study|Lack of Efficacy|9|||
156629639|NCT00463385|565389248|FG000|Overall Study|Withdrawal by Subject|3|||
156629640|NCT00463385|565389249|FG001|Overall Study|Withdrawal by Subject|3|||
156629641|NCT00463385|565389250|FG002|Overall Study|Withdrawal by Subject|3|||
156629642|NCT00463385|565389251|FG003|Overall Study|Withdrawal by Subject|4|||
156629643|NCT00463385|565389248|FG000|Overall Study|Lost to Follow-up|0|||
156629644|NCT00463385|565389249|FG001|Overall Study|Lost to Follow-up|0|||
156629645|NCT00463385|565389250|FG002|Overall Study|Lost to Follow-up|0|||
156629646|NCT00463385|565389251|FG003|Overall Study|Lost to Follow-up|1|||
156629647|NCT00463385|565389248|FG000|Overall Study|Death|2|||
156629648|NCT00463385|565389249|FG001|Overall Study|Death|1|||
156629649|NCT00463385|565389250|FG002|Overall Study|Death|2|||
156629650|NCT00463385|565389251|FG003|Overall Study|Death|0|||
156629651|NCT00463385|565389248|FG000|Overall Study|Missing|2|||
156629652|NCT00463385|565389249|FG001|Overall Study|Missing|0|||
156629653|NCT00463385|565389250|FG002|Overall Study|Missing|0|||
156629654|NCT00463385|565389251|FG003|Overall Study|Missing|2|||
156629655|NCT00463385|565389248|FG000|Overall Study|1 participant received commercial drug|0|||
156629656|NCT00463385|565389249|FG001|Overall Study|1 participant received commercial drug|1|||
156629657|NCT00463385|565389250|FG002|Overall Study|1 participant received commercial drug|0|||
156629658|NCT00463385|565389251|FG003|Overall Study|1 participant received commercial drug|0|||
156629659|NCT00798161|565389252|FG000|Overall Study|Adverse Event|3|||
156629660|NCT00798161|565389253|FG001|Overall Study|Adverse Event|4|||
156629661|NCT00798161|565389254|FG002|Overall Study|Adverse Event|6|||
156629662|NCT00798161|565389255|FG003|Overall Study|Adverse Event|6|||
156629663|NCT00798161|565389256|FG004|Overall Study|Adverse Event|5|||
156629664|NCT00798161|565389257|FG005|Overall Study|Adverse Event|2|||
156629665|NCT00798161|565389258|FG006|Overall Study|Adverse Event|4|||
156629666|NCT00798161|565389252|FG000|Overall Study|Protocol Violation|2|||
156629667|NCT00798161|565389253|FG001|Overall Study|Protocol Violation|1|||
156629668|NCT00798161|565389254|FG002|Overall Study|Protocol Violation|3|||
156629669|NCT00798161|565389255|FG003|Overall Study|Protocol Violation|3|||
156629670|NCT00798161|565389256|FG004|Overall Study|Protocol Violation|3|||
156629671|NCT00798161|565389257|FG005|Overall Study|Protocol Violation|2|||
156629672|NCT00798161|565389258|FG006|Overall Study|Protocol Violation|0|||
156629673|NCT00798161|565389252|FG000|Overall Study|Lost to Follow-up|1|||
156629674|NCT00798161|565389253|FG001|Overall Study|Lost to Follow-up|3|||
156629675|NCT00798161|565389254|FG002|Overall Study|Lost to Follow-up|4|||
156629676|NCT00798161|565389255|FG003|Overall Study|Lost to Follow-up|3|||
156629677|NCT00798161|565389256|FG004|Overall Study|Lost to Follow-up|4|||
156629678|NCT00798161|565389257|FG005|Overall Study|Lost to Follow-up|0|||
156629679|NCT00798161|565389258|FG006|Overall Study|Lost to Follow-up|0|||
156629680|NCT00798161|565389252|FG000|Overall Study|Withdrawal by Subject|5|||
156629681|NCT00798161|565389253|FG001|Overall Study|Withdrawal by Subject|4|||
156629682|NCT00798161|565389254|FG002|Overall Study|Withdrawal by Subject|5|||
156629683|NCT00798161|565389255|FG003|Overall Study|Withdrawal by Subject|4|||
156629684|NCT00798161|565389256|FG004|Overall Study|Withdrawal by Subject|2|||
156629685|NCT00798161|565389257|FG005|Overall Study|Withdrawal by Subject|3|||
156629686|NCT00798161|565389258|FG006|Overall Study|Withdrawal by Subject|1|||
156629687|NCT00798161|565389252|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
156629688|NCT00798161|565389253|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
156629689|NCT00798161|565389254|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
156629690|NCT00798161|565389255|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
156629691|NCT00798161|565389256|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
156629692|NCT00798161|565389257|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
156629693|NCT00798161|565389258|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
156629694|NCT00344968|565389259|FG000|Overall Study|Adverse Event|5|||
156629695|NCT00344968|565389260|FG001|Overall Study|Adverse Event|4|||
156629696|NCT00344968|565389261|FG002|Overall Study|Adverse Event|15|||
156629697|NCT00344968|565389259|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156629698|NCT00344968|565389260|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156629699|NCT00344968|565389261|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
156629700|NCT00344968|565389259|FG000|Overall Study|Protocol Violation|2|||
156629701|NCT00344968|565389260|FG001|Overall Study|Protocol Violation|2|||
156629702|NCT00344968|565389261|FG002|Overall Study|Protocol Violation|5|||
156629703|NCT00344968|565389259|FG000|Overall Study|Withdrawal by Subject|14|||
156629704|NCT00344968|565389260|FG001|Overall Study|Withdrawal by Subject|31|||
156629705|NCT00344968|565389261|FG002|Overall Study|Withdrawal by Subject|27|||
156629706|NCT00344968|565389259|FG000|Overall Study|Lost to Follow-up|24|||
156629707|NCT00344968|565389260|FG001|Overall Study|Lost to Follow-up|37|||
156629708|NCT00344968|565389261|FG002|Overall Study|Lost to Follow-up|37|||
156629709|NCT00344968|565389259|FG000|Overall Study|Death|11|||
156629710|NCT00344968|565389260|FG001|Overall Study|Death|27|||
156629711|NCT00344968|565389261|FG002|Overall Study|Death|31|||
156629712|NCT00344968|565389259|FG000|Overall Study|Other|0|||
156629713|NCT00344968|565389260|FG001|Overall Study|Other|1|||
156629714|NCT00344968|565389261|FG002|Overall Study|Other|0|||
156629715|NCT00503035|565389265|FG000|Overall Study|Lost to Follow-up|2|||
156629716|NCT00503035|565389265|FG000|Overall Study|Physician Decision|3|||
156629717|NCT00503035|565389265|FG000|Overall Study|Ineligible|15|||
156629718|NCT01982942|565389271|FG000|Overall Study|Adverse Event|10|||
156629719|NCT01982942|565389272|FG001|Overall Study|Adverse Event|5|||
156629720|NCT01982942|565389271|FG000|Overall Study|Lost to Follow-up|4|||
156629721|NCT01982942|565389272|FG001|Overall Study|Lost to Follow-up|3|||
156629722|NCT01982942|565389271|FG000|Overall Study|Multiple sclerosis progression|3|||
156629723|NCT01982942|565389272|FG001|Overall Study|Multiple sclerosis progression|2|||
156629724|NCT01982942|565389271|FG000|Overall Study|Wanted to try therapy not permitted|1|||
156629725|NCT01982942|565389272|FG001|Overall Study|Wanted to try therapy not permitted|0|||
156629726|NCT01982942|565389271|FG000|Overall Study|Subject declined future visits|0|||
156629727|NCT01982942|565389272|FG001|Overall Study|Subject declined future visits|1|||
156629728|NCT01982942|565389271|FG000|Overall Study|Left geographical area|2|||
156629729|NCT01982942|565389272|FG001|Overall Study|Left geographical area|0|||
156629730|NCT01982942|565389271|FG000|Overall Study|Too many pills|1|||
156629731|NCT01982942|565389272|FG001|Overall Study|Too many pills|0|||
156629732|NCT01982942|565389271|FG000|Overall Study|MS Relapse|0|||
156629733|NCT01982942|565389272|FG001|Overall Study|MS Relapse|1|||
156629734|NCT01982942|565389271|FG000|Overall Study|Chose to join a stem cell trial|0|||
156629735|NCT01982942|565389272|FG001|Overall Study|Chose to join a stem cell trial|1|||
156629736|NCT01982942|565389271|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
156629737|NCT01982942|565389272|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
156629738|NCT04576702|565389273|FG000|Overall Study|Death|1|||
156629739|NCT04576702|565389274|FG001|Overall Study|Death|0|||
156629740|NCT04576702|565389275|FG002|Overall Study|Death|0|||
156629741|NCT04576702|565389276|FG003|Overall Study|Death|0|||
156629742|NCT04576702|565389273|FG000|Overall Study|Withdrawal by Subject|0|||
156629743|NCT04576702|565389274|FG001|Overall Study|Withdrawal by Subject|2|||
156629744|NCT04576702|565389275|FG002|Overall Study|Withdrawal by Subject|1|||
156629745|NCT04576702|565389276|FG003|Overall Study|Withdrawal by Subject|0|||
156629746|NCT04576702|565389273|FG000|Overall Study|Lost to Follow-up|3|||
156629747|NCT04576702|565389274|FG001|Overall Study|Lost to Follow-up|3|||
156629748|NCT04576702|565389275|FG002|Overall Study|Lost to Follow-up|3|||
156629749|NCT04576702|565389276|FG003|Overall Study|Lost to Follow-up|4|||
156629750|NCT01151085|565389279|FG000|Overall Study|Lost to Follow-up|31|||
156629751|NCT01151085|565389279|FG000|Overall Study|Protocol Violation|25|||
156629752|NCT02059265|565389280|FG000|Overall Study|Ineligible|4|||
156629753|NCT00465101|565389281|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
156629754|NCT00465101|565389281|FG000|Overall Study|Change in health precluded follow up|4|||
156629755|NCT00465101|565389281|FG000|Overall Study|Did not meet study criteria|4|||
156629756|NCT00465101|565389281|FG000|Overall Study|Lost to Follow-up|5|||
156629757|NCT00465101|565389281|FG000|Overall Study|Other|6|||
156629758|NCT00465101|565389281|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
156629759|NCT00465101|565389281|FG000|Overall Study|Patient postponed procedure|1|||
156629760|NCT00465101|565389281|FG000|Overall Study|Site closed due to IRB expiration|1|||
156629761|NCT00465101|565389281|FG000|Overall Study|Unable to obtain IRB approval|1|||
156629762|NCT00465101|565389281|FG000|Overall Study|Death|3|||
156629763|NCT00465101|565389281|FG000|Overall Study|Withdrawal by Subject|25|||
156629764|NCT00465101|565389281|FG000|Overall Study|Physician Decision|1|||
156629765|NCT00465101|565389281|FG000|Overall Study|Withdrew consent prior to procedure|3|||
156629766|NCT02985996|565389287|FG000|Overall Study|Withdrawal by Subject|0|||
156629767|NCT02985996|565389288|FG001|Overall Study|Withdrawal by Subject|0|||
156629768|NCT02985996|565389289|FG002|Overall Study|Withdrawal by Subject|1|||
156629769|NCT02985996|565389290|FG003|Overall Study|Withdrawal by Subject|0|||
156629770|NCT02985996|565389291|FG004|Overall Study|Withdrawal by Subject|0|||
156629771|NCT02985996|565389287|FG000|Overall Study|Protocol Violation|0|||
156629772|NCT02985996|565389288|FG001|Overall Study|Protocol Violation|1|||
156629773|NCT02985996|565389289|FG002|Overall Study|Protocol Violation|0|||
156629774|NCT02985996|565389290|FG003|Overall Study|Protocol Violation|0|||
156629775|NCT02985996|565389291|FG004|Overall Study|Protocol Violation|0|||
156629776|NCT00401726|565389292|FG000|Overall Study|Adverse Event|34|||
156629777|NCT00401726|565389293|FG001|Overall Study|Adverse Event|45|||
156629778|NCT00401726|565389292|FG000|Overall Study|Death|0|||
156629779|NCT00401726|565389293|FG001|Overall Study|Death|3|||
156629780|NCT00401726|565389292|FG000|Overall Study|Sponsor Request|0|||
156629781|NCT00401726|565389293|FG001|Overall Study|Sponsor Request|1|||
156629782|NCT00401726|565389292|FG000|Overall Study|Physician Decision|3|||
156629783|NCT00401726|565389293|FG001|Overall Study|Physician Decision|6|||
156629784|NCT00401726|565389292|FG000|Overall Study|Lost to Follow-up|23|||
156629785|NCT00401726|565389293|FG001|Overall Study|Lost to Follow-up|20|||
156629786|NCT00401726|565389292|FG000|Overall Study|Protocol Violation|6|||
156629787|NCT00401726|565389293|FG001|Overall Study|Protocol Violation|3|||
156629788|NCT00401726|565389292|FG000|Overall Study|Withdrawal by Subject|18|||
156629789|NCT00401726|565389293|FG001|Overall Study|Withdrawal by Subject|24|||
156629790|NCT00401726|565389292|FG000|Overall Study|Lack of Efficacy|4|||
156629791|NCT00401726|565389293|FG001|Overall Study|Lack of Efficacy|6|||
156629792|NCT00401726|565389292|FG000|Overall Study|Protocol Deviation|9|||
156629793|NCT00401726|565389293|FG001|Overall Study|Protocol Deviation|4|||
156629794|NCT02067728|565389294|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
156629795|NCT02067728|565389295|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
156629796|NCT02067728|565389294|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
156629797|NCT02067728|565389295|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
156629798|NCT02067728|565389294|FG000|6 Month Measurements|Unable to attend|114|||
156629799|NCT02067728|565389295|FG001|6 Month Measurements|Unable to attend|97|||
156629800|NCT00933543|565389297|FG000|Overall Study|Adverse Event|2|||
156629801|NCT00933543|565389298|FG001|Overall Study|Adverse Event|1|||
156629802|NCT00933543|565389297|FG000|Overall Study|Lost to Follow-up|0|||
156629803|NCT00933543|565389298|FG001|Overall Study|Lost to Follow-up|1|||
156629804|NCT00933543|565389297|FG000|Overall Study|Withdrawal by Subject|0|||
156629805|NCT00933543|565389298|FG001|Overall Study|Withdrawal by Subject|1|||
156629806|NCT00933543|565389297|FG000|Overall Study|Lack of Efficacy|0|||
156629807|NCT00933543|565389298|FG001|Overall Study|Lack of Efficacy|3|||
156629808|NCT00933543|565389297|FG000|Overall Study|Other|1|||
156629809|NCT00933543|565389298|FG001|Overall Study|Other|1|||
156629810|NCT04988035|565389300|FG000|Overall Study|Death|19|||
156629811|NCT04988035|565389301|FG001|Overall Study|Death|13|||
156629812|NCT04988035|565389300|FG000|Overall Study|Lost to Follow-up|12|||
156629813|NCT04988035|565389301|FG001|Overall Study|Lost to Follow-up|6|||
156629814|NCT04988035|565389300|FG000|Overall Study|Protocol Violation|0|||
156629815|NCT04988035|565389301|FG001|Overall Study|Protocol Violation|1|||
156629816|NCT04988035|565389300|FG000|Overall Study|Withdrawal by Subject|2|||
156629817|NCT04988035|565389301|FG001|Overall Study|Withdrawal by Subject|4|||
156629818|NCT04988035|565389300|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
156629819|NCT04988035|565389301|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
156629820|NCT03532048|565389302|FG000|Overall Study|Lost to Follow-up|12|||
156629821|NCT03532048|565389303|FG001|Overall Study|Lost to Follow-up|17|||
156629822|NCT03532048|565389302|FG000|Overall Study|Withdrawal by Subject|7|||
156629823|NCT03532048|565389303|FG001|Overall Study|Withdrawal by Subject|0|||
156629824|NCT04585906|565389304|FG000|Overall Study|Lost to Follow-up|8|||
156629825|NCT04585906|565389305|FG001|Overall Study|Lost to Follow-up|5|||
156629826|NCT04626947|565389306|FG000|Overall Study|Study terminated|14|||
156629827|NCT01050998|565389311|FG000|Overall Study|Adverse Event|1|||
156629828|NCT01050998|565389312|FG001|Overall Study|Adverse Event|0|||
156629829|NCT01050998|565389313|FG002|Overall Study|Adverse Event|1|||
156629830|NCT01050998|565389314|FG003|Overall Study|Adverse Event|0|||
156629831|NCT01050998|565389315|FG004|Overall Study|Adverse Event|2|||
156629832|NCT01050998|565389311|FG000|Overall Study|Withdrawal by Subject|0|||
156629833|NCT01050998|565389312|FG001|Overall Study|Withdrawal by Subject|0|||
156629834|NCT01050998|565389313|FG002|Overall Study|Withdrawal by Subject|0|||
156629835|NCT01050998|565389314|FG003|Overall Study|Withdrawal by Subject|1|||
156629836|NCT01050998|565389315|FG004|Overall Study|Withdrawal by Subject|3|||
156629837|NCT01050998|565389311|FG000|Overall Study|Other|3|||
156629838|NCT01050998|565389312|FG001|Overall Study|Other|2|||
156629839|NCT01050998|565389313|FG002|Overall Study|Other|1|||
156629840|NCT01050998|565389314|FG003|Overall Study|Other|1|||
156629841|NCT01050998|565389315|FG004|Overall Study|Other|5|||
156629842|NCT01050998|565389311|FG000|Overall Study|Data integrity issues|0|||
156629843|NCT01050998|565389312|FG001|Overall Study|Data integrity issues|0|||
156629844|NCT01050998|565389313|FG002|Overall Study|Data integrity issues|1|||
156629845|NCT01050998|565389314|FG003|Overall Study|Data integrity issues|1|||
156629846|NCT01050998|565389315|FG004|Overall Study|Data integrity issues|4|||
156629847|NCT01428882|565389318|FG000|Overall Study|Lack of Efficacy|2|||
156629848|NCT01428882|565389319|FG001|Overall Study|Lack of Efficacy|7|||
156629849|NCT01428882|565389318|FG000|Overall Study|Protocol Violation|4|||
156629850|NCT01428882|565389319|FG001|Overall Study|Protocol Violation|3|||
156629851|NCT00903357|565389320|FG000|First Intervention|Withdrawal by Subject|5|||
156629852|NCT00903357|565389321|FG001|First Intervention|Withdrawal by Subject|3|||
156629853|NCT00903357|565389320|FG000|First Intervention|Flu|0|||
156629854|NCT00903357|565389321|FG001|First Intervention|Flu|1|||
156629855|NCT00903357|565389320|FG000|Wash Out Period of 2 Weeks|Flu|0|||
156629856|NCT00903357|565389321|FG001|Wash Out Period of 2 Weeks|Flu|1|||
156629857|NCT00903357|565389320|FG000|Second Intervention|Lost to Follow-up|1|||
156629858|NCT00903357|565389321|FG001|Second Intervention|Lost to Follow-up|0|||
156629859|NCT02221882|565389327|FG000|Overall Study|Withdrawal by Subject|0|||
156629860|NCT02221882|565389328|FG001|Overall Study|Withdrawal by Subject|0|||
156629861|NCT02221882|565389329|FG002|Overall Study|Withdrawal by Subject|4|||
156629862|NCT02221882|565389330|FG003|Overall Study|Withdrawal by Subject|2|||
156629863|NCT02221882|565389331|FG004|Overall Study|Withdrawal by Subject|2|||
156629864|NCT02221882|565389332|FG005|Overall Study|Withdrawal by Subject|2|||
156629865|NCT02221882|565389327|FG000|Overall Study|Death|0|||
156629866|NCT02221882|565389328|FG001|Overall Study|Death|1|||
156629867|NCT02221882|565389329|FG002|Overall Study|Death|0|||
156629868|NCT02221882|565389330|FG003|Overall Study|Death|0|||
156629869|NCT02221882|565389331|FG004|Overall Study|Death|0|||
156629870|NCT02221882|565389332|FG005|Overall Study|Death|0|||
156629871|NCT05664672|565389337|FG000|Overall Study|Adverse Event|0|||
156629872|NCT05664672|565389338|FG001|Overall Study|Adverse Event|0|||
156629873|NCT05664672|565389339|FG002|Overall Study|Adverse Event|0|||
156629874|NCT05664672|565389340|FG003|Overall Study|Adverse Event|0|||
156629875|NCT05664672|565389341|FG004|Overall Study|Adverse Event|0|||
156629876|NCT05664672|565389342|FG005|Overall Study|Adverse Event|1|||
156629877|NCT05664672|565389337|FG000|Overall Study|Withdrawal by Subject|0|||
156629878|NCT05664672|565389338|FG001|Overall Study|Withdrawal by Subject|1|||
156629879|NCT05664672|565389339|FG002|Overall Study|Withdrawal by Subject|3|||
156629880|NCT05664672|565389340|FG003|Overall Study|Withdrawal by Subject|0|||
156629881|NCT05664672|565389341|FG004|Overall Study|Withdrawal by Subject|5|||
156629882|NCT05664672|565389342|FG005|Overall Study|Withdrawal by Subject|6|||
156629883|NCT05664672|565389337|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
156629884|NCT05664672|565389338|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
156629885|NCT05664672|565389339|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
156629886|NCT05664672|565389340|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
156629887|NCT05664672|565389341|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
156629888|NCT05664672|565389342|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
156629889|NCT05664672|565389337|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
156629890|NCT05664672|565389338|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
156629891|NCT05664672|565389339|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
156629892|NCT05664672|565389340|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
156629893|NCT05664672|565389341|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
156629894|NCT05664672|565389342|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
156629895|NCT04095039|565389355|FG000|Overall Study|Withdrawal by Subject|2|||
156629896|NCT04095039|565389356|FG001|Overall Study|Withdrawal by Subject|16|||
156629897|NCT04095039|565389355|FG000|Overall Study|Transplanted|21|||
156629898|NCT04095039|565389356|FG001|Overall Study|Transplanted|24|||
156629899|NCT04095039|565389355|FG000|Overall Study|Transferred to Non-study Facility|47|||
156629900|NCT04095039|565389356|FG001|Overall Study|Transferred to Non-study Facility|44|||
156629901|NCT04095039|565389355|FG000|Overall Study|Withdrawal from internvention target|0|||
156629902|NCT04095039|565389356|FG001|Overall Study|Withdrawal from internvention target|2|||
156629903|NCT04095039|565389355|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
156629904|NCT04095039|565389356|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
156629905|NCT04095039|565389355|FG000|Overall Study|Cacliphylaxis|0|||
156629906|NCT04095039|565389356|FG001|Overall Study|Cacliphylaxis|1|||
156629907|NCT04095039|565389355|FG000|Overall Study|Pregnancy|1|||
156629908|NCT04095039|565389356|FG001|Overall Study|Pregnancy|0|||
156629909|NCT02370173|565389357|FG000|Overall Study|Protocol Violation|1|||
156629910|NCT02370173|565389358|FG001|Overall Study|Protocol Violation|1|||
156629911|NCT02370173|565389357|FG000|Overall Study|Withdrawal by Subject|2|||
156629912|NCT02370173|565389358|FG001|Overall Study|Withdrawal by Subject|2|||
156629913|NCT01326481|565389359|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
156629914|NCT04794491|565389360|FG000|Overall Study|Adverse Event|1|||
156629915|NCT04794491|565389360|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
156629916|NCT04794491|565389360|FG000|Overall Study|Noncompliance With Study Intervention|1|||
156629917|NCT04794491|565389360|FG000|Overall Study|Withdrawal by Subject|2|||
156629918|NCT01038609|565389365|FG000|Overall Study|Adverse Event|0|||
156629919|NCT01038609|565389366|FG001|Overall Study|Adverse Event|0|||
156629920|NCT01038609|565389367|FG002|Overall Study|Adverse Event|1|||
156629921|NCT01038609|565389368|FG003|Overall Study|Adverse Event|0|||
156629922|NCT01038609|565389369|FG004|Overall Study|Adverse Event|0|||
156629923|NCT01038609|565389365|FG000|Overall Study|Dosing Error|0|||
156629924|NCT01038609|565389366|FG001|Overall Study|Dosing Error|0|||
156629925|NCT01038609|565389367|FG002|Overall Study|Dosing Error|0|||
156629926|NCT01038609|565389368|FG003|Overall Study|Dosing Error|1|||
156629927|NCT01038609|565389369|FG004|Overall Study|Dosing Error|1|||
156629928|NCT01038609|565389365|FG000|Overall Study|Death in the Family|1|||
156629929|NCT01038609|565389366|FG001|Overall Study|Death in the Family|0|||
156629930|NCT01038609|565389367|FG002|Overall Study|Death in the Family|0|||
156629931|NCT01038609|565389368|FG003|Overall Study|Death in the Family|0|||
156629932|NCT01038609|565389369|FG004|Overall Study|Death in the Family|0|||
156629933|NCT01038609|565389365|FG000|Overall Study|Refusal of Blood Draws|0|||
156629934|NCT01038609|565389366|FG001|Overall Study|Refusal of Blood Draws|1|||
156629935|NCT01038609|565389367|FG002|Overall Study|Refusal of Blood Draws|0|||
156629936|NCT01038609|565389368|FG003|Overall Study|Refusal of Blood Draws|0|||
156629937|NCT01038609|565389369|FG004|Overall Study|Refusal of Blood Draws|0|||
156629938|NCT01314261|565389370|FG000|Overall Study|Adverse Event|1|||
156629939|NCT01314261|565389371|FG001|Overall Study|Adverse Event|0|||
156629940|NCT01314261|565389372|FG002|Overall Study|Adverse Event|0|||
156629941|NCT01314261|565389373|FG003|Overall Study|Adverse Event|0|||
156629942|NCT01314261|565389370|FG000|Overall Study|Withdrawal by Subject|0|||
156629943|NCT01314261|565389371|FG001|Overall Study|Withdrawal by Subject|3|||
156629944|NCT01314261|565389372|FG002|Overall Study|Withdrawal by Subject|1|||
156629945|NCT01314261|565389373|FG003|Overall Study|Withdrawal by Subject|0|||
156629946|NCT01314261|565389370|FG000|Overall Study|Lost to Follow-up|1|||
156629947|NCT01314261|565389371|FG001|Overall Study|Lost to Follow-up|0|||
156629948|NCT01314261|565389372|FG002|Overall Study|Lost to Follow-up|2|||
156629949|NCT01314261|565389373|FG003|Overall Study|Lost to Follow-up|2|||
156629950|NCT01314261|565389370|FG000|Overall Study|Virologic Failure|0|||
156629951|NCT01314261|565389371|FG001|Overall Study|Virologic Failure|1|||
156629952|NCT01314261|565389372|FG002|Overall Study|Virologic Failure|0|||
156629953|NCT01314261|565389373|FG003|Overall Study|Virologic Failure|1|||
156629954|NCT02129192|565389374|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
156629955|NCT02129192|565389375|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
156629956|NCT01231620|565389377|FG000|Overall Study|Physician Decision|3|||
156629957|NCT01231620|565389378|FG001|Overall Study|Physician Decision|5|||
156629958|NCT01231620|565389379|FG002|Overall Study|Physician Decision|10|||
156629959|NCT01231620|565389377|FG000|Overall Study|Death|12|||
156629960|NCT01231620|565389378|FG001|Overall Study|Death|14|||
156629961|NCT01231620|565389379|FG002|Overall Study|Death|11|||
156629962|NCT01231620|565389377|FG000|Overall Study|Adverse Event|2|||
156629963|NCT01231620|565389378|FG001|Overall Study|Adverse Event|2|||
156629964|NCT01231620|565389379|FG002|Overall Study|Adverse Event|1|||
156629965|NCT01231620|565389377|FG000|Overall Study|Withdrawal by Subject|6|||
156629966|NCT01231620|565389378|FG001|Overall Study|Withdrawal by Subject|6|||
156629967|NCT01231620|565389379|FG002|Overall Study|Withdrawal by Subject|8|||
156629968|NCT01231620|565389377|FG000|Overall Study|Lost to Follow-up|3|||
156629969|NCT01231620|565389378|FG001|Overall Study|Lost to Follow-up|4|||
156629970|NCT01231620|565389379|FG002|Overall Study|Lost to Follow-up|9|||
156629971|NCT04557189|565389388|FG000|Overall Study|Adverse Event|0|||
156629972|NCT04557189|565389389|FG001|Overall Study|Adverse Event|1|||
156629973|NCT04557189|565389388|FG000|Overall Study|Lost to Follow-up|1|||
156629974|NCT04557189|565389389|FG001|Overall Study|Lost to Follow-up|1|||
156629975|NCT04557189|565389388|FG000|Overall Study|Withdrawal by Subject|2|||
156629976|NCT04557189|565389389|FG001|Overall Study|Withdrawal by Subject|1|||
156629977|NCT04557189|565389388|FG000|Overall Study|Reason not Specified|3|||
156629978|NCT04557189|565389389|FG001|Overall Study|Reason not Specified|6|||
156629979|NCT03590613|565389398|FG000|Period 2, 4 Days|Physician Decision|0|||
156629980|NCT03590613|565389399|FG001|Period 2, 4 Days|Physician Decision|0|||
156629981|NCT03590613|565389400|FG002|Period 2, 4 Days|Physician Decision|0|||
156629982|NCT03590613|565389401|FG003|Period 2, 4 Days|Physician Decision|1|||
156629983|NCT01087944|565389402|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
156629984|NCT01087944|565389403|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
156629985|NCT01087944|565389402|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
156629986|NCT01087944|565389403|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
156629987|NCT01731600|565389404|FG000|Overall Study|Adverse Event|2|||
156629988|NCT01731600|565389405|FG001|Overall Study|Adverse Event|0|||
156629989|NCT01731600|565389404|FG000|Overall Study|Withdrawal criteria|1|||
156629990|NCT01731600|565389405|FG001|Overall Study|Withdrawal criteria|0|||
156629991|NCT01731600|565389404|FG000|Overall Study|Other reasons|3|||
156629992|NCT01731600|565389405|FG001|Overall Study|Other reasons|0|||
156629993|NCT02911285|565389406|FG000|Overall Study|Lost to Follow-up|8|||
156629994|NCT02911285|565389407|FG001|Overall Study|Lost to Follow-up|5|||
156629995|NCT02911285|565389406|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
156629996|NCT02911285|565389407|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
156629997|NCT00422227|565389408|FG000|Overall Study|Adverse Event|3|||
156629998|NCT00422227|565389409|FG001|Overall Study|Adverse Event|8|||
156629999|NCT00422227|565389408|FG000|Overall Study|Lost to Follow-up|1|||
156630000|NCT00422227|565389409|FG001|Overall Study|Lost to Follow-up|3|||
156630001|NCT00422227|565389408|FG000|Overall Study|Withdrawal by Subject|0|||
156630002|NCT00422227|565389409|FG001|Overall Study|Withdrawal by Subject|4|||
156630003|NCT00686894|565389411|FG000|Overall Study|Relapse|2|||
156630004|NCT00686894|565389411|FG000|Overall Study|Protocol Violation|4|||
156630005|NCT03996694|565391277|FG000|First Washout (7 Days)|positive urine drug screen|0|||
156630006|NCT03996694|565391278|FG001|First Washout (7 Days)|positive urine drug screen|0|||
156630007|NCT03996694|565391279|FG002|First Washout (7 Days)|positive urine drug screen|1|||
156630008|NCT03996694|565391280|FG003|First Washout (7 Days)|positive urine drug screen|0|||
156630009|NCT03996694|565391281|FG004|First Washout (7 Days)|positive urine drug screen|0|||
156630010|NCT03996694|565391282|FG005|First Washout (7 Days)|positive urine drug screen|0|||
156630011|NCT03996694|565391277|FG000|First Washout (7 Days)|Adverse Event|0|||
156630012|NCT03996694|565391278|FG001|First Washout (7 Days)|Adverse Event|1|||
156630013|NCT03996694|565391279|FG002|First Washout (7 Days)|Adverse Event|0|||
156630014|NCT03996694|565391280|FG003|First Washout (7 Days)|Adverse Event|0|||
156630015|NCT03996694|565391281|FG004|First Washout (7 Days)|Adverse Event|0|||
156630016|NCT03996694|565391282|FG005|First Washout (7 Days)|Adverse Event|0|||
156630017|NCT03996694|565391277|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
156630018|NCT03996694|565391278|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
156630019|NCT03996694|565391279|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
156630020|NCT03996694|565391280|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
156630021|NCT03996694|565391281|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
156630022|NCT03996694|565391282|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
156630023|NCT03996694|565391277|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
156630024|NCT03996694|565391278|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
156630025|NCT03996694|565391279|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
156630026|NCT03996694|565391280|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
156630027|NCT03996694|565391281|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
156630028|NCT03996694|565391282|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
156630029|NCT01241591|565391285|FG000|Overall Study|Lack of Efficacy|5|||
156630030|NCT01241591|565391286|FG001|Overall Study|Lack of Efficacy|2|||
156630031|NCT01241591|565391287|FG002|Overall Study|Lack of Efficacy|2|||
156630032|NCT01241591|565391288|FG003|Overall Study|Lack of Efficacy|3|||
156630033|NCT01241591|565391285|FG000|Overall Study|Protocol Violation|5|||
156630034|NCT01241591|565391286|FG001|Overall Study|Protocol Violation|2|||
156630035|NCT01241591|565391287|FG002|Overall Study|Protocol Violation|3|||
156630036|NCT01241591|565391288|FG003|Overall Study|Protocol Violation|0|||
156630037|NCT01241591|565391285|FG000|Overall Study|Lost to Follow-up|1|||
156630038|NCT01241591|565391286|FG001|Overall Study|Lost to Follow-up|2|||
156630039|NCT01241591|565391287|FG002|Overall Study|Lost to Follow-up|2|||
156630040|NCT01241591|565391288|FG003|Overall Study|Lost to Follow-up|2|||
156630041|NCT01241591|565391285|FG000|Overall Study|Screen Failure|3|||
156630042|NCT01241591|565391286|FG001|Overall Study|Screen Failure|2|||
156630043|NCT01241591|565391287|FG002|Overall Study|Screen Failure|1|||
156630044|NCT01241591|565391288|FG003|Overall Study|Screen Failure|0|||
156630045|NCT01241591|565391285|FG000|Overall Study|Withdrawal by Subject|6|||
156630046|NCT01241591|565391286|FG001|Overall Study|Withdrawal by Subject|4|||
156630047|NCT01241591|565391287|FG002|Overall Study|Withdrawal by Subject|2|||
156630048|NCT01241591|565391288|FG003|Overall Study|Withdrawal by Subject|2|||
156630049|NCT01241591|565391285|FG000|Overall Study|Other|0|||
156630050|NCT01241591|565391286|FG001|Overall Study|Other|1|||
156630051|NCT01241591|565391287|FG002|Overall Study|Other|0|||
156630052|NCT01241591|565391288|FG003|Overall Study|Other|1|||
156630053|NCT01241591|565391285|FG000|Overall Study|Adverse Event|3|||
156630054|NCT01241591|565391286|FG001|Overall Study|Adverse Event|11|||
156630055|NCT01241591|565391287|FG002|Overall Study|Adverse Event|12|||
156630056|NCT01241591|565391288|FG003|Overall Study|Adverse Event|4|||
156630057|NCT02389621|565391291|FG000|Treatment Period|Withdrawal by Subject|1|||
156630058|NCT02389621|565391292|FG001|Treatment Period|Withdrawal by Subject|1|||
156630059|NCT02389621|565391291|FG000|Posttreatment Period|Adverse Event|3|||
156630060|NCT02389621|565391292|FG001|Posttreatment Period|Adverse Event|1|||
156630061|NCT02389621|565391291|FG000|Posttreatment Period|Withdrawal by Subject|3|||
156630062|NCT02389621|565391292|FG001|Posttreatment Period|Withdrawal by Subject|2|||
156630063|NCT02389621|565391291|FG000|Posttreatment Period|Lost to Follow-up|1|||
156630064|NCT02389621|565391292|FG001|Posttreatment Period|Lost to Follow-up|1|||
156630065|NCT02389621|565391291|FG000|Posttreatment Period|Other - Miscellaneous|2|||
156630066|NCT02389621|565391292|FG001|Posttreatment Period|Other - Miscellaneous|0|||
156630067|NCT00726882|565391296|FG000|Overall Study|Withdrawal by Subject|5|||
156630068|NCT00726882|565391296|FG000|Overall Study|Lost to Follow-up|7|||
156630069|NCT00726882|565391296|FG000|Overall Study|Other|10|||
156630070|NCT02526017|565391297|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
156630071|NCT02526017|565391298|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
156630072|NCT02526017|565391299|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
156630073|NCT02526017|565391300|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
156630074|NCT02526017|565391301|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
156630075|NCT02526017|565391302|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
156630076|NCT02526017|565391303|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
156630077|NCT02526017|565391304|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
156630078|NCT02526017|565391305|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
156630079|NCT01548573|565391309|FG000|Overall Study|Death|3|||
156630080|NCT01548573|565391309|FG000|Overall Study|Withdrawal by Subject|2|||
156630081|NCT00290511|565391315|FG000|Overall Study|Adverse Event|1|||
156630082|NCT00290511|565391315|FG000|Overall Study|Death|1|||
156630083|NCT00290511|565391315|FG000|Overall Study|Physician Decision|1|||
156630084|NCT00290511|565391315|FG000|Overall Study|Withdrawal by Subject|1|||
156630085|NCT00447265|565391316|FG000|Overall Study|Physician Decision|1|||
156630086|NCT00447265|565391317|FG001|Overall Study|Physician Decision|0|||
156630087|NCT05028816|565391321|FG000|Overall Study|Lost to Follow-up|5|||
156630088|NCT05028816|565391322|FG001|Overall Study|Lost to Follow-up|3|||
156630089|NCT05028816|565391321|FG000|Overall Study|Withdrawal by Subject|4|||
156630090|NCT05028816|565391322|FG001|Overall Study|Withdrawal by Subject|1|||
156630091|NCT05028816|565391321|FG000|Overall Study|Physician Decision|1|||
156630092|NCT05028816|565391322|FG001|Overall Study|Physician Decision|0|||
156630093|NCT03246152|565391325|FG000|Overall Study|Lost to Follow-up|2|||
156630094|NCT03246152|565391325|FG000|Overall Study|Protocol Violation|1|||
156630095|NCT00423137|565391326|FG000|Overall Study|Lost to Follow-up|0|||
156630096|NCT00423137|565391327|FG001|Overall Study|Lost to Follow-up|0|||
156630097|NCT00423137|565391328|FG002|Overall Study|Lost to Follow-up|1|||
156630098|NCT00423137|565391329|FG003|Overall Study|Lost to Follow-up|0|||
156630099|NCT00423137|565391326|FG000|Overall Study|Protocol Violation|0|||
156630100|NCT00423137|565391327|FG001|Overall Study|Protocol Violation|0|||
156630101|NCT00423137|565391328|FG002|Overall Study|Protocol Violation|0|||
156630102|NCT00423137|565391329|FG003|Overall Study|Protocol Violation|1|||
156630103|NCT00423137|565391326|FG000|Overall Study|Adverse Event Study disease worse|1|||
156630104|NCT00423137|565391327|FG001|Overall Study|Adverse Event Study disease worse|0|||
156630105|NCT00423137|565391328|FG002|Overall Study|Adverse Event Study disease worse|3|||
156630106|NCT00423137|565391329|FG003|Overall Study|Adverse Event Study disease worse|1|||
156630107|NCT00423137|565391326|FG000|Overall Study|Adverse Event Other|0|||
156630108|NCT00423137|565391327|FG001|Overall Study|Adverse Event Other|0|||
156630109|NCT00423137|565391328|FG002|Overall Study|Adverse Event Other|2|||
156630110|NCT00423137|565391329|FG003|Overall Study|Adverse Event Other|0|||
156630111|NCT01243762|565391331|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
156630112|NCT01243762|565391332|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
156630113|NCT01243762|565391333|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
156630114|NCT01243762|565391334|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
156630115|NCT01243762|565391335|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
156630116|NCT01243762|565391336|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
156630117|NCT01243762|565391337|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
156630118|NCT01243762|565391331|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
156630119|NCT01243762|565391332|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
156630120|NCT01243762|565391333|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
156630121|NCT01243762|565391334|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
156630122|NCT01243762|565391335|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
156630123|NCT01243762|565391336|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
156630124|NCT01243762|565391337|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
156630125|NCT01243762|565391331|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
156630126|NCT01243762|565391332|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
156630127|NCT01243762|565391333|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
156630128|NCT01243762|565391334|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
156630129|NCT01243762|565391335|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
156630130|NCT01243762|565391336|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
156630131|NCT01243762|565391337|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
156630132|NCT01243762|565391331|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
156630133|NCT01243762|565391332|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
156630134|NCT01243762|565391333|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
156630135|NCT01243762|565391334|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
156630136|NCT01243762|565391335|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
156630137|NCT01243762|565391336|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
156630138|NCT01243762|565391337|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
156630139|NCT01243762|565391331|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
156630140|NCT01243762|565391332|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
156630141|NCT01243762|565391333|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
156630142|NCT01243762|565391334|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
156630143|NCT01243762|565391335|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
156630144|NCT01243762|565391336|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
156630145|NCT01243762|565391337|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
156630146|NCT01243762|565391331|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
156630147|NCT01243762|565391332|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
156630148|NCT01243762|565391333|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
156630149|NCT01243762|565391334|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
156630150|NCT01243762|565391335|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
156630151|NCT01243762|565391336|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
156630152|NCT01243762|565391337|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
156630153|NCT01243762|565391331|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
156630154|NCT01243762|565391332|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
156630155|NCT01243762|565391333|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
156630156|NCT01243762|565391334|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
156630157|NCT01243762|565391335|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
156630158|NCT01243762|565391336|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
156630159|NCT01243762|565391337|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
156630160|NCT01243762|565391331|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
156630161|NCT01243762|565391332|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
156630162|NCT01243762|565391333|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
156630163|NCT01243762|565391334|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
156630164|NCT01243762|565391335|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
156630165|NCT01243762|565391336|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
156630166|NCT01243762|565391337|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
156630167|NCT00003526|565391338|FG000|Overall Study|Not evaluable|6|||
156630168|NCT03557775|565391339|FG000|Overall Study|Withdrawal by Subject|1|||
156630169|NCT03557775|565391340|FG001|Overall Study|Withdrawal by Subject|2|||
156630170|NCT03557775|565391341|FG002|Overall Study|Withdrawal by Subject|4|||
156630171|NCT03557775|565391339|FG000|Overall Study|Physician Decision|0|||
156630172|NCT03557775|565391340|FG001|Overall Study|Physician Decision|1|||
156630173|NCT03557775|565391341|FG002|Overall Study|Physician Decision|0|||
156630174|NCT00308555|565391342|FG000|Overall Study|Withdrawal by Subject|1|||
156630175|NCT00308555|565391343|FG001|Overall Study|Withdrawal by Subject|0|||
156630176|NCT00308555|565391342|FG000|Overall Study|Physician Decision|2|||
156630177|NCT00308555|565391343|FG001|Overall Study|Physician Decision|0|||
156630178|NCT04113746|565391351|FG000|Overall Study|Lost to Follow-up|4|||
156630179|NCT04113746|565391352|FG001|Overall Study|Lost to Follow-up|4|||
156630180|NCT00429026|565391354|FG000|Overall Study|Inevaluable for response.|40|||
156630181|NCT04338685|565391357|FG000|Overall Study|Death|3|||
156630182|NCT04338685|565391358|FG001|Overall Study|Death|4|||
156630183|NCT04338685|565391359|FG002|Overall Study|Death|2|||
156630184|NCT04338685|565391360|FG003|Overall Study|Death|4|||
156630185|NCT04338685|565391361|FG004|Overall Study|Death|4|||
156630186|NCT04338685|565391362|FG005|Overall Study|Death|8|||
156630187|NCT04338685|565391363|FG006|Overall Study|Death|1|||
156630188|NCT04338685|565391364|FG007|Overall Study|Death|0|||
156630189|NCT04338685|565391365|FG008|Overall Study|Death|0|||
156630190|NCT04338685|565391357|FG000|Overall Study|Study terminated by Sponsor|0|||
156630191|NCT04338685|565391358|FG001|Overall Study|Study terminated by Sponsor|0|||
156630192|NCT04338685|565391359|FG002|Overall Study|Study terminated by Sponsor|1|||
156630193|NCT04338685|565391360|FG003|Overall Study|Study terminated by Sponsor|4|||
156630194|NCT04338685|565391361|FG004|Overall Study|Study terminated by Sponsor|0|||
156630195|NCT04338685|565391362|FG005|Overall Study|Study terminated by Sponsor|5|||
156630196|NCT04338685|565391363|FG006|Overall Study|Study terminated by Sponsor|2|||
156630197|NCT04338685|565391364|FG007|Overall Study|Study terminated by Sponsor|4|||
156630198|NCT04338685|565391365|FG008|Overall Study|Study terminated by Sponsor|1|||
156630199|NCT04338685|565391357|FG000|Overall Study|Withdrawal by Subject|1|||
156630200|NCT04338685|565391358|FG001|Overall Study|Withdrawal by Subject|2|||
156630201|NCT04338685|565391359|FG002|Overall Study|Withdrawal by Subject|0|||
156630202|NCT04338685|565391360|FG003|Overall Study|Withdrawal by Subject|2|||
156630203|NCT04338685|565391361|FG004|Overall Study|Withdrawal by Subject|0|||
156630204|NCT04338685|565391362|FG005|Overall Study|Withdrawal by Subject|5|||
156630205|NCT04338685|565391363|FG006|Overall Study|Withdrawal by Subject|1|||
156630206|NCT04338685|565391364|FG007|Overall Study|Withdrawal by Subject|1|||
156630207|NCT04338685|565391365|FG008|Overall Study|Withdrawal by Subject|0|||
156630208|NCT00234533|565391366|FG000|Overall Study|Withdrawal by Subject|6|||
156630209|NCT00234533|565391366|FG000|Overall Study|Adverse Event|2|||
156630210|NCT00234533|565391366|FG000|Overall Study|Enrolled but not treated|3|||
156630211|NCT02967055|565391367|FG000|Overall Study|Excluded|40|||
156630212|NCT02967055|565391367|FG000|Overall Study|Screen fail|3|||
156630213|NCT02967055|565391367|FG000|Overall Study|Lost to Follow-up|2|||
156630214|NCT02967055|565391367|FG000|Overall Study|Stopped due to side effects|3|||
156630215|NCT02967055|565391367|FG000|Overall Study|Stopped due to drug cost|1|||
156630216|NCT00908375|565391368|FG000|Overall Study|Withdrawal by Subject|2|||
156630217|NCT00908375|565391369|FG001|Overall Study|Withdrawal by Subject|4|||
156630218|NCT00908375|565391368|FG000|Overall Study|Lost to Follow-up|8|||
156630219|NCT00908375|565391369|FG001|Overall Study|Lost to Follow-up|6|||
156630220|NCT02279888|565391370|FG000|Overall Study|Death|326|||
156630221|NCT02279888|565391370|FG000|Overall Study|Withdrawal by Subject|38|||
156630222|NCT02279888|565391370|FG000|Overall Study|Lost to Follow-up|21|||
156630223|NCT02279888|565391370|FG000|Overall Study|Physician Decision|62|||
156630224|NCT02279888|565391370|FG000|Overall Study|Subject Non-compliance|43|||
156630225|NCT02279888|565391370|FG000|Overall Study|Not implanted|14|||
156630226|NCT02279888|565391370|FG000|Overall Study|Visit not performed|26|||
156630227|NCT04668157|565391371|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
156630228|NCT04668157|565391372|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
156630229|NCT04668157|565391371|FG000|Treatment Period (52 Weeks)|Other|0|||
156630230|NCT04668157|565391372|FG001|Treatment Period (52 Weeks)|Other|2|||
156630231|NCT03958045|565391373|FG000|Overall Study|Withdrawal by Subject|1|||
156630232|NCT02283411|565391374|FG000|Overall Study|Withdrawal by Subject|3|||
156630233|NCT02283411|565391374|FG000|Overall Study|Screen Failed|28|||
156630234|NCT01683565|565391375|FG000|Overall Study|Lost to Follow-up|2|||
156630235|NCT01683565|565391376|FG001|Overall Study|Lost to Follow-up|0|||
156630236|NCT01683565|565391375|FG000|Overall Study|Discontinued Intervention|1|||
156630237|NCT01683565|565391376|FG001|Overall Study|Discontinued Intervention|1|||
156630238|NCT03282123|565391378|FG000|Overall Study|Withdrawal by Subject|5|||
156630239|NCT00674440|565391379|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
156630240|NCT00674440|565391379|FG000|Overall Study|did not have surgery, so unevaluable|7|||
156630241|NCT00674440|565391379|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
156630242|NCT01195662|565391380|FG000|Double Blind Treatment Period|Adverse Event|4|||
156630243|NCT01195662|565391381|FG001|Double Blind Treatment Period|Adverse Event|1|||
156630244|NCT01195662|565391382|FG002|Double Blind Treatment Period|Adverse Event|2|||
156630245|NCT01195662|565391380|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
156630246|NCT01195662|565391381|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
156630247|NCT01195662|565391382|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
156630248|NCT01195662|565391380|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
156630249|NCT01195662|565391381|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
156630250|NCT01195662|565391382|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
156630251|NCT01195662|565391380|FG000|Double Blind Treatment Period|Administrative reason|2|||
156630252|NCT01195662|565391381|FG001|Double Blind Treatment Period|Administrative reason|1|||
156630253|NCT01195662|565391382|FG002|Double Blind Treatment Period|Administrative reason|1|||
156630254|NCT01195662|565391380|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
156630255|NCT01195662|565391381|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
156630256|NCT01195662|565391382|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
156630257|NCT01195662|565391380|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
156630258|NCT01195662|565391381|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
156630259|NCT01195662|565391382|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
156630260|NCT01195662|565391380|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
156630261|NCT01195662|565391381|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
156630262|NCT01195662|565391382|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
156630263|NCT01195662|565391380|FG000|Double Blind Treatment Period|Non-specified|3|||
156630264|NCT01195662|565391381|FG001|Double Blind Treatment Period|Non-specified|0|||
156630265|NCT01195662|565391382|FG002|Double Blind Treatment Period|Non-specified|0|||
156630266|NCT01195662|565391380|FG000|Double Blind Treatment Period|Missing disposition information|0|||
156630267|NCT01195662|565391381|FG001|Double Blind Treatment Period|Missing disposition information|1|||
156630268|NCT01195662|565391382|FG002|Double Blind Treatment Period|Missing disposition information|1|||
156630269|NCT01195662|565391380|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
156630270|NCT01195662|565391381|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
156630271|NCT01195662|565391382|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
156630272|NCT01195662|565391380|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
156630273|NCT01195662|565391381|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
156630274|NCT01195662|565391382|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
156630275|NCT03457701|565391383|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
156630276|NCT03457701|565391384|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
156630277|NCT03457701|565391383|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
156635567|NCT00602667|565409961|FG001|Overall Study|Excessive toxicity|1|||
156630278|NCT03457701|565391384|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
156630279|NCT00796367|565391385|FG000|Overall Study|Adverse Event|6|||
156630280|NCT00796367|565391386|FG001|Overall Study|Adverse Event|4|||
156630281|NCT00796367|565391387|FG002|Overall Study|Adverse Event|7|||
156630282|NCT00796367|565391385|FG000|Overall Study|Lost to Follow-up|5|||
156630283|NCT00796367|565391386|FG001|Overall Study|Lost to Follow-up|4|||
156630284|NCT00796367|565391387|FG002|Overall Study|Lost to Follow-up|21|||
156630285|NCT00796367|565391385|FG000|Overall Study|Withdrawal by Subject|9|||
156630286|NCT00796367|565391386|FG001|Overall Study|Withdrawal by Subject|11|||
156630287|NCT00796367|565391387|FG002|Overall Study|Withdrawal by Subject|12|||
156630288|NCT00796367|565391385|FG000|Overall Study|Lack of Efficacy|2|||
156630289|NCT00796367|565391386|FG001|Overall Study|Lack of Efficacy|1|||
156630290|NCT00796367|565391387|FG002|Overall Study|Lack of Efficacy|0|||
156630291|NCT00796367|565391385|FG000|Overall Study|non compliance|3|||
156630292|NCT00796367|565391386|FG001|Overall Study|non compliance|1|||
156630293|NCT00796367|565391387|FG002|Overall Study|non compliance|1|||
156630294|NCT00796367|565391385|FG000|Overall Study|Pregnancy|1|||
156630295|NCT00796367|565391386|FG001|Overall Study|Pregnancy|0|||
156630296|NCT00796367|565391387|FG002|Overall Study|Pregnancy|1|||
156630297|NCT00796367|565391385|FG000|Overall Study|Requirement for restricted medication|2|||
156630298|NCT00796367|565391386|FG001|Overall Study|Requirement for restricted medication|0|||
156630299|NCT00796367|565391387|FG002|Overall Study|Requirement for restricted medication|2|||
156630300|NCT00796367|565391385|FG000|Overall Study|other|2|||
156630301|NCT00796367|565391386|FG001|Overall Study|other|4|||
156630302|NCT00796367|565391387|FG002|Overall Study|other|3|||
156630303|NCT04409262|565391389|FG000|Overall Study|Adverse Event|0|||
156630304|NCT04409262|565391390|FG001|Overall Study|Adverse Event|2|||
156630305|NCT04409262|565391389|FG000|Overall Study|Death|55|||
156630306|NCT04409262|565391390|FG001|Overall Study|Death|97|||
156630307|NCT04409262|565391389|FG000|Overall Study|Lost to Follow-up|12|||
156630308|NCT04409262|565391390|FG001|Overall Study|Lost to Follow-up|23|||
156630309|NCT04409262|565391389|FG000|Overall Study|Lack of Staff|0|||
156630310|NCT04409262|565391390|FG001|Overall Study|Lack of Staff|1|||
156630311|NCT04409262|565391389|FG000|Overall Study|Protocol Violation|3|||
156630312|NCT04409262|565391390|FG001|Overall Study|Protocol Violation|1|||
156630313|NCT04409262|565391389|FG000|Overall Study|Withdrawal by Subject|5|||
156630314|NCT04409262|565391390|FG001|Overall Study|Withdrawal by Subject|10|||
156630315|NCT00948896|565391394|FG000|Randomization to 24 Months of Age|Death|1|||
156630316|NCT00948896|565391395|FG001|Randomization to 24 Months of Age|Death|0|||
156630317|NCT00948896|565391396|FG002|Randomization to 24 Months of Age|Death|0|||
156630318|NCT00948896|565391397|FG003|Randomization to 24 Months of Age|Death|0|||
156630319|NCT00948896|565391398|FG004|Randomization to 24 Months of Age|Death|2|||
156630320|NCT00948896|565391399|FG005|Randomization to 24 Months of Age|Death|1|||
156630321|NCT00948896|565391400|FG006|Randomization to 24 Months of Age|Death|2|||
156630322|NCT00948896|565391401|FG007|Randomization to 24 Months of Age|Death|1|||
156630323|NCT00948896|565391394|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
156630324|NCT00948896|565391395|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
156630325|NCT00948896|565391396|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
156630326|NCT00948896|565391397|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
156630327|NCT00948896|565391398|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
156630328|NCT00948896|565391399|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
156630329|NCT00948896|565391400|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
156630330|NCT00948896|565391401|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
156635568|NCT00602667|565409962|FG002|Overall Study|Excessive toxicity|0|||
156630331|NCT00948896|565391394|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
156630332|NCT00948896|565391395|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
156630333|NCT00948896|565391396|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
156630334|NCT00948896|565391397|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
156630335|NCT00948896|565391398|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
156630336|NCT00948896|565391399|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
156630337|NCT00948896|565391400|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
156630338|NCT00948896|565391401|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
156630339|NCT00948896|565391394|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
156630340|NCT00948896|565391395|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
156630341|NCT00948896|565391396|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
156630342|NCT00948896|565391397|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
156630343|NCT00948896|565391398|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
156630344|NCT00948896|565391399|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
156630345|NCT00948896|565391400|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
156630346|NCT00948896|565391401|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
156630347|NCT00948896|565391394|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
156630348|NCT00948896|565391395|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
156630349|NCT00948896|565391396|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
156630350|NCT00948896|565391397|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
156630351|NCT00948896|565391398|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
156630352|NCT00948896|565391399|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
156630353|NCT00948896|565391400|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
156630354|NCT00948896|565391401|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
156630355|NCT00948896|565391394|FG000|24 Months of Age to 36 Months of Age|Death|0|||
156630356|NCT00948896|565391395|FG001|24 Months of Age to 36 Months of Age|Death|2|||
156630357|NCT00948896|565391396|FG002|24 Months of Age to 36 Months of Age|Death|2|||
156630358|NCT00948896|565391397|FG003|24 Months of Age to 36 Months of Age|Death|0|||
156630359|NCT00948896|565391398|FG004|24 Months of Age to 36 Months of Age|Death|0|||
156630360|NCT00948896|565391399|FG005|24 Months of Age to 36 Months of Age|Death|1|||
156630361|NCT00948896|565391400|FG006|24 Months of Age to 36 Months of Age|Death|0|||
156630362|NCT00948896|565391401|FG007|24 Months of Age to 36 Months of Age|Death|0|||
156630363|NCT00948896|565391394|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
156630364|NCT00948896|565391395|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
156630365|NCT00948896|565391396|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
156630366|NCT00948896|565391397|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
156630367|NCT00948896|565391398|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
156630368|NCT00948896|565391399|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
156630369|NCT00948896|565391400|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
156630370|NCT00948896|565391401|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
156630371|NCT00948896|565391394|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
156630372|NCT00948896|565391395|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
156630373|NCT00948896|565391396|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
156630374|NCT00948896|565391397|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
156630375|NCT00948896|565391398|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
156630376|NCT00948896|565391399|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
156630377|NCT00948896|565391400|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
156630378|NCT00948896|565391401|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
156630379|NCT00948896|565391394|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
156630380|NCT00948896|565391395|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
156630381|NCT00948896|565391396|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
156630382|NCT00948896|565391397|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
156630383|NCT00948896|565391398|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
156630384|NCT00948896|565391399|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
156630385|NCT00948896|565391400|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
156630386|NCT00948896|565391401|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
156630387|NCT00948896|565391394|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
156630388|NCT00948896|565391395|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
156630389|NCT00948896|565391396|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
156630390|NCT00948896|565391397|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
156630391|NCT00948896|565391398|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
156630392|NCT00948896|565391399|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
156630393|NCT00948896|565391400|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
156630394|NCT00948896|565391401|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
156630395|NCT00945815|565391402|FG000|Overall Study|Death|3|||
156630396|NCT00945815|565391402|FG000|Overall Study|Not protocol specified|1|||
156630397|NCT00945815|565391402|FG000|Overall Study|Ineligible|3|||
156630398|NCT00945815|565391402|FG000|Overall Study|Did not begin protocol therapy|1|||
156630399|NCT01590810|565391403|FG000|Overall Study|Physician Decision|0|||
156630400|NCT01590810|565391404|FG001|Overall Study|Physician Decision|1|||
156630401|NCT01590810|565391405|FG002|Overall Study|Physician Decision|1|||
156630402|NCT01590810|565391406|FG003|Overall Study|Physician Decision|0|||
156630403|NCT01590810|565391407|FG004|Overall Study|Physician Decision|0|||
156630404|NCT02400281|565391408|FG000|Overall Study|Adverse Event|0|||
156630405|NCT02400281|565391409|FG001|Overall Study|Adverse Event|0|||
156630406|NCT02400281|565391410|FG002|Overall Study|Adverse Event|1|||
156630407|NCT02400281|565391411|FG003|Overall Study|Adverse Event|0|||
156630408|NCT02400281|565391412|FG004|Overall Study|Adverse Event|1|||
156630409|NCT02400281|565391413|FG005|Overall Study|Adverse Event|0|||
156630410|NCT02400281|565391408|FG000|Overall Study|Physician Decision|0|||
156630411|NCT02400281|565391409|FG001|Overall Study|Physician Decision|0|||
156630412|NCT02400281|565391410|FG002|Overall Study|Physician Decision|1|||
156630413|NCT02400281|565391411|FG003|Overall Study|Physician Decision|0|||
156630414|NCT02400281|565391412|FG004|Overall Study|Physician Decision|0|||
156630415|NCT02400281|565391413|FG005|Overall Study|Physician Decision|0|||
156630416|NCT04524507|565391414|FG000|Overall Study|Lost to Follow-up|2|||
156630417|NCT04524507|565391415|FG001|Overall Study|Lost to Follow-up|4|||
156630418|NCT04524507|565391414|FG000|Overall Study|Withdrawal by Subject|2|||
156630419|NCT04524507|565391415|FG001|Overall Study|Withdrawal by Subject|9|||
156630420|NCT04524507|565391414|FG000|Overall Study|Death|2|||
156630421|NCT04524507|565391415|FG001|Overall Study|Death|10|||
156630422|NCT02441517|565391422|FG000|Overall Study|Lost to Follow-up|1|||
156630423|NCT02441517|565391422|FG000|Overall Study|Withdrawal by Subject|2|||
156630424|NCT02441517|565391422|FG000|Overall Study|Study Terminated by Sponsor|1|||
156630425|NCT03039699|565391423|FG000|Overall Study|Incorrect inclusion|5|||
156630426|NCT03039699|565391424|FG001|Overall Study|Incorrect inclusion|4|||
156630427|NCT03039699|565391423|FG000|Overall Study|Lack of data to assess study endpoint|5|||
156630428|NCT03039699|565391424|FG001|Overall Study|Lack of data to assess study endpoint|3|||
156630429|NCT03039699|565391423|FG000|Overall Study|Bacterial infection|12|||
156630430|NCT03039699|565391424|FG001|Overall Study|Bacterial infection|28|||
156630431|NCT01790633|565391425|FG000|Overall Study|Protocol Violation|1|||
156630432|NCT01790633|565391426|FG001|Overall Study|Protocol Violation|2|||
156630433|NCT01790633|565391425|FG000|Overall Study|Did not have serology performed|47|||
156630434|NCT01790633|565391426|FG001|Overall Study|Did not have serology performed|0|||
156630435|NCT01790633|565391425|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
156630436|NCT01790633|565391426|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
156630437|NCT01479777|565393109|FG000|Overall Study|Physician Decision|2|||
156630438|NCT00869362|565393118|FG000|Overall Study|Death|0|||
156630439|NCT00869362|565393119|FG001|Overall Study|Death|2|||
156630440|NCT00869362|565393118|FG000|Overall Study|Lost to Follow-up|1|||
156630441|NCT00869362|565393119|FG001|Overall Study|Lost to Follow-up|3|||
156630442|NCT02815540|565393123|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
156630443|NCT00594568|565393124|FG000|Initial Treatment|Adverse Event|51|||
156630444|NCT00594568|565393125|FG001|Initial Treatment|Adverse Event|121|||
156630445|NCT00594568|565393126|FG002|Initial Treatment|Adverse Event|144|||
156630446|NCT00594568|565393124|FG000|Initial Treatment|Death|6|||
156630447|NCT00594568|565393125|FG001|Initial Treatment|Death|11|||
156630448|NCT00594568|565393126|FG002|Initial Treatment|Death|15|||
156630449|NCT00594568|565393124|FG000|Initial Treatment|Lost to Follow-up|4|||
156630450|NCT00594568|565393125|FG001|Initial Treatment|Lost to Follow-up|1|||
156630451|NCT00594568|565393126|FG002|Initial Treatment|Lost to Follow-up|4|||
156630452|NCT00594568|565393124|FG000|Initial Treatment|Physician Decision|3|||
156630453|NCT00594568|565393125|FG001|Initial Treatment|Physician Decision|2|||
156630454|NCT00594568|565393126|FG002|Initial Treatment|Physician Decision|4|||
156630455|NCT00594568|565393124|FG000|Initial Treatment|Protocol Violation|2|||
156630456|NCT00594568|565393125|FG001|Initial Treatment|Protocol Violation|2|||
156630457|NCT00594568|565393126|FG002|Initial Treatment|Protocol Violation|5|||
156630458|NCT00594568|565393124|FG000|Initial Treatment|Withdrawal by Subject|25|||
156630459|NCT00594568|565393125|FG001|Initial Treatment|Withdrawal by Subject|31|||
156630460|NCT00594568|565393126|FG002|Initial Treatment|Withdrawal by Subject|46|||
156630461|NCT00594568|565393124|FG000|Initial Treatment|Sponsor decision|193|||
156630462|NCT00594568|565393125|FG001|Initial Treatment|Sponsor decision|142|||
156630463|NCT00594568|565393126|FG002|Initial Treatment|Sponsor decision|147|||
156630464|NCT00594568|565393124|FG000|Initial Treatment|Caregiver decision|21|||
156630465|NCT00594568|565393125|FG001|Initial Treatment|Caregiver decision|36|||
156630466|NCT00594568|565393126|FG002|Initial Treatment|Caregiver decision|36|||
156630467|NCT00594568|565393124|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
156630468|NCT00594568|565393125|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
156630469|NCT00594568|565393126|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
156630470|NCT00594568|565393124|FG000|Initial Treatment|Entry criteria exclusion|0|||
156630471|NCT00594568|565393125|FG001|Initial Treatment|Entry criteria exclusion|1|||
156630472|NCT00594568|565393126|FG002|Initial Treatment|Entry criteria exclusion|1|||
156630473|NCT00594568|565393124|FG000|Delayed Start|Death|0|||
156630474|NCT00594568|565393125|FG001|Delayed Start|Death|0|||
156630475|NCT00594568|565393126|FG002|Delayed Start|Death|1|||
156630476|NCT00594568|565393124|FG000|Delayed Start|Adverse Event|12|||
156630477|NCT00594568|565393125|FG001|Delayed Start|Adverse Event|2|||
156630478|NCT00594568|565393126|FG002|Delayed Start|Adverse Event|2|||
156630479|NCT00594568|565393124|FG000|Delayed Start|Withdrawal by Subject|4|||
156630480|NCT00594568|565393125|FG001|Delayed Start|Withdrawal by Subject|3|||
156630481|NCT00594568|565393126|FG002|Delayed Start|Withdrawal by Subject|0|||
156630482|NCT00594568|565393124|FG000|Delayed Start|Physician Decision|0|||
156630483|NCT00594568|565393125|FG001|Delayed Start|Physician Decision|0|||
156630484|NCT00594568|565393126|FG002|Delayed Start|Physician Decision|1|||
156630485|NCT00594568|565393124|FG000|Delayed Start|Lost to Follow-up|0|||
156630486|NCT00594568|565393125|FG001|Delayed Start|Lost to Follow-up|0|||
156630487|NCT00594568|565393126|FG002|Delayed Start|Lost to Follow-up|1|||
156630488|NCT00594568|565393124|FG000|Delayed Start|Caregiver Decision|5|||
156630489|NCT00594568|565393125|FG001|Delayed Start|Caregiver Decision|6|||
156630490|NCT00594568|565393126|FG002|Delayed Start|Caregiver Decision|2|||
156630491|NCT00594568|565393124|FG000|Delayed Start|Sponsor Decision|77|||
156630492|NCT00594568|565393125|FG001|Delayed Start|Sponsor Decision|66|||
156630493|NCT00594568|565393126|FG002|Delayed Start|Sponsor Decision|59|||
156630494|NCT00594568|565393124|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
156630495|NCT00594568|565393125|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
156630496|NCT00594568|565393126|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
156630497|NCT00594568|565393124|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
156630498|NCT00594568|565393125|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
156630499|NCT00594568|565393126|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
156630500|NCT00594568|565393124|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
156630501|NCT00594568|565393125|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
156630502|NCT00594568|565393126|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
156630503|NCT00594568|565393124|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
156630504|NCT00594568|565393125|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
156630505|NCT00594568|565393126|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
156630506|NCT00594568|565393124|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
156630507|NCT00594568|565393125|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
156630508|NCT00594568|565393126|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
156630509|NCT00594568|565393124|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
156630510|NCT00594568|565393125|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
156630511|NCT00594568|565393126|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
156630512|NCT02204449|565393129|FG000|Overall Study|Lost to Follow-up|7|||
156630513|NCT02204449|565393130|FG001|Overall Study|Lost to Follow-up|9|||
156630514|NCT02204449|565393129|FG000|Overall Study|Death|0|||
156630515|NCT02204449|565393130|FG001|Overall Study|Death|1|||
156630516|NCT02204449|565393129|FG000|Overall Study|Withdrawal by Subject|0|||
156630517|NCT02204449|565393130|FG001|Overall Study|Withdrawal by Subject|1|||
156630518|NCT01976663|565393133|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
156630519|NCT01976663|565393133|FG000|Overall Study|Personal Reasons|6|||
156630520|NCT01976663|565393133|FG000|Overall Study|Withdrawal by Subject|4|||
156630521|NCT01976663|565393133|FG000|Overall Study|Screen Failure|3|||
156630522|NCT01976663|565393133|FG000|Overall Study|Adverse Event|2|||
156630523|NCT01976663|565393133|FG000|Overall Study|Lost to Follow-up|3|||
156630524|NCT04780776|565393138|FG000|Titration Week 1-5|Lost to Follow-up|2|||
156630525|NCT04780776|565393139|FG001|Titration Week 1-5|Lost to Follow-up|8|||
156630526|NCT04780776|565393138|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
156630527|NCT04780776|565393139|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
156630528|NCT04780776|565393138|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
156630529|NCT04780776|565393139|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
156630530|NCT03113760|565393141|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
156630531|NCT03113760|565393142|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
156630532|NCT03113760|565393143|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
156630533|NCT03113760|565393144|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
156630534|NCT03113760|565393141|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
156630535|NCT03113760|565393142|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
156630536|NCT03113760|565393143|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
156630537|NCT03113760|565393144|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
156630538|NCT03113760|565393141|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
156630539|NCT03113760|565393142|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
156630540|NCT03113760|565393143|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
156630541|NCT03113760|565393144|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
156630542|NCT04196023|565393148|FG000|Overall Study|Withdrawal by Subject|0|||
156630543|NCT04196023|565393149|FG001|Overall Study|Withdrawal by Subject|1|||
156630544|NCT04196023|565393148|FG000|Overall Study|Adverse Event|3|||
156630545|NCT04196023|565393149|FG001|Overall Study|Adverse Event|1|||
156630546|NCT04196023|565393148|FG000|Overall Study|Lost to Follow-up|0|||
156630547|NCT04196023|565393149|FG001|Overall Study|Lost to Follow-up|1|||
156630548|NCT04359758|565393156|FG000|Overall Study|Protocol Violation|3|||
156630549|NCT04359758|565393157|FG001|Overall Study|Protocol Violation|2|||
156630550|NCT03358407|565393161|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630551|NCT03358407|565393162|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630552|NCT03358407|565393163|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
156630553|NCT03358407|565393164|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630554|NCT03358407|565393165|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630555|NCT03358407|565393166|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630556|NCT03358407|565393167|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630557|NCT03358407|565393168|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630558|NCT03358407|565393169|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630559|NCT03358407|565393170|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
156630560|NCT03358407|565393161|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630561|NCT03358407|565393162|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630562|NCT03358407|565393163|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630563|NCT03358407|565393164|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630564|NCT03358407|565393165|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
156630565|NCT03358407|565393166|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630566|NCT03358407|565393167|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630567|NCT03358407|565393168|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630568|NCT03358407|565393169|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630569|NCT03358407|565393170|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630570|NCT03358407|565393161|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
156630571|NCT03358407|565393162|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
156630572|NCT03358407|565393163|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
156630573|NCT03358407|565393164|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
156630574|NCT03358407|565393165|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
156630575|NCT03358407|565393166|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
156630576|NCT03358407|565393167|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
156630577|NCT03358407|565393168|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
156630578|NCT03358407|565393169|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
156630579|NCT03358407|565393170|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
156630580|NCT03358407|565393161|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
156630581|NCT03358407|565393162|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
156630582|NCT03358407|565393163|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
156630583|NCT03358407|565393164|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
156630584|NCT03358407|565393165|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
156630585|NCT03358407|565393166|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
156630586|NCT03358407|565393167|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
156630587|NCT03358407|565393168|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
156630588|NCT03358407|565393169|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
156630589|NCT03358407|565393170|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
156630590|NCT03358407|565393161|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630591|NCT03358407|565393162|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630592|NCT03358407|565393163|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630593|NCT03358407|565393164|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630594|NCT03358407|565393165|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630595|NCT03358407|565393166|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
156630596|NCT03358407|565393167|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
156630597|NCT03358407|565393168|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630598|NCT03358407|565393169|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630599|NCT03358407|565393170|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
156630600|NCT03358407|565393161|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
156630601|NCT03358407|565393162|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
156630602|NCT03358407|565393163|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
156630603|NCT03358407|565393164|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
156630604|NCT03358407|565393165|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
156630605|NCT03358407|565393166|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
156630606|NCT03358407|565393167|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
156630607|NCT03358407|565393168|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
156630608|NCT03358407|565393169|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
156630609|NCT03358407|565393170|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
156630610|NCT00483574|565393171|FG000|Overall Study|Adverse Event|6|||
156630611|NCT00483574|565393172|FG001|Overall Study|Adverse Event|0|||
156630612|NCT00483574|565393171|FG000|Overall Study|Protocol Violation|28|||
156630613|NCT00483574|565393172|FG001|Overall Study|Protocol Violation|9|||
156630614|NCT00483574|565393171|FG000|Overall Study|Lost to Follow-up|16|||
156630615|NCT00483574|565393172|FG001|Overall Study|Lost to Follow-up|4|||
156630616|NCT00483574|565393171|FG000|Overall Study|Withdrawal by Subject|52|||
156630617|NCT00483574|565393172|FG001|Overall Study|Withdrawal by Subject|0|||
156630618|NCT03605758|565393173|FG000|Overall Study|Lost to Follow-up|2|||
156630619|NCT03605758|565393174|FG001|Overall Study|Lost to Follow-up|1|||
156630620|NCT03605758|565393173|FG000|Overall Study|Illness|0|||
156630621|NCT03605758|565393174|FG001|Overall Study|Illness|1|||
156630622|NCT03605758|565393173|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
156630623|NCT03605758|565393174|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
156630624|NCT04753606|565393177|FG000|Overall Study|Adverse Event|1|||
156630625|NCT04753606|565393178|FG001|Overall Study|Adverse Event|0|||
156630626|NCT04753606|565393179|FG002|Overall Study|Adverse Event|0|||
156630627|NCT00489411|565393180|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
156630628|NCT00489411|565393181|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
156630629|NCT00489411|565393180|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
156630630|NCT00489411|565393181|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
156630631|NCT00489411|565393180|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
156630632|NCT00489411|565393181|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
156630633|NCT00489411|565393180|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
156630634|NCT00489411|565393181|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
156630635|NCT00489411|565393180|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
156630636|NCT00489411|565393181|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
156630637|NCT01748162|565393184|FG000|Overall Study|no additional croup episodes to evaluate|2|||
156630638|NCT01748162|565393185|FG001|Overall Study|no additional croup episodes to evaluate|2|||
156630639|NCT01748162|565393184|FG000|Overall Study|participant consented but did not begin|0|||
156630640|NCT01748162|565393185|FG001|Overall Study|participant consented but did not begin|1|||
156630641|NCT01748162|565393184|FG000|Overall Study|reasons not available|3|||
156630642|NCT01748162|565393185|FG001|Overall Study|reasons not available|2|||
156630643|NCT03219372|565393186|FG000|Overall Study|Withdrawal by Subject|1|||
156630644|NCT03219372|565393187|FG001|Overall Study|Withdrawal by Subject|0|||
156630645|NCT03841331|565393188|FG000|Overall Study|Withdrawal by Subject|4|||
156630646|NCT03841331|565393189|FG001|Overall Study|Withdrawal by Subject|9|||
156630647|NCT03841331|565393188|FG000|Overall Study|Lost to Follow-up|5|||
156630648|NCT03841331|565393189|FG001|Overall Study|Lost to Follow-up|1|||
156630649|NCT04145531|565393190|FG000|Part A|Adverse Event|2|||
156630650|NCT04145531|565393191|FG001|Part A|Adverse Event|12|||
156630651|NCT04145531|565393192|FG002|Part A|Adverse Event|6|||
156630652|NCT04145531|565393193|FG003|Part A|Adverse Event|0|||
156630653|NCT04145531|565393190|FG000|Part A|Death|1|||
156630654|NCT04145531|565393191|FG001|Part A|Death|2|||
156630655|NCT04145531|565393192|FG002|Part A|Death|0|||
156630656|NCT04145531|565393193|FG003|Part A|Death|0|||
156630657|NCT04145531|565393190|FG000|Part A|Physician Decision|2|||
156630658|NCT04145531|565393191|FG001|Part A|Physician Decision|5|||
156630659|NCT04145531|565393192|FG002|Part A|Physician Decision|2|||
156630660|NCT04145531|565393193|FG003|Part A|Physician Decision|0|||
156630661|NCT04145531|565393190|FG000|Part A|Progressive disease|0|||
156630662|NCT04145531|565393191|FG001|Part A|Progressive disease|2|||
156630663|NCT04145531|565393192|FG002|Part A|Progressive disease|1|||
156630664|NCT04145531|565393193|FG003|Part A|Progressive disease|0|||
156630665|NCT04145531|565393190|FG000|Part A|Protocol deviation|0|||
156630666|NCT04145531|565393191|FG001|Part A|Protocol deviation|0|||
156630667|NCT04145531|565393192|FG002|Part A|Protocol deviation|1|||
156630668|NCT04145531|565393193|FG003|Part A|Protocol deviation|0|||
156630669|NCT04145531|565393190|FG000|Part A|Withdrawal by parent or guardian|1|||
156630670|NCT04145531|565393191|FG001|Part A|Withdrawal by parent or guardian|0|||
156630671|NCT04145531|565393192|FG002|Part A|Withdrawal by parent or guardian|0|||
156630672|NCT04145531|565393193|FG003|Part A|Withdrawal by parent or guardian|0|||
156630673|NCT04145531|565393190|FG000|Part A|Withdrawal by participant|0|||
156630674|NCT04145531|565393191|FG001|Part A|Withdrawal by participant|0|||
156630675|NCT04145531|565393192|FG002|Part A|Withdrawal by participant|1|||
156630676|NCT04145531|565393193|FG003|Part A|Withdrawal by participant|0|||
156630677|NCT04145531|565393190|FG000|Part A|Other|0|||
156630678|NCT04145531|565393191|FG001|Part A|Other|0|||
156630679|NCT04145531|565393192|FG002|Part A|Other|1|||
156630680|NCT04145531|565393193|FG003|Part A|Other|0|||
156630681|NCT04145531|565393190|FG000|Part B|Adverse Event|0|||
156630682|NCT04145531|565393191|FG001|Part B|Adverse Event|0|||
156630683|NCT04145531|565393192|FG002|Part B|Adverse Event|0|||
156630684|NCT04145531|565393193|FG003|Part B|Adverse Event|21|||
156630685|NCT04145531|565393190|FG000|Part B|Physician Decision|0|||
156630686|NCT04145531|565393191|FG001|Part B|Physician Decision|0|||
156630687|NCT04145531|565393192|FG002|Part B|Physician Decision|0|||
156630688|NCT04145531|565393193|FG003|Part B|Physician Decision|7|||
156630689|NCT04145531|565393190|FG000|Part B|Progressive disease|0|||
156630690|NCT04145531|565393191|FG001|Part B|Progressive disease|0|||
156630691|NCT04145531|565393192|FG002|Part B|Progressive disease|0|||
156630692|NCT04145531|565393193|FG003|Part B|Progressive disease|1|||
156630693|NCT04145531|565393190|FG000|Part B|Recurrent disease|0|||
156630694|NCT04145531|565393191|FG001|Part B|Recurrent disease|0|||
156630695|NCT04145531|565393192|FG002|Part B|Recurrent disease|0|||
156630696|NCT04145531|565393193|FG003|Part B|Recurrent disease|1|||
156630697|NCT04145531|565393190|FG000|Part B|Withdrawal by parent or guardian|0|||
156630698|NCT04145531|565393191|FG001|Part B|Withdrawal by parent or guardian|0|||
156630699|NCT04145531|565393192|FG002|Part B|Withdrawal by parent or guardian|0|||
156630700|NCT04145531|565393193|FG003|Part B|Withdrawal by parent or guardian|3|||
156630701|NCT04145531|565393190|FG000|Part B|Withdrawal by participant|0|||
156630702|NCT04145531|565393191|FG001|Part B|Withdrawal by participant|0|||
156630703|NCT04145531|565393192|FG002|Part B|Withdrawal by participant|0|||
156630704|NCT04145531|565393193|FG003|Part B|Withdrawal by participant|1|||
156630705|NCT04145531|565393190|FG000|Part B|Other|0|||
156630706|NCT04145531|565393191|FG001|Part B|Other|0|||
156630707|NCT04145531|565393192|FG002|Part B|Other|0|||
156630708|NCT04145531|565393193|FG003|Part B|Other|1|||
156630709|NCT04640168|565393194|FG000|Overall Study|Withdrawal by Subject|8|||
156630710|NCT04640168|565393195|FG001|Overall Study|Withdrawal by Subject|7|||
156630711|NCT04640168|565393194|FG000|Overall Study|Lost to Follow-up|1|||
156630712|NCT04640168|565393195|FG001|Overall Study|Lost to Follow-up|0|||
156630713|NCT04640168|565393194|FG000|Overall Study|Enrolled but not treated|12|||
156630714|NCT04640168|565393195|FG001|Overall Study|Enrolled but not treated|12|||
156630715|NCT00779857|565393196|FG000|Overall Study|Death|1|||
156630716|NCT00779857|565393196|FG000|Overall Study|Withdrawal by Subject|3|||
156630717|NCT00779857|565393196|FG000|Overall Study|Missed Visit|2|||
156630718|NCT00442572|565393204|FG000|Overall Study|Relapse|8|||
156630719|NCT00442572|565393205|FG001|Overall Study|Relapse|1|||
156630720|NCT00442572|565393204|FG000|Overall Study|Lost to Follow-up|0|||
156630721|NCT00442572|565393205|FG001|Overall Study|Lost to Follow-up|1|||
156630722|NCT00442572|565393204|FG000|Overall Study|Withdrawal by Subject|0|||
156630723|NCT00442572|565393205|FG001|Overall Study|Withdrawal by Subject|1|||
156630724|NCT04366258|565393206|FG000|Baseline Assessments|Screen Failure|21|||
156630725|NCT04366258|565393206|FG000|Baseline Assessments|Early Termination|3|||
156630726|NCT00276458|565393208|FG000|Overall Study|Adverse Event|0|||
156630727|NCT00276458|565393209|FG001|Overall Study|Adverse Event|2|||
156630728|NCT00276458|565393208|FG000|Overall Study|Lost to Follow-up|2|||
156630729|NCT00276458|565393209|FG001|Overall Study|Lost to Follow-up|2|||
156630730|NCT00276458|565393208|FG000|Overall Study|Protocol Violation|4|||
156630731|NCT00276458|565393209|FG001|Overall Study|Protocol Violation|3|||
156630732|NCT03205046|565393213|FG000|Overall Study|Death|10|||
156630733|NCT03205046|565393214|FG001|Overall Study|Death|6|||
156630734|NCT03205046|565393213|FG000|Overall Study|Withdrawal by Subject|1|||
156630735|NCT03205046|565393214|FG001|Overall Study|Withdrawal by Subject|2|||
156630736|NCT03205046|565393213|FG000|Overall Study|Lost to Follow-up|0|||
156630737|NCT03205046|565393214|FG001|Overall Study|Lost to Follow-up|1|||
156630738|NCT03205046|565393213|FG000|Overall Study|Study terminated by sponsor|2|||
156630739|NCT03205046|565393214|FG001|Overall Study|Study terminated by sponsor|1|||
156630740|NCT01023815|565393215|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
156630741|NCT01023815|565393216|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
156630742|NCT01023815|565393217|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
156630743|NCT01023815|565393218|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
156630744|NCT01023815|565393215|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
156630745|NCT01023815|565393216|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
156630746|NCT01023815|565393217|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
156630747|NCT01023815|565393218|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
156630748|NCT01023815|565393215|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
156630749|NCT01023815|565393216|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
156630750|NCT01023815|565393217|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
156630751|NCT01023815|565393218|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
156630752|NCT01023815|565393215|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
156630753|NCT01023815|565393216|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
156630754|NCT01023815|565393217|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
156630755|NCT01023815|565393218|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
156630756|NCT01023815|565393215|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
156630757|NCT01023815|565393216|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
156630758|NCT01023815|565393217|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
156630759|NCT01023815|565393218|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
156630760|NCT01977625|565393224|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
156630761|NCT01977625|565393225|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156630762|NCT01977625|565393224|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156635569|NCT00602667|565409960|FG000|Overall Study|Second malignancy|0|||
156630763|NCT01977625|565393225|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156630764|NCT00634933|565393228|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
156630765|NCT00634933|565393229|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
156630766|NCT00634933|565393230|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
156630767|NCT00634933|565393231|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
156630768|NCT00634933|565393232|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
156630769|NCT00634933|565393228|FG000|Part A: Baseline to Week 24|Death|1|||
156630770|NCT00634933|565393229|FG001|Part A: Baseline to Week 24|Death|0|||
156630771|NCT00634933|565393230|FG002|Part A: Baseline to Week 24|Death|0|||
156630772|NCT00634933|565393231|FG003|Part A: Baseline to Week 24|Death|0|||
156630773|NCT00634933|565393232|FG004|Part A: Baseline to Week 24|Death|0|||
156630774|NCT00634933|565393228|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
156630775|NCT00634933|565393229|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
156630776|NCT00634933|565393230|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
156630777|NCT00634933|565393231|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
156630778|NCT00634933|565393232|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
156630779|NCT00634933|565393228|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
156630780|NCT00634933|565393229|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
156630781|NCT00634933|565393230|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
156630782|NCT00634933|565393231|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
156630783|NCT00634933|565393232|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
156630784|NCT00634933|565393228|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
156630785|NCT00634933|565393229|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
156630786|NCT00634933|565393230|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
156630787|NCT00634933|565393231|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
156630788|NCT00634933|565393232|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
156630789|NCT00634933|565393228|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
156630790|NCT00634933|565393229|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
156630791|NCT00634933|565393230|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
156630792|NCT00634933|565393231|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
156630793|NCT00634933|565393232|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
156630794|NCT00634933|565393228|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
156630795|NCT00634933|565393229|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
156630796|NCT00634933|565393230|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
156630797|NCT00634933|565393231|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
156630798|NCT00634933|565393232|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
156630799|NCT00634933|565393228|FG000|Part A: Baseline to Week 24|Other|1|||
156630800|NCT00634933|565393229|FG001|Part A: Baseline to Week 24|Other|8|||
156630801|NCT00634933|565393230|FG002|Part A: Baseline to Week 24|Other|5|||
156630802|NCT00634933|565393231|FG003|Part A: Baseline to Week 24|Other|0|||
156630803|NCT00634933|565393232|FG004|Part A: Baseline to Week 24|Other|0|||
156630804|NCT00634933|565393228|FG000|Between Part A and Part B|Physician Decision|0|||
156630805|NCT00634933|565393229|FG001|Between Part A and Part B|Physician Decision|1|||
156630806|NCT00634933|565393230|FG002|Between Part A and Part B|Physician Decision|0|||
156630807|NCT00634933|565393231|FG003|Between Part A and Part B|Physician Decision|0|||
156630808|NCT00634933|565393232|FG004|Between Part A and Part B|Physician Decision|0|||
156630809|NCT00634933|565393228|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
156630810|NCT00634933|565393229|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
156630811|NCT00634933|565393230|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
156630812|NCT00634933|565393231|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
156630813|NCT00634933|565393232|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
156630814|NCT00634933|565393228|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
156630815|NCT00634933|565393229|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
156630816|NCT00634933|565393230|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
156630817|NCT00634933|565393231|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
156630818|NCT00634933|565393232|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
156630819|NCT00634933|565393228|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
156630820|NCT00634933|565393229|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
156630821|NCT00634933|565393230|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
156630822|NCT00634933|565393231|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
156630823|NCT00634933|565393232|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
156630824|NCT00634933|565393228|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
156630825|NCT00634933|565393229|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
156630826|NCT00634933|565393230|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
156630827|NCT00634933|565393231|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
156630828|NCT00634933|565393232|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
156630829|NCT00634933|565393228|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
156630830|NCT00634933|565393229|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
156630831|NCT00634933|565393230|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
156630832|NCT00634933|565393231|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
156630833|NCT00634933|565393232|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
156630834|NCT00634933|565393228|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
156630835|NCT00634933|565393229|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
156630836|NCT00634933|565393230|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
156630837|NCT00634933|565393231|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
156630838|NCT00634933|565393232|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
156630839|NCT00634933|565393228|FG000|Part B: Week 24 to Week 52|Other|0|||
156630840|NCT00634933|565393229|FG001|Part B: Week 24 to Week 52|Other|0|||
156630841|NCT00634933|565393230|FG002|Part B: Week 24 to Week 52|Other|5|||
156630842|NCT00634933|565393231|FG003|Part B: Week 24 to Week 52|Other|0|||
156630843|NCT00634933|565393232|FG004|Part B: Week 24 to Week 52|Other|1|||
156630844|NCT02304484|565393233|FG000|Overall Study|Death|9|||
156630845|NCT02304484|565393233|FG000|Overall Study|Withdrawal by Subject|14|||
156630846|NCT02304484|565393233|FG000|Overall Study|Lost to Follow-up|2|||
156630847|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Adverse Event|6|||
156630848|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Adverse Event|6|||
156630849|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Death|14|||
156630850|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Death|11|||
156630851|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
156630852|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
156630853|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
156630854|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
156630855|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
156630856|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
156630857|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Disease Progression|1|||
156630858|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Disease Progression|0|||
156630859|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
156630860|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
156630861|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
156630862|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
156630863|NCT04419558|565393234|FG000|DB Period (48 Weeks)|Participant Decision|4|||
156630864|NCT04419558|565393235|FG001|DB Period (48 Weeks)|Participant Decision|3|||
156630865|NCT04419558|565393234|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
156630866|NCT04419558|565393235|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
156630867|NCT04419558|565393234|FG000|OLE Period (48 Weeks)|Death|4|||
156630868|NCT04419558|565393235|FG001|OLE Period (48 Weeks)|Death|6|||
156630869|NCT04419558|565393234|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
156630870|NCT04419558|565393235|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
156630871|NCT04419558|565393234|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
156630872|NCT04419558|565393235|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
156630873|NCT01539512|565393236|FG000|Overall Study|Adverse Event|9|||
156630874|NCT01539512|565393237|FG001|Overall Study|Adverse Event|7|||
156630875|NCT01539512|565393236|FG000|Overall Study|Physician Decision|1|||
156630876|NCT01539512|565393237|FG001|Overall Study|Physician Decision|1|||
156630877|NCT01539512|565393236|FG000|Overall Study|Withdrawal by Subject|12|||
156630878|NCT01539512|565393237|FG001|Overall Study|Withdrawal by Subject|5|||
156630879|NCT01539512|565393236|FG000|Overall Study|Richter's Transformation|1|||
156630880|NCT01539512|565393237|FG001|Overall Study|Richter's Transformation|0|||
156630881|NCT03522506|565393238|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156630882|NCT03522506|565393239|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156630883|NCT03522506|565393240|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156630884|NCT03522506|565393241|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156630885|NCT03522506|565393238|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
156630886|NCT03522506|565393239|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
156630887|NCT03522506|565393240|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
156630888|NCT03522506|565393241|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
156630889|NCT03480243|565393242|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
156630890|NCT03480243|565393242|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
156630891|NCT04365387|565393243|FG000|Overall Study|Adverse Event|4|||
156630892|NCT04365387|565393244|FG001|Overall Study|Adverse Event|2|||
156630893|NCT04365387|565393243|FG000|Overall Study|Participants request|14|||
156630894|NCT04365387|565393244|FG001|Overall Study|Participants request|14|||
156630895|NCT04365387|565393243|FG000|Overall Study|Lost to Follow-up|8|||
156630896|NCT04365387|565393244|FG001|Overall Study|Lost to Follow-up|5|||
156630897|NCT04365387|565393243|FG000|Overall Study|Protocol deviation|3|||
156630898|NCT04365387|565393244|FG001|Overall Study|Protocol deviation|4|||
156630899|NCT04365387|565393243|FG000|Overall Study|Participant compliance with visit schedule|1|||
156630900|NCT04365387|565393244|FG001|Overall Study|Participant compliance with visit schedule|0|||
156630901|NCT04365387|565393243|FG000|Overall Study|Participant incarcerated|1|||
156630902|NCT04365387|565393244|FG001|Overall Study|Participant incarcerated|0|||
156630903|NCT04365387|565393243|FG000|Overall Study|Participant moved out of town (relocated)|0|||
156630904|NCT04365387|565393244|FG001|Overall Study|Participant moved out of town (relocated)|1|||
156630905|NCT04365387|565393243|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
156630906|NCT04365387|565393244|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
156630907|NCT04365387|565393243|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
156630908|NCT04365387|565393244|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
156630909|NCT05770401|565393245|FG000|Overall Study|Lost to Follow-up|5|||
156630910|NCT05770401|565393246|FG001|Overall Study|Lost to Follow-up|4|||
156630911|NCT04410991|565393249|FG000|Overall Study|Poor compliance to protocol|5|||
156630912|NCT04410991|565393250|FG001|Overall Study|Poor compliance to protocol|4|||
156630913|NCT04410991|565393249|FG000|Overall Study|Withdrawal by Subject|59|||
156630914|NCT04410991|565393250|FG001|Overall Study|Withdrawal by Subject|55|||
156630915|NCT04410991|565393249|FG000|Overall Study|Other|10|||
156630916|NCT04410991|565393250|FG001|Overall Study|Other|4|||
156630917|NCT00764465|565393251|FG000|Overall Study|Adverse Event|2|||
156630918|NCT00764465|565393252|FG001|Overall Study|Adverse Event|0|||
156630919|NCT00764465|565393253|FG002|Overall Study|Adverse Event|0|||
156630920|NCT00764465|565393254|FG003|Overall Study|Adverse Event|1|||
156630921|NCT00764465|565393255|FG004|Overall Study|Adverse Event|1|||
156630922|NCT00764465|565393256|FG005|Overall Study|Adverse Event|1|||
156630923|NCT00764465|565393251|FG000|Overall Study|Withdrawal by Subject|0|||
156630924|NCT00764465|565393252|FG001|Overall Study|Withdrawal by Subject|1|||
156630925|NCT00764465|565393253|FG002|Overall Study|Withdrawal by Subject|1|||
156630926|NCT00764465|565393254|FG003|Overall Study|Withdrawal by Subject|0|||
156630927|NCT00764465|565393255|FG004|Overall Study|Withdrawal by Subject|0|||
156630928|NCT00764465|565393256|FG005|Overall Study|Withdrawal by Subject|0|||
156630929|NCT03329404|565393257|FG000|Overall Study|The study was suspended.|1|||
156630930|NCT03329404|565393258|FG001|Overall Study|The study was suspended.|4|||
156630931|NCT00761462|565394906|FG000|Treatment|Subjects never received study medication|23|||
156630932|NCT00761462|565394907|FG001|Treatment|Subjects never received study medication|12|||
156630933|NCT00761462|565394906|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
156630934|NCT00761462|565394907|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
156630935|NCT00761462|565394906|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
156630936|NCT00761462|565394907|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
156630937|NCT00761462|565394906|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
156630938|NCT00761462|565394907|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
156630939|NCT02985541|565394911|FG000|Overall Study|Withdrawal by Subject|33|||
156630940|NCT02985541|565394911|FG000|Overall Study|Lost to Follow-up|26|||
156630941|NCT02985541|565394911|FG000|Overall Study|Adverse Event|27|||
156630942|NCT02985541|565394911|FG000|Overall Study|Physician Decision|2|||
156630943|NCT02985541|565394911|FG000|Overall Study|Pregnancy|2|||
156630944|NCT02985541|565394911|FG000|Overall Study|Wish for pregnancy|44|||
156630945|NCT02985541|565394911|FG000|Overall Study|Other reason|5|||
156630946|NCT02985541|565394911|FG000|Overall Study|Not valid for analysis|2|||
156630947|NCT02163759|565394912|FG000|Overall Study|Withdrawal by Subject|1|||
156630948|NCT02163759|565394913|FG001|Overall Study|Withdrawal by Subject|5|||
156630949|NCT02163759|565394914|FG002|Overall Study|Withdrawal by Subject|1|||
156630950|NCT02163759|565394912|FG000|Overall Study|Adverse Event|0|||
156630951|NCT02163759|565394913|FG001|Overall Study|Adverse Event|0|||
156630952|NCT02163759|565394914|FG002|Overall Study|Adverse Event|1|||
156630953|NCT02163759|565394912|FG000|Overall Study|Death|0|||
156630954|NCT02163759|565394913|FG001|Overall Study|Death|0|||
156630955|NCT02163759|565394914|FG002|Overall Study|Death|1|||
156630956|NCT00451191|565394923|FG000|Overall Study|withdrawal or received alternate tx|15|||
156630957|NCT00451191|565394924|FG001|Overall Study|withdrawal or received alternate tx|11|||
156630958|NCT00656669|565394932|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
156630959|NCT00656669|565394932|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
156630960|NCT00656669|565394932|FG000|AC (Cycles 6-9)|Adverse Event|1|||
156630961|NCT00656669|565394932|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
156630962|NCT03575806|565394933|FG000|Overall Study|Withdrawal by Subject|0|||
156630963|NCT03575806|565394934|FG001|Overall Study|Withdrawal by Subject|2|||
156630964|NCT03575806|565394933|FG000|Overall Study|Protocol Violation|0|||
156630965|NCT03575806|565394934|FG001|Overall Study|Protocol Violation|2|||
156630966|NCT00219349|565394935|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
156630967|NCT00219349|565394935|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
156630968|NCT00219349|565394935|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
156630969|NCT00219349|565394935|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
156630970|NCT01945034|565394936|FG000|Overall Study|Medication Error|0|||
156630971|NCT01945034|565394937|FG001|Overall Study|Medication Error|1|||
156630972|NCT01945034|565394938|FG002|Overall Study|Medication Error|0|||
156630973|NCT01945034|565394936|FG000|Overall Study|Withdrawal by Subject|0|||
156630974|NCT01945034|565394937|FG001|Overall Study|Withdrawal by Subject|3|||
156630975|NCT01945034|565394938|FG002|Overall Study|Withdrawal by Subject|1|||
156630976|NCT01945034|565394936|FG000|Overall Study|Other|0|||
156630977|NCT01945034|565394937|FG001|Overall Study|Other|1|||
156630978|NCT01945034|565394938|FG002|Overall Study|Other|3|||
156630979|NCT01945034|565394936|FG000|Overall Study|Lost to Follow-up|0|||
156630980|NCT01945034|565394937|FG001|Overall Study|Lost to Follow-up|0|||
156630981|NCT01945034|565394938|FG002|Overall Study|Lost to Follow-up|2|||
156630982|NCT01945034|565394936|FG000|Overall Study|Protocol Violation|1|||
156630983|NCT01945034|565394937|FG001|Overall Study|Protocol Violation|0|||
156630984|NCT01945034|565394938|FG002|Overall Study|Protocol Violation|1|||
156630985|NCT02222246|565394946|FG000|Overall Study|No Emergency Department Visits|27|||
156630986|NCT02222246|565394947|FG001|Overall Study|No Emergency Department Visits|26|||
156630987|NCT02222246|565394946|FG000|Overall Study|Physician Decision|0|||
156630988|NCT02222246|565394947|FG001|Overall Study|Physician Decision|1|||
156630989|NCT02064231|565394950|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
156630990|NCT02064231|565394951|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
156630991|NCT02064231|565394952|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
156630992|NCT02064231|565394953|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
156630993|NCT02064231|565394950|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
156630994|NCT02064231|565394951|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
156630995|NCT02064231|565394952|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
156630996|NCT02064231|565394953|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
156630997|NCT02064231|565394950|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
156630998|NCT02064231|565394951|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
156630999|NCT02064231|565394952|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
156631000|NCT02064231|565394953|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
156631001|NCT02064231|565394950|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
156631002|NCT02064231|565394951|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
156631003|NCT02064231|565394952|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
156631004|NCT02064231|565394953|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
156631005|NCT00560573|565394956|FG000|Overall Study|Death|4|||
156631006|NCT00560573|565394957|FG001|Overall Study|Death|1|||
156631007|NCT00560573|565394958|FG002|Overall Study|Death|4|||
156631008|NCT00560573|565394959|FG003|Overall Study|Death|5|||
156631009|NCT00560573|565394960|FG004|Overall Study|Death|1|||
156631010|NCT00560573|565394961|FG005|Overall Study|Death|10|||
156631011|NCT00560573|565394956|FG000|Overall Study|Lost to Follow-up|0|||
156631012|NCT00560573|565394957|FG001|Overall Study|Lost to Follow-up|0|||
156631013|NCT00560573|565394958|FG002|Overall Study|Lost to Follow-up|0|||
156631014|NCT00560573|565394959|FG003|Overall Study|Lost to Follow-up|1|||
156631015|NCT00560573|565394960|FG004|Overall Study|Lost to Follow-up|1|||
156631016|NCT00560573|565394961|FG005|Overall Study|Lost to Follow-up|0|||
156631017|NCT00560573|565394956|FG000|Overall Study|Withdrawal by Subject|0|||
156631018|NCT00560573|565394957|FG001|Overall Study|Withdrawal by Subject|0|||
156631019|NCT00560573|565394958|FG002|Overall Study|Withdrawal by Subject|0|||
156631020|NCT00560573|565394959|FG003|Overall Study|Withdrawal by Subject|1|||
156631021|NCT00560573|565394960|FG004|Overall Study|Withdrawal by Subject|1|||
156631022|NCT00560573|565394961|FG005|Overall Study|Withdrawal by Subject|0|||
156631023|NCT00560573|565394956|FG000|Overall Study|Other|2|||
156631024|NCT00560573|565394957|FG001|Overall Study|Other|2|||
156631025|NCT00560573|565394958|FG002|Overall Study|Other|2|||
156631026|NCT00560573|565394959|FG003|Overall Study|Other|3|||
156631027|NCT00560573|565394960|FG004|Overall Study|Other|3|||
156631028|NCT00560573|565394961|FG005|Overall Study|Other|3|||
156631029|NCT00560573|565394956|FG000|Overall Study|Enrolled, not treated|0|||
156631030|NCT00560573|565394957|FG001|Overall Study|Enrolled, not treated|0|||
156631031|NCT00560573|565394958|FG002|Overall Study|Enrolled, not treated|0|||
156631032|NCT00560573|565394959|FG003|Overall Study|Enrolled, not treated|0|||
156631033|NCT00560573|565394960|FG004|Overall Study|Enrolled, not treated|1|||
156631034|NCT00560573|565394961|FG005|Overall Study|Enrolled, not treated|0|||
156631035|NCT01339273|565394962|FG000|Overall Study|Lost to Follow-up|8|||
156631036|NCT01339273|565394963|FG001|Overall Study|Lost to Follow-up|8|||
156631037|NCT01422876|565394965|FG000|Week 24|Lost to Follow-up|1|||
156631038|NCT01422876|565394966|FG001|Week 24|Lost to Follow-up|1|||
156631039|NCT01422876|565394967|FG002|Week 24|Lost to Follow-up|2|||
156631040|NCT01422876|565394968|FG003|Week 24|Lost to Follow-up|4|||
156631041|NCT01422876|565394969|FG004|Week 24|Lost to Follow-up|2|||
156631042|NCT01422876|565394970|FG005|Week 24|Lost to Follow-up|0|||
156631043|NCT01422876|565394971|FG006|Week 24|Lost to Follow-up|1|||
156631044|NCT01422876|565394972|FG007|Week 24|Lost to Follow-up|3|||
156631045|NCT01422876|565394973|FG008|Week 24|Lost to Follow-up|3|||
156631046|NCT01422876|565394974|FG009|Week 24|Lost to Follow-up|4|||
156631047|NCT01422876|565394965|FG000|Week 24|Consent withdrawn|5|||
156631048|NCT01422876|565394966|FG001|Week 24|Consent withdrawn|1|||
156631049|NCT01422876|565394967|FG002|Week 24|Consent withdrawn|3|||
156631050|NCT01422876|565394968|FG003|Week 24|Consent withdrawn|4|||
156631051|NCT01422876|565394969|FG004|Week 24|Consent withdrawn|5|||
156631052|NCT01422876|565394970|FG005|Week 24|Consent withdrawn|6|||
156631053|NCT01422876|565394971|FG006|Week 24|Consent withdrawn|5|||
156631054|NCT01422876|565394972|FG007|Week 24|Consent withdrawn|4|||
156631055|NCT01422876|565394973|FG008|Week 24|Consent withdrawn|3|||
156631056|NCT01422876|565394974|FG009|Week 24|Consent withdrawn|6|||
156631057|NCT01422876|565394965|FG000|Week 24|Death|0|||
156631058|NCT01422876|565394966|FG001|Week 24|Death|1|||
156631059|NCT01422876|565394967|FG002|Week 24|Death|0|||
156631060|NCT01422876|565394968|FG003|Week 24|Death|0|||
156631061|NCT01422876|565394969|FG004|Week 24|Death|0|||
156631062|NCT01422876|565394970|FG005|Week 24|Death|0|||
156631063|NCT01422876|565394971|FG006|Week 24|Death|0|||
156631064|NCT01422876|565394972|FG007|Week 24|Death|0|||
156631065|NCT01422876|565394973|FG008|Week 24|Death|0|||
156631066|NCT01422876|565394974|FG009|Week 24|Death|0|||
156631067|NCT01422876|565394965|FG000|Week 52|Lost to Follow-up|3|||
156631068|NCT01422876|565394966|FG001|Week 52|Lost to Follow-up|5|||
156631069|NCT01422876|565394967|FG002|Week 52|Lost to Follow-up|7|||
156631070|NCT01422876|565394968|FG003|Week 52|Lost to Follow-up|5|||
156631071|NCT01422876|565394969|FG004|Week 52|Lost to Follow-up|8|||
156631072|NCT01422876|565394970|FG005|Week 52|Lost to Follow-up|5|||
156631073|NCT01422876|565394971|FG006|Week 52|Lost to Follow-up|5|||
156631074|NCT01422876|565394972|FG007|Week 52|Lost to Follow-up|8|||
156631075|NCT01422876|565394973|FG008|Week 52|Lost to Follow-up|7|||
156631076|NCT01422876|565394974|FG009|Week 52|Lost to Follow-up|8|||
156631077|NCT01422876|565394965|FG000|Week 52|Consent withdrawn|9|||
156631078|NCT01422876|565394966|FG001|Week 52|Consent withdrawn|4|||
156631079|NCT01422876|565394967|FG002|Week 52|Consent withdrawn|6|||
156631080|NCT01422876|565394968|FG003|Week 52|Consent withdrawn|12|||
156631081|NCT01422876|565394969|FG004|Week 52|Consent withdrawn|7|||
156631082|NCT01422876|565394970|FG005|Week 52|Consent withdrawn|12|||
156631083|NCT01422876|565394971|FG006|Week 52|Consent withdrawn|10|||
156631084|NCT01422876|565394972|FG007|Week 52|Consent withdrawn|12|||
156631085|NCT01422876|565394973|FG008|Week 52|Consent withdrawn|13|||
156631086|NCT01422876|565394974|FG009|Week 52|Consent withdrawn|9|||
156631087|NCT01422876|565394965|FG000|Week 52|Death|0|||
156631088|NCT01422876|565394966|FG001|Week 52|Death|1|||
156631089|NCT01422876|565394967|FG002|Week 52|Death|0|||
156631090|NCT01422876|565394968|FG003|Week 52|Death|1|||
156631091|NCT01422876|565394969|FG004|Week 52|Death|0|||
156631092|NCT01422876|565394970|FG005|Week 52|Death|0|||
156631093|NCT01422876|565394971|FG006|Week 52|Death|1|||
156631094|NCT01422876|565394972|FG007|Week 52|Death|3|||
156631095|NCT01422876|565394973|FG008|Week 52|Death|1|||
156631096|NCT01422876|565394974|FG009|Week 52|Death|0|||
156631097|NCT00938392|565394976|FG000|Overall Study|Adverse Event|0|||
156631098|NCT00938392|565394977|FG001|Overall Study|Adverse Event|1|||
156631099|NCT00938392|565394976|FG000|Overall Study|Withdrawal by Subject|0|||
156631100|NCT00938392|565394977|FG001|Overall Study|Withdrawal by Subject|1|||
156631101|NCT00938392|565394976|FG000|Overall Study|Lost to Follow-up|2|||
156631102|NCT00938392|565394977|FG001|Overall Study|Lost to Follow-up|2|||
156631103|NCT01366846|565394978|FG000|Overall Study|Withdrawal by Subject|2|||
156631104|NCT01366846|565394979|FG001|Overall Study|Withdrawal by Subject|0|||
156631105|NCT01366846|565394980|FG002|Overall Study|Withdrawal by Subject|0|||
156631106|NCT01366846|565394981|FG003|Overall Study|Withdrawal by Subject|0|||
156631107|NCT01366846|565394978|FG000|Overall Study|Communication Difficulties|1|||
156631108|NCT01366846|565394979|FG001|Overall Study|Communication Difficulties|4|||
156631109|NCT01366846|565394980|FG002|Overall Study|Communication Difficulties|0|||
156631110|NCT01366846|565394981|FG003|Overall Study|Communication Difficulties|1|||
156631111|NCT01366846|565394978|FG000|Overall Study|Scheduling Conflicts|0|||
156631112|NCT01366846|565394979|FG001|Overall Study|Scheduling Conflicts|0|||
156631113|NCT01366846|565394980|FG002|Overall Study|Scheduling Conflicts|1|||
156631114|NCT01366846|565394981|FG003|Overall Study|Scheduling Conflicts|0|||
156631115|NCT00558831|565394986|FG000|Overall Study|Lost to Follow-up|1|||
156631116|NCT04341727|565394987|FG000|Overall Study|Withdrawal by Subject|0|||
156631117|NCT04341727|565394988|FG001|Overall Study|Withdrawal by Subject|0|||
156631118|NCT04341727|565394989|FG002|Overall Study|Withdrawal by Subject|1|||
156631119|NCT04341727|565394990|FG003|Overall Study|Withdrawal by Subject|0|||
156631120|NCT04341727|565394987|FG000|Overall Study|Lost to Follow-up|0|||
156631121|NCT04341727|565394988|FG001|Overall Study|Lost to Follow-up|0|||
156631122|NCT04341727|565394989|FG002|Overall Study|Lost to Follow-up|0|||
156631123|NCT04341727|565394990|FG003|Overall Study|Lost to Follow-up|1|||
156631124|NCT02856282|565394991|FG000|Overall Study|Withdrawal by Subject|1|||
156631125|NCT00057330|565394992|FG000|Overall Study|Adverse Event|9|||
156631126|NCT00057330|565394993|FG001|Overall Study|Adverse Event|12|||
156631127|NCT00057330|565394992|FG000|Overall Study|Death|1|||
156631128|NCT00057330|565394993|FG001|Overall Study|Death|0|||
156631129|NCT00057330|565394992|FG000|Overall Study|Protocol Violation|1|||
156631130|NCT00057330|565394993|FG001|Overall Study|Protocol Violation|1|||
156631131|NCT00057330|565394992|FG000|Overall Study|Withdrawal by Subject|115|||
156631132|NCT00057330|565394993|FG001|Overall Study|Withdrawal by Subject|84|||
156631133|NCT00057330|565394992|FG000|Overall Study|Lost to Follow-up|745|||
156631134|NCT00057330|565394993|FG001|Overall Study|Lost to Follow-up|617|||
156631135|NCT00057330|565394992|FG000|Overall Study|Physician Decision|1|||
156631136|NCT00057330|565394993|FG001|Overall Study|Physician Decision|0|||
156631137|NCT00057330|565394992|FG000|Overall Study|Other|260|||
156631138|NCT00057330|565394993|FG001|Overall Study|Other|206|||
156631139|NCT04311411|565394997|FG000|Overall Study|Adverse Event|2|||
156631140|NCT04311411|565394998|FG001|Overall Study|Adverse Event|3|||
156631141|NCT04311411|565394999|FG002|Overall Study|Adverse Event|2|||
156631142|NCT04311411|565394997|FG000|Overall Study|Withdrawal by Subject|3|||
156631143|NCT04311411|565394998|FG001|Overall Study|Withdrawal by Subject|3|||
156631144|NCT04311411|565394999|FG002|Overall Study|Withdrawal by Subject|0|||
156631145|NCT02743117|565395002|FG000|Overall Study|Lost to Follow-up|0|||
156631146|NCT02743117|565395003|FG001|Overall Study|Lost to Follow-up|1|||
156631147|NCT02743117|565395002|FG000|Overall Study|Other|1|||
156631148|NCT02743117|565395003|FG001|Overall Study|Other|0|||
156631149|NCT02940392|565395008|FG000|Overall Study|Lost to Follow-up|3|||
156631150|NCT02940392|565395008|FG000|Overall Study|Retreatment|3|||
156631151|NCT02940392|565395008|FG000|Overall Study|Death|2|||
156631152|NCT00978120|565395009|FG000|Overall Study|Death|0|||
156631153|NCT00978120|565395010|FG001|Overall Study|Death|0|||
156631154|NCT00978120|565395011|FG002|Overall Study|Death|0|||
156631155|NCT00978120|565395012|FG003|Overall Study|Death|1|||
156631156|NCT00978120|565395009|FG000|Overall Study|Lost to Follow-up|0|||
156631157|NCT00978120|565395010|FG001|Overall Study|Lost to Follow-up|0|||
156631158|NCT00978120|565395011|FG002|Overall Study|Lost to Follow-up|3|||
156631159|NCT00978120|565395012|FG003|Overall Study|Lost to Follow-up|0|||
156631160|NCT00978120|565395009|FG000|Overall Study|Withdrawal by Subject|2|||
156631161|NCT00978120|565395010|FG001|Overall Study|Withdrawal by Subject|0|||
156631162|NCT00978120|565395011|FG002|Overall Study|Withdrawal by Subject|0|||
156631163|NCT00978120|565395012|FG003|Overall Study|Withdrawal by Subject|0|||
156631164|NCT00978120|565395009|FG000|Overall Study|Moved out of state|0|||
156631165|NCT00978120|565395010|FG001|Overall Study|Moved out of state|0|||
156631166|NCT00978120|565395011|FG002|Overall Study|Moved out of state|0|||
156631167|NCT00978120|565395012|FG003|Overall Study|Moved out of state|1|||
156631168|NCT03253809|565395013|FG000|Overall Study|Unable to obtain study related data|14|||
156631169|NCT00762073|565395016|FG000|Overall Study|Lack of Efficacy|1|||
156631170|NCT00762073|565395017|FG001|Overall Study|Lack of Efficacy|1|||
156631171|NCT00762073|565395018|FG002|Overall Study|Lack of Efficacy|0|||
156631172|NCT00762073|565395019|FG003|Overall Study|Lack of Efficacy|0|||
156631173|NCT00762073|565395016|FG000|Overall Study|Adverse Event|1|||
156631174|NCT00762073|565395017|FG001|Overall Study|Adverse Event|0|||
156631175|NCT00762073|565395018|FG002|Overall Study|Adverse Event|1|||
156631176|NCT00762073|565395019|FG003|Overall Study|Adverse Event|1|||
156631177|NCT00762073|565395016|FG000|Overall Study|Significant Subject Noncompliance|0|||
156631178|NCT00762073|565395017|FG001|Overall Study|Significant Subject Noncompliance|1|||
156631179|NCT00762073|565395018|FG002|Overall Study|Significant Subject Noncompliance|0|||
156631180|NCT00762073|565395019|FG003|Overall Study|Significant Subject Noncompliance|1|||
156631181|NCT00762073|565395016|FG000|Overall Study|Withdrawal by Subject|1|||
156631182|NCT00762073|565395017|FG001|Overall Study|Withdrawal by Subject|2|||
156631183|NCT00762073|565395018|FG002|Overall Study|Withdrawal by Subject|1|||
156631184|NCT00762073|565395019|FG003|Overall Study|Withdrawal by Subject|1|||
156631185|NCT00762073|565395016|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
156631186|NCT00762073|565395017|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
156631187|NCT00762073|565395018|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
156631188|NCT00762073|565395019|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
156631189|NCT01068418|565395020|FG000|Overall Study|Physician Decision|12|||
156631190|NCT02388906|565395022|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
156631191|NCT02388906|565395023|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
156631192|NCT02388906|565395022|FG000|Treatment Period|Disease progression|121|||
156631193|NCT02388906|565395023|FG001|Treatment Period|Disease progression|100|||
156631194|NCT02388906|565395022|FG000|Treatment Period|Study drug toxicity|41|||
156631195|NCT02388906|565395023|FG001|Treatment Period|Study drug toxicity|208|||
156631196|NCT02388906|565395022|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
156631197|NCT02388906|565395023|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
156631198|NCT02388906|565395022|FG000|Treatment Period|Participant request to stop treatment|5|||
156631199|NCT02388906|565395023|FG001|Treatment Period|Participant request to stop treatment|9|||
156631200|NCT02388906|565395022|FG000|Treatment Period|Participant withdrew consent|2|||
156631201|NCT02388906|565395023|FG001|Treatment Period|Participant withdrew consent|3|||
156631202|NCT02388906|565395022|FG000|Treatment Period|Poor/non-compliance|0|||
156631203|NCT02388906|565395023|FG001|Treatment Period|Poor/non-compliance|1|||
156631204|NCT02388906|565395022|FG000|Treatment Period|Participant no longer meets study criteria|0|||
156631205|NCT02388906|565395023|FG001|Treatment Period|Participant no longer meets study criteria|1|||
156631206|NCT02388906|565395022|FG000|Treatment Period|Other reasons|3|||
156631207|NCT02388906|565395023|FG001|Treatment Period|Other reasons|3|||
156631208|NCT00402298|565395032|FG000|Overall Study|Withdrawal by Subject|1|||
156631209|NCT00402298|565395033|FG001|Overall Study|Withdrawal by Subject|0|||
156631210|NCT00480077|565395034|FG000|Overall Study|Death|19|||
156631211|NCT00480077|565395035|FG001|Overall Study|Death|15|||
156631212|NCT00480077|565395034|FG000|Overall Study|early exit|12|||
156631213|NCT00480077|565395035|FG001|Overall Study|early exit|11|||
156631214|NCT01250418|565395048|FG000|Overall Study|monitor data failure|1|||
156631215|NCT01250418|565395049|FG001|Overall Study|monitor data failure|1|||
156631216|NCT05966129|565395052|FG000|Overall Study|Death|1|||
156631217|NCT05966129|565395053|FG001|Overall Study|Death|2|||
156631218|NCT05966129|565395052|FG000|Overall Study|Lost to Follow-up|63|||
156631219|NCT05966129|565395053|FG001|Overall Study|Lost to Follow-up|66|||
156631220|NCT05966129|565395052|FG000|Overall Study|Protocol Violation|1|||
156631221|NCT05966129|565395053|FG001|Overall Study|Protocol Violation|0|||
156631222|NCT05966129|565395052|FG000|Overall Study|Withdrawal by Subject|26|||
156631223|NCT05966129|565395053|FG001|Overall Study|Withdrawal by Subject|25|||
156631224|NCT05966129|565395052|FG000|Overall Study|Surgery not completed|63|||
156631225|NCT05966129|565395053|FG001|Overall Study|Surgery not completed|69|||
156631226|NCT05966129|565395052|FG000|Overall Study|Surgery logistics issue|2|||
156631227|NCT05966129|565395053|FG001|Overall Study|Surgery logistics issue|1|||
156631228|NCT01298323|565395054|FG000|Overall Study|Adverse Event|2|||
156631229|NCT01298323|565395055|FG001|Overall Study|Adverse Event|4|||
156631230|NCT01298323|565395054|FG000|Overall Study|Death|11|||
156631231|NCT01298323|565395055|FG001|Overall Study|Death|16|||
156631232|NCT01298323|565395054|FG000|Overall Study|Lost to Follow-up|1|||
156631233|NCT01298323|565395055|FG001|Overall Study|Lost to Follow-up|0|||
156631234|NCT01298323|565395054|FG000|Overall Study|Withdrawal by Subject|6|||
156631235|NCT01298323|565395055|FG001|Overall Study|Withdrawal by Subject|3|||
156631236|NCT01298323|565395054|FG000|Overall Study|Protocol Violation|1|||
156631237|NCT01298323|565395055|FG001|Overall Study|Protocol Violation|0|||
156631238|NCT01298323|565395054|FG000|Overall Study|Other|10|||
156631239|NCT01298323|565395055|FG001|Overall Study|Other|9|||
156631240|NCT01298323|565395054|FG000|Overall Study|Ongoing|55|||
156631241|NCT01298323|565395055|FG001|Overall Study|Ongoing|55|||
156631242|NCT01298323|565395054|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156631243|NCT01298323|565395055|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156631244|NCT01761565|565395056|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
156631245|NCT02161380|565395057|FG000|Overall Study|Lost to Follow-up|0|||
156631246|NCT02161380|565395058|FG001|Overall Study|Lost to Follow-up|1|||
156631247|NCT02161380|565395059|FG002|Overall Study|Lost to Follow-up|0|||
156631248|NCT02161380|565395060|FG003|Overall Study|Lost to Follow-up|0|||
156631249|NCT00412360|565395062|FG000|Overall Study|Lost to Follow-up|0|||
156631250|NCT00412360|565395063|FG001|Overall Study|Lost to Follow-up|1|||
156631251|NCT00412360|565395062|FG000|Overall Study|Not Transplanted|1|||
156631252|NCT00412360|565395063|FG001|Overall Study|Not Transplanted|2|||
156631253|NCT03655951|565395064|FG000|Overall Study|Lost to Follow-up|39|||
156631254|NCT03655951|565395065|FG001|Overall Study|Lost to Follow-up|20|||
156631255|NCT03655951|565395064|FG000|Overall Study|Withdrawal by Subject|0|||
156631256|NCT03655951|565395065|FG001|Overall Study|Withdrawal by Subject|1|||
156631257|NCT01078974|565395070|FG000|Overall Study|Adverse Event|3|||
156631258|NCT01393444|565395071|FG000|Overall Study|Withdrawal by Subject|1|||
156631259|NCT01393444|565395071|FG000|Overall Study|Determined ineligible during screening.|2|||
156631260|NCT01397409|565395074|FG000|Stage 2|Adverse Event|0|||
156631261|NCT01397409|565395075|FG001|Stage 2|Adverse Event|0|||
156631262|NCT01397409|565395076|FG002|Stage 2|Adverse Event|0|||
156631263|NCT01397409|565395077|FG003|Stage 2|Adverse Event|0|||
156631264|NCT01397409|565395078|FG004|Stage 2|Adverse Event|6|||
156631265|NCT01397409|565395079|FG005|Stage 2|Adverse Event|3|||
156631266|NCT01397409|565395080|FG006|Stage 2|Adverse Event|0|||
156631267|NCT01397409|565395081|FG007|Stage 2|Adverse Event|0|||
156631268|NCT01397409|565395082|FG008|Stage 2|Adverse Event|0|||
156631269|NCT01397409|565395083|FG009|Stage 2|Adverse Event|0|||
156631270|NCT01397409|565395074|FG000|Stage 2|Personal Reasons|0|||
156631271|NCT01397409|565395075|FG001|Stage 2|Personal Reasons|0|||
156631272|NCT01397409|565395076|FG002|Stage 2|Personal Reasons|0|||
156631273|NCT01397409|565395077|FG003|Stage 2|Personal Reasons|0|||
156631274|NCT01397409|565395078|FG004|Stage 2|Personal Reasons|1|||
156631275|NCT01397409|565395079|FG005|Stage 2|Personal Reasons|0|||
156631276|NCT01397409|565395080|FG006|Stage 2|Personal Reasons|0|||
156631277|NCT01397409|565395081|FG007|Stage 2|Personal Reasons|0|||
156631278|NCT01397409|565395082|FG008|Stage 2|Personal Reasons|0|||
156631279|NCT01397409|565395083|FG009|Stage 2|Personal Reasons|0|||
156631280|NCT01397409|565395074|FG000|Stage 2|Other Miscellaneous Reasons|0|||
156631281|NCT01397409|565395075|FG001|Stage 2|Other Miscellaneous Reasons|0|||
156631282|NCT01397409|565395076|FG002|Stage 2|Other Miscellaneous Reasons|0|||
156631283|NCT01397409|565395077|FG003|Stage 2|Other Miscellaneous Reasons|0|||
156631284|NCT01397409|565395078|FG004|Stage 2|Other Miscellaneous Reasons|1|||
156631285|NCT01397409|565395079|FG005|Stage 2|Other Miscellaneous Reasons|1|||
156631286|NCT01397409|565395080|FG006|Stage 2|Other Miscellaneous Reasons|0|||
156631287|NCT01397409|565395081|FG007|Stage 2|Other Miscellaneous Reasons|0|||
156631288|NCT01397409|565395082|FG008|Stage 2|Other Miscellaneous Reasons|0|||
156631289|NCT01397409|565395083|FG009|Stage 2|Other Miscellaneous Reasons|0|||
156631290|NCT01397409|565395074|FG000|Stage 3|Adverse Event|0|||
156631291|NCT01397409|565395075|FG001|Stage 3|Adverse Event|0|||
156631292|NCT01397409|565395076|FG002|Stage 3|Adverse Event|0|||
156631293|NCT01397409|565395077|FG003|Stage 3|Adverse Event|0|||
156631294|NCT01397409|565395078|FG004|Stage 3|Adverse Event|0|||
156631295|NCT01397409|565395079|FG005|Stage 3|Adverse Event|0|||
156631296|NCT01397409|565395080|FG006|Stage 3|Adverse Event|0|||
156631297|NCT01397409|565395081|FG007|Stage 3|Adverse Event|1|||
156631298|NCT01397409|565395082|FG008|Stage 3|Adverse Event|0|||
156631299|NCT01397409|565395083|FG009|Stage 3|Adverse Event|0|||
156631300|NCT01397409|565395074|FG000|Stage 3|Other Miscellaneous Reasons|0|||
156631301|NCT01397409|565395075|FG001|Stage 3|Other Miscellaneous Reasons|0|||
156631302|NCT01397409|565395076|FG002|Stage 3|Other Miscellaneous Reasons|0|||
156631303|NCT01397409|565395077|FG003|Stage 3|Other Miscellaneous Reasons|0|||
156631304|NCT01397409|565395078|FG004|Stage 3|Other Miscellaneous Reasons|0|||
156631305|NCT01397409|565395079|FG005|Stage 3|Other Miscellaneous Reasons|0|||
156631306|NCT01397409|565395080|FG006|Stage 3|Other Miscellaneous Reasons|0|||
156631307|NCT01397409|565395081|FG007|Stage 3|Other Miscellaneous Reasons|1|||
156631308|NCT01397409|565395082|FG008|Stage 3|Other Miscellaneous Reasons|0|||
156631309|NCT01397409|565395083|FG009|Stage 3|Other Miscellaneous Reasons|0|||
156631310|NCT03418727|565395084|FG000|Overall Study|Adverse Event|1|||
156631311|NCT03418727|565395085|FG001|Overall Study|Adverse Event|2|||
156631312|NCT03418727|565395086|FG002|Overall Study|Adverse Event|0|||
156631313|NCT03418727|565395084|FG000|Overall Study|Withdrawal by Subject|0|||
156631314|NCT03418727|565395085|FG001|Overall Study|Withdrawal by Subject|0|||
156631315|NCT03418727|565395086|FG002|Overall Study|Withdrawal by Subject|2|||
156631316|NCT01791543|565395087|FG000|Overall Study|Lost to Follow-up|1|||
156631317|NCT01791543|565395087|FG000|Overall Study|Adverse Event|1|||
156631318|NCT03145207|565395088|FG000|Overall Study|volunteer started taking allergy shots|1|||
156631319|NCT03145207|565395088|FG000|Overall Study|baseline blood pressure high|1|||
156631320|NCT01396434|565395090|FG000|Overall Study|Lost to Follow-up|1|||
156631321|NCT01396434|565395091|FG001|Overall Study|Lost to Follow-up|0|||
156631322|NCT01396434|565395092|FG002|Overall Study|Lost to Follow-up|0|||
156631323|NCT01396434|565395090|FG000|Overall Study|Other|10|||
156631324|NCT01396434|565395091|FG001|Overall Study|Other|0|||
156631325|NCT01396434|565395092|FG002|Overall Study|Other|0|||
156631326|NCT04678557|565395093|FG000|Overall Study|Withdrawal by Subject|1|||
156631327|NCT04678557|565395094|FG001|Overall Study|Withdrawal by Subject|0|||
156631328|NCT04678557|565395093|FG000|Overall Study|Lack of Efficacy|0|||
156631329|NCT04678557|565395094|FG001|Overall Study|Lack of Efficacy|13|||
156631330|NCT04678557|565395093|FG000|Overall Study|Safety Evaluation|0|||
156631331|NCT04678557|565395094|FG001|Overall Study|Safety Evaluation|1|||
156631332|NCT01740297|565396966|FG000|Overall Study|Withdrawal by Subject|4|||
156631333|NCT01740297|565396967|FG001|Overall Study|Withdrawal by Subject|16|||
156631334|NCT01740297|565396968|FG002|Overall Study|Withdrawal by Subject|17|||
156631335|NCT01740297|565396966|FG000|Overall Study|Death|8|||
156631336|NCT01740297|565396967|FG001|Overall Study|Death|46|||
156631337|NCT01740297|565396968|FG002|Overall Study|Death|40|||
156631338|NCT01740297|565396966|FG000|Overall Study|Lost to Follow-up|1|||
156631339|NCT01740297|565396967|FG001|Overall Study|Lost to Follow-up|2|||
156631340|NCT01740297|565396968|FG002|Overall Study|Lost to Follow-up|4|||
156631341|NCT00563706|565396973|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
156631342|NCT00563706|565396974|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
156631343|NCT00563706|565396975|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
156631344|NCT00563706|565396976|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
156631345|NCT00563706|565396977|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
156631346|NCT00563706|565396978|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
156631347|NCT00563706|565396979|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
156631348|NCT00563706|565396980|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
156631349|NCT00563706|565396981|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
156631350|NCT00563706|565396973|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
156631351|NCT00563706|565396974|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
156631352|NCT00563706|565396975|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
156631353|NCT00563706|565396976|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
156631354|NCT00563706|565396977|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
156631355|NCT00563706|565396978|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
156631356|NCT00563706|565396979|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
156631357|NCT00563706|565396980|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
156631358|NCT00563706|565396981|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
156631359|NCT00563706|565396973|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
156631360|NCT00563706|565396974|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
156631361|NCT00563706|565396975|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
156631362|NCT00563706|565396976|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
156631363|NCT00563706|565396977|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
156631364|NCT00563706|565396978|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
156631365|NCT00563706|565396979|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
156631366|NCT00563706|565396980|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
156631367|NCT00563706|565396981|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
156631368|NCT00563706|565396973|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
156631369|NCT00563706|565396974|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
156631370|NCT00563706|565396975|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
156631371|NCT00563706|565396976|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
156631372|NCT00563706|565396977|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
156631373|NCT00563706|565396978|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
156631374|NCT00563706|565396979|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
156631375|NCT00563706|565396980|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
156631376|NCT00563706|565396981|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
156631377|NCT00563706|565396973|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
156631378|NCT00563706|565396974|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
156631379|NCT00563706|565396975|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
156631380|NCT00563706|565396976|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
156631381|NCT00563706|565396977|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
156631382|NCT00563706|565396978|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
156631383|NCT00563706|565396979|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
156631384|NCT00563706|565396980|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
156631385|NCT00563706|565396981|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
156631386|NCT03280628|565396984|FG000|Overall Study|Lost to Follow-up|8|||
156631387|NCT03280628|565396985|FG001|Overall Study|Lost to Follow-up|6|||
156631388|NCT03280628|565396986|FG002|Overall Study|Lost to Follow-up|11|||
156631389|NCT02383966|565396987|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
156631390|NCT02383966|565396988|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
156631391|NCT02383966|565396987|FG000|Overall Study|Randomized, but not treated|1|||
156631392|NCT02383966|565396988|FG001|Overall Study|Randomized, but not treated|3|||
156631393|NCT03839693|565396998|FG000|Overall Study|Lost to Follow-up|0|||
156631394|NCT03839693|565396999|FG001|Overall Study|Lost to Follow-up|2|||
156631395|NCT03839693|565397000|FG002|Overall Study|Lost to Follow-up|2|||
156631396|NCT03839693|565396998|FG000|Overall Study|Withdrawal by Subject|1|||
156631397|NCT03839693|565396999|FG001|Overall Study|Withdrawal by Subject|0|||
156631398|NCT03839693|565397000|FG002|Overall Study|Withdrawal by Subject|2|||
156631399|NCT03839693|565396998|FG000|Overall Study|subject moved out of the area|1|||
156631400|NCT03839693|565396999|FG001|Overall Study|subject moved out of the area|0|||
156631401|NCT03839693|565397000|FG002|Overall Study|subject moved out of the area|0|||
156631402|NCT00270205|565397009|FG000|Overall Study|Lost to Follow-up|1|||
156631403|NCT00270205|565397010|FG001|Overall Study|Lost to Follow-up|0|||
156631404|NCT00270205|565397011|FG002|Overall Study|Lost to Follow-up|0|||
156631405|NCT00270205|565397012|FG003|Overall Study|Lost to Follow-up|1|||
156631406|NCT00066573|565397013|FG000|Overall Study|Did not received protocol treatment|28|||
156631407|NCT00066573|565397014|FG001|Overall Study|Did not received protocol treatment|28|||
156631408|NCT00700115|565397015|FG000|Overall Study|Withdrawal by Subject|1|||
156631409|NCT00700115|565397016|FG001|Overall Study|Withdrawal by Subject|0|||
156631410|NCT00700115|565397015|FG000|Overall Study|Lost to Follow-up|0|||
156631411|NCT00700115|565397016|FG001|Overall Study|Lost to Follow-up|1|||
156631412|NCT02983305|565397017|FG000|Overall Study|incomplete data|2|||
156631413|NCT02983305|565397018|FG001|Overall Study|incomplete data|0|||
156631414|NCT00706901|565397019|FG000|Overall Study|Lost to Follow-up|2|||
156631415|NCT00706901|565397020|FG001|Overall Study|Lost to Follow-up|3|||
156631416|NCT00706901|565397021|FG002|Overall Study|Lost to Follow-up|2|||
156631417|NCT00706901|565397019|FG000|Overall Study|Withdrawal by Subject|4|||
156631418|NCT00706901|565397020|FG001|Overall Study|Withdrawal by Subject|2|||
156631419|NCT00706901|565397021|FG002|Overall Study|Withdrawal by Subject|5|||
156631420|NCT00706901|565397019|FG000|Overall Study|In Jail|1|||
156631421|NCT00706901|565397020|FG001|Overall Study|In Jail|0|||
156631422|NCT00706901|565397021|FG002|Overall Study|In Jail|1|||
156631423|NCT00706901|565397019|FG000|Overall Study|Death|1|||
156631424|NCT00706901|565397020|FG001|Overall Study|Death|0|||
156631425|NCT00706901|565397021|FG002|Overall Study|Death|0|||
156631426|NCT00822237|565397022|FG000|Dose 1 Vaccination|Not vaccinated|3|||
156631427|NCT00822237|565397023|FG001|Dose 1 Vaccination|Not vaccinated|0|||
156631428|NCT00822237|565397022|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
156631429|NCT00822237|565397023|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
156631430|NCT00822237|565397022|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
156631431|NCT00822237|565397023|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
156631432|NCT00822237|565397022|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
156631433|NCT00822237|565397023|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
156631434|NCT00822237|565397022|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
156631435|NCT00822237|565397023|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
156631436|NCT03433482|565397024|FG000|Overall Study|Lost to Follow-up|1|||
156631437|NCT03433482|565397025|FG001|Overall Study|Lost to Follow-up|0|||
156631438|NCT03433482|565397026|FG002|Overall Study|Lost to Follow-up|1|||
156631439|NCT03433482|565397027|FG003|Overall Study|Lost to Follow-up|1|||
156631440|NCT03433482|565397024|FG000|Overall Study|Withdrawal by Subject|0|||
156631441|NCT03433482|565397025|FG001|Overall Study|Withdrawal by Subject|0|||
156631442|NCT03433482|565397026|FG002|Overall Study|Withdrawal by Subject|1|||
156631443|NCT03433482|565397027|FG003|Overall Study|Withdrawal by Subject|0|||
156631444|NCT03433482|565397024|FG000|Overall Study|Unknown reason|0|||
156631445|NCT03433482|565397025|FG001|Overall Study|Unknown reason|0|||
156631446|NCT03433482|565397026|FG002|Overall Study|Unknown reason|2|||
156631447|NCT03433482|565397027|FG003|Overall Study|Unknown reason|0|||
156631448|NCT00437294|565397028|FG000|Overall Study|Adverse Event|5|||
156631449|NCT00437294|565397029|FG001|Overall Study|Adverse Event|4|||
156631450|NCT00437294|565397028|FG000|Overall Study|Death|5|||
156631451|NCT00437294|565397029|FG001|Overall Study|Death|2|||
156631452|NCT00437294|565397028|FG000|Overall Study|Physician Decision|0|||
156631453|NCT00437294|565397029|FG001|Overall Study|Physician Decision|3|||
156635570|NCT00602667|565409961|FG001|Overall Study|Second malignancy|1|||
156631454|NCT00437294|565397028|FG000|Overall Study|Withdrawal by Subject|5|||
156631455|NCT00437294|565397029|FG001|Overall Study|Withdrawal by Subject|0|||
156631456|NCT00437294|565397028|FG000|Overall Study|Progressive Disease|19|||
156631457|NCT00437294|565397029|FG001|Overall Study|Progressive Disease|23|||
156631458|NCT00437294|565397028|FG000|Overall Study|Sponsor Decision|8|||
156631459|NCT00437294|565397029|FG001|Overall Study|Sponsor Decision|9|||
156631460|NCT00437294|565397028|FG000|Overall Study|Protocol Violation|0|||
156631461|NCT00437294|565397029|FG001|Overall Study|Protocol Violation|1|||
156631462|NCT00437294|565397028|FG000|Overall Study|Entry criteria not met|1|||
156631463|NCT00437294|565397029|FG001|Overall Study|Entry criteria not met|1|||
156631464|NCT01646268|565397033|FG000|Overall Study|Adverse Event|6|||
156631465|NCT01646268|565397034|FG001|Overall Study|Adverse Event|7|||
156631466|NCT01646268|565397033|FG000|Overall Study|Lack of Efficacy|1|||
156631467|NCT01646268|565397034|FG001|Overall Study|Lack of Efficacy|3|||
156631468|NCT01646268|565397033|FG000|Overall Study|Protocol Violation|0|||
156631469|NCT01646268|565397034|FG001|Overall Study|Protocol Violation|1|||
156631470|NCT01646268|565397033|FG000|Overall Study|Withdrawal by Subject|2|||
156631471|NCT01646268|565397034|FG001|Overall Study|Withdrawal by Subject|5|||
156631472|NCT01646268|565397033|FG000|Overall Study|Other|2|||
156631473|NCT01646268|565397034|FG001|Overall Study|Other|0|||
156631474|NCT01473602|565397039|FG000|Overall Study|Adverse Event|1|||
156631475|NCT01473602|565397040|FG001|Overall Study|Adverse Event|2|||
156631476|NCT01473602|565397039|FG000|Overall Study|Death|0|||
156631477|NCT01473602|565397040|FG001|Overall Study|Death|1|||
156631478|NCT01473602|565397039|FG000|Overall Study|Lost to Follow-up|1|||
156631479|NCT01473602|565397040|FG001|Overall Study|Lost to Follow-up|1|||
156631480|NCT01473602|565397039|FG000|Overall Study|Withdrawal by Subject|5|||
156631481|NCT01473602|565397040|FG001|Overall Study|Withdrawal by Subject|4|||
156631482|NCT01473602|565397039|FG000|Overall Study|Physician Decision|1|||
156631483|NCT01473602|565397040|FG001|Overall Study|Physician Decision|0|||
156631484|NCT00449761|565397041|FG000|Overall Study|Disease progression|12|||
156631485|NCT00449761|565397041|FG000|Overall Study|Death|5|||
156631486|NCT00449761|565397041|FG000|Overall Study|New cancer therapy|1|||
156631487|NCT00536991|565397044|FG000|Overall Study|Withdrawal by Subject|10|||
156631488|NCT00536991|565397044|FG000|Overall Study|Physician Decision|1|||
156631489|NCT00536991|565397044|FG000|Overall Study|patient ineligible|2|||
156631490|NCT00518531|565397045|FG000|Treatment Period 1|Adverse Event|5|||
156631491|NCT00518531|565397046|FG001|Treatment Period 1|Adverse Event|0|||
156631492|NCT00518531|565397045|FG000|Treatment Period 1|Lost to Follow-up|5|||
156631493|NCT00518531|565397046|FG001|Treatment Period 1|Lost to Follow-up|3|||
156631494|NCT00518531|565397045|FG000|Treatment Period 1|Physician Decision|1|||
156631495|NCT00518531|565397046|FG001|Treatment Period 1|Physician Decision|0|||
156631496|NCT00518531|565397045|FG000|Treatment Period 1|Protocol Violation|2|||
156631497|NCT00518531|565397046|FG001|Treatment Period 1|Protocol Violation|0|||
156631498|NCT00518531|565397045|FG000|Treatment Period 1|Withdrawal by Subject|4|||
156631499|NCT00518531|565397046|FG001|Treatment Period 1|Withdrawal by Subject|6|||
156631500|NCT00518531|565397045|FG000|Treatment Period 1|Early crossover|1|||
156631501|NCT00518531|565397046|FG001|Treatment Period 1|Early crossover|3|||
156631502|NCT00518531|565397045|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156631503|NCT00518531|565397046|FG001|Treatment Period 2|Withdrawal by Subject|8|||
156631504|NCT00518531|565397045|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
156631505|NCT00518531|565397046|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
156631506|NCT00518531|565397045|FG000|Treatment Period 2|Adverse Event|1|||
156631507|NCT00518531|565397046|FG001|Treatment Period 2|Adverse Event|7|||
156631508|NCT00518531|565397045|FG000|Treatment Period 2|Protocol-specified criteria|0|||
156631509|NCT00518531|565397046|FG001|Treatment Period 2|Protocol-specified criteria|1|||
156631510|NCT00518531|565397045|FG000|Treatment Period 2|Non-compliance|1|||
156631511|NCT00518531|565397046|FG001|Treatment Period 2|Non-compliance|2|||
156631512|NCT00054639|565397047|FG000|Overall Study|Lack of Efficacy|1|||
156631513|NCT00054639|565397047|FG000|Overall Study|Physician Decision|1|||
156631514|NCT01600755|565397048|FG000|Overall Study|Withdrawal by Subject|6|||
156631515|NCT00122954|565397053|FG000|Overall Study|Withdrawal by Subject|2|||
156631516|NCT00122954|565397054|FG001|Overall Study|Withdrawal by Subject|2|||
156631517|NCT00122954|565397053|FG000|Overall Study|Protocol Violation|0|||
156631518|NCT00122954|565397054|FG001|Overall Study|Protocol Violation|1|||
156631519|NCT01491737|565397055|FG000|Overall Study|Withdrawal by Subject|20|||
156631520|NCT01491737|565397056|FG001|Overall Study|Withdrawal by Subject|17|||
156631521|NCT01491737|565397055|FG000|Overall Study|Lost to Follow-up|2|||
156631522|NCT01491737|565397056|FG001|Overall Study|Lost to Follow-up|10|||
156631523|NCT01491737|565397055|FG000|Overall Study|Death|63|||
156631524|NCT01491737|565397056|FG001|Overall Study|Death|57|||
156631525|NCT01491737|565397055|FG000|Overall Study|Study Termination by Sponsor|36|||
156631526|NCT01491737|565397056|FG001|Overall Study|Study Termination by Sponsor|36|||
156631527|NCT01491737|565397055|FG000|Overall Study|Reason Not Specified|8|||
156631528|NCT01491737|565397056|FG001|Overall Study|Reason Not Specified|9|||
156631529|NCT00812968|565397057|FG000|Overall Study|Relapse after erythroid response|6|||
156631530|NCT00812968|565397057|FG000|Overall Study|Disease progression|1|||
156631531|NCT00812968|565397057|FG000|Overall Study|No further treatment required|1|||
156631532|NCT00812968|565397057|FG000|Overall Study|Study closed due to marketing approval|3|||
156631533|NCT02696382|565397058|FG000|Overall Study|Death|7|||
156631534|NCT02696382|565397059|FG001|Overall Study|Death|2|||
156631535|NCT02696382|565397058|FG000|Overall Study|Withdrawal by Subject|5|||
156631536|NCT02696382|565397059|FG001|Overall Study|Withdrawal by Subject|12|||
156631537|NCT02696382|565397058|FG000|Overall Study|Lost to Follow-up|4|||
156631538|NCT02696382|565397059|FG001|Overall Study|Lost to Follow-up|7|||
156631539|NCT00494234|565397060|FG000|Overall Study|Withdrawal by Subject|1|||
156631540|NCT00494234|565397061|FG001|Overall Study|Withdrawal by Subject|0|||
156631541|NCT00494234|565397060|FG000|Overall Study|Disease progression|11|||
156631542|NCT00494234|565397061|FG001|Overall Study|Disease progression|8|||
156631543|NCT00494234|565397060|FG000|Overall Study|Death|2|||
156631544|NCT00494234|565397061|FG001|Overall Study|Death|1|||
156631545|NCT00505765|565397067|FG000|Overall Study|Withdrawal by Subject|1|||
156631546|NCT00505765|565397068|FG001|Overall Study|Withdrawal by Subject|0|||
156631547|NCT00505765|565397069|FG002|Overall Study|Withdrawal by Subject|0|||
156631548|NCT00505765|565397067|FG000|Overall Study|Adverse Event|1|||
156631549|NCT00505765|565397068|FG001|Overall Study|Adverse Event|2|||
156631550|NCT00505765|565397069|FG002|Overall Study|Adverse Event|0|||
156631551|NCT00505765|565397067|FG000|Overall Study|Noncompliance|0|||
156631552|NCT00505765|565397068|FG001|Overall Study|Noncompliance|1|||
156631553|NCT00505765|565397069|FG002|Overall Study|Noncompliance|3|||
156631554|NCT03992456|565397070|FG000|Overall Study|Withdrawal by Subject|1|||
156631555|NCT03992456|565397071|FG001|Overall Study|Withdrawal by Subject|0|||
156631556|NCT03992456|565397070|FG000|Overall Study|Disease progression|4|||
156631557|NCT03992456|565397071|FG001|Overall Study|Disease progression|5|||
156631558|NCT03992456|565397070|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
156631559|NCT03992456|565397071|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
156631560|NCT00910000|565397072|FG000|Overall Study|Adverse Event|0|||
156631561|NCT00910000|565397073|FG001|Overall Study|Adverse Event|3|||
156631562|NCT00910000|565397074|FG002|Overall Study|Adverse Event|2|||
156631563|NCT00910000|565397075|FG003|Overall Study|Adverse Event|2|||
156631564|NCT00910000|565397076|FG004|Overall Study|Adverse Event|0|||
156631565|NCT00910000|565397077|FG005|Overall Study|Adverse Event|1|||
156631566|NCT00910000|565397072|FG000|Overall Study|Withdrawal by Subject|0|||
156631567|NCT00910000|565397073|FG001|Overall Study|Withdrawal by Subject|0|||
156631568|NCT00910000|565397074|FG002|Overall Study|Withdrawal by Subject|1|||
156631569|NCT00910000|565397075|FG003|Overall Study|Withdrawal by Subject|0|||
156631570|NCT00910000|565397076|FG004|Overall Study|Withdrawal by Subject|1|||
156631571|NCT00910000|565397077|FG005|Overall Study|Withdrawal by Subject|0|||
156631572|NCT04637815|565397078|FG000|Overall Study|Death|1|||
156631573|NCT04637815|565397079|FG001|Overall Study|Death|0|||
156631574|NCT04637815|565397078|FG000|Overall Study|Lost to Follow-up|5|||
156631575|NCT04637815|565397079|FG001|Overall Study|Lost to Follow-up|2|||
156631576|NCT02594384|565397080|FG000|Overall Study|Disease Progression|3|||
156631577|NCT02594384|565397081|FG001|Overall Study|Disease Progression|7|||
156631578|NCT02594384|565397082|FG002|Overall Study|Disease Progression|0|||
156631579|NCT02594384|565397083|FG003|Overall Study|Disease Progression|2|||
156631580|NCT02594384|565397084|FG004|Overall Study|Disease Progression|2|||
156631581|NCT02594384|565397085|FG005|Overall Study|Disease Progression|12|||
156631582|NCT02594384|565397086|FG006|Overall Study|Disease Progression|5|||
156631583|NCT02594384|565397087|FG007|Overall Study|Disease Progression|5|||
156631584|NCT02594384|565397080|FG000|Overall Study|Adverse Event|0|||
156631585|NCT02594384|565397081|FG001|Overall Study|Adverse Event|1|||
156631586|NCT02594384|565397082|FG002|Overall Study|Adverse Event|4|||
156631587|NCT02594384|565397083|FG003|Overall Study|Adverse Event|1|||
156631588|NCT02594384|565397084|FG004|Overall Study|Adverse Event|0|||
156631589|NCT02594384|565397085|FG005|Overall Study|Adverse Event|6|||
156631590|NCT02594384|565397086|FG006|Overall Study|Adverse Event|1|||
156631591|NCT02594384|565397087|FG007|Overall Study|Adverse Event|1|||
156631592|NCT02594384|565397080|FG000|Overall Study|Withdrawal by Subject|0|||
156631593|NCT02594384|565397081|FG001|Overall Study|Withdrawal by Subject|0|||
156631594|NCT02594384|565397082|FG002|Overall Study|Withdrawal by Subject|0|||
156631595|NCT02594384|565397083|FG003|Overall Study|Withdrawal by Subject|1|||
156631596|NCT02594384|565397084|FG004|Overall Study|Withdrawal by Subject|0|||
156631597|NCT02594384|565397085|FG005|Overall Study|Withdrawal by Subject|0|||
156631598|NCT02594384|565397086|FG006|Overall Study|Withdrawal by Subject|0|||
156631599|NCT02594384|565397087|FG007|Overall Study|Withdrawal by Subject|1|||
156631600|NCT02594384|565397080|FG000|Overall Study|Physician Decision|0|||
156631601|NCT02594384|565397081|FG001|Overall Study|Physician Decision|0|||
156631602|NCT02594384|565397082|FG002|Overall Study|Physician Decision|0|||
156631603|NCT02594384|565397083|FG003|Overall Study|Physician Decision|0|||
156631604|NCT02594384|565397084|FG004|Overall Study|Physician Decision|0|||
156631605|NCT02594384|565397085|FG005|Overall Study|Physician Decision|1|||
156631606|NCT02594384|565397086|FG006|Overall Study|Physician Decision|2|||
156631607|NCT02594384|565397087|FG007|Overall Study|Physician Decision|0|||
156631608|NCT02594384|565397080|FG000|Overall Study|Progressive Leukocytosis|0|||
156631609|NCT02594384|565397081|FG001|Overall Study|Progressive Leukocytosis|0|||
156631610|NCT02594384|565397082|FG002|Overall Study|Progressive Leukocytosis|1|||
156631611|NCT02594384|565397083|FG003|Overall Study|Progressive Leukocytosis|0|||
156631612|NCT02594384|565397084|FG004|Overall Study|Progressive Leukocytosis|0|||
156631613|NCT02594384|565397085|FG005|Overall Study|Progressive Leukocytosis|0|||
156631614|NCT02594384|565397086|FG006|Overall Study|Progressive Leukocytosis|0|||
156631615|NCT02594384|565397087|FG007|Overall Study|Progressive Leukocytosis|0|||
156631616|NCT02594384|565397080|FG000|Overall Study|Lack of Efficacy|0|||
156631617|NCT02594384|565397081|FG001|Overall Study|Lack of Efficacy|0|||
156631618|NCT02594384|565397082|FG002|Overall Study|Lack of Efficacy|0|||
156631619|NCT02594384|565397083|FG003|Overall Study|Lack of Efficacy|0|||
156631620|NCT02594384|565397084|FG004|Overall Study|Lack of Efficacy|1|||
156631621|NCT02594384|565397085|FG005|Overall Study|Lack of Efficacy|0|||
156631622|NCT02594384|565397086|FG006|Overall Study|Lack of Efficacy|0|||
156631623|NCT02594384|565397087|FG007|Overall Study|Lack of Efficacy|0|||
156631624|NCT02594384|565397080|FG000|Overall Study|Substantial noncompliance|0|||
156631625|NCT02594384|565397081|FG001|Overall Study|Substantial noncompliance|0|||
156631626|NCT02594384|565397082|FG002|Overall Study|Substantial noncompliance|0|||
156631627|NCT02594384|565397083|FG003|Overall Study|Substantial noncompliance|0|||
156631628|NCT02594384|565397084|FG004|Overall Study|Substantial noncompliance|0|||
156631629|NCT02594384|565397085|FG005|Overall Study|Substantial noncompliance|0|||
156631630|NCT02594384|565397086|FG006|Overall Study|Substantial noncompliance|1|||
156631631|NCT02594384|565397087|FG007|Overall Study|Substantial noncompliance|0|||
156631632|NCT01265875|565397090|FG000|Overall Study|Uncooperative/unreliable|1|||
156631633|NCT02369874|565397093|FG000|Overall Study|Lost to Follow-up|2|||
156631634|NCT02369874|565397094|FG001|Overall Study|Lost to Follow-up|2|||
156631635|NCT02369874|565397095|FG002|Overall Study|Lost to Follow-up|2|||
156631636|NCT02369874|565397093|FG000|Overall Study|Withdrawal by Subject|7|||
156631637|NCT02369874|565397094|FG001|Overall Study|Withdrawal by Subject|9|||
156631638|NCT02369874|565397095|FG002|Overall Study|Withdrawal by Subject|27|||
156631639|NCT02369874|565397093|FG000|Overall Study|Miscellaneous|1|||
156631640|NCT02369874|565397094|FG001|Overall Study|Miscellaneous|1|||
156631641|NCT02369874|565397095|FG002|Overall Study|Miscellaneous|0|||
156631642|NCT02369874|565397093|FG000|Overall Study|On Treatment/Off Study|34|||
156631643|NCT02369874|565397094|FG001|Overall Study|On Treatment/Off Study|45|||
156631644|NCT02369874|565397095|FG002|Overall Study|On Treatment/Off Study|32|||
156631645|NCT02058849|565397096|FG000|Overall Study|Hospitalization|1|||
156631646|NCT02058849|565397097|FG001|Overall Study|Hospitalization|1|||
156631647|NCT02058849|565397096|FG000|Overall Study|Death|1|||
156631648|NCT02058849|565397097|FG001|Overall Study|Death|0|||
156631649|NCT02058849|565397096|FG000|Overall Study|Lost to Follow-up|1|||
156631650|NCT02058849|565397097|FG001|Overall Study|Lost to Follow-up|0|||
156631651|NCT02058849|565397096|FG000|Overall Study|Withdrawal by Subject|4|||
156631652|NCT02058849|565397097|FG001|Overall Study|Withdrawal by Subject|0|||
156631653|NCT01049360|565397098|FG000|Period 1|Adverse Event|0|||
156631654|NCT01049360|565397099|FG001|Period 1|Adverse Event|1|||
156631655|NCT01049360|565397100|FG002|Period 1|Adverse Event|0|||
156631656|NCT01049360|565397101|FG003|Period 1|Adverse Event|1|||
156631657|NCT01049360|565397102|FG004|Period 1|Adverse Event|0|||
156631658|NCT01049360|565397103|FG005|Period 1|Adverse Event|0|||
156631659|NCT01049360|565397104|FG006|Period 1|Adverse Event|0|||
156631660|NCT01049360|565397105|FG007|Period 1|Adverse Event|1|||
156631661|NCT01049360|565397106|FG008|Period 1|Adverse Event|0|||
156631662|NCT01049360|565397107|FG009|Period 1|Adverse Event|0|||
156631663|NCT01049360|565397108|FG010|Period 1|Adverse Event|0|||
156631664|NCT01049360|565397109|FG011|Period 1|Adverse Event|0|||
156631665|NCT01049360|565397110|FG012|Period 1|Adverse Event|1|||
156631666|NCT01049360|565397111|FG013|Period 1|Adverse Event|1|||
156631667|NCT01049360|565397112|FG014|Period 1|Adverse Event|0|||
156631668|NCT01049360|565397113|FG015|Period 1|Adverse Event|0|||
156631669|NCT01049360|565397114|FG016|Period 1|Adverse Event|1|||
156631670|NCT01049360|565397115|FG017|Period 1|Adverse Event|0|||
156631671|NCT01049360|565397116|FG018|Period 1|Adverse Event|1|||
156631672|NCT01049360|565397117|FG019|Period 1|Adverse Event|0|||
156631673|NCT01049360|565397098|FG000|Period 1|Did not meet inc/exc criteria|0|||
156631674|NCT01049360|565397099|FG001|Period 1|Did not meet inc/exc criteria|0|||
156631675|NCT01049360|565397100|FG002|Period 1|Did not meet inc/exc criteria|0|||
156631676|NCT01049360|565397101|FG003|Period 1|Did not meet inc/exc criteria|0|||
156631677|NCT01049360|565397102|FG004|Period 1|Did not meet inc/exc criteria|0|||
156631678|NCT01049360|565397103|FG005|Period 1|Did not meet inc/exc criteria|0|||
156631679|NCT01049360|565397104|FG006|Period 1|Did not meet inc/exc criteria|0|||
156631680|NCT01049360|565397105|FG007|Period 1|Did not meet inc/exc criteria|1|||
156631681|NCT01049360|565397106|FG008|Period 1|Did not meet inc/exc criteria|1|||
156631682|NCT01049360|565397107|FG009|Period 1|Did not meet inc/exc criteria|0|||
156631683|NCT01049360|565397108|FG010|Period 1|Did not meet inc/exc criteria|0|||
156631684|NCT01049360|565397109|FG011|Period 1|Did not meet inc/exc criteria|0|||
156631685|NCT01049360|565397110|FG012|Period 1|Did not meet inc/exc criteria|0|||
156631686|NCT01049360|565397111|FG013|Period 1|Did not meet inc/exc criteria|0|||
156631687|NCT01049360|565397112|FG014|Period 1|Did not meet inc/exc criteria|0|||
156631688|NCT01049360|565397113|FG015|Period 1|Did not meet inc/exc criteria|0|||
156631689|NCT01049360|565397114|FG016|Period 1|Did not meet inc/exc criteria|0|||
156631690|NCT01049360|565397115|FG017|Period 1|Did not meet inc/exc criteria|0|||
156631691|NCT01049360|565397116|FG018|Period 1|Did not meet inc/exc criteria|0|||
156631692|NCT01049360|565397117|FG019|Period 1|Did not meet inc/exc criteria|0|||
156631693|NCT01049360|565397098|FG000|Period 1|Withdrawal by Subject|0|||
156631694|NCT01049360|565397099|FG001|Period 1|Withdrawal by Subject|0|||
156631695|NCT01049360|565397100|FG002|Period 1|Withdrawal by Subject|0|||
156631696|NCT01049360|565397101|FG003|Period 1|Withdrawal by Subject|0|||
156631697|NCT01049360|565397102|FG004|Period 1|Withdrawal by Subject|0|||
156631698|NCT01049360|565397103|FG005|Period 1|Withdrawal by Subject|0|||
156631699|NCT01049360|565397104|FG006|Period 1|Withdrawal by Subject|0|||
156631700|NCT01049360|565397105|FG007|Period 1|Withdrawal by Subject|0|||
156631701|NCT01049360|565397106|FG008|Period 1|Withdrawal by Subject|1|||
156631702|NCT01049360|565397107|FG009|Period 1|Withdrawal by Subject|0|||
156631703|NCT01049360|565397108|FG010|Period 1|Withdrawal by Subject|1|||
156631704|NCT01049360|565397109|FG011|Period 1|Withdrawal by Subject|0|||
156631705|NCT01049360|565397110|FG012|Period 1|Withdrawal by Subject|1|||
156631706|NCT01049360|565397111|FG013|Period 1|Withdrawal by Subject|0|||
156631707|NCT01049360|565397112|FG014|Period 1|Withdrawal by Subject|0|||
156631708|NCT01049360|565397113|FG015|Period 1|Withdrawal by Subject|0|||
156631709|NCT01049360|565397114|FG016|Period 1|Withdrawal by Subject|0|||
156631710|NCT01049360|565397115|FG017|Period 1|Withdrawal by Subject|0|||
156631711|NCT01049360|565397116|FG018|Period 1|Withdrawal by Subject|0|||
156631712|NCT01049360|565397117|FG019|Period 1|Withdrawal by Subject|0|||
156631713|NCT01049360|565397098|FG000|Period 2|Protocol Violation|0|||
156631714|NCT01049360|565397099|FG001|Period 2|Protocol Violation|0|||
156631715|NCT01049360|565397100|FG002|Period 2|Protocol Violation|0|||
156631716|NCT01049360|565397101|FG003|Period 2|Protocol Violation|1|||
156631717|NCT01049360|565397102|FG004|Period 2|Protocol Violation|0|||
156631718|NCT01049360|565397103|FG005|Period 2|Protocol Violation|0|||
156631719|NCT01049360|565397104|FG006|Period 2|Protocol Violation|0|||
156631720|NCT01049360|565397105|FG007|Period 2|Protocol Violation|0|||
156631721|NCT01049360|565397106|FG008|Period 2|Protocol Violation|0|||
156631722|NCT01049360|565397107|FG009|Period 2|Protocol Violation|0|||
156631723|NCT01049360|565397108|FG010|Period 2|Protocol Violation|0|||
156631724|NCT01049360|565397109|FG011|Period 2|Protocol Violation|0|||
156631725|NCT01049360|565397110|FG012|Period 2|Protocol Violation|0|||
156631726|NCT01049360|565397111|FG013|Period 2|Protocol Violation|0|||
156631727|NCT01049360|565397112|FG014|Period 2|Protocol Violation|1|||
156631728|NCT01049360|565397113|FG015|Period 2|Protocol Violation|1|||
156631729|NCT01049360|565397114|FG016|Period 2|Protocol Violation|0|||
156631730|NCT01049360|565397115|FG017|Period 2|Protocol Violation|0|||
156631731|NCT01049360|565397116|FG018|Period 2|Protocol Violation|0|||
156631732|NCT01049360|565397117|FG019|Period 2|Protocol Violation|0|||
156631733|NCT01049360|565397098|FG000|Period 2|Adverse Event|0|||
156631734|NCT01049360|565397099|FG001|Period 2|Adverse Event|1|||
156631735|NCT01049360|565397100|FG002|Period 2|Adverse Event|0|||
156631736|NCT01049360|565397101|FG003|Period 2|Adverse Event|0|||
156631737|NCT01049360|565397102|FG004|Period 2|Adverse Event|0|||
156631738|NCT01049360|565397103|FG005|Period 2|Adverse Event|0|||
156631739|NCT01049360|565397104|FG006|Period 2|Adverse Event|0|||
156631740|NCT01049360|565397105|FG007|Period 2|Adverse Event|0|||
156631741|NCT01049360|565397106|FG008|Period 2|Adverse Event|1|||
156631742|NCT01049360|565397107|FG009|Period 2|Adverse Event|0|||
156631743|NCT01049360|565397108|FG010|Period 2|Adverse Event|0|||
156631744|NCT01049360|565397109|FG011|Period 2|Adverse Event|0|||
156631745|NCT01049360|565397110|FG012|Period 2|Adverse Event|0|||
156631746|NCT01049360|565397111|FG013|Period 2|Adverse Event|0|||
156631747|NCT01049360|565397112|FG014|Period 2|Adverse Event|0|||
156631748|NCT01049360|565397113|FG015|Period 2|Adverse Event|0|||
156631749|NCT01049360|565397114|FG016|Period 2|Adverse Event|0|||
156631750|NCT01049360|565397115|FG017|Period 2|Adverse Event|0|||
156631751|NCT01049360|565397116|FG018|Period 2|Adverse Event|0|||
156631752|NCT01049360|565397117|FG019|Period 2|Adverse Event|1|||
156631753|NCT01049360|565397098|FG000|Period 2|Withdrawal by Subject|0|||
156631754|NCT01049360|565397099|FG001|Period 2|Withdrawal by Subject|0|||
156631755|NCT01049360|565397100|FG002|Period 2|Withdrawal by Subject|0|||
156631756|NCT01049360|565397101|FG003|Period 2|Withdrawal by Subject|1|||
156631757|NCT01049360|565397102|FG004|Period 2|Withdrawal by Subject|0|||
156631758|NCT01049360|565397103|FG005|Period 2|Withdrawal by Subject|0|||
156631759|NCT01049360|565397104|FG006|Period 2|Withdrawal by Subject|0|||
156631760|NCT01049360|565397105|FG007|Period 2|Withdrawal by Subject|0|||
156631761|NCT01049360|565397106|FG008|Period 2|Withdrawal by Subject|0|||
156631762|NCT01049360|565397107|FG009|Period 2|Withdrawal by Subject|0|||
156631763|NCT01049360|565397108|FG010|Period 2|Withdrawal by Subject|0|||
156631764|NCT01049360|565397109|FG011|Period 2|Withdrawal by Subject|0|||
156631765|NCT01049360|565397110|FG012|Period 2|Withdrawal by Subject|0|||
156631766|NCT01049360|565397111|FG013|Period 2|Withdrawal by Subject|0|||
156631767|NCT01049360|565397112|FG014|Period 2|Withdrawal by Subject|1|||
156631768|NCT01049360|565397113|FG015|Period 2|Withdrawal by Subject|0|||
156631769|NCT01049360|565397114|FG016|Period 2|Withdrawal by Subject|0|||
156631770|NCT01049360|565397115|FG017|Period 2|Withdrawal by Subject|0|||
156631771|NCT01049360|565397116|FG018|Period 2|Withdrawal by Subject|0|||
156631772|NCT01049360|565397117|FG019|Period 2|Withdrawal by Subject|1|||
156631773|NCT01049360|565397098|FG000|Period 2|Lack of Efficacy|0|||
156631774|NCT01049360|565397099|FG001|Period 2|Lack of Efficacy|0|||
156631775|NCT01049360|565397100|FG002|Period 2|Lack of Efficacy|0|||
156631776|NCT01049360|565397101|FG003|Period 2|Lack of Efficacy|0|||
156631777|NCT01049360|565397102|FG004|Period 2|Lack of Efficacy|0|||
156631778|NCT01049360|565397103|FG005|Period 2|Lack of Efficacy|1|||
156631779|NCT01049360|565397104|FG006|Period 2|Lack of Efficacy|0|||
156631780|NCT01049360|565397105|FG007|Period 2|Lack of Efficacy|0|||
156631781|NCT01049360|565397106|FG008|Period 2|Lack of Efficacy|0|||
156631782|NCT01049360|565397107|FG009|Period 2|Lack of Efficacy|0|||
156631783|NCT01049360|565397108|FG010|Period 2|Lack of Efficacy|0|||
156631784|NCT01049360|565397109|FG011|Period 2|Lack of Efficacy|0|||
156631785|NCT01049360|565397110|FG012|Period 2|Lack of Efficacy|0|||
156631786|NCT01049360|565397111|FG013|Period 2|Lack of Efficacy|0|||
156631787|NCT01049360|565397112|FG014|Period 2|Lack of Efficacy|0|||
156631788|NCT01049360|565397113|FG015|Period 2|Lack of Efficacy|0|||
156631789|NCT01049360|565397114|FG016|Period 2|Lack of Efficacy|0|||
156631790|NCT01049360|565397115|FG017|Period 2|Lack of Efficacy|0|||
156631791|NCT01049360|565397116|FG018|Period 2|Lack of Efficacy|0|||
156631792|NCT01049360|565397117|FG019|Period 2|Lack of Efficacy|0|||
156631793|NCT01049360|565397098|FG000|Period 4|Protocol Violation|0|||
156631794|NCT01049360|565397099|FG001|Period 4|Protocol Violation|0|||
156631795|NCT01049360|565397100|FG002|Period 4|Protocol Violation|0|||
156631796|NCT01049360|565397101|FG003|Period 4|Protocol Violation|0|||
156631797|NCT01049360|565397102|FG004|Period 4|Protocol Violation|0|||
156631798|NCT01049360|565397103|FG005|Period 4|Protocol Violation|0|||
156631799|NCT01049360|565397104|FG006|Period 4|Protocol Violation|0|||
156631800|NCT01049360|565397105|FG007|Period 4|Protocol Violation|0|||
156631801|NCT01049360|565397106|FG008|Period 4|Protocol Violation|0|||
156631802|NCT01049360|565397107|FG009|Period 4|Protocol Violation|0|||
156631803|NCT01049360|565397108|FG010|Period 4|Protocol Violation|0|||
156631804|NCT01049360|565397109|FG011|Period 4|Protocol Violation|0|||
156631805|NCT01049360|565397110|FG012|Period 4|Protocol Violation|0|||
156631806|NCT01049360|565397111|FG013|Period 4|Protocol Violation|0|||
156631807|NCT01049360|565397112|FG014|Period 4|Protocol Violation|0|||
156631808|NCT01049360|565397113|FG015|Period 4|Protocol Violation|0|||
156631809|NCT01049360|565397114|FG016|Period 4|Protocol Violation|0|||
156631810|NCT01049360|565397115|FG017|Period 4|Protocol Violation|1|||
156631811|NCT01049360|565397116|FG018|Period 4|Protocol Violation|0|||
156631812|NCT01049360|565397117|FG019|Period 4|Protocol Violation|0|||
156631813|NCT01049360|565397098|FG000|Period 4|Withdrawal by Subject|0|||
156631814|NCT01049360|565397099|FG001|Period 4|Withdrawal by Subject|0|||
156631815|NCT01049360|565397100|FG002|Period 4|Withdrawal by Subject|0|||
156631816|NCT01049360|565397101|FG003|Period 4|Withdrawal by Subject|1|||
156631817|NCT01049360|565397102|FG004|Period 4|Withdrawal by Subject|0|||
156631818|NCT01049360|565397103|FG005|Period 4|Withdrawal by Subject|0|||
156631819|NCT01049360|565397104|FG006|Period 4|Withdrawal by Subject|0|||
156631820|NCT01049360|565397105|FG007|Period 4|Withdrawal by Subject|0|||
156631821|NCT01049360|565397106|FG008|Period 4|Withdrawal by Subject|0|||
156631822|NCT01049360|565397107|FG009|Period 4|Withdrawal by Subject|0|||
156631823|NCT01049360|565397108|FG010|Period 4|Withdrawal by Subject|0|||
156631824|NCT01049360|565397109|FG011|Period 4|Withdrawal by Subject|0|||
156631825|NCT01049360|565397110|FG012|Period 4|Withdrawal by Subject|0|||
156631826|NCT01049360|565397111|FG013|Period 4|Withdrawal by Subject|0|||
156631827|NCT01049360|565397112|FG014|Period 4|Withdrawal by Subject|0|||
156631828|NCT01049360|565397113|FG015|Period 4|Withdrawal by Subject|0|||
156631829|NCT01049360|565397114|FG016|Period 4|Withdrawal by Subject|0|||
156631830|NCT01049360|565397115|FG017|Period 4|Withdrawal by Subject|0|||
156631831|NCT01049360|565397116|FG018|Period 4|Withdrawal by Subject|0|||
156631832|NCT01049360|565397117|FG019|Period 4|Withdrawal by Subject|0|||
156631833|NCT05147311|565397120|FG000|Overall Study|Did not complete survey|2|||
156631834|NCT05147311|565397121|FG001|Overall Study|Did not complete survey|1|||
156631835|NCT05147311|565397120|FG000|Overall Study|Patient too sick|1|||
156631836|NCT05147311|565397121|FG001|Overall Study|Patient too sick|2|||
156631837|NCT05147311|565397120|FG000|Overall Study|Death|0|||
156631838|NCT05147311|565397121|FG001|Overall Study|Death|1|||
156631839|NCT05147311|565397120|FG000|Overall Study|Declined survey|1|||
156631840|NCT05147311|565397121|FG001|Overall Study|Declined survey|0|||
156631841|NCT00145795|565397123|FG000|Overall Study|Adverse Event|1|||
156631842|NCT00145795|565397124|FG001|Overall Study|Adverse Event|0|||
156631843|NCT03901274|565397132|FG000|Overall Study|Lost to Follow-up|120|||
156631844|NCT03901274|565397133|FG001|Overall Study|Lost to Follow-up|124|||
156631845|NCT03901274|565397132|FG000|Overall Study|Withdrawal by Subject|0|||
156631846|NCT03901274|565397133|FG001|Overall Study|Withdrawal by Subject|6|||
156631847|NCT04527380|565397134|FG000|Overall Study|Lack of Efficacy|0|||
156631848|NCT04527380|565397135|FG001|Overall Study|Lack of Efficacy|1|||
156631849|NCT04527380|565397134|FG000|Overall Study|Withdrawal by Subject|1|||
156631850|NCT04527380|565397135|FG001|Overall Study|Withdrawal by Subject|0|||
156631851|NCT05116241|565397136|FG000|Study|Withdrawal by Subject|5|||
156631852|NCT05116241|565397137|FG001|Study|Withdrawal by Subject|2|||
156631853|NCT05116241|565397138|FG002|Study|Withdrawal by Subject|1|||
156631854|NCT05116241|565397136|FG000|Study|Lost to Follow-up|0|||
156631855|NCT05116241|565397137|FG001|Study|Lost to Follow-up|2|||
156631856|NCT05116241|565397138|FG002|Study|Lost to Follow-up|2|||
156631857|NCT00938366|565397139|FG000|Overall Study|Withdrawal by Subject|1|||
156631858|NCT00938366|565397140|FG001|Overall Study|Withdrawal by Subject|0|||
156631859|NCT05182840|565397141|FG000|Run-in Period|Not treated|0|||
156631860|NCT05182840|565397142|FG001|Run-in Period|Not treated|1|||
156631861|NCT05182840|565397143|FG002|Run-in Period|Not treated|0|||
156631862|NCT05182840|565397144|FG003|Run-in Period|Not treated|0|||
156631863|NCT05182840|565397145|FG004|Run-in Period|Not treated|0|||
156631864|NCT05182840|565397146|FG005|Run-in Period|Not treated|0|||
156631865|NCT05182840|565397147|FG006|Run-in Period|Not treated|0|||
156631866|NCT05182840|565397148|FG007|Run-in Period|Not treated|0|||
156631867|NCT05182840|565397149|FG008|Run-in Period|Not treated|0|||
156631868|NCT05182840|565397150|FG009|Run-in Period|Not treated|0|||
156631869|NCT05182840|565397141|FG000|Run-in Period|Other reason but not sponsor termination|14|||
156631870|NCT05182840|565397142|FG001|Run-in Period|Other reason but not sponsor termination|18|||
156631871|NCT05182840|565397143|FG002|Run-in Period|Other reason but not sponsor termination|0|||
156631872|NCT05182840|565397144|FG003|Run-in Period|Other reason but not sponsor termination|0|||
156631873|NCT05182840|565397145|FG004|Run-in Period|Other reason but not sponsor termination|0|||
156631874|NCT05182840|565397146|FG005|Run-in Period|Other reason but not sponsor termination|0|||
156631875|NCT05182840|565397147|FG006|Run-in Period|Other reason but not sponsor termination|0|||
156631876|NCT05182840|565397148|FG007|Run-in Period|Other reason but not sponsor termination|0|||
156631877|NCT05182840|565397149|FG008|Run-in Period|Other reason but not sponsor termination|0|||
156631878|NCT05182840|565397150|FG009|Run-in Period|Other reason but not sponsor termination|0|||
156631879|NCT05182840|565397141|FG000|Run-in Period|No reason available|2|||
156631880|NCT05182840|565397142|FG001|Run-in Period|No reason available|2|||
156631881|NCT05182840|565397143|FG002|Run-in Period|No reason available|0|||
156631882|NCT05182840|565397144|FG003|Run-in Period|No reason available|0|||
156631883|NCT05182840|565397145|FG004|Run-in Period|No reason available|0|||
156631884|NCT05182840|565397146|FG005|Run-in Period|No reason available|0|||
156631885|NCT05182840|565397147|FG006|Run-in Period|No reason available|0|||
156631886|NCT05182840|565397148|FG007|Run-in Period|No reason available|0|||
156631887|NCT05182840|565397149|FG008|Run-in Period|No reason available|0|||
156631888|NCT05182840|565397150|FG009|Run-in Period|No reason available|0|||
156631889|NCT05182840|565397141|FG000|Run-in Period|Burden of study procedures|2|||
156631890|NCT05182840|565397142|FG001|Run-in Period|Burden of study procedures|2|||
156631891|NCT05182840|565397143|FG002|Run-in Period|Burden of study procedures|0|||
156631892|NCT05182840|565397144|FG003|Run-in Period|Burden of study procedures|0|||
156631893|NCT05182840|565397145|FG004|Run-in Period|Burden of study procedures|0|||
156631894|NCT05182840|565397146|FG005|Run-in Period|Burden of study procedures|0|||
156631895|NCT05182840|565397147|FG006|Run-in Period|Burden of study procedures|0|||
156631896|NCT05182840|565397148|FG007|Run-in Period|Burden of study procedures|0|||
156631897|NCT05182840|565397149|FG008|Run-in Period|Burden of study procedures|0|||
156631898|NCT05182840|565397150|FG009|Run-in Period|Burden of study procedures|0|||
156631899|NCT05182840|565397141|FG000|Run-in Period|Change of residence|1|||
156631900|NCT05182840|565397142|FG001|Run-in Period|Change of residence|0|||
156631901|NCT05182840|565397143|FG002|Run-in Period|Change of residence|0|||
156631902|NCT05182840|565397144|FG003|Run-in Period|Change of residence|0|||
156631903|NCT05182840|565397145|FG004|Run-in Period|Change of residence|0|||
156631904|NCT05182840|565397146|FG005|Run-in Period|Change of residence|0|||
156631905|NCT05182840|565397147|FG006|Run-in Period|Change of residence|0|||
156631906|NCT05182840|565397148|FG007|Run-in Period|Change of residence|0|||
156631907|NCT05182840|565397149|FG008|Run-in Period|Change of residence|0|||
156631908|NCT05182840|565397150|FG009|Run-in Period|Change of residence|0|||
156631909|NCT05182840|565397141|FG000|Run-in Period|Adverse Event|5|||
156631910|NCT05182840|565397142|FG001|Run-in Period|Adverse Event|5|||
156631911|NCT05182840|565397143|FG002|Run-in Period|Adverse Event|0|||
156631912|NCT05182840|565397144|FG003|Run-in Period|Adverse Event|0|||
156631913|NCT05182840|565397145|FG004|Run-in Period|Adverse Event|0|||
156631914|NCT05182840|565397146|FG005|Run-in Period|Adverse Event|0|||
156631915|NCT05182840|565397147|FG006|Run-in Period|Adverse Event|0|||
156631916|NCT05182840|565397148|FG007|Run-in Period|Adverse Event|0|||
156631917|NCT05182840|565397149|FG008|Run-in Period|Adverse Event|0|||
156631918|NCT05182840|565397150|FG009|Run-in Period|Adverse Event|0|||
156631919|NCT05182840|565397141|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
156631920|NCT05182840|565397142|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
156631921|NCT05182840|565397143|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
156631922|NCT05182840|565397144|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
156631923|NCT05182840|565397145|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
156631924|NCT05182840|565397146|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
156631925|NCT05182840|565397147|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
156631926|NCT05182840|565397148|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
156631927|NCT05182840|565397149|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
156631928|NCT05182840|565397150|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
156631929|NCT05182840|565397141|FG000|Treatment Period|Reason missing|0|||
156631930|NCT05182840|565397142|FG001|Treatment Period|Reason missing|0|||
156631931|NCT05182840|565397143|FG002|Treatment Period|Reason missing|1|||
156631932|NCT05182840|565397144|FG003|Treatment Period|Reason missing|0|||
156631933|NCT05182840|565397145|FG004|Treatment Period|Reason missing|0|||
156631934|NCT05182840|565397146|FG005|Treatment Period|Reason missing|0|||
156631935|NCT05182840|565397147|FG006|Treatment Period|Reason missing|0|||
156631936|NCT05182840|565397148|FG007|Treatment Period|Reason missing|0|||
156631937|NCT05182840|565397149|FG008|Treatment Period|Reason missing|0|||
156631938|NCT05182840|565397150|FG009|Treatment Period|Reason missing|0|||
156631939|NCT05182840|565397141|FG000|Treatment Period|Other but not sponsor termination|0|||
156631940|NCT05182840|565397142|FG001|Treatment Period|Other but not sponsor termination|0|||
156631941|NCT05182840|565397143|FG002|Treatment Period|Other but not sponsor termination|8|||
156631942|NCT05182840|565397144|FG003|Treatment Period|Other but not sponsor termination|6|||
156631943|NCT05182840|565397145|FG004|Treatment Period|Other but not sponsor termination|6|||
156631944|NCT05182840|565397146|FG005|Treatment Period|Other but not sponsor termination|7|||
156631945|NCT05182840|565397147|FG006|Treatment Period|Other but not sponsor termination|5|||
156631946|NCT05182840|565397148|FG007|Treatment Period|Other but not sponsor termination|8|||
156631947|NCT05182840|565397149|FG008|Treatment Period|Other but not sponsor termination|7|||
156631948|NCT05182840|565397150|FG009|Treatment Period|Other but not sponsor termination|2|||
156631949|NCT05182840|565397141|FG000|Treatment Period|Protocol deviation|0|||
156631950|NCT05182840|565397142|FG001|Treatment Period|Protocol deviation|0|||
156631951|NCT05182840|565397143|FG002|Treatment Period|Protocol deviation|0|||
156631952|NCT05182840|565397144|FG003|Treatment Period|Protocol deviation|0|||
156631953|NCT05182840|565397145|FG004|Treatment Period|Protocol deviation|0|||
156631954|NCT05182840|565397146|FG005|Treatment Period|Protocol deviation|0|||
156631955|NCT05182840|565397147|FG006|Treatment Period|Protocol deviation|0|||
156631956|NCT05182840|565397148|FG007|Treatment Period|Protocol deviation|0|||
156631957|NCT05182840|565397149|FG008|Treatment Period|Protocol deviation|1|||
156631958|NCT05182840|565397150|FG009|Treatment Period|Protocol deviation|0|||
156631959|NCT05182840|565397141|FG000|Treatment Period|No reason available|0|||
156631960|NCT05182840|565397142|FG001|Treatment Period|No reason available|0|||
156631961|NCT05182840|565397143|FG002|Treatment Period|No reason available|0|||
156631962|NCT05182840|565397144|FG003|Treatment Period|No reason available|1|||
156631963|NCT05182840|565397145|FG004|Treatment Period|No reason available|0|||
156631964|NCT05182840|565397146|FG005|Treatment Period|No reason available|2|||
156631965|NCT05182840|565397147|FG006|Treatment Period|No reason available|0|||
156631966|NCT05182840|565397148|FG007|Treatment Period|No reason available|1|||
156631967|NCT05182840|565397149|FG008|Treatment Period|No reason available|0|||
156631968|NCT05182840|565397150|FG009|Treatment Period|No reason available|0|||
156631969|NCT05182840|565397141|FG000|Treatment Period|Burden of study procedures|0|||
156631970|NCT05182840|565397142|FG001|Treatment Period|Burden of study procedures|0|||
156631971|NCT05182840|565397143|FG002|Treatment Period|Burden of study procedures|0|||
156631972|NCT05182840|565397144|FG003|Treatment Period|Burden of study procedures|0|||
156631973|NCT05182840|565397145|FG004|Treatment Period|Burden of study procedures|1|||
156631974|NCT05182840|565397146|FG005|Treatment Period|Burden of study procedures|0|||
156631975|NCT05182840|565397147|FG006|Treatment Period|Burden of study procedures|0|||
156631976|NCT05182840|565397148|FG007|Treatment Period|Burden of study procedures|0|||
156631977|NCT05182840|565397149|FG008|Treatment Period|Burden of study procedures|0|||
156631978|NCT05182840|565397150|FG009|Treatment Period|Burden of study procedures|0|||
156631979|NCT05182840|565397141|FG000|Treatment Period|Change of residence|0|||
156631980|NCT05182840|565397142|FG001|Treatment Period|Change of residence|0|||
156631981|NCT05182840|565397143|FG002|Treatment Period|Change of residence|0|||
156631982|NCT05182840|565397144|FG003|Treatment Period|Change of residence|0|||
156631983|NCT05182840|565397145|FG004|Treatment Period|Change of residence|0|||
156631984|NCT05182840|565397146|FG005|Treatment Period|Change of residence|1|||
156631985|NCT05182840|565397147|FG006|Treatment Period|Change of residence|0|||
156631986|NCT05182840|565397148|FG007|Treatment Period|Change of residence|0|||
156631987|NCT05182840|565397149|FG008|Treatment Period|Change of residence|0|||
156631988|NCT05182840|565397150|FG009|Treatment Period|Change of residence|0|||
156631989|NCT05182840|565397141|FG000|Treatment Period|Adverse Event|0|||
156631990|NCT05182840|565397142|FG001|Treatment Period|Adverse Event|0|||
156631991|NCT05182840|565397143|FG002|Treatment Period|Adverse Event|4|||
156631992|NCT05182840|565397144|FG003|Treatment Period|Adverse Event|16|||
156631993|NCT05182840|565397145|FG004|Treatment Period|Adverse Event|12|||
156631994|NCT05182840|565397146|FG005|Treatment Period|Adverse Event|6|||
156631995|NCT05182840|565397147|FG006|Treatment Period|Adverse Event|4|||
156631996|NCT05182840|565397148|FG007|Treatment Period|Adverse Event|8|||
156631997|NCT05182840|565397149|FG008|Treatment Period|Adverse Event|16|||
156631998|NCT05182840|565397150|FG009|Treatment Period|Adverse Event|5|||
156631999|NCT05182840|565397141|FG000|Treatment Period|Not treated with study drug|0|||
156632000|NCT05182840|565397142|FG001|Treatment Period|Not treated with study drug|0|||
156632001|NCT05182840|565397143|FG002|Treatment Period|Not treated with study drug|0|||
156632002|NCT05182840|565397144|FG003|Treatment Period|Not treated with study drug|1|||
156632003|NCT05182840|565397145|FG004|Treatment Period|Not treated with study drug|0|||
156632004|NCT05182840|565397146|FG005|Treatment Period|Not treated with study drug|0|||
156632005|NCT05182840|565397147|FG006|Treatment Period|Not treated with study drug|1|||
156632006|NCT05182840|565397148|FG007|Treatment Period|Not treated with study drug|1|||
156632007|NCT05182840|565397149|FG008|Treatment Period|Not treated with study drug|0|||
156632008|NCT05182840|565397150|FG009|Treatment Period|Not treated with study drug|0|||
156632009|NCT00509223|565399436|FG000|Overall Study|Lost to Follow-up|1|||
156632010|NCT00509223|565399437|FG001|Overall Study|Lost to Follow-up|1|||
156632011|NCT00509223|565399436|FG000|Overall Study|Adverse Event|1|||
156632012|NCT00509223|565399437|FG001|Overall Study|Adverse Event|1|||
156632013|NCT00509223|565399436|FG000|Overall Study|Withdrawal by Subject|25|||
156632014|NCT00509223|565399437|FG001|Overall Study|Withdrawal by Subject|6|||
156632015|NCT00509223|565399436|FG000|Overall Study|Including: subject change of address|5|||
156632016|NCT00509223|565399437|FG001|Overall Study|Including: subject change of address|2|||
156632017|NCT00509223|565399436|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
156632018|NCT00509223|565399437|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
156632019|NCT01361308|565399440|FG000|Overall Study|Withdrawal by Subject|9|||
156632020|NCT01361308|565399441|FG001|Overall Study|Withdrawal by Subject|13|||
156632021|NCT01361308|565399440|FG000|Overall Study|Physician Decision|3|||
156632022|NCT01361308|565399441|FG001|Overall Study|Physician Decision|3|||
156632023|NCT01361308|565399440|FG000|Overall Study|Lack of Efficacy|2|||
156632024|NCT01361308|565399441|FG001|Overall Study|Lack of Efficacy|0|||
156632025|NCT01361308|565399440|FG000|Overall Study|Protocol Violation|1|||
156632026|NCT01361308|565399441|FG001|Overall Study|Protocol Violation|0|||
156632027|NCT01361308|565399440|FG000|Overall Study|Lost to Follow-up|5|||
156632028|NCT01361308|565399441|FG001|Overall Study|Lost to Follow-up|4|||
156632029|NCT01361308|565399440|FG000|Overall Study|Adverse Event|8|||
156632030|NCT01361308|565399441|FG001|Overall Study|Adverse Event|4|||
156632031|NCT01361308|565399440|FG000|Overall Study|Eligibility Criteria Not Met|2|||
156632032|NCT01361308|565399441|FG001|Overall Study|Eligibility Criteria Not Met|3|||
156632033|NCT01361308|565399440|FG000|Overall Study|Failed C-SSRS|5|||
156632034|NCT01361308|565399441|FG001|Overall Study|Failed C-SSRS|2|||
156632035|NCT01361308|565399440|FG000|Overall Study|Other|0|||
156632036|NCT01361308|565399441|FG001|Overall Study|Other|1|||
156632037|NCT04621227|565399442|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
156632038|NCT04621227|565399442|FG000|Period 3 (29 Days)|Adverse Event|1|||
156632039|NCT04621227|565399442|FG000|Period 8 (2 Days)|Adverse Event|1|||
156632040|NCT02916056|565399443|FG000|Overall Study|Adverse Event|6|||
156632041|NCT02916056|565399443|FG000|Overall Study|Lost to Follow-up|1|||
156632042|NCT02916056|565399443|FG000|Overall Study|Other|12|||
156632043|NCT02916056|565399443|FG000|Overall Study|Protocol Violation|1|||
156632044|NCT02916056|565399443|FG000|Overall Study|Withdrawal by Subject|8|||
156632045|NCT02916056|565399443|FG000|Overall Study|Study Terminated by Sponsor|269|||
156632046|NCT00124709|565399444|FG000|Overall Study|Randomized but did not take medication|3|||
156632047|NCT00124709|565399445|FG001|Overall Study|Randomized but did not take medication|1|||
156632048|NCT00124709|565399444|FG000|Overall Study|Adverse Event|3|||
156632049|NCT00124709|565399445|FG001|Overall Study|Adverse Event|0|||
156632050|NCT00124709|565399444|FG000|Overall Study|Lack of Efficacy|5|||
156632051|NCT00124709|565399445|FG001|Overall Study|Lack of Efficacy|10|||
156632052|NCT00124709|565399444|FG000|Overall Study|Protocol Violation|3|||
156632053|NCT00124709|565399445|FG001|Overall Study|Protocol Violation|5|||
156632054|NCT00124709|565399444|FG000|Overall Study|Withdrawal by Subject|127|||
156632055|NCT00124709|565399445|FG001|Overall Study|Withdrawal by Subject|136|||
156632056|NCT00124709|565399444|FG000|Overall Study|Lost to Follow-up|114|||
156632057|NCT00124709|565399445|FG001|Overall Study|Lost to Follow-up|120|||
156632058|NCT01728376|565399446|FG000|Overall Study|Adverse Event|1|||
156632059|NCT01728376|565399447|FG001|Overall Study|Adverse Event|1|||
156632060|NCT01728376|565399448|FG002|Overall Study|Adverse Event|1|||
156632061|NCT01728376|565399449|FG003|Overall Study|Adverse Event|1|||
156632062|NCT01728376|565399450|FG004|Overall Study|Adverse Event|1|||
156632063|NCT01728376|565399451|FG005|Overall Study|Adverse Event|0|||
156632064|NCT01728376|565399446|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
156632065|NCT01728376|565399447|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
156632066|NCT01728376|565399448|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
156632067|NCT01728376|565399449|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
156632068|NCT01728376|565399450|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
156632069|NCT01728376|565399451|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
156632070|NCT01728376|565399446|FG000|Overall Study|No relevant bacteria|2|||
156632071|NCT01728376|565399447|FG001|Overall Study|No relevant bacteria|0|||
156632072|NCT01728376|565399448|FG002|Overall Study|No relevant bacteria|0|||
156632073|NCT01728376|565399449|FG003|Overall Study|No relevant bacteria|0|||
156632074|NCT01728376|565399450|FG004|Overall Study|No relevant bacteria|1|||
156632075|NCT01728376|565399451|FG005|Overall Study|No relevant bacteria|1|||
156632076|NCT01728376|565399446|FG000|Overall Study|Did not receive treatment|0|||
156632077|NCT01728376|565399447|FG001|Overall Study|Did not receive treatment|1|||
156632078|NCT01728376|565399448|FG002|Overall Study|Did not receive treatment|0|||
156632079|NCT01728376|565399449|FG003|Overall Study|Did not receive treatment|0|||
156632080|NCT01728376|565399450|FG004|Overall Study|Did not receive treatment|0|||
156632081|NCT01728376|565399451|FG005|Overall Study|Did not receive treatment|0|||
156632082|NCT01728376|565399446|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
156632083|NCT01728376|565399447|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
156632084|NCT01728376|565399448|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
156632085|NCT01728376|565399449|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
156632086|NCT01728376|565399450|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
156632087|NCT01728376|565399451|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
156632088|NCT05299359|565399462|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
156632089|NCT05299359|565399463|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
156632090|NCT05299359|565399462|FG000|Main Part: Day 1 up to Day 366|Other|2|||
156632091|NCT05299359|565399463|FG001|Main Part: Day 1 up to Day 366|Other|0|||
156632092|NCT05299359|565399462|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
156632093|NCT05299359|565399463|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
156632094|NCT05299359|565399462|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
156632095|NCT05299359|565399463|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
156632096|NCT05299359|565399462|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
156632097|NCT05299359|565399463|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
156632098|NCT05299359|565399462|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
156632099|NCT05299359|565399463|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
156632100|NCT05299359|565399462|FG000|Extension Part: Day 1 to Day 366|Other|0|||
156632101|NCT05299359|565399463|FG001|Extension Part: Day 1 to Day 366|Other|1|||
156632102|NCT03110107|565399464|FG000|Treatment Period|Disease Progression|3|||
156632103|NCT03110107|565399465|FG001|Treatment Period|Disease Progression|9|||
156632104|NCT03110107|565399466|FG002|Treatment Period|Disease Progression|8|||
156632105|NCT03110107|565399467|FG003|Treatment Period|Disease Progression|11|||
156632106|NCT03110107|565399468|FG004|Treatment Period|Disease Progression|8|||
156632107|NCT03110107|565399469|FG005|Treatment Period|Disease Progression|4|||
156632108|NCT03110107|565399470|FG006|Treatment Period|Disease Progression|6|||
156632109|NCT03110107|565399471|FG007|Treatment Period|Disease Progression|7|||
156632110|NCT03110107|565399472|FG008|Treatment Period|Disease Progression|2|||
156632111|NCT03110107|565399473|FG009|Treatment Period|Disease Progression|10|||
156632112|NCT03110107|565399474|FG010|Treatment Period|Disease Progression|5|||
156632113|NCT03110107|565399475|FG011|Treatment Period|Disease Progression|2|||
156632114|NCT03110107|565399476|FG012|Treatment Period|Disease Progression|0|||
156632115|NCT03110107|565399477|FG013|Treatment Period|Disease Progression|5|||
156632116|NCT03110107|565399478|FG014|Treatment Period|Disease Progression|14|||
156632117|NCT03110107|565399479|FG015|Treatment Period|Disease Progression|14|||
156632118|NCT03110107|565399480|FG016|Treatment Period|Disease Progression|4|||
156632119|NCT03110107|565399481|FG017|Treatment Period|Disease Progression|3|||
156632120|NCT03110107|565399482|FG018|Treatment Period|Disease Progression|16|||
156632121|NCT03110107|565399483|FG019|Treatment Period|Disease Progression|14|||
156632122|NCT03110107|565399484|FG020|Treatment Period|Disease Progression|12|||
156632123|NCT03110107|565399485|FG021|Treatment Period|Disease Progression|16|||
156632124|NCT03110107|565399486|FG022|Treatment Period|Disease Progression|18|||
156632125|NCT03110107|565399487|FG023|Treatment Period|Disease Progression|13|||
156632126|NCT03110107|565399488|FG024|Treatment Period|Disease Progression|16|||
156632127|NCT03110107|565399489|FG025|Treatment Period|Disease Progression|31|||
156632128|NCT03110107|565399464|FG000|Treatment Period|Study drug toxicity|1|||
156632129|NCT03110107|565399465|FG001|Treatment Period|Study drug toxicity|0|||
156632130|NCT03110107|565399466|FG002|Treatment Period|Study drug toxicity|1|||
156632131|NCT03110107|565399467|FG003|Treatment Period|Study drug toxicity|2|||
156632132|NCT03110107|565399468|FG004|Treatment Period|Study drug toxicity|0|||
156632133|NCT03110107|565399469|FG005|Treatment Period|Study drug toxicity|3|||
156632134|NCT03110107|565399470|FG006|Treatment Period|Study drug toxicity|1|||
156632135|NCT03110107|565399471|FG007|Treatment Period|Study drug toxicity|1|||
156632136|NCT03110107|565399472|FG008|Treatment Period|Study drug toxicity|3|||
156632137|NCT03110107|565399473|FG009|Treatment Period|Study drug toxicity|2|||
156632138|NCT03110107|565399474|FG010|Treatment Period|Study drug toxicity|0|||
156632139|NCT03110107|565399475|FG011|Treatment Period|Study drug toxicity|2|||
156632140|NCT03110107|565399476|FG012|Treatment Period|Study drug toxicity|0|||
156632141|NCT03110107|565399477|FG013|Treatment Period|Study drug toxicity|0|||
156632142|NCT03110107|565399478|FG014|Treatment Period|Study drug toxicity|2|||
156632143|NCT03110107|565399479|FG015|Treatment Period|Study drug toxicity|3|||
156632144|NCT03110107|565399480|FG016|Treatment Period|Study drug toxicity|3|||
156632145|NCT03110107|565399481|FG017|Treatment Period|Study drug toxicity|3|||
156632146|NCT03110107|565399482|FG018|Treatment Period|Study drug toxicity|1|||
156632147|NCT03110107|565399483|FG019|Treatment Period|Study drug toxicity|2|||
156632148|NCT03110107|565399484|FG020|Treatment Period|Study drug toxicity|2|||
156632149|NCT03110107|565399485|FG021|Treatment Period|Study drug toxicity|0|||
156632150|NCT03110107|565399486|FG022|Treatment Period|Study drug toxicity|2|||
156632151|NCT03110107|565399487|FG023|Treatment Period|Study drug toxicity|6|||
156632152|NCT03110107|565399488|FG024|Treatment Period|Study drug toxicity|7|||
156632153|NCT03110107|565399489|FG025|Treatment Period|Study drug toxicity|6|||
156632154|NCT03110107|565399464|FG000|Treatment Period|Death|0|||
156632155|NCT03110107|565399465|FG001|Treatment Period|Death|0|||
156632156|NCT03110107|565399466|FG002|Treatment Period|Death|0|||
156632157|NCT03110107|565399467|FG003|Treatment Period|Death|0|||
156632158|NCT03110107|565399468|FG004|Treatment Period|Death|0|||
156632159|NCT03110107|565399469|FG005|Treatment Period|Death|0|||
156632160|NCT03110107|565399470|FG006|Treatment Period|Death|0|||
156632161|NCT03110107|565399471|FG007|Treatment Period|Death|0|||
156632162|NCT03110107|565399472|FG008|Treatment Period|Death|0|||
156632163|NCT03110107|565399473|FG009|Treatment Period|Death|0|||
156632164|NCT03110107|565399474|FG010|Treatment Period|Death|0|||
156632165|NCT03110107|565399475|FG011|Treatment Period|Death|0|||
156632166|NCT03110107|565399476|FG012|Treatment Period|Death|1|||
156632167|NCT03110107|565399477|FG013|Treatment Period|Death|0|||
156632168|NCT03110107|565399478|FG014|Treatment Period|Death|0|||
156632169|NCT03110107|565399479|FG015|Treatment Period|Death|0|||
156632170|NCT03110107|565399480|FG016|Treatment Period|Death|0|||
156632171|NCT03110107|565399481|FG017|Treatment Period|Death|0|||
156632172|NCT03110107|565399482|FG018|Treatment Period|Death|0|||
156632173|NCT03110107|565399483|FG019|Treatment Period|Death|0|||
156632174|NCT03110107|565399484|FG020|Treatment Period|Death|0|||
156632175|NCT03110107|565399485|FG021|Treatment Period|Death|0|||
156632176|NCT03110107|565399486|FG022|Treatment Period|Death|0|||
156632177|NCT03110107|565399487|FG023|Treatment Period|Death|0|||
156632178|NCT03110107|565399488|FG024|Treatment Period|Death|0|||
156632179|NCT03110107|565399489|FG025|Treatment Period|Death|0|||
156632180|NCT03110107|565399464|FG000|Treatment Period|Adverse Event|0|||
156632181|NCT03110107|565399465|FG001|Treatment Period|Adverse Event|0|||
156632182|NCT03110107|565399466|FG002|Treatment Period|Adverse Event|1|||
156632183|NCT03110107|565399467|FG003|Treatment Period|Adverse Event|0|||
156632184|NCT03110107|565399468|FG004|Treatment Period|Adverse Event|0|||
156632185|NCT03110107|565399469|FG005|Treatment Period|Adverse Event|2|||
156632186|NCT03110107|565399470|FG006|Treatment Period|Adverse Event|0|||
156632187|NCT03110107|565399471|FG007|Treatment Period|Adverse Event|2|||
156632188|NCT03110107|565399472|FG008|Treatment Period|Adverse Event|0|||
156632189|NCT03110107|565399473|FG009|Treatment Period|Adverse Event|1|||
156632190|NCT03110107|565399474|FG010|Treatment Period|Adverse Event|0|||
156632191|NCT03110107|565399475|FG011|Treatment Period|Adverse Event|0|||
156632192|NCT03110107|565399476|FG012|Treatment Period|Adverse Event|0|||
156632193|NCT03110107|565399477|FG013|Treatment Period|Adverse Event|0|||
156632194|NCT03110107|565399478|FG014|Treatment Period|Adverse Event|0|||
156632195|NCT03110107|565399479|FG015|Treatment Period|Adverse Event|2|||
156632196|NCT03110107|565399480|FG016|Treatment Period|Adverse Event|0|||
156632197|NCT03110107|565399481|FG017|Treatment Period|Adverse Event|1|||
156632198|NCT03110107|565399482|FG018|Treatment Period|Adverse Event|2|||
156632199|NCT03110107|565399483|FG019|Treatment Period|Adverse Event|1|||
156632200|NCT03110107|565399484|FG020|Treatment Period|Adverse Event|4|||
156632201|NCT03110107|565399485|FG021|Treatment Period|Adverse Event|2|||
156632202|NCT03110107|565399486|FG022|Treatment Period|Adverse Event|2|||
156632203|NCT03110107|565399487|FG023|Treatment Period|Adverse Event|2|||
156632204|NCT03110107|565399488|FG024|Treatment Period|Adverse Event|2|||
156632205|NCT03110107|565399489|FG025|Treatment Period|Adverse Event|4|||
156632206|NCT03110107|565399464|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
156632207|NCT03110107|565399465|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
156632208|NCT03110107|565399466|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
156632209|NCT03110107|565399467|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
156632210|NCT03110107|565399468|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
156632211|NCT03110107|565399469|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
156632212|NCT03110107|565399470|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
156632213|NCT03110107|565399471|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
156632214|NCT03110107|565399472|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
156632215|NCT03110107|565399473|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
156632216|NCT03110107|565399474|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
156632217|NCT03110107|565399475|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
156632218|NCT03110107|565399476|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
156632219|NCT03110107|565399477|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
156632220|NCT03110107|565399478|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
156632221|NCT03110107|565399479|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
156632222|NCT03110107|565399480|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
156632223|NCT03110107|565399481|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
156632224|NCT03110107|565399482|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
156632225|NCT03110107|565399483|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
156632226|NCT03110107|565399484|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
156632227|NCT03110107|565399485|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
156632228|NCT03110107|565399486|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
156632229|NCT03110107|565399487|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
156632230|NCT03110107|565399488|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
156632231|NCT03110107|565399489|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
156632232|NCT03110107|565399464|FG000|Treatment Period|Participant withdrew consent|0|||
156632233|NCT03110107|565399465|FG001|Treatment Period|Participant withdrew consent|0|||
156632234|NCT03110107|565399466|FG002|Treatment Period|Participant withdrew consent|1|||
156632235|NCT03110107|565399467|FG003|Treatment Period|Participant withdrew consent|0|||
156632236|NCT03110107|565399468|FG004|Treatment Period|Participant withdrew consent|4|||
156632237|NCT03110107|565399469|FG005|Treatment Period|Participant withdrew consent|3|||
156632238|NCT03110107|565399470|FG006|Treatment Period|Participant withdrew consent|0|||
156632239|NCT03110107|565399471|FG007|Treatment Period|Participant withdrew consent|0|||
156632240|NCT03110107|565399472|FG008|Treatment Period|Participant withdrew consent|0|||
156632241|NCT03110107|565399473|FG009|Treatment Period|Participant withdrew consent|1|||
156632242|NCT03110107|565399474|FG010|Treatment Period|Participant withdrew consent|0|||
156632243|NCT03110107|565399475|FG011|Treatment Period|Participant withdrew consent|0|||
156632244|NCT03110107|565399476|FG012|Treatment Period|Participant withdrew consent|0|||
156632245|NCT03110107|565399477|FG013|Treatment Period|Participant withdrew consent|0|||
156632246|NCT03110107|565399478|FG014|Treatment Period|Participant withdrew consent|0|||
156632247|NCT03110107|565399479|FG015|Treatment Period|Participant withdrew consent|0|||
156632248|NCT03110107|565399480|FG016|Treatment Period|Participant withdrew consent|0|||
156632249|NCT03110107|565399481|FG017|Treatment Period|Participant withdrew consent|0|||
156632250|NCT03110107|565399482|FG018|Treatment Period|Participant withdrew consent|0|||
156632251|NCT03110107|565399483|FG019|Treatment Period|Participant withdrew consent|1|||
156632252|NCT03110107|565399484|FG020|Treatment Period|Participant withdrew consent|0|||
156632253|NCT03110107|565399485|FG021|Treatment Period|Participant withdrew consent|2|||
156632254|NCT03110107|565399486|FG022|Treatment Period|Participant withdrew consent|0|||
156632255|NCT03110107|565399487|FG023|Treatment Period|Participant withdrew consent|0|||
156632256|NCT03110107|565399488|FG024|Treatment Period|Participant withdrew consent|0|||
156632257|NCT03110107|565399489|FG025|Treatment Period|Participant withdrew consent|2|||
156632258|NCT03110107|565399464|FG000|Treatment Period|Participants no longer meets study criteria|0|||
156632259|NCT03110107|565399465|FG001|Treatment Period|Participants no longer meets study criteria|0|||
156632260|NCT03110107|565399466|FG002|Treatment Period|Participants no longer meets study criteria|0|||
156632261|NCT03110107|565399467|FG003|Treatment Period|Participants no longer meets study criteria|0|||
156632262|NCT03110107|565399468|FG004|Treatment Period|Participants no longer meets study criteria|0|||
156632263|NCT03110107|565399469|FG005|Treatment Period|Participants no longer meets study criteria|0|||
156632264|NCT03110107|565399470|FG006|Treatment Period|Participants no longer meets study criteria|0|||
156632265|NCT03110107|565399471|FG007|Treatment Period|Participants no longer meets study criteria|0|||
156632266|NCT03110107|565399472|FG008|Treatment Period|Participants no longer meets study criteria|0|||
156632267|NCT03110107|565399473|FG009|Treatment Period|Participants no longer meets study criteria|0|||
156632268|NCT03110107|565399474|FG010|Treatment Period|Participants no longer meets study criteria|0|||
156632269|NCT03110107|565399475|FG011|Treatment Period|Participants no longer meets study criteria|0|||
156632270|NCT03110107|565399476|FG012|Treatment Period|Participants no longer meets study criteria|0|||
156632271|NCT03110107|565399477|FG013|Treatment Period|Participants no longer meets study criteria|0|||
156632272|NCT03110107|565399478|FG014|Treatment Period|Participants no longer meets study criteria|0|||
156632273|NCT03110107|565399479|FG015|Treatment Period|Participants no longer meets study criteria|0|||
156632274|NCT03110107|565399480|FG016|Treatment Period|Participants no longer meets study criteria|0|||
156632275|NCT03110107|565399481|FG017|Treatment Period|Participants no longer meets study criteria|0|||
156632276|NCT03110107|565399482|FG018|Treatment Period|Participants no longer meets study criteria|0|||
156632277|NCT03110107|565399483|FG019|Treatment Period|Participants no longer meets study criteria|0|||
156632278|NCT03110107|565399484|FG020|Treatment Period|Participants no longer meets study criteria|0|||
156632279|NCT03110107|565399485|FG021|Treatment Period|Participants no longer meets study criteria|0|||
156632280|NCT03110107|565399486|FG022|Treatment Period|Participants no longer meets study criteria|0|||
156632281|NCT03110107|565399487|FG023|Treatment Period|Participants no longer meets study criteria|1|||
156632282|NCT03110107|565399488|FG024|Treatment Period|Participants no longer meets study criteria|0|||
156632283|NCT03110107|565399489|FG025|Treatment Period|Participants no longer meets study criteria|0|||
156632284|NCT03110107|565399464|FG000|Treatment Period|Other Reasons|0|||
156632285|NCT03110107|565399465|FG001|Treatment Period|Other Reasons|0|||
156632286|NCT03110107|565399466|FG002|Treatment Period|Other Reasons|1|||
156632287|NCT03110107|565399467|FG003|Treatment Period|Other Reasons|1|||
156632288|NCT03110107|565399468|FG004|Treatment Period|Other Reasons|0|||
156632289|NCT03110107|565399469|FG005|Treatment Period|Other Reasons|1|||
156632290|NCT03110107|565399470|FG006|Treatment Period|Other Reasons|0|||
156632291|NCT03110107|565399471|FG007|Treatment Period|Other Reasons|0|||
156632292|NCT03110107|565399472|FG008|Treatment Period|Other Reasons|0|||
156632293|NCT03110107|565399473|FG009|Treatment Period|Other Reasons|0|||
156632294|NCT03110107|565399474|FG010|Treatment Period|Other Reasons|0|||
156632295|NCT03110107|565399475|FG011|Treatment Period|Other Reasons|0|||
156632296|NCT03110107|565399476|FG012|Treatment Period|Other Reasons|0|||
156632297|NCT03110107|565399477|FG013|Treatment Period|Other Reasons|0|||
156632298|NCT03110107|565399478|FG014|Treatment Period|Other Reasons|0|||
156632299|NCT03110107|565399479|FG015|Treatment Period|Other Reasons|0|||
156632300|NCT03110107|565399480|FG016|Treatment Period|Other Reasons|0|||
156632301|NCT03110107|565399481|FG017|Treatment Period|Other Reasons|0|||
156632302|NCT03110107|565399482|FG018|Treatment Period|Other Reasons|0|||
156632303|NCT03110107|565399483|FG019|Treatment Period|Other Reasons|0|||
156632304|NCT03110107|565399484|FG020|Treatment Period|Other Reasons|0|||
156632305|NCT03110107|565399485|FG021|Treatment Period|Other Reasons|0|||
156632306|NCT03110107|565399486|FG022|Treatment Period|Other Reasons|0|||
156632307|NCT03110107|565399487|FG023|Treatment Period|Other Reasons|0|||
156632308|NCT03110107|565399488|FG024|Treatment Period|Other Reasons|1|||
156632309|NCT03110107|565399489|FG025|Treatment Period|Other Reasons|0|||
156632310|NCT03927989|565399495|FG000|Overall Study|Withdrawal by Subject|0|||
156632311|NCT03927989|565399496|FG001|Overall Study|Withdrawal by Subject|1|||
156632312|NCT02593175|565399497|FG000|Overall Study|Adverse Event|5|||
156632313|NCT02593175|565399497|FG000|Overall Study|Disease progression|4|||
156632314|NCT02506101|565399502|FG000|Overall Study|Transportation issues|1|||
156632315|NCT02506101|565399503|FG001|Overall Study|Transportation issues|0|||
156632316|NCT02506101|565399502|FG000|Overall Study|No enrollment and staff unavailability|1|||
156632317|NCT02506101|565399503|FG001|Overall Study|No enrollment and staff unavailability|0|||
156632318|NCT01308476|565399504|FG000|Overall Study|Lost to Follow-up|2|||
156632319|NCT01308476|565399505|FG001|Overall Study|Lost to Follow-up|2|||
156632320|NCT01308476|565399504|FG000|Overall Study|Other|1|||
156632321|NCT01308476|565399505|FG001|Overall Study|Other|0|||
156632322|NCT03772574|565399506|FG000|Overall Study|Protocol Violation|2|||
156632323|NCT03772574|565399507|FG001|Overall Study|Protocol Violation|0|||
156632324|NCT03772574|565399508|FG002|Overall Study|Protocol Violation|0|||
156632325|NCT03772574|565399506|FG000|Overall Study|Discomfort|0|||
156632326|NCT03772574|565399507|FG001|Overall Study|Discomfort|5|||
156632327|NCT03772574|565399508|FG002|Overall Study|Discomfort|4|||
156632328|NCT01207219|565399513|FG000|Overall Study|changed diagnosis during study period|5|||
156632329|NCT01207219|565399514|FG001|Overall Study|changed diagnosis during study period|3|||
156632330|NCT01207219|565399515|FG002|Overall Study|changed diagnosis during study period|1|||
156632331|NCT01207219|565399513|FG000|Overall Study|Lost to Follow-up|6|||
156632332|NCT01207219|565399514|FG001|Overall Study|Lost to Follow-up|8|||
156632333|NCT01207219|565399515|FG002|Overall Study|Lost to Follow-up|6|||
156632334|NCT01012609|565399516|FG000|Overall Study|Withdrawal by Subject|1|||
156632335|NCT01012609|565399517|FG001|Overall Study|Withdrawal by Subject|1|||
156632336|NCT01453296|565399518|FG000|Treatment Period 1|Adverse Event|0|||
156632337|NCT01453296|565399519|FG001|Treatment Period 1|Adverse Event|1|||
156632338|NCT01453296|565399518|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
156632339|NCT01453296|565399519|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
156632340|NCT01453296|565399518|FG000|Treatment Period 2|Adverse Event|1|||
156632341|NCT01453296|565399519|FG001|Treatment Period 2|Adverse Event|0|||
156632342|NCT01453296|565399518|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156632343|NCT01453296|565399519|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156632344|NCT00620776|565399520|FG000|Overall Study|Did not receive treatment|3|||
156632345|NCT00620776|565399521|FG001|Overall Study|Did not receive treatment|5|||
156632346|NCT00620776|565399520|FG000|Overall Study|Adverse Event|2|||
156632347|NCT00620776|565399521|FG001|Overall Study|Adverse Event|3|||
156632348|NCT00620776|565399520|FG000|Overall Study|Lack of Efficacy|2|||
156632349|NCT00620776|565399521|FG001|Overall Study|Lack of Efficacy|1|||
156632350|NCT00620776|565399520|FG000|Overall Study|Lost to Follow-up|2|||
156632351|NCT00620776|565399521|FG001|Overall Study|Lost to Follow-up|5|||
156632352|NCT00620776|565399520|FG000|Overall Study|Withdrawal by Subject|3|||
156632353|NCT00620776|565399521|FG001|Overall Study|Withdrawal by Subject|2|||
156632354|NCT04983589|565399522|FG000|Overall Study|Withdrawal by Subject|0|||
156632355|NCT04983589|565399523|FG001|Overall Study|Withdrawal by Subject|3|||
156632356|NCT04983589|565399522|FG000|Overall Study|COVID-19 Infection|1|||
156632357|NCT04983589|565399523|FG001|Overall Study|COVID-19 Infection|0|||
156632358|NCT04983589|565399522|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
156632359|NCT04983589|565399523|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
156632360|NCT00924820|565399524|FG000|Overall Study|Death|2|||
156632361|NCT00924820|565399524|FG000|Overall Study|Ineligible, Screen Failure|5|||
156632362|NCT00761969|565399525|FG000|Overall Study|Death|112|||
156632363|NCT00761969|565399526|FG001|Overall Study|Death|47|||
156632364|NCT00761969|565399525|FG000|Overall Study|Lost to Follow-up|88|||
156632365|NCT00761969|565399526|FG001|Overall Study|Lost to Follow-up|93|||
156632366|NCT01725217|565399527|FG000|Overall Study|Withdrawal by Subject|1|||
156632367|NCT01725217|565399528|FG001|Overall Study|Withdrawal by Subject|0|||
156632368|NCT01725217|565399529|FG002|Overall Study|Withdrawal by Subject|0|||
156632369|NCT00585468|565399530|FG000|First Intervention|Withdrawal by Subject|1|||
156632370|NCT00585468|565399531|FG001|First Intervention|Withdrawal by Subject|1|||
156632371|NCT03155269|565399534|FG000|Overall Study|Withdrawal by Subject|4|||
156632372|NCT03155269|565399535|FG001|Overall Study|Withdrawal by Subject|5|||
156632373|NCT03155269|565399534|FG000|Overall Study|Lost to Follow-up|1|||
156632374|NCT03155269|565399535|FG001|Overall Study|Lost to Follow-up|2|||
156632375|NCT03919669|565399536|FG000|Overall Study|Withdrawal by Subject|1|||
156632376|NCT03919669|565399537|FG001|Overall Study|Withdrawal by Subject|0|||
156632377|NCT03919669|565399538|FG002|Overall Study|Withdrawal by Subject|0|||
156632378|NCT02686749|565399539|FG000|Overall Study|terminated for poor enrollment|2|||
156632379|NCT02686749|565399540|FG001|Overall Study|terminated for poor enrollment|2|||
156632380|NCT02319642|565399543|FG000|Overall Study|Adverse Event|2|||
156632381|NCT02319642|565399544|FG001|Overall Study|Adverse Event|4|||
156632382|NCT02319642|565399543|FG000|Overall Study|Lack of Efficacy|1|||
156632383|NCT02319642|565399544|FG001|Overall Study|Lack of Efficacy|1|||
156632384|NCT02319642|565399543|FG000|Overall Study|Withdrawal by Subject|1|||
156632385|NCT02319642|565399544|FG001|Overall Study|Withdrawal by Subject|1|||
156632386|NCT04409509|565399545|FG000|Overall Study|Failure to meet randomization requirement|1|||
156632387|NCT04409509|565399546|FG001|Overall Study|Failure to meet randomization requirement|0|||
156632388|NCT04409509|565399545|FG000|Overall Study|Adverse Event|0|||
156632389|NCT04409509|565399546|FG001|Overall Study|Adverse Event|1|||
156632390|NCT04409509|565399545|FG000|Overall Study|Death|11|||
156632391|NCT04409509|565399546|FG001|Overall Study|Death|10|||
156632392|NCT04409509|565399545|FG000|Overall Study|Non-compliance with study drug|0|||
156632393|NCT04409509|565399546|FG001|Overall Study|Non-compliance with study drug|1|||
156632394|NCT04409509|565399545|FG000|Overall Study|Lost to Follow-up|0|||
156632395|NCT04409509|565399546|FG001|Overall Study|Lost to Follow-up|3|||
156632396|NCT04409509|565399545|FG000|Overall Study|Withdrawal by Subject|0|||
156632397|NCT04409509|565399546|FG001|Overall Study|Withdrawal by Subject|3|||
156632398|NCT04409509|565399545|FG000|Overall Study|Randomized by mistake|0|||
156632399|NCT04409509|565399546|FG001|Overall Study|Randomized by mistake|1|||
156632400|NCT04409509|565399545|FG000|Overall Study|Other|1|||
156632401|NCT04409509|565399546|FG001|Overall Study|Other|1|||
156632402|NCT00483119|565399547|FG000|Overall Study|Adverse Event|0|||
156632403|NCT00483119|565399548|FG001|Overall Study|Adverse Event|1|||
156632404|NCT00483119|565399547|FG000|Overall Study|Physician Decision|1|||
156632405|NCT00483119|565399548|FG001|Overall Study|Physician Decision|0|||
156632406|NCT04668066|565399549|FG000|Part 1: Treatment Phase|Adverse Event|0|||
156632407|NCT04668066|565399550|FG001|Part 1: Treatment Phase|Adverse Event|0|||
156632408|NCT04668066|565399551|FG002|Part 1: Treatment Phase|Adverse Event|0|||
156632409|NCT04668066|565399552|FG003|Part 1: Treatment Phase|Adverse Event|0|||
156632410|NCT04668066|565399553|FG004|Part 1: Treatment Phase|Adverse Event|0|||
156632411|NCT04668066|565399554|FG005|Part 1: Treatment Phase|Adverse Event|0|||
156632412|NCT04668066|565399555|FG006|Part 1: Treatment Phase|Adverse Event|0|||
156632413|NCT04668066|565399556|FG007|Part 1: Treatment Phase|Adverse Event|0|||
156632414|NCT04668066|565399557|FG008|Part 1: Treatment Phase|Adverse Event|0|||
156632415|NCT04668066|565399558|FG009|Part 1: Treatment Phase|Adverse Event|0|||
156632416|NCT04668066|565399559|FG010|Part 1: Treatment Phase|Adverse Event|0|||
156632417|NCT04668066|565399560|FG011|Part 1: Treatment Phase|Adverse Event|1|||
156632418|NCT04668066|565399561|FG012|Part 1: Treatment Phase|Adverse Event|1|||
156632419|NCT04668066|565399562|FG013|Part 1: Treatment Phase|Adverse Event|0|||
156632420|NCT04668066|565399563|FG014|Part 1: Treatment Phase|Adverse Event|0|||
156632421|NCT04668066|565399564|FG015|Part 1: Treatment Phase|Adverse Event|0|||
156632422|NCT04668066|565399565|FG016|Part 1: Treatment Phase|Adverse Event|0|||
156632423|NCT04668066|565399566|FG017|Part 1: Treatment Phase|Adverse Event|0|||
156632424|NCT04668066|565399567|FG018|Part 1: Treatment Phase|Adverse Event|0|||
156632425|NCT04668066|565399549|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632426|NCT04668066|565399550|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632427|NCT04668066|565399551|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
156632428|NCT04668066|565399552|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632429|NCT04668066|565399553|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632430|NCT04668066|565399554|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632431|NCT04668066|565399555|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632432|NCT04668066|565399556|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632433|NCT04668066|565399557|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632434|NCT04668066|565399558|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632435|NCT04668066|565399559|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632436|NCT04668066|565399560|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632437|NCT04668066|565399561|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632438|NCT04668066|565399562|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632439|NCT04668066|565399563|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632440|NCT04668066|565399564|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632441|NCT04668066|565399565|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632442|NCT04668066|565399566|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632443|NCT04668066|565399567|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
156632444|NCT04668066|565399549|FG000|Part 1: Treatment Phase|Other|0|||
156632445|NCT04668066|565399550|FG001|Part 1: Treatment Phase|Other|0|||
156632446|NCT04668066|565399551|FG002|Part 1: Treatment Phase|Other|0|||
156632447|NCT04668066|565399552|FG003|Part 1: Treatment Phase|Other|0|||
156632448|NCT04668066|565399553|FG004|Part 1: Treatment Phase|Other|0|||
156632449|NCT04668066|565399554|FG005|Part 1: Treatment Phase|Other|0|||
156632450|NCT04668066|565399555|FG006|Part 1: Treatment Phase|Other|0|||
156632451|NCT04668066|565399556|FG007|Part 1: Treatment Phase|Other|0|||
156632452|NCT04668066|565399557|FG008|Part 1: Treatment Phase|Other|0|||
156632453|NCT04668066|565399558|FG009|Part 1: Treatment Phase|Other|0|||
156632454|NCT04668066|565399559|FG010|Part 1: Treatment Phase|Other|0|||
156632455|NCT04668066|565399560|FG011|Part 1: Treatment Phase|Other|1|||
156632456|NCT04668066|565399561|FG012|Part 1: Treatment Phase|Other|0|||
156632457|NCT04668066|565399562|FG013|Part 1: Treatment Phase|Other|0|||
156632458|NCT04668066|565399563|FG014|Part 1: Treatment Phase|Other|0|||
156632459|NCT04668066|565399564|FG015|Part 1: Treatment Phase|Other|0|||
156632460|NCT04668066|565399565|FG016|Part 1: Treatment Phase|Other|0|||
156632461|NCT04668066|565399566|FG017|Part 1: Treatment Phase|Other|0|||
156632462|NCT04668066|565399567|FG018|Part 1: Treatment Phase|Other|0|||
156632463|NCT04668066|565399549|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632464|NCT04668066|565399550|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632465|NCT04668066|565399551|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632466|NCT04668066|565399552|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632467|NCT04668066|565399553|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632468|NCT04668066|565399554|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632469|NCT04668066|565399555|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632470|NCT04668066|565399556|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632471|NCT04668066|565399557|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632472|NCT04668066|565399558|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632473|NCT04668066|565399559|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632474|NCT04668066|565399560|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632475|NCT04668066|565399561|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
156632476|NCT04668066|565399562|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632477|NCT04668066|565399563|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632478|NCT04668066|565399564|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
156632479|NCT04668066|565399565|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632480|NCT04668066|565399566|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632481|NCT04668066|565399567|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
156632482|NCT04668066|565399549|FG000|Part 1: Follow-Up|Adverse Event|0|||
156632483|NCT04668066|565399550|FG001|Part 1: Follow-Up|Adverse Event|0|||
156632484|NCT04668066|565399551|FG002|Part 1: Follow-Up|Adverse Event|0|||
156632485|NCT04668066|565399552|FG003|Part 1: Follow-Up|Adverse Event|0|||
156632486|NCT04668066|565399553|FG004|Part 1: Follow-Up|Adverse Event|0|||
156632487|NCT04668066|565399554|FG005|Part 1: Follow-Up|Adverse Event|0|||
156632488|NCT04668066|565399555|FG006|Part 1: Follow-Up|Adverse Event|0|||
156632489|NCT04668066|565399556|FG007|Part 1: Follow-Up|Adverse Event|0|||
156632490|NCT04668066|565399557|FG008|Part 1: Follow-Up|Adverse Event|0|||
156632491|NCT04668066|565399558|FG009|Part 1: Follow-Up|Adverse Event|0|||
156632492|NCT04668066|565399559|FG010|Part 1: Follow-Up|Adverse Event|0|||
156632493|NCT04668066|565399560|FG011|Part 1: Follow-Up|Adverse Event|1|||
156632494|NCT04668066|565399561|FG012|Part 1: Follow-Up|Adverse Event|0|||
156632495|NCT04668066|565399562|FG013|Part 1: Follow-Up|Adverse Event|0|||
156632496|NCT04668066|565399563|FG014|Part 1: Follow-Up|Adverse Event|0|||
156632497|NCT04668066|565399564|FG015|Part 1: Follow-Up|Adverse Event|0|||
156632498|NCT04668066|565399565|FG016|Part 1: Follow-Up|Adverse Event|0|||
156632499|NCT04668066|565399566|FG017|Part 1: Follow-Up|Adverse Event|0|||
156632500|NCT04668066|565399567|FG018|Part 1: Follow-Up|Adverse Event|0|||
156632501|NCT04668066|565399549|FG000|Part 1: Follow-Up|Other|0|||
156632502|NCT04668066|565399550|FG001|Part 1: Follow-Up|Other|0|||
156632503|NCT04668066|565399551|FG002|Part 1: Follow-Up|Other|0|||
156632504|NCT04668066|565399552|FG003|Part 1: Follow-Up|Other|0|||
156632505|NCT04668066|565399553|FG004|Part 1: Follow-Up|Other|0|||
156632506|NCT04668066|565399554|FG005|Part 1: Follow-Up|Other|0|||
156632507|NCT04668066|565399555|FG006|Part 1: Follow-Up|Other|0|||
156632508|NCT04668066|565399556|FG007|Part 1: Follow-Up|Other|0|||
156632509|NCT04668066|565399557|FG008|Part 1: Follow-Up|Other|0|||
156632510|NCT04668066|565399558|FG009|Part 1: Follow-Up|Other|0|||
156632511|NCT04668066|565399559|FG010|Part 1: Follow-Up|Other|0|||
156632512|NCT04668066|565399560|FG011|Part 1: Follow-Up|Other|1|||
156632513|NCT04668066|565399561|FG012|Part 1: Follow-Up|Other|1|||
156632514|NCT04668066|565399562|FG013|Part 1: Follow-Up|Other|0|||
156632515|NCT04668066|565399563|FG014|Part 1: Follow-Up|Other|0|||
156632516|NCT04668066|565399564|FG015|Part 1: Follow-Up|Other|0|||
156632517|NCT04668066|565399565|FG016|Part 1: Follow-Up|Other|0|||
156632518|NCT04668066|565399566|FG017|Part 1: Follow-Up|Other|0|||
156632519|NCT04668066|565399567|FG018|Part 1: Follow-Up|Other|0|||
156632520|NCT04668066|565399549|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632521|NCT04668066|565399550|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632522|NCT04668066|565399551|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632523|NCT04668066|565399552|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632524|NCT04668066|565399553|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632525|NCT04668066|565399554|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632526|NCT04668066|565399555|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632527|NCT04668066|565399556|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632528|NCT04668066|565399557|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632529|NCT04668066|565399558|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632530|NCT04668066|565399559|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632531|NCT04668066|565399560|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632532|NCT04668066|565399561|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
156632533|NCT04668066|565399562|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632534|NCT04668066|565399563|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632535|NCT04668066|565399564|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
156632536|NCT04668066|565399565|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632537|NCT04668066|565399566|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632538|NCT04668066|565399567|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
156632539|NCT04668066|565399549|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632540|NCT04668066|565399550|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632541|NCT04668066|565399551|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632542|NCT04668066|565399552|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632543|NCT04668066|565399553|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632544|NCT04668066|565399554|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632545|NCT04668066|565399555|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632546|NCT04668066|565399556|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632547|NCT04668066|565399557|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632548|NCT04668066|565399558|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632549|NCT04668066|565399559|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632550|NCT04668066|565399560|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632551|NCT04668066|565399561|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632552|NCT04668066|565399562|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632553|NCT04668066|565399563|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632554|NCT04668066|565399564|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632555|NCT04668066|565399565|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632556|NCT04668066|565399566|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
156632557|NCT04668066|565399567|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
156632558|NCT04668066|565399549|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632559|NCT04668066|565399550|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632560|NCT04668066|565399551|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632561|NCT04668066|565399552|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632562|NCT04668066|565399553|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632563|NCT04668066|565399554|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632564|NCT04668066|565399555|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632565|NCT04668066|565399556|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632566|NCT04668066|565399557|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632567|NCT04668066|565399558|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632568|NCT04668066|565399559|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632569|NCT04668066|565399560|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632570|NCT04668066|565399561|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632571|NCT04668066|565399562|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632572|NCT04668066|565399563|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632573|NCT04668066|565399564|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632574|NCT04668066|565399565|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632575|NCT04668066|565399566|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
156632576|NCT04668066|565399567|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
156632577|NCT04668066|565399549|FG000|Part 2: Treatment Phase|Other|0|||
156632578|NCT04668066|565399550|FG001|Part 2: Treatment Phase|Other|0|||
156632579|NCT04668066|565399551|FG002|Part 2: Treatment Phase|Other|0|||
156632580|NCT04668066|565399552|FG003|Part 2: Treatment Phase|Other|0|||
156632581|NCT04668066|565399553|FG004|Part 2: Treatment Phase|Other|0|||
156632582|NCT04668066|565399554|FG005|Part 2: Treatment Phase|Other|0|||
156632583|NCT04668066|565399555|FG006|Part 2: Treatment Phase|Other|0|||
156632584|NCT04668066|565399556|FG007|Part 2: Treatment Phase|Other|0|||
156632585|NCT04668066|565399557|FG008|Part 2: Treatment Phase|Other|0|||
156632586|NCT04668066|565399558|FG009|Part 2: Treatment Phase|Other|0|||
156632587|NCT04668066|565399559|FG010|Part 2: Treatment Phase|Other|0|||
156632588|NCT04668066|565399560|FG011|Part 2: Treatment Phase|Other|0|||
156632589|NCT04668066|565399561|FG012|Part 2: Treatment Phase|Other|0|||
156632590|NCT04668066|565399562|FG013|Part 2: Treatment Phase|Other|0|||
156632591|NCT04668066|565399563|FG014|Part 2: Treatment Phase|Other|0|||
156632592|NCT04668066|565399564|FG015|Part 2: Treatment Phase|Other|0|||
156632593|NCT04668066|565399565|FG016|Part 2: Treatment Phase|Other|0|||
156632594|NCT04668066|565399566|FG017|Part 2: Treatment Phase|Other|0|||
156632595|NCT04668066|565399567|FG018|Part 2: Treatment Phase|Other|1|||
156632596|NCT04668066|565399549|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632597|NCT04668066|565399550|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632598|NCT04668066|565399551|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632599|NCT04668066|565399552|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632600|NCT04668066|565399553|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632601|NCT04668066|565399554|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632602|NCT04668066|565399555|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632603|NCT04668066|565399556|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632604|NCT04668066|565399557|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632605|NCT04668066|565399558|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632606|NCT04668066|565399559|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632607|NCT04668066|565399560|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632608|NCT04668066|565399561|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632609|NCT04668066|565399562|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632610|NCT04668066|565399563|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632611|NCT04668066|565399564|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632612|NCT04668066|565399565|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632613|NCT04668066|565399566|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
156632614|NCT04668066|565399567|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
156632615|NCT02331680|565399568|FG000|Overall Study|Adverse Event|3|||
156632616|NCT02331680|565399569|FG001|Overall Study|Adverse Event|0|||
156632617|NCT02331680|565399570|FG002|Overall Study|Adverse Event|2|||
156632618|NCT02331680|565399568|FG000|Overall Study|Physician Decision|1|||
156632619|NCT02331680|565399569|FG001|Overall Study|Physician Decision|1|||
156632620|NCT02331680|565399570|FG002|Overall Study|Physician Decision|2|||
156632621|NCT02331680|565399568|FG000|Overall Study|Withdrawal by Subject|0|||
156632622|NCT02331680|565399569|FG001|Overall Study|Withdrawal by Subject|1|||
156632623|NCT02331680|565399570|FG002|Overall Study|Withdrawal by Subject|2|||
156632624|NCT02331680|565399568|FG000|Overall Study|Met withdrawal criteria|2|||
156632625|NCT02331680|565399569|FG001|Overall Study|Met withdrawal criteria|2|||
156632626|NCT02331680|565399570|FG002|Overall Study|Met withdrawal criteria|5|||
156632627|NCT02331680|565399568|FG000|Overall Study|Non-compliance with study drug|0|||
156632628|NCT02331680|565399569|FG001|Overall Study|Non-compliance with study drug|0|||
156632629|NCT02331680|565399570|FG002|Overall Study|Non-compliance with study drug|1|||
156632630|NCT02331680|565399568|FG000|Overall Study|Protocol Violation|0|||
156632631|NCT02331680|565399569|FG001|Overall Study|Protocol Violation|0|||
156632632|NCT02331680|565399570|FG002|Overall Study|Protocol Violation|3|||
156632633|NCT02219477|565399571|FG000|Overall Study|Adverse Event|0|||
156632634|NCT02219477|565399572|FG001|Overall Study|Adverse Event|1|||
156632635|NCT02219477|565399573|FG002|Overall Study|Adverse Event|1|||
156632636|NCT02219477|565399571|FG000|Overall Study|Withdrawal by Subject|0|||
156632637|NCT02219477|565399572|FG001|Overall Study|Withdrawal by Subject|1|||
156632638|NCT02219477|565399573|FG002|Overall Study|Withdrawal by Subject|0|||
156632639|NCT00596466|565399574|FG000|Overall Study|Lack of Efficacy|5|||
156632640|NCT00596466|565399574|FG000|Overall Study|Adverse Event|4|||
156632641|NCT00596466|565399574|FG000|Overall Study|Withdrawal by Subject|2|||
156632642|NCT00596466|565399574|FG000|Overall Study|Protocol Violation|2|||
156632643|NCT00596466|565399574|FG000|Overall Study|Unpecified|2|||
156632644|NCT00596466|565399574|FG000|Overall Study|Enrolled, not treated|2|||
156632645|NCT04505592|565399575|FG000|Overall Study|Death|2|||
156632646|NCT04505592|565399576|FG001|Overall Study|Death|1|||
156632647|NCT01891669|565399577|FG000|Overall Study|Death|0|||
156632648|NCT01891669|565399578|FG001|Overall Study|Death|0|||
156632649|NCT01891669|565399579|FG002|Overall Study|Death|0|||
156632650|NCT01891669|565399580|FG003|Overall Study|Death|0|||
156632651|NCT01891669|565399581|FG004|Overall Study|Death|0|||
156632652|NCT01891669|565399582|FG005|Overall Study|Death|0|||
156632653|NCT01891669|565399583|FG006|Overall Study|Death|0|||
156632654|NCT01891669|565399584|FG007|Overall Study|Death|1|||
156632655|NCT01891669|565399585|FG008|Overall Study|Death|0|||
156632656|NCT01891669|565399586|FG009|Overall Study|Death|1|||
156632657|NCT01891669|565399577|FG000|Overall Study|Withdrawal by Subject|1|||
156632658|NCT01891669|565399578|FG001|Overall Study|Withdrawal by Subject|1|||
156632659|NCT01891669|565399579|FG002|Overall Study|Withdrawal by Subject|0|||
156632660|NCT01891669|565399580|FG003|Overall Study|Withdrawal by Subject|0|||
156632661|NCT01891669|565399581|FG004|Overall Study|Withdrawal by Subject|0|||
156632662|NCT01891669|565399582|FG005|Overall Study|Withdrawal by Subject|0|||
156632663|NCT01891669|565399583|FG006|Overall Study|Withdrawal by Subject|1|||
156632664|NCT01891669|565399584|FG007|Overall Study|Withdrawal by Subject|2|||
156632665|NCT01891669|565399585|FG008|Overall Study|Withdrawal by Subject|1|||
156632666|NCT01891669|565399586|FG009|Overall Study|Withdrawal by Subject|1|||
156632667|NCT01891669|565399577|FG000|Overall Study|Other|1|||
156632668|NCT01891669|565399578|FG001|Overall Study|Other|0|||
156632669|NCT01891669|565399579|FG002|Overall Study|Other|0|||
156632670|NCT01891669|565399580|FG003|Overall Study|Other|0|||
156632671|NCT01891669|565399581|FG004|Overall Study|Other|0|||
156632672|NCT01891669|565399582|FG005|Overall Study|Other|0|||
156632673|NCT01891669|565399583|FG006|Overall Study|Other|0|||
156632674|NCT01891669|565399584|FG007|Overall Study|Other|1|||
156632675|NCT01891669|565399585|FG008|Overall Study|Other|0|||
156632676|NCT01891669|565399586|FG009|Overall Study|Other|0|||
156632677|NCT01015118|565399587|FG000|Overall Study|Protocol Violation|5|||
156632678|NCT01015118|565399588|FG001|Overall Study|Protocol Violation|6|||
156632679|NCT01015118|565399587|FG000|Overall Study|Withdrawal by Subject|103|||
156632680|NCT01015118|565399588|FG001|Overall Study|Withdrawal by Subject|27|||
156632681|NCT01015118|565399587|FG000|Overall Study|Other Adverse Event (AE)|141|||
156632682|NCT01015118|565399588|FG001|Overall Study|Other Adverse Event (AE)|33|||
156632683|NCT01015118|565399587|FG000|Overall Study|Worsening or AE of underlying disease|5|||
156632684|NCT01015118|565399588|FG001|Overall Study|Worsening or AE of underlying disease|4|||
156632685|NCT01015118|565399587|FG000|Overall Study|Progressive disease|364|||
156632686|NCT01015118|565399588|FG001|Overall Study|Progressive disease|229|||
156632687|NCT01015118|565399587|FG000|Overall Study|Not treated|9|||
156632688|NCT01015118|565399588|FG001|Overall Study|Not treated|5|||
156632689|NCT01015118|565399587|FG000|Overall Study|Other than stated above|42|||
156632690|NCT01015118|565399588|FG001|Overall Study|Other than stated above|23|||
156632691|NCT04784455|565399593|FG000|Overall Study|Death|4|||
156632692|NCT04298229|565399596|FG000|Overall Study|Physician Decision|1|||
156632693|NCT04298229|565399597|FG001|Overall Study|Physician Decision|1|||
156632694|NCT04298229|565399596|FG000|Overall Study|Withdrawal by Subject|1|||
156632695|NCT04298229|565399597|FG001|Overall Study|Withdrawal by Subject|1|||
156632696|NCT04298229|565399596|FG000|Overall Study|Did not receive IV loop diuretics|2|||
156632697|NCT04298229|565399597|FG001|Overall Study|Did not receive IV loop diuretics|0|||
156632698|NCT00262119|565399598|FG000|Overall Study|Lost to Follow-up|38|||
156632699|NCT00262119|565399599|FG001|Overall Study|Lost to Follow-up|51|||
156632700|NCT00262119|565399600|FG002|Overall Study|Lost to Follow-up|42|||
156632701|NCT00262119|565399598|FG000|Overall Study|Death|20|||
156632702|NCT00262119|565399599|FG001|Overall Study|Death|19|||
156632703|NCT00262119|565399600|FG002|Overall Study|Death|16|||
156632704|NCT00071006|565399601|FG000|Overall Study|Lack of Efficacy|7|||
156632705|NCT00071006|565399601|FG000|Overall Study|Adverse Event|1|||
156632706|NCT00071006|565399601|FG000|Overall Study|Withdrawal by Subject|1|||
156632707|NCT00071006|565399601|FG000|Overall Study|Other|3|||
156632708|NCT00859313|565399602|FG000|Overall Study|Lack of Efficacy|2|||
156632709|NCT00859313|565399602|FG000|Overall Study|Adverse Event|1|||
156632710|NCT00859313|565399602|FG000|Overall Study|staff error|1|||
156632711|NCT05261126|565399607|FG000|Overall Study|Death|0|||
156632712|NCT05261126|565399608|FG001|Overall Study|Death|0|||
156632713|NCT05261126|565399609|FG002|Overall Study|Death|1|||
156632714|NCT05261126|565399610|FG003|Overall Study|Death|0|||
156632715|NCT05261126|565399611|FG004|Overall Study|Death|0|||
156632716|NCT05261126|565399607|FG000|Overall Study|Lost to Follow-up|0|||
156632717|NCT05261126|565399608|FG001|Overall Study|Lost to Follow-up|0|||
156632718|NCT05261126|565399609|FG002|Overall Study|Lost to Follow-up|0|||
156632719|NCT05261126|565399610|FG003|Overall Study|Lost to Follow-up|0|||
156632720|NCT05261126|565399611|FG004|Overall Study|Lost to Follow-up|1|||
156632721|NCT05261126|565399607|FG000|Overall Study|Physician Decision|1|||
156632722|NCT05261126|565399608|FG001|Overall Study|Physician Decision|0|||
156632723|NCT05261126|565399609|FG002|Overall Study|Physician Decision|0|||
156632724|NCT05261126|565399610|FG003|Overall Study|Physician Decision|0|||
156632725|NCT05261126|565399611|FG004|Overall Study|Physician Decision|0|||
156632726|NCT05261126|565399607|FG000|Overall Study|Screen Failure|0|||
156632727|NCT05261126|565399608|FG001|Overall Study|Screen Failure|0|||
156632728|NCT05261126|565399609|FG002|Overall Study|Screen Failure|0|||
156632729|NCT05261126|565399610|FG003|Overall Study|Screen Failure|0|||
156632730|NCT05261126|565399611|FG004|Overall Study|Screen Failure|1|||
156632731|NCT05261126|565399607|FG000|Overall Study|Withdrawal by Subject|1|||
156632732|NCT05261126|565399608|FG001|Overall Study|Withdrawal by Subject|0|||
156632733|NCT05261126|565399609|FG002|Overall Study|Withdrawal by Subject|1|||
156632734|NCT05261126|565399610|FG003|Overall Study|Withdrawal by Subject|1|||
156632735|NCT05261126|565399611|FG004|Overall Study|Withdrawal by Subject|0|||
156632736|NCT05261126|565399607|FG000|Overall Study|Not Recorded|0|||
156632737|NCT05261126|565399608|FG001|Overall Study|Not Recorded|0|||
156632738|NCT05261126|565399609|FG002|Overall Study|Not Recorded|0|||
156632739|NCT05261126|565399610|FG003|Overall Study|Not Recorded|1|||
156632740|NCT05261126|565399611|FG004|Overall Study|Not Recorded|0|||
156632741|NCT05939388|565399612|FG000|Overall Study|Lost to Follow-up|1|||
156632742|NCT05570604|565399613|FG000|Overall Study|Lost to Follow-up|1|||
156632743|NCT05570604|565399614|FG001|Overall Study|Lost to Follow-up|5|||
156632744|NCT05570604|565399613|FG000|Overall Study|Illness|2|||
156632745|NCT05570604|565399614|FG001|Overall Study|Illness|2|||
156632746|NCT04479358|565399617|FG000|Overall Study|Withdrawal by Subject|0|||
156632747|NCT04479358|565399618|FG001|Overall Study|Withdrawal by Subject|0|||
156632748|NCT04479358|565399619|FG002|Overall Study|Withdrawal by Subject|1|||
156632749|NCT04479358|565399620|FG003|Overall Study|Withdrawal by Subject|0|||
156632750|NCT04479358|565399621|FG004|Overall Study|Withdrawal by Subject|0|||
156632751|NCT04479358|565399622|FG005|Overall Study|Withdrawal by Subject|1|||
156632752|NCT02396849|565399639|FG000|Overall Study|Lost to Follow-up|1|||
156632753|NCT02396849|565399640|FG001|Overall Study|Lost to Follow-up|1|||
156632754|NCT02396849|565399639|FG000|Overall Study|Did not tolerate intervention|1|||
156632755|NCT02396849|565399640|FG001|Overall Study|Did not tolerate intervention|1|||
156632756|NCT00157157|565399644|FG000|Overall Study|Withdrawal by Subject|6|||
156632757|NCT00157157|565399644|FG000|Overall Study|Physician Decision|1|||
156632758|NCT00157157|565399644|FG000|Overall Study|Lost to Follow-up|1|||
156632759|NCT00157157|565399644|FG000|Overall Study|Enrolled in another study|1|||
156632760|NCT00157157|565399644|FG000|Overall Study|Met exclusion criteria|1|||
156632761|NCT00157157|565399644|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
156632762|NCT02260804|565399645|FG000|Induction Study Period|Protocol Violation|2|||
156632763|NCT02260804|565399646|FG001|Induction Study Period|Protocol Violation|0|||
156632764|NCT02260804|565399645|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
156632765|NCT02260804|565399646|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
156632766|NCT02260804|565399645|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
156632767|NCT02260804|565399646|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
156632768|NCT02260804|565399645|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
156632769|NCT02260804|565399646|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
156632770|NCT02260804|565399645|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
156632771|NCT02260804|565399646|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
156632772|NCT02260804|565399645|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
156632773|NCT02260804|565399646|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
156632774|NCT02260804|565399645|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
156632775|NCT02260804|565399646|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
156632776|NCT02260804|565399645|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
156632777|NCT02260804|565399646|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
156632778|NCT02260804|565399645|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
156632779|NCT02260804|565399646|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
156632780|NCT02260804|565399645|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
156632781|NCT02260804|565399646|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
156632782|NCT02260804|565399645|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
156632783|NCT02260804|565399646|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
156632784|NCT02503215|565401254|FG000|Overall Study|Unable to wear compression stockings|1|||
156632785|NCT02503215|565401254|FG000|Overall Study|Unable to use positive airway pressure|2|||
156632786|NCT04478994|565401255|FG000|Overall Study|Withdrawal by Subject|1|||
156632787|NCT04478994|565401256|FG001|Overall Study|Withdrawal by Subject|1|||
156632788|NCT00457249|565401257|FG000|Overall Study|Lost to Follow-up|3|||
156632789|NCT00457249|565401258|FG001|Overall Study|Lost to Follow-up|0|||
156632790|NCT00457249|565401257|FG000|Overall Study|Protocol Violation|4|||
156632791|NCT00457249|565401258|FG001|Overall Study|Protocol Violation|1|||
156632792|NCT00457249|565401257|FG000|Overall Study|Withdrawal by Subject|3|||
156632793|NCT00457249|565401258|FG001|Overall Study|Withdrawal by Subject|1|||
156632794|NCT00457249|565401257|FG000|Overall Study|Serious Adverse Events|2|||
156632795|NCT00457249|565401258|FG001|Overall Study|Serious Adverse Events|0|||
156632796|NCT02094573|565401261|FG000|Overall Study|Adverse Event|4|||
156632797|NCT02094573|565401262|FG001|Overall Study|Adverse Event|14|||
156632798|NCT02094573|565401261|FG000|Overall Study|Clinical Progressive Disease|9|||
156632799|NCT02094573|565401262|FG001|Overall Study|Clinical Progressive Disease|13|||
156632800|NCT02094573|565401261|FG000|Overall Study|Death|11|||
156632801|NCT02094573|565401262|FG001|Overall Study|Death|3|||
156632802|NCT02094573|565401261|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
156632803|NCT02094573|565401262|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
156632804|NCT02094573|565401261|FG000|Overall Study|Non-compliance with Study Drug|1|||
156632805|NCT02094573|565401262|FG001|Overall Study|Non-compliance with Study Drug|1|||
156632806|NCT02094573|565401261|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
156632807|NCT02094573|565401262|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
156632808|NCT02094573|565401261|FG000|Overall Study|Physician Decision|4|||
156632809|NCT02094573|565401262|FG001|Overall Study|Physician Decision|4|||
156632810|NCT02094573|565401261|FG000|Overall Study|Site Terminated by Sponsor|10|||
156632811|NCT02094573|565401262|FG001|Overall Study|Site Terminated by Sponsor|17|||
156632812|NCT02094573|565401261|FG000|Overall Study|Withdrawal by Subject|6|||
156632813|NCT02094573|565401262|FG001|Overall Study|Withdrawal by Subject|8|||
156632814|NCT02094573|565401261|FG000|Overall Study|Randomized but not Treated|3|||
156632815|NCT02094573|565401262|FG001|Overall Study|Randomized but not Treated|0|||
156632816|NCT02875340|565401263|FG000|Overall Study|Death|2|||
156632817|NCT02875340|565401263|FG000|Overall Study|Withdrawal by Subject|2|||
156632818|NCT02875340|565401263|FG000|Overall Study|Physician Decision|3|||
156632819|NCT02875340|565401263|FG000|Overall Study|Adverse Event|1|||
156632820|NCT01160770|565401266|FG000|Overall Study|Adverse Event|10|||
156632821|NCT01160770|565401266|FG000|Overall Study|Protocol Violation|2|||
156632822|NCT01160770|565401266|FG000|Overall Study|Subject/parent/caregiver request|33|||
156632823|NCT01160770|565401266|FG000|Overall Study|Physician Decision|1|||
156632824|NCT01160770|565401266|FG000|Overall Study|Lost to Follow-up|7|||
156632825|NCT01160770|565401266|FG000|Overall Study|Study termination or sponsor request|1|||
156632826|NCT01160770|565401266|FG000|Overall Study|Death|9|||
156632827|NCT01160770|565401266|FG000|Overall Study|Lack of Efficacy|15|||
156632828|NCT01160770|565401266|FG000|Overall Study|Other Reasons|1|||
156632829|NCT02411110|565401267|FG000|Treatment Period 1|Adverse Event|4|||
156632830|NCT02411110|565401268|FG001|Treatment Period 1|Adverse Event|2|||
156632831|NCT02411110|565401267|FG000|Treatment Period 1|Lost to Follow-up|1|||
156632832|NCT02411110|565401268|FG001|Treatment Period 1|Lost to Follow-up|0|||
156632833|NCT02411110|565401267|FG000|Treatment Period 1|Personal Reasons|2|||
156632834|NCT02411110|565401268|FG001|Treatment Period 1|Personal Reasons|5|||
156632835|NCT02411110|565401267|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
156632836|NCT02411110|565401268|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
156632837|NCT02411110|565401267|FG000|Treatment Period 2|Adverse Event|1|||
156632838|NCT02411110|565401268|FG001|Treatment Period 2|Adverse Event|0|||
156632839|NCT02411110|565401267|FG000|Treatment Period 2|Lost to Follow-up|0|||
156632840|NCT02411110|565401268|FG001|Treatment Period 2|Lost to Follow-up|2|||
156632841|NCT02411110|565401267|FG000|Treatment Period 2|Personal Reasons|0|||
156632842|NCT02411110|565401268|FG001|Treatment Period 2|Personal Reasons|2|||
156632843|NCT04888377|565401269|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
156632844|NCT04888377|565401270|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
156632845|NCT04888377|565401269|FG000|Overall Study|Physician Decision|6|||
156632846|NCT04888377|565401270|FG001|Overall Study|Physician Decision|6|||
156632847|NCT04888377|565401269|FG000|Overall Study|Withdrawal by Subject|7|||
156632848|NCT04888377|565401270|FG001|Overall Study|Withdrawal by Subject|3|||
156632849|NCT00526162|565401271|FG000|Overall Study|Device not implanted|3|||
156632850|NCT05279807|565401272|FG000|Overall Study|Withdrawal by Subject|1|||
156632851|NCT05279807|565401273|FG001|Overall Study|Withdrawal by Subject|0|||
156632852|NCT05279807|565401272|FG000|Overall Study|Adverse Event|0|||
156632853|NCT05279807|565401273|FG001|Overall Study|Adverse Event|1|||
156632854|NCT05279807|565401272|FG000|Overall Study|Laboratory Abnormal Results|1|||
156632855|NCT05279807|565401273|FG001|Overall Study|Laboratory Abnormal Results|0|||
156632856|NCT04242446|565401278|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
156632857|NCT04242446|565401279|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
156632858|NCT04242446|565401280|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
156632859|NCT04242446|565401281|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
156632860|NCT04242446|565401282|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
156632861|NCT04242446|565401283|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
156632862|NCT04242446|565401284|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
156632863|NCT04242446|565401278|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156632864|NCT04242446|565401279|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
156632865|NCT04242446|565401280|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
156632866|NCT04242446|565401281|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156632867|NCT04242446|565401282|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156632868|NCT04242446|565401283|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156632869|NCT04242446|565401284|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156632870|NCT04242446|565401278|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
156632871|NCT04242446|565401279|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
156632872|NCT04242446|565401280|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
156632873|NCT04242446|565401281|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156632874|NCT04242446|565401282|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156632875|NCT04242446|565401283|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156632876|NCT04242446|565401284|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156632877|NCT04242446|565401278|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
156632878|NCT04242446|565401279|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
156632879|NCT04242446|565401280|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
156632880|NCT04242446|565401281|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
156632881|NCT04242446|565401282|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
156632882|NCT04242446|565401283|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
156632883|NCT04242446|565401284|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
156632884|NCT04242446|565401278|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
156632885|NCT04242446|565401279|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
156632886|NCT04242446|565401280|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
156632887|NCT04242446|565401281|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
156632888|NCT04242446|565401282|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
156632889|NCT04242446|565401283|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
156632890|NCT04242446|565401284|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
156632891|NCT04242446|565401278|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
156632892|NCT04242446|565401279|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
156632893|NCT04242446|565401280|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
156632894|NCT04242446|565401281|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
156632895|NCT04242446|565401282|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
156632896|NCT04242446|565401283|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
156632897|NCT04242446|565401284|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
156632898|NCT04242446|565401278|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
156632899|NCT04242446|565401279|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
156632900|NCT04242446|565401280|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
156632901|NCT04242446|565401281|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
156632902|NCT04242446|565401282|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
156632903|NCT04242446|565401283|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
156632904|NCT04242446|565401284|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
156632905|NCT04242446|565401278|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156632906|NCT04242446|565401279|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
156632907|NCT04242446|565401280|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
156632908|NCT04242446|565401281|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156632909|NCT04242446|565401282|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156632910|NCT04242446|565401283|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156632911|NCT04242446|565401284|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156632912|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
156632913|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
156632914|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
156632915|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
156632916|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
156632917|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
156632918|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
156632919|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
156632920|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
156632921|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
156632922|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
156632923|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
156632924|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
156632925|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
156632926|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
156632927|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
156632928|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
156632929|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
156632930|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
156632931|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
156632932|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
156632933|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
156632934|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
156632935|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
156632936|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
156632937|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
156632938|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
156632939|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
156632940|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
156632941|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
156632942|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
156632943|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
156632944|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
156632945|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
156632946|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
156632947|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
156632948|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
156632949|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
156632950|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
156632951|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
156632952|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
156632953|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
156632954|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
156632955|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
156635571|NCT00602667|565409962|FG002|Overall Study|Second malignancy|0|||
156632956|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
156632957|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
156632958|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
156632959|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
156632960|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
156632961|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
156632962|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
156632963|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
156632964|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
156632965|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
156632966|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
156632967|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
156632968|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
156632969|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
156632970|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
156632971|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
156632972|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
156632973|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
156632974|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
156632975|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
156632976|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
156632977|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
156632978|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
156632979|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
156632980|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
156632981|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
156632982|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
156632983|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
156632984|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
156632985|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
156632986|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
156632987|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
156632988|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
156632989|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
156632990|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
156632991|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
156632992|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
156632993|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
156632994|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
156632995|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
156632996|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
156632997|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
156632998|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
156632999|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
156633000|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
156633001|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
156633002|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
156633003|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
156633004|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
156633005|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
156633006|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
156633007|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
156633008|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
156633009|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
156633010|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
156633011|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
156633012|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
156633013|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
156633014|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
156633015|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
156633016|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
156633017|NCT04242446|565401278|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
156633018|NCT04242446|565401279|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
156633019|NCT04242446|565401280|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
156633020|NCT04242446|565401281|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
156633021|NCT04242446|565401282|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
156633022|NCT04242446|565401283|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
156633023|NCT04242446|565401284|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
156633024|NCT03587116|565401285|FG000|Overall Study|Lost to Follow-up|0|||
156633025|NCT03587116|565401286|FG001|Overall Study|Lost to Follow-up|1|||
156633026|NCT03587116|565401285|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
156633027|NCT03587116|565401286|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
156633028|NCT03587116|565401285|FG000|Overall Study|Withdrawal by Subject|4|||
156633029|NCT03587116|565401286|FG001|Overall Study|Withdrawal by Subject|0|||
156633030|NCT05993299|565401290|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
156633031|NCT05993299|565401290|FG000|Overall Study|Ongoing|4|||
156633032|NCT05644756|565401291|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
156633033|NCT05644756|565401291|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
156633034|NCT03985982|565401292|FG000|Double-Blind Phase|Lost to Follow-up|4|||
156633035|NCT03985982|565401293|FG001|Double-Blind Phase|Lost to Follow-up|3|||
156633036|NCT03985982|565401294|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156633037|NCT03985982|565401292|FG000|Double-Blind Phase|Physician Decision|1|||
156633038|NCT03985982|565401293|FG001|Double-Blind Phase|Physician Decision|0|||
156633039|NCT03985982|565401294|FG002|Double-Blind Phase|Physician Decision|0|||
156633040|NCT03985982|565401292|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
156633041|NCT03985982|565401293|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
156633042|NCT03985982|565401294|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156633043|NCT03985982|565401292|FG000|Double-Blind Phase|COVID-19|1|||
156633044|NCT03985982|565401293|FG001|Double-Blind Phase|COVID-19|0|||
156633045|NCT03985982|565401294|FG002|Double-Blind Phase|COVID-19|0|||
156633046|NCT03985982|565401292|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
156633047|NCT03985982|565401293|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
156633048|NCT03985982|565401294|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
156633049|NCT03985982|565401292|FG000|Open-Label Phase|Lost to Follow-up|0|||
156633050|NCT03985982|565401293|FG001|Open-Label Phase|Lost to Follow-up|0|||
156633051|NCT03985982|565401294|FG002|Open-Label Phase|Lost to Follow-up|13|||
156633052|NCT03985982|565401292|FG000|Open-Label Phase|Physician Decision|0|||
156633053|NCT03985982|565401293|FG001|Open-Label Phase|Physician Decision|0|||
156633054|NCT03985982|565401294|FG002|Open-Label Phase|Physician Decision|2|||
156633055|NCT03985982|565401292|FG000|Open-Label Phase|Withdrawal by Subject|0|||
156633056|NCT03985982|565401293|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156633057|NCT03985982|565401294|FG002|Open-Label Phase|Withdrawal by Subject|11|||
156633058|NCT03526549|565401296|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
156633059|NCT03526549|565401297|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
156633060|NCT03526549|565401296|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
156633061|NCT03526549|565401297|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
156633062|NCT03526549|565401296|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
156633063|NCT03526549|565401297|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
156633064|NCT03526549|565401296|FG000|Open-label Phase|Adverse Event|4|||
156633065|NCT03526549|565401297|FG001|Open-label Phase|Adverse Event|0|||
156633066|NCT03526549|565401296|FG000|Open-label Phase|Withdrawal by Subject|54|||
156633067|NCT03526549|565401297|FG001|Open-label Phase|Withdrawal by Subject|0|||
156633068|NCT03526549|565401296|FG000|Open-label Phase|Lost to Follow-up|35|||
156633069|NCT03526549|565401297|FG001|Open-label Phase|Lost to Follow-up|0|||
156633070|NCT03526549|565401296|FG000|Open-label Phase|Other than Specified|5|||
156633071|NCT03526549|565401297|FG001|Open-label Phase|Other than Specified|0|||
156633072|NCT05981365|565401298|FG000|Period 1|Adverse Event|1|||
156633073|NCT05981365|565401299|FG001|Period 1|Adverse Event|0|||
156633074|NCT00478933|565401300|FG000|Overall Study|Protocol Violation|22|||
156633075|NCT00478933|565401300|FG000|Overall Study|Informed consent not verified|3|||
156633076|NCT00478933|565401300|FG000|Overall Study|Inadequate data available|53|||
156633077|NCT00643006|565401301|FG000|Overall Study|Lost to Follow-up|5|||
156633078|NCT00643006|565401302|FG001|Overall Study|Lost to Follow-up|4|||
156633079|NCT03586427|565401306|FG000|Overall Study|Lost to Follow-up|0|||
156633080|NCT03586427|565401307|FG001|Overall Study|Lost to Follow-up|3|||
156633081|NCT03586427|565401308|FG002|Overall Study|Lost to Follow-up|1|||
156633082|NCT03586427|565401309|FG003|Overall Study|Lost to Follow-up|3|||
156633083|NCT03586427|565401310|FG004|Overall Study|Lost to Follow-up|3|||
156633084|NCT03586427|565401306|FG000|Overall Study|Withdrawal by Subject|0|||
156633085|NCT03586427|565401307|FG001|Overall Study|Withdrawal by Subject|1|||
156633086|NCT03586427|565401308|FG002|Overall Study|Withdrawal by Subject|2|||
156633087|NCT03586427|565401309|FG003|Overall Study|Withdrawal by Subject|1|||
156633088|NCT03586427|565401310|FG004|Overall Study|Withdrawal by Subject|1|||
156633089|NCT03586427|565401306|FG000|Overall Study|Adverse Event|0|||
156633090|NCT03586427|565401307|FG001|Overall Study|Adverse Event|0|||
156633091|NCT03586427|565401308|FG002|Overall Study|Adverse Event|1|||
156633092|NCT03586427|565401309|FG003|Overall Study|Adverse Event|0|||
156633093|NCT03586427|565401310|FG004|Overall Study|Adverse Event|0|||
156633094|NCT03586427|565401306|FG000|Overall Study|Protocol Violation|0|||
156633095|NCT03586427|565401307|FG001|Overall Study|Protocol Violation|0|||
156633096|NCT03586427|565401308|FG002|Overall Study|Protocol Violation|1|||
156633097|NCT03586427|565401309|FG003|Overall Study|Protocol Violation|0|||
156633098|NCT03586427|565401310|FG004|Overall Study|Protocol Violation|1|||
156633099|NCT03586427|565401306|FG000|Overall Study|Noncompliance with study drug|0|||
156633100|NCT03586427|565401307|FG001|Overall Study|Noncompliance with study drug|0|||
156633101|NCT03586427|565401308|FG002|Overall Study|Noncompliance with study drug|1|||
156633102|NCT03586427|565401309|FG003|Overall Study|Noncompliance with study drug|0|||
156633103|NCT03586427|565401310|FG004|Overall Study|Noncompliance with study drug|0|||
156633104|NCT03193996|565401313|FG000|Overall Study|Withdrawal by Subject|4|||
156633105|NCT03193996|565401313|FG000|Overall Study|Lost to Follow-up|4|||
156633106|NCT03193996|565401313|FG000|Overall Study|Physician Decision|2|||
156633107|NCT03193996|565401313|FG000|Overall Study|Pregnancy|1|||
156633108|NCT03193996|565401313|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
156633109|NCT03193996|565401313|FG000|Overall Study|Complicating disease|1|||
156633110|NCT00593385|565401316|FG000|Overall Study|Death|14|||
156633111|NCT00593385|565401316|FG000|Overall Study|Lost to Follow-up|17|||
156633112|NCT00593385|565401316|FG000|Overall Study|Withdrawal by Subject|9|||
156633113|NCT01471197|565401317|FG000|Overall Study|Disease Progression|4|||
156633114|NCT01471197|565401318|FG001|Overall Study|Disease Progression|2|||
156633115|NCT01471197|565401317|FG000|Overall Study|Death|1|||
156633116|NCT01471197|565401318|FG001|Overall Study|Death|0|||
156633117|NCT01471197|565401317|FG000|Overall Study|Study Drug Toxicity|1|||
156633118|NCT01471197|565401318|FG001|Overall Study|Study Drug Toxicity|0|||
156633119|NCT00924313|565401321|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
156633120|NCT01298362|565401322|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
156633121|NCT01298362|565401323|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
156633122|NCT01283009|565401329|FG000|Overall Study|Death|83|||
156633123|NCT01283009|565401330|FG001|Overall Study|Death|78|||
156633124|NCT01283009|565401329|FG000|Overall Study|Study ended early|23|||
156633125|NCT01283009|565401330|FG001|Overall Study|Study ended early|26|||
156633126|NCT01283009|565401329|FG000|Overall Study|Withdrawal by Subject|10|||
156633127|NCT01283009|565401330|FG001|Overall Study|Withdrawal by Subject|8|||
156633128|NCT01283009|565401329|FG000|Overall Study|Physician Decision|1|||
156633129|NCT01283009|565401330|FG001|Overall Study|Physician Decision|1|||
156633130|NCT01283009|565401329|FG000|Overall Study|Lost to Follow-up|1|||
156633131|NCT01283009|565401330|FG001|Overall Study|Lost to Follow-up|0|||
156633132|NCT01283009|565401329|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
156633133|NCT01283009|565401330|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
156633134|NCT00183170|565401333|FG000|First Intervention|Did not complete study|1|||
156633135|NCT00183170|565401334|FG001|First Intervention|Did not complete study|0|||
156633136|NCT00183170|565401333|FG000|First Intervention|Did not meet targeted BrAC|1|||
156633137|NCT00183170|565401334|FG001|First Intervention|Did not meet targeted BrAC|0|||
156633138|NCT00183170|565401333|FG000|Washout 1 Week|Did not complete study|6|||
156633139|NCT00183170|565401334|FG001|Washout 1 Week|Did not complete study|8|||
156633140|NCT00183170|565401333|FG000|Second Intervention|Did not complete study|1|||
156633141|NCT00183170|565401334|FG001|Second Intervention|Did not complete study|0|||
156633142|NCT00183170|565401333|FG000|Second Intervention|Did not meet targeted BrAC|0|||
156633143|NCT00183170|565401334|FG001|Second Intervention|Did not meet targeted BrAC|2|||
156633144|NCT00455923|565401339|FG000|Overall Study|Pregnancy|0|||
156633145|NCT00455923|565401340|FG001|Overall Study|Pregnancy|2|||
156633146|NCT00455923|565401339|FG000|Overall Study|Other|3|||
156633147|NCT00455923|565401340|FG001|Overall Study|Other|1|||
156633148|NCT05643573|565401341|FG000|Overall Study|Adverse Event|117|||
156633149|NCT05643573|565401342|FG001|Overall Study|Adverse Event|90|||
156633150|NCT05643573|565401341|FG000|Overall Study|Death|53|||
156633151|NCT05643573|565401342|FG001|Overall Study|Death|57|||
156633152|NCT05643573|565401341|FG000|Overall Study|Lost to Follow-up|6|||
156633153|NCT05643573|565401342|FG001|Overall Study|Lost to Follow-up|3|||
156633154|NCT05643573|565401341|FG000|Overall Study|Other|18|||
156633155|NCT05643573|565401342|FG001|Overall Study|Other|15|||
156633156|NCT05643573|565401341|FG000|Overall Study|Outcome event|64|||
156633157|NCT05643573|565401342|FG001|Overall Study|Outcome event|36|||
156633158|NCT05643573|565401341|FG000|Overall Study|Physician Decision|33|||
156633159|NCT05643573|565401342|FG001|Overall Study|Physician Decision|19|||
156633160|NCT05643573|565401341|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
156633161|NCT05643573|565401342|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
156633162|NCT05643573|565401341|FG000|Overall Study|Site terminated by sponsor|10|||
156633163|NCT05643573|565401342|FG001|Overall Study|Site terminated by sponsor|10|||
156633164|NCT05643573|565401341|FG000|Overall Study|Study terminated by sponsor|1|||
156633165|NCT05643573|565401342|FG001|Overall Study|Study terminated by sponsor|0|||
156633166|NCT05643573|565401341|FG000|Overall Study|Withdrawal by Subject|178|||
156633167|NCT05643573|565401342|FG001|Overall Study|Withdrawal by Subject|130|||
156633168|NCT03328325|565401345|FG000|Overall Study|Lost to Follow-up|4|||
156633169|NCT03328325|565401345|FG000|Overall Study|Physician Decision|1|||
156633170|NCT03328325|565401345|FG000|Overall Study|Withdrawal by Subject|3|||
156633171|NCT03328325|565401345|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
156633172|NCT00931515|565401346|FG000|Overall Study|Lost to Follow-up|2|||
156633173|NCT00931515|565401347|FG001|Overall Study|Lost to Follow-up|5|||
156633174|NCT01054443|565401348|FG000|Overall Study|Withdrawal by Subject|0|||
156633175|NCT01054443|565401349|FG001|Overall Study|Withdrawal by Subject|0|||
156633176|NCT01054443|565401350|FG002|Overall Study|Withdrawal by Subject|0|||
156633177|NCT01054443|565401351|FG003|Overall Study|Withdrawal by Subject|1|||
156633178|NCT00985114|565401352|FG000|Overall Study|Adverse Event|1|||
156633179|NCT00985114|565401353|FG001|Overall Study|Adverse Event|0|||
156633180|NCT00985114|565401352|FG000|Overall Study|Withdrawal by Subject|0|||
156633181|NCT00985114|565401353|FG001|Overall Study|Withdrawal by Subject|2|||
156633182|NCT02950831|565401354|FG000|Overall Study|Lost to Follow-up|1|||
156633183|NCT02950831|565401354|FG000|Overall Study|Withdrawal by Subject|3|||
156633184|NCT02950831|565401354|FG000|Overall Study|stimulation trail failure|5|||
156633185|NCT01869959|565401358|FG000|Randomization Period|Physician Decision|0|||
156633186|NCT01869959|565401359|FG001|Randomization Period|Physician Decision|0|||
156633187|NCT01869959|565401360|FG002|Randomization Period|Physician Decision|0|||
156633188|NCT01869959|565401361|FG003|Randomization Period|Physician Decision|0|||
156633189|NCT01869959|565401362|FG004|Randomization Period|Physician Decision|1|||
156633190|NCT01869959|565401358|FG000|Treatment Period|Adverse Event|1|||
156633191|NCT01869959|565401359|FG001|Treatment Period|Adverse Event|0|||
156633192|NCT01869959|565401360|FG002|Treatment Period|Adverse Event|3|||
156633193|NCT01869959|565401361|FG003|Treatment Period|Adverse Event|1|||
156633194|NCT01869959|565401362|FG004|Treatment Period|Adverse Event|0|||
156633195|NCT01869959|565401358|FG000|Treatment Period|Sponsor decision|0|||
156633196|NCT01869959|565401359|FG001|Treatment Period|Sponsor decision|1|||
156633197|NCT01869959|565401360|FG002|Treatment Period|Sponsor decision|0|||
156633198|NCT01869959|565401361|FG003|Treatment Period|Sponsor decision|1|||
156633199|NCT01869959|565401362|FG004|Treatment Period|Sponsor decision|0|||
156633200|NCT01869959|565401358|FG000|Treatment Period|Withdrawal by Subject|0|||
156633201|NCT01869959|565401359|FG001|Treatment Period|Withdrawal by Subject|1|||
156633202|NCT01869959|565401360|FG002|Treatment Period|Withdrawal by Subject|0|||
156633203|NCT01869959|565401361|FG003|Treatment Period|Withdrawal by Subject|0|||
156633204|NCT01869959|565401362|FG004|Treatment Period|Withdrawal by Subject|0|||
156633205|NCT01965600|565401363|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
156633206|NCT01965600|565401364|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
156633207|NCT01965600|565401365|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
156633208|NCT01965600|565401366|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
156633209|NCT01965600|565401363|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
156633210|NCT01965600|565401364|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
156633211|NCT01965600|565401365|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
156633212|NCT01965600|565401366|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
156633213|NCT01965600|565401363|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
156633214|NCT01965600|565401364|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
156633215|NCT01965600|565401365|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
156633216|NCT01965600|565401366|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
156633217|NCT01965600|565401363|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
156633218|NCT01965600|565401364|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
156633219|NCT01965600|565401365|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
156633220|NCT01965600|565401366|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
156633221|NCT01965600|565401363|FG000|Second Intervention|Study terminated by Sponsor|0|||
156633222|NCT01965600|565401364|FG001|Second Intervention|Study terminated by Sponsor|0|||
156633223|NCT01965600|565401365|FG002|Second Intervention|Study terminated by Sponsor|2|||
156633224|NCT01965600|565401366|FG003|Second Intervention|Study terminated by Sponsor|2|||
156633225|NCT00828009|565401367|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
156633226|NCT00828009|565401367|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
156633227|NCT00828009|565401367|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
156635572|NCT00602667|565409960|FG000|Overall Study|Physician Decision|2|||
156633228|NCT00828009|565401367|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
156633229|NCT00828009|565401367|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
156633230|NCT00828009|565401367|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
156633231|NCT00828009|565401367|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
156633232|NCT00828009|565401367|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
156633233|NCT00828009|565401367|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
156633234|NCT00828009|565401367|FG000|Step 2 - Maintenance Therapy|Death|1|||
156633235|NCT00828009|565401367|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
156633236|NCT00828009|565401367|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
156633237|NCT00828009|565401367|FG000|Step 2 - Maintenance Therapy|Other|1|||
156633238|NCT05102162|565402510|FG000|Overall Study|Withdrawal by Subject|3|||
156633239|NCT05102162|565402511|FG001|Overall Study|Withdrawal by Subject|0|||
156633240|NCT05102162|565402510|FG000|Overall Study|Baseline cultures negative|4|||
156633241|NCT05102162|565402511|FG001|Overall Study|Baseline cultures negative|2|||
156633242|NCT05102162|565402510|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
156633243|NCT05102162|565402511|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
156633244|NCT05102162|565402510|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
156633245|NCT05102162|565402511|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
156633246|NCT01353586|565402512|FG000|Overall Study|Procedure terminated prior to ablation|3|||
156633247|NCT01353586|565402513|FG001|Overall Study|Procedure terminated prior to ablation|0|||
156633248|NCT01353586|565402512|FG000|Overall Study|Never had insertion of study catheter|4|||
156633249|NCT01353586|565402513|FG001|Overall Study|Never had insertion of study catheter|1|||
156633250|NCT01353586|565402512|FG000|Overall Study|Neurological exam not done|0|||
156633251|NCT01353586|565402513|FG001|Overall Study|Neurological exam not done|1|||
156633252|NCT05027958|565402514|FG000|Overall Study|Lost to Follow-up|1|||
156633253|NCT05027958|565402515|FG001|Overall Study|Lost to Follow-up|1|||
156633254|NCT05027958|565402514|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
156633255|NCT05027958|565402515|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
156633256|NCT05027958|565402514|FG000|Overall Study|Physician Decision|1|||
156633257|NCT05027958|565402515|FG001|Overall Study|Physician Decision|4|||
156633258|NCT05027958|565402514|FG000|Overall Study|Adverse Event|0|||
156633259|NCT05027958|565402515|FG001|Overall Study|Adverse Event|1|||
156633260|NCT02871921|565402516|FG000|Overall Study|Withdrawal by Subject|34|||
156633261|NCT02871921|565402517|FG001|Overall Study|Withdrawal by Subject|27|||
156633262|NCT02871921|565402518|FG002|Overall Study|Withdrawal by Subject|27|||
156633263|NCT02871921|565402519|FG003|Overall Study|Withdrawal by Subject|30|||
156633264|NCT00326625|565402523|FG000|Overall Study|Adverse Event|20|||
156633265|NCT00326625|565402524|FG001|Overall Study|Adverse Event|9|||
156633266|NCT00326625|565402523|FG000|Overall Study|Withdrawal by Subject|15|||
156633267|NCT00326625|565402524|FG001|Overall Study|Withdrawal by Subject|12|||
156633268|NCT00326625|565402523|FG000|Overall Study|Death|18|||
156633269|NCT00326625|565402524|FG001|Overall Study|Death|16|||
156633270|NCT00326625|565402523|FG000|Overall Study|Lost to Follow-up|1|||
156633271|NCT00326625|565402524|FG001|Overall Study|Lost to Follow-up|0|||
156633272|NCT00326625|565402523|FG000|Overall Study|prescheduled medical intervention|0|||
156633273|NCT00326625|565402524|FG001|Overall Study|prescheduled medical intervention|1|||
156633274|NCT00625846|565402525|FG000|Overall Study|Withdrawal by Subject|2|||
156633275|NCT00625846|565402526|FG001|Overall Study|Withdrawal by Subject|0|||
156633276|NCT00625846|565402527|FG002|Overall Study|Withdrawal by Subject|1|||
156633277|NCT00625846|565402528|FG003|Overall Study|Withdrawal by Subject|2|||
156633278|NCT00890409|565402533|FG000|Overall Study|Lost to Follow-up|20|||
156633279|NCT00890409|565402534|FG001|Overall Study|Lost to Follow-up|21|||
156633280|NCT02353572|565402535|FG000|Overall Study|Withdrawal by Subject|1|||
156633281|NCT02353572|565402535|FG000|Overall Study|Study terminated|2|||
156633282|NCT03707145|565402546|FG000|Overall Study|Lost to Follow-up|0|||
156633283|NCT03707145|565402547|FG001|Overall Study|Lost to Follow-up|1|||
156633284|NCT03707145|565402548|FG002|Overall Study|Lost to Follow-up|1|||
156633285|NCT03707145|565402549|FG003|Overall Study|Lost to Follow-up|0|||
156633286|NCT04221477|565402550|FG000|Overall Study|Adverse Event|1|||
156633287|NCT04221477|565402551|FG001|Overall Study|Adverse Event|1|||
156633288|NCT04221477|565402550|FG000|Overall Study|Death|5|||
156633289|NCT04221477|565402551|FG001|Overall Study|Death|4|||
156633290|NCT04221477|565402550|FG000|Overall Study|Lack of Efficacy|1|||
156633291|NCT04221477|565402551|FG001|Overall Study|Lack of Efficacy|2|||
156633292|NCT04221477|565402550|FG000|Overall Study|Lost to Follow-up|1|||
156633293|NCT04221477|565402551|FG001|Overall Study|Lost to Follow-up|2|||
156633294|NCT04221477|565402550|FG000|Overall Study|Non-compliance with Study Drug|1|||
156633295|NCT04221477|565402551|FG001|Overall Study|Non-compliance with Study Drug|0|||
156633296|NCT04221477|565402550|FG000|Overall Study|Reason not Specified|0|||
156633297|NCT04221477|565402551|FG001|Overall Study|Reason not Specified|5|||
156633298|NCT04221477|565402550|FG000|Overall Study|Physician Decision|0|||
156633299|NCT04221477|565402551|FG001|Overall Study|Physician Decision|6|||
156633300|NCT04221477|565402550|FG000|Overall Study|Withdrawal by Subject|10|||
156633301|NCT04221477|565402551|FG001|Overall Study|Withdrawal by Subject|14|||
156633302|NCT04221477|565402550|FG000|Overall Study|Ongoing in the Study|116|||
156633303|NCT04221477|565402551|FG001|Overall Study|Ongoing in the Study|102|||
156633304|NCT02242942|565402552|FG000|Overall Study|Death|17|||
156633305|NCT02242942|565402553|FG001|Overall Study|Death|20|||
156633306|NCT02242942|565402554|FG002|Overall Study|Death|2|||
156633307|NCT02242942|565402552|FG000|Overall Study|Physician Decision|1|||
156633308|NCT02242942|565402553|FG001|Overall Study|Physician Decision|0|||
156633309|NCT02242942|565402554|FG002|Overall Study|Physician Decision|0|||
156633310|NCT02242942|565402552|FG000|Overall Study|Withdrawal by Subject|8|||
156633311|NCT02242942|565402553|FG001|Overall Study|Withdrawal by Subject|10|||
156633312|NCT02242942|565402554|FG002|Overall Study|Withdrawal by Subject|0|||
156633313|NCT02242942|565402552|FG000|Overall Study|On-going in Study|190|||
156633314|NCT02242942|565402553|FG001|Overall Study|On-going in Study|186|||
156633315|NCT02242942|565402554|FG002|Overall Study|On-going in Study|11|||
156633316|NCT01215968|565402560|FG000|Overall Study|Adverse Event|0|||
156633317|NCT01215968|565402561|FG001|Overall Study|Adverse Event|2|||
156633318|NCT01215968|565402560|FG000|Overall Study|Protocol Violation|2|||
156633319|NCT01215968|565402561|FG001|Overall Study|Protocol Violation|4|||
156633320|NCT01215968|565402560|FG000|Overall Study|Not received study drug|0|||
156633321|NCT01215968|565402561|FG001|Overall Study|Not received study drug|1|||
156633322|NCT04242498|565402564|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
156633323|NCT04242498|565402565|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
156633324|NCT04242498|565402566|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
156633325|NCT04242498|565402567|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
156633326|NCT04242498|565402568|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
156633327|NCT04242498|565402569|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
156633328|NCT04242498|565402570|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
156633329|NCT04242498|565402564|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
156633330|NCT04242498|565402565|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
156633331|NCT04242498|565402566|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
156633332|NCT04242498|565402567|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
156633333|NCT04242498|565402568|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
156633334|NCT04242498|565402569|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
156633335|NCT04242498|565402570|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
156633336|NCT04242498|565402564|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
156633337|NCT04242498|565402565|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156633338|NCT04242498|565402566|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
156633339|NCT04242498|565402567|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156633340|NCT04242498|565402568|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156633341|NCT04242498|565402569|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156633342|NCT04242498|565402570|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
156633343|NCT04242498|565402564|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
156633344|NCT04242498|565402565|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156633345|NCT04242498|565402566|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
156633346|NCT04242498|565402567|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156633347|NCT04242498|565402568|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156633348|NCT04242498|565402569|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156633349|NCT04242498|565402570|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
156633350|NCT04242498|565402564|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
156633351|NCT04242498|565402565|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
156633352|NCT04242498|565402566|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
156633353|NCT04242498|565402567|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
156633354|NCT04242498|565402568|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
156633355|NCT04242498|565402569|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
156633356|NCT04242498|565402570|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
156633357|NCT04242498|565402564|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
156633358|NCT04242498|565402565|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
156633359|NCT04242498|565402566|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
156633360|NCT04242498|565402567|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
156633361|NCT04242498|565402568|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
156633362|NCT04242498|565402569|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
156633363|NCT04242498|565402570|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
156633364|NCT04242498|565402564|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
156633365|NCT04242498|565402565|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
156633366|NCT04242498|565402566|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
156633367|NCT04242498|565402567|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
156633368|NCT04242498|565402568|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
156633369|NCT04242498|565402569|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
156633370|NCT04242498|565402570|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
156633371|NCT04242498|565402564|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156633372|NCT04242498|565402565|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
156633373|NCT04242498|565402566|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
156633374|NCT04242498|565402567|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156633375|NCT04242498|565402568|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156633376|NCT04242498|565402569|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156633377|NCT04242498|565402570|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
156633378|NCT04242498|565402564|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
156633379|NCT04242498|565402565|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
156633380|NCT04242498|565402566|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
156633381|NCT04242498|565402567|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
156633382|NCT04242498|565402568|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
156633383|NCT04242498|565402569|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
156633384|NCT04242498|565402570|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
156633385|NCT04242498|565402564|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
156633386|NCT04242498|565402565|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
156633387|NCT04242498|565402566|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
156633388|NCT04242498|565402567|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
156633389|NCT04242498|565402568|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
156633390|NCT04242498|565402569|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
156633391|NCT04242498|565402570|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
156633392|NCT04242498|565402564|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
156633393|NCT04242498|565402565|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
156633394|NCT04242498|565402566|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
156633395|NCT04242498|565402567|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
156633396|NCT04242498|565402568|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
156633397|NCT04242498|565402569|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
156633398|NCT04242498|565402570|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
156633399|NCT04242498|565402564|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
156633400|NCT04242498|565402565|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
156633401|NCT04242498|565402566|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
156633402|NCT04242498|565402567|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
156633403|NCT04242498|565402568|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
156633404|NCT04242498|565402569|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
156633405|NCT04242498|565402570|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
156633406|NCT04242498|565402564|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
156633407|NCT04242498|565402565|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
156633408|NCT04242498|565402566|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
156633409|NCT04242498|565402567|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
156633410|NCT04242498|565402568|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
156633411|NCT04242498|565402569|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
156633412|NCT04242498|565402570|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
156633413|NCT04242498|565402564|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
156633414|NCT04242498|565402565|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
156633415|NCT04242498|565402566|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
156633416|NCT04242498|565402567|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
156633417|NCT04242498|565402568|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
156633418|NCT04242498|565402569|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
156633419|NCT04242498|565402570|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
156633420|NCT04242498|565402564|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
156633421|NCT04242498|565402565|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
156633422|NCT04242498|565402566|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
156633423|NCT04242498|565402567|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
156633424|NCT04242498|565402568|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
156633425|NCT04242498|565402569|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
156633426|NCT04242498|565402570|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
156633427|NCT04242498|565402564|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
156633428|NCT04242498|565402565|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
156633429|NCT04242498|565402566|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
156633430|NCT04242498|565402567|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
156633431|NCT04242498|565402568|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
156633432|NCT04242498|565402569|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
156633433|NCT04242498|565402570|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
156633434|NCT02500732|565402573|FG000|Overall Study|Physician Decision|0|||
156633435|NCT02500732|565402574|FG001|Overall Study|Physician Decision|1|||
156633436|NCT01958619|565402575|FG000|Overall Study|Protocol Violation|2|||
156633437|NCT01958619|565402576|FG001|Overall Study|Protocol Violation|0|||
156633438|NCT01958619|565402577|FG002|Overall Study|Protocol Violation|1|||
156633439|NCT01958619|565402578|FG003|Overall Study|Protocol Violation|0|||
156633440|NCT03205605|565402579|FG000|Overall Study|Withdrawal by Subject|1|||
156633441|NCT03759340|565402584|FG000|Overall Study|Adverse Event|2|||
156633442|NCT03759340|565402584|FG000|Overall Study|Lost to Follow-up|1|||
156633443|NCT03759340|565402584|FG000|Overall Study|Withdrawal by Subject|15|||
156633444|NCT03759340|565402584|FG000|Overall Study|Study Terminated by Sponsor|38|||
156633445|NCT03795233|565402585|FG000|Overall Study|Withdrawal by Subject|2|||
156633446|NCT03795233|565402586|FG001|Overall Study|Withdrawal by Subject|1|||
156633447|NCT03795233|565402585|FG000|Overall Study|Lost to Follow-up|1|||
156633448|NCT03795233|565402586|FG001|Overall Study|Lost to Follow-up|0|||
156633449|NCT03795233|565402585|FG000|Overall Study|Death|1|||
156633450|NCT03795233|565402586|FG001|Overall Study|Death|0|||
156633451|NCT02756182|565402587|FG000|Overall Study|StudyTechnical Difficulties|4|||
156633452|NCT01003691|565402589|FG000|Overall Study|Adverse Event|0|||
156633453|NCT01003691|565402590|FG001|Overall Study|Adverse Event|0|||
156633454|NCT01003691|565402591|FG002|Overall Study|Adverse Event|0|||
156633455|NCT01003691|565402592|FG003|Overall Study|Adverse Event|1|||
156633456|NCT01676818|565402602|FG000|Overall Study|Physician Decision|1|||
156633457|NCT01676818|565402602|FG000|Overall Study|Withdrawal by Subject|1|||
156633458|NCT01519635|565403988|FG000|Overall Study|Withdrawal by Subject|0|||
156633459|NCT01519635|565403989|FG001|Overall Study|Withdrawal by Subject|1|||
156633460|NCT01519635|565403988|FG000|Overall Study|No possibility to put a catheter|1|||
156633461|NCT01519635|565403989|FG001|Overall Study|No possibility to put a catheter|2|||
156633462|NCT00347776|565403990|FG000|1.5 Month Follow-up|Death|2|||
156633463|NCT00347776|565403991|FG001|1.5 Month Follow-up|Death|0|||
156633464|NCT00347776|565403992|FG002|1.5 Month Follow-up|Death|0|||
156633465|NCT00347776|565403990|FG000|1.5 Month Follow-up|reached the endpoint|12|||
156633466|NCT00347776|565403991|FG001|1.5 Month Follow-up|reached the endpoint|8|||
156633467|NCT00347776|565403992|FG002|1.5 Month Follow-up|reached the endpoint|12|||
156633468|NCT00347776|565403990|FG000|6 Month Follow-up|Death|2|||
156633469|NCT00347776|565403991|FG001|6 Month Follow-up|Death|1|||
156633470|NCT00347776|565403992|FG002|6 Month Follow-up|Death|3|||
156633471|NCT00347776|565403990|FG000|6 Month Follow-up|reached endpont|20|||
156633472|NCT00347776|565403991|FG001|6 Month Follow-up|reached endpont|12|||
156633473|NCT00347776|565403992|FG002|6 Month Follow-up|reached endpont|15|||
156633474|NCT00347776|565403990|FG000|12 Month Follow-up|Lost to Follow-up|7|||
156633475|NCT00347776|565403991|FG001|12 Month Follow-up|Lost to Follow-up|6|||
156633476|NCT00347776|565403992|FG002|12 Month Follow-up|Lost to Follow-up|6|||
156633477|NCT00347776|565403990|FG000|12 Month Follow-up|Death|3|||
156633478|NCT00347776|565403991|FG001|12 Month Follow-up|Death|4|||
156633479|NCT00347776|565403992|FG002|12 Month Follow-up|Death|4|||
156633480|NCT00347776|565403990|FG000|12 Month Follow-up|Reached endpoint|13|||
156633481|NCT00347776|565403991|FG001|12 Month Follow-up|Reached endpoint|6|||
156633482|NCT00347776|565403992|FG002|12 Month Follow-up|Reached endpoint|9|||
156633483|NCT01100073|565403993|FG000|Overall Study|Lack of Efficacy|4|||
156633484|NCT01100073|565403993|FG000|Overall Study|Insufficient Tolerability|21|||
156633485|NCT01100073|565403993|FG000|Overall Study|Withdrawal by Subject|13|||
156633486|NCT01100073|565403993|FG000|Overall Study|Lost to Follow-up|39|||
156633487|NCT01100073|565403993|FG000|Overall Study|Lack of effect + patient's wish|2|||
156633488|NCT01100073|565403993|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
156633489|NCT01100073|565403993|FG000|Overall Study|Other|8|||
156633490|NCT01100073|565403993|FG000|Overall Study|Missing|5|||
156633491|NCT00299546|565403994|FG000|Overall Study|Death|3|||
156633492|NCT00299546|565403995|FG001|Overall Study|Death|2|||
156633493|NCT00299546|565403996|FG002|Overall Study|Death|0|||
156633494|NCT00299546|565403994|FG000|Overall Study|Lost to Follow-up|2|||
156633495|NCT00299546|565403995|FG001|Overall Study|Lost to Follow-up|2|||
156633496|NCT00299546|565403996|FG002|Overall Study|Lost to Follow-up|5|||
156633497|NCT00299546|565403994|FG000|Overall Study|Adverse Event|37|||
156633498|NCT00299546|565403995|FG001|Overall Study|Adverse Event|22|||
156633499|NCT00299546|565403996|FG002|Overall Study|Adverse Event|27|||
156633500|NCT00299546|565403994|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
156633501|NCT00299546|565403995|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
156633502|NCT00299546|565403996|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
156633503|NCT00299546|565403994|FG000|Overall Study|Other|24|||
156633504|NCT00299546|565403995|FG001|Overall Study|Other|26|||
156633505|NCT00299546|565403996|FG002|Overall Study|Other|19|||
156633506|NCT00299546|565403994|FG000|Overall Study|Not treated|0|||
156633507|NCT00299546|565403995|FG001|Overall Study|Not treated|1|||
156633508|NCT00299546|565403996|FG002|Overall Study|Not treated|1|||
156633509|NCT03099265|565403997|FG000|Overall Study|Adverse Event|1|||
156633510|NCT01656850|565404005|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
156633511|NCT01656850|565404006|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
156633512|NCT00968539|565404007|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
156633513|NCT00968539|565404008|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156633514|NCT00396318|565404009|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
156633515|NCT00326118|565404010|FG000|Active Phase|Withdrawal by Subject|4|||
156633516|NCT00326118|565404011|FG001|Active Phase|Withdrawal by Subject|1|||
156633517|NCT00602927|565404012|FG000|Period 1: 13 Days|Protocol Violation|2|||
156633518|NCT00602927|565404013|FG001|Period 1: 13 Days|Protocol Violation|4|||
156633519|NCT00602927|565404012|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
156633520|NCT00602927|565404013|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
156633521|NCT00602927|565404012|FG000|Period 1: 13 Days|Time|1|||
156633522|NCT00602927|565404013|FG001|Period 1: 13 Days|Time|0|||
156633523|NCT00602927|565404012|FG000|Period 1: 13 Days|Claustrophobia|0|||
156633524|NCT00602927|565404013|FG001|Period 1: 13 Days|Claustrophobia|1|||
156633525|NCT00602927|565404012|FG000|Period 2: 14 Days|Protocol Violation|0|||
156633526|NCT00602927|565404013|FG001|Period 2: 14 Days|Protocol Violation|2|||
156633527|NCT00602927|565404012|FG000|Period 3: 13 Days|Protocol Violation|0|||
156633528|NCT00602927|565404013|FG001|Period 3: 13 Days|Protocol Violation|1|||
156633529|NCT00602927|565404012|FG000|Period 3: 13 Days|MRI data quality|2|||
156633530|NCT00602927|565404013|FG001|Period 3: 13 Days|MRI data quality|2|||
156633531|NCT01741259|565404022|FG000|Overall Study|Protocol Violation|6|||
156633532|NCT01741259|565404023|FG001|Overall Study|Protocol Violation|4|||
156633533|NCT01741259|565404022|FG000|Overall Study|Withdrawal by Subject|0|||
156633534|NCT01741259|565404023|FG001|Overall Study|Withdrawal by Subject|2|||
156633535|NCT05604521|565404028|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
156633536|NCT05604521|565404029|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
156633537|NCT05604521|565404028|FG000|Overall Study|Adverse Event|1|||
156633538|NCT05604521|565404029|FG001|Overall Study|Adverse Event|0|||
156633539|NCT02074982|565404030|FG000|Overall Study|Adverse Event|15|||
156633540|NCT02074982|565404031|FG001|Overall Study|Adverse Event|7|||
156633541|NCT02074982|565404030|FG000|Overall Study|Lack of Efficacy|6|||
156633542|NCT02074982|565404031|FG001|Overall Study|Lack of Efficacy|1|||
156633543|NCT02074982|565404030|FG000|Overall Study|Lost to Follow-up|9|||
156633544|NCT02074982|565404031|FG001|Overall Study|Lost to Follow-up|10|||
156633545|NCT02074982|565404030|FG000|Overall Study|Non-compliance with study treatment|0|||
156633546|NCT02074982|565404031|FG001|Overall Study|Non-compliance with study treatment|2|||
156633547|NCT02074982|565404030|FG000|Overall Study|Physician Decision|1|||
156633548|NCT02074982|565404031|FG001|Overall Study|Physician Decision|1|||
156633549|NCT02074982|565404030|FG000|Overall Study|Pregnancy|1|||
156633550|NCT02074982|565404031|FG001|Overall Study|Pregnancy|2|||
156633551|NCT02074982|565404030|FG000|Overall Study|Protocol deviation|4|||
156633552|NCT02074982|565404031|FG001|Overall Study|Protocol deviation|3|||
156633553|NCT02074982|565404030|FG000|Overall Study|Technical problems|0|||
156633554|NCT02074982|565404031|FG001|Overall Study|Technical problems|2|||
156633555|NCT02074982|565404030|FG000|Overall Study|Subject/guardian decision|15|||
156633556|NCT02074982|565404031|FG001|Overall Study|Subject/guardian decision|24|||
156633557|NCT02074982|565404030|FG000|Overall Study|Death|0|||
156633558|NCT02074982|565404031|FG001|Overall Study|Death|2|||
156633559|NCT02525627|565404036|FG000|Overall Study|Revision|1|||
156633560|NCT02525627|565404037|FG001|Overall Study|Revision|1|||
156633561|NCT02525627|565404036|FG000|Overall Study|Withdrawal by Subject|1|||
156633562|NCT02525627|565404037|FG001|Overall Study|Withdrawal by Subject|2|||
156633563|NCT02525627|565404036|FG000|Overall Study|Death|1|||
156633564|NCT02525627|565404037|FG001|Overall Study|Death|0|||
156633565|NCT02525627|565404036|FG000|Overall Study|Site terminated|11|||
156633566|NCT02525627|565404037|FG001|Overall Study|Site terminated|10|||
156633567|NCT00242567|565404038|FG000|Overall Study|Adverse Event|70|||
156633568|NCT00242567|565404039|FG001|Overall Study|Adverse Event|43|||
156633569|NCT00242567|565404038|FG000|Overall Study|Disease Progression|17|||
156633570|NCT00242567|565404039|FG001|Overall Study|Disease Progression|22|||
156633571|NCT00242567|565404038|FG000|Overall Study|Symptomatic deterioration|9|||
156633572|NCT00242567|565404039|FG001|Overall Study|Symptomatic deterioration|3|||
156633573|NCT00242567|565404038|FG000|Overall Study|Lack of Efficacy|2|||
156633574|NCT00242567|565404039|FG001|Overall Study|Lack of Efficacy|2|||
156633575|NCT00242567|565404038|FG000|Overall Study|Lost to Follow-up|9|||
156633576|NCT00242567|565404039|FG001|Overall Study|Lost to Follow-up|19|||
156633577|NCT00242567|565404038|FG000|Overall Study|Withdrawal by Subject|33|||
156633578|NCT00242567|565404039|FG001|Overall Study|Withdrawal by Subject|28|||
156633579|NCT00242567|565404038|FG000|Overall Study|Protocol Violation|12|||
156633580|NCT00242567|565404039|FG001|Overall Study|Protocol Violation|12|||
156633581|NCT00242567|565404038|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
156633582|NCT00242567|565404039|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
156633583|NCT00242567|565404038|FG000|Overall Study|Other|14|||
156633584|NCT00242567|565404039|FG001|Overall Study|Other|9|||
156633585|NCT00630994|565404040|FG000|Overall Study|Adverse Event|1|||
156633586|NCT00630994|565404040|FG000|Overall Study|Disease Progression|1|||
156633587|NCT00630994|565404040|FG000|Overall Study|Lack of Efficacy|1|||
156633588|NCT00630994|565404040|FG000|Overall Study|Other|1|||
156633589|NCT05553600|565404041|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
156633590|NCT05553600|565404042|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
156633591|NCT05553600|565404043|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
156633592|NCT05553600|565404044|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
156633593|NCT05553600|565404041|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
156633594|NCT05553600|565404042|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
156633595|NCT05553600|565404043|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
156633596|NCT05553600|565404044|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
156633597|NCT05553600|565404041|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
156633598|NCT05553600|565404042|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
156633599|NCT05553600|565404043|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
156633600|NCT05553600|565404044|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
156633601|NCT05553600|565404041|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
156633602|NCT05553600|565404042|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
156633603|NCT05553600|565404043|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
156633604|NCT05553600|565404044|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
156633605|NCT05553600|565404041|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
156633606|NCT05553600|565404042|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
156633607|NCT05553600|565404043|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
156633608|NCT05553600|565404044|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
156633609|NCT05553600|565404041|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
156633610|NCT05553600|565404042|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
156633611|NCT05553600|565404043|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
156633612|NCT05553600|565404044|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
156633613|NCT05553600|565404041|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
156633614|NCT05553600|565404042|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
156633615|NCT05553600|565404043|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
156633616|NCT05553600|565404044|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
156633617|NCT05553600|565404041|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
156633618|NCT05553600|565404042|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
156633619|NCT05553600|565404043|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
156633620|NCT05553600|565404044|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
156633621|NCT05553600|565404041|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
156633622|NCT05553600|565404042|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
156633623|NCT05553600|565404043|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
156633624|NCT05553600|565404044|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
156633625|NCT05553600|565404041|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
156633626|NCT05553600|565404042|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
156633627|NCT05553600|565404043|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
156633628|NCT05553600|565404044|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
156633629|NCT05553600|565404041|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
156633630|NCT05553600|565404042|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
156633631|NCT05553600|565404043|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
156633632|NCT05553600|565404044|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
156633633|NCT05553600|565404041|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
156633634|NCT05553600|565404042|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
156633635|NCT05553600|565404043|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
156633636|NCT05553600|565404044|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
156633637|NCT03710824|565404052|FG000|Overall Study|Withdrawal by Subject|1|||
156633638|NCT03710824|565404052|FG000|Overall Study|Lost to Follow-up|3|||
156633639|NCT03710824|565404052|FG000|Overall Study|Adverse Event|25|||
156633640|NCT03710824|565404052|FG000|Overall Study|Treatment discontinuation|2|||
156633641|NCT01605370|565404053|FG000|Overall Study|Adverse Event|1|||
156633642|NCT01605370|565404054|FG001|Overall Study|Adverse Event|0|||
156633643|NCT01870921|565404061|FG000|Overall Study|Subject decision|80|||
156633644|NCT01870921|565404061|FG000|Overall Study|Severe non-compliance to protocol|7|||
156633645|NCT01870921|565404061|FG000|Overall Study|Subject Lost to Follow up|2|||
156633646|NCT01870921|565404061|FG000|Overall Study|Other|1|||
156633647|NCT02060188|565404065|FG000|Overall Study|Disease Progression|36|||
156633648|NCT02060188|565404066|FG001|Overall Study|Disease Progression|42|||
156633649|NCT02060188|565404067|FG002|Overall Study|Disease Progression|8|||
156633650|NCT02060188|565404068|FG003|Overall Study|Disease Progression|5|||
156633651|NCT02060188|565404069|FG004|Overall Study|Disease Progression|6|||
156633652|NCT02060188|565404070|FG005|Overall Study|Disease Progression|3|||
156633653|NCT02060188|565404071|FG006|Overall Study|Disease Progression|23|||
156633654|NCT02060188|565404072|FG007|Overall Study|Disease Progression|20|||
156633655|NCT02060188|565404073|FG008|Overall Study|Disease Progression|43|||
156633656|NCT02060188|565404065|FG000|Overall Study|Study Drug Toxicity|10|||
156633657|NCT02060188|565404066|FG001|Overall Study|Study Drug Toxicity|18|||
156633658|NCT02060188|565404067|FG002|Overall Study|Study Drug Toxicity|7|||
156633659|NCT02060188|565404068|FG003|Overall Study|Study Drug Toxicity|4|||
156633660|NCT02060188|565404069|FG004|Overall Study|Study Drug Toxicity|3|||
156633661|NCT02060188|565404070|FG005|Overall Study|Study Drug Toxicity|0|||
156633662|NCT02060188|565404071|FG006|Overall Study|Study Drug Toxicity|2|||
156633663|NCT02060188|565404072|FG007|Overall Study|Study Drug Toxicity|5|||
156633664|NCT02060188|565404073|FG008|Overall Study|Study Drug Toxicity|0|||
156633665|NCT02060188|565404065|FG000|Overall Study|Adverse event unrelated to study drug|2|||
156633666|NCT02060188|565404066|FG001|Overall Study|Adverse event unrelated to study drug|5|||
156633667|NCT02060188|565404067|FG002|Overall Study|Adverse event unrelated to study drug|6|||
156633668|NCT02060188|565404068|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156633669|NCT02060188|565404069|FG004|Overall Study|Adverse event unrelated to study drug|1|||
156633670|NCT02060188|565404070|FG005|Overall Study|Adverse event unrelated to study drug|0|||
156633671|NCT02060188|565404071|FG006|Overall Study|Adverse event unrelated to study drug|4|||
156633672|NCT02060188|565404072|FG007|Overall Study|Adverse event unrelated to study drug|4|||
156633673|NCT02060188|565404073|FG008|Overall Study|Adverse event unrelated to study drug|1|||
156633674|NCT02060188|565404065|FG000|Overall Study|Participant request to discontinue study treatment|7|||
156633675|NCT02060188|565404066|FG001|Overall Study|Participant request to discontinue study treatment|7|||
156633676|NCT02060188|565404067|FG002|Overall Study|Participant request to discontinue study treatment|4|||
156633677|NCT02060188|565404068|FG003|Overall Study|Participant request to discontinue study treatment|0|||
156633678|NCT02060188|565404069|FG004|Overall Study|Participant request to discontinue study treatment|0|||
156633679|NCT02060188|565404070|FG005|Overall Study|Participant request to discontinue study treatment|0|||
156633680|NCT02060188|565404071|FG006|Overall Study|Participant request to discontinue study treatment|1|||
156633681|NCT02060188|565404072|FG007|Overall Study|Participant request to discontinue study treatment|1|||
156633682|NCT02060188|565404073|FG008|Overall Study|Participant request to discontinue study treatment|0|||
156633683|NCT02060188|565404065|FG000|Overall Study|Participant withdrew consent|3|||
156633684|NCT02060188|565404066|FG001|Overall Study|Participant withdrew consent|0|||
156633685|NCT02060188|565404067|FG002|Overall Study|Participant withdrew consent|0|||
156633686|NCT02060188|565404068|FG003|Overall Study|Participant withdrew consent|0|||
156633687|NCT02060188|565404069|FG004|Overall Study|Participant withdrew consent|0|||
156633688|NCT02060188|565404070|FG005|Overall Study|Participant withdrew consent|0|||
156633689|NCT02060188|565404071|FG006|Overall Study|Participant withdrew consent|0|||
156633690|NCT02060188|565404072|FG007|Overall Study|Participant withdrew consent|0|||
156633691|NCT02060188|565404073|FG008|Overall Study|Participant withdrew consent|0|||
156633692|NCT02060188|565404065|FG000|Overall Study|Maximum clinical benefit|13|||
156633693|NCT02060188|565404066|FG001|Overall Study|Maximum clinical benefit|38|||
156633694|NCT02060188|565404067|FG002|Overall Study|Maximum clinical benefit|19|||
156633695|NCT02060188|565404068|FG003|Overall Study|Maximum clinical benefit|0|||
156633696|NCT02060188|565404069|FG004|Overall Study|Maximum clinical benefit|0|||
156633697|NCT02060188|565404070|FG005|Overall Study|Maximum clinical benefit|0|||
156633698|NCT02060188|565404071|FG006|Overall Study|Maximum clinical benefit|0|||
156633699|NCT02060188|565404072|FG007|Overall Study|Maximum clinical benefit|10|||
156633700|NCT02060188|565404073|FG008|Overall Study|Maximum clinical benefit|0|||
156633701|NCT02060188|565404065|FG000|Overall Study|Other reason|3|||
156633702|NCT02060188|565404066|FG001|Overall Study|Other reason|7|||
156633703|NCT02060188|565404067|FG002|Overall Study|Other reason|0|||
156633704|NCT02060188|565404068|FG003|Overall Study|Other reason|1|||
156633705|NCT02060188|565404069|FG004|Overall Study|Other reason|0|||
156633706|NCT02060188|565404070|FG005|Overall Study|Other reason|0|||
156633707|NCT02060188|565404071|FG006|Overall Study|Other reason|0|||
156633708|NCT02060188|565404072|FG007|Overall Study|Other reason|9|||
156633709|NCT02060188|565404073|FG008|Overall Study|Other reason|0|||
156633710|NCT02060188|565404065|FG000|Overall Study|Death|0|||
156633711|NCT02060188|565404066|FG001|Overall Study|Death|1|||
156633712|NCT02060188|565404067|FG002|Overall Study|Death|0|||
156633713|NCT02060188|565404068|FG003|Overall Study|Death|0|||
156633714|NCT02060188|565404069|FG004|Overall Study|Death|0|||
156633715|NCT02060188|565404070|FG005|Overall Study|Death|0|||
156633716|NCT02060188|565404071|FG006|Overall Study|Death|0|||
156633717|NCT02060188|565404072|FG007|Overall Study|Death|1|||
156633718|NCT02060188|565404073|FG008|Overall Study|Death|0|||
156633719|NCT02060188|565404065|FG000|Overall Study|Administrative reasons by sponsor|0|||
156633720|NCT02060188|565404066|FG001|Overall Study|Administrative reasons by sponsor|1|||
156633721|NCT02060188|565404067|FG002|Overall Study|Administrative reasons by sponsor|0|||
156633722|NCT02060188|565404068|FG003|Overall Study|Administrative reasons by sponsor|0|||
156633723|NCT02060188|565404069|FG004|Overall Study|Administrative reasons by sponsor|0|||
156633724|NCT02060188|565404070|FG005|Overall Study|Administrative reasons by sponsor|0|||
156633725|NCT02060188|565404071|FG006|Overall Study|Administrative reasons by sponsor|0|||
156633726|NCT02060188|565404072|FG007|Overall Study|Administrative reasons by sponsor|0|||
156633727|NCT02060188|565404073|FG008|Overall Study|Administrative reasons by sponsor|0|||
156633728|NCT02060188|565404065|FG000|Overall Study|Lost to Follow-up|0|||
156633729|NCT02060188|565404066|FG001|Overall Study|Lost to Follow-up|0|||
156633730|NCT02060188|565404067|FG002|Overall Study|Lost to Follow-up|1|||
156633731|NCT02060188|565404068|FG003|Overall Study|Lost to Follow-up|0|||
156633732|NCT02060188|565404069|FG004|Overall Study|Lost to Follow-up|0|||
156633733|NCT02060188|565404070|FG005|Overall Study|Lost to Follow-up|0|||
156633734|NCT02060188|565404071|FG006|Overall Study|Lost to Follow-up|0|||
156633735|NCT02060188|565404072|FG007|Overall Study|Lost to Follow-up|0|||
156633736|NCT02060188|565404073|FG008|Overall Study|Lost to Follow-up|0|||
156633737|NCT04456998|565404076|FG000|Overall Study|Adverse Event|0|||
156633738|NCT04456998|565404077|FG001|Overall Study|Adverse Event|4|||
156633739|NCT04456998|565404076|FG000|Overall Study|Protocol Deviation|0|||
156633740|NCT04456998|565404077|FG001|Overall Study|Protocol Deviation|1|||
156633741|NCT04456998|565404076|FG000|Overall Study|Withdrawal by Subject|0|||
156633742|NCT04456998|565404077|FG001|Overall Study|Withdrawal by Subject|1|||
156633743|NCT04882085|565404081|FG000|Overall Study|Death|6|||
156633744|NCT04882085|565404082|FG001|Overall Study|Death|9|||
156633745|NCT04882085|565404081|FG000|Overall Study|Withdrawal by Subject|0|||
156633746|NCT04882085|565404082|FG001|Overall Study|Withdrawal by Subject|3|||
156633747|NCT04882085|565404081|FG000|Overall Study|Randomized not treated|1|||
156633748|NCT04882085|565404082|FG001|Overall Study|Randomized not treated|0|||
156633749|NCT04455620|565404086|FG000|Overall Study|Withdrawal by Subject|0|||
156633750|NCT04455620|565404087|FG001|Overall Study|Withdrawal by Subject|0|||
156633751|NCT04455620|565404088|FG002|Overall Study|Withdrawal by Subject|2|||
156633752|NCT04455620|565404089|FG003|Overall Study|Withdrawal by Subject|0|||
156633753|NCT04455620|565404090|FG004|Overall Study|Withdrawal by Subject|1|||
156633754|NCT04455620|565404086|FG000|Overall Study|Lost to Follow-up|0|||
156633755|NCT04455620|565404087|FG001|Overall Study|Lost to Follow-up|0|||
156633756|NCT04455620|565404088|FG002|Overall Study|Lost to Follow-up|1|||
156633757|NCT04455620|565404089|FG003|Overall Study|Lost to Follow-up|1|||
156633758|NCT04455620|565404090|FG004|Overall Study|Lost to Follow-up|0|||
156633759|NCT04455620|565404086|FG000|Overall Study|Death|1|||
156633760|NCT04455620|565404087|FG001|Overall Study|Death|6|||
156633761|NCT04455620|565404088|FG002|Overall Study|Death|20|||
156633762|NCT04455620|565404089|FG003|Overall Study|Death|1|||
156633763|NCT04455620|565404090|FG004|Overall Study|Death|7|||
156633764|NCT04455620|565404086|FG000|Overall Study|Study Termination|0|||
156633765|NCT04455620|565404087|FG001|Overall Study|Study Termination|2|||
156633766|NCT04455620|565404088|FG002|Overall Study|Study Termination|1|||
156633767|NCT04455620|565404089|FG003|Overall Study|Study Termination|0|||
156633768|NCT04455620|565404090|FG004|Overall Study|Study Termination|6|||
156633769|NCT03792633|565404091|FG000|Overall Study|Alternative Treatment|17|||
156633770|NCT03792633|565404092|FG001|Overall Study|Alternative Treatment|19|||
156633771|NCT03792633|565404091|FG000|Overall Study|Death|2|||
156633772|NCT03792633|565404092|FG001|Overall Study|Death|0|||
156633773|NCT03792633|565404091|FG000|Overall Study|Disease progression|8|||
156633774|NCT03792633|565404092|FG001|Overall Study|Disease progression|9|||
156633775|NCT03792633|565404091|FG000|Overall Study|Lost to Follow-up|1|||
156633776|NCT03792633|565404092|FG001|Overall Study|Lost to Follow-up|1|||
156633777|NCT03792633|565404091|FG000|Overall Study|Screen fail|1|||
156633778|NCT03792633|565404092|FG001|Overall Study|Screen fail|0|||
156633779|NCT03792633|565404091|FG000|Overall Study|Second malignancy|0|||
156633780|NCT03792633|565404092|FG001|Overall Study|Second malignancy|1|||
156633781|NCT00145119|565404093|FG000|Overall Study|Death|45|||
156633782|NCT05681715|565404094|FG000|Training Period (6-weeks)|Adverse Event|3|||
156633783|NCT05681715|565404095|FG001|Training Period (6-weeks)|Adverse Event|0|||
156633784|NCT05681715|565404096|FG002|Training Period (6-weeks)|Adverse Event|0|||
156633785|NCT05681715|565404094|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
156633786|NCT05681715|565404095|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
156633787|NCT05681715|565404096|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
156633788|NCT05681715|565404094|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
156633789|NCT05681715|565404095|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
156633790|NCT05681715|565404096|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
156633791|NCT05681715|565404094|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
156633792|NCT05681715|565404095|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
156633793|NCT05681715|565404096|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
156633794|NCT05681715|565404094|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
156634748|NCT03426995|565407774|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156633795|NCT05681715|565404095|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
156633796|NCT05681715|565404096|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
156633797|NCT05681715|565404094|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
156633798|NCT05681715|565404095|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
156633799|NCT05681715|565404096|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
156633800|NCT05681715|565404094|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
156633801|NCT05681715|565404095|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
156633802|NCT05681715|565404096|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
156633803|NCT05681715|565404094|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
156633804|NCT05681715|565404095|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
156633805|NCT05681715|565404096|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
156633806|NCT05455684|565404097|FG000|Overall Study|Withdrawal by Subject|7|||
156633807|NCT05455684|565404098|FG001|Overall Study|Withdrawal by Subject|4|||
156633808|NCT05455684|565404097|FG000|Overall Study|Lost to Follow-up|3|||
156633809|NCT05455684|565404098|FG001|Overall Study|Lost to Follow-up|3|||
156633810|NCT05455684|565404097|FG000|Overall Study|Adverse Event|2|||
156633811|NCT05455684|565404098|FG001|Overall Study|Adverse Event|3|||
156633812|NCT05455684|565404097|FG000|Overall Study|Protocol Violation|1|||
156633813|NCT05455684|565404098|FG001|Overall Study|Protocol Violation|1|||
156633814|NCT05455684|565404097|FG000|Overall Study|Non-Compliant with study drug|0|||
156633815|NCT05455684|565404098|FG001|Overall Study|Non-Compliant with study drug|1|||
156633816|NCT05455684|565404097|FG000|Overall Study|Other|1|||
156633817|NCT05455684|565404098|FG001|Overall Study|Other|2|||
156633818|NCT05455684|565404097|FG000|Overall Study|Randomized but not treated|1|||
156633819|NCT05455684|565404098|FG001|Overall Study|Randomized but not treated|0|||
156633820|NCT05204563|565404099|FG000|Overall Study|Other than Specified|2|||
156633821|NCT05204563|565404100|FG001|Overall Study|Other than Specified|1|||
156633822|NCT05204563|565404099|FG000|Overall Study|Death|18|||
156633823|NCT05204563|565404100|FG001|Overall Study|Death|4|||
156633824|NCT05204563|565404099|FG000|Overall Study|Lost to Follow-up|6|||
156633825|NCT05204563|565404100|FG001|Overall Study|Lost to Follow-up|3|||
156633826|NCT05204563|565404099|FG000|Overall Study|Withdrawal by Subject|12|||
156633827|NCT05204563|565404100|FG001|Overall Study|Withdrawal by Subject|3|||
156633828|NCT05204563|565404099|FG000|Overall Study|Enrolled, Not Treated|1|||
156633829|NCT05204563|565404100|FG001|Overall Study|Enrolled, Not Treated|0|||
156633830|NCT04411641|565404101|FG000|DB Period|Other|7|||
156633831|NCT04411641|565404102|FG001|DB Period|Other|27|||
156633832|NCT04411641|565404103|FG002|DB Period|Other|0|||
156633833|NCT04411641|565404104|FG003|DB Period|Other|0|||
156633834|NCT04411641|565404101|FG000|DB Period|Withdrawal by Subject|67|||
156633835|NCT04411641|565404102|FG001|DB Period|Withdrawal by Subject|122|||
156633836|NCT04411641|565404103|FG002|DB Period|Withdrawal by Subject|0|||
156633837|NCT04411641|565404104|FG003|DB Period|Withdrawal by Subject|0|||
156633838|NCT04411641|565404101|FG000|DB Period|Progressive disease|76|||
156633839|NCT04411641|565404102|FG001|DB Period|Progressive disease|116|||
156633840|NCT04411641|565404103|FG002|DB Period|Progressive disease|0|||
156633841|NCT04411641|565404104|FG003|DB Period|Progressive disease|0|||
156633842|NCT04411641|565404101|FG000|DB Period|Poor compliance to protocol|1|||
156633843|NCT04411641|565404102|FG001|DB Period|Poor compliance to protocol|5|||
156633844|NCT04411641|565404103|FG002|DB Period|Poor compliance to protocol|0|||
156633845|NCT04411641|565404104|FG003|DB Period|Poor compliance to protocol|0|||
156633846|NCT04411641|565404101|FG000|DB Period|Lack of Efficacy|19|||
156633847|NCT04411641|565404102|FG001|DB Period|Lack of Efficacy|19|||
156633848|NCT04411641|565404103|FG002|DB Period|Lack of Efficacy|0|||
156633849|NCT04411641|565404104|FG003|DB Period|Lack of Efficacy|0|||
156633850|NCT04411641|565404101|FG000|DB Period|Adverse Event|13|||
156633851|NCT04411641|565404102|FG001|DB Period|Adverse Event|29|||
156633852|NCT04411641|565404103|FG002|DB Period|Adverse Event|0|||
156633853|NCT04411641|565404104|FG003|DB Period|Adverse Event|0|||
156633854|NCT04411641|565404101|FG000|DB Period|Randomized and not treated|2|||
156633855|NCT04411641|565404102|FG001|DB Period|Randomized and not treated|2|||
156633856|NCT04411641|565404103|FG002|DB Period|Randomized and not treated|0|||
156633857|NCT04411641|565404104|FG003|DB Period|Randomized and not treated|0|||
156633858|NCT04411641|565404101|FG000|OL|Withdrawal by Subject|0|||
156633859|NCT04411641|565404102|FG001|OL|Withdrawal by Subject|0|||
156633860|NCT04411641|565404103|FG002|OL|Withdrawal by Subject|6|||
156633861|NCT04411641|565404104|FG003|OL|Withdrawal by Subject|17|||
156633862|NCT04411641|565404101|FG000|OL|Progressive disease|0|||
156633863|NCT04411641|565404102|FG001|OL|Progressive disease|0|||
156633864|NCT04411641|565404103|FG002|OL|Progressive disease|1|||
156633865|NCT04411641|565404104|FG003|OL|Progressive disease|2|||
156633866|NCT04411641|565404101|FG000|OL|Poor compliance to protocol|0|||
156633867|NCT04411641|565404102|FG001|OL|Poor compliance to protocol|0|||
156633868|NCT04411641|565404103|FG002|OL|Poor compliance to protocol|1|||
156633869|NCT04411641|565404104|FG003|OL|Poor compliance to protocol|0|||
156633870|NCT04411641|565404101|FG000|OL|Adverse Event|0|||
156633871|NCT04411641|565404102|FG001|OL|Adverse Event|0|||
156633872|NCT04411641|565404103|FG002|OL|Adverse Event|1|||
156633873|NCT04411641|565404104|FG003|OL|Adverse Event|0|||
156633874|NCT04411641|565404101|FG000|OL|Other|0|||
156633875|NCT04411641|565404102|FG001|OL|Other|0|||
156633876|NCT04411641|565404103|FG002|OL|Other|0|||
156633877|NCT04411641|565404104|FG003|OL|Other|6|||
156633878|NCT02268214|565404109|FG000|Overall Study|Subject no longer meets study criteria|0|||
156633879|NCT02268214|565404110|FG001|Overall Study|Subject no longer meets study criteria|2|||
156633880|NCT02268214|565404111|FG002|Overall Study|Subject no longer meets study criteria|0|||
156633881|NCT02268214|565404109|FG000|Overall Study|Pregnancy|2|||
156633882|NCT02268214|565404110|FG001|Overall Study|Pregnancy|2|||
156633883|NCT02268214|565404111|FG002|Overall Study|Pregnancy|1|||
156633884|NCT02268214|565404109|FG000|Overall Study|Lost to Follow-up|3|||
156633885|NCT02268214|565404110|FG001|Overall Study|Lost to Follow-up|3|||
156633886|NCT02268214|565404111|FG002|Overall Study|Lost to Follow-up|4|||
156633887|NCT02268214|565404109|FG000|Overall Study|Lack of Efficacy|1|||
156633888|NCT02268214|565404110|FG001|Overall Study|Lack of Efficacy|0|||
156633889|NCT02268214|565404111|FG002|Overall Study|Lack of Efficacy|2|||
156633890|NCT02268214|565404109|FG000|Overall Study|Adverse Event|11|||
156633891|NCT02268214|565404110|FG001|Overall Study|Adverse Event|14|||
156633892|NCT02268214|565404111|FG002|Overall Study|Adverse Event|9|||
156633893|NCT02268214|565404109|FG000|Overall Study|Withdrawal by Subject|4|||
156633894|NCT02268214|565404110|FG001|Overall Study|Withdrawal by Subject|5|||
156633895|NCT02268214|565404111|FG002|Overall Study|Withdrawal by Subject|10|||
156633896|NCT02268214|565404109|FG000|Overall Study|Subject request to discontinue treatment|10|||
156633897|NCT02268214|565404110|FG001|Overall Study|Subject request to discontinue treatment|8|||
156633898|NCT02268214|565404111|FG002|Overall Study|Subject request to discontinue treatment|6|||
156633899|NCT02268214|565404109|FG000|Overall Study|Poor/non-compliance|2|||
156633900|NCT02268214|565404110|FG001|Overall Study|Poor/non-compliance|1|||
156633901|NCT02268214|565404111|FG002|Overall Study|Poor/non-compliance|2|||
156633902|NCT02268214|565404109|FG000|Overall Study|Other reasons|7|||
156633903|NCT02268214|565404110|FG001|Overall Study|Other reasons|3|||
156633904|NCT02268214|565404111|FG002|Overall Study|Other reasons|3|||
156633905|NCT02268214|565404109|FG000|Overall Study|Not entering long-term period|2|||
156633906|NCT02268214|565404110|FG001|Overall Study|Not entering long-term period|3|||
156633907|NCT02268214|565404111|FG002|Overall Study|Not entering long-term period|5|||
156633908|NCT04342390|565404112|FG000|Overall Study|Lost to Follow-up|3|||
156633909|NCT04342390|565404113|FG001|Overall Study|Lost to Follow-up|0|||
156633910|NCT02951130|565404114|FG000|Overall Study|Protocol Violation|1|||
156633911|NCT02951130|565404115|FG001|Overall Study|Protocol Violation|1|||
156633912|NCT04584294|565404116|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
156633913|NCT04584294|565404117|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
156633914|NCT04584294|565404116|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
156633915|NCT04584294|565404117|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
156633916|NCT04584294|565404116|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
156633917|NCT04584294|565404117|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
156633918|NCT04584294|565404116|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
156633919|NCT04584294|565404117|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
156633920|NCT04584294|565404116|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
156633921|NCT04584294|565404117|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
156633922|NCT04584294|565404116|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
156633923|NCT04584294|565404117|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
156633924|NCT01119118|565404128|FG000|Overall Study|Adverse Event|1|||
156633925|NCT02711306|565404129|FG000|Overall Study|Withdrawal by Subject|2|||
156633926|NCT02711306|565404130|FG001|Overall Study|Withdrawal by Subject|2|||
156633927|NCT00157820|565404135|FG000|Randomized|Physician Decision|4|||
156633928|NCT00157820|565404136|FG001|Randomized|Physician Decision|2|||
156633929|NCT00157820|565404137|FG002|Randomized|Physician Decision|3|||
156633930|NCT00157820|565404135|FG000|Randomized|Withdrawal by Subject|1|||
156633931|NCT00157820|565404136|FG001|Randomized|Withdrawal by Subject|2|||
156633932|NCT00157820|565404137|FG002|Randomized|Withdrawal by Subject|3|||
156633933|NCT00157820|565404135|FG000|Randomized|Protocol Violation|2|||
156633934|NCT00157820|565404136|FG001|Randomized|Protocol Violation|1|||
156633935|NCT00157820|565404137|FG002|Randomized|Protocol Violation|2|||
156633936|NCT00157820|565404135|FG000|1st 8 Month|Death|7|||
156633937|NCT00157820|565404136|FG001|1st 8 Month|Death|8|||
156633938|NCT00157820|565404137|FG002|1st 8 Month|Death|3|||
156633939|NCT00157820|565404135|FG000|1st 8 Month|Lost to Follow-up|1|||
156633940|NCT00157820|565404136|FG001|1st 8 Month|Lost to Follow-up|2|||
156633941|NCT00157820|565404137|FG002|1st 8 Month|Lost to Follow-up|1|||
156633942|NCT00157820|565404135|FG000|1st 8 Month|Premature cross-over|0|||
156633943|NCT00157820|565404136|FG001|1st 8 Month|Premature cross-over|2|||
156633944|NCT00157820|565404137|FG002|1st 8 Month|Premature cross-over|2|||
156633945|NCT00157820|565404135|FG000|2nd 8 Months|Death|3|||
156633946|NCT00157820|565404136|FG001|2nd 8 Months|Death|1|||
156633947|NCT00157820|565404137|FG002|2nd 8 Months|Death|3|||
156633948|NCT00157820|565404135|FG000|2nd 8 Months|Lost to Follow-up|1|||
156633949|NCT00157820|565404136|FG001|2nd 8 Months|Lost to Follow-up|5|||
156633950|NCT00157820|565404137|FG002|2nd 8 Months|Lost to Follow-up|2|||
156633951|NCT00157820|565404135|FG000|2nd 8 Months|Premature cross-over|1|||
156633952|NCT00157820|565404136|FG001|2nd 8 Months|Premature cross-over|7|||
156633953|NCT00157820|565404137|FG002|2nd 8 Months|Premature cross-over|9|||
156633954|NCT02207413|565404138|FG000|Overall Study|Withdrawal by Subject|1|||
156633955|NCT02207413|565404139|FG001|Overall Study|Withdrawal by Subject|0|||
156633956|NCT02207413|565404140|FG002|Overall Study|Withdrawal by Subject|0|||
156633957|NCT02207413|565404141|FG003|Overall Study|Withdrawal by Subject|0|||
156633958|NCT02207413|565404142|FG004|Overall Study|Withdrawal by Subject|3|||
156633959|NCT02207413|565404143|FG005|Overall Study|Withdrawal by Subject|7|||
156633960|NCT02207413|565404138|FG000|Overall Study|Lost to Follow-up|0|||
156633961|NCT02207413|565404139|FG001|Overall Study|Lost to Follow-up|0|||
156633962|NCT02207413|565404140|FG002|Overall Study|Lost to Follow-up|0|||
156633963|NCT02207413|565404141|FG003|Overall Study|Lost to Follow-up|1|||
156633964|NCT02207413|565404142|FG004|Overall Study|Lost to Follow-up|1|||
156633965|NCT02207413|565404143|FG005|Overall Study|Lost to Follow-up|5|||
156633966|NCT02207413|565404138|FG000|Overall Study|Adverse Event|0|||
156633967|NCT02207413|565404139|FG001|Overall Study|Adverse Event|0|||
156633968|NCT02207413|565404140|FG002|Overall Study|Adverse Event|0|||
156633969|NCT02207413|565404141|FG003|Overall Study|Adverse Event|0|||
156633970|NCT02207413|565404142|FG004|Overall Study|Adverse Event|2|||
156633971|NCT02207413|565404143|FG005|Overall Study|Adverse Event|1|||
156633972|NCT02207413|565404138|FG000|Overall Study|Migrated/moved from study area|0|||
156633973|NCT02207413|565404139|FG001|Overall Study|Migrated/moved from study area|0|||
156633974|NCT02207413|565404140|FG002|Overall Study|Migrated/moved from study area|0|||
156633975|NCT02207413|565404141|FG003|Overall Study|Migrated/moved from study area|0|||
156633976|NCT02207413|565404142|FG004|Overall Study|Migrated/moved from study area|1|||
156633977|NCT02207413|565404143|FG005|Overall Study|Migrated/moved from study area|0|||
156633978|NCT04075656|565404144|FG000|Overall Study|Withdrawal by Subject|5|||
156633979|NCT04075656|565404145|FG001|Overall Study|Withdrawal by Subject|5|||
156633980|NCT01317199|565405736|FG000|Dose-escalation Phase 1|Physician Decision|5|||
156633981|NCT01317199|565405737|FG001|Dose-escalation Phase 1|Physician Decision|0|||
156633982|NCT01317199|565405738|FG002|Dose-escalation Phase 1|Physician Decision|0|||
156633983|NCT01317199|565405739|FG003|Dose-escalation Phase 1|Physician Decision|0|||
156633984|NCT01317199|565405736|FG000|Dose-escalation Phase 1|Disease progression|1|||
156633985|NCT01317199|565405737|FG001|Dose-escalation Phase 1|Disease progression|0|||
156633986|NCT01317199|565405738|FG002|Dose-escalation Phase 1|Disease progression|0|||
156633987|NCT01317199|565405739|FG003|Dose-escalation Phase 1|Disease progression|0|||
156633988|NCT01317199|565405736|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
156633989|NCT01317199|565405737|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
156633990|NCT01317199|565405738|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
156633991|NCT01317199|565405739|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
156633992|NCT01317199|565405736|FG000|Randomized Phase 2|Disease progression|0|||
156633993|NCT01317199|565405737|FG001|Randomized Phase 2|Disease progression|3|||
156633994|NCT01317199|565405738|FG002|Randomized Phase 2|Disease progression|7|||
156633995|NCT01317199|565405739|FG003|Randomized Phase 2|Disease progression|5|||
156633996|NCT01317199|565405736|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
156633997|NCT01317199|565405737|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
156633998|NCT01317199|565405738|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
156633999|NCT01317199|565405739|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
156634000|NCT01317199|565405736|FG000|Randomized Phase 2|Adverse Event|0|||
156634001|NCT01317199|565405737|FG001|Randomized Phase 2|Adverse Event|0|||
156634002|NCT01317199|565405738|FG002|Randomized Phase 2|Adverse Event|0|||
156634003|NCT01317199|565405739|FG003|Randomized Phase 2|Adverse Event|1|||
156634004|NCT01317199|565405736|FG000|Randomized Phase 2|Comorbidities|0|||
156634005|NCT01317199|565405737|FG001|Randomized Phase 2|Comorbidities|2|||
156634006|NCT01317199|565405738|FG002|Randomized Phase 2|Comorbidities|2|||
156634007|NCT01317199|565405739|FG003|Randomized Phase 2|Comorbidities|2|||
156634008|NCT01317199|565405736|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
156634009|NCT01317199|565405737|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
156634010|NCT01317199|565405738|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
156634011|NCT01317199|565405739|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
156634012|NCT01317199|565405736|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
156634013|NCT01317199|565405737|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
156634014|NCT01317199|565405738|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
156634015|NCT01317199|565405739|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
156634016|NCT01317199|565405736|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
156634017|NCT01317199|565405737|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
156634018|NCT01317199|565405738|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
156634019|NCT01317199|565405739|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
156634020|NCT01317199|565405736|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
156634021|NCT01317199|565405737|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
156635573|NCT00602667|565409961|FG001|Overall Study|Physician Decision|3|||
156634022|NCT01317199|565405738|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
156634023|NCT01317199|565405739|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
156634024|NCT01353209|565405740|FG000|Overall Study|Adverse Event|1|||
156634025|NCT01353209|565405741|FG001|Overall Study|Adverse Event|1|||
156634026|NCT01301625|565405743|FG000|Overall Study|Death|5|||
156634027|NCT01301625|565405743|FG000|Overall Study|Not Due|21|||
156634028|NCT01301625|565405743|FG000|Overall Study|Expected|8|||
156634029|NCT01301625|565405743|FG000|Overall Study|Lost to Follow-up|1|||
156634030|NCT02684370|565405746|FG000|Part A|Adverse Event|2|||
156634031|NCT02684370|565405747|FG001|Part A|Adverse Event|0|||
156634032|NCT02684370|565405748|FG002|Part A|Adverse Event|1|||
156634033|NCT02684370|565405749|FG003|Part A|Adverse Event|0|||
156634034|NCT02684370|565405750|FG004|Part A|Adverse Event|0|||
156634035|NCT02684370|565405751|FG005|Part A|Adverse Event|0|||
156634036|NCT02684370|565405746|FG000|Part A|Lost to Follow-up|1|||
156634037|NCT02684370|565405747|FG001|Part A|Lost to Follow-up|1|||
156634038|NCT02684370|565405748|FG002|Part A|Lost to Follow-up|0|||
156634039|NCT02684370|565405749|FG003|Part A|Lost to Follow-up|0|||
156634040|NCT02684370|565405750|FG004|Part A|Lost to Follow-up|0|||
156634041|NCT02684370|565405751|FG005|Part A|Lost to Follow-up|0|||
156634042|NCT02684370|565405746|FG000|Part A|Subject Withdrawal|1|||
156634043|NCT02684370|565405747|FG001|Part A|Subject Withdrawal|0|||
156634044|NCT02684370|565405748|FG002|Part A|Subject Withdrawal|3|||
156634045|NCT02684370|565405749|FG003|Part A|Subject Withdrawal|0|||
156634046|NCT02684370|565405750|FG004|Part A|Subject Withdrawal|0|||
156634047|NCT02684370|565405751|FG005|Part A|Subject Withdrawal|0|||
156634048|NCT02684370|565405746|FG000|Part A|Other|0|||
156634049|NCT02684370|565405747|FG001|Part A|Other|0|||
156634050|NCT02684370|565405748|FG002|Part A|Other|1|||
156634051|NCT02684370|565405749|FG003|Part A|Other|0|||
156634052|NCT02684370|565405750|FG004|Part A|Other|0|||
156634053|NCT02684370|565405751|FG005|Part A|Other|0|||
156634054|NCT02684370|565405746|FG000|Part B|Adverse Event|0|||
156634055|NCT02684370|565405747|FG001|Part B|Adverse Event|0|||
156634056|NCT02684370|565405748|FG002|Part B|Adverse Event|0|||
156634057|NCT02684370|565405749|FG003|Part B|Adverse Event|0|||
156634058|NCT02684370|565405750|FG004|Part B|Adverse Event|2|||
156634059|NCT02684370|565405751|FG005|Part B|Adverse Event|1|||
156634060|NCT02684370|565405746|FG000|Part B|Lost to Follow-up|0|||
156634061|NCT02684370|565405747|FG001|Part B|Lost to Follow-up|0|||
156634062|NCT02684370|565405748|FG002|Part B|Lost to Follow-up|0|||
156634063|NCT02684370|565405749|FG003|Part B|Lost to Follow-up|1|||
156634064|NCT02684370|565405750|FG004|Part B|Lost to Follow-up|2|||
156634065|NCT02684370|565405751|FG005|Part B|Lost to Follow-up|5|||
156634066|NCT02684370|565405746|FG000|Part B|Subject Withdrawal|0|||
156634067|NCT02684370|565405747|FG001|Part B|Subject Withdrawal|0|||
156634068|NCT02684370|565405748|FG002|Part B|Subject Withdrawal|0|||
156634069|NCT02684370|565405749|FG003|Part B|Subject Withdrawal|1|||
156634070|NCT02684370|565405750|FG004|Part B|Subject Withdrawal|1|||
156634071|NCT02684370|565405751|FG005|Part B|Subject Withdrawal|2|||
156634072|NCT02181673|565405754|FG000|Up to Week 24|Adverse Event|2|||
156634073|NCT02181673|565405755|FG001|Up to Week 24|Adverse Event|0|||
156634074|NCT02181673|565405756|FG002|Up to Week 24|Adverse Event|3|||
156634075|NCT02181673|565405754|FG000|Up to Week 24|Death|1|||
156634076|NCT02181673|565405755|FG001|Up to Week 24|Death|0|||
156634077|NCT02181673|565405756|FG002|Up to Week 24|Death|0|||
156634078|NCT02181673|565405754|FG000|Up to Week 24|Lack of Efficacy|1|||
156634079|NCT02181673|565405755|FG001|Up to Week 24|Lack of Efficacy|0|||
156634080|NCT02181673|565405756|FG002|Up to Week 24|Lack of Efficacy|0|||
156634081|NCT02181673|565405754|FG000|Up to Week 24|Lost to Follow-up|1|||
156634082|NCT02181673|565405755|FG001|Up to Week 24|Lost to Follow-up|0|||
156634083|NCT02181673|565405756|FG002|Up to Week 24|Lost to Follow-up|0|||
156634084|NCT02181673|565405754|FG000|Up to Week 24|Physician Decision|0|||
156634085|NCT02181673|565405755|FG001|Up to Week 24|Physician Decision|0|||
156634086|NCT02181673|565405756|FG002|Up to Week 24|Physician Decision|3|||
156634087|NCT02181673|565405754|FG000|Up to Week 24|Withdrawal by Subject|10|||
156634088|NCT02181673|565405755|FG001|Up to Week 24|Withdrawal by Subject|0|||
156634089|NCT02181673|565405756|FG002|Up to Week 24|Withdrawal by Subject|1|||
156634090|NCT02181673|565405754|FG000|Up to Week 24|Other|2|||
156634091|NCT02181673|565405755|FG001|Up to Week 24|Other|0|||
156634092|NCT02181673|565405756|FG002|Up to Week 24|Other|3|||
156634093|NCT02181673|565405754|FG000|Up to Week 24|Randomized not Treated|0|||
156634094|NCT02181673|565405755|FG001|Up to Week 24|Randomized not Treated|0|||
156634095|NCT02181673|565405756|FG002|Up to Week 24|Randomized not Treated|1|||
156634096|NCT02181673|565405754|FG000|Week 24-Week 60|Adverse Event|0|||
156634097|NCT02181673|565405755|FG001|Week 24-Week 60|Adverse Event|4|||
156634098|NCT02181673|565405756|FG002|Week 24-Week 60|Adverse Event|10|||
156634099|NCT02181673|565405754|FG000|Week 24-Week 60|Other|0|||
156634100|NCT02181673|565405755|FG001|Week 24-Week 60|Other|2|||
156634101|NCT02181673|565405756|FG002|Week 24-Week 60|Other|1|||
156634102|NCT02181673|565405754|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
156634103|NCT02181673|565405755|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
156634104|NCT02181673|565405756|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
156634105|NCT02181673|565405754|FG000|Week 24-Week 60|Pregnancy|0|||
156634106|NCT02181673|565405755|FG001|Week 24-Week 60|Pregnancy|0|||
156634107|NCT02181673|565405756|FG002|Week 24-Week 60|Pregnancy|1|||
156634108|NCT02181673|565405754|FG000|Week 24-Week 60|Lack of Efficacy|0|||
156634109|NCT02181673|565405755|FG001|Week 24-Week 60|Lack of Efficacy|0|||
156634110|NCT02181673|565405756|FG002|Week 24-Week 60|Lack of Efficacy|1|||
156634111|NCT02181673|565405754|FG000|Week 24-Week 60|Lost to Follow-up|0|||
156634112|NCT02181673|565405755|FG001|Week 24-Week 60|Lost to Follow-up|0|||
156634113|NCT02181673|565405756|FG002|Week 24-Week 60|Lost to Follow-up|1|||
156634114|NCT02181673|565405754|FG000|Week 24-Week 60|Physician Decision|0|||
156634115|NCT02181673|565405755|FG001|Week 24-Week 60|Physician Decision|0|||
156634116|NCT02181673|565405756|FG002|Week 24-Week 60|Physician Decision|1|||
156634117|NCT00320801|565405759|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
156634118|NCT00320801|565405760|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
156634119|NCT00320801|565405761|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
156634120|NCT00320801|565405762|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
156634121|NCT00320801|565405759|FG000|Open-label Run-in Period|Adverse Event|33|||
156634122|NCT00320801|565405760|FG001|Open-label Run-in Period|Adverse Event|0|||
156634123|NCT00320801|565405761|FG002|Open-label Run-in Period|Adverse Event|0|||
156634124|NCT00320801|565405762|FG003|Open-label Run-in Period|Adverse Event|0|||
156634125|NCT00320801|565405759|FG000|Open-label Run-in Period|Administrative|10|||
156634126|NCT00320801|565405760|FG001|Open-label Run-in Period|Administrative|0|||
156634127|NCT00320801|565405761|FG002|Open-label Run-in Period|Administrative|0|||
156634128|NCT00320801|565405762|FG003|Open-label Run-in Period|Administrative|0|||
156634129|NCT00320801|565405759|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
156634130|NCT00320801|565405760|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
156634131|NCT00320801|565405761|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
156634132|NCT00320801|565405762|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
156634133|NCT00320801|565405759|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
156634134|NCT00320801|565405760|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
156634135|NCT00320801|565405761|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
156634136|NCT00320801|565405762|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
156634137|NCT00320801|565405759|FG000|Open-label Run-in Period|Did not qualify|1|||
156634138|NCT00320801|565405760|FG001|Open-label Run-in Period|Did not qualify|0|||
156634139|NCT00320801|565405761|FG002|Open-label Run-in Period|Did not qualify|0|||
156634140|NCT00320801|565405762|FG003|Open-label Run-in Period|Did not qualify|0|||
156634141|NCT00320801|565405759|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156634142|NCT00320801|565405760|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156634143|NCT00320801|565405761|FG002|Double-blind Phase|Withdrawal by Subject|1|||
156634144|NCT00320801|565405762|FG003|Double-blind Phase|Withdrawal by Subject|0|||
156634145|NCT00320801|565405759|FG000|Double-blind Phase|Adverse Event|0|||
156634146|NCT00320801|565405760|FG001|Double-blind Phase|Adverse Event|2|||
156634147|NCT00320801|565405761|FG002|Double-blind Phase|Adverse Event|8|||
156634148|NCT00320801|565405762|FG003|Double-blind Phase|Adverse Event|0|||
156634149|NCT00320801|565405759|FG000|Double-blind Phase|Administrative|0|||
156634150|NCT00320801|565405760|FG001|Double-blind Phase|Administrative|0|||
156634151|NCT00320801|565405761|FG002|Double-blind Phase|Administrative|4|||
156634152|NCT00320801|565405762|FG003|Double-blind Phase|Administrative|0|||
156634153|NCT00320801|565405759|FG000|Double-blind Phase|Lack of Efficacy|0|||
156634154|NCT00320801|565405760|FG001|Double-blind Phase|Lack of Efficacy|9|||
156634155|NCT00320801|565405761|FG002|Double-blind Phase|Lack of Efficacy|1|||
156634156|NCT00320801|565405762|FG003|Double-blind Phase|Lack of Efficacy|0|||
156634157|NCT00320801|565405759|FG000|Extension Phase|Withdrawal by Subject|0|||
156634158|NCT00320801|565405760|FG001|Extension Phase|Withdrawal by Subject|0|||
156634159|NCT00320801|565405761|FG002|Extension Phase|Withdrawal by Subject|0|||
156634160|NCT00320801|565405762|FG003|Extension Phase|Withdrawal by Subject|6|||
156634161|NCT00320801|565405759|FG000|Extension Phase|Adverse Event|0|||
156634162|NCT00320801|565405760|FG001|Extension Phase|Adverse Event|0|||
156634163|NCT00320801|565405761|FG002|Extension Phase|Adverse Event|0|||
156634164|NCT00320801|565405762|FG003|Extension Phase|Adverse Event|8|||
156634165|NCT00320801|565405759|FG000|Extension Phase|Administrative|0|||
156634166|NCT00320801|565405760|FG001|Extension Phase|Administrative|0|||
156634167|NCT00320801|565405761|FG002|Extension Phase|Administrative|0|||
156634168|NCT00320801|565405762|FG003|Extension Phase|Administrative|29|||
156634169|NCT00320801|565405759|FG000|Extension Phase|Lack of Efficacy|0|||
156634170|NCT00320801|565405760|FG001|Extension Phase|Lack of Efficacy|0|||
156634171|NCT00320801|565405761|FG002|Extension Phase|Lack of Efficacy|0|||
156634172|NCT00320801|565405762|FG003|Extension Phase|Lack of Efficacy|2|||
156634173|NCT00320801|565405759|FG000|Extension Phase|Lost to Follow-up|0|||
156634174|NCT00320801|565405760|FG001|Extension Phase|Lost to Follow-up|0|||
156634175|NCT00320801|565405761|FG002|Extension Phase|Lost to Follow-up|0|||
156634176|NCT00320801|565405762|FG003|Extension Phase|Lost to Follow-up|3|||
156634177|NCT00337727|565405763|FG000|Overall Study|Adverse Event|5|||
156634178|NCT00337727|565405764|FG001|Overall Study|Adverse Event|3|||
156634179|NCT00337727|565405763|FG000|Overall Study|Lost to Follow-up|5|||
156634180|NCT00337727|565405764|FG001|Overall Study|Lost to Follow-up|4|||
156634181|NCT00337727|565405763|FG000|Overall Study|Physician Decision|1|||
156634182|NCT00337727|565405764|FG001|Overall Study|Physician Decision|0|||
156634183|NCT00337727|565405763|FG000|Overall Study|Protocol Violation|4|||
156634184|NCT00337727|565405764|FG001|Overall Study|Protocol Violation|0|||
156634185|NCT00337727|565405763|FG000|Overall Study|Withdrawal by Subject|3|||
156634186|NCT00337727|565405764|FG001|Overall Study|Withdrawal by Subject|5|||
156634187|NCT00491322|565405766|FG000|Overall Study|Protocol Violation|1|||
156634188|NCT00491322|565405767|FG001|Overall Study|Protocol Violation|0|||
156634189|NCT00491322|565405766|FG000|Overall Study|Pregnancy|0|||
156634190|NCT00491322|565405767|FG001|Overall Study|Pregnancy|1|||
156634191|NCT06067191|565405773|FG000|Overall Study|Withdrawal by Subject|0|||
156634192|NCT06067191|565405774|FG001|Overall Study|Withdrawal by Subject|1|||
156634193|NCT00807040|565405775|FG000|Overall Study|Death|24|||
156634194|NCT00807040|565405776|FG001|Overall Study|Death|29|||
156634195|NCT00807040|565405775|FG000|Overall Study|Withdrawal by Subject|8|||
156634196|NCT00807040|565405776|FG001|Overall Study|Withdrawal by Subject|6|||
156634197|NCT00807040|565405775|FG000|Overall Study|Lost to Follow-up|4|||
156634198|NCT00807040|565405776|FG001|Overall Study|Lost to Follow-up|6|||
156634199|NCT00806416|565405778|FG000|Period 1 - Part I|Adverse Event|0|||
156634200|NCT00806416|565405779|FG001|Period 1 - Part I|Adverse Event|1|||
156634201|NCT00806416|565405780|FG002|Period 1 - Part I|Adverse Event|0|||
156634202|NCT00806416|565405781|FG003|Period 1 - Part I|Adverse Event|0|||
156634203|NCT00806416|565405778|FG000|Period 1 - Part I|Lost to Follow-up|0|||
156634204|NCT00806416|565405779|FG001|Period 1 - Part I|Lost to Follow-up|2|||
156634205|NCT00806416|565405780|FG002|Period 1 - Part I|Lost to Follow-up|0|||
156634206|NCT00806416|565405781|FG003|Period 1 - Part I|Lost to Follow-up|0|||
156634207|NCT00806416|565405778|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
156634208|NCT00806416|565405779|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
156634209|NCT00806416|565405780|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
156634210|NCT00806416|565405781|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
156634211|NCT00806416|565405778|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
156634212|NCT00806416|565405779|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
156634213|NCT00806416|565405780|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
156634214|NCT00806416|565405781|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
156634215|NCT01244516|565405785|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
156634216|NCT01244516|565405786|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
156634217|NCT01244516|565405787|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
156634218|NCT01244516|565405785|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
156634219|NCT01244516|565405786|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
156634220|NCT01244516|565405787|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
156634221|NCT01244516|565405785|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
156634222|NCT01244516|565405786|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
156634223|NCT01244516|565405787|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
156634224|NCT01244516|565405785|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
156634225|NCT01244516|565405786|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
156634226|NCT01244516|565405787|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
156634227|NCT01244516|565405785|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
156634228|NCT01244516|565405786|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
156634229|NCT01244516|565405787|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
156634230|NCT01244516|565405785|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
156634231|NCT01244516|565405786|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
156634232|NCT01244516|565405787|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
156634233|NCT01244516|565405785|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
156634234|NCT01244516|565405786|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
156634235|NCT01244516|565405787|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
156634236|NCT01102972|565405790|FG000|Overall Study|Adverse Event|8|||
156634237|NCT01102972|565405791|FG001|Overall Study|Adverse Event|2|||
156634238|NCT01102972|565405790|FG000|Overall Study|Lack of Efficacy|2|||
156634239|NCT01102972|565405791|FG001|Overall Study|Lack of Efficacy|1|||
156634240|NCT01102972|565405790|FG000|Overall Study|Protocol Violation|1|||
156634241|NCT01102972|565405791|FG001|Overall Study|Protocol Violation|0|||
156634242|NCT01102972|565405790|FG000|Overall Study|Lost to Follow-up|10|||
156634243|NCT01102972|565405791|FG001|Overall Study|Lost to Follow-up|5|||
156634244|NCT01102972|565405790|FG000|Overall Study|Investigator Discretion|2|||
156634245|NCT01102972|565405791|FG001|Overall Study|Investigator Discretion|0|||
156634246|NCT01102972|565405790|FG000|Overall Study|Withdrawal by Subject|6|||
156634247|NCT01102972|565405791|FG001|Overall Study|Withdrawal by Subject|6|||
156634248|NCT03664024|565405795|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
156634249|NCT03664024|565405795|FG000|Overall Study|Lost to Follow-up|2|||
156634250|NCT03664024|565405795|FG000|Overall Study|Withdrawal by Subject|2|||
156634251|NCT03664024|565405795|FG000|Overall Study|Death|80|||
156634252|NCT01157065|565405796|FG000|Overall Study|Death|0|||
156634253|NCT01157065|565405797|FG001|Overall Study|Death|1|||
156634254|NCT05275673|565405800|FG000|Overall Study|Study Termination by Sponsor|2|||
156634255|NCT05275673|565405801|FG001|Overall Study|Study Termination by Sponsor|3|||
156634256|NCT05275673|565405800|FG000|Overall Study|Death|1|||
156634257|NCT05275673|565405801|FG001|Overall Study|Death|0|||
156634258|NCT05275673|565405800|FG000|Overall Study|Withdrawal by Subject|1|||
156634259|NCT05275673|565405801|FG001|Overall Study|Withdrawal by Subject|0|||
156634260|NCT02325739|565405802|FG000|Phase I Part|Adverse Event|1|||
156634261|NCT02325739|565405803|FG001|Phase I Part|Adverse Event|0|||
156634262|NCT02325739|565405804|FG002|Phase I Part|Adverse Event|1|||
156634263|NCT02325739|565405805|FG003|Phase I Part|Adverse Event|2|||
156634264|NCT02325739|565405806|FG004|Phase I Part|Adverse Event|3|||
156634265|NCT02325739|565405807|FG005|Phase I Part|Adverse Event|1|||
156634266|NCT02325739|565405808|FG006|Phase I Part|Adverse Event|0|||
156634267|NCT02325739|565405809|FG007|Phase I Part|Adverse Event|2|||
156634268|NCT02325739|565405810|FG008|Phase I Part|Adverse Event|0|||
156634269|NCT02325739|565405811|FG009|Phase I Part|Adverse Event|0|||
156634270|NCT02325739|565405812|FG010|Phase I Part|Adverse Event|0|||
156634271|NCT02325739|565405802|FG000|Phase I Part|Progressive disease|9|||
156634272|NCT02325739|565405803|FG001|Phase I Part|Progressive disease|6|||
156634273|NCT02325739|565405804|FG002|Phase I Part|Progressive disease|3|||
156634274|NCT02325739|565405805|FG003|Phase I Part|Progressive disease|23|||
156634275|NCT02325739|565405806|FG004|Phase I Part|Progressive disease|14|||
156634276|NCT02325739|565405807|FG005|Phase I Part|Progressive disease|6|||
156634277|NCT02325739|565405808|FG006|Phase I Part|Progressive disease|6|||
156634278|NCT02325739|565405809|FG007|Phase I Part|Progressive disease|3|||
156634279|NCT02325739|565405810|FG008|Phase I Part|Progressive disease|0|||
156634280|NCT02325739|565405811|FG009|Phase I Part|Progressive disease|0|||
156634281|NCT02325739|565405812|FG010|Phase I Part|Progressive disease|0|||
156634282|NCT02325739|565405802|FG000|Phase I Part|Subject/guardian decision|1|||
156634283|NCT02325739|565405803|FG001|Phase I Part|Subject/guardian decision|0|||
156634284|NCT02325739|565405804|FG002|Phase I Part|Subject/guardian decision|1|||
156634285|NCT02325739|565405805|FG003|Phase I Part|Subject/guardian decision|1|||
156634286|NCT02325739|565405806|FG004|Phase I Part|Subject/guardian decision|0|||
156634287|NCT02325739|565405807|FG005|Phase I Part|Subject/guardian decision|0|||
156634288|NCT02325739|565405808|FG006|Phase I Part|Subject/guardian decision|0|||
156634289|NCT02325739|565405809|FG007|Phase I Part|Subject/guardian decision|1|||
156634290|NCT02325739|565405810|FG008|Phase I Part|Subject/guardian decision|0|||
156634291|NCT02325739|565405811|FG009|Phase I Part|Subject/guardian decision|0|||
156634292|NCT02325739|565405812|FG010|Phase I Part|Subject/guardian decision|0|||
156634293|NCT02325739|565405802|FG000|Phase I Part|Death|0|||
156634294|NCT02325739|565405803|FG001|Phase I Part|Death|0|||
156634295|NCT02325739|565405804|FG002|Phase I Part|Death|0|||
156634296|NCT02325739|565405805|FG003|Phase I Part|Death|0|||
156634297|NCT02325739|565405806|FG004|Phase I Part|Death|2|||
156634298|NCT02325739|565405807|FG005|Phase I Part|Death|0|||
156634299|NCT02325739|565405808|FG006|Phase I Part|Death|0|||
156634300|NCT02325739|565405809|FG007|Phase I Part|Death|0|||
156634301|NCT02325739|565405810|FG008|Phase I Part|Death|0|||
156634302|NCT02325739|565405811|FG009|Phase I Part|Death|0|||
156634303|NCT02325739|565405812|FG010|Phase I Part|Death|0|||
156634304|NCT02325739|565405802|FG000|Phase II Part|Adverse Event|0|||
156634305|NCT02325739|565405803|FG001|Phase II Part|Adverse Event|0|||
156634306|NCT02325739|565405804|FG002|Phase II Part|Adverse Event|0|||
156634307|NCT02325739|565405805|FG003|Phase II Part|Adverse Event|0|||
156634308|NCT02325739|565405806|FG004|Phase II Part|Adverse Event|0|||
156634309|NCT02325739|565405807|FG005|Phase II Part|Adverse Event|0|||
156634310|NCT02325739|565405808|FG006|Phase II Part|Adverse Event|0|||
156634311|NCT02325739|565405809|FG007|Phase II Part|Adverse Event|0|||
156634312|NCT02325739|565405810|FG008|Phase II Part|Adverse Event|4|||
156634313|NCT02325739|565405811|FG009|Phase II Part|Adverse Event|5|||
156634314|NCT02325739|565405812|FG010|Phase II Part|Adverse Event|1|||
156634315|NCT02325739|565405802|FG000|Phase II Part|Physician Decision|0|||
156634316|NCT02325739|565405803|FG001|Phase II Part|Physician Decision|0|||
156634317|NCT02325739|565405804|FG002|Phase II Part|Physician Decision|0|||
156634318|NCT02325739|565405805|FG003|Phase II Part|Physician Decision|0|||
156634319|NCT02325739|565405806|FG004|Phase II Part|Physician Decision|0|||
156634320|NCT02325739|565405807|FG005|Phase II Part|Physician Decision|0|||
156634321|NCT02325739|565405808|FG006|Phase II Part|Physician Decision|0|||
156634322|NCT02325739|565405809|FG007|Phase II Part|Physician Decision|0|||
156634323|NCT02325739|565405810|FG008|Phase II Part|Physician Decision|0|||
156634324|NCT02325739|565405811|FG009|Phase II Part|Physician Decision|1|||
156634325|NCT02325739|565405812|FG010|Phase II Part|Physician Decision|0|||
156634326|NCT02325739|565405802|FG000|Phase II Part|Progressive disease|0|||
156634327|NCT02325739|565405803|FG001|Phase II Part|Progressive disease|0|||
156634328|NCT02325739|565405804|FG002|Phase II Part|Progressive disease|0|||
156634329|NCT02325739|565405805|FG003|Phase II Part|Progressive disease|0|||
156634330|NCT02325739|565405806|FG004|Phase II Part|Progressive disease|0|||
156634331|NCT02325739|565405807|FG005|Phase II Part|Progressive disease|0|||
156634332|NCT02325739|565405808|FG006|Phase II Part|Progressive disease|0|||
156634333|NCT02325739|565405809|FG007|Phase II Part|Progressive disease|0|||
156634334|NCT02325739|565405810|FG008|Phase II Part|Progressive disease|22|||
156634335|NCT02325739|565405811|FG009|Phase II Part|Progressive disease|29|||
156634336|NCT02325739|565405812|FG010|Phase II Part|Progressive disease|18|||
156634337|NCT02325739|565405802|FG000|Phase II Part|Subject/guardian decision|0|||
156634338|NCT02325739|565405803|FG001|Phase II Part|Subject/guardian decision|0|||
156634339|NCT02325739|565405804|FG002|Phase II Part|Subject/guardian decision|0|||
156634340|NCT02325739|565405805|FG003|Phase II Part|Subject/guardian decision|0|||
156634341|NCT02325739|565405806|FG004|Phase II Part|Subject/guardian decision|0|||
156634342|NCT02325739|565405807|FG005|Phase II Part|Subject/guardian decision|0|||
156634343|NCT02325739|565405808|FG006|Phase II Part|Subject/guardian decision|0|||
156634344|NCT02325739|565405809|FG007|Phase II Part|Subject/guardian decision|0|||
156634345|NCT02325739|565405810|FG008|Phase II Part|Subject/guardian decision|4|||
156634346|NCT02325739|565405811|FG009|Phase II Part|Subject/guardian decision|1|||
156634347|NCT02325739|565405812|FG010|Phase II Part|Subject/guardian decision|1|||
156634348|NCT03075826|565405814|FG000|Overall Study|Withdrawal by Subject|1|||
156634349|NCT03075826|565405814|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
156634350|NCT04228107|565405815|FG000|Overall Study|Protocol Violation|1|||
156634351|NCT04228107|565405816|FG001|Overall Study|Protocol Violation|0|||
156634352|NCT04228107|565405815|FG000|Overall Study|Withdrawal by Subject|6|||
156634353|NCT04228107|565405816|FG001|Overall Study|Withdrawal by Subject|0|||
156634354|NCT04228107|565405815|FG000|Overall Study|Lost to Follow-up|18|||
156634355|NCT04228107|565405816|FG001|Overall Study|Lost to Follow-up|0|||
156634356|NCT04228107|565405815|FG000|Overall Study|No controller use data|1|||
156634357|NCT04228107|565405816|FG001|Overall Study|No controller use data|0|||
156634358|NCT04228107|565405815|FG000|Overall Study|No medication data collected|1|||
156634359|NCT04228107|565405816|FG001|Overall Study|No medication data collected|0|||
156634360|NCT00965562|565405817|FG000|Overall Study|Lost to Follow-up|1|||
156634361|NCT00965562|565405818|FG001|Overall Study|Lost to Follow-up|2|||
156634362|NCT00965562|565405819|FG002|Overall Study|Lost to Follow-up|3|||
156634363|NCT00965562|565405817|FG000|Overall Study|Withdrawal by Subject|2|||
156634364|NCT00965562|565405818|FG001|Overall Study|Withdrawal by Subject|2|||
156634365|NCT00965562|565405819|FG002|Overall Study|Withdrawal by Subject|0|||
156634366|NCT04755283|565405820|FG000|Overall Study|Withdrawal by Subject|14|||
156634367|NCT04755283|565405821|FG001|Overall Study|Withdrawal by Subject|3|||
156634368|NCT04755283|565405822|FG002|Overall Study|Withdrawal by Subject|6|||
156634369|NCT04755283|565405820|FG000|Overall Study|Lost to Follow-up|0|||
156634370|NCT04755283|565405821|FG001|Overall Study|Lost to Follow-up|0|||
156634371|NCT04755283|565405822|FG002|Overall Study|Lost to Follow-up|1|||
156634372|NCT04755283|565405820|FG000|Overall Study|Death|31|||
156634373|NCT04755283|565405821|FG001|Overall Study|Death|36|||
156634374|NCT04755283|565405822|FG002|Overall Study|Death|34|||
156634375|NCT03179462|565405825|FG000|Overall Study|screening failure|1|||
156634376|NCT03179462|565405826|FG001|Overall Study|screening failure|2|||
156634377|NCT03179462|565405827|FG002|Overall Study|screening failure|0|||
156634378|NCT05153629|565405831|FG000|Overall Study|Withdrawal by Subject|0|||
156634379|NCT05153629|565405832|FG001|Overall Study|Withdrawal by Subject|2|||
156634380|NCT04115488|565405838|FG000|Overall Study|Adverse Event|8|||
156634381|NCT04115488|565405839|FG001|Overall Study|Adverse Event|4|||
156634382|NCT04115488|565405838|FG000|Overall Study|Withdrawal by Subject|3|||
156634383|NCT04115488|565405839|FG001|Overall Study|Withdrawal by Subject|6|||
156634384|NCT04115488|565405838|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
156634385|NCT04115488|565405839|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
156634386|NCT04115488|565405838|FG000|Overall Study|Patient 's location change|1|||
156634387|NCT04115488|565405839|FG001|Overall Study|Patient 's location change|0|||
156634388|NCT04115488|565405838|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
156634389|NCT04115488|565405839|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
156634390|NCT01233284|565405854|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
156634391|NCT01233284|565405855|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
156634392|NCT01233284|565405856|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
156634393|NCT01233284|565405857|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
156634394|NCT01233284|565405858|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
156634395|NCT01233284|565405854|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
156634396|NCT01233284|565405855|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
156634397|NCT01233284|565405856|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
156634398|NCT01233284|565405857|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
156634399|NCT01233284|565405858|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
156634400|NCT01233284|565405854|FG000|Period 1 (4 Weeks)|Other|0|||
156634401|NCT01233284|565405855|FG001|Period 1 (4 Weeks)|Other|0|||
156634402|NCT01233284|565405856|FG002|Period 1 (4 Weeks)|Other|1|||
156634403|NCT01233284|565405857|FG003|Period 1 (4 Weeks)|Other|0|||
156634404|NCT01233284|565405858|FG004|Period 1 (4 Weeks)|Other|0|||
156634405|NCT01233284|565405854|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156634406|NCT01233284|565405855|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156634407|NCT01233284|565405856|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
156634408|NCT01233284|565405857|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156634409|NCT01233284|565405858|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156634410|NCT01233284|565405854|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156634411|NCT01233284|565405855|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156634412|NCT01233284|565405856|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
156634413|NCT01233284|565405857|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156634414|NCT01233284|565405858|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156634415|NCT01233284|565405854|FG000|Period 3 (4 Weeks)|Other|0|||
156634416|NCT01233284|565405855|FG001|Period 3 (4 Weeks)|Other|0|||
156634417|NCT01233284|565405856|FG002|Period 3 (4 Weeks)|Other|0|||
156634418|NCT01233284|565405857|FG003|Period 3 (4 Weeks)|Other|1|||
156634419|NCT01233284|565405858|FG004|Period 3 (4 Weeks)|Other|0|||
156634420|NCT01233284|565405854|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
156634421|NCT01233284|565405855|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
156634422|NCT01233284|565405856|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
156634423|NCT01233284|565405857|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
156634424|NCT01233284|565405858|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
156634425|NCT01233284|565405854|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
156634426|NCT01233284|565405855|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
156634427|NCT01233284|565405856|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
156634428|NCT01233284|565405857|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
156634429|NCT01233284|565405858|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
156634430|NCT05403502|565405860|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
156634431|NCT05403502|565405860|FG000|Humalog Lead-In Period|Physician Decision|2|||
156634432|NCT05403502|565405860|FG000|Humalog Lead-In Period|Protocol Violation|1|||
156634433|NCT05403502|565405860|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
156634434|NCT05403502|565405860|FG000|Lyumjev Treatment Period|Physician Decision|2|||
156634435|NCT01058707|565405861|FG000|Overall Study|Disease Progression|15|||
156634436|NCT01058707|565405862|FG001|Overall Study|Disease Progression|20|||
156634437|NCT01058707|565405863|FG002|Overall Study|Disease Progression|20|||
156634438|NCT01058707|565405864|FG003|Overall Study|Disease Progression|15|||
156634439|NCT01058707|565405865|FG004|Overall Study|Disease Progression|23|||
156634440|NCT01058707|565405866|FG005|Overall Study|Disease Progression|10|||
156634441|NCT01058707|565405867|FG006|Overall Study|Disease Progression|12|||
156634442|NCT01058707|565405861|FG000|Overall Study|Adverse Event|11|||
156634443|NCT01058707|565405862|FG001|Overall Study|Adverse Event|4|||
156634444|NCT01058707|565405863|FG002|Overall Study|Adverse Event|7|||
156634445|NCT01058707|565405864|FG003|Overall Study|Adverse Event|6|||
156634446|NCT01058707|565405865|FG004|Overall Study|Adverse Event|7|||
156634447|NCT01058707|565405866|FG005|Overall Study|Adverse Event|3|||
156634448|NCT01058707|565405867|FG006|Overall Study|Adverse Event|1|||
156634449|NCT01058707|565405861|FG000|Overall Study|Subject Decision|5|||
156634450|NCT01058707|565405862|FG001|Overall Study|Subject Decision|3|||
156634451|NCT01058707|565405863|FG002|Overall Study|Subject Decision|3|||
156634452|NCT01058707|565405864|FG003|Overall Study|Subject Decision|1|||
156634453|NCT01058707|565405865|FG004|Overall Study|Subject Decision|2|||
156634454|NCT01058707|565405866|FG005|Overall Study|Subject Decision|3|||
156634455|NCT01058707|565405867|FG006|Overall Study|Subject Decision|6|||
156634456|NCT01058707|565405861|FG000|Overall Study|Lost to Follow-up|0|||
156634457|NCT01058707|565405862|FG001|Overall Study|Lost to Follow-up|0|||
156634458|NCT01058707|565405863|FG002|Overall Study|Lost to Follow-up|1|||
156634459|NCT01058707|565405864|FG003|Overall Study|Lost to Follow-up|0|||
156634460|NCT01058707|565405865|FG004|Overall Study|Lost to Follow-up|0|||
156634461|NCT01058707|565405866|FG005|Overall Study|Lost to Follow-up|0|||
156634462|NCT01058707|565405867|FG006|Overall Study|Lost to Follow-up|0|||
156634463|NCT01058707|565405861|FG000|Overall Study|Reason Not Specified|0|||
156634464|NCT01058707|565405862|FG001|Overall Study|Reason Not Specified|3|||
156634465|NCT01058707|565405863|FG002|Overall Study|Reason Not Specified|2|||
156634466|NCT01058707|565405864|FG003|Overall Study|Reason Not Specified|0|||
156634467|NCT01058707|565405865|FG004|Overall Study|Reason Not Specified|7|||
156634468|NCT01058707|565405866|FG005|Overall Study|Reason Not Specified|1|||
156634469|NCT01058707|565405867|FG006|Overall Study|Reason Not Specified|7|||
156634470|NCT00167414|565405870|FG000|Overall Study|Death|10|||
156634471|NCT01593761|565405871|FG000|Overall Study|Lost to Follow-up|1|||
156634472|NCT01593761|565405871|FG000|Overall Study|culture negative for MRSA at baseline|5|||
156634473|NCT01593761|565405871|FG000|Overall Study|positive for hepatitis C virus|1|||
156634474|NCT01593761|565405871|FG000|Overall Study|secondary cellulitis|1|||
156634475|NCT00795886|565405876|FG000|Overall Study|Death|10|||
156634476|NCT05554471|565405877|FG000|Overall Study|Physician Decision|2|||
156634477|NCT05554471|565405878|FG001|Overall Study|Physician Decision|1|||
156634478|NCT05554471|565405877|FG000|Overall Study|Lost to Follow-up|2|||
156634479|NCT05554471|565405878|FG001|Overall Study|Lost to Follow-up|1|||
156634480|NCT05554471|565405877|FG000|Overall Study|Death|0|||
156634481|NCT05554471|565405878|FG001|Overall Study|Death|1|||
156634482|NCT04814654|565405879|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
156634483|NCT04814654|565405880|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
156634484|NCT04814654|565405881|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
156634485|NCT03505606|565407707|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
156634486|NCT03505606|565407708|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
156634487|NCT03505606|565407709|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
156634488|NCT03505606|565407707|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
156634489|NCT03505606|565407708|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
156634490|NCT03505606|565407709|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
156634491|NCT03505606|565407707|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
156634492|NCT03505606|565407708|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
156634493|NCT03505606|565407709|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
156634494|NCT03505606|565407707|FG000|Overall Study|Poor compliance with refractive correction|0|||
156634495|NCT03505606|565407708|FG001|Overall Study|Poor compliance with refractive correction|0|||
156634496|NCT03505606|565407709|FG002|Overall Study|Poor compliance with refractive correction|1|||
156634497|NCT03505606|565407707|FG000|Overall Study|Insufficient anisometropia|0|||
156634498|NCT03505606|565407708|FG001|Overall Study|Insufficient anisometropia|0|||
156634499|NCT03505606|565407709|FG002|Overall Study|Insufficient anisometropia|2|||
156634500|NCT03505606|565407707|FG000|Overall Study|Ectopia Lentis|0|||
156634501|NCT03505606|565407708|FG001|Overall Study|Ectopia Lentis|0|||
156634502|NCT03505606|565407709|FG002|Overall Study|Ectopia Lentis|1|||
156634503|NCT03505606|565407707|FG000|Overall Study|alternation of amblyopic eye|0|||
156634504|NCT03505606|565407708|FG001|Overall Study|alternation of amblyopic eye|1|||
156634505|NCT03505606|565407709|FG002|Overall Study|alternation of amblyopic eye|0|||
156634506|NCT03606109|565407715|FG000|Overall Study|Lost to Follow-up|2|||
156634507|NCT03606109|565407716|FG001|Overall Study|Lost to Follow-up|1|||
156634508|NCT01817764|565407717|FG000|Overall Study|Adverse Event|7|||
156634509|NCT01817764|565407718|FG001|Overall Study|Adverse Event|10|||
156634510|NCT01817764|565407717|FG000|Overall Study|Lack of Efficacy|9|||
156634511|NCT01817764|565407718|FG001|Overall Study|Lack of Efficacy|7|||
156634512|NCT01817764|565407717|FG000|Overall Study|Protocol Violation|7|||
156634513|NCT01817764|565407718|FG001|Overall Study|Protocol Violation|5|||
156634514|NCT01817764|565407717|FG000|Overall Study|Lost to Follow-up|1|||
156634515|NCT01817764|565407718|FG001|Overall Study|Lost to Follow-up|4|||
156634516|NCT01817764|565407717|FG000|Overall Study|Withdrawal by Subject|10|||
156634517|NCT01817764|565407718|FG001|Overall Study|Withdrawal by Subject|12|||
156634518|NCT04292171|565407719|FG000|Overall Study|Pharmacy error|2|||
156634519|NCT04292171|565407720|FG001|Overall Study|Pharmacy error|0|||
156634520|NCT04292171|565407719|FG000|Overall Study|Delivered prior to procedure|0|||
156634521|NCT04292171|565407720|FG001|Overall Study|Delivered prior to procedure|1|||
156634522|NCT04633434|565407721|FG000|Overall Study|Lost to Follow-up|32|||
156634523|NCT04633434|565407722|FG001|Overall Study|Lost to Follow-up|32|||
156634524|NCT02116309|565407724|FG000|Overall Study|Lost to Follow-up|0|||
156634525|NCT02116309|565407725|FG001|Overall Study|Lost to Follow-up|1|||
156634526|NCT03292731|565407726|FG000|Overall Study|Protocol Violation|4|||
156634527|NCT03292731|565407727|FG001|Overall Study|Protocol Violation|11|||
156634528|NCT03292731|565407728|FG002|Overall Study|Protocol Violation|1|||
156634529|NCT00471237|565407729|FG000|Overall Study|Adverse Event|6|||
156634530|NCT00471237|565407730|FG001|Overall Study|Adverse Event|5|||
156634531|NCT00471237|565407731|FG002|Overall Study|Adverse Event|4|||
156634532|NCT00471237|565407732|FG003|Overall Study|Adverse Event|8|||
156634533|NCT00471237|565407733|FG004|Overall Study|Adverse Event|7|||
156634534|NCT00471237|565407734|FG005|Overall Study|Adverse Event|5|||
156634535|NCT00471237|565407735|FG006|Overall Study|Adverse Event|0|||
156634536|NCT00471237|565407729|FG000|Overall Study|Lost to Follow-up|1|||
156634537|NCT00471237|565407730|FG001|Overall Study|Lost to Follow-up|1|||
156634538|NCT00471237|565407731|FG002|Overall Study|Lost to Follow-up|0|||
156634539|NCT00471237|565407732|FG003|Overall Study|Lost to Follow-up|2|||
156634540|NCT00471237|565407733|FG004|Overall Study|Lost to Follow-up|3|||
156634541|NCT00471237|565407734|FG005|Overall Study|Lost to Follow-up|0|||
156634542|NCT00471237|565407735|FG006|Overall Study|Lost to Follow-up|0|||
156634543|NCT00471237|565407729|FG000|Overall Study|Protocol Violation|3|||
156634544|NCT00471237|565407730|FG001|Overall Study|Protocol Violation|6|||
156634545|NCT00471237|565407731|FG002|Overall Study|Protocol Violation|3|||
156634546|NCT00471237|565407732|FG003|Overall Study|Protocol Violation|2|||
156634547|NCT00471237|565407733|FG004|Overall Study|Protocol Violation|2|||
156634548|NCT00471237|565407734|FG005|Overall Study|Protocol Violation|4|||
156634549|NCT00471237|565407735|FG006|Overall Study|Protocol Violation|1|||
156634550|NCT00471237|565407729|FG000|Overall Study|Withdrawal by Subject|8|||
156634551|NCT00471237|565407730|FG001|Overall Study|Withdrawal by Subject|6|||
156634552|NCT00471237|565407731|FG002|Overall Study|Withdrawal by Subject|5|||
156634553|NCT00471237|565407732|FG003|Overall Study|Withdrawal by Subject|8|||
156634554|NCT00471237|565407733|FG004|Overall Study|Withdrawal by Subject|7|||
156634555|NCT00471237|565407734|FG005|Overall Study|Withdrawal by Subject|4|||
156634556|NCT00471237|565407735|FG006|Overall Study|Withdrawal by Subject|2|||
156634557|NCT00471237|565407729|FG000|Overall Study|Sponsor terminated study|20|||
156634558|NCT00471237|565407730|FG001|Overall Study|Sponsor terminated study|23|||
156634559|NCT00471237|565407731|FG002|Overall Study|Sponsor terminated study|19|||
156634560|NCT00471237|565407732|FG003|Overall Study|Sponsor terminated study|22|||
156634561|NCT00471237|565407733|FG004|Overall Study|Sponsor terminated study|18|||
156634562|NCT00471237|565407734|FG005|Overall Study|Sponsor terminated study|24|||
156634563|NCT00471237|565407735|FG006|Overall Study|Sponsor terminated study|0|||
156634564|NCT00471237|565407729|FG000|Overall Study|Non-compliance|0|||
156634565|NCT00471237|565407730|FG001|Overall Study|Non-compliance|1|||
156634566|NCT00471237|565407731|FG002|Overall Study|Non-compliance|0|||
156634567|NCT00471237|565407732|FG003|Overall Study|Non-compliance|1|||
156634568|NCT00471237|565407733|FG004|Overall Study|Non-compliance|0|||
156634569|NCT00471237|565407734|FG005|Overall Study|Non-compliance|0|||
156634570|NCT00471237|565407735|FG006|Overall Study|Non-compliance|0|||
156634571|NCT00471237|565407729|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
156634572|NCT00471237|565407730|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
156634573|NCT00471237|565407731|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
156634574|NCT00471237|565407732|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
156634575|NCT00471237|565407733|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
156634576|NCT00471237|565407734|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
156634577|NCT00471237|565407735|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
156634578|NCT00471237|565407729|FG000|Overall Study|Early stopping due to non-efficacy|1|||
156634579|NCT00471237|565407730|FG001|Overall Study|Early stopping due to non-efficacy|0|||
156634580|NCT00471237|565407731|FG002|Overall Study|Early stopping due to non-efficacy|0|||
156634581|NCT00471237|565407732|FG003|Overall Study|Early stopping due to non-efficacy|0|||
156634582|NCT00471237|565407733|FG004|Overall Study|Early stopping due to non-efficacy|1|||
156634583|NCT00471237|565407734|FG005|Overall Study|Early stopping due to non-efficacy|0|||
156634584|NCT00471237|565407735|FG006|Overall Study|Early stopping due to non-efficacy|0|||
156634585|NCT00471237|565407729|FG000|Overall Study|Participant planned to travel to abraod|1|||
156634586|NCT00471237|565407730|FG001|Overall Study|Participant planned to travel to abraod|0|||
156634587|NCT00471237|565407731|FG002|Overall Study|Participant planned to travel to abraod|0|||
156634588|NCT00471237|565407732|FG003|Overall Study|Participant planned to travel to abraod|0|||
156634589|NCT00471237|565407733|FG004|Overall Study|Participant planned to travel to abraod|0|||
156634590|NCT00471237|565407734|FG005|Overall Study|Participant planned to travel to abraod|1|||
156634591|NCT00471237|565407735|FG006|Overall Study|Participant planned to travel to abraod|0|||
156634592|NCT00471237|565407729|FG000|Overall Study|High parathyroid hormone|0|||
156634593|NCT00471237|565407730|FG001|Overall Study|High parathyroid hormone|0|||
156634594|NCT00471237|565407731|FG002|Overall Study|High parathyroid hormone|1|||
156634595|NCT00471237|565407732|FG003|Overall Study|High parathyroid hormone|0|||
156634596|NCT00471237|565407733|FG004|Overall Study|High parathyroid hormone|0|||
156634597|NCT00471237|565407734|FG005|Overall Study|High parathyroid hormone|0|||
156634598|NCT00471237|565407735|FG006|Overall Study|High parathyroid hormone|0|||
156634599|NCT00471237|565407729|FG000|Overall Study|Participant lost medication|0|||
156634600|NCT00471237|565407730|FG001|Overall Study|Participant lost medication|0|||
156634601|NCT00471237|565407731|FG002|Overall Study|Participant lost medication|0|||
156634602|NCT00471237|565407732|FG003|Overall Study|Participant lost medication|0|||
156634603|NCT00471237|565407733|FG004|Overall Study|Participant lost medication|1|||
156634604|NCT00471237|565407734|FG005|Overall Study|Participant lost medication|0|||
156634605|NCT00471237|565407735|FG006|Overall Study|Participant lost medication|0|||
156634606|NCT00471237|565407729|FG000|Overall Study|Administration of prohibited medicine|0|||
156634607|NCT00471237|565407730|FG001|Overall Study|Administration of prohibited medicine|0|||
156634608|NCT00471237|565407731|FG002|Overall Study|Administration of prohibited medicine|0|||
156634609|NCT00471237|565407732|FG003|Overall Study|Administration of prohibited medicine|0|||
156634610|NCT00471237|565407733|FG004|Overall Study|Administration of prohibited medicine|1|||
156634611|NCT00471237|565407734|FG005|Overall Study|Administration of prohibited medicine|0|||
156634612|NCT00471237|565407735|FG006|Overall Study|Administration of prohibited medicine|0|||
156634613|NCT00471237|565407729|FG000|Overall Study|Participant shifted residence|0|||
156634614|NCT00471237|565407730|FG001|Overall Study|Participant shifted residence|0|||
156634615|NCT00471237|565407731|FG002|Overall Study|Participant shifted residence|0|||
156634616|NCT00471237|565407732|FG003|Overall Study|Participant shifted residence|0|||
156634617|NCT00471237|565407733|FG004|Overall Study|Participant shifted residence|1|||
156634618|NCT00471237|565407734|FG005|Overall Study|Participant shifted residence|0|||
156634619|NCT00471237|565407735|FG006|Overall Study|Participant shifted residence|0|||
156634620|NCT00471237|565407729|FG000|Overall Study|Participant's decision|0|||
156634621|NCT00471237|565407730|FG001|Overall Study|Participant's decision|0|||
156634622|NCT00471237|565407731|FG002|Overall Study|Participant's decision|0|||
156634623|NCT00471237|565407732|FG003|Overall Study|Participant's decision|0|||
156634624|NCT00471237|565407733|FG004|Overall Study|Participant's decision|0|||
156634625|NCT00471237|565407734|FG005|Overall Study|Participant's decision|1|||
156634626|NCT00471237|565407735|FG006|Overall Study|Participant's decision|0|||
156634627|NCT00848965|565407736|FG000|Overall Study|Adverse Event|1|||
156634628|NCT00848965|565407736|FG000|Overall Study|Withdrawal by Subject|1|||
156634629|NCT00348348|565407737|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
156634630|NCT00348348|565407738|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
156634631|NCT00348348|565407737|FG000|Overall Study|Lack of Efficacy|1|||
156634632|NCT00348348|565407738|FG001|Overall Study|Lack of Efficacy|1|||
156634633|NCT00348348|565407737|FG000|Overall Study|Lost to Follow-up|8|||
156634634|NCT00348348|565407738|FG001|Overall Study|Lost to Follow-up|10|||
156634635|NCT00348348|565407737|FG000|Overall Study|Withdrawal by Subject|4|||
156634636|NCT00348348|565407738|FG001|Overall Study|Withdrawal by Subject|1|||
156634637|NCT00348348|565407737|FG000|Overall Study|Other|7|||
156634638|NCT00348348|565407738|FG001|Overall Study|Other|4|||
156634639|NCT00348348|565407737|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
156634640|NCT00348348|565407738|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
156634641|NCT00348348|565407737|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
156634642|NCT00348348|565407738|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
156634643|NCT00348348|565407737|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
156634644|NCT00348348|565407738|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
156634645|NCT00348348|565407737|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
156634646|NCT00348348|565407738|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
156634647|NCT00348348|565407737|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
156634648|NCT00348348|565407738|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
156634649|NCT00348348|565407737|FG000|Overall Study|Adverse event probably related to study|1|||
156634650|NCT00348348|565407738|FG001|Overall Study|Adverse event probably related to study|0|||
156634651|NCT02329834|565407739|FG000|Overall Study|Physician Decision|1|||
156634652|NCT02329834|565407740|FG001|Overall Study|Physician Decision|0|||
156634653|NCT00578448|565407743|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
156634654|NCT00578448|565407743|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
156634655|NCT00578448|565407743|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
156634656|NCT00578448|565407743|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
156634657|NCT01976104|565407744|FG000|Overall Study|Adverse Event|0|||
156634658|NCT01976104|565407745|FG001|Overall Study|Adverse Event|0|||
156634659|NCT01976104|565407746|FG002|Overall Study|Adverse Event|1|||
156634660|NCT01976104|565407747|FG003|Overall Study|Adverse Event|0|||
156634661|NCT01976104|565407744|FG000|Overall Study|Lost to Follow-up|3|||
156634662|NCT01976104|565407745|FG001|Overall Study|Lost to Follow-up|0|||
156634663|NCT01976104|565407746|FG002|Overall Study|Lost to Follow-up|1|||
156634664|NCT01976104|565407747|FG003|Overall Study|Lost to Follow-up|1|||
156634665|NCT01976104|565407744|FG000|Overall Study|Subject Choice|0|||
156634666|NCT01976104|565407745|FG001|Overall Study|Subject Choice|1|||
156634667|NCT01976104|565407746|FG002|Overall Study|Subject Choice|0|||
156634668|NCT01976104|565407747|FG003|Overall Study|Subject Choice|1|||
156634669|NCT01976104|565407744|FG000|Overall Study|Withdrawal by Subject|3|||
156634670|NCT01976104|565407745|FG001|Overall Study|Withdrawal by Subject|0|||
156634671|NCT01976104|565407746|FG002|Overall Study|Withdrawal by Subject|0|||
156634672|NCT01976104|565407747|FG003|Overall Study|Withdrawal by Subject|1|||
156634673|NCT01976104|565407744|FG000|Overall Study|Other|0|||
156634674|NCT01976104|565407745|FG001|Overall Study|Other|1|||
156634675|NCT01976104|565407746|FG002|Overall Study|Other|0|||
156634676|NCT01976104|565407747|FG003|Overall Study|Other|0|||
156634677|NCT03237325|565407753|FG000|Overall Study|Lost to Follow-up|3|||
156634678|NCT03237325|565407754|FG001|Overall Study|Lost to Follow-up|5|||
156634679|NCT03237325|565407753|FG000|Overall Study|Physician Decision|2|||
156634680|NCT03237325|565407754|FG001|Overall Study|Physician Decision|4|||
156634681|NCT03237325|565407753|FG000|Overall Study|Withdrawal by Subject|9|||
156634682|NCT03237325|565407754|FG001|Overall Study|Withdrawal by Subject|12|||
156634683|NCT03237325|565407753|FG000|Overall Study|Noncompliance with Study Procedures|1|||
156634684|NCT03237325|565407754|FG001|Overall Study|Noncompliance with Study Procedures|1|||
156634685|NCT03237325|565407753|FG000|Overall Study|Termination by Sponsor|0|||
156634686|NCT03237325|565407754|FG001|Overall Study|Termination by Sponsor|1|||
156634687|NCT03237325|565407753|FG000|Overall Study|Reason other than described|0|||
156634688|NCT03237325|565407754|FG001|Overall Study|Reason other than described|2|||
156634689|NCT00433771|565407758|FG000|Overall Study|screen fail|14|||
156634690|NCT00433771|565407758|FG000|Overall Study|Treated and later found to be ineligible|2|||
156634691|NCT00433771|565407758|FG000|Overall Study|Death|2|||
156634692|NCT00433771|565407758|FG000|Overall Study|Failure to deploy stent|1|||
156634693|NCT00138658|565407759|FG000|Overall Study|Adverse Event|23|||
156634694|NCT00138658|565407759|FG000|Overall Study|Death|1|||
156634695|NCT00138658|565407759|FG000|Overall Study|Disease Progression|21|||
156634696|NCT00138658|565407759|FG000|Overall Study|Physician Decision|11|||
156634697|NCT00138658|565407759|FG000|Overall Study|Withdrawal by Subject|5|||
156634698|NCT03426995|565407762|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634699|NCT03426995|565407763|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634700|NCT03426995|565407764|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
156634701|NCT03426995|565407765|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634702|NCT03426995|565407766|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634703|NCT03426995|565407767|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634704|NCT03426995|565407768|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634705|NCT03426995|565407769|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634706|NCT03426995|565407770|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634707|NCT03426995|565407771|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634708|NCT03426995|565407772|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634709|NCT03426995|565407773|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634710|NCT03426995|565407774|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156634711|NCT03426995|565407775|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
156635574|NCT00602667|565409962|FG002|Overall Study|Physician Decision|8|||
156634750|NCT03426995|565407776|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634751|NCT03426995|565407777|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634752|NCT03426995|565407778|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634753|NCT03426995|565407779|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634754|NCT03426995|565407780|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
156634755|NCT03426995|565407762|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634756|NCT03426995|565407763|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634757|NCT03426995|565407764|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634758|NCT03426995|565407765|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634759|NCT03426995|565407766|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634760|NCT03426995|565407767|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634761|NCT03426995|565407768|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634762|NCT03426995|565407769|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634763|NCT03426995|565407770|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634764|NCT03426995|565407771|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634765|NCT03426995|565407772|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
156634766|NCT03426995|565407773|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634767|NCT03426995|565407774|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634768|NCT03426995|565407775|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634769|NCT03426995|565407776|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634770|NCT03426995|565407777|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634771|NCT03426995|565407778|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634772|NCT03426995|565407779|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634773|NCT03426995|565407780|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
156634774|NCT03426995|565407762|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634775|NCT03426995|565407763|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634776|NCT03426995|565407764|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634777|NCT03426995|565407765|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634778|NCT03426995|565407766|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634779|NCT03426995|565407767|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634780|NCT03426995|565407768|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634781|NCT03426995|565407769|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
156634782|NCT03426995|565407770|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634783|NCT03426995|565407771|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634784|NCT03426995|565407772|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634785|NCT03426995|565407773|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634786|NCT03426995|565407774|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634787|NCT03426995|565407775|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634788|NCT03426995|565407776|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634789|NCT03426995|565407777|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634790|NCT03426995|565407778|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634791|NCT03426995|565407779|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634792|NCT03426995|565407780|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
156634793|NCT03426995|565407762|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634794|NCT03426995|565407763|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634795|NCT03426995|565407764|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634796|NCT03426995|565407765|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634797|NCT03426995|565407766|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634798|NCT03426995|565407767|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634799|NCT03426995|565407768|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634800|NCT03426995|565407769|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634801|NCT03426995|565407770|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634802|NCT03426995|565407771|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634803|NCT03426995|565407772|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634804|NCT03426995|565407773|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634805|NCT03426995|565407774|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634806|NCT03426995|565407775|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634807|NCT03426995|565407776|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
156634808|NCT03426995|565407777|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
156634809|NCT03426995|565407778|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634810|NCT03426995|565407779|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634811|NCT03426995|565407780|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
156634812|NCT03426995|565407762|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634813|NCT03426995|565407763|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634814|NCT03426995|565407764|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634815|NCT03426995|565407765|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634816|NCT03426995|565407766|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634817|NCT03426995|565407767|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634818|NCT03426995|565407768|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634819|NCT03426995|565407769|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634820|NCT03426995|565407770|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634821|NCT03426995|565407771|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634822|NCT03426995|565407772|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634823|NCT03426995|565407773|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634824|NCT03426995|565407774|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634825|NCT03426995|565407775|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634826|NCT03426995|565407776|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
156634827|NCT03426995|565407777|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
156634828|NCT03426995|565407778|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634829|NCT03426995|565407779|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634830|NCT03426995|565407780|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
156634831|NCT00227591|565407781|FG000|Overall Study|Withdrawal by Subject|1|||
156634832|NCT02335411|565407782|FG000|Overall Study|Death|223|||
156634833|NCT02335411|565407783|FG001|Overall Study|Death|22|||
156634834|NCT02335411|565407784|FG002|Overall Study|Death|26|||
156634835|NCT02335411|565407782|FG000|Overall Study|Physician Decision|3|||
156634836|NCT02335411|565407783|FG001|Overall Study|Physician Decision|0|||
156634837|NCT02335411|565407784|FG002|Overall Study|Physician Decision|0|||
156634838|NCT02335411|565407782|FG000|Overall Study|Protocol Violation|1|||
156634839|NCT02335411|565407783|FG001|Overall Study|Protocol Violation|0|||
156634840|NCT02335411|565407784|FG002|Overall Study|Protocol Violation|0|||
156634841|NCT02335411|565407782|FG000|Overall Study|Withdrawal by Subject|11|||
156634842|NCT02335411|565407783|FG001|Overall Study|Withdrawal by Subject|0|||
156634843|NCT02335411|565407784|FG002|Overall Study|Withdrawal by Subject|3|||
156634844|NCT02335411|565407782|FG000|Overall Study|Sponsor Decision|12|||
156634845|NCT02335411|565407783|FG001|Overall Study|Sponsor Decision|3|||
156634846|NCT02335411|565407784|FG002|Overall Study|Sponsor Decision|2|||
156634847|NCT02335411|565407782|FG000|Overall Study|Adverse Event|9|||
156634848|NCT02335411|565407783|FG001|Overall Study|Adverse Event|0|||
156634849|NCT02335411|565407784|FG002|Overall Study|Adverse Event|0|||
156634850|NCT01886105|565407785|FG000|Overall Study|Lack of Efficacy|3|||
156634851|NCT01360021|565407788|FG000|Overall Study|Eligibility criteria + other|2|||
156634852|NCT01360021|565407789|FG001|Overall Study|Eligibility criteria + other|1|||
156634853|NCT01360021|565407790|FG002|Overall Study|Eligibility criteria + other|1|||
156634854|NCT01360021|565407788|FG000|Overall Study|Protocol Violation|0|||
156634855|NCT01360021|565407789|FG001|Overall Study|Protocol Violation|0|||
156634856|NCT01360021|565407790|FG002|Overall Study|Protocol Violation|1|||
156634857|NCT01360021|565407788|FG000|Overall Study|Withdrawal by Subject|4|||
156634858|NCT01360021|565407789|FG001|Overall Study|Withdrawal by Subject|0|||
156634859|NCT01360021|565407790|FG002|Overall Study|Withdrawal by Subject|2|||
156634860|NCT01360021|565407788|FG000|Overall Study|Adverse Event|2|||
156634861|NCT01360021|565407789|FG001|Overall Study|Adverse Event|3|||
156634862|NCT01360021|565407790|FG002|Overall Study|Adverse Event|3|||
156634863|NCT00530621|565407794|FG000|Overall Study|Adverse Event|11|||
156634864|NCT00530621|565407795|FG001|Overall Study|Adverse Event|8|||
156634865|NCT00530621|565407794|FG000|Overall Study|Physician Decision|2|||
156634866|NCT00530621|565407795|FG001|Overall Study|Physician Decision|4|||
156634867|NCT00530621|565407794|FG000|Overall Study|Progressive Disease (PD)|47|||
156634868|NCT00530621|565407795|FG001|Overall Study|Progressive Disease (PD)|40|||
156634869|NCT00530621|565407794|FG000|Overall Study|Sponsor Decision|12|||
156634870|NCT00530621|565407795|FG001|Overall Study|Sponsor Decision|15|||
156634871|NCT00530621|565407794|FG000|Overall Study|Subject Decision|4|||
156634872|NCT00530621|565407795|FG001|Overall Study|Subject Decision|7|||
156634873|NCT00530621|565407794|FG000|Overall Study|Death|3|||
156634874|NCT00530621|565407795|FG001|Overall Study|Death|6|||
156634875|NCT00530621|565407794|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
156634876|NCT00530621|565407795|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
156634877|NCT02596009|565407796|FG000|Overall Study|Administrative problems|0|||
156634878|NCT02596009|565407797|FG001|Overall Study|Administrative problems|1|||
156634879|NCT02596009|565407798|FG002|Overall Study|Administrative problems|0|||
156634880|NCT02596009|565407799|FG003|Overall Study|Administrative problems|0|||
156634881|NCT02596009|565407800|FG004|Overall Study|Administrative problems|0|||
156634882|NCT02596009|565407801|FG005|Overall Study|Administrative problems|0|||
156634883|NCT04611152|565407802|FG000|Overall Study|Adverse Event|9|||
156634884|NCT04611152|565407803|FG001|Overall Study|Adverse Event|8|||
156634885|NCT04611152|565407802|FG000|Overall Study|Non-compliance with study schedule|1|||
156634886|NCT04611152|565407803|FG001|Overall Study|Non-compliance with study schedule|3|||
156634887|NCT04611152|565407802|FG000|Overall Study|Withdrawal by Subject|5|||
156634888|NCT04611152|565407803|FG001|Overall Study|Withdrawal by Subject|6|||
156634889|NCT04611152|565407802|FG000|Overall Study|Lost to Follow-up|11|||
156634890|NCT04611152|565407803|FG001|Overall Study|Lost to Follow-up|2|||
156634915|NCT03917654|565407815|FG000|Year 1|Subject moved away from site|0|||
156634916|NCT03917654|565407816|FG001|Year 1|Subject moved away from site|1|||
156634917|NCT03917654|565407817|FG002|Year 1|Subject moved away from site|0|||
156634918|NCT03917654|565407818|FG003|Year 1|Subject moved away from site|0|||
156634919|NCT03917654|565407819|FG004|Year 1|Subject moved away from site|0|||
156634920|NCT03917654|565407820|FG005|Year 1|Subject moved away from site|0|||
156634921|NCT03917654|565407821|FG006|Year 1|Subject moved away from site|1|||
156634922|NCT03917654|565407822|FG007|Year 1|Subject moved away from site|2|||
156634923|NCT03917654|565407823|FG008|Year 1|Subject moved away from site|1|||
156634924|NCT03917654|565407824|FG009|Year 1|Subject moved away from site|0|||
156634925|NCT03917654|565407825|FG010|Year 1|Subject moved away from site|0|||
156634926|NCT03917654|565407826|FG011|Year 1|Subject moved away from site|3|||
156634927|NCT03917654|565407815|FG000|Year 1|Spouse/Family member request|0|||
156634928|NCT03917654|565407816|FG001|Year 1|Spouse/Family member request|0|||
156634929|NCT03917654|565407817|FG002|Year 1|Spouse/Family member request|1|||
156634930|NCT03917654|565407818|FG003|Year 1|Spouse/Family member request|0|||
156634931|NCT03917654|565407819|FG004|Year 1|Spouse/Family member request|1|||
156634932|NCT03917654|565407820|FG005|Year 1|Spouse/Family member request|0|||
156634933|NCT03917654|565407821|FG006|Year 1|Spouse/Family member request|0|||
156634934|NCT03917654|565407822|FG007|Year 1|Spouse/Family member request|2|||
156634935|NCT03917654|565407823|FG008|Year 1|Spouse/Family member request|0|||
156634936|NCT03917654|565407824|FG009|Year 1|Spouse/Family member request|0|||
156634937|NCT03917654|565407825|FG010|Year 1|Spouse/Family member request|0|||
156634938|NCT03917654|565407826|FG011|Year 1|Spouse/Family member request|1|||
156634939|NCT03917654|565407815|FG000|Year 1|Death|0|||
156634940|NCT03917654|565407816|FG001|Year 1|Death|0|||
156634941|NCT03917654|565407817|FG002|Year 1|Death|0|||
156634942|NCT03917654|565407818|FG003|Year 1|Death|0|||
156634943|NCT03917654|565407819|FG004|Year 1|Death|0|||
156634944|NCT03917654|565407820|FG005|Year 1|Death|0|||
156634945|NCT03917654|565407821|FG006|Year 1|Death|0|||
156634946|NCT03917654|565407822|FG007|Year 1|Death|0|||
156634947|NCT03917654|565407823|FG008|Year 1|Death|1|||
156634948|NCT03917654|565407824|FG009|Year 1|Death|1|||
156634949|NCT03917654|565407825|FG010|Year 1|Death|0|||
156634950|NCT03917654|565407826|FG011|Year 1|Death|0|||
156634951|NCT03917654|565407815|FG000|Year 1|Lost to Follow-up|0|||
156634952|NCT03917654|565407816|FG001|Year 1|Lost to Follow-up|0|||
156634953|NCT03917654|565407817|FG002|Year 1|Lost to Follow-up|0|||
156634954|NCT03917654|565407818|FG003|Year 1|Lost to Follow-up|0|||
156634955|NCT03917654|565407819|FG004|Year 1|Lost to Follow-up|0|||
156634956|NCT03917654|565407820|FG005|Year 1|Lost to Follow-up|0|||
156634957|NCT03917654|565407821|FG006|Year 1|Lost to Follow-up|2|||
156634958|NCT03917654|565407822|FG007|Year 1|Lost to Follow-up|0|||
156634959|NCT03917654|565407823|FG008|Year 1|Lost to Follow-up|0|||
156634960|NCT03917654|565407824|FG009|Year 1|Lost to Follow-up|0|||
156634961|NCT03917654|565407825|FG010|Year 1|Lost to Follow-up|0|||
156634962|NCT03917654|565407826|FG011|Year 1|Lost to Follow-up|0|||
156634963|NCT03917654|565407815|FG000|Year 1|Missed visits|0|||
156634964|NCT03917654|565407816|FG001|Year 1|Missed visits|0|||
156634965|NCT03917654|565407817|FG002|Year 1|Missed visits|0|||
156634966|NCT03917654|565407818|FG003|Year 1|Missed visits|0|||
156634967|NCT03917654|565407819|FG004|Year 1|Missed visits|0|||
156634968|NCT03917654|565407820|FG005|Year 1|Missed visits|0|||
156634969|NCT03917654|565407821|FG006|Year 1|Missed visits|0|||
156634970|NCT03917654|565407822|FG007|Year 1|Missed visits|0|||
156634971|NCT03917654|565407823|FG008|Year 1|Missed visits|0|||
156634972|NCT03917654|565407824|FG009|Year 1|Missed visits|0|||
156634973|NCT03917654|565407825|FG010|Year 1|Missed visits|1|||
156634974|NCT03917654|565407826|FG011|Year 1|Missed visits|1|||
156634975|NCT03917654|565407815|FG000|Year 1|Pregnancy|0|||
156634976|NCT03917654|565407816|FG001|Year 1|Pregnancy|0|||
156634977|NCT03917654|565407817|FG002|Year 1|Pregnancy|0|||
156634978|NCT03917654|565407818|FG003|Year 1|Pregnancy|0|||
156634979|NCT03917654|565407819|FG004|Year 1|Pregnancy|0|||
156634980|NCT03917654|565407820|FG005|Year 1|Pregnancy|0|||
156634981|NCT03917654|565407821|FG006|Year 1|Pregnancy|0|||
156634982|NCT03917654|565407822|FG007|Year 1|Pregnancy|1|||
156634983|NCT03917654|565407823|FG008|Year 1|Pregnancy|0|||
156634984|NCT03917654|565407824|FG009|Year 1|Pregnancy|1|||
156634985|NCT03917654|565407825|FG010|Year 1|Pregnancy|0|||
156634986|NCT03917654|565407826|FG011|Year 1|Pregnancy|0|||
156634987|NCT03917654|565407815|FG000|Year 2|Travel|1|||
156634988|NCT03917654|565407816|FG001|Year 2|Travel|0|||
156634989|NCT03917654|565407817|FG002|Year 2|Travel|0|||
156634990|NCT03917654|565407818|FG003|Year 2|Travel|0|||
156634991|NCT03917654|565407819|FG004|Year 2|Travel|1|||
156634992|NCT03917654|565407820|FG005|Year 2|Travel|1|||
156634993|NCT03917654|565407821|FG006|Year 2|Travel|2|||
156634994|NCT03917654|565407822|FG007|Year 2|Travel|1|||
156634995|NCT03917654|565407823|FG008|Year 2|Travel|0|||
156634996|NCT03917654|565407824|FG009|Year 2|Travel|1|||
156634997|NCT03917654|565407825|FG010|Year 2|Travel|0|||
156634998|NCT03917654|565407826|FG011|Year 2|Travel|1|||
156634999|NCT03917654|565407815|FG000|Year 2|Married|1|||
156635000|NCT03917654|565407816|FG001|Year 2|Married|0|||
156635001|NCT03917654|565407817|FG002|Year 2|Married|0|||
156635002|NCT03917654|565407818|FG003|Year 2|Married|0|||
156635011|NCT03917654|565407815|FG000|Year 2|Subject moved away from site|1|||
156635012|NCT03917654|565407816|FG001|Year 2|Subject moved away from site|0|||
156635013|NCT03917654|565407817|FG002|Year 2|Subject moved away from site|0|||
156635014|NCT03917654|565407818|FG003|Year 2|Subject moved away from site|0|||
156635015|NCT03917654|565407819|FG004|Year 2|Subject moved away from site|1|||
156635016|NCT03917654|565407820|FG005|Year 2|Subject moved away from site|0|||
156635017|NCT03917654|565407821|FG006|Year 2|Subject moved away from site|2|||
156635018|NCT03917654|565407822|FG007|Year 2|Subject moved away from site|3|||
156635019|NCT03917654|565407823|FG008|Year 2|Subject moved away from site|0|||
156635020|NCT03917654|565407824|FG009|Year 2|Subject moved away from site|2|||
156635021|NCT03917654|565407825|FG010|Year 2|Subject moved away from site|0|||
156635022|NCT03917654|565407826|FG011|Year 2|Subject moved away from site|1|||
156635023|NCT03917654|565407815|FG000|Year 2|Year 2 Screening failure|0|||
156635024|NCT03917654|565407816|FG001|Year 2|Year 2 Screening failure|1|||
156635025|NCT03917654|565407817|FG002|Year 2|Year 2 Screening failure|0|||
156635026|NCT03917654|565407818|FG003|Year 2|Year 2 Screening failure|0|||
156635027|NCT03917654|565407819|FG004|Year 2|Year 2 Screening failure|2|||
156635028|NCT03917654|565407820|FG005|Year 2|Year 2 Screening failure|0|||
156635029|NCT03917654|565407821|FG006|Year 2|Year 2 Screening failure|4|||
156635030|NCT03917654|565407822|FG007|Year 2|Year 2 Screening failure|3|||
156635031|NCT03917654|565407823|FG008|Year 2|Year 2 Screening failure|10|||
156635032|NCT03917654|565407824|FG009|Year 2|Year 2 Screening failure|2|||
156635033|NCT03917654|565407825|FG010|Year 2|Year 2 Screening failure|1|||
156635034|NCT03917654|565407826|FG011|Year 2|Year 2 Screening failure|1|||
156635035|NCT03917654|565407815|FG000|Year 2|Death|0|||
156635036|NCT03917654|565407816|FG001|Year 2|Death|0|||
156635037|NCT03917654|565407817|FG002|Year 2|Death|0|||
156635038|NCT03917654|565407818|FG003|Year 2|Death|0|||
156635039|NCT03917654|565407819|FG004|Year 2|Death|0|||
156635040|NCT03917654|565407820|FG005|Year 2|Death|1|||
156635041|NCT03917654|565407821|FG006|Year 2|Death|0|||
156635042|NCT03917654|565407822|FG007|Year 2|Death|0|||
156635043|NCT03917654|565407823|FG008|Year 2|Death|1|||
156635044|NCT03917654|565407824|FG009|Year 2|Death|1|||
156635045|NCT03917654|565407825|FG010|Year 2|Death|0|||
156635046|NCT03917654|565407826|FG011|Year 2|Death|0|||
156635047|NCT03917654|565407815|FG000|Year 2|Withdrawal by Subject|0|||
156635048|NCT03917654|565407816|FG001|Year 2|Withdrawal by Subject|0|||
156635049|NCT03917654|565407817|FG002|Year 2|Withdrawal by Subject|0|||
156635050|NCT03917654|565407818|FG003|Year 2|Withdrawal by Subject|0|||
156635051|NCT03917654|565407819|FG004|Year 2|Withdrawal by Subject|0|||
156635052|NCT03917654|565407820|FG005|Year 2|Withdrawal by Subject|0|||
156635053|NCT03917654|565407821|FG006|Year 2|Withdrawal by Subject|3|||
156635054|NCT03917654|565407822|FG007|Year 2|Withdrawal by Subject|0|||
156635055|NCT03917654|565407823|FG008|Year 2|Withdrawal by Subject|2|||
156635056|NCT03917654|565407824|FG009|Year 2|Withdrawal by Subject|5|||
156635057|NCT03917654|565407825|FG010|Year 2|Withdrawal by Subject|0|||
156635058|NCT03917654|565407826|FG011|Year 2|Withdrawal by Subject|0|||
156635059|NCT03917654|565407815|FG000|Year 2|Spouse/family member request|0|||
156635060|NCT03917654|565407816|FG001|Year 2|Spouse/family member request|0|||
156635061|NCT03917654|565407817|FG002|Year 2|Spouse/family member request|0|||
156635062|NCT03917654|565407818|FG003|Year 2|Spouse/family member request|0|||
156635063|NCT03917654|565407819|FG004|Year 2|Spouse/family member request|0|||
156635064|NCT03917654|565407820|FG005|Year 2|Spouse/family member request|0|||
156635065|NCT03917654|565407821|FG006|Year 2|Spouse/family member request|1|||
156635066|NCT03917654|565407822|FG007|Year 2|Spouse/family member request|0|||
156635067|NCT03917654|565407823|FG008|Year 2|Spouse/family member request|0|||
156635068|NCT03917654|565407824|FG009|Year 2|Spouse/family member request|0|||
156635069|NCT03917654|565407825|FG010|Year 2|Spouse/family member request|0|||
156635070|NCT03917654|565407826|FG011|Year 2|Spouse/family member request|0|||
156635071|NCT03917654|565407815|FG000|Year 2|Lost to Follow-up|0|||
156635072|NCT03917654|565407816|FG001|Year 2|Lost to Follow-up|0|||
156635073|NCT03917654|565407817|FG002|Year 2|Lost to Follow-up|0|||
156635074|NCT03917654|565407818|FG003|Year 2|Lost to Follow-up|0|||
156635075|NCT03917654|565407819|FG004|Year 2|Lost to Follow-up|0|||
156635076|NCT03917654|565407820|FG005|Year 2|Lost to Follow-up|0|||
156635077|NCT03917654|565407821|FG006|Year 2|Lost to Follow-up|1|||
156635078|NCT03917654|565407822|FG007|Year 2|Lost to Follow-up|0|||
156635079|NCT03917654|565407823|FG008|Year 2|Lost to Follow-up|1|||
156635080|NCT03917654|565407824|FG009|Year 2|Lost to Follow-up|0|||
156635081|NCT03917654|565407825|FG010|Year 2|Lost to Follow-up|0|||
156635082|NCT03917654|565407826|FG011|Year 2|Lost to Follow-up|1|||
156635083|NCT03917654|565407815|FG000|Year 2|Adverse Event|0|||
156635084|NCT03917654|565407816|FG001|Year 2|Adverse Event|0|||
156635085|NCT03917654|565407817|FG002|Year 2|Adverse Event|0|||
156635086|NCT03917654|565407818|FG003|Year 2|Adverse Event|0|||
156635087|NCT03917654|565407819|FG004|Year 2|Adverse Event|0|||
156635088|NCT03917654|565407820|FG005|Year 2|Adverse Event|0|||
156635089|NCT03917654|565407821|FG006|Year 2|Adverse Event|0|||
156635090|NCT03917654|565407822|FG007|Year 2|Adverse Event|0|||
156635091|NCT03917654|565407823|FG008|Year 2|Adverse Event|0|||
156635092|NCT03917654|565407824|FG009|Year 2|Adverse Event|1|||
156635093|NCT03917654|565407825|FG010|Year 2|Adverse Event|0|||
156635098|NCT05012943|565407827|FG000|Overall Study|Withdrawal by Subject|1052|||
156635099|NCT05012943|565407828|FG001|Overall Study|Withdrawal by Subject|1006|||
156635100|NCT05012943|565407829|FG002|Overall Study|Withdrawal by Subject|20|||
156635101|NCT05012943|565407827|FG000|Overall Study|Death|25|||
156635102|NCT05012943|565407828|FG001|Overall Study|Death|17|||
156635103|NCT05012943|565407829|FG002|Overall Study|Death|4|||
156635104|NCT05012943|565407827|FG000|Overall Study|Lost to Follow-up|11|||
156635105|NCT05012943|565407828|FG001|Overall Study|Lost to Follow-up|24|||
156635106|NCT05012943|565407829|FG002|Overall Study|Lost to Follow-up|3|||
156635107|NCT05012943|565407827|FG000|Overall Study|Physician Decision|1|||
156635108|NCT05012943|565407828|FG001|Overall Study|Physician Decision|1|||
156635109|NCT05012943|565407829|FG002|Overall Study|Physician Decision|0|||
156635110|NCT05012943|565407827|FG000|Overall Study|Other than Specified|2|||
156635111|NCT05012943|565407828|FG001|Overall Study|Other than Specified|1|||
156635112|NCT05012943|565407829|FG002|Overall Study|Other than Specified|0|||
156635113|NCT00400985|565407831|FG000|Overall Study|Withdrawal by Subject|5|||
156635114|NCT00400985|565407831|FG000|Overall Study|system modification|8|||
156635115|NCT00400985|565407831|FG000|Overall Study|Death|30|||
156635116|NCT00400985|565407831|FG000|Overall Study|Lost to Follow-up|9|||
156635117|NCT05048875|565407833|FG000|Overall Study|Withdrawal by Subject|1|||
156635118|NCT05048875|565407834|FG001|Overall Study|Withdrawal by Subject|0|||
156635119|NCT05048875|565407835|FG002|Overall Study|Withdrawal by Subject|0|||
156635120|NCT05048875|565407836|FG003|Overall Study|Withdrawal by Subject|0|||
156635121|NCT05048875|565407837|FG004|Overall Study|Withdrawal by Subject|0|||
156635122|NCT05048875|565407838|FG005|Overall Study|Withdrawal by Subject|0|||
156635123|NCT05048875|565407839|FG006|Overall Study|Withdrawal by Subject|0|||
156635124|NCT05048875|565407840|FG007|Overall Study|Withdrawal by Subject|0|||
156635125|NCT05048875|565407833|FG000|Overall Study|Adverse Event|0|||
156635126|NCT05048875|565407834|FG001|Overall Study|Adverse Event|0|||
156635127|NCT05048875|565407835|FG002|Overall Study|Adverse Event|0|||
156635128|NCT05048875|565407836|FG003|Overall Study|Adverse Event|1|||
156635129|NCT05048875|565407837|FG004|Overall Study|Adverse Event|0|||
156635130|NCT05048875|565407838|FG005|Overall Study|Adverse Event|0|||
156635131|NCT05048875|565407839|FG006|Overall Study|Adverse Event|0|||
156635132|NCT05048875|565407840|FG007|Overall Study|Adverse Event|0|||
156635133|NCT04410978|565407847|FG000|Overall Study|Poor compliance to protocol|2|||
156635134|NCT04410978|565407848|FG001|Overall Study|Poor compliance to protocol|4|||
156635135|NCT04410978|565407847|FG000|Overall Study|Withdrawal by Subject|64|||
156635136|NCT04410978|565407848|FG001|Overall Study|Withdrawal by Subject|66|||
156635137|NCT04410978|565407847|FG000|Overall Study|Other|6|||
156635138|NCT04410978|565407848|FG001|Overall Study|Other|7|||
156635139|NCT04410978|565407847|FG000|Overall Study|Missing study status|1|||
156635140|NCT04410978|565407848|FG001|Overall Study|Missing study status|0|||
156635141|NCT02684162|565407849|FG000|Overall Study|Physician Decision|0|||
156635142|NCT02684162|565407850|FG001|Overall Study|Physician Decision|1|||
156635143|NCT02684162|565407851|FG002|Overall Study|Physician Decision|0|||
156635144|NCT04089566|565407854|FG000|Overall Study|Death|0|||
156635145|NCT04089566|565407855|FG001|Overall Study|Death|6|||
156635146|NCT04089566|565407856|FG002|Overall Study|Death|10|||
156635147|NCT04089566|565407857|FG003|Overall Study|Death|0|||
156635148|NCT04089566|565407858|FG004|Overall Study|Death|0|||
156635149|NCT04089566|565407859|FG005|Overall Study|Death|0|||
156635150|NCT04089566|565407854|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
156635151|NCT04089566|565407855|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
156635152|NCT04089566|565407856|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
156635153|NCT04089566|565407857|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
156635154|NCT04089566|565407858|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
156635155|NCT04089566|565407859|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
156635156|NCT04089566|565407854|FG000|Overall Study|Reason not Specified|0|||
156635157|NCT04089566|565407855|FG001|Overall Study|Reason not Specified|4|||
156635158|NCT04089566|565407856|FG002|Overall Study|Reason not Specified|4|||
156635159|NCT04089566|565407857|FG003|Overall Study|Reason not Specified|1|||
156635160|NCT04089566|565407858|FG004|Overall Study|Reason not Specified|0|||
156635161|NCT04089566|565407859|FG005|Overall Study|Reason not Specified|0|||
156635162|NCT01083121|565407860|FG000|Overall Study|Use of Humira outside the approved label|81|||
156635163|NCT03743571|565407863|FG000|Overall Study|Withdrawal by Subject|1|||
156635164|NCT03743571|565407864|FG001|Overall Study|Withdrawal by Subject|1|||
156635165|NCT03743571|565407863|FG000|Overall Study|Lost to Follow-up|1|||
156635166|NCT03743571|565407864|FG001|Overall Study|Lost to Follow-up|2|||
156635167|NCT00885677|565407865|FG000|Overall Study|Death|40|||
156635168|NCT00885677|565407866|FG001|Overall Study|Death|34|||
156635169|NCT00885677|565407865|FG000|Overall Study|Lost to Follow-up|15|||
156635170|NCT00885677|565407866|FG001|Overall Study|Lost to Follow-up|13|||
156635171|NCT00885677|565407865|FG000|Overall Study|Protocol Violation|54|||
156635172|NCT00885677|565407866|FG001|Overall Study|Protocol Violation|54|||
156635173|NCT00885677|565407865|FG000|Overall Study|premature study closure|41|||
156635174|NCT00885677|565407866|FG001|Overall Study|premature study closure|44|||
156635175|NCT00885677|565407865|FG000|Overall Study|device/lead revision or replacement|7|||
156635176|NCT00885677|565407866|FG001|Overall Study|device/lead revision or replacement|6|||
156635177|NCT00885677|565407865|FG000|Overall Study|Heart transplantation|1|||
156635178|NCT00885677|565407866|FG001|Overall Study|Heart transplantation|0|||
156635179|NCT00885677|565407865|FG000|Overall Study|Inclusion/exclusion not met|25|||
156635180|NCT00885677|565407866|FG001|Overall Study|Inclusion/exclusion not met|27|||
156635181|NCT01875731|565407867|FG000|Overall Study|Fail to obtain lab sample|1|||
156635182|NCT01875731|565407868|FG001|Overall Study|Fail to obtain lab sample|0|||
156635183|NCT02576951|565407869|FG000|Overall Study|Lost to Follow-up|0|||
156635184|NCT02576951|565407870|FG001|Overall Study|Lost to Follow-up|0|||
156635185|NCT02576951|565407871|FG002|Overall Study|Lost to Follow-up|2|||
156635186|NCT02576951|565407872|FG003|Overall Study|Lost to Follow-up|2|||
156635187|NCT02576951|565407869|FG000|Overall Study|Withdrawal by Subject|1|||
156635188|NCT02576951|565407870|FG001|Overall Study|Withdrawal by Subject|0|||
156635189|NCT02576951|565407871|FG002|Overall Study|Withdrawal by Subject|0|||
156635190|NCT02576951|565407872|FG003|Overall Study|Withdrawal by Subject|2|||
156635191|NCT02576951|565407869|FG000|Overall Study|Protocol Violation|0|||
156635192|NCT02576951|565407870|FG001|Overall Study|Protocol Violation|0|||
156635193|NCT02576951|565407871|FG002|Overall Study|Protocol Violation|0|||
156635194|NCT02576951|565407872|FG003|Overall Study|Protocol Violation|1|||
156635195|NCT03417102|565407873|FG000|Overall Study|Adverse Event|0|||
156635196|NCT03417102|565407874|FG001|Overall Study|Adverse Event|1|||
156635197|NCT03417102|565407873|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
156635198|NCT03417102|565407874|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
156635199|NCT03417102|565407873|FG000|Overall Study|Other|0|||
156635200|NCT03417102|565407874|FG001|Overall Study|Other|1|||
156635201|NCT02062385|565407878|FG000|Overall Study|Adverse Event|19|||
156635202|NCT02062385|565407879|FG001|Overall Study|Adverse Event|13|||
156635203|NCT02062385|565407880|FG002|Overall Study|Adverse Event|1|||
156635204|NCT02062385|565407881|FG003|Overall Study|Adverse Event|0|||
156635205|NCT02062385|565407878|FG000|Overall Study|Protocol Violation|1|||
156635206|NCT02062385|565407879|FG001|Overall Study|Protocol Violation|0|||
156635207|NCT02062385|565407880|FG002|Overall Study|Protocol Violation|0|||
156635208|NCT02062385|565407881|FG003|Overall Study|Protocol Violation|0|||
156635209|NCT02062385|565407878|FG000|Overall Study|Incomplete EPI by database lock|2|||
156635210|NCT02062385|565407879|FG001|Overall Study|Incomplete EPI by database lock|0|||
156635211|NCT02062385|565407880|FG002|Overall Study|Incomplete EPI by database lock|0|||
156635212|NCT02062385|565407881|FG003|Overall Study|Incomplete EPI by database lock|0|||
156635213|NCT02062385|565407878|FG000|Overall Study|Moved|10|||
156635214|NCT02062385|565407879|FG001|Overall Study|Moved|11|||
156635215|NCT02062385|565407880|FG002|Overall Study|Moved|1|||
156635216|NCT02062385|565407881|FG003|Overall Study|Moved|0|||
156635217|NCT02062385|565407878|FG000|Overall Study|Withdrawn by parent/guardian|46|||
156635218|NCT02062385|565407879|FG001|Overall Study|Withdrawn by parent/guardian|41|||
156635219|NCT02062385|565407880|FG002|Overall Study|Withdrawn by parent/guardian|9|||
156635220|NCT02062385|565407881|FG003|Overall Study|Withdrawn by parent/guardian|8|||
156635221|NCT02062385|565407878|FG000|Overall Study|Death|0|||
156635222|NCT02062385|565407879|FG001|Overall Study|Death|0|||
156635223|NCT02062385|565407880|FG002|Overall Study|Death|0|||
156635224|NCT02062385|565407881|FG003|Overall Study|Death|1|||
156635225|NCT02062385|565407878|FG000|Overall Study|Lost to Follow-up|0|||
156635226|NCT02062385|565407879|FG001|Overall Study|Lost to Follow-up|0|||
156635227|NCT02062385|565407880|FG002|Overall Study|Lost to Follow-up|1|||
156635228|NCT02062385|565407881|FG003|Overall Study|Lost to Follow-up|0|||
156635229|NCT03188991|565407882|FG000|Overall Study|Withdrawal by Subject|0|||
156635230|NCT03188991|565407883|FG001|Overall Study|Withdrawal by Subject|0|||
156635231|NCT03188991|565407884|FG002|Overall Study|Withdrawal by Subject|0|||
156635232|NCT03188991|565407885|FG003|Overall Study|Withdrawal by Subject|1|||
156635233|NCT00223990|565407886|FG000|Overall Study|Moved from area|2|||
156635234|NCT00223990|565407887|FG001|Overall Study|Moved from area|1|||
156635235|NCT00223990|565407886|FG000|Overall Study|Withdrawal by Subject|4|||
156635236|NCT00223990|565407887|FG001|Overall Study|Withdrawal by Subject|8|||
156635237|NCT00223990|565407886|FG000|Overall Study|Lost to Follow-up|1|||
156635238|NCT00223990|565407887|FG001|Overall Study|Lost to Follow-up|0|||
156635239|NCT02087865|565409782|FG000|Overall Study|Withdrawal by Subject|6|||
156635240|NCT02087865|565409783|FG001|Overall Study|Withdrawal by Subject|0|||
156635241|NCT02087865|565409784|FG002|Overall Study|Withdrawal by Subject|1|||
156635242|NCT02087865|565409782|FG000|Overall Study|Lost to Follow-up|0|||
156635243|NCT02087865|565409783|FG001|Overall Study|Lost to Follow-up|0|||
156635244|NCT02087865|565409784|FG002|Overall Study|Lost to Follow-up|1|||
156635245|NCT02087865|565409782|FG000|Overall Study|Drug Non-compliance|0|||
156635246|NCT02087865|565409783|FG001|Overall Study|Drug Non-compliance|2|||
156635247|NCT02087865|565409784|FG002|Overall Study|Drug Non-compliance|0|||
156635248|NCT02087865|565409782|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
156635249|NCT02087865|565409783|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
156635250|NCT02087865|565409784|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
156635251|NCT01319994|565409785|FG000|Overall Study|Protocol Violation|7|||
156635252|NCT01319994|565409786|FG001|Overall Study|Protocol Violation|6|||
156635253|NCT01340794|565409787|FG000|Overall Study|Withdrawal by Subject|0|||
156635254|NCT01340794|565409788|FG001|Overall Study|Withdrawal by Subject|1|||
156635255|NCT01392469|565409794|FG000|Overall Study|Adverse Event|2|||
156635256|NCT01392469|565409794|FG000|Overall Study|Withdrawal by Subject|1|||
156635257|NCT01392469|565409794|FG000|Overall Study|Protocol Violation|1|||
156635258|NCT02674568|565409798|FG000|Overall Study|Withdrawal by Subject|5|||
156635259|NCT02674568|565409798|FG000|Overall Study|Death|303|||
156635260|NCT02674568|565409798|FG000|Overall Study|Physician Decision|2|||
156635261|NCT02674568|565409798|FG000|Overall Study|Lost to Follow-up|9|||
156635262|NCT02674568|565409798|FG000|Overall Study|Other, Not Specified|20|||
156635263|NCT01808508|565409801|FG000|Overall Study|Lost to Follow-up|1|||
156635264|NCT01808508|565409802|FG001|Overall Study|Lost to Follow-up|0|||
156635265|NCT01808508|565409803|FG002|Overall Study|Lost to Follow-up|0|||
156635266|NCT01118949|565409804|FG000|Overall Study|Adverse Event|5|||
156635267|NCT01118949|565409804|FG000|Overall Study|Withdrawal by Subject|4|||
156635268|NCT01017731|565409808|FG000|Overall Study|Lost to Follow-up|2|||
156635269|NCT01017731|565409808|FG000|Overall Study|Withdrawal by Subject|3|||
156635270|NCT01017731|565409808|FG000|Overall Study|Physician Decision|2|||
156635271|NCT01017731|565409808|FG000|Overall Study|Adverse Event|1|||
156635272|NCT00648739|565409809|FG000|Overall Study|Adverse Event|1|||
156635273|NCT00648739|565409810|FG001|Overall Study|Adverse Event|0|||
156635274|NCT00648739|565409811|FG002|Overall Study|Adverse Event|1|||
156635275|NCT00648739|565409812|FG003|Overall Study|Adverse Event|2|||
156635276|NCT00648739|565409813|FG004|Overall Study|Adverse Event|1|||
156635277|NCT00648739|565409814|FG005|Overall Study|Adverse Event|0|||
156635278|NCT00648739|565409815|FG006|Overall Study|Adverse Event|0|||
156635279|NCT00648739|565409809|FG000|Overall Study|Withdrawal by Subject|1|||
156635280|NCT00648739|565409810|FG001|Overall Study|Withdrawal by Subject|0|||
156635281|NCT00648739|565409811|FG002|Overall Study|Withdrawal by Subject|1|||
156635282|NCT00648739|565409812|FG003|Overall Study|Withdrawal by Subject|0|||
156635283|NCT00648739|565409813|FG004|Overall Study|Withdrawal by Subject|0|||
156635284|NCT00648739|565409814|FG005|Overall Study|Withdrawal by Subject|2|||
156635285|NCT00648739|565409815|FG006|Overall Study|Withdrawal by Subject|0|||
156635286|NCT00648739|565409809|FG000|Overall Study|Lack of Efficacy|0|||
156635287|NCT00648739|565409810|FG001|Overall Study|Lack of Efficacy|0|||
156635288|NCT00648739|565409811|FG002|Overall Study|Lack of Efficacy|0|||
156635289|NCT00648739|565409812|FG003|Overall Study|Lack of Efficacy|0|||
156635290|NCT00648739|565409813|FG004|Overall Study|Lack of Efficacy|1|||
156635291|NCT00648739|565409814|FG005|Overall Study|Lack of Efficacy|2|||
156635292|NCT00648739|565409815|FG006|Overall Study|Lack of Efficacy|0|||
156635293|NCT00648739|565409809|FG000|Overall Study|Investigator Considered it Advisable|0|||
156635294|NCT00648739|565409810|FG001|Overall Study|Investigator Considered it Advisable|0|||
156635295|NCT00648739|565409811|FG002|Overall Study|Investigator Considered it Advisable|0|||
156635296|NCT00648739|565409812|FG003|Overall Study|Investigator Considered it Advisable|0|||
156635297|NCT00648739|565409813|FG004|Overall Study|Investigator Considered it Advisable|0|||
156635298|NCT00648739|565409814|FG005|Overall Study|Investigator Considered it Advisable|1|||
156635299|NCT00648739|565409815|FG006|Overall Study|Investigator Considered it Advisable|1|||
156635300|NCT00648739|565409809|FG000|Overall Study|Death|0|||
156635301|NCT00648739|565409810|FG001|Overall Study|Death|1|||
156635302|NCT00648739|565409811|FG002|Overall Study|Death|0|||
156635303|NCT00648739|565409812|FG003|Overall Study|Death|0|||
156635304|NCT00648739|565409813|FG004|Overall Study|Death|0|||
156635305|NCT00648739|565409814|FG005|Overall Study|Death|0|||
156635306|NCT00648739|565409815|FG006|Overall Study|Death|0|||
156635307|NCT00648739|565409809|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
156635308|NCT00648739|565409810|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
156635309|NCT00648739|565409811|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
156635310|NCT00648739|565409812|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
156635311|NCT00648739|565409813|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
156635312|NCT00648739|565409814|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
156635313|NCT00648739|565409815|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
156635314|NCT00648739|565409809|FG000|Overall Study|Follow-up Visits Not Completed|0|||
156635315|NCT00648739|565409810|FG001|Overall Study|Follow-up Visits Not Completed|1|||
156635316|NCT00648739|565409811|FG002|Overall Study|Follow-up Visits Not Completed|0|||
156635317|NCT00648739|565409812|FG003|Overall Study|Follow-up Visits Not Completed|0|||
156635318|NCT00648739|565409813|FG004|Overall Study|Follow-up Visits Not Completed|0|||
156635319|NCT00648739|565409814|FG005|Overall Study|Follow-up Visits Not Completed|0|||
156635320|NCT00648739|565409815|FG006|Overall Study|Follow-up Visits Not Completed|0|||
156635321|NCT00685763|565409816|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
156635322|NCT00685763|565409816|FG000|Overall Study|Protocol Violation|1|||
156635323|NCT00698009|565409824|FG000|Overall Study|Withdrawal by Subject|1|||
156635324|NCT03862807|565409825|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
156635325|NCT04362761|565409826|FG000|Part A (48 Weeks)|Adverse Event|2|||
156635326|NCT04362761|565409826|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
156635327|NCT04362761|565409826|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
156635328|NCT04362761|565409826|FG000|Part A (48 Weeks)|Other|5|||
156635575|NCT00602667|565409960|FG000|Overall Study|Progressive disease|13|||
156635329|NCT04362761|565409826|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
156635330|NCT04362761|565409826|FG000|Part B (86 Weeks)|Other|4|||
156635331|NCT00929201|565409834|FG000|Period 1|Withdrawal by Subject|0|||
156635332|NCT00929201|565409835|FG001|Period 1|Withdrawal by Subject|1|||
156635333|NCT03286426|565409840|FG000|Overall Study|Physician Decision|3|||
156635334|NCT04930536|565409841|FG000|Overall Study|Adverse Event|1|||
156635335|NCT04930536|565409842|FG001|Overall Study|Adverse Event|0|||
156635336|NCT04930536|565409841|FG000|Overall Study|Disease Progression|2|||
156635337|NCT04930536|565409842|FG001|Overall Study|Disease Progression|0|||
156635338|NCT04930536|565409841|FG000|Overall Study|Patient Decision|4|||
156635339|NCT04930536|565409842|FG001|Overall Study|Patient Decision|2|||
156635340|NCT04930536|565409841|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
156635341|NCT04930536|565409842|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
156635342|NCT00267020|565409843|FG000|Overall Study|Adverse Event|22|||
156635343|NCT00267020|565409844|FG001|Overall Study|Adverse Event|5|||
156635344|NCT00267020|565409843|FG000|Overall Study|Death|2|||
156635345|NCT00267020|565409844|FG001|Overall Study|Death|1|||
156635346|NCT00267020|565409843|FG000|Overall Study|Withdrawal by Subject|17|||
156635347|NCT00267020|565409844|FG001|Overall Study|Withdrawal by Subject|7|||
156635348|NCT00267020|565409843|FG000|Overall Study|Physician Decision|3|||
156635349|NCT00267020|565409844|FG001|Overall Study|Physician Decision|2|||
156635350|NCT00267020|565409843|FG000|Overall Study|Disease Progression|39|||
156635351|NCT00267020|565409844|FG001|Overall Study|Disease Progression|25|||
156635352|NCT00267020|565409843|FG000|Overall Study|Unrelated Complication|1|||
156635353|NCT00267020|565409844|FG001|Overall Study|Unrelated Complication|1|||
156635354|NCT00267020|565409843|FG000|Overall Study|Sponsor Request|1|||
156635355|NCT00267020|565409844|FG001|Overall Study|Sponsor Request|0|||
156635356|NCT00267020|565409843|FG000|Overall Study|Other|1|||
156635357|NCT00267020|565409844|FG001|Overall Study|Other|2|||
156635358|NCT02209454|565409845|FG000|Second Period|Adverse Event|1|||
156635359|NCT02209454|565409846|FG001|Second Period|Adverse Event|0|||
156635360|NCT03079869|565409851|FG000|Overall Study|Adverse Event|6|||
156635361|NCT03079869|565409852|FG001|Overall Study|Adverse Event|8|||
156635362|NCT03079869|565409851|FG000|Overall Study|Withdrawal by Subject|4|||
156635363|NCT03079869|565409852|FG001|Overall Study|Withdrawal by Subject|1|||
156635364|NCT03079869|565409851|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
156635365|NCT03079869|565409852|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
156635366|NCT01325701|565409853|FG000|Overall Study|Adverse Event|12|||
156635367|NCT01325701|565409854|FG001|Overall Study|Adverse Event|0|||
156635368|NCT01325701|565409853|FG000|Overall Study|Protocol Violation|1|||
156635369|NCT01325701|565409854|FG001|Overall Study|Protocol Violation|0|||
156635370|NCT01325701|565409853|FG000|Overall Study|Physician Decision|2|||
156635371|NCT01325701|565409854|FG001|Overall Study|Physician Decision|2|||
156635372|NCT01325701|565409853|FG000|Overall Study|Withdrawal by Subject|2|||
156635373|NCT01325701|565409854|FG001|Overall Study|Withdrawal by Subject|1|||
156635374|NCT01325701|565409853|FG000|Overall Study|Rollerover Extension Study|4|||
156635375|NCT01325701|565409854|FG001|Overall Study|Rollerover Extension Study|0|||
156635376|NCT00297882|565409872|FG000|Day 14|Lack of Efficacy|12|||
156635377|NCT00297882|565409873|FG001|Day 14|Lack of Efficacy|49|||
156635378|NCT00297882|565409872|FG000|Day 28|Lost to Follow-up|13|||
156635379|NCT00297882|565409873|FG001|Day 28|Lost to Follow-up|23|||
156635380|NCT00297882|565409872|FG000|Day 28|Lack of Efficacy|3|||
156635381|NCT00297882|565409873|FG001|Day 28|Lack of Efficacy|0|||
156635382|NCT04242264|565409874|FG000|Overall Study|Lost to Follow-up|2|||
156635383|NCT04242264|565409875|FG001|Overall Study|Lost to Follow-up|2|||
156635384|NCT04242264|565409876|FG002|Overall Study|Lost to Follow-up|1|||
156635385|NCT04242264|565409877|FG003|Overall Study|Lost to Follow-up|1|||
156635386|NCT04242264|565409874|FG000|Overall Study|Withdrawal by Subject|1|||
156635387|NCT04242264|565409875|FG001|Overall Study|Withdrawal by Subject|0|||
156635388|NCT04242264|565409876|FG002|Overall Study|Withdrawal by Subject|0|||
156635389|NCT04242264|565409877|FG003|Overall Study|Withdrawal by Subject|0|||
156635390|NCT04221373|565409880|FG000|Overall Study|Physician Decision|4|||
156635391|NCT04221373|565409881|FG001|Overall Study|Physician Decision|0|||
156635392|NCT00627094|565409885|FG000|Overall Study|Adverse Event|8|||
156635393|NCT00627094|565409886|FG001|Overall Study|Adverse Event|7|||
156635394|NCT00627094|565409885|FG000|Overall Study|Lost to Follow-up|1|||
156635395|NCT00627094|565409886|FG001|Overall Study|Lost to Follow-up|0|||
156635396|NCT00627094|565409885|FG000|Overall Study|Withdrawal by Subject|1|||
156635397|NCT00627094|565409886|FG001|Overall Study|Withdrawal by Subject|1|||
156635398|NCT00627094|565409885|FG000|Overall Study|ulcer healed|1|||
156635399|NCT00627094|565409886|FG001|Overall Study|ulcer healed|7|||
156635400|NCT00627094|565409885|FG000|Overall Study|Other reason|1|||
156635401|NCT00627094|565409886|FG001|Overall Study|Other reason|0|||
156635402|NCT01165424|565409893|FG000|Overall Study|Clinical adverse experiences|1|||
156635403|NCT01165424|565409893|FG000|Overall Study|Laboratory adverse experiences|1|||
156635404|NCT01165424|565409893|FG000|Overall Study|Did not meet entry criteria|1|||
156635405|NCT01165424|565409893|FG000|Overall Study|Participant moved (relocated)|1|||
156635406|NCT04139642|565409894|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
156635407|NCT04139642|565409895|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
156635408|NCT03733301|565409906|FG000|Overall Study|Screen Fail|1|||
156635409|NCT03733301|565409907|FG001|Overall Study|Screen Fail|0|||
156635410|NCT03733301|565409908|FG002|Overall Study|Screen Fail|0|||
156635411|NCT03733301|565409906|FG000|Overall Study|Non-compliance|1|||
156635412|NCT03733301|565409907|FG001|Overall Study|Non-compliance|0|||
156635413|NCT03733301|565409908|FG002|Overall Study|Non-compliance|0|||
156635414|NCT03733301|565409906|FG000|Overall Study|Lack of Efficacy|2|||
156635415|NCT03733301|565409907|FG001|Overall Study|Lack of Efficacy|3|||
156635416|NCT03733301|565409908|FG002|Overall Study|Lack of Efficacy|0|||
156635417|NCT03733301|565409906|FG000|Overall Study|Adverse Event|0|||
156635418|NCT03733301|565409907|FG001|Overall Study|Adverse Event|1|||
156635419|NCT03733301|565409908|FG002|Overall Study|Adverse Event|3|||
156635420|NCT03733301|565409906|FG000|Overall Study|Withdrawal by Subject|3|||
156635421|NCT03733301|565409907|FG001|Overall Study|Withdrawal by Subject|5|||
156635422|NCT03733301|565409908|FG002|Overall Study|Withdrawal by Subject|1|||
156635423|NCT01965431|565409911|FG000|Overall Study|Adverse Event|0|||
156635424|NCT01965431|565409912|FG001|Overall Study|Adverse Event|1|||
156635425|NCT01965431|565409913|FG002|Overall Study|Adverse Event|0|||
156635426|NCT01965431|565409914|FG003|Overall Study|Adverse Event|0|||
156635427|NCT01965431|565409915|FG004|Overall Study|Adverse Event|0|||
156635428|NCT01965431|565409916|FG005|Overall Study|Adverse Event|0|||
156635429|NCT01965431|565409911|FG000|Overall Study|Other than stated above|6|||
156635430|NCT01965431|565409912|FG001|Overall Study|Other than stated above|5|||
156635431|NCT01965431|565409913|FG002|Overall Study|Other than stated above|6|||
156635432|NCT01965431|565409914|FG003|Overall Study|Other than stated above|6|||
156635433|NCT01965431|565409915|FG004|Overall Study|Other than stated above|6|||
156635434|NCT01965431|565409916|FG005|Overall Study|Other than stated above|6|||
156635435|NCT04635631|565409917|FG000|Overall Study|Adverse Event|1|||
156635436|NCT04635631|565409917|FG000|Overall Study|Progressive disease|13|||
156635437|NCT04635631|565409917|FG000|Overall Study|Withdrawal by Subject|1|||
156635438|NCT00943826|565409918|FG000|Concurrent Phase|Adverse Event|50|||
156635439|NCT00943826|565409919|FG001|Concurrent Phase|Adverse Event|27|||
156635440|NCT00943826|565409918|FG000|Concurrent Phase|Withdrew consent|3|||
156635441|NCT00943826|565409919|FG001|Concurrent Phase|Withdrew consent|7|||
156635442|NCT00943826|565409918|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
156635443|NCT00943826|565409919|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
156635444|NCT00943826|565409918|FG000|Concurrent Phase|Administrative reasons|2|||
156635445|NCT00943826|565409919|FG001|Concurrent Phase|Administrative reasons|1|||
156635446|NCT00943826|565409918|FG000|Concurrent Phase|Protocol Violation|1|||
156635447|NCT00943826|565409919|FG001|Concurrent Phase|Protocol Violation|0|||
156635448|NCT00943826|565409918|FG000|Maintenance Phase|Adverse Event|31|||
156635449|NCT00943826|565409919|FG001|Maintenance Phase|Adverse Event|30|||
156635450|NCT00943826|565409918|FG000|Maintenance Phase|Withdrew consent|2|||
156635451|NCT00943826|565409919|FG001|Maintenance Phase|Withdrew consent|4|||
156635452|NCT00943826|565409918|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
156635453|NCT00943826|565409919|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
156635454|NCT00943826|565409918|FG000|Maintenance Phase|Administrative reasons|4|||
156635455|NCT00943826|565409919|FG001|Maintenance Phase|Administrative reasons|1|||
156635456|NCT00943826|565409918|FG000|Maintenance Phase|Failure to return|0|||
156635457|NCT00943826|565409919|FG001|Maintenance Phase|Failure to return|1|||
156635458|NCT00943826|565409918|FG000|Monotherapy Phase|Adverse Event|42|||
156635459|NCT00943826|565409919|FG001|Monotherapy Phase|Adverse Event|5|||
156635460|NCT00943826|565409918|FG000|Monotherapy Phase|Administrative reasons|11|||
156635461|NCT00943826|565409919|FG001|Monotherapy Phase|Administrative reasons|5|||
156635462|NCT00943826|565409918|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
156635463|NCT00943826|565409919|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
156635464|NCT00943826|565409918|FG000|Monotherapy Phase|Withdrew Consent|2|||
156635465|NCT00943826|565409919|FG001|Monotherapy Phase|Withdrew Consent|3|||
156635466|NCT00943826|565409918|FG000|Monotherapy Phase|Failure to return|2|||
156635467|NCT00943826|565409919|FG001|Monotherapy Phase|Failure to return|1|||
156635468|NCT00943826|565409918|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
156635469|NCT00943826|565409919|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
156635470|NCT00943826|565409918|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
156635471|NCT00943826|565409919|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
156635472|NCT00943826|565409918|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
156635473|NCT00943826|565409919|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
156635474|NCT00943826|565409918|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
156635475|NCT00943826|565409919|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
156635476|NCT01067339|565409922|FG000|Overall Study|Withdrawal by Subject|6|||
156635477|NCT01067339|565409923|FG001|Overall Study|Withdrawal by Subject|5|||
156635478|NCT01179191|565409924|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
156635479|NCT01179191|565409924|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
156635480|NCT01179191|565409924|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
156635481|NCT01179191|565409924|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
156635482|NCT01179191|565409924|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
156635483|NCT01179191|565409924|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
156635484|NCT01179191|565409924|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
156635485|NCT01179191|565409924|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
156635486|NCT01179191|565409924|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
156635487|NCT01179191|565409924|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
156635488|NCT01179191|565409924|FG000|Maintenance Phase (8 Weeks)|Other|66|||
156635489|NCT01833897|565409936|FG000|Overall Study|Lack of Efficacy|1|||
156635490|NCT00669110|565409937|FG000|Overall Study|Adverse Event|4|||
156635491|NCT00669110|565409938|FG001|Overall Study|Adverse Event|3|||
156635492|NCT00669110|565409937|FG000|Overall Study|Caregiver request|3|||
156635493|NCT00669110|565409938|FG001|Overall Study|Caregiver request|2|||
156635494|NCT00669110|565409937|FG000|Overall Study|Physician Decision|0|||
156635495|NCT00669110|565409938|FG001|Overall Study|Physician Decision|1|||
156635496|NCT00669110|565409937|FG000|Overall Study|Lost to Follow-up|1|||
156635497|NCT00669110|565409938|FG001|Overall Study|Lost to Follow-up|0|||
156635498|NCT00669110|565409937|FG000|Overall Study|Protocol Violation|0|||
156635499|NCT00669110|565409938|FG001|Overall Study|Protocol Violation|5|||
156635500|NCT00669110|565409937|FG000|Overall Study|Withdrawal by Subject|0|||
156635501|NCT00669110|565409938|FG001|Overall Study|Withdrawal by Subject|2|||
156635502|NCT03843775|565409941|FG000|Overall Study|Adverse Event|1|||
156635503|NCT03843775|565409942|FG001|Overall Study|Adverse Event|1|||
156635504|NCT03843775|565409941|FG000|Overall Study|Lack of Efficacy|2|||
156635505|NCT03843775|565409942|FG001|Overall Study|Lack of Efficacy|6|||
156635506|NCT03843775|565409941|FG000|Overall Study|Withdrawal by Subject|0|||
156635507|NCT03843775|565409942|FG001|Overall Study|Withdrawal by Subject|1|||
156635508|NCT00650806|565409944|FG000|Overall Study|Adverse Event|0|||
156635509|NCT00650806|565409945|FG001|Overall Study|Adverse Event|5|||
156635510|NCT00650806|565409946|FG002|Overall Study|Adverse Event|3|||
156635511|NCT00650806|565409947|FG003|Overall Study|Adverse Event|4|||
156635512|NCT00650806|565409944|FG000|Overall Study|Lost to Follow-up|7|||
156635513|NCT00650806|565409945|FG001|Overall Study|Lost to Follow-up|6|||
156635514|NCT00650806|565409946|FG002|Overall Study|Lost to Follow-up|11|||
156635515|NCT00650806|565409947|FG003|Overall Study|Lost to Follow-up|10|||
156635516|NCT00650806|565409944|FG000|Overall Study|Protocol Violation|0|||
156635517|NCT00650806|565409945|FG001|Overall Study|Protocol Violation|0|||
156635518|NCT00650806|565409946|FG002|Overall Study|Protocol Violation|0|||
156635519|NCT00650806|565409947|FG003|Overall Study|Protocol Violation|1|||
156635520|NCT00650806|565409944|FG000|Overall Study|Pregnancy|0|||
156635521|NCT00650806|565409945|FG001|Overall Study|Pregnancy|0|||
156635522|NCT00650806|565409946|FG002|Overall Study|Pregnancy|0|||
156635523|NCT00650806|565409947|FG003|Overall Study|Pregnancy|1|||
156635524|NCT00650806|565409944|FG000|Overall Study|Withdrawal by Subject|7|||
156635525|NCT00650806|565409945|FG001|Overall Study|Withdrawal by Subject|5|||
156635526|NCT00650806|565409946|FG002|Overall Study|Withdrawal by Subject|8|||
156635527|NCT00650806|565409947|FG003|Overall Study|Withdrawal by Subject|6|||
156635528|NCT00650806|565409944|FG000|Overall Study|Noncompliance with study drug regimen|1|||
156635529|NCT00650806|565409945|FG001|Overall Study|Noncompliance with study drug regimen|1|||
156635530|NCT00650806|565409946|FG002|Overall Study|Noncompliance with study drug regimen|0|||
156635531|NCT00650806|565409947|FG003|Overall Study|Noncompliance with study drug regimen|0|||
156635532|NCT00650806|565409944|FG000|Overall Study|Study terminated by sponsor|2|||
156635533|NCT00650806|565409945|FG001|Overall Study|Study terminated by sponsor|3|||
156635534|NCT00650806|565409946|FG002|Overall Study|Study terminated by sponsor|5|||
156635535|NCT00650806|565409947|FG003|Overall Study|Study terminated by sponsor|4|||
156635536|NCT00650806|565409944|FG000|Overall Study|Other|1|||
156635537|NCT00650806|565409945|FG001|Overall Study|Other|1|||
156635538|NCT00650806|565409946|FG002|Overall Study|Other|2|||
156635539|NCT00650806|565409947|FG003|Overall Study|Other|0|||
156635540|NCT00605839|565409950|FG000|Overall Study|Protocol Violation|1|||
156635541|NCT00605839|565409951|FG001|Overall Study|Protocol Violation|0|||
156635542|NCT00605839|565409952|FG002|Overall Study|Protocol Violation|0|||
156635543|NCT02255422|565409953|FG000|Overall Study|Withdrawal by Subject|0|||
156635544|NCT02255422|565409954|FG001|Overall Study|Withdrawal by Subject|0|||
156635545|NCT02255422|565409955|FG002|Overall Study|Withdrawal by Subject|0|||
156635546|NCT02255422|565409956|FG003|Overall Study|Withdrawal by Subject|0|||
156635547|NCT02255422|565409957|FG004|Overall Study|Withdrawal by Subject|0|||
156635548|NCT02255422|565409958|FG005|Overall Study|Withdrawal by Subject|0|||
156635549|NCT02255422|565409959|FG006|Overall Study|Withdrawal by Subject|2|||
156635550|NCT02255422|565409953|FG000|Overall Study|Lost to Follow-up|0|||
156635551|NCT02255422|565409954|FG001|Overall Study|Lost to Follow-up|0|||
156635552|NCT02255422|565409955|FG002|Overall Study|Lost to Follow-up|1|||
156635553|NCT02255422|565409956|FG003|Overall Study|Lost to Follow-up|0|||
156635554|NCT02255422|565409957|FG004|Overall Study|Lost to Follow-up|0|||
156635555|NCT02255422|565409958|FG005|Overall Study|Lost to Follow-up|0|||
156635556|NCT02255422|565409959|FG006|Overall Study|Lost to Follow-up|0|||
156635557|NCT00602667|565409960|FG000|Overall Study|Still on Therapy|0|||
156635558|NCT00602667|565409961|FG001|Overall Study|Still on Therapy|2|||
156635578|NCT00602667|565409960|FG000|Overall Study|Progressive disease prior to therapy|0|||
156635579|NCT00602667|565409961|FG001|Overall Study|Progressive disease prior to therapy|0|||
156635580|NCT00602667|565409962|FG002|Overall Study|Progressive disease prior to therapy|1|||
156635581|NCT01489865|565409970|FG000|Overall Study|Progression of Disease|4|||
156635582|NCT01489865|565409971|FG001|Overall Study|Progression of Disease|2|||
156635583|NCT01489865|565409972|FG002|Overall Study|Progression of Disease|2|||
156635584|NCT01489865|565409973|FG003|Overall Study|Progression of Disease|3|||
156635585|NCT01489865|565409974|FG004|Overall Study|Progression of Disease|1|||
156635586|NCT01489865|565409975|FG005|Overall Study|Progression of Disease|6|||
156635587|NCT01489865|565409976|FG006|Overall Study|Progression of Disease|3|||
156635588|NCT01489865|565409977|FG007|Overall Study|Progression of Disease|0|||
156635589|NCT01489865|565409978|FG008|Overall Study|Progression of Disease|23|||
156635590|NCT01489865|565409970|FG000|Overall Study|Adverse Event|2|||
156635591|NCT01489865|565409971|FG001|Overall Study|Adverse Event|0|||
156635592|NCT01489865|565409972|FG002|Overall Study|Adverse Event|0|||
156635593|NCT01489865|565409973|FG003|Overall Study|Adverse Event|0|||
156635594|NCT01489865|565409974|FG004|Overall Study|Adverse Event|1|||
156635595|NCT01489865|565409975|FG005|Overall Study|Adverse Event|0|||
156635596|NCT01489865|565409976|FG006|Overall Study|Adverse Event|2|||
156635597|NCT01489865|565409977|FG007|Overall Study|Adverse Event|0|||
156635598|NCT01489865|565409978|FG008|Overall Study|Adverse Event|5|||
156635599|NCT01489865|565409970|FG000|Overall Study|Death|0|||
156635600|NCT01489865|565409971|FG001|Overall Study|Death|1|||
156635601|NCT01489865|565409972|FG002|Overall Study|Death|0|||
156635602|NCT01489865|565409973|FG003|Overall Study|Death|0|||
156635603|NCT01489865|565409974|FG004|Overall Study|Death|1|||
156635604|NCT01489865|565409975|FG005|Overall Study|Death|0|||
156635605|NCT01489865|565409976|FG006|Overall Study|Death|0|||
156635606|NCT01489865|565409977|FG007|Overall Study|Death|0|||
156635607|NCT01489865|565409978|FG008|Overall Study|Death|2|||
156635608|NCT01489865|565409970|FG000|Overall Study|Withdrawal by Subject|0|||
156635609|NCT01489865|565409971|FG001|Overall Study|Withdrawal by Subject|0|||
156635610|NCT01489865|565409972|FG002|Overall Study|Withdrawal by Subject|0|||
156635611|NCT01489865|565409973|FG003|Overall Study|Withdrawal by Subject|0|||
156635612|NCT01489865|565409974|FG004|Overall Study|Withdrawal by Subject|0|||
156635613|NCT01489865|565409975|FG005|Overall Study|Withdrawal by Subject|1|||
156635614|NCT01489865|565409976|FG006|Overall Study|Withdrawal by Subject|1|||
156635615|NCT01489865|565409977|FG007|Overall Study|Withdrawal by Subject|0|||
156635616|NCT01489865|565409978|FG008|Overall Study|Withdrawal by Subject|2|||
156635617|NCT01489865|565409970|FG000|Overall Study|Shifted|0|||
156635618|NCT01489865|565409971|FG001|Overall Study|Shifted|0|||
156635619|NCT01489865|565409972|FG002|Overall Study|Shifted|1|||
156635620|NCT01489865|565409973|FG003|Overall Study|Shifted|0|||
156635621|NCT01489865|565409974|FG004|Overall Study|Shifted|0|||
156635622|NCT01489865|565409975|FG005|Overall Study|Shifted|0|||
156635623|NCT01489865|565409976|FG006|Overall Study|Shifted|0|||
156635624|NCT01489865|565409977|FG007|Overall Study|Shifted|0|||
156635625|NCT01489865|565409978|FG008|Overall Study|Shifted|0|||
156635626|NCT00972309|565409979|FG000|Overall Study|Switched to alternative treatment|0|||
156635627|NCT00972309|565409980|FG001|Overall Study|Switched to alternative treatment|2|||
156635628|NCT00972309|565409979|FG000|Overall Study|Refused further treatment|0|||
156635629|NCT00972309|565409980|FG001|Overall Study|Refused further treatment|1|||
156635630|NCT00972309|565409979|FG000|Overall Study|Late determination of ineligibility|0|||
156635631|NCT00972309|565409980|FG001|Overall Study|Late determination of ineligibility|1|||
156635632|NCT00972309|565409979|FG000|Overall Study|Second malignancy|1|||
156635633|NCT00972309|565409980|FG001|Overall Study|Second malignancy|1|||
156635634|NCT00972309|565409979|FG000|Overall Study|Visa issues|0|||
156635635|NCT00972309|565409980|FG001|Overall Study|Visa issues|1|||
156635636|NCT00972309|565409979|FG000|Overall Study|Secondary cancer (SCC)|0|||
156635637|NCT00972309|565409980|FG001|Overall Study|Secondary cancer (SCC)|1|||
156635638|NCT00972309|565409979|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
156635639|NCT00972309|565409980|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
156635640|NCT00972309|565409979|FG000|Overall Study|Lost to Follow-up|1|||
156635641|NCT00972309|565409980|FG001|Overall Study|Lost to Follow-up|1|||
156635642|NCT00972309|565409979|FG000|Overall Study|Disease progression on study|10|||
156635643|NCT00972309|565409980|FG001|Overall Study|Disease progression on study|4|||
